PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Cui, X; Bray, S; Reiss, AL				Cui, Xu; Bray, Signe; Reiss, Allan L.			Speeded Near Infrared Spectroscopy (NIRS) Response Detection	PLOS ONE			English	Article							COMPUTER INTERFACE BCI; NEURAL ACTIVITY; BRAIN; SIGNALS; REWARD; FMRI; REINFORCEMENT; PREDICTION	The hemodynamic response measured by Near Infrared Spectroscopy (NIRS) is temporally delayed from the onset of the underlying neural activity. As a consequence, NIRS based brain-computer-interfaces (BCIs) and neurofeedback learning systems, may have a latency of several seconds in responding to a change in participants' behavioral or mental states, severely limiting the practical use of such systems. To explore the possibility of reducing this delay, we used a multivariate pattern classification technique (linear support vector machine, SVM) to decode the true behavioral state from the measured neural signal and systematically evaluated the performance of different feature spaces (signal history, history gradient, oxygenated or deoxygenated hemoglobin signal and spatial pattern). We found that the latency to decode a change in behavioral state can be reduced by 50% (from 4.8 s to 2.4 s), which will enhance the feasibility of NIRS for real-time applications.	[Cui, Xu; Bray, Signe; Reiss, Allan L.] Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; [Cui, Xu; Bray, Signe; Reiss, Allan L.] Stanford Univ, Ctr Interdisciplinary Brain Sci Res, Stanford, CA 94305 USA	Stanford University; Stanford University	Cui, X (corresponding author), Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA.	cuixu@stanford.edu			Shared Instrument grant [S10RR024657]; Stanford Institute for Neuro-Innovation and Translational Neurosciences (SINTN); NARSAD Young Investigator's Award; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR024657] Funding Source: NIH RePORTER	Shared Instrument grant; Stanford Institute for Neuro-Innovation and Translational Neurosciences (SINTN); NARSAD Young Investigator's Award(NARSAD); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work is supported by Shared Instrument grant (S10RR024657, ALR PI), the Stanford Institute for Neuro-Innovation and Translational Neurosciences (SINTN) fellowship (XC and ALR), and NARSAD Young Investigator's Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Birbaumer N, 2000, IEEE T REHABIL ENG, V8, P190, DOI 10.1109/86.847812; Bray S, 2007, J NEUROPHYSIOL, V97, P3036, DOI 10.1152/jn.01211.2006; Bray S, 2007, J NEUROSCI, V27, P7498, DOI 10.1523/JNEUROSCI.2118-07.2007; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chestek CA, 2009, IEEE ENG MED BIO, P3369, DOI 10.1109/IEMBS.2009.5332822; Coyle SM, 2007, J NEURAL ENG, V4, P219, DOI 10.1088/1741-2560/4/3/007; Cui X, 2010, NEUROIMAGE, V49, P3039, DOI 10.1016/j.neuroimage.2009.11.050; deCharms RC, 2005, P NATL ACAD SCI USA, V102, P18626, DOI 10.1073/pnas.0505210102; Devor A, 2003, NEURON, V39, P353, DOI 10.1016/S0896-6273(03)00403-3; GRICE GR, 1948, J EXP PSYCHOL, V38, P1, DOI 10.1037/h0061016; Hinterberger T, 2003, CLIN NEUROPHYSIOL, V114, P416, DOI 10.1016/S1388-2457(02)00411-X; LIAO CH, 2002, NEUROIMAGE; Lieberman DA, 2008, Q J EXP PSYCHOL, V61, P194, DOI 10.1080/17470210701557506; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Luu S, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/1/016003; Malonek D, 1996, SCIENCE, V272, P551, DOI 10.1126/science.272.5261.551; Musallam S, 2004, SCIENCE, V305, P258, DOI 10.1126/science.1097938; NG B, 2008, P 1 WORKSH AN FUNCT, P81; PEPLOW M, 2004, NATURE; Pesaran B, 2006, CURR BIOL, V16, pR77, DOI 10.1016/j.cub.2006.01.043; Saad ZS, 2001, HUM BRAIN MAPP, V13, P74, DOI 10.1002/hbm.1026; Sheth SA, 2004, NEURON, V42, P347, DOI 10.1016/S0896-6273(04)00221-1; Sitaram R, 2007, NEUROIMAGE, V34, P1416, DOI 10.1016/j.neuroimage.2006.11.005; Sorger B, 2009, PROG BRAIN RES, V177, P275, DOI 10.1016/S0079-6123(09)17719-1; Stetson C, 2006, NEURON, V51, P651, DOI 10.1016/j.neuron.2006.08.006; Utsugi K, 2007, P ANN INT IEEE EMBS, P5338, DOI 10.1109/IEMBS.2007.4353547; Weiskopf N, 2004, IEEE T BIO-MED ENG, V51, P966, DOI 10.1109/TBME.2004.827063; Wessberg J, 2000, NATURE, V408, P361, DOI 10.1038/35042582; Yoo SS, 2004, NEUROREPORT, V15, P1591, DOI 10.1097/01.wnr.0000133296.39160.fe; Yousry TA, 1997, BRAIN, V120, P141, DOI 10.1093/brain/120.1.141	30	88	89	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2010	5	11							e15474	10.1371/journal.pone.0015474	http://dx.doi.org/10.1371/journal.pone.0015474			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	678OA	21085607	Green Submitted, Green Published, gold			2022-12-27	WOS:000284087800027
J	Pugacheva, EM; Suzuki, T; Pack, SD; Kosaka-Suzuki, N; Yoon, J; Vostrov, AA; Barsov, E; Strunnikov, AV; Morse, HC; Loukinov, D; Lobanenkov, V				Pugacheva, Elena M.; Suzuki, Teruhiko; Pack, Svetlana D.; Kosaka-Suzuki, Natsuki; Yoon, Jeongheon; Vostrov, Alexander A.; Barsov, Eugene; Strunnikov, Alexander V.; Morse, Herbert C., III; Loukinov, Dmitri; Lobanenkov, Victor			The Structural Complexity of the Human BORIS Gene in Gametogenesis and Cancer	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; ENHANCER-BLOCKING; IMPRINTED SITES; TESTIS ANTIGEN; CTCF-BINDING; H19 GENE; EXPRESSION; PROMOTER; METHYLATION; CELLS	Background: BORIS/CTCFL is a paralogue of CTCF, the major epigenetic regulator of vertebrate genomes. BORIS is normally expressed only in germ cells but is aberrantly activated in numerous cancers. While recent studies demonstrated that BORIS is a transcriptional activator of testis-specific genes, little is generally known about its biological and molecular functions. Methodology/Principal Findings: Here we show that BORIS is expressed as 23 isoforms in germline and cancer cells. The isoforms are comprised of alternative N- and C-termini combined with varying numbers of zinc fingers (ZF) in the DNA binding domain. The patterns of BORIS isoform expression are distinct in germ and cancer cells. Isoform expression is activated by downregulation of CTCF, upregulated by reduction in CpG methylation caused by inactivation of DNMT1 or DNMT3b, and repressed by activation of p53. Studies of ectopically expressed isoforms showed that all are translated and localized to the nucleus. Using the testis-specific cerebroside sulfotransferase (CST) promoter and the IGF2/H19 imprinting control region (ICR), it was shown that binding of BORIS isoforms to DNA targets in vitro is methylation-sensitive and depends on the number and specific composition of ZF. The ability to bind target DNA and the presence of a specific long amino terminus (N258) in different isoforms are necessary and sufficient to activate CST transcription. Comparative sequence analyses revealed an evolutionary burst in mammals with strong conservation of BORIS isoproteins among primates. Conclusions: The extensive repertoire of spliced BORIS variants in humans that confer distinct DNA binding and transcriptional activation properties, and their differential patterns of expression among germ cells and neoplastic cells suggest that the gene is involved in a range of functionally important aspects of both normal gametogenesis and cancer development. In addition, a burst in isoform diversification may be evolutionarily tied to unique aspects of primate speciation.	[Pugacheva, Elena M.; Suzuki, Teruhiko; Kosaka-Suzuki, Natsuki; Yoon, Jeongheon; Strunnikov, Alexander V.; Morse, Herbert C., III; Loukinov, Dmitri; Lobanenkov, Victor] NIAID, Immunopathol Lab, NIH, Rockville, MD USA; [Pack, Svetlana D.] NCI, Chromosome Pathol Unit, Pathol Lab, CCR,NIH, Bethesda, MD 20892 USA; [Vostrov, Alexander A.] SUNY Stony Brook, Dept Psychiat & Behav Sci, Stony Brook, NY 11794 USA; [Barsov, Eugene] SAIC Frederick NCI Frederick, AIDS & Canc Viruses Program, Frederick, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick	Pugacheva, EM (corresponding author), NIAID, Immunopathol Lab, NIH, Rockville, MD USA.	epugacheva@niaid.nih.gov	Pack, Svetlana D./C-2020-2014; Pugacheva, Elena M/GNH-1756-2022; Lobanenkov, Victor/ABD-5710-2021; Lobanenkov, Victor V./AGQ-8903-2022	Pack, Svetlana D./0000-0003-3256-6626; Pugacheva, Elena M/0000-0001-9693-9853; Strunnikov, Alexander/0000-0002-9058-2256; Lobanenkov, Victor/0000-0001-6665-3635; Morse, Herbert/0000-0002-9331-3705	NIAID; NIH Office of AIDS Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000858] Funding Source: NIH RePORTER	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH Office of AIDS Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the intramural research program of NIAID and by the intramural grant from NIH Office of AIDS Research to A. V. S. and D. L. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bell AC, 2000, NATURE, V405, P482, DOI 10.1038/35013100; Blencowe BJ, 2006, CELL, V126, P37, DOI 10.1016/j.cell.2006.06.023; Chao W, 2002, SCIENCE, V295, P345, DOI 10.1126/science.1065982; Cheever MA, 2009, CLIN CANCER RES, V15, P5323, DOI 10.1158/1078-0432.CCR-09-0737; D'Arcy V, 2008, BRIT J CANCER, V98, P571, DOI 10.1038/sj.bjc.6604181; Darcy V, 2006, CLIN CANCER RES, V12, P5978, DOI 10.1158/1078-0432.CCR-05-2731; De Cesare D, 2000, J ENDOCRINOL INVEST, V23, P592, DOI 10.1007/BF03343781; De la Rosa-Velazquez IA, 2007, CANCER RES, V67, P2577, DOI 10.1158/0008-5472.CAN-06-2024; Fedoriw AM, 2004, SCIENCE, V303, P238, DOI 10.1126/science.1090934; Feinberg AP, 2004, NAT REV CANCER, V4, P143, DOI 10.1038/nrc1279; Gazin C, 2007, NATURE, V449, P1073, DOI 10.1038/nature06251; Gedye C, 2009, CANCER IMMUNOL IMMUN, V58, P1635, DOI 10.1007/s00262-009-0672-0; Ghochikyan A, 2007, J IMMUNOL, V178, P566, DOI 10.4049/jimmunol.178.1.566; Hark AT, 2000, NATURE, V405, P486, DOI 10.1038/35013106; Hirahara Y, 2000, EUR J BIOCHEM, V267, P1909, DOI 10.1046/j.1432-1327.2000.01139.x; Hoffmann MJ, 2006, BIOCHEM PHARMACOL, V72, P1577, DOI 10.1016/j.bcp.2006.06.020; Hong JA, 2005, CANCER RES, V65, P7763, DOI 10.1158/0008-5472.CAN-05-0823; Hore TA, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000169; Jelinic P, 2006, PLOS BIOL, V4, P1910, DOI 10.1371/journal.pbio.0040355; Kanduri C, 2000, CURR BIOL, V10, P853, DOI 10.1016/S0960-9822(00)00597-2; Kawashima I, 1992, DNA Seq, V2, P313, DOI 10.3109/10425179209030964; Klenova EA, 2002, SEMIN CANCER BIOL, V12, P399, DOI 10.1016/S1044-579X(02)00060-3; Libby RT, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000257; Loukinov DI, 2002, P NATL ACAD SCI USA, V99, P6806, DOI 10.1073/pnas.092123699; Loukinov D, 2006, J CELL BIOCHEM, V98, P1037, DOI 10.1002/jcb.20953; Monk M, 2008, MOL HUM REPROD, V14, P347, DOI 10.1093/molehr/gan025; Moon H, 2005, EMBO REP, V6, P165, DOI 10.1038/sj.embor.7400334; Nguyen P, 2008, CANCER RES, V68, P5546, DOI 10.1158/0008-5472.CAN-08-1005; Ohlsson R, 2001, TRENDS GENET, V17, P520, DOI 10.1016/S0168-9525(01)02366-6; Pack SD, 1999, CANCER RES, V59, P5560; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Pugacheva EM, 2006, GENE, V375, P26, DOI 10.1016/j.gene.2006.01.036; Pugacheva EM, 2005, HUM MOL GENET, V14, P953, DOI 10.1093/hmg/ddi089; Quitschke WW, 2000, NUCLEIC ACIDS RES, V28, P3370, DOI 10.1093/nar/28.17.3370; RENAUD S, 2010, NUCL ACIDS RES; Renaud S, 2007, NUCLEIC ACIDS RES, V35, P7372, DOI 10.1093/nar/gkm896; Rhee I, 2002, NATURE, V416, P552, DOI 10.1038/416552a; Risinger JI, 2007, CLIN CANCER RES, V13, P1713, DOI 10.1158/1078-0432.CCR-05-2569; Simpson AJG, 2005, NAT REV CANCER, V5, P615, DOI 10.1038/nrc1669; Smith IM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004961; SUZUKI T, 2010, MOL CELL BIOL; Szabo PE, 2000, CURR BIOL, V10, P607, DOI 10.1016/S0960-9822(00)00489-9; Takai D, 2001, HUM MOL GENET, V10, P2619, DOI 10.1093/hmg/10.23.2619; Vatolin S, 2005, CANCER RES, V65, P7751, DOI 10.1158/0008-5472.CAN-05-0858; Vostrov AA, 1997, J BIOL CHEM, V272, P33353, DOI 10.1074/jbc.272.52.33353; Wendt KS, 2008, NATURE, V451, P796, DOI 10.1038/nature06634; Yawata T, 2010, MOL CARCINOGEN, V49, P532, DOI 10.1002/mc.20614	48	43	45	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2010	5	11							e13872	10.1371/journal.pone.0013872	http://dx.doi.org/10.1371/journal.pone.0013872			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	676NU	21079786	Green Submitted, Green Published, gold			2022-12-27	WOS:000283920000006
J	Han, YY; Wang, QL; Song, P; Zhu, Y; Zou, MH				Han, Yingying; Wang, Qilong; Song, Ping; Zhu, Yi; Zou, Ming-Hui			Redox Regulation of the AMP-Activated Protein Kinase	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; ENDOTHELIAL-CELLS; CARCINOMA-CELLS; MUSCLE-CELLS; IN-VIVO; BERBERINE; MECHANISM; APOPTOSIS; PHOSPHORYLATION; INDUCTION	Redox state is a critical determinant of cell function, and any major imbalances can cause severe damage or death. Objectives: The aim of this study is to determine if AMP-activated protein kinase (AMPK), a cellular energy sensor, is activated by oxidants generated by Berberine in endothelial cells (EC). Methods: Bovine aortic endothelial cells (BAEC) were exposed to Berberine. AMPK activity and reactive oxygen species were monitored after the incubation. Results: In BAEC, Berberine caused a dose- and time-dependent increase in the phosphorylation of AMPK at Thr172 and acetyl CoA carboxylase (ACC) at Ser79, a well characterized downstream target of AMPK. Concomitantly, Berberine increased peroxynitrite, a potent oxidant formed by simultaneous generation of superoxide and nitric oxide. Pre-incubation of BAEC with anti-oxidants markedly attenuated Berberine-enhanced phosphorylation of both AMPK and ACC. Consistently, adenoviral expression of superoxide dismutase and pretreatment of L-N-G-Nitroarginine methyl ester (L-NAME; a non-selective NOS inhibitor) blunted Berberine-induced phosphorylation of AMPK. Furthermore, mitochondria-targeted tempol (mito-tempol) pretreatment or expression of uncoupling protein attenuated AMPK activation caused by Berberine. Depletion of mitochondria abolished the effects of Berberine on AMPK in EC. Finally, Berberine significantly increased the phosphorylation of LKB1 at Ser307 and gene silencing of LKB1 attenuated Berberine-enhanced AMPK Thr172 phosphorylation in BAEC. Conclusion: Our results suggest that mitochondria-derived superoxide anions and peroxynitrite are required for Berberine-induced AMPK activation in endothelial cells.	[Han, Yingying; Wang, Qilong; Song, Ping; Zou, Ming-Hui] Univ Oklahoma, Hlth Sci Ctr, Dept Biochem, Oklahoma City, OK 73190 USA; [Han, Yingying; Wang, Qilong; Song, Ping; Zou, Ming-Hui] Univ Oklahoma, Hlth Sci Ctr, Dept Med, Oklahoma City, OK USA; [Han, Yingying; Zhu, Yi] Peking Univ, Hlth Sci Ctr, Dept Physiol & Pathophysiol, Beijing 100871, Peoples R China	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; Peking University	Han, YY (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Biochem, Oklahoma City, OK 73190 USA.	ming-hui-zou@ouhsc.edu	Song, Ping/N-8456-2018; Song, Ping/D-6972-2011; wang, qilong/O-1962-2013	Song, Ping/0000-0002-6143-4270; Song, Ping/0000-0002-2654-6162; 	National Institutes of Health (NIH) [HL079584, HL080499, HL074399, HL089920, HL096032, HL105157]; American Diabetes Association; Travis Endowed Chair of the University of Oklahoma Health Science Center; American Heart Association; Chinese National Science Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089920, R01HL110488, R01HL074399, R01HL079584, R01HL096032, R01HL105157, R01HL080499] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); Travis Endowed Chair of the University of Oklahoma Health Science Center; American Heart Association(American Heart Association); Chinese National Science Foundation(National Natural Science Foundation of China (NSFC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding: This study was supported by National Institutes of Health (NIH) grants (HL079584, HL080499, HL074399, HL089920, HL096032, and HL105157), and a Research Award from the American Diabetes Association, and funds from the Travis Endowed Chair of the University of Oklahoma Health Science Center (all to Dr. Zou). Dr. M. H. Zou is a recipient of Established Investigator Award of American Heart Association. Part of this work was also supported by an international cooperation grant from the Chinese National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acker T, 2006, CARDIOVASC RES, V71, P195, DOI 10.1016/j.cardiores.2006.04.008; An ZB, 2007, J BIOL CHEM, V282, P26793, DOI 10.1074/jbc.M703701200; BOVA S, 1992, J PHARMACOL EXP THER, V261, P318; Brusq JM, 2006, J LIPID RES, V47, P1281, DOI 10.1194/jlr.M600020-JLR200; Ceolotto G, 2007, ARTERIOSCL THROM VAS, V27, P2627, DOI 10.1161/ATVBAHA.107.155762; Choi HC, 2008, J BIOL CHEM, V283, P20186, DOI 10.1074/jbc.M803020200; Choi MS, 2008, ANTICANCER RES, V28, P3777; Coven DL, 2003, AM J PHYSIOL-ENDOC M, V285, pE629, DOI 10.1152/ajpendo.00171.2003; CUI G, 2009, J BIOL CHEM; Fernandes DC, 2007, AM J PHYSIOL-CELL PH, V292, pC413, DOI 10.1152/ajpcell.00188.2006; Foretz M, 2006, M S-MED SCI, V22, P381, DOI 10.1051/medsci/2006224381; Fukuyama Y, 2007, J DENT RES, V86, P903, DOI 10.1177/154405910708600919; Hardie DG, 2006, PHYSIOLOGY, V21, P48, DOI 10.1152/physiol.00044.2005; Jeong HW, 2009, AM J PHYSIOL-ENDOC M, V296, pE955, DOI 10.1152/ajpendo.90599.2008; Johnson LN, 1996, CELL, V85, P149, DOI 10.1016/S0092-8674(00)81092-2; Kemp BE, 2003, BIOCHEM SOC T, V31, P162; Kim WS, 2009, AM J PHYSIOL-ENDOC M, V296, pE812, DOI 10.1152/ajpendo.90710.2008; Kou R, 2009, J BIOL CHEM, V284, P14734, DOI 10.1074/jbc.M808664200; Kukidome D, 2006, DIABETES, V55, P120, DOI 10.2337/diabetes.55.01.06.db05-0943; Lee YS, 2006, DIABETES, V55, P2256, DOI 10.2337/db06-0006; Letasiova S, 2006, J PHARM PHARMACOL, V58, P263, DOI 10.1211/jpp.58.2.0015; Li XX, 2008, ARTERIOSCL THROM VAS, V28, P1789, DOI 10.1161/ATVBAHA.108.172452; Long YC, 2006, J CLIN INVEST, V116, P1776, DOI 10.1172/JCI29044; Mantena SK, 2006, MOL CANCER THER, V5, P296, DOI 10.1158/1535-7163.MCT-05-0448; McCrimmon RJ, 2004, DIABETES, V53, P1953, DOI 10.2337/diabetes.53.8.1953; Minokoshi Y, 2002, NATURE, V415, P339, DOI 10.1038/415339a; Mueller CFH, 2005, ARTERIOSCL THROM VAS, V25, P274, DOI 10.1161/01.ATV.0000149143.04821.eb; Nagata D, 2003, J BIOL CHEM, V278, P31000, DOI 10.1074/jbc.M300643200; Pereira CV, 2008, TOXICOL SCI, V105, P408, DOI 10.1093/toxsci/kfn131; Pereira GC, 2007, J PHARMACOL EXP THER, V323, P636, DOI 10.1124/jpet.107.128017; Song P, 2008, J BIOL CHEM, V283, P12446, DOI 10.1074/jbc.M708208200; Song P, 2009, J BIOL CHEM, V284, P17120, DOI 10.1074/jbc.M109.012583; Turner N, 2008, DIABETES, V57, P1414, DOI 10.2337/db07-1552; Wang YQ, 2009, CARDIOVASC RES, V82, P484, DOI 10.1093/cvr/cvp078; Wu Y, 2007, J BIOL CHEM, V282, P9777, DOI 10.1074/jbc.M608310200; XIAO X, 2009, J NUTR BIOCH; Xie ZL, 2009, MOL CELL BIOL, V29, P3582, DOI 10.1128/MCB.01417-08; Yin J, 2008, AM J PHYSIOL-ENDOC M, V294, pE148, DOI 10.1152/ajpendo.00211.2007; Zang MW, 2006, DIABETES, V55, P2180, DOI 10.2337/db05-1188; Zhang JH, 2008, J BIOL CHEM, V283, P27452, DOI 10.1074/jbc.M802578200; Zhang M, 2008, CIRC RES, V102, P328, DOI 10.1161/CIRCRESAHA.107.163253; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505; Zhou LJ, 2009, J BIOL CHEM, V284, P22426, DOI 10.1074/jbc.M109.028357; Zou MH, 2004, J BIOL CHEM, V279, P43940, DOI 10.1074/jbc.M404421200; Zou MH, 2002, J BIOL CHEM, V277, P32552, DOI 10.1074/jbc.M204512200	45	55	57	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2010	5	11							e15420	10.1371/journal.pone.0015420	http://dx.doi.org/10.1371/journal.pone.0015420			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675OD	21079763	gold, Green Submitted, Green Published			2022-12-27	WOS:000283839100022
J	Wersinger, E; McLean, WJ; Fuchs, PA; Pyott, SJ				Wersinger, Eric; McLean, Will J.; Fuchs, Paul A.; Pyott, Sonja J.			BK Channels Mediate Cholinergic Inhibition of High Frequency Cochlear Hair Cells	PLOS ONE			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; ACTIVATED POTASSIUM CHANNELS; CA2+-ACTIVATED K+ CHANNELS; SMALL-CONDUCTANCE; MESSENGER-RNA; ALPHA-SUBUNIT; DEVELOPMENTAL EXPRESSION; DIFFERENTIAL EXPRESSION; INNER; CURRENTS	Background: Outer hair cells are the specialized sensory cells that empower the mammalian hearing organ, the cochlea, with its remarkable sensitivity and frequency selectivity. Sound-evoked receptor potentials in outer hair cells are shaped by both voltage-gated K+ channels that control the membrane potential and also ligand-gated K+ channels involved in the cholinergic efferent modulation of the membrane potential. The objectives of this study were to investigate the tonotopic contribution of BK channels to voltage-and ligand-gated currents in mature outer hair cells from the rat cochlea. Methodology/Principal: Findings In this work we used patch clamp electrophysiology and immunofluorescence in tonotopically defined segments of the rat cochlea to determine the contribution of BK channels to voltage-and ligand-gated currents in outer hair cells. Although voltage and ligand-gated currents have been investigated previously in hair cells from the rat cochlea, little is known about their tonotopic distribution or potential contribution to efferent inhibition. We found that apical (low frequency) outer hair cells had no BK channel immunoreactivity and little or no BK current. In marked contrast, basal (high frequency) outer hair cells had abundant BK channel immunoreactivity and BK currents contributed significantly to both voltage-gated and ACh-evoked K+ currents. Conclusions/Significance: Our findings suggest that basal (high frequency) outer hair cells may employ an alternative mechanism of efferent inhibition mediated by BK channels instead of SK2 channels. Thus, efferent synapses may use different mechanisms of action both developmentally and tonotopically to support high frequency audition. High frequency audition has required various functional specializations of the mammalian cochlea, and as shown in our work, may include the utilization of BK channels at efferent synapses. This mechanism of efferent inhibition may be related to the unique acetylcholine receptors that have evolved in mammalian hair cells compared to those of other vertebrates.	[Wersinger, Eric; Fuchs, Paul A.] Johns Hopkins Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Ctr Hearing & Balance, Baltimore, MD 21205 USA; [Wersinger, Eric; Fuchs, Paul A.] Johns Hopkins Univ, Sch Med, Ctr Sensory Biol, Baltimore, MD 21205 USA; [McLean, Will J.; Pyott, Sonja J.] Univ N Carolina, Dept Biol & Marine Biol, Wilmington, NC 28401 USA	Johns Hopkins University; Johns Hopkins University; University of North Carolina; University of North Carolina Wilmington	Wersinger, E (corresponding author), Johns Hopkins Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Ctr Hearing & Balance, Baltimore, MD 21205 USA.	pyotts@uncw.edu	Pyott, Sonja/AAW-8789-2020	Pyott, Sonja/0000-0001-7750-2437; McLean, Will/0000-0003-1335-4556	Deafness Research Foundation [R01 DC001508, P30 DC005211]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [P30DC005211, R01DC001508] Funding Source: NIH RePORTER	Deafness Research Foundation; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by a research grant from the Deafness Research Foundation to SJP, R01 DC001508 to PAF, and P30 DC005211 to the Center for Hearing and Balance at Johns Hopkins. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASHMORE JF, 1986, NATURE, V322, P368, DOI 10.1038/322368a0; Belyantseva IA, 2000, J NEUROSCI, V20, part. no.; Cui J, 2009, CELL MOL LIFE SCI, V66, P852, DOI 10.1007/s00018-008-8609-x; DALLOS P, 1992, SOC GEN PHY, V47, P371; DALLOS P, 1978, J NEUROPHYSIOL, V41, P365, DOI 10.1152/jn.1978.41.2.365; Martin JZD, 2010, J NEUROSCI, V30, P12157, DOI 10.1523/JNEUROSCI.2541-10.2010; Dulon D, 1998, EUR J NEUROSCI, V10, P907, DOI 10.1046/j.1460-9568.1998.00098.x; ELGOYHEN AB, 1994, CELL, V79, P705, DOI 10.1016/0092-8674(94)90555-X; Elgoyhen AB, 2001, P NATL ACAD SCI USA, V98, P3501, DOI 10.1073/pnas.051622798; Engel J, 2006, NEUROSCIENCE, V143, P837, DOI 10.1016/j.neuroscience.2006.08.060; Franchini LF, 2006, MOL PHYLOGENET EVOL, V41, P622, DOI 10.1016/j.ympev.2006.05.042; GITTER AH, 1992, HEARING RES, V60, P13, DOI 10.1016/0378-5955(92)90053-P; Glowatzki E, 2000, SCIENCE, V288, P2366, DOI 10.1126/science.288.5475.2366; Hafidi A, 2005, NEUROSCIENCE, V130, P475, DOI 10.1016/j.neuroscience.2004.09.038; Hiel H, 1996, BRAIN RES, V738, P347, DOI 10.1016/S0006-8993(96)01046-3; HOUSLEY GD, 1992, J PHYSIOL-LONDON, V448, P73, DOI 10.1113/jphysiol.1992.sp019030; Katz E, 2004, J NEUROSCI, V24, P7814, DOI 10.1523/JNEUROSCI.2102-04.2004; Kharkovets T, 2006, EMBO J, V25, P642, DOI 10.1038/sj.emboj.7600951; Kharkovets T, 2000, P NATL ACAD SCI USA, V97, P4333, DOI 10.1073/pnas.97.8.4333; Knirsch M, 2007, J NEUROSCI, V27, P6442, DOI 10.1523/JNEUROSCI.5364-06.2007; Kong JH, 2008, J PHYSIOL-LONDON, V586, P5471, DOI 10.1113/jphysiol.2008.160077; Kong WJ, 2005, HEARING RES, V209, P1, DOI 10.1016/j.heares.2005.06.001; KROS CJ, 1990, J PHYSIOL-LONDON, V421, P263, DOI 10.1113/jphysiol.1990.sp017944; Kubisch C, 1999, CELL, V96, P437, DOI 10.1016/S0092-8674(00)80556-5; Langer P, 2003, J COMP NEUROL, V455, P198, DOI 10.1002/cne.10471; Latorre R, 2006, BIOL RES, V39, P385, DOI 10.4067/S0716-97602006000300003; Lin MT, 2008, NAT NEUROSCI, V11, P170, DOI 10.1038/nn2041; Lioudyno M, 2004, J NEUROSCI, V24, P11160, DOI 10.1523/JNEUROSCI.3674-04.2004; Mammano F, 1996, J PHYSIOL-LONDON, V496, P639, DOI 10.1113/jphysiol.1996.sp021715; Marcotti W, 2004, J PHYSIOL-LONDON, V560, P691, DOI 10.1113/jphysiol.2004.072868; Marcotti W, 2004, J PHYSIOL-LONDON, V557, P613, DOI 10.1113/jphysiol.2003.060137; Marcotti W, 1999, J PHYSIOL-LONDON, V520, P653, DOI 10.1111/j.1469-7793.1999.00653.x; MARTY A, 1981, NATURE, V291, P497, DOI 10.1038/291497a0; McLean WJ, 2009, JARO-J ASSOC RES OTO, V10, P37, DOI 10.1007/s10162-008-0152-9; Meera P, 2000, P NATL ACAD SCI USA, V97, P5562, DOI 10.1073/pnas.100118597; Morley BJ, 2002, DEV BRAIN RES, V139, P87, DOI 10.1016/S0165-3806(02)00514-X; MULLER M, 1991, HEARING RES, V51, P247, DOI 10.1016/0378-5955(91)90041-7; Murthy V, 2009, MOL CELL NEUROSCI, V40, P39, DOI 10.1016/j.mcn.2008.08.011; NAKAGAWA T, 1994, EUR ARCH OTO-RHINO-L, V251, pS57, DOI 10.1007/BF02565221; Nenov AP, 1997, HEARING RES, V105, P146, DOI 10.1016/S0378-5955(96)00207-9; Nenov AP, 1996, HEARING RES, V101, P149, DOI 10.1016/S0378-5955(96)00143-8; Oliver D, 2006, J NEUROSCI, V26, P6181, DOI 10.1523/JNEUROSCI.1047-06.2006; Oliver D, 2000, NEURON, V26, P595, DOI 10.1016/S0896-6273(00)81197-6; PALLOTTA BS, 1981, NATURE, V293, P471, DOI 10.1038/293471a0; Pyott SJ, 2004, J NEUROSCI, V24, P9469, DOI 10.1523/JNEUROSCI.3162-04.2004; Pyott SJ, 2007, J BIOL CHEM, V282, P3312, DOI 10.1074/jbc.M608726200; Ruttiger L, 2004, P NATL ACAD SCI USA, V101, P12922, DOI 10.1073/pnas.0402660101; RYAN A, 1975, NATURE, V253, P44, DOI 10.1038/253044a0; Sanchez M, 1996, NEUROPHARMACOLOGY, V35, P963, DOI 10.1016/0028-3908(96)00137-2; Simmons DD, 1998, MOL BRAIN RES, V56, P287, DOI 10.1016/S0169-328X(98)00056-4; Simmons DD, 1996, DEV BRAIN RES, V95, P213; Soh H, 2002, BIOPHYS J, V83, P2528, DOI 10.1016/S0006-3495(02)75264-8; Spreadbury IC, 2004, HEARING RES, V190, P115, DOI 10.1016/S0378-5955(03)00376-9; Thurm H, 2005, J PHYSIOL-LONDON, V569, P137, DOI 10.1113/jphysiol.2005.094680; Van den Abbeele T, 1999, AM J PHYSIOL-CELL PH, V277, pC913, DOI 10.1152/ajpcell.1999.277.5.C913; WANGEMANN P, 1993, HEARING RES, V66, P123, DOI 10.1016/0378-5955(93)90133-L; Weisstaub N, 2002, HEARING RES, V167, P122, DOI 10.1016/S0378-5955(02)00380-5; Winter H, 2007, HISTOCHEM CELL BIOL, V128, P65, DOI 10.1007/s00418-007-0294-6; Yoshida N, 2001, J NEUROPHYSIOL, V85, P84, DOI 10.1152/jn.2001.85.1.84; Yuhas WA, 1999, J COMP PHYSIOL A, V185, P455, DOI 10.1007/s003590050406	60	51	51	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2010	5	11							e13836	10.1371/journal.pone.0013836	http://dx.doi.org/10.1371/journal.pone.0013836			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675NY	21079807	Green Published, Green Submitted, gold			2022-12-27	WOS:000283838600011
J	Popova, TG; Turell, MJ; Espina, V; Kehn-Hall, K; Kidd, J; Narayanan, A; Liotta, L; Petricoin, EF; Kashanchi, F; Bailey, C; Popov, SG				Popova, Taissia G.; Turell, Michael J.; Espina, Virginia; Kehn-Hall, Kylene; Kidd, Jessica; Narayanan, Aarthi; Liotta, Lance; Petricoin, Emanuel F., III; Kashanchi, Fatah; Bailey, Charles; Popov, Serguei G.			Reverse-Phase Phosphoproteome Analysis of Signaling Pathways Induced by Rift Valley Fever Virus in Human Small Airway Epithelial Cells	PLOS ONE			English	Article							PROTEIN-KINASE PATHWAY; MAP KINASES; APOPTOSIS; ACTIVATION; EXPRESSION; TARGET; DEATH; TRANSCRIPTION; TRANSDUCTION; INHIBITOR	Rift valley fever virus (RVFV) infection is an emerging zoonotic disease endemic in many countries of sub-Saharan Africa and in Egypt. In this study we show that human small airway epithelial cells are highly susceptible to RVFV virulent strain ZH-501 and the attenuated strain MP-12. We used the reverse-phase protein arrays technology to identify phosphoprotein signaling pathways modulated during infection of cultured airway epithelium. ZH-501 infection induced activation of MAP kinases (p38, JNK and ERK) and downstream transcriptional factors [STAT1 (Y701), ATF2 (T69/71), MSK1 (S360) and CREB (S133)]. NF-kappa B phosphorylation was also increased. Activation of p53 (S15, S46) correlated with the increased levels of cleaved effector caspase-3, -6 and -7, indicating activation of the extrinsic apoptotic pathway. RVFV infection downregulated phosphorylation of a major anti-apoptotic regulator of survival pathways, AKT (S473), along with phosphorylation of FOX 01/03 (T24/31) which controls cell cycle arrest downstream from AKT. Consistent with this, the level of apoptosis inhibitor XIAP was decreased. However, the intrinsic apoptotic pathway marker, caspase-9, demonstrated only a marginal activation accompanied by an increased level of the inhibitor of apoptosome formation, HSP27. Concentration of the autophagy marker, LC3B, which often accompanies the pro-survival signaling, was decreased. Cumulatively, our analysis of RVFV infection in lung epithelium indicated a viral strategy directed toward the control of cell apoptosis through a number of transcriptional factors. Analyses of MP-12 titers in challenged cells in the presence of MAPK inhibitors indicated that activation of p38 represents a protective cell response while ERK activation controls viral replication.	[Popova, Taissia G.; Kehn-Hall, Kylene; Kidd, Jessica; Narayanan, Aarthi; Kashanchi, Fatah; Bailey, Charles; Popov, Serguei G.] George Mason Univ, Natl Ctr Biodef & Infect Dis, Manassas, VA USA; [Turell, Michael J.] US Med Res Inst Infect Dis, Div Virol, Ft Detrick, MD USA; [Espina, Virginia; Liotta, Lance; Petricoin, Emanuel F., III] George Mason Univ, Ctr Appl Prote & Mol Med, Manassas, VA USA	George Mason University; George Mason University	Popova, TG (corresponding author), George Mason Univ, Natl Ctr Biodef & Infect Dis, Manassas, VA USA.	spopov@gmu.edu	Turell, Michael/ABE-1826-2020; Kehn-Hall, Kylene/I-5752-2013	Turell, Michael/0000-0003-1902-7740; Espina, Virginia/0000-0001-5080-5972; Kehn-Hall, Kylene/0000-0001-8036-7213	Department of Energy [DE-FC52- FC04NA25455]	Department of Energy(United States Department of Energy (DOE))	This work was supported by the Department of Energy grant DE-FC52- FC04NA25455. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altieri DC, 1999, LAB INVEST, V79, P1327; Balachandran S, 2000, J VIROL, V74, P1513, DOI 10.1128/JVI.74.3.1513-1523.2000; Balkhy HH, 2003, INT J ANTIMICROB AG, V21, P153, DOI 10.1016/S0924-8579(02)00295-9; Ballif BA, 2001, CELL GROWTH DIFFER, V12, P397; Bouloy M, 2001, J VIROL, V75, P1371, DOI 10.1128/JVI.75.3.1371-1377.2001; BROWN JL, 1981, INFECT IMMUN, V33, P848, DOI 10.1128/IAI.33.3.848-853.1981; Bulavin DV, 2004, ADV CANCER RES, V92, P95, DOI 10.1016/S0065-230X(04)92005-2; BURGERING BMT, 1995, NATURE, V376, P599, DOI 10.1038/376599a0; Cain K, 2002, BIOCHIMIE, V84, P203, DOI 10.1016/S0300-9084(02)01376-7; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Deveraux QL, 1997, NATURE, V388, P300, DOI 10.1038/40901; Easterday B C, 1965, Adv Vet Sci, V10, P65; Eckelman BP, 2006, EMBO REP, V7, P988, DOI 10.1038/sj.embor.7400795; ELLIOTT RM, 2000, VIRUS TAXONOMY CLASS; Flick R, 2005, CURR MOL MED, V5, P827, DOI 10.2174/156652405774962263; FRANKE TF, 1995, CELL, V81, P727, DOI 10.1016/0092-8674(95)90534-0; Franke TF, 1997, CELL, V88, P435, DOI 10.1016/S0092-8674(00)81883-8; Garrido C, 1999, FASEB J, V13, P2061, DOI 10.1096/fasebj.13.14.2061; Gauthier ML, 2005, CANCER RES, V65, P1792, DOI 10.1158/0008-5472.CAN-04-3507; Gerdes GH, 2002, VET CLIN N AM-FOOD A, V18, P549, DOI 10.1016/S0749-0720(02)00029-4; Ikegami T, 2006, J VIROL, V80, P2933, DOI 10.1128/JVI.80.6.2933-2940.2006; Ikegami T, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000287; Ji Wen-Tsai, 2008, Recent Pat Biotechnol, V2, P218, DOI 10.2174/187220808786241042; Kasof GM, 2001, J BIOL CHEM, V276, P3238, DOI 10.1074/jbc.M003670200; Le May N, 2004, CELL, V116, P541, DOI 10.1016/S0092-8674(04)00132-1; Le May N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040013; Li SP, 2003, CANCER RES, V63, P3473; Ludwig S, 2009, J ANTIMICROB CHEMOTH, V64, P1, DOI 10.1093/jac/dkp161; MEEGAN JM, 1979, T ROY SOC TROP MED H, V73, P618, DOI 10.1016/0035-9203(79)90004-X; Meloche S, 2007, ONCOGENE, V26, P3227, DOI 10.1038/sj.onc.1210414; Olsson A, 2007, CELL DEATH DIFFER, V14, P1561, DOI 10.1038/sj.cdd.4402196; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; PETERS CJ, 1989, RIFT VALLEY FEVER; Pleschka S, 2001, NAT CELL BIOL, V3, P301, DOI 10.1038/35060098; Porras A, 2004, MOL BIOL CELL, V15, P922, DOI 10.1091/mbc.E03-08-0592; Rubinfeld H, 2005, MOL BIOTECHNOL, V31, P151, DOI 10.1385/MB:31:2:151; Sandhu KS, 2009, BIOTECHNOL BIOENG, V104, P752, DOI 10.1002/bit.22439; Tamm I, 2000, CLIN CANCER RES, V6, P1796; Tobiume K, 2001, EMBO REP, V2, P222, DOI 10.1093/embo-reports/kve046; Weston CR, 2007, CURR OPIN CELL BIOL, V19, P142, DOI 10.1016/j.ceb.2007.02.001; Won SY, 2007, J VIROL, V81, P13335, DOI 10.1128/JVI.01238-07; Wulfkuhle JD, 2006, NAT CLIN PRACT ONCOL, V3, P256, DOI 10.1038/ncponc0485; Wurzer WJ, 2003, EMBO J, V22, P2717, DOI 10.1093/emboj/cdg279; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326	44	44	44	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2010	5	11							e13805	10.1371/journal.pone.0013805	http://dx.doi.org/10.1371/journal.pone.0013805			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	674WJ	21072193	Green Published, Green Submitted, gold			2022-12-27	WOS:000283780800008
J	Angel, TE; Luft, BJ; Yang, XH; Nicora, CD; Camp, DG; Jacobs, JM; Smith, RD				Angel, Thomas E.; Luft, Benjamin J.; Yang, Xiaohua; Nicora, Carrie D.; Camp, David G., II; Jacobs, Jon M.; Smith, Richard D.			Proteome Analysis of Borrelia burgdorferi Response to Environmental Change	PLOS ONE			English	Article							LYME-DISEASE SPIROCHETE; OUTER SURFACE PROTEIN; HOST-SPECIFIC SIGNALS; GENE-EXPRESSION; MAMMALIAN HOST; INFECTIOUS CYCLE; FACTOR-H; BINDING; TRANSCRIPTOME; REGULATOR	We examined global changes in protein expression in the B31 strain of Borrelia burgdorferi, in response to two environmental cues (pH and temperature) chosen for their reported similarity to those encountered at different stages of the organism's life cycle. Multidimensional nano-liquid chromatographic separations coupled with tandem mass spectrometry were used to examine the array of proteins (i.e., the proteome) of B. burgdorferi for different pH and temperature culture conditions. Changes in pH and temperature elicited in vitro adaptations of this spirochete known to cause Lyme disease and led to alterations in protein expression that are associated with increased microbial pathogenesis. We identified 1,031 proteins that represent 59% of the annotated genome of B. burgdorferi and elucidated a core proteome of 414 proteins that were present in all environmental conditions investigated. Observed changes in protein abundances indicated varied replicon usage, as well as proteome functional distributions between the in vitro cell culture conditions. Surprisingly, the pH and temperature conditions that mimicked B. burgdorferi residing in the gut of a fed tick showed a marked reduction in protein diversity. Additionally, the results provide us with leading candidates for exploring how B. burgdorferi adapts to and is able to survive in a wide variety of environmental conditions and lay a foundation for planned in situ studies of B. burgdorferi isolated from the tick midgut and infected animals.	[Angel, Thomas E.; Nicora, Carrie D.; Camp, David G., II; Jacobs, Jon M.; Smith, Richard D.] Pacific NW Natl Lab, Div Biol Sci, Richland, WA 99352 USA; [Luft, Benjamin J.; Yang, Xiaohua] SUNY Stony Brook, Sch Med, Div Infect Dis, Stony Brook, NY 11794 USA	United States Department of Energy (DOE); Pacific Northwest National Laboratory; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Angel, TE (corresponding author), Pacific NW Natl Lab, Div Biol Sci, Richland, WA 99352 USA.	rds@pnl.gov	Smith, Richard D/J-3664-2012	Smith, Richard D/0000-0002-2381-2349; Luft, Benjamin/0000-0001-9008-7004	National Institutes of Health (NIH) [U01-AI56480]; National Center for Research Resources [RR18522]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR018522] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI056480] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Portions of this research were supported by National Institutes of Health (NIH) grant U01-AI56480 (to BJL) and the National Center for Research Resources (RR18522 to RDS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boardman BK, 2008, INFECT IMMUN, V76, P3844, DOI 10.1128/IAI.00467-08; Brooks CS, 2003, INFECT IMMUN, V71, P3371, DOI 10.1128/IAI.71.6.3371-3383.2003; BURGDORFER W, 1982, SCIENCE, V216, P1317, DOI 10.1126/science.7043737; Byram R, 2004, J BACTERIOL, V186, P3561, DOI 10.1128/JB.186.11.3561-3569.2004; Carroll JA, 2000, INFECT IMMUN, V68, P6677, DOI 10.1128/IAI.68.12.6677-6684.2000; Carroll JA, 1999, INFECT IMMUN, V67, P3181, DOI 10.1128/IAI.67.7.3181-3187.1999; Feng SL, 1998, INFECT IMMUN, V66, P2827, DOI 10.1128/IAI.66.6.2827-2835.1998; Fischer JR, 2003, P NATL ACAD SCI USA, V100, P7307, DOI 10.1073/pnas.1231043100; Fraser CM, 1997, NATURE, V390, P580, DOI 10.1038/37551; Gilmore RD, 2010, P NATL ACAD SCI USA, V107, P7515, DOI 10.1073/pnas.1000268107; Gruber TM, 2003, ANNU REV MICROBIOL, V57, P441, DOI 10.1146/annurev.micro.57.030502.090913; Hughes JL, 2008, INFECT IMMUN, V76, P2498, DOI 10.1128/IAI.01583-07; Jacobs JM, 2005, PROTEOMICS, V5, P1446, DOI 10.1002/pmic.200401052; Kraiczy P, 2004, J BIOL CHEM, V279, P2421, DOI 10.1074/jbc.M308343200; Liang FT, 2002, INFECT IMMUN, V70, P3300, DOI 10.1128/IAI.70.6.3300-3303.2002; Mulay V, 2007, J BACTERIOL, V189, P2063, DOI 10.1128/JB.01239-06; Mulay VB, 2009, J BACTERIOL, V191, P2783, DOI 10.1128/JB.01802-08; Narasimhan S, 2003, P NATL ACAD SCI USA, V100, P15953, DOI 10.1073/pnas.2432412100; Narasimhan S, 2002, J BACTERIOL, V184, P3122, DOI 10.1128/JB.184.11.3122-3125.2002; Norris SJ, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-3-209; Nowalk AJ, 2006, PROTEOMICS, V6, P2121, DOI 10.1002/pmic.200500187; Ojaimi C, 2003, INFECT IMMUN, V71, P1689, DOI 10.1128/IAI.71.4.1689-1705.2003; Polpitiya AD, 2008, BIOINFORMATICS, V24, P1556, DOI 10.1093/bioinformatics/btn217; Qian WJ, 2005, J PROTEOME RES, V4, P53, DOI 10.1021/pr0498638; Ramamoorthi N, 2005, NATURE, V436, P573, DOI 10.1038/nature03812; Revel AT, 2002, P NATL ACAD SCI USA, V99, P1562, DOI 10.1073/pnas.032667699; Scheckelhoff MR, 2007, P NATL ACAD SCI USA, V104, P7247, DOI 10.1073/pnas.0607263104; SCHWAN TG, 1995, P NATL ACAD SCI USA, V92, P2909, DOI 10.1073/pnas.92.7.2909; Setubal JC, 2006, MICROBIOL-SGM, V152, P113, DOI 10.1099/mic.0.28317-0; Stevenson B, 2002, INFECT IMMUN, V70, P491, DOI 10.1128/IAI.70.2.491-497.2002; Stevenson B, 2006, WIEN KLIN WOCHENSCHR, V118, P643, DOI 10.1007/s00508-006-0690-2; Stewart PE, 2008, INFECT IMMUN, V76, P1970, DOI 10.1128/IAI.00714-07; Tokarz R, 2004, INFECT IMMUN, V72, P5419, DOI 10.1128/IAI.72.9.5419-5432.2004; Xu Y, 2008, MICROB PATHOGENESIS, V45, P403, DOI 10.1016/j.micpath.2008.09.006; Yang XF, 2008, INFECT IMMUN, V76, P4439, DOI 10.1128/IAI.00740-08; Yang XF, 2000, MOL MICROBIOL, V37, P1470, DOI 10.1046/j.1365-2958.2000.02104.x; YATES JR, 1995, ANAL CHEM, V67, P1426, DOI 10.1021/ac00104a020; Zhiming OY, 2008, MICROBIOL-SGM, V154, P2641, DOI 10.1099/mic.0.2008/019992-0	38	27	27	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2010	5	11							e13800	10.1371/journal.pone.0013800	http://dx.doi.org/10.1371/journal.pone.0013800			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	674VY	21072190	gold, Green Published, Green Submitted			2022-12-27	WOS:000283779700012
J	Niesen, FH; Schultz, L; Jadhav, A; Bhatia, C; Guo, KD; Maloney, DJ; Pilka, ES; Wang, MH; Oppermann, U; Heightman, TD; Simeonov, A				Niesen, Frank H.; Schultz, Lena; Jadhav, Ajit; Bhatia, Chitra; Guo, Kunde; Maloney, David J.; Pilka, Ewa S.; Wang, Minghua; Oppermann, Udo; Heightman, Tom D.; Simeonov, Anton			High-Affinity Inhibitors of Human NAD(+)-Dependent 15-Hydroxyprostaglandin Dehydrogenase: Mechanisms of Inhibition and Structure-Activity Relationships	PLOS ONE			English	Article							SHORT-CHAIN DEHYDROGENASE/REDUCTASE; PROSTAGLANDIN-E SYNTHASE; ALCOHOL-DEHYDROGENASE; STATISTICAL PARAMETER; SEQUENCE-ANALYSIS; CRYSTAL-STRUCTURE; CRITICAL RESIDUES; EXPRESSION; ENZYME; LIGAND	Background: 15-hydroxyprostaglandin dehydrogenase (15-PGDH, EC 1.1.1.141) is the key enzyme for the inactivation of prostaglandins, regulating processes such as inflammation or proliferation. The anabolic pathways of prostaglandins, especially with respect to regulation of the cyclooxygenase (COX) enzymes have been studied in detail; however, little is known about downstream events including functional interaction of prostaglandin-processing and -metabolizing enzymes. High-affinity probes for 15-PGDH will, therefore, represent important tools for further studies. Principal Findings: To identify novel high-affinity inhibitors of 15-PGDH we performed a quantitative high-throughput screen (qHTS) by testing > 160 thousand compounds in a concentration-response format and identified compounds that act as noncompetitive inhibitors as well as a competitive inhibitor, with nanomolar affinity. Both types of inhibitors caused strong thermal stabilization of the enzyme, with cofactor dependencies correlating with their mechanism of action. We solved the structure of human 15-PGDH and explored the binding modes of the inhibitors to the enzyme in silico. We found binding modes that are consistent with the observed mechanisms of action. Conclusions: Low cross-reactivity in screens of over 320 targets, including three other human dehydrogenases/reductases, suggest selectivity of the present inhibitors for 15-PGDH. The high potencies and different mechanisms of action of these chemotypes make them a useful set of complementary chemical probes for functional studies of prostaglandin-signaling pathways.	[Niesen, Frank H.; Bhatia, Chitra; Guo, Kunde; Pilka, Ewa S.; Wang, Minghua; Heightman, Tom D.] Univ Oxford, Nuffield Dept Clin Med, Struct Genom Consortium, Oxford, England; [Schultz, Lena; Jadhav, Ajit; Maloney, David J.; Oppermann, Udo; Simeonov, Anton] NHGRI, NIH Chem Genom Ctr, NIH, Bethesda, MD 20892 USA; [Oppermann, Udo] Univ Oxford, Botnar Res Ctr, Nuffield Dept Orthoped Surg Rheumatol & Musculosk, Biomed Res Unit, Oxford, England	University of Oxford; National Institutes of Health (NIH) - USA; NIH National Center for Advancing Translational Sciences (NCATS); NIH National Human Genome Research Institute (NHGRI); University of Oxford	Niesen, FH (corresponding author), Univ Oxford, Nuffield Dept Clin Med, Struct Genom Consortium, Oxford, England.	asimeono@mail.nih.gov		Jadhav, Ajit/0000-0001-7955-1451; Seewooruthun, Chitra/0000-0002-9047-188X	Molecular Libraries Initiative of the NIH Roadmap for Medical Research; NHGRI, NIH; Oxford Biomedical Research Unit; Canadian Institutes for Health Research [1097737]; Canadian Foundation for Innovation; Genome Canada through the Ontario Genomics Institute; GlaxoSmithKline; Karolinska Institutet; Knut and Alice Wallenberg Foundation; Ontario Innovation Trust; Ontario Ministry for Research and Innovation; Merck Co., Inc.; Novartis Research Foundation; Swedish Agency for Innovation Systems; Swedish Foundation for Strategic Research; Wellcome Trust; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIBHG200319] Funding Source: NIH RePORTER	Molecular Libraries Initiative of the NIH Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHGRI, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Oxford Biomedical Research Unit; Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation); Genome Canada through the Ontario Genomics Institute(Genome Canada); GlaxoSmithKline(GlaxoSmithKline); Karolinska Institutet(Karolinska Institutet); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Ontario Innovation Trust; Ontario Ministry for Research and Innovation(Ministry of Research and Innovation, Ontario); Merck Co., Inc.(Merck & Company); Novartis Research Foundation; Swedish Agency for Innovation Systems(Vinnova); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This research was supported in part by the Molecular Libraries Initiative of the NIH Roadmap for Medical Research, the Intramural Research Program of the NHGRI, NIH, and the Oxford Biomedical Research Unit. The Structural Genomics Consortium is a registered charity (number 1097737) that receives funds from the Canadian Institutes for Health Research, the Canadian Foundation for Innovation, Genome Canada through the Ontario Genomics Institute, GlaxoSmithKline, Karolinska Institutet, the Knut and Alice Wallenberg Foundation, the Ontario Innovation Trust, the Ontario Ministry for Research and Innovation, Merck & Co., Inc., the Novartis Research Foundation, the Swedish Agency for Innovation Systems, the Swedish Foundation for Strategic Research and the Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BERRY CN, 1983, BIOCHEM PHARMACOL, V32, P2863, DOI 10.1016/0006-2952(83)90390-8; Buczynski MW, 2009, J LIPID RES, V50, P1015, DOI 10.1194/jlr.R900004-JLR200; Cer RZ, 2009, NUCLEIC ACIDS RES, V37, pW441, DOI 10.1093/nar/gkp253; Cho H, 2002, PROSTAG LEUKOTR ESS, V67, P461, DOI 10.1054/plef.2002.0457; Cho H, 2005, ARCH BIOCHEM BIOPHYS, V433, P447, DOI 10.1016/j.abb.2004.09.036; Cho H, 2002, ARCH BIOCHEM BIOPHYS, V405, P247, DOI 10.1016/S0003-9861(02)00352-1; Cohen EG, 2003, CLIN CANCER RES, V9, P3425; DEKOK PMT, 1988, EUR J BIOCHEM, V175, P581; Dubinett SM, 2008, CANCER PREV RES, V1, P223, DOI 10.1158/1940-6207.CAPR-08-0148; Eastwood BJ, 2006, J BIOMOL SCREEN, V11, P253, DOI 10.1177/1087057105285611; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ENSOR CM, 1994, BBA-PROTEIN STRUCT M, V1208, P151, DOI 10.1016/0167-4838(94)90172-4; ENSOR CM, 1990, J BIOL CHEM, V265, P14888; FEDOROV O, METHODS BIO IN PRESS; Filling C, 2002, J BIOL CHEM, V277, P25677, DOI 10.1074/jbc.M202160200; FitzGerald G, 2003, NAT REV DRUG DISCOV, V2, P879, DOI 10.1038/nrd1225; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Hill A.V, 1910, J PHYSL, V40, piv, DOI DOI 10.1113/JPHYSIOL.1910.SP001386; Inglese J, 2006, P NATL ACAD SCI USA, V103, P11473, DOI 10.1073/pnas.0604348103; Ito K, 2006, J MOL BIOL, V355, P722, DOI 10.1016/j.jmb.2005.10.072; Jadhav A, 2010, J MED CHEM, V53, P37, DOI 10.1021/jm901070c; JORGENSEN WL, 1988, J AM CHEM SOC, V110, P1657, DOI 10.1021/ja00214a001; JORNVALL H, 1995, BIOCHEMISTRY-US, V34, P6003, DOI 10.1021/bi00018a001; Kallberg Y, 2002, PROTEIN SCI, V11, P636, DOI 10.1110/ps.26902; Kavanagh K, 2008, CELL MOL LIFE SCI, V65, P3895, DOI 10.1007/s00018-008-8588-y; Kim EH, 2008, BIOCHEM PHARMACOL, V76, P1544, DOI 10.1016/j.bcp.2008.07.043; Kroe RR, 2003, J MED CHEM, V46, P4669, DOI 10.1021/jm030120s; KROOK M, 1990, BIOCHEMISTRY-US, V29, P738, DOI 10.1021/bi00455a021; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Lo MC, 2004, ANAL BIOCHEM, V332, P153, DOI 10.1016/j.ab.2004.04.031; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Michael S, 2008, ASSAY DRUG DEV TECHN, V6, P637, DOI 10.1089/adt.2008.150; Morris RJ, 2002, ACTA CRYSTALLOGR D, V58, P968, DOI 10.1107/S0907444902005462; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Oppermann U, 2003, CHEM-BIOL INTERACT, V143, P247, DOI 10.1016/S0009-2797(02)00164-3; Persson B, 2009, CHEM-BIOL INTERACT, V178, P94, DOI 10.1016/j.cbi.2008.10.040; Rizzo G, 2006, CURR OPIN PHARMACOL, V6, P421, DOI 10.1016/j.coph.2006.03.012; Rudolph F B, 1979, Methods Enzymol, V63, P411; Samuelsson B, 2000, AM J RESP CRIT CARE, V161, pS2, DOI 10.1164/ajrccm.161.supplement_1.ltta-1; SAMUELSSON B, 1983, BIOSCIENCE REP, V3, P791, DOI 10.1007/BF01133779; SAMUELSSON B, 1986, PROG LIPID RES, V25, P13, DOI 10.1016/0163-7827(86)90006-8; Schlieben NH, 2005, J MOL BIOL, V349, P801, DOI 10.1016/j.jmb.2005.04.029; Segel IH., 1993, ENZYME KINETICS BEHA; Sheng HM, 1998, CANCER RES, V58, P362; Simeonov A, 2008, J MED CHEM, V51, P2363, DOI 10.1021/jm701301m; Sogabe S, 2003, J BIOL CHEM, V278, P19387, DOI 10.1074/jbc.M208146200; Tai HH, 2002, PROSTAG OTH LIPID M, V68-9, P483, DOI 10.1016/S0090-6980(02)00050-3; Tai HH, 2007, PROSTAG OTH LIPID M, V83, P203, DOI 10.1016/j.prostaglandins.2007.01.007; Tong M, 2000, BIOCHEM BIOPH RES CO, V276, P77, DOI 10.1006/bbrc.2000.3437; Wang D, 2006, GUT, V55, P115, DOI 10.1136/gut.2004.047100; WERMUTH B, 1988, J BIOL CHEM, V263, P16185; Yasgar Adam, 2008, JALA Charlottesv Va, V13, P79, DOI 10.1016/j.jala.2007.12.004; Yoshimatsu K, 2001, CLIN CANCER RES, V7, P3971; Yoshimatsu K, 2001, CLIN CANCER RES, V7, P2669; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhou HP, 2001, EUR J BIOCHEM, V268, P3368, DOI 10.1046/j.1432-1327.2001.02218.x	58	22	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2010	5	11							e13719	10.1371/journal.pone.0013719	http://dx.doi.org/10.1371/journal.pone.0013719			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	674VY	21072165	Green Submitted, Green Published, gold			2022-12-27	WOS:000283779700002
J	Zaehle, T; Rach, S; Herrmann, CS				Zaehle, Tino; Rach, Stefan; Herrmann, Christoph S.			Transcranial Alternating Current Stimulation Enhances Individual Alpha Activity in Human EEG	PLOS ONE			English	Article							RANGE TEMPORAL CORRELATIONS; THETA-OSCILLATIONS; BRAIN-STIMULATION; ELECTRICAL-STIMULATION; COGNITIVE PERFORMANCE; WORKING-MEMORY; CORTEX; STATE; NEUROFEEDBACK; EXCITABILITY	Non-invasive electrical stimulation of the human cortex by means of transcranial direct current stimulation (tDCS) has been instrumental in a number of important discoveries in the field of human cortical function and has become a well-established method for evaluating brain function in healthy human participants. Recently, transcranial alternating current stimulation (tACS) has been introduced to directly modulate the ongoing rhythmic brain activity by the application of oscillatory currents on the human scalp. Until now the efficiency of tACS in modulating rhythmic brain activity has been indicated only by inference from perceptual and behavioural consequences of electrical stimulation. No direct electrophysiological evidence of tACS has been reported. We delivered tACS over the occipital cortex of 10 healthy participants to entrain the neuronal oscillatory activity in their individual alpha frequency range and compared results with those from a separate group of participants receiving sham stimulation. The tACS but not the sham stimulation elevated the endogenous alpha power in parieto-central electrodes of the electroencephalogram. Additionally, in a network of spiking neurons, we simulated how tACS can be affected even after the end of stimulation. The results show that spike-timing-dependent plasticity (STDP) selectively modulates synapses depending on the resonance frequencies of the neural circuits that they belong to. Thus, tACS influences STDP which in turn results in aftereffects upon neural activity. The present findings are the first direct electrophysiological evidence of an interaction of tACS and ongoing oscillatory activity in the human cortex. The data demonstrate the ability of tACS to specifically modulate oscillatory brain activity and show its potential both at fostering knowledge on the functional significance of brain oscillations and for therapeutic application.	[Zaehle, Tino] Otto Von Guericke Univ, Dept Neurol, Magdeburg, Germany; [Zaehle, Tino] German Ctr Neurodegenerat Dis DZNE, Magdeburg, Germany; [Rach, Stefan; Herrmann, Christoph S.] Carl von Ossietzky Univ Oldenburg, Expt Psychol Lab, Oldenburg, Germany	Otto von Guericke University; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Carl von Ossietzky Universitat Oldenburg	Zaehle, T (corresponding author), Otto Von Guericke Univ, Dept Neurol, Magdeburg, Germany.	christoph.herrmann@uni-oldenburg.de	Zaehle, Tino/A-5088-2019	Zaehle, Tino/0000-0003-3673-4869; Rach, Stefan/0000-0001-5241-0253; Herrmann, Christoph/0000-0003-0323-2272	German Research foundation(DFG) [SFB/TRR 31]; Magdeburg Center for Behavioral Systems (CBBS) [UC3-3803H]	German Research foundation(DFG)(German Research Foundation (DFG)); Magdeburg Center for Behavioral Systems (CBBS)	The study was supported by the German Research foundation(DFG, SFB/TRR 31) and the Magdeburg Center for Behavioral Systems (CBBS, UC3-3803H). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelakis E, 2007, CLIN NEUROPSYCHOL, V21, P110, DOI 10.1080/13854040600744839; Antal A, 2006, BRAIN RES BULL, V68, P459, DOI 10.1016/j.brainresbull.2005.10.006; Antal A, 2008, PERCEPTION, V37, P367, DOI 10.1068/p5872; Basar E, 2001, INT J PSYCHOPHYSIOL, V39, P241, DOI 10.1016/S0167-8760(00)00145-8; Berger H, 1929, ARCH PSYCHIAT NERVEN, V87, P527, DOI 10.1007/BF01797193; Boggio PS, 2009, J NEUROL NEUROSUR PS, V80, P444, DOI 10.1136/jnnp.2007.141853; Boggio PS, 2008, INT J NEUROPSYCHOPH, V11, P249, DOI 10.1017/S1461145707007833; Boggio PS, 2006, J NEUROL SCI, V249, P31, DOI 10.1016/j.jns.2006.05.062; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Buzsaki G., 2006, RHYTHMS BRAIN; Engel AK, 2001, NAT REV NEUROSCI, V2, P704, DOI 10.1038/35094565; Ferrucci R, 2008, NEUROLOGY, V71, P493, DOI 10.1212/01.wnl.0000317060.43722.a3; Ferrucci R, 2009, J AFFECT DISORDERS, V118, P215, DOI 10.1016/j.jad.2009.02.015; Francis JT, 2003, J NEUROSCI, V23, P7255; Friederici AD, 2006, CORTEX, V42, P472, DOI 10.1016/S0010-9452(08)70380-0; Hanslmayr S, 2005, APPL PSYCHOPHYS BIOF, V30, P1, DOI 10.1007/s10484-005-2169-8; Hanslmayr S, 2007, NEUROIMAGE, V37, P1465, DOI 10.1016/j.neuroimage.2007.07.011; Herrmann CS, 2005, CLIN NEUROPHYSIOL, V116, P2719, DOI 10.1016/j.clinph.2005.07.007; Hummel FC, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-73; Hutcheon B, 2000, TRENDS NEUROSCI, V23, P216, DOI 10.1016/S0166-2236(00)01547-2; Jo JM, 2009, AM J PHYS MED REHAB, V88, P404, DOI 10.1097/PHM.0b013e3181a0e4cb; Kanai R, 2010, CLIN NEUROPHYSIOL, V121, P1551, DOI 10.1016/j.clinph.2010.03.022; Kanai R, 2008, CURR BIOL, V18, P1839, DOI 10.1016/j.cub.2008.10.027; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kirov R, 2009, P NATL ACAD SCI USA, V106, P15460, DOI 10.1073/pnas.0904438106; Klimesch W, 2003, EUR J NEUROSCI, V17, P1129, DOI 10.1046/j.1460-9568.2003.02517.x; Klimesch W, 1999, BRAIN RES REV, V29, P169, DOI 10.1016/S0165-0173(98)00056-3; Knyazev GG, 2007, NEUROSCI BIOBEHAV R, V31, P377, DOI 10.1016/j.neubiorev.2006.10.004; Linkenkaer-Hansen K, 2005, J NEUROSCI, V25, P10131, DOI 10.1523/JNEUROSCI.3244-05.2005; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; Marshall L, 2006, NATURE, V444, P610, DOI 10.1038/nature05278; McDonnell MD, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000348; MERTON PA, 1980, NATURE, V285, P227, DOI 10.1038/285227a0; MERTON PA, 1982, LANCET, V2, P597; Miranda PC, 2006, CLIN NEUROPHYSIOL, V117, P1623, DOI 10.1016/j.clinph.2006.04.009; Montez T, 2009, P NATL ACAD SCI USA, V106, P1614, DOI 10.1073/pnas.0811699106; Monti A, 2008, J NEUROL NEUROSUR PS, V79, P451, DOI 10.1136/jnnp.2007.135277; Monto S, 2007, CEREB CORTEX, V17, P1386, DOI 10.1093/cercor/bhl049; Nitsche MA, 2001, NEUROLOGY, V57, P1899, DOI 10.1212/WNL.57.10.1899; NITSCHE MA, 2008, OXFORD HDB TRANSCRAN, P201; Nitsche MA, 2009, EXP NEUROL, V219, P14, DOI 10.1016/j.expneurol.2009.03.038; Nitsche MA, 2009, NEUROTHERAPEUTICS, V6, P244, DOI 10.1016/j.nurt.2009.01.003; Nitsche MA, 2008, BRAIN STIMUL, V1, P206, DOI 10.1016/j.brs.2008.06.004; Palva S, 2007, TRENDS NEUROSCI, V30, P150, DOI 10.1016/j.tins.2007.02.001; Parish LM, 2004, NEUROSCIENCE, V125, P1069, DOI 10.1016/j.neuroscience.2004.03.002; Paulus W, 2010, CLIN NEUROPHYSIOL, V121, P987, DOI 10.1016/j.clinph.2010.01.029; Pogosyan A, 2009, CURR BIOL, V19, P1637, DOI 10.1016/j.cub.2009.07.074; Romei V, 2010, J NEUROSCI, V30, P8692, DOI 10.1523/JNEUROSCI.0160-10.2010; Sauseng P, 2009, CURR BIOL, V19, P1846, DOI 10.1016/j.cub.2009.08.062; Schlaug G, 2008, EXPERT REV MED DEVIC, V5, P759, DOI 10.1586/17434440.5.6.759; Schlaug G, 2008, ARCH NEUROL-CHICAGO, V65, P1571, DOI 10.1001/archneur.65.12.1571; Schmid RG, 1997, ELECTROEN CLIN NEURO, V103, P516, DOI 10.1016/S0013-4694(97)00054-0; Schutter DJLG, 2010, CLIN NEUROPHYSIOL, V121, P1080, DOI 10.1016/j.clinph.2009.10.038; Schwiedrzik CM, 2009, FRONT INTEGR NEUROSC, V3, DOI 10.3389/neuro.07.006.2009; Silvanto J, 2008, TRENDS COGN SCI, V12, P447, DOI 10.1016/j.tics.2008.09.004; Thut G, 2006, J NEUROSCI, V26, P9494, DOI 10.1523/JNEUROSCI.0875-06.2006; Thut G, 2010, BRAIN TOPOGR, V22, P219, DOI 10.1007/s10548-009-0115-4; Tovee MJ, 1998, CURR BIOL, V8, pR317, DOI 10.1016/S0960-9822(98)70197-6; Uhhaas PJ, 2006, NEURON, V52, P155, DOI 10.1016/j.neuron.2006.09.020; Van Dijk H, 2008, J NEUROSCI, V28, P1816, DOI 10.1523/JNEUROSCI.1853-07.2008; Vogel Friedrich, 2000, GENETICS ELECTROENCE; Ward LM, 2003, TRENDS COGN SCI, V7, P553, DOI 10.1016/j.tics.2003.10.012; Wassermann EM, 2005, TRENDS COGN SCI, V9, P503, DOI 10.1016/j.tics.2005.09.001; Womelsdorf T, 2007, SCIENCE, V316, P1609, DOI [10.1126/science.1139597, 10.1126/science.1139178]; Zoefel B, 2011, NEUROIMAGE, V54, P1427, DOI 10.1016/j.neuroimage.2010.08.078	65	456	471	6	119	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2010	5	11							e13766	10.1371/journal.pone.0013766	http://dx.doi.org/10.1371/journal.pone.0013766			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673FY	21072168	Green Published, gold, Green Submitted			2022-12-27	WOS:000283645700002
J	Chan, KH; Zhang, AJX; To, KKW; Chan, CCS; Poon, VKM; Guo, KY; Ng, F; Zhang, QW; Leung, VHC; Cheung, ANY; Lau, CCY; Woo, PCY; Tse, H; Wu, WL; Chen, HL; Zheng, BJ; Yuen, KY				Chan, Kwok-Hung; Zhang, Anna J. X.; To, Kelvin K. W.; Chan, Chris C. S.; Poon, Vincent K. M.; Guo, Kunyuan; Ng, Fai; Zhang, Qi-Wei; Leung, Virtual H. C.; Cheung, Annie N. Y.; Lau, Candy C. Y.; Woo, Patrick C. Y.; Tse, Herman; Wu, Wailan; Chen, Honglin; Zheng, Bo-Jian; Yuen, Kwok-Yung			Wild Type and Mutant 2009 Pandemic Influenza A (H1N1) Viruses Cause More Severe Disease and Higher Mortality in Pregnant BALB/c Mice	PLOS ONE			English	Article							HONG-KONG; HEMAGGLUTININ; SUBSTITUTION; INFECTION	Background: Pregnant women infected by the pandemic influenza A (H1N1) 2009 virus had more severe disease and higher mortality but its pathogenesis is still unclear. Principal Findings: We showed that higher mortality, more severe pneumonitis, higher pulmonary viral load, lower peripheral blood T lymphocytes and antibody responses, higher levels of proinflammatory cytokines and chemokines, and worse fetal development occurred in pregnant mice than non-pregnant controls infected by either wild type (clinical isolate) or mouse-adapted mutant virus with D222G substitution in hemagglutinin. These disease-associated changes and the lower respiratory tract involvement were worse in pregnant mice challenged by mutant virus. Though human placental origin JEG-3 cell line could be infected and proinflammatory cytokines or chemokines were elevated in amniotic fluid of some mice, no placental or fetal involvement by virus were detected by culture, real-time reverse transcription polymerase chain reaction or histopathological changes. Dual immunofluorescent staining of viral nucleoprotein and type II alveolar cell marker SP-C protein suggested that the majority of infected alveolar epithelial cells were type II pneumocytes. Conclusion: The adverse effect of this pandemic virus on maternal and fetal outcome is largely related to the severe pulmonary disease and the indirect effect of inflammatory cytokine spillover into the systemic circulation.	[Chan, Kwok-Hung; Zhang, Anna J. X.; To, Kelvin K. W.; Chan, Chris C. S.; Poon, Vincent K. M.; Guo, Kunyuan; Ng, Fai; Zhang, Qi-Wei; Leung, Virtual H. C.; Lau, Candy C. Y.; Woo, Patrick C. Y.; Tse, Herman; Wu, Wailan; Chen, Honglin; Zheng, Bo-Jian; Yuen, Kwok-Yung] Univ Hong Kong, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China; [Cheung, Annie N. Y.] Univ Hong Kong, Dept Pathol, Hong Kong, Hong Kong, Peoples R China; [Zhang, Anna J. X.; To, Kelvin K. W.; Woo, Patrick C. Y.; Tse, Herman; Chen, Honglin; Zheng, Bo-Jian; Yuen, Kwok-Yung] Univ Hong Kong, Res Ctr Infect & Immunol, Hong Kong, Hong Kong, Peoples R China; [Zhang, Anna J. X.; To, Kelvin K. W.; Woo, Patrick C. Y.; Tse, Herman; Chen, Honglin; Zheng, Bo-Jian; Yuen, Kwok-Yung] Univ Hong Kong, State Key Lab Emerging Infect Dis, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Hong Kong	Chan, KH (corresponding author), Univ Hong Kong, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China.	kyyuen@hkucc.hku.hk	Chan, Kwok Hung/ABD-5399-2021; Tse, Herman/C-4425-2009; Chen, Honglin/C-4224-2009; To, Kelvin/AAV-7007-2020; Zhang, Qiwei/AAX-1977-2020; Zhang, Qiwei/D-9110-2012; Woo, Patrick Chiu Yat/C-4449-2009; Cheung, Annie Nga Yin/C-4231-2009; Zhang, Jinxia/C-4470-2009	Chen, Honglin/0000-0001-5108-8338; To, Kelvin/0000-0002-1921-5824; Zhang, Qiwei/0000-0002-2770-111X; Poon, Vincent kwok-man/0000-0002-7737-8912; Woo, Patrick Chiu Yat/0000-0001-9401-1832; Cheung, Annie Nga Yin/0000-0002-1584-7568; Yuen, Kwok-yung/0000-0002-2083-1552; Zhang, Jinxia/0000-0002-5087-3614	Ted Sun Foundation; Ms. Teresa Wong On Yik, Research Fund for the Control of Infectious Diseases of the Food and Health Bureau; Research Grants Council of the Hong Kong Special Administrative Region, China	Ted Sun Foundation; Ms. Teresa Wong On Yik, Research Fund for the Control of Infectious Diseases of the Food and Health Bureau; Research Grants Council of the Hong Kong Special Administrative Region, China(Hong Kong Research Grants Council)	The authors are grateful to the support from the Ted Sun Foundation, the Clinical Infectious Diseases Research Endowment Fund from Ms. Teresa Wong On Yik, Research Fund for the Control of Infectious Diseases of the Food and Health Bureau, and the Research Grants Council of the Hong Kong Special Administrative Region, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acs N, 2005, BIRTH DEFECTS RES A, V73, P989, DOI 10.1002/bdra.20195; Chen BY, 2009, MOL VIS, V15, P2821; Chen HL, 2010, J INFECT DIS, V201, P1517, DOI 10.1086/652661; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; Glaser L, 2005, J VIROL, V79, P11533, DOI 10.1128/JVI.79.17.11533-11536.2005; Gordon CL, 2010, CLIN INFECT DIS, V50, P672, DOI 10.1086/650462; Napolitano L. M., 2009, Morbidity and Mortality Weekly Report, V58, P749; Gu J, 2007, LANCET, V370, P1137, DOI 10.1016/S0140-6736(07)61515-3; Hancock K, 2009, NEW ENGL J MED, V361, P1945, DOI 10.1056/NEJMoa0906453; Hensley SE, 2009, SCIENCE, V326, P734, DOI 10.1126/science.1178258; Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260; Jain S, 2009, NEW ENGL J MED, V361, P1935, DOI 10.1056/NEJMoa0906695; Jamieson DJ, 2006, EMERG INFECT DIS, V12, P1638, DOI 10.3201/eid1211.060152; Jamieson DJ, 2009, LANCET, V374, P451, DOI 10.1016/S0140-6736(09)61304-0; Kilander A, 2010, EURO SURVEILL, V15; Lau SKP, 2009, J CLIN MICROBIOL, V47, P2344, DOI 10.1128/JCM.00924-09; Li IWS, 2009, J CLIN VIROL, V46, P325, DOI 10.1016/j.jcv.2009.09.013; Louie JK, 2010, NEW ENGL J MED, V362, P27, DOI 10.1056/NEJMoa0910444; Maines TR, 2009, SCIENCE, V325, P484, DOI 10.1126/science.1177238; Mak GC, 2010, EUROSURVEILLANCE, V15, P15; Melidou A, 2010, VIRUS RES, V151, P192, DOI 10.1016/j.virusres.2010.05.005; MILLER RR, 2010, EURO SURVEILL, V15; Neuzil KM, 1998, AM J EPIDEMIOL, V148, P1094, DOI 10.1093/oxfordjournals.aje.a009587; Seppelt I, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1279; SHORT SJ, 2010, BIOL PSYCHIAT; To KKW, 2010, CLIN INFECT DIS, V50, P850, DOI 10.1086/650581; TO KK, 2010, POSTGRAD MED J; Tunbridge AJ, 2008, J INFECTION, V57, P95, DOI 10.1016/j.jinf.2008.03.004; Woo PCY, 2010, J INFECT DIS, V201, P346, DOI 10.1086/649785; World Health Organization, 2010, WKLY EPIDEMIOL REC, V85, P21; YAWN DH, 1971, J AMER MED ASSOC, V216, P1022, DOI 10.1001/jama.216.6.1022; ZHENG BJ, 2010, EXP BIOL MED; Zheng BJ, 2008, P NATL ACAD SCI USA, V105, P8091, DOI 10.1073/pnas.0711942105	33	57	62	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2010	5	10							e13757	10.1371/journal.pone.0013757	http://dx.doi.org/10.1371/journal.pone.0013757			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673FU	21060798	Green Published, Green Submitted, gold			2022-12-27	WOS:000283645300036
J	Li, QA; Wang, XH; Lu, ZM; Zhang, BZ; Guan, ZP; Liu, ZJ; Zhong, QM; Gu, LK; Zhou, J; Zhu, BD; Ji, JF; Deng, DJ				Li, Qiang; Wang, Xiuhong; Lu, Zheming; Zhang, Baozhen; Guan, Zhenpo; Liu, Zhaojun; Zhong, Qiming; Gu, Liankun; Zhou, Jing; Zhu, Budong; Ji, Jiafu; Deng, Dajun			Polycomb CBX7 Directly Controls Trimethylation of Histone H3 at Lysine 9 at the p16 Locus	PLOS ONE			English	Article							TUMOR-SUPPRESSOR; CHROMOBOX PROTEIN; GENE-EXPRESSION; INK4A-ARF LOCUS; DNA METHYLATION; HUMAN CANCERS; CELLS; ISLAND; HETEROCHROMATIN; PROGRESSION	Background: H3K9 trimethylation (H3K9me3) and binding of PcG repressor complex-1 (PRC1) may play crucial roles in the epigenetic silencing of the p16 gene. However, the mechanism of the initiation of this trimethylation is unknown. Methodology/Principal Findings: In the present study, we found that upregulating the expression of PRC1 component Cbx7 in gastric cancer cell lines MGC803 and BGC823 led to significantly suppress the expression of genes within the p16-Arf-p15 locus. H3K9me3 formation was observed at the p16 promoter and Regulatory Domain (RD). CBX7 and SUV39H2 binding to these regions were also detectable in the CBX7-stably upregulated cells. CBX7-SUV39H2 complexes were observed within nucleus in bimolecular fluorescence complementation assay (BiFC). Mutations of the chromodomain or deletion of Pc-box abolished the CBX7-binding and H3K9me3 formation, and thus partially repressed the function of CBX7. SiRNA-knockdown of Suv39h2 blocked the repressive effect of CBX7 on p16 transcription. Moreover, we found that expression of CBX7 in gastric carcinoma tissues with p16 methylation was significantly lower than that in their corresponding normal tissues, which showed a negative correlation with transcription of p16 in gastric mucosa. Conclusion/Significance: These results demonstrated for the first time, to our knowledge, that CBX7 could initiate H3K9me3 formation at the p16 promoter.	[Li, Qiang; Wang, Xiuhong; Lu, Zheming; Zhang, Baozhen; Guan, Zhenpo; Liu, Zhaojun; Zhong, Qiming; Gu, Liankun; Zhou, Jing; Deng, Dajun] Peking Univ, Canc Hosp & Inst, Dept Etiol, Key Lab Carcinogenesis & Translat Res,Minist Educ, Beijing 100871, Peoples R China; [Zhu, Budong] Peking Univ, Canc Hosp & Inst, Dept Internal Med, Beijing 100871, Peoples R China; [Ji, Jiafu] Peking Univ, Canc Hosp & Inst, Dept Surg, Beijing 100871, Peoples R China	Peking University; Peking University; Peking University	Li, QA (corresponding author), Peking Univ, Canc Hosp & Inst, Dept Etiol, Key Lab Carcinogenesis & Translat Res,Minist Educ, Beijing 100871, Peoples R China.	dengdajun@bjmu.edu.cn	Deng, Dajun/D-4605-2009; liu, zhao/GXV-6141-2022	Deng, Dajun/0000-0001-5161-5943; JI, JIAFU/0000-0001-6878-5543	National Basic Research Program of China (973 Program) [2005CB522403, 2011CB504201]; Natural Science Foundation of China [30571056, 90919015, 30921140311]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by National Basic Research Program of China (973 Program 2005CB522403 and 2011CB504201) and Natural Science Foundation of China (30571056, 90919015, and 30921140311). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bernard D, 2005, ONCOGENE, V24, P5543, DOI 10.1038/sj.onc.1208735; Bernstein E, 2006, MOL CELL BIOL, V26, P2560, DOI 10.1128/MCB.26.7.2560-2569.2006; Bracken AP, 2007, GENE DEV, V21, P525, DOI 10.1101/gad.415507; Cao J, 2009, CLIN CANCER RES, V15, P5178, DOI 10.1158/1078-0432.CCR-09-0580; Dietrich N, 2007, EMBO J, V26, P1637, DOI 10.1038/sj.emboj.7601632; Eads C, 2002, METHOD MOL BIOL, V200, P53; Ezhkova E, 2009, CELL, V136, P1122, DOI 10.1016/j.cell.2008.12.043; Federico A, 2009, CANCER RES, V69, P7079, DOI 10.1158/0008-5472.CAN-09-1542; Gil J, 2004, NAT CELL BIOL, V6, P67, DOI 10.1038/ncb1077; Gil J, 2006, NAT REV MOL CELL BIO, V7, P667, DOI 10.1038/nrm1987; Gonzalez S, 2006, NATURE, V440, P702, DOI 10.1038/nature04585; GONZALEZZULUETA M, 1995, CANCER RES, V55, P4531; Guo WJ, 2007, CANCER RES, V67, P5083, DOI 10.1158/0008-5472.CAN-06-4368; Hahn MA, 2008, CANCER RES, V68, P10280, DOI 10.1158/0008-5472.CAN-08-1957; HERMAN JG, 1995, CANCER RES, V55, P4525; Hinz S, 2008, TUMOR BIOL, V29, P323, DOI 10.1159/000170879; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Luo DY, 2006, LAB INVEST, V86, P591, DOI 10.1038/labinvest.3700415; Maertens GN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006380; MERLO A, 1995, NAT MED, V1, P686, DOI 10.1038/nm0795-686; Mohammad HP, 2009, CANCER RES, V69, P6322, DOI 10.1158/0008-5472.CAN-09-0065; O'Carroll D, 2000, MOL CELL BIOL, V20, P9423, DOI 10.1128/MCB.20.24.9423-9433.2000; Pallante P, 2008, CANCER RES, V68, P6770, DOI 10.1158/0008-5472.CAN-08-0695; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Scott CL, 2007, P NATL ACAD SCI USA, V104, P5389, DOI 10.1073/pnas.0608721104; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Simon JA, 2009, NAT REV MOL CELL BIO, V10, P697, DOI 10.1038/nrm2763; Sparmann A, 2006, NAT REV CANCER, V6, P846, DOI 10.1038/nrc1991; Tachibana M, 2002, GENE DEV, V16, P1779, DOI 10.1101/gad.989402; Vincenz C, 2008, P NATL ACAD SCI USA, V105, P16572, DOI 10.1073/pnas.0805317105; Vire E, 2006, NATURE, V439, P871, DOI 10.1038/nature04431; Zhang BZ, 2008, CANCER EPIDEM BIOMAR, V17, P2402, DOI 10.1158/1055-9965.EPI-08-0315	35	24	29	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2010	5	10							e13732	10.1371/journal.pone.0013732	http://dx.doi.org/10.1371/journal.pone.0013732			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673FU	21060834	Green Submitted, Green Published, gold			2022-12-27	WOS:000283645300013
J	Mittapalli, O; Bai, XD; Mamidala, P; Rajarapu, SP; Bonello, P; Herms, DA				Mittapalli, Omprakash; Bai, Xiaodong; Mamidala, Praveen; Rajarapu, Swapna Priya; Bonello, Pierluigi; Herms, Daniel A.			Tissue-Specific Transcriptomics of the Exotic Invasive Insect Pest Emerald Ash Borer (Agrilus planipennis)	PLOS ONE			English	Article							CYTOCHROME-P450 GENES; NORTH-AMERICAN; WOLBACHIA INFECTION; TOBACCO HORNWORM; CYP4 FAMILY; EXPRESSION; RESISTANCE; ANNOTATION; PROTEIN; MIDGUT	Background: The insect midgut and fat body represent major tissue interfaces that deal with several important physiological functions including digestion, detoxification and immune response. The emerald ash borer (Agrilus planipennis), is an exotic invasive insect pest that has killed millions of ash trees (Fraxinus spp.) primarily in the Midwestern United States and Ontario, Canada. However, despite its high impact status little knowledge exists for A. planipennis at the molecular level. Methodology and Principal Findings: Newer-generation Roche-454 pyrosequencing was used to obtain 126,185 reads for the midgut and 240,848 reads for the fat body, which were assembled into 25,173 and 37,661 high quality expressed sequence tags (ESTs) for the midgut and the fat body of A. planipennis larvae, respectively. Among these ESTs, 36% of the midgut and 38% of the fat body sequences showed similarity to proteins in the GenBank nr database. A high number of the midgut sequences contained chitin-binding peritrophin (248) and trypsin (98) domains; while the fat body sequences showed high occurrence of cytochrome P450s (85) and protein kinase (123) domains. Further, the midgut transcriptome of A. planipennis revealed putative microbial transcripts encoding for cell-wall degrading enzymes such as polygalacturonases and endoglucanases. A significant number of SNPs (137 in midgut and 347 in fat body) and microsatellite loci (317 in midgut and 571 in fat body) were predicted in the A. planipennis transcripts. An initial assessment of cytochrome P450s belonging to various CYP clades revealed distinct expression patterns at the tissue level. Conclusions and Significance: To our knowledge this study is one of the first to illuminate tissue-specific gene expression in an invasive insect of high ecological and economic consequence. These findings will lay the foundation for future gene expression and functional studies in A. planipennis.	[Mittapalli, Omprakash; Bai, Xiaodong; Mamidala, Praveen; Rajarapu, Swapna Priya; Herms, Daniel A.] Ohio State Univ, Ohio Agr & Res Dev Ctr, Dept Entomol, Wooster, OH USA; [Bonello, Pierluigi] Ohio State Univ, Dept Plant Pathol, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Mittapalli, O (corresponding author), Ohio State Univ, Ohio Agr & Res Dev Ctr, Dept Entomol, Wooster, OH USA.	mittapalli.1@osu.edu	Rajarapu, Swapna Priya/H-3514-2019; Bonello, Pierluigi/E-2776-2011	Bonello, Pierluigi/0000-0002-7207-7651; Mamidala, Praveen/0000-0001-8587-0635	USDA APHIS/USDA Forest Service [GRT00011769/60016270]; Ohio Agricultural Research and Development Center, The Ohio State University	USDA APHIS/USDA Forest Service(United States Department of Agriculture (USDA)United States Forest Service); Ohio Agricultural Research and Development Center, The Ohio State University(Ohio State University)	The research was supported by a grant from the USDA APHIS/USDA Forest Service Accelerated Emerald Ash Borer Research Program (GRT00011769/60016270), and by State and Federal funds appropriated to the Ohio Agricultural Research and Development Center, The Ohio State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKIYAMA K, 2000, ICONIC SERIES INSECT, V4; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anulewicz Andrea C., 2007, Arboriculture & Urban Forestry, V33, P338; Arrese EL, 2010, ANNU REV ENTOMOL, V55, P207, DOI 10.1146/annurev-ento-112408-085356; Bai XD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011370; Bauer LS, 2005, P EM ASH BOR RES TEC, P71; Bentley DR, 2006, CURR OPIN GENET DEV, V16, P545, DOI 10.1016/j.gde.2006.10.009; BERENBAUM MR, 1992, ACS SYM SER, V505, P114; Bhandary Binny, 2010, J Vis Exp, DOI 10.3791/1974; Bishop JG, 2005, GENETICS, V169, P1009, DOI 10.1534/genetics.103.025098; Bogwitz MR, 2005, P NATL ACAD SCI USA, V102, P12807, DOI 10.1073/pnas.0503709102; Bourtzis K, 1996, GENETICS, V144, P1063; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Cappaert David, 2005, American Entomologist, V51, P152; Chuma S, 2006, P NATL ACAD SCI USA, V103, P15894, DOI 10.1073/pnas.0601878103; Claudianos C, 2006, INSECT MOL BIOL, V15, P615, DOI 10.1111/j.1365-2583.2006.00672.x; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Davies L, 2006, INSECT BIOCHEM MOLEC, V36, P801, DOI 10.1016/j.ibmb.2006.08.001; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Elvin CM, 1996, J BIOL CHEM, V271, P8925, DOI 10.1074/jbc.271.15.8925; Eyles A, 2007, J CHEM ECOL, V33, P1430, DOI 10.1007/s10886-007-9312-3; FELTON GW, 1991, J CHEM ECOL, V17, P1715, DOI 10.1007/BF00993724; Feyereisen R, 2006, BIOCHEM SOC T, V34, P1252, DOI 10.1042/BST0341252; Feyereisen R, 1999, ANNU REV ENTOMOL, V44, P507, DOI 10.1146/annurev.ento.44.1.507; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Gandhi KJK, 2010, BIOL INVASIONS, V12, P1839, DOI 10.1007/s10530-009-9594-1; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; GOULD J, 2004, USDA FOREST HLTH TEC, P73; Haack R.A., 2002, NEWSLETTER MICHIGAN, V47, P1; Hartman JJ, 1998, CELL, V93, P277, DOI 10.1016/S0092-8674(00)81578-0; Heddi A, 1999, P NATL ACAD SCI USA, V96, P6814, DOI 10.1073/pnas.96.12.6814; Hegedus D, 2009, ANNU REV ENTOMOL, V54, P285, DOI 10.1146/annurev.ento.54.110807.090559; Hemingway J, 1998, MED VET ENTOMOL, V12, P1, DOI 10.1046/j.1365-2915.1998.00082.x; Herms D. A., 2004, Special Circular - Ohio Agricultural Research and Development Center, P62; HOU Y, 2007, SHENG WU GONG CHENG, V5, P867; Houwing S, 2007, CELL, V129, P69, DOI 10.1016/j.cell.2007.03.026; Jeyaprakash A, 2000, INSECT MOL BIOL, V9, P393, DOI 10.1046/j.1365-2583.2000.00203.x; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kim VN, 2006, GENE DEV, V20, P1993, DOI 10.1101/gad.1456106; Lehane MJ, 1997, ANNU REV ENTOMOL, V42, P525, DOI 10.1146/annurev.ento.42.1.525; Liebherr J.K., 2003, ENCY INSECTS, P209; LIEBHOLD AM, 1995, FOREST SCI, V41, P1; Mao YB, 2007, NAT BIOTECHNOL, V25, P1307, DOI 10.1038/nbt1352; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Mittapalli O, 2005, INSECT BIOCHEM MOLEC, V35, P981, DOI 10.1016/j.ibmb.2005.03.011; Mittapalli O, 2007, P NATL ACAD SCI USA, V104, P1889, DOI 10.1073/pnas.0604722104; Mittapalli O, 2006, J INSECT PHYSIOL, V52, P1143, DOI 10.1016/j.jinsphys.2006.08.007; Morozova O, 2008, GENOMICS, V92, P255, DOI 10.1016/j.ygeno.2008.07.001; Nakabachi A, 2005, P NATL ACAD SCI USA, V102, P5477, DOI 10.1073/pnas.0409034102; Pauchet Y, 2010, INSECT MOL BIOL, V19, P61, DOI 10.1111/j.1365-2583.2009.00936.x; Pauchet Y, 2009, INSECT BIOCHEM MOLEC, V39, P403, DOI 10.1016/j.ibmb.2009.04.001; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Poland TM, 2006, J FOREST, V104, P118; Rebek EJ, 2008, ENVIRON ENTOMOL, V37, P242, DOI 10.1603/0046-225X(2008)37[242:IVIRTE]2.0.CO;2; Rewitz KF, 2006, INSECT BIOCHEM MOLEC, V36, P188, DOI 10.1016/j.ibmb.2005.12.002; Richards S, 2008, NATURE, V452, P949, DOI 10.1038/nature06784; Rogers R., 1990, SILVICS N AM, V2; Salzberg S. L., 2005, GENOME BIOL, V6; SCHAEFER PW, 2005, USDA FOREST HLTH TEC, P67; Scharf ME, 2001, INSECT MOL BIOL, V10, P139, DOI 10.1046/j.1365-2583.2001.00248.x; Smith A., 2006, THESIS OHIO STATE U, P122; Smith TF, 1999, TRENDS BIOCHEM SCI, V24, P181, DOI 10.1016/S0968-0004(99)01384-5; SNYDER MJ, 1995, ARCH BIOCHEM BIOPHYS, V321, P13, DOI 10.1006/abbi.1995.1362; THURSTON MI, 2005, MSATFINDER DETECTION; Tittiger C, 2005, RECENT ADV PHYTOCHEM, V39, P57; Vasanthakumar A, 2008, ENVIRON ENTOMOL, V37, P1344, DOI 10.1603/0046-225X(2008)37[1344:GMOAIS]2.0.CO;2; Vasemagi A, 2005, MOL BIOL EVOL, V22, P1067, DOI 10.1093/molbev/msi093; Vlachou D, 2005, CURR BIOL, V15, P1185, DOI 10.1016/j.cub.2005.06.044; Wang G, 2008, CURR BIOL, V18, P861, DOI 10.1016/j.cub.2008.05.009; WERCKREICHHART, 2000, GENOME BIOL, V1; Werren JH, 2000, P ROY SOC B-BIOL SCI, V267, P1277, DOI 10.1098/rspb.2000.1139; Yang YH, 2006, J ECON ENTOMOL, V99, P1784, DOI 10.1603/0022-0493-99.5.1784; Yu C., 1992, FOREST INSECTS CHINA, V2nd, P400; Yu QY, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-553; Zimmer C, 2001, SCIENCE, V292, P1093, DOI 10.1126/science.292.5519.1093	76	68	75	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2010	5	10							e13708	10.1371/journal.pone.0013708	http://dx.doi.org/10.1371/journal.pone.0013708			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	672HN	21060843	gold, Green Published, Green Submitted			2022-12-27	WOS:000283573800009
J	Albert, E; Walker, J; Thiesen, A; Churchill, T; Madsen, K				Albert, Eric; Walker, John; Thiesen, Aducio; Churchill, Thomas; Madsen, Karen			cis-Urocanic Acid Attenuates Acute Dextran Sodium Sulphate-Induced Intestinal Inflammation	PLOS ONE			English	Article							DELTA-T-CELL; BOWEL-DISEASE; INTERLEUKIN-10-DEFICIENT MICE; ULTRAVIOLET-RADIATION; INDUCED COLITIS; SUPPRESSES; GENE; SUSCEPTIBILITY; DEFICIENT; RESPONSES	On exposure to sunlight, urocanic acid (UCA) in the skin is converted from trans to the cis form and distributed systemically where it confers systemic immunosuppression. The aim of this study was to determine if administration of cis-UCA would be effective in attenuating colitis and the possible role of IL-10. Colitis was induced in 129/SvEv mice by administering 5% dextran sodium sulfate (DSS) for 7 days in drinking water. During this period mice received daily subcutaneously injections of cis-UCA or vehicle. To examine a role for IL-10, 129/SvEv IL-10(-/-) mice were injected for 24 days with cis-UCA or vehicle. Clinical disease was assessed by measurement of body weight, stool consistency, and presence of blood. At sacrifice, colonic tissue was collected for histology and measurement of myeloperoxidase and cytokines. Splenocytes were analyzed for CD4+CD25+FoxP3+ T-regulatory cells via flow cytometry. Murine bone-marrow derived antigen-presenting cells were treated with lipopolysaccharide (LPS) +/- UCA and cytokine secretion measured. Our results demonstrated that cis-UCA at a dose of 50 mu g was effective in ameliorating DSS-induced colitis as evidenced by reduced weight loss and attenuated changes in colon weight/length. This protection was associated with reduced colonic expression of CXCL1, an increased expression of IL-17A and a significant preservation of splenic CD4+CD25+FoxP3+ T-regulatory cells. cis-UCA decreased LPS induced CXCL1, but not TNF alpha secretion, from antigen-presenting cells in vitro. UCA reduced colonic levels of IFN gamma in IL-10(-/-) mice but did not attenuate colitis. In conclusion, this study demonstrates that cis-urocanic acid is effective in reducing the severity of colitis in a chemically-induced mouse model, indicating that pathways induced by ultraviolet radiation to the skin can influence distal sites of inflammation. This provides further evidence for a possible role for sunlight exposure in modulating inflammatory disorders.	[Albert, Eric; Walker, John; Madsen, Karen] Univ Alberta, Dept Med, Edmonton, AB, Canada; [Thiesen, Aducio] Univ Alberta, Dept Lab Med & Pathol, Edmonton, AB, Canada; [Churchill, Thomas] Univ Alberta, Dept Surg, Edmonton, AB, Canada	University of Alberta; University of Alberta; University of Alberta	Albert, E (corresponding author), Univ Alberta, Dept Med, Edmonton, AB, Canada.	karen.madsen@ualberta.ca	Madsen, Karen L/H-5898-2011		Alberta Heritage Foundation for Medical Research; Canadian Institutes for Health Research; Alberta IBD Consortium; Crohns and Colitis Foundation of Canada	Alberta Heritage Foundation for Medical Research(Alberta Heritage Foundation for Medical ResearchGeneral Electric); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Alberta IBD Consortium; Crohns and Colitis Foundation of Canada	These studies were supported by the Alberta Heritage Foundation for Medical Research, Canadian Institutes for Health Research, Alberta IBD Consortium, and Crohns and Colitis Foundation of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Beissert S, 1997, J IMMUNOL, V159, P92; Berg DJ, 1996, J CLIN INVEST, V98, P1010, DOI 10.1172/JCI118861; Buanne P, 2007, J LEUKOCYTE BIOL, V82, P1239, DOI 10.1189/jlb.0207118; Danese S, 2004, AUTOIMMUN REV, V3, P394, DOI 10.1016/j.autrev.2004.03.002; DEFABO EC, 1983, J EXP MED, V158, P84, DOI 10.1084/jem.158.1.84; DIELEMAN LA, 1994, GASTROENTEROLOGY, V107, P1643, DOI 10.1016/0016-5085(94)90803-6; Freitas A, 2009, J IMMUNOL, V182, P7846, DOI 10.4049/jimmunol.0803039; Garssen J, 1999, IMMUNOLOGY, V96, P298, DOI 10.1046/j.1365-2567.1999.00698.x; Gibbs NK, 2008, PHOTOCH PHOTOBIO SCI, V7, P655, DOI 10.1039/b717398a; HART PH, 1993, J IMMUNOL, V150, P4514; Henry T, 2010, J IMMUNOL, V184, P3755, DOI 10.4049/jimmunol.0902065; Holan V, 1998, J IMMUNOL, V161, P3237; Iwakura Y, 2008, IMMUNOL REV, V226, P57, DOI 10.1111/j.1600-065X.2008.00699.x; Kaneko K, 2008, J IMMUNOL, V181, P217, DOI 10.4049/jimmunol.181.1.217; Kapp JA, 2004, IMMUNOLOGY, V111, P155, DOI 10.1111/j.0019-2805.2003.01793.x; Kivisto K, 1996, INFLAMMATION, V20, P451, DOI 10.1007/BF01487038; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Loftus EV, 2004, GASTROENTEROLOGY, V126, P1504, DOI 10.1053/j.gastro.2004.01.063; Madsen KL, 1999, GASTROENTEROLOGY, V116, P1107, DOI 10.1016/S0016-5085(99)70013-2; Martin B, 2009, IMMUNITY, V31, P321, DOI 10.1016/j.immuni.2009.06.020; MAZZUCCHELLI L, 1994, AM J PATHOL, V144, P997; MORA JR, 2008, NAT REV IMMUNOL; Nerich V, 2006, INFLAMM BOWEL DIS, V12, P218, DOI 10.1097/01.MIB.0000206540.38834.8c; O'Connor W, 2009, NAT IMMUNOL, V10, P603, DOI 10.1038/ni.1736; Ogawa A, 2004, CLIN IMMUNOL, V110, P55, DOI 10.1016/j.clim.2003.09.013; Peyrin-Biroulet L, 2009, MED HYPOTHESES, V73, P94, DOI 10.1016/j.mehy.2009.01.022; Ponsoby AL, 2002, TOXICOLOGY, V181, P71, DOI 10.1016/S0300-483X(02)00257-3; Prater MR, 2003, PHOTODERMATOL PHOTO, V19, P287, DOI 10.1046/j.1600-0781.2003.00058.x; Rhodes KA, 2008, EUR J IMMUNOL, V38, P2274, DOI 10.1002/eji.200838354; Rinaldi M, 2006, J DAIRY SCI, V89, P4188, DOI 10.3168/jds.S0022-0302(06)72464-X; Roark CL, 2008, CURR OPIN IMMUNOL, V20, P353, DOI 10.1016/j.coi.2008.03.006; Schwarz A, 2004, J IMMUNOL, V172, P1036, DOI 10.4049/jimmunol.172.2.1036; Shea-Donohue T, 2008, INNATE IMMUN-LONDON, V14, P117, DOI 10.1177/1753425908088724; Shreedhar VK, 1998, J IMMUNOL, V161, P1327; SONNENBERG A, 1991, GASTROENTEROLOGY, V100, P143, DOI 10.1016/0016-5085(91)90594-B; Sutton CE, 2009, IMMUNITY, V31, P331, DOI 10.1016/j.immuni.2009.08.001; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Xu S, 2010, CELL MOL IMMUNOL, V7, P164, DOI 10.1038/cmi.2010.21	40	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2010	5	10							e13676	10.1371/journal.pone.0013676	http://dx.doi.org/10.1371/journal.pone.0013676			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671UN	21060867	gold, Green Published, Green Submitted			2022-12-27	WOS:000283537000042
J	Pardini, R; Bueno, AD; Gardner, TA; Prado, PI; Metzger, JP				Pardini, Renata; Bueno, Adriana de Arruda; Gardner, Toby A.; Prado, Paulo Inacio; Metzger, Jean Paul			Beyond the Fragmentation Threshold Hypothesis: Regime Shifts in Biodiversity Across Fragmented Landscapes	PLOS ONE			English	Article							ATLANTIC-FOREST; HABITAT FRAGMENTATION; SPECIES-DIVERSITY; SMALL MAMMALS; STABLE STATES; CONSERVATION; RESPONSES; RESILIENCE; COVER; TIME	Ecological systems are vulnerable to irreversible change when key system properties are pushed over thresholds, resulting in the loss of resilience and the precipitation of a regime shift. Perhaps the most important of such properties in human-modified landscapes is the total amount of remnant native vegetation. In a seminal study Andren proposed the existence of a fragmentation threshold in the total amount of remnant vegetation, below which landscape-scale connectivity is eroded and local species richness and abundance become dependent on patch size. Despite the fact that species patch-area effects have been a mainstay of conservation science there has yet to be a robust empirical evaluation of this hypothesis. Here we present and test a new conceptual model describing the mechanisms and consequences of biodiversity change in fragmented landscapes, identifying the fragmentation threshold as a first step in a positive feedback mechanism that has the capacity to impair ecological resilience, and drive a regime shift in biodiversity. The model considers that local extinction risk is defined by patch size, and immigration rates by landscape vegetation cover, and that the recovery from local species losses depends upon the landscape species pool. Using a unique dataset on the distribution of non-volant small mammals across replicate landscapes in the Atlantic forest of Brazil, we found strong evidence for our model predictions - that patch-area effects are evident only at intermediate levels of total forest cover, where landscape diversity is still high and opportunities for enhancing biodiversity through local management are greatest. Furthermore, high levels of forest loss can push native biota through an extinction filter, and result in the abrupt, landscape-wide loss of forest-specialist taxa, ecological resilience and management effectiveness. The proposed model links hitherto distinct theoretical approaches within a single framework, providing a powerful tool for analysing the potential effectiveness of management interventions.	[Pardini, Renata; Bueno, Adriana de Arruda] Univ Sao Paulo, Inst Biociencias, Dept Zool, Sao Paulo, Brazil; [Gardner, Toby A.] Univ Cambridge, Dept Zool, Cambridge, England; [Prado, Paulo Inacio; Metzger, Jean Paul] Univ Sao Paulo, Inst Biociencias, Dept Ecol, Sao Paulo, Brazil	Universidade de Sao Paulo; University of Cambridge; Universidade de Sao Paulo	Pardini, R (corresponding author), Univ Sao Paulo, Inst Biociencias, Dept Zool, Sao Paulo, Brazil.	renatapardini@uol.com.br	Gardner, Toby/B-7516-2008; Prado, Paulo I/G-3353-2012; Prado, Paulo Inácio/AAN-6512-2021; Metzger, Jean Paul/C-2514-2012; Pardini, Renata/C-4095-2012; McLean, Laurence JA/C-7367-2014	Prado, Paulo Inácio/0000-0002-7174-5005; Metzger, Jean Paul/0000-0002-0087-5240; Pardini, Renata/0000-0002-3769-8401; 	FAPESP - Fundacao de Amaparo a Pesquisa do Estado de Sao Paulo [05/56555-4]; CNPq - Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; BMBF - Bundesministerium fur Bildung und Forschung [690144/01-6]; CAPES - Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; NERC - Natural Environment Research Council [NE/F01614X/1]; NERC [NE/F01614X/1] Funding Source: UKRI; Natural Environment Research Council [NE/F01614X/1] Funding Source: researchfish	FAPESP - Fundacao de Amaparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq - Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); BMBF - Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); CAPES - Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); NERC - Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was funded by FAPESP - Fundacao de Amaparo a Pesquisa do Estado de Sao Paulo - http://www.fapesp.br (05/56555-4); CNPq - Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - http://www.cnpq.br/BMBF - Bundesministerium fur Bildung und Forschung - http://www.bmbf.de (690144/01-6); CAPES - Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - http://www.capes.gov.br; and NERC - Natural Environment Research Council - http://www.nerc.ac.uk (NE/F01614X/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andren H, 1997, OIKOS, V80, P193, DOI 10.2307/3546534; Andren H, 1996, OIKOS, V76, P235, DOI 10.2307/3546195; ANDREN H, 1994, OIKOS, V71, P355, DOI 10.2307/3545823; Arroyo-Rodriguez V, 2009, CONSERV BIOL, V23, P729, DOI 10.1111/j.1523-1739.2008.01120.x; Bengtsson J, 2003, AMBIO, V32, P389, DOI 10.1639/0044-7447(2003)032[0389:RRADL]2.0.CO;2; Bennett AF, 2006, BIOL CONSERV, V133, P250, DOI 10.1016/j.biocon.2006.06.008; Biggs R, 2009, P NATL ACAD SCI USA, V106, P826, DOI 10.1073/pnas.0811729106; BOLKER B, 2008, PACKAGE BBMLE TOOLS; Bottrill MC, 2008, TRENDS ECOL EVOL, V23, P649, DOI 10.1016/j.tree.2008.07.007; Brewer SW, 1999, J VEG SCI, V10, P165, DOI 10.2307/3237138; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Charrette NA, 2006, ECOLOGY, V87, P2330, DOI 10.1890/0012-9658(2006)87[2330:RSBBAL]2.0.CO;2; Colles A, 2009, ECOL LETT, V12, P849, DOI 10.1111/j.1461-0248.2009.01336.x; DeLonge M, 2008, GLOBAL CHANGE BIOL, V14, P154, DOI 10.1111/j.1365-2486.2007.01470.x; Devictor V, 2010, J APPL ECOL, V47, P15, DOI 10.1111/j.1365-2664.2009.01744.x; Devictor V, 2009, DIVERS DISTRIB, V15, P122, DOI 10.1111/j.1472-4642.2008.00510.x; Fahrig L, 2002, ECOL APPL, V12, P346, DOI 10.1890/1051-0761(2002)012[0346:EOHFOT]2.0.CO;2; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Ferraro PJ, 2006, PLOS BIOL, V4, P482, DOI 10.1371/journal.pbio.0040105; Figueiredo LTM, 2009, EMERG INFECT DIS, V15, P561, DOI 10.3201/eid1504.080289; Filippi-Codaccioni O, 2010, BIOL CONSERV, V143, P1493, DOI 10.1016/j.biocon.2010.03.031; Fischer J, 2007, CONSERV SCI PRACT, V1, P229, DOI 10.1002/9780470692400.ch20; Folke C, 2004, ANNU REV ECOL EVOL S, V35, P557, DOI 10.1146/annurev.ecolsys.35.021103.105711; Gaggiotti Oscar E., 2004, P337, DOI 10.1016/B978-012323448-3/50016-7; Gardner TA, 2009, ECOL LETT, V12, P561, DOI 10.1111/j.1461-0248.2009.01294.x; Glazier DS, 2002, J BIOGEOGR, V29, P81, DOI 10.1046/j.1365-2699.2002.00646.x; Griffen BD, 2008, J ANIM ECOL, V77, P1274, DOI 10.1111/j.1365-2656.2008.01426.x; Hastings A, 2010, ECOL LETT, V13, P464, DOI 10.1111/j.1461-0248.2010.01439.x; Isaac JL, 2009, DIVERS DISTRIB, V15, P280, DOI 10.1111/j.1472-4642.2008.00531.x; Keesing F, 2006, ECOL LETT, V9, P485, DOI 10.1111/j.1461-0248.2006.00885.x; Krauss J, 2010, ECOL LETT, V13, P597, DOI 10.1111/j.1461-0248.2010.01457.x; Lawrence D, 2007, P NATL ACAD SCI USA, V104, P20696, DOI 10.1073/pnas.0705005104; Lindenmayer D, 2008, ECOL LETT, V11, P78, DOI 10.1111/j.1461-0248.2007.01114.x; Lindenmayer DB, 2005, BIOL CONSERV, V124, P351, DOI 10.1016/j.biocon.2005.01.041; Metzger JP, 2009, BIOL CONSERV, V142, P1166, DOI 10.1016/j.biocon.2009.01.033; Metzger JP, 2009, BIOL CONSERV, V142, P1138, DOI 10.1016/j.biocon.2008.10.012; Metzger JP, 1997, ACTA OECOL, V18, P1, DOI 10.1016/S1146-609X(97)80075-6; NAXARA L, 2008, THESIS U SAO PAULO S; Oliveira de Filho FJB, 2006, LANDSCAPE ECOL, V21, P1061, DOI 10.1007/s10980-006-6913-0; Pardini R, 2004, BIODIVERS CONSERV, V13, P2567, DOI 10.1023/B:BIOC.0000048452.18878.2d; Pardini R, 2005, BIOL CONSERV, V124, P253, DOI 10.1016/j.biocon.2005.01.033; Pardini R, 2009, BIOL CONSERV, V142, P1178, DOI 10.1016/j.biocon.2009.02.010; Prugh LR, 2008, P NATL ACAD SCI USA, V105, P20770, DOI 10.1073/pnas.0806080105; R Core Team, 2018, R LANG ENV STAT COMP; Radford JQ, 2005, BIOL CONSERV, V124, P317, DOI 10.1016/j.biocon.2005.01.039; Ribeiro MC, 2009, BIOL CONSERV, V142, P1141, DOI 10.1016/j.biocon.2009.02.021; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; Scheffer M, 2009, NATURE, V461, P53, DOI 10.1038/nature08227; Schroder A, 2005, OIKOS, V110, P3, DOI 10.1111/j.0030-1299.2005.13962.x; Stenseth NC, 2003, FRONT ECOL ENVIRON, V1, P367, DOI 10.2307/3868189; Suding KN, 2009, TRENDS ECOL EVOL, V24, P271, DOI 10.1016/j.tree.2008.11.012; Suzan G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005461; Swift TL, 2010, BIOL REV, V85, P35, DOI 10.1111/j.1469-185X.2009.00093.x; Tscharntke T, 2005, ECOL LETT, V8, P857, DOI 10.1111/j.1461-0248.2005.00782.x; Tscharntke T, 2008, ECOLOGY, V89, P944, DOI 10.1890/07-0455.1; Umetsu F, 2007, LANDSCAPE ECOL, V22, P517, DOI 10.1007/s10980-006-9041-y; Umetsu F, 2006, J MAMMAL, V87, P757, DOI 10.1644/05-MAMM-A-285R2.1; Walker B, 2004, ECOL SOC, V9; With KA, 1999, LANDSCAPE ECOL, V14, P73, DOI 10.1023/A:1008030215600; WITH KA, 1995, ECOLOGY, V76, P2446, DOI 10.2307/2265819; Zurita GA, 2010, LANDSCAPE ECOL, V25, P147, DOI 10.1007/s10980-009-9410-4	61	377	385	3	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2010	5	10							e13666	10.1371/journal.pone.0013666	http://dx.doi.org/10.1371/journal.pone.0013666			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671UN	21060870	Green Published, gold			2022-12-27	WOS:000283537000035
J	Bender, JA; Simpson, EM; Ritzmann, RE				Bender, John A.; Simpson, Elaine M.; Ritzmann, Roy E.			Computer-Assisted 3D Kinematic Analysis of All Leg Joints in Walking Insects	PLOS ONE			English	Article							COCKROACH PERIPLANETA-AMERICANA; COXAL DEPRESSOR MUSCLES; HUMAN MOTION CAPTURE; BLABERUS-DISCOIDALIS; MOTOR-ACTIVITY; MULTIJOINT COORDINATION; TETHERED WALKING; SLIPPERY SURFACE; STICK INSECTS; LOCOMOTION	High-speed video can provide fine-scaled analysis of animal behavior. However, extracting behavioral data from video sequences is a time-consuming, tedious, subjective task. These issues are exacerbated where accurate behavioral descriptions require analysis of multiple points in three dimensions. We describe a new computer program written to assist a user in simultaneously extracting three-dimensional kinematics of multiple points on each of an insect's six legs. Digital video of a walking cockroach was collected in grayscale at 500 fps from two synchronized, calibrated cameras. We improved the legs' visibility by painting white dots on the joints, similar to techniques used for digitizing human motion. Compared to manual digitization of 26 points on the legs over a single, 8-second bout of walking (or 106,496 individual 3D points), our software achieved approximately 90% of the accuracy with 10% of the labor. Our experimental design reduced the complexity of the tracking problem by tethering the insect and allowing it to walk in place on a lightly oiled glass surface, but in principle, the algorithms implemented are extensible to free walking. Our software is free and open-source, written in the free language Python and including a graphical user interface for configuration and control. We encourage collaborative enhancements to make this tool both better and widely utilized.	[Bender, John A.; Simpson, Elaine M.; Ritzmann, Roy E.] Case Western Reserve Univ, Dept Biol, Cleveland, OH 44106 USA	Case Western Reserve University	Bender, JA (corresponding author), Case Western Reserve Univ, Dept Biol, Cleveland, OH 44106 USA.	jbender@case.edu			National Science Foundation [IOS-0845417]; Air Force Office of Sponsored Research [FA9550-07-1-0149]	National Science Foundation(National Science Foundation (NSF)); Air Force Office of Sponsored Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR))	This material is based upon work supported by the National Science Foundation under Grant No. IOS-0845417 and the Air Force Office of Sponsored Research under grant FA9550-07-1-0149. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baden T, 2008, J EXP BIOL, V211, P2123, DOI 10.1242/jeb.019125; Buschges A, 2005, J NEUROPHYSIOL, V93, P1127, DOI 10.1152/jn.00615.2004; Carbonell C. S., 1947, SMITHSONIAN MISC COLL, V107, P1; Card G, 2008, CURR BIOL, V18, P1300, DOI 10.1016/j.cub.2008.07.094; DELCOMYN F, 1973, J EXP BIOL, V59, P643; DELCOMYN F, 1971, J EXP BIOL, V54, P443; DELCOMYN F, 1973, J EXP BIOL, V59, P629; EPSTEIN S, 1983, J EXP BIOL, V105, P215; Frantsevich L, 2009, ARTHROPOD STRUCT DEV, V38, P16, DOI 10.1016/j.asd.2008.06.002; Fry SN, 2005, J EXP BIOL, V208, P2303, DOI 10.1242/jeb.01612; Fry SN, 2004, J NEUROSCI METH, V135, P149, DOI 10.1016/j.jneumeth.2003.12.012; FULL RJ, 1990, J EXP BIOL, V148, P129; GRAHAM D, 1981, J EXP BIOL, V92, P229; Gruhn M, 2006, J NEUROSCI METH, V158, P195, DOI 10.1016/j.jneumeth.2006.05.029; Harley CM, 2009, J EXP BIOL, V212, P1463, DOI 10.1242/jeb.028381; HUGHES GM, 1952, J EXP BIOL, V29, P267; ILES JF, 1971, J EXP BIOL, V55, P151; Kram R, 1997, J EXP BIOL, V200, P1919; Krupczynski P, 2008, CURR BIOL, V18, P1961, DOI 10.1016/j.cub.2008.10.066; LAURENT G, 1986, J EXP BIOL, V123, P285; Moeslund TB, 2001, COMPUT VIS IMAGE UND, V81, P231, DOI 10.1006/cviu.2000.0897; Moeslund TB, 2006, COMPUT VIS IMAGE UND, V104, P90, DOI 10.1016/j.cviu.2006.08.002; Mu LY, 2005, J COMP PHYSIOL A, V191, P1037, DOI 10.1007/s00359-005-0029-x; NYE SW, 1992, J COMP PHYSIOL A, V171, P183, DOI 10.1007/BF00188926; PEARSON KG, 1970, J EXP BIOL, V52, P139; PEARSON KG, 1971, J EXP BIOL, V54, P215; PEARSON KG, 1973, J EXP BIOL, V58, P725; Pringle JWS, 1938, J EXP BIOL, V15, P114; Rosano H, 2007, BIOL CYBERN, V97, P229, DOI 10.1007/s00422-007-0170-4; SPIRITO CP, 1979, J EXP BIOL, V78, P233; Tryba AK, 2000, J NEUROPHYSIOL, V83, P3337, DOI 10.1152/jn.2000.83.6.3337; Tryba AK, 2000, J NEUROPHYSIOL, V83, P3323, DOI 10.1152/jn.2000.83.6.3323; Watson JT, 1998, J COMP PHYSIOL A, V182, P23, DOI 10.1007/s003590050154; Watson JT, 1998, J COMP PHYSIOL A, V182, P11, DOI 10.1007/s003590050153; Watson JT, 2002, J COMP PHYSIOL A, V188, P39, DOI 10.1007/s00359-002-0277-y; Zakotnik J, 2004, J NEUROSCI METH, V135, P43, DOI 10.1016/j.jneumeth.2003.11.013; Zhang ZY, 2000, IEEE T PATTERN ANAL, V22, P1330, DOI 10.1109/34.888718	37	20	20	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2010	5	10							e13617	10.1371/journal.pone.0013617	http://dx.doi.org/10.1371/journal.pone.0013617			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671GB	21049024	Green Submitted, Green Published, gold			2022-12-27	WOS:000283487400012
J	Galan, A; Montaner, D; Poo, ME; Valbuena, D; Ruiz, V; Aguilar, C; Dopazo, J; Simon, C				Galan, Amparo; Montaner, David; Eugenia Poo, M.; Valbuena, Diana; Ruiz, Veronica; Aguilar, Cristobal; Dopazo, Joaquin; Simon, Carlos			Functional Genomics of 5-to 8-Cell Stage Human Embryos by Blastomere Single-Cell cDNA Analysis	PLOS ONE			English	Article							GENE-EXPRESSION SIGNATURES; STEM-CELL; SIGNALING PATHWAYS; ZYGOTIC TRANSITION; BLASTOCYST; CLEAVAGE; LINEAGE; DIFFERENTIATION; TROPHECTODERM; 4-CELL	Blastomere fate and embryonic genome activation (EGA) during human embryonic development are unsolved areas of high scientific and clinical interest. Forty-nine blastomeres from 5- to 8-cell human embryos have been investigated following an efficient single-cell cDNA amplification protocol to provide a template for high-density microarray analysis. The previously described markers, characteristic of Inner Cell Mass (ICM) (n = 120), stemness (n = 190) and Trophectoderm (TE) (n = 45), were analyzed, and a housekeeping pattern of 46 genes was established. All the human blastomeres from the 5- to 8-cell stage embryo displayed a common gene expression pattern corresponding to ICM markers (e.g., DDX3, FOXD3, LEFTY1, MYC, NANOG, POU5F1), stemness (e.g., POU5F1, DNMT3B, GABRB3, SOX2, ZFP42, TERT), and TE markers (e.g., GATA6, EOMES, CDX2, LHCGR). The EGA profile was also investigated between the 5-6- and 8-cell stage embryos, and compared to the blastocyst stage. Known genes (n = 92) such as depleted maternal transcripts (e.g., CCNA1, CCNB1, DPPA2) and embryo-specific activation (e.g., POU5F1, CDH1, DPPA4), as well as novel genes, were confirmed. In summary, the global single-cell cDNA amplification microarray analysis of the 5- to 8-cell stage human embryos reveals that blastomere fate is not committed to ICM or TE. Finally, new EGA features in human embryogenesis are presented.	[Galan, Amparo; Eugenia Poo, M.; Valbuena, Diana; Ruiz, Veronica; Aguilar, Cristobal; Simon, Carlos] CIPF, Valencia Node Natl Stem Cell Bank, Valencia, Spain; [Montaner, David; Dopazo, Joaquin] CIPF, Dept Bioinformat & Genom, Valencia, Spain; [Simon, Carlos] Univ Valencia, IUIVI, FIVI, Valencia, Spain	Prince Felipe Research Center; Prince Felipe Research Center; University of Valencia	Galan, A (corresponding author), CIPF, Valencia Node Natl Stem Cell Bank, Valencia, Spain.	csimon@cipf.es	Dopazo, Joaquin/A-9270-2014; Aguilar-Gallardo, Cristobal/I-1841-2017; Valbuena, Diana M/I-1949-2015; t, lf/AAJ-4924-2020; Simon, Carlos/G-2186-2014; Galán, Amparo/ABG-8474-2020; Montaner, David/A-9362-2014	Dopazo, Joaquin/0000-0003-3318-120X; Aguilar-Gallardo, Cristobal/0000-0002-1594-3648; Valbuena, Diana M/0000-0002-0742-3669; Simon, Carlos/0000-0003-0902-9531; Galán, Amparo/0000-0003-4265-8516; Montaner, David/0000-0002-2484-3278	Institute of Health Carlos III (ISCIII), Regional Ministry of Health (GVA); CIPF for the Research on Regenerative Medicine; ISCIII of the Spanish Government [PI08-1134]; Spanish Ministry of Science and Innovation [BIO2008-0412]; GVA [PROMETEO/2010/001]	Institute of Health Carlos III (ISCIII), Regional Ministry of Health (GVA)(Instituto de Salud Carlos III); CIPF for the Research on Regenerative Medicine; ISCIII of the Spanish Government; Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); GVA	This work was supported by Agreement between Institute of Health Carlos III (ISCIII), Regional Ministry of Health (GVA) and CIPF for the Research on Regenerative Medicine and FIS Project PI08-1134 from the ISCIII of the Spanish Government, as well as by grants from projects BIO2008-0412 from the Spanish Ministry of Science and Innovation and PROMETEO/2010/001 from the GVA. The National Institute of Bioinformatics (www.inab.org) is an initiative of the ISCIII. The funders had no role in study design, data collection and analysis decision to publish, or preparation of the manuscript.	Abeyta MJ, 2004, HUM MOL GENET, V13, P601, DOI 10.1093/hmg/ddh068; Adewumi O, 2007, NAT BIOTECHNOL, V25, P803, DOI 10.1038/nbt1318; Adjaye J, 2005, STEM CELLS, V23, P1514, DOI 10.1634/stemcells.2005-0113; Assou S, 2007, STEM CELLS, V25, P961, DOI 10.1634/stemcells.2006-0352; Bell CE, 2008, MOL HUM REPROD, V14, P691, DOI 10.1093/molehr/gan063; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bhattacharya B, 2009, CURR STEM CELL RES T, V4, P98, DOI 10.2174/157488809788167409; Bischoff M, 2008, DEVELOPMENT, V135, P953, DOI 10.1242/dev.014316; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; BRAUDE P, 1988, NATURE, V332, P459, DOI 10.1038/332459a0; Cauffman G, 2009, HUM REPROD, V24, P63, DOI 10.1093/humrep/den351; Chan KKK, 2009, STEM CELLS, V27, P2114, DOI 10.1002/stem.143; Chickarmane V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003478; Chung Y, 2008, CELL STEM CELL, V2, P113, DOI 10.1016/j.stem.2007.12.013; Dobson AT, 2004, HUM MOL GENET, V13, P1461, DOI 10.1093/hmg/ddh157; Edwards RG, 2005, REPROD BIOMED ONLINE, V11, P206; Fujimori T, 2003, DEVELOPMENT, V130, P5113, DOI 10.1242/dev.00725; Fujimori T, 2009, REPROD SCI, V16, P171, DOI 10.1177/1933719108331120; Galan A, 2010, METHODS MOL BIOL, V584, P135, DOI 10.1007/978-1-60761-369-5_8; Gardner DK, 1999, TOWARDS REPRODUCTIVE CERTAINTY, P378; Gardner RL, 1997, DEVELOPMENT, V124, P289; Gardner RL, 2001, DEVELOPMENT, V128, P839; Ginis I, 2004, DEV BIOL, V269, P360, DOI 10.1016/j.ydbio.2003.12.034; Guzeloglu-Kayisli O, 2008, MOL HUM REPROD, V14, P581, DOI 10.1093/molehr/gan047; Hamatani T, 2004, P NATL ACAD SCI USA, V101, P10326, DOI 10.1073/pnas.0402597101; Hamatani Toshio, 2006, Hum Cell, V19, P98; HEKIMI S, 1995, GENETICS, V141, P1351; Hierholzer A, 2009, GENESIS, V47, P204, DOI 10.1002/dvg.20484; Hiiragi T, 2004, NATURE, V430, P360, DOI 10.1038/nature02595; Huntriss J, 2004, MOL REPROD DEV, V67, P323, DOI 10.1002/mrd.20030; Kimber SJ, 2008, REPRODUCTION, V135, P635, DOI 10.1530/REP-07-0359; Klimanskaya I, 2006, NATURE, V444, P481, DOI 10.1038/nature05142; Kurimoto K, 2007, NAT PROTOC, V2, P739, DOI 10.1038/nprot.2007.79; Kurotaki Y, 2007, SCIENCE, V316, P719, DOI 10.1126/science.1138591; Kwon MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006162; Latham KE, 2001, FRONT BIOSCI, V6, pD748, DOI 10.2741/Latham; Leon J, 2009, CELL CYCLE, V8, P1148, DOI 10.4161/cc.8.8.8126; Louvet-Vallee S, 2005, CURR BIOL, V15, P464, DOI 10.1016/j.cub.2004.12.078; May A, 2008, EXP CELL RES, V314, P2788, DOI 10.1016/j.yexcr.2008.07.009; Medina I, 2010, NUCLEIC ACIDS RES, V38, pW210, DOI 10.1093/nar/gkq388; Montaner D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010348; Morisato D, 1995, ANNU REV GENET, V29, P371, DOI 10.1146/annurev.genet.29.1.371; Motosugi N, 2005, GENE DEV, V19, P1081, DOI 10.1101/gad.1304805; NEWPORT J, 1982, CELL, V30, P687, DOI 10.1016/0092-8674(82)90273-2; Pearson H, 2002, NATURE, V418, P14, DOI 10.1038/418014a; Pehlivan T, 2003, Reprod Biomed Online, V6, P232; Pera RAR, 2009, DIFFERENTIATION, V78, P18, DOI 10.1016/j.diff.2009.03.004; Phipps SMO, 2009, MOL BIOTECHNOL, V41, P201, DOI 10.1007/s12033-008-9118-8; Piotrowska K, 2001, DEVELOPMENT, V128, P3739; Piotrowska K, 2001, NATURE, V409, P517, DOI 10.1038/35054069; Player A, 2006, STEM CELLS DEV, V15, P315, DOI 10.1089/scd.2006.15.315; Plusa B, 2005, NATURE, V434, P391, DOI 10.1038/nature03388; Roberts R Michael, 2004, Reprod Biol Endocrinol, V2, P47, DOI 10.1186/1477-7827-2-47; Saitou M, 2008, REPROD BIOMED ONLINE, V16, P26, DOI 10.1016/S1472-6483(10)60554-8; Sartor MA, 2009, BIOINFORMATICS, V25, P211, DOI 10.1093/bioinformatics/btn592; Sato N, 2003, DEV BIOL, V260, P404, DOI 10.1016/S0012-1606(03)00256-2; Schier AF, 2007, SCIENCE, V316, P406, DOI 10.1126/science.1140693; SCHULTZ RM, 1993, BIOESSAYS, V15, P531, DOI 10.1002/bies.950150806; Schultz RM, 2002, HUM REPROD UPDATE, V8, P323, DOI 10.1093/humupd/8.4.323; Sermon K, 2004, LANCET, V363, P1633, DOI 10.1016/S0140-6736(04)16209-0; Skottman H, 2006, STEM CELLS, V24, P151, DOI 10.1634/stemcells.2004-0189; Skottman H, 2005, STEM CELLS, V23, P1343, DOI 10.1634/stemcells.2004-0341; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Stitzel ML, 2007, SCIENCE, V316, P407, DOI 10.1126/science.1138236; Strelchenko N, 2004, REPROD BIOMED ONLINE, V9, P623, DOI 10.1016/S1472-6483(10)61772-5; Sudheer Smita, 2007, Briefings in Functional Genomics & Proteomics, V6, P120, DOI 10.1093/bfgp/elm012; TELFORD NA, 1990, MOL REPROD DEV, V26, P90, DOI 10.1002/mrd.1080260113; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Thorrez L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001854; Torres-Padilla ME, 2006, J CELL BIOL, V174, P329, DOI 10.1083/jcb.200603146; Veeck LL., 1999, ATLAS HUMAN GAMETES; Wang QT, 2004, DEV CELL, V6, P133, DOI 10.1016/S1534-5807(03)00404-0; Wang QX, 2000, BIOL REPROD, V62, P969, DOI 10.1095/biolreprod62.4.969; Yagi R, 2007, DEVELOPMENT, V134, P3827, DOI 10.1242/dev.010223; Zeng FY, 2005, DEV BIOL, V283, P40, DOI 10.1016/j.ydbio.2005.03.038; Zeng FY, 2004, DEV BIOL, V272, P483, DOI 10.1016/j.ydbio.2004.05.018	77	55	57	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2010	5	10							e13615	10.1371/journal.pone.0013615	http://dx.doi.org/10.1371/journal.pone.0013615			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671GB	21049019	Green Published, Green Submitted, gold			2022-12-27	WOS:000283487400011
J	Sherman, CDH; Sagvik, J; Olsson, M				Sherman, Craig D. H.; Sagvik, Jorgen; Olsson, Mats			Female Choice for Males with Greater Fertilization Success in the Swedish Moor Frog, Rana arvalis	PLOS ONE			English	Article							PERONS TREE FROG; SPERM DNA-DAMAGE; REPRODUCTIVE SUCCESS; MULTIPLE PATERNITY; SEXUAL SELECTION; MATE SELECTION; TOAD; SKELETOCHRONOLOGY; POPULATIONS; COLORATION	Background: Studies of mate choice in anuran amphibians have shown female preference for a wide range of male traits despite females gaining no direct resources from males (i.e. non-resource based mating system). Nevertheless, theoretical and empirical studies have shown that females may still gain indirect genetic benefits from choosing males of higher genetic quality and thereby increase their reproductive success. Methodology/Principal Findings: We investigated two components of sexual selection in the Moor frog (Rana arvalis), precopulatory female choice between two males of different size ('large' vs. 'small'), and their fertilization success in sperm competition and in isolation. Females' showed no significant preference for male size (13 small and six large male preferences) but associated preferentially with the male that subsequently was the most successful at fertilizing her eggs in isolation. Siring success of males in competitive fertilizations was unrelated to genetic similarity with the female and we detected no effect of sperm viability on fertilization success. There was, however, a strong positive association between a male's innate fertilization ability with a female and his siring success in sperm competition. We also detected a strong negative effect of a male's thumb length on his competitive siring success. Conclusions/Significance: Our results show that females show no preference for male size but are still able to choose males which have greater fertilization success. Genetic similarity and differences in the proportion of viable sperm within a males ejaculate do not appear to affect siring success. These results could be explained through pre- and/or postcopulatory choice for genetic benefits and suggest that females are able to perceive the genetic quality of males, possibly basing their choice on multiple phenotypic male traits.	[Sherman, Craig D. H.] Deakin Univ, Sch Life & Environm Sci, Ctr Integrat Ecol, Waurn Ponds, Vic, Australia; [Sherman, Craig D. H.; Olsson, Mats] Univ Wollongong, Sch Biol Sci, Wollongong, NSW, Australia; [Sagvik, Jorgen] Univ Gothenburg, Dept Zool, Gothenburg, Sweden; [Olsson, Mats] Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia	Deakin University; University of Wollongong; University of Gothenburg; University of Sydney	Sherman, CDH (corresponding author), Deakin Univ, Sch Life & Environm Sci, Ctr Integrat Ecol, Waurn Ponds, Vic, Australia.	craig.sherman@deakin.edu.au	Sherman, Craig/A-2484-2010; Olsson, Mats/AAK-5565-2021	Sherman, Craig/0000-0003-2099-0462; Olsson, Mats/0000-0002-4130-1323	Collianders Stiftelse and Helge Ax:son Johnsson's Stiftelse foundations; Australian Research Council	Collianders Stiftelse and Helge Ax:son Johnsson's Stiftelse foundations; Australian Research Council(Australian Research Council)	This study was funded by the Collianders Stiftelse and Helge Ax:son Johnsson's Stiftelse foundations and the Australian Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson Malte, 1994; ARAK A, 1988, BEHAV ECOL SOCIOBIOL, V22, P317; BARBAULT R, 1980, B SOC ZOOL FR, V105, P347; Bosch J, 2001, COPEIA, P169, DOI 10.1643/0045-8511(2001)001[0169:CTIMMA]2.0.CO;2; Byrne PG, 2000, EVOLUTION, V54, P968; Chandler CH, 2008, MOL ECOL, V17, P1564, DOI 10.1111/j.1365-294X.2007.03614.x; Cho C, 2003, BIOL REPROD, V69, P211, DOI 10.1095/biolreprod.102.015115; Dziminski MA, 2008, EVOLUTION, V62, P879, DOI 10.1111/j.1558-5646.2008.00328.x; Dziminski MA, 2010, REPROD FERT DEVELOP, V22, P516, DOI 10.1071/RD09124; Eden CJ, 2007, COPEIA, P471, DOI 10.1643/0045-8511(2007)7[471:AAOSIT]2.0.CO;2; Fatehi AN, 2006, J ANDROL, V27, P176, DOI 10.2164/jandrol.04152; Fog K, 1997, NORDENS PADDER KRYBD; Garner TWJ, 2001, CONSERV GENET, V2, P77, DOI 10.1023/A:1011546712741; Greene AE, 2009, J HERPETOL, V43, P244, DOI 10.1670/08-112R.1; Hettyey A, 2006, BEHAV ECOL SOCIOBIOL, V59, P389, DOI 10.1007/s00265-005-0062-3; Hettyey A, 2009, AMPHIBIA-REPTILIA, V30, P37, DOI 10.1163/156853809787392784; Knopp T, 2008, MOL ECOL, V17, P2522, DOI 10.1111/j.1365-294X.2008.03748.x; Knopp T, 2007, CONSERV GENET, V8, P45, DOI 10.1007/s10592-006-9147-4; Knopp T, 2009, AMPHIBIA-REPTILIA, V30, P515, DOI 10.1163/156853809789647112; Kupfer A, 2008, J EXP ZOOL PART A, V309A, P460, DOI 10.1002/jez.475; Lee JC, 2002, J HERPETOL, V36, P502, DOI 10.2307/1566198; Marangoni F, 2009, J HERPETOL, V43, P546, DOI 10.1670/08-230R1.1; Morrison C, 2004, HERPETOLOGICA, V60, P34, DOI 10.1655/02-68; Morrison C, 2001, AUSTRAL ECOL, V26, P223, DOI 10.1046/j.1442-9993.2001.01107.x; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pryke SR, 2009, EVOLUTION, V63, P793, DOI 10.1111/j.1558-5646.2008.00584.x; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Rosenthal GG, 2004, ANIM BEHAV, V68, P55, DOI 10.1016/j.anbehav.2003.07.013; RYAN MJ, 1992, TUNGARA FROG STUDY S; Sagvik J, 2008, EVOL ECOL, V22, P193, DOI 10.1007/s10682-007-9168-6; Sheldon BC, 1999, NATURE, V402, P874, DOI 10.1038/47239; Sherman CDH, 2008, P R SOC B, V275, P971, DOI 10.1098/rspb.2007.1626; Sherman CDH, 2008, NATURWISSENSCHAFTEN, V95, P1055, DOI 10.1007/s00114-008-0423-7; Sherman CDH, 2008, AUSTRAL ECOL, V33, P348, DOI 10.1111/j.1442-9993.2007.01823.x; Sherman CDH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008252; Sherman CDH, 2009, BIOL LETTERS, V5, P232, DOI 10.1098/rsbl.2008.0796; Taylor RC, 2007, ANIM BEHAV, V74, P1753, DOI 10.1016/j.anbehav.2007.03.010; Uller T, 2006, BIOL J LINN SOC, V89, P189, DOI 10.1111/j.1095-8312.2006.00673.x; Vasquez T, 2007, BEHAV ECOL SOCIOBIOL, V62, P127, DOI 10.1007/s00265-007-0446-7; Vieites DR, 2004, NATURE, V431, P305, DOI 10.1038/nature02879; Welch AM, 1998, SCIENCE, V280, P1928, DOI 10.1126/science.280.5371.1928; Zini A, 2006, CAN MED ASSOC J, V175, P495, DOI 10.1503/cmaj.060218	42	10	10	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2010	5	10							e13634	10.1371/journal.pone.0013634	http://dx.doi.org/10.1371/journal.pone.0013634			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671GB	21049015	Green Published, Green Submitted, gold			2022-12-27	WOS:000283487400024
J	Karkey, A; Arjyal, A; Anders, KL; Boni, MF; Dongol, S; Koirala, S; Phan, VTM; Tran, VTN; Clements, ACA; Holt, KE; Pham, TD; Day, JN; Campbell, JI; Dougan, G; Dolecek, C; Farrar, J; Basnyat, B; Baker, S				Karkey, Abhilasha; Arjyal, Amit; Anders, Katherine L.; Boni, Maciej F.; Dongol, Sabina; Koirala, Samir; Phan Vu Tra My; Tran Vu Thieu Nga; Clements, Archie C. A.; Holt, Kathryn E.; Pham Thanh Duy; Day, Jeremy N.; Campbell, James I.; Dougan, Gordon; Dolecek, Christiane; Farrar, Jeremy; Basnyat, Buddha; Baker, Stephen			The Burden and Characteristics of Enteric Fever at a Healthcare Facility in a Densely Populated Area of Kathmandu	PLOS ONE			English	Article							TYPHOID-FEVER; PARATYPHOID FEVER; EFFECTIVENESS TRIAL; RISK-FACTORS; INDIA; NEPAL; VACCINE; INDONESIA; PAKISTAN; KOLKATA	Enteric fever, caused by Salmonella enterica serovars Typhi and Paratyphi A (S. Typhi and S. Paratyphi A) remains a major public health problem in many settings. The disease is limited to locations with poor sanitation which facilitates the transmission of the infecting organisms. Efficacious and inexpensive vaccines are available for S. Typhi, yet are not commonly deployed to control the disease. Lack of vaccination is due partly to uncertainty of the disease burden arising from a paucity of epidemiological information in key locations. We have collected and analyzed data from 3,898 cases of blood culture-confirmed enteric fever from Patan Hospital in Lalitpur Sub-Metropolitan City (LSMC), between June 2005 and May 2009. Demographic data was available for a subset of these patients (n = 527) that were resident in LSMC and who were enrolled in trials. We show a considerable burden of enteric fever caused by S. Typhi (2,672; 68.5%) and S. Paratyphi A (1,226; 31.5%) at this Hospital over a four year period, which correlate with seasonal fluctuations in rainfall. We found that local population density was not related to incidence and we identified a focus of infections in the east of LSMC. With data from patients resident in LSMC we found that the median age of those with S. Typhi (16 years) was significantly less than S. Paratyphi A (20 years) and that males aged 15 to 25 were disproportionately infected. Our findings provide a snapshot into the epidemiological patterns of enteric fever in Kathmandu. The uneven distribution of enteric fever patients within the population suggests local variation in risk factors, such as contaminated drinking water. These findings are important for initiating a vaccination scheme and improvements in sanitation. We suggest any such intervention should be implemented throughout the LSMC area.	[Karkey, Abhilasha; Arjyal, Amit; Dongol, Sabina; Koirala, Samir; Basnyat, Buddha] Univ Oxford, Patan Acad Hlth Sci, Clin Res Unit, Kathmandu, Nepal; [Anders, Katherine L.; Boni, Maciej F.; Phan Vu Tra My; Tran Vu Thieu Nga; Pham Thanh Duy; Day, Jeremy N.; Campbell, James I.; Dolecek, Christiane; Farrar, Jeremy; Baker, Stephen] Univ Oxford, Clin Res Unit, Wellcome Trust Major Overseas Programme, Hosp Trop Dis, Ho Chi Minh City, Vietnam; [Boni, Maciej F.] MRC Ctr Genom & Global Hlth, Oxford, England; [Clements, Archie C. A.] Univ Queensland, Sch Populat Hlth, Brisbane, Qld, Australia; [Holt, Kathryn E.] Univ Melbourne, Dept Microbiol & Immunol, Melbourne, Vic, Australia; [Dougan, Gordon] Wellcome Trust Sanger Inst, Cambridge, England	University of Oxford; University of Oxford; University of Queensland; University of Melbourne; Wellcome Trust Sanger Institute	Karkey, A (corresponding author), Univ Oxford, Patan Acad Hlth Sci, Clin Res Unit, Kathmandu, Nepal.	sbaker@oucru.org	Holt, Kathryn E/A-8108-2012; Pham, Thanh Duy/AAX-3845-2020; Farrar, Jeremy J./HGA-7610-2022; Clements, Archie/D-9619-2013	Holt, Kathryn E/0000-0003-3949-2471; Pham, Thanh Duy/0000-0001-7029-9210; Farrar, Jeremy/0000-0002-2700-623X; Baker, Stephen/0000-0003-1308-5755; Phan, My VT/0000-0002-6905-8513	Wellcome Trust, Euston Road, London, United Kingdom; Medical Research Council [G0600718]; OAK foundation through Oxford University; MRC [G0600718] Funding Source: UKRI	Wellcome Trust, Euston Road, London, United Kingdom(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); OAK foundation through Oxford University; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by The Wellcome Trust, Euston Road, London, United Kingdom. MFB is supported by the Medical Research Council (grant G0600718). SB is supported by an OAK foundation fellowship through Oxford University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, Wkly Epidemiol Rec, V83, P49; Baker S, 2008, J CLIN MICROBIOL, V46, P1741, DOI 10.1128/JCM.02249-07; Basnyat B, 2005, CLIN INFECT DIS, V41, P1467, DOI 10.1086/497136; Bhan MK, 2005, LANCET, V366, P749, DOI 10.1016/S0140-6736(05)67181-4; Chanh NQ, 2004, CLIN INFECT DIS, V39, P61, DOI 10.1086/421555; Cook J, 2009, J HEALTH POPUL NUTR, V27, P711; Crump JA, 2004, B WORLD HEALTH ORGAN, V82, P346; Crump JA, 2010, CLIN INFECT DIS, V50, P241, DOI 10.1086/649541; DeRoeck D, 2007, NEW ENGL J MED, V357, P1069, DOI 10.1056/NEJMp078144; Holt KE, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-144; Karkey A, 2008, J INFECT DEV COUNTR, V2, P461; *KATHM HIS MAJ GOV, 2002, POP NEP POP CENS 200; Kelly-Hope LA, 2007, AM J TROP MED HYG, V76, P706, DOI 10.4269/ajtmh.2007.76.706; Khan MI, 2006, TRIALS, V7, DOI 10.1186/1745-6215-7-17; Kothari A, 2008, J INFECT DEV COUNTR, V2, P253; Lin FYC, 2000, AM J TROP MED HYG, V62, P644, DOI 10.4269/ajtmh.2000.62.644; Lynch MF, 2009, JAMA-J AM MED ASSOC, V302, P859, DOI 10.1001/jama.2009.1229; Maskey AP, 2006, CLIN INFECT DIS, V42, P1247, DOI 10.1086/503033; Maskey AP, 2008, T ROY SOC TROP MED H, V102, P91, DOI 10.1016/j.trstmh.2007.10.003; Mermin JH, 1999, J INFECT DIS, V179, P1416, DOI 10.1086/314766; *MOHP NEP NE, 2007, NEP DEM HLTH SURV 20; Ochiai RL, 2008, B WORLD HEALTH ORGAN, V86, P260, DOI 10.2471/BLT.06.039818; Ochiai RL, 2005, EMERG INFECT DIS, V11, P1764, DOI 10.3201/eid1111.050168; PANDIT A, 2007, PLOS CLIN TRIALS, V2, pNIL12; Parry CM, 2002, NEW ENGL J MED, V347, P1770, DOI 10.1056/NEJMra020201; Pulickal AS, 2009, CLIN VACCINE IMMUNOL, V16, P1413, DOI 10.1128/CVI.00245-09; Siddiqui FJ, 2006, INT J INFECT DIS, V10, P215, DOI 10.1016/j.ijid.2005.03.010; Sood S, 1999, EMERG INFECT DIS, V5, P483, DOI 10.3201/eid0503.990329; Steele D, 2008, J INFECT DEV COUNTR, V2, P250, DOI 10.3855/jidc.217; Sur D, 2009, HUM VACCINES, V5, P614, DOI 10.4161/hv.9313; Sur D, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-289; Sur D, 2009, NEW ENGL J MED, V361, P335, DOI 10.1056/NEJMoa0807521; Vollaard AM, 2004, JAMA-J AM MED ASSOC, V291, P2607, DOI 10.1001/jama.291.21.2607; WHO, 2008, WEEKLY EPIDEMIOLOGY, V83, P1; Woods CW, 2006, T ROY SOC TROP MED H, V100, P1063, DOI 10.1016/j.trstmh.2005.12.011; *WORLD BANK, 2007, NEP DAT STAT WORLD D	36	52	54	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2010	5	11							e13988	10.1371/journal.pone.0013988	http://dx.doi.org/10.1371/journal.pone.0013988			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	680KW	21085575	Green Published, Green Submitted, gold			2022-12-27	WOS:000284231800018
J	Templeton, DJ; Aye, MS; Rady, J; Xu, F; Cross, JV				Templeton, Dennis J.; Aye, Myo-Sabai; Rady, Joshua; Xu, Fang; Cross, Janet V.			Purification of Reversibly Oxidized Proteins (PROP) Reveals a Redox Switch Controlling p38 MAP Kinase Activity	PLOS ONE			English	Article							OXIDATIVE STRESS; THIOREDOXIN REDUCTASE; CYSTEINE RESIDUES; IN-VIVO; GLUTATHIONYLATION; P53; PROSTAGLANDINS; IDENTIFICATION; INACTIVATION; ACTIVATION	Oxidation of cysteine residues of proteins is emerging as an important means of regulation of signal transduction, particularly of protein kinase function. Tools to detect and quantify cysteine oxidation of proteins have been a limiting factor in understanding the role of cysteine oxidation in signal transduction. As an example, the p38 MAP kinase is activated by several stress-related stimuli that are often accompanied by in vitro generation of hydrogen peroxide. We noted that hydrogen peroxide inhibited p38 activity despite paradoxically increasing the activating phosphorylation of p38. To address the possibility that cysteine oxidation may provide a negative regulatory effect on p38 activity, we developed a biochemical assay to detect reversible cysteine oxidation in intact cells. This procedure, PROP, demonstrated in vivo oxidation of p38 in response to hydrogen peroxide and also to the natural inflammatory lipid prostaglandin J2. Mutagenesis of the potential target cysteines showed that oxidation occurred preferentially on residues near the surface of the p38 molecule. Cysteine oxidation thus controls a functional redox switch regulating the intensity or duration of p38 activity that would not be revealed by immunodetection of phosphoprotein commonly interpreted as reflective of p38 activity.	[Templeton, Dennis J.; Aye, Myo-Sabai; Rady, Joshua; Xu, Fang; Cross, Janet V.] Univ Virginia, Sch Med, Dept Pathol, Charlottesville, VA 22908 USA	University of Virginia	Templeton, DJ (corresponding author), Univ Virginia, Sch Med, Dept Pathol, Charlottesville, VA 22908 USA.	dtempleton@virginia.edu; jvc5b@virginia.edu	Cross, Janet V/F-8276-2011; Templeton, Dennis J/F-7695-2011	Rady, Joshua/0000-0002-7806-136X	NIH [R01CA113899, R01AT004323]; NATIONAL CANCER INSTITUTE [R01CA113899] Funding Source: NIH RePORTER; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [R01AT004323] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine)	This work was supported by NIH grants R01CA113899 to DJT and R01AT004323 to JVC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aracena-Parks P, 2006, J BIOL CHEM, V281, P40354, DOI 10.1074/jbc.M600876200; Boivin B, 2008, P NATL ACAD SCI USA, V105, P9959, DOI 10.1073/pnas.0804336105; Burgoyne JR, 2007, SCIENCE, V317, P1393, DOI 10.1126/science.1144318; Cassidy PB, 2006, CARCINOGENESIS, V27, P2538, DOI 10.1093/carcin/bgl111; Chu F, 2003, CARCINOGENESIS, V24, P317, DOI 10.1093/carcin/24.2.317; Chu F, 2001, CARCINOGENESIS, V22, P1221, DOI 10.1093/carcin/22.8.1221; Cross JV, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-183; Cross JV, 2006, ANTIOXID REDOX SIGN, V8, P1819, DOI 10.1089/ars.2006.8.1819; Cross JV, 2004, J CELL BIOCHEM, V93, P104, DOI 10.1002/jcb.20202; Cross JV, 2004, BIOCHEM J, V381, P675, DOI 10.1042/BJ20040591; Ghezzi P, 2002, MOL IMMUNOL, V38, P773, DOI 10.1016/S0161-5890(01)00114-6; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; HELD JM, MOL CELL PROTEOMICS, V9, P1400; Humphries KM, 2005, J BIOL CHEM, V280, P2750, DOI 10.1074/jbc.M410242200; Humphries KM, 2002, J BIOL CHEM, V277, P43505, DOI 10.1074/jbc.M207088200; Jaffrey SR, 2005, METHOD ENZYMOL, V396, P105, DOI 10.1016/S0076-6879(05)96011-4; Le Moan Natacha, 2008, V476, P181, DOI 10.1007/978-1-59745-129-1_13; Leichert LI, 2008, P NATL ACAD SCI USA, V105, P8197, DOI 10.1073/pnas.0707723105; Leonberg AK, 2007, MOL CELL BIOCHEM, V304, P207, DOI 10.1007/s11010-007-9501-y; Mamoon NM, 2007, BIOCHEMISTRY-US, V46, P14810, DOI 10.1021/bi701118u; Moos PJ, 2003, J BIOL CHEM, V278, P745, DOI 10.1074/jbc.M211134200; Murata H, 2003, J BIOL CHEM, V278, P50226, DOI 10.1074/jbc.M310171200; Natoli G, 1997, SCIENCE, V275, P200, DOI 10.1126/science.275.5297.200; Piotukh K, 2007, FREE RADICAL BIO MED, V43, P1263, DOI 10.1016/j.freeradbiomed.2007.06.010; Saurin AT, 2004, P NATL ACAD SCI USA, V101, P17982, DOI 10.1073/pnas.0404762101; Seanor KL, 2003, ANTIOXID REDOX SIGN, V5, P103, DOI 10.1089/152308603321223595; Sun GQ, 2009, CELL CYCLE, V8, P2353, DOI 10.4161/cc.8.15.9225; Wagner TM, 2006, J BIOL CHEM, V281, P2598, DOI 10.1074/jbc.M509723200; Wilson KP, 1996, J BIOL CHEM, V271, P27696, DOI 10.1074/jbc.271.44.27696; Wu HH, 2000, BIOCHEM J, V351, P87, DOI 10.1042/0264-6021:3510087; Zhang XS, 1997, FREE RADICAL BIO MED, V23, P980, DOI 10.1016/S0891-5849(97)00126-3	31	33	33	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2010	5	11							e15012	10.1371/journal.pone.0015012	http://dx.doi.org/10.1371/journal.pone.0015012			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	680KW	21085594	gold, Green Published, Green Submitted			2022-12-27	WOS:000284231800028
J	Bowden, SD; Ramachandran, VK; Knudsen, GM; Hinton, JCD; Thompson, A				Bowden, Steven D.; Ramachandran, Vinoy K.; Knudsen, Gitte M.; Hinton, Jay C. D.; Thompson, Arthur			An Incomplete TCA Cycle Increases Survival of Salmonella Typhimurium during Infection of Resting and Activated Murine Macrophages	PLOS ONE			English	Article							ENTERICA SEROVAR TYPHIMURIUM; ESCHERICHIA-COLI; HOST-CELLS; MYCOBACTERIUM-TUBERCULOSIS; INTRACELLULAR SALMONELLA; PHAGOCYTE OXIDASE; EPITHELIAL-CELLS; TYPHOID-FEVER; BALB/C MICE; GENE	Background: In comparison to the comprehensive analyses performed on virulence gene expression, regulation and action, the intracellular metabolism of Salmonella during infection is a relatively under-studied area. We investigated the role of the tricarboxylic acid (TCA) cycle in the intracellular replication of Salmonella Typhimurium in resting and activated macrophages, epithelial cells, and during infection of mice. Methodology/Principal Findings: We constructed deletion mutations of 5 TCA cycle genes in S. Typhimurium including gltA, mdh, sdhCDAB, sucAB, and sucCD. We found that the mutants exhibited increased net intracellular replication in resting and activated murine macrophages compared to the wild-type. In contrast, an epithelial cell infection model showed that the S. Typhimurium Delta sucCD and Delta gftA strains had reduced net intracellular replication compared to the wild-type. The glyoxylate shunt was not responsible for the net increased replication of the TCA cycle mutants within resting macrophages. We also confirmed that, in a murine infection model, the S. Typhimurium Delta sucAB and Delta sucCD strains are attenuated for virulence. Conclusions/Significance: Our results suggest that disruption of the TCA cycle increases the ability of S. Typhimurium to survive within resting and activated murine macrophages. In contrast, epithelial cells are non-phagocytic cells and unlike macrophages cannot mount an oxidative and nitrosative defence response against pathogens; our results show that in HeLa cells the S. Typhimurium TCA cycle mutant strains show reduced or no change in intracellular levels compared to the wild-type [1]. The attenuation of the S. Typhimurium Delta sucAB and Delta sucCD mutants in mice, compared to their increased net intracellular replication in resting and activated macrophages suggest that Salmonella may encounter environments within the host where a complete TCA cycle is advantageous.	[Bowden, Steven D.; Ramachandran, Vinoy K.; Knudsen, Gitte M.; Thompson, Arthur] Inst Food Res, Norwich NR4 7UA, Norfolk, England; [Hinton, Jay C. D.] Trinity Coll Dublin, Moyne Inst Prevent Med, Sch Genet & Microbiol, Dublin, Ireland	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Quadram Institute; University of East Anglia; Trinity College Dublin	Bowden, SD (corresponding author), Inst Food Res, Colney Lane, Norwich NR4 7UA, Norfolk, England.	arthur.thompson@bbsrc.ac.uk	Hinton, Jay C. D./B-2142-2008; Knudsen, Gitte/J-1858-2015; Ramachandran, Vinoy/H-6790-2013; Knudsen, Gitte Moos/C-1368-2013	Hinton, Jay C. D./0000-0003-2671-6026; Knudsen, Gitte Moos/0000-0003-1508-6866; Knudsen, Gitte Maegaard/0000-0002-3983-0541	Biotechnology and Biological Sciences Research Council (BBSRC) [BB/D004810/1]; BBSRC [BB/D004810/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D004810/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The authors are grateful to the Biotechnology and Biological Sciences Research Council (BBSRC) for funding this work (Grant BB/D004810/1 to AT, and the Core Strategic Grant to JCDH). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams GL, 2006, CELL MICROBIOL, V8, P728, DOI 10.1111/j.1462-5822.2006.00706.x; Alteri CJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000448; Baumler AJ, 1997, INFECT IMMUN, V65, P2254; Beuzon CR, 2000, EMBO J, V19, P3235, DOI 10.1093/emboj/19.13.3235; Bowden SD, 2009, INFECT IMMUN, V77, P3117, DOI 10.1128/IAI.00093-09; Bumann D, 2009, CURR OPIN MICROBIOL, V12, P559, DOI 10.1016/j.mib.2009.08.004; CARRILLO.G, 1970, J BACTERIOL, V102, P524; Chakravortty D, 2002, J EXP MED, V195, P1155, DOI 10.1084/jem.20011547; CRONAN JEJ, 1996, TRICARBOXYLIC ACID C, P206; Crump JA, 2004, B WORLD HEALTH ORGAN, V82, P346; Cvitkovitch DG, 1997, J BACTERIOL, V179, P650, DOI 10.1128/jb.179.3.650-655.1997; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Ehrt S, 2001, J EXP MED, V194, P1123, DOI 10.1084/jem.194.8.1123; Eriksson S, 2000, CELL MICROBIOL, V2, P239, DOI 10.1046/j.1462-5822.2000.00051.x; Galan JE, 2001, ANNU REV CELL DEV BI, V17, P53, DOI 10.1146/annurev.cellbio.17.1.53; Grant AJ, 2008, PLOS BIOL, V6, P757, DOI 10.1371/journal.pbio.0060074; GREENE RC, 1996, ESCHERICHIA COLI SAL, P542; Haraga A, 2008, NAT REV MICROBIOL, V6, P53, DOI 10.1038/nrmicro1788; Hautefort I, 2008, CELL MICROBIOL, V10, P958, DOI 10.1111/j.1462-5822.2007.01099.x; Humphreys S, 1999, INFECT IMMUN, V67, P1560; Husain M, 2008, J BIOL CHEM, V283, P7682, DOI 10.1074/jbc.M708845200; Klose KE, 1997, INFECT IMMUN, V65, P587, DOI 10.1128/IAI.65.2.587-596.1997; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; Kohanski MA, 2010, NAT REV MICROBIOL, V8, P423, DOI 10.1038/nrmicro2333; Mastroeni P, 1998, INFECT IMMUN, V66, P4767, DOI 10.1128/IAI.66.10.4767-4776.1998; McKinney JD, 2000, NATURE, V406, P735, DOI 10.1038/35021074; Mota LJ, 2009, CELL MICROBIOL, V11, P1236, DOI 10.1111/j.1462-5822.2009.01329.x; Nathan C, 2000, P NATL ACAD SCI USA, V97, P8841, DOI 10.1073/pnas.97.16.8841; OSWALD IP, 1992, CLIN EXP IMMUNOL, V87, P373, DOI 10.1111/j.1365-2249.1992.tb03005.x; Paterson GK, 2009, MICROB PATHOGENESIS, V46, P261, DOI 10.1016/j.micpath.2009.01.008; Paterson GK, 2009, FEMS MICROBIOL LETT, V294, P45, DOI 10.1111/j.1574-6968.2009.01553.x; Portillo FGD, 2001, MICROBES INFECT, V3, P1305, DOI 10.1016/S1286-4579(01)01491-5; RichterDahlfors A, 1997, J EXP MED, V186, P569, DOI 10.1084/jem.186.4.569; Rosenberger CM, 2002, J BIOL CHEM, V277, P18753, DOI 10.1074/jbc.M110649200; Santos RL, 2001, MICROBES INFECT, V3, P1335, DOI 10.1016/S1286-4579(01)01495-2; Schilling CH, 2000, J THEOR BIOL, V203, P249, DOI 10.1006/jtbi.2000.1088; Schilling CH, 2002, J BACTERIOL, V184, P4582, DOI 10.1128/JB.184.16.4582-4593.2002; Shiloh MU, 2000, CURR OPIN MICROBIOL, V3, P35, DOI 10.1016/S1369-5274(99)00048-X; SMITH HO, 1967, VIROLOGY, V31, P207, DOI 10.1016/0042-6822(67)90164-X; Steele-Mortimer O, 1999, CELL MICROBIOL, V1, P33, DOI 10.1046/j.1462-5822.1999.00003.x; Vazquez-Torres A, 2001, P NATL ACAD SCI USA, V98, P2561, DOI 10.1073/pnas.041618998; WANG RF, 1991, GENE, V100, P195, DOI 10.1016/0378-1119(91)90366-J; WILSON RB, 1987, J BACTERIOL, V169, P3029, DOI 10.1128/jb.169.7.3029-3034.1987; WOODCOCK DM, 1989, NUCLEIC ACIDS RES, V17, P3469, DOI 10.1093/nar/17.9.3469; WRAY C, 1978, RES VET SCI, V25, P139, DOI 10.1016/S0034-5288(18)32968-0; Yimga MT, 2006, INFECT IMMUN, V74, P1130, DOI 10.1128/IAI.74.2.1130-1140.2006	46	39	39	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2010	5	11							e13871	10.1371/journal.pone.0013871	http://dx.doi.org/10.1371/journal.pone.0013871			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	676NU	21079785	gold, Green Submitted, Green Published			2022-12-27	WOS:000283920000005
J	Elgaaen, BV; Haug, KBF; Wang, JB; Olstad, OK; Fortunati, D; Onsrud, M; Staff, AC; Sauer, T; Gautvik, KM				Elgaaen, Bente Vilming; Haug, Kari Bente Foss; Wang, Junbai; Olstad, Ole Kristoffer; Fortunati, Dario; Onsrud, Mathias; Staff, Anne Cathrine; Sauer, Torill; Gautvik, Kaare M.			POLD2 and KSP37 (FGFBP2) Correlate Strongly with Histology, Stage and Outcome in Ovarian Carcinomas	PLOS ONE			English	Article							SURFACE EPITHELIAL-CELLS; GENE-EXPRESSION; CLEAR-CELL; CANCER; PROTEIN; MODEL; GROWTH; PCR	Background: Epithelial ovarian cancer (EOC) constitutes more than 90% of ovarian cancers and is associated with high mortality. EOC comprises a heterogeneous group of tumours, and the causes and molecular pathology are essentially unknown. Improved insight into the molecular characteristics of the different subgroups of EOC is urgently needed, and should eventually lead to earlier diagnosis as well as more individualized and effective treatments. Previously, we reported a limited number of mRNAs strongly upregulated in human osteosarcomas and other malignancies, and six were selected to be tested for a possible association with three subgroups of ovarian carcinomas and clinical parameters. Methodology/Principal Findings: The six selected mRNAs were quantified by RT-qPCR in biopsies from eleven poorly differentiated serous carcinomas (PDSC, stage III-IV), twelve moderately differentiated serous carcinomas (MDSC, stage III-IV) and eight clear cell carcinomas (CCC, stage I-IV) of the ovary. Superficial scrapings from six normal ovaries (SNO), as well as biopsies from three normal ovaries (BNO) and three benign ovarian cysts (BBOC) were analyzed for comparison. The gene expression level was related to the histological and clinical parameters of human ovarian carcinoma samples. One of the mRNAs, DNA polymerase delta 2 small subunit (POLD2), was increased in average 2.5- to almost 20-fold in MDSC and PDSC, respectively, paralleling the degree of dedifferentiation and concordant with a poor prognosis. Except for POLD2, the serous carcinomas showed a similar transcription profile, being clearly different from CCC. Another mRNA, Killer-specific secretory protein of 37 kDa (KSP37) showed six-to eight-fold higher levels in CCC stage I compared with the more advanced staged carcinomas, and correlated positively with an improved clinical outcome. Conclusions/Significance: We have identified two biomarkers which are markedly upregulated in two subgroups of ovarian carcinomas and are also associated with stage and outcome. The results suggest that POLD2 and KSP37 might be potential prognostic biomarkers.	[Elgaaen, Bente Vilming; Onsrud, Mathias; Staff, Anne Cathrine] Oslo Univ Hosp, Dept Gynaecol, Oslo, Norway; [Haug, Kari Bente Foss; Olstad, Ole Kristoffer; Fortunati, Dario; Gautvik, Kaare M.] Oslo Univ Hosp, Dept Med Biochem, Oslo, Norway; [Wang, Junbai; Sauer, Torill] Oslo Univ Hosp, Dept Pathol, Oslo, Norway; [Onsrud, Mathias; Staff, Anne Cathrine; Sauer, Torill; Gautvik, Kaare M.] Univ Oslo, Fac Med, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; University of Oslo	Elgaaen, BV (corresponding author), Oslo Univ Hosp, Dept Gynaecol Oncol, Oslo, Norway.	bente.vilming.elgaaen@medisin.uio.no	Sauer, Torill/H-7041-2019; wang, junbai/B-2093-2008; wang, junbai/AFQ-5325-2022	wang, junbai/0000-0001-5505-5613	Former Eastern Norway Regional Health Authority; Organon; Merck; Sharp; Dohme	Former Eastern Norway Regional Health Authority; Organon; Merck(Merck & Company); Sharp; Dohme	The authors acknowledge former Eastern Norway Regional Health Authority for economical support as well as Organon (currently part of Merck, Sharp and Dohme) for providing a research grant through the Norwegian Society for Gynecology and Obstetrics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auersperg N, 2001, ENDOCR REV, V22, P255, DOI 10.1210/er.22.2.255; BATTINI R, 1987, J BIOL CHEM, V262, P4355; Bell DA, 2005, MODERN PATHOL, V18, pS19, DOI 10.1038/modpathol.3800306; Bray F, 2009, CANC NORWAY 2008 CAN; Bredel M, 2009, JAMA-J AM MED ASSOC, V302, P261, DOI 10.1001/jama.2009.997; Chan WY, 2000, AM J PATHOL, V156, P409, DOI 10.1016/S0002-9440(10)64744-X; Farley J, 2008, CELL RES, V18, P538, DOI 10.1038/cr.2008.52; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Landen CN, 2008, J CLIN ONCOL, V26, P995, DOI 10.1200/JCO.2006.07.9970; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Matsushima-Nishiu M, 2001, CANCER RES, V61, P3741; Meinhold-Heerlein I, 2005, ONCOGENE, V24, P1053, DOI 10.1038/sj.onc.1208298; Naora Honami, 2007, Expert Reviews in Molecular Medicine, V9, DOI 10.1017/S1462399407000324; Ogawa K, 2001, J IMMUNOL, V166, P6404, DOI 10.4049/jimmunol.166.10.6404; Okamura H, 2005, INT REV CYTOL, V242, P1; Olstad OK, 2003, ANTICANCER RES, V23, P2201; Orsulic S, 2002, CANCER CELL, V1, P53, DOI 10.1016/S1535-6108(01)00002-2; Perez A, 2000, BBA-GENE STRUCT EXPR, V1493, P231, DOI 10.1016/S0167-4781(00)00153-6; Pogacic V, 2000, MOL CELL BIOL, V20, P9028, DOI 10.1128/MCB.20.23.9028-9040.2000; PRAT J, 2009, ROBBOYS PATHOLOGY FE; Sasaki R, 2009, CARCINOGENESIS, V30, P423, DOI 10.1093/carcin/bgp007; Schwartz DR, 2002, CANCER RES, V62, P4722; Shih IM, 2004, AM J PATHOL, V164, P1511, DOI 10.1016/S0002-9440(10)63708-X; Shimizu M, 1999, CANCER, V85, P669, DOI 10.1002/(SICI)1097-0142(19990201)85:3<669::AID-CNCR17>3.0.CO;2-F; Wakabayashi Y, 2006, J IMMUNOL, V177, P1772, DOI 10.4049/jimmunol.177.3.1772; Wang JB, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-36; Wang JB, 2007, J BIOMED INFORM, V40, P707, DOI 10.1016/j.jbi.2007.02.003; Woo HN, 2004, FEBS LETT, V578, P239, DOI 10.1016/j.febslet.2004.10.094; Yamanaka R, 2006, ONCOGENE, V25, P5994, DOI 10.1038/sj.onc.1209585; Zorn KK, 2003, CLIN CANCER RES, V9, P4811	30	24	27	4	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2010	5	11							e13837	10.1371/journal.pone.0013837	http://dx.doi.org/10.1371/journal.pone.0013837			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675NY	21079801	gold, Green Submitted, Green Published			2022-12-27	WOS:000283838600012
J	Chittka, A				Chittka, Alexandra			Dynamic Distribution of Histone H4 Arginine 3 Methylation Marks in the Developing Murine Cortex	PLOS ONE			English	Article							CELL FATE; OLIGODENDROCYTE LINEAGE; PROTEIN METHYLATION; EPIGENETIC CONTROL; SPINAL-CORD; RADIAL GLIA; SPECIFICATION; ORIGIN; DIFFERENTIATION; TELENCEPHALON	Background: Epigenetic modifications regulate key transitions in cell fate during development of the central nervous system (CNS). During cortical development the initial population of proliferative neuroepithelial precursor cells give rise to neurons and then glia in a strict temporal order. Neurogenesis and gliogenesis are accompanied by a switch from symmetric to asymmetric divisions of the neural precursor cells generating another precursor and a differentiated progeny. To investigate whether specific post-translational histone modifications define specific stages of neural precursor differentiation during cortical development I focussed on the appearance of two different types of histone arginine methylation, the dimethyl symmetric H4R3 (H4R3me2s) and dimethyl asymmetric H4R3 (H4R3me2a) in the developing mouse cortex. Methodology/Principal Findings: An immunohistochemical study of the developing cortex at different developmental stages was performed to detect the distribution of H4R3me2s and H4R3me2a modifications. I analysed the distribution of these modifications in: 1) undifferentiated neural precursors, 2) post-mitotic neurons and 3) developing oligodendrocyte precursors (OLPs) using lineage-specific and histone modification-specific antibodies to co-label the cells. I found that the proliferative neuroepithelium during the stage of mainly symmetric expansive divisions is characterised by the prevalence of H4R3me2s modification and almost no detectable H4R3me2a modification. However, at a later stage, when the cortical layers with post-mitotic neurons have begun forming, both H4R3me2a and H4R3me2s modifications are detected in the post-mitotic neurons and in the developing OLPs. Conclusions/Significance: I propose that the H4R3me2s modification forms part of the "histone code" of undifferentiated neural precursors. The later appearance of the H4R3me2a modifications specifies the onset of neurogenesis and gliogenesis and the commitment of the NSCs to differentiate. Thus, the sequential appearance of the two different H4R3 methylation marks may define a particular cellular state of the NSCs during their development and differentiation demonstrating the role of histone arginine methylation in cortical development.	UCL, Wolfson Inst Biomed Res, London, England	University of London; University College London	Chittka, A (corresponding author), UCL, Wolfson Inst Biomed Res, London, England.	a.chittka@ucl.ac.uk	Chittka, Alexandra/AAR-9370-2021; Messier, Claude/A-2322-2008	Chittka, Alexandra/0000-0002-3495-270X; Messier, Claude/0000-0002-4791-1763	Wellcome Trust [WT076656MA]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by a Wellcome Trust Career Re-entry Fellowship WT076656MA to Alexandra Chittka. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ancelin K, 2006, NAT CELL BIOL, V8, P623, DOI 10.1038/ncb1413; Bayer S.A., 1991, NEOCORTICAL DEV; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Berthet C, 2002, GENES CELLS, V7, P29, DOI 10.1046/j.1356-9597.2001.00497.x; Chen SL, 2002, J BIOL CHEM, V277, P4324, DOI 10.1074/jbc.M109835200; Chittka A, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000532; CHOI BH, 1983, DEV BRAIN RES, V8, P119, DOI 10.1016/0165-3806(83)90163-3; Cimato TR, 1997, J CELL BIOL, V138, P1089, DOI 10.1083/jcb.138.5.1089; Cimato TR, 2002, J NEUROSCI RES, V67, P435, DOI 10.1002/jnr.10123; Dehay C, 2007, NAT REV NEUROSCI, V8, P438, DOI 10.1038/nrn2097; Fischle W, 2003, CURR OPIN CELL BIOL, V15, P172, DOI 10.1016/S0955-0674(03)00013-9; Fogarty M, 2005, DEVELOPMENT, V132, P1951, DOI 10.1242/dev.01777; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; Guillemot F, 2007, PROG NEUROBIOL, V83, P37, DOI 10.1016/j.pneurobio.2007.02.009; Hirabayashi Y, 2010, NAT REV NEUROSCI, V11, P377, DOI 10.1038/nrn2810; HIRANO M, 1988, J NEUROSCI RES, V21, P155, DOI 10.1002/jnr.490210208; Hsieh J, 2004, CURR OPIN GENET DEV, V14, P461, DOI 10.1016/j.gde.2004.07.006; Iacopetti P, 1999, P NATL ACAD SCI USA, V96, P4639, DOI 10.1073/pnas.96.8.4639; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kessaris N, 2008, PHILOS T R SOC B, V363, P71, DOI 10.1098/rstb.2006.2013; Miller FD, 2007, NEURON, V54, P357, DOI 10.1016/j.neuron.2007.04.019; Okano H, 2009, CURR OPIN NEUROBIOL, V19, P112, DOI 10.1016/j.conb.2009.04.003; PRINGLE NP, 1993, DEVELOPMENT, V117, P525; Sarmento OF, 2004, J CELL SCI, V117, P4449, DOI 10.1242/jcs.01328; Spassky N, 1998, J NEUROSCI, V18, P8331; Tekki-Kessaris N, 2001, DEVELOPMENT, V128, P2545; Zhang Y, 2001, GENE DEV, V15, P2343, DOI 10.1101/gad.927301; Zhao Q, 2009, NAT STRUCT MOL BIOL, V16, P304, DOI 10.1038/nsmb.1568	28	19	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2010	5	11							e13807	10.1371/journal.pone.0013807	http://dx.doi.org/10.1371/journal.pone.0013807			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	674WJ	21072194	Green Published, gold			2022-12-27	WOS:000283780800010
J	Karenina, K; Giljov, A; Baranov, V; Osipova, L; Krasnova, V; Malashichev, Y				Karenina, Karina; Giljov, Andrey; Baranov, Vladimir; Osipova, Ludmila; Krasnova, Vera; Malashichev, Yegor			Visual Laterality of Calf-Mother Interactions in Wild Whales	PLOS ONE			English	Article							INFANT SPATIAL RELATIONS; BOTTLE-NOSED DOLPHINS; SOCIAL-STIMULI; HEMISPHERIC-SPECIALIZATION; DELPHINAPTERUS-LEUCAS; BEHAVIORAL ASYMMETRY; DOMESTIC CHICK; BUFO-MARINUS; EYE USE; RESPONSES	Background: Behavioral laterality is known for a variety of vertebrate and invertebrate animals. Laterality in social interactions has been described for a wide range of species including humans. Although evidence and theoretical predictions indicate that in social species the degree of population level laterality is greater than in solitary ones, the origin of these unilateral biases is not fully understood. It is especially poorly studied in the wild animals. Little is known about the role, which laterality in social interactions plays in natural populations. A number of brain characteristics make cetaceans most suitable for investigation of lateralization in social contacts. Methodology/Principal Findings: Observations were made on wild beluga whales (Delphinapterus leucas) in the greatest breeding aggregation in the White Sea. Here we show that young calves (in 29 individually identified and in over a hundred of individually not recognized mother-calf pairs) swim and rest significantly longer on a mother's right side. Further observations along with the data from other cetaceans indicate that found laterality is a result of the calves' preference to observe their mothers with the left eye, i.e., to analyze the information on a socially significant object in the right brain hemisphere. Conclusions/Significance: Data from our and previous work on cetacean laterality suggest that basic brain lateralizations are expressed in the same way in cetaceans and other vertebrates. While the information on social partners and novel objects is analyzed in the right brain hemisphere, the control of feeding behavior is performed by the left brain hemisphere. Continuous unilateral visual contacts of calves to mothers with the left eye may influence social development of the young by activation of the contralateral (right) brain hemisphere, indicating a possible mechanism on how behavioral lateralization may influence species life and welfare. This hypothesis is supported by evidence from other vertebrates.	[Karenina, Karina; Giljov, Andrey; Osipova, Ludmila; Malashichev, Yegor] St Petersburg State Univ, Fac Biol & Soil Sci, Dept Vertebrate Zool, St Petersburg, Russia; [Baranov, Vladimir; Krasnova, Vera] PP Shirshov Oceanol Inst, Lab Marine Mammals, Moscow, Russia; [Malashichev, Yegor] St Petersburg State Univ, Fac Biol & Soil Sci, Dept Embryol, St Petersburg, Russia	Saint Petersburg State University; Russian Academy of Sciences; Shirshov Institute of Oceanology; Saint Petersburg State University	Karenina, K (corresponding author), St Petersburg State Univ, Fac Biol & Soil Sci, Dept Vertebrate Zool, St Petersburg, Russia.	malashichev@embryo.pu.ru	Giljov, Andrey/O-4755-2014; Karenina, Karina/B-9781-2012; Malashichev, Yegor/D-3511-2013	Giljov, Andrey/0000-0002-7533-1600; Karenina, Karina/0000-0001-8200-6876; Malashichev, Yegor/0000-0003-3813-5712	Federal Grant-in-Aid Program "Human Capital for Science and Education in Innovative Russia" [P2379]	Federal Grant-in-Aid Program "Human Capital for Science and Education in Innovative Russia"	This work was supported by the Federal Grant-in-Aid Program "Human Capital for Science and Education in Innovative Russia" (Governmental Contract No. P2379). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anfora G, 2010, BEHAV BRAIN RES, V206, P236, DOI 10.1016/j.bbr.2009.09.023; Bel'kovich V. M., 2002, MORSKIE MLEKOPITAYUS, P53; Bisazza A, 2000, LATERALITY, V5, P269, DOI 10.1080/135765000406111; Bisazza A, 2003, BEHAV BRAIN RES, V141, P131, DOI 10.1016/S0166-4328(02)00344-3; Bisazza A, 2002, BEHAV BRAIN RES, V134, P417, DOI 10.1016/S0166-4328(02)00055-4; Cantalupo C, 1995, NEUROPSYCHOLOGIA, V33, P1637, DOI 10.1016/0028-3932(95)00043-7; Casperd JM, 1996, BEHAV PROCESS, V37, P57, DOI 10.1016/0376-6357(95)00075-5; Daisley JN, 2009, PHILOS T R SOC B, V364, P965, DOI 10.1098/rstb.2008.0229; Damerose E., 2002, P306, DOI 10.1017/CBO9780511546372.011; DECKEL AW, 1995, J EXP ZOOL, V272, P194, DOI 10.1002/jez.1402720304; Gero S, 2007, MAR MAMMAL SCI, V23, P398, DOI 10.1111/j.1748-7692.2007.00113.x; Ghirlanda S, 2004, P ROY SOC B-BIOL SCI, V271, P853, DOI 10.1098/rspb.2003.2669; Ghirlanda S, 2009, PHILOS T R SOC B, V364, P861, DOI 10.1098/rstb.2008.0227; Giljov AN, 2009, LATERALITY, V14, P273, DOI 10.1080/13576500802379665; Gouchie GM, 2008, BEHAV ECOL SOCIOBIOL, V62, P1821, DOI 10.1007/s00265-008-0611-7; Gubbins C, 1999, MAR MAMMAL SCI, V15, P751, DOI 10.1111/j.1748-7692.1999.tb00841.x; HAMILTON CR, 1988, SCIENCE, V242, P1691, DOI 10.1126/science.3201258; Harris LJ, 2010, LATERALITY, V15, P15, DOI 10.1080/13576500701650430; Harris LJ, 2009, LATERALITY, V14, P590, DOI 10.1080/13576500902745781; Harris LJ, 2001, BRAIN COGNITION, V46, P159, DOI 10.1016/S0278-2626(01)80056-7; Karenina KA., 2010, J ASYMM, V4, P3; Kilian A, 2000, BEHAV BRAIN RES, V116, P211, DOI 10.1016/S0166-4328(00)00273-4; Kilian A, 2005, BEHAV PROCESS, V68, P179, DOI 10.1016/j.beproc.2004.11.003; Krasnova VV, 2009, RUSS J MAR BIOL +, V35, P53, DOI 10.1134/S1063074009010088; Krasnova VV, 2006, BIOL BULL+, V33, P53, DOI 10.1134/S1062359006010079; Lippolis G, 2005, LATERALITY, V10, P457, DOI 10.1080/13576500442000210; Lippolis G, 2002, LATERALITY, V7, P163, DOI 10.1080/13576500143000221; Lyamin O, 2007, PHYSIOL BEHAV, V92, P725, DOI 10.1016/j.physbeh.2007.05.064; MacNeilage PF, 2009, SCI AM, V301, P60, DOI 10.1038/scientificamerican0709-60; Malashichev Y, 2002, LATERALITY, V7, P195, DOI 10.1080/13576500244000094; Malashichev YB, 2006, MOL B INT U, P33; Malashichev YB, 2006, J COMP PSYCHOL, V120, P401, DOI 10.1037/0735-7036.120.4.401; Maleashichev YB, 2006; Mann J, 1999, BEHAVIOUR, V136, P529, DOI 10.1163/156853999501469; MANN J, 1997, FAMILY SYSTEMS, V4, P35; Marino L, 2004, ANAT REC PART A, V281A, P1256, DOI 10.1002/ar.a.20075; MENCH JA, 1986, BEHAV NEURAL BIOL, V46, P107, DOI 10.1016/S0163-1047(86)90570-4; Miklosi A, 2001, BEHAV BRAIN RES, V122, P57, DOI 10.1016/S0166-4328(01)00167-X; Miklosi A, 1999, BEHAV BRAIN RES, V105, P199, DOI 10.1016/S0166-4328(99)00071-6; Peirce JW, 2000, NEUROPSYCHOLOGIA, V38, P475, DOI 10.1016/S0028-3932(99)00088-3; Poliakova EC., 1978, ELECTROPHYSIOLOGICAL; Reddon AR, 2010, BEHAV PROCESS, V85, P68, DOI 10.1016/j.beproc.2010.06.008; Regolin L, 1996, BEHAV PROCESS, V37, P67, DOI 10.1016/0376-6357(95)00076-3; REGOLIN L, 1995, ANIM BEHAV, V50, P203, DOI 10.1006/anbe.1995.0232; Ridgway S.H., 1986, P31; Rizhova LY, 2006, MOL BIOL INTELL UNIT, P160; Rizhova LY, 2005, BEHAV BRAIN RES, V161, P75, DOI 10.1016/j.bbr.2005.01.007; Robins A, 2005, NEUROREPORT, V16, P849, DOI 10.1097/00001756-200505310-00014; Robins A, 2004, ANIM BEHAV, V68, P767, DOI 10.1016/j.anbehav.2003.12.014; Robins A, 2006, NEUROBIOL LEARN MEM, V86, P214, DOI 10.1016/j.nlm.2006.03.002; Rogers Lesley J., 1989, INT J COMP PSYCHOL, V3, P5; Rogers LJ, 2000, BRAIN LANG, V73, P236, DOI 10.1006/brln.2000.2305; Rogers LJ, 2002, ADV STUD BEHAV, V31, P107, DOI 10.1016/S0065-3454(02)80007-9; Rogers LJ, 2002, COMP VERTEBRATE LATE; Rot-Nikcevic I, 2006, BEHAV ECOL SOCIOBIOL, V60, P19, DOI 10.1007/s00265-005-0133-5; Sakai M, 2006, BEHAV BRAIN RES, V170, P204, DOI 10.1016/j.bbr.2006.02.018; SALK L, 1973, SCI AM, V228, P24, DOI 10.1038/scientificamerican0573-24; SALK L, 1970, Diseases of the Nervous System, V31, P110; Salk L., 1960, WORLD MENT HLTH, V12, P168; Sieratzki JS, 1996, LANCET, V347, P1746, DOI 10.1016/S0140-6736(96)90813-2; Silber Gregory K., 1995, Aquatic Mammals, V21, P183; Siniscalchi M, 2010, BEHAV BRAIN RES, V208, P516, DOI 10.1016/j.bbr.2009.12.042; Sovrano VA, 1999, BEHAV BRAIN RES, V106, P175, DOI 10.1016/S0166-4328(99)00105-9; Sovrano VA, 2004, BEHAV BRAIN RES, V152, P385, DOI 10.1016/j.bbr.2003.10.022; Sovrano VA, 2001, PHYSIOL BEHAV, V74, P237, DOI 10.1016/S0031-9384(01)00552-2; TARPLEY RJ, 1994, BRAIN BEHAV EVOLUT, V44, P156, DOI 10.1159/000113587; Tommasi L, 2009, PHILOS T R SOC B, V364, P855, DOI 10.1098/rstb.2008.0293; VALLORTIGARA G, 1992, NEUROPSYCHOLOGIA, V30, P761, DOI 10.1016/0028-3932(92)90080-6; Vallortigara G, 1998, NEUROREPORT, V9, P3341, DOI 10.1097/00001756-199810050-00035; Vallortigara G, 2005, BEHAV BRAIN SCI, V28, P575, DOI 10.1017/S0140525X05000105; Vallortigara G, 2001, CURR BIOL, V11, P29, DOI 10.1016/S0960-9822(00)00027-0; VALLORTIGARA G, 1994, BEHAV PROCESS, V33, P41, DOI 10.1016/0376-6357(94)90059-0; Vallortigara G, 2006, DEV PSYCHOBIOL, V48, P418, DOI 10.1002/dev.20166; von Fersen L, 2000, BEHAV BRAIN RES, V107, P177, DOI 10.1016/S0166-4328(99)00142-4; Woodward BL, 2006, MAR MAMMAL SCI, V22, P64, DOI 10.1111/j.1748-7692.2006.00006.x	75	48	51	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2010	5	11							e13787	10.1371/journal.pone.0013787	http://dx.doi.org/10.1371/journal.pone.0013787			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	674WJ	21072179	Green Published, Green Submitted, gold			2022-12-27	WOS:000283780800004
J	Chow, HY; Stepanova, D; Koch, J; Chernoff, J				Chow, Hoi Yee; Stepanova, Dina; Koch, Jennifer; Chernoff, Jonathan			p21-Activated Kinases Are Required for Transformation in a Cell-Based Model of Neurofibromatosis Type 2	PLOS ONE			English	Article							NF2 TUMOR-SUPPRESSOR; HUMAN SCHWANNOMA CELLS; PAK PROTEIN-KINASES; REGULATED KINASE; GENE-PRODUCT; FERM DOMAIN; MERLIN; GROWTH; RAC; ACTIVATION	Background: NF2 is an autosomal dominant disease characterized by development of bilateral vestibular schwannomas and other benign tumors in central nervous system. Loss of the NF2 gene product, Merlin, leads to aberrant Schwann cell proliferation, motility, and survival, but the mechanisms by which this tumor suppressor functions remain unclear. One well-defined target of Merlin is the group I family of p21-activated kinases, which are allosterically inhibited by Merlin and which, when activated, stimulate cell cycle progression, motility, and increased survival. Here, we examine the effect of Pak inhibition on cells with diminished Merlin function. Methodology/Principal Findings: Using a specific peptide inhibitor of group I Paks, we show that loss of Pak activity restores normal cell movement in cells lacking Merlin function. In addition, xenografts of such cells form fewer and smaller tumors than do cells without Pak inhibition. However, in tumors, loss of Pak activity does not reduce Erk or Akt activity, two signaling proteins that are thought to mediate Pak function in growth factor pathways. Conclusions/Significance: These results suggest that Pak functions in novel signaling pathways in NF2, and may serve as a useful therapeutic target in this disease.	[Chow, Hoi Yee; Stepanova, Dina; Koch, Jennifer; Chernoff, Jonathan] Fox Chase Canc Ctr, Canc Biol Program, Philadelphia, PA 19111 USA	Fox Chase Cancer Center	Chow, HY (corresponding author), Fox Chase Canc Ctr, Canc Biol Program, 7701 Burholme Ave, Philadelphia, PA 19111 USA.	J_Chernoff@fccc.edu	Chernoff, Jonathan/I-7631-2014; Stepanova, Dina/T-3999-2019	Chernoff, Jonathan/0000-0002-4803-7836; Stepanova, Dina/0000-0001-6138-8502	Department of Defense [W81XWH-06-1-0213, W81XWH-10-1-0092]; National Institutes of Health [CA117884]; Fox Chase Cancer Center [P30 CA006927]; State of Pennsylvania; NATIONAL CANCER INSTITUTE [R01CA117884, P30CA006927] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fox Chase Cancer Center; State of Pennsylvania; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the Department of Defense to JC (W81XWH-06-1-0213) and H-CC (W81XWH-10-1-0092) and from the National Institutes of Health to JC (CA117884) and to the Fox Chase Cancer Center (P30 CA006927), as well as by an appropriation from the state of Pennsylvania. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammoun S, 2008, CANCER RES, V68, P5236, DOI 10.1158/0008-5472.CAN-07-5849; Arias-Romero LE, 2008, BIOL CELL, V100, P97, DOI 10.1042/BC20070109; Bashour AM, 2002, MOL CELL BIOL, V22, P1150, DOI 10.1128/MCB.22.4.1150-1157.2002; Beeser A, 2005, J BIOL CHEM, V280, P36609, DOI 10.1074/jbc.M502306200; Bokoch GM, 2003, ANNU REV BIOCHEM, V72, P743, DOI 10.1146/annurev.biochem.72.121801.161742; Chadee DN, 2006, P NATL ACAD SCI USA, V103, P4463, DOI 10.1073/pnas.0510651103; Deacon SW, 2008, CHEM BIOL, V15, P322, DOI 10.1016/j.chembiol.2008.03.005; Dummler B, 2009, CANCER METAST REV, V28, P51, DOI 10.1007/s10555-008-9168-1; Eblen ST, 2002, MOL CELL BIOL, V22, P6023, DOI 10.1128/MCB.22.17.6023-6033.2002; Evans DGR, 2000, J MED GENET, V37, P897, DOI 10.1136/jmg.37.12.897; Flaiz C, 2009, EXP NEUROL, V218, P137, DOI 10.1016/j.expneurol.2009.04.019; Hage B, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-23; Hofmann C, 2004, J CELL SCI, V117, P4343, DOI 10.1242/jcs.01392; James MF, 2009, MOL CELL BIOL, V29, P4250, DOI 10.1128/MCB.01581-08; Jin HC, 2006, NATURE, V442, P576, DOI 10.1038/nature04856; Johnson KC, 2002, ONCOGENE, V21, P5990, DOI 10.1038/sj.onc.1205693; King AJ, 1998, NATURE, V396, P180, DOI 10.1038/24184; Kiosses WB, 2002, CIRC RES, V90, P697, DOI 10.1161/01.RES.0000014227.76102.5D; Kissil JL, 2003, MOL CELL, V12, P841, DOI 10.1016/S1097-2765(03)00382-4; Kissil JL, 2002, J BIOL CHEM, V277, P10394, DOI 10.1074/jbc.M200083200; KUMAR A, 2009, J CELL BIOCH; LaJeunesse DR, 1998, J CELL BIOL, V141, P1589, DOI 10.1083/jcb.141.7.1589; Lopez-Lago MA, 2009, MOL CELL BIOL, V29, P4235, DOI 10.1128/MCB.01578-08; Lozano E, 2008, J CELL SCI, V121, P933, DOI 10.1242/jcs.016121; Maksimoska J, 2008, J AM CHEM SOC, V130, P15764, DOI 10.1021/ja805555a; Maroto B, 2008, ONCOGENE, V27, P4900, DOI 10.1038/onc.2008.131; McLaughlin ME, 2007, P NATL ACAD SCI USA, V104, P3261, DOI 10.1073/pnas.0700044104; Morrison H, 2007, CANCER RES, V67, P520, DOI 10.1158/0008-5472.CAN-06-1608; Obermeier A, 1998, EMBO J, V17, P4328, DOI 10.1093/emboj/17.15.4328; Okada T, 2005, J CELL BIOL, V171, P361, DOI 10.1083/jcb.200503165; Pelton PD, 1998, ONCOGENE, V17, P2195, DOI 10.1038/sj.onc.1202141; Ray RM, 2007, CELL MOTIL CYTOSKEL, V64, P143, DOI 10.1002/cm.20172; Reed N, 2001, TRENDS MOL MED, V7, P157, DOI 10.1016/S1471-4914(01)01955-4; Say E, 2010, MOL CELL, V38, P236, DOI 10.1016/j.molcel.2010.04.004; Shaw RJ, 2001, DEV CELL, V1, P63, DOI 10.1016/S1534-5807(01)00009-0; Sherman L, 1997, ONCOGENE, V15, P2505, DOI 10.1038/sj.onc.1201418; Shimizu T, 2002, J BIOL CHEM, V277, P10332, DOI 10.1074/jbc.M109979200; Slack-Davis JK, 2003, J CELL BIOL, V162, P281, DOI 10.1083/jcb.200212141; Stokowski RP, 2000, AM J HUM GENET, V66, P873, DOI 10.1086/302812; Tang Y, 1998, P NATL ACAD SCI USA, V95, P5139, DOI 10.1073/pnas.95.9.5139; Tang Y, 1997, MOL CELL BIOL, V17, P4454, DOI 10.1128/MCB.17.8.4454; Xiao GH, 2002, J BIOL CHEM, V277, P883, DOI 10.1074/jbc.C100553200; Yi CL, 2008, CANCER RES, V68, P7932, DOI 10.1158/0008-5472.CAN-08-0866; Zhao LX, 2006, NAT NEUROSCI, V9, P234, DOI 10.1038/nn1630; Zhao ZS, 2005, MOL CELL, V20, P237, DOI 10.1016/j.molcel.2005.08.035	45	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2010	5	11							e13791	10.1371/journal.pone.0013791	http://dx.doi.org/10.1371/journal.pone.0013791			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	674VY	21072183	Green Published, gold, Green Submitted			2022-12-27	WOS:000283779700007
J	Sanz-Arigita, EJ; Schoonheim, MM; Damoiseaux, JS; Rombouts, SARB; Maris, E; Barkhof, F; Scheltens, P; Stam, CJ				Sanz-Arigita, Ernesto J.; Schoonheim, Menno M.; Damoiseaux, Jessica S.; Rombouts, Serge A. R. B.; Maris, Erik; Barkhof, Frederik; Scheltens, Philip; Stam, Cornelis J.			Loss of 'Small-World' Networks in Alzheimer's Disease: Graph Analysis of fMRI Resting-State Functional Connectivity	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; THEORETICAL ANALYSIS; DEFAULT-MODE; SYNCHRONIZATION LIKELIHOOD; HIPPOCAMPAL ATROPHY; NEURAL MECHANISMS; BRAIN; DEMENTIA; PATTERNS; AGE	Background: Local network connectivity disruptions in Alzheimer's disease patients have been found using graph analysis in BOLD fMRI. Other studies using MEG and cortical thickness measures, however, show more global long distance connectivity changes, both in functional and structural imaging data. The form and role of functional connectivity changes thus remains ambiguous. The current study shows more conclusive data on connectivity changes in early AD using graph analysis on resting-state condition fMRI data. Methodology/Principal Findings: 18 mild AD patients and 21 healthy age-matched control subjects without memory complaints were investigated in resting-state condition with MRI at 1.5 Tesla. Functional coupling between brain regions was calculated on the basis of pair-wise synchronizations between regional time-series. Local (cluster coefficient) and global (path length) network measures were quantitatively defined. Compared to controls, the characteristic path length of AD functional networks is closer to the theoretical values of random networks, while no significant differences were found in cluster coefficient. The whole-brain average synchronization does not differ between Alzheimer and healthy control groups. Post-hoc analysis of the regional synchronization reveals increased AD synchronization involving the frontal cortices and generalized decreases located at the parietal and occipital regions. This effectively translates in a global reduction of functional long-distance links between frontal and caudal brain regions. Conclusions/Significance: We present evidence of AD-induced changes in global brain functional connectivity specifically affecting long-distance connectivity. This finding is highly relevant for it supports the anterior-posterior disconnection theory and its role in AD. Our results can be interpreted as reflecting the randomization of the brain functional networks in AD, further suggesting a loss of global information integration in disease.	[Sanz-Arigita, Ernesto J.; Schoonheim, Menno M.; Barkhof, Frederik] Vrije Univ Amsterdam Med Ctr, Dept Radiol, Amsterdam, Netherlands; [Sanz-Arigita, Ernesto J.] CITA Alzheimer Fdn, Dept Radiol, San Sebastian, Spain; [Damoiseaux, Jessica S.] Stanford Univ, Stanford Cognit & Syst Neurosci Lab, Palo Alto, CA 94304 USA; [Rombouts, Serge A. R. B.] Leiden Univ, Leiden Inst Brain & Cognit LIBC, Dept Radiol, Med Ctr,Inst Psycholog Res, Leiden, Netherlands; [Maris, Erik] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands; [Stam, Cornelis J.] Vrije Univ Amsterdam Med Ctr, Clin Neurophysiol, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Stanford University; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Radboud University Nijmegen; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Sanz-Arigita, EJ (corresponding author), Vrije Univ Amsterdam Med Ctr, Dept Radiol, Amsterdam, Netherlands.	e.sanz.arigita@gmail.com	Schoonheim, Menno/AAI-6853-2021; Damoiseaux, Jessica/G-3228-2012; Barkhof, Frederik/AAJ-6226-2020; Schoonheim, Menno M/X-5398-2018; Rombouts, Serge A./AAL-7691-2021; Maris, Eric/E-4876-2012; Scheltens, Philip/E-1205-2012; Scheltens, Philip/AAL-9631-2020	Schoonheim, Menno/0000-0002-2504-6959; Barkhof, Frederik/0000-0003-3543-3706; Schoonheim, Menno M/0000-0002-2504-6959; Rombouts, Serge A./0000-0001-6351-4779; Maris, Eric/0000-0001-5166-1800; Scheltens, Philip/0000-0002-1046-6408; Stam, Cornelis/0000-0001-9163-7274; Sanz-Arigita, Ernesto J./0000-0001-9858-9666	Institute for the Study of Aging [231002]; Netherlands Organization for Scientific Research [916.36.117]	Institute for the Study of Aging; Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	The data acquisition was supported by the Institute for the Study of Aging (http://www.alzdiscovery.org; grant 231002) and Netherlands Organization for Scientific Research (http://www.nwo.nl; grant 916.36.117). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Alsop DC, 2000, ANN NEUROL, V47, P93, DOI 10.1002/1531-8249(200001)47:1<93::AID-ANA15>3.0.CO;2-8; Bassett DS, 2006, NEUROSCIENTIST, V12, P512, DOI 10.1177/1073858406293182; Block F, 2005, PROG NEUROBIOL, V75, P342, DOI 10.1016/j.pneurobio.2005.03.004; Buckner RL, 2005, J NEUROSCI, V25, P7709, DOI 10.1523/JNEUROSCI.2177-05.2005; DAMOISEAUX J, 2008, NEUROIMAGE, V41, pS144; Damoiseaux JS, 2008, CEREB CORTEX, V18, P1856, DOI 10.1093/cercor/bhm207; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; de Leeuw FE, 2004, NEUROLOGY, V62, P310, DOI 10.1212/01.WNL.0000103289.03648.AD; Delbeuck X, 2003, NEUROPSYCHOL REV, V13, P79, DOI 10.1023/A:1023832305702; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Eguiluz VM, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.018102; FAZEKAS F, 1987, AM J ROENTGENOL, V149, P351, DOI 10.2214/ajr.149.2.351; Fein G, 2000, NEUROLOGY, V55, P1626, DOI 10.1212/WNL.55.11.1626; Ferri R, 2007, CLIN NEUROPHYSIOL, V118, P449, DOI 10.1016/j.clinph.2006.10.021; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Friston KJ, 2002, PROG NEUROBIOL, V68, P113, DOI 10.1016/S0301-0082(02)00076-X; Grady CL, 2007, NEUROPSYCHOLOGY, V21, P371, DOI 10.1037/0894-4105.21.3.371; Grady CL, 2003, J NEUROSCI, V23, P986, DOI 10.1523/jneurosci.23-03-00986.2003; Grady CL, 2001, BRAIN, V124, P739, DOI 10.1093/brain/124.4.739; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Hagmann P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000597; Hao J, 2005, NEUROSCI LETT, V385, P18, DOI 10.1016/j.neulet.2005.05.028; He Y, 2008, J NEUROSCI, V28, P4756, DOI 10.1523/JNEUROSCI.0141-08.2008; He Y, 2007, NEUROIMAGE, V35, P488, DOI 10.1016/j.neuroimage.2006.11.042; Honey CJ, 2008, HUM BRAIN MAPP, V29, P802, DOI 10.1002/hbm.20579; Hopfinger JB, 2000, NAT NEUROSCI, V3, P284, DOI 10.1038/72999; Horwitz B, 1995, NEUROREPORT, V6, P2287, DOI 10.1097/00001756-199511270-00005; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Kaiser M, 2007, PHILOS T R SOC A, V365, P3033, DOI 10.1098/rsta.2007.0007; Kaiser M, 2006, PLOS COMPUT BIOL, V2, P805, DOI 10.1371/journal.pcbi.0020095; Karas GB, 2003, NEUROIMAGE, V18, P895, DOI 10.1016/S1053-8119(03)00041-7; Lago-Fernandez LF, 2000, PHYS REV LETT, V84, P2758, DOI 10.1103/PhysRevLett.84.2758; Lindeboom J, 2004, EUR J PHARMACOL, V490, P83, DOI 10.1016/j.ejphar.2004.02.046; Liu Y, 2008, BRAIN, V131, P945, DOI 10.1093/brain/awn018; Lustig C, 2003, P NATL ACAD SCI USA, V100, P14504, DOI 10.1073/pnas.2235925100; Maris E, 2007, J NEUROSCI METH, V164, P177, DOI 10.1016/j.jneumeth.2007.03.024; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Mason Isobel, 2007, Nurs Stand, V22, P43; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Micheloyannis S, 2006, SCHIZOPHR RES, V87, P60, DOI 10.1016/j.schres.2006.06.028; Montez T, 2006, NEUROIMAGE, V33, P1117, DOI 10.1016/j.neuroimage.2006.06.066; Newman MEJ, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.026121; O'Sullivan M, 2001, NEUROLOGY, V57, P632, DOI 10.1212/WNL.57.4.632; Ponten SC, 2007, CLIN NEUROPHYSIOL, V118, P918, DOI 10.1016/j.clinph.2006.12.002; Prvulovic D, 2002, NEUROIMAGE, V17, P1403, DOI 10.1006/nimg.2002.1271; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Reijneveld JC, 2007, CLIN NEUROPHYSIOL, V118, P2317, DOI 10.1016/j.clinph.2007.08.010; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Sole-Padulles C, 2009, NEUROBIOL AGING, V30, P1114, DOI 10.1016/j.neurobiolaging.2007.10.008; Sorg C, 2007, P NATL ACAD SCI USA, V104, P18760, DOI 10.1073/pnas.0708803104; Sporns O, 2000, CEREB CORTEX, V10, P127, DOI 10.1093/cercor/10.2.127; Sporns O, 2004, TRENDS COGN SCI, V8, P418, DOI 10.1016/j.tics.2004.07.008; Sporns O, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001049; Stam CJ, 2007, CEREB CORTEX, V17, P92, DOI 10.1093/cercor/bhj127; Stam CJ, 2006, NEUROIMAGE, V32, P1335, DOI 10.1016/j.neuroimage.2006.05.033; Stam CJ, 2009, BRAIN, V132, P213, DOI 10.1093/brain/awn262; Stam CJ, 2002, PHYSICA D, V163, P236, DOI 10.1016/S0167-2789(01)00386-4; Stam CJ, 2004, NEUROSCI LETT, V355, P25, DOI 10.1016/j.neulet.2003.10.063; Strogatz SH, 2001, NATURE, V410, P268, DOI 10.1038/35065725; Supekar K, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000100; Tononi G, 1998, SCIENCE, V282, P1846, DOI 10.1126/science.282.5395.1846; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Villain N, 2008, J NEUROSCI, V28, P6174, DOI 10.1523/JNEUROSCI.1392-08.2008; Wang HY, 2008, LUPUS, V17, P638, DOI 10.1177/0961203308089408; Wang K, 2007, HUM BRAIN MAPP, V28, P967, DOI 10.1002/hbm.20324; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Whitwell JL, 2007, BRAIN, V130, P1777, DOI 10.1093/brain/awm112; Woodard JL, 1998, NEUROPSYCHOLOGY, V12, P491, DOI 10.1037/0894-4105.12.4.491	71	420	437	5	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2010	5	11							e13788	10.1371/journal.pone.0013788	http://dx.doi.org/10.1371/journal.pone.0013788			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673FY	21072180	Green Submitted, gold, Green Published			2022-12-27	WOS:000283645700010
J	Lahiri, A; Lahiri, A; Das, P; Vani, J; Shaila, MS; Chakravortty, D				Lahiri, Amit; Lahiri, Ayan; Das, Priyanka; Vani, Janakiraman; Shaila, M. S.; Chakravortty, Dipshikha			TLR 9 Activation in Dendritic Cells Enhances Salmonella Killing and Antigen Presentation via Involvement of the Reactive Oxygen Species	PLOS ONE			English	Article							CONTROLS PHAGOSOMAL PH; CROSS-PRESENTATION; NADPH OXIDASE; SURFACE EXPRESSION; OLIGONUCLEOTIDES; PHAGOCYTOSIS; MACROPHAGES; INHIBITION; GROWTH	Synthetic CpG containing oligodeoxynucleotide Toll like receptor-9 agonist (CpG DNA) activates innate immunity and can stimulate antigen presentation against numerous intracellular pathogens. It was observed that Salmonella Typhimurium growth can be inhibited by the CpG DNA treatment in the murine dendritic cells. This inhibitory effect was mediated by an increased reactive oxygen species production. In addition, it was noted that CpG DNA treatment of dendritic cells during Salmonella infection leads to an increased antigen presentation. Further this increased antigen presentation was dependent on the enhanced reactive oxygen species production elicited by Toll like receptor-9 activation. With the help of an exogenous antigen it was shown that Salmonella antigen could also be cross-presented in a better way by CpG induction. These data collectively indicate that CpG DNA enhance the ability of murine dendritic cells to contain the growth of virulent Salmonella through reactive oxygen species dependent killing.	[Lahiri, Amit] Indian Inst Sci, Dept Microbiol & Cell Biol, Ctr Infect Dis Res, Bangalore 560012, Karnataka, India; Indian Inst Sci, Dept Microbiol & Cell Biol, Biosafety Labs, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore; Indian Institute of Science (IISC) - Bangalore	Lahiri, A (corresponding author), Indian Inst Sci, Dept Microbiol & Cell Biol, Ctr Infect Dis Res, Bangalore 560012, Karnataka, India.	dipa@mcbl.iisc.ernet.in	Chakravortty, Dipshikha/AAI-4448-2020; J, Vani/B-4882-2013	Lahiri, Ayan/0000-0003-1621-2051; LAHIRI, AMIT/0000-0003-0307-3478; Chakravortty, Dipshikha/0000-0002-7838-5145	Indian Institute of Science, Bangalore, India [191/MCB]; Department of Biotechnology, India [DBT 197, DBT 172]	Indian Institute of Science, Bangalore, India; Department of Biotechnology, India(Department of Biotechnology (DBT) India)	This work was supported by the grant, Provision (2A) Tenth Plan (191/MCB) from the Director of Indian Institute of Science, Bangalore, India, and Department of Biotechnology (DBT 197 and DBT 172), India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babior BM, 2002, ARCH BIOCHEM BIOPHYS, V397, P342, DOI 10.1006/abbi.2001.2642; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Cheminay C, 2005, J IMMUNOL, V174, P2892, DOI 10.4049/jimmunol.174.5.2892; Datta SK, 2003, J IMMUNOL, V170, P4102, DOI 10.4049/jimmunol.170.8.4102; Eguchi M, 2007, FEMS IMMUNOL MED MIC, V50, P411, DOI 10.1111/j.1574-695X.2007.00275.x; Ewaschuk JB, 2007, INFECT IMMUN, V75, P2572, DOI 10.1128/IAI.01662-06; Gong J, 2003, INT IMMUNOPHARMACOL, V3, P1841, DOI 10.1016/j.intimp.2003.08.010; Guermonprez P, 2002, ANNU REV IMMUNOL, V20, P621, DOI 10.1146/annurev.immunol.20.100301.064828; Guermonprez P, 2003, NATURE, V425, P397, DOI 10.1038/nature01911; Halici S, 2008, INFECT IMMUN, V76, P4924, DOI 10.1128/IAI.00531-08; Houde M, 2003, NATURE, V425, P402, DOI 10.1038/nature01912; Kaisho T, 2004, MICROBES INFECT, V6, P1388, DOI 10.1016/j.micinf.2004.08.019; Kawai T, 2007, SEMIN IMMUNOL, V19, P24, DOI 10.1016/j.smim.2006.12.004; Kirby AC, 2001, J IMMUNOL, V166, P6802, DOI 10.4049/jimmunol.166.11.6802; Lahiri A, 2008, VACCINE, V26, P6777, DOI 10.1016/j.vaccine.2008.09.045; Lanzavecchia A, 2001, CELL, V106, P263, DOI 10.1016/S0092-8674(01)00455-X; Lapaque N, 2009, P NATL ACAD SCI USA, V106, P14052, DOI 10.1073/pnas.0906735106; Latz E, 2007, NAT IMMUNOL, V8, P772, DOI 10.1038/ni1479; Maemura K, 2005, IMMUNOL CELL BIOL, V83, P336, DOI 10.1111/j.1440-1711.2005.01323.x; Mantegazza AR, 2008, BLOOD, V112, P4712, DOI 10.1182/blood-2008-01-134791; Matsue H, 2003, J IMMUNOL, V171, P3010, DOI 10.4049/jimmunol.171.6.3010; McPhail L C, 1992, Immunol Ser, V57, P47; MCPHAIL LC, 1994, J EXP MED, V180, P2011, DOI 10.1084/jem.180.6.2011; Miggin SM, 2006, J LEUKOCYTE BIOL, V80, P220, DOI 10.1189/jlb.1105672; Nakamura H, 1997, ANNU REV IMMUNOL, V15, P351, DOI 10.1146/annurev.immunol.15.1.351; Riezman H, 1997, CELL, V91, P731, DOI 10.1016/S0092-8674(00)80461-4; Rock KL, 2003, NAT IMMUNOL, V4, P941, DOI 10.1038/ni1003-941; Sanchez-Campillo M, 2004, MICROBES INFECT, V6, P813, DOI 10.1016/j.micinf.2004.04.010; Savina A, 2007, IMMUNOL REV, V219, P143, DOI 10.1111/j.1600-065X.2007.00552.x; Savina A, 2006, CELL, V126, P205, DOI 10.1016/j.cell.2006.05.035; Sousa CRE, 2001, IMMUNITY, V14, P495; Trieu A, 2009, IMMUNOL CELL BIOL, V87, P218, DOI 10.1038/icb.2008.95; Turpaev KT, 2002, BIOCHEMISTRY-MOSCOW+, V67, P281, DOI 10.1023/A:1014819832003; Vani J, 2007, CELL IMMUNOL, V246, P17, DOI 10.1016/j.cellimm.2007.05.001; Vani J, 2007, IMMUNOLOGY, V120, P486, DOI 10.1111/j.1365-2567.2006.02519.x; Vignais PV, 2002, CELL MOL LIFE SCI, V59, P1428, DOI 10.1007/s00018-002-8520-9; Vulcano M, 2004, J IMMUNOL, V173, P5749, DOI 10.4049/jimmunol.173.9.5749; Wang JP, 2005, FEMS IMMUNOL MED MIC, V45, P303, DOI 10.1016/j.femsim.2005.05.007; Watson JL, 2006, CLIN CHIM ACTA, V364, P1, DOI 10.1016/j.cca.2005.05.017; Xiang SD, 2006, METHODS, V40, P1, DOI 10.1016/j.ymeth.2006.05.016; Yrlid U, 2001, MICROBES INFECT, V3, P1239, DOI 10.1016/S1286-4579(01)01484-8; Yrlid U, 2000, FEMS IMMUNOL MED MIC, V27, P313, DOI 10.1111/j.1574-695X.2000.tb01445.x; Zenk SF, 2009, J IMMUNOL, V183, P2697, DOI 10.4049/jimmunol.0900937	44	24	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2010	5	10							e13772	10.1371/journal.pone.0013772	http://dx.doi.org/10.1371/journal.pone.0013772			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673FU	21048937	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000283645300046
J	Roll, P; Sanlaville, D; Cillario, J; Labalme, A; Bruneau, N; Massacrier, A; Delepine, M; Dessen, P; Lazar, V; Robaglia-Schlupp, A; Lesca, G; Jouve, E; Rudolf, G; Rochette, J; Lathrop, GM; Szepetowski, P				Roll, Patrice; Sanlaville, Damien; Cillario, Jennifer; Labalme, Audrey; Bruneau, Nadine; Massacrier, Annick; Delepine, Marc; Dessen, Philippe; Lazar, Vladimir; Robaglia-Schlupp, Andree; Lesca, Gaetan; Jouve, Elisabeth; Rudolf, Gabrielle; Rochette, Jacques; Lathrop, G. Mark; Szepetowski, Pierre			Infantile Convulsions with Paroxysmal Dyskinesia (ICCA Syndrome) and Copy Number Variation at Human Chromosome 16p11	PLOS ONE			English	Article							KINESIGENIC DYSKINESIA; HUMAN GENOME; CHOREOATHETOSIS SYNDROME; LINKAGE; GENE; ASSOCIATION; SEIZURES; MUTATIONS; 16P12-Q12; FAMILIES	Background: Benign infantile convulsions and paroxysmal dyskinesia are episodic cerebral disorders that can share common genetic bases. They can be co-inherited as one single autosomal dominant trait (ICCA syndrome); the disease ICCA gene maps at chromosome 16p12-q12. Despite intensive and conventional mutation screening, the ICCA gene remains unknown to date. The critical area displays highly complicated genomic architecture and is the site of deletions and duplications associated with various diseases. The possibility that the ICCA syndrome is related to the existence of large-scale genomic alterations was addressed in the present study. Methodology/Principal Findings: A combination of whole genome and dedicated oligonucleotide array comparative genomic hybridization coupled with quantitative polymerase chain reaction was used. Low copy number of a region corresponding to a genomic variant (Variation_7105) located at 16p11 nearby the centromere was detected with statistical significance at much higher frequency in patients from ICCA families than in ethnically matched controls. The genomic variant showed no apparent difference in size and copy number between patients and controls, making it very unlikely that the genomic alteration detected here is ICCA-specific. Furthermore, no other genomic alteration that would directly cause the ICCA syndrome in those nine families was detected in the ICCA critical area. Conclusions/Significance: Our data excluded that inherited genomic deletion or duplication events directly cause the ICCA syndrome; rather, they help narrowing down the critical ICCA region dramatically and indicate that the disease ICCA genetic defect lies very close to or within Variation_7105 and hence should now be searched in the corresponding genomic area and its surrounding regions.	[Roll, Patrice; Robaglia-Schlupp, Andree] INSERM, U910, F-13258 Marseille, France; [Roll, Patrice; Cillario, Jennifer; Bruneau, Nadine; Massacrier, Annick; Robaglia-Schlupp, Andree; Szepetowski, Pierre] Univ Aix Marseille 2, Aix En Provence, France; [Sanlaville, Damien; Labalme, Audrey; Lesca, Gaetan] Hosp Civils Lyon, Serv Cytogenet Constitut, Lyon, France; [Sanlaville, Damien] Univ Lyon 1, EA 4171, F-69365 Lyon, France; [Cillario, Jennifer; Bruneau, Nadine; Massacrier, Annick; Szepetowski, Pierre] INSERM, U901, F-13258 Marseille, France; [Cillario, Jennifer; Bruneau, Nadine; Massacrier, Annick; Szepetowski, Pierre] INMED, Marseille, France; [Delepine, Marc; Lathrop, G. Mark] Univ Evry, CNG, Evry, France; [Dessen, Philippe] Inst Cancerol Gustave Roussy IGR, Unite Genom Fonct, Villejuif, France; [Jouve, Elisabeth] AP HM, CIC UPCET, Marseille, France; [Rudolf, Gabrielle] Hop Univ Strasbourg, Neurol Clin, Strasbourg, France; [Rochette, Jacques] INSERM, UMR925, Amiens, France; [Rochette, Jacques] Univ Picardie Jules Verne, Unite Neuropediat, Amiens, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Institut National de la Sante et de la Recherche Medicale (Inserm); Picardie Universites; Universite de Picardie Jules Verne (UPJV)	Roll, P (corresponding author), INSERM, U910, F-13258 Marseille, France.	szepetowski@inmed.univ-mrs.fr	Sanlaville, Damien/M-4716-2014; Jouve, Elisabeth/GSN-9120-2022; Lazar, Vladimir/AAV-2087-2020; ROLL, Patrice/I-4355-2016; ROLL, Patrice/GLS-4467-2022; Lazar, Vladimir/AAQ-2086-2020; Lesca, Gaetan/C-6111-2019; Bruneau, Nadine/O-2100-2016	Sanlaville, Damien/0000-0001-9939-2849; Jouve, Elisabeth/0000-0002-4873-6522; ROLL, Patrice/0000-0002-0045-5641; ROLL, Patrice/0000-0002-0045-5641; Bruneau, Nadine/0000-0002-1523-3128; Rudolf, Gabrielle/0000-0002-2050-3911; Lesca, Gaetan/0000-0001-7691-9492	Institut National de la Sante Et de la Recherche Medicale (INSERM); Groupement d' Interet Scientifique (GIS)/Institut des Maladies Rares; French Ministere de la Recherche et de la Technologie (MRT)	Institut National de la Sante Et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Groupement d' Interet Scientifique (GIS)/Institut des Maladies Rares; French Ministere de la Recherche et de la Technologie (MRT)	This work was supported by Institut National de la Sante Et de la Recherche Medicale (INSERM) and by a grant from Groupement d' Interet Scientifique (GIS)/Institut des Maladies Rares. JC is a recipient of a French Ministere de la Recherche et de la Technologie (MRT) PhD fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballif BC, 2007, NAT GENET, V39, P1071, DOI 10.1038/ng2107; Bayou N, 2008, COMP FUNCT GENOM, DOI 10.1155/2008/609684; Bennett LB, 2000, NEUROLOGY, V54, P125, DOI 10.1212/WNL.54.1.125; Bochukova EG, 2010, NATURE, V463, P666, DOI 10.1038/nature08689; Callenbach PMC, 2005, CLIN GENET, V67, P517, DOI 10.1111/j.1399-0004.2005.00445.x; Caraballo R, 2001, AM J HUM GENET, V68, P788, DOI 10.1086/318805; Caraballo RH, 2007, BENIGN FOCAL EPILEPS, P31; de Smith AJ, 2007, HUM MOL GENET, V16, P2783, DOI 10.1093/hmg/ddm208; Eichler EE, 1996, HUM MOL GENET, V5, P899, DOI 10.1093/hmg/5.7.899; Hahn KA, 2002, AM J HUM GENET, V70, P1349, DOI 10.1086/340092; HO G, 2005, BIOCHEM BIOPH RES CO, V336, P175; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Kidd JM, 2008, NATURE, V453, P56, DOI 10.1038/nature06862; Kikuchi T, 2007, J HUM GENET, V52, P334, DOI 10.1007/s10038-007-0116-7; Kumar RA, 2008, HUM MOL GENET, V17, P628, DOI 10.1093/hmg/ddm376; Lee HY, 2004, HUM MOL GENET, V13, P3161, DOI 10.1093/hmg/ddh330; Lee JA, 2006, NEURON, V52, P103, DOI 10.1016/j.neuron.2006.09.027; Lee WL, 1998, HUM GENET, V103, P608, DOI 10.1007/s004390050876; Lipton J, 2009, NEUROLOGY, V73, P479, DOI 10.1212/WNL.0b013e3181b16393; Locke DP, 2006, AM J HUM GENET, V79, P275, DOI 10.1086/505653; Loftus BJ, 1999, GENOMICS, V60, P295, DOI 10.1006/geno.1999.5927; Lupski JR, 2007, NAT GENET, V39, pS43, DOI 10.1038/ng2084; Martin J, 2004, NATURE, V432, P988, DOI 10.1038/nature03187; McCarroll SA, 2007, NAT GENET, V39, pS37, DOI 10.1038/ng2080; McCarthy SE, 2009, NAT GENET, V41, P1223, DOI 10.1038/ng.474; Ng CC, 1999, GENE CHROMOSOME CANC, V26, P329, DOI 10.1002/(SICI)1098-2264(199912)26:4<329::AID-GCC7>3.0.CO;2-C; Rainier S, 2004, ARCH NEUROL-CHICAGO, V61, P1025, DOI 10.1001/archneur.61.7.1025; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Rochette J, 2008, J MED GENET, V45, P773, DOI 10.1136/jmg.2008.059519; Rochette J, 2010, EPILEPTIC DISORD, V12, P199, DOI 10.1684/epd.2010.0328; Sadamatsu M, 1999, EPILEPSIA, V40, P942, DOI 10.1111/j.1528-1157.1999.tb00801.x; Sharp AJ, 2005, AM J HUM GENET, V77, P78, DOI 10.1086/431652; Shinawi M, 2010, J MED GENET, V47, P332, DOI 10.1136/jmg.2009.073015; Striano P, 2006, EPILEPSIA, V47, P1029, DOI 10.1111/j.1528-1167.2006.00521.x; Swoboda KJ, 2000, NEUROLOGY, V55, P224, DOI 10.1212/WNL.55.2.224; Szepetowski P, 1997, AM J HUM GENET, V61, P889, DOI 10.1086/514877; SZEPETOWSKI P, 2007, BENIGN FOCAL EPILEPS, P51; Thiriaux A, 2002, MOVEMENT DISORD, V17, P98, DOI 10.1002/mds.1195; Tomita H, 1999, AM J HUM GENET, V65, P1688, DOI 10.1086/302682; Walters RG, 2010, NATURE, V463, P671, DOI 10.1038/nature08727; Weber YG, 2004, EPILEPSIA, V45, P601, DOI 10.1111/j.0013-9580.2004.48203.x; Weber YG, 2008, J CLIN INVEST, V118, P2157, DOI 10.1172/JCI34438; Weiss LA, 2008, NEW ENGL J MED, V358, P667, DOI 10.1056/NEJMoa075974	43	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2010	5	10							e13750	10.1371/journal.pone.0013750	http://dx.doi.org/10.1371/journal.pone.0013750			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673FU	21060786	Green Published, Green Submitted, gold			2022-12-27	WOS:000283645300029
J	Harris, GM; Dodelzon, K; Gong, LJ; Gonzalez-Alegre, P; Paulson, HL				Harris, Ginny Marie; Dodelzon, Katerina; Gong, Lijie; Gonzalez-Alegre, Pedro; Paulson, Henry L.			Splice Isoforms of the Polyglutamine Disease Protein Ataxin-3 Exhibit Similar Enzymatic yet Different Aggregation Properties	PLOS ONE			English	Article							MACHADO-JOSEPH-DISEASE; MESSENGER-RNA DECAY; NUCLEAR-LOCALIZATION; GENOMIC STRUCTURE; TRANSGENIC MICE; GENE; IDENTIFICATION; PATHWAY; CELLS; EXPANSIONS	Protein context clearly influences neurotoxicity in polyglutamine diseases, but the contribution of alternative splicing to this phenomenon has rarely been investigated. Ataxin-3, a deubiquitinating enzyme and the disease protein in SCA3, is alternatively spliced to encode either a C-terminal hydrophobic stretch or a third ubiquitin interacting motif (termed 2UIM and 3UIM isoforms, respectively). In light of emerging insights into ataxin-3 function, we examined the significance of this splice variation. We confirmed neural expression of several minor 5' variants and both of the known 3' ataxin-3 splice variants. Regardless of polyglutamine expansion, 3UIM ataxin-3 is the predominant isoform in brain. Although 2UIM and 3UIM ataxin-3 display similar in vitro deubiquitinating activity, 2UIM ataxin-3 is more prone to aggregate and more rapidly degraded by the proteasome. Our data demonstrate how alternative splicing of sequences distinct from the trinucleotide repeat can alter properties of the encoded polyglutamine disease protein and thereby perhaps contribute to selective neurotoxicity.	[Harris, Ginny Marie] Univ Iowa, Grad Program Mol & Cellular Biol, Iowa City, IA 52242 USA; [Harris, Ginny Marie] Univ Iowa, Med Sci Training Program, Iowa City, IA USA; [Dodelzon, Katerina] Univ Iowa, Carver Coll Med, Iowa City, IA USA; [Gong, Lijie; Paulson, Henry L.] Univ Michigan, Dept Neurol, Ann Arbor, MI USA; [Gonzalez-Alegre, Pedro] Univ Iowa, Dept Neurol, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; University of Iowa; University of Michigan System; University of Michigan; University of Iowa	Harris, GM (corresponding author), Univ Iowa, Grad Program Mol & Cellular Biol, Iowa City, IA 52242 USA.	henryp@umich.edu			NIH (NIND) [RO1 38712]; University of Iowa; Glenn Labs	NIH (NIND)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Iowa; Glenn Labs	We thank Sue Travis for invaluable advice on recombinant protein expression and in vitro DUB assays, Fredrick Oakley for his generous gifts of time and expertise in 2D-PAGE, Sokol Todi and Edgar Rodriguez for their insights into experimental design and interpretation, and Tina Knudson for preliminary management of the transgenic lines. We are grateful to Charles Brenner and Matthew Wean for providing the equipment and technical expertise necessary to complete the Ub-AMC assays. We also are grateful to all members of the Paulson, Gonzalez-Alegre, and Glenn Labs for their support and comments.; This work was funded by the NIH (NIND RO1 38712 to HLP), the University of Iowa Molecular and Cellular Biology Training Grant, and the University of Iowa Medical Scientist Training Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affaitati A, 2001, GENE, V267, P89, DOI 10.1016/S0378-1119(01)00402-4; BANFI S, 1994, NAT GENET, V7, P513, DOI 10.1038/ng0894-513; Berke SJS, 2005, J BIOL CHEM, V280, P32026, DOI 10.1074/jbc.M506084200; Bettencourt C, 2010, NEUROGENETICS, V11, P193, DOI 10.1007/s10048-009-0216-y; Bichelmeier U, 2007, J NEUROSCI, V27, P7418, DOI 10.1523/JNEUROSCI.4540-06.2007; Burnett B, 2003, HUM MOL GENET, V12, P3195, DOI 10.1093/hmg/ddg344; Cemal CK, 2002, HUM MOL GENET, V11, P1075, DOI 10.1093/hmg/11.9.1075; Chai YH, 2002, P NATL ACAD SCI USA, V99, P9310, DOI 10.1073/pnas.152101299; Costa MD, 2002, J HUM GENET, V47, P205; Einum DD, 2003, ARCH NEUROL-CHICAGO, V60, P97, DOI 10.1001/archneur.60.1.97; Ellisdon AM, 2006, J BIOL CHEM, V281, P16888, DOI 10.1074/jbc.M601470200; Fisher RD, 2003, J BIOL CHEM, V278, P28976, DOI 10.1074/jbc.M302596200; Goti D, 2004, J NEUROSCI, V24, P10266, DOI 10.1523/JNEUROSCI.2734-04.2004; Goto J, 1997, NEUROSCI RES, V28, P373, DOI 10.1016/S0168-0102(97)00056-4; Hirata S, 2003, TRENDS ENDOCRIN MET, V14, P124, DOI 10.1016/S1043-2760(03)00028-6; Ichikawa Y, 2001, J HUM GENET, V46, P413, DOI 10.1007/s100380170060; Johnson JM, 2003, SCIENCE, V302, P2141, DOI 10.1126/science.1090100; Kanumilli S, 2006, PHYSIOL GENOMICS, V24, P86, DOI 10.1152/physiolgenomics.00149.2005; KAWAGUCHI Y, 1994, NAT GENET, V8, P221, DOI 10.1038/ng1194-221; Lim J, 2008, NATURE, V452, P713, DOI 10.1038/nature06731; Maquat LE, 2005, J CELL SCI, V118, P1773, DOI 10.1242/jcs.01701; Matsuyama Z, 2004, NEUROBIOL DIS, V17, P198, DOI 10.1016/j.nbd.2004.07.013; Mueller T, 2009, HUM MOL GENET, V18, P3334, DOI 10.1093/hmg/ddp274; Orr HT, 2007, ANNU REV NEUROSCI, V30, P575, DOI 10.1146/annurev.neuro.29.051605.113042; Paulson HL, 1997, ANN NEUROL, V41, P453, DOI 10.1002/ana.410410408; Perez MK, 1998, J CELL BIOL, V143, P1457, DOI 10.1083/jcb.143.6.1457; Reid SJ, 2009, BRAIN RES, V1268, P190, DOI 10.1016/j.brainres.2009.03.004; Sahba S, 1998, GENOMICS, V47, P359, DOI 10.1006/geno.1997.5131; Saunders HM, 2009, PROTEIN ENG DES SEL, V22, P447, DOI 10.1093/protein/gzp033; Schmidt T, 1998, BRAIN PATHOL, V8, P669, DOI 10.1111/j.1750-3639.1998.tb00193.x; Schmitt I, 2007, BIOCHEM BIOPH RES CO, V362, P734, DOI 10.1016/j.bbrc.2007.08.062; Silva AL, 2009, FEBS LETT, V583, P499, DOI 10.1016/j.febslet.2008.12.058; Tadokoro K, 2005, J HUM GENET, V50, P382, DOI 10.1007/s10038-005-0261-9; Todi SV, 2007, J BIOL CHEM, V282, P29348, DOI 10.1074/jbc.M704126200; Todi SV, 2009, EMBO J, V28, P372, DOI 10.1038/emboj.2008.289; Tsunemi T, 2008, NEUROSCI LETT, V447, P78, DOI 10.1016/j.neulet.2008.09.065; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Warrick JM, 2005, MOL CELL, V18, P37, DOI 10.1016/j.molcel.2005.02.030; Williams AJ, 2009, NEUROBIOL DIS, V33, P342, DOI 10.1016/j.nbd.2008.10.016; Winborn BJ, 2008, J BIOL CHEM, V283, P26436, DOI 10.1074/jbc.M803692200; Yang F, 2009, NEUROSCI LETT, V454, P203, DOI 10.1016/j.neulet.2009.03.027; Zhuchenko O, 1997, NAT GENET, V15, P62, DOI 10.1038/ng0197-62	42	46	46	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2010	5	10							e13695	10.1371/journal.pone.0013695	http://dx.doi.org/10.1371/journal.pone.0013695			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671UN	21060878	Green Published, Green Submitted, gold			2022-12-27	WOS:000283537000056
J	Rosen, DB; Minden, MD; Kornblau, SM; Cohen, A; Gayko, U; Putta, S; Woronicz, J; Evensen, E; Fantl, WJ; Cesano, A				Rosen, David B.; Minden, Mark D.; Kornblau, Steven M.; Cohen, Aileen; Gayko, Urte; Putta, Santosh; Woronicz, John; Evensen, Erik; Fantl, Wendy J.; Cesano, Alessandra			Functional Characterization of FLT3 Receptor Signaling Deregulation in Acute Myeloid Leukemia by Single Cell Network Profiling (SCNP)	PLOS ONE			English	Article							INTERNAL TANDEM DUPLICATION; ACUTE MYELOGENOUS LEUKEMIA; OPERATING CHARACTERISTIC CURVES; HEMATOPOIETIC STEM-CELLS; NORMAL CYTOGENETICS; PROGNOSTIC-SIGNIFICANCE; GENE-MUTATIONS; NUCLEOPHOSMIN NPM1; TYROSINE KINASE; FAVORABLE PROGNOSIS	Background: Molecular characterization of the FMS-like tyrosine kinase 3 receptor (FLT3) in cytogenetically normal acute myeloid leukemia (AML) has recently been incorporated into clinical guidelines based on correlations between FLT3 internal tandem duplications (FLT3-ITD) and decreased disease-free and overall survival. These mutations result in constitutive activation of FLT3, and FLT3 inhibitors are currently undergoing trials in AML patients selected on FLT3 molecular status. However, the transient and partial responses observed suggest that FLT3 mutational status alone does not provide complete information on FLT3 biological activity at the individual patient level. Examination of variation in cellular responsiveness to signaling modulation may be more informative. Methodology/Principal Findings: Using single cell network profiling (SCNP), cells were treated with extracellular modulators and their functional responses were quantified by multiparametric flow cytometry. Intracellular signaling responses were compared between healthy bone marrow myeloblasts (BMMb) and AML leukemic blasts characterized as FLT3 wild type (FLT3-WT) or FLT3-ITD. Compared to healthy BMMb, FLT3-WT leukemic blasts demonstrated a wide range of signaling responses to FLT3 ligand (FLT3L), including elevated and sustained PI3K and Ras/Raf/Erk signaling. Distinct signaling and apoptosis profiles were observed in FLT3-WT and FLT3-ITD AML samples, with more uniform signaling observed in FLT3-ITD AML samples. Specifically, increased basal p-Stat5 levels, decreased FLT3L induced activation of the PI3K and Ras/Raf/Erk pathways, decreased IL-27 induced activation of the Jak/Stat pathway, and heightened apoptotic responses to agents inducing DNA damage were observed in FLT3-ITD AML samples. Preliminary analysis correlating these findings with clinical outcomes suggests that classification of patient samples based on signaling profiles may more accurately reflect FLT3 signaling deregulation and provide additional information for disease characterization and management. Conclusions/Significance: These studies show the feasibility of SCNP to assess modulated intracellular signaling pathways and characterize the biology of individual AML samples in the context of genetic alterations.	[Rosen, David B.; Cohen, Aileen; Gayko, Urte; Putta, Santosh; Woronicz, John; Evensen, Erik; Fantl, Wendy J.; Cesano, Alessandra] Nodality Inc, San Francisco, CA USA; [Minden, Mark D.] Univ Toronto, Princess Margaret Hosp, Dept Med Oncol Hematol, Toronto, ON, Canada; [Kornblau, Steven M.] Univ Texas MD Anderson Canc Ctr, Dept Stem Cell Transplantat & Cellular Therapy, Houston, TX 77030 USA	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Texas System; UTMD Anderson Cancer Center	Rosen, DB (corresponding author), Nodality Inc, San Francisco, CA USA.	Alessandra.Cesano@Nodality.com			Nodality, Inc.	Nodality, Inc.	Funding for these studies was provided by Nodality, Inc.. Employees and stockholders of Nodality, Inc., participated in all aspects of the manuscript.	Baker SJ, 2007, ONCOGENE, V26, P6724, DOI 10.1038/sj.onc.1210757; Baldus CD, 2006, J CLIN ONCOL, V24, P790, DOI 10.1200/JCO.2005.01.6253; Beran M, 2004, LEUKEMIA RES, V28, P547, DOI 10.1016/j.leukres.2003.09.016; Bewick V, 2004, CRIT CARE, V8, P508, DOI 10.1186/cc3000; BROWN MB, 1974, J AM STAT ASSOC, V69, P364, DOI 10.2307/2285659; Bruserud O, 1998, CYTOKINES CELL MOL T, V4, P187; Chalhoub N, 2009, ANNU REV PATHOL-MECH, V4, P127, DOI 10.1146/annurev.pathol.4.110807.092311; Cheson BD, 2003, J CLIN ONCOL, V21, P4642, DOI 10.1200/JCO.2003.04.036; Choudhary C, 2005, BLOOD, V106, P265, DOI 10.1182/blood-2004-07-2942; Choudhary C, 2007, BLOOD, V110, P370, DOI 10.1182/blood-2006-05-024018; Covey TM, 2010, ASSAY DRUG DEV TECHN, V8, P321, DOI 10.1089/adt.2009.0251; de Jonge-Peeters SDPWM, 2007, CRIT REV ONCOL HEMAT, V62, P214, DOI 10.1016/j.critrevonc.2007.02.003; Dohner H, 2010, BLOOD, V115, P453, DOI 10.1182/blood-2009-07-235358; Dohner K, 2005, BLOOD, V106, P3740, DOI 10.1182/blood-2005-05-2164; DOSIL M, 1993, MOL CELL BIOL, V13, P6572, DOI 10.1128/MCB.13.10.6572; Frohling S, 2002, BLOOD, V100, P4372, DOI 10.1182/blood-2002-05-1440; Gale RE, 2005, BLOOD, V106, P3658, DOI 10.1182/blood-2005-03-1323; Gale RE, 2008, BLOOD, V111, P2776, DOI 10.1182/blood-2007-08-109090; Gorello P, 2006, LEUKEMIA, V20, P1103, DOI 10.1038/sj.leu.2404149; Green CL, 2010, J CLIN ONCOL, V28, P2739, DOI 10.1200/JCO.2009.26.2501; Grundler R, 2005, BLOOD, V105, P4792, DOI 10.1182/blood-2004-11-4430; HANLEY JA, 1983, RADIOLOGY, V148, P839, DOI 10.1148/radiology.148.3.6878708; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hayakawa F, 2000, ONCOGENE, V19, P624, DOI 10.1038/sj.onc.1203354; Irish JM, 2006, NAT REV CANCER, V6, P146, DOI 10.1038/nrc1804; Irish JM, 2004, CELL, V118, P217, DOI 10.1016/j.cell.2004.06.028; Iwai T, 1999, LEUKEMIA, V13, P38, DOI 10.1038/sj.leu.2401241; Kayser S, 2009, BLOOD, V114, P2386, DOI 10.1182/blood-2009-03-209999; Kikushige Y, 2008, J IMMUNOL, V180, P7358, DOI 10.4049/jimmunol.180.11.7358; Kiyoi H, 1999, BLOOD, V93, P3074; Kondo M, 1999, MED PEDIATR ONCOL, V33, P525; Kornblau SM, 2010, CLIN CANCER RES, V16, P3721, DOI 10.1158/1078-0432.CCR-10-0093; Kottaridis PD, 2001, BLOOD, V98, P1752, DOI 10.1182/blood.V98.6.1752; Krause DS, 2005, NEW ENGL J MED, V353, P172, DOI 10.1056/NEJMra044389; Krutzik PO, 2006, NAT METHODS, V3, P361, DOI 10.1038/NMETH872; Lavagna-Sevenier C, 1998, LEUKEMIA, V12, P301, DOI 10.1038/sj.leu.2400921; Lyman SD, 1998, BLOOD, V91, P1101, DOI 10.1182/blood.V91.4.1101; Marcucci G, 2005, CURR OPIN HEMATOL, V12, P68, DOI 10.1097/01.moh.0000149608.29685.d1; Meshinchi S, 2001, BLOOD, V97, P89, DOI 10.1182/blood.V97.1.89; Meshinchi S, 2008, BLOOD, V111, P4930, DOI 10.1182/blood-2008-01-117770; Meshinchi S, 2009, CLIN CANCER RES, V15, P4263, DOI 10.1158/1078-0432.CCR-08-1123; Mizuki M, 2000, BLOOD, V96, P3907, DOI 10.1182/blood.V96.12.3907; Moreno I, 2003, HAEMATOLOGICA, V88, P19; OBERMANN EC, 2010, ANN HEMATOL; Pradhan A, 2007, P NATL ACAD SCI USA, V104, P18502, DOI 10.1073/pnas.0702388104; Rosnet O, 1996, ACTA HAEMATOL-BASEL, V95, P218; Rusten LS, 1996, BLOOD, V87, P1317, DOI 10.1182/blood.V87.4.1317.bloodjournal8741317; Sachs K, 2005, SCIENCE, V308, P523, DOI 10.1126/science.1105809; Schlenk RF, 2008, NEW ENGL J MED, V358, P1909, DOI 10.1056/NEJMoa074306; Schnittger S, 2005, BLOOD, V106, P3733, DOI 10.1182/blood-2005-06-2248; Scholl C, 2008, SEMIN ONCOL, V35, P336, DOI 10.1053/j.seminoncol.2008.04.004; Seedhouse C, 2009, CLIN CANCER RES, V15, P7291, DOI 10.1158/1078-0432.CCR-09-1222; Seita J, 2008, BLOOD, V111, P1903, DOI 10.1182/blood-2007-06-093328; Shah AJ, 1996, BLOOD, V87, P3563, DOI 10.1182/blood.V87.9.3563.bloodjournal8793563; Sheikhha Mohammad Hasan, 2003, Hematol J, V4, P41, DOI 10.1038/sj.thj.6200224; Srinivasa SP, 2002, LEUKEMIA, V16, P244, DOI 10.1038/sj.leu.2402367; Stelzer GT, 2000, IMMUNOPHENOTYPING, P215; Stirewalt DL, 2006, BLOOD, V107, P3724, DOI 10.1182/blood-2005-08-3453; Svirnovski AI, 2009, HEMATOLOGY, V14, P204, DOI 10.1179/102453309X426218; Tang JL, 2009, BLOOD, V114, P5352, DOI 10.1182/blood-2009-05-223784; Thiede C, 2002, BLOOD, V99, P4326, DOI 10.1182/blood.V99.12.4326; Touw IP, 2007, FRONT BIOSCI-LANDMRK, V12, P800, DOI 10.2741/2103; Verhaak RGW, 2005, BLOOD, V106, P3747, DOI 10.1182/blood-2005-05-2168; Whitman SP, 2001, CANCER RES, V61, P7233; Wouters BJ, 2009, BLOOD, V113, P3088, DOI 10.1182/blood-2008-09-179895; Yamamoto Y, 2001, BLOOD, V97, P2434, DOI 10.1182/blood.V97.8.2434; Zhang SL, 2000, BIOCHEM BIOPH RES CO, V277, P195, DOI 10.1006/bbrc.2000.3662; Zhang SL, 1999, J LEUKOCYTE BIOL, V65, P372, DOI 10.1002/jlb.65.3.372	68	22	34	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2010	5	10							e13543	10.1371/journal.pone.0013543	http://dx.doi.org/10.1371/journal.pone.0013543			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671UN	21048955	Green Published, gold, Green Submitted			2022-12-27	WOS:000283537000005
J	Wang, YW; Devkota, S; Musch, MW; Jabri, B; Nagler, C; Antonopoulos, DA; Chervonsky, A; Chang, EB				Wang, Yunwei; Devkota, Suzanne; Musch, Mark W.; Jabri, Bana; Nagler, Cathryn; Antonopoulos, Dionysios A.; Chervonsky, Alexander; Chang, Eugene B.			Regional Mucosa-Associated Microbiota Determine Physiological Expression of TLR2 and TLR4 in Murine Colon	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; VITAMIN-D-RECEPTOR; INNATE IMMUNITY; DISTAL COLON; GUT; INTESTINE; FLORA; DIVERSITY; COLONIZATION; BACTERIA	Many colonic mucosal genes that are highly regulated by microbial signals are differentially expressed along the rostral-caudal axis. This would suggest that differences in regional microbiota exist, particularly mucosa-associated microbes that are less likely to be transient. We therefore explored this possibility by examining the bacterial populations associated with the normal proximal and distal colonic mucosa in context of host Toll-like receptors (TLR) expression in C57BL/6J mice housed in specific pathogen-free (SPF) and germ-free (GF) environments. 16S rRNA gene-based terminal restriction fragment length polymorphism (T-RFLP) and clone library analysis revealed significant differences in the community structure and diversity of the mucosa-associated microbiota located in the distal colon compared to proximal colon and stool, the latter two clustering closely. Differential expression of colonic TLR2 and TLR4 along the proximal-distal axis was also found in SPF mice, but not in GF mice, suggesting that enteric microbes are essential in maintaining the regional expression of these TLRs. TLR2 is more highly expressed in proximal colon and decreases in a gradient to distal while TLR4 expression is highest in distal colon and a gradient of decreased expression to proximal colon is observed. After transfaunation in GF mice, both regional colonization of mucosa-associated microbes and expression of TLRs in the mouse colon were reestablished. In addition, exposure of the distal colon to cecal (proximal) microbiota induced TLR2 expression. These results demonstrate that regional colonic mucosa-associated microbiota determine the region-specific expression of TLR2 and TLR4. Conversely, region-specific host assembly rules are essential in determining the structure and function of mucosa-associated microbial populations. We believe this type of host-microbial mutualism is pivotal to the maintenance of intestinal and immune homeostasis.	[Wang, Yunwei; Devkota, Suzanne; Musch, Mark W.; Jabri, Bana; Antonopoulos, Dionysios A.; Chang, Eugene B.] Univ Chicago, Knapp Ctr Biomed Discovery, Dept Med, Chicago, IL 60637 USA; [Nagler, Cathryn; Chervonsky, Alexander] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA; [Antonopoulos, Dionysios A.] Argonne Natl Lab, Inst Genom & Syst Biol, Argonne, IL 60439 USA	University of Chicago; University of Chicago; United States Department of Energy (DOE); Argonne National Laboratory	Wang, YW (corresponding author), Univ Chicago, Knapp Ctr Biomed Discovery, Dept Med, Chicago, IL 60637 USA.	echang@medicine.bsd.uchicago.edu	Devkota, Suzanne/AAG-1958-2021; Antonopoulos, Dionysios/ABE-6212-2020	Devkota, Suzanne/0000-0001-5575-9362; Antonopoulos, Dionysios/0000-0002-2238-5031; Chervonsky, Alexander/0000-0001-7547-871X	Human Microbiome Project [DK083993, HG004858]; Digestive Disease Research Core Center of the University of Chicago [DK-42086]; Crohns and Colitis Foundation of America;  [R37 DK47722];  [F31 AT006073-01]; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [F31AT006073] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R21HG004858] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [UH2DK083993, UH3DK083993, P30DK042086, R37DK047722] Funding Source: NIH RePORTER	Human Microbiome Project; Digestive Disease Research Core Center of the University of Chicago(University of Chicago); Crohns and Colitis Foundation of America; ; ; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the Human Microbiome Project (DK083993, HG004858), R37 DK47722 (EBC), the Digestive Disease Research Core Center DK-42086 of the University of Chicago, F31 AT006073-01 (SD), and Research Fellowship Award (YW) from the Crohns and Colitis Foundation of America. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelbaqi M, 2006, LAB INVEST, V86, P380, DOI 10.1038/labinvest.3700398; Abdo Z, 2006, ENVIRON MICROBIOL, V8, P929, DOI 10.1111/j.1462-2920.2005.00959.x; Arvans DL, 2005, AM J PHYSIOL-GASTR L, V288, pG696, DOI 10.1152/ajpgi.00206.2004; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; BAUER H, 1963, AM J PATHOL, V42, P471; Bogunovic M, 2007, AM J PHYSIOL-GASTR L, V292, pG1770, DOI 10.1152/ajpgi.00249.2006; Chowdhury Shankar R, 2007, BMC Genomics, V8, P215, DOI 10.1186/1471-2164-8-215; Cole JR, 2003, NUCLEIC ACIDS RES, V31, P442, DOI 10.1093/nar/gkg039; Comelli EM, 2008, GENOMICS, V91, P70, DOI 10.1016/j.ygeno.2007.09.006; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; He WM, 2003, GASTROENTEROLOGY, V125, P1388, DOI 10.1016/j.gastro.2003.07.009; Hooper LV, 2001, SCIENCE, V292, P1115, DOI 10.1126/science.1058709; Hooper LV, 2002, ANNU REV NUTR, V22, P283, DOI 10.1146/annurev.nutr.22.011602.092259; Hooper LV, 2001, SCIENCE, V291, P881, DOI 10.1126/science.291.5505.881; Hu SE, 2009, AM J PHYSIOL-GASTR L, V296, pG1003, DOI 10.1152/ajpgi.00027.2009; Kong J, 2008, AM J PHYSIOL-GASTR L, V294, pG208, DOI 10.1152/ajpgi.00398.2007; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Love W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010739; Lozupone C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-371; Lundin A, 2008, CELL MICROBIOL, V10, P1093, DOI 10.1111/j.1462-5822.2007.01108.x; MICHIE MG, 1982, J INT ASS MATH GEOL, V14, P661, DOI 10.1007/BF01033886; Ortega-Cava CF, 2003, J IMMUNOL, V170, P3977, DOI 10.4049/jimmunol.170.8.3977; Rijcken E, 2007, AM J PHYSIOL-GASTR L, V293, pG446, DOI 10.1152/ajpgi.00097.2007; Sodir NM, 2006, CANCER RES, V66, P8430, DOI 10.1158/0008-5472.CAN-06-1437; Su WD, 2007, PHYSIOL GENOMICS, V30, P342, DOI 10.1152/physiolgenomics.00042.2007; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Voltan S, 2007, CLIN VACCINE IMMUNOL, V14, P1138, DOI 10.1128/CVI.00079-07; Wang YW, 2009, ISME J, V3, P944, DOI 10.1038/ismej.2009.37; Waterhouse JC, 2009, ANN NY ACAD SCI, V1173, P757, DOI 10.1111/j.1749-6632.2009.04637.x; Wen L, 2008, NATURE, V455, P1109, DOI 10.1038/nature07336; Zoetendal EG, 2002, APPL ENVIRON MICROB, V68, P3401, DOI 10.1128/AEM.68.7.3401-3407.2002	31	101	104	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2010	5	10							e13607	10.1371/journal.pone.0013607	http://dx.doi.org/10.1371/journal.pone.0013607			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	670KA	21042588	Green Published, Green Submitted, gold			2022-12-27	WOS:000283419100025
J	Prykhozhij, SV				Prykhozhij, Sergey V.			In the Absence of Sonic Hedgehog, p53 Induces Apoptosis and Inhibits Retinal Cell Proliferation, Cell-Cycle Exit and Differentiation in Zebrafish	PLOS ONE			English	Article							PROTEIN-KINASE-A; STEM-CELL; REGULATES PROLIFERATION; FATE DETERMINATION; SIGNALING PATHWAY; TUMOR SUPPRESSION; CDK INHIBITOR; NEURAL-TUBE; EXPRESSION; GROWTH	Background: Sonic hedgehog (Shh) signaling regulates cell proliferation during vertebrate development via induction of cell-cycle regulator gene expression or activation of other signalling pathways, prevents cell death by an as yet unclear mechanism and is required for differentiation of retinal cell types. Thus, an unsolved question is how the same signalling molecule can regulate such distinct cell processes as proliferation, cell survival and differentiation. Methodology/Principal Findings: Analysis of the zebrafish shh(-/-) mutant revealed that in this context p53 mediates elevated apoptosis during nervous system and retina development and interferes with retinal proliferation and differentiation. While in shh(-/-) mutants there is activation of p53 target genes and p53-mediated apoptosis, an increase in Hedgehog (Hh) signalling by over-expression of dominant-negative Protein Kinase A strongly decreased p53 target gene expression and apoptosis levels in shh(-/-) mutants. Using a novel p53 reporter transgene, I confirm that p53 is active in tissues that require Shh for cell survival. Proliferation assays revealed that loss of p53 can rescue normal cell-cycle exit and the mitotic indices in the shh(-/-) mutant retina at 24, 36 and 48 hpf. Moreover, generation of amacrine cells and photoreceptors was strongly enhanced in the double p53(-/-) shh(-/-) mutant retina suggesting the effect of p53 on retinal differentiation. Conclusions: Loss of Shh signalling leads to the p53-dependent apoptosis in the developing nervous system and retina. Moreover, Shh-mediated control of p53 activity is required for proliferation and cell cycle exit of retinal cells as well as differentiation of amacrine cells and photoreceptors.	[Prykhozhij, Sergey V.] European Mol Biol Lab, Dev Biol Unit, Heidelberg, Germany	European Molecular Biology Laboratory (EMBL)	Prykhozhij, SV (corresponding author), Max Planck Inst Mol Genet, Berlin, Germany.	rykhozh@embl.de			European Molecular Biology Laboratory (EMBL); EMBL; EMBL Heidelberg	European Molecular Biology Laboratory (EMBL); EMBL; EMBL Heidelberg	The study was supported by laboratory budget funds from European Molecular Biology Laboratory (EMBL) Heidelberg in the labs of Carl Neumann and Francesca Peri. The author was supported by a fellowship from EMBL International PhD Program and later by a post-doctoral fellowship from EMBL Heidelberg, web address: http://www.embl.de. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe Y, 2008, P NATL ACAD SCI USA, V105, P4838, DOI 10.1073/pnas.0712216105; Ahlgren SC, 1999, CURR BIOL, V9, P1304, DOI 10.1016/S0960-9822(00)80052-4; Altaba AR, 2003, CURR OPIN GENET DEV, V13, P513, DOI 10.1016/j.gde.2003.08.005; Berghmans S, 2005, P NATL ACAD SCI USA, V102, P407, DOI 10.1073/pnas.0406252102; Bigelow RLH, 2004, J BIOL CHEM, V279, P1197, DOI 10.1074/jbc.M310589200; Bilitou A, 2010, DEV DYNAM, V239, P727, DOI 10.1002/dvdy.22223; Borycki AG, 1999, DEVELOPMENT, V126, P4053; Britto J, 2002, NAT NEUROSCI, V5, P103, DOI 10.1038/nn797; Burke R, 1996, DEVELOPMENT, V122, P2261; Cai C, 2008, STEM CELLS, V26, P1097, DOI 10.1634/stemcells.2007-0684; Cayuso J, 2006, DEVELOPMENT, V133, P517, DOI 10.1242/dev.02228; CHAO MV, 2003, SCI STKE, pPE38; Charrier JB, 2001, DEVELOPMENT, V128, P4011; Chen HY, 2007, J HIGH ENERGY PHYS, DOI 10.1088/1126-6708/2007/03/005; Chen J, 2005, GENE DEV, V19, P2900, DOI 10.1101/gad.1366405; Concordet JP, 1996, DEVELOPMENT, V122, P2835; Dahmane N, 1999, DEVELOPMENT, V126, P3089; Dahmane N, 2001, DEVELOPMENT, V128, P5201; Dierks C, 2007, NAT MED, V13, P944, DOI 10.1038/nm1614; Dorak M.T., 2006, REAL TIME PCR, P89; Duman-Scheel M, 2002, NATURE, V417, P299, DOI 10.1038/417299a; Dyer MA, 2001, J COMP NEUROL, V429, P601; Fan HR, 1999, J CELL BIOL, V147, P71, DOI 10.1083/jcb.147.1.71; Fischer S, 2007, CELL CYCLE, V6, P2962, DOI 10.4161/cc.6.23.4950; Georgia S, 2006, DEV BIOL, V298, P22, DOI 10.1016/j.ydbio.2006.05.036; Guerrero I, 2003, SCIENCE, V301, P774, DOI 10.1126/science.1088625; Hammerschmidt M, 1996, GENE DEV, V10, P647, DOI 10.1101/gad.10.6.647; Hendzel MJ, 1997, CHROMOSOMA, V106, P348, DOI 10.1007/s004120050256; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Jensen AM, 1997, DEVELOPMENT, V124, P363; Jeong JH, 2004, GENE DEV, V18, P937, DOI 10.1101/gad.1190304; Jia JL, 2007, MOL CELL BIOL, V27, P7236, DOI 10.1128/MCB.00780-07; Jiang J, 2008, DEV CELL, V15, P801, DOI 10.1016/j.devcel.2008.11.010; Jowett T, 2001, METHODS, V23, P345, DOI 10.1006/meth.2000.1147; Katoh Y, 2008, INT J ONCOL, V33, P881, DOI 10.3892/ijo_00000076; Kay JN, 2005, DEVELOPMENT, V132, P2573, DOI 10.1242/dev.01831; KERN SE, 1992, SCIENCE, V256, P827, DOI 10.1126/science.1589764; Kok FO, 2007, DEV BIOL, V307, P214, DOI 10.1016/j.ydbio.2007.04.039; Kratz E, 2006, CELL DEATH DIFFER, V13, P1631, DOI 10.1038/sj.cdd.4402016; Kwan KM, 2007, DEV DYNAM, V236, P3088, DOI 10.1002/dvdy.21343; Langenau DM, 2005, BLOOD, V105, P3278, DOI 10.1182/blood-2004-08-3073; Langheinrich U, 2002, CURR BIOL, V12, P2023, DOI 10.1016/S0960-9822(02)01319-2; Lee KC, 2008, ONCOGENE, V27, P629, DOI 10.1038/sj.onc.1210695; Lefort K, 2007, GENE DEV, V21, P562, DOI 10.1101/gad.1484707; Levine EM, 1997, J NEUROSCI, V17, P6277; Lin TX, 2005, NAT CELL BIOL, V7, P165, DOI 10.1038/ncb1211; Locker M, 2006, GENE DEV, V20, P3036, DOI 10.1101/gad.391106; Machold R, 2003, NEURON, V39, P937, DOI 10.1016/S0896-6273(03)00561-0; Martin-Castellanos C, 2002, DEVELOPMENT, V129, P1003; Masai I, 2005, DEVELOPMENT, V132, P1539, DOI 10.1242/dev.01714; Meeker ND, 2007, BIOTECHNIQUES, V43, P610, DOI 10.2144/000112619; Michalak E, 2005, BIOCHEM BIOPH RES CO, V331, P786, DOI 10.1016/j.bbrc.2005.03.183; Moshiri A, 2005, DEV DYNAM, V233, P66, DOI 10.1002/dvdy.20299; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Neumann CJ, 2000, SCIENCE, V289, P2137, DOI 10.1126/science.289.5487.2137; Neumann CJ, 2005, CELL CYCLE, V4, P1139, DOI 10.4161/cc.4.9.1999; Ohnuma S, 2002, DEVELOPMENT, V129, P2435; Ohnuma S, 1999, CELL, V99, P499, DOI 10.1016/S0092-8674(00)81538-X; Palma V, 2005, DEVELOPMENT, V132, P335, DOI 10.1242/dev.01567; Park HC, 2005, J NEUROSCI, V25, P6836, DOI 10.1523/JNEUROSCI.0981-05.2005; Plaster N, 2006, CELL DEATH DIFFER, V13, P223, DOI 10.1038/sj.cdd.4401747; Qin H, 2007, J BIOL CHEM, V282, P5842, DOI 10.1074/jbc.M610464200; Riccio O, 2008, EMBO REP, V9, P377, DOI 10.1038/embor.2008.7; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Schauerte HE, 1998, DEVELOPMENT, V125, P2983; SECCHIERO P, 2009, BLOOD; SHKUMATAVA A, 2005, EMBO REPORTS, P563; Stecca B, 2009, EMBO J, V28, P663, DOI 10.1038/emboj.2009.16; Stenkamp DL, 2003, DEV BIOL, V258, P349, DOI 10.1016/S0012-1606(03)00121-0; Stenkamp DL, 2002, DEV DYNAM, V225, P344, DOI 10.1002/dvdy.10165; Thibert C, 2003, SCIENCE, V301, P843, DOI 10.1126/science.1085405; Ungar AR, 1996, DEV BIOL, V178, P186, DOI 10.1006/dbio.1996.0209; Varjosalo M, 2008, GENE DEV, V22, P2454, DOI 10.1101/gad.1693608; Vernon AE, 2006, EMBO REP, V7, P643, DOI 10.1038/sj.embor.7400691; Wang YP, 2005, DEVELOPMENT, V132, P5103, DOI 10.1242/dev.02096; Wechsler-Reya RJ, 1999, NEURON, V22, P103, DOI 10.1016/S0896-6273(00)80682-0; Westerfield M., 1995, ZEBRAFISH BOOK GUIDE; Yamaguchi M, 2008, DEVELOPMENT, V135, P1247, DOI 10.1242/dev.011015; Ying LT, 2000, NAT NEUROSCI, V3, P979, DOI 10.1038/79916; Zhang JK, 2004, NAT GENET, V36, P351, DOI 10.1038/ng1318; Zhang WW, 2000, J BIOTECHNOL, V84, P79, DOI 10.1016/S0168-1656(00)00330-8	82	26	28	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2010	5	10							e13549	10.1371/journal.pone.0013549	http://dx.doi.org/10.1371/journal.pone.0013549			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	668TQ	21042410	Green Published, gold, Green Submitted			2022-12-27	WOS:000283293800016
J	De Chiara, G; Marcocci, ME; Civitelli, L; Argnani, R; Piacentini, R; Ripoli, C; Manservigi, R; Grassi, C; Garaci, E; Palamara, AT				De Chiara, Giovanna; Marcocci, Maria Elena; Civitelli, Livia; Argnani, Rafaela; Piacentini, Roberto; Ripoli, Cristian; Manservigi, Roberto; Grassi, Claudio; Garaci, Enrico; Palamara, Anna Teresa			APP Processing Induced by Herpes Simplex Virus Type 1 (HSV-1) Yields Several APP Fragments in Human and Rat Neuronal Cells	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; INTRACELLULAR DOMAIN AICD; ALZHEIMERS-DISEASE; BETA-SECRETASE; OXIDATIVE STRESS; NERVOUS-SYSTEM; UP-REGULATION; CYTOSKELETAL DYNAMICS; ANTEROGRADE TRANSPORT; VIRAL-INFECTIONS	Lifelong latent infections of the trigeminal ganglion by the neurotropic herpes simplex virus type 1 (HSV-1) are characterized by periodic reactivation. During these episodes, newly produced virions may also reach the central nervous system (CNS), causing productive but generally asymptomatic infections. Epidemiological and experimental findings suggest that HSV-1 might contribute to the pathogenesis of Alzheimer's disease (AD). This multifactorial neurodegenerative disorder is related to an overproduction of amyloid beta (A beta) and other neurotoxic peptides, which occurs during amyloidogenic endoproteolytic processing of the transmembrane amyloid precursor protein (APP). The aim of our study was to identify the effects of productive HSV-1 infection on APP processing in neuronal cells. We found that infection of SH-SY5Y human neuroblastoma cells and rat cortical neurons is followed by multiple cleavages of APP, which result in the intra-and/or extra-cellular accumulation of various neurotoxic species. These include: i) APP fragments (APP-Fs) of 35 and 45 kDa (APP-F35 and APP-F45) that comprise portions of Ab; ii) N-terminal APP-Fs that are secreted; iii) intracellular C-terminal APP-Fs; and iv) A beta(1-40) and A beta(1-42). Western blot analysis of infected-cell lysates treated with formic acid suggests that APP-F35 may be an Ab oligomer. The multiple cleavages of APP that occur in infected cells are produced in part by known components of the amyloidogenic APP processing pathway, i.e., host-cell beta-secretase, gamma-secretase, and caspase-3-like enzymes. These findings demonstrate that HSV-1 infection of neuronal cells can generate multiple APP fragments with well-documented neurotoxic potentials. It is tempting to speculate that intra-and extracellular accumulation of these species in the CNS resulting from repeated HSV-1 reactivation could, in the presence of other risk factors, play a co-factorial role in the development of AD.	[De Chiara, Giovanna] Ist Super Sanita, Dept Cell Biol & Neurosci, I-00161 Rome, Italy; [Palamara, Anna Teresa] Univ Roma La Sapienza, Dept Publ Hlth & Infect Dis, Inst Pasteur, Cenci Bolognetti Fdn, Rome, Italy; [Argnani, Rafaela; Manservigi, Roberto] Univ Ferrara, Dept Expt Med & Diagnost, I-44100 Ferrara, Italy; [Piacentini, Roberto; Ripoli, Cristian; Grassi, Claudio] Catholic Univ, Sch Med, Inst Human Physiol, Rome, Italy; [Garaci, Enrico] Univ Roma Tor Vergata, Dept Expt Med & Biochem Sci, I-00173 Rome, Italy; [Palamara, Anna Teresa] San Raffaele Pisana Sci Inst Res Hospitalizat & H, Rome, Italy	Istituto Superiore di Sanita (ISS); Fondazione Cenci Bolognetti; Sapienza University Rome; University of Ferrara; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; University of Rome Tor Vergata; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	De Chiara, G (corresponding author), Ist Super Sanita, Dept Cell Biol & Neurosci, Viale Regina Elena 299, I-00161 Rome, Italy.	annateresa.palamara@uniroma1.it	Piacentini, Roberto/K-7526-2016; GARACI, ENRICO/AAB-3349-2021; Ripoli, Cristian/K-8954-2016; Elena, Marcocci Maria/I-9550-2014; De Chiara, Giovanna/AAJ-7843-2021; Grassi, Claudio/C-3188-2017	Piacentini, Roberto/0000-0003-4215-1643; Elena, Marcocci Maria/0000-0003-4751-4263; De Chiara, Giovanna/0000-0002-2219-6097; Grassi, Claudio/0000-0001-7253-1685; Civitelli, Livia/0000-0003-2399-1436; PALAMARA, ANNA TERESA/0000-0001-8330-4381; RIPOLI, Cristian/0000-0002-5315-0163; MANSERVIGI, Roberto/0000-0002-2827-229X	Italian Ministry of Education University and Research; Italian Ministry of Health-Ricerca Finalizzata	Italian Ministry of Education University and Research(Ministry of Education, Universities and Research (MIUR)); Italian Ministry of Health-Ricerca Finalizzata(Ministry of Health, Italy)	This work was supported by grants from the Italian Ministry of Education University and Research (PRIN2007 and FIRB2006), and the Italian Ministry of Health-Ricerca Finalizzata 2007. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALL MJ, 1982, CAN J NEUROL SCI, V9, P303, DOI 10.1017/S0317167100044115; Bearer EL, 2004, AGING CELL, V3, P81, DOI 10.1111/j.1474-9728.2004.00089.x; Chang KA, 2005, J PHARMACOL SCI, V97, P461, DOI 10.1254/jphs.CR0050014; Chyung ASC, 1997, J CELL BIOL, V138, P671, DOI 10.1083/jcb.138.3.671; Cook DG, 1997, NAT MED, V3, P1021, DOI 10.1038/nm0997-1021; Cribbs DH, 2000, BIOCHEMISTRY-US, V39, P5988, DOI 10.1021/bi000029f; DEATLY AM, 1990, NEUROPATH APPL NEURO, V16, P213, DOI 10.1111/j.1365-2990.1990.tb01158.x; Dobson CB, 1999, NEUROBIOL AGING, V20, P457, DOI 10.1016/S0197-4580(99)00055-X; Fan YW, 2002, J NEUROSCI METH, V120, P17, DOI 10.1016/S0165-0270(02)00181-4; Fujii S, 1999, VIROLOGY, V256, P203, DOI 10.1006/viro.1999.9610; Gianni D, 2003, J BIOL CHEM, V278, P9290, DOI 10.1074/jbc.M211899200; Goodger ZV, 2009, J CELL SCI, V122, P3703, DOI 10.1242/jcs.048090; Hartmann T, 1997, NAT MED, V3, P1016, DOI 10.1038/nm0997-1016; He B, 1998, J BIOL CHEM, V273, P20737, DOI 10.1074/jbc.273.33.20737; Hill JM, 2005, MED HYPOTHESES, V64, P320, DOI 10.1016/j.mehy.2003.11.045; Itabashi S, 1997, LANCET, V349, P1102, DOI 10.1016/S0140-6736(05)62325-2; Itzhaki Ruth, 2004, Herpes, V11 Suppl 2, p77A; JAMIESON GA, 1991, J MED VIROL, V33, P224, DOI 10.1002/jmv.1890330403; JAMIESON GA, 1991, BIOCHEM SOC T, V19, pS122, DOI 10.1042/bst019122s; KASTRUKOFF L, 1982, J NEUROIMMUNOL, V2, P295, DOI 10.1016/0165-5728(82)90062-5; Kavouras JH, 2007, J NEUROVIROL, V13, P416, DOI 10.1080/13550280701460573; Killington RA, 1991, VIROLOGY PRATICAL AP, P212; KOO EH, 1994, J BIOL CHEM, V269, P17386; KWONG AD, 1989, J VIROL, V63, P4834, DOI 10.1128/JVI.63.11.4834-4839.1989; LaFerla FM, 2007, NAT REV NEUROSCI, V8, P499, DOI 10.1038/nrn2168; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Letenneur L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003637; Lewandowski G, 2002, ARCH VIROL, V147, P167, DOI 10.1007/s705-002-8309-9; Lu DC, 2000, NAT MED, V6, P397, DOI 10.1038/74656; Matis J, 2001, ACTA VIROL, V45, P269; Mori I, 2004, J MED VIROL, V73, P605, DOI 10.1002/jmv.20133; Muller T, 2008, PROG NEUROBIOL, V85, P393, DOI 10.1016/j.pneurobio.2008.05.002; Muller T, 2007, MOL BIOL CELL, V18, P201, DOI 10.1091/mbc.E06-04-0283; Ohyagi Y, 2005, FASEB J, V19, P255, DOI 10.1096/fj.04-2637fje; PALAMARA AT, 1995, ANTIVIR RES, V27, P237, DOI 10.1016/0166-3542(95)00008-A; Park SA, 2009, BIOCHEM BIOPH RES CO, V388, P450, DOI 10.1016/j.bbrc.2009.08.042; Piacentini R, 2008, J CELL PHYSIOL, V215, P129, DOI 10.1002/jcp.21293; Piacentini R, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.06.009; Roizman B, 2001, FIELDS VIROLOGY, P2432; Satpute-Krishnan P, 2003, AGING CELL, V2, P305, DOI 10.1046/j.1474-9728.2003.00069.x; Satpute-Krishnan P, 2006, P NATL ACAD SCI USA, V103, P16532, DOI 10.1073/pnas.0607527103; Schmutzhard E, 2001, J NEUROL, V248, P469, DOI 10.1007/s004150170155; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Shipley SJ, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-48; Sinha S, 1999, NATURE, V402, P537, DOI 10.1038/990114; Skovronsky DM, 1998, J CELL BIOL, V141, P1031, DOI 10.1083/jcb.141.4.1031; Tamagno E, 2005, J NEUROCHEM, V92, P628, DOI 10.1111/j.1471-4159.2004.02895.x; Tamagno E, 2002, NEUROBIOL DIS, V10, P279, DOI 10.1006/nbdi.2002.0515; Tamagno E, 2008, J NEUROCHEM, V104, P683, DOI 10.1111/j.1471-4159.2007.05072.x; Valyi-Nagy T, 2005, HISTOL HISTOPATHOL, V20, P957, DOI 10.14670/HH-20.957; Valyi-Nagy T, 2000, VIROLOGY, V278, P309, DOI 10.1006/viro.2000.0678; Vassar R, 2001, J MOL NEUROSCI, V17, P157, DOI 10.1385/JMN:17:2:157; Wozniak MA, 2009, J PATHOL, V217, P131, DOI 10.1002/path.2449; Wozniak MA, 2005, J MED VIROL, V75, P300, DOI 10.1002/jmv.20271; Wozniak MA, 2007, NEUROSCI LETT, V429, P95, DOI 10.1016/j.neulet.2007.09.077; Xu HX, 1997, P NATL ACAD SCI USA, V94, P3748, DOI 10.1073/pnas.94.8.3748	56	103	103	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2010	5	11							e13989	10.1371/journal.pone.0013989	http://dx.doi.org/10.1371/journal.pone.0013989			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	680KW	21085580	gold, Green Published, Green Submitted			2022-12-27	WOS:000284231800019
J	Lucarelli, AP; Buroni, S; Pasca, MR; Rizzi, M; Cavagnino, A; Valentini, G; Riccardi, G; Chiarelli, LR				Lucarelli, Anna P.; Buroni, Silvia; Pasca, Maria R.; Rizzi, Menico; Cavagnino, Andrea; Valentini, Giovanna; Riccardi, Giovanna; Chiarelli, Laurent R.			+Mycobacterium tuberculosis Phosphoribosylpyrophosphate Synthetase: Biochemical Features of a Crucial Enzyme for Mycobacterial Cell Wall Biosynthesis	PLOS ONE			English	Article							MULTIDRUG-RESISTANT TUBERCULOSIS; ESCHERICHIA-COLI; DIPHOSPHATE SYNTHASE; BACILLUS-SUBTILIS; PURIFICATION; BINDING; MECHANISM; CATALYSIS; ARABINAN; RIBOSE	The selection and soaring spread of Mycobacterium tuberculosis multidrug-resistant (MDR-TB) and extensively drug-resistant strains (XDR-TB) is a severe public health problem. Currently, there is an urgent need for new drugs for tuberculosis treatment, with novel mechanisms of action and, moreover, the necessity to identify new drug targets. Mycobacterial phosphoribosylpyrophosphate synthetase (MtbPRPPase) is a crucial enzyme involved in the biosynthesis of decaprenylphosphoryl-arabinose, an essential precursor for the mycobacterial cell wall biosynthesis. Moreover, phosphoribosylpyrophosphate, which is the product of the PRPPase catalyzed reaction, is the precursor for the biosynthesis of nucleotides and of some amino acids such as histidine and tryptophan. In this context, the elucidation of the molecular and functional features of MtbPRPPase is mandatory. MtbPRPPase was obtained as a recombinant form, purified to homogeneity and characterized. According to its hexameric form, substrate specificity and requirement of phosphate for activity, the enzyme proved to belong to the class I of PRPPases. Although the sulfate mimicked the phosphate, it was less effective and required higher concentrations for the enzyme activation. MtbPRPPase showed hyperbolic response to ribose 5-phosphate, but sigmoidal behaviour towards Mg-ATP. The enzyme resulted to be allosterically activated by Mg(2+) or Mn(2+) and inhibited by Ca(2+) and Cu(2+) but, differently from other characterized PRPPases, it showed a better affinity for the Mn(2+) and Cu(2+) ions, indicating a different cation binding site geometry. Moreover, the enzyme from M. tuberculosis was allosterically inhibited by ADP, but less sensitive to inhibition by GDP. The characterization of M. tuberculosis PRPPase provides the starting point for the development of inhibitors for antitubercular drug design.	[Lucarelli, Anna P.; Buroni, Silvia; Pasca, Maria R.; Riccardi, Giovanna] Univ Pavia, Dipartimento Genet & Microbiol, I-27100 Pavia, Italy; [Valentini, Giovanna; Chiarelli, Laurent R.] Univ Pavia, Dipartimento Biochim A Castellani, I-27100 Pavia, Italy; [Rizzi, Menico; Cavagnino, Andrea] Univ Piemonte Orientale, DISCAFF, Novara, Italy	University of Pavia; University of Pavia; University of Eastern Piedmont Amedeo Avogadro	Lucarelli, AP (corresponding author), Univ Pavia, Dipartimento Genet & Microbiol, Via Palestro 3, I-27100 Pavia, Italy.	laurent.chiarelli@unipv.it	Chiarelli, Laurent Roberto/J-8368-2016; Pasca, Maria Rosalia/J-8752-2016; Buroni, Silvia/AAX-5454-2020; riccardi, gabriele/A-9269-2012	Chiarelli, Laurent Roberto/0000-0003-0348-9764; Pasca, Maria Rosalia/0000-0002-8906-4937; RICCARDI, Giovanna/0000-0003-3295-0070; Buroni, Silvia/0000-0002-6979-2275	EC [LSHP-CT-2005-018923]	EC(European CommissionEuropean Commission Joint Research Centre)	This work was supported by EC-VI Framework, Contract no. LSHP-CT-2005-018923. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNVIG K, 1990, EUR J BIOCHEM, V192, P195, DOI 10.1111/j.1432-1033.1990.tb19214.x; Barry Clifton E., 2007, Infectious Disorders - Drug Targets, V7, P182; Blasi P, 2009, EXPERT OPIN DRUG DEL, V6, P977, DOI 10.1517/17425240903130577; Cho Y, 2008, J MED CHEM, V51, P5984, DOI 10.1021/jm800328v; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Eriksen TA, 2002, PROTEIN SCI, V11, P271, DOI 10.1110/ps.28502; Eriksen TA, 2000, NAT STRUCT BIOL, V7, P303; FOX IH, 1971, J BIOL CHEM, V246, P5739; GIBSON KJ, 1982, J BIOL CHEM, V257, P2391; HOVEJENSEN B, 1986, J BIOL CHEM, V261, P6765; HOVEJENSEN B, 1988, J BACTERIOL, V170, P1148, DOI 10.1128/jb.170.3.1148-1152.1988; ISHIJIMA S, 1991, J BIOL CHEM, V266, P15693; Jain A, 2008, FEMS IMMUNOL MED MIC, V53, P145, DOI 10.1111/j.1574-695X.2008.00400.x; Kadziola A, 2005, J MOL BIOL, V354, P815, DOI 10.1016/j.jmb.2005.10.001; Krath BN, 1999, BBA-PROTEIN STRUCT M, V1430, P403, DOI 10.1016/S0167-4838(99)00022-9; Krath BN, 2001, J BIOL CHEM, V276, P17851, DOI 10.1074/jbc.M010172200; Krath BN, 2001, PROTEIN SCI, V10, P2317, DOI 10.1110/ps.11801; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li S, 2007, BIOCHEM J, V401, P39, DOI 10.1042/BJ20061066; Loughran ST, 2006, ANAL BIOCHEM, V355, P148, DOI 10.1016/j.ab.2006.05.011; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Makarov V, 2009, SCIENCE, V324, P801, DOI 10.1126/science.1171583; Manina G, 2010, CURR MED CHEM, V17, P3099, DOI 10.2174/092986710791959693; Mikusova K, 2005, J BACTERIOL, V187, P8020, DOI 10.1128/JB.187.23.8020-8025.2005; MILLER GA, 1975, ARCH BIOCHEM BIOPHYS, V171, P732, DOI 10.1016/0003-9861(75)90086-7; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Nathanson E, 2006, EMERG INFECT DIS, V12, P1389, DOI 10.3201/eid1209.051618; NOSAL JM, 1993, J BIOL CHEM, V268, P10168; Palomino JC, 2009, CURR MED CHEM, V16, P1898, DOI 10.2174/092986709788186066; Pan F, 2001, J BACTERIOL, V183, P3991, DOI 10.1128/JB.183.13.3991-3998.2001; ROTH DG, 1974, J BIOL CHEM, V249, P297; Russell DG, 2010, SCIENCE, V328, P852, DOI 10.1126/science.1184784; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Sharma SK, 2006, CHEST, V130, P261, DOI [10.1378/chest.130.1.261, 10.1016/S0012-3692(15)50981-1]; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; SWITZER RL, 1973, J BIOL CHEM, V248, P1063; Willemoes M, 1997, BIOCHEMISTRY-US, V36, P5078, DOI 10.1021/bi962610a; Wolucka BA, 2008, FEBS J, V275, P2691, DOI 10.1111/j.1742-4658.2008.06395.x; World Health Organization, 2008, GLOB TUB CONTR SURV	40	17	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2010	5	11							e15494	10.1371/journal.pone.0015494	http://dx.doi.org/10.1371/journal.pone.0015494			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	680KW	21085589	gold, Green Published, Green Submitted			2022-12-27	WOS:000284231800038
J	Schaefer, U; Kodzius, R; Kai, C; Kawai, J; Carninci, P; Hayashizaki, Y; Bajic, VB				Schaefer, Ulf; Kodzius, Rimantas; Kai, Chikatoshi; Kawai, Jun; Carninci, Piero; Hayashizaki, Yoshihide; Bajic, Vladimir B.			High Sensitivity TSS Prediction: Estimates of Locations Where TSS Cannot Occur	PLOS ONE			English	Article							TRANSCRIPTION START SITES; APPROXIMATE LOCATIONS; GENE-EXPRESSION; IDENTIFICATION; GENOME; RECOGNITION; PROMOTERS; FINDER; ARCHITECTURE	Background: Although transcription in mammalian genomes can initiate from various genomic positions (e. g., 3'UTR, coding exons, etc.), most locations on genomes are not prone to transcription initiation. It is of practical and theoretical interest to be able to estimate such collections of non-TSS locations (NTLs). The identification of large portions of NTLs can contribute to better focusing the search for TSS locations and thus contribute to promoter and gene finding. It can help in the assessment of 59 completeness of expressed sequences, contribute to more successful experimental designs, as well as more accurate gene annotation. Methodology: Using comprehensive collections of Cap Analysis of Gene Expression (CAGE) and other transcript data from mouse and human genomes, we developed a methodology that allows us, by performing computational TSS prediction with very high sensitivity, to annotate, with a high accuracy in a strand specific manner, locations of mammalian genomes that are highly unlikely to harbor transcription start sites (TSSs). The properties of the immediate genomic neighborhood of 98,682 accurately determined mouse and 113,814 human TSSs are used to determine features that distinguish genomic transcription initiation locations from those that are not likely to initiate transcription. In our algorithm we utilize various constraining properties of features identified in the upstream and downstream regions around TSSs, as well as statistical analyses of these surrounding regions. Conclusions: Our analysis of human chromosomes 4, 21 and 22 estimates,46%,,41% and,27% of these chromosomes, respectively, as being NTLs. This suggests that on average more than 40% of the human genome can be expected to be highly unlikely to initiate transcription. Our method represents the first one that utilizes high-sensitivity TSS prediction to identify, with high accuracy, large portions of mammalian genomes as NTLs. The server with our algorithm implemented is available at http://cbrc.kaust.edu.sa/ddm/.	[Schaefer, Ulf; Bajic, Vladimir B.] King Abdullah Univ Sci & Technol, CBRC, Thuwal, Saudi Arabia; [Kodzius, Rimantas] King Abdullah Univ Sci & Technol, Div Phys Sci & Engn, Thuwal, Saudi Arabia; [Kai, Chikatoshi; Kawai, Jun; Hayashizaki, Yoshihide] RIKEN Yokohama Inst, RIKEN Genom Sci Ctr, Genome Explorat Res Grp, Genome Network Project Core Grp, Kanagawa, Japan; [Carninci, Piero] RIKEN Wako Inst, Discovery Res Inst, Genome Sci Lab, Wako, Saitama, Japan	King Abdullah University of Science & Technology; King Abdullah University of Science & Technology; RIKEN; RIKEN	Schaefer, U (corresponding author), King Abdullah Univ Sci & Technol, CBRC, Thuwal, Saudi Arabia.	vladimir.bajic@kaust.edu.sa	Carninci, Piero/K-1568-2014; K, Rimantas/H-4512-2019; Hayashizaki, Yoshihide/N-6590-2015; Kawai, Jun/A-6451-2016; Bajic, Vladimir/D-2810-2009	Carninci, Piero/0000-0001-7202-7243; K, Rimantas/0000-0001-9417-8894; Bajic, Vladimir/0000-0001-5435-4750	Ministry of Education, Culture, Sports, Science and Technology of the Japanese Government; Ministry of Education, Culture, Sports, Science and Technology, Japan; European Union	Ministry of Education, Culture, Sports, Science and Technology of the Japanese Government(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); European Union(European Commission)	This study was supported by the following research grants: a) Research Grant for the RIKEN (RIkagaku KENkyusho, Engl.: Institute of Physical and Chemical Research) Genome Exploration Research Project from the Ministry of Education, Culture, Sports, Science and Technology of the Japanese Government to YH. b) A grant of the Genome Network Project from the Ministry of Education, Culture, Sports, Science and Technology, Japan to YH. c) Grant for the Strategic Programs for R&D of RIKEN to YH. d) Individual fellowship from the European Union (FP5 program INCO2 to Japan) to RK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, DISCRIMINANT ANAL ST; Bajic VB, 2004, NAT BIOTECHNOL, V22, P1467, DOI 10.1038/nbt1032; Bajic VB, 2003, GENOME RES, V13, P1923, DOI 10.1101/gr.869803; Bajic VB, 2002, BIOINFORMATICS, V18, P198, DOI 10.1093/bioinformatics/18.1.198; Bajic VB, 2003, NUCLEIC ACIDS RES, V31, P3560, DOI 10.1093/nar/gkg570; Bajic VB, 2003, J MOL GRAPH MODEL, V21, P323, DOI 10.1016/S1093-3263(02)00179-1; BAJIC VB, 2002, IEEE INTELL SYST APP, P64; Bajic VB, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s3; Bajic VB, 2006, PLOS GENET, V2, P614, DOI 10.1371/journal.pgen.0020054; Carninci P, 1999, METHOD ENZYMOL, V303, P19; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Carninci P, 1997, DNA Res, V4, P61, DOI 10.1093/dnares/4.1.61; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; Cohen N, 2005, MOL BIOL EVOL, V22, P1260, DOI 10.1093/molbev/msi115; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Davuluri RV, 2001, NAT GENET, V29, P412, DOI 10.1038/ng780; Down TA, 2002, GENOME RES, V12, P458, DOI 10.1101/gr.216102; Frith MC, 2008, GENOME RES, V18, P1, DOI 10.1101/gr.6831208; Hashimoto S, 2004, NAT BIOTECHNOL, V22, P1146, DOI 10.1038/nbt998; Kanhere A, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-1; Kapranov P, 2005, GENOME RES, V15, P987, DOI 10.1101/gr.3455305; Kapranov P, 2002, SCIENCE, V296, P916, DOI 10.1126/science.1068597; Kawaji H, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-12-r118; Knudsen S, 1999, BIOINFORMATICS, V15, P356, DOI 10.1093/bioinformatics/15.5.356; Korf I, 2001, BIOINFORMATICS, V17, pS140, DOI DOI 10.1093/BI0INF0RMATICS/17.SUPPL_; MARUYAMA K, 1994, GENE, V138, P171; Ng P, 2005, NAT METHODS, V2, P105, DOI 10.1038/NMETH733; Ohler U, 2000, Pac Symp Biocomput, P380; Ovcharenko I, 2005, GENOME RES, V15, P137, DOI 10.1101/gr.3015505; Ponger L, 2002, BIOINFORMATICS, V18, P631, DOI 10.1093/bioinformatics/18.4.631; Reese MG, 2001, COMPUT CHEM, V26, P51, DOI 10.1016/S0097-8485(01)00099-7; Rinn JL, 2003, GENE DEV, V17, P529, DOI 10.1101/gad.1055203; Shiraki T, 2003, P NATL ACAD SCI USA, V100, P15776, DOI 10.1073/pnas.2136655100; Solovyev VV, 2003, NUCLEIC ACIDS RES, V31, P3540, DOI 10.1093/nar/gkg525; Sugahara Y, 2001, GENE, V263, P93, DOI 10.1016/S0378-1119(00)00557-6; Wakaguri H, 2008, NUCLEIC ACIDS RES, V36, pD97, DOI 10.1093/nar/gkm901; Wei CL, 2004, P NATL ACAD SCI USA, V101, P11701, DOI 10.1073/pnas.0403514101	37	9	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2010	5	11							e13934	10.1371/journal.pone.0013934	http://dx.doi.org/10.1371/journal.pone.0013934			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	680KW	21085627	Green Published, Green Submitted, gold			2022-12-27	WOS:000284231800003
J	Lise, MC; Sparsa, A; Marie, I; Lalloue, F; Ly, K; Martel, C; Bezanahary, H; Gondran, G; Loustaud-Ratti, V; Bonnetblanc, JM; Vidal, E; Jauberteau, MO; Fauchais, AL				Lise, Marie-Claude; Sparsa, Agnes; Marie, Isabelle; Lalloue, Fabrice; Ly, Kim; Martel, Clothilde; Bezanahary, Holy; Gondran, Guillaume; Loustaud-Ratti, Veronique; Bonnetblanc, Jean-Marie; Vidal, Elisabeth; Jauberteau, Marie-Odile; Fauchais, Anne-Laure			Serum Neurotrophin Profile in Systemic Sclerosis	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; LUPUS-ERYTHEMATOSUS PATIENTS; OXIDATIVE STRESS; ANTIPHOSPHOLIPID ANTIBODIES; RHEUMATOID-ARTHRITIS; ENDOTHELIAL-CELLS; SURVIVAL FACTOR; B-LYMPHOCYTES; FACTOR-BETA; IN-VITRO	Background: Neurotrophins (NTs) are able to activate lymphocytes and fibroblasts; they can modulate angiogenesis and sympathic vascular function. Thus, they can be implicated in the three pathogenic processes of systemic sclerosis (SSc). The aims of this study are to determine blood levels of Nerve Growth Factor (NGF), Brain-Derived Neurotrophic Factor (BDNF) and Neurotrophin-3 (NT-3) in SSc and to correlate them with clinical and biological data. Methods: Serum samples were obtained from 55 SSc patients and 32 control subjects to measure NTs levels by ELISA and to determine their relationships with SSc profiles. Findings: Serum NGF levels were higher in SSc patients (288.26 +/- 170.34 pg/mL) than in control subjects (170.34 +/- 50.8 pg/mL, p<0.001) and correlated with gammaglobulins levels and the presence of both anti-cardiolipin and anti-Scl-70 antibodies (p<0.05). In contrast, BDNF levels were lower in SSc patients than in controls (1121.9 +/- 158.1 vs 1372.9 +/- 190.9 pg/mL, p<0.0001), especially in pulmonary arterial hypertension and diffuse SSc as compared to limited forms (all p<0.05). NT-3 levels were similar in SSc and in the control group (2657.2 +/- 2296 vs 2959.3 +/- 2555 pg/mL, NS). BDNF levels correlated negatively with increased NGF levels in the SSc group (and not in controls). Conclusion: Low BDNF serum levels were not previously documented in SSc, particularly in the diffuse SSc subset and in patients with pulmonary hypertension or anti-Scl-70 antibodies. The negative correlation between NGF and BDNF levels observed in SSc and not in healthy controls could be implicated in sympathic vascular dysfunction in SSc.	[Lise, Marie-Claude; Sparsa, Agnes; Lalloue, Fabrice; Martel, Clothilde; Vidal, Elisabeth; Jauberteau, Marie-Odile; Fauchais, Anne-Laure] Limoges Univ Hosp, IFR 145, Homeostasie Cellulaire & Pathol EA3842, Limoges, France; [Ly, Kim; Bezanahary, Holy; Gondran, Guillaume; Loustaud-Ratti, Veronique; Vidal, Elisabeth; Fauchais, Anne-Laure] Limoges Univ Hosp, Dept Internal Med, Limoges, France; [Sparsa, Agnes; Bonnetblanc, Jean-Marie] Limoges Univ Hosp, Dept Dermatol, Limoges, France; [Jauberteau, Marie-Odile] Limoges Univ Hosp, Dept Immunol, Limoges, France; [Marie, Isabelle] Rouen Univ Hosp, Dept Internal Med, Rouen, France	CHU Limoges; CHU Limoges; CHU Limoges; CHU Limoges; CHU de Rouen	Lise, MC (corresponding author), Limoges Univ Hosp, IFR 145, Homeostasie Cellulaire & Pathol EA3842, Limoges, France.	anne-laure.fauchais@chu-limoges.fr	Loustaud-Ratti, Véronique/A-5262-2017; Ly, Kim/AAN-4092-2021	Lalloue, Fabrice/0000-0003-0382-4948; Fauchais, Anne Laure/0000-0002-0489-8570; Ly, Kim Heang/0000-0002-8511-903X; Jauberteau, Marie-Odile/0000-0002-8811-8948	AREML, Association Regionale d'Entraide a la Maladie Lupique	AREML, Association Regionale d'Entraide a la Maladie Lupique	This work was supported by AREML, Association Regionale d'Entraide a la Maladie Lupique, a local association of patients with lupus erythematosus and auto-immune disease. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aalto K, 2002, CYTOKINE, V20, P136, DOI 10.1006/cyto.2002.1991; Abe T, 1997, CIRCULATION, V95, P213, DOI 10.1161/01.CIR.95.1.213; Aloe L, 1997, ALLERGY, V52, P883, DOI 10.1111/j.1398-9995.1997.tb01247.x; Alves JD, 2005, RHEUMATOLOGY, V44, P1238, DOI 10.1093/rheumatology/keh722; Assous N, 2005, CLIN EXP RHEUMATOL, V23, P199; Barthel C, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2716; Besser M, 1999, J IMMUNOL, V162, P6303; BRACCILAUDIERO L, 1993, NEUROREPORT, V4, P563, DOI 10.1097/00001756-199305000-00025; Chaldakov G N, 2001, Arch Physiol Biochem, V109, P357, DOI 10.1076/apab.109.3.357.9353; Chul BL, 2009, ALCOHOL, V43, P265, DOI 10.1016/j.alcohol.2009.04.003; CLEMENTS P, 1995, J RHEUMATOL, V22, P1281; Coassin M, 2006, GRAEF ARCH CLIN EXP, V244, P485, DOI 10.1007/s00417-005-0098-0; Del Porto F, 2006, ANN NY ACAD SCI, V1069, P438, DOI 10.1196/annals.1351.042; Denton CP, 2001, CURR OPIN RHEUMATOL, V13, P505, DOI 10.1097/00002281-200111000-00010; DICOU E, 1993, NEUROREPORT, V5, P321, DOI 10.1097/00001756-199312000-00036; DONOVAN MJ, 1995, AM J PATHOL, V147, P309; Donovan MJ, 2000, DEVELOPMENT, V127, P4531; Fauchais AL, 2009, SCAND J RHEUMATOL, V38, P50, DOI 10.1080/03009740802378832; Goss JR, 1997, EXP NEUROL, V146, P291, DOI 10.1006/exnr.1997.6515; Grimsholm O, 2008, CLIN RHEUMATOL, V27, P1289, DOI 10.1007/s10067-008-0910-4; Gupta SK, 2005, MOL CELL BIOCHEM, V275, P67, DOI 10.1007/s11010-005-1999-2; Hiltunen JO, 2001, J PATHOL, V194, P247, DOI 10.1002/path.878; Iwata Y, 2007, RHEUMATOLOGY, V46, P790, DOI 10.1093/rheumatology/kem010; Julio-Pieper M, 2009, J CLIN ENDOCR METAB, V94, P3065, DOI 10.1210/jc.2009-0542; Kapczinski F, 2008, REV BRAS PSIQUIATR, V30, P243, DOI 10.1590/S1516-44462008000300011; Kasselman LJ, 2006, J NEUROIMMUNOL, V175, P118, DOI 10.1016/j.jneuroim.2006.03.008; Kawaguchi-Manabe H, 2007, LIFE SCI, V81, P385, DOI 10.1016/j.lfs.2007.05.024; Kermani P, 2005, J CLIN INVEST, V115, P653, DOI 10.1172/JCI200522655; Kermani P, 2007, TRENDS CARDIOVAS MED, V17, P140, DOI 10.1016/j.tcm.2007.03.002; Kerschensteiner M, 1999, J EXP MED, V189, P865, DOI 10.1084/jem.189.5.865; LEROY EC, 1988, J RHEUMATOL, V15, P202; Lonzetti LS, 2001, ARTHRITIS RHEUM-US, V44, P735; Manni L, 2005, INT J CARDIOL, V102, P169, DOI 10.1016/j.ijcard.2004.10.041; Matucci-Cerinic M, 2009, RHEUMATOLOGY, V48, P8, DOI 10.1093/rheumatology/ken482; Matucci-Cerinic M, 2001, ANN RHEUM DIS, V60, P487, DOI 10.1136/ard.60.5.487; Medsger TA, 2003, CLIN EXP RHEUMATOL, V21, pS42; Micera A, 2005, CLIN EXP ALLERGY, V35, P650, DOI 10.1111/j.1365-2222.2005.02241.x; Micera A, 2001, P NATL ACAD SCI USA, V98, P6162, DOI 10.1073/pnas.101130898; Nakahashi T, 2000, FEBS LETT, V470, P113, DOI 10.1016/S0014-5793(00)01302-8; Noga O, 2001, CLIN EXP ALLERGY, V31, P1906, DOI 10.1046/j.1365-2222.2001.01249.x; Ogawa F, 2006, RHEUMATOLOGY, V45, P815, DOI 10.1093/rheumatology/kel012; OTTEN U, 1989, P NATL ACAD SCI USA, V86, P10059, DOI 10.1073/pnas.86.24.10059; Piga, 2000, Eur J Intern Med, V11, P156, DOI 10.1016/S0953-6205(00)00084-4; Ricci A, 2000, J VASC RES, V37, P355, DOI 10.1159/000025751; Rihl M, 2005, ANN RHEUM DIS, V64, P1542, DOI 10.1136/ard.2004.032599; SANTHANAM AV, STROKE, V41, P350; SEIDEL MF, 2009, SEMIN ARTHRITIS RHEU; Steen VD, 1996, SYSTEMIC SCLEROSIS, P51; Torcia M, 1996, CELL, V85, P345, DOI 10.1016/S0092-8674(00)81113-7; TUVERI MA, 1993, CLIN EXP RHEUMATOL, V11, P319; Wu AG, 2004, EUR J NEUROSCI, V19, P1699, DOI 10.1111/j.1460-9568.2004.03246.x; Xu M, 2008, AM J PHYSIOL-HEART C, V295, pH1529, DOI 10.1152/ajpheart.00115.2008; Yang ZF, 2006, ONCOL REP, V16, P1237	53	11	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2010	5	11							e13918	10.1371/journal.pone.0013918	http://dx.doi.org/10.1371/journal.pone.0013918			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	677ZE	21085492	Green Published, Green Submitted, gold			2022-12-27	WOS:000284035900023
J	Rodriguez-Bies, E; Calvo, SSC; Fontan-Lozano, A; Amaro, JP; de la Rosa, FJB; Carrion, AM; Navas, P; Lopez-Lluch, G				Rodriguez-Bies, Elizabeth; Santa-Cruz Calvo, Sara; Fontan-Lozano, Angela; Pena Amaro, Jose; Berral de la Rosa, Francisco J.; Carrion, Angel M.; Navas, Placido; Lopez-Lluch, Guillermo			Muscle Physiology Changes Induced by Every Other Day Feeding and Endurance Exercise in Mice: Effects on Physical Performance	PLOS ONE			English	Article							CALORIC RESTRICTION; SKELETAL-MUSCLE; MITOCHONDRIAL BIOGENESIS; DIETARY RESTRICTION; OXIDATIVE STRESS; FISCHER-344 RATS; BLOOD-PRESSURE; MOUSE-LIVER; COENZYME-Q; PROTEIN	Every other day feeding (EOD) and exercise induce changes in cell metabolism. The aim of the present work was to know if both EOD and exercise produce similar effects on physical capacity, studying their physiological, biochemical and metabolic effects on muscle. Male OF-1 mice were fed either ad libitum (AL) or under EOD. After 18 weeks under EOD, animals were also trained by using a treadmill for another 6 weeks and then analyzed for physical activity. Both, EOD and endurance exercise increased the resistance of animals to extenuating activity and improved motor coordination. Among the groups that showed the highest performance, AL and EOD trained animals, ALT and EODT respectively, only the EODT group was able to increase glucose and triglycerides levels in plasma after extenuating exercise. No high effects on mitochondrial respiratory chain activities or protein levels neither on coenzyme Q levels were found in gastrocnemius muscle. However, exercise and EOD did increase beta-oxidation activity in this muscle accompanied by increased CD36 levels in animals fed under EOD and by changes in shape and localization of mitochondria in muscle fibers. Furthermore, EOD and training decreased muscle damage after strenuous exercise. EOD also reduced the levels of lipid peroxidation in muscle. Our results indicate that EOD improves muscle performance and resistance by increasing lipid catabolism in muscle mitochondria at the same time that prevents lipid peroxidation and muscle damage.	[Rodriguez-Bies, Elizabeth; Santa-Cruz Calvo, Sara; Navas, Placido; Lopez-Lluch, Guillermo] Univ Pablo de Olavide, CSIC, Inst Salud Carlos III, CIBERER,CABD, Seville, Spain; [Fontan-Lozano, Angela; Carrion, Angel M.] Univ Pablo de Olavide, Dept Fisiol Anat & Biol Celular, Div Neurociencia, Seville, Spain; [Pena Amaro, Jose] Univ Cordoba, Fac Med, Dept Ciencias Morfol, Cordoba, Spain; [Berral de la Rosa, Francisco J.] Univ Pablo de Olavide, Fac Deporte, Dept Deporte & Informat, Seville, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; CSIC - Andalusian Center for Developmental Biology (CABD); Instituto de Salud Carlos III; Universidad Pablo de Olavide; Universidad de Cordoba; Universidad Pablo de Olavide	Rodriguez-Bies, E (corresponding author), Univ Pablo de Olavide, CSIC, Inst Salud Carlos III, CIBERER,CABD, Seville, Spain.	glopllu@upo.es	Berral de la Rosa, Francisco José/C-6553-2013; De La Rosa, Francisco/GWU-4894-2022; Carrion, Angel Manuel/K-5875-2014; Bies, Elisabet Rodríguez/A-4459-2016; Peña-Amaro, Jose/ABG-9424-2020; Lopez-Lluch, Guillermo/N-4742-2014; FONTÁN-LOZANO, ÁNGELA/R-9081-2019; NAVAS, PLACIDO/R-5943-2019	Carrion, Angel Manuel/0000-0001-8158-9512; Bies, Elisabet Rodríguez/0000-0002-5910-2920; Peña-Amaro, Jose/0000-0002-2637-1112; Lopez-Lluch, Guillermo/0000-0001-9830-8502; FONTÁN-LOZANO, ÁNGELA/0000-0003-1646-0952; NAVAS, PLACIDO/0000-0002-4115-7966; Santa-Cruz Calvo, Sara/0000-0001-6037-8986	Spanish Ministry of Science and Innovation [DEP2005-00238-C04-04, DEP2009-12019]; Spanish Sport Council [01/UPB31/07, 15/UPB31/06]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Spanish Sport Council	This work was supported by the Spanish Ministry of Science and Innovation grants DEP2005-00238-C04-04 and DEP2009-12019. E. Rodriguez-Bies has been supported by the 01/UPB31/07 and 15/UPB31/06 grants from the Spanish Sport Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acin-Perez R, 2009, CELL METAB, V9, P265, DOI 10.1016/j.cmet.2009.01.012; Anson RM, 2003, P NATL ACAD SCI USA, V100, P6216, DOI 10.1073/pnas.1035720100; Azab M, 2009, J TOXICOL ENV HEAL A, V72, P295, DOI 10.1080/15287390802526357; Baker DJ, 2006, J GERONTOL A-BIOL, V61, P675, DOI 10.1093/gerona/61.7.675; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Bonkowski MS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004567; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Burelle Y, 2002, J APPL PHYSIOL, V92, P2429, DOI 10.1152/japplphysiol.01024.2001; Campbell SE, 2004, J BIOL CHEM, V279, P36235, DOI 10.1074/jbc.M400566200; Caro P, 2008, REJUV RES, V11, P621, DOI 10.1089/rej.2008.0704; Cerqueira FM, 2010, AGEING RES REV, V9, P424, DOI 10.1016/j.arr.2010.05.002; Chomentowski P, 2009, J GERONTOL A-BIOL, V64, P575, DOI 10.1093/gerona/glp007; Civitarese AE, 2007, PLOS MED, V4, P485, DOI 10.1371/journal.pmed.0040076; Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196; Cooper CE, 2002, BIOCHEM SOC T, V30, P280, DOI 10.1042/BST0300280; Crescenzo R, 2006, DIABETES, V55, P2286, DOI 10.2337/db06-0312; De Cabo R, 2004, EXP GERONTOL, V39, P297, DOI 10.1016/j.exger.2003.12.003; Desai VG, 1996, ARCH BIOCHEM BIOPHYS, V333, P145, DOI 10.1006/abbi.1996.0375; FAVIER RJ, 1998, AM J PHYSIOL, V254, pR877; Fernandez-Ayala DJM, 2005, BBA-BIOENERGETICS, V1706, P174, DOI 10.1016/j.bbabio.2004.10.009; Fontana L, 2004, P NATL ACAD SCI USA, V101, P6659, DOI 10.1073/pnas.0308291101; Freyssenet D, 2007, J APPL PHYSIOL, V102, P529, DOI 10.1152/japplphysiol.01126.2005; Gerard-Monnier D, 1998, CHEM RES TOXICOL, V11, P1176, DOI 10.1021/tx9701790; Hepple RT, 2006, REJUV RES, V9, P219, DOI 10.1089/rej.2006.9.219; HOPPELER H, 1986, INT J SPORTS MED, V7, P187, DOI 10.1055/s-2008-1025758; Horska A, 1999, AM J PHYSIOL-ENDOC M, V276, pE766, DOI 10.1152/ajpendo.1999.276.4.E766; Huffman DM, 2008, AM J PHYSIOL-REG I, V294, pR1618, DOI 10.1152/ajpregu.00890.2007; Irrcher I, 2003, SPORTS MED, V33, P783, DOI 10.2165/00007256-200333110-00001; Kalain R, 2006, J GERONTOL A-BIOL, V61, P211, DOI 10.1093/gerona/61.3.211; Kim JH, 2009, CELL DEATH DIFFER, V16, P584, DOI 10.1038/cdd.2008.186; Kim JH, 2008, EXP GERONTOL, V43, P317, DOI 10.1016/j.exger.2007.12.012; King KL, 2007, ARCH BIOCHEM BIOPHYS, V467, P234, DOI 10.1016/j.abb.2007.08.020; Kirkendall DT, 1998, AM J SPORT MED, V26, P598, DOI 10.1177/03635465980260042401; KRIEGER DA, 1980, J APPL PHYSIOL, V48, P23, DOI 10.1152/jappl.1980.48.1.23; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Lanza IR, 2008, DIABETES, V57, P2933, DOI 10.2337/db08-0349; Larson-Meyer DE, 2010, MED SCI SPORT EXER, V42, P152, DOI 10.1249/MSS.0b013e3181ad7f17; Lass A, 1999, BIOFACTORS, V9, P199, DOI 10.1002/biof.5520090215; Leeuwenburgh C, 1999, FREE RADICAL BIO MED, V27, P186, DOI 10.1016/S0891-5849(99)00071-4; Lopez-Lluch G, 2005, AGE, V27, P153, DOI 10.1007/s11357-005-2726-3; Lopez-Lluch G, 2006, P NATL ACAD SCI USA, V103, P1768, DOI 10.1073/pnas.0510452103; Lopez-Lluch G, 2008, EXP GERONTOL, V43, P813, DOI 10.1016/j.exger.2008.06.014; Lopez-Lluch G, 2010, MECH AGEING DEV, V131, P225, DOI 10.1016/j.mad.2010.02.003; Lowenthal DT, 2006, THESCIENTIFICWORLDJO, V6, P1339, DOI 10.1100/tsw.2006.183; Mager DE, 2006, FASEB J, V20, P631, DOI 10.1096/fj.05-5263com; Marzetti E, 2009, BIOFACTORS, V35, P28, DOI 10.1002/biof.5; Mattson MP, 2005, J NUTR BIOCHEM, V16, P129, DOI 10.1016/j.jnutbio.2004.12.007; Mattson MP, 2003, J NEUROCHEM, V84, P417, DOI 10.1046/j.1471-4159.2003.01586.x; MCCARTER RJM, 2000, HDB OXIDANTS ANTIOXI, P797; MCMURRAY RG, 1991, INT J SPORTS MED, V12, P167, DOI 10.1055/s-2007-1024662; MEANS LW, 1993, PHYSIOL BEHAV, V54, P503, DOI 10.1016/0031-9384(93)90243-9; Murase T, 2002, J LIPID RES, V43, P1312, DOI 10.1194/jlr.M200094-JLR200; Poehlman ET, 2001, J GERONTOL A-BIOL, V56, P45, DOI 10.1093/gerona/56.suppl_1.45; RODRIGUEZBIES E, 2009, REV ANDALUZA MED DEP, V2, P13; Senchina DS, 2007, CLIN INTERV AGING, V2, P3, DOI 10.2147/ciia.2007.2.1.3; Shimotoyodome A, 2005, MED SCI SPORT EXER, V37, P1884, DOI 10.1249/01.mss.0000178062.66981.a8; Smith PJ, 2010, HYPERTENSION, V55, P1331, DOI 10.1161/HYPERTENSIONAHA.109.146795; Sreekumar R, 2002, AM J PHYSIOL-ENDOC M, V283, pE38, DOI 10.1152/ajpendo.00387.2001; Takahashi S, 2006, PHARMACOL RES, V53, P501, DOI 10.1016/j.phrs.2006.03.019; WANG N, 1993, PFLUG ARCH EUR J PHY, V424, P494, DOI 10.1007/BF00374913; Wang Y, 2004, PLOS BIOL, V2, P610, DOI 10.1371/journal.pbio.0020128; Weiss EP, 2006, AM J CLIN NUTR, V84, P1033; Wright DC, 2007, J BIOL CHEM, V282, P194, DOI 10.1074/jbc.M606116200; Wu H, 2002, SCIENCE, V296, P349, DOI 10.1126/science.1071163; YU BP, 1985, J GERONTOL, V40, P657, DOI 10.1093/geronj/40.6.657	65	19	19	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2010	5	11							e13900	10.1371/journal.pone.0013900	http://dx.doi.org/10.1371/journal.pone.0013900			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	677ZE	21085477	Green Published, gold			2022-12-27	WOS:000284035900011
J	Abaffy, T; Duncan, R; Riemer, DD; Tietje, O; Elgart, G; Milikowski, C; DeFazio, RA				Abaffy, Tatjana; Duncan, Robert; Riemer, Daniel D.; Tietje, Olaf; Elgart, George; Milikowski, Clara; DeFazio, R. Anthony			Differential Volatile Signatures from Skin, Naevi and Melanoma: A Novel Approach to Detect a Pathological Process	PLOS ONE			English	Article							ORGANIC-COMPOUNDS; OXIDATIVE STRESS; EXHALED BREATH; SPECTROMETRY; BIOMARKERS; IDENTIFICATION; PATHOGENESIS; EXPRESSION; PROFILES; BIOLOGY	Background: Early detection of melanoma is of great importance to reduce mortality. Discovering new melanoma biomarkers would improve early detection and diagnosis. Here, we present a novel approach to detect volatile compounds from skin. Methods and Findings: We used Head Space Solid Phase Micro-Extraction (HS-SPME) and gas chromatography/mass spectrometry (GC/MS) to identify volatile signatures from melanoma, naevi and skin samples. We hypothesized that the metabolic state of tissue alters the profile of volatile compounds. Volatiles released from fresh biopsy tissue of melanoma and benign naevus were compared based on their difference in frequency distribution and their expression level. We also analyzed volatile profiles from frozen tissue, including skin and melanoma. Conclusions: Three volatiles, 4-methyl decane, dodecane and undecane were preferentially expressed in both fresh and frozen melanoma, indicating that they are candidate biomarkers. Twelve candidate biomarkers evaluated by fuzzy logic analysis of frozen samples distinguished melanoma from skin with 89% sensitivity and 90% specificity. Our results demonstrate proof-of-principle that there is differential expression of volatiles in melanoma. Our volatile metabolomic approach will lead to a better understanding of melanoma and can enable development of new diagnostic and treatment strategies based on altered metabolism.	[Abaffy, Tatjana; Duncan, Robert] Univ Miami, Miller Sch Med, Dept Epidemiol & Publ Hlth, Div Biostat, Miami, FL 33136 USA; [Riemer, Daniel D.] Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Miami, FL 33149 USA; [Tietje, Olaf] Systaim GmbH, Zurich, Switzerland; [Elgart, George] Univ Miami, Dept Dermatol & Cutaneous Surg, Miami, FL USA; [Milikowski, Clara] Univ Miami, Dept Pathol, Miami, FL USA; [DeFazio, R. Anthony] Univ Miami, Dept Neurol, Miami, FL USA	University of Miami; University of Miami; University of Miami; University of Miami; University of Miami	Abaffy, T (corresponding author), Univ Miami, Miller Sch Med, Dept Epidemiol & Publ Hlth, Div Biostat, Miami, FL 33136 USA.	tabaffy@med.miami.edu	Abaffy, Tatjana/C-2071-2015; DeFazio, Richard/AFO-0041-2022	DeFazio, Richard/0000-0001-7302-7528; milikowski, clara/0000-0002-6410-2300	University of Miami; Florida Biomedical Bankhead-Coley Research Program; National Institutes of Health (NIH) National Cancer Institute (NCI) [R21CA 132046]; NATIONAL CANCER INSTITUTE [R21CA132046] Funding Source: NIH RePORTER	University of Miami; Florida Biomedical Bankhead-Coley Research Program; National Institutes of Health (NIH) National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the University of Miami (TA), Florida Biomedical Bankhead-Coley Research Program (TA) and from National Institutes of Health (NIH) National Cancer Institute (NCI) R21CA 132046 (TA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bajtarevic A, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-348; BALARD B, 1989, MUTAT RES, V219, P71, DOI 10.1016/0921-8734(89)90042-8; BAMSHAD J, 1964, J INVEST DERMATOL, V43, P111, DOI 10.1038/jid.1964.125; Benevenga NJ, 2007, AM J CLIN NUTR, V85, P946, DOI 10.1093/ajcn/85.4.946; BENJAMIN RC, 1980, J BIOL CHEM, V255, P493; Bernier UR, 2000, ANAL CHEM, V72, P747, DOI 10.1021/ac990963k; Bickers DR, 2006, J INVEST DERMATOL, V126, P2565, DOI 10.1038/sj.jid.5700340; Cedar H, 2009, NAT REV GENET, V10, P295, DOI 10.1038/nrg2540; Cellarier E, 2003, CANCER TREAT REV, V29, P489, DOI 10.1016/S0305-7372(03)00118-X; Chan HP, 2009, LUNG CANCER, V63, P164, DOI 10.1016/j.lungcan.2008.05.020; D'Amico A, 2008, SKIN RES TECHNOL, V14, P226, DOI 10.1111/j.1600-0846.2007.00284.x; De Marzo AM, 1999, CANCER RES, V59, P3855; Deng CH, 2004, J CHROMATOGR B, V808, P269, DOI 10.1016/j.jchromb.2004.05.015; Dettmer K, 2004, ENVIRON HEALTH PERSP, V112, pA396; Dettmer K, 2007, MASS SPECTROM REV, V26, P51, DOI 10.1002/mas.20108; Dunn WB, 2008, INT J EPIDEMIOL, V37, P23, DOI 10.1093/ije/dym281; Gallagher M, 2008, BRIT J DERMATOL, V159, P780, DOI 10.1111/j.1365-2133.2008.08748.x; GHOLSON RK, 1966, NATURE, V212, P933, DOI 10.1038/212933a0; Griffin JL, 2004, NAT REV CANCER, V4, P551, DOI 10.1038/nrc1390; Haze S, 2001, J INVEST DERMATOL, V116, P520, DOI 10.1046/j.0022-202x.2001.01287.x; HOFFMAN RM, 1985, ANTICANCER RES, V5, P1; Horst B, 2009, AM J PATHOL, V174, P1524, DOI 10.2353/ajpath.2009.080543; Horvath I, 2009, EUR RESPIR J, V34, P261, DOI 10.1183/09031936.00142508; Howell PM, 2009, CANCER CONTROL, V16, P200, DOI 10.1177/107327480901600302; Ji J, 2006, TALANTA, V69, P894, DOI 10.1016/j.talanta.2005.11.032; Lee BWK, 2010, J AM CHEM SOC, V132, P3642, DOI 10.1021/ja908995p; Lin JY, 2007, NATURE, V445, P843, DOI 10.1038/nature05660; Lin WS, 1997, J BIOL CHEM, V272, P11895, DOI 10.1074/jbc.272.18.11895; Mazzone PJ, 2008, J THORAC ONCOL, V3, P774, DOI 10.1097/JTO.0b013e31817c7439; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; Montgomery BD, 2009, CAN FAM PHYSICIAN, V55, P24; Nicholson JK, 2008, NATURE, V455, P1054, DOI 10.1038/4551054a; Olivares C, 2009, PIGM CELL MELANOMA R, V22, P750, DOI 10.1111/j.1755-148X.2009.00636.x; Oliver SG, 2002, PHILOS T R SOC B, V357, P17, DOI 10.1098/rstb.2001.1049; Pawliszyn J, 2000, J CHROMATOGR SCI, V38, P270, DOI 10.1093/chromsci/38.7.270; Pfahlberg A, 2004, PREV MED, V38, P382, DOI 10.1016/j.ypmed.2003.11.015; Phillips Michael, 2007, Cancer Biomarkers, V3, P95; Phillips Michael, 2003, Breast J, V9, P184, DOI 10.1046/j.1524-4741.2003.09309.x; Risticevic S, 2009, ANAL BIOANAL CHEM, V393, P781, DOI 10.1007/s00216-008-2375-3; Rivers JK, 2004, LANCET, V363, P728, DOI 10.1016/S0140-6736(04)15649-3; Robertson KD, 1999, NUCLEIC ACIDS RES, V27, P2291, DOI 10.1093/nar/27.11.2291; Saghatelian A, 2004, BIOCHEMISTRY-US, V43, P14332, DOI 10.1021/bi0480335; Sanchez-del-Campo L, 2008, INT J CANCER, V123, P2446, DOI 10.1002/ijc.23813; Schubert HL, 2003, TRENDS BIOCHEM SCI, V28, P329, DOI 10.1016/S0968-0004(03)00090-2; Smit NPM, 1995, BIOCHEM PHARMACOL, V50, P1955, DOI 10.1016/0006-2952(95)00243-X; Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59; Sreekumar A, 2009, NATURE, V457, P910, DOI 10.1038/nature07762; Stepien K, 2009, J AM SOC MASS SPECTR, V20, P464, DOI 10.1016/j.jasms.2008.11.003; Tagore R, 2008, J AM CHEM SOC, V130, P14111, DOI 10.1021/ja806463c; Takata M, 2010, PIGM CELL MELANOMA R, V23, P64, DOI 10.1111/j.1755-148X.2009.00645.x; Urayama S, 2010, RAPID COMMUN MASS SP, V24, P613, DOI 10.1002/rcm.4420; Viros A, 2008, PLOS MED, V5, P941, DOI 10.1371/journal.pmed.0050120; ZHANG ZY, 1993, ANAL CHEM, V65, P1843, DOI 10.1021/ac00062a008	53	51	53	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2010	5	11							e13813	10.1371/journal.pone.0013813	http://dx.doi.org/10.1371/journal.pone.0013813			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675NY	21079799	gold, Green Published, Green Submitted			2022-12-27	WOS:000283838600006
J	Pinos, T; Barbosa-Desongles, A; Hurtado, A; Santamaria-Martinez, A; de Torres, I; Reventos, J; Munell, F				Pinos, Tomas; Barbosa-Desongles, Anna; Hurtado, Antoni; Santamaria-Martinez, Albert; de Torres, Ines; Reventos, Jaume; Munell, Francina			Human SHBG mRNA Translation Is Modulated by Alternative 5 '-Non-Coding Exons 1A and 1B	PLOS ONE			English	Article							HORMONE-BINDING GLOBULIN; PROTEIN; 5'-UTR; GENE; EXPRESSION; INITIATION; ISOFORM	Background: The human sex hormone-binding globulin (SHBG) gene comprises at least 6 different transcription units (TU-1, -1A,-1B,-1C,-1D and -1E), and is regulated by no less than 6 different promoters. The best characterized are TU-1 and TU-1A: TU-1 is responsible for producing plasma SHBG, while TU-1A is transcribed and translated in the testis. Transcription of the recently described TU-1B,-1C, and-1D has been demonstrated in human prostate tissue and prostate cancer cell lines, as well as in other human cell lines such as HeLa, HepG2, HeK 293, CW 9019 and imr 32. However, there are no reported data demonstrating their translation. In the present study, we aimed to determine whether TU-1A and TU-1B are indeed translated in the human prostate and whether 5' UTR exons 1A and 1B differently regulate SHBG translation. Results: Cis-regulatory elements that could potentially regulate translation were identified within the 5'UTRs of SHBG TU-1A and TU-1B. Although full-length SHBG TU-1A and TU-1B mRNAs were present in prostate cancer cell lines, the endogenous SHBG protein was not detected by western blot in any of them. LNCaP prostate cancer cells transfected with several SHBG constructs containing exons 2 to 8 but lacking the 5'UTR sequence did show SHBG translation, whereas inclusion of the 5'UTR sequences of either exon 1A or 1B caused a dramatic decrease in SHBG protein levels. The molecular weight of SHBG did not vary between cells transfected with constructs with or without the 5'UTR sequence, thus confirming that the first in-frame ATG of exon 2 is the translation start site of TU-1A and TU-1B. Conclusions: The use of alternative SHBG first exons 1A and 1B differentially inhibits translation from the ATG situated in exon 2, which codes for methionine 30 of transcripts that begin with the exon 1 sequence.	[Pinos, Tomas; Barbosa-Desongles, Anna; Hurtado, Antoni; Santamaria-Martinez, Albert; Reventos, Jaume; Munell, Francina] Inst Recerca Hosp Univ Vall Hebron, Barcelona, Spain; [Pinos, Tomas] Ctr Invest Biomed Red Enfermedades Raras CIBERER, Valencia, Spain; [de Torres, Ines] Hosp Univ Vall Hebron, Serv Anat Patol, Barcelona, Spain	Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Hospital Universitari Vall d'Hebron	Pinos, T (corresponding author), Inst Recerca Hosp Univ Vall Hebron, Barcelona, Spain.	fmunell@ir.vhebron.net	Reventos, Jaume/I-1633-2012; Santamaria-Martínez, Albert/X-1411-2018	Santamaria-Martínez, Albert/0000-0001-5436-9207; Munell Casadesus, Francina/0000-0001-8580-2819; Hurtado, Antoni/0000-0002-0145-4763	Ministerio de Sanidad y Consumo, Fundacion para la Investigacion en Urologia [PI052684]	Ministerio de Sanidad y Consumo, Fundacion para la Investigacion en Urologia	This work was supported by grants from the Ministerio de Sanidad y Consumo (PI052684), Fundacion para la Investigacion en Urologia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araud T, 2007, NUCLEIC ACIDS RES, V35, P4649, DOI 10.1093/nar/gkm482; Babendure JR, 2006, RNA, V12, P851, DOI 10.1261/rna.2309906; Baek D, 2007, GENOME RES, V17, P145, DOI 10.1101/gr.5872707; Davuluri RV, 2000, GENOME RES, V10, P1807, DOI 10.1101/gr.GR-1460R; GERSHAGEN S, 1989, NUCLEIC ACIDS RES, V17, P9245, DOI 10.1093/nar/17.22.9245; Gruber AR, 2008, NUCLEIC ACIDS RES, V36, pW70, DOI 10.1093/nar/gkn188; Gupta R., BMC BIOINFORMATIC S1, V11, pS65; HAMMOND GL, 1989, MOL ENDOCRINOL, V3, P1869, DOI 10.1210/mend-3-11-1869; Iadevaia V, 2008, RNA, V14, P1730, DOI 10.1261/rna.1037108; Janne M, 1998, J BIOL CHEM, V273, P34105, DOI 10.1074/jbc.273.51.34105; JOSEPH DR, 1994, VITAM HORM, V49, P197; KOZAK M, 1986, P NATL ACAD SCI USA, V83, P2850, DOI 10.1073/pnas.83.9.2850; Morris DR, 2000, MOL CELL BIOL, V20, P8635, DOI 10.1128/MCB.20.23.8635-8642.2000; Nakhla AM, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-37; Nie L, 2006, GENETICS, V174, P2229, DOI 10.1534/genetics.106.065862; Pickering BM, 2005, SEMIN CELL DEV BIOL, V16, P39, DOI 10.1016/j.semcdb.2004.11.006; Pinos T, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-59; Raveh-Amit H, 2009, MOL CELL BIOL, V29, P6140, DOI 10.1128/MCB.01044-09; Resch AM, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-162; Roberts AG, 2005, FEBS LETT, V579, P1061, DOI 10.1016/j.febslet.2004.12.080; Selva DM, 2006, HORM METAB RES, V38, P230, DOI 10.1055/s-2006-925336; Selva DM, 2005, J CLIN ENDOCR METAB, V90, P6275, DOI 10.1210/jc.2005-1192; Selva DM, 2002, J BIOL CHEM, V277, P45291, DOI 10.1074/jbc.M205903200; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Wang GD, 2005, AM J PHYSIOL-GASTR L, V289, pG614, DOI 10.1152/ajpgi.00119.2005; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	26	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2010	5	11							e13844	10.1371/journal.pone.0013844	http://dx.doi.org/10.1371/journal.pone.0013844			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675NY	21079794	Green Submitted, Green Published, gold			2022-12-27	WOS:000283838600018
J	Gonese, E; Dzangare, J; Gregson, S; Jonga, N; Mugurungi, O; Mishra, V				Gonese, Elizabeth; Dzangare, Janet; Gregson, Simon; Jonga, Nicholas; Mugurungi, Owen; Mishra, Vinod			Comparison of HIV Prevalence Estimates for Zimbabwe from Antenatal Clinic Surveillance (2006) and the 2005-06 Zimbabwe Demographic and Health Survey	PLOS ONE			English	Article							POPULATION-BASED SURVEYS; SUB-SAHARAN AFRICA; SENTINEL SURVEILLANCE; FERTILITY; EPIDEMICS; UGANDA; BIAS	Objective: To assess whether HIV surveillance data from pregnant women attending antenatal care (ANC) clinics in Zimbabwe represent infection levels in the general population. Methods: HIV prevalence estimates from ANC surveillance sites in 2006 were compared with estimates from the corresponding Zimbabwe Demographic and Health Survey 2005-06 (ZDHS) clusters using geographic information systems. Results: The ANC HIV prevalence estimate (17.9%, 95% CI 17.0%-18.8%) was similar to the ZDHS estimates for all men and women aged 15-49 years (18.1%, 16.9%-18.8%), for pregnant women (17.5%, 13.9%-21.9%), and for ANC attendees living within 30 km of ANC surveillance sites (19.9%, 17.1%-22.8%). However, the ANC surveillance estimate (17.9%) was lower than the ZDHS estimates for all women (21.1%, 19.7%-22.6%) and for women living within 30 km catchment areas of ANC surveillance sites (20.9%, 19.4%-22.3%). HIV prevalence in ANC sites classified as urban and rural was significantly lower than in sites classified as "other". Conclusions: Periodic population surveys can be used to validate ANC surveillance estimates. In Zimbabwe, ANC surveillance provides reliable estimates of HIV prevalence among men and women aged 15-49 years in the general population. Three classifications of ANC sites (rural/urban/other) should be used when generating national HIV estimates.	[Gonese, Elizabeth; Dzangare, Janet; Mugurungi, Owen] Minist Hlth & Child Welf, AIDS & TB Unit, Harare, Zimbabwe; [Gregson, Simon] Biomed Res & Training Inst, Harare, Zimbabwe; [Gregson, Simon] Univ London Imperial Coll Sci Technol & Med, London, England; [Jonga, Nicholas] Cent Stat Off, Harare, Zimbabwe; [Mishra, Vinod] ICF Macro, Calverton, MD USA	Biomedical Research Training Institute; Imperial College London	Gonese, E (corresponding author), Minist Hlth & Child Welf, AIDS & TB Unit, Harare, Zimbabwe.	Sajgregson@aol.com		Gregson, Simon/0000-0003-2707-0714	United States Agency for International Development (USAID); U.K. Department for International Development (DFID) through Population Services International (PSI), Zimbabwe and Centre for Disease Control and Prevention Zimbabwe (CDC); ICF Macro	United States Agency for International Development (USAID)(United States Agency for International Development (USAID)); U.K. Department for International Development (DFID) through Population Services International (PSI), Zimbabwe and Centre for Disease Control and Prevention Zimbabwe (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); ICF Macro	Funding for this research was provided by the United States Agency for International Development (USAID) through the MEASURE DHS project at Macro International Inc., Calverton, Maryland, USA, and by the U.K. Department for International Development (DFID) through Population Services International (PSI), Zimbabwe and Centre for Disease Control and Prevention Zimbabwe (CDC). ICF Macro contributed to the funding of the study as employer of one of the authors, Vinod Mishra, who was involved in the design of the study and the data analysis and contributed to the write-up of the paper. Apart from ICF Macro being the employer of one of the authors, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The findings and conclusions in this study are those of the authors and do not necessarily represent the views of the funding agencies or the organizations to which the authors belong.	Boerma JT, 2003, LANCET, V362, P1929, DOI 10.1016/S0140-6736(03)14967-7; *ESRI, 2006, ARCVIEW GIS REL 9 1; Fylkesnes K, 1998, AIDS, V12, P1227, DOI 10.1097/00002030-199810000-00015; Glynn JR, 2001, AIDS, V15, P1717, DOI 10.1097/00002030-200109070-00016; Gouws E, 2008, SEX TRANSM INFECT, V84, pI17, DOI 10.1136/sti.2008.030452; Gregson S, 2002, AIDS, V16, P643, DOI 10.1097/00002030-200203080-00017; Gregson S, 2000, AIDS, V14, pS85; Hong R., 2008, SEX TRANSM INFECT S1, V84, pi78, DOI DOI 10.1136/STI.2008.030106; Mahomva A, 2006, SEX TRANSM INFECT, V82, pI42, DOI 10.1136/sti.2005.019174; *MIN HLTH CHILD WE, 2006, NAT SURV HIV SYPH PR; Mishra V, 2008, SEX TRANSM INFECT, V84, pI63, DOI 10.1136/sti.2008.030411; Mishra V., 2009, DHS COMP REPORTS, V22; Musinguzi J, 2009, JAIDS-J ACQ IMM DEF, V51, P78, DOI 10.1097/QAI.0b013e3181990713; Ross A, 2004, AIDS, V18, P799, DOI 10.1097/00002030-200403260-00012; Schwartlander B, 1999, AIDS, V13, P2445, DOI 10.1097/00002030-199912030-00017; *STATA CORP, 2007, STATA REL 10 1; *UNAIDS, 2009, QUICK START GUID EPP; *UNAIDS, 2005, EV HIV DECL ZIMB COM; UNAIDS/WHO, 2002, IN 2 GEN HIV SURV SY; [WHO UNAIDS], 2003, REC ANT CLIN BAS SUR; Zaba B, 1998, AIDS, V12, pS41	21	12	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2010	5	11							e13819	10.1371/journal.pone.0013819	http://dx.doi.org/10.1371/journal.pone.0013819			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	674WJ	21072202	gold, Green Published, Green Submitted			2022-12-27	WOS:000283780800017
J	Xiang, YW; Xu, GL; Weigel-Van Aken, KAK				Xiang, Yiwen; Xu, Guilian; Weigel-Van Aken, Kirsten A. K.			Lactic Acid Induces Aberrant Amyloid Precursor Protein Processing by Promoting Its Interaction with Endoplasmic Reticulum Chaperone Proteins	PLOS ONE			English	Article							BETA-SECRETASE SITE; ENERGY-METABOLISM; HUMAN BRAIN; NEURODEGENERATIVE DISEASES; MITOCHONDRIAL-FUNCTION; LACTATE; STRESS; EXERCISE; CELLS; ACCUMULATION	Background: Lactic acid, a natural by-product of glycolysis, is produced at excess levels in response to impaired mitochondrial function, high-energy demand, and low oxygen availability. The enzyme involved in the production of beta-amyloid peptide (A beta) of Alzheimer's disease, BACE1, functions optimally at lower pH, which led us to investigate a potential role of lactic acid in the processing of amyloid precursor protein (APP). Methodology/Principal Findings: Lactic acid increased levels of A beta 40 and 42, as measured by ELISA, in culture medium of human neuroblastoma cells (SH-SY5Y), whereas it decreased APP metabolites, such as sAPP alpha. In cell lysates, APP levels were increased and APP was found to interact with ER-chaperones in a perinuclear region, as determined by co-immunoprecipitation and fluorescence microscopy studies. Lactic acid had only a very modest effect on cellular pH, did increase the levels of ER chaperones Grp78 and Grp94 and led to APP aggregate formation reminiscent of aggresomes. Conclusions/Significance: These findings suggest that sustained elevations in lactic acid levels could be a risk factor in amyloidogenesis related to Alzheimer's disease through enhanced APP interaction with ER chaperone proteins and aberrant APP processing leading to increased generation of amyloid peptides and APP aggregates.	[Xiang, Yiwen; Weigel-Van Aken, Kirsten A. K.] Univ Florida, Coll Med, Div Cellular & Mol Therapy, Dept Pediat, Gainesville, FL 32611 USA; [Weigel-Van Aken, Kirsten A. K.] Univ Florida, Coll Med, Powell Gene Therapy Ctr, Gainesville, FL USA; [Weigel-Van Aken, Kirsten A. K.] Univ Florida, Coll Med, Dept Mol Genet & Microbiol, Gainesville, FL USA; [Xu, Guilian] Univ Florida, Coll Med, Dept Neurosci, Gainesville, FL 32610 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Xiang, YW (corresponding author), Univ Florida, Coll Med, Div Cellular & Mol Therapy, Dept Pediat, Gainesville, FL 32611 USA.	weigel@ufl.edu			Santa Fe Health Care Alzheimer's Disease Research Center; National Institutes of Health [NS 044278]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS044278] Funding Source: NIH RePORTER	Santa Fe Health Care Alzheimer's Disease Research Center; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by the Santa Fe Health Care Alzheimer's Disease Research Center and the National Institutes of Health (NS 044278). The funding agency had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoyama K, 2005, J CEREBR BLOOD F MET, V25, P358, DOI 10.1038/sj.jcbfm.9600043; Bai Y, 2008, MOL CELL PROTEOMICS, V7, P15, DOI 10.1074/mcp.M700077-MCP200; Brody DL, 2008, SCIENCE, V321, P1221, DOI 10.1126/science.1161591; Coco M, 2009, BRAIN RES, V1302, P205, DOI 10.1016/j.brainres.2009.09.032; Dalsgaard MK, 2004, J PHYSIOL-LONDON, V554, P571, DOI 10.1113/jphysiol.2003.055053; Debray FG, 2008, CURR OPIN PEDIATR, V20, P471, DOI 10.1097/MOP.0b013e328306ebb6; Evans CG, 2006, J BIOL CHEM, V281, P33182, DOI 10.1074/jbc.M606192200; FEDDERSEN K, 1986, ANN THORAC SURG, V41, P395, DOI 10.1016/S0003-4975(10)62694-X; GARDINER M, 1982, J CEREBR BLOOD F MET, V2, P429, DOI 10.1038/jcbfm.1982.49; Hoshino T, 2007, BIOCHEM J, V402, P581, DOI 10.1042/BJ20061318; Kudo T, 2006, BIOCHEM BIOPH RES CO, V344, P525, DOI 10.1016/j.bbrc.2006.03.173; Ladilov Y, 2000, CARDIOVASC RES, V47, P394, DOI 10.1016/S0008-6363(00)00108-5; Lin XL, 2000, P NATL ACAD SCI USA, V97, P1456, DOI 10.1073/pnas.97.4.1456; Lindholm D, 2006, CELL DEATH DIFFER, V13, P385, DOI 10.1038/sj.cdd.4401778; MADUREIRA G, 1988, COMP BIOCHEM PHYS A, V89, P693, DOI 10.1016/0300-9629(88)90854-7; NORBERG K, 1975, ACTA PHYSIOL SCAND, V95, P301, DOI 10.1111/j.1748-1716.1975.tb10054.x; Olzmann JA, 2008, CURR MED CHEM, V15, P47; Peraus GC, 1997, J NEUROSCI, V17, P7714; Quistorff B, 2008, FASEB J, V22, P3443, DOI 10.1096/fj.08-106104; Redjems-Bennani N, 1998, GERONTOLOGY, V44, P300, DOI 10.1159/000022031; Schurr A, 2002, INT J MOL MED, V10, P131, DOI 10.3892/ijmm.10.2.131; Siesjo B K, 1982, Ciba Found Symp, V87, P77, DOI 10.1002/9780470720691.ch5; Steiner H, 2008, CURR ALZHEIMER RES, V5, P147, DOI 10.2174/156720508783954677; Thinakaran G, 1996, J BIOL CHEM, V271, P9390, DOI 10.1074/jbc.271.16.9390; Um HS, 2008, INT J MOL MED, V22, P529, DOI 10.3892/ijmm_00000052; Vantelon N, 2007, EUR J NEUROSCI, V26, P689, DOI 10.1111/j.1460-9568.2007.05698.x; Wolfe MS, 2007, J CELL SCI, V120, P3157, DOI 10.1242/jcs.03481; YAMAKAWA H, J BIOL CHEM, V285, P1634; Yang YN, 1998, J BIOL CHEM, V273, P25552, DOI 10.1074/jbc.273.40.25552	30	18	19	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2010	5	11							e13820	10.1371/journal.pone.0013820	http://dx.doi.org/10.1371/journal.pone.0013820			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	674WJ	21072203	Green Published, gold			2022-12-27	WOS:000283780800018
J	Suen, JY; Gardiner, B; Grimmond, S; Fairlie, DP				Suen, Jacky Y.; Gardiner, Brooke; Grimmond, Sean; Fairlie, David P.			Profiling Gene Expression Induced by Protease-Activated Receptor 2 (PAR2) Activation in Human Kidney Cells	PLOS ONE			English	Article							HISTONE DEACETYLASE INHIBITORS; PROINFLAMMATORY ROLE; COUPLED RECEPTORS; UP-REGULATION; MOUSE MODEL; INFLAMMATION; CANCER; PROLIFERATION; AGONISTS; TRYPSIN	Protease-Activated Receptor-2 (PAR2) has been implicated through genetic knockout mice with cytokine regulation and arthritis development. Many studies have associated PAR2 with inflammatory conditions (arthritis, airways inflammation, IBD) and key events in tumor progression (angiogenesis, metastasis), but they have relied heavily on the use of single agonists to identify physiological roles for PAR2. However such probes are now known not to be highly selective for PAR2, and thus precisely what PAR2 does and what mechanisms of downstream regulation are truly affected remain obscure. Effects of PAR2 activation on gene expression in Human Embryonic Kidney cells (HEK293), a commonly studied cell line in PAR2 research, were investigated here by comparing 19,000 human genes for intersecting up-or down-regulation by both trypsin (an endogenous protease that activates PAR2) and a PAR2 activating hexapeptide (2f-LIGRLO-NH2). Among 2,500 human genes regulated similarly by both agonists, there were clear associations between PAR2 activation and cellular metabolism (1,000 genes), the cell cycle, the MAPK pathway, HDAC and sirtuin enzymes, inflammatory cytokines, and anticomplement function. PAR-2 activation up-regulated four genes more than 5 fold (DUSP6, WWOX, AREG, SERPINB2) and down-regulated another six genes more than 3 fold (TXNIP, RARG, ITGB4, CTSD, MSC and TM4SF15). Both PAR2 and PAR1 activation resulted in up-regulated expression of several genes (CD44, FOSL1, TNFRSF12A, RAB3A, COPEB, CORO1C, THBS1, SDC4) known to be important in cancer. This is the first widespread profiling of specific activation of PAR2 and provides a valuable platform for better understanding key mechanistic roles of PAR2 in human physiology. Results clearly support the development of both antagonists and agonists of human PAR2 as potential disease modifying therapeutic agents.	[Suen, Jacky Y.; Gardiner, Brooke; Grimmond, Sean; Fairlie, David P.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia	University of Queensland	Suen, JY (corresponding author), Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia.	d.fairlie@imb.uq.edu.au	Gardiner, Brooke B/C-7773-2011; Fairlie, David P/F-8865-2014; Grimmond, Sean M/J-5304-2016; Grimmond, Sean/K-3246-2019; Suen, Jacky/G-4077-2015	Gardiner, Brooke B/0000-0003-3740-3244; Fairlie, David P/0000-0002-7856-8566; Grimmond, Sean M/0000-0002-8102-7998; Grimmond, Sean/0000-0002-8102-7998; Suen, Jacky/0000-0002-0309-2524	National Health and Medical Research Council of Australia [NHMRC569595]; Australian Research Council [FF0668733]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council)	Research funding is from the National Health and Medical Research Council of Australia (NHMRC569595; www.nhmrc.gov.au) and the Australian Research Council for a Federation Fellowship to DPF (FF0668733; www.arc.gov.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abey HT, 2006, J PHARMACOL EXP THER, V317, P598, DOI 10.1124/jpet.105.097121; Aqeilan RI, 2007, J CELL PHYSIOL, V212, P307, DOI 10.1002/jcp.21099; Aqeilan RI, 2004, P NATL ACAD SCI USA, V101, P4401, DOI 10.1073/pnas.0400805101; Aung HT, 2006, FASEB J, V20, P1315, DOI 10.1096/fj.05-5360com; Barry GD, 2006, CURR MED CHEM, V13, P243, DOI 10.2174/092986706775476070; Blanchard F, 2005, DRUG DISCOV TODAY, V10, P197, DOI 10.1016/S1359-6446(04)03309-4; Buddenkotte J, 2005, J INVEST DERMATOL, V124, P38, DOI 10.1111/j.0022-202X.2004.23539.x; Camelo S, 2005, J NEUROIMMUNOL, V164, P10, DOI 10.1016/j.jneuroim.2005.02.022; CAMPO BAD, 2005, BRIT J PHARMACOL, V144, P1100; Challen G, 2005, PHYSIOL GENOMICS, V23, P159, DOI 10.1152/physiolgenomics.00043.2005; Choi JH, 2005, CLIN EXP ALLERGY, V35, P89, DOI 10.1111/j.1365-2222.2004.02006.x; Chokki M, 2005, FEBS J, V272, P6387, DOI 10.1111/j.1742-4658.2005.05035.x; Chung CD, 2003, J IMMUNOL, V170, P581, DOI 10.4049/jimmunol.170.1.581; Cicala C, 2002, BRIT J PHARMACOL, V135, P14, DOI 10.1038/sj.bjp.0704438; Coates PJ, 2006, J PATHOL, V210, P385, DOI 10.1002/path.2080; Darmoul D, 2004, J BIOL CHEM, V279, P20927, DOI 10.1074/jbc.M401430200; Elefsinioti AL, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-208; Fiorucci S, 2001, P NATL ACAD SCI USA, V98, P13936, DOI 10.1073/pnas.241377298; Fiorucci S, 2004, HEPATOLOGY, V39, P365, DOI 10.1002/hep.20054; Gaca MDA, 2002, J HEPATOL, V36, P362, DOI 10.1016/S0168-8278(01)00285-9; Giancotti FG, 2007, TRENDS PHARMACOL SCI, V28, P506, DOI 10.1016/j.tips.2007.08.004; Grandaliano G, 2003, J AM SOC NEPHROL, V14, P2072, DOI 10.1097/01.ASN.0000080315.37254.A1; Halili MA, 2009, CURR TOP MED CHEM, V9, P309, DOI 10.2174/156802609788085250; Hansen KK, 2005, P NATL ACAD SCI USA, V102, P8363, DOI 10.1073/pnas.0409535102; Hill SJ, 2006, BRIT J PHARMACOL, V147, pS27, DOI 10.1038/sj.bjp.0706455; Hjortoe GM, 2004, BLOOD, V103, P3029, DOI 10.1182/blood-2003-10-3417; Holzhausen M, 2005, MEM I OSWALDO CRUZ, V100, P177, DOI 10.1590/S0074-02762005000900030; JACOB C, 2005, J BIOL CHEM; Johansson U, 2005, J LEUKOCYTE BIOL, V78, P967, DOI 10.1189/jlb.0704422; Kanke T, 2005, BRIT J PHARMACOL, V145, P255, DOI 10.1038/sj.bjp.0706189; Kawabata A, 2005, BRIT J PHARMACOL, V144, P212, DOI 10.1038/sj.bjp.0706059; Kawabata A, 2003, LIFE SCI, V74, P247, DOI 10.1016/j.lfs.2003.09.011; Kelso EB, 2007, ARTHRITIS RHEUM, V56, P765, DOI 10.1002/art.22423; Lee YCG, 2005, AM J PHYSIOL-LUNG C, V288, pL734, DOI 10.1152/ajplung.00173.2004; Lindner JR, 2000, J IMMUNOL, V165, P6504, DOI 10.4049/jimmunol.165.11.6504; Maeda K, 2005, PANCREAS, V31, P54, DOI 10.1097/01.mpa.0000163178.37050.0d; Marwick JA, 2007, EXPERT OPIN THER TAR, V11, P745, DOI 10.1517/14728222.11.6.745; Masamune A, 2005, J PHARMACOL EXP THER, V312, P651, DOI 10.1124/jpet.104.076232; McGuire JJ, 2004, J PHARMACOL EXP THER, V309, P1124, DOI 10.1124/jpet.103.064584; McLaughlin JN, 2005, J BIOL CHEM, V280, P22172, DOI 10.1074/jbc.M500721200; Moffatt JD, 2007, N-S ARCH PHARMACOL, V375, P1, DOI 10.1007/s00210-007-0139-9; Nishida K, 2004, ARTHRITIS RHEUM-US, V50, P3365, DOI 10.1002/art.20709; Reed CE, 2004, J ALLERGY CLIN IMMUN, V114, P997, DOI 10.1016/j.jaci.2004.07.060; Reilly CM, 2004, J IMMUNOL, V173, P4171, DOI 10.4049/jimmunol.173.6.4171; Schioth HB, 2005, GEN COMP ENDOCR, V142, P94, DOI 10.1016/j.ygcen.2004.12.018; Schmidlin F, 2001, AM J RESP CRIT CARE, V164, P1276, DOI 10.1164/ajrccm.164.7.2101157; Shichijo Michitaka, 2006, Allergol Int, V55, P271, DOI 10.2332/allergolint.55.271; Shimamoto R, 2004, INT J ONCOL, V24, P1401; Steinhoff M, 2005, ENDOCR REV, V26, P1, DOI 10.1210/er.2003-0025; Stenton GR, 2002, J PHARMACOL EXP THER, V302, P466, DOI 10.1124/jpet.302.2.466; Takizawa T, 2005, J PHARMACOL SCI, V98, P99, DOI 10.1254/jphs.SCZ050138; Tanaka M, 2005, KIDNEY INT, V67, P2123, DOI 10.1111/j.1523-1755.2005.00317.x; Vesey DA, 2007, NEPHROLOGY, V12, P36, DOI 10.1111/j.1440-1797.2006.00746.x; Wilson S, 2005, BIOCHEM J, V388, P967, DOI 10.1042/BJ20041066; Yada K, 2005, J SURG ONCOL, V89, P79, DOI 10.1002/jso.20197; Zhao AP, 2003, AM J PHYSIOL-GASTR L, V285, pG696, DOI 10.1152/ajpgi.00064.2003	56	41	43	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2010	5	11							e13809	10.1371/journal.pone.0013809	http://dx.doi.org/10.1371/journal.pone.0013809			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	674VY	21072196	Green Submitted, gold, Green Published			2022-12-27	WOS:000283779700016
J	Derycke, S; Vanaverbeke, J; Rigaux, A; Backeljau, T; Moens, T				Derycke, Sofie; Vanaverbeke, Jan; Rigaux, Annelien; Backeljau, Thierry; Moens, Tom			Exploring the Use of Cytochrome Oxidase c Subunit 1 (COI) for DNA Barcoding of Free-Living Marine Nematodes	PLOS ONE			English	Article							POPULATION GENETIC-STRUCTURE; MITOCHONDRIAL-DNA; SEQUENCE ALIGNMENT; FEEDING ECOLOGY; IDENTIFICATION; PHYLOGENY; PSEUDOGENES; WOLBACHIA	Background: The identification of free-living marine nematodes is difficult because of the paucity of easily scorable diagnostic morphological characters. Consequently, molecular identification tools could solve this problem. Unfortunately, hitherto most of these tools relied on 18S rDNA and 28S rDNA sequences, which often lack sufficient resolution at the species level. In contrast, only a few mitochondrial COI data are available for free-living marine nematodes. Therefore, we investigate the amplification and sequencing success of two partitions of the COI gene, the M1-M6 barcoding region and the I3-M11 partition. Methodology: Both partitions were analysed in 41 nematode species from a wide phylogenetic range. The taxon specific primers for the I3-M11 partition outperformed the universal M1-M6 primers in terms of amplification success (87.8% vs. 65.8%, respectively) and produced a higher number of bidirectional COI sequences (65.8% vs 39.0%, respectively). A threshold value of 5% K2P genetic divergence marked a clear DNA barcoding gap separating intra-and interspecific distances: 99.3% of all interspecific comparisons were >0.05, while 99.5% of all intraspecific comparisons were <0.05 K2P distance. Conclusion: The I3-M11 partition reliably identifies a wide range of marine nematodes, and our data show the need for a strict scrutiny of the obtained sequences, since contamination, nuclear pseudogenes and endosymbionts may confuse nematode species identification by COI sequences.	[Derycke, Sofie; Vanaverbeke, Jan; Rigaux, Annelien; Moens, Tom] Univ Ghent, Dept Biol, Marine Biol Res Grp, B-9000 Ghent, Belgium; [Derycke, Sofie; Rigaux, Annelien] Univ Ghent, Ctr Mol Phylogeny & Evolut, B-9000 Ghent, Belgium; [Backeljau, Thierry] Royal Belgian Inst Nat Sci, Joint Expt Mol Unit, Brussels, Belgium; [Backeljau, Thierry] Univ Antwerp, Evolutionary Biol Grp, Dept Biol, B-2020 Antwerp, Belgium	Ghent University; Ghent University; Royal Belgian Institute of Natural Sciences; University of Antwerp	Derycke, S (corresponding author), Univ Ghent, Dept Biol, Marine Biol Res Grp, B-9000 Ghent, Belgium.	s.derycke@ugent.be	Moens, Tom/AAB-8701-2019; Vanaverbeke, jan/A-1118-2012		Flemish Fund for Scientific Research (F.W.O.) [3G040407, 1507709]; Ghent University [B/07778/02]	Flemish Fund for Scientific Research (F.W.O.)(FWO); Ghent University(Ghent University)	This research was financially supported by the Flemish Fund for Scientific Research (F.W.O.) through the project 3G040407 and the research grant 1507709, and by Ghent University through the Special Research Fund (B.O.F.) project B/07778/02. S.D. acknowledges a postdoctoral fellowship from the F.W.O. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AVISE J, 1994, NATURAL HIST EVOLUTI; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0905845106, 10.1073/pnas.0812297106]; Bensasson D, 2001, TRENDS ECOL EVOL, V16, P314, DOI 10.1016/S0169-5347(01)02151-6; Bhadury P, 2006, MAR ECOL PROG SER, V320, P1, DOI 10.3354/meps320001; Bhadury P, 2009, AQUAT BIOL, V5, P149, DOI 10.3354/ab00145; Blouin MS, 2002, INT J PARASITOL, V32, P527, DOI 10.1016/S0020-7519(01)00357-5; Bordenstein SR, 2003, J NEMATOL, V35, P266; BOWLES J, 1992, MOL BIOCHEM PARASIT, V54, P165, DOI 10.1016/0166-6851(92)90109-W; Casiraghi M, 2001, PARASITOLOGY, V122, P93, DOI 10.1017/S0031182000007149; Creer S, 2010, MOL ECOL, V19, P4, DOI 10.1111/j.1365-294X.2009.04473.x; De Ley P, 2005, PHILOS T R SOC B, V360, P1945, DOI 10.1098/rstb.2005.1726; DEMESE, 2003, J EXP MAR BIOL ECOL, V296, P227; DEMESE, 2004, ENVIRON MICROBIOL, V6, P733; DEMESE, 2006, MAR ECOL PROG SER, V321, P157; Derycke S, 2008, MOL ECOL, V17, P3306, DOI 10.1111/j.1365-294X.2008.03846.x; Derycke S, 2007, MAR BIOL, V151, P1799, DOI 10.1007/s00227-007-0609-0; Derycke S, 2005, MAR ECOL PROG SER, V300, P91, DOI 10.3354/meps300091; Derycke S, 2010, ZOOL SCR, V39, P276, DOI 10.1111/j.1463-6409.2009.00420.x; dos Santos GAP, 2008, J EXP MAR BIOL ECOL, V355, P27, DOI 10.1016/j.jembe.2007.11.015; dos Santos GAP, 2009, MAR BIOL, V156, P629, DOI 10.1007/s00227-008-1114-9; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Elsasser SC, 2009, MOL ECOL RESOUR, V9, P707, DOI 10.1111/j.1755-0998.2008.02393.x; Erpenbeck D, 2006, MOL ECOL NOTES, V6, P550, DOI 10.1111/j.1471-8286.2005.01259.x; Ferri E, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-1; FITCH DHA, 1995, MOL BIOL EVOL, V12, P346; Floyd R, 2002, MOL ECOL, V11, P839, DOI 10.1046/j.1365-294X.2002.01485.x; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Galtier N, 1996, COMPUT APPL BIOSCI, V12, P543; Hamels I, 2001, AQUAT MICROB ECOL, V26, P61, DOI 10.3354/ame026061; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; HEIP C, 1985, OCEANOGR MAR BIOL, V23, P399; Hu M, 2002, ELECTROPHORESIS, V23, P27, DOI [10.1002/1522-2683(200201)23:1<27::AID-ELPS27>3.0.CO;2-7, 10.1002/1522-2683(200201)23:1&lt;27::AID-ELPS27&gt;3.0.CO;2-7]; Huang DW, 2008, J MOL EVOL, V66, P167, DOI 10.1007/s00239-008-9069-5; Jacob Joachim E M, 2009, BMC Res Notes, V2, P192, DOI 10.1186/1756-0500-2-192; Jansen G, 2009, ZOOL SCR, V38, P527, DOI 10.1111/j.1463-6409.2009.00386.x; Leduc D, 2009, J MAR BIOL ASSOC UK, V89, P337, DOI 10.1017/S0025315408002464; Meier R, 2008, SYST BIOL, V57, P809, DOI 10.1080/10635150802406343; Meldal BHM, 2007, MOL PHYLOGENET EVOL, V42, P622, DOI 10.1016/j.ympev.2006.08.025; Moens T, 1997, J MAR BIOL ASSOC UK, V77, P211, DOI 10.1017/S0025315400033889; Porazinska DL, 2009, MOL ECOL RESOUR, V9, P1439, DOI 10.1111/j.1755-0998.2009.02611.x; Postma-Blaauw MB, 2005, OECOLOGIA, V142, P428, DOI 10.1007/s00442-004-1741-x; Richly E, 2004, MOL BIOL EVOL, V21, P1081, DOI 10.1093/molbev/msh110; Seifert KA, 2007, P NATL ACAD SCI USA, V104, P3901, DOI 10.1073/pnas.0611691104; Seifert KA, 2009, MOL ECOL RESOUR, V9, P83, DOI 10.1111/j.1755-0998.2009.02635.x; Song H, 2008, P NATL ACAD SCI USA, V105, P13486, DOI 10.1073/pnas.0803076105; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Whitworth TL, 2007, P ROY SOC B-BIOL SCI, V274, P1731, DOI 10.1098/rspb.2007.0062; Zhang DX, 1996, TRENDS ECOL EVOL, V11, P247, DOI 10.1016/0169-5347(96)10031-8	48	144	158	5	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2010	5	10							e13716	10.1371/journal.pone.0013716	http://dx.doi.org/10.1371/journal.pone.0013716			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	672HN	21060838	Green Published, gold			2022-12-27	WOS:000283573800015
J	Mohammed, H; Ramos, M; Armstrong, J; Munoz-Jordan, J; Arnold-Lewis, KO; Ayala, A; Clark, GG; Tull, ES; Beatty, ME				Mohammed, Hamish; Ramos, Mary; Armstrong, Julie; Munoz-Jordan, Jorge; Arnold-Lewis, Kathleen O.; Ayala, Aurimar; Clark, Gary G.; Tull, Eugene S.; Beatty, Mark E.			An Outbreak of Dengue Fever in St. Croix (US Virgin Islands), 2005	PLOS ONE			English	Article							HEMORRHAGIC-FEVER; VIRUSES; DISEASE; CUBA; TRANSMISSION; PATHOGENESIS; INFECTIONS; ANTIBODIES; EPIDEMIC; SEROTYPE	Background: Periodic outbreaks of dengue fever occur in the United States Virgin Islands. In June 2005, an outbreak of dengue virus (DENV) serotype-2 with cases of dengue hemorrhagic fever (DHF) was detected in St. Croix, US Virgin Islands. The objective of this report is to describe this outbreak of DENV-2 and the findings of a case-control study examining risk factors for DHF. Methodology/Principal Findings: This is the largest dengue outbreak ever recorded in St. Croix, with 331 suspected dengue cases reported island-wide during 2005 (62.2 cases/10,000 population); 54% were hospitalized, 21% had at least one hemorrhagic manifestation, 28% had thrombocytopenia, 5% had DHF and 1 patient died. Eighty-nine laboratory-positive hospitalized patients were identified. Of these, there were 15 (17%) who met the WHO criteria for DHF (cases) and 74 (83%) who did not (controls). The only variable significantly associated with DHF on bivariate or multivariable analysis was age, with an adjusted odds ratio (95% confidence interval) of 1.033 (1.003, 1.064). Conclusions/Significance: During this outbreak of DENV-2, a high proportion of cases developed DHF and increasing age was significantly associated with DHF.	[Mohammed, Hamish; Ramos, Mary; Munoz-Jordan, Jorge; Ayala, Aurimar] Ctr Dis Control & Prevent, Dengue Branch, Div Vector Borne Infect Dis, San Juan, PR USA; [Ramos, Mary] Univ New Mexico, Dept Pediat, Albuquerque, NM 87131 USA; [Armstrong, Julie; Tull, Eugene S.] US Virgin Islands, Dept Hlth, St Croix, VI USA; [Armstrong, Julie] Ctr Dis Control & Prevent, Off Director, Atlanta, GA USA; [Arnold-Lewis, Kathleen O.] Governor Juan F Luis Hosp, St Croix, VI USA; [Clark, Gary G.] USDA, Mosquito & Fly Res Unit, Gainesville, FL USA; [Beatty, Mark E.] Pediat Dengue Vaccine Initiat, Seoul, South Korea	Centers for Disease Control & Prevention - USA; University of New Mexico; University of the Virgin Islands; Centers for Disease Control & Prevention - USA; United States Department of Agriculture (USDA)	Mohammed, H (corresponding author), Ctr Dis Control & Prevent, Dengue Branch, Div Vector Borne Infect Dis, San Juan, PR USA.	hamohammed@rossvet.edu.kn		beatty, mark/0000-0002-9614-5938; Mohammed, Hamish/0000-0002-2060-7286; Tull, Eugene S./0000-0002-6825-0511				Acioli-Santos B, 2008, HUM IMMUNOL, V69, P122, DOI 10.1016/j.humimm.2008.01.005; Beal AC, 2006, PEDIATRICS, V117, P1618, DOI 10.1542/peds.2005-1203; Blanton RE, 2008, EUR J HUM GENET, V16, P762, DOI 10.1038/ejhg.2008.4; BURKE DS, 1982, J CLIN MICROBIOL, V16, P1034, DOI 10.1128/JCM.16.6.1034-1042.1982; Chien LJ, 2006, J CLIN MICROBIOL, V44, P1295, DOI 10.1128/JCM.44.4.1295-1304.2006; GUBLER DJ, 1984, AM J TROP MED HYG, V33, P158, DOI 10.4269/ajtmh.1984.33.158; Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480; GUBLER DJ, 1983, MMWR-MORBID MORTAL W, V32, P23; GUZMAN MG, 1990, AM J TROP MED HYG, V42, P179, DOI 10.4269/ajtmh.1990.42.179; Halstead SB, 2001, AM J TROP MED HYG, V65, P180, DOI 10.4269/ajtmh.2001.65.180; HALSTEAD SB, 1981, AM J EPIDEMIOL, V114, P632, DOI 10.1093/oxfordjournals.aje.a113235; Kalayanarooj S, 2007, J INFECT DIS, V195, P1014, DOI 10.1086/512244; Kouri G, 1998, EMERG INFECT DIS, V4, P89; KOURI GP, 1987, T ROY SOC TROP MED H, V81, P821, DOI 10.1016/0035-9203(87)90042-3; MCELROY K, 2010, EMERG INFEC IN PRESS; Miagostovich MP, 1999, J CLIN VIROL, V14, P183, DOI 10.1016/S1386-6532(99)00059-1; Nagao Y, 2008, P NATL ACAD SCI USA, V105, P2238, DOI 10.1073/pnas.0709029105; Nguyen TL, 1997, RES VIROLOGY, V148, P273, DOI 10.1016/S0923-2516(97)88364-1; *PAN AM HLTH ORG, 2008, NUM REP CAS DENG DEN; Pelaez O, 2004, EMERG INFECT DIS, V10, P719, DOI 10.3201/eid1004.030271; Restrepo BN, 2008, AM J TROP MED HYG, V79, P673, DOI 10.4269/ajtmh.2008.79.673; RicoHesse R, 1997, VIROLOGY, V230, P244, DOI 10.1006/viro.1997.8504; Rigau-Perez Jose G., 1994, Morbidity and Mortality Weekly Report, V43, P7; ROSEN L, 1977, AM J TROP MED HYG, V26, P337, DOI 10.4269/ajtmh.1977.26.337; ROSEN L, 1974, AM J TROP MED HYG, V23, P1153, DOI 10.4269/ajtmh.1974.23.1153; Siqueira JB, 2005, EMERG INFECT DIS, V11, P48, DOI 10.3201/eid1101.031091; Soldin SJ., 1997, PEDIAT REFERENCE RAN; Stephens HAF, 2002, TISSUE ANTIGENS, V60, P309, DOI 10.1034/j.1399-0039.2002.600405.x; Tomashek KM, 2009, AM J TROP MED HYG, V81, P467, DOI 10.4269/ajtmh.2009.81.467; *US BUR CENS, 2003, US VIRG ISL 2000 SOC; WHO, 1997, DENG HAEM FEV DIAGN; [No title captured]	32	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2010	5	10							e13729	10.1371/journal.pone.0013729	http://dx.doi.org/10.1371/journal.pone.0013729			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	672HN	21060852	Green Published, Green Submitted, gold			2022-12-27	WOS:000283573800023
J	Al-Shami, A; Jhaver, KG; Vogel, P; Wilkins, C; Humphries, J; Davis, JJ; Xu, NH; Potter, DG; Gerhardt, B; Mullinax, R; Shirley, CR; Anderson, SJ; Oravecz, T				Al-Shami, Amin; Jhaver, Kanchan G.; Vogel, Peter; Wilkins, Carrie; Humphries, Juliane; Davis, John J.; Xu, Nianhua; Potter, David G.; Gerhardt, Brenda; Mullinax, Robert; Shirley, Cynthia R.; Anderson, Stephen J.; Oravecz, Tamas			Regulators of the Proteasome Pathway, Uch37 and Rpn13, Play Distinct Roles in Mouse Development	PLOS ONE			English	Article							GROWTH-HORMONE RECEPTOR; DEUBIQUITINATING ENZYME; GAMMA-INTERFERON; PROTEIN; CELLS; MICE; GENE; ACTIVATOR; SUBUNIT; COMPLEX	Rpn13 is a novel mammalian proteasomal receptor that has recently been identified as an amplification target in ovarian cancer. It can interact with ubiquitin and activate the deubiquitinating enzyme Uch37 at the 26S proteasome. Since neither Rpn13 nor Uch37 is an integral proteasomal subunit, we explored whether either protein is essential for mammalian development and survival. Deletion of Uch37 resulted in prenatal lethality in mice associated with severe defect in embryonic brain development. In contrast, the majority of Rpn13-deficient mice survived to adulthood, although they were smaller at birth and fewer in number than wild-type littermates. Absence of Rpn13 produced tissue-specific effects on proteasomal function: increased proteasome activity in adrenal gland and lymphoid organs, and decreased activity in testes and brain. Adult Rpn13(-/-) mice reached normal body weight but had increased body fat content and were infertile due to defective gametogenesis. Additionally, Rpn13(-/-) mice showed increased T-cell numbers, resembling growth hormone-mediated effects. Indeed, serum growth hormone and follicular stimulating hormone levels were significantly increased in Rpn13(-/-) mice, while growth hormone receptor expression was reduced in the testes. In conclusion, this is the first report characterizing the physiological roles of Uch37 and Rpn13 in murine development and implicating a non-ATPase proteasomal protein, Rpn13, in the process of gametogenesis.	[Al-Shami, Amin; Jhaver, Kanchan G.; Vogel, Peter; Wilkins, Carrie; Humphries, Juliane; Davis, John J.; Xu, Nianhua; Potter, David G.; Gerhardt, Brenda; Mullinax, Robert; Shirley, Cynthia R.; Anderson, Stephen J.; Oravecz, Tamas] Lexicon Pharmaceut Inc, The Woodlands, TX USA	Lexicon Pharmaceuticals	Al-Shami, A (corresponding author), Lexicon Pharmaceut Inc, The Woodlands, TX USA.	aalshami@lexpharma.com	Vogel, Peter/N-2490-2018	Vogel, Peter/0000-0002-7535-0545	Lexicon Pharmaceuticals, Inc.	Lexicon Pharmaceuticals, Inc.	The work described in this paper was funded by Lexicon Pharmaceuticals, Inc. The authors designed the study, conducted data collection and analysis, and prepared the manuscript. Lexicon Pharmaceuticals approved the decision to publish this manuscript.	AHN JY, 1995, FEBS LETT, V366, P37, DOI 10.1016/0014-5793(95)00492-R; Auerbach W, 2000, BIOTECHNIQUES, V29, P1024, DOI 10.2144/00295st04; Baumeister W, 1998, CELL, V92, P367, DOI 10.1016/S0092-8674(00)80929-0; Burns KH, 2002, ENDOCRINOLOGY, V143, P2823, DOI 10.1210/en.143.8.2823; Carvalho B, 2009, GUT, V58, P79, DOI 10.1136/gut.2007.143065; CASANOVA JL, 1991, J EXP MED, V174, P1371, DOI 10.1084/jem.174.6.1371; Coschigano KT, 2003, ENDOCRINOLOGY, V144, P3799, DOI 10.1210/en.2003-0374; Fejzo MS, 2008, GENE CHROMOSOME CANC, V47, P873, DOI 10.1002/gcc.20592; Hamazaki J, 2007, MOL CELL BIOL, V27, P6629, DOI 10.1128/MCB.00509-07; Hamazaki J, 2006, EMBO J, V25, P4524, DOI 10.1038/sj.emboj.7601338; Hasegawa K, 2001, DEV GROWTH DIFFER, V43, P25; Husnjak K, 2008, NATURE, V453, P481, DOI 10.1038/nature06926; Jorgensen JP, 2006, J MOL BIOL, V360, P1043, DOI 10.1016/j.jmb.2006.06.011; Keene DE, 2002, J ANDROL, V23, P661; Khor B, 2006, MOL CELL BIOL, V26, P2999, DOI 10.1128/MCB.26.8.2999-3007.2006; Kloetzel PM, 2004, NAT IMMUNOL, V5, P661, DOI 10.1038/ni1090; Koulich E, 2008, MOL BIOL CELL, V19, P1072, DOI 10.1091/mbc.E07-10-1040; Lamerant N, 2005, FEBS J, V272, P1833, DOI 10.1111/j.1742-4658.2005.04613.x; Le Roith D, 2001, ENDOCR REV, V22, P53, DOI 10.1210/er.22.1.53; Mazumdar T, 2010, P NATL ACAD SCI USA, V107, P13854, DOI 10.1073/pnas.0913495107; Montecino-Rodriguez E, 1998, ENDOCRINOLOGY, V139, P4120, DOI 10.1210/en.139.10.4120; Napolitano LA, 2002, AIDS, V16, P1103, DOI 10.1097/00002030-200205240-00003; Olsen NJ, 1998, ENDOCRINOLOGY, V139, P748, DOI 10.1210/en.139.2.748; Pilarsky C, 2004, NEOPLASIA, V6, P744, DOI 10.1593/neo.04277; Qiu XB, 2006, EMBO J, V25, P5742, DOI 10.1038/sj.emboj.7601450; Rechsteiner M, 2005, TRENDS CELL BIOL, V15, P27, DOI 10.1016/j.tcb.2004.11.003; Schreiner P, 2008, NATURE, V453, P548, DOI 10.1038/nature06924; Schrick JJ, 2006, AM J PATHOL, V168, P1288, DOI 10.2353/ajpath.2006.050941; SHIMADA S, 1994, CANCER RES, V54, P3831; Shimada Shinya, 1993, In Vivo (Attiki), V7, P1; Simins AB, 1999, CLIN EXP METASTAS, V17, P641, DOI 10.1023/A:1006790912877; Stone M, 2004, J MOL BIOL, V344, P697, DOI 10.1016/j.jmb.2004.09.057; Tansey WP, 2004, NEW ENGL J MED, V351, P393, DOI 10.1056/NEJMcibr041505; UTSUYAMA M, 1989, MECH AGEING DEV, V47, P175, DOI 10.1016/0047-6374(89)90030-4; van Kerkhof P, 2000, J BIOL CHEM, V275, P1575, DOI 10.1074/jbc.275.3.1575; Velasco-Velazquez MA, 2008, CANCER CELL INT, V8, DOI 10.1186/1475-2867-8-8; Verma R, 2000, MOL BIOL CELL, V11, P3425, DOI 10.1091/mbc.11.10.3425; Wang X, 1998, J IMMUNOL, V160, P788; Wang X, 1997, EUR J IMMUNOL, V27, P2781, DOI 10.1002/eji.1830271106; Wicks SJ, 2006, BIOCHEM SOC T, V34, P761, DOI 10.1042/BST0340761; Yao T, 2008, MOL CELL, V31, P909, DOI 10.1016/j.molcel.2008.08.027; Yao TT, 2006, NAT CELL BIOL, V8, P994, DOI 10.1038/ncb1460; Zambrowicz BP, 1998, INT J DEV BIOL, V42, P1025; Zambrowicz BP, 2003, P NATL ACAD SCI USA, V100, P14109, DOI 10.1073/pnas.2336103100; Zhou YH, 1997, P NATL ACAD SCI USA, V94, P13215, DOI 10.1073/pnas.94.24.13215	45	70	73	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2010	5	10							e13654	10.1371/journal.pone.0013654	http://dx.doi.org/10.1371/journal.pone.0013654			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671UN	21048919	Green Submitted, Green Published, gold			2022-12-27	WOS:000283537000025
J	Giraudeau, M; Czirjak, GA; Duval, C; Bretagnolle, V; Eraud, C; McGraw, KJ; Heeb, P				Giraudeau, Mathieu; Czirjak, Gabor A.; Duval, Camille; Bretagnolle, Vincent; Eraud, Cyril; McGraw, Kevin J.; Heeb, Philipp			Effect of Restricted Preen-Gland Access on Maternal Self Maintenance and Reproductive Investment in Mallards	PLOS ONE			English	Article							EGG-SIZE; CHICK SURVIVAL; CAROTENOIDS; ATTRACTIVENESS; SECRETIONS; INFECTION; PARASITES; LYSOZYME; BACTERIA; SUCCESS	Background: As egg production and offspring care are costly, females should invest resources adaptively into their eggs to optimize current offspring quality and their own lifetime reproductive success. Parasite infections can influence maternal investment decisions due to their multiple negative physiological effects. The act of preening - applying oils with antimicrobial properties to feathers - is thought to be a means by which birds combat pathogens and parasites, but little is known of how preening during the reproductive period (and its expected disease-protecting effects) influences maternal investment decisions at the level of the egg. Methodology/Principal Findings: Here, we experimentally prevented female mallards (Anas platyrhynchos) from accessing their preen gland during breeding and monitored female immunoresponsiveness (e.g., plasma lysozyme concentration) as well as some egg traits linked to offspring quality (e.g., egg mass, yolk carotenoid content, and albumen lysozyme levels). Females with no access to their preen gland showed an increase in plasma lysozyme level compared to control, normally preening females. In addition, preen-gland-restricted females laid significantly lighter eggs and deposited higher carotenoid concentrations in the yolk compared to control females. Albumen lysozyme activity did not differ significantly between eggs laid by females with or without preen gland access. Conclusion/Significance: Our results establish a new link between an important avian self-maintenance behaviour and aspects of maternal health and reproduction. We suggest that higher yolk carotenoid levels in eggs laid by preen-gland-restricted females may serve to boost health of offspring that would hatch in a comparatively microbe-rich environment.	[Giraudeau, Mathieu; McGraw, Kevin J.] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA; [Giraudeau, Mathieu; Czirjak, Gabor A.; Duval, Camille; Heeb, Philipp] Univ Toulouse 3, CNRS, Lab Evolut & Divers Biol, UMR 5174, F-31062 Toulouse, France; [Czirjak, Gabor A.] Univ Agr Sci & Vet Med, Fac Vet Med, Dept Infect Dis, Cluj Napoca, Romania; [Bretagnolle, Vincent] CNRS, Ctr Etud Biol Chize, UPR 1934, Beauvoir Sur Niort, France; [Eraud, Cyril] Ctr Natl Etude & Rech Appl Avifaune Migratrice, Direct Etud & Rech, Off Natl Chasse & Faune Sauvage, Villiers En Bois, France	Arizona State University; Arizona State University-Tempe; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Ecole Nationale Formation Agronomique (ENSFEA); University of Agricultural Sciences & Veterinary Medicine Cluj Napoca; Centre National de la Recherche Scientifique (CNRS)	Giraudeau, M (corresponding author), Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA.	giraudeau.mathieu@gmail.com	Czirják, Gábor Árpád/F-5440-2011	Czirják, Gábor Árpád/0000-0001-9488-0069	French government; Romanian Ministry of Education and Research; French Ministry of Foreign Affairs; French research grant [ANR-05, NT05-3_42075]; National Science Foundation [IOS-0746364]	French government; Romanian Ministry of Education and Research(Ministry of Education and Research - Romania); French Ministry of Foreign Affairs; French research grant; National Science Foundation(National Science Foundation (NSF))	MG was supported by a PhD scholarship of the French government. GAC was supported by a PhD scholarship of the Romanian Ministry of Education and Research and by an Eiffel grant from the French Ministry of Foreign Affairs. This project was supported by a French research grant (ANR-05, NT05-3_42075) to PH. During this study, KJM was supported by the National Science Foundation (grant # IOS-0746364). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexan A. F., 2009, Global Veterinaria, V3, P465; Berger S, 2003, J ORNITHOL, V144, P317, DOI 10.1007/BF02465631; Biard C, 2005, OECOLOGIA, V144, P32, DOI 10.1007/s00442-005-0048-x; Biard C, 2007, J EVOLUTION BIOL, V20, P326, DOI 10.1111/j.1420-9101.2006.01194.x; Blomqvist D, 1997, OECOLOGIA, V110, P18, DOI 10.1007/s004420050128; Blount Jonathan D., 2008, V4, P213, DOI 10.1007/978-3-7643-7499-0_11; BOLTON M, 1991, J ANIM ECOL, V60, P949, DOI 10.2307/5424; Bonisoli-Alquati A, 2010, BEHAV ECOL SOCIOBIOL, V64, P845, DOI 10.1007/s00265-010-0901-8; Bonneaud C, 2003, AM NAT, V161, P367, DOI 10.1086/346134; Burtt EH, 1999, AUK, V116, P364, DOI 10.2307/4089371; Callewaert L, 2010, J BIOSCIENCES, V35, P127, DOI 10.1007/s12038-010-0015-5; CLAYTON DH, 1997, HOST PARASITE EVOLUT; COOK ME, 1993, POULTRY SCI, V72, P1301, DOI 10.3382/ps.0721301; Cook MI, 2003, P ROY SOC B-BIOL SCI, V270, P2233, DOI 10.1098/rspb.2003.2508; CROXALL JP, 1992, IBIS, V134, P219, DOI 10.1111/j.1474-919X.1992.tb03803.x; Cunningham EJA, 2000, NATURE, V404, P74, DOI 10.1038/35003565; CURRIE GA, 1976, BRIT J CANCER, V33, P51, DOI 10.1038/bjc.1976.6; Dufva R, 1996, J AVIAN BIOL, V27, P83, DOI 10.2307/3676964; Eraud C, 2007, J EXP BIOL, V210, P3571, DOI 10.1242/jeb.005496; FEINGOLD KR, 1992, DIABETES, V41, P97, DOI 10.2337/diab.41.2.S97; GALBRAITH H, 1988, J ZOOL, V214, P383, DOI 10.1111/j.1469-7998.1988.tb03747.x; Giraudeau M, 2010, NATURWISSENSCHAFTEN, V97, P577, DOI 10.1007/s00114-010-0673-z; Gunderson AR, 2008, AUK, V125, P972, DOI 10.1525/auk.2008.91008; Haribal M, 2009, BIOCHEM SYST ECOL, V37, P80, DOI 10.1016/j.bse.2008.12.005; Jacob J., 1982, AVIAN BIOL, DOI [10.1016/B978-0-12-249406-2.50013-7, DOI 10.1016/B978-0-12-249406-2.50013-7]; KOLATTUKUDY PE, 1978, ARCH BIOCHEM BIOPHYS, V191, P244, DOI 10.1016/0003-9861(78)90087-5; Kulkarni S, 2007, BEHAV PROCESS, V74, P88, DOI 10.1016/j.beproc.2006.10.005; MAGRATH RD, 1992, J ZOOL, V227, P639, DOI 10.1111/j.1469-7998.1992.tb04420.x; Martin-Vivaldi M, 2010, P ROY SOC B-BIOL SCI, V277, P123, DOI 10.1098/rspb.2009.1377; McGraw KJ, 2005, NATURWISSENSCHAFTEN, V92, P375, DOI 10.1007/s00114-005-0003-z; McGraw KJ, 2003, AM NAT, V162, P704, DOI 10.1086/378904; Mennerat A, 2009, OECOLOGIA, V161, P849, DOI 10.1007/s00442-009-1418-6; Mougeot F, 2010, J EVOLUTION BIOL, V23, P643, DOI 10.1111/j.1420-9101.2009.01926.x; Mousseau T.A., 1998, MATERNAL EFFECTS ADA; Moyer BR, 2003, AUK, V120, P490, DOI 10.1642/0004-8038(2003)120[0490:ETOTIO]2.0.CO;2; OSSERMAN EF, 1966, J EXP MED, V124, P921, DOI 10.1084/jem.124.5.921; Parmentier HK, 1998, POULTRY SCI, V77, P248, DOI 10.1093/ps/77.2.248; POTTI J, 1993, CAN J ZOOL, V71, P1534, DOI 10.1139/z93-217; Reneerkens J, 2008, AUK, V125, P285, DOI 10.1525/auk.2008.06217; RHYMER JM, 1988, OECOLOGIA, V75, P20, DOI 10.1007/BF00378809; Romano M, 2008, J EVOLUTION BIOL, V21, P1626, DOI 10.1111/j.1420-9101.2008.01599.x; Saino N, 2002, P ROY SOC B-BIOL SCI, V269, P1005, DOI 10.1098/rspb.2002.1992; Saino N, 2002, J EVOLUTION BIOL, V15, P735, DOI 10.1046/j.1420-9101.2002.00448.x; Saino N, 2002, P ROY SOC B-BIOL SCI, V269, P1729, DOI 10.1098/rspb.2002.2088; Shawkey MD, 2005, MICROB ECOL, V50, P40, DOI 10.1007/s00248-004-0089-4; Shawkey MD, 2003, J AVIAN BIOL, V34, P345, DOI 10.1111/j.0908-8857.2003.03193.x; Stearns S.C., 1992, pi; Surai P.F., 2002, NATURAL ANTIOXIDANTS; Tschirren B, 2004, P ROY SOC B-BIOL SCI, V271, P1371, DOI 10.1098/rspb.2004.2730; vanHeugten E, 1996, J ANIM SCI, V74, P2431; Wellman-Labadie O, 2007, WORLD POULTRY SCI J, V63, P421, DOI 10.1017/S0043933907001559; WIGGINS DA, 1990, ORNIS SCAND, V21, P157, DOI 10.2307/3676812; WILLIAMS TD, 1994, BIOL REV, V69, P35, DOI 10.1111/j.1469-185X.1994.tb01485.x	54	25	25	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2010	5	10							e13555	10.1371/journal.pone.0013555	http://dx.doi.org/10.1371/journal.pone.0013555			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671UN	21048952	Green Published, gold			2022-12-27	WOS:000283537000009
J	Hoang, MV; Nagy, JA; Fox, JEB; Senger, DR				Hoang, Mien V.; Nagy, Janice A.; Fox, Joan E. B.; Senger, Donald R.			Moderation of Calpain Activity Promotes Neovascular Integration and Lumen Formation during VEGF-Induced Pathological Angiogenesis	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; CELL-MIGRATION; INHIBITOR-I; RETINAL NEOVASCULARIZATION; TUBE FORMATION; KAPPA-B; RHO; ORGANIZATION; ACTIVATION; MECHANISM	Background: Successful neovascularization requires that sprouting endothelial cells (ECs) integrate to form new vascular networks. However, architecturally defective, poorly integrated vessels with blind ends are typical of pathological angiogenesis induced by vascular endothelial growth factor-A (VEGF), thereby limiting the utility of VEGF for therapeutic angiogenesis and aggravating ischemia-related pathologies. Here we investigated the possibility that over-exuberant calpain activity is responsible for aberrant VEGF neovessel architecture and integration. Calpains are a family of intracellular calcium-dependent, non-lysosomal cysteine proteases that regulate cellular functions through proteolysis of numerous substrates. Methodology/Principal Findings: In a mouse skin model of VEGF-driven angiogenesis, retroviral transduction with dominant-negative (DN) calpain-I promoted neovessel integration and lumen formation, reduced blind ends, and improved vascular perfusion. Moderate doses of calpain inhibitor-I improved VEGF-driven angiogenesis similarly to DN calpain-I. Conversely, retroviral transduction with wild-type (WT) calpain-I abolished neovessel integration and lumen formation. In vitro, moderate suppression of calpain activity with DN calpain-I or calpain inhibitor-I increased the microtubule-stabilizing protein tau in endothelial cells (ECs), increased the average length of microtubules, increased actin cable length, and increased the interconnectivity of vascular cords. Conversely, WT calpain-I diminished tau, collapsed microtubules, disrupted actin cables, and inhibited integration of cord networks. Consistent with the critical importance of microtubules for vascular network integration, the microtubule-stabilizing agent taxol supported vascular cord integration whereas microtubule dissolution with nocodazole collapsed cord networks. Conclusions/Significance: These findings implicate VEGF-induction of calpain activity and impairment of cytoskeletal dynamics in the failure of VEGF-induced neovessels to form and integrate properly. Accordingly, calpain represents an important target for rectifying key vascular defects associated with pathological angiogenesis and for improving therapeutic angiogenesis with VEGF.	[Hoang, Mien V.; Nagy, Janice A.; Senger, Donald R.] Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02215 USA; [Hoang, Mien V.; Nagy, Janice A.; Senger, Donald R.] Beth Israel Deaconess Med Ctr, Vasc Biol Res Ctr, Boston, MA 02215 USA; [Hoang, Mien V.; Nagy, Janice A.; Senger, Donald R.] Harvard Univ, Sch Med, Boston, MA USA; [Fox, Joan E. B.] Cleveland Clin, Lerner Res Inst, Dept Mol Cardiol, Cleveland, OH 44106 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Cleveland Clinic Foundation	Hoang, MV (corresponding author), Beth Israel Deaconess Med Ctr, Dept Pathol, 330 Brookline Ave, Boston, MA 02215 USA.	dsenger@bidmc.harvard.edu	Hoang, Mien V/H-8270-2012	Hoang, Mien V/0000-0003-0859-2170	National Cancer Institute [CA129339]; NATIONAL CANCER INSTITUTE [R01CA129339] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by NIH grant CA129339 from the National Cancer Institute (to D.R.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bayless KJ, 2004, J BIOL CHEM, V279, P11686, DOI 10.1074/jbc.M308373200; Bhatt A, 2002, J CELL SCI, V115, P3415; Bodnar RJ, 2006, CIRC RES, V98, P617, DOI 10.1161/01.RES.0000209968.66606.10; Boodhwani M, 2009, ANTIOXID REDOX SIGN, V11, P1945, DOI 10.1089/ARS.2009.2439; BROCK TA, 1991, AM J PATHOL, V138, P213; Chae JK, 2000, ARTERIOSCL THROM VAS, V20, P2573, DOI 10.1161/01.ATV.20.12.2573; Cuzzocrea S, 2000, AM J PATHOL, V157, P2065, DOI 10.1016/S0002-9440(10)64845-6; Davis GE, 1996, EXP CELL RES, V224, P39, DOI 10.1006/excr.1996.0109; DAVIS GE, 1995, EXP CELL RES, V216, P113, DOI 10.1006/excr.1995.1015; De Smet F, 2009, ARTERIOSCL THROM VAS, V29, P639, DOI 10.1161/ATVBAHA.109.185165; Dourdin N, 2001, J BIOL CHEM, V276, P48382, DOI 10.1074/jbc.M108893200; Drake CJ, 1999, J HISTOCHEM CYTOCHEM, V47, P1351, DOI 10.1177/002215549904701101; Drake CJ, 2000, BLOOD, V95, P1671, DOI 10.1182/blood.V95.5.1671.005k39_1671_1679; ESMAELIAZAD B, 1994, J CELL SCI, V107, P869; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Franco SJ, 2005, J CELL SCI, V118, P3829, DOI 10.1242/jcs.02562; Fujitani K, 1997, J CELL BIOCHEM, V66, P197, DOI 10.1002/(SICI)1097-4644(19970801)66:2<197::AID-JCB7>3.0.CO;2-L; Glading A, 2004, MOL CELL BIOL, V24, P2499, DOI 10.1128/MCB.24.6.2499-2512.2004; Glading A, 2002, TRENDS CELL BIOL, V12, P46, DOI 10.1016/S0962-8924(01)02179-1; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Gonscherowski V, 2006, AM J PHYSIOL-HEART C, V290, pH2035, DOI 10.1152/ajpheart.00772.2004; Grant DS, 2003, INT J CANCER, V104, P121, DOI 10.1002/ijc.10907; Hoang MV, 2004, P NATL ACAD SCI USA, V101, P1874, DOI 10.1073/pnas.0308525100; Hoang V., 2004, V294, P269; HORWITZ SB, 1992, TRENDS PHARMACOL SCI, V13, P134; Hotchkiss KA, 2002, MOL CANCER THER, V1, P1191; Huttenlocher A, 1997, J BIOL CHEM, V272, P32719, DOI 10.1074/jbc.272.52.32719; Jain RK, 2003, NAT MED, V9, P685, DOI 10.1038/nm0603-685; Kaibuchi K, 1999, ANNU REV BIOCHEM, V68, P459, DOI 10.1146/annurev.biochem.68.1.459; Kroll J, 1997, J BIOL CHEM, V272, P32521, DOI 10.1074/jbc.272.51.32521; Kulkarni S, 1999, J BIOL CHEM, V274, P21265, DOI 10.1074/jbc.274.30.21265; Kulkarni S, 2002, J BIOL CHEM, V277, P24435, DOI 10.1074/jbc.M203457200; Le Doux JM, 2001, HUM GENE THER, V12, P1611, DOI 10.1089/10430340152528110; Lovestone S, 1996, NEUROSCIENCE, V73, P1145, DOI 10.1016/0306-4522(96)00126-1; MAKI M, 1989, J BIOL CHEM, V264, P18866; McDonald MC, 2001, FASEB J, V15, P171, DOI 10.1096/fj.99-0645com; Nagy JA, 2006, EXP CELL RES, V312, P538, DOI 10.1016/j.yexcr.2005.10.017; NAGY JA, 1995, CANCER RES, V55, P376; Ozawa CR, 2004, J CLIN INVEST, V113, P516, DOI 10.1172/JCI200418420; Pocock TM, 2004, AM J PHYSIOL-HEART C, V286, pH1015, DOI 10.1152/ajpheart.00826.2003; Potter DA, 1998, J CELL BIOL, V141, P647, DOI 10.1083/jcb.141.3.647; RAMI A, 1993, BRAIN RES, V609, P67, DOI 10.1016/0006-8993(93)90856-I; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; Richard L, 1998, EXP CELL RES, V240, P1, DOI 10.1006/excr.1998.3936; Robinson GS, 1996, P NATL ACAD SCI USA, V93, P4851, DOI 10.1073/pnas.93.10.4851; Robles E, 2003, NEURON, V38, P597, DOI 10.1016/S0896-6273(03)00260-5; Rosser BG, 2000, METH MOL B, V144, P245; Ruetten H, 1997, BRIT J PHARMACOL, V121, P695, DOI 10.1038/sj.bjp.0701180; SENGER DR, 1990, CANCER RES, V50, P1774; Senger DR, 2002, AM J PATHOL, V160, P195, DOI 10.1016/S0002-9440(10)64363-5; Senger DR, 1997, P NATL ACAD SCI USA, V94, P13612, DOI 10.1073/pnas.94.25.13612; Shannon KB, 2005, MOL BIOL CELL, V16, P4423, DOI 10.1091/mbc.E04-11-0974; SIOUSSAT TM, 1993, ARCH BIOCHEM BIOPHYS, V301, P15, DOI 10.1006/abbi.1993.1109; Smith LEH, 1999, NAT MED, V5, P1390, DOI 10.1038/70963; Su YC, 2006, FASEB J, V20, P1443, DOI 10.1096/fj.05-5354com; TAKEMURA R, 1992, J CELL SCI, V103, P953; Tapon N, 1997, CURR OPIN CELL BIOL, V9, P86, DOI 10.1016/S0955-0674(97)80156-1; Tompa P, 2004, J BIOL CHEM, V279, P20775, DOI 10.1074/jbc.M313873200; VERNON RB, 1995, AM J PATHOL, V147, P873; Voisine P, 2004, SURGERY, V136, P407, DOI 10.1016/j.surg.2004.05.017; Wang ZY, 2003, CHINESE CHEM LETT, V14, P13; Whelan MC, 2003, J BIOL CHEM, V278, P327, DOI 10.1074/jbc.M207554200; Wilson MT, 2000, J NEUROBIOL, V43, P159, DOI 10.1002/(SICI)1097-4695(200005)43:2<159::AID-NEU6>3.0.CO;2-N; Xiao H, 2006, P NATL ACAD SCI USA, V103, P10166, DOI 10.1073/pnas.0603704103; Xie HQ, 1998, BRAIN RES, V798, P173, DOI 10.1016/S0006-8993(98)00407-7; Zeng HY, 2006, J EXP MED, V203, P719, DOI 10.1084/jem.20051523	66	27	27	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2010	5	10							e13612	10.1371/journal.pone.0013612	http://dx.doi.org/10.1371/journal.pone.0013612			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	670LB	21049044	Green Published, Green Submitted, gold			2022-12-27	WOS:000283422100017
J	Wager, E; Mhaskar, R; Warburton, S; Djulbegovic, B				Wager, Elizabeth; Mhaskar, Rahul; Warburton, Stephanie; Djulbegovic, Benjamin			JAMA Published Fewer Industry-Funded Studies after Introducing a Requirement for Independent Statistical Analysis	PLOS ONE			English	Article								Background: JAMA introduced a requirement for independent statistical analysis for industry-funded trials in July 2005. We wanted to see whether this policy affected the number of industry-funded trials published by JAMA. Methods and Findings: We undertook a retrospective, before-and-after study of published papers. Two investigators independently extracted data from all issues of JAMA published between 1 July 2002 and 30 June 2008 (i.e., three years before and after the policy). They were not blinded to publication date. The randomized controlled trials (RCTs) were classified as industry funded (IF), joint industry/non-commercial funding (J), industry supported (IS) (when manufacturers provided materials only), non-commercial (N) or funding not stated (NS). Findings were compared and discrepancies resolved by discussion or further analysis of the reports. RCTs published in The Lancet and NEJM over the same period were used as a control group. Between July 2002 and July 2008, JAMA published 1,314 papers, of which 311 were RCTs. The number of industry studies (IF, J or IS) fell significantly after the policy (p = 0.02) especially for categories J and IS. However, over the same period, the number of industry studies rose in both The Lancet and NEJM. Conclusions: After the requirement for independent statistical analysis for industry-funded studies, JAMA published significantly fewer RCTs and significantly fewer industry-funded RCTs. This pattern was not seen in the control journals. This suggests the JAMA policy affected the number of submissions, the acceptance rate, or both. Without analysing the submissions, we cannot check these hypotheses but, assuming the number of published papers is related to the number submitted, our findings suggest that JAMA's policy may have resulted in a significant reduction in the number of industry-sponsored trials it received and published.	[Wager, Elizabeth] Sideview, Princes Risborough, Bucks, England; [Mhaskar, Rahul; Warburton, Stephanie; Djulbegovic, Benjamin] Univ S Florida, Ctr Evidence Based Med & Hlth Outcomes Res, Tampa, FL USA; [Djulbegovic, Benjamin] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA	State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute	Wager, E (corresponding author), Sideview, Princes Risborough, Bucks, England.	liz@sideview.demon.co.uk	Djulbegovic, Benjamin/I-3661-2012; Mhaskar, Rahul/I-4944-2012; Florida, University of South/GRT-0107-2022	Djulbegovic, Benjamin/0000-0003-0671-1447; Florida, University of South/0000-0002-3728-6052; Wager, Elizabeth/0000-0002-4202-7813	NIH	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	EW is a freelance trainer and publications consultant who advises pharmaceutical companies on publication strategy; she also trains and advises journal editors and publishers. BD is Professor of Medicine and Oncology whose research has been funded both by public funding (NIH) and industry. SW and RM declare no competing interests. This does not alter the authors' adherence to all the PLoS One policies on sharing data.	Fontanarosa PB, 2005, JAMA-J AM MED ASSOC, V294, P110, DOI 10.1001/jama.294.1.110; Fontanarosa PB, 2009, JAMA-J AM MED ASSOC, V301, P870, DOI 10.1001/jama.2009.206; Lexchin J, 2003, BMJ-BRIT MED J, V326, P1167, DOI 10.1136/bmj.326.7400.1167; Rothman KJ, 2005, BRIT MED J, V331, P1350, DOI 10.1136/bmj.331.7529.1350	4	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2010	5	10							e13591	10.1371/journal.pone.0013591	http://dx.doi.org/10.1371/journal.pone.0013591			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	670KA	21042585	Green Published, gold, Green Submitted			2022-12-27	WOS:000283419100020
J	Kang, Y; Zarzycki-Siek, J; Walton, CB; Norris, MH; Hoang, TT				Kang, Yun; Zarzycki-Siek, Jan; Walton, Chad B.; Norris, Michael H.; Hoang, Tung T.			Multiple FadD Acyl-CoA Synthetases Contribute to Differential Fatty Acid Degradation and Virulence in Pseudomonas aeruginosa	PLOS ONE			English	Article							COENZYME-A SYNTHETASE; TRANSCRIPTION FACTOR FADR; III SECRETION SYSTEM; ESCHERICHIA-COLI; BETA-OXIDATION; CYSTIC-FIBROSIS; MYCOBACTERIUM-TUBERCULOSIS; NOSOCOMIAL PNEUMONIA; NUTRIENT ACQUISITION; MULTIENZYME COMPLEX	A close interconnection between nutrient metabolism and virulence factor expression contributes to the pathophysiology of Pseudomonas aeruginosa as a successful pathogen. P. aeruginosa fatty acid (FA) degradation is complicated with multiple acyl-CoA synthetase homologs (FadDs) expressed in vivo in lung tissue during cystic fibrosis infections. The promoters of two genetically linked P. aeruginosa fadD genes (fadD1 and fadD2) were mapped and northern blot analysis indicated they could exist on two different transcripts. These FadDs contain ATP/AMP signature and FA-binding motifs highly homologous to those of the Escherichia coli FadD. Upon introduction into an E. coli fadD(-)/fadR(-) double mutant, both P. aeruginosa fadDs functionally complemented the E. coli fadD(-)/fadR(-) mutant, allowing degradation of different chain-length FAs. Chromosomal mutagenesis, growth analysis, induction studies, and determination of kinetic parameters suggested that FadD1 has a substrate preference for long-chain FAs while FadD2 prefers shorter-chain FAs. When compared to the wild type strain, the fadD2 mutant exhibited decreased production of lipase, protease, rhamnolipid and phospholipase, and retardation of both swimming and swarming motilities. Interestingly, fadD1 mutant showed only increased swarming motility. Growth analysis of the fadD mutants showed noticeable deficiencies in utilizing FAs and phosphatidylcholine (major components of lung surfactant) as the sole carbon source. This defect translated into decreased in vivo fitness of P. aeruginosa in a BALB/c mouse lung infection model, supporting the role of lipids as a significant nutrient source for this bacterium in vivo.	[Kang, Yun; Norris, Michael H.; Hoang, Tung T.] Univ Hawaii Manoa, Dept Mol Biosci & Bioengn, Honolulu, HI 96822 USA; [Zarzycki-Siek, Jan; Hoang, Tung T.] Univ Hawaii Manoa, Dept Microbiol, Honolulu, HI 96822 USA; [Walton, Chad B.] Univ Hawaii Manoa, Dept Med, Honolulu, HI 96822 USA	University of Hawaii System; University of Hawaii Manoa; University of Hawaii System; University of Hawaii Manoa; University of Hawaii System; University of Hawaii Manoa	Kang, Y (corresponding author), Univ Hawaii Manoa, Dept Mol Biosci & Bioengn, Honolulu, HI 96822 USA.	tongh@hawaii.edu	Heacock-Kang, Yun/O-9767-2016	Heacock-Kang, Yun/0000-0002-7304-9687; Norris, Michael/0000-0002-5285-0432	National Institutes of Health (NIH) [R21-AI073816, G12RR003061]; National Center for Research Resources (NCRR) [P20RR01872]; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003061] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI073816] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This project was supported by a National Institutes of Health (NIH) grant R21-AI073816 and in parts by NIH grant numbers G12RR003061 and P20RR01872 from the National Center for Research Resources (NCRR), a component of the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd H, 2008, J EUKARYOT MICROBIOL, V55, P235, DOI 10.1111/j.1550-7408.2008.00311.x; Bajaj V, 1996, MOL MICROBIOL, V22, P703, DOI 10.1046/j.1365-2958.1996.d01-1718.x; BALTCH AL, 1977, AM J MED SCI, V274, P119, DOI 10.1097/00000441-197709000-00002; Barber CE, 1997, MOL MICROBIOL, V24, P555, DOI 10.1046/j.1365-2958.1997.3721736.x; BARTANA J, 1971, BIOCHEM J, V122, P353, DOI 10.1042/bj1220353; Bernhard W, 2001, AM J RESP CELL MOL, V25, P725, DOI 10.1165/ajrcmb.25.6.4616; BLACK PN, 1991, J BACTERIOL, V173, P435, DOI 10.1128/jb.173.2.435-442.1991; BLACK PN, 1994, BBA-LIPID LIPID MET, V1210, P123, DOI 10.1016/0005-2760(94)90113-9; BLACK PN, 1992, J BIOL CHEM, V267, P25513; Black PN, 1997, J BIOL CHEM, V272, P4896, DOI 10.1074/jbc.272.8.4896; BLACK PN, 1988, J BACTERIOL, V170, P2850, DOI 10.1128/jb.170.6.2850-2854.1988; Bowton DL, 1999, CHEST, V115, p28S, DOI 10.1378/chest.115.suppl_1.28S; Brickman TJ, 2006, INFECT IMMUN, V74, P1741, DOI 10.1128/IAI.74.3.1741-1744.2006; Caiazza NC, 2005, J BACTERIOL, V187, P7351, DOI 10.1128/JB.187.21.7351-7361.2005; Campbell JW, 2003, MOL MICROBIOL, V47, P793, DOI 10.1046/j.1365-2958.2003.03341.x; Campbell JW, 2002, J BACTERIOL, V184, P3759, DOI 10.1128/JB.184.13.3759-3764.2002; Clark D. P., 1996, ESCHERICHIA COLI SAL, P343; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Cox JS, 1999, NATURE, V402, P79, DOI 10.1038/47042; DIRUSSO CC, 1992, J BIOL CHEM, V267, P8685; Doring G, 1997, Monaldi Arch Chest Dis, V52, P363; DOWD JE, 1965, J BIOL CHEM, V240, P863; FERNANDEZVALVERDE M, 1993, APPL ENVIRON MICROB, V59, P1149; Garcia B, 1999, J BIOL CHEM, V274, P29228, DOI 10.1074/jbc.274.41.29228; Greenberger PA, 1997, JAMA-J AM MED ASSOC, V278, P1924, DOI 10.1001/jama.278.22.1924; Groot P H, 1976, Adv Lipid Res, V14, P75; Hoang TT, 2002, MICROBIOL-SGM, V148, P3849, DOI 10.1099/00221287-148-12-3849; Hoang TT, 1997, J BACTERIOL, V179, P5326, DOI 10.1128/jb.179.17.5326-5332.1997; Hoang TT, 2000, PLASMID, V43, P59, DOI 10.1006/plas.1999.1441; Hoang TT, 1998, GENE, V212, P77, DOI 10.1016/S0378-1119(98)00130-9; Hoffmann N, 2005, INFECT IMMUN, V73, P2504, DOI 10.1128/IAI.73.4.2504-2514.2005; HOLLOWAY BW, 1994, MICROBIOL-UK, V140, P2907, DOI 10.1099/13500872-140-11-2907; ICHIHARA K, 1991, J LIPID RES, V32, P1709; IMAMURA S, 1990, J BIOCHEM, V107, P184, DOI 10.1093/oxfordjournals.jbchem.a123023; Iram SH, 2006, J BACTERIOL, V188, P599, DOI 10.1128/JB.188.2.599-608.2006; Kang Y, 2008, MICROBIOL-SGM, V154, P1584, DOI 10.1099/mic.0.2008/018135-0; Kang Y, 2009, MOL MICROBIOL, V73, P120, DOI 10.1111/j.1365-2958.2009.06757.x; Kazakov AE, 2009, J BACTERIOL, V191, P52, DOI 10.1128/JB.01175-08; KOUKER G, 1987, APPL ENVIRON MICROB, V53, P211, DOI 10.1128/AEM.53.1.211-213.1987; KRIEG DP, 1988, INFECT IMMUN, V56, P864, DOI 10.1128/IAI.56.4.864-873.1988; KUMAR GB, 1993, J BIOL CHEM, V268, P15469; Lode H, 2000, CURR OPIN INFECT DIS, V13, P377, DOI 10.1097/00001432-200008000-00009; Lucas RL, 2000, J BACTERIOL, V182, P1872, DOI 10.1128/JB.182.7.1872-1882.2000; Matz C, 2008, ISME J, V2, P843, DOI 10.1038/ismej.2008.47; Miller JH., 1992, SHORT COURSE BACTERI, P72; Miller RM, 2008, J BACTERIOL, V190, P4038, DOI 10.1128/JB.00129-08; Mulcahy H, 2010, ENVIRON MICROBIOL, V12, P1621, DOI 10.1111/j.1462-2920.2010.02208.x; Olivera ER, 2001, MOL MICROBIOL, V39, P863, DOI 10.1046/j.1365-2958.2001.02296.x; OVERATH P, 1969, EUR J BIOCHEM, V7, P559; Overhage J, 2007, J BACTERIOL, V189, P2164, DOI 10.1128/JB.01623-06; Pinzon NM, 2009, APPL MICROBIOL BIOT, V82, P975, DOI 10.1007/s00253-009-1896-9; Postle AD, 1999, AM J RESP CELL MOL, V20, P90, DOI 10.1165/ajrcmb.20.1.3253; RAHME LG, 1995, SCIENCE, V268, P1899, DOI 10.1126/science.7604262; Raman N, 1997, J BIOL CHEM, V272, P30645, DOI 10.1074/jbc.272.49.30645; Richards MJ, 1999, CRIT CARE MED, V27, P887, DOI 10.1097/00003246-199905000-00020; Rindi L, 2002, MICROBIOL-SGM, V148, P3873, DOI 10.1099/00221287-148-12-3873; SATO S, 1992, J BIOCHEM-TOKYO, V111, P8, DOI 10.1093/oxfordjournals.jbchem.a123722; SATO S, 1992, J BIOCHEM, V111, P16, DOI 10.1093/oxfordjournals.jbchem.a123711; Son MS, 2008, PLASMID, V59, P111, DOI 10.1016/j.plasmid.2007.12.002; Son MS, 2007, INFECT IMMUN, V75, P5313, DOI 10.1128/IAI.01807-06; Soto MJ, 2002, MOL MICROBIOL, V43, P371, DOI 10.1046/j.1365-2958.2002.02749.x; STANIER RY, 1966, J GEN MICROBIOL, V43, P159, DOI 10.1099/00221287-43-2-159; van Aalten DMF, 2001, EMBO J, V20, P2041, DOI 10.1093/emboj/20.8.2041; van den Berg B, 2004, SCIENCE, V304, P1506, DOI 10.1126/science.1097524; Wargo MJ, 2008, J BACTERIOL, V190, P2690, DOI 10.1128/JB.01393-07; Wehrmann A, 1996, NAT BIOTECHNOL, V14, P1274, DOI 10.1038/nbt1096-1274; Weimar JD, 2002, J BIOL CHEM, V277, P29369, DOI 10.1074/jbc.M107022200; Weir TL, 2008, APPL ENVIRON MICROB, V74, P5784, DOI 10.1128/AEM.00860-08; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9	69	56	61	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2010	5	10							e13557	10.1371/journal.pone.0013557	http://dx.doi.org/10.1371/journal.pone.0013557			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	668TQ	21042406	Green Published, Green Submitted, gold			2022-12-27	WOS:000283293800021
J	Malik, AK; Khaldoyanidi, S; Auci, DL; Miller, SC; Ahlem, CN; Reading, CL; Page, T; Frincke, JM				Malik, Ajay K.; Khaldoyanidi, Sophia; Auci, Dominick L.; Miller, Scott C.; Ahlem, Clarence N.; Reading, Christopher L.; Page, Theodore; Frincke, James M.			5-Androstene-3 beta,7 beta,17 beta-triol (beta-AET) Slows Thermal Injury Induced Osteopenia in Mice: Relation to Aging and Osteoporosis	PLOS ONE			English	Article							BONE-MINERAL DENSITY; MESENCHYMAL STEM-CELLS; DEHYDROEPIANDROSTERONE DHEA; PROGENITOR CELLS; RECEPTOR-ALPHA; STROMAL CELLS; SELF-RENEWAL; IN-VITRO; GLUCOCORTICOIDS; METABOLISM	5-androstene-3 beta, 7 beta, 17 beta-triol (beta-AET), an active metabolite of dehydroepiandrosterone ( DHEA), reversed glucocorticoid ( GC)induced suppression of IL-6, IL-8 and osteoprotegerin production by human osteoblast-like MG-63 cells and promoted osteoblast differentiation of human mesenchymal stem cells (MSCs). In a murine thermal injury model that includes glucocorticoid-induced osteopenia, beta-AET significantly (p<0.05) preserved bone mineral content, restored whole body bone mineral content and endochondral growth, suggesting reversal of GC-mediated decreases in chondrocyte proliferation, maturation and osteogenesis in the growth plate. In men and women, levels of beta-AET decline with age, consistent with a role for beta-AET relevant to diseases associated with aging. beta-AET, related compounds or synthetic derivatives may be part of effective therapeutic strategies to accelerate tissue regeneration and prevent or treat diseases associated with aging such as osteoporosis.	[Malik, Ajay K.; Auci, Dominick L.; Ahlem, Clarence N.; Reading, Christopher L.; Page, Theodore; Frincke, James M.] Harbor Biosci Inc, San Diego, CA USA; [Khaldoyanidi, Sophia] Torrey Pines Inst Mol Studies, San Diego, CA USA; [Miller, Scott C.] Univ Utah, Div Radiobiol, Salt Lake City, UT 84112 USA	Torrey Pines Institute for Molecular Studies, California; Utah System of Higher Education; University of Utah	Malik, AK (corresponding author), Harbor Biosci Inc, San Diego, CA USA.	Dauci@harborbiosciences.com		MALIK, AJAY/0000-0002-4831-3597; Miller, Scott/0000-0002-2127-1243	Harbor Biosciences	Harbor Biosciences	This study was funded by Harbor Biosciences. The funders participated in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Abu EO, 2000, J CLIN ENDOCR METAB, V85, P883, DOI 10.1210/jc.85.2.883; Akune T, 2004, J CLIN INVEST, V113, P846, DOI 10.1172/JCI200419900; ARANEO BA, 1993, J INFECT DIS, V167, P830, DOI 10.1093/infdis/167.4.830; AUCI DL, 2003, MOD ASP IMMUNOBIOL, V3, P64; Auci DL, 2009, AUTOIMMUN REV, V8, P369, DOI 10.1016/j.autrev.2008.11.011; Balazs Z, 2008, J AM SOC NEPHROL, V19, P92, DOI 10.1681/ASN.2007030263; Benten WPM, 2001, ENDOCRINOLOGY, V142, P1669, DOI 10.1210/en.142.4.1669; Bovenberg SA, 2005, NETH J MED, V63, P300; BOWMAN BM, 2001, COMP INJURY STRESS R; Boyce BF, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2165; Bruder SP, 1997, J CELL BIOCHEM, V64, P278, DOI 10.1002/(SICI)1097-4644(199702)64:2<278::AID-JCB11>3.0.CO;2-F; Buxton EC, 2004, J CLIN ENDOCR METAB, V89, P3332, DOI 10.1210/jc.2003-032066; Canning MO, 2000, EUR J ENDOCRINOL, V143, P687, DOI 10.1530/eje.0.1430687; CERMAK K, 2009, CLIN ORTHOP RELAT RE; CLEARY MP, 1991, P SOC EXP BIOL MED, V196, P8; Clerici M, 1997, PSYCHONEUROENDOCRINO, V22, pS27, DOI 10.1016/S0306-4530(97)00019-X; Cock TA, 2004, EMBO REP, V5, P1007, DOI 10.1038/sj.embor.7400254; Corral DA, 1998, P NATL ACAD SCI USA, V95, P13835, DOI 10.1073/pnas.95.23.13835; CROISILLE L, 1994, BLOOD, V84, P4116, DOI 10.1182/blood.V84.12.4116.bloodjournal84124116; Cui H, 2003, MOL CELL ENDOCRINOL, V203, P13, DOI 10.1016/S0303-7207(03)00121-7; Davidson M, 2000, CLIN INVEST MED, V23, P300; DAVIDSON MH, 1998, FASEB J         0418, pA764; Daynes RA, 2002, NAT REV IMMUNOL, V2, P748, DOI 10.1038/nri912; Dovio A, 2004, CLIN EXP RHEUMATOL, V22, P79; Dovio A, 2006, EUR J ENDOCRINOL, V154, P745, DOI 10.1530/eje.1.02147; Edelman Linda S., 1997, Journal of Burn Care and Rehabilitation, V18, P483, DOI 10.1097/00004630-199711000-00003; Eijken M, 2005, MOL ENDOCRINOL, V19, P621, DOI 10.1210/me.2004-0212; ERLEBACHER A, 1995, CELL, V80, P371, DOI 10.1016/0092-8674(95)90487-5; Feldman BJ, 2009, PEDIATR RES, V65, P249, DOI 10.1203/PDR.0b013e3181989667; Foradori CD, 2008, FRONT NEUROENDOCRIN, V29, P169, DOI 10.1016/j.yfrne.2007.10.005; GODDARD MS, 2009, ORTHOPEDICS, V32; Gunther T, 2007, NAT CELL BIOL, V9, P1229, DOI 10.1038/ncb1107-1229; Hammer F, 2005, J CLIN ENDOCR METAB, V90, P3600, DOI 10.1210/jc.2004-2386; Harding G, 2006, CYTOKINE, V36, P57, DOI 10.1016/j.cyto.2006.10.012; Hartkamp A, 2004, ARTHRITIS RHEUM-US, V50, P3591, DOI 10.1002/art.20610; Jankowski CM, 2006, J CLIN ENDOCR METAB, V91, P2986, DOI 10.1210/jc.2005-2484; Kahn SE, 2008, DIABETES CARE, V31, P845, DOI 10.2337/dc07-2270; KALAK R, 2009, BONE; Klein Gordon L, 2006, J Burns Wounds, V5, pe5; Kolf CM, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2116; Kong YY, 1999, NATURE, V402, P304, DOI 10.1038/35005552; Korczowska Izabela, 2003, Yale Journal of Biology and Medicine, V76, P45; Labrie F, 2005, J ENDOCRINOL, V187, P169, DOI 10.1677/joe.1.06264; Lardy H, 2005, VITAM HORM, V71, P263, DOI 10.1016/S0083-6729(05)71009-8; Lardy H, 2002, LIPIDS, V37, P1187, DOI 10.1007/s11745-002-1019-7; Lardy H, 2003, J BIOL CHEM, V278, P3499, DOI 10.1074/jbc.X200003200; Liu DM, 2004, STEROIDS, V69, P279, DOI 10.1016/j.steroids.2004.02.004; Loria RM, 1997, PSYCHONEUROENDOCRINO, V22, pS103, DOI 10.1016/S0306-4530(97)00005-X; Loria RM, 1996, J ENDOCRINOL, V150, pS209; Marks SC, 2000, INT J DEV BIOL, V44, P309; Martin C, 2001, BIOCHEM J, V355, P509, DOI 10.1042/0264-6021:3550509; Marwah A, 2002, J CHROMATOGR B, V767, P285, DOI 10.1016/S1570-0232(01)00570-0; McDonough AK, 2008, NAT CLIN PRACT ENDOC, V4, P507, DOI 10.1038/ncpendmet0920; Meier C, 2008, ARCH INTERN MED, V168, P820, DOI 10.1001/archinte.168.8.820; Miller SC, 2002, CALCIFIED TISSUE INT, V71, P429, DOI 10.1007/s00223-001-1139-2; Mushtaq T, 2002, J ENDOCRINOL, V175, P705, DOI 10.1677/joe.0.1750705; Nashev LG, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000561; Padgett DA, 1998, J NEUROIMMUNOL, V84, P61, DOI 10.1016/S0165-5728(97)00244-0; Padgett DA, 1995, ANN NY ACAD SCI, V774, P323; PADGETT DA, 1994, J IMMUNOL, V153, P1544; Przkora R, 2007, BONE, V41, P297, DOI 10.1016/j.bone.2007.04.195; Reyes M, 2001, ANN NY ACAD SCI, V938, P231; Rose KA, 1997, P NATL ACAD SCI USA, V94, P4925, DOI 10.1073/pnas.94.10.4925; Sahin Gunsah, 2002, SMJ Singapore Medical Journal, V43, P576; Sanchez-Guerrero J, 2008, J RHEUMATOL, V35, P1567; Sher LB, 2006, CALCIFIED TISSUE INT, V79, P118, DOI 10.1007/s00223-005-0297-z; Sher LB, 2004, ENDOCRINOLOGY, V145, P922, DOI 10.1210/en.2003-0655; STEWART PM, 1995, STEROIDS, V60, P143, DOI 10.1016/0039-128X(94)00024-7; Svec F, 1998, P SOC EXP BIOL MED, V218, P174; Takayanagi R, 2002, MECH AGEING DEV, V123, P1107, DOI 10.1016/S0047-6374(01)00394-3; Tamasi V, 2008, MOL PHARMACOL, V73, P968, DOI 10.1124/mol.107.036780; Urban NH, 2008, J STEROID BIOCHEM, V110, P223, DOI 10.1016/j.jsbmb.2008.04.005; Vicent GP, 2008, J STEROID BIOCHEM, V109, P344, DOI 10.1016/j.jsbmb.2008.03.015; VONMUHLE, 2008, OSTEOPOROSIS INT, V19, P699; Wang L, 2007, J MOL ENDOCRINOL, V38, P467, DOI 10.1677/jme.1.02173; WANG T, J PHARM EXP THER; Webb SJ, 2006, DRUG METAB REV, V38, P89, DOI 10.1080/03602530600569877; Wolf OT, 1999, BRAIN RES REV, V30, P264, DOI 10.1016/S0165-0173(99)00021-1; Yaturu S, 2007, DIABETES CARE, V30, P1574, DOI 10.2337/dc06-2606; Zhou H, 2008, J BIOL CHEM, V283, P1936, DOI 10.1074/jbc.M702687200	80	10	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2010	5	10							e13566	10.1371/journal.pone.0013566	http://dx.doi.org/10.1371/journal.pone.0013566			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	668TQ	21042414	Green Published, Green Submitted, gold			2022-12-27	WOS:000283293800024
J	Glynn, RW; Chin, JZ; Kerin, MJ; Sweeney, KJ				Glynn, Ronan W.; Chin, Ji Z.; Kerin, Michael J.; Sweeney, Karl J.			Representation of Cancer in the Medical Literature - A Bibliometric Analysis	PLOS ONE			English	Article							WEB-OF-SCIENCE; IMPACT	Background: There exists a lack of knowledge regarding the quantity and quality of scientific yield in relation to individual cancer types. We aimed to measure the proportion, quality and relevance of oncology-related articles, and to relate this output to their associated disease burden. By incorporating the impact factor(IF) and Eigenfactor (TM)(EF) into our analysis we also assessed the relationship between these indices and the output under study. Methods: All publications in 2007 were retrieved for the 26 most common cancers. The top 20 journals ranked by IF and EF in general medicine and oncology, and the presence of each malignancy within these titles was analysed. Journals publishing most prolifically on each cancer were identified and their impact assessed. Principal Findings: 63260 (PubMed) and 126845 (WoS) entries were generated, respectively. 26 neoplasms accounted for 25% of total output from the top medical publications. 5 cancers dominated the first quartile of output in the top oncology journals; breast, prostate, lung, and intestinal cancer, and leukaemia. Journals associated with these cancers were associated with much higher IFs and EFs than those journals associated with the other cancer types under study, although these measures were not equivalent across all sub-specialties. In addition, yield on each cancer was related to its disease burden as measured by its incidence and prevalence. Conclusions: Oncology enjoys disproportionate representation in the more prestigious medical journals. 5 cancers dominate yield, although this attention is justified given their associated disease burden. The commonly used IF and the recently introduced EF do not correlate in the assessment of the preeminent oncology journals, nor at the level of individual malignancies; there is a need to delineate between proxy measures of quality and the relevance of output when assessing its merit. These results raise significant questions regarding the best method of assessment of research and scientific output in the field of oncology.	[Glynn, Ronan W.; Chin, Ji Z.; Kerin, Michael J.; Sweeney, Karl J.] Natl Univ Ireland Galway, Inst Clin Sci, Dept Surg, Galway, Ireland	Ollscoil na Gaillimhe-University of Galway	Glynn, RW (corresponding author), Natl Univ Ireland Galway, Inst Clin Sci, Dept Surg, Galway, Ireland.	ronanglynn@doctors.org.uk	Kerin, Michael J/D-6748-2013	Kerin, Michael/0000-0003-4164-5561	National Breast Cancer Research Institute (NBCRI) of Ireland	National Breast Cancer Research Institute (NBCRI) of Ireland	RWG was funded by the National Breast Cancer Research Institute (NBCRI) of Ireland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler KB, 2009, AM J RESP CELL MOL, V41, P127, DOI 10.1165/rcmb.2009-0201ED; Al-Shahi R, 2001, BRIT MED J, V323, P1461, DOI 10.1136/bmj.323.7327.1461; [Anonymous], SURVEILLANCE EPIDEMI; Bergstrom CT, 2008, J NEUROSCI, V28, P11433, DOI 10.1523/JNEUROSCI.0003-08.2008; Brin S, 1998, COMPUT NETWORKS ISDN, V30, P107, DOI 10.1016/S0169-7552(98)00110-X; Cambrosio A, 2006, EUR J CANCER, V42, P3140, DOI 10.1016/j.ejca.2006.07.020; Falagas ME, 2008, FASEB J, V22, P338, DOI 10.1096/fj.07-9492LSF; FERNANDEZ P, 2006, GOOGLES PAGERANK SCI, P1; Garfield E, 2006, JAMA-J AM MED ASSOC, V295, P90, DOI 10.1001/jama.295.1.90; Grossi F, 2003, EUR J CANCER, V39, P106, DOI 10.1016/S0959-8049(02)00239-3; Kamath PS, 2009, HEPATOLOGY, V49, P1787, DOI 10.1002/hep.23040; Lopez-Illescas C, 2008, J INFORMETR, V2, P304, DOI 10.1016/j.joi.2008.08.001; McNally N, 2003, BRIT MED J, V327, P550, DOI 10.1136/bmj.327.7414.550; Michon F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006544; O'Toole L, 2003, NAT REV CANCER, V3, P139, DOI 10.1038/nrc994; Rossner M, 2007, J CELL BIOL, V179, P1091, DOI 10.1083/jcb.200711140; Simons K, 2008, SCIENCE, V322, P165, DOI 10.1126/science.1165316; Sosa JA, 2009, ANN SURG, V250, P152, DOI 10.1097/SLA.0b013e3181ad8905; Ugolini D, 2007, CARCINOGENESIS, V28, P1774, DOI 10.1093/carcin/bgm129	19	42	43	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2010	5	11							e13902	10.1371/journal.pone.0013902	http://dx.doi.org/10.1371/journal.pone.0013902			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	677ZE	21085482	Green Published, Green Submitted, gold			2022-12-27	WOS:000284035900012
J	Orbach, DN; Fenton, B				Orbach, Dara N.; Fenton, Brock			Vision Impairs the Abilities of Bats to Avoid Colliding with Stationary Obstacles	PLOS ONE			English	Article							MACROTUS-CALIFORNICUS CHIROPTERA; MYOTIS-LUCIFUGUS CHIROPTERA; ECHOLOCATING BATS; BROWN BATS; DISTRESS CALLS; RESPONSES; VESPERTILIONIDAE; DISCRIMINATION; PHYLLOSTOMIDAE; BEHAVIOR	Background: Free-flying insectivorous bats occasionally collide with stationary objects they should easily detect by echolocation and avoid. Collisions often occur with lighted objects, suggesting ambient light may deleteriously affect obstacle avoidance capabilities. We tested the hypothesis that free-flying bats may orient by vision when they collide with some obstacles. We additionally tested whether acoustic distractions, such as "distress calls'' of other bats, contributed to probabilities of collision. Methodology/Principal Findings: To investigate the role of visual cues in the collisions of free-flying little brown bats (Myotis lucifugus) with stationary objects, we set up obstacles in an area of high bat traffic during swarming. We used combinations of light intensities and visually dissimilar obstacles to verify that bats orient by vision. In early August, bats collided more often in the light than the dark, and probabilities of collision varied with the visibility of obstacles. However, the probabilities of collisions altered in mid to late August, coincident with the start of behavioural, hormonal, and physiological changes occurring during swarming and mating. Distress calls did not distract bats and increase the incidence of collisions. Conclusions/Significance: Our findings indicate that visual cues are more important for free-flying bats than previously recognized, suggesting integration of multi-sensory modalities during orientation. Furthermore, our study highlights differences between responses of captive and wild bats, indicating a need for more field experiments.	[Orbach, Dara N.; Fenton, Brock] Univ Western Ontario, Dept Biol, London, ON, Canada	Western University (University of Western Ontario)	Orbach, DN (corresponding author), Univ Western Ontario, Dept Biol, London, ON, Canada.	dnorbach@gmail.com	Vazquez-Dominguez, Guillermo GVD/L-7818-2014		Natural Sciences and Engineering Research Council of Canada [3331]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This project was supported by a grant from the Natural Sciences and Engineering Research Council of Canada to M.B. Fenton (3331). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALDRIDGE H, 1986, CAN J ZOOL, V64, P1878, DOI 10.1139/z86-280; Altringham JD, 2003, BAT ECOLOGY, P90; AVERY M, 1972, Prairie Naturalist, V4, P87; BELL GP, 1986, ANIM BEHAV, V34, P409, DOI 10.1016/S0003-3472(86)80110-5; BELL GP, 1985, BEHAV ECOL SOCIOBIOL, V16, P343, DOI 10.1007/BF00295547; BRADBURY JW, 1969, ANIM BEHAV, V17, P480, DOI 10.1016/0003-3472(69)90150-X; CHASE J, 1983, ANIM BEHAV, V31, P526, DOI 10.1016/S0003-3472(83)80075-X; CHASE J, 1981, ANIM BEHAV, V29, P708, DOI 10.1016/S0003-3472(81)80005-X; CHASE J, 1969, ANIM BEHAV, V17, P201, DOI 10.1016/0003-3472(69)90001-3; CHASE J, 1972, THESIS INDIANA U BLO; CONDON CJ, 1994, J NEUROPHYSIOL, V71, P768, DOI 10.1152/jn.1994.71.2.768; CRAWFORD RL, 1981, J MAMMAL, V62, P651, DOI 10.2307/1380421; Davis W. H., 1965, Journal of Mammalogy, V46, P296, DOI 10.2307/1377850; DAVIS WH, 1965, AM MIDL NAT, V74, P497, DOI 10.2307/2423278; Eklof J, 2003, ANIM BEHAV, V66, P949, DOI 10.1006/anbe.2003.2272; Eklof J, 2002, MAMM BIOL, V67, P42, DOI 10.1078/1616-5047-00004; ELLINS SR, 1974, BRAIN BEHAV EVOLUT, V9, P248, DOI 10.1159/000123669; FENTON MB, 1969, CAN J ZOOLOG, V47, P597, DOI 10.1139/z69-103; FENTON MB, 1976, CAN J ZOOL, V54, P1443, DOI 10.1139/z76-167; Galambos R, 1942, J EXP ZOOL, V89, P475, DOI 10.1002/jez.1400890308; Ganier A.F., 1962, MIGRANT, V33, P58; Gollop M. A., 1965, Blue Jay, V23, P15; Griffin D. R., 1960, Animal Behaviour, V8, P141, DOI 10.1016/0003-3472(60)90022-1; GUSTAFSON AW, 1976, BIOL REPROD, V15, P9, DOI 10.1093/biolreprod/15.1.9; HALL HS, 1968, J MAMMAL, V49, P779; HOPE GM, 1979, EXPERIENTIA, V35, P1191, DOI 10.1007/BF01963280; Jen P.H.-S., 1982, PROCEEDINGS OF THE NATIONAL SCIENCE COUNCIL REPUBLIC OF CHINA PART B BASIC SCIENCE, V6, P71; JEN PHS, 1980, P 5 INT BAT RES C, P23; Kronfeld-Schor N, 2000, AM J PHYSIOL-REG I, V279, pR1277, DOI 10.1152/ajpregu.2000.279.4.R1277; MASTERSON FA, 1974, BEHAVIOUR, V51, P88, DOI 10.1163/156853974X00156; McGuire LP, 2009, CAN J ZOOL, V87, P515, DOI 10.1139/Z09-041; McGuire LP, 2010, ACTA CHIROPTEROL, V12, P247, DOI 10.3161/150811010X504734; Neuweiler G., 2000, BIOL BATS, P210; NORBERG U M, 1987, Philosophical Transactions of the Royal Society of London B Biological Sciences, V316, P335, DOI 10.1098/rstb.1987.0030; Russ JM, 2004, ANIM BEHAV, V67, P1005, DOI 10.1016/j.anbehav.2003.09.003; Russ JM, 1998, ANIM BEHAV, V55, P705, DOI 10.1006/anbe.1997.0665; Rydell J, 2003, NATURWISSENSCHAFTEN, V90, P481, DOI 10.1007/s00114-003-0464-x; SAUNDERS W. E., 1930, AUK, V47, P507; Skowronski MD, 2008, J ACOUST SOC AM, V124, P328, DOI 10.1121/1.2924122; SUTHERS R, 1969, BIOL BULL, V137, P535, DOI 10.2307/1540174; Suthers R. A., 1970, BIOL BATS, P265; SUTHERS RA, 1970, VISION RES, V10, P1165, DOI 10.1016/0042-6989(70)90034-9; SUTHERS RA, 1966, SCIENCE, V152, P1102, DOI 10.1126/science.152.3725.1102; TEST FH, 1967, J MAMMAL, V48, P482, DOI 10.2307/1377791; THOMAS DW, 1979, BEHAV ECOL SOCIOBIOL, V6, P129, DOI 10.1007/BF00292559; Timm R.M., 1989, Bulletin of the Chicago Academy of Sciences, V14, P1; Van Gelder R. G., 1956, Transactions of the Kansas Academy of Science, V59, P220; WAIPING V, 1988, J MAMMAL, V69, P641, DOI 10.2307/1381364; ZINN TL, 1979, J MAMMAL, V60, P634, DOI 10.2307/1380110; [No title captured]	50	38	38	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2010	5	11							e13912	10.1371/journal.pone.0013912	http://dx.doi.org/10.1371/journal.pone.0013912			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	677ZE	21085481	Green Published, gold			2022-12-27	WOS:000284035900019
J	Tonjes, A; Fasshauer, M; Kratzsch, J; Stumvoll, M; Bluher, M				Toenjes, Anke; Fasshauer, Mathias; Kratzsch, Juergen; Stumvoll, Michael; Blueher, Matthias			Adipokine Pattern in Subjects with Impaired Fasting Glucose and Impaired Glucose Tolerance in Comparison to Normal Glucose Tolerance and Diabetes	PLOS ONE			English	Article							INSULIN-RESISTANCE; ADIPOSE-TISSUE; PLASMA-GLUCOSE; DYSFUNCTION; CHEMERIN; MELLITUS; LIVER; COMPLICATIONS; PREDICTORS; CYTOKINE	Aim: Altered adipokine serum concentrations early reflect impaired adipose tissue function in obese patients with type 2 diabetes (T2D). It is not entirely clear whether these adipokine alterations are already present in prediabetic states and so far there is no comprehensive adipokine panel available. Therefore, the aim of this study was to assess distinct adipokine profiles in patients with normal glucose tolerance (NGT), impaired fasting glucose (IFG), impaired glucose tolerance (IGT) or T2D. Methods: Based on 75 g oral glucose tolerance tests, 124 individuals were divided into groups of IFG (n = 35), IGT (n = 45), or NGT (n = 43). Furthermore, 56 subjects with T2D were included. Serum concentrations of adiponectin, chemerin, fetuin-A, leptin, interleukin (IL)-6, retinol-binding protein 4 (RBP4), monocyte chemoattractant protein (MCP)-1, vaspin, progranulin, and soluble leptin receptor (sOBR) were measured by ELISAs. Results: Chemerin, progranulin, fetuin-A, and RBP4, IL-6, adiponectin and leptin serum concentrations were differentially regulated among the four investigated groups but only circulating chemerin was significantly different in patients with IGT compared to those with IFG. Compared to T2D the IFG subjects had higher serum chemerin, progranulin, fetuin-A and RBP4 levels which was not detectable in the comparison of the T2D and IGT group. Conclusion: Alterations in adipokine serum concentrations are already detectable in prediabetic states, mainly for chemerin, and may reflect adipose tissue dysfunction as an early pathogenetic event in T2D development. In addition, distinct adipokine serum patterns in individuals with IFG and IGT suggest a specific role of adipose tissue in the pathogenesis of these prediabetic states.	[Toenjes, Anke; Fasshauer, Mathias; Stumvoll, Michael; Blueher, Matthias] Univ Leipzig, Dept Med, Leipzig, Germany; [Kratzsch, Juergen] Univ Leipzig, Inst Lab Med Clin Chem & Mol Diagnost, Leipzig, Germany	Leipzig University; Leipzig University	Tonjes, A (corresponding author), Univ Leipzig, Dept Med, Leipzig, Germany.	Anke.Toenjes@medizin.uni-leipzig.de	Stumvoll, Michael/ABE-1121-2021	Stumvoll, Michael/0000-0001-6225-8240	Federal Ministry of Education and Research [FKZ 01GI0829]; Deutsche Forschungsgemeinschaft (DFG) the Clinical Research Group [KFO 152, BL 833/1-1, FA 476/4-1]	Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft (DFG) the Clinical Research Group(German Research Foundation (DFG))	This work was supported by the Kompetenznetz Adipositas (Competence Network for Obesity) funded by the Federal Ministry of Education and Research (FKZ 01GI0829) and grants from Deutsche Forschungsgemeinschaft (DFG) the Clinical Research Group 'Atherobesity' KFO 152 (project BL 833/1-1 (MB) and project FA 476/4-1 (MF)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Ghani MA, 2009, CURR DIABETES REP, V9, P193, DOI 10.1007/s11892-009-0032-7; Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Bluher M, 2010, CURR OPIN LIPIDOL, V21, P38, DOI 10.1097/MOL.0b013e3283346ccc; Bluhre M, 2009, EXP CLIN ENDOCR DIAB, V117, P241, DOI 10.1055/s-0029-1192044; Bluher M, 2002, DIABETOLOGIA, V45, P210, DOI 10.1007/s00125-001-0723-3; Bozaoglu K, 2009, J CLIN ENDOCR METAB, V94, P3085, DOI 10.1210/jc.2008-1833; Faerch K, 2009, DIABETIC MED, V26, P377, DOI 10.1111/j.1464-5491.2009.02688.x; Faerch K, 2009, DIABETOLOGIA, V52, P1714, DOI 10.1007/s00125-009-1443-3; Gautier A, 2010, DIABETES CARE, V33, P1850, DOI 10.2337/dc10-0368; Gavin JR, 2000, DIABETES CARE, V23, pS4; Goldberg RB, 2009, J CLIN ENDOCR METAB, V94, P3171, DOI 10.1210/jc.2008-2534; Goralski KB, 2007, J BIOL CHEM, V282, P28175, DOI 10.1074/jbc.M700793200; Graham TE, 2006, NEW ENGL J MED, V354, P2552, DOI 10.1056/NEJMoa054862; Ix JH, 2006, CIRCULATION, V113, pE337; Ix JH, 2008, JAMA-J AM MED ASSOC, V300, P182, DOI 10.1001/jama.300.2.182; Kloeting N, 2007, CELL METAB, V6, P79, DOI 10.1016/j.cmet.2007.06.002; Kratzsch J, 2006, EUR J ENDOCRINOL, V155, P609, DOI 10.1530/eje.1.02261; Li SS, 2009, JAMA-J AM MED ASSOC, V302, P179, DOI 10.1001/jama.2009.976; Marra F, 2009, HEPATOLOGY, V50, P957, DOI 10.1002/hep.23046; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Moschen AR, 2009, J HEPATOL, V51, P765, DOI 10.1016/j.jhep.2009.06.016; Rabe K, 2008, MOL MED, V14, P741, DOI 10.2119/2008-00058.Rabe; Stefan N, 2006, DIABETES CARE, V29, P853, DOI 10.2337/diacare.29.04.06.dc05-1938; Tan BK, 2009, DIABETES, V58, P1971, DOI 10.2337/db08-1528; Tilg H, 2006, GASTROENTEROLOGY, V131, P934, DOI 10.1053/j.gastro.2006.05.054; Van Gaal LF, 2006, NATURE, V444, P875, DOI 10.1038/nature05487; You BS, 2008, DIABETES, V57, P372, DOI 10.2337/db07-1045; Youn BS, 2009, DIABETES, V58, P627, DOI 10.2337/db08-1147	28	97	99	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2010	5	11							e13911	10.1371/journal.pone.0013911	http://dx.doi.org/10.1371/journal.pone.0013911			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	677ZE	21085476	Green Submitted, gold, Green Published			2022-12-27	WOS:000284035900018
J	Aguilar-Morante, D; Morales-Garcia, JA; Sanz-SanCristobal, M; Garcia-Cabezas, MA; Santos, A; Perez-Castillo, A				Aguilar-Morante, Diana; Angel Morales-Garcia, Jose; Sanz-SanCristobal, Marina; Angel Garcia-Cabezas, Miguel; Santos, Angel; Perez-Castillo, Ana			Inhibition of Glioblastoma Growth by the Thiadiazolidinone Compound TDZD-8	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE-3-BETA; NF-KAPPA-B; EXPERIMENTAL BRAIN-TUMORS; COLORECTAL-CANCER CELLS; NEURAL STEM-CELLS; PROGENITOR CELLS; P53-DEPENDENT APOPTOSIS; ALZHEIMERS-DISEASE; INITIATING CELLS; BINDING PROTEIN	Background: Thiadiazolidinones (TDZD) are small heterocyclic compounds first described as non-ATP competitive inhibitors of glycogen synthase kinase 3 beta (GSK-3 beta). In this study, we analyzed the effects of 4-benzyl-2-methyl-1,2,4-thiadiazolidine-3,5- dione (TDZD-8), on murine GL261 cells growth in vitro and on the growth of established intracerebral murine gliomas in vivo. Methodology/Principal Findings: Our data show that TDZD-8 decreased proliferation and induced apoptosis of GL261 glioblastoma cells in vitro, delayed tumor growth in vivo, and augmented animal survival. These effects were associated with an early activation of extracellular signal-regulated kinase (ERK) pathway and increased expression of EGR-1 and p21 genes. Also, we observed a sustained activation of the ERK pathway, a concomitant phosphorylation and activation of ribosomal S6 kinase (p90RSK) and an inactivation of GSK-3 beta by phosphorylation at Ser 9. Finally, treatment of glioblastoma stem cells with TDZD-8 resulted in an inhibition of proliferation and self-renewal of these cells. Conclusions/Significance: Our results suggest that TDZD-8 uses a novel mechanism to target glioblastoma cells, and that malignant progenitor population could be a target of this compound.	[Aguilar-Morante, Diana; Angel Morales-Garcia, Jose; Sanz-SanCristobal, Marina; Perez-Castillo, Ana] Univ Autonoma Madrid, Inst Invest Biomed, Consejo Super Invest Cient, Madrid, Spain; [Aguilar-Morante, Diana; Angel Morales-Garcia, Jose; Sanz-SanCristobal, Marina; Perez-Castillo, Ana] Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid, Spain; [Santos, Angel] Univ Complutense Madrid, Fac Med, Dept Bioquim & Biol Mol, Madrid, Spain; [Angel Garcia-Cabezas, Miguel] Hosp Univ La Paz, Dept Anat Patol, Madrid, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CIBERNED; Complutense University of Madrid; Hospital Universitario La Paz	Aguilar-Morante, D (corresponding author), Univ Autonoma Madrid, Inst Invest Biomed, Consejo Super Invest Cient, Madrid, Spain.	piedras3@med.ucm.es	Santos, Angel/K-3744-2014; García-Cabezas, Miguel Ángel/K-4737-2019; Perez-Castillo, Ana/A-9505-2015; Morales-Garcia, Jose A/L-4552-2014; Aguilar-Morante, Diana/AAE-8572-2019	Santos, Angel/0000-0002-7551-8483; García-Cabezas, Miguel Ángel/0000-0003-0534-5182; Morales-Garcia, Jose A/0000-0001-9008-0056; Aguilar-Morante, Diana/0000-0001-9775-0841; Perez-Castillo, Ana/0000-0002-2632-5853	Ministerio de Educacion y Ciencia [SAF2007-62811]; Instituto de Salud Carlos III	Ministerio de Educacion y Ciencia(Spanish Government); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission)	This work was supported by the Ministerio de Educacion y Ciencia grant SAF2007-62811 (to A.P.-C.). CIBERNED is funded by the Instituto de Salud Carlos III. JA.M.-G. and M.S.-S. are fellows of CIBERNED. D.A.-M. is a fellow of the Consejo Superior de Investigaciones Cienti-ficas. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Benedetti S, 2000, NAT MED, V6, P447, DOI 10.1038/74710; BOTTOMLEY PA, 1987, ANN NY ACAD SCI, V508, P333, DOI 10.1111/j.1749-6632.1987.tb32915.x; Chin PC, 2005, MOL BRAIN RES, V137, P193, DOI 10.1016/j.molbrainres.2005.03.004; Choi BH, 2008, CANCER RES, V68, P1369, DOI 10.1158/0008-5472.CAN-07-5222; Collino M, 2009, DIABETES, V58, P235, DOI 10.2337/db08-0691; Cortes-Canteli M, 2004, J BIOL CHEM, V279, P14409, DOI 10.1074/jbc.M313253200; Cuzzocrea S, 2006, CLIN IMMUNOL, V120, P57, DOI 10.1016/j.clim.2006.03.005; Cuzzocrea S, 2006, J PHARMACOL EXP THER, V318, P79, DOI 10.1124/jpet.106.102863; De Ferrari GV, 2000, BRAIN RES REV, V33, P1, DOI 10.1016/S0165-0173(00)00021-7; DeAngelis LM, 2001, NEW ENGL J MED, V344, P114, DOI 10.1056/NEJM200101113440207; Deng J, 2004, MOL CARCINOGEN, V39, P139, DOI 10.1002/mc.10169; Dugo L, 2006, SHOCK, V25, P485, DOI 10.1097/01.shk.0000209545.29671.31; Edwards E, 2002, CANCER RES, V62, P4671; El Andaloussi A, 2006, GLIA, V54, P526, DOI 10.1002/glia.20401; Eldar-Finkelman H, 2002, TRENDS MOL MED, V8, P126, DOI 10.1016/S1471-4914(01)02266-3; Fomchenko EI, 2006, CLIN CANCER RES, V12, P5288, DOI 10.1158/1078-0432.CCR-06-0438; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; Gao HK, 2008, J CARDIOVASC PHARM, V52, P286, DOI 10.1097/FJC.0b013e318186a84d; Ghosh JC, 2005, CLIN CANCER RES, V11, P4580, DOI 10.1158/1078-0432.CCR-04-2624; Goulet AC, 2005, CARCINOGENESIS, V26, P109, DOI 10.1093/carcin/bgh306; Guzman ML, 2007, BLOOD, V110, P4436, DOI 10.1182/blood-2007-05-088815; HENNIG J, 1986, MAGNET RESON MED, V3, P823, DOI 10.1002/mrm.1910030602; Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574; Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004; Kaidanovich Oksana, 2002, Expert Opin Ther Targets, V6, P555; Kim L, 2000, CURR OPIN GENET DEV, V10, P508, DOI 10.1016/S0959-437X(00)00120-9; Kim SD, 2007, BRAIN RES, V1186, P12, DOI 10.1016/j.brainres.2007.10.018; Kjaergaard J, 2000, CANCER RES, V60, P5514; Kong H, 2008, J CELL SCI, V121, P4029, DOI 10.1242/jcs.035758; Kotliarova S, 2008, CANCER RES, V68, P6643, DOI 10.1158/0008-5472.CAN-08-0850; Luna-Medina R, 2005, J BIOL CHEM, V280, P21453, DOI 10.1074/jbc.M414390200; Luna-Medina R, 2007, J NEUROSCI, V27, P5766, DOI 10.1523/JNEUROSCI.1004-07.2007; Ma CL, 2008, J BIOL CHEM, V283, P9248, DOI 10.1074/jbc.M707316200; Martinez A, 2002, MED RES REV, V22, P373, DOI 10.1002/med.10011; Martinez A, 2002, J MED CHEM, V45, P1292, DOI 10.1021/jm011020u; Miyatake SI, 1997, CANCER GENE THER, V4, P222; Palmer TD, 2000, J COMP NEUROL, V425, P479, DOI 10.1002/1096-9861(20001002)425:4<479::AID-CNE2>3.0.CO;2-3; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Phillips TM, 2006, JNCI-J NATL CANCER I, V98, P1777, DOI 10.1093/jnci/djj495; Pignatelli M, 2005, CARCINOGENESIS, V26, P81, DOI 10.1093/carcin/bgh308; Roux PP, 2003, MOL CELL BIOL, V23, P4796, DOI 10.1128/MCB.23.14.4796-4804.2003; Sanai N, 2005, NEW ENGL J MED, V353, P811, DOI 10.1056/NEJMra043666; Singh SK, 2004, ONCOGENE, V23, P7267, DOI 10.1038/sj.onc.1207946; Singh SK, 2003, CANCER RES, V63, P5821; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Sun AJ, 2007, PROSTATE, V67, P976, DOI 10.1002/pros.20586; Takada Y, 2004, J BIOL CHEM, V279, P39541, DOI 10.1074/jbc.M403449200; Tan J, 2005, CANCER RES, V65, P9012, DOI 10.1158/0008-5472.CAN-05-1226; Tang DM, 2002, J BIOL CHEM, V277, P12710, DOI 10.1074/jbc.M111598200; Taylor MD, 2005, CANCER CELL, V8, P323, DOI 10.1016/j.ccr.2005.09.001; Tewari R, 2008, J NEUROCHEM, V107, P616, DOI 10.1111/j.1471-4159.2008.05625.x; Tkac I, 1999, MAGNET RESON MED, V41, P649, DOI 10.1002/(SICI)1522-2594(199904)41:4<649::AID-MRM2>3.0.CO;2-G; Wang ZQ, 2003, J BIOL CHEM, V278, P11138, DOI 10.1074/jbc.M209108200; Whittle BJR, 2006, BRIT J PHARMACOL, V147, P575, DOI 10.1038/sj.bjp.0706509; Woodward WA, 2007, P NATL ACAD SCI USA, V104, P618, DOI 10.1073/pnas.0606599104; Zagzag D, 2003, BRAIN PATHOL, V13, P34; Zhou Y, 2008, LEUKEMIA LYMPHOMA, V49, P1945, DOI 10.1080/10428190802304966	58	23	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2010	5	11							e13879	10.1371/journal.pone.0013879	http://dx.doi.org/10.1371/journal.pone.0013879			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	676NU	21079728	Green Published, gold			2022-12-27	WOS:000283920000012
J	Jacobs, H; Moalin, M; Bast, A; van der Vijgh, WJF; Haenen, GRMM				Jacobs, Hilde; Moalin, Mohamed; Bast, Aalt; van der Vijgh, Wim J. F.; Haenen, Guido R. M. M.			An Essential Difference between the Flavonoids MonoHER and Quercetin in Their Interplay with the Endogenous Antioxidant Network	PLOS ONE			English	Article							DOXORUBICIN-INDUCED CARDIOTOXICITY; VITAMIN-C; GLUTATHIONE; MONOHYDROXYETHYLRUTOSIDE; TOCOPHEROL; ASCORBATE; OXIDATION	Antioxidants can scavenge highly reactive radicals. As a result the antioxidants are converted into oxidation products that might cause damage to vital cellular components. To prevent this damage, the human body possesses an intricate network of antioxidants that pass over the reactivity from one antioxidant to another in a controlled way. The aim of the present study was to investigate how the semi-synthetic flavonoid 7-mono-O-(beta-hydroxyethyl)-rutoside (monoHER), a potential protective agent against doxorubicin-induced cardiotoxicity, fits into this antioxidant network. This position was compared with that of the well-known flavonoid quercetin. The present study shows that the oxidation products of both monoHER and quercetin are reactive towards thiol groups of both GSH and proteins. However, in human blood plasma, oxidized quercetin easily reacts with protein thiols, whereas oxidized monoHER does not react with plasma protein thiols. Our results indicate that this can be explained by the presence of ascorbate in plasma; ascorbate is able to reduce oxidized monoHER to the parent compound monoHER before oxidized monoHER can react with thiols. This is a major difference with oxidized quercetin that preferentially reacts with thiols rather than ascorbate. The difference in selectivity between monoHER and quercetin originates from an intrinsic difference in the chemical nature of their oxidation products, which was corroborated by molecular quantum chemical calculations. These findings point towards an essential difference between structurally closely related flavonoids in their interplay with the endogenous antioxidant network. The advantage of monoHER is that it can safely channel the reactivity of radicals into the antioxidant network where the reactivity is completely neutralized.	[Jacobs, Hilde; Moalin, Mohamed; Bast, Aalt; van der Vijgh, Wim J. F.; Haenen, Guido R. M. M.] Maastricht Univ Med Ctr MUMC, Dept Pharmacol & Toxicol, NUTRIM Sch Nutr Toxicol & Metab, Maastricht, Netherlands; [Moalin, Mohamed] Hogesch Zuyd, Fac Life Sci, Heerlen, Netherlands	Maastricht University; Maastricht University Medical Centre (MUMC)	Jacobs, H (corresponding author), Maastricht Univ Med Ctr MUMC, Dept Pharmacol & Toxicol, NUTRIM Sch Nutr Toxicol & Metab, Maastricht, Netherlands.	hilde.jacobs@maastrichtuniversity.nl	Haenen, Guido/H-9209-2013; Bast, Aalt/I-7809-2013	Haenen, Guido/0000-0001-6986-290X; Bast, Aalt/0000-0002-5383-2789				Amic D, 2007, CURR MED CHEM, V14, P827, DOI 10.2174/092986707780090954; BAST A, 1991, AM J MED, V91, pS2, DOI 10.1016/0002-9343(91)90278-6; Bast A, 2002, ENVIRON TOXICOL PHAR, V11, P251, DOI 10.1016/S1382-6689(01)00118-1; Boots AW, 2008, EUR J PHARMACOL, V585, P325, DOI 10.1016/j.ejphar.2008.03.008; Boots AW, 2007, TOXICOL APPL PHARM, V222, P89, DOI 10.1016/j.taap.2007.04.004; Boots AW, 2003, BIOCHEM BIOPH RES CO, V308, P560, DOI 10.1016/S0006-291X(03)01438-4; BOWRY VW, 1992, BIOCHEM J, V288, P341, DOI 10.1042/bj2880341; Brubacher D, 2000, INT J VITAM NUTR RES, V70, P226, DOI 10.1024/0300-9831.70.5.226; Bruynzeel AME, 2007, BRIT J CANCER, V97, P1084, DOI 10.1038/sj.bjc.6603994; Formica JV, 1995, FOOD CHEM TOXICOL, V33, P1061, DOI 10.1016/0278-6915(95)00077-1; Galati G, 2001, FREE RADICAL BIO MED, V30, P370, DOI 10.1016/S0891-5849(00)00481-0; Haenen G.R., 1993, PHLEBOLOGY S, V1, P10; Haenen GRMM, 2002, THERAPIE, V57, P119; HERTOG MGL, 1993, NUTR CANCER, V20, P21, DOI 10.1080/01635589309514267; Jacobs H, 2009, FREE RADICAL BIO MED, V46, P1567, DOI 10.1016/j.freeradbiomed.2009.02.031; KALYANARAMAN B, 1987, J BIOL CHEM, V262, P11080; Kuhnau J, 1976, World Rev Nutr Diet, V24, P117; Landis-Piwowar K R, 2008, Curr Mol Pharmacol, V1, P233; Liu HL, 2010, RECENT PAT ANTI-CANC, V5, P152, DOI 10.2174/157489210790936261; MEISTER A, 1994, J BIOL CHEM, V269, P9397; MEISTER A, 1994, CANCER RES, V54, pS1969; MOORE GA, 1988, ARCH BIOCHEM BIOPHYS, V267, P539, DOI 10.1016/0003-9861(88)90061-6; MUKAI K, 1991, J BIOL CHEM, V266, P274; NIKI E, 1987, ANN NY ACAD SCI, V498, P186, DOI 10.1111/j.1749-6632.1987.tb23761.x; OBRIEN PJ, 1991, CHEM-BIOL INTERACT, V80, P1, DOI 10.1016/0009-2797(91)90029-7; PACKER JE, 1979, NATURE, V278, P737, DOI 10.1038/278737a0; PEARSON, 1963, J AM CHEM SOC, V85, P3533; Petruzzellis V, 2002, ANGIOLOGY, V53, P257, DOI 10.1177/000331970205300302; Rathee Permender, 2009, Inflammation & Allergy Drug Targets, V8, P229; Upston JM, 1999, FASEB J, V13, P977, DOI 10.1096/fasebj.13.9.977; van Acker FAA, 2000, CLIN CANCER RES, V6, P1337; VANACKER SAB, 1993, PHLEBOLOGY S, V1, P31; VANACKER SABE, 1995, BRIT J PHARMACOL, V115, P1260; Willems AM, 2006, CANCER CHEMOTH PHARM, V57, P678, DOI 10.1007/s00280-005-0083-7; Yen GC, 2003, BIOSCI BIOTECH BIOCH, V67, P1215, DOI 10.1271/bbb.67.1215; YU BP, 1994, PHYSIOL REV, V74, P139, DOI 10.1152/physrev.1994.74.1.139	36	28	31	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2010	5	11							e13880	10.1371/journal.pone.0013880	http://dx.doi.org/10.1371/journal.pone.0013880			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	676NU	21079733	Green Submitted, Green Published, gold			2022-12-27	WOS:000283920000013
J	Mann, D; Hill-Cook, M; Manire, C; Greenhow, D; Montie, E; Powell, J; Wells, R; Bauer, G; Cunningham-Smith, P; Lingenfelser, R; DiGiovanni, R; Stone, A; Brodsky, M; Stevens, R; Kieffer, G; Hoetjes, P				Mann, David; Hill-Cook, Mandy; Manire, Charles; Greenhow, Danielle; Montie, Eric; Powell, Jessica; Wells, Randall; Bauer, Gordon; Cunningham-Smith, Petra; Lingenfelser, Robert; DiGiovanni, Robert, Jr.; Stone, Abigale; Brodsky, Micah; Stevens, Robert; Kieffer, George; Hoetjes, Paul			Hearing Loss in Stranded Odontocete Dolphins and Whales	PLOS ONE			English	Article							EVOKED-POTENTIAL AUDIOMETRY; TEMPORARY THRESHOLD SHIFTS; TURSIOPS-TRUNCATUS; NOISE EXPOSURE; ORCINUS-ORCA; SENSITIVITY; AUDIOGRAMS	The causes of dolphin and whale stranding can often be difficult to determine. Because toothed whales rely on echolocation for orientation and feeding, hearing deficits could lead to stranding. We report on the results of auditory evoked potential measurements from eight species of odontocete cetaceans that were found stranded or severely entangled in fishing gear during the period 2004 through 2009. Approximately 57% of the bottlenose dolphins and 36% of the rough-toothed dolphins had significant hearing deficits with a reduction in sensitivity equivalent to severe (70-90 dB) or profound (>90 dB) hearing loss in humans. The only stranded short-finned pilot whale examined had profound hearing loss. No impairments were detected in seven Risso's dolphins from three different stranding events, two pygmy killer whales, one Atlantic spotted dolphin, one spinner dolphin, or a juvenile Gervais' beaked whale. Hearing impairment could play a significant role in some cetacean stranding events, and the hearing of all cetaceans in rehabilitation should be tested.	[Mann, David; Greenhow, Danielle; Montie, Eric; Powell, Jessica; Wells, Randall] Univ S Florida, Coll Marine Sci, St Petersburg, FL 33701 USA; [Wells, Randall] Mote Marine Lab, Chicago Zool Soc, Sarasota, FL 34236 USA; [Hill-Cook, Mandy] Portland State Univ, Dept Biol, Portland, OR 97207 USA; [Bauer, Gordon] New Coll Florida, Div Social Sci, Sarasota, FL USA; [Lingenfelser, Robert] Marine Mammal Conservancy, Key Largo, FL USA; [DiGiovanni, Robert, Jr.] Riverhead Fdn Marine Res & Preservat, Riverhead, NY USA; [Stone, Abigale] Clearwater Marine Aquarium, Clearwater, FL USA; [Brodsky, Micah] Dolphins Plus, Key Largo, FL USA; [Kieffer, George] SCCN, Bapor Kibra, Curacao, Neth Antilles; [Hoetjes, Paul] Dept Environm & Nat, Willemstad, Curacao, Neth Antilles	State University System of Florida; University of South Florida; Mote Marine Laboratory & Aquarium; Portland State University; State University System of Florida; New College Florida	Mann, D (corresponding author), Univ S Florida, Coll Marine Sci, St Petersburg, FL 33701 USA.	dmann@marine.usf.edu			National Oceanographic and Atmospheric Administration (NOAA); Office of Naval Research (ONR)	National Oceanographic and Atmospheric Administration (NOAA)(National Oceanic Atmospheric Admin (NOAA) - USA); Office of Naval Research (ONR)(Office of Naval Research)	Funding was provided by National Oceanographic and Atmospheric Administration (NOAA) Ocean Acoustics program for equipment and the Office of Naval Research (ONR) for pilot whale testing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Au W. W., 1993, SONAR DOLPHINS; AWBREY FT, 1988, J ACOUST SOC AM, V84, P2273, DOI 10.1121/1.397022; Brill RL, 2001, J ACOUST SOC AM, V109, P1717, DOI 10.1121/1.1356704; BRODIE PF, 1969, AM MIDL NAT, V82, P312, DOI 10.2307/2423849; Clark J G, 1981, ASHA, V23, P493; Cook MLH, 2006, J COMP PHYSIOL A, V192, P489, DOI 10.1007/s00359-005-0086-1; COOK MLH, 2006, THESIS U S FLORIDA; Dobie RA, 1996, J ACOUST SOC AM, V100, P2236, DOI 10.1121/1.417933; DOLPHIN WF, 1995, J COMP PHYSIOL A, V177, P235; Finitzo T, 1998, PEDIATRICS, V102, P1452, DOI 10.1542/peds.102.6.1452; Finneran JJ, 2005, J ACOUST SOC AM, V118, P2696, DOI 10.1121/1.2032087; Finneran JJ, 2002, J ACOUST SOC AM, V111, P2929, DOI 10.1121/1.1479150; Goldey ES, 1998, TOXICOL SCI, V45, P94, DOI 10.1006/toxs.1998.2495; HALL JD, 1972, J ACOUST SOC AM, V51, P515, DOI 10.1121/1.1912871; Houser DS, 2008, MAR MAMMAL SCI, V24, P28, DOI 10.1111/j.1748-7692.2007.00148.x; Houser DS, 2006, J ACOUST SOC AM, V120, P4090, DOI 10.1121/1.2357993; Houser DS, 2006, J ACOUST SOC AM, V120, P1713, DOI 10.1121/1.2229286; JOHNSON C. SCOTT, 1967, MAR BIO ACOUSTICS, V2, P247; Kastelein RA, 2003, J ACOUST SOC AM, V113, P1130, DOI 10.1121/1.1532310; Lucke K, 2009, J ACOUST SOC AM, V125, P4060, DOI 10.1121/1.3117443; MATZ GJ, 1980, AM J OTOL, V1, P169; Nachtigall PE, 2005, J EXP BIOL, V208, P4181, DOI 10.1242/jeb.01876; Nachtigall PE, 2004, MAR MAMMAL SCI, V20, P673, DOI 10.1111/j.1748-7692.2004.tb01187.x; Nachtigall PE, 2003, J ACOUST SOC AM, V113, P3425, DOI 10.1121/1.1570438; Odell D.K., 1987, Cetus, V7, P2; POPOV VV, 1990, J COMP PHYSIOL A, V166, P385; Prahl S, 2011, MYCOSES, V54, pE260, DOI 10.1111/j.1439-0507.2010.01863.x; Ridgway SH, 1997, J ACOUST SOC AM, V101, P590, DOI 10.1121/1.418122; Ross PS, 2000, MAR POLLUT BULL, V40, P504, DOI 10.1016/S0025-326X(99)00233-7; Supin AY, 1995, HEARING RES, V92, P38, DOI 10.1016/0378-5955(95)00194-8; Szymanski MD, 1999, J ACOUST SOC AM, V106, P1134, DOI 10.1121/1.427121; TARTER SK, 1990, J OCCUP ENVIRON MED, V32, P685; Wells R.S., 2004, ECOHEALTH, V1, P246, DOI [10.1007/s10393-004-0094-6, DOI 10.1007/S10393-004-0094-6]; Wells RS, 2005, SCI TOTAL ENVIRON, V349, P106, DOI 10.1016/j.scitotenv.2005.01.010; Yuen MML, 2005, J ACOUST SOC AM, V118, P2688, DOI 10.1121/1.2010350	35	39	40	4	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2010	5	11							e13824	10.1371/journal.pone.0013824	http://dx.doi.org/10.1371/journal.pone.0013824			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	674WJ	21072206	gold, Green Submitted, Green Published			2022-12-27	WOS:000283780800021
J	Tsitoura, P; Andronopoulou, E; Tsikou, D; Agalou, A; Papakonstantinou, MP; Kotzia, GA; Labropoulou, V; Swevers, L; Georgoussi, Z; Iatrou, K				Tsitoura, Panagiota; Andronopoulou, Evi; Tsikou, Daniela; Agalou, Adamantia; Papakonstantinou, Maria P.; Kotzia, Georgia A.; Labropoulou, Vassiliki; Swevers, Luc; Georgoussi, Zafiroula; Iatrou, Kostas			Expression and Membrane Topology of Anopheles gambiae Odorant Receptors in Lepidopteran Insect Cells	PLOS ONE			English	Article							THROUGHPUT SCREENING PLATFORMS; PROTEIN-COUPLED RECEPTORS; OPIOID-RECEPTORS; BOMBYX-MORI; FUNCTIONAL EXPRESSION; REGULATORY CASCADE; MOLECULAR-BASIS; CELLULAR BASIS; DROSOPHILA; MOSQUITO	A lepidopteran insect cell-based expression system has been employed to express three Anopheles gambiae odorant receptors (ORs), OR1 and OR2, which respond to components of human sweat, and OR7, the ortholog of Drosophila's OR83b, the heteromerization partner of all functional ORs in that system. With the aid of epitope tagging and specific antibodies, efficient expression of all ORs was demonstrated and intrinsic properties of the proteins were revealed. Moreover, analysis of the orientation of OR1 and OR2 on the cellular plasma membrane through the use of a novel 'topology screen' assay and FACS analysis demonstrates that, as was recently reported for the ORs in Drosophila melanogaster, mosquito ORs also have a topology different than their mammalian counterparts with their N-terminal ends located in the cytoplasm and their C-terminal ends facing outside the cell. These results set the stage for the production of mosquito ORs in quantities that should permit their detailed biochemical and structural characterization and the exploration of their functional properties.	[Tsitoura, Panagiota; Andronopoulou, Evi; Tsikou, Daniela; Kotzia, Georgia A.; Labropoulou, Vassiliki; Swevers, Luc; Iatrou, Kostas] Natl Ctr Sci Res Demokritos, Inst Biol, Insect Mol Genet & Biotechnol Grp, Athens, Greece; [Agalou, Adamantia; Papakonstantinou, Maria P.; Georgoussi, Zafiroula] Natl Ctr Sci Res Demokritos, Inst Biol, Lab Cellular Signaling & Mol Pharmacol, Athens, Greece	National Centre of Scientific Research "Demokritos"; National Centre of Scientific Research "Demokritos"	Tsitoura, P (corresponding author), Natl Ctr Sci Res Demokritos, Inst Biol, Insect Mol Genet & Biotechnol Grp, Athens, Greece.	iatrou@bio.demokritos.gr	Labropoulou, Vassiliki/E-7567-2013; Tsikou, Daniela/AAT-3646-2021	Labropoulou, Vassiliki/0000-0002-9247-6617; Tsikou, Daniela/0000-0001-6295-4860	General Secretariat for Research and Technology, Greek Ministry of Development (Greece-USA) [052]; European Union [FP7/2007-2013, FP7-222927]	General Secretariat for Research and Technology, Greek Ministry of Development (Greece-USA)(Greek Ministry of Development-GSRT); European Union(European Commission)	This research was funded by grants of the General Secretariat for Research and Technology, Greek Ministry of Development (Greece-USA grant No 052) and the European Union (FP7/2007-2013, grant agreement No FP7-222927) to KI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson AR, 2009, INSECT BIOCHEM MOLEC, V39, P189, DOI 10.1016/j.ibmb.2008.11.002; Bargmann CI, 2006, NATURE, V444, P295, DOI 10.1038/nature05402; Benton R, 2006, PLOS BIOL, V4, P240, DOI 10.1371/journal.pbio.0040020; Biessmann H, 2002, INSECT MOL BIOL, V11, P123, DOI 10.1046/j.1365-2583.2002.00316.x; Carey AF, 2010, NATURE, V464, P66, DOI 10.1038/nature08834; CARRINGTON JC, 1988, P NATL ACAD SCI USA, V85, P3391, DOI 10.1073/pnas.85.10.3391; Cook BL, 2009, P NATL ACAD SCI USA, V106, P11925, DOI 10.1073/pnas.0811089106; Cook BL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002920; Dobritsa AA, 2003, NEURON, V37, P827, DOI 10.1016/S0896-6273(03)00094-1; Douris V, 2006, ADV VIRUS RES, V68, P113, DOI 10.1016/S0065-3527(06)68004-4; Eystathioy T, 2001, MECH DEVELOP, V103, P107, DOI 10.1016/S0925-4773(01)00335-5; Farrell P.J., 2005, P475; Farrell PJ, 1998, BIOTECHNOL BIOENG, V60, P656, DOI 10.1002/(SICI)1097-0290(19981220)60:6<656::AID-BIT2>3.0.CO;2-9; Farrell PJ, 1999, BIOTECHNOL BIOENG, V64, P426, DOI 10.1002/(SICI)1097-0290(19990820)64:4&lt;426::AID-BIT5&gt;3.0.CO;2-#; Farrell PJ, 2000, PROTEINS, V41, P144, DOI 10.1002/1097-0134(20001001)41:1<144::AID-PROT160>3.3.CO;2-8; Gauczynski S, 2001, EMBO J, V20, P5863, DOI 10.1093/emboj/20.21.5863; GEORGANTA EM, 2010, NEUROPHARMACOLO 0428; GRACE TDC, 1967, NATURE, V216, P613, DOI 10.1038/216613a0; Hallem EA, 2006, CELL, V125, P143, DOI 10.1016/j.cell.2006.01.050; Hallem EA, 2004, TRENDS GENET, V20, P453, DOI 10.1016/j.tig.2004.06.015; Hallem EA, 2004, NATURE, V427, P212, DOI 10.1038/427212a; Hill CA, 2002, SCIENCE, V298, P176, DOI 10.1126/science.1076196; Iatrou K, 2008, INSECT BIOCHEM MOLEC, V38, P268, DOI 10.1016/j.ibmb.2007.11.008; JOHNSON R, 1992, VIROLOGY, V190, P815, DOI 10.1016/0042-6822(92)90919-G; Jordan BA, 1999, NATURE, V399, P697, DOI 10.1038/21441; Jordan MD, 2009, CHEM SENSES, V34, P383, DOI 10.1093/chemse/bjp010; Kapust RB, 2001, PROTEIN ENG, V14, P993, DOI 10.1093/protein/14.12.993; Kaupp UB, 2010, NAT REV NEUROSCI, V11, P188, DOI 10.1038/nrn2789; Keith DE, 1996, J BIOL CHEM, V271, P19021, DOI 10.1074/jbc.271.32.19021; Keith MB, 1999, BIOTECHNOL PROGR, V15, P1046, DOI 10.1021/bp990119f; Kiely A, 2007, J NEUROSCI METH, V159, P189, DOI 10.1016/j.jneumeth.2006.07.005; Kost TA, 2005, NAT BIOTECHNOL, V23, P567, DOI 10.1038/nbt1095; Krietsch T, 2006, MOL ENDOCRINOL, V20, P3146, DOI 10.1210/me.2006-0129; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Lee SP, 2000, NEUROPSYCHOPHARMACOL, V23, pS32, DOI 10.1016/S0893-133X(00)00155-X; Leontiadis LJ, 2009, CELL SIGNAL, V21, P1218, DOI 10.1016/j.cellsig.2009.03.013; Lu M, 1997, J BIOL CHEM, V272, P30724, DOI 10.1074/jbc.272.49.30724; Lu ML, 1996, VIROLOGY, V218, P103, DOI 10.1006/viro.1996.0170; Lundin C, 2007, FEBS LETT, V581, P5601, DOI 10.1016/j.febslet.2007.11.007; Megaritis G, 2000, RECEPTOR CHANNEL, V7, P199; Milligan G, 2010, CURR OPIN PHARMACOL, V10, P23, DOI 10.1016/j.coph.2009.09.010; Morou E, 2005, J PHARMACOL EXP THER, V315, P1368, DOI 10.1124/jpet.105.089946; Nakagawa T, 2009, CURR OPIN NEUROBIOL, V19, P284, DOI 10.1016/j.conb.2009.07.015; Pellegrino M, 2009, J EXP BIOL, V212, P1973, DOI 10.1242/jeb.023036; Pelletier J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010090; Pitts RJ, 2004, P NATL ACAD SCI USA, V101, P5058, DOI 10.1073/pnas.0308146101; Rajagopal S, 2010, NAT REV DRUG DISCOV, V9, P373, DOI 10.1038/nrd3024; Rath A, 2009, P NATL ACAD SCI USA, V106, P1760, DOI 10.1073/pnas.0813167106; Sagne C, 1996, BIOCHEM J, V316, P825, DOI 10.1042/bj3160825; Sahni J, 2007, BIOCHEM J, V401, P505, DOI 10.1042/BJ20060673; Sarramegna V, 2005, PROTEIN EXPRES PURIF, V43, P85, DOI 10.1016/j.pep.2005.05.007; Sato K, 2008, NATURE, V452, P1002, DOI 10.1038/nature06850; Seck T, 2005, MOL ENDOCRINOL, V19, P2132, DOI 10.1210/me.2004-0472; Smart R, 2008, INSECT BIOCHEM MOLEC, V38, P770, DOI 10.1016/j.ibmb.2008.05.002; Swevers L, 2002, J BIOL CHEM, V277, P41637, DOI 10.1074/jbc.M203581200; Swevers L, 2005, CELL MOL LIFE SCI, V62, P919, DOI 10.1007/s00018-005-4537-1; Swevers L, 2003, INSECT BIOCHEM MOLEC, V33, P1285, DOI 10.1016/j.ibmb.2003.06.012; Swevers L, 1999, INSECT BIOCHEM MOLEC, V29, P955, DOI 10.1016/S0965-1748(99)00059-4; Szerencsei RT, 2000, J BIOL CHEM, V275, P669, DOI 10.1074/jbc.275.1.669; Vicentic A, 2002, J PHARMACOL EXP THER, V302, P58, DOI 10.1124/jpet.302.1.58; Wang GR, 2010, P NATL ACAD SCI USA, V107, P4418, DOI 10.1073/pnas.0913392107; Wetzel CH, 2001, P NATL ACAD SCI USA, V98, P9377, DOI 10.1073/pnas.151103998; Wicher D, 2008, NATURE, V452, P1007, DOI 10.1038/nature06861; WICKHAM TJ, 1992, BIOTECHNOL PROGR, V8, P391, DOI 10.1021/bp00017a003; Wistrand M, 2006, PROTEIN SCI, V15, P509, DOI 10.1110/ps.051745906; Xia YF, 2008, P NATL ACAD SCI USA, V105, P6433, DOI 10.1073/pnas.0801007105	66	43	50	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2010	5	11							e15428	10.1371/journal.pone.0015428	http://dx.doi.org/10.1371/journal.pone.0015428			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	800AR	21082026	gold, Green Submitted, Green Published			2022-12-27	WOS:000293329500004
J	Ayaz, A; Saleem, S				Ayaz, Afsheen; Saleem, Sarah			Neonatal Mortality and Prevalence of Practices for Newborn Care in a Squatter Settlement of Karachi, Pakistan: A Cross-Sectional Study	PLOS ONE			English	Article							SYLHET DISTRICT; BANGLADESH; INTERVENTIONS; PREVENTION; TRIALS; IMPACT; COST; ASIA	Background: During the past two decades there has been a sustained decline in child and infant mortality, however neonatal mortality has remained relatively unchanged. Almost all neonatal deaths (99%) occur in developing countries, where the majority are delivered at homes. Evidence suggests that these deaths could be prevented by simple, inexpensive practices and interventions during the pregnancy, delivery and postnatal period. In Pakistan over the last decade extensive efforts have been made by the international donors and government to implement these practices. However, limited attempts have been made to explore if these efforts have made a difference at the grass root level. This study assessed the burden of neonatal mortality and prevalence of practices for newborn care in a squatter settlement of Karachi, Pakistan. Methodology/Principal Findings: A community based cross-sectional study was performed. A pre-tested structured questionnaire was administered to 565 women who had recently delivered. Information was collected on neonatal morbidity, mortality and practices of women regarding care during pregnancy, child birth and for newborn, till 28th day of birth. Although 70% of women mentioned receiving antenatal care by a skilled provider, only 54.5% had four or more visits. Tetanus toxoid was received by 79% of women while only 56% delivered at a health care facility by a skilled attendant. Newborn care practices like bathing the baby immediately after birth (56%), giving pre-lacteals (79.5%), late initiation of breast feeding (80.3%), application of substances on umbilical cord (58%) and body massage (89%) were common. Most neonates (81.1%) received BCG injection and polio drops after birth. Neonatal mortality rate was 27/1000 live births with the majority of deaths occurring during the first three days of life. Conclusion: Even after years of efforts by government and nongovernmental sector to reduce newborn morbidity and mortality, inadequate antenatal care, home deliveries and unhealthy newborn care practices are highly prevalent. This leads us to important questions of why practices and behaviors have not changed. Who is responsible and what strategies are needed to bring this change?	[Ayaz, Afsheen] Aga Khan Univ Hosp, Dept Microbiol, Karachi, Pakistan; [Saleem, Sarah] Aga Khan Univ Hosp, Dept Community Hlth Sci, Karachi, Pakistan	Aga Khan University; Aga Khan University	Ayaz, A (corresponding author), Aga Khan Univ Hosp, Dept Microbiol, Karachi, Pakistan.	afsheen.ayaz@aku.edu			Aga Khan University	Aga Khan University	This study was conducted as a requirement (thesis) of MSc Epidemiology and Biostatistics and was funded by the Aga Khan University. The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Baqui AH, 2008, B WORLD HEALTH ORGAN, V86, P796, DOI 10.2471/BLT.07.042226; Baqui AH, 2008, LANCET, V371, P1936, DOI 10.1016/S0140-6736(08)60835-1; BENNETT J, 1995, INT J EPIDEMIOL, V24, P643, DOI 10.1093/ije/24.3.643; Berg C J, 1995, J Am Med Womens Assoc (1972), V50, P182; Berry RJ, 1999, NEW ENGL J MED, V341, P1485, DOI 10.1056/NEJM199911113412001; Bhutta ZA, 2005, PEDIATRICS, V115, P519, DOI 10.1542/peds.2004-1441; Bhutta ZA, 2008, B WORLD HEALTH ORGAN, V86, P452, DOI 10.2471/BLT.07.045849; Bower C, 1996, J ROY SOC MED, V89, P436, DOI 10.1177/014107689608900806; Carroli G, 2001, LANCET, V357, P1565, DOI 10.1016/S0140-6736(00)04723-1; Darmstadt GL, 2008, HEALTH POLICY PLANN, V23, P101, DOI 10.1093/heapol/czn001; Darmstadt GL, 2005, LANCET, V365, P1039, DOI 10.1016/S0140-6736(05)74228-8; Darmstadt GL, 2005, LANCET, V365, P977, DOI 10.1016/S0140-6736(05)71088-6; Darmstadt GL, 2003, B WORLD HEALTH ORGAN, V81, P224; Hyder AA, 2003, BJOG-INT J OBSTET GY, V110, P894, DOI 10.1111/j.1471-0528.2003.02446.x; Jehan I, 2007, AM J OBSTET GYNECOL, V197, DOI 10.1016/j.ajog.2007.07.012; Jokhio AH, 2005, NEW ENGL J MED, V352, P2091, DOI 10.1056/NEJMsa042830; Kumar V, 2008, LANCET, V372, P1151, DOI 10.1016/S0140-6736(08)61483-X; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; Moran AC, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-54; Moss William, 2002, J Perinatol, V22, P484; Mullany LC, 2005, J TROP PEDIATRICS, V51, P82, DOI 10.1093/tropej/fmh083; National Institute of Population Studies, 2012, PAK DEM HLTH SURV 20; SANIA N, 2010, CHOKED PIPES REFORMI; *SAV CHILDR, 2004, EV NEWB HLTH REC CAR; Saving Newborn Lives, 2001, SAV NEWB LIV STAT WO, P1; SENLET P, 2008, MIDTERM EVALUATION U; Sreeramareddy Chandrashekhar T, 2006, BMC Pregnancy Childbirth, V6, P27, DOI 10.1186/1471-2393-6-27; Stanton C, 2006, LANCET, V367, P1487, DOI 10.1016/S0140-6736(06)68586-3; Stordal Ketil, 2009, Tidsskr Nor Laegeforen, V129, P2270, DOI 10.4045/tidsskr.08.0697; TINKER A, GLOB PUBLIC HLTH, V5, P28; *UNICEF WHO, 10 STEPS SUCC BREAST; United Nations Childrens Fund, MAT NEWB HLTH DISP C; Villar J, 2001, LANCET, V357, P1551, DOI 10.1016/S0140-6736(00)04722-X; Winch PJ, 2005, LANCET, V366, P478, DOI 10.1016/S0140-6736(05)66836-5; World Health Organization, 2006, NEON PER MORT COUNTR; World Health Organization, WORLD HLTH REP 2005; World Health Organization and the United Nations Children's Fund, 2009, BAB FRIENDL HOSP IN; WHOCHD989	38	32	32	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2010	5	11							e13783	10.1371/journal.pone.0013783	http://dx.doi.org/10.1371/journal.pone.0013783			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673FY	21072175	Green Published, gold, Green Submitted			2022-12-27	WOS:000283645700008
J	Hahn, P; Wegener, I; Burrells, A; Bose, J; Wolf, A; Erck, C; Butler, D; Schofield, CJ; Bottger, A; Lengeling, A				Hahn, Phillip; Wegener, Ivonne; Burrells, Alison; Boese, Jens; Wolf, Alexander; Erck, Christian; Butler, Danica; Schofield, Christopher J.; Boettger, Angelika; Lengeling, Andreas			Analysis of Jmjd6 Cellular Localization and Testing for Its Involvement in Histone Demethylation	PLOS ONE			English	Article							PHOSPHATIDYLSERINE RECEPTOR; NUCLEAR-LOCALIZATION; CHROMATIN REGULATION; PROTEIN; METHYLATION; GENE; 2-OXOGLUTARATE; CLEARANCE; LANGUAGE; HOMOLOG	Background: Methylation of residues in histone tails is part of a network that regulates gene expression. JmjC domain containing proteins catalyze the oxidative removal of methyl groups on histone lysine residues. Here, we report studies to test the involvement of Jumonji domain-containing protein 6 (Jmjd6) in histone lysine demethylation. Jmjd6 has recently been shown to hydroxylate RNA splicing factors and is known to be essential for the differentiation of multiple tissues and cells during embryogenesis. However, there have been conflicting reports as to whether Jmjd6 is a histone-modifying enzyme. Methodology/Principal Findings: Immunolocalization studies reveal that Jmjd6 is distributed throughout the nucleoplasm outside of regions containing heterochromatic DNA, with occasional localization in nucleoli. During mitosis, Jmjd6 is excluded from the nucleus and reappears in the telophase of the cell cycle. Western blot analyses confirmed that Jmjd6 forms homo-multimers of different molecular weights in the nucleus and cytoplasm. A comparison of mono-, di-, and trimethylation states of H3K4, H3K9, H3K27, H3K36, and H4K20 histone residues in wildtype and Jmjd6-knockout cells indicate that Jmjd6 is not involved in the demethylation of these histone lysine residues. This is further supported by overexpression of enzymatically active and inactive forms of Jmjd6 and subsequent analysis of histone methylation patterns by immunocytochemistry and western blot analysis. Finally, treatment of cells with RNase A and DNase I indicate that Jmjd6 may preferentially associate with RNA/RNA complexes and less likely with chromatin. Conclusions/Significance: Taken together, our results provide further evidence that Jmjd6 is unlikely to be involved in histone lysine demethylation. We confirmed that Jmjd6 forms multimers and showed that nuclear localization of the protein involves association with a nucleic acid matrix.	[Hahn, Phillip; Wegener, Ivonne; Boese, Jens; Lengeling, Andreas] Helmholtz Ctr Infect Res, Dept Expt Mouse Genet, Braunschweig, Germany; [Wolf, Alexander; Boettger, Angelika] Univ Munich, Dept Biol 2, Planeeg Martinsried, Germany; [Erck, Christian] Synapt Syst GmbH, Gottingen, Germany; [Butler, Danica; Schofield, Christopher J.] Univ Oxford, Chem Res Lab, Oxford, England; [Butler, Danica; Schofield, Christopher J.] Univ Oxford, Oxford Ctr Integrat Syst Biol, Oxford, England; [Lengeling, Andreas] Univ Edinburgh, Roslin Inst, Roslin, Midlothian, Scotland; [Lengeling, Andreas] Univ Edinburgh, Royal Dick Sch Vet Studies, Roslin, Midlothian, Scotland	Helmholtz Association; Helmholtz-Center for Infection Research; University of Munich; University of Oxford; University of Oxford; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh	Hahn, P (corresponding author), Helmholtz Ctr Infect Res, Dept Expt Mouse Genet, Braunschweig, Germany.	Andreas.Lengeling@ed.ac.uk	Hahn, Phillip/A-4812-2012; Wolf, Alexander/K-2178-2013	Hahn, Phillip/0000-0002-8741-3603; Wolf, Alexander/0000-0003-0649-3363; Schofield, Christopher/0000-0002-0290-6565; Bottger, Angelika/0000-0003-3273-9558; Burrells, Alison/0000-0002-8608-8781	Deutsche Forschungsgemeinschaft [LE2130/2-1, BO1748-3]; UK Biotechnology and Biological Sciences Research Council	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This study was funded by the Deutsche Forschungsgemeinschaft (A.L., LE2130/2-1; A.B., BO1748-3) and the UK Biotechnology and Biological Sciences Research Council (A.L. and C.J.S.). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agger K, 2007, NATURE, V449, P731, DOI 10.1038/nature06145; Allis CD, 2007, CELL, V131, P633, DOI 10.1016/j.cell.2007.10.039; Andersen JS, 2005, NATURE, V433, P77, DOI 10.1038/nature03207; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Bernstein BE, 2007, CELL, V128, P669, DOI 10.1016/j.cell.2007.01.033; BOSE J, 2004, J BIOL LONDON, V3, pNIL5; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Chang BS, 2007, SCIENCE, V318, P444, DOI 10.1126/science.1145801; Christensen J, 2007, CELL, V128, P1063, DOI 10.1016/j.cell.2007.02.003; Cikala M, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-26; Cui P, 2004, EXP CELL RES, V293, P154, DOI 10.1016/j.yexcr.2003.09.023; De Santa F, 2007, CELL, V130, P1083, DOI 10.1016/j.cell.2007.08.019; Dellaire G, 2003, NUCLEIC ACIDS RES, V31, P328, DOI 10.1093/nar/gkg018; Eissenberg JC, 2007, NAT STRUCT MOL BIOL, V14, P344, DOI 10.1038/nsmb1217; Hahn P, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-293; Hake SB, 2006, P NATL ACAD SCI USA, V103, P6428, DOI 10.1073/pnas.0600803103; Hewitson KS, 2008, J BIOL CHEM, V283, P25971, DOI 10.1074/jbc.M804999200; Hong JR, 2004, DEVELOPMENT, V131, P5417, DOI 10.1242/dev.01409; Hong X, 2010, P NATL ACAD SCI USA, V107, P14568, DOI 10.1073/pnas.1008832107; Iwase S, 2007, CELL, V128, P1077, DOI 10.1016/j.cell.2007.02.017; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Klose RJ, 2007, NAT REV MOL CELL BIO, V8, P307, DOI 10.1038/nrm2143; Klose RJ, 2007, CELL, V128, P889, DOI 10.1016/j.cell.2007.02.013; Klose RJ, 2006, NAT REV GENET, V7, P715, DOI 10.1038/nrg1945; Klose RJ, 2006, NATURE, V442, P312, DOI 10.1038/nature04853; Kopito RR, 2000, TRENDS CELL BIOL, V10, P524, DOI 10.1016/S0962-8924(00)01852-3; Krieser RJ, 2007, DEVELOPMENT, V134, P2407, DOI 10.1242/dev.02860; Kunisaki Y, 2004, BLOOD, V103, P3362, DOI 10.1182/blood-2003-09-3245; Lan F, 2007, NATURE, V449, P689, DOI 10.1038/nature06192; Lee MG, 2007, CELL, V128, P877, DOI 10.1016/j.cell.2007.02.004; Li MO, 2003, SCIENCE, V302, P1560, DOI 10.1126/science.1087621; Liang G, 2007, NAT STRUCT MOL BIOL, V14, P243, DOI 10.1038/nsmb1204; Loenarz C, 2008, NAT CHEM BIOL, V4, P152, DOI 10.1038/nchembio0308-152; Mantri M, 2010, J MOL BIOL, V401, P211, DOI 10.1016/j.jmb.2010.05.054; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Mayer C, 2005, GENE DEV, V19, P933, DOI 10.1101/gad.333205; Meissner A, 2007, ENVIRON MICROBIOL, V9, P2475, DOI 10.1111/j.1462-2920.2007.01366.x; Mekhail K, 2004, NAT CELL BIOL, V6, P642, DOI 10.1038/ncb1144; Metzger E, 2005, NATURE, V437, P436, DOI 10.1038/nature04020; Mitchell JE, 2006, J BIOL CHEM, V281, P5718, DOI 10.1074/jbc.M509775200; Peters AHFM, 2003, MOL CELL, V12, P1577, DOI 10.1016/S1097-2765(03)00477-5; Reinberg D, 2004, COLD SPRING HARB SYM, V69, P171, DOI 10.1101/sqb.2004.69.171; Schneider Juergen E., 2004, BMC Developmental Biology, V4, P1; Schotta G, 2004, GENE DEV, V18, P1251, DOI 10.1101/gad.300704; Schubeler D, 2004, GENE DEV, V18, P1263, DOI 10.1101/gad.1198204; Secombe J, 2007, GENE DEV, V21, P537, DOI 10.1101/gad.1523007; Seward DJ, 2007, NAT STRUCT MOL BIOL, V14, P240, DOI 10.1038/nsmb1200; Shi Y, 2007, MOL CELL, V25, P1, DOI 10.1016/j.molcel.2006.12.010; Shi YJ, 2005, MOL CELL, V19, P857, DOI 10.1016/j.molcel.2005.08.027; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Tahiliani M, 2007, NATURE, V447, P601, DOI 10.1038/nature05823; Takeuchi T, 2006, DEV DYNAM, V235, P2449, DOI 10.1002/dvdy.20851; Tibrewal N, 2007, MOL CELL BIOCHEM, V304, P119, DOI 10.1007/s11010-007-9492-8; TORRES RM, 1997, LAB PROTOCOLS CONDIT, P62; Tsukada Y, 2006, NATURE, V439, P811, DOI 10.1038/nature04433; Tsukada YI, 2010, GENE DEV, V24, P432, DOI 10.1101/gad.1864410; Webby CJ, 2009, SCIENCE, V325, P90, DOI 10.1126/science.1175865; Wesierska-Gadek J, 2003, ANN NY ACAD SCI, V1010, P266, DOI 10.1196/annals.1299.046; Yamane K, 2007, MOL CELL, V25, P801, DOI 10.1016/j.molcel.2007.03.001	61	57	59	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2010	5	10							e13769	10.1371/journal.pone.0013769	http://dx.doi.org/10.1371/journal.pone.0013769			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673FU	21060799	Green Published, Green Submitted, gold			2022-12-27	WOS:000283645300044
J	Leignadier, J; Labrecque, N				Leignadier, Julie; Labrecque, Nathalie			Epitope Density Influences CD8(+) Memory T Cell Differentiation	PLOS ONE			English	Article							DENDRITIC CELLS; EFFECTOR; RECEPTOR; ANTIGEN; GENERATION; ACTIVATION; EXPRESSION; BET; EOMESODERMIN; CONTRIBUTE	Background: The generation of long-lived memory T cells is critical for successful vaccination but the factors controlling their differentiation are still poorly defined. We tested the hypothesis that the strength of T cell receptor (TCR) signaling contributed to memory CD8(+) T cell generation. Methodology/Principal Findings: We manipulated the density of antigenic epitope presented by dendritic cells to mouse naive CD8(+) T cells, without varying TCR affinity. Our results show that a two-fold decrease in antigen dose selectively affects memory CD8(+) T cell generation without influencing T cell expansion and acquisition of effector functions. Moreover, we show that low antigen dose alters the duration of the interaction between T cells and dendritic cells and finely tunes the expression level of the transcription factors Eomes and Bcl6. Furthermore, we demonstrate that priming with higher epitope density results in a 2-fold decrease in the expression of Neuron-derived orphan nuclear receptor 1 (Nor-1) and this correlates with a lower level of conversion of Bcl-2 into a pro-apoptotic molecule and an increased number of memory T cells. Conclusions: Our results show that the amount of antigen encountered by naive CD8(+) T cells following immunization with dendritic cells does not influence the generation of functional effector CD8(+) T cells but rather the number of CD8(+) memory T cells that persist in the host. Our data support a model where antigenic epitope density sensed by CD8(+) T cells at priming influences memory generation by modulating Bcl6, Eomes and Nor-1 expression.	[Leignadier, Julie; Labrecque, Nathalie] Univ Montreal, Maisonneuve Rosemont Hosp, Res Ctr, Montreal, PQ, Canada; [Leignadier, Julie; Labrecque, Nathalie] Univ Montreal, Dept Microbiol & Immunol, Montreal, PQ, Canada; [Labrecque, Nathalie] Univ Montreal, Dept Med, Montreal, PQ, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal	Leignadier, J (corresponding author), Univ Montreal, Maisonneuve Rosemont Hosp, Res Ctr, Montreal, PQ, Canada.	nathalie.labrecque@umontreal.ca	leignadier, julie/G-2701-2017	leignadier, julie/0000-0002-6546-1874	Canadian Institutes of Health Research (CIHR) [MOP-77545]; Department of Microbiology and Immunology of the University of Montreal	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Department of Microbiology and Immunology of the University of Montreal	This work was supported by a grant (MOP-77545) from the Canadian Institutes of Health Research (CIHR) to N.L. N.L. was supported by a CIHR New Investigator award and is currently a Senior Scholar of the FRSQ. J. L. received a studentship from the Department of Microbiology and Immunology of the University of Montreal. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badovinac VP, 2005, NAT MED, V11, P748, DOI 10.1038/nm1257; Benvenuti F, 2004, J IMMUNOL, V172, P292, DOI 10.4049/jimmunol.172.1.292; Cheng LEC, 1997, EMBO J, V16, P1865, DOI 10.1093/emboj/16.8.1865; Davis MM, 2007, ANNU REV IMMUNOL, V25, P681, DOI 10.1146/annurev.immunol.24.021605.090600; Ebert PJR, 2009, NAT IMMUNOL, V10, P1162, DOI 10.1038/ni.1797; Fukuda T, 1997, J EXP MED, V186, P439, DOI 10.1084/jem.186.3.439; Gett AV, 2003, NAT IMMUNOL, V4, P355, DOI 10.1038/ni908; HEDVAT CV, 1995, MOL ENDOCRINOL, V9, P1692, DOI 10.1210/me.9.12.1692; Henrickson SE, 2008, NAT IMMUNOL, V9, P282, DOI 10.1038/ni1559; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; HOU S, 1994, NATURE, V369, P652, DOI 10.1038/369652a0; Ichii H, 2004, J IMMUNOL, V173, P883, DOI 10.4049/jimmunol.173.2.883; Ichii H, 2002, NAT IMMUNOL, V3, P558, DOI 10.1038/ni802; Ichii H, 2007, INT IMMUNOL, V19, P427, DOI 10.1093/intimm/dxm007; Intlekofer AM, 2005, NAT IMMUNOL, V6, P1236, DOI 10.1038/ni1268; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Krogsgaard M, 2005, NATURE, V434, P238, DOI 10.1038/nature03391; La Gruta NL, 2006, P NATL ACAD SCI USA, V103, P994, DOI 10.1073/pnas.0510429103; Labrecque N, 2001, IMMUNITY, V15, P71, DOI 10.1016/S1074-7613(01)00170-4; Lacombe MH, 2005, J IMMUNOL, V175, P4400, DOI 10.4049/jimmunol.175.7.4400; LEIGNADIER J, IMMUNOL CELL BIOL; Lo WL, 2009, NAT IMMUNOL, V10, P1155, DOI 10.1038/ni.1796; Lozza L, 2008, EUR J IMMUNOL, V38, P30, DOI 10.1002/eji.200737852; Norbury CC, 2001, J IMMUNOL, V166, P4355, DOI 10.4049/jimmunol.166.7.4355; Scholer A, 2008, IMMUNITY, V28, P258, DOI 10.1016/j.immuni.2007.12.016; Takemoto N, 2006, J IMMUNOL, V177, P7515, DOI 10.4049/jimmunol.177.11.7515; Teixeiro E, 2009, SCIENCE, V323, P502, DOI 10.1126/science.1163612; Thompson J, 2008, J EXP MED, V205, P1029, DOI 10.1084/jem.20080101; Tunyaplin C, 2004, J IMMUNOL, V173, P1158, DOI 10.4049/jimmunol.173.2.1158; Wherry EJ, 2002, J IMMUNOL, V168, P4455, DOI 10.4049/jimmunol.168.9.4455; Williams MA, 2008, IMMUNITY, V28, P533, DOI 10.1016/j.immuni.2008.02.014; Williams MA, 2007, ANNU REV IMMUNOL, V25, P171, DOI 10.1146/annurev.immunol.25.022106.141548; Wulfing C, 2002, NAT IMMUNOL, V3, P42, DOI 10.1038/ni741; Yachi PP, 2005, NAT IMMUNOL, V6, P785, DOI 10.1038/ni1220; Zehn D, 2009, NATURE, V458, P211, DOI 10.1038/nature07657	35	25	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2010	5	10							e13740	10.1371/journal.pone.0013740	http://dx.doi.org/10.1371/journal.pone.0013740			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673FU	21060788	Green Published, Green Submitted, gold			2022-12-27	WOS:000283645300020
J	Lucchi, NW; Demas, A; Narayanan, J; Sumari, D; Kabanywanyi, A; Kachur, SP; Barnwell, JW; Udhayakumar, V				Lucchi, Naomi W.; Demas, Allison; Narayanan, Jothikumar; Sumari, Deborah; Kabanywanyi, Abdunoor; Kachur, S. Patrick; Barnwell, John W.; Udhayakumar, Venkatachalam			Real-Time Fluorescence Loop Mediated Isothermal Amplification for the Diagnosis of Malaria	PLOS ONE			English	Article							FALCIPARUM-MALARIA; RAPID DETECTION; VIRUS; SYSTEM; ASSAY	Background: Molecular diagnostic methods can complement existing tools to improve the diagnosis of malaria. However, they require good laboratory infrastructure thereby restricting their use to reference laboratories and research studies. Therefore, adopting molecular tools for routine use in malaria endemic countries will require simpler molecular platforms. The recently developed loop-mediated isothermal amplification (LAMP) method is relatively simple and can be improved for better use in endemic countries. In this study, we attempted to improve this method for malaria diagnosis by using a simple and portable device capable of performing both the amplification and detection (by fluorescence) of LAMP in one platform. We refer to this as the RealAmp method. Methodology and Significant Findings: Published genus-specific primers were used to test the utility of this method. DNA derived from different species of malaria parasites was used for the initial characterization. Clinical samples of P. falciparum were used to determine the sensitivity and specificity of this system compared to microscopy and a nested PCR method. Additionally, directly boiled parasite preparations were compared with a conventional DNA isolation method. The RealAmp method was found to be simple and allowed real-time detection of DNA amplification. The time to amplification varied but was generally less than 60 minutes. All human-infecting Plasmodium species were detected. The sensitivity and specificity of RealAmp in detecting P. falciparum was 96.7% and 91.7% respectively, compared to microscopy and 98.9% and 100% respectively, compared to a standard nested PCR method. In addition, this method consistently detected P. falciparum from directly boiled blood samples. Conclusion: This RealAmp method has great potential as a field usable molecular tool for diagnosis of malaria. This tool can provide an alternative to conventional PCR based diagnostic methods for field use in clinical and operational programs.	[Lucchi, Naomi W.; Demas, Allison; Kachur, S. Patrick; Barnwell, John W.; Udhayakumar, Venkatachalam] Ctr Dis Control & Prevent, Malaria Branch, Div Parasit Dis & Malaria, Ctr Global Hlth, Atlanta, GA 30333 USA; [Lucchi, Naomi W.; Udhayakumar, Venkatachalam] Atlanta Res & Educ Fdn, VA Med Ctr, Decatur, GA USA; [Narayanan, Jothikumar] Ctr Dis Control & Prevent, Waterborne Dis Prevent Branch, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA USA; [Sumari, Deborah; Kabanywanyi, Abdunoor] Ifakara Hlth Inst, Dar Es Salaam, Tanzania	Centers for Disease Control & Prevention - USA; US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System; Centers for Disease Control & Prevention - USA; Ifakara Health Institute	Lucchi, NW (corresponding author), Ctr Dis Control & Prevent, Malaria Branch, Div Parasit Dis & Malaria, Ctr Global Hlth, 4770 Buford Highway,Mail Stop F-12, Atlanta, GA 30333 USA.	NLucchi@cdc.gov	Kachur, Patrick/ABE-7220-2021	Lucchi, Naomi/0000-0001-8789-8041	Centers for Disease Control and Prevention - University of Georgia (CDC-UGA); Association of Public Health Laboratories/Emerging Infectious Disease; Atlanta Research and Education Foundation/VA Medical Center, Atlanta GA	Centers for Disease Control and Prevention - University of Georgia (CDC-UGA); Association of Public Health Laboratories/Emerging Infectious Disease; Atlanta Research and Education Foundation/VA Medical Center, Atlanta GA	Funding for this work was received from the Centers for Disease Control and Prevention - University of Georgia (CDC-UGA) collaborative Seed Award Program. Allison Demas was supported by the Association of Public Health Laboratories/Emerging Infectious Disease Fellowship. Naomi Lucchi is supported by Atlanta Research and Education Foundation/VA Medical Center, Atlanta GA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annaka Toshimitsu, 2003, Rinsho Biseibutshu Jinsoku Shindan Kenkyukai Shi, V14, P25; Bronzan RN, 2008, MOL DIAGN THER, V12, P299, DOI 10.1007/BF03256295; Cox-Singh J, 2008, CLIN INFECT DIS, V46, P165, DOI 10.1086/524888; Fukuda S, 2006, J CLIN MICROBIOL, V44, P1376, DOI 10.1128/JCM.44.4.1376-1381.2006; Gamboa D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008091; Han ET, 2007, J CLIN MICROBIOL, V45, P2521, DOI 10.1128/JCM.02117-06; Imai M, 2006, VACCINE, V24, P6679, DOI 10.1016/j.vaccine.2006.05.046; Jain V, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-83; Lin XA, 2009, DIAGN MICR INFEC DIS, V63, P237, DOI 10.1016/j.diagmicrobio.2008.10.012; Nagamine K, 2002, MOL CELL PROBE, V16, P223, DOI 10.1006/mcpr.2002.0415; Njiru ZK, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000147; NJIRU ZK, 2010, EXP PARASITOL; Notomi T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e63; Parida M, 2004, J CLIN MICROBIOL, V42, P257, DOI 10.1128/JCM.42.1.257-263.2004; Paris DH, 2007, AM J TROP MED HYG, V77, P972, DOI 10.4269/ajtmh.2007.77.972; Poon LLM, 2006, CLIN CHEM, V52, P303; Singh B, 1999, AM J TROP MED HYG, V60, P687, DOI 10.4269/ajtmh.1999.60.687; Thai HTC, 2004, J CLIN MICROBIOL, V42, P1956, DOI 10.1128/JCM.42.5.1956-1961.2004; Varga A, 2006, J VIROL METHODS, V138, P184, DOI 10.1016/j.jviromet.2006.08.014; WHO, 2010, GUID TREATM MAL, V2nd; World Health Organization, 2008, WORLD MAL REP; Yamamura M, 2009, JPN J INFECT DIS, V62, P20; Zheng CF, 2002, PARASITOL INT, V51, P1, DOI 10.1016/S1383-5769(01)00094-0	23	160	174	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2010	5	10							e13733	10.1371/journal.pone.0013733	http://dx.doi.org/10.1371/journal.pone.0013733			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673FU	21060829	Green Published, Green Submitted, gold			2022-12-27	WOS:000283645300014
J	Verpelli, C; Bertani, G; Cea, V; Patti, M; Bikfalvi, A; Bello, L; Sala, C				Verpelli, Chiara; Bertani, Giulio; Cea, Valentina; Patti, Monica; Bikfalvi, Andreas; Bello, Lorenzo; Sala, Carlo			Anti-Angiogenic Therapy Induces Integrin-Linked Kinase 1 Up-Regulation in a Mouse Model of Glioblastoma	PLOS ONE			English	Article							GLUTATHIONE-S-TRANSFERASE; DEPENDENT PROTEIN-KINASE; MALIGNANT GLIOMA; ILK; CELLS; GROWTH; INHIBITION; ACTIVATION; TUMOR; MICROENVIRONMENT	Background: In order to improve our understanding of the molecular pathways that mediate tumor proliferation and angiogenesis, and to evaluate the biological response to anti-angiogenic therapy, we analyzed the changes in the protein profile of glioblastoma in response to treatment with recombinant human Platelet Factor 4-DLR mutated protein (PF4-DLR), an inhibitor of angiogenesis. Methodology/Principal Findings: U87-derived experimental glioblastomas were grown in the brain of xenografted nude mice, treated with PF4-DLR, and processed for proteomic analysis. More than fifty proteins were differentially expressed in response to PF4-DLR treatment. Among them, integrin-linked kinase 1 (ILK1) signaling pathway was first down-regulated but then up-regulated after treatment for prolonged period. The activity of PF4-DLR can be increased by simultaneously treating mice orthotopically implanted with glioblastomas, with ILK1-specific siRNA. As ILK1 is related to malignant progression and a poor prognosis in various types of tumors, we measured ILK1 expression in human glioblatomas, astrocytomas and oligodendrogliomas, and found that it varied widely; however, a high level of ILK1 expression was correlated to a poor prognosis. Conclusions/Significance: Our results suggest that identifying the molecular pathways induced by anti-angiogenic therapies may help the development of combinaatorial treatment strategies that increase the therapeutic efficacy of angiogenesis inhibitors by association with specific agents that disrupt signaling in tumor cells.	[Verpelli, Chiara; Bertani, Giulio; Cea, Valentina; Patti, Monica; Bikfalvi, Andreas; Bello, Lorenzo; Sala, Carlo] Univ Milan, ELAT European Lab Angiogenesis & Translat Res, Milan, Italy; [Verpelli, Chiara; Cea, Valentina; Patti, Monica; Sala, Carlo] Univ Milan, CNR, Inst Neurosci, Milan, Italy; [Verpelli, Chiara; Cea, Valentina; Patti, Monica; Sala, Carlo] Univ Milan, Dept Pharmacol, Milan, Italy; [Bikfalvi, Andreas] INSERM, U920 Ex E0113, Talence, France; [Bikfalvi, Andreas] Univ Bordeaux 1, F-33405 Talence, France; [Verpelli, Chiara; Bertani, Giulio; Bello, Lorenzo] Univ Milan, Dept Neurol Sci, Milan, Italy	University of Milan; Consiglio Nazionale delle Ricerche (CNR); University of Milan; University of Milan; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; University of Milan	Verpelli, C (corresponding author), Univ Milan, ELAT European Lab Angiogenesis & Translat Res, Milan, Italy.	lorenzo.bello@unimi.it; c.sala@in.cnr.it	Sala, Carlo/A-2493-2009; Bello, Lorenzo/AAB-2884-2022; Verpelli, Chiara/AAH-1140-2020; Verpelli, Chiara/K-6673-2016; Bertani, Giulio/ABD-8401-2021	Sala, Carlo/0000-0003-0662-9523; Bello, Lorenzo/0000-0001-6797-7105; Verpelli, Chiara/0000-0003-2949-9725; Verpelli, Chiara/0000-0003-2949-9725; Bertani, Giulio/0000-0003-1470-3391	AIRC (the Italian Cancer Research Association); Fondazione Italo Monzino; Fondazione Berlucchi; Association sur la Recherche sur le Cancer (ARC); Ligue contre le Cancer; Fondazione CARIPLO [2009.264]; Regione Lombardia	AIRC (the Italian Cancer Research Association)(Fondazione AIRC per la ricerca sul cancro); Fondazione Italo Monzino; Fondazione Berlucchi; Association sur la Recherche sur le Cancer (ARC); Ligue contre le Cancer(Ligue nationale contre le cancer); Fondazione CARIPLO(Fondazione Cariplo); Regione Lombardia(Regione Lombardia)	This study was supported by grants from the AIRC (the Italian Cancer Research Association), Fondazione Italo Monzino and Fondazione Berlucchi (to LB), from "the Association sur la Recherche sur le Cancer (ARC)" and the "Ligue contre le Cancer" (to AB) and Fondazione CARIPLO (grant 2009.264) and Regione Lombardia (grant TERDISMENTAL) (to CS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali-Osman F, 1997, CLIN CANCER RES, V3, P2253; Almond JB, 2002, LEUKEMIA, V16, P433, DOI 10.1038/sj.leu.2402417; Attwell S, 2000, ONCOGENE, V19, P3811, DOI 10.1038/sj.onc.1203711; Bello L, 2004, CLIN CANCER RES, V10, P4527, DOI 10.1158/1078-0432.CCR-04-0194; Bello L, 2001, CANCER RES, V61, P7501; Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; BOYLAND E, 1969, ADV ENZYMOL RAMB, V32, P173; Dai DL, 2003, CLIN CANCER RES, V9, P4409; Delcommenne M, 1998, P NATL ACAD SCI USA, V95, P11211, DOI 10.1073/pnas.95.19.11211; Driver GA, 2006, CANCER CELL INT, V6, DOI 10.1186/1475-2867-6-12; Duxbury MS, 2005, CLIN CANCER RES, V11, P3433, DOI 10.1158/1078-0432.CCR-04-1510; Edwards LA, 2005, ONCOGENE, V24, P3596, DOI 10.1038/sj.onc.1208427; Edwards LA, 2006, MOL CANCER THER, V5, P645, DOI 10.1158/1535-7163.MCT-05-0099; Edwards LA, 2008, MOL CANCER THER, V7, P59, DOI 10.1158/1535-7163.MCT-07-0329; Fuchs BC, 2008, CANCER RES, V68, P2391, DOI 10.1158/0008-5472.CAN-07-2460; GROOTHUIS DR, 1983, CANCER RES, V43, P3362; Hagedorn M, 2002, CANCER RES, V62, P6884; Hannigan GE, 1996, NATURE, V379, P91, DOI 10.1038/379091a0; Jing RF, 2005, GLIA, V50, P107, DOI 10.1002/glia.20158; Kallio PJ, 1999, J BIOL CHEM, V274, P6519, DOI 10.1074/jbc.274.10.6519; Lim LHK, 2007, FASEB J, V21, P968, DOI 10.1096/fj.06-7464rev; Lo HW, 2004, CANCER RES, V64, P9131, DOI 10.1158/0008-5472.CAN-04-0283; Marotta A, 2001, ONCOGENE, V20, P6250, DOI 10.1038/sj.onc.1204791; Monferran S, 2008, INT J CANCER, V123, P357, DOI 10.1002/ijc.23498; Nagy JA, 2002, J EXP MED, V196, P1497, DOI 10.1084/jem.20021244; Obara S, 2004, CANCER LETT, V208, P115, DOI 10.1016/j.canlet.2003.11.020; Parmer TG, 1997, CELL GROWTH DIFFER, V8, P327; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Persad S, 2001, J BIOL CHEM, V276, P27462, DOI 10.1074/jbc.M102940200; Radeva G, 1997, J BIOL CHEM, V272, P13937, DOI 10.1074/jbc.272.21.13937; Shevchenko A, 1996, P NATL ACAD SCI USA, V93, P14440, DOI 10.1073/pnas.93.25.14440; Sundberg C, 2001, AM J PATHOL, V158, P1145, DOI 10.1016/S0002-9440(10)64062-X; Tan C, 2004, CANCER CELL, V5, P79, DOI 10.1016/S1535-6108(03)00281-2; TANNOCK I, 1982, CANCER RES, V42, P4921; Tong GM, 2000, IN VITRO CELL DEV-AN, V36, P493, DOI 10.1290/1071-2690(2000)036<0493:TDIOEI>2.0.CO;2; Troussard AA, 2003, J BIOL CHEM, V278, P22374, DOI 10.1074/jbc.M303083200; Troussard AA, 2000, ONCOGENE, V19, P5444, DOI 10.1038/sj.onc.1203928; Vajkoczy P, 2004, CANC TREAT, V117, P249; Villafania A, 2000, ANN CLIN LAB SCI, V30, P57	39	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2010	5	10							e13710	10.1371/journal.pone.0013710	http://dx.doi.org/10.1371/journal.pone.0013710			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673FU	21060779	Green Published, gold			2022-12-27	WOS:000283645300008
J	Scerri, TS; Paracchini, S; Morris, A; MacPhie, IL; Talcott, J; Stein, J; Smith, SD; Pennington, BF; Olson, RK; DeFries, JC; Monaco, AP				Scerri, Thomas S.; Paracchini, Silvia; Morris, Andrew; MacPhie, I. Laurence; Talcott, Joel; Stein, John; Smith, Shelley D.; Pennington, Bruce F.; Olson, Richard K.; DeFries, John C.; Monaco, Anthony P.			Identification of Candidate Genes for Dyslexia Susceptibility on Chromosome 18	PLOS ONE			English	Article							MULTIPLE-REGRESSION ANALYSIS; QUANTITATIVE-TRAIT LOCUS; MULTILOCUS GENOTYPE DATA; GENOME-WIDE ASSOCIATION; MSH-ACTH 4-10; DEVELOPMENTAL DYSLEXIA; READING-DISABILITY; LINKAGE ANALYSES; BLOOD-PRESSURE; ENVIRONMENTAL-INFLUENCES	Background: Six independent studies have identified linkage to chromosome 18 for developmental dyslexia or general reading ability. Until now, no candidate genes have been identified to explain this linkage. Here, we set out to identify the gene(s) conferring susceptibility by a two stage strategy of linkage and association analysis. Methodology/Principal Findings: Linkage analysis: 264 UK families and 155 US families each containing at least one child diagnosed with dyslexia were genotyped with a dense set of microsatellite markers on chromosome 18. Association analysis: Using a discovery sample of 187 UK families, nearly 3000 SNPs were genotyped across the chromosome 18 dyslexia susceptibility candidate region. Following association analysis, the top ranking SNPs were then genotyped in the remaining samples. The linkage analysis revealed a broad signal that spans approximately 40 Mb from 18p11.2 to 18q12.2. Following the association analysis and subsequent replication attempts, we observed consistent association with the same SNPs in three genes; melanocortin 5 receptor (MC5R), dymeclin (DYM) and neural precursor cell expressed, developmentally down-regulated 4-like (NEDD4L). Conclusions: Along with already published biological evidence, MC5R, DYM and NEDD4L make attractive candidates for dyslexia susceptibility genes. However, further replication and functional studies are still required.	[Scerri, Thomas S.; Paracchini, Silvia; Morris, Andrew; MacPhie, I. Laurence; Monaco, Anthony P.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Talcott, Joel] Aston Univ, Sch Life & Hlth Sci, Birmingham B4 7ET, W Midlands, England; [Stein, John] Univ Oxford, Dept Physiol, Oxford, England; [Smith, Shelley D.] Univ Nebraska, Med Ctr, Dept Pediat, Omaha, NE USA; [Smith, Shelley D.] Univ Nebraska, Med Ctr, Munroe Meyer Inst, Omaha, NE USA; [Pennington, Bruce F.] Univ Denver, Dept Psychol, Denver, CO 80208 USA; [Olson, Richard K.; DeFries, John C.] Univ Colorado, Inst Behav Genet, Boulder, CO 80309 USA	University of Oxford; Wellcome Centre for Human Genetics; Aston University; University of Oxford; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Denver; University of Colorado System; University of Colorado Boulder	Scerri, TS (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England.	anthony.monaco@well.ox.ac.uk	Monaco, Anthony P/A-4495-2010; Paracchini, Silvia/AAU-6813-2021	Monaco, Anthony P/0000-0001-7480-3197; Paracchini, Silvia/0000-0001-9934-8602; Richardson, Alex/0000-0001-5650-4409; Stein, John/0000-0001-5843-8986	Wellcome Trust [075491/Z/04, 076566]; National Institute of Child Health and Human Development [HD-27802]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P50HD027802] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by the Wellcome Trust grants [075491/Z/04] and [076566]. This support included all costs (staff and material) related to design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript. In addition, the Colorado Learning Disabilities Research Center is supported by P50 grant HD-27802 (R.K. Olson, Director) from the National Institute of Child Health and Human Development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis GR, 2000, AM J HUM GENET, V66, P279, DOI 10.1086/302698; Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Abecasis GR, 2000, EUR J HUM GENET, V8, P545, DOI 10.1038/sj.ejhg.5200494; Anthoni H, 2007, HUM MOL GENET, V16, P667, DOI 10.1093/hmg/ddm009; BAKWIN H, 1973, DEV MED CHILD NEUROL, V15, P184; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bates TC, 2007, EUR J HUM GENET, V15, P194, DOI 10.1038/sj.ejhg.5201739; BECKWITH BE, 1977, PHYSIOL BEHAV, V18, P63, DOI 10.1016/0031-9384(77)90095-6; Castles A, 1999, J EXP CHILD PSYCHOL, V72, P73, DOI 10.1006/jecp.1998.2482; Catania A, 2004, PHARMACOL REV, V56, P1, DOI 10.1124/pr.56.1.1; Chapman NH, 2004, AM J MED GENET B, V131B, P67, DOI 10.1002/ajmg.b.30018; Cohn DH, 2003, AM J HUM GENET, V72, P419, DOI 10.1086/346176; de Kovel CGF, 2008, AM J MED GENET B, V147B, P294, DOI 10.1002/ajmg.b.30598; de Kovel CGF, 2004, J MED GENET, V41, P652, DOI 10.1136/jmg.2003.012294; Defries J.C., 2015, DEV DISABIL RES REV, V2, P39, DOI [DOI 10.1002/(SICI)1098-2779(1996)2:1<39::AID-MRDD7>3.0.CO;2-S, 10.1002/(sici)1098-2779(1996)2:13.0.co;2-s, DOI 10.1002/(SICI)1098-2779(1996)2:13.0.CO;2-S]; DEFRIES JC, 1987, NATURE, V329, P537, DOI 10.1038/329537a0; Dennis MY, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000436; Falush D, 2003, GENETICS, V164, P1567; Fan JB, 2003, COLD SPRING HARB SYM, V68, P69, DOI 10.1101/sqb.2003.68.69; Fava C, 2006, KIDNEY INT, V70, P562, DOI 10.1038/sj.ki.5001590; Fiddy S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-210; Fisher SE, 2002, NAT GENET, V30, P86, DOI 10.1038/ng792; FULKER DW, 2004, READ WRIT, V3, P299; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; GANTZ I, 1994, BIOCHEM BIOPH RES CO, V200, P1214, DOI 10.1006/bbrc.1994.1580; Gayan J, 2001, DEV NEUROPSYCHOL, V20, P483, DOI 10.1207/S15326942DN2002_3; Habib M, 2000, BRAIN, V123, P2373, DOI 10.1093/brain/123.12.2373; Hallgren B, 1950, ACTA PSYCH NEUROL SU, P1; Hannula-Jouppi K, 2005, PLOS GENET, V1, P467, DOI 10.1371/journal.pgen.0010050; Harvey KF, 2001, J BIOL CHEM, V276, P8597, DOI 10.1074/jbc.C000906200; HASEMAN JK, 1972, BEHAV GENET, V2, P3, DOI 10.1007/BF01066731; HASSLER M, 1992, INT J NEUROSCI, V65, P45, DOI 10.3109/00207459209003277; Hinshelwood J., 1907, BMJ-BRIT MED J, V1, P608; Igo RP, 2006, AM J MED GENET B, V141B, P15, DOI 10.1002/ajmg.b.30245; Kaminen N, 2003, J MED GENET, V40, P340, DOI 10.1136/jmg.40.5.340; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Lasky-Su J, 2008, AM J MED GENET B, V147B, P1345, DOI 10.1002/ajmg.b.30867; Lessem JL, 2001, BIOINFORMATICS, V17, P371, DOI 10.1093/bioinformatics/17.4.371; Marlow AJ, 2003, AM J HUM GENET, V72, P561, DOI 10.1086/368201; Meng HY, 2005, P NATL ACAD SCI USA, V102, P17053, DOI 10.1073/pnas.0508591102; Nopola-Hemmi J, 2001, J MED GENET, V38, P658, DOI 10.1136/jmg.38.10.658; Norton N, 2000, AM J MED GENET, V96, P556; Pankow JS, 2005, AM J HYPERTENS, V18, P672, DOI 10.1016/j.amjhyper.2004.12.004; Paracchini S, 2006, HUM MOL GENET, V15, P1659, DOI 10.1093/hmg/ddl089; Paracchini S, 2007, ANNU REV GENOM HUM G, V8, P57, DOI 10.1146/annurev.genom.8.080706.092312; Pritchard JK, 2000, GENETICS, V155, P945; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Raskind WH, 2005, MOL PSYCHIATR, V10, P699, DOI 10.1038/sj.mp.4001657; Russo CJ, 2005, HYPERTENSION, V46, P488, DOI 10.1161/01.HYP.0000178594.63193.c0; Schumacher J, 2006, J NEURAL TRANSM, V113, P417, DOI 10.1007/s00702-005-0336-y; Schumacher J, 2007, J MED GENET, V44, P289, DOI 10.1136/jmg.2006.046516; Seshadri S, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S15; Shaywitz SE, 1998, NEW ENGL J MED, V338, P307, DOI 10.1056/NEJM199801293380507; Sile S, 2008, HUM HERED, V65, P33, DOI 10.1159/000106060; Smolnik R, 2000, J CLIN PSYCHOPHARM, V20, P445, DOI 10.1097/00004714-200008000-00009; Stephenson S., 1907, OPHTHALMOSCOPE, V5, P482; STEVENSON J, 1987, J CHILD PSYCHOL PSYC, V28, P229, DOI 10.1111/j.1469-7610.1987.tb00207.x; Storm Niels, 2003, Methods Mol Biol, V212, P241; Taipale M, 2003, P NATL ACAD SCI USA, V100, P11553, DOI 10.1073/pnas.1833911100; Tang K, 2003, INT J MASS SPECTROM, V226, P37, DOI 10.1016/S1387-3806(02)00980-6; Taylor K, 2002, ARCH DIS CHILD, V86, P30, DOI 10.1136/adc.86.1.30; THOMAS CJ, 2005, OPHTHALMOSCOPE, V3; VEITH JL, 1978, PHYSIOL BEHAV, V20, P43, DOI 10.1016/0031-9384(78)90201-9; VEITH JL, 1985, PSYCHONEUROENDOCRINO, V10, P33, DOI 10.1016/0306-4530(85)90037-X; WARD MM, 1979, PHYSIOL BEHAV, V22, P669, DOI 10.1016/0031-9384(79)90228-2; Wen H, 2008, CLIN EXP HYPERTENS, V30, P87, DOI 10.1080/10641960801949909; *WHO, 1993, ICD 10 CLASS MENT BE, pR12; Wigginton JE, 2005, BIOINFORMATICS, V21, P3445, DOI 10.1093/bioinformatics/bti529; Willcutt EG, 2000, J LEARN DISABIL, V33, P179, DOI 10.1177/002221940003300206; Williams J, 2006, EUR J HUM GENET, V14, P681, DOI 10.1038/sj.ejhg.5201575	70	28	29	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2010	5	10							e13712	10.1371/journal.pone.0013712	http://dx.doi.org/10.1371/journal.pone.0013712			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	672HN	21060895	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000283573800012
J	Wangge, G; Klungel, OH; Roes, KCB; de Boer, A; Hoes, AW; Knol, MJ				Wangge, Grace; Klungel, Olaf H.; Roes, Kit C. B.; de Boer, Anthonius; Hoes, Arno W.; Knol, Mirjam J.			Room for Improvement in Conducting and Reporting Non-Inferiority Randomized Controlled Trials on Drugs: A Systematic Review	PLOS ONE			English	Article							INTENT-TO-TREAT; EQUIVALENCE; PROTOCOL; CHOICE	Background: A non-inferiority (NI) trial is intended to show that the effect of a new treatment is not worse than the comparator. We conducted a review to identify how NI trials were conducted and reported, and whether the standard requirements from the guidelines were followed. Methodology and Principal Findings: From 300 randomly selected articles on NI trials registered in PubMed at 5 February 2009, we included 227 NI articles that referred to 232 trials. We excluded studies on bioequivalence, trials on healthy volunteers, non-drug trials, and articles of which the full-text version could not be retrieved. A large proportion of trials (34.0%) did not use blinding. The NI margin was reported in 97.8% of the trials, but only 45.7% of the trials reported the method to determine the margin. Most of the trials used either intention to treat (ITT) (34.9%) or per-protocol (PP) analysis (19.4%), while 41.8% of the trials used both methods. Less than 10% of the trials included a placebo arm to confirm the efficacy of the new drug and active comparator against placebo, and less than 5.0% were reporting the similarity of the current trial with the previous comparator's trials. In general, no difference was seen in the quality of reporting before and after the release of the CONSORT statement extension 2006 or between the high-impact and low-impact journals. Conclusion: The conduct and reporting of NI trials can be improved, particularly in terms of maximizing the use of blinding, the use of both ITT and PP analysis, reporting the similarity with the previous comparator's trials to guarantee a valid constancy assumption, and most importantly reporting the method to determine the NI margin.	[Wangge, Grace; Klungel, Olaf H.; de Boer, Anthonius; Hoes, Arno W.; Knol, Mirjam J.] Univ Utrecht, UIPS, Div Pharmacoepidemiol & Clin Pharmacol, Utrecht, Netherlands; [Roes, Kit C. B.; Knol, Mirjam J.] Julius Ctr Hlth Sci & Primary Care, Univ Med Ctr Utrecht, Utrecht, Netherlands	Utrecht University; Utrecht University; Utrecht University Medical Center	Wangge, G (corresponding author), Univ Utrecht, UIPS, Div Pharmacoepidemiol & Clin Pharmacol, Utrecht, Netherlands.	M.J.Knol@umcutrecht.nl	Wangge, Grace/E-5982-2013; Roes, Kit/AAC-4093-2019; Wangge, Grace/AAS-5241-2020	Roes, Kit/0000-0002-6775-1963; Wangge, Grace/0000-0002-5416-273X	Top Institute Pharma, The Netherlands	Top Institute Pharma, The Netherlands(Netherlands Government)	Funding was provided by the Top Institute Pharma, The Netherlands. The funders had no role in study design, data collection and analysis or preparation of the manuscript.	Brittain E, 2005, STAT MED, V24, P1, DOI 10.1002/sim.1934; *CDER, 2010, DRAFT GUID GUID IND, P66; *CDER, 2003, INS CLIN TRIALS TEST; *CPMP, 2003, US TEAFTEOMPEOMFH; *CPMP, 1999, PROD TEAFTEOM; D'Agostino RB, 2003, STAT MED, V22, P169, DOI 10.1002/sim.1425; Flerning TR, 2008, STAT MED, V27, P317, DOI 10.1002/sim.2855; Garattini S, 2007, LANCET, V370, P1875, DOI 10.1016/S0140-6736(07)61604-3; Hung HMJ, 2005, BIOMETRICAL J, V47, P28, DOI 10.1002/bimj.200410084; *ICH, 1997, US IOH; *ICH EXP WORK GROU, 2001, USE ICOHOTRFROPFH; *ICH EXP WORK GROU, 1998, US IC; KAY R, 2007, EQUIVALENCE NONINFER, P173; KOCH A, 2004, HYPOTHESIS TESTING, P315; Lange S, 2005, BIOMETRICAL J, V47, P12, DOI 10.1002/bimj.200410085; Le Henanff A, 2006, JAMA-J AM MED ASSOC, V295, P1147, DOI 10.1001/jama.295.10.1147; MCCAFFREY N, 2006, HDB HLTH TECHNOL ASS; Piaggio G, 2006, JAMA-J AM MED ASSOC, V295, P1152, DOI 10.1001/jama.295.10.1152; Sanchez MM, 2006, STAT MED, V25, P1169, DOI 10.1002/sim.2244; SENN S, 2007, STAT ISSUES DRUG DEV, P235; Sheng D, 2006, STAT MED, V25, P1183, DOI 10.1002/sim.2230; Snapinn Steven M, 2000, Curr Control Trials Cardiovasc Med, V1, P19, DOI 10.1186/CVM-1-1-019; 2009, NAT REV DRUG DISCOV, V8, P10	24	61	61	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2010	5	10							e13550	10.1371/journal.pone.0013550	http://dx.doi.org/10.1371/journal.pone.0013550			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671UN	21048948	Green Published, Green Submitted, gold			2022-12-27	WOS:000283537000007
J	Knowlton, ML; Selfors, LM; Wrobel, CN; Gu, TL; Ballif, BA; Gygi, SP; Polakiewicz, R; Brugge, JS				Knowlton, Melodie L.; Selfors, Laura M.; Wrobel, Carolyn N.; Gu, Ting-Lei; Ballif, Bryan A.; Gygi, Steven P.; Polakiewicz, Roberto; Brugge, Joan S.			Profiling Y561-Dependent and -Independent Substrates of CSF-1R in Epithelial Cells	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; SRC FAMILY KINASES; GROWTH-FACTOR RECEPTORS; ATP-CITRATE LYASE; BREAST-CANCER; SIGNAL-TRANSDUCTION; TYROSINE KINASES; LUNG-CANCER; E-CADHERIN; C-SRC	Receptor tyrosine kinases (RTKs) activate multiple downstream cytosolic tyrosine kinases following ligand stimulation. SRC family kinases (SFKs), which are recruited to activated RTKs through SH2 domain interactions with RTK autophosphorylation sites, are targets of many subfamilies of RTKs. To date, there has not been a systematic analysis of the downstream substrates of such receptor-activated SFKs. Here, we conducted quantitative mass spectrometry utilizing stable isotope labeling (SILAC) analysis to profile candidate SRC-substrates induced by the CSF-1R tyrosine kinase by comparing the phosphotyrosine-containing peptides from cells expressing either CSF-1R or a mutant form of this RTK that is unable to bind to SFKs. This analysis identified previously uncharacterized changes in tyrosine phosphorylation induced by CSF-1R in mammary epithelial cells as well as a set of candidate substrates dependent on SRC recruitment to CSF-1R. Many of these candidates may be direct SRC targets as the amino acids flanking the phosphorylation sites in these proteins are similar to known SRC kinase phosphorylation motifs. The putative SRC-dependent proteins include known SRC substrates as well as previously unrecognized SRC targets. The collection of substrates includes proteins involved in multiple cellular processes including cell-cell adhesion, endocytosis, and signal transduction. Analyses of phosphoproteomic data from breast and lung cancer patient samples identified a subset of the SRC-dependent phosphorylation sites as being strongly correlated with SRC activation, which represent candidate markers of SRC activation downstream of receptor tyrosine kinases in human tumors. In summary, our data reveal quantitative site-specific changes in tyrosine phosphorylation induced by CSF-1R activation in epithelial cells and identify many candidate SRC-dependent substrates phosphorylated downstream of an RTK.	[Knowlton, Melodie L.; Selfors, Laura M.; Wrobel, Carolyn N.; Ballif, Bryan A.; Gygi, Steven P.; Brugge, Joan S.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Gu, Ting-Lei; Polakiewicz, Roberto] Cell Signaling Technol Inc, Danvers, MA USA	Harvard University; Harvard Medical School	Knowlton, ML (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.	joan_brugge@hms.harvard.edu		SELFORS, LAURA/0000-0002-1317-7353	NCI [CA CA089393]; NIH [HG3456]; Ford Foundation; National Center for Research Resources [P20 RR16462]; NATIONAL CANCER INSTITUTE [P50CA089393] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016462] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003456] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ford Foundation; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was funded by an NCI SPORE grant to JSB (CA CA089393) and NIH grant HG3456 (S.P.G.), a Ford Foundation Predoctoral Fellowship (MLK), and funding from the Vermont Genetics Network through National Institutes of Health grant P20 RR16462 from the INBRE Program of the National Center for Research Resources (B.A.B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The work by Ting-Lei Gu and Roberto Polakiewicz in this study was funded by Cell Signaling Technology, Inc, who played a role in the design, data collection and analysis but not in the decision to publish, or the preparation of the first draft of the manuscript.	Alema S, 2007, BBA-MOL CELL RES, V1773, P47, DOI 10.1016/j.bbamcr.2006.06.001; ALONSO G, 1995, J BIOL CHEM, V270, P9840, DOI 10.1074/jbc.270.17.9840; Alvarez RH, 2006, CANCER-AM CANCER SOC, V107, P1918, DOI 10.1002/cncr.22215; AMANCHY R, 2009, MOL ONCOL; Amanchy R, 2008, J PROTEOME RES, V7, P3900, DOI 10.1021/pr800198w; Berwick DC, 2002, J BIOL CHEM, V277, P33895, DOI 10.1074/jbc.M204681200; Bose R, 2006, P NATL ACAD SCI USA, V103, P9773, DOI 10.1073/pnas.0603948103; Brauer PM, 2009, CELL CYCLE, V8, P2728, DOI 10.4161/cc.8.17.9389; Bromann PA, 2004, ONCOGENE, V23, P7957, DOI 10.1038/sj.onc.1208079; Chambers SK, 1997, CLIN CANCER RES, V3, P999; Courtneidge SA, 2002, BIOCHEM SOC T, V30, P11, DOI 10.1042/bst0300011; Davis MA, 2003, J CELL BIOL, V163, P525, DOI 10.1083/jcb.200307111; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Douglass TG, 2008, INT IMMUNOPHARMACOL, V8, P1354, DOI 10.1016/j.intimp.2008.04.016; Engelman JA, 2008, CLIN CANCER RES, V14, P2895, DOI 10.1158/1078-0432.CCR-07-2248; Finn RS, 2008, ANN ONCOL, V19, P1379, DOI 10.1093/annonc/mdn291; Flick MB, 1997, ONCOGENE, V14, P2553, DOI 10.1038/sj.onc.1201092; Frame MC, 2002, NAT REV MOL CELL BIO, V3, P233, DOI 10.1038/nrm779; Fujita Y, 2002, NAT CELL BIOL, V4, P222, DOI 10.1038/ncb758; Gunawardane RN, 2005, CANCER RES, V65, P11572, DOI 10.1158/0008-5472.CAN-05-1196; Hatzfeld M, 2003, J CELL SCI, V116, P1219, DOI 10.1242/jcs.00275; Heibeck TH, 2009, J PROTEOME RES, V8, P3852, DOI 10.1021/pr900044c; Hornbeck PV, 2004, PROTEOMICS, V4, P1551, DOI 10.1002/pmic.200300772; Hynes NE, 2009, CURR OPIN CELL BIOL, V21, P177, DOI 10.1016/j.ceb.2008.12.010; Ireton RC, 2002, J CELL BIOL, V159, P465, DOI 10.1083/jcb.200205115; Ishizawar R, 2004, CANCER CELL, V6, P209, DOI 10.1016/j.ccr.2004.09.001; Kacinski BM, 1997, MOL REPROD DEV, V46, P71, DOI 10.1002/(SICI)1098-2795(199701)46:1<71::AID-MRD11>3.0.CO;2-6; Leroy C, 2009, CANCER RES, V69, P2279, DOI 10.1158/0008-5472.CAN-08-2354; Luo W, 2008, J PROTEOME RES, V7, P3447, DOI 10.1021/pr800187n; Maher MG, 1998, CLIN CANCER RES, V4, P1851; Marks D C, 1999, Mol Cell Biol Res Commun, V1, P144, DOI 10.1006/mcbr.1999.0123; Migita T, 2008, CANCER RES, V68, P8547, DOI 10.1158/0008-5472.CAN-08-1235; Mosesson Y, 2004, SEMIN CANCER BIOL, V14, P262, DOI 10.1016/j.semcancer.2004.04.005; Mukherji M, 2006, BIOCHEMISTRY-US, V45, P15529, DOI 10.1021/bi060971c; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Palacios F, 2005, MOL CELL BIOL, V25, P389, DOI 10.1128/MCB.25.1.389-402.2005; PAN JG, 2007, SCI STKE, pPE14, DOI DOI 10.1126/STKE.3812007PE14; PATSIALOU A, 2009, CANC RES; Peng JM, 2003, J PROTEOME RES, V2, P43, DOI 10.1021/pr025556v; Pixley FJ, 2004, TRENDS CELL BIOL, V14, P628, DOI 10.1016/j.tcb.2004.09.016; Pucharcos C, 2000, FEBS LETT, V478, P43, DOI 10.1016/S0014-5793(00)01793-2; Putignani L, 2008, BREAST CANCER RES TR, V110, P439, DOI 10.1007/s10549-007-9738-x; Raiborg C, 2002, CELL STRUCT FUNCT, V27, P403, DOI 10.1247/csf.27.403; Raiborg C, 2002, NAT CELL BIOL, V4, P394, DOI 10.1038/ncb791; Raiborg C, 2001, BIOCHEM SOC T, V29, P472, DOI 10.1042/BST0290472; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Reynolds AB, 2007, BBA-MOL CELL RES, V1773, P2, DOI 10.1016/j.bbamcr.2006.09.019; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; Rohde CM, 2004, J BIOL CHEM, V279, P43448, DOI 10.1074/jbc.M314170200; Rush J, 2005, NAT BIOTECHNOL, V23, P94, DOI 10.1038/nbt1046; Russello SV, 2004, FRONT BIOSCI-LANDMRK, V9, P139; Sapi E, 2004, EXP BIOL MED, V229, P1; Schwartz D, 2005, NAT BIOTECHNOL, V23, P1391, DOI 10.1038/nbt1146; Songyang Zhou, 1995, Trends in Biochemical Sciences, V20, P470, DOI 10.1016/S0968-0004(00)89103-3; Summy JM, 2003, CANCER METAST REV, V22, P337, DOI 10.1023/A:1023772912750; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; Toy EP, 2001, GYNECOL ONCOL, V80, P194, DOI 10.1006/gyno.2000.6070; Weinberg F, 2009, ANN NY ACAD SCI, V1177, P66, DOI 10.1111/j.1749-6632.2009.05039.x; Wrobel CN, 2004, J CELL BIOL, V165, P263, DOI 10.1083/jcb.200309102; Yancy Haile F, 2007, J Carcinog, V6, P8; Yap AS, 2007, CURR OPIN CELL BIOL, V19, P508, DOI 10.1016/j.ceb.2007.09.008; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Yeatman TJ, 2004, NAT REV CANCER, V4, P470, DOI 10.1038/nrc1366; Yeung YG, 2003, MOL CELL PROTEOMICS, V2, P1143, DOI 10.1074/mcp.R300009-MCP200; Yim EK, 2009, CANCER CELL, V15, P304, DOI 10.1016/j.ccr.2009.02.012; Zimmerman B, 2009, CELL SIGNAL, V21, P103, DOI 10.1016/j.cellsig.2008.09.013	66	17	17	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2010	5	10							e13587	10.1371/journal.pone.0013587	http://dx.doi.org/10.1371/journal.pone.0013587			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671GB	21049007	Green Published, Green Submitted, gold			2022-12-27	WOS:000283487400004
J	Roodveldt, C; Labrador-Garrido, A; Gonzalez-Rey, E; Fernandez-Montesinos, R; Caro, M; Lachaud, CC; Waudby, CA; Delgado, M; Dobson, CM; Pozo, D				Roodveldt, Cintia; Labrador-Garrido, Adahir; Gonzalez-Rey, Elena; Fernandez-Montesinos, Rafael; Caro, Marta; Lachaud, Christian C.; Waudby, Christopher A.; Delgado, Mario; Dobson, Christopher M.; Pozo, David			Glial Innate Immunity Generated by Non-Aggregated Alpha-Synuclein in Mouse: Differences between Wild-type and Parkinson's Disease-Linked Mutants	PLOS ONE			English	Article							NEURONAL CELL-DEATH; MICROGLIAL ACTIVATION; ALZHEIMERS-DISEASE; MATRIX METALLOPROTEINASES; DOPAMINERGIC-NEURONS; HUMAN PLASMA; MODEL; PROTEIN; PATHOGENESIS; MUTATION	Background: Parkinson's disease (PD) is a progressive neurodegenerative disorder characterized pathologically by the presence in the brain of intracellular protein inclusions highly enriched in aggregated alpha-synuclein (alpha-Syn). Although it has been established that progression of the disease is accompanied by sustained activation of microglia, the underlying molecules and factors involved in these immune-triggered mechanisms remain largely unexplored. Lately, accumulating evidence has shown the presence of extracellular alpha-Syn both in its aggregated and monomeric forms in cerebrospinal fluid and blood plasma. However, the effect of extracellular alpha-Syn on cellular activation and immune mediators, as well as the impact of familial PD-linked alpha-Syn mutants on this stimulation, are still largely unknown. Methods and Findings: In this work, we have compared the activation profiles of non-aggregated, extracellular wild-type and PD-linked mutant alpha-Syn variants on primary glial and microglial cell cultures. After stimulation of cells with alpha-Syn, we measured the release of Th1- and Th2-type cytokines as well as IP-10/CXCL10, RANTES/CCL5, MCP-1/CCL2 and MIP-1 alpha/CCL3 chemokines. Contrary to what had been observed using cell lines or for the case of aggregated alpha-Syn, we found strong differences in the immune response generated by wild-type alpha-Syn and the familial PD mutants (A30P, E46K and A53T). Conclusions: These findings might contribute to explain the differences in the onset and progression of this highly debilitating disease, which could be of value in the development of rational approaches towards effective control of immune responses that are associated with PD.	[Roodveldt, Cintia; Labrador-Garrido, Adahir; Fernandez-Montesinos, Rafael; Lachaud, Christian C.; Pozo, David] Univ Seville UPO Junta de Andalucia, Consejo Super Invest Cient, CABIMER Andalusian Ctr Mol Biol & Regenerat Med, Seville, Spain; [Gonzalez-Rey, Elena; Caro, Marta; Delgado, Mario] CSIC, Inst Parasitol & Biomed Lopez Neyra, Granada, Spain; [Waudby, Christopher A.; Dobson, Christopher M.] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England; [Waudby, Christopher A.] UCL, Dept Struct & Mol Biol, London, England	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; University of Sevilla; CSIC - Centro Andaluz de Biologia Molecular y Medicina Regenerativa (CABIMER); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Parasitologia y Biomedicina Lopez-Neyra (IPBLN); University of Cambridge; University of London; University College London	Roodveldt, C (corresponding author), Univ Seville UPO Junta de Andalucia, Consejo Super Invest Cient, CABIMER Andalusian Ctr Mol Biol & Regenerat Med, Seville, Spain.	david.pozo@cabimer.es	Waudby, Christopher/AAT-1736-2021; Roodveldt, Cintia/I-9118-2014; GONZALEZ-REY, ELENA/L-3296-2014; Delgado, Mario/P-1524-2016; Caro, Marta/ABG-9963-2020; Lachaud, Christian Claude/C-2036-2017; Fernández-Montesinos, Rafael/ABG-1691-2021; Pozo Perez, PhD, David/C-2149-2017	Waudby, Christopher/0000-0001-7810-3753; Roodveldt, Cintia/0000-0003-4124-8769; GONZALEZ-REY, ELENA/0000-0003-3917-9020; Delgado, Mario/0000-0003-1893-5982; Lachaud, Christian Claude/0000-0001-8698-4589; Fernandez, Rafael/0000-0002-5062-4239; Pozo Perez, PhD, David/0000-0002-3732-4960; Caro, Marta/0000-0003-3385-4734; Labrador-Garrido, Adahir/0000-0001-5098-9601	Spanish Ministry of Science and Innovation; University of Seville Department of Normal and Pathological Cytology and Histology; Instituto de Salud Carlos III - Fund for Health of Spain; Junta de Andalucia [BIO-323, CTS-541]; Alicia Kloplowitz Foundation; Wellcome Trust; Leverhulme Trust	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); University of Seville Department of Normal and Pathological Cytology and Histology; Instituto de Salud Carlos III - Fund for Health of Spain; Junta de Andalucia(Junta de Andalucia); Alicia Kloplowitz Foundation; Wellcome Trust(Wellcome Trust); Leverhulme Trust(Leverhulme Trust)	CR held a Federation of the Societies of Biochemistry and Molecular Biology Long-Term Fellowship during part of this work, and currently holds a postdoctoral fellowship by the Spanish Ministry of Science and Innovation (Juan de la Cierva Programme). RFM holds an FPI fellowship at the University of Seville Department of Normal and Pathological Cytology and Histology. This work was supported by Instituto de Salud Carlos III - Fund for Health of Spain (to MD and DP); Junta de Andalucia BIO-323 (DP) and CTS-541 (MD); Alicia Kloplowitz Foundation (to MD and DP); and Wellcome Trust and Leverhulme Trust grants (CMD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin SA, 2006, J NEUROSCI, V26, P10558, DOI 10.1523/JNEUROSCI.1799-06.2006; Banati RB, 1998, MOVEMENT DISORD, V13, P221, DOI 10.1002/mds.870130205; Barreiro O, 2010, CARDIOVASC RES, V86, P174, DOI 10.1093/cvr/cvq001; Benner EJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001376; Bertoncini CW, 2005, P NATL ACAD SCI USA, V102, P1430, DOI 10.1073/pnas.0407146102; Bertoncini CW, 2005, J BIOL CHEM, V280, P30649, DOI 10.1074/jbc.C500288200; Bonifati V, 2004, CELL MOL LIFE SCI, V61, P1729, DOI 10.1007/s00018-004-4104-1; Borghi R, 2000, NEUROSCI LETT, V287, P65, DOI 10.1016/S0304-3940(00)01153-8; Bostantjopoulou S, 2001, MOVEMENT DISORD, V16, P1007, DOI 10.1002/mds.1221; Candiano G, 2004, ELECTROPHORESIS, V25, P1327, DOI 10.1002/elps.200305844; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Chung CY, 2009, J NEUROSCI, V29, P3365, DOI 10.1523/JNEUROSCI.5427-08.2009; Cole NB, 2002, J BIOL CHEM, V277, P6344, DOI 10.1074/jbc.M108414200; Colton CA, 2010, CNS NEUROL DISORD-DR, V9, P174, DOI 10.2174/187152710791012053; Cookson MR, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-9; Croisier E, 2005, J NEUROINFLAMM, V2, DOI 10.1186/1742-2094-2-14; Dedmon MM, 2005, J AM CHEM SOC, V127, P476, DOI 10.1021/ja044834j; Delgado M, 2003, FASEB J, V17, P944, DOI 10.1096/fj.02-0799fje; Dufour JH, 2002, J IMMUNOL, V168, P3195, DOI 10.4049/jimmunol.168.7.3195; El-Agnaf OMA, 2003, FASEB J, V17, P1945, DOI 10.1096/fj.03-0098fje; El-Agnaf OMA, 2006, FASEB J, V20, P419, DOI 10.1096/fj.03-1449com; Eriksen JL, 2005, ARCH NEUROL-CHICAGO, V62, P353, DOI 10.1001/archneur.62.3.353; Forno LS, 1996, J NEUROPATH EXP NEUR, V55, P259, DOI 10.1097/00005072-199603000-00001; Gangemi S, 2003, MEDIAT INFLAMM, V12, P251, DOI 10.1080/09629350310001599701; Gasser T, 2005, CURR OPIN NEUROL, V18, P363, DOI 10.1097/01.wco.0000170951.08924.3d; Giasson BI, 2000, SCIENCE, V290, P985, DOI 10.1126/science.290.5493.985; Golbe LI, 1996, ANN NEUROL, V40, P767, DOI 10.1002/ana.410400513; Gu XL, 2010, MOL BRAIN, V3, DOI 10.1186/1756-6606-3-12; Hirsch EC, 2009, LANCET NEUROL, V8, P382, DOI 10.1016/S1474-4422(09)70062-6; Hoyer W, 2002, J MOL BIOL, V322, P383, DOI 10.1016/S0022-2836(02)00775-1; Jensen PH, 1997, BIOCHEM J, V323, P539, DOI 10.1042/bj3230539; Joo SH, 2010, NEUROSCI LETT, V469, P352, DOI 10.1016/j.neulet.2009.12.026; Kim SH, 2004, PARKINSONISM RELAT D, V10, pS9, DOI 10.1016/j.parkreldis.2003.11.005; Kim YS, 2006, EXP MOL MED, V38, P333, DOI 10.1038/emm.2006.40; Klegeris A, 2008, NEUROBIOL AGING, V29, P739, DOI 10.1016/j.neurobiolaging.2006.11.013; Klegeris A, 2006, FASEB J, V20, P2000, DOI 10.1096/fj.06-6183com; Knott C, 2000, MOL CELL NEUROSCI, V16, P724, DOI 10.1006/mcne.2000.0914; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Lashuel HA, 2002, NATURE, V418, P291, DOI 10.1038/418291a; Lee EJ, 2010, J IMMUNOL, V185, P615, DOI 10.4049/jimmunol.0903480; Lee HJ, 2005, J NEUROSCI, V25, P6016, DOI 10.1523/JNEUROSCI.0692-05.2005; Lee SJ, 2008, J MOL NEUROSCI, V34, P17, DOI 10.1007/s12031-007-0012-9; Liu J, 2007, J PROTEOME RES, V6, P3614, DOI 10.1021/pr0701512; Long-Smith CM, 2009, PROG NEUROBIOL, V89, P277, DOI 10.1016/j.pneurobio.2009.08.001; MCGEER PL, 1988, NEUROLOGY, V38, P1285, DOI 10.1212/WNL.38.8.1285; Mestas J, 2004, J IMMUNOL, V172, P2731, DOI 10.4049/jimmunol.172.5.2731; Mirza B, 2000, NEUROSCIENCE, V95, P425; Moore DJ, 2005, ANNU REV NEUROSCI, V28, P57, DOI 10.1146/annurev.neuro.28.061604.135718; Mori F, 2002, EXP NEUROL, V176, P98, DOI 10.1006/exnr.2002.7929; Moussa CEH, 2004, NEUROSCI LETT, V371, P239, DOI 10.1016/j.neulet.2004.09.004; Papapetropoulos S, 2001, J NEUROL NEUROSUR PS, V70, P662, DOI 10.1136/jnnp.70.5.662; Park JY, 2008, GLIA, V56, P1215, DOI 10.1002/glia.20691; Perez RG, 2004, J NEUROCHEM, V89, P1318, DOI 10.1111/j.1471-4159.2004.02423.x; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Reale M, 2009, BRAIN BEHAV IMMUN, V23, P55, DOI 10.1016/j.bbi.2008.07.003; Rentzos M, 2007, ACTA NEUROL SCAND, V116, P374, DOI 10.1111/j.1600-0404.2007.00894.x; Reynolds AD, 2008, J NEUROCHEM, V104, P1504, DOI 10.1111/j.1471-4159.2007.05087.x; Reynolds AD, 2007, J LEUKOCYTE BIOL, V82, P1083, DOI 10.1189/jlb.0507296; Reynolds AD, 2009, J IMMUNOL, V182, P4137, DOI 10.4049/jimmunol.0803982; Rich RR., 2008, CLIN IMMUNOLOGY PRIN, piv; Richter-Landsberg C, 2000, J NEUROSCI RES, V62, P9, DOI 10.1002/1097-4547(20001001)62:1<9::AID-JNR2>3.0.CO;2-U; Roodveldt C, 2008, J CELL MOL MED, V12, P1820, DOI 10.1111/j.1582-4934.2008.00450.x; Sanchez-Guajardo V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008784; Sanchez-Pernaute R, 2004, J NEUROINFLAMM, V1, DOI 10.1186/1742-2094-1-6; Saura J, 2003, GLIA, V44, P183, DOI 10.1002/glia.10274; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Schwartz M, 2010, BRAIN BEHAV IMMUN, V24, P1054, DOI 10.1016/j.bbi.2010.01.010; Souza JM, 2000, J BIOL CHEM, V275, P18344, DOI 10.1074/jbc.M000206200; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Spira PJ, 2001, ANN NEUROL, V49, P313, DOI 10.1002/ana.67; Stone DK, 2009, ANTIOXID REDOX SIGN, V11, P2151, DOI [10.1089/ars.2009.2460, 10.1089/ARS.2009.2460]; Su XM, 2008, NEUROBIOL AGING, V29, P1690, DOI 10.1016/j.neurobiolaging.2007.04.006; Su XM, 2009, NEUROTOX RES, V16, P238, DOI 10.1007/s12640-009-9053-x; Sung JY, 2001, J BIOL CHEM, V276, P27441, DOI 10.1074/jbc.M101318200; Sung JY, 2005, J BIOL CHEM, V280, P25216, DOI 10.1074/jbc.M503341200; Theodore S, 2008, J NEUROPATH EXP NEUR, V67, P1149, DOI 10.1097/NEN.0b013e31818e5e99; Thomas MP, 2007, J NEUROCHEM, V100, P503, DOI 10.1111/j.1471-4159.2006.04315.x; Vila M, 2001, CURR OPIN NEUROL, V14, P483, DOI 10.1097/00019052-200108000-00009; Weinreb PH, 1996, BIOCHEMISTRY-US, V35, P13709, DOI 10.1021/bi961799n; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Wu DC, 2002, J NEUROSCI, V22, P1763, DOI 10.1523/JNEUROSCI.22-05-01763.2002; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795; Zhang W, 2005, FASEB J, V19, P533, DOI 10.1096/fj.04-2751com; Zhang W, 2007, GLIA, V55, P1178, DOI 10.1002/glia.20532	84	69	69	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2010	5	10							e13481	10.1371/journal.pone.0013481	http://dx.doi.org/10.1371/journal.pone.0013481			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671GB	21048992	Green Published, gold			2022-12-27	WOS:000283487400002
J	Tannour-Louet, M; Han, S; Corbett, ST; Louet, JF; Yatsenko, S; Meyers, L; Shaw, CA; Kang, SHL; Cheung, SW; Lamb, DJ				Tannour-Louet, Mounia; Han, Shuo; Corbett, Sean T.; Louet, Jean-Francois; Yatsenko, Svetlana; Meyers, Lindsay; Shaw, Chad A.; Kang, Sung-Hae L.; Cheung, Sau Wai; Lamb, Dolores J.			Identification of De Novo Copy Number Variants Associated with Human Disorders of Sexual Development	PLOS ONE			English	Article							CHROMOSOMAL MICROARRAY ANALYSIS; MICRODELETION SYNDROME; BETA-CATENIN; REVERSAL; CRYPTORCHIDISM; HYPOSPADIAS; DIFFERENTIATION; GENE; DUPLICATIONS; POLYMORPHISM	Disorders of sexual development (DSD), ranging in severity from genital abnormalities to complete sex reversal, are among the most common human birth defects with incidence rates reaching almost 3%. Although causative alterations in key genes controlling gonad development have been identified, the majority of DSD cases remain unexplained. To improve the diagnosis, we screened 116 children born with idiopathic DSD using a clinically validated array-based comparative genomic hybridization platform. 8951 controls without urogenital defects were used to compare with our cohort of affected patients. Clinically relevant imbalances were found in 21.5% of the analyzed patients. Most anomalies (74.2%) evaded detection by the routinely ordered karyotype and were scattered across the genome in gene-enriched subtelomeric loci. Among these defects, confirmed de novo duplication and deletion events were noted on 1p36.33, 9p24.3 and 19q12-q13.11 for ambiguous genitalia, 10p14 and Xq28 for cryptorchidism and 12p13 and 16p11.2 for hypospadias. These variants were significantly associated with genitourinary defects (P = 6.08 x 10(-12)). The causality of defects observed in 5p15.3, 9p24.3, 22q12.1 and Xq28 was supported by the presence of overlapping chromosomal rearrangements in several unrelated patients. In addition to known gonad determining genes including SRY and DMRT1, novel candidate genes such as FGFR2, KANK1, ADCY2 and ZEB2 were encompassed. The identification of risk germline rearrangements for urogenital birth defects may impact diagnosis and genetic counseling and contribute to the elucidation of the molecular mechanisms underlying the pathogenesis of human sexual development.	[Tannour-Louet, Mounia; Corbett, Sean T.; Lamb, Dolores J.] Baylor Coll Med, Scott Dept Urol, Houston, TX 77030 USA; [Han, Shuo; Louet, Jean-Francois; Lamb, Dolores J.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Yatsenko, Svetlana; Meyers, Lindsay; Shaw, Chad A.; Kang, Sung-Hae L.; Cheung, Sau Wai] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Tannour-Louet, M (corresponding author), Baylor Coll Med, Scott Dept Urol, Houston, TX 77030 USA.	mlouet@bcm.edu; dlamb@bcm.edu	Mounia, TANNOUR LOUET/T-2622-2019; TANNOUR LOUET, Mounia/G-5413-2017	Mounia, TANNOUR LOUET/0000-0003-0614-063X; TANNOUR LOUET, Mounia/0000-0003-0614-063X; Shaw, Chad/0000-0001-7267-5398; Louet, Jean-Francois/0000-0002-1626-7098	National Institute of Kidney and Digestive Diseases [1R01DK078121]; American Urological Association Foundation; Eunice Kennedy Shriver National Institute of Child Health and Human Development [P01HD36289]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD036289] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078121] Funding Source: NIH RePORTER	National Institute of Kidney and Digestive Diseases; American Urological Association Foundation; Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by Grants 1R01DK078121 from the National Institute of Kidney and Digestive Diseases to DJL, the American Urological Association Foundation (SC and DJL), and by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (P01HD36289) to DJL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitman TJ, 2006, NATURE, V439, P851, DOI 10.1038/nature04489; Bagheri-Fam S, 2008, DEV BIOL, V314, P71, DOI 10.1016/j.ydbio.2007.11.010; Ballif BC, 2007, NAT GENET, V39, P1071, DOI 10.1038/ng2107; BARDONI B, 1994, NAT GENET, V7, P497, DOI 10.1038/ng0894-497; Beleza-Meireles A, 2007, EUR J HUM GENET, V15, P405, DOI 10.1038/sj.ejhg.5201777; Cheung SW, 2005, GENET MED, V7, P422, DOI 10.1097/01.GIM.0000170992.63691.32; Cox MJ, 2008, J UROLOGY, V180, P2649, DOI 10.1016/j.juro.2008.08.058; Foresta C, 2008, ENDOCR REV, V29, P560, DOI 10.1210/er.2007-0042; Gonzalez E, 2005, SCIENCE, V307, P1434, DOI 10.1126/science.1101160; Higashi Y, 2002, GENESIS, V32, P82, DOI 10.1002/gene.10048; Huang B, 1999, AM J MED GENET, V87, P349, DOI 10.1002/(SICI)1096-8628(19991203)87:4<349::AID-AJMG13>3.0.CO;2-N; Hughes IA, 2007, ENDOCRIN DEV, V11, P47, DOI 10.1159/000111057; Jeays-Ward K, 2003, DEVELOPMENT, V130, P3663, DOI 10.1242/dev.00591; Jordan BK, 2001, AM J HUM GENET, V68, P1102, DOI 10.1086/320125; Kim Y, 2007, P NATL ACAD SCI USA, V104, P16558, DOI 10.1073/pnas.0702581104; Koolen DA, 2006, NAT GENET, V38, P999, DOI 10.1038/ng1853; Lu XY, 2008, PEDIATRICS, V122, P1310, DOI 10.1542/peds.2008-0297; Lu XY, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000327; Lupski JR, 2007, NAT GENET, V39, pS43, DOI 10.1038/ng2084; Maatouk DM, 2008, HUM MOL GENET, V17, P2949, DOI 10.1093/hmg/ddn193; Matzuk MM, 2008, NAT MED, V14, P1197, DOI 10.1038/nm.f.1895; Miquelajauregui A, 2007, P NATL ACAD SCI USA, V104, P12919, DOI 10.1073/pnas.0609863104; Moreno-Garcia M, 2002, J UROLOGY, V168, P2170, DOI 10.1016/S0022-5347(05)64346-7; Ou Z, 2008, GENET MED, V10, P278, DOI 10.1097/GIM.0b013e31816b4420; Pohl HG, 2007, J UROLOGY, V177, P1646, DOI 10.1016/j.juro.2007.01.058; Raymond CS, 2000, GENE DEV, V14, P2587, DOI 10.1101/gad.834100; Shaffer LG, 1997, AM J MED GENET, V69, P325, DOI 10.1002/(SICI)1096-8628(19970331)69:3<325::AID-AJMG20>3.0.CO;2-S; Sharp AJ, 2006, NAT GENET, V38, P1038, DOI 10.1038/ng1862; Shaw-Smith C, 2006, NAT GENET, V38, P1032, DOI 10.1038/ng1858; Smyk M, 2007, HUM GENET, V122, P63, DOI 10.1007/s00439-007-0373-8; Virtanen HE, 2007, ACTA PAEDIATR, V96, P611, DOI 10.1111/j.1651-2227.2007.00241.x; Vissers LELM, 2004, NAT GENET, V36, P955, DOI 10.1038/ng1407; Wain LV, 2009, LANCET, V374, P340, DOI 10.1016/S0140-6736(09)60249-X; Wang MH, 2008, J ANDROL, V29, P499, DOI 10.2164/jandrol.108.004945; Wang Y, 2006, J CELL SCI, V119, P4002, DOI 10.1242/jcs.03169; Wilhelm D, 2006, NAT REV GENET, V7, P620, DOI 10.1038/nrg1903	36	110	117	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2010	5	10							e15392	10.1371/journal.pone.0015392	http://dx.doi.org/10.1371/journal.pone.0015392			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671GB	21048976	gold, Green Submitted, Green Published			2022-12-27	WOS:000283487400033
J	Voituron, N; Shvarev, Y; Menuet, C; Bevengut, M; Fasano, C; Vigneault, E; El Mestikawy, S; Hilaire, G				Voituron, Nicolas; Shvarev, Yuri; Menuet, Clement; Bevengut, Michelle; Fasano, Caroline; Vigneault, Erika; El Mestikawy, Salah; Hilaire, Gerard			Fluoxetine Treatment Abolishes the In Vitro Respiratory Response to Acidosis in Neonatal Mice	PLOS ONE			English	Article							INFANT-DEATH-SYNDROME; PHRENIC MOTONEURON ACTIVITY; RAT RETROTRAPEZOID NUCLEUS; BRAIN-STEM NEURONS; RHYTHM GENERATOR; SEROTONERGIC MODULATION; SPINAL-CORD; VENTRAL MEDULLA; MOUSE; CHEMOSENSITIVITY	Background: To secure pH homeostasis, the central respiratory network must permanently adapt its rhythmic motor drive to environment and behaviour. In neonates, it is commonly admitted that the retrotrapezoid/parafacial respiratory group of neurons of the ventral medulla plays the primary role in the respiratory response to acidosis, although the serotonergic system may also contribute to this response. Methodology/Principal Findings: Using en bloc medullary preparations from neonatal mice, we have shown for the first time that the respiratory response to acidosis is abolished after pre-treatment with the serotonin-transporter blocker fluoxetine (25-50 mu M, 20 min), a commonly used antidepressant. Using mRNA in situ hybridization and immunohistology, we have also shown the expression of the serotonin transporter mRNA and serotonin-containing neurons in the vicinity of the RTN/pFRG of neonatal mice. Conclusions: These results reveal that the serotonergic system plays a pivotal role in pH homeostasis. Although obtained in vitro in neonatal mice, they suggest that drugs targeting the serotonergic system should be used with caution in infants, pregnant women and breastfeeding mothers.	[Voituron, Nicolas; Shvarev, Yuri; Menuet, Clement; Bevengut, Michelle; Hilaire, Gerard] Univ Mediterranee Univ Paul Cezanne, CNRS, Unite Mixte Rech 6231, Marseille, France; [Shvarev, Yuri] Karolinska Inst, Dept Woman & Child Hlth, Stockholm, Sweden; [Shvarev, Yuri] Russian Acad Sci, Inst Cytol & Genet, Siberian Div, Novosibirsk 630090, Russia; [Fasano, Caroline; Vigneault, Erika; El Mestikawy, Salah] McGill Univ, Dept Psychiat, Douglas Hosp Res Ctr, Montreal, PQ H3A 2T5, Canada; [El Mestikawy, Salah] Inst Natl Sante & Rech Med, Unite 952, Paris, France; [El Mestikawy, Salah] CNRS, Unite Mixte Rech 7224, Paris, France; [El Mestikawy, Salah] Univ Paris 06, Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Karolinska Institutet; Russian Academy of Sciences; Institute of Cytology & Genetics ICG SB RAS; McGill University; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite	Voituron, N (corresponding author), Univ Mediterranee Univ Paul Cezanne, CNRS, Unite Mixte Rech 6231, Marseille, France.	gerard.hilaire@univ-cezanne.fr		voituron, nicolas/0000-0002-2092-4900; Menuet, Clement/0000-0002-7419-6427; el mestikawy, salah/0000-0002-6253-0002	International Rett Syndrome Foundation; Agence Nationale de la Recherche Prageder; Paul Cezanne University	International Rett Syndrome Foundation; Agence Nationale de la Recherche Prageder(French National Research Agency (ANR)); Paul Cezanne University	NV was supported by an International Rett Syndrome Foundation grant and Agence Nationale de la Recherche Prageder, YS by a Paul Cezanne University fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott SBG, 2009, J NEUROSCI, V29, P5806, DOI 10.1523/JNEUROSCI.1106-09.2009; Amiel J, 2009, RESP PHYSIOL NEUROBI, V168, P125, DOI 10.1016/j.resp.2009.03.005; Belik J, 2008, SEMIN PERINATOL, V32, P350, DOI 10.1053/j.semperi.2008.08.001; Blanchi B, 2003, NAT NEUROSCI, V6, P1091, DOI 10.1038/nn1129; Bou-Flores C, 2001, J NEUROPHYSIOL, V85, P1543, DOI 10.1152/jn.2001.85.4.1543; Bou-Flores C, 2000, J NEUROSCI, V20, P4646, DOI 10.1523/JNEUROSCI.20-12-04646.2000; CAUBIT X, 2010, J NEUROSCI IN PRESS; Corcoran AE, 2009, RESP PHYSIOL NEUROBI, V168, P49, DOI 10.1016/j.resp.2009.04.014; DIPASQUALE E, 1994, DEV BRAIN RES, V80, P222, DOI 10.1016/0165-3806(94)90107-4; DIPASQUALE E, 1992, NEUROSCI LETT, V143, P91, DOI 10.1016/0304-3940(92)90240-8; DiPasquale E, 1997, NEUROSCI LETT, V230, P29, DOI 10.1016/S0304-3940(97)00469-2; Duncan JR, 2010, JAMA-J AM MED ASSOC, V303, P430, DOI 10.1001/jama.2010.45; Erickson JT, 2007, RESP PHYSIOL NEUROBI, V159, P85, DOI 10.1016/j.resp.2007.06.002; Erlichman JS, 2010, J APPL PHYSIOL, V108, P1803, DOI 10.1152/japplphysiol.01321.2009; Erlichman JS, 2009, J NEUROPHYSIOL, V102, P1577, DOI 10.1152/jn.00381.2009; Fortin G, 2009, RESP PHYSIOL NEUROBI, V168, P86, DOI 10.1016/j.resp.2009.06.013; Gaspar P, 2003, NAT REV NEUROSCI, V4, P1002, DOI 10.1038/nrn1256; Gras C, 2008, NAT NEUROSCI, V11, P292, DOI 10.1038/nn2052; Guyenet PG, 2009, RESP PHYSIOL NEUROBI, V168, P59, DOI 10.1016/j.resp.2009.02.001; GUYENET PG, 2010, RESP PHYSL IN PRESS; Hewitt A, 2004, AM J PHYSIOL-REG I, V287, pR1407, DOI 10.1152/ajpregu.00404.2004; Hilaire G, 2004, RESP PHYSIOL NEUROBI, V143, P187, DOI 10.1016/j.resp.2004.04.016; Hilaire G, 1997, EUR J PHARMACOL, V329, P115, DOI 10.1016/S0014-2999(97)10117-0; HILAIRE G, 2010, RESP PHYSL NEUROBIOL; Hodges MR, 2008, J NEUROSCI, V28, P2495, DOI 10.1523/JNEUROSCI.4729-07.2008; HODGES MR, 2010, RESP PHYSL IN PRESS; ISSA FG, 1992, J APPL PHYSIOL, V72, P439, DOI 10.1152/jappl.1992.72.2.439; Kawai A, 1996, J PHYSIOL-LONDON, V492, P277, DOI 10.1113/jphysiol.1996.sp021308; Kim DK, 2005, NEUROPHARMACOLOGY, V49, P798, DOI 10.1016/j.neuropharm.2005.08.010; Kinney HC, 2009, ANNU REV PATHOL-MECH, V4, P517, DOI 10.1146/annurev.pathol.4.110807.092322; Lanoir J, 2006, J COMP NEUROL, V495, P607, DOI 10.1002/cne.20916; Li AH, 2008, J PHYSIOL-LONDON, V586, P2321, DOI 10.1113/jphysiol.2008.152231; Liu QL, 2010, J COMP NEUROL, V518, P1082, DOI 10.1002/cne.22265; Moss BL, 2005, J NEUROPHYSIOL, V94, P2575, DOI 10.1152/jn.00322.2005; Mulkey DK, 2007, J NEUROSCI, V27, P14128, DOI 10.1523/JNEUROSCI.4167-07.2007; Nattie E, 1999, PROG NEUROBIOL, V59, P299, DOI 10.1016/S0301-0082(99)00008-8; Nichols NL, 2008, ADV EXP MED BIOL, V605, P348; Okada Y, 2007, EUR J NEUROSCI, V26, P2834, DOI 10.1111/j.1460-9568.2007.05891.x; Onimaru H, 2009, RESP PHYSIOL NEUROBI, V168, P13, DOI 10.1016/j.resp.2009.03.007; Onimaru H, 2008, J NEUROSCI, V28, P12845, DOI 10.1523/JNEUROSCI.3625-08.2008; Oyamada Y, 1998, J PHYSIOL-LONDON, V513, P381, DOI 10.1111/j.1469-7793.1998.381bb.x; Paterson DS, 2006, JAMA-J AM MED ASSOC, V296, P2124, DOI 10.1001/jama.296.17.2124; Paterson DS, 2009, RESP PHYSIOL NEUROBI, V168, P133, DOI 10.1016/j.resp.2009.05.010; Richerson GB, 2004, NAT REV NEUROSCI, V5, P449, DOI 10.1038/nrn1409; Ritucci NA, 2005, AM J PHYSIOL-REG I, V289, pR851, DOI 10.1152/ajpregu.00132.2005; Rorig B, 1996, EUR J NEUROSCI, V8, P1685, DOI 10.1111/j.1460-9568.1996.tb01312.x; Rosin DL, 2006, J COMP NEUROL, V499, P64, DOI 10.1002/cne.21105; Rudnick G, 2006, HANDB EXP PHARM, V175, P59; SMITH JC, 1991, SCIENCE, V254, P726, DOI 10.1126/science.1683005; STEZHKA VV, 1995, EXP BRAIN RES, V105, P383; Stornetta RL, 2006, J NEUROSCI, V26, P10305, DOI 10.1523/JNEUROSCI.2917-06.2006; Thoby-Brisson M, 2009, NAT NEUROSCI, V12, P1028, DOI 10.1038/nn.2354; Yang L, 2008, RESP PHYSIOL NEUROBI, V160, P147, DOI 10.1016/j.resp.2007.09.006; Zanella S, 2008, J NEUROSCI, V28, P1745, DOI 10.1523/JNEUROSCI.4334-07.2008; Zanella S, 2006, RESP PHYSIOL NEUROBI, V153, P126, DOI 10.1016/j.resp.2005.09.009	55	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2010	5	10							e13644	10.1371/journal.pone.0013644	http://dx.doi.org/10.1371/journal.pone.0013644			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671GB	21048979	Green Published, gold, Green Submitted			2022-12-27	WOS:000283487400031
J	Oba, S; Kumano, S; Suzuki, E; Nishimatsu, H; Takahashi, M; Takamori, H; Kasuya, M; Ogawa, Y; Sato, K; Kimura, K; Homma, Y; Hirata, Y; Fujita, T				Oba, Shigeyoshi; Kumano, Shintaro; Suzuki, Etsu; Nishimatsu, Hiroaki; Takahashi, Masao; Takamori, Hajime; Kasuya, Masatoshi; Ogawa, Yousuke; Sato, Kenichiro; Kimura, Kenjiro; Homma, Yukio; Hirata, Yasunobu; Fujita, Toshiro			miR-200b Precursor Can Ameliorate Renal Tubulointerstitial Fibrosis	PLOS ONE			English	Article							MESENCHYMAL TRANSITION; INTERSTITIAL FIBROSIS; FAMILY; INFLAMMATION; EXPRESSION; ZEB1; EPITHELIUM	Members of the miR-200 family of micro RNAs (miRNAs) have been shown to inhibit epithelial-mesenchymal transition (EMT). EMT of tubular epithelial cells is the mechanism by which renal fibroblasts are generated. Here we show that miR-200 family members inhibit transforming growth factor-beta (TGF-beta)-induced EMT of tubular cells. Unilateral ureter obstruction (UUO) is a common model of EMT of tubular cells and subsequent tubulointerstitial fibrosis. In order to examine the role of miR-200 family members in tubulointerstitial fibrosis, their expression was investigated in the kidneys of UUO mice. The expression of miR-200 family miRNAs was increased in a time-dependent manner, with induction of miR-200b most pronounced. To clarify the effect of miR-200b on tubulointerstitial fibrosis, we injected miR-200b precursor intravenously. A single injection of 0.5 nM miR-200b precursor was sufficient to inhibit the increase of collagen types I, III and fibronectin in obstructed kidneys, and amelioration of fibrosis was confirmed by observation of the kidneys with Azan staining. miR-200 family members have been previously shown to inhibit EMT by reducing the expression of ZEB-1 and ZEB-2 which are known repressors of E-cadherin. We demonstrated that expression of ZEB-1 and ZEB-2 was increased after ureter obstruction and that administration of the miR-200b precursor reversed this effect. In summary, these results indicate that miR-200 family is up-regulated after ureter obstruction, miR-200b being strongly induced, and that miR-200b ameliorates tubulointerstitial fibrosis in obstructed kidneys. We suggest that members of the miR-200 family, and miR-200b specifically, might constitute novel therapeutic targets in kidney disease.	[Oba, Shigeyoshi; Takamori, Hajime; Kasuya, Masatoshi; Ogawa, Yousuke; Sato, Kenichiro; Fujita, Toshiro] Univ Tokyo, Sch Med, Dept Nephrol & Endocrinol, Tokyo 113, Japan; [Kumano, Shintaro; Nishimatsu, Hiroaki; Homma, Yukio] Univ Tokyo, Sch Med, Dept Urol, Tokyo 113, Japan; [Suzuki, Etsu] St Marianna Univ, Sch Med, Inst Med Sci, Kawasaki, Kanagawa, Japan; [Takahashi, Masao; Hirata, Yasunobu] Univ Tokyo, Sch Med, Dept Cardiovasc Dis, Tokyo 113, Japan; [Kimura, Kenjiro] St Marianna Univ, Sch Med, Dept Hypertens & Nephrol, Kawasaki, Kanagawa, Japan	University of Tokyo; University of Tokyo; Saint Marianna University; University of Tokyo; Saint Marianna University	Oba, S (corresponding author), Univ Tokyo, Sch Med, Dept Nephrol & Endocrinol, Tokyo 113, Japan.	OBA-2IM@h.u-tokyo.ac.jp		Takahashi, Masao/0000-0002-3799-2256				Bracken CP, 2008, CANCER RES, V68, P7846, DOI 10.1158/0008-5472.CAN-08-1942; Burk U, 2008, EMBO REP, V9, P582, DOI 10.1038/embor.2008.74; Duband JL, 1995, ACTA ANAT, V154, P63; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Harvey SJ, 2008, J AM SOC NEPHROL, V19, P2150, DOI 10.1681/ASN.2008020233; Iwano M, 2002, J CLIN INVEST, V110, P341, DOI 10.1172/JCI200215518; Kato M, 2007, P NATL ACAD SCI USA, V104, P3432, DOI 10.1073/pnas.0611192104; Kawai T, 2009, LAB INVEST, V89, P47, DOI 10.1038/labinvest.2008.104; KLAHR S, 1995, AM J KIDNEY DIS, V26, P141, DOI 10.1016/0272-6386(95)90167-1; Korpal M, 2008, J BIOL CHEM, V283, P14910, DOI 10.1074/jbc.C800074200; Leemans JC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005704; Mukai H, 2008, BIOCHEM BIOPH RES CO, V372, P383, DOI 10.1016/j.bbrc.2008.04.097; MULLER GA, 1992, J AM SOC NEPHROL, V2, pS198; NATH KA, 1992, AM J KIDNEY DIS, V20, P1; Oba S, 1998, AM J KIDNEY DIS, V32, P419, DOI 10.1053/ajkd.1998.v32.pm9740158; SHARMA AK, 1993, KIDNEY INT, V44, P774, DOI 10.1038/ki.1993.312; Sun YQ, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh186; Tan XY, 2007, J STEROID BIOCHEM, V103, P491, DOI 10.1016/j.jsbmb.2006.11.011; Thiery JP, 2003, CURR OPIN CELL BIOL, V15, P740, DOI 10.1016/j.ceb.2003.10.006; Tian ZM, 2008, GENOME RES, V18, P404, DOI 10.1101/gr.6587008; Vieira JM, 2005, NEPHROL DIAL TRANSPL, V20, P1582, DOI 10.1093/ndt/gfh859; Vitalone MJ, 2008, J AM SOC NEPHROL, V19, P1571, DOI 10.1681/ASN.2007050580; Wang Q, 2008, FASEB J, V22, P4126, DOI 10.1096/fj.08-112326; Yokoi H, 2002, AM J PHYSIOL-RENAL, V282, pF933, DOI 10.1152/ajprenal.00122.2001	24	108	118	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2010	5	10							e13614	10.1371/journal.pone.0013614	http://dx.doi.org/10.1371/journal.pone.0013614			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	670LB	21049046	Green Submitted, Green Published, gold			2022-12-27	WOS:000283422100019
J	Amarir, S; Marx, M; Calothy, G				Amarir, Samira; Marx, Maria; Calothy, Georges			Notch Signaling Activation Suppresses v-Src-Induced Transformation of Neural Cells by Restoring TGF-beta-Mediated Differentiation	PLOS ONE			English	Article							ROUS-SARCOMA-VIRUS; EMBRYO NEURORETINAL CELLS; GROWTH-FACTOR; RETINAL CELLS; IN-VITRO; EXPRESSION; CHICK; CANCER; INHIBITOR; INDUCTION	Background: We have been investigating how interruption of differentiation contributes to the oncogenic process and the possibility to reverse the transformed phenotype by restoring differentiation. In a previous report, we correlated the capacity of intracellular Notch (ICN) to suppress v-Src-mediated transformation of quail neuroretina (QNR/v-src(ts)) cells with the acquisition by these undifferentiated cells of glial differentiation markers. Methodology/Principal Findings: In this work, we have identified autocrine TGF-beta 3 signaling activation as a major effector of Notch-induced phenotypic changes, sufficient to induce transition in differentiation markers expression, suppress morphological transformation and significantly inhibit anchorage-independent growth. We also show that this signaling is constitutive of and contributes to ex-vivo autonomous QNR cell differentiation and that its down-regulation is essential to achieve v-Src-induced transformation. Conclusions/Significance: These results support the possibility that Notch signaling induces differentiation and suppresses transformation by a novel mechanism, involving secreted proteins. They also underline the importance of extracellular signals in controlling the balance between normal and transformed phenotypes.	[Amarir, Samira; Marx, Maria; Calothy, Georges] Inst Curie, CNRS UMR3347, INSERM U1021, Sect Rech, F-91405 Orsay, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Saclay	Amarir, S (corresponding author), Inst Curie, CNRS UMR3347, INSERM U1021, Sect Rech, F-91405 Orsay, France.	georges.calothy@curie.u-psud.fr			Centre National de la Recherche Scientifique; Institut Curie; Ministere de la Recherche et de l'Enseignement Superieur; Association pour la Recherche sur le Cancer; Ligue Nationale contre le Cancer (Comite de l'Essonne)	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Institut Curie; Ministere de la Recherche et de l'Enseignement Superieur; Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Ligue Nationale contre le Cancer (Comite de l'Essonne)	This work was supported by the Centre National de la Recherche Scientifique and the Institut Curie. S.A was supported by fellowships from the Ministere de la Recherche et de l'Enseignement Superieur, the Association pour la Recherche sur le Cancer and Ligue Nationale contre le Cancer (Comite de l'Essonne). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANZANO MA, 1983, P NATL ACAD SCI-BIOL, V80, P6264, DOI 10.1073/pnas.80.20.6264; Bao ZZ, 1997, J NEUROSCI, V17, P1425; Bierie B, 2006, NAT REV CANCER, V6, P506, DOI 10.1038/nrc1926; BIRCHENALLROBERTS MC, 1990, MOL CELL BIOL, V10, P4978, DOI 10.1128/MCB.10.9.4978; Bissell MJ, 2005, CANCER CELL, V7, P17, DOI 10.1016/j.ccr.2004.12.013; Burnside J, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-13; CALOTHY G, 1976, VIROLOGY, V71, P336, DOI 10.1016/0042-6822(76)90117-3; CALOTHY G, 1980, COLD SPRING HARB SYM, V44, P983, DOI 10.1101/SQB.1980.044.01.106; COMBES PC, 1977, CELL TISSUE RES, V185, P159; DATTO MB, 1995, P NATL ACAD SCI USA, V92, P5545, DOI 10.1073/pnas.92.12.5545; Derynck R, 2001, NAT GENET, V29, P117, DOI 10.1038/ng1001-117; Douer D, 2002, INT J HEMATOL, V76, P179, DOI 10.1007/BF03165115; Furukawa T, 2000, NEURON, V26, P383, DOI 10.1016/S0896-6273(00)81171-X; Gronemeyer H, 2001, CELL MOL BIOL LETT, V6, P3; GUERMAH M, 1990, MOL CELL BIOL, V10, P3584, DOI 10.1128/MCB.10.7.3584; GUERMAH M, 1991, P NATL ACAD SCI USA, V88, P4503, DOI 10.1073/pnas.88.10.4503; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hansen LA, 2000, CARCINOGENESIS, V21, P1271, DOI 10.1093/carcin/21.7.1271; Hendrix MJC, 2007, NAT REV CANCER, V7, P246, DOI 10.1038/nrc2108; Henrique D, 1997, CURR BIOL, V7, P661, DOI 10.1016/S0960-9822(06)00293-4; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Jean D, 1998, MECH DEVELOP, V76, P3, DOI 10.1016/S0925-4773(98)00117-8; Koch U, 2007, CELL MOL LIFE SCI, V64, P2746, DOI 10.1007/s00018-007-7164-1; KRYCEVEMARTINERIE C, 1985, INT J CANCER, V35, P553, DOI 10.1002/ijc.2910350421; LAYER PG, 1989, CELL TISSUE RES, V258, P233; Liu GM, 2006, J BIOL CHEM, V281, P29479, DOI 10.1074/jbc.M600579200; Masker K, 2007, VIROLOGY, V364, P10, DOI 10.1016/j.virol.2007.03.026; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Mateos S, 2007, ONCOGENE, V26, P3338, DOI 10.1038/sj.onc.1210124; Mey J, 2000, BRAIN RES REV, V32, P343, DOI 10.1016/S0165-0173(99)00022-3; Moustakas A, 2008, FEBS LETT, V582, P2051, DOI 10.1016/j.febslet.2008.03.027; Oren A, 1999, MOL CELL BIOL, V19, P1742; PESSAC B, 1983, NATURE, V302, P616, DOI 10.1038/302616a0; PESSAC B, 1974, SCIENCE, V185, P709, DOI 10.1126/science.185.4152.709; Rangarajan A, 2001, EMBO J, V20, P3427, DOI 10.1093/emboj/20.13.3427; Ridley AJ, 2001, TRENDS CELL BIOL, V11, P471, DOI 10.1016/S0962-8924(01)02153-5; Spira AI, 2003, CURR OPIN PHARMACOL, V3, P338, DOI 10.1016/S1471-4892(03)00081-X; Tanaka M, 1999, J NEUROBIOL, V41, P524, DOI 10.1002/(SICI)1097-4695(199912)41:4<524::AID-NEU8>3.3.CO;2-9; Wakamatsu Y, 2000, DEVELOPMENT, V127, P2811; Wakefield LM, 2002, CURR OPIN GENET DEV, V12, P22, DOI 10.1016/S0959-437X(01)00259-3	41	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2010	5	10							e13572	10.1371/journal.pone.0013572	http://dx.doi.org/10.1371/journal.pone.0013572			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	670KA	21042581	gold, Green Published, Green Submitted			2022-12-27	WOS:000283419100012
J	Vaine, M; Wang, SX; Liu, Q; Arthos, J; Montefiori, D; Goepfert, P; McElrath, MJ; Lu, S				Vaine, Michael; Wang, Shixia; Liu, Qin; Arthos, James; Montefiori, David; Goepfert, Paul; McElrath, M. Juliana; Lu, Shan			Profiles of Human Serum Antibody Responses Elicited by Three Leading HIV Vaccines Focusing on the Induction of Env-Specific Antibodies	PLOS ONE			English	Article							VIRUS-LIKE PARTICLES; NEUTRALIZING ANTIBODIES; CONFORMATIONAL EPITOPES; MONOCLONAL-ANTIBODIES; PASSIVE-IMMUNIZATION; NEONATAL MACAQUES; SUBTYPE-B; PROTECTION; BROAD; INFECTION	In the current report, we compared the specificities of antibody responses in sera from volunteers enrolled in three US NIH-supported HIV vaccine trials using different immunization regimens. HIV-1 Env-specific binding antibody, neutralizing antibody, antibody-dependent cell-mediated cytotoxicity (ADCC), and profiles of antibody specificity were analyzed for human immune sera collected from vaccinees enrolled in the NIH HIV Vaccine Trial Network (HVTN) Study #041 (recombinant protein alone), HVTN Study #203 (poxviral vector prime-protein boost), and the DP6-001 study (DNA prime-protein boost). Vaccinees from HVTN Study #041 had the highest neutralizing antibody activities against the sensitive virus along with the highest binding antibody responses, particularly those directed toward the V3 loop. DP6-001 sera showed a higher frequency of positive neutralizing antibody activities against more resistant viral isolate with a significantly higher CD4 binding site (CD4bs) antibody response compared to both HVTN studies #041 and #203. No differences were found in CD4-induced (CD4i) antibody responses, ADCC activity, or complement activation by Env-specific antibody among these sera. Given recent renewed interest in realizing the importance of antibody responses for next generation HIV vaccine development, different antibody profiles shown in the current report, based on the analysis of a wide range of antibody parameters, provide critical biomarker information for the selection of HIV vaccines for more advanced human studies and, in particular, those that can elicit antibodies targeting conformational-sensitive and functionally conserved epitopes.	[Vaine, Michael; Wang, Shixia; Lu, Shan] Univ Massachusetts, Sch Med, Dept Med, Lab Nucle Acid Vaccines, Worcester, MA 01605 USA; [Liu, Qin] Univ Massachusetts, Sch Med, Dept Med, Div Prevent & Behav Med, Worcester, MA USA; [Arthos, James] NIAID, NIH, Immunoregulat Lab, Bethesda, MD 20892 USA; [Montefiori, David] Duke Univ, Med Ctr, Durham, NC USA; [Goepfert, Paul] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Goepfert, Paul] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA; [McElrath, M. Juliana] Univ Washington, Sch Med, Dept Med, Seattle, WA 98195 USA; [McElrath, M. Juliana] Univ Washington, Sch Med, Lab Med, Seattle, WA 98195 USA; [McElrath, M. Juliana] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Inst, Seattle, WA 98104 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Duke University; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center	Vaine, M (corresponding author), Univ Massachusetts, Sch Med, Dept Med, Lab Nucle Acid Vaccines, Worcester, MA 01605 USA.	shan.lu@umassmed.edu		Lu, Shan/0000-0002-8417-7588	NIH [AI065250, AI082274, AI082676, AI 27742]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000883, U19AI082676, P01AI082274, U01AI068618, R01AI065250, P30AI027742, R21AI087191] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by NIH grants AI065250, AI082274, & AI082676. Dr. Susan Zolla-Pazner provided mAb 447-52D supported under NIH grant AI 27742. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barouch DH, 2008, NATURE, V455, P613, DOI 10.1038/nature07352; Binley JM, 2008, J VIROL, V82, P11651, DOI 10.1128/JVI.01762-08; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; Casimiro DR, 2005, J VIROL, V79, P15547, DOI 10.1128/JVI.79.24.15547-15555.2005; Christensen ND, 2001, VIROLOGY, V291, P324, DOI 10.1006/viro.2001.1220; Clements-Mann ML, 1998, J INFECT DIS, V177, P1230, DOI 10.1086/515288; Conley AJ, 1996, J VIROL, V70, P6751, DOI 10.1128/JVI.70.10.6751-6758.1996; Conway JF, 2003, J VIROL, V77, P6466, DOI 10.1128/JVI.77.11.6466-6473.2003; Crooks ET, 2007, VIROLOGY, V366, P245, DOI 10.1016/j.virol.2007.04.033; Decker JM, 2005, J EXP MED, V201, P1407, DOI 10.1084/jem.20042510; Derby NR, 2006, J VIROL, V80, P8745, DOI 10.1128/JVI.00956-06; EMINI EA, 1992, NATURE, V355, P728, DOI 10.1038/355728a0; Fleury MJJ, 2006, ARCH VIROL, V151, P1511, DOI 10.1007/s00705-006-0734-y; Flynn MN, 2005, J INFECT DIS, V191, P654, DOI 10.1086/428404; Forsell MNE, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000171; Goepfert PA, 2007, VACCINE, V25, P510, DOI 10.1016/j.vaccine.2006.07.050; Gomez-Roman VR, 2006, J IMMUNOL METHODS, V308, P53, DOI 10.1016/j.jim.2005.09.018; Haynes BF, 2006, EXPERT REV VACCINES, V5, P578; Hessell AJ, 2009, NAT MED, V15, P951, DOI 10.1038/nm.1974; Hofmann-Lehmann R, 2002, J MED PRIMATOL, V31, P109, DOI 10.1034/j.1600-0684.2002.01014.x; Hofmann-Lehmann R, 2001, J VIROL, V75, P7470, DOI 10.1128/JVI.75.16.7470-7480.2001; Karnasuta C, 2005, VACCINE, V23, P2522, DOI 10.1016/j.vaccine.2004.10.028; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; Li YX, 2007, NAT MED, V13, P1032, DOI 10.1038/nm1624; Li YX, 2009, J VIROL, V83, P1045, DOI 10.1128/JVI.01992-08; Mascola JR, 1999, J VIROL, V73, P4009, DOI 10.1128/JVI.73.5.4009-4018.1999; Mascola JR, 2000, NAT MED, V6, P207, DOI 10.1038/72318; MONTEFIORI DC, 2004, CURRENT PROTOCOLS IM, P1; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Russell ND, 2007, JAIDS-J ACQ IMM DEF, V44, P203, DOI 10.1097/01.qai.0000248356.48501.ff; Scheid JF, 2009, NATURE, V458, P636, DOI 10.1038/nature07930; Srivastava IK, 2005, HUM VACCINES, V1, P45, DOI 10.4161/hv.1.2.1764; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wang S, 2008, VACCINE, V26, P3946, DOI 10.1016/j.vaccine.2008.04.025; Wu XL, 2008, VIROLOGY, V380, P285, DOI 10.1016/j.virol.2008.07.007; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819	36	38	50	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2010	5	11							e13916	10.1371/journal.pone.0013916	http://dx.doi.org/10.1371/journal.pone.0013916			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	677ZE	21085486	Green Published, gold			2022-12-27	WOS:000284035900021
J	Yoon, H; Kim, TS; Braciale, TJ				Yoon, Heesik; Kim, Taeg S.; Braciale, Thomas J.			The Cell Cycle Time of CD8(+) T Cells Responding In Vivo Is Controlled by the Type of Antigenic Stimulus	PLOS ONE			English	Article							RETINOBLASTOMA PROTEIN; DIFFERENTIATION; NAIVE; ACTIVATION; RB; STIMULATION; PROGRESSION; INHIBITORS; INDUCTION; FREQUENCY	A hallmark of cells comprising the mammalian adaptive immune system is the requirement for these rare naive T (and B) lymphocytes directed to a specific microorganism to undergo proliferative expansion upon first encounter with this antigen. In the case of naive CD8(+) T cells the ability of these rare quiescent lymphocytes to rapidly activate and expand into effector T cells in numbers sufficient to control viral and certain bacterial infections can be essential for survival. In this report we examined the activation, cell cycle time and initial proliferative response of naive murine CD8(+) T cells responding in vivo to Influenza and Vaccinia virus infection or vaccination with viral antigens. Remarkably, we observed that CD8(+) T cells could divide and proliferate with an initial cell division time of as short as 2 hours. The initial cell cycle time of responding CD8(+) T cells is not fixed but is controlled by the antigenic stimulus provided by the APC in vivo. Initial cell cycle time influences the rate of T cell expansion and the numbers of effector T cells subsequently accumulating at the site of infection. The T cell cycle time varies with duration of the G(1) phase of the cell cycle. The duration of G(1) is inversely correlated with the phosphorylation state of the retinoblastoma (Rb) protein in the responding T cells. The implication of these findings for the development of adaptive immune responses and the regulation of cell cycle in higher eukaryotic cells is discussed.	[Yoon, Heesik; Kim, Taeg S.; Braciale, Thomas J.] Univ Virginia, Carter Immunol Ctr, Charlottesville, VA 22903 USA; [Braciale, Thomas J.] Univ Virginia, Dept Microbiol, Charlottesville, VA 22908 USA; [Kim, Taeg S.; Braciale, Thomas J.] Univ Virginia, Dept Pathol, Charlottesville, VA 22903 USA	University of Virginia; University of Virginia; University of Virginia	Yoon, H (corresponding author), Univ Virginia, Carter Immunol Ctr, Charlottesville, VA 22903 USA.	tjb2r@virginia.edu			National Institutes of Health [R01 AI-15608, R01 AI-37293, R01 HL-33391, U-19 AI-83024]; American Lung Association [RT 82757 N]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL033391] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI015608, R01AI037293, R37AI015608, U19AI083024] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lung Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	These studies were supported by grants from the National Institutes of Health (R01 AI-15608, R01 AI-37293, R01 HL-33391 and U-19 AI-83024) to T.J.B., and an American Lung Association fellowship (RT 82757 N) to T.S.K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki K, 2003, NAT GENET, V35, P323, DOI 10.1038/ng1265; Bar JJ, 2008, IMMUNITY, V28, P859, DOI 10.1016/j.immuni.2008.04.010; Geginat J, 2002, ADV EXP MED BIOL, V512, P107; Hao XL, 2008, J VIROL, V82, P4908, DOI 10.1128/JVI.02367-07; Harbour JW, 2000, NAT CELL BIOL, V2, pE65, DOI 10.1038/35008695; Harty JT, 2000, ANNU REV IMMUNOL, V18, P275, DOI 10.1146/annurev.immunol.18.1.275; Hataye J, 2006, SCIENCE, V312, P114, DOI 10.1126/science.1124228; Hermeking H, 2000, P NATL ACAD SCI USA, V97, P2229, DOI 10.1073/pnas.050586197; Homann D, 2001, NAT MED, V7, P913, DOI 10.1038/90950; Ivanchuk SM, 2004, NEUROSURGERY, V54, P692, DOI 10.1227/01.NEU.0000109534.28063.5D; Kaech SM, 2001, NAT IMMUNOL, V2, P415, DOI 10.1038/87720; Kaech SM, 2002, NAT REV IMMUNOL, V2, P251, DOI 10.1038/nri778; Kim TS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004204; Knudsen ES, 1998, GENE DEV, V12, P2278, DOI 10.1101/gad.12.15.2278; Lanzavecchia A, 2000, SCIENCE, V290, P92, DOI 10.1126/science.290.5489.92; Lawrence CW, 2004, J IMMUNOL, V173, P1209, DOI 10.4049/jimmunol.173.2.1209; Lawrence CW, 2005, J IMMUNOL, V174, P5332, DOI 10.4049/jimmunol.174.9.5332; Lee WT, 2002, J IMMUNOL, V168, P1682, DOI 10.4049/jimmunol.168.4.1682; Lezzi G, 1998, IMMUNITY, V8, P89, DOI 10.1016/S1074-7613(00)80461-6; Li LQ, 2006, NAT IMMUNOL, V7, P1157, DOI 10.1038/ni1398; Macagno A, 2007, TRENDS IMMUNOL, V28, P227, DOI 10.1016/j.it.2007.03.008; Mateyak MK, 1999, MOL CELL BIOL, V19, P4672; Moon JJ, 2007, IMMUNITY, V27, P203, DOI 10.1016/j.immuni.2007.07.007; Murali-Krishna K, 1998, IMMUNITY, V8, P177, DOI 10.1016/S1074-7613(00)80470-7; Murray AW, 2004, CELL, V116, P221, DOI 10.1016/S0092-8674(03)01080-8; O'Farrell PH, 2004, CURR BIOL, V14, pR35, DOI 10.1016/j.cub.2003.12.022; PARDEE AB, 1989, SCIENCE, V246, P603, DOI 10.1126/science.2683075; Ream RM, 2010, J IMMUNOL, V184, P2401, DOI 10.4049/jimmunol.0902448; Sage J, 2000, GENE DEV, V14, P3037, DOI 10.1101/gad.843200; Savatier P, 1996, ONCOGENE, V12, P309; SAVATIER P, 1994, ONCOGENE, V9, P809; Schorl C, 2003, MOL BIOL CELL, V14, P823, DOI 10.1091/mbc.E02-10-0649; Sclafani RA, 2007, ANNU REV GENET, V41, P237, DOI 10.1146/annurev.genet.41.110306.130308; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Smith-Garvin JE, 2009, ANNU REV IMMUNOL, V27, P591, DOI 10.1146/annurev.immunol.021908.132706; Veiga-Fernandes H, 2000, NAT IMMUNOL, V1, P47, DOI 10.1038/76907; von Andrian UH, 2003, NAT REV IMMUNOL, V3, P867, DOI 10.1038/nri1222; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; Wells AD, 1997, J CLIN INVEST, V100, P3173, DOI 10.1172/JCI119873; Whitmire JK, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000041; Yoon H, 2007, J IMMUNOL, V179, P391, DOI 10.4049/jimmunol.179.1.391	41	67	67	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2010	5	11							e15423	10.1371/journal.pone.0015423	http://dx.doi.org/10.1371/journal.pone.0015423			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	676NU	21079741	Green Published, Green Submitted, gold			2022-12-27	WOS:000283920000023
J	Kale, S; Yende, S; Kong, L; Perkins, A; Kellum, JA; Newman, AB; Vallejo, AN; Angus, DC				Kale, Sachin; Yende, Sachin; Kong, Lan; Perkins, Amy; Kellum, John A.; Newman, Anne B.; Vallejo, Abbe N.; Angus, Derek C.		GenIMS Investigators	The Effects of Age on Inflammatory and Coagulation-Fibrinolysis Response in Patients Hospitalized for Pneumonia	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; PLASMINOGEN-ACTIVATOR INHIBITOR-1; CYTOKINE PRODUCTION; TERM MORTALITY; UNITED-STATES; OLDER-ADULTS; SEPSIS; MARKERS; FRAILTY; BACTEREMIA	Objective: To determine whether inflammatory and hemostasis response in patients hospitalized for pneumonia varies by age and whether these differences explain higher mortality in the elderly. Methods: In an observational cohort of subjects with community-acquired pneumonia (CAP) recruited from emergency departments (ED) in 28 hospitals, we divided subjects into 5 age groups (<50, 51-64, 65-74, 75-84, and >= 85). We measured circulating levels of inflammatory (TNF, IL-6, and IL-10), hemostasis (D-dimer, Factor IX, thrombin-antithrombin complex, antithrombin and plasminogen-activator inhibitor-1), and cell-surface markers (TLR-2, TLR-4, and HLA-DR) during the first week of hospitalization and at discharge and compared 90-day mortality. We used logistic regression to compare odds ratios (OR) for 90-day mortality between age groups, adjusting for differences in pre-infection factors alone and then additionally adjusting for immune markers. Results: Of 2,183 subjects, 495, 444, 403, 583, and 258 subjects were,50, 51-64, 65-74, 75-84, and >= 85 years of age, respectively. Large age-related differences were observed in 90-day mortality (0.82% vs. 3.2% vs. 6.4% vs. 12.8% vs. 13.6%, p<0.01). No age-related differences in inflammatory and cell surface markers occurred during the first week. Older subjects had higher pro-coagulant markers on ED presentation and over first week (p <= 0.03), but these differences were modest (1.0-1.7-fold differences). Odds of death for older adults changed minimally in models incorporating differences in hemostasis and inflammatory markers (for subjects >= 85 compared to those,50, OR = 4.36, when adjusted for pre-infection factors and OR = 3.49 when additionally adjusted for hemostasis markers). At discharge, despite clinical recovery as evidenced by normal vital signs in >85% subjects, older subjects had modestly increased hemostasis markers and IL-6 levels (p<0.01). Conclusions: Modest age-related increases in coagulation response occur during hospitalization for CAP; however these differences do not explain the large differences in mortality. Despite clinical recovery, immune resolution may be delayed in older adults at discharge.	[Kale, Sachin; Yende, Sachin; Kellum, John A.; Angus, Derek C.] Univ Pittsburgh, Clin Res Invest & Syst Modeling Acute Illness CRI, Pittsburgh, PA USA; [Kale, Sachin; Yende, Sachin; Kellum, John A.; Angus, Derek C.] Univ Pittsburgh, Dept Crit Care Med, Pittsburgh, PA USA; [Kong, Lan; Perkins, Amy] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Biostat, Pittsburgh, PA 15261 USA; [Newman, Anne B.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA 15261 USA; [Vallejo, Abbe N.] Univ Pittsburgh, Childrens Hosp Pittsburgh, Dept Pediat, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Kale, S (corresponding author), Univ Pittsburgh, Clin Res Invest & Syst Modeling Acute Illness CRI, Pittsburgh, PA USA.	yendes@upmc.edu	Angus, Derek C/E-9671-2012; Newman, Anne B./C-6408-2013; Kellum, John A/HCH-2944-2022; Kellum, John/AAP-3072-2020	Newman, Anne B./0000-0002-0106-1150; Kellum, John A/0000-0003-1995-2653; Kellum, John/0000-0003-1995-2653	National Institute of General Medical Sciences (NIGMS) [R01 GM61992]; NIH [T32 AG021885];  [K23 GM083215]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K23GM083215, R01GM061992] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG021885, P30AG024827] Funding Source: NIH RePORTER	National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	GenIMS was funded by National Institute of General Medical Sciences (NIGMS) R01 GM61992 with additional support from GlaxoSmithKline for enrollment and clinical data collection, and Diagnostic Products Corporation for the cytokine assays. Sachin Kale is supported by NIH T32 AG021885. Dr. Sachin Yende is supported by K23 GM083215. The funders had no role in study design, data analysis, decision to publish, or preparation of the manuscript.	Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Bone RC, 1996, ANN INTERN MED, V125, P680, DOI 10.7326/0003-4819-125-8-199610150-00009; Bretz WA, 2005, J AM GERIATR SOC, V53, P1532, DOI 10.1111/j.1532-5415.2005.53468.x; Bruunsgaard H, 2003, IMMUNOL ALLERGY CLIN, V23, P15, DOI 10.1016/S0889-8561(02)00056-5; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Christ-Crain M, 2010, CRIT CARE, V14, DOI 10.1186/cc8155; Devaraj S, 2008, J CLIN ENDOCR METAB, V93, P578, DOI 10.1210/jc.2007-2185; Dhainaut JF, 2005, CLIN INFECT DIS, V41, pS481, DOI 10.1086/432001; Epstein MP, 2003, AM J HUM GENET, V72, P611, DOI 10.1086/367924; Fine MJ, 1997, NEW ENGL J MED, V336, P243, DOI 10.1056/NEJM199701233360402; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Girard TD, 2007, CLIN GERIATR MED, V23, P633, DOI 10.1016/j.cger.2007.05.003; Halm EA, 2002, NEW ENGL J MED, V347, P2039, DOI 10.1056/NEJMcp020499; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; Jones BL, 2001, SOCIOL METHOD RES, V29, P374, DOI 10.1177/0049124101029003005; KANE RL, 1994, ESSENTIALS CLIN GERI; Kaplan V, 2003, ARCH INTERN MED, V163, P317, DOI 10.1001/archinte.163.3.317; Kaplan V, 2002, AM J RESP CRIT CARE, V165, P766, DOI 10.1164/ajrccm.165.6.2103038; Kellum JA, 2007, ARCH INTERN MED, V167, P1655, DOI 10.1001/archinte.167.15.1655; Kelly E, 2009, RESPIROLOGY, V14, P210, DOI 10.1111/j.1440-1843.2008.01423.x; KNAUS WA, 1991, CHEST, V100, P1619, DOI 10.1378/chest.100.6.1619; Krabbe KS, 2004, EXP GERONTOL, V39, P687, DOI 10.1016/j.exger.2004.01.009; Kumar AT, 2009, INDIAN J CRIT CARE M, V13, P74, DOI 10.4103/0972-5229.56052; Lekkou A, 2004, CLIN DIAGN LAB IMMUN, V11, P161, DOI 10.1128/CDLI.11.1.161-167.2004; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159; Marik PE, 2001, J AM GERIATR SOC, V49, P5, DOI 10.1046/j.1532-5415.2001.49003.x; Martin GS, 2006, CRIT CARE MED, V34, P15, DOI 10.1097/01.CCM.0000194535.82812.BA; MCDONALD AP, 2009, THROMB RES; Metersky ML, 2004, AM J RESP CRIT CARE, V169, P342, DOI 10.1164/rccm.200309-1248OC; Mokdad AH, 2004, JAMA-J AM MED ASSOC, V291, P1238, DOI 10.1001/jama.291.10.1238; Nourhashemi F, 2001, J GERONTOL A-BIOL, V56, pM448, DOI 10.1093/gerona/56.7.M448; Opal SM, 2005, CLIN INFECT DIS, V41, pS504, DOI 10.1086/432007; Pajkrt D, 1997, BLOOD, V89, P2701, DOI 10.1182/blood.V89.8.2701; Pieper CF, 2000, J GERONTOL A-BIOL, V55, pM649, DOI 10.1093/gerona/55.11.M649; PRALONG G, 1989, THROMB HAEMOSTASIS, V61, P459; RICHEDWARDS JW, 1994, AM J EPIDEMIOL, V140, P1016, DOI 10.1093/oxfordjournals.aje.a117191; Roubenoff R, 1998, J GERONTOL A-BIOL, V53, pM20, DOI 10.1093/gerona/53A.1.M20; Samarakoon R, 2010, CELL SIGNAL, V22, P1413, DOI 10.1016/j.cellsig.2010.03.020; Saurwein-Teissl M, 2000, CYTOKINE, V12, P1160, DOI 10.1006/cyto.2000.0679; Singh M, 2008, MAYO CLIN PROC, V83, P1146, DOI 10.4065/83.10.1146; Sogaard M, 2008, J AM GERIATR SOC, V56, P1593, DOI 10.1111/j.1532-5415.2008.01855.x; Steinbach G, 2004, CLIN CHEM LAB MED, V42, P440, DOI 10.1515/CCLM.2004.077; STOWE RP, J GERONTOL A, V65, P429; Turnbull IR, 2009, CRIT CARE MED, V37, P1018, DOI 10.1097/CCM.0b013e3181968f3a; van Duin D, 2007, J AM GERIATR SOC, V55, P1438, DOI 10.1111/j.1532-5415.2007.01300.x; Vincent JL, 2006, CRIT CARE MED, V34, P344, DOI 10.1097/01.CCM.0000194725.48928.3A; Walston J, 2002, ARCH INTERN MED, V162, P2333, DOI 10.1001/archinte.162.20.2333; Waterer GW, 2004, AM J RESP CRIT CARE, V169, P910, DOI 10.1164/rccm.200310-1448OC; Yamamoto K, 2002, AM J PATHOL, V161, P1805, DOI 10.1016/S0002-9440(10)64457-4; Yende S, 2005, AM J RESP CRIT CARE, V172, P1440, DOI 10.1164/rccm.200506-888OC; Yende S, 2008, AM J RESP CRIT CARE, V177, P1242, DOI 10.1164/rccm.200712-1777OC; Yende S, 2007, J AM GERIATR SOC, V55, P518, DOI 10.1111/j.1532-5415.2007.01100.x; Yende Sachin, 2007, Curr Infect Dis Rep, V9, P382, DOI 10.1007/s11908-007-0059-3; Zeerleder S, 2006, THROMB RES, V118, P205, DOI 10.1016/j.thromres.2005.06.007	55	24	26	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2010	5	11							e13852	10.1371/journal.pone.0013852	http://dx.doi.org/10.1371/journal.pone.0013852			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	675NY	21085465	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000283838600022
J	Buenemann, M; Lenz, P				Buenemann, Mathias; Lenz, Peter			A Geometrical Model for DNA Organization in Bacteria	PLOS ONE			English	Article							ESCHERICHIA-COLI CHROMOSOME; SEPARATE CELL HALVES; CAULOBACTER-CRESCENTUS; SUPERCOILED DNA; SEGREGATION; REPLICATION; DYNAMICS; PROTEINS; MOVEMENT; TERMINUS	Recent experimental studies have revealed that bacteria, such as C. crescentus, show a remarkable spatial ordering of their chromosome. A strong linear correlation has been found between the position of genes on the chromosomal map and their spatial position in the cellular volume. We show that this correlation can be explained by a purely geometrical model. Namely, self-avoidance of DNA, specific positioning of one or few DNA loci (such as origin or terminus) together with the action of DNA compaction proteins (that organize the chromosome into topological domains) are sufficient to get a linear arrangement of the chromosome along the cell axis. We develop a Monte-Carlo method that allows us to test our model numerically and to analyze the dependence of the spatial ordering on various physiologically relevant parameters. We show that the proposed geometrical ordering mechanism is robust and universal (i.e. does not depend on specific bacterial details). The geometrical mechanism should work in all bacteria that have compacted chromosomes with spatially fixed regions. We use our model to make specific and experimentally testable predictions about the spatial arrangement of the chromosome in mutants of C. crescentus and the growth-stage dependent ordering in E. coli.	[Buenemann, Mathias; Lenz, Peter] Univ Calif San Diego, Dept Phys, La Jolla, CA 92093 USA; [Buenemann, Mathias; Lenz, Peter] Univ Calif San Diego, Ctr Theoret Biol Phys, La Jolla, CA 92093 USA; [Buenemann, Mathias] Univ Marburg, Fachbereich Phys, D-3550 Marburg, Germany; [Buenemann, Mathias] Univ Marburg, Zentrum Synthet Mikrobiol, Marburg, Germany	University of California System; University of California San Diego; University of California System; University of California San Diego; Philipps University Marburg; Philipps University Marburg	Buenemann, M (corresponding author), Univ Calif San Diego, Dept Phys, La Jolla, CA 92093 USA.	peter.lenz@Physik.Uni-Marburg.DE	Lenz, Peter/L-5980-2013	Lenz, Peter/0000-0001-7705-3950	DAAD	DAAD(Deutscher Akademischer Austausch Dienst (DAAD))	This work was supported (in part) by the DAAD (www.daad.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin RH, 1997, PHYS TODAY, V50, P32, DOI 10.1063/1.881674; Bates D, 2005, CELL, V121, P899, DOI 10.1016/j.cell.2005.04.013; Bowman GR, 2008, CELL, V134, P945, DOI 10.1016/j.cell.2008.07.015; Bremer H, 1996, ESCHERICHIA COLI SAL; Colby R.H., 2003, POLYM PHYS; DEGNEN ST, 1972, J MOL BIOL, V64, P671, DOI 10.1016/0022-2836(72)90090-3; Ebersbach G, 2008, CELL, V134, P956, DOI 10.1016/j.cell.2008.07.016; Hardy CD, 2005, MOL MICROBIOL, V57, P1636, DOI 10.1111/j.1365-2958.2005.04799.x; HAYS JB, 1969, BIOPOLYMERS, V8, P531, DOI 10.1002/bip.1969.360080410; HILHORST HJ, 1975, J CHEM PHYS, V63, P5153, DOI 10.1063/1.431297; Hirano T, 2002, GENE DEV, V16, P399, DOI 10.1101/gad.955102; Jensen RB, 1999, P NATL ACAD SCI USA, V96, P10661, DOI 10.1073/pnas.96.19.10661; Kornyshev AA, 2000, PHYS REV E, V62, P2576, DOI 10.1103/PhysRevE.62.2576; Kruse T, 2006, GENE DEV, V20, P113, DOI 10.1101/gad.366606; Li YF, 2003, MOL MICROBIOL, V50, P825, DOI 10.1046/j.1365-2958.2003.03746.x; Li YF, 2002, MOL MICROBIOL, V46, P985, DOI 10.1046/j.1365-2958.2002.03234.x; MADRAS N, 1990, J STAT PHYS, V58, P159, DOI 10.1007/BF01020290; Marko JF, 1995, MACROMOLECULES, V28, P8759, DOI 10.1021/ma00130a008; MARR A. G., 1966, J BACTERIOL, V91, P2388; Nanninga N, 1985, MOL CYTOLOGY ESCHERI, P259; Nielsen HJ, 2007, J BACTERIOL, V189, P8660, DOI 10.1128/JB.01212-07; Nielsen HJ, 2006, MOL MICROBIOL, V62, P331, DOI 10.1111/j.1365-2958.2006.05346.x; Niki H, 2000, GENE DEV, V14, P212; NORRIS V, 1995, MOL MICROBIOL, V16, P1051, DOI 10.1111/j.1365-2958.1995.tb02330.x; Postow L, 2004, GENE DEV, V18, P1766, DOI 10.1101/gad.1207504; Rappaport SM, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.038101; Reyes-Lamothe R, 2008, CELL, V133, P90, DOI 10.1016/j.cell.2008.01.044; Sawitzke J, 2001, MOL MICROBIOL, V40, P786, DOI 10.1046/j.1365-2958.2001.02350.x; Sherratt DJ, 2003, SCIENCE, V301, P780, DOI 10.1126/science.1084780; Skoko D, 2004, BIOCHEMISTRY-US, V43, P13867, DOI 10.1021/bi048428o; Strick TR, 1996, SCIENCE, V271, P1835, DOI 10.1126/science.271.5257.1835; Swinger KK, 2004, CURR OPIN STRUC BIOL, V14, P28, DOI 10.1016/j.sbi.2003.12.003; Teleman AA, 1998, CURR BIOL, V8, P1102, DOI 10.1016/S0960-9822(98)70464-6; Thanbichler M, 2005, J CELL BIOCHEM, V96, P506, DOI 10.1002/jcb.20519; Toro E, 2008, P NATL ACAD SCI USA, V105, P15435, DOI 10.1073/pnas.0807448105; Toro E, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000349; TRUEBA FJ, 1982, ARCH MICROBIOL, V131, P235, DOI 10.1007/BF00405885; VERDIER PH, 1962, J CHEM PHYS, V36, P227, DOI 10.1063/1.1732301; Viollier PH, 2004, P NATL ACAD SCI USA, V101, P9257, DOI 10.1073/pnas.0402606101; VOLOGODSKII AV, 1994, ANNU REV BIOPH BIOM, V23, P609, DOI 10.1146/annurev.bb.23.060194.003141; Wang XD, 2006, GENE DEV, V20, P1727, DOI 10.1101/gad.388406; Weber SC, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.011913; Weber SC, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.238102; White MA, 2008, NATURE, V455, P1248, DOI 10.1038/nature07282; Wiggins PA, 2010, P NATL ACAD SCI USA, V107, P4991, DOI 10.1073/pnas.0912062107; Yamaichi Y, 2004, EMBO J, V23, P221, DOI 10.1038/sj.emboj.7600028	46	21	21	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2010	5	11							e13806	10.1371/journal.pone.0013806	http://dx.doi.org/10.1371/journal.pone.0013806			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	674WJ	21085464	gold, Green Published, Green Submitted			2022-12-27	WOS:000283780800009
J	Kompier, LC; Lurkin, I; van der Aa, MNM; van Rhijn, BWG; van der Kwast, TH; Zwarthoff, EC				Kompier, Lucie C.; Lurkin, Irene; van der Aa, Madelon N. M.; van Rhijn, Bas W. G.; van der Kwast, Theo H.; Zwarthoff, Ellen C.			FGFR3, HRAS, KRAS, NRAS and PIK3CA Mutations in Bladder Cancer and Their Potential as Biomarkers for Surveillance and Therapy	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR-3; UROTHELIAL CELL-CARCINOMA; PHOSPHOINOSITIDE 3-KINASE; BIOLOGICAL BEHAVIOR; MULTIPLE-MYELOMA; ONCOGENE PRODUCT; MEK INHIBITORS; GENE-MUTATIONS; PI3K PATHWAY; PHASE-III	Background: Fifty percent of patients with muscle-invasive bladder cancer (MI-BC) die from their disease and current chemotherapy treatment only marginally increases survival. Novel therapies targeting receptor tyrosine kinases or activated oncogenes may improve outcome. Hence, it is necessary to stratify patients based on mutations in relevant oncogenes. Patients with non-muscle-invasive bladder cancer (NMI-BC) have excellent survival, however two-thirds develop recurrences. Tumor specific mutations can be used to detect recurrences in urine assays, presenting a more patient-friendly diagnostic procedure than cystoscopy. Methodology/Principal Findings: To address these issues, we developed a mutation assay for the simultaneous detection of 19 possible mutations in the HRAS, KRAS, and NRAS genes. With this assay and mutation assays for the FGFR3 and PIK3CA oncogenes, we screened primary bladder tumors of 257 patients and 184 recurrences from 54 patients. Additionally, in primary tumors p53 expression was obtained by immunohistochemistry. Of primary tumors 64% were mutant for FGFR3, 11% for RAS, 24% for PIK3CA, and 26% for p53. FGFR3 mutations were mutually exclusive with RAS mutations (p = 0.001) and co-occurred with PIK3CA mutations (p = 0.016). P53 overexpression was mutually exclusive with PIK3CA and FGFR3 mutations (p <= 0.029). Mutations in the RAS and PIK3CA genes were not predictors for recurrence-free, progression-free and disease-specific survival. In patients presenting with NMI-BC grade 3 and MI-BC, 33 and 36% of the primary tumors were mutant. In patients with low-grade NMI-BC, 88% of the primary tumors carried a mutation and 88% of the recurrences were mutant. Conclusions/Significance: The mutation assays present a companion diagnostic to define patients for targeted therapies. In addition, the assays are a potential biomarker to detect recurrences during surveillance. We showed that 88% of patients presenting with low-grade NMI-BC are eligible for such a follow-up. This may contribute to a reduction in the number of cystoscopical examinations.	[Kompier, Lucie C.; Lurkin, Irene; van der Aa, Madelon N. M.; Zwarthoff, Ellen C.] Erasmus MC, Dept Pathol, Rotterdam, Netherlands; [van Rhijn, Bas W. G.] Toronto Gen Hosp, Univ Hlth Network, Dept Urol, Toronto, ON, Canada; [van der Kwast, Theo H.] Toronto Gen Hosp, Univ Hlth Network, Dept Lab Med & Pathobiol, Toronto, ON, Canada	Erasmus University Rotterdam; Erasmus MC; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital	Kompier, LC (corresponding author), Erasmus MC, Dept Pathol, Rotterdam, Netherlands.	e.zwarthoff@erasmusmc.nl		Van der Kwast, Theodorus/0000-0001-8640-5786	Erasmus MC Breedtestrategie; Netherlands Organization for Health Research and Development (ZON-MW) [945-02-046]	Erasmus MC Breedtestrategie; Netherlands Organization for Health Research and Development (ZON-MW)(Netherlands Organization for Health Research and Development)	This study was supported by an Erasmus MC Breedtestrategie Grant (2002-2006) and The Netherlands Organization for Health Research and Development (ZON-MW, 945-02-046). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agazie YM, 2003, ONCOGENE, V22, P6909, DOI 10.1038/sj.onc.1206798; Babjuk M, 2008, EUR UROL, V54, P303, DOI 10.1016/j.eururo.2008.04.051; Bakkar AA, 2003, CANCER RES, V63, P8108; Billerey C, 2001, AM J PATHOL, V158, P1955, DOI 10.1016/S0002-9440(10)64665-2; Birkhahn M, 2010, EUR UROL, V57, P12, DOI 10.1016/j.eururo.2009.09.013; Black PC, 2007, UROL ONCOL-SEMIN ORI, V25, P433, DOI 10.1016/j.urolonc.2007.05.011; Botteman MF, 2003, PHARMACOECONOMICS, V21, P1315, DOI 10.1007/BF03262330; Budman LI, 2008, CUAJ-CAN UROL ASSOC, V2, P212; Caraway NP, 2010, CANCER CYTOPATHOL, V118, P175, DOI 10.1002/cncy.20080; Chaussade C, 2009, BIOCHEM BIOPH RES CO, V381, P577, DOI 10.1016/j.bbrc.2009.02.081; Cully M, 2006, NAT REV CANCER, V6, P184, DOI 10.1038/nrc1819; di Martino E, 2009, ONCOGENE, V28, P4306, DOI 10.1038/onc.2009.280; Engelman JA, 2008, NAT MED, V14, P1351, DOI 10.1038/nm.1890; Gomez-Roman JJ, 2005, CLIN CANCER RES, V11, P459; Grossman HB, 2007, J UROLOGY, V178, P62, DOI 10.1016/j.juro.2007.03.034; Gymnopoulos M, 2007, P NATL ACAD SCI USA, V104, P5569, DOI 10.1073/pnas.0701005104; Hafner C, 2009, BRIT J DERMATOL, V160, P546, DOI 10.1111/j.1365-2133.2008.08963.x; Hafner C, 2007, P NATL ACAD SCI USA, V104, P13450, DOI 10.1073/pnas.0705218104; Hart KC, 2001, MOL BIOL CELL, V12, P931, DOI 10.1091/mbc.12.4.931; Hurst Carolyn D, 2009, BMC Res Notes, V2, P66, DOI 10.1186/1756-0500-2-66; Jebar AH, 2005, ONCOGENE, V24, P5218, DOI 10.1038/sj.onc.1208705; Jocham D, 2005, J UROLOGY, V174, P862, DOI 10.1097/01.ju.0000169257.19841.2a; Kanai M, 1997, J BIOL CHEM, V272, P6621, DOI 10.1074/jbc.272.10.6621; Kassouf W, 2005, CANCER RES, V65, P10524, DOI 10.1158/0008-5472.CAN-05-1536; Kassouf W, 2008, J UROLOGY, V179, P353, DOI 10.1016/j.juro.2007.08.087; KIEMENEY LALM, 1993, BRIT J CANCER, V67, P806, DOI 10.1038/bjc.1993.147; Knowles MA, 2009, CANCER METAST REV, V28, P305, DOI 10.1007/s10555-009-9198-3; Kompier LC, 2009, J PATHOL, V218, P104, DOI 10.1002/path.2507; Kozaki KI, 2006, CANCER SCI, V97, P1351, DOI 10.1111/j.1349-7006.2006.00343.x; Li WQ, 2004, J BIOL CHEM, V279, P37398, DOI 10.1074/jbc.M405730200; Lopez-Knowles E, 2006, CANCER RES, V66, P7401, DOI 10.1158/0008-5472.CAN-06-1182; Lotan Y, 2010, UROL ONCOL-SEMIN ORI, V28, P441, DOI 10.1016/j.urolonc.2009.11.004; Louhelainen J, 2000, INT J CANCER, V87, P522; Lurkin I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008802; Martinez-Torrecuadrada JL, 2008, MOL CANCER THER, V7, P862, DOI 10.1158/1535-7163.MCT-07-0394; Masih-Khan E, 2006, BLOOD, V108, P3465, DOI 10.1182/blood-2006-04-017087; MIAO TJ, 1991, EUR UROL, V20, P307; Mitra AP, 2009, ANNU REV PATHOL-MECH, V4, P251, DOI 10.1146/annurev.pathol.4.110807.092230; Miyake M, 2010, J PHARMACOL EXP THER, V332, P795, DOI 10.1124/jpet.109.162768; MORIYAMA N, 1989, UROL INT, V44, P260, DOI 10.1159/000281520; Mostofi FK, 1973, HISTOLOGICAL TYPING; Muller CI, 2007, LEUKEMIA RES, V31, P27, DOI 10.1016/j.leukres.2006.04.011; Muezzinoglu T, 2005, ONKOLOGIE, V28, P260, DOI 10.1159/00085110; NEAL DE, 1992, UROL INT, V48, P365, DOI 10.1159/000282357; Ogino S, 2009, J CLIN ONCOL, V27, P1477, DOI 10.1200/JCO.2008.18.6544; Pacold ME, 2000, CELL, V103, P931, DOI 10.1016/S0092-8674(00)00196-3; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Paterson JL, 2004, BRIT J HAEMATOL, V124, P595, DOI 10.1111/j.1365-2141.2004.04814.x; Platt FM, 2009, CLIN CANCER RES, V15, P6008, DOI 10.1158/1078-0432.CCR-09-0898; Pollard C, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399410001407; Rabbani F, 2007, BJU INT, V100, P259, DOI 10.1111/j.1464-410X.2007.06927.x; Ramjaun AR, 2007, CELL CYCLE, V6, P2902, DOI 10.4161/cc.6.23.4996; RILEY GF, 1995, MED CARE, V33, P828, DOI 10.1097/00005650-199508000-00007; RODRIGUEZVICIANA P, 1994, NATURE, V370, P527, DOI 10.1038/370527a0; Samuels Y, 2006, CURR OPIN ONCOL, V18, P77, DOI 10.1097/01.cco.0000198021.99347.b9; Santarpia L, 2008, J CLIN ENDOCR METAB, V93, P278, DOI 10.1210/jc.2007-1076; Sartore-Bianchi A, 2009, CANCER RES, V69, P1851, DOI 10.1158/0008-5472.CAN-08-2466; Schulz WA, 2006, INT J CANCER, V119, P1513, DOI 10.1002/ijc.21852; Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869; SIDRANSKY D, 1992, NEW ENGL J MED, V326, P737, DOI 10.1056/NEJM199203123261104; Siena S, 2009, JNCI-J NATL CANCER I, V101, P1308, DOI 10.1093/jnci/djp280; Sobin LH, 1997, CANCER, V80, P1803, DOI 10.1002/(SICI)1097-0142(19971101)80:9<1803::AID-CNCR16>3.0.CO;2-9; Tomlinson D, 2007, ONCOGENE, V26, P5889, DOI 10.1038/sj.onc.1210399; Tomlinson DC, 2007, J PATHOL, V213, P91, DOI 10.1002/path.2207; van der Aa MNM, 2008, BJU INT, V101, P1106, DOI 10.1111/j.1464-410X.2007.07224.x; van Oers JMM, 2005, CLIN CANCER RES, V11, P7743, DOI 10.1158/1078-0432.CCR-05-1045; van Oers JMM, 2009, EUR UROL, V55, P650, DOI 10.1016/j.eururo.2008.06.013; van Rhijn BSW, 2004, CANCER RES, V64, P1911, DOI 10.1158/0008-5472.CAN-03-2421; van Rhijn BWG, 2003, J CLIN ONCOL, V21, P1912, DOI 10.1200/JCO.2003.05.073; van Tilborg AAG, 2000, HUM MOL GENET, V9, P2973, DOI 10.1093/hmg/9.20.2973; van Tilborg AAG, 2009, INT J UROL, V16, P23, DOI 10.1111/j.1442-2042.2008.02174.x; Villares GJ, 2007, WORLD J UROL, V25, P573, DOI 10.1007/s00345-007-0202-7; Vriesema JLJ, 2000, UROLOGY, V56, P793, DOI 10.1016/S0090-4295(00)00777-9; Wee S, 2009, CANCER RES, V69, P4286, DOI 10.1158/0008-5472.CAN-08-4765; Yan J, 1998, J BIOL CHEM, V273, P24052, DOI 10.1074/jbc.273.37.24052; Yasoda A, 2004, NAT MED, V10, P80, DOI 10.1038/nm971; YE DW, 1993, UROL RES, V21, P39; YE YK, 2010, CLIN EXP MED; Zhao L, 2008, P NATL ACAD SCI USA, V105, P2652, DOI 10.1073/pnas.0712169105; Zieger K, 2000, BJU INT, V85, P824, DOI 10.1046/j.1464-410x.2000.00547.x; ZUIVERLOON TCM, 2010, CLIN CANC RES; Zwarthoff EC, 2008, SCAND J UROL NEPHROL, V42, P147, DOI 10.1080/03008880802283953	82	219	238	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2010	5	11							e13821	10.1371/journal.pone.0013821	http://dx.doi.org/10.1371/journal.pone.0013821			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	674WJ	21072204	Green Published, gold, Green Submitted			2022-12-27	WOS:000283780800019
J	Lee, JW; Park, S; Takahashi, Y; Wang, HG				Lee, Jong Woo; Park, Sungman; Takahashi, Yoshinori; Wang, Hong-Gang			The Association of AMPK with ULK1 Regulates Autophagy	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; INHIBITS CELL-GROWTH; SACCHAROMYCES-CEREVISIAE; COMPLEX; INDUCTION; ATG13; PHOSPHORYLATION; DEGENERATION; METABOLISM; MACHINERY	Autophagy is a highly orchestrated intracellular bulk degradation process that is activated by various environmental stresses. The serine/threonine kinase ULK1, like its yeast homologue Atg1, is a key initiator of autophagy that is negatively regulated by the mTOR kinase. However, the molecular mechanism that controls the inhibitory effect of mTOR on ULK1-mediated autophagy is not fully understood. Here we identified AMPK, a central energy sensor, as a new ULK1-binding partner. We found that AMPK binds to the PS domain of ULK1 and this interaction is required for ULK1-mediated autophagy. Interestingly, activation of AMPK by AICAR induces 14-3-3 binding to the AMPK-ULK1-mTORC1 complex, which coincides with raptor Ser792 phosphorylation and mTOR inactivation. Consistently, AICAR induces autophagy in TSC2-deficient cells expressing wild-type raptor but not the mutant raptor that lacks the AMPK phosphorylation sites (Ser722 and Ser792). Taken together, these results suggest that AMPK association with ULK1 plays an important role in autophagy induction, at least in part, by phosphorylation of raptor to lift the inhibitory effect of mTOR on the ULK1 autophagic complex.	[Lee, Jong Woo] Penn State Univ, Coll Med, Dept Pharmacol, Hershey, PA USA; Penn State Univ, Coll Med, Penn State Hershey Canc Inst, Hershey, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Lee, JW (corresponding author), Penn State Univ, Coll Med, Dept Pharmacol, Hershey, PA USA.	huw11@psu.edu	Wang, Hong-Gang/A-3018-2015	Wang, Hong-Gang/0000-0003-0551-0571; Takahashi, Yoshinori/0000-0002-8004-4817	American Cancer Society [RSG-05-244-01-CCG]; Flight Attendant Medical Research Institute [FAMRI062463-CIA]; National Institutes of Health [CA82197, CA129682]; NATIONAL CANCER INSTITUTE [R01CA129682, R01CA082197] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); Flight Attendant Medical Research Institute; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from American Cancer Society (RSG-05-244-01-CCG), Flight Attendant Medical Research Institute (FAMRI062463-CIA), and National Institutes of Health (CA82197 and CA129682). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Behrends C, 2010, NATURE, V466, P68, DOI 10.1038/nature09204; Buzzai M, 2007, CANCER RES, V67, P6745, DOI 10.1158/0008-5472.CAN-06-4447; Chang YY, 2009, MOL BIOL CELL, V20, P2004, DOI 10.1091/mbc.E08-12-1250; Gan BY, 2005, J CELL BIOL, V170, P379, DOI 10.1083/jcb.200411106; Ganley IG, 2009, J BIOL CHEM, V284, P12297, DOI 10.1074/jbc.M900573200; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Hara T, 2008, J CELL BIOL, V181, P497, DOI 10.1083/jcb.200712064; Hosokawa N, 2009, AUTOPHAGY, V5, P973, DOI 10.4161/auto.5.7.9296; Hosokawa N, 2009, MOL BIOL CELL, V20, P1981, DOI 10.1091/mbc.E08-12-1248; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; Jung CH, 2009, MOL BIOL CELL, V20, P1992, DOI 10.1091/mbc.E08-12-1249; Kabeya Y, 2005, MOL BIOL CELL, V16, P2544, DOI 10.1091/mbc.E04-08-0669; Kamada Y, 2000, J CELL BIOL, V150, P1507, DOI 10.1083/jcb.150.6.1507; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Komatsu M, 2007, P NATL ACAD SCI USA, V104, P14489, DOI 10.1073/pnas.0701311104; Lee SB, 2007, EMBO REP, V8, P360, DOI 10.1038/sj.embor.7400917; Liang JY, 2007, NAT CELL BIOL, V9, P218, DOI 10.1038/ncb1537; Matsuura A, 1997, GENE, V192, P245, DOI 10.1016/S0378-1119(97)00084-X; Meijer AJ, 2007, AUTOPHAGY, V3, P238, DOI 10.4161/auto.3710; Meley D, 2006, J BIOL CHEM, V281, P34870, DOI 10.1074/jbc.M605488200; Mercer CA, 2009, AUTOPHAGY, V5, P649, DOI 10.4161/auto.5.5.8249; MIZUSHIMA N, 2010, CURR OPIN CELL BIOL; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Nakatogawa H, 2009, NAT REV MOL CELL BIO, V10, P458, DOI 10.1038/nrm2708; Okazaki N, 2000, MOL BRAIN RES, V85, P1, DOI 10.1016/S0169-328X(00)00218-7; Samari HR, 2005, BIOCHEM J, V386, P237, DOI 10.1042/BJ20040609; Samari HR, 1998, J BIOL CHEM, V273, P23758, DOI 10.1074/jbc.273.37.23758; Sancak Y, 2007, MOL CELL, V25, P903, DOI 10.1016/j.molcel.2007.03.003; Scott RC, 2007, CURR BIOL, V17, P1, DOI 10.1016/j.cub.2006.10.053; Shackelford DB, 2009, NAT REV CANCER, V9, P563, DOI 10.1038/nrc2676; Tomoda T, 2004, GENE DEV, V18, P541, DOI 10.1101/gad.1151204; TSUKADA M, 1993, FEBS LETT, V333, P169, DOI 10.1016/0014-5793(93)80398-E; Vander Haar E, 2007, NAT CELL BIOL, V9, P316, DOI 10.1038/ncb1547; Viana R, 2008, BIOCHEM BIOPH RES CO, V369, P964, DOI 10.1016/j.bbrc.2008.02.126; Wang G, 2004, J VIROL, V78, P7097, DOI 10.1128/JVI.78.13.7097-7111.2004; Wang QJ, 2006, J NEUROSCI, V26, P8057, DOI 10.1523/JNEUROSCI.2261-06.2006; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yamaguchi H, 2009, J BIOL CHEM, V284, P11171, DOI 10.1074/jbc.M809268200	39	214	230	3	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2010	5	11							e15394	10.1371/journal.pone.0015394	http://dx.doi.org/10.1371/journal.pone.0015394			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	674WJ	21072212	Green Published, gold, Green Submitted			2022-12-27	WOS:000283780800026
J	Mazar, J; DeYoung, K; Khaitan, D; Meister, E; Almodovar, A; Goydos, J; Ray, A; Perera, RJ				Mazar, Joseph; DeYoung, Katherine; Khaitan, Divya; Meister, Edward; Almodovar, Alvin; Goydos, James; Ray, Animesh; Perera, Ranjan J.			The Regulation of miRNA-211 Expression and Its Role in Melanoma Cell Invasiveness	PLOS ONE			English	Article							CUTANEOUS MALIGNANT-MELANOMA; SKIN-CANCER; TRANSCRIPTION FACTOR; TUMOR SUPPRESSORS; DNA-REPAIR; UV DAMAGE; MICRORNAS; GENE; METHYLATION; PROGRESSION	The immediate molecular mechanisms behind invasive melanoma are poorly understood. Recent studies implicate microRNAs (miRNAs) as important agents in melanoma and other cancers. To investigate the role of miRNAs in melanoma, we subjected human melanoma cell lines to miRNA expression profiling, and report a range of variations in several miRNAs. Specifically, compared with expression levels in melanocytes, levels of miR-211 were consistently reduced in all eight nonpigmented melanoma cell lines we examined; they were also reduced in 21 out of 30 distinct melanoma samples from patients, classified as primary in situ, regional metastatic, distant metastatic, and nodal metastatic. The levels of several predicted target mRNAs of miR-211 were reduced in melanoma cell lines that ectopically expressed miR-211. In vivo target cleavage assays confirmed one such target mRNA encoded by KCNMA1. Mutating the miR-211 binding site seed sequences at the KCNMA1 3'-UTR abolished target cleavage. KCNMA1 mRNA and protein expression levels varied inversely with miR211 levels. Two different melanoma cell lines ectopically expressing miR-211 exhibited significant growth inhibition and reduced invasiveness compared with the respective parental melanoma cell lines. An shRNA against KCNMA1 mRNA also demonstrated similar effects on melanoma cells. miR-211 is encoded within the sixth intron of TRPM1, a candidate suppressor of melanoma metastasis. The transcription factor MITF, important for melanocyte development and function, is needed for high TRPM1 expression. MITF is also needed for miR-211 expression, suggesting that the tumor-suppressor activities of MITF and/or TRPM1 may at least partially be due to miR-211's negative post transcriptional effects on the KCNMA1 transcript. Given previous reports of high KCNMA1 levels in metastasizing melanoma, prostate cancer and glioma, our findings that miR-211 is a direct posttranscriptional regulator of KCNMA1 expression as well as the dependence of this miRNA's expression on MITF activity, establishes miR-211 as an important regulatory agent in human melanoma.	[Mazar, Joseph; Khaitan, Divya; Almodovar, Alvin; Perera, Ranjan J.] Sanford Burnham Med Res Inst, Orlando, FL USA; [DeYoung, Katherine; Meister, Edward; Perera, Ranjan J.] Curtis & Elizabeth Anderson Canc Inst, Savannah, GA USA; [Goydos, James] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Canc Inst New Jersey, New Brunswick, NJ USA; [Ray, Animesh] Keck Grad Inst, Claremont, CA USA	Sanford Burnham Prebys Medical Discovery Institute; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; Claremont Colleges; Keck Graduate Institute	Mazar, J (corresponding author), Sanford Burnham Med Res Inst, Orlando, FL USA.	rperera@sanfordburnham.org	Mazar, Joseph/AAQ-8199-2020; Goydos, James/AAR-8990-2020	Goydos, James/0000-0001-9811-939X; Mazar, Joseph/0000-0002-3713-4251; Ray, Animesh/0000-0002-0120-5820	National Institutes of Health [1R01GM084881-01]; National Science Foundation [FIBR 0527023]; Anderson Cancer Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084881] Funding Source: NIH RePORTER; Division of Computing and Communication Foundations [0941078] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Anderson Cancer Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Division of Computing and Communication Foundations(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	This work was supported by grants from the National Institutes of Health (1R01GM084881-01) and the National Science Foundation (FIBR 0527023) to AR, and the Anderson Cancer Institute support for RP's research program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aqeilan RI, 2010, CELL DEATH DIFFER, V17, P215, DOI 10.1038/cdd.2009.69; Aubert B, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.222001; Baugh LR, 2009, SCIENCE, V324, P92, DOI 10.1126/science.1169628; Bemis LT, 2008, CANCER RES, V68, P1362, DOI 10.1158/0008-5472.CAN-07-2912; Bloch M, 2007, ONCOGENE, V26, P2525, DOI 10.1038/sj.onc.1210036; Carr KM, 2003, ONCOGENE, V22, P3076, DOI 10.1038/sj.onc.1206448; Chen AL, 2008, BIOTECHNOL LETT, V30, P2045, DOI 10.1007/s10529-008-9800-8; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen CZ, 2005, NEW ENGL J MED, V353, P1768, DOI 10.1056/NEJMp058190; Chen M, 2009, J BIOL CHEM, V284, P1484, DOI 10.1074/jbc.M803997200; Cleaver JE, 2002, FRONT BIOSCI-LANDMRK, V7, pD1024, DOI 10.2741/cleaver; Conn EM, 2008, J BIOL CHEM, V283, P26518, DOI 10.1074/jbc.M803337200; Cretnik M, 2009, INT J ONCOL, V34, P1045, DOI 10.3892/ijo_00000230; Crijns APG, 2007, EUR J CANCER, V43, P2495, DOI 10.1016/j.ejca.2007.08.025; Curtin JA, 2005, NEW ENGL J MED, V353, P2135, DOI 10.1056/NEJMoa050092; Dalmay T, 2006, ONCOGENE, V25, P6170, DOI 10.1038/sj.onc.1209911; Dankort D, 2009, NAT GENET, V41, P544, DOI 10.1038/ng.356; de Gruijl FR, 2001, J PHOTOCH PHOTOBIO B, V63, P19, DOI 10.1016/S1011-1344(01)00199-3; Duncan LM, 2001, J CLIN ONCOL, V19, P568, DOI 10.1200/JCO.2001.19.2.568; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Felicetti F, 2008, EXPERT REV ANTICANC, V8, P1759, DOI 10.1586/14737140.8.11.1759; Felicetti F, 2008, CANCER RES, V68, P2745, DOI 10.1158/0008-5472.CAN-07-2538; Gaur A, 2007, CANCER RES, V67, P2456, DOI 10.1158/0008-5472.CAN-06-2698; Geerts D, 2003, CANCER LETT, V197, P87, DOI 10.1016/S0304-3835(03)00087-9; Geng J, 2008, J EUR ACAD DERMATOL, V22, P852, DOI 10.1111/j.1468-3083.2007.02574.x; Gonzalgo ML, 1997, CANCER RES, V57, P5336; Guan X, 2003, INT J CANCER, V107, P202, DOI 10.1002/ijc.11376; Gupta PB, 2009, CELL, V138, P645, DOI 10.1016/j.cell.2009.06.034; Gyorffy B, 2006, MELANOMA RES, V16, P147; Hammond SM, 2006, CURR OPIN GENET DEV, V16, P4, DOI 10.1016/j.gde.2005.12.005; Hoek K, 2004, CANCER RES, V64, P5270, DOI 10.1158/0008-5472.CAN-04-0731; Hoon DSB, 2004, ONCOGENE, V23, P4014, DOI 10.1038/sj.onc.1207505; Houghton AN, 2002, CANCER CELL, V2, P275, DOI 10.1016/S1535-6108(02)00161-7; Igoucheva O, 2009, BIOCHEM BIOPH RES CO, V379, P790, DOI 10.1016/j.bbrc.2008.12.152; Jukic DM, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-27; Kent OA, 2006, ONCOGENE, V25, P6188, DOI 10.1038/sj.onc.1209913; Lee WJ, 2002, CELL SIGNAL, V14, P1015, DOI 10.1016/S0898-6568(02)00049-9; Li G, 2001, CANCER RES, V61, P3819; Liu ZJ, 2006, CANCER RES, V66, P4182, DOI 10.1158/0008-5472.CAN-05-3589; von Zangen IL, 2007, ACTA NEUROPATHOL, V113, P325, DOI 10.1007/s00401-006-0190-5; Lynam-Lennon N, 2009, BIOL REV, V84, P55, DOI 10.1111/j.1469-185X.2008.00061.x; Ma XJ, 2004, CANCER CELL, V5, P607, DOI 10.1016/j.ccr.2004.05.015; Mancuso M, 2009, CARCINOGENESIS, V30, P340, DOI 10.1093/carcin/bgn243; Massi D, 2006, MODERN PATHOL, V19, p85A; Matsumura Y, 2002, FRONT BIOSCI-LANDMRK, V7, pD765, DOI 10.2741/matsumur; Miller AJ, 2004, CANCER RES, V64, P509, DOI 10.1158/0008-5472.CAN-03-2440; MUELLER DW, 2009, J INVEST DERMATOL; Nashan D, 2007, J EUR ACAD DERMATOL, V21, P1305, DOI 10.1111/j.1468-3083.2007.02475.x; Oancea E, 2009, SCI SIGNAL, V2, pra21; Perera RF, 2007, BIODRUGS, V21, P97, DOI 10.2165/00063030-200721020-00004; Qi JF, 2005, MOL BIOL CELL, V16, P4386, DOI 10.1091/mbc.E05-03-0186; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; Rass K, 2008, ADV EXP MED BIOL, V624, P162, DOI 10.1007/978-0-387-77574-6_13; REPESH LA, 1989, INVAS METAST, V9, P192; Schmittgen TD, 2008, J CELL MOL MED, V12, P1811, DOI 10.1111/j.1582-4934.2008.00483.x; Schultz J, 2008, CELL RES, V18, P549, DOI 10.1038/cr.2008.45; Segura MF, 2009, P NATL ACAD SCI USA, V106, P1814, DOI 10.1073/pnas.0808263106; Shenouda SK, 2009, CANCER METAST REV, V28, P369, DOI 10.1007/s10555-009-9188-5; Soehnge Holly, 1997, Frontiers in Bioscience, V2, pD538; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Storey John D, 2003, Methods Mol Biol, V224, P149; Suarez-Martinez Edu B, 2007, P R Health Sci J, V26, P349; Tajima N, 2006, J PHYSIOL-LONDON, V571, P349, DOI 10.1113/jphysiol.2005.096818; Weaver AK, 2006, GLIA, V54, P223, DOI 10.1002/glia.20364; Worm J, 2000, ONCOGENE, V19, P5111, DOI 10.1038/sj.onc.1203891; Worm J, 2004, ONCOGENE, V23, P5215, DOI 10.1038/sj.onc.1207647; ZHANG B, 2006, DEV BIOL	67	160	167	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2010	5	11							e13779	10.1371/journal.pone.0013779	http://dx.doi.org/10.1371/journal.pone.0013779			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673FY	21072171	Green Submitted, Green Published, gold			2022-12-27	WOS:000283645700004
J	Trankenschuh, W; Puls, F; Christgen, M; Albat, C; Heim, A; Poczkaj, J; Fleming, P; Kreipe, H; Lehmann, U				Traenkenschuh, Wolfgang; Puls, Florian; Christgen, Matthias; Albat, Cord; Heim, Albert; Poczkaj, Jeanette; Fleming, Peer; Kreipe, Hans; Lehmann, Ulrich			Frequent and Distinct Aberrations of DNA Methylation Patterns in Fibrolamellar Carcinoma of the Liver	PLOS ONE			English	Article							CPG ISLAND HYPERMETHYLATION; EPIGENETIC INACTIVATION; RASSF1A GENE; CANCER; HYPOMETHYLATION; MICRORNA; INSTABILITY; PCR	Background: Gene silencing due to aberrant DNA methylation is a frequent event in hepatocellular carcinoma (HCC) and also in hepatocellular adenoma (HCA). However, very little is known about epigenetic defects in fibrolamellar carcinoma (FLC), a rare variant of hepatocellular carcinoma that displays distinct clinical and morphological features. Methodology/Principal Findings: We analyzed the methylation status of the APC, CDH1, cyclinD2, GST pi 1, hsa-mir-9-1, hsa-mir- 9-2, and RASSF1A gene in a series of 15 FLC and paired normal liver tissue specimens by quantitative high-resolution pyrosequencing. Results were compared with common HCC arising in non-cirrhotic liver (n = 10). Frequent aberrant hypermethylation was found for the cyclinD2 (19%) and the RASSF1A (38%) gene as well as for the microRNA genes mir-9-1 (13%) and mir-9-2 (33%). In contrast to common HCC the APC and CDH1 (E-cadherin) genes were found devoid of any DNA methylation in FLC, whereas the GSTp1 gene showed comparable DNA methylation in tumor and surrounding tissue at a moderate level. Changes in global DNA methylation level were measured by analyzing methylation status of the highly repetitive LINE-1 sequences. No evidence of global hypomethylation could be found in FLCs, whereas HCCs without cirrhosis showed a significant reduction in global methylation level as described previously. Conclusions: FLCs display frequent and distinct gene-specific hypermethylation in the absence of significant global hypomethylation indicating that these two epigenetic aberrations are induced by different pathways and that full-blown malignancy can develop in the absence of global loss of DNA methylation. Only quantitative DNA methylation detection methodology was able to identify these differences.	[Traenkenschuh, Wolfgang; Puls, Florian; Christgen, Matthias; Albat, Cord; Poczkaj, Jeanette; Fleming, Peer; Kreipe, Hans; Lehmann, Ulrich] Hannover Med Sch, Inst Pathol, D-30623 Hannover, Germany; [Heim, Albert] Hannover Med Sch, Inst Virol, D-30623 Hannover, Germany	Hannover Medical School; Hannover Medical School	Trankenschuh, W (corresponding author), Hannover Med Sch, Inst Pathol, D-30623 Hannover, Germany.	Lehmann.Ulrich@MH-Hannover.de		Puls, Florian/0000-0002-9841-4230	Deutsche Forschungsgemeinschaft (DFG) [SFB/TRR77, B1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by SFB/TRR77-"Liver cancer'' (Project B1) of the Deutsche Forschungsgemeinschaft (DFG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agirre X, 2009, CANCER RES, V69, P4443, DOI 10.1158/0008-5472.CAN-08-4025; Baylin Stephen B, 2005, Nat Clin Pract Oncol, V2 Suppl 1, pS4, DOI 10.1038/ncponc0354; Brakensiek K, 2004, BLOOD, V104, P1586, DOI 10.1182/blood-2004-03-0898; Bueno MJ, 2008, CANCER CELL, V13, P496, DOI 10.1016/j.ccr.2008.04.018; Chan AOO, 2006, CURR MOL MED, V6, P401, DOI 10.2174/156652406777435417; Cho NY, 2009, VIRCHOWS ARCH, V454, P17, DOI 10.1007/s00428-008-0706-6; Colella S, 2003, BIOTECHNIQUES, V35, P146, DOI 10.2144/03351md01; Dakubo GD, 2007, CANCER CELL INT, V7, DOI 10.1186/1475-2867-7-2; DATTA J, CANC RES, V68, P5049; De Smet C, 2010, EPIGENETICS-US, V5; Ehrlich M, 2006, CURR TOP MICROBIOL, V310, P251; Furuta M, 2010, CARCINOGENESIS, V31, P766, DOI 10.1093/carcin/bgp250; Grady WM, 2008, GASTROENTEROLOGY, V135, P1079, DOI 10.1053/j.gastro.2008.07.076; Huang J, 2009, SCI CHINA SER C, V52, P31, DOI 10.1007/s11427-009-0014-7; Kakar S, 2009, MODERN PATHOL, V22, P134, DOI 10.1038/modpathol.2008.178; Kim MJ, 2009, MODERN PATHOL, V22, P442, DOI 10.1038/modpathol.2008.203; Laird PW, 2003, NAT REV CANCER, V3, P253, DOI 10.1038/nrc1045; Lee ES, 2008, CLIN CANCER RES, V14, P2664, DOI 10.1158/1078-0432.CCR-07-1232; Lee HS, 2009, CLIN CANCER RES, V15, P812, DOI 10.1158/1078-0432.CCR-08-0266; Lehmann U, 2008, J PATHOL, V214, P17, DOI 10.1002/path.2251; Lehmann U, 2005, CLIN CANCER RES, V11, P3654, DOI 10.1158/1078-0432.CCR-04-2462; Liu S, 2009, AM J GASTROENTEROL, V104, P2617, DOI 10.1038/ajg.2009.440; Lujambio A, 2007, CANCER RES, V67, P1424, DOI 10.1158/0008-5472.CAN-06-4218; Park SY, 2009, J PATHOL, V219, P410, DOI 10.1002/path.2596; Pfeifer GP, 2002, BIOL CHEM, V383, P907, DOI 10.1515/BC.2002.097; Schagdarsurengin U, 2003, ONCOGENE, V22, P1866, DOI 10.1038/sj.onc.1206338; Simon R, 2007, CANCER INFORM, V3, P11; Torbenson M, 2007, ADV ANAT PATHOL, V14, P217, DOI 10.1097/PAP.0b013e3180504913; Vivekanandan P, 2008, MODERN PATHOL, V21, P670, DOI 10.1038/modpathol.2008.32; Wilkens L, 2000, AM J CLIN PATHOL, V114, P867, DOI 10.1309/BMTT-JBPD-D13H-1UVD; Yang AS, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh032	31	27	31	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2010	5	10							e13688	10.1371/journal.pone.0013688	http://dx.doi.org/10.1371/journal.pone.0013688			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673FU	21060828	Green Submitted, gold, Green Published			2022-12-27	WOS:000283645300005
J	Wang, JW; Jia, MW; Zhu, LP; Yuan, ZJ; Li, P; Chang, C; Luo, JA; Liu, MY; Shi, TL				Wang, Junwei; Jia, Meiwen; Zhu, Liping; Yuan, Zengjin; Li, Peng; Chang, Chang; Luo, Jian; Liu, Mingyao; Shi, Tieliu			Systematical Detection of Significant Genes in Microarray Data by Incorporating Gene Interaction Relationship in Biological Systems	PLOS ONE			English	Article							BREAST-CANCER; STATISTICAL TESTS; T-TEST; EXPRESSION; DISCOVERY; SKEWNESS; CELLS; TP53; RECEPTORS; VARIANCE	Many methods, including parametric, nonparametric, and Bayesian methods, have been used for detecting differentially expressed genes based on the assumption that biological systems are linear, which ignores the nonlinear characteristics of most biological systems. More importantly, those methods do not simultaneously consider means, variances, and high moments, resulting in relatively high false positive rate. To overcome the limitations, the SWang test is proposed to determine differentially expressed genes according to the equality of distributions between case and control. Our method not only latently incorporates functional relationships among genes to consider nonlinear biological system but also considers the mean, variance, skewness, and kurtosis of expression profiles simultaneously. To illustrate biological significance of high moments, we construct a nonlinear gene interaction model, demonstrating that skewness and kurtosis could contain useful information of function association among genes in microarrays. Simulations and real microarray results show that false positive rate of SWang is lower than currently popular methods (T-test, F-test, SAM, and Fold-change) with much higher statistical power. Additionally, SWang can uniquely detect significant genes in real microarray data with imperceptible differential expression but higher variety in kurtosis and skewness. Those identified genes were confirmed with previous published literature or RT-PCR experiments performed in our lab.	[Wang, Junwei; Jia, Meiwen; Yuan, Zengjin; Li, Peng; Chang, Chang; Luo, Jian; Liu, Mingyao; Shi, Tieliu] E China Normal Univ, Sch Life Sci, Inst Biomed Sci, Ctr Bioinformat & Computat Biol, Shanghai 200062, Peoples R China; [Zhu, Liping] E China Normal Univ, Coll Financial & Stat, Shanghai 200062, Peoples R China	East China Normal University; East China Normal University	Wang, JW (corresponding author), E China Normal Univ, Sch Life Sci, Inst Biomed Sci, Ctr Bioinformat & Computat Biol, Shanghai 200062, Peoples R China.	tlshi@sibs.ac.cn	Zhu, Li/GXH-9801-2022; Luo, Jian/H-3362-2016	Liu, Mingyao/0000-0001-7339-5048; Luo, Jian/0000-0003-3583-0154	State Key Program of Basic Research of China [2010CB945400, 2007CB108800, 2009CB918400]; National High Technology Research and Development Program of China [2006AA02Z313]; National Natural Science Foundation of China [30870575]	State Key Program of Basic Research of China(State Key Development Program for Basic Research of China); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the State Key Program of Basic Research of China grants (2010CB945400, 2007CB108800, 2009CB918400), the National High Technology Research and Development Program of China (863 project) (Grant No. 2006AA02Z313) and National Natural Science Foundation of China grants (30870575). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], TESTING STAT HYPOTHE; ANTOIS P, 2009, SOS NONLIEAR DELAYED, P133; Baldi P, 2001, BIOINFORMATICS, V17, P509, DOI 10.1093/bioinformatics/17.6.509; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Borresen-Dale AL, 2003, HUM MUTAT, V21, P292, DOI 10.1002/humu.10174; Brown AMC, 2001, BREAST CANCER RES, V3, P351, DOI 10.1186/bcr321; Calzolari D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000547; Choe SE, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-2-r16; Cui XG, 2005, BIOSTATISTICS, V6, P59, DOI 10.1093/biostatistics/kxh018; Cui XQ, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-210; D'Agostino RB, 1986, GOODNESS OF FIT TECH; DAVID LN, LEHNINGER PRINCPLES; Devarajan E, 2002, ONCOGENE, V21, P8843, DOI 10.1038/sj.onc.1206044; Dufour JM, 2003, OXFORD B ECON STAT, V65, P891, DOI 10.1046/j.0305-9049.2003.00085.x; Elsheikh S, 2008, BREAST CANCER RES TR, V109, P325, DOI 10.1007/s10549-007-9659-8; Fox RJ, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-126; GENTLE JE, MATRIX ALGEBRA THEOT, P101; GEORGE C, STAT INFERENCE; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; HAHN G, 1967, STAT MODEL ENG, P13; HERRMANN M, 2007, STAT ANAL SAMPLE SIZ, P416; Hirakawa A, 2008, BIOINFORM BIOL INSIG, V2, P145; Hofer EL, 2005, STEM CELLS DEV, V14, P587, DOI 10.1089/scd.2005.14.587; Holstege H, 2009, CANCER RES, V69, P3625, DOI 10.1158/0008-5472.CAN-08-3426; Huang B, 2005, CANCER RES, V65, P5009, DOI 10.1158/0008-5472.CAN-05-0784; Joanes DN, 1998, J ROY STAT SOC D-STA, V47, P183; JOHANNA M, 2009, BMC BIOINFORMATICS, V10, P448; KEVIN RM, SIMPLE GEN MODEL TRA, P10; Langerod A, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1675; Liu XJ, 2006, BIOINFORMATICS, V22, P2107, DOI 10.1093/bioinformatics/btl361; LUO XC, 1993, ASTROPHYS J, V408, P33, DOI 10.1086/172567; LUYAN, 2005, BIOINFORMATICS, V21, P3105; MALLOWS CL, 1960, TRABAJOS ESTADISTICA, V11, P119; MARYLYN DR, 2001, AM SOC HUMAN GENETIC, V69, P138; MASUDA Y, 2009, BREAST CANCER RES, V11, pR32; Mayo M, 2005, BIOSYSTEMS, V82, P74, DOI 10.1016/j.biosystems.2005.06.002; MICHEL S, 1997, J APPL PHYSIOL, V83, P975; ROBERT H, NONLINEAR SYSTEM IDE, V2, P416; ROSE C, MATH STAT MATH; Sato F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005540; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; Shi L, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-88; Shima N, 2007, CELL CYCLE, V6, P1135, DOI 10.4161/cc.6.10.4250; Sprague BL, 2007, CARCINOGENESIS, V28, P1680, DOI 10.1093/carcin/bgm097; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Storey JD, 2007, BIOSTATISTICS, V8, P414, DOI 10.1093/biostatistics/kxl019; Tan YD, 2006, GENOMICS, V88, P846, DOI 10.1016/j.ygeno.2006.08.003; Tomaru Y, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r121; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wissmann C, 2003, J PATHOL, V201, P204, DOI 10.1002/path.1449; Zhang P, 2008, MOL IMMUNOL, V45, P1470, DOI 10.1016/j.molimm.2007.08.013; ZHANG QY, 2005, P AM STAT ASS, P463	52	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2010	5	10							e13721	10.1371/journal.pone.0013721	http://dx.doi.org/10.1371/journal.pone.0013721			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673FU	21060778	Green Published, Green Submitted, gold			2022-12-27	WOS:000283645300009
J	Looker, C; Carville, K; Grant, K; Kelly, H				Looker, Clare; Carville, Kylie; Grant, Kristina; Kelly, Heath			Influenza A (H1N1) in Victoria, Australia: A Community Case Series and Analysis of Household Transmission	PLOS ONE			English	Article							CRITICALLY-ILL PATIENTS; SWINE INFLUENZA; UNITED-STATES; VIRUS; PREVENTION; EXPERIENCE; INFECTION; A(H1N1); LESSONS; HUMANS	Background: We characterise the clinical features and household transmission of pandemic influenza A (pH1N1) in community cases from Victoria, Australia in 2009. Methods: Questionnaires were used to collect information on epidemiological characteristics, illness features and comorbidities of cases identified in the 2009 Victorian Influenza Sentinel Surveillance program. Results: The median age of 132 index cases was 21 years, of whom 54 (41%) were under 18 years old and 28 (21%) had medical co-morbidities. The median symptom duration was significantly shorter for children who received antivirals than in those who did not (p = 0.03). Assumed influenza transmission was observed in 63 (51%) households. Influenza-like illness (ILI) developed in 115 of 351 household contacts, a crude secondary attack rate of 33%. Increased ILI rates were seen in households with larger numbers of children but not larger numbers of adults. Multivariate analysis indicated contacts of cases with cough and diarrhoea, and contacts in quarantined households were significantly more likely to develop influenza-like symptoms. Conclusion: Most cases of pH1N1 in our study were mild with similar clinical characteristics to seasonal influenza. Illness and case features relating to virus excretion, age and household quarantine may have influenced secondary ILI rates within households.	[Looker, Clare; Carville, Kylie; Grant, Kristina; Kelly, Heath] Victorian Infect Dis Reference Lab, Melbourne, Vic, Australia	Victorian Infectious Diseases Reference Laboratory	Looker, C (corresponding author), Victorian Infect Dis Reference Lab, Melbourne, Vic, Australia.	heath.kelly@mh.org.au		Carville, Kylie/0000-0002-3663-8802	Australian National Health and Medical Research Council [604982]	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This study was supported by the Australian National Health and Medical Research Council Strategic Awards, Urgent Research - H1N1 Influenza grant number 604982. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Australian Government Department of Health and Ageing, 2008, AUSTR HLTH MAN PLAN; Blachere FM, 2009, CLIN INFECT DIS, V48, P438, DOI 10.1086/596478; Cauchemez S, 2004, STAT MED, V23, P3469, DOI 10.1002/sim.1912; Cauchemez S, 2009, NEW ENGL J MED, V361, P2619, DOI 10.1056/NEJMoa0905498; Cheng AC, 2009, MED J AUSTRALIA, V191, P142, DOI 10.5694/j.1326-5377.2009.tb02722.x; Chowell G, 2009, NEW ENGL J MED, V361, P674, DOI 10.1056/NEJMoa0904023; COWLING BJ, N ENGL J MED, V362, P2175; Cox NJ, 1999, LANCET, V354, P1277, DOI 10.1016/S0140-6736(99)01241-6; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Denholm JT, 2010, MED J AUSTRALIA, V192, P84, DOI 10.5694/j.1326-5377.2010.tb03424.x; Dixon GA, 2010, INFLUENZA OTHER RESP, V4, P231, DOI 10.1111/j.1750-2659.2010.00141.x; Dominguez-Cherit G, 2009, JAMA-J AM MED ASSOC, V302, P1880, DOI 10.1001/jama.2009.1536; Doshi P, 2010, J INFECT DIS, V201, P1444, DOI 10.1086/651701; Effler PV, 2010, EMERG INFECT DIS, V16, P205, DOI 10.3201/eid1602.091372; Eizenberg P, 2009, MED J AUSTRALIA, V191, P151, DOI 10.5694/j.1326-5377.2009.tb02725.x; Gambotto A, 2008, LANCET, V371, P1464, DOI 10.1016/S0140-6736(08)60627-3; Grant KA, 2009, COMMUN DIS INTELL, V33, P328; Gubareva LV, 2002, J INFECT DIS, V186, P1575, DOI 10.1086/345372; Hayden FG, 2000, NEW ENGL J MED, V343, P1282, DOI 10.1056/NEJM200011023431801; Jain S, 2009, NEW ENGL J MED, V361, P1935, DOI 10.1056/NEJMoa0906695; Jefferson T, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b5106; KELLY H, 2009, EUROSURVEILL, V14; Kelly HA, 2009, MED J AUSTRALIA, V191, P146, DOI 10.5694/j.1326-5377.2009.tb02723.x; Kumar A, 2009, JAMA-J AM MED ASSOC, V302, P1872, DOI 10.1001/jama.2009.1496; LONGINI IM, 1982, AM J EPIDEMIOL, V115, P736, DOI 10.1093/oxfordjournals.aje.a113356; Lum ME, 2009, MED J AUSTRALIA, V191, P502, DOI 10.5694/j.1326-5377.2009.tb02914.x; Miller N., 2009, AGE             0530; MONTO AS, 1994, EPIDEMIOL REV, V16, P351, DOI 10.1093/oxfordjournals.epirev.a036158; Mubareka S, 2009, J INFECT DIS, V199, P858, DOI 10.1086/597073; Nicoll A, 2010, PUBLIC HEALTH, V124, P14, DOI 10.1016/j.puhe.2009.12.001; O'Riordan S, 2010, CAN MED ASSOC J, V182, P39, DOI 10.1503/cmaj.091724; Patel M, 2009, ANAESTHESIA, V64, P1241, DOI 10.1111/j.1365-2044.2009.06128.x; Petrosillo N, 2009, ANN THORAC MED, V4, P163, DOI 10.4103/1817-1737.56008; *PROMEDMAIL, 2009, INFL A H1N1 WORLDW 4; Shinde V, 2009, NEW ENGL J MED, V360, P2616, DOI 10.1056/NEJMoa0903812; *STAT GOV HLTH DEP, 2010, H1N1 INFL 09 HUM SWI; Thursky K, 2003, J CLIN VIROL, V27, P170, DOI 10.1016/S1386-6532(02)00172-5; Tuite AR, 2010, CAN MED ASSOC J, V182, P128, DOI 10.1503/cmaj.091807; Viboud C, 2004, BRIT J GEN PRACT, V54, P684; *VICT INF DIS REF, 2010, VICT INFL VACC EFF A; Welliver R, 2001, JAMA-J AM MED ASSOC, V285, P748, DOI 10.1001/jama.285.6.748; WHO, 2009, WKLY EPIDEMIOL REC, V84, P185; Wilson N, 2009, EUROSURVEILLANCE, V14; 2009, STATELINE VICTORIA S	44	25	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2010	5	10							e13702	10.1371/journal.pone.0013702	http://dx.doi.org/10.1371/journal.pone.0013702			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	672HN	21060887	Green Published, gold, Green Submitted			2022-12-27	WOS:000283573800005
J	Reilly, PT; Afzal, S; Wakeham, A; Haight, J; You-Ten, A; Zaugg, K; Dembowy, J; Young, A; Mak, TW				Reilly, Patrick T.; Afzal, Samia; Wakeham, Andrew; Haight, Jillian; You-Ten, Annick; Zaugg, Kathrin; Dembowy, Joanna; Young, Ashley; Mak, Tak W.			Generation and Characterization of the Anp32e-Deficient Mouse	PLOS ONE			English	Article							PROTEIN PHOSPHATASE 2A; CELL-PROLIFERATION; CYTOCHROME-C; APOPTOSIS; EXPRESSION; PP32; DIFFERENTIATION; INHIBITOR; CANCER; PAL31	Background: Accumulated literature suggests that the acidic nuclear phosphoprotein 32 kilodalton (Anp32) proteins control multiple cellular activities through different molecular mechanisms. Like other Anp32 family members, Anp32e (a.k.a. Cpd1, PhapIII) has been conserved throughout vertebrate evolution, suggesting that it has an important function in organismal survival. Principal Findings: Here, we demonstrate that the Anp32e gene can be deleted in mice without any apparent effect on their wellbeing. No defects in thymocyte apoptosis in response to various stresses, fibroblast growth, gross behaviour, physical ability, or pathogenesis were defined. Furthermore, combined deletion of Anp32a and Anp32e also resulted in a viable and apparently healthy mouse. Significance: These results provide evidence that significant functional redundancy exists among Anp32 family members.	[Reilly, Patrick T.; Mak, Tak W.] Natl Canc Ctr Singapore, Dept Cellular & Mol Res, Singapore, Singapore; [Reilly, Patrick T.; Afzal, Samia; Wakeham, Andrew; Haight, Jillian; You-Ten, Annick; Zaugg, Kathrin; Dembowy, Joanna; Young, Ashley; Mak, Tak W.] Univ Hlth Network, Campbell Family Canc Res Inst, Toronto, ON, Canada; [Afzal, Samia] Univ Toronto, Grad Program Immunol, Toronto, ON, Canada	National Cancer Centre Singapore (NCCS); University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto	Reilly, PT (corresponding author), Natl Canc Ctr Singapore, Dept Cellular & Mol Res, Singapore, Singapore.	tmak@uhnres.utoronto.ca			Prostate Cancer Research Foundation of Canada; U.S. Department of Defense [PC020806]	Prostate Cancer Research Foundation of Canada; U.S. Department of Defense(United States Department of Defense)	This research was partially supported by the Prostate Cancer Research Foundation of Canada and the U.S. Department of Defense award number PC020806. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adegbola O, 2005, J BIOL CHEM, V280, P15497, DOI 10.1074/jbc.M411382200; Amasaki H, 2003, ANN ANAT, V185, P517, DOI 10.1016/S0940-9602(03)80116-4; Anisimov SV, 2002, GENOMICS, V79, P169, DOI 10.1006/geno.2002.6687; Beresford PJ, 2001, J BIOL CHEM, V276, P43285, DOI 10.1074/jbc.M108137200; Bjorck E, 2005, BLOOD, V105, P2908, DOI 10.1182/blood-2004-07-2721; Brody JR, 2004, AM J PATHOL, V164, P273, DOI 10.1016/S0002-9440(10)63117-3; Buszczak M, 2007, GENETICS, V175, P1505, DOI 10.1534/genetics.106.065961; Costanzo RV, 2006, EUR J NEUROSCI, V23, P309, DOI 10.1111/j.1460-9568.2005.04555.x; Cvetanovic M, 2007, EMBO REP, V8, P671, DOI 10.1038/sj.embor.7400983; Fan Z, 2006, CELL DEATH DIFFER, V13, P1485, DOI 10.1038/sj.cdd.4401825; Fan ZS, 2003, CELL, V112, P659, DOI 10.1016/S0092-8674(03)00150-8; Fries B, 2007, J BIOL CHEM, V282, P4504, DOI 10.1074/jbc.M608849200; Fukukawa C, 2005, CANCER LETT, V226, P155, DOI 10.1016/j.canlet.2004.11.026; Gallouzi IE, 2001, RNA, V7, P1348, DOI 10.1017/s1355838201016089; Hao ZY, 2005, CELL, V121, P579, DOI 10.1016/j.cell.2005.03.016; Higashino F, 2005, J CELL BIOL, V170, P15, DOI 10.1083/jcb.200405112; Hill MM, 2004, EMBO J, V23, P2134, DOI 10.1038/sj.emboj.7600210; Hoffarth S, 2008, CELL DEATH DIFFER, V15, P161, DOI 10.1038/sj.cdd.4402256; Itin C, 1999, MOL BIOL CELL, V10, P2191, DOI 10.1091/mbc.10.7.2191; Jiang M, 2002, CYTOGENET GENOME RES, V97, P68, DOI 10.1159/000064058; Jiang XJ, 2003, SCIENCE, V299, P223, DOI 10.1126/science.1076807; Kular RK, 2009, J BIOL CHEM, V284, P7783, DOI 10.1074/jbc.M806150200; LI M, 1995, BIOCHEMISTRY-US, V34, P1988, DOI 10.1021/bi00006a020; MALEK SN, 1990, J BIOL CHEM, V265, P13400; Matilla A, 2005, CEREBELLUM, V4, P7, DOI 10.1080/14734220410019020; Okada H, 2002, MOL CELL BIOL, V22, P3509, DOI 10.1128/MCB.22.10.3509-3517.2002; Opal P, 2003, J BIOL CHEM, V278, P34691, DOI 10.1074/jbc.M302785200; Opal P, 2004, MOL CELL BIOL, V24, P3140, DOI 10.1128/MCB.24.8.3140-3149.2004; Pan W, 2009, J BIOL CHEM, V284, P6946, DOI 10.1074/jbc.M805801200; Puente LG, 2004, FEBS LETT, V574, P138, DOI 10.1016/j.febslet.2004.08.019; Radrizzani M, 2001, BRAIN RES, V907, P162, DOI 10.1016/S0006-8993(01)02351-4; Reilly PT, 2002, EXP CELL RES, V277, P119, DOI 10.1006/excr.2002.5551; Ruland J, 2001, P NATL ACAD SCI USA, V98, P1859, DOI 10.1073/pnas.98.4.1859; Santa-Coloma TA, 2003, CEREBELLUM, V2, P310, DOI 10.1080/14734220310017212; Schafer ZT, 2006, CANCER RES, V66, P2210, DOI 10.1158/0008-5472.CAN-05-3923; Schneider R, 2004, J BIOL CHEM, V279, P23859, DOI 10.1074/jbc.C400151200; Seo SB, 2002, J BIOL CHEM, V277, P14005, DOI 10.1074/jbc.M112455200; Sun W, 2006, BIOCHEM BIOPH RES CO, V342, P817, DOI 10.1016/j.bbrc.2006.02.026; Sun WY, 2001, BIOCHEM BIOPH RES CO, V280, P1048, DOI 10.1006/bbrc.2000.4244; Tsukamoto Y, 2008, J PATHOL, V216, P471, DOI 10.1002/path.2424; WALKER BA, BLOOD	41	24	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2010	5	10							e13597	10.1371/journal.pone.0013597	http://dx.doi.org/10.1371/journal.pone.0013597			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671GB	21049064	Green Published, Green Submitted, gold			2022-12-27	WOS:000283487400006
J	Colak, R; Moser, F; Chu, JSC; Schonhuth, A; Chen, NS; Ester, M				Colak, Recep; Moser, Flavia; Chu, Jeffrey Shih-Chieh; Schoenhuth, Alexander; Chen, Nansheng; Ester, Martin			Module Discovery by Exhaustive Search for Densely Connected, Co-Expressed Regions in Biomolecular Interaction Networks	PLOS ONE			English	Article							GENE-EXPRESSION; PROTEIN COMPLEXES; BETA-CATENIN; MEDIATED TRANSCRIPTION; HIR PROTEINS; HISTONE H3; YEAST; HETEROCHROMATIN; IDENTIFICATION; CHROMATIN	Background: Computational prediction of functionally related groups of genes (functional modules) from large-scale data is an important issue in computational biology. Gene expression experiments and interaction networks are well studied largescale data sources, available for many not yet exhaustively annotated organisms. It has been well established, when analyzing these two data sources jointly, modules are often reflected by highly interconnected (dense) regions in the interaction networks whose participating genes are co-expressed. However, the tractability of the problem had remained unclear and methods by which to exhaustively search for such constellations had not been presented. Methodology/Principal Findings: We provide an algorithmic framework, referred to as Densely Connected Biclustering (DECOB), by which the aforementioned search problem becomes tractable. To benchmark the predictive power inherent to the approach, we computed all co-expressed, dense regions in physical protein and genetic interaction networks from human and yeast. An automatized filtering procedure reduces our output which results in smaller collections of modules, comparable to state-of-the-art approaches. Our results performed favorably in a fair benchmarking competition which adheres to standard criteria. We demonstrate the usefulness of an exhaustive module search, by using the unreduced output to more quickly perform GO term related function prediction tasks. We point out the advantages of our exhaustive output by predicting functional relationships using two examples. Conclusion/Significance: We demonstrate that the computation of all densely connected and co-expressed regions in interaction networks is an approach to module discovery of considerable value. Beyond confirming the well settled hypothesis that such co-expressed, densely connected interaction network regions reflect functional modules, we open up novel computational ways to comprehensively analyze the modular organization of an organism based on prevalent and largely available large-scale datasets.	[Colak, Recep; Ester, Martin] Simon Fraser Univ, Sch Comp Sci, Burnaby, BC V5A 1S6, Canada; [Moser, Flavia] Univ British Columbia, Ctr Dis Control, Burnaby, BC, Canada; [Chu, Jeffrey Shih-Chieh; Chen, Nansheng] Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada; [Schoenhuth, Alexander] Univ Calif Berkeley, Dept Math, Berkeley, CA 94720 USA	Simon Fraser University; University of British Columbia; Simon Fraser University; University of California System; University of California Berkeley	Colak, R (corresponding author), Simon Fraser Univ, Sch Comp Sci, Burnaby, BC V5A 1S6, Canada.	ester@cs.sfu.ca	Chen, Nansheng/E-6450-2012		Canadian Institute for Health Research (CIHR) /Michael Smith Foundation for Health Research (MSFHR); Simon Fraser University Community; Pacific Institute for the Mathematical Sciences (PIMS); National Sciences and Engineering Research Council (NSERC); Michael Smith Foundation for Health Research (MSFHR)	Canadian Institute for Health Research (CIHR) /Michael Smith Foundation for Health Research (MSFHR)(Michael Smith Foundation for Health ResearchCanadian Institutes of Health Research (CIHR)); Simon Fraser University Community; Pacific Institute for the Mathematical Sciences (PIMS); National Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Michael Smith Foundation for Health Research (MSFHR)(Michael Smith Foundation for Health Research)	RC was funded by the Canadian Institute for Health Research (CIHR) /Michael Smith Foundation for Health Research (MSFHR) Bioinformatics Training Program for Health Research. RC, AS, ME and NC are members of the Bioinformatics for Combating Infectious Diseases (BCID) project, which is funded by the Simon Fraser University Community Trust Endowment Fund. AS is also funded by a postdoctoral stipend from the Pacific Institute for the Mathematical Sciences (PIMS). ME and NC are supported in part by a National Sciences and Engineering Research Council (NSERC) Discovery grant. NC is also a Michael Smith Foundation for Health Research (MSFHR) scholar. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiyar SE, 2004, GENE DEV, V18, P2134, DOI 10.1101/gad.1214104; Albert R, 2005, J CELL SCI, V118, P4947, DOI 10.1242/jcs.02714; Alon N, 2008, BIOINFORMATICS, V24, pI241, DOI 10.1093/bioinformatics/btn163; Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2; Ben-Dor A, 2003, J COMPUT BIOL, V10, P373, DOI 10.1089/10665270360688075; Beyer A, 2007, NAT REV GENET, V8, P699, DOI 10.1038/nrg2144; Botstein D, 1997, SCIENCE, V277, P1259, DOI 10.1126/science.277.5330.1259; Bouck DC, 2008, ANNU REV GENET, V42, P335, DOI 10.1146/annurev.genet.42.110807.091620; Brohee S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-488; Caspi M, 2008, ONCOGENE, V27, P3546, DOI 10.1038/sj.onc.1211026; Celic I, 2006, CURR BIOL, V16, P1280, DOI 10.1016/j.cub.2006.06.023; CHENG Y, 2000, ISMB, V8, P93; COLAK R, 2008, THESIS SIMON FRASER; Crasta K, 2008, NAT CELL BIOL, V10, P665, DOI 10.1038/ncb1729; de Lichtenberg U, 2005, SCIENCE, V307, P724, DOI 10.1126/science.1105103; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Essers MAG, 2005, SCIENCE, V308, P1181, DOI 10.1126/science.1109083; Gasch AP, 2002, GENOME BIOL, V3; Ge H, 2001, NAT GENET, V29, P482, DOI 10.1038/ng776; Georgii E, 2009, BIOINFORMATICS, V25, P933, DOI 10.1093/bioinformatics/btp080; Grewal SIS, 2007, NAT REV GENET, V8, P35, DOI 10.1038/nrg2008; Grigoriev A, 2001, NUCLEIC ACIDS RES, V29, P3513, DOI 10.1093/nar/29.17.3513; GROCHOW J, 2008, P RECOMB 92; Gunsalus KC, 2005, NATURE, V436, P861, DOI 10.1038/nature03876; Hanisch D., 2002, BIOINFORMATICS, V18, pS145, DOI [10.1093/bioinformatics/18.suppl_1.S145, DOI 10.1093/BI0INF0RMATICS/18.SUPPL_]; Hu HY, 2005, BIOINFORMATICS, V21, pI213, DOI 10.1093/bioinformatics/bti1049; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Ideker Trey, 2002, Bioinformatics, V18 Suppl 1, pS233; Karp R. M., 1972, P COMPL COMP COMP, P85; King AD, 2004, BIOINFORMATICS, V20, P3013, DOI 10.1093/bioinformatics/bth351; Kouzmenko AP, 2004, J BIOL CHEM, V279, P40255, DOI 10.1074/jbc.C400331200; Koyuturk M, 2007, J COMPUT BIOL, V14, P747, DOI 10.1089/cmb.2007.R014; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Leung HCM, 2009, J COMPUT BIOL, V16, P133, DOI 10.1089/cmb.2008.01TT; Lindroos HB, 2006, MOL CELL, V22, P755, DOI 10.1016/j.molcel.2006.05.014; Mendez P, 2006, ENDOCRINOLOGY, V147, P3027, DOI 10.1210/en.2005-1224; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; MOSER F, 2009, P 2009 SIAM INT C DA, P593; Pebernard S, 2004, MOL BIOL CELL, V15, P4866, DOI 10.1091/mbc.E04-05-0436; Pebernard S, 2008, EMBO J, V27, P3011, DOI 10.1038/emboj.2008.220; Prelic A, 2006, BIOINFORMATICS, V22, P1122, DOI 10.1093/bioinformatics/btl060; Rubinfeld B, 1996, SCIENCE, V272, P1023, DOI 10.1126/science.272.5264.1023; Schliep A, 2005, IEEE ACM T COMPUT BI, V2, P179, DOI 10.1109/TCBB.2005.31; Schliep A, 2004, BIOINFORMATICS, V20, P283, DOI 10.1093/bioinformatics/bth937; Segal E, 2003, BIOINFORMATICS, V19, pi264, DOI 10.1093/bioinformatics/btg1037; Sharan R, 2005, J COMPUT BIOL, V12, P835, DOI 10.1089/cmb.2005.12.835; Sharan R, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100129; Sharp JA, 2002, GENE DEV, V16, P85, DOI 10.1101/gad.925302; Sharp JA, 2001, CURR BIOL, V11, P463, DOI 10.1016/S0960-9822(01)00140-3; Shyamsundar R, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-r22; Singer MS, 1998, GENETICS, V150, P613; Spirin V, 2003, P NATL ACAD SCI USA, V100, P12123, DOI 10.1073/pnas.2032324100; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Talukder AH, 2003, J BIOL CHEM, V278, P11676, DOI 10.1074/jbc.M209570200; Tamayo P, 1999, P NATL ACAD SCI USA, V96, P2907, DOI 10.1073/pnas.96.6.2907; Tanay Amos, 2002, Bioinformatics, V18 Suppl 1, pS136; Tavazoie S, 1999, NAT GENET, V22, P281, DOI 10.1038/10343; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Torres-Rosell J, 2005, NAT CELL BIOL, V7, P412, DOI 10.1038/ncb1239; Tyler JK, 1999, NATURE, V402, P555, DOI 10.1038/990147; Ulitsky I, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-8; Ulitsky I, 2009, BIOINFORMATICS, V25, P1158, DOI 10.1093/bioinformatics/btp118; Yamagishi Y, 2008, NATURE, V455, P251, DOI 10.1038/nature07217; Yan XF, 2007, BIOINFORMATICS, V23, pI577, DOI 10.1093/bioinformatics/btm227; Yang B, 2008, MOL BIOL CELL, V19, P4993, DOI 10.1091/mbc.E08-05-0524; Zappulla DC, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-40; Zeeberg BR, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-r28; Zhu XW, 2007, GENE DEV, V21, P1010, DOI 10.1101/gad.1528707	69	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2010	5	10							e13348	10.1371/journal.pone.0013348	http://dx.doi.org/10.1371/journal.pone.0013348			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	670LB	21049092	Green Submitted, Green Published, gold			2022-12-27	WOS:000283422100002
J	Unge, C; Sodergard, B; Marrone, G; Thorson, A; Lukhwaro, A; Carter, J; Ilako, F; Ekstrom, AM				Unge, Christian; Sodergard, Bjorn; Marrone, Gaetano; Thorson, Anna; Lukhwaro, Abigael; Carter, Jane; Ilako, Festus; Ekstrom, Anna Mia			Long-Term Adherence to Antiretroviral Treatment and Program Drop-Out in a High-Risk Urban Setting in Sub-Saharan Africa: A Prospective Cohort Study	PLOS ONE			English	Article							SELF-REPORTED ADHERENCE; FOLLOW-UP; PATIENTS LOST; INHIBITOR THERAPY; HIV-1 INFECTION; ART ADHERENCE; HEALTH-CARE; BASE-LINE; PROTEASE; OUTCOMES	Background: Seventy percent of urban populations in sub-Saharan Africa live in slums. Sustaining HIV patients in these high-risk and highly mobile settings is a major future challenge. This study seeks to assess program retention and to find determinants for low adherence to antiretroviral treatment (ART) and drop-out from an established HIV/ART program in Kibera, Nairobi, one of Africa's largest informal urban settlements. Methods and Findings: A prospective open cohort study of 800 patients was performed at the African Medical Research Foundation (AMREF) clinic in the Kibera slum. Adherence to ART and drop-out from the ART program were independent outcomes. Two different adherence measures were used: (1) "dose adherence" (the proportion of a prescribed dose taken over the past 4 days) and (2) "adherence index" (based on three adherence questions covering dosing, timing and special instructions). Drop-out from the program was calculated based on clinic appointment dates and number of prescribed doses, and a patient was defined as being lost to follow-up if over 90 days had expired since the last prescribed dose. More than one third of patients were non-adherent when all three aspects of adherence - dosing, timing and special instructions - were taken into account. Multivariate logistic regression revealed that not disclosing HIV status, having a low level of education, living below the poverty limit (US$ 2/day) and not having a treatment buddy were significant predictors for non-adherence. Additionally, one quarter of patients dropped out for more than 90 days after the last prescribed ART dose. Not having a treatment buddy was associated with increased risk for drop-out (hazard ratio 1.4, 95% CI = 1.0-1.9). Conclusion: These findings point to the dilemma of trying to sustain a growing number of people on life-long ART in conditions where prevailing stigma, poverty and food shortages threatens the long-term success of HIV treatment.	[Unge, Christian; Sodergard, Bjorn; Marrone, Gaetano; Thorson, Anna; Ekstrom, Anna Mia] Karolinska Inst, Dept Publ Hlth Sci, Div Global Hlth IHCAR, Stockholm, Sweden; [Lukhwaro, Abigael; Carter, Jane; Ilako, Festus] African Med & Res Fdn, Kenya Country Program, Nairobi, Kenya	Karolinska Institutet; African Medical & Research Foundation (AMREF)	Unge, C (corresponding author), Karolinska Inst, Dept Publ Hlth Sci, Div Global Hlth IHCAR, Stockholm, Sweden.	christianunge@gmail.com		Marrone, Gaetano/0000-0002-2991-1663; Thorson, Anna/0000-0002-8703-6561; Sodergard, Bjorn/0000-0002-7841-3396				Amberbir A, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-265; Bangsberg DR, 2006, CLIN INFECT DIS, V43, P939, DOI 10.1086/507526; Bangsberg DR, 2006, AIDS, V20, P223, DOI 10.1097/01.aids.0000199825.34241.49; Bangsberg DR, 2000, AIDS, V14, P357, DOI 10.1097/00002030-200003100-00008; Bangsberg DR, 2001, AIDS, V15, P1181, DOI 10.1097/00002030-200106150-00015; BANGSBERG DR, ANN INT MED, V152; Brinkhof MWG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005790; Carrieri P, 2001, J ACQ IMMUN DEF SYND, V28, P232, DOI 10.1097/00042560-200111010-00005; CHALKER J, J ACQUIR IMMUNE DEFI, V53, P159; Chesney MA, 2000, AIDS CARE, V12, P255, DOI 10.1080/09540120050042891; Coetzee D, 2004, AIDS, V18, P887, DOI 10.1097/00002030-200404090-00006; Dalal RP, 2008, JAIDS-J ACQ IMM DEF, V47, P101, DOI 10.1097/QAI.0b013e31815b833a; Diabate S, 2007, AIDS, V21, P1799, DOI 10.1097/QAD.0b013e3282a5667b; Duong M, 2001, CLIN INFECT DIS, V33, P386, DOI 10.1086/321876; Flexner C, 1998, NEW ENGL J MED, V338, P1281, DOI 10.1056/NEJM199804303381808; Frick PA, 2001, INT J STD AIDS, V12, P329, DOI 10.1258/0956462011923048; GENG EH, 2009, J ACQ IMMUN DEF SYND, V53, P405; Hardon AP, 2007, AIDS CARE, V19, P658, DOI 10.1080/09540120701244943; Hogg RS, 2002, AIDS, V16, P1051, DOI 10.1097/00002030-200205030-00012; Ivers LC, 2005, CLIN INFECT DIS, V41, P217, DOI 10.1086/431199; Kyobutungi Catherine, 2008, Popul Health Metr, V6, P1, DOI 10.1186/1478-7954-6-1; Laurent C, 2005, CLIN INFECT DIS, V41, P108, DOI 10.1086/430712; Liu HH, 2001, ANN INTERN MED, V134, P968, DOI 10.7326/0003-4819-134-10-200105150-00011; Magadi MA, 2003, POP STUD-J DEMOG, V57, P347, DOI 10.1080/0032472032000137853; Mannheimer SB, 2006, AIDS CARE, V18, P853, DOI 10.1080/09540120500465160; Massaquoi M, 2009, T ROY SOC TROP MED H, V103, P594, DOI 10.1016/j.trstmh.2009.02.012; Mills EJ, 2006, PLOS MED, V3, P2039, DOI 10.1371/journal.pmed.0030438; Mills EJ, 2006, JAMA-J AM MED ASSOC, V296, P679, DOI 10.1001/jama.296.6.679; Muhamadi L, 2010, HEALTH POLICY, V97, P187, DOI 10.1016/j.healthpol.2010.06.003; NACHEGA JB, ANN INT MED, V152, P18; Nieuwkerk PT, 2005, JAIDS-J ACQ IMM DEF, V38, P445, DOI 10.1097/01.qai.0000147522.34369.12; Nieuwkerk PT, 2001, ARCH INTERN MED, V161, P1962, DOI 10.1001/archinte.161.16.1962; Osterberg L, 2005, NEW ENGL J MED, V353, P487, DOI 10.1056/NEJMra050100; Oyugi JH, 2007, AIDS, V21, P965, DOI 10.1097/QAD.0b013e32802e6bfa; Panel on antiretroviral guidelines for adults and adolescents, 2009, GUID US ANT AG HIV 1, P1; Paterson DL, 2000, ANN INTERN MED, V133, P21, DOI 10.7326/0003-4819-133-1-200007040-00004; Riley Lee W, 2007, BMC Int Health Hum Rights, V7, P2, DOI 10.1186/1472-698X-7-2; Rosen S, 2007, PLOS MED, V4, P1691, DOI 10.1371/journal.pmed.0040298; Schonnesson LN, 2006, AIDS CARE, V18, P246, DOI 10.1080/09540120500456631; Simoni JM, 2006, AIDS BEHAV, V10, P227, DOI 10.1007/s10461-006-9078-6; Singh N, 1999, CLIN INFECT DIS, V29, P824, DOI 10.1086/520443; Taffa Negussie, 2003, Int J Adolesc Med Health, V15, P321; Tuller DM, 2010, AIDS BEHAV, V14, P778, DOI 10.1007/s10461-009-9533-2; Unge C, 2008, AIDS CARE, V20, P146, DOI 10.1080/09540120701513677; Unge C, 2009, JAIDS-J ACQ IMM DEF, V50, P397, DOI 10.1097/QAI.0b013e318194618e; van Oosterhout JJ, 2005, TROP MED INT HEALTH, V10, P464, DOI 10.1111/j.1365-3156.2005.01409.x; WANG H, J CLIN NURS, V19, P380; Ware NC, 2009, PLOS MED, V6, P39, DOI 10.1371/journal.pmed.1000011; Weiser SD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010340; Yu JKL, 2007, B WORLD HEALTH ORGAN, V85, P550, DOI 10.2471/BLT.06.037739; Zachariah R, 2008, T ROY SOC TROP MED H, V102, P288, DOI 10.1016/j.trstmh.2007.12.007	51	53	54	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2010	5	10							e13613	10.1371/journal.pone.0013613	http://dx.doi.org/10.1371/journal.pone.0013613			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	670LB	21049045	Green Published, Green Submitted, gold			2022-12-27	WOS:000283422100018
J	Scotti, C; Sommi, P; Pasquetto, MV; Cappelletti, D; Stivala, S; Mignosi, P; Savio, M; Chiarelli, LR; Valentini, G; Bolanos-Garcia, VM; Merrell, DS; Franchini, S; Verona, ML; Bolis, C; Solcia, E; Manca, R; Franciotta, D; Casasco, A; Filipazzi, P; Zardini, E; Vannini, V				Scotti, Claudia; Sommi, Patrizia; Pasquetto, Maria Valentina; Cappelletti, Donata; Stivala, Simona; Mignosi, Paola; Savio, Monica; Chiarelli, Laurent Roberto; Valentini, Giovanna; Bolanos-Garcia, Victor M.; Merrell, Douglas Scott; Franchini, Silvia; Verona, Maria Luisa; Bolis, Cristina; Solcia, Enrico; Manca, Rachele; Franciotta, Diego; Casasco, Andrea; Filipazzi, Paola; Zardini, Elisabetta; Vannini, Vanio			Cell-Cycle Inhibition by Helicobacter pylori L-Asparaginase	PLOS ONE			English	Article							GAMMA-GLUTAMYL-TRANSPEPTIDASE; GASTRIC EPITHELIAL-CELLS; ACUTE LYMPHOBLASTIC-LEUKEMIA; COLI L-ASPARAGINASE; PROTEOME ANALYSIS; CRYSTAL-STRUCTURE; PROLIFERATION; APOPTOSIS; INFECTION; CARCINOMA	Helicobacter pylori (H. pylori) is a major human pathogen causing chronic gastritis, peptic ulcer, gastric cancer, and mucosa-associated lymphoid tissue lymphoma. One of the mechanisms whereby it induces damage depends on its interference with proliferation of host tissues. We here describe the discovery of a novel bacterial factor able to inhibit the cell-cycle of exposed cells, both of gastric and non-gastric origin. An integrated approach was adopted to isolate and characterise the molecule from the bacterial culture filtrate produced in a protein-free medium: size-exclusion chromatography, nonreducing gel electrophoresis, mass spectrometry, mutant analysis, recombinant protein expression and enzymatic assays. L-asparaginase was identified as the factor responsible for cell-cycle inhibition of fibroblasts and gastric cell lines. Its effect on cell-cycle was confirmed by inhibitors, a knockout strain and the action of recombinant L-asparaginase on cell lines. Interference with cell-cycle in vitro depended on cell genotype and was related to the expression levels of the concurrent enzyme asparagine synthetase. Bacterial subcellular distribution of L-asparaginase was also analysed along with its immunogenicity. H. pylori L-asparaginase is a novel antigen that functions as a cell-cycle inhibitor of fibroblasts and gastric cell lines. We give evidence supporting a role in the pathogenesis of H. pylori-related diseases and discuss its potential diagnostic application.	[Scotti, Claudia; Pasquetto, Maria Valentina; Cappelletti, Donata; Stivala, Simona; Mignosi, Paola; Savio, Monica; Vannini, Vanio] Univ Pavia, Dept Expt Med, Sect Gen Pathol, I-27100 Pavia, Italy; [Sommi, Patrizia] Univ Pavia, Dept Physiol, Sect Human Physiol, I-27100 Pavia, Italy; [Chiarelli, Laurent Roberto; Valentini, Giovanna] Univ Pavia, Dept Biochem A Castellani, I-27100 Pavia, Italy; [Bolanos-Garcia, Victor M.] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England; [Merrell, Douglas Scott] Uniformed Serv Univ Hlth Sci, Dept Microbiol & Immunol, Bethesda, MD 20814 USA; [Franchini, Silvia] Univ Modena & Reggio Emilia, Dept Pharmaceut Sci, Modena, Italy; [Verona, Maria Luisa; Bolis, Cristina] CAM, Monza, Italy; [Solcia, Enrico; Manca, Rachele] Univ Pavia, Dept Human Pathol, I-27100 Pavia, Italy; [Solcia, Enrico; Manca, Rachele] Fdn Ist Ricovero & Cura Carattere Sci IRCCS Polic, Serv Anat Pathol, I-27100 Pavia, Italy; [Franciotta, Diego; Zardini, Elisabetta] Fdn Ist Ricovero & Cura Carattere Sci IRCCS Polic, Neurol Inst C Mondino, Lab Neuroimmunol, I-27100 Pavia, Italy; [Casasco, Andrea] Univ Pavia, Dept Expt Med, Sect Histol & Gen Embriol, I-27100 Pavia, Italy; [Filipazzi, Paola] Fdn Ist Ricovero & Cura Carattere Sci Ist Nazl Tu, Unit Immunotherapy Human Tumours, Milan, Italy	University of Pavia; University of Pavia; University of Pavia; University of Cambridge; Uniformed Services University of the Health Sciences - USA; Universita di Modena e Reggio Emilia; University of Pavia; IRCCS Fondazione Casimiro Mondino; University of Pavia	Scotti, C (corresponding author), Univ Pavia, Dept Expt Med, Sect Gen Pathol, Via Palestro 3, I-27100 Pavia, Italy.	claudia.scotti@unipv.it	Franchini, Silvia/R-2040-2019; Franciotta, Diego/ABE-0957-2022; Bolanos-Garcia, Victor M./AAN-8575-2020; Franciotta, Diego/K-8262-2016; Scotti, Claudia/A-7126-2012; Chiarelli, Laurent Roberto/J-8368-2016; Franchini, Silvia/C-5733-2015; Scotti, Claudia/AAM-3372-2021	Franchini, Silvia/0000-0002-6320-9712; Franciotta, Diego/0000-0002-3014-3913; Bolanos-Garcia, Victor M./0000-0003-2700-1479; Franciotta, Diego/0000-0002-3014-3913; Scotti, Claudia/0000-0002-5790-1833; Chiarelli, Laurent Roberto/0000-0003-0348-9764; Franchini, Silvia/0000-0002-6320-9712; Stivala, Simona/0000-0003-1549-8932	Ministry of Education, University and Research, MIUR; Ministero della Salute	Ministry of Education, University and Research, MIUR(Ministry of Education, Universities and Research (MIUR)); Ministero della Salute(Ministry of Health, Italy)	This work was supported by a grant from the Ministry of Education, University and Research, MIUR (Progetti di Ricerca di Interesse Nazionale, 2004) and by funding from the Ministero della Salute to IRCCS Fondazione Policlinico S. Matteo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alyamani EJ, 2007, MICROBIOL-SGM, V153, P1006, DOI 10.1099/mic.0.29184-0; BAHARI HMM, 1982, GUT, V23, P513, DOI 10.1136/gut.23.6.513; BARRANCO SC, 1983, CANCER RES, V43, P1703; BEERS RF, 1952, J BIOL CHEM, V195, P133; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bergmeyer HU, 1983, METHOD ENZYMAT AN, P163; Bumann D, 2002, INFECT IMMUN, V70, P3396, DOI 10.1128/IAI.70.7.3396-3403.2002; Cappelletti D, 2008, BIOCHEM BIOPH RES CO, V377, P1222, DOI 10.1016/j.bbrc.2008.10.118; Chang K, 1993, J Physiol Pharmacol, V44, P17; de Freitas D, 2004, HEPATO-GASTROENTEROL, V51, P876; Ding Y, 2005, LEUKEMIA, V19, P420, DOI 10.1038/sj.leu.2403639; EGUIGUREN JM, 1992, MED PEDIATR ONCOL, V20, P58, DOI 10.1002/mpo.2950200112; Fan XG, 1996, GUT, V38, P19, DOI 10.1136/gut.38.1.19; Ferreira AC, 2008, HELICOBACTER, V13, P28, DOI 10.1111/j.1523-5378.2008.00633.x; Fiocca R, 1999, J PATHOL, V188, P220, DOI 10.1002/(SICI)1096-9896(199906)188:2<220::AID-PATH307>3.0.CO;2-C; Gardy JL, 2005, BIOINFORMATICS, V21, P617, DOI 10.1093/bioinformatics/bti057; Gerhard M, 2005, GASTROENTEROLOGY, V128, P1327, DOI 10.1053/j.gastro.2005.03.018; HANADA T, 1989, EUR J PEDIATR, V149, P162, DOI 10.1007/BF01958270; Havard TJ, 1996, J CLIN PATHOL, V49, P68, DOI 10.1136/jcp.49.1.68; HO PPK, 1970, BIOCHIM BIOPHYS ACTA, V206, P196, DOI 10.1016/0005-2744(70)90101-4; Hochstrasser D F, 1988, Appl Theor Electrophor, V1, P35; Honda S, 1998, CANCER RES, V58, P4255; HOWARD JB, 1972, J BIOL CHEM, V247, P1020; Jones NL, 1997, AM J PATHOL, V151, P1695; KAARTINEN V, 1991, J BIOL CHEM, V266, P5860; Keating M J, 1993, Leuk Lymphoma, V10 Suppl, P153, DOI 10.3109/10428199309149129; Kim KM, 2010, J MICROBIOL, V48, P372, DOI 10.1007/s12275-010-9293-8; Leduc D, 2010, INFECT IMMUN, V78, P2782, DOI 10.1128/IAI.00149-10; Lubkowski J, 1996, EUR J BIOCHEM, V241, P201, DOI 10.1111/j.1432-1033.1996.0201t.x; LYNCH DAF, 1995, GUT, V36, P346, DOI 10.1136/gut.36.3.346; Marcus EA, 2005, J BACTERIOL, V187, P729, DOI 10.1128/JB.187.2.729-738.2005; Merrell DS, 2003, INFECT IMMUN, V71, P3529, DOI 10.1128/IAI.71.6.3529-3539.2003; MOOLA ZB, 1994, BIOCHEM J, V302, P921, DOI 10.1042/bj3020921; Moss SF, 1996, GUT, V38, P498, DOI 10.1136/gut.38.4.498; MOTOYAMA T, 1986, ACTA PATHOL JAPON, V36, P65; Necchi V, 2007, GASTROENTEROLOGY, V132, P1009, DOI 10.1053/j.gastro.2007.01.049; NOMURA A, 1991, NEW ENGL J MED, V325, P1132, DOI 10.1056/NEJM199110173251604; Pai R, 1998, AM J PATHOL, V152, P1617; PARSONNET J, 1991, NEW ENGL J MED, V325, P1127, DOI 10.1056/NEJM199110173251603; Pitson SM, 1999, EUR J BIOCHEM, V260, P258, DOI 10.1046/j.1432-1327.1999.00153.x; Ricci V, 1996, INFECT IMMUN, V64, P2829, DOI 10.1128/IAI.64.7.2829-2833.1996; Romiti A, 2005, WORLD J GASTROENTERO, V11, P4400; Rotoli BM, 2005, CELL PHYSIOL BIOCHEM, V15, P281, DOI 10.1159/000087238; Sahoo S, 2003, SEMIN LIVER DIS, V23, P295; Schmees C, 2007, GASTROENTEROLOGY, V132, P1820, DOI 10.1053/j.gastro.2007.02.031; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shirin H, 1999, CANCER RES, V59, P2277; Smith TJ, 2005, CLIN EXP IMMUNOL, V141, P388, DOI 10.1111/j.1365-2249.2005.02824.x; Sommi P, 2002, EXP CELL RES, V281, P128, DOI 10.1006/excr.2002.5629; STORY MD, 1993, CANCER CHEMOTH PHARM, V32, P129, DOI 10.1007/BF00685615; SWAIN AL, 1993, P NATL ACAD SCI USA, V90, P1474, DOI 10.1073/pnas.90.4.1474; SZASZ G, 1974, Z KLIN CHEM KLIN BIO, V12, P228; Testerman TL, 2001, J CLIN MICROBIOL, V39, P3842, DOI 10.1128/JCM.39.11.3842-3850.2001; THORSLUND A, 1967, EUR J BIOCHEM, V3, P117, DOI 10.1111/j.1432-1033.1967.tb19504.x; Top PC, 2005, PEDIATR BLOOD CANCER, V44, P95, DOI 10.1002/pbc.20187; Ueno T, 1997, LEUKEMIA, V11, P1858, DOI 10.1038/sj.leu.2400834; Wacker P, 2007, J PEDIAT HEMATOL ONC, V29, P627, DOI 10.1097/MPH.0b013e3181483df1; Wagner S, 1997, GASTROENTEROLOGY, V113, P1836, DOI 10.1016/S0016-5085(97)70003-9; WRISTON JC, 1973, ADV ENZYMOL RAMB, V39, P185; Xia HHX, 2005, WORLD J GASTROENTERO, V11, P1946; Xia HHX, 2004, J GASTROEN HEPATOL, V19, P1257, DOI 10.1111/j.1440-1746.2004.03489.x	61	46	46	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2010	5	11							e13892	10.1371/journal.pone.0013892	http://dx.doi.org/10.1371/journal.pone.0013892			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	677ZE	21085483	Green Submitted, Green Published, gold			2022-12-27	WOS:000284035900009
J	Goldhaber-Fiebert, JD; Lipsitch, M; Mahal, A; Zaslavsky, AM; Salomon, JA				Goldhaber-Fiebert, Jeremy D.; Lipsitch, Marc; Mahal, Ajay; Zaslavsky, Alan M.; Salomon, Joshua A.			Quantifying Child Mortality Reductions Related to Measles Vaccination	PLOS ONE			English	Article							HEALTH; COVERAGE	Background: This study characterizes the historical relationship between coverage of measles containing vaccines (MCV) and mortality in children under 5 years, with a view toward ongoing global efforts to reduce child mortality. Methodology/Principal Findings: Using country-level, longitudinal panel data, from 44 countries over the period 19602005, we analyzed the relationship between MCV coverage and measles mortality with (1) logistic regressions for no measles deaths in a country-year, and (2) linear regressions for the logarithm of the measles death rate. All regressions allowed a flexible, non-linear relationship between coverage and mortality. Covariates included birth rate, death rates from other causes, percent living in urban areas, population density, per-capita GDP, use of the two-dose MCV, year, and mortality coding system. Regressions used lagged covariates, country fixed effects, and robust standard errors clustered by country. The likelihood of no measles deaths increased nonlinearly with higher MCV coverage (ORs: 13.8 [1.6-122.7] for 80-89% to 40.7 [3.2-517.6] for >= 95%), compared to pre-vaccination risk levels. Measles death rates declined nonlinearly with higher MCV coverage, with benefits accruing more slowly above 90% coverage. Compared to no coverage, predicted average reductions in death rates were -79% at 70% coverage, -93% at 90%, and -95% at 95%. Conclusions/Significance: 40 years of experience with MCV vaccination suggests that extremely high levels of vaccination coverage are needed to produce sharp reductions in measles deaths. Achieving sustainable benefits likely requires a combination of extended vaccine programs and supplementary vaccine efforts.	[Goldhaber-Fiebert, Jeremy D.] Stanford Univ, Dept Med, Sch Med, Ctr Hlth Policy, Stanford, CA 94305 USA; [Goldhaber-Fiebert, Jeremy D.] Stanford Univ, Sch Med, Ctr Primary Care & Outcomes Res, Stanford, CA 94305 USA; [Goldhaber-Fiebert, Jeremy D.; Salomon, Joshua A.] Harvard Univ, Sch Publ Hlth, Program Hlth Decis Sci, Boston, MA 02115 USA; [Lipsitch, Marc] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Lipsitch, Marc] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; [Mahal, Ajay; Salomon, Joshua A.] Harvard Univ, Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA; [Zaslavsky, Alan M.] Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA	Stanford University; Stanford University; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School	Goldhaber-Fiebert, JD (corresponding author), Stanford Univ, Dept Med, Sch Med, Ctr Hlth Policy, Stanford, CA 94305 USA.	jeremygf@stanford.edu	Salomon, Joshua A/D-3898-2009; Salomon, Joshua/S-1929-2019	Salomon, Joshua A/0000-0003-3929-5515; Salomon, Joshua/0000-0003-3929-5515; Goldhaber-Fiebert, Jeremy/0000-0002-4007-5192; Lipsitch, Marc/0000-0003-1504-9213	United States' National Institutes of Health's (NIH) National Institute of Allergy and Infectious Disease	United States' National Institutes of Health's (NIH) National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The research was supported in part by a training grant in the Epidemiology of Infectious Diseases and Biodefense from the United States' National Institutes of Health's (NIH) National Institute of Allergy and Infectious Disease administered via the Harvard School of Public Health made to Dr. Goldhaber-Fiebert during the final year of his doctoral dissertation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Anand S, 2004, LANCET, V364, P1603, DOI 10.1016/S0140-6736(04)17313-3; Anand S, 2007, LANCET, V369, P1277, DOI 10.1016/S0140-6736(07)60599-6; Andrews N, 2008, B WORLD HEALTH ORGAN, V86, P197, DOI 10.2471/BLT.07.041129; [Anonymous], MMWR MORB MORTAL WKL; Barton M, 2010, PEDIATRICS, V125, P361, DOI 10.1542/peds.2009-2037; Bauch CT, 2009, VACCINE, V27, P4090, DOI 10.1016/j.vaccine.2009.04.079; Bloom DE, 2000, SCIENCE, V287, P1207, DOI 10.1126/science.287.5456.1207; Bryce J, 2006, LANCET, V368, P1067, DOI 10.1016/S0140-6736(06)69339-2; Burton A, 2009, B WORLD HEALTH ORGAN, V87, P535, DOI 10.2471/BLT.08.053819; de Melker H, 2001, EPIDEMIOL INFECT, V126, P249, DOI 10.1017/S0950268801005234; Edmunds WJ, 2000, EPIDEMIOL INFECT, V125, P635, DOI 10.1017/S0950268800004672; Ferrari MJ, 2008, NATURE, V451, P679, DOI 10.1038/nature06509; Filmer D, 1999, SOC SCI MED, V49, P1309, DOI 10.1016/S0277-9536(99)00150-1; FINE PEM, 1993, EPIDEMIOL REV, V15, P265, DOI 10.1093/oxfordjournals.epirev.a036121; FLEGG AT, 1982, POP STUD-J DEMOG, V36, P441, DOI 10.2307/2174055; Grenfell BT, 2001, NATURE, V414, P716, DOI 10.1038/414716a; HESTON A, 2006, PENN WORLD TABLES VE; Hutchins SS, 2001, AM J EPIDEMIOL, V154, P1064, DOI 10.1093/aje/154.11.1064; KEELE L, 2008, SEMIPARAMETRIC REGRE, pR16; Keeling MJ, 1997, SCIENCE, V275, P65, DOI 10.1126/science.275.5296.65; KEELING MJ, 2008, MODELING INFECT DIS, pR11; Mathers CD, 2005, B WORLD HEALTH ORGAN, V83, P171; McLean AR, 1995, TRENDS MICROBIOL, V3, P458, DOI 10.1016/S0966-842X(00)89010-1; Murray CJL, 2007, LANCET, V370, P1040, DOI 10.1016/S0140-6736(07)61478-0; Murray Emily T, 2010, Am J Epidemiol, V171, P1099, DOI 10.1093/aje/kwq044; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; *UN, UN WORLD POP PROSP 2; *WHO, WHO YEAR INTR SEL VA; *WHO UNICEF, WHO UNICEF EST IMM C; Wolfson LJ, 2007, LANCET, V369, P191, DOI 10.1016/S0140-6736(07)60107-X; Wolfson LJ, 2009, INT J EPIDEMIOL, V38, P192, DOI 10.1093/ije/dyn224; WOOLDRIDGE JM, 2003, INTRO ECONOMETRICS M, pR27; *WORLD BANK, 2008, WORLD BANK WORLD DEV; 2009, WKLY EPIDEMIOL REC, V84, P509; 2004, WEEKLY EPIDEMIOLOGIC, V79, P129	36	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2010	5	11							e13842	10.1371/journal.pone.0013842	http://dx.doi.org/10.1371/journal.pone.0013842			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675NY	21079809	Green Published, gold, Green Submitted			2022-12-27	WOS:000283838600016
J	Carmo, EVD; Katz, S; Barbieri, CL				de Souza Carmo, Erico Vinicius; Katz, Simone; Barbieri, Clara Lucia			Neutrophils Reduce the Parasite Burden in Leishmania (Leishmania) amazonensis-Infected Macrophages	PLOS ONE			English	Article							PLATELET-ACTIVATING-FACTOR; TUMOR-NECROSIS-FACTOR; MAJOR INFECTION; HUMAN-MONOCYTES; POLYMORPHONUCLEAR LEUKOCYTES; IMMUNE-RESPONSE; FACTOR-ALPHA; IFN-GAMMA; MICE; INVOLVEMENT	Background: Studies on the role of neutrophils in Leishmania infection were mainly performed with L. (L) major, whereas less information is available for L. (L) amazonensis. Previous results from our laboratory showed a large infiltrate of neutrophils in the site of infection in a mouse strain resistant to L. (L.) amazonensis (C3H/HePas). In contrast, the susceptible strain (BALB/c) displayed a predominance of macrophages harboring a high number of amastigotes and very few neutrophils. These findings led us to investigate the interaction of inflammatory neutrophils with L. (L.) amazonensis-infected macrophages in vitro. Methodology/Principal Findings: Mouse peritoneal macrophages infected with L. (L.) amazonensis were co-cultured with inflammatory neutrophils, and after four days, the infection was quantified microscopically. Data are representative of three experiments with similar results. The main findings were 1) intracellular parasites were efficiently destroyed in the co-cultures; 2) the leishmanicidal effect was similar when cells were obtained from mouse strains resistant (C3H/HePas) or susceptible (BALB/c) to L. (L.) amazonensis; 3) parasite destruction did not require contact between infected macrophages and neutrophils; 4) tumor necrosis factor alpha (TNF-alpha), neutrophil elastase and platelet activating factor (PAF) were involved with the leishmanicidal activity, and 5) destruction of the parasites did not depend on generation of oxygen or nitrogen radicals, indicating that parasite clearance did not involve the classical pathway of macrophage activation by TNF-alpha, as reported for other Leishmania species. Conclusions/Significance: The present results provide evidence that neutrophils in concert with macrophages play a previously unrecognized leishmanicidal effect on L. (L.) amazonensis. We believe these findings may help to understand the mechanisms involved in innate immunity in cutaneous infection by this Leishmania species.	[de Souza Carmo, Erico Vinicius; Katz, Simone; Barbieri, Clara Lucia] Univ Fed Sao Paulo, Dept Microbiol Imunol & Parasitol, Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP)	Carmo, EVD (corresponding author), Univ Fed Sao Paulo, Dept Microbiol Imunol & Parasitol, Sao Paulo, Brazil.	barbieri.clara@unifesp.br	Barbiéri, Clara L./E-1505-2012	Barbiéri, Clara L./0000-0001-9426-2308	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonso L, 2008, J LEUKOCYTE BIOL, V84, P389, DOI 10.1189/jlb.0108018; Appelberg R, 2007, TRENDS MICROBIOL, V15, P87, DOI 10.1016/j.tim.2006.11.009; Badolato R, 1996, EXP PARASITOL, V82, P21, DOI 10.1006/expr.1996.0003; BARBIERI CL, 1990, EXP PARASITOL, V71, P218, DOI 10.1016/0014-4894(90)90024-7; Bliss SK, 1999, J IMMUNOL, V163, P2081; CAMUSSI G, 1987, J EXP MED, V166, P1390, DOI 10.1084/jem.166.5.1390; CHANG KP, 1981, AM J TROP MED HYG, V30, P322, DOI 10.4269/ajtmh.1981.30.322; Charmoy M, 2007, J LEUKOCYTE BIOL, V82, P288, DOI 10.1189/jlb.0706440; Chen L, 2005, PARASITOL INT, V54, P109, DOI 10.1016/j.parint.2005.02.001; Fadok VA, 2001, J IMMUNOL, V166, P6847, DOI 10.4049/jimmunol.166.11.6847; FORDHUTCHINSON AW, 1980, NATURE, V286, P264, DOI 10.1038/286264a0; GOLDYNE ME, 1984, J BIOL CHEM, V259, P8815; GOOSSENS V, 1995, P NATL ACAD SCI USA, V92, P8115, DOI 10.1073/pnas.92.18.8115; Guimaraes-Costa AB, 2009, P NATL ACAD SCI USA, V106, P6748, DOI 10.1073/pnas.0900226106; LIEW FY, 1990, J IMMUNOL, V145, P4306; LONARDONI MVC, 1994, MEDIAT INFLAMM, V3, P137, DOI 10.1155/S0962935194000177; Lonardoni MVC, 2000, INFECT IMMUN, V68, P6355, DOI 10.1128/IAI.68.11.6355-6361.2000; Matte C, 2002, J INFECT DIS, V185, P673, DOI 10.1086/339260; McFarlane E, 2008, INFECT IMMUN, V76, P532, DOI 10.1128/IAI.01388-07; MURRAY HW, 1982, J IMMUNOL, V129, P351; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; Novais FO, 2009, J IMMUNOL, V183, P8088, DOI 10.4049/jimmunol.0803720; PEARSON RD, 1981, J IMMUNOL, V127, P1438; Peters NC, 2008, SCIENCE, V321, P970, DOI 10.1126/science.1159194; PIMENTA PFP, 1987, J SUBMICR CYTOL PATH, V19, P387; POMPEU ML, 1991, ACTA TROP, V48, P185, DOI 10.1016/0001-706X(91)90046-M; POUBELLE PE, 1991, IMMUNOLOGY, V72, P181; RACCOSIN EL, 1997, EXP PARASITOL, V85, P283; Ribeiro-Gomes FL, 2004, J IMMUNOL, V172, P4454, DOI 10.4049/jimmunol.172.7.4454; Ribeiro-Gomes FL, 2007, J IMMUNOL, V179, P3988, DOI 10.4049/jimmunol.179.6.3988; Romani L, 1997, J IMMUNOL, V158, P2356; Rousseau D, 2001, BMC Microbiol, V1, P17, DOI 10.1186/1471-2180-1-17; SCHULZEOSTHOFF K, 1992, J BIOL CHEM, V267, P5317; Serezani CH, 2006, J IMMUNOL, V177, P3201, DOI 10.4049/jimmunol.177.5.3201; SORENSEN AL, 1989, APMIS, V97, P754, DOI 10.1111/j.1699-0463.1989.tb00474.x; SPEER CP, 1984, J IMMUNOL, V133, P2151; Tacchini-Cottier F, 2000, J IMMUNOL, V165, P2628, DOI 10.4049/jimmunol.165.5.2628; van Zandbergen G, 2004, J IMMUNOL, V173, P6521, DOI 10.4049/jimmunol.173.11.6521; Vasquez RE, 2006, INFECT IMMUN, V74, P6769, DOI 10.1128/IAI.01073-06	39	35	36	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2010	5	11							e13815	10.1371/journal.pone.0013815	http://dx.doi.org/10.1371/journal.pone.0013815			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	674WJ	21082032	Green Submitted, gold, Green Published			2022-12-27	WOS:000283780800013
J	Mukherjee, S; Krishnan, A; Tamma, K; Home, C; Navya, R; Joseph, S; Das, A; Ramakrishnan, U				Mukherjee, Shomita; Krishnan, Anand; Tamma, Krishnapriya; Home, Chandrima; Navya, R.; Joseph, Sonia; Das, Arundhati; Ramakrishnan, Uma			Ecology Driving Genetic Variation: A Comparative Phylogeography of Jungle Cat (Felis chaus) and Leopard Cat (Prionailurus bengalensis) in India	PLOS ONE			English	Article							RIBOSOMAL-RNA; MITOCHONDRIAL; POPULATION; DISPERSAL; MAXIMUM; DISTRIBUTIONS; PHILOPATRY; PHYLOGENY; MODELTEST; DIVERSITY	Background: Comparative phylogeography links historical population processes to current/ecological processes through congruent/incongruent patterns of genetic variation among species/lineages. Despite high biodiversity, India lacks a phylogeographic paradigm due to limited comparative studies. We compared the phylogenetic patterns of Indian populations of jungle cat (Felis chaus) and leopard cat (Prionailurus bengalensis). Given similarities in their distribution within India, evolutionary histories, body size and habits, congruent patterns of genetic variation were expected. Methodology/Principal Findings: We collected scats from various biogeographic zones in India and analyzed mtDNA from 55 jungle cats (460 bp NADH5, 141 bp cytochrome b) and 40 leopard cats (362 bp NADH5, 202 bp cytochrome b). Jungle cats revealed high genetic variation, relatively low population structure and demographic expansion around the mid-Pleistocene. In contrast, leopard cats revealed lower genetic variation and high population structure with a F-ST of 0.86 between North and South Indian populations. Niche-model analyses using two approaches (BIOCLIM and MaxEnt) support absence of leopard cats from Central India, indicating a climate associated barrier. We hypothesize that high summer temperatures limit leopard cat distribution and that a rise in temperature in the peninsular region of India during the LGM caused the split in leopard cat population in India. Conclusions/Significance: Our results indicate that ecological variables describing a species range can predict genetic patterns. Our study has also resolved the confusion over the distribution of the leopard cat in India. The reciprocally monophyletic island population in the South mandates conservation attention.	[Mukherjee, Shomita; Krishnan, Anand; Tamma, Krishnapriya; Home, Chandrima; Navya, R.; Joseph, Sonia; Ramakrishnan, Uma] Natl Ctr Biol Sci, Bangalore, Karnataka, India; [Home, Chandrima; Das, Arundhati] Royal Enclave, Ashoka Trust Res Ecol & Environm, Bangalore, Karnataka, India; [Mukherjee, Shomita] Salim Ali Ctr Ornithol & Nat Hist, Coimbatore, Tamil Nadu, India	Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS); Salim Ali Center for Ornithology & Natural History (SACON)	Mukherjee, S (corresponding author), Natl Ctr Biol Sci, Bangalore, Karnataka, India.	shomitam@gmail.com	Home, Chandrima/J-8925-2019; Das, Arundhati/H-5988-2019	Home, Chandrima/0000-0002-0369-8198; Ramakrishnan, Uma/0000-0002-5370-5966; Das, Arundhati/0000-0002-3103-5957	Tata Institute of Fundamental Research, Mumbai, India (National Centre for Biological Sciences) [4138]; Department of Biotechnology, Government of India; laboratory 3; NCBS	Tata Institute of Fundamental Research, Mumbai, India (National Centre for Biological Sciences); Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); laboratory 3; NCBS	Sources of Funding: Tata Institute of Fundamental Research, Mumbai, India start-up grant to UR. Grant Number 4138 (National Centre for Biological Sciences) http://www.tifr.res.in. SM was supported by the NCBS-TIFR visiting fellows program, and a postdoctoral fellowship from the Department of Biotechnology, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank all members of laboratory 3, NCBS, for support during our work. We also thank the State Forest Departments of Arunachal Pradesh, Assam, Delhi, Gujarat, Himachal Pradesh, Jammu Kashmir, Karnataka, Kerala, Madhya Pradesh, Maharashtra, Mizoram, Orissa, Rajasthan, Sikkim, Tamil Nadu, Uttar Pradesh, Uttarakhand and West Bengal for permits to collect samples.	Acharjyo L.N., 1998, ENVIS WILDLIFE PROTE, V1, P18; Adams JM, 1997, J ARCHAEOL SCI, V24, P623, DOI 10.1006/jasc.1996.0146; Akaike H, 1973, INFORM THEORY EXTENS, P267, DOI DOI 10.1007/978-1-4612-1694-0_15; AVISE JC, 1989, EVOLUTION, V43, P1192, DOI [10.1111/j.1558-5646.1989.tb02568.x, 10.2307/2409356]; AVISE JC, 1987, ANNU REV ECOL SYST, V18, P489, DOI 10.1146/annurev.es.18.110187.002421; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; BATANOUNY KH, 1988, OECOLOGIA, V75, P539, DOI 10.1007/BF00776418; Biswas S, 2006, J BIOSCIENCES, V31, P95, DOI 10.1007/BF02705240; Bohonak AJ, 2002, J HERED, V93, P153, DOI 10.1093/jhered/93.2.153; Cerling TE, 1997, NATURE, V389, P153, DOI 10.1038/38229; Chen SF, 2008, J ZOOL, V274, P207, DOI 10.1111/j.1469-7998.2007.00391.x; Chesser RK, 1996, GENETICS, V144, P1225; Culver M, 2000, J HERED, V91, P186, DOI 10.1093/jhered/91.3.186; Daniels RJR, 2001, CURR SCI INDIA, V81, P240; DOBSON FS, 1982, ANIM BEHAV, V30, P1183; Duckworth JW, 2005, BIODIVERS CONSERV, V14, P1263, DOI 10.1007/s10531-004-1653-4; Edwards EJ, 2008, ECOL LETT, V11, P266, DOI 10.1111/j.1461-0248.2007.01144.x; EISENBERG JF, 1981, MAMMALIAN RAD, P610; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; ERSTS PJ, GEOGRAPHIC DISTANCE; Excoffier L, 2006, ARLEQUIN VERSION 3 0; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; FUYX, 1996, GENETICS, V143, P557; GREENWOOD PJ, 1980, ANIM BEHAV, V28, P1140, DOI 10.1016/S0003-3472(80)80103-5; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt Godfrey M, 2004, Front Zool, V1, P4; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hofreiter M, 2004, P NATL ACAD SCI USA, V101, P12963, DOI 10.1073/pnas.0403618101; Janecka JE, 2007, WILDLIFE BIOL, V13, P38, DOI 10.2981/0909-6396(2007)13[38:EFMDIB]2.0.CO;2; Johnson WE, 2006, SCIENCE, V311, P73, DOI 10.1126/science.1122277; Johnson WE, 1997, J MOL EVOL, V44, pS98, DOI 10.1007/PL00000060; Karanth KP, 2003, CURR SCI INDIA, V85, P1276; Lozier JD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005901; Manel S, 2005, TRENDS ECOL EVOL, V20, P136, DOI 10.1016/j.tree.2004.12.004; Masuda R, 1996, MOL PHYLOGENET EVOL, V6, P351, DOI 10.1006/mpev.1996.0085; Moodley Y, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000454; Mukherjee N, 2007, CONSERV GENET, V8, P1465, DOI 10.1007/s10592-007-9289-z; Mukherjee Shomita, 2010, BMC Research Notes, V3, DOI 10.1186/1756-0500-3-159; Nix H. A., 1986, ATLAS ELAPID SNAKES, V7, P4; Nowell K, 1996, WILD CATS STATUS SUR; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; POCOCK RI, 1985, MAMMALIA, V1; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Posada D, 2006, NUCLEIC ACIDS RES, V34, pW700, DOI 10.1093/nar/gkl042; Pulliam HR, 2000, ECOL LETT, V3, P349, DOI 10.1046/j.1461-0248.2000.00143.x; Ray N., 2001, INTERNET ARCHAEOLOGY, V11, P1, DOI [DOI 10.11141/IA.11.2, 10.11141/ia.11.2]; Rodgers W.A., 1988, PLANNING WILDLIFE PR; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Saatchi S, 2008, REMOTE SENS ENVIRON, V112, P2000, DOI 10.1016/j.rse.2008.01.008; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SANDERSON J, 2008, IUCN 2008 2008 IUCN; Santiapillai C., 1985, Tigerpaper (Bangkok), V12, P8; Schmitt T, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-11; Schneider S, 1999, GENETICS, V152, P1079; Sliwa A, 2004, MAMM BIOL, V69, P96, DOI 10.1078/1616-5047-00124; Storz JF, 2001, J HERED, V92, P497, DOI 10.1093/jhered/92.6.497; Sunquist M., 2002, WILD CATS WORLD, DOI [DOI 10.7208/CHICAGO/9780226518237.001.0001, 10.7208/chicago/9780226518237.001.0001]; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; TAJIMA F, 1989, GENETICS, V123, P585; Tamada T, 2008, ZOOL SCI, V25, P154, DOI 10.2108/zsj.25.154; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Udvardy MDF, 1975, 18 IUCN; WASER PM, 1983, Q REV BIOL, V58, P355, DOI 10.1086/413385; Zink RM, 2002, INTEGR COMP BIOL, V42, P953, DOI 10.1093/icb/42.5.953	65	26	27	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2010	5	10							e13724	10.1371/journal.pone.0013724	http://dx.doi.org/10.1371/journal.pone.0013724			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673FU	21060831	gold, Green Published, Green Submitted			2022-12-27	WOS:000283645300010
J	Walter, S; Kostpopoulos, P; Haass, A; Helwig, S; Keller, I; Licina, T; Schlechtriemen, T; Roth, C; Papanagiotou, P; Zimmer, A; Vierra, J; Korner, H; Schmidt, K; Romann, MS; Alexandrou, M; Yilmaz, U; Grunwald, I; Kubulus, D; Lesmeister, M; Ziegeler, S; Pattar, A; Golinski, M; Liu, Y; Volk, T; Bertsch, T; Reith, W; Fassbender, K				Walter, Silke; Kostpopoulos, Panagiotis; Haass, Anton; Helwig, Stefan; Keller, Isabel; Licina, Tamara; Schlechtriemen, Thomas; Roth, Christian; Papanagiotou, Panagiotis; Zimmer, Anna; Vierra, Julio; Koerner, Heiko; Schmidt, Kathrin; Romann, Marie-Sophie; Alexandrou, Maria; Yilmaz, Umut; Grunwald, Iris; Kubulus, Darius; Lesmeister, Martin; Ziegeler, Stephan; Pattar, Alexander; Golinski, Martin; Liu, Yang; Volk, Thomas; Bertsch, Thomas; Reith, Wolfgang; Fassbender, Klaus			Bringing the Hospital to the Patient: First Treatment of Stroke Patients at the Emergency Site	PLOS ONE			English	Article							GUIDELINES; MANAGEMENT; HEMORRHAGE; MORTALITY; PENUMBRA; OUTCOMES; COUNCIL; EVENTS; ADULTS	Background: Early treatment with rt-PA is critical for favorable outcome of acute stroke. However, only a very small proportion of stroke patients receive this treatment, as most arrive at hospital too late to be eligible for rt-PA therapy. Methods and Findings: We developed a "Mobile Stroke Unit'', consisting of an ambulance equipped with computed tomography, a point-of-care laboratory system for complete stroke laboratory work-up, and telemedicine capabilities for contact with hospital experts, to achieve delivery of etiology-specific and guideline-adherent stroke treatment at the site of the emergency, well before arrival at the hospital. In a departure from current practice, stroke patients could be differentially treated according to their ischemic or hemorrhagic etiology even in the prehospital phase of stroke management. Immediate diagnosis of cerebral ischemia and exclusion of thrombolysis contraindications enabled us to perform prehospital rt-PA thrombolysis as bridging to later intra-arterial recanalization in one patient. In a complementary patient with cerebral hemorrhage, prehospital diagnosis allowed immediate initiation of hemorrhage-specific blood pressure management and telemedicine consultation regarding surgery. Call-to-therapy-decision times were 35 minutes. Conclusion: This preliminary study proves the feasibility of guideline-adherent, etiology-specific and causal treatment of acute stroke directly at the emergency site.	[Walter, Silke; Kostpopoulos, Panagiotis; Haass, Anton; Helwig, Stefan; Keller, Isabel; Licina, Tamara; Lesmeister, Martin; Liu, Yang; Fassbender, Klaus] Univ Hosp Saarland, Dept Neurol, Homburg, Germany; [Schlechtriemen, Thomas] Zweckverband Rettungsdienst & Feuerwehralarmierun, Saarland, Germany; [Roth, Christian; Papanagiotou, Panagiotis; Zimmer, Anna; Vierra, Julio; Koerner, Heiko; Schmidt, Kathrin; Romann, Marie-Sophie; Alexandrou, Maria; Yilmaz, Umut; Grunwald, Iris; Reith, Wolfgang] Univ Hosp Saarland, Dept Neuroradiol, Homburg, Germany; [Kubulus, Darius; Ziegeler, Stephan; Pattar, Alexander; Golinski, Martin; Volk, Thomas] Univ Hosp Saarland, Dept Anaesthesiol & Intens Care, Homburg, Germany; [Bertsch, Thomas] Nurnberg Hosp, Dept Clin Chem, Nurnberg, Germany	Universitatsklinikum des Saarlandes; Universitatsklinikum des Saarlandes; Universitatsklinikum des Saarlandes	Walter, S (corresponding author), Univ Hosp Saarland, Dept Neurol, Homburg, Germany.	Klaus.Fassbender@uks.eu	Liu, Yang/GSD-5476-2022; Roth, Christian/B-6952-2015; Papanagiotou, Panagiotis/B-1434-2012; Grunwald, Iris/AAY-2521-2021; Romann, Michael/H-3571-2019; Yilmaz, Umut/A-9508-2012	Roth, Christian/0000-0001-5147-2241; Grunwald, Iris/0000-0002-3404-7590; Romann, Michael/0000-0003-4139-2955; Yilmaz, Umut/0000-0003-4940-3575; Lesmeister, Martin/0000-0001-5228-6483; Liu, Yang/0000-0002-7614-4233; Walter, Silke/0000-0002-1176-2911; Fassbender, Klaus/0000-0003-3596-868X	Ministry of Health of the Saarland, Germany; Jackstaedt-Foundation, Germany; Else Kroener-Fresenius Foundation, Germany; "Zweckverband fur Rettungsdienst und Feuerwehralarmierung Saar", Germany; German Red Cross, Saarland, Germany	Ministry of Health of the Saarland, Germany; Jackstaedt-Foundation, Germany; Else Kroener-Fresenius Foundation, Germany; "Zweckverband fur Rettungsdienst und Feuerwehralarmierung Saar", Germany; German Red Cross, Saarland, Germany	This study was funded by grants from the Ministry of Health of the Saarland, Germany; Jackstaedt-Foundation, Germany; Else Kroener-Fresenius Foundation, Germany; "Zweckverband fur Rettungsdienst und Feuerwehralarmierung Saar", Germany, and German Red Cross, Saarland, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams HP, 2007, CIRCULATION, V115, pE478, DOI 10.1161/CIRCULATIONAHA.107.181486; BOEHRINGER, 2009, SUMMARY PRODUCT CHAR; Bose A, 2008, AM J NEURORADIOL, V29, P1409, DOI 10.3174/ajnr.A1110; Broderick J, 2007, CIRCULATION, V116, pE391, DOI 10.1161/CIRCULATIONAHA.107.183689; *EUR STROK IN WORK, 2008, CEREBROVASC DIS, V22, P294; Fassbender K, 2003, STROKE, V34, pE44, DOI 10.1161/01.STR.0000075573.22885.3B; Hacke W, 2008, CEREBROVASC DIS, V25, P457, DOI 10.1159/000131083; HOSSMANN KA, 1994, ANN NEUROL, V36, P557, DOI 10.1002/ana.410360404; Howells DW, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000224; Katzan IL, 2004, ARCH NEUROL-CHICAGO, V61, P346, DOI 10.1001/archneur.61.3.346; Kleindorfer DO, 2008, STROKE, V39, pE43, DOI 10.1161/STROKEAHA.107.509109; Lichtman JH, 2009, STROKE, V40, pE127; MARLER JR, 1995, NEW ENGL J MED, V333, P1581, DOI 10.1056/nejm199512143332401; Marler JR, 2000, NEUROLOGY, V55, P1649, DOI 10.1212/WNL.55.11.1649; Mazighi M, 2009, LANCET NEUROL, V8, P802, DOI 10.1016/S1474-4422(09)70182-6; Nor AM, 2005, LANCET NEUROL, V4, P727, DOI 10.1016/S1474-4422(05)70201-5; Price CI, 2009, EXPERT REV NEUROTHER, V9, P211, DOI 10.1586/14737175.9.2.211; Qureshi AI, 2005, NEUROSURGERY, V57, P647, DOI 10.1227/01.NEU.0000175546.62088.D6; Rothwell PM, 2005, LANCET, V366, P1773, DOI 10.1016/S0140-6736(05)67702-1; van der Worp HB, 2007, NEW ENGL J MED, V357, P572, DOI 10.1056/NEJMcp072057; VONKUMMER R, 1994, AM J NEURORADIOL, V15, P9; WEIR CJ, 1994, LANCET, V344, P999, DOI 10.1016/S0140-6736(94)91648-9	22	86	91	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2010	5	10							e13758	10.1371/journal.pone.0013758	http://dx.doi.org/10.1371/journal.pone.0013758			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673FU	21060800	Green Published, gold			2022-12-27	WOS:000283645300037
J	Buttner, S; Delay, C; Franssens, V; Bammens, T; Ruli, D; Zaunschirm, S; de Oliveira, RM; Outeiro, TF; Madeo, F; Buee, L; Galas, MC; Winderickx, J				Buettner, Sabrina; Delay, Charlotte; Franssens, Vanessa; Bammens, Tine; Ruli, Doris; Zaunschirm, Sandra; de Oliveira, Rita Machado; Outeiro, Tiago Fleming; Madeo, Frank; Buee, Luc; Galas, Marie-Christine; Winderickx, Joris			Synphilin-1 Enhances alpha-Synuclein Aggregation in Yeast and Contributes to Cellular Stress and Cell Death in a Sir2-Dependent Manner	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; PARKINSONS-DISEASE; SACCHAROMYCES-CEREVISIAE; INTERACTING PROTEIN; INCLUSION FORMATION; PROMOTE LONGEVITY; TRANSGENIC MICE; BODY FORMATION; IN-VITRO; TOXICITY	Background: Parkinson's disease is characterized by the presence of cytoplasmic inclusions, known as Lewy bodies, containing both aggregated alpha-synuclein and its interaction partner, synphilin-1. While synphilin-1 is known to accelerate inclusion formation by alpha-synuclein in mammalian cells, its effect on cytotoxicity remains elusive. Methodology/Principal Findings: We expressed wild-type synphilin-1 or its R621C mutant either alone or in combination with alpha-synuclein in the yeast Saccharomyces cerevisiae and monitored the intracellular localization and inclusion formation of the proteins as well as the repercussions on growth, oxidative stress and cell death. We found that wild-type and mutant synphilin-1 formed inclusions and accelerated inclusion formation by alpha-synuclein in yeast cells, the latter being correlated to enhanced phosphorylation of serine-129. Synphilin-1 inclusions co-localized with lipid droplets and endomembranes. Consistently, we found that wild-type and mutant synphilin-1 interacts with detergent-resistant membrane domains, known as lipid rafts. The expression of synphilin-1 did not incite a marked growth defect in exponential cultures, which is likely due to the formation of aggresomes and the retrograde transport of inclusions from the daughter cells back to the mother cells. However, when the cultures approached stationary phase and during subsequent ageing of the yeast cells, both wild-type and mutant synphilin-1 reduced survival and triggered apoptotic and necrotic cell death, albeit to a different extent. Most interestingly, synphilin-1 did not trigger cytotoxicity in ageing cells lacking the sirtuin Sir2. This indicates that the expression of synphilin-1 in wild-type cells causes the deregulation of Sir2-dependent processes, such as the maintenance of the autophagic flux in response to nutrient starvation. Conclusions/Significance: Our findings demonstrate that wild-type and mutant synphilin-1 are lipid raft interacting proteins that form inclusions and accelerate inclusion formation of alpha-synuclein when expressed in yeast. Synphilin-1 thereby induces cytotoxicity, an effect most pronounced for the wild-type protein and mediated via Sir2-dependent processes.	[Buettner, Sabrina; Ruli, Doris; Zaunschirm, Sandra; Madeo, Frank] Graz Univ, Inst Mol Biosci, Graz, Austria; [Delay, Charlotte; Franssens, Vanessa; Bammens, Tine; Winderickx, Joris] Katholieke Univ Leuven, B-3001 Heverlee, Belgium; [Delay, Charlotte; Buee, Luc; Galas, Marie-Christine] INSERM, U837, F-59045 Lille, France; [Delay, Charlotte; Buee, Luc; Galas, Marie-Christine] Univ Lille Nord France, Jean Pierre Aubert Res Ctr, Lille, France; [Delay, Charlotte; Buee, Luc; Galas, Marie-Christine] Univ Lille 2, Fac Med Pole Rech, Lille, France; [Delay, Charlotte; Buee, Luc; Galas, Marie-Christine] CHU Lille, F-59037 Lille, France; [de Oliveira, Rita Machado; Outeiro, Tiago Fleming] Inst Mol Med, Cell & Mol Neurosci Unit, Lisbon, Portugal; [de Oliveira, Rita Machado; Outeiro, Tiago Fleming] Univ Lisbon, Inst Fisiol, P-1699 Lisbon, Portugal	University of Graz; KU Leuven; Universite de Lille - ISITE; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; CHU Lille; Universidade de Lisboa; Universidade de Lisboa	Buttner, S (corresponding author), Graz Univ, Inst Mol Biosci, Graz, Austria.	joris.winderickx@bio.kuleuven.be	Outeiro, Tiago F/C-1067-2008; Outeiro, Tiago/M-8106-2019; de Oliveira, Rita M/E-9696-2015; Outeiro, Tiago/L-7351-2019; Galas, Marie-Christine/AAL-9812-2020; Delay, Charlotte/F-3139-2011; BUEE, Luc/B-3126-2010	Outeiro, Tiago F/0000-0003-1679-1727; de Oliveira, Rita M/0000-0002-0970-4501; Outeiro, Tiago/0000-0003-1679-1727; BUEE, Luc/0000-0002-6261-4230; Madeo, Frank/0000-0002-5070-1329; Galas, Marie-Christine/0000-0002-3766-7103; Buttner, Sabrina/0000-0002-2786-8542	IWT-Vlaanderen; K.U.Leuven BOF-IOF; K.U.Leuven RD; Egide (Partenariat Hubert Curien) in France; Flemish Ministry of Education; Flanders (FWO) in Belgium; EU-Marie Curie PhD Graduate School NEURAD; Austrian Science Fund FWF (Austria) [S-9304-B05, T-414-B09]; EMBO; IRG; Fundacao para a Ciencia e Tecnologia [PTDC/SAU-NEU/105215/2008]	IWT-Vlaanderen(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); K.U.Leuven BOF-IOF; K.U.Leuven RD(KU Leuven); Egide (Partenariat Hubert Curien) in France; Flemish Ministry of Education; Flanders (FWO) in Belgium(FWO); EU-Marie Curie PhD Graduate School NEURAD; Austrian Science Fund FWF (Austria)(Austrian Science Fund (FWF)); EMBO(European Molecular Biology Organization (EMBO)); IRG; Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was supported by grants from IWT-Vlaanderen (SBO NEURO-TARGET), the K.U.Leuven Research Fund (K.U.Leuven BOF-IOF) and K.U.Leuven R&D to JW, a Tournesol grant from Egide (Partenariat Hubert Curien) in France in collaboration with the Flemish Ministry of Education and the Fund of Scientific Research of Flanders (FWO) in Belgium to JW, MCG and LB, a shared PhD fellowship of the EU-Marie Curie PhD Graduate School NEURAD to JW, MCG and LB, grants of the Austrian Science Fund FWF (Austria) to FM and DR (S-9304-B05), to FM and SB (LIPOTOX), and to SB (T-414-B09; Hertha-Firnberg Fellowship) and an EMBO Installation Grant, a Marie Curie IRG, and a grant of the Fundacao para a Ciencia e Tecnologia (PTDC/SAU-NEU/105215/2008) to TFO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams IR, 2000, TRENDS CELL BIOL, V10, P329, DOI 10.1016/S0962-8924(00)01798-0; Ahn M, 2006, BIOCHEM BIOPH RES CO, V346, P1142, DOI 10.1016/j.bbrc.2006.05.213; Anderson JP, 2006, J BIOL CHEM, V281, P29739, DOI 10.1074/jbc.M600933200; Bodner RA, 2006, P NATL ACAD SCI USA, V103, P4246, DOI 10.1073/pnas.0511256103; BORNIG H, 1974, ACTA HISTOCHEM, V50, P110; Buttner S, 2008, J BIOL CHEM, V283, P7554, DOI 10.1074/jbc.M708477200; Chandra S, 2005, CELL, V123, P383, DOI 10.1016/j.cell.2005.09.028; Chen L, 2005, NAT NEUROSCI, V8, P657, DOI 10.1038/nn1443; Chen QH, 2005, J BIOL CHEM, V280, P30009, DOI 10.1074/jbc.M501308200; Cooper AA, 2006, SCIENCE, V313, P324, DOI 10.1126/science.1129462; da Silveira SA, 2009, HUM MOL GENET, V18, P872, DOI 10.1093/hmg/ddn417; Dixon C, 2005, GENETICS, V170, P47, DOI 10.1534/genetics.104.035493; Engelender S, 1999, NAT GENET, V22, P110, DOI 10.1038/8820; Eyal A, 2006, CELL CYCLE, V5, P2082, DOI 10.4161/cc.5.18.3209; Fabrizio P, 2005, CELL, V123, P655, DOI 10.1016/j.cell.2005.08.042; Fei WH, 2009, BIOCHEM J, V424, P61, DOI 10.1042/BJ20090785; Fleming J, 2008, METHOD ENZYMOL, V439, P339, DOI 10.1016/S0076-6879(07)00425-9; Franssens V, 2010, CELL DEATH DIFFER, V17, P746, DOI 10.1038/cdd.2009.203; Fujiwara H, 2002, NAT CELL BIOL, V4, P160, DOI 10.1038/ncb748; Garcia-Mata R, 2002, TRAFFIC, V3, P388, DOI 10.1034/j.1600-0854.2002.30602.x; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; Haynes CM, 2004, MOL CELL, V15, P767, DOI 10.1016/j.molcel.2004.08.025; Hodara R, 2004, J BIOL CHEM, V279, P47746, DOI 10.1074/jbc.M408906200; Inoue Y, 2010, SEMIN CELL DEV BIOL, V21, P664, DOI 10.1016/j.semcdb.2010.03.009; Janes PW, 1999, J CELL BIOL, V147, P447, DOI 10.1083/jcb.147.2.447; Jin HG, 2008, NEUROSCI LETT, V445, P12, DOI 10.1016/j.neulet.2008.08.073; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Kahle PJ, 2002, EMBO REP, V3, P583, DOI 10.1093/embo-reports/kvf109; Kanki T, 2010, MOL MICROBIOL, V75, P795, DOI 10.1111/j.1365-2958.2009.07035.x; KILMARTIN JV, 1984, J CELL BIOL, V98, P922, DOI 10.1083/jcb.98.3.922; Kim TD, 2000, PROTEIN SCI, V9, P2489, DOI 10.1110/ps.9.12.2489; Kim TD, 2004, BIOCHEM BIOPH RES CO, V324, P1352, DOI 10.1016/j.bbrc.2004.09.208; Krenz A, 2009, J NEUROCHEM, V108, P139, DOI 10.1111/j.1471-4159.2008.05755.x; Krishnan S, 2003, BIOCHEMISTRY-US, V42, P829, DOI 10.1021/bi026528t; Kruger R, 2004, CELL TISSUE RES, V318, P195, DOI 10.1007/s00441-004-0953-z; Larsen KE, 2006, J NEUROSCI, V26, P11915, DOI 10.1523/JNEUROSCI.3821-06.2006; Lee G, 2004, J BIOL CHEM, V279, P6834, DOI 10.1074/jbc.M312760200; Li WX, 2005, P NATL ACAD SCI USA, V102, P2162, DOI 10.1073/pnas.0406976102; Liu BD, 2010, CELL, V140, P257, DOI 10.1016/j.cell.2009.12.031; Madeo F, 2002, MOL CELL, V9, P911, DOI 10.1016/S1097-2765(02)00501-4; Madeo F, 1997, J CELL BIOL, V139, P729, DOI 10.1083/jcb.139.3.729; Madeo F, 1999, J CELL BIOL, V145, P757, DOI 10.1083/jcb.145.4.757; Madeo F, 2010, NAT CELL BIOL, V12, P842, DOI 10.1038/ncb0910-842; Marx FP, 2003, HUM MOL GENET, V12, P1223, DOI 10.1093/hmg/ddg134; Marx FP, 2007, FASEB J, V21, P1759, DOI 10.1096/fj.06-6734com; McLean PJ, 2002, J NEUROCHEM, V83, P846, DOI 10.1046/j.1471-4159.2002.01190.x; McLean PJ, 2001, NEUROSCIENCE, V104, P901, DOI 10.1016/S0306-4522(01)00113-0; Morselli E, 2010, AUTOPHAGY, V6, P186, DOI 10.4161/auto.6.1.10817; Murray IVJ, 2003, ACTA NEUROPATHOL, V105, P177, DOI 10.1007/s00401-002-0629-2; Myhre R, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-19; Neystat M, 2002, NEUROSCI LETT, V325, P119, DOI 10.1016/S0304-3940(02)00253-7; Nishie M, 2004, ACTA NEUROPATHOL, V107, P292, DOI 10.1007/s00401-003-0811-1; Nuber S, 2010, NEUROGENETICS, V11, P107, DOI 10.1007/s10048-009-0212-2; O'Farrell C, 2001, MOL BRAIN RES, V97, P94, DOI 10.1016/S0169-328X(01)00292-3; Okochi M, 2000, J BIOL CHEM, V275, P390, DOI 10.1074/jbc.275.1.390; Outeiro TF, 2003, SCIENCE, V302, P1772, DOI 10.1126/science.1090439; Outeiro TF, 2007, SCIENCE, V317, P516, DOI 10.1126/science.1143780; Palermo LM, 1997, CURR GENET, V32, P93, DOI 10.1007/s002940050252; Ribeiro CS, 2002, J BIOL CHEM, V277, P23927, DOI 10.1074/jbc.M201115200; Ron D, 2004, J CELL BIOL, V167, P23, DOI 10.1083/jcb.200408117; Salminen A, 2009, CELL SIGNAL, V21, P1356, DOI 10.1016/j.cellsig.2009.02.014; Shults CW, 2006, P NATL ACAD SCI USA, V103, P1661, DOI 10.1073/pnas.0509567103; Smith WW, 2010, HUM MOL GENET, V19, P2087, DOI 10.1093/hmg/ddq086; SU LJ, 2009, DIS MODEL MECH; Takahashi M, 2003, NEUROSCI LETT, V336, P155, DOI 10.1016/S0304-3940(02)01258-2; Takahashi T, 2006, FEBS LETT, V580, P4479, DOI 10.1016/j.febslet.2006.07.019; Tanaka M, 2004, J BIOL CHEM, V279, P4625, DOI 10.1074/jbc.M310994200; Tang BL, 2008, MOL ASPECTS MED, V29, P187, DOI 10.1016/j.mam.2007.02.001; Tofaris GK, 2007, CELL MOL LIFE SCI, V64, P2194, DOI 10.1007/s00018-007-7217-5; Vamvaca K, 2009, J MOL BIOL, V389, P413, DOI 10.1016/j.jmb.2009.03.021; Volles MJ, 2007, J MOL BIOL, V366, P1510, DOI 10.1016/j.jmb.2006.12.044; Wakamatsu M, 2007, J NEUROSCI RES, V85, P1819, DOI 10.1002/jnr.21310; Wang YS, 2009, J EUR ACAD DERMATOL, V23, P451, DOI 10.1111/j.1468-3083.2008.02895.x; Willingham S, 2003, SCIENCE, V302, P1769, DOI 10.1126/science.1090389; Winderickx J, 2008, BBA-MOL CELL RES, V1783, P1381, DOI 10.1016/j.bbamcr.2008.01.020; Wong ESP, 2008, HUM MOL GENET, V17, P2570, DOI 10.1093/hmg/ddn157; Xie Xiao-jin, 2010, Zhongguo Shuidao Kexue, V24, P196, DOI 10.3969/j.issn.1001-7216.2010.02.15; Zaarur N, 2008, J BIOL CHEM, V283, P27575, DOI 10.1074/jbc.M802216200; Zabrocki P, 2005, FEBS J, V272, P1386, DOI 10.1111/j.1742-4658.2005.04571.x; Zabrocki P, 2008, BBA-MOL CELL RES, V1783, P1767, DOI 10.1016/j.bbamcr.2008.06.010	80	32	33	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2010	5	10							e13700	10.1371/journal.pone.0013700	http://dx.doi.org/10.1371/journal.pone.0013700			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671UN	21060871	gold, Green Submitted, Green Published			2022-12-27	WOS:000283537000059
J	Dunn, MR; Connell, AM; Forman, J; Stevens, DW; Horn, PL				Dunn, Matthew R.; Connell, Amelia M.; Forman, Jeff; Stevens, Darren W.; Horn, Peter L.			Diet of Two Large Sympatric Teleosts, the Ling (Genypterus blacodes) and Hake (Merluccius australis)	PLOS ONE			English	Article							NEW-ZEALAND; CHATHAM RISE; SUBTROPICAL FRONT; FEEDING-HABITS; FISH; COMMUNITIES; VARIABILITY; OPHIDIIDAE; EVOLUTION; BIOMASS	Ling and hake are tertiary consumers, and as a result both may have an important structuring role in marine communities. The diets of 2064 ling and 913 hake from Chatham Rise, New Zealand, were determined from examination of stomach contents. Ling was a benthic generalist, and hake a demersal piscivore. The diet of ling was characterised by benthic crustaceans, mainly Munida gracilis and Metanephrops challengeri, and demersal fishes, mainly Macrourids and scavenged offal from fishing vessels. The diet of hake was characterised by teleost fishes, mainly macrourids and merlucciids. Multivariate analyses using distance-based linear models found the most important predictors of diet variability were depth, fish length, and vessel type (whether the sample was collected from a commercial or research vessel) for ling, and fish length and vessel type for hake. There was no interspecific predation between ling and hake, and resource competition was largely restricted to macrourid prey, although the dominant macrourid species predated by ling and hake were different. Cluster analysis of average diet of intraspecific groups of ling and hake confirmed the persistent diet separation. Although size is a central factor in determining ecological processes, similar sized ling and hake had distinctly different foraging ecology, and therefore could influence the ecosystem in different ways, and be unequally affected by ecosystem fluctuations.	[Dunn, Matthew R.; Connell, Amelia M.; Forman, Jeff; Stevens, Darren W.; Horn, Peter L.] Natl Inst Water & Atmospher Res Ltd, Wellington, New Zealand	National Institute of Water & Atmospheric Research (NIWA) - New Zealand	Dunn, MR (corresponding author), Natl Inst Water & Atmospher Res Ltd, Wellington, New Zealand.	m.dunn@niwa.co.nz		Horn, Peter/0000-0003-4163-5064	New Zealand Ministry of Fisheries [ZBD2004-02, ENV2007-06]; New Zealand Foundation for Research, Science and Technology [C01X0501]	New Zealand Ministry of Fisheries; New Zealand Foundation for Research, Science and Technology(New Zealand Foundation for Research, Science and Technology)	This work was part-funded by the New Zealand Ministry of Fisheries (http://www.mfish.govt.nz) projects ZBD2004-02 and ENV2007-06, and the New Zealand Foundation for Research, Science and Technology (http://www.frst.govt.nz/) project C01X0501 (Coasts & Oceans OBI, IO2). The New Zealand Ministry of Fisheries had a role in determining the availability of the samples and scope of the study, and allowing the research to be published, but had no role in the design and completion of the data collection and analysis, or preparation of the manuscript. The New Zealand Foundation for Research, Science and Technology had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguayo-Hernandez M., 1995, HAKE FISHERIES ECOLO, P305; Alonso MK, 2002, ENVIRON BIOL FISH, V63, P193; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Anderson OF, 1998, 42 NIWA; Arkhipkin A, 2003, J FISH BIOL, V63, P428, DOI 10.1046/j.1095-8649.2003.00164.x; BEZZI SI, 1995, HAKE FISHERIES ECOLO, P239; BLABER SJM, 1987, MAR BIOL, V95, P345, DOI 10.1007/BF00409564; Bradford-Grieve JM, 1999, J PLANKTON RES, V21, P405, DOI 10.1093/plankt/21.3.405; BRAY JR, 1957, ECOL MONOGR, V27, P326, DOI 10.2307/1942268; Bull B, 2001, NEW ZEAL J MAR FRESH, V35, P795, DOI 10.1080/00288330.2001.9517043; Bulman C, 2001, MAR FRESHWATER RES, V52, P537, DOI 10.1071/MF99152; CLARK MR, 1985, NEW ZEAL J MAR FRESH, V19, P339, DOI 10.1080/00288330.1985.9516100; Clarke KR., 2006, CHANGE MARINE COMMUN; COLMAN JA, 1995, HAKE BIOL FISHERIES, P365; CONNELL AM, NZ J MAR FR IN PRESS; Cortes E, 1997, CAN J FISH AQUAT SCI, V54, P726, DOI 10.1139/cjfas-54-3-726; DEVINE J, 2009, 200921 MIN FISH; Dunn MR, 2009, NEW ZEAL J MAR FRESH, V43, P1103, DOI 10.1080/00288330.2009.9626533; Dunn MR, 2010, DEEP-SEA RES PT I, V57, P923, DOI 10.1016/j.dsr.2010.02.006; Dunn MR, 2010, MAR ECOL PROG SER, V407, P209, DOI 10.3354/meps08580; Franca FMG, 2007, OPER DENT, V32, P217, DOI 10.2341/06-61; Gorley C.K., 2006, GETTING STARTED PRIM; Groenewold S, 2000, ICES J MAR SCI, V57, P1395, DOI 10.1006/jmsc.2000.0914; Haedrich RL, 1996, J FISH BIOL, V49, P40, DOI 10.1111/j.1095-8649.1996.tb06066.x; HEATH RA, 1985, NEW ZEAL J MAR FRESH, V19, P79, DOI 10.1080/00288330.1985.9516077; Horn P. L., 2005, 200559 MIN FISH; HORN PL, 1993, NEW ZEAL J MAR FRESH, V27, P385, DOI 10.1080/00288330.1993.9516580; Horn PL, 1997, MAR FRESHWATER RES, V48, P201, DOI 10.1071/MF96091; HORN PL, 2010, 201014 MIN FISH; HORN PL, 2008, 200824 MIN FISH; HUNTER MD, 1992, ECOLOGY, V73, P724; JAKSIC FM, 1990, OECOLOGIA, V82, P87, DOI 10.1007/BF00318537; Leathwick JR, 2006, MAR ECOL PROG SER, V321, P267, DOI 10.3354/meps321267; LIVINGSTON ME, 2002, 113 NIWA; MACKENZIE K, 1995, CAN J FISH AQUAT SCI, V52, P213, DOI 10.1139/f95-529; Mahe K, 2007, ICES J MAR SCI, V64, P1210, DOI 10.1093/icesjms/fsm100; McClatchie S, 2003, DEEP-SEA RES PT I, V50, P1263, DOI 10.1016/S0967-0637(03)00128-6; McKnight DG, 1997, NEW ZEAL J MAR FRESH, V31, P505, DOI 10.1080/00288330.1997.9516784; Ministry of Fisheries, 2010, REP FISH ASS PLEN MA; MITCHELL SJ, 1984, NEW ZEAL J MAR FRESH, V18, P265, DOI 10.1080/00288330.1984.9516048; Mittelbach GG, 1998, CAN J FISH AQUAT SCI, V55, P1454, DOI 10.1139/f98-041; Murphy RJ, 2001, NEW ZEAL J MAR FRESH, V35, P343, DOI 10.1080/00288330.2001.9517005; Nodder SD, 2003, DEEP-SEA RES PT I, V50, P959, DOI 10.1016/S0967-0637(03)00094-3; Nyegaard M, 2004, J FISH BIOL, V65, P666, DOI 10.1111/j.0022-1112.2004.00476.x; PAYA I, 1992, S AFR J MARINE SCI, V12, P753; Pinkas L, 1971, FISH B CALIF DEP FIS; POLIS GA, 1989, ANNU REV ECOL SYST, V20, P297, DOI 10.1146/annurev.es.20.110189.001501; Probert PK, 1996, INT REV GES HYDROBIO, V81, P577, DOI 10.1002/iroh.19960810411; ROBERTSON DA, 1978, NEW ZEAL J MAR FRESH, V12, P295, DOI 10.1080/00288330.1978.9515757; Ryer CH, 2004, ICES J MAR SCI, V61, P1157, DOI 10.1016/j.icesjms.2004.06.004; Stevens DW, 2011, MAR BIOL, V158, P59, DOI 10.1007/s00227-010-1542-1; STEVENS DW, 2009, 200918 MIN FISH; STOWASSER G, 2009, DEEP-SEA RES PT 1, V56, P182; Sutton P, 2001, J GEOPHYS RES-OCEANS, V106, P31045, DOI 10.1029/2000JC000562; Tirasin EM, 1999, MAR ECOL PROG SER, V182, P243; Uddstrom MJ, 1999, J GEOPHYS RES-OCEANS, V104, P20729, DOI 10.1029/1999JC900167; WERNER EE, 1984, ANNU REV ECOL SYST, V15, P393, DOI 10.1146/annurev.es.15.110184.002141; Yamamura O, 1997, J FISH BIOL, V50, P919, DOI 10.1111/j.1095-8649.1997.tb01618.x	58	23	23	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2010	5	10							e13647	10.1371/journal.pone.0013647	http://dx.doi.org/10.1371/journal.pone.0013647			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671UN	21048962	Green Submitted, Green Published, gold			2022-12-27	WOS:000283537000019
J	Liljander, A; Chandramohan, D; Kweku, M; Olsson, D; Montgomery, SM; Greenwood, B; Farnert, A				Liljander, Anne; Chandramohan, Daniel; Kweku, Margaret; Olsson, Daniel; Montgomery, Scott M.; Greenwood, Brian; Farnert, Anna			Influences of Intermittent Preventive Treatment and Persistent Multiclonal Plasmodium falciparum Infections on Clinical Malaria Risk	PLOS ONE			English	Article							PLACEBO-CONTROLLED TRIAL; SULFADOXINE-PYRIMETHAMINE; TANZANIAN CHILDREN; GHANAIAN CHILDREN; EASTERN SUDAN; REDUCED RISK; DOUBLE-BLIND; TRANSMISSION; COMPLEXITY; MORBIDITY	Background: Intermittent preventive treatment (IPT) of malaria involves administration of curative doses of antimalarials at specified time points to vulnerable populations in endemic areas, regardless whether a subject is known to be infected. The effect of this new intervention on the development and maintenance of protective immunity needs further understanding. We have investigated how seasonal IPT affects the genetic diversity of Plasmodium falciparum infections and the risk of subsequent clinical malaria. Material and Methods: The study included 2227 Ghanaian children (3-59 months) who were given sulphadoxine-pyrimethamine (SP) bimonthly, artesunate plus amodiaquine (AS+AQ) monthly or bimonthly, or placebo monthly for six months spanning the malaria transmission season. Blood samples collected at three post-interventional surveys were analysed by genotyping of the polymorphic merozoite surface protein 2 gene. Malaria morbidity and anaemia was monitored during 12 months follow-up. Results: Monthly IPT with AS+AQ resulted in a marked reduction in number of concurrent clones and only children parasite negative just after the intervention period developed clinical malaria during follow-up. In the placebo group, children without parasites as well as those infected with >= 2 clones had a reduced risk of subsequent malaria. The bimonthly SP or AS+AQ groups had similar number of clones as placebo after intervention; however, diversity and parasite negativity did not predict the risk of malaria. An interaction effect showed that multiclonal infections were only associated with protection in children without intermittent treatment. Conclusion: Molecular typing revealed effects of the intervention not detected by ordinary microscopy. Effective seasonal IPT temporarily reduced the prevalence and genetic diversity of P. falciparum infections. The reduced risk of malaria in children with multiclonal infections only seen in untreated children suggests that persistence of antigenically diverse P. falciparum infections is important for the maintenance of protective malaria immunity in high transmission settings.	[Liljander, Anne; Farnert, Anna] Karolinska Inst, Dept Med Solna, Infect Dis Unit, Stockholm, Sweden; [Chandramohan, Daniel; Kweku, Margaret; Greenwood, Brian] London Sch Hyg & Trop Med, Infect & Trop Dis Dept, London WC1, England; [Kweku, Margaret] Univ Ghana, Ghana Hlth Serv, Accra, Ghana; [Olsson, Daniel] Karolinska Inst, Dept Learning Informat Management & Eth, Med Stat Unit, Stockholm, Sweden; [Montgomery, Scott M.] Karolinska Inst, Dept Med Solna, Clin Epidemiol Unit, Stockholm, Sweden; [Montgomery, Scott M.] Orebro Univ Hosp, Clin Epidemiol & Biostat Unit, Orebro, Sweden; [Montgomery, Scott M.] Univ London Imperial Coll Sci Technol & Med, Charing Cross Hosp, Dept Primary Care & Social Med, London, England	Karolinska Institutet; University of London; London School of Hygiene & Tropical Medicine; Ghana Health Service; University of Ghana; Karolinska Institutet; Karolinska Institutet; Orebro University; Imperial College London	Liljander, A (corresponding author), Karolinska Inst, Dept Med Solna, Infect Dis Unit, Stockholm, Sweden.	anna.farnert@ki.se		Montgomery, Scott/0000-0001-6328-5494; Olsson, Daniel/0000-0003-0535-2729; Farnert, Anna/0000-0001-7583-282X	Swedish International Development Agency [SWE-2005-025]	Swedish International Development Agency	This work was supported by the Swedish International Development Agency (SWE-2005-025). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AlYaman F, 1997, T ROY SOC TROP MED H, V91, P602, DOI 10.1016/S0035-9203(97)90046-8; Aponte JJ, 2009, LANCET, V374, P1533, DOI 10.1016/S0140-6736(09)61258-7; Babiker HA, 1998, AM J TROP MED HYG, V59, P582, DOI 10.4269/ajtmh.1998.59.582; Beck HP, 1997, J INFECT DIS, V175, P921, DOI 10.1086/513991; Bendixen M, 2001, T ROY SOC TROP MED H, V95, P143, DOI 10.1016/S0035-9203(01)90140-3; Bereczky S, 2007, MICROBES INFECT, V9, P103, DOI 10.1016/j.micinf.2006.10.014; Branch OH, 2001, INFECT IMMUN, V69, P7783, DOI 10.1128/IAI.69.12.7783-7792.2001; Chandramohan D, 2005, BMJ-BRIT MED J, V331, P727, DOI 10.1136/bmj.331.7519.727; Cisse B, 2006, LANCET, V367, P659, DOI 10.1016/S0140-6736(06)68264-0; Dicko A, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-123; Farnert A, 1999, J INFECT DIS, V179, P989, DOI 10.1086/314652; Farnert A, 2009, J INFECT DIS, V200, P1166, DOI 10.1086/605652; FRUH K, 1991, INFECT IMMUN, V59, P1319; Gies S, 2009, TROP MED INT HEALTH, V14, P174, DOI 10.1111/j.1365-3156.2008.02215.x; Greenwood BM, 1995, T ROY SOC TROP MED H, V89, P629, DOI 10.1016/0035-9203(95)90419-0; Henning L, 2004, T ROY SOC TROP MED H, V98, P687, DOI 10.1016/j.trstmh.2004.03.010; Konate L, 1999, T ROY SOC TROP MED H, V93, pS21, DOI 10.1016/S0035-9203(99)90323-1; Kweku M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004000; Liljander A, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-78; Mayor A, 2003, TROP MED INT HEALTH, V8, P3, DOI 10.1046/j.1365-3156.2003.00968.x; Menendez C, 1997, LANCET, V350, P844, DOI 10.1016/S0140-6736(97)04229-3; Mockenhaupt FP, 2007, ANTIMICROB AGENTS CH, V51, P3273, DOI 10.1128/AAC.00513-07; Muller DA, 2001, ACTA TROP, V78, P155, DOI 10.1016/S0001-706X(01)00067-5; Nassir E, 2005, INT J PARASITOL, V35, P49, DOI 10.1016/j.ijpara.2004.10.014; Ofosu-Okyere A, 2001, PARASITOLOGY, V123, P113, DOI 10.1017/S0031182001008162; OTOO LN, 1988, T ROY SOC TROP MED H, V82, P59, DOI 10.1016/0035-9203(88)90263-5; Roper C, 1998, PARASITOLOGY, V116, P501, DOI 10.1017/S0031182098002650; Schreiber N, 2007, TROP MED INT HEALTH, V12, P1157, DOI 10.1111/j.1365-3156.2007.01902.x; *WHO, 2009, WHO REP TECHN CONS I; WHO, WHO WORLD MAL REP	30	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2010	5	10							e13649	10.1371/journal.pone.0013649	http://dx.doi.org/10.1371/journal.pone.0013649			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671UN	21048970	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000283537000021
J	Roy, S; Tyagi, A; Shukla, V; Kumar, A; Singh, UM; Chaudhary, LB; Datt, B; Bag, SK; Singh, PK; Nair, NK; Husain, T; Tuli, R				Roy, Sribash; Tyagi, Antariksh; Shukla, Virendra; Kumar, Anil; Singh, Uma M.; Chaudhary, Lal Babu; Datt, Bhaskar; Bag, Sumit K.; Singh, Pradhyumna K.; Nair, Narayanan K.; Husain, Tariq; Tuli, Rakesh			Universal Plant DNA Barcode Loci May Not Work in Complex Groups: A Case Study with Indian Berberis Species	PLOS ONE			English	Article							LAND PLANTS; PHYLOGENETIC-RELATIONSHIPS; DIVERSITY; SEQUENCES; TAXONOMY; GENUS; AFLP; POPULATIONS; RBCL	Background: The concept of DNA barcoding for species identification has gained considerable momentum in animals because of fairly successful species identification using cytochrome oxidase I (COI). In plants, matK and rbcL have been proposed as standard barcodes. However, barcoding in complex genera is a challenging task. Methodology and Principal Findings: We investigated the species discriminatory power of four reportedly most promising plant DNA barcoding loci (one from nuclear genome-ITS, and three from plastid genome- trnH-psbA, rbcL and matK) in species of Indian Berberis L. (Berberidaceae) and two other genera, Ficus L. (Moraceae) and Gossypium L. (Malvaceae). Berberis species were delineated using morphological characters. These characters resulted in a well resolved species tree. Applying both nucleotide distance and nucleotide character-based approaches, we found that none of the loci, either singly or in combinations, could discriminate the species of Berberis. ITS resolved all the tested species of Ficus and Gossypium and trnH-psbA resolved 82% of the tested species in Ficus. The highly regarded matK and rbcL could not resolve all the species. Finally, we employed amplified fragment length polymorphism test in species of Berberis to determine their relationships. Using ten primer pair combinations in AFLP, the data demonstrated incomplete species resolution. Further, AFLP analysis showed that there was a tendency of the Berberis accessions to cluster according to their geographic origin rather than species affiliation. Conclusions/Significance: We reconfirm the earlier reports that the concept of universal barcode in plants may not work in a number of genera. Our results also suggest that the matK and rbcL, recommended as universal barcode loci for plants, may not work in all the genera of land plants. Morphological, geographical and molecular data analyses of Indian species of Berberis suggest probable reticulate evolution and thus barcode markers may not work in this case.	[Roy, Sribash; Tyagi, Antariksh; Shukla, Virendra; Kumar, Anil; Singh, Uma M.; Bag, Sumit K.; Singh, Pradhyumna K.; Tuli, Rakesh] CSIR, Natl Bot Res Inst, Dept Plant Mol Biol & Genet Engn, Lucknow, Uttar Pradesh, India; [Chaudhary, Lal Babu; Datt, Bhaskar; Nair, Narayanan K.; Husain, Tariq] CSIR, Natl Bot Res Inst, Dept Plant Biodivers & Conservat Biol, Lucknow, Uttar Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Botanical Research Institute (NBRI); Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Botanical Research Institute (NBRI)	Roy, S (corresponding author), CSIR, Natl Bot Res Inst, Dept Plant Mol Biol & Genet Engn, Lucknow, Uttar Pradesh, India.	rakeshtuli@hotmail.com	TULI, RAKESH/AAD-3047-2021; Bag, Sumit K/B-4010-2013; Bag, Sumit/AAP-5728-2020; Tyagi, Antariksh/F-4367-2015	Bag, Sumit K/0000-0001-8907-2841; Bag, Sumit/0000-0001-8907-2841; Tyagi, Antariksh/0000-0002-4662-077X	Department of Biotechnology, Government of India	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	Funding from Department of Biotechnology, Government of India is acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdalla AM, 2001, THEOR APPL GENET, V102, P222, DOI 10.1007/s001220051639; AHRENDT LESLIE WALTER ALLAM, 1961, JOUR LINNEAN SOC LONDON BOT, V57, P1; Alvarez I, 2003, MOL PHYLOGENET EVOL, V29, P417, DOI 10.1016/S1055-7903(03)00208-2; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0905845106, 10.1073/pnas.0812297106]; Blaxter M, 2003, NATURE, V421, P122, DOI 10.1038/421122a; Bottini MCJ, 2007, BOT J LINN SOC, V153, P321, DOI 10.1111/j.1095-8339.2007.00586.x; BOTTINI MCJ, 1999, 16 INT BOT C ST LOUI; Cervera MT, 2005, THEOR APPL GENET, V111, P1440, DOI 10.1007/s00122-005-0076-2; Chase MW, 2007, TAXON, V56, P295, DOI 10.1002/tax.562004; Chase MW, 2005, PHILOS T R SOC B, V360, P1889, DOI 10.1098/rstb.2005.1720; Chen SL, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008613, 10.1371/journal.pone.0015633]; CORNER E. J. H., 1958, REINWARDTIA, V4, P325; CORNER E. J. H., 1965, GARD BULL [SINGAPORE], V21, P1; DeSaille R, 2007, BIOESSAYS, V29, P1289, DOI 10.1002/bies.20667; Dodd RS, 2003, THEOR APPL GENET, V107, P884, DOI 10.1007/s00122-003-1290-4; Edwards D, 2008, TAXON, V57, P1317, DOI 10.1002/tax.574021; ERSTS PJ, GEOGRAPHIC DISTANCE; Fazekas AJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002802; Feliner GN, 2007, MOL PHYLOGENET EVOL, V44, P911, DOI 10.1016/j.ympev.2007.01.013; GAO T, 2010, J ETHNOPHARMACOL; HARLAN J R, 1971, Taxon, V20, P509, DOI 10.2307/1218252; HAWKES JG, 1990, POTATO EVOLUTION BIO; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; HOOKER F, 1888, FLORA BRIT INDIA, P494; Jobes DV, 1997, PLANT MOL BIOL REP, V15, P326, DOI 10.1023/A:1007462330699; Kelly RP, 2007, MOL ECOL NOTES, V7, P177, DOI 10.1111/j.1471-8286.2006.01641.x; Kim YD, 2004, J PLANT RES, V117, P175, DOI 10.1007/s10265-004-0145-7; KING G, 1888, ANN ROYAL BOT GARDEN, P1; Kress WJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000508; Kress WJ, 2005, P NATL ACAD SCI USA, V102, P8369, DOI 10.1073/pnas.0503123102; Lahaye R, 2008, P NATL ACAD SCI USA, V105, P2923, DOI 10.1073/pnas.0709936105; Landrum LR, 1999, ANN MO BOT GARD, V86, P793, DOI 10.2307/2666170; LUBELL JD, 2008, J HORT SCI BIOTECHNO, V83; Lubell JD, 2008, AM J BOT, V95, P700, DOI 10.3732/ajb.2007336; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Miura F, 2005, BIOINFORMATICS, V21, P4363, DOI 10.1093/bioinformatics/bti716; Newmaster SG, 2006, CAN J BOT, V84, P335, DOI 10.1139/B06-047; Onodera K, 2004, MOL CELL PROBE, V18, P369, DOI 10.1016/j.mcp.2004.05.007; ORSI MC, 1984, BERBERIDACEAE, P325; Pennisi E, 2007, SCIENCE, V318, P190, DOI 10.1126/science.318.5848.190; PURI GS, 1946, J INDIAN BOT SOC, V25, P177; Rach J, 2008, P ROY SOC B-BIOL SCI, V275, P237, DOI 10.1098/rspb.2007.1290; RAO RR, 1998, RHEEDEA, V3, P109; Rohlfs Marko, 2005, Front Zool, V2, P2, DOI 10.1186/1742-9994-2-2; Ronsted N, 2008, MOL PHYLOGENET EVOL, V48, P12, DOI 10.1016/j.ympev.2008.04.005; Rubinoff D, 2006, TRENDS ECOL EVOL, V21, P1, DOI 10.1016/j.tree.2005.10.019; Schmidt-Lebuhn AN, 2007, BOT J LINN SOC, V153, P9, DOI 10.1111/j.1095-8339.2007.00588.x; Schmidt-Lebuhn AN, 2006, SYST BOT, V31, P547, DOI 10.1600/036364406778388629; SCHNEIDER CK, 1905, B HERB BOISSIER 2, V5, P33; Seberg O, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004598; Shaw J, 2007, AM J BOT, V94, P275, DOI 10.3732/ajb.94.3.275; Singer GAC, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S6-S14; SINGH PB, 1986, INJURY, V17, P228, DOI 10.1016/0020-1383(86)90225-1; Smith MA, 2005, PHILOS T R SOC B, V360, P1825, DOI 10.1098/rstb.2005.1714; SPOONER DM, 2006, STRUCTURE BIOSYSTEMA, P1; SPOONER DM, 2009, MOL ECOL RESOUR, V9, P1177; Starr JR, 2009, MOL ECOL RESOUR, V9, P151, DOI 10.1111/j.1755-0998.2009.02640.x; STOREY WB, 1975, FIGS ADV FRUIT BREED, P568; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; Taberlet P, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl938; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tautz D, 2002, NATURE, V418, P479, DOI 10.1038/418479a; Vences M, 2005, PHILOS T R SOC B, V360, P1859, DOI 10.1098/rstb.2005.1717; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Waugh J, 2007, BIOESSAYS, V29, P188, DOI 10.1002/bies.20529; Weiblen GD, 2000, AM J BOT, V87, P1342, DOI 10.2307/2656726; WENDEL JF, 1989, P NATL ACAD SCI USA, V86, P4132, DOI 10.1073/pnas.86.11.4132; WENDEL JF, 1995, P NATL ACAD SCI USA, V92, P280, DOI 10.1073/pnas.92.1.280; Wong EHK, 2009, MOL ECOL RESOUR, V9, P243, DOI 10.1111/j.1755-0998.2009.02653.x	69	124	143	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2010	5	10							e13674	10.1371/journal.pone.0013674	http://dx.doi.org/10.1371/journal.pone.0013674			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671UN	21060687	Green Published, Green Submitted, gold			2022-12-27	WOS:000283537000041
J	Zhang, J; Zhang, Y				Zhang, Jian; Zhang, Yang			A Novel Side-Chain Orientation Dependent Potential Derived from Random-Walk Reference State for Protein Fold Selection and Structure Prediction	PLOS ONE			English	Article							FORCE-FIELD; STATISTICAL POTENTIALS; TERTIARY STRUCTURES; MOLECULAR-DYNAMICS; SCORING FUNCTION; MEAN FORCE; MODEL; REFINEMENT	Background: An accurate potential function is essential to attack protein folding and structure prediction problems. The key to developing efficient knowledge-based potential functions is to design reference states that can appropriately counteract generic interactions. The reference states of many knowledge-based distance-dependent atomic potential functions were derived from non-interacting particles such as ideal gas, however, which ignored the inherent sequence connectivity and entropic elasticity of proteins. Methodology: We developed a new pair-wise distance-dependent, atomic statistical potential function (RW), using an ideal random-walk chain as reference state, which was optimized on CASP models and then benchmarked on nine structural decoy sets. Second, we incorporated a new side-chain orientation-dependent energy term into RW (RWplus) and found that the side-chain packing orientation specificity can further improve the decoy recognition ability of the statistical potential. Significance: RW and RWplus demonstrate a significantly better ability than the best performing pair-wise distance-dependent atomic potential functions in both native and near-native model selections. It has higher energy-RMSD and energy TM-score correlations compared with other potentials of the same type in real-life structure assembly decoys. When benchmarked with a comprehensive list of publicly available potentials, RW and RWplus shows comparable performance to the state-of-the-art scoring functions, including those combining terms from multiple resources. These data demonstrate the usefulness of random-walk chain as reference states which correctly account for sequence connectivity and entropic elasticity of proteins. It shows potential usefulness in structure recognition and protein folding simulations. The RW and RWplus potentials, as well as the newly generated I-TASSER decoys, are freely available in http://zhanglab.ccmb.med.umich.edu/RW.	[Zhang, Jian; Zhang, Yang] Univ Michigan, Ctr Computat Med & Bioinformat, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Zhang, J (corresponding author), Univ Michigan, Ctr Computat Med & Bioinformat, Ann Arbor, MI 48109 USA.	zhng@umich.edu	YZ, YZ/B-3243-2011; zhang, jian/B-9296-2011		Alfred P. Sloan Foundation; National Science Foundation [DBI 1027394]; National Institute of General Medical Sciences [GM083107, GM084222]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083107, R01GM084222] Funding Source: NIH RePORTER	Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); National Science Foundation(National Science Foundation (NSF)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The project is supported in part by the Alfred P. Sloan Foundation, National Science Foundation Career Award (DBI 1027394), and the National Institute of General Medical Sciences (GM083107, GM084222). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aloy P, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-71; ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; Benkert P, 2009, NUCLEIC ACIDS RES, V37, pW510, DOI 10.1093/nar/gkp322; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bronshtein IN, 2003, HDB MATH; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Chen JH, 2007, PROTEINS, V67, P922, DOI 10.1002/prot.21345; Cheng J, 2007, BIOPHYS J, V92, P3868, DOI 10.1529/biophysj.106.102152; Das R, 2007, PROTEINS, V69, P118, DOI 10.1002/prot.21636; Doi M., 1986, THEORY POLYM DYNAMIC; Fitzgerald JE, 2007, PROTEIN SCI, V16, P2123, DOI 10.1110/ps.072939707; FOGOLARI F, 2007, BMC STRUCTURAL BIOL, V7; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; John B, 2003, NUCLEIC ACIDS RES, V31, P3982, DOI 10.1093/nar/gkg460; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; Kellermayer MSZ, 1997, SCIENCE, V276, P1112, DOI 10.1126/science.276.5315.1112; Kolinski A, 1999, PROTEINS, V37, P592, DOI 10.1002/(SICI)1097-0134(19991201)37:4<592::AID-PROT10>3.3.CO;2-U; Lee MR, 2001, J MOL BIOL, V313, P417, DOI 10.1006/jmbi.2001.5032; Li YQ, 2009, PROTEINS, V76, P665, DOI 10.1002/prot.22380; Lu H, 2001, PROTEINS, V44, P223, DOI 10.1002/prot.1087; Lu MY, 2008, J MOL BIOL, V376, P288, DOI 10.1016/j.jmb.2007.11.033; Ma JP, 2009, ACCOUNTS CHEM RES, V42, P1087, DOI 10.1021/ar900009e; Makino Y, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-46; Moult J, 2007, PROTEINS, V69, P3, DOI 10.1002/prot.21767; Moult J, 2009, PROTEINS, V77, P1, DOI 10.1002/prot.22589; Mukherjee A, 2005, J CHEM PHYS, V123, DOI 10.1063/1.1940058; Panchenko AR, 2000, J MOL BIOL, V296, P1319, DOI 10.1006/jmbi.2000.3541; Park B, 1996, J MOL BIOL, V258, P367, DOI 10.1006/jmbi.1996.0256; Qian B, 2007, NATURE, V450, P259, DOI 10.1038/nature06249; Rajgaria R, 2006, PROTEINS, V65, P726, DOI 10.1002/prot.21149; Rief M, 1997, SCIENCE, V276, P1109, DOI 10.1126/science.276.5315.1109; Rief M, 1998, PHYS REV LETT, V81, P4764, DOI 10.1103/PhysRevLett.81.4764; Rykunov D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-128; Samudrala R, 2000, PROTEIN SCI, V9, P1399, DOI 10.1110/ps.9.7.1399; Samudrala R, 1998, J MOL BIOL, V275, P895, DOI 10.1006/jmbi.1997.1479; Schuler LD, 2001, J COMPUT CHEM, V22, P1205, DOI 10.1002/jcc.1078; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Simons KT, 1997, J MOL BIOL, V268, P209, DOI 10.1006/jmbi.1997.0959; SIPPL MJ, 1990, J MOL BIOL, V213, P859, DOI 10.1016/S0022-2836(05)80269-4; Skolnick J, 2006, CURR OPIN STRUC BIOL, V16, P166, DOI 10.1016/j.sbi.2006.02.004; Skolnick J, 2000, PROTEINS, V38, P3, DOI 10.1002/(SICI)1097-0134(20000101)38:1<3::AID-PROT2>3.0.CO;2-S; Tobi D, 2000, PROTEINS, V40, P71, DOI 10.1002/(SICI)1097-0134(20000701)40:1<71::AID-PROT90>3.0.CO;2-3; Tobi D, 2000, PROTEINS, V41, P40, DOI 10.1002/1097-0134(20001001)41:1<40::AID-PROT70>3.0.CO;2-U; WANG G, 2002, BIOPOLYMERS UNPUB; Wu ST, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-17; Xia Y, 2000, J MOL BIOL, V300, P171, DOI 10.1006/jmbi.2000.3835; XU JR, 2010, BIOINFORMAT IN PRESS; XU JR, 2010, BIOINFORMATICS; Yang CY, 2006, J MED CHEM, V49, P5903, DOI 10.1021/jm050043w; Yang YD, 2008, PROTEIN SCI, V17, P1212, DOI 10.1110/ps.033480.107; Zhang C, 1997, J MOL BIOL, V267, P707, DOI 10.1006/jmbi.1996.0859; Zhang Y, 2004, P NATL ACAD SCI USA, V101, P7594, DOI 10.1073/pnas.0305695101; Zhang Y, 2004, J COMPUT CHEM, V25, P865, DOI 10.1002/jcc.20011; Zhang Y, 2003, BIOPHYS J, V85, P1145, DOI 10.1016/S0006-3495(03)74551-2; Zhang Y, 2004, PROTEINS, V57, P702, DOI 10.1002/prot.20264; Zhang Y, 2001, BIOPHYS J, V81, P1133, DOI 10.1016/S0006-3495(01)75770-0; Zhang Y, 2009, PROTEINS, V77, P100, DOI 10.1002/prot.22588; Zhang Y, 2009, CURR OPIN STRUC BIOL, V19, P145, DOI 10.1016/j.sbi.2009.02.005; Zhou HY, 2002, PROTEIN SCI, V11, P2714, DOI 10.1110/ps.0217002	61	155	157	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2010	5	10							e15386	10.1371/journal.pone.0015386	http://dx.doi.org/10.1371/journal.pone.0015386			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671UN	21060880	gold, Green Published, Green Submitted			2022-12-27	WOS:000283537000063
J	Gloor, GB; Hummelen, R; Macklaim, JM; Dickson, RJ; Fernandes, AD; MacPhee, R; Reid, G				Gloor, Gregory B.; Hummelen, Ruben; Macklaim, Jean M.; Dickson, Russell J.; Fernandes, Andrew D.; MacPhee, Roderick; Reid, Gregor			Microbiome Profiling by Illumina Sequencing of Combinatorial Sequence-Tagged PCR Products	PLOS ONE			English	Article							NONPARAMETRIC-ESTIMATION; NEW-GENERATION; DIVERSITY; TOOLS; SOFTWARE; DESIGN; NUMBER; BLAST	We developed a low-cost, high-throughput microbiome profiling method that uses combinatorial sequence tags attached to PCR primers that amplify the rRNA V6 region. Amplified PCR products are sequenced using an Illumina paired-end protocol to generate millions of overlapping reads. Combinatorial sequence tagging can be used to examine hundreds of samples with far fewer primers than is required when sequence tags are incorporated at only a single end. The number of reads generated permitted saturating or near-saturating analysis of samples of the vaginal microbiome. The large number of reads allowed an in-depth analysis of errors, and we found that PCR-induced errors composed the vast majority of non-organism derived species variants, an observation that has significant implications for sequence clustering of similar high-throughput data. We show that the short reads are sufficient to assign organisms to the genus or species level in most cases. We suggest that this method will be useful for the deep sequencing of any short nucleotide region that is taxonomically informative; these include the V3, V5 regions of the bacterial 16S rRNA genes and the eukaryotic V9 region that is gaining popularity for sampling protist diversity.	[Gloor, Gregory B.; Macklaim, Jean M.; Dickson, Russell J.; Fernandes, Andrew D.; Reid, Gregor] Univ Western Ontario, Dept Biochem, London, ON, Canada; [Hummelen, Ruben; Macklaim, Jean M.; MacPhee, Roderick; Reid, Gregor] Lawson Hlth Res Inst, Canadian Res & Dev Ctr Probiot, London, ON, Canada; [Hummelen, Ruben] Univ Med Ctr Rotterdam, Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands; [Fernandes, Andrew D.] Univ Western Ontario, Dept Appl Math, London, ON N6A 5B9, Canada; [MacPhee, Roderick; Reid, Gregor] Univ Western Ontario, Dept Microbiol & Immunol, London, ON, Canada; [Reid, Gregor] Univ Western Ontario, Dept Surg, London, ON N6A 3K7, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Erasmus University Rotterdam; Erasmus MC; Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario)	Gloor, GB (corresponding author), Univ Western Ontario, Dept Biochem, London, ON, Canada.	ggloor@uwo.ca	Reid, Gregor/ABE-8327-2020; Hummelen, Ruben/ABG-5746-2021; Gloor, Greg B/D-1671-2013	Reid, Gregor/0000-0001-9658-5696; Gloor, Gregory/0000-0001-5803-3380	NSERC [CRDPJ379477-08]	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	Partial funding by NSERC grand CRDPJ379477-08 (http://www.nserc-crsng.gc.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1996, METHOD ENZYMOL, V266, P460; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Amaral-Zettler LA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006372; Andersson AF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002836; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; CAPORASO JG, 2010, P NATL ACAD SCI US; CHAO A, 1984, SCAND J STAT, V11, P265; CHAO A, 1992, J AM STAT ASSOC, V87, P210, DOI 10.2307/2290471; Cock PJA, 2010, NUCLEIC ACIDS RES, V38, P1767, DOI 10.1093/nar/gkp1137; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Colwell RK, 2009, ESTIMATES STAT ESTIM; EFRON B, 1981, BIOMETRIKA, V68, P589, DOI 10.1093/biomet/68.3.589; ENGELS WR, 1993, TRENDS BIOCHEM SCI, V18, P448, DOI 10.1016/0968-0004(93)90148-G; Frank DN, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-362; Hamady M, 2009, GENOME RES, V19, P1141, DOI 10.1101/gr.085464.108; Hummelen R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012078; HURLBERT SH, 1971, ECOLOGY, V52, P577, DOI 10.2307/1934145; Huse SM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000255; Lahr DJG, 2009, BIOTECHNIQUES, V47, P857, DOI 10.2144/000113219; Lauber CL, 2009, APPL ENVIRON MICROB, V75, P5111, DOI 10.1128/AEM.00335-09; LAURIKARI V, 2010, TRE FREE PORTABLE AP; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nocker A, 2007, MICROB ECOL, V54, P276, DOI 10.1007/s00248-006-9199-5; Oksanen J., 2017, COMMUNITY ECOLOGY PA; Pawlowski J, 2010, J EUKARYOT MICROBIOL, V57, P197, DOI 10.1111/j.1550-7408.2009.00468.x; Petrosino JF, 2009, CLIN CHEM, V55, P856, DOI 10.1373/clinchem.2008.107565; Polymenakou PN, 2009, SYST APPL MICROBIOL, V32, P17, DOI 10.1016/j.syapm.2008.09.006; Quince C, 2009, NAT METHODS, V6, P639, DOI [10.1038/NMETH.1361, 10.1038/nmeth.1361]; RAVEL J, 2010, P NATL ACAD SCI USA, DOI DOI 10.1073/PNAS.100611107; Reeder J, 2009, NAT METHODS, V6, P636, DOI 10.1038/nmeth0909-636; Rodrigue S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011840; Schellenberg J, 2009, APPL ENVIRON MICROB, V75, P2889, DOI 10.1128/AEM.01640-08; Shi Y, 2009, J OBSTET GYNAECOL RE, V35, P525, DOI 10.1111/j.1447-0756.2008.00971.x; Smith DR, 2008, GENOME RES, V18, P1638, DOI 10.1101/gr.077776.108; SMITH EP, 1984, BIOMETRICS, V40, P119, DOI 10.2307/2530750; SRINIVASAN S, 2008, HUMAN VAGINAL BACTER; Wang YF, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0005368, 10.1371/journal.pone.0007401]; Whiteford N, 2009, BIOINFORMATICS, V25, P2194, DOI 10.1093/bioinformatics/btp383	40	208	239	2	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2010	5	10							e15406	10.1371/journal.pone.0015406	http://dx.doi.org/10.1371/journal.pone.0015406			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671GB	21048977	Green Submitted, Green Published, gold			2022-12-27	WOS:000283487400034
J	Zughaier, SM; Svoboda, P; Pohl, J; Stephens, DS; Shafer, WM				Zughaier, Susu M.; Svoboda, Pavel; Pohl, Jan; Stephens, David S.; Shafer, William M.			The Human Host Defense Peptide LL-37 Interacts with Neisseria meningitidis Capsular Polysaccharides and Inhibits Inflammatory Mediators Release	PLOS ONE			English	Article							PLASMACYTOID DENDRITIC CELLS; ANTIMICROBIAL PEPTIDE; LIPOOLIGOSACCHARIDE STRUCTURE; ACTIN BUNDLES; INNATE; SUSCEPTIBILITY; RECOGNITION; GONORRHOEAE; CONTRIBUTE; RESISTANCE	Capsular polysaccharides (CPS) are a major virulence factor in meningococcal infections and form the basis for serogroup designation and protective vaccines. Our work has identified meningococcal CPS as a pro-inflammatory ligand that functions through TLR2 and TLR4-MD2-dependent activation. We hypothesized that human cationic host defense peptides interact with CPS and influence its biologic activity. Accordingly, the interaction of meningococcal CPS with the human-derived cationic peptide LL-37, which is expressed by phagocytic and epithelial cells that interface with meningococci during infection, was investigated. LL-37 neutralized the pro-inflammatory activity of endotoxin-free CPS as assessed by TLR2 and TLR4-MD-2-dependent release of TNF alpha, IL-6 and IL-8 from human and murine macrophages. The cationic and hydrophobic properties of LL-37 were crucial for this inhibition, which was due to binding of LL-37 to CPS. LL-37 also inhibited the ability of meningococcal CPS to induce nitric oxide release, as well as TNF alpha and CXCL10 (IP-10) release from TLR4-sufficient and TLR4-deficient murine macrophages. Truncated LL-37 analogs, especially those that retained the antibacterial domain, inhibited vaccine grade CPS and meningococcal CPS prepared from the major serogroups (A, B C, Y and W135). Thus, LL-37 interaction with CPS was independent of specific glucan structure. We conclude that the capacity of meningococcal CPS to activate macrophages via TLR2 and TLR4-MD-2 can be inhibited by the human cationic host defense peptide LL-37 and propose that this impacts CPS-based vaccine responses.	[Zughaier, Susu M.; Stephens, David S.] Emory Univ, Sch Med, Dept Med, Div Infect Dis, Atlanta, GA 30322 USA; [Zughaier, Susu M.; Svoboda, Pavel; Pohl, Jan; Stephens, David S.; Shafer, William M.] Labs Microbial Pathogenesis, Atlanta, GA USA; [Svoboda, Pavel; Pohl, Jan] Emory Univ, Sch Med, Microchem & Prote Facil, Atlanta, GA USA; [Stephens, David S.; Shafer, William M.] Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA; [Stephens, David S.; Shafer, William M.] Dept Vet Affairs Med Ctr, Atlanta, GA USA	Emory University; Emory University; Emory University	Zughaier, SM (corresponding author), Emory Univ, Sch Med, Dept Med, Div Infect Dis, Atlanta, GA 30322 USA.	szughai@emory.edu	Zughaier, Susu/GLQ-9288-2022; Stephens, David S/A-8788-2012; Zughaier, Susu/N-3185-2019	Zughaier, Susu/0000-0001-7487-8770	Georgia Research Alliance (GRA); National Institutes of Health (NIH) [R01 AI033517, R01 AI062755, S10RR022440]; VA Medical Research Services; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR022440] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI062755, R01AI033517] Funding Source: NIH RePORTER	Georgia Research Alliance (GRA); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VA Medical Research Services; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a grant to Susu M. Zughaier from the Georgia Research Alliance (GRA), and National Institutes of Health (NIH) grants R01 AI033517 to David S. Stephens, R01 AI062755 to William M. Shafer, and S10RR022440 to Jan Pohl. William M. Shafer is the recipient of a Senior Research Career Scientist Award from the VA Medical Research Services. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Bucki R, 2007, EUR RESPIR J, V29, P624, DOI 10.1183/09031936.00080806; Castellheim A, 2009, SCAND J IMMUNOL, V69, P479, DOI 10.1111/j.1365-3083.2009.02255.x; Chennupati SK, 2009, AM J RHINOL ALLERGY, V23, P46, DOI 10.2500/ajra.2009.23.3261; Choudhury B, 2008, CARBOHYD RES, V343, P2971, DOI 10.1016/j.carres.2008.08.026; Cox DL, 2003, PEPTIDES, V24, P1741, DOI 10.1016/j.peptides.2003.07.026; Foschiatti M, 2009, MOL MICROBIOL, V72, P1137, DOI 10.1111/j.1365-2958.2009.06707.x; Ganguly D, 2009, J EXP MED, V206, P1983, DOI 10.1084/jem.20090480; Graveline R, 2007, INT IMMUNOL, V19, P375, DOI 10.1093/intimm/dxm003; Gudlavalleti SK, 2004, J BIOL CHEM, V279, P42765, DOI 10.1074/jbc.M313552200; HAILMAN E, 1994, J EXP MED, V179, P269, DOI 10.1084/jem.179.1.269; Hurtado P, 2010, J IMMUNOL, V184, P1425, DOI 10.4049/jimmunol.0902305; Jones A, 2009, J BACTERIOL, V191, P3861, DOI 10.1128/JB.01313-08; Kahler CM, 1998, INFECT IMMUN, V66, P5939, DOI 10.1128/IAI.66.12.5939-5947.1998; Kai-Larsen Y, 2007, PEDIATR RES, V61, P530, DOI 10.1203/pdr.0b013e318045be83; Kawai T, 2009, INT IMMUNOL, V21, P317, DOI 10.1093/intimm/dxp017; Lande R, 2007, NATURE, V449, P564, DOI 10.1038/nature06116; MELLY MA, 1979, J INFECT DIS, V140, P605, DOI 10.1093/infdis/140.4.605; Moal VLL, 2006, CLIN MICROBIOL REV, V19, P315, DOI 10.1128/CMR.19.2.315-337.2006; Nijnik A, 2009, CURR OPIN HEMATOL, V16, P41, DOI 10.1097/MOH.0b013e32831ac517; Rehaume LM, 2008, CRIT REV IMMUNOL, V28, P185, DOI 10.1615/CritRevImmunol.v28.i3.10; Salzman NH, 2007, SEMIN IMMUNOL, V19, P70, DOI 10.1016/j.smim.2007.04.002; Sandgren S, 2004, J BIOL CHEM, V279, P17951, DOI 10.1074/jbc.M311440200; Shafer WM, 1998, P NATL ACAD SCI USA, V95, P1829, DOI 10.1073/pnas.95.4.1829; Spinosa MR, 2007, INFECT IMMUN, V75, P3594, DOI 10.1128/IAI.01945-06; Stephens DS, 2007, LANCET, V369, P2196, DOI 10.1016/S0140-6736(07)61016-2; Swartley JS, 1997, P NATL ACAD SCI USA, V94, P271, DOI 10.1073/pnas.94.1.271; Tzeng YL, 2005, J BACTERIOL, V187, P5387, DOI 10.1128/JB.187.15.5387-5396.2005; Tzeng YL, 2005, INFECT IMMUN, V73, P1491, DOI 10.1128/IAI.73.3.1491-1505.2005; Wang Q, 2006, J EXP MED, V203, P2853, DOI 10.1084/jem.20062008; Weiner DJ, 2003, AM J RESP CELL MOL, V28, P738, DOI 10.1165/rcmb.2002-0191OC; Zughaier SM, 2005, CELL MICROBIOL, V7, P1251, DOI 10.1111/j.1462-5822.2005.00549.x; Zughaier SM, 2005, INFECT IMMUN, V73, P2940, DOI 10.1128/IAI.73.5.2940-2950.2005; Zughaier SM, 2004, INFECT IMMUN, V72, P371, DOI 10.1128/IAI.72.1.371-380.2004	34	25	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2010	5	10							e13627	10.1371/journal.pone.0013627	http://dx.doi.org/10.1371/journal.pone.0013627			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671GB	21049021	Green Published, Green Submitted, gold			2022-12-27	WOS:000283487400018
J	Lin, DD; Liu, CL; Xue, MX; Liu, RY; Jiang, L; Yu, XA; Bao, GM; Deng, F; Yu, MJ; Ao, JF; Zhou, YF; Wu, DP; Liu, HY				Lin, Dandan; Liu, Chunliang; Xue, Mengxing; Liu, Rengyun; Jiang, Lan; Yu, Xiao; Bao, Guangming; Deng, Fang; Yu, Mingjie; Ao, Jiafu; Zhou, Yifeng; Wu, Depei; Liu, Haiyan			The Role of Interleukin-15 Polymorphisms in Adult Acute Lymphoblastic Leukemia	PLOS ONE			English	Article							LYMPHOID HOMEOSTASIS; RECEPTOR; IL-15; EXPRESSION; BIOLOGY; CELLS; STRATEGIES; CHILDREN; THERAPY; DISEASE	Background: Interleukin-15 (IL-15) plays important roles in the immune system and in the development of hematopoietic cells. Previous studies revealed that five SNPs in IL-15, rs10519612, rs10519613, rs35964658, rs17007695 and rs17015014, were significantly associated with childhood Acute Lymphoblastic Leukemia (ALL) treatment response. In adult ALL, the expression of IL-15 was also correlated with the immunophenotypes of ALL. Therefore, we hypothesize that SNPs of IL-15 might also be associated with adult ALL. Methods and Findings: We genotyped the above five SNPs of IL-15 gene by PCR-RFLP assays in adult ALL case-control studies. The current study included 121 adult ALL patients and 263 healthy controls. IL-15 genotypes and haplotypes were determined and the associations with the risk of ALL were analyzed by logistic regression. SNPs rs10519612 and rs17007695 were significantly associated with ALL (P = 0.013 and P = 0.001). We observed a 2-fold and 2.4-fold excess risk of developing ALL for the rs10519612 CC and rs17007695 TC genotype carriers compared with non-carriers, respectively. Haplotype analysis revealed that haplotypes ACAC, CAGT and CCAT were significantly associated with adult B-ALL, while haplotype CCAT conferred susceptibility to T-ALL. Conclusion: These findings suggest that IL-15 gene polymorphisms are significantly associated with ALL in adult Chinese population.	[Lin, Dandan; Xue, Mengxing; Jiang, Lan; Yu, Xiao; Bao, Guangming; Zhou, Yifeng; Wu, Depei; Liu, Haiyan] Soochow Univ, Affiliated Hosp 1, Jiangsu Inst Hematol, Cyrus Tang Hematol Ctr,Dept Hematol,Lab Cellular, Suzhou, Peoples R China; [Lin, Dandan; Xue, Mengxing; Wu, Depei; Liu, Haiyan] Soochow Univ, Minist Hlth, Thrombosis & Hemostasis Key Lab, Suzhou, Peoples R China; [Liu, Chunliang] Soochow Univ, Coll Med, Dept Biochem & Mol Biol, Suzhou, Peoples R China; [Liu, Rengyun] Soochow Univ, Coll Med, Lab Canc Mol Genet, Suzhou, Jiangsu, Peoples R China; [Deng, Fang; Yu, Mingjie; Ao, Jiafu] Peoples Hosp Bozhou, Bozhou, Peoples R China	Soochow University - China; Soochow University - China; Soochow University - China; Soochow University - China	Lin, DD (corresponding author), Soochow Univ, Affiliated Hosp 1, Jiangsu Inst Hematol, Cyrus Tang Hematol Ctr,Dept Hematol,Lab Cellular, Suzhou, Peoples R China.	wudepei@medmail.com.cn; hliu@suda.edu.cn	Lin, Dandan/GRJ-2233-2022; Liu, Haiyan/ABD-8689-2021; Liu, Reng-Yun/C-4437-2011; Liu, Rengyun/O-4039-2018	Liu, Haiyan/0000-0002-4652-469X; Liu, Rengyun/0000-0002-1408-2372	Key Laboratory of Suzhou City; Soochow University	Key Laboratory of Suzhou City; Soochow University	This work has been supported by funds from the Key Laboratory of Suzhou City, startup funds and the Key Project in Science & Technology Cultivation Program from Soochow University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARMITAGE RJ, 1995, J IMMUNOL, V154, P483; Bassan R, 2004, CRIT REV ONCOL HEMAT, V50, P223, DOI 10.1016/j.critrevonc.2003.11.003; BAZAN JF, 1990, IMMUNOL TODAY, V11, P350, DOI 10.1016/0167-5699(90)90139-Z; Berman E, 2000, CURR OPIN HEMATOL, V7, P205, DOI 10.1097/00062752-200007000-00002; Blaser BW, 2005, BLOOD, V105, P894, DOI 10.1182/blood-2004-05-1687; Budagian V, 2006, CYTOKINE GROWTH F R, V17, P259, DOI 10.1016/j.cytogfr.2006.05.001; Bulfone-Paus S, 2006, BIOESSAYS, V28, P362, DOI 10.1002/bies.20380; Cario G, 2007, J CLIN ONCOL, V25, P4813, DOI 10.1200/JCO.2007.11.8166; CARSON WE, 1994, J EXP MED, V180, P1395, DOI 10.1084/jem.180.4.1395; Faderl S, 2010, CANCER-AM CANCER SOC, V116, P1165, DOI 10.1002/cncr.24862; Fehniger TA, 2001, BLOOD, V97, P14, DOI 10.1182/blood.V97.1.14; Giron-Michel J, 2005, BLOOD, V106, P2302, DOI 10.1182/blood-2005-01-0064; Goldberg JM, 2003, J CLIN ONCOL, V21, P3616, DOI 10.1200/JCO.2003.10.116; GOLDSTONE AH, 2009, TRANSPLANTATION ADUL, P593; GRABSTEIN KH, 1994, SCIENCE, V264, P965, DOI 10.1126/science.8178155; HOELZER D, 1992, LEUKEMIA, V6, P49; Hoelzer D, 2000, CRIT REV ONCOL HEMAT, V36, P49, DOI 10.1016/S1040-8428(00)00097-4; Irving JAE, 2005, CANCER RES, V65, P3053, DOI 10.1158/0008-5472.CAN-04-2604; Klebanoff CA, 2004, P NATL ACAD SCI USA, V101, P1969, DOI 10.1073/pnas.0307298101; KLUMPER E, 1995, BLOOD, V86, P3861, DOI 10.1182/blood.V86.10.3861.bloodjournal86103861; Li ZQ, 2009, CELL RES, V19, P519, DOI 10.1038/cr.2009.33; Lodolce JP, 2002, CYTOKINE GROWTH F R, V13, P429, DOI 10.1016/S1359-6101(02)00029-1; Ma A, 2006, ANNU REV IMMUNOL, V24, P657, DOI 10.1146/annurev.immunol.24.021605.090727; Maloney KW, 1999, BLOOD, V93, P2380, DOI 10.1182/blood.V93.7.2380.407k27_2380_2385; Mullighan CG, 2008, SCIENCE, V322, P1377, DOI 10.1126/science.1164266; Pui CH, 2006, NEW ENGL J MED, V354, P166, DOI 10.1056/NEJMra052603; Pui CH, 2008, LANCET, V371, P1030, DOI 10.1016/S0140-6736(08)60457-2; Pui CH, 2007, NAT REV DRUG DISCOV, V6, P149, DOI 10.1038/nrd2240; RAIMONDI SC, 1993, BLOOD, V82, P576; Shi YY, 2005, CELL RES, V15, P97, DOI 10.1038/sj.cr.7290272; Tinhofer I, 2000, BLOOD, V95, P610, DOI 10.1182/blood.V95.2.610; Trentin L, 1996, BLOOD, V87, P3327, DOI 10.1182/blood.V87.8.3327.bloodjournal8783327; VanBuskirk AM, 1997, JAMA-J AM MED ASSOC, V278, P1993, DOI 10.1001/jama.278.22.1993; Waldmann TA, 2006, NAT REV IMMUNOL, V6, P595, DOI 10.1038/nri1901; Wu SL, 2010, CANCER, V116, P387, DOI 10.1002/cncr.24729; Yajima T, 2006, J IMMUNOL, V176, P507, DOI 10.4049/jimmunol.176.1.507; Yang JJ, 2009, JAMA-J AM MED ASSOC, V301, P393, DOI 10.1001/jama.2009.7; Zhang XJ, 2007, J INVEST DERMATOL, V127, P2544, DOI 10.1038/sj.jid.5700896	38	14	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2010	5	10							e13626	10.1371/journal.pone.0013626	http://dx.doi.org/10.1371/journal.pone.0013626			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	670LB	21049047	gold, Green Submitted, Green Published			2022-12-27	WOS:000283422100022
J	Klucken, T; Brouwer, AM; Chatziastros, A; Kagerer, S; Netter, P; Hennig, J				Klucken, Tim; Brouwer, Anne-Marie; Chatziastros, Astros; Kagerer, Sabine; Netter, Petra; Hennig, Juergen			The Impact of Coping Style on Gaze Duration	PLOS ONE			English	Article							ATTENTIONAL BIAS; TRAIT-ANXIETY; EMOTIONAL FACES; TIME-COURSE; THREAT; INFORMATION; REPRESSORS; VIGILANCE; RESPONSES; AVOIDANCE	The understanding of individual differences in response to threat (e.g., attentional bias) is important to better understand the development of anxiety disorders. Previous studies revealed only a small attentional bias in high-anxious (HA) subjects. One explanation for this finding may be the assumption that all HA-subjects show a constant attentional bias. Current models distinguish HA-subjects depending on their level of tolerance for uncertainty and for arousal. These models assume that only HA-subjects with intolerance for uncertainty but tolerance for arousal ("sensitizers") show an attentional bias, compared to HA-subjects with intolerance for uncertainty and intolerance for arousal ("fluctuating subjects"). Further, it is assumed that repressors (defined as intolerance for arousal but tolerance for uncertainty) would react with avoidance behavior when confronted with threatening stimuli. The present study investigated the influence of coping styles on attentional bias. After an extensive recruiting phase, 36 subjects were classified into three groups (sensitizers, fluctuating, and repressors). All subjects were exposed to presentations of happy and threatening faces, while recording gaze durations with an eye-tracker. The results showed that only sensitizer showed an attentional bias: they gazed longer at the threatening face rather than at the happy face during the first 500 ms. The results support the findings of the relationship between anxiety and attention and extend these by showing variations according to coping styles. The differentiation of subjects according to a multifaceted coping style allows a better prediction of the attentional bias and contributes to an insight into the complex interplay of personality, coping, and behavior.	[Klucken, Tim; Kagerer, Sabine] Univ Giessen, Bender Inst Neuroimaging, Giessen, Germany; [Brouwer, Anne-Marie] TNO Human Factors, Soesterberg, Netherlands; [Netter, Petra; Hennig, Juergen] Univ Giessen, Dept Psychol, Giessen, Germany; [Chatziastros, Astros] Max Planck Inst Biol Cybernet, Tubingen, Germany	Justus Liebig University Giessen; Netherlands Organization Applied Science Research; Justus Liebig University Giessen; Max Planck Society	Klucken, T (corresponding author), Univ Giessen, Bender Inst Neuroimaging, Giessen, Germany.	Tim.Klucken@psychol.uni-giessen.de	Klucken, Tim/F-7669-2013	Klucken, Tim/0000-0003-2433-6652; Brouwer, Anne-Marie/0000-0003-1961-4291; Lauwereyns, Jan/0000-0003-0551-2550	University of Giessen; TNO Human factors	University of Giessen; TNO Human factors	This work was supported by the postdoc stipend "Junior Science and Teaching Units" from the University of Giessen to the first author. The second author is supported by TNO Human factors. All funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bar-Haim Y, 2007, PSYCHOL BULL, V133, P1, DOI 10.1037/0033-2909.133.1.1; Bar-Haim Y, 2010, J CHILD PSYCHOL PSYC, V51, P859, DOI 10.1111/j.1469-7610.2010.02251.x; Bradley BP, 2000, COGNITION EMOTION, V14, P789, DOI 10.1080/02699930050156636; Browning M, 2010, COGN AFFECT BEHAV NE, V10, P8, DOI 10.3758/CABN.10.1.8; Calvo MG, 2005, COGNITION EMOTION, V19, P433, DOI 10.1080/02699930441000157; Davidson RJ, 2002, ANNU REV PSYCHOL, V53, P545, DOI 10.1146/annurev.psych.53.100901.135148; Davidson RJ, 2003, PSYCHOPHYSIOLOGY, V40, pS3; DERAKSHAN N, 2000, EUROPEAN PSYCHOL, V2, P235; Derakshan N, 2007, COGNITION EMOTION, V21, P1585, DOI 10.1080/02699930701499857; Eippert F, 2007, HUM BRAIN MAPP, V28, P409, DOI 10.1002/hbm.20291; FOX E, 1994, COGNITION EMOTION, V8, P165, DOI 10.1080/02699939408408934; FOX E, 1993, BEHAV RES THER, V31, P487, DOI 10.1016/0005-7967(93)90129-I; Hock M, 2004, EMOTION, V4, P65, DOI 10.1037/1528-3542.4.1.65; Ioannou MC, 2004, PERS INDIV DIFFER, V36, P1879, DOI 10.1016/j.paid.2003.08.018; Johnson DC, 2008, PERS INDIV DIFFER, V44, P552, DOI 10.1016/j.paid.2007.09.009; KLEINER M, 2004, 123 MAX PLANCK I BIO; Kohlmann CW, 1997, PERSONLICHKEIT EMOTI; Koster EHW, 2006, BEHAV RES THER, V44, P1757, DOI 10.1016/j.brat.2005.12.011; Krohne H. W. E., 1993, ATTENTION AVOIDANCE; Krohne HW, 2000, COGNITIVE THER RES, V24, P297, DOI 10.1023/A:1005511320194; Kross E, 2009, BIOL PSYCHIAT, V65, P361, DOI 10.1016/j.biopsych.2008.10.019; Lee LO, 2009, PSYCHOL AGING, V24, P741, DOI 10.1037/a0016409; Mogg K, 2005, PSYCHOPHARMACOLOGY, V180, P333, DOI 10.1007/s00213-005-2158-x; Mogg K, 2000, PERS INDIV DIFFER, V28, P1063, DOI 10.1016/S0191-8869(99)00157-9; Mogg K, 2007, BIOL PSYCHOL, V76, P163, DOI 10.1016/j.biopsycho.2007.07.005; Moriguchi Y, 2009, HUM BRAIN MAPP, V30, P2063, DOI 10.1002/hbm.20653; Patrick CJ, 2002, PSYCHOL ASSESSMENT, V14, P150, DOI 10.1037//1040-3590.14.2.150; Perlman SB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005952; Phaf RH, 2007, J BEHAV THER EXP PSY, V38, P184, DOI 10.1016/j.jbtep.2006.10.008; Proyer RT, 2007, STUD PSYCHOL, V49, P145; Rauch AV, 2007, CEREB CORTEX, V17, P2526, DOI 10.1093/cercor/bhl158; Rohrmann S, 2003, ANXIETY STRESS COPIN, V16, P321, DOI 10.1080/1061580031000095461; ROHRMANN S, 1998, MANIPULATION STRESSR; Rohrmann S, 2009, ANXIETY STRESS COPIN, V22, P215, DOI 10.1080/10615800802016591; Roy AK, 2008, J AM ACAD CHILD PSY, V47, P1189, DOI 10.1097/CHI.0b013e3181825ace; Sass SM, 2010, PSYCHOPHYSIOLOGY, V47, P247, DOI 10.1111/j.1469-8986.2009.00926.x; Schweckendiek J, 2011, NEUROIMAGE, V54, P681, DOI 10.1016/j.neuroimage.2010.07.049; Tellegen A., 1982, BRIEF MANUAL MULTIDI; Tellegen A., 2008, SAGE HDB PERSONALITY, P261, DOI [10.4135/9781849200479.n13, DOI 10.4135/9781849200479.N13]; Van Damme S, 2004, NEUROPHYSIOL CLIN, V34, P33, DOI 10.1016/j.neucli.2003.11.001; Waters AM, 2008, J AM ACAD CHILD PSY, V47, P435, DOI 10.1097/CHI.0b013e3181642992	41	4	4	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2010	5	11							e15395	10.1371/journal.pone.0015395	http://dx.doi.org/10.1371/journal.pone.0015395			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	680KW	21085590	gold, Green Published, Green Submitted			2022-12-27	WOS:000284231800030
J	Scherag, A; Jarick, I; Grothe, J; Biebermann, H; Scherag, S; Volckmar, AL; Vogel, CIG; Greene, B; Hebebrand, J; Hinney, A				Scherag, Andre; Jarick, Ivonne; Grothe, Jessica; Biebermann, Heike; Scherag, Susann; Volckmar, Anna-Lena; Vogel, Carla Ivane Ganz; Greene, Brandon; Hebebrand, Johannes; Hinney, Anke			Investigation of a Genome Wide Association Signal for Obesity: Synthetic Association and Haplotype Analyses at the Melanocortin 4 Receptor Gene Locus	PLOS ONE			English	Article							PROOPIOMELANOCORTIN-DERIVED AGONISTS; DISEASE-ASSOCIATED VARIANTS; FUNCTIONAL-CHARACTERIZATION; PHARMACOLOGICAL CHARACTERIZATION; SYSTEMATIC ANALYSIS; RARE VARIANTS; BODY-MASS; MUTATIONS; POLYMORPHISMS; MC4R	Background: Independent genome-wide association studies (GWAS) showed an obesogenic effect of two single nucleotide polymorphisms (SNP; rs12970134 and rs17782313) more than 150 kb downstream of the melanocortin 4 receptor gene (MC4R). It is unclear if the SNPs directly influence MC4R function or expression, or if the SNPs are on a haplotype that predisposes to obesity or includes functionally relevant genetic variation (synthetic association). As both exist, functionally relevant mutations and polymorphisms in the MC4R coding region and a robust association downstream of the gene, MC4R is an ideal model to explore synthetic association. Methodology/Principal Findings: We analyzed a genomic region (364.9 kb) encompassing the MC4R in GWAS data of 424 obesity trios (extremely obese child/adolescent and both parents). SNP rs12970134 showed the lowest p-value (p = 0.004; relative risk for the obesity effect allele: 1.37); conditional analyses on this SNP revealed that 7 of 78 analyzed SNPs provided independent signals (p <= 0.05). These 8 SNPs were used to derive two-marker haplotypes. The three best (according to p-value) haplotype combinations were chosen for confirmation in 363 independent obesity trios. The confirmed obesity effect haplotype includes SNPs 39 and 59 of the MC4R. Including MC4R coding variants in a joint model had almost no impact on the effect size estimators expected under synthetic association. Conclusions/Significance: A haplotype reaching from a region 59 of the MC4R to a region at least 150 kb from the 39 end of the gene showed a stronger association to obesity than single SNPs. Synthetic association analyses revealed that MC4R coding variants had almost no impact on the association signal. Carriers of the haplotype should be enriched for relevant mutations outside the MC4R coding region and could thus be used for re-sequencing approaches. Our data also underscore the problems underlying the identification of relevant mutations depicted by GWAS derived SNPs.	[Scherag, Andre] Univ Duisburg Essen, Inst Med Informat Biometry & Epidemiol, Essen, Germany; [Jarick, Ivonne; Greene, Brandon] Univ Marburg, Inst Med Biometry & Epidemiol, Marburg, Germany; [Grothe, Jessica; Biebermann, Heike] Charite, Inst Expt Paediat Endocrinol, D-13353 Berlin, Germany; [Scherag, Susann; Volckmar, Anna-Lena; Vogel, Carla Ivane Ganz; Hebebrand, Johannes; Hinney, Anke] Univ Duisburg Essen, Dept Child & Adolescent Psychiat & Psychotherapy, Essen, Germany	University of Duisburg Essen; Philipps University Marburg; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Duisburg Essen	Scherag, A (corresponding author), Univ Duisburg Essen, Inst Med Informat Biometry & Epidemiol, Essen, Germany.	UUanke.hinney@uni-due.deUU	Scherag, Andre/B-3805-2014; Hinney, Anke/D-6953-2011	Hinney, Anke/0000-0001-5659-0706; Scherag, Andre/0000-0002-9406-4704; Vogel, Carla/0000-0003-1715-2556; Biebermann, Heike/0000-0002-2024-7778	Bundesministerium fuer Bildung und Forschung [01GS0903, 01KU0903, NGFNplus 01GS0820, 01GS0830, 01GS0825]; Deutsche Forschungsgemeinschaft [HE 1446/4-1]; European Union [LSHMCT-2003-503041]	Bundesministerium fuer Bildung und Forschung; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Union(European Commission)	This work was supported by grants from the Bundesministerium fuer Bildung und Forschung (01GS0903; 01KU0903; NGFNplus 01GS0820, 01GS0830, 01GS0825), the Deutsche Forschungsgemeinschaft (HE 1446/4-1) and the European Union (FP6 LSHMCT-2003-503041). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chambers JC, 2008, NAT GENET, V40, P716, DOI 10.1038/ng.156; Chen JM, 2006, HUM GENET, V120, P1, DOI 10.1007/s00439-006-0180-7; Chen JM, 2006, HUM GENET, V120, P301, DOI 10.1007/s00439-006-0218-x; Cirulli ET, 2010, NAT REV GENET, V11, P415, DOI 10.1038/nrg2779; Dempfle A, 2004, J MED GENET, V41, P795, DOI 10.1136/jmg.2004.018614; Dickson SP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000294; Fan ZC, 2009, J CELL MOL MED, V13, P3268, DOI 10.1111/j.1582-4934.2009.00726.x; Farooqi IS, 2003, NEW ENGL J MED, V348, P1085, DOI 10.1056/NEJMoa022050; FENG T, 2010, HUM GENET       0613; Geller F, 2004, AM J HUM GENET, V74, P572, DOI 10.1086/382490; Hebebrand J, 1994, AKTUELLE ERNAHRUNGSM, V19, P259; Heid IM, 2005, J MED GENET, V42, DOI 10.1136/jmg.2004.027011; Herold C, 2009, BIOINFORMATICS, V25, P134, DOI 10.1093/bioinformatics/btn581; Hinney A, 2006, J CLIN ENDOCR METAB, V91, P1761, DOI 10.1210/jc.2005-2056; Hinney A, 2003, J CLIN ENDOCR METAB, V88, P4258, DOI 10.1210/jc.2003-030233; Hinney A, 1999, J CLIN ENDOCR METAB, V84, P1483, DOI 10.1210/jc.84.4.1483; Hinney A, 2010, EUR CHILD ADOLES PSY, V19, P297, DOI 10.1007/s00787-010-0096-6; Hinney A, 2009, OBESITY FACTS, V2, P3, DOI 10.1159/000200020; Kleinjan DA, 2005, AM J HUM GENET, V76, P8, DOI 10.1086/426833; Larsen LH, 2005, J CLIN ENDOCR METAB, V90, P219, DOI 10.1210/jc.2004-0497; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; Loos RJF, 2008, NAT GENET, V40, P768, DOI 10.1038/ng.140; Meyre D, 2009, NAT GENET, V41, P157, DOI 10.1038/ng.301; Nijenhuis WAJ, 2003, J BIOL CHEM, V278, P22939, DOI 10.1074/jbc.M211326200; SPELIOTES EK, 2010, NAT GE IN PRESS 1010; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Stutzmann F, 2007, HUM MOL GENET, V16, P1837, DOI 10.1093/hmg/ddm132; Tao YX, 2003, ENDOCRINOLOGY, V144, P4544, DOI 10.1210/en.2003-0524; Thorleifsson G, 2009, NAT GENET, V41, P18, DOI 10.1038/ng.274; Vaisse C, 2000, J CLIN INVEST, V106, P253, DOI 10.1172/JCI9238; Wang D, 2010, OBESITY, V18, P573, DOI 10.1038/oby.2009.268; Wang K, 2010, AM J HUM GENET, V86, P730, DOI 10.1016/j.ajhg.2010.04.003; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287; Xiang ZM, 2006, BIOCHEMISTRY-US, V45, P7277, DOI 10.1021/bi0600300; Xiang ZM, 2010, BIOCHEMISTRY-US, V49, P4583, DOI 10.1021/bi100068u; Ye S, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.17.e88; Yeo GSH, 2003, HUM MOL GENET, V12, P561, DOI 10.1093/hmg/ddg057; Young EH, 2007, INT J OBESITY, V31, P1437, DOI 10.1038/sj.ijo.0803609	38	41	41	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2010	5	11							e13967	10.1371/journal.pone.0013967	http://dx.doi.org/10.1371/journal.pone.0013967			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	680KW	21085626	Green Published, Green Submitted, gold			2022-12-27	WOS:000284231800006
J	Wittig, RM; Boesch, C				Wittig, Roman M.; Boesch, Christophe			Receiving Post-Conflict Affiliation from the Enemy's Friend Reconciles Former Opponents	PLOS ONE			English	Article							CHIMPANZEES PAN-TROGLODYTES; POSTCONFLICT 3RD-PARTY AFFILIATION; LONG-TAILED MACAQUES; WILD FEMALE BABOONS; SOCIAL BONDS; CAPTIVE CHIMPANZEES; COPING MECHANISMS; NATIONAL-PARK; CONSOLATION; PRIMATES	The adaptive function of bystander initiated post-conflict affiliation (also: consolation & appeasement) has been debated for 30 years. Three influential hypotheses compete for the most likely explanation but have not previously been tested with a single data set. The consolation hypothesis argues that bystander affiliation calms the victim and reduces their stress levels. The self-protection hypothesis proposes that a bystander offers affiliation to either opponent to protect himself from redirected aggression by this individual. The relationship-repair hypothesis suggests a bystander can substitute for a friend to reconcile the friend with the friend's former opponent. Here, we contrast all three hypotheses and tested their predictions with data on wild chimpanzees (Pan troglodytes verus) of the Tai National Park, Cote d'Ivoire. We examined the first and second post-conflict interactions with respect to both the dyadic and triadic relationships between the bystander and the two opponents. Results showed that female bystanders offered affiliation to their aggressor friends and the victims of their friends, while male bystanders offered affiliation to their victim friends and the aggressors of their friends. For both sexes, bystander affiliation resulted in a subsequent interaction pattern that is expected for direct reconciliation. Bystander affiliation offered to the opponent's friend was more likely to lead to affiliation among opponents in their subsequent interaction. Also, tolerance levels among former opponents were reset to normal levels. In conclusion, this study provides strong evidence for the relationship-repair hypothesis, moderate evidence for the consolation hypothesis and no evidence for the self-protection hypothesis. Furthermore, that bystanders can repair a relationship on behalf of their friend indicates that recipient chimpanzees are aware of the relationships between others, even when they are not kin. This presents a mechanism through which chimpanzees may gain benefits from social knowledge.	[Wittig, Roman M.; Boesch, Christophe] Max Planck Inst Evolutionary Anthropol, Leipzig, Germany; [Wittig, Roman M.] Univ St Andrews, Sch Psychol, St Andrews, Fife, Scotland	Max Planck Society; University of St Andrews	Wittig, RM (corresponding author), Max Planck Inst Evolutionary Anthropol, Leipzig, Germany.	rmw12@st-andrews.ac.uk			Max Planck Society; Swiss National Foundation; German Research Foundation; Leverhulme Trust	Max Planck Society(Max Planck Society); Swiss National Foundation(Swiss National Science Foundation (SNSF)); German Research Foundation(German Research Foundation (DFG)); Leverhulme Trust(Leverhulme Trust)	This study was financed by the Max Planck Society (http://www.mpg.de), the Swiss National Foundation (http://www.snf.ch), the German Research Foundation (http://www.dfg.de) and the Leverhulme Trust (www.leverhulme.org.uk). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1984, BEHAV ECOLOGY; Aureli F, 2002, BEHAVIOUR, V139, P393, DOI 10.1163/156853902760102726; AURELI F, 1991, ETHOLOGY, V89, P89; BOESCH C, 1991, Behaviour, V117, P220, DOI 10.1163/156853991X00544; Boesch C, 2000, CHIMPANZEES TAI FORE; Boesch C, 2008, AM J PRIMATOL, V70, P519, DOI 10.1002/ajp.20524; Call J, 2002, ANIM BEHAV, V63, P209, DOI 10.1006/anbe.2001.1908; Cameron EZ, 2009, P NATL ACAD SCI USA, V106, P13850, DOI 10.1073/pnas.0900639106; Cheney DL, 2004, INT J PRIMATOL, V25, P401, DOI 10.1023/B:IJOP.0000019159.75573.13; Cheney DL, 2009, ADV STUD BEHAV, V39, P1, DOI 10.1016/S0065-3454(09)39001-4; Cools AKA, 2008, ETHOLOGY, V114, P53, DOI 10.1111/j.1439-0310.2007.01443.x; CORDS M, 1992, ANIM BEHAV, V44, P57, DOI 10.1016/S0003-3472(05)80754-7; Crockford C, 2008, HORM BEHAV, V53, P254, DOI 10.1016/j.yhbeh.2007.10.007; de Waal FBM, 2000, SCIENCE, V289, P586, DOI 10.1126/science.289.5479.586; De Waal Frans B. M., 1996, P80; DEWAAL FBM, 1981, BEHAVIOUR, V77, P164, DOI 10.1163/156853981X00211; DEWAAL FBM, 1979, BEHAV ECOL SOCIOBIOL, V5, P55, DOI 10.1007/BF00302695; DiCiccio TJ, 1996, STAT SCI, V11, P189; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; Fraser ON, 2009, COMMUN INTEGR BIOL, V2, P1; Fraser ON, 2008, P NATL ACAD SCI USA, V105, P8557, DOI 10.1073/pnas.0804141105; Fraser ON, 2010, INT J PRIMATOL, V31, P39, DOI 10.1007/s10764-009-9377-7; Goodall J., 1986, CHIMPANZEES GOMBE PA; Hawkes K, 2004, NATURE, V428, P128, DOI 10.1038/428128a; Hill K, 2001, J HUM EVOL, V40, P437, DOI 10.1006/jhev.2001.0469; JUDGE PG, 1991, AM J PRIMATOL, V23, P225, DOI 10.1002/ajp.1350230403; Koski SE, 2007, ANIM BEHAV, V73, P133, DOI 10.1016/j.anbehav.2006.04.009; Koski SE, 2009, AM J PRIMATOL, V71, P409, DOI 10.1002/ajp.20668; Krause J, 2002, LIVING GROUPS; Kutsukake N, 2004, PRIMATES, V45, P157, DOI 10.1007/s10329-004-0082-z; Lewis S, 2007, BIOL LETTERS, V3, P386, DOI 10.1098/rsbl.2007.0258; Mitani JC, 2010, CURR BIOL, V20, pR507, DOI 10.1016/j.cub.2010.04.021; Nishida Toshisada, 1996, P114, DOI 10.1017/CBO9780511752414.011; Palagi E, 2004, AM J PRIMATOL, V62, P15, DOI 10.1002/ajp.20000; Preuschoft S, 2002, INT J PRIMATOL, V23, P29, DOI 10.1023/A:1013293623158; Romero T, 2010, P NATL ACAD SCI USA, V107, P12110, DOI 10.1073/pnas.1006991107; Seed AM, 2007, CURR BIOL, V17, P152, DOI 10.1016/j.cub.2006.11.025; Silk JB, 2003, SCIENCE, V302, P1231, DOI 10.1126/science.1088580; Silk JB, 2010, CURR BIOL, V20, P1359, DOI 10.1016/j.cub.2010.05.067; Silk JB, 2009, P ROY SOC B-BIOL SCI, V276, P3099, DOI 10.1098/rspb.2009.0681; WATTS DP, 1995, ETHOLOGY, V100, P158; Weidt A, 2008, ANIM BEHAV, V75, P801, DOI 10.1016/j.anbehav.2007.06.017; Wittig RM, 2005, ETHOLOGY, V111, P736, DOI 10.1111/j.1439-0310.2005.01093.x; Wittig RM, 2003, BEHAVIOUR, V140, P1527, DOI 10.1163/156853903771980701; Wittig RM, 2003, BEHAV ECOL SOCIOBIOL, V54, P491, DOI 10.1007/s00265-003-0654-8; Wittig RM, 2003, INT J PRIMATOL, V24, P847, DOI 10.1023/A:1024632923180; Wittig RM, 2008, HORM BEHAV, V54, P170, DOI 10.1016/j.yhbeh.2008.02.009; Wittig RM, 2007, P R SOC B, V274, P1109, DOI 10.1098/rspb.2006.0203; Wittig Roman M., 2010, P208	49	36	36	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2010	5	11							e13995	10.1371/journal.pone.0013995	http://dx.doi.org/10.1371/journal.pone.0013995			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	680KW	21085592	gold, Green Published, Green Submitted			2022-12-27	WOS:000284231800024
J	Prell, J; Bourdes, A; Kumar, S; Lodwig, E; Hosie, A; Kinghorn, S; White, J; Poole, P				Prell, Jurgen; Bourdes, Alexandre; Kumar, Shalini; Lodwig, Emma; Hosie, Arthur; Kinghorn, Seonag; White, James; Poole, Philip			Role of Symbiotic Auxotrophy in the Rhizobium-Legume Symbioses	PLOS ONE			English	Article							LEGUMINOSARUM BV VICIAE; GRAM-NEGATIVE BACTERIA; ROOT-NODULES; SINORHIZOBIUM-MELILOTI; NITROGEN-FIXATION; TRANSPORT MUTANTS; GENE-EXPRESSION; DIFFERENTIATION; IDENTIFICATION; SPECIFICITY	Background: Rhizobium leguminosarum bv. viciae mutants unable to transport branched-chain amino acids via the two main amino acid ABC transport complexes AapJQMP and BraDEFGC produce a nitrogen starvation phenotype when inoculated on pea (Pisum sativum) plants [1,2]. Bacteroids in indeterminate pea nodules have reduced abundance and a lower chromosome number. They reduce transcription of pathways for branched-chain amino acid biosynthesis and become dependent on their provision by the host. This has been called "symbiotic auxotrophy''. Methodology/Principal Findings: A region important in solute specificity was identified in AapQ and changing P144D in this region reduced branched-chain amino acid transport to a very low rate. Strains carrying P144D were still fully effective for N(2) fixation on peas demonstrating that a low rate of branched amino acid transport in R. leguminosarum bv. viciae supports wild-type rates of nitrogen fixation. The importance of branched-chain amino acid transport was then examined in other legume-Rhizobium symbioses. An aap bra mutant of R. leguminosarum bv. phaseoli also showed nitrogen starvation symptoms when inoculated on French bean (Phaseolus vulgaris), a plant producing determinate nodules. The phenotype is different from that observed on pea and is accompanied by reduced nodule numbers and nitrogen fixation per nodule. However, an aap bra double mutant of Sinorhizobium meliloti 2011 showed no phenotype on alfalfa (Medicago sativa). Conclusions/Significance: Symbiotic auxotrophy occurs in both determinate pea and indeterminate bean nodules demonstrating its importance for bacteroid formation and nodule function in legumes with different developmental programmes. However, only small quantities of branched chain amino acids are needed and symbiotic auxotrophy did not occur in the Sinorhizobium meliloti-alfalfa symbiosis under the conditions measured. The contrasting symbiotic phenotypes of aap bra mutants inoculated on different legumes probably reflects altered timing of amino acid availability, development of symbiotic auxotrophy and nodule developmental programmes.	[Prell, Jurgen; Bourdes, Alexandre; Poole, Philip] John Innes Ctr Plant Sci Res, Norwich NR4 7UH, Norfolk, England; [Kumar, Shalini; Lodwig, Emma; Hosie, Arthur; Kinghorn, Seonag; White, James] Univ Reading, Sch Biol Sci, Reading, Berks, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; University of Reading	Prell, J (corresponding author), John Innes Ctr Plant Sci Res, Norwich Res Pk, Norwich NR4 7UH, Norfolk, England.	philip.poole@bbsrc.ac.uk	Hosie, Arthur/J-9615-2012	Hosie, Arthur/0000-0002-1327-7901; Lodwig, Emma/0000-0001-6941-7996	Biotechnology and Biological Sciences Research Council UK [BB/F013159/1]; BBSRC [BB/F013159/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F013159/1, BB/C517025/1, BB/C517025/2, BBS/B/02916] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biotechnology and Biological Sciences Research Council UK (http://www.bbsrc.ac.uk/) with grant no BB/F013159/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akashi H, 2002, P NATL ACAD SCI USA, V99, P3695, DOI 10.1073/pnas.062526999; Allaway D, 2000, MOL MICROBIOL, V36, P508, DOI 10.1046/j.1365-2958.2000.01884.x; Barnett MJ, 2004, P NATL ACAD SCI USA, V101, P16636, DOI 10.1073/pnas.0407269101; Becker A, 2004, MOL PLANT MICROBE IN, V17, P292, DOI 10.1094/MPMI.2004.17.3.292; BERINGER JE, 1974, J GEN MICROBIOL, V84, P188; Capela D, 2006, MOL PLANT MICROBE IN, V19, P363, DOI 10.1094/MPMI-19-0363; DOWNIE JA, 1983, MOL GEN GENET, V190, P359, DOI 10.1007/BF00331059; FELLAY R, 1987, GENE, V52, P147, DOI 10.1016/0378-1119(87)90041-2; FINAN TM, 1983, J BACTERIOL, V154, P1403, DOI 10.1128/JB.154.3.1403-1413.1983; FREIDMAN AM, 1982, GENE, V18, P289; Gage DJ, 2004, MICROBIOL MOL BIOL R, V68, P280, DOI 10.1128/MMBR.68.2.280-300.2004; HIRSCH PR, 1984, PLASMID, V12, P139, DOI 10.1016/0147-619X(84)90059-3; Hosie AHF, 2002, J BACTERIOL, V184, P4071, DOI 10.1128/JB.184.15.4071-4080.2002; Hosie AHF, 2001, MOL MICROBIOL, V40, P1449, DOI 10.1046/j.1365-2958.2001.02497.x; JOHNSTON AWB, 1975, J GEN MICROBIOL, V87, P343, DOI 10.1099/00221287-87-2-343; Karunakaran R, 2009, J BACTERIOL, V191, P4002, DOI 10.1128/JB.00165-09; LAMB JW, 1982, MOL GEN GENET, V186, P449, DOI 10.1007/BF00729468; Lodwig E, 2003, CRIT REV PLANT SCI, V22, P37, DOI 10.1080/713610850; Lodwig EM, 2003, NATURE, V422, P722, DOI 10.1038/nature01527; Lodwig EM, 2005, MOL PLANT MICROBE IN, V18, P67, DOI 10.1094/MPMI-18-0067; Mergaert P, 2006, P NATL ACAD SCI USA, V103, P5230, DOI 10.1073/pnas.0600912103; NEWTON WE, 2000, NITROGEN FIXATION MO, P3; Oldroyd GED, 2008, ANNU REV PLANT BIOL, V59, P519, DOI 10.1146/annurev.arplant.59.032607.092839; Oono R, 2010, NEW PHYTOL, V187, P508, DOI 10.1111/j.1469-8137.2010.03261.x; Pessi G, 2007, MOL PLANT MICROBE IN, V20, P1353, DOI 10.1094/MPMI-20-11-1353; Pobigaylo N, 2006, APPL ENVIRON MICROB, V72, P4329, DOI 10.1128/AEM.03072-05; POOLE PS, 1994, MICROBIOL-SGM, V140, P2787, DOI 10.1099/00221287-140-10-2787; Prell J, 2006, TRENDS MICROBIOL, V14, P161, DOI 10.1016/j.tim.2006.02.005; Prell J, 2009, P NATL ACAD SCI USA, V106, P12477, DOI 10.1073/pnas.0903653106; Prell J, 2002, MICROBIOL-SGM, V148, P615, DOI 10.1099/00221287-148-2-615; QUANDT HJ, 1993, MOL PLANT MICROBE IN, V6, P699, DOI 10.1094/MPMI-6-699; QUANDT J, 1993, GENE, V127, P15, DOI 10.1016/0378-1119(93)90611-6; RONSON CW, 1981, P NATL ACAD SCI-BIOL, V78, P4284, DOI 10.1073/pnas.78.7.4284; TRINICK MJ, 1976, NEW PHYTOL, V77, P359, DOI 10.1111/j.1469-8137.1976.tb01525.x; Van de Velde W, 2010, SCIENCE, V327, P1122, DOI 10.1126/science.1184057; Walshaw DL, 1997, FEBS LETT, V414, P397, DOI 10.1016/S0014-5793(97)01023-5; White J, 2007, PLANT PHYSIOL, V144, P604, DOI 10.1104/pp.107.097741	37	42	43	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2010	5	11							e13933	10.1371/journal.pone.0013933	http://dx.doi.org/10.1371/journal.pone.0013933			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	678OA	21085630	Green Published, Green Submitted, gold			2022-12-27	WOS:000284087800007
J	de Carvalho, ECA; Jayanti, MK; Batilana, AP; Kozan, AMO; Rodrigues, MJ; Shah, J; Loures, MR; Patil, S; Payne, P; Pietrobon, R				de Carvalho, Elias Cesar Araujo; Jayanti, Madhav Kishore; Batilana, Adelia Portero; Kozan, Andreia M. O.; Rodrigues, Maria J.; Shah, Jatin; Loures, Marco R.; Patil, Sunita; Payne, Philip; Pietrobon, Ricardo			Standardizing Clinical Trials Workflow Representation in UML for International Site Comparison	PLOS ONE			English	Article							CARE	Background: With the globalization of clinical trials, a growing emphasis has been placed on the standardization of the workflow in order to ensure the reproducibility and reliability of the overall trial. Despite the importance of workflow evaluation, to our knowledge no previous studies have attempted to adapt existing modeling languages to standardize the representation of clinical trials. Unified Modeling Language (UML) is a computational language that can be used to model operational workflow, and a UML profile can be developed to standardize UML models within a given domain. This paper's objective is to develop a UML profile to extend the UML Activity Diagram schema into the clinical trials domain, defining a standard representation for clinical trial workflow diagrams in UML. Methods: Two Brazilian clinical trial sites in rheumatology and oncology were examined to model their workflow and collect time-motion data. UML modeling was conducted in Eclipse, and a UML profile was developed to incorporate information used in discrete event simulation software. Results: Ethnographic observation revealed bottlenecks in workflow: these included tasks requiring full commitment of CRCs, transferring notes from paper to computers, deviations from standard operating procedures, and conflicts between different IT systems. Time-motion analysis revealed that nurses' activities took up the most time in the workflow and contained a high frequency of shorter duration activities. Administrative assistants performed more activities near the beginning and end of the workflow. Overall, clinical trial tasks had a greater frequency than clinic routines or other general activities. Conclusions: This paper describes a method for modeling clinical trial workflow in UML and standardizing these workflow diagrams through a UML profile. In the increasingly global environment of clinical trials, the standardization of workflow modeling is a necessary precursor to conducting a comparative analysis of international clinical trials workflows.	[de Carvalho, Elias Cesar Araujo; Batilana, Adelia Portero; Kozan, Andreia M. O.; Rodrigues, Maria J.; Shah, Jatin] Duke Univ, Dept Surg, Res Res Grp, Durham, NC 27706 USA; [Jayanti, Madhav Kishore] Ohio State Univ, Coll Med, Biomed Informat Program, Columbus, OH 43210 USA; [Shah, Jatin; Pietrobon, Ricardo] Duke NUS Grad Med Sch, Singapore, Singapore; [Loures, Marco R.] Univ Estadual Maringa, Dept Med, Maringa, Parana, Brazil; [Payne, Philip] Ohio State Univ, Dept Biomed Informat, Columbus, OH 43210 USA; [Payne, Philip] Ohio State Univ, Ctr Clin & Translat Sci, Biomed Informat Program, Columbus, OH 43210 USA; [Pietrobon, Ricardo] Duke Univ Hlth Syst, Dept Surg, Durham, NC USA; [Patil, Sunita] Kalpavriksha Healthcare & Res, Thana, India	Duke University; University System of Ohio; Ohio State University; National University of Singapore; Universidade Estadual de Maringa; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Duke University	de Carvalho, ECA (corresponding author), Duke Univ, Dept Surg, Res Res Grp, Durham, NC 27706 USA.	rpietro@duke.edu; rpietro@duke.edu	Shah, Jatin/B-6039-2011; Carvalho, Elias/J-7086-2012	Shah, Jatin/0000-0002-2457-491X; Carvalho, Elias/0000-0002-2638-7202; Payne, Philip/0000-0002-9532-2998				DUMAS M, 2001, P UML 2001 C; Fontoura M, 2002, UML PROFILE FRAMEWOR; Fowler M., 2004, UML DISTILLED, VThird; Glickman SW, 2009, NEW ENGL J MED, V360, P2793; Hunt KL, 1997, PROCEEDINGS OF THE 1997 WINTER SIMULATION CONFERENCE, P1275, DOI 10.1145/268437.268771; Johnson KB, 2006, J AM MED INFORM ASSN, V13, P391, DOI 10.1197/jamia.M2008; KHAN SA, 2006, P AMIA; Khan SA, 2007, STUD HEALTH TECHNOL, V129, P247; Knape T, 2003, Stud Health Technol Inform, V95, P635; Liaw Siaw-Teng, 2006, Health Informatics J, V12, P199, DOI 10.1177/1460458206066772; Lo HG, 2007, J AM MED INFORM ASSN, V14, P609, DOI 10.1197/jamia.M2318; Lopez DM, 2008, STUD HEALTH TECHNOL, V136, P735; Meyers Fred E., 2002, MOTION TIME STUDY LE; O'Neill P, 1999, TECHNOVATION, V19, P571, DOI 10.1016/S0166-4972(99)00059-0; Payne Philip R O, 2007, AMIA Annu Symp Proc, P593; REHNQUIST J, 2001, J INT BIOETHIQUE, V14, P165; Reijiers HA, 2005, OMEGA-INT J MANAGE S, V33, P283, DOI 10.1016/j.omega.2004.04.012; *ROCKW AUT TECHN, 2007, AR US GUID, P119; RUSSELL N, 2006, CONC MOD 2006 P APCC; Shah J, 2009, ACAD MED, V84, P511, DOI 10.1097/ACM.0b013e31819a8c3c; Thiers FA, 2008, NAT REV DRUG DISCOV, V7, P13, DOI 10.1038/nrd2441; Zerhouni E, 2003, SCIENCE, V302, P63, DOI 10.1126/science.1091867	22	15	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2010	5	11							e13893	10.1371/journal.pone.0013893	http://dx.doi.org/10.1371/journal.pone.0013893			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	677ZE	21085484	Green Published, gold, Green Submitted			2022-12-27	WOS:000284035900010
J	Mougi, A				Mougi, Akihiko			Coevolution in a One Predator-Two Prey System	PLOS ONE			English	Article							RED-QUEEN DYNAMICS; POPULATION-DYNAMICS; QUANTITATIVE TRAITS; CHARACTER SHIFTS; EVOLUTION; ECOSYSTEMS; ENRICHMENT; STABILITY; BEHAVIOR	Background: Our understanding of coevolution in a predator-prey system is based mostly on pair-wise interactions. Methodology and Principal Findings: Here I analyze a one-predator-two-prey system in which the predator's attack ability and the defense abilities of the prey all evolve. The coevolutionary consequences can differ dramatically depending on the initial trait value and the timing of the alternative prey's invasion into the original system. If the invading prey species has relatively low defense ability when it invades, its defense is likely to evolve to a lower level, stabilizing the population dynamics. In contrast, if when it invades its defense ability is close to that of the resident prey, its defense can evolve to a higher level and that of the resident prey may suddenly cease to evolve, destabilizing the population dynamics. Destabilization due to invasion is likely when the invading prey is adaptively superior (evolution of its defense is less constrained and fast), and it can also occur in a broad condition even when the invading prey is adaptively inferior. In addition, invasion into a resident system far from equilibrium characterized by population oscillations is likely to cause further destabilization. Conclusions and Significance: An invading prey species is thus likely to destabilize a resident community.	Kyushu Univ, Fac Sci, Dept Biol, Fukuoka 812, Japan	Kyushu University	Mougi, A (corresponding author), Kyushu Univ, Fac Sci, Dept Biol, Fukuoka 812, Japan.	mougi@bio-math10.biology.kyushu-u.ac.jp			Japan Society for the Promotion of Science [20*01655]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	A Grant-in-Aid for a Research Fellow from the Japan Society for the Promotion of Science and a Research Fellowship for Young Scientists (no. 20*01655) to A.M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abram PA, 2000, AM NAT, V156, pS45, DOI 10.1086/303415; ABRAMS P, 1993, EVOL ECOL, V7, P312, DOI 10.1007/BF01237749; ABRAMS PA, 1991, THEOR POPUL BIOL, V39, P241, DOI 10.1016/0040-5809(91)90022-8; Abrams PA, 1997, EVOL ECOL, V11, P1, DOI 10.1023/A:1018445517101; ABRAMS PA, 1993, EVOL ECOL, V7, P465, DOI 10.1007/BF01237642; Abrams PA, 2000, ANNU REV ECOL SYST, V31, P79, DOI 10.1146/annurev.ecolsys.31.1.79; Abrams PA, 2006, AM NAT, V168, P645, DOI 10.1086/507878; Dercole F, 2006, P ROY SOC B-BIOL SCI, V273, P983, DOI 10.1098/rspb.2005.3398; DERCOLE F, 2010, P R SOC B IN PRESS; DERUITER PC, 1995, SCIENCE, V269, P1257, DOI 10.1126/science.269.5228.1257; DIECKMANN U, 1995, J THEOR BIOL, V176, P91, DOI 10.1006/jtbi.1995.0179; FAGAN WF, 1994, ECOLOGY, V75, P2022, DOI 10.2307/1941607; Ferriere R, 2007, ECOL LETT, V10, P115, DOI 10.1111/j.1461-0248.2006.01008.x; Fussmann GF, 2007, FUNCT ECOL, V21, P465, DOI 10.1111/j.1365-2435.2007.01275.x; Futuyma D. J., 1998, EVOLUTIONARY BIOL; Genkai-Kato M, 2000, P ROY SOC B-BIOL SCI, V267, P2397, DOI 10.1098/rspb.2000.1297; JANZEN DH, 1980, EVOLUTION, V34, P611, DOI 10.1111/j.1558-5646.1980.tb04849.x; Kopp M, 2006, EVOLUTION, V60, P1321, DOI 10.1111/j.0014-3820.2006.tb01212.x; MARROW P, 1992, P ROY SOC B-BIOL SCI, V250, P133, DOI 10.1098/rspb.1992.0141; Mougi A, 2008, P ROY SOC B-BIOL SCI, V275, P2563, DOI 10.1098/rspb.2008.0889; Mougi A, 2010, P ROY SOC B-BIOL SCI, V277, P3163, DOI 10.1098/rspb.2010.0691; Mougi A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006731; Nuismer SL, 2007, EVOLUTION, V61, P1823, DOI 10.1111/j.1558-5646.2007.00158.x; Nuismer SL, 2004, EVOLUTION, V58, P1165, DOI 10.1111/j.0014-3820.2004.tb01697.x; PAINE RT, 1992, NATURE, V355, P73, DOI 10.1038/355073a0; Raffaelli David G., 1996, P185; Thompson J. N., 2005, INTERSPEC INTERACT; Urban MC, 2008, TRENDS ECOL EVOL, V23, P311, DOI 10.1016/j.tree.2008.02.007; Vamosi SM, 2004, EVOLUTION, V58, P376, DOI 10.1111/j.0014-3820.2004.tb01653.x; Van Valen L., 1973, EVOL THEORY, V1, P1, DOI DOI 10.1038/344864A0; WINEMILLER KO, 1990, ECOL MONOGR, V60, P331, DOI 10.2307/1943061; WOOTTON T, 1997, ECOL MONOGR, V67, P45; Yamauchi A, 2005, ECOLOGY, V86, P2513, DOI 10.1890/04-1524; Yoshida T, 2003, NATURE, V424, P303, DOI 10.1038/nature01767	34	9	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2010	5	11							e13887	10.1371/journal.pone.0013887	http://dx.doi.org/10.1371/journal.pone.0013887			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	677ZE	21085473	Green Published, Green Submitted, gold			2022-12-27	WOS:000284035900006
J	Martinez-Sanchez, JM; Fernandez, E; Fu, M; Gallus, S; Martinez, C; Sureda, X; La Vecchia, C; Clancy, L				Martinez-Sanchez, Jose M.; Fernandez, Esteve; Fu, Marcela; Gallus, Silvano; Martinez, Cristina; Sureda, Xisca; La Vecchia, Carlo; Clancy, Luke			Smoking Behaviour, Involuntary Smoking, Attitudes towards Smoke-Free Legislations, and Tobacco Control Activities in the European Union	PLOS ONE			English	Article							CONTROL POLICIES; FREE WORKPLACES; HEALTH; IMPACT	Background: The six most important cost-effective policies on tobacco control can be measured by the Tobacco Control Scale (TCS). The objective of our study was to describe the correlation between the TCS and smoking prevalence, self-reported exposure to secondhand smoke (SHS) and attitudes towards smoking restrictions in the 27 countries of the European Union (EU27). Methods/Principal Findings: Ecologic study in the EU27. We used data from the TCS in 2007 and from the Eurobarometer on Tobacco Survey in 2008. We analysed the relations between the TCS and prevalence of smoking, self-reported exposure to SHS (home and work), and attitudes towards smoking bans by means of scatter plots and Spearman rank-correlation coefficients (r(sp)). Among the EU27, smoking prevalence varied from 22.6% in Slovenia to 42.1% in Greece. Austria was the country with the lowest TCS score (35) and the UK had the highest one (93). The correlation between smoking prevalence and TCS score was negative (r(sp) = -0.42, p = 0.03) and the correlation between TCS score and support to smoking bans in all workplaces was positive (r(sp) = 0.47, p = 0.01 in restaurants; r(sp) = 0.5, p = 0.008 in bars, pubs, and clubs; and r(sp) = 0.31, p = 0.12 in other indoor workplaces). The correlation between TCS score and self-reported exposure to SHS was negative, but statistically non-significant. Conclusions/Significance: Countries with a higher score in the TCS have higher support towards smoking bans in all workplaces (including restaurants, bars, pubs and clubs, and other indoor workplaces). TCS scores were strongly, but not statistically, associated with a lower prevalence of smokers and a lower self-reported exposure to SHS.	[Martinez-Sanchez, Jose M.; Fernandez, Esteve; Fu, Marcela; Martinez, Cristina; Sureda, Xisca] ICO, Tobacco Control Unit, Barcelona, Spain; [Martinez-Sanchez, Jose M.; Fernandez, Esteve; Fu, Marcela; Martinez, Cristina; Sureda, Xisca] Univ Barcelona, Dept Clin Sci, Sch Med, Barcelona, Spain; [Martinez-Sanchez, Jose M.; Fernandez, Esteve; Fu, Marcela; Martinez, Cristina; Sureda, Xisca] Inst Invest Biomed Bellvitge IDIBELL, Canc Prevent & Control Grp, Barcelona, Spain; [Gallus, Silvano; La Vecchia, Carlo] Ist Ric Farmacol Mario Negri, Dept Epidemiol, Milan, Italy; [La Vecchia, Carlo] Univ Milan, Sch Med, Dept Occupat Med, Milan, Italy; [Clancy, Luke] Tobacco Free Res Inst, Dublin, Ireland	University of Barcelona; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Istituto di Ricerche Farmacologiche Mario Negri IRCCS; University of Milan	Martinez-Sanchez, JM (corresponding author), ICO, Tobacco Control Unit, Barcelona, Spain.	efernandez@iconcologia.net	Clancy, Luke/O-6597-2019; Martínez-Sánchez, Jose M/ABH-3093-2020; Martínez, Cristina/H-6103-2017; Martinez, Cristina/AAG-4172-2020; Gallus, Silvano/AAB-4127-2019; Fernandez, Esteve/A-9750-2008; Martínez-Sánchez, Jose/AAA-6343-2019; clancy, luke/ABA-1826-2020	Clancy, Luke/0000-0003-2407-2263; Martínez-Sánchez, Jose M/0000-0002-9632-5701; Martínez, Cristina/0000-0002-0108-3288; Martinez, Cristina/0000-0002-0108-3288; Gallus, Silvano/0000-0002-8967-0400; Fernandez, Esteve/0000-0003-4239-723X; Sureda Llull, Francisca/0000-0002-6262-2257; Fu, Marcela/0000-0002-4962-0927; La Vecchia, Carlo/0000-0003-1441-897X	Instituto de Salud Carlos III (the Thematic Network of Cooperative Research on Cancer), Government of Spain [RD06/0020/0089]; Ministry of Universities and Research, Government of Catalonia [2009SGR192]; Escuela Nacional de Sanidad; University of Barcelona	Instituto de Salud Carlos III (the Thematic Network of Cooperative Research on Cancer), Government of Spain(Instituto de Salud Carlos III); Ministry of Universities and Research, Government of Catalonia; Escuela Nacional de Sanidad; University of Barcelona	This project was funded by the Instituto de Salud Carlos III (the Thematic Network of Cooperative Research on Cancer, RD06/0020/0089) from the Government of Spain; the Ministry of Universities and Research (2009SGR192), Government of Catalonia; the "V Ayuda Enrique Najera para jovenes epidemiologos'' of the Spanish Society of Epidemiology funded by the Escuela Nacional de Sanidad; and a grant for short pre-doctoral research stays from the University of Barcelona. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, LANCET, V365, P1282; Callinan JE, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005992.pub2; Chapman S, 1999, AM J PUBLIC HEALTH, V89, P1018, DOI 10.2105/AJPH.89.7.1018; Chapman S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000216; Diez-Roux AV, 2000, ANNU REV PUBL HEALTH, V21, P171, DOI 10.1146/annurev.publhealth.21.1.171; Fichtenberg CM, 2002, BMJ-BRIT MED J, V325, P188, DOI 10.1136/bmj.325.7357.188; Fong GT, 2006, TOB CONTROL, V15, P3, DOI 10.1136/tc.2005.015438; *GALL ORG EUR COMM, 2009, FLASH EUR, V253; Gallus S, 2007, PREV MED, V45, P198, DOI 10.1016/j.ypmed.2007.03.009; GOODMAN P, 2009, INT J PUBLIC HLTH; Gorber SC, 2009, NICOTINE TOB RES, V11, P12, DOI 10.1093/ntr/ntn010; HILTON S, 2007, BMC PUBLIC HEALTH, V7, pNIL1; Hublet A, 2009, ADDICTION, V104, P1918, DOI 10.1111/j.1360-0443.2009.02686.x; IARC Working Group, 2009, IARC HDB CANC PREV T, P13; Jaakkola MS, 2006, EUR RESPIR J, V28, P397, DOI 10.1183/09031936.06.00001306; Joossens L, 2006, TOB CONTROL, V15, P247, DOI 10.1136/tc.2005.015347; JOOSSENS L, PROGR TOB CONTR 30 E; Lopez AD, 1994, TOB CONTROL, V3, P242, DOI [DOI 10.1136/TC.3.3.242, 10.1136/tc.3.3.242]; Martinez-Sanchez JM, 2010, GAC SANIT, V24, P241, DOI 10.1016/j.gaceta.2010.02.007; Muggli ME, 2010, TOB CONTROL, V19, P24, DOI 10.1136/tc.2009.031831; Pursell L, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-131; Schaap MM, 2008, TOB CONTROL, V17, P248, DOI 10.1136/tc.2007.024265; Sebrie EM, 2007, TOB CONTROL, V16, DOI 10.1136/tc.2006.018275; Thyrian JR, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-2; U. S. Department of Health and Human Services, 2006, HLTH CONS INV EXP TO; US Department of Health and Human Services, 2004, HLTH CONS SMOK; West R, 2010, ADDICTION, V105, P1867, DOI 10.1111/j.1360-0443.2010.03111.x; *WHO, 2008, MPOWER; WHO, PART WHO FRAM CONV T; *WORLD BANK, 2003, TOB CONTR GLANC	30	63	63	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2010	5	11							e13881	10.1371/journal.pone.0013881	http://dx.doi.org/10.1371/journal.pone.0013881			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	676NU	21079729	gold, Green Submitted, Green Published			2022-12-27	WOS:000283920000014
J	Zhang, L; Pei, YF; Li, JA; Papasian, CJ; Deng, HW				Zhang, Lei; Pei, Yu-Fang; Li, Jian; Papasian, Christopher J.; Deng, Hong-Wen			Improved Detection of Rare Genetic Variants for Diseases	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISMS; FREQUENCY-SPECTRUM; COMMON DISEASES; GENOME; ASSOCIATION; POWER; DISCOVERY; ELEMENTS; DATABASE; ALLELES	Technology advances have promoted gene-based sequencing studies with the aim of identifying rare mutations responsible for complex diseases. A complication in these types of association studies is that the vast majority of non-synonymous mutations are believed to be neutral to phenotypes. It is thus critical to distinguish potential causative variants from neutral variation before performing association tests. In this study, we used existing predicting algorithms to predict functional amino acid substitutions, and incorporated that information into association tests. Using simulations, we comprehensively studied the effects of several influential factors, including the sensitivity and specificity of functional variant predictions, number of variants, and proportion of causative variants, on the performance of association tests. Our results showed that incorporating information regarding functional variants obtained from existing prediction algorithms improves statistical power under certain conditions, particularly when the proportion of causative variants is moderate. The application of the proposed tests to a real sequencing study confirms our conclusions. Our work may help investigators who are planning to pursue gene-based sequencing studies.	[Zhang, Lei; Pei, Yu-Fang; Deng, Hong-Wen] Shanghai Univ Sci & Technol, Ctr Syst Biomed Sci, Shanghai 201800, Peoples R China; [Zhang, Lei; Pei, Yu-Fang] Xi An Jiao Tong Univ, Key Lab Biomed Informat Engn, Sch Life Sci & Technol, Minist Educ, Xian 710049, Shaanxi, Peoples R China; [Zhang, Lei; Pei, Yu-Fang] Xi An Jiao Tong Univ, Inst Mol Genet, Xian 710049, Shaanxi, Peoples R China; [Li, Jian; Papasian, Christopher J.; Deng, Hong-Wen] Univ Missouri, Sch Med, Kansas City, MO 64108 USA; [Deng, Hong-Wen] Beijing Jiao Tong Univ, Coll Life Sci & Engn, Beijing, Peoples R China	University of Shanghai for Science & Technology; Xi'an Jiaotong University; Xi'an Jiaotong University; University of Missouri System; University of Missouri Kansas City; Beijing Jiaotong University	Zhang, L (corresponding author), Shanghai Univ Sci & Technol, Ctr Syst Biomed Sci, Shanghai 201800, Peoples R China.	dengh@umkc.edu	Li, Jian/G-4445-2015; Zhang, Lei/L-1016-2016	Zhang, Lei/0000-0002-1007-4834; Deng, Hong-Wen/0000-0002-0387-8818	Xi'an Jiaotong University; National Science Foundation of China; Huo Ying Dong Education Foundation, Hunan Province; Ministry of Education of China; National Institutes of Health [R01 AR050496, R21 AG027110, R01 AG026564, P50 AR055081, R21 AA015973]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR057049, P50AR055081, R01AR050496] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG026564, R21AG027110] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R21AA015973] Funding Source: NIH RePORTER	Xi'an Jiaotong University(Xi'an Jiaotong University); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Huo Ying Dong Education Foundation, Hunan Province; Ministry of Education of China(Ministry of Education, China); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	The study was partially supported by Xi'an Jiaotong University. The investigators of this work also benefited from support of the grants from the National Science Foundation of China, National Institutes of Health (R01 AR050496, R21 AG027110, R01 AG026564, P50 AR055081 and R21 AA015973), Huo Ying Dong Education Foundation, Hunan Province, and the Ministry of Education of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams AM, 2004, GENETICS, V168, P1699, DOI 10.1534/genetics.104.030171; Ahituv N, 2007, PLOS BIOL, V5, P1906, DOI 10.1371/journal.pbio.0050234; Ahituv N, 2007, AM J HUM GENET, V80, P779, DOI 10.1086/513471; Asthana S, 2007, PLOS COMPUT BIOL, V3, P2559, DOI 10.1371/journal.pcbi.0030254; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Chakravarti A, 1999, NAT GENET, V21, P56, DOI 10.1038/4482; Chang HG, 2001, BIOCHEM BIOPH RES CO, V287, P288, DOI 10.1006/bbrc.2001.5576; Chen GK, 2007, AM J HUM GENET, V81, P397, DOI 10.1086/519794; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; Cohen JC, 2004, SCIENCE, V305, P869, DOI 10.1126/science.1099870; Ferrer-Costa C, 2005, BIOINFORMATICS, V21, P3176, DOI 10.1093/bioinformatics/bti486; Frazer KA, 2009, NAT REV GENET, V10, P241, DOI 10.1038/nrg2554; Genovese CR, 2006, BIOMETRIKA, V93, P509, DOI 10.1093/biomet/93.3.509; Gorlov IP, 2008, AM J HUM GENET, V82, P100, DOI 10.1016/j.ajhg.2007.09.006; Hindorff LA, 2009, CATALOG PUBLISHED GE; Kryukov GV, 2007, AM J HUM GENET, V80, P727, DOI 10.1086/513473; Kryukov GV, 2009, P NATL ACAD SCI USA, V106, P3871, DOI 10.1073/pnas.0812824106; Levy S, 2007, PLOS BIOL, V5, P2113, DOI 10.1371/journal.pbio.0050254; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; Li BS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000481; Madsen BE, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000384; Marth GT, 2004, GENETICS, V166, P351, DOI 10.1534/genetics.166.1.351; Mooney SD, 2003, BIOINFORMATICS, V19, P1858, DOI 10.1093/bioinformatics/btg241; Morgenthaler S, 2007, MUTAT RES-FUND MOL M, V615, P28, DOI 10.1016/j.mrfmmm.2006.09.003; Ng PC, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000160; Ng PC, 2006, ANNU REV GENOM HUM G, V7, P61, DOI 10.1146/annurev.genom.7.080505.115630; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; NG SB, 2009, NATURE; Pritchard JK, 2001, AM J HUM GENET, V69, P124, DOI 10.1086/321272; Pritchard JK, 2002, HUM MOL GENET, V11, P2417, DOI 10.1093/hmg/11.20.2417; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Reich DE, 2001, TRENDS GENET, V17, P502, DOI 10.1016/S0168-9525(01)02410-6; Reumers J, 2005, NUCLEIC ACIDS RES, V33, pD527; Reumers J, 2006, BIOINFORMATICS, V22, P2183, DOI 10.1093/bioinformatics/btl348; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Roeder K, 2006, AM J HUM GENET, V78, P243, DOI 10.1086/500026; Roeder K, 2007, GENET EPIDEMIOL, V31, P741, DOI 10.1002/gepi.20237; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Siva Nayanah, 2008, Nat Biotechnol, V26, P256, DOI 10.1038/nbt0308-256b; Stitziel NO, 2004, NUCLEIC ACIDS RES, V32, pD520, DOI 10.1093/nar/gkh104; Sunyaev S, 2001, HUM MOL GENET, V10, P591, DOI 10.1093/hmg/10.6.591; Sunyaev SR, 1999, PROTEIN ENG, V12, P387, DOI 10.1093/protein/12.5.387; Tarpey PS, 2009, NAT GENET, V41, P535, DOI 10.1038/ng.367; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Tucker T, 2009, AM J HUM GENET, V85, P142, DOI 10.1016/j.ajhg.2009.06.022; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884; Yue P, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-166	48	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2010	5	11							e13857	10.1371/journal.pone.0013857	http://dx.doi.org/10.1371/journal.pone.0013857			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	676NU	21079782	gold, Green Submitted, Green Published			2022-12-27	WOS:000283920000002
J	Manetti, AGO; Koeller, T; Becherelli, M; Buccato, S; Kreikemeyer, B; Podbielski, A; Grandi, G; Margarit, I				Manetti, Andrea G. O.; Koeller, Thomas; Becherelli, Marco; Buccato, Scilla; Kreikemeyer, Bernd; Podbielski, Andreas; Grandi, Guido; Margarit, Immaculada			Environmental Acidification Drives S. pyogenes Pilus Expression and Microcolony Formation on Epithelial Cells in a FCT-Dependent Manner	PLOS ONE			English	Article							GROUP-A STREPTOCOCCUS; VIRULENCE GENE-EXPRESSION; GROUP-B STREPTOCOCCUS; STAPHYLOCOCCUS-AUREUS; FIBRONECTIN-BINDING; BIOFILM FORMATION; PATHOGENICITY REGION; REGULATORY NETWORKS; SEROTYPE M49; T-ANTIGENS	Group A Streptococcus (GAS, Streptococcus pyogenes) is a Gram-positive human pathogen responsible for a diverse variety of diseases, including pharyngitis, skin infections, invasive necrotizing fasciitis and autoimmune sequelae. We have recently shown that GAS cell adhesion and biofilm formation is associated with the presence of pili on the surface of these bacteria. GAS pilus proteins are encoded in the FCT (Fibronectin- Collagen-T antigen) genomic region, of which nine different variants have been identified so far. In the present study we undertook a global analysis of GAS isolates representing the majority of FCT-variants to investigate the effect of environmental growth conditions on their capacity to form multicellular communities. For FCT-types 2, 3, 5 and 6 and a subset of FCT-4 strains, we observed that acidification resulting from fermentative sugar metabolism leads to an increased ability of the bacteria to form biofilm on abiotic surfaces and microcolonies on epithelial cells. The higher biofilm forming capacity at low environmental pH was directly associated with an enhanced expression of the genes encoding the pilus components and of their transcription regulators. The data indicate that environmental pH affects the expression of most pilus types and thereby the formation of multicellular cell-adhering communities that assist the initial steps of GAS infection.	[Manetti, Andrea G. O.; Becherelli, Marco; Buccato, Scilla; Grandi, Guido; Margarit, Immaculada] Novartis Vaccines & Diagnost, Siena, Italy; [Koeller, Thomas; Kreikemeyer, Bernd; Podbielski, Andreas] Inst Med Microbiol Virol & Hyg, Rostock, Germany	Novartis	Manetti, AGO (corresponding author), Novartis Vaccines & Diagnost, Siena, Italy.	immaculada.margarit_y_ros@novartis.com		Grandi, Guido/0000-0001-9724-2185; Kreikemeyer, Bernd/0000-0001-9527-5098	Univerity of Bologna; Medical Faculty of the University of Rostock, Germany; Novartis Vaccines and Diagnostics	Univerity of Bologna; Medical Faculty of the University of Rostock, Germany; Novartis Vaccines and Diagnostics	Funding: M. B. is a recipient of a Novartis fellowship from the PhD program in cellular, molecular and industrial biology of the Univerity of Bologna. T. K. and B. K. acknowledge support by the 2008 FORUN program of the Medical Faculty of the University of Rostock, Germany. This work was funded by Novartis Vaccines and Diagnostics. The funders had a role in study design, data collection and analysis, preparation of the manuscript and decision to publish.	Abbot EL, 2007, CELL MICROBIOL, V9, P1822, DOI 10.1111/j.1462-5822.2007.00918.x; Akiyama H, 2003, J DERMATOL SCI, V32, P193, DOI 10.1016/S0923-1811(03)00096-3; Baldassarri L, 2006, J CLIN MICROBIOL, V44, P2721, DOI 10.1128/JCM.00512-06; Beckert S, 2001, INFECT IMMUN, V69, P534, DOI 10.1128/IAI.69.1.534-537.2001; Beenken KE, 2004, J BACTERIOL, V186, P4665, DOI 10.1128/JB.186.14.4665-4684.2004; Bessen DE, 2005, J BACTERIOL, V187, P4163, DOI 10.1128/JB.187.12.4163-4172.2005; Bessen DE, 2002, INFECT IMMUN, V70, P1159, DOI 10.1128/IAI.70.3.1159-1167.2002; Buccato S, 2006, J INFECT DIS, V194, P331, DOI 10.1086/505433; Cho KH, 2005, MOL MICROBIOL, V57, P1545, DOI 10.1111/j.1365-2958.2005.04786.x; Courtney HS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004166; Cunningham MW, 2000, CLIN MICROBIOL REV, V13, P470, DOI 10.1128/CMR.13.3.470-511.2000; Dalton TL, 2004, J BACTERIOL, V186, P3928, DOI 10.1128/JB.186.12.3928-3937.2004; Dong YM, 1999, CARIES RES, V33, P428, DOI 10.1159/000016547; Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002; Edwards AM, 2008, MOL MICROBIOL, V68, P1378, DOI 10.1111/j.1365-2958.2008.06220.x; Ehlers C, 2001, SKIN RES TECHNOL, V7, P90, DOI 10.1034/j.1600-0846.2001.70206.x; Falugi F, 2008, J INFECT DIS, V198, P1834, DOI 10.1086/593176; FOGG GC, 1994, MOL MICROBIOL, V11, P671, DOI 10.1111/j.1365-2958.1994.tb00345.x; Fogg GC, 1997, J BACTERIOL, V179, P6172, DOI 10.1128/jb.179.19.6172-6180.1997; Froehlich BJ, 2009, J BACTERIOL, V191, P673, DOI 10.1128/JB.01256-08; Granok AB, 2000, J BACTERIOL, V182, P1529, DOI 10.1128/JB.182.6.1529-1540.2000; Gryllos I, 2007, MOL MICROBIOL, V65, P671, DOI 10.1111/j.1365-2958.2007.05818.x; Hamilton IR, 1998, ORAL MICROBIOL IMMUN, V13, P292, DOI 10.1111/j.1399-302X.1998.tb00710.x; Hanski E, 1996, ADV EXP MED BIOL, V408, P141; KOLLER T, J MED MICROBIOL, V59, P442; Kratovac Z, 2007, J BACTERIOL, V189, P1299, DOI 10.1128/JB.01301-06; Kreikemeyer B, 2004, J BIOL CHEM, V279, P15850, DOI 10.1074/jbc.M313613200; Kreikemeyer B, 2003, TRENDS MICROBIOL, V11, P224, DOI 10.1016/S0966-842X(03)00098-2; Kreikemeyer B, 2007, INFECT IMMUN, V75, P5698, DOI 10.1128/IAI.00175-07; Li LP, 2002, P NATL ACAD SCI USA, V99, P12369, DOI 10.1073/pnas.192439499; Lizano S, 2007, J BACTERIOL, V189, P1426, DOI 10.1128/JB.01179-06; Loughman JA, 2006, J BACTERIOL, V188, P399, DOI 10.1128/JB.188.2.399-408.2006; Luo F, 2008, INFECT IMMUN, V76, P2490, DOI 10.1128/IAI.01567-07; Lyon WR, 1998, EMBO J, V17, P6263, DOI 10.1093/emboj/17.21.6263; Manetti AGO, 2007, MOL MICROBIOL, V64, P968, DOI 10.1111/j.1365-2958.2007.05704.x; Marsh Philip D, 2006, BMC Oral Health, V6 Suppl 1, pS14, DOI 10.1186/1472-6831-6-S1-S14; Mora M, 2005, P NATL ACAD SCI USA, V102, P15641, DOI 10.1073/pnas.0507808102; Moscoso M, 2006, J BACTERIOL, V188, P7785, DOI 10.1128/JB.00673-06; Musser JM, 2009, J CLIN INVEST, V119, P2455, DOI 10.1172/JCI38095; Nakata M, 2005, MOL MICROBIOL, V57, P786, DOI 10.1111/j.1365-2958.2005.04730.x; Nakata M, 2009, INFECT IMMUN, V77, P32, DOI 10.1128/IAI.00772-08; Neely MN, 2002, INFECT IMMUN, V70, P3904, DOI 10.1128/IAI.70.7.3904-3914.2002; O'Neill E, 2008, J BACTERIOL, V190, P3835, DOI 10.1128/JB.00167-08; Perez JC, 2007, MOL MICROBIOL, V63, P283, DOI 10.1111/j.1365-2958.2006.05512.x; Pflock M, 2006, J BIOTECHNOL, V126, P52, DOI 10.1016/j.jbiotec.2006.03.045; Podbielski A, 1999, MOL MICROBIOL, V31, P1051, DOI 10.1046/j.1365-2958.1999.01241.x; REGASSA LB, 1992, INFECT IMMUN, V60, P3381, DOI 10.1128/IAI.60.8.3381-3388.1992; Rice KC, 2005, J BACTERIOL, V187, P813, DOI 10.1128/JB.187.3.813-821.2005; Rippke F, 2004, AM J CLIN DERMATOL, V5, P217, DOI 10.2165/00128071-200405040-00002; Rippke Frank, 2002, Am J Clin Dermatol, V3, P261, DOI 10.2165/00128071-200203040-00004; Rosch JW, 2008, INFECT IMMUN, V76, P3187, DOI 10.1128/IAI.00054-08; Santi I, 2009, J BACTERIOL, V191, P5387, DOI 10.1128/JB.00370-09; Shelburne SA, 2008, P NATL ACAD SCI USA, V105, P1698, DOI 10.1073/pnas.0711767105; Simmen HP, 1995, J HAND SURG-BRIT EUR, V20B, P797, DOI 10.1016/S0266-7681(95)80050-6; Telford JL, 2006, NAT REV MICROBIOL, V4, P509, DOI 10.1038/nrmicro1443; Weinrick B, 2004, J BACTERIOL, V186, P8407, DOI 10.1128/JB.186.24.8407-8423.2004	56	46	46	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2010	5	11							e13864	10.1371/journal.pone.0013864	http://dx.doi.org/10.1371/journal.pone.0013864			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675OD	21079780	Green Submitted, gold, Green Published			2022-12-27	WOS:000283839100016
J	Zhuang, J; Cai, GQ; Lin, QY; Wu, ZJ; Xie, LH				Zhuang, Jun; Cai, Guiqin; Lin, Qiying; Wu, Zujian; Xie, Lianhui			A Bacteriophage-Related Chimeric Marine Virus Infecting Abalone	PLOS ONE			English	Article							HALIOTIS-TUBERCULATA; HEMOCYANIN; GENOME; ORGANIZATION; SUBUNITS; SEQUENCE; HTH1	Marine viruses shape microbial communities with the most genetic diversity in the sea by multiple genetic exchanges and infect multiple marine organisms. Here we provide proof from experimental infection that abalone shriveling syndrome-associated virus (AbSV) can cause abalone shriveling syndrome. This malady produces histological necrosis and abnormally modified macromolecules (hemocyanin and ferritin). The AbSV genome is a 34.952-kilobase circular double-stranded DNA, containing putative genes with similarity to bacteriophages, eukaryotic viruses, bacteria and endosymbionts. Of the 28 predicted open reading frames (ORFs), eight ORF-encoded proteins have identifiable functional homologues. The 4 ORF products correspond to a predicted terminase large subunit and an endonuclease in bacteriophage, and both an integrase and an exonuclease from bacteria. The other four proteins are homologous to an endosymbiont-derived helicase, primase, single-stranded binding (SSB) protein, and thymidylate kinase, individually. Additionally, AbSV exhibits a common gene arrangement similar to the majority of bacteriophages. Unique to AbSV, the viral genome also contains genes associated with bacterial outer membrane proteins and may lack the structural protein-encoding ORFs. Genomic characterization of AbSV indicates that it may represent a transitional form of microbial evolution from viruses to bacteria.	[Zhuang, Jun; Cai, Guiqin; Lin, Qiying; Wu, Zujian; Xie, Lianhui] Fujian Agr & Forestry Univ, Inst Plant Virol, Key Lab Plant Virol Fujian Prov, Fuzhou, Peoples R China; [Zhuang, Jun; Lin, Qiying; Wu, Zujian; Xie, Lianhui] Fujian Agr & Forestry Univ, Key Lab Biopesticide & Chem Biol, Fuzhou, Peoples R China; [Zhuang, Jun; Lin, Qiying; Wu, Zujian; Xie, Lianhui] Minist Educ, Fuzhou, Peoples R China	Fujian Agriculture & Forestry University; Fujian Agriculture & Forestry University	Zhuang, J (corresponding author), Fujian Agr & Forestry Univ, Inst Plant Virol, Key Lab Plant Virol Fujian Prov, Fuzhou, Peoples R China.	wuzujian@126.com; fjxlh@126.com			National Natural Science Foundations of China [30671357]; Fujian Provincial Department of Science and Technology [2006NZ0002-2]; Natural Science Foundation of Fujian Province, China [2010J01073]	National Natural Science Foundations of China(National Natural Science Foundation of China (NSFC)); Fujian Provincial Department of Science and Technology; Natural Science Foundation of Fujian Province, China(Natural Science Foundation of Fujian Province)	Funding: This work was supported by the National Natural Science Foundations of China 30671357 to L. H. X., the Key Project of Fujian Provincial Department of Science and Technology 2006NZ0002-2 to Z.J.W. and the Natural Science Foundation of Fujian Province, China (Grant No. 2010J01073) to J.Z. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERGH O, 1989, NATURE, V340, P467, DOI 10.1038/340467a0; Bezier A, 2009, SCIENCE, V323, P926, DOI 10.1126/science.1166788; Boyer M, 2009, P NATL ACAD SCI USA, V106, P21848, DOI 10.1073/pnas.0911354106; COSTANZI C, 1987, METHOD ENZYMOL, V152, P582; De Zoysa M, 2007, FISH SHELLFISH IMMUN, V23, P624, DOI 10.1016/j.fsi.2007.01.013; DEUFF RML, 1999, J GEN VIROL, V80, P1317; Favoreel HW, 2005, P NATL ACAD SCI USA, V102, P8990, DOI 10.1073/pnas.0409099102; FELSENSTEIN J, 2007, PHYLIP PHYLOGENY INF; Fuhrman JA, 1999, NATURE, V399, P541, DOI 10.1038/21119; Fuller DN, 2007, P NATL ACAD SCI USA, V104, P11245, DOI 10.1073/pnas.0701323104; GARDNER GR, 1995, J INVERTEBR PATHOL, V66, P111, DOI 10.1006/jipa.1995.1072; Harris JR, 1998, MICRON, V29, P329, DOI 10.1016/S0968-4328(98)00019-5; Harris JR, 2000, MICRON, V31, P1, DOI 10.1016/S0968-4328(99)00059-1; Hendrix RW, 1999, P NATL ACAD SCI USA, V96, P2192, DOI 10.1073/pnas.96.5.2192; Hertveldt K, 2005, J MOL BIOL, V354, P536, DOI 10.1016/j.jmb.2005.08.075; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Igakura T, 2003, SCIENCE, V299, P1713, DOI 10.1126/science.1080115; Keller H, 1999, EUR J BIOCHEM, V264, P27, DOI 10.1046/j.1432-1327.1999.00564.x; Kwan T, 2005, P NATL ACAD SCI USA, V102, P5174, DOI 10.1073/pnas.0501140102; La Scola B, 2008, NATURE, V455, P100, DOI 10.1038/nature07218; Lieb B, 1999, EUR J BIOCHEM, V265, P134, DOI 10.1046/j.1432-1327.1999.00694.x; Lieb B, 2001, P NATL ACAD SCI USA, V98, P4546, DOI 10.1073/pnas.071049998; Lukashin AV, 1998, NUCLEIC ACIDS RES, V26, P1107, DOI 10.1093/nar/26.4.1107; Macia L, 2006, J IMMUNOL, V177, P5997, DOI 10.4049/jimmunol.177.9.5997; Meissner U, 2000, J MOL BIOL, V298, P21, DOI 10.1006/jmbi.2000.3631; Meissner U, 2007, MICRON, V38, P754, DOI 10.1016/j.micron.2006.11.005; Mesyanzhinov VV, 2002, J MOL BIOL, V317, P1, DOI 10.1006/jmbi.2001.5396; Miller ES, 2003, MICROBIOL MOL BIOL R, V67, P86, DOI 10.1128/MMBR.67.1.86-156.2003; Newsome TP, 2004, SCIENCE, V306, P124, DOI 10.1126/science.1101509; Pedulla ML, 2003, CELL, V113, P171, DOI 10.1016/S0092-8674(03)00233-2; PROCTOR LM, 1990, NATURE, V343, P60, DOI 10.1038/343060a0; Stothard P, 2005, BIOINFORMATICS, V21, P537, DOI 10.1093/bioinformatics/bti054; Suttle CA, 2005, NATURE, V437, P356, DOI 10.1038/nature04160; Suttle CA, 2007, NAT REV MICROBIOL, V5, P801, DOI 10.1038/nrmicro1750; Swerdlow RD, 1996, COMP BIOCHEM PHYS B, V113, P537, DOI 10.1016/0305-0491(95)02091-8; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; XING RL, 2003, J DALIAN FISH U, V18, P191; YE L, 1997, J FISHERY SCI CHINA, V4, P43	38	15	20	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2010	5	11							e13850	10.1371/journal.pone.0013850	http://dx.doi.org/10.1371/journal.pone.0013850			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675OD	21079776	Green Submitted, Green Published, gold			2022-12-27	WOS:000283839100009
J	Sun, ZK; He, WM				Sun, Zhen-Kai; He, Wei-Ming			Evidence for Enhanced Mutualism Hypothesis: Solidago canadensis Plants from Regular Soils Perform Better	PLOS ONE			English	Article							ARBUSCULAR MYCORRHIZAL FUNGI; CENTAUREA-MACULOSA; INVASIVE PLANT; COMPETITIVE ABILITY; ROOT EXUDATE; BIOTA; GROWTH; CHINA; PRODUCTIVITY; COMMUNITIES	The important roles of plant-soil microbe interactions have been documented in exotic plant invasion, but we know very little about how soil mutualists enhance this process (i.e. enhanced mutualism hypothesis). To test this hypothesis we conducted two greenhouse experiments with Solidago canadensis (hereafter Solidago), an invasive forb from North America, and Stipa bungeana (hereafter Stipa), a native Chinese grass. In a germination experiment, we found soil microbes from the rhizospheres of Solidago and Stipa exhibited much stronger facilitative effects on emergence of Solidago than that of Stipa. In a growth and competition experiment, we found that soil microbes strongly facilitated Solidago to outgrow Stipa, and greatly increased the competitive effects of Solidago on Stipa but decreased the competitive effects of Stipa on Solidago. These findings from two experiments suggest that in situ soil microbes enhance the recruitment potential of Solidago and its ability to outcompete native plants, thereby providing strong evidence for the enhanced mutualism hypothesis. On the other hand, to some extent this outperformance of Solidago in the presence of soil microbes seems to be unbeneficial to control its rapid expansion, particularly in some ranges where this enhanced mutualism dominates over other mechanisms.	[Sun, Zhen-Kai; He, Wei-Ming] Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Botany, CAS	He, WM (corresponding author), Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China.	weiminghe@ibcas.ac.cn			National Natural Science Foundation of China [30770335]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The National Natural Science Foundation of China grant (30770335) to Dr. WM He funded this research. The website is www.nsfc.gov.cn. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abhilasha D, 2008, J ECOL, V96, P993, DOI 10.1111/j.1365-2745.2008.01413.x; Armas C, 2004, ECOLOGY, V85, P2682, DOI 10.1890/03-0650; Bennett AE, 2007, ECOLOGY, V88, P210, DOI 10.1890/0012-9658(2007)88[210:MSDAPG]2.0.CO;2; Bray SR, 2003, ECOL APPL, V13, P565, DOI 10.1890/1051-0761(2003)013[0565:MDAGPA]2.0.CO;2; Cai Xiaobu, 2006, Yingyong Shengtai Xuebao, V17, P2121; Callaway RM, 2006, TRENDS ECOL EVOL, V21, P369, DOI 10.1016/j.tree.2006.04.008; Callaway RM, 2004, ECOLOGY, V85, P1062, DOI 10.1890/02-0775; Callaway RM, 2004, NATURE, V427, P731, DOI 10.1038/nature02322; Callaway RM, 2003, ECOLOGY, V84, P129, DOI 10.1890/0012-9658(2003)084[0129:SFATEO]2.0.CO;2; Cui QG, 2009, WEED RES, V49, P201, DOI 10.1111/j.1365-3180.2008.00679.x; Diez JM, 2010, ECOL LETT, V13, P803, DOI 10.1111/j.1461-0248.2010.01474.x; Donath TW, 2008, J ECOL, V96, P272, DOI 10.1111/j.1365-2745.2007.01338.x; Dong M, 2006, ACTA PHYTOTAXON SIN, V44, P72, DOI 10.1360/aps050068; *ED BOARD FLOR CHI, 1987, FLOR CHIN, V9; Facelli E, 2010, NEW PHYTOL, V185, P1050, DOI 10.1111/j.1469-8137.2009.03162.x; Fayolle A, 2009, OECOLOGIA, V159, P817, DOI 10.1007/s00442-008-1254-0; He WM, 2009, OECOLOGIA, V159, P803, DOI 10.1007/s00442-008-1234-4; Klironomos JN, 2002, NATURE, V417, P67, DOI 10.1038/417067a; Klironomos JN, 2003, ECOLOGY, V84, P2292, DOI 10.1890/02-0413; KOLASA J, 1991, ECOLOGICAL HETEROGEN; Kulmatiski A, 2008, ECOL LETT, V11, P980, DOI 10.1111/j.1461-0248.2008.01209.x; Lu JZ, 2007, ACTA PHYTOTAXON SIN, V45, P670, DOI 10.1360/aps06200; Mangla S, 2008, J ECOL, V96, P58, DOI 10.1111/j.1365-2745.2007.01312.x; Marler MJ, 1999, ECOLOGY, V80, P1180, DOI 10.1890/0012-9658(1999)080[1180:MIECEO]2.0.CO;2; Nunez MA, 2009, ECOLOGY, V90, P2352, DOI 10.1890/08-2139.1; Pollock JL, 2009, J ECOL, V97, P1234, DOI 10.1111/j.1365-2745.2009.01553.x; Pringle A, 2009, ANNU REV ECOL EVOL S, V40, P699, DOI 10.1146/annurev.ecolsys.39.110707.173454; Reinhart KO, 2006, NEW PHYTOL, V170, P445, DOI 10.1111/j.1469-8137.2006.01715.x; Reinhart KO, 2004, ECOL APPL, V14, P1737, DOI 10.1890/03-5204; Reinhart KO, 2003, ECOL LETT, V6, P1046, DOI 10.1046/j.1461-0248.2003.00539.x; Rout ME, 2009, PLANT SOIL, V315, P163, DOI 10.1007/s11104-008-9740-z; Smith S., 1997, MYCORRHIZAL SYMBIOSI, V2nd Edn; Stuefer JF, 1996, VEGETATIO, V127, P55, DOI 10.1007/BF00054847; Thorpe AS, 2009, J ECOL, V97, P641, DOI 10.1111/j.1365-2745.2009.01520.x; van der Heijden MGA, 2008, ECOL LETT, V11, P296, DOI 10.1111/j.1461-0248.2007.01139.x; van der Heijden MGA, 1998, NATURE, V396, P69, DOI 10.1038/23932; van Kleunen M, 2003, ECOLOGY, V84, P2816, DOI 10.1890/02-0494; Vogelsang KM, 2009, ECOLOGY, V90, P399, DOI 10.1890/07-2144.1; Weber E., 2003, INVASIVE PLANT SPECI; Wolfe BE, 2005, BIOSCIENCE, V55, P477, DOI 10.1641/0006-3568(2005)055[0477:BNGSCA]2.0.CO;2; Xie YZ, 2004, ACTA OECOL, V25, P197, DOI 10.1016/j.actao.2004.01.004; Yang RY, 2007, ALLELOPATHY J, V19, P241; Yu YW, 2009, GRASS FORAGE SCI, V64, P395, DOI 10.1111/j.1365-2494.2009.00704.x; Zimmer K, 2007, NEW PHYTOL, V175, P166, DOI 10.1111/j.1469-8137.2007.02065.x	44	50	53	2	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2010	5	11							e15418	10.1371/journal.pone.0015418	http://dx.doi.org/10.1371/journal.pone.0015418			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	800AR	21082028	Green Published, gold, Green Submitted			2022-12-27	WOS:000293329500003
J	Vandewoestijne, S; Van Dyck, H				Vandewoestijne, Sofie; Van Dyck, Hans			Population Genetic Differences along a Latitudinal Cline between Original and Recently Colonized Habitat in a Butterfly	PLOS ONE			English	Article							MICROSATELLITE NULL ALLELES; MANIOLA-JURTINA LEPIDOPTERA; PARARGE-AEGERIA; PHENOTYPIC PLASTICITY; DISPERSAL; LANDSCAPE; BEHAVIOR; FRAGMENTATION; EVOLUTION; FLIGHT	Background: Past and current range or spatial expansions have important consequences on population genetic structure. Habitat-use expansion, i.e. changing habitat associations, may also influence genetic population parameters, but has been less studied. Here we examined the genetic population structure of a Palaeartic woodland butterfly Pararge aegeria (Nymphalidae) which has recently colonized agricultural landscapes in NW-Europe. Butterflies from woodland and agricultural landscapes differ in several phenotypic traits (including morphology, behavior and life history). We investigated whether phenotypic divergence is accompanied by genetic divergence between populations of different landscapes along a 700 km latitudinal gradient. Methodology/Principal Findings: Populations (23) along the latitudinal gradient in both landscape types were analyzed using microsatellite and allozyme markers. A general decrease in genetic diversity with latitude was detected, likely due to post-glacial colonization effects. Contrary to expectations, agricultural landscapes were not less diverse and no significant bottlenecks were detected. Nonetheless, a genetic signature of recent colonization is reflected in the absence of clinal genetic differentiation within the agricultural landscape, significantly lower gene flow between agricultural populations (3.494) than between woodland populations (4.183), and significantly higher genetic differentiation between agricultural (0.050) than woodland (0.034) pairwise comparisons, likely due to multiple founder events. Globally, the genetic data suggest multiple long distance dispersal/colonization events and subsequent high intra-and inter-landscape gene flow in this species. Phosphoglucomutase deviated from other enzymes and microsatellite markers, and hence may be under selection along the latitudinal gradient but not between landscape types. Phenotypic divergence was greater than genetic divergence, indicating directional selection on some flight morphology traits. Main Conclusions/Significance: Clinal differentiation characterizes the population structure within the original woodland habitat. Genetic signatures of recent habitat expansion remain, notwithstanding high gene flow. After differentiation through drift was excluded, both latitude and landscape were significant factors inducing spatially variable phenotypic variation.	[Vandewoestijne, Sofie; Van Dyck, Hans] Catholic Univ Louvain, Biodivers Res Ctr, Earth & Life Inst, B-1348 Louvain, Belgium	Universite Catholique Louvain	Vandewoestijne, S (corresponding author), Catholic Univ Louvain, Biodivers Res Ctr, Earth & Life Inst, B-1348 Louvain, Belgium.	Sofie.Vandewoestijne@uclouvain.be			Fund for Scientific Research FNRS (FRFC) [2.4595.07]; ARC (Actions de recherche concertees, Communaute francaise de Belgique/Academie Louvain) [10/15-031]	Fund for Scientific Research FNRS (FRFC)(Fonds de la Recherche Scientifique - FNRS); ARC (Actions de recherche concertees, Communaute francaise de Belgique/Academie Louvain)	This research was supported by a research grant of the Fund for Scientific Research FNRS (FRFC 2.4595.07) and an ARC research grant (Actions de recherche concertees, Communaute francaise de Belgique/Academie Louvain, Convention no10/15-031). S Vandewoestijne is postdoctoral researcher of the Fund for Scientific Research - FNRS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdoullaye D, 2010, MOL ECOL RESOUR, V10, P232, DOI 10.1111/j.1755-0998.2009.02796.x; Allendorf F., 2007, CONSERVATION GENETIC; Antao T, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-323; Austerlitz F, 1997, THEOR POPUL BIOL, V51, P148, DOI 10.1006/tpbi.1997.1302; Baguette M, 2007, LANDSCAPE ECOL, V22, P1117, DOI 10.1007/s10980-007-9108-4; BARTON NH, 1986, HEREDITY, V56, P409, DOI 10.1038/hdy.1986.63; Beaumont MA, 1996, P ROY SOC B-BIOL SCI, V263, P1619, DOI 10.1098/rspb.1996.0237; Beerli P, 2001, P NATL ACAD SCI USA, V98, P4563, DOI 10.1073/pnas.081068098; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berwaerts K, 1998, NETH J ZOOL, V48, P241, DOI 10.1163/156854298X00093; Bialozyt R, 2006, J EVOLUTION BIOL, V19, P12, DOI 10.1111/j.1420-9101.2005.00995.x; Breuker C.J., 2010, MORPHOMETRICS NONMOR, P271; Brookfield JFY, 1996, MOL ECOL, V5, P453, DOI 10.1046/j.1365-294X.1996.00098.x; Chapuis MP, 2007, MOL BIOL EVOL, V24, P621, DOI 10.1093/molbev/msl191; Corander J, 2003, GENETICS, V163, P367; Corander J, 2008, COMPUTATION STAT, V23, P111, DOI 10.1007/s00180-007-0072-x; Cornuet JM, 1996, GENETICS, V144, P2001; Dakin EE, 2004, HEREDITY, V93, P504, DOI 10.1038/sj.hdy.6800545; Darling JA, 2009, MOL ECOL, V18, P4827, DOI 10.1111/j.1365-294X.2009.04405.x; Dover J, 2000, J ENVIRON MANAGE, V60, P51, DOI 10.1006/jema.2000.0361; Edelaar P, 2008, EVOLUTION, V62, P2462, DOI 10.1111/j.1558-5646.2008.00459.x; Evans KL, 2009, P ROY SOC B-BIOL SCI, V276, P2403, DOI 10.1098/rspb.2008.1712; Excoffier L, 2009, ANNU REV ECOL EVOL S, V40, P481, DOI 10.1146/annurev.ecolsys.39.110707.173414; Finger A, 2009, ECOGRAPHY, V32, P382, DOI 10.1111/j.1600-0587.2008.05766.x; Goslee SC, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i07; GOULSON D, 1993, HEREDITY, V71, P386, DOI 10.1038/hdy.1993.153; Harper GL, 2003, MOL ECOL, V12, P3349, DOI 10.1046/j.1365-294X.2003.02012.x; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hill JK, 2006, BIOL LETTERS, V2, P152, DOI 10.1098/rsbl.2005.0401; Jombart T, 2008, HEREDITY, V101, P92, DOI 10.1038/hdy.2008.34; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Karl I, 2009, ECOGRAPHY, V32, P488, DOI 10.1111/j.1600-0587.2008.05660.x; Karlsson B, 2005, P ROY SOC B-BIOL SCI, V272, P1257, DOI 10.1098/rspb.2005.3074; Kemp DJ, 2006, BEHAV ECOL SOCIOBIOL, V59, P403, DOI 10.1007/s00265-005-0064-1; Leinonen T, 2008, J EVOLUTION BIOL, V21, P1, DOI 10.1111/j.1420-9101.2007.01445.x; Marrs RA, 2008, BIOL INVASIONS, V10, P561, DOI 10.1007/s10530-007-9153-6; Merckx T, 2005, ANIM BEHAV, V70, P411, DOI 10.1016/j.anbehav.2004.12.005; Merckx T, 2003, P ROY SOC B-BIOL SCI, V270, P1815, DOI 10.1098/rspb.2003.2459; Merckx T, 2008, BASIC APPL ECOL, V9, P433, DOI 10.1016/j.baae.2007.03.009; Merckx T, 2007, ANIM BEHAV, V74, P1029, DOI 10.1016/j.anbehav.2006.12.020; Merckx T, 2006, OIKOS, V113, P226, DOI 10.1111/j.2006.0030-1299.14501.x; NYLIN S, 1989, BIOL J LINN SOC, V38, P155, DOI 10.1111/j.1095-8312.1989.tb01571.x; Oliver T, 2009, ECOL LETT, V12, P1091, DOI 10.1111/j.1461-0248.2009.01367.x; Olivieri I, 2009, TRENDS ECOL EVOL, V24, P289, DOI 10.1016/j.tree.2009.01.015; Orsini L, 2008, MOL ECOL, V17, P2629, DOI 10.1111/j.1365-294X.2008.03782.x; Parmesan C, 1999, NATURE, V399, P579, DOI 10.1038/21181; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pritchard JK, 2000, GENETICS, V155, P945; Raufaste N, 2000, THEOR POPUL BIOL, V57, P285, DOI 10.1006/tpbi.2000.1457; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Schmitt T, 2005, BIOL J LINN SOC, V85, P419, DOI 10.1111/j.1095-8312.2005.00504.x; Schneider S., 2000, ARLEQUIN VER 2 000 S; Settele Josef, 2008, BioRisk, V1, P1; Shreeve Tim, 2009, P171; Skrede I, 2009, HEREDITY, V102, P293, DOI 10.1038/hdy.2008.120; Stevens VM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011123; Thomas CD, 2001, NATURE, V411, P577, DOI 10.1038/35079066; Travis JMJ, 2002, EVOL ECOL RES, V4, P1119; Van der Veken S, 2008, FRONT ECOL ENVIRON, V6, P212, DOI 10.1890/070063; Van Dyck H, 2002, J EVOLUTION BIOL, V15, P216, DOI 10.1046/j.1420-9101.2002.00384.x; Van Dyck H, 2005, BASIC APPL ECOL, V6, P535, DOI 10.1016/j.baae.2005.03.005; Van Dyck Hans, 2003, P353; Van Dyck H, 2009, CONSERV BIOL, V23, P957, DOI 10.1111/j.1523-1739.2009.01175.x; Vandewoestijne S, 1999, MOL ECOL, V8, P1539, DOI 10.1046/j.1365-294x.1999.00725.x; Vandewoestijne S, 2004, BASIC APPL ECOL, V5, P581, DOI 10.1016/j.baae.2004.07.004; VANDEWOESTIJNE S, FLIGHT MORPHOL UNPUB; WATT WB, 1977, GENETICS, V87, P177; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Williams BL, 2003, MOL ECOL, V12, P11, DOI 10.1046/j.1365-294X.2003.01700.x; Wilson GA, 2003, GENETICS, V163, P1177; Wood BC, 2002, BIODIVERS CONSERV, V11, P1451, DOI 10.1023/A:1016223907962; Wright S, 1943, GENETICS, V28, P114; Zakharov EV, 2008, MOL ECOL, V17, P3035, DOI 10.1111/j.1365-294X.2008.03825.x	74	31	31	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2010	5	11							e13810	10.1371/journal.pone.0013810	http://dx.doi.org/10.1371/journal.pone.0013810			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	674WJ	21072197	Green Published, gold, Green Submitted			2022-12-27	WOS:000283780800011
J	Wei, J; Ghosh, AK; Sargent, JL; Komura, K; Wu, MH; Huang, QQ; Jain, M; Whitfield, ML; Feghali-Bostwick, C; Varga, J				Wei, Jun; Ghosh, Asish K.; Sargent, Jennifer L.; Komura, Kazuhiro; Wu, Minghua; Huang, Qi-Quan; Jain, Manu; Whitfield, Michael L.; Feghali-Bostwick, Carol; Varga, John			PPAR gamma Downregulation by TGF beta in Fibroblast and Impaired Expression and Function in Systemic Sclerosis: A Novel Mechanism for Progressive Fibrogenesis	PLOS ONE			English	Article							ACTIVATED-RECEPTOR-GAMMA; GROWTH-FACTOR-BETA; COLLAGEN GENE-EXPRESSION; HUMAN SKIN FIBROBLASTS; I COLLAGEN; PROFIBROTIC RESPONSES; MOUSE MODEL; ADIPOGENESIS; SCLERODERMA; INHIBITION	The nuclear orphan receptor peroxisome proliferator-activated receptor-gamma (PPAR-gamma) is expressed in multiple cell types in addition to adipocytes. Upon its activation by natural ligands such as fatty acids and eicosanoids, or by synthetic agonists such as rosiglitazone, PPAR-gamma regulates adipogenesis, glucose uptake and inflammatory responses. Recent studies establish a novel role for PPAR-gamma signaling as an endogenous mechanism for regulating transforming growth factor-beta (TGF-beta)-dependent fibrogenesis. Here, we sought to characterize PPAR-gamma function in the prototypic fibrosing disorder systemic sclerosis (SSc), and delineate the factors governing PPAR-gamma expression. We report that PPAR-gamma levels were markedly diminished in skin and lung biopsies from patients with SSc, and in fibroblasts explanted from the lesional skin. In normal fibroblasts, treatment with TGF-beta resulted in a time- and dose-dependent down-regulation of PPAR-gamma expression. Inhibition occurred at the transcriptional level and was mediated via canonical Smad signal transduction. Genome-wide expression profiling of SSc skin biopsies revealed a marked attenuation of PPAR-gamma levels and transcriptional activity in a subset of patients with diffuse cutaneous SSc, which was correlated with the presence of a "TGF-beta responsive gene signature" in these biopsies. Together, these results demonstrate that the expression and function of PPAR-gamma are impaired in SSc, and reveal the existence of a reciprocal inhibitory cross-talk between TGF-beta activation and PPAR-gamma signaling in the context of fibrogenesis. In light of the potent anti-fibrotic effects attributed to PPAR-gamma, these observations lead us to propose that excessive TGF-beta activity in SSc accounts for impaired PPAR-gamma function, which in turn contributes to unchecked fibroblast activation and progressive fibrosis.	[Wei, Jun; Ghosh, Asish K.; Komura, Kazuhiro; Wu, Minghua; Huang, Qi-Quan; Varga, John] Northwestern Univ, Feinberg Sch Med, Div Rheumatol, Chicago, IL 60611 USA; [Jain, Manu] Northwestern Univ, Feinberg Sch Med, Div Resp & Crit Care Med, Chicago, IL 60611 USA; [Sargent, Jennifer L.; Whitfield, Michael L.] Dartmouth Med Coll, Dept Genet, Hanover, NH USA; [Feghali-Bostwick, Carol] Univ Pittsburgh, Sch Med, Div Pulm Allergy & Crit Care Med, Pittsburgh, PA USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Dartmouth College; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Wei, J (corresponding author), Northwestern Univ, Feinberg Sch Med, Div Rheumatol, Chicago, IL 60611 USA.	j-varga@northwestern.edu	Wei, Jun/G-3295-2012; Komura, Kazuhiro/AAS-8380-2021; Varga, John/AAK-6472-2021; Whitfield, Michael/AAC-5010-2020	Komura, Kazuhiro/0000-0002-4775-7356; 	National Institutes of Health [AR-42309, AR-49025]; Scleroderma Research Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049025, R56AR042309, R01AR042309] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Scleroderma Research Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The work was supported by grants from the National Institutes of Health (AR-42309 and AR-49025) and the Scleroderma Research Foundation. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berger J, 2002, ANNU REV MED, V53, P409, DOI 10.1146/annurev.med.53.082901.104018; Beyer C, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2598; Burgess HA, 2005, AM J PHYSIOL-LUNG C, V288, pL1146, DOI 10.1152/ajplung.00383.2004; Chen SJ, 1999, J INVEST DERMATOL, V112, P49, DOI 10.1046/j.1523-1747.1999.00477.x; Culver DA, 2004, AM J RESP CELL MOL, V30, P1; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Dong CM, 2002, P NATL ACAD SCI USA, V99, P3908, DOI 10.1073/pnas.062010399; Duan SZ, 2007, J CLIN INVEST, V117, P812, DOI 10.1172/JCI28859; Dudas M, 2004, DEV BIOL, V266, P96, DOI 10.1016/j.ydbio.2003.10.007; Fajas L, 1997, J BIOL CHEM, V272, P18779, DOI 10.1074/jbc.272.30.18779; FLEISCHMAJER R, 1972, ARCH DERMATOL, V105, P59, DOI 10.1001/archderm.105.1.59; Galli A, 2002, GASTROENTEROLOGY, V122, pA488; Ghosh AK, 2004, ARTHRITIS RHEUM-US, V50, P1305, DOI 10.1002/art.20104; Ghosh AK, 2000, ONCOGENE, V19, P3546, DOI 10.1038/sj.onc.1203693; Ghosh A, 2009, FASEB J, V23; Ghosh AK, 2008, BIOCHEM BIOPH RES CO, V374, P231, DOI 10.1016/j.bbrc.2008.07.014; Gressner OA, 2008, J HEPATOL, V49, P758, DOI 10.1016/j.jhep.2008.03.029; Ha H, 2009, NAT REV NEPHROL, V5, P203, DOI 10.1038/nrneph.2009.15; Higgins LS, 2010, AM J CLIN NUTR, V91, p267S, DOI 10.3945/ajcn.2009.28449E; Hong KM, 2005, FASEB J, V19, pA1052; Kapoor M, 2007, PROSTAG LEUKOTR ESS, V76, P103, DOI 10.1016/j.plefa.2006.11.006; Kapoor M, 2009, ARTHRITIS RHEUM-US, V60, P2822, DOI 10.1002/art.24761; Karnik P, 2009, J INVEST DERMATOL, V129, P1243, DOI 10.1038/jid.2008.369; Kawai T, 2009, LAB INVEST, V89, P47, DOI 10.1038/labinvest.2008.104; Kim S, 2007, P NATL ACAD SCI USA, V104, P16627, DOI 10.1073/pnas.0707797104; Kis A, 2009, EUR J HEART FAIL, V11, P533, DOI 10.1093/eurjhf/hfp048; Lakos G, 2004, AM J PATHOL, V165, P203, DOI 10.1016/S0002-9440(10)63289-0; Lehrke M, 2005, CELL, V123, P993, DOI 10.1016/j.cell.2005.11.026; Li X, 2007, NEPHROL DIAL TRANSPL, V22, P1041, DOI 10.1093/ndt/gfl766; LIU SH, CELL MOL LIFE SCI; Liu XD, 1997, P NATL ACAD SCI USA, V94, P10669, DOI 10.1073/pnas.94.20.10669; Longo KA, 2004, J BIOL CHEM, V279, P35503, DOI 10.1074/jbc.M402937200; McIntyre TM, 2003, P NATL ACAD SCI USA, V100, P131, DOI 10.1073/pnas.0135855100; Milam JE, 2008, AM J PHYSIOL-LUNG C, V294, pL891, DOI 10.1152/ajplung.00333.2007; Milano A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002696; Miyahara T, 2000, J BIOL CHEM, V275, P35715, DOI 10.1074/jbc.M006577200; Mori Y, 2004, ARTHRITIS RHEUM-US, V50, P4008, DOI 10.1002/art.20658; Mori Y, 2003, ARTHRITIS RHEUM-US, V48, P1964, DOI 10.1002/art.11157; Park Y, 2003, DIABETOLOGIA, V46, P365, DOI 10.1007/s00125-003-1037-4; Psaty BM, 2007, NEW ENGL J MED, V356, P2522, DOI 10.1056/NEJMe078099; Rosen ED, 1999, MOL CELL, V4, P611, DOI 10.1016/S1097-2765(00)80211-7; Rosen ED, 2002, GENE DEV, V16, P22, DOI 10.1101/gad.948702; Ross SE, 2000, SCIENCE, V289, P950, DOI 10.1126/science.289.5481.950; SARGENT JL, 2009, J INVEST DERMATOL; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Shiomi T, 2002, CIRCULATION, V106, P3126, DOI 10.1161/01.CIR.0000039346.31538.2C; SHIWEN X, RHEUMATOLOGY OXFORD, V49, P259; Simon MF, 2005, J BIOL CHEM, V280, P14656, DOI 10.1074/jbc.M412585200; Sonnylal S, 2007, ARTHRITIS RHEUM-US, V56, P334, DOI 10.1002/art.22328; Tan JTM, 2008, AM J PHYSIOL-CELL PH, V295, pC740, DOI 10.1152/ajpcell.00333.2007; TAN X, RESP RES, V11, P21; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Trojanowska M, 2007, CURR OPIN RHEUMATOL, V19, P568, DOI 10.1097/BOR.0b013e3282e6f495; Varga J, 2007, J CLIN INVEST, V117, P557, DOI 10.1172/JCI31139; Varga J, 2009, NAT REV RHEUMATOL, V5, P200, DOI 10.1038/nrrheum.2009.26; Verrecchia F, 2007, RHEUMATOLOGY, V46, P833, DOI 10.1093/rheumatology/kel451; Wang YQ, 2006, ARTHRITIS RHEUM-US, V54, P2271, DOI 10.1002/art.21948; Willis BC, 2005, AM J PATHOL, V166, P1321, DOI 10.1016/S0002-9440(10)62351-6; Wu MH, 2009, AM J PATHOL, V174, P519, DOI 10.2353/ajpath.2009.080574; Yang L, 2006, AM J PHYSIOL-GASTR L, V291, pG902, DOI 10.1152/ajpgi.00124.2006; Yuan WH, 2001, J BIOL CHEM, V276, P38502, DOI 10.1074/jbc.M107081200; Yun Z, 2002, DEV CELL, V2, P331, DOI 10.1016/S1534-5807(02)00131-4; Zheng F, 2002, AM J PHYSIOL-RENAL, V282, pF639, DOI 10.1152/ajprenal.00189.2001; Zheng SZ, 2007, AM J PHYSIOL-GASTR L, V292, pG113, DOI 10.1152/ajpgi.00200.2006; Vincent ZA, 2007, BBA-MOL CELL BIOL L, V1771, P915, DOI 10.1016/j.bbalip.2007.01.007	65	111	116	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2010	5	11							e13778	10.1371/journal.pone.0013778	http://dx.doi.org/10.1371/journal.pone.0013778			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	674VY	21072170	Green Published, gold, Green Submitted			2022-12-27	WOS:000283779700003
J	Coelmont, L; Hanoulle, X; Chatterji, U; Berger, C; Snoeck, J; Bobardt, M; Lim, P; Vliegen, I; Paeshuyse, J; Vuagniaux, G; Vandamme, AM; Bartenschlager, R; Gallay, P; Lippens, G; Neyts, J				Coelmont, Lotte; Hanoulle, Xavier; Chatterji, Udayan; Berger, Carola; Snoeck, Joke; Bobardt, Michael; Lim, Precious; Vliegen, Inge; Paeshuyse, Jan; Vuagniaux, Gregoire; Vandamme, Anne-Mieke; Bartenschlager, Ralf; Gallay, Philippe; Lippens, Guy; Neyts, Johan			DEB025 (Alisporivir) Inhibits Hepatitis C Virus Replication by Preventing a Cyclophilin A Induced Cis-Trans Isomerisation in Domain II of NS5A	PLOS ONE			English	Article							NONSTRUCTURAL PROTEIN 5A; CYCLOSPORINE-A; ISOMERASE ACTIVITY; RNA REPLICATION; RESISTANCE; BINDING; DEBIO-025; IDENTIFICATION; COMBINATION; POLYMERASE	DEB025/Debio 025 (Alisporivir) is a cyclophilin (Cyp)-binding molecule with potent anti-hepatitis C virus (HCV) activity both in vitro and in vivo. It is currently being evaluated in phase II clinical trials. DEB025 binds to CypA, a peptidyl-prolyl cis-trans isomerase which is a crucial cofactor for HCV replication. Here we report that it was very difficult to select resistant replicons (genotype 1b) to DEB025, requiring an average of 20 weeks (four independent experiments), compared to the typically <2 weeks with protease or polymerase inhibitors. This indicates a high genetic barrier to resistance for DEB025. Mutation D320E in NS5A was the only mutation consistently selected in the replicon genome. This mutation alone conferred a low-level (3.9-fold) resistance. Replacing the NS5A gene (but not the NS5B gene) from the wild type (WT) genome with the corresponding sequence from the DEB025(res) replicon resulted in transfer of resistance. Cross-resistance with cyclosporine A (CsA) was observed, whereas NS3 protease and NS5B polymerase inhibitors retained WT-activity against DEB025(res) replicons. Unlike WT, DEB025(res) replicon replicated efficiently in CypA knock down cells. However, DEB025 disrupted the interaction between CypA and NS5A regardless of whether the NS5A protein was derived from WT or DEB025(res) replicon. NMR titration experiments with peptides derived from the WT or the DEB025(res) domain II of NS5A corroborated this observation in a quantitative manner. Interestingly, comparative NMR studies on two 20-mer NS5A peptides that contain D320 or E320 revealed a shift in population between the major and minor conformers. These data suggest that D320E conferred low-level resistance to DEB025 probably by reducing the need for CypA-dependent isomerisation of NS5A. Prolonged DEB025 treatment and multiple genotypic changes may be necessary to generate significant resistance to DEB025, underlying the high barrier to resistance.	[Coelmont, Lotte; Snoeck, Joke; Vliegen, Inge; Paeshuyse, Jan; Vandamme, Anne-Mieke; Neyts, Johan] Katholieke Univ Leuven, Dept Microbiol & Immunol, Rega Inst Med Res, Louvain, Belgium; [Hanoulle, Xavier; Lippens, Guy] Univ Lille 1, Ctr Natl Rech Sci, Unite Mixte Rech 8576, F-59655 Villeneuve Dascq, France; [Chatterji, Udayan; Bobardt, Michael; Lim, Precious; Gallay, Philippe] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Berger, Carola; Bartenschlager, Ralf] Heidelberg Univ, Dept Mol Virol, Heidelberg, Germany; [Vuagniaux, Gregoire] Debiopharm, Pharmacol & Screening Unit, Lausanne, Switzerland	KU Leuven; Centre National de la Recherche Scientifique (CNRS); Universite de Lille - ISITE; Universite de Lille; Scripps Research Institute; Ruprecht Karls University Heidelberg; Debiopharm	Coelmont, L (corresponding author), Katholieke Univ Leuven, Dept Microbiol & Immunol, Rega Inst Med Res, Louvain, Belgium.	johan.neyts@rega.kuleuven.be	Hanoulle, Xavier/AAK-7236-2021; HANOULLE, Xavier/HHN-4815-2022; Neyts, Johan/U-8267-2017; Vandamme, Anne-Mieke/I-4127-2012; Bartenschlager, Ralf/L-2582-2015	Hanoulle, Xavier/0000-0002-3755-2680; Neyts, Johan/0000-0002-0033-7514; Vandamme, Anne-Mieke/0000-0002-6594-2766; Bartenschlager, Ralf/0000-0001-5601-9307; Lippens, Guy/0000-0002-8236-0901; Paeshuyse, Jan/0000-0003-2396-354X	Fonds voor Wetenschappelijk Onderzoek, Vlaanderen (FWO) [G.0728.09N]; Debiopharm (Lausanne, Switzerland); Deutsche Forschungsgemeinschaft [BA 1505/2]; U.S. Public Health Service [AI087746]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI087746] Funding Source: NIH RePORTER	Fonds voor Wetenschappelijk Onderzoek, Vlaanderen (FWO)(FWO); Debiopharm (Lausanne, Switzerland); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); U.S. Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work is supported in part by grant G.0728.09N from the "Fonds voor Wetenschappelijk Onderzoek, Vlaanderen (FWO)". J. Paeshuyse and J. Snoeck are supported by a post-doctoral position of the FWO. Part of this study was sponsored by Debiopharm (Lausanne, Switzerland). G. Vuagniaux is an employee of Debiopharm. R. Bartenschlager is supported by a grant from the "Deutsche Forschungsgemeinschaft" (BA 1505/2). P. Gallay is supported by U.S. Public Health Service grants no. AI087746 (P.A.G.). The funder Debiopharm had a role in study design, decision to publish and preparation of the manuscript, but not in data collection and analysis.	Appel N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000035; Chatterji U, 2010, J HEPATOL, V53, P50, DOI 10.1016/j.jhep.2010.01.041; Chatterji U, 2009, J BIOL CHEM, V284, P16998, DOI 10.1074/jbc.M109.007625; Coelmont L, 2009, ANTIMICROB AGENTS CH, V53, P967, DOI 10.1128/AAC.00939-08; Combet C, 2007, NUCLEIC ACIDS RES, V35, pD363, DOI 10.1093/nar/gkl970; Craxi A, 2003, SEMIN LIVER DIS, V23, P35; Delang L, 2010, VIRUSES-BASEL, V2, P826, DOI 10.3390/v2040826; Evans MJ, 2004, P NATL ACAD SCI USA, V101, P13038, DOI 10.1073/pnas.0405152101; Fernandes F, 2007, HEPATOLOGY, V46, P1026, DOI 10.1002/hep.21809; Fernandes F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009815; Flisiak R, 2008, HEPATOLOGY, V47, P817, DOI 10.1002/hep.22131; Flisiak R, 2009, HEPATOLOGY, V49, P1460, DOI 10.1002/hep.22835; Foster TL, 2010, J VIROL, V84, P9267, DOI 10.1128/JVI.00616-10; Goto K, 2009, CANCER SCI, V100, P1943, DOI 10.1111/j.1349-7006.2009.01263.x; Hanoulle X, 2010, PROTEIN PEPTIDE LETT, V17, P1012, DOI 10.2174/092986610791498920; Hanoulle X, 2009, J BIOL CHEM, V284, P13589, DOI 10.1074/jbc.M809244200; Hopkins S, 2010, ANTIMICROB AGENTS CH, V54, P660, DOI 10.1128/AAC.00660-09; Huang LY, 2005, J BIOL CHEM, V280, P36417, DOI 10.1074/jbc.M508175200; Huang LY, 2004, PROTEIN EXPRES PURIF, V37, P144, DOI 10.1016/j.pep.2004.05.005; Inoue K, 2005, TRANSPLANT P, V37, P1233, DOI 10.1016/j.transproceed.2004.11.041; Kaul A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000546; Koutsoudakis G, 2006, J VIROL, V80, P5308, DOI 10.1128/JVI.02460-05; Landrieu I, 2010, BIOCHEMISTRY-US, V49, P4679, DOI 10.1021/bi1003266; Lemm JA, 2010, J VIROL, V84, P482, DOI 10.1128/JVI.01360-09; Liang Y, 2007, BIOCHEMISTRY-US, V46, P11550, DOI 10.1021/bi700776e; Liu Z, 2009, J VIROL, V83, P6554, DOI 10.1128/JVI.02550-08; Liu Z, 2009, HEPATOLOGY, V50, P25, DOI 10.1002/hep.22987; Lohmann V, 2001, J VIROL, V75, P1437, DOI 10.1128/JVI.75.3.1437-1449.2001; Lohmann V, 1999, SCIENCE, V285, P110, DOI 10.1126/science.285.5424.110; Ma S, 2006, ANTIMICROB AGENTS CH, V50, P2976, DOI 10.1128/AAC.00310-06; Macdonald A, 2004, J GEN VIROL, V85, P2485, DOI 10.1099/vir.0.80204-0; Masaki T, 2008, J VIROL, V82, P7964, DOI 10.1128/JVI.00826-08; Nakagawa M, 2005, GASTROENTEROLOGY, V129, P1031, DOI 10.1053/j.gastro.2005.06.031; Nakagawa M, 2004, BIOCHEM BIOPH RES CO, V313, P42, DOI 10.1016/j.bbrc.2003.11.080; Paeshuyse J, 2006, HEPATOLOGY, V43, P761, DOI 10.1002/hep.21102; Ptak RG, 2008, ANTIMICROB AGENTS CH, V52, P1302, DOI 10.1128/AAC.01324-07; Puyang XL, 2010, ANTIMICROB AGENTS CH, V54, P1981, DOI 10.1128/AAC.01236-09; QUINKERT D, 2008, 15 INT S HEP C VIR R; Reddy KR, 2009, J HEPATOL, V50, P402, DOI 10.1016/j.jhep.2008.11.006; Robida JM, 2007, J VIROL, V81, P5829, DOI 10.1128/JVI.02524-06; Saphire ACS, 1999, EMBO J, V18, P6771, DOI 10.1093/emboj/18.23.6771; Shirota Y, 2002, J BIOL CHEM, V277, P11149, DOI 10.1074/jbc.M111392200; Susser S, 2009, HEPATOLOGY, V50, P1709, DOI 10.1002/hep.23192; Targett-Adams P, 2005, J GEN VIROL, V86, P3075, DOI 10.1099/vir.0.81334-0; Tellinghuisen TL, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000032; Tellinghuisen TL, 2008, J VIROL, V82, P1073, DOI 10.1128/JVI.00328-07; Tellinghuisen TL, 2005, NATURE, V435, P374, DOI 10.1038/nature03580; Tellinghuisen TL, 2004, J BIOL CHEM, V279, P48576, DOI 10.1074/jbc.M407787200; van den Hoff M J, 1995, Methods Mol Biol, V48, P185; Vrolijk JM, 2003, J VIROL METHODS, V110, P201, DOI 10.1016/S0166-0934(03)00134-4; Watashi K, 2003, HEPATOLOGY, V38, P1282, DOI 10.1053/jhep.2003.50449; Watashi K, 2005, MOL CELL, V19, P111, DOI 10.1016/j.molcel.2005.05.014; Yang F, 2008, J VIROL, V82, P5269, DOI 10.1128/JVI.02614-07; Zoulim F, 2003, REV MED VIROL, V13, P57, DOI 10.1002/rmv.371	54	138	142	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2010	5	10							e13687	10.1371/journal.pone.0013687	http://dx.doi.org/10.1371/journal.pone.0013687			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671UN	21060866	Green Published, gold, Green Submitted			2022-12-27	WOS:000283537000052
J	Langley, AR; Chambers, H; Christov, CP; Krude, T				Langley, Alexander R.; Chambers, Helen; Christov, Christo P.; Krude, Torsten			Ribonucleoprotein Particles Containing Non-Coding Y RNAs, Ro60, La and Nucleolin Are Not Required for Y RNA Function in DNA Replication	PLOS ONE			English	Article							SMALL CYTOPLASMIC RIBONUCLEOPROTEINS; PROTEIN-A; INTRACELLULAR-LOCALIZATION; SUBCELLULAR-DISTRIBUTION; CONSERVED FEATURES; QUALITY-CONTROL; IN-VITRO; AUTOANTIGEN; INITIATION; BINDING	Background: Ro ribonucleoprotein particles (Ro RNPs) consist of a non-coding Y RNA bound by Ro60, La and possibly other proteins. The physiological function of Ro RNPs is controversial as divergent functions have been reported for its different constituents. We have recently shown that Y RNAs are essential for the initiation of mammalian chromosomal DNA replication, whereas Ro RNPs are implicated in RNA stability and RNA quality control. Therefore, we investigate here the functional consequences of RNP formation between Ro60, La and nucleolin proteins with hY RNAs for human chromosomal DNA replication. Methodology/Principal Findings: We first immunoprecipitated Ro60, La and nucleolin together with associated hY RNAs from HeLa cytosolic cell extract, and analysed the protein and RNA compositions of these precipitated RNPs by Western blotting and quantitative RT-PCR. We found that Y RNAs exist in several RNP complexes. One RNP comprises Ro60, La and hY RNA, and a different RNP comprises nucleolin and hY RNA. In addition about 50% of the Y RNAs in the extract are present outside of these two RNPs. Next, we immunodepleted these RNP complexes from the cytosolic extract and tested the ability of the depleted extracts to reconstitute DNA replication in a human cell-free system. We found that depletion of these RNP complexes from the cytosolic extract does not inhibit DNA replication in vitro. Finally, we tested if an excess of recombinant pure Ro or La protein inhibits Y RNA-dependent DNA replication in this cell-free system. We found that Ro60 and La proteins do not inhibit DNA replication in vitro. Conclusions/Significance: We conclude that RNPs containing hY RNAs and Ro60, La or nucleolin are not required for the function of hY RNAs in chromosomal DNA replication in a human cell-free system, which can be mediated by Y RNAs outside of these RNPs. These data suggest that Y RNAs can support different cellular functions depending on associated proteins.	[Langley, Alexander R.; Chambers, Helen; Christov, Christo P.; Krude, Torsten] Univ Cambridge, Dept Zool, Cambridge, England	University of Cambridge	Langley, AR (corresponding author), Univ Cambridge, Dept Zool, Cambridge, England.	tk1@mole.bio.cam.ac.uk		Krude, Torsten/0000-0002-1842-1933	Cancer Research UK [C1471/A8448]; Medical Research Council (MRC); Nuffield Foundation [URB/33112]	Cancer Research UK(Cancer Research UK); Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Nuffield Foundation	This work was supported by Cancer Research UK (project grant C1471/A8448; URL: http://www.cancerresearchuk.org/). A.R.L was supported by a Research Studentship from the Medical Research Council (MRC; URL: http://www.mrc.ac.uk/index.htm), and H. C. was supported by an Undergraduate Research Bursary from the Nuffield Foundation (URB/33112; URL: http://www.nuffieldfoundation.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belisova A, 2005, RNA, V11, P1084, DOI 10.1261/rna.7263905; BOIRE G, 1990, J CLIN INVEST, V85, P1182, DOI 10.1172/JCI114551; Chen XG, 2004, J MOL MED, V82, P232, DOI 10.1007/s00109-004-0529-0; Chen XG, 2003, CURR BIOL, V13, P2206, DOI 10.1016/j.cub.2003.11.028; Christov CP, 2008, BRIT J CANCER, V98, P981, DOI 10.1038/sj.bjc.6604254; Christov CP, 2006, MOL CELL BIOL, V26, P6993, DOI 10.1128/MCB.01060-06; Daniely Y, 2000, J CELL BIOL, V149, P799, DOI 10.1083/jcb.149.4.799; Daniely Y, 2002, MOL CELL BIOL, V22, P6014, DOI 10.1128/MCB.22.16.6014-6022.2002; Fabini G, 2000, EUR J BIOCHEM, V267, P2778, DOI 10.1046/j.1432-1327.2000.01298.x; Fabini G, 2001, J BIOL CHEM, V276, P20711, DOI 10.1074/jbc.M101360200; Farris AD, 1999, NUCLEIC ACIDS RES, V27, P1070, DOI 10.1093/nar/27.4.1070; Fouraux MA, 2002, J MOL BIOL, V320, P475, DOI 10.1016/S0022-2836(02)00518-1; Fuchs G, 2006, NAT STRUCT MOL BIOL, V13, P1002, DOI 10.1038/nsmb1156; Garcia EL, 2009, J VIROL, V83, P12526, DOI 10.1128/JVI.01219-09; Gardiner TJ, 2009, RNA, V15, P1375, DOI 10.1261/rna.1472009; GOTTLIEB E, 1989, EMBO J, V8, P851, DOI 10.1002/j.1460-2075.1989.tb03446.x; GOTTLIEB EL, 1989, EMBO J, V8, P841, DOI 10.1002/j.1460-2075.1989.tb03445.x; Green CD, 1998, RNA, V4, P750, DOI 10.1017/S1355838298971667; HENDRICK JP, 1981, MOL CELL BIOL, V1, P1138, DOI 10.1128/MCB.1.12.1138; Kim K, 2005, MOL CELL BIOL, V25, P2463, DOI 10.1128/MCB.25.6.2463-2474.2005; Krude T, 2000, J BIOL CHEM, V275, P13699, DOI 10.1074/jbc.275.18.13699; Krude T, 1997, CELL, V88, P109, DOI 10.1016/S0092-8674(00)81863-2; Krude T, 1999, EXP CELL RES, V247, P148, DOI 10.1006/excr.1998.4342; Krude T, 2009, J CELL SCI, V122, P2836, DOI 10.1242/jcs.047563; LERNER MR, 1981, SCIENCE, V211, P400, DOI 10.1126/science.6164096; MATHEWS MB, 1984, MOL CELL BIOL, V4, P1134, DOI 10.1128/MCB.4.6.1134; Mosig A, 2007, THEOR BIOSCI, V126, P9, DOI 10.1007/s12064-007-0003-y; OBRIEN CA, 1994, GENE DEV, V8, P2891, DOI 10.1101/gad.8.23.2891; PEEK R, 1993, J CELL SCI, V106, P929; Perreault J, 2007, MOL BIOL EVOL, V24, P1678, DOI 10.1093/molbev/msm084; Pruijn GJM, 1997, EUR J CELL BIOL, V74, P123; PRUIJN GJM, 1991, NUCLEIC ACIDS RES, V19, P5173, DOI 10.1093/nar/19.19.5173; Sim S, 2009, MOL BIOL CELL, V20, P1555, DOI 10.1091/mbc.E08-11-1094; Simons FHM, 1996, RNA, V2, P264; SIMONS FHM, 1994, J CELL BIOL, V125, P981, DOI 10.1083/jcb.125.5.981; STEFANO JE, 1984, CELL, V36, P145, DOI 10.1016/0092-8674(84)90083-7; Stein AJ, 2005, CELL, V121, P529, DOI 10.1016/j.cell.2005.03.009; Szuts D, 2003, NUCLEIC ACIDS RES, V31, P1725, DOI 10.1093/nar/gkg269; Szuts D, 2005, EXP CELL RES, V311, P240, DOI 10.1016/j.yexcr.2005.09.009; Teunissen SWM, 2000, NUCLEIC ACIDS RES, V28, P610, DOI 10.1093/nar/28.2.610; Wang YZ, 2001, J BIOL CHEM, V276, P20579, DOI 10.1074/jbc.M100874200; Wolin SL, 2002, ANNU REV BIOCHEM, V71, P375, DOI 10.1146/annurev.biochem.71.090501.150003; WOLIN SL, 1984, P NATL ACAD SCI-BIOL, V81, P1996, DOI 10.1073/pnas.81.7.1996; Xue DH, 2003, P NATL ACAD SCI USA, V100, P7503, DOI 10.1073/pnas.0832411100	44	31	31	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2010	5	10							e13673	10.1371/journal.pone.0013673	http://dx.doi.org/10.1371/journal.pone.0013673			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671UN	21060685	Green Published, gold, Green Submitted			2022-12-27	WOS:000283537000040
J	Passannante, M; Marti, CO; Pfefferli, C; Moroni, PS; Kaeser-Pebernard, S; Puoti, A; Hunziker, P; Wicky, C; Muller, F				Passannante, Myriam; Marti, Claude-Olivier; Pfefferli, Catherine; Moroni, Paolo S.; Kaeser-Pebernard, Stephanie; Puoti, Alessandro; Hunziker, Peter; Wicky, Chantal; Mueller, Fritz			Different Mi-2 Complexes for Various Developmental Functions in Caenorhabditis elegans	PLOS ONE			English	Article							TANDEM AFFINITY PURIFICATION; NURD-COMPLEX; VULVAL DEVELOPMENT; LIN-35 RB; PROTEIN; GENES; HOMOLOG; BINDING; ANTAGONIZE; EXPRESSION	Biochemical purifications from mammalian cells and Xenopus oocytes revealed that vertebrate Mi-2 proteins reside in multisubunit NuRD (Nucleosome Remodeling and Deacetylase) complexes. Since all NuRD subunits are highly conserved in the genomes of C. elegans and Drosophila, it was suggested that NuRD complexes also exist in invertebrates. Recently, a novel dMec complex, composed of dMi-2 and dMEP-1 was identified in Drosophila. The genome of C. elegans encodes two highly homologous Mi-2 orthologues, LET-418 and CHD-3. Here we demonstrate that these proteins define at least three different protein complexes, two distinct NuRD complexes and one MEC complex. The two canonical NuRD complexes share the same core subunits HDA-1/HDAC, LIN-53/RbAp and LIN-40/MTA, but differ in their Mi-2 orthologues LET-418 or CHD-3. LET-418 but not CHD-3, interacts with the Kruppel-like protein MEP-1 in a distinct complex, the MEC complex. Based on microarrays analyses, we propose that MEC constitutes an important LET-418 containing regulatory complex during C. elegans embryonic and early larval development. It is required for the repression of germline potential in somatic cells and acts when blastomeres are still dividing and differentiating. The two NuRD complexes may not be important for the early development, but may act later during postembryonic development. Altogether, our data suggest a considerable complexity in the composition, the developmental function and the tissue-specificity of the different C. elegans Mi-2 complexes.	[Passannante, Myriam; Marti, Claude-Olivier; Pfefferli, Catherine; Moroni, Paolo S.; Kaeser-Pebernard, Stephanie; Puoti, Alessandro; Wicky, Chantal; Mueller, Fritz] Univ Fribourg, Dept Biol, CH-1700 Fribourg, Switzerland; [Hunziker, Peter] Univ ETH Zurich, Funct Genom Ctr Zurich, Zurich, Switzerland	University of Fribourg; Swiss Federal Institutes of Technology Domain; ETH Zurich	Passannante, M (corresponding author), Univ Fribourg, Dept Biol, CH-1700 Fribourg, Switzerland.	fritz.mueller@unifr.ch	Puoti, Alessandro/ABE-9963-2021; Käser-Pébernard, Stéphanie GM/C-4219-2014; Puoti, Alessandro/E-5700-2012; Müller, Fritz/C-9905-2015	Puoti, Alessandro/0000-0002-1396-7662; Käser-Pébernard, Stéphanie GM/0000-0002-6035-6979; Müller, Fritz/0000-0002-3275-7417; Wicky, Chantal/0000-0002-0034-4992	Swiss National Science Foundation [31003A-109938, 31003A-125577]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work is funded by the Swiss National Science Foundation (http://www.snf.ch/E/Pages/default.aspx) (SNF grants: 31003A-109938 and 31003A-125577). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahringer J, 2000, TRENDS GENET, V16, P351, DOI 10.1016/S0168-9525(00)02066-7; Al-Shahrour F, 2006, NUCLEIC ACIDS RES, V34, pW472, DOI 10.1093/nar/gkl172; Andersen EC, 2006, DEVELOPMENT, V133, P2695, DOI 10.1242/dev.02444; Ballestar E, 2001, EUR J BIOCHEM, V268, P5397, DOI 10.1046/j.0014-2956.2001.02480.x; Belfiore M, 2002, RNA, V8, P725, DOI 10.1017/S1355838202028595; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berezikov E, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh033; Bettinger JC, 1996, DEVELOPMENT, V122, P2517; Bouazoune K, 2006, CHROMOSOME RES, V14, P433, DOI 10.1007/s10577-006-1067-0; Bowen NJ, 2004, BBA-GENE STRUCT EXPR, V1677, P52, DOI 10.1016/j.bbaexp.2003.10.010; Brehm A, 2000, EMBO J, V19, P4332, DOI 10.1093/emboj/19.16.4332; BRENNER S, 1974, GENETICS, V77, P71; Chen Z, 2001, DEVELOPMENT, V128, P4911; Chen Z, 2001, CURR BIOL, V11, P1874, DOI 10.1016/S0960-9822(01)00596-6; Chuang PT, 1996, SCIENCE, V274, P1736, DOI 10.1126/science.274.5293.1736; Couteau F, 2005, GENE DEV, V19, P2744, DOI 10.1101/gad.1348205; Denslow SA, 2007, ONCOGENE, V26, P5433, DOI 10.1038/sj.onc.1210611; Dufourcq P, 2002, MOL CELL BIOL, V22, P3024, DOI 10.1128/MCB.22.9.3024-3034.2002; FELSENSTEIN J, 1988, ANNU REV GENET, V22, P521, DOI 10.1146/annurev.ge.22.120188.002513; Felsenstein J., 2004, INFERRING PHYLOGENIE; GE Q, 1995, J CLIN INVEST, V96, P1730, DOI 10.1172/JCI118218; Goodyer W, 2008, DEV CELL, V14, P263, DOI 10.1016/j.devcel.2007.11.016; Gould KL, 2004, METHODS, V33, P239, DOI 10.1016/j.ymeth.2003.11.019; Guerry F, 2007, DEV BIOL, V306, P469, DOI 10.1016/j.ydbio.2007.03.026; Gutierrez A, 2004, NUCLEIC ACIDS RES, V32, P6388, DOI 10.1093/nar/gkh982; Harrison MM, 2006, P NATL ACAD SCI USA, V103, P16782, DOI 10.1073/pnas.0608461103; HARRISON MM, 2007, GENETICS; HELLMAN U, 1995, ANAL BIOCHEM, V224, P451, DOI 10.1006/abio.1995.1070; Herman MA, 1999, DEVELOPMENT, V126, P1055; Ho L, 2010, NATURE, V463, P474, DOI 10.1038/nature08911; Hubbell E, 2002, BIOINFORMATICS, V18, P1585, DOI 10.1093/bioinformatics/18.12.1585; KIEFER JC, 2006, DEV BIOL; KON C, 2005, GENETICS; KUNERT N, 2009, EMBO J; Lu XW, 1998, CELL, V95, P981, DOI 10.1016/S0092-8674(00)81722-5; Lynch M, 2004, TRENDS GENET, V20, P544, DOI 10.1016/j.tig.2004.09.001; Marhold J, 2004, BMC MOL BIOL, V5, DOI 10.1186/1471-2199-5-20; Murawska M, 2008, MOL CELL BIOL, V28, P2745, DOI 10.1128/MCB.01839-07; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; POULIN G, 2005, EMBO J; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Reinke V, 2004, DEVELOPMENT, V131, P311, DOI 10.1242/dev.00914; Rocheleau CE, 1999, CELL, V97, P717, DOI 10.1016/S0092-8674(00)80784-9; SEELIG HP, 1995, ARTHRITIS RHEUM-US, V38, P1389, DOI 10.1002/art.1780381006; Shakhnovich BE, 2006, GENOME RES, V16, P1529, DOI 10.1101/gr.5346206; Shi Y, 1998, GENE DEV, V12, P943, DOI 10.1101/gad.12.7.943; Siegfried KR, 2002, DEVELOPMENT, V129, P443; Solari F, 2000, CURR BIOL, V10, P223, DOI 10.1016/S0960-9822(00)00343-2; Sternberg Paul W, 2005, WormBook, P1, DOI 10.1895/wormbook.1.6.1; Thomas JH, 2003, GENETICS, V164, P135; Unhavaithaya Y, 2002, CELL, V111, P991, DOI 10.1016/S0092-8674(02)01202-3; UPDIKE DL, 2009, J ANDROL; von Zelewsky T, 2000, DEVELOPMENT, V127, P5277; Wang X, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-213; Wood WB, 1988, NEMATODE CAENORHABDI; Yuzyuk T, 2009, DEV CELL, V16, P699, DOI 10.1016/j.devcel.2009.03.008	56	24	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2010	5	10							e13681	10.1371/journal.pone.0013681	http://dx.doi.org/10.1371/journal.pone.0013681			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671UN	21060680	Green Published, gold, Green Submitted			2022-12-27	WOS:000283537000047
J	Willerth, SM; Pedro, HAM; Pachter, L; Humeau, LM; Arkin, AP; Schaffer, DV				Willerth, Stephanie M.; Pedro, Helder A. M.; Pachter, Lior; Humeau, Laurent M.; Arkin, Adam P.; Schaffer, David V.			Development of a Low Bias Method for Characterizing Viral Populations Using Next Generation Sequencing Technology	PLOS ONE			English	Article							LENTIVIRAL VECTOR; DRUG-RESISTANCE; HIV-1; CELLS; INTEGRATION; EVOLUTION; GENOMICS	Background: With an estimated 38 million people worldwide currently infected with human immunodeficiency virus (HIV), and an additional 4.1 million people becoming infected each year, it is important to understand how this virus mutates and develops resistance in order to design successful therapies. Methodology/Principal Findings: We report a novel experimental method for amplifying full-length HIV genomes without the use of sequence-specific primers for high throughput DNA sequencing, followed by assembly of full length viral genome sequences from the resulting large dataset. Illumina was chosen for sequencing due to its ability to provide greater coverage of the HIV genome compared to prior methods, allowing for more comprehensive characterization of the heterogeneity present in the HIV samples analyzed. Our novel amplification method in combination with Illumina sequencing was used to analyze two HIV populations: a homogenous HIV population based on the canonical NL4-3 strain and a heterogeneous viral population obtained from a HIV patient's infected T cells. In addition, the resulting sequence was analyzed using a new computational approach to obtain a consensus sequence and several metrics of diversity. Significance: This study demonstrates how a lower bias amplification method in combination with next generation DNA sequencing provides in-depth, complete coverage of the HIV genome, enabling a stronger characterization of the quasispecies present in a clinically relevant HIV population as well as future study of how HIV mutates in response to a selective pressure.	[Willerth, Stephanie M.; Schaffer, David V.] Univ Calif Berkeley, Dept Chem Engn, Berkeley, CA 94720 USA; [Willerth, Stephanie M.; Schaffer, David V.] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; [Pedro, Helder A. M.; Arkin, Adam P.; Schaffer, David V.] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA; [Pachter, Lior] Univ Calif Berkeley, Dept Math & Mol & Cell Biol, Berkeley, CA 94720 USA; [Humeau, Laurent M.] VIRxSYS Corp, Gaithersburg, MD USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Willerth, SM (corresponding author), Univ Calif Berkeley, Dept Chem Engn, Berkeley, CA 94720 USA.	aparkin@lbl.gov; schaffer@berkeley.edu	Arkin, Adam/M-9941-2019; Arkin, Adam P/A-6751-2008; Willerth, Stephanie/S-4754-2019	Arkin, Adam/0000-0002-4999-2931; Arkin, Adam P/0000-0002-4999-2931; Willerth, Stephanie/0000-0002-1665-7723; Pachter, Lior/0000-0002-9164-6231	VIRxSYS corporation; NIH [R01 GM073058]; Fundacao Para a Ciencia e a Tecnologia [FCT]; Fundacao Calouste Gulbenkian; Siemens SA Portugal; FCT [SFRH/BD/33204/2007]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073058] Funding Source: NIH RePORTER	VIRxSYS corporation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fundacao Para a Ciencia e a Tecnologia [FCT](Portuguese Foundation for Science and TechnologyEuropean Commission); Fundacao Calouste Gulbenkian(European Commission); Siemens SA Portugal; FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by VIRxSYS corporation and NIH R01 GM073058. H.P. is sponsored by Fundacao Para a Ciencia e a Tecnologia [FCT], Fundacao Calouste Gulbenkian, Siemens SA Portugal and was supported by FCT fellowship SFRH/BD/33204/2007. The funders (specifically the VIRxSYS corporation) provided samples for analysis and input in the experimental design of this project.	ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; Alfano JR, 2009, MOL PLANT PATHOL, V10, P805, DOI 10.1111/j.1364-3703.2009.00588.x; [Anonymous], 2006, OVERVIEW GLOBAL AIDS; Archer J, 2009, AIDS, V23, P1209, DOI 10.1097/QAD.0b013e32832b4399; BRAVO HC, 2009, MODEL BASED QUALITY; Bruselles A, 2009, AIDS RES HUM RETROV, V25, P937, DOI 10.1089/aid.2009.0083; Bushman FD, 2008, AIDS, V22, P1411, DOI 10.1097/QAD.0b013e3282fc972e; Eriksson N, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000074; Fields B. N., 2007, FIELDS VIROLOGY; GIBBS JS, 1994, AIDS RES HUM RETROV, V10, P343, DOI 10.1089/aid.1994.10.343; Han YF, 2007, NAT REV MICROBIOL, V5, P95, DOI 10.1038/nrmicro1580; HITTINGER CT, P NATL ACAD SCI US; Hoffmann C, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm435; Humeau LM, 2004, MOL THER, V9, P902, DOI 10.1016/j.ymthe.2004.03.005; Kamp C, 2003, MICROBES INFECT, V5, P1397, DOI 10.1016/j.micinf.2003.10.001; Kao WC, 2009, GENOME RES, V19, P1884, DOI 10.1101/gr.095299.109; Leonard JN, 2008, CELL HOST MICROBE, V4, P484, DOI 10.1016/j.chom.2008.09.008; Levine BL, 2006, P NATL ACAD SCI USA, V103, P17372, DOI 10.1073/pnas.0608138103; LI WH, 1988, MOL BIOL EVOL, V5, P313; Lu XB, 2004, J GENE MED, V6, P963, DOI 10.1002/jgm.593; MAMANOVA L, NAT METHODS, V7, P111; Mardis ER, 2009, GENOME MED, V1, DOI 10.1186/gm40; Medvedev P, 2009, NAT METHODS, V6, pS13, DOI [10.1038/NMETH.1374, 10.1038/nmeth.1374]; Morozova O, 2008, GENOMICS, V92, P255, DOI 10.1016/j.ygeno.2008.07.001; Morozova O, 2009, ANNU REV GENOM HUM G, V10, P135, DOI 10.1146/annurev-genom-082908-145957; Rambaut A, 2004, NAT REV GENET, V5, P52, DOI 10.1038/nrg1246; Rozera G, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-15; Shafer RW, 2006, J INFECT DIS, V194, pS51, DOI 10.1086/505356; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; Solmone M, 2009, J VIROL, V83, P1718, DOI 10.1128/JVI.02011-08; Tebit DM, 2007, AIDS REV, V9, P75; Tsibris AMN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005683; Wang CL, 2007, GENOME RES, V17, P1195, DOI 10.1101/gr.6468307; Wang GP, 2007, GENOME RES, V17, P1186, DOI 10.1101/gr.6286907; Wang GP, 2009, MOL THER, V17, P844, DOI 10.1038/mt.2009.16	35	41	44	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2010	5	10							e13564	10.1371/journal.pone.0013564	http://dx.doi.org/10.1371/journal.pone.0013564			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	670KA	21042592	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000283419100008
J	Xu, W; Cornel, AJ; Leal, WS				Xu, Wei; Cornel, Anthony J.; Leal, Walter S.			Odorant-Binding Proteins of the Malaria Mosquito Anopheles funestus sensu stricto	PLOS ONE			English	Article							YELLOW-FEVER MOSQUITO; PHEROMONE-BINDING; AEDES-AEGYPTI; CRYSTAL-STRUCTURE; CARBON-DIOXIDE; RELEASE MECHANISM; CULEX MOSQUITOS; LIGAND-BINDING; NMR STRUCTURE; BOMBYX-MORI	Background: The mosquito Anopheles funestus is one of the major malaria vector species in sub-Saharan Africa. Olfaction is essential in guiding mosquito behaviors. Odorant-binding proteins (OBPs) are highly expressed in insect olfactory tissues and involved in the first step of odorant reception. An improved understanding of the function of malaria mosquito OBPs may contribute to identifying new attractants/repellents and assist in the development of more efficient and environmentally friendly mosquito controlling strategies. Methodology: In this study, a large screening of over 50 ecologically significant odorant compounds led to the identification of 12 ligands that elicit significant electroantennographic (EAG) responses from An. funestus female antennae. To compare the absolute efficiency/potency of these chemicals, corrections were made for differences in volatility by determining the exact amount in a stimulus puff. Fourteen AfunOBP genes were cloned and their expression patterns were analyzed. AfunOBP1, 3, 7, 20 and 66 showed olfactory tissue specificity by reverse transcriptase PCR (RT-PCR). Quantitative real-time PCR (qRT-PCR) analysis showed that among olfactory-specific OBPs, AfunOBP1 and 3 are the most enriched OBPs in female antennae. Binding assay experiments showed that at pH 7, AfunOBP1 significantly binds to 2-undecanone, nonyl acetate, octyl acetate and 1-octen-3-ol but AfunOBP3, which shares 68% identify with AfunOBP1 at amino acid level, showed nearly no binding activity to the selected 12 EAG-active odorant compounds. Conclusion: This work presents for the first time a study on the odorants and OBPs of the malaria vector mosquito An. funestus, which may provide insight into the An. funestus olfactory research, assist in a comparative study between major malaria mosquitoes An. gambiae and An. funestus olfactory system, and help developing new mosquito control strategies to reduce malaria transmission.	[Xu, Wei; Cornel, Anthony J.; Leal, Walter S.] Univ Calif Davis, Dept Entomol, Davis, CA 95616 USA	University of California System; University of California Davis	Xu, W (corresponding author), Univ Calif Davis, Dept Entomol, Davis, CA 95616 USA.	wsleal@ucdavis.edu	Leal, Walter/ABC-6940-2021; Xu, Wei/G-4709-2010	Leal Filho, Walter/0000-0002-1241-5225; Leal, Walter/0000-0002-6800-1240; Xu, Wei/0000-0003-4019-5140	National Science Foundation [0918177]; USDA-AFRI [2010-65105-20582]; Bedoukian Research Incorporation; Fuji Flavor Co., Ltd.	National Science Foundation(National Science Foundation (NSF)); USDA-AFRI(United States Department of Agriculture (USDA)); Bedoukian Research Incorporation; Fuji Flavor Co., Ltd.	This work was supported by the National Science Foundation (0918177), USDA-AFRI grant 2010-65105-20582, and unrestricted research funds (defined per university policy as gifts) provided by Bedoukian Research Incorporation, and Fuji Flavor Co., Ltd. The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1987, SUPPLEMENT ANOPHELIN; [Anonymous], 1968, ANOPHELINAE AFR S SA; Bernier UR, 2000, ANAL CHEM, V72, P747, DOI 10.1021/ac990963k; Biessmann H, 2002, INSECT MOL BIOL, V11, P123, DOI 10.1046/j.1365-2583.2002.00316.x; Biessmann H, 2005, INSECT MOL BIOL, V14, P575, DOI 10.1111/j.1365-2583.2005.00590.x; Biessmann H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009471; Bissinger BW, 2009, AM J TROP MED HYG, V81, P685, DOI 10.4269/ajtmh.2009.09-0114; Cork A, 1996, MED VET ENTOMOL, V10, P269, DOI 10.1111/j.1365-2915.1996.tb00742.x; Costantini C, 2001, MED VET ENTOMOL, V15, P259, DOI 10.1046/j.0269-283x.2001.00297.x; Damberger F, 2000, PROTEIN SCI, V9, P1038, DOI 10.1110/ps.9.5.1038; Damberger FF, 2007, J MOL BIOL, V373, P811, DOI 10.1016/j.jmb.2007.07.078; FARRAR RR, 1987, ENTOMOL EXP APPL, V43, P17, DOI 10.1007/BF00350369; FOSTER WA, 1995, ANNU REV ENTOMOL, V40, P443, DOI 10.1146/annurev.en.40.010195.002303; Hallem EA, 2006, ANNU REV ENTOMOL, V51, P113, DOI 10.1146/annurev.ento.51.051705.113646; HALLETT MB, 1984, CELL CALCIUM, V5, P1, DOI 10.1016/0143-4160(84)90150-7; Holt RA, 2002, SCIENCE, V298, P129, DOI 10.1126/science.1076181; Horst R, 2001, P NATL ACAD SCI USA, V98, P14374, DOI 10.1073/pnas.251532998; Hunt RH, 2005, MED VET ENTOMOL, V19, P271, DOI 10.1111/j.1365-2915.2005.00574.x; Innocent E, 2008, Tanzan J Health Res, V10, P50; Ishida Y, 2004, NATURWISSENSCHAFTEN, V91, P426, DOI 10.1007/s00114-004-0551-7; Ishida Y, 2002, J CHEM ECOL, V28, P867, DOI 10.1023/A:1015253214273; KEIL TA, 1984, TISSUE CELL, V16, P705, DOI 10.1016/0040-8166(84)90004-1; Kline DL, 2003, J MED ENTOMOL, V40, P463, DOI 10.1603/0022-2585-40.4.463; KLINE DL, 1991, J MED ENTOMOL, V28, P254, DOI 10.1093/jmedent/28.2.254; KLINE DL, 1994, J AM MOSQUITO CONTR, V10, P280; KLINE DL, 1990, MED VET ENTOMOL, V4, P383, DOI 10.1111/j.1365-2915.1990.tb00455.x; Konate L, 2001, LANCET, V358, P336, DOI 10.1016/S0140-6736(01)05517-9; Kruse SW, 2003, NAT STRUCT BIOL, V10, P694, DOI 10.1038/nsb960; Lartigue A, 2004, J BIOL CHEM, V279, P4459, DOI 10.1074/jbc.M311212200; Lartigue A, 2003, J BIOL CHEM, V278, P30213, DOI 10.1074/jbc.M304688200; LAURENCE BR, 1982, J CHEM SOC CHEM COMM, P59, DOI 10.1039/c39820000059; Leal WS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003045; Leal WS, 2005, P NATL ACAD SCI USA, V102, P5386, DOI 10.1073/pnas.0501447102; Leal WS., 2003, INSECT PHEROMONE BIO; Leite NR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008006; Li ZX, 2005, ARCH INSECT BIOCHEM, V58, P175, DOI 10.1002/arch.20047; Manga L, 1997, T ROY SOC TROP MED H, V91, P387, DOI 10.1016/S0035-9203(97)90249-2; Matsui M, 2007, EUR NEUROL, V57, P57, DOI 10.1159/000097120; Meijerink J, 1999, J INSECT PHYSIOL, V45, P365, DOI 10.1016/S0022-1910(98)00135-8; Muller GC, 2008, J AM MOSQUITO CONTR, V24, P150, DOI 10.2987/8756-971X(2008)24[150:IPAMAS]2.0.CO;2; Ndjemai HNM, 2009, T ROY SOC TROP MED H, V103, P1127, DOI 10.1016/j.trstmh.2008.11.018; Pelletier J, 2010, J CHEM ECOL, V36, P245, DOI 10.1007/s10886-010-9762-x; Pelletier J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006237; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sato K, 2008, NATURE, V452, P1002, DOI 10.1038/nature06850; Sengul MS, 2010, INSECT MOL BIOL, V19, P49, DOI 10.1111/j.1365-2583.2009.00929.x; Sharakhov IV, 2002, SCIENCE, V298, P182, DOI 10.1126/science.1076803; Spillings BL, 2009, AM J TROP MED HYG, V81, P510, DOI 10.4269/ajtmh.2009.81.510; Syed Z, 2006, P NATL ACAD SCI USA, V103, P16538, DOI 10.1073/pnas.0607874103; Syed Z, 2009, P NATL ACAD SCI USA, V106, P18803, DOI 10.1073/pnas.0906932106; TAKKEN W, 1989, J AM MOSQUITO CONTR, V5, P311; Takken W, 1999, ANNU REV ENTOMOL, V44, P131, DOI 10.1146/annurev.ento.44.1.131; VOGT RG, 1981, NATURE, V293, P161, DOI 10.1038/293161a0; Wicher D, 2008, NATURE, V452, P1007, DOI 10.1038/nature06861; Witting-Bissinger BE, 2008, J MED ENTOMOL, V45, P891, DOI 10.1603/0022-2585(2008)45[891:NARBIA]2.0.CO;2; Wogulis M, 2006, BIOCHEM BIOPH RES CO, V339, P157, DOI 10.1016/j.bbrc.2005.10.191; Wojtasek H, 1999, J BIOL CHEM, V274, P30950, DOI 10.1074/jbc.274.43.30950; Wondji CS, 2009, GENOME RES, V19, P452, DOI 10.1101/gr.087916.108; World Health Organization, 2008, WORLD MAL REP; Xu PX, 2003, INSECT MOL BIOL, V12, P549, DOI 10.1046/j.1365-2583.2003.00440.x; Xu PX, 2005, NEURON, V45, P193, DOI 10.1016/j.neuron.2004.12.031; Zhou JJ, 2008, INSECT MOL BIOL, V17, P147, DOI 10.1111/j.1365-2583.2007.00789.x	63	37	42	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2010	5	10							e15403	10.1371/journal.pone.0015403	http://dx.doi.org/10.1371/journal.pone.0015403			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	670KA	21042539	gold, Green Submitted, Green Published			2022-12-27	WOS:000283419100029
J	Havelaar, AH; van Rosse, F; Bucura, C; Toetenel, MA; Haagsma, JA; Kurowicka, D; Heesterbeek, JAP; Speybroeck, N; Langelaar, MFM; van der Giessen, JWB; Cooke, RM; Braks, MAH				Havelaar, Arie H.; van Rosse, Floor; Bucura, Catalin; Toetenel, Milou A.; Haagsma, Juanita A.; Kurowicka, Dorota; Heesterbeek, J. (Hans) A. P.; Speybroeck, Niko; Langelaar, Merel F. M.; van der Giessen, Johanna W. B.; Cooke, Roger M.; Braks, Marieta A. H.			Prioritizing Emerging Zoonoses in The Netherlands	PLOS ONE			English	Article							RISK; INFECTIONS; PATHOGENS; DISEASES	Background: To support the development of early warning and surveillance systems of emerging zoonoses, we present a general method to prioritize pathogens using a quantitative, stochastic multi-criteria model, parameterized for the Netherlands. Methodology/Principal Findings: A risk score was based on seven criteria, reflecting assessments of the epidemiology and impact of these pathogens on society. Criteria were weighed, based on the preferences of a panel of judges with a background in infectious disease control. Conclusions/Significance: Pathogens with the highest risk for the Netherlands included pathogens in the livestock reservoir with a high actual human disease burden (e.g.Campylobacter spp., Toxoplasma gondii, Coxiella burnetii) or a low current but higher historic burden (e.g. Mycobacterium bovis), rare zoonotic pathogens in domestic animals with severe disease manifestations in humans (e.g. BSE prion, Capnocytophaga canimorsus) as well as arthropod-borne and wildlife associated pathogens which may pose a severe risk in future (e.g. Japanese encephalitis virus and West-Nile virus). These agents are key targets for development of early warning and surveillance.	[Havelaar, Arie H.; Haagsma, Juanita A.; Heesterbeek, J. (Hans) A. P.; Langelaar, Merel F. M.; van der Giessen, Johanna W. B.; Braks, Marieta A. H.] Natl Inst Publ Hlth & Environm, NL-3720 BA Bilthoven, Netherlands; [Havelaar, Arie H.; van Rosse, Floor] Univ Utrecht, Utrecht, Netherlands; [Bucura, Catalin; Kurowicka, Dorota; Cooke, Roger M.] Delft Univ Technol, Delft, Netherlands; [Toetenel, Milou A.] Univ Wageningen & Res Ctr, Wageningen, Netherlands; [Haagsma, Juanita A.] Erasmus MC, Rotterdam, Netherlands; [Speybroeck, Niko] Inst Trop Med, B-2000 Antwerp, Belgium; [Speybroeck, Niko] Catholic Univ Louvain, Inst Hlth & Soc, B-1200 Brussels, Belgium	Netherlands National Institute for Public Health & the Environment; Utrecht University; Delft University of Technology; Wageningen University & Research; Erasmus University Rotterdam; Erasmus MC; Institute of Tropical Medicine (ITM); Universite Catholique Louvain	Havelaar, AH (corresponding author), Natl Inst Publ Hlth & Environm, NL-3720 BA Bilthoven, Netherlands.	arie.havelaar@rivm.nl	Smith, Gary B/A-8235-2013; Zixuan, Huang/ABI-3557-2020; Havelaar, Arie H./P-8495-2014	Havelaar, Arie H./0000-0002-6456-5460; Heesterbeek, Hans/0000-0001-8537-6418; Speybroeck, Niko/0000-0003-3322-3502	Dutch Ministry of Agriculture, Nature and Food Quality	Dutch Ministry of Agriculture, Nature and Food Quality	The EmZoo project is funded by the Dutch Ministry of Agriculture, Nature and Food Quality (www.minlnv.nl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript, other than guidance and feedback by the EmZoo Supervisory Committee on the relevance of criteria for policy decisions.	Brown C, 2004, REV SCI TECH OIE, V23, P435, DOI 10.20506/rst.23.2.1495; Cardoen S, 2009, FOODBORNE PATHOG DIS, V6, P1083, DOI 10.1089/fpd.2009.0291; Fauci AS, 2005, ACAD MED, V80, P1079, DOI 10.1097/00001888-200512000-00002; King LJ, 2004, REV SCI TECH OIE, V23, P717, DOI 10.20506/rst.23.2.1507; Krause G, 2008, EURO SURVEILL, V13; KUROWICKA D, 2010, RISK ANAL; McKenzie J, 2007, PREV VET MED, V81, P194, DOI 10.1016/j.prevetmed.2007.04.003; Morgan D, 2009, EPIDEMIOL INFECT, V137, P1521, DOI 10.1017/S0950268809990227; Mourits MCM, 2007, WAG UR FRON, V20, P131; NESLOO REJ, APPL STOCHASTIC MODE; Palmer S, 2005, BMJ-BRIT MED J, V331, P1256, DOI 10.1136/bmj.331.7527.1256; Speybroeck N, 2004, AGR SYST, V80, P133, DOI 10.1016/j.agsy.2003.06.006; Steinberg D., 1995, CART TREE STRUCTURED; Tait J., 2006, FORESIGHT INFECT DIS; Taylor LH, 2001, PHILOS T R SOC B, V356, P983, DOI 10.1098/rstb.2001.0888; Valenciano M., 2001, DEFINITION PRIORITES; VANDERGIESSEN J, 2002, ZOONOSES EUROPE RISK; Vorou RM, 2007, EPIDEMIOL INFECT, V135, P1231, DOI 10.1017/S0950268807008527; Walsh AL, 2005, VET REC, V157, P684, DOI 10.1136/vr.157.22.684; 2004, WHOFAOOIEWHOCDSCPEZF	20	106	107	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2010	5	11							e13965	10.1371/journal.pone.0013965	http://dx.doi.org/10.1371/journal.pone.0013965			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	680KW	21085625	Green Published, Green Submitted, gold			2022-12-27	WOS:000284231800005
J	Ruppender, NS; Merkel, AR; Martin, TJ; Mundy, GR; Sterling, JA; Guelcher, SA				Ruppender, Nazanin S.; Merkel, Alyssa R.; Martin, T. John; Mundy, Gregory R.; Sterling, Julie A.; Guelcher, Scott A.			Matrix Rigidity Induces Osteolytic Gene Expression of Metastatic Breast Cancer Cells	PLOS ONE			English	Article							HORMONE-RELATED PROTEIN; GROWTH-FACTOR; PEPTIDE GENE; IN-VIVO; BONE; HEDGEHOG; KINASE; ACTIVATION; MIGRATION; STIFFNESS	Nearly 70% of breast cancer patients with advanced disease will develop bone metastases. Once established in bone, tumor cells produce factors that cause changes in normal bone remodeling, such as parathyroid hormone-related protein (PTHrP). While enhanced expression of PTHrP is known to stimulate osteoclasts to resorb bone, the environmental factors driving tumor cells to express PTHrP in the early stages of development of metastatic bone disease are unknown. In this study, we have shown that tumor cells known to metastasize to bone respond to 2D substrates with rigidities comparable to that of the bone microenvironment by increasing expression and production of PTHrP. The cellular response is regulated by Rhodependent actomyosin contractility mediated by TGF-beta signaling. Inhibition of Rho-associated kinase (ROCK) using both pharmacological and genetic approaches decreased PTHrP expression. Furthermore, cells expressing a dominant negative form of the TGF-beta receptor did not respond to substrate rigidity, and inhibition of ROCK decreased PTHrP expression induced by exogenous TGF-beta. These observations suggest a role for the differential rigidity of the mineralized bone microenvironment in early stages of tumor-induced osteolysis, which is especially important in metastatic cancer since many cancers (such as those of the breast and lung) preferentially metastasize to bone.	[Ruppender, Nazanin S.; Guelcher, Scott A.] Vanderbilt Univ, Dept Chem & Biomol Engn, Nashville, TN 37235 USA; [Ruppender, Nazanin S.; Merkel, Alyssa R.; Martin, T. John; Mundy, Gregory R.; Sterling, Julie A.; Guelcher, Scott A.] Vanderbilt Univ, Med Ctr, Ctr Bone Biol, Nashville, TN USA; [Merkel, Alyssa R.; Mundy, Gregory R.] Vanderbilt Univ, Med Ctr, Dept Med, Div Clin Pharmacol, Nashville, TN USA; [Mundy, Gregory R.; Sterling, Julie A.] Vet Affairs Tennessee Valley Healthcare Syst, Nashville, TN USA; [Sterling, Julie A.] Vanderbilt Univ, Med Ctr, Dept Canc Biol, Nashville, TN USA; [Martin, T. John] St Vincents Inst, Melbourne, Vic, Australia	Vanderbilt University; Vanderbilt University; Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System; Vanderbilt University; St. Vincent's Institute of Medical Research	Ruppender, NS (corresponding author), Vanderbilt Univ, Dept Chem & Biomol Engn, Nashville, TN 37235 USA.	scott.guelcher@vanderbilt.edu		Merkel, Alyssa/0000-0001-6498-4211	National Institutes of Health Breast Cancer SPORE [P50 CA098131, P01 CA040035]; Tumor Microenvironment Network (TMEN) [U54 CA126505]; NATIONAL CANCER INSTITUTE [U54CA126505, P50CA098131, P01CA040035] Funding Source: NIH RePORTER	National Institutes of Health Breast Cancer SPORE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tumor Microenvironment Network (TMEN); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors acknowledge financial support from the National Institutes of Health Breast Cancer SPORE (P50 CA098131), P01 CA040035, and Tumor Microenvironment Network (TMEN) (U54 CA126505) grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander NR, 2008, CURR BIOL, V18, P1295, DOI 10.1016/j.cub.2008.07.090; Baker AB, 2008, CIRC RES, V103, P289, DOI 10.1161/CIRCRESAHA.108.179465; Barman SA, 2009, VASC HEALTH RISK MAN, V5, P663, DOI 10.2147/VHRM.S4711; Butcher DT, 2009, NAT REV CANCER, V9, P108, DOI 10.1038/nrc2544; Candiello J, 2007, FEBS J, V274, P2897, DOI 10.1111/j.1742-4658.2007.05823.x; Cuppone M, 2004, CALCIFIED TISSUE INT, V74, P302, DOI 10.1007/s00223-002-2123-1; DAIFOTIS AG, 1992, J BIOL CHEM, V267, P23455; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Eichberger T, 2008, J BIOL CHEM, V283, P12426, DOI 10.1074/jbc.M707117200; Enderling H, 2008, BIOPHYS J, V95, P2203, DOI 10.1529/biophysj.108.133199; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; GUELCHER S, 2008, TISSUE ENG IN PRESS; Guelcher SA, 2008, BIOMATERIALS, V29, P1762, DOI 10.1016/j.biomaterials.2007.12.046; Guise TA, 1996, J CLIN INVEST, V98, P1544, DOI 10.1172/JCI118947; GUISE TA, 1993, J CLIN ENDOCR METAB, V77, P40, DOI 10.1210/jc.77.1.40; Hafeman AE, 2008, PHARM RES-DORDR, V25, P2387, DOI 10.1007/s11095-008-9618-z; Hotte SJ, 2002, CANCER-AM CANCER SOC, V95, P506, DOI 10.1002/cncr.10709; Itoh K, 1999, NAT MED, V5, P221, DOI 10.1038/5587; Javelaud D, 2007, CANCER RES, V67, P2317, DOI 10.1158/0008-5472.CAN-06-3950; JOHNSON RW, CANC RES UNPUB; Kakonen SM, 2002, J BIOL CHEM, V277, P24571, DOI 10.1074/jbc.M202561200; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; KHATIWALA CB, 2006, J CELLULAR PHYSL, V211, P661; Kostic A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006361; Liu SJ, 2009, CANCER RES, V69, P8742, DOI 10.1158/0008-5472.CAN-09-1541; Miao DS, 2004, EXP CELL RES, V294, P210, DOI 10.1016/j.yexcr.2003.10.021; Mill P, 2003, GENE DEV, V17, P282, DOI 10.1101/gad.1038103; Moore SW, 2010, DEV CELL, V19, P194, DOI 10.1016/j.devcel.2010.07.018; Narumiya S, 2009, CANCER METAST REV, V28, P65, DOI 10.1007/s10555-008-9170-7; Nowlan NC, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000250; OHNO M, 1995, J CLIN INVEST, V95, P1363, DOI 10.1172/JCI117787; Paszek MJ, 2004, J MAMMARY GLAND BIOL, V9, P325, DOI 10.1007/s10911-004-1404-x; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Philbrick WM, 1996, PHYSIOL REV, V76, P127, DOI 10.1152/physrev.1996.76.1.127; PIROLA CJ, 1994, ENDOCRINOLOGY, V134, P2230, DOI 10.1210/en.134.5.2230; POWELL GJ, 1991, CANCER RES, V51; Raeber GP, 2005, BIOPHYS J, V89, P1374, DOI 10.1529/biophysj.104.050682; Sakata R, 2004, EUR J CLIN INVEST, V34, P129, DOI 10.1111/j.1365-2362.2004.01302.x; SOUTHBY J, 1990, CANCER RES, V50, P7710; Sperling L. H., 2001, INTRO PHYS POLYM SCI; Sterling JA, 2006, CANCER RES, V66, P7548, DOI 10.1158/0008-5472.CAN-06-0452; Tang GH, 2004, J DENT RES, V83, P434, DOI 10.1177/154405910408300516; THIEDE MA, 1990, P NATL ACAD SCI USA, V87, P6969, DOI 10.1073/pnas.87.18.6969; THIEDE MA, 1988, SCIENCE, V242, P278, DOI 10.1126/science.3175653; VanderVeldeZimmermann D, 1997, EXP CELL RES, V230, P111, DOI 10.1006/excr.1996.3405; Wells RG, 2008, SCI SIGNAL, V1, DOI 10.1126/stke.110pe13; Wipff PJ, 2007, J CELL BIOL, V179, P1311, DOI 10.1083/jcb.200704042; YAMAMOTO M, 1992, P NATL ACAD SCI USA, V89, P5326, DOI 10.1073/pnas.89.12.5326; Yin JJ, 1999, J CLIN INVEST, V103, P197, DOI 10.1172/JCI3523; Zaman MH, 2005, BIOPHYS J, V89, P1389, DOI 10.1529/biophysj.105.060723; Zaman MH, 2006, P NATL ACAD SCI USA, V103, P10889, DOI 10.1073/pnas.0604460103	51	60	61	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2010	5	11							e15451	10.1371/journal.pone.0015451	http://dx.doi.org/10.1371/journal.pone.0015451			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	680KW	21085597	gold, Green Published, Green Submitted			2022-12-27	WOS:000284231800033
J	Wu, W; Shen, OX; Qin, YF; Niu, XB; Lu, CC; Xia, YK; Song, L; Wang, SL; Wang, XR				Wu, Wei; Shen, Ouxi; Qin, Yufeng; Niu, Xiaobing; Lu, Chuncheng; Xia, Yankai; Song, Ling; Wang, Shoulin; Wang, Xinru			Idiopathic Male Infertility Is Strongly Associated with Aberrant Promoter Methylation of Methylenetetrahydrofolate Reductase (MTHFR)	PLOS ONE			English	Article							DNA METHYLATION; IMPRINTED LOCI; HUMAN SPERM; GENE; HYPERMETHYLATION; OLIGOZOOSPERMIA; EPIGENETICS; AZOOSPERMIA; POPULATION; CANCER	Background: Abnormal germline DNA methylation in males has been proposed as a possible mechanism compromising spermatogenesis of some men currently diagnosed with idiopathic infertility. Previous studies have been focused on imprinted genes with DNA methylation in poor quality human sperms. However, recent but limited data have revealed that sperm methylation abnormalities may involve large numbers of genes or shown that genes that are not imprinted are also affected. Methodology/Principal Findings: Using the methylation-specific polymerase chain reaction and bisulfite sequencing method, we examined methylation patterns of the promoter of methylenetetrahydrofolate reductase (MTHFR) gene (NG_013351: 1538-1719) in sperm DNA obtained from 94 idiopathic infertile men and 54 normal fertile controls. Subjects with idiopathic infertility were further divided into groups of normozoospermia and oligozoospermia. Overall, 45% (41/94) of idiopathic infertile males had MTHFR hypermethylation (both hemimethylation and full methylation), compared with 15% of fertile controls (P<0.05). Subjects with higher methylation level of MTHFR were more likely to have idiopathic male infertility (P-value for trend = 0.0007). Comparing the two groups of idiopathic infertile subjects with different sperm concentrations, a higher methylation pattern was found in the group with oligozoospermia. Conclusions: Hypermethylation of the promoter of MTHFR gene in sperms is associated with idiopathic male infertility. The functional relevance of hypermathylation of MTHFR to male fertility warrants further investigation.	[Wu, Wei; Shen, Ouxi; Qin, Yufeng; Lu, Chuncheng; Xia, Yankai; Song, Ling; Wang, Shoulin; Wang, Xinru] Nanjing Med Univ, Inst Toxicol, Key Lab Reprod Med, Nanjing, Peoples R China; [Niu, Xiaobing] Nanjing Med Univ, Affiliated Hosp 1, Dept Urol, Nanjing, Peoples R China	Nanjing Medical University; Nanjing Medical University	Wu, W (corresponding author), Nanjing Med Univ, Inst Toxicol, Key Lab Reprod Med, Nanjing, Peoples R China.	xrwang@njmu.edu.cn	Wu, Wei/C-4409-2012	Wu, Wei/0000-0002-0267-1284	National Basic Research Program of China (973 Program) [2009CB941703]; National Natural Science Foundation of China [30930079, 30800927]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported in part by National Basic Research Program of China (973 Program) (No. 2009CB941703); The Key Project of National Natural Science Foundation of China (No. 30930079) and National Natural Science Foundation of China (No. 30800927). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	A ZC, 2007, ASIAN J ANDROL, V9, P57, DOI 10.1111/j.1745-7262.2007.00225.x; BAHNAK BR, 1988, NUCLEIC ACIDS RES, V16, P1208, DOI 10.1093/nar/16.3.1208; Biermann K, 2007, J ANDROL, V28, P466, DOI 10.2164/jandrol.106.002048; Calvanese V, 2009, AGEING RES REV, V8, P268, DOI 10.1016/j.arr.2009.03.004; Chen ZT, 2001, HUM MOL GENET, V10, P433, DOI 10.1093/hmg/10.5.433; Dallosso AR, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000745; deKretser DM, 1997, LANCET, V349, P787, DOI 10.1016/S0140-6736(96)08341-9; Dhillon VS, 2007, MOL HUM REPROD, V13, P213, DOI 10.1093/molehr/gal118; Filipponi D, 2009, EPIGENETICS-US, V4, P27, DOI 10.4161/epi.4.1.7311; Gopalakrishnan S, 2008, MUTAT RES-FUND MOL M, V647, P30, DOI 10.1016/j.mrfmmm.2008.08.006; Handel AE, 2010, TRENDS MOL MED, V16, P7, DOI 10.1016/j.molmed.2009.11.003; Heard E, 1997, ANNU REV GENET, V31, P571, DOI 10.1146/annurev.genet.31.1.571; Henrique R, 2004, EUR UROL, V46, P660, DOI 10.1016/j.eururo.2004.06.014; Houshdaran S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001289; Jung AY, 2008, CANCER EPIDEM BIOMAR, V17, P330, DOI 10.1158/1055-9965.EPI-07-2608; Kelly TLJ, 2005, BIOL REPROD, V72, P667, DOI 10.1095/biolreprod.104.035238; Khazamipour N, 2009, HUM REPROD, V24, P2361, DOI 10.1093/humrep/dep194; Kobayashi H, 2007, HUM MOL GENET, V16, P2542, DOI 10.1093/hmg/ddm187; Kobayashi H, 2009, EUR J HUM GENET, V17, P1582, DOI 10.1038/ejhg.2009.68; Lee HC, 2006, HUM REPROD, V21, P3162, DOI 10.1093/humrep/del280; Marques CJ, 2008, MOL HUM REPROD, V14, P67, DOI 10.1093/molehr/gam093; Marques CJ, 2004, LANCET, V363, P1700, DOI 10.1016/S0140-6736(04)16256-9; Schuebel KE, 2007, PLOS GENET, V3, P1709, DOI 10.1371/journal.pgen.0030157; Schwahn BC, 2004, BIOCHEM J, V382, P831, DOI 10.1042/BJ20030822; Singh K, 2005, INT J ANDROL, V28, P115, DOI 10.1111/j.1365-2605.2004.00513.x; Ushijima C, 2000, HUM REPROD, V15, P1107, DOI 10.1093/humrep/15.5.1107; World Health Organization (WHO), 1999, WHO LAB MANUAL EXAMI, V4th; Wu B, 2007, HUM REPROD, V22, P1107, DOI 10.1093/humrep/del499	29	102	113	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2010	5	11							e13884	10.1371/journal.pone.0013884	http://dx.doi.org/10.1371/journal.pone.0013884			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	677ZE	21085488	Green Submitted, Green Published, gold			2022-12-27	WOS:000284035900005
J	Zhang, J; Cao, J; Weng, QJ; Wu, R; Yan, Y; Jing, H; Zhu, H; He, QJ; Yang, B				Zhang, Jun; Cao, Ji; Weng, Qinjie; Wu, Rui; Yan, Yan; Jing, Hui; Zhu, Hong; He, Qiaojun; Yang, Bo			Suppression of Hypoxia-Inducible Factor 1 alpha (HIF-1 alpha) by Tirapazamine Is Dependent on eIF2 alpha Phosphorylation Rather Than the mTORC1/4E-BP1 Pathway	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM-STRESS; UNFOLDED PROTEIN RESPONSE; ENDOTHELIAL GROWTH-FACTOR; MAMMALIAN TARGET; PROTEASOME INHIBITION; CERVICAL-CANCER; MOUSE MODEL; EXPRESSION; COMPLEX; FACTOR-1-ALPHA	Hypoxia-inducible factor 1 (HIF-1), a heterodimeric transcription factor that mediates the adaptation of tumor cells and tissues to the hypoxic microenvironment, has attracted considerable interest as a potential therapeutic target. Tirapazamine (TPZ), a well-characterized bioreductive anticancer agent, is currently in Phase II and III clinical trials. A major aspect of the anticancer activity of TPZ is its identity as a tumor-specific topoisomerase II alpha inhibitor. In the study, for the first time, we found that TPZ acts in a novel manner to inhibit HIF-1 alpha accumulation driven by hypoxia or growth factors in human cancer cells and in HepG2 cell-derived tumors in athymic nude mice. We investigated the mechanism of TPZ on HIF-1 alpha in HeLa human cervical cancer cells by western blot analysis, reverse transcription-PCR assay, luciferase reporter assay and small interfering RNA (siRNA) assay. Mechanistic studies demonstrated that neither HIF-1 alpha mRNA levels nor HIF-1 alpha protein degradation are affected by TPZ. However, TPZ was found to be involved in HIF-1 alpha translational regulation. Further studies revealed that the inhibitory effect of TPZ on HIF-1 alpha protein synthesis is dependent on the phosphorylation of translation initiation factor 2 alpha (eIF2 alpha) rather than the mTOR complex 1/eukaryotic initiation factor 4E-binding protein-1 (mTORC1/4E-BP1) pathway. Immunofluorescence analysis of tumor sections provide the in vivo evidences to support our hypothesis. Additionally, siRNA specifically targeting topoisomerase II alpha did not reverse the ability of TPZ to inhibit HIF-1 alpha expression, suggesting that the HIF-1 alpha inhibitory activity of TPZ is independent of its topoisomerase II alpha inhibition. In conclusion, our findings suggest that TPZ is a potent regulator of HIF-1 alpha and provide new insight into the potential molecular mechanism whereby TPZ serves to reduce HIF-1 alpha expression.	[Zhang, Jun; Cao, Ji; Weng, Qinjie; Wu, Rui; Yan, Yan; Jing, Hui; Zhu, Hong; He, Qiaojun; Yang, Bo] Zhejiang Univ, Inst Pharmacol & Toxicol, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University	Zhang, J (corresponding author), Zhejiang Univ, Inst Pharmacol & Toxicol, Hangzhou 310003, Zhejiang, Peoples R China.	qiaojunhe@zju.edu.cn; yang924@zju.edu.cn	Jing, Hui/AAL-7810-2020; Jing, Hui/GXM-4109-2022	Jing, Hui/0000-0002-2129-7937; Jing, Hui/0000-0002-8389-8252; Zhu, Hong/0000-0002-2575-4031	National Natural Science Foundation [81072657]; Zhejiang Provincial Natural Science Foundation [Z2090053, R2080326]; Fundamental Research Funds for the Central Universities	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation(Natural Science Foundation of Zhejiang Province); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by The National Natural Science Foundation (No. 81072657); Zhejiang Provincial Natural Science Foundation (No. Z2090053 and No. R2080326); Fundamental Research Funds for the Central Universities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharonowiz M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003145; Brugarolas J, 2004, GENE DEV, V18, P2893, DOI 10.1101/gad.1256804; Craighead PS, 2000, INT J RADIAT ONCOL, V48, P791, DOI 10.1016/S0360-3016(00)00720-3; Creighton-Gutteridge M, 2007, CLIN CANCER RES, V13, P1010, DOI 10.1158/1078-0432.CCR-06-2301; DAI M, 2009, J CELL MOL MED; Delahoussaye YM, 2001, BIOCHEM PHARMACOL, V62, P1201, DOI 10.1016/S0006-2952(01)00784-5; Dunlop EA, 2009, CELL SIGNAL, V21, P827, DOI 10.1016/j.cellsig.2009.01.012; Duyndam MCA, 2007, BIOCHEM PHARMACOL, V74, P191, DOI 10.1016/j.bcp.2007.04.003; Fu BB, 2007, MOL CANCER THER, V6, P220, DOI 10.1158/1535-7163.MCT-06-0526; Hosoi T, 2010, CLIN SCI, V118, P19, DOI 10.1042/CS20080680; Iwawaki T, 2004, NAT MED, V10, P98, DOI 10.1038/nm970; Jeong JW, 2002, CELL, V111, P709, DOI 10.1016/S0092-8674(02)01085-1; Jiang BH, 2001, CELL GROWTH DIFFER, V12, P363; Jiang HY, 2005, J BIOL CHEM, V280, P14189, DOI 10.1074/jbc.M413660200; Kapoor A, 2009, CLIN LIVER DIS, V13, P581, DOI 10.1016/j.cld.2009.07.004; Ke QD, 2006, MOL PHARMACOL, V70, P1469, DOI 10.1124/mol.106.027029; Kim KM, 2007, CIRC RES, V101, P919, DOI 10.1161/CIRCRESAHA.107.154781; Li J, 2005, J BIOL CHEM, V280, P12041, DOI 10.1074/jbc.M412445200; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; LOWELL BB, 1986, BIOCHEM J, V234, P237, DOI 10.1042/bj2340237; Mabjeesh NJ, 2003, CANCER CELL, V3, P363, DOI 10.1016/S1535-6108(03)00077-1; Magagnin MG, 2008, PROTEOMICS, V8, P1019, DOI 10.1002/pmic.200700551; Maluf FC, 2006, INT J GYNECOL CANCER, V16, P1165, DOI 10.1111/j.1525-1438.2006.00454.x; Manolescu B, 2009, BIOCHIMIE, V91, P1347, DOI 10.1016/j.biochi.2009.08.005; Ogiso Y, 2000, CANCER RES, V60, P2429; Peters KB, 2002, CANCER RES, V62, P5248; Reck M, 2004, Pneumologie, V58, P845, DOI 10.1055/s-2004-830056; Roybal CN, 2004, J BIOL CHEM, V279, P14844, DOI 10.1074/jbc.M312948200; Rutkowski DT, 2004, TRENDS CELL BIOL, V14, P20, DOI 10.1016/j.tcb.2003.11.001; Sabatini DM, 2006, NAT REV CANCER, V6, P729, DOI 10.1038/nrc1974; Safran M, 2006, P NATL ACAD SCI USA, V103, P105, DOI 10.1073/pnas.0509459103; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; SEGLEN PO, 1979, EUR J BIOCHEM, V95, P215, DOI 10.1111/j.1432-1033.1979.tb12956.x; Semenza GL, 2009, CURR PHARM DESIGN, V15, P3839, DOI 10.2174/138161209789649402; Sun HL, 2007, ONCOGENE, V26, P3941, DOI 10.1038/sj.onc.1210169; Sun SY, 2005, CANCER RES, V65, P7052, DOI 10.1158/0008-5472.CAN-05-0917; Unruh A, 2003, ONCOGENE, V22, P3213, DOI 10.1038/sj.onc.1206385; Vega F, 2006, CANCER RES, V66, P6589, DOI 10.1158/0008-5472.CAN-05-3018; Zhu KY, 2009, CANCER RES, V69, P1836, DOI 10.1158/0008-5472.CAN-08-4103	40	35	37	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2010	5	11							e13910	10.1371/journal.pone.0013910	http://dx.doi.org/10.1371/journal.pone.0013910			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	677ZE	21085474	gold, Green Published, Green Submitted			2022-12-27	WOS:000284035900017
J	Cespedes, MA; Galindo, MI; Couso, JP				Cespedes, Miguel Angel; Galindo, Maximo Ibo; Couso, Juan Pablo			Dioxin Toxicity In Vivo Results from an Increase in the Dioxin-Independent Transcriptional Activity of the Aryl Hydrocarbon Receptor	PLOS ONE			English	Article							DROSOPHILA LEG DEVELOPMENT; AH RECEPTOR; SPINELESS-ARISTAPEDIA; SIGNALING PATHWAYS; TARSAL DEVELOPMENT; MICE LACKING; BINDING; 2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN; EXPRESSION; PROTEINS	The Aryl hydrocarbon receptor (Ahr) is the nuclear receptor mediating the toxicity of dioxins -widespread and persistent pollutants whose toxic effects include tumor promotion, teratogenesis, wasting syndrome and chloracne. Elimination of Ahr in mice eliminates dioxin toxicity but also produces adverse effects, some seemingly unrelated to dioxin. Thus the relationship between the toxic and dioxin-independent functions of Ahr is not clear, which hampers understanding and treatment of dioxin toxicity. Here we develop a Drosophila model to show that dioxin actually increases the in vivo dioxin-independent activity of Ahr. This hyperactivation resembles the effects caused by an increase in the amount of its dimerisation partner Ahr nuclear translocator (Arnt) and entails an increased transcriptional potency of Ahr, in addition to the previously described effect on nuclear translocation. Thus the two apparently different functions of Ahr, dioxin-mediated and dioxin-independent, are in fact two different levels (hyperactivated and basal, respectively) of a single function.	[Cespedes, Miguel Angel; Galindo, Maximo Ibo; Couso, Juan Pablo] Univ Sussex, Sch Life Sci, Brighton, E Sussex, England	University of Sussex	Cespedes, MA (corresponding author), Univ Sussex, Sch Life Sci, Brighton, E Sussex, England.	j.p.couso@sussex.ac.uk	Couso, Juan Pablo/ABH-5860-2020; Galindo, Máximo Ibo/A-5299-2010	Galindo, Máximo Ibo/0000-0001-8448-9760	Wellcome Trust [087516]; University of Sussex	Wellcome Trust(Wellcome TrustEuropean Commission); University of Sussex	This work was funded by a Wellcome Trust Senior fellowship to JPC (ref. 087516) and a University of Sussex GTA studentship to MAC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bell DR, 2000, J BIOL CHEM, V275, P36407, DOI 10.1074/jbc.M004236200; Bock KW, 2006, BIOCHEM PHARMACOL, V72, P393, DOI 10.1016/j.bcp.2006.01.017; Butler RA, 2001, GENE, V278, P223, DOI 10.1016/S0378-1119(01)00724-7; Chan WK, 1999, J BIOL CHEM, V274, P12115, DOI 10.1074/jbc.274.17.12115; COUMAILLEAU P, 1995, J BIOL CHEM, V270, P25291, DOI 10.1074/jbc.270.42.25291; Duncan DM, 1998, GENE DEV, V12, P1290, DOI 10.1101/gad.12.9.1290; Emmons RB, 1999, DEVELOPMENT, V126, P3937; FERNANDEZSALGUERO P, 1995, SCIENCE, V268, P722, DOI 10.1126/science.7732381; FernandezSalguero PM, 1996, TOXICOL APPL PHARM, V140, P173, DOI 10.1006/taap.1996.0210; Fortini ME, 2000, TRENDS GENET, V16, P161, DOI 10.1016/S0168-9525(99)01939-3; Hahn ME, 2002, CHEM-BIOL INTERACT, V141, P131, DOI 10.1016/S0009-2797(02)00070-4; HOFFMAN EC, 1991, SCIENCE, V252, P954, DOI 10.1126/science.1852076; Ikuta T, 1998, J BIOL CHEM, V273, P2895, DOI 10.1074/jbc.273.5.2895; Kim MD, 2006, GENE DEV, V20, P2806, DOI 10.1101/gad.1459706; Kozu S, 2006, DEV BIOL, V294, P497, DOI 10.1016/j.ydbio.2006.03.015; Martinez AM, 2009, NAT GENET, V41, P1076, DOI 10.1038/ng.414; McMillan BJ, 2007, MOL PHARMACOL, V72, P487, DOI 10.1124/mol.107.037259; Meharg AA, 2003, NATURE, V421, P909, DOI 10.1038/421909a; Mimura J, 1997, GENES CELLS, V2, P645, DOI 10.1046/j.1365-2443.1997.1490345.x; Pueyo JI, 2008, DEV BIOL, V324, P192, DOI 10.1016/j.ydbio.2008.08.025; Qin HT, 2006, DEV BIOL, V298, P606, DOI 10.1016/j.ydbio.2006.07.017; Santiago-Josefat B, 2001, MOL CELL BIOL, V21, P1700, DOI 10.1128/MCB.21.5.1700-1709.2001; Schmidt JV, 1996, ANNU REV CELL DEV BI, V12, P55, DOI 10.1146/annurev.cellbio.12.1.55; St Pierre SE, 2002, DEVELOPMENT, V129, P1273; Steenland K, 2004, ENVIRON HEALTH PERSP, V112, P1265, DOI 10.1289/ehp.7219; SWANSON HI, 1995, J BIOL CHEM, V270, P26292, DOI 10.1074/jbc.270.44.26292; Tijet N, 2006, MOL PHARMACOL, V69, P140, DOI 10.1124/mol.105.018705; Wernet MF, 2006, NATURE, V440, P174, DOI 10.1038/nature04615; WHITLOCK JP, 1990, ANNU REV PHARMACOL, V30, P251	29	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2010	5	11							e15382	10.1371/journal.pone.0015382	http://dx.doi.org/10.1371/journal.pone.0015382			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	676NU	21079739	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000283920000020
J	Zhang, JY; Song, CH; Shi, F; Zhang, Z; Fu, JL; Wang, FS				Zhang, Ji-Yuan; Song, Chun-Hui; Shi, Feng; Zhang, Zheng; Fu, Jun-Liang; Wang, Fu-Sheng			Decreased Ratio of Treg Cells to Th17 Cells Correlates with HBV DNA Suppression in Chronic Hepatitis B Patients Undergoing Entecavir Treatment	PLOS ONE			English	Article							REGULATORY T-CELLS; ANTIVIRAL IMMUNE-RESPONSE; LAMIVUDINE TREATMENT; VIRAL REPLICATION; CYTOKINE MILIEU; TGF-BETA; VIRUS; THERAPY; INHIBITION; INTERPLAY	Background: Treatment with nucleotide analogs is known to be effective in inhibiting HBV replication; however, patients with chronic hepatitis B (CHB) often show a wide range of clinical responses to these drugs. Therefore, the identification of an early immunologic marker associated with the clinical outcomes in such cases is critical for the improved clinical management. In our study, we aimed to investigate whether the viral load in CHB patients affected the ratio of the number of regulatory T cells (Tregs) to the number of interleukin-17-producing helper (Th17) cells. Further, we evaluated the clinical implications of the alterations in this ratio. Methodology/Principal Findings: Nine patients seropositive for hepatitis B e antigen received entecavir monotherapy for 12 months and the percentages of Tregs and Th17 cells as well as the HBV-specific IL-17 productions in these patients were longitudinally analyzed. The entecavir-induced suppression of HBV replication was accompanied by a rapid increase in the number of Th17 cells, together with a decrease in Treg cells, which lead to a significant reduction of Treg/Th17 ratios. In addition, peripheral blood mononuclear cells (PBMCs) exhibited a decreased IL-17 production upon stimulation with the HBV core antigen in vitro. Conclusions: The inhibition of viral replication results in an increase in Th17 cells and concomitant decrease in Treg cells. This imbalance of Treg cells to Th17 cells might have an important role in HBV persistence during entecavir treatment.	[Zhang, Ji-Yuan; Song, Chun-Hui; Zhang, Zheng; Fu, Jun-Liang; Wang, Fu-Sheng] Beijing 302 Hosp, Res Ctr Biol Therapy, Beijing, Peoples R China; [Shi, Feng] Chinese Acad Sci, Inst Microbiol, Beijing, Peoples R China	Fifth Medical Center of Chinese PLA General Hospital; Chinese Academy of Sciences; Institute of Microbiology, CAS	Zhang, JY (corresponding author), Beijing 302 Hosp, Res Ctr Biol Therapy, Beijing, Peoples R China.	fswang@public.bta.net.cn			National Natural Science Foundation of China [30801039]; National Grand Program on Key Infectious Disease [2009ZX10004-103, 2009ZX10004-309, 2008ZX10002-007]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Grand Program on Key Infectious Disease	This study is supported by the National Natural Science Foundation of China (No. 30801039) and the National Grand Program on Key Infectious Disease (No. 2009ZX10004-103, No. 2009ZX10004-309 and 2008ZX10002-007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Billerbeck E, 2010, P NATL ACAD SCI USA, V107, P3006, DOI 10.1073/pnas.0914839107; Boni C, 2001, HEPATOLOGY, V33, P963, DOI 10.1053/jhep.2001.23045; Boni C, 1998, J CLIN INVEST, V102, P968, DOI 10.1172/JCI3731; Boni C, 2003, J HEPATOL, V39, P595, DOI 10.1016/S0168-8278(03)00292-7; Choe WH, 2009, ANTIVIR THER, V14, P985, DOI 10.3851/IMP1417; Dienstag JL, 2008, NEW ENGL J MED, V359, P1486, DOI 10.1056/NEJMra0801644; Franzese O, 2005, J VIROL, V79, P3322, DOI 10.1128/JVI.79.6.3322-3328.2005; Huang YW, 2010, ANTIVIR THER, V15, P177, DOI 10.3851/IMP1508; Karino Y, 2010, HEPATOL INT, V4, P414, DOI 10.1007/s12072-009-9162-x; Lee JM, 2009, ANTIVIR THER, V14, P705; Lemmers A, 2009, HEPATOLOGY, V49, P646, DOI 10.1002/hep.22680; Leung S, 2010, CELL MOL IMMUNOL, V7, P182, DOI 10.1038/cmi.2010.22; Marinos G, 1996, HEPATOLOGY, V24, P991; Oukka M, 2007, ANN RHEUM DIS, V66, P87, DOI 10.1136/ard.2007.078527; Rehermann B, 2005, NAT REV IMMUNOL, V5, P215, DOI 10.1038/nri1573; Rowan AG, 2008, J IMMUNOL, V181, P4485, DOI 10.4049/jimmunol.181.7.4485; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; Sprengers D, 2007, ANTIVIR THER, V12, P1087; Stoop JN, 2007, VIROLOGY, V361, P141, DOI 10.1016/j.virol.2006.11.018; Stoop JN, 2005, HEPATOLOGY, V41, P771, DOI 10.1002/hep.20649; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Wang FS, 2007, HEPATOL RES, V37, pS339, DOI 10.1111/j.1872-034X.2007.00222.x; Wang Fu-Sheng, 2009, Expert Rev Gastroenterol Hepatol, V3, P499, DOI 10.1586/egh.09.50; Weaver CT, 2007, ANNU REV IMMUNOL, V25, P821, DOI 10.1146/annurev.immunol.25.022106.141557; Weaver CT, 2009, NAT REV IMMUNOL, V9, P883, DOI 10.1038/nri2660; Xu DP, 2006, J IMMUNOL, V177, P739, DOI 10.4049/jimmunol.177.1.739; Yasumi Y, 2007, HEPATOL RES, V37, P248, DOI 10.1111/j.1872-034X.2007.00040.x; Yokosuka O, 2010, J HEPATOL, V52, P791, DOI 10.1016/j.jhep.2009.12.036; Zhang JY, 2008, J IMMUNOL, V181, P3741, DOI 10.4049/jimmunol.181.6.3741; Zhang JY, 2010, HEPATOLOGY, V51, P81, DOI 10.1002/hep.23273; Zhou L, 2008, NATURE, V453, P236, DOI 10.1038/nature06878	32	57	80	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2010	5	11							e13869	10.1371/journal.pone.0013869	http://dx.doi.org/10.1371/journal.pone.0013869			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	676NU	21079784	Green Published, Green Submitted, gold			2022-12-27	WOS:000283920000004
J	Ahtiainen, L; Mirantes, C; Jahkola, T; Escutenaire, S; Diaconu, I; Osterlund, P; Kanerva, A; Cerullo, V; Hemminki, A				Ahtiainen, Laura; Mirantes, Cristina; Jahkola, Tiina; Escutenaire, Sophie; Diaconu, Iulia; Osterlund, Pamela; Kanerva, Anna; Cerullo, Vincenzo; Hemminki, Akseli			Defects in Innate Immunity Render Breast Cancer Initiating Cells Permissive to Oncolytic Adenovirus	PLOS ONE			English	Article							VESICULAR STOMATITIS-VIRUS; STEM-CELLS; OVARIAN-CANCER; IN-VIVO; RESPONSES; TLR9; DNA; IDENTIFICATION; EFFICACY; TRIGGERS	Background: Cancer stem cells/initiating cells (CSC/CIC), are thought to exist as a small population in malignant tissues. They are resistant to conventional cancer treatments and possibly underlie post-treatment relapse. The CIC population can be targeted with capsid modified oncolytic adenoviruses. Methodology/Principal Findings: We studied the mechanisms of innate immunity to oncolytic adenovirus Ad5/3-Delta24 in conventional treatment resistant non-CIC breast cancer cells, breast cancer CD44(+)/CD24(-/low) CIC population and normal breast tissue CD44(+)/CD24(-/low) stem cells. We compared virus recognition by pattern recognition receptors for adenovirus, Toll-like receptors (TLR) 2 and 9 and virus induced type I interferon (IFN) response regulation in these cell types. We show TLR mediated virus recognition in these non-immune cell types. Normal tissue stem cells have intact type I IFN signaling. Furthermore, TLR9 and TLR2 reside constantly in recognition sites, implying constant activation. In contrast, breast cancer CD44(+)/CD24(-/low) CIC have dysregulated innate immune responses featuring dysfunctional virus recognition caused by impaired trafficking of TLR9 and cofactor MyD88 and the absence of TLR2, having a deleterious impact on TLR pattern recognition receptor signaling. Furthermore, the CIC have increased inhibitory signaling via the suppressor of cytokine signaling/Tyro3/Axl/Mer receptor tyrosine kinase (SOCS/TAM) pathway. These defects in contribute to dysfunctional induction of type I IFN response in CIC and therefore permissivity to oncolytic adenovirus. Conclusions/Significance: CICs may underlie the incurable nature of relapsed or metastatic cancers and are therefore an important target regarding diagnostic and prognostic aspects as well as treatment of the disease. This study addresses the mechanisms of innate infection immunity in stem cells deepening the understanding of stem cell biology and may benefit not only virotherapy but also immunotherapy in general.	[Ahtiainen, Laura; Mirantes, Cristina; Escutenaire, Sophie; Diaconu, Iulia; Kanerva, Anna; Cerullo, Vincenzo; Hemminki, Akseli] Univ Helsinki, Transplantat Lab, Canc Gene Therapy Grp, Mol Canc Biol Program,Haartman Inst, Helsinki, Finland; [Ahtiainen, Laura; Mirantes, Cristina; Escutenaire, Sophie; Diaconu, Iulia; Kanerva, Anna; Cerullo, Vincenzo; Hemminki, Akseli] Univ Helsinki, Finnish Inst Mol Med, Helsinki, Finland; [Ahtiainen, Laura; Mirantes, Cristina; Escutenaire, Sophie; Diaconu, Iulia; Cerullo, Vincenzo; Hemminki, Akseli] Univ Helsinki, Cent Hosp, HUSLAB, Helsinki, Finland; [Jahkola, Tiina] Univ Helsinki, Cent Hosp, Dept Plast Surg, Helsinki, Finland; [Osterlund, Pamela] Natl Inst Hlth & Welf, Dept Vaccinat & Immune Protect, Viral Infect Unit, Helsinki, Finland; [Kanerva, Anna] Univ Helsinki, Cent Hosp, Dept Obstet & Gynaecol, Helsinki, Finland	University of Helsinki; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Helsinki University Central Hospital; Finland National Institute for Health & Welfare; University of Helsinki; Helsinki University Central Hospital	Ahtiainen, L (corresponding author), Univ Helsinki, Transplantat Lab, Canc Gene Therapy Grp, Mol Canc Biol Program,Haartman Inst, Helsinki, Finland.	laura.ahtiainen@helsinki.fi; akseli.hemminki@helsinki.fi	Österlund, Pamela/L-2528-2015; Österlund, Pamela/AGH-9008-2022; Cerullo, Vincenzo/B-9075-2015	Österlund, Pamela/0000-0002-2229-6661; Österlund, Pamela/0000-0002-2229-6661; Cerullo, Vincenzo/0000-0003-4901-3796; Ahtiainen, Laura/0000-0002-6636-1584	European Research Council; EU; Helsinki University Central Hospital; Finnish Cancer Society; Sigrid Juselius Foundation; K. Albin Johansson Fund; Academy of Finland; Biocentrum Helsinki; University of Helsinki	European Research Council(European Research Council (ERC)European Commission); EU(European Commission); Helsinki University Central Hospital; Finnish Cancer Society; Sigrid Juselius Foundation(Sigrid Juselius Foundation); K. Albin Johansson Fund; Academy of Finland(Academy of Finland); Biocentrum Helsinki; University of Helsinki	Funding: This study was supported by the European Research Council, EU FP6 APOTHERAPY, Helsinki University Central Hospital Research Funds (EVO), Finnish Cancer Society, Sigrid Juselius Foundation, K. Albin Johansson Fund, Academy of Finland, Biocentrum Helsinki and University of Helsinki. A. Hemminki is K. Albin Johansson Research Professor of the Foundation for the Finnish Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CURR TOP MICROBIOL, V311, P1; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Appledorn DM, 2008, J IMMUNOL, V181, P2134, DOI 10.4049/jimmunol.181.3.2134; Bauerschmitz GJ, 2008, CANCER RES, V68, P5533, DOI 10.1158/0008-5472.CAN-07-5288; Brendel C, 2007, LEUKEMIA, V21, P1267, DOI 10.1038/sj.leu.2404638; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Cerullo V, 2007, MOL THER, V15, P378, DOI 10.1038/sj.mt.6300031; Eriksson M, 2007, MOL THER, V15, P2088, DOI 10.1038/sj.mt.6300300; Fan X, 2006, CANCER RES, V66, P7445, DOI 10.1158/0008-5472.CAN-06-0858; Fernandez M, 2002, J VIROL, V76, P895, DOI 10.1128/JVI.76.2.895-904.2002; Fueyo J, 2000, ONCOGENE, V19, P2, DOI 10.1038/sj.onc.1203251; Garcia-Sastre A, 2006, SCIENCE, V312, P879, DOI 10.1126/science.1125676; Hakkarainen T, 2007, HUM GENE THER, V18, P627, DOI 10.1089/hum.2007.034; Heise C, 2000, NAT MED, V6, P1134, DOI 10.1038/80474; HUANG X, 2009, HUM GENE THER; Jiang H, 2007, J NATL CANCER I, V99, P1410, DOI 10.1093/jnci/djm102; Kakarala M, 2008, J CLIN ONCOL, V26, P2813, DOI 10.1200/JCO.2008.16.3931; Kanerva A, 2002, CLIN CANCER RES, V8, P275; Kanerva A, 2005, ANN MED, V37, P33, DOI 10.1080/07853890410018934; Kanerva A, 2003, MOL THER, V8, P449, DOI 10.1016/S1525-0016(03)00200-4; Kelly KJ, 2008, HUM GENE THER, V19, P774, DOI 10.1089/hum.2008.036; Latz E, 2004, NAT IMMUNOL, V5, P190, DOI 10.1038/ni1028; Leifer CA, 2004, J IMMUNOL, V173, P1179, DOI 10.4049/jimmunol.173.2.1179; Lobo NA, 2007, ANNU REV CELL DEV BI, V23, P675, DOI 10.1146/annurev.cellbio.22.010305.104154; Look DC, 1998, IMMUNITY, V9, P871, DOI 10.1016/S1074-7613(00)80652-4; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Marcato P, 2009, MOL THER, V17, P972, DOI 10.1038/mt.2009.58; MUROHASHI M, 2009, BR J CANC; Phillips TM, 2006, JNCI-J NATL CANCER I, V98, P1777, DOI 10.1093/jnci/djj495; Ribacka C, 2008, CURR GENE THER, V8, P88, DOI 10.2174/156652308784049372; Sagar J, 2007, CANCER CELL INT, V7, DOI 10.1186/1475-2867-7-9; Saitoh SI, 2009, IMMUNOL REV, V227, P32, DOI 10.1111/j.1600-065X.2008.00729.x; Sansone P, 2007, J CLIN INVEST, V117, P3988, DOI 10.1172/JCI32533; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Small EJ, 2006, MOL THER, V14, P107, DOI 10.1016/j.ymthe.2006.02.011; Szotek PP, 2006, P NATL ACAD SCI USA, V103, P11154, DOI 10.1073/pnas.0603672103; Takaoka A, 2008, ADV DRUG DELIVER REV, V60, P847, DOI 10.1016/j.addr.2007.12.002; Takaoka Akinori, 2008, Virus (Nagoya), V58, P37; Tu LC, 2009, CURR STEM CELL RES T, V4, P147, DOI 10.2174/157488809788167373; Wang TH, 2004, NAT MED, V10, P48, DOI 10.1038/nm976; Wollmann G, 2007, J VIROL, V81, P1479, DOI 10.1128/JVI.01861-06	41	25	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2010	5	11							e13859	10.1371/journal.pone.0013859	http://dx.doi.org/10.1371/journal.pone.0013859			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675OD	21079774	gold, Green Published, Green Submitted			2022-12-27	WOS:000283839100013
J	Hsu, CT; Dollar, P; Chang, D; Steele, AD				Hsu, Cynthia T.; Dollar, Piotr; Chang, Daniel; Steele, Andrew D.			Daily Timed Sexual Interaction Induces Moderate Anticipatory Activity in Mice	PLOS ONE			English	Article							ACTIVITY RHYTHMS; CIRCADIAN-RHYTHMS; WATER ACCESS; FOOD; ENTRAINMENT; REWARD; BEHAVIOR; RATS; HYPOTHALAMUS; TEMPERATURE	Anticipation of resource availability is a vital skill yet it is poorly understood in terms of neuronal circuitry. Rodents display robust anticipatory activity in the several hours preceding timed daily access to food when access is limited to a short temporal duration. We tested whether this anticipatory behavior could be generalized to timed daily social interaction by examining if singly housed male mice could anticipate either a daily novel female or a familiar female. We observed that anticipatory activity was moderate under both conditions, although both a novel female partner and sexual experience are moderate contributing factors to increasing anticipatory activity. In contrast, restricted access to running wheels did not produce any anticipatory activity, suggesting that an increase in activity during the scheduled access time was not sufficient to induce anticipation. To tease apart social versus sexual interaction, we tested the effect of exposing singly housed female mice to a familiar companion female mouse daily. The female mice did not show anticipatory activity for restricted female access, despite a large amount of social interaction, suggesting that daily timed social interaction between mice of the same gender is insufficient to induce anticipatory activity. Our study demonstrates that male mice will show anticipatory activity, albeit inconsistently, for a daily timed sexual encounter.	[Hsu, Cynthia T.; Chang, Daniel; Steele, Andrew D.] CALTECH, Div Biol, Broad Fellows Program Brain Circuitry, Pasadena, CA 91125 USA; [Dollar, Piotr] CALTECH, Div Engn & Appl Sci, Pasadena, CA 91125 USA	California Institute of Technology; California Institute of Technology	Hsu, CT (corresponding author), CALTECH, Div Biol, Broad Fellows Program Brain Circuitry, Pasadena, CA 91125 USA.	steelea@caltech.edu			Brain Circuitry Program at Caltech; Ellison Medical Foundation; Klarman Family Foundation	Brain Circuitry Program at Caltech; Ellison Medical Foundation(Lawrence Ellison Foundation); Klarman Family Foundation	This work was funded by the Broad Fellows in Brain Circuitry Program at Caltech, the Ellison Medical Foundation new scholar award, and the Klarman Family Foundation Grants Program in Eating Disorders Research to ADS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angeles-Castellanos M, 2008, NEUROSCIENCE, V155, P297, DOI 10.1016/j.neuroscience.2008.06.001; Blum ID, 2009, NEUROSCIENCE, V164, P351, DOI 10.1016/j.neuroscience.2009.08.009; DAMATO FR, 1988, J COMP PSYCHOL, V102, P146, DOI 10.1037/0735-7036.102.2.146; Davidson AJ, 2009, EUR J NEUROSCI, V30, P1658, DOI 10.1111/j.1460-9568.2009.06961.x; Hsu CT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012903; Kaur S, 2008, BRAIN RES, V1205, P47, DOI 10.1016/j.brainres.2008.02.026; LeSauter J, 2009, P NATL ACAD SCI USA, V106, P13582, DOI 10.1073/pnas.0906426106; Lett BT, 2002, PHARMACOL BIOCHEM BE, V72, P101, DOI 10.1016/S0091-3057(01)00722-5; Marchant EG, 1997, BRAIN RES, V765, P273, DOI 10.1016/S0006-8993(97)00571-4; McGILL THOMAS E., 1962, BEHAVIOUR, V19, P341, DOI 10.1163/156853962X00087; Mendoza J, 2005, NEUROSCIENCE, V133, P293, DOI 10.1016/j.neuroscience.2005.01.064; Mieda M, 2006, P NATL ACAD SCI USA, V103, P12150, DOI 10.1073/pnas.0604189103; MISTLBERGER R, 1987, PHYSIOL BEHAV, V41, P219, DOI 10.1016/0031-9384(87)90356-8; Mistlberger RE, 2009, EUR J NEUROSCI, V30, P1718, DOI 10.1111/j.1460-9568.2009.06965.x; Mistlberger RE, 2003, BRAIN RES, V980, P161, DOI 10.1016/S0006-8993(03)02755-0; MISTLBERGER RE, 1993, PHYSIOL BEHAV, V53, P509, DOI 10.1016/0031-9384(93)90145-6; MISTLBERGER RE, 1992, J BIOL RHYTHM, V7, P149, DOI 10.1177/074873049200700206; MISTLBERGER RE, 1993, AM J PHYSIOL, V264, pR22, DOI 10.1152/ajpregu.1993.264.1.R22; Pardon MC, 2004, EUR J NEUROSCI, V20, P1033, DOI 10.1111/j.1460-9568.2004.03549.x; Ribeiro AC, 2009, EUR J NEUROSCI, V30, P1730, DOI 10.1111/j.1460-9568.2009.06969.x; SHIBATA S, 1994, NEUROSCI LETT, V172, P107, DOI 10.1016/0304-3940(94)90673-4; Steele AD, 2008, P NATL ACAD SCI USA, V105, P13626, DOI 10.1073/pnas.0806319105; Steele AD, 2007, P NATL ACAD SCI USA, V104, P1983, DOI 10.1073/pnas.0610779104; Sutton GM, 2008, J NEUROSCI, V28, P12946, DOI 10.1523/JNEUROSCI.3615-08.2008; Swaney WT, 2007, P NATL ACAD SCI USA, V104, P6084, DOI 10.1073/pnas.0609471104; Vargas-Perez H, 2004, NEUROSCI LETT, V366, P172, DOI 10.1016/j.neulet.2004.05.029; Verwey M, 2009, EUR J NEUROSCI, V30, P1650, DOI 10.1111/j.1460-9568.2009.06960.x; Webb IC, 2009, J BIOL RHYTHM, V24, P465, DOI 10.1177/0748730409346657; Webb IC, 2009, EUR J NEUROSCI, V30, P1739, DOI 10.1111/j.1460-9568.2009.06966.x	29	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2010	5	11							e15429	10.1371/journal.pone.0015429	http://dx.doi.org/10.1371/journal.pone.0015429			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	800AR	21082027	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000293329500005
J	Jessup, JA; Lindsey, SH; Wang, H; Chappell, MC; Groban, L				Jessup, Jewell A.; Lindsey, Sarah H.; Wang, Hao; Chappell, Mark C.; Groban, Leanne			Attenuation of Salt-Induced Cardiac Remodeling and Diastolic Dysfunction by the GPER Agonist G-1 in Female mRen2.Lewis Rats	PLOS ONE			English	Article							VENTRICULAR FILLING PRESSURES; PRONE SHHF/MCC-FA(CP) RATS; RENIN-ANGIOTENSIN SYSTEM; HEART-FAILURE; ESTROGEN-RECEPTOR; BLOOD-PRESSURE; DOPPLER-ECHOCARDIOGRAPHY; SYSTOLIC FUNCTION; TISSUE DOPPLER; HYPERTENSION	Introduction: The G protein-coupled estrogen receptor (GPER) is expressed in various tissues including the heart. Since the mRen2.Lewis strain exhibits salt-dependent hypertension and early diastolic dysfunction, we assessed the effects of the GPER agonist (G-1, 40 nmol/kg/hr for 14 days) or vehicle (VEH, DMSO/EtOH) on cardiac function and structure. Methods: Intact female mRen2.Lewis rats were fed a normal salt (0.5% sodium; NS) diet or a high salt (4% sodium; HS) diet for 10 weeks beginning at 5 weeks of age. Results: Prolonged intake of HS in mRen2.Lewis females resulted in significantly increased blood pressure, mildly reduced systolic function, and left ventricular (LV) diastolic compliance (as signified by a reduced E deceleration time and E deceleration slope), increased relative wall thickness, myocyte size, and mid-myocardial interstitial and perivascular fibrosis. G-1 administration attenuated wall thickness and myocyte hypertrophy, with nominal effects on blood pressure, LV systolic function, LV compliance and cardiac fibrosis in the HS group. G-1 treatment significantly increased LV lusitropy [early mitral annular descent (e')] independent of prevailing salt, and improved the e'/a' ratio in HS versus NS rats (P < 0.05) as determined by tissue Doppler. Conclusion: Activation of GPER improved myocardial relaxation in the hypertensive female mRen2.Lewis rat and reduced cardiac myocyte hypertrophy and wall thickness in those rats fed a high salt diet. Moreover, these advantageous effects of the GPER agonist on ventricular lusitropy and remodeling do not appear to be associated with overt changes in blood pressure.	[Jessup, Jewell A.; Chappell, Mark C.] Wake Forest Univ, Bowman Gray Sch Med, Dept Physiol & Pharmacol, Winston Salem, NC 27103 USA; [Lindsey, Sarah H.; Chappell, Mark C.; Groban, Leanne] Wake Forest Univ, Bowman Gray Sch Med, Hypertens & Vasc Res Ctr, Winston Salem, NC 27103 USA; [Wang, Hao; Groban, Leanne] Wake Forest Univ, Bowman Gray Sch Med, Dept Anesthesiol, Winston Salem, NC 27103 USA	Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center	Jessup, JA (corresponding author), Wake Forest Univ, Bowman Gray Sch Med, Dept Physiol & Pharmacol, Winston Salem, NC 27103 USA.	lgroban@wfubmc.edu	Chappell, Mark/AAX-9087-2021; Lindsey, Sarah/AAG-4185-2021; Lindsey, Sarah H/J-2593-2012	Lindsey, Sarah/0000-0002-9837-4582; Lindsey, Sarah H/0000-0002-9837-4582; Groban, Leanne/0000-0001-8934-7358; Wang, Hao/0000-0003-1537-661X	National Institutes of Health [R01-AG033727-01, KO8-AG026764-05]; American Heart Association;  [LH-56973]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL056973, R29HL056973] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K08AG026764, R01AG033727] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The work described here was supported in part by grants from the National Institutes of Health grants R01-AG033727-01 (LG), KO8-AG026764-05 Paul Beeson award (LG), American Heart Association Postdoctoral Fellowship (SHL), and LH-56973 (MCC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APPLETON CP, 1991, J AM COLL CARDIOL, V17, P227, DOI 10.1016/0735-1097(91)90731-N; Bologa CG, 2006, NAT CHEM BIOL, V2, P207, DOI 10.1038/nchembio775; Bopassa JC, 2010, AM J PHYSIOL-HEART C, V298, pH16, DOI 10.1152/ajpheart.00588.2009; Brosnihan KB, 1997, J HYPERTENS, V15, P719, DOI 10.1097/00004872-199715070-00003; BUNAG RD, 1973, J APPL PHYSIOL, V34, P279, DOI 10.1152/jappl.1973.34.2.279; Chappell MC, 2008, GENDER MED, V5, pS65, DOI 10.1016/j.genm.2008.03.007; Chappell MC, 2006, AM J PHYSIOL-REG I, V291, pR1557, DOI 10.1152/ajpregu.00051.2006; Chappell MC, 2003, HYPERTENSION, V42, P781, DOI 10.1161/01.HYP.0000085210.66399.A3; CHOONG CY, 1987, J AM COLL CARDIOL, V10, P800, DOI 10.1016/S0735-1097(87)80273-5; Cleland JGF, 2003, EUR HEART J, V24, P442, DOI 10.1016/S0195-668X(02)00823-0; Dai QX, 2008, GENDER MED, V5, P74, DOI 10.1016/S1550-8579(08)80010-1; de Jager T, 2001, J BIOL CHEM, V276, P27873, DOI 10.1074/jbc.M010984200; Deschamps AM, 2009, AM J PHYSIOL-HEART C, V297, pH1806, DOI 10.1152/ajpheart.00283.2009; Devereux RB, 2000, AM J CARDIOL, V86, P1090, DOI 10.1016/S0002-9149(00)01165-6; Dubey RK, 2001, J APPL PHYSIOL, V91, P1868, DOI 10.1152/jappl.2001.91.4.1868; Dumesnil JG, 2002, J AM SOC ECHOCARDIOG, V15, P1226, DOI 10.1067/mje.2002.123396; Filardo E, 2007, ENDOCRINOLOGY, V148, P3236, DOI 10.1210/en.2006-1605; Filardo EJ, 2005, TRENDS ENDOCRIN MET, V16, P362, DOI 10.1016/j.tem.2005.08.005; GARAVAGLIA GE, 1989, EUR HEART J, V10, P1110, DOI 10.1093/oxfordjournals.eurheartj.a059434; Groban L, 2008, J GERONTOL A-BIOL, V63, P3, DOI 10.1093/gerona/63.1.3; Grohe C, 1997, FEBS LETT, V416, P107, DOI 10.1016/S0014-5793(97)01179-4; Haugen E, 2007, INT J CARDIOL, V115, P24, DOI 10.1016/j.ijcard.2006.01.031; HEIMANN JC, 1991, J CARDIOVASC PHARM, V17, pS122, DOI 10.1097/00005344-199117002-00028; Holycross BJ, 1997, AM J PHYSIOL-HEART C, V273, pH228, DOI 10.1152/ajpheart.1997.273.1.H228; JUNQUEIRA LCU, 1979, HISTOCHEM J, V11, P447, DOI 10.1007/BF01002772; Kitzman DW, 2001, AM J CARDIOL, V87, P413, DOI 10.1016/S0002-9149(00)01393-X; Leenen FHH, 1998, J HYPERTENS, V16, P885, DOI 10.1097/00004872-199816060-00020; Lindsey SH, 2009, ENDOCRINOLOGY, V150, P3753, DOI 10.1210/en.2008-1664; Lombardi W L, 2000, Curr Cardiol Rep, V2, P90, DOI 10.1007/s11886-000-0004-7; Masoudi FA, 2003, J AM COLL CARDIOL, V41, P217, DOI 10.1016/S0735-1097(02)02696-7; Nagueh SF, 1996, CIRCULATION, V94, P2138, DOI 10.1161/01.CIR.94.9.2138; Nagueh SF, 1998, CIRCULATION, V98, P1644, DOI 10.1161/01.CIR.98.16.1644; Nagueh SF, 2001, J AM COLL CARDIOL, V37, P278, DOI 10.1016/S0735-1097(00)01056-1; NAKAGAWA O, 1995, J CLIN INVEST, V96, P1280, DOI 10.1172/JCI118162; Nickenig G, 1998, CIRCULATION, V97, P2197, DOI 10.1161/01.CIR.97.22.2197; Noorlander ML, 2002, J HISTOCHEM CYTOCHEM, V50, P1469, DOI 10.1177/002215540205001106; Oh JK, 2006, J AM COLL CARDIOL, V47, P500, DOI 10.1016/j.jacc.2005.09.032; Ommen SR, 2000, CIRCULATION, V102, P1788; Pelzer T, 1997, ADV EXP MED BIOL, V432, P83; Prossnitz ER, 2008, ANNU REV PHYSIOL, V70, P165, DOI 10.1146/annurev.physiol.70.113006.100518; Revankar CM, 2007, ACS CHEM BIOL, V2, P536, DOI 10.1021/cb700072n; Revankar CM, 2005, SCIENCE, V307, P1625, DOI 10.1126/science.1106943; Roesch DM, 2000, ENDOCRINOLOGY, V141, P4629, DOI 10.1210/en.141.12.4629; Schunkert H, 1997, CIRCULATION, V95, P39, DOI 10.1161/01.CIR.95.1.39; Sharkey LC, 1999, J MOL CELL CARDIOL, V31, P1527, DOI 10.1006/jmcc.1999.0985; Silvestre JS, 1998, J BIOL CHEM, V273, P4883, DOI 10.1074/jbc.273.9.4883; SMITH SA, 1989, BRIT HEART J, V61, P344; Solomon SD, 2010, HYPERTENSION, V55, P241, DOI 10.1161/HYPERTENSIONAHA.109.138529; STODDARD MF, 1989, CIRCULATION, V79, P1226, DOI 10.1161/01.CIR.79.6.1226; Thohan V, 2009, CURR OPIN CARDIOL, V24, P230, DOI 10.1097/HCO.0b013e328329f8fd; WEINBERGER MH, 1991, AM J HYPERTENS, V4, pS615, DOI 10.1093/ajh/4.11S.615S; Whitesall SE, 2004, AM J PHYSIOL-HEART C, V286, pH2408, DOI 10.1152/ajpheart.01089.2003; Xu Y, 2003, CARDIOVASC RES, V57, P388, DOI 10.1016/S0008-6363(02)00705-8; Yang CM, 1997, CARDIOVASC RES, V36, P236, DOI 10.1016/S0008-6363(97)00186-7	54	75	79	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2010	5	11							e15433	10.1371/journal.pone.0015433	http://dx.doi.org/10.1371/journal.pone.0015433			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	800AR	21082029	gold, Green Published, Green Submitted			2022-12-27	WOS:000293329500006
J	Schmidt-Lucke, C; Fichtlscherer, S; Aicher, A; Tschope, C; Schultheiss, HP; Zeiher, AM; Dimmeler, S				Schmidt-Lucke, Caroline; Fichtlscherer, Stephan; Aicher, Alexandra; Tschoepe, Carsten; Schultheiss, Heinz-Peter; Zeiher, Andreas M.; Dimmeler, Stefanie			Quantification of Circulating Endothelial Progenitor Cells Using the Modified ISHAGE Protocol	PLOS ONE			English	Article							FLOW-CYTOMETRIC ENUMERATION; CORONARY-ARTERY DISEASE; CD34(+) HEMATOPOIETIC STEM; VASCULAR REPAIR; STATIN THERAPY; RISK-FACTORS; ANGIOGENESIS; PRECURSORS; INCREASE; NUMBER	Aims: Circulating endothelial progenitor cells (EPC), involved in endothelial regeneration, neovascularisation, and determination of prognosis in cardiovascular disease can be characterised with functional assays or using immunofluorescence and flow cytometry. Combinations of markers, including CD34+KDR+ or CD133+KDR+, are used. This approach, however may not consider all characteristics of EPC. The lack of a standardised protocol with regards to reagents and gating strategies may account for the widespread inter-laboratory variations in quantification of EPC. We, therefore developed a novel protocol adapted from the standardised so-called ISHAGE protocol for enumeration of haematopoietic stem cells to enable comparison of clinical and laboratory data. Methods and Results: In 25 control subjects, 65 patients with coronary artery disease (CAD; 40 stable CAD, 25 acute coronary syndrome/acute myocardial infarction (ACS)), EPC were quantified using the following approach: Whole blood was incubated with CD45, KDR, and CD34. The ISHAGE sequential strategy was used, and finally, CD45(dim)CD34(+) cells were quantified for KDR. A minimum of 100 CD34(+) events were collected. For comparison, CD45(+)CD34(+) and CD45(-)CD34(+) were analysed simultaneously. The number of CD45(dim)CD34(+)KDR(+) cells only were significantly higher in healthy controls compared to patients with CAD or ACS (p = 0.005 each, p<0.001 for trend). An inverse correlation of CD45(dim)CD34(+)KDR(+) with disease activity (r = -0.475, p<0.001) was confirmed. Only CD45(dim)CD34(+)KDR(+) correlated inversely with the number of diseased coronaries (r = -0.344; p<0.005). In a second study, a 4-week de-novo treatment of atorvastatin in stable CAD evoked an increase only of CD45(dim)CD34(+)KDR(+) EPC (p<0.05). CD45(+)CD34(+)KDR(+) and CD45(-)CD34(+)KDR(+) were indifferent between the three groups. Conclusion: Our newly established protocol adopted from the standardised ISHAGE protocol achieved higher accuracy in EPC enumeration confirming previous findings with respect to the correlation of EPC with disease activity and the increase of EPC during statin therapy. The data of this study show the CD45(dim) fraction to harbour EPC.	[Schmidt-Lucke, Caroline; Fichtlscherer, Stephan; Aicher, Alexandra; Zeiher, Andreas M.; Dimmeler, Stefanie] Goethe Univ Frankfurt, Dept Mol Cardiol, Frankfurt, Germany; [Schmidt-Lucke, Caroline; Tschoepe, Carsten; Schultheiss, Heinz-Peter] Charite, Dept Cardiol & Pulmonol, Berlin, Germany	Goethe University Frankfurt; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Schmidt-Lucke, C (corresponding author), Goethe Univ Frankfurt, Dept Mol Cardiol, Frankfurt, Germany.	caroline.schmidt-lucke@charite.de	Aicher, Alexandra/GZK-8031-2022	Aicher, Alexandra/0000-0002-8920-9577; Tschope, Carsten/0000-0001-5243-8985; Dimmeler, Stefanie/0000-0002-1045-2436	Deutsche Forschungsgemeinschaft [Di 600/4-1, Exc 147/1]; "Rahel Hirsch"-grant; Berlin-Brandenburg Centre for Regenerative Therapies	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); "Rahel Hirsch"-grant; Berlin-Brandenburg Centre for Regenerative Therapies	This study was supported by the Deutsche Forschungsgemeinschaft Di 600/4-1 to S. D., Exc 147/1 to S. F., A.M.Z. and S. D., the "Rahel Hirsch''-grant to C.S.-L. and the Berlin-Brandenburg Centre for Regenerative Therapies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aicher A, 2006, CIRCULATION, V114, P2823, DOI 10.1161/CIRCULATIONAHA.106.628623; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Barnett D, 1999, CLIN LAB HAEMATOL, V21, P301, DOI 10.1046/j.1365-2257.1999.00253.x; De Backer G, 2004, ATHEROSCLEROSIS, V173, P379, DOI 10.1016/j.atherosclerosis.2004.02.014; Dimmeler S, 2004, J MOL MED, V82, P671, DOI 10.1007/s00109-004-0580-x; Dimmeler S, 2005, J CLIN INVEST, V115, P572, DOI 10.1172/JCI200524283; Fadini GP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011488; Gratama JW, 2001, SEMIN HEMATOL, V38, P139, DOI 10.1053/shem.2001.21925; Gratama JW, 1998, CYTOMETRY, V34, P128, DOI 10.1002/(SICI)1097-0320(19980615)34:3<128::AID-CYTO3>3.0.CO;2-D; Hill JM, 2003, NEW ENGL J MED, V348, P593, DOI 10.1056/NEJMoa022287; Ingram DA, 2005, BLOOD, V106, P1525, DOI 10.1182/blood-2005-04-1509; Peichev M, 2000, BLOOD, V95, P952, DOI 10.1182/blood.V95.3.952.003k27_952_958; ROMAGNANI PAF, 2005, CIRC RES, V97, P299; Schmidt-Lucke C, 2005, CIRCULATION, V111, P2981, DOI 10.1161/CIRCULATIONAHA.104.504340; Shantsila E, 2008, J THROMB HAEMOST, V6, P1021, DOI 10.1111/j.1538-7836.2008.02985.x; Sieveking DP, 2008, J AM COLL CARDIOL, V51, P660, DOI 10.1016/j.jacc.2007.09.059; Sutherland D R, 1996, J Hematother, V5, P213, DOI 10.1089/scd.1.1996.5.213; Timmermans F, 2007, ARTERIOSCL THROM VAS, V27, P1572, DOI 10.1161/ATVBAHA.107.144972; Vasa M, 2001, CIRC RES, V89, pE1, DOI 10.1161/hh1301.093953; Vasa M, 2001, CIRCULATION, V103, P2885, DOI 10.1161/hc2401.092816; VITA JA, 1990, CIRCULATION, V81, P491, DOI 10.1161/01.CIR.81.2.491; Walter DH, 2002, CIRCULATION, V105, P3017, DOI 10.1161/01.CIR.0000018166.84319.55; Werner N, 2005, NEW ENGL J MED, V353, P999, DOI 10.1056/NEJMoa043814	23	120	125	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2010	5	11							e13790	10.1371/journal.pone.0013790	http://dx.doi.org/10.1371/journal.pone.0013790			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	674WJ	21072182	gold, Green Submitted, Green Published			2022-12-27	WOS:000283780800005
J	Miyaji, K; Nagao, K; Bannai, M; Asakawa, H; Kohyama, K; Ohtsu, D; Terasawa, F; Ito, S; Iwao, H; Ohtani, N; Ohta, M				Miyaji, Kazuki; Nagao, Kenji; Bannai, Makoto; Asakawa, Hiroshi; Kohyama, Kaoru; Ohtsu, Dai; Terasawa, Fumio; Ito, Shu; Iwao, Hajime; Ohtani, Nobuyo; Ohta, Mitsuaki			Characteristic Metabolism of Free Amino Acids in Cetacean Plasma: Cluster Analysis and Comparison with Mice	PLOS ONE			English	Article							BOTTLE-NOSED DOLPHINS; ANTIOXIDANT ACTIVITY; CARNOSINE; STRESS; 3-METHYLHISTIDINE; HOMOCARNOSINE; ANSERINE; EXCHANGE; MUSCLE	From an evolutionary perspective, the ancestors of cetaceans first lived in terrestrial environments prior to adapting to aquatic environments. Whereas anatomical and morphological adaptations to aquatic environments have been well studied, few studies have focused on physiological changes. We focused on plasma amino acid concentrations (aminograms) since they show distinct patterns under various physiological conditions. Plasma and urine aminograms were obtained from bottlenose dolphins, pacific white-sided dolphins, Risso's dolphins, false-killer whales and C57BL/6J and ICR mice. Hierarchical cluster analyses were employed to uncover a multitude of amino acid relationships among different species, which can help us understand the complex interrelations comprising metabolic adaptations. The cetacean aminograms formed a cluster that was markedly distinguishable from the mouse cluster, indicating that cetaceans and terrestrial mammals have quite different metabolic machinery for amino acids. Levels of carnosine and 3-methylhistidine, both of which are antioxidants, were substantially higher in cetaceans. Urea was markedly elevated in cetaceans, whereas the level of urea cycle-related amino acids was lower. Because diving mammals must cope with high rates of reactive oxygen species generation due to alterations in apnea/reoxygenation and ischemia-reperfusion processes, high concentrations of antioxidative amino acids are advantageous. Moreover, shifting the set point of urea cycle may be an adaption used for body water conservation in the hyperosmotic sea water environment, because urea functions as a major blood osmolyte. Furthermore, since dolphins are kept in many aquariums for observation, the evaluation of these aminograms may provide useful diagnostic indices for the assessment of cetacean health in artificial environments in the future.	[Miyaji, Kazuki; Ohtani, Nobuyo; Ohta, Mitsuaki] Azabu Univ, Dept Anim Sci & Biotechnol, Sagamihara, Kanagawa, Japan; [Nagao, Kenji; Bannai, Makoto] Ajinomoto Co Inc, Inst Life Sci, Kawasaki, Kanagawa, Japan; [Asakawa, Hiroshi] Shimoda Floating Aquarium, Dept Anim Care, Shimoda, Japan; [Kohyama, Kaoru] Izu Mito Sea Paradise, Dept Anim Care & Management, Numazu, Japan; [Ohtsu, Dai] Yokohama Hakkeijima Sea Paradise, Aqua Resorts, Yokohama, Kanagawa, Japan; [Terasawa, Fumio] Enoshima Aquarium, Fujisawa, Kanagawa, Japan; [Ito, Shu] Vet Hosp, Nishimuro, Japan; [Iwao, Hajime] Niigata City Aquarium Marinepia Nihonkai, Exhibit Div, Niigata, Japan	Azabu University; Ajinomoto Co Inc	Miyaji, K (corresponding author), Azabu Univ, Dept Anim Sci & Biotechnol, Sagamihara, Kanagawa, Japan.	makoto_bannai@ajinomoto.com	Nagao, Kenji/AAE-7377-2021	Nagao, Kenji/0000-0002-0946-1431	Japan Society for the Promotion of Science [18858116, 21658101]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	The work was funded by the Japan Society for the Promotion of Science grant number: 18858116, 21658101, website: http://www.jsps.go.jp/english/e-grants/grants.html. The Japan Society for the Promotion of Science had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Ajinomoto Co., Inc., Shimoda Floating Aquarium, Izu-Mito Sea Paradise, Yokohama-Hakkeijima Sea Paradise, Enoshima Aquarium, Adventure World, Niigata City Aquarium Marinepia Nihonkai did have a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babizhayev MA, 2009, AM J THER, V16, P517, DOI 10.1097/MJT.0b013e318195e327; Bonfanti L, 1999, PROG NEUROBIOL, V59, P333, DOI 10.1016/S0301-0082(99)00010-6; COULOMBE HN, 1965, SCIENCE, V149, P86, DOI 10.1126/science.149.3679.86; Decker EA, 2000, BIOCHEMISTRY-MOSCOW+, V65, P766; FELIG P, 1975, ANNU REV BIOCHEM, V44, P933, DOI 10.1146/annurev.bi.44.070175.004441; FERENCI P, 1978, J NEURAL TRANSM, P87; FISCHER JE, 1975, SURGERY, V78, P276; FISCHER JE, 1976, SURGERY, V80, P77; GARDNER MLG, 1991, J PHYSIOL-LONDON, V439, P411, DOI 10.1113/jphysiol.1991.sp018673; Goto S, 2010, NEUROSCIENCE, V166, P333, DOI 10.1016/j.neuroscience.2009.12.013; Gray J, 1936, J EXP BIOL, V13, P192; Guiotto A, 2005, CURR MED CHEM, V12, P2293, DOI 10.2174/0929867054864796; HARRISON RJ, 1972, J ANAT, V111, P498; Holm E, 1999, Curr Opin Clin Nutr Metab Care, V2, P47, DOI 10.1097/00075197-199901000-00009; Hong S Y, 1998, J Ren Nutr, V8, P34, DOI 10.1016/S1051-2276(98)90035-8; Kang JH, 2002, BBA-GEN SUBJECTS, V1570, P89, DOI 10.1016/S0304-4165(02)00158-7; Kimura T, 2009, CURR OPIN CLIN NUTR, V12, P49, DOI 10.1097/MCO.0b013e3283169242; KOHEN R, 1988, P NATL ACAD SCI USA, V85, P3175, DOI 10.1073/pnas.85.9.3175; Kooyman GL, 1998, ANNU REV PHYSIOL, V60, P19, DOI 10.1146/annurev.physiol.60.1.19; LAMBERTSEN RH, 1986, J WILDLIFE DIS, V22, P389, DOI 10.7589/0090-3558-22.3.389; LeBoucher J, 1997, CLIN CHEM, V43, P1421; MURRAY AJ, 1985, BIOCHEM J, V232, P409, DOI 10.1042/bj2320409; Nagao K, 2010, AM J PHYSIOL-ENDOC M, V298, pE1170, DOI 10.1152/ajpendo.00763.2009; Nagao K, 2009, AMINO ACIDS, V36, P555, DOI 10.1007/s00726-008-0117-7; Ninfali P, 1998, FREE RADICAL RES, V29, P399, DOI 10.1080/10715769800300441; Noda K, 2007, J VET MED SCI, V69, P379, DOI 10.1292/jvms.69.379; Noguchi Y, 2006, AM J CLIN NUTR, V83, p513S; Noguchi Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012057; Noguchi Y, 2008, PHYSIOL GENOMICS, V34, P315, DOI 10.1152/physiolgenomics.00007.2008; Obeid OA, 2005, INT J VITAM NUTR RES, V75, P267, DOI 10.1024/0300-9831.75.4.267; Ohtsuka Y, 1992, Nihon Rinsho, V50, P1631; Pillans RD, 2004, COMP BIOCHEM PHYS A, V138, P363, DOI 10.1016/j.cbpb.2004.05.006; Rathmacher JA, 1996, J ANIM SCI, V74, P46; REDDY VP, 2005, SCI AGING KNOWLEDGE, pPE12; RIDGEWAY S, 1972, HOMEOSTASIS AQUATIC, P590; SALWAY JG, 2004, METABOLISM GLANCE GL; Shikama K, 1998, CHEM REV, V98, P1357, DOI 10.1021/cr970042e; Shikata N, 2007, AMINO ACIDS, V33, P113, DOI 10.1007/s00726-006-0412-0; Shikata N, 2010, AMINO ACIDS, V38, P179, DOI 10.1007/s00726-008-0226-3; SOETERS PB, 1976, LANCET, V2, P880; SOLTESZ G, 1978, PEDIATRICS, V61, P77; Terasawa Fumio, 1999, Japanese Journal of Zoo and Wildlife Medicine, V4, P117; Waples KA, 2002, ZOO BIOL, V21, P5, DOI 10.1002/zoo.10004; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; WATANABE A, 1984, CANCER, V54, P1875, DOI 10.1002/1097-0142(19841101)54:9<1875::AID-CNCR2820540918>3.0.CO;2-O; Weinlich G, 2007, DERMATOLOGY, V214, P8, DOI 10.1159/000096906; Wilhelm D, 2002, COMP BIOCHEM PHYS A, V133, P885, DOI 10.1016/S1095-6433(02)00253-2; Williams TM, 2001, COMP BIOCHEM PHYS A, V129, P785, DOI 10.1016/S1095-6433(01)00347-6; WILLIAMS TM, 1993, J EXP BIOL, V179, P31; YANCEY PH, 1982, SCIENCE, V217, P1214, DOI 10.1126/science.7112124; YOUNG VR, 1972, J BIOL CHEM, V247, P3592	51	8	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2010	5	11							e13808	10.1371/journal.pone.0013808	http://dx.doi.org/10.1371/journal.pone.0013808			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	674VY	21072195	Green Published, gold, Green Submitted			2022-12-27	WOS:000283779700015
J	Van Simaeys, D; Lopez-Colon, D; Sefah, K; Sutphen, R; Jimenez, E; Tan, WH				Van Simaeys, Dimitri; Lopez-Colon, Dalia; Sefah, Kwame; Sutphen, Rebecca; Jimenez, Elizabeth; Tan, Weihong			Study of the Molecular Recognition of Aptamers Selected through Ovarian Cancer Cell-SELEX	PLOS ONE			English	Article							LIVE CELLS; PATTERNS; UPDATE; PROBES	Background: Ovarian cancer is the most lethal gynecological malignancy, and the ovarian clear cell carcinoma subtype (OCCA) demonstrates a particularly poor response to standard treatment. Improvements in ovarian cancer outcomes, especially for OCCA, could be expected from a clearer understanding of the molecular pathology that might guide strategies for earlier diagnosis and more effective treatment. Methodology/Principal Findings: Cell-SELEX technology was employed to develop new molecular probes for ovarian cancer cell surface markers. A total of thirteen aptamers with K-d's to ovarian cancer cells in the pico- to nanomolar range were obtained. Preliminary investigation of the targets of these aptamers and their binding characteristics was also performed. Conclusions/Significance: We have selected a series of aptamers that bind to different types of ovarian cancer, but not cervical cancer. Though binding to other cancer cell lines was observed, these aptamers could lead to identification of biomarkers that are related to cancer.	[Van Simaeys, Dimitri; Lopez-Colon, Dalia; Sefah, Kwame; Jimenez, Elizabeth; Tan, Weihong] Univ Florida, Dept Chem, Ctr Res Bio Nano Interface, Gainesville, FL 32611 USA; [Van Simaeys, Dimitri; Lopez-Colon, Dalia; Sefah, Kwame; Jimenez, Elizabeth; Tan, Weihong] Univ Florida, Shands Canc & Genet Res Ctr, Dept Physiol & Funct Gen, Gainesville, FL 32611 USA; [Sutphen, Rebecca] Univ S Florida, Coll Med, Dept Pediat, Tampa, FL 33612 USA; [Tan, Weihong] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute	Van Simaeys, D (corresponding author), Univ Florida, Dept Chem, Ctr Res Bio Nano Interface, Gainesville, FL 32611 USA.	tan@chem.ufl.edu	Jimenez, Elizabeth/GQB-5576-2022; Tan, Weihong/AAA-4536-2020; Tan, Weihong/A-5412-2008	Jimenez, Elizabeth/0000-0001-7798-2194; Tan, Weihong/0000-0002-8066-1524; Van Simaeys, Dimitri/0000-0003-3457-761X	National Institutes of Health (NIH) [R01GM079359, R01 CA133086, R01-CA106414]; NATIONAL CANCER INSTITUTE [R01CA106414, R01CA133086] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079359] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank National Institutes of Health (NIH) for support (R01GM079359, R01 CA133086, R01-CA106414). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAST RC, 1992, J NATL CANCER I, V84, P556, DOI 10.1093/jnci/84.8.556; BING T, 2010, BIOORG MED CHEM; Cerchia L, 2005, PLOS BIOL, V3, P697, DOI 10.1371/journal.pbio.0030123; Chen HW, 2008, CHEMMEDCHEM, V3, P991, DOI 10.1002/cmdc.200800030; Crotzer DR, 2007, GYNECOL ONCOL, V105, P404, DOI 10.1016/j.ygyno.2006.12.024; Faca VM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002425; Fang XH, 2010, ACCOUNTS CHEM RES, V43, P48, DOI 10.1021/ar900101s; Fitter S, 2005, J BIOL CHEM, V280, P34193, DOI 10.1074/jbc.M504772200; Hartge P, 2010, JNCI-J NATL CANCER I, V102, P3, DOI 10.1093/jnci/djp450; Jacobs IJ, 2004, MOL CELL PROTEOMICS, V3, P355, DOI 10.1074/mcp.R400006-MCP200; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Jhaveri S, 2000, NAT BIOTECHNOL, V18, P1293, DOI 10.1038/82414; KURMAN RJ, 2010, AM J SURG PATHOL; LU C, 2010, CANC BIOL THER, V9; Maines-Bandiera S, 2010, INT J GYNECOL CANCER, V20, P16, DOI 10.1111/IGC.0b013e3181bcc96d; Mallikaratchy P, 2007, MOL CELL PROTEOMICS, V6, P2230, DOI 10.1074/mcp.M700026-MCP200; Munkarah A, 2007, CURR OPIN OBSTET GYN, V19, P22, DOI 10.1097/GCO.0b013e328011ec99; Nosov V, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.12.042; Oaknin A, 2010, INT J GYNECOL CANCER, V20, P87, DOI 10.1111/IGC.0b013e3181c16ba1; Provencher DM, 2000, IN VITRO CELL DEV-AN, V36, P357; Reynolds EA, 2006, CURR PROB CANCER, V30, P203, DOI 10.1016/j.currproblcancer.2006.06.001; Shangguan D, 2008, J PROTEOME RES, V7, P2133, DOI 10.1021/pr700894d; Shangguan DH, 2008, ANAL CHEM, V80, P721, DOI 10.1021/ac701962v; Shangguan DH, 2007, CLIN CHEM, V53, P1153, DOI 10.1373/clinchem.2006.083246; Shangguan D, 2006, P NATL ACAD SCI USA, V103, P11838, DOI 10.1073/pnas.0602615103; Shirai T, 2009, J OBSTET GYNAECOL RE, V35, P926, DOI 10.1111/j.1447-0756.2009.01033.x; Tang ZW, 2009, CLIN CHEM, V55, P813, DOI 10.1373/clinchem.2008.113514; Ulrich H, 2009, CYTOM PART A, V75A, P727, DOI 10.1002/cyto.a.20766; Williams TI, 2007, J PROTEOME RES, V6, P2936, DOI 10.1021/pr070041v; Willmott LJ, 2010, J ONCOL, V2010, DOI 10.1155/2010/740472; Zhao ZL, 2009, ANALYST, V134, P1808, DOI 10.1039/b904476k	31	81	86	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2010	5	11							e13770	10.1371/journal.pone.0013770	http://dx.doi.org/10.1371/journal.pone.0013770			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673FY	21072169	gold, Green Published, Green Submitted			2022-12-27	WOS:000283645700003
J	Bozaquel-Morais, BL; Madeira, JB; Maya-Monteiro, CM; Masuda, CA; Montero-Lomeli, M				Bozaquel-Morais, Bruno L.; Madeira, Juliana B.; Maya-Monteiro, Clarissa M.; Masuda, Claudio A.; Montero-Lomeli, Monica			A New Fluorescence-Based Method Identifies Protein Phosphatases Regulating Lipid Droplet Metabolism	PLOS ONE			English	Article							YEAST SACCHAROMYCES-CEREVISIAE; ACETYL-COA CARBOXYLASE; ENDOPLASMIC-RETICULUM; BODY FORMATION; NILE RED; IN-VIVO; PARTICLES; SNF1; TRIACYLGLYCEROL; ACID	In virtually every cell, neutral lipids are stored in cytoplasmic structures called lipid droplets (LDs) and also referred to as lipid bodies or lipid particles. We developed a rapid high-throughput assay based on the recovery of quenched BODIPY-fluorescence that allows to quantify lipid droplets. The method was validated by monitoring lipid droplet turnover during growth of a yeast culture and by screening a group of strains deleted in genes known to be involved in lipid metabolism. In both tests, the fluorimetric assay showed high sensitivity and good agreement with previously reported data using microscopy. We used this method for high-throughput identification of protein phosphatases involved in lipid droplet metabolism. From 65 yeast knockout strains encoding protein phosphatases and its regulatory subunits, 13 strains revealed to have abnormal levels of lipid droplets, 10 of them having high lipid droplet content. Strains deleted for type I protein phosphatases and related regulators (ppz2, gac1, bni4), type 2A phosphatase and its related regulator (pph21 and sap185), type 2C protein phosphatases (ptc1, ptc4, ptc7) and dual phosphatases (pps1, msg5) were catalogued as high-lipid droplet content strains. Only reg1, a targeting subunit of the type 1 phosphatase Glc7p, and members of the nutrient-sensitive TOR pathway (sit4 and the regulatory subunit sap190) were catalogued as low-lipid droplet content strains, which were studied further. We show that Snf1, the homologue of the mammalian AMP-activated kinase, is constitutively phosphorylated (hyperactive) in sit4 and sap190 strains leading to a reduction of acetyl-CoA carboxylase activity. In conclusion, our fast and highly sensitive method permitted us to catalogue protein phosphatases involved in the regulation of LD metabolism and present evidence indicating that the TOR pathway and the SNF1/AMPK pathway are connected through the Sit4p-Sap190p pair in the control of lipid droplet biogenesis.	[Bozaquel-Morais, Bruno L.; Madeira, Juliana B.; Masuda, Claudio A.; Montero-Lomeli, Monica] Univ Fed Rio de Janeiro, Inst Bioquim Med, Programa Biol Mol & Biotecnol, Rio De Janeiro, Brazil; [Maya-Monteiro, Clarissa M.] Fundacao Oswaldo Cruz, Lab Imunofarmacol, Inst Oswaldo Cruz, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Fundacao Oswaldo Cruz	Bozaquel-Morais, BL (corresponding author), Univ Fed Rio de Janeiro, Inst Bioquim Med, Programa Biol Mol & Biotecnol, Rio De Janeiro, Brazil.	montero@bioqmed.ufrj.br	Montero-Lomeli, Monica/D-9885-2013; Masuda, Claudio A/F-7214-2014	Masuda, Claudio A/0000-0002-0310-7108; Bozaquel Morais, Bruno Leonardo/0000-0001-5477-4851	Conselho Nacional de Ciencia e Tecnologia (CNPq); Fundao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); Fundao Universitaria Jose Bonifacio/UFRJ; PEW Charitable Trust	Conselho Nacional de Ciencia e Tecnologia (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Fundao Universitaria Jose Bonifacio/UFRJ; PEW Charitable Trust	This research was supported by Conselho Nacional de Ciencia e Tecnologia (CNPq, http://www.cnpq.br) and Fundao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ, http://www.faperj.br) awards to MML and CAM; a Fundao Universitaria Jose Bonifacio/UFRJ (http://www.ufrj.br/) award to CAM; a PEW Charitable Trust (http://www.pewtrusts.org/) award to CAM. JM and BBM were the recipients of an undergraduate fellowship and a doctoral fellowship, respectively, from CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Athenstaedt K, 2005, J BIOL CHEM, V280, P37301, DOI 10.1074/jbc.M507261200; Athenstaedt K, 1997, J BACTERIOL, V179, P7611, DOI 10.1128/jb.179.24.7611-7616.1997; Athenstaedt K, 2003, J BIOL CHEM, V278, P23317, DOI 10.1074/jbc.M302577200; BLANCHETTEMACKIE EJ, 1995, J LIPID RES, V36, P1211; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bostrom P, 2007, NAT CELL BIOL, V9, P1286, DOI 10.1038/ncb1648; Bozza PT, 2007, PHARMACOL THERAPEUT, V113, P30, DOI 10.1016/j.pharmthera.2006.06.006; Bozza PT, 2010, PROSTAG LEUKOTR ESS, V82, P243, DOI 10.1016/j.plefa.2010.02.005; Bozza PT, 1996, P NATL ACAD SCI USA, V93, P11091, DOI 10.1073/pnas.93.20.11091; Ceulemans H, 2004, PHYSIOL REV, V84, P1, DOI 10.1152/physrev.00013.2003; CLAUSEN MK, 1974, FEBS LETT, V43, P176, DOI 10.1016/0014-5793(74)80994-4; Cole NB, 2002, J BIOL CHEM, V277, P6344, DOI 10.1074/jbc.M108414200; Dahlqvist A, 2000, P NATL ACAD SCI USA, V97, P6487, DOI 10.1073/pnas.120067297; DiDonato D, 2003, J HISTOCHEM CYTOCHEM, V51, P773, DOI 10.1177/002215540305100608; Fei WH, 2008, J CELL BIOL, V180, P473, DOI 10.1083/jcb.200711136; FOWLER SD, 1985, J HISTOCHEM CYTOCHEM, V33, P833, DOI 10.1177/33.8.4020099; Frederick DL, 1996, MOL CELL BIOL, V16, P2922; Garbarino J, 2005, BIOCHEM SOC T, V33, P1182, DOI 10.1042/BST20051182; Garbarino J, 2009, J BIOL CHEM, V284, P30994, DOI 10.1074/jbc.M109.050443; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; GOCZE PM, 1994, CYTOMETRY, V17, P151, DOI 10.1002/cyto.990170207; GREENSPAN P, 1985, J LIPID RES, V26, P781; GREENSPAN P, 1985, J CELL BIOL, V100, P965, DOI 10.1083/jcb.100.3.965; Hess D, 2005, GENETICS, V170, P87, DOI 10.1534/genetics.104.039214; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Jablonowski D, 2009, EUKARYOT CELL, V8, P1637, DOI 10.1128/EC.00205-09; KAROLIN J, 1994, J AM CHEM SOC, V116, P7801, DOI 10.1021/ja00096a042; Koffel R, 2005, MOL CELL BIOL, V25, P1655, DOI 10.1128/MCB.25.5.1655-1668.2005; Kohlwein SD, 2007, CURR HYPERTENS REP, V9, P455, DOI 10.1007/s11906-007-0084-5; Kozubowski L, 2003, MOL BIOL CELL, V14, P26, DOI 10.1091/mbc.E02-06-0373; Kurat CF, 2006, J BIOL CHEM, V281, P491, DOI 10.1074/jbc.M508414200; Kurat CF, 2009, MOL CELL, V33, P53, DOI 10.1016/j.molcel.2008.12.019; Leber R, 1998, MOL BIOL CELL, V9, P375, DOI 10.1091/mbc.9.2.375; Liao JF, 2005, J LIPID RES, V46, P597, DOI 10.1194/jlr.D400023-JLR200; Lockshon D, 2007, GENETICS, V175, P77, DOI 10.1534/genetics.106.064428; Logan MR, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-336; LORENZ RT, 1990, ANTIMICROB AGENTS CH, V34, P1660, DOI 10.1128/AAC.34.9.1660; Ludin K, 1998, P NATL ACAD SCI USA, V95, P6245, DOI 10.1073/pnas.95.11.6245; Luke MM, 1996, MOL CELL BIOL, V16, P2744; Maya-Monteiro CM, 2008, J BIOL CHEM, V283, P2203, DOI 10.1074/jbc.M706706200; McCartney RR, 2001, J BIOL CHEM, V276, P36460, DOI 10.1074/jbc.M104418200; Montero-Lomeli M, 2002, J BIOL CHEM, V277, P21542, DOI 10.1074/jbc.M201977200; Mullner H, 2005, J BIOL CHEM, V280, P13321, DOI 10.1074/jbc.M409914200; Murphy DJ, 2001, PROG LIPID RES, V40, P325, DOI 10.1016/S0163-7827(01)00013-3; Murphy DJ, 1999, TRENDS BIOCHEM SCI, V24, P109, DOI 10.1016/S0968-0004(98)01349-8; Natter K, 2005, MOL CELL PROTEOMICS, V4, P662, DOI 10.1074/mcp.M400123-MCP200; Nickels JT, 1996, GENE DEV, V10, P382, DOI 10.1101/gad.10.4.382; Oelkers P, 2002, J BIOL CHEM, V277, P8877, DOI 10.1074/jbc.M111646200; Petschnigg J, 2009, J BIOL CHEM, V284, P30981, DOI 10.1074/jbc.M109.024752; Rohde JR, 2008, CURR OPIN MICROBIOL, V11, P153, DOI 10.1016/j.mib.2008.02.013; Rohde JR, 2004, MOL CELL BIOL, V24, P8332, DOI 10.1128/MCB.24.19.8332-8341.2004; Samsa MM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000632; Schneiter R, 1999, MOL CELL BIOL, V19, P3415; Shirra MK, 2001, MOL CELL BIOL, V21, P5710, DOI 10.1128/MCB.21.17.5710-5722.2001; Sorger D, 2002, J BACTERIOL, V184, P519, DOI 10.1128/JB.184.2.519-524.2002; Szymanski KM, 2007, P NATL ACAD SCI USA, V104, P20890, DOI 10.1073/pnas.0704154104; Tauchi-Sato K, 2002, J BIOL CHEM, V277, P44507, DOI 10.1074/jbc.M207712200; Tehlivets O, 2007, BBA-MOL CELL BIOL L, V1771, P255, DOI 10.1016/j.bbalip.2006.07.004; TU JL, 1995, EMBO J, V14, P5939, DOI 10.1002/j.1460-2075.1995.tb00282.x; VAHLENSIECK HF, 1994, CURR GENET, V25, P95, DOI 10.1007/BF00309532; WOODS A, 1994, J BIOL CHEM, V269, P19509; Worsfold P., 2005, ENCY ANAL SCI, P97, DOI DOI 10.1016/B0-12-369397-7/00161-8; Wu X, 2001, MOL GENET GENOMICS, V265, P622, DOI 10.1007/s004380100455; YAFFE MP, 1984, P NATL ACAD SCI-BIOL, V81, P4819, DOI 10.1073/pnas.81.15.4819; Zanghellini J, 2008, FEBS J, V275, P5552, DOI 10.1111/j.1742-4658.2008.06681.x; Zhang J, 2010, CURR OPIN MICROBIOL, V13, P382, DOI 10.1016/j.mib.2010.04.004; ZINSER E, 1991, J BACTERIOL, V173, P2026, DOI 10.1128/jb.173.6.2026-2034.1991; Zweytick D, 2000, EUR J BIOCHEM, V267, P1075, DOI 10.1046/j.1432-1327.2000.01103.x	68	47	49	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2010	5	10							e13692	10.1371/journal.pone.0013692	http://dx.doi.org/10.1371/journal.pone.0013692			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	672HN	21060891	Green Published, gold, Green Submitted			2022-12-27	WOS:000283573800003
J	Gravitt, PE; Paul, P; Katki, HA; Vendantham, H; Ramakrishna, G; Sudula, M; Kalpana, B; Ronnett, BM; Vijayaraghavan, K; Shah, KV				Gravitt, Patti E.; Paul, Proma; Katki, Hormuzd A.; Vendantham, Haripriya; Ramakrishna, Gayatri; Sudula, Mrudula; Kalpana, Basany; Ronnett, Brigitte M.; Vijayaraghavan, K.; Shah, Keerti V.		CATCH Study Team	Effectiveness of VIA, Pap, and HPV DNA Testing in a Cervical Cancer Screening Program in a Peri-Urban Community in Andhra Pradesh, India	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; LOW-RESOURCE SETTINGS; LUGOLS IODINE VILI; VISUAL INSPECTION; ACETIC-ACID; HUMAN-PAPILLOMAVIRUS; DEVELOPING-COUNTRIES; RURAL INDIA; CYTOLOGY; ACCURACY	Background: While many studies have compared the efficacy of Pap cytology, visual inspection with acetic acid (VIA) and human papillomavirus (HPV) DNA assays for the detection cervical intraepithelial neoplasia and cancer, few have evaluated the program effectiveness. Methods and Findings: A population-based sample of 5603 women from Medchal Mandal in Andhra Pradesh, India were invited to participate in a study comparing Pap cytology, VIA, and HPV DNA screening for the detection of CIN3+. Participation in primary screening and all subsequent follow-up visits was rigorously tracked. A 20% random sample of all women screened, in addition to all women with a positive screening test result underwent colposcopy with directed biopsy for final diagnosis. Sensitivity, specificity, positive and negative predictive values were adjusted for verification bias. HPV testing had a higher sensitivity (100%) and specificity (90.6%) compared to Pap cytology (sensitivity = 78.2%; specificity = 86.0%) and VIA (sensitivity = 31.6%; specificity = 87.5%). Since 58% of the sample refused involvement and another 28% refused colposcopy or biopsy, we estimated that potentially 87.6% of the total underlying cases of CIN3 and cancer may have been missed due to program failures. Conclusions: We conclude that despite our use of available resources, infrastructure, and guidelines for cervical cancer screening implementation in resource limited areas, community participation and non-compliance remain the major obstacles to successful reduction in cervical cancer mortality in this Indian population. HPV DNA testing was both more sensitive and specific than Pap cytology and VIA. The use of a less invasive and more user-friendly primary screening strategy (such as self-collected swabs for HPV DNA testing) may be required to achieve the coverage necessary for effective reduction in cervical cancer mortality.	[Gravitt, Patti E.; Paul, Proma] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Gravitt, Patti E.; Shah, Keerti V.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD USA; [Katki, Hormuzd A.] NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; [Vendantham, Haripriya; Sudula, Mrudula; Kalpana, Basany; Vijayaraghavan, K.] Mediciti Inst Med Sci, SHARE INDIA, Ghanpur, India; [Ramakrishna, Gayatri] Ctr DNA Fingerprinting & Diagnost, Hyderabad, Andhra Pradesh, India; [Ronnett, Brigitte M.] Johns Hopkins Univ, Sch Med & Hosp, Dept Pathol, Baltimore, MD USA; [Ronnett, Brigitte M.] Johns Hopkins Univ, Sch Med & Hosp, Dept Gynecol & Obstet, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Department of Biotechnology (DBT) India; Centre for DNA Fingerprinting & Diagnostics (CDFD); Johns Hopkins University; Johns Hopkins University	Gravitt, PE (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA.	pgravitt@jhsph.edu	Katki, Hormuzd A/B-4003-2015		Department of Biotechnology, Ministry of Science and Technology, Government of India; NIH, USA [BT/IN/US/CRHR/PP/2002]; Research Excellence (SPORE) in Cervical Cancer [P50 CA98252]; NATIONAL CANCER INSTITUTE [P50CA098252] Funding Source: NIH RePORTER	Department of Biotechnology, Ministry of Science and Technology, Government of India(Department of Biotechnology (DBT) IndiaMinistry of Science and Technology, Government of India); NIH, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research Excellence (SPORE) in Cervical Cancer; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	INDO-US collaborative program of Department of Biotechnology, Ministry of Science and Technology, Government of India and the NIH, USA (BT/IN/US/CRHR/PP/2002). NIH Specialized Programs of Research Excellence (SPORE) in Cervical Cancer P50 CA98252. Reagent discounts from Qiagen Corp (formerly Digene) and reagent gifts from Roche Molecular Systems. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Hady ES, 2006, INT J GYNECOL OBSTET, V93, P118, DOI 10.1016/j.ijgo.2006.01.024; Almonte M, 2007, INT J CANCER, V121, P796, DOI 10.1002/ijc.22757; [Anonymous], 1999, LANCET, V353, P869; Arbyn M, 2008, INT J CANCER, V123, P153, DOI 10.1002/ijc.23489; Basu P, 2006, CANCER DETECT PREV, V30, P369, DOI 10.1016/j.cdp.2006.07.004; Basu PS, 2003, INT J GYNECOL CANCER, V13, P626, DOI 10.1046/j.1525-1438.2003.13394.x; Belinson J, 2001, GYNECOL ONCOL, V83, P439, DOI 10.1006/gyno.2001.6370; Belinson JL, 2003, INT J GYNECOL CANCER, V13, P819, DOI 10.1111/j.1525-1438.2003.13611.x; Blumenthal PD, 2005, INT J GYNECOL OBSTET, V89, pS30, DOI 10.1016/j.ijgo.2005.01.012; CAGLE AJ, INT J CANC, V126, P156; CASTLE PE, AM J EPIDEMIOL, V171, P155; Cronje HS, 2001, INT J GYNECOL OBSTET, V72, P151, DOI 10.1016/S0020-7292(00)00382-9; Cuzick J, 2008, VACCINE, V26, pK29, DOI 10.1016/j.vaccine.2008.06.019; De Vuyst H, 2005, INT J GYNECOL OBSTET, V89, P120, DOI 10.1016/j.ijgo.2005.01.035; Denny L, 2000, CANCER-AM CANCER SOC, V89, P826, DOI 10.1002/1097-0142(20000815)89:4&lt;826::AID-CNCR15&gt;3.0.CO;2-5; Denny L, 2002, CANCER-AM CANCER SOC, V94, P1699, DOI 10.1002/cncr.10381; Denny L, 2005, JAMA-J AM MED ASSOC, V294, P2173, DOI 10.1001/jama.294.17.2173; Denny L, 2006, VACCINE, V24, P71, DOI 10.1016/j.vaccine.2006.05.121; Gaffikin L, 2003, LANCET, V361, P814, DOI 10.1016/S0140-6736(03)12707-9; Gravitt PE, 1998, J CLIN MICROBIOL, V36, P3020, DOI 10.1128/JCM.36.10.3020-3027.1998; Gravitt PE, 2000, J CLIN MICROBIOL, V38, P357; JERONIMO J, 2006, AM J OBSTET GYNECOL; Jonsson M, 1997, OBSTET GYNECOL, V90, P744, DOI 10.1016/S0029-7844(97)00418-3; Li N, 2009, BRIT J CANCER, V100, P532, DOI 10.1038/sj.bjc.6604840; Mahe C, 2005, CANCER CAUSE CONTROL, V16, P657, DOI 10.1007/s10552-005-0296-4; Nene BM, 1996, INT J CANCER, V68, P770, DOI 10.1002/(SICI)1097-0215(19961211)68:6<770::AID-IJC14>3.0.CO;2-4; Pretorius RG, 2007, INT J CANCER, V121, P2218, DOI 10.1002/ijc.22991; Pretorius Robert G, 2006, J Low Genit Tract Dis, V10, P5, DOI 10.1097/01.lgt.0000192694.85549.3d; Qiao YL, 2008, LANCET ONCOL, V9, P929, DOI 10.1016/S1470-2045(08)70210-9; Sankaranarayanan R, 2003, INT J CANCER, V106, P404, DOI 10.1002/ijc.11245; Sankaranarayanan R, 2005, INT J CANCER, V116, P617, DOI 10.1002/ijc.21050; Sankaranarayanan R, 2004, INT J CANCER, V110, P907, DOI 10.1002/ijc.20190; Sankaranarayanan R, 2001, B WORLD HEALTH ORGAN, V79, P954; Sankaranarayanan R, 1998, CANCER-AM CANCER SOC, V83, P2150, DOI 10.1002/(SICI)1097-0142(19981115)83:10<2150::AID-CNCR13>3.3.CO;2-S; Sankaranarayanan R, 1999, INT J CANCER, V80, P161, DOI 10.1002/(SICI)1097-0215(19990105)80:1<161::AID-IJC28>3.3.CO;2-#; Sankaranarayanan R, 2009, NEW ENGL J MED, V360, P1385, DOI 10.1056/NEJMoa0808516; Sarian LO, 2005, J MED SCREEN, V12, P142, DOI 10.1258/0969141054855328; Solomon D, 2002, JAMA-J AM MED ASSOC, V287, P2114, DOI 10.1001/jama.287.16.2114; Sowjanya AP, 2009, CANCER EPIDEM BIOMAR, V18, P1373, DOI 10.1158/1055-9965.EPI-08-1171; Trimble CL, 2005, CLIN CANCER RES, V11, P4717, DOI 10.1158/1078-0432.CCR-04-2599; Vedantham H, 2010, CANCER EPIDEM BIOMAR, V19, P1373, DOI 10.1158/1055-9965.EPI-09-1282	41	74	74	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2010	5	10							e13711	10.1371/journal.pone.0013711	http://dx.doi.org/10.1371/journal.pone.0013711			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	672HN	21060889	Green Published, gold, Green Accepted			2022-12-27	WOS:000283573800011
J	Crucitti, T; Fransen, K; Maharaj, R; Tenywa, T; Loembe, MM; Murugavel, KG; Mendonca, K; Abdellati, S; Beelaert, G; Van Damme, L				Crucitti, Tania; Fransen, Katrien; Maharaj, Rashika; Tenywa, Tom; Loembe, Marguerite Massinga; Murugavel, Kailapuri Gangatharan; Mendonca, Kevin; Abdellati, Said; Beelaert, Greet; Van Damme, Lut			Obtaining Valid Laboratory Data in Clinical Trials Conducted in Resource Diverse Settings: Lessons Learned from a Microbicide Phase III Clinical Trial	PLOS ONE			English	Article								Background: Over the last decade several phase III microbicides trials have been conducted in developing countries. However, laboratories in resource constrained settings do not always have the experience, infrastructure, and the capacity to deliver laboratory data meeting the high standards of clinical trials. This paper describes the design and outcomes of a laboratory quality assurance program which was implemented during a phase III clinical trial evaluating the efficacy of the candidate microbicide Cellulose Sulfate 6% (CS) [1]. Methodology: In order to assess the effectiveness of CS for HIV and STI prevention, a phase III clinical trial was conducted in 5 sites: 3 in Africa and 2 in India. The trial sponsor identified an International Central Reference Laboratory (ICRL), responsible for the design and management of a quality assurance program, which would guarantee the reliability of laboratory data. The ICRL provided advice on the tests, assessed local laboratories, organized trainings, conducted supervision visits, performed re-tests, and prepared control panels. Local laboratories were provided with control panels for HIV rapid tests and Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) amplification technique. Aliquots from respective control panels were tested by local laboratories and were compared with results obtained at the ICRL. Results: Overall, good results were observed. However, discordances between the ICRL and site laboratories were identified for HIV and CT/NG results. One particular site experienced difficulties with HIV rapid testing shortly after study initiation. At all sites, DNA contamination was identified as a cause of invalid CT/NG results. Both problems were timely detected and solved. Through immediate feedback, guidance and repeated training of laboratory staff, additional inaccuracies were prevented. Conclusions: Quality control guidelines when applied in field laboratories ensured the reliability and validity of final study data. It is essential that sponsors provide adequate resources for implementation of such comprehensive technical assessment and monitoring systems.	[Crucitti, Tania; Fransen, Katrien; Abdellati, Said; Beelaert, Greet] Inst Trop Med, HIV STI Reference Lab, B-2000 Antwerp, Belgium; [Maharaj, Rashika] MRC, HIV Prevent Res Unit, Durban, South Africa; [Tenywa, Tom] Makarere Univ, STI Reference Lab, Kampala, Uganda; [Loembe, Marguerite Massinga] Univ Laval, Dept Social & Prevent Med, Quebec City, PQ, Canada; [Loembe, Marguerite Massinga] Univ Quebec, Ctr Hosp Affilie, Unite Rech Sante Populat, Quebec City, PQ, Canada; [Murugavel, Kailapuri Gangatharan] Voluntary Hlth Serv Campus, YR Gaitonde Ctr AIDS Res & Educ YRG CARE, Chennai, Tamil Nadu, India; [Mendonca, Kevin] St Johns Med Coll, Bangalore, Karnataka, India; [Van Damme, Lut] CONRAD, Arlington, VA USA; [Van Damme, Lut] Family Hlth Int, Res Triangle Pk, NC 27709 USA	Institute of Tropical Medicine (ITM); Makerere University; Laval University; Laval University; University of Quebec; St. John's National Academy of Health Sciences; St. John's Medical College	Crucitti, T (corresponding author), Inst Trop Med, HIV STI Reference Lab, B-2000 Antwerp, Belgium.	tcrucitti@itg.be	Crucitti, Tania/AAB-9967-2019; Crucitti, Tania/AEQ-9792-2022; Crucitti, Tania/AAH-1902-2021	Crucitti, Tania/0000-0002-2235-6038; Crucitti, Tania/0000-0002-2235-6038; Mendonca, Kevin/0000-0001-9930-5231; Massinga Loembe, Marguerite/0000-0002-7822-566X	United States Agency for International Development; Bill & Melinda Gates Foundation	United States Agency for International Development(United States Agency for International Development (USAID)); Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This work was supported by grants from the United States Agency for International Development and the Bill & Melinda Gates Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bompart F, 2008, THERAPIE, V63, P83, DOI [10.2515/therapie:2008023, 10.2515/therapie:2008022]; Crucitti T, 2007, DIAGN MICR INFEC DIS, V57, P97, DOI 10.1016/j.diagmicrobio.2006.05.010; Ezzelle J, 2008, J PHARMACEUT BIOMED, V46, P18, DOI 10.1016/j.jpba.2007.10.010; Petti CA, 2006, CLIN INFECT DIS, V42, P377, DOI 10.1086/499363; Sarzotti-Kelsoe M, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000067; Stevens W, 2003, Qual Assur, V10, P83; STILES T, 2005, GOOD CLIN LAB PRACTI; Van Damme L, 2008, NEW ENGL J MED, V359, P463, DOI 10.1056/NEJMoa0707957; Wertheim HFL, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000231; World Health Organization, 2004, RAP HIV TESTS GUID U	10	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2010	5	10							e13592	10.1371/journal.pone.0013592	http://dx.doi.org/10.1371/journal.pone.0013592			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671UN	21048963	gold, Green Published, Green Submitted			2022-12-27	WOS:000283537000013
J	Mitrovic, D; Klanke, S; Osu, R; Kawato, M; Vijayakumar, S				Mitrovic, Djordje; Klanke, Stefan; Osu, Rieko; Kawato, Mitsuo; Vijayakumar, Sethu			A Computational Model of Limb Impedance Control Based on Principles of Internal Model Uncertainty	PLOS ONE			English	Article							OPTIMAL FEEDBACK-CONTROL; MULTIJOINT ARM MOVEMENT; SIGNAL-DEPENDENT NOISE; MOTOR ADAPTATION; ADAPTIVE-CONTROL; STIFFNESS; DYNAMICS; COACTIVATION; COCONTRACTION; VARIABILITY	Efficient human motor control is characterized by an extensive use of joint impedance modulation, which is achieved by co-contracting antagonistic muscles in a way that is beneficial to the specific task. While there is much experimental evidence available that the nervous system employs such strategies, no generally-valid computational model of impedance control derived from first principles has been proposed so far. Here we develop a new impedance control model for antagonistic limb systems which is based on a minimization of uncertainties in the internal model predictions. In contrast to previously proposed models, our framework predicts a wide range of impedance control patterns, during stationary and adaptive tasks. This indicates that many well-known impedance control phenomena naturally emerge from the first principles of a stochastic optimization process that minimizes for internal model prediction uncertainties, along with energy and accuracy demands. The insights from this computational model could be used to interpret existing experimental impedance control data from the viewpoint of optimality or could even govern the design of future experiments based on principles of internal model uncertainty.	[Mitrovic, Djordje; Klanke, Stefan; Vijayakumar, Sethu] Univ Edinburgh, Sch Informat, IPAB, Edinburgh, Midlothian, Scotland; [Osu, Rieko; Kawato, Mitsuo] ATR Computat Neurosci Labs, Keihanna Sci City, Kyoto, Japan; [Osu, Rieko] Natl Inst Informat & Commun, Kyoto, Japan	University of Edinburgh; National Institute of Information & Communications Technology (NICT) - Japan	Mitrovic, D (corresponding author), Univ Edinburgh, Sch Informat, IPAB, Edinburgh, Midlothian, Scotland.	d.mitrovic@ed.ac.uk			EU	EU(European Commission)	This work was supported by the funding from EU FP7 project STIFF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENNETT DJ, 1993, EXP BRAIN RES, V95, P488; Burdet E, 2006, BIOL CYBERN, V94, P20, DOI 10.1007/s00422-005-0025-9; Burdet E, 2001, NATURE, V414, P446, DOI 10.1038/35106566; Chhabra M, 2006, J NEUROSCI, V26, P10883, DOI 10.1523/JNEUROSCI.2238-06.2006; Davidson PR, 2005, J NEURAL ENG, V2, DOI 10.1088/1741-2560/2/3/S11; Faisal AA, 2008, NAT REV NEUROSCI, V9, P292, DOI 10.1038/nrn2258; FLASH T, 1985, J NEUROSCI, V5, P1688, DOI 10.1523/jneurosci.05-07-01688.1985; Franklin DW, 2008, J NEUROSCI, V28, P11165, DOI 10.1523/JNEUROSCI.3099-08.2008; Franklin DW, 2007, J NEUROSCI, V27, P7705, DOI 10.1523/JNEUROSCI.0968-07.2007; Gomi H, 1996, SCIENCE, V272, P117, DOI 10.1126/science.272.5258.117; Gribble PL, 2003, J NEUROPHYSIOL, V89, P2396, DOI 10.1152/jn.01020.2002; Gribble PL, 1998, EXP BRAIN RES, V123, P355, DOI 10.1007/s002210050580; Harris CM, 1998, NATURE, V394, P780, DOI 10.1038/29528; Haruno M, 2005, J NEUROPHYSIOL, V94, P4244, DOI 10.1152/jn.00404.2005; HOGAN N, 1984, IEEE T AUTOMAT CONTR, V29, P681, DOI 10.1109/TAC.1984.1103644; Izawa J, 2008, J NEUROSCI, V28, P2883, DOI 10.1523/JNEUROSCI.5359-07.2008; Jones KE, 2002, J NEUROPHYSIOL, V88, P1533, DOI 10.1152/jn.2002.88.3.1533; KATAYAMA M, 1993, BIOL CYBERN, V69, P353, DOI 10.1007/BF01185407; Kawato M, 1999, CURR OPIN NEUROBIOL, V9, P718, DOI 10.1016/S0959-4388(99)00028-8; Krutky MA, 2010, J NEUROPHYSIOL, V103, P429, DOI 10.1152/jn.00679.2009; Lametti DR, 2007, J NEUROPHYSIOL, V98, P3516, DOI 10.1152/jn.00970.2007; Laursen B, 1998, EUR J APPL PHYSIOL, V78, P544, DOI 10.1007/s004210050458; Li W, 2007, INT J CONTROL, V80, P1439, DOI 10.1080/00207170701364913; Li W., 2006, THESIS U CALIFORNIA; Lockhart DB, 2007, NAT NEUROSCI, V10, P1329, DOI 10.1038/nn1986; McIntyre J, 1996, EXP BRAIN RES, V110, P248; Milner TE, 2005, J PHYSIOL-LONDON, V567, P651, DOI 10.1113/jphysiol.2005.090449; MITROVIC D, 2008, P 10 INT C SIM AD BE; Osu R, 1999, J NEUROPHYSIOL, V81, P1458, DOI 10.1152/jn.1999.81.4.1458; Osu R, 2004, J NEUROPHYSIOL, V92, P1199, DOI 10.1152/jn.00519.2003; Scott SH, 2004, NAT REV NEUROSCI, V5, P534, DOI 10.1038/nrn1427; Selen LPJ, 2005, BIOL CYBERN, V93, P373, DOI 10.1007/s00422-005-0015-y; SELEN LPJ, 2007, THESIS VRIJE U AMSTE; Selen LPJ, 2009, J NEUROSCI, V29, P12606, DOI 10.1523/JNEUROSCI.2826-09.2009; SHADMEHR R, 1994, J NEUROSCI, V14, P3208; Shadmehr R, 2008, EXP BRAIN RES, V185, P359, DOI 10.1007/s00221-008-1280-5; Stengel R. F., 1994, OPTIMAL CONTROL ESTI; Suzuki M, 2001, EXP BRAIN RES, V140, P171, DOI 10.1007/s002210100797; Tee KP, 2004, BIOL CYBERN, V90, P368, DOI 10.1007/s00422-004-0484-4; Thoroughman KA, 1999, J NEUROSCI, V19, P8573; Todorov E, 2005, NEURAL COMPUT, V17, P1084, DOI 10.1162/0899766053491887; Todorov E, 2004, NAT NEUROSCI, V7, P907, DOI 10.1038/nn1309; Todorov E, 2002, NAT NEUROSCI, V5, P1226, DOI 10.1038/nn963; Trumbower RD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005411; UNO Y, 1989, BIOL CYBERN, V61, P89, DOI 10.1007/BF00204593; Valero-Cuevas FJ, 2009, ADV EXP MED BIOL, V629, P619, DOI 10.1007/978-0-387-77064-2_33; van Beers RJ, 2004, J NEUROPHYSIOL, V91, P1050, DOI 10.1152/jn.00652.2003; van Beers RJ, 2009, NEURON, V63, P406, DOI 10.1016/j.neuron.2009.06.025; Vijayakumar S, 2005, NEURAL COMPUT, V17, P2602, DOI 10.1162/089976605774320557; Wang T, 2001, BIOL CYBERN, V85, P437, DOI 10.1007/s004220100277; WIERZBICKA MM, 1986, EXP BRAIN RES, V63, P331; WOLPERT DM, 1995, SCIENCE, V269, P1880, DOI 10.1126/science.7569931	52	38	39	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2010	5	10							e13601	10.1371/journal.pone.0013601	http://dx.doi.org/10.1371/journal.pone.0013601			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671GB	21049061	Green Published, Green Submitted, gold			2022-12-27	WOS:000283487400008
J	Starostik, MR; Rebello, MR; Cotter, KA; Kulik, A; Medler, KF				Starostik, Margaret R.; Rebello, Michelle R.; Cotter, Kellie A.; Kulik, Akos; Medler, Kathryn F.			Expression of GABAergic Receptors in Mouse Taste Receptor Cells	PLOS ONE			English	Article							GAMMA-AMINOBUTYRIC-ACID; PLASMA-MEMBRANE TRANSPORTERS; GABA(B) RECEPTORS; IMMUNOCYTOCHEMICAL LOCALIZATION; COEXPRESSION PATTERNS; AIRWAY EPITHELIUM; RAT-BRAIN; BUDS; SEROTONIN; PHARMACOLOGY	Background: Multiple excitatory neurotransmitters have been identified in the mammalian taste transduction, with few studies focused on inhibitory neurotransmitters. Since the synthetic enzyme glutamate decarboxylase (GAD) for gamma-aminobutyric acid (GABA) is expressed in a subset of mouse taste cells, we hypothesized that other components of the GABA signaling pathway are likely expressed in this system. GABA signaling is initiated by the activation of either ionotropic receptors (GABA(A) and GABA(C)) or metabotropic receptors (GABA(B)) while it is terminated by the re-uptake of GABA through transporters (GATs). Methodology/Principal Findings: Using reverse transcriptase-PCR (RT-PCR) analysis, we investigated the expression of different GABA signaling molecules in the mouse taste system. Taste receptor cells (TRCs) in the circumvallate papillae express multiple subunits of the GABA(A) and GABA(B) receptors as well as multiple GATs. Immunocytochemical analyses examined the distribution of the GABA machinery in the circumvallate papillae. Both GABA(A)- and GABA(B)-immunoreactivity were detected in the peripheral taste receptor cells. We also used transgenic mice that express green fluorescent protein (GFP) in either the Type II taste cells, which can respond to bitter, sweet or umami taste stimuli, or in the Type III GAD67 expressing taste cells. Thus, we were able to identify that GABAergic receptors are expressed in some Type II and Type III taste cells. Mouse GAT4 labeling was concentrated in the cells surrounding the taste buds with a few positively labeled TRCs at the margins of the taste buds. Conclusions/Significance: The presence of GABAergic receptors localized on Type II and Type III taste cells suggests that GABA is likely modulating evoked taste responses in the mouse taste bud.	[Starostik, Margaret R.; Rebello, Michelle R.; Cotter, Kellie A.; Medler, Kathryn F.] SUNY Buffalo, Dept Biol Sci, Buffalo, NY 14260 USA; [Kulik, Akos] Univ Freiburg, Inst Anat & Cell Biol, Dept Neuroanat, Freiburg, Germany	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; University of Freiburg	Starostik, MR (corresponding author), SUNY Buffalo, Dept Biol Sci, Buffalo, NY 14260 USA.	kmedler@buffalo.edu		Cotter, Kellie/0000-0002-2574-815X; Starostik, Margaret/0000-0002-5274-2765; Medler, Kathryn/0000-0001-9664-3606	NIH [DC006358]; NSF [0917893]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R03DC006358] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by NIH Grant DC006358 and NSF 0917893 to KM. The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belenky MA, 2008, J COMP NEUROL, V506, P708, DOI 10.1002/cne.21553; Bettler B, 2006, PHARMACOL THERAPEUT, V110, P533, DOI 10.1016/j.pharmthera.2006.03.006; BORDEN LA, 1992, J BIOL CHEM, V267, P21098; BOWERY NG, 1980, NATURE, V283, P92, DOI 10.1038/283092a0; Cao Y, 2009, P NATL ACAD SCI USA, V106, P4006, DOI 10.1073/pnas.0808672106; Clapp TR, 2001, BMC NEUROSCI, V2, DOI 10.1186/1471-2202-2-6; Clapp TR, 2004, J COMP NEUROL, V468, P311, DOI 10.1002/cne.10963; CLARK JA, 1992, NEURON, V9, P337, DOI 10.1016/0896-6273(92)90172-A; Cossart R, 2005, TRENDS NEUROSCI, V28, P108, DOI 10.1016/j.tins.2004.11.011; Couve A, 2000, MOL CELL NEUROSCI, V16, P296, DOI 10.1006/mcne.2000.0908; Cromer BA, 2002, TRENDS BIOCHEM SCI, V27, P280, DOI 10.1016/S0968-0004(02)02092-3; CURTIS DR, 1974, ERG PHYSIOL BIOL CH, V69, P97; DeFazio RA, 2006, J NEUROSCI, V26, P3971, DOI 10.1523/JNEUROSCI.0515-06.2006; DELAY RJ, 1988, J COMP NEUROL, V277, P268, DOI 10.1002/cne.902770208; Deriu D, 2005, BIOCHEM J, V386, P423, DOI 10.1042/BJ20040804; ERLANDER MG, 1991, NEURON, V7, P91, DOI 10.1016/0896-6273(91)90077-D; Ernst M, 2005, MOL PHARMACOL, V68, P1291, DOI 10.1124/mol.105.015982; EWALD DA, 1994, J NEUROSCI, V14, P3791; FEIGENSPAN A, 1993, NATURE, V361, P159, DOI 10.1038/361159a0; Ferguson RE, 2005, PROTEOMICS, V5, P566, DOI 10.1002/pmic.200400941; Finger TE, 2005, SCIENCE, V310, P1495, DOI 10.1126/science.1118435; GUASTELLA J, 1990, SCIENCE, V249, P1303, DOI 10.1126/science.1975955; Guo C, 2009, J COMP NEUROL, V512, P6, DOI 10.1002/cne.21846; Hacker K, 2008, J NEUROPHYSIOL, V99, P1503, DOI 10.1152/jn.00892.2007; HALES TG, 1994, J NEUROSCI, V14, P5429; Herness S, 2002, J NEUROSCI, V22, P10018; Herness S, 2005, CHEM SENSES, V30, pI37, DOI 10.1093/chemse/bjh101; Hevers W, 1998, MOL NEUROBIOL, V18, P35, DOI 10.1007/BF02741459; Hirota JA, 2010, CLIN EXP ALLERGY, V40, P820, DOI 10.1111/j.1365-2222.2010.03458.x; Huang YJ, 2005, J NEUROSCI, V25, P843, DOI 10.1523/JNEUROSCI.4446-04.2005; Huang ZJ, 2006, NEURON, V50, P521, DOI 10.1016/j.neuron.2006.05.005; IVERSEN LL, 1975, BIOCHEM PHARMACOL, V24, P933, DOI 10.1016/0006-2952(75)90422-0; JAIN S, 1991, J COMP NEUROL, V307, P675, DOI 10.1002/cne.903070412; Jin N, 2005, CELL TISSUE RES, V321, P173, DOI 10.1007/s00441-005-1130-8; Johnson J, 1996, J COMP NEUROL, V375, P212; Kaupmann K, 1997, NATURE, V386, P239, DOI 10.1038/386239a0; Kaya N, 2004, AM J PHYSIOL-REG I, V286, pR649, DOI 10.1152/ajpregu.00572.2003; KIM DJ, 1995, J COMP NEUROL, V353, P364, DOI 10.1002/cne.903530304; KINNAMON JC, 1988, J COMP NEUROL, V270, P1, DOI 10.1002/cne.902700102; KROGSGAARDLARSEN P, 1979, J NEUROCHEM, V32, P1717, DOI 10.1111/j.1471-4159.1979.tb02284.x; Kulik A, 2002, EUR J NEUROSCI, V15, P291, DOI 10.1046/j.0953-816x.2001.01855.x; Li JL, 2001, NEUROSCI LETT, V315, P93, DOI 10.1016/S0304-3940(01)02321-7; LIU QR, 1993, J BIOL CHEM, V268, P2106; Marshall FH, 1999, TRENDS PHARMACOL SCI, V20, P396, DOI 10.1016/S0165-6147(99)01383-8; Mukherjee RS, 2006, MOL PHARMACOL, V70, P1406, DOI 10.1124/mol.106.024463; NADA O, 1975, HISTOCHEMISTRY, V43, P237, DOI 10.1007/BF00499704; Nagai T, 1998, J COMP NEUROL, V392, P199, DOI 10.1002/(SICI)1096-9861(19980309)392:2<199::AID-CNE4>3.0.CO;2-Y; Nagai T, 1996, CHEM SENSES, V21, P353, DOI 10.1093/chemse/21.3.353; Nakamura Y, 2007, CHEM SENSES, V32, pJ19; Obata H, 1997, MOL BRAIN RES, V49, P29, DOI 10.1016/S0169-328X(97)00118-6; Ogura T, 2005, CHEM SENSES, V30, pI41, DOI 10.1093/chemse/bjh103; Ogura T, 2002, J NEUROPHYSIOL, V87, P2643, DOI 10.1152/jn.2002.87.6.2643; Ogura T, 2007, CELL TISSUE RES, V330, P17, DOI 10.1007/s00441-007-0470-y; Olsen RW, 2008, PHARMACOL REV, V60, P243, DOI 10.1124/pr.108.00505; Olsen RW, 2009, NEUROPHARMACOLOGY, V56, P141, DOI 10.1016/j.neuropharm.2008.07.045; ORTELLS MO, 1995, TRENDS NEUROSCI, V18, P121, DOI 10.1016/0166-2236(95)93887-4; Owens DF, 2002, NAT REV NEUROSCI, V3, P715, DOI 10.1038/nrn919; Queva S, 2003, BRIT J PHARMACOL, V140, P315, DOI 10.1038/sj.bjp.0705447; Ren Y, 1999, MOL BRAIN RES, V74, P221, DOI 10.1016/S0169-328X(99)00253-3; Represa A, 2005, TRENDS NEUROSCI, V28, P278, DOI 10.1016/j.tins.2005.03.010; Ribak CE, 1996, J COMP NEUROL, V367, P595, DOI 10.1002/(SICI)1096-9861(19960415)367:4<595::AID-CNE9>3.0.CO;2-#; Roper SD, 2006, CELL MOL LIFE SCI, V63, P1494, DOI 10.1007/s00018-006-6112-9; Roper SD, 2007, PFLUG ARCH EUR J PHY, V454, P759, DOI 10.1007/s00424-007-0247-x; Rozzo A, 2002, EUR J NEUROSCI, V15, P1747, DOI 10.1046/j.1460-9568.2002.02013.x; Rudolph U, 2004, ANNU REV PHARMACOL, V44, P475, DOI 10.1146/annurev.pharmtox.44.101802.121429; Shen T, 2005, NEUROSCIENCE, V130, P229, DOI 10.1016/j.neuroscience.2004.09.017; Sieghart W., 2002, Current Topics in Medicinal Chemistry, V2, P795, DOI 10.2174/1568026023393507; Takanaga T, 2001, J CEREBR BLOOD F MET, V21, P1232, DOI 10.1097/00004647-200110000-00012; Thellin O, 1999, J BIOTECHNOL, V75, P291, DOI 10.1016/S0168-1656(99)00163-7; Tomchik SM, 2007, J NEUROSCI, V27, P10840, DOI 10.1523/JNEUROSCI.1863-07.2007; UCHIDA T, 1985, JAP J ORAL BIOL, V27, P132; Wagner DA, 2001, J NEUROSCI, V21, P67, DOI 10.1523/JNEUROSCI.21-01-00067.2001; Wegelius K, 1998, EUR J NEUROSCI, V10, P350, DOI 10.1046/j.1460-9568.1998.00023.x; Wu Y, 2006, ANN NEUROL, V59, P42, DOI 10.1002/ana.20686; Xiang YY, 2007, NAT MED, V13, P862, DOI 10.1038/nm1604; Yamamoto T, 1998, JPN J PHARMACOL, V76, P325, DOI 10.1254/jjp.76.325; Yang RB, 2000, J COMP NEUROL, V424, P205, DOI 10.1002/1096-9861(20000821)424:2<205::AID-CNE2>3.0.CO;2-F; Yee CL, 2001, J COMP NEUROL, V440, P97, DOI 10.1002/cne.1372; Zhao FL, 2005, P NATL ACAD SCI USA, V102, P11100, DOI 10.1073/pnas.0501988102	79	14	16	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2010	5	10							e13639	10.1371/journal.pone.0013639	http://dx.doi.org/10.1371/journal.pone.0013639			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671GB	21049022	Green Published, Green Submitted, gold			2022-12-27	WOS:000283487400027
J	Asikainen, S; Dogan, B; Turgut, Z; Paster, BJ; Bodur, A; Oscarsson, J				Asikainen, Sirkka; Dogan, Basak; Turgut, Zeynep; Paster, Bruce J.; Bodur, Aysen; Oscarsson, Jan			Specified Species in Gingival Crevicular Fluid Predict Bacterial Diversity	PLOS ONE			English	Article							PERIODONTAL-DISEASE; MICROFLORA; IDENTIFICATION; INFLAMMATION; COMPONENTS; MARKERS; CARIES	Background: Analysis of gingival crevicular fluid (GCF) samples may give information of unattached (planktonic) subgingival bacteria. Our study represents the first one targeting the identity of bacteria in GCF. Methodology/Principal Findings: We determined bacterial species diversity in GCF samples of a group of periodontitis patients and delineated contributing bacterial and host-associated factors. Subgingival paper point (PP) samples from the same sites were taken for comparison. After DNA extraction, 16S rRNA genes were PCR amplified and DNA-DNA hybridization was performed using a microarray for over 300 bacterial species or groups. Altogether 133 species from 41 genera and 8 phyla were detected with 9 to 62 and 18 to 64 species in GCF and PP samples, respectively, per patient. Projection to latent structures by means of partial least squares (PLS) was applied to the multivariate data analysis. PLS regression analysis showed that species of genera including Campylobacter, Selenomonas, Porphyromonas, Catonella, Tannerella, Dialister, Peptostreptococcus, Streptococcus and Eubacterium had significant positive correlations and the number of teeth with low-grade attachment loss a significant negative correlation to species diversity in GCF samples. OPLS/O2PLS discriminant analysis revealed significant positive correlations to GCF sample group membership for species of genera Campylobacter, Leptotrichia, Prevotella, Dialister, Tannerella, Haemophilus, Fusobacterium, Eubacterium, and Actinomyces. Conclusions/Significance: Among a variety of detected species those traditionally classified as Gram-negative anaerobes growing in mature subgingival biofilms were the main predictors for species diversity in GCF samples as well as responsible for distinguishing GCF samples from PP samples. GCF bacteria may provide new prospects for studying dynamic properties of subgingival biofilms.	[Asikainen, Sirkka; Oscarsson, Jan] Umea Univ, Inst Odontol, Sect Oral Microbiol, Umea, Sweden; [Dogan, Basak] Marmara Univ, Fac Dent, Dept Periodontol, Istanbul, Turkey; [Turgut, Zeynep; Bodur, Aysen] Gazi Univ, Dept Periodontol, Ankara, Turkey; [Paster, Bruce J.] Forsyth Inst, Dept Mol Genet, Boston, MA USA; [Paster, Bruce J.] Harvard Univ, Sch Dent Med, Dept Oral Med Infect & Immun, Boston, MA 02115 USA	Umea University; Marmara University; Gazi University; Harvard University; Forsyth Institute; Harvard University; Harvard School of Dental Medicine	Asikainen, S (corresponding author), Kuwait Univ, Fac Dent, Safat, Kuwait.	sirkka.asikainen@odont.umu.se	çankaya, zeynep turgut/AAF-3306-2020; Paster, Bruce J/AAP-8559-2021; Bodur, Ayşen/AAC-2762-2021	Dogan, Basak/0000-0002-3602-4886	Swedish Medical Research Council [2006-06X-14747-04-3/SA]; County Council of Vasterbotten, Sweden [VLL 1165-2005/SA]	Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); County Council of Vasterbotten, Sweden	This work was funded by grants from the Swedish Medical Research Council 2006-06X-14747-04-3/SA, County Council of Vasterbotten, Sweden VLL 1165-2005/SA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aas JA, 2005, J CLIN MICROBIOL, V43, P5721, DOI 10.1128/JCM.43.11.5721-5732.2005; Armitage GC, 2004, PERIODONTOL 2000, V34, P109, DOI 10.1046/j.0906-6713.2002.003427.x; Baelum V, 2007, J ORAL REHABIL, V34, P872, DOI 10.1111/j.1365-2842.2007.01799.x; Colombo APV, 2009, J PERIODONTOL, V80, P1421, DOI 10.1902/jop.2009.090185; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; de Lillo A, 2006, ORAL MICROBIOL IMMUN, V21, P61, DOI 10.1111/j.1399-302X.2005.00255.x; Dige I, 2009, ORAL MICROBIOL IMMUN, V24, P69, DOI 10.1111/j.1399-302X.2008.00482.x; Dogan B, 2005, J PERIODONTOL, V76, P740, DOI 10.1902/jop.2005.76.5.740; Dogan BA, 2003, J PERIODONTOL, V74, P803, DOI 10.1902/jop.2003.74.6.803; Downes J, 2002, INT J SYST EVOL MICR, V52, P1469, DOI 10.1099/00207713-52-5-1469; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Eriksson L, 2004, ANAL BIOANAL CHEM, V380, P419, DOI 10.1007/s00216-004-2783-y; Faveri M, 2008, ORAL MICROBIOL IMMUN, V23, P112, DOI 10.1111/j.1399-302X.2007.00397.x; Furukawa S, 2006, J BACTERIOL, V188, P1211, DOI 10.1128/JB.188.4.1211-1217.2006; Kamma JJ, 2000, ORAL MICROBIOL IMMUN, V15, P103, DOI 10.1034/j.1399-302x.2000.150206.x; Kaplan JB, 2010, J DENT RES, V89, P205, DOI 10.1177/0022034509359403; Karatan E, 2009, MICROBIOL MOL BIOL R, V73, P310, DOI 10.1128/MMBR.00041-08; Karched M, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-18; Kolenbrander PE, 2006, PERIODONTOL 2000, V42, P47, DOI 10.1111/j.1600-0757.2006.00187.x; Kumar PS, 2005, J CLIN MICROBIOL, V43, P3944, DOI 10.1128/JCM.43.8.3944-3955.2005; Lamster IB, 2007, ANN NY ACAD SCI, V1098, P216, DOI 10.1196/annals.1384.027; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Loos BG, 2005, J PERIODONTOL, V76, P2106, DOI 10.1902/jop.2005.76.11-S.2106; Marsh P D, 1994, Adv Dent Res, V8, P263; Nakashima K, 1996, J CLIN PERIODONTOL, V23, P832, DOI 10.1111/j.1600-051X.1996.tb00620.x; Oscarsson J, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-206; Paster BJ, 2001, J BACTERIOL, V183, P3770, DOI 10.1128/JB.183.12.3770-3783.2001; Preza D, 2009, EUR J CLIN MICROBIOL, V28, P509, DOI 10.1007/s10096-008-0662-8; Ridker PM, 2008, J PERIODONTOL, V79, P1544, DOI 10.1902/jop.2008.080249; SLOTS J, 1977, SCAND J DENT RES, V85, P247; SOCRANSKY SS, 1977, J PERIODONTAL RES, V12, P90, DOI 10.1111/j.1600-0765.1977.tb00112.x; SOCRANSKY SS, 1992, J PERIODONTOL, V63, P322, DOI 10.1902/jop.1992.63.4s.322; Wiklund S, 2008, ANAL CHEM, V80, P115, DOI 10.1021/ac0713510; Willems A, 1996, INT J SYST BACTERIOL, V46, P1083, DOI 10.1099/00207713-46-4-1083	34	15	15	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2010	5	10							e13589	10.1371/journal.pone.0013589	http://dx.doi.org/10.1371/journal.pone.0013589			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	670LB	21049043	Green Published, Green Submitted, gold			2022-12-27	WOS:000283422100009
J	Frost, JM; Monk, D; Stojilkovic-Mikic, T; Woodfine, K; Chitty, LS; Murrell, A; Stanier, P; Moore, GE				Frost, Jennifer M.; Monk, Dave; Stojilkovic-Mikic, Taita; Woodfine, Kathryn; Chitty, Lyn S.; Murrell, Adele; Stanier, Philip; Moore, Gudrun E.			Evaluation of Allelic Expression of Imprinted Genes in Adult Human Blood	PLOS ONE			English	Article							BECKWITH-WIEDEMANN-SYNDROME; COLORECTAL-CANCER; METHYLATION CHANGES; GROWTH DISORDERS; BLADDER-CANCER; FETAL-GROWTH; IGF2; H19; HYPOMETHYLATION; BRAIN	Background: Imprinted genes are expressed from only one allele in a parent-of-origin dependent manner. Loss of imprinted expression can result in a variety of human disorders and is frequently reported in cancer. Biallelic expression of imprinted genes in adult blood has been suggested as a useful biomarker and is currently being investigated in colorectal cancer. In general, the expression profiles of imprinted genes are well characterised during human and mouse fetal development, but not in human adults. Methodology/Principal Findings: We investigated quantitative expression of 36 imprinted genes in adult human peripheral blood leukocytes obtained from healthy individuals. Allelic expression was also investigated in B and T lymphocytes and myeloid cells. We found that 21 genes were essentially undetectable in adult blood. Only six genes were demonstrably monoallelic, and most importantly, we found that nine genes were either biallelic or showed variable expression in different individuals. Separated leukocyte populations showed the same expression patterns as whole blood. Differential methylation at each of the imprinting control loci analysed was maintained, including regions that contained biallelically expressed genes. This suggests in some cases methylation has become uncoupled from its role in regulating gene expression. Conclusions/Significance: We conclude that only a limited set of imprinted genes, including IGF2 and SNRPN, may be useful for LOI cancer biomarker studies. In addition, blood is not a good tissue to use for the discovery of new imprinted genes. Finally, lymphocyte DNA methylation status in the adult may not always be a reliable indicator of monoallelic gene expression.	[Frost, Jennifer M.; Monk, Dave; Stojilkovic-Mikic, Taita; Chitty, Lyn S.; Stanier, Philip; Moore, Gudrun E.] UCL, Inst Child Hlth, Clin & Mol Genet Unit, London, England; [Frost, Jennifer M.] Univ London Imperial Coll Sci Technol & Med, Inst Reprod & Dev Biol, London, England; [Stojilkovic-Mikic, Taita; Chitty, Lyn S.] UCL, Acad Dept Obstet & Gynaecol, London, England; [Monk, Dave] Hosp Duran I Reynals, Catalan Inst Oncol, Canc Epigenet & Biol Program, Imprinting & Canc Grp, Barcelona, Spain; [Woodfine, Kathryn; Murrell, Adele] Cambridge Res Inst, Canc Res UK, Cambridge, England	University of London; University College London; Imperial College London; University of London; University College London; Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Hospital Duran i Reynals; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge	Frost, JM (corresponding author), UCL, Inst Child Hlth, Clin & Mol Genet Unit, London, England.	j.frost@ich.ucl.ac.uk	Stanier, Philip/C-1593-2008; Moore, Gudrun/A-2092-2009; Frost, Jennifer/D-1867-2015	Stanier, Philip/0000-0001-9340-8117; chitty, lyn/0000-0002-4857-7138; Frost, Jennifer/0000-0002-3057-6313; Murrell, adele/0000-0003-2647-3511	Medical Research Council; March of Dimes and Wellbeing of Women; Cancer Research UK Senior Cancer Research Fellowship; Association for International Cancer Research; University of Cambridge, and Cancer Research UK; Great Ormond Street Hospital Childrens Charity [V0909] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); March of Dimes and Wellbeing of Women(March of Dimes); Cancer Research UK Senior Cancer Research Fellowship(Cancer Research UK); Association for International Cancer Research; University of Cambridge, and Cancer Research UK(University of Cambridge); Great Ormond Street Hospital Childrens Charity	This work was supported by grants from the Medical Research Council, the March of Dimes and Wellbeing of Women. AM and KW would like to acknowledge a Cancer Research UK Senior Cancer Research Fellowship and Association for International Cancer Research Project grant, as well as the support of The University of Cambridge, and Cancer Research UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. (http://www.mrc.ac.uk/index.htm; http://www.marchofdimes.com/; http://www.wellbeingofwomen.org.uk/; http://www.cancerresearchuk.org/; http://www.aicr.org.uk/)	Abu-Amero S, 2008, J MED GENET, V45, P193, DOI 10.1136/jmg.2007.053017; Apostolidou S, 2007, J MOL MED, V85, P379, DOI 10.1007/s00109-006-0131-8; Arnaud P, 2003, HUM MOL GENET, V12, P1005, DOI 10.1093/hmg/ddg110; Azzi S, 2009, HUM MOL GENET, V18, P4724, DOI 10.1093/hmg/ddp435; Babak T, 2008, CURR BIOL, V18, P1735, DOI 10.1016/j.cub.2008.09.044; Bastepe M, 2005, NAT GENET, V37, P25, DOI 10.1038/ng1487; Bourc'his D, 2001, SCIENCE, V294, P2536, DOI 10.1126/science.1065848; Byun HM, 2007, CANCER RES, V67, P10753, DOI 10.1158/0008-5472.CAN-07-0329; Choi JD, 2005, MOL CELL BIOL, V25, P5514, DOI 10.1128/MCB.25.13.5514-5522.2005; Constancia M, 2002, NATURE, V417, P945, DOI 10.1038/nature00819; Cui HM, 2003, SCIENCE, V299, P1753, DOI 10.1126/science.1080902; Cui HM, 2002, CANCER RES, V62, P6442; DAVIES SM, 1994, CANCER RES, V54, P2560; DECHIARA TM, 1991, CELL, V64, P849, DOI 10.1016/0092-8674(91)90513-X; Diaz-Meyer N, 2003, J MED GENET, V40, P797, DOI 10.1136/jmg.40.11.797; Feinberg AP, 2006, NAT REV GENET, V7, P21, DOI 10.1038/nrg1748; FROST JM, 2011, EPIGENETICS, V6; Gimelbrant A, 2007, SCIENCE, V318, P1136, DOI 10.1126/science.1148910; Ideraabdullah FY, 2008, MUTAT RES-FUND MOL M, V647, P77, DOI 10.1016/j.mrfmmm.2008.08.008; Ito Y, 2008, HUM MOL GENET, V17, P2633, DOI 10.1093/hmg/ddn163; Jelinic P, 2007, J PATHOL, V211, P261, DOI 10.1002/path.2116; Kosaki K, 2000, AM J HUM GENET, V66, P309, DOI 10.1086/302712; Liu J, 2003, J CLIN ENDOCR METAB, V88, P4336, DOI 10.1210/jc.2003-030393; Luedi PP, 2007, GENOME RES, V17, P1723, DOI 10.1101/gr.6584707; Monk D, 2006, P NATL ACAD SCI USA, V103, P6623, DOI 10.1073/pnas.0511031103; MOORE T, 1991, TRENDS GENET, V7, P45, DOI 10.1016/0168-9525(91)90230-N; Morison IM, 2005, TRENDS GENET, V21, P457, DOI 10.1016/j.tig.2005.06.008; Murrell A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001849; Paulsen M, 1998, HUM MOL GENET, V7, P1149, DOI 10.1093/hmg/7.7.1149; Pham NV, 1998, BRAIN RES, V810, P1, DOI 10.1016/S0006-8993(98)00783-5; Pollard KS, 2008, HUM GENET, V122, P625, DOI 10.1007/s00439-007-0440-1; Sakatani T, 2001, BIOCHEM BIOPH RES CO, V283, P1124, DOI 10.1006/bbrc.2001.4916; Shin JY, 2008, EMBO J, V27, P168, DOI 10.1038/sj.emboj.7601960; Takai D, 2001, HUM MOL GENET, V10, P2619, DOI 10.1093/hmg/10.23.2619; TANIGUCHI T, 1995, P NATL ACAD SCI USA, V92, P2159, DOI 10.1073/pnas.92.6.2159; Ulaner GA, 2003, HUM MOL GENET, V12, P535, DOI 10.1093/hmg/ddg034; Valleley EM, 2007, HUM MOL GENET, V16, P972, DOI 10.1093/hmg/ddm041; Wang X, 2008, PLOS ONE, V3, DOI [10.1371/journal.pone.0003839, 10.1371/journal.pone.0002557]; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Weksberg R, 2001, HUM MOL GENET, V10, P2989, DOI 10.1093/hmg/10.26.2989; Wilkinson LS, 2007, NAT REV NEUROSCI, V8, P832, DOI 10.1038/nrn2235; Wood AJ, 2007, PLOS GENET, V3, P192, DOI 10.1371/journal.pgen.0030020	42	20	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2010	5	10							e13556	10.1371/journal.pone.0013556	http://dx.doi.org/10.1371/journal.pone.0013556			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	668TQ	21042416	Green Published, Green Submitted, gold			2022-12-27	WOS:000283293800020
J	White, RE; Groves, IJ; Turro, E; Yee, J; Kremmer, E; Allday, MJ				White, Robert E.; Groves, Ian J.; Turro, Ernest; Yee, Jade; Kremmer, Elisabeth; Allday, Martin J.			Extensive Co-Operation between the Epstein-Barr Virus EBNA3 Proteins in the Manipulation of Host Gene Expression and Epigenetic Chromatin Modification	PLOS ONE			English	Article							NUCLEAR ANTIGEN 3C; LYMPHOBLASTOID CELL-LINES; RBP-J-KAPPA; GENOMIC INSTABILITY; HISTONE DEACETYLASE; BURKITTS-LYMPHOMA; TARGET GENES; CYCLIN-A; TRANSCRIPTION; BINDING	Epstein-Barr virus (EBV) is able to drive the transformation of B-cells, resulting in the generation of lymphoblastoid cell lines (LCLs) in vitro. EBV nuclear proteins EBNA3A and EBNA3C are necessary for efficient transformation, while EBNA3B is dispensable. We describe a transcriptome analysis of BL31 cells infected with a series of EBNA3-knockout EBVs, including one deleted for all three EBNA3 genes. Using Affymetrix Exon 1.0 ST microarrays analysed with the MMBGX algorithm, we have identified over 1000 genes whose regulation by EBV requires one of the EBNA3s. Remarkably, a third of the genes identified require more than one EBNA3 for their regulation, predominantly EBNA3C co-operating with either EBNA3B, EBNA3A or both. The microarray was validated by real-time PCR, while ChIP analysis of a selection of co-operatively repressed promoters indicates a role for polycomb group complexes. Targets include genes involved in apoptosis, cell migration and B-cell differentiation, and show a highly significant but subtle alteration in genes involved in mitosis. In order to assess the relevance of the BL31 system to LCLs, we analysed the transcriptome of a set of EBNA3B knockout (3BKO) LCLs. Around a third of the genes whose expression level in LCLs was altered in the absence of EBNA3B were also altered in 3BKO-BL31 cell lines. Among these are TERT and TCL1A, implying that EBV-induced changes in the expression of these genes are not required for B-cell transformation. We also identify 26 genes that require both EBNA3A and EBNA3B for their regulation in LCLs. Together, this shows the complexity of the interaction between EBV and its host, whereby multiple EBNA3 proteins co-operate to modulate the behaviour of the host cell.	[White, Robert E.; Groves, Ian J.; Yee, Jade; Allday, Martin J.] Univ London Imperial Coll Sci Technol & Med, Virol Sect, London, England; [Turro, Ernest] Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Biostat, London, England; [Kremmer, Elisabeth] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Mol Immunol, Munich, Germany	Imperial College London; Imperial College London; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	White, RE (corresponding author), Univ London Imperial Coll Sci Technol & Med, Virol Sect, London, England.	robert.e.white@imperial.ac.uk	Groves, Ian John/HGU-5954-2022	Groves, Ian John/0000-0001-8882-6701; White, Robert/0000-0002-5115-2173; Turro, Ernest/0000-0002-1820-6563	Wellcome Trust [077489, 049293]; Biotechnology and Biological Sciences Research Council (BBSRC) [28EGM16093]	Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This project was funded by program grant 077489 and project grant 049293 from the Wellcome Trust (http://www.wellcome.ac.uk). ET was supported by the Biotechnology and Biological Sciences Research Council (BBSRC) 'Exploiting Genomics' grant 28EGM16093 (http://www.bbsrc.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLAN GJ, 1989, VIROLOGY, V173, P489, DOI 10.1016/0042-6822(89)90561-8; Anderton E, 2008, ONCOGENE, V27, P421, DOI 10.1038/sj.onc.1210668; Baik SY, 2007, CELL PROLIFERAT, V40, P268, DOI 10.1111/j.1365-2184.2007.00429.x; Bain M, 1996, J VIROL, V70, P2481, DOI 10.1128/JVI.70.4.2481-2489.1996; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bourillot PY, 1998, J GEN VIROL, V79, P363, DOI 10.1099/0022-1317-79-2-363; Bracken AP, 2009, NAT REV CANCER, V9, P773, DOI 10.1038/nrc2736; Burgess A, 2006, J GEN VIROL, V87, P789, DOI 10.1099/vir.0.81640-0; CALDERWOOD MA, 2010, EPSTEINBARR VIRUS LA, pCH6; Calderwood MA, 2007, P NATL ACAD SCI USA, V104, P7606, DOI 10.1073/pnas.0702332104; CALENDER A, 1987, P NATL ACAD SCI USA, V84, P8060, DOI 10.1073/pnas.84.22.8060; Chen A, 2005, J VIROL, V79, P4506, DOI 10.1128/JVI.79.7.4506-4509.2005; Chen A, 2006, J VIROL, V80, P10139, DOI 10.1128/JVI.00854-06; Cludts I, 1998, J VIROL, V72, P1862, DOI 10.1128/JVI.72.3.1862-1869.1998; COUNTER CM, 1995, BLOOD, V85, P2315, DOI 10.1182/blood.V85.9.2315.bloodjournal8592315; Crawford DH, 2001, PHILOS T R SOC B, V356, P461, DOI 10.1098/rstb.2000.0783; Delecluse HJ, 1998, P NATL ACAD SCI USA, V95, P8245, DOI 10.1073/pnas.95.14.8245; FINKE J, 1987, J VIROL, V61, P3870, DOI 10.1128/JVI.61.12.3870-3878.1987; Fossum E, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000570; Gruhne B, 2009, ONCOGENE, V28, P3997, DOI 10.1038/onc.2009.258; Harada S, 1997, J VIROL, V71, P6611, DOI 10.1128/JVI.71.9.6611-6618.1997; HENKEL T, 1994, SCIENCE, V265, P92, DOI 10.1126/science.8016657; Hertle ML, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000506; Hickabottom M, 2002, J BIOL CHEM, V277, P47197, DOI 10.1074/jbc.M208116200; Kamranvar SA, 2007, ONCOGENE, V26, P5115, DOI 10.1038/sj.onc.1210324; Klein U, 2003, P NATL ACAD SCI USA, V100, P2639, DOI 10.1073/pnas.0437996100; Knight JS, 2005, P NATL ACAD SCI USA, V102, P18562, DOI 10.1073/pnas.0503886102; Knight JS, 2005, MOL CELL BIOL, V25, P1749, DOI 10.1128/MCB.25.5.1749-1763.2005; Knight JS, 2004, J VIROL, V78, P12857, DOI 10.1128/JVI.78.23.12857-12867.2004; Knight JS, 2004, J VIROL, V78, P1981, DOI 10.1128/JVI.78.4.1981-1991.2004; Knight JS, 2003, J VIROL, V77, P4261, DOI 10.1128/JVI.77.7.4261-4272.2003; Krauer KG, 2004, VIROLOGY, V318, P280, DOI 10.1016/j.virol.2003.09.032; KREMMER E, 1995, VIROLOGY, V208, P336, DOI 10.1006/viro.1995.1157; Lee JE, 2010, CELL PROLIFERAT, V43, P378, DOI 10.1111/j.1365-2184.2010.00687.x; Lee S, 2009, J VIROL, V83, P12368, DOI 10.1128/JVI.01403-09; LEROUX A, 1994, VIROLOGY, V205, P596, DOI 10.1006/viro.1994.1687; Ling PD, 2005, EMBO J, V24, P3565, DOI 10.1038/sj.emboj.7600820; Lucchesi W, 2008, J VIROL, V82, P7456, DOI 10.1128/JVI.00223-08; Maier S, 2006, J VIROL, V80, P9761, DOI 10.1128/JVI.00665-06; MARSHALL D, 1995, J VIROL, V69, P3624, DOI 10.1128/JVI.69.6.3624-3630.1995; Maruo S, 2006, P NATL ACAD SCI USA, V103, P19500, DOI 10.1073/pnas.0604919104; MURRAY RJ, 1988, J VIROL, V62, P894, DOI 10.1128/JVI.62.3.894-901.1988; Neuhierl B, 2002, P NATL ACAD SCI USA, V99, P15036, DOI 10.1073/pnas.232381299; Nitsche F, 1997, J VIROL, V71, P6619, DOI 10.1128/JVI.71.9.6619-6628.1997; Northrup DL, 2008, IMMUNOL RES, V42, P106, DOI 10.1007/s12026-008-8043-z; O'Nions F, 2004, ADV CANCER RES, V92, P119; Ochiai K, 2008, INT IMMUNOL, V20, P453, DOI 10.1093/intimm/dxn005; Parker GA, 1996, ONCOGENE, V13, P2541; Parker GA, 2000, ONCOGENE, V19, P700, DOI 10.1038/sj.onc.1203327; Paschos K, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000492; Pillai S, 2009, NAT REV IMMUNOL, V9, P767, DOI 10.1038/nri2656; Radkov SA, 1999, J VIROL, V73, P5688, DOI 10.1128/JVI.73.7.5688-5697.1999; Radkov SA, 1997, J VIROL, V71, P8552, DOI 10.1128/JVI.71.11.8552-8562.1997; ROBERTSON ES, 1995, J VIROL, V69, P3108, DOI 10.1128/JVI.69.5.3108-3116.1995; Roughan JE, 2009, J VIROL, V83, P3968, DOI 10.1128/JVI.02609-08; ROWE M, 1987, EMBO J, V6, P2743, DOI 10.1002/j.1460-2075.1987.tb02568.x; Saha A, 2009, J VIROL, V83, P4652, DOI 10.1128/JVI.02408-08; Scheeren FA, 2008, J EXP MED, V205, P2033, DOI 10.1084/jem.20070447; Schmidlin H, 2009, TRENDS IMMUNOL, V30, P277, DOI 10.1016/j.it.2009.03.008; Simon JA, 2009, NAT REV MOL CELL BIO, V10, P697, DOI 10.1038/nrm2763; Skalska L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000951; Souza TA, 2007, J IMMUNOL, V179, P3153, DOI 10.4049/jimmunol.179.5.3153; Spender LC, 2006, J GEN VIROL, V87, P2859, DOI 10.1099/vir.0.82128-0; Sugimoto M, 2004, CANCER RES, V64, P3361, DOI 10.1158/0008-5472.CAN-04-0079; Swaminathan S, 2008, J CELL PHYSIOL, V216, P321, DOI 10.1002/jcp.21480; TERRIN L, 2008, J VIROLOGY; Thorley-Lawson DA, 2004, NEW ENGL J MED, V350, P1328, DOI 10.1056/NEJMra032015; Thorley-Lawson DA, 2008, NAT REV MICROBIOL, V6, P913, DOI 10.1038/nrmicro2015; TOMKINSON B, 1992, J VIROL, V66, P2893, DOI 10.1128/JVI.66.5.2893-2903.1992; TOMKINSON B, 1993, J VIROL, V67, P2014, DOI 10.1128/JVI.67.4.2014-2025.1993; Touitou R, 2005, J GEN VIROL, V86, P1269, DOI 10.1099/vir.0.80763-0; Touitou R, 2001, J VIROL, V75, P7749, DOI 10.1128/JVI.75.16.7749-7755.2001; Turro E, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp853; Wade M, 2000, MOL CELL BIOL, V20, P1344, DOI 10.1128/MCB.20.4.1344-1360.2000; Waltzer L, 1996, J VIROL, V70, P5909, DOI 10.1128/JVI.70.9.5909-5915.1996; White RE, 2003, J GEN VIROL, V84, P3393, DOI 10.1099/vir.0.19387-0; Wu KJ, 1999, NAT GENET, V21, P220, DOI 10.1038/6010; Yang J, 2004, J EXP CLIN CANC RES, V23, P495; Yi FM, 2009, VIROLOGY, V388, P236, DOI 10.1016/j.virol.2009.03.027; Young LS, 2004, NAT REV CANCER, V4, P757, DOI 10.1038/nrc1452; Young LS, 2003, ONCOGENE, V22, P5108, DOI 10.1038/sj.onc.1206556; Young P, 2008, J GEN VIROL, V89, P866, DOI 10.1099/vir.0.83414-0; Zimber-Strobl U, 2001, SEMIN CANCER BIOL, V11, P423, DOI 10.1006/scbi.2001.0409	83	65	66	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2010	5	11							e13979	10.1371/journal.pone.0013979	http://dx.doi.org/10.1371/journal.pone.0013979			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	680KW	21085583	Green Published, gold, Green Submitted			2022-12-27	WOS:000284231800009
J	Yu, XT; Zhang, YJ; Lasky, RE; Datta, S; Parikh, NA; Narayana, PA				Yu, Xintian; Zhang, Yanjie; Lasky, Robert E.; Datta, Sushmita; Parikh, Nehal A.; Narayana, Ponnada A.			Comprehensive Brain MRI Segmentation in High Risk Preterm Newborns	PLOS ONE			English	Article							LOW-BIRTH-WEIGHT; INTRAUTERINE GROWTH RESTRICTION; WORKING-MEMORY DEFICITS; TERM-EQUIVALENT AGE; PREMATURE-INFANTS; WHITE-MATTER; NEURODEVELOPMENTAL OUTCOMES; AUTOMATIC SEGMENTATION; HIPPOCAMPAL VOLUMES; NEUROLEPTIC-NAIVE	Most extremely preterm newborns exhibit cerebral atrophy/growth disturbances and white matter signal abnormalities on MRI at term-equivalent age. MRI brain volumes could serve as biomarkers for evaluating the effects of neonatal intensive care and predicting neurodevelopmental outcomes. This requires detailed, accurate, and reliable brain MRI segmentation methods. We describe our efforts to develop such methods in high risk newborns using a combination of manual and automated segmentation tools. After intensive efforts to accurately define structural boundaries, two trained raters independently performed manual segmentation of nine subcortical structures using axial T2-weighted MRI scans from 20 randomly selected extremely preterm infants. All scans were re-segmented by both raters to assess reliability. High intra-rater reliability was achieved, as assessed by repeatability and intra-class correlation coefficients (ICC range: 0.97 to 0.99) for all manually segmented regions. Inter-rater reliability was slightly lower (ICC range: 0.93 to 0.99). A semi-automated segmentation approach was developed that combined the parametric strengths of the Hidden Markov Random Field Expectation Maximization algorithm with non-parametric Parzen window classifier resulting in accurate white matter, gray matter, and CSF segmentation. Final manual correction of misclassification errors improved accuracy (similarity index range: 0.87 to 0.89) and facilitated objective quantification of white matter signal abnormalities. The semi-automated and manual methods were seamlessly integrated to generate full brain segmentation within two hours. This comprehensive approach can facilitate the evaluation of large cohorts to rigorously evaluate the utility of regional brain volumes as biomarkers of neonatal care and surrogate endpoints for neurodevelopmental outcomes.	[Yu, Xintian; Zhang, Yanjie; Lasky, Robert E.; Parikh, Nehal A.] Univ Texas Hlth Sci Ctr Houston, Sch Med, Div Neonatal Perinatal Med, Dept Pediat, Houston, TX USA; [Lasky, Robert E.] Univ Texas Hlth Sci Ctr Houston, Sch Med, Ctr Clin Res & Evidence Based Med, Houston, TX USA; [Datta, Sushmita; Narayana, Ponnada A.] Univ Texas Hlth Sci Ctr Houston, Sch Med, Dept Diagnost & Intervent Imaging, Houston, TX USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston	Yu, XT (corresponding author), Univ Texas Hlth Sci Ctr Houston, Sch Med, Div Neonatal Perinatal Med, Dept Pediat, Houston, TX USA.	Nehal.A.Parikh@uth.tmc.edu	Parikh, Nehal/AAB-9981-2022	Parikh, Nehal/0000-0002-1375-1247	NINDS/NIH [K23NS048152]; Center for Clinical Research and Evidence Based Medicine; NIBIB (National Institute of Biomedical Imaging and Bioengineering)/NIH [R01 EB02095]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB002095] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K23NS048152] Funding Source: NIH RePORTER	NINDS/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Center for Clinical Research and Evidence Based Medicine; NIBIB (National Institute of Biomedical Imaging and Bioengineering)/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Supported by NINDS/NIH, grant # K23NS048152 and a Clinical Investigator Award from the Center for Clinical Research and Evidence Based Medicine. The development of automatic algorithms that formed the basis for tissue segmentation was supported by NIBIB (National Institute of Biomedical Imaging and Bioengineering)/NIH, grant # R01 EB02095 awarded to PAN. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anbeek P, 2004, NEUROIMAGE, V21, P1037, DOI 10.1016/j.neuroimage.2003.10.012; Anbeek P, 2008, PEDIATR RES, V63, P158, DOI 10.1203/PDR.0b013e31815ed071; Anderson P, 2003, JAMA-J AM MED ASSOC, V289, P3264, DOI 10.1001/jama.289.24.3264; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; BAYER SA, 2003, HUMAN BRAIN DURING T; Beauchamp MH, 2008, BRAIN, V131, P2986, DOI 10.1093/brain/awn227; Benders MJNL, 2009, PEDIATR RES, V66, P555, DOI 10.1203/PDR.0b013e3181b3aec5; Bland JM, 1996, BRIT MED J, V313, P41, DOI 10.1136/bmj.313.7048.41; BLAND JM, 1996, MEASUREMENT, V313, P744; Cheong JLY, 2008, PEDIATRICS, V121, pE1534, DOI 10.1542/peds.2007-2671; Convit A, 1999, PSYCHIAT RES-NEUROIM, V90, P113, DOI 10.1016/S0925-4927(99)00007-4; Counsell SJ, 2006, PEDIATRICS, V117, P376, DOI 10.1542/peds.2005-0820; DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409; DUDA RO, 2001, PATTERN CLASSIFICATI, P164; Dyet LE, 2006, PEDIATRICS, V118, P536, DOI 10.1542/peds.2005-1866; Gao FQ, 2003, NEUROBIOL AGING, V24, P49, DOI 10.1016/S0197-4580(02)00013-1; Gur RE, 1998, AM J PSYCHIAT, V155, P1711, DOI 10.1176/ajp.155.12.1711; Hack M, 2005, JAMA-J AM MED ASSOC, V294, P318, DOI 10.1001/jama.294.3.318; Haines D., 1991, NEUROANATOMY ATLAS S; Harris DL, 2006, ARCH DIS CHILD-FETAL, V91, pF11, DOI 10.1136/adc.2005.079806; HART AR, 2010, PEDIAT RADIOL MAR, V24; Hastings RS, 2004, NEUROPSYCHOPHARMACOL, V29, P952, DOI 10.1038/sj.npp.1300371; Hintz SR, 2007, J PEDIATR-US, V150, P592, DOI 10.1016/j.jpeds.2007.02.012; Holland D, 2009, P NATL ACAD SCI USA, V106, P20954, DOI 10.1073/pnas.0906053106; Honeycutt NA, 1998, PSYCHIAT RES-NEUROIM, V83, P85, DOI 10.1016/S0925-4927(98)00035-3; Inder TE, 2005, PEDIATRICS, V115, P286, DOI 10.1542/peds.2004-0326; Institute of Medicine (IOM), 2010, EV BIOM SURR ENDP CH; Laptook AR, 2005, PEDIATRICS, V115, P673, DOI 10.1542/peds.2004-0667; Levitt JJ, 2002, AM J PSYCHIAT, V159, P1190, DOI 10.1176/appi.ajp.159.7.1190; Limperopoulos C, 2005, PEDIATRICS, V116, P844, DOI 10.1542/peds.2004-2282; Lind A, 2010, EUR CHILD ADOLES PSY, V19, P407, DOI 10.1007/s00787-009-0070-3; Lodygensky GA, 2008, PEDIATR RES, V63, P438, DOI 10.1203/PDR.0b013e318165c005; Maalouf EF, 1999, J PEDIATR-US, V135, P351, DOI 10.1016/S0022-3476(99)70133-2; Matsuzawa J, 2001, CEREB CORTEX, V11, P335, DOI 10.1093/cercor/11.4.335; *MI STAT U BRAIN B, HUM BRAIN ATL; NARAYANA PA, 1995, MAGNET RESON MED, V33, P396, DOI 10.1002/mrm.1910330312; Nishida M, 2006, NEUROIMAGE, V32, P1041, DOI 10.1016/j.neuroimage.2006.05.020; Noulhiane A, 2006, J NEUROSCI METH, V156, P293, DOI 10.1016/j.jneumeth.2006.02.021; Nyul LG, 2000, IEEE T MED IMAGING, V19, P143, DOI 10.1109/42.836373; Parikh NA, 2009, J PERINATOL, V29, P143, DOI 10.1038/jp.2008.184; Parikh NA, 2007, PEDIATRICS, V119, P265, DOI 10.1542/peds.2006-1354; PERONA P, 1990, IEEE T PATTERN ANAL, V12, P629, DOI 10.1109/34.56205; Peterson BS, 2003, PEDIATRICS, V111, P939, DOI 10.1542/peds.111.5.939; PINTOMARTIN JA, 1995, PEDIATRICS, V95, P249; Postle BR, 2003, COGN AFFECT BEHAV NE, V3, P133, DOI 10.3758/CABN.3.2.133; Prastawa M, 2005, MED IMAGE ANAL, V9, P457, DOI 10.1016/j.media.2005.05.007; Pruessner JC, 2000, CEREB CORTEX, V10, P433, DOI 10.1093/cercor/10.4.433; Sajja BR, 2006, ANN BIOMED ENG, V34, P142, DOI 10.1007/s10439-005-9009-0; Shah DK, 2006, INVEST OPHTH VIS SCI, V47, P3366, DOI 10.1167/iovs.05-0811; Shah DK, 2006, PEDIATR RES, V60, P97, DOI 10.1203/01.pdr.0000220324.27597.f0; Srinivasan L, 2007, PEDIATRICS, V119, P759, DOI 10.1542/peds.2006-2508; Stokking R, 2000, NEUROIMAGE, V12, P726, DOI 10.1006/nimg.2000.0661; Thompson DK, 2008, ANN NEUROL, V63, P642, DOI 10.1002/ana.21367; Thompson DK, 2007, BRAIN, V130, P667, DOI 10.1093/brain/awl277; Tolsa CB, 2004, PEDIATR RES, V56, P132, DOI 10.1203/01.PDR.0000128983.54614.7E; Tyson JE, 2008, NEW ENGL J MED, V358, P1672, DOI 10.1056/NEJMoa073059; *U WA, DIG AN INT BRAIN ATL; Van Leemput K, 1999, IEEE T MED IMAGING, V18, P897, DOI 10.1109/42.811270; Volpe JJ, 2009, LANCET NEUROL, V8, P110, DOI 10.1016/S1474-4422(08)70294-1; Warfield SK, 2000, MED IMAGE ANAL, V4, P43, DOI 10.1016/S1361-8415(00)00003-7; Weisenfeld NI, 2006, I S BIOMED IMAGING, P766; Weisenfeld NI, 2009, NEUROIMAGE, V47, P564, DOI 10.1016/j.neuroimage.2009.04.068; Wells WM, 1996, IEEE T MED IMAGING, V15, P429, DOI 10.1109/42.511747; Whitaker AH, 1996, PEDIATRICS, V98, P719; Wilde EA, 2007, DEV MED CHILD NEUROL, V49, P294, DOI 10.1111/j.1469-8749.2007.00294.x; Woodward LJ, 2006, NEW ENGL J MED, V355, P685, DOI 10.1056/NEJMoa053792; Woodward LJ, 2005, BRAIN, V128, P2578, DOI 10.1093/brain/awh618; Xue H, 2007, NEUROIMAGE, V38, P461, DOI 10.1016/j.neuroimage.2007.07.030; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424	69	24	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2010	5	11							e13874	10.1371/journal.pone.0013874	http://dx.doi.org/10.1371/journal.pone.0013874			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	676NU	21079730	Green Published, Green Submitted, gold			2022-12-27	WOS:000283920000008
J	Leao, RN; Reis, A; Emirandetti, A; Lewicka, M; Hermanson, O; Fisahn, A				Leao, Richardson N.; Reis, Amilcar; Emirandetti, Amanda; Lewicka, Michalina; Hermanson, Ola; Fisahn, Andre			A Voltage-Sensitive Dye-Based Assay for the Identification of Differentiated Neurons Derived from Embryonic Neural Stem Cell Cultures	PLOS ONE			English	Article							ACTION-POTENTIAL INITIATION; IN-VITRO; POPULATIONS; DYNAMICS; DENDRITES; RESPONSES; BRAIN; SITE; CNS	Background: Pluripotent and multipotent stem cells hold great therapeutical promise for the replacement of degenerated tissue in neurological diseases. To fulfill that promise we have to understand the mechanisms underlying the differentiation of multipotent cells into specific types of neurons. Embryonic stem cell (ESC) and embryonic neural stem cell (NSC) cultures provide a valuable tool to study the processes of neural differentiation, which can be assessed using immunohistochemistry, gene expression, Ca2+-imaging or electrophysiology. However, indirect methods such as protein and gene analysis cannot provide direct evidence of neuronal functionality. In contrast, direct methods such as electrophysiological techniques are well suited to produce direct evidence of neural functionality but are limited to the study of a few cells on a culture plate. Methodology/Principal Findings: In this study we describe a novel method for the detection of action potential-capable neurons differentiated from embryonic NSC cultures using fast voltage-sensitive dyes (VSD). We found that the use of extracellularly applied VSD resulted in a more detailed labeling of cellular processes compared to calcium indicators. In addition, VSD changes in fluorescence translated precisely to action potential kinetics as assessed by the injection of simulated slow and fast sodium currents using the dynamic clamp technique. We further demonstrate the use of a finite element model of the NSC culture cover slip for optimizing electrical stimulation parameters. Conclusions/Significance: Our method allows for a repeatable fast and accurate stimulation of neurons derived from stem cell cultures to assess their differentiation state, which is capable of monitoring large amounts of cells without harming the overall culture.	[Leao, Richardson N.; Fisahn, Andre] Karolinska Inst, Neuronal Oscillat Lab, Stockholm, Sweden; [Reis, Amilcar; Lewicka, Michalina; Hermanson, Ola] Karolinska Inst, Dept Neurosci, Stockholm, Sweden; [Emirandetti, Amanda] Uppsala Univ, Dept Neurosci, Dev Genet Grp, Uppsala, Sweden	Karolinska Institutet; Karolinska Institutet; Uppsala University	Leao, RN (corresponding author), Karolinska Inst, Neuronal Oscillat Lab, Stockholm, Sweden.	andre.fisahn@ki.se	Leao, Richardson/AAX-4985-2020; , Ola/AAF-5126-2021	Leao, Richardson/0000-0001-8496-1965; Hermanson, Ola/0000-0001-9320-7921	International Human Frontier Science Program; Portuguese Foundation for Science and Technology; Bejers Foundation; Swedish Research Council; European Commission [LSHM-CT-2005-19063]	International Human Frontier Science Program(Human Frontier Science Program); Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology); Bejers Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by a Long-Term Fellowship from the International Human Frontier Science Program (R.N.L.), a PhD fellowship from the Portuguese Foundation for Science and Technology (A. R.), a Bejers Foundation Grant to R.N.L. (A. E.), the Swedish Research Council (O.H. and A. F.) and the European Commission Coordination Action ENINET (contract number LSHM-CT-2005-19063, A. F.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abranches E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006286; Albantakis L, 2009, J NEUROSCI METH, V184, P206, DOI 10.1016/j.jneumeth.2009.08.004; Anderson DJ, 2001, NAT MED, V7, P393, DOI 10.1038/86439; Andersson T, 2009, J BIOL CHEM, V284, P3672, DOI 10.1074/jbc.M808119200; Antic S, 1997, BIOL BULL, V193, P261, DOI 10.1086/BBLv193n2p261; Aponte Y, 2008, J PHYSIOL-LONDON, V586, P2061, DOI 10.1113/jphysiol.2007.147298; Billups B, 2002, PFLUG ARCH EUR J PHY, V444, P663, DOI 10.1007/s00424-002-0861-6; Chemla S, 2010, J PHYSIOL-PARIS, V104, P40, DOI 10.1016/j.jphysparis.2009.11.009; Davoine F, 1996, IEEE T IMAGE PROCESS, V5, P338, DOI 10.1109/83.480769; DUNCAN GH, 1977, ANAT REC, V188, P273, DOI 10.1002/ar.1091880211; HOLST G, 2009, LASER PHOTONICS; Homma R, 2009, PHILOS T R SOC B, V364, P2453, DOI 10.1098/rstb.2009.0084; Illes S, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-93; Jepsen K, 2007, NATURE, V450, P415, DOI 10.1038/nature06270; Johe KK, 1996, GENE DEV, V10, P3129, DOI 10.1101/gad.10.24.3129; JOHNSON CR, 1995, BIOMEDICAL ENG HDB, P162; Knopfel T, 2006, TRENDS NEUROSCI, V29, P160, DOI 10.1016/j.tins.2006.01.004; Kuba H, 2006, NATURE, V444, P1069, DOI 10.1038/nature05347; Laeng P, 2004, J NEUROCHEM, V91, P238, DOI 10.1111/j.1471-4159.2004.02725.x; Lang SB, 2006, NAT PROTOC, V1, P1859, DOI 10.1038/nprot.2006.267; Leao RN, 2004, J NEUROSCI METH, V133, P115, DOI 10.1016/j.jneumeth.2003.10.003; Li HW, 2009, BMC NEUROSCI, V10, DOI [10.1186/1471-2202-10-122, 10.1186/1471-2105-10-418]; Liao CW, 2009, NEUROSCIENCE, V164, P1701, DOI 10.1016/j.neuroscience.2009.09.052; Matiukas A, 2006, AM J PHYSIOL-HEART C, V290, pH2633, DOI 10.1152/ajpheart.00884.2005; Meyer JS, 2009, CELL MOL NEUROBIOL, V29, P1191, DOI 10.1007/s10571-009-9413-3; Paemeleire K, 1999, EXP BRAIN RES, V126, P473, DOI 10.1007/s002210050755; Palmer LM, 2006, J NEUROSCI, V26, P1854, DOI 10.1523/JNEUROSCI.4812-05.2006; Rattay F, 2001, HEARING RES, V153, P64, DOI 10.1016/S0378-5955(00)00257-4; Rattay F, 1990, ELECT NERVE STIMULAT; Ravin R, 2008, CELL STEM CELL, V3, P670, DOI 10.1016/j.stem.2008.09.012; Rowe EW, 2005, STEM CELLS, V23, P1044, DOI 10.1634/stemcells.2005-0037; Smetters D, 1999, METHODS, V18, P215, DOI 10.1006/meth.1999.0774; Stuart G, 1997, TRENDS NEUROSCI, V20, P125, DOI 10.1016/S0166-2236(96)10075-8; Waldau B, 2008, CELL MOL LIFE SCI, V65, P2372, DOI 10.1007/s00018-008-8053-y; Yermolaieva O, 2001, J NEUROSCI, V21, P7474, DOI 10.1523/JNEUROSCI.21-19-07474.2001; Zhou WL, 2007, J NEUROSCI METH, V164, P225, DOI 10.1016/j.jneumeth.2007.05.002	36	10	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2010	5	11							e13833	10.1371/journal.pone.0013833	http://dx.doi.org/10.1371/journal.pone.0013833			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675NY	21079795	Green Published, Green Submitted, gold			2022-12-27	WOS:000283838600008
J	Shen, CM; Zhu, BF; Deng, YJ; Ye, SH; Yan, JW; Yang, G; Wang, HD; Qin, HX; Huang, QZ; Zhang, JJ				Shen, Chun-mei; Zhu, Bo-feng; Deng, Ya-jun; Ye, Shi-hui; Yan, Jiang-wei; Yang, Guang; Wang, Hong-dan; Qin, Hai-xia; Huang, Qi-zhao; Zhang, Jing-Jing			Allele Polymorphism and Haplotype Diversity of HLA-A, -B and-DRB1 Loci in Sequence-Based Typing for Chinese Uyghur Ethnic Group	PLOS ONE			English	Article							CLASS-I POLYMORPHISM; HAN POPULATION; STRS HAPLOTYPES; GENES; FREQUENCIES; HLA-DRB1; UYGUR; DNA; GENETICS; JAPANESE	Background: Previous studies indicate that the frequency distributions of HLA alleles and haplotypes vary from one ethnic group to another or between the members of the same ethnic group living in different geographic areas. It is necessary and meaningful to study the high-resolution allelic and haplotypic distributions of HLA loci in different groups. Methodology/Principal Findings: High-resolution HLA typing for the Uyghur ethnic minority group using polymerase chain reaction-sequence-based-typing method was first reported. HLA-A, -B and -DRB1 allelic distributions were determined in 104 unrelated healthy Uyghur individuals and haplotypic frequencies and linkage disequilibrium parameters for HLA loci were estimated using the maximum-likelihood method. A total of 35 HLA-A, 51 HLA-B and 33 HLA-DRB1 alleles were identified at the four-digit level in the population. High frequency alleles were HLA-A*1101 (13.46%), A*0201 (12.50%), A*0301 (10.10%); HLA-B*5101(8.17%), B*3501(6.73%), B*5001 (6.25%); HLA-DRB1*0701 (16.35%), DRB1*1501 (8.65%) and DRB1*0301 (7.69%). The two-locus haplotypes at the highest frequency were HLA-A*3001-B*1302 (2.88%), A*2402-B*5101 (2.86%); HLA-B*5001-DRB1*0701 (4.14%) and B*0702-DRB1*1501 (3.37%). The three-locus haplotype at the highest frequency was HLA-A*3001-B*1302-DRB1*0701(2.40%). Significantly high linkage disequilibrium was observed in six two-locus haplotypes, with their corresponding relative linkage disequilibrium parameters equal to 1. Neighbor-joining phylogenetic tree between the Uyghur group and other previously reported populations was constructed on the basis of standard genetic distances among the populations calculated using the four-digit sequence-level allelic frequencies at HLA-A, HLA-B and HLA-DRB1 loci. The phylogenetic analyses reveal that the Uyghur group belongs to the northwestern Chinese populations and is most closely related to the Xibe group, and then to Kirgiz, Hui, Mongolian and Northern Han. Conclusions/Significance: The present findings could be useful to elucidate the genetic background of the population and to provide valuable data for HLA matching in clinical bone marrow transplantation, HLA-linked disease-association studies, population genetics, human identification and paternity tests in forensic sciences.	[Shen, Chun-mei; Zhu, Bo-feng; Wang, Hong-dan] Xi An Jiao Tong Univ, Minist Educ, Key Lab Environm & Gene Related Dis, Xian 710049, Shaanxi, Peoples R China; [Shen, Chun-mei; Zhu, Bo-feng; Ye, Shi-hui] Blood Ctr Shaanxi Prov, Xian, Shaanxi, Peoples R China; [Shen, Chun-mei; Zhu, Bo-feng; Wang, Hong-dan] Xi An Jiao Tong Univ, Sch Med, Key Lab Minist Hlth Forens Sci, Xian 710049, Shaanxi, Peoples R China; [Zhu, Bo-feng; Wang, Hong-dan] Xi An Jiao Tong Univ, Sch Med, Dept Forens Sci, Xian 710049, Shaanxi, Peoples R China; [Deng, Ya-jun] Beijing Genom Inst, Ctr Forens Sci, Beijing, Peoples R China; [Yan, Jiang-wei] Chinese Acad Sci, Beijing Inst Genom, Beijing, Peoples R China; [Yang, Guang] Med Coll Georgia, Vasc Biol Ctr, Augusta, GA 30912 USA; [Qin, Hai-xia] Med Coll Georgia, Inst Mol Med & Genet, Augusta, GA 30912 USA; [Huang, Qi-zhao] Third Mil Med Univ, Team Students Brigade 2, Chongqing, Peoples R China	Xi'an Jiaotong University; Xi'an Jiaotong University; Xi'an Jiaotong University; Beijing Genomics Institute (BGI); Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; University System of Georgia; Augusta University; University System of Georgia; Augusta University; Army Medical University	Zhu, BF (corresponding author), Xi An Jiao Tong Univ, Minist Educ, Key Lab Environm & Gene Related Dis, Xian 710049, Shaanxi, Peoples R China.	bfzhu2008@yahoo.com.cn		Shen, Chun mei/0000-0003-2039-0838	National Natural Science Foundation of China [30700470, 81072511]; Postdoctoral Science Foundation of China [20100471602]; Item of Science Technology Foundation of Shaanxi Province, PR China [2008K08-02]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Postdoctoral Science Foundation of China(China Postdoctoral Science Foundation); Item of Science Technology Foundation of Shaanxi Province, PR China	This project was supported by National Natural Science Foundation of China (NSFC, No. 30700470,81072511), by the Postdoctoral Science Foundation of China (No. 20100471602), by the Item of Science Technology Foundation of Shaanxi Province, PR China (No. 2008K08-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai Ru-feng, 2008, Zhonghua Yixue Yichuanxue Zazhi, V25, P469; Cao K, 2001, HUM IMMUNOL, V62, P1009, DOI 10.1016/S0198-8859(01)00298-1; Chen S, 2007, INT J IMMUNOGENET, V34, P131, DOI 10.1111/j.1744-313X.2007.00669.x; Chen S, 2006, INT J IMMUNOGENET, V33, P439, DOI 10.1111/j.1744-313X.2006.00637.x; Chen S, 2007, HUM IMMUNOL, V68, P928, DOI 10.1016/j.humimm.2007.09.006; Chen SW, 2007, MOL IMMUNOL, V44, P2017, DOI 10.1016/j.molimm.2006.09.018; Deng Y.J., 2005, J FORENSIC MED, V21, P280; Deng Ya-jun, 2006, Zhonghua Yixue Yichuanxue Zazhi, V23, P103; Edinur HA, 2009, HUM IMMUNOL, V70, P518, DOI 10.1016/j.humimm.2009.04.003; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; Hahn ReinhardFriedrich., 1998, TURK LANG, P379; HATTEMER HH, 1982, THEOR APPL GENET, V62, P219, DOI 10.1007/BF00276242; Hoa BK, 2008, TISSUE ANTIGENS, V71, P127, DOI 10.1111/j.1399-0039.2007.00982.x; Hong WG, 2007, HUM IMMUNOL, V68, P439, DOI 10.1016/j.humimm.2007.01.020; Hu SP, 2007, AM J PHYS ANTHROPOL, V132, P140, DOI 10.1002/ajpa.20460; IMANISHI T, 1992, HLA 1991, P627; Jia Zong-Jian, 2002, Yichuan, V24, P131; Jinam TA, 2010, TISSUE ANTIGENS, V75, P151, DOI 10.1111/j.1399-0039.2009.01417.x; Katsuyama Y, 1998, HUM HERED, V48, P126, DOI 10.1159/000022793; Klitz W, 2009, TISSUE ANTIGENS, V74, P508, DOI 10.1111/j.1399-0039.2009.01374.x; Kurz B, 1999, TISSUE ANTIGENS, V53, P81, DOI 10.1034/j.1399-0039.1999.530109.x; Lee J, 1990, HLA SYSTEM NEW APPRO, V6, P141; Lee KW, 2005, TISSUE ANTIGENS, V65, P437, DOI 10.1111/j.1399-0039.2005.00386.x; Mack SJ, 2009, TISSUE ANTIGENS, V73, P17, DOI 10.1111/j.1399-0039.2008.01151.x; Middleton D, 2004, TISSUE ANTIGENS, V63, P555, DOI 10.1111/j.0001-2815.2004.00234.x; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Mizuki N, 1997, TISSUE ANTIGENS, V50, P527, DOI 10.1111/j.1399-0039.1997.tb02909.x; Mizuki N, 1998, TISSUE ANTIGENS, V51, P287; NEI M, 1987, MOLECILAR EVOLUTIONA; Ogata S, 2007, TISSUE ANTIGENS, V69, P154, DOI 10.1111/j.1399-0039.2006.00698.x; Powell GT, 2007, FORENSIC SCI INT-GEN, V1, P115, DOI 10.1016/j.fsigen.2007.01.015; Pozzi S, 1999, TISSUE ANTIGENS, V53, P275, DOI 10.1034/j.1399-0039.1999.530308.x; Qiu Xiao-ping, 2006, Zhonghua Yixue Yichuanxue Zazhi, V23, P219; Saito S, 2000, TISSUE ANTIGENS, V56, P522, DOI 10.1034/j.1399-0039.2000.560606.x; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SALMON DB, 1978, AM J HUM GENET, V30, P65; Schipper RF, 1996, TISSUE ANTIGENS, V47, P169, DOI 10.1111/j.1399-0039.1996.tb02537.x; Schmidt AH, 2009, HUM IMMUNOL, V70, P895, DOI 10.1016/j.humimm.2009.08.006; Shen CM, 2010, HUM IMMUNOL, V71, P627, DOI 10.1016/j.humimm.2010.02.012; Shen Chun-Mei, 2008, Yichuan, V30, P164, DOI 10.3724/SP.J.1005.2008.00164; Shen CM, 2008, CROAT MED J, V49, P476, DOI 10.3325/cmj.2008.4.476; [沈春梅 SHEN ChunMei], 2008, [第四军医大学学报, Journal of the Fourth Military Medical University], V29, P1540; Shete S, 2000, THEOR POPUL BIOL, V57, P265, DOI 10.1006/tpbi.2000.1452; Shi L, 2010, TISSUE ANTIGENS, V75, P159, DOI 10.1111/j.1399-0039.2009.01407.x; Shi L, 2008, HUM IMMUNOL, V69, P58, DOI 10.1016/j.humimm.2007.11.007; Single RM, 2002, GENET EPIDEMIOL, V22, P186, DOI 10.1002/gepi.0163; Spinola H, 2006, MOL IMMUNOL, V43, P1726, DOI 10.1016/j.molimm.2005.10.001; Tereba A, 1999, PROFILES DNA, P14; Trachtenberg E, 2007, TISSUE ANTIGENS, V70, P455, DOI 10.1111/j.1399-0039.2007.00932.x; VOLZ A, 1994, GENOMICS, V21, P464, DOI 10.1006/geno.1994.1302; Wen SH, 2008, HUM IMMUNOL, V69, P430, DOI 10.1016/j.humimm.2008.05.012; Williams F, 2001, HUM IMMUNOL, V62, P645, DOI 10.1016/S0198-8859(01)00247-6; Williams F, 2004, HUM IMMUNOL, V65, P66, DOI 10.1016/j.humimm.2003.10.004; Xu Ming-Yan, 2006, Yichuan, V28, P913; YAKUP A, 2005, TURFAN DIALECT UYGHU, P63; Yan Chun-Xia, 2002, Acta Genetica Sinica, V29, P384; Yang G, 2006, TISSUE ANTIGENS, V67, P146, DOI 10.1111/j.1399-0039.2006.00529.x; Yao Y, 2009, TISSUE ANTIGENS, V73, P561, DOI 10.1111/j.1399-0039.2009.01237.x; YU MS, 1988, SCI CHINA SER B, V31, P860; Yuliwulandari R, 2009, TISSUE ANTIGENS, V73, P46, DOI 10.1111/j.1399-0039.2008.01178.x; Zhou RX, 2008, ANN HUM BIOL, V35, P198, DOI 10.1080/03014460801922927; Zhu BF, 2005, FORENSIC SCI INT, V153, P260, DOI 10.1016/j.forsciint.2004.11.002; Zhu BF, 2005, INT J LEGAL MED, V119, P306, DOI 10.1007/s00414-005-0549-5; Zhu BF, 2005, J FORENSIC SCI, V50, P1235; ZHU BF, 2005, ACAD J XJTU, V17, P49; Zhu BF, 2010, J ZHEJIANG UNIV-SC B, V11, P127, DOI 10.1631/jzus.B0900232; Zhu BF, 2006, FORENSIC SCI INT, V161, P78, DOI 10.1016/j.forsciint.2005.09.003	68	33	40	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2010	5	11							e13458	10.1371/journal.pone.0013458	http://dx.doi.org/10.1371/journal.pone.0013458			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675NY	21079793	Green Published, Green Submitted, gold			2022-12-27	WOS:000283838600002
J	Itzek, A; Gillen, CM; Fulde, M; Friedrichs, C; Rodloff, AC; Chhatwal, GS; Nitsche-Schmitz, DP				Itzek, Andreas; Gillen, Christine M.; Fulde, Marcus; Friedrichs, Claudia; Rodloff, Arne C.; Chhatwal, Gursharan S.; Nitsche-Schmitz, Daniel Patric			Contribution of Plasminogen Activation towards the Pathogenic Potential of Oral Streptococci	PLOS ONE			English	Article							GROUP-A STREPTOCOCCI; ALPHA-ENOLASE; BINDING-PROTEIN; MILLERI GROUP; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; VIRIDANS STREPTOCOCCI; SURFACE ENOLASE; LYS-PLASMINOGEN; GROUP-C; VIRULENCE	Oral streptococci are a heterogeneous group of human commensals, with a potential to cause serious infections. Activation of plasminogen has been shown to increase the virulence of typical human pathogenic streptococci such as S. pneumoniae. One important factor for plasminogen activation is the streptococcal alpha-enolase. Here we report that plasminogen activation is also common in oral streptococci species involved in clinical infection and that it depends on the action of human plasminogen activators. The ability to activate plasminogen did not require full conservation of the internal plasminogen binding sequence motif FYDKERKVY of alpha-enolase that was previously described as crucial for increased plasminogen binding, activation and virulence. Instead, experiments with recombinant alpha-enolase variants indicate that the naturally occurring variations do not impair plasminogen binding. In spite of these variations in the internal plasminogen binding motif oral streptococci showed similar activation of plasminogen. We conclude that the pathomechanism of plasminogen activation is conserved in oral streptococci that cause infections in human. This may contribute to their opportunistic pathogenic character that is unfurled in certain niches.	[Itzek, Andreas; Gillen, Christine M.; Fulde, Marcus; Chhatwal, Gursharan S.; Nitsche-Schmitz, Daniel Patric] Helmholtz Ctr Infect Res, Dept Med Microbiol, Braunschweig, Germany; [Friedrichs, Claudia; Rodloff, Arne C.] Univ Leipzig, Inst Med Microbiol & Epidemiol Infect Dis, Leipzig, Germany	Helmholtz Association; Helmholtz-Center for Infection Research; Leipzig University	Itzek, A (corresponding author), Helmholtz Ctr Infect Res, Dept Med Microbiol, Braunschweig, Germany.	Patric.Nitsche@helmholtz-hzi.de	Gillen, Christine M/A-2717-2014	Duplancic, Christine/0000-0002-1775-3055	Helmholtz Association	Helmholtz Association(Helmholtz Association)	This work was supported by the Presidential Fund of the Helmholtz Association in the framework of the Virtual Institute: Oral Streptococci (http://www.helmholtz.de/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1947, J EXP MED, V85, P441; Antikainen J, 2007, FEMS IMMUNOL MED MIC, V51, P526, DOI 10.1111/j.1574-695X.2007.00330.x; BENNASR A, 1994, EUR J BIOCHEM, V222, P267, DOI 10.1111/j.1432-1033.1994.tb18865.x; BERGE A, 1993, J BIOL CHEM, V268, P25417; Bergmann S, 2005, THROMB HAEMOSTASIS, V94, P304, DOI 10.1160/TH05-05-0369; Bergmann S, 2004, INFECT IMMUN, V72, P2416, DOI 10.1128/IAI.72.4.2416-2419.2004; Bergmann S, 2003, MOL MICROBIOL, V49, P411, DOI 10.1046/j.1365-2958.2003.03557.x; Bergmann S, 2001, MOL MICROBIOL, V40, P1273, DOI 10.1046/j.1365-2958.2001.02448.x; CHRISTENSEN LR, 1945, J GEN PHYSIOL, V28, P363, DOI 10.1085/jgp.28.4.363; Clarridge JE, 2001, CLIN INFECT DIS, V32, P1511, DOI 10.1086/320163; Coleman JL, 1999, J LAB CLIN MED, V134, P567, DOI 10.1016/S0022-2143(99)90095-1; Colombo AP, 1998, J CLIN PERIODONTOL, V25, P169, DOI 10.1111/j.1600-051X.1998.tb02424.x; Cork AJ, 2009, J BIOL CHEM, V284, P17129, DOI 10.1074/jbc.M109.004317; Derbise A, 2004, INFECT IMMUN, V72, P94, DOI 10.1128/IAI.72.1.94-105.2004; DOUGLAS CWI, 1993, J MED MICROBIOL, V39, P179, DOI 10.1099/00222615-39-3-179; Friedrichs C, 2007, J CLIN MICROBIOL, V45, P2392, DOI 10.1128/JCM.00556-07; JACOBS JA, 1994, CLIN INFECT DIS, V19, P704, DOI 10.1093/clinids/19.4.704; Jones MN, 2007, BIOCHEM BIOPH RES CO, V364, P924, DOI 10.1016/j.bbrc.2007.10.098; KAWAMURA Y, 1995, INT J SYST BACTERIOL, V45, P406, DOI 10.1099/00207713-45-2-406; Khil J, 2003, J INFECT DIS, V188, P497, DOI 10.1086/377100; KUUSELA P, 1992, INFECT IMMUN, V60, P196, DOI 10.1128/IAI.60.1.196-201.1992; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lahteenmaki K, 2001, FEMS MICROBIOL REV, V25, P531, DOI 10.1111/j.1574-6976.2001.tb00590.x; Lottenberg Richard, 1994, Trends in Microbiology, V2, P20, DOI 10.1016/0966-842X(94)90340-9; MANGEL WF, 1990, SCIENCE, V248, P69, DOI 10.1126/science.2108500; MARKUS G, 1978, J BIOL CHEM, V253, P727; MARSHALL JM, 1994, BIOCHEMISTRY-US, V33, P3599, DOI 10.1021/bi00178a017; Nitsche DP, 2006, J BIOL CHEM, V281, P1670, DOI 10.1074/jbc.M506776200; Pancholi V, 1998, J BIOL CHEM, V273, P14503, DOI 10.1074/jbc.273.23.14503; Pancholi V, 2003, INT J MED MICROBIOL, V293, P391, DOI 10.1078/1438-4221-00283; PANCHOLI V, 1993, P NATL ACAD SCI USA, V90, P8154, DOI 10.1073/pnas.90.17.8154; Pancholi V, 2003, MICROB PATHOGENESIS, V35, P293, DOI 10.1016/j.micpath.2003.08.004; RAMAKRISHNAN V, 1991, BIOCHEMISTRY-US, V30, P3963, DOI 10.1021/bi00230a023; RUOFF K L, 1988, Clinical Microbiology Reviews, V1, P102; Sanderson-Smith ML, 2008, FASEB J, V22, P2715, DOI 10.1096/fj.07-105643; Sanderson-Smith ML, 2007, J BACTERIOL, V189, P1435, DOI 10.1128/JB.01218-06; Sun HM, 2004, SCIENCE, V305, P1283, DOI 10.1126/science.1101245; Walker MJ, 2005, TRENDS MICROBIOL, V13, P308, DOI 10.1016/j.tim.2005.05.006; Westling K, 2008, J INFECTION, V56, P204, DOI 10.1016/j.jinf.2007.12.006; WHILEY RA, 1992, J CLIN MICROBIOL, V30, P243, DOI 10.1128/JCM.30.1.243-244.1992	40	22	22	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2010	5	11							e13826	10.1371/journal.pone.0013826	http://dx.doi.org/10.1371/journal.pone.0013826			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	674WJ	21072208	Green Published, Green Submitted, gold			2022-12-27	WOS:000283780800023
J	Prud'homme, GJ; Glinka, Y; Toulina, A; Ace, O; Subramaniam, V; Jothy, S				Prud'homme, Gerald J.; Glinka, Yelena; Toulina, Anna; Ace, Olga; Subramaniam, Venkateswaran; Jothy, Serge			Breast Cancer Stem-Like Cells Are Inhibited by a Non-Toxic Aryl Hydrocarbon Receptor Agonist	PLOS ONE			English	Article							IN-VITRO PROPAGATION; SIDE POPULATION; CYCLE PROGRESSION; ABC TRANSPORTERS; MAMMARY-GLAND; TRANILAST; DRUG; GROWTH; CHEMOTHERAPY; ACTIVATION	Background: Cancer stem cells (CSCs) have increased resistance to cancer chemotherapy. They can be enriched as drug-surviving CSCs (D-CSCs) by growth with chemotherapeutic drugs, and/or by sorting of cells expressing CSC markers such as aldehyde dehydrogenase-1 (ALDH). CSCs form colonies in agar, mammospheres in low-adherence cultures, and tumors following xenotransplantation in Scid mice. We hypothesized that tranilast, a non-toxic orally active drug with anti-cancer activities, would inhibit breast CSCs. Methodology/Findings: We examined breast cancer cell lines or D-CSCs generated by growth of these cells with mitoxantrone. Tranilast inhibited colony formation, mammosphere formation and stem cell marker expression. Mitoxantrone-selected cells were enriched for CSCs expressing stem cell markers ALDH, c-kit, Oct-4, and ABCG2, and efficient at forming mammospheres. Tranilast markedly inhibited mammosphere formation by D-CSCs and dissociated formed mammospheres, at pharmacologically relevant concentrations. It was effective against D-CSCs of both HER-2+ and triple-negative cell lines. Tranilast was also effective in vivo, since it prevented lung metastasis in mice injected i.v. with triple-negative (MDA-MB-231) mitoxantrone-selected cells. The molecular targets of tranilast in cancer have been unknown, but here we demonstrate it is an aryl hydrocarbon receptor (AHR) agonist and this plays a key role. AHR is a transcription factor activated by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), polycyclic aromatic hydrocarbons and other ligands. Tranilast induced translocation of the AHR to the nucleus and stimulated CYP1A1 expression (a marker of AHR activation). It inhibited binding of the AHR to CDK4, which has been linked to cell-cycle arrest. D-CSCs expressed higher levels of the AHR than other cells. Knockdown of the AHR with siRNA, or blockade with an AHR antagonist, entirely abrogated the anti-proliferative and anti-mammosphere activity of tranilast. Thus, the anti-cancer effects of tranilast are AHR dependent. Conclusion/Significance: We show that tranilast is an AHR agonist with inhibitory effects on breast CSCs. It is effective against CSCs of triple-negative breast cancer cells selected for anti-cancer drug resistance. These results suggest it might find applications in the treatment of breast cancer.	[Prud'homme, Gerald J.; Glinka, Yelena; Toulina, Anna; Ace, Olga; Subramaniam, Venkateswaran; Jothy, Serge] St Michaels Hosp, Dept Lab Med, Toronto, ON M5B 1W8, Canada; [Prud'homme, Gerald J.; Glinka, Yelena; Toulina, Anna; Ace, Olga; Subramaniam, Venkateswaran; Jothy, Serge] St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1W8, Canada; [Prud'homme, Gerald J.; Glinka, Yelena; Toulina, Anna; Ace, Olga; Subramaniam, Venkateswaran; Jothy, Serge] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto	Prud'homme, GJ (corresponding author), St Michaels Hosp, Dept Lab Med, 30 Bond St, Toronto, ON M5B 1W8, Canada.	prudhommeg@smh.ca			Canadian Breast Cancer Research Alliance [020644]; Ontario Institute for Cancer Research (Province of Ontario, Canada) [05NOV194]; Canadian Institutes of Health Research [III 94588]; Li Ka Shing Knowledge Institute and Keenan Research Centre of St. Michael's Hospital (Toronto, Canada)	Canadian Breast Cancer Research Alliance; Ontario Institute for Cancer Research (Province of Ontario, Canada); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Li Ka Shing Knowledge Institute and Keenan Research Centre of St. Michael's Hospital (Toronto, Canada)	This study was funded by the Canadian Breast Cancer Research Alliance (grant # 020644; URL: www.breast.cancer.ca), the Ontario Institute for Cancer Research (Province of Ontario, Canada; grant # 05NOV194; URL: www.oicr.on.ca), the Canadian Institutes of Health Research (grant # III 94588; URL: www.cihr-irsc.gc.ca), and the Li Ka Shing Knowledge Institute and Keenan Research Centre of St. Michael's Hospital (Toronto, Canada) (URL: www.stmichaelshospital.com). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barhoover MA, 2010, MOL PHARMACOL, V77, P195, DOI 10.1124/mol.109.059675; Bencko V, 2009, NEOPLASMA, V56, P353, DOI 10.4149/neo_2009_04_353; Blum R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005722; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Brent PJ, 1996, BRAIN RES, V725, P155, DOI 10.1016/0006-8993(96)00170-9; Casado FL, 2010, BLOOD CELL MOL DIS, V44, P199, DOI 10.1016/j.bcmd.2010.01.005; Chakrabarti R, 2009, ANTI-CANCER DRUG, V20, P334, DOI 10.1097/CAD.0b013e328327994e; Chang XQ, 2007, MOL CELL BIOL, V27, P6127, DOI 10.1128/MCB.00323-07; Charafe-Jauffret E, 2009, CANCER RES, V69, P1302, DOI 10.1158/0008-5472.CAN-08-2741; Chuthapisith S, 2010, SURG ONCOL, V19, P27, DOI 10.1016/j.suronc.2009.01.004; Croker AK, 2009, J CELL MOL MED, V13, P2236, DOI 10.1111/j.1582-4934.2008.00455.x; Dean M, 2009, J MAMMARY GLAND BIOL, V14, P3, DOI 10.1007/s10911-009-9109-9; Denison MS, 2003, ANNU REV PHARMACOL, V43, P309, DOI 10.1146/annurev.pharmtox.43.100901.135828; Ding XW, 2010, LIFE SCI, V86, P631, DOI 10.1016/j.lfs.2010.02.012; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Fillmore CM, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1982; Fritz WA, 2007, CARCINOGENESIS, V28, P497, DOI 10.1093/carcin/bgl179; Furness SGB, 2009, PHARMACOL THERAPEUT, V124, P336, DOI 10.1016/j.pharmthera.2009.09.004; Glinka Y, 2006, MOL THER, V14, P578, DOI 10.1016/j.ymthe.2006.03.021; Gomez-Duran A, 2009, BIOCHEM PHARMACOL, V77, P700, DOI 10.1016/j.bcp.2008.08.032; Grimshaw MJ, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2106; Hall JM, 2010, MOL ENDOCRINOL, V24, P359, DOI 10.1210/me.2009-0346; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Hirschmann-Jax C, 2004, P NATL ACAD SCI USA, V101, P14228, DOI 10.1073/pnas.0400067101; Holmes DR, 2002, CIRCULATION, V106, P1243, DOI 10.1161/01.CIR.0000028335.31300.DA; Isaji M, 1998, CARDIOVASC DRUG REV, V16, P288, DOI 10.1111/j.1527-3466.1998.tb00359.x; Izawa A, 2001, ARTERIOSCL THROM VAS, V21, P1172, DOI 10.1161/hq0701.092119; Jonker JW, 2005, STEM CELLS, V23, P1059, DOI 10.1634/stemcells.2005-0150; Kao J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006146; Kerkvliet NI, 2009, BIOCHEM PHARMACOL, V77, P746, DOI 10.1016/j.bcp.2008.11.021; Kim M, 2002, CLIN CANCER RES, V8, P22; Konneh M, 1998, IDrugs, V1, P141; Korah RM, 2000, CANCER RES, V60, P733; Levina V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003077; Li XX, 2008, JNCI-J NATL CANCER I, V100, P672, DOI 10.1093/jnci/djn123; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; McNamee JP, 1997, DRUG METAB DISPOS, V25, P437; Morel AP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002888; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; O'Brien CA, 2009, SEMIN RADIAT ONCOL, V19, P71, DOI 10.1016/j.semradonc.2008.11.001; Ponti D, 2005, CANCER RES, V65, P5506, DOI 10.1158/0008-5472.CAN-05-0626; Prud'homme GJ, 2007, LAB INVEST, V87, P1077, DOI 10.1038/labinvest.3700669; Puga A, 2000, J BIOL CHEM, V275, P2943, DOI 10.1074/jbc.275.4.2943; Ruby CE, 2002, MOL PHARMACOL, V62, P722, DOI 10.1124/mol.62.3.722; Savouret JF, 2001, J BIOL CHEM, V276, P3054, DOI 10.1074/jbc.M005988200; Shipitsin M, 2007, CANCER CELL, V11, P259, DOI 10.1016/j.ccr.2007.01.013; Sladek NE, 2002, CANCER CHEMOTH PHARM, V49, P309, DOI 10.1007/s00280-001-0412-4; Steiniger SCJ, 2008, STEM CELLS, V26, P3037, DOI 10.1634/stemcells.2008-0397; Subramaniam V, 2003, BRIT J CANCER, V89, P1538, DOI 10.1038/sj.bjc.6601301; Subramaniam V, 2010, ANTI-CANCER DRUG, V21, P351, DOI 10.1097/CAD.0b013e328334992c; Tang C, 2007, FASEB J, V21, pA287; WANG T, 2010, INT J CANC; Winquist RJ, 2010, CURR OPIN PHARMACOL, V10, P385, DOI 10.1016/j.coph.2010.06.008; Zhang S, 2009, ENDOCR-RELAT CANCER, V16, P835, DOI 10.1677/ERC-09-0054; Zhou BBS, 2009, NAT REV DRUG DISCOV, V8, P806, DOI 10.1038/nrd2137; Zhou JB, 2008, BREAST CANCER RES TR, V111, P419, DOI 10.1007/s10549-007-9798-y; Zucchi I, 2007, P NATL ACAD SCI USA, V104, P10476, DOI 10.1073/pnas.0703071104	57	108	122	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2010	5	11							e13831	10.1371/journal.pone.0013831	http://dx.doi.org/10.1371/journal.pone.0013831			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	674WJ	21072210	Green Submitted, gold, Green Published			2022-12-27	WOS:000283780800025
J	Billings, NA; Emerson, MM; Cepko, CL				Billings, Nathan A.; Emerson, Mark M.; Cepko, Constance L.			Analysis of Thyroid Response Element Activity during Retinal Development	PLOS ONE			English	Article							HORMONE RECEPTOR-ALPHA; TYPE-2 IODOTHYRONINE DEIODINASE; CONE OPSIN EXPRESSION; BRAIN-DEVELOPMENT; FUNCTIONAL-CHARACTERIZATION; NUCLEAR RECEPTORS; RNA INTERFERENCE; ORPHAN RECEPTORS; GENE-EXPRESSION; CEREBRAL-CORTEX	Thyroid hormone (TH) signaling components are expressed during retinal development in dynamic spatial and temporal patterns. To probe the competence of retinal cells to mount a transcriptional response to TH, reporters that included thyroid response elements (TREs) were introduced into developing retinal tissue. The TREs were placed upstream of a minimal TATA-box and two reporter genes, green fluorescent protein (GFP) and human placental alkaline phosphatase (PLAP). Six of the seven tested TREs were first tested in vitro where they were shown to drive TH-dependent expression. However, when introduced into the developing retina, the TREs reported in different cell types in both a TH-dependent and TH-independent manner, as well as revealed specific spatial patterns in their expression. The role of the known thyroid receptors (TR), TR alpha and TR beta, was probed using shRNAs, which were co-electroporated into the retina with the TREs. Some TREs were positively activated by TR+TH in the developing outer nuclear layer (ONL), where photoreceptors reside, as well as in the outer neuroblastic layer (ONBL) where cycling progenitor cells are located. Other TREs were actively repressed by TR+TH in cells of the ONBL. These data demonstrate that non-TRs can activate some TREs in a spatially regulated manner, whereas other TREs respond only to the known TRs, which also read out activity in a spatially regulated manner. The transcriptional response to even simple TREs provides a starting point for understanding the regulation of genes by TH, and highlights the complexity of transcriptional regulation within developing tissue.	[Billings, Nathan A.; Cepko, Constance L.] Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Genet, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Billings, NA (corresponding author), Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Genet, Boston, MA 02115 USA.	cepko@genetics.med.harvard.edu			Howard Hughes Medical Institute; NIH [F32 EY018287-01]; NATIONAL EYE INSTITUTE [F32EY018287] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the Howard Hughes Medical Institute (NAB) and by a NIH Kirschstein NRSA fellowship, F32 EY018287-01 (MME). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison WT, 2006, J COMP NEUROL, V499, P702, DOI 10.1002/cne.21164; Applebury ML, 2007, DEV DYNAM, V236, P1203, DOI 10.1002/dvdy.21155; Applebury ML, 2000, NEURON, V27, P513, DOI 10.1016/S0896-6273(00)00062-3; BANIAHMAD A, 1990, CELL, V61, P505, DOI 10.1016/0092-8674(90)90532-J; BEATO M, 1989, CELL, V56, P335, DOI 10.1016/0092-8674(89)90237-7; Bernal J, 2003, THYROID, V13, P1005, DOI 10.1089/105072503770867174; Bernal J, 2005, VITAM HORM, V71, P95, DOI 10.1016/S0083-6729(05)71004-9; Bernal J, 2007, NAT CLIN PRACT ENDOC, V3, P249, DOI 10.1038/ncpendmet0424; Bianco AC, 2002, ENDOCR REV, V23, P38, DOI 10.1210/er.23.1.38; BRENT GA, 1989, J BIOL CHEM, V264, P178; BRENT GA, 1989, MOL ENDOCRINOL, V3, P1996, DOI 10.1210/mend-3-12-1996; Bruhn SL, 1996, J NEUROSCI, V16, P1430; CHEN JD, 1995, NATURE, V377, P454, DOI 10.1038/377454a0; Cheng CL, 2009, INVEST OPHTH VIS SCI, V50, P3024, DOI 10.1167/iovs.08-2713; COONEY AJ, 1993, J BIOL CHEM, V268, P4152; CRANTZ FR, 1982, ENDOCRINOLOGY, V110, P367, DOI 10.1210/endo-110-2-367; Das RM, 2006, DEV BIOL, V294, P554, DOI 10.1016/j.ydbio.2006.02.020; Dentice M, 2005, NAT CELL BIOL, V7, P698, DOI 10.1038/ncb1272; Dentice M, 2007, P NATL ACAD SCI USA, V104, P14466, DOI 10.1073/pnas.0706754104; Desouza LA, 2005, MOL CELL NEUROSCI, V29, P414, DOI 10.1016/j.mcn.2005.03.010; DESVERGNE B, 1991, J BIOL CHEM, V266, P1008; DEWET JR, 1987, MOL CELL BIOL, V7, P725, DOI 10.1128/MCB.7.2.725; Dodd M.H.I., 1976, P467; DUNN JT, 1993, ANN N Y ACAD SCI, V678, P158; DUSSAULT JH, 1987, ANNU REV PHYSIOL, V49, P321, DOI 10.1146/annurev.ph.49.030187.001541; Ehrhardt C., 2006, SIGNAL TRANSDUCT BAN, V6, P179, DOI [10.1002/sita.200500073, DOI 10.1002/SITA.200500073]; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; FORREST D, 1994, SEMIN CANCER BIOL, V5, P167; Forrest D, 1996, NAT GENET, V13, P354, DOI 10.1038/ng0796-354; Freitas BCG, 2010, J CLIN INVEST, V120, P2206, DOI 10.1172/JCI41977; Galton VA, 2009, ENDOCRINOLOGY, V150, P2957, DOI 10.1210/en.2008-1572; Gereben B, 2008, CELL MOL LIFE SCI, V65, P570, DOI 10.1007/s00018-007-7396-0; Gereben B, 2008, ENDOCR REV, V29, P898, DOI 10.1210/er.2008-0019; GLASS CK, 1988, CELL, V54, P313, DOI 10.1016/0092-8674(88)90194-8; GuadanoFerraz A, 1997, P NATL ACAD SCI USA, V94, P10391, DOI 10.1073/pnas.94.19.10391; Heuer H, 2007, BEST PRACT RES CL EN, V21, P265, DOI 10.1016/j.beem.2007.03.003; HILFER SR, 1980, DEV BIOL, V79, P107, DOI 10.1016/0012-1606(80)90076-7; Hitoshi N., 1991, GENE, V108, P193; HO R, 1995, NATURE, V377, P397; Inoue M, 2010, EXP EYE RES, V90, P49, DOI 10.1016/j.exer.2009.09.009; Jones I, 2007, MOL ENDOCRINOL, V21, P1108, DOI 10.1210/me.2007-0037; KELLEY MW, 1995, DEVELOPMENT, V121, P3777; Kim DS, 2008, J COMP NEUROL, V507, P1795, DOI 10.1002/cne.21639; Kim DS, 2008, J NEUROSCI, V28, P7748, DOI 10.1523/JNEUROSCI.0397-08.2008; KLIEWER SA, 1992, P NATL ACAD SCI USA, V89, P1448, DOI 10.1073/pnas.89.4.1448; KOENIG RJ, 1988, P NATL ACAD SCI USA, V85, P5031, DOI 10.1073/pnas.85.14.5031; Mader M, 2006, MOL VIS, V12, P915; MANGELSDORF DJ, 1995, CELL, V83, P841, DOI 10.1016/0092-8674(95)90200-7; Marsh-Armstrong N, 1999, NEURON, V24, P871, DOI 10.1016/S0896-6273(00)81034-X; Matsuda T, 2004, P NATL ACAD SCI USA, V101, P16, DOI 10.1073/pnas.2235688100; McCaffery P, 1999, MECH DEVELOP, V82, P119, DOI 10.1016/S0925-4773(99)00022-2; McEwan Iain J., 2009, V505, P3, DOI 10.1007/978-1-60327-575-0_1; Mey J, 1997, J NEUROSCI, V17, P7441; Morte B, 2010, ENDOCRINOLOGY, V151, P2381, DOI 10.1210/en.2009-0944; Nagaya T, 1996, BIOCHEM BIOPH RES CO, V226, P426, DOI 10.1006/bbrc.1996.1372; Ng L, 2004, P NATL ACAD SCI USA, V101, P3474, DOI 10.1073/pnas.0307402101; Ng L, 2001, HUM MOL GENET, V10, P2701, DOI 10.1093/hmg/10.23.2701; Ng L, 2001, NAT GENET, V27, P94, DOI 10.1038/83829; Ng L, 2009, NEUROREPORT, V20, P627, DOI 10.1097/WNR.0b013e32832a2c63; Ng L, 2009, ENDOCRINOLOGY, V150, P1952, DOI 10.1210/en.2008-1419; Nillni EA, 2010, FRONT NEUROENDOCRIN, V31, P134, DOI 10.1016/j.yfrne.2010.01.001; Oppenheimer JH, 1997, ENDOCR REV, V18, P462, DOI 10.1210/er.18.4.462; PARK HY, 1993, MOL ENDOCRINOL, V7, P319, DOI 10.1210/me.7.3.319; Pessoa CN, 2008, INVEST OPHTH VIS SCI, V49, P2039, DOI 10.1167/iovs.07-0908; PETTY KJ, 1990, J BIOL CHEM, V265, P7395; PRATI M, 1992, ENDOCRINOLOGY, V130, P2651, DOI 10.1210/en.130.5.2651; PROST E, 1988, NUCLEIC ACIDS RES, V16, P6248, DOI 10.1093/nar/16.13.6248; Raine JC, 2010, J EXP BIOL, V213, P493, DOI 10.1242/jeb.036301; Raine JC, 2009, J EXP BIOL, V212, P2781, DOI 10.1242/jeb.030866; Roberts MR, 2006, P NATL ACAD SCI USA, V103, P6218, DOI 10.1073/pnas.0509981103; Rusch A, 2001, J NEUROSCI, V21, P9792, DOI 10.1523/JNEUROSCI.21-24-09792.2001; Sakai Y, 2004, DEV BIOL, V276, P143, DOI 10.1016/j.ydbio.2004.08.032; SECHMAN A, 1988, GEN COMP ENDOCR, V69, P99, DOI 10.1016/0016-6480(88)90057-3; Simonides WS, 2008, J CLIN INVEST, V118, P975, DOI 10.1172/JCI32824; Sprecher SG, 2008, NATURE, V454, P533, DOI 10.1038/nature07062; TRAN P, 1992, MOL CELL BIOL, V12, P4666, DOI 10.1128/MCB.12.10.4666; Trimarchi JM, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-101; Tsui KH, 2008, PROSTATE, V68, P610, DOI 10.1002/pros.20725; UMESONO K, 1988, NATURE, V336, P262, DOI 10.1038/336262a0; UMESONO K, 1991, CELL, V65, P1255, DOI 10.1016/0092-8674(91)90020-Y; Visser W, 2007, BEST PRACT RES CL EN, V21, P223, DOI 10.1016/j.beem.2007.03.008; WEINBERGER C, 1990, ANNU REV PHYSIOL, V52, P823; Wilson CM, 1997, GEN COMP ENDOCR, V107, P153, DOI 10.1006/gcen.1997.6906; YAMAMOTO KR, 1985, ANNU REV GENET, V19, P209, DOI 10.1146/annurev.genet.19.1.209; Zavacki AM, 1996, ENDOCRINOLOGY, V137, P2833, DOI 10.1210/en.137.7.2833; Zavacki AM, 1996, ENDOCRINOLOGY, V137, P1438, DOI 10.1210/en.137.4.1438; ZHANG XK, 1992, NATURE, V355, P441, DOI 10.1038/355441a0	87	24	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2010	5	10							e13739	10.1371/journal.pone.0013739	http://dx.doi.org/10.1371/journal.pone.0013739			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673FU	21060789	gold, Green Published, Green Submitted			2022-12-27	WOS:000283645300019
J	Haebig, K; Gloeckner, CJ; Miralles, MG; Gillardon, F; Schulte, C; Riess, O; Ueffing, M; Biskup, S; Bonin, M				Haebig, Karina; Gloeckner, Christian Johannes; Miralles, Marta Garcia; Gillardon, Frank; Schulte, Claudia; Riess, Olaf; Ueffing, Marius; Biskup, Saskia; Bonin, Michael			ARHGEF7 (BETA-PIX) Acts as Guanine Nucleotide Exchange Factor for Leucine-Rich Repeat Kinase 2	PLOS ONE			English	Article							FAMILIAL PARKINSONS-DISEASE; LEUCINE-RICH-REPEAT-KINASE-2 LRRK2; NEURONAL TOXICITY; SH-SY5Y CELLS; GTP-BINDING; MUTATIONS; GENE; PROTEIN; TANDEM; DOMAIN	Background: Mutations within the leucine-rich repeat kinase 2 (LRRK2) gene are a common cause of familial and sporadic Parkinson's disease. The multidomain protein LRRK2 exhibits overall low GTPase and kinase activity in vitro. Methodology/Principal Findings: Here, we show that the rho guanine nucleotide exchange factor ARHGEF7 and the small GTPase CDC42 are interacting with LRRK2 in vitro and in vivo. GTPase activity of full-length LRRK2 increases in the presence of recombinant ARHGEF7. Interestingly, LRRK2 phosphorylates ARHGEF7 in vitro at previously unknown phosphorylation sites. We provide evidence that ARHGEF7 might act as a guanine nucleotide exchange factor for LRRK2 and that R1441C mutant LRRK2 with reduced GTP hydrolysis activity also shows reduced binding to ARHGEF7. Conclusions/Significance: Downstream effects of phosphorylation of ARHGEF7 through LRRK2 could be (i) a feedback control mechanism for LRRK2 activity as well as (ii) an impact of LRRK2 on actin cytoskeleton regulation. A newly identified familial mutation N1437S, localized within the GTPase domain of LRRK2, further underlines the importance of the GTPase domain of LRRK2 in Parkinson's disease pathogenesis.	[Haebig, Karina; Riess, Olaf; Biskup, Saskia; Bonin, Michael] Univ Tubingen, Dept Med Genet, Inst Human Genet, Tubingen, Germany; [Gloeckner, Christian Johannes; Ueffing, Marius] Helmholtz Zentrum Munchen, Dept Prot Sci, Munich, Germany; [Gloeckner, Christian Johannes; Ueffing, Marius] Univ Tubingen, Ctr Ophthalmol, Inst Ophthalm Res, Tubingen, Germany; [Miralles, Marta Garcia; Schulte, Claudia; Biskup, Saskia] Univ Tubingen, Hertie Inst Clin Brain Res, Tubingen, Germany; [Miralles, Marta Garcia; Schulte, Claudia; Biskup, Saskia] Univ Tubingen, German Ctr Neurodegenerat Dis, Tubingen, Germany; [Gillardon, Frank] Boehringer Ingelheim Pharma GmbH & Co KG, CNS Res, Biberach, Germany	Eberhard Karls University of Tubingen; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Boehringer Ingelheim	Haebig, K (corresponding author), Univ Tubingen, Dept Med Genet, Inst Human Genet, Tubingen, Germany.	saskia.biskup@medizin.uni-tuebingen.de; michael.bonin@med.uni-tuebingen.de	Gloeckner, Christian Johannes/R-5374-2019	Gloeckner, Christian Johannes/0000-0001-6494-6944; Garcia Miralles, Marta/0000-0001-7250-5778; Schulte, Claudia/0000-0003-4006-1265	Helmholtz Alliance for Mental Health in an Aging Society (HelMA) in Germany [FKZ: HA-215]; NGFNPlus [FKZ: 01GS08140]; University of Tuebingen	Helmholtz Alliance for Mental Health in an Aging Society (HelMA) in Germany; NGFNPlus; University of Tuebingen	CJG is supported by the Helmholtz Alliance for Mental Health in an Aging Society (HelMA, FKZ: HA-215) in Germany. SB is supported by IZKF Junior Group founding through the University of Tuebingen. This work was supported by the NGFNPlus grant to OR and MU (FKZ: 01GS08140). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aasly JO, 2010, MOVEMENT DISORD, V25, P2156, DOI 10.1002/mds.23265; Anand VS, 2009, FEBS J, V276, P6428, DOI 10.1111/j.1742-4658.2009.07341.x; Bauer M, 2009, GENE THER, V16, P142, DOI 10.1038/gt.2008.123; Biskup S, 2009, BBA-MOL BASIS DIS, V1792, P625, DOI 10.1016/j.bbadis.2008.09.015; Encinas M, 2000, J NEUROCHEM, V75, P991, DOI 10.1046/j.1471-4159.2000.0750991.x; Farrer M, 1999, HUM MOL GENET, V8, P81, DOI 10.1093/hmg/8.1.81; Feng QY, 2002, J BIOL CHEM, V277, P5644, DOI 10.1074/jbc.M107704200; Gandhi PN, 2008, J NEUROSCI RES, V86, P1711, DOI 10.1002/jnr.21622; Gillardon F, 2009, NEUROSCIENCE, V163, P533, DOI 10.1016/j.neuroscience.2009.06.051; Gillardon F, 2009, J NEUROCHEM, V110, P1514, DOI 10.1111/j.1471-4159.2009.06235.x; Gloeckner CJ, 2007, PROTEOMICS, V7, P4228, DOI 10.1002/pmic.200700038; Gloeckner Christian Johannes, 2009, Curr Protoc Protein Sci, VChapter 19, DOI 10.1002/0471140864.ps1920s57; Gloeckner CJ, 2006, HUM MOL GENET, V15, P223, DOI 10.1093/hmg/ddi439; GLOECKNER CJ, J PROTEOME RES, V9, P1738; GLOECKNER CJ, 2009, J NEUROCHEM; Gotthardt K, 2008, EMBO J, V27, P2239, DOI 10.1038/emboj.2008.150; Greggio E, 2008, J BIOL CHEM, V283, P16906, DOI 10.1074/jbc.M708718200; Greggio E, 2009, BIOCHEM BIOPH RES CO, V389, P449, DOI 10.1016/j.bbrc.2009.08.163; Guo LX, 2007, EXP CELL RES, V313, P3658, DOI 10.1016/j.yexcr.2007.07.007; Habig K, 2008, NEUROGENETICS, V9, P83, DOI 10.1007/s10048-007-0114-0; Ito G, 2007, BIOCHEMISTRY-US, V46, P1380, DOI 10.1021/bi061960m; Jaleel M, 2007, BIOCHEM J, V405, P307, DOI 10.1042/BJ20070209; Jensen SS, 2007, RAPID COMMUN MASS SP, V21, P3635, DOI 10.1002/rcm.3254; Kamikawaji S, 2009, BIOCHEMISTRY-US, V48, P10963, DOI 10.1021/bi9011379; Klein CL, 2009, J NEUROCHEM, V111, P703, DOI 10.1111/j.1471-4159.2009.06358.x; Lewis PA, 2007, BIOCHEM BIOPH RES CO, V357, P668, DOI 10.1016/j.bbrc.2007.04.006; Li XT, 2007, J NEUROCHEM, V103, P238, DOI 10.1111/j.1471-4159.2007.04743.x; Luzon-Toro B, 2007, HUM MOL GENET, V16, P2031, DOI 10.1093/hmg/ddm151; MacLeod D, 2006, NEURON, V52, P587, DOI 10.1016/j.neuron.2006.10.008; Manser E, 1998, MOL CELL, V1, P183, DOI 10.1016/S1097-2765(00)80019-2; Paisan-Ruiz C, 2004, NEURON, V44, P595, DOI 10.1016/j.neuron.2004.10.023; Plowey ED, 2008, J NEUROCHEM, V105, P1048, DOI 10.1111/j.1471-4159.2008.05217.x; Sancho RM, 2009, HUM MOL GENET, V18, P3955, DOI 10.1093/hmg/ddp337; Sen S, 2009, J BIOL CHEM, V284, P36346, DOI 10.1074/jbc.M109.025437; Smith WLW, 2006, NAT NEUROSCI, V9, P1231, DOI 10.1038/nn1776; Smith WW, 2005, P NATL ACAD SCI USA, V102, P18676, DOI 10.1073/pnas.0508052102; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Tomasson MH, 1999, BLOOD, V93, P1707, DOI 10.1182/blood.V93.5.1707.405k24_1707_1714; van Egmond Wouter N, 2008, J Biol Chem, V283, P30412, DOI 10.1074/jbc.M804265200; Webber PJ, 2009, FEBS J, V276, P6436, DOI 10.1111/j.1742-4658.2009.07342.x; West AB, 2005, P NATL ACAD SCI USA, V102, P16842, DOI 10.1073/pnas.0507360102; West AB, 2007, HUM MOL GENET, V16, P223, DOI 10.1093/hmg/ddl471; Yue ZY, 2009, FEBS J, V276, P6445, DOI 10.1111/j.1742-4658.2009.07343.x; Zimprich A, 2004, NEURON, V44, P601, DOI 10.1016/j.neuron.2004.11.005	44	49	49	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2010	5	10							e13762	10.1371/journal.pone.0013762	http://dx.doi.org/10.1371/journal.pone.0013762			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673FU	21048939	Green Published, gold, Green Submitted			2022-12-27	WOS:000283645300040
J	Mallory, RM; Malkin, E; Ambrose, CS; Bellamy, T; Shi, L; Yi, TT; Jones, T; Kemble, G; Dubovsky, F				Mallory, Raburn M.; Malkin, Elissa; Ambrose, Christopher S.; Bellamy, Terramika; Shi, Li; Yi, Tingting; Jones, Taff; Kemble, George; Dubovsky, Filip			Safety and Immunogenicity Following Administration of a Live, Attenuated Monovalent 2009 H1N1 Influenza Vaccine to Children and Adults in Two Randomized Controlled Trials	PLOS ONE			English	Article							CULTURE-CONFIRMED INFLUENZA; VIRUS VACCINE; YOUNG-CHILDREN; A H1N1; CAIV-T; TRIVALENT; EFFICACY; HEALTHY; COMBINATION; PREVENTION	Background: The safety, tolerability, and immunogenicity of a monovalent intranasal 2009 A/H1N1 live attenuated influenza vaccine (LAIV) were evaluated in children and adults. Methods/Principal Findings: Two randomized, double-blind, placebo-controlled studies were completed in children (2-17 y) and adults (18-49 y). Subjects were assigned 4: 1 to receive 2 doses of H1N1 LAIV or placebo 28 days apart. The primary safety endpoint was fever >= 38.3 degrees C during days 1-8 after the first dose; the primary immunogenicity endpoint was the proportion of subjects experiencing a postdose seroresponse. Solicited symptoms and adverse events were recorded for 14 days after each dose and safety data were collected for 180 days post-final dose. In total, 326 children (H1N1 LAIV, n = 261; placebo, n = 65) and 300 adults (H1N1 LAIV, n = 240; placebo, n = 60) were enrolled. After dose 1, fever >= 38.3 degrees C occurred in 4 (1.5%) pediatric vaccine recipients and 1 (1.5%) placebo recipient (rate difference, 0%; 95% CI: -6.4%, 3.1%). No adults experienced fever following dose 1. Seroresponse rates in children (H1N1 LAIV vs. placebo) were 11.1% vs. 6.3% after dose 1 (rate difference, 4.8%; 95% CI: -9.6%, 13.8%) and 32.0% vs. 14.5% after dose 2 (rate difference, 17.5%; 95% CI: 5.5%, 27.1%). Seroresponse rates in adults were 6.1% vs. 0% (rate difference, 6.1%; 95% CI: -5.6%, 12.6%) and 14.9% vs. 5.6% (rate difference, 9.3%; 95% CI: -0.8%, 16.3%) after dose 1 and dose 2, respectively. Solicited symptoms after dose 1 (H1N1 LAIV vs. placebo) occurred in 37.5% vs. 32.3% of children and 41.7% vs. 31.7% of adults. Solicited symptoms occurred less frequently after dose 2 in adults and children. No vaccine-related serious adverse events occurred. Conclusions/Significance: In subjects aged 2 to 49 years, two doses of H1N1 LAIV have a safety and immunogenicity profile similar to other previously studied and efficacious formulations of seasonal trivalent LAIV.	[Mallory, Raburn M.; Malkin, Elissa; Ambrose, Christopher S.; Bellamy, Terramika; Shi, Li; Yi, Tingting; Jones, Taff; Kemble, George; Dubovsky, Filip] Medimmune LLC, Gaithersburg, MD USA	AstraZeneca; Medimmune	Mallory, RM (corresponding author), Medimmune LLC, Gaithersburg, MD USA.	malloryr@medimmune.com		Ambrose, Christopher/0000-0003-4175-7336	HHS/ASPR/BARDA [HHSO100200900002I]	HHS/ASPR/BARDA	This study was sponsored by MedImmune. This project has been funded in whole or in part with federal funds from the HHS/ASPR/BARDA, under contract number HHSO100200900002I. The opinions expressed herein do not represent opinions or statements made or expressed by the US Department of Health and Human Services. The authors are all employees of MedImmune. Because of the authors' status as employees of the study sponsor, the sponsor participated in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Anonymous, 2009, Morbidity and Mortality Weekly Report, V58, P1100; Belshe RB, 2000, J PEDIATR-US, V136, P168, DOI 10.1016/S0022-3476(00)70097-7; Belshe RB, 1998, NEW ENGL J MED, V338, P1405, DOI 10.1056/NEJM199805143382002; Belshe Robert, 2004, Expert Rev Vaccines, V3, P643, DOI 10.1586/14760584.3.6.643; Belshe RB, 2007, NEW ENGL J MED, V356, P685, DOI 10.1056/NEJMoa065368; Block SL, 2008, VACCINE, V26, P4940, DOI 10.1016/j.vaccine.2008.07.013; BRACCO H, 2009, PEDIATR INFECT DIS J, P365; Breiman RF, 2009, VACCINE, V27, P5472, DOI 10.1016/j.vaccine.2009.07.002; Broder K., 2009, Morbidity and Mortality Weekly Report, V58, P1351; Carpenter LR, 2007, PEDIATRICS, V120, pE172, DOI 10.1542/peds.2006-2603; Chan ISF, 1999, BIOMETRICS, V55, P1202, DOI 10.1111/j.0006-341X.1999.01202.x; Chen ZY, 2010, J VIROL, V84, P44, DOI 10.1128/JVI.02106-09; EDWARDS KM, 1994, J INFECT DIS, V169, P68, DOI 10.1093/infdis/169.1.68; Englund JA, 2005, PEDIATRICS, V115, P1039, DOI 10.1542/peds.2004-2373; Forrest BD, 2008, CLIN VACCINE IMMUNOL, V15, P1042, DOI 10.1128/CVI.00397-07; Halloran ME, 2003, AM J EPIDEMIOL, V158, P305, DOI 10.1093/aje/kwg163; Hull HF, 2008, VACCINE, V26, P4312, DOI 10.1016/j.vaccine.2008.06.015; Jackson LA, 2006, PEDIATRICS, V118, P2032, DOI 10.1542/peds.2006-1422; Jin H, 2003, VIROLOGY, V306, P18, DOI 10.1016/S0042-6822(02)00035-1; King JC, 2006, NEW ENGL J MED, V355, P2523, DOI 10.1056/NEJMoa055414; King JC, 1998, J INFECT DIS, V177, P1394, DOI 10.1086/517822; Lee MS, 2004, PEDIATR INFECT DIS J, V23, P852, DOI 10.1097/01.inf.0000137566.87691.3b; Lum LCS, 2010, VACCINE, V28, P1566, DOI 10.1016/j.vaccine.2009.11.054; MAASSAB HF, 1969, B WORLD HEALTH ORGAN, V41, P589; MAASSAB HF, 1969, J IMMUNOL, V102, P728; NEUZILKM, 2006, J Infect Dis, V194, P1032; Nichol KL, 1999, JAMA-J AM MED ASSOC, V282, P137, DOI 10.1001/jama.282.2.137; PIEDRA P, 2010, 13 ANN C VACC RES BE; Piedra PA, 2005, PEDIATRICS, V116, pE397, DOI 10.1542/peds.2004-2258; Piedra PA, 2007, PEDIATRICS, V120, pE553, DOI 10.1542/peds.2006-2836; Rhorer J, 2009, VACCINE, V27, P1101, DOI 10.1016/j.vaccine.2008.11.093; Rowe T, 1999, J CLIN MICROBIOL, V37, P937, DOI 10.1128/JCM.37.4.937-943.1999; Tam JS, 2007, PEDIATR INFECT DIS J, V26, P619, DOI 10.1097/INF.0b013e31806166f8; Treanor JJ, 1999, VACCINE, V18, P899, DOI 10.1016/S0264-410X(99)00334-5; Treanor JJ, 2006, NEW ENGL J MED, V354, P1343, DOI 10.1056/NEJMoa055778; *WHO, 2008, BUS PLAN GLOB PAND I; Zangwill KM, 2004, PEDIATR INFECT DIS J, V23, P189, DOI 10.1097/01.inf.0000116292.46143.d6; Zangwill KM, 2001, PEDIATR INFECT DIS J, V20, P740, DOI 10.1097/00006454-200108000-00005	38	48	49	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2010	5	10							e13755	10.1371/journal.pone.0013755	http://dx.doi.org/10.1371/journal.pone.0013755			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673FU	21060780	Green Submitted, Green Published, gold			2022-12-27	WOS:000283645300034
J	Wang, JTH; Kerr, MC; Karunaratne, S; Jeanes, A; Yap, AS; Teasdale, RD				Wang, Jack T. H.; Kerr, Markus C.; Karunaratne, Seetha; Jeanes, Angela; Yap, Alpha S.; Teasdale, Rohan D.			The SNX-PX-BAR Family in Macropinocytosis: The Regulation of Macropinosome Formation by SNX-PX-BAR Proteins	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; EPITHELIAL-CELL INVASION; STIMULATED A431 CELLS; PLASMA-MEMBRANE; PHOSPHOINOSITIDE 3-KINASE; RECEPTOR DEGRADATION; SHIGELLA-FLEXNERI; SORTING NEXIN-1; COATED VESICLES; DOMAINS	Background: Macropinocytosis is an actin-driven endocytic process, whereby membrane ruffles fold back onto the plasma membrane to form large (> 0.2 mu m in diameter) endocytic organelles called macropinosomes. Relative to other endocytic pathways, little is known about the molecular mechanisms involved in macropinocytosis. Recently, members of the Sorting Nexin (SNX) family have been localized to the cell surface and early macropinosomes, and implicated in macropinosome formation. SNX-PX-BAR proteins form a subset of the SNX family and their lipid-binding (PX) and membrane-curvature sensing (BAR) domain architecture further implicates their functional involvement in macropinosome formation. Methodology/Principal Findings: We exploited the tractability of macropinosomes through image-based screening and systematic overexpression of SNX-PX-BAR proteins to quantitate their effect on macropinosome formation. SNX1 (40.9+/-3.19 macropinosomes), SNX5 (36.99+/-4.48 macropinosomes), SNX9 (37.55+/-2.4 macropinosomes), SNX18 (88.2+/-8 macropinosomes), SNX33 (65.25+/-6.95 macropinosomes) all exhibited statistically significant (p < 0.05) increases in average macropinosome numbers per 100 transfected cells as compared to control cells (24.44+/-1.81 macropinosomes). SNX1, SNX5, SNX9, and SNX18 were also found to associate with early-stage macropinosomes within 5 minutes following organelle formation. The modulation of intracellular PI(3,4,5)P-3 levels through overexpression of PTEN or a lipid phosphatase-deficient mutant PTEN(G129E) was also observed to significantly reduce or elevate macropinosome formation respectively; coexpression of PTEN(G129E) with SNX9 or SNX18 synergistically elevated macropinosome formation to 119.4+/-7.13 and 91.4+/-6.37 macropinosomes respectively (p < 0.05). Conclusions/Significance: SNX1, SNX5, SNX9, SNX18, and SNX33 were all found to elevate macropinosome formation and (with the exception of SNX33) associate with early-stage macropinosomes. Moreover the effects of SNX9 and SNX18 overexpression in elevating macropinocytosis is likely to be synergistic with the increase in PI(3,4,5)P-3 levels, which is known to accumulate on the cell surface and early-stage macropinocytic cups. Together these findings represent the first systematic functional study into the impact of the SNX-PX-BAR family on macropinocytosis.	[Wang, Jack T. H.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia; Univ Queensland, ARC, Ctr Excellence Bioinformat, Brisbane, Qld, Australia	University of Queensland; University of Queensland	Wang, JTH (corresponding author), Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia.	R.Teasdale@imb.uq.edu.au	Kerr, Markus C/A-9864-2014; Jeanes, Angela/D-9770-2011; Wang, Jack T.H./B-4855-2013; Teasdale, Rohan D/B-2538-2009; Yap, Alpha S./J-1554-2014; Teasdale, Rohan/AAD-6698-2019	Jeanes, Angela/0000-0003-0717-6298; Teasdale, Rohan D/0000-0001-7455-5269; Yap, Alpha S./0000-0002-1038-8956; Teasdale, Rohan/0000-0001-7455-5269; Wang, Jack/0000-0002-9956-6041	National Health and Medical Research Council (NHMRC) of Australia [455824, 566727]; Australian Research Council [DP0771706]; Australian Postgraduate Award; NHMRC [351448, 511042]	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); Australian Postgraduate Award(Australian Government); NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by funding from the National Health and Medical Research Council (NHMRC) of Australia (455824, 566727) and Australian Research Council (DP0771706). JTHW was supported by an Australian Postgraduate Award, AJ by an NHMRC Dora Lush scholarship, and AY and RDT are supported by NHMRC Senior Research Fellowships (351448 and 511042 respectively). Confocal microscopy was performed at the Australian Cancer Research Foundation (ACRF)/Institute for Molecular Bioscience Dynamic Imaging Facility for Cancer Biology, which was established with the support of the ACRF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALPUCHEARANDA CM, 1994, J EXP MED, V179, P601, DOI 10.1084/jem.179.2.601; Amyere M, 2002, INT J MED MICROBIOL, V291, P487; Amyere M, 2000, MOL BIOL CELL, V11, P3453, DOI 10.1091/mbc.11.10.3453; Araki N, 1996, J CELL BIOL, V135, P1249, DOI 10.1083/jcb.135.5.1249; Araki N, 2006, CELL STRUCT FUNCT, V31, P145, DOI 10.1247/csf.06029; Araki N, 2007, EXP CELL RES, V313, P1496, DOI 10.1016/j.yexcr.2007.02.012; Carlton J, 2004, CURR BIOL, V14, P1791, DOI 10.1016/j.cub.2004.09.077; Carlton JG, 2005, TRENDS CELL BIOL, V15, P540, DOI 10.1016/j.tcb.2005.08.005; Cheever ML, 2001, NAT CELL BIOL, V3, P613, DOI 10.1038/35083000; Coyne CB, 2007, CELL HOST MICROBE, V2, P181, DOI 10.1016/j.chom.2007.07.003; Cozier GE, 2002, J BIOL CHEM, V277, P48730, DOI 10.1074/jbc.M206986200; DOWRICK P, 1993, EUR J CELL BIOL, V61, P44; Ellson CD, 2001, NAT CELL BIOL, V3, P679, DOI 10.1038/35083076; Garcia-Perez BE, 2008, MICROB PATHOGENESIS, V45, P1, DOI 10.1016/j.micpath.2008.01.009; Evans TM, 2003, TRAFFIC, V4, P869, DOI 10.1046/j.1600-0854.2003.00141.x; FRANCIS CL, 1993, NATURE, V364, P639, DOI 10.1038/364639a0; GARCIADELPORTILLO F, 1994, INFECT IMMUN, V62, P4641, DOI 10.1128/IAI.62.10.4641-4645.1994; Haberg K, 2008, J CELL SCI, V121, P1495, DOI 10.1242/jcs.028530; Habermann B, 2004, EMBO REP, V5, P250, DOI 10.1038/sj.embor.7400105; HAIGLER HT, 1979, J CELL BIOL, V83, P82, DOI 10.1083/jcb.83.1.82; HAMILTON N, 2005, CURRENT PRO IN PRESS; HEWLETT LJ, 1994, J CELL BIOL, V124, P689, DOI 10.1083/jcb.124.5.689; Itoh T, 2006, BBA-MOL CELL BIOL L, V1761, P897, DOI 10.1016/j.bbalip.2006.06.015; Kanai F, 2001, NAT CELL BIOL, V3, P675, DOI 10.1038/35083070; Kasahara K, 2007, J CELL PHYSIOL, V211, P220, DOI 10.1002/jcp.20931; Kavran JM, 1998, J BIOL CHEM, V273, P30497, DOI 10.1074/jbc.273.46.30497; Kerr MC, 2006, J CELL SCI, V119, P3967, DOI 10.1242/jcs.03167; Kerr MC, 2010, EMBO J, V29, P1331, DOI 10.1038/emboj.2010.28; Kerr MC, 2009, TRAFFIC, V10, P364, DOI 10.1111/j.1600-0854.2009.00878.x; Kirkham M, 2005, J CELL BIOL, V168, P465, DOI 10.1083/jcb.200407078; Koivusalo M, 2010, J CELL BIOL, V188, P547, DOI 10.1083/jcb.200908086; Lanzavecchia A, 1996, CURR OPIN IMMUNOL, V8, P348, DOI 10.1016/S0952-7915(96)80124-5; Lim JP, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-58; Lindmo K, 2006, J CELL SCI, V119, P605, DOI 10.1242/jcs.02855; Liu H, 2006, BIOCHEM BIOPH RES CO, V342, P537, DOI 10.1016/j.bbrc.2006.01.179; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; Mercer J, 2008, SCIENCE, V320, P531, DOI 10.1126/science.1155164; Merino-Trigo A, 2004, J CELL SCI, V117, P6413, DOI 10.1242/jcs.01561; Park J, 2010, J CELL SCI, V123, P1742, DOI 10.1242/jcs.064170; Parton RG, 2003, TRAFFIC, V4, P724, DOI 10.1034/j.1600-0854.2003.00128.x; PEARSE BMF, 1976, P NATL ACAD SCI USA, V73, P1255, DOI 10.1073/pnas.73.4.1255; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; PORATSHLIOM N, 2007, MOL BIOL CELL; RACOOSIN EL, 1993, J CELL BIOL, V121, P1011, DOI 10.1083/jcb.121.5.1011; Roberts RL, 1999, J CELL SCI, V112, P3667; RUBENSTEIN JLR, 1981, J CELL BIOL, V89, P357, DOI 10.1083/jcb.89.2.357; Sansonetti PJ, 1998, ANTON LEEUW INT J G, V74, P191, DOI 10.1023/A:1001519806727; Sansonetti PJ, 1997, CR ACAD SCI III-VIE, V320, P729, DOI 10.1016/S0764-4469(97)84821-4; Schnatwinkel C, 2004, PLOS BIOL, V2, P1363, DOI 10.1371/journal.pbio.0020261; Seet LF, 2006, BBA-MOL CELL BIOL L, V1761, P878, DOI 10.1016/j.bbalip.2006.04.011; Shin N, 2008, J CELL SCI, V121, P1252, DOI 10.1242/jcs.016709; Sonnichsen B, 2000, J CELL BIOL, V149, P901, DOI 10.1083/jcb.149.4.901; STENMARK H, 1994, EMBO J, V13, P1287, DOI 10.1002/j.1460-2075.1994.tb06381.x; Sun P, 2003, J BIOL CHEM, V278, P4063, DOI 10.1074/jbc.M208699200; SWANSON JA, 1995, TRENDS CELL BIOL, V5, P424, DOI 10.1016/S0962-8924(00)89101-1; Tran Van Nhieu G., 1997, EMBO J, V16, P2717; Venkateswarlu K, 1999, J CELL SCI, V112, P1957; Wassmer T, 2007, J CELL SCI, V120, P45, DOI 10.1242/jcs.03302; WEST MA, 1989, J CELL BIOL, V109, P2731, DOI 10.1083/jcb.109.6.2731; Xiao Y, 2007, CELL SIGNAL, V19, P1434, DOI 10.1016/j.cellsig.2007.01.021; Xu Y, 2001, NAT CELL BIOL, V3, P658, DOI 10.1038/35083051; YAMADA E, 1955, J BIOPHYS BIOCHEM CY, V1, P445, DOI 10.1083/jcb.1.5.445; Yarar D, 2008, TRAFFIC, V9, P133, DOI 10.1111/j.1600-0854.2007.00675.x; Yarar D, 2007, DEV CELL, V13, P43, DOI 10.1016/j.devcel.2007.04.014; Yoshida S, 2009, J CELL SCI, V122, P3250, DOI 10.1242/jcs.053207; Yu JW, 2001, J BIOL CHEM, V276, P44179, DOI 10.1074/jbc.M108811200; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zhang J, 2009, J BIOL CHEM, V284, P21659, DOI 10.1074/jbc.M109.007278; Zimmerberg J, 2004, CURR BIOL, V14, pR250, DOI 10.1016/j.cub.2004.02.060	70	42	48	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2010	5	10							e13763	10.1371/journal.pone.0013763	http://dx.doi.org/10.1371/journal.pone.0013763			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673FU	21048941	Green Published, Green Submitted, gold			2022-12-27	WOS:000283645300041
J	Hamilton, NK; Maizels, N				Hamilton, Nicolle K.; Maizels, Nancy			MRE11 Function in Response to Topoisomerase Poisons Is Independent of its Function in Double-Strand Break Repair in Saccharomyces cerevisiae	PLOS ONE			English	Article							DNA PHOSPHODIESTERASE TDP1; I COVALENT COMPLEXES; NUCLEASE ACTIVITY; MRE11-RAD50-XRS2 COMPLEX; BUDDING YEAST; DAMAGE; GENE; RECOMBINATION; MUTATIONS; PATHWAYS	Camptothecin (CPT) and etoposide (ETP) trap topoisomerase-DNA covalent intermediates, resulting in formation of DNA damage that can be cytotoxic if unrepaired. CPT and ETP are prototypes for molecules widely used in chemotherapy of cancer, so defining the mechanisms for repair of damage induced by treatment with these compounds is of great interest. In S. cerevisiae, deficiency in MRE11, which encodes a highly conserved factor, greatly enhances sensitivity to treatment with CPT or ETP. This has been thought to reflect the importance of double-strand break (DSB) repair pathways in the response to these to agents. Here we report that an S. cerevisiae strain expressing the mre11-H59A allele, mutant at a conserved active site histidine, is sensitive to hydroxyurea and also to ionizing radiation, which induces DSBs, but not to CPT or ETP. We show that TDP1, which encodes a tyrosyl-DNA phosphodiesterase activity able to release both 5'- and 3'-covalent topoisomerase-DNA complexes in vitro, contributes to ETP-resistance but not CPT-resistance in the mre11-H59A background. We further show that CPT- and ETP-resistance mediated by MRE11 is independent of SAE2, and thus independent of the coordinated functions of MRE11 and SAE2 in homology-directed repair and removal of Spo11 from DNA ends in meiosis. These results identify a function for MRE11 in the response to topoisomerase poisons that is distinct from its functions in DSB repair or meiotic DNA processing. They also establish that cellular proficiency in repair of DSBs may not correlate with resistance to topoisomerase poisons, a finding with potential implications for stratification of tumors with specific DNA repair deficiencies for treatment with these compounds.	[Hamilton, Nicolle K.; Maizels, Nancy] Univ Washington, Dept Immunol, Sch Med, Seattle, WA 98195 USA; [Maizels, Nancy] Univ Washington, Dept Biochem, Sch Med, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Hamilton, NK (corresponding author), Univ Washington, Dept Immunol, Sch Med, Seattle, WA 98195 USA.	maizels@u.washington.edu			National Institutes of Health [P01 CA77852, T32 GM07270]; NATIONAL CANCER INSTITUTE [P01CA077852] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007270] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding was provided by National Institutes of Health P01 CA77852 to NM; National Institutes of Health T32 GM07270 to NKH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arthur LM, 2004, NUCLEIC ACIDS RES, V32, P1886, DOI 10.1093/nar/gkh343; Baldwin EL, 2005, NUCLEIC ACIDS RES, V33, P1021, DOI 10.1093/nar/gki246; BAUDIN A, 1993, NUCLEIC ACIDS RES, V21, P3329, DOI 10.1093/nar/21.14.3329; Ben Hassine S, 2009, EMBO J, V28, P632, DOI 10.1038/emboj.2009.9; Chamankhah M, 1999, NUCLEIC ACIDS RES, V27, P2072, DOI 10.1093/nar/27.10.2072; Deng CC, 2005, GENETICS, V170, P591, DOI 10.1534/genetics.104.028795; Farah JA, 2005, GENETICS, V169, P1261, DOI 10.1534/genetics.104.037515; Giannini G, 2004, ONCOGENE, V23, P2640, DOI 10.1038/sj.onc.1207409; Giannini G, 2002, EMBO REP, V3, P248, DOI 10.1093/embo-reports/kvf044; Hartsuiker E, 2009, MOL CELL BIOL, V29, P1671, DOI 10.1128/MCB.01182-08; Hopfner KP, 2001, CELL, V105, P473, DOI 10.1016/S0092-8674(01)00335-X; Hopkins BB, 2008, CELL, V135, P250, DOI 10.1016/j.cell.2008.09.054; Interthal H, 2001, P NATL ACAD SCI USA, V98, P12009, DOI 10.1073/pnas.211429198; Krogh BO, 2005, GENETICS, V171, P1561, DOI 10.1534/genetics.105.049478; Larson ED, 2005, MOL CELL, V20, P367, DOI 10.1016/j.molcel.2005.09.018; Ledesma FC, 2009, NATURE, V461, P674, DOI 10.1038/nature08444; Lengsfeld BM, 2007, MOL CELL, V28, P638, DOI 10.1016/j.molcel.2007.11.001; Lewis LK, 2004, GENETICS, V166, P1701, DOI 10.1534/genetics.166.4.1701; Liu CY, 2004, DNA REPAIR, V3, P593, DOI 10.1016/j.dnarep.2004.03.030; Liu CY, 2002, P NATL ACAD SCI USA, V99, P14970, DOI 10.1073/pnas.182557199; Mimitou EP, 2009, DNA REPAIR, V8, P983, DOI 10.1016/j.dnarep.2009.04.017; Neale MJ, 2005, NATURE, V436, P1053, DOI 10.1038/nature03872; Nitiss KC, 2006, P NATL ACAD SCI USA, V103, P8953, DOI 10.1073/pnas.0603455103; Paull TT, 1998, MOL CELL, V1, P969, DOI 10.1016/S1097-2765(00)80097-0; Pouliot JJ, 1999, SCIENCE, V286, P552, DOI 10.1126/science.286.5439.552; Pouliot JJ, 2001, GENES CELLS, V6, P677, DOI 10.1046/j.1365-2443.2001.00452.x; Stracker TH, 2008, CELL CYCLE, V7, P3618, DOI 10.4161/cc.7.23.7064; Trujillo KM, 2001, J BIOL CHEM, V276, P35458, DOI 10.1074/jbc.M105482200; Tsubouchi H, 1998, MOL CELL BIOL, V18, P260, DOI 10.1128/MCB.18.1.260; Usui T, 1998, CELL, V95, P705, DOI 10.1016/S0092-8674(00)81640-2; Vance JR, 2002, P NATL ACAD SCI USA, V99, P13669, DOI 10.1073/pnas.202242599; Williams RS, 2008, CELL, V135, P97, DOI 10.1016/j.cell.2008.08.017; Yang SW, 1996, P NATL ACAD SCI USA, V93, P11534, DOI 10.1073/pnas.93.21.11534	33	29	29	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2010	5	10							e15387	10.1371/journal.pone.0015387	http://dx.doi.org/10.1371/journal.pone.0015387			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	672HN	21060845	gold, Green Published, Green Submitted			2022-12-27	WOS:000283573800025
J	Knight, CJ; Bailey, AM; Foster, GD				Knight, Claire J.; Bailey, Andy M.; Foster, Gary D.			Investigating Agrobacterium-Mediated Transformation of Verticillium albo-atrum on Plant Surfaces	PLOS ONE			English	Article							GENETIC-TRANSFORMATION; AGARICUS-BISPORUS; TUMEFACIENS; DNA; BIOLOGY; GROWTH; CELLS; TOOL	Background: Agrobacterium tumefaciens has long been known to transform plant tissue in nature as part of its infection process. This natural mechanism has been utilised over the last few decades in laboratories world wide to genetically manipulate many species of plants. More recently this technology has been successfully applied to non-plant organisms in the laboratory, including fungi, where the plant wound hormone acetosyringone, an inducer of transformation, is supplied exogenously. In the natural environment it is possible that Agrobacterium and fungi may encounter each other at plant wound sites, where acetosyringone would be present, raising the possibility of natural gene transfer from bacterium to fungus. Methodology/Principal Findings: We investigate this hypothesis through the development of experiments designed to replicate such a situation at a plant wound site. A. tumefaciens harbouring the plasmid pCAMDsRed was co-cultivated with the common plant pathogenic fungus Verticillium albo-atrum on a range of wounded plant tissues. Fungal transformants were obtained from co-cultivation on a range of plant tissue types, demonstrating that plant tissue provides sufficient vir gene inducers to allow A. tumefaciens to transform fungi in planta. Conclusions/Significance: This work raises interesting questions about whether A. tumefaciens may be able to transform organisms other than plants in nature, or indeed should be considered during GM risk assessments, with further investigations required to determine whether this phenomenon has already occurred in nature.	[Knight, Claire J.; Bailey, Andy M.; Foster, Gary D.] Univ Bristol, Sch Biol Sci, Bristol, Avon, England	University of Bristol	Knight, CJ (corresponding author), Univ Bristol, Sch Biol Sci, Bristol, Avon, England.	Gary.Foster@bristol.ac.uk	Foster, Gary D/A-7985-2011	Foster, Gary D/0000-0002-1979-1397; Bailey, Andy/0000-0002-7594-3703	Natural Environment Research Council (NERC)	Natural Environment Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was funded by a Natural Environment Research Council (NERC) PhD studentship awarded to CJK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amey RC, 2002, MYCOL RES, V106, P4, DOI 10.1017/S0953756201005251; Barrett C, 1997, PLANT CELL TISS ORG, V47, P135, DOI 10.1007/BF02318949; BUNDOCK P, 1995, EMBO J, V14, P3206, DOI 10.1002/j.1460-2075.1995.tb07323.x; Burns C, 2006, MOL BIOTECHNOL, V32, P129, DOI 10.1385/MB:32:2:129; Chen X, 2000, APPL ENVIRON MICROB, V66, P4510, DOI 10.1128/AEM.66.10.4510-4513.2000; CHILTON MD, 1977, CELL, V11, P263, DOI 10.1016/0092-8674(77)90043-5; COLLINS C, 2010, J MICROBIOL IN PRESS; Covert SF, 2001, MYCOL RES, V105, P259, DOI 10.1017/S0953756201003872; [杨敏生 YANG MinSheng], 2006, [生态学报, Acta Ecologica Sinica], V26, P3555, DOI 10.1016/S1872-2032(06)60055-3; de Groot MJA, 1998, NAT BIOTECHNOL, V16, P839, DOI 10.1038/nbt0998-839; dos Reis MC, 2004, J MICROBIOL METH, V58, P197, DOI 10.1016/j.mimet.2004.03.012; Eckert M, 2005, FEMS MICROBIOL LETT, V253, P67, DOI 10.1016/j.femsle.2005.09.041; Gelvin SB, 2005, NATURE, V433, P583, DOI 10.1038/433583a; Gelvin SB, 2003, MICROBIOL MOL BIOL R, V67, P16, DOI 10.1128/MMBR.67.1.16-37.2003; Hartley AJ, 2009, FEMS MICROBIOL LETT, V297, P24, DOI 10.1111/j.1574-6968.2009.01656.x; Keon J, 1998, FEMS MICROBIOL LETT, V161, P337, DOI 10.1111/j.1574-6968.1998.tb12966.x; Kilaru S, 2009, APPL ENVIRON MICROB, V75, P7196, DOI 10.1128/AEM.01151-09; Kilaru S, 2009, CURR GENET, V55, P543, DOI 10.1007/s00294-009-0266-6; KNIGHT CJ, 2009, J PLANT PATHOL, V91, P637; Kunik T, 2001, P NATL ACAD SCI USA, V98, P1871, DOI 10.1073/pnas.041327598; Machida M, 2005, NATURE, V438, P1157, DOI 10.1038/nature04300; McCullen CA, 2006, ANNU REV CELL DEV BI, V22, P101, DOI 10.1146/annurev.cellbio.22.011105.102022; Michielse CB, 2004, J BACTERIOL, V186, P2038, DOI 10.1128/JB.186.7.2038-2045.2004; Mullins ED, 2001, PHYTOPATHOLOGY, V91, P173, DOI 10.1094/PHYTO.2001.91.2.173; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; NAZAR RN, 1991, PHYSIOL MOL PLANT P, V39, P1, DOI 10.1016/0885-5765(91)90027-F; Patel AD, 2008, PLANT SOIL ENVIRON, V54, P367, DOI 10.17221/407-PSE; Pegg GF, 2002, VERTICILLUM WILTS, DOI [DOI 10.1079/9780851995298.0000, 10.1079/9780851995298.0000]; Sambrook J., 2002, MOL CLONING LAB MANU; Tzfira T, 2003, PLANT PHYSIOL, V133, P943, DOI 10.1104/pp.103.032821	31	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2010	5	10							e13684	10.1371/journal.pone.0013684	http://dx.doi.org/10.1371/journal.pone.0013684			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671UN	21060684	Green Published, gold, Green Submitted			2022-12-27	WOS:000283537000049
J	Nguyen-Hieu, T; Aboudharam, G; Signoli, M; Rigeade, C; Drancourt, M; Raoult, D				Nguyen-Hieu, Tung; Aboudharam, Gerard; Signoli, Michel; Rigeade, Catherine; Drancourt, Michel; Raoult, Didier			Evidence of a Louse-Borne Outbreak Involving Typhus in Douai, 1710-1712 during the War of Spanish Succession	PLOS ONE			English	Article							EPIDEMIC TYPHUS; DENTAL-PULP; BARTONELLA-QUINTANA; YERSINIA-PESTIS; RICKETTSIA-PROWAZEKII; MOLECULAR-DETECTION; COXIELLA-BURNETII; SPOTTED-FEVER; TRENCH FEVER; DISEASES	Background: The new field of paleomicrobiology allows past outbreaks to be identified by testing dental pulp of human remains with PCR. Methods: We identified a mass grave in Douai, France dating from the early XVIII(th) century. This city was besieged during the European war of Spanish succession. We tested dental pulp from 1192 teeth (including 40 from Douai) by quantitative PCR (qPCR) for R. prowazekii and B. quintana. We also used ultra-sensitive suicide PCR to detect R. prowazekii and genotyped positive samples. Results and Discussion: In the Douai remains, we identified one case of B. quintana infection (by qPCR) and R. prowazekii (by suicide PCR) in 6/21 individuals (29%). The R. prowazekii was genotype B, a genotype previously found in a Spanish isolate obtained in the first part of the XX(th) century. Conclusion: Louse-borne outbreaks were raging during the XVIII(th) century; our results support the hypothesis that typhus was imported into Europe by Spanish soldiers from America.	[Nguyen-Hieu, Tung; Aboudharam, Gerard; Drancourt, Michel; Raoult, Didier] Univ Aix Marseille 2, Unite Rech Malad Infect & Trop Emergentes, UMR CNRS 6236, IRD198,IFR48,Fac Med, Marseille, France; [Signoli, Michel; Rigeade, Catherine] Univ Aix Marseille 2, Unite Anthropol, UMR CNRS 6578, Fac Med, Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite	Nguyen-Hieu, T (corresponding author), Univ Aix Marseille 2, Unite Rech Malad Infect & Trop Emergentes, UMR CNRS 6236, IRD198,IFR48,Fac Med, Marseille, France.	didier.raoult@gmail.com	RAOULT, Didier/A-8434-2008	RAOULT, Didier/0000-0002-0633-5974				Aboudharam G, 2004, EUR J CLIN MICROBIOL, V23, P920, DOI 10.1007/s10096-004-1244-z; Aboudharam G, 2004, MICROB PATHOGENESIS, V36, P349, DOI 10.1016/j.micpath.2004.02.002; Aboudharam G, 2000, MICROB PATHOGENESIS, V28, P249, DOI 10.1006/mpat.1999.0343; Badiaga S, 2005, AM J TROP MED HYG, V72, P638, DOI 10.4269/ajtmh.2005.72.638; Bechah Y, 2010, GENOME RES, V20, P655, DOI 10.1101/gr.103564.109; Bechah Y, 2008, LANCET INFECT DIS, V8, P417, DOI 10.1016/S1473-3099(08)70150-6; Corvisier A, 1985, HOMMES GUERRE MORT; de Sauvages F. B., 1772, NOSOLOGIE METHODIQUE; DEPERINI EH, 1906, BATAILLES FRANCAISES; Drancourt M, 2005, J INFECT DIS, V191, P607, DOI 10.1086/427041; Drancourt M, 2005, NAT REV MICROBIOL, V3, P23, DOI 10.1038/nrmicro1063; Drancourt M, 2004, MICROBIOL-SGM, V150, P263, DOI 10.1099/mic.0.26885-0; Drancourt M, 1998, P NATL ACAD SCI USA, V95, P12637, DOI 10.1073/pnas.95.21.12637; DUMLER JS, 1991, JAMA-J AM MED ASSOC, V265, P718, DOI 10.1001/jama.265.6.718; Mokrani K, 2004, J CLIN MICROBIOL, V42, P3898, DOI 10.1128/JCM.42.8.3898-3900.2004; Raoult D, 2000, P NATL ACAD SCI USA, V97, P12800, DOI 10.1073/pnas.220225197; Raoult D, 1999, CLIN INFECT DIS, V29, P434, DOI 10.1086/520229; Raoult D, 2006, J INFECT DIS, V193, P112, DOI 10.1086/498534; Raoult D, 1998, LANCET, V352, P353, DOI 10.1016/S0140-6736(97)12433-3; Raoult D, 2004, INFECT DIS CLIN N AM, V18, P127, DOI 10.1016/S0891-5520(03)00093-X; Raoult D, 1999, CLIN INFECT DIS, V29, P888, DOI 10.1086/520454; RIGEADE C, 2005, SOCIOLOGIE SANTE, P117; Rigeade C, 2006, CR PALEVOL, V5, P901, DOI 10.1016/j.crpv.2006.06.002; Signoli M, 2004, CR PALEVOL, V3, P219, DOI 10.1016/j.crpv.2004.02.003; Stenos J, 2005, AM J TROP MED HYG, V73, P1083, DOI 10.4269/ajtmh.2005.73.1083; Svraka S, 2006, EMERG INFECT DIS, V12, P428, DOI 10.3201/eid1203.050888; Tarasevich I, 1998, LANCET, V352, P1151, DOI 10.1016/S0140-6736(05)79799-3; Tran-Hung L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001062; Zhu Y, 2005, J CLIN MICROBIOL, V43, P4708, DOI 10.1128/JCM.43.9.4708-4712.2005; Zinsser Hans., 1935, RATS LICE HIST	30	35	35	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2010	5	10							e15405	10.1371/journal.pone.0015405	http://dx.doi.org/10.1371/journal.pone.0015405			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671UN	21060879	gold, Green Published			2022-12-27	WOS:000283537000065
J	Piekielko-Witkowska, A; Wiszomirska, H; Wojcicka, A; Poplawski, P; Boguslawska, J; Tanski, Z; Nauman, A				Piekielko-Witkowska, Agnieszka; Wiszomirska, Hanna; Wojcicka, Anna; Poplawski, Piotr; Boguslawska, Joanna; Tanski, Zbigniew; Nauman, Alicja			Disturbed Expression of Splicing Factors in Renal Cancer Affects Alternative Splicing of Apoptosis Regulators, Oncogenes, and Tumor Suppressors	PLOS ONE			English	Article							PRE-MESSENGER-RNA; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEINS; GENE-EXPRESSION; IN-VIVO; TYROSINE KINASE; CELL CARCINOMA; VARIANTS; ADHESION; RAC1B; OVEREXPRESSION	Background: Clear cell renal cell carcinoma (ccRCC) is the most common type of renal cancer. One of the processes disturbed in this cancer type is alternative splicing, although phenomena underlying these disturbances remain unknown. Alternative splicing consists of selective removal of introns and joining of residual exons of the primary transcript, to produce mRNA molecules of different sequence. Splicing aberrations may lead to tumoral transformation due to synthesis of impaired splice variants with oncogenic potential. In this paper we hypothesized that disturbed alternative splicing in ccRCC may result from improper expression of splicing factors, mediators of splicing reactions. Methodology/Principal Findings: Using real-time PCR and Western-blot analysis we analyzed expression of seven splicing factors belonging to SR proteins family (SF2/ASF, SC35, SRp20, SRp75, SRp40, SRp55 and 9G8), and one non-SR factor, hnRNP A1 (heterogeneous nuclear ribonucleoprotein A1) in 38 pairs of tumor-control ccRCC samples. Moreover, we analyzed splicing patterns of five genes involved in carcinogenesis and partially regulated by analyzed splicing factors: RON, CEACAM1, Rac1, Caspase-9, and GLI1. Conclusions/Significance: We found that the mRNA expression of splicing factors was disturbed in tumors when compared to paired controls, similarly as levels of SF2/ASF and hnRNP A1 proteins. The correlation coefficients between expression levels of specific splicing factors were increased in tumor samples. Moreover, alternative splicing of five analyzed genes was also disturbed in ccRCC samples and splicing pattern of two of them, Caspase-9 and CEACAM1 correlated with expression of SF2/ASF in tumors. We conclude that disturbed expression of splicing factors in ccRCC may possibly lead to impaired alternative splicing of genes regulating tumor growth and this way contribute to the process of carcinogenesis.	[Piekielko-Witkowska, Agnieszka; Wiszomirska, Hanna; Wojcicka, Anna; Poplawski, Piotr; Boguslawska, Joanna; Nauman, Alicja] Med Ctr Postgrad Educ, Dept Biochem & Mol Biol, Warsaw, Poland; [Tanski, Zbigniew] Reg Hosp, Ostroleka, Poland	Centre of Postgraduate Medical Education - Poland	Piekielko-Witkowska, A (corresponding author), Med Ctr Postgrad Educ, Dept Biochem & Mol Biol, Warsaw, Poland.	anauman@cmkp.edu.pl	Poplawski, Piotr/V-1030-2019; Piekielko-Witkowska, Agnieszka/V-1011-2019; Wojcicka, Anna/K-4134-2012; Bogusławska, Joanna/I-7189-2019	Poplawski, Piotr/0000-0002-9477-7595; Piekielko-Witkowska, Agnieszka/0000-0002-5348-0760; Wojcicka, Anna/0000-0001-5803-6397; Boguslawska, Joanna/0000-0003-2568-1546	Polish State Committee for Scientific Research [NN401354733, NN401073636]; Medical Centre of Postgraduate Education [501-2-25-01/09]	Polish State Committee for Scientific Research(Polish State Committee for Scientific Research); Medical Centre of Postgraduate Education	The work was supported by: the Polish State Committee for Scientific Research Grants NN401354733 (to APW) and NN401073636 (to AN), and The Medical Centre of Postgraduate Education grant 501-2-25-01/09 (to APW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahram M, 2002, MOL CARCINOGEN, V33, P9, DOI 10.1002/mc.10019; Audebert M, 2000, CANCER RES, V60, P4740; Bardella C, 2004, CANCER RES, V64, P5154, DOI 10.1158/0008-5472.CAN-04-0600; Benvenuti S, 2007, J CELL PHYSIOL, V213, P316, DOI 10.1002/jcp.21183; Bosco EE, 2009, CELL MOL LIFE SCI, V66, P370, DOI 10.1007/s00018-008-8552-x; Brinkman BMN, 2004, CLIN BIOCHEM, V37, P584, DOI 10.1016/j.clinbiochem.2004.05.015; CACERES JF, 1994, SCIENCE, V265, P1706, DOI 10.1126/science.8085156; Cartegni L, 2003, NUCLEIC ACIDS RES, V31, P3568, DOI 10.1093/nar/gkg616; Chandradas S, 2010, J LEUKOCYTE BIOL, V87, P147, DOI 10.1189/jlb.0409252; Chen X, 2002, MOL BIOL CELL, V13, P1929, DOI 10.1091/mbc.02-02-0023; Dormoy V, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-123; Engers R, 2001, J BIOL CHEM, V276, P41889, DOI 10.1074/jbc.M105049200; Expert-Bezancon A, 2004, J BIOL CHEM, V279, P38249, DOI 10.1074/jbc.M405377200; Fackenthal JD, 2008, DIS MODEL MECH, V1, P37, DOI 10.1242/dmm.000331; Fernandez-Zapico ME, 2008, PANCREATOLOGY, V8, P227, DOI 10.1159/000134271; Gagne JP, 2003, BIOCHEM J, V371, P331, DOI 10.1042/BJ20021675; Gaur S, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-46; Gereben B, 2009, THYROID, V19, P1027, DOI 10.1089/thy.2009.1593; Ghigna C, 2005, MOL CELL, V20, P881, DOI 10.1016/j.molcel.2005.10.026; Goncalves V, 2009, HUM MOL GENET, V18, P3696, DOI 10.1093/hmg/ddp317; Hanamura A, 1998, RNA, V4, P430; Hartmann B, 2009, CURR OPIN CELL BIOL, V21, P377, DOI 10.1016/j.ceb.2009.02.006; He YW, 2009, CELL MOL LIFE SCI, V66, P1239, DOI 10.1007/s00018-008-8532-1; Ji YB, 2009, NUCLEIC ACIDS RES, V37, P3501, DOI 10.1093/nar/gkp218; Jordan P, 1999, ONCOGENE, V18, P6835, DOI 10.1038/sj.onc.1203233; Kammerer R, 2004, J PATHOL, V204, P258, DOI 10.1002/path.1657; Karni R, 2007, NAT STRUCT MOL BIOL, V14, P185, DOI 10.1038/nsmb1209; Kempkensteffen C, 2009, TUMOR BIOL, V30, P73, DOI 10.1159/000215826; Klein CA, 2002, LANCET, V360, P683, DOI 10.1016/S0140-6736(02)09838-0; Kleinerman DI, 1996, CANCER RES, V56, P3431; KLEINERMAN DI, 1995, CANCER RES, V55, P1215; LIU Q, 1995, MOL CELL BIOL, V15, P2800; LJUNGBERG B, 2009, GUIDELINES RENAL CEL; Long JC, 2009, BIOCHEM J, V417, P15, DOI 10.1042/BJ20081501; Lopez-Beltran A, 2006, EUR UROL, V49, P798, DOI 10.1016/j.eururo.2005.11.035; Luo WP, 1997, ONCOGENE, V14, P1697, DOI 10.1038/sj.onc.1200999; Mahotka C, 2002, INT J CANCER, V100, P30, DOI 10.1002/ijc.10450; Malanga M, 2008, J BIOL CHEM, V283, P19991, DOI 10.1074/jbc.M709495200; Massiello A, 2006, J LIPID RES, V47, P892, DOI 10.1194/jlr.C600003-JLR200; Master A, 2010, BBA-MOL BASIS DIS, V1802, P995, DOI 10.1016/j.bbadis.2010.07.025; Matafora V, 2009, MOL CELL PROTEOMICS, V8, P2243, DOI 10.1074/mcp.M900079-MCP200; Matos P, 2008, MOL CANCER RES, V6, P1178, DOI 10.1158/1541-7786.MCR-08-0008; MCLAREN J, 1994, TOXICOLOGY, V88, P101, DOI 10.1016/0300-483X(94)90113-9; Merdzhanova G, 2008, CELL DEATH DIFFER, V15, P1815, DOI 10.1038/cdd.2008.135; Mizutani Y, 2007, INT J ONCOL, V30, P919; Mole S, 2009, J PATHOL, V219, P383, DOI 10.1002/path.2608; Muller MM, 2009, J CELL BIOL, V187, P569, DOI 10.1083/jcb.200904150; Novara G, 2007, J UROLOGY, V177, P430, DOI 10.1016/j.juro.2006.09.034; Obrink B, 2008, LUNG CANCER, V60, P309, DOI 10.1016/j.lungcan.2008.03.020; Patel NA, 2005, J BIOL CHEM, V280, P14302, DOI 10.1074/jbc.M411485200; Patry C, 2003, CANCER RES, V63, P7679; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Piekielko-Witkowska A, 2009, THYROID, V19, P1105, DOI 10.1089/thy.2008.0284; PIEKIELKOWITKOW.A, 2006, ADV BIOCH, V52, P383; Porta C, 2009, J UROLOGY, V182, P2569, DOI 10.1016/j.juro.2009.08.085; Schoffski P, 2006, ANN ONCOL, V17, P1185, DOI 10.1093/annonc/mdj133; Schwerk C, 2005, MOL CELL, V19, P1, DOI 10.1016/j.molcel.2005.05.026; Shiina H, 2003, CLIN CANCER RES, V9, P2121; Shimokawa T, 2008, J BIOL CHEM, V283, P14345, DOI 10.1074/jbc.M800299200; Singh A, 2004, ONCOGENE, V23, P9369, DOI 10.1038/sj.onc.1208182; Sinha R, 2010, MOL CELL BIOL, V30, P2762, DOI 10.1128/MCB.01270-09; Smith PJ, 2006, HUM MOL GENET, V15, P2490, DOI 10.1093/hmg/ddl171; Sultmann H, 2005, CLIN CANCER RES, V11, P646; Takahashi M, 2001, P NATL ACAD SCI USA, V98, P9754, DOI 10.1073/pnas.171209998; Tun HW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010696; Turowska O, 2007, THYROID, V17, P1039, DOI 10.1089/thy.2007.0075; Venables JP, 2006, BIOESSAYS, V28, P378, DOI 10.1002/bies.20390; Warrenfeltz S, 2004, MOL CANCER, V3, DOI 10.1186/1476-4598-3-27; Wei T., CORRPLOT VISUALIZATI; Zhao HJ, 2006, PLOS MED, V3, P115, DOI 10.1371/journal.pmed.0030013; Zhou MI, 2005, P NATL ACAD SCI USA, V102, P11035, DOI 10.1073/pnas.0500757102; Zhou YQ, 2003, ONCOGENE, V22, P186, DOI 10.1038/sj.onc.1206075	72	40	43	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2010	5	10							e13690	10.1371/journal.pone.0013690	http://dx.doi.org/10.1371/journal.pone.0013690			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671UN	21082031	Green Published, gold, Green Submitted			2022-12-27	WOS:000283537000053
J	Verstraete, E; van den Heuvel, MP; Veldink, JH; Blanken, N; Mandl, RC; Pol, HEH; van den Berg, LH				Verstraete, Esther; van den Heuvel, Martijn P.; Veldink, Jan H.; Blanken, Niels; Mandl, Rene C.; Pol, Hilleke E. Hulshoff; van den Berg, Leonard H.			Motor Network Degeneration in Amyotrophic Lateral Sclerosis: A Structural and Functional Connectivity Study	PLOS ONE			English	Article							VOXEL-BASED MORPHOMETRY; HUMAN CEREBRAL-CORTEX; GRAPH-THEORETICAL ANALYSIS; RESTING-STATE NETWORKS; DIFFUSION TENSOR MRI; HUMAN BRAIN; CORTICAL HYPEREXCITABILITY; TRACT DEGENERATION; MULTIPLE-SCLEROSIS; COMPONENT ANALYSIS	Background: Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease characterised by motor neuron degeneration. How this disease affects the central motor network is largely unknown. Here, we combined for the first time structural and functional imaging measures on the motor network in patients with ALS and healthy controls. Methodology/Principal Findings: Structural measures included whole brain cortical thickness and diffusion tensor imaging (DTI) of crucial motor tracts. These structural measures were combined with functional connectivity analysis of the motor network based on resting state fMRI. Focal cortical thinning was observed in the primary motor area in patients with ALS compared to controls and was found to correlate with disease progression. DTI revealed reduced FA values in the corpus callosum and in the rostral part of the corticospinal tract. Overall functional organisation of the motor network was unchanged in patients with ALS compared to healthy controls, however the level of functional connectedness was significantly correlated with disease progression rate. Patients with increased connectedness appear to have a more progressive disease course. Conclusions/Significance: We demonstrate structural motor network deterioration in ALS with preserved functional connectivity measures. The positive correlation between functional connectedness of the motor network and disease progression rate could suggest spread of disease along functional connections of the motor network.	[Verstraete, Esther; Veldink, Jan H.; van den Berg, Leonard H.] Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Dept Neurol, Utrecht, Netherlands; [van den Heuvel, Martijn P.; Mandl, Rene C.; Pol, Hilleke E. Hulshoff] Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Dept Psychiat, Utrecht, Netherlands; [Blanken, Niels] Univ Med Ctr Utrecht, Dept Radiol, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	Verstraete, E (corresponding author), Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Dept Neurol, Utrecht, Netherlands.	L.H.vandenBerg@umcutrecht.nl	van den Heuvel, Martijn/AFR-3213-2022; Hulshoff Pol, Hilleke Evertje/B-4795-2014; Mandl, René C.W./AAU-7037-2020	Hulshoff Pol, Hilleke Evertje/0000-0002-2038-5281; van den Heuvel, Martijn/0000-0003-1570-1195; Veldink, Jan/0000-0001-5572-9657	Netherlands Amyotrophic Lateral Sclerosis (ALS) foundation; 'Prinses Beatrix fonds'	Netherlands Amyotrophic Lateral Sclerosis (ALS) foundation; 'Prinses Beatrix fonds'	This study was funded by the Netherlands Amyotrophic Lateral Sclerosis (ALS) foundation and the 'Prinses Beatrix fonds'. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; AERTSEN AMHJ, 1989, J NEUROPHYSIOL, V61, P900, DOI 10.1152/jn.1989.61.5.900; Agosta F, 2007, HUM BRAIN MAPP, V28, P1430, DOI 10.1002/hbm.20364; AGOSTA F, 2010, AJNR AM J NEURO 0401; Bakkour A, 2009, NEUROLOGY, V72, P1048, DOI 10.1212/01.wnl.0000340981.97664.2f; Bartels C, 2008, NEUROMUSCULAR DISORD, V18, P398, DOI 10.1016/j.nmd.2008.02.005; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Brooks BR, 2000, AMYOTROPH LATERAL SC, V1, P293, DOI 10.1080/146608200300079536; Budde MD, 2008, NMR BIOMED, V21, P589, DOI 10.1002/nbm.1229; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Ciccarelli O, 2009, HUM BRAIN MAPP, V30, P615, DOI 10.1002/hbm.20527; Clavaguera F, 2009, NAT CELL BIOL, V11, P909, DOI 10.1038/ncb1901; Cordes D, 2000, AM J NEURORADIOL, V21, P1636; Cordes D, 2001, AM J NEURORADIOL, V22, P1326; Damoiseaux JS, 2008, CEREB CORTEX, V18, P1856, DOI 10.1093/cercor/bhm207; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Eisen A, 2009, MUSCLE NERVE, V40, P297, DOI 10.1002/mus.21404; Ellis CM, 2001, NEUROLOGY, V57, P1571, DOI 10.1212/WNL.57.9.1571; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; FRISTON KJ, 1993, J CEREBR BLOOD F MET, V13, P5, DOI 10.1038/jcbfm.1993.4; Graham JM, 2004, NEUROLOGY, V63, P2111, DOI 10.1212/01.WNL.0000145766.03057.E7; Grossman M, 2008, NEUROLOGY, V71, P1396, DOI 10.1212/01.wnl.0000319701.50168.8c; Honey CJ, 2009, P NATL ACAD SCI USA, V106, P2035, DOI 10.1073/pnas.0811168106; Hutton C, 2009, NEUROIMAGE, V48, P371, DOI 10.1016/j.neuroimage.2009.06.043; Jones DK, 2004, MAGNET RESON MED, V51, P807, DOI 10.1002/mrm.20033; Jones DK, 1999, MAGNET RESON MED, V42, P515, DOI 10.1002/(SICI)1522-2594(199909)42:3<515::AID-MRM14>3.0.CO;2-Q; Kahkonen S, 2004, J PSYCHOPHARMACOL, V18, P257, DOI 10.1177/0269881104042631; KIERNAN JA, 1991, BRAIN, V114, P843, DOI 10.1093/brain/114.2.843; Kim JH, 2007, MAGN RESON MED, V58, P253, DOI 10.1002/mrm.21316; Kunst CB, 2004, AM J HUM GENET, V75, P933, DOI 10.1086/426001; Lowe MJ, 2008, HUM BRAIN MAPP, V29, P818, DOI 10.1002/hbm.20576; Lowe MJ, 2000, NEUROIMAGE, V12, P582, DOI 10.1006/nimg.2000.0654; Mandl RC, 2008, SCHIZOPHR B, V36, P778; Mohammadi B, 2009, EXP NEUROL, V217, P147, DOI 10.1016/j.expneurol.2009.01.025; Morgan VL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006660; Mori S, 2002, MAGN RESON MED, V47, P215, DOI 10.1002/mrm.10074; Reijneveld JC, 2007, CLIN NEUROPHYSIOL, V118, P2317, DOI 10.1016/j.clinph.2007.08.010; Rivara CB, 2003, ANAT REC PART A, V270A, P137, DOI 10.1002/ar.a.10015; Rogers J, 2007, HUM BRAIN MAPP, V28, P576, DOI 10.1002/hbm.20407; Rohrer JD, 2009, NEUROLOGY, V72, P1562, DOI 10.1212/WNL.0b013e3181a4124e; Rosas HD, 2008, BRAIN, V131, P1057, DOI 10.1093/brain/awn025; Rothstein JD, 2009, ANN NEUROL, V65, pS3, DOI 10.1002/ana.21543; Sach M, 2004, BRAIN, V127, P340, DOI 10.1093/brain/awh041; Sage CA, 2007, NEUROIMAGE, V34, P486, DOI 10.1016/j.neuroimage.2006.09.025; Salvador R, 2007, NEUROIMAGE, V35, P83, DOI 10.1016/j.neuroimage.2006.12.001; Schoenfeld MA, 2005, J NEUROL, V252, P944, DOI 10.1007/s00415-005-0787-y; Seeley WW, 2009, NEURON, V62, P42, DOI 10.1016/j.neuron.2009.03.024; Senda J, 2009, AMYOTROPH LATERAL SC, V10, P288, DOI 10.3109/17482960802651717; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Stam Cornelis J, 2007, Nonlinear Biomed Phys, V1, P3, DOI 10.1186/1753-4631-1-3; Stanton BR, 2007, J NEUROL, V254, P1260, DOI 10.1007/s00415-006-0513-4; Tessitore A, 2006, BRAIN RES BULL, V69, P489, DOI 10.1016/j.brainresbull.2006.01.013; Thivard L, 2007, J NEUROL NEUROSUR PS, V78, P889, DOI 10.1136/jnnp.2006.101758; Turner MR, 2007, AMYOTROPH LATERAL SC, V8, P343, DOI 10.1080/17482960701538734; van den Heuvel MP, 2008, NEUROIMAGE, V43, P528, DOI 10.1016/j.neuroimage.2008.08.010; van den Heuvel M, 2008, J NEUROSCI, V28, P10844, DOI 10.1523/JNEUROSCI.2964-08.2008; van den Heuvel MP, 2009, HUM BRAIN MAPP, V30, P3127, DOI 10.1002/hbm.20737; van den Heuvel MP, 2009, J NEUROSCI, V29, P7619, DOI 10.1523/JNEUROSCI.1443-09.2009; van der Schot AC, 2009, ARCH GEN PSYCHIAT, V66, P142, DOI 10.1001/archgenpsychiatry.2008.541; Vucic S, 2008, BRAIN, V131, P1540, DOI 10.1093/brain/awn071; Vucic S, 2009, EXP NEUROL, V220, P177, DOI 10.1016/j.expneurol.2009.08.017; Wahl M, 2007, J NEUROSCI, V27, P12132, DOI 10.1523/JNEUROSCI.2320-07.2007; Wittstock M, 2007, CLIN NEUROPHYSIOL, V118, P301, DOI 10.1016/j.clinph.2006.09.026; Zhou J, 2010, BRAIN, V133, P1352, DOI 10.1093/brain/awq075	68	133	137	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2010	5	10							e13664	10.1371/journal.pone.0013664	http://dx.doi.org/10.1371/journal.pone.0013664			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671UN	21060689	Green Published, Green Submitted, gold			2022-12-27	WOS:000283537000033
J	Oude Griep, LM; Geleijnse, JM; Kromhout, D; Ocke, MC; Verschuren, WMM				Oude Griep, Linda M.; Geleijnse, Johanna M.; Kromhout, Daan; Ocke, Marga C.; Verschuren, W. M. Monique			Raw and Processed Fruit and Vegetable Consumption and 10-Year Coronary Heart Disease Incidence in a Population-Based Cohort Study in the Netherlands	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; ANTIOXIDANT VITAMINS; BLOOD-PRESSURE; DIETARY FIBER; RELATIVE VALIDITY; POOLED ANALYSIS; METAANALYSIS; RISK; PREVENTION; MORTALITY	Background: Prospective cohort studies have shown that high fruit and vegetable consumption is inversely associated with coronary heart disease (CHD). Whether food processing affects this association is unknown. Therefore, we quantified the association of fruit and vegetable consumption with 10-year CHD incidence in a population-based study in the Netherlands and the effect of processing on these associations. Methods: Prospective population-based cohort study, including 20,069 men and women aged 20 to 65 years, enrolled between 1993 and 1997 and free of cardiovascular disease at baseline. Diet was assessed using a validated 178-item food frequency questionnaire. Hazard ratios (HR) were calculated for CHD incidence using multivariable Cox proportional hazards models. Results: During a mean follow-up time of 10.5y, 245 incident cases of CHD were documented, which comprised 211 non-fatal acute myocardial infarctions and 34 fatal CHD events. The risk of CHD incidence was 34% lower for participants with a high intake of total fruit and vegetables (>475 g/d; HR: 0.66; 95% CI: 0.45-0.99) compared to participants with a low total fruit and vegetable consumption (<= 241 g/d). Intake of raw fruit and vegetables (>262 g/d vs <= 92 g/d; HR: 0.70; 95% CI: 0.47-1.04) as well as processed fruit and vegetables (>234 g/d vs <= 113 g/d; HR: 0.79; 95% CI: 0.54-1.16) were inversely related with CHD incidence. Conclusion: Higher consumption of fruit and vegetables, whether consumed raw or processed, may protect against CHD incidence.	[Oude Griep, Linda M.; Geleijnse, Johanna M.; Kromhout, Daan] Wageningen Univ, Div Human Nutr, Wageningen, Netherlands; [Ocke, Marga C.; Verschuren, W. M. Monique] Natl Inst Publ Hlth & Environm, NL-3720 BA Bilthoven, Netherlands	Wageningen University & Research; Netherlands National Institute for Public Health & the Environment	Oude Griep, LM (corresponding author), Wageningen Univ, Div Human Nutr, Wageningen, Netherlands.	Linda.oudegriep@wur.nl	Geleijnse, Johanna Marianna M/B-5749-2012; Kromhout, Daan/A-8566-2014; Oude Griep, Linda/M-5112-2013	Geleijnse, Johanna Marianna M/0000-0001-7638-0589; Oude Griep, Linda/0000-0001-7697-7473	Product Board for Horticulture, Zoetermeer, the Netherlands [13281]; Ministry of Health, Welfare and Sport of the Netherlands; National Institute of Public Health and the Environment, Bilthoven, the Netherlands; European Union	Product Board for Horticulture, Zoetermeer, the Netherlands(Netherlands Government); Ministry of Health, Welfare and Sport of the Netherlands; National Institute of Public Health and the Environment, Bilthoven, the Netherlands(Netherlands Government); European Union(European Commission)	Dr. Geleijnse obtained an unrestricted grant (13281) from the Product Board for Horticulture, Zoetermeer, the Netherlands, to cover the costs of data-analysis for the present study. The other authors report no financial disclosures. The Monitoring Project on Risk Factors and chronic diseases in the Netherlands (MORGEN) Study was supported by the Ministry of Health, Welfare and Sport of the Netherlands, the National Institute of Public Health and the Environment, Bilthoven, the Netherlands and the Europe Against Cancer Program of the European Union. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1992, INT CLASS DIS; Appel LJ, 1997, NEW ENGL J MED, V336, P1117, DOI 10.1056/NEJM199704173361601; Brown L, 1999, AM J CLIN NUTR, V69, P30; Colin-Henrion M, 2009, FOOD CHEM, V117, P254, DOI 10.1016/j.foodchem.2009.03.109; Danesi F, 2008, J FOOD SCI, V73, pH109, DOI 10.1111/j.1750-3841.2008.00826.x; Dauchet L, 2004, BRIT J NUTR, V92, P963, DOI 10.1079/BJN20041286; Dauchet L, 2006, J NUTR, V136, P2588, DOI 10.1093/jn/136.10.2588; DEBRUIN A, 2003, LINKING DATA NATL AM; Eichholzer M, 2001, INT J VITAM NUTR RES, V71, P5, DOI 10.1024/0300-9831.71.1.5; Flood-Obbagy JE, 2009, APPETITE, V52, P416, DOI 10.1016/j.appet.2008.12.001; Gartner C, 1997, AM J CLIN NUTR, V66, P116; Gaziano J. Michael, 1995, Annals of Epidemiology, V5, P255, DOI 10.1016/1047-2797(94)00090-G; He FJ, 2007, J HUM HYPERTENS, V21, P717, DOI 10.1038/sj.jhh.1002212; HOEVENAARBLOM MP, 2010, EUR J CARDIOVASC PRE; Hof KHV, 2000, J NUTR, V130, P503; Homero-Mendez D, 2007, INNOV FOOD SCI EMERG, V8, P407, DOI 10.1016/j.ifset.2007.03.014; Hung HC, 2004, JNCI-J NATL CANCER I, V96, P1577, DOI 10.1093/jnci/djh296; Huxley RR, 2003, EUR J CLIN NUTR, V57, P904, DOI 10.1038/sj.ejcn.1601624; Jacobs DR, 2009, AM J CLIN NUTR, V89, pS1543, DOI 10.3945/ajcn.2009.26736B; Jansen MCJF, 2004, EUR J CLIN NUTR, V58, P1386, DOI 10.1038/sj.ejcn.1601981; Joshipura KJ, 2001, ANN INTERN MED, V134, P1106, DOI 10.7326/0003-4819-134-12-200106190-00010; Key TJA, 1996, BMJ-BRIT MED J, V313, P775, DOI 10.1136/bmj.313.7060.775; Knekt P, 2004, AM J CLIN NUTR, V80, P1508, DOI 10.1093/ajcn/80.6.1508; Kohlmeier L, 1997, AM J EPIDEMIOL, V146, P618, DOI 10.1093/oxfordjournals.aje.a009327; Melse-Boonstra A, 2004, AM J CLIN NUTR, V79, P424; Melse-Boonstra A, 2002, J AGR FOOD CHEM, V50, P3473, DOI 10.1021/jf0112318; Merry AHH, 2009, EUR J EPIDEMIOL, V24, P237, DOI 10.1007/s10654-009-9335-x; *NETH NUTR CTR, 1996, NETH FOOD COMP DAT; Obarzanek E, 2001, AM J CLIN NUTR, V74, P80; Ocke MC, 1997, INT J EPIDEMIOL, V26, pS37, DOI 10.1093/ije/26.suppl_1.S37; Ocke MC, 1997, INT J EPIDEMIOL, V26, pS49, DOI 10.1093/ije/26.suppl_1.S49; Paran E, 2009, CARDIOVASC DRUG THER, V23, P145, DOI 10.1007/s10557-008-6155-2; Pereira MA, 2004, ARCH INTERN MED, V164, P370, DOI 10.1001/archinte.164.4.370; Pols MA, 1997, INT J EPIDEMIOL, V26, pS181, DOI 10.1093/ije/26.suppl_1.S181; Rao AV, 1999, NUTR RES, V19, P305, DOI 10.1016/S0271-5317(98)00193-6; Riboli E, 1997, INT J EPIDEMIOL, V26, pS6, DOI 10.1093/ije/26.suppl_1.S6; Rickman JC, 2007, J SCI FOOD AGR, V87, P930, DOI 10.1002/jsfa.2825; Ruiz-Rodriguez Alejandro, 2008, Phytochemistry Reviews, V7, P345, DOI 10.1007/s11101-007-9073-1; Ruxton CHS, 2006, INT J FOOD SCI NUTR, V57, P249, DOI 10.1080/09637480600858134; Sesso HD, 2008, JAMA-J AM MED ASSOC, V300, P2123, DOI 10.1001/jama.2008.600; Streppel MT, 2005, ARCH INTERN MED, V165, P150, DOI 10.1001/archinte.165.2.150; Thygesen K, 2007, CIRCULATION, V116, P2634, DOI 10.1161/CIRCULATIONAHA.107.187397; Verschuren WMM, 2008, INT J EPIDEMIOL, V37, P1236, DOI 10.1093/ije/dym292; Vivekananthan DP, 2003, LANCET, V361, P2017, DOI 10.1016/S0140-6736(03)13637-9; Whelton PK, 1997, JAMA-J AM MED ASSOC, V277, P1624, DOI 10.1001/jama.277.20.1624; World Health Organization, 1977, INT CLASS DIS; Ye Z, 2008, EUR J CARDIOV PREV R, V15, P26, DOI 10.1097/HJR.0b013e3282f11f95	47	66	68	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2010	5	10							e13609	10.1371/journal.pone.0013609	http://dx.doi.org/10.1371/journal.pone.0013609			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	670LB	21049053	Green Submitted, Green Published, gold			2022-12-27	WOS:000283422100016
J	Lorenzetti, MA; De Matteo, E; Gass, H; Vazquez, PM; Lara, J; Gonzalez, P; Preciado, MV; Chabay, PA				Lorenzetti, Mario A.; De Matteo, Elena; Gass, Hugo; Martinez Vazquez, Paula; Lara, Julia; Gonzalez, Pedro; Victoria Preciado, Maria; Chabay, Paola A.			Characterization of Epstein Barr Virus Latency Pattern in Argentine Breast Carcinoma	PLOS ONE			English	Article							GENE-EXPRESSION; VIRAL CARCINOGENESIS; GASTRIC-CARCINOMA; EPITHELIAL-CELLS; EBV INFECTION; HUMAN CANCERS; RISK-FACTORS; ASSOCIATION; DISEASE; PROTEIN	Introduction: Epstein-Barr virus (EBV)-associated tumors show different expression patterns of latency genes. Since in breast carcinoma this pattern is not yet fully described, our aim was to characterize EBV latency pattern in our EBV positive breast carcinoma series. Methods: The study was conducted on 71 biopsies of breast carcinoma and in 48 non-neoplastic breast controls. EBNA1, LMP2A and LMP1 expression was assessed by immunohistochemistry with monoclonal antibodies, while viral genomic DNA and EBERs RNA transcripts expression was performed by in situ hybridization. EBV presence was confirmed by PCR. Results: EBV genomic DNA and EBNA1 expression were detected in 31% (22/71) of patients specifically restricted to tumor epithelial cells in breast carcinoma while all breast control samples were negative for both viral DNA and EBNA1 protein. LMP2A was detected in 73% of EBNA1 positive cases, none of which expressed either LMP1 protein or EBERs transcripts. Conclusions: These findings suggest that EBV expression pattern in the studied biopsies could be different from those previously observed in breast carcinoma cell lines and lead us to suggest a new, EBNA1, LMP2A positive and LMP1 and EBERs negative latency profile in breast carcinoma in our population.	[Lorenzetti, Mario A.; Lara, Julia; Victoria Preciado, Maria; Chabay, Paola A.] Ricardo Gutierrez Children Hosp, Mol Biol Lab, Div Pathol, Buenos Aires, Argentina; [De Matteo, Elena] Ricardo Gutierrez Children Hosp, Div Pathol, Buenos Aires, DF, Argentina; [Gass, Hugo; Martinez Vazquez, Paula] Magdalena Villegas de Martinez Hosp, Gynecol Div, Tigre, Prov Buenos Air, Argentina; [Gonzalez, Pedro] Magdalena Villegas de Martinez Hosp, Div Pathol, Tigre, Prov Buenos Air, Argentina	Hospital de Ninos Doctor Ricardo Gutierrez; Hospital de Ninos Doctor Ricardo Gutierrez	Lorenzetti, MA (corresponding author), Ricardo Gutierrez Children Hosp, Mol Biol Lab, Div Pathol, Buenos Aires, Argentina.	marioloren@yahoo.com.ar	Lorenzetti, Mario Alejandro/O-8976-2019	Lorenzetti, Mario Alejandro/0000-0002-9434-399X; Preciado, Maria Victoria/0000-0003-4082-0698	National Agency for Science and Technology Promotion [1071]; National Research Council (CONICET)	National Agency for Science and Technology Promotion; National Research Council (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This study was partially supported by a grant from National Agency for Science and Technology Promotion (PICT 2007 No 1071). M.L. is supported by a fellowship from the National Research Council (CONICET), P.A.Ch. and M.V.P. are members of the National Research Council (CONICET), Research Career Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AM JOINT COMM CAN, 2007, CANC STAG MAN; Arbach H, 2006, J VIROL, V80, P845, DOI 10.1128/JVI.80.2.845-853.2006; Bonnet M, 1999, J NATL CANCER I, V91, P1376, DOI 10.1093/jnci/91.16.1376; Brink AATP, 2000, J NATL CANCER I, V92, P655, DOI 10.1093/jnci/92.8.655; Butel JS, 2000, CARCINOGENESIS, V21, P405, DOI 10.1093/carcin/21.3.405; Chan KH, 2001, J CLIN VIROL, V21, P57, DOI 10.1016/S1386-6532(01)00149-4; Chu PGG, 2001, AM J PATHOL, V159, P571, DOI 10.1016/S0002-9440(10)61728-2; Cohen JI, 2000, NEW ENGL J MED, V343, P481, DOI 10.1056/NEJM200008173430707; Delecluse HJ, 2007, J CLIN PATHOL, V60, P1358, DOI 10.1136/jcp.2006.044586; Deshpande CG, 2002, LAB INVEST, V82, P1193, DOI 10.1097/01.LAB.0000029150.90532.24; Fawzy S, 2008, CLIN BIOCHEM, V41, P486, DOI 10.1016/j.clinbiochem.2007.12.017; Fukuda M, 2007, J VIROL, V81, P9299, DOI 10.1128/JVI.00537-07; Gan YJ, 2002, AM J PATHOL, V160, P781, DOI 10.1016/S0002-9440(10)64900-0; Glaser SL, 2004, CANCER EPIDEM BIOMAR, V13, P688; Grinstein S, 2002, CANCER RES, V62, P4876; Hennard C, 2006, J PATHOL, V209, P430, DOI 10.1002/path.1996; Herrmann K, 2003, BREAST CANCER RES, V5, DOI 10.1186/bcr561; IMAI S, 1994, P NATL ACAD SCI USA, V91, P9131, DOI 10.1073/pnas.91.19.9131; Joshi D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008180; Kuppers R, 2003, NAT REV IMMUNOL, V3, P801, DOI 10.1038/nri1201; LESPAGNARD L, 1995, AM J CLIN PATHOL, V103, P449; Lin JH, 2007, J VIROL, V81, P5705, DOI 10.1128/JVI.00076-07; LONGNECKER R, 1998, HUMAN TUMOR VIRUSES, P135; Lu J, 2006, J BIOL CHEM, V281, P8806, DOI 10.1074/jbc.M507305200; MADIGAN MP, 1995, J NATL CANCER I, V87, P1681, DOI 10.1093/jnci/87.22.1681; Martin AM, 2000, JNCI-J NATL CANCER I, V92, P1126, DOI 10.1093/jnci/92.14.1126; Morrison JA, 2003, J VIROL, V77, P12276, DOI 10.1128/JVI.77.22.12276-12284.2003; Murray PG, 2003, CANCER RES, V63, P2338; Preciado MV, 2005, ARCH PATHOL LAB MED, V129, P377; Ribeiro-Silva A, 2004, BRAZ J MED BIOL RES, V37, P89, DOI 10.1590/S0100-879X2004000100013; Rickinson AB, 2007, FIELDS VIROLOGY, V5, P2655; RIES L, 2002, CANC STAT REV BETHES, P1973; Rowe M, 2009, SEMIN CANCER BIOL, V19, P377, DOI 10.1016/j.semcancer.2009.07.004; Stewart S, 2004, P NATL ACAD SCI USA, V101, P15730, DOI 10.1073/pnas.0402135101; Sugiura M, 1996, BRIT J CANCER, V74, P625, DOI 10.1038/bjc.1996.412; Thorley-Lawson DA, 2004, NEW ENGL J MED, V350, P1328, DOI 10.1056/NEJMra032015; Thorley-Lawson DA, 2008, TRENDS IMMUNOL, V29, P195, DOI 10.1016/j.it.2008.01.006; Uozaki H, 2008, INT J CLIN EXP PATHO, V1, P198; Xue SA, 2003, BRIT J CANCER, V89, P113, DOI 10.1038/sj.bjc.6601027; Young LS, 2004, NAT REV CANCER, V4, P757, DOI 10.1038/nrc1452; zur Hausen A, 2000, CANCER RES, V60, P2745; zur Hausen H, 2009, VIROLOGY, V392, P1, DOI 10.1016/j.virol.2009.06.001	42	31	31	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2010	5	10							e13603	10.1371/journal.pone.0013603	http://dx.doi.org/10.1371/journal.pone.0013603			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	670KA	21042577	Green Submitted, Green Published, gold			2022-12-27	WOS:000283419100023
J	Xiao, SY; Manley, NR				Xiao, Shiyun; Manley, Nancy R.			Impaired Thymic Selection and Abnormal Antigen-Specific T Cell Responses in Foxn1(Delta/Delta) Mutant Mice	PLOS ONE			English	Article							THYMOCYTE POSITIVE SELECTION; EPITHELIAL-CELLS; IN-VIVO; PERIPHERAL TOLERANCE; NEGATIVE SELECTION; DEFICIENT MICE; ORAL ANTIGEN; DIFFERENTIATION; PROGENITORS; FIBROBLASTS	Background: Foxn1(Delta/Delta) mutant mice have a specific defect in thymic development, characterized by a block in TEC differentiation at an intermediate progenitor stage, and blocks in thymocyte development at both the DN1 and DP cell stages, resulting in the production of abnormally functioning T cells that develop from an atypical progenitor population. In the current study, we tested the effects of these defects on thymic selection. Methodology/Principal Findings: We used Foxn1(Delta/Delta); DO11 Tg and Foxn1(Delta/Delta); OT1 Tg mice as positive selection and Foxn1(Delta/Delta); MHCII I-E mice as negative selection models. We also used an in vivo system of antigen-specific reactivity to test the function of peripheral T cells. Our data show that the capacity for positive and negative selection of both CD4 and CD8 SP thymocytes was reduced in Foxn1(Delta/Delta) mutants compared to Foxn1(+/Delta) control mice. These defects were associated with reduction of both MHC Class I and Class II expression, although the resulting peripheral T cells have a broad TCR V beta repertoire. In this deficient thymic environment, immature CD4 and CD8 SP thymocytes emigrate from the thymus into the periphery. These T cells had an incompletely activated profile under stimulation of the TCR signal in vitro, and were either hypersensitive or hyporesponsive to antigen-specific stimulation in vivo. These cell-autonomous defects were compounded by the hypocellular peripheral environment caused by low thymic output. Conclusions/Significance: These data show that a primary defect in the thymic microenvironment can cause both direct defects in selection which can in turn cause indirect effects on the periphery, exacerbating functional defects in T cells.	[Xiao, Shiyun; Manley, Nancy R.] Univ Georgia, Dept Genet, Coverdell Ctr, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Xiao, SY (corresponding author), Univ Georgia, Dept Genet, Coverdell Ctr, Athens, GA 30602 USA.	shiyun@uga.edu			National Institute of Allergy and Infectious Diseases (NIAID) at the National Institutes of Health (NIH) [AI055001]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI055001] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID) at the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a grant to N.R.M. from the National Institute of Allergy and Infectious Diseases (NIAID) at the National Institutes of Health (NIH). Grant No. is AI055001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON G, 1994, J EXP MED, V179, P2027, DOI 10.1084/jem.179.6.2027; Anderson G, 2001, NAT REV IMMUNOL, V1, P31, DOI 10.1038/35095500; ANDERSON G, 1993, NATURE, V362, P70, DOI 10.1038/362070a0; Bateman HE, 1999, J RHEUMATOL, V26, P2482; Blackburn CC, 1996, P NATL ACAD SCI USA, V93, P5742, DOI 10.1073/pnas.93.12.5742; CARDELL S, 1995, J EXP MED, V182, P993, DOI 10.1084/jem.182.4.993; Chen LZ, 2009, BLOOD, V113, P567, DOI 10.1182/blood-2008-05-156265; CHEN YH, 1995, NATURE, V376, P177, DOI 10.1038/376177a0; COSGROVE D, 1992, INT IMMUNOL, V4, P707, DOI 10.1093/intimm/4.6.707; DeKoning J, 1997, J IMMUNOL, V158, P2558; FOWLKES BJ, 1995, CURR OPIN IMMUNOL, V7, P188, DOI 10.1016/0952-7915(95)80003-4; Gordon J, 2004, NAT IMMUNOL, V5, P546, DOI 10.1038/ni1064; HUGO P, 1993, P NATL ACAD SCI USA, V90, P10335, DOI 10.1073/pnas.90.21.10335; HUGO P, 1992, NATURE, V360, P679, DOI 10.1038/360679a0; Itoi M, 2001, INT IMMUNOL, V13, P1203, DOI 10.1093/intimm/13.9.1203; Itoi M, 2007, INT IMMUNOL, V19, P127, DOI 10.1093/intimm/dxl129; Jameson SC, 1998, CURR OPIN IMMUNOL, V10, P214, DOI 10.1016/S0952-7915(98)80251-3; JENKINSON EJ, 1992, J EXP MED, V176, P845, DOI 10.1084/jem.176.3.845; KAPPLER JW, 1987, CELL, V49, P273, DOI 10.1016/0092-8674(87)90568-X; KEARNEY ER, 1994, IMMUNITY, V1, P327, DOI 10.1016/1074-7613(94)90084-1; Kishimoto H, 1997, J EXP MED, V185, P263, DOI 10.1084/jem.185.2.263; Kurts C, 1999, P NATL ACAD SCI USA, V96, P12703, DOI 10.1073/pnas.96.22.12703; Laufer TM, 1996, NATURE, V383, P81, DOI 10.1038/383081a0; McCaughtry TM, 2007, J EXP MED, V204, P2513, DOI 10.1084/jem.20070601; MCCORMACK JE, 1994, J IMMUNOL, V180, P7305; Nehls M, 1996, SCIENCE, V272, P886, DOI 10.1126/science.272.5263.886; NEHLS M, 1994, NATURE, V372, P103, DOI 10.1038/372103a0; Ortman CL, 2002, INT IMMUNOL, V14, P813, DOI 10.1093/intimm/dxf042; PAWLOWSKI T, 1993, NATURE, V364, P642, DOI 10.1038/364642a0; Peacock CD, 2003, J IMMUNOL, V171, P655, DOI 10.4049/jimmunol.171.2.655; Saijo K, 1997, J EXP MED, V185, P351, DOI 10.1084/jem.185.2.351; SCOLLAY R, 1995, IMMUNOL TODAY, V16, P268, DOI 10.1016/0167-5699(95)80179-0; Shakib S, 2009, J IMMUNOL, V182, P130, DOI 10.4049/jimmunol.182.1.130; Su DM, 2003, NAT IMMUNOL, V4, P1128, DOI 10.1038/ni983; Sun JB, 1999, J IMMUNOL, V163, P1045; Thorstenson KM, 2001, J IMMUNOL, V167, P188, DOI 10.4049/jimmunol.167.1.188; VUKMANOVIC S, 1992, NATURE, V359, P729, DOI 10.1038/359729a0; Winstead CJ, 2008, J IMMUNOL, V180, P7305, DOI 10.4049/jimmunol.180.11.7305; Xiao SY, 2008, J IMMUNOL, V180, P914, DOI 10.4049/jimmunol.180.2.914; Xiao SY, 2007, J IMMUNOL, V179, P8153, DOI 10.4049/jimmunol.179.12.8153; Yamazaki S, 2006, IMMUNOL REV, V212, P314, DOI 10.1111/j.0105-2896.2006.00422.x; Zhang XM, 2001, J IMMUNOL, V167, P4245, DOI 10.4049/jimmunol.167.8.4245	42	4	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2010	5	11							e15396	10.1371/journal.pone.0015396	http://dx.doi.org/10.1371/journal.pone.0015396			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675NY	21079757	Green Published, Green Submitted, gold			2022-12-27	WOS:000283838600025
J	Pavlopoulou, A; Pampalakis, G; Michalopoulos, I; Sotiropoulou, G				Pavlopoulou, Athanasia; Pampalakis, Georgios; Michalopoulos, Ioannis; Sotiropoulou, Georgia			Evolutionary History of Tissue Kallikreins	PLOS ONE			English	Article							PROSTATE-SPECIFIC ANTIGEN; MULTIPLE PROTEIN-SEQUENCE; SERINE PROTEASES; GENE FAMILY; PROTEOLYTIC CASCADE; NETHERTON-SYNDROME; MOLECULAR-CLONING; CRYSTAL-STRUCTURE; WEB SERVER; E-CADHERIN	The gene family of human kallikrein-related peptidases (KLKs) encodes proteins with diverse and pleiotropic functions in normal physiology as well as in disease states. Currently, the most widely known KLK is KLK3 or prostate-specific antigen (PSA) that has applications in clinical diagnosis and monitoring of prostate cancer. The KLK gene family encompasses the largest contiguous cluster of serine proteases in humans which is not interrupted by non-KLK genes. This exceptional and unique characteristic of KLKs makes them ideal for evolutionary studies aiming to infer the direction and timing of gene duplication events. Previous studies on the evolution of KLKs were restricted to mammals and the emergence of KLKs was suggested about 150 million years ago (mya). In order to elucidate the evolutionary history of KLKs, we performed comprehensive phylogenetic analyses of KLK homologous proteins in multiple genomes including those that have been completed recently. Interestingly, we were able to identify novel reptilian, avian and amphibian KLK members which allowed us to trace the emergence of KLKs 330 mya. We suggest that a series of duplication and mutation events gave rise to the KLK gene family. The prominent feature of the KLK family is that it consists of tandemly and uninterruptedly arrayed genes in all species under investigation. The chromosomal co-localization in a single cluster distinguishes KLKs from trypsin and other trypsin-like proteases which are spread in different genetic loci. All the defining features of the KLKs were further found to be conserved in the novel KLK protein sequences. The study of this unique family will further assist in selecting new model organisms for functional studies of proteolytic pathways involving KLKs.	[Pavlopoulou, Athanasia; Pampalakis, Georgios; Sotiropoulou, Georgia] Univ Patras, Dept Pharm, Sch Hlth Sci, Rion, Greece; [Michalopoulos, Ioannis] Acad Athens, Biomed Res Fdn, Athens, Greece	University of Patras; Academy of Athens	Pavlopoulou, A (corresponding author), Univ Patras, Dept Pharm, Sch Hlth Sci, Rion, Greece.	gdsotiro@upatras.gr	, 0000-0001-8991-8712/S-4398-2016; Pavlopoulou, Athanasia/AAH-1204-2020; Pavlopoulou, Athanasia/ABB-3275-2021	, 0000-0001-8991-8712/0000-0001-8991-8712; Pavlopoulou, Athanasia/0000-0002-0815-3808	Research Committee (ELKE) of the University of Patras [C.186]	Research Committee (ELKE) of the University of Patras	The authors acknowledge financial support by K. Karatheodoris grant (C.186) funded by the Research Committee (ELKE) of the University of Patras (http://www.upatras.gr/index/page/id/70/lang/en). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hashimi N, 2009, J MOL EVOL, V69, P635, DOI 10.1007/s00239-009-9302-x; ALHASHIMI N, 2010, MOL BIOL EV IN PRESS; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Aminetzach YT, 2009, CURR BIOL, V19, P1925, DOI 10.1016/j.cub.2009.09.022; Bairoch A, 2005, NUCLEIC ACIDS RES, V33, pD154, DOI 10.1093/nar/gki070; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Bernett MJ, 2002, J BIOL CHEM, V277, P24562, DOI 10.1074/jbc.M202392200; Bonnart C, 2010, J CLIN INVEST, V120, P871, DOI 10.1172/JCI41440; Borgono CA, 2004, NAT REV CANCER, V4, P876, DOI 10.1038/nrc1474; Borgono CA, 2007, J BIOL CHEM, V282, P3640, DOI 10.1074/jbc.M607567200; Brattsand M, 2005, J INVEST DERMATOL, V124, P198, DOI 10.1111/j.0022-202X.2004.23547.x; Carvalho AL, 2002, J MOL BIOL, V322, P325, DOI 10.1016/S0022-2836(02)00705-2; Caubet C, 2004, J INVEST DERMATOL, V122, P1235, DOI 10.1111/j.0022-202X.2004.22512.x; CHAPDELAINE P, 1991, DNA CELL BIOL, V10, P49, DOI 10.1089/dna.1991.10.49; Cheng HT, 2007, BIOINFORMATICS, V23, P2628, DOI 10.1093/bioinformatics/btm379; Cheng J, 2005, NUCLEIC ACIDS RES, V33, pW72, DOI 10.1093/nar/gki396; Clark NL, 2005, PLOS GENET, V1, P335, DOI 10.1371/journal.pgen.0010035; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; de Castro E, 2006, NUCLEIC ACIDS RES, V34, pW362, DOI 10.1093/nar/gkl124; Debela M, 2007, J MOL BIOL, V373, P1017, DOI 10.1016/j.jmb.2007.08.042; Descargues P, 2005, NAT GENET, V37, P56, DOI 10.1038/ng1493; Dong Y, 2010, CANCER RES, V70, P2624, DOI 10.1158/0008-5472.CAN-09-3415; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Egelrud T, 2005, BRIT J DERMATOL, V153, P1200, DOI 10.1111/j.1365-2133.2005.06834.x; Elliott MB, 2006, GENOMICS, V88, P591, DOI 10.1016/j.ygeno.2006.06.001; EVANS BA, 1987, J BIOL CHEM, V262, P8027; FAHNESTOCK M, 1994, DNA CELL BIOL, V13, P293, DOI 10.1089/dna.1994.13.293; Fantuzzi G, 2005, J ALLERGY CLIN IMMUN, V115, P911, DOI 10.1016/j.jaci.2005.02.023; Fernando SC, 2007, GENOMICS, V89, P429, DOI 10.1016/j.ygeno.2006.11.010; Fiedler F, 1999, BIOL CHEM, V380, P63, DOI 10.1515/BC.1999.008; Fong Jessica H, 2008, BMC Res Notes, V1, P114, DOI 10.1186/1756-0500-1-114; FORSGREN M, 1987, FEBS LETT, V213, P254, DOI 10.1016/0014-5793(87)81501-6; Fujimori H, 1986, Adv Exp Med Biol, V198 Pt A, P219; Galliano MF, 2005, GENOMICS, V85, P483, DOI 10.1016/j.ygeno.2005.01.001; GAUTHIER ER, 1993, BIOCHIM BIOPHYS ACTA, V1174, P207, DOI 10.1016/0167-4781(93)90118-W; GiovanniDeSimone S, 1997, J PROTEIN CHEM, V16, P809, DOI 10.1023/A:1026372018547; Gomis-Ruth FX, 2002, J BIOL CHEM, V277, P27273, DOI 10.1074/jbc.M201534200; Guindon S, 2005, NUCLEIC ACIDS RES, V33, pW557, DOI 10.1093/nar/gki352; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hallstrom BM, 2007, MOL BIOL EVOL, V24, P2059, DOI 10.1093/molbev/msm136; Hart PS, 2004, J MED GENET, V41, P545, DOI 10.1136/jmg.2003.017657; Harvey TJ, 2000, J BIOL CHEM, V275, P37397, DOI 10.1074/jbc.M004525200; Hubbard TJP, 2009, NUCLEIC ACIDS RES, V37, pD690, DOI 10.1093/nar/gkn828; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; Jensen-Seaman MI, 2003, J MOL EVOL, V57, P261, DOI 10.1007/s00239-003-2474-x; KARR JF, 1995, CANCER RES, V55, P2455; KIM WS, 1991, J BIOL CHEM, V266, P19283; Kita M, 2004, P NATL ACAD SCI USA, V101, P7542, DOI 10.1073/pnas.0402517101; Kita M, 2009, J AM CHEM SOC, V131, P18038, DOI 10.1021/ja908148z; Klucky B, 2007, CANCER RES, V67, P8198, DOI 10.1158/0008-5472.CAN-07-0607; Knudsen B, 2001, P NATL ACAD SCI USA, V98, P14512, DOI 10.1073/pnas.251526398; Komatsu N, 2002, J INVEST DERMATOL, V118, P436, DOI 10.1046/j.0022-202x.2001.01663.x; Kong HJ, 2009, FISH SHELLFISH IMMUN, V27, P486, DOI 10.1016/j.fsi.2009.06.022; Kroon Evert, 1997, Genes and Function, V1, P309; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; LAWRENCE MG, 2010, ENDOCR REV IN PRESS; Laxmikanthan G, 2005, PROTEINS, V58, P802, DOI 10.1002/prot.20368; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; Letunic I, 2009, NUCLEIC ACIDS RES, V37, pD229, DOI 10.1093/nar/gkn808; Lilja H, 2008, NAT REV CANCER, V8, P268, DOI 10.1038/nrc2351; Lillywhite HB, 2006, J EXP BIOL, V209, P202, DOI 10.1242/jeb.02007; LIN FK, 1993, BIOCHIM BIOPHYS ACTA, V1173, P325, DOI 10.1016/0167-4781(93)90131-V; Lovgren J, 1997, BIOCHEM BIOPH RES CO, V238, P549, DOI 10.1006/bbrc.1997.7333; Lundwall A, 2008, CELL MOL LIFE SCI, V65, P2019, DOI 10.1007/s00018-008-8024-3; Lundwall A, 2006, BIOL CHEM, V387, P637, DOI 10.1515/BC.2006.082; LUNDWALL A, 1995, FEBS LETT, V374, P53, DOI 10.1016/0014-5793(95)01076-Q; Marchler-Bauer A, 2009, NUCLEIC ACIDS RES, V37, pD205, DOI 10.1093/nar/gkn845; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Miriam F-F, 2010, BIOCHIM BIOPHYS ACTA, V1803, P3, DOI DOI 10.1016/J.BBAMCR.2009.07.004; Nikolaev S, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030002; Oikonomopoulou K, 2006, J BIOL CHEM, V281, P32095, DOI 10.1074/jbc.M513138200; Olsson AY, 2004, GENE, V343, P347, DOI 10.1016/j.gene.2004.09.020; Olsson AY, 2004, GENOMICS, V84, P147, DOI 10.1016/j.ygeno.2004.01.009; Olsson AY, 2002, BIOCHEM BIOPH RES CO, V299, P305; Pampalakis G, 2008, COMPUT BIOL CHEM, V32, P111, DOI 10.1016/j.compbiolchem.2007.11.002; Pampalakis G, 2007, BBA-REV CANCER, V1776, P22, DOI 10.1016/j.bbcan.2007.06.001; Pampalakis G, 2009, CANCER RES, V69, P3779, DOI 10.1158/0008-5472.CAN-08-1976; Pei JM, 2008, NUCLEIC ACIDS RES, V36, pW30, DOI 10.1093/nar/gkn322; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; Pollastri G, 2005, BIOINFORMATICS, V21, P1719, DOI 10.1093/bioinformatics/bti203; Puente XS, 2004, GENOME RES, V14, P609, DOI 10.1101/gr.1946304; Quaranta A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007699; Quesada V, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-220; ROSEN BS, 1989, SCIENCE, V244, P1483, DOI 10.1126/science.2734615; Sales KU, 2010, NAT GENET, V42, P676, DOI 10.1038/ng.629; Schmidt AE, 2004, J BIOL CHEM, V279, P29485, DOI 10.1074/jbc.M402971200; Scordis P, 1999, BIOINFORMATICS, V15, P799, DOI 10.1093/bioinformatics/15.10.799; Shaw JLV, 2007, J PROTEOME RES, V6, P2859, DOI 10.1021/pr0701658; Shaw JLV, 2007, CLIN CHEM, V53, P1423, DOI 10.1373/clinchem.2007.088104; Shaw JLV, 2008, BIOL CHEM, V389, P1513, DOI 10.1515/BC.2008.171; Simmer JP, 2009, J BIOL CHEM, V284, P19110, DOI 10.1074/jbc.M109.013623; Sotiropoulou G, 2003, ONCOL RES, V13, P381; Sotiropoulou G, 2009, J BIOL CHEM, V284, P32989, DOI 10.1074/jbc.R109.027946; Tian X, 2009, BIOL REPROD, V80, P616, DOI 10.1095/biolreprod.108.073684; Veveris-Lowe TL, 2005, ENDOCR-RELAT CANCER, V12, P631, DOI 10.1677/erc.1.00958; Warren WC, 2008, NATURE, V453, P175, DOI 10.1038/nature06936; Warren WC, 2010, NATURE, V464, P757, DOI 10.1038/nature08819; Wheeler DL, 2006, NUCLEIC ACIDS RES, V34, pD173, DOI 10.1093/nar/gkj158; WINES DR, 1989, J BIOL CHEM, V264, P7653; WOLFSBERG TG, 2007, CURR PROTOC BIOINFOR, pCH1; Yoon H, 2009, BIOL CHEM, V390, P373, DOI 10.1515/BC.2009.026; Yousef GM, 2004, BRIT J CANCER, V90, P167, DOI 10.1038/sj.bjc.6601451; Yousef GM, 2003, CANCER RES, V63, P2223; Zhang P, 2005, SYST BIOL, V54, P391, DOI 10.1080/10635150590945278	106	52	53	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2010	5	11							e13781	10.1371/journal.pone.0013781	http://dx.doi.org/10.1371/journal.pone.0013781			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673FY	21072173	Green Published, gold, Green Submitted			2022-12-27	WOS:000283645700006
J	Malla, R; Gopinath, S; Alapati, K; Gondi, CS; Gujrati, M; Dinh, DH; Mohanam, S; Rao, JS				Malla, Ramarao; Gopinath, Sreelatha; Alapati, Kiranmai; Gondi, Christopher S.; Gujrati, Meena; Dinh, Dzung H.; Mohanam, Sanjeeva; Rao, Jasti S.			Downregulation of uPAR and Cathepsin B Induces Apoptosis via Regulation of Bcl-2 and Bax and Inhibition of the PI3K/Akt Pathway in Gliomas	PLOS ONE			English	Article							PLASMINOGEN-ACTIVATOR RECEPTOR; RESPONSE ELEMENT; CELL INVASION; TUMOR-GROWTH; TRANSCRIPTION FACTOR; HAIRPIN RNA; UROKINASE; CREB; EXPRESSION; PROTEIN	Background: Glioma is the most commonly diagnosed primary brain tumor and is characterized by invasive and infiltrative behavior. uPAR and cathepsin B are known to be overexpressed in high-grade gliomas and are strongly correlated with invasive cancer phenotypes. Methodology/Principal Findings: In the present study, we observed that simultaneous downregulation of uPAR and cathepsin B induces upregulation of some pro-apoptotic genes and suppression of anti-apoptotic genes in human glioma cells. uPAR and cathepsin B (pCU)-downregulated cells exhibited decreases in the Bcl-2/Bax ratio and initiated the collapse of mitochondrial membrane potential. We also observed that the broad caspase inhibitor, Z-Asp-2, 6-dichlorobenzoyl-methylketone rescued pCU-induced apoptosis in U251 cells but not in 5310 cells. Immunoblot analysis of caspase-9 immunoprecipitates for Apaf-1 showed that uPAR and cathepsin B knockdown activated apoptosome complex formation in U251 cells. Downregulation of uPAR and cathepsin B also retarded nuclear translocation and interfered with DNA binding activity of CREB in both U251 and 5310 cells. Further western blotting analysis demonstrated that downregulation of uPAR and cathepsin B significantly decreased expression of the signaling molecules p-PDGFR-beta, p-PI3K and p-Akt. An increase in the number of TUNEL-positive cells, increased Bax expression, and decreased Bcl-2 expression in nude mice brain tumor sections and brain tissue lysates confirm our in vitro results. Conclusions/Significance: In conclusion, RNAi-mediated downregulation of uPAR and cathepsin B initiates caspase-dependent mitochondrial apoptosis in U251 cells and caspase-independent mitochondrial apoptosis in 5310 cells. Thus, targeting uPAR and cathepsin B-mediated signaling using siRNA may serve as a novel therapeutic strategy for the treatment of gliomas.	[Malla, Ramarao; Gopinath, Sreelatha; Alapati, Kiranmai; Gondi, Christopher S.; Mohanam, Sanjeeva; Rao, Jasti S.] Univ Illinois, Coll Med Peoria, Dept Canc Biol & Pharmacol, Peoria, IL USA; [Gujrati, Meena] Univ Illinois, Coll Med Peoria, Dept Pathol, Peoria, IL USA; [Dinh, Dzung H.; Rao, Jasti S.] Univ Illinois, Coll Med Peoria, Dept Neurosurg, Peoria, IL USA	University of Illinois System; University of Illinois Peoria; University of Illinois System; University of Illinois Peoria; University of Illinois System; University of Illinois Peoria	Malla, R (corresponding author), Univ Illinois, Coll Med Peoria, Dept Canc Biol & Pharmacol, Peoria, IL USA.	jsrao@uic.edu	Malla, Rama/E-2438-2019; Malla, Rama Rao/AAU-8455-2021; Alapati, Kiranmai/F-7171-2013	Malla, Rama/0000-0003-2448-1681; Malla, Rama Rao/0000-0003-2448-1681; 	National Institutes of Health [CA116708, CA75557]; NATIONAL CANCER INSTITUTE [R01CA075557, R01CA116708] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by a grant from National Institutes of Health, CA116708 and CA75557 (to J.S.R.). The contents are solely the responsibility of the authors and do not necessarily represent the official views of NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JM, 2001, TRENDS BIOCHEM SCI, V26, P61, DOI 10.1016/S0968-0004(00)01740-0; Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; Andrisani OM, 1999, CRIT REV EUKAR GENE, V9, P19, DOI 10.1615/CritRevEukaryotGeneExpr.v9.i1.20; Brooks SA, 2010, ACTA HISTOCHEM, V112, P3, DOI 10.1016/j.acthis.2008.11.022; Brunelle JK, 2009, J CELL SCI, V122, P437, DOI 10.1242/jcs.031682; Cho SG, 2002, J BIOCHEM MOL BIOL, V35, P24, DOI 10.5483/BMBRep.2002.35.1.024; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; Cregan SP, 2004, ONCOGENE, V23, P2785, DOI 10.1038/sj.onc.1207517; Creson TK, 2009, J MOL NEUROSCI, V37, P123, DOI 10.1007/s12031-008-9122-2; Dasari VR, 2008, NEUROBIOL DIS, V32, P486, DOI 10.1016/j.nbd.2008.09.005; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Du KY, 1998, J BIOL CHEM, V273, P32377, DOI 10.1074/jbc.273.49.32377; Duronio V, 2008, BIOCHEM J, V415, P333, DOI 10.1042/BJ20081056; Finkbeiner S, 1997, NEURON, V19, P1031, DOI 10.1016/S0896-6273(00)80395-5; Finkbeiner S, 2000, NEURON, V25, P11, DOI 10.1016/S0896-6273(00)80866-1; Fuhrman B, 2009, CARDIOVASC RES, V84, P145, DOI 10.1093/cvr/cvp184; Giovannini Claudio, 2007, Ann Ist Super Sanita, V43, P406; GLADSON CL, 1995, AM J PATHOL, V146, P1150; Gondi CS, 2007, CLIN CANCER RES, V13, P4051, DOI 10.1158/1078-0432.CCR-06-3032; Gondi CS, 2004, NEURON GLIA BIOL, V1, P165, DOI 10.1017/S1740925X04000237; Gondi CS, 2006, MOL CANCER THER, V5, P3197, DOI 10.1158/1535-7163.MCT-05-0531; Gondi CS, 2009, INT J ONCOL, V35, P851, DOI 10.3892/ijo_00000399; Gondi CS, 2004, ONCOGENE, V23, P8486, DOI 10.1038/sj.onc.1207879; GONG JP, 1994, ANAL BIOCHEM, V218, P314, DOI 10.1006/abio.1994.1184; Gopinath S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011668; Gopinath S, 2009, CELL MOL LIFE SCI, V66, P3967, DOI 10.1007/s00018-009-0157-5; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; Hajra KM, 2004, APOPTOSIS, V9, P691, DOI 10.1023/B:APPT.0000045786.98031.1d; Huppertz B, 1999, ANAT EMBRYOL, V200, P1, DOI 10.1007/s004290050254; ISHIZAKI Y, 1995, MOL BIOL CELL, V6, P1443, DOI 10.1091/mbc.6.11.1443; Kane LP, 1999, CURR BIOL, V9, P601, DOI 10.1016/S0960-9822(99)80265-6; Kin Y, 2000, INT J ONCOL, V17, P61; Kiyan J, 2005, EMBO J, V24, P1787, DOI 10.1038/sj.emboj.7600669; Korsmeyer SJ, 1999, CANCER RES, V59, p1693S; Kroemer G, 2000, NAT MED, V6, P513, DOI 10.1038/74994; Lademann U, 2003, MOL CELL BIOL, V23, P7829, DOI 10.1128/MCB.23.21.7829-7837.2003; Lakka SS, 2004, ONCOGENE, V23, P4681, DOI 10.1038/sj.onc.1207616; Lee TJ, 2006, MOL CANCER THER, V5, P2398, DOI 10.1158/1535-7163.MCT-06-0167; Lonze BE, 2002, NEURON, V34, P371, DOI 10.1016/S0896-6273(02)00686-4; Martin S, 2001, J NEURO-ONCOL, V52, P129, DOI 10.1023/A:1010689121904; Mayer B, 2003, NEWS PHYSIOL SCI, V18, P89, DOI 10.1152/nips.01433.2002; Meller R, 2005, J CEREBR BLOOD F MET, V25, P234, DOI 10.1038/sj.jcbfm.9600024; Mohamed MM, 2006, NAT REV CANCER, V6, P764, DOI 10.1038/nrc1949; MOHANAM S, 1993, CANCER RES, V53, P4143; MONTMINY MR, 1987, NATURE, V328, P175, DOI 10.1038/328175a0; Nalla AK, 2010, CANCER GENE THER, V17, P599, DOI 10.1038/cgt.2010.16; OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O; Pugazhenthi S, 1999, J BIOL CHEM, V274, P27529, DOI 10.1074/jbc.274.39.27529; Pugazhenthi S, 2000, J BIOL CHEM, V275, P10761, DOI 10.1074/jbc.275.15.10761; Rao JS, 2003, NAT REV CANCER, V3, P489, DOI 10.1038/nrc1121; Reed JC, 1999, J CLIN ONCOL, V17, P2941, DOI 10.1200/JCO.1999.17.9.2941; Reed JC, 1997, NATURE, V387, P773, DOI 10.1038/42867; Riccio A, 1999, SCIENCE, V286, P2358, DOI 10.1126/science.286.5448.2358; Shih CM, 2003, J CELL BIOCHEM, V89, P335, DOI 10.1002/jcb.10488; SIVAPARVATHI M, 1995, CLIN EXP METASTAS, V13, P49, DOI 10.1007/BF00144018; Steinbach JP, 2004, J NEURO-ONCOL, V70, P245, DOI 10.1007/s11060-004-2753-4; Tsuruta F, 2002, J BIOL CHEM, V277, P14040, DOI 10.1074/jbc.M108975200; Vander Heiden MG, 1999, NAT CELL BIOL, V1, pE209, DOI 10.1038/70237; WIJSMAN JH, 1993, J HISTOCHEM CYTOCHEM, V41, P7, DOI 10.1177/41.1.7678025; Wilson BE, 1996, MOL CELL BIOL, V16, P5546; Wyllie A H, 1980, Int Rev Cytol, V68, P251; YAMAMOTO M, 1994, CANCER RES, V54, P5016	63	75	90	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2010	5	10							e13731	10.1371/journal.pone.0013731	http://dx.doi.org/10.1371/journal.pone.0013731			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673FU	21060833	gold, Green Published, Green Submitted			2022-12-27	WOS:000283645300012
J	Barrio, RA; Hernandez-Machado, A; Varea, C; Romero-Arias, JR; Alvarez-Buylla, E				Angel Barrio, Rafael; Hernandez-Machado, Aurora; Varea, C.; Roberto Romero-Arias, Jose; Alvarez-Buylla, Elena			Flower Development as an Interplay between Dynamical Physical Fields and Genetic Networks	PLOS ONE			English	Article							ARABIDOPSIS-THALIANA; REGULATORY NETWORK; ROBUST; MODEL	In this paper we propose a model to describe the mechanisms by which undifferentiated cells attain gene configurations underlying cell fate determination during morphogenesis. Despite the complicated mechanisms that surely intervene in this process, it is clear that the fundamental fact is that cells obtain spatial and temporal information that bias their destiny. Our main hypothesis assumes that there is at least one macroscopic field that breaks the symmetry of space at a given time. This field provides the information required for the process of cell differentiation to occur by being dynamically coupled to a signal transduction mechanism that, in turn, acts directly upon the gene regulatory network (GRN) underlying cell-fate decisions within cells. We illustrate and test our proposal with a GRN model grounded on experimental data for cell fate specification during organ formation in early Arabidopsis thaliana flower development. We show that our model is able to recover the multigene configurations characteristic of sepal, petal, stamen and carpel primordial cells arranged in concentric rings, in a similar pattern to that observed during actual floral organ determination. Such pattern is robust to alterations of the model parameters and simulated failures predict altered spatio-temporal patterns that mimic those described for several mutants. Furthermore, simulated alterations in the physical fields predict a pattern equivalent to that found in Lacandonia schismatica, the only flowering species with central stamens surrounded by carpels.	[Angel Barrio, Rafael; Varea, C.; Roberto Romero-Arias, Jose] Univ Nacl Autonoma Mexico, Inst Fis, Dept Fis Qum, Mexico City, DF, Mexico; [Hernandez-Machado, Aurora] Univ Barcelona, Fac Fis, Dept Struct & Constituents Matter, E-08028 Barcelona, Spain; [Alvarez-Buylla, Elena] Univ Nacl Autonoma Mexico, Inst Ecol, Mexico City 04510, DF, Mexico	Universidad Nacional Autonoma de Mexico; University of Barcelona; Universidad Nacional Autonoma de Mexico	Barrio, RA (corresponding author), Univ Nacl Autonoma Mexico, Inst Fis, Dept Fis Qum, Mexico City, DF, Mexico.	barrio@fisica.unam.mx; eabuylla@gmail.com	Hernandez-Machado, Aurora/H-7425-2012; Hernandez-Machado, Aurora/N-3362-2019; Romero-Arias, Jose Roberto/ABY-7195-2022	Hernandez-Machado, Aurora/0000-0002-0397-5255; Hernandez-Machado, Aurora/0000-0002-0397-5255; Romero-Arias, Jose Roberto/0000-0002-3423-6455; Alvarez-Buylla Roces, Maria Elena/0000-0002-7938-6473	Conacyt [79641]; Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica Universidad Nacional Autonoma de Mexico [IN229009-3]; Consejo Nacional de Ciencia y Tecnologa [81542]; UNAM y a la Direccion General de Investigacion (Spain) [FIS2009-12964-C05-02]	Conacyt(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica Universidad Nacional Autonoma de Mexico(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)Universidad Nacional Autonoma de Mexico); Consejo Nacional de Ciencia y Tecnologa(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); UNAM y a la Direccion General de Investigacion (Spain)	This work was financed in part by: Conacyt (http://www.conacyt.mx) through project No. 79641. EAB akcnowledges financial support from: Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica Universidad Nacional Autonoma de Mexico (http;//www.unam.mx) IN229009-3, Consejo Nacional de Ciencia y Tecnologa grant to E. A. B, 81542. JRRA akcnowledges the scholarship received from Conacyt. AHM agradece la hospitalidad de la UNAM y a la Direccion General de Investigacion (Spain) under project: FIS2009-12964-C05-02. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2004, BIOPHYS J, V86, P2650, DOI 10.1016/S0006-3495(04)74321-0; Alvarez-Buylla ER, 2010, SEMIN CELL DEV BIOL, V21, P108, DOI 10.1016/j.semcdb.2009.11.010; ALVAREZBULLYA ER, 2008, PLOS ONE; Benitez M, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-98; Benitez-Alfonso Y, 2009, P NATL ACAD SCI USA, V106, P3615, DOI 10.1073/pnas.0808717106; Campelo F, 2007, EUR PHYS J-SPEC TOP, V143, P101, DOI 10.1140/epjst/e2007-00077-y; Campelo F, 2006, EUR PHYS J E, V20, P37, DOI 10.1140/epje/i2005-10079-5; CAMPELO F, 2005, THESIS U BARCELONA; CHAOS A, 2006, GENES FLOWER PATTERN; COEN ES, 1991, NATURE, V353, P31, DOI 10.1038/353031a0; Espinosa-soto C, 2004, PLANT CELL, V16, P2923, DOI 10.1105/tpc.104.021725; Gonzalez-Cinca R., 2004, ADV CONDENSED MATTER, P203; Hamant O, 2008, SCIENCE, V322, P1650, DOI 10.1126/science.1165594; Jonsson H, 2005, BIOINFORMATICS, V21, pI232, DOI 10.1093/bioinformatics/bti1036; KOGI G, 1996, J BIOSCIENCE, V21, P369; Kwiatkowska D, 2006, J EXP BOT, V57, P571, DOI 10.1093/jxb/erj042; Kwiatkowska D, 2008, J EXP BOT, V59, P187, DOI 10.1093/jxb/erm290; Mattsson J, 2003, PLANT PHYSIOL, V131, P1327, DOI 10.1104/pp.013623; Mendoza L, 1998, J THEOR BIOL, V193, P307, DOI 10.1006/jtbi.1998.0701; Mendoza L, 1999, BIOINFORMATICS, V15, P593, DOI 10.1093/bioinformatics/15.7.593; Prunet N, 2009, PLANT PHYSIOL, V150, P1764, DOI 10.1104/pp.109.141812; Scheres B, 2001, PLANT PHYSIOL, V125, P112, DOI 10.1104/pp.125.1.112; SMYTH DR, 1990, PLANT CELL, V2, P755, DOI 10.1105/tpc.2.8.755; von Dassow G, 2000, NATURE, V406, P188, DOI 10.1038/35018085	24	24	25	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2010	5	10							e13523	10.1371/journal.pone.0013523	http://dx.doi.org/10.1371/journal.pone.0013523			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671UN	21048956	gold, Green Published, Green Submitted			2022-12-27	WOS:000283537000004
J	Budding, AE; Vandenbroucke-Grauls, CMJE; Melles, DC; van Duijkeren, E; Kluytmans, JA; Savelkoul, PHM				Budding, Andries E.; Vandenbroucke-Grauls, Christina M. J. E.; Melles, Damian C.; van Duijkeren, Engeline; Kluytmans, Jan A.; Savelkoul, Paul H. M.			Binary IS Typing for Staphylococcus aureus	PLOS ONE			English	Article							SPACER SEQUENCES; PCR ANALYSIS; STRAINS; AMPLIFICATION; IDENTIFICATION	Background: We present an easily applicable test for rapid binary typing of Staphylococcus aureus: binary interspace (IS) typing. This test is a further development of a previously described molecular typing technique that is based on length polymorphisms of the 16S-23S rDNA interspace region of S. aureus. Methodology/Principal Findings: A novel approach of IS-typing was performed in which binary profiles are created. 424 human and animal derived MRSA and MSSA isolates were tested and a subset of these isolates was compared with multi locus sequence typing (MLST) and Amplified Fragment Length Polymorphism (AFLP). Binary IS typing had a high discriminatory potential and a good correlation with MLST and AFLP. Conclusions/Significance: Binary IS typing is easy to perform and binary profiles can be generated in a standardized fashion. These two features, combined with the high correlation with MLST clonal complexes, make the technique applicable for large-scale inter-laboratory molecular epidemiological comparisons.	[Budding, Andries E.; Vandenbroucke-Grauls, Christina M. J. E.; Kluytmans, Jan A.; Savelkoul, Paul H. M.] Vrije Univ Amsterdam Med Ctr, Amsterdam, Netherlands; [Melles, Damian C.] Erasmus MC, Dept Med Microbiol, Rotterdam, Netherlands; [van Duijkeren, Engeline] Univ Utrecht, Fac Vet Med, Dept Infect Dis & Immunol, Utrecht, Netherlands; [Kluytmans, Jan A.] Amphia Hosp, Lab Microbiol & Infect Control, Breda, Netherlands	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Erasmus University Rotterdam; Erasmus MC; Utrecht University; Amphia Hospital	Budding, AE (corresponding author), Vrije Univ Amsterdam Med Ctr, Amsterdam, Netherlands.	d.budding@vumc.nl	Vandenbroucke-Grauls, Christina/AAO-7953-2020	Vandenbroucke-Grauls, Christina/0000-0003-2074-1597; Budding, Andries/0000-0001-5128-5411	Department of Medical Microbiology, VU University Medical Center	Department of Medical Microbiology, VU University Medical Center	The authors received internal funding from the Department of Medical Microbiology, VU University Medical Center. No external funding was received. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Deplano A, 2000, J CLIN MICROBIOL, V38, P3527, DOI 10.1128/JCM.38.10.3527-3533.2000; DOLZANI L, 1994, FEMS MICROBIOL LETT, V119, P167, DOI 10.1016/0378-1097(94)90409-X; GURTLER V, 1995, MICROBIOL-SGM, V141, P1255, DOI 10.1099/13500872-141-5-1255; Khanna T, 2008, VET MICROBIOL, V128, P298, DOI 10.1016/j.vetmic.2007.10.006; Kluytmans J, 2009, BMJ-BRIT MED J, V338, P532; Kumari DNP, 1997, J CLIN MICROBIOL, V35, P881, DOI 10.1128/JCM.35.4.881-885.1997; Meeniken D, 2008, DEUT TIERARZTL WOCH, V115, P132, DOI 10.2377/0341-6593-115-132; MELLES DC, 2007, J MICROBIOL METHODS; Mendoza M, 1998, INT J SYST BACTERIOL, V48, P1049, DOI 10.1099/00207713-48-3-1049; Saruta K, 1997, FEMS MICROBIOL LETT, V146, P271, DOI 10.1016/S0378-1097(96)00487-9; Schmitz FJ, 1998, J MED MICROBIOL, V47, P341, DOI 10.1099/00222615-47-4-341; Schmitz FJ, 1997, ZBL HYG UMWELTMED, V200, P172; Struelens MJ, 2009, CLIN MICROBIOL INFEC, V15, P112, DOI 10.1111/j.1469-0691.2009.02698.x; van Loo I, 2007, EMERG INFECT DIS, V13, P1834, DOI 10.3201/eid1312.070384; Wulf M, 2008, CLIN MICROBIOL INFEC, V14, P519, DOI 10.1111/j.1469-0691.2008.01970.x; Wulf MWH, 2008, CLIN MICROBIOL INFEC, V14, P29, DOI 10.1111/j.1469-0691.2007.01873.x	16	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2010	5	10							e13671	10.1371/journal.pone.0013671	http://dx.doi.org/10.1371/journal.pone.0013671			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671UN	21060683	Green Published, gold, Green Submitted			2022-12-27	WOS:000283537000038
J	Martens, S; Dun, M; Wyble, B; Potter, MC				Martens, Sander; Dun, Mathijs; Wyble, Brad; Potter, Mary C.			A Quick Mind with Letters Can Be a Slow Mind with Natural Scenes: Individual Differences in Attentional Selection	PLOS ONE			English	Article							BLINK; CONJUNCTIONS; COLOR; SHAPE	Background: Most people show a remarkable deficit in reporting the second of two targets (T2) when presented 200-500 ms after the first (T1), reflecting an 'attentional blink' (AB). However, there are large individual differences in the magnitude of the effect, with some people, referred to as 'non-blinkers', showing no such attentional restrictions. Methodology/Principal Findings: Here we replicate these individual differences in a task requiring identification of two letters amongst digits, and show that the observed differences in T2 performance cannot be attributed to individual differences in T1 performance. In a second experiment, the generality of the non-blinkers' superior performance was tested using a task containing novel pictures rather than alphanumeric stimuli. A substantial AB was obtained in non-blinkers that was equivalent to that of 'blinkers'. Conclusion/Significance: The results suggest that non-blinkers employ an efficient target selection strategy that relies on well-learned alphabetic and numeric category sets.	[Martens, Sander; Dun, Mathijs] Univ Groningen, Neuroimaging Ctr, Groningen, Netherlands; [Martens, Sander; Dun, Mathijs] Univ Med Ctr Groningen, Dept Neurosci, NL-9713 AV Groningen, Netherlands; [Wyble, Brad] Syracuse Univ, Dept Psychol, Syracuse, NY USA; [Potter, Mary C.] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA	University of Groningen; University of Groningen; Syracuse University; Massachusetts Institute of Technology (MIT)	Martens, S (corresponding author), Univ Groningen, Neuroimaging Ctr, Groningen, Netherlands.	s.martens@med.umcg.nl	Martens, Sander/C-5353-2008	Martens, Sander/0000-0001-8237-7984	Behavioural and Cognitive Neurosciences (BCN) Research School	Behavioural and Cognitive Neurosciences (BCN) Research School	This research was supported by a grant of the Behavioural and Cognitive Neurosciences (BCN) Research School (http://www.rug.nl/bcn/index). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CHUN MM, 1995, J EXP PSYCHOL HUMAN, V21, P109; DUX PE, 2008, PLOS ONE, V3; Esterman M, 2004, PSYCHON B REV, V11, P681, DOI 10.3758/BF03196620; Evans KK, 2005, J EXP PSYCHOL HUMAN, V31, P1476, DOI 10.1037/0096-1523.31.6.1476; Hamilton JP, 2006, PSYCHON B REV, V13, P1074, DOI 10.3758/BF03213928; MARTENS S, 2008, EXPT BRAIN RES, V129, P43; MARTENS S, PLOS ONE IN PRESS; Martens S, 2009, EXP BRAIN RES, V192, P43, DOI 10.1007/s00221-008-1551-1; Martens S, 2006, J COGNITIVE NEUROSCI, V18, P1423, DOI 10.1162/jocn.2006.18.9.1423; Martens S, 2010, NEUROSCI BIOBEHAV R, V34, P947, DOI 10.1016/j.neubiorev.2009.12.005; Martens S, 2009, EXP PSYCHOL, V56, P33, DOI 10.1027/1618-3169.56.1.33; Martens S, 2009, EXP PSYCHOL, V56, P18, DOI 10.1027/1618-3169.56.1.18; POTTER MC, J EXPT PSYC IN PRESS; RAYMOND JE, 1992, J EXP PSYCHOL HUMAN, V18, P849, DOI 10.1037/0096-1523.18.3.849; Rotte M, 1997, BIOL PSYCHOL, V46, P199, DOI 10.1016/S0301-0511(97)00018-5; Schneider W., 2002, E PRIME USERS GUIDE; Smid HGOM, 1997, BIOL PSYCHOL, V44, P161, DOI 10.1016/S0301-0511(96)05216-7	17	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2010	5	10							e13562	10.1371/journal.pone.0013562	http://dx.doi.org/10.1371/journal.pone.0013562			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	671UN	21048954	Green Published, Green Submitted, gold			2022-12-27	WOS:000283537000010
J	Skoe, E; Kraus, N				Skoe, Erika; Kraus, Nina			Hearing It Again and Again: On-Line Subcortical Plasticity in Humans	PLOS ONE			English	Article							AUDITORY BRAIN-STEM; FREQUENCY-FOLLOWING RESPONSES; CORTICOFUGAL MODULATION; INFERIOR COLLICULUS; SPEECH STREAM; PURE-TONE; ADAPTATION; LANGUAGE; PITCH; VARIABILITY	Background: Human brainstem activity is sensitive to local sound statistics, as reflected in an enhanced response in repetitive compared to pseudo-random stimulus conditions [1]. Here we probed the short-term time course of this enhancement using a paradigm that assessed how the local sound statistics (i.e., repetition within a five-note melody) interact with more global statistics (i.e., repetition of the melody). Methodology/Principal Findings: To test the hypothesis that subcortical repetition enhancement builds over time, we recorded auditory brainstem responses in young adults to a five-note melody containing a repeated note, and monitored how the response changed over the course of 1.5 hrs. By comparing response amplitudes over time, we found a robust time-dependent enhancement to the locally repeating note that was superimposed on a weaker enhancement of the globally repeating pattern. Conclusions/Significance: We provide the first demonstration of on-line subcortical plasticity in humans. This complements previous findings that experience-dependent subcortical plasticity can occur on a number of time scales, including life-long experiences with music and language, and short-term auditory training. Our results suggest that the incoming stimulus stream is constantly being monitored, even when the stimulus is physically invariant and attention is directed elsewhere, to augment the neural response to the most statistically salient features of the ongoing stimulus stream. These real-time transformations, which may subserve humans' strong disposition for grouping auditory objects, likely reflect a mix of local processes and corticofugal modulation arising from statistical regularities and the influences of expectation. Our results contribute to our understanding of the biological basis of statistical learning and initiate a new investigational approach relating to the time-course of subcortical plasticity. Although the reported time-dependent enhancements are believed to reflect universal neurophysiological processes, future experiments utilizing a larger array of stimuli are needed to establish the generalizability of our findings.	[Skoe, Erika; Kraus, Nina] Northwestern Univ, Auditory Neurosci Lab, Evanston, IL 60208 USA; [Skoe, Erika; Kraus, Nina] Northwestern Univ, Dept Commun Sci & Disorders, Evanston, IL USA; [Kraus, Nina] Northwestern Univ, Dept Neurobiol & Physiol, Evanston, IL 60208 USA; [Kraus, Nina] Northwestern Univ, Dept Otolaryngol, Evanston, IL USA	Northwestern University; Northwestern University; Northwestern University; Northwestern University	Skoe, E (corresponding author), Northwestern Univ, Auditory Neurosci Lab, Evanston, IL 60208 USA.	eeskoe@northwestern.edu			NSF (National Science Foundation) [0842376]; NIH (National Institutes of Health) [R01 DC01510, F32 DC 008052]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [F32DC008052, R01DC001510] Funding Source: NIH RePORTER	NSF (National Science Foundation)(National Science Foundation (NSF)); NIH (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	Work was supported by NSF (National Science Foundation) 0842376 and NIH (National Institutes of Health) R01 DC01510, F32 DC 008052. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abla D, 2008, J COGNITIVE NEUROSCI, V20, P952, DOI 10.1162/jocn.2008.20058; Aiken SJ, 2006, AUDIOL NEURO-OTOL, V11, P213, DOI 10.1159/000092589; Bajo VM, 2010, NAT NEUROSCI, V13, P253, DOI 10.1038/nn.2466; Baldwin D, 2008, COGNITION, V106, P1382, DOI 10.1016/j.cognition.2007.07.005; Bekinschtein TA, 2009, P NATL ACAD SCI USA, V106, P1672, DOI 10.1073/pnas.0809667106; Bregman A.S., 1994, AUDITORY SCENE ANAL; CARHART R, 1959, J SPEECH HEAR DISORD, V24, P330, DOI 10.1044/jshd.2404.330; Chandrasekaran B, 2009, NEURON, V64, P311, DOI 10.1016/j.neuron.2009.10.006; Chandrasekaran B, 2010, PSYCHOPHYSIOLOGY, V47, P236, DOI 10.1111/j.1469-8986.2009.00928.x; CHIAPPA KH, 1979, ARCH NEUROL-CHICAGO, V36, P81, DOI 10.1001/archneur.1979.00500380051005; Cunillera T, 2009, NEUROIMAGE, V48, P541, DOI 10.1016/j.neuroimage.2009.06.069; Dean I, 2005, NAT NEUROSCI, V8, P1684, DOI 10.1038/nn1541; Dean I, 2008, J NEUROSCI, V28, P6430, DOI 10.1523/JNEUROSCI.0470-08.2008; DON M, 1994, J ACOUST SOC AM, V96, P2746, DOI 10.1121/1.411281; Drake C, 2001, ANN NY ACAD SCI, V930, P17, DOI 10.1111/j.1749-6632.2001.tb05722.x; EDWARDS RM, 1982, ELECTROEN CLIN NEURO, V53, P125, DOI 10.1016/0013-4694(82)90018-9; Engel AK, 2001, NAT REV NEUROSCI, V2, P704, DOI 10.1038/35094565; Evans JL, 2009, J SPEECH LANG HEAR R, V52, P321, DOI 10.1044/1092-4388(2009/07-0189); GALBRAITH GC, 1994, ELECTROEN CLIN NEURO, V92, P321, DOI 10.1016/0168-5597(94)90100-7; Gao E, 1998, P NATL ACAD SCI USA, V95, P12663, DOI 10.1073/pnas.95.21.12663; Gao EQ, 2000, P NATL ACAD SCI USA, V97, P8081, DOI 10.1073/pnas.97.14.8081; Garrido MI, 2009, NEUROIMAGE, V48, P269, DOI 10.1016/j.neuroimage.2009.06.034; Gilbert CD, 2007, NEURON, V54, P677, DOI 10.1016/j.neuron.2007.05.019; GREENBERG S, 1987, HEARING RES, V25, P91, DOI 10.1016/0378-5955(87)90083-9; HALL JW, 1979, SCIENCE, V205, P1297, DOI 10.1126/science.472748; Hall JW III, 2015, EHANDBOOK AUDITORY E; Hauser MD, 2001, COGNITION, V78, pB53, DOI 10.1016/S0010-0277(00)00132-3; He C, 2009, J NEUROSCI, V29, P7718, DOI 10.1523/JNEUROSCI.0157-09.2009; HOORMANN J, 1992, HEARING RES, V59, P179, DOI 10.1016/0378-5955(92)90114-3; Koelsch S, 2008, BRAIN RES, V1212, P55, DOI 10.1016/j.brainres.2007.10.078; Kraus N, 2010, NAT REV NEUROSCI, V11, P599, DOI 10.1038/nrn2882; Kraus N, 2009, ANN NY ACAD SCI, V1169, P543, DOI 10.1111/j.1749-6632.2009.04549.x; Krishnan A., 2007, AUDITORY EVOKED POTE, P313; Krishnan A, 2009, BRAIN LANG, V110, P135, DOI 10.1016/j.bandl.2009.03.005; Large EW, 1999, PSYCHOL REV, V106, P119, DOI 10.1037/0033-295X.106.1.119; LAUTER JL, 1986, SCAND AUDIOL, V15, P167, DOI 10.3109/01050398609070693; Luo F, 2008, J NEUROSCI, V28, P11615, DOI 10.1523/JNEUROSCI.3972-08.2008; Malmierca MS, 2009, J NEUROSCI, V29, P5483, DOI 10.1523/JNEUROSCI.4153-08.2009; Micheyl C, 2010, HEARING RES, V266, P36, DOI 10.1016/j.heares.2009.09.012; MOUSHEGIAN G, 1973, ELECTROEN CLIN NEURO, V35, P665, DOI 10.1016/0013-4694(73)90223-X; OSTERHAMMEL PA, 1985, SCAND AUDIOL, V14, P47, DOI 10.3109/01050398509045921; Perez-Gonzalez D, 2005, EUR J NEUROSCI, V22, P2879, DOI 10.1111/j.1460-9568.2005.04472.x; Pressnitzer D, 2008, CURR BIOL, V18, P1124, DOI 10.1016/j.cub.2008.06.053; Repp BH, 2007, COGNITION, V102, P434, DOI 10.1016/j.cognition.2006.02.003; ROSENHAMER H J, 1978, Scandinavian Audiology, V7, P193, DOI 10.3109/01050397809076287; Ross B, 2009, HEARING RES, V248, P48, DOI 10.1016/j.heares.2008.11.012; Russo N, 2004, CLIN NEUROPHYSIOL, V115, P2021, DOI 10.1016/j.clinph.2004.04.003; Russo NM, 2005, BEHAV BRAIN RES, V156, P95, DOI 10.1016/j.bbr.2004.05.012; Ruusuvirta T, 2007, CEREB CORTEX, V17, P2777, DOI 10.1093/cercor/bhm005; Saffran JR, 1996, SCIENCE, V274, P1926, DOI 10.1126/science.274.5294.1926; Saffran JR, 1999, COGNITION, V70, P27, DOI 10.1016/S0010-0277(98)00075-4; Saffran JR, 2003, ANN NY ACAD SCI, V999, P397, DOI 10.1196/annals.1284.050; Schroeder CE, 2008, TRENDS COGN SCI, V12, P106, DOI 10.1016/j.tics.2008.01.002; SCOTTVAN Z, 2010, BIOL PSYCHIAT, P345; Skoe E, 2010, EAR HEARING, V31, P302, DOI 10.1097/AUD.0b013e3181cdb272; SONG JH, 2010, CLIN NEUROPHYSIOL; Song JH, 2008, J COGNITIVE NEUROSCI, V20, P1892, DOI 10.1162/jocn.2008.20131; Suga N, 2002, NEURON, V36, P9, DOI 10.1016/S0896-6273(02)00933-9; Teinonen T, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-21; Toro JM, 2005, PERCEPT PSYCHOPHYS, V67, P867, DOI 10.3758/BF03193539; Tremblay KL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010283; Turk-Browne NB, 2009, J COGNITIVE NEUROSCI, V21, P1934, DOI 10.1162/jocn.2009.21131; Tzounopoulos T, 2009, NEURON, V62, P463, DOI 10.1016/j.neuron.2009.05.002; Ulanovsky N, 2004, J NEUROSCI, V24, P10440, DOI 10.1523/JNEUROSCI.1905-04.2004; Wen B, 2009, J NEUROSCI, V29, P13797, DOI 10.1523/JNEUROSCI.5610-08.2009; Wible B, 2002, CLIN NEUROPHYSIOL, V113, P485, DOI 10.1016/S1388-2457(02)00017-2; Winkler I, 2009, TRENDS COGN SCI, V13, P532, DOI 10.1016/j.tics.2009.09.003; Winkler I, 2009, P NATL ACAD SCI USA, V106, P2468, DOI 10.1073/pnas.0809035106; Yan J, 2005, J NEUROPHYSIOL, V93, P71, DOI 10.1152/jn.00348.2004; Yan W, 1998, NAT NEUROSCI, V1, P54, DOI 10.1038/255; Yoshida KA, 2010, COGNITION, V115, P356, DOI 10.1016/j.cognition.2010.01.005	71	48	53	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2010	5	10							e13645	10.1371/journal.pone.0013645	http://dx.doi.org/10.1371/journal.pone.0013645			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671GB	21049035	Green Published, gold, Green Submitted			2022-12-27	WOS:000283487400032
J	Bouligand, J; Delemer, B; Hecart, AC; Meduri, G; Viengchareun, S; Amazit, L; Trabado, S; Feve, B; Guiochon-Mantel, A; Young, J; Lombes, M				Bouligand, Jerome; Delemer, Brigitte; Hecart, Annie-Claude; Meduri, Geri; Viengchareun, Say; Amazit, Larbi; Trabado, Severine; Feve, Bruno; Guiochon-Mantel, Anne; Young, Jacques; Lombes, Marc			Familial Glucocorticoid Receptor Haploinsufficiency by Non-Sense Mediated mRNA Decay, Adrenal Hyperplasia and Apparent Mineralocorticoid Excess	PLOS ONE			English	Article							MOLECULAR-MECHANISMS; SENSITIVITY; RESISTANCE; HORMONE; DEHYDROGENASE; EXPRESSION; PROMOTER; DOMAIN	Primary glucocorticoid resistance (OMIM 138040) is a rare hereditary disease that causes a generalized partial insensitivity to glucocorticoid action, due to genetic alterations of the glucocorticoid receptor (GR). Investigation of adrenal incidentalomas led to the discovery of a family (eight affected individuals spanning three generations), prone to cortisol resistance, bilateral adrenal hyperplasia, arterial hypertension and hypokalemia. This phenotype exacerbated over time, cosegregates with the first heterozygous nonsense mutation p.R469[R,X] reported to date for the GR, replacing an arginine (CGA) by a stop (TGA) at amino-acid 469 in the second zinc finger of the DNA-binding domain of the receptor. In vitro, this mutation leads to a truncated 50-kDa GR lacking hormone and DNA binding capacity, devoid of hormone-dependent nuclear translocation and transactivation properties. In the proband's fibroblasts, we provided evidence for the lack of expression of the defective allele in vivo. The absence of detectable mutated GR mRNA was accompanied by a 50% reduction in wild type GR transcript and protein. This reduced GR expression leads to a significantly below-normal induction of glucocorticoid-induced target genes, FKBP5 in fibroblasts. We demonstrated that the molecular mechanisms of glucocorticoid signaling dysfunction involved GR haploinsufficiency due to the selective degradation of the mutated GR transcript through a nonsense-mediated mRNA Decay that was experimentally validated on emetine-treated propositus' fibroblasts. GR haploinsufficiency leads to hypertension due to illicit occupation of renal mineralocorticoid receptor by elevated cortisol rather than to increased mineralocorticoid production reported in primary glucocorticoid resistance. Indeed, apparent mineralocorticoid excess was demonstrated by a decrease in urinary tetrahydrocortisone-tetrahydrocortisol ratio in affected patients, revealing reduced glucocorticoid degradation by renal activity of the 11 beta-hydroxysteroid dehydrogenase type 2, a GR regulated gene. We propose thus that GR haploinsufficiency compromises glucocorticoid sensitivity and may represent a novel genetic cause of subclinical hypercortisolism, incidentally revealed bilateral adrenal hyperplasia and mineralocorticoid-independent hypertension.	[Bouligand, Jerome; Meduri, Geri; Trabado, Severine; Feve, Bruno; Guiochon-Mantel, Anne; Young, Jacques; Lombes, Marc] Hop Bicetre, AP HP, Serv Genet Mol Pharmacogenet & Hormonol, Le Kremlin Bicetre, France; [Bouligand, Jerome; Meduri, Geri; Viengchareun, Say; Amazit, Larbi; Trabado, Severine; Feve, Bruno; Guiochon-Mantel, Anne; Young, Jacques; Lombes, Marc] INSERM, U693, F-94275 Le Kremlin Bicetre, France; [Bouligand, Jerome; Viengchareun, Say; Amazit, Larbi; Trabado, Severine; Guiochon-Mantel, Anne] Univ Paris Sud, Fac Med Paris Sud, UMR S693, F-94275 Le Kremlin Bicetre, France; [Delemer, Brigitte; Hecart, Annie-Claude] Ctr Hosp Robert Debre, Serv Endocrinol, Reims, France; [Feve, Bruno; Young, Jacques; Lombes, Marc] Hop Bicetre, AP HP, Serv Endocrinol & Malad Reprod, Le Kremlin Bicetre, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; CHU de Reims; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay	Bouligand, J (corresponding author), Hop Bicetre, AP HP, Serv Genet Mol Pharmacogenet & Hormonol, Le Kremlin Bicetre, France.	marc.lombes@u-psud.fr	Viengchareun, Say/GOV-6812-2022; Viengchareun, Say/M-6612-2017; BOULIGAND, Jérôme/S-5716-2018; Lombes, Marc/L-5933-2018; Young, Jacques/T-2976-2018; Guiochon-Mantel, Anne S/S-8408-2018; Young, Jacques/N-5251-2019	Lombes, Marc/0000-0003-3189-023X; Young, Jacques/0000-0001-9286-5631; Guiochon-Mantel, Anne S/0000-0003-1737-1409; Young, Jacques/0000-0001-9286-5631; Feve, Bruno/0000-0001-6577-9009; viengchareun, say/0000-0003-4280-3250; Trabado, Severine/0000-0002-1925-1999	Institut National de la Sante et de la Recherche Medicale (INSERM); Universite Paris-Sud 11	Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Universite Paris-Sud 11	This work has been supported by fundings from Institut National de la Sante et de la Recherche Medicale (INSERM), the Universite Paris-Sud 11. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alikhani-Koupaei R, 2007, FASEB J, V21, P3618, DOI 10.1096/fj.07-8140com; Caprio M, 2007, FASEB J, V21, P2185, DOI 10.1096/fj.06-7970com; Charmandari E, 2008, J CLIN ENDOCR METAB, V93, P1563, DOI 10.1210/jc.2008-0040; Frio TR, 2008, J CLIN INVEST, V118, P1519, DOI 10.1172/JCI34211; Gesina E, 2006, DIABETOLOGIA, V49, P2939, DOI 10.1007/s00125-006-0449-3; Gross KL, 2008, TRENDS ENDOCRIN MET, V19, P331, DOI 10.1016/j.tem.2008.07.009; Gross KL, 2009, MOL CELL ENDOCRINOL, V300, P7, DOI 10.1016/j.mce.2008.10.001; Gummow BM, 2006, MOL ENDOCRINOL, V20, P2711, DOI 10.1210/me.2005-0461; Kamenicky P, 2008, ENDOCRINOLOGY, V149, P3294, DOI 10.1210/en.2008-0143; Karst H, 2005, P NATL ACAD SCI USA, V102, P19204, DOI 10.1073/pnas.0507572102; Lu NZ, 2006, PHARMACOL REV, V58, P782, DOI 10.1124/pr.58.4.9; Lu NZ, 2004, ANN NY ACAD SCI, V1024, P102, DOI 10.1196/annals.1321.008; Mansmann G, 2004, ENDOCR REV, V25, P309, DOI 10.1210/er.2002-0031; McMahon SK, 2010, J CLIN ENDOCR METAB, V95, P297, DOI 10.1210/jc.2009-1003; Michailidou Z, 2008, FASEB J, V22, P3896, DOI 10.1096/fj.08-111914; Nader N, 2010, J CLIN ENDOCR METAB, V95, P2281, DOI 10.1210/jc.2009-2463; Newell-Price J, 2006, LANCET, V367, P1605, DOI 10.1016/S0140-6736(06)68699-6; Pascual-Le Tallec L, 2003, MOL ENDOCRINOL, V17, P2529, DOI 10.1210/me.2003-0299; Pitt B, 2003, NEW ENGL J MED, V348, P1309, DOI 10.1056/NEJMoa030207; Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001; Rhen T, 2005, NEW ENGL J MED, V353, P1711, DOI 10.1056/NEJMra050541; Shyu AB, 2008, EMBO J, V27, P471, DOI 10.1038/sj.emboj.7601977; Stalder L, 2008, TRENDS CELL BIOL, V18, P315, DOI 10.1016/j.tcb.2008.04.005; Vermeer H, 2003, J CLIN ENDOCR METAB, V88, P277, DOI 10.1210/jc.2002-020354; Viengchareun Say, 2007, Nucl Recept Signal, V5, pe012, DOI 10.1621/nrs.05012; Watts LM, 2005, DIABETES, V54, P1846, DOI 10.2337/diabetes.54.6.1846; White PC, 1997, ENDOCR REV, V18, P135, DOI 10.1210/er.18.1.135	27	43	44	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2010	5	10							e13563	10.1371/journal.pone.0013563	http://dx.doi.org/10.1371/journal.pone.0013563			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	670KA	21042587	Green Published, Green Submitted, gold			2022-12-27	WOS:000283419100007
J	Flynn, JM; Meadows, E; Fiorotto, M; Klein, WH				Flynn, Jesse M.; Meadows, Eric; Fiorotto, Marta; Klein, William H.			Myogenin Regulates Exercise Capacity and Skeletal Muscle Metabolism in the Adult Mouse	PLOS ONE			English	Article							PYRUVATE-CARBOXYLASE DEFICIENCY; LACTIC-ACID; LACTATE ACCUMULATION; SIGNALING PATHWAYS; ADAPTATIONS; MECHANISMS; DIVERSITY; HEAVY; MICE; FORM	Although skeletal muscle metabolism is a well-studied physiological process, little is known about how it is regulated at the transcriptional level. The myogenic transcription factor myogenin is required for skeletal muscle development during embryonic and fetal life, but myogenin's role in adult skeletal muscle is unclear. We sought to determine myogenin's function in adult muscle metabolism. A Myog conditional allele and Cre-ER transgene were used to delete Myog in adult mice. Mice were analyzed for exercise capacity by involuntary treadmill running. To assess oxidative and glycolytic metabolism, we performed indirect calorimetry, monitored blood glucose and lactate levels, and performed histochemical analyses on muscle fibers. Surprisingly, we found that Myog-deleted mice performed significantly better than controls in high-and low-intensity treadmill running. This enhanced exercise capacity was due to more efficient oxidative metabolism during low-and high-intensity exercise and more efficient glycolytic metabolism during high-intensity exercise. Furthermore, Myog-deleted mice had an enhanced response to long-term voluntary exercise training on running wheels. We identified several candidate genes whose expression was altered in exercise-stressed muscle of mice lacking myogenin. The results suggest that myogenin plays a critical role as a high-level transcriptional regulator to control the energy balance between aerobic and anaerobic metabolism in adult skeletal muscle.	[Flynn, Jesse M.; Meadows, Eric; Klein, William H.] Univ Texas MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Flynn, Jesse M.; Meadows, Eric; Klein, William H.] Univ Texas Sch Biomed Sci Houston, Grad Training Program Genes & Dev, Houston, TX USA; [Fiorotto, Marta] Baylor Coll Med, Childrens Nutr Res Ctr, USDA ARS, Dept Pediat, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; Baylor College of Medicine; United States Department of Agriculture (USDA)	Flynn, JM (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Houston, TX 77030 USA.	whklein@mdanderson.org			National Cancer Institute Cancer Center [CA016672]; Muscular Dystrophy Association [MDA4289]; Robert A. Welch Foundation [G-0010]; USDA/Agricultural Research Service [58-6250-6001]; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER	National Cancer Institute Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Muscular Dystrophy Association(Muscular Dystrophy Association); Robert A. Welch Foundation(The Welch Foundation); USDA/Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Facilities are supported in part by a National Cancer Institute Cancer Center Core Grant (CA016672). The work was supported by grants to W. H. K. from the Muscular Dystrophy Association (MDA4289) and from the Robert A. Welch Foundation (G-0010). M. L. F. was supported with funds from USDA/Agricultural Research Service under Cooperative Agreement number 58-6250-6001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Alapat DV, 2009, CELL SIGNAL, V21, P128, DOI 10.1016/j.cellsig.2008.09.020; BALDWIN KM, 1977, J APPL PHYSIOL, V42, P267, DOI 10.1152/jappl.1977.42.2.267; BALDWIN KM, 1972, AM J PHYSIOL, V222, P373, DOI 10.1152/ajplegacy.1972.222.2.373; Bassel-Duby R, 2006, ANNU REV BIOCHEM, V75, P19, DOI 10.1146/annurev.biochem.75.103004.142622; Brooks GA, 2009, J PHYSIOL-LONDON, V587, P5591, DOI 10.1113/jphysiol.2009.178350; Carbone MA, 2002, HUM MUTAT, V20, P48, DOI 10.1002/humu.10093; DUDLEY GA, 1982, J APPL PHYSIOL, V53, P844, DOI 10.1152/jappl.1982.53.4.844; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; FISCHER KF, 1986, NEW ENGL J MED, V315, P1245, DOI 10.1056/NEJM198611133152002; FITTS RH, 1994, PHYSIOL REV, V74, P49, DOI 10.1152/physrev.1994.74.1.49; FITTS RH, 2004, MECH MUSCULAR FATIGU; Frey N, 2008, J CLIN INVEST, V118, P3598, DOI 10.1172/JCI36277; Gladden LB, 2000, MED SCI SPORT EXER, V32, P764, DOI 10.1097/00005768-200004000-00008; Gundersen K, 1998, ACTA PHYSIOL SCAND, V162, P333, DOI 10.1046/j.1365-201X.1998.0336e.x; Guo W, 2009, MITOCHONDRION, V9, P261, DOI 10.1016/j.mito.2009.03.003; HAGBERG H, 1985, PFLUG ARCH EUR J PHY, V404, P342, DOI 10.1007/BF00585346; Hakimi P, 2007, J BIOL CHEM, V282, P32844, DOI 10.1074/jbc.M706127200; HASTY P, 1993, NATURE, V364, P501, DOI 10.1038/364501a0; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; HOLLOSZY JO, 1970, BIOCHEM BIOPH RES CO, V40, P1368, DOI 10.1016/0006-291X(70)90017-3; Hughes SM, 1999, J CELL BIOL, V145, P633, DOI 10.1083/jcb.145.3.633; HUGHES SM, 1993, DEVELOPMENT, V118, P1137; ISHIHARA A, 1991, EUR J APPL PHYSIOL, V62, P211, DOI 10.1007/BF00643744; Katz S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-464; Knapp JR, 2006, DEVELOPMENT, V133, P601, DOI 10.1242/dev.02249; Le Grand F, 2007, CURR OPIN CELL BIOL, V19, P628, DOI 10.1016/j.ceb.2007.09.012; Meadows E, 2008, DEV BIOL, V322, P406, DOI 10.1016/j.ydbio.2008.07.024; Molkentin JD, 1996, CURR OPIN GENET DEV, V6, P445, DOI 10.1016/S0959-437X(96)80066-9; MORESI V, 2010, MYOGENIN CLASS 2 HDA; Nabben M, 2008, PHYSIOL BEHAV, V94, P259, DOI 10.1016/j.physbeh.2007.11.039; Noakes TD, 1997, MED SCI SPORT EXER, V29, P571, DOI 10.1097/00005768-199705000-00001; PETTE D, 1983, J PHYSIOL-LONDON, V338, P1; Robergs RA, 2004, AM J PHYSIOL-REG I, V287, pR502, DOI 10.1152/ajpregu.00114.2004; ROBINSON BH, 1987, AM J HUM GENET, V40, P50; ROBINSON BH, 1984, AM J HUM GENET, V36, P283; Robinson BH, 2006, MOL GENET METAB, V89, P3, DOI 10.1016/j.ymgme.2006.05.015; RODNICK KJ, 1989, J APPL PHYSIOL, V66, P1250, DOI 10.1152/jappl.1989.66.3.1250; Sahlin K, 1998, ACTA PHYSIOL SCAND, V162, P261, DOI 10.1046/j.1365-201X.1998.0298f.x; SAHLIN K, 1987, BIOCHEM J, V245, P551, DOI 10.1042/bj2450551; SAHLIN K, 1981, AM J PHYSIOL, V240, pC121, DOI 10.1152/ajpcell.1981.240.3.C121; SAHLIN K, 1984, ACTA PHYSIOL SCAND, V122, P331, DOI 10.1111/j.1748-1716.1984.tb07517.x; SAHLIN K, 1976, PFLUG ARCH EUR J PHY, V367, P143, DOI 10.1007/BF00585150; Sahlin K., 1986, BIOCH EXERCISE, VVI, P323; SCHIAFFINO S, 1989, J MUSCLE RES CELL M, V10, P197, DOI 10.1007/BF01739810; Schiaffino S, 1996, PHYSIOL REV, V76, P371, DOI 10.1152/physrev.1996.76.2.371; Schiaffino S, 2007, PHYSIOLOGY, V22, P269, DOI 10.1152/physiol.00009.2007; SERVICE FJ, 1995, NEW ENGL J MED, V332, P1144, DOI 10.1056/NEJM199504273321707; SEXTON WL, 1995, J APPL PHYSIOL, V79, P287, DOI 10.1152/jappl.1995.79.1.287; Spangenburg EE, 2009, MOL CELL BIOCHEM, V332, P225, DOI 10.1007/s11010-009-0195-1; Stringer W, 1995, EUR J APPL PHYSIOL, V72, P25, DOI 10.1007/BF00964110; Tang HB, 2009, MOL BIOL CELL, V20, P1120, DOI 10.1091/mbc.E08-07-0759; Wang YX, 2004, PLOS BIOL, V2, P1532, DOI 10.1371/journal.pbio.0020294; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Yalcin A, 2009, EXP MOL PATHOL, V86, P174, DOI 10.1016/j.yexmp.2009.01.003	55	41	41	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2010	5	10							e13535	10.1371/journal.pone.0013535	http://dx.doi.org/10.1371/journal.pone.0013535			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	670KA	21042574	Green Published, gold, Green Submitted			2022-12-27	WOS:000283419100004
J	Caudron, F; Denarier, E; Thibout-Quintana, JC; Brocard, J; Andrieux, A; Fourest-Lieuvin, A				Caudron, Fabrice; Denarier, Eric; Thibout-Quintana, Jenny-Constanza; Brocard, Jacques; Andrieux, Annie; Fourest-Lieuvin, Anne			Mutation of Ser172 in Yeast beta Tubulin Induces Defects in Microtubule Dynamics and Cell Division	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; PLUS-END; BUDDING YEAST; SPINDLE ORIENTATION; CORTICAL SITES; CAPTURE; PROTEIN; TRACKING; CORTEX; DYNEIN	Ser172 of beta tubulin is an important residue that is mutated in a human brain disease and phosphorylated by the cyclin-dependent kinase Cdk1 in mammalian cells. To examine the role of this residue, we used the yeast S. cerevisiae as a model and produced two different mutations (S172A and S172E) of the conserved Ser172 in the yeast beta tubulin Tub2p. The two mutants showed impaired cell growth on benomyl-containing medium and at cold temperatures, altered microtubule (MT) dynamics, and altered nucleus positioning and segregation. When cytoplasmic MT effectors Dyn1p or Kar9p were deleted in S172A and S172E mutants, cells were viable but presented increased ploidy. Furthermore, the two beta tubulin mutations exhibited synthetic lethal interactions with Bik1p, Bim1p or Kar3p, which are effectors of cytoplasmic and spindle MTs. In the absence of Mad2p-dependent spindle checkpoint, both mutations are deleterious. These findings show the importance of Ser172 for the correct function of both cytoplasmic and spindle MTs and for normal cell division.	[Caudron, Fabrice] Swiss Fed Inst Technol, Inst Biochem, Zurich, Switzerland; [Denarier, Eric; Brocard, Jacques; Andrieux, Annie; Fourest-Lieuvin, Anne] Univ Grenoble 1, INSERM, Grenoble Inst Neurosci, U836, Grenoble, France; [Denarier, Eric; Andrieux, Annie; Fourest-Lieuvin, Anne] Commissariat Energie Atom & Energies Alternat, Direct Sci Vivant, Inst Rec Technol & Sci Vivant, Grp Physiopathol Cytosquelette, Grenoble, France; [Thibout-Quintana, Jenny-Constanza] Ctr Hosp Lyon Sud, F-69310 Pierre Benite, France	Swiss Federal Institutes of Technology Domain; ETH Zurich; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; CHU Lyon	Caudron, F (corresponding author), Swiss Fed Inst Technol, Inst Biochem, Zurich, Switzerland.	anne.fourest-lieuvin@ujf-grenoble.fr	Fourest-Lieuvin, Anne/AGA-6504-2022; ANDRIEUX, ANNIE/B-2134-2017; Denarier, Eric/X-6137-2019; Denarier, Eric/H-3555-2017; Caudron, Fabrice/AAE-3039-2021; Brocard, Jacques/I-3135-2017	Fourest-Lieuvin, Anne/0000-0003-1325-6788; ANDRIEUX, ANNIE/0000-0002-4022-6405; Denarier, Eric/0000-0002-4169-397X; Denarier, Eric/0000-0002-4169-397X; Brocard, Jacques/0000-0002-0752-5737; Caudron, Fabrice/0000-0001-5159-1507	Agence Nationale Recherche Tyr-TIPs [Blan07-2_187328]; La Ligue contre le cancer [R07Job]; Association Recherche sur le Cancer [4892, 7927]	Agence Nationale Recherche Tyr-TIPs; La Ligue contre le cancer(Ligue nationale contre le cancer); Association Recherche sur le Cancer	This work was supported in part by grants from Agence Nationale Recherche Tyr-TIPs (Blan07-2_187328), La Ligue contre le cancer (R07Job), Association Recherche sur le Cancer (4892 and 7927) to AA team. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adames NR, 2000, J CELL BIOL, V149, P863, DOI 10.1083/jcb.149.4.863; Akhmanova A, 2005, CURR OPIN CELL BIOL, V17, P47, DOI 10.1016/j.ceb.2004.11.001; Akhmanova A, 2008, NAT REV MOL CELL BIO, V9, P309, DOI 10.1038/nrm2369; Andersen SSL, 1999, BIOESSAYS, V21, P53, DOI 10.1002/(SICI)1521-1878(199901)21:1<53::AID-BIES7>3.0.CO;2-L; Badin-Larcon AC, 2004, P NATL ACAD SCI USA, V101, P5577, DOI 10.1073/pnas.0307917101; Burke D., 2000, METHODS YEAST GENETI; Busson S, 1998, CURR BIOL, V8, P541, DOI 10.1016/S0960-9822(98)70208-8; Byers B, 1981, MOL BIOL YEAST SACCH, P59; Carvalho P, 2004, DEV CELL, V6, P815, DOI 10.1016/j.devcel.2004.05.001; Carvalho P, 2003, TRENDS CELL BIOL, V13, P229, DOI 10.1016/S0962-8924(03)00074-6; Caudron F, 2008, J CELL SCI, V121, P1506, DOI 10.1242/jcs.023374; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; Fourest-Lieuvin A, 2006, MOL BIOL CELL, V17, P1041, DOI 10.1091/mbc.E05-07-0621; Galjart N, 2003, CURR OPIN CELL BIOL, V15, P48, DOI 10.1016/S0955-0674(02)00007-8; Gardner MK, 2008, J CELL BIOL, V180, P91, DOI 10.1083/jcb.200710164; Grava S, 2006, DEV CELL, V10, P425, DOI 10.1016/j.devcel.2006.02.018; He XW, 2001, CELL, V106, P195, DOI 10.1016/S0092-8674(01)00438-X; Huang BY, 2006, J CELL BIOL, V175, P17, DOI 10.1083/jcb.200606021; Huisman SM, 2005, J CELL SCI, V118, P463, DOI 10.1242/jcs.01650; Jaglin XH, 2009, NAT GENET, V41, P746, DOI 10.1038/ng.380; Korinek WS, 2000, SCIENCE, V287, P2257, DOI 10.1126/science.287.5461.2257; Kosco KA, 2001, MOL BIOL CELL, V12, P2870, DOI 10.1091/mbc.12.9.2870; Kusch J, 2003, TRENDS CELL BIOL, V13, P562, DOI 10.1016/j.tcb.2003.09.008; Lee L, 2000, SCIENCE, V287, P2260, DOI 10.1126/science.287.5461.2260; Liakopoulos D, 2003, CELL, V112, P561, DOI 10.1016/S0092-8674(03)00119-3; LIEUVIN A, 1994, J CELL BIOL, V124, P985, DOI 10.1083/jcb.124.6.985; Lin HJ, 2001, J CELL BIOL, V155, P1173, DOI 10.1083/jcb.200108119; Maekawa H, 2004, GENE DEV, V18, P1709, DOI 10.1101/gad.298704; Maekawa H, 2003, EMBO J, V22, P438, DOI 10.1093/emboj/cdg063; Miller RK, 1998, J CELL BIOL, V140, P377, DOI 10.1083/jcb.140.2.377; Moore JK, 2007, MOL BIOL CELL, V18, P1187, DOI 10.1091/mbc.E06-04-0360; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; REIJO RA, 1994, MOL BIOL CELL, V5, P29, DOI 10.1091/mbc.5.1.29; Schuyler SC, 2001, J CELL SCI, V114, P247; Straight AF, 1997, SCIENCE, V277, P574, DOI 10.1126/science.277.5325.574; Verhey KJ, 2007, CELL CYCLE, V6, P2152, DOI 10.4161/cc.6.17.4633; Wittmann T, 2001, NAT CELL BIOL, V3, pE28, DOI 10.1038/35050669; Wolyniak MJ, 2006, MOL BIOL CELL, V17, P2789, DOI 10.1091/mbc.E05-09-0892	38	10	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2010	5	10							e13553	10.1371/journal.pone.0013553	http://dx.doi.org/10.1371/journal.pone.0013553			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	668TQ	21042413	Green Published, gold			2022-12-27	WOS:000283293800019
J	Grayson, BL; Smith, ME; Thomas, JW; Wang, L; Dexheimer, P; Jeffrey, J; Fain, PR; Nanduri, P; Eisenbarth, GS; Aune, TM				Grayson, Britney L.; Smith, Mary Ellen; Thomas, James W.; Wang, Lily; Dexheimer, Phil; Jeffrey, Joy; Fain, Pamela R.; Nanduri, Priyaanka; Eisenbarth, George S.; Aune, Thomas M.			Genome-Wide Analysis of Copy Number Variation in Type 1 Diabetes	PLOS ONE			English	Article							MARIE-TOOTH-DISEASE; DIAGNOSTIC-CRITERIA; MULTIPLE-SCLEROSIS; GENE-EXPRESSION; CLASSIFICATION; SUSCEPTIBILITY; AUTOIMMUNITY; ASSOCIATION; DEFINITION; DISCORDANT	Type 1 diabetes (T1D) tends to cluster in families, suggesting there may be a genetic component predisposing to disease. However, a recent large-scale genome-wide association study concluded that identified genetic factors, single nucleotide polymorphisms, do not account for overall familiality. Another class of genetic variation is the amplification or deletion of >1 kilobase segments of the genome, also termed copy number variations (CNVs). We performed genome-wide CNV analysis on a cohort of 20 unrelated adults with T1D and a control (Ctrl) cohort of 20 subjects using the Affymetrix SNP Array 6.0 in combination with the Birdsuite copy number calling software. We identified 39 CNVs as enriched or depleted in T1D versus Ctrl. Additionally, we performed CNV analysis in a group of 10 monozygotic twin pairs discordant for T1D. Eleven of these 39 CNVs were also respectively enriched or depleted in the Twin cohort, suggesting that these variants may be involved in the development of islet autoimmunity, as the presently unaffected twin is at high risk for developing islet autoimmunity and T1D in his or her lifetime. These CNVs include a deletion on chromosome 6p21, near an HLA-DQ allele. CNVs were found that were both enriched or depleted in patients with or at high risk for developing T1D. These regions may represent genetic variants contributing to development of islet autoimmunity in T1D.	[Grayson, Britney L.; Thomas, James W.; Aune, Thomas M.] Vanderbilt Univ, Sch Med, Dept Microbiol & Immunol, Nashville, TN 37212 USA; [Smith, Mary Ellen; Thomas, James W.; Aune, Thomas M.] Vanderbilt Univ, Sch Med, Div Rheumatol, Dept Med, Nashville, TN 37212 USA; [Wang, Lily] Vanderbilt Univ, Sch Med, Dept Biostat, Nashville, TN 37212 USA; [Jeffrey, Joy; Fain, Pamela R.; Nanduri, Priyaanka; Eisenbarth, George S.] Univ Colorado, Barbara Davis Ctr Childhood Diabet, Aurora, CO USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; University of Colorado System; University of Colorado Anschutz Medical Campus	Grayson, BL (corresponding author), Vanderbilt Univ, Sch Med, Dept Microbiol & Immunol, Nashville, TN 37212 USA.	tom.aune@vanderbilt.edu		Dexheimer, Phillip/0000-0003-3965-6894; Thomas, James/0000-0002-2098-6458	National Institutes of Health [R42 AI 053984, T32 GM07347, T32 DK07563, TL1 RR024978, AI50964]; NATIONAL CENTER FOR RESEARCH RESOURCES [TL1RR024978] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R42AI053984] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007563] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007347] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (http://www.nih.gov/) grants R42 AI 053984, T32 GM07347, T32 DK07563, TL1 RR024978, and AI50964. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; BAISCH JM, 1990, NEW ENGL J MED, V322, P1836, DOI 10.1056/NEJM199006283222602; Baranzini SE, 2010, NATURE, V464, P1351, DOI 10.1038/nature08990; Barrett JC, 2009, NAT GENET, V41, P703, DOI 10.1038/ng.381; Bashiardes S, 2004, HUM GENET, V115, P81, DOI 10.1007/s00439-004-1121-y; Bluestone JA, 2010, NATURE, V464, P1293, DOI 10.1038/nature08933; Bruder CEG, 2008, AM J HUM GENET, V82, P763, DOI 10.1016/j.ajhg.2007.12.011; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cahan P, 2009, NAT GENET, V41, P430, DOI 10.1038/ng.350; Craddock N, 2010, NATURE, V464, P713, DOI 10.1038/nature08979; DAVIES JL, 1994, NATURE, V371, P130, DOI 10.1038/371130a0; Grozeva D, 2010, ARCH GEN PSYCHIAT, V67, P318, DOI 10.1001/archgenpsychiatry.2010.25; Han KD, 2008, P NATL ACAD SCI USA, V105, P19366, DOI 10.1073/pnas.0807866105; Hindorff LA, CATALOG PUBLISHED GE; Hyttinen V, 2003, DIABETES, V52, P1052, DOI 10.2337/diabetes.52.4.1052; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Javierre BM, 2010, GENOME RES, V20, P170, DOI 10.1101/gr.100289.109; Kaminsky ZA, 2009, NAT GENET, V41, P240, DOI 10.1038/ng.286; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Korn JM, 2008, NAT GENET, V40, P1253, DOI 10.1038/ng.237; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lleo A, 2010, AUTOIMMUN REV, V9, pA259, DOI 10.1016/j.autrev.2009.12.002; LUPSKI JR, 1991, CELL, V66, P219, DOI 10.1016/0092-8674(91)90613-4; McCarroll SA, 2008, NAT GENET, V40, P1166, DOI 10.1038/ng.238; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; Ovcharenko I, 2004, NUCLEIC ACIDS RES, V32, pW280, DOI 10.1093/nar/gkh355; Piotrowski A, 2008, HUM MUTAT, V29, P1118, DOI 10.1002/humu.20815; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; PUGLIESE A, 1995, DIABETES, V44, P608, DOI 10.2337/diabetes.44.6.608; Redondo MJ, 2008, NEW ENGL J MED, V359, P2849, DOI 10.1056/NEJMc0805398; Rudd MK, 2009, HUM MOL GENET, V18, P2957, DOI 10.1093/hmg/ddp233; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; Schuster-Bockler B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009474; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Szigeti K, 2006, GENET MED, V8, P86, DOI 10.1097/01.gim.0000200160.29385.73; Tisch R, 1996, CELL, V85, P291, DOI 10.1016/S0092-8674(00)81106-X; Willcocks LC, 2008, J EXP MED, V205, P1573, DOI 10.1084/jem.20072413	39	26	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2010	5	11							e15393	10.1371/journal.pone.0015393	http://dx.doi.org/10.1371/journal.pone.0015393			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	680KW	21085585	Green Published, Green Submitted, gold			2022-12-27	WOS:000284231800029
J	Brown, LJ; Alawoki, M; Crawford, ME; Reida, T; Sears, A; Torma, T; Albig, AR				Brown, Leslie J.; Alawoki, Mariam; Crawford, Mary E.; Reida, Tiffany; Sears, Allison; Torma, Tory; Albig, Allan R.			Lipocalin-7 Is a Matricellular Regulator of Angiogenesis	PLOS ONE			English	Article							ENDOTHELIAL-CELL PROLIFERATION; RECEPTOR-LIKE KINASE-1; GROWTH-FACTOR-BETA; B-RELATED PROTEIN; VASCULAR DEVELOPMENT; EXPRESSION; GENE; IDENTIFICATION; MIGRATION; ROLES	Background: Matricellular proteins are extracellular regulators of cellular adhesion, signaling and performing a variety of physiological behaviors such as proliferation, migration and differentiation. Within vascular microenvironments, matricellular proteins exert both positive and negative regulatory cues to vascular endothelium. The relative balance of these matricellular cues is believed to be critical for vascular homeostasis, angiogenesis activation or angiogenesis resolution. However, our knowledge of matricellular proteins within vascular microenvironments and the mechanisms by which these proteins impact vascular function remain largely undefined. The matricellular protein lipocalin-7 (LCN7) is found throughout vascular microenvironments, and circumstantial evidence suggests that LCN7 may be an important regulator of angiogenesis. Therefore, we hypothesized that LCN7 may be an important regulator of vascular function. Methodology and Principal Findings: To test this hypothesis, we examined the effect of LCN7 overexpression, recombinant protein and gene knockdown in a series of in vitro and in vivo models of angiogenesis. We found that overexpression of LCN7 in MB114 and SVEC murine endothelial cell lines or administration of highly purified recombinant LCN7 protein increased endothelial cell invasion. Similarly, LCN7 increased angiogenic sprouting from quiescent endothelial cell monolayers and ex vivo aortic rings. Moreover, LCN7 increased endothelial cell sensitivity to TGF-beta but did not affect sensitivity to other pro-angiogenic growth factors including bFGF and VEGF. Finally, morpholino based knockdown of LCN7 in zebrafish embryos specifically inhibited angiogenic sprouting but did not affect vasculogenesis within injected embryos. Conclusions and Significance: No functional analysis has previously been performed to elucidate the function of LCN7 in vascular or other cellular processes. Collectively, our results show for the first time that LCN7 is an important pro-angiogenic matricellular protein of vascular microenvironments.	[Brown, Leslie J.; Alawoki, Mariam; Crawford, Mary E.; Reida, Tiffany; Sears, Allison; Torma, Tory; Albig, Allan R.] Indiana State Univ, Dept Biol, Terre Haute, IN 47809 USA	Indiana State University	Brown, LJ (corresponding author), Indiana State Univ, Dept Biol, Terre Haute, IN 47809 USA.	allen.albig@indstate.edu			National Institutes of Health [3R15CA133829-01A1S1]; Indiana State University; Indiana State University Research Council [UNR286]; NATIONAL CANCER INSTITUTE [R15CA133829] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Indiana State University; Indiana State University Research Council; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the National Institutes of Health (# 3R15CA133829-01A1S1), the Indiana State University Promising Scholars Fund, and the Indiana State University Research Council (UNR286) to ARA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albig Allan R., 2007, Angiogenesis, V10, P197, DOI 10.1007/s10456-007-9075-z; Albig AR, 2006, CANCER RES, V66, P2621, DOI 10.1158/0008-5472.CAN-04-4096; Albig AR, 2005, MOL BIOL CELL, V16, P609, DOI 10.1091/mbc.e04-06-0479; Albig AR, 2004, DNA CELL BIOL, V23, P367, DOI 10.1089/104454904323145254; ALBIG AR, 2008, MICROVASC RES; Bornstein P, 2002, CURR OPIN CELL BIOL, V14, P608, DOI 10.1016/S0955-0674(02)00361-7; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; David L, 2007, J CELL PHYSIOL, V213, P484, DOI 10.1002/jcp.21126; Favre CJ, 2003, AM J PHYSIOL-HEART C, V285, pH1917, DOI 10.1152/ajpheart.00983.2002; Fee D, 2000, CYTOKINE, V12, P655, DOI 10.1006/cyto.1999.0599; Flower DR, 2000, BBA-PROTEIN STRUCT M, V1482, P9, DOI 10.1016/S0167-4838(00)00148-5; FOLKMAN J, 1992, J BIOL CHEM, V267, P10931; Folkman J, 2003, CURR MOL MED, V3, P643, DOI 10.2174/1566524033479465; Helton R, 2005, J NEUROSCI, V25, P4099, DOI 10.1523/JNEUROSCI.4555-04.2005; Igarashi T, 2009, BIOL REPROD, V81, P948, DOI 10.1095/biolreprod.109.078162; Jain RK, 2003, NAT MED, V9, P685, DOI 10.1038/nm0603-685; Kobayashi M, 2001, J STEROID BIOCHEM, V77, P109, DOI 10.1016/S0960-0760(01)00039-5; Lamouille S, 2002, BLOOD, V100, P4495, DOI 10.1182/blood.V100.13.4495; Lawson ND, 2001, DEVELOPMENT, V128, P3675; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; Lebrin F, 2005, CARDIOVASC RES, V65, P599, DOI 10.1016/j.cardiores.2004.10.036; Lebrin F, 2004, EMBO J, V23, P4018, DOI 10.1038/sj.emboj.7600386; Lee NY, 2008, J BIOL CHEM, V283, P32527, DOI 10.1074/jbc.M803059200; Li D, 2007, FEBS J, V274, P2506, DOI 10.1111/j.1742-4658.2007.05786.x; Liotta LA, 2001, NATURE, V411, P375, DOI 10.1038/35077241; Lutgens SPM, 2007, FASEB J, V21, P3029, DOI 10.1096/fj.06-7924com; Maquart FX, 2004, CRIT REV ONCOL HEMAT, V49, P199, DOI 10.1016/j.critrevonc.2003.06.007; Mettouchi A, 2006, EUR J CELL BIOL, V85, P243, DOI 10.1016/j.ejcb.2005.09.010; Mukai K, 2003, J BIOL CHEM, V278, P17084, DOI 10.1074/jbc.M301477200; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; OCONNELL KA, 1990, J IMMUNOL, V144, P521; Oh SP, 2000, P NATL ACAD SCI USA, V97, P2626, DOI 10.1073/pnas.97.6.2626; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Scharpfenecker M, 2007, J CELL SCI, V120, P964, DOI 10.1242/jcs.002949; Sottile J, 2004, BBA-REV CANCER, V1654, P13, DOI 10.1016/j.bbcan.2003.07.002; Tajiri Y, 2010, BIOL REPROD, V82, P263, DOI 10.1095/biolreprod.109.080028; Tian MZ, 2009, TRANSL ONCOL, V2, P174, DOI 10.1593/tlo.09145; Tong ZM, 2008, CANCER RES, V68, P6100, DOI 10.1158/0008-5472.CAN-08-0540; Wex T, 2001, BIOCHEMISTRY-US, V40, P1350, DOI 10.1021/bi002266o	39	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2010	5	11							e13905	10.1371/journal.pone.0013905	http://dx.doi.org/10.1371/journal.pone.0013905			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	677ZE	21085487	Green Submitted, Green Published, gold			2022-12-27	WOS:000284035900013
J	Curchoe, CL; Maurer, J; McKeown, SJ; Cattarossi, G; Cimadamore, F; Nilbratt, M; Snyder, EY; Bronner-Fraser, M; Terskikh, AV				Curchoe, Carol Lynn; Maurer, Jochen; McKeown, Sonja J.; Cattarossi, Giulio; Cimadamore, Flavio; Nilbratt, Mats; Snyder, Evan Y.; Bronner-Fraser, Marianne; Terskikh, Alexey V.			Early Acquisition of Neural Crest Competence During hESCs Neuralization	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; HORMONE GNRH CELLS; EXTRACELLULAR-MATRIX; NERVOUS-SYSTEM; AVIAN EMBRYOS; BMP GRADIENT; DANIO-RERIO; IN-VITRO; HUMAN ES; C-RET	Background: Neural crest stem cells (NCSCs) are a transient multipotent embryonic cell population that represents a defining characteristic of vertebrates. The neural crest (NC) gives rise to many derivatives including the neurons and glia of the sensory and autonomic ganglia of the peripheral nervous system, enteric neurons and glia, melanocytes, and the cartilaginous, bony and connective tissue of the craniofacial skeleton, cephalic neuroendocrine organs, and some heart vessels. Methodology/Principal Findings: We present evidence that neural crest (NC) competence can be acquired very early when human embryonic stem cells (hESCs) are selectively neuralized towards dorsal neuroepithelium in the absence of feeder cells in fully defined conditions. When hESC-derived neurospheres are plated on fibronectin, some cells emigrate onto the substrate. These early migratory Neural Crest Stem Cells (emNCSCs) uniformly upregulate Sox10 and vimentin, downregulate N-cadherin, and remodel F-actin, consistent with a transition from neuroepithelium to a mesenchymal NC cell. Over 13% of emNCSCs upregulate CD73, a marker of mesenchymal lineage characteristic of cephalic NC and connexin 43, found on early migratory NC cells. We demonstrated that emNCSCs give rise in vitro to all NC lineages, are multipotent on clonal level, and appropriately respond to developmental factors. We suggest that human emNCSC resemble cephalic NC described in model organisms. Ex vivo emNCSCs can differentiate into neurons in Ret.k(-) mouse embryonic gut tissue cultures and transplanted emNCSCs incorporate into NC-derived structures but not CNS tissues in chick embryos. Conclusions/Significance: These findings will provide a framework for further studying early human NC development including the epithelial to mesenchymal transition during NC delamination.	[Curchoe, Carol Lynn; Maurer, Jochen; Cattarossi, Giulio; Cimadamore, Flavio; Nilbratt, Mats; Snyder, Evan Y.; Terskikh, Alexey V.] Sanford Burnham Inst Med Res, La Jolla, CA USA; [McKeown, Sonja J.; Bronner-Fraser, Marianne] CALTECH, Pasadena, CA 91125 USA	Sanford Burnham Prebys Medical Discovery Institute; California Institute of Technology	Curchoe, CL (corresponding author), Sanford Burnham Inst Med Res, La Jolla, CA USA.	terskikh@burnham.org	Maurer, Jochen/G-4832-2018; Terskikh, Alexey/U-8407-2019; Curchoe, Carol/AAL-6318-2021	Maurer, Jochen/0000-0003-3962-3128; Bronner, Marianne/0000-0003-4274-1862; McKeown, Sonja/0000-0002-7318-116X; Cimadamore, Flavio/0000-0002-3649-0545	California Institute for Regenerative Medicine Seed [RS1-00466-1]	California Institute for Regenerative Medicine Seed	Funded by California Institute for Regenerative Medicine Seed grant RS1-00466-1 to Alexey V. Terskikh. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DJ, 1997, COLD SPRING HARB SYM, V62, P493; Anderson RB, 2006, ADV EXP MED BIOL, V589, P181; Bajpai R, 2009, CELL DEATH DIFFER, V16, P807, DOI 10.1038/cdd.2009.18; Bannerman P, 2000, J NEUROSCI RES, V61, P605, DOI 10.1002/1097-4547(20000915)61:6<605::AID-JNR4>3.0.CO;2-U; Barembaum M, 2005, SEMIN CELL DEV BIOL, V16, P642, DOI 10.1016/j.semcdb.2005.06.006; BAROFFIO A, 1988, P NATL ACAD SCI USA, V85, P5325, DOI 10.1073/pnas.85.14.5325; Basch ML, 2006, NATURE, V441, P218, DOI 10.1038/nature04684; Bobola N, 2008, GENESIS, V46, P52, DOI 10.1002/dvg.20360; Bronner-Fraser M, 2002, J PHYSIOLOGY-PARIS, V96, P3, DOI 10.1016/S0928-4257(01)00074-2; Bronner-Fraser Marianne, 2003, Harvey Lect, V99, P129; BRONNERFRASER M, 1986, DEV BIOL, V115, P44, DOI 10.1016/0012-1606(86)90226-5; Burstyn-Cohen T, 2004, DEVELOPMENT, V131, P5327, DOI 10.1242/dev.01424; Carmona-Fontaine C, 2007, DEV BIOL, V309, P208, DOI 10.1016/j.ydbio.2007.07.006; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Cheung M, 2003, DEVELOPMENT, V130, P5681, DOI 10.1242/dev.00808; Colleoni S, 2010, EXP CELL RES, V316, P1148, DOI 10.1016/j.yexcr.2010.02.013; Creuzet S, 2005, J ANAT, V207, P447, DOI 10.1111/j.1469-7580.2005.00485.x; Dottori M, 2001, DEVELOPMENT, V128, P4127; Duband JL, 2006, ADV EXP MED BIOL, V589, P45; Durbec PL, 1996, DEVELOPMENT, V122, P349; Elkabetz Y, 2008, GENE DEV, V22, P152, DOI 10.1101/gad.1616208; Engler A. J., 2007, Journal of Musculoskeletal & Neuronal Interactions, V7, P335; Even-Ram S, 2006, CELL, V126, P645, DOI 10.1016/j.cell.2006.08.008; Fang D, 2006, STEM CELLS, V24, P1668, DOI 10.1634/stemcells.2005-0414; Garcia-Castro MI, 2002, SCIENCE, V297, P848, DOI 10.1126/science.1070824; Gossrau G, 2007, STEM CELLS, V25, P939, DOI 10.1634/stemcells.2006-0299; Grillet N, 2003, J NEUROSCI, V23, P10613; Hearn CJ, 1999, DEV DYNAM, V214, P239, DOI 10.1002/(SICI)1097-0177(199903)214:3<239::AID-AJA7>3.0.CO;2-O; Henderson DJ, 1997, J ANAT, V191, P507, DOI 10.1046/j.1469-7580.1997.19140507.x; Hong CS, 2007, MOL BIOL CELL, V18, P2192, DOI 10.1091/mbc.E06-11-1047; Ido A, 2006, DEV DYNAM, V235, P361, DOI 10.1002/dvdy.20635; JIANG X, 2008, STEM CELLS DEV; Kawaguchi J, 2010, DEVELOPMENT, V137, P693, DOI 10.1242/dev.046896; Kleber M, 2005, J CELL BIOL, V169, P309, DOI 10.1083/jcb.200411095; Knecht AK, 2002, NAT REV GENET, V3, P453, DOI 10.1038/nrg819; LaBonne C, 1999, ANNU REV CELL DEV BI, V15, P81, DOI 10.1146/annurev.cellbio.15.1.81; LaBonne C, 1998, DEVELOPMENT, V125, P2403; Lang D, 2000, J CLIN INVEST, V106, P963, DOI 10.1172/JCI10828; Lazzari G, 2006, STEM CELLS, V24, P2514, DOI 10.1634/stemcells.2006-0149; Le Douarin NM, 2008, CELL CYCLE, V7, P1013, DOI 10.4161/cc.7.8.5641; Lee G, 2007, NAT BIOTECHNOL, V25, P1468, DOI 10.1038/nbt1365; Marchant L, 1998, DEV BIOL, V198, P319, DOI 10.1006/dbio.1998.8902; Marsot-Dupuch K, 2004, AM J NEURORADIOL, V25, P285; Maurer J, 2007, DIFFERENTIATION, V75, P580, DOI 10.1111/j.1432-0436.2007.00164.x; McKeown SJ, 2003, DEV BIOL, V255, P62, DOI 10.1016/S0012-1606(02)00076-3; Meulemans D, 2004, DEV CELL, V7, P291, DOI 10.1016/j.devcel.2004.08.007; Mizuseki K, 2003, P NATL ACAD SCI USA, V100, P5828, DOI 10.1073/pnas.1037282100; Monsoro-Burq AH, 2005, DEV CELL, V8, P167, DOI 10.1016/j.devcel.2004.12.017; Morrison SJ, 1999, CELL, V96, P737, DOI 10.1016/S0092-8674(00)80583-8; Newgreen DF, 1996, DEV BIOL, V176, P300, DOI 10.1006/dbio.1996.0135; NEWGREEN DF, 1985, CELL TISSUE RES, V239, P329; Nikopoulos GN, 2007, STEM CELLS, V25, P3133, DOI 10.1634/stemcells.2007-0327; O'Rahilly R, 2007, J ANAT, V211, P335, DOI 10.1111/j.1469-7580.2007.00773.x; Paratore C, 2001, DEVELOPMENT, V128, P3949; Pattyn A, 1999, NATURE, V399, P366, DOI 10.1038/20700; Pla P, 2001, J CELL PHYSIOL, V189, P121, DOI 10.1002/jcp.10008; POMP O, 2005, STEM CELLS; PORTIER MM, 1984, DEV NEUROSCI-BASEL, V6, P335, DOI 10.1159/000112360; Raible DW, 2006, CURR OPIN CELL BIOL, V18, P698, DOI 10.1016/j.ceb.2006.09.003; Rao MS, 1997, J NEUROBIOL, V32, P722, DOI 10.1002/(SICI)1097-4695(19970620)32:7<722::AID-NEU7>3.0.CO;2-6; Relaix F, 2004, GENE DEV, V18, P1088, DOI 10.1101/gad.301004; Sakai D, 2006, DEVELOPMENT, V133, P1323, DOI 10.1242/dev.02297; Sander M, 2000, GENE DEV, V14, P2134, DOI 10.1101/gad.820400; Sato T, 2005, DEVELOPMENT, V132, P2355, DOI 10.1242/dev.01823; Selleck MAJ, 1998, DEVELOPMENT, V125, P4919; SERBEDZIJA GN, 1989, DEVELOPMENT, V106, P809; Shah NM, 1996, CELL, V85, P331, DOI 10.1016/S0092-8674(00)81112-5; Shoval I, 2007, DEVELOPMENT, V134, P491, DOI 10.1242/dev.02742; Stanke M, 1999, DEVELOPMENT, V126, P4087; Tagra Sunita, 2006, Indian J Dermatol Venereol Leprol, V72, P326; Taneyhill LA, 2005, MOL BIOL CELL, V16, P5283, DOI 10.1091/mbc.e05-03-0210; Thomas S, 2008, HUM MOL GENET, V17, P3411, DOI 10.1093/hmg/ddn235; Tribulo C, 2003, DEVELOPMENT, V130, P6441, DOI 10.1242/dev.00878; Wakamatsu Y, 1997, DEVELOPMENT, V124, P3449; Whitlock KE, 2003, DEV BIOL, V257, P140, DOI 10.1016/S0012-1606(03)00039-3; Whitlock KE, 2005, DEVELOPMENT, V132, P5491, DOI 10.1242/dev.02158; Wilson YM, 2004, DEVELOPMENT, V131, P6153, DOI 10.1242/dev.01533; Wong CE, 2006, J CELL BIOL, V175, P1005, DOI 10.1083/jcb.200606062; Yoshida S, 2006, STEM CELLS, V24, P2714, DOI 10.1634/stemcells.2006-0156; Yu HS, 2002, J BIOMED SCI, V9, P564, DOI 10.1159/000037283	80	63	66	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2010	5	11							e13890	10.1371/journal.pone.0013890	http://dx.doi.org/10.1371/journal.pone.0013890			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	677ZE	21085480	Green Published, gold, Green Accepted			2022-12-27	WOS:000284035900007
J	Doitsidou, M; Poole, RJ; Sarin, S; Bigelow, H; Hobert, O				Doitsidou, Maria; Poole, Richard J.; Sarin, Sumeet; Bigelow, Henry; Hobert, Oliver			C. elegans Mutant Identification with a One-Step Whole-Genome-Sequencing and SNP Mapping Strategy	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS	Whole-genome sequencing (WGS) is becoming a fast and cost-effective method to pinpoint molecular lesions in mutagenized genetic model systems, such as Caenorhabditis elegans. As mutagenized strains contain a significant mutational load, it is often still necessary to map mutations to a chromosomal interval to elucidate which of the WGS-identified sequence variants is the phenotype-causing one. We describe here our experience in setting up and testing a simple strategy that incorporates a rapid SNP-based mapping step into the WGS procedure. In this strategy, a mutant retrieved from a genetic screen is crossed with a polymorphic C. elegans strain, individual F2 progeny from this cross is selected for the mutant phenotype, the progeny of these F2 animals are pooled and then whole-genome-sequenced. The density of polymorphic SNP markers is decreased in the region of the phenotype-causing sequence variant and therefore enables its identification in the WGS data. As a proof of principle, we use this strategy to identify the molecular lesion in a mutant strain that produces an excess of dopaminergic neurons. We find that the molecular lesion resides in the Pax-6/Eyeless ortholog vab-3. The strategy described here will further reduce the time between mutant isolation and identification of the molecular lesion.	[Doitsidou, Maria; Poole, Richard J.; Sarin, Sumeet; Bigelow, Henry; Hobert, Oliver] Columbia Univ, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, Med Ctr, New York, NY 10032 USA	Columbia University; Howard Hughes Medical Institute	Doitsidou, M (corresponding author), Columbia Univ, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, Med Ctr, New York, NY 10032 USA.	md2398@columbia.edu; or38@columbia.edu		Hobert, Oliver/0000-0002-7634-2854; Poole, Richard/0000-0001-6414-2479	Howard Hughes Medical Institute; National Institutes of Health	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded by the Howard Hughes Medical Institute and the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bigelow H, 2009, NAT METHODS, V6, P549, DOI 10.1038/nmeth.f.260; CHISHOLM AD, 1995, NATURE, V377, P52, DOI 10.1038/377052a0; Davis MW, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-118; Doitsidou M, 2008, NAT METHODS, V5, P869, DOI 10.1038/NMETH.1250; Flowers EB, 2010, DEVELOPMENT, V137, P1799, DOI 10.1242/dev.046219; Hillier LW, 2008, NAT METHODS, V5, P183, DOI 10.1038/NMETH.1179; HOBERT O, 2010, GENETICS IN PRESS; Hodgkin J, 1997, GENETICS, V146, P149; Kennedy S, 2004, NATURE, V427, P645, DOI 10.1038/nature02302; Rockman MV, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000419; Sarin S, 2008, NAT METHODS, V5, P865, DOI 10.1038/NMETH.1249; Sarin S, 2010, GENETICS, V185, P417, DOI 10.1534/genetics.110.116319; Schneeberger K, 2009, NAT METHODS, V6, P550, DOI 10.1038/nmeth0809-550; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Wicks SR, 2001, NAT GENET, V28, P160, DOI 10.1038/88878; WILLIAMS BD, 1992, GENETICS, V131, P609; Zuryn S, 2010, GENETICS, V186, P427, DOI 10.1534/genetics.110.119230	17	146	149	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2010	5	11							e15435	10.1371/journal.pone.0015435	http://dx.doi.org/10.1371/journal.pone.0015435			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	676NU	21079745	Green Published, Green Submitted, gold			2022-12-27	WOS:000283920000025
J	Iken, K; Konar, B; Benedetti-Cecchi, L; Cruz-Motta, JJ; Knowlton, A; Pohle, G; Mead, A; Miloslavich, P; Wong, M; Trott, T; Mieszkowska, N; Riosmena-Rodriguez, R; Airoldi, L; Kimani, E; Shirayama, Y; Fraschetti, S; Ortiz-Touzet, M; Silva, A				Iken, Katrin; Konar, Brenda; Benedetti-Cecchi, Lisandro; Jose Cruz-Motta, Juan; Knowlton, Ann; Pohle, Gerhard; Mead, Angela; Miloslavich, Patricia; Wong, Melisa; Trott, Thomas; Mieszkowska, Nova; Riosmena-Rodriguez, Rafael; Airoldi, Laura; Kimani, Edward; Shirayama, Yoshihisa; Fraschetti, Simonetta; Ortiz-Touzet, Manuel; Silva, Angelica			Large-Scale Spatial Distribution Patterns of Echinoderms in Nearshore Rocky Habitats	PLOS ONE			English	Article							SEA STARS ECHINODERMATA; SPECIES-DIVERSITY; LATITUDINAL GRADIENTS; TAXONOMIC DISTINCTNESS; BIODIVERSITY PATTERNS; PARACENTROTUS-LIVIDUS; LYTECHINUS-VARIEGATUS; BENTHIC COMMUNITIES; ARBACIA-LIXULA; ASSEMBLAGES	This study examined echinoderm assemblages from nearshore rocky habitats for large-scale distribution patterns with specific emphasis on identifying latitudinal trends and large regional hotspots. Echinoderms were sampled from 76 globally-distributed sites within 12 ecoregions, following the standardized sampling protocol of the Census of Marine Life NaGISA project (www.nagisa.coml.org). Sample-based species richness was overall low (<1-5 species per site), with a total of 32 asteroid, 18 echinoid, 21 ophiuroid, and 15 holothuroid species. Abundance and species richness in intertidal assemblages sampled with visual methods (organisms >2 cm in 1 m(2) quadrats) was highest in the Caribbean ecoregions and echinoids dominated these assemblages with an average of 5 ind m(-2). In contrast, intertidal echinoderm assemblages collected from clearings of 0.0625 m(2) quadrats had the highest abundance and richness in the Northeast Pacific ecoregions where asteroids and holothurians dominated with an average of 14 ind 0.0625 m(-2). Distinct latitudinal trends existed for abundance and richness in intertidal assemblages with declines from peaks at high northern latitudes. No latitudinal trends were found for subtidal echinoderm assemblages with either sampling technique. Latitudinal gradients appear to be superseded by regional diversity hotspots. In these hotspots echinoderm assemblages may be driven by local and regional processes, such as overall productivity and evolutionary history. We also tested a set of 14 environmental variables (six natural and eight anthropogenic) as potential drivers of echinoderm assemblages by ecoregions. The natural variables of salinity, sea-surface temperature, chlorophyll a, and primary productivity were strongly correlated with echinoderm assemblages; the anthropogenic variables of inorganic pollution and nutrient contamination also contributed to correlations. Our results indicate that nearshore echinoderm assemblages appear to be shaped by a network of environmental and ecological processes, and by the differing responses of various echinoderm taxa, making generalizations about the patterns of nearshore rocky habitat echinoderm assemblages difficult.	[Iken, Katrin; Konar, Brenda; Knowlton, Ann] Univ Alaska Fairbanks, Sch Fisheries & Ocean Sci, Fairbanks, AK USA; [Benedetti-Cecchi, Lisandro] Univ Pisa, Dept Biol, Pisa, Italy; [Jose Cruz-Motta, Juan; Miloslavich, Patricia] Univ Simon Bolivar, Ctr Biodiversidad Marina, Dept Estudios Ambientales, Caracas, Venezuela; [Pohle, Gerhard] Huntsman Marine Sci Ctr, Atlantic Reference Ctr, St Andrews, NB, Canada; [Mead, Angela] Univ Cape Town, Dept Zool, ZA-7700 Rondebosch, South Africa; [Wong, Melisa; Silva, Angelica] Bedford Inst Oceanog, Dartmouth, NS, Canada; [Trott, Thomas] Suffolk Univ, Dept Biol, Boston, MA 02114 USA; [Mieszkowska, Nova] Marine Biol Assoc UK, Plymouth, Devon, England; [Riosmena-Rodriguez, Rafael] Univ Bologna, Ctr Interdipartimentale Ric Sci Ambientali, Ravenna, Italy; [Airoldi, Laura] Kenya Marine & Fisheries Res Inst, Mombasa, Kenya; [Kimani, Edward] Univ Autonoma Baja California Sur, Dept Biol Marina, Programa Invest Bot Marina, La Paz, Baja Calif Sur, Mexico; [Shirayama, Yoshihisa] Kyoto Univ, Seto Marine Biol Lab, Wakayama, Japan; [Fraschetti, Simonetta] Univ Salento, Dipartimento Sci & Tecnol Biol & Ambientali, Lab Zool & Biol Marina, Lecce, Italy; [Ortiz-Touzet, Manuel] Univ La Habana, Ctr Invest Marinas, Havana, Cuba	University of Alaska System; University of Alaska Fairbanks; University of Pisa; Simon Bolivar University; University of Cape Town; Bedford Institute of Oceanography; Suffolk University; Marine Biological Association United Kingdom; University of Bologna; Universidad Autonoma de Baja California; Kyoto University; University of Salento; Universidad de la Habana	Iken, K (corresponding author), Univ Alaska Fairbanks, Sch Fisheries & Ocean Sci, Fairbanks, AK USA.	iken@ims.uaf.edu	Airoldi, Laura/I-3553-2019; Fraschetti, Simonetta/R-8716-2019; Mieszkowska, Nova/U-8479-2019; Trott, Thomas J/N-4660-2018; Benedetti-Cecchi, Lisandro/J-8225-2019; Silva, Angelica J/GRO-4906-2022	Airoldi, Laura/0000-0001-5046-0871; Fraschetti, Simonetta/0000-0002-1780-1651; Mieszkowska, Nova/0000-0002-9570-7759; Trott, Thomas J/0000-0002-1851-5243; Benedetti-Cecchi, Lisandro/0000-0001-5244-5202; Miloslavich, Patricia/0000-0001-5409-1401; Cruz Motta, Juan Jose/0000-0001-6117-9014	Alfred P. Sloan Foundation; History of the Near Shore program; Suffolk University, Boston, Massachusetts, USA; Department of Fisheries and Oceans Canada; University of Bologna; Nippon Foundation; Japan Society for Promotion of Science; Gulf Ecosystem Monitoring Program; US Minerals Management Service; NERC [mba010003] Funding Source: UKRI; Natural Environment Research Council [mba010003] Funding Source: researchfish	Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); History of the Near Shore program; Suffolk University, Boston, Massachusetts, USA; Department of Fisheries and Oceans Canada; University of Bologna; Nippon Foundation(Nippon Foundation); Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Gulf Ecosystem Monitoring Program; US Minerals Management Service; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Funding: We would like to express our most sincere gratitude to the Alfred P. Sloan Foundation for funding. Support from the History of the Near Shore program was instrumental for collections in South Africa (AM), United Kingdom (NM), and Maine, USA (TT). For sampling in Maine, logistical support in the field and financial aid for data collection and processing was also provided by Suffolk University, Boston, Massachusetts, USA to TT. Collections at Canso, Canada were support by the Department of Fisheries and Oceans Canada to MS and AS. Collections at Conero Riviera, Italy were supported by the AdriaBio project (University of Bologna Strategic Project, 2007-2009) to LA. Support for sites in Japan was provided by the Nippon Foundation, Japan Society for Promotion of Science to YS. Funding for data collection in the Gulf of Alaska came from the Gulf Ecosystem Monitoring Program to BK and KI. Sampling in the Arctic was supported by the US Minerals Management Service to KI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADDESSI L, 1994, ECOL APPL, V4, P786, DOI 10.2307/1942008; Airoldi L, 2007, OCEANOGR MAR BIOL, V45, P345; Allen AP, 2006, P NATL ACAD SCI USA, V103, P9130, DOI 10.1073/pnas.0603587103; Allen AP, 2002, SCIENCE, V297, P1545, DOI 10.1126/science.1072380; Ambrose WG, 2001, MAR BIOL, V139, P937; Aronson RB, 2001, AM ZOOL, V41, P27, DOI 10.1668/0003-1569(2001)041[0027:GCCATO]2.0.CO;2; Barnes DKA, 1999, J MAR BIOL ASSOC UK, V79, P401, DOI 10.1017/S0025315498000514; Barnes DKA, 2003, MAR ECOL PROG SER, V259, P17, DOI 10.3354/meps259017; Barnes DKA, 2002, P ROY SOC B-BIOL SCI, V269, P2061, DOI 10.1098/rspb.2002.2105; BEAUCHAMP KA, 1982, MAR ENVIRON RES, V7, P279, DOI 10.1016/0141-1136(82)90020-4; Beck MW., 2003, ISSUES ECOL, V11, P1; Behrenfeld MJ, 1997, LIMNOL OCEANOGR, V42, P1, DOI 10.4319/lo.1997.42.1.0001; Benedetti-Cecchi L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012946; BENEDETTICECCHI L, 1995, MAR ECOL PROG SER, V126, P203, DOI 10.3354/meps126203; Benkendorff K, 2005, T ROY SOC SOUTH AUST, V129, P145; BILLETT DSM, 1991, OCEANOGR MAR BIOL, V29, P259; BLAKE DB, 1990, B MAR SCI, V46, P701; Blanchette CA, 2009, PROG OCEANOGR, V83, P107, DOI 10.1016/j.pocean.2009.07.038; BOLTON JJ, 1994, BOT MAR, V37, P241, DOI 10.1515/botm.1994.37.3.241; Brandt A, 2007, NATURE, V447, P307, DOI 10.1038/nature05827; BREY T, 1994, NATURE, V368, P297, DOI 10.1038/368297a0; Brickley PJ, 2004, DEEP-SEA RES PT II, V51, P229, DOI 10.1016/j.dsr2.2003.06.003; BUSTAMANTE RH, 1995, OECOLOGIA, V102, P189, DOI 10.1007/BF00333251; Carr ME, 2001, DEEP-SEA RES PT II, V49, P59; CHAPMAN ARO, 1981, MAR BIOL, V62, P307, DOI 10.1007/BF00397697; Chenelot Heloise, 2007, V8, P11; Chiarucci A, 2008, COMMUNITY ECOL, V9, P121, DOI 10.1556/ComEc.9.2008.1.14; Cintra-Buenrostro CE, 2005, REV BIOL TROP, V53, P245; Clarke A, 2004, ANTARCT SCI, V16, P559, DOI 10.1017/S0954102004002329; Clarke A, 2006, P ROY SOC B-BIOL SCI, V273, P2257, DOI 10.1098/rspb.2006.3545; Clarke KR, 2006, J EXP MAR BIOL ECOL, V330, P55, DOI 10.1016/j.jembe.2005.12.017; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; Coates M, 1998, GLOBAL ECOL BIOGEOGR, V7, P115, DOI 10.2307/2997814; CONNELL JH, 1964, AM NAT, V98, P399, DOI 10.1086/282335; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; Coteur G, 2001, MAR POLLUT BULL, V42, P667, DOI 10.1016/S0025-326X(01)00063-7; Crame J. Alistair, 2001, Diversity and Distributions, V7, P175, DOI 10.1111/j.1472-4642.2001.00106.x; Crame JA, 2002, PALEOBIOLOGY, V28, P184; CRUZMOTTA JJ, 2010, PLOS ONE IN PRESS; DAFNI J, 1980, J EXP MAR BIOL ECOL, V47, P259, DOI 10.1016/0022-0981(80)90043-X; Dafni J., 2008, AQABA EILAT IMPROBAB, P225; De Domenico F, 2006, ANTARCT SCI, V18, P655, DOI 10.1017/S095410200600068X; Dimech M, 2002, B MAR SCI, V71, P1309; Dulvy NK, 2003, FISH FISH, V4, P25, DOI 10.1046/j.1467-2979.2003.00105.x; Ebert T.A., 1983, Echinoderm Studies, V1, P169; Edmunds PJ, 2001, P NATL ACAD SCI USA, V98, P5067, DOI 10.1073/pnas.071524598; Ellingsen KE, 2002, J ANIM ECOL, V71, P373, DOI 10.1046/j.1365-2656.2002.00606.x; Ellis JR, 2000, J MAR BIOL ASSOC UK, V80, P127, DOI 10.1017/S0025315499001642; ENGEMAN RM, 1994, ECOLOGY, V75, P1769, DOI 10.2307/1939636; ESTES JA, 1974, SCIENCE, V185, P1058, DOI 10.1126/science.185.4156.1058; FRANCOUR P, 1994, MAR POLLUT BULL, V28, P523, DOI 10.1016/0025-326X(94)90071-X; Fraser RH, 1996, AM NAT, V148, P138, DOI 10.1086/285915; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; Gray JS, 1997, BIODIVERS CONSERV, V6, P153, DOI 10.1023/A:1018335901847; Gray JS, 2001, POLAR BIOL, V24, P633, DOI 10.1007/s003000100244; Gray JS, 2000, J EXP MAR BIOL ECOL, V250, P23, DOI 10.1016/S0022-0981(00)00178-7; Guidetti P, 2007, MAR ENVIRON RES, V63, P168, DOI 10.1016/j.marenvres.2006.08.002; Guidetti P, 2005, MAR BIOL, V147, P797, DOI 10.1007/s00227-005-1611-z; Guidetti P, 2007, MAR ECOL PROG SER, V335, P43, DOI 10.3354/meps335043; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Harrold C., 1987, Echinoderm Studies, V2, P137; Hickman Cleveland P. Jr., 2009, Galapagos Research, V66, P32; Hillebrand H, 2004, AM NAT, V163, P192, DOI 10.1086/381004; Huston MA, 1999, OIKOS, V86, P393, DOI 10.2307/3546645; Iken K, 2001, PROG OCEANOGR, V50, P383, DOI 10.1016/S0079-6611(01)00062-3; Jennings LB, 2010, MAR BIOL, V157, P307, DOI 10.1007/s00227-009-1318-7; KENDALL MA, 1993, J EXP MAR BIOL ECOL, V172, P157, DOI 10.1016/0022-0981(93)90095-6; Kilpatrick KA, 2001, J GEOPHYS RES-OCEANS, V106, P9179, DOI 10.1029/1999JC000065; KOBAYASHI N, 1977, PUBL SETO MAR BIOL, V24, P9; KONAR B, 2010, PLOS ONE IN PRESS; Konar B, 2009, MAR ECOL-EVOL PERSP, V30, P63, DOI 10.1111/j.1439-0485.2008.00259.x; Kotwicki L, 2005, BIODIVERS CONSERV, V14, P461, DOI 10.1007/10531-004-6272-6; Kuklinski P, 2006, MAR BIOL, V149, P1577, DOI 10.1007/s00227-006-0311-7; LEIGH EG, 1987, P NATL ACAD SCI USA, V84, P1314, DOI 10.1073/pnas.84.5.1314; Lindeboom H, 2002, OCEANS 2020: SCIENCE TRENDS AND THE CHALLENGE OF SUSTAINABILITY, P49; Magurran Anne E., 2009, MEASURING BIOL DIVER; McClain CR, 2004, DEEP-SEA RES PT II, V51, P5, DOI 10.1016/j.dsr2.2003.11.001; MCCLANAHAN TR, 1990, OECOLOGIA, V83, P362, DOI 10.1007/BF00317561; MCCLINTOCK JB, 1986, PSZNI MAR ECOL, V7, P321, DOI 10.1111/j.1439-0485.1986.tb00167.x; Menge BA, 1997, P NATL ACAD SCI USA, V94, P14530, DOI 10.1073/pnas.94.26.14530; Miller AW, 2000, MAR ECOL PROG SER, V196, P1, DOI 10.3354/meps196001; Mittelbach GG, 2007, ECOL LETT, V10, P315, DOI 10.1111/j.1461-0248.2007.01020.x; Neira R, 2005, REV BIOL TROP, V53, P195; O'Hara TD, 2000, J BIOGEOGR, V27, P1321, DOI 10.1046/j.1365-2699.2000.00499.x; Okuda T, 2004, POPUL ECOL, V46, P159, DOI 10.1007/s10144-004-0185-9; PAINE RT, 1966, AM NAT, V100, P65, DOI 10.1086/282400; PAINE RT, 1974, OECOLOGIA, V15, P93, DOI 10.1007/BF00345739; Pancucci M.A, 1993, QUANTIFIED PHENOTYPI, P247; PEARSE JS, 2009, J CORAL REEF STUD, V11, P1; PIANKA ER, 1966, AM NAT, V100, P33, DOI 10.1086/282398; Piepenburg D, 1997, POLAR BIOL, V17, P305, DOI 10.1007/PL00013372; PIEPENBURG D, 1995, MAR ECOL PROG SER, V118, P199, DOI 10.3354/meps118199; POORE GCB, 1993, NATURE, V361, P597, DOI 10.1038/361597a0; PORTER JW, 1972, AM NAT, V106, P487, DOI 10.1086/282789; PRICE ARG, 1982, J NAT HIST, V16, P519, DOI 10.1080/00222938200770421; Price ARG, 1999, BIOL J LINN SOC, V66, P187, DOI 10.1111/j.1095-8312.1999.tb01883.x; REX MA, 1993, NATURE, V365, P636, DOI 10.1038/365636a0; RIGBY PR, 2007, SAMPLING DIVERSITY C; Rivadeneira MM, 2002, MAR ECOL PROG SER, V245, P123, DOI 10.3354/meps245123; ROHDE K, 1992, OIKOS, V65, P514, DOI 10.2307/3545569; ROLLER RA, 1993, MAR BIOL, V116, P583, DOI 10.1007/BF00355477; Ronnback P, 2007, AMBIO, V36, P534, DOI 10.1579/0044-7447(2007)36[534:EGASFS]2.0.CO;2; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; Rowe FWE, 2004, J NAT HIST, V38, P3273, DOI 10.1080/002229301695105; Roy K, 2000, P ROY SOC B-BIOL SCI, V267, P293, DOI 10.1098/rspb.2000.0999; Sala E, 1998, OIKOS, V82, P425, DOI 10.2307/3546364; SAMMARCO PW, 1980, J EXP MAR BIOL ECOL, V45, P245, DOI 10.1016/0022-0981(80)90061-1; Santelices Bernabe, 1998, Diversity and Distributions, V4, P71, DOI 10.1046/j.1472-4642.1998.00005.x; Schoch GC, 2006, LIMNOL OCEANOGR, V51, P2564, DOI 10.4319/lo.2006.51.6.2564; SMITH EP, 1985, HYDROBIOLOGIA, V120, P167, DOI 10.1007/BF00032138; Sokal R.R., 2012, BIOMETRY; SOUSA WP, 1981, OECOLOGIA, V48, P297, DOI 10.1007/BF00346486; STARR M, 1993, CAN J FISH AQUAT SCI, V50, P894, DOI 10.1139/f93-103; Stickle W.B., 1987, Echinoderm Studies, V2, P235; Thompson RC, 2002, ENVIRON CONSERV, V29, P168, DOI 10.1017/S0376892902000115; Tsujino M, 2010, POPUL ECOL, V52, P171, DOI 10.1007/s10144-009-0150-8; UNDERWOOD AJ, 1989, PATTERNS PROCESSES H, P351; Vazquez-Dominguez E, 2003, REV BIOL TROP, V51, P183; Vidolin D, 2007, J MAR BIOL ASSOC UK, V87, P769, DOI 10.1017/S0025315407054124; Viejo RM, 2009, MAR ECOL PROG SER, V390, P55, DOI 10.3354/meps08171; Warwick RM, 1995, MAR ECOL PROG SER, V129, P301, DOI 10.3354/meps129301; Willig MR, 2003, ANNU REV ECOL EVOL S, V34, P273, DOI 10.1146/annurev.ecolsys.34.012103.144032; Witman JD, 2004, P NATL ACAD SCI USA, V101, P15664, DOI 10.1073/pnas.0404300101; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294; WRIGHT DH, 1983, OIKOS, V41, P496, DOI 10.2307/3544109; Wulff A, 2009, BOT MAR, V52, P491, DOI 10.1515/BOT.2009.072; Zacharias MA, 2001, J BIOGEOGR, V28, P471, DOI 10.1046/j.1365-2699.2001.00559.x	127	31	34	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2010	5	11							e13845	10.1371/journal.pone.0013845	http://dx.doi.org/10.1371/journal.pone.0013845			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675OD	21079760	Green Published, gold			2022-12-27	WOS:000283839100006
J	Akagi, T; Thoennissen, NH; George, A; Crooks, G; Song, JH; Okamoto, R; Nowak, D; Gombart, AF; Koeffler, HP				Akagi, Tadayuki; Thoennissen, Nils H.; George, Ann; Crooks, Gay; Song, Jee Hoon; Okamoto, Ryoko; Nowak, Daniel; Gombart, Adrian F.; Koeffler, H. Phillip			In Vivo Deficiency of Both C/EBP beta and C/EBP epsilon Results in Highly Defective Myeloid Differentiation and Lack of Cytokine Response	PLOS ONE			English	Article							BINDING-PROTEIN-ALPHA; TRANSCRIPTION FACTOR; GENE LOCUS; EXPRESSION; GRANULOCYTE; MUTATIONS; MACROPHAGES; SUFFICIENT; INDUCTION; ABSENCE	The CCAAT/enhancer binding proteins (C/EBPs) are transcription factors involved in hematopoietic cell development and induction of several inflammatory mediators. Here, we generated C/EBP beta and C/EBP epsilon double-knockout (bbee) mice and compared their phenotypes to those of single deficient (bbEE and BBee) and wild-type (BBEE) mice. The bbee mice were highly susceptible to fatal infections and died within 2-3 months. Morphologically, their neutrophils were blocked at the myelocytes/metamyelocytes stage, and clonogenic assays of bone marrow cells indicated a significant decrease in the number of myeloid colonies of the bbee mice. In addition, the proportion of hematopoietic progenitor cells [Lin(2) Sca1(+) c-Kit(+)] in the bone marrow of the bbee mice was significantly increased, reflecting the defective differentiation of the myeloid compartment. Furthermore, microarray expression analysis of LPS- and IFN gamma-activated bone marrow-derived macrophages from bbee compared to single knockout mice revealed decreased expression of essential immune response-related genes and networks, including some direct C/EBP-targets such as Marco and Clec4e. Overall, the phenotype of the bbee mice is distinct from either the bbEE or BBee mice, demonstrating that both transcription factors are crucial for the maturation of neutrophils and macrophages, as well as the innate immune system, and can at least in part compensate for each other in the single knockout mice.	[Akagi, Tadayuki; Thoennissen, Nils H.; Song, Jee Hoon; Okamoto, Ryoko; Nowak, Daniel; Koeffler, H. Phillip] Univ Calif Los Angeles, Cedars Sinai Med Ctr, Sch Med, Div Hematol & Oncol, Los Angeles, CA 90048 USA; [George, Ann] Childrens Hosp Los Angeles, Div Res Immunol BMT, Los Angeles, CA 90027 USA; [Crooks, Gay] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; [Gombart, Adrian F.] Oregon State Univ, Dept Biochem & Biophys, Linus Pauling Inst, Corvallis, OR 97331 USA; [Koeffler, H. Phillip] Natl Univ Singapore, Canc Sci Inst Singapore, Singapore 117548, Singapore	Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Children's Hospital Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Oregon State University; National University of Singapore	Akagi, T (corresponding author), Univ Calif Los Angeles, Cedars Sinai Med Ctr, Sch Med, Div Hematol & Oncol, Los Angeles, CA 90048 USA.	tadayuki@staff.kanazawa-u.ac.jp	Gombart, Adrian/AAV-4738-2020; Akagi, Tadayuki/E-1078-2011	Gombart, Adrian/0000-0001-7830-0693; Akagi, Tadayuki/0000-0002-1733-9452; Nowak, Daniel/0000-0001-7130-7921	NIH [5R01CA026038-31, 5R01AI065604-04]; A*STAR; Inger Foundation; Tom Collier Memorial Regatta Foundation; Parker Hughes Fund; Deutsche Forschungsgemeinschaft (Bonn, Germany) [TH 1438/1-1]; Life Science Foundation of Japan; NATIONAL CANCER INSTITUTE [R01CA026038] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI065604] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); A*STAR(Agency for Science Technology & Research (A*STAR)); Inger Foundation; Tom Collier Memorial Regatta Foundation; Parker Hughes Fund; Deutsche Forschungsgemeinschaft (Bonn, Germany)(German Research Foundation (DFG)); Life Science Foundation of Japan(Life Science Foundation of Japan); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH grant 5R01CA026038-31 and A*STAR grant from Singapore to H. P. K., NIH grant 5R01AI065604-04 to A. F. G., Inger Foundation (H. P. K.), the Tom Collier Memorial Regatta Foundation (H. P. K.), Parker Hughes Fund (H. P. K.), Deutsche Forschungsgemeinschaft (Bonn, Germany) [TH 1438/1-1 to N.H.T.], as well as Life Science Foundation of Japan (T. A.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. H. P. K. is the holder of the Mark Goodson endowed Chair in Oncology Research and is a member of the Jonsson Cancer Center and the Molecular Biology Institute, UCLA.	Akagi T, 2008, BLOOD, V111, P2999, DOI 10.1182/blood-2007-04-087213; Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Antonson P, 1996, GENOMICS, V35, P30, DOI 10.1006/geno.1996.0319; Bedi R, 2009, BLOOD, V113, P317, DOI 10.1182/blood-2008-02-139741; Begay V, 2004, MOL CELL BIOL, V24, P9744, DOI 10.1128/MCB.24.22.9744-9751.2004; Chen SS, 2000, MOL CELL BIOL, V20, P7292, DOI 10.1128/MCB.20.19.7292-7299.2000; Cloutier A, 2009, J IMMUNOL, V182, P563, DOI 10.4049/jimmunol.182.1.563; Friedman AD, 2002, ONCOGENE, V21, P3377, DOI 10.1038/sj.onc.1205324; Gery S, 2004, BLOOD, V103, P828, DOI 10.1182/blood-2003-01-0159; Gombart AF, 2002, BLOOD, V99, P1332, DOI 10.1182/blood.V99.4.1332; Gorgoni B, 2002, J IMMUNOL, V168, P4055, DOI 10.4049/jimmunol.168.8.4055; Hackanson B, 2008, CANCER RES, V68, P3142, DOI 10.1158/0008-5472.CAN-08-0483; Hirai H, 2006, NAT IMMUNOL, V7, P732, DOI 10.1038/ni1354; Hu HM, 1998, J IMMUNOL, V160, P2334; Iwasaki H, 2007, IMMUNITY, V26, P726, DOI 10.1016/j.immuni.2007.06.004; Jones LC, 2002, BLOOD, V99, P2032, DOI 10.1182/blood.V99.6.2032; Lekstrom-Himes J, 1999, BLOOD, V93, P3096; McKnight SL, 2001, CELL, V107, P259, DOI 10.1016/S0092-8674(01)00543-8; Morosetti R, 1997, BLOOD, V90, P2591, DOI 10.1182/blood.V90.7.2591.2591_2591_2600; NATSUKA S, 1992, BLOOD, V79, P460; Pabst T, 2001, NAT GENET, V27, P263, DOI 10.1038/85820; Pizarro-Cerda J, 1999, J IMMUNOL, V162, P3519; POPE RM, 1994, J CLIN INVEST, V94, P1449, DOI 10.1172/JCI117482; Preudhomme C, 2002, BLOOD, V100, P2717, DOI 10.1182/blood-2002-03-0990; Radomska HS, 1998, MOL CELL BIOL, V18, P4301, DOI 10.1128/MCB.18.7.4301; Ramji DP, 2002, BIOCHEM J, V365, P561, DOI 10.1042/BJ20020508; SCOTT LM, 1992, BLOOD, V80, P1725; SCREPANTI I, 1995, EMBO J, V14, P1932, DOI 10.1002/j.1460-2075.1995.tb07185.x; Smith LT, 1996, BLOOD, V88, P1234, DOI 10.1182/blood.V88.4.1234.bloodjournal8841234; Sterneck E, 1997, GENE DEV, V11, P2153, DOI 10.1101/gad.11.17.2153; TANAKA T, 1995, CELL, V80, P353, DOI 10.1016/0092-8674(95)90418-2; Tavor S, 2002, BLOOD, V99, P1794, DOI 10.1182/blood.V99.5.1794; Uematsu S, 2007, J IMMUNOL, V179, P5378, DOI 10.4049/jimmunol.179.8.5378; Verbeek W, 2001, LEUKEMIA, V15, P103, DOI 10.1038/sj.leu.2401995; Yamanaka R, 1997, P NATL ACAD SCI USA, V94, P13187, DOI 10.1073/pnas.94.24.13187; Zhang DE, 1997, P NATL ACAD SCI USA, V94, P569, DOI 10.1073/pnas.94.2.569; Zhang P, 2004, IMMUNITY, V21, P853, DOI 10.1016/j.immuni.2004.11.006	37	42	42	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2010	5	11							e15419	10.1371/journal.pone.0015419	http://dx.doi.org/10.1371/journal.pone.0015419			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	674WJ	21072215	Green Published, gold			2022-12-27	WOS:000283780800028
J	Wyatt, E; Wu, RX; Rabeh, W; Park, HW; Ghanefar, M; Ardehali, H				Wyatt, Eugene; Wu, Rongxue; Rabeh, Wael; Park, Hee-Won; Ghanefar, Mohsen; Ardehali, Hossein			Regulation and Cytoprotective Role of Hexokinase III	PLOS ONE			English	Article							RAT-BRAIN HEXOKINASE; C-TERMINAL HALVES; FUNCTIONAL-ORGANIZATION; MAMMALIAN HEXOKINASES; STRUCTURAL DOMAIN; GLUCOSE PHOSPHORYLATION; MITOCHONDRIAL BINDING; CATALYTIC-ACTIVITY; CELL-DEATH; N-TERMINUS	Background: Hexokinases (HKs) catalyze the first step in glucose metabolism. Of the three mammalian 100-kDa HK isoforms, HKI and II can bind to mitochondria and protect against cell death. HKIII does not bind mitochondria, and little is known about its regulation or cytoprotective effects. We studied the regulation of HKIII at the transcriptional and protein levels and investigated its role in cellular protection. Methodology/Principal Findings: We show that like HKII, HKIII expression is regulated by hypoxia, but other factors that regulate HKII expression have no effect on HKIII levels. This transcriptional regulation is partially dependent on hypoxia-inducible factor (HIF) signaling. We also demonstrate regulation at the protein level, as mutations in putative N-terminal substrate binding residues altered C-terminal catalytic activity, suggesting that HKIII activity is governed, in part, by interactions between these two domains. Overexpression of HKIII reduced oxidant-induced cell death, increased ATP levels, decreased the production of reactive oxygen species (ROS), and preserved mitochondrial membrane potential. HKIII overexpression was also associated with higher levels of transcription factors that regulate mitochondrial biogenesis, and greater total mitochondrial DNA content. Attempts to target HKIII to the mitochondria by replacing its N-terminal 32-aminoacid sequence with the mitochondrial-targeting sequence of HKII led to protein aggregation, suggesting that this region is necessary to maintain proper protein folding and solubility. Conclusions/Significance: These results suggest that HKIII is regulated by hypoxia and there are functional interactions between its two halves. Furthermore, HKIII exerts protective effects against oxidative stress, perhaps by increasing ATP levels, reducing oxidant-induced ROS production, preserving mitochondrial membrane potential, and increasing mitochondrial biogenesis.	[Wyatt, Eugene; Wu, Rongxue; Ghanefar, Mohsen; Ardehali, Hossein] Northwestern Univ, Dept Med, Feinberg Sch Med, Div Cardiol, Chicago, IL 60611 USA; [Rabeh, Wael; Park, Hee-Won] Univ Toronto, Struct Genom Consortium, Toronto, ON, Canada; [Park, Hee-Won] Univ Toronto, Dept Pharmacol, Toronto, ON, Canada	Northwestern University; Feinberg School of Medicine; University of Toronto; Structural Genomics Consortium; University of Toronto	Wyatt, E (corresponding author), Northwestern Univ, Dept Med, Feinberg Sch Med, Div Cardiol, Chicago, IL 60611 USA.	h-ardehali@northwestern.edu	Rabeh, Wael/AAO-4647-2020; Wu, Rongxue/AAH-2858-2020	Rabeh, Wael/0000-0001-6071-8581; Wu, Rongxue/0000-0003-4857-4655	National Institutes of Health [K08 HL079387, R01 HL087149]; American Heart Association; Northwestern University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL079387, R01HL087149] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Northwestern University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	H.A. is supported by National Institutes of Health grants K08 HL079387 and R01 HL087149 http://grants.nih.gov/grants/oer.htm. E. W. and R. W. are supported by grants from the American Heart Association http://www.americanheart.org. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. Graeme Bell (University of Chicago) for the HKIII plasmid and Dr. Mircea Ivan (Indiana University) for the HIF plasmids. We would also like to thank the Northwestern University Interdepartmental ImmunoBiology Flow Cytometry Core Facility for their support.	Ahmad A, 2002, AM J PHYSIOL-LUNG C, V283, pL573, DOI 10.1152/ajplung.00410.2001; Aleshin AE, 1998, J MOL BIOL, V282, P345, DOI 10.1006/jmbi.1998.2017; Aleshin AE, 2000, J MOL BIOL, V296, P1001, DOI 10.1006/jmbi.1999.3494; Ardehali H, 1996, J BIOL CHEM, V271, P1849, DOI 10.1074/jbc.271.4.1849; Ardehali H, 1999, J BIOL CHEM, V274, P15986, DOI 10.1074/jbc.274.23.15986; ARORA KK, 1993, J BIOL CHEM, V268, P18259; ARORA KK, 1991, J BIOL CHEM, V266, P5359; Azoulay-Zohar H, 2004, BIOCHEM J, V377, P347, DOI 10.1042/BJ20031465; BAIJAL M, 1992, ARCH BIOCHEM BIOPHYS, V298, P271, DOI 10.1016/0003-9861(92)90123-E; BELL GI, 1993, J BIOL CHEM, V268, P19161; Bryson JM, 2002, J BIOL CHEM, V277, P11392, DOI 10.1074/jbc.M110927200; Cardenas ML, 1998, BBA-MOL CELL RES, V1401, P242, DOI 10.1016/S0167-4889(97)00150-X; Furuta H, 1996, GENOMICS, V36, P206, DOI 10.1006/geno.1996.0448; GOULD GW, 1993, BIOCHEM J, V295, P329, DOI 10.1042/bj2950329; Halestrap AP, 2002, BIOCHIMIE, V84, P153, DOI 10.1016/S0300-9084(02)01375-5; Holloszy JO, 2008, J PHYSIOL PHARMACOL, V59, P5; Holmes BF, 1999, J APPL PHYSIOL, V87, P1990, DOI 10.1152/jappl.1999.87.5.1990; Kulshreshtha R, 2007, MOL CELL BIOL, V27, P1859, DOI 10.1128/MCB.01395-06; MAGNANI M, 1992, BIOCHEM J, V285, P193, DOI 10.1042/bj2850193; Majewski N, 2004, MOL CELL, V16, P819, DOI 10.1016/j.molcel.2004.11.014; MIDDLETON RJ, 1990, BIOCHEM SOC T, V18, P180, DOI 10.1042/bst0180180; MUECKLER M, 1994, EUR J BIOCHEM, V219, P713, DOI 10.1111/j.1432-1033.1994.tb18550.x; Narayanan PK, 2003, CYTOM PART A, V52A, P28, DOI 10.1002/cyto.a.10011; NEMATGORGANI M, 1986, ARCH BIOCHEM BIOPHYS, V251, P97, DOI 10.1016/0003-9861(86)90055-X; Palma F, 2002, PREP BIOCHEM BIOTECH, V32, P393, DOI 10.1081/PB-120015469; Pastorino JG, 2003, CURR MED CHEM, V10, P1535, DOI 10.2174/0929867033457269; Pastorino JG, 2002, J BIOL CHEM, V277, P7610, DOI 10.1074/jbc.M109950200; PRELLER A, 1992, ARCH BIOCHEM BIOPHYS, V294, P482, DOI 10.1016/0003-9861(92)90715-9; Printz RL, 1997, BIOCHEM SOC T, V25, P107, DOI 10.1042/bst0250107; Rempel A, 1996, CANCER RES, V56, P2468; Riordan MM, 2008, AM J PHYSIOL-HEART C, V294, pH1174, DOI 10.1152/ajpheart.01236.2007; SCHIRCH DM, 1987, ARCH BIOCHEM BIOPHYS, V254, P385, DOI 10.1016/0003-9861(87)90116-0; Sebastian S, 2001, ARCH BIOCHEM BIOPHYS, V395, P113, DOI 10.1006/abbi.2001.2584; Southworth R, 2007, AM J PHYSIOL-HEART C, V292, pH378, DOI 10.1152/ajpheart.00664.2006; Sui DX, 1997, ARCH BIOCHEM BIOPHYS, V345, P111, DOI 10.1006/abbi.1997.0241; Sun L, 2008, MOL CELL BIOL, V28, P1007, DOI 10.1128/MCB.00224-07; Tsai HJ, 1997, ARCH BIOCHEM BIOPHYS, V338, P183, DOI 10.1006/abbi.1996.9850; Tsai HJ, 1999, ARCH BIOCHEM BIOPHYS, V369, P149, DOI 10.1006/abbi.1999.1326; URETA T, 1982, COMP BIOCHEM PHYS B, V71, P549, DOI 10.1016/0305-0491(82)90461-8; WHITE TK, 1989, ARCH BIOCHEM BIOPHYS, V274, P375, DOI 10.1016/0003-9861(89)90451-7; WHITE TK, 1987, ARCH BIOCHEM BIOPHYS, V259, P402, DOI 10.1016/0003-9861(87)90506-6; Wilson JE, 2003, J EXP BIOL, V206, P2049, DOI 10.1242/jeb.00241; WILSON JE, 1995, REV PHYSIOL BIOCH P, V126, P65, DOI 10.1007/BFb0049776; XIE GC, 1988, ARCH BIOCHEM BIOPHYS, V267, P803, DOI 10.1016/0003-9861(88)90090-2	44	43	44	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2010	5	11							e13823	10.1371/journal.pone.0013823	http://dx.doi.org/10.1371/journal.pone.0013823			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	674WJ	21072205	Green Submitted, Green Published, gold			2022-12-27	WOS:000283780800020
J	Adams-Cioaba, MA; Guo, YH; Bian, CB; Amaya, MF; Lam, R; Wasney, GA; Vedadi, M; Xu, C; Min, JR				Adams-Cioaba, Melanie A.; Guo, Yahong; Bian, ChuanBing; Amaya, Maria F.; Lam, Robert; Wasney, Gregory A.; Vedadi, Masoud; Xu, Chao; Min, Jinrong			Structural Studies of the Tandem Tudor Domains of Fragile X Mental Retardation Related Proteins FXR1 and FXR2	PLOS ONE			English	Article							HISTONE H3; FMRP; RECOGNITION; BINDING; PHENIX; MODEL; LOCALIZATION; TRANSLATION; REFINEMENT; LENGTH	Background: Expansion of the CGG trinucleotide repeat in the 5'-untranslated region of the FMR1, fragile X mental retardation 1, gene results in suppression of protein expression for this gene and is the underlying cause of Fragile X syndrome. In unaffected individuals, the FMRP protein, together with two additional paralogues (Fragile X Mental Retardation Syndrome-related Protein 1 and 2), associates with mRNA to form a ribonucleoprotein complex in the nucleus that is transported to dendrites and spines of neuronal cells. It is thought that the fragile X family of proteins contributes to the regulation of protein synthesis at sites where mRNAs are locally translated in response to stimuli. Methodology/Principal Findings: Here, we report the X-ray crystal structures of the non-canonical nuclear localization signals of the FXR1 and FXR2 autosomal paralogues of FMRP, which were determined at 2.50 and 1.92 angstrom, respectively. The nuclear localization signals of the FXR1 and FXR2 comprise tandem Tudor domain architectures, closely resembling that of UHRF1, which is proposed to bind methylated histone H3K9. Conclusions: The FMRP, FXR1 and FXR2 proteins comprise a small family of highly conserved proteins that appear to be important in translational regulation, particularly in neuronal cells. The crystal structures of the N-terminal tandem Tudor domains of FXR1 and FXR2 revealed a conserved architecture with that of FMRP. Biochemical analysis of the tandem Tudor doamins reveals their ability to preferentially recognize trimethylated peptides in a sequence-specific manner.	[Adams-Cioaba, Melanie A.; Guo, Yahong; Bian, ChuanBing; Amaya, Maria F.; Lam, Robert; Wasney, Gregory A.; Vedadi, Masoud; Xu, Chao; Min, Jinrong] Univ Toronto, Struct Genom Consortium, Toronto, ON, Canada; [Min, Jinrong] Univ Toronto, Dept Physiol, Toronto, ON, Canada	University of Toronto; Structural Genomics Consortium; University of Toronto	Adams-Cioaba, MA (corresponding author), Univ Toronto, Struct Genom Consortium, Toronto, ON, Canada.	jr.min@utoronto.ca	Min, Jinrong/G-3449-2011; Xu, Chao/G-3885-2010	Min, Jinrong/0000-0001-5210-3130; Xu, Chao/0000-0003-0444-7080	Canadian Institutes for Health Research [1097737]; Canadian Foundation for Innovation; Genome Canada through the Ontario Genomics Institute; GlaxoSmithKline; Karolinska Institutet; Knut and Alice Wallenberg Foundation; Ontario Innovation Trust; Ontario Ministry for Research and Innovation; Merck Co Inc.; Novartis Research Foundation; Swedish Agency for Innovationrefer Systems; Swedish Foundation for Strategic Research; Wellcome Trust	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation); Genome Canada through the Ontario Genomics Institute(Genome Canada); GlaxoSmithKline(GlaxoSmithKline); Karolinska Institutet(Karolinska Institutet); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Ontario Innovation Trust; Ontario Ministry for Research and Innovation(Ministry of Research and Innovation, Ontario); Merck Co Inc.(Merck & Company); Novartis Research Foundation; Swedish Agency for Innovationrefer Systems; Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Wellcome Trust(Wellcome TrustEuropean Commission)	The Structural Genomics Consortium is a registered charity (number 1097737) that receives funds from the Canadian Institutes for Health Research, the Canadian Foundation for Innovation, Genome Canada through the Ontario Genomics Institute, GlaxoSmithKline, Karolinska Institutet, the Knut and Alice Wallenberg Foundation, the Ontario Innovation Trust, the Ontario Ministry for Research and Innovation, Merck & Co Inc., the Novartis Research Foundation, the Swedish Agency for Innovationrefer Systems, the Swedish Foundation for Strategic Research and the Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Adams-Cioaba MA, 2009, BIOCHEM CELL BIOL, V87, P93, DOI 10.1139/O08-129; Bardoni B, 1997, NEUROBIOL DIS, V4, P329, DOI 10.1006/nbdi.1997.0142; Bassell GJ, 2008, NEURON, V60, P201, DOI 10.1016/j.neuron.2008.10.004; Blonden L, 2005, INT J DEV BIOL, V49, P437, DOI 10.1387/ijdb.051974lb; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Cohen SX, 2008, ACTA CRYSTALLOGR D, V64, P49, DOI 10.1107/S0907444907047580; DEVYS D, 1993, NAT GENET, V4, P335, DOI 10.1038/ng0893-335; Eberhart DE, 1996, HUM MOL GENET, V5, P1083, DOI 10.1093/hmg/5.8.1083; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Eryilmaz J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007274; Feng Y, 1997, J NEUROSCI, V17, P1539; Feng Y, 1997, MOL CELL, V1, P109, DOI 10.1016/S1097-2765(00)80012-X; Fridell RA, 1996, EMBO J, V15, P5408, DOI 10.1002/j.1460-2075.1996.tb00924.x; Guo YH, 2009, NUCLEIC ACIDS RES, V37, P2204, DOI 10.1093/nar/gkp086; Kenneson A, 2001, HUM MOL GENET, V10, P1449, DOI 10.1093/hmg/10.14.1449; Kim M, 2009, MOL CELL BIOL, V29, P214, DOI 10.1128/MCB.01377-08; Laggerbauer B, 2001, HUM MOL GENET, V10, P329, DOI 10.1093/hmg/10.4.329; Li XK, 2009, NEUROMOL MED, V11, P200, DOI 10.1007/s12017-009-8081-2; Li ZZ, 2001, NUCLEIC ACIDS RES, V29, P2276, DOI 10.1093/nar/29.11.2276; Min JR, 2007, NAT STRUCT MOL BIOL, V14, P1229, DOI 10.1038/nsmb1340; Min JR, 2003, GENE DEV, V17, P1823, DOI 10.1101/gad.269603; Muddashetty RS, 2007, J NEUROSCI, V27, P5338, DOI 10.1523/JNEUROSCI.0937-07.2007; NEWPORT J, 1982, CELL, V30, P675, DOI 10.1016/0092-8674(82)90272-0; Ramos A, 2006, STRUCTURE, V14, P21, DOI 10.1016/j.str.2005.09.018; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Schuetz A, 2006, EMBO J, V25, P4245, DOI 10.1038/sj.emboj.7601316; SIOMI MC, 1995, EMBO J, V14, P2401, DOI 10.1002/j.1460-2075.1995.tb07237.x; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Terwilliger TC, 2009, ACTA CRYSTALLOGR D, V65, P582, DOI 10.1107/S0907444909012098; Turner G, 1996, AM J MED GENET, V64, P196, DOI 10.1002/(SICI)1096-8628(19960712)64:1<196::AID-AJMG35>3.0.CO;2-G; van 't Padje S, 2005, DEV GENES EVOL, V215, P198, DOI 10.1007/s00427-005-0466-0; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; WARREN ST, 1994, JAMA-J AM MED ASSOC, V271, P536, DOI 10.1001/jama.271.7.536; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; ZHANG Y, 1995, EMBO J, V14, P5358, DOI 10.1002/j.1460-2075.1995.tb00220.x; ZOaW Minor, 1997, PROCESSING XRAY DIFF, P307	38	42	44	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2010	5	11							e13559	10.1371/journal.pone.0013559	http://dx.doi.org/10.1371/journal.pone.0013559			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	674VY	21072162	Green Published, Green Submitted, gold			2022-12-27	WOS:000283779700001
J	Laukens, D; Georges, M; Libioulle, C; Sandor, C; Mni, M; Vander Cruyssen, B; Peeters, H; Elewaut, D; De Vos, M				Laukens, Debby; Georges, Michel; Libioulle, Cecile; Sandor, Cynthia; Mni, Myriam; Vander Cruyssen, Bert; Peeters, Harald; Elewaut, Dirk; De Vos, Martine			Evidence for Significant Overlap between Common Risk Variants for Crohn's Disease and Ankylosing Spondylitis	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; GENOME-WIDE ASSOCIATION; GENE; SUSCEPTIBILITY; EXPRESSION; CONTRIBUTE; ASTHMA; CELLS; JOINT; IL23R	Background: A multicenter genome-wide association scan for Crohn's Disease (CD) has recently reported 40 CD susceptibility loci, including 29 novel ones (19 significant and 10 putative). To gain insight into the genetic overlap between CD and ankylosing spondylitis (AS), these markers were tested for association in AS patients. Principal Findings: Two previously established associations, namely with the MHC and IL23R loci, were confirmed. In addition, rs2872507, which maps to a locus associated with asthma and influences the expression of the ORMDL3 gene in lymphoblastoid cells, showed a significant association with AS (p = 0.03). In gut biopsies of AS and CD patients, ORMDL3 expression was not significantly different from controls and no correlation was found with the rs2872507 genotype (Spearman's rho: -0.067). The distribution of p-values for the remaining 36 SNPs was significantly skewed towards low p-values unless the top 5 ranked SNPs (ORMDL3, NKX2-3, PTPN2, ICOSLG and MST1) were excluded from the analysis. Conclusions: Association analysis using risk variants for CD led to the identification of a new risk variant associated with AS (ORMDL3), underscoring a role for ER stress in AS. In addition, two known and five potentially relevant associations were detected, contributing to common susceptibility of CD and AS.	[Laukens, Debby; Peeters, Harald; De Vos, Martine] Univ Ghent, Dept Gastroenterol, B-9000 Ghent, Belgium; [Georges, Michel; Libioulle, Cecile; Sandor, Cynthia; Mni, Myriam] Univ Liege, GIGA R, Unit Anim Genom, Liege, Belgium; [Georges, Michel; Libioulle, Cecile; Sandor, Cynthia; Mni, Myriam] Univ Liege, Fac Vet Med, Liege, Belgium; [Vander Cruyssen, Bert; Elewaut, Dirk] Univ Ghent, Dept Rheumatol, B-9000 Ghent, Belgium	Ghent University; University of Liege; University of Liege; Ghent University	Laukens, D (corresponding author), Univ Ghent, Dept Gastroenterol, B-9000 Ghent, Belgium.	martine.devos@ugent.be	Elewaut, Dirk/K-6831-2014	Georges, Michel/0000-0003-4124-2375; Laukens, Debby/0000-0002-1984-5850; Elewaut, Dirk/0000-0002-7468-974X	La Direction Generale des Technologies de la Recherche et de l'Energie from the Walloon Region (DGTRE) [315422]; Walloon Region called CIBLES; Communaute Francaise de Belgique (Biomod ARC); Belgian Science Policy organization (SSTC Genefunc and Biomagnet PAI); Ghent University, Belgium [BOF07/GOA/002]	La Direction Generale des Technologies de la Recherche et de l'Energie from the Walloon Region (DGTRE); Walloon Region called CIBLES; Communaute Francaise de Belgique (Biomod ARC); Belgian Science Policy organization (SSTC Genefunc and Biomagnet PAI); Ghent University, Belgium(Ghent University)	This work was supported by grants from (i) La Direction Generale des Technologies de la Recherche et de l'Energie from the Walloon Region (DGTRE, nr 315422), (ii) The 2nd Excellence Programme from the Walloon Region called CIBLES, (iii) from the Communaute Francaise de Belgique (Biomod ARC), (iv) the Belgian Science Policy organization (SSTC Genefunc and Biomagnet PAI) and (v) by a concerted action grant BOF07/GOA/002 of Ghent University, Belgium. Cynthia Sandor is a fellow of the Formation a la Recherche dans l'Industrie et dans l'Agriculture (FRIA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; BREWERTON DA, 1973, LANCET, V1, P904; Brown MA, 2002, CLIN EXP RHEUMATOL, V20, pS43; Cantero-Recasens G, 2010, HUM MOL GENET, V19, P111, DOI 10.1093/hmg/ddp471; Cargill M, 2007, AM J HUM GENET, V80, P273, DOI 10.1086/511051; Cho JH, 2008, NAT REV IMMUNOL, V8, P458, DOI 10.1038/nri2340; de Vlam K, 2000, J RHEUMATOL, V27, P2860; De Vos M, 2004, ALIMENT PHARM THER, V20, P36, DOI 10.1111/j.1365-2036.2004.02044.x; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Goyette P, 2008, MUCOSAL IMMUNOL, V1, P131, DOI 10.1038/mi.2007.15; Ito T, 2007, J EXP MED, V204, P105, DOI 10.1084/jem.20061660; Kontoyiannis D, 1999, IMMUNITY, V10, P387, DOI 10.1016/S1074-7613(00)80038-2; Laukens D, 2005, ANN RHEUM DIS, V64, P930, DOI 10.1136/ard.2004.028837; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; Miceli-Richard C, 2002, ARTHRITIS RHEUM, V46, P1405, DOI 10.1002/art.10196; Moffatt MF, 2007, NATURE, V448, P470, DOI 10.1038/nature06014; Nakazawa A, 2004, GASTROENTEROLOGY, V126, P1347, DOI 10.1053/j.gastro.2004.02.004; Newport M, 2007, NAT GENET, V39, P1329, DOI 10.1038/ng.2007.17; Parkes M, 2007, NAT GENET, V39, P830, DOI 10.1038/ng2061; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; TAUROG JD, 1993, J IMMUNOL, V150, P4168; Todd JA, 2007, NAT GENET, V39, P857, DOI 10.1038/ng2068; VANDERLINDEN S, 1984, ARTHRITIS RHEUM, V27, P361	23	42	46	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2010	5	11							e13795	10.1371/journal.pone.0013795	http://dx.doi.org/10.1371/journal.pone.0013795			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	674VY	21072187	Green Published, gold			2022-12-27	WOS:000283779700009
J	Ni, WJ; Ji, J; Dai, ZY; Papp, A; Johnson, AJ; Ahn, S; Farley, KL; Lin, TS; Dalton, JT; Li, XB; Jarjoura, D; Byrd, JC; Sadee, W; Grever, MR; Phelps, MA				Ni, Wenjun; Ji, Jia; Dai, Zunyan; Papp, Audrey; Johnson, Amy J.; Ahn, Sunjoo; Farley, Katherine L.; Lin, Thomas S.; Dalton, James T.; Li, Xiaobai; Jarjoura, David; Byrd, John C.; Sadee, Wolfgang; Grever, Michael R.; Phelps, Mitch A.			Flavopiridol Pharmacogenetics: Clinical and Functional Evidence for the Role of SLCO1B1/OATP1B1 in Flavopiridol Disposition	PLOS ONE			English	Article							DEPENDENT KINASE INHIBITOR; CANCER RESISTANCE PROTEIN; CONTINUOUS-INFUSION FLAVOPIRIDOL; BREAST-CARCINOMA CELLS; HUMAN LIVER-MICROSOMES; PHASE-I; TRANSCRIPTIONAL REPRESSION; DOWN-REGULATION; LEUKEMIA-CELLS; HEPATIC-UPTAKE	Background: Flavopiridol is a cyclin-dependent kinase inhibitor in phase II clinical development for treatment of various forms of cancer. When administered with a pharmacokinetically (PK)-directed dosing schedule, flavopiridol exhibited striking activity in patients with refractory chronic lymphocytic leukemia. This study aimed to evaluate pharmacogenetic factors associated with inter-individual variability in pharmacokinetics and outcomes associated with flavopiridol therapy. Methodology/Principal Findings: Thirty-five patients who received single-agent flavopiridol via the PK-directed schedule were genotyped for 189 polymorphisms in genes encoding 56 drug metabolizing enzymes and transporters. Genotypes were evaluated in univariate and multivariate analyses as covariates in a population PK model. Transport of flavopiridol and its glucuronide metabolite was evaluated in uptake assays in HEK-293 and MDCK-II cells transiently transfected with SLCO1B1. Polymorphisms in ABCC2, ABCG2, UGT1A1, UGT1A9, and SLCO1B1 were found to significantly correlate with flavopiridol PK in univariate analysis. Transport assay results indicated both flavopiridol and flavopiridol-glucuronide are substrates of the SLCO1B1/OATP1B1 transporter. Covariates incorporated into the final population PK model included bilirubin, SLCO1B1 rs11045819 and ABCC2 rs8187710. Associations were also observed between genotype and response. To validate these findings, a second set of data with 51 patients was evaluated, and overall trends for associations between PK and PGx were found to be consistent. Conclusions/Significance: Polymorphisms in transport genes were found to be associated with flavopiridol disposition and outcomes. Observed clinical associations with SLCO1B1 were functionally validated indicating for the first time its relevance as a transporter of flavopiridol and its glucuronide metabolite. A second 51-patient dataset indicated similar trends between genotype in the SLCO1B1 and other candidate genes, thus providing support for these findings. Further study in larger patient populations will be necessary to fully characterize and validate the clinical impact of polymorphisms in SLCO1B1 and other transporter and metabolizing enzyme genes on outcomes from flavopiridol therapy.	[Ni, Wenjun; Ahn, Sunjoo; Dalton, James T.; Byrd, John C.; Sadee, Wolfgang; Phelps, Mitch A.] Ohio State Univ, Coll Pharm, Div Pharmaceut, Columbus, OH 43210 USA; [Ji, Jia; Farley, Katherine L.; Lin, Thomas S.; Byrd, John C.; Sadee, Wolfgang; Grever, Michael R.; Phelps, Mitch A.] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA; [Dai, Zunyan; Papp, Audrey; Sadee, Wolfgang; Phelps, Mitch A.] Ohio State Univ, Coll Med, Dept Pharmacol, Columbus, OH 43210 USA; [Johnson, Amy J.; Lin, Thomas S.; Dalton, James T.; Byrd, John C.; Grever, Michael R.] Ohio State Univ, Div Hematol & Oncol, Columbus, OH 43210 USA; [Li, Xiaobai; Jarjoura, David] Ohio State Univ, Div Biostat, Coll Publ Hlth, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Ni, WJ (corresponding author), Ohio State Univ, Coll Pharm, Div Pharmaceut, 500 W 12Th Ave, Columbus, OH 43210 USA.	mitch.phelps@osumc.edu	Johnson, Amy/A-5662-2009; Phelps, Mitch A/H-3941-2013	Phelps, Mitch A/0000-0002-1615-5280; Dalton, James T/0000-0002-3915-7326	Leukemia and Lymphoma Society; D. Warren Brown Foundation; NIH/NCI [5 U01 CA76576-07, 1 R21 CA112947-02];  [P01 CA81534-06/PO 10267714];  [5KL2RR025754-02]; NATIONAL CANCER INSTITUTE [P50CA140158, R21CA112947, P01CA081534, U01CA076576] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR025754, UL1RR025755] Funding Source: NIH RePORTER	Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); D. Warren Brown Foundation; NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Leukemia and Lymphoma Society SCOR grant (to JB), the D. Warren Brown Foundation (to JB), NIH/NCI (5 U01 CA76576-07 to MG, 1 R21 CA112947-02 to TL); P01 CA81534-06/PO 10267714; and 5KL2RR025754-02 (PI: Jackson, Trainee: MP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Byrd JC, 1998, BLOOD, V92, P3804, DOI 10.1182/blood.V92.10.3804; Carlson B, 1999, CANCER RES, V59, P4634; Carlson BA, 1996, CANCER RES, V56, P2973; Chen N, 2007, J CLIN PHARMACOL, V47, P1466, DOI 10.1177/0091270007309563; Dai ZY, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-24; Decker RH, 2001, CELL DEATH DIFFER, V8, P715, DOI 10.1038/sj.cdd.4400868; Doyle LA, 2003, ONCOGENE, V22, P7340, DOI 10.1038/sj.onc.1206938; Elens L, 2009, PHARMACOGENOMICS, V10, P1589, DOI [10.2217/pgs.09.88, 10.2217/PGS.09.88]; Ette EI, 1997, J CLIN PHARMACOL, V37, P486, DOI 10.1002/j.1552-4604.1997.tb04326.x; Giacomini KM, 2010, NAT REV DRUG DISCOV, V9, P215, DOI 10.1038/nrd3028; Gojo I, 2002, CLIN CANCER RES, V8, P3527; Hagenauer B, 2001, DRUG METAB DISPOS, V29, P407; Hirano M, 2004, J PHARMACOL EXP THER, V311, P139, DOI 10.1124/jpet.104.068056; Innocenti F, 2000, CLIN CANCER RES, V6, P3400; Innocenti F, 2009, J CLIN ONCOL, V27, P2604, DOI 10.1200/JCO.2008.20.6300; Jager W, 2003, Int J Clin Pharmacol Ther, V41, P610; Jager W, 2003, LIFE SCI, V73, P2841, DOI 10.1016/S0024-3205(03)00699-4; Khan S, 2005, J PHARMACEUT BIOMED, V37, P135, DOI 10.1016/j.jpba.2004.09.053; Lin TS, 2009, J CLIN ONCOL, V27, P6012, DOI 10.1200/JCO.2009.22.6944; Lin TS, 2002, LEUKEMIA LYMPHOMA, V43, P793, DOI 10.1080/10428190290016908; LIU Q, 2008, THER DRUG MONIT; Mani S, 2001, AAPS PHARMSCI, V3, pU30; Nagar S, 2006, DRUG METAB REV, V38, P393, DOI 10.1080/03602530600739835; Nakanishi T, 2003, CLIN CANCER RES, V9, P3320; Nakanishi T, 2003, MOL PHARMACOL, V64, P1452, DOI 10.1124/mol.64.6.1452; Niemi M, 2010, CLIN PHARMACOL THER, V87, P130, DOI 10.1038/clpt.2009.197; Nozawa T, 2005, DRUG METAB DISPOS, V33, P434, DOI 10.1124/dmd.104.001909; Parke J, 1999, COMPUT METH PROG BIO, V59, P19, DOI 10.1016/S0169-2607(98)00098-4; Parker BW, 1998, BLOOD, V91, P458, DOI 10.1182/blood.V91.2.458.458_458_465; Pasanen MK, 2008, PHARMACOGENOMICS, V9, P19, DOI 10.2217/14622416.9.1.19; Phelps MA, 2008, J CHROMATOGR B, V868, P110, DOI 10.1016/j.jchromb.2008.04.023; Phelps MA, 2009, BLOOD, V113, P2637, DOI 10.1182/blood-2008-07-168583; Ramirez J, 2002, PHARM RES-DORDR, V19, P588, DOI 10.1023/A:1015341726183; Robey RW, 2001, CLIN CANCER RES, V7, P145; Romaine SPR, 2010, PHARMACOGENOMICS J, V10, P1, DOI 10.1038/tpj.2009.54; Rosner GL, 2008, CLIN PHARMACOL THER, V84, P393, DOI 10.1038/clpt.2008.63; Rudek MA, 2003, ANN PHARMACOTHER, V37, P1369, DOI 10.1345/aph.1C404; Schwartz GK, 2002, J CLIN ONCOL, V20, P2157, DOI 10.1200/JCO.2002.08.080; Senderowicz AM, 2000, JNCI-J NATL CANCER I, V92, P376, DOI 10.1093/jnci/92.5.376; Senderowicz AM, 1998, J CLIN ONCOL, V16, P2986, DOI 10.1200/JCO.1998.16.9.2986; Sookoian S, 2009, J NUTR BIOCHEM, V20, P765, DOI 10.1016/j.jnutbio.2008.07.005; Sugimoto Y, 2005, CANCER SCI, V96, P457, DOI 10.1111/j.1349-7006.2005.00081.x; Takane H, 2009, CANCER CHEMOTH PHARM, V63, P1165, DOI 10.1007/s00280-008-0864-x; Thomas JP, 2002, CANCER CHEMOTH PHARM, V50, P465, DOI 10.1007/s00280-002-0527-2; Villeneuve L, 2003, J PHARMACOL EXP THER, V307, P117, DOI 10.1124/jpet.103.054072; WATTEL E, 1994, BLOOD, V84, P3148, DOI 10.1182/blood.V84.9.3148.3148; Wittmann S, 2003, CANCER RES, V63, P93; Wojnowski L, 2005, CIRCULATION, V112, P3754, DOI 10.1161/CIRCULATIONAHA.105.576850; WORLAND PJ, 1993, BIOCHEM PHARMACOL, V46, P1831, DOI 10.1016/0006-2952(93)90590-S; Zhai SP, 2003, ANTI-CANCER DRUG, V14, P125, DOI 10.1097/00001813-200302000-00006	50	36	37	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2010	5	11							e13792	10.1371/journal.pone.0013792	http://dx.doi.org/10.1371/journal.pone.0013792			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673FY	21072184	Green Published, Green Submitted, gold			2022-12-27	WOS:000283645700011
J	Censi, F; Calcagnini, G; Bartolini, P; Giuliani, A				Censi, Federica; Calcagnini, Giovanni; Bartolini, Pietro; Giuliani, Alessandro			A Systems Biology Strategy on Differential Gene Expression Data Discloses Some Biological Features of Atrial Fibrillation	PLOS ONE			English	Article							MOLECULAR-MECHANISMS; STROKE	Atrial fibrillation (AF), the most common cardiac arrhythmia, is associated with extensive structural, contractile, and electrophysiological remodeling. In this manuscript we re-analyzed gene expression data from a microarray experiment on AF patients and control tissues, using a new paradigm based on a posteriori unsupervised strategy in which the discrimination of patients comes out from purely syntactical premises. This paradigm, more adherent to biological reality where genes work in highly connected networks, allowed us to get both a very precise patients/control discrimination and the discovery of cell adhesion/tissue modeling and inflammation processes as the main dimensions of AF.	[Censi, Federica; Calcagnini, Giovanni; Bartolini, Pietro] Ist Super Sanita, Dept Technol & Hlth, I-00161 Rome, Italy; [Giuliani, Alessandro] Ist Super Sanita, Dept Environm & Hlth, I-00161 Rome, Italy	Istituto Superiore di Sanita (ISS); Istituto Superiore di Sanita (ISS)	Censi, F (corresponding author), Ist Super Sanita, Dept Technol & Hlth, Viale Regina Elena 299, I-00161 Rome, Italy.	federica.censi@iss.it	Giuliani, Alessandro/AAF-1740-2020; BARTOLINI, PIETRO/E-4619-2015; CALCAGNINI, GIOVANNI/E-3711-2015; Giuliani, Alessandro/K-7589-2016; CENSI, FEDERICA/E-3712-2015	Giuliani, Alessandro/0000-0002-4640-804X; Giuliani, Alessandro/0000-0002-4640-804X; 	Italian National Institute of Health	Italian National Institute of Health	The only funder is the authors' institution, Italian National Institute of Health. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam O, 2010, J AM COLL CARDIOL, V55, P469, DOI 10.1016/j.jacc.2009.08.064; Allison DB, 2006, NAT REV GENET, V7, P55, DOI 10.1038/nrg1749; Bar-Yam Y, 2009, SCIENCE, V323, P1016, DOI 10.1126/science.1163225; Barth AS, 2005, PFLUG ARCH EUR J PHY, V450, P201, DOI 10.1007/s00424-005-1404-8; Barth AS, 2005, CIRC RES, V96, P1022, DOI 10.1161/01.RES.0000165480.82737.33; Brundel BJJM, 2002, CARDIOVASC RES, V54, P315, DOI 10.1016/S0008-6363(02)00222-5; Centurion OA, 2009, INT J CARDIOL, V134, P6, DOI 10.1016/j.ijcard.2008.12.072; FEINBERG WM, 1995, ARCH INTERN MED, V155, P469, DOI 10.1001/archinte.155.5.469; Giuliani A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-S1-S2; Go AS, 2001, JAMA-J AM MED ASSOC, V285, P2370, DOI 10.1001/jama.285.18.2370; Huang S, 2009, BIOESSAYS, V31, P546, DOI 10.1002/bies.200800189; Kim YH, 2003, EXP MOL MED, V35, P336, DOI 10.1038/emm.2003.45; Lai LP, 2004, J CARDIOVASC ELECTR, V15, P214, DOI 10.1046/j.1540-8167.2004.03423.x; Lamirault G, 2006, J MOL CELL CARDIOL, V40, P173, DOI 10.1016/j.yjmcc.2005.09.004; MCBRIDE D, 2008, VALUE HLTH      0724; Noble D, 2008, PHILOS T R SOC A, V366, P3001, DOI 10.1098/rsta.2008.0086; Ohki-Kaneda R, 2004, BIOCHEM BIOPH RES CO, V320, P1328, DOI 10.1016/j.bbrc.2004.06.090; Patel P, 2010, J CARDIOVASC ELECTR, V21, P1064, DOI 10.1111/j.1540-8167.2010.01774.x; Podgoreanu MV, 2005, J AM COLL CARDIOL, V46, P1965, DOI 10.1016/j.jacc.2005.08.040; Ramasamy A, 2008, PLOS MED, V5, P1320, DOI 10.1371/journal.pmed.0050184; Rencher AC, 2002, METHODS MULTIVARIATE; Romualdi C, 2009, OMICS, V13, P173, DOI 10.1089/omi.2009.0003; Surovyatkina E, 2010, PROG BIOPHYS MOL BIO, V103, P131, DOI 10.1016/j.pbiomolbio.2010.01.004; Van Regenmortel MHV, 2007, PROTEOMICS, V7, P965, DOI 10.1002/pmic.200600407; Wilkins AS, 2007, BIOESSAYS, V29, P1179, DOI 10.1002/bies.20685; Wolf PA, 1998, ARCH INTERN MED, V158, P229, DOI 10.1001/archinte.158.3.229; Yue LX, 1999, CIRC RES, V84, P776	27	19	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2010	5	10							e13668	10.1371/journal.pone.0013668	http://dx.doi.org/10.1371/journal.pone.0013668			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673FU	21060823	Green Published, gold, Green Submitted			2022-12-27	WOS:000283645300003
J	Ouedraogo, R; Flaudrops, C; Ben Amara, A; Capo, C; Raoult, D; Mege, JL				Ouedraogo, Richard; Flaudrops, Christophe; Ben Amara, Amira; Capo, Christian; Raoult, Didier; Mege, Jean-Louis			Global Analysis of Circulating Immune Cells by Matrix-Assisted Laser Desorption Ionization Time-of-Flight Mass Spectrometry	PLOS ONE			English	Article							HUMAN PERIPHERAL-BLOOD; DENDRITIC CELLS; MALDI-TOF; IDENTIFICATION; PROTEOME; BACTERIA; DIFFERENTIATION; MACROPHAGES; LEUKOCYTES; INFECTION	Background: MALDI-TOF mass spectrometry is currently used in microbiological diagnosis to characterize bacterial populations. Our aim was to determine whether this technique could be applied to intact eukaryotic cells, and in particular, to cells involved in the immune response. Methodology/Principal Findings: A comparison of frozen monocytes, T lymphocytes and polymorphonuclear leukocytes revealed specific peak profiles. We also found that twenty cell types had specific profiles, permitting the establishment of a cell database. The circulating immune cells, namely monocytes, T lymphocytes and polymorphonuclear cells, were distinct from tissue immune cells such as monocyte-derived macrophages and dendritic cells. In addition, MALDI-TOF mass spectrometry was valuable to easily identify the signatures of monocytes and T lymphocytes in peripheral mononuclear cells. Conclusions/Significance: This method was rapid and easy to perform, and unlike flow cytometry, it did not require any additional components such as specific antibodies. The MALDI-TOF mass spectrometry approach could be extended to analyze the cell composition of tissues and the activation state of immune cells.	[Ouedraogo, Richard; Flaudrops, Christophe; Ben Amara, Amira; Capo, Christian; Raoult, Didier; Mege, Jean-Louis] Univ Aix Marseille 2, Fac Med, Unite Rech Malad Infect Trop & Emergentes, Ctr Natl Rech Sci,Inst Rech Dev Unite Mixte Rech, Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD)	Ouedraogo, R (corresponding author), Univ Aix Marseille 2, Fac Med, Unite Rech Malad Infect Trop & Emergentes, Ctr Natl Rech Sci,Inst Rech Dev Unite Mixte Rech, Marseille, France.	Jean-Louis.Mege@univmed.fr	RAOULT, Didier/A-8434-2008; MEGE, JEAN-LOUIS/O-6063-2016	RAOULT, Didier/0000-0002-0633-5974; 	Centre National de la Recherche Scientifique and Assistance Publique - Hopitaux de Marseille	Centre National de la Recherche Scientifique and Assistance Publique - Hopitaux de Marseille(Centre National de la Recherche Scientifique (CNRS))	This work was supported by the Centre National de la Recherche Scientifique and Assistance Publique - Hopitaux de Marseille. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Benoit M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000066; Degand N, 2008, J CLIN MICROBIOL, V46, P3361, DOI 10.1128/JCM.00569-08; Desnues B, 2005, J IMMUNOL, V175, P4575, DOI 10.4049/jimmunol.175.7.4575; Dieckmann R, 2008, APPL ENVIRON MICROB, V74, P7767, DOI 10.1128/AEM.01402-08; Drancourt M, 2002, APPL ENVIRON MICROB, V68, P6403, DOI 10.1128/AEM.68.12.6403-6404.2002; Dupont A, 2004, PROTEOMICS, V4, P1761, DOI 10.1002/pmic.200300691; Fouchier RAM, 1997, EMBO J, V16, P4531, DOI 10.1093/emboj/16.15.4531; Fournier PE, 2009, J MED MICROBIOL, V58, P1154, DOI 10.1099/jmm.0.009647-0; Greub G, 2002, APPL ENVIRON MICROB, V68, P3076, DOI 10.1128/AEM.68.6.3076-3084.2002; Hartman H, 2002, P NATL ACAD SCI USA, V99, P1420, DOI 10.1073/pnas.032658599; Horlock C, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-3-r30; Jiang Y, 2010, J PROTEOME RES, V9, P79, DOI 10.1021/pr900532r; Johnson RP, 2009, J BIOL CHEM, V284, P16562, DOI 10.1074/jbc.M109.010918; Karger A, 2010, J VIROL METHODS, V164, P116, DOI 10.1016/j.jviromet.2009.11.022; KLIMAN HJ, 1986, ENDOCRINOLOGY, V118, P1567, DOI 10.1210/endo-118-4-1567; Lay JO, 2000, METH MOL B, V146, P461, DOI 10.1385/1-59259-045-4:461; Lehtonen A, 2007, J LEUKOCYTE BIOL, V82, P710, DOI 10.1189/jlb.0307194; LEPIDI H, 1992, J CELL SCI, V103, P145; Li XY, 2009, MOL BIOCHEM PARASIT, V165, P162, DOI 10.1016/j.molbiopara.2009.02.001; Majcherczyk PA, 2006, FEMS MICROBIOL LETT, V255, P233, DOI 10.1111/j.1574-6968.2005.00060.x; Meghari S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040023; Mellmann A, 2008, J CLIN MICROBIOL, V46, P1946, DOI 10.1128/JCM.00157-08; Palmer C, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-115; Petersen Catherine E., 2009, V492, P367, DOI 10.1007/978-1-59745-493-3_22; Robertson JWF, 2007, P NATL ACAD SCI USA, V104, P8207, DOI 10.1073/pnas.0611085104; Seng P, 2009, CLIN INFECT DIS, V49, P543, DOI 10.1086/600885; Srisomsap C, 2004, PROTEOMICS, V4, P1135, DOI 10.1002/pmic.200300651; Trost M, 2009, IMMUNITY, V30, P143, DOI 10.1016/j.immuni.2008.11.006; Zhang X, 2006, J AM SOC MASS SPECTR, V17, P490, DOI 10.1016/j.jasms.2005.12.007; Zhao CQ, 2009, J PROTEOME RES, V8, P4028, DOI 10.1021/pr900364p	30	33	35	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2010	5	10							e13691	10.1371/journal.pone.0013691	http://dx.doi.org/10.1371/journal.pone.0013691			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671UN	21060873	Green Submitted, gold, Green Published			2022-12-27	WOS:000283537000054
J	Saederup, N; Cardona, AE; Croft, K; Mizutani, M; Cotleur, AC; Tsou, CL; Ransohoff, RM; Charo, IF				Saederup, Noah; Cardona, Astrid E.; Croft, Kelsey; Mizutani, Makiko; Cotleur, Anne C.; Tsou, Chia-Lin; Ransohoff, Richard M.; Charo, Israel F.			Selective Chemokine Receptor Usage by Central Nervous System Myeloid Cells in CCR2-Red Fluorescent Protein Knock-In Mice	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; MONOCYTE CHEMOATTRACTANT PROTEIN-1; BLOOD MONOCYTES; DENDRITIC CELLS; IMMUNE-RESPONSE; FRACTALKINE RECEPTOR; MULTIPLE-SCLEROSIS; MICROGLIAL CELLS; BONE-MARROW; SUBSETS	Background: Monocyte subpopulations distinguished by differential expression of chemokine receptors CCR2 and CX3CR1 are difficult to track in vivo, partly due to lack of CCR2 reagents. Methodology/Principal Findings: We created CCR2-red fluorescent protein (RFP) knock-in mice and crossed them with CX3CR1-GFP mice to investigate monocyte subset trafficking. In mice with experimental autoimmune encephalomyelitis, CCR2 was critical for efficient intrathecal accumulation and localization of Ly6C(hi)/CCR2(hi) monocytes. Surprisingly, neutrophils, not Ly6C(lo) monocytes, largely replaced Ly6C(hi) cells in the central nervous system of these mice. CCR2-RFP expression allowed the first unequivocal distinction between infiltrating monocytes/macrophages from resident microglia. Conclusion/Significance: These results refine the concept of monocyte subsets, provide mechanistic insight about monocyte entry into the central nervous system, and present a novel model for imaging and quantifying inflammatory myeloid populations.	[Saederup, Noah; Croft, Kelsey; Tsou, Chia-Lin; Charo, Israel F.] Gladstone Inst Cardiovasc Dis, San Francisco, CA USA; [Cardona, Astrid E.; Mizutani, Makiko; Cotleur, Anne C.; Ransohoff, Richard M.] Cleveland Clin, Neuroinflammat Res Ctr, Dept Neurosci, Lerner Res Inst, Cleveland, OH 44106 USA; [Charo, Israel F.] Univ Calif San Francisco, Cardiovasc Res Inst, Dept Med, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; Cleveland Clinic Foundation; University of California System; University of California San Francisco	Saederup, N (corresponding author), Gladstone Inst Cardiovasc Dis, San Francisco, CA USA.	ransohr@ccf.org; icharo@gladstone.ucsf.edu	Cardona, Astrid E/K-4749-2013	Cardona, Astrid E/0000-0002-5093-8078	National Institutes of Health [HL52773, HL63894, NIH R01NS32151]; Multiple Sclerosis Society [TA3121-A1/T]; National MS Society [RG3980]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL063894, R01HL052773] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS032151] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Multiple Sclerosis Society(National Multiple Sclerosis Society); National MS Society(National Multiple Sclerosis Society); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Sources of funding are: National Institutes of Health (HL52773 and HL63894 to IFC, NIH R01NS32151 to RMR), the Multiple Sclerosis Society (TA3121-A1/T to AEC), and the National MS Society (RG3980 to RMR).	Ancuta P, 2003, J EXP MED, V197, P1701, DOI 10.1084/jem.20022156; Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; Auffray C, 2009, ANNU REV IMMUNOL, V27, P669, DOI 10.1146/annurev.immunol.021908.132557; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Boring L, 1997, J CLIN INVEST, V100, P2552, DOI 10.1172/JCI119798; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Cardona AE, 1999, J IMMUNOL, V162, P995; Cardona AE, 2006, NAT PROTOC, V1, P1947, DOI 10.1038/nprot.2006.327; Cardona AE, 2006, NAT NEUROSCI, V9, P917, DOI 10.1038/nn1715; Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723; El Khoury J, 2007, NAT MED, V13, P432, DOI 10.1038/nm1555; Fife BT, 2000, J EXP MED, V192, P899, DOI 10.1084/jem.192.6.899; Gaupp S, 2003, AM J PATHOL, V162, P139, DOI 10.1016/S0002-9440(10)63805-9; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Glabinski AR, 1997, METHOD ENZYMOL, V288, P182; Glabinski AR, 1997, AM J PATHOL, V150, P617; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Gordon S, 2002, CELL, V111, P927, DOI 10.1016/S0092-8674(02)01201-1; Grace-Griebenow E, 2000, IMMUNOBIOLOGY, V202, P42, DOI 10.1016/S0171-2985(00)80051-0; Grage-Griebenow E, 2001, J LEUKOCYTE BIOL, V69, P11; Huang D, 2006, FASEB J, V20, P896, DOI 10.1096/fj.05-5465com; Huang DR, 2001, J EXP MED, V193, P713, DOI 10.1084/jem.193.6.713; Izikson L, 2000, J EXP MED, V192, P1075, DOI 10.1084/jem.192.7.1075; Jung HS, 2009, J NEUROSCI, V29, P8051, DOI 10.1523/JNEUROSCI.0485-09.2009; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; King IL, 2009, BLOOD, V113, P3190, DOI 10.1182/blood-2008-07-168575; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Mahad DJ, 2003, SEMIN IMMUNOL, V15, P23, DOI 10.1016/S1044-5323(02)00125-2; Mildner A, 2009, BRAIN, V132, P2487, DOI 10.1093/brain/awp144; Nahrendorf M, 2007, J EXP MED, V204, P3037, DOI 10.1084/jem.20070885; Qu CF, 2004, J EXP MED, V200, P1231, DOI 10.1084/jem.20032152; Randolph GJ, 1999, IMMUNITY, V11, P753, DOI 10.1016/S1074-7613(00)80149-1; RANSOHOFF RM, 1993, FASEB J, V7, P592, DOI 10.1096/fasebj.7.6.8472896; Rostene W, 2007, NAT REV NEUROSCI, V8, P895, DOI 10.1038/nrn2255; SEDGWICK JD, 1991, P NATL ACAD SCI USA, V88, P7438, DOI 10.1073/pnas.88.16.7438; Serbina NV, 2006, NAT IMMUNOL, V7, P311, DOI 10.1038/ni1309; Sunderkotter C, 2004, J IMMUNOL, V172, P4410, DOI 10.4049/jimmunol.172.7.4410; Swirski FK, 2007, J CLIN INVEST, V117, P195, DOI 10.1172/JCI29950; Tacke F, 2007, J CLIN INVEST, V117, P185, DOI 10.1172/JCI28549; Tacke F, 2006, IMMUNOBIOLOGY, V211, P609, DOI 10.1016/j.imbio.2006.05.025; Tsou CL, 2007, J CLIN INVEST, V117, P902, DOI 10.1172/JCI29919; Varol C, 2009, IMMUNOL CELL BIOL, V87, P30, DOI 10.1038/icb.2008.90; Weber C, 2000, J LEUKOCYTE BIOL, V67, P699, DOI 10.1002/jlb.67.5.699; Wong LM, 1997, J BIOL CHEM, V272, P1038, DOI 10.1074/jbc.272.2.1038; Ziegler-Heitbrock HWL, 2000, J LEUKOCYTE BIOL, V67, P603, DOI 10.1002/jlb.67.5.603	45	380	384	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2010	5	10							e13693	10.1371/journal.pone.0013693	http://dx.doi.org/10.1371/journal.pone.0013693			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671UN	21060874	Green Published, gold, Green Submitted			2022-12-27	WOS:000283537000055
J	Georgopoulos, NT; Kirkwood, LA; Walker, DC; Southgate, J				Georgopoulos, Nikolaos T.; Kirkwood, Lisa A.; Walker, Dawn C.; Southgate, Jennifer			Differential Regulation of Growth-Promoting Signalling Pathways by E-Cadherin	PLOS ONE			English	Article							HUMAN UROTHELIAL CELLS; LIGAND-INDEPENDENT ACTIVATION; HUMAN EPIDERMAL-KERATINOCYTES; FACTOR RECEPTOR; BLADDER-CANCER; IN-VITRO; PROTEIN-KINASE; TERMINAL DIFFERENTIATION; CARCINOMA-CELLS; ADHESION	Background: Despite the well-documented association between loss of E-cadherin and carcinogenesis, as well as the link between restoration of its expression and suppression of proliferation in carcinoma cells, the ability of E-cadherin to modulate growth-promoting cell signalling in normal epithelial cells is less well understood and frequently contradictory. The potential for E-cadherin to co-ordinate different proliferation-associated signalling pathways has yet to be fully explored. Methodology/Principal Findings: Using a normal human urothelial (NHU) cell culture system and following a calcium-switch approach, we demonstrate that the stability of NHU cell-cell contacts differentially regulates the Epidermal Growth Factor Receptor (EGFR)/Extracellular Signal-Regulated Kinase (ERK) and Phosphatidylinositol 3-Kinase (PI3-K)/AKT pathways. We show that stable cell contacts down-modulate the EGFR/ERK pathway, whilst inducing PI3-K/AKT activity, which transiently enhances cell growth at low density. Functional inactivation of E-cadherin interferes with the capacity of NHU cells to form stable calcium-mediated contacts, attenuates E-cadherin-mediated PI3-K/AKT induction and enhances NHU cell proliferation by allowing de-repression of the EGFR/ERK pathway and constitutive activation of beta-catenin-TCF signalling. Conclusions/Significance: Our findings provide evidence that E-cadherin can differentially and concurrently regulate specific growth-related signalling pathways in a context-specific fashion, with direct, functional consequences for cell proliferation and population growth. Our observations not only reveal a novel, complex role for E-cadherin in normal epithelial cell homeostasis and tissue regeneration, but also provide the basis for a more complete understanding of the consequences of E-cadherin loss on malignant transformation.	[Georgopoulos, Nikolaos T.; Kirkwood, Lisa A.; Southgate, Jennifer] Univ York, Dept Biol, Jack Birch Unit Mol Carcinogenesis, York YO10 5DD, N Yorkshire, England; [Walker, Dawn C.] Univ Sheffield, Dept Comp Sci, Kroto Res Inst, Sheffield S10 2TN, S Yorkshire, England	University of York - UK; University of Sheffield	Georgopoulos, NT (corresponding author), Univ York, Dept Biol, Jack Birch Unit Mol Carcinogenesis, York YO10 5DD, N Yorkshire, England.	js35@york.ac.uk	Southgate, Jennifer/AAJ-9089-2021	Southgate, Jennifer/0000-0002-0135-480X; Georgopoulos, Nik/0000-0002-6330-4947	Engineering and Physical Sciences Research Council (EPSRC) [GR/S62338/01]; RCUK; York Against Cancer; Engineering and Physical Sciences Research Council [GR/S62338/01] Funding Source: researchfish	Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); RCUK(UK Research & Innovation (UKRI)); York Against Cancer; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	The study was funded by the Engineering and Physical Sciences Research Council (EPSRC; grant reference GR/S62338/01), on which NTG was employed. DCW is supported by an RCUK fellowship. LAC is a postgraduate student and JS holds a research chair supported by York Against Cancer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andl CD, 2003, J BIOL CHEM, V278, P1824, DOI 10.1074/jbc.M209148200; BIRCHMEIER W, 1994, BBA-REV CANCER, V1198, P11, DOI 10.1016/0304-419X(94)90003-5; Bissell MJ, 2001, NAT REV CANCER, V1, P46, DOI 10.1038/35094059; Black PC, 2008, CLIN CANCER RES, V14, P1478, DOI 10.1158/1078-0432.CCR-07-1593; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Bornman DM, 2001, AM J PATHOL, V159, P831, DOI 10.1016/S0002-9440(10)61758-0; Chopra B, 2009, CELL PROLIFERAT, V42, P688, DOI 10.1111/j.1365-2184.2009.00628.x; Conacci-Sorrell M, 2002, J CLIN INVEST, V109, P987, DOI 10.1172/JCI200215429; Crallan RA, 2006, CARCINOGENESIS, V27, P374, DOI 10.1093/carcin/bgi266; Cross WR, 2005, AM J PHYSIOL-RENAL, V289, pF459, DOI 10.1152/ajprenal.00040.2005; Deng JO, 2002, CANCER CELL, V2, P323, DOI 10.1016/S1535-6108(02)00154-X; Fadare Oluwole, 2005, World J Surg Oncol, V3, P38, DOI 10.1186/1477-7819-3-38; FRIXEN UH, 1991, J CELL BIOL, V113, P173, DOI 10.1083/jcb.113.1.173; Georgopoulos NT, 2007, INT J CANCER, V121, P1373, DOI 10.1002/ijc.22846; Liu WF, 2006, J CELL BIOL, V173, P431, DOI 10.1083/jcb.200510087; MacLaine NJ, 2008, MOL CANCER RES, V6, P53, DOI 10.1158/1541-7786.MCR-07-0134; Margulis A, 2005, CANCER RES, V65, P1783, DOI 10.1158/0008-5472.CAN-04-3399; Maruyama R, 2001, CANCER RES, V61, P8659; Masters, 2003, CULTURE EPITHELIAL C, V8, P381, DOI DOI 10.1002/0471221201.CH12; MOLL R, 1993, AM J PATHOL, V143, P1731; Nelson CM, 2002, FEBS LETT, V514, P238, DOI 10.1016/S0014-5793(02)02370-0; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; Onder TT, 2008, CANCER RES, V68, P3645, DOI 10.1158/0008-5472.CAN-07-2938; Orsulic S, 1999, J CELL SCI, V112, P1237; Pece S, 1999, J BIOL CHEM, V274, P19347, DOI 10.1074/jbc.274.27.19347; Pece S, 2000, J BIOL CHEM, V275, P41227, DOI 10.1074/jbc.M006578200; Perl AK, 1998, NATURE, V392, P190, DOI 10.1038/32433; Perrais M, 2007, MOL BIOL CELL, V18, P2013, DOI 10.1091/mbc.E06-04-0348; Qian XL, 2004, EMBO J, V23, P1739, DOI 10.1038/sj.emboj.7600136; Reddy P, 2005, MOL ENDOCRINOL, V19, P2564, DOI 10.1210/me.2004-0342; Ribeiro LA, 2002, MOL CARCINOGEN, V34, P187, DOI 10.1002/mc.10064; RIEGER KM, 1995, BRIT J CANCER, V72, P683, DOI 10.1038/bjc.1995.394; SHAPIRO L, 1995, NATURE, V374, P327, DOI 10.1038/374327a0; Shaw NJ, 2005, INT J CANCER, V116, P634, DOI 10.1002/ijc.21114; Shen XD, 2004, AM J PATHOL, V165, P1315, DOI 10.1016/S0002-9440(10)63390-1; SOUTHGATE J, 1994, LAB INVEST, V71, P583; St Croix B, 1998, J CELL BIOL, V142, P557, DOI 10.1083/jcb.142.2.557; Stockinger A, 2001, J CELL BIOL, V154, P1185, DOI 10.1083/jcb.200104036; T Georgopoulos N, 2006, CELL DEATH DIFFER, V13, P1789, DOI 10.1038/sj.cdd.4401859; Takahashi K, 1996, EXP CELL RES, V226, P214, DOI 10.1006/excr.1996.0221; TAKEICHI M, 1995, CURR OPIN CELL BIOL, V7, P619, DOI 10.1016/0955-0674(95)80102-2; Takeichi M, 1993, CURR OPIN CELL BIOL, V5, P806, DOI 10.1016/0955-0674(93)90029-P; Thievessen I, 2003, BRIT J CANCER, V88, P1932, DOI 10.1038/sj.bjc.6601031; Urakami S, 2006, CLIN CANCER RES, V12, P2109, DOI 10.1158/1078-0432.CCR-05-2468; Urakami S, 2006, CLIN CANCER RES, V12, P383, DOI 10.1158/1078-0432.CCR-05-1344; Varley C, 2005, EXP CELL RES, V306, P216, DOI 10.1016/j.yexcr.2005.02.004; Varley CL, 2004, J CELL SCI, V117, P2029, DOI 10.1242/jcs.01042; VLEMINCKX K, 1991, CELL, V66, P107, DOI 10.1016/0092-8674(91)90143-M; Walker DC, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-102; Walker D, 2006, J THEOR BIOL, V242, P774, DOI 10.1016/j.jtbi.2006.04.020; Walker DC, 2004, BIOSYSTEMS, V76, P89, DOI 10.1016/j.biosystems.2004.05.025; Walker DC, 2004, IEEE T NANOBIOSCI, V3, P153, DOI 10.1109/TNB.2004.833680; Yates DR, 2007, CLIN CANCER RES, V13, P2046, DOI 10.1158/1078-0432.CCR-06-2476; Zhu AJ, 1999, DEVELOPMENT, V126, P2285; Zhu AJ, 1996, J CELL SCI, V109, P3013; Zhu AJ, 1999, P NATL ACAD SCI USA, V96, P6728, DOI 10.1073/pnas.96.12.6728	56	25	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2010	5	10							e13621	10.1371/journal.pone.0013621	http://dx.doi.org/10.1371/journal.pone.0013621			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671GB	21049033	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000283487400014
J	Hennigan, SL; Driskell, JD; Dluhy, RA; Zhao, YP; Tripp, RA; Waites, KB; Krause, DC				Hennigan, Suzanne L.; Driskell, Jeremy D.; Dluhy, Richard A.; Zhao, Yiping; Tripp, Ralph A.; Waites, Ken B.; Krause, Duncan C.			Detection of Mycoplasma pneumoniae in Simulated and True Clinical Throat Swab Specimens by Nanorod Array-Surface-Enhanced Raman Spectroscopy	PLOS ONE			English	Article							SENSITIVE DETECTION; LEAST-SQUARES; SCATTERING; PCR; IDENTIFICATION; DIAGNOSIS; PROTEIN; GENE; SERS; PATHOGENESIS	The prokaryote Mycoplasma pneumoniae is a major cause of respiratory disease in humans, accounting for 20% of all community-acquired pneumonia and the leading cause of pneumonia in older children and young adults. The limitations of existing options for mycoplasma diagnosis highlight a critical need for a new detection platform with high sensitivity, specificity, and expediency. Here we evaluated silver nanorod arrays (NA) as a biosensing platform for detection and differentiation of M. pneumoniae in culture and in spiked and true clinical throat swab samples by surface-enhanced Raman spectroscopy (SERS). Three M. pneumoniae strains were reproducibly differentiated by NA-SERS with 95%-100% specificity and 94-100% sensitivity, and with a lower detection limit exceeding standard PCR. Analysis of throat swab samples spiked with M. pneumoniae yielded detection in a complex, clinically relevant background with >90% accuracy and high sensitivity. In addition, NA-SERS correctly classified with >97% accuracy, ten true clinical throat swab samples previously established by real-time PCR and culture to be positive or negative for M. pneumoniae. Our findings suggest that the unique biochemical specificity of Raman spectroscopy, combined with reproducible spectral enhancement by silver NA, holds great promise as a superior platform for rapid and sensitive detection and identification of M. pneumoniae, with potential for point-of-care application.	[Hennigan, Suzanne L.; Krause, Duncan C.] Univ Georgia, Dept Microbiol, Athens, GA 30602 USA; [Driskell, Jeremy D.; Tripp, Ralph A.] Univ Georgia, Dept Infect Dis, Athens, GA 30602 USA; [Dluhy, Richard A.] Univ Georgia, Dept Chem, Athens, GA 30602 USA; [Zhao, Yiping] Univ Georgia, Dept Phys & Astron, Athens, GA 30602 USA; [Waites, Ken B.] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [Waites, Ken B.] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Hennigan, SL (corresponding author), Univ Georgia, Dept Microbiol, Athens, GA 30602 USA.	dkrause@uga.edu	Tripp, Ralph/F-5218-2011; Zhao, Yiping/A-4968-2008	Tripp, Ralph/0000-0002-2924-9956; Zhao, Yiping/0000-0002-3710-4159; Hennigan, Suzanne/0000-0003-0551-6703; Driskell, Jeremy/0000-0001-5082-898X	U.S. Army Research Laboratory [W911NF-07-0065]; National Science Foundation [ECS-0701787]; Georgia Research Alliance; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI096364] Funding Source: NIH RePORTER	U.S. Army Research Laboratory(United States Department of DefenseUS Army Research Laboratory (ARL)); National Science Foundation(National Science Foundation (NSF)); Georgia Research Alliance; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was funded in part by the U.S. Army Research Laboratory (http://www.arl.army.mil/www/default.htm) through contract number W911NF-07-0065, the National Science Foundation (http://www.nsf.gov) under contract ECS-0701787, and the Georgia Research Alliance (http://www.gra.org/default.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abell JL, 2009, BIOSENS BIOELECTRON, V24, P3663, DOI 10.1016/j.bios.2009.05.039; Adams M. J., 2004, CHEMOMETRICS ANAL SP; Alfassi ZB, 2004, J AM SOC MASS SPECTR, V15, P385, DOI 10.1016/j.jasms.2003.11.008; Atkinson TP, 2008, FEMS MICROBIOL REV, V32, P956, DOI 10.1111/j.1574-6976.2008.00129.x; Barker M, 2003, J CHEMOMETR, V17, P166, DOI 10.1002/cem.785; Beebe K.R., 1998, CHEMOMETRICS PRACTIC, V1st; Chu HY, 2008, APPL SPECTROSC, V62, P922, DOI 10.1366/000370208785284330; Dallo SF, 1996, INFECT IMMUN, V64, P2595, DOI 10.1128/IAI.64.7.2595-2601.1996; Daxboeck F, 2003, CLIN MICROBIOL INFEC, V9, P263, DOI 10.1046/j.1469-0691.2003.00590.x; Demirel MC, 2009, BIOINTERPHASES, V4, P35, DOI 10.1116/1.3147962; Dorigo-Zetsma JW, 1999, J CLIN MICROBIOL, V37, P14, DOI 10.1128/JCM.37.1.14-17.1999; Driskell JD, 2008, J PHYS CHEM C, V112, P895, DOI 10.1021/jp075288u; Driskell JD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010222; Dumke R, 2003, INT J MED MICROBIOL, V292, P513, DOI 10.1078/1438-4221-00231; Dumke R, 2007, J CLIN MICROBIOL, V45, P2726, DOI 10.1128/JCM.00321-07; Esbensen K.H, 2004, MULTIVARIATE DATA AN; Jacobs E, 1996, EUR J CLIN MICROBIOL, V15, P38, DOI 10.1007/BF01586183; Jarvis RM, 2004, ANAL CHEM, V76, P40, DOI 10.1021/ac034689c; Kenri T, 2008, J MED MICROBIOL, V57, P469, DOI 10.1099/jmm.0.47634-0; KRAUSE DC, 1982, INFECT IMMUN, V35, P809, DOI 10.1128/IAI.35.3.809-817.1982; Leverette CL, 2006, APPL SPECTROSC, V60, P906, DOI 10.1366/000370206778062084; LIPMAN RP, 1969, J BACTERIOL, V100, P1037, DOI 10.1128/JB.100.2.1037-1043.1969; Liu YJ, 2009, J PHYS CHEM C, V113, P9664, DOI 10.1021/jp902142y; Loens K, 2003, J CLIN MICROBIOL, V41, P4915, DOI 10.1128/JCM.41.11.4915-4923.2003; Loens K, 2010, EUR J CLIN MICROBIOL, V29, P1055, DOI 10.1007/s10096-010-0975-2; Maquelin K, 2009, MICROBIOL-SGM, V155, P2068, DOI 10.1099/mic.0.026724-0; Musumarra G, 2004, J CHEMOMETR, V18, P125, DOI 10.1002/cem.846; Naumann D, 2001, APPL SPECTROSC REV, V36, P239, DOI 10.1081/ASR-100106157; Patel IS, 2008, J RAMAN SPECTROSC, V39, P1660, DOI 10.1002/jrs.2064; Premasiri WR, 2005, J PHYS CHEM B, V109, P312, DOI 10.1021/jp040442n; PROFT T, 1995, J BACTERIOL, V177, P3370, DOI 10.1128/jb.177.12.3370-3378.1995; Romero-Arroyo CE, 1999, J BACTERIOL, V181, P1079, DOI 10.1128/JB.181.4.1079-1087.1999; RULAND K, 1994, J BACTERIOL, V176, P5202, DOI 10.1128/JB.176.17.5202-5209.1994; SAVITZKY A, 1964, ANAL CHEM, V36, P1627, DOI 10.1021/ac60214a047; Shanmukh S, 2006, NANO LETT, V6, P2630, DOI 10.1021/nl061666f; SU CJ, 1990, INFECT IMMUN, V58, P2669, DOI 10.1128/IAI.58.8.2669-2674.1990; TULLY JG, 1977, SCIENCE, V195, P892, DOI 10.1126/science.841314; Ursi D, 2003, J MICROBIOL METH, V55, P149, DOI 10.1016/S0167-7012(03)00131-3; VANKUPPEVELD FJM, 1992, APPL ENVIRON MICROB, V58, P2606, DOI 10.1128/AEM.58.8.2606-2615.1992; VO-DINH T, 1994, ANAL CHEM, V66, P3379, DOI 10.1021/ac00092a014; Waites KB, 2004, CLIN MICROBIOL REV, V17, P697, DOI 10.1128/CMR.17.4.697-728.2004; Waitest KB, 2008, FUTURE MICROBIOL, V3, P635, DOI 10.2217/17460913.3.6.635; Waring AL, 2001, J CLIN MICROBIOL, V39, P1385, DOI 10.1128/JCM.39.4.1385-1390.2001; Wold S, 2001, CHEMOMETR INTELL LAB, V58, P109, DOI 10.1016/S0169-7439(01)00155-1; Yakes BJ, 2008, CLIN VACCINE IMMUNOL, V15, P235, DOI 10.1128/CVI.00335-07; Zhao YP, 2006, J PHYS CHEM B, V110, P3153, DOI 10.1021/jp057406o	46	41	42	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2010	5	10							e13633	10.1371/journal.pone.0013633	http://dx.doi.org/10.1371/journal.pone.0013633			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671GB	21049032	gold, Green Published, Green Submitted			2022-12-27	WOS:000283487400023
J	Ng, WC; Wong, V; Muller, B; Rawlin, G; Brown, LE				Ng, Wy Ching; Wong, Victor; Muller, Brian; Rawlin, Grant; Brown, Lorena E.			Prevention and Treatment of Influenza with Hyperimmune Bovine Colostrum Antibody	PLOS ONE			English	Article							OSELTAMIVIR-RESISTANT INFLUENZA; A VIRUSES; PASSIVE IMMUNOTHERAPY; ADAMANTANE RESISTANCE; SCID MICE; INFECTION; HEMAGGLUTININ; FRAGMENTS; PROTECTION; PNEUMONIA	Background: Despite the availability of specific vaccines and antiviral drugs, influenza continues to impose a heavy toll on human health worldwide. Passive transfer of specific antibody (Ab) may provide a useful means of preventing or treating disease in unvaccinated individuals or those failing to adequately seroconvert, especially now that resistance to antiviral drugs is on the rise. However, preparation of appropriate Ab in large scale, quickly and on a yearly basis is viewed as a significant logistical hurdle for this approach to control seasonal influenza. Methodology/Principal Findings: In this study, bovine colostrum, which contains approximately 500 g of IgG per milking per animal, has been investigated as a source of polyclonal antibody for delivery to the respiratory tract. IgG and F(ab')2 were purified from the hyperimmune colostrum of cows vaccinated with influenza A/Puerto Rico/8/34 (PR8) vaccine and were shown to have high hemagglutination-inhibitory and virus-neutralizing titers. In BALB/c mice, a single administration of either IgG or F(ab')2 could prevent the establishment of infection with a sublethal dose of PR8 virus when given as early as 7 days prior to exposure to virus. Pre-treated mice also survived an otherwise lethal dose of virus, the IgG-but not the F(ab')2-treated mice showing no weight loss. Successful reduction of established infection with this highly virulent virus was also observed with a single treatment 24 hr after virus exposure. Conclusions/Significance: These data suggest that a novel and commercially-scalable technique for preparing Ab from hyperimmune bovine colostrum could allow production of a valuable substitute for antiviral drugs to control influenza with the advantage of eliminating the need for daily administration.	[Ng, Wy Ching; Brown, Lorena E.] Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3052, Australia; [Wong, Victor; Muller, Brian; Rawlin, Grant] Immuron Ltd, Melbourne, Vic, Australia	University of Melbourne	Ng, WC (corresponding author), Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3052, Australia.	lorena@unimelb.edu.au	Ng, Wy Ching/GQT-0056-2022	Brown, Lorena/0000-0001-9342-909X	National Health and Medical Research Council of Australia; Australian Research Council [LP0990420]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council)	The study was funded by grants from the National Health and Medical Research Council of Australia and the Australian Research Council (Linkage project LP0990420), who had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript, and by Immuron Limited who had no role in data collection and analysis and decision to publish but provided input into study design and manuscript preparation.	BLEEKER WK, 1989, CLIN EXP IMMUNOL, V77, P338; Bright RA, 2006, JAMA-J AM MED ASSOC, V295, P891, DOI 10.1001/jama.295.8.joc60020; Bright RA, 2005, LANCET, V366, P1175, DOI 10.1016/S0140-6736(05)67338-2; Casadevall A, 1999, CLIN IMMUNOL, V93, P5, DOI 10.1006/clim.1999.4768; DAVIES WL, 1964, SCIENCE, V144, P862, DOI 10.1126/science.144.3620.862; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; de Jong JC, 2000, J MED VIROL, V61, P94, DOI 10.1002/(SICI)1096-9071(200005)61:1&lt;94::AID-JMV15&gt;3.0.CO;2-C; Dowdle W.A., 1979, DIAGNOSTIC PROCEDURE, V5th ed., P585; Hammarstrom L, 2008, ADV EXP MED BIOL, V606, P321, DOI 10.1007/978-0-387-74087-4_13; Hanson BJ, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-126; Hayden FG, 2001, PHILOS T R SOC B, V356, P1877, DOI 10.1098/rstb.2001.1007; HIRSCH RL, 1982, MICROBIOL REV, V46, P71, DOI 10.1128/MMBR.46.1.71-85.1982; Jackson LA, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-71; Jones RGA, 2003, J IMMUNOL METHODS, V275, P239, DOI 10.1016/S0022-1759(03)00005-X; Kawai N, 2005, CLIN INFECT DIS, V40, P1309, DOI 10.1086/429241; Kiso M, 2004, LANCET, V364, P759, DOI 10.1016/S0140-6736(04)16934-1; Korhonen H, 2000, BRIT J NUTR, V84, pS135; Lu JH, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-43; Monto AS, 2008, PEDIATR INFECT DIS J, V27, pS110, DOI 10.1097/INF.0b013e318168b739; MORGAN EL, 1980, J EXP MED, V152, P113, DOI 10.1084/jem.152.1.113; Moscona A, 2004, LANCET, V364, P733, DOI 10.1016/S0140-6736(04)16947-X; Mozdzanowska K, 2003, J VIROL, V77, P8322, DOI 10.1128/JVI.77.15.8322-8328.2003; Nicoll A., 2008, EURO SURVEILL, V13; Ober RJ, 2001, INT IMMUNOL, V13, P1551, DOI 10.1093/intimm/13.12.1551; PALLADINO G, 1995, J VIROL, V69, P2075, DOI 10.1128/JVI.69.4.2075-2081.1995; Pejoski D, 2010, IMMUNOL CELL BIOL, V88, P605, DOI 10.1038/icb.2010.15; Ramisse F, 1998, CLIN EXP IMMUNOL, V111, P583; Roopenian DC, 2007, NAT REV IMMUNOL, V7, P715, DOI 10.1038/nri2155; Sawyer LA, 2000, ANTIVIR RES, V47, P57, DOI 10.1016/S0166-3542(00)00111-X; Simmons CP, 2007, PLOS MED, V4, P928, DOI 10.1371/journal.pmed.0040178; Tamura D, 2009, J CLIN MICROBIOL, V47, P1424, DOI 10.1128/JCM.02396-08; TAMURA S, 1991, EUR J IMMUNOL, V21, P1337, DOI 10.1002/eji.1830210602; WONG JP, 1994, IMMUNOLOGY, V81, P280	33	29	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2010	5	10							e13622	10.1371/journal.pone.0013622	http://dx.doi.org/10.1371/journal.pone.0013622			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671GB	21049034	Green Published, gold			2022-12-27	WOS:000283487400015
J	Gao, QA; Liu, FB; Zhang, TC; Zhang, J; Jia, SR; Yu, CY; Jiang, KY; Gao, NF				Gao, Qiang; Liu, Fabao; Zhang, Tongcun; Zhang, Jian; Jia, Shiru; Yu, Changyan; Jiang, Kunyu; Gao, Nianfa			The Role of Lactic Acid Adsorption by Ion Exchange Chromatography	PLOS ONE			English	Article							FERMENTATION; BIOREACTOR; RECOVERY; SORPTION	Background: The polyacrylic resin Amberlite IRA-67 is a promising adsorbent for lactic acid extraction from aqueous solution, but little systematic research has been devoted to the separation efficiency of lactic acid under different operating conditions. Methodology/Principal Findings: In this paper, we investigated the effects of temperature, resin dose and lactic acid loading concentration on the adsorption of lactic acid by Amberlite IRA-67 in batch kinetic experiments. The obtained kinetic data followed the pseudo-second order model well and both the equilibrium and ultimate adsorption slightly decreased with the increase of the temperature at 293-323K and 42.5 g/liter lactic acid loading concentration. The adsorption was a chemically heterogeneous process with a mean free energy value of 12.18 kJ/mol. According to the Boyd plot, the lactic acid uptake process was primarily found to be an intraparticle diffusion at a lower concentration (<50 g/liter) but a film diffusion at a higher concentration (>70 g/liter). The values of effective diffusion coefficient D-i increased with temperature. By using our Equation (21), the negative values of Delta G degrees and Delta H degrees revealed that the adsorption process was spontaneous and exothermic. Moreover, the negative value of Delta S degrees reflected the decrease of solid-liquid interface randomness at the solid-liquid interface when adsorbing lactic acid on IRA-67. Conclusions/Significance: With the weakly basic resin IRA-67, in situ product removal of lactic acid can be accomplished especially from an open and thermophilic fermentation system without sterilization.	[Gao, Qiang; Liu, Fabao; Zhang, Tongcun; Zhang, Jian; Jia, Shiru; Yu, Changyan; Jiang, Kunyu; Gao, Nianfa] Tianjin Univ Sci & Technol, Coll Biotechnol, Minist Educ & Tianjin City, Key Lab Ind Microbiol, Tianjin, Peoples R China	Tianjin University Science & Technology	Gao, QA (corresponding author), Tianjin Univ Sci & Technol, Coll Biotechnol, Minist Educ & Tianjin City, Key Lab Ind Microbiol, Tianjin, Peoples R China.	gaoqiang@tust.edu.cn	Zhang, Tong/HGC-1090-2022; jia, shi/HHS-4172-2022		National Basic Research Program of China [2007CB714305, 2011CB707401]; Tianjin Natural Science Foundation of China [08JCZDJC15100]	National Basic Research Program of China(National Basic Research Program of China); Tianjin Natural Science Foundation of China	The work for this manuscript is financially supported by National Basic Research Program of China (2007CB714305 and 2011CB707401) (973 Program: http://www.most.gov.cn/eng/programmes1/200610/t20061009_36223.htm), National High-Tech R & D Program of China (2008AA10Z336) (863 Program: http://www.most.gov.cn/eng/programmes1/200610/t20061009_36225.htm) and Key Project of Tianjin Natural Science Foundation of China (08JCZDJC15100) (http://www.tstc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation for this manuscript.	Beard DA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000144; BOYD GE, 1947, J AM CHEM SOC, V69, P2836, DOI 10.1021/ja01203a066; Chabani M, 2009, J HAZARD MATER, V165, P27, DOI 10.1016/j.jhazmat.2008.08.091; Chen CC, 1998, SEP SCI TECHNOL, V33, P1423, DOI 10.1080/01496399808545058; DUBININ MM, 1947, ZH FIZ KHIM+, V21, P1351; El-Beyrouty C, 2006, ANN PHARMACOTHER, V40, P1602, DOI 10.1345/aph.1G740; Fontes MPF, 2003, APPL GEOCHEM, V18, P795, DOI 10.1016/S0883-2927(02)00188-9; Freundlich H, 1906, Z PHYS CHEM-STOCH VE, V57, P385; Gupta VK, 2001, WATER RES, V35, P33, DOI 10.1016/S0043-1354(00)00232-3; Helfferich F., 1962, ION EXCHANGE; Ho YS, 1999, PROCESS BIOCHEM, V34, P451, DOI 10.1016/S0032-9592(98)00112-5; Ho YS, 1999, RESOUR CONSERV RECY, V25, P171, DOI 10.1016/S0921-3449(98)00053-6; Kasuga T, 2001, BIOMATERIALS, V22, P19, DOI 10.1016/S0142-9612(00)00091-0; KHAN AA, 1987, COLLOID SURFACE, V24, P33, DOI 10.1016/0166-6622(87)80259-7; Langmuir I, 1918, J AM CHEM SOC, V40, P1361, DOI 10.1021/ja02242a004; Moldes AB, 2003, BIOPROC BIOSYST ENG, V25, P357, DOI 10.1007/s00449-002-0316-7; Patel M, 2008, BIOTECHNOL PROGR, V24, P821, DOI [10.1002/btpr.6, 10.1021/bp.6]; Qin JY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004359; SARL A, 2009, J HAZARD MATER, V171, P973; SRIVASTAVA A, 1992, BIOTECHNOL BIOENG, V39, P607, DOI 10.1002/bit.260390604; Uslu H, 2010, J CHEM ENG DATA, V55, P1295, DOI 10.1021/je900635z; WANG E, 1988, J CHEM ENG JPN, V21, P36, DOI 10.1252/jcej.21.36	22	31	34	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2010	5	11							e13948	10.1371/journal.pone.0013948	http://dx.doi.org/10.1371/journal.pone.0013948			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	678OA	21085600	Green Published, Green Submitted, gold			2022-12-27	WOS:000284087800014
J	Fraser, A; Williams, D; Lawlor, DA				Fraser, Abigail; Williams, Dylan; Lawlor, Debbie A.			Associations of Serum 25-Hydroxyvitamin D, Parathyroid Hormone and Calcium with Cardiovascular Risk Factors: Analysis of 3 NHANES Cycles (2001-2006)	PLOS ONE			English	Article							VITAMIN-D DEFICIENCY; MIDDLE-AGED MEN; INSULIN-RESISTANCE; MYOCARDIAL-INFARCTION; INCIDENT HYPERTENSION; METABOLIC SYNDROME; BLOOD-PRESSURE; US ADULTS; DISEASE; PREVALENCE	Background: Increasing evidence suggests a role for mineral metabolism in cardiovascular disease risk. 25-hydroxyvitamin D (25(OH)D), parathyroid hormone (PTH), and calcium may be directly associated with cardiovascular risk factors or mediated by each other. Methodology/Principal Findings: We combined data for adult participants in three cycles of the National Health and Nutrition Examination Survey (2001-2, 2003-4, 2005-6), a representative sample of the civilian, non-institutionalized US population (N = 3,958). Using this data we examined joint associations of 25(OH)D, PTH and calcium with a range of cardiovascular risk factors. 25(OH)D was inversely associated with fasting insulin (mean difference in insulin per 1 standard deviation 25(OH)D: -0.053 (95%CI: -0.091, -0.015)), glucose (-0.046 95%CI: -0.081, -0.012) and systolic blood pressure (SBP) (-0.032 95%CI: -0.062, -0.001), and positively associated with high density lipoprotein cholesterol HDL-c (0.088 95%CI: 0.044, 0.148), after adjustment for ethnicity, smoking, socio-economic status and waist circumference. PTH was positively associated with diastolic blood pressure (0.110, 95%CI: 0.055, 0.164) in confounder adjusted models, but was not associated with other cardiovascular risk factors. Albumin adjusted calcium was associated with triglycerides (0.102 95%CI: 0.063, 0.141), postload glucose (0.078, 95%CI: 0.025, 0.130), fasting insulin (0.074, 95%CI: 0.044, 0.104), HbA1c (0.070, 95%CI: 0.036, 0.105), SBP (0.064, 95%CI: 0.028, 0.100), fasting glucose (0.055, 95%CI: 0.018, 0.092) and low density lipoprotein cholesterol (0.052, 95%CI: 0.014, 0.091). With mutual adjustment for each other, these associations remained essentially unchanged. Conclusions/Significance: Lower levels of 25(OH)D and higher levels of calcium and PTH appear to be associated with different cardiovascular risk factors and may therefore affect cardiovascular disease risk through different mechanisms.	[Fraser, Abigail; Williams, Dylan; Lawlor, Debbie A.] Univ Bristol, Dept Social Med, MRC, Ctr Causal Anal Translat Epidemiol, Bristol, Avon, England	University of Bristol	Fraser, A (corresponding author), Univ Bristol, Dept Social Med, MRC, Ctr Causal Anal Translat Epidemiol, Bristol, Avon, England.	Abigail.fraser@bristol.ac.uk		Lawlor, Debbie A/0000-0002-6793-2262; Fraser, Abigail/0000-0002-7741-9470; Williams, Dylan/0000-0002-3825-2487	UK MRC [G0701603]; University of Bristol; Wellcome Trust; Medical Research Council [G0701603, G0600705, G0701594] Funding Source: researchfish; MRC [G0701603, G0600705, G0701594] Funding Source: UKRI	UK MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University of Bristol; Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Work on this study is funded by an UK MRC Grant (G0701603). The UK Medical Research Council (MRC) and the University of Bristol provide core funding for the MRC Centre of Causal Analyses in Translational Epidemiology. AF is funded by a UK Medical Research Council research fellowship. DW is funded by a Wellcome Trust studentship. The views expressed in this paper are those of the authors and not necessarily those of any funding body or others whose support is acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlstrom T, 2009, CLIN ENDOCRINOL, V71, P673, DOI 10.1111/j.1365-2265.2009.03558.x; BOLLAND MJ, 2010, BRIT MED J, V341, pNIL1; *CDCP, 2008, DOC COD PROC VIT D; *CDCP, 2008, DOC COD FREQ PLASM F; Cozzolino M, 2010, EUR J HEART FAIL, V12, P1031, DOI 10.1093/eurjhf/hfq112; Dobnig H, 2008, ARCH INTERN MED, V168, P1340, DOI 10.1001/archinte.168.12.1340; Forman JP, 2007, HYPERTENSION, V49, P1063, DOI 10.1161/HYPERTENSIONAHA.107.087288; Forouhi NG, 2008, DIABETES, V57, P2619, DOI 10.2337/db08-0593; Giovannucci E, 2008, ARCH INTERN MED, V168, P1174, DOI 10.1001/archinte.168.11.1174; Hagstrom E, 2009, CIRCULATION, V119, P2765, DOI 10.1161/CIRCULATIONAHA.108.808733; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Lawlor DA, 2008, STAT MED, V27, P1133, DOI 10.1002/sim.3034; Levey AS, 2003, ANN INTERN MED, V139, P137, DOI 10.7326/0003-4819-139-2-200307150-00013; Lind L, 1997, J CLIN EPIDEMIOL, V50, P967, DOI 10.1016/S0895-4356(97)00104-2; LIND L, 1995, AM J HYPERTENS, V8, P894, DOI 10.1016/0895-7061(95)00154-H; Martins D, 2007, ARCH INTERN MED, V167, P1159, DOI 10.1001/archinte.167.11.1159; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Mattila C, 2007, DIABETES CARE, V30, P2569, DOI 10.2337/dc07-0292; Perkovic V, 2003, KIDNEY BLOOD PRESS R, V26, P27, DOI 10.1159/000069761; Poole KES, 2005, CURR OPIN PHARMACOL, V5, P612, DOI 10.1016/j.coph.2005.07.004; Reis JP, 2008, EUR J ENDOCRINOL, V159, P41, DOI 10.1530/EJE-08-0072; Reis JP, 2007, DIABETES CARE, V30, P1549, DOI 10.2337/dc06-2438; Rose G, 1982, CARDIOVASCULAR SURVE; Snijder MB, 2007, J INTERN MED, V261, P558, DOI 10.1111/j.1365-2796.2007.01778.x; Tai K, 2008, NUTRITION, V24, P279, DOI 10.1016/j.nut.2007.11.006; Taylor EN, 2008, J HYPERTENS, V26, P1390, DOI 10.1097/HJH.0b013e3282ffb43b; Wang TJ, 2008, CIRCULATION, V117, P503, DOI 10.1161/CIRCULATIONAHA.107.706127; Wang YT, 2009, AM J EPIDEMIOL, V170, P88, DOI 10.1093/aje/kwp086; Zhao GX, 2010, DIABETES CARE, V33, P344, DOI 10.2337/dc09-0924; Zittermann A, 2006, PROG BIOPHYS MOL BIO, V92, P39, DOI 10.1016/j.pbiomolbio.2006.02.001	30	66	68	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2010	5	11							e13882	10.1371/journal.pone.0013882	http://dx.doi.org/10.1371/journal.pone.0013882			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	677ZE	21085485	gold, Green Published			2022-12-27	WOS:000284035900004
J	Brennan, LA; Lee, W; Kantorow, M				Brennan, Lisa A.; Lee, Wanda; Kantorow, Marc			TXNL6 Is a Novel Oxidative Stress-Induced Reducing System for Methionine Sulfoxide Reductase A Repair of alpha-Crystallin and Cytochrome C in the Eye Lens	PLOS ONE			English	Article							PROTEIN OXIDATION; EPITHELIAL-CELLS; NUCLEAR CATARACT; MITOCHONDRIAL; MSRA; LOCALIZATION; THIOREDOXIN; RESIDUES; DISEASE; IDENTIFICATION	A key feature of many age-related diseases is the oxidative stress-induced accumulation of protein methionine sulfoxide (PMSO) which causes lost protein function and cell death. Proteins whose functions are lost upon PMSO formation can be repaired by the enzyme methionine sulfoxide reductase A (MsrA) which is a key regulator of longevity. One disease intimately associated with PMSO formation and loss of MsrA activity is age-related human cataract. PMSO levels increase in the eye lens upon aging and in age-related human cataract as much as 70% of total lens protein is converted to PMSO. MsrA is required for lens cell maintenance, defense against oxidative stress damage, mitochondrial function and prevention of lens cataract formation. Essential for MsrA action in the lens and other tissues is the availability of a reducing system sufficient to catalytically regenerate active MsrA. To date, the lens reducing system(s) required for MsrA activity has not been defined. Here, we provide evidence that a novel thioredoxin-like protein called thioredoxin-like 6 (TXNL6) can serve as a reducing system for MsrA repair of the essential lens chaperone alpha-crystallin/sHSP and mitochondrial cytochrome c. We also show that TXNL6 is induced at high levels in human lens epithelial cells exposed to H2O2-induced oxidative stress. Collectively, these data suggest a critical role for TXNL6 in MsrA repair of essential lens proteins under oxidative stress conditions and that TXNL6 is important for MsrA defense protection against cataract. They also suggest that MsrA uses multiple reducing systems for its repair activity that may augment its function under different cellular conditions.	[Brennan, Lisa A.; Lee, Wanda; Kantorow, Marc] Florida Atlantic Univ, Dept Biomed Sci, Charles E Schmidt Coll Med, Boca Raton, FL 33431 USA	State University System of Florida; Florida Atlantic University	Brennan, LA (corresponding author), Florida Atlantic Univ, Dept Biomed Sci, Charles E Schmidt Coll Med, Boca Raton, FL 33431 USA.	mkantoro@fau.edu			National Institutes of Health (NIH.gov) [RO1 EY13022, EY13022]; NATIONAL EYE INSTITUTE [R01EY013022] Funding Source: NIH RePORTER	National Institutes of Health (NIH.gov)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by RO1 EY13022 and EY13022 supplement grants from the National Institutes of Health (NIH.gov) awarded to Marc Kantorow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andley UP, 1996, INVEST OPHTH VIS SCI, V37, P142; Andley UP, 2000, J BIOL CHEM, V275, P36823, DOI 10.1074/jbc.M004233200; Arner ESJ, 2000, EUR J BIOCHEM, V267, P6102, DOI 10.1046/j.1432-1327.2000.01701.x; AUGUSTEYN RC, 2010, EXPT EYE RES, V90; Basova LV, 2007, BIOCHEMISTRY-US, V46, P3423, DOI 10.1021/bi061854k; Berlett BS, 1997, J BIOL CHEM, V272, P20313, DOI 10.1074/jbc.272.33.20313; Boschi-Muller S, 2005, BBA-PROTEINS PROTEOM, V1703, P231, DOI 10.1016/j.bbapap.2004.09.016; Boschi-Muller S, 2008, ARCH BIOCHEM BIOPHYS, V474, P266, DOI 10.1016/j.abb.2008.02.007; BRADY J, 1997, SCIENCES, V94, P884; Brennan LA, 2009, MOL VIS, V15, P985; Brennan LA, 2009, BBA-GEN SUBJECTS, V1790, P1665, DOI 10.1016/j.bbagen.2009.08.011; Brennan LA, 2009, EXP EYE RES, V88, P195, DOI 10.1016/j.exer.2008.05.018; BROT N, 1981, P NATL ACAD SCI-BIOL, V78, P2155, DOI 10.1073/pnas.78.4.2155; BROT N, 1983, ARCH BIOCHEM BIOPHYS, V223, P271, DOI 10.1016/0003-9861(83)90592-1; Cadenas E, 2000, FREE RADICAL BIO MED, V29, P222, DOI 10.1016/S0891-5849(00)00317-8; Cassina AM, 2000, J BIOL CHEM, V275, P21409, DOI 10.1074/jbc.M909978199; Chen YR, 2002, J BIOL CHEM, V277, P29781, DOI 10.1074/jbc.M200709200; Cronin T, 2010, CELL DEATH DIFFER, V17, P1199, DOI 10.1038/cdd.2010.2; DELAMERE NA, 2009, EXPT EYE RES, V88; Friguet B, 2006, FEBS LETT, V580, P2910, DOI 10.1016/j.febslet.2006.03.028; Gabbita SP, 1999, J NEUROCHEM, V73, P1660, DOI 10.1046/j.1471-4159.1999.0731660.x; GARNER MH, 1980, P NATL ACAD SCI-BIOL, V77, P1274, DOI 10.1073/pnas.77.3.1274; Glaser CB, 2005, BBA-PROTEINS PROTEOM, V1703, P157, DOI 10.1016/j.bbapap.2004.10.008; Goswami S, 2003, INVEST OPHTH VIS SCI, V44, P2084, DOI 10.1167/iovs.02-0882; Hawkins CL, 2003, AMINO ACIDS, V25, P259, DOI 10.1007/s00726-003-0016-x; Hawse JR, 2005, MOL VIS, V11, P274; Hejtmancik JF, 2004, EXP EYE RES, V79, P3, DOI 10.1016/j.exer.2004.03.014; HOLMGREN A, 2010, BIOCH BIOPHYSICAL RE, V396; HORWITZ J, 1992, P NATL ACAD SCI USA, V89, P10449, DOI 10.1073/pnas.89.21.10449; Horwitz J, 2003, EXP EYE RES, V76, P145, DOI 10.1016/S0014-4835(02)00278-6; Jacob C, 2003, ANGEW CHEM INT EDIT, V42, P4742, DOI 10.1002/anie.200300573; JAKOB U, 1993, J BIOL CHEM, V268, P1517; KAGAN V, 2009, FREE RADICAL BIO MED, V46; Kantorow M, 2004, P NATL ACAD SCI USA, V101, P9654, DOI 10.1073/pnas.0403532101; Kim G, 2010, J BIOL CHEM, V285, P18085, DOI 10.1074/jbc.M110.119701; Lee W, 2007, MOL VIS, V13, P1469; Leveillard T, 2004, NAT GENET, V36, P755, DOI 10.1038/ng1386; Lillig CH, 2007, ANTIOXID REDOX SIGN, V9, P25, DOI 10.1089/ars.2007.9.25; Liu F, 2008, FREE RADICAL BIO MED, V45, P242, DOI 10.1016/j.freeradbiomed.2008.03.022; Lou MF, 2003, PROG RETIN EYE RES, V22, P657, DOI 10.1016/S1350-9462(03)00050-8; Marchetti MA, 2006, EXP EYE RES, V83, P1281, DOI 10.1016/j.exer.2006.07.005; Moskovitz J, 1998, P NATL ACAD SCI USA, V95, P14071, DOI 10.1073/pnas.95.24.14071; Moskovitz J, 2001, P NATL ACAD SCI USA, V98, P12920, DOI 10.1073/pnas.231472998; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Ow YLP, 2008, NAT REV MOL CELL BIO, V9, P532, DOI 10.1038/nrm2434; PHELPSBROWN N, 1995, LENS DISORDERS CLIN, P91; PICOT R, 2005, FREE RADICAL BIO MED, V39, P1332, DOI DOI 10.1016/J.FREERADBI0MED.2005.06.017; REDDY VN, 1971, EXP EYE RES, V11, P310, DOI 10.1016/S0014-4835(71)80043-X; Ruan H, 2002, P NATL ACAD SCI USA, V99, P2748, DOI 10.1073/pnas.032671199; Saghert D, 2006, P NATL ACAD SCI USA, V103, P8656, DOI 10.1073/pnas.0602826103; Salm M, 2006, AM J OPHTHALMOL, V142, P976, DOI 10.1016/j.ajo.2006.07.057; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; Schoneich C, 2005, BBA-PROTEINS PROTEOM, V1703, P111, DOI 10.1016/j.bbapap.2004.09.009; SPECTOR A, 1995, FASEB J, V9, P1173, DOI 10.1096/fasebj.9.12.7672510; Stadtman ER, 2003, ANTIOXID REDOX SIGN, V5, P577, DOI 10.1089/152308603770310239; Truscott RJW, 2005, EXP EYE RES, V80, P709, DOI 10.1016/j.exer.2004.12.007; TRUSCOTT RJW, 1977, BIOCHIM BIOPHYS ACTA, V492, P43, DOI 10.1016/0005-2795(77)90212-4; Vinson Joe A, 2006, Pathophysiology, V13, P151, DOI 10.1016/j.pathophys.2006.05.006; VOGT W, 1995, FREE RADICAL BIO MED, V18, P93, DOI 10.1016/0891-5849(94)00158-G; Vougier S, 2003, BIOCHEM J, V373, P531, DOI 10.1042/BJ20030443; Wassef R, 2007, J NEUROSCI, V27, P12808, DOI 10.1523/JNEUROSCI.0322-07.2007; WEI XW, 2008, FREE RADICAL BIO MED, V45, P336, DOI DOI 10.1016/J.FREERADBI0MED.2008.04.028; XING K, 2010, INFOCOM, P1; Yegorova S, 2003, INVEST OPHTH VIS SCI, V44, P3263, DOI 10.1167/iovs.02-1322; Zhao H, 2010, FREE RADICAL BIO MED, V49, P641, DOI 10.1016/j.freeradbiomed.2010.05.017	65	21	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2010	5	11							e15421	10.1371/journal.pone.0015421	http://dx.doi.org/10.1371/journal.pone.0015421			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675NY	21079812	gold, Green Submitted, Green Published			2022-12-27	WOS:000283838600028
J	Faisal, A; Stout, D; Apel, J; Bradley, B				Faisal, Aldo; Stout, Dietrich; Apel, Jan; Bradley, Bruce			The Manipulative Complexity of Lower Paleolithic Stone Toolmaking	PLOS ONE			English	Article							HAND; LANGUAGE; ORGANIZATION; TECHNOLOGY; EVOLUTION; BEHAVIOR; SPEECH; BRAIN; TOOL; ARTIFACTS	Background: Early stone tools provide direct evidence of human cognitive and behavioral evolution that is otherwise unavailable. Proper interpretation of these data requires a robust interpretive framework linking archaeological evidence to specific behavioral and cognitive actions. Methodology/Principal Findings: Here we employ a data glove to record manual joint angles in a modern experimental toolmaker (the 4(th) author) replicating ancient tool forms in order to characterize and compare the manipulative complexity of two major Lower Paleolithic technologies (Oldowan and Acheulean). To this end we used a principled and general measure of behavioral complexity based on the statistics of joint movements. Conclusions/Significance: This allowed us to confirm that previously observed differences in brain activation associated with Oldowan versus Acheulean technologies reflect higher-level behavior organization rather than lower-level differences in manipulative complexity. This conclusion is consistent with a scenario in which the earliest stages of human technological evolution depended on novel perceptual-motor capacities (such as the control of joint stiffness) whereas later developments increasingly relied on enhanced mechanisms for cognitive control. This further suggests possible links between toolmaking and language evolution.	[Faisal, Aldo] Univ London Imperial Coll Sci Technol & Med, Dept Bioengn, London, England; [Faisal, Aldo] Univ London Imperial Coll Sci Technol & Med, Dept Comp, London, England; [Stout, Dietrich] Emory Univ, Dept Anthropol, Atlanta, GA 30322 USA; [Apel, Jan] Gotland Univ Coll, Dept Archaeol & Osteol, Visby, Sweden; [Bradley, Bruce] Univ Exeter, Dept Archaeol, Exeter, Devon, England	Imperial College London; Imperial College London; Emory University; University of Exeter	Faisal, A (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Bioengn, London, England.	aldo.faisal@imperial.ac.uk; dwstout@emory.edu	Faisal, Aldo/A-2367-2009	Faisal, Aldo/0000-0003-0813-7207; Stout, Dietrich/0000-0003-3555-7637	Commission of the European Communities Research Directorate [029065]	Commission of the European Communities Research Directorate	This work was supported by the Commission of the European Communities Research Directorate-General Specific Targeted Project number 029065, Hand to Mouth: A framework for understanding the archaeological and fossil records of human cognitive evolution. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrose SH, 2001, SCIENCE, V291, P1748, DOI 10.1126/science.1059487; Aron AR, 2004, TRENDS COGN SCI, V8, P170, DOI 10.1016/j.tics.2004.02.010; Bookheimer S, 2002, ANNU REV NEUROSCI, V25, P151, DOI 10.1146/annurev.neuro.25.112701.142946; Bril B, 2005, STONE KNAPPING NECES, P353; Bril B., 2005, STONE KNAPPING NECES, P53; Bril B., 2000, PERLES CAMBAY PRACTI, P211; Burdet E, 2001, NATURE, V414, P446, DOI 10.1038/35106566; Byrne Richard W., 2004, P31, DOI 10.1017/CBO9780511542299.005; Callahan E., 1979, ARCHAEOLOGY E N AM, V7, P1; Chao LL, 2000, NEUROIMAGE, V12, P478, DOI 10.1006/nimg.2000.0635; CHASE PG, 1991, J ANTHROPOL ARCHAEOL, V10, P193, DOI 10.1016/0278-4165(91)90013-N; Clark J. D., 1994, INTEGRATIVE PATHS PA, P451; Corballis MC, 2003, BEHAV BRAIN SCI, V26, P199, DOI 10.1017/S0140525X03000062; Deacon T., 1997, SYMBOLIC SPECIES COE; FAISAL A, 2009, COSYNE 2009; Faisal AA, 2008, NAT REV NEUROSCI, V9, P292, DOI 10.1038/nrn2258; Frey SH, 2006, J NEUROSCI, V26, P13194, DOI 10.1523/JNEUROSCI.3914-06.2006; Gowlett J. A. J., 1984, HOMINID EVOLUTION CO, P167; GOWLETT JAJ, 1996, MODELLING EARLY HUMA; GREENFIELD PM, 1991, BEHAV BRAIN SCI, V14, P531, DOI 10.1017/S0140525X00071235; GUIARD Y, 1987, J MOTOR BEHAV, V19, P486; Hagoort P, 2005, TRENDS COGN SCI, V9, P416, DOI 10.1016/j.tics.2005.07.004; Hartmann K, 2005, NEUROPSYCHOLOGIA, V43, P625, DOI 10.1016/j.neuropsychologia.2004.07.015; Higuchi S, 2009, NEUROREPORT, V20, P1376, DOI 10.1097/WNR.0b013e3283315570; HOLLOWAY RL, 1969, CURR ANTHROPOL, V10, P395, DOI 10.1086/201036; Ingram JN, 2008, EXP BRAIN RES, V188, P223, DOI 10.1007/s00221-008-1355-3; ISAAC GL, 1976, ANN NY ACAD SCI, V280, P275, DOI 10.1111/j.1749-6632.1976.tb25494.x; Jubault T, 2007, J NEUROSCI, V27, P11028, DOI 10.1523/JNEUROSCI.1986-07.2007; Koechlin E, 2006, NEURON, V50, P963, DOI 10.1016/j.neuron.2006.05.017; Lang CE, 2004, J NEUROPHYSIOL, V92, P2802, DOI 10.1152/jn.00480.2004; Liberman AM, 2000, TRENDS COGN SCI, V4, P187, DOI 10.1016/S1364-6613(00)01471-6; Lieberman P, 2002, YEARB PHYS ANTHROPOL, V45, P36, DOI 10.1002/ajpa.10171; MACNEILAGE PF, 1991, BEHAV BRAIN SCI, V14, P568, DOI 10.1017/S0140525X00071405; Marzke MW, 1998, AM J PHYS ANTHROPOL, V105, P315, DOI 10.1002/(SICI)1096-8644(199803)105:3<315::AID-AJPA3>3.3.CO;2-D; MARZKE MW, 1986, J HUM EVOL, V15, P439, DOI 10.1016/S0047-2484(86)80027-6; Milner TE, 1998, IEEE T BIO-MED ENG, V45, P1363, DOI 10.1109/10.725333; MUNHALL KG, 1994, J ACOUST SOC AM, V95, P3605, DOI 10.1121/1.409929; Ottoni EB, 2000, BEHAV RES METH INS C, V32, P446, DOI 10.3758/BF03200814; Rearick MP, 2002, EXP BRAIN RES, V144, P38, DOI 10.1007/s00221-002-1024-x; Rizzolatti G, 1998, TRENDS NEUROSCI, V21, P188, DOI 10.1016/S0166-2236(98)01260-0; Ross ED, 2008, BRAIN LANG, V104, P51, DOI 10.1016/j.bandl.2007.04.007; ROUX V, 1995, WORLD ARCHAEOL, V27, P63, DOI 10.1080/00438243.1995.9980293; Roux V., 2005, STONE KNAPPING NECES, P243; Santello M, 1998, J NEUROSCI, V18, P10105; Sato M, 2009, BRAIN LANG, V111, P1, DOI 10.1016/j.bandl.2009.03.002; SAVAGERUMBAUGH S, 2006, OLDOWAN CASE STUDIES, P223; Schick K. D., 1993, MAKING SILENT STONES; Schieber MH, 2004, J APPL PHYSIOL, V96, P2293, DOI 10.1152/japplphysiol.01063.2003; Selen LPJ, 2009, J NEUROSCI, V29, P12606, DOI 10.1523/JNEUROSCI.2826-09.2009; Semaw S, 2000, J ARCHAEOL SCI, V27, P1197, DOI 10.1006/jasc.1999.0592; Shadmehr R., 2005, COMPUTATIONAL NEUROB; Stephan KE, 2003, SCIENCE, V301, P384, DOI 10.1126/science.1086025; Stout D, 2008, PHILOS T R SOC B, V363, P1939, DOI 10.1098/rstb.2008.0001; Stout D, 2007, NEUROPSYCHOLOGIA, V45, P1091, DOI 10.1016/j.neuropsychologia.2006.09.014; Stout D, 2010, J HUM EVOL, V58, P474, DOI 10.1016/j.jhevol.2010.02.005; Stout D, 2009, CAMB ARCHAEOL J, V19, P85, DOI 10.1017/S0959774309000055; Studdert-Kennedy M., 2003, STUDIES EVOLUTION LA, P235, DOI DOI 10.1093/ACPROF:OSO/9780199244843.003.0013; Tocheri MW, 2008, J ANAT, V212, P544, DOI 10.1111/j.1469-7580.2008.00865.x; Todorov E, 2004, P ANN INT IEEE EMBS, V26, P4637; Uomini NT, 2009, J HUM EVOL, V57, P411, DOI 10.1016/j.jhevol.2009.02.012; WYNN T, 1989, MAN, V24, P383, DOI 10.2307/2802697; [No title captured]	62	83	84	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2010	5	11							e13718	10.1371/journal.pone.0013718	http://dx.doi.org/10.1371/journal.pone.0013718			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	674WJ	21072164	Green Submitted, Green Published, gold			2022-12-27	WOS:000283780800002
J	Kim, JH; Park, BL; Cheong, HS; Bae, JS; Park, JS; Jang, AS; Uh, ST; Choi, JS; Kim, YH; Kim, MK; Choi, IS; Cho, SH; Choi, BW; Park, CS; Shin, HD				Kim, Jeong-Hyun; Park, Byung-Lae; Cheong, Hyun Sub; Bae, Joon Seol; Park, Jong Sook; Jang, An Soo; Uh, Soo-Taek; Choi, Jae-Sung; Kim, Yong-Hoon; Kim, Mi-Kyeong; Choi, Inseon S.; Cho, Sang Heon; Choi, Byoung Whui; Park, Choon-Sik; Shin, Hyoung Doo			Genome-Wide and Follow-Up Studies Identify CEP68 Gene Variants Associated with Risk of Aspirin-Intolerant Asthma	PLOS ONE			English	Article							LEUKOTRIENE C-4 SYNTHASE; PROMOTER POLYMORPHISM; RECEPTOR ANTAGONIST; HAPLOTYPE; PHARMACOGENETICS; 5-LIPOXYGENASE; DISEQUILIBRIUM; REQUIREMENT; POPULATION; EXPRESSION	Aspirin-intolerant asthma (AIA) is a rare condition that is characterized by the development of bronchoconstriction in asthmatic patients after ingestion of non-steroidal anti-inflammatory drugs including aspirin. However, the underlying mechanisms of AIA occurrence are still not fully understood. To identify the genetic variations associated with aspirin intolerance in asthmatics, the first stage of genome-wide association study with 109,365 single nucleotide polymorphisms (SNPs) was undertaken in a Korean AIA (n = 80) cohort and aspirin-tolerant asthma (ATA, n = 100) subjects as controls. For the second stage of follow-up study, 150 common SNPs from 11 candidate genes were genotyped in 163 AIA patients including intermediate AIA (AIA-I) subjects and 429 ATA controls. Among 11 candidate genes, multivariate logistic analyses showed that SNPs of CEP68 gene showed the most significant association with aspirin intolerance (P values of co-dominant for CEP68, 6.0x10(-5) to 4.0x10(-5)). All seven SNPs of the CEP68 gene showed linkage disequilibrium (LD), and the haplotype of CEP68_ht4 (T-G-A-A-A-C-G) showed a highly significant association with aspirin intolerance (OR = 2.63; 95% CI = 1.64-4.21; P = 6.0x10(-5)). Moreover, the nonsynonymous CEP68 rs7572857G>A variant that replaces glycine with serine showed a higher decline of forced expiratory volume in 1s (FEV(1)) by aspirin provocation than other variants (P = 3.0x10(-5)). Our findings imply that CEP68 could be a susceptible gene for aspirin intolerance in asthmatics, suggesting that the nonsynonymous Gly74Ser could affect the polarity of the protein structure.	[Kim, Jeong-Hyun; Bae, Joon Seol; Shin, Hyoung Doo] Sogang Univ, Dept Life Sci, Seoul, South Korea; [Park, Byung-Lae; Cheong, Hyun Sub; Shin, Hyoung Doo] SNP Genet Inc, Dept Genet Epidemiol, Seoul, South Korea; [Park, Jong Sook; Jang, An Soo; Uh, Soo-Taek; Park, Choon-Sik] Soonchunhyang Univ, Bucheon Hosp, Div Allergy & Resp Med, Puchon, South Korea; [Choi, Jae-Sung; Kim, Yong-Hoon] Soonchunhyang Univ, Cheonan Hosp, Div Allergy & Resp Med, Cheonan, South Korea; [Kim, Mi-Kyeong] Chungbuk Natl Univ, Div Internal Med, Cheongju, South Korea; [Choi, Inseon S.] Chonnam Natl Univ, Dept Allergy, Kwangju, South Korea; [Cho, Sang Heon] Seoul Natl Univ, Dept Internal Med, Seoul, South Korea; [Choi, Byoung Whui] Chung Ang Univ, Dept Internal Med, Yongsan Hosp, Seoul 156756, South Korea	Sogang University; SNP Genetics; Soonchunhyang University; Soonchunhyang University; Chungbuk National University; Chonnam National University; Seoul National University (SNU); Chung Ang University	Kim, JH (corresponding author), Sogang Univ, Dept Life Sci, Seoul, South Korea.	schalr@schbc.ac.kr; hdshin@sogang.ac.kr	Cho, Sang Heon/J-2793-2012	Park, Choon-Sik/0000-0003-2977-0255	Korean government (MEST) [M1-0302-00-0073, 2009-0080157]; Ministry of Education, Science and Technology [2009-0093822]; Korea Health 21 RD Project [A010249]; Ministry of Health, Welfare and Family Affairs, Republic of Korea	Korean government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Korea Health 21 RD Project; Ministry of Health, Welfare and Family Affairs, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	Hyoung Doo Shin received grant number M1-0302-00-0073 from the Korea Science and Engineering Foundation (KOSEF) funded by the Korean government (MEST) (No. 2009-0080157), and a Priority Research Centers Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2009-0093822). Choon-Sik Park received a grant from the Korea Health 21 R&D Project (A010249). SNP Genetics, Inc. provided the Beadstation500 scanner instrument and BeadStudio 3.0 software used in the research. They also were involved in the study design, data collection and analysis, decision to publish and preparation of the manuscript.; The DNA samples were generously provided by the Soonchunhyang University, Bucheon Hospital Biobank, a member of the National Biobank of Korea, supported by the Ministry of Health, Welfare and Family Affairs, Republic of Korea.	Akahoshi M, 2005, HUM GENET, V117, P16, DOI 10.1007/s00439-005-1285-0; Altshuler D, 2008, SCIENCE, V322, P881, DOI 10.1126/science.1156409; Babu KS, 2000, CHEST, V118, P1470, DOI 10.1378/chest.118.5.1470; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Chen Y, 2007, PROTEOMICS, V7, P2384, DOI 10.1002/pmic.200600968; Choi JH, 2004, J ALLERGY CLIN IMMUN, V113, P562, DOI 10.1016/j.jaci.2003.12.012; Choi JH, 2004, HUM GENET, V114, P337, DOI 10.1007/s00439-004-1082-1; Cirulli ET, 2010, NAT REV GENET, V11, P415, DOI 10.1038/nrg2779; Cormican LJ, 2005, CLIN EXP ALLERGY, V35, P717, DOI 10.1111/j.1365-2222.2005.02261.x; Dahlen SE, 2002, AM J RESP CRIT CARE, V165, P9, DOI 10.1164/ajrccm.165.1.2010080; Dekker JW, 1997, CLIN EXP ALLERGY, V27, P574, DOI 10.1046/j.1365-2222.1997.540848.x; Devlin B, 2001, THEOR POPUL BIOL, V60, P155, DOI 10.1006/tpbi.2001.1542; Drazen JM, 1999, NEW ENGL J MED, V340, P197, DOI 10.1056/NEJM199901213400306; Duroudier NP, 2009, ALLERGY, V64, P823, DOI 10.1111/j.1398-9995.2009.02015.x; Goldstein DB, 2009, NEW ENGL J MED, V360, P1696, DOI 10.1056/NEJMp0806284; Graser S, 2007, J CELL SCI, V120, P4321, DOI 10.1242/jcs.020248; Gudbjartsson DF, 2009, NAT GENET, V41, P342, DOI 10.1038/ng.323; HEDRICK PW, 1987, GENETICS, V117, P331; Himes BE, 2009, AM J HUM GENET, V84, P581, DOI 10.1016/j.ajhg.2009.04.006; Hirschhorn JN, 2005, NAT REV GENET, V6, P95, DOI 10.1038/nrg1521; Hitomi Y, 2009, J ALLERGY CLIN IMMUN, V124, P779, DOI 10.1016/j.jaci.2009.07.044; Jeffreys AJ, 2001, NAT GENET, V29, P217, DOI 10.1038/ng1001-217; Jinnai N, 2004, HUM MOL GENET, V13, P3203, DOI 10.1093/hmg/ddh332; Kawagishi Y, 2002, J ALLERGY CLIN IMMUN, V109, P936, DOI 10.1067/mai.2002.124466; Kim S, 2005, BONE MARROW TRANSPL, V35, pS330; Kim SH, 2006, CLIN EXP ALLERGY, V36, P1247, DOI 10.1111/j.1365-2222.2006.02567.x; Kim SH, 2009, ALLERGY, V64, P1221, DOI 10.1111/j.1398-9995.2009.01989.x; Kim SH, 2007, PHARMACOGENOMICS, V8, P1143, DOI 10.2217/14622416.8.9.1143; Kim SH, 2006, CLIN EXP ALLERGY, V36, P433, DOI 10.1111/j.1365-2222.2006.02457.x; Kim SH, 2005, ALLERGY, V60, P760, DOI 10.1111/j.1398-9995.2005.00780.x; Kim TH, 2008, CLIN EXP ALLERGY, V38, P1727, DOI 10.1111/j.1365-2222.2008.03082.x; Kowalski Marek L, 2007, Clin Allergy Immunol, V19, P147; Kraft P, 2009, NEW ENGL J MED, V360, P1701, DOI 10.1056/NEJMp0810107; Leff AR, 2001, ANNU REV MED, V52, P1; Maheshwari R, 2004, J COLLOID INTERF SCI, V277, P79, DOI 10.1016/j.jcis.2004.04.023; Moffatt MF, 2007, NATURE, V448, P470, DOI 10.1038/nature06014; *NIH, 1995, NIH PUBL, P95; Palikhe NS, 2008, J CLIN PHARM THER, V33, P465, DOI 10.1111/j.1365-2710.2008.00961.x; Park HS, 2004, J ALLERGY CLIN IMMUN, V114, P688, DOI 10.1016/j.jaci.2004.05.051; Park JS, 2010, ALLERGY ASTHMA IMMUN, V2, P48, DOI 10.4168/aair.2010.2.1.48; Park JS, 2005, PHARMACOGENET GENOM, V15, P483, DOI 10.1097/01.fpc.0000166456.84905.a0; Roses AD, 2008, NAT REV DRUG DISCOV, V7, P807, DOI 10.1038/nrd2593; Rouse RL, 2007, ENVIRON HEALTH PERSP, V115, P1757, DOI 10.1289/ehp.10358; Sanak M, 2001, J ALLERGY CLIN IMMUN, V107, P561, DOI 10.1067/mai.2001.112853; Sanak M, 1997, LANCET, V350, P1599, DOI 10.1016/S0140-6736(05)64015-9; Slatkin M, 2008, NAT REV GENET, V9, P477, DOI 10.1038/nrg2361; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; STEVENSON DD, 1997, ASTHMA, P2025; Szczeklik A, 2003, J ALLERGY CLIN IMMUN, V111, P913, DOI 10.1067/mai.2003.1487; Tantisira KG, 2009, J ALLERGY CLIN IMMUN, V124, P422, DOI 10.1016/j.jaci.2009.06.035; Van Sambeek R, 2000, J ALLERGY CLIN IMMUN, V106, P72, DOI 10.1067/mai.2000.107603; Weinshilboum R, 2004, NAT REV DRUG DISCOV, V3, P739, DOI 10.1038/nrd1497; WIDAL F, 1993, ALLERGY PROC, V14, P373, DOI 10.2500/108854193778774065; ZABANEH D, 2010, PLOS ONE IN PRESS	54	64	64	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2010	5	11							e13818	10.1371/journal.pone.0013818	http://dx.doi.org/10.1371/journal.pone.0013818			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	674WJ	21072201	Green Submitted, Green Published, gold			2022-12-27	WOS:000283780800016
J	Brandariz-Nunez, A; Menaya-Vargas, R; Benavente, J; Martinez-Costas, J				Brandariz-Nunez, Alberto; Menaya-Vargas, Rebeca; Benavente, Javier; Martinez-Costas, Jose			IC-Tagging and Protein Relocation to ARV muNS Inclusions: A Method to Study Protein-Protein Interactions in the Cytoplasm or Nucleus of Living Cells	PLOS ONE			English	Article							AVIAN REOVIRUS MORPHOGENESIS; LARGE-T-ANTIGEN; SIGMA-NS; VIRUS; REPLICATION; FACTORIES; TRANSFORMATION; ASSOCIATIONS; PLATFORMS	Background: Characterization of protein-protein interactions is essential for understanding cellular functions. Although there are many published methods to analyze protein-protein interactions, most of them present serious limitations. In a different study we have characterized a novel avian reovirus muNS-based protein tagging and inclusion targeting method, and demonstrated its validity to purify free an immobilized protein. Methodology/Principal Findings: Here we present a method to identify protein-protein interactions inside living eukaryotic cells (tested in primate and avian cells). When p53 was tagged with Intercoil (IC; muNS residues 477-542), it not only got integrated into muNS cytoplasmic inclusions, but also attracted its known ligand SV40 large T antigen (TAg) to these structures. We have also adapted this system to work within the cell nucleus, by creating muNS-related protein chimeras that form nuclear inclusions. We show that nuclear muNS-derived inclusions are as efficient as cytoplasmic ones in capturing IC-tagged proteins, and that the proteins targeted to nuclear inclusions are able to interact with their known ligands. Conclusions/Significance: Our protein redistribution method does not present the architectural requirement of reconstructing a transcription factor as any of the two-hybrid systems do. The method is simple and requires only cell transfection and a fluorescence microscope. Our tagging method can be used either in the cytoplasm or the nucleus of living cells to test protein-protein interactions or to perform functional studies by protein ligand sequestration.	[Brandariz-Nunez, Alberto] Univ Santiago de Compostela, Fac Pharm, Dept Biochem & Mol Biol, Santiago De Compostela, Spain; Univ Santiago de Compostela, Ctr Res Biol Chem & Mol Mat, Santiago De Compostela, Spain	Universidade de Santiago de Compostela; Universidade de Santiago de Compostela; CiQUS	Brandariz-Nunez, A (corresponding author), Univ Santiago de Compostela, Fac Pharm, Dept Biochem & Mol Biol, Santiago De Compostela, Spain.	jose.martinez.costas@usc.es	Martinez-Costas, Jose/E-9005-2011; Brandariz, Alberto/S-2630-2016; Benavente, Javier/N-6475-2016	Martinez-Costas, Jose/0000-0002-8877-7775; Brandariz, Alberto/0000-0002-0640-1599; Benavente, Javier/0000-0003-4857-0312	European Commission [ERAS-CT-2003-980409]; Spanish Ministerio de Ciencia y Tecnologia [BFU2007-61330, BFU 205-24982-E]; Xunta de Galicia [08CSA009203PR]; Spanish Ministerio de Ciencia y Tecnologia	European Commission(European CommissionEuropean Commission Joint Research Centre); Spanish Ministerio de Ciencia y Tecnologia(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Xunta de Galicia(Xunta de GaliciaEuropean Commission); Spanish Ministerio de Ciencia y Tecnologia(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was supported by grants from the European Commission under contracts ERAS-CT-2003-980409 (as part of the European Science Foundation EUROCORES Programme EuroSCOPE, web: http://www.esf.org/euroscope); the Spanish Ministerio de Ciencia y Tecnologia (BFU2007-61330, BFU 205-24982-E, web: http://www.mityc.es/) and Xunta de Galicia (08CSA009203PR, web: http://www.conselleriaiei.org/ga/dxidi/index.php). ABN was the recipient of a predoctoral FPI fellowship from the Spanish Ministerio de Ciencia y Tecnologia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali SH, 2001, SEMIN CANCER BIOL, V11, P15, DOI 10.1006/scbi.2000.0342; Attoui H, 2000, J GEN VIROL, V81, P1507, DOI 10.1099/0022-1317-81-6-1507; Benavente J, 2006, CURR TOP MICROBIOL, V309, P67; Benavente J, 2007, VIRUS RES, V123, P105, DOI 10.1016/j.virusres.2006.09.005; Brandariz-Nunez A, 2010, J VIROL, V84, P4289, DOI 10.1128/JVI.02534-09; BRANDARIZNUNEZ J, 2010, PLOS ONE IN PRESS; Costas C, 2005, J VIROL, V79, P2141, DOI 10.1128/JVI.79.4.2141-2150.2005; FUJIMURO M, 1994, FEBS LETT, V349, P173, DOI 10.1016/0014-5793(94)00647-4; GLUZMAN Y, 1981, CELL, V23, P175, DOI 10.1016/0092-8674(81)90282-8; Guan HT, 2008, ADV BIOCHEM ENG BIOT, V110, P1, DOI 10.1007/10_2007_092; Jones RC, 2000, REV SCI TECH OIE, V19, P614, DOI 10.20506/rst.19.2.1237; KALDERON D, 1984, CELL, V39, P499, DOI 10.1016/0092-8674(84)90457-4; Lievens S, 2009, TRENDS BIOCHEM SCI, V34, P579, DOI 10.1016/j.tibs.2009.06.009; MARTINEZCOSTAS J, 1995, VIROLOGY, V206, P1017, DOI 10.1006/viro.1995.1024; Mertens P, 2004, VIRUS RES, V101, P3, DOI 10.1016/j.virusres.2003.12.002; Miller CL, 2007, MOL CELL PROTEOMICS, V6, P1027, DOI 10.1074/mcp.M700056-MCP200; Netherton C, 2007, ADV VIRUS RES, V70, P101, DOI 10.1016/S0065-3527(07)70004-0; Novoa RR, 2005, BIOL CELL, V97, P147, DOI 10.1042/BC20040058; Schmitz AM, 2009, NAT METHODS, V6, P500, DOI 10.1038/nmeth.1337; Touris-Otero F, 2004, J MOL BIOL, V341, P361, DOI 10.1016/j.jmb.2004.06.026; Touris-Otero F, 2004, VIROLOGY, V319, P94, DOI 10.1016/j.virol.2003.10.034; van der Heide L, 2000, AVIAN DIS, V44, P638, DOI 10.2307/1593104; Vazquez-Iglesias L, 2009, J VIROL, V83, P10163, DOI 10.1128/JVI.01080-09; ZALVIDE J, 1995, MOL CELL BIOL, V15, P5800; Zhang X, 2005, VIROLOGY, V343, P25, DOI 10.1016/j.virol.2005.08.002	25	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2010	5	11							e13785	10.1371/journal.pone.0013785	http://dx.doi.org/10.1371/journal.pone.0013785			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	674VY	21072177	Green Submitted, gold, Green Published			2022-12-27	WOS:000283779700005
J	Chen, XY; Kim, P; Farinelli, B; Doukas, A; Yun, SH; Gelfand, JA; Anderson, RR; Wu, MX				Chen, Xinyuan; Kim, Pilhan; Farinelli, Bill; Doukas, Apostolos; Yun, Seok-Hyun; Gelfand, Jeffrey A.; Anderson, Richard R.; Wu, Mei X.			A Novel Laser Vaccine Adjuvant Increases the Motility of Antigen Presenting Cells	PLOS ONE			English	Article							ANTIBODIES; RESPONSES; DELIVERY; SQUALENE; THERAPY	Background: Development of a potent vaccine adjuvant without introduction of any side effects remains an unmet challenge in the field of the vaccine research. Methodology/Principal Findings: We found that laser at a specific setting increased the motility of antigen presenting cells (APCs) and immune responses, with few local or systemic side effects. This laser vaccine adjuvant (LVA) effect was induced by brief illumination of a small area of the skin or muscle with a nondestructive, 532 nm green laser prior to intradermal (i.d.) or intramuscular (i.m.) administration of vaccines at the site of laser illumination. The pre-illumination accelerated the motility of APCs as shown by intravital confocal microscopy, leading to sufficient antigen (Ag)-uptake at the site of vaccine injection and transportation of the Ag-captured APCs to the draining lymph nodes. As a result, the number of Ag+ dendritic cells (DCs) in draining lymph nodes was significantly higher in both the 1 degrees and 2 degrees draining lymph nodes in the presence than in the absence of LVA. Laser-mediated increases in the motility and lymphatic transportation of APCs augmented significantly humoral immune responses directed against a model vaccine ovalbumin (OVA) or influenza vaccine i.d. injected in both primary and booster vaccinations as compared to the vaccine itself. Strikingly, when the laser was delivered by a hair-like diffusing optical fiber into muscle, laser illumination greatly boosted not only humoral but also cell-mediated immune responses provoked by i.m. immunization with OVA relative to OVA alone. Conclusion/Significance: The results demonstrate the ability of this safe LVA to augment both humoral and cell-mediated immune responses. In comparison with all current vaccine adjuvants that are either chemical compounds or biological agents, LVA is novel in both its form and mechanism; it is risk-free and has distinct advantages over traditional vaccine adjuvants.	[Chen, Xinyuan; Kim, Pilhan; Farinelli, Bill; Doukas, Apostolos; Yun, Seok-Hyun; Anderson, Richard R.; Wu, Mei X.] Harvard Univ, Sch Med, Dept Dermatol, Wellman Ctr Photomed,Massachusetts Gen Hosp, Boston, MA 02115 USA; [Gelfand, Jeffrey A.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Med, Boston, MA USA; [Anderson, Richard R.; Wu, Mei X.] Harvard MIT Div Hlth Sci & Technol, Boston, MA USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University	Chen, XY (corresponding author), Harvard Univ, Sch Med, Dept Dermatol, Wellman Ctr Photomed,Massachusetts Gen Hosp, Boston, MA 02115 USA.	mwu2@partners.org	Kim, Pilhan/C-1836-2011; Gelfand, Jeffrey A/G-1885-2018	Kim, Pilhan/0000-0001-8388-1840; Gelfand, Jeffrey A/0000-0002-4118-5676	National Institutes of Health [AI070785, RC1 DA028378]; Boston Biocom LLC. [2008A2565]; Bill and Melinda Gates Foundation [53273]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K02AI070785, R01AI089779] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [RC1DA028378] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Boston Biocom LLC.; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work is supported in part by the National Institutes of Health grants AI070785 and RC1 DA028378, Sponsored Research agreement grant #2008A25652 from Boston Biocom LLC., and Grand Challenges Explorations grant #53273 from the Bill and Melinda Gates Foundation (to M.X.W.). As Boston Biocom partially employed J.G., Boston Biocom did play a role in data analysis and preparation of the manuscript. Other funders had no role in the study design, data analysis, preparation of the manuscript and the decision to publish or preparation of the manuscript.	Aguilar JC, 2007, VACCINE, V25, P3752, DOI 10.1016/j.vaccine.2007.01.111; ALVING CR, 1993, ANN NY ACAD SCI, V690, P265; APRILE MA, 1966, C J PUBLIC HEALTH, V57, P343; Asa PB, 2000, EXP MOL PATHOL, V68, P55, DOI 10.1006/exmp.1999.2295; Asa PB, 2002, EXP MOL PATHOL, V73, P19, DOI 10.1006/exmp.2002.2429; Boes M, 2002, NATURE, V418, P983, DOI 10.1038/nature01004; Castano AP, 2008, P NATL ACAD SCI USA, V105, P5495, DOI 10.1073/pnas.0709256105; Chen WR, 2006, J ENVIRON PATHOL TOX, V25, P281, DOI 10.1615/JEnvironPatholToxicolOncol.v25.i1-2.180; CLAESSON BA, 1988, J PEDIATR-US, V112, P695, DOI 10.1016/S0022-3476(88)80684-X; CVJETANOVIC B, 1965, ORGAN */* B WORLD HL, V32, P29; DAVENPORT FM, 1968, J IMMUNOL, V100, P1139; Doukas AG, 2004, ADV DRUG DELIVER REV, V56, P559, DOI 10.1016/j.addr.2003.10.031; Gherardi RK, 2001, BRAIN, V124, P1821, DOI 10.1093/brain/124.9.1821; GUPTA RK, 1995, VACCINE, V13, P1263, DOI 10.1016/0264-410X(95)00011-O; GUPTA RK, 1995, VACCINE, V13, P1623, DOI 10.1016/0264-410X(95)00112-E; Kandolf-Sekulovic L, 2003, PHOTODERMATOL PHOTO, V19, P203, DOI 10.1034/j.1600-0781.2003.00040.x; Kim P, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2839043; Klas SD, 2008, VACCINE, V26, P5494, DOI 10.1016/j.vaccine.2008.07.062; Lindblad EB, 2004, IMMUNOL CELL BIOL, V82, P497, DOI 10.1111/j.0818-9641.2004.01286.x; Ng CP, 2005, J CELL SCI, V118, P4731, DOI 10.1242/jcs.02605; Nishibu A, 2006, J INVEST DERMATOL, V126, P787, DOI 10.1038/sj.jid.5700107; Onikienko SB, 2006, DONOSOLOGIYA ST PETE, V1, P32; Ostberg JR, 2003, INT J HYPERTHER, V19, P520, DOI 10.1080/02656730310001607986; Posten W, 2005, DERMATOL SURG, V31, P334, DOI 10.1097/00042728-200503000-00016; Reed SG, 2009, TRENDS IMMUNOL, V30, P23, DOI 10.1016/j.it.2008.09.006; Satoh M, 2003, J AUTOIMMUN, V21, P1, DOI 10.1016/S0896-8411(03)00083-0; Stoute JA, 1997, NEW ENGL J MED, V336, P86, DOI 10.1056/NEJM199701093360202; Zeira E, 2007, FASEB J, V21, P3522, DOI 10.1096/fj.06-7528com	28	45	46	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2010	5	10							e13776	10.1371/journal.pone.0013776	http://dx.doi.org/10.1371/journal.pone.0013776			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673FU	21048884	Green Published, gold, Green Submitted			2022-12-27	WOS:000283645300050
J	den Besten, HMW; Arvind, A; Gaballo, HMS; Moezelaar, R; Zwietering, MH; Abee, T				den Besten, Heidy M. W.; Arvind, Aarathi; Gaballo, Heidi M. S.; Moezelaar, Roy; Zwietering, Marcel H.; Abee, Tjakko			Short- and Long-Term Biomarkers for Bacterial Robustness: A Framework for Quantifying Correlations between Cellular Indicators and Adaptive Behavior	PLOS ONE			English	Article							GRAM-POSITIVE BACTERIA; GENERAL STRESS-RESPONSE; BACILLUS-CEREUS ATCC-14579; LISTERIA-MONOCYTOGENES; HYDROGEN-PEROXIDE; ENVIRONMENTAL-CHANGES; STAPHYLOCOCCUS-AUREUS; FOOD PRESERVATION; SIGMA(B) REGULON; SALT STRESS	The ability of microorganisms to adapt to changing environments challenges the prediction of their history-dependent behavior. Cellular biomarkers that are quantitatively correlated to stress adaptive behavior will facilitate our ability to predict the impact of these adaptive traits. Here, we present a framework for identifying cellular biomarkers for mild stress induced enhanced microbial robustness towards lethal stresses. Several candidate-biomarkers were selected by comparing the genome-wide transcriptome profiles of our model-organism Bacillus cereus upon exposure to four mild stress conditions (mild heat, acid, salt and oxidative stress). These candidate-biomarkers-a transcriptional regulator (activating general stress responses), enzymes (removing reactive oxygen species), and chaperones and proteases (maintaining protein quality)were quantitatively determined at transcript, protein and/or activity level upon exposure to mild heat, acid, salt and oxidative stress for various time intervals. Both unstressed and mild stress treated cells were also exposed to lethal stress conditions (severe heat, acid and oxidative stress) to quantify the robustness advantage provided by mild stress pretreatment. To evaluate whether the candidate-biomarkers could predict the robustness enhancement towards lethal stress elicited by mild stress pretreatment, the biomarker responses upon mild stress treatment were correlated to mild stress induced robustness towards lethal stress. Both short-and long-term biomarkers could be identified of which their induction levels were correlated to mild stress induced enhanced robustness towards lethal heat, acid and/ or oxidative stress, respectively, and are therefore predictive cellular indicators for mild stress induced enhanced robustness. The identified biomarkers are among the most consistently induced cellular components in stress responses and ubiquitous in biology, supporting extrapolation to other microorganisms than B. cereus. Our quantitative, systematic approach provides a framework to search for these biomarkers and to evaluate their predictive quality in order to select promising biomarkers that can serve to early detect and predict adaptive traits.	[den Besten, Heidy M. W.; Arvind, Aarathi; Gaballo, Heidi M. S.; Moezelaar, Roy; Abee, Tjakko] Top Inst Food & Nutr, Wageningen, Netherlands; [den Besten, Heidy M. W.; Arvind, Aarathi; Gaballo, Heidi M. S.; Zwietering, Marcel H.; Abee, Tjakko] Univ Wageningen & Res Ctr, Food Microbiol Lab, Wageningen, Netherlands	Top Institute Food & Nutrition; Wageningen University & Research	den Besten, HMW (corresponding author), Top Inst Food & Nutr, Wageningen, Netherlands.	tjakko.abee@wur.nl	Zwietering, Marcel/C-2479-2008	Zwietering, Marcel/0000-0003-2704-5690				Abee T, 1999, INT J FOOD MICROBIOL, V50, P65, DOI 10.1016/S0168-1605(99)00078-1; Allen KJ, 2008, FOODBORNE PATHOG DIS, V5, P437, DOI 10.1089/fpd.2008.0100; Bischoff M, 2004, J BACTERIOL, V186, P4085, DOI 10.1128/JB.186.13.4085-4099.2004; Browne N, 2002, J APPL MICROBIOL, V92, P404, DOI 10.1046/j.1365-2672.2002.01541.x; Browne N, 2001, J APPL MICROBIOL, V91, P1085, DOI 10.1046/j.1365-2672.2001.01478.x; Brul S, 2006, INT J FOOD MICROBIOL, V112, P195, DOI 10.1016/j.ijfoodmicro.2006.04.014; Bsat N, 1998, MOL MICROBIOL, V29, P189, DOI 10.1046/j.1365-2958.1998.00921.x; Causton HC, 2001, MOL BIOL CELL, V12, P323, DOI 10.1091/mbc.12.2.323; Ceragioli M, 2010, APPL ENVIRON MICROB, V76, P3352, DOI 10.1128/AEM.03003-09; Cotter PD, 2003, MICROBIOL MOL BIOL R, V67, P429, DOI 10.1128/MMBR.67.3.429-453.2003; Culligan EP, 2009, GUT PATHOG, V1, DOI 10.1186/1757-4749-1-19; de Been M, 2010, ENVIRON MICROBIOL, V12, P730, DOI 10.1111/j.1462-2920.2009.02116.x; den Besten HMW, 2006, APPL ENVIRON MICROB, V72, P5884, DOI 10.1128/AEM.00780-06; den Besten HMW, 2009, APPL ENVIRON MICROB, V75, P4111, DOI 10.1128/AEM.02891-08; Derre I, 1999, MOL MICROBIOL, V31, P117, DOI 10.1046/j.1365-2958.1999.01152.x; Estruch F, 2000, FEMS MICROBIOL REV, V24, P469, DOI 10.1016/S0168-6445(00)00035-8; Frees D, 2007, MOL MICROBIOL, V63, P1285, DOI 10.1111/j.1365-2958.2007.05598.x; Gahan CGM, 1999, INT J FOOD MICROBIOL, V50, P93, DOI 10.1016/S0168-1605(99)00079-3; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Gunasekera TS, 2008, J BACTERIOL, V190, P3712, DOI 10.1128/JB.01990-07; Hain T, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-20; Hecker M, 2007, ANNU REV MICROBIOL, V61, P215, DOI 10.1146/annurev.micro.61.080706.093445; Herbig AF, 2001, MOL MICROBIOL, V41, P849, DOI 10.1046/j.1365-2958.2001.02543.x; Hill C, 2002, INT DAIRY J, V12, P273, DOI 10.1016/S0958-6946(01)00125-X; Hols P, 2005, FEMS MICROBIOL REV, V29, P435, DOI 10.1016/j.femsre.2005.04.008; Horsburgh MJ, 2001, INFECT IMMUN, V69, P3744, DOI 10.1128/IAI.69.6.3744-3754.2001; Imlay JA, 2008, ANNU REV BIOCHEM, V77, P755, DOI 10.1146/annurev.biochem.77.061606.161055; Kazmierczak MJ, 2003, J BACTERIOL, V185, P5722, DOI 10.1128/JB.185.19.5722-5734.2003; Koburger T, 2005, MOL GENET GENOMICS, V274, P1, DOI 10.1007/s00438-005-1119-8; LEISTNER L, 1995, TRENDS FOOD SCI TECH, V6, P41, DOI 10.1016/S0924-2244(00)88941-4; Mitchell A, 2009, NATURE, V460, P220, DOI 10.1038/nature08112; Mols M, 2010, INT J FOOD MICROBIOL, V137, P13, DOI 10.1016/j.ijfoodmicro.2009.09.027; PANE F, 2006, INT J MED MICROBIOL, V296, P237; Periago PM, 2002, APPL ENVIRON MICROB, V68, P3486, DOI 10.1128/AEM.68.7.3486-3495.2002; Petersohn A, 2001, J BACTERIOL, V183, P5617, DOI 10.1128/JB.183.19.5617-5631.2001; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Price CW, 2001, MOL MICROBIOL, V41, P757, DOI 10.1046/j.1365-2958.2001.02534.x; Rea R, 2005, APPL ENVIRON MICROB, V71, P8314, DOI 10.1128/AEM.71.12.8314-8322.2005; Serrazanetti DI, 2009, FOOD MICROBIOL, V26, P700, DOI 10.1016/j.fm.2009.07.007; Skandamis PN, 2008, FOOD MICROBIOL, V25, P294, DOI 10.1016/j.fm.2007.10.008; van de Guchte M, 2002, ANTON LEEUW INT J G, V82, P187, DOI 10.1023/A:1020631532202; van Schaik W, 2005, APPL ENVIRON MICROB, V71, P6427, DOI 10.1128/AEM.71.10.6427-6430.2005; van Schaik W, 2005, J BACTERIOL, V187, P5846, DOI 10.1128/JB.187.16.5846-5851.2005; van Schaik W, 2005, CURR OPIN BIOTECH, V16, P218, DOI 10.1016/j.copbio.2005.01.008; van Schaik W, 2004, J BACTERIOL, V186, P316, DOI 10.1128/JB.186.2.316-325.2004; van Schaik W, 2007, J BACTERIOL, V189, P4384, DOI 10.1128/JB.00313-07; VAND V, 2007, MICROBIOLOGY, V153, P3593; Wolf DM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001700; WOODBURY W, 1971, ANAL BIOCHEM, V44, P301, DOI 10.1016/0003-2697(71)90375-7	49	44	45	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2010	5	10							e13746	10.1371/journal.pone.0013746	http://dx.doi.org/10.1371/journal.pone.0013746			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673FU	21060783	Green Submitted, Green Published, gold			2022-12-27	WOS:000283645300026
J	Dou, ZH; Chen, RY; Wang, Z; Ji, GP; Peng, GP; Qiao, XC; Fu, JH; Meng, XD; Bulterys, M; Ma, Y; Zhao, Y; Wang, N; Zhang, FJ				Dou, Zhihui; Chen, Ray Y.; Wang, Zhe; Ji, Guoping; Peng, Guoping; Qiao, Xiaochun; Fu, Jihua; Meng, Xiangdong; Bulterys, Marc; Ma, Ye; Zhao, Yan; Wang, Ning; Zhang, Fujie			HIV-Infected Former Plasma Donors in Rural Central China: From Infection to Survival Outcomes, 1985-2008	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; HUMAN-IMMUNODEFICIENCY-VIRUS; HEPATITIS-C VIRUS; MIDDLE-INCOME COUNTRIES; TREATMENT PROGRAM; BLOOD-DONORS; DRUG-USERS; FOLLOW-UP; SEROCONVERSION; MORTALITY	Background: The HIV epidemic among former plasma donors (FPDs) in rural Central China in the early-mid 1990s is likely the largest known HIV-infected cohort in the world related to commercial plasma donation but has never been fully described. The objectives of this study are to estimate the timing and geographic spread of HIV infection in this cohort and to demonstrate the impact of antiretroviral therapy on survival outcomes. Methodology/Principal Findings: HIV-infected FPDs were identified using the national HIV epidemiology and treatment databases. Locations of subjects were mapped. Dates of infection and survival were estimated using the midpoint date between initial-final plasma donation dates from 1985-2008 among those with plasma donation windows <= 2 years. Among 37084 FPDs in the two databases, 36110 were included. 95% were located in focal areas of Henan Province and adjacent areas of surrounding provinces. Midpoint year between initial-final plasma donation dates was 1994 among FPDs with known donation dates. Median survival from infection to AIDS was 11.8 years and, among those not treated, 1.6 years from AIDS to death. Among those on treatment, 71% were still alive after five years. Using Cox proportional hazard modeling, untreated AIDS patients were 4.9 times (95% confidence interval 4.6-5.2) more likely to die than those on treatment. Conclusions/Significance: The epidemic of HIV-infected FPD in China was not widespread throughout China but rather was centered in Henan Province and the adjacent areas of surrounding provinces. Even in these areas, infections were concentrated in focal locations. Overall, HIV infections in this cohort peaked in 1994, with median survival of 13.4 years from infection to death among those not treated. Among AIDS patients on treatment, 71% were still alive after five years.	[Dou, Zhihui; Ma, Ye; Zhao, Yan; Wang, Ning; Zhang, Fujie] Chinese Ctr Dis Control & Prevent, Natl Ctr AIDS STD Control & Prevent, Beijing, Peoples R China; [Chen, Ray Y.] US Natl Inst Hlth, Natl Inst Allergy & Infect Dis, Beijing, Peoples R China; [Wang, Zhe] Henan Ctr Dis Control & Prevent, Zhengzhou, Peoples R China; [Ji, Guoping] Anhui Ctr Dis Control & Prevent, Hefei, Peoples R China; [Peng, Guoping] Hubei Ctr Dis Control & Prevent, Wuhan, Peoples R China; [Qiao, Xiaochun] Shanxi Ctr Dis Control & Prevent, Taiyuan, Peoples R China; [Fu, Jihua] Shandong Ctr Dis Control & Prevent, Jinan, Peoples R China; [Meng, Xiangdong] Jilin Ctr Dis Control & Prevent, Changchun, Peoples R China; [Bulterys, Marc] US Ctr Dis Control & Prevent, Global AIDS Program, Beijing, Peoples R China; [Zhang, Fujie] Beijing Ditan Hosp, Beijing, Peoples R China	Chinese Center for Disease Control & Prevention; National Center for AIDS/STD Control & Prevention, Chinese Center for Disease Control & Prevention; Capital Medical University	Dou, ZH (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Ctr AIDS STD Control & Prevent, Beijing, Peoples R China.	wangnbj@163.com; treatment@chinaaids.cn	Chen, Ray/GRJ-6736-2022; Chen, Ray/T-5102-2019	Chen, Ray/0000-0001-6344-1442	China Ministry of Science and Technology [973:2006CB504201]	China Ministry of Science and Technology(Ministry of Science and Technology, China)	This work was supported in part by a grant from the China Ministry of Science and Technology Chinese National Basic Research Program (973:2006CB504201). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babiker A, 2000, LANCET, V355, P1131, DOI 10.1016/S0140-6736(00)02061-4; Brettle RP, 1996, AIDS, V10, P419, DOI 10.1097/00002030-199604000-00011; Chinese Center for Disease Control and Prevention, 2005, CHIN FREE ART MAN; Ghys PD, 2007, AIDS, V21, pS1, DOI 10.1097/01.aids.0000299404.99033.bf; Glynn JR, 2007, AIDS, V21, P625, DOI 10.1097/QAD.0b013e328017f857; He N, 2005, CELL RES, V15, P825, DOI 10.1038/sj.cr.7290354; Ji GP, 2006, AIDS, V20, P585, DOI 10.1097/01.aids.0000210613.45212.c4; MA Y, 2009, INT J EPIDEMIOL; *MIN HLTH, 1987, PROV MON CONTR AIDS; PANTALEO G, 1993, NEW ENGL J MED, V328, P327, DOI 10.1056/NEJM199302043280508; PORTER K, 2004, AIDS S2, V2, pS9; PORTER K, 2004, AIDS S2, V2, pS17; Qian HZ, 2006, AIDS, V20, P1429, DOI 10.1097/01.aids.0000233577.33973.fa; Qian HZ, 2005, J INFECT DIS, V192, P1694, DOI 10.1086/497148; Sun XH, 2007, AIDS, V21, pS33, DOI 10.1097/01.aids.0000304694.54884.06; SUN YD, 1991, CHINESE MED J-PEKING, V104, P975; TODD J, 2007, AIDS S6, V6, pS55; Volkow P, 2001, LANCET, V358, P2001, DOI 10.1016/S0140-6736(01)06996-3; Wang N, 1991, Zhonghua Yi Xue Za Zhi, V71, P671; WANG N, 1991, ZHONGHUA YI XUE ZA Z, V71, P646; Wang S, 1991, Zhonghua Yi Xue Za Zhi, V71, P76; WARD JW, 1989, NEW ENGL J MED, V321, P947, DOI 10.1056/NEJM198910053211406; Wu ZY, 2007, LANCET, V369, P679, DOI 10.1016/S0140-6736(07)60315-8; Wu ZY, 2006, SCIENCE, V312, P1475, DOI 10.1126/science.1120682; WU ZY, 1995, LANCET, V346, P61, DOI 10.1016/S0140-6736(95)92698-4; Wu ZY, 2001, HEALTH POLICY PLANN, V16, P41, DOI 10.1093/heapol/16.1.41; Xu JQ, 2006, CHINESE MED J-PEKING, V119, P1941, DOI 10.1097/00029330-200612010-00002; ZHANG FJ, 2008, DECADE HAART; Zhang FJ, 2008, CLIN INFECT DIS, V47, P825, DOI 10.1086/590945; Zhang FJ, 2007, AIDS, V21, pS143, DOI 10.1097/01.aids.0000304710.10036.2b; Zhang FJ, 2009, ANN INTERN MED, V151, P241, DOI 10.7326/0003-4819-151-4-200908180-00006; Zhang LQ, 2004, J VIROL, V78, P13591, DOI 10.1128/JVI.78.24.13591-13599.2004; Zhang Xiao-fei, 2005, Zhonghua Liu Xing Bing Xue Za Zhi, V26, P314; Zheng X, 2000, Zhonghua Liu Xing Bing Xue Za Zhi, V21, P253; 2008, SEX TRANSM INFECT S1, V84, P31	35	58	72	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2010	5	10							e13737	10.1371/journal.pone.0013737	http://dx.doi.org/10.1371/journal.pone.0013737			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673FU	21060835	Green Submitted, gold, Green Published			2022-12-27	WOS:000283645300017
J	Miller, MP; Haig, SM				Miller, Mark P.; Haig, Susan M.			Identifying Shared Genetic Structure Patterns among Pacific Northwest Forest Taxa: Insights from Use of Visualization Tools and Computer Simulations	PLOS ONE			English	Article							RANGE EXPANSION; INTRASPECIFIC PHYLOGEOGRAPHY; POPULATION; LANDSCAPE; FLOW; DIVERSITY; EVOLUTIONARY; HYPOTHESES; DIVERGENCE; DISPERSAL	Background: Identifying causal relationships in phylogeographic and landscape genetic investigations is notoriously difficult, but can be facilitated by use of multispecies comparisons. Methodology/Principal Findings: We used data visualizations to identify common spatial patterns within single lineages of four taxa inhabiting Pacific Northwest forests (northern spotted owl: Strix occidentalis caurina; red tree vole: Arborimus longicaudus; southern torrent salamander: Rhyacotriton variegatus; and western white pine: Pinus monticola). Visualizations suggested that, despite occupying the same geographical region and habitats, species responded differently to prevailing historical processes. S. o. caurina and P. monticola demonstrated directional patterns of spatial genetic structure where genetic distances and diversity were greater in southern versus northern locales. A. longicaudus and R. variegatus displayed opposite patterns where genetic distances were greater in northern versus southern regions. Statistical analyses of directional patterns subsequently confirmed observations from visualizations. Based upon regional climatological history, we hypothesized that observed latitudinal patterns may have been produced by range expansions. Subsequent computer simulations confirmed that directional patterns can be produced by expansion events. Conclusions/Significance: We discuss phylogeographic hypotheses regarding historical processes that may have produced observed patterns. Inferential methods used here may become increasingly powerful as detailed simulations of organisms and historical scenarios become plausible. We further suggest that inter-specific comparisons of historical patterns take place prior to drawing conclusions regarding effects of current anthropogenic change within landscapes.	[Miller, Mark P.] Utah State Univ, Dept Biol, Logan, UT 84322 USA; [Miller, Mark P.] Utah State Univ, Ctr High Performance Comp, Logan, UT 84322 USA; [Miller, Mark P.; Haig, Susan M.] US Geol Survey, Forest & Rangeland Ecosyst Sci Ctr, Corvallis, OR USA	Utah System of Higher Education; Utah State University; Utah System of Higher Education; Utah State University; United States Department of the Interior; United States Geological Survey	Miller, MP (corresponding author), Utah State Univ, Dept Biol, Logan, UT 84322 USA.	mpmiller@usgs.gov	Miller, Mark/A-5488-2011	Miller, Mark/0000-0003-1045-1772	U.S. Geological Survey Forest; Rangeland Ecosystem Science Center	U.S. Geological Survey Forest(United States Geological Survey); Rangeland Ecosystem Science Center	This work was supported by the U.S. Geological Survey Forest and Rangeland Ecosystem Science Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen B. G., 1994, ICE AGE WORLD INTRO; Austerlitz F, 2001, GENETICS, V157, P851; Balkenhol N, 2009, LANDSCAPE ECOL, V24, P455, DOI 10.1007/s10980-009-9334-z; BONNICKSEN T. M., 2000, AM ANCIENT FORESTS I; Brunsfeld S., 2001, INTEGRATING ECOLOGY, V14, P319; Burns KJ, 2006, MOL PHYLOGENET EVOL, V38, P117, DOI 10.1016/j.ympev.2005.07.008; Chen C, 2007, MOL ECOL NOTES, V7, P747, DOI 10.1111/j.1471-8286.2007.01769.x; Crida A, 2007, MOL ECOL NOTES, V7, P588, DOI 10.1111/j.1471-8286.2007.01753.x; Cushman SA, 2006, AM NAT, V168, P486, DOI 10.1086/506976; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Dupanloup I, 2002, MOL ECOL, V11, P2571, DOI 10.1046/j.1365-294X.2002.01650.x; Epperson BK, 2010, MOL ECOL, V19, P3549, DOI 10.1111/j.1365-294X.2010.04678.x; Excoffier L, 2004, MOL ECOL, V13, P853, DOI 10.1046/j.1365-294X.2003.02004.x; Excoffier L, 2008, TRENDS ECOL EVOL, V23, P347, DOI 10.1016/j.tree.2008.04.004; Excoffier L, 2006, NAT REV GENET, V7, P745, DOI 10.1038/nrg1904; Fagundes NJR, 2007, P NATL ACAD SCI USA, V104, P17614, DOI 10.1073/pnas.0708280104; FU YX, 1993, GENETICS, V133, P693; Funk WC, 2008, EVOL APPL, V1, P161, DOI 10.1111/j.1752-4571.2007.00002.x; FUYX, 1997, GENETICS, V147, P915; Garrick RC, 2008, MOL ECOL, V17, P1401, DOI 10.1111/j.1365-294X.2008.03675.x; GRAHAM RT, 2004, USDA HDB, V654, P775; Guillot G, 2005, GENETICS, V170, P1261, DOI 10.1534/genetics.104.033803; Haig SM, 2004, CONSERV GENET, V5, P683, DOI 10.1007/s10592-004-1864-y; Hartl D., 1989, PRINCIPLES POPULATIO; Irwin DE, 2002, EVOLUTION, V56, P2383; Johnson JA, 2008, J HERED, V99, P165, DOI 10.1093/jhered/esn002; Knowles LL, 2002, MOL ECOL, V11, P2623, DOI 10.1046/j.1365-294X.2002.01637.x; Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520; Manel S, 2007, MOL ECOL, V16, P2031, DOI 10.1111/j.1365-294X.2007.03293.x; Manel S, 2003, TRENDS ECOL EVOL, V18, P189, DOI 10.1016/S0169-5347(03)00008-9; Manni F, 2004, HUM BIOL, V76, P173, DOI 10.1353/hub.2004.0034; MANTEL N, 1967, CANCER RES, V27, P209; Martin PR, 2004, EVOLUTION, V58, P938; Mila B, 2007, P R SOC B, V274, P2653, DOI 10.1098/rspb.2007.0852; Miller MP, 2006, J HERED, V97, P561, DOI 10.1093/jhered/esl038; Miller MP, 2005, J HERED, V96, P722, DOI 10.1093/jhered/esi119; Miller MP, 2006, MOL ECOL, V15, P145, DOI 10.1111/j.1365-294X.2005.02765.x; NEI M, 1978, GENETICS, V89, P583; Nielsen R, 2009, MOL ECOL, V18, P1034, DOI 10.1111/j.1365-294X.2008.04059.x; Nielson M, 2001, EVOLUTION, V55, P147; Panchal M, 2007, EVOLUTION, V61, P1466, DOI 10.1111/j.1558-5646.2007.00124.x; Petit RJ, 2008, MOL ECOL, V17, P1404, DOI 10.1111/j.1365-294X.2008.03692.x; Petit RJ, 2008, MOL ECOL, V17, P516, DOI 10.1111/j.1365-294X.2007.03589.x; Petit RJ, 2002, GENETICS, V161, P469; Ray N, 2003, MOL BIOL EVOL, V20, P76, DOI 10.1093/molbev/msg009; Rousset F, 1997, GENETICS, V145, P1219; Schneider S, 1999, GENETICS, V152, P1079; SLATKIN M, 1989, EVOLUTION, V43, P1349, DOI 10.1111/j.1558-5646.1989.tb02587.x; SOKAL RR, 1978, BIOL J LINN SOC, V10, P229, DOI 10.1111/j.1095-8312.1978.tb00014.x; Soltis DE, 1997, PLANT SYST EVOL, V206, P353, DOI 10.1007/BF00987957; STEINHOFF RJ, 1983, CAN J FOREST RES, V13, P1122, DOI 10.1139/x83-150; TAJIMA F, 1989, GENETICS, V123, P597; TAJIMA F, 1989, GENETICS, V123, P585; Templeton AR, 2008, MOL ECOL, V17, P1877, DOI 10.1111/j.1365-294X.2008.03731.x; Templeton AR, 2009, MOL ECOL, V18, P319, DOI 10.1111/j.1365-294X.2008.04026.x; Templeton AR, 1998, MOL ECOL, V7, P381, DOI 10.1046/j.1365-294x.1998.00308.x; Templeton AR, 2002, GENETICS, V161, P473; USDA/USDI [U.S.D.A. Forest Service; U.S.D.I. Bureau of Land Management], 2000, FIN SUPPL ENV IMP ST, V1; USFWS, 1990, FED REGISTER, V55, P26114; Vandergast AG, 2008, BIOL CONSERV, V141, P1648, DOI 10.1016/j.biocon.2008.04.009; Wilke T, 2004, MOL ECOL, V13, P2303, DOI 10.1111/j.1365-294X.2004.02234.x; WRIGHT S, 1946, GENETICS, V31, P39; 2000, FED REG, V65, P35951	63	6	6	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2010	5	10							e13683	10.1371/journal.pone.0013683	http://dx.doi.org/10.1371/journal.pone.0013683			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673FU	21060824	Green Published, gold, Green Submitted			2022-12-27	WOS:000283645300004
J	Prosperi, MCF; Rosen-Zvi, M; Altmann, A; Zazzi, M; Di Giambenedetto, S; Kaiser, R; Schulter, E; Struck, D; Sloot, P; van de Vijver, DA; Vandamme, AM; Sonnerborg, A				Prosperi, Mattia C. F.; Rosen-Zvi, Michal; Altmann, Andre; Zazzi, Maurizio; Di Giambenedetto, Simona; Kaiser, Rolf; Schuelter, Eugen; Struck, Daniel; Sloot, Peter; van de Vijver, David A.; Vandamme, Anne-Mieke; Sonnerborg, Anders		EuResist Study Grp; Virolab Study Grp	Antiretroviral Therapy Optimisation without Genotype Resistance Testing: A Perspective on Treatment History Based Models	PLOS ONE			English	Article							HIV-1 DRUG-RESISTANCE; FOLLOW-UP; VALIDATION; PREDICTION; MANAGEMENT; SYSTEMS; ASSAY	Background: Although genotypic resistance testing (GRT) is recommended to guide combination antiretroviral therapy (cART), funding and/or facilities to perform GRT may not be available in low to middle income countries. Since treatment history (TH) impacts response to subsequent therapy, we investigated a set of statistical learning models to optimise cART in the absence of GRT information. Methods and Findings: The EuResist database was used to extract 8-week and 24-week treatment change episodes (TCE) with GRT and additional clinical, demographic and TH information. Random Forest (RF) classification was used to predict 8- and 24-week success, defined as undetectable HIV-1 RNA, comparing nested models including (i) GRT+TH and (ii) TH without GRT, using multiple cross-validation and area under the receiver operating characteristic curve (AUC). Virological success was achieved in 68.2% and 68.0% of TCE at 8- and 24-weeks (n = 2,831 and 2,579), respectively. RF (i) and (ii) showed comparable performances, with an average (st.dev.) AUC 0.77 (0.031) vs. 0.757 (0.035) at 8-weeks, 0.834 (0.027) vs. 0.821 (0.025) at 24-weeks. Sensitivity analyses, carried out on a data subset that included antiretroviral regimens commonly used in low to middle income countries, confirmed our findings. Training on subtype B and validation on non-B isolates resulted in a decline of performance for models (i) and (ii). Conclusions: Treatment history-based RF prediction models are comparable to GRT-based for classification of virological outcome. These results may be relevant for therapy optimisation in areas where availability of GRT is limited. Further investigations are required in order to account for different demographics, subtypes and different therapy switching strategies.	[Prosperi, Mattia C. F.; Di Giambenedetto, Simona] Univ Cattolica Sacro Cuore, Clin Infect Dis, I-00168 Rome, Italy; [Prosperi, Mattia C. F.] Informa CRO, Rome, Italy; [Prosperi, Mattia C. F.] Univ Florida, Coll Med Pathol Immunol & Lab Med, EPI, Gainesville, FL USA; [Rosen-Zvi, Michal] IBM Haifa Res Lab, Haifa, Israel; [Altmann, Andre] Max Planck Inst Informat, Saarbrucken, Germany; [Zazzi, Maurizio] Univ Siena, I-53100 Siena, Italy; [Kaiser, Rolf; Schuelter, Eugen] Univ Cologne, Cologne, Germany; [Struck, Daniel] Ctr Rech Publ Sante, Luxembourg, Luxembourg; [Sloot, Peter] Univ Amsterdam, Amsterdam, Netherlands; [van de Vijver, David A.] Univ Med Ctr Rotterdam, Dept Virol, Erasmus MC, Utrecht, Netherlands; [Vandamme, Anne-Mieke] Katholieke Univ Leuven, Rega Inst, Louvain, Belgium; [Sonnerborg, Anders] Karolinska Inst, Stockholm, Sweden	Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; State University System of Florida; University of Florida; International Business Machines (IBM); Max Planck Society; University of Siena; University of Cologne; Luxembourg Institute of Health; University of Amsterdam; Erasmus University Rotterdam; Erasmus MC; KU Leuven; Karolinska Institutet	Prosperi, MCF (corresponding author), Univ Cattolica Sacro Cuore, Clin Infect Dis, I-00168 Rome, Italy.	ahnven@yahoo.it	Rosen-Zvi, Michal/AAF-4649-2020; Sönnerborg, Anders/W-2011-2019; Altmann, Andre/ABF-1675-2020; digiambenedetto, simona/AAL-4429-2020; Vandamme, Anne-Mieke/I-4127-2012; Zazzi, Maurizio/K-3422-2018; Sloot, Peter/B-3078-2014	Sönnerborg, Anders/0000-0001-8928-3374; Altmann, Andre/0000-0002-9265-2393; Vandamme, Anne-Mieke/0000-0002-6594-2766; Zazzi, Maurizio/0000-0002-0344-6281; Sloot, Peter/0000-0002-3848-5395; van de Vijver, David/0000-0001-5877-8526	EuResist Foundation [IST-2004-027173]; EU [027446]	EuResist Foundation; EU(European Commission)	The EuResist Foundation: www.euresist.org/(former EU grant IST-2004-027173). The Virolab project: www.virolab.org/(EU grant #027446). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmann A, 2007, ANTIVIR THER, V12, P169; Altmann A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003470; Altmann A, 2009, J INFECT DIS, V199, P999, DOI 10.1086/597305; Alvarez M, 2004, J MED VIROL, V73, P151, DOI 10.1002/jmv.20069; Baxter JD, 2000, AIDS, V14, pF83, DOI 10.1097/00002030-200006160-00001; Beck IA, 2008, JAIDS-J ACQ IMM DEF, V48, P418, DOI 10.1097/QAI.0b013e31817ed7d7; Bishai D, 2007, AIDS, V21, P1333, DOI 10.1097/QAD.0b013e328137709e; Boyd MA, 2007, AIDS, V21, pS55, DOI 10.1097/01.aids.0000279707.01557.b2; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Brenner BG, 2007, CURR OPIN HIV AIDS, V2, P94, DOI 10.1097/COH.0b013e32801682e2; Brun-Vezinet F, 2004, ANTIVIR THER, V9, P465; Colebunders R, 2006, LANCET INFECT DIS, V6, P53, DOI 10.1016/S1473-3099(05)70327-3; Cozzi-Lepri A, 2008, HIV MED, V9, P27, DOI 10.1111/j.1468-1293.2008.00523.x; De Luca A, 2006, ANTIVIR THER, V11, P321; Deforche K, 2008, BIOINFORMATICS, V24, P34, DOI 10.1093/bioinformatics/btm540; Diaz T, 2009, CURR OPIN HIV AIDS, V4, P253, DOI 10.1097/COH.0b013e32832c1898; Durant J, 1999, LANCET, V353, P2195, DOI 10.1016/S0140-6736(98)12291-2; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Forster M, 2008, B WORLD HEALTH ORGAN, V86, P939, DOI 10.2471/BLT.07.049908; Gilks CF, 2006, LANCET, V368, P505, DOI 10.1016/S0140-6736(06)69158-7; Gupta RK, 2009, LANCET INFECT DIS, V9, P409, DOI 10.1016/S1473-3099(09)70136-7; Harrigan PR, 2005, J INFECT DIS, V191, P1325, DOI 10.1086/428852; Hastie T., 2009, ELEMENTS STAT LEARNI, V2nd ed.; Gupta RK, 2007, INT J ANTIMICROB AG, V29, P510, DOI 10.1016/j.ijantimicag.2007.01.003; Larder B, 2007, ANTIVIR THER, V12, P15; Le TT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005189; Liu TF, 2006, CLIN INFECT DIS, V42, P1608, DOI 10.1086/503914; Marconi A, 2009, CLIN MICROBIOL INFEC, V15, P93, DOI 10.1111/j.1469-0691.2008.02116.x; Metzner KJ, 2009, CLIN INFECT DIS, V48, P239, DOI 10.1086/595703; Moore DM, 2006, JAIDS-J ACQ IMM DEF, V43, P436, DOI 10.1097/01.qai.0000243105.80393.42; NADEAU C, 2000, ADV NEURAL INFORM PR, P12; Nash D, 2008, AIDS, V22, P2291, DOI 10.1097/QAD.0b013e3283121ca9; Petrella M, 2001, DRUG RESIST UPDATE, V4, P339, DOI 10.1054/drup.2002.0235; Prosperi MCF, 2009, ANTIVIR THER, V14, P433; R Core Team, 2021, R LANGUAGE ENV STAT; Revell AD, 2010, J ANTIMICROB CHEMOTH, V65, P605, DOI 10.1093/jac/dkq032; Rosen-Zvi M, 2008, BIOINFORMATICS, V24, pI399, DOI 10.1093/bioinformatics/btn141; Steegen K, 2007, J VIROL METHODS, V146, P178, DOI 10.1016/j.jviromet.2007.06.019; Thompson MA, 2010, JAMA-J AM MED ASSOC, V304, P321, DOI 10.1001/jama.2010.1004; Van Laethem K, 2006, AIDS REV, V8, P37; Walensky RP, 2007, AIDS, V21, P973, DOI 10.1097/QAD.0b013e328011ec53; Wang D, 2009, ARTIF INTELL MED, V47, P63, DOI 10.1016/j.artmed.2009.05.002; Witten I.H., 2005, DATA MINING PRACTICA; Yari A, 2007, BIOINFORMATION, V2, P97, DOI 10.6026/97320630002097; Zaccarelli M, 2009, ANTIVIR THER, V14, P285	45	19	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2010	5	10							e13753	10.1371/journal.pone.0013753	http://dx.doi.org/10.1371/journal.pone.0013753			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673FU	21060792	Green Published, gold			2022-12-27	WOS:000283645300032
J	Ferret-Bernard, S; Remot, A; Lacroix-Lamande, S; Metton, C; Bernardet, N; Drouet, F; Laurent, F				Ferret-Bernard, Stephanie; Remot, Aude; Lacroix-Lamande, Sonia; Metton, Coralie; Bernardet, Nelly; Drouet, Francoise; Laurent, Fabrice			Cellular and Molecular Mechanisms Underlying the Strong Neonatal IL-12 Response of Lamb Mesenteric Lymph Node Cells to R-848	PLOS ONE			English	Article							BLOOD MONONUCLEAR-CELLS; DENDRITIC CELLS; INNATE IMMUNITY; CYTOKINE PRODUCTION; BASIC MECHANISMS; IDENTIFICATION; MODULATION; AGONISTS; TH1	Background: Comparative studies on the response of neonates and adults to TLR stimulation have been almost exclusively limited to comparisons of human neonatal cord blood cells with peripheral blood from adults, and analyses of spleen cell responses in mice. We need to extend these studies and gain further information regarding such responses at mucosal sites. Methodology/Principal Findings: We used sheep as a large animal model to study TLR agonist responses in the lymph nodes draining the intestine, an organ that must adapt to profound changes after birth. In response to the imidazoquinoline compound R-848, neonatal mesenteric lymph node (MLN) and spleen cells produced more IL-12 and, consequently, more IFN gamma than their adult counterparts. This difference was age-related for both organs, but the preferential IL-12 response decreased more rapidly in the MLN, with young animals producing similar amounts of this cytokine to adults, from the age of 20 days onwards. Intracellular assays and depletion experiments identified CD14(+)CD11b(+)CD40(+) cells as the main producer of IL-12. These cells accounted for a greater proportion of neonatal than of adult MLN cells, and also produced, in direct response to R-848, more IL-12 after isolation. This strong IL-12 response in neonates occurred despite the production of larger amounts of the regulatory cytokine IL-10 and the stronger upregulation of SOCS-1 and SOCS-3 mRNA levels than in adult cells, and was correlated with an increase in p38/MAPK phosphorylation. Conclusions/Significance: This is the first attempt to decipher the mechanism by which neonatal MLN cells produce more IL-12 than adult cells in response to the TLR8 agonist R-848. CD14(+)CD11b(+)CD40(+) IL-12-producing cells were more numerous in neonate than in adult MLN cells and displayed higher intracellular responsiveness upon R-848 stimulation. This work provides relevant information for future vaccination or immunostimulation strategies targeting neonates.	[Ferret-Bernard, Stephanie; Remot, Aude; Lacroix-Lamande, Sonia; Metton, Coralie; Bernardet, Nelly; Drouet, Francoise; Laurent, Fabrice] INRA, Equipe Control & Immunol Malad Enter Nouveau Ne, Infectiol Anim & St Publ UR1282, F-37380 Nouzilly, France	INRAE	Ferret-Bernard, S (corresponding author), INRA, Equipe Control & Immunol Malad Enter Nouveau Ne, Infectiol Anim & St Publ UR1282, F-37380 Nouzilly, France.	fabrice.laurent@tours.inra.fr	Laurent, fabrice/AAC-2266-2019; Ferret-Bernard, Stéphanie/AAD-4465-2019	Laurent, fabrice/0000-0002-9687-7952; Ferret-Bernard, Stéphanie/0000-0002-1439-9206; Remot, Aude/0000-0001-9896-3216; LAMANDE, Sonia/0000-0002-7865-4587	French National Institute for Agricultural Research (INRA); Scottish Executive Environment and Rural Affairs Department (SEERAD)	French National Institute for Agricultural Research (INRA); Scottish Executive Environment and Rural Affairs Department (SEERAD)	This work was funded by The French National Institute for Agricultural Research (INRA). S.F.B. had a Postdoctoral Research Fellowship supported by INRA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank T. Chaumeil and E. Guitton for supplying us with animals and for helping us with the neonates in the animal facilities. We would also like to thank Y. Le Vern for expert technical assistance with cell sorting and P.Y. Sizaret for help with electron microscopy. We thank S. Wattegedera for providing recombinant ovine cytokines, which were produced at the Moredun Research Institute with funding from the Scottish Executive Environment and Rural Affairs Department (SEERAD) in collaboration with the BBSRC/SEERAD Immunological Toolbox initiative. The authors also thank J. Naessens for producing, and J. C. Hope and I. Schwartz-Cornil for supplying, the anti-ovine CD40. Finally, we would also like to thank L. Guzylack-Piriou for providing His<INF>6</INF>-tagged porcine Flt3 ligand.	Adkins B, 2004, NAT REV IMMUNOL, V4, P553, DOI 10.1038/nri1394; Baetz A, 2004, J BIOL CHEM, V279, P54708, DOI 10.1074/jbc.M410992200; Barrier M, 2006, J INFECT DIS, V193, P1400, DOI 10.1086/503748; Bonneau M, 2006, J LEUKOCYTE BIOL, V79, P268, DOI 10.1189/jlb.0605288; Booth JS, 2009, MUCOSAL IMMUNOL, V2, P265, DOI 10.1038/mi.2009.6; Buza J, 2008, VET IMMUNOL IMMUNOP, V126, P273, DOI 10.1016/j.vetimm.2008.08.001; Caron JE, 2010, NEONATOLOGY, V97, P266, DOI 10.1159/000255165; Chelvarajan L, 2007, J LEUKOCYTE BIOL, V82, P403, DOI 10.1189/jlb.0107071; Chelvarajan RL, 2004, J LEUKOCYTE BIOL, V75, P982, DOI 10.1189/jlb.0403179; Elhmouzi-Younes J, 2009, VET RES, V40, DOI 10.1051/vetres/2009037; Fach SJ, 2006, VET IMMUNOL IMMUNOP, V112, P171, DOI 10.1016/j.vetimm.2006.02.012; Foulon E, 2008, J IMMUNOL METHODS, V339, P1, DOI 10.1016/j.jim.2008.07.012; Goriely S, 2004, J EXP MED, V199, P1011, DOI 10.1084/jem.20031272; Guzylack-Piriou L, 2010, DEV COMP IMMUNOL, V34, P455, DOI 10.1016/j.dci.2009.12.006; Hemmi H, 2002, NAT IMMUNOL, V3, P196, DOI 10.1038/ni758; Hope JC, 2002, J IMMUNOL METHODS, V266, P117, DOI 10.1016/S0022-1759(02)00113-8; Jurk M, 2002, NAT IMMUNOL, V3, P499, DOI 10.1038/ni0602-499; Kollmann TR, 2009, J IMMUNOL, V183, P7150, DOI 10.4049/jimmunol.0901481; Kwong LS, 2002, VET IMMUNOL IMMUNOP, V85, P213, DOI 10.1016/S0165-2427(02)00007-7; Lacroix-Lamande S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008291; Lahiri A, 2008, VACCINE, V26, P6777, DOI 10.1016/j.vaccine.2008.09.045; Levy O, 2004, J IMMUNOL, V173, P4627, DOI 10.4049/jimmunol.173.7.4627; Levy O, 2007, NAT REV IMMUNOL, V7, P379, DOI 10.1038/nri2075; Levy O, 2006, BLOOD, V108, P1284, DOI 10.1182/blood-2005-12-4821; Macpherson AJ, 2006, J EXP MED, V203, P497, DOI 10.1084/jem.20060227; Marodi L, 2002, CLIN EXP IMMUNOL, V128, P1, DOI 10.1046/j.1365-2249.2002.01873.x; Pascale F, 2008, J IMMUNOL, V180, P5963, DOI 10.4049/jimmunol.180.9.5963; Pedersen LG, 2002, VET IMMUNOL IMMUNOP, V88, P111, DOI 10.1016/S0165-2427(02)00139-3; Philbin VJ, 2007, BIOCHEM SOC T, V35, P1485, DOI 10.1042/BST0351485; Siegrist C A, 2000, Int Rev Immunol, V19, P195, DOI 10.3109/08830180009088505; Sun CM, 2005, IMMUNITY, V22, P467, DOI 10.1016/j.immuni.2005.02.008; Sun CM, 2003, BLOOD, V102, P585, DOI 10.1182/blood-2002-09-2966; Tourais-Esteves I, 2008, DEV COMP IMMUNOL, V32, P1231, DOI 10.1016/j.dci.2008.03.011; van Duin D, 2006, TRENDS IMMUNOL, V27, P49, DOI 10.1016/j.it.2005.11.005; Vanden Eijnden S, 2006, EUR J IMMUNOL, V36, P21, DOI 10.1002/eji.200535467; Wagner TL, 1999, CELL IMMUNOL, V191, P10, DOI 10.1006/cimm.1998.1406; Wattegedera S, 2004, VET IMMUNOL IMMUNOP, V102, P67, DOI 10.1016/j.vetimm.2004.06.006; Wynn JL, 2008, BLOOD, V112, P1750, DOI 10.1182/blood-2008-01-130500; Zhao J, 2008, P NATL ACAD SCI USA, V105, P7528, DOI 10.1073/pnas.0800152105	39	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2010	5	10							e13705	10.1371/journal.pone.0013705	http://dx.doi.org/10.1371/journal.pone.0013705			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	672HN	21060840	Green Published, gold, Green Submitted			2022-12-27	WOS:000283573800007
J	Tebbenkamp, ATN; Borchelt, DR				Tebbenkamp, Andrew T. N.; Borchelt, David R.			Analysis of Chaperone mRNA Expression in the Adult Mouse Brain by Meta Analysis of the Allen Brain Atlas	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; ALPHA-B-CRYSTALLIN; AMYOTROPHIC-LATERAL-SCLEROSIS; STRIATAL GENE-EXPRESSION; MOLECULAR CHAPERONES; HUNTINGTONS-DISEASE; CYTOSOLIC CHAPERONIN; TARGETED DISRUPTION; MICROARRAY ANALYSIS; SENSORY NEUROPATHY	The pathology of many neurodegenerative diseases is characterized by the accumulation of misfolded and aggregated proteins in various cell types and regional substructures throughout the central and peripheral nervous systems. The accumulation of these aggregated proteins signals dysfunction of cellular protein homeostatic mechanisms such as the ubiquitin/proteasome system, autophagy, and the chaperone network. Although there are several published studies in which transcriptional profiling has been used to examine gene expression in various tissues, including tissues of neurodegenerative disease models, there has not been a report that focuses exclusively on expression of the chaperone network. In the present study, we used the Allen Brain Atlas online database to analyze chaperone expression levels. This database utilizes a quantitative in situ hybridization approach and provides data on 270 chaperone genes within many substructures of the adult mouse brain. We determined that 256 of these chaperone genes are expressed at some level. Surprisingly, relatively few genes, only 30, showed significant variations in levels of mRNA across different substructures of the brain. The greatest degree of variability was exhibited by genes of the DnaJ co-chaperone, Tetratricopeptide repeat, and the HSPH families. Our analysis provides a valuable resource towards determining how variations in chaperone gene expression may modulate the vulnerability of specific neuronal populations of mammalian brain.	[Tebbenkamp, Andrew T. N.; Borchelt, David R.] Univ Florida, Dept Neurosci, SantaFe Hlth Alzheimers Dis Ctr, McKnight Brain Inst, Gainesville, FL 32610 USA	State University System of Florida; University of Florida	Tebbenkamp, ATN (corresponding author), Univ Florida, Dept Neurosci, SantaFe Hlth Alzheimers Dis Ctr, McKnight Brain Inst, Gainesville, FL 32610 USA.	atebbenk@ufl.edu; borchelt@mbi.ufl.edu		Tebbenkamp, Andrew/0000-0002-9015-3427	Huntington's Disease Society of America Coalition for the Cure; CHDI Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS044278] Funding Source: NIH RePORTER	Huntington's Disease Society of America Coalition for the Cure; CHDI Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by the Huntington's Disease Society of America Coalition for the Cure (www.hdsa.org) and the CHDI Foundation (www.highqfoundation.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alirol E, 2006, MOL BIOL CELL, V17, P4593, DOI 10.1091/mbc.E06-05-0377; BECANOVIC K, 2010, HUM MOL GEN IN PRESS; Becher MW, 1998, NEUROBIOL DIS, V4, P387, DOI 10.1006/nbdi.1998.0168; Blatch GL, 1999, BIOESSAYS, V21, P932, DOI 10.1002/(SICI)1521-1878(199911)21:11<932::AID-BIES5>3.0.CO;2-N; Bouhouche A, 2006, J MED GENET, V43, P441, DOI 10.1136/jmg.2005.039230; Braak H, 1998, J NEURAL TRANSM-SUPP, P97; Brady JP, 2001, INVEST OPHTH VIS SCI, V42, P2924; Carpentier M, 2002, BIOCHEMISTRY-US, V41, P5222, DOI 10.1021/bi015951j; Chen S, 2007, CELL STRESS CHAPERON, V12, P51, DOI 10.1379/CSC-236R.1; Cotto JJ, 1999, BIOCHEM SOC SYMP, P105; Crocker SF, 2006, BRAIN RES, V1088, P176, DOI 10.1016/j.brainres.2006.02.102; D'Souza SM, 1998, CELL STRESS CHAPERON, V3, P188, DOI 10.1379/1466-1268(1998)003<0188:CEOHSP>2.3.CO;2; DESHAIES RJ, 1988, NATURE, V332, P800, DOI 10.1038/332800a0; Desplats PA, 2006, J NEUROCHEM, V96, P743, DOI 10.1111/j.1471-4159.2005.03588.x; Dierick I, 2005, ANN MED, V37, P413, DOI 10.1080/07853890500296410; Doran P, 2007, EUR J CELL BIOL, V86, P629, DOI 10.1016/j.ejcb.2007.07.003; Dragovic Z, 2006, EMBO J, V25, P2519, DOI 10.1038/sj.emboj.7601138; Dron M, 2002, GENOMICS, V79, P315, DOI 10.1006/geno.2002.6709; DUBIN RA, 1989, MOL CELL BIOL, V9, P1083, DOI 10.1128/MCB.9.3.1083; Ecroyd H, 2009, CELL MOL LIFE SCI, V66, P62, DOI 10.1007/s00018-008-8327-4; Felts SJ, 2000, J BIOL CHEM, V275, P3305, DOI 10.1074/jbc.275.5.3305; Ferraiuolo L, 2007, J NEUROSCI, V27, P9201, DOI 10.1523/JNEUROSCI.1470-07.2007; Fujimoto M, 2004, EMBO J, V23, P4297, DOI 10.1038/sj.emboj.7600435; Fukada Y, 2007, BRAIN RES, V1160, P1, DOI 10.1016/j.brainres.2007.05.044; Ginsberg SD, 2000, ANN NEUROL, V48, P77, DOI 10.1002/1531-8249(200007)48:1<77::AID-ANA12>3.3.CO;2-1; Hampton CR, 2003, AM J PHYSIOL-HEART C, V285, pH866, DOI 10.1152/ajpheart.00596.2002; Han ZH, 2003, P NATL ACAD SCI USA, V100, P1256, DOI 10.1073/pnas.252764399; Hansen JJ, 2002, AM J HUM GENET, V70, P1328, DOI 10.1086/339935; Hanson PI, 2005, NAT REV MOL CELL BIO, V6, P519, DOI 10.1038/nrm1684; Hatziioannou T, 2005, J VIROL, V79, P176, DOI 10.1128/JVI.79.1.176-183.2005; Hennessy F, 2005, PROTEIN SCI, V14, P1697, DOI 10.1110/ps.051406805; Horwich AL, 2007, ANNU REV CELL DEV BI, V23, P115, DOI 10.1146/annurev.cellbio.23.090506.123555; Howarth JL, 2009, J NEUROCHEM, V108, P945, DOI [10.1111/j.1471-4159.2008.05847.x, 10.1111/j.0022-3042.2008.05847.x]; Jarczowski F, 2009, J BIOL CHEM, V284, P766, DOI 10.1074/jbc.M709779200; Kallio M, 2002, EMBO J, V21, P2591, DOI 10.1093/emboj/21.11.2591; Kampinga HH, 2009, CELL STRESS CHAPERON, V14, P105, DOI 10.1007/s12192-008-0068-7; Karch CM, 2010, J NEUROCHEM, V113, P1092, DOI 10.1111/j.1471-4159.2010.06572.x; KIM RY, 1992, P NATL ACAD SCI USA, V89, P9292, DOI 10.1073/pnas.89.19.9292; Kuhn A, 2007, HUM MOL GENET, V16, P1845, DOI 10.1093/hmg/ddm133; Lee MJ, 2003, HUM MOL GENET, V12, P1917, DOI 10.1093/hmg/ddg198; Lee SH, 2001, STROKE, V32, P2905, DOI 10.1161/hs1201.099604; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Luthi-Carter R, 2002, HUM MOL GENET, V11, P1927, DOI 10.1093/hmg/11.17.1927; Magen D, 2008, AM J HUM GENET, V83, P30, DOI 10.1016/j.ajhg.2008.05.016; Martin-Benito J, 2002, EMBO J, V21, P6377, DOI 10.1093/emboj/cdf640; MATSUMOTO M, 1990, BIOCHEM BIOPH RES CO, V166, P43, DOI 10.1016/0006-291X(90)91909-C; McLaughlin SH, 2006, J MOL BIOL, V356, P746, DOI 10.1016/j.jmb.2005.11.085; McMillan DR, 1998, J BIOL CHEM, V273, P7523, DOI 10.1074/jbc.273.13.7523; McMillan DR, 2002, MOL CELL BIOL, V22, P8005, DOI 10.1128/MCB.22.22.8005-8014.2002; Mirnics K, 2008, MOL NEURODEGENER, V3, DOI 10.1186/1750-1326-3-14; Morimoto RI, 2008, GENE DEV, V22, P1427, DOI 10.1101/gad.1657108; Morimoto RI, 2009, J GERONTOL A-BIOL, V64, P167, DOI 10.1093/gerona/gln071; Muchowski PJ, 2005, NAT REV NEUROSCI, V6, P11, DOI 10.1038/nrn1587; Ostling P, 2007, J BIOL CHEM, V282, P7077, DOI 10.1074/jbc.M607556200; Ozelius LJ, 1999, GENOMICS, V62, P377, DOI 10.1006/geno.1999.6039; Picard D, 2006, TRENDS ENDOCRIN MET, V17, P229, DOI 10.1016/j.tem.2006.06.003; Pongrac JL, 2004, BIOL PSYCHIAT, V56, P943, DOI 10.1016/j.biopsych.2004.09.005; Pratt WB, 2003, EXP BIOL MED, V228, P111, DOI 10.1177/153537020322800201; Qiu XB, 2006, CELL MOL LIFE SCI, V63, P2560, DOI 10.1007/s00018-006-6192-6; Quraishe S, 2008, NEUROSCIENCE, V153, P483, DOI 10.1016/j.neuroscience.2008.01.058; Rallu M, 1997, P NATL ACAD SCI USA, V94, P2392, DOI 10.1073/pnas.94.6.2392; Raviol H, 2006, EMBO J, V25, P2510, DOI 10.1038/sj.emboj.7601139; Robert A, 2007, J CELL SCI, V120, P628, DOI 10.1242/jcs.03366; Rodriguez F, 2008, MOL CELL, V32, P347, DOI 10.1016/j.molcel.2008.09.016; Satyal SH, 1998, GENE DEV, V12, P1962, DOI 10.1101/gad.12.13.1962; SHARP AH, 1995, NEURON, V14, P1065, DOI 10.1016/0896-6273(95)90345-3; Slominsky P A, 1999, Hum Mutat, V14, P269, DOI 10.1002/(SICI)1098-1004(1999)14:3<269::AID-HUMU12>3.0.CO;2-9; Smith DF, 2008, MOL ENDOCRINOL, V22, P2229, DOI 10.1210/me.2008-0089; Song YT, 2005, J BIOL CHEM, V280, P34178, DOI 10.1074/jbc.M505420200; Soti C, 2002, NEUROCHEM INT, V41, P383, DOI 10.1016/S0197-0186(02)00043-8; Soti C, 2005, BRIT J PHARMACOL, V146, P769, DOI 10.1038/sj.bjp.0706396; Soto C, 2008, ARCH NEUROL-CHICAGO, V65, P184, DOI 10.1001/archneurol.2007.56; Spiess C, 2004, TRENDS CELL BIOL, V14, P598, DOI 10.1016/j.tcb.2004.09.015; Sun Y, 2005, CELL MOL LIFE SCI, V62, P2460, DOI 10.1007/s00018-005-5190-4; Taguwa S, 2008, J VIROL, V82, P2631, DOI 10.1128/JVI.02153-07; TAVARIA M, 1995, GENOMICS, V29, P266, DOI 10.1006/geno.1995.1242; TERADA K, 1995, MOL CELL BIOL, V15, P3708; Vainberg IE, 1998, CELL, V93, P863, DOI 10.1016/S0092-8674(00)81446-4; Van Molle W, 2002, IMMUNITY, V16, P685, DOI 10.1016/S1074-7613(02)00310-2; Voellmy R, 2007, ADV EXP MED BIOL, V594, P89; Voos W, 2002, BBA-MOL CELL RES, V1592, P51, DOI 10.1016/S0167-4889(02)00264-1; Vos MJ, 2008, BIOCHEMISTRY-US, V47, P7001, DOI 10.1021/bi800639z; Voss AK, 2000, DEVELOPMENT, V127, P1; Wang GH, 2003, GENESIS, V36, P48, DOI 10.1002/gene.10200; Wang J, 2005, HUM MOL GENET, V14, P2335, DOI 10.1093/hmg/ddi236; Westerheide SD, 2009, SCIENCE, V323, P1063, DOI 10.1126/science.1165946; Westerheide SD, 2005, J BIOL CHEM, V280, P33097, DOI 10.1074/jbc.R500010200; Wochnik GM, 2005, J BIOL CHEM, V280, P4609, DOI 10.1074/jbc.M407498200; Yoshihara T, 2002, J NEUROCHEM, V80, P158, DOI 10.1046/j.0022-3042.2001.00683.x; Young JC, 2003, CELL, V112, P41, DOI 10.1016/S0092-8674(02)01250-3; Young JC, 2004, NAT REV MOL CELL BIO, V5, P781, DOI 10.1038/nrm1492; Zhang Y, 2001, J CELL BIOCHEM, V82, P692, DOI 10.1002/jcb.1191; Zou JY, 1998, CELL, V94, P471, DOI 10.1016/S0092-8674(00)81588-3	93	24	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2010	5	10							e13675	10.1371/journal.pone.0013675	http://dx.doi.org/10.1371/journal.pone.0013675			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	672HN	21060842	Green Published, gold, Green Submitted			2022-12-27	WOS:000283573800002
J	Vauchelles, R; Stalder, D; Botton, T; Arkowitz, RA; Bassilana, M				Vauchelles, Romain; Stalder, Daniele; Botton, Thomas; Arkowitz, Robert A.; Bassilana, Martine			Rac1 Dynamics in the Human Opportunistic Fungal Pathogen Candida albicans	PLOS ONE			English	Article							STAT TRANSCRIPTION FACTORS; GTPASE-ACTIVATING PROTEIN; RAS-LIKE GTPASES; RHO-FAMILY; NUCLEAR-LOCALIZATION; MEMBRANE ASSOCIATION; FILAMENTOUS GROWTH; POLYBASIC REGION; EXCHANGE FACTOR; HYPHAL GROWTH	The small Rho G-protein Rac1 is highly conserved from fungi to humans, with approximately 65% overall sequence identity in Candida albicans. As observed with human Rac1, we show that C. albicans Rac1 can accumulate in the nucleus, and fluorescence recovery after photobleaching ( FRAP) together with fluorescence loss in photobleaching ( FLIP) studies indicate that this Rho G-protein undergoes nucleo-cytoplasmic shuttling. Analyses of different chimeras revealed that nuclear accumulation of C. albicans Rac1 requires the NLS-motifs at its carboxyl-terminus, which are blocked by prenylation of the adjacent cysteine residue. Furthermore, we show that C. albicans Rac1 dynamics, both at the plasma membrane and in the nucleus, are dependent on its activation state and in particular that the inactive form accumulates faster in the nucleus. Heterologous expression of human Rac1 in C. albicans also results in nuclear accumulation, yet accumulation is more rapid than that of C. albicans Rac1. Taken together our results indicate that Rac1 nuclear accumulation is an inherent property of this G-protein and suggest that the requirements for its nucleo-cytoplasmic shuttling are conserved from fungi to humans.	[Vauchelles, Romain; Stalder, Daniele; Botton, Thomas; Arkowitz, Robert A.; Bassilana, Martine] Univ Nice, CNRS, Fac Sci Parc Valrose, Inst Dev Biol & Canc,UMR 6543, F-06034 Nice, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur	Vauchelles, R (corresponding author), Univ Nice, CNRS, Fac Sci Parc Valrose, Inst Dev Biol & Canc,UMR 6543, F-06034 Nice, France.	mbassila@unice.fr	arkowitz, robert/ABC-1860-2021; Botton, Thomas/AAA-9258-2020; Bassilana, Martine/AAS-5814-2021	arkowitz, robert/0000-0002-5216-5013; Botton, Thomas/0000-0001-9079-7014; Bassilana, Martine/0000-0001-9965-567X	Centre National de la Recherche Scientifique; Fondation pour la Recherche Medicale-BNP-Paribas	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Fondation pour la Recherche Medicale-BNP-Paribas	This work was supported by the Centre National de la Recherche Scientifique and Fondation pour la Recherche Medicale-BNP-Paribas. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bassilana M, 2006, EUKARYOT CELL, V5, P321, DOI 10.1128/EC.5.2.321-329.2006; Bassilana M, 2003, EUKARYOT CELL, V2, P9, DOI 10.1128/EC.2.1.9-18.2003; Bosco EE, 2009, CELL MOL LIFE SCI, V66, P370, DOI 10.1007/s00018-008-8552-x; Boureux A, 2007, MOL BIOL EVOL, V24, P203, DOI 10.1093/molbev/msl145; Brown DH, 1999, MOL MICROBIOL, V34, P651, DOI 10.1046/j.1365-2958.1999.01619.x; Chen HJ, 2008, NUMER MATH-THEORY ME, V1, P1; Cole KC, 2007, EUKARYOT CELL, V6, P378, DOI 10.1128/EC.00368-06; Cote JF, 2007, TRENDS CELL BIOL, V17, P383, DOI 10.1016/j.tcb.2007.05.001; Court H, 2007, MOL BIOL CELL, V18, P265, DOI 10.1091/mbc.E06-05-0411; DerMardirossian C, 2005, TRENDS CELL BIOL, V15, P356, DOI 10.1016/j.tcb.2005.05.001; Dovas A, 2005, BIOCHEM J, V390, P1, DOI 10.1042/BJ20050104; Fitzpatrick DA, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-99; HOPE H, 2010, MOL MICROBIOL; Hope H, 2008, MOL BIOL CELL, V19, P3638, DOI 10.1091/mbc.E07-12-1272; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Kawashima T, 2006, J CELL BIOL, V175, P937, DOI 10.1083/jcb.200604073; Kawashima T, 2009, MOL CELL BIOL, V29, P1796, DOI 10.1128/MCB.01423-08; Koster M, 2005, CURR OPIN BIOTECH, V16, P28, DOI 10.1016/j.copbio.2004.11.002; Kraynov VS, 2000, SCIENCE, V290, P333, DOI 10.1126/science.290.5490.333; Lanning CC, 2004, J BIOL CHEM, V279, P44197, DOI 10.1074/jbc.M404977200; Lanning CC, 2003, J BIOL CHEM, V278, P12495, DOI 10.1074/jbc.M211286200; Lin Q, 2003, CURR BIOL, V13, P1469, DOI 10.1016/S0960-9822(03)00613-4; Lin R, 1999, J BIOL CHEM, V274, P23633, DOI 10.1074/jbc.274.33.23633; Mahlert M, 2006, MOL MICROBIOL, V59, P567, DOI 10.1111/j.1365-2958.2005.04952.x; Meller N, 2005, J CELL SCI, V118, P4937, DOI 10.1242/jcs.02671; Michaelson D, 2008, J CELL BIOL, V181, P485, DOI 10.1083/jcb.200801047; Michel S, 2002, MOL MICROBIOL, V46, P269, DOI 10.1046/j.1365-2958.2002.03167.x; Nern A, 2000, MOL CELL, V5, P853, DOI 10.1016/S1097-2765(00)80325-1; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Sandrock K, 2010, TRAFFIC, V11, P198, DOI 10.1111/j.1600-0854.2009.01015.x; Seabra MC, 1998, CELL SIGNAL, V10, P167, DOI 10.1016/S0898-6568(97)00120-4; Slaughter BD, 2009, DEV CELL, V17, P823, DOI 10.1016/j.devcel.2009.10.022; Tiedje C, 2008, MOL BIOL CELL, V19, P2885, DOI 10.1091/mbc.E07-11-1152; Ushinsky SC, 2002, EUKARYOT CELL, V1, P95, DOI 10.1128/EC.1.1.95-104.2002; Vallim MA, 2005, EUKARYOT CELL, V4, P1066, DOI 10.1128/EC.4.6.1066-1078.2005; Virag A, 2007, MOL MICROBIOL, V66, P1579, DOI 10.1111/j.1365-2958.2007.06021.x; Williams CL, 2003, CELL SIGNAL, V15, P1071, DOI 10.1016/S0898-6568(03)00098-6; Wilson RB, 1999, J BACTERIOL, V181, P1868, DOI 10.1128/JB.181.6.1868-1874.1999; Yin JH, 2004, ARCH BIOCHEM BIOPHYS, V429, P23, DOI 10.1016/j.abb.2004.05.014; Yoshizaki H, 2003, J CELL BIOL, V162, P223, DOI 10.1083/jcb.200212049	40	8	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2010	5	10							e15400	10.1371/journal.pone.0015400	http://dx.doi.org/10.1371/journal.pone.0015400			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	672HN	21060846	Green Published, Green Submitted, gold			2022-12-27	WOS:000283573800026
J	Zhang, GH; Mai, RQ; Huang, B				Zhang, Guohong; Mai, Ruiqin; Huang, Bo			ADH1B Arg47His Polymorphism Is Associated with Esophageal Cancer Risk in High-Incidence Asian Population: Evidence from a Meta-Analysis	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; GENETIC POLYMORPHISMS; ALDEHYDE DEHYDROGENASES; ADH1B-ASTERISK-47HIS ALLELE; ALCOHOL; ALDH2; CONSUMPTION; FREQUENCY; EASTERN; TOBACCO	Background and Objectives: Incidence of Esophageal squamous cell carcinoma (ESCC) is prevalent in Asian populations, especially in the ones from the "Asian esophageal cancer belt" along the Silk Road and the ones from East Asia (including Japan). Silk Road and Eastern Asia population genetics are relevant to the ancient population migration from central China. The Arg47His (rs1229984) polymorphism of ADH1B is the highest in East Asians, and ancient migrations along the Silk Road were thought to be contributive to a frequent ADH1B*47His allele in Central Asians. This polymorphism was identified as responsible for susceptibility in the first large-scale genome-wide association study of ESCC and that's explained by its modulation of alcohol oxidization capability. To investigate the association of ADH1B Arg47His with ESCC in Asian populations under a common ancestry scenario of the susceptibility loci, we combined all available studies into a meta-analysis. Methods: A dataset composed of 4,220 cases and 8,946 controls from twelve studies of Asian populations was analyzed for ADH1B Arg47His association with ESCC and its interactions with alcohol drinking and ALDH2 Glu504Lys. Heterogeneity among studies and their publication bias were also tested. Results: The ADH1B*47Arg allele was found to be associated to increased risk of ESCC, with the odds ratios (OR) being 1.62 (95% CI: 1.49-1.76) and 3.86 (2.96-5.03) for the His/Arg and the Arg/Arg genotypes, respectively. When compared with the His/His genotype of non-drinkers, the Arg/Arg genotype can interact with alcohol drinking and greatly increase the risk of ESCC (OR = 20.69, 95% CI: 5.09-84.13). Statistical tests also showed gene-gene interaction of ADH1B Arg+ with ALDH2 Lys+ can bring more risk to ESCC (OR = 13.46, 95% CI: 2.32-78.07). Conclusion: Revealed by this meta-analysis, ADH1B*47Arg as a common ancestral allele can significantly increase the risk of ESCC in Asians, especially when coupled with alcohol drinking or the ALDH2*504Lys allele.	[Zhang, Guohong; Huang, Bo] Shantou Univ, Coll Med, Dept Pathol, Shantou, Peoples R China; [Mai, Ruiqin] Shantou Univ, Coll Med, Dept Lab Med, Affiliated Hosp 1, Shantou, Peoples R China	Shantou University; Shantou University	Zhang, GH (corresponding author), Shantou Univ, Coll Med, Dept Pathol, Shantou, Peoples R China.	g_ghzhang@yahoo.com.cn			Natural Science Foundation of China [30901726]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was funded by grant No. 30901726 from The Natural Science Foundation of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbari MR, 2009, CANCER RES, V69, P7994, DOI 10.1158/0008-5472.CAN-09-1149; Borinskaya S, 2009, AM J HUM GENET, V84, P89, DOI 10.1016/j.ajhg.2008.12.007; BOSRON WF, 1986, HEPATOLOGY, V6, P502, DOI 10.1002/hep.1840060330; Brooks PJ, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000050; Chen YJ, 2006, INT J CANCER, V119, P2827, DOI 10.1002/ijc.22199; CRABB DW, 1989, J CLIN INVEST, V83, P314, DOI 10.1172/JCI113875; Cui R, 2009, GASTROENTEROLOGY, V137, P1768, DOI 10.1053/j.gastro.2009.07.070; Di Rienzo A, 2005, TRENDS GENET, V21, P596, DOI 10.1016/j.tig.2005.08.007; Ding JH, 2009, WORLD J GASTROENTERO, V15, P2395, DOI 10.3748/wjg.15.2395; Guo YM, 2008, WORLD J GASTROENTERO, V14, P1444, DOI 10.3748/wjg.14.1444; Hori H, 1997, J CLIN GASTROENTEROL, V25, P568, DOI 10.1097/00004836-199712000-00003; Lee CH, 2008, INT J CANCER, V122, P1347, DOI 10.1002/ijc.23264; Lewis SJ, 2005, CANCER EPIDEM BIOMAR, V14, P1967, DOI 10.1158/1055-9965.EPI-05-0196; Li H, 2007, AM J HUM GENET, V81, P842, DOI 10.1086/521201; Li H, 2009, AM J HUM GENET, V85, P934, DOI 10.1016/j.ajhg.2009.10.024; Li H, 2009, AM J HUM GENET, V84, P92, DOI 10.1016/j.ajhg.2008.12.006; Li H, 2009, ANN HUM GENET, V73, P335, DOI 10.1111/j.1469-1809.2009.00517.x; Li XY, 2007, GENOMICS, V90, P474, DOI 10.1016/j.ygeno.2007.06.006; Oota H, 1999, AM J HUM GENET, V64, P250, DOI 10.1086/302197; Osier MV, 2002, AM J HUM GENET, V71, P84, DOI 10.1086/341290; Oze I, 2009, CANCER EPIDEM BIOMAR, V18, P3097, DOI 10.1158/1055-9965.EPI-09-0499; Peng Y, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-15; SMITH M, 1986, ADV HUM GENET, V15, P249; Szumilo Justyna, 2009, Pol Merkur Lekarski, V26, P82; Wu CF, 2005, WORLD J GASTROENTERO, V11, P5103, DOI 10.3748/wjg.v11.i33.5103; Yang Chun-Xia, 2005, Asian Pac J Cancer Prev, V6, P256; Yang SJ, 2007, WORLD J GASTROENTERO, V13, P5760, DOI 10.3748/wjg.v13.i43.5760; Yao YG, 2004, MOL BIOL EVOL, V21, P2265, DOI 10.1093/molbev/msh238; Yokoyama A, 2002, CARCINOGENESIS, V23, P1851, DOI 10.1093/carcin/23.11.1851	29	19	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2010	5	10							e13679	10.1371/journal.pone.0013679	http://dx.doi.org/10.1371/journal.pone.0013679			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671UN	21048924	Green Published, gold, Green Submitted			2022-12-27	WOS:000283537000045
J	Lafont, E; Milhas, D; Teissie, J; Therville, N; Andrieu-Abadie, N; Levade, T; Benoist, H; Segui, B				Lafont, Elodie; Milhas, Delphine; Teissie, Justin; Therville, Nicole; Andrieu-Abadie, Nathalie; Levade, Thierry; Benoist, Herve; Segui, Bruno			Caspase-10-Dependent Cell Death in Fas/CD95 Signalling Is Not Abrogated by Caspase Inhibitor zVAD-fmk	PLOS ONE			English	Article							AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME; NF-KAPPA-B; INDUCED APOPTOSIS; EPITHELIAL-CELLS; FAS; DOMAIN; FADD; RECEPTOR; PATHWAY; PROTEIN	Background: Upon CD95/Fas ligation, the initiator caspase-8 is known to activate effector caspases leading to apoptosis. In the presence of zVAD-fmk, a broad-spectrum caspase inhibitor, Fas engagement can also trigger an alternative, nonapoptotic caspase-independent form of cell death, which is initiated by RIP1. Controversy exists as to the ability of caspase-10 to mediate cell death in response to FasL (CD95L or CD178). Herein, the role of caspase-10 in FasL-induced cell death has been re-evaluated. Methodology and Principal Findings: The present study shows that FasL-induced cell death was completely impaired in caspase-8- and caspase-10-doubly deficient (I9-2e) Jurkat leukaemia T-cell lines. Over-expressing of either caspase-8 or caspase-10 in I9-2e cells triggered cell death and restored sensitivity to FasL, further arguing for a role of both initiator caspases in Fas apoptotic signalling. In the presence of zVAD-fmk, FasL triggered an alternative form of cell death similarly in wild-type (A3) and in caspase-8-deficient Jurkat cells expressing endogenous caspase-10 (clone I9-2d). Cell death initiated by Fas stimulation in the presence of zVAD-fmk was abrogated in I9-2e cells as well as in HeLa cells, which did not express endogenous caspase-10, indicating that caspase-10 somewhat participates in this alternative form of cell death. Noteworthy, ectopic expression of caspase-10 in I9-2e and HeLa cells restored the ability of FasL to trigger cell death in the presence of zVAD-fmk. As a matter of fact, FasL-triggered caspase-10 processing still occurred in the presence of zVAD-fmk. Conclusions and Significance: Altogether, these data provide genetic evidence for the involvement of initiator caspase-10 in FasL-induced cell death and indicate that zVAD-fmk does not abrogate caspase-10 processing and cytotoxicity in Fas signalling. Our study also questions the existence of an alternative caspase-independent cell death pathway in Fas signalling.	[Lafont, Elodie; Milhas, Delphine; Therville, Nicole; Andrieu-Abadie, Nathalie; Levade, Thierry; Benoist, Herve; Segui, Bruno] U858 INSERM Inst Natl Sante & Rech Med, Equipe 14, Dept Canc, Toulouse, France; [Lafont, Elodie; Milhas, Delphine; Therville, Nicole; Andrieu-Abadie, Nathalie; Levade, Thierry; Benoist, Herve; Segui, Bruno] Inst Med Mol Rangueil, Inst Federatif Rech 150, Toulouse, France; [Lafont, Elodie; Benoist, Herve; Segui, Bruno] Univ Toulouse 3, Fac Pharmaceut Sci, F-31062 Toulouse, France; [Teissie, Justin] CNRS, IPBS, Inst Pharmacol & Biol Struct, Unite Mixte Rech 5089, Toulouse, France	Institut National de la Sante et de la Recherche Medicale (Inserm); CHU de Toulouse; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS)	Lafont, E (corresponding author), U858 INSERM Inst Natl Sante & Rech Med, Equipe 14, Dept Canc, Toulouse, France.	bruno.segui@inserm.fr	Lafont, Elodie/L-3288-2019; Andrieu-Abadie, Nathalie/N-6793-2013; Therville, Nicole/P-2371-2014; Lafont, Elodie/GPS-9642-2022; Teissie, Justin/AAA-5697-2019; Benoist, Hervé/P-2927-2014; Levade, Thierry/O-8948-2014; Ségui, Bruno/O-8957-2014	Lafont, Elodie/0000-0003-1978-7491; Andrieu-Abadie, Nathalie/0000-0003-2698-1970; Therville, Nicole/0000-0002-7068-1361; Lafont, Elodie/0000-0003-1978-7491; Teissie, Justin/0000-0002-7588-8062; Ségui, Bruno/0000-0002-6119-1889	INSERM; Paul Sabatier University; Association pour la Recherche sur le Cancer (ARC) [3417]	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Paul Sabatier University; Association pour la Recherche sur le Cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer)	This study was supported by INSERM, Paul Sabatier University, and grant 3417 from the Association pour la Recherche sur le Cancer (ARC) (to BS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barcia RN, 2003, CELL IMMUNOL, V226, P78, DOI 10.1016/j.cellimm.2003.11.006; Boone E, 2000, J BIOL CHEM, V275, P37596, DOI 10.1074/jbc.M007166200; CHINNAIYAN AM, 1995, CELL, V81, P505, DOI 10.1016/0092-8674(95)90071-3; Cohen GM, 1997, BIOCHEM J, V326, P1, DOI 10.1042/bj3260001; Cuvillier O, 2000, J BIOL CHEM, V275, P15691, DOI 10.1074/jbc.M000280200; Denecker G, 2001, CELL MOL LIFE SCI, V58, P356, DOI 10.1007/PL00000863; FernandesAlnemri T, 1996, P NATL ACAD SCI USA, V93, P7464, DOI 10.1073/pnas.93.15.7464; Fischer U, 2006, ONCOGENE, V25, P152, DOI 10.1038/sj.onc.1209015; Gabriel B, 2003, EXP CELL RES, V289, P195, DOI 10.1016/S0014-4827(03)00255-6; Holler N, 2000, NAT IMMUNOL, V1, P489, DOI 10.1038/82732; Juo P, 1998, CURR BIOL, V8, P1001, DOI 10.1016/S0960-9822(07)00420-4; Kadohara K, 2009, J BIOL CHEM, V284, P5478, DOI 10.1074/jbc.M808523200; Kawahara A, 1998, J CELL BIOL, V143, P1353, DOI 10.1083/jcb.143.5.1353; Kischkel FC, 2001, J BIOL CHEM, V276, P46639, DOI 10.1074/jbc.M105102200; Lenardo MJ, 2003, IMMUNOL RES, V27, P387, DOI 10.1385/IR:27:2-3:387; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; Maelfait J, 2008, BIOCHEM PHARMACOL, V76, P1365, DOI 10.1016/j.bcp.2008.07.034; Matsumura H, 2000, J CELL BIOL, V151, P1247, DOI 10.1083/jcb.151.6.1247; Milhas D, 2005, J BIOL CHEM, V280, P19836, DOI 10.1074/jbc.M414358200; Morgan MJ, 2001, CELL DEATH DIFFER, V8, P696, DOI 10.1038/sj.cdd.4400866; Muzio M, 1996, CELL, V85, P817, DOI 10.1016/S0092-8674(00)81266-0; Muzio M, 1997, J BIOL CHEM, V272, P2952, DOI 10.1074/jbc.272.5.2952; Rao VK, 2006, HEMATOLOGY, V11, P15, DOI 10.1080/10245330500329094; Rieux-Laucat F, 2006, CURR DIRECT AUTOIMMU, V9, P18; Shikama Y, 2003, EUR J IMMUNOL, V33, P1998, DOI 10.1002/eji.200324013; Shimizu M, 1999, J IMMUNOL, V162, P7350; Siegel RM, 1998, J CELL BIOL, V141, P1243, DOI 10.1083/jcb.141.5.1243; Sprick MR, 2002, EMBO J, V21, P4520, DOI 10.1093/emboj/cdf441; Thorburn J, 2003, MOL BIOL CELL, V14, P67, DOI 10.1091/mbc.E02-04-0207; Vincenz C, 1997, J BIOL CHEM, V272, P6578, DOI 10.1074/jbc.272.10.6578; Wang H, 2007, BBA-GEN SUBJECTS, V1770, P1528, DOI 10.1016/j.bbagen.2007.07.010; Wang L, 2001, P NATL ACAD SCI USA, V98, P13884, DOI 10.1073/pnas.241358198; Worth A, 2006, BRIT J HAEMATOL, V133, P124, DOI 10.1111/j.1365-2141.2006.05993.x; Zhu SG, 2006, HUM GENET, V119, P284, DOI 10.1007/s00439-006-0138-9	35	13	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2010	5	10							e13638	10.1371/journal.pone.0013638	http://dx.doi.org/10.1371/journal.pone.0013638			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671GB	21049020	Green Submitted, Green Published, gold			2022-12-27	WOS:000283487400026
J	Liu, L; Vira, A; Friedman, E; Minas, J; Bolger, D; Bitan, T; Booth, J				Liu, Li; Vira, Amit; Friedman, Emma; Minas, Jennifer; Bolger, Donald; Bitan, Tali; Booth, James			Children with Reading Disability Show Brain Differences in Effective Connectivity for Visual, but Not Auditory Word Comprehension	PLOS ONE			English	Article							FUNCTIONAL CONNECTIVITY; DEVELOPMENTAL DYSLEXIA; ANGULAR GYRUS; DISSOCIATION; RECOGNITION; ACTIVATION; LANGUAGE; MODEL; DIFFICULTIES; ORGANIZATION	Background: Previous literature suggests that those with reading disability (RD) have more pronounced deficits during semantic processing in reading as compared to listening comprehension. This discrepancy has been supported by recent neuroimaging studies showing abnormal activity in RD during semantic processing in the visual but not in the auditory modality. Whether effective connectivity between brain regions in RD could also show this pattern of discrepancy has not been investigated. Methodology/Principal Findings: Children (8- to 14-year-olds) were given a semantic task in the visual and auditory modality that required an association judgment as to whether two sequentially presented words were associated. Effective connectivity was investigated using Dynamic Causal Modeling (DCM) on functional magnetic resonance imaging (fMRI) data. Bayesian Model Selection (BMS) was used separately for each modality to find a winning family of DCM models separately for typically developing (TD) and RD children. BMS yielded the same winning family with modulatory effects on bottom-up connections from the input regions to middle temporal gyrus (MTG) and inferior frontal gyrus(IFG) with inconclusive evidence regarding top-down modulations. Bayesian Model Averaging (BMA) was thus conducted across models in this winning family and compared across groups. The bottom-up effect from the fusiform gyrus (FG) to MTG rather than the top-down effect from IFG to MTG was stronger in TD compared to RD for the visual modality. The stronger bottom-up influence in TD was only evident for related word pairs but not for unrelated pairs. No group differences were noted in the auditory modality. Conclusions/Significance: This study revealed a modality-specific deficit for children with RD in bottom-up effective connectivity from orthographic to semantic processing regions. There were no group differences in connectivity from frontal regions, suggesting that the core deficit in RD is not in top-down modulation.	[Liu, Li] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China; [Liu, Li; Vira, Amit; Friedman, Emma; Minas, Jennifer; Booth, James] Northwestern Univ, Dept Commun Sci & Disorders, Evanston, IL USA; [Bolger, Donald] Univ Maryland, Dept Human Dev, College Pk, MD 20742 USA; [Bitan, Tali] Univ Haifa, Dept Commun Disorders, IL-31999 Haifa, Israel	Beijing Normal University; Northwestern University; University System of Maryland; University of Maryland College Park; University of Haifa	Liu, L (corresponding author), Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China.	lilyliu@bnu.edu.cn; j-booth@northwestern.edu	Bolger, Donald J/D-1748-2011	Bolger, Donald J/0000-0001-5114-8484; Bitan, Tali/0000-0001-6160-587X	National Institute of Child Health and Human Development [HD042049]; Beijing Natural Science Foundation [7102089]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD042049] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R56HD042049] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This research was supported by grants from the National Institute of Child Health and Human Development (HD042049, http://www.nichd.nih.gov/). This research was also supported by grants to the State Key Laboratory of Cognitive Neuroscience and Learning (Beijing Normal University), from Beijing Natural Science Foundation (7102089, http://www.bjnsf.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaron P.G., 1989, DYSLEXIA HYPERLEXIA; AARON PG, 1991, J LEARN DISABIL, V24, P178, DOI 10.1177/002221949102400306; [Anonymous], 1998, U S FLORIDA WORD ASS; Badian NA, 1999, J LEARN DISABIL, V32, P138, DOI 10.1177/002221949903200204; Binder JR, 2009, CEREB CORTEX, V19, P2767, DOI 10.1093/cercor/bhp055; Binder JR, 2000, CEREB CORTEX, V10, P512, DOI 10.1093/cercor/10.5.512; Bookheimer S, 2002, ANNU REV NEUROSCI, V25, P151, DOI 10.1146/annurev.neuro.25.112701.142946; Booth JR, 2007, NEUROPSYCHOLOGIA, V45, P775, DOI 10.1016/j.neuropsychologia.2006.08.015; Brambati SM, 2006, BRAIN RES, V1113, P174, DOI 10.1016/j.brainres.2006.06.099; Brunswick N, 1999, BRAIN, V122, P1901, DOI 10.1093/brain/122.10.1901; Burock MA, 1998, NEUROREPORT, V9, P3735, DOI 10.1097/00001756-199811160-00030; Cao F, 2008, BRAIN LANG, V107, P91, DOI 10.1016/j.bandl.2007.12.009; Chee MWL, 1999, HUM BRAIN MAPP, V7, P15, DOI 10.1002/(SICI)1097-0193(1999)7:1<15::AID-HBM2>3.3.CO;2-Y; Chou TL, 2006, HUM BRAIN MAPP, V27, P915, DOI 10.1002/hbm.20231; Chou TL, 2006, NEUROIMAGE, V29, P1141, DOI 10.1016/j.neuroimage.2005.09.064; Cohen L, 2000, BRAIN, V123, P291, DOI 10.1093/brain/123.2.291; Coltheart M, 2001, PSYCHOL REV, V108, P204, DOI 10.1037//0033-295X.108.1.204; Friston KJ, 2003, NEUROIMAGE, V19, P1273, DOI 10.1016/S1053-8119(03)00202-7; Helenius P, 1999, CEREB CORTEX, V9, P476, DOI 10.1093/cercor/9.5.476; Helenius P, 1999, J COGNITIVE NEUROSCI, V11, P535, DOI 10.1162/089892999563599; Hoeft F, 2007, P NATL ACAD SCI USA, V104, P4234, DOI 10.1073/pnas.0609399104; Horwitz B, 1998, P NATL ACAD SCI USA, V95, P8939, DOI 10.1073/pnas.95.15.8939; Humphries C, 2006, J COGNITIVE NEUROSCI, V18, P665, DOI 10.1162/jocn.2006.18.4.665; Lau EF, 2008, NAT REV NEUROSCI, V9, P920, DOI 10.1038/nrn2532; McDermott KB, 2003, NEUROPSYCHOLOGIA, V41, P293, DOI 10.1016/S0028-3932(02)00162-8; Mechelli A, 2003, J COGNITIVE NEUROSCI, V15, P925, DOI 10.1162/089892903770007317; Mechelli A, 2007, HUM BRAIN MAPP, V28, P205, DOI 10.1002/hbm.20272; MILES J, 1994, J CLIN EXP NEUROPSYC, V16, P43, DOI 10.1080/01688639408402616; NELSON CA, 1995, DEV PSYCHOL, V31, P723, DOI 10.1037/0012-1649.31.5.723; Penny WD, 2004, NEUROIMAGE, V22, P1157, DOI 10.1016/j.neuroimage.2004.03.026; Penny WD, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000709; Plante E, 2000, NEUROPSYCHOLOGIA, V38, P1669, DOI 10.1016/S0028-3932(00)00083-X; Pugh KR, 2000, PSYCHOL SCI, V11, P51, DOI 10.1111/1467-9280.00214; Quaglino V, 2008, NEUROPHYSIOL CLIN, V38, P73, DOI 10.1016/j.neucli.2007.12.007; RUMSEY JM, 1994, ARCH NEUROL-CHICAGO, V51, P27, DOI 10.1001/archneur.1994.00540130037011; Rumsey JM, 1997, ARCH NEUROL-CHICAGO, V54, P562, DOI 10.1001/archneur.1997.00550170042013; Sabisch B, 2006, J COGNITIVE NEUROSCI, V18, P1676, DOI 10.1162/jocn.2006.18.10.1676; Schulz E, 2009, NEUROPSYCHOLOGIA, V47, P2544, DOI 10.1016/j.neuropsychologia.2009.04.028; SEIDENBERG MS, 1989, PSYCHOL REV, V96, P523, DOI 10.1037/0033-295X.96.4.523; Shaywitz B., 1999, SCI STUD READ, V3, P95; Shaywitz BA, 2002, BIOL PSYCHIAT, V52, P101, DOI 10.1016/S0006-3223(02)01365-3; Shaywitz SE, 2003, BIOL PSYCHIAT, V54, P25, DOI 10.1016/S0006-3223(02)01836-X; Shaywitz SE, 1998, P NATL ACAD SCI USA, V95, P2636, DOI 10.1073/pnas.95.5.2636; Silva-Pereyra J, 2003, INT J PSYCHOPHYSIOL, V49, P187, DOI 10.1016/S0167-8760(03)00116-8; Snowling M, 1997, TRENDS COGN SCI, V1, P88, DOI 10.1016/S1364-6613(97)89053-5; Stephan KE, 2010, NEUROIMAGE, V49, P3099, DOI 10.1016/j.neuroimage.2009.11.015; Stephan KE, 2009, NEUROIMAGE, V46, P1004, DOI 10.1016/j.neuroimage.2009.03.025; STOTHARD SE, 1995, J CHILD PSYCHOL PSYC, V36, P399, DOI 10.1111/j.1469-7610.1995.tb01298.x; Torgesen J.K., 1999, COMPREHENSIVE TEST P; Torgeson J. K., 1999, TEST WORD READING EF; Wechsler D., 2011, WASI 2 WECHSLER ABBR; Wilkinson G.S, 1993, WIDE RANGE ACHIEVEME; Woodcock R. W., 2001, WOODCOCK JOHNSON 3 T	53	17	17	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2010	5	10							e13492	10.1371/journal.pone.0013492	http://dx.doi.org/10.1371/journal.pone.0013492			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	670LB	21049093	gold, Green Published, Green Submitted			2022-12-27	WOS:000283422100004
J	Liang, L; Xu, B; Chen, YL; Liu, Y; Cao, WC; Fang, LQ; Feng, LM; Goodchild, MF; Gong, P				Liang, Lu; Xu, Bing; Chen, Yanlei; Liu, Yang; Cao, Wuchun; Fang, Liqun; Feng, Limin; Goodchild, Michael F.; Gong, Peng			Combining Spatial-Temporal and Phylogenetic Analysis Approaches for Improved Understanding on Global H5N1 Transmission	PLOS ONE			English	Article							AVIAN INFLUENZA-VIRUSES; WILD BIRDS; SPREAD; MODEL; ACCURATE	Background: Since late 2003, the highly pathogenic influenza A H5N1 had initiated several outbreak waves that swept across the Eurasia and Africa continents. Getting prepared for reassortment or mutation of H5N1 viruses has become a global priority. Although the spreading mechanism of H5N1 has been studied from different perspectives, its main transmission agents and spread route problems remain unsolved. Methodology/Principal Findings: Based on a compilation of the time and location of global H5N1 outbreaks from November 2003 to December 2006, we report an interdisciplinary effort that combines the geospatial informatics approach with a bioinformatics approach to form an improved understanding on the transmission mechanisms of H5N1 virus. Through a spherical coordinate based analysis, which is not conventionally done in geographical analyses, we reveal obvious spatial and temporal clusters of global H5N1 cases on different scales, which we consider to be associated with two different transmission modes of H5N1 viruses. Then through an interdisciplinary study of both geographic and phylogenetic analysis, we obtain a H5N1 spreading route map. Our results provide insight on competing hypotheses as to which avian hosts are responsible for the spread of H5N1. Conclusions/Significance: We found that although South China and Southeast Asia may be the virus pool of avian flu, East Siberia may be the source of the H5N1 epidemic. The concentration of migratory birds from different places increases the possibility of gene mutation. Special attention should be paid to East Siberia, Middle Siberia and South China for improved surveillance of H5N1 viruses and monitoring of migratory birds.	[Liang, Lu; Gong, Peng] Beijing Normal Univ, Chinese Acad Sci, Inst Remote Sensing Applicat, State Key Lab Remote Sensing Sci, Beijing 100875, Peoples R China; [Liang, Lu; Gong, Peng] Tsinghua Univ, Ctr Earth Syst Sci, Beijing 100084, Peoples R China; [Xu, Bing] Univ Utah, Dept Geog, Salt Lake City, UT USA; [Xu, Bing] Tsinghua Univ, Dept Environm Sci & Engn, Beijing 100084, Peoples R China; [Chen, Yanlei; Gong, Peng] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; [Liu, Yang] Univ Bern, Inst Ecol & Evolut, Bern, Switzerland; [Cao, Wuchun; Fang, Liqun] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China; [Feng, Limin] Beijing Normal Univ, Coll Life Sci, Minist Educ, Key Lab Biodivers Sci & Ecol Engn, Beijing 100875, Peoples R China; [Goodchild, Michael F.] Univ Calif Santa Barbara, Dept Geog, Santa Barbara, CA 93106 USA	Beijing Normal University; Chinese Academy of Sciences; Tsinghua University; Utah System of Higher Education; University of Utah; Tsinghua University; University of California System; University of California Berkeley; University of Bern; Beijing Institute of Microbiology & Epidemiology; Beijing Normal University; University of California System; University of California Santa Barbara	Liang, L (corresponding author), Beijing Normal Univ, Chinese Acad Sci, Inst Remote Sensing Applicat, State Key Lab Remote Sensing Sci, Beijing 100875, Peoples R China.	penggong@berkeley.edu	Liu, Yang/B-4877-2011; Xu, Bing/C-7732-2015; Gong, Peng/AAM-1516-2021; Feng, Limin/G-9539-2014; Fang, Li-Qun/GWD-0296-2022	Gong, Peng/0000-0003-1513-3765; Feng, Limin/0000-0001-9526-1681; liang, lu/0000-0002-9892-8346	National Natural Science Foundation of China [30590370]; National High Technology Research and Development Program of China [2009AA12200101]; National Basic Research Program of China [2010CB530304]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Basic Research Program of China(National Basic Research Program of China)	This research was partially supported by a major grant from the National Natural Science Foundation of China (Grant No 30590370), National High Technology Research and Development Program of China (Grant No 2009AA12200101), National Basic Research Program of China (Grant No 2010CB530304). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; *AN HLTH AUSTR, 2006, DIS STRAT AV INFL VE, P27; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; [Anonymous], GLOBAL LAND COVER FA; BAILEY TC, INTERACTIVE SPATIAL; Bunge J., J AM STAT ASSOC, V88, P364, DOI 10.2307/2290733; Butler D., 2006, SPREAD AVIAN FLU TIM; Chen H, 2004, P NATL ACAD SCI USA, V101, P10452, DOI 10.1073/pnas.0403212101; Chen H, 2006, P NATL ACAD SCI USA, V103, P2845, DOI 10.1073/pnas.0511120103; Duan L, 2008, VIROLOGY, V380, P243, DOI 10.1016/j.virol.2008.07.038; Feare CJ, 2007, AVIAN DIS, V51, P440, DOI 10.1637/7575-040106R1.1; FELSENSTEIN J, 2004, INFERRING PHYLOGENIE, V8, P85; Gaidet N, 2007, EMERG INFECT DIS, V13, P626, DOI 10.3201/eid1304.061011; Gatrell AC, 1996, T I BRIT GEOGR, V21, P256, DOI 10.2307/622936; GILBERT M, 2006, HPAI SPREAD W SIBERI; Gilbert M, 2008, P NATL ACAD SCI USA, V105, P4769, DOI 10.1073/pnas.0710581105; Gu X, 1997, MOL BIOL EVOL, V14, P1106, DOI 10.1093/oxfordjournals.molbev.a025720; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Henderson M, 2003, INT J REMOTE SENS, V24, P595, DOI 10.1080/01431160304982; Janies D, 2007, SYST BIOL, V56, P321, DOI 10.1080/10635150701266848; *JOINT RES CTR EUR, 2003, GLOB LAND COV 2000 D; Kilpatrick AM, 2006, P NATL ACAD SCI USA, V103, P19368, DOI 10.1073/pnas.0609227103; Kiselev OI, 2008, MOL BIOL+, V42, P70, DOI 10.1134/S002689330801010X; Kiss I, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-113; KULLDORFF M, 2005, SATSCAN V 703 SOFTWA; Le Gall-Recule G, 2008, AVIAN PATHOL, V37, P15, DOI 10.1080/03079450701774835; Li IWS, 2009, J CLIN VIROL, V46, P325, DOI 10.1016/j.jcv.2009.09.013; Li KS, 2004, NATURE, V430, P209, DOI 10.1038/nature02746; Liu N, 2005, J ENVIRON INFORM, V5, P1, DOI 10.3808/jei.200500040; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; RAMBAUT A, 2006, FIGTREE; Riede K., 2001, GLOBAL REGISTER MIGR; Salzberg SL, 2007, EMERG INFECT DIS, V13, P713, DOI 10.3201/eid1305.070013; Si YL, 2009, GEOSPATIAL HEALTH, V4, P65, DOI 10.4081/gh.2009.211; Smith GJD, 2006, P NATL ACAD SCI USA, V103, P16936, DOI 10.1073/pnas.0608157103; Sutton PC, 2003, REMOTE SENS ENVIRON, V86, P353, DOI 10.1016/S0034-4257(03)00078-6; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Vijaykrishna D, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000161; Waddell PJ, 1997, MOL PHYLOGENET EVOL, V8, P398, DOI 10.1006/mpev.1997.0452; Wang J, 2008, J Virol, V82, P3405, DOI 10.1128/JVI.02468-07; Weber S, 2007, J GEN VIROL, V88, P554, DOI 10.1099/vir.0.82300-0; WEBSTER RG, 1978, VIROLOGY, V84, P268, DOI 10.1016/0042-6822(78)90247-7; *WHO WORLD ORG AN, 2008, UN NOM SYST HIGHL PA; IMAGE DATA PROCESSIN; 2004, FAOAIDE NEWS, V6	49	67	75	4	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2010	5	10							e13575	10.1371/journal.pone.0013575	http://dx.doi.org/10.1371/journal.pone.0013575			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	670KA	21042591	gold, Green Submitted, Green Published			2022-12-27	WOS:000283419100015
J	Lodillinsky, C; Langle, Y; Guionet, A; Gongora, A; Baldi, A; Sandes, EO; Casabe, A; Eijan, AM				Lodillinsky, Catalina; Langle, Yanina; Guionet, Ariel; Gongora, Adrian; Baldi, Alberto; Sandes, Eduardo O.; Casabe, Alberto; Maria Eijan, Ana			Bacillus Calmette Guerin Induces Fibroblast Activation Both Directly and through Macrophages in a Mouse Bladder Cancer Model	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; GROWTH-FACTOR; MECHANISMS; EXPRESSION; CARCINOMA; APOPTOSIS; CELLS; ANGIOGENESIS; SURVEILLANCE; PROGRESSION	Background: Bacillus Calmette-Guerin (BCG) is the most effective treatment for non-muscle invasive bladder cancer. However, a failure in the initial response or relapse within the first five years of treatment has been observed in 20% of patients. We have previously observed that in vivo administration of an inhibitor of nitric oxide improved the response to BCG of bladder tumor bearing mice. It was described that this effect was due to a replacement of tumor tissue by collagen depots. The aim of the present work was to clarify the mechanism involved in this process. Methodology/Principal Findings: We demonstrated that BCG induces NIH-3T3 fibroblast proliferation by activating the MAPK and PI3K signaling pathways and also differentiation determined by alpha-smooth muscle actin (alpha-SMA) expression. In vivo, intratumoral inoculation of BCG also increased alpha-SMA and collagen expression. Oral administration of L-NAME enhanced the pro-fibrotic effect of BCG. Peritoneal macrophages obtained from MB49 tumor-bearing mice treated in vivo with combined treatment of BCG with L-NAME also enhanced fibroblast proliferation. We observed that FGF-2 is one of the factors released by BCG-activated macrophages that is able to induce fibroblast proliferation. The involvement of FGF-2 was evidenced using an anti-FGF2 antibody. At the same time, this macrophage population improved wound healing rate in normal mice and FGF-2 expression was also increased in these wounds. Conclusions/Significance: Our findings suggest that fibroblasts are targeted by BCG both directly and through activated macrophages in an immunotherapy context of a bladder murine model. We also described, for the first time, that FGF-2 is involved in a dialog between fibroblasts and macrophages induced after BCG treatment. The fact that L-NAME administration improves the BCG effect on fibroblasts, NO inhibition, might represent a new approach to add to the conventional BCG therapy.	[Lodillinsky, Catalina; Langle, Yanina; Guionet, Ariel; Sandes, Eduardo O.; Casabe, Alberto; Maria Eijan, Ana] Univ Buenos Aires, Inst Oncol Angel H Roffo, Res Area, Buenos Aires, DF, Argentina; [Gongora, Adrian; Baldi, Alberto] Natl Res Council Argentina CONICET, Inst Biol & Expt Med IBYME, Mol Pathol & Pharmacol Lab, Buenos Aires, DF, Argentina	University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Institute of Biology & Experimental Medicine	Lodillinsky, C (corresponding author), Univ Buenos Aires, Inst Oncol Angel H Roffo, Res Area, Buenos Aires, DF, Argentina.	anamariaeijan@gmail.com	EIJAN, ANA MARIA/AAC-8849-2022		Consejo Nacional de Investigaciones Cientificas y Tecnicas; Consejo Nacional de Investigaciones Cientificas y Tecnicas-PIP; Universidad de Buenos Aires [UBACYT M017]	Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Consejo Nacional de Investigaciones Cientificas y Tecnicas-PIP(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Universidad de Buenos Aires(University of Buenos Aires)	This study was supported by Consejo Nacional de Investigaciones Cientificas y Tecnicas (CL, YL, AB, AME), and grants from the Consejo Nacional de Investigaciones Cientificas y Tecnicas-PIP, and Universidad de Buenos Aires -UBACYT M017 (www.conicet.gov.ar.www.uba.ar). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allavena P, 2008, IMMUNOL REV, V222, P155, DOI 10.1111/j.1600-065X.2008.00607.x; Alvarez V, 2005, INT J MOL MED, V16, P565; Amadeu TP, 2006, J CUTAN PATHOL, V33, P465, DOI 10.1111/j.1600-0560.2006.00472.x; Aoi Y, 2008, J PHYSIOL PHARMACOL, V59, P315; Babaei S, 1998, CIRC RES, V82, P1007, DOI 10.1161/01.RES.82.9.1007; Babjuk M, 2008, EUR UROL, V54, P303, DOI 10.1016/j.eururo.2008.04.051; Barrientos S, 2008, WOUND REPAIR REGEN, V16, P585, DOI 10.1111/j.1524-475X.2008.00410.x; BROSMAN SA, 1982, J UROLOGY, V128, P27, DOI 10.1016/S0022-5347(17)52736-6; Chen Fanghong, 2005, BMC Urol, V5, P8, DOI 10.1186/1471-2490-5-8; Chen Mingliang, 2009, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V34, P705; Coleman AB, 2000, MOL PHARMACOL, V57, P324; Cristina C, 2007, AM J PHYSIOL-ENDOC M, V293, pE1341, DOI 10.1152/ajpendo.00260.2007; DVORAK HF, 1986, NEW ENGL J MED, V315, P1650; Friday BB, 2008, CLIN CANCER RES, V14, P342, DOI 10.1158/1078-0432.CCR-07-4790; Isenberg JS, 2004, MICROSURG, V24, P385, DOI 10.1002/micr.20051; Jiang BH, 2009, ADV CANCER RES, V102, P19, DOI 10.1016/S0065-230X(09)02002-8; Malavaud B, 2004, ONCOGENE, V23, P6769, DOI 10.1038/sj.onc.1207135; Mitropoulos D, 2005, NITRIC OXIDE-BIOL CH, V13, P36, DOI 10.1016/j.niox.2005.04.012; MORALES A, 1976, J UROLOGY, V116, P180, DOI 10.1016/S0022-5347(17)58737-6; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Murakami H, 2005, J ORTHOP SCI, V10, P84, DOI 10.1007/s00776-004-0858-4; Prescott S, 2000, CLIN INFECT DIS, V31, pS91, DOI 10.1086/314066; Riemensberger J, 2002, CLIN EXP IMMUNOL, V127, P20, DOI 10.1046/j.1365-2249.2002.01734.x; Saban MR, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-4; Sandes E, 2007, INT J MOL MED, V20, P823; Sandes EO, 2005, NITRIC OXIDE-BIOL CH, V12, P39, DOI 10.1016/j.niox.2004.11.003; Schafer M, 2008, NAT REV MOL CELL BIO, V9, P628, DOI 10.1038/nrm2455; Schultz GS, 2009, WOUND REPAIR REGEN, V17, P153, DOI 10.1111/j.1524-475X.2009.00466.x; Serini G, 1999, EXP CELL RES, V250, P273, DOI 10.1006/excr.1999.4543; SHELLEY MD, 2010, CANC TREAT REV; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; SKALLI O, 1986, J CELL BIOL, V103, P2787, DOI 10.1083/jcb.103.6.2787; Smaldone M C, 2009, Minerva Urol Nefrol, V61, P71; Strutz F, 2000, KIDNEY INT, V57, P1521, DOI 10.1046/j.1523-1755.2000.00997.x; Suttmann H, 2006, CANCER RES, V66, P8250, DOI 10.1158/0008-5472.CAN-06-1416; SYLVESTER RJ, 2009, EUR UROL; Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809; Turner N, 2010, NAT REV CANCER, V10, P116, DOI 10.1038/nrc2780; ZHANG S, 1995, ZHONGHUA JIE HE HE H, V18, P62; Zhang Shangming, 1995, Zhonghua Jiehe He Huxi Zazhi, V18, P26	40	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2010	5	10							e13571	10.1371/journal.pone.0013571	http://dx.doi.org/10.1371/journal.pone.0013571			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	670KA	21042580	Green Published, gold, Green Submitted			2022-12-27	WOS:000283419100011
J	Homaira, N; Rahman, M; Hossain, MJ; Nahar, N; Khan, R; Rahman, M; Podder, G; Nahar, K; Khan, D; Gurley, ES; Rollin, PE; Comer, JA; Ksiazek, TG; Luby, SP				Homaira, Nusrat; Rahman, Mahmudur; Hossain, M. Jahangir; Nahar, Nazmun; Khan, Rasheda; Rahman, Mostafizur; Podder, Goutam; Nahar, Kamrun; Khan, Dawlat; Gurley, Emily S.; Rollin, Pierre E.; Comer, James A.; Ksiazek, Thomas G.; Luby, Stephen P.			Cluster of Nipah Virus Infection, Kushtia District, Bangladesh, 2007	PLOS ONE			English	Article							TO-PERSON TRANSMISSION; OUTBREAK; ENCEPHALITIS	Objective: In March 2007, we investigated a cluster of Nipah encephalitis to identify risk factors for Nipah infection in Bangladesh. Methods: We defined confirmed Nipah cases by the presence of IgM and IgG antibodies against Nipah virus in serum. Case-patients, who resided in the same village during the outbreak period but died before serum could be collected, were classified as probable cases. Results: We identified three confirmed and five probable Nipah cases. There was a single index case. Five of the secondary cases came in close physical contact to the index case when she was ill. Case-patients were more likely to have physical contact with the index case (71% cases versus 0% controls, p = < 0.001). The index case, on her third day of illness, and all the subsequent cases attended the same religious gathering. For three probable cases including the index case, we could not identify any known risk factors for Nipah infection such as physical contact with Nipah case-patients, consumption of raw date palm juice, or contact with sick animals or fruit bats. Conclusion: Though person-to-person transmission remains an important mode of transmission for Nipah infection, we could not confirm the source of infection for three of the probable Nipah case-patients. Continued surveillance and outbreak investigations will help better understand the transmission of Nipah virus and develop preventive strategies.	[Homaira, Nusrat; Hossain, M. Jahangir; Nahar, Nazmun; Khan, Rasheda; Podder, Goutam; Nahar, Kamrun; Khan, Dawlat; Gurley, Emily S.; Luby, Stephen P.] Int Ctr Diarrhoeal Dis Res, Bangladesh ICDDRB, Dhaka 1000, Bangladesh; [Homaira, Nusrat; Rahman, Mahmudur; Rahman, Mostafizur] Inst Epidemiol Dis Control & Res, Dhaka, Bangladesh; [Rollin, Pierre E.; Comer, James A.; Ksiazek, Thomas G.; Luby, Stephen P.] Ctr Dis Control & Prevent, Special Pathogens Branch, Atlanta, GA USA	International Centre for Diarrhoeal Disease Research (ICDDR); Centers for Disease Control & Prevention - USA	Homaira, N (corresponding author), Int Ctr Diarrhoeal Dis Res, Bangladesh ICDDRB, GPO Box 128, Dhaka 1000, Bangladesh.	nhomaira@icddrb.org	Gurley, Emily S/B-7903-2010; Homaira, Nusrat/U-4526-2019	Gurley, Emily S/0000-0002-8648-9403; Homaira, Nusrat/0000-0003-3341-7964; Rollin, Pierre/0000-0002-4608-2641; Nahar, Nazmun/0000-0002-4530-6009	Centers for Disease Control and Prevention (CDC), Atlanta; U.S. National Institutes of Health, International Collaborations in Infectious Disease Research (ICIDR) Opportunity Pool; Government of Bangladesh (GoB) through IHP-HNPRP	Centers for Disease Control and Prevention (CDC), Atlanta(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); U.S. National Institutes of Health, International Collaborations in Infectious Disease Research (ICIDR) Opportunity Pool(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Government of Bangladesh (GoB) through IHP-HNPRP	This work was funded by the Centers for Disease Control and Prevention (CDC), Atlanta, the U.S. National Institutes of Health, International Collaborations in Infectious Disease Research (ICIDR) Opportunity Pool and the Government of Bangladesh (GoB) through IHP-HNPRP. Pierre E. Rollin, James A. Comer and Thomas G. Ksiazek from CDC and Mahmudur Rahman and Mostafizur Rahman from Government of Bangladesh (the two funding organizations) are also co-authors of this manuscript and were involved in study design and preparation of the manuscript.	Blum LS, 2009, AM J TROP MED HYG, V80, P96, DOI 10.4269/ajtmh.2009.80.96; Chua KB, 2003, J CLIN VIROL, V26, P265, DOI 10.1016/S1386-6532(02)00268-8; Chua KB, 2001, J INFECTION, V42, P40, DOI 10.1053/jinf.2000.0782; Daniels P, 2001, MICROBES INFECT, V3, P289, DOI 10.1016/S1286-4579(01)01382-X; Gurley ES, 2007, EMERG INFECT DIS, V13, P1031, DOI 10.3201/eid1307.061128; Harcourt BH, 2005, EMERG INFECT DIS, V11, P1594, DOI 10.3201/eid1110.050513; Harit AK, 2006, INDIAN J MED RES, V123, P553; Homaira N, 2010, EPIDEMIOL INFECT, V138, P1630, DOI 10.1017/S0950268810000695; Hossain MJ, 2008, CLIN INFECT DIS, V46, P977, DOI 10.1086/529147; LUBY SP, 2009, EMERGING INFECT DIS, V15; Luby SP, 2006, EMERG INFECT DIS, V12, P1888; Luby SP, 2009, CLIN INFECT DIS, V49, P1743, DOI 10.1086/647951; Montgomery JM, 2008, EMERG INFECT DIS, V14, P1526, DOI 10.3201/eid1410.060507	13	22	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2010	5	10							e13570	10.1371/journal.pone.0013570	http://dx.doi.org/10.1371/journal.pone.0013570			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	668TQ	21042407	Green Published, gold			2022-12-27	WOS:000283293800027
J	Domingo, P; Torres-Torronteras, J; Pomar, V; Giralt, M; Domingo, JC; Gutierrez, MD; Gallego-Escuredo, JM; Mateo, MG; Cano-Soldado, P; Fernandez, I; Pastor-Anglada, M; Vidal, F; Villarroya, F; Andreu, A; Marti, R				Domingo, Pere; Torres-Torronteras, Javier; Pomar, Virginia; Giralt, Marta; Carles Domingo, Joan; del Mar Gutierrez, Maria; Gallego-Escuredo, Jose M.; Gracia Mateo, Maria; Cano-Soldado, Pedro; Fernandez, Irene; Pastor-Anglada, Marcal; Vidal, Francesc; Villarroya, Francesc; Andreu, Antoni; Marti, Ramon			Uridine Metabolism in HIV-1-Infected Patients: Effect of Infection, of Antiretroviral Therapy and of HIV-1/ART-Associated Lipodystrophy Syndrome	PLOS ONE			English	Article							MITOCHONDRIAL-DNA; TOXICITY; RAT; SUPPLEMENTATION; PHOSPHORYLASE; LIPOATROPHY; INHIBITOR; STAVUDINE; DEPLETION; DISEASE	Background: Uridine has been advocated for the treatment of HIV-1/HAART-associated lipodystrophy (HALS), although its metabolism in HIV-1-infected patients is poorly understood. Methods: Plasma uridine concentrations were measured in 35 controls and 221 HIV-1-infected patients and fat uridine in 15 controls and 19 patients. The diagnosis of HALS was performed following the criteria of the Lipodystrophy Severity Grading Scale. Uridine was measured by a binary gradient-elution HPLC method. Analysis of genes encoding uridine metabolizing enzymes in fat was performed with TaqMan RT-PCR. Results: Median plasma uridine concentrations for HIV-1-infected patients were 3.80 mmol/l (interquartile range: 1.60), and for controls 4.60 mmol/l (IQR: 1.8) (P = 0.0009). In fat, they were of 6.0 (3.67), and 2.8 (4.65) nmol/mg of protein, respectively (P = 0.0118). Patients with a mixed HALS form had a median plasma uridine level of 4.0 (IC95%: 3.40-4.80) whereas in those with isolated lipoatrophy it was 3.25 (2.55-4.15) mmol/l/l (P = 0.0066). The expression of uridine cytidine kinase and uridine phosphorylase genes was significantly decreased in all groups of patients with respect to controls. A higher expression of the mRNAs for concentrative nucleoside transporters was found in HIV-1-infected patients with respect to healthy controls. Conclusions: HIV-1 infection is associated with a decrease in plasma uridine and a shift of uridine to the adipose tissue compartment. Antiretroviral therapy was not associated with plasma uridine concentrations, but pure lipoatrophic HALS was associated with significantly lower plasma uridine concentrations.	[Domingo, Pere; Pomar, Virginia; del Mar Gutierrez, Maria; Gracia Mateo, Maria; Fernandez, Irene] Hosp Santa Crue & St Pau, Infect Dis Unit, Barcelona, Spain; [Torres-Torronteras, Javier; Andreu, Antoni; Marti, Ramon] Inst Recerca Hosp Vall dHebron, Lab Mitochondrial Disorders, Barcelona, Spain; [Torres-Torronteras, Javier; Andreu, Antoni; Marti, Ramon] CIBERER, Barcelona, Spain; [Giralt, Marta; Carles Domingo, Joan; Gallego-Escuredo, Jose M.; Cano-Soldado, Pedro; Pastor-Anglada, Marcal; Villarroya, Francesc] Univ Barcelona, Dept Bioquim & Biol Mol, Barcelona, Spain; [Giralt, Marta; Carles Domingo, Joan; Gallego-Escuredo, Jose M.; Cano-Soldado, Pedro; Pastor-Anglada, Marcal; Villarroya, Francesc] Univ Barcelona, Inst Biomed, Barcelona, Spain; [Vidal, Francesc] Hosp Univ Joan XXIII, Infect Dis Unit, Tarragona, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERER; University of Barcelona; University of Barcelona	Domingo, P (corresponding author), Hosp Santa Crue & St Pau, Infect Dis Unit, Barcelona, Spain.	pdomingo@santpau.cat	Domingo, Pere/CAF-3577-2022; Domingo, Pere/AAP-7571-2021; Villarroya, Francesc/K-4357-2014; Torres-Torronteras, Javier/K-4974-2014; Pedrol, Joan Carles C Domingo/A-4856-2019; Martí, Ramon/Q-3442-2016; Giralt, Marta/A-4756-2013	Domingo, Pere/0000-0003-1138-5770; Torres-Torronteras, Javier/0000-0002-6092-9458; Pedrol, Joan Carles C Domingo/0000-0002-6356-0836; Martí, Ramon/0000-0002-8273-9540; Giralt, Marta/0000-0001-7968-4190; ANDREU, antonio luis/0000-0002-3936-3234; Villarroya, Francesc/0000-0003-1266-9142; GALLEGO-ESCUREDO, JOSE MIGUEL/0000-0001-7899-8585; Vidal, Francesc/0000-0002-6692-6186	Fondo de Investigaciones Sanitarias (FIS) [02/1280, 05/1591, 07/0976, EC08/00256]; Fundacion para la Prevencion del SIDA en Espana (FIPSE) [36610, 36572/06, 36621/06]; Ministerio de Ciencia e Innovacion [SAF2008-00577]; Red de Investigacion en SIDA (RIS) [RD06/006/0022, RD06/0006/1004]	Fondo de Investigaciones Sanitarias (FIS)(Instituto de Salud Carlos III); Fundacion para la Prevencion del SIDA en Espana (FIPSE); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Red de Investigacion en SIDA (RIS)	This work was partially funded by the Fondo de Investigaciones Sanitarias (FIS 02/1280, 05/1591, 07/0976, EC08/00256), the Fundacion para la Prevencion del SIDA en Espana (FIPSE 36610, 36572/06, 36621/06), Ministerio de Ciencia e Innovacion (SAF2008-00577), and the Red de Investigacion en SIDA (RIS RD06/006/0022, RD06/0006/1004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUSSEDAT J, 1983, CARDIOVASC RES, V17, P145, DOI 10.1093/cvr/17.3.145; BENZI G, 1984, J NEUROSCI RES, V11, P437, DOI 10.1002/jnr.490110410; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Calzolari I, 2009, CURR PHARM DESIGN, V15, P4094, DOI 10.2174/138161209789909755; CDC, 1993, MMWR-MORBID MORTAL W, V41, P1; Connolly GP, 1999, TRENDS PHARMACOL SCI, V20, P218, DOI 10.1016/S0165-6147(99)01298-5; Cote HCF, 2002, NEW ENGL J MED, V346, P811, DOI 10.1056/NEJMoa012035; Domingo P, 2010, CLIN INFECT DIS, V50, P1033, DOI 10.1086/651117; GALLAI V, 1992, ACTA NEUROL SCAND, V86, P3, DOI 10.1111/j.1600-0404.1992.tb08045.x; GASSER T, 1981, SCIENCE, V213, P777, DOI 10.1126/science.7256279; GEIGER A, 1956, J NEUROCHEM, V1, P93, DOI 10.1111/j.1471-4159.1956.tb12059.x; Giralt M, 2006, ANTIVIR THER, V11, P729; Guggr JP, 2007, ANTIVIR THER, V12, P853; LANGMANN P, 2008, AIDS 2008 17 INT AID; LEPAGE G, 1986, J LIPID RES, V27, P114; LEWIS W, 1995, NAT MED, V1, P417, DOI 10.1038/nm0595-417; Loffler M, 2005, TRENDS MOL MED, V11, P430, DOI 10.1016/j.molmed.2005.07.003; Maagaard A, 2006, HIV MED, V7, P53, DOI 10.1111/j.1468-1293.2005.00336.x; McComsey G, 2010, 17 C RETR OPP INF SA; McComsey GA, 2010, AIDS, V24, P2503, DOI 10.1097/QAD.0b013e32833ea9bc; Moreno-Torres A, 2007, ANTIVIR THER, V12, P195; Mouton JW, 2008, J ANTIMICROB CHEMOTH, V61, P235, DOI 10.1093/jac/dkm476; MOYER JD, 1981, CANCER RES, V41, P3010; Pastor-Anglada M, 2004, LEUKEMIA, V18, P385, DOI 10.1038/sj.leu.2403271; Pizzorno G, 1998, CLIN CANCER RES, V4, P1165; Pizzorno G, 2002, BBA-MOL BASIS DIS, V1587, P133, DOI 10.1016/S0925-4439(02)00076-5; Setzer B, 2008, AM J PATHOL, V172, P681, DOI 10.2353/ajpath.2008.070613; Simmonds HA, 1995, BIOCHEM SOC T, V23, P877, DOI 10.1042/bst0230877; Sutinen J, 2007, ANTIVIR THER, V12, P97; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361; VANGROENINGEN CJ, 1986, CANCER TREAT REP, V70, P745; Walker UA, 2006, ANTIVIR THER, V11, P25	32	10	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2010	5	11							e13896	10.1371/journal.pone.0013896	http://dx.doi.org/10.1371/journal.pone.0013896			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	680KW	21085568	gold, Green Submitted, Green Published			2022-12-27	WOS:000284231800001
J	Jones, L; Holmans, PA; Hamshere, ML; Harold, D; Moskvina, V; Ivanov, D; Pocklington, A; Abraham, R; Hollingworth, P; Sims, R; Gerrish, A; Pahwa, JS; Jones, N; Stretton, A; Morgan, AR; Lovestone, S; Powell, J; Proitsi, P; Lupton, MK; Brayne, C; Rubinsztein, DC; Gill, M; Lawlor, B; Lynch, A; Morgan, K; Brown, KS; Passmore, PA; Craig, D; McGuinness, B; Todd, S; Holmes, C; Mann, D; Smith, AD; Love, S; Kehoe, PG; Mead, S; Fox, N; Rossor, M; Collinge, J; Maier, W; Jessen, F; Schurmann, B; van den Bussche, H; Heuser, I; Peters, O; Kornhuber, J; Wiltfang, J; Dichgans, M; Frolich, L; Hampel, H; Hull, M; Rujescu, D; Goate, AM; Kauwe, JSK; Cruchaga, C; Nowotny, P; Morris, JC; Mayo, K; Livingston, G; Bass, NJ; Gurling, H; McQuillin, A; Gwilliam, R; Deloukas, P; Al-Chalabi, A; Shaw, CE; Singleton, AB; Guerreiro, R; Muhleisen, TW; Nothen, MM; Moebus, S; Jockel, KH; Klopp, N; Wichmann, HE; Ruther, E; Carrasquillo, MM; Pankratz, VS; Younkin, SG; Hardy, J; O'Donovan, MC; Owen, MJ; Williams, J				Jones, Lesley; Holmans, Peter A.; Hamshere, Marian L.; Harold, Denise; Moskvina, Valentina; Ivanov, Dobril; Pocklington, Andrew; Abraham, Richard; Hollingworth, Paul; Sims, Rebecca; Gerrish, Amy; Pahwa, Jaspreet Singh; Jones, Nicola; Stretton, Alexandra; Morgan, Angharad R.; Lovestone, Simon; Powell, John; Proitsi, Petroula; Lupton, Michelle K.; Brayne, Carol; Rubinsztein, David C.; Gill, Michael; Lawlor, Brian; Lynch, Aoibhinn; Morgan, Kevin; Brown, Kristelle S.; Passmore, Peter A.; Craig, David; McGuinness, Bernadette; Todd, Stephen; Holmes, Clive; Mann, David; Smith, A. David; Love, Seth; Kehoe, Patrick G.; Mead, Simon; Fox, Nick; Rossor, Martin; Collinge, John; Maier, Wolfgang; Jessen, Frank; Schuermann, Britta; van den Bussche, Hendrik; Heuser, Isabella; Peters, Oliver; Kornhuber, Johannes; Wiltfang, Jens; Dichgans, Martin; Froelich, Lutz; Hampel, Harald; Huell, Michael; Rujescu, Dan; Goate, Alison M.; Kauwe, John S. K.; Cruchaga, Carlos; Nowotny, Petra; Morris, John C.; Mayo, Kevin; Livingston, Gill; Bass, Nicholas J.; Gurling, Hugh; McQuillin, Andrew; Gwilliam, Rhian; Deloukas, Panos; Al-Chalabi, Ammar; Shaw, Christopher E.; Singleton, Andrew B.; Guerreiro, Rita; Muehleisen, Thomas W.; Noethen, Markus M.; Moebus, Susanne; Joeckel, Karl-Heinz; Klopp, Norman; Wichmann, H. -Erich; Ruether, Eckhard; Carrasquillo, Minerva M.; Pankratz, V. Shane; Younkin, Steven G.; Hardy, John; O'Donovan, Michael C.; Owen, Michael J.; Williams, Julie			Genetic Evidence Implicates the Immune System and Cholesterol Metabolism in the Aetiology of Alzheimer's Disease	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; IDENTIFIES VARIANTS; APOLIPOPROTEIN-E; DEMENTIA; RISK; INFLAMMATION; POPULATION; MICROGLIA; PATHWAYS; DATABASE	Background: Late Onset Alzheimer's disease (LOAD) is the leading cause of dementia. Recent large genome-wide association studies (GWAS) identified the first strongly supported LOAD susceptibility genes since the discovery of the involvement of APOE in the early 1990s. We have now exploited these GWAS datasets to uncover key LOAD pathophysiological processes. Methodology: We applied a recently developed tool for mining GWAS data for biologically meaningful information to a LOAD GWAS dataset. The principal findings were then tested in an independent GWAS dataset. Principal Findings: We found a significant overrepresentation of association signals in pathways related to cholesterol metabolism and the immune response in both of the two largest genome-wide association studies for LOAD. Significance: Processes related to cholesterol metabolism and the innate immune response have previously been implicated by pathological and epidemiological studies of Alzheimer's disease, but it has been unclear whether those findings reflected primary aetiological events or consequences of the disease process. Our independent evidence from two large studies now demonstrates that these processes are aetiologically relevant, and suggests that they may be suitable targets for novel and existing therapeutic approaches.	[Jones, Lesley; Holmans, Peter A.; Hamshere, Marian L.; Harold, Denise; Moskvina, Valentina; Ivanov, Dobril; Pocklington, Andrew; Abraham, Richard; Hollingworth, Paul; Sims, Rebecca; Gerrish, Amy; Pahwa, Jaspreet Singh; Jones, Nicola; Stretton, Alexandra; Morgan, Angharad R.; O'Donovan, Michael C.; Owen, Michael J.; Williams, Julie] Cardiff Univ, Sch Med, Dept Psychol Med & Neurol, Ctr Neuropsychiat Genet & Genom,MRC, Cardiff, S Glam, Wales; [Lovestone, Simon] Kings Coll London, S London & Maudsley Natl Hlth Serv Fdn Trust, Natl Inst Hlth Res, Biomed Res Ctr Mental Hlth, London WC2R 2LS, England; [Powell, John; Proitsi, Petroula; Lupton, Michelle K.] Kings Coll London, Inst Psychiat, Dept Neurosci, London WC2R 2LS, England; [Brayne, Carol] Univ Cambridge, Inst Publ Hlth, Cambridge, England; [Rubinsztein, David C.] Univ Cambridge, Cambridge Inst Med Res, Cambridge, England; [Gill, Michael; Lawlor, Brian; Lynch, Aoibhinn] St James Hosp, Mercers Inst Res Aging, Dublin 8, Ireland; [Gill, Michael; Lawlor, Brian; Lynch, Aoibhinn] Trinity Coll Dublin, Dublin, Ireland; [Morgan, Kevin; Brown, Kristelle S.] Univ Nottingham, Queens Med Ctr, Inst Genet, Nottingham NG7 2RD, England; [Passmore, Peter A.; Craig, David; McGuinness, Bernadette; Todd, Stephen] Queens Univ Belfast, Ageing Grp, Ctr Publ Hlth, Sch Med Dent & Biomed Sci, Belfast, Antrim, North Ireland; [Holmes, Clive] Univ Southampton, Sch Med, Div Clin Neurosci, Southampton, Hants, England; [Mann, David] Univ Manchester, Greater Manchester Neurosci Ctr, Clin Neurosci Res Grp, Salford, Lancs, England; [Smith, A. David] Univ Oxford, John Radcliffe Hosp, Oxford Project Invest Memory & Ageing, Oxford OX3 9DU, England; [Love, Seth; Kehoe, Patrick G.] Univ Bristol, Frenchay Hosp, Inst Clin Neurosci, Dementia Res Grp, Bristol, Avon, England; [Mead, Simon; Collinge, John] UCL Inst Neurol, Dept Neurodegenerat Dis, MRC Prion Unit, London, England; [Fox, Nick; Rossor, Martin] UCL Inst Neurol, Dept Neurodegenerat Dis, Dementia Res Ctr, London, England; [Maier, Wolfgang; Jessen, Frank; Schuermann, Britta] Univ Bonn, Dept Psychiat, D-5300 Bonn, Germany; [van den Bussche, Hendrik; Heuser, Isabella; Peters, Oliver] Univ Med Ctr Hamburg Eppendorf, Inst Primary Med Care, Hamburg, Germany; [Kornhuber, Johannes] Univ Erlangen Nurnberg, Dept Psychiat & Psychotherapy, Erlangen, Germany; [Wiltfang, Jens] Univ Duisburg Essen, Dept Psychiat & Psychotherapy, Landschaftsverband Rheinland Hosp Essen, Essen, Germany; [Dichgans, Martin] Klinikum Univ Munchen, Inst Stroke & Dementia Res, Munich, Germany; [Dichgans, Martin] Klinikum Univ Munchen, Dept Neurol, Munich, Germany; [Froelich, Lutz] Heidelberg Univ, Med Fac Mannheim, Cent Inst Mental Hlth, Dept Geriatr Psychiat, D-6800 Mannheim, Germany; [Hampel, Harald] Univ Dublin Trinity Coll, Sch Med, Discipline Psychiat, Dublin 2, Ireland; [Hampel, Harald] Univ Dublin Trinity Coll, Trinity Coll Inst Neurosci, Lab Neuroimaging & Biomarker Res, Dublin 2, Ireland; [Hampel, Harald; Rujescu, Dan] Univ Munich, Alzheimer Mem Ctr, Munich, Germany; [Hampel, Harald; Rujescu, Dan] Univ Munich, Dept Psychiat, Geriatr Psychiat Branch, D-8000 Munich, Germany; [Huell, Michael] Univ Freiburg, Sch Med, Ctr Geriatr Med, Freiburg, Germany; [Huell, Michael] Univ Freiburg, Sch Med, Sect Gerontopsychiat & Neuropsychol, Freiburg, Germany; [Goate, Alison M.; Cruchaga, Carlos; Nowotny, Petra; Morris, John C.; Mayo, Kevin] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; [Goate, Alison M.; Cruchaga, Carlos; Nowotny, Petra; Morris, John C.; Mayo, Kevin] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Goate, Alison M.; Cruchaga, Carlos; Nowotny, Petra; Morris, John C.; Mayo, Kevin] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; [Kauwe, John S. K.] Brigham Young Univ, Dept Biol, Provo, UT 84602 USA; [Livingston, Gill; Bass, Nicholas J.; Gurling, Hugh; McQuillin, Andrew] UCL, Dept Mental Hlth Sci, London, England; [Gwilliam, Rhian; Deloukas, Panos] Wellcome Trust Sanger Inst, Hinxton, England; [Al-Chalabi, Ammar; Shaw, Christopher E.] Kings Coll London, Inst Psychiat, Dept Clin Neurosci, MRC Ctr Neurodegenerat Res, London WC2R 2LS, England; [Singleton, Andrew B.; Guerreiro, Rita] NIA, Neurogenet Lab, NIH, Bethesda, MD 20892 USA; [Muehleisen, Thomas W.; Noethen, Markus M.] Univ Bonn, Life & Brain Ctr, Dept Genom, D-5300 Bonn, Germany; [Muehleisen, Thomas W.; Noethen, Markus M.] Univ Bonn, Inst Human Genet, D-5300 Bonn, Germany; [Moebus, Susanne] Univ Duisburg Essen, Univ Hosp Essen, Inst Med Informat Biometry & Epidemiol, Essen, Germany; [Klopp, Norman; Wichmann, H. -Erich] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Epidemiol, Neuherberg, Germany; [Wichmann, H. -Erich] Univ Munich, Inst Med Informat Biometry & Epidemiol, Munich, Germany; [Ruether, Eckhard] Univ Gottingen, Dept Psychiat, Gottingen, Germany; [Wichmann, H. -Erich] Univ Munich, Klinikum Grosshadern, D-8000 Munich, Germany; [Carrasquillo, Minerva M.; Younkin, Steven G.] Mayo Clin, Coll Med, Dept Neurosci, Jacksonville, FL 32224 USA; [Pankratz, V. Shane] Mayo Clin & Mayo Fdn, Div Biomed Stat & Informat, Rochester, MN 55905 USA; [Hardy, John] Inst Neurol, Dept Mol Neurosci, London WC1N 3BG, England; [Hardy, John] Inst Neurol, Reta Lilla Weston Labs, London WC1N 3BG, England	Cardiff University; South London & Maudsley NHS Trust; University of London; King's College London; University of London; King's College London; University of Cambridge; University of Cambridge; Trinity College Dublin; Trinity College Dublin; University of Nottingham; Queens University Belfast; University of Southampton; University of Manchester; University of Oxford; University of Bristol; University of London; University College London; University of London; University College London; University of Bonn; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Erlangen Nuremberg; University of Duisburg Essen; University of Munich; University of Munich; Central Institute of Mental Health; Ruprecht Karls University Heidelberg; Trinity College Dublin; Trinity College Dublin; University of Munich; University of Munich; University of Freiburg; University of Freiburg; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Brigham Young University; University of London; University College London; Wellcome Trust Sanger Institute; University of London; King's College London; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Bonn; University of Bonn; University of Duisburg Essen; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; University of Gottingen; University of Munich; Mayo Clinic; Mayo Clinic; University of London; University College London; University of London; University College London	Jones, L (corresponding author), Cardiff Univ, Sch Med, Dept Psychol Med & Neurol, Ctr Neuropsychiat Genet & Genom,MRC, Cardiff, S Glam, Wales.	owenmj@cf.ac.uk; williamsj@cf.ac.uk	Cruchaga, Carlos/ABF-4065-2020; Todd, Stephen/AAF-6729-2020; McQuillin, Andrew/C-1623-2008; Smith, Anthony D./A-4233-2010; Livingston, G/C-7081-2008; Brayne, Carol/AAA-4285-2020; McGuinness, Bernadette/AAH-2755-2021; Kauwe, John/B-2034-2009; Deloukas, Panos/B-2922-2013; Morris, John C/A-1686-2012; Dichgans, Martin/HCH-3247-2022; Rujescu, Dan/GRS-3875-2022; Wichmann, Heinz Erich/AAA-5695-2022; Fox, Nick C/AAE-1849-2021; Fox, Nick C/B-1319-2009; Al-Chalabi, Ammar/E-5361-2010; Guerreiro, Rita J L/A-1327-2011; O'Donovan, Michael C/P-7005-2018; , beccie/AAM-3770-2021; Love, Seth/E-6545-2012; Mead, Simon/E-9414-2011; Kauwe, John/AAC-6646-2021; Hardy, John/C-2451-2009; Gurling, Hugh M/A-5029-2010; Cruz e Silva, Odete/AAH-5595-2020; Hüll, Michael/F-2618-2012; Rossor, Martin/C-1598-2008; Singleton, Andrew B/C-3010-2009; Jessen, Frank/AAK-6170-2020; Jessen, Frank/E-7655-2012; Rubinsztein, David C/C-3472-2011; Holmans, Peter/F-4518-2015; Kornhuber, Johannes/B-9613-2014; Powell, John F/G-4412-2011; Frölich, Lutz/AAA-6940-2019; Kehoe, Patrick/P-8760-2018	Cruchaga, Carlos/0000-0002-0276-2899; McQuillin, Andrew/0000-0003-1567-2240; Smith, Anthony D./0000-0002-1095-6722; Brayne, Carol/0000-0001-5307-663X; McGuinness, Bernadette/0000-0002-7028-5633; Kauwe, John/0000-0001-8641-2468; Deloukas, Panos/0000-0001-9251-070X; Dichgans, Martin/0000-0002-0654-387X; Fox, Nick C/0000-0002-6660-657X; Fox, Nick C/0000-0002-6660-657X; Al-Chalabi, Ammar/0000-0002-4924-7712; O'Donovan, Michael C/0000-0001-7073-2379; , beccie/0000-0002-3885-1199; Mead, Simon/0000-0002-4326-1468; Kauwe, John/0000-0001-8641-2468; Hardy, John/0000-0002-3122-0423; Holmans, Peter/0000-0003-0870-9412; Kornhuber, Johannes/0000-0002-8096-3987; Powell, John F/0000-0001-6124-439X; Frölich, Lutz/0000-0003-1494-0813; Goate, Alison/0000-0002-0576-2472; Proitsi, Petroula/0000-0002-2553-6974; Harold, Denise/0000-0001-5195-0143; Hampel, Harald/0000-0003-0894-8982; Love, Seth/0000-0001-8683-3625; Williams, Julie/0000-0002-4069-0259; Escott-Price, Valentina/0000-0003-1784-5483; Kehoe, Patrick/0000-0002-7542-1139; Lovestone, Simon/0000-0003-0473-4565; Denning, Nicola/0000-0001-8467-7382; Lupton, Michelle/0000-0002-7274-7299; Rossor, Martin/0000-0001-8215-3120; Gill, Michael/0000-0003-0206-5337; Guerreiro, Rita/0000-0001-5879-3486; Pocklington, Andrew/0000-0002-2137-0452; Moebus, Susanne/0000-0002-0072-5410; Todd, Stephen/0000-0002-2312-9195; Peters, Oliver/0000-0003-0568-2998; Livingston, Gill/0000-0001-6741-5516; Nothen, Markus/0000-0002-8770-2464; Ivanov, Dobril/0000-0001-6271-6301; Wiltfang, Jens/0000-0003-1492-5330; Shaw, Christopher/0000-0003-0251-0146; Morgan, Kevin/0000-0002-8217-2396	Wellcome Trust; Medical Research Council (MRC, UK); Alzheimer's Research Trust (ART); Welsh Assembly Government; Alzheimer's Society; Ulster Garden Villages; Northern Ireland Research and Development Office; Royal College of Physicians-Dunhill Medical Trust; Trinity College group; Bristol Research into Alzheimer's and Care of the Elderly; Oxford Project to Investigate Memory and Ageing (OPTIMA) group; Motor Neurone Disease Association; MRC; US National Institutes of Health (NIH); Barnes Jewish Foundation; Charles and Joanne Knight Alzheimer's Research Initiative; NIH; Robert and Clarice Smith and Abigail Van Buren AD Research Program; UCL Hospital/UCL Biomedical Centre; Helmholtz Zentrum Munchen; German Research Center for Environmental Health; BMBF; German National Genome Research Network; Munich Center of Health Sciences; National Institute on Aging (NIA); NIA, NIH, Department of Health and Human Services [Z01 AG000950-06]; University of Antwerp; Fund for Scientific Research-Flanders; Belgian Federal Science Policy Office [P6/43]; Alzheimers Research UK [ART-BIG2009-1, ART-PG2010-1, ART-RF2007-3, ART-NCG2008A-1] Funding Source: researchfish; Medical Research Council [G0300429, G0600974, G0701075, G0801418, G0801418B, MC_U123192748, MC_U123160651, G0601846, G0900688] Funding Source: researchfish; MRC [MC_U123192748, G0701075, G0801418, MC_U123160651, G0300429, G0601846, G0900688, G0600974] Funding Source: UKRI; NATIONAL INSTITUTE ON AGING [ZIAAG000950, Z01AG000950] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome Trust); Medical Research Council (MRC, UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Alzheimer's Research Trust (ART); Welsh Assembly Government; Alzheimer's Society; Ulster Garden Villages; Northern Ireland Research and Development Office; Royal College of Physicians-Dunhill Medical Trust(Dunhill Medical Trust); Trinity College group; Bristol Research into Alzheimer's and Care of the Elderly; Oxford Project to Investigate Memory and Ageing (OPTIMA) group; Motor Neurone Disease Association; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Barnes Jewish Foundation; Charles and Joanne Knight Alzheimer's Research Initiative; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert and Clarice Smith and Abigail Van Buren AD Research Program; UCL Hospital/UCL Biomedical Centre; Helmholtz Zentrum Munchen(Helmholtz Association); German Research Center for Environmental Health; BMBF(Federal Ministry of Education & Research (BMBF)); German National Genome Research Network; Munich Center of Health Sciences; National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA, NIH, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); University of Antwerp; Fund for Scientific Research-Flanders(FWO); Belgian Federal Science Policy Office(Belgian Federal Science Policy Office); Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Cardiff University was supported by the Wellcome Trust, Medical Research Council (MRC, UK), Alzheimer's Research Trust (ART) and the Welsh Assembly Government. ART supported sample collections at the Institute of Psychiatry, the South West Dementia Bank and the Universities of Cambridge, Nottingham, Manchester and Belfast. The Belfast group acknowledges support from the Alzheimer's Society, Ulster Garden Villages, Northern Ireland Research and Development Office and the Royal College of Physicians-Dunhill Medical Trust. The MRC and Mercer's Institute for Research on Ageing supported the Trinity College group. The South West Dementia Brain Bank acknowledges support from Bristol Research into Alzheimer's and Care of the Elderly. The Charles Wolfson Charitable Trust supported the Oxford Project to Investigate Memory and Ageing (OPTIMA) group. A. A-C. and C. E. S. thank the Motor Neurone Disease Association and MRC for support. D. C. R. is a Wellcome Trust Senior Clinical Research Fellow. Washington University was funded by US National Institutes of Health (NIH) grants, the Barnes Jewish Foundation and the Charles and Joanne Knight Alzheimer's Research Initiative. The Mayo GWAS was supported by NIH grants, the Robert and Clarice Smith and Abigail Van Buren AD Research Program, and the Palumbo Professorship in AD Research. Patient recruitment for the MRC Prion Unit/University College London Department of Neurodegenerative Disease collection was supported by the UCL Hospital/UCL Biomedical Centre. London and the South East Region (LASER)-AD was funded by Lundbeck. The Bonn group was supported by the German Federal Ministry of Education and Research (BMBF), Competence Network Dementia and Competence Network Degenerative Dementia, and by the Alfried Krupp von Bohlen und Halbach-Stiftung. The Kooperative gesundheitsforschung in der region Augsburg (KORA) F4 studies were financed by Helmholtz Zentrum Munchen, the German Research Center for Environmental Health, BMBF, the German National Genome Research Network and the Munich Center of Health Sciences. The Heinz Nixdorf Recall cohort was funded by the Heinz Nixdorf Foundation (G. Schmidt, chairman) and BMBF. Coriell Cell Repositories is supported by the US National Institute of Neurological Disorders and Stroke and the Intramural Research Program (IRP) of the National Institute on Aging (NIA). Work on this sample was supported in part by the IRP of the NIA, NIH, Department of Health and Human Services; Z01 AG000950-06. The authors acknowledge use of DNA from the 1958 Birth Cohort collection, funded by the MRC and the Wellcome Trust, which was genotyped by the Wellcome Trust Case Control Consortium and the Type-1 Diabetes Genetics Consortium, sponsored by the US National Institute of Diabetes and Digestive and Kidney Diseases, National Institute of Allergy and Infectious Diseases, National Human Genome Research Institute, National Institute of Child Health and Human Development and Juvenile Diabetes Research Foundation International. The Antwerp site was supported by the VIB Genetic Service Facility, the Biobank of the Institute Born-Bunge, the Special Research Fund of the University of Antwerp, the Fund for Scientific Research-Flanders, the Foundation for Alzheimer Research and the Interuniversity Attraction Poles program P6/43 of the Belgian Federal Science Policy Office. K. S. is a postdoctoral fellow and K. B. a PhD fellow (Fund for Scientific Research-Flanders). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anstey KJ, 2008, AM J GERIAT PSYCHIAT, V16, P343, DOI 10.1097/JGP.0b013e31816b72d4; Baranzini SE, 2009, HUM MOL GENET, V18, P2078, DOI 10.1093/hmg/ddp120; Bates KA, 2009, MOL PSYCHIATR, V14, P469, DOI 10.1038/mp.2008.96; Bertram L, 2009, INT REV NEUROBIOL, V84, P167, DOI 10.1016/S0074-7742(09)00409-7; Birks J, 2006, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001190.pub2, 10.1002/14651858.CD001190.pub3]; Blasko I, 2004, AGING CELL, V3, P169, DOI 10.1111/j.1474-9728.2004.00101.x; Blennow K, 2006, LANCET, V368, P387, DOI 10.1016/S0140-6736(06)69113-7; Bu GJ, 2009, NAT REV NEUROSCI, V10, P333, DOI 10.1038/nrn2620; Bult CJ, 2008, NUCLEIC ACIDS RES, V36, pD724, DOI 10.1093/nar/gkm961; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Camon EB, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-S1-S17; Carrasquillo MM, 2010, ARCH NEUROL; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Corneveaux JJ, 2010, HUM MOL GENET; Duron E, 2008, VASC HEALTH RISK MAN, V4, P363; Gatz M, 2006, ARCH GEN PSYCHIAT, V63, P168, DOI 10.1001/archpsyc.63.2.168; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Hardy J, 2009, J NEUROCHEM, V110, P1129, DOI 10.1111/j.1471-4159.2009.06181.x; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Hebert LE, 2003, ARCH NEUROL-CHICAGO, V60, P1119, DOI 10.1001/archneur.60.8.1119; Hirschhorn JN, 2009, NEW ENGL J MED, V360, P1699, DOI 10.1056/NEJMp0808934; Holmans P, 2009, AM J HUM GENET, V85, P13, DOI 10.1016/j.ajhg.2009.05.011; Hong MG, 2009, HUM GENET, V126, P289, DOI 10.1007/s00439-009-0676-z; Jiang Q, 2008, NEURON, V58, P681, DOI 10.1016/j.neuron.2008.04.010; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Koudinov AR, 1998, CLIN CHIM ACTA, V270, P75, DOI 10.1016/S0009-8981(97)00207-6; LAMBERT JC, 2010, J ALZHEIMERS DIS; Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439; McGeer E G, 2001, Mol Interv, V1, P22; Moskvina V, 2008, GENET EPIDEMIOL, V32, P567, DOI 10.1002/gepi.20331; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Reynolds CA, 2010, HUM MOL GENET, V19, P2068, DOI 10.1093/hmg/ddq079; Ritchie MD, 2009, GENOME MED, V1, DOI 10.1186/gm65; SIMES RJ, 1986, BIOMETRIKA, V73, P751, DOI 10.2307/2336545; Wancata J, 2003, EUR PSYCHIAT, V18, P306, DOI 10.1016/j.eurpsy.2003.03.003; Wang K, 2007, AM J HUM GENET, V81, P1278, DOI 10.1086/522374; Weggen S, 2007, TRENDS PHARMACOL SCI, V28, P536, DOI 10.1016/j.tips.2007.09.004; Wyss-Coray T, 2006, NAT MED, V12, P1005, DOI 10.1038/nml1484; Yang J, 2010, NAT GENET	40	274	276	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2010	5	11							e13950	10.1371/journal.pone.0013950	http://dx.doi.org/10.1371/journal.pone.0013950			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	680KW	21085570	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000284231800004
J	Poncelet, J; Rinck, F; Ziessel, A; Joussain, P; Thevenet, M; Rouby, C; Bensafi, M				Poncelet, Johan; Rinck, Fanny; Ziessel, Anne; Joussain, Pauline; Thevenet, Marc; Rouby, Catherine; Bensafi, Moustafa			Semantic Knowledge Influences Prewired Hedonic Responses to Odors	PLOS ONE			English	Article							OLFACTORY CORTEX; PLEASANTNESS; PERCEPTION; INTENSITY; HUMANS; SMELL; REPRESENTATIONS; DISCRIMINATION; IDENTIFICATION; THRESHOLDS	Background: Odor hedonic perception relies on decoding the physicochemical properties of odorant molecules and can be influenced in humans by semantic knowledge. The effect of semantic knowledge on such prewired hedonic processing over the life span has remained unclear. Methodology/Principal Findings: The present study measured hedonic response to odors in different age groups (children, teenagers, young adults, and seniors) and found that children and seniors, two age groups characterized by either low level of (children) or weak access to (seniors) odor semantic knowledge, processed odor hedonics more on the basis of their physicochemical properties. In contrast, in teenagers and young adults, who show better levels of semantic odor representation, the role of physicochemical properties was less marked. Conclusions/Significance: These findings demonstrate for the first time that the biological determinants that make an odor pleasant or unpleasant are more powerful at either end of the life span.	[Poncelet, Johan] Univ Lyon, Lyon, France; Ctr Natl Rech Sci, UMR5020, Lyon, France	Centre National de la Recherche Scientifique (CNRS)	Poncelet, J (corresponding author), Univ Lyon, Lyon, France.	bensafi@olfac.univ-lyon1.fr	Mutafungwa, Edward/C-5574-2013; Bensafi, Moustafa/H-6618-2017	Mutafungwa, Edward/0000-0002-4413-5631; Bensafi, Moustafa/0000-0002-2991-3036; Rinck, Fanny/0000-0002-3660-0716; Rouby, Catherine/0000-0002-5683-5491	French Centre National de la Recherche Scientifique (CNRS); Region Rhone Alpes in France; L'Oreal (France)	French Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Region Rhone Alpes in France(Region Auvergne-Rhone-Alpes); L'Oreal (France)	This work was supported by the French Centre National de la Recherche Scientifique (CNRS), Programme Longevite et Vieillissement 2009-2010); by the Region Rhone Alpes in France (Cluster HNV 2009-2010); and by L'Oreal (France). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson AK, 2003, NAT NEUROSCI, V6, P196, DOI 10.1038/nn1001; Ayabe-Kanamura S, 1998, CHEM SENSES, V23, P31, DOI 10.1093/chemse/23.1.31; Barkat S, 2008, NEUROSCI LETT, V434, P108, DOI 10.1016/j.neulet.2008.01.037; Bensafi M, 2007, CLIN NEUROPHYSIOL, V118, P696, DOI 10.1016/j.clinph.2006.10.022; Bensafi M, 2007, J NEUROPHYSIOL, V98, P3254, DOI 10.1152/jn.00349.2007; Bensafi M, 2007, CHEM SENSES, V32, P855, DOI 10.1093/chemse/bjm055; Berridge KC, 2003, TRENDS NEUROSCI, V26, P507, DOI 10.1016/S0166-2236(03)00233-9; Boesveldt S, 2010, BIOL PSYCHOL, V84, P313, DOI 10.1016/j.biopsycho.2010.03.006; CAIN WS, 1978, PERCEPTION, V7, P459, DOI 10.1068/p070459; Dalton P, 1999, HEALTH PSYCHOL, V18, P579, DOI 10.1037/0278-6133.18.6.579; de Araujo IE, 2005, NEURON, V46, P671, DOI 10.1016/j.neuron.2005.04.021; DEWIJK RA, 1994, PERCEPT PSYCHOPHYS, V56, P12, DOI 10.3758/BF03211686; Distel H, 2001, CHEM SENSES, V26, P247, DOI 10.1093/chemse/26.3.247; Djordjevic J, 2008, J NEUROPHYSIOL, V99, P386, DOI 10.1152/jn.00896.2007; DOTY RL, 1986, CHEM SENSES, V11, P259, DOI 10.1093/chemse/11.2.259; DOTY RL, 1984, SCIENCE, V226, P1441, DOI 10.1126/science.6505700; Forestell CA, 2005, PSYCHOL ADDICT BEHAV, V19, P423, DOI 10.1037/0893-164X.19.4.423; Gottfried JA, 2002, J NEUROSCI, V22, P10819; HENION KE, 1971, J EXP PSYCHOL, V90, P275, DOI 10.1037/h0031549; Herz RS, 2003, J EXP PSYCHOL GEN, V132, P595, DOI 10.1037/0096-3445.132.4.595; Hummel T, 2007, EUR ARCH OTO-RHINO-L, V264, P237, DOI 10.1007/s00405-006-0173-0; Hummel T, 2007, BEHAV BRAIN RES, V180, P133, DOI 10.1016/j.bbr.2007.02.040; Khan RM, 2007, J NEUROSCI, V27, P10015, DOI 10.1523/JNEUROSCI.1158-07.2007; Mandairon N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004209; Mennella JA, 2000, ALCOHOL CLIN EXP RES, V24, P1167, DOI 10.1111/j.1530-0277.2000.tb02079.x; Monnery-Patris S, 2009, Dev Psychobiol, V51, P268, DOI 10.1002/dev.20363; Moskowitz H. R., 1979, PREFERENCE BEHAV CHE, P131; MOSKOWITZ HR, 1974, J EXP PSYCHOL, V103, P216, DOI 10.1037/h0036793; MOSKOWITZ HR, 1976, PERCEPT PSYCHOPHYS, V19, P122, DOI 10.3758/BF03204218; Poncelet J, 2010, BEHAV BRAIN RES, V208, P458, DOI 10.1016/j.bbr.2009.12.011; RINCK F, 2010, CHEM SENSES IN PRESS; Rolls ET, 1997, PHYSIOL BEHAV, V61, P461, DOI 10.1016/S0031-9384(96)00464-7; Rolls ET, 2003, EUR J NEUROSCI, V18, P695, DOI 10.1046/j.1460-9568.2003.02779.x; Rouby C, 2009, ANN NY ACAD SCI, V1170, P333, DOI 10.1111/j.1749-6632.2009.03915.x; Rouby C, 2009, FOOD QUAL PREFER, V20, P545, DOI 10.1016/j.foodqual.2009.05.004; Schaal B, 2000, CHEM SENSES, V25, P729, DOI 10.1093/chemse/25.6.729; SCHIFFMAN SS, 1974, SCIENCE, V185, P112, DOI 10.1126/science.185.4146.112; Stevenson RJ, 2007, DEV PSYCHOL, V43, P253, DOI 10.1037/0012-1649.43.1.253; Sullivan RM, 2003, ANN NY ACAD SCI, V1008, P122, DOI 10.1196/annals.1301.013; Thomas-Danguin T, 2003, RHINOLOGY, V41, P142; Yeomans MR, 2006, PHYSIOL BEHAV, V89, P10, DOI [10.1016/j.physbeh.2006.04.010, 10.1016/j.physbeh.2006.01.029]; Zelano C, 2007, J NEUROPHYSIOL, V97, P1969, DOI 10.1152/jn.01122.2006	42	25	25	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2010	5	11							e13878	10.1371/journal.pone.0013878	http://dx.doi.org/10.1371/journal.pone.0013878			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	676NU	21079734	Green Published, gold, Green Submitted			2022-12-27	WOS:000283920000011
J	Serbecic, N; Aboul-Enein, F; Beutelspacher, SC; Graf, M; Kircher, K; Geitzenauer, W; Brannath, W; Lang, P; Kristoferitsch, W; Lassmann, H; Reitner, A; Schmidt-Erfurth, U				Serbecic, Nermin; Aboul-Enein, Fahmy; Beutelspacher, Sven C.; Graf, Martin; Kircher, Karl; Geitzenauer, Wolfgang; Brannath, Werner; Lang, Priska; Kristoferitsch, Wolfgang; Lassmann, Hans; Reitner, Andreas; Schmidt-Erfurth, Ursula			Heterogeneous Pattern of Retinal Nerve Fiber Layer in Multiple Sclerosis. High Resolution Optical Coherence Tomography: Potential and Limitations	PLOS ONE			English	Article							THICKNESS MEASUREMENT; NEUROMYELITIS-OPTICA; SIGNAL STRENGTH; NEURITIS; ACCURACY; MS	Background: Recently the reduction of the retinal nerve fibre layer (RNFL) was suggested to be associated with diffuse axonal damage in the whole CNS of multiple sclerosis (MS) patients. However, several points are still under discussion. (1) Is high resolution optical coherence tomography (OCT) required to detect the partly very subtle RNFL changes seen in MS patients? (2) Can a reduction of RNFL be detected in all MS patients, even in early disease courses and in all MS subtypes? (3) Does an optic neuritis (ON) or focal lesions along the visual pathways, which are both very common in MS, limit the predication of diffuse axonal degeneration in the whole CNS? The purpose of our study was to determine the baseline characteristics of clinical definite relapsing-remitting (RRMS) and secondary progressive (SPMS) MS patients with high resolution OCT technique. Methodology: Forty-two RRMS and 17 SPMS patients with and without history of uni- or bilateral ON, and 59 age-and sex-matched healthy controls were analysed prospectively with the high resolution spectral-domain OCT device (SD-OCT) using the Spectralis 3.5mm circle scan protocol with locked reference images and eye tracking mode. Furthermore we performed tests for visual and contrast acuity and sensitivity (ETDRS, Sloan and Pelli-Robson-charts), for color vision (Lanthony D-15), the Humphrey visual field and visual evoked potential testing (VEP). Principal Findings: All 4 groups (RRMS and SPMS with or without ON) showed significantly reduced RNFL globally, or at least in one of the peripapillary sectors compared to age-/sex-matched healthy controls. In patients with previous ON additional RNFL reduction was found. However, in many RRMS patients the RNFL was found within normal range. We found no correlation between RNFL reduction and disease duration (range 9-540 months). Conclusions: RNFL baseline characteristics of RRMS and SPMS are heterogeneous (range from normal to markedly reduced levels).	[Serbecic, Nermin; Kircher, Karl; Geitzenauer, Wolfgang; Reitner, Andreas; Schmidt-Erfurth, Ursula] Med Univ Vienna, Dept Ophthalmol, Vienna, Austria; [Aboul-Enein, Fahmy; Graf, Martin; Kristoferitsch, Wolfgang] SMZ Ost Donauspital, Dept Neurol, Vienna, Austria; [Beutelspacher, Sven C.] Univ Heidelberg, Dept Ophthalmol, Fac Med Mannheim, D-6800 Mannheim, Germany; [Brannath, Werner; Lang, Priska] Med Univ Vienna, Dept Biostat, Vienna, Austria; [Lassmann, Hans] Med Univ Vienna, Brain Res Ctr, Vienna, Austria	Medical University of Vienna; Donauspital; Ruprecht Karls University Heidelberg; Medical University of Vienna; Medical University of Vienna	Serbecic, N (corresponding author), Med Univ Vienna, Dept Ophthalmol, Vienna, Austria.	fahmy.aboul-enein@telering.at	Lassmann, Hans/Z-2269-2019	Lassmann, Hans/0000-0001-8617-5052; Schmidt-Erfurth, Ursula/0000-0002-7788-7311	Medical Research Society Vienna, DC	Medical Research Society Vienna, DC	This study was funded by the Medical Research Society Vienna, DC (www.mfg22.at). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboul-Enein F, 2010, AM J NEURORADIOL, V31, P76, DOI 10.3174/ajnr.A1791; Aboul-Enein F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011625; Chen HY, 2005, J FORMOS MED ASSOC, V104, P927; Cheung CYL, 2008, OPHTHALMOLOGY, V115, P1347, DOI 10.1016/j.ophtha.2007.11.027; Costello F, 2006, ANN NEUROL, V59, P963, DOI 10.1002/ana.20851; Han IC, 2009, AM J OPHTHALMOL, V147, P847, DOI 10.1016/j.ajo.2008.11.019; Henderson APD, 2008, BRAIN, V131, P277, DOI 10.1093/brain/awm285; Henderson APD, 2010, J NEUROL, V257, P1083, DOI 10.1007/s00415-010-5467-x; Kallenbach K, 2007, EUR J NEUROL, V14, P841, DOI 10.1111/j.1468-1331.2007.01736.x; Kim JS, 2009, BRIT J OPHTHALMOL, V93, P1057, DOI 10.1136/bjo.2009.157875; Krampla W, 2009, EUR RADIOL, V19, P2535, DOI 10.1007/s00330-009-1425-3; LOWITZSCH K, 1991, EEG-EMG-Z ELEK ELEKT, V22, P230; Mader S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010455; Petzold A, 2010, LANCET NEUROL, V9, P921, DOI 10.1016/S1474-4422(10)70168-X; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Sepulcre J, 2007, NEUROLOGY, V68, P1488, DOI 10.1212/01.wnl.0000260612.51849.ed; SERBECIC N, 2010, BR J OPHTHA IN PRESS; Sergott RC, 2007, J NEUROL SCI, V263, P3, DOI 10.1016/j.jns.2007.05.024; Tinnefeld M, 2005, EUR ARCH PSY CLIN N, V255, P319, DOI 10.1007/s00406-005-0565-y; Wu ZQ, 2009, J GLAUCOMA, V18, P213, DOI 10.1097/IJG.0b013e31817eee20	20	28	29	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2010	5	11							e13877	10.1371/journal.pone.0013877	http://dx.doi.org/10.1371/journal.pone.0013877			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	676NU	21079732	gold, Green Published, Green Submitted			2022-12-27	WOS:000283920000010
J	Eddy, TD; Gardner, JPA; Perez-Matus, A				Eddy, Tyler D.; Gardner, Jonathan P. A.; Perez-Matus, Alejandro			Applying Fishers' Ecological Knowledge to Construct Past and Future Lobster Stocks in the Juan Fernandez Archipelago, Chile	PLOS ONE			English	Article							JASUS-EDWARDSII; SPINY LOBSTER; MARINE-RESERVE; MANAGEMENT; COMANAGEMENT; SIZE; CONSERVATION; PALINURIDAE; ECOSYSTEMS; ABUNDANCE	Over-exploited fisheries are a common feature of the modern world and a range of solutions including area closures (marine reserves; MRs), effort reduction, gear changes, ecosystem-based management, incentives and co-management have been suggested as techniques to rebuild over-fished populations. Historic accounts of lobster (Jasus frontalis) on the Chilean Juan Fernandez Archipelago indicate a high abundance at all depths (intertidal to approximately 165 m), but presently lobsters are found almost exclusively in deeper regions of their natural distribution. Fishers' ecological knowledge (FEK) tells a story of serial depletion in lobster abundance at fishing grounds located closest to the fishing port with an associated decline in catch per unit effort (CPUE) throughout recent history. We have re-constructed baselines of lobster biomass throughout human history on the archipelago using historic data, the fishery catch record and FEK to permit examination of the potential effects of MRs, effort reduction and co-management (stewardship of catch) to restore stocks. We employed a bioeconomic model using FEK, fishery catch and effort data, underwater survey information, predicted population growth and response to MR protection (no-take) to explore different management strategies and their trade-offs to restore stocks and improve catches. Our findings indicate that increased stewardship of catch coupled with 30% area closure (MR) provides the best option to reconstruct historic baselines. Based on model predictions, continued exploitation under the current management scheme is highly influenced by annual fluctuations and unsustainable. We propose a community-based co-management program to implement a MR in order to rebuild the lobster population while also providing conservation protection for marine species endemic to the Archipelago.	[Eddy, Tyler D.; Gardner, Jonathan P. A.] Victoria Univ Wellington, Sch Biol Sci, Ctr Marine Environm & Econ Res, Wellington, New Zealand; [Perez-Matus, Alejandro] Victoria Univ Wellington, Sch Biol Sci, Victoria Univ Coastal Ecol Lab, Wellington, New Zealand	Victoria University Wellington; Victoria University Wellington	Eddy, TD (corresponding author), Victoria Univ Wellington, Sch Biol Sci, Ctr Marine Environm & Econ Res, Wellington, New Zealand.	tylereddy@gmail.com	Pérez-Matus, Alejandro/F-5019-2014; Gardner, Jonathan/M-3224-2016; Eddy, Tyler/ABE-7092-2021	Pérez-Matus, Alejandro/0000-0001-9591-6721; Eddy, Tyler/0000-0002-2833-9407; Gardner, Jonathan/0000-0002-6943-2413	Education New Zealand; Te Papa Museum of New Zealand; Victoria University of Wellington; CONICYT; FRST [C01X0501]	Education New Zealand; Te Papa Museum of New Zealand; Victoria University of Wellington; CONICYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); FRST(New Zealand Foundation for Research, Science and Technology)	Funding: Funding for this research has been provided by Education New Zealand's Postgraduate Study Abroad Award and Te Papa Museum of New Zealand. T. D. Eddy is supported by a Victoria University of Wellington Doctoral Scholarship and a Victoria University of Wellington Submission Scholarship. A. Perez-Matus is supported by a CONICYT PhD Scholarship and a FRST contract C01X0501. The History of Marine Animal Populations Publications Group provided publication support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnew DJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004570; Ainsworth CH, 2008, ECOL MODEL, V216, P354, DOI 10.1016/j.ecolmodel.2008.05.005; Akaike H., 1973, P 2 INT S INF THEOR, VI, P610, DOI DOI 10.1007/978-1-4612-1694-0_15; ALBERT F, 1898, REV CHIL HIST NAT, V2, P6; ANNALA JH, 1980, NEW ZEAL J MAR FRESH, V14, P217, DOI 10.1080/00288330.1980.9515864; ANNALA JH, 1987, NEW ZEAL J MAR FRESH, V21, P591, DOI 10.1080/00288330.1987.9516263; ARANA P, 1985, CICLO REPROD TALLA P, P187; ARANA P, 1985, ANTECEDENTES GEN ACT, P125; ARANA P, 1985, DISTRIBUCION ESFUERZ, P157; Arana P.M., 2000, INVEST MAR, V28, P117; Beddington JR, 2007, SCIENCE, V316, P1713, DOI 10.1126/science.1137362; Blaikie P, 2006, WORLD DEV, V34, P1942, DOI 10.1016/j.worlddev.2005.11.023; Booth JD, 2000, MAR ECOL PROG SER, V200, P241, DOI 10.3354/meps200241; Browman HI, 2004, MAR ECOL PROG SER, V274, P269, DOI 10.3354/meps274269; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; CABRAL JM, 2004, FUNDAMENTACION PROYE; Castilla JC, 1998, ECOL APPL, V8, pS124, DOI 10.1890/1051-0761(1998)8[S124:SBFICO]2.0.CO;2; Cheung WWL, 2010, GLOBAL CHANGE BIOL, V16, P24, DOI 10.1111/j.1365-2486.2009.01995.x; Cinner JE, 2009, CONSERV BIOL, V23, P124, DOI 10.1111/j.1523-1739.2008.01041.x; Coll M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003881; Cudney-Bueno R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006253; Davidson RJ, 2002, AQUAT CONSERV, V12, P213, DOI 10.1002/aqc.505; DIAZ PO, 1985, ESTIMACIONES MORTALI, P237; Dupre EM, 2000, J SHELLFISH RES, V19, P711; Dupre M. Enrique, 1996, Investigaciones Marinas Universidad Catolica de Valparaiso, V24, P39; EDDY TD, 2008, JMBA GLOBAL MARINE E, V7, P16; ERNST B, 2010, SCIENCE, V86, P215; Freeman DJ, 2009, MAR FRESHWATER RES, V60, P140, DOI 10.1071/MF08091; Freeman DJ, 2009, MAR ECOL PROG SER, V388, P159, DOI 10.3354/meps08122; Game ET, 2009, ECOL LETT, V12, P1336, DOI 10.1111/j.1461-0248.2009.01384.x; Gelcich S, 2005, CONSERV BIOL, V19, P865, DOI 10.1111/j.1523-1739.2005.00534.x; Gelcich S, 2008, ECOL APPL, V18, P273, DOI 10.1890/06-1896.1; Gelcich S, 2007, ECOL ECON, V61, P246, DOI 10.1016/j.ecolecon.2006.02.017; Gelcich S, 2006, ECOSYSTEMS, V9, P951, DOI 10.1007/s10021-005-0007-8; Greenstreet SPR, 2009, ICES J MAR SCI, V66, P90, DOI 10.1093/icesjms/fsn214; HARDIN G, 1968, SCIENCE, V162, P1243, DOI 10.1126/science.162.3859.1243; Hilborn R, 2002, SCIENCE, V295, P1233; HILBORN R, 1992; Hilborn R, 2010, FISHERIES, V35, P113, DOI 10.1577/1548-8446-35.3.113; Jennings S, 2010, J MARINE SYST, V79, P418, DOI 10.1016/j.jmarsys.2008.12.016; Johannes RE, 2000, FISH FISH, V1, P257, DOI 10.1046/j.1467-2979.2000.00019.x; Kelly S, 2003, NEW ZEAL J MAR FRESH, V37, P149, DOI 10.1080/00288330.2003.9517153; Kelly S, 2002, COAST MANAGE, V30, P153, DOI 10.1080/089207502753504689; Kelly S, 2001, MAR FRESHWATER RES, V52, P323, DOI 10.1071/MF00028; Kelly S, 2000, BIOL CONSERV, V92, P359, DOI 10.1016/S0006-3207(99)00109-3; LUNDQUIST CJ, 2008, 288 NZ DEP CONS SCI; MACDIARMID AB, 1991, MAR ECOL PROG SER, V70, P129, DOI 10.3354/meps070129; McClanahan TR, 2006, CURR BIOL, V16, P1408, DOI 10.1016/j.cub.2006.05.062; Meltzoff SK, 2002, COAST MANAGE, V30, P85, DOI 10.1080/08920750252692634; MOLINA GI, 1808, GEOGRAPHICAL NATURAL, V1, pR1; Mora C, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000131; Murawski SA, 2005, ICES J MAR SCI, V62, P1150, DOI 10.1016/j.icesjms.2005.04.005; Pande A, 2008, MAR ECOL PROG SER, V366, P147, DOI 10.3354/meps07494; PAULY D, 1995, TRENDS ECOL EVOL, V10, P430, DOI 10.1016/S0169-5347(00)89171-5; Pauly D, 2002, NATURE, V418, P689, DOI 10.1038/nature01017; Pequeno G, 2000, GLOBAL ECOL BIOGEOGR, V9, P431, DOI 10.1046/j.1365-2699.2000.00207.x; Petrillo Mario, 2005, Rev. biol. mar. oceanogr., V40, P63; Pitcher TJ, 2001, ECOL APPL, V11, P601; Pitcher T, 2009, NATURE, V457, P658, DOI 10.1038/457658a; POLLNAC R, 2010, P NATL ACAD IN PRESS, DOI DOI 10.1073/PNAS.09082661; Powers JE, 2009, FISH RES, V99, P216, DOI 10.1016/j.fishres.2009.06.011; Rivera Jorge, 2004, Investigaciones Marinas Universidad Catolica de Valparaiso, V32, P99; Rosenberg AA, 2005, FRONT ECOL ENVIRON, V3, P84, DOI 10.2307/3868514; Rosenberg AA, 2007, NATURE, V449, P989, DOI 10.1038/449989a; Rozbaczylo N., 1987, ISLAS OCEANICAS CHIL, P167; Ruth M., 2002, DYNAMIC MODELING MAR; Santelices B., 1992, Pacific Science, V46, P438; Schaefer MB., 1954, INT AM TROPICAL TUNA, V1, P23; *SERN, 2009, AN EST PESC 2009; Shears NT, 2006, BIOL CONSERV, V132, P222, DOI 10.1016/j.biocon.2006.04.001; SKOTTSBERG C, 1956, NATURAL HIST J FERNA, V1, P178; Stokstad E, 2009, SCIENCE, V324, P170, DOI 10.1126/science.324.5924.170; Sutinen J.G., 1999, INT J SOC ECON, V26, P174, DOI [10.1108/03068299910229569, DOI 10.1108/03068299910229569]; Thurstan RH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011767; WALTER R, 1776, VOYAGE ROUND WORLD Y, pR1; Wilen JE, 2002, B MAR SCI, V70, P553; Worm B, 2009, SCIENCE, V325, P578, DOI 10.1126/science.1173146; YANEZ E, 1985, DINAMICA STOCK LANGO, P251; Yanez R. Eleuterio, 2000, Investigaciones Marinas Universidad Catolica de Valparaiso, V28, P135	79	39	40	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2010	5	11							e13670	10.1371/journal.pone.0013670	http://dx.doi.org/10.1371/journal.pone.0013670			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675OD	21079761	Green Published, Green Submitted, gold			2022-12-27	WOS:000283839100003
J	Kaida, A; Laher, F; Strathdee, SA; Money, D; Janssen, PA; Hogg, RS; Gray, G				Kaida, Angela; Laher, Fatima; Strathdee, Steffanie A.; Money, Deborah; Janssen, Patricia A.; Hogg, Robert S.; Gray, Glenda			Contraceptive Use and Method Preference among Women in Soweto, South Africa: The Influence of Expanding Access to HIV Care and Treatment Services	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; POSITIVE WOMEN; FERTILITY INTENTIONS; DISEASE PROGRESSION; SEXUAL-ACTIVITY; INFECTED WOMEN; TRANSMISSION; UGANDA; HAART; PREGNANCY	Objective: Preventing unintended pregnancy among HIV-positive women constitutes a critical and cost-effective approach to primary prevention of mother-to-child transmission of HIV and is a global public health priority for addressing the desperate state of maternal and child health in HIV hyper-endemic settings. We sought to investigate whether the prevalence of contraceptive use and method preferences varied by HIV status and receipt of highly active antiretroviral therapy (HAART) among women in Soweto, South Africa. Methods: We used survey data from 563 sexually active, non-pregnant women (18-44 years) recruited from the Perinatal HIV Research Unit in Soweto (May-December, 2007); 171 women were HIV-positive and receiving HAART (median duration of use = 31 months; IQR = 28, 33), 178 were HIV-positive and HAART-naive, and 214 were HIV-negative. Medical record review was conducted to confirm HIV status and clinical variables. Logistic regression models estimated adjusted associations between HIV status, receipt of HAART, and contraceptive use. Results: Overall, 78% of women reported using contraception, with significant variation by HIV status: 86% of HAART users, 82% of HAART-naive women, and 69% of HIV-negative women (p<0.0001). In adjusted models, compared with HIV-negative women, women receiving HAART were significantly more likely to use contraception while HAART-naive women were non-significantly more likely (AOR: 2.40; 95% CI: 1.25, 4.62 and AOR: 1.59; 95% CI: 0.88, 2.85; respectively). Among HIV-positive women, HAART users were non-significantly more likely to use contraception compared with HAART-naive women (AOR: 1.55; 95% CI: 0.84, 2.88). Similar patterns held for specific use of barrier (primarily male condoms), permanent, and dual protection contraceptive methods. Conclusion: Among HIV-positive women receiving HAART, the observed higher prevalence of contraceptive use overall and condoms in particular promises to yield fewer unintended pregnancies and reduced risks of vertical and sexual HIV transmission. These findings highlight the potential of integrated HIV and reproductive health services to positively impact maternal, partner, and child health.	[Kaida, Angela; Hogg, Robert S.] Simon Fraser Univ, Fac Hlth Sci, Burnaby, BC V5A 1S6, Canada; [Laher, Fatima; Gray, Glenda] Univ Witwatersrand, Perinatal HIV Res Unit, Soweto, South Africa; [Strathdee, Steffanie A.] Univ Calif San Diego, Sch Med, Div Global Publ Hlth, San Diego, CA 92103 USA; [Money, Deborah] Womens Hlth Res Inst, Vancouver, BC, Canada; [Money, Deborah] Univ British Columbia, Dept Obstet & Gynaecol, Vancouver, BC V5Z 1M9, Canada; [Janssen, Patricia A.] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC V5Z 1M9, Canada; [Janssen, Patricia A.] Child & Family Res Inst, Vancouver, BC, Canada; [Hogg, Robert S.] BC Ctr Excellence HIV AIDS, Vancouver, BC, Canada	Simon Fraser University; University of Witwatersrand; University of California System; University of California San Diego; University of British Columbia; University of British Columbia; Child & Family Research Institute; B.C. Centre for Excellence in HIV/AIDS	Kaida, A (corresponding author), Simon Fraser Univ, Fac Hlth Sci, Burnaby, BC V5A 1S6, Canada.	angela_kaida@sfu.ca	Janssen, Patricia/B-1036-2018; Hogg, Robert S/B-2783-2012; Strathdee, Steffanie A/B-9042-2009	Janssen, Patricia/0000-0002-4178-1195; Hogg, Robert S/0000-0003-3463-5488; Strathdee, Steffanie/0000-0002-7724-691X	Canadian Foundation for AIDS Research (CANFAR); University of California San Diego Center for AIDS Research (National Institute of Allergy and Infectious Diseases) [P30AI036214]; Social Sciences and Humanities Research Council (SSHRC) of Canada; Canadian Institutes of Health Research (CIHR); Michael Smith Foundation for Health Research (MSFHR); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI036214] Funding Source: NIH RePORTER	Canadian Foundation for AIDS Research (CANFAR); University of California San Diego Center for AIDS Research (National Institute of Allergy and Infectious Diseases)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Social Sciences and Humanities Research Council (SSHRC) of Canada(Social Sciences and Humanities Research Council of Canada (SSHRC)); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation for Health Research (MSFHR)(Michael Smith Foundation for Health Research); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding: This research was supported by the Canadian Foundation for AIDS Research (CANFAR), the University of California San Diego Center for AIDS Research (grant P30AI036214 from the National Institute of Allergy and Infectious Diseases), and the Social Sciences and Humanities Research Council (SSHRC) of Canada. A. K. is supported by the Canadian Institutes of Health Research (CIHR) and the Michael Smith Foundation for Health Research (MSFHR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adair T, 2009, J BIOSOC SCI, V41, P269, DOI 10.1017/S0021932008003076; ALLEN S, 1993, AM J PUBLIC HEALTH, V83, P705, DOI 10.2105/AJPH.83.5.705; Andia I, 2009, AM J PUBLIC HEALTH, V99, P340, DOI 10.2105/AJPH.2007.129528; Baeten JM, 2007, CLIN INFECT DIS, V45, P360, DOI 10.1086/519432; Balkus J, 2007, SEX TRANSM DIS, V34, P25, DOI 10.1097/01.olq.0000218880.88179.36; Barker PM, 2007, SAMJ S AFR MED J, V97, P916; Castilla J, 2005, JAIDS-J ACQ IMM DEF, V40, P96, DOI 10.1097/01.qai.0000157389.78374.45; Coll O, 2008, CURR OPIN HIV AIDS, V3, P186, DOI 10.1097/COH.0b013e3282f51219; Cooper D, 2007, SOC SCI MED, V65, P274, DOI 10.1016/j.socscimed.2007.03.019; Cooper ER, 2002, J ACQ IMMUN DEF SYND, V29, P484, DOI 10.1097/00126334-200204150-00009; *DEP HLTH SA, 2007, NAT HIV SYPH PREV SU; Department of Health SA, 2004, NAT ANT TREATM GUID; Desgrees-du-Lou A, 2002, INT J STD AIDS, V13, P462, DOI 10.1258/09564620260079617; Gruskin S, 2007, REPROD HEALTH MATTER, V15, P4, DOI 10.1016/S0968-8080(07)29028-7; Hladik W, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007691; Hoffman IF, 2008, JAIDS-J ACQ IMM DEF, V47, P477, DOI 10.1097/QAI.0b013e318165dc52; Hogan M., LANCET, V375, P1609; Hogg RS, 1997, LANCET, V349, P1294, DOI 10.1016/S0140-6736(05)62505-6; Hogg RS, 1998, JAMA-J AM MED ASSOC, V279, P450, DOI 10.1001/jama.279.6.450; Hogg RS, 2001, JAMA-J AM MED ASSOC, V286, P2568, DOI 10.1001/jama.286.20.2568; Homsy J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004149; HORTON R, LANCET, V375, P1941; Kaida A, 2008, AIDS CARE, V20, P21, DOI 10.1080/09540120701426540; Kaida Angela, 2006, Curr HIV/AIDS Rep, V3, P187, DOI 10.1007/s11904-006-0015-0; Kaida A, 2009, AIDS BEHAV, V13, pS72, DOI 10.1007/s10461-009-9553-y; Laher F, 2009, AIDS BEHAV, V13, pS47, DOI 10.1007/s10461-009-9544-z; Mitchell HS, 2004, SEX TRANSM INFECT, V80, P167, DOI 10.1136/sti.2003.008441; Myer L, 2006, AIDS CARE, V18, P772, DOI 10.1080/09540120500409283; *NAT COMM CONF ENQ, 2003, SAV MOTH 1999 2001; PAGANO M, 2000, PRINC BIOST; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; *PAN ANT GUID AD A, 2008, GUID US ANT AG HIV 1; Peltzer K, 2009, AIDS BEHAV, V13, P973, DOI 10.1007/s10461-008-9365-5; Petruney T, 2008, B WHO, V86, pB; Rehle T, 2007, SAMJ S AFR MED J, V97, P194; Reynolds HW, 2006, SEX TRANSM DIS, V33, P350, DOI 10.1097/01.olq.0000194602.01058.e1; Rochat TJ, 2006, JAMA-J AM MED ASSOC, V295, P1376, DOI 10.1001/jama.295.12.1376; *SADHS, 2004, S AFR DEM HLTH SURV; Seiber EE, 2007, INT FAM PLAN PERSPEC, V33, P117, DOI 10.1363/3311707; UN, 2007, WORLD CONTR US; *UNAIDS, 2008, REP GLOB HIV AIDS EP; UNAIDS UNICEF & USAID, 2004, CHILDR BRINK 2004 JO; Van Ness PH, 2007, USING SAS INVESTIGAT; Wallerstein N., 2006, WHAT IS EVIDENCE EFF; [WHO UNAIDS UNICEF], 2009, UN ACC SCAL PRIOR HI; WHO, 2006, ANT DRUGS TREAT PREG; WHO, 1995, HLTH BEN FAM PLANN; Wilcher R, 2009, AIDS, V23, pS1, DOI 10.1097/01.aids.0000363772.45635.35; Williams HA, 1996, CLIN OBSTET GYNECOL, V39, P333, DOI 10.1097/00003081-199606000-00008; World Health Organization, 2002, PREV HIV INF YOUNG C; World Health Organization, 2008, UN ACC SCAL PRIOR HI	51	57	57	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2010	5	11							e13868	10.1371/journal.pone.0013868	http://dx.doi.org/10.1371/journal.pone.0013868			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	675OD	21079770	gold, Green Published, Green Submitted			2022-12-27	WOS:000283839100018
J	Tsai, MT; Chern, TC; Chuang, JH; Hsueh, CW; Kuo, HS; Liau, CJ; Riley, S; Shen, BJ; Shen, CH; Wang, DW; Hsu, TS				Tsai, Meng-Tsung; Chern, Tsurng-Chen; Chuang, Jen-Hsiang; Hsueh, Chih-Wen; Kuo, Hsu-Sung; Liau, Churn-Jung; Riley, Steven; Shen, Bing-Jie; Shen, Chih-Hao; Wang, Da-Wei; Hsu, Tsan-Sheng			Efficient Simulation of the Spatial Transmission Dynamics of Influenza	PLOS ONE			English	Article							PANDEMIC INFLUENZA; STRATEGIES; EPIDEMIC	Early data from the 2009 H1N1 pandemic (H1N1pdm) suggest that previous studies over-estimated the within-country rate of spatial spread of pandemic influenza. As large spatially resolved data sets are constructed, the need for efficient simulation code with which to investigate the spatial patterns of the pandemic becomes clear. Here, we present a significant improvement to the efficiency of an individual-based stochastic disease simulation framework commonly used in multiple previous studies. We quantify the efficiency of the revised algorithm and present an alternative parameterization of the model in terms of the basic reproductive number. We apply the model to the population of Taiwan and demonstrate how the location of the initial seed can influence spatial incidence profiles and the overall spread of the epidemic. Differences in incidence are driven by the relative connectivity of alternate seed locations. The ability to perform efficient simulation allows us to run a batch of simulations and take account of their average in real time. The averaged data are stable and can be used to differentiate spreading patterns that are not readily seen by only conducting a few runs.	[Tsai, Meng-Tsung; Chern, Tsurng-Chen; Liau, Churn-Jung; Wang, Da-Wei; Hsu, Tsan-Sheng] Acad Sinica, Inst Informat Sci, Taipei, Taiwan; [Chuang, Jen-Hsiang] Ctr Dis Control, Epidem Intelligence Ctr, Taipei, Taiwan; [Hsueh, Chih-Wen] Natl Taiwan Univ, Dept Comp Sci & Informat Engn, Taipei 10764, Taiwan; [Riley, Steven] Univ Hong Kong, Dept Infect Dis Epidemiol, Hong Kong, Hong Kong, Peoples R China; [Shen, Bing-Jie] Far Eastern Mem Hosp, Dept Radiat Oncol, Taipei, Taiwan; [Shen, Chih-Hao] Univ Virginia, Dept Comp Sci, Charlottesville, VA 22903 USA	Academia Sinica - Taiwan; Centers For Disease Control - Taiwan; National Taiwan University; University of Hong Kong; Far Eastern Memorial Hospital; University of Virginia	Tsai, MT (corresponding author), Acad Sinica, Inst Informat Sci, Taipei, Taiwan.	tshsu@iis.sinica.edu.tw	Liau, Churn-Jung/AAI-7047-2020; Tsai, Meng-Tsung/ABB-4079-2020; Chuang, Jen-Hsiang/G-4356-2010; Liau, Churn-Jung/ABA-7779-2020	Tsai, Meng-Tsung/0000-0002-2243-8666; Chuang, Jen-Hsiang/0000-0002-7114-3418; Liau, Churn-Jung/0000-0001-6842-9637; Riley, Steven/0000-0001-7904-4804	Centers for Disease Control, Department of Health, Taiwan, R.O.C. [DOH98-DC-2036]; National Science Council, Taiwan, R.O.C. [97-2221-E-001-011-MY3, 98-2221-E-001-013-MY3]; Fogarty International Centre with the Science and Technology Directorate Department of Homeland Security [R01 TW008246-01]; Government of the Hong Kong SAR; FOGARTY INTERNATIONAL CENTER [R01TW008246] Funding Source: NIH RePORTER	Centers for Disease Control, Department of Health, Taiwan, R.O.C.; National Science Council, Taiwan, R.O.C.(Ministry of Science and Technology, Taiwan); Fogarty International Centre with the Science and Technology Directorate Department of Homeland Security(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)United States Department of Homeland Security (DHS)); Government of the Hong Kong SAR; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This work was supported in part by the following grants: Jen-Hsiang Chuang is supported in part by DOH98-DC-2036 from the Centers for Disease Control, Department of Health, Taiwan, R.O.C.; Tsan-sheng Hsu and Bing-Jie Shen are supported in part by 97-2221-E-001-011-MY3 from National Science Council, Taiwan, R.O.C.; Churn-Jung Liau is supported in part by 98-2221-E-001-013-MY3 from National Science Council, Taiwan, R.O.C.; Steven Riley is supported in part by R01 TW008246-01 from Fogarty International Centre, RAPIDD program from Fogarty International Centre with the Science and Technology Directorate Department of Homeland Security, and Research Fund for the Control of Infectious Disease of the Government of the Hong Kong SAR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017; FLAHAULT A, 1988, STAT MED, V7, P1147, DOI 10.1002/sim.4780071107; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Germann TC, 2006, P NATL ACAD SCI USA, V103, P5935, DOI 10.1073/pnas.0601266103; Halloran ME, 2002, VACCINE, V20, P3254; Halloran ME, 2002, SCIENCE, V298, P1428, DOI 10.1126/science.1074674; Heesterbeek JAP, 2002, ACTA BIOTHEOR, V50, P189, DOI 10.1023/A:1016599411804; Heffernan JM, 2005, J R SOC INTERFACE, V2, P281, DOI 10.1098/rsif.2005.0042; Hethcote HW, 2000, SIAM REV, V42, P599, DOI 10.1137/S0036144500371907; Lee BY, 2010, J PUBLIC HEALTH MAN, V16, P252, DOI 10.1097/PHH.0b013e3181ce594e; Longini IM, 2004, AM J EPIDEMIOL, V159, P623, DOI 10.1093/aje/kwh092; Longini IM, 2005, SCIENCE, V309, P1083, DOI 10.1126/science.1115717; NIST/SEMATECH, NIST SEMATECH E HDB; RILEY S, 2006, PNAS, V103, P12221; Riley S, 2007, SCIENCE, V316, P1298, DOI 10.1126/science.1134695; TSAI MT, 2010, P LNCS, V6196, P500; Viboud C, 2006, SCIENCE, V312, P447, DOI 10.1126/science.1125237; Yang Y, 2009, SCIENCE, V326, P729, DOI 10.1126/science.1177373	19	19	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2010	5	11							e13292	10.1371/journal.pone.0013292	http://dx.doi.org/10.1371/journal.pone.0013292			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675NY	21079810	Green Submitted, gold, Green Published			2022-12-27	WOS:000283838600001
J	Wang, JH; Valo, Z; Bowers, CW; Smith, DD; Liu, Z; Singer-Sam, J				Wang, Jinhui; Valo, Zuzana; Bowers, Chauncey W.; Smith, David D.; Liu, Zheng; Singer-Sam, Judith			Dual DNA Methylation Patterns in the CNS Reveal Developmentally Poised Chromatin and Monoallelic Expression of Critical Genes	PLOS ONE			English	Article							HUMAN-CELLS; STEM-CELLS; ALLELIC EXCLUSION; TWINS DISCORDANT; GENOME BROWSER; MOUSE; WIDE; PROTEOGLYCAN; INACTIVATION; REGIONS	As a first step towards discovery of genes expressed from only one allele in the CNS, we used a tiling array assay for DNA sequences that are both methylated and unmethylated (the MAUD assay). We analyzed regulatory regions of the entire mouse brain transcriptome, and found that approximately 10% of the genes assayed showed dual DNA methylation patterns. They include a large subset of genes that display marks of both active and silent, i.e., poised, chromatin during development, consistent with a link between differential DNA methylation and lineage-specific differentiation within the CNS. Sixty-five of the MAUD hits and 57 other genes whose function is of relevance to CNS development and/or disorders were tested for allele-specific expression in F-1 hybrid clonal neural stem cell (NSC) lines. Eight MAUD hits and one additional gene showed such expression. They include Lgi1, which causes a subtype of inherited epilepsy that displays autosomal dominance with incomplete penetrance; Gfra2, a receptor for glial cell line-derived neurotrophic factor GDNF that has been linked to kindling epilepsy; Unc5a, a netrin-1 receptor important in neurodevelopment; and Cspg4, a membrane chondroitin sulfate proteoglycan associated with malignant melanoma and astrocytoma in human. Three of the genes, Camk2a, Kcnc4, and Unc5a, show preferential expression of the same allele in all clonal NSC lines tested. The other six genes show a stochastic pattern of monoallelic expression in some NSC lines and bi-allelic expression in others. These results support the estimate that 1-2% of genes expressed in the CNS may be subject to allelic exclusion, and demonstrate that the group includes genes implicated in major disorders of the CNS as well as neurodevelopment.	[Wang, Jinhui; Valo, Zuzana; Singer-Sam, Judith] City Hope Natl Med Ctr, Beckman Res Inst, Div Biol, Duarte, CA 91010 USA; [Bowers, Chauncey W.] City Hope Natl Med Ctr, Beckman Res Inst, Div Computat Biol, Duarte, CA 91010 USA; [Smith, David D.] City Hope Natl Med Ctr, Div Biostat, Duarte, CA 91010 USA; [Liu, Zheng] City Hope Natl Med Ctr, Beckman Res Inst, Dept Mol Med, Bioinformat Core Facil, Duarte, CA 91010 USA	City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope; City of Hope; City of Hope; Beckman Research Institute of City of Hope	Wang, JH (corresponding author), City Hope Natl Med Ctr, Beckman Res Inst, Div Biol, Duarte, CA 91010 USA.	jsam@coh.org	Smith, David/A-4115-2017	Smith, David/0000-0001-9644-2353; Liu, Zheng/0000-0002-1635-1556	National Institutes of Health [R21 MH073754]; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH073754] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported in part by National Institutes of Health grant R21 MH073754 to JSS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBADI N, 1994, AM J MED GENET, V52, P198, DOI 10.1002/ajmg.1320520215; Ball MP, 2009, NAT BIOTECHNOL, V27, P361, DOI 10.1038/nbt.1533; Bartoe JL, 2006, J NEUROSCI, V26, P3192, DOI 10.1523/JNEUROSCI.3469-05.2006; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Bix M, 1998, SCIENCE, V281, P1352, DOI 10.1126/science.281.5381.1352; Brekke C, 2006, NEUROIMAGE, V29, P965, DOI 10.1016/j.neuroimage.2005.08.026; Brown JP, 2003, J COMP NEUROL, V467, P1, DOI 10.1002/cne.10874; CATTANACH BM, 1972, GENET RES, V19, P229, DOI 10.1017/S001667230001449X; CHEN C, 1994, SCIENCE, V266, P291, DOI 10.1126/science.7939668; CHESS A, 1994, CELL, V78, P823, DOI 10.1016/S0092-8674(94)90562-2; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; GARTLER SM, 1964, COLD SPRING HARB SYM, V29, P253, DOI 10.1101/SQB.1964.029.01.028; Gimelbrant AA, 2005, J BIOL CHEM, V280, P1354, DOI 10.1074/jbc.M411283200; Gimelbrant A, 2007, SCIENCE, V318, P1136, DOI 10.1126/science.1148910; Held W, 1997, EUR J IMMUNOL, V27, P2876, DOI 10.1002/eji.1830271120; Herculano-Houzel S, 2005, J NEUROSCI, V25, P2518, DOI 10.1523/JNEUROSCI.4526-04.2005; Hilgetag CC, 2009, BRAIN STRUCT FUNCT, V213, P365, DOI 10.1007/s00429-009-0202-z; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Illingworth R, 2008, PLOS BIOL, V6, P37, DOI 10.1371/journal.pbio.0060022; Irizarry RA, 2008, GENOME RES, V18, P780, DOI 10.1101/gr.7301508; JORGENSEN AL, 1992, AM J HUM GENET, V51, P291; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kerkel K, 2008, NAT GENET, V40, P904, DOI 10.1038/ng.174; Khulan B, 2006, GENOME RES, V16, P1046, DOI 10.1101/gr.5273806; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; Leonardo ED, 1997, NATURE, V386, P833, DOI 10.1038/386833a0; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Mostoslavsky R, 1998, GENE DEV, V12, P1801, DOI 10.1101/gad.12.12.1801; Nanobashvili A, 2000, P NATL ACAD SCI USA, V97, P12312, DOI 10.1073/pnas.97.22.12312; Pluschke G, 1996, P NATL ACAD SCI USA, V93, P9710, DOI 10.1073/pnas.93.18.9710; Rhead B, 2010, NUCLEIC ACIDS RES, V38, pD613, DOI 10.1093/nar/gkp939; RIMM IJ, 1989, MOL BIOL MED, V6, P355; Riviere I, 1998, IMMUNITY, V9, P217, DOI 10.1016/S1074-7613(00)80604-4; Rodriguez I, 1999, CELL, V97, P199, DOI 10.1016/S0092-8674(00)80730-8; Rosanoff MJ, 2008, NEUROLOGY, V71, P567, DOI 10.1212/01.wnl.0000323926.77565.ee; Rouhi A, 2006, J IMMUNOL, V176, P2991, DOI 10.4049/jimmunol.176.5.2991; Schumacher A, 2006, NUCLEIC ACIDS RES, V34, P528, DOI 10.1093/nar/gkj461; Seyfried NT, 2008, CANCER LETT, V263, P243, DOI 10.1016/j.canlet.2008.01.007; Shen L, 2007, PLOS GENET, V3, P2023, DOI 10.1371/journal.pgen.0030181; Shi YH, 2004, NATURE, V427, P78, DOI 10.1038/nature02211; Smith RJ, 2003, GENOME RES, V13, P558, DOI 10.1101/gr.781503; Song F, 2005, P NATL ACAD SCI USA, V102, P3336, DOI 10.1073/pnas.0408436102; Stegmuller J, 2003, J BIOL CHEM, V278, P3590, DOI 10.1074/jbc.M210010200; Suzuki M, 2007, GENES CELLS, V12, P1305, DOI 10.1111/j.1365-2443.2007.01136.x; Wang JH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001293; Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Wen B, 2008, GENOME RES, V18, P1806, DOI 10.1101/gr.067587.108; Williams ME, 2006, NAT NEUROSCI, V9, P996, DOI 10.1038/nn1736; Wilson CB, 2005, SEMIN IMMUNOL, V17, P105, DOI 10.1016/j.smim.2005.01.005; Zampetaki A, 2006, BIOCHEM BIOPH RES CO, V347, P89, DOI 10.1016/j.bbrc.2006.06.055	52	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2010	5	11							e13843	10.1371/journal.pone.0013843	http://dx.doi.org/10.1371/journal.pone.0013843			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675NY	21079792	Green Submitted, gold, Green Published			2022-12-27	WOS:000283838600017
J	Aparicio, E; Parera, M; Franco, S; Perez-Alvarez, N; Tural, C; Clotet, B; Martinez, MA				Aparicio, Ester; Parera, Mariona; Franco, Sandra; Perez-Alvarez, Nuria; Tural, Cristina; Clotet, Bonaventura; Angel Martinez, Miguel			IL28B SNP rs8099917 Is Strongly Associated with Pegylated Interferon-alpha and Ribavirin Therapy Treatment Failure in HCV/HIV-1 Coinfected Patients	PLOS ONE			English	Article							HEPATITIS-C VIRUS; HUMAN-IMMUNODEFICIENCY-VIRUS; PLUS RIBAVIRIN; ANTIVIRAL THERAPY; GENETIC-VARIATION; RANDOMIZED-TRIAL; PEG-INTERFERON; HCV INFECTION; PEGINTERFERON; HIV	Recent genome-wide association studies report that the SNP rs8099917, located 8.9 kb upstream of the start codon of IL28B, is associated with both disease chronicity and therapeutic response to pegIFN-alpha and RBV in patients infected with genotype 1 HCV. To determine the effect of rs8099917 variation on the response of HCV to therapy, we genotyped this variant in a cohort of 160 HCV/HIV-1 coinfected patients in our clinic unit who received combined peg-IFN-alpha/RBV therapy. The rs8099917 T/G or G/G genotypes were observed in 56 patients (35%). Treatment failure occurred in 80% of G-allele carriers versus 48% of non-carriers (P < 0.0001). This result reveals that the G allele was strongly associated with treatment failure in this patient cohort. Importantly, a highly significant association was found between the G-allele and response to therapy in HCV genotype 1-infected patients (P < 0.0001) but not in HCV genotype 3-infected patients. Multivariate analysis (odds ratio; 95% confidence interval; P value) indicated that the rs8099917 TT genotype was a strong predictor of treatment success (5.83; 1.26-26.92; P = 0.021), independent of baseline plasma HCV-RNA load less than 500 000 IU/ml (4.85; 1.18-19.95; P = 0.025) and absence of advanced liver fibrosis (5.24; 1.20-22.91; P = 0.025). These results reveal the high prevalence of the rs8099917 G allele in HCV/HIV-1 coinfected patients as well as its strong association with treatment failure in HCV genotype 1-infected patients. rs8099917 SNP genotyping may be a valid pre-treatment predictor of which patients are likely to respond to treatment in this group of difficult-to-treat HCV/HIV-infected patients.	[Aparicio, Ester; Parera, Mariona; Franco, Sandra; Clotet, Bonaventura; Angel Martinez, Miguel] Univ Autonoma Barcelona, Hosp Univ Germans Trias & Pujol, Fundacio IrsiCaixa, E-08193 Barcelona, Spain; [Perez-Alvarez, Nuria; Tural, Cristina; Clotet, Bonaventura] Hosp Badalona Germans Trias & Pujol, Fundacio Lluita Sida, Badalona, Spain; [Perez-Alvarez, Nuria] Tech Univ Catalonia, Stat & Operat Res Dept, Barcelona, Spain	Autonomous University of Barcelona; Hospital Germans Trias i Pujol; Institut de Recerca de la Sida - IrsiCaixa; Hospital Germans Trias i Pujol; Universitat Politecnica de Catalunya	Aparicio, E (corresponding author), Univ Autonoma Barcelona, Hosp Univ Germans Trias & Pujol, Fundacio IrsiCaixa, E-08193 Barcelona, Spain.	mmartinez@irsicaixa.es	Franco, Sandra/S-6843-2019; Franco, Sandra/E-6114-2016; Martinez, Miguel Angel/K-6435-2014; Perez-Alvarez, Nuria/O-9244-2014	Franco, Sandra/0000-0003-4126-2202; Franco, Sandra/0000-0003-4126-2202; Martinez, Miguel Angel/0000-0002-6681-4950; Perez-Alvarez, Nuria/0000-0001-6582-1553; Parera Sallent, Mariona/0000-0002-0756-8307	Spanish Ministerio de Ciencia e Innovacion, Fondo de Investigaciones Sanitarias [PI07/0098]; Red Tematica de Investigacion Cooperativa en SIDA [RD06/0006]	Spanish Ministerio de Ciencia e Innovacion, Fondo de Investigaciones Sanitarias(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentInstituto de Salud Carlos III); Red Tematica de Investigacion Cooperativa en SIDA	This study was supported by the Spanish Ministerio de Ciencia e Innovacion, Fondo de Investigaciones Sanitarias project PI07/0098 and through "Red Tematica de Investigacion Cooperativa en SIDA" Grant RD06/0006. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballesteros AL, 2004, AIDS, V18, P59, DOI 10.1097/00002030-200401020-00007; Berenguer J, 2009, HEPATOLOGY, V50, P407, DOI 10.1002/hep.23020; Chen TY, 2009, CLIN INFECT DIS, V49, P1605, DOI 10.1086/644771; Chevaliez S, 2007, WORLD J GASTROENTERO, V13, P2461, DOI 10.3748/wjg.v13.i17.2461; Dodds MG, 2009, J HEPATOL, V50, pS342, DOI 10.1016/S0168-8278(09)60944-2; Firmann M, 2008, BMC CARDIOVASC DISOR, V8, DOI 10.1186/1471-2261-8-6; Franco S, 2007, HEPATOLOGY, V45, P899, DOI 10.1002/hep.21623; Fried MW, 2000, AM J GASTROENTEROL, V95, P3225, DOI 10.1111/j.1572-0241.2000.03433.x; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Gao B, 2004, HEPATOLOGY, V39, P880, DOI 10.1002/hep.20139; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Hadziyannis SJ, 2004, ANN INTERN MED, V140, P346, DOI 10.7326/0003-4819-140-5-200403020-00010; Hezode C, 2009, NEW ENGL J MED, V360, P1839, DOI 10.1056/NEJMoa0807650; Ibanez A, 1998, J MED VIROL, V55, P293, DOI 10.1002/(SICI)1096-9071(199808)55:4&lt;293::AID-JMV7&gt;3.0.CO;2-W; Kotenko SV, 2003, NAT IMMUNOL, V4, P69, DOI 10.1038/ni875; Kronenberger B, 2009, ANN HEPATOL, V8, P103, DOI 10.1016/S1665-2681(19)31786-7; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; MAS A, J MOL BIOL, V397, P865; Muir A, 2009, HEPATOLOGY, V50, p1039A; Pineda JA, 2010, CLIN INFECT DIS, V51, P788, DOI 10.1086/656235; RALLON NI, 1928, AIDS, V24, pF23; Rauch A, 2010, GASTROENTEROLOGY, V138, P1338, DOI 10.1053/j.gastro.2009.12.056; Rockstroh JK, 2008, HIV MED, V9, P82, DOI 10.1111/j.1468-1293.2007.00535.x; Rockstroh JK, 2004, LANCET INFECT DIS, V4, P437, DOI 10.1016/S1473-3099(04)01059-X; Sarrazin C, 2010, GASTROENTEROLOGY, V138, P447, DOI 10.1053/j.gastro.2009.11.055; Suppiah V, 2009, NAT GENET, V41, P1100, DOI 10.1038/ng.447; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Thomas DL, 2009, NATURE, V461, P798, DOI 10.1038/nature08463; Torriani FJ, 2004, NEW ENGL J MED, V351, P438, DOI 10.1056/NEJMoa040842; Walsh MJ, 2006, GUT, V55, P529, DOI 10.1136/gut.2005.069674	30	66	72	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2010	5	10							e13771	10.1371/journal.pone.0013771	http://dx.doi.org/10.1371/journal.pone.0013771			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673FU	21048934	Green Published, Green Submitted, gold			2022-12-27	WOS:000283645300045
J	Lard, M; Backman, J; Yakovleva, M; Danielsson, B; Hansson, LA				Lard, Mercy; Backman, Johan; Yakovleva, Maria; Danielsson, Bengt; Hansson, Lars-Anders			Tracking the Small with the Smallest - Using Nanotechnology in Tracking Zooplankton	PLOS ONE			English	Article							SEMICONDUCTOR QUANTUM DOTS; VERTICAL MIGRATION; DAPHNIA-MAGNA; NANOPARTICLES; UV; STREPTAVIDIN; PIGMENTATION; NANOCRYSTALS; THREATS	A major problem when studying behavior and migration of small organisms is that many of the questions addressed for larger animals are not possible to formulate due to constraints on tracking smaller animals. In aquatic ecosystems, this problem is particularly problematic for zoo- and phytoplankton, since tracking devices are too heavy to allow the organism to act naturally. However, recent advances in nanotechnology have made it possible to track individual animals and thereby to focus on important and urgent questions which previously have not been possible to address. Here we report on a novel approach to track movement and migratory behavior of millimeter sized aquatic animals, particularly Daphnia magna, using the commercially available nanometer sized fluorescent probes known as quantum dots. Experimental trials with and without quantum dots showed that they did not affect behavior, reproduction or mortality of the tested animals. Compared to previously used methods to label small animals, the nano-labeling method presented here offers considerable improvements including: 24 h fluorescence, studies in both light and darkness, much improved optical properties, potential to study large volumes and even track animals in semi-natural conditions. Hence, the suggested method, developed in close cooperation between biologists, chemists and physicists, offers new opportunities to routinely study zooplankton responses to light, food and predation, opening up advancements within research areas such as diel vertical/horizontal migration, partial migration and other differences in intra- and interspecific movements and migration.	[Lard, Mercy; Backman, Johan; Hansson, Lars-Anders] Lund Univ, Inst Biol, Lund, Sweden; [Yakovleva, Maria] Lund Univ, Dept Infect Dis & Med Microbiol, Lund, Sweden; [Danielsson, Bengt] Lund Univ, Dept Pure & Appl Biochem, Lund, Sweden	Lund University; Lund University; Lund University	Lard, M (corresponding author), Lund Univ, Inst Biol, Lund, Sweden.	lars-anders.hansson@limnol.lu.se	Lard, Mercy/C-4193-2011; Lard, Mercy/AAV-6577-2021; Hansson, Lars-Anders/HCI-2735-2022; Lard, Mercy/R-2035-2019	Lard, Mercy/0000-0001-9243-4735; Lard, Mercy/0000-0001-9243-4735; Hansson, Lars-Anders/0000-0002-3035-1317	Swedish Research Council; Linnean Grant	Swedish Research Council(Swedish Research CouncilEuropean Commission); Linnean Grant	The study was financed by the Swedish Research Council (VR) and the Linnean Grant to the Center for Animal Migration (CanMove). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alivisatos AP, 1996, J PHYS CHEM-US, V100, P13226, DOI 10.1021/jp9535506; Ballou B, 2007, BIOCONJUGATE CHEM, V18, P389, DOI 10.1021/bc060261j; Biju V, 2008, ANAL BIOANAL CHEM, V391, P2469, DOI 10.1007/s00216-008-2185-7; BRO N, 2010, HYDROBIOLOGIA, V646, P91; Bruchez M, 1998, SCIENCE, V281, P2013, DOI 10.1126/science.281.5385.2013; Chan WCW, 1998, SCIENCE, V281, P2016, DOI 10.1126/science.281.5385.2016; Galarza A., 2009, Animal Biodiversity and Conservation, V32, P117; Gao XH, 2004, NAT BIOTECHNOL, V22, P969, DOI 10.1038/nbt994; GITLIN G, 1988, BIOCHEM J, V256, P279, DOI 10.1042/bj2560279; Hansson LA, 2000, ECOLOGY, V81, P842, DOI 10.2307/177381; Hansson LA, 2007, ECOLOGY, V88, P1932, DOI 10.1890/06-2038.1; Hansson LA, 2007, OIKOS, V116, P585, DOI 10.1111/j.2007.0030-1299.15754.x; Hansson LA, 2009, P R SOC B, V276, P331, DOI 10.1098/rspb.2008.1088; Hauck TS, 2010, SMALL, V6, P138, DOI 10.1002/smll.200900626; Hylander S, 2009, LIMNOL OCEANOGR, V54, P483, DOI 10.4319/lo.2009.54.2.0483; Jackson BP, 2009, ANAL BIOANAL CHEM, V394, P911, DOI 10.1007/s00216-009-2768-y; Jaiswal JK, 2003, NAT BIOTECHNOL, V21, P47, DOI 10.1038/nbt767; Liu W, 2008, J AM CHEM SOC, V130, P1274, DOI 10.1021/ja076069p; Morell V, 2009, SCIENCE, V323, P1284, DOI 10.1126/science.323.5919.1284; OBRIEN JJ, 1991, BIOL BULL, V181, P427, DOI 10.2307/1542363; Rogach A.L., 2008, SEMICONDUCTOR NANOCR; Smith AM, 2008, ADV DRUG DELIVER REV, V60, P1226, DOI 10.1016/j.addr.2008.03.015; SMITH KC, 1990, J COMP PHYSIOL A, V166, P597; Sperling RA, 2010, PHILOS T R SOC A, V368, P1333, DOI 10.1098/rsta.2009.0273; STICH HB, 1981, NATURE, V293, P396, DOI 10.1038/293396a0; Sun MM, 2010, STEROIDS, V75, P400, DOI 10.1016/j.steroids.2010.02.002	26	21	22	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2010	5	10							e13516	10.1371/journal.pone.0013516	http://dx.doi.org/10.1371/journal.pone.0013516			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673FU	21060826	Green Submitted, Green Published, gold			2022-12-27	WOS:000283645300001
J	Zhao, H; Shen, J; Medico, L; Wang, D; Ambrosone, CB; Liu, S				Zhao, Hua; Shen, Jie; Medico, Leonard; Wang, Dan; Ambrosone, Christine B.; Liu, Song			A Pilot Study of Circulating miRNAs as Potential Biomarkers of Early Stage Breast Cancer	PLOS ONE			English	Article							MICRORNA-21 TARGETS; TUMOR INVASION; METASTASIS; SERUM; MARKERS	Background: To date, there are no highly sensitive and specific minimally invasive biomarkers for detection of breast cancer at an early stage. The occurrence of circulating microRNAs (miRNAs) in blood components (including serum and plasma) has been repeatedly observed in cancer patients as well as healthy controls. Because of the significance of miRNA in carcinogenesis, circulating miRNAs in blood may be unique biomarkers for early and minimally invasive diagnosis of human cancers. The objective of this pilot study was to discover a panel of circulating miRNAs as potential novel breast cancer biomarkers. Methodology/Principal Findings: Using microarray-based expression profiling followed by Real-Time quantitative Polymerase Cycle Reaction (RT-qPCR) validation, we compared the levels of circulating miRNAs in plasma samples from 20 women with early stage breast cancer (10 Caucasian American (CA) and 10 African American (AA)) and 20 matched healthy controls (10 CAs and 10 AAs). Using the significance level of p<0.05 constrained by at least two-fold expression change as selection criteria, we found that 31 miRNAs were differentially expressed in CA study subjects (17 up and 14 down) and 18 miRNAs were differentially expressed in AA study subjects (9 up and 9 down). Interestingly, only 2 differentially expressed miRNAs overlapped between CA and AA study subjects. Using receiver operational curve (ROC) analysis, we show that not only up-regulated but also down-regulated miRNAs can discriminate patients with breast cancer from healthy controls with reasonable sensitivity and specificity. To further explore the potential roles of these circulating miRNAs in breast carcinogenesis, we applied pathway-based bioinformatics exploratory analysis and predicted a number of significantly enriched pathways which are predicted to be regulated by these circulating miRNAs, most of which are involved in critical cell functions, cancer development and progression. Conclusions: Our observations from this pilot study suggest that the altered levels of circulating miRNAs might have great potential to serve as novel, noninvasive biomarkers for early detection of breast cancer.	[Zhao, Hua; Shen, Jie; Medico, Leonard; Ambrosone, Christine B.] Roswell Pk Canc Inst, Dept Canc Prevent & Controls, Buffalo, NY 14263 USA; [Wang, Dan; Liu, Song] Roswell Pk Canc Inst, Dept Biostat, Buffalo, NY 14263 USA	Roswell Park Cancer Institute; Roswell Park Cancer Institute	Zhao, H (corresponding author), Roswell Pk Canc Inst, Dept Canc Prevent & Controls, Buffalo, NY 14263 USA.	hua.zhao@roswellpark.org; song.liu@roswellpark.org			NIH/NCI [5R01CA136483]; Congressionally directed Medical Research Program [BC074340]; NATIONAL CANCER INSTITUTE [P30CA016056, R01CA136483] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Congressionally directed Medical Research Program(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The study is supported by grants from NIH/NCI (5R01CA136483) www.nih.gov and Congressionally directed Medical Research Program (BC074340) http://cdmrp.army.mil/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrosone CB, 2006, CANCER EPIDEM BIOMAR, V15, P1575, DOI 10.1158/1055-9965.EPI-06-0628; Asangani IA, 2008, ONCOGENE, V27, P2128, DOI 10.1038/sj.onc.1210856; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Friedlander MR, 2008, NAT BIOTECHNOL, V26, P407, DOI 10.1038/nbt1394; Gilad S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003148; Grinchuk OV, 2010, NUCLEIC ACIDS RES, V38, P534, DOI 10.1093/nar/gkp954; Harris L, 2007, J CLIN ONCOL, V25, P5287, DOI 10.1200/JCO.2007.14.2364; Heneghan HM, 2010, ANN SURG, V251, P499, DOI 10.1097/SLA.0b013e3181cc939f; Huang DW, 2007, NUCLEIC ACIDS RES, V35, pW169, DOI 10.1093/nar/gkm415; Huang QH, 2008, NAT CELL BIOL, V10, P202, DOI 10.1038/ncb1681; Huang ZH, 2010, INT J CANCER, V127, P118, DOI 10.1002/ijc.25007; Hurst DR, 2009, CANCER RES, V69, P7495, DOI 10.1158/0008-5472.CAN-09-2111; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Johnson R, 2008, NEUROBIOL DIS, V29, P438, DOI 10.1016/j.nbd.2007.11.001; Lawrie CH, 2008, BRIT J HAEMATOL, V141, P672, DOI 10.1111/j.1365-2141.2008.07077.x; Lodes MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006229; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Mattie MD, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-24; Millikan RC, 2008, BREAST CANCER RES TR, V109, P123, DOI 10.1007/s10549-007-9632-6; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Morozova O, 2009, ANNU REV GENOM HUM G, V10, P135, DOI 10.1146/annurev-genom-082908-145957; OHANLON DM, 1995, BRIT J CANCER, V71, P1288, DOI 10.1038/bjc.1995.249; Piccart-Gebhart MJ, 2005, NEW ENGL J MED, V353, P1659, DOI 10.1056/NEJMoa052306; Resnick KE, 2009, GYNECOL ONCOL, V112, P55, DOI 10.1016/j.ygyno.2008.08.036; Selcuklu SD, 2009, CANCER GENET CYTOGEN, V189, P15, DOI 10.1016/j.cancergencyto.2008.09.009; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; Smyth GK, 2004, STAT APPL GENET MOL, V5, pR3; Taplin S, 2008, J NATL CANCER I, V100, P876, DOI 10.1093/jnci/djn172; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; Thompson A, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1983; Uehara M, 2008, INT J CLIN ONCOL, V13, P447, DOI 10.1007/s10147-008-0773-3; Valastyan S, 2009, CELL, V137, P1032, DOI 10.1016/j.cell.2009.03.047; Van der Auwera I, 2009, CANCER RES, V69, p862S; Wang K, 2009, P NATL ACAD SCI USA, V106, P4402, DOI 10.1073/pnas.0813371106; ZHAO Y, 2010, BREAST CANC RES 0610; Zhu SM, 2008, CELL RES, V18, P350, DOI 10.1038/cr.2008.24; Zhu SM, 2007, J BIOL CHEM, V282, P14328, DOI 10.1074/jbc.M611393200	40	304	331	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2010	5	10							e13735	10.1371/journal.pone.0013735	http://dx.doi.org/10.1371/journal.pone.0013735			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673FU	21060830	gold, Green Published, Green Submitted			2022-12-27	WOS:000283645300015
J	Graves, JA; Rothermund, K; Wang, T; Qian, W; Van Houten, B; Prochownik, EV				Graves, J. Anthony; Rothermund, Kristi; Wang, Tao; Qian, Wei; Van Houten, Bennett; Prochownik, Edward V.			Point Mutations in c-Myc Uncouple Neoplastic Transformation from Multiple Other Phenotypes in Rat Fibroblasts	PLOS ONE			English	Article							N-TERMINAL DOMAIN; GENOMIC INSTABILITY; GENE-EXPRESSION; GLUTAMATE EXCITOTOXICITY; TRANSACTIVATION DOMAIN; AEROBIC GLYCOLYSIS; TUMOR-SUPPRESSOR; BURKITT-LYMPHOMA; CANCER-CELLS; DNA-DAMAGE	Deregulation of c-Myc (Myc) occurs in many cancers. In addition to transforming various cell types, Myc also influences additional transformation-associated cellular phenotypes including proliferation, survival, genomic instability, reactive oxygen species production, and metabolism. Although Myc is wild type in most cancers (wtMyc), it occasionally acquires point mutations in certain lymphomas. Some of these mutations confer a survival advantage despite partially attenuating proliferation and transformation. Here, we have evaluated four naturally-occurring or synthetic point mutations of Myc for their ability to affect these phenotypes, as well as to promote genomic instability, to generate reactive oxygen species and to up-regulate aerobic glycolysis and oxidative phosphorylation. Our findings indicate that many of these phenotypes are genetically and functionally independent of one another and are not necessary for transformation. Specifically, the higher rate of glucose metabolism known to be associated with wtMyc deregulation was found to be independent of transformation. One mutation (Q131R) was greatly impaired for nearly all of the studied Myc phenotypes, yet was able to retain some ability to transform. These findings indicate that, while the Myc phenotypes examined here make additive contributions to transformation, none, with the possible exception of increased reliance on extracellular glutamine for survival, are necessary for achieving this state.	[Graves, J. Anthony; Rothermund, Kristi; Prochownik, Edward V.] Univ Pittsburgh, Dept Pediat, Div Hematol Oncol, Childrens Hosp Pittsburgh,Med Ctr, Pittsburgh, PA 15260 USA; [Wang, Tao; Qian, Wei; Van Houten, Bennett; Prochownik, Edward V.] Univ Pittsburgh, Inst Canc, Pittsburgh, PA 15260 USA; [Wang, Tao; Qian, Wei; Van Houten, Bennett] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Med Ctr, Pittsburgh, PA 15260 USA; [Prochownik, Edward V.] Univ Pittsburgh, Dept Microbiol & Mol Genet, Med Ctr, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Graves, JA (corresponding author), Univ Pittsburgh, Dept Pediat, Div Hematol Oncol, Childrens Hosp Pittsburgh,Med Ctr, Pittsburgh, PA 15260 USA.	gravja@chp.edu	Van Houten, Bennett/K-2284-2019		National Institutes of Health (NIH) [CA140624, CA78259]; University of Pittsburgh Cancer Institute; Pennsylvania Settlement Fund; NIH [HD052892]; Robert Wood Johnson Foundation; Hyundai Hope on Wheels Scholarship; Commonwealth Universal Research Enhancement (C.U.R.E.); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD052892] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA078259, R01CA140624] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Pittsburgh Cancer Institute; Pennsylvania Settlement Fund; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); Hyundai Hope on Wheels Scholarship; Commonwealth Universal Research Enhancement (C.U.R.E.); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health (NIH) grants CA140624 and CA78259 to EVP, by The University of Pittsburgh Cancer Institute and Commonwealth Universal Research Enhancement (C.U.R.E.) Program, Pennsylvania Settlement Fund to BVH, and by the K12 NIH Mentored Clinical Scientist Development Program Award HD052892, the Harold Amos Medical Faculty Development Program sponsored by the Robert Wood Johnson Foundation and the Hyundai Hope on Wheels Scholarship to JAG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERT T, 1994, ONCOGENE, V9, P759; Altenberg B, 2004, GENOMICS, V84, P1014, DOI 10.1016/j.ygeno.2004.08.010; Bahram F, 2000, BLOOD, V95, P2104, DOI 10.1182/blood.V95.6.2104; Barrett John F., 2005, BMC Biochemistry, V6, DOI 10.1186/1471-2091-6-7; BHATIA K, 1994, BLOOD, V84, P883; Boxer LM, 2001, ONCOGENE, V20, P5595, DOI 10.1038/sj.onc.1204595; BROUGH DE, 1995, MOL CELL BIOL, V15, P1536; Chang DW, 2000, MOL CELL BIOL, V20, P4309, DOI 10.1128/MCB.20.12.4309-4319.2000; Dang CV, 2009, CLIN CANCER RES, V15, P6479, DOI 10.1158/1078-0432.CCR-09-0889; DeBerardinis RJ, 2008, CURR OPIN GENET DEV, V18, P54, DOI 10.1016/j.gde.2008.02.003; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; Egler RA, 2005, ONCOGENE, V24, P8038, DOI 10.1038/sj.onc.1208821; Elstrom RL, 2004, CANCER RES, V64, P3892, DOI 10.1158/0008-5472.CAN-03-2904; EVAN GI, 1992, CELL, V69, P119, DOI 10.1016/0092-8674(92)90123-T; Funes JM, 2007, P NATL ACAD SCI USA, V104, P6223, DOI 10.1073/pnas.0700690104; Ganem NJ, 2007, CELL, V131, P437, DOI 10.1016/j.cell.2007.10.024; Graves JA, 2009, J BIOL CHEM, V284, P6520, DOI 10.1074/jbc.M807564200; HOANG AT, 1995, MOL CELL BIOL, V15, P4031; Hoffman B, 2008, ONCOGENE, V27, P6462, DOI 10.1038/onc.2008.312; Kim JW, 2006, CANCER RES, V66, P8927, DOI 10.1158/0008-5472.CAN-06-1501; Kroemer G, 2008, CANCER CELL, V13, P472, DOI 10.1016/j.ccr.2008.05.005; Kuttler F, 2001, ONCOGENE, V20, P6084, DOI 10.1038/sj.onc.1204827; Li F, 2005, MOL CELL BIOL, V25, P6225, DOI 10.1128/MCB.25.14.6225-6234.2005; Li Y, 2008, ONCOGENE, V27, P1599, DOI 10.1038/sj.onc.1210794; Mannava S, 2008, CELL CYCLE, V7, P2392, DOI 10.4161/cc.6390; Matoba S, 2006, SCIENCE, V312, P1650, DOI 10.1126/science.1126863; McMahon SB, 1998, CELL, V94, P363, DOI 10.1016/S0092-8674(00)81479-8; Morrish F, 2008, CELL CYCLE, V7, P1054, DOI 10.4161/cc.7.8.5739; Mu ZM, 2002, J BIOL CHEM, V277, P43175, DOI 10.1074/jbc.M206066200; Nesbit CE, 1999, ONCOGENE, V18, P3004, DOI 10.1038/sj.onc.1202746; Nesbit CE, 2000, ONCOGENE, V19, P3200, DOI 10.1038/sj.onc.1203636; Nicholls DG, 2007, J NEUROSCI RES, V85, P3206, DOI 10.1002/jnr.21290; Oster SK, 2003, ONCOGENE, V22, P1998, DOI 10.1038/sj.onc.1206228; Osthus RC, 2000, J BIOL CHEM, V275, P21797, DOI 10.1074/jbc.C000023200; Papas KK, 1999, FEBS LETT, V446, P338, DOI 10.1016/S0014-5793(99)00240-9; Prochownik EV, 2008, CURR MOL MED, V8, P446, DOI 10.2174/156652408785747988; PULVERER BJ, 1994, ONCOGENE, V9, P59; RABBITTS TH, 1983, NATURE, V306, P760, DOI 10.1038/306760a0; Rarnanathan A, 2005, P NATL ACAD SCI USA, V102, P5992, DOI 10.1073/pnas.0502267102; Rogulski K, 2005, ONCOGENE, V24, P7524, DOI 10.1038/sj.onc.1208897; Rothermund K, 2005, CANCER RES, V65, P2097, DOI 10.1158/0008-5472.CAN-04-2928; Sakamuro D, 1996, NAT GENET, V14, P69, DOI 10.1038/ng0996-69; SETH A, 1991, J BIOL CHEM, V266, P23521; Shim H, 1998, P NATL ACAD SCI USA, V95, P1511, DOI 10.1073/pnas.95.4.1511; STONE J, 1987, MOL CELL BIOL, V7, P1697, DOI 10.1128/MCB.7.5.1697; Stone JR, 2006, ANTIOXID REDOX SIGN, V8, P243, DOI 10.1089/ars.2006.8.243; TOMAYKO MM, 1989, CANCER CHEMOTH PHARM, V24, P148, DOI 10.1007/BF00300234; Vafa O, 2002, MOL CELL, V9, P1031, DOI 10.1016/S1097-2765(02)00520-8; Wang H, 2008, ONCOGENE, V27, P1905, DOI 10.1038/sj.onc.1210823; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Wu M, 2007, AM J PHYSIOL-CELL PH, V292, pC125, DOI 10.1152/ajpcell.00247.2006; Yadava N, 2007, J NEUROSCI, V27, P7310, DOI 10.1523/JNEUROSCI.0212-07.2007; YANO T, 1993, ONCOGENE, V8, P2741; Yin XY, 1999, ONCOGENE, V18, P1177, DOI 10.1038/sj.onc.1202410; Yin XY, 2002, J BIOL CHEM, V277, P19998, DOI 10.1074/jbc.M200860200; Yin XY, 2001, CANCER RES, V61, P6487; Yuneva M, 2007, J CELL BIOL, V178, P93, DOI 10.1083/jcb.200703099; Zhang H, 1997, J BIOL CHEM, V272, P17416, DOI 10.1074/jbc.272.28.17416	58	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2010	5	10							e13717	10.1371/journal.pone.0013717	http://dx.doi.org/10.1371/journal.pone.0013717			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	672HN	21060841	Green Published, gold, Green Accepted			2022-12-27	WOS:000283573800016
J	Bao, F; Feng, LL; Gao, J; Tan, ZF; Xing, B; Ma, R; Yan, CJ				Bao, Feng; Feng, Lingling; Gao, Jie; Tan, Zhifang; Xing, Bin; Ma, Rui; Yan, Chunjie			New Cobalt-Mediated Radical Polymerization (CMRP) of Methyl Methacrylate Initiated by Two Single-Component Dinuclear beta-Diketone Cobalt (II) Catalysts	PLOS ONE			English	Article							ORGANOCOBALT PORPHYRIN COMPLEXES; VINYL-ACETATE; ACRYLATES; LIGANDS; STYRENE	Two dinuclear cobalt complexes based on bis-diketonate ligands (ligand 1: 3,3'-(1,3-phenylene)bis(1-phenylpropane-1,3-dione); ligand 2: 3,3'-(1,4-phenylene)bis(1-phenylpropane-1,3-dione)) were successfully synthesized. The two neutral catalysts all showed satisfactory activities in the cobalt-mediated radical polymerization (CMRP) of methyl methacrylate (MMA) with the common initiator of azodiisobutyronitrile (AIBN). The resulting polymerizations have all of the characteristics of a living polymerization and displayed linear semilogarithmic kinetic plots, a linear correlation between the number-average molecular weight and the monomer conversion, and low polydispersities. Mono-or dicomponent low polydispersity polymers could be obtained by using the two dinuclear catalysts under proper reaction conditions. All these improvements facilitate the implementation of the acrylate CMRP and open the door to the scale-up of the syntheses and applications of the multicomponent low polydispersity polymers.	[Bao, Feng; Feng, Lingling; Gao, Jie; Tan, Zhifang; Xing, Bin] Cent China Normal Univ, Coll Chem, Wuhan, Peoples R China; [Ma, Rui; Yan, Chunjie] China Univ Geosci, Dept Mat Sci & Chem Engn, Wuhan 430074, Peoples R China	Central China Normal University; China University of Geosciences	Bao, F (corresponding author), Cent China Normal Univ, Coll Chem, Wuhan, Peoples R China.	polymerbaofeng@yahoo.com.cn; marui.cug@gmail.com			Fundamental Research Funds for the Central Universities [CUGL100407]; National Natural Science Foundation of China [50903077, 20872044]; Natural Science Foundation of Hubei Province [2009CDB163, 2008CDZ065]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hubei Province(Natural Science Foundation of Hubei Province)	This work was supported by the Fundamental Research Funds for the Central Universities (CUGL100407) and the National Natural Science Foundation of China (50903077, 20872044), the Natural Science Foundation of Hubei Province (2009CDB163, 2008CDZ065). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARVANITOPOULOS LD, 1994, POLYM PREPR AM CHEM, V35, P549; Bassett AP, 2004, J AM CHEM SOC, V126, P9413, DOI 10.1021/ja048022z; Bryaskova R, 2006, MACROMOLECULES, V39, P8263, DOI 10.1021/ma060339r; Burgess J, 2000, ACTA CRYSTALLOGR C, V56, P649; Clegg JK, 2008, DALTON T, P1331, DOI 10.1039/b716653b; COTTON FA, 1964, INORG CHEM, V3, P1, DOI 10.1021/ic50011a001; Debuigne A, 2005, ANGEW CHEM INT EDIT, V44, P1101, DOI 10.1002/anie.200461333; Debuigne A, 2005, ANGEW CHEM INT EDIT, V44, P3439, DOI 10.1002/anie.200500112; Goto A, 2004, PROG POLYM SCI, V29, P329, DOI 10.1016/j.progpolymsci.2004.01.002; Hu T, 2005, ORGANOMETALLICS, V24, P2628, DOI 10.1021/om049223e; Huang YB, 2008, ORGANOMETALLICS, V27, P259, DOI 10.1021/om700901x; Kaneyoshi H, 2005, MACROMOLECULES, V38, P8163, DOI 10.1021/ma051433v; Lu Z, 2004, MACROMOLECULES, V37, P2686, DOI 10.1021/ma035924w; Maria S, 2007, CHEM-EUR J, V13, P2480, DOI 10.1002/chem.200601457; Matsubara K, 2006, J POLYM SCI POL CHEM, V44, P4222, DOI 10.1002/pola.21498; Matyjaszewski K, 2001, CHEM REV, V101, P2921, DOI 10.1021/cr940534g; Patten TE, 1996, SCIENCE, V272, P866, DOI 10.1126/science.272.5263.866; Peng CH, 2008, MACROMOLECULES, V41, P2368, DOI 10.1021/ma702500b; PERCEC V, 1995, MACROMOLECULES, V28, P7970, DOI 10.1021/ma00127a057; Soldatov DV, 2003, CRYST GROWTH DES, V3, P1005, DOI 10.1021/cg030016b; Tang HD, 2006, J AM CHEM SOC, V128, P16277, DOI 10.1021/ja0653369; Wang BQ, 2003, MACROMOLECULES, V36, P9684, DOI 10.1021/ma035334y; Wang LC, 2002, J AM CHEM SOC, V124, P9448, DOI 10.1021/ja020223k; Wayland BB, 1997, MACROMOLECULES, V30, P8109, DOI 10.1021/ma9707493; WAYLAND BB, 1994, J AM CHEM SOC, V116, P7943, DOI 10.1021/ja00096a080; Weiser MS, 2005, J POLYM SCI POL CHEM, V43, P3804, DOI 10.1002/pola.20873; Zhang D, 2003, ORGANOMETALLICS, V22, P2851, DOI 10.1021/om030068y	27	6	6	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2010	5	10							e13629	10.1371/journal.pone.0013629	http://dx.doi.org/10.1371/journal.pone.0013629			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671GB	21049027	Green Published, Green Submitted, gold			2022-12-27	WOS:000283487400019
J	He, J; Zhang, JF; Yi, C; Lv, Q; Xie, WD; Li, JN; Wan, G; Cui, K; Kung, HF; Yang, J; Yang, BB; Zhang, YO				He, Jie; Zhang, Jin-fang; Yi, Can; Lv, Qing; Xie, Wei-dong; Li, Jian-na; Wan, Gang; Cui, Kai; Kung, Hsiang-fu; Yang, Jennifer; Yang, Burton B.; Zhang, Yaou			miRNA-Mediated Functional Changes through Co-Regulating Function Related Genes	PLOS ONE			English	Article							BONE MORPHOGENETIC PROTEINS; OSTEOBLAST DIFFERENTIATION; MICRORNAS; EXPRESSION; GROWTH	Background: microRNAs play important roles in various biological processes involving fairly complex mechanism. Analysis of genome-wide miRNA microarray demonstrate that a single miRNA can regulate hundreds of genes, but the regulative extent on most individual genes is surprisingly mild so that it is difficult to understand how a miRNA provokes detectable functional changes with such mild regulation. Results: To explore the internal mechanism of miRNA-mediated regulation, we re-analyzed the data collected from genome-wide miRNA microarray with bioinformatics assay, and found that the transfection of miR-181b and miR-34a in Hela and HCT-116 tumor cells regulated large numbers of genes, among which, the genes related to cell growth and cell death demonstrated high Enrichment scores, suggesting that these miRNAs may be important in cell growth and cell death. MiR-181b induced changes in protein expression of most genes that were seemingly related to enhancing cell growth and decreasing cell death, while miR-34a mediated contrary changes of gene expression. Cell growth assays further confirmed this finding. In further study on miR-20b-mediated osteogenesis in hMSCs, miR-20b was found to enhance osteogenesis by activating BMPs/Runx2 signaling pathway in several stages by co-repressing of PPAR gamma, Bambi and Crim1. Conclusions: With its multi-target characteristics, miR-181b, miR-34a and miR-20b provoked detectable functional changes by co-regulating functionally-related gene groups or several genes in the same signaling pathway, and thus mild regulation from individual miRNA targeting genes could have contributed to an additive effect. This might also be one of the modes of miRNA-mediated gene regulation.	[He, Jie; Zhang, Jin-fang; Yi, Can; Lv, Qing; Wan, Gang; Cui, Kai] Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China; [He, Jie; Zhang, Jin-fang; Yi, Can; Lv, Qing; Xie, Wei-dong; Li, Jian-na; Wan, Gang; Cui, Kai; Zhang, Yaou] Tsinghua Univ, Grad Sch Shenzhen, Div Life Sci, Shenzhen 518057, Peoples R China; [Kung, Hsiang-fu] Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Hong Kong, Hong Kong, Peoples R China; [Yang, Burton B.] Univ Toronto, Sunnybrook Hlth Sci Ctr, Dept Lab Med & Pathol, Toronto, ON, Canada; [Yang, Jennifer] Univ Toronto, Dept Physiol, Toronto, ON, Canada	Tsinghua University; Tsinghua University; University Town of Shenzhen; Tsinghua Shenzhen International Graduate School; Chinese University of Hong Kong; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto	He, J (corresponding author), Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China.	byang@sri.utoronto.ca; zhangyo@sz.tsinghua.edu.cn	Lyu, Qing/AAF-5181-2021; Lyu, Qing/AAP-8387-2020	Lyu, Qing/0000-0002-1325-6828; 	National Natural Science and Foundation of China [30911120492]	National Natural Science and Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by a China-Canada Joint Health Research Grant (from the National Natural Science and Foundation of China to Yaou Zhang) (No. 30911120492) http://www.nsfc.gov.cn/Portal0/default106.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, NAT REV GENET, V5, P396, DOI 10.1038/nrg1328; Chen JQ, 2007, GENESIS, V45, P482, DOI 10.1002/dvg.20320; Eiring AM, 2010, CELL, V140, P652, DOI 10.1016/j.cell.2010.01.007; Fontana L, 2007, NAT CELL BIOL, V9, P775, DOI 10.1038/ncb1613; Garzon R, 2009, ANNU REV MED, V60, P167, DOI 10.1146/annurev.med.59.053006.104707; Gazzerro E, 2006, REV ENDOCR METAB DIS, V7, P51, DOI 10.1007/s11154-006-9000-6; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Hayashita Y, 2005, CANCER RES, V65, P9628, DOI 10.1158/0008-5472.CAN-05-2352; Hua Z, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000116; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jeon MJ, 2003, J BIOL CHEM, V278, P23270, DOI 10.1074/jbc.M211610200; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Kahai S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007535; Karp X, 2005, SCIENCE, V310, P1288, DOI 10.1126/science.1121566; Kim DH, 2008, P NATL ACAD SCI USA, V105, P16230, DOI 10.1073/pnas.0808830105; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lian JB, 2006, REV ENDOCR METAB DIS, V7, P1, DOI 10.1007/s11154-006-9001-5; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Nilsen TW, 2007, TRENDS GENET, V23, P243, DOI 10.1016/j.tig.2007.02.011; Pennisi DJ, 2007, DEV DYNAM, V236, P502, DOI 10.1002/dvdy.21015; Phimphilai M, 2006, J BONE MINER RES, V21, P637, DOI 10.1359/JBMR.060109; Place RF, 2008, P NATL ACAD SCI USA, V105, P1608, DOI 10.1073/pnas.0707594105; Seitz H, 2009, CURR BIOL, V19, P870, DOI 10.1016/j.cub.2009.03.059; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Shan SW, 2009, NAT CELL BIOL, V11, P1031, DOI 10.1038/ncb1917; Shockley KR, 2009, J CELL BIOCHEM, V106, P232, DOI 10.1002/jcb.21994; Tazawa H, 2007, P NATL ACAD SCI USA, V104, P15472, DOI 10.1073/pnas.0707351104; Wang YM, 2009, CANCER RES, V69, P4093, DOI 10.1158/0008-5472.CAN-09-0309; Wilkinson L, 2003, J BIOL CHEM, V278, P34181, DOI 10.1074/jbc.M301247200; Xu PZ, 2004, TRENDS GENET, V20, P617, DOI 10.1016/j.tig.2004.09.010; Ye WB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001719; ZHANG Y, ENCY LIFE SCI, DOI DOI 10.1002/9780470015902.A0021754	36	45	51	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2010	5	10							e13558	10.1371/journal.pone.0013558	http://dx.doi.org/10.1371/journal.pone.0013558			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	670KA	21042576	Green Submitted, Green Published, gold			2022-12-27	WOS:000283419100006
J	Hong, Y; Kang, J; Lee, D; van Rossum, DB				Hong, Yoojin; Kang, Jaewoo; Lee, Dongwon; van Rossum, Damian B.			Adaptive GDDA-BLAST: Fast and Efficient Algorithm for Protein Sequence Embedding	PLOS ONE			English	Article							PHYLOGENETIC PROFILES; TWILIGHT ZONE; PSI-BLAST; DATABASE; DOMAIN; ALIGNMENTS; INFORMATION; SPACE	A major computational challenge in the genomic era is annotating structure/function to the vast quantities of sequence information that is now available. This problem is illustrated by the fact that most proteins lack comprehensive annotations, even when experimental evidence exists. We previously theorized that embedded-alignment profiles (simply "alignment profiles" hereafter) provide a quantitative method that is capable of relating the structural and functional properties of proteins, as well as their evolutionary relationships. A key feature of alignment profiles lies in the interoperability of data format (e.g., alignment information, physio-chemical information, genomic information, etc.). Indeed, we have demonstrated that the Position Specific Scoring Matrices (PSSMs) are an informative M-dimension that is scored by quantitatively measuring the embedded or unmodified sequence alignments. Moreover, the information obtained from these alignments is informative, and remains so even in the "twilight zone" of sequence similarity (<25% identity) [1-5]. Although our previous embedding strategy was powerful, it suffered from contaminating alignments (embedded AND unmodified) and high computational costs. Herein, we describe the logic and algorithmic process for a heuristic embedding strategy named "Adaptive GDDA-BLAST." Adaptive GDDA-BLAST is, on average, up to 19 times faster than, but has similar sensitivity to our previous method. Further, data are provided to demonstrate the benefits of embedded-alignment measurements in terms of detecting structural homology in highly divergent protein sequences and isolating secondary structural elements of transmembrane and ankyrin-repeat domains. Together, these advances allow further exploration of the embedded alignment data space within sufficiently large data sets to eventually induce relevant statistical inferences. We show that sequence embedding could serve as one of the vehicles for measurement of low-identity alignments and for incorporation thereof into high-performance PSSM-based alignment profiles.	[Hong, Yoojin; Lee, Dongwon] Penn State Univ, Dept Comp Sci & Engn, University Pk, PA 16802 USA; [Hong, Yoojin; van Rossum, Damian B.] Penn State Univ, Ctr Computat Prote, University Pk, PA 16802 USA; [Kang, Jaewoo] Korea Univ, Dept Comp Sci & Engn, Seoul, South Korea; [Kang, Jaewoo] Korea Univ, Coll Med, Dept Biostat, Seoul 136705, South Korea; [Lee, Dongwon] Penn State Univ, Coll Informat Sci & Technol, University Pk, PA 16802 USA; [van Rossum, Damian B.] Penn State Univ, Dept Biol, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Korea University; Korea University; Korea University Medicine (KU Medicine); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Hong, Y (corresponding author), Penn State Univ, Dept Comp Sci & Engn, University Pk, PA 16802 USA.	kangj@korea.ac.kr; dbv10@psu.edu		van Rossum, Damian/0000-0003-1011-2586	NCSA [TG-MCB070027N]; The National Science Foundation [428-15 691M]; The National Institutes of Health [R01 GM087410-01]; Eberly College of Sciences and the Huck Institutes of the Life Sciences; Pennsylvania Department of Health; Brain Korea 21 Project; Microsoft; Korean Government (MOEHRD) [KRF-2008-331-D00481]; Korea government (MEST) [2009-0077688, 2009-0086140, R01-2008-000-20564-0]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087410] Funding Source: NIH RePORTER	NCSA; The National Science Foundation(National Science Foundation (NSF)); The National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eberly College of Sciences and the Huck Institutes of the Life Sciences; Pennsylvania Department of Health; Brain Korea 21 Project(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea); Microsoft(Microsoft); Korean Government (MOEHRD)(Ministry of Education & Human Resources Development (MOEHRD), Republic of KoreaKorean Government); Korea government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NCSA grant TG-MCB070027N (DVR), The National Science Foundation 428-15 691M (DVR), and The National Institutes of Health R01 GM087410-01 (DVR). This project was also funded by a Fellowship from the Eberly College of Sciences and the Huck Institutes of the Life Sciences (DVR) and a grant from the Pennsylvania Department of Health using Tobacco Settlement Funds (DVR). The Department of Health specifically disclaims responsibility for any analyses, interpretations or conclusions. This work was also supported by the Second Brain Korea 21 Project Grant (JK), Microsoft Research Asia Grant (JK), the Korea Research Foundation Grant funded by the Korean Government (MOEHRD, Basic Research Promotion Fund) (KRF-2008-331-D00481) (JK), the National Research Foundation of Korea (NRF) grant funded by the Korea government (MEST) (2009-0077688, 2009-0086140) (JK), and the Korea Science and Engineering Foundation (KOSEF) grant funded by the Korea government (MEST) (R01-2008-000-20564-0) (JK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Baleanu-Gogonea C, 2006, J MOL MODEL, V12, P325, DOI 10.1007/s00894-005-0049-z; BERNSTEIN FC, 1977, J MOL BIOL, V112, P535, DOI 10.1016/S0022-2836(77)80200-3; Blake JD, 2001, J MOL BIOL, V307, P721, DOI 10.1006/jmbi.2001.4495; Caraveo G, 2006, SCIENCE, V314, P122, DOI 10.1126/science.1127815; Chakraborty A, 2008, P NATL ACAD SCI USA, V105, P1134, DOI 10.1073/pnas.0711168105; Chang GS, 2008, P NATL ACAD SCI USA, V105, P13474, DOI 10.1073/pnas.0803860105; Henikoff S, 1997, PROTEIN SCI, V6, P698; Hong Yoojin, 2009, J Proteomics Bioinform, V2, P139; Huang WC, 2006, BIOINFORMATICS, V22, P29, DOI 10.1093/bioinformatics/bti772; HUANG XQ, 1990, COMPUT APPL BIOSCI, V6, P373; Kim Y, 2006, PROTEINS, V62, P1115, DOI 10.1002/prot.20830; KO K, 2009, ARXIV09110652 PHYS A; KO KD, 2008, ARXIV0806239QBIOQ PH; Letunic I, 2004, NUCLEIC ACIDS RES, V32, pD142, DOI 10.1093/nar/gkh088; Marchler-Bauer A, 2005, NUCLEIC ACIDS RES, V33, pD192, DOI 10.1093/nar/gki069; MICHAELY P, CRYSTAL STRUCTURE 12; MUSTAFA A, 2009, P NATL ACAD IN PRESS; Nikolaidis N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000204; Park J, 1998, J MOL BIOL, V284, P1201, DOI 10.1006/jmbi.1998.2221; Pellegrini M, 1999, P NATL ACAD SCI USA, V96, P4285, DOI 10.1073/pnas.96.8.4285; Rognes T, 1998, BIOINFORMATICS, V14, P839, DOI 10.1093/bioinformatics/14.10.839; Schaffer AA, 1999, BIOINFORMATICS, V15, P1000; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; Sonnhammer ELL, 1997, PROTEINS, V28, P405, DOI 10.1002/(SICI)1097-0134(199707)28:3<405::AID-PROT10>3.0.CO;2-L; van Rossum DB, 2008, J BIOL CHEM, V283, P34384, DOI 10.1074/jbc.M804707200; van Rossum DB, 2005, NATURE, V434, P99, DOI 10.1038/nature03340; Van Walle I, 2005, BIOINFORMATICS, V21, P1267, DOI 10.1093/bioinformatics/bth493; Wu Jie, 2005, Genome Inform, V16, P142; Yona G, 2002, J MOL BIOL, V315, P1257, DOI 10.1006/jmbi.2001.5293; ZACHOS N, 2009, J BIOL CHEM IN PRESS	31	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2010	5	10							e13596	10.1371/journal.pone.0013596	http://dx.doi.org/10.1371/journal.pone.0013596			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	670KA	21042584	Green Published, Green Submitted, gold			2022-12-27	WOS:000283419100022
J	Ranucci, M; Ballotta, A; Castelvecchio, S; Baryshnikova, E; Brozzi, S; Boncilli, A				Ranucci, Marco; Ballotta, Andrea; Castelvecchio, Serenella; Baryshnikova, Ekaterina; Brozzi, Simonetta; Boncilli, Alessandra		Surgical Clinical Outcome Res	Intensive Care Unit Admission Parameters Improve the Accuracy of Operative Mortality Predictive Models in Cardiac Surgery	PLOS ONE			English	Article							BLOOD LACTATE LEVELS; RISK-FACTORS; CARDIOPULMONARY BYPASS; LOGISTIC EUROSCORE; GLUCOSE-METABOLISM; CARDIOGENIC-SHOCK; HYPERLACTATEMIA; STRATIFICATION; PERFORMANCE; MORBIDITY	Background: Operative mortality risk in cardiac surgery is usually assessed using preoperative risk models. However, intraoperative factors may change the risk profile of the patients, and parameters at the admission in the intensive care unit may be relevant in determining the operative mortality. This study investigates the association between a number of parameters at the admission in the intensive care unit and the operative mortality, and verifies the hypothesis that including these parameters into the preoperative risk models may increase the accuracy of prediction of the operative mortality. Methodology: 929 adult patients who underwent cardiac surgery were admitted to the study. The preoperative risk profile was assessed using the logistic EuroSCORE and the ACEF score. A number of parameters recorded at the admission in the intensive care unit were explored for univariate and multivariable association with the operative mortality. Principal Findings: A heart rate higher than 120 beats per minute and a blood lactate value higher than 4 mmol/L at the admission in the intensive care unit were independent predictors of operative mortality, with odds ratio of 6.7 and 13.4 respectively. Including these parameters into the logistic EuroSCORE and the ACEF score increased their accuracy (area under the curve 0.85 to 0.88 for the logistic EuroSCORE and 0.81 to 0.86 for the ACEF score). Conclusions: A double-stage assessment of operative mortality risk provides a higher accuracy of the prediction. Elevated blood lactates and tachycardia reflect a condition of inadequate cardiac output. Their inclusion in the assessment of the severity of the clinical conditions after cardiac surgery may offer a useful tool to introduce more sophisticated hemodynamic monitoring techniques. Comparison between the predicted operative mortality risk before and after the operation may offer an assessment of the operative performance.	[Ranucci, Marco; Ballotta, Andrea; Castelvecchio, Serenella; Baryshnikova, Ekaterina; Brozzi, Simonetta; Boncilli, Alessandra; Surgical Clinical Outcome Res] IRCCS Policlin San Donato, Dept Cardiothorac Vasc Anesthesia & Intens Care, San Donato Milanese, Italy	IRCCS Policlinico San Donato	Ranucci, M (corresponding author), IRCCS Policlin San Donato, Dept Cardiothorac Vasc Anesthesia & Intens Care, San Donato Milanese, Italy.	cardioanestesia@virgilio.it	, CASTELVECCHIO/J-9091-2016; Baryshnikova, Ekaterina/K-4452-2016; Ranucci, Marco/K-1040-2016	, CASTELVECCHIO/0000-0001-5365-7063; Ranucci, Marco/0000-0002-4915-3572; Baryshnikova, Ekaterina/0000-0001-7476-2823	Local Institutional Research funds	Local Institutional Research funds	This work was supported by local Institutional Research funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKKER J, 1991, CHEST, V99, P956, DOI 10.1378/chest.99.4.956; Bhatti F, 2006, HEART, V92, P1817, DOI 10.1136/hrt.2005.083204; Chiolero RL, 2000, CRIT CARE MED, V28, P3784, DOI 10.1097/00003246-200012000-00002; Cook NR, 2007, CIRCULATION, V115, P928, DOI 10.1161/CIRCULATIONAHA.106.672402; D'Errigo P, 2008, EUR J CARDIO-THORAC, V33, P325, DOI 10.1016/j.ejcts.2007.12.001; Demers P, 2000, ANN THORAC SURG, V70, P2082, DOI 10.1016/S0003-4975(00)02160-3; HIGGINS TL, 1992, JAMA-J AM MED ASSOC, V267, P2344, DOI 10.1001/jama.267.17.2344; Higgins TL, 1997, ANN THORAC SURG, V64, P1050, DOI 10.1016/S0003-4975(97)00553-5; Jin Ruyun, 2006, Interact Cardiovasc Thorac Surg, V5, P15; Maillet JM, 2003, CHEST, V123, P1361, DOI 10.1378/chest.123.5.1361; Martinez-Alario J, 1999, CIRCULATION, V99, P2378, DOI 10.1161/01.CIR.99.18.2378; OCONNOR GT, 1992, CIRCULATION, V85, P2110, DOI 10.1161/01.CIR.85.6.2110; PARSONNET V, 1989, CIRCULATION, V79, P3; PINSKY MR, 1994, INTENS CARE MED, V20, P1, DOI 10.1007/BF02425045; Ranucci M, 2006, CRIT CARE, V10, DOI 10.1186/cc5113; Ranucci M, 2009, EUR J CARDIO-THORAC, V36, P791, DOI 10.1016/j.ejcts.2009.02.023; Ranucci M, 2009, CIRCULATION, V119, P3053, DOI 10.1161/CIRCULATIONAHA.108.842393; Revelly JP, 2005, CRIT CARE MED, V33, P2235, DOI 10.1097/01.CCM.0000181525.99295.8F; Roques F, 1999, EUR J CARDIO-THORAC, V15, P816, DOI 10.1016/S1010-7940(99)00106-2; Roques F, 2003, EUR HEART J, V24, P881, DOI 10.1016/S0195-668X(02)00799-6; Shanmugam Ganesh, 2005, Interact Cardiovasc Thorac Surg, V4, P299, DOI 10.1510/icvts.2004.104042; Toraman F, 2004, HEART SURG FORUM, V7, pE155, DOI 10.1532/HSF98.20041002; Yap CH, 2006, EUR J CARDIO-THORAC, V29, P441, DOI 10.1016/j.ejcts.2005.12.046; Zingone B, 2004, EUR J CARDIO-THORAC, V26, P1134, DOI 10.1016/j.ejcts.2004.09.003	24	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2010	5	10							e13551	10.1371/journal.pone.0013551	http://dx.doi.org/10.1371/journal.pone.0013551			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	668TQ	21042411	Green Published, Green Submitted, gold			2022-12-27	WOS:000283293800017
J	Beauquis, J; Roig, P; De Nicola, AF; Saravia, F				Beauquis, Juan; Roig, Paulina; De Nicola, Alejandro F.; Saravia, Flavia			Short-Term Environmental Enrichment Enhances Adult Neurogenesis, Vascular Network and Dendritic Complexity in the Hippocampus of Type 1 Diabetic Mice	PLOS ONE			English	Article							DENTATE GYRUS; SYNAPTIC PLASTICITY; CELL-PROLIFERATION; MOUSE MODEL; NERVOUS-SYSTEM; CHRONIC STRESS; STREPTOZOTOCIN; RATS; BRAIN; NEURONS	Background: Several brain disturbances have been described in association to type 1 diabetes in humans. In animal models, hippocampal pathological changes were reported together with cognitive deficits. The exposure to a variety of environmental stimuli during a certain period of time is able to prevent brain alterations and to improve learning and memory in conditions like stress, aging and neurodegenerative processes. Methodology/Principal Findings: We explored the modulation of hippocampal alterations in streptozotocin-induced type 1 diabetic mice by environmental enrichment. In diabetic mice housed in standard conditions we found a reduction of adult neurogenesis in the dentate gyrus, decreased dendritic complexity in CA1 neurons and a smaller vascular fractional area in the dentate gyrus, compared with control animals in the same housing condition. A short exposure - 10 days-to an enriched environment was able to enhance proliferation, survival and dendritic arborization of newborn neurons, to recover dendritic tree length and spine density of pyramidal CA1 neurons and to increase the vascular network of the dentate gyrus in diabetic animals. Conclusions/Significance: The environmental complexity seems to constitute a strong stimulator competent to rescue the diabetic brain from neurodegenerative progression.	[Beauquis, Juan; Roig, Paulina; De Nicola, Alejandro F.; Saravia, Flavia] Natl Res Council CONICET, Inst Biol & Expt Med, Buenos Aires, DF, Argentina; [De Nicola, Alejandro F.; Saravia, Flavia] Univ Buenos Aires, Fac Med, Dept Biochem, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Institute of Biology & Experimental Medicine; University of Buenos Aires	Beauquis, J (corresponding author), Natl Res Council CONICET, Inst Biol & Expt Med, Buenos Aires, DF, Argentina.	fsaravia@dna.uba.ar	Beauquis, Juan/AAT-5042-2020	Beauquis, Juan/0000-0003-1404-5632; Saravia, Flavia/0000-0002-0781-0140	National Research Council of Argentina (CONICET) [PIP 542]; National Agency for the Promotion of Science and Technology (ANPCYT) [1845]; University of Buenos Aires (UBACYT) [M437, M016]; CONICET	National Research Council of Argentina (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); National Agency for the Promotion of Science and Technology (ANPCYT)(ANPCyT); University of Buenos Aires (UBACYT)(University of Buenos Aires); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This study was done with the economical support of the National Research Council of Argentina (PIP 542, CONICET), the National Agency for the Promotion of Science and Technology (PICT 2006, # 1845, ANPCYT) and the University of Buenos Aires (UBACYT M437 and M016, UBA). JB is a recipient of a CONICET doctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Alvarez EO, 2009, BEHAV BRAIN RES, V198, P224, DOI 10.1016/j.bbr.2008.11.001; Beauquis J, 2008, EXP NEUROL, V210, P359, DOI 10.1016/j.expneurol.2007.11.009; Beauquis J, 2006, EUR J NEUROSCI, V23, P1539, DOI 10.1111/j.1460-9568.2006.04691.x; Beauquis J, 2010, EXP NEUROL, V222, P125, DOI 10.1016/j.expneurol.2009.12.022; Biessels GJ, 2005, NEUROBIOL AGING, V26, pS36, DOI 10.1016/j.neurobiolaging.2005.08.015; Biessels GJ, 1998, BRAIN RES, V800, P125, DOI 10.1016/S0006-8993(98)00510-1; Biessels GJ, 1996, DIABETES, V45, P1259, DOI 10.2337/diabetes.45.9.1259; Bindu B, 2007, NEUROSCIENCE, V144, P412, DOI 10.1016/j.neuroscience.2006.09.057; Brownlee M, 2005, DIABETES, V54, P1615, DOI 10.2337/diabetes.54.6.1615; Costa DA, 2007, NEUROBIOL AGING, V28, P831, DOI 10.1016/j.neurobiolaging.2006.04.009; Couillard-Despres S, 2005, EUR J NEUROSCI, V21, P1, DOI 10.1111/j.1460-9568.2004.03813.x; De Nicola AF, 2009, EXP GERONTOL, V44, P34, DOI 10.1016/j.exger.2008.03.005; During Matthew J., 2006, Current Alzheimer Research, V3, P29, DOI 10.2174/156720506775697133; Ekdahl CT, 2003, P NATL ACAD SCI USA, V100, P13632, DOI 10.1073/pnas.2234031100; Ekstrand J, 2008, NEUROSCI LETT, V442, P203, DOI 10.1016/j.neulet.2008.06.085; Eriksson PS, 2004, ACTA NEUROL SCAND, V110, P275, DOI 10.1111/j.1600-0404.2004.00328.x; Faherty CJ, 2003, DEV BRAIN RES, V141, P55, DOI 10.1016/S0165-3806(02)00642-9; Fernandez CI, 2004, ANN NY ACAD SCI, V1019, P53, DOI 10.1196/annals.1297.012; Fox C, 2006, BEHAV BRAIN RES, V175, P1, DOI 10.1016/j.bbr.2006.08.016; Gibb R, 1998, J NEUROSCI METH, V79, P1, DOI 10.1016/S0165-0270(97)00163-5; GONZALEZBURGOS I, 1992, BIOTECH HISTOCHEM, V67, P288, DOI 10.3109/10520299209110037; Gould E, 1997, J NEUROSCI, V17, P2492; GUNDERSEN HJG, 1988, APMIS, V96, P857, DOI 10.1111/j.1699-0463.1988.tb00954.x; Hattiangady B, 2008, NEUROBIOL AGING, V29, P129, DOI 10.1016/j.neurobiolaging.2006.09.015; Hebb D.O., 1947, AM PSYCHOL, V2, P306; Jackson-Guilford J, 2000, NEUROSCI LETT, V293, P91, DOI 10.1016/S0304-3940(00)01502-0; Jankowsky JL, 2005, J NEUROSCI, V25, P5217, DOI 10.1523/JNEUROSCI.5080-04.2005; Kamal A, 1999, NEUROSCIENCE, V90, P737, DOI 10.1016/S0306-4522(98)00485-0; Kempermann G, 1998, J NEUROSCI, V18, P3206; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Kempermann G, 2002, ANN NEUROL, V52, P135, DOI 10.1002/ana.10262; KOLB B, 2008, NEUROBIOL LEARN MEM; KRECH D, 1962, J COMP PHYSIOL PSYCH, V55, P801, DOI 10.1037/h0044220; Kuczewski N, 2009, MOL NEUROBIOL, V39, P37, DOI 10.1007/s12035-009-8050-7; Kuhad A, 2007, EUR J PHARMACOL, V576, P34, DOI 10.1016/j.ejphar.2007.08.001; Kuhn HG, 1996, J NEUROSCI, V16, P2027; LEHMANN A, 1974, ATLAS STEREOTAXIQUE; Lenzen S, 2008, DIABETOLOGIA, V51, P216, DOI 10.1007/s00125-007-0886-7; Liu LP, 2009, SYNAPSE, V63, P636, DOI 10.1002/syn.20644; Llorens-Martin M, 2006, HIPPOCAMPUS, V16, P480, DOI 10.1002/hipo.20175; LOLOVA I, 1989, Acta Morphologica Hungarica, V37, P3; Magarinos AM, 2000, P NATL ACAD SCI USA, V97, P11056, DOI 10.1073/pnas.97.20.11056; Mankovsky BN, 1996, J DIABETES COMPLICAT, V10, P228, DOI 10.1016/S1056-8727(96)90006-9; Martinez-Tellez R, 2005, BRAIN RES, V1048, P108, DOI 10.1016/j.brainres.2005.04.048; MCCALL AL, 1992, DIABETES, V41, P557, DOI 10.2337/diabetes.41.5.557; MOSER MB, 1994, P NATL ACAD SCI USA, V91, P12673, DOI 10.1073/pnas.91.26.12673; Nithianantharajah J, 2006, NAT REV NEUROSCI, V7, P697, DOI 10.1038/nrn1970; Nitta A, 2002, NEUROTOXICOL TERATOL, V24, P695, DOI 10.1016/S0892-0362(02)00220-9; Olson AK, 2006, HIPPOCAMPUS, V16, P250, DOI 10.1002/hipo.20157; Oomen CA, 2007, EUR J NEUROSCI, V26, P3395, DOI 10.1111/j.1460-9568.2007.05972.x; Oomen CA, 2010, J NEUROSCI, V30, P6635, DOI 10.1523/JNEUROSCI.0247-10.2010; Palmer TD, 2000, J COMP NEUROL, V425, P479, DOI 10.1002/1096-9861(20001002)425:4<479::AID-CNE2>3.0.CO;2-3; Piatti VC, 2006, NEUROSCIENTIST, V12, P463, DOI 10.1177/1073858406293538; Plumpe T, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-77; Reisi P, 2008, BRAIN RES, V1211, P30, DOI 10.1016/j.brainres.2008.03.024; Revsin Y, 2005, BRAIN RES, V1038, P22, DOI 10.1016/j.brainres.2004.12.032; Revsin Y, 2009, NEUROPSYCHOPHARMACOL, V34, P747, DOI 10.1038/npp.2008.136; Saravia F, 2004, J NEUROENDOCRINOL, V16, P704, DOI 10.1111/j.1365-2826.2004.01223.x; Saravia FE, 2002, BRAIN RES, V957, P345, DOI 10.1016/S0006-8993(02)03675-2; Saravia F, 2007, PSYCHONEUROENDOCRINO, V32, P480, DOI 10.1016/j.psyneuen.2007.02.012; SHOLL DA, 1953, J ANAT, V87, P387; Shors TJ, 2002, HIPPOCAMPUS, V12, P578, DOI 10.1002/hipo.10103; SIREVAAG AM, 1988, DEV BRAIN RES, V43, P299, DOI 10.1016/0165-3806(88)90107-1; Stranahan AM, 2008, NAT NEUROSCI, V11, P309, DOI 10.1038/nn2055; Takeda S, 2010, P NATL ACAD SCI USA, V107, P7036, DOI 10.1073/pnas.1000645107; Tuzcu M, 2006, EUR J PHARMACOL, V537, P106, DOI 10.1016/j.ejphar.2006.03.024; van Praag H, 1999, P NATL ACAD SCI USA, V96, P13427, DOI 10.1073/pnas.96.23.13427; van Praag H, 2007, J NEUROSCI, V27, P5869, DOI 10.1523/JNEUROSCI.0914-07.2007; WATANABE Y, 1992, BRAIN RES, V588, P341, DOI 10.1016/0006-8993(92)91597-8; WILL BE, 1976, PHYSIOL BEHAV, V16, P603, DOI 10.1016/0031-9384(76)90221-3; Wright RL, 2008, BEHAV BRAIN RES, V187, P41, DOI 10.1016/j.bbr.2007.08.025; Zacchigna S, 2008, NAT REV NEUROSCI, V9, P169, DOI 10.1038/nrn2336; Zhang WJ, 2008, ACTA NEUROL SCAND, V117, P205, DOI 10.1111/j.1600-0404.2007.00928.x	74	90	93	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2010	5	11							e13993	10.1371/journal.pone.0013993	http://dx.doi.org/10.1371/journal.pone.0013993			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	680KW	21085588	Green Published, Green Submitted, gold			2022-12-27	WOS:000284231800023
J	Hamed, S; Egozi, D; Kruchevsky, D; Teot, L; Gilhar, A; Ullmann, Y				Hamed, Saher; Egozi, Dana; Kruchevsky, Danny; Teot, Luc; Gilhar, Amos; Ullmann, Yehuda			Erythropoietin Improves the Survival of Fat Tissue after Its Transplantation in Nude Mice	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; ADIPOSE-TISSUE; PROGENITOR CELLS; STEM-CELLS; IN-VIVO; ANGIOGENESIS; VEGF; EXPRESSION; GRAFTS; NEOVASCULARIZATION	Background: Autologous transplanted fat has a high resorption rate, providing a clinical challenge for the means to reduce it. Erythropoietin (EPO) has non-hematopoietic targets, and we hypothesized that EPO may improve long-term fat graft survival because it has both pro-angiogenic and anti-apoptotic properties. We aimed to determine the effect of EPO on the survival of human fat tissue after its transplantation in nude mice. Methodology/Principal Findings: Human fat tissue was injected subcutaneously into immunologically-compromised nude mice, and the grafts were then treated with either 20 IU or 100 IU EPO. At the end of the 15-week study period, the extent of angiogenesis, apoptosis, and histology were assessed in the fat grafts. The results were compared to vascular endothelial growth factor(VEGF)-treated and phosphate-buffered saline (PBS)-treated fat grafts. The weight and volume of the EPO-treated grafts were higher than those of the PBS-treated grafts, whose weights and volumes were not different from those of the VEGF-treated grafts. EPO treatment also increased the expression of angiogenic factors and microvascular density, and reduced inflammation and apoptosis in a dose-dependent manner in the fat grafts. Conclusions/Significance: Our data suggest that stimulation of angiogenesis by a cluster of angiogenic factors and decreased fat cell apoptosis account for potential mechanisms that underlie the improved long-term survival of fat transplants following EPO treatment.	[Hamed, Saher; Kruchevsky, Danny; Gilhar, Amos] Technion Israel Inst Technol, Bruce Rappaport Fac Med, IL-31096 Haifa, Israel; [Egozi, Dana; Ullmann, Yehuda] Rambam Hlth Care Campus, Dept Plast & Reconstruct Surg, Haifa, Israel; [Teot, Luc] Dept Plast & Reconstruct Surg & Wound Healing, Montpellier, France	Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Rambam Health Care Campus; Universite de Montpellier	Hamed, S (corresponding author), Technion Israel Inst Technol, Bruce Rappaport Fac Med, POB 9649, IL-31096 Haifa, Israel.	www.saher@gmail.com		Hamed, Saher/0000-0003-4293-2001	Research & Development division of Remedor Biomed Ltd., Nazareth, Israel [514361310]; Remedor Biomed Ltd.	Research & Development division of Remedor Biomed Ltd., Nazareth, Israel; Remedor Biomed Ltd.	This work was supported by a grant to Dr. Saher Hamed from the Research & Development division of Remedor Biomed Ltd., Nazareth, Israel (#514361310). Remedor Biomed Ltd. financed the study, has rights to the results of the research and has no objections with respect to the publication of the manuscript.	Aicher A, 2005, HYPERTENSION, V45, P321, DOI 10.1161/01.HYP.0000154789.28695.ea; ANAGNOSTOU A, 1990, P NATL ACAD SCI USA, V87, P5978, DOI 10.1073/pnas.87.15.5978; Ayhan M, 2001, AESTHET PLAST SURG, V25, P338, DOI 10.1007/s002660010145; Bluher S, 2005, BEST PRACT RES CL EN, V19, P577, DOI 10.1016/j.beem.2005.07.011; CARLINI RG, 1995, KIDNEY INT, V47, P740, DOI 10.1038/ki.1995.113; Chong Zhao Zhong, 2003, Current Drug Targets - Cardiovascular & Haematological Disorders, V3, P141, DOI 10.2174/1568006033481483; Chong ZZ, 2003, BRIT J PHARMACOL, V138, P1107, DOI 10.1038/sj.bjp.0705161; Darland DC, 1999, J CLIN INVEST, V103, P157, DOI 10.1172/JCI6127; Hamed S, 2006, EUR HEART J, V27, P1876, DOI 10.1093/eurheartj/ehl044; Hamed S, 2010, J INVEST DERMATOL, V130, P287, DOI 10.1038/jid.2009.219; Hausman GJ, 2004, J ANIM SCI, V82, P925; Henry TD, 2003, CIRCULATION, V107, P1359, DOI 10.1161/01.CIR.0000061911.47710.8A; Jelkmann W, 2008, CRIT REV ONCOL HEMAT, V67, P39, DOI 10.1016/j.critrevonc.2008.03.006; Kuramochi D, 2008, EUR J CLIN INVEST, V38, P752, DOI 10.1111/j.1365-2362.2008.02023.x; Kurita M, 2008, PLAST RECONSTR SURG, V121, P1033, DOI 10.1097/01.prs.0000299384.53131.87; Lei M, 2008, CHIN J TRAUMATOL, V11, P49, DOI 10.1016/S1008-1275(08)60011-5; LEUNG DW, 1989, SCIENCE, V246, P1306, DOI 10.1126/science.2479986; Li FQ, 2004, NEUROSIGNALS, V13, P265, DOI 10.1159/000081963; Li ZJ, 2005, J CELL BIOCHEM, V95, P559, DOI 10.1002/jcb.20436; Locke MB, 2008, ANN PLAS SURG, V60, P98, DOI 10.1097/SAP.0b013e318038f74c; Lu F, 2009, PLAST RECONSTR SURG, V124, P1437, DOI 10.1097/PRS.0b013e3181babbb6; Nakano M, 2007, CIRC RES, V100, P662, DOI 10.1161/01.RES.0000260179.43672.fe; Nishimura T, 2000, LARYNGOSCOPE, V110, P1333, DOI 10.1097/00005537-200008000-00021; Pallua N, 2009, PLAST RECONSTR SURG, V123, P826, DOI 10.1097/PRS.0b013e318199ef31; Ribatti D, 1999, BLOOD, V93, P2627, DOI 10.1182/blood.V93.8.2627.408k21_2627_2636; Ribatti D, 2003, EUR J CLIN INVEST, V33, P891, DOI 10.1046/j.1365-2362.2003.01245.x; Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0; Rophael JA, 2007, AM J PATHOL, V171, P2048, DOI 10.2353/ajpath.2007.070066; SCHWEIGERER L, 1987, NATURE, V325, P257, DOI 10.1038/325257a0; Shoshani O, 2005, PLAST RECONSTR SURG, V115, P853, DOI 10.1097/01.PRS.0000153036.71928.30; Siren AL, 2009, NEUROTHERAPEUTICS, V6, P108, DOI 10.1016/j.nurt.2008.10.041; Somervaille TCP, 2001, BLOOD, V98, P1374, DOI 10.1182/blood.V98.5.1374; Ullmann Y, 2005, DERMATOL SURG, V31, P1304, DOI 10.1097/00042728-200510000-00007; Wang L, 2008, J CEREBR BLOOD F MET, V28, P1361, DOI 10.1038/jcbfm.2008.32; Wen TC, 2002, J NEUROSCI RES, V67, P795, DOI 10.1002/jnr.10166; Westenbrink BD, 2007, EUR HEART J, V28, P2018, DOI 10.1093/eurheartj/ehm177; Yamaguchi M, 2005, EXP BIOL MED, V230, P742, DOI 10.1177/153537020523001007; Yi CG, 2007, J PLAST RECONSTR AES, V60, P272, DOI 10.1016/j.bjps.2006.01.052; Yoshimura K, 2008, DERMATOL SURG, V34, P1178, DOI 10.1111/j.1524-4725.2008.34256.x	39	56	59	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2010	5	11							e13986	10.1371/journal.pone.0013986	http://dx.doi.org/10.1371/journal.pone.0013986			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	680KW	21085572	Green Submitted, Green Published, gold			2022-12-27	WOS:000284231800016
J	Li, TT; Du, PF; Xu, NF				Li, Tingting; Du, Pufeng; Xu, Nanfang			Identifying Human Kinase-Specific Protein Phosphorylation Sites by Integrating Heterogeneous Information from Various Sources	PLOS ONE			English	Article							CELL-CYCLE CONTROL; PREDICTION; SEQUENCE; PHOSPHO.ELM; FEATURES; DATABASE; COMPLEX; GENOME	Phosphorylation is an important type of protein post-translational modification. Identification of possible phosphorylation sites of a protein is important for understanding its functions. Unbiased screening for phosphorylation sites by in vitro or in vivo experiments is time consuming and expensive; in silico prediction can provide functional candidates and help narrow down the experimental efforts. Most of the existing prediction algorithms take only the polypeptide sequence around the phosphorylation sites into consideration. However, protein phosphorylation is a very complex biological process in vivo. The polypeptide sequences around the potential sites are not sufficient to determine the phosphorylation status of those residues. In the current work, we integrated various data sources such as protein functional domains, protein subcellular location and protein-protein interactions, along with the polypeptide sequences to predict protein phosphorylation sites. The heterogeneous information significantly boosted the prediction accuracy for some kinase families. To demonstrate potential application of our method, we scanned a set of human proteins and predicted putative phosphorylation sites for Cyclin-dependent kinases, Casein kinase 2, Glycogen synthase kinase 3, Mitogen-activated protein kinases, protein kinase A, and protein kinase C families (avaiable at http://cmbi.bjmu.edu.cn/huphospho). The predicted phosphorylation sites can serve as candidates for further experimental validation. Our strategy may also be applicable for the in silico identification of other post-translational modification substrates.	[Li, Tingting; Xu, Nanfang] Peking Univ, Hlth Sci Ctr, Dept Biomed Informat, Beijing 100871, Peoples R China; [Xu, Nanfang] Peking Univ, Hosp 1, Beijing 100871, Peoples R China; [Du, Pufeng] Tianjin Univ, Sch Comp Sci & Technol, Tianjin 300072, Peoples R China; [Li, Tingting; Du, Pufeng] Tsinghua Univ, Dept Automat, Tsinghua Natl Lab Informat Sci & Technol, Minist Educ,Key Lab Bioinformat & Bioinformat Div, Beijing 100084, Peoples R China	Peking University; Peking University; Tianjin University; Tsinghua University	Li, TT (corresponding author), Peking Univ, Hlth Sci Ctr, Dept Biomed Informat, Beijing 100871, Peoples R China.	litt@hsc.pku.edu.cn	Du, Pu-Feng/R-9002-2019		NSFC [60905014, 60721003]	NSFC(National Natural Science Foundation of China (NSFC))	This work was supported by NSFC 60905014 and 60721003 (http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akamine P, 2003, J MOL BIOL, V327, P159, DOI 10.1016/S0022-2836(02)01446-8; Andres V, 2004, CARDIOVASC RES, V63, P11, DOI 10.1016/j.cardiores.2004.02.009; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; Chang EJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000656; Dang TH, 2008, BIOINFORMATICS, V24, P2857, DOI 10.1093/bioinformatics/btn546; Diella F, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-79; Diella F, 2008, NUCLEIC ACIDS RES, V36, pD240, DOI 10.1093/nar/gkm772; Gnad F, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r250; Iakoucheva LM, 2004, NUCLEIC ACIDS RES, V32, P1037, DOI 10.1093/nar/gkh253; Kim JH, 2004, BIOINFORMATICS, V20, P3179, DOI 10.1093/bioinformatics/bth382; Kreegipuu A, 1998, FEBS LETT, V430, P45, DOI 10.1016/S0014-5793(98)00503-1; Li TT, 2008, PROTEINS, V70, P404, DOI 10.1002/prot.21563; Linding R, 2007, CELL, V129, P1415, DOI 10.1016/j.cell.2007.05.052; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Oelgeschlager T, 2002, J CELL PHYSIOL, V190, P160, DOI 10.1002/JCP.10058; Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075; Pinna LA, 1996, BBA-MOL CELL RES, V1314, P191, DOI 10.1016/S0167-4889(96)00083-3; Sharrocks AD, 2000, TRENDS BIOCHEM SCI, V25, P448, DOI 10.1016/S0968-0004(00)01627-3; Stillman B, 1996, SCIENCE, V274, P1659, DOI 10.1126/science.274.5293.1659; Team RDC, 2010, R LANG ENV STAT COMP; Ubersax JA, 2007, NAT REV MOL CELL BIO, V8, P530, DOI 10.1038/nrm2203; Vapnik VN, 1999, IEEE T NEURAL NETWOR, V10, P988, DOI 10.1109/72.788640; Wagner M, 2005, J COMPUT BIOL, V12, P355, DOI 10.1089/cmb.2005.12.355; Xue Y, 2008, MOL CELL PROTEOMICS, V7, P1598, DOI 10.1074/mcp.M700574-MCP200; Yaffe MB, 2001, NAT BIOTECHNOL, V19, P348, DOI 10.1038/86737; Yao S, 2002, MOL CELL BIOL, V22, P6750, DOI 10.1128/MCB.22.19.6750-6758.2002; Zachariae W, 1999, GENE DEV, V13, P2039, DOI 10.1101/gad.13.16.2039; LIN C CCAC J LIBSVM	29	38	41	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2010	5	11							e15411	10.1371/journal.pone.0015411	http://dx.doi.org/10.1371/journal.pone.0015411			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	680KW	21085571	Green Published, Green Submitted, gold			2022-12-27	WOS:000284231800031
J	Merico, D; Isserlin, R; Stueker, O; Emili, A; Bader, GD				Merico, Daniele; Isserlin, Ruth; Stueker, Oliver; Emili, Andrew; Bader, Gary D.			Enrichment Map: A Network-Based Method for Gene-Set Enrichment Visualization and Interpretation	PLOS ONE			English	Article							COLORECTAL-CANCER; EXPRESSION DATA; ONTOLOGY; BIOINFORMATICS; TOOLS; OVERREPRESENTATION; ANNOTATION; DISCOVERY; PATHWAYS; ESTROGEN	Background: Gene-set enrichment analysis is a useful technique to help functionally characterize large gene lists, such as the results of gene expression experiments. This technique finds functionally coherent gene-sets, such as pathways, that are statistically over-represented in a given gene list. Ideally, the number of resulting sets is smaller than the number of genes in the list, thus simplifying interpretation. However, the increasing number and redundancy of gene-sets used by many current enrichment analysis software works against this ideal. Principal Findings: To overcome gene-set redundancy and help in the interpretation of large gene lists, we developed "Enrichment Map", a network-based visualization method for gene-set enrichment results. Gene-sets are organized in a network, where each set is a node and edges represent gene overlap between sets. Automated network layout groups related gene-sets into network clusters, enabling the user to quickly identify the major enriched functional themes and more easily interpret the enrichment results. Conclusions: Enrichment Map is a significant advance in the interpretation of enrichment analysis. Any research project that generates a list of genes can take advantage of this visualization framework. Enrichment Map is implemented as a freely available and user friendly plug-in for the Cytoscape network visualization software (http://baderlab.org/Software/EnrichmentMap/).	[Merico, Daniele; Isserlin, Ruth; Stueker, Oliver; Emili, Andrew; Bader, Gary D.] Univ Toronto, Banting & Best Dept Med Res, Dept Mol Genet, Donnelly Ctr Cellular & Biomol Res, Toronto, ON, Canada	University of Toronto	Merico, D (corresponding author), Univ Toronto, Banting & Best Dept Med Res, Dept Mol Genet, Donnelly Ctr Cellular & Biomol Res, Toronto, ON, Canada.	daniele.merico@gmail.com; gary.bader@utoronto.ca	Bader, Gary/C-1176-2009	Bader, Gary/0000-0003-0185-8861; Merico, Daniele/0000-0002-3728-4401; Stueker, Oliver/0000-0003-2547-0140	US National Institutes of Health (NIH) via National Human Genome Research Institute (NHGRI) [P41 P41HG04118]; Canada Foundation for Innovation; Genome Canada via the Ontario Genomics Institute; Ontario Research Fund (ORF); Heart and Stroke Foundation of Canada; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P41HG004118] Funding Source: NIH RePORTER	US National Institutes of Health (NIH) via National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Genome Canada via the Ontario Genomics Institute(Genome Canada); Ontario Research Fund (ORF); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	Gary D. Bader acknowledges funding from the US National Institutes of Health (NIH) via National Human Genome Research Institute (NHGRI) grant P41 P41HG04118, the Canada Foundation for Innovation and Ontario Research Fund (ORF) and Genome Canada via the Ontario Genomics Institute. Andrew Emili acknowledges funding from the Ontario Research Fund and the Heart and Stroke Foundation of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexa A, 2006, BIOINFORMATICS, V22, P1600, DOI 10.1093/bioinformatics/btl140; Allison DB, 2006, NAT REV GENET, V7, P55, DOI 10.1038/nrg1749; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Begleiter A, 2006, CANCER EPIDEM BIOMAR, V15, P2422, DOI 10.1158/1055-9965.EPI-06-0661; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Calarco JA, 2007, ADV EXP MED BIOL, V623, P64, DOI 10.1007/978-0-387-77374-2_5; Cary MP, 2005, FEBS LETT, V579, P1815, DOI 10.1016/j.febslet.2005.02.005; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; De Angelis PM, 2004, INT J ONCOL, V24, P1279; DEMIR E, 2010, NATURE BIOT IN PRESS; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Doisneau-Sixou SF, 2003, ENDOCR-RELAT CANCER, V10, P179, DOI 10.1677/erc.0.0100179; Draghici S, 2003, GENOMICS, V81, P98, DOI 10.1016/S0888-7543(02)00021-6; Draghici S, 2003, NUCLEIC ACIDS RES, V31, P3775, DOI 10.1093/nar/gkg624; Draghici S, 2007, GENOME RES, V17, P1537, DOI 10.1101/gr.6202607; Efroni S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000425; Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567; Fisher RA, 1922, J R STAT SOC, V85, P87, DOI 10.2307/2340521; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Glez-Pena D, 2009, NUCLEIC ACIDS RES, V37, pW329, DOI 10.1093/nar/gkp263; Gonzalez FJ, 2005, MUTAT RES-FUND MOL M, V569, P101, DOI 10.1016/j.mrfmmm.2004.04.021; Grossmann S, 2007, BIOINFORMATICS, V23, P3024, DOI 10.1093/bioinformatics/btm440; Hong Y, 2007, CLIN CANCER RES, V13, P1107, DOI 10.1158/1078-0432.CCR-06-1633; Horton Janet K, 2005, Clin Colorectal Cancer, V4, P302, DOI 10.3816/CCC.2005.n.002; Huang DW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r183; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Ideker Trey, 2002, Bioinformatics, V18 Suppl 1, pS233; ISSERLIN R, 2010, PROTEOMICS IN PRESS; Joshi-Tope G, 2005, NUCLEIC ACIDS RES, V33, pD428, DOI 10.1093/nar/gki072; Kaiser S, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r131; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Khatri P, 2002, GENOMICS, V79, P266, DOI 10.1006/geno.2002.6698; Kim JY, 2006, NEUROLOGY, V66, pA79; Lewin A, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-426; Lin CY, 2007, PLOS GENET, V3, P867, DOI 10.1371/journal.pgen.0030087; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Nam D, 2008, BRIEF BIOINFORM, V9, P189, DOI 10.1093/bib/bbn001; Nesvizhskii AI, 2007, NAT METHODS, V4, P787, DOI 10.1038/NMETH1088; Pan KH, 2005, P NATL ACAD SCI USA, V102, P8961, DOI 10.1073/pnas.0502674102; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Pradines Joel, 2004, J Biopharm Stat, V14, P701, DOI 10.1081/BIP-200025678; Quackenbush J, 2001, NAT REV GENET, V2, P418, DOI 10.1038/35076576; Raman D, 2007, CANCER LETT, V256, P137, DOI 10.1016/j.canlet.2007.05.013; Rhodes DR, 2007, NEOPLASIA, V9, P443, DOI 10.1593/neo.07292; Rivals I, 2007, BIOINFORMATICS, V23, P401, DOI 10.1093/bioinformatics/btl633; Robinson MD, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-35; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tarca AL, 2009, BIOINFORMATICS, V25, P75, DOI 10.1093/bioinformatics/btn577; Tavazoie S, 1999, NAT GENET, V22, P281, DOI 10.1038/10343; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475; Zhang H, 2007, INT J COLORECTAL DIS, V22, P1185, DOI 10.1007/s00384-007-0308-9	54	1261	1283	0	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2010	5	11							e13984	10.1371/journal.pone.0013984	http://dx.doi.org/10.1371/journal.pone.0013984			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	680KW	21085593	Green Published, gold, Green Submitted			2022-12-27	WOS:000284231800014
J	Mejias, JF; Kappen, HJ; Torres, JJ				Mejias, Jorge F.; Kappen, Hilbert J.; Torres, Joaquin J.			Irregular Dynamics in Up and Down Cortical States	PLOS ONE			English	Article							TERM SYNAPTIC DEPRESSION; PERSISTENT ACTIVITY; BISTABLE SYSTEM; NEURAL-NETWORKS; NEURONS; SLOW; FACILITATION; MEMORY; MODEL; FLUCTUATIONS	Complex coherent dynamics is present in a wide variety of neural systems. A typical example is the voltage transitions between up and down states observed in cortical areas in the brain. In this work, we study this phenomenon via a biologically motivated stochastic model of up and down transitions. The model is constituted by a simple bistable rate dynamics, where the synaptic current is modulated by short-term synaptic processes which introduce stochasticity and temporal correlations. A complete analysis of our model, both with mean-field approaches and numerical simulations, shows the appearance of complex transitions between high (up) and low (down) neural activity states, driven by the synaptic noise, with permanence times in the up state distributed according to a power-law. We show that the experimentally observed large fluctuation in up and down permanence times can be explained as the result of sufficiently noisy dynamical synapses with sufficiently large recovery times. Static synapses cannot account for this behavior, nor can dynamical synapses in the absence of noise.	[Mejias, Jorge F.] Univ Ottawa, Ctr Neural Dynam, Ottawa, ON, Canada; [Mejias, Jorge F.; Torres, Joaquin J.] Univ Granada, Dept Electromagnetism & Matter Phys, Granada, Spain; [Kappen, Hilbert J.] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands	University of Ottawa; University of Granada; Radboud University Nijmegen	Mejias, JF (corresponding author), Univ Ottawa, Ctr Neural Dynam, Ottawa, ON, Canada.	jmejias@uottawa.ca	Kappen, H.J./L-4425-2015; Torres, Joaquín J./AAE-6228-2019; Torres, Joaquín J./C-1385-2012	Torres, Joaquín J./0000-0001-6175-9676; Mejias, Jorge/0000-0002-8096-4891	MEyC-FEDER [FIS2009-08451]; Junta de Andalucia [P07-FQM-02725]	MEyC-FEDER; Junta de Andalucia(Junta de Andalucia)	This work was supported by the MEyC-FEDER project FIS2009-08451 and the Junta de Andalucia project P07-FQM-02725. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott LF, 1997, SCIENCE, V275, P220, DOI 10.1126/science.275.5297.221; Alili A, 2005, STOCH MODELS, V21, P967, DOI 10.1080/15326340500294702; Anderson J, 2000, NAT NEUROSCI, V3, P617, DOI 10.1038/75797; Arieli A, 1996, SCIENCE, V273, P1868, DOI 10.1126/science.273.5283.1868; Beggs JM, 2003, J NEUROSCI, V23, P11167; Brunel N, 2000, J COMPUT NEUROSCI, V8, P183, DOI 10.1023/A:1008925309027; Chandrasekhar S, 1943, REV MOD PHYS, V15, P0001, DOI 10.1103/RevModPhys.15.1; Compte A, 2006, NEUROSCIENCE, V139, P135, DOI 10.1016/j.neuroscience.2005.06.011; Cortes JM, 2006, NEURAL COMPUT, V18, P614, DOI 10.1162/089976606775623342; Cossart R, 2003, NATURE, V423, P283, DOI 10.1038/nature01614; de la Rocha J, 2005, J NEUROSCI, V25, P8416, DOI 10.1523/JNEUROSCI.0631-05.2005; Deco G, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000587; DEFRANCISCIS S, 2010, UNPUB; Dobrunz LE, 1997, NEURON, V18, P995, DOI 10.1016/S0896-6273(00)80338-4; Eguiluz VM, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.018102; FABER DS, 1992, SCIENCE, V258, P1494, DOI 10.1126/science.1279813; FUSTER JM, 1971, SCIENCE, V173, P652, DOI 10.1126/science.173.3997.652; Gerstner W, 2000, NEURAL COMPUT, V12, P43, DOI 10.1162/089976600300015899; Gerstner W, 2002, SPIKING NEURON MODEL; GOLDMANRAKIC PS, 1995, NEURON, V14, P477, DOI 10.1016/0896-6273(95)90304-6; GOMEZ V, 2009, ADV NEURAL INF PROCE, V22, P513; Hasenstaub A, 2005, NEURON, V47, P423, DOI 10.1016/j.neuron.2005.06.016; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Holcman D, 2006, PLOS COMPUT BIOL, V2, P174, DOI 10.1371/journal.pcbi.0020023; Johnson S, 2008, EPL-EUROPHYS LETT, V83, DOI 10.1209/0295-5075/83/46006; Kandel E., 2000, PRINCIPLES NEURAL SC; Kang S, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000022; Lampl I, 1999, NEURON, V22, P361, DOI 10.1016/S0896-6273(00)81096-X; Lazar A, 2007, NEURAL NETWORKS, V20, P312, DOI 10.1016/j.neunet.2007.04.020; Lazar A, 2009, FRONT COMPUT NEUROSC, V3, DOI 10.3389/neuro.10.023.2009; Li DX, 2008, COMMUN THEOR PHYS, V50, P669, DOI 10.1088/0253-6102/50/3/29; Lo CC, 2004, P NATL ACAD SCI USA, V101, P17545, DOI 10.1073/pnas.0408242101; Loewenstein Y, 2005, NAT NEUROSCI, V8, P202, DOI 10.1038/nn1393; MADUREIRA AJR, 1995, PHYS REV E, V51, P3849, DOI 10.1103/PhysRevE.51.3849; MAYOR G, 2004, CURR OPIN NEUROBIOL, V14, P675; McCormick DA, 2005, CURR BIOL, V15, pR294, DOI 10.1016/j.cub.2005.04.009; MEJIAS JF, 2010, ARXIV09060756; Mejias JF, 2008, J COMPUT NEUROSCI, V24, P222, DOI 10.1007/s10827-007-0052-8; Mejias JF, 2009, NEURAL COMPUT, V21, P851, DOI 10.1162/neco.2008.02-08-719; Melamed O, 2008, J COMPUT NEUROSCI, V25, P308, DOI 10.1007/s10827-008-0080-z; Newman MEJ, 2005, CONTEMP PHYS, V46, P323, DOI 10.1080/00107510500052444; Pantic L, 2002, NEURAL COMPUT, V14, P2903, DOI 10.1162/089976602760805331; Pargaa N, 2007, FRONT NEUROSCI-SWITZ, V1, P57, DOI 10.3389/neuro.01.1.1.004.2007; Pearlmutter BA, 2009, NEURAL COMPUT, V21, P1622, DOI 10.1162/neco.2009.05-08-787; PECHUKAS P, 1994, PHYS REV LETT, V73, P2772, DOI 10.1103/PhysRevLett.73.2772; Petersen CCH, 2003, P NATL ACAD SCI USA, V100, P13638, DOI 10.1073/pnas.2235811100; Ping Z, 2006, CHINESE J PHYS, V44, P117; Puccini GD, 2006, J PHYSIOL-PARIS, V100, P1, DOI 10.1016/j.jphysparis.2006.09.005; Rotstein HG, 2005, J NEUROPHYSIOL, V94, P1509, DOI 10.1152/jn.00957.2004; Sanchez-Vives MV, 2000, NAT NEUROSCI, V3, P1027, DOI 10.1038/79848; SCANNELL JW, 1995, J NEUROSCI, V15, P1463; Seamari Y, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000888; Shu YS, 2003, NATURE, V423, P288, DOI 10.1038/nature01616; STERIADE M, 1993, J NEUROSCI, V13, P3266; STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588; Steriade M, 2001, J NEUROPHYSIOL, V85, P1969, DOI 10.1152/jn.2001.85.5.1969; STERIADE M, 1993, J NEUROSCI, V13, P3252, DOI 10.1523/jneurosci.13-08-03252.1993; Timofeev I, 2000, J PHYSIOLOGY-PARIS, V94, P343, DOI 10.1016/S0928-4257(00)01097-4; Torres JJ, 2007, NEURAL COMPUT, V19, P2739, DOI 10.1162/neco.2007.19.10.2739; Tsodyks MV, 1997, P NATL ACAD SCI USA, V94, P719, DOI 10.1073/pnas.94.2.719; Tu YH, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.208101; Van Kampen N. G., 1990, STOCHASTIC PROCESSES; Vierling-Claassen D, 2008, J NEUROPHYSIOL, V99, P2656, DOI 10.1152/jn.00870.2007; Wang XJ, 1999, J NEUROSCI, V19, P9587; WILSON HR, 1972, BIOPHYS J, V12, P1, DOI 10.1016/S0006-3495(72)86068-5; Zador A, 1998, J NEUROPHYSIOL, V79, P1219, DOI 10.1152/jn.1998.79.3.1219; Zador AM, 1997, NEURON, V19, P1, DOI 10.1016/S0896-6273(00)80341-4	67	39	39	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2010	5	11							e13651	10.1371/journal.pone.0013651	http://dx.doi.org/10.1371/journal.pone.0013651			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	676NU	21079740	Green Published, Green Submitted, gold			2022-12-27	WOS:000283920000001
J	Ciesielski, BG; Armstrong, T; Zald, DH; Olatunji, BO				Ciesielski, Bethany G.; Armstrong, Thomas; Zald, David H.; Olatunji, Bunmi O.			Emotion Modulation of Visual Attention: Categorical and Temporal Characteristics	PLOS ONE			English	Article							AROUSING DISTRACTORS; INDUCED BLINDNESS; FEAR; PERCEPTION; BENEFITS; CAPTURE	Background: Experimental research has shown that emotional stimuli can either enhance or impair attentional performance. However, the relative effects of specific emotional stimuli and the specific time course of these differential effects are unclear. Methodology/Principal Findings: In the present study, participants (n = 50) searched for a single target within a rapid serial visual presentation of images. Irrelevant fear, disgust, erotic or neutral images preceded the target by two, four, six, or eight items. At lag 2, erotic images induced the greatest deficits in subsequent target processing compared to other images, consistent with a large emotional attentional blink. Fear and disgust images also produced a larger attentional blinks at lag 2 than neutral images. Erotic, fear, and disgust images continued to induce greater deficits than neutral images at lag 4 and 6. However, target processing deficits induced by erotic, fear, and disgust images at intermediate lags (lag 4 and 6) did not consistently differ from each other. In contrast to performance at lag 2, 4, and 6, enhancement in target processing for emotional stimuli was observed in comparison to neutral stimuli at lag 8. Conclusions/Significance: These findings suggest that task-irrelevant emotion information, particularly erotica, impairs intentional allocation of attention at early temporal stages, but at later temporal stages, emotional stimuli can have an enhancing effect on directed attention. These data suggest that the effects of emotional stimuli on attention can be both positive and negative depending upon temporal factors.	[Ciesielski, Bethany G.; Armstrong, Thomas; Zald, David H.; Olatunji, Bunmi O.] Vanderbilt Univ, Dept Psychol, Nashville, TN 37240 USA	Vanderbilt University	Ciesielski, BG (corresponding author), Vanderbilt Univ, Dept Psychol, Nashville, TN 37240 USA.	olabunmi.o.olatunji@vanderbilt.edu			National Institute of Mental Health [RO3MH082210-01A1]; NATIONAL INSTITUTE OF MENTAL HEALTH [R03MH082210] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Funding: This research was supported, in part, by an RO3MH082210-01A1 grant from the National Institute of Mental Health awarded to BOO. The funding agency had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson AK, 2005, J EXP PSYCHOL GEN, V134, P258, DOI 10.1037/0096-3445.134.2.258; Arnell KM, 2007, EMOTION, V7, P465, DOI 10.1037/1528-3542.7.3.465; Becker MW, 2009, PSYCHOL SCI, V20, P435, DOI 10.1111/j.1467-9280.2009.02303.x; Bocanegra BR, 2009, EMOTION, V9, P865, DOI 10.1037/a0017749; Cisler JM, 2009, COGNITION EMOTION, V23, P675, DOI 10.1080/02699930802051599; DUNCAN J, 1994, NATURE, V369, P313, DOI 10.1038/369313a0; Dux PE, 2009, ATTEN PERCEPT PSYCHO, V71, P1683, DOI 10.3758/APP.71.8.1683; Lang P. J., 1999, INT AFFECTIVE PICTUR; MacKay DG, 2004, MEM COGNITION, V32, P474, DOI 10.3758/BF03195840; Most SB, 2005, PSYCHON B REV, V12, P654, DOI 10.3758/BF03196754; Most SB, 2008, VIS COGN, V16, P262, DOI 10.1080/13506280701490062; Most SB, 2007, COGNITION EMOTION, V21, P964, DOI 10.1080/02699930600959340; Oatley K., 1987, COGNITION EMOTION, V1, P29, DOI [10.1080/02699938708408362, DOI 10.1080/02699938708408362]; Ohman A, 2001, J EXP PSYCHOL GEN, V130, P466, DOI 10.1037/0096-3445.130.3.466; Phelps EA, 2006, PSYCHOL SCI, V17, P292, DOI 10.1111/j.1467-9280.2006.01701.x; Santos IM, 2008, NEUROPSYCHOLOGIA, V46, P1468, DOI 10.1016/j.neuropsychologia.2007.12.024; Susskind JM, 2008, NAT NEUROSCI, V11, P843, DOI 10.1038/nn.2138; Vermeulen N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007924; Whalen PJ, 2001, EMOTION, V1, P70, DOI 10.1037/1528-3542.1.1.70; Woody SR, 2000, CLIN PSYCHOL-SCI PR, V7, P291, DOI 10.1093/clipsy/7.3.291; ZEELENBERG R, COGNITION, V115, P202	21	59	59	4	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2010	5	11							e13860	10.1371/journal.pone.0013860	http://dx.doi.org/10.1371/journal.pone.0013860			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	675OD	21079773	Green Published, gold			2022-12-27	WOS:000283839100014
J	Kelley, LC; Hayes, KE; Ammer, AG; Martin, KH; Weed, SA				Kelley, Laura C.; Hayes, Karen E.; Ammer, Amanda Gatesman; Martin, Karen H.; Weed, Scott A.			Cortactin Phosphorylated by ERK1/2 Localizes to Sites of Dynamic Actin Regulation and Is Required for Carcinoma Lamellipodia Persistence	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; TYROSINE PHOSPHORYLATION; ARP2/3 COMPLEX; N-WASP; CONTACT SITES; MATRIX-METALLOPROTEINASE; FACIOGENITAL DYSPLASIA; 11Q13 AMPLIFICATION; BINDING PROTEIN; FAMILY KINASES	Background: Tumor cell motility and invasion is governed by dynamic regulation of the cortical actin cytoskeleton. The actin-binding protein cortactin is commonly upregulated in multiple cancer types and is associated with increased cell migration. Cortactin regulates actin nucleation through the actin related protein (Arp) 2/3 complex and stabilizes the cortical actin cytoskeleton. Cortactin is regulated by multiple phosphorylation events, including phosphorylation of S405 and S418 by extracellular regulated kinases (ERK) 1/2. ERK1/2 phosphorylation of cortactin has emerged as an important positive regulatory modification, enabling cortactin to bind and activate the Arp2/3 regulator neuronal Wiskott-Aldrich syndrome protein (N-WASp), promoting actin polymerization and enhancing tumor cell movement. Methodology/Principal Findings: In this report we have developed phosphorylation-specific antibodies against phosphorylated cortactin S405 and S418 to analyze the subcellular localization of this cortactin form in tumor cells and patient samples by microscopy. We evaluated the interplay between cortactin S405 and S418 phosphorylation with cortactin tyrosine phosphorylation in regulating cortactin conformational forms by Western blotting. Cortactin is simultaneously phosphorylated at S405/418 and Y421 in tumor cells, and through the use of point mutant constructs we determined that serine and tyrosine phosphorylation events lack any co-dependency. Expression of S405/418 phosphorylation-null constructs impaired carcinoma motility and adhesion, and also inhibited lamellipodia persistence monitored by live cell imaging. Conclusions/Significance: Cortactin phosphorylated at S405/418 is localized to sites of dynamic actin assembly in tumor cells. Concurrent phosphorylation of cortactin by ERK1/2 and tyrosine kinases enables cells with the ability to regulate actin dynamics through N-WASp and other effector proteins by synchronizing upstream regulatory pathways, confirming cortactin as an important integration point in actin-based signal transduction. Reduced lamellipodia persistence in cells with S405/418A expression identifies an essential motility-based process reliant on ERK1/2 signaling, providing additional understanding as to how this pathway impacts tumor cell migration.	[Kelley, Laura C.; Hayes, Karen E.; Ammer, Amanda Gatesman; Martin, Karen H.; Weed, Scott A.] W Virginia Univ, Dept Neurobiol & Anat, Program Canc Cell Biol, Mary Babb Randolph Canc Ctr, Morgantown, WV 26506 USA	West Virginia University	Kelley, LC (corresponding author), W Virginia Univ, Dept Neurobiol & Anat, Program Canc Cell Biol, Mary Babb Randolph Canc Ctr, Morgantown, WV 26506 USA.	sweed@hsc.wvu.edu		Martin, Karen/0000-0001-8916-4092; Weed, Scott/0000-0001-7033-9999	National Institutes of Health [R01 DE014578, P20 RR16440]; West Virginia University Office of Research and Graduate Education; Protea Biosciences; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016440] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE014578] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); West Virginia University Office of Research and Graduate Education; Protea Biosciences; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	These studies were supported by National Institutes of Health grants R01 DE014578 and P20 RR16440 to SAW. LCK was supported in part by the West Virginia University Office of Research and Graduate Education. Protea Biosciences provided exclusive funding for the production and validation of the pS405 and pS418 antibodies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMMER AG, 2009, J CANC SCI THERAPY, V1; Ammer AG, 2008, CELL MOTIL CYTOSKEL, V65, P687, DOI 10.1002/cm.20296; Ammer Amanda Gatesman, 2009, J Cancer Sci Ther, V1, P52; Artym VV, 2006, CANCER RES, V66, P3034, DOI 10.1158/0008-5472.CAN-05-2177; Ayala I., 2008, J CELL SCI; Bailly M, 1998, MICROSC RES TECHNIQ, V43, P433, DOI 10.1002/(SICI)1097-0029(19981201)43:5<433::AID-JEMT9>3.0.CO;2-2; Boguslavsky S, 2007, P NATL ACAD SCI USA, V104, P10882, DOI 10.1073/pnas.0702731104; Boyle SN, 2007, CURR BIOL, V17, P445, DOI 10.1016/j.cub.2007.01.057; Bryce NS, 2005, CURR BIOL, V15, P1276, DOI 10.1016/j.cub.2005.06.043; Campbell DH, 1999, CANCER RES, V59, P5376; Clark ES, 2007, CANCER RES, V67, P4227, DOI 10.1158/0008-5472.CAN-06-3928; Cosen-Binker LI, 2006, PHYSIOLOGY, V21, P352, DOI 10.1152/physiol.00012.2006; Cowieson NP, 2008, J BIOL CHEM, V283, P16187, DOI 10.1074/jbc.M708917200; Crostella L, 2001, ONCOGENE, V20, P3735, DOI 10.1038/sj.onc.1204474; Daly RJ, 2004, BIOCHEM J, V382, P13, DOI 10.1042/BJ20040737; Dry JR, 2010, CANCER RES, V70, P2264, DOI 10.1158/0008-5472.CAN-09-1577; Du YR, 1998, MOL CELL BIOL, V18, P5838, DOI 10.1128/MCB.18.10.5838; Eblen ST, 2002, MOL CELL BIOL, V22, P6023, DOI 10.1128/MCB.22.17.6023-6033.2002; El-Sibai M, 2007, J CELL SCI, V120, P3465, DOI 10.1242/jcs.005942; Gallet C, 1999, J BIOL CHEM, V274, P23610, DOI 10.1074/jbc.274.33.23610; Garcia-Castillo J, 2009, J BIOL CHEM, V284, P25302, DOI 10.1074/jbc.M109.001982; Grassart A, 2010, TRAFFIC; Head JA, 2003, MOL BIOL CELL, V14, P3216, DOI 10.1091/mbc.e02-11-0753; Helwani FM, 2004, J CELL BIOL, V164, P899, DOI 10.1083/jcb.200309034; Hou P, 2003, HUM MOL GENET, V12, P1981, DOI 10.1093/hmg/ddg209; Huang C, 1998, J BIOL CHEM, V273, P25770, DOI 10.1074/jbc.273.40.25770; Huang C, 1997, J BIOL CHEM, V272, P13911, DOI 10.1074/jbc.272.21.13911; Huang JH, 2003, J BIOL CHEM, V278, P48367, DOI 10.1074/jbc.M308213200; Insall RH, 2009, DEV CELL, V17, P310, DOI 10.1016/j.devcel.2009.08.012; Kapus A, 2000, J BIOL CHEM, V275, P32289, DOI 10.1074/jbc.M003172200; Kempiak SJ, 2005, J BIOL CHEM, V280, P5836, DOI 10.1074/jbc.M410713200; Kim K, 2004, BIOCHEMISTRY-US, V43, P2422, DOI 10.1021/bi036173t; Kinley AW, 2003, CURR BIOL, V13, P384, DOI 10.1016/S0960-9822(03)00107-6; Kowalski JR, 2005, J CELL SCI, V118, P79, DOI 10.1242/jcs.01586; KRAUSE CJ, 1981, ARCH OTOLARYNGOL, V107, P703; Kruchten AE, 2008, AM J PHYSIOL-CELL PH, V295, pC1113, DOI 10.1152/ajpcell.00238.2008; LAI FP, 2009, MOL BIOL CELL; Lapetina S, 2009, J CELL BIOL, V185, P503, DOI 10.1083/jcb.200809085; Le Clainche C, 2008, PHYSIOL REV, V88, P489, DOI 10.1152/physrev.00021.2007; Lua BL, 2005, FEBS LETT, V579, P577, DOI 10.1016/j.febslet.2004.12.055; Machesky LM, 2008, FEBS LETT, V582, P2102, DOI 10.1016/j.febslet.2008.03.039; MANSER E, 1994, NATURE, V367, P40, DOI 10.1038/367040a0; Martin KH, 2006, J CELL SCI, V119, P2851, DOI 10.1242/jcs03034; Martinez-Quiles N, 2004, MOL CELL BIOL, V24, P5269, DOI 10.1128/MCB.24.12.5269-5280.2004; McDermott U, 2007, P NATL ACAD SCI USA, V104, P19936, DOI 10.1073/pnas.0707498104; Ohoka Y, 1998, GENES CELLS, V3, P603, DOI 10.1046/j.1365-2443.1998.00216.x; Olson MF, 1996, CURR BIOL, V6, P1628, DOI 10.1016/S0960-9822(02)70786-0; Olson MF, 2009, CLIN EXP METASTAS, V26, P273, DOI 10.1007/s10585-008-9174-2; Oser M, 2009, J CELL BIOL, V186, P571, DOI 10.1083/jcb.200812176; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Ren G, 2009, J BIOL CHEM, V284, P18913, DOI 10.1074/jbc.M109.000307; Rothsschild BL, 2006, CANCER RES, V66, P8017, DOI 10.1158/0008-5472.CAN-05-4490; SACKS PG, 1988, CANCER RES, V48, P2858; Sarmiento C, 2008, J CELL BIOL, V180, P1245, DOI 10.1083/jcb.200708123; SCHUURING E, 1993, MOL CELL BIOL, V13, P2891, DOI 10.1128/MCB.13.5.2891; Segall JE, 1996, CLIN EXP METASTAS, V14, P61, DOI 10.1007/BF00157687; Small JV, 2002, TRENDS CELL BIOL, V12, P112, DOI 10.1016/S0962-8924(01)02237-1; Smith SD, 2008, J CELL SCI, V121, P3729, DOI 10.1242/jcs.027680; Tehrani S, 2007, P NATL ACAD SCI USA, V104, P11933, DOI 10.1073/pnas.0701077104; Uruno T, 2001, NAT CELL BIOL, V3, P259, DOI 10.1038/35060051; van Rossum AGSH, 2006, EXP CELL RES, V312, P1658, DOI 10.1016/j.yexcr.2006.01.033; van Rossum AGSH, 2003, J BIOL CHEM, V278, P45672, DOI 10.1074/jbc.M306688200; vanDamme H, 1997, J BIOL CHEM, V272, P7374, DOI 10.1074/jbc.272.11.7374; Walker VG, 2007, AM J PHYSIOL-CELL PH, V293, pC119, DOI 10.1152/ajpcell.00525.2006; Weaver AM, 2008, CANCER LETT, V265, P157, DOI 10.1016/j.canlet.2008.02.066; Weaver AM, 2002, CURR BIOL, V12, P1270, DOI 10.1016/S0960-9822(02)01035-7; Weaver AM, 2001, CURR BIOL, V11, P370, DOI 10.1016/S0960-9822(01)00098-7; Weed SA, 2001, ONCOGENE, V20, P6418, DOI 10.1038/sj.onc.1204783; Weed SA, 2000, J CELL BIOL, V151, P29, DOI 10.1083/jcb.151.1.29; WU H, 1991, MOL CELL BIOL, V11, P5113, DOI 10.1128/MCB.11.10.5113; Xu XZ, 2010, MODERN PATHOL, V23, P187, DOI 10.1038/modpathol.2009.157; YAMAGUCHI H, 2006, BIOCH BIOPHYS ACTA; YILMAZ M, 2010, MOL CANC RES; Zhang LH, 2006, J CANCER RES CLIN, V132, P113, DOI 10.1007/s00432-005-0046-8	74	62	62	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2010	5	11							e13847	10.1371/journal.pone.0013847	http://dx.doi.org/10.1371/journal.pone.0013847			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675NY	21079800	Green Published, gold, Green Submitted			2022-12-27	WOS:000283838600019
J	Kusi, KA; Faber, BW; Riasat, V; Thomas, AW; Kocken, CHM; Remarque, EJ				Kusi, Kwadwo A.; Faber, Bart W.; Riasat, Vanessa; Thomas, Alan W.; Kocken, Clemens H. M.; Remarque, Edmond J.			Generation of Humoral Immune Responses to Multi-Allele PfAMA1 Vaccines; Effect of Adjuvant and Number of Component Alleles on the Breadth of Response	PLOS ONE			English	Article							APICAL MEMBRANE ANTIGEN-1; PLASMODIUM-FALCIPARUM APICAL-MEMBRANE-ANTIGEN-1; MALARIA VACCINE; ANTIBODY; SPECIFICITY; CANDIDATE; STAGE; PROTEIN; IMMUNIZATION; RECOGNITION	There is increasing interest in multi-allele vaccines to overcome strain-specificity against polymorphic vaccine targets such as Apical Membrane Antigen 1 (AMA1). These have been shown to induce broad inhibitory antibodies in vitro and formed the basis for the design of three Diversity-Covering (DiCo) proteins with similar immunological effects. The antibodies produced are to epitopes that are shared between vaccine alleles and theoretically, increasing the number of component AMA1 alleles is expected to broaden the antibody response. A plateau effect could however impose a limit on the number of alleles needed to achieve the broadest specificity. Moreover, production cost and the vaccine formulation process would limit the number of component alleles. In this paper, we compare rabbit antibody responses elicited with multi-allele vaccines incorporating seven (three DiCos and four natural AMA1 alleles) and three (DiCo mix) antigens for gains in broadened specificity. We also investigate the effect of three adjuvant platforms on antigen specificity and antibody functionality. Our data confirms a broadened response after immunisation with DiCo mix in all three adjuvants. Higher antibody titres were elicited with either CoVaccine HT (TM) or Montanide ISA 51, resulting in similar in vitro inhibition (65-82%) of five out of six culture-adapted P. falciparum strains. The antigen binding specificities of elicited antibodies were also similar and independent of the adjuvant used or the number of vaccine component alleles. Thus neither the four extra antigens nor adjuvant had any observable benefits with respect to specificity broadening, although adjuvant choice influenced the absolute antibody levels and thus the extent of parasite inhibition. Our data confirms the feasibility and potential of multi-allele PfAMA1 formulations, and highlights the need for adjuvants with improved antibody potentiation properties for AMA1-based vaccines.	[Kusi, Kwadwo A.; Faber, Bart W.; Riasat, Vanessa; Thomas, Alan W.; Kocken, Clemens H. M.; Remarque, Edmond J.] Biomed Primate Res Ctr, Dept Parasitol, Rijswijk, Netherlands; [Kusi, Kwadwo A.] Univ Ghana, Coll Hlth Sci, Noguchi Mem Inst Med Res, Dept Immunol, Accra, Ghana	University of Ghana	Kusi, KA (corresponding author), Biomed Primate Res Ctr, Dept Parasitol, Rijswijk, Netherlands.	remarque@bprc.nl	Remarque, Ed/AAE-8643-2020; Kusi, Kwadwo Asamoah/J-5941-2019	Kusi, Kwadwo Asamoah/0000-0001-5483-9985; Kocken, Clemens/0000-0002-4784-1734; Faber, Bart/0000-0001-6808-1204	European Malaria Vaccine Initiative (EMVI) [5-2007]; European Malaria Vaccine Development Association (EMVDA) [LSHP-CT-2007-037506]; Ghana Education Trust	European Malaria Vaccine Initiative (EMVI); European Malaria Vaccine Development Association (EMVDA)(European Commission); Ghana Education Trust	This work was funded by the European Malaria Vaccine Initiative (EMVI), grant number 5-2007, and the European Malaria Vaccine Development Association (EMVDA), grant number LSHP-CT-2007-037506. KAK was also supported by the Ghana Education Trust Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aide P, 2007, ARCH DIS CHILD, V92, P476, DOI 10.1136/adc.2005.092551; Andersen PH, 2006, PROTEIN SCI, V15, P2558, DOI 10.1110/ps.062405906; Aucouturier J, 2006, VACCINE, V24, pS44, DOI 10.1016/j.vaccine.2005.01.116; Aucouturier J, 2000, ANN NY ACAD SCI, V916, P600, DOI 10.1111/j.1749-6632.2000.tb05343.x; Barclay VC, 2008, VACCINE, V26, P6099, DOI 10.1016/j.vaccine.2008.09.004; Blom AG, 2004, VACCINE, V23, P743, DOI 10.1016/j.vaccine.2004.07.021; BONHOURE F, 2006, J IMMUNOTHERAPY, V29; Coley AM, 2006, INFECT IMMUN, V74, P2628, DOI 10.1128/IAI.74.5.2628-2636.2006; Collins CR, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000273; COLLINS WE, 1994, AM J TROP MED HYG, V51, P711, DOI 10.4269/ajtmh.1994.51.711; Cortes A, 2005, INFECT IMMUN, V73, P422, DOI 10.1128/IAI.73.1.422-430.2005; Crewther PE, 1996, INFECT IMMUN, V64, P3310, DOI 10.1128/IAI.64.8.3310-3317.1996; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Doolan DL, 2009, CLIN MICROBIOL REV, V22, P13, DOI 10.1128/CMR.00025-08; DUBOIS P, 1995, RES IMMUNOL, V146, P263, DOI 10.1016/0923-2494(96)80261-6; Dutta S, 2007, P NATL ACAD SCI USA, V104, P12488, DOI 10.1073/pnas.0701464104; Dutta S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008138; FABER BW, 2008, VACCINE; Gatton ML, 2004, PARASITOLOGY, V128, P367, DOI 10.1017/S0031182003004608; Good MF, 2005, TRENDS PARASITOL, V21, P29, DOI 10.1016/j.pt.2004.10.006; Hodder AN, 2001, INFECT IMMUN, V69, P3286, DOI 10.1128/IAI.69.5.3286-3294.2001; Howell SA, 2001, J BIOL CHEM, V276, P31311, DOI 10.1074/jbc.M103076200; Hui G, 2008, CLIN VACCINE IMMUNOL, V15, P1145, DOI 10.1128/CVI.00058-08; Hui GS, 2008, INT IMMUNOPHARMACOL, V8, P1012, DOI 10.1016/j.intimp.2008.03.005; HUI GSN, 1991, J IMMUNOL, V147, P3935; Kennedy MC, 2002, INFECT IMMUN, V70, P6948, DOI 10.1128/IAI.70.12.6948-6960.2002; Kusi KA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008110; Miura K, 2007, INFECT IMMUN, V75, P5827, DOI 10.1128/IAI.00593-07; Mullen GED, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002940; NARUM DL, 1994, MOL BIOCHEM PARASIT, V67, P59, DOI 10.1016/0166-6851(94)90096-5; Noedl H, 2009, NEW ENGL J MED, V361, P540, DOI 10.1056/NEJMc0900231; Polley SD, 2004, VACCINE, V23, P718, DOI 10.1016/j.vaccine.2004.05.031; Polley SD, 2001, GENETICS, V158, P1505; RAWLINGS DJ, 1992, J EXP MED, V176, P1483, DOI 10.1084/jem.176.5.1483; Remarque EJ, 2008, INFECT IMMUN, V76, P2660, DOI 10.1128/IAI.00170-08; Remarque EJ, 2008, TRENDS PARASITOL, V24, P74, DOI 10.1016/j.pt.2007.12.002; Richards JS, 2009, IMMUNOL CELL BIOL, V87, P377, DOI 10.1038/icb.2009.27; Spring MD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005254; Struik SS, 2004, IMMUNOL REV, V201, P268, DOI 10.1111/j.0105-2896.2004.00181.x; Todryk SM, 2007, NAT REV MICROBIOL, V5, P487, DOI 10.1038/nrmicro1712; Van Bortel W, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-102	41	34	35	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2010	5	11							e15391	10.1371/journal.pone.0015391	http://dx.doi.org/10.1371/journal.pone.0015391			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	800AR	21082025	gold, Green Published, Green Submitted			2022-12-27	WOS:000293329500001
J	Hagino, Y; Kasai, S; Han, WH; Yamamoto, H; Nabeshima, T; Mishina, M; Ikeda, K				Hagino, Yoko; Kasai, Shinya; Han, Wenhua; Yamamoto, Hideko; Nabeshima, Toshitaka; Mishina, Masayoshi; Ikeda, Kazutaka			Essential Role of NMDA Receptor Channel epsilon 4 Subunit (GluN2D) in the Effects of Phencyclidine, but Not Methamphetamine	PLOS ONE			English	Article							MICE LACKING; IN-VIVO; BEHAVIORAL SENSITIZATION; RAT-BRAIN; NONCOMPETITIVE ANTAGONISTS; EXTRACELLULAR LEVELS; CATECHOLAMINE UPTAKE; TARGETED DISRUPTION; LOCOMOTOR-ACTIVITY; ANESTHETIZED RATS	Phencyclidine (PCP), a noncompetitive N-methyl-D-aspartate (NMDA) receptor antagonist, increases locomotor activity in rodents and causes schizophrenia-like symptoms in humans. Although activation of the dopamine (DA) pathway is hypothesized to mediate these effects of PCP, the precise mechanisms by which PCP induces its effects remain to be elucidated. The present study investigated the effect of PCP on extracellular levels of DA (DA(ex)) in the striatum and prefrontal cortex (PFC) using in vivo microdialysis in mice lacking the NMDA receptor channel epsilon 1 or epsilon 4 subunit (GluR epsilon 1 [GluN2A] or GluR epsilon 4 [GluN2D]) and locomotor activity. PCP significantly increased DA(ex) in wildtype and GluR epsilon 1 knockout mice, but not in GluR epsilon 4 knockout mice, in the striatum and PFC. Acute and repeated administration of PCP did not increase locomotor activity in GluR epsilon 4 knockout mice. The present results suggest that PCP enhances dopaminergic transmission and increases locomotor activity by acting at GluR epsilon 4.	[Hagino, Yoko; Kasai, Shinya; Han, Wenhua; Yamamoto, Hideko; Ikeda, Kazutaka] Tokyo Inst Psychiat, Div Psychobiol, Tokyo, Japan; [Nabeshima, Toshitaka] Meijo Univ, Comparat Cognit Sci Inst, Grad Sch Pharmaceut Sci, Nagoya, Aichi, Japan; [Nabeshima, Toshitaka] Meijo Univ, Dept Chem Pharmacol, Grad Sch Pharmaceut Sci, Nagoya, Aichi, Japan; [Mishina, Masayoshi] Univ Tokyo, Dept Mol Neurobiol & Pharmacol, Grad Sch Med, Tokyo, Japan	Tokyo Institute of Psychiatry; Meijo University; Meijo University; University of Tokyo	Hagino, Y (corresponding author), Tokyo Inst Psychiat, Div Psychobiol, Tokyo, Japan.	ikeda-kz@igakuken.or.jp	Ikeda, Kazutaka/I-4694-2013	Ikeda, Kazutaka/0000-0001-8342-0278	Ministry of Health, Labour and Welfare of Japan [H19-Iyaku-023, H22-Iyaku-015]; Ministry of Education, Culture, Sports, Science and Technology of Japan; Naito Foundation; Mitsubishi Foundation	Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Naito Foundation(Naito Memorial Foundation); Mitsubishi Foundation	This work was supported by grants from the Ministry of Health, Labour and Welfare of Japan (H19-Iyaku-023, H22-Iyaku-015), the Ministry of Education, Culture, Sports, Science and Technology of Japan, The Naito Foundation, and The Mitsubishi Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams B, 1998, J NEUROSCI, V18, P5545, DOI 10.1523/JNEUROSCI.18-14-05545.1998; ANIS NA, 1983, BRIT J PHARMACOL, V79, P565, DOI 10.1111/j.1476-5381.1983.tb11031.x; BENWELL MEM, 1993, PSYCHOPHARMACOLOGY, V112, P467, DOI 10.1007/BF02244896; Boyce-Rustay JM, 2006, NEUROPSYCHOPHARMACOL, V31, P2405, DOI 10.1038/sj.npp.1301039; Carlsson A, 2000, BRAIN RES REV, V31, P342, DOI 10.1016/S0165-0173(99)00050-8; CASTELLANI S, 1981, EUR J PHARMACOL, V73, P143, DOI 10.1016/0014-2999(81)90086-8; CHAPMAN CD, 1990, NEUROPHARMACOLOGY, V29, P319, DOI 10.1016/0028-3908(90)90089-A; Ebralidze AK, 1996, J NEUROSCI, V16, P5014; FISCHER JF, 1979, J PHARMACOL EXP THER, V208, P203; FORREST D, 1994, NEURON, V13, P325, DOI 10.1016/0896-6273(94)90350-6; Franklin K. B. J., 2008, PAXINOS FRANKLINS MO; GAREY RE, 1976, LIFE SCI, V18, P1105, DOI 10.1016/0024-3205(76)90145-4; Geyer MA, 2003, PROG NEURO-PSYCHOPH, V27, P1071, DOI 10.1016/j.pnpbp.2003.09.003; GREEN AL, 1978, J PHARM PHARMACOL, V30, P262, DOI 10.1111/j.2042-7158.1978.tb13223.x; GREEN AL, 1971, BIOCHEM J, V121, pP37, DOI 10.1042/bj1210037P; HEIKKILA RE, 1975, BIOCHEM PHARMACOL, V24, P847, DOI 10.1016/0006-2952(75)90152-5; Hertel P, 1996, BEHAV BRAIN RES, V72, P103, DOI 10.1016/0166-4328(96)00138-6; HONDO H, 1994, BRAIN RES, V633, P337, DOI 10.1016/0006-8993(94)91558-X; HORN AS, 1971, MOL PHARMACOL, V7, P66; IKEDA K, 1995, MOL BRAIN RES, V33, P61, DOI 10.1016/0169-328X(95)00107-4; IKEDA K, 1992, FEBS LETT, V313, P34, DOI 10.1016/0014-5793(92)81178-O; JAVITT DC, 1991, AM J PSYCHIAT, V148, P1301; Jentsch JD, 1999, NEUROPSYCHOPHARMACOL, V20, P201, DOI 10.1016/S0893-133X(98)00060-8; Jones S, 2005, J PHYSIOL-LONDON, V569, P209, DOI 10.1113/jphysiol.2005.095554; Kadotani H, 1996, J NEUROSCI, V16, P7859; KEMP JA, 1987, TRENDS NEUROSCI, V10, P294, DOI 10.1016/0166-2236(87)90176-7; Kew JNC, 2005, PSYCHOPHARMACOLOGY, V179, P4, DOI 10.1007/s00213-005-2200-z; KURIBARA H, 1992, PSYCHOPHARMACOLOGY, V108, P271, DOI 10.1007/BF02245111; Kutsuwada T, 1996, NEURON, V16, P333, DOI 10.1016/S0896-6273(00)80051-3; KUTSUWADA T, 1992, NATURE, V358, P36, DOI 10.1038/358036a0; LI YQ, 1994, CELL, V76, P427, DOI 10.1016/0092-8674(94)90108-2; LILLRANK SM, 1994, ACTA PHYSIOL SCAND, V150, P109, DOI 10.1111/j.1748-1716.1994.tb09667.x; Lindahl JS, 2004, NEUROPSYCHOPHARMACOL, V29, P2065, DOI 10.1038/sj.npp.1300485; LODGE D, 1990, TRENDS PHARMACOL SCI, V11, P81, DOI 10.1016/0165-6147(90)90323-Z; LUBY ED, 1959, ARCH NEURO PSYCHIATR, V81, P363, DOI 10.1001/archneurpsyc.1959.02340150095011; Makins R, 2005, GROWTH HORM IGF RES, V15, P215, DOI 10.1016/j.ghir.2005.02.010; Masuo Y, 1997, BRAIN RES PROTOC, V1, P321, DOI 10.1016/S1385-299X(97)00005-6; MEGURO H, 1992, NATURE, V357, P70, DOI 10.1038/357070a0; Millan MJ, 2005, PSYCHOPHARMACOLOGY, V179, P30, DOI 10.1007/s00213-005-2199-1; MILLER HH, 1980, BIOCHEM PHARMACOL, V29, P1347, DOI 10.1016/0006-2952(80)90429-3; Miyamoto Y, 2001, J NEUROSCI, V21, P750, DOI 10.1523/JNEUROSCI.21-02-00750.2001; Miyamoto Y, 2004, EUR J NEUROSCI, V19, P151, DOI 10.1111/j.1460-9568.2004.03086.x; Miyamoto Y, 2002, J NEUROSCI, V22, P2335, DOI 10.1523/JNEUROSCI.22-06-02335.2002; MONYER H, 1992, SCIENCE, V256, P1217, DOI 10.1126/science.256.5060.1217; Mori H, 2003, LIFE SCI, V74, P329, DOI 10.1016/j.lfs.2003.09.020; Mouri A, 2007, NEUROCHEM INT, V51, P173, DOI 10.1016/j.neuint.2007.06.019; NABESHIMA T, 1987, EUR J PHARMACOL, V135, P23, DOI 10.1016/0014-2999(87)90753-9; Nishijima K, 1996, SYNAPSE, V22, P304, DOI 10.1002/(SICI)1098-2396(199604)22:4<304::AID-SYN2>3.0.CO;2-F; OHMORI T, 1994, PHARMACOL BIOCHEM BE, V48, P587, DOI 10.1016/0091-3057(94)90318-2; PARKER EM, 1988, J PHARMACOL EXP THER, V245, P199; Pierce RC, 1997, BRAIN RES REV, V25, P192, DOI 10.1016/S0165-0173(97)00021-0; ROBINSON TE, 1986, BRAIN RES REV, V11, P157, DOI 10.1016/0165-0173(86)90002-0; SAKIMURA K, 1995, NATURE, V373, P151, DOI 10.1038/373151a0; Schmitz Y, 2001, J NEUROSCI, V21, P5916, DOI 10.1523/JNEUROSCI.21-16-05916.2001; SEIDEN LS, 1993, ANNU REV PHARMACOL, V33, P639, DOI 10.1146/annurev.pa.33.040193.003231; SMITH RC, 1977, BIOCHEM PHARMACOL, V26, P1435, DOI 10.1016/0006-2952(77)90370-7; SNELL LD, 1988, EUR J PHARMACOL, V145, P223, DOI 10.1016/0014-2999(88)90235-X; Sprengel R, 1998, CELL, V92, P279, DOI 10.1016/S0092-8674(00)80921-6; STANDAERT DG, 1994, J COMP NEUROL, V343, P1, DOI 10.1002/cne.903430102; STURGEON RD, 1979, EUR J PHARMACOL, V59, P169; SULZER D, 1993, J NEUROCHEM, V60, P527, DOI 10.1111/j.1471-4159.1993.tb03181.x; TROUPIN AS, 1986, CURRENT PROBLEMS EPI, V4, P191; WATANABE M, 1992, NEUROREPORT, V3, P1138, DOI 10.1097/00001756-199212000-00027; WOLF ME, 1993, BRAIN RES, V613, P291, DOI 10.1016/0006-8993(93)90913-8; WOLF ME, 1991, BRAIN RES, V562, P164, DOI 10.1016/0006-8993(91)91202-C; XU XJ, 1994, PHARMACOL BIOCHEM BE, V47, P603, DOI 10.1016/0091-3057(94)90165-1; YAMAKURA T, 1993, NEUROREPORT, V4, P687, DOI 10.1097/00001756-199306000-00021	67	36	37	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2010	5	10							e13722	10.1371/journal.pone.0013722	http://dx.doi.org/10.1371/journal.pone.0013722			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	672HN	21060893	Green Submitted, gold, Green Published			2022-12-27	WOS:000283573800017
J	Ayestaran, A; Giurfa, M; de Brito Sanchez, MG				Ayestaran, Ainara; Giurfa, Martin; de Brito Sanchez, Maria Gabriela			Toxic but Drank: Gustatory Aversive Compounds Induce Post-ingestional Malaise in Harnessed Honeybees	PLOS ONE			English	Article							APIS-MELLIFERA; UNCONDITIONED STIMULUS; COLOR DISCRIMINATION; OLFACTORY RECEPTORS; CAFFEINE RESPONSE; LITHIUM-CHLORIDE; FORAGING SPEED; TASTE; INSECT; FOOD	Background: Deterrent substances produced by plants are relevant due to their potential toxicity. The fact that most of these substances have an unpalatable taste for humans and other mammals contrasts with the fact that honeybees do not reject them in the range of concentrations in which these compounds are present in flower nectars. Here we asked whether honeybees detect and ingest deterrent substances and whether these substances are really toxic to them. Results: We show that pairing aversive substances with an odor retards learning of this odor when it is subsequently paired with sucrose. Harnessed honeybees in the laboratory ingest without reluctance a considerable volume (20 mu l) of various aversive substances, even if some of them induce significant post-ingestional mortality. These substances do not seem, therefore, to be unpalatable to harnessed bees but induce a malaise-like state that in some cases results in death. Consistently with this finding, bees learning that one odor is associated with sugar, and experiencing in a subsequent phase that the sugar was paired with 20 mu l of an aversive substance (devaluation phase), respond less than control bees to the odor and the sugar. Such stimulus devaluation can be accounted for by the malaise-like state induced by the aversive substances. Conclusion: Our results indicate that substances that taste bitter to humans as well as concentrated saline solutions base their aversive effect on the physiological consequences that their ingestion generates in harnessed bees rather than on an unpalatable taste. This conclusion is only valid for harnessed bees in the laboratory as freely-moving bees might react differently to aversive compounds could actively reject aversive substances. Our results open a new possibility to study conditioned taste aversion based on post-ingestional malaise and thus broaden the spectrum of aversive learning protocols available in honeybees.	[Ayestaran, Ainara; Giurfa, Martin; de Brito Sanchez, Maria Gabriela] Univ Toulouse UPS, Ctr Rech Cognit Anim, Toulouse, France; [Ayestaran, Ainara; Giurfa, Martin; de Brito Sanchez, Maria Gabriela] CNRS, Ctr Rech Cognit Anim, Toulouse, France	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite Federale Toulouse Midi-Pyrenees (ComUE); Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Ayestaran, A (corresponding author), Univ Toulouse UPS, Ctr Rech Cognit Anim, Toulouse, France.	debrito@cict.fr	Giurfa, Martin/H-5140-2016; Giurfa, Martin MG/A-7322-2008; Giurfa, Martin/AAS-4945-2020	Giurfa, Martin/0000-0001-7173-769X; Giurfa, Martin/0000-0001-7173-769X; de Brito Sanchez, Maria Gabriela/0000-0001-6940-8088	National Research Agency (ANR) [ANR-BLAN08- 3_337040]; University Paul Sabatier; Centre National de la Recherche Scientifique (CNRS)	National Research Agency (ANR)(French National Research Agency (ANR)); University Paul Sabatier; Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS))	National Research Agency (ANR; Project INSAVEL ANR-BLAN08- 3_337040), the University Paul Sabatier (Project APIGENE) and the Centre National de la Recherche Scientifique (CNRS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amrein H, 2005, CURR BIOL, V15, pR673, DOI 10.1016/j.cub.2005.08.021; AVARGUESWEBER A, 2010, PLOS ONE IN PRESS; BATEMAN DN, 1986, ADVERSE DRUG REACT T, V5, P215; BERNAYS EA, 1988, PHYSIOL ENTOMOL, V13, P131, DOI 10.1111/j.1365-3032.1988.tb00916.x; Bewick V, 2004, CRIT CARE, V8, P389, DOI 10.1186/cc2955; BITTERMAN ME, 1983, J COMP PSYCHOL, V97, P107, DOI 10.1037/0735-7036.97.2.107; Chandra S, 1998, J EXP BIOL, V201, P3113; Chittka L, 2003, NATURE, V424, P388, DOI 10.1038/424388a; COOPER PD, 1994, J INSECT PHYSIOL, V40, P475, DOI 10.1016/0022-1910(94)90120-1; de Brito Sanchez M. G., 2008, J COMP PHYSIOL A, V194, P861, DOI DOI 10.1007/S00359-008-0357-8; de Brito Sanchez MG, 2005, EUR J NEUROSCI, V22, P3161, DOI 10.1111/j.1460-9568.2005.04516.x; Deisig N, 2002, LEARN MEMORY, V9, P112, DOI 10.1101/lm.41002; Detzel Andreas, 1993, Chemoecology, V4, P8, DOI 10.1007/BF01245891; Dunipace L, 2001, CURR BIOL, V11, P822, DOI 10.1016/S0960-9822(01)00258-5; Dyer AG, 2004, J COMP PHYSIOL A, V190, P759, DOI 10.1007/s00359-004-0547-y; FLANAGAN LM, 1988, NEUROENDOCRINOLOGY, V48, P668, DOI 10.1159/000125080; Freeman KB, 2005, BEHAV PHARMACOL, V16, P591, DOI 10.1097/01.fbp.0000181593.01244.6c; Garcia J, 1966, PSYCHON SCI, V4, P123, DOI [10.3758/BF03342209, DOI 10.3758/BF03342209]; Garcia J, 1966, PSYCHON SCI, V5, P121, DOI DOI 10.3758/BF03328311; Giurfa M, 2007, J COMP PHYSIOL A, V193, P801, DOI 10.1007/s00359-007-0235-9; Giurfa M, 2009, LEARN MEMORY, V16, P761, DOI 10.1101/lm.1603009; GLENDINNING JI, 1994, PHYSIOL ENTOMOL, V19, P173, DOI 10.1111/j.1365-3032.1994.tb01040.x; Guerrieri F, 2005, PLOS BIOL, V3, P718, DOI 10.1371/journal.pbio.0030060; HAGLER JR, 1993, J KANSAS ENTOMOL SOC, V66, P223; HELVERSEN OV, 1972, J COMP PHYSIOL, V80, P439, DOI 10.1007/BF00696438; Hill CA, 2002, SCIENCE, V298, P176, DOI 10.1126/science.1076196; HOLLAND PC, 1975, J EXP PSYCHOL ANIM B, V1, P355, DOI 10.1037/0097-7403.1.4.355; Holland PC, 2008, LEARN MOTIV, V39, P265, DOI 10.1016/j.lmot.2008.08.001; Hori S, 2007, J COMP PHYSIOL A, V193, P825, DOI 10.1007/s00359-007-0234-x; Hori S, 2006, J COMP PHYSIOL A, V192, P691, DOI 10.1007/s00359-005-0091-4; Howarth CJ, 2002, J INSECT PHYSIOL, V48, P43, DOI 10.1016/S0022-1910(01)00142-1; Ish-Am G, 1998, J HORTIC SCI BIOTECH, V73, P195, DOI 10.1080/14620316.1998.11510965; Ishimoto H, 2004, CELL MOL LIFE SCI, V61, P10, DOI 10.1007/s00018-003-3182-9; Jorgensen K, 2007, J EXP BIOL, V210, P2563, DOI 10.1242/jeb.004283; Kent LB, 2008, CHEM SENSES, V33, P79, DOI 10.1093/chemse/bjm067; LEE JC, 1990, ANIM BEHAV, V39, P163, DOI 10.1016/S0003-3472(05)80736-5; Lee Y, 2009, P NATL ACAD SCI USA, V106, P4495, DOI 10.1073/pnas.0811744106; Liu F, 2007, FUNCT ECOL, V21, P96, DOI 10.1111/j.1365-2435.2006.01200.x; Liu FL, 2006, BEHAV ECOL SOCIOBIOL, V59, P582, DOI 10.1007/s00265-005-0084-x; Liu FL, 2004, J APICULT RES, V43, P155; London-Shafir I, 2003, PLANT SYST EVOL, V238, P87, DOI 10.1007/s00606-003-0272-y; LORENZO E, 2009, THESIS U P SABATIER, P26; LUFFY D, 1992, J INSECT PHYSIOL, V38, P287, DOI 10.1016/0022-1910(92)90129-2; LUNNEY GH, 1970, J EDUC MEAS, V7, P263, DOI 10.1111/j.1745-3984.1970.tb00727.x; Marella S, 2006, NEURON, V49, P285, DOI 10.1016/j.neuron.2005.11.037; MCCANN MJ, 1989, AM J PHYSIOL-REG I, V256, pR436; Mitri C, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000147; Moon SJ, 2006, CURR BIOL, V16, P1812, DOI 10.1016/j.cub.2006.07.024; Mueller KL, 2005, NATURE, V434, P225, DOI 10.1038/nature03352; NACHMAN M, 1963, J COMP PHYSIOL PSYCH, V56, P343, DOI 10.1037/h0046484; NEWTON GW, 1981, WESTERN J MED, V134, P97; Niggebrugge C, 2009, J EXP BIOL, V212, P1344, DOI 10.1242/jeb.021881; NUNEZ JA, 1966, Z VERGL PHYSIOL, V53, P142; NUNEZ JA, 1982, J APICULT RES, V21, P139, DOI 10.1080/00218839.1982.11100531; OLDFIELD H, 1982, COMP BIOCH PHYSL C, V73, P303; Olszewski PK, 2000, AM J PHYSIOL-REG I, V279, pR1504, DOI 10.1152/ajpregu.2000.279.4.R1504; Pontoh J, 2002, INSECT BIOCHEM MOLEC, V32, P679, DOI 10.1016/S0965-1748(01)00147-3; Reilly S., 2009, CONDITIONED TASTE AV; Robertson HM, 2003, P NATL ACAD SCI USA, V100, P14537, DOI 10.1073/pnas.2335847100; Robertson HM, 2006, GENOME RES, V16, P1395, DOI 10.1101/gr.5057506; Roussel E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004197; SANCHEZ GD, 2007, ARTHROPOD-PLANT INTE, V1, P69; Schwaerzel M, 2003, J NEUROSCI, V23, P10495, DOI 10.1523/jneurosci.23-33-10495.2003; Scott K, 2005, NEURON, V48, P455, DOI 10.1016/j.neuron.2005.10.015; Scott K, 2004, CURR OPIN NEUROBIOL, V14, P423, DOI 10.1016/j.conb.2004.06.003; Scott K, 2001, CELL, V104, P661, DOI 10.1016/S0092-8674(02)02052-4; Singaravelan N, 2005, J CHEM ECOL, V31, P2791, DOI 10.1007/s10886-005-8394-z; Smadja C, 2009, MOL BIOL EVOL, V26, P2073, DOI 10.1093/molbev/msp116; TAKEDA K, 1961, J INSECT PHYSIOL, V6, P168, DOI 10.1016/0022-1910(61)90060-9; Teixeira EW, 2005, EVID-BASED COMPL ALT, V2, P85, DOI 10.1093/ecam/neh055; Unoki S, 2005, EUR J NEUROSCI, V22, P1409, DOI 10.1111/j.1460-9568.2005.04318.x; Unoki S, 2006, EUR J NEUROSCI, V24, P2031, DOI 10.1111/j.1460-9568.2006.05099.x; Vergoz V, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000288; Walker LE, 1999, ANN ENTOMOL SOC AM, V92, P902, DOI 10.1093/aesa/92.6.902; Wanner KW, 2008, INSECT MOL BIOL, V17, P621, DOI 10.1111/j.1365-2583.2008.00836.x; Weinstock GM, 2006, NATURE, V443, P931, DOI 10.1038/nature05260; WINK M, 1988, THEOR APPL GENET, V75, P225, DOI 10.1007/BF00303957; Wittstock U, 2002, CURR OPIN PLANT BIOL, V5, P300, DOI 10.1016/S1369-5266(02)00264-9; WYKES GR, 1952, J EXP BIOL, V29, P511	79	52	54	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2010	5	10							e15000	10.1371/journal.pone.0015000	http://dx.doi.org/10.1371/journal.pone.0015000			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671UN	21060877	Green Submitted, Green Published, gold			2022-12-27	WOS:000283537000060
J	Johansson, H; Svensson, F; Runnberg, R; Simonsson, T; Simonsson, S				Johansson, Helena; Svensson, Frida; Runnberg, Rikard; Simonsson, Tomas; Simonsson, Stina			Phosphorylated Nucleolin Interacts with Translationally Controlled Tumor Protein during Mitosis and with Oct4 during Interphase in ES Cells	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; TRANSCRIPTION FACTOR; GENE-EXPRESSION; BINDING-PROTEIN; SELF-RENEWAL; LR1; DIFFERENTIATION; IDENTIFICATION; MICROTUBULES; REGIONS	Background: Reprogramming of somatic cells for derivation of either embryonic stem (ES) cells, by somatic cell nuclear transfer (SCNT), or ES-like cells, by induced pluripotent stem (iPS) cell procedure, provides potential routes toward non-immunogenic cell replacement therapies. Nucleolar proteins serve as markers for activation of embryonic genes, whose expression is crucial for successful reprogramming. Although Nucleolin (Ncl) is one of the most abundant nucleolar proteins, its interaction partners in ES cells have remained unidentified. Methodology: Here we explored novel Ncl-interacting proteins using in situ proximity ligation assay (PLA), colocalization and immunoprecipitation (IP) in ES cells. Principal Findings: We found that phosphorylated Ncl (Ncl-P) interacted with translationally controlled tumor protein (Tpt1) in murine ES cells. The Ncl-P/Tpt1 complex peaked during mitosis and was reduced upon retinoic acid induced differentiation, signifying a role in cell proliferation. In addition, we showed that Ncl-P interacted with the transcription factor Oct4 during interphase in human as well as murine ES cells, indicating of a role in transcription. The Ncl-P/Oct4 complex peaked during early stages of spontaneous human ES cell differentiation and may thus be involved in the initial differentiation event(s) of mammalian development. Conclusions: Here we described two novel protein-protein interactions in ES cells, which give us further insight into the complex network of interacting proteins in pluripotent cells.	[Johansson, Helena; Svensson, Frida; Runnberg, Rikard; Simonsson, Tomas; Simonsson, Stina] Univ Gothenburg, Dept Med Biochem & Cell Biol, Inst Biomed, Gothenburg, Sweden	University of Gothenburg	Johansson, H (corresponding author), Univ Gothenburg, Dept Med Biochem & Cell Biol, Inst Biomed, Gothenburg, Sweden.	stina.simonsson@gu.se	Simonsson, Stina/R-2699-2016	Simonsson, Stina/0000-0001-9020-3714	Swedish Research Council [K2009-67X-15422-05-2]; Ake Wiberg Stiftelse; Magnus Bergvalls Stiftelse	Swedish Research Council(Swedish Research CouncilEuropean Commission); Ake Wiberg Stiftelse; Magnus Bergvalls Stiftelse	This work was supported by the Swedish Research Council Grant number K2009-67X-15422-05-2, Ake Wiberg Stiftelse, and Magnus Bergvalls Stiftelse. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baharvand H, 2008, J PROTEOME RES, V7, P412, DOI 10.1021/pr700560t; Bazile F, 2009, CARCINOGENESIS, V30, P555, DOI 10.1093/carcin/bgp022; BELENGUER P, 1989, NUCLEIC ACIDS RES, V17, P6625; Boiani M, 2002, GENE DEV, V16, P1209, DOI 10.1101/gad.966002; BRYS A, 1994, P NATL ACAD SCI USA, V91, P4915, DOI 10.1073/pnas.91.11.4915; Byrne JA, 2003, CURR BIOL, V13, P1206, DOI 10.1016/S0960-9822(03)00462-7; CHEN CM, 1991, J BIOL CHEM, V266, P7754; Darnfors C, 2005, STEM CELLS, V23, P483, DOI 10.1634/stemcells.2004-0254; DERENZINI M, 1995, LAB INVEST, V73, P497; Elliott ST, 2004, PROTEOMICS, V4, P3813, DOI 10.1002/pmic.200300820; Gachet Y, 1999, J CELL SCI, V112, P1257; Greasley PJ, 2000, NUCLEIC ACIDS RES, V28, P446, DOI 10.1093/nar/28.2.446; Grinstein E, 2007, J BIOL CHEM, V282, P12439, DOI 10.1074/jbc.M608068200; Grinstein E, 2006, J BIOL CHEM, V281, P22223, DOI 10.1074/jbc.M513335200; Hanakahi LA, 1997, P NATL ACAD SCI USA, V94, P3605, DOI 10.1073/pnas.94.8.3605; Hanakahi LA, 2000, NUCLEIC ACIDS RES, V28, P2651, DOI 10.1093/nar/28.14.2651; JOHANSSON H, 2010, CELL CYCLE IN PRESS; Liu HT, 1999, CANCER LETT, V144, P45, DOI 10.1016/S0304-3835(99)00184-6; Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105; Ma N, 2007, J CELL SCI, V120, P2091, DOI 10.1242/jcs.008771; Mahlapuu M, 2001, DEVELOPMENT, V128, P155; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Orford KW, 2008, NAT REV GENET, V9, P115, DOI 10.1038/nrg2269; Park IH, 2007, NATURE; PETER M, 1990, CELL, V60, P791, DOI 10.1016/0092-8674(90)90093-T; Richards M, 2004, STEM CELLS, V22, P51, DOI 10.1634/stemcells.22-1-51; ROSNER MH, 1990, NATURE, V345, P686, DOI 10.1038/345686a0; Schramm RD, 1999, BIOL REPROD, V60, P721, DOI 10.1095/biolreprod60.3.721; Simonsson S, 2004, NAT CELL BIOL, V6, P984, DOI 10.1038/ncb1176; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Srivastava M, 1999, FASEB J, V13, P1911, DOI 10.1096/fasebj.13.14.1911; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Ugrinova I, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-66; WILLIAMS M, 1991, GENE DEV, V5, P2353, DOI 10.1101/gad.5.12a.2353; Yarm FR, 2002, MOL CELL BIOL, V22, P6209, DOI 10.1128/MCB.22.17.6209-6221.2002; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	38	22	23	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2010	5	10							e13678	10.1371/journal.pone.0013678	http://dx.doi.org/10.1371/journal.pone.0013678			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671UN	21048921	Green Published, Green Submitted, gold			2022-12-27	WOS:000283537000044
J	Maradeo, ME; Skibbens, RV				Maradeo, Marie E.; Skibbens, Robert V.			Replication Factor C Complexes Play Unique Pro- and Anti-Establishment Roles in Sister Chromatid Cohesion	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; DNA-REPLICATION; S-PHASE; REMODELING COMPLEX; ESTABLISHMENT; YEAST; PROTEIN; ACETYLATION; ECO1; IDENTIFICATION	Recent studies have lead to a rapid expansion of sister chromatid cohesion pathways. Of particular interest is the growth in classifications of anti-establishment factors-now including those that are cohesin-associated (Rad61/WAPL and Pds5) or DNA replication fork-associated (Elg1-RFC). In this study, we show that the two classes of anti-establishment complexes are indistinguishable when challenged both genetically and functionally. These findings suggest that both classes function in a singular pathway that is centered on Ctf7/Eco1 (herein termed Ctf7) regulation. The anti-establishment activity of Elg1-RFC complex is particular intriguing given that an alternate Ctf18-RFC complex exhibits robust pro-establishment activity. Here, we provide several lines of evidence, including the use of Ctf7 bypass suppressors, indicating that these activities are not simply antagonistic. Moreover, the results suggest that Ctf18-RFC is capable of promoting sister chromatid pairing reactions independent of Ctf7. The combination of these studies suggest a new model of sister chromatid pairing regulation.	[Maradeo, Marie E.; Skibbens, Robert V.] Lehigh Univ, Dept Biol Sci, Bethlehem, PA 18015 USA	Lehigh University	Maradeo, ME (corresponding author), Fox Chase Canc Ctr, 7701 Burholme Ave, Philadelphia, PA 19111 USA.	rvs3@lehigh.edu		Skibbens, Robert/0000-0003-4216-8306	National Institutes of General Medicine [1R15GM083269]; Susan G. Komen for a Cure Foundation [BCTR0707708]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM083269] Funding Source: NIH RePORTER	National Institutes of General Medicine; Susan G. Komen for a Cure Foundation(Susan G. Komen Breast Cancer Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	RVS is supported by award 1R15GM083269 from the National Institutes of General Medicine (http://www.nih.gov) and also by award BCTR0707708 from the Susan G. Komen for a Cure Foundation (http://ww5.komen.org). Any opinions, findings, and conclusions or recommendations expressed in this study are those of the author(s) and do not necessarily reflect the views of the National Institutes of General Medicine nor those of the Susan G. Komen Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin NS, 1996, GENETICS, V144, P479; Ansbach AB, 2008, MOL BIOL CELL, V19, P595, DOI 10.1091/mbc.E07-06-0618; Baetz KK, 2004, MOL CELL BIOL, V24, P1232, DOI 10.1128/MCB.24.3.1232-1244.2003; Ben-Shahar TR, 2008, SCIENCE, V321, P563, DOI 10.1126/science.1157774; Ciosk R, 2000, MOL CELL, V5, P243, DOI 10.1016/S1097-2765(00)80420-7; Dorsett D, 2007, CHROMOSOMA, V116, P1, DOI 10.1007/s00412-006-0072-6; Guacci V, 1997, CELL, V91, P47, DOI 10.1016/S0092-8674(01)80008-8; Hanna JS, 2001, MOL CELL BIOL, V21, P3144, DOI 10.1128/MCB.21.9.3144-3158.2001; Heidinger-Pauli JM, 2008, MOL CELL, V31, P47, DOI 10.1016/j.molcel.2008.06.005; Heidinger-Pauli JM, 2009, MOL CELL, V34, P311, DOI 10.1016/j.molcel.2009.04.008; Huang J, 2004, MOL CELL, V13, P739, DOI 10.1016/S1097-2765(04)00103-0; Ivanov D, 2002, CURR BIOL, V12, P323, DOI 10.1016/S0960-9822(02)00681-4; Kenna MA, 2003, MOL CELL BIOL, V23, P2999, DOI 10.1128/MCB.23.8.2999-3007.2003; KOUPRINA N, 1994, GENETICS, V138, P1067; Losada A, 1998, GENE DEV, V12, P1986, DOI 10.1101/gad.12.13.1986; Majka J, 2004, PROG NUCLEIC ACID RE, V78, P227, DOI 10.1016/S0079-6603(04)78006-X; Maradeo ME, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004707; Mayer ML, 2001, MOL CELL, V7, P959, DOI 10.1016/S1097-2765(01)00254-4; Mayer ML, 2004, MOL BIOL CELL, V15, P1736, DOI 10.1091/mbc.E03-08-0619; Michaelis C, 1997, CELL, V91, P35, DOI 10.1016/S0092-8674(01)80007-6; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; Moldovan GL, 2006, MOL CELL, V23, P723, DOI 10.1016/j.molcel.2006.07.007; Ogiwara H, 2007, CELL CYCLE, V6, P1090, DOI 10.4161/cc.6.9.4130; Parnas O, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005497; Petronczki M, 2004, J CELL SCI, V117, P3547, DOI 10.1242/jcs.01231; Rose MD., 1990, METHODS YEAST GENETI; Rowland BD, 2009, MOL CELL, V33, P763, DOI 10.1016/j.molcel.2009.02.028; Skibbens RV, 2008, INT REV CEL MOL BIO, V269, P283, DOI 10.1016/S1937-6448(08)01005-8; Skibbens RV, 2008, CELL CYCLE, V7, P449, DOI 10.4161/cc.7.4.5435; Skibbens RV, 2009, CURR BIOL, V19, pR1126, DOI 10.1016/j.cub.2009.10.067; Skibbens RV, 2000, GENOME RES, V10, P1664, DOI 10.1101/gr.153600; Skibbens RV, 1999, GENE DEV, V13, P307, DOI 10.1101/gad.13.3.307; Skibbens RV, 2004, GENETICS, V166, P33, DOI 10.1534/genetics.166.1.33; SKIBBENS RV, 2010, TRENDS CELL IN PRESS, V9; Strom L, 2007, SCIENCE, V317, P242, DOI 10.1126/science.1140649; Sutani T, 2009, CURR BIOL, V19, P492, DOI 10.1016/j.cub.2009.01.062; Tanaka K, 2001, EMBO J, V20, P5779, DOI 10.1093/emboj/20.20.5779; Terret ME, 2009, NATURE, V462, P231, DOI 10.1038/nature08550; Unal E, 2007, SCIENCE, V317, P245, DOI 10.1126/science.1140637; Unal E, 2008, SCIENCE, V321, P566, DOI 10.1126/science.1157880; Warren CD, 2004, MOL BIOL CELL, V15, P1724, DOI 10.1091/mbc.E03-09-0637; Zhang JL, 2008, MOL CELL, V31, P143, DOI 10.1016/j.molcel.2008.06.006	45	23	23	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2010	5	10							e15381	10.1371/journal.pone.0015381	http://dx.doi.org/10.1371/journal.pone.0015381			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671UN	21060875	gold, Green Published			2022-12-27	WOS:000283537000062
J	Scott, IML; Pound, N; Stephen, ID; Clark, AP; Penton-Voak, IS				Scott, Isabel M. L.; Pound, Nicholas; Stephen, Ian D.; Clark, Andrew P.; Penton-Voak, Ian S.			Does Masculinity Matter? The Contribution of Masculine Face Shape to Male Attractiveness in Humans	PLOS ONE			English	Article							FACIAL ATTRACTIVENESS; SEXUAL-DIMORPHISM; EVOLUTIONARY PSYCHOLOGY; TESTOSTERONE; HEALTH; PERCEPTION; SYMMETRY; IMMUNOCOMPETENCE; PREFERENCES; AGE	Background: In many animals, exaggerated sex-typical male traits are preferred by females, and may be a signal of both past and current disease resistance. The proposal that the same is true in humans - i.e., that masculine men are immunocompetent and attractive - underpins a large literature on facial masculinity preferences. Recently, theoretical models have suggested that current condition may be a better index of mate value than past immunocompetence. This is particularly likely in populations where pathogenic fluctuation is fast relative to host life history. As life history is slow in humans, there is reason to expect that, among humans, condition-dependent traits might contribute more to attractiveness than relatively stable traits such as masculinity. To date, however, there has been little rigorous assessment of whether, in the presence of variation in other cues, masculinity predicts attractiveness or not. Methodology/Principal Findings: The relationship between masculinity and attractiveness was assessed in two samples of male faces. Most previous research has assessed masculinity either with subjective ratings or with simple anatomical measures. Here, we used geometric morphometric techniques to assess facial masculinity, generating a morphological masculinity measure based on a discriminant function that correctly classified >96% faces as male or female. When assessed using this measure, there was no relationship between morphological masculinity and rated attractiveness. In contrast, skin colour - a fluctuating, condition-dependent cue - was a significant predictor of attractiveness. Conclusions/Significance: These findings suggest that facial morphological masculinity may contribute less to men's attractiveness than previously assumed. Our results are consistent with the hypothesis that current condition is more relevant to male mate value than past disease resistance, and hence that temporally fluctuating traits (such as colour) contribute more to male attractiveness than stable cues of sexual dimorphism.	[Scott, Isabel M. L.; Stephen, Ian D.; Penton-Voak, Ian S.] Univ Bristol, Sch Expt Psychol, Bristol, Avon, England; [Pound, Nicholas; Clark, Andrew P.] Brunel Univ, Dept Psychol, Uxbridge UB8 3PH, Middx, England	University of Bristol; Brunel University	Scott, IML (corresponding author), Univ Bristol, Sch Expt Psychol, Bristol, Avon, England.	I.S.Penton-Voak@bristol.ac.uk	Pound, Nicholas/B-5453-2008; Stephen, Ian/ABA-6218-2021	Pound, Nicholas/0000-0003-2170-9943; Stephen, Ian/0000-0001-9714-8295; Penton-Voak, Ian/0000-0003-4232-0953	University of Bristol; Economic and Social Research Council, UK	University of Bristol; Economic and Social Research Council, UK(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This research was supported by the University of Bristol. IDS is supported by the Economic and Social Research Council, UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamo SA, 2005, BEHAV ECOL, V16, P871, DOI 10.1093/beheco/ari068; Adamo SA, 2009, ANIM BEHAV, V77, P67, DOI 10.1016/j.anbehav.2008.09.011; Angele MK, 2000, SHOCK, V14, P81, DOI 10.1097/00024382-200014020-00001; Booth A, 1999, J BEHAV MED, V22, P1, DOI 10.1023/A:1018705001117; Boothroyd LG, 2005, EVOL HUM BEHAV, V26, P417, DOI 10.1016/j.evolhumbehav.2005.01.001; Brown WM, 2008, P NATL ACAD SCI USA, V105, P12938, DOI 10.1073/pnas.0710420105; CUNNINGHAM MR, 1990, J PERS SOC PSYCHOL, V59, P61, DOI 10.1037/0022-3514.59.1.61; Daly M, 1999, ANIM BEHAV, V57, P509, DOI 10.1006/anbe.1998.1027; DeBruine LM, 2006, P ROY SOC B-BIOL SCI, V273, P1355, DOI 10.1098/rspb.2005.3445; DEBRUINE LM, J EXPT PSYC IN PRESS; Eagly AH, 1999, AM PSYCHOL, V54, P408, DOI 10.1037/0003-066X.54.6.408; Fink B, 2006, EVOL HUM BEHAV, V27, P433, DOI 10.1016/j.evolhumbehav.2006.08.007; FOLSTAD I, 1992, AM NAT, V139, P603, DOI 10.1086/285346; Frazier PA, 2004, J COUNS PSYCHOL, V51, P115, DOI 10.1037/0022-0167.51.1.115; GOODALL C, 1991, J ROY STAT SOC B MET, V53, P285, DOI 10.1111/j.2517-6161.1991.tb01825.x; GOWER JC, 1975, PSYCHOMETRIKA, V40, P33, DOI 10.1007/BF02291478; Granger DA, 2000, PSYCHOSOM MED, V62, P583, DOI 10.1097/00006842-200007000-00018; HAMILTON WD, 1982, SCIENCE, V218, P384, DOI 10.1126/science.7123238; Henderson JJA, 2003, EVOL HUM BEHAV, V24, P351, DOI 10.1016/S1090-5138(03)00036-9; HILL H, 1995, P ROY SOC B-BIOL SCI, V261, P367, DOI 10.1098/rspb.1995.0161; Jones B., 2008, Animals in transit: the journey ahead. RSPCA Australia Scientific Seminar 2008, 26 February, CSIRO Discovery Centre, Canberra, Australia, P1; Jones BC, 2004, PERCEPTION, V33, P569, DOI 10.1068/p3463; Jones BC, 2001, EVOL HUM BEHAV, V22, P417, DOI 10.1016/S1090-5138(01)00083-6; JONES D, 1993, HUM NATURE-INT BIOS, V4, P271, DOI 10.1007/BF02692202; Kalick SM, 1998, PSYCHOL SCI, V9, P8, DOI 10.1111/1467-9280.00002; Koehler N, 2003, AUST J PSYCHOL, V55, P83; Komori M, 2009, ACTA PSYCHOL, V131, P136, DOI 10.1016/j.actpsy.2009.03.008; Komori M, 2009, VISION RES, V49, P862, DOI 10.1016/j.visres.2009.03.005; Lassek WD, 2009, EVOL HUM BEHAV, V30, P322, DOI 10.1016/j.evolhumbehav.2009.04.002; Lie HC, 2008, EVOLUTION, V62, P2473, DOI 10.1111/j.1558-5646.2008.00478.x; Martinkauppi B, 2002, FACE COLOR VARYING I; Matts PJ, 2007, J AM ACAD DERMATOL, V57, P977, DOI 10.1016/j.jaad.2007.07.040; Messingham KAN, 2001, J ENDOCRINOL, V169, P299, DOI 10.1677/joe.0.1690299; Muehlenbein MP, 2005, AM J HUM BIOL, V17, P527, DOI 10.1002/ajhb.20419; Neave N, 2003, P ROY SOC B-BIOL SCI, V270, P2167, DOI 10.1098/rspb.2003.2502; O'Higgins P, 1998, J ANAT, V193, P251, DOI 10.1046/j.1469-7580.1998.19320251.x; Pawlowski B, 2002, EVOL HUM BEHAV, V23, P139, DOI 10.1016/S1090-5138(01)00092-7; Penton-Voak IS, 2001, P ROY SOC B-BIOL SCI, V268, P1617, DOI 10.1098/rspb.2001.1703; Perrett DI, 1998, NATURE, V394, P884, DOI 10.1038/29772; Peters M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004138; Pound N, 2009, P ROY SOC B-BIOL SCI, V276, P153, DOI 10.1098/rspb.2008.0990; Rennels JL, 2008, J EXP PSYCHOL HUMAN, V34, P884, DOI 10.1037/0096-1523.34.4.884; Rhodes G, 2006, ANNU REV PSYCHOL, V57, P199, DOI 10.1146/annurev.psych.57.102904.190208; Rhodes G, 2003, P ROY SOC B-BIOL SCI, V270, pS93, DOI 10.1098/rsbl.2003.0023; Rhodes G, 2000, BRIT J PSYCHOL, V91, P125, DOI 10.1348/000712600161718; Rhodes G, 2007, PERCEPTION, V36, P1244, DOI 10.1068/p5712; Roberts ML, 2004, ANIM BEHAV, V68, P227, DOI 10.1016/j.anbehav.2004.05.001; ROHLF FJ, 1990, SYST ZOOL, V39, P40, DOI 10.2307/2992207; Russell R, 2006, PERCEPTION, V35, P749, DOI 10.1068/p5490; RYAN MJ, 1992, AM NAT, V139, pS4, DOI 10.1086/285303; Scott I, 2008, EVOL HUM BEHAV, V29, P289, DOI 10.1016/j.evolhumbehav.2008.02.004; Shackelford TK, 1999, EVOL HUM BEHAV, V20, P71, DOI 10.1016/S1090-5138(98)00036-1; Stephan C. N., 2005, COMPUTER GRAPHIC FAC; Stephen ID, 2009, INT J PRIMATOL, V30, P845, DOI 10.1007/s10764-009-9380-z; Stephen ID, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005083; Swaddle JP, 2002, P ROY SOC B-BIOL SCI, V269, P2285, DOI 10.1098/rspb.2002.2165; Tarr M. J., 2010, J VISION, V1, P337, DOI [10.1167/1.3.337, DOI 10.1167/1.3.337]; Thornhill R, 2006, EVOL HUM BEHAV, V27, P131, DOI 10.1016/j.evolhumbehav.2005.06.001; Thornhill R, 1999, TRENDS COGN SCI, V3, P452, DOI 10.1016/S1364-6613(99)01403-5; Tiddeman B, 2001, IEEE COMPUT GRAPH, V21, P42, DOI 10.1109/38.946630; van Anders SM, 2010, AM J HUM BIOL, V22, P348, DOI 10.1002/ajhb.20997; Weeden J, 2005, PSYCHOL BULL, V131, P635, DOI 10.1037/0033-2909.131.5.635; ZAHAVI A, 1975, J THEOR BIOL, V53, P205, DOI 10.1016/0022-5193(75)90111-3; Zebrowitz LA, 2004, J NONVERBAL BEHAV, V28, P167, DOI 10.1023/B:JONB.0000039648.30935.1b; ZHANG D, 2010, BENCHMARK GEOMETRIC, P21	65	104	104	3	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2010	5	10							e13585	10.1371/journal.pone.0013585	http://dx.doi.org/10.1371/journal.pone.0013585			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	671UN	21048972	Green Published, gold			2022-12-27	WOS:000283537000012
J	Villar-Pique, A; Sabate, R; Lopera, O; Gibert, J; Torne, JM; Santos, M; Ventura, S				Villar-Pique, Anna; Sabate, Raimon; Lopera, Oriol; Gibert, Jordi; Maria Torne, Josep; Santos, Mireya; Ventura, Salvador			Amyloid-Like Protein Inclusions in Tobacco Transgenic Plants	PLOS ONE			English	Article							AGGREGATION; BODIES; TRANSGLUTAMINASE; DISEASES; PEPTIDE; RICE; TOXICITY; FIBRILS; MODEL	The formation of insoluble protein deposits in human tissues is linked to the onset of more than 40 different disorders, ranging from dementia to diabetes. In these diseases, the proteins usually self-assemble into ordered beta-sheet enriched aggregates known as amyloid fibrils. Here we study the structure of the inclusions formed by maize transglutaminase (TGZ) in the chloroplasts of tobacco transplastomic plants and demonstrate that they have an amyloid-like nature. Together with the evidence of amyloid structures in bacteria and fungi our data argue that amyloid formation is likely a ubiquitous process occurring across the different kingdoms of life. The discovery of amyloid conformations inside inclusions of genetically modified plants might have implications regarding their use for human applications.	[Villar-Pique, Anna; Sabate, Raimon; Ventura, Salvador] Univ Autonoma Barcelona, Inst Biotecnol & Biomed, Bellaterra, Spain; [Villar-Pique, Anna; Sabate, Raimon; Ventura, Salvador] Univ Autonoma Barcelona, Dept Bioquim & Biol Mol, Bellaterra, Spain; [Lopera, Oriol; Gibert, Jordi; Maria Torne, Josep; Santos, Mireya] UAB, IRTA, CSIC, Mol Genet Lab,CRAG, Barcelona, Spain	Autonomous University of Barcelona; Autonomous University of Barcelona; Autonomous University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); Centre de Recerca en Agrigenomica (CRAG); IRTA; University of Barcelona	Villar-Pique, A (corresponding author), Univ Autonoma Barcelona, Inst Biotecnol & Biomed, Bellaterra, Spain.	salvador.ventura@uab.es	Ventura, Salvador/C-7021-2008; Ventura, Salvador/AAY-3170-2021; sabate, raimon/I-7849-2014	Ventura, Salvador/0000-0002-9652-6351; Ventura, Salvador/0000-0002-9652-6351; sabate, raimon/0000-0003-3894-2362	Ministerio de Ciencia e Innovacion (Spain) [BIO2007-68046, BFU2006-15115-CO2-01/BMC, BFU2009-08575]; AGAUR(Agencia de Gestio d'Ajuts Universitaris i de Recerca-Generalitat de Catalunya) [2009-SGR 760]; Universidad Autonoma de Barcelona (UAB); UAB-Generalitat de Catalunya [I3]; Generalitat de Catalunya; ICREA-Institucio Catalana de Recerca i Estudis Avancats	Ministerio de Ciencia e Innovacion (Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); AGAUR(Agencia de Gestio d'Ajuts Universitaris i de Recerca-Generalitat de Catalunya)(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)); Universidad Autonoma de Barcelona (UAB); UAB-Generalitat de Catalunya; Generalitat de Catalunya(Generalitat de Catalunya); ICREA-Institucio Catalana de Recerca i Estudis Avancats(ICREA)	This work was supported by grants BIO2007-68046, BFU2006-15115-CO2-01/BMC and BFU2009-08575 from Ministerio de Ciencia e Innovacion (Spain), by grant 2009-SGR 760 from AGAUR(Agencia de Gestio d'Ajuts Universitaris i de Recerca-Generalitat de Catalunya). AV was beneficiary of a PIF fellowship from Universidad Autonoma de Barcelona (UAB). RS was beneficiary of an I3 contract (UAB-Generalitat de Catalunya). JG was beneficiary of a FPI fellowship awarded by Generalitat de Catalunya. SV has been granted with an ICREA ACADEMIA award (ICREA-Institucio Catalana de Recerca i Estudis Avancats). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Barnhart MM, 2006, ANNU REV MICROBIOL, V60, P131, DOI 10.1146/annurev.micro.60.080805.142106; Boehm R, 2007, ANN NY ACAD SCI, V1102, P121, DOI 10.1196/annals.1408.009; Bravo R, 2008, J BIOL CHEM, V283, P32471, DOI 10.1074/jbc.M709870200; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Carvajal-Vallejos PK, 2007, BIOTECHNOL LETT, V29, P1255, DOI 10.1007/s10529-007-9377-7; Castelli S, 2005, J EXP BOT, V56, P1379, DOI 10.1093/jxb/eri139; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Conchillo-Sole O, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-65; de Groot NS, 2009, TRENDS BIOCHEM SCI, V34, P408, DOI 10.1016/j.tibs.2009.03.009; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Fernandez-Busquets X, 2008, CURR MED CHEM, V15, P1336, DOI 10.2174/092986708784534938; Fernandez-Escamilla AM, 2004, NAT BIOTECHNOL, V22, P1302, DOI 10.1038/nbt1012; Gonzalez-Montalban N, 2007, BIOCHEM BIOPH RES CO, V355, P637, DOI 10.1016/j.bbrc.2007.01.192; Ioannidis NE, 2009, BBA-BIOENERGETICS, V1787, P1215, DOI 10.1016/j.bbabio.2009.05.014; Ivanova MI, 2004, P NATL ACAD SCI USA, V101, P10584, DOI 10.1073/pnas.0403756101; Kisilevsky R, 2000, NAT MED, V6, P633, DOI 10.1038/76203; Kopito RR, 2000, TRENDS CELL BIOL, V10, P524, DOI 10.1016/S0962-8924(00)01852-3; Lorand L, 1996, P NATL ACAD SCI USA, V93, P14310, DOI 10.1073/pnas.93.25.14310; Meredith SC, 2005, ANN NY ACAD SCI, V1066, P181, DOI 10.1196/annals.1363.030; Millan AFS, 2008, PLANT BIOTECHNOL J, V6, P427, DOI 10.1111/j.1467-7652.2008.00338.x; Morell M, 2008, BBA-MOL CELL RES, V1783, P1815, DOI 10.1016/j.bbamcr.2008.06.007; Nelson R, 2006, CURR OPIN STRUC BIOL, V16, P260, DOI 10.1016/j.sbi.2006.03.007; Oh J, 2007, J BIOL CHEM, V282, P13601, DOI 10.1074/jbc.M602576200; Oono Y, 2010, PLANT BIOTECHNOL J, V8, P691, DOI 10.1111/j.1467-7652.2010.00502.x; ORTIGOSA S, 2010, PLANTA IN PRESS; Pepys MB, 2006, ANNU REV MED, V57, P223, DOI 10.1146/annurev.med.57.121304.131243; QUERFURTH HW, NEW ENGLAND J MED, V362, P329; Ritter C, 2005, NATURE, V435, P844, DOI 10.1038/nature03793; Sabate R, 2010, CELL MOL LIFE SCI, V67, P2695, DOI 10.1007/s00018-010-0344-4; Saito Y, 2009, J EXP BOT, V60, P615, DOI 10.1093/jxb/ern311; Takaiwa F, 2009, PLANTA, V229, P1147, DOI 10.1007/s00425-009-0905-7; Vendruscolo M, 2008, MOL BIOSYST, V4, P1170, DOI 10.1039/b805710a; Ventura S, 2004, P NATL ACAD SCI USA, V101, P7258, DOI 10.1073/pnas.0308249101; Villalobos E, 2004, GENE, V336, P93, DOI 10.1016/j.gene.2004.03.025; Wang L, 2009, PRION, V3, P139, DOI 10.4161/pri.3.3.9922; Wang L, 2008, PLOS BIOL, V6, P1791, DOI 10.1371/journal.pbio.0060195; Westermark P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006041; Wickner RB, 2007, NAT REV MICROBIOL, V5, P611, DOI 10.1038/nrmicro1708; Wickner S, 1999, SCIENCE, V286, P1888, DOI 10.1126/science.286.5446.1888	40	36	37	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2010	5	10							e13625	10.1371/journal.pone.0013625	http://dx.doi.org/10.1371/journal.pone.0013625			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671GB	21049018	Green Submitted, Green Published, gold			2022-12-27	WOS:000283487400017
J	Cheng, WX; Li, JS; Huang, CP; Yao, DP; Liu, N; Cui, SX; Jin, Y; Duan, ZJ				Cheng, Wei-xia; Li, Jin-song; Huang, Can-ping; Yao, Dong-ping; Liu, Na; Cui, Shu-xian; Jin, Yu; Duan, Zhao-jun			Identification and Nearly Full-Length Genome Characterization of Novel Porcine Bocaviruses	PLOS ONE			English	Article							HUMAN PARVOVIRUS; BOVINE PARVOVIRUS; CAPSID PROTEIN; MINUTE VIRUS; INFECTIVITY; SAMPLES; VP1; B19; RECOMBINATION; DISEASE	The genus bocavirus includes bovine parvovirus (BPV), minute virus of canines (MVC), and a group of human bocaviruses (HBoV1-4). Using sequence-independent single primer amplification (SISPA), a novel bocavirus group was discovered with high prevalence (12.59%) in piglet stool samples. Two nearly full-length genome sequences were obtained, which were approximately 5,100 nucleotides in length. Multiple alignments revealed that they share 28.7-56.8% DNA sequence identity with other members of Parvovirinae. Phylogenetic analyses indicated their closest neighbors were members of the genus bocavirus. The new viruses had a putative non-structural NP1 protein, which was unique to bocaviruses. They were provisionally named porcine bocavirus 1 and 2 (PBoV1, PBoV2). PBoV1 and PBoV2 shared 94.2% nucleotide identity in NS1 gene sequence, suggesting that they represented two different bocavirus species. Two additional samples (6V, 7V) were amplified for 2,407 bp and 2,434 bp products, respectively, including a partial NP1 gene and the complete VP1 gene; Phylogenetic analysis indicated that 6Vand 7V grouped with PBoV1 and PBoV2 in the genus of bocavirus, but were in the separate clusters. Like other parvoviruses, PBoV1, PBoV2, 6Vand 7V also contained a putative secretory phospholipase A(2) (sPLA(2)) motif in the VP1 unique region, with a conserved HDXXY motif in the catalytic center. The conserved motif YXGXF of the Ca2+-binding loop of sPLA2 identified in human bocavirus was also found in porcine bocavirus, which differs from the YXGXG motif carried by most other parvoviruses. The observation of PBoV and potentially other new bocavirus genus members may aid in molecular and functional characterization of the genus bocavirus.	[Cheng, Wei-xia; Li, Jin-song; Huang, Can-ping; Yao, Dong-ping; Liu, Na; Cui, Shu-xian; Duan, Zhao-jun] China Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, State Key Lab Mol Virol & Genet Engn, Beijing, Peoples R China; [Cheng, Wei-xia; Jin, Yu] Lanzhou Univ, Sch Basic Med Sci, Lanzhou 730000, Peoples R China; [Jin, Yu] Nanjing Univ, Sch Med, Nanjing 210008, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Lanzhou University; Nanjing University	Cheng, WX (corresponding author), China Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, State Key Lab Mol Virol & Genet Engn, Beijing, Peoples R China.	jinyuldyy@163.com; zhaojund@126.com			China Mega-Project for Infectious Disease [2009ZX10004-001]; "973" National Key Basic Research Program of China [2007CB310500]	China Mega-Project for Infectious Disease; "973" National Key Basic Research Program of China(National Basic Research Program of China)	This work was partly supported by China Mega-Project for Infectious Disease (2009ZX10004-001) and "973" National Key Basic Research Program of China (Grant No. 2007CB310500). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABINANTI FR, 1961, VIROLOGY, V14, P288, DOI 10.1016/0042-6822(61)90206-9; Allander T, 2005, P NATL ACAD SCI USA, V102, P12891, DOI 10.1073/pnas.0504666102; Allander T, 2001, P NATL ACAD SCI USA, V98, P11609, DOI 10.1073/pnas.211424698; Arthur JL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000391; Bekhit MT, 2009, FETAL DIAGN THER, V25, P153, DOI 10.1159/000209200; Biagini P, 2007, J GEN VIROL, V88, P2696, DOI 10.1099/vir.0.83071-0; BINN L N, 1970, Infection and Immunity, V1, P503; Blomstrom AL, 2009, VIRUS RES, V146, P125, DOI 10.1016/j.virusres.2009.09.006; Blomstrom AL, 2010, VIRUS RES, V152, P59, DOI 10.1016/j.virusres.2010.06.004; Cheng WX, 2008, CLIN INFECT DIS, V47, P161, DOI 10.1086/589244; Fauquet CM, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-64; Finkbeiner SR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000011; Finkbeiner SR, 2009, J VIROL, V83, P10836, DOI 10.1128/JVI.00998-09; Girod A, 2002, J GEN VIROL, V83, P973, DOI 10.1099/0022-1317-83-5-973; Kapoor A, 2009, J INFECT DIS, V199, P196, DOI 10.1086/595831; Kapoor A, 2010, J INFECT DIS, V201, P1633, DOI 10.1086/652416; KARALAR L, 2009, CLIN MICROBIOL INFEC; Kirkland PD, 2007, VIRUS RES, V129, P26, DOI 10.1016/j.virusres.2007.05.002; Lau SKP, 2008, J GEN VIROL, V89, P1840, DOI 10.1099/vir.0.2008/000380-0; Li LL, 2009, J VIROL, V83, P12002, DOI 10.1128/JVI.01241-09; Lindner J, 2008, INTERVIROLOGY, V51, P116, DOI 10.1159/000137411; Lopez-Bueno A, 2006, CURR TOP MICROBIOL, V299, P349; Lukashov VV, 2001, J VIROL, V75, P2729, DOI 10.1128/JVI.75.6.2729-2740.2001; Lupescu A, 2006, J VIROL, V80, P11370, DOI 10.1128/JVI.01041-06; Manteufel J, 2008, INTERVIROLOGY, V51, P328, DOI 10.1159/000173734; Qu XW, 2008, BIOCHEM BIOPH RES CO, V365, P158, DOI 10.1016/j.bbrc.2007.10.164; REYES GR, 1991, MOL CELL PROBE, V5, P473, DOI 10.1016/S0890-8508(05)80020-9; Ros C, 2006, J VIROL, V80, P12017, DOI 10.1128/JVI.01435-06; Schroder C, 2006, TRANSPLANTATION, V81, P1165, DOI 10.1097/01.tp.0000203170.77195.e4; Schwartz D, 2002, VIROLOGY, V302, P219, DOI 10.1006/viro.2002.1674; Shackelton LA, 2007, J GEN VIROL, V88, P3294, DOI 10.1099/vir.0.83255-0; Simon MA, 2008, COMPARATIVE MED, V58, P47; Simpson AA, 1998, STRUCT FOLD DES, V6, P1355, DOI 10.1016/S0969-2126(98)00136-1; Suikkanen S, 2003, VIROLOGY, V316, P267, DOI 10.1016/j.virol.2003.08.031; Sun YN, 2009, J VIROL, V83, P3956, DOI 10.1128/JVI.02569-08; Suzuki M, 2009, J VIROL, V83, P10975, DOI 10.1128/JVI.00273-09; Taylor LH, 2001, PHILOS T R SOC B, V356, P983, DOI 10.1098/rstb.2001.0888; Tolfvenstam T, 2009, SEMIN FETAL NEONAT M, V14, P218, DOI 10.1016/j.siny.2009.01.007; Tozer SJ, 2009, J MED VIROL, V81, P488, DOI 10.1002/jmv.21409; Zadori Z, 2001, DEV CELL, V1, P291, DOI 10.1016/S1534-5807(01)00031-4; Zhai SL, 2010, ARCH VIROL, V155, P1313, DOI 10.1007/s00705-010-0698-9	41	94	113	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2010	5	10							e13583	10.1371/journal.pone.0013583	http://dx.doi.org/10.1371/journal.pone.0013583			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	670LB	21049037	gold, Green Submitted, Green Published			2022-12-27	WOS:000283422100007
J	Chen, R; Davydov, EV; Sirota, M; Butte, AJ				Chen, Rong; Davydov, Eugene V.; Sirota, Marina; Butte, Atul J.			Non-Synonymous and Synonymous Coding SNPs Show Similar Likelihood and Effect Size of Human Disease Association	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; CROHNS-DISEASE; DATABASE; SUSCEPTIBILITY; POLYMORPHISM; TNFSF15; SYSTEM	Many DNA variants have been identified on more than 300 diseases and traits using Genome-Wide Association Studies (GWASs). Some have been validated using deep sequencing, but many fewer have been validated functionally, primarily focused on non-synonymous coding SNPs (nsSNPs). It is an open question whether synonymous coding SNPs (sSNPs) and other non-coding SNPs can lead to as high odds ratios as nsSNPs. We conducted a broad survey across 21,429 disease-SNP associations curated from 2,113 publications studying human genetic association, and found that nsSNPs and sSNPs shared similar likelihood and effect size for disease association. The enrichment of disease-associated SNPs around the 80(th) base in the first introns might provide an effective way to prioritize intronic SNPs for functional studies. We further found that the likelihood of disease association was positively associated with the effect size across different types of SNPs, and SNPs in the 3'untranslated regions, such as the microRNA binding sites, might be under-investigated. Our results suggest that sSNPs are just as likely to be involved in disease mechanisms, so we recommend that sSNPs discovered from GWAS should also be examined with functional studies.	[Chen, Rong; Sirota, Marina; Butte, Atul J.] Stanford Univ, Sch Med, Dept Pediat, Stanford, CA 94305 USA; [Chen, Rong; Sirota, Marina; Butte, Atul J.] Lucile Packard Childrens Hosp, Palo Alto, CA USA; [Davydov, Eugene V.] Stanford Univ, Sch Med, Dept Comp Sci, Stanford, CA 94305 USA	Stanford University; Lucile Packard Children's Hospital (LPCH); Stanford University	Chen, R (corresponding author), Stanford Univ, Sch Med, Dept Pediat, Stanford, CA 94305 USA.	rchen1@stanford.edu		Sirota, Marina/0000-0002-7246-6083	Lucile Packard Foundation for Children's Health; National Institute of General Medical Sciences [R01 GM079719]; National Library of Medicine [R01 LM009719]; National Cancer Institute [R01 CA138256]; Howard Hughes Medical Institute; Pharmaceutical Research and Manufacturers of America Foundation; Hewlett Packard Foundation; NATIONAL CANCER INSTITUTE [R01CA138256] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079719] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM009719] Funding Source: NIH RePORTER	Lucile Packard Foundation for Children's Health; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Pharmaceutical Research and Manufacturers of America Foundation; Hewlett Packard Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported by Lucile Packard Foundation for Children's Health, National Institute of General Medical Sciences (R01 GM079719), National Library of Medicine (R01 LM009719), National Cancer Institute (R01 CA138256), Howard Hughes Medical Institute, Pharmaceutical Research and Manufacturers of America Foundation, and Hewlett Packard Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amberger J, 2009, NUCLEIC ACIDS RES, V37, pD793, DOI 10.1093/nar/gkn665; [Anonymous], 2007, NATURE, V447, P661; Ashley EA, 2010, LANCET, V375, P1525, DOI 10.1016/S0140-6736(10)60452-7; Becker KG, 2004, NAT GENET, V36, P431, DOI 10.1038/ng0504-431; Bodenreider O, 2004, NUCLEIC ACIDS RES, V32, pD267, DOI 10.1093/nar/gkh061; Capon F, 2004, HUM MOL GENET, V13, P2361, DOI 10.1093/hmg/ddh273; Dickson SP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000294; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hunt R, 2009, METHODS MOL BIOL, V578, P23, DOI 10.1007/978-1-60327-411-1_2; Johnson AD, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-6; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; Li JJ, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000910; Nakagome S, 2010, ANN HUM GENET, V74, P126, DOI 10.1111/j.1469-1809.2010.00567.x; Nelson SJ, 2004, ST HEAL T, V107, P67; OROZCO G, 2010, HUM MOL GENET; Saunders MA, 2007, P NATL ACAD SCI USA, V104, P3300, DOI 10.1073/pnas.0611347104; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; SIONTIS KC, 2010, EUR J HUM GENET; Stenson PD, 2009, GENOME MED, V1, DOI 10.1186/gm13; Waters KM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001078; Yamazaki K, 2005, HUM MOL GENET, V14, P3499, DOI 10.1093/hmg/ddi379; Yang SK, 2008, AM J GASTROENTEROL, V103, P1437, DOI 10.1111/j.1572-0241.2007.01752.x	24	127	137	8	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2010	5	10							e13574	10.1371/journal.pone.0013574	http://dx.doi.org/10.1371/journal.pone.0013574			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	670KA	21042586	gold, Green Submitted, Green Published			2022-12-27	WOS:000283419100014
J	Bodas, M; Min, T; Vij, N				Bodas, Manish; Min, Taehong; Vij, Neeraj			Early-Age-Related Changes in Proteostasis Augment Immunopathogenesis of Sepsis and Acute Lung Injury	PLOS ONE			English	Article							VALOSIN-CONTAINING PROTEIN; ENDOPLASMIC-RETICULUM; PROTEASOME ACTIVITY; CELL-PROLIFERATION; AAA ATPASE; DISEASE; DEGRADATION; EXPRESSION; REGULATOR; UBIQUITIN	Background: The decline of proteasomal activity is known to be associated with the age-related disorders but the early events involved in this process are not apparent. To address this, we investigated the early-age-related (pediatric vs. adult) mechanisms that augment immunopathogenesis of sepsis and acute lung injury. Methodology/Principal Findings: The 3-weeks (pediatric) and 6-months (adult) old C57BL/6 mice were selected as the study groups. Mice were subjected to 1x20 cecal ligation and puncture (CLP) mediated sepsis or intratracheal Psuedomonas aeruginosa (Pa)-LPS induced acute lung injury (ALI).We observed a significant increase in basal levels of pro-inflammatory cytokine, IL-6 and neutrophil activity marker, myeloperoxidase (MPO) in the adult mice compared to the pediatric indicating the age-related constitutive increase in inflammatory response. Next, we found that age-related decrease in PSMB6 (proteasomal subunit) expression in adult mice results in accumulation of ubiquitinated proteins that triggers the unfolded protein response (UPR). We identified that Pa-LPS induced activation of UPR modifier, p97/VCP (valosin-containing protein) in the adult mice lungs correlates with increase in Pa-LPS induced NF kappa B levels. Moreover, we observed a constitutive increase in p-eIF2 alpha indicating a protective ER stress response to accumulation of ubiquitinated-proteins. We used MG-132 treatment of HBE cells as an in vitro model to standardize the efficacy of salubrinal (inhibitor of eIF2 alpha de-phosphorylation) in controlling the accumulation of ubiquitinated proteins and the NF kappa B levels. Finally, we evaluated the therapeutic efficacy of salubrinal to correct proteostasis-imbalance in the adult mice based on its ability to control CLP induced IL-6 secretion or recruitment of pro-inflammatory cells. Conclusions/Significance: Our data demonstrate the critical role of early-age-related proteostasis-imbalance as a novel mechanism that augments the NF kappa B mediated inflammation in sepsis and ALI. Moreover, our data suggest the therapeutic efficacy of salubrinal in restraining NF kappa B mediated inflammation in the adult or older subjects.	[Bodas, Manish; Min, Taehong; Vij, Neeraj] Johns Hopkins Univ, Dept Pediat Resp Sci, Baltimore, MD 21218 USA; [Vij, Neeraj] Johns Hopkins Univ, Inst Clin & Translat Res, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University	Bodas, M (corresponding author), Johns Hopkins Univ, Dept Pediat Resp Sci, Baltimore, MD 21218 USA.	nvij1@jhmi.edu	Bodas, Manish/AAE-4016-2020	Bodas, Manish/0000-0002-1046-9799	Cystic Fibrosis Foundation [R025-CR07, VIJ07IO]; Flight Attendant Medical Research Institute (FAMRI); National Aeronautics and Space Administration (NASA) [NNJ06HI17G]; National Institutes of Health [CTSA UL RR 025005, RHL096931]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025005] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R03HL096931] Funding Source: NIH RePORTER	Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); Flight Attendant Medical Research Institute (FAMRI); National Aeronautics and Space Administration (NASA)(National Aeronautics & Space Administration (NASA)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding support was provided by Cystic Fibrosis Foundation (R025-CR07 and VIJ07IO), Flight Attendant Medical Research Institute (FAMRI), National Aeronautics and Space Administration (NASA) (NNJ06HI17G) and National Institutes of Health (CTSA UL RR 025005 and RHL096931) grants to NV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asai T, 2002, JPN J CANCER RES, V93, P296, DOI 10.1111/j.1349-7006.2002.tb02172.x; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547; Ben-Zvi A, 2009, P NATL ACAD SCI USA, V106, P14914, DOI 10.1073/pnas.0902882106; Bishop NA, 2010, NATURE, V464, P529, DOI 10.1038/nature08983; Boyce M, 2005, SCIENCE, V307, P935, DOI 10.1126/science.1101902; Breusing N, 2008, BIOL CHEM, V389, P203, DOI 10.1515/BC.2008.029; Carrard G, 2002, INT J BIOCHEM CELL B, V34, P1461, DOI 10.1016/S1357-2725(02)00085-7; Carson WF, 2010, EUR J IMMUNOL, V40, P998, DOI 10.1002/eji.200939739; CEBOTARU L, 2008, J BIOL CHEM; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Ciechanover A, 2000, J CELL BIOCHEM, P40; Dahlmann B, 2007, BMC BIOCHEM, V8, DOI 10.1186/1471-2091-8-S1-S3; Dai RM, 1998, J BIOL CHEM, V273, P3562, DOI 10.1074/jbc.273.6.3562; GACZYNSKA M, 1993, ENZYME PROTEIN, V47, P354, DOI 10.1159/000468693; GIOVANNINI S, J GERONTOL A, V65, P369; Gomez CR, 2007, CRIT CARE MED, V35, P246, DOI 10.1097/01.CCM.0000251639.05135.E0; GRAY DA, 2003, SCI AGING KNOWLEDGE, pRE6; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Hinault MP, 2006, J MOL NEUROSCI, V30, P249, DOI 10.1385/JMN:30:3:249; Hirabayashi M, 2001, CELL DEATH DIFFER, V8, P977, DOI 10.1038/sj.cdd.4400907; Hobler SC, 1999, AM J PHYSIOL-REG I, V277, pR434, DOI 10.1152/ajpregu.1999.277.2.R434; Hussain SG, 2007, BIOCHEM BIOPH RES CO, V355, P365, DOI 10.1016/j.bbrc.2007.01.156; Ishigaki S, 2004, J BIOL CHEM, V279, P51376, DOI 10.1074/jbc.M406683200; Ito K, 2009, CHEST, V135, P173, DOI 10.1378/chest.08-1419; Kirkwood TBL, 2005, CELL, V120, P437, DOI 10.1016/j.cell.2005.01.027; Kobayashi T, 2007, GENES CELLS, V12, P889, DOI 10.1111/j.1365-2443.2007.01099.x; Lee CK, 1999, SCIENCE, V285, P1390, DOI 10.1126/science.285.5432.1390; Lindner AB, 2009, BBA-GEN SUBJECTS, V1790, P980, DOI 10.1016/j.bbagen.2009.06.005; MacNee William, 2009, Proc Am Thorac Soc, V6, P527, DOI 10.1513/pats.200905-027DS; Malhotra D, 2009, AM J RESP CRIT CARE, V180, P1196, DOI 10.1164/rccm.200903-0324OC; Martin GS, 2006, CRIT CARE MED, V34, P15, DOI 10.1097/01.CCM.0000194535.82812.BA; Martin Thomas R, 2005, Proc Am Thorac Soc, V2, P214, DOI 10.1513/pats.200504-031AC; McNaught KSP, 2001, NEUROSCI LETT, V297, P191, DOI 10.1016/S0304-3940(00)01701-8; Nakajima S, 2010, BIOCHEM BIOPH RES CO, V397, P176, DOI 10.1016/j.bbrc.2010.05.069; Nakatsukasa K, 2008, TRAFFIC, V9, P861, DOI 10.1111/j.1600-0854.2008.00729.x; Naujokat C, 2002, LAB INVEST, V82, P965, DOI 10.1097/01.LAB.0000022226.23741.37; Oh S, 2005, MECH AGEING DEV, V126, P1292, DOI 10.1016/j.mad.2005.07.006; Plemper RK, 1999, MOL BIOL REP, V26, P125, DOI 10.1023/A:1006913215484; Powers ET, 2009, ANNU REV BIOCHEM, V78, P959, DOI 10.1146/annurev.biochem.052308.114844; Son TG, 2005, FREE RADICAL RES, V39, P283, DOI 10.1080/10715760500053461; Tanaka K, 1998, GENES CELLS, V3, P499, DOI 10.1046/j.1365-2443.1998.00207.x; Thimmulappa RK, 2006, J CLIN INVEST, V116, P984, DOI 10.1172/JCI25790; Turnbull IR, 2004, SHOCK, V22, P364, DOI 10.1097/01.shk.0000142552.77473.7d; Turnbull IR, 2003, SHOCK, V19, P310, DOI 10.1097/00024382-200304000-00003; Turnbull IR, 2009, CRIT CARE MED, V37, P1018, DOI 10.1097/CCM.0b013e3181968f3a; Ujiie M, 2002, FRONT BIOSCI-LANDMRK, V7, pE42, DOI 10.2741/ujiie; van Huizen R, 2003, J BIOL CHEM, V278, P15558, DOI 10.1074/jbc.M212074200; Vasto S, 2007, MECH AGEING DEV, V128, P83, DOI 10.1016/j.mad.2006.11.015; Vij N, 2005, INVEST OPHTH VIS SCI, V46, P88, DOI 10.1167/iovs.04-0833; Vij N, 2004, EXP EYE RES, V78, P957, DOI 10.1016/j.exer.2003.12.006; Vij N, 2006, PEDIAT PULMONOLOGY, V41, P209; Vij N, 2006, J BIOL CHEM, V281, P17369, DOI 10.1074/jbc.M600509200; Vij N, 2008, J CELL MOL MED, V12, P2511, DOI 10.1111/j.1582-4934.2008.00462.x; Wek RC, 2007, ANTIOXID REDOX SIGN, V9, P2357, DOI 10.1089/ars.2007.1764; Wiseman RL, 2005, TRENDS MOL MED, V11, P347, DOI 10.1016/j.molmed.2005.06.011; Yamamoto S, 2004, ANN SURG ONCOL, V11, P697, DOI 10.1245/ASO.2004.10.018; Yamamoto S, 2004, ANN SURG ONCOL, V11, P165, DOI 10.1245/ASO.2004.05.012; Ye YH, 2006, J STRUCT BIOL, V156, P29, DOI 10.1016/j.jsb.2006.01.005; Zetterberg M, 2003, CURR EYE RES, V27, P45, DOI 10.1076/ceyr.27.2.45.15457	61	32	34	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2010	5	11							e15480	10.1371/journal.pone.0015480	http://dx.doi.org/10.1371/journal.pone.0015480			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	680KW	21085581	Green Submitted, Green Published, gold			2022-12-27	WOS:000284231800036
J	Mendoza-Maldonado, R; Paolinelli, R; Galbiati, L; Giadrossi, S; Giacca, M				Mendoza-Maldonado, Ramiro; Paolinelli, Roberta; Galbiati, Laura; Giadrossi, Sara; Giacca, Mauro			Interaction of the Retinoblastoma Protein with Orc1 and Its Recruitment to Human Origins of DNA Replication	PLOS ONE			English	Article							HUMAN CYCLIN T1; BINDING DOMAIN; IN-VIVO; S-PHASE; PRB; E2F; COMPLEX; LOCALIZATION; ACETYLATION; CHROMATIN	Background: The retinoblastoma protein (Rb) is a crucial regulator of cell cycle progression by binding with E2F transcription factor and repressing the expression of a variety of genes required for the G1-S phase transition. Methodology/Principal Findings: Here we show that Rb and E2F1 directly participate in the control of initiation of DNA replication in human HeLa, U2OS and T98G cells by specifically binding to origins of DNA replication in a cell cycle regulated manner. We show that, both in vitro and inside the cells, the largest subunit of the origin recognition complex (Orc1) specifically binds hypo-phosphorylated Rb and that this interaction is competitive with the binding of Rb to E2F1. The displacement of Rb-bound Orc1 by E2F1 at origins of DNA replication marks the progression of the G1 phase of the cell cycle toward the G1-S border. Conclusions/Significance: The participation of Rb and E2F1 in the formation of the multiprotein complex that binds origins of DNA replication in mammalian cells appears to represent an effective mechanism to couple the expression of genes required for cell cycle progression to the activation of DNA replication.	[Mendoza-Maldonado, Ramiro; Galbiati, Laura; Giadrossi, Sara; Giacca, Mauro] Int Ctr Genet Engn & Biotechnol, Mol Med Lab, I-34012 Trieste, Italy; [Paolinelli, Roberta] Scuola Normale Super Pisa, Mol Biol Lab, Pisa, Italy; [Giacca, Mauro] Univ Trieste, Fac Med, Dept Biomed, Trieste, Italy	International Center for Genetic Engineering & Biotechnology (ICGEB); Scuola Normale Superiore di Pisa; University of Trieste	Mendoza-Maldonado, R (corresponding author), Int Ctr Genet Engn & Biotechnol, Mol Med Lab, Padriciano 99, I-34012 Trieste, Italy.	giacca@icgeb.org	Giacca, Mauro/J-9287-2016	Giacca, Mauro/0000-0003-2927-7225	International Centre for Genetic Engineering and Biotechnology	International Centre for Genetic Engineering and Biotechnology	This work was supported by the International Centre for Genetic Engineering and Biotechnology intramural support to the Molecular Medicine Laboratory. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdurashidova G, 2000, SCIENCE, V287, P2023, DOI 10.1126/science.287.5460.2023; Ahlander J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002831; Avni D, 2003, MOL CELL, V12, P735, DOI 10.1016/S1097-2765(03)00355-1; Barbie DA, 2005, TRENDS CELL BIOL, V15, P378, DOI 10.1016/j.tcb.2005.05.005; Barbie DA, 2004, MOL CELL BIOL, V24, P595, DOI 10.1128/MCB.24.2.595-607.2004; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; BIAMONTI G, 1992, MOL CELL BIOL, V12, P3499, DOI 10.1128/MCB.12.8.3499; Bookout Angie L, 2003, Nucl Recept Signal, V1, pe012; Bosco G, 2001, NAT CELL BIOL, V3, P289, DOI 10.1038/35060086; Chan HM, 2001, ONCOGENE, V20, P6152, DOI 10.1038/sj.onc.1204793; Claudio P, 2002, GENOME BIOL, V3; Cobrinik D, 2005, ONCOGENE, V24, P2796, DOI 10.1038/sj.onc.1208619; Dick FA, 2003, MOL CELL, V12, P639, DOI 10.1016/S1097-2765(03)00344-7; Diffley JFX, 2004, CURR BIOL, V14, pR778, DOI 10.1016/j.cub.2004.09.019; Galbiati L, 2005, CELL CYCLE, V4, P930, DOI 10.4161/cc.4.7.1784; GIACCA M, 1994, P NATL ACAD SCI USA, V91, P7119, DOI 10.1073/pnas.91.15.7119; GIACCA M, 2002, CHEMTRACTS, V15, P519; Gladden AB, 2003, J BIOL CHEM, V278, P9754, DOI 10.1074/jbc.M212088200; Hauser PJ, 1997, J BIOL CHEM, V272, P22954, DOI 10.1074/jbc.272.36.22954; Kneissl M, 2003, J MOL BIOL, V327, P111, DOI 10.1016/S0022-2836(03)00079-2; Li CJ, 2002, MOL CELL BIOL, V22, P105, DOI 10.1128/MCB.22.1.105-116.2002; Lidonnici MR, 2004, J CELL SCI, V117, P5221, DOI 10.1242/jcs.01405; Mailand N, 2005, CELL, V122, P915, DOI 10.1016/j.cell.2005.08.013; Marcello A, 2003, EMBO J, V22, P2156, DOI 10.1093/emboj/cdg205; Marcello A, 2001, J BIOL CHEM, V276, P39220, DOI 10.1074/jbc.M104830200; Marzio G, 2000, J BIOL CHEM, V275, P10887, DOI 10.1074/jbc.275.15.10887; Morris EJ, 2001, ADV CANCER RES, V82, P1, DOI 10.1016/S0065-230X(01)82001-7; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; Pacek M, 2004, EMBO J, V23, P3667, DOI 10.1038/sj.emboj.7600369; Paolinelli R, 2009, NAT STRUCT MOL BIOL, V16, P412, DOI 10.1038/nsmb.1583; Pennaneach V, 2001, MOL CELL, V7, P715, DOI 10.1016/S1097-2765(01)00217-9; Royzman I, 1999, GENE DEV, V13, P827, DOI 10.1101/gad.13.7.827; Schmitz NMR, 2004, BIOCHEM BIOPH RES CO, V317, P779, DOI 10.1016/j.bbrc.2004.03.109; Sibani S, 2005, BIOCHEMISTRY-US, V44, P7885, DOI 10.1021/bi047327n; Sidle A, 1996, CRIT REV BIOCHEM MOL, V31, P237, DOI 10.3109/10409239609106585; Sterner JM, 1998, MOL CELL BIOL, V18, P2748, DOI 10.1128/MCB.18.5.2748; Stevaux O, 2002, CURR OPIN CELL BIOL, V14, P684, DOI 10.1016/S0955-0674(02)00388-5; Takahashi Y, 2000, GENE DEV, V14, P804; Takemura M, 1997, ONCOGENE, V15, P2483, DOI 10.1038/sj.onc.1201431; Tamrakar S, 2000, FRONT BIOSCI-LANDMRK, V5, pD121, DOI 10.2741/Tamrakar; Thangavel S, 2010, MOL CELL BIOL, V30, P1382, DOI 10.1128/MCB.01290-09; Todorovic V, 2005, MOL CELL, V19, P567, DOI 10.1016/j.molcel.2005.07.005; Vashee S, 2001, J BIOL CHEM, V276, P26666, DOI 10.1074/jbc.M102493200; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; WELCH PJ, 1993, CELL, V75, P779, DOI 10.1016/0092-8674(93)90497-E; Wells J, 2003, ONCOGENE, V22, P1445, DOI 10.1038/sj.onc.1206264	46	18	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2010	5	11							e13720	10.1371/journal.pone.0013720	http://dx.doi.org/10.1371/journal.pone.0013720			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	677ZE	21085491	Green Submitted, Green Published, gold			2022-12-27	WOS:000284035900001
J	Du, WW; Yang, BB; Shatseva, TA; Yang, BL; Deng, ZQ; Shan, SW; Lee, DY; Seth, A; Yee, AJ				Du, William Weidong; Yang, Burton B.; Shatseva, Tatiana A.; Yang, Bing L.; Deng, Zhaoqun; Shan, Sze Wan; Lee, Daniel Y.; Seth, Arun; Yee, Albert J.			Versican G3 Promotes Mouse Mammary Tumor Cell Growth, Migration, and Metastasis by Influencing EGF Receptor Signaling	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX COMPONENTS; GLYCOGEN-SYNTHASE KINASE-3; SULFATE PROTEOGLYCAN; CHONDROITIN SULFATE; BREAST-CANCER; PG-M; EXPRESSION; DOMAIN; BINDING; PROTEIN	Increased versican expression in breast tumors is predictive of relapse and has negative impact on survival rates. The C-terminal G3 domain of versican influences local and systemic tumor invasiveness in pre-clinical murine models. However, the mechanism(s) by which G3 influences breast tumor growth and metastasis is not well characterized. Here we evaluated the expression of versican in mouse mammary tumor cell lines observing that 4T1 cells expressed highest levels while 66c14 cells expressed low levels. We exogenously expressed a G3 construct in 66c14 cells and analyzed its effects on cell proliferation, migration, cell cycle progression, and EGFR signaling. Experiments in a syngeneic orthotopic animal model demonstrated that G3 promoted tumor growth and systemic metastasis in vivo. Activation of pERK correlated with high levels of G3 expression. In vitro, G3 enhanced breast cancer cell proliferation and migration by up-regulating EGFR signaling, and enhanced cell motility through chemotactic mechanisms to bone stromal cells, which was prevented by inhibitor AG 1478. G3 expressing cells demonstrated increased CDK2 and GSK-3 beta (S9P) expression, which were related to cell growth. The activity of G3 on mouse mammary tumor cell growth, migration and its effect on spontaneous metastasis to bone in an orthotopic model was modulated by up-regulating the EGFR-mediated signaling pathway. Taken together, EGFR-signaling appears to be an important pathway in versican G3-mediated breast cancer tumor invasiveness and metastasis.	[Du, William Weidong; Yang, Bing L.; Yee, Albert J.] Univ Toronto, Sunnybrook Hlth Sci Ctr, Dept Surg, Toronto, ON, Canada; [Du, William Weidong; Yang, Bing L.; Yee, Albert J.] Univ Toronto, Ctr Study Bone Metastasis, Odette Canc Ctr, Toronto, ON, Canada; [Du, William Weidong; Yang, Burton B.; Shatseva, Tatiana A.; Yang, Bing L.; Deng, Zhaoqun; Shan, Sze Wan; Lee, Daniel Y.; Seth, Arun] Univ Toronto, Sunnybrook Res Inst, Dept Lab Med & Pathobiol, Toronto, ON, Canada	University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center	Du, WW (corresponding author), Univ Toronto, Sunnybrook Hlth Sci Ctr, Dept Surg, Toronto, ON, Canada.	albert.yee@sunnybrook.ca	Xie, Huangming/B-2260-2012	SHAN, SW/0000-0001-6876-9914	Canadian Breast Cancer Research Alliance; Canadian Breast Cancer Foundation Ontario Chapter; Heart and Stroke Foundation of Ontario [CI 5958, NA 6282]; National Sciences and Engineering Research Council of Canada [227937-01]	Canadian Breast Cancer Research Alliance; Canadian Breast Cancer Foundation Ontario Chapter; Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); National Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	Funding: This work was partly supported by the Canadian Breast Cancer Research Alliance special program grant on metastasis, an operating grant from the Canadian Breast Cancer Foundation Ontario Chapter, and a Career Investigator Award (CI 5958) from Heart and Stroke Foundation of Ontario to BBY (NA 6282). A support grant was kindly provided by the National Sciences and Engineering Research Council of Canada (227937-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre-Ghiso JA, 2001, MOL BIOL CELL, V12, P863, DOI 10.1091/mbc.12.4.863; Akli S, 2003, CANCER BIOL THER, V2, pS38; Ang LC, 1999, J NEUROPATH EXP NEUR, V58, P597, DOI 10.1097/00005072-199906000-00004; Aspberg A, 1999, J BIOL CHEM, V274, P20444, DOI 10.1074/jbc.274.29.20444; ASPBERG A, 1995, P NATL ACAD SCI USA, V92, P10590, DOI 10.1073/pnas.92.23.10590; Berdiaki A, 2008, BBA-GEN SUBJECTS, V1780, P194, DOI 10.1016/j.bbagen.2007.10.005; Bhat RV, 2000, P NATL ACAD SCI USA, V97, P11074, DOI 10.1073/pnas.190297597; Bhatia P, 2005, CLIN CANCER RES, V11, P162; BINETTE F, 1994, J BIOL CHEM, V269, P19116; CAMPBELL JS, 1995, RECENT PROG HORM RES, V50, P131; Cattaruzza S, 2004, FASEB J, V18, P779, DOI 10.1096/fj.03-0660fje; Cervantes M, 1996, Ginecol Obstet Mex, V64, P230; Chen G, 2000, J BIOL CHEM, V275, P38973, DOI 10.1074/jbc.M002856200; CROSS DAE, 1994, BIOCHEM J, V303, P21, DOI 10.1042/bj3030021; Cross DAE, 2001, J NEUROCHEM, V77, P94, DOI 10.1046/j.1471-4159.2001.00251.x; DICKSON RB, 1995, ENDOCR REV, V16, P559, DOI 10.1210/er.16.5.559; DIFIORE PP, 1987, SCIENCE, V237, P178, DOI 10.1126/science.2885917; DOURSZIMMERMANN MT, 1994, J BIOL CHEM, V269, P32992; Dykxhoorn DM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007181; Frame S, 2001, BIOCHEM J, V359, P1, DOI 10.1042/0264-6021:3590001; Hoshino R, 1999, ONCOGENE, V18, P813, DOI 10.1038/sj.onc.1202367; Isogai Z, 2002, J BIOL CHEM, V277, P4565, DOI 10.1074/jbc.M110583200; ITO K, 1995, J BIOL CHEM, V270, P958, DOI 10.1074/jbc.270.2.958; Jeffs AR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008461; Jin G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010993; Kahai S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007535; Kawashima H, 2000, J BIOL CHEM, V275, P35448, DOI 10.1074/jbc.M003387200; Kolch W, 2005, NAT REV MOL CELL BIO, V6, P827, DOI 10.1038/nrm1743; Kong A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002881; LaPierre DP, 2007, CANCER RES, V67, P4742, DOI 10.1158/0008-5472.CAN-06-3610; LEBARON RG, 1992, J BIOL CHEM, V267, P10003; Lee DY, 2007, P NATL ACAD SCI USA, V104, P20350, DOI 10.1073/pnas.0706901104; Lee DY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004527; Lelekakis M, 1999, CLIN EXP METASTAS, V17, P163, DOI 10.1023/A:1006689719505; Lemire JM, 1999, ARTERIOSCL THROM VAS, V19, P1630, DOI 10.1161/01.ATV.19.7.1630; Mi ZY, 2006, CARCINOGENESIS, V27, P1134, DOI 10.1093/carcin/bgi352; Nara Y, 1997, HISTOCHEM J, V29, P21, DOI 10.1023/A:1026460700592; NASO MF, 1994, J BIOL CHEM, V269, P32999; Paulus W, 1996, J NEUROPATH EXP NEUR, V55, P528, DOI 10.1097/00005072-199605000-00005; Ricciardelli C, 2002, CLIN CANCER RES, V8, P1054; SAINSBURY JRC, 1985, LANCET, V1, P364; SCHLESSINGER J, 1992, NEURON, V9, P383, DOI 10.1016/0896-6273(92)90177-F; Schmalfeldt M, 1998, J BIOL CHEM, V273, P15758, DOI 10.1074/jbc.273.25.15758; Schmidt M, 2002, DRUG RESIST UPDATE, V5, P11, DOI 10.1016/S1368-7646(02)00004-3; Sheng W, 2005, MOL BIOL CELL, V16, P1330, DOI 10.1091/mbc.e04-04-0295; SHINOMURA T, 1993, J BIOL CHEM, V268, P14461; Sloan EK, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1398; Smith RA, 2006, CURR TOP MED CHEM, V6, P1071, DOI 10.2174/156802606777812077; Suwiwat S, 2004, CLIN CANCER RES, V10, P2491, DOI 10.1158/1078-0432.CCR-03-0146; Tao K, 2001, INT J ONCOL, V19, P1333; Wang CH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002420; Wu YJ, 2005, CELL RES, V15, P483, DOI 10.1038/sj.cr.7290318; Wu YJ, 2004, J CELL SCI, V117, P2227, DOI 10.1242/jcs.01057; Wu YJ, 2002, J BIOL CHEM, V277, P12294, DOI 10.1074/jbc.M110748200; Wu YJ, 2001, J BIOL CHEM, V276, P14178, DOI 10.1074/jbc.M100618200; Xiang YY, 2006, J BIOL CHEM, V281, P19358, DOI 10.1074/jbc.M512980200; YAMAGATA M, 1986, J BIOL CHEM, V261, P3526; Yamaguchi Y, 2000, CELL MOL LIFE SCI, V57, P276, DOI 10.1007/PL00000690; Yang BL, 2000, J BIOL CHEM, V275, P21255, DOI 10.1074/jbc.M001443200; Yee AJ, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1751; Zhang Y, 2001, EXP CELL RES, V263, P33, DOI 10.1006/excr.2000.5095; Zheng PS, 2004, FASEB J, V18, P754, DOI 10.1096/fj.03-0545fje; Zhou BHP, 2004, NAT CELL BIOL, V6, P931, DOI 10.1038/ncb1173; ZIMMERMANN DR, 1989, EMBO J, V8, P2975, DOI 10.1002/j.1460-2075.1989.tb08447.x	64	58	62	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2010	5	11							e13828	10.1371/journal.pone.0013828	http://dx.doi.org/10.1371/journal.pone.0013828			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675OD	21079779	Green Submitted, Green Published, gold			2022-12-27	WOS:000283839100004
J	Tschopp, M; Takamiya, M; Cerveny, KL; Gestri, G; Biehlmaier, O; Wilson, SW; Strahle, U; Neuhauss, SCF				Tschopp, Markus; Takamiya, Masanari; Cerveny, Kara L.; Gestri, Gaia; Biehlmaier, Oliver; Wilson, Stephen W.; Straehle, Uwe; Neuhauss, Stephan C. F.			Funduscopy in Adult Zebrafish and Its Application to Isolate Mutant Strains with Ocular Defects	PLOS ONE			English	Article							MOUSE MODEL; NEOVASCULARIZATION; MICE; EYE; SYSTEM; LOCI	Funduscopy is one of the most commonly used diagnostic tools in the ophthalmic practice, allowing for a ready assessment of pathological changes in the retinal vasculature and the outer retina. This non-invasive technique has so far been rarely used in animal model for ophthalmic diseases, albeit its potential as a screening assay in genetic screens. The zebrafish (Danio rerio) is well suited for such genetic screens for ocular alterations. Therefore we developed funduscopy in adult zebrafish and employed it as a screening tool to find alterations in the anterior segment and the fundus of the eye of genetically modified adult animals. A stereomicroscope with coaxial reflected light illumination was used to obtain fundus color images of the zebrafish. In order to find lens and retinal alterations, a pilot screen of 299 families of the F3 generation of ENU-treated adult zebrafish was carried out. Images of the fundus of the eye and the anterior segment can be rapidly obtained and be used to identify alterations in genetically modified animals. A number of putative mutants with cataracts, defects in the cornea, eye pigmentation, ocular vessels and retina were identified. This easily implemented method can also be used to obtain fundus images from rodent retinas. In summary, we present funduscopy as a valuable tool to analyse ocular abnormalities in adult zebrafish and other small animal models. A proof of principle screen identified a number of putative mutants, making funduscopy based screens in zebrafish feasible.	[Tschopp, Markus; Biehlmaier, Oliver; Neuhauss, Stephan C. F.] Univ Zurich, Inst Mol Life Sci, Zurich, Switzerland; [Takamiya, Masanari; Straehle, Uwe] Karlsruhe Inst Technol, Inst Toxicol & Genet, Karlsruhe, Germany; [Cerveny, Kara L.; Gestri, Gaia; Wilson, Stephen W.] UCL, Dept Cell & Dev Biol, London, England	University of Zurich; Helmholtz Association; Karlsruhe Institute of Technology; University of London; University College London	Tschopp, M (corresponding author), Univ Bern, Inselspital, Dept Ophthalmol, CH-3010 Bern, Switzerland.	stephan.neuhauss@imls.uzh.ch	Straehle, Uwe/K-7054-2013; Zebrafish, UCL/A-3125-2009; Neuhauss, Stephan/AAX-9915-2020; Wilson, Stephen W/B-9404-2008	Neuhauss, Stephan/0000-0002-9615-480X; Wilson, Stephen W/0000-0002-8557-5940; Cerveny, Kara/0000-0003-0667-827X; Tschopp, Markus/0000-0001-6684-7325; Biehlmaier, Oliver/0000-0003-0825-8500; Gestri, Gaia/0000-0001-8854-1546; Takamiya, Masanari/0000-0002-6524-5813	European Commission [LSHG-CT-2003-503496]; MRC; Wellcome Trust; Telethon Foundation; Damon Runyon Foundation; Novartis Stiftung fur medizinisch-biologische Forschung; MRC [G0501487] Funding Source: UKRI; Medical Research Council [G0501487] Funding Source: researchfish	European Commission(European CommissionEuropean Commission Joint Research Centre); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Telethon Foundation(Fondazione Telethon); Damon Runyon Foundation; Novartis Stiftung fur medizinisch-biologische Forschung; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Funding: This work was supported by the European Commission as part of the ZF-MODELS Integrated Project in the 6th Framework Programme, Contract No. LSHG-CT-2003-503496, MRC, Wellcome Trust, Telethon and Damon Runyon Foundations (SW, GG and KC) and the Novartis Stiftung fur medizinisch-biologische Forschung (MT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez Y, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-114; Brand Michael, 2002, P7; Cohan BE, 2003, INVEST OPHTH VIS SCI, V44, P160, DOI 10.1167/iovs.02-0105; Curcio CA, 2009, PROG RETIN EYE RES, V28, P393, DOI 10.1016/j.preteyeres.2009.08.001; Dahm R, 2007, EXP EYE RES, V85, P74, DOI 10.1016/j.exer.2007.02.015; Fadool JM, 2008, PROG RETIN EYE RES, V27, P89, DOI 10.1016/j.preteyeres.2007.08.002; Hart WE, 1999, INT J MED INFORM, V53, P239, DOI 10.1016/S1386-5056(98)00163-4; HAWES NL, 1999, MOL VIS, V5, pIL1; Heckenlively JR, 2003, RETINA-J RET VIT DIS, V23, P518, DOI 10.1097/00006982-200308000-00012; Helmholtz H., 1851, BESCHREIBUNG AUGENSP; Hubert MF, 1999, LAB ANIM SCI, V49, P232; Imamura Y, 2006, P NATL ACAD SCI USA, V103, P11282, DOI 10.1073/pnas.0602131103; Klein BEK, 1998, ARCH OPHTHALMOL-CHIC, V116, P219, DOI 10.1001/archopht.116.2.219; Lee P, 1998, SURV OPHTHALMOL, V43, P245, DOI 10.1016/S0039-6257(98)00035-6; Li L, 1997, P NATL ACAD SCI USA, V94, P11645, DOI 10.1073/pnas.94.21.11645; LI ZY, 1995, OPHTHALMOLOGY, V102, P805, DOI 10.1016/S0161-6420(95)30953-0; Lyons BL, 2006, INVEST OPHTH VIS SCI, V47, P1201, DOI 10.1167/iovs.05-1161; Maaswinkel H, 2005, MECH AGEING DEV, V126, P1079, DOI 10.1016/j.mad.2005.03.025; Neuhauss SCF, 1999, J NEUROSCI, V19, P8603; Neuhauss SCF, 2003, J NEUROBIOL, V54, P148, DOI 10.1002/neu.10165; Pang JJ, 2005, MOL VIS, V11, P152; Paques M, 2006, VISION RES, V46, P1336, DOI 10.1016/j.visres.2005.09.037; Paques M, 2003, INVEST OPHTH VIS SCI, V44, P4960, DOI 10.1167/iovs.02-0738; Paques M, 2007, INVEST OPHTH VIS SCI, V48, P2769, DOI 10.1167/iovs.06-1099; Pinto LH, 2004, VISION RES, V44, P3335, DOI 10.1016/j.visres.2004.07.025; Ravin JG, 1999, ARCH OPHTHALMOL-CHIC, V117, P1634; Seeliger MW, 2005, VISION RES, V45, P3512, DOI 10.1016/j.visres.2005.08.014; Wong T, 2007, LANCET, V369, P425, DOI 10.1016/S0140-6736(07)60198-6	28	12	12	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2010	5	11							e15427	10.1371/journal.pone.0015427	http://dx.doi.org/10.1371/journal.pone.0015427			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675OD	21079775	Green Published, gold, Green Submitted			2022-12-27	WOS:000283839100023
J	Hoffmann, TJ; Marini, NJ; Witte, JS				Hoffmann, Thomas J.; Marini, Nicholas J.; Witte, John S.			Comprehensive Approach to Analyzing Rare Genetic Variants	PLOS ONE			English	Article							COMMON DISEASES; SUSCEPTIBILITY; ASSOCIATIONS; MUTATIONS; MODELS	Recent findings suggest that rare variants play an important role in both monogenic and common diseases. Due to their rarity, however, it remains unclear how to appropriately analyze the association between such variants and disease. A common approach entails combining rare variants together based on a priori information and analyzing them as a single group. Here one must make some assumptions about what to aggregate. Instead, we propose two approaches to empirically determine the most efficient grouping of rare variants. The first considers multiple possible groupings using existing information. The second is an agnostic "step-up" approach that determines an optimal grouping of rare variants analytically and does not rely on prior information. To evaluate these approaches, we undertook a simulation study using sequence data from genes in the one-carbon folate metabolic pathway. Our results show that using prior information to group rare variants is advantageous only when information is quite accurate, but the step-up approach works well across a broad range of plausible scenarios. This agnostic approach allows one to efficiently analyze the association between rare variants and disease while avoiding assumptions required by other approaches for grouping such variants.	[Hoffmann, Thomas J.; Witte, John S.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Hoffmann, Thomas J.; Witte, John S.] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA; [Marini, Nicholas J.] Univ Calif Berkeley, Dept Mol & Cellular Biol, Calif Inst Quantitat Biosci, Berkeley, CA 94720 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California Berkeley	Hoffmann, TJ (corresponding author), Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA.	WitteJ@humgen.ucsf.edu			National Institutes of Health (NIH) [R25CA112355, R01GM072859, R01CA88164, U01CA127298]; NATIONAL CANCER INSTITUTE [R25CA112355, R01CA088164, U01CA127298] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072859] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	TJH was supported by National Institutes of Health (NIH) R25CA112355 training grant. NJM was supported by NIH grant R01GM072859 (NIGMS). JSW was supported by NIH grants R01CA88164 and U01CA127298. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azzopardi D, 2008, CANCER RES, V68, P358, DOI 10.1158/0008-5472.CAN-07-5733; Bodmer W, 2008, NAT GENET, V40, P695, DOI 10.1038/ng.f.136; Capanu M, 2008, STAT MED, V27, P2536, DOI 10.1002/sim.3049; Chun S, 2009, GENOME RES, V19, P1553, DOI 10.1101/gr.092619.109; Cohen JC, 2004, SCIENCE, V305, P869, DOI 10.1126/science.1099870; Dickson SP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000294; Ferrer-Costa C, 2004, PROTEINS, V57, P811, DOI 10.1002/prot.20252; Han F, 2010, HUM HERED, V70, P42, DOI 10.1159/000288704; HERSHBERGER RE, 2010, CIRC CARDIOVASC GENE; Iyengar Sudha K, 2007, Methods Mol Biol, V376, P71; Lewinger JP, 2007, GENET EPIDEMIOL, V31, P871, DOI 10.1002/gepi.20248; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; Madsen BE, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000384; Mardis ER, 2008, TRENDS GENET, V24, P133, DOI 10.1016/j.tig.2007.12.007; Morgenthaler S, 2007, MUTAT RES-FUND MOL M, V615, P28, DOI 10.1016/j.mrfmmm.2006.09.003; Nejentsev S, 2009, SCIENCE, V324, P387, DOI 10.1126/science.1167728; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Price AL, 2010, AM J HUM GENET, V86, P832, DOI 10.1016/j.ajhg.2010.04.005; Pritchard JK, 2001, AM J HUM GENET, V69, P124, DOI 10.1086/321272; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Reed MC, 2006, J NUTR, V136, P2653, DOI 10.1093/jn/136.10.2653; Smith DJ, 2002, HUM MOL GENET, V11, P2455, DOI 10.1093/hmg/11.20.2455; Stenson PD, 2009, GENOME MED, V1, DOI 10.1186/gm13; THOMAS DC, 1985, AM J EPIDEMIOL, V122, P1080, DOI 10.1093/oxfordjournals.aje.a114189; Witte JS, 1997, GENET EPIDEMIOL, V14, P1137, DOI 10.1002/(SICI)1098-2272(1997)14:6<1137::AID-GEPI96>3.0.CO;2-H	25	98	105	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2010	5	11							e13584	10.1371/journal.pone.0013584	http://dx.doi.org/10.1371/journal.pone.0013584			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	674WJ	21072163	Green Published, Green Submitted, gold			2022-12-27	WOS:000283780800001
J	Restelli, E; Fioriti, L; Mantovani, S; Airaghi, S; Forloni, G; Chiesa, R				Restelli, Elena; Fioriti, Luana; Mantovani, Susanna; Airaghi, Simona; Forloni, Gianluigi; Chiesa, Roberto			Cell Type-Specific Neuroprotective Activity of Untranslocated Prion Protein	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM; MESSENGER-RNA; ER STRESS; TRANSMEMBRANE FORM; COMMON PATHWAY; PRP; TRANSLOCATION; EXPRESSION; APOPTOSIS; GENE	Background: A key pathogenic role in prion diseases was proposed for a cytosolic form of the prion protein (PrP). However, it is not clear how cytosolic PrP localization influences neuronal viability, with either cytotoxic or anti-apoptotic effects reported in different studies. The cellular mechanism by which PrP is delivered to the cytosol of neurons is also debated, and either retrograde transport from the endoplasmic reticulum or inefficient translocation during biosynthesis has been proposed. We investigated cytosolic PrP biogenesis and effect on cell viability in primary neuronal cultures from different mouse brain regions. Principal Findings: Mild proteasome inhibition induced accumulation of an untranslocated form of cytosolic PrP in cortical and hippocampal cells, but not in cerebellar granules. A cyclopeptolide that interferes with the correct insertion of the PrP signal sequence into the translocon increased the amount of untranslocated PrP in cortical and hippocampal cells, and induced its synthesis in cerebellar neurons. Untranslocated PrP boosted the resistance of cortical and hippocampal neurons to apoptotic insults but had no effect on cerebellar cells. Significance: These results indicate cell type-dependent differences in the efficiency of PrP translocation, and argue that cytosolic PrP targeting might serve a physiological neuroprotective function.	[Restelli, Elena; Fioriti, Luana; Mantovani, Susanna; Airaghi, Simona; Chiesa, Roberto] Dulbecco Telethon Inst, Milan, Italy; [Restelli, Elena; Fioriti, Luana; Mantovani, Susanna; Airaghi, Simona; Forloni, Gianluigi; Chiesa, Roberto] Mario Negri Inst Pharmacol Res, Dept Neurosci, I-20157 Milan, Italy	Fondazione Telethon; Dulbecco Telethon Institute (DTI); Istituto di Ricerche Farmacologiche Mario Negri IRCCS	Restelli, E (corresponding author), Dulbecco Telethon Inst, Milan, Italy.	roberto.chiesa@marionegri.it	Restelli, Elena/J-7449-2018; Forloni, Gianluigi/AAB-2115-2020; Fioriti, Luana/AAN-7207-2021; Chiesa, Roberto/G-1561-2017	Restelli, Elena/0000-0002-6081-5178; Forloni, Gianluigi/0000-0001-5374-3914; Chiesa, Roberto/0000-0002-3842-3733; Mantovani, Susanna/0000-0001-7046-6541; fioriti, luana/0000-0003-2429-8967	Telethon-Italy [TRC08005]; Fondazione Monzino	Telethon-Italy(Fondazione Telethon); Fondazione Monzino	This work was supported by Telethon-Italy to RC (TRC08005). L.F. was supported by a fellowship from the Fondazione Monzino. R.C. is an Associate Telethon Scientist (Dulbecco Telethon Institute, Fondazione Telethon). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailly Y, 2004, J COMP NEUROL, V473, P244, DOI 10.1002/cne.20117; Barmada S, 2004, NEUROBIOL DIS, V16, P527, DOI 10.1016/j.nbd.2004.05.005; BERTRAND R, 1994, EXP CELL RES, V211, P314, DOI 10.1006/excr.1994.1093; Besemer J, 2005, NATURE, V436, P290, DOI 10.1038/nature03670; Bragason BT, 2005, MOL CELL NEUROSCI, V29, P232, DOI 10.1016/j.mcn.2005.02.013; BUELER H, 1992, NATURE, V356, P577, DOI 10.1038/356577a0; Campana V, 2005, TRENDS CELL BIOL, V15, P102, DOI 10.1016/j.tcb.2004.12.002; Chakrabarti O, 2009, TRENDS BIOCHEM SCI, V34, P287, DOI 10.1016/j.tibs.2009.03.001; Chiesa R, 1998, NEURON, V21, P1339, DOI 10.1016/S0896-6273(00)80653-4; Chiesa R, 2004, TECHNIQUES PRION RES, P176; CROZET C, 2006, MOL CELL NEUROSCI; Drisaldi B, 2003, J BIOL CHEM, V278, P21732, DOI 10.1074/jbc.M213247200; Faas H, 2010, NEUROIMAGE, V49, P2607, DOI 10.1016/j.neuroimage.2009.10.009; Fioriti L, 2005, J BIOL CHEM, V280, P11320, DOI 10.1074/jbc.M412441200; Fons RD, 2003, J CELL BIOL, V160, P529, DOI 10.1083/jcb.200210095; Grenier C, 2006, J NEUROCHEM, V97, P1456, DOI 10.1111/j.1471-4159.2006.03837.x; Harant H, 2006, J BIOL CHEM, V281, P30492, DOI 10.1074/jbc.M607243200; HARRIS DA, 1993, P NATL ACAD SCI USA, V90, P4309, DOI 10.1073/pnas.90.9.4309; Hegde RS, 1999, NATURE, V402, P822, DOI 10.1038/45574; Hegde RS, 1998, SCIENCE, V279, P827, DOI 10.1126/science.279.5352.827; Juanes ME, 2009, J BIOL CHEM, V284, P2787, DOI 10.1074/jbc.M804051200; Kang SW, 2006, CELL, V127, P999, DOI 10.1016/j.cell.2006.10.032; KASCSAK RJ, 1987, J VIROL, V61, P3688, DOI 10.1128/JVI.61.12.3688-3693.1987; Kaufman RJ, 2002, J CLIN INVEST, V110, P1389, DOI 10.1172/JC1200216886; Kim SJ, 2002, MOL BIOL CELL, V13, P3775, DOI 10.1091/mbc.E02-05-0293; KOH JY, 1995, EXP NEUROL, V135, P153, DOI 10.1006/exnr.1995.1074; Kristiansen M, 2005, J BIOL CHEM, V280, P38851, DOI 10.1074/jbc.M506600200; KURSCHNER C, 1995, MOL BRAIN RES, V30, P165, DOI 10.1016/0169-328X(95)00013-I; Lang-Rollin I, 2004, J NEUROCHEM, V90, P1511, DOI 10.1111/j.1471-4159.2004.02684.x; Langeveld Jan P M, 2006, BMC Vet Res, V2, P19, DOI 10.1186/1746-6148-2-19; Lee K, 2002, GENE DEV, V16, P452, DOI 10.1101/gad.964702; LEHMANN S, 1995, J BIOL CHEM, V270, P24589, DOI 10.1074/jbc.270.41.24589; Levine CG, 2005, MOL BIOL CELL, V16, P279, DOI 10.1091/mbc.E04-06-0508; Lin DTS, 2008, BBA-MOL CELL RES, V1783, P2001, DOI 10.1016/j.bbamcr.2008.05.022; Lund C, 2009, J BIOL CHEM, V284, P19668, DOI 10.1074/jbc.M109.003566; Ma JY, 2002, SCIENCE, V298, P1781, DOI 10.1126/science.1073725; Ma JY, 2001, P NATL ACAD SCI USA, V98, P14955, DOI 10.1073/pnas.011578098; MANSON J, 1992, DEVELOPMENT, V115, P117; Massignan T, 2010, MOL CELL PROTEOMICS, V9, P611, DOI 10.1074/mcp.M900271-MCP200; Miller TM, 1996, J NEUROSCI, V16, P7487; Mironov A, 2003, J NEUROSCI, V23, P7183, DOI 10.1523/JNEUROSCI.23-18-07183.2003; MOSER M, 1995, NEURON, V14, P509, DOI 10.1016/0896-6273(95)90307-0; Orsi A, 2006, J BIOL CHEM, V281, P30431, DOI 10.1074/jbc.M605320200; Orsi A, 2007, PRION, V1, P236, DOI 10.4161/pri.1.4.5727; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; RAMBOLD AS, 2006, MOL BIOL CELL; Rane NS, 2008, DEV CELL, V15, P359, DOI 10.1016/j.devcel.2008.06.015; Rane NS, 2004, EMBO J, V23, P4550, DOI 10.1038/sj.emboj.7600462; Rapoport TA, 2007, NATURE, V450, P663, DOI 10.1038/nature06384; Roucou X, 2003, J BIOL CHEM, V278, P40877, DOI 10.1074/jbc.M306177200; Rutkowski DT, 2001, P NATL ACAD SCI USA, V98, P7823, DOI 10.1073/pnas.141125098; Steele AD, 2006, P NATL ACAD SCI USA, V103, P3416, DOI 10.1073/pnas.0511290103; Stewart RS, 2005, J NEUROSCI, V25, P3469, DOI 10.1523/JNEUROSCI.0105-05.2005; Stewart RS, 2003, J BIOL CHEM, V278, P45960, DOI 10.1074/jbc.M307833200; Stockton JD, 2003, BIOCHEMISTRY-US, V42, P12821, DOI 10.1021/bi035087q; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Wang X, 2009, BMB REP, V42, P444, DOI 10.5483/BMBRep.2009.42.7.444; Wang XH, 2009, BBA-MOL BASIS DIS, V1792, P555, DOI 10.1016/j.bbadis.2009.02.014; Yedidia Y, 2001, EMBO J, V20, P5383, DOI 10.1093/emboj/20.19.5383; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0	60	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2010	5	10							e13725	10.1371/journal.pone.0013725	http://dx.doi.org/10.1371/journal.pone.0013725			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	672HN	21060848	Green Published, Green Submitted, gold			2022-12-27	WOS:000283573800019
J	Simmler, C; Antheaume, C; Lobstein, A				Simmler, Charlotte; Antheaume, Cyril; Lobstein, Annelise			Antioxidant Biomarkers from Vanda coerulea Stems Reduce Irradiated HaCaT PGE-2 Production as a Result of COX-2 Inhibition	PLOS ONE			English	Article							ULTRAVIOLET-IRRADIATION; SCAVENGING ACTIVITY; PROSTAGLANDIN E-2; OXIDATIVE STRESS; NITRIC-OXIDE; HUMAN SKIN; 9,10-DIHYDROPHENANTHRENE; EXPRESSION; DERIVATIVES; FLAVIDIN	Background: In our investigations towards the isolation of potentially biologically active constituents from Orchidaceae, we carried out phytochemical and biological analyses of Vanda species. A preliminary biological screening revealed that Vanda coerulea (Griff. ex. Lindl) crude hydro-alcoholic stem extract displayed the best DPPH/(OH)-O-center dot radical scavenging activity and in vitro inhibition of type 2 prostaglandin (PGE-2) release from UVB (60 mJ/cm(2)) irradiated HaCaT keratinocytes. Principal Findings: Bio-guided fractionation and phytochemical analysis led to the isolation of five stilbenoids: imbricatin (1) methoxycoelonin (2) gigantol (3) flavidin (4) and coelonin (5). Stilbenoids (1-3) were the most concentrated in crude hydroalcoholic stem extract and were considered as Vanda coerulea stem biomarkers. Dihydro-phenanthropyran (1) and dihydrophenanthrene (2) displayed the best DPPH/(OH)-O-center dot radical scavenging activities as well as HaCaT intracellular antioxidant properties (using DCFH-DA probe: IC50 8.8 mu M and 9.4 mu M, respectively) compared to bibenzyle (3) (IC50 20.6 mu M). In turn, the latter showed a constant inhibition of PGE-2 production, stronger than stilbenoids (1) and (2) (IC50 12.2 mu M and 19.3 mu M, respectively). Western blot analysis revealed that stilbenoids (1-3) inhibited COX-2 expression at 23 mu M. Interestingly, stilbenoids (1) and (2) but not (3) were able to inhibit human recombinant COX-2 activity. Conclusions: Major antioxidant stilbenoids (1-3) from Vanda coerulea stems displayed an inhibition of UVB-induced COX-2 expression. Imbricatin (1) and methoxycoelonin (2) were also able to inhibit COX-2 activity in a concentration-dependent manner thereby reducing PGE-2 production from irradiated HaCaT cells. Our studies suggest that stilbenoids (1-3) could be potentially used for skin protection against the damage caused by UVB exposure.	[Simmler, Charlotte; Antheaume, Cyril; Lobstein, Annelise] Univ Strasbourg, Fac Pharm, Illkirch Graffenstaden, France; [Simmler, Charlotte; Lobstein, Annelise] CNRS, Lab Pharmacognosie, UMR 7200, Illkirch Graffenstaden, France; [Antheaume, Cyril] Serv Commun Anal SCA RMN, Illkirch Graffenstaden, France	UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC)	Simmler, C (corresponding author), Univ Strasbourg, Fac Pharm, Illkirch Graffenstaden, France.	charlotte.simmler@pharma.u-strasbg.fr		Simmler, Charlotte/0000-0002-6923-2630	Louis Vuitton Moet Hennessy (LVMH) Recherche; Guerlain Societe Anonyme (SA)	Louis Vuitton Moet Hennessy (LVMH) Recherche; Guerlain Societe Anonyme (SA)	This work was supported by Louis Vuitton Moet Hennessy (LVMH) Recherche and Guerlain Societe Anonyme (SA), www.lvmh.fr/groupe. The funders did not have any role in study design, data collection and analysis. Funders have supplied facilities for all biological analyses and gave their approval for the manuscript to be published.	Ahn SM, 2002, BRIT J PHARMACOL, V137, P497, DOI 10.1038/sj.bjp.0704896; Anuradha V, 1998, PHYTOCHEMISTRY, V48, P181, DOI 10.1016/S0031-9422(97)00610-9; Anuradha V, 1998, PHYTOCHEMISTRY, V48, P185, DOI 10.1016/S0031-9422(97)00612-2; Bae JY, 2010, EXP DERMATOL, V19, pE182, DOI 10.1111/j.1600-0625.2009.01044.x; Baliga MS, 2006, PHOTOCH PHOTOBIO SCI, V5, P243, DOI 10.1039/b505311k; Bickers DR, 2006, J INVEST DERMATOL, V126, P2565, DOI 10.1038/sj.jid.5700340; Buckman SY, 1998, CARCINOGENESIS, V19, P723, DOI 10.1093/carcin/19.5.723; CHASE MW, DNA DATA ORCHIDACEAE; Deciga-Campos M, 2007, J ETHNOPHARMACOL, V114, P161, DOI 10.1016/j.jep.2007.07.021; Fisher GJ, 2002, ARCH DERMATOL, V138, P1462, DOI 10.1001/archderm.138.11.1462; Guo XY, 2007, J ASIAN NAT PROD RES, V9, P165, DOI 10.1080/10286020500480522; GUO XY, 2006, ZHONGCAOYAO, V37, P492; Harman D, 2001, ANN NY ACAD SCI, V928, P1, DOI 10.1111/j.1749-6632.2001.tb05631.x; Isoherranen K, 1999, BRIT J DERMATOL, V140, P1017; Jayaprakasha GK, 2004, BIOORGAN MED CHEM, V12, P5141, DOI 10.1016/j.bmc.2004.07.028; JUNEJA RK, 1985, PHYTOCHEMISTRY, V24, P321, DOI 10.1016/S0031-9422(00)83544-X; JUNEJA RK, 1987, PHYTOCHEMISTRY, V26, P1123, DOI 10.1016/S0031-9422(00)82362-6; Kovacs A, 2008, PHYTOCHEMISTRY, V69, P1084, DOI 10.1016/j.phytochem.2007.12.005; LECOUFLE M, 2004, TRAITE ORCHIDEES, P42; MAJUMDER P, 1982, PHYTOCHEMISTRY, V21, P478, DOI 10.1016/S0031-9422(00)95300-7; MAJUMDER PL, 1982, INDIAN J CHEM B, V21, P829; MAJUMDER PL, 1982, J NAT PROD, V45, P730, DOI 10.1021/np50024a016; MAJUMDER PL, 1995, PHYTOCHEMISTRY, V39, P649, DOI 10.1016/0031-9422(95)00942-Z; MILLER CC, 1994, J BIOL CHEM, V269, P3529; Nayak B S, 2005, Int J Low Extrem Wounds, V4, P200, DOI 10.1177/1534734605282994; Nichols JA, 2010, ARCH DERMATOL RES, V302, P71, DOI 10.1007/s00403-009-1001-3; Parejo I, 2003, LIFE SCI, V73, P1667, DOI 10.1016/S0024-3205(03)00488-0; Pinnell SR, 2003, J AM ACAD DERMATOL, V48, P1, DOI 10.1067/mjd.2003.16; Pyo MK, 2004, ARCH PHARM RES, V27, P381, DOI 10.1007/BF02980077; Rhodes LE, 2001, J INVEST DERMATOL, V117, P880, DOI 10.1046/j.0022-202x.2001.01514.x; ROEHM NW, 1991, J IMMUNOL METHODS, V142, P257, DOI 10.1016/0022-1759(91)90114-U; ROSENKRANZ AR, 1992, J IMMUNOL METHODS, V156, P39, DOI 10.1016/0022-1759(92)90008-H; Seo JY, 2003, MECH AGEING DEV, V124, P903, DOI 10.1016/S0047-6374(03)00150-7; Tripp CS, 2003, J INVEST DERMATOL, V121, P853, DOI 10.1046/j.1523-1747.2003.12495.x; VEERRAJU P, 1989, PHYTOCHEMISTRY, V28, P3031, DOI 10.1016/0031-9422(89)80273-0; Wang J, 2007, J NAT MED, V61, P381, DOI 10.1007/s11418-007-0162-7; WILLIAMS CA, 1976, PHYTOCHEMISTRY, V15, P349, DOI 10.1016/S0031-9422(00)89036-6; Won JH, 2006, PLANTA MED, V72, P1181, DOI 10.1055/s-2006-947201; Yang L, 2006, J CHROMATOGR A, V1104, P230, DOI 10.1016/j.chroma.2005.12.012; Zeng XH, 2006, PLANTA MED, V72, P1359, DOI 10.1055/s-2006-951709; Zhang X, 2007, J NAT PROD, V70, P24, DOI 10.1021/np060449r; ZHU H, 1994, ARCH TOXICOL, V68, P582, DOI 10.1007/s002040050118	42	38	40	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2010	5	10							e13713	10.1371/journal.pone.0013713	http://dx.doi.org/10.1371/journal.pone.0013713			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	672HN	21060890	Green Submitted, gold, Green Published			2022-12-27	WOS:000283573800013
J	van Wijk, BCM; Stam, CJ; Daffertshofer, A				van Wijk, Bernadette C. M.; Stam, Cornelis J.; Daffertshofer, Andreas			Comparing Brain Networks of Different Size and Connectivity Density Using Graph Theory	PLOS ONE			English	Article							SMALL-WORLD NETWORKS; FUNCTIONAL CONNECTIVITY; THEORETICAL ANALYSIS; CORTICAL NETWORKS; SCALE-FREE; LOGISTIC REGRESSIONS; ANATOMICAL NETWORKS; SOCIAL NETWORKS; LOGIT-MODELS; EEG	Graph theory is a valuable framework to study the organization of functional and anatomical connections in the brain. Its use for comparing network topologies, however, is not without difficulties. Graph measures may be influenced by the number of nodes (N) and the average degree (k) of the network. The explicit form of that influence depends on the type of network topology, which is usually unknown for experimental data. Direct comparisons of graph measures between empirical networks with different N and/or k can therefore yield spurious results. We list benefits and pitfalls of various approaches that intend to overcome these difficulties. We discuss the initial graph definition of unweighted graphs via fixed thresholds, average degrees or edge densities, and the use of weighted graphs. For instance, choosing a threshold to fix N and k does eliminate size and density effects but may lead to modifications of the network by enforcing (ignoring) nonsignificant (significant) connections. Opposed to fixing N and k, graph measures are often normalized via random surrogates but, in fact, this may even increase the sensitivity to differences in N and k for the commonly used clustering coefficient and small-world index. To avoid such a bias we tried to estimate the N, k-dependence for empirical networks, which can serve to correct for size effects, if successful. We also add a number of methods used in social sciences that build on statistics of local network structures including exponential random graph models and motif counting. We show that none of the here-investigated methods allows for a reliable and fully unbiased comparison, but some perform better than others.	[van Wijk, Bernadette C. M.; Daffertshofer, Andreas] Vrije Univ Amsterdam, Res Inst MOVE, Amsterdam, Netherlands; [Stam, Cornelis J.] Vrije Univ Amsterdam, Dept Clin Neurophysiol, Med Ctr, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam	van Wijk, BCM (corresponding author), Vrije Univ Amsterdam, Res Inst MOVE, Amsterdam, Netherlands.	b.vanwijk@fbw.vu.nl		Daffertshofer, Andreas/0000-0001-9107-3552; Stam, Cornelis/0000-0001-9163-7274; van Wijk, Bernadette/0000-0002-6129-0801	Netherlands Organisation for Scientific Research (NWO) [021-002-047, 452-04-332]	Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This work was financially supported by the Netherlands Organisation for Scientific Research (NWO, http://www.nwo.nl) grant numbers 021-002-047 and 452-04-332. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Anderson BS, 1999, SOC NETWORKS, V21, P239, DOI 10.1016/S0378-8733(99)00011-8; ANTIQUEIRA L, 2010, NEUROIMAGE IN PRESS; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Bartolomei F, 2006, CLIN NEUROPHYSIOL, V117, P2039, DOI 10.1016/j.clinph.2006.05.018; Bassett DS, 2008, J NEUROSCI, V28, P9239, DOI 10.1523/JNEUROSCI.1929-08.2008; Bassettt DS, 2006, P NATL ACAD SCI USA, V103, P19518, DOI 10.1073/pnas.0606005103; Bosma Ingeborg, 2009, Nonlinear Biomed Phys, V3, P9, DOI 10.1186/1753-4631-3-9; Brown L. D., 1986, FUNDAMENTALS STAT EX; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Butts CT, 2008, ASIAN J SOC PSYCHOL, V11, P13, DOI 10.1111/j.1467-839X.2007.00241.x; Butts CT, 2007, J MATH SOCIOL, V31, P295, DOI 10.1080/00222500701542517; Butts CT, 2009, SCIENCE, V325, P414, DOI 10.1126/science.1171022; Carrington P. J., 2005, MODELS METHODS SOCIA; Chen ZJ, 2008, CEREB CORTEX, V18, P2374, DOI 10.1093/cercor/bhn003; Costa LD, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-16; Davis J. A., 1972, SOCIOLOGICAL THEORIE, V2, P218; de Haan W, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-101; Dimitriadis SI, 2009, BRAIN TOPOGR, V22, P119, DOI 10.1007/s10548-008-0071-4; Eguiluz VM, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.018102; Fallani FDV, 2008, NEUROINFORMATICS, V6, P23, DOI 10.1007/s12021-007-9006-6; Faust K, 2002, SOCIOL METHODOL, V32, P267, DOI 10.1111/1467-9531.00118; Ferrarini L, 2009, HUM BRAIN MAPP, V30, P2220, DOI 10.1002/hbm.20663; Ferri R, 2008, CLIN NEUROPHYSIOL, V119, P2026, DOI 10.1016/j.clinph.2008.04.294; Fornito A, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00022; FRANK O, 1986, J AM STAT ASSOC, V81, P832, DOI 10.2307/2289017; Gong GL, 2009, CEREB CORTEX, V19, P524, DOI 10.1093/cercor/bhn102; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Handcock Mark S., 2003, STATNET SOFTWARE TOO; Handcock MS, 2003, DYNAMIC SOCIAL NETWORK MODELING AND ANALYSIS, P229; Handcock MS., 2003, 39 U WASH CTR STAT S; Hayasaka S, 2010, NEUROIMAGE, V50, P499, DOI 10.1016/j.neuroimage.2009.12.051; He Y, 2008, J NEUROSCI, V28, P4756, DOI 10.1523/JNEUROSCI.0141-08.2008; He Y, 2007, CEREB CORTEX, V17, P2407, DOI 10.1093/cercor/bhl149; HOLLAND PW, 1970, AM J SOCIOL, V76, P492, DOI 10.1086/224954; Humphries MD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002051; Hunter DR, 2006, J COMPUT GRAPH STAT, V15, P565, DOI 10.1198/106186006X133069; HUNTER DR, 2010, ERGM PACKAGE FIT SIM; Iturria-Medina Y, 2007, NEUROIMAGE, V36, P645, DOI 10.1016/j.neuroimage.2007.02.012; Katz L., 1953, PSYCHOMETRIKA, V18, P249; Klemm K, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.057102; Kramer MA, 2008, EPILEPSY RES, V79, P173, DOI 10.1016/j.eplepsyres.2008.02.002; Lee SH, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.016102; Li YH, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000395; Liu Y, 2008, BRAIN, V131, P945, DOI 10.1093/brain/awn018; Martin S, 2006, PHYSICA A, V371, P870, DOI 10.1016/j.physa.2006.04.046; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Meunier D, 2009, NEUROIMAGE, V44, P715, DOI 10.1016/j.neuroimage.2008.09.062; Micheloyannis S, 2006, NEUROSCI LETT, V402, P273, DOI 10.1016/j.neulet.2006.04.006; Micheloyannis S, 2009, HUM BRAIN MAPP, V30, P200, DOI 10.1002/hbm.20492; Ponten SC, 2010, NEUROIMAGE, V52, P985, DOI 10.1016/j.neuroimage.2009.10.049; Ponten SC, 2009, EXP NEUROL, V217, P197, DOI 10.1016/j.expneurol.2009.02.001; Robins G, 1999, PSYCHOMETRIKA, V64, P371, DOI 10.1007/BF02294302; Robins G, 2007, SOC NETWORKS, V29, P173, DOI 10.1016/j.socnet.2006.08.002; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Rubinov M, 2009, HUM BRAIN MAPP, V30, P403, DOI 10.1002/hbm.20517; Salvador R, 2005, CEREB CORTEX, V15, P1332, DOI 10.1093/cercor/bhi016; Schindler KA, 2008, CHAOS, V18, DOI 10.1063/1.2966112; SIMPSON SL, 2010, ARXIV10073230V1STATA; Smit DJA, 2008, HUM BRAIN MAPP, V29, P1368, DOI 10.1002/hbm.20468; Snijders TAB., 2002, J SOCIAL STRUCTURE, V3(2), P1, DOI DOI 10.1016/j.socnet.2006.08.001; Snijders TAB, 2006, SOCIOL METHODOL, V36, P99, DOI 10.1111/j.1467-9531.2006.00176.x; Sporns O, 2004, PLOS BIOL, V2, P1910, DOI 10.1371/journal.pbio.0020369; Sporns O, 2004, NEUROINFORMATICS, V2, P145, DOI 10.1385/NI:2:2:145; Stam CJ, 2007, CEREB CORTEX, V17, P92, DOI 10.1093/cercor/bhj127; Stam CJ, 2009, BRAIN, V132, P213, DOI 10.1093/brain/awn262; Stam CJ, 2004, NEUROSCI LETT, V355, P25, DOI 10.1016/j.neulet.2003.10.063; Stam Cornelis J, 2007, Nonlinear Biomed Phys, V1, P3, DOI 10.1186/1753-4631-1-3; Stumpf MPH, 2005, P NATL ACAD SCI USA, V102, P4221, DOI 10.1073/pnas.0501179102; Supekar K, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000100; van den Heuvel MP, 2008, NEUROIMAGE, V43, P528, DOI 10.1016/j.neuroimage.2008.08.010; van den Heuvel MP, 2009, J NEUROSCI, V29, P7619, DOI 10.1523/JNEUROSCI.1443-09.2009; Wagenmakers EJ, 2004, PSYCHON B REV, V11, P192, DOI 10.3758/BF03206482; Wang JH, 2009, HUM BRAIN MAPP, V30, P1511, DOI 10.1002/hbm.20623; Wang L, 2009, HUM BRAIN MAPP, V30, P638, DOI 10.1002/hbm.20530; Wasserman S, 1996, PSYCHOMETRIKA, V61, P401, DOI 10.1007/BF02294547; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Zalesky A, 2010, NEUROIMAGE, V50, P970, DOI 10.1016/j.neuroimage.2009.12.027; Zamora-Lopez G, 2009, CHAOS, V19, DOI 10.1063/1.3089559	81	739	742	9	88	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2010	5	10							e13701	10.1371/journal.pone.0013701	http://dx.doi.org/10.1371/journal.pone.0013701			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	672HN	21060892	Green Submitted, Green Published, gold			2022-12-27	WOS:000283573800004
J	Lee, DY; Jeyapalan, Z; Fang, L; Yang, J; Zhang, Y; Yee, AY; Li, MH; Du, WW; Shatseva, T; Yang, BB				Lee, Daniel Y.; Jeyapalan, Zina; Fang, Ling; Yang, Jennifer; Zhang, Yaou; Yee, Albert Y.; Li, Minhui; Du, William W.; Shatseva, Tatiana; Yang, Burton B.			Expression of Versican 3 '-Untranslated Region Modulates Endogenous MicroRNA Functions	PLOS ONE			English	Article							MESSENGER-RNA DEGRADATION; OSTEOBLAST DIFFERENTIATION; CELL-PROLIFERATION; PROFILING REVEALS; MAMMALIAN-CELLS; STEM-CELLS; IN-VIVO; GENE; MIRNA; APOPTOSIS	Background: Mature microRNAs (miRNAs) are single-stranded RNAs that regulate post-transcriptional gene expression. In our previous study, we have shown that versican 3'UTR, a fragment of non-coding transcript, has the ability to antagonize miR-199a-3p function thereby regulating expression of the matrix proteins versican and fibronectin, and thus resulting in enhanced cell-cell adhesion and organ adhesion. However, the impact of this non-coding fragment on tumorigenesis is yet to be determined. Methods and Findings: Using computational prediction confirmed with in vitro and in vivo experiments, we report that the expression of versican 3'UTR not only antagonizes miR-199a-3p but can also lower its steady state expression. We found that expression of versican 3'UTR in a mouse breast carcinoma cell line, 4T1, decreased miR-199a-3p levels. The decrease in miRNA activity consequently translated into differences in tumor growth. Computational analysis indicated that both miR-199a-3p and miR-144 targeted a cell cycle regulator, Rb1. In addition, miR-144 and miR-136, which have also been shown to interact with versican 3'UTR, was found to target PTEN. Expression of Rb1 and PTEN were up-regulated synergistically in vitro and in vivo, suggesting that the 3'UTR binds and modulates miRNA activities, freeing Rb1 and PTEN mRNAs for translation. In tumor formation assays, cells transfected with the 3'UTR formed smaller tumors compared with cells transfected with a control vector. Conclusion: Our results demonstrated that a 3'UTR fragment can be used to modulate miRNA functions. Our study also suggests that miRNAs in the cancer cells are more susceptible to degradation, due to its interaction with a non-coding 3'UTR. This non-coding component of mRNA may be used retrospectively to modulate miRNA activities.	[Lee, Daniel Y.; Jeyapalan, Zina; Fang, Ling; Yang, Jennifer; Yee, Albert Y.; Li, Minhui; Du, William W.; Shatseva, Tatiana; Yang, Burton B.] Sunnybrook Hlth Sci Ctr, Sunnybrook Res Inst, Toronto, ON M4N 3M5, Canada; [Zhang, Yaou] Tsinghua Univ, Grad Sch Shenzhen, Div Life Sci, Shenzhen 518057, Guangdong, Peoples R China; [Lee, Daniel Y.; Jeyapalan, Zina; Fang, Ling; Li, Minhui; Shatseva, Tatiana; Yang, Burton B.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada	University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; Tsinghua University; University Town of Shenzhen; Tsinghua Shenzhen International Graduate School; University of Toronto	Lee, DY (corresponding author), Sunnybrook Hlth Sci Ctr, Sunnybrook Res Inst, Toronto, ON M4N 3M5, Canada.	byang@sri.utoronto.ca			National Sciences and Engineering Research Council of Canada [227937-01]; Canadian Institutes of Health Research; National Natural Science Foundation of China; Heart and Stroke Foundation of Ontario [CI 5958]; Canada Graduate Scholarship	National Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Canada Graduate Scholarship	This work was supported by a grant from National Sciences and Engineering Research Council of Canada (227937-01) to BBY and a China-Canada Joint Health Research Grant (from Canadian Institutes of Health Research and the National Natural Science Foundation of China to BBY and YZ). BBY is the recipient of Career Investigator Award (CI 5958) from the Heart and Stroke Foundation of Ontario. DYL is the recipient of Canada Graduate Scholarship. There are no current external funding sources for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bagga S, 2005, CELL, V122, P553, DOI 10.1016/j.cell.2005.07.031; Brown BD, 2007, NAT BIOTECHNOL, V25, P1457, DOI 10.1038/nbt1372; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Cardinali B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007607; Chen YX, 2007, CANCER RES, V67, P976, DOI 10.1158/0008-5472.CAN-06-3667; Chhabra R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005848; Cordes KR, 2009, CIRC RES, V104, P724, DOI 10.1161/CIRCRESAHA.108.192872; Ebert MS, 2007, NAT METHODS, V4, P721, DOI 10.1038/NMETH1079; Eulalio A, 2008, CELL, V132, P9, DOI 10.1016/j.cell.2007.12.024; FANG L, 2010, ONCOGENE IN PRESS; Fang L, 2010, FEBS LETT, V584, P2877, DOI 10.1016/j.febslet.2010.04.074; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Fu YF, 2009, BLOOD, V113, P1340, DOI 10.1182/blood-2008-08-174854; FURUKAWA Y, 1990, P NATL ACAD SCI USA, V87, P2770, DOI 10.1073/pnas.87.7.2770; Gentner B, 2009, NAT METHODS, V6, P63, DOI [10.1038/NMETH.1277, 10.1038/nmeth.1277]; Haraguchi T, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp040; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; Bueno MJ, 2008, CELL CYCLE, V7, P3143, DOI 10.4161/cc.7.20.6833; Kahai S, 2010, FEBS LETT, V584, P233, DOI 10.1016/j.febslet.2009.11.077; Kahai S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007535; Kedde M, 2007, CELL, V131, P1273, DOI 10.1016/j.cell.2007.11.034; Koga T, 2005, CURR EYE RES, V30, P455, DOI 10.1080/02713680590959376; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; LaPierre DP, 2007, CANCER RES, V67, P4742, DOI 10.1158/0008-5472.CAN-06-3610; Lee DY, 2007, P NATL ACAD SCI USA, V104, P20350, DOI 10.1073/pnas.0706901104; Lee DY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004527; Lee YB, 2009, NUCLEIC ACIDS RES, V37, P123, DOI 10.1093/nar/gkn920; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; MURPHREE AL, 1984, SCIENCE, V223, P1028, DOI 10.1126/science.6320372; Orom UA, 2006, GENE, V372, P137, DOI 10.1016/j.gene.2005.12.031; Ramachandran V, 2008, SCIENCE, V321, P1490, DOI 10.1126/science.1163728; Schmalfeldt M, 1998, J BIOL CHEM, V273, P15758, DOI 10.1074/jbc.273.25.15758; Schoolmeesters A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005605; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Shan SW, 2009, NAT CELL BIOL, V11, P1031, DOI 10.1038/ncb1917; Sheng W, 2005, MOL BIOL CELL, V16, P1330, DOI 10.1091/mbc.e04-04-0295; Takahashi Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006677; Tzur G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007511; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Vella MC, 2004, GENE DEV, V18, P132, DOI 10.1101/gad.1165404; Wang CH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002420; Wang XB, 2010, J BIOL CHEM, V285, P23239, DOI 10.1074/jbc.M109.084673; Wang YM, 2009, CANCER RES, V69, P4093, DOI 10.1158/0008-5472.CAN-09-0309; Weng LP, 2001, HUM MOL GENET, V10, P599, DOI 10.1093/hmg/10.6.599; Wu HQ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001020; Xiao CC, 2009, CELL, V136, P26, DOI 10.1016/j.cell.2008.12.027; Yu ZB, 2007, NUCLEIC ACIDS RES, V35, P152, DOI 10.1093/nar/gkl1032	50	120	131	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2010	5	10							e13599	10.1371/journal.pone.0013599	http://dx.doi.org/10.1371/journal.pone.0013599			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	670LB	21049042	gold, Green Published, Green Submitted			2022-12-27	WOS:000283422100012
J	Nelson, ESD; Harris, S; Soulsbury, CD; Richards, SA; Stephens, PA				Nelson, Eleanor S. Devenish; Harris, Stephen; Soulsbury, Carl D.; Richards, Shane A.; Stephens, Philip A.			Uncertainty in Population Growth Rates: Determining Confidence Intervals from Point Estimates of Parameters	PLOS ONE			English	Article							FOXES VULPES-VULPES; NEW-SOUTH-WALES; RED FOXES; REPRODUCTIVE-PERFORMANCE; MATRIX MODELS; DEMOGRAPHY; DYNAMICS; PATTERNS; MAMMALS; SAMPLE	Background: Demographic models are widely used in conservation and management, and their parameterisation often relies on data collected for other purposes. When underlying data lack clear indications of associated uncertainty, modellers often fail to account for that uncertainty in model outputs, such as estimates of population growth. Methodology/Principal Findings: We applied a likelihood approach to infer uncertainty retrospectively from point estimates of vital rates. Combining this with resampling techniques and projection modelling, we show that confidence intervals for population growth estimates are easy to derive. We used similar techniques to examine the effects of sample size on uncertainty. Our approach is illustrated using data on the red fox, Vulpes vulpes, a predator of ecological and cultural importance, and the most widespread extant terrestrial mammal. We show that uncertainty surrounding estimated population growth rates can be high, even for relatively well-studied populations. Halving that uncertainty typically requires a quadrupling of sampling effort. Conclusions/Significance: Our results compel caution when comparing demographic trends between populations without accounting for uncertainty. Our methods will be widely applicable to demographic studies of many species.	[Nelson, Eleanor S. Devenish; Richards, Shane A.; Stephens, Philip A.] Univ Durham, Sch Biol & Biomed Sci, Durham, England; [Harris, Stephen; Soulsbury, Carl D.] Univ Bristol, Sch Biol Sci, Bristol, Avon, England	Durham University; University of Bristol	Nelson, ESD (corresponding author), Univ Durham, Sch Biol & Biomed Sci, Durham, England.	e.s.nelson@durham.ac.uk	Stephens, Philip/B-8397-2008; Soulsbury, Carl D./F-3137-2010; Soulsbury, Carl/P-1492-2019	Stephens, Philip/0000-0001-5849-788X; Soulsbury, Carl D./0000-0001-8808-5210; Soulsbury, Carl/0000-0001-8808-5210; Richards, Shane/0000-0002-9638-5827; Devenish-Nelson, Eleanor/0000-0002-9029-4772	Durham University; Dulverton Trust	Durham University; Dulverton Trust	This work was funded by a Durham University Doctoral Fellowship (EDN). S. Harris was funded by the Dulverton Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN SH, 1984, J MAMMAL, V65, P246, DOI 10.2307/1381163; Beissinger SR, 1998, J WILDLIFE MANAGE, V62, P821, DOI 10.2307/3802534; Bischof R, 2008, J WILDLIFE MANAGE, V72, P79, DOI 10.2193/2007-149; Caswell, 2000, MATRIX POPULATION MO; Caughley G., 1977, ANAL VERTEBRATE POPU; COMAN BJ, 1988, AUST WILDLIFE RES, V15, P223, DOI 10.1071/WR9880223; de Valpine P, 2009, ECOLOGY, V90, P2889, DOI 10.1890/08-0703.1; Doak DF, 2005, ECOLOGY, V86, P1154, DOI 10.1890/04-0611; Ezard THG, 2010, J APPL ECOL, V47, P515, DOI 10.1111/j.1365-2664.2010.01801.x; Fiske IJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003080; Gross K, 2002, ECOLOGY, V83, P1762, DOI 10.1890/0012-9658(2002)083[1762:EDCFEG]2.0.CO;2; Hagen CA, 2008, J WILDLIFE MANAGE, V72, P1369, DOI 10.2193/2007-390; HARRIS S, 1987, J APPL ECOL, V24, P75, DOI 10.2307/2403788; Heppell SS, 2000, ECOLOGY, V81, P654, DOI 10.1890/0012-9658(2000)081[0654:LHAEPP]2.0.CO;2; Heydon MJ, 2000, J ZOOL, V251, P265, DOI 10.1111/j.1469-7998.2000.tb00609.x; Hobbs NT, 2006, ECOL APPL, V16, P5, DOI 10.1890/04-0645; Hone J, 1999, J APPL ECOL, V36, P709, DOI 10.1046/j.1365-2664.1999.00439.x; KALISZ S, 1992, ECOLOGY, V73, P1082, DOI 10.2307/1940182; Kendall BE, 2010, AM NAT, V175, P461, DOI 10.1086/650724; Marboutin E, 2003, J APPL ECOL, V40, P580, DOI 10.1046/j.1365-2664.2003.00813.x; Marlow NJ, 2000, WILDLIFE RES, V27, P457, DOI 10.1071/WR99035; McCarthy MA, 2007, BAYESIAN METHODS FOR ECOLOGY, P1, DOI 10.1017/CBO9780511802454; McIlroy J, 2001, CAN J ZOOL, V79, P545, DOI 10.1139/cjz-79-4-545; McLeod SR, 2001, WILDLIFE RES, V28, P333, DOI 10.1071/WR00104; Mills L. S., 2007, CONSERVATION WILDLIF; Milner-Gulland, 2007, CONSERVATION SUSTAIN; Morris W. F., 2002, QUANTITATIVE CONSERV; NELSON BB, 1982, Z SAUGETIERKD, V47, P296; Oli MK, 2003, AM NAT, V161, P422, DOI 10.1086/367591; Pech R, 1997, REPROD FERT DEVELOP, V9, P41, DOI 10.1071/R96059; Reed DH, 2003, BIOL CONSERV, V113, P23, DOI 10.1016/S0006-3207(02)00346-4; Salguero-Gomez R, 2010, J ECOL, V98, P250, DOI 10.1111/j.1365-2745.2009.01635.x; Saunders G, 2002, MAMMALIA, V66, P247, DOI 10.1515/mamm.2002.66.2.247; Saunders GR, 2010, MAMMAL REV, V40, P181, DOI 10.1111/j.1365-2907.2010.00159.x; Schipper J, 2008, SCIENCE, V322, P225, DOI 10.1126/science.1165115; Schleuning M, 2009, CONSERV BIOL, V23, P174, DOI 10.1111/j.1523-1739.2008.01054.x; Solberg EJ, 1999, J ANIM ECOL, V68, P186, DOI 10.1046/j.1365-2656.1999.00275.x; Soulsbury CD, 2008, BEHAV ECOL SOCIOBIOL, V62, P1289, DOI 10.1007/s00265-008-0557-9; Storm G.L., 1976, Wildlife Monogr, V49, P3; Tenhumberg B, 2008, J APPL ECOL, V45, P438, DOI 10.1111/j.1365-2664.2007.01427.x; TULLAR BF, 1981, NEW YORK FISH GAME J, V28, P138; TULLAR BF, 1982, NEW YORK FISH GAME J, V29, P127; Vos Ad, 2001, Lutra, V44, P15; Wisdom MJ, 2000, ECOLOGY, V81, P628, DOI 10.1890/0012-9658(2000)081[0628:LSSAEV]2.0.CO;2	44	13	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2010	5	10							e13628	10.1371/journal.pone.0013628	http://dx.doi.org/10.1371/journal.pone.0013628			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	670LB	21049049	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000283422100023
J	Lewis, TW; Blott, SC; Woolliams, JA				Lewis, Thomas W.; Blott, Sarah C.; Woolliams, John A.			Genetic Evaluation of Hip Score in UK Labrador Retrievers	PLOS ONE			English	Article							MOUNTAIN DOG; DYSPLASIA; HERITABILITY; PEDIGREE; FINLAND	Hip dysplasia is an important and complex genetic disease in dogs with both genetic and environmental influences. Since the osteoarthritis that develops is irreversible the only way to improve welfare, through reducing the prevalence, is through genetic selection. This study aimed to evaluate the progress of selection against hip dysplasia, to quantify potential improvements in the response to selection via use of genetic information and increases in selection intensity, and to prepare for public provision of estimated breeding values (EBV) for hip dysplasia in the UK. Data consisted of 25,243 single records of hip scores of Labrador Retrievers between one and four years old, from radiographs evaluated between 2000 and 2007 as part of the British Veterinary Association (BVA) hip score scheme. A natural logarithm transformation was applied to improve normality and linear mixed models were evaluated using ASREML. Genetic correlations between left and right scores, and total hip scores at one, two and three years of age were found to be close to one, endorsing analysis of total hip score in dogs aged one to three as an appropriate approach. A heritability of 0.35 +/- 0.016 and small but significant litter effect (0.07 +/- 0.009) were estimated. The observed trends in both mean hip score and mean EBV over year of birth indicate that a small genetic improvement has been taking place, approximately equivalent to avoiding those dogs with the worst 15% of scores. Deterministic analysis supported by simulations showed that a 19% greater response could be achieved using EBV compared to phenotype through increases in accuracy alone. This study establishes that consistent but slow genetic improvement in the hip score of UK Labrador Retrievers has been achieved over the previous decade, and demonstrates that progress may be easily enhanced through the use of EBVs and more intense selection.	[Lewis, Thomas W.; Blott, Sarah C.] Anim Hlth Trust, Kennel Club Genet Ctr, Newmarket, Suffolk, England; [Woolliams, John A.] Univ Edinburgh, Roslin Inst, Roslin, Midlothian, Scotland; [Woolliams, John A.] Univ Edinburgh, Royal Dick Sch Vet Studies, Roslin, Midlothian, Scotland	Animal Health Trust; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh	Lewis, TW (corresponding author), Anim Hlth Trust, Kennel Club Genet Ctr, Newmarket, Suffolk, England.	tom.lewis@aht.org.uk		Blott, Sarah/0000-0003-0233-6846; Lewis, Thomas/0000-0003-4166-7955	Kennel Club Charitable Trust; BBSRC through ISPG; BBSRC [BBS/E/D/05191133] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/D/05191133] Funding Source: researchfish	Kennel Club Charitable Trust; BBSRC through ISPG(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by the Kennel Club Charitable Trust. JAW is grateful to BBSRC for funding through an ISPG. The funders had no role in study design, data analysis, decision to publish, or preparation of the manuscript. Hip score and pedigree data was collated and provided by the UK Kennel Club.	Bateson P., 2010, INDEPENDENT INQUIRY; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; BRASS W, 1989, J SMALL ANIM PRACT, V30, P166, DOI 10.1111/j.1748-5827.1989.tb01525.x; Darwash AO, 1997, J DAIRY SCI, V80, P1227, DOI 10.3168/jds.S0022-0302(97)76051-X; Falconer D. S., 1996, INTRO QUANTITATIVE G; Flint APF, 2008, PHILOS T R SOC B, V363, P573, DOI 10.1098/rstb.2007.2171; Fluckiger M., 2007, EUROPEAN J COMPANION, V17, P135; Gibbs C, 1997, VET REC, V141, P275; Gilmour A., 2006, ASREML USER GUIDE RE; HARRIS DL, 1994, J ANIM SCI, V72, P2178, DOI 10.2527/1994.7282178x; Higgins A, 2008, VET J, V178, P157, DOI 10.1016/j.tvjl.2008.10.004; HOU Y, PLOS ONE, V5, pE9410; Leppanen M, 1999, PREV VET MED, V42, P121, DOI 10.1016/S0167-5877(99)00059-8; Leppanen M, 2000, J ANIM BREED GENET, V117, P97, DOI 10.1111/j.1439-0388.2000x.00229.x; LEWIS T, 2010, VET J, DOI DOI 10.1016/J.TVJL.2010.1002.1016; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Lohi H, 2009, VET J, V181, P77, DOI 10.1016/j.tvjl.2009.02.007; Lust G, 1997, J AM VET MED ASSOC, V210, P1443; Maki K, 2004, THESIS U HELSINKI; Malm S, 2008, J ANIM BREED GENET, V125, P403, DOI 10.1111/j.1439-0388.2008.00725.x; Ohlerth S, 1998, DEUT TIERARZTL WOCH, V105, P378; Silvestre AM, 2007, J ANIM SCI, V85, P1880, DOI 10.2527/jas.2007-0166; Solberg TR, 2008, J ANIM SCI, V86, P2447, DOI 10.2527/jas.2007-0010; Steinetz BG, 2008, AM J VET RES, V69, P59, DOI 10.2460/ajvr.69.1.59; Todhunter RJ, 2005, MAMM GENOME, V16, P720, DOI 10.1007/s00335-005-0004-4; Willis MB, 1997, J AM VET MED ASSOC, V210, P1480; Wood JLN, 2003, VET REC, V152, P69, DOI 10.1136/vr.152.3.69; Wood JLN, 2002, PREV VET MED, V55, P95, DOI 10.1016/S0167-5877(02)00090-9	28	40	40	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2010	5	10							e12797	10.1371/journal.pone.0012797	http://dx.doi.org/10.1371/journal.pone.0012797			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	670KA	21042573	Green Published, Green Submitted, gold			2022-12-27	WOS:000283419100001
J	Desvignes, T; Pontarotti, P; Bobe, J				Desvignes, Thomas; Pontarotti, Pierre; Bobe, Julien			Nme Gene Family Evolutionary History Reveals Pre-Metazoan Origins and High Conservation between Humans and the Sea Anemone, Nematostella vectensis	PLOS ONE			English	Article							NUCLEOSIDE DIPHOSPHATE KINASE; MULTIPLE SEQUENCE ALIGNMENT; TUMOR-METASTASIS; ESCHERICHIA-COLI; NM23 HOMOLOG; SUPPRESSOR; GENOME; ANNOTATION; COMPLEXITY; EXPRESSION	Background: The Nme gene family is involved in multiple physiological and pathological processes such as cellular differentiation, development, metastatic dissemination, and cilia functions. Despite the known importance of Nme genes and their use as clinical markers of tumor aggressiveness, the associated cellular mechanisms remain poorly understood. Over the last 20 years, several non-vertebrate model species have been used to investigate Nme functions. However, the evolutionary history of the family remains poorly understood outside the vertebrate lineage. The aim of the study was thus to elucidate the evolutionary history of the Nme gene family in Metazoans. Methodology/Principal Findings: Using a total of 21 eukaryote species including 14 metazoans, the evolutionary history of Nme genes was reconstructed in the metazoan lineage. We demonstrated that the complexity of the Nme gene family, initially thought to be restricted to chordates, was also shared by the metazoan ancestor. We also provide evidence suggesting that the complexity of the family is mainly a eukaryotic innovation, with the exception of Nme8 that is likely to be a choanoflagellate/metazoan innovation. Highly conserved gene structure, genomic linkage, and protein domains were identified among metazoans, some features being also conserved in eukaryotes. When considering the entire Nme family, the starlet sea anemone is the studied metazoan species exhibiting the most conserved gene and protein sequence features with humans. In addition, we were able to show that most of the proteins known to interact with human NME proteins were also found in starlet sea anemone. Conclusion/Significance: Together, our observations further support the association of Nme genes with key cellular functions that have been conserved throughout metazoan evolution. Future investigations of evolutionarily conserved Nme gene functions using the starlet sea anemone could shed new light on a wide variety of key developmental and cellular processes.	[Desvignes, Thomas; Pontarotti, Pierre; Bobe, Julien] Univ Provence Aix Marseille, IFR48, CNRS 1, UMR 6632, F-13000 Marseille, France; [Desvignes, Thomas] LALR, IFREMER, F-34250 Palavas Les Flots, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Ifremer	Desvignes, T (corresponding author), Univ Provence Aix Marseille, IFR48, CNRS 1, UMR 6632, F-13000 Marseille, France.	Julien.Bobe@rennes.inra.fr	Bobe, Julien/I-6851-2017; , pontarotti/ABB-1753-2021; Thomas, Desvignes/AAX-3526-2020	Bobe, Julien/0000-0002-9355-8227; Thomas, Desvignes/0000-0001-5126-8785; Pierre, Pontarotti/0000-0001-7202-3648	INRA; European Community [222719 - LIFECYCLE]	INRA; European Community(European Commission)	This work was supported by an INRA - IFREMER PhD fellowship to TD. The research leading to these results has received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement no. 222719 - LIFECYCLE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boissan M, 2009, MOL CELL BIOCHEM, V329, P51, DOI 10.1007/s11010-009-0120-7; Catchen JM, 2009, GENOME RES, V19, P1497, DOI 10.1101/gr.090480.108; CHERFILS J, 1994, BIOCHEMISTRY-US, V33, P9062, DOI 10.1021/bi00197a006; Choi YJ, 2009, FEBS LETT, V583, P1292, DOI 10.1016/j.febslet.2009.03.023; Degnan BM, 2009, CURR OPIN GENET DEV, V19, P591, DOI 10.1016/j.gde.2009.09.008; Desvignes T, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-256; Duriez B, 2007, P NATL ACAD SCI USA, V104, P3336, DOI 10.1073/pnas.0611405104; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Flicek P, 2010, NUCLEIC ACIDS RES, V38, pD557, DOI 10.1093/nar/gkp972; Gouret P, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-198; HAMA H, 1991, GENE, V105, P31, DOI 10.1016/0378-1119(91)90510-I; Hammargren J, 2007, PHYSIOL PLANTARUM, V129, P79, DOI 10.1111/j.1399-3054.2006.00794.x; Hedges SB, 2006, BIOINFORMATICS, V22, P2971, DOI 10.1093/bioinformatics/btl505; Hwang KC, 2003, BIOCHEM BIOPH RES CO, V306, P198, DOI 10.1016/S0006-291X(03)00916-1; Ikeda T, 2010, CELL STRUCT FUNCT, V35, P23, DOI 10.1247/csf.09016; Ishikawa N, 2003, J BIOENERG BIOMEMBR, V35, P7, DOI 10.1023/A:1023433504713; Jung H, 2008, J BIOL CHEM, V283, P32669, DOI 10.1074/jbc.M806225200; Jung HY, 2007, J BIOL CHEM, V282, P35293, DOI 10.1074/jbc.M705181200; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Lascu I, 2000, J BIOENERG BIOMEMBR, V32, P227, DOI 10.1023/A:1005580828141; LU Q, 1995, J MOL BIOL, V254, P337, DOI 10.1006/jmbi.1995.0620; Marchler-Bauer A, 2009, NUCLEIC ACIDS RES, V37, pD205, DOI 10.1093/nar/gkn845; Mehta A, 2009, MOL CELL BIOCHEM, V329, P3, DOI 10.1007/s11010-009-0114-5; Munier A, 1998, FEBS LETT, V434, P289, DOI 10.1016/S0014-5793(98)00996-X; Napolitano F, 2008, NEUROCHEM RES, V33, P2547, DOI 10.1007/s11064-008-9683-z; Nikolaidis N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000204; Ogawa K, 1996, MOL BIOL CELL, V7, P1895, DOI 10.1091/mbc.7.12.1895; Otsuki Y, 2001, P NATL ACAD SCI USA, V98, P4385, DOI 10.1073/pnas.071411598; Pankow S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000782; Polosina YY, 1998, EXTREMOPHILES, V2, P333, DOI 10.1007/s007920050076; POSTEL EH, 1993, SCIENCE, V261, P478, DOI 10.1126/science.8392752; Postel EH, 2000, J BIOENERG BIOMEMBR, V32, P277, DOI 10.1023/A:1005541114029; Postel EH, 2003, J BIOENERG BIOMEMBR, V35, P31, DOI 10.1023/A:1023485505621; Putnam NH, 2007, SCIENCE, V317, P86, DOI 10.1126/science.1139158; ROSENGARD AM, 1989, NATURE, V342, P177, DOI 10.1038/342177a0; Ryan JF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000153; Srivastava M, 2010, NATURE, V466, P720, DOI 10.1038/nature09201; STEEG PS, 1988, J NATL CANCER I, V80, P200, DOI 10.1093/jnci/80.3.200; Takahashi T, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-240; TROLL H, 1993, J BIOL CHEM, V268, P25469; Vogel P, 2010, VET PATHOL, V47, P120, DOI 10.1177/0300985809353553; Woolworth JA, 2009, MOL CELL BIOL, V29, P4679, DOI 10.1128/MCB.00297-09; Yamada A, 2007, EVOL DEV, V9, P220, DOI 10.1111/j.1525-142X.2007.00154.x; Yang MM, 2009, MUTAT RES-FUND MOL M, V660, P74, DOI 10.1016/j.mrfmmm.2008.09.015	46	26	27	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2010	5	11							e15506	10.1371/journal.pone.0015506	http://dx.doi.org/10.1371/journal.pone.0015506			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	678OA	21085602	Green Published, gold			2022-12-27	WOS:000284087800028
J	Pretorius, C; Stover, J; Bollinger, L; Bacaer, N; Williams, B				Pretorius, Carel; Stover, John; Bollinger, Lori; Bacaer, Nicolas; Williams, Brian			Evaluating the Cost-Effectiveness of Pre-Exposure Prophylaxis (PrEP) and Its Impact on HIV-1 Transmission in South Africa	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; DRUG-RESISTANCE; PREVENTION; MORTALITY; EPIDEMIC; TREAT	Background: Mathematical modelers have given little attention to the question of how pre-exposure prophylaxis (PrEP) may impact on a generalized national HIV epidemic and its cost-effectiveness, in the context of control strategies such as condom use promotion and expanding ART programs. Methodology/Principal Findings: We use an age-and gender-structured model of the generalized HIV epidemic in South Africa to investigate the potential impact of PrEP in averting new infections. The model utilizes age-structured mortality, fertility, partnership and condom use data to model the spread of HIV and the shift of peak prevalence to older age groups. The model shows that universal PrEP coverage would have to be impractically high to have a significant effect on incidence reduction while ART coverage expands. PrEP targeted to 15-35-year-old women would avert 10%-25% (resp. 13%-28%) of infections in this group and 5%-12% (resp. 7%-16%) of all infections in the period 2014-2025 if baseline incidence is 0.5% per year at 2025 (resp. 0.8% per year at 2025). The cost would be $12,500-$20,000 per infection averted, depending on the level of ART coverage and baseline incidence. An optimistic scenario of 30%-60% PrEP coverage, efficacy of at least 90%, no behavior change among PrEP users and ART coverage less than three times its 2010 levels is required to achieve this result. Targeting PrEP to 25-35-year-old women (at highest risk of infection) improves impact and cost-effectiveness marginally. Relatively low levels of condom substitution (e. g., 30%) do not nullify the efficacy of PrEP, but reduces cost-effectiveness by 35%-40%. Conclusions/Significance: PrEP can avert as many as 30% of new infections in targeted age groups of women at highest risk of infection. The cost-effectiveness of PrEP relative to ART decreases rapidly as ART coverage increases beyond three times its coverage in 2010, after which the ART program would provide coverage to more than 65% of HIV+ individuals. To have a high relative cost-effective impact on reducing infections in generalized epidemics, PrEP must utilize a window of opportunity until ART has been scaled up beyond this level.	[Pretorius, Carel; Stover, John; Bollinger, Lori] Futures Inst, Glastonbury, CT USA; [Bacaer, Nicolas] IRD, Bondy, France; [Williams, Brian] Univ Stellenbosch, SACEMA, DST NRF Ctr Excellence Epidemiol Modelling & Anal, ZA-7600 Stellenbosch, South Africa	Institut de Recherche pour le Developpement (IRD); National Research Foundation - South Africa; Stellenbosch University	Pretorius, C (corresponding author), Futures Inst, Glastonbury, CT USA.	cpretorius@futuresinstitute.org		Williams, Brian/0000-0002-3174-4876	Bill and Melinda Gates Foundation [GH5182]	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	Funding: Support for this work was provided by the Bill and Melinda Gates Foundation under Grant GH5182. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas UL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000875; ANDERSON BA, 2006, 030905 STAT S AFR; [Anonymous], 2001, MACR HLTH INV HLTH E; [Anonymous], COUNTRY PROGR REPORT; *AVAC, PREEXP PROPH TRIALS; Bacaer N, 2010, B MATH BIOL, V72, P2180, DOI 10.1007/s11538-010-9535-2; BOLLINGER L, CHANGING HIV AIDS LA, P1; Bongaarts J, 2007, POP STUD-J DEMOG, V61, P73, DOI 10.1080/00324720601048343; Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; Dandona Lalit, 2010, BMC Health Serv Res, V10, P117, DOI 10.1186/1472-6963-10-117; *DEP HLTH, HIV AIDS STI STRAT P; *DEP HLTH, NAT ANT SENT HIV SYP; Dodd PJ, 2010, AIDS, V24, P729, DOI 10.1097/QAD.0b013e32833433fe; Donnell D, 2010, LANCET, V375, P2092, DOI 10.1016/S0140-6736(10)60705-2; DORRINGTON R, 2006, DEM IMP HIV AIDS S A; Evans DB, 2005, BMJ-BRIT MED J, V331, P1137, DOI 10.1136/bmj.331.7525.1137; Gallant JE, 2004, JAMA-J AM MED ASSOC, V292, P191, DOI 10.1001/jama.292.2.191; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Grant RM, 2010, CLIN INFECT DIS, V50, pS96, DOI 10.1086/651479; Guay LA, 1999, LANCET, V354, P795, DOI 10.1016/S0140-6736(99)80008-7; Hallett TB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002212; Hankins C, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000109; Hargrove J, 2008, S AFR J SCI, V104, P53; Jahn A, 2008, LANCET, V371, P1603, DOI 10.1016/S0140-6736(08)60693-5; Johnson LF, 2006, DEMOGR RES, V14, P541, DOI 10.4054/DemRes.2006.14.22; Johnson LF, 2009, DEMOGR RES, V21, P289, DOI 10.4054/DemRes.2009.21.11; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Paltiel AD, 2009, CLIN INFECT DIS, V48, P806, DOI 10.1086/597095; Rehle TM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011094; Shisana O., 2002, N MANDELA HSRC STUDY; Shisana O., 2009, S AFRICAN NATL HIV P; SMITH D, 2006, 16 INT AIDS C TOR CA; Supervie V, 2010, P NATL ACAD SCI USA, V107, P12381, DOI 10.1073/pnas.1006061107; Szekeres G., 2004, ANTICIPATING EFFICAC; The World Bank, WORLD BANK WORLD DEV; *US BUR CENS, US CENS BUR INT DAT; van de Vijver DAMC, 2009, J INFECT DIS, V199, P1310, DOI 10.1086/597804; Vissers DCJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002077; Wagner BG, 2010, AIDS, V24, P775, DOI 10.1097/QAD.0b013e3283366782; [WHO UNAIDS UNICEF], 2009, UN ACC SCAL PRIOR HI; *WHO, 2010, RIGHTS HER RIGHTS NO; Williams BG, 2006, PLOS MED, V3, P1032, DOI 10.1371/journal.pmed.0030262; 2009, MORTALITY CAUSES DEA	43	86	87	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2010	5	11							e13646	10.1371/journal.pone.0013646	http://dx.doi.org/10.1371/journal.pone.0013646			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675OD	21079767	Green Published, gold, Green Submitted			2022-12-27	WOS:000283839100002
J	Slater, GJ; Figueirido, B; Louis, L; Yang, P; Van Valkenburgh, B				Slater, Graham J.; Figueirido, Borja; Louis, Leeann; Yang, Paul; Van Valkenburgh, Blaire			Biomechanical Consequences of Rapid Evolution in the Polar Bear Lineage	PLOS ONE			English	Article							FINITE-ELEMENT-ANALYSIS; COMPUTER-SIMULATION; CRANIAL MECHANICS; FEEDING-BEHAVIOR; FRONTAL SINUSES; GRIZZLY BEARS; BONE-CRACKING; URSUS-ARCTOS; BROWN BEARS; CARNIVORA	The polar bear is the only living ursid with a fully carnivorous diet. Despite a number of well-documented craniodental adaptations for a diet of seal flesh and blubber, molecular and paleontological data indicate that this morphologically distinct species evolved less than a million years ago from the omnivorous brown bear. To better understand the evolution of this dietary specialization, we used phylogenetic tests to estimate the rate of morphological specialization in polar bears. We then used finite element analysis (FEA) to compare the limits of feeding performance in the polar bear skull to that of the phylogenetically and geographically close brown bear. Results indicate that extremely rapid evolution of semi-aquatic adaptations and dietary specialization in the polar bear lineage produced a cranial morphology that is weaker than that of brown bears and less suited to processing tough omnivorous or herbivorous diets. Our results suggest that continuation of current climate trends could affect polar bears by not only eliminating their primary food source, but also through competition with northward advancing, generalized brown populations for resources that they are ill-equipped to utilize.	[Slater, Graham J.; Yang, Paul; Van Valkenburgh, Blaire] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA 90024 USA; [Figueirido, Borja] Univ Malaga, Fac Ciencias, Area Paleontol, Dept Ecol & Geol, E-29071 Malaga, Spain; [Louis, Leeann] Cornell Univ, Museum Vertebrates, Ithaca, NY USA	University of California System; University of California Los Angeles; Universidad de Malaga; Cornell University	Slater, GJ (corresponding author), Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA 90024 USA.	gslater@ucla.edu	Figueirido, Borja/G-9665-2015; Figueirido, Borja/AAV-7882-2020	Figueirido, Borja/0000-0003-2542-3977; Figueirido, Borja/0000-0003-2542-3977; Louis, Leeann/0000-0002-0796-1838	National Science Foundation [NSF 0709792, 0517748]; Ministerio de Cinencia E Innovacion	National Science Foundation(National Science Foundation (NSF)); Ministerio de Cinencia E Innovacion	Funding: The work was funded by the National Science Foundation (http://www.nsf.gov/) NSF 0709792, 0517748; Ministerio de Cinencia E Innovacion (http://www.micinn.es/portal/site/MICINN/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, R LANG ENV STAT COMP; Barnes I, 2002, SCIENCE, V295, P2267, DOI 10.1126/science.1067814; Christiansen P, 2005, J ZOOL, V266, P133, DOI 10.1017/S0952836905006643; COOK SD, 1982, J DENT RES, V61, P25, DOI 10.1177/00220345820610010501; DAVIS D. DWIGHT, 1955, FIELDIANA ZOOL, V37, P25; Derocher AE, 2004, INTEGR COMP BIOL, V44, P163, DOI 10.1093/icb/44.2.163; DESSEM D, 1989, J ANAT, V164, P101; Dumont ER, 2009, J THEOR BIOL, V256, P96, DOI 10.1016/j.jtbi.2008.08.017; Dumont ER, 2005, ANAT REC PART A, V283A, P319, DOI 10.1002/ar.a.20165; Evans AR, 2007, NATURE, V445, P78, DOI 10.1038/nature05433; Farke AA, 2008, J EXP BIOL, V211, P3085, DOI 10.1242/jeb.019042; Figueirido B, 2009, J ZOOL, V277, P70, DOI 10.1111/j.1469-7998.2008.00511.x; Grosse IR, 2007, ANAT REC, V290, P1069, DOI 10.1002/ar.20568; Harmon LJ, 2008, BIOINFORMATICS, V24, P129, DOI 10.1093/bioinformatics/btm538; Howell A.B., 1930, AQUATIC MAMMALS THEI; Jasinoski SC, 2010, J VERTEBR PALEONTOL, V30, P1283, DOI 10.1080/02724634.2010.483556; Joeckel RM, 1998, J VERTEBR PALEONTOL, V18, P627, DOI 10.1080/02724634.1998.10011089; Kangas AT, 2004, NATURE, V432, P211, DOI 10.1038/nature02927; Kavanagh KD, 2007, NATURE, V449, P427, DOI 10.1038/nature06153; Killengreen ST, 2007, BIOL CONSERV, V135, P459, DOI 10.1016/j.biocon.2006.10.039; Krause J, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-220; Kurten B., 1964, Acta Zoologica Fennica, V108, P1; Lindqvist C, 2010, P NATL ACAD SCI USA, V107, P5053, DOI 10.1073/pnas.0914266107; Lister AM, 2004, PHILOS T R SOC B, V359, P221, DOI 10.1098/rstb.2003.1436; McHenry CR, 2007, P NATL ACAD SCI USA, V104, P16010, DOI 10.1073/pnas.0706086104; McPeek MA, 2008, AM NAT, V171, pE158, DOI 10.1086/587076; Moazen M, 2009, P ROY SOC B-BIOL SCI, V276, P39, DOI 10.1098/rspb.2008.0863; Nalla RK, 2003, NAT MATER, V2, P164, DOI 10.1038/nmat832; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Polly PD, 2007, NATURE, V449, P413, DOI 10.1038/449413a; Rayfield EJ, 2004, P ROY SOC B-BIOL SCI, V271, P1451, DOI 10.1098/rspb.2004.2755; Rockwell R, 2008, CAN FIELD NAT, V122, P323, DOI 10.22621/cfn.v122i4.639; Rode KD, 2001, OECOLOGIA, V128, P62, DOI 10.1007/s004420100637; Sacco T, 2004, J ZOOL, V263, P41, DOI 10.1017/S0952836904004856; Slater GJ, 2009, J EVOLUTION BIOL, V22, P2278, DOI 10.1111/j.1420-9101.2009.01845.x; Slater GJ, 2009, J ZOOL, V278, P181, DOI 10.1111/j.1469-7998.2009.00567.x; STIRLING I, 1977, J FISH RES BOARD CAN, V34, P1126, DOI 10.1139/f77-169; Strait DS, 2009, P NATL ACAD SCI USA, V106, P2124, DOI 10.1073/pnas.0808730106; Strait DS, 2005, ANAT REC PART A, V283A, P275, DOI 10.1002/ar.a.20172; Talbot SL, 1996, MOL PHYLOGENET EVOL, V5, P477, DOI 10.1006/mpev.1996.0044; Tanner JB, 2008, BIOL J LINN SOC, V95, P246, DOI 10.1111/j.1095-8312.2008.01052.x; Tannerfeldt M, 2002, OECOLOGIA, V132, P213, DOI 10.1007/s00442-002-0967-8; Tseng ZJ, 2009, BIOL J LINN SOC, V96, P51, DOI 10.1111/j.1095-8312.2008.01095.x; TURNBULL WD, 1970, FIELDIANA GEOLOGY, V18, P149; Verrue V, 2001, EUR J ORTHODONT, V23, P517, DOI 10.1093/ejo/23.5.517; WALL WP, 1983, J PALEONTOL, V57, P197; WERDELIN L, 1989, PALEOBIOLOGY, V15, P387, DOI 10.1017/S009483730000957X; Wroe S, 2008, J ZOOL, V274, P332, DOI 10.1111/j.1469-7998.2007.00389.x; Wroe S, 2007, P ROY SOC B-BIOL SCI, V274, P2819, DOI 10.1098/rspb.2007.0906; [No title captured]; [No title captured]	52	51	51	10	143	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2010	5	11							e13870	10.1371/journal.pone.0013870	http://dx.doi.org/10.1371/journal.pone.0013870			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675OD	21079768	Green Submitted, gold, Green Published			2022-12-27	WOS:000283839100019
J	Kispersky, T; White, JA; Rotstein, HG				Kispersky, Tilman; White, John A.; Rotstein, Horacio G.			The Mechanism of Abrupt Transition between Theta and Hyper-Excitable Spiking Activity in Medial Entorhinal Cortex Layer II Stellate Cells	PLOS ONE			English	Article							SYNCHRONIZED HIPPOCAMPAL BURSTS; MIXED-MODE OSCILLATIONS; GATED ION CHANNELS; SUBTHRESHOLD OSCILLATIONS; INHIBITION; NEURONS; RHYTHM; INTERNEURONS; BIFURCATION; NOISE	Recent studies have shown that stellate cells (SCs) of the medial entorhinal cortex become hyper-excitable in animal models of temporal lobe epilepsy. These studies have also demonstrated the existence of recurrent connections among SCs, reduced levels of recurrent inhibition in epileptic networks as compared to control ones, and comparable levels of recurrent excitation among SCs in both network types. In this work, we investigate the biophysical and dynamic mechanism of generation of the fast time scale corresponding to hyper-excitable firing and the transition between theta and fast firing frequency activity in SCs. We show that recurrently connected minimal networks of SCs exhibit abrupt, threshold-like transition between theta and hyper-excitable firing frequencies as the result of small changes in the maximal synaptic (AMPAergic) conductance. The threshold required for this transition is modulated by synaptic inhibition. Similar abrupt transition between firing frequency regimes can be observed in single, self-coupled SCs, which represent a network of recurrently coupled neurons synchronized in phase, but not in synaptically isolated SCs as the result of changes in the levels of the tonic drive. Using dynamical systems tools (phase-space analysis), we explain the dynamic mechanism underlying the genesis of the fast time scale and the abrupt transition between firing frequency regimes, their dependence on the intrinsic SC's currents and synaptic excitation. This abrupt transition is mechanistically different from others observed in similar networks with different cell types. Most notably, there is no bistability involved. 'In vitro' experiments using single SCs self-coupled with dynamic clamp show the abrupt transition between firing frequency regimes, and demonstrate that our theoretical predictions are not an artifact of the model. In addition, these experiments show that high-frequency firing is burst-like with a duration modulated by an M-current.	[Kispersky, Tilman] Boston Univ, Program Neurosci, Boston, MA 02215 USA; [Kispersky, Tilman] Boston Univ, Ctr BioDynam, Boston, MA 02215 USA; [White, John A.] Univ Utah, Dept Bioengn, Salt Lake City, UT 84112 USA; [Rotstein, Horacio G.] New Jersey Inst Technol, Dept Math Sci, Newark, NJ 07102 USA; [Rotstein, Horacio G.] New Jersey Inst Technol, Ctr Appl Math & Stat, Newark, NJ 07102 USA	Boston University; Boston University; Utah System of Higher Education; University of Utah; New Jersey Institute of Technology; New Jersey Institute of Technology	Kispersky, T (corresponding author), Boston Univ, Program Neurosci, Boston, MA 02215 USA.	horacio@njit.edu		White, John/0000-0003-1073-2638; Rotstein, Horacio/0000-0002-4387-5160	National Science Foundation [DMS-0817241]; National Institute of Neurological Disorders and Stroke; National Institue of Mental Health; National Center for Research Resources; NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR020115] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH085074] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institue of Mental Health; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was partially supported by the National Science Foundation DMS-0817241 (HGR), National Institute of Neurological Disorders and Stroke (JW and TK), National Institue of Mental Health (JW and TK) and National Center for Research Resources (JW and TK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acker CD, 2003, J COMPUT NEUROSCI, V15, P71, DOI 10.1023/A:1024474819512; ALONSO A, 1989, NATURE, V342, P175, DOI 10.1038/342175a0; ALONSO A, 1987, EXP BRAIN RES, V67, P493, DOI 10.1007/BF00247282; Amaral David G., 1995, P443; BAER SM, 1992, SIAM J APPL MATH, V52, P1651, DOI 10.1137/0152095; Bear J, 1996, J NEUROPHYSIOL, V76, P2928, DOI 10.1152/jn.1996.76.5.2928; BEKENSTEIN JW, 1993, SCIENCE, V259, P97, DOI 10.1126/science.8093417; Ben-Menachem Elinor, 2007, Epilepsy Curr, V7, P153, DOI 10.1111/j.1535-7511.2007.00209.x; BROWN DA, 1980, NATURE, V283, P673, DOI 10.1038/283673a0; Burden RL., 1980, NUMERICAL ANAL; Destexhe A, 1994, J Comput Neurosci, V1, P195, DOI 10.1007/BF00961734; Dickson CT, 2000, J NEUROPHYSIOL, V83, P2562, DOI 10.1152/jn.2000.83.5.2562; Dorval AD, 2005, J NEUROSCI, V25, P10025, DOI 10.1523/JNEUROSCI.3557-05.2005; Drover J, 2004, SIAM J APPL MATH, V65, P69, DOI 10.1137/S0036139903431233; DU F, 1995, J NEUROSCI, V15, P6301; Dudman JT, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000290; Eid T, 1999, EXP BRAIN RES, V125, P463, DOI 10.1007/s002210050704; Engel TA, 2008, J NEUROPHYSIOL, V100, P1576, DOI 10.1152/jn.01282.2007; Ermentrout G. B., 2002, SIMULATING ANAL ANIM; Fernandez FR, 2008, J NEUROSCI, V28, P3790, DOI 10.1523/JNEUROSCI.5658-07.2008; Fransen E, 2004, HIPPOCAMPUS, V14, P368, DOI 10.1002/hipo.10198; Fyhn M, 2004, SCIENCE, V305, P1258, DOI 10.1126/science.1099901; Haas JS, 2002, J NEUROPHYSIOL, V88, P2422, DOI 10.1152/jn.00598.2002; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Izhikevich EM, 2001, NEURAL NETWORKS, V14, P883, DOI 10.1016/S0893-6080(01)00078-8; Jalics J, 2010, DYNAM SYST, V25, P445, DOI 10.1080/14689360903535760; Johnston D., 2004, SYNAPTIC ORG BRAIN, V5th, P455; Kahana MJ, 1999, NATURE, V399, P781, DOI 10.1038/21645; Klink R, 1997, J NEUROPHYSIOL, V77, P1829, DOI 10.1152/jn.1997.77.4.1829; Kobayashi M, 2003, J NEUROSCI, V23, P2440; Krupa M, 2001, SIAM J MATH ANAL, V33, P286, DOI 10.1137/S0036141099360919; Kumar SS, 2007, J NEUROSCI, V27, P1239, DOI 10.1523/JNEUROSCI.3182-06.2007; Kumar SS, 2006, J NEUROSCI, V26, P4613, DOI 10.1523/JNEUROSCI.0064-06.2006; Middleton S, 2008, P NATL ACAD SCI USA, V105, P18572, DOI 10.1073/pnas.0809302105; Moser EI, 2008, HIPPOCAMPUS, V18, P1142, DOI 10.1002/hipo.20483; Netoff TI, 2005, J NEUROPHYSIOL, V93, P1197, DOI 10.1152/jn.00982.2004; Richardson MJE, 2003, J NEUROPHYSIOL, V89, P2538, DOI 10.1152/jn.00955.2002; Rotstein HG, 2005, J NEUROPHYSIOL, V94, P1509, DOI 10.1152/jn.00957.2004; Rotstein HG, 2006, J COMPUT NEUROSCI, V21, P271, DOI 10.1007/s10827-006-8096-8; Rotstein HG, 2008, SIAM J APPL DYN SYST, V7, P1582, DOI 10.1137/070699093; Rutishauser U, 2010, NATURE, V464, P903, DOI 10.1038/nature08860; Sargolini F, 2006, SCIENCE, V312, P758, DOI 10.1126/science.1125572; Scharfman HE, 1998, J NEUROPHYSIOL, V80, P3031, DOI 10.1152/jn.1998.80.6.3031; SCHARFMAN HE, 2000, ANN NEW YORK ACAD SC, V911; Schreiber S, 2004, J NEUROPHYSIOL, V92, P408, DOI 10.1152/jn.01116.2003; Schwarcz R, 2000, ANN NY ACAD SCI, V911, P328; SLOVITER RS, 1987, SCIENCE, V235, P73, DOI 10.1126/science.2879352; Sutherland C, 2009, BIOL CYBERN, V100, P475, DOI 10.1007/s00422-009-0298-5; Tolner EA, 2005, J NEUROSCI, V25, P8755, DOI 10.1523/JNEUROSCI.1165-05.2005; TRAUB RD, 1989, SCIENCE, V243, P1319, DOI 10.1126/science.2646715; TRAUB RD, 1987, J NEUROPHYSIOL, V58, P752, DOI 10.1152/jn.1987.58.4.752; TRAUB RD, 1987, J NEUROPHYSIOL, V58, P739, DOI 10.1152/jn.1987.58.4.739; TRAUB RD, 1988, J NEUROPHYSIOL, V60, P1481; Wang XJ, 1999, J NEUROSCI, V19, P9587; Wang XJ, 1996, J NEUROSCI, V16, P6402; Wechselberger M, 2005, SIAM J APPL DYN SYST, V4, P101, DOI 10.1137/030601995; WHITE JA, 1995, BIOPHYS J, V69, P1203, DOI 10.1016/S0006-3495(95)79995-7; White JA, 1998, J NEUROPHYSIOL, V80, P262, DOI 10.1152/jn.1998.80.1.262; White JA., 2001, HDB BIOL PHYS, V4, P257, DOI 10.1016/S1383-8121(01)80011-7; WINSON J, 1978, SCIENCE, V201, P160, DOI 10.1126/science.663646; Yoshida M, 2007, J NEUROPHYSIOL, V98, P2779, DOI 10.1152/jn.00033.2007; Yue CY, 2004, J NEUROSCI, V24, P4614, DOI 10.1523/JNEUROSCI.0765-04.2004	62	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2010	5	11							e13697	10.1371/journal.pone.0013697	http://dx.doi.org/10.1371/journal.pone.0013697			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675NY	21079802	Green Published, gold			2022-12-27	WOS:000283838600003
J	Godet, AN; Guergnon, J; Croset, A; Cayla, X; Falanga, PB; Colle, JH; Garcia, A				Godet, Angelique N.; Guergnon, Julien; Croset, Amelie; Cayla, Xavier; Falanga, Pierre Barthelemy; Colle, Jean-Herve; Garcia, Alphonse			PP2A(1) Binding, Cell Transducing and Apoptotic Properties of Vpr(77-92): A New Functional Domain of HIV-1 Vpr Proteins	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; YEAST SCHIZOSACCHAROMYCES-POMBE; MITOCHONDRIAL-MEMBRANE PERMEABILIZATION; C-TERMINAL DOMAIN; FISSION YEAST; BIOCHEMICAL-MECHANISM; PHOSPHATASE 2A; CYCLE ARREST; G(2) ARREST; EXPRESSION	Background: The hallmark of HIV-1 pathogenesis is the progressive CD4(+) T cell depletion and high propensity of CD4(+) T cells to apoptosis. HIV-1 viral protein R (Vpr) is a major pro-apoptotic gene product. A first Vpr-mediated apoptotic mechanism that requires a physical interaction of HIV-1 Vpr(71-82) mitochondriotoxic domain containing the conserved sequence (71-)HFRIGCRHSRIG(-82) with the Adenine Nucleotide Translocator (ANT) has been characterized. The family of Ser/Thr protein phosphatase PP2A interacts with several viral proteins to regulate cell growth and apoptotic pathways. Previous studies based on yeast two hybrid assays and mutational experiments indicated that PP2A(1) is involved in the induction of G2 arrest by HIV-1 Vpr. Principal Findings: Experiments combining pull-down, cell penetration and apoptosis analyses in distinct human cells indicate that the PP2A(1) binding sequence from Vpr(77-92) is a new cell penetrating apoptotic sequence. We also found that the I84P mutation or the IIQ/VTR83-85 and T89A substitutions in the Vpr(77-92) sequence prevent PP2A(1) binding, cell penetration and apoptosis. In addition the double R77A and R80A mutation known to inactivate the mitochondriotoxic Vpr(71-82) domain, has no effect on the biological properties of the Vpr(77-92) domain. Conclusion: Together our data provide evidence for the first time that the Vpr(77-92) sequence delineates a biological active domain of Vpr with PP2A(1) binding and pro-apopototic capacities and, it is conceivable that this cell penetrating sequence may account for the Vpr internalization in uninfected cells. Finally, our data also implicate the existence of two partially overlapping pro-apoptotic domains in the Vpr C-terminal part, a redundancy that represents a new approach to address the question of biological relevance of HIV-1 Vpr. In this context, future studies will be required to determine the functional relevance of the Vpr(77-92) domain in full length Vpr protein and also in entire HIV provirus.	[Godet, Angelique N.; Guergnon, Julien; Croset, Amelie; Falanga, Pierre Barthelemy; Garcia, Alphonse] Inst Pasteur, Lab Phosphatases E3, Unite Signalisat Mol & Activat Cellulaire, Paris, France; [Cayla, Xavier] Univ Tours, INRA, CNRS, IFR 135,UMR 6175, Nouzilly, France; [Colle, Jean-Herve] CNRS, Inst Pasteur, Unite Biol Populat Lymphocytaires, URA 1961, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Universite de Tours; INRAE; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Godet, AN (corresponding author), Inst Pasteur, Lab Phosphatases E3, Unite Signalisat Mol & Activat Cellulaire, Paris, France.	agarcia@pasteur.fr			Institut-Pasteur; French Government; Caisse Nationale de Maladie (CANAM)	Institut-Pasteur; French Government; Caisse Nationale de Maladie (CANAM)	This work was supported by the Institut-Pasteur. A.N.G. is a recipient of a Ministere Recherche et Technique (MRT) fellowship from the French Government. A. C. was supported by Institut-Pasteur. J.G. was supported by Caisse Nationale de Maladie (CANAM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alimonti JB, 2003, J GEN VIROL, V84, P1649, DOI 10.1099/vir.0.19110-0; Andersen JL, 2008, EXP MOL PATHOL, V85, P2, DOI 10.1016/j.yexmp.2008.03.015; Andersen JL, 2006, PLOS PATHOG, V2, P1106, DOI 10.1371/journal.ppat.0020127; Arunagiri C, 1997, APOPTOSIS, V2, P69, DOI 10.1023/A:1026487609215; BOSCH M, 1995, EUR J BIOCHEM, V230, P1037, DOI 10.1111/j.1432-1033.1995.tb20653.x; Bourbigot S, 2005, BIOCHEM J, V387, P333, DOI 10.1042/BJ20041759; Chen MZ, 1999, J VIROL, V73, P3236, DOI 10.1128/JVI.73.4.3236-3245.1999; Coeytaux E, 2003, J BIOL CHEM, V278, P18110, DOI 10.1074/jbc.M300248200; Deniaud A, 2004, MITOCHONDRION, V4, P223, DOI 10.1016/j.mito.2004.06.012; DENORONHA C, 1993, MOL BIOL CELL; Elder RT, 2001, VIROLOGY, V287, P359, DOI 10.1006/viro.2001.1007; EVERALL IP, 1993, J NEUROL NEUROSUR PS, V56, P481, DOI 10.1136/jnnp.56.5.481; Frank R, 1996, Methods Mol Biol, V66, P149; Fuller RA, 2004, BMC NEUROSCI, V5, DOI 10.1186/1471-2202-5-10; Garcia A, 2003, BIOCHIMIE, V85, P721, DOI 10.1016/j.biochi.2003.09.004; Guergnon J, 2006, MOL PHARMACOL, V69, P1115, DOI 10.1124/mol.105.019364; Guergnon J, 2006, APOPTOSIS, V11, P1263, DOI 10.1007/s10495-006-7702-6; Huang MB, 2000, J NEUROVIROL, V6, P202, DOI 10.3109/13550280009015823; Jacotot E, 2001, J EXP MED, V193, P509, DOI 10.1084/jem.193.4.509; Jacotot E, 2000, J EXP MED, V191, P33, DOI 10.1084/jem.191.1.33; Janoo A, 2005, J CELL BIOCHEM, V94, P816, DOI 10.1002/jcb.20347; Jones GJ, 2007, J NEUROSCI, V27, P3703, DOI 10.1523/JNEUROSCI.5522-06.2007; Lamine A, 2007, AIDS, V21, P1043, DOI 10.1097/QAD.0b013e3280d5a7ac; LEVY DN, 1995, J VIROL, V69, P1243, DOI 10.1128/JVI.69.2.1243-1252.1995; LEVY DN, 1994, P NATL ACAD SCI USA, V91, P10873, DOI 10.1073/pnas.91.23.10873; Li G, 2007, J BIOL CHEM, V282, P7287, DOI 10.1074/jbc.M607951200; Lum JJ, 2003, J CLIN INVEST, V111, P1547, DOI 10.1172/JCI200316233; Masuda M, 2000, J VIROL, V74, P2636, DOI 10.1128/JVI.74.6.2636-2646.2000; Patel CA, 2002, J NEUROVIROL, V8, P86, DOI 10.1080/13550280290049552; Piller SC, 1999, J VIROL, V73, P4230, DOI 10.1128/JVI.73.5.4230-4238.1999; RE F, 1995, J VIROL, V69, P6859, DOI 10.1128/JVI.69.11.6859-6864.1995; Romani B, 2009, J GEN VIROL, V90, P1795, DOI 10.1099/vir.0.011726-0; Sabbah EN, 2005, J NEUROVIROL, V11, P489, DOI 10.1080/13550280500384941; Schwarze SR, 1999, SCIENCE, V285, P1569, DOI 10.1126/science.285.5433.1569; Sontag E, 2007, J NEUROSCI, V27, P2751, DOI 10.1523/JNEUROSCI.3316-06.2007; Stewart SA, 1997, J VIROL, V71, P5579, DOI 10.1128/JVI.71.7.5579-5592.1997; Taguchi T, 2004, BIOCHEM BIOPH RES CO, V320, P18, DOI 10.1016/j.bbrc.2004.05.126; TAKADORIKONDO A, 1996, INT C AIDS, V11, P22; TRISTEM M, 1992, EMBO J, V11, P3405, DOI 10.1002/j.1460-2075.1992.tb05419.x; Virshup DM, 2009, MOL CELL, V33, P537, DOI 10.1016/j.molcel.2009.02.015; WAELKENS E, 1987, J BIOL CHEM, V262, P1049; Wheeler EDA, 2006, J NEUROVIROL, V12, P200, DOI 10.1080/13550280600827377; ZHAO LJ, 1994, J BIOL CHEM, V269, P32131; ZHAO LJ, 1994, J BIOL CHEM, V269, P15577; Zhao YQ, 1996, J VIROL, V70, P5821, DOI 10.1128/JVI.70.9.5821-5826.1996	45	25	26	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2010	5	11							e13760	10.1371/journal.pone.0013760	http://dx.doi.org/10.1371/journal.pone.0013760			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673FY	21072166	gold, Green Published, Green Submitted			2022-12-27	WOS:000283645700001
J	Desiderio, UV; Zhu, XL; Evans, JP				Desiderio, Ulyana V.; Zhu, Xiaoling; Evans, Janice P.			ADAM2 Interactions with Mouse Eggs and Cell Lines Expressing alpha(4)/alpha(9) (ITGA4/ITGA9) Integrins: Implications for Integrin-Based Adhesion and Fertilization	PLOS ONE			English	Article							SEQUENCE-SPECIFIC INTERACTION; DISINTEGRIN-LIKE DOMAIN; HETERODIMERIC DISINTEGRIN; PLATELET-AGGREGATION; NEUTROPHIL MIGRATION; BIOLOGICAL FUNCTION; ALPHA(V) INTEGRINS; REPRODUCTIVE ADAMS; BETA(1) INTEGRIN; N-GLYCOSYLATION	Background: Integrins are heterodimeric cell adhesion molecules, with 18 alpha (ITGA) and eight beta (ITGB) subunits forming 24 heterodimers classified into five families. Certain integrins, especially the alpha(4)/alpha(9) (ITGA4/ITGA9) family, interact with members of the ADAM (a disintegrin and metalloprotease) family. ADAM2 is among the better characterized and also of interest because of its role in sperm function. Having shown that ITGA9 on mouse eggs participates in mouse sperm-egg interactions, we sought to characterize ITGA4/ITGA9-ADAM2 interactions. Methodology/Principal Findings: An anti-beta(1)/ITGB1 function-blocking antibody that reduces sperm-egg binding significantly inhibited ADAM2 binding to mouse eggs. Analysis of integrin subunit expression indicates that mouse eggs could express at least ten different integrins, five in the RGD-binding family, two in the laminin-binding family, two in the collagen-binding family, and ITGA9-ITGB1. Adhesion assays to characterize ADAM2 interactions with ITGA4/ITGA9 family members produced the surprising result that RPMI 8866 cell adhesion to ADAM2 was inhibited by an anti-ITGA9 antibody, noteworthy because ITGA9 has only been reported to dimerize with ITGB1, and RPMI 8866 cells lack detectable ITGB1. Antibody and siRNA studies demonstrate that ITGB7 is the beta subunit contributing to RPMI 8866 adhesion to ADAM2. Conclusions/Significance: These data indicate that a novel integrin alpha-beta combination, ITGA9-ITGB7 (alpha(9)beta(7)), in RPMI 8866 cells functions as a binding partner for ADAM2. ITGA9 had previously only been reported to dimerize with ITGB1. Although ITGA9-ITGB7 is unlikely to be a widely expressed integrin and appears to be the result of "compensatory dimerization" occurring in the context of little/no ITGB1 expression, the data indicate that ITGA9-ITGB7 functions as an ADAM binding partner in certain cellular contexts, with implications for mammalian fertilization and integrin function.	[Desiderio, Ulyana V.; Zhu, Xiaoling; Evans, Janice P.] Johns Hopkins Univ, Dept Biochem & Mol Biol, Bloomberg Sch Publ Hlth, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Desiderio, UV (corresponding author), Johns Hopkins Univ, Dept Biochem & Mol Biol, Bloomberg Sch Publ Hlth, Baltimore, MD 21218 USA.	jpevans@jhsph.edu	Evans, Janice/Q-8483-2019		National Institutes of Health [R01 HD037696]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD037696] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was funded by grant # R01 HD037696 from the National Institutes of Health to the corresponding author. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALMEIDA EAC, 1995, CELL, V81, P1095, DOI 10.1016/S0092-8674(05)80014-5; ANDERSON DJ, 1993, P NATL ACAD SCI USA, V90, P10051, DOI 10.1073/pnas.90.21.10051; ANDREW DP, 1994, J IMMUNOL, V153, P3847; Arribas J, 2006, CANCER METAST REV, V25, P57, DOI 10.1007/s10555-006-7889-6; Baessler KA, 2009, ACS CHEM BIOL, V4, P357, DOI 10.1021/cb900013d; Bigler D, 2000, J BIOL CHEM, V275, P11576, DOI 10.1074/jbc.275.16.11576; BJARNASON J, 1995, SNAKE */* REPROLYSIN, V248, P345; Brando C, 2000, BIOCHEM BIOPH RES CO, V267, P413, DOI 10.1006/bbrc.1999.1897; Bridges LC, 2005, BIOCHEM J, V387, P101, DOI 10.1042/BJ20041444; Bridges LC, 2003, BIOCHEMISTRY-US, V42, P3734, DOI 10.1021/bi026871y; CAMPBELL S, 1995, HUM REPROD, V10, P1571, DOI 10.1093/HUMREP/10.6.1571; Chen MS, 1999, P NATL ACAD SCI USA, V96, P11830, DOI 10.1073/pnas.96.21.11830; Cho CH, 2000, DEV BIOL, V222, P289, DOI 10.1006/dbio.2000.9703; Conesa M, 2003, BIOCHEM J, V370, P703, DOI 10.1042/BJ20021301; Danen EHJ, 2003, J PATHOL, V200, P471, DOI 10.1002/path.1416; Danen EHJ, 2007, ENCY LIFE SCI; deNadai C, 1996, ZYGOTE, V4, P31, DOI 10.1017/S0967199400002860; Desgrosellier JS, 2010, NAT REV CANCER, V10, P9, DOI 10.1038/nrc2748; Duffy MJ, 2009, CLIN CANCER RES, V15, P1140, DOI 10.1158/1078-0432.CCR-08-1585; Duffy MJ, 2003, THROMB HAEMOSTASIS, V89, P622; Edwards DR, 2008, MOL ASPECTS MED, V29, P258, DOI 10.1016/j.mam.2008.08.001; ERLE DJ, 1994, J IMMUNOL, V153, P517; Eto K, 2002, J BIOL CHEM, V277, P17804, DOI 10.1074/jbc.M200086200; Evans JP, 1997, DEV BIOL, V187, P79, DOI 10.1006/dbio.1997.8611; EVANS JP, 1995, MOL REPROD DEV, V40, P211, DOI 10.1002/mrd.1080400210; Evsikov AV, 2006, GENE DEV, V20, P2713, DOI 10.1101/gad.1471006; FITZGERALD LA, 1987, J BIOL CHEM, V262, P3936; Fujihara Y, 2010, J CELL SCI, V123, P1531, DOI 10.1242/jcs.067363; FUSI FM, 1993, MOL REPROD DEV, V36, P212, DOI 10.1002/mrd.1080360212; Glazar AI, 2009, REPROD FERT DEVELOP, V21, P293, DOI 10.1071/RD08158; Han C, 2009, BIOL REPROD, V80, P1001, DOI 10.1095/biolreprod.108.073700; He ZY, 2003, DEV BIOL, V254, P226, DOI 10.1016/S0012-1606(02)00043-X; HEINO J, 1989, J BIOL CHEM, V264, P380; HOLZMANN B, 1989, CELL, V56, P37, DOI 10.1016/0092-8674(89)90981-1; Huang J, 2005, MOL BIOL CELL, V16, P4982, DOI 10.1091/mbc.E05-03-0258; Hughes AL, 2001, J MOL EVOL, V52, P63, DOI 10.1007/s002390010134; Huhtala M, 2005, MATRIX BIOL, V24, P83, DOI 10.1016/j.matbio.2005.01.003; Humphries MJ, 2001, MOL BIOTECHNOL, V18, P57, DOI 10.1385/MB:18:1:57; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Ikawa M, 2010, J CLIN INVEST, V120, P984, DOI 10.1172/JCI41585; Isaji T, 2006, J BIOL CHEM, V281, P33258, DOI 10.1074/jbc.M607771200; Isaji T, 2009, J BIOL CHEM, V284, P12207, DOI 10.1074/jbc.M807920200; JASPERS M, 1994, FEBS LETT, V353, P239, DOI 10.1016/0014-5793(94)01054-4; Jia LG, 1997, J BIOL CHEM, V272, P13094, DOI 10.1074/jbc.272.20.13094; Kim T, 2006, BIOL REPROD, V74, P744, DOI 10.1095/biolreprod.105.048892; Koistinen P, 2002, J BIOL CHEM, V277, P24835, DOI 10.1074/jbc.M203149200; Li YH, 2004, REPRODUCTION, V127, P151, DOI 10.1530/rep.1.00006; Lin X, 2006, PROTEINS, V65, P274, DOI 10.1002/prot.21072; Linfor J, 2000, J REPROD FERTIL, V120, P65, DOI 10.1530/reprod/120.1.65; Lu X., 2007, Cardiovascular & Hematological Agents in Medicinal Chemistry, V5, P29; Marcinkiewicz C, 1999, J BIOL CHEM, V274, P12468, DOI 10.1074/jbc.274.18.12468; Marcinkiewicz C, 2000, J BIOL CHEM, V275, P31930, DOI 10.1074/jbc.M003209200; Mariano-Oliveira A, 2003, EUR J BIOCHEM, V270, P4799, DOI 10.1046/j.1432-1033.2003.03867.x; Miller BJ, 2000, J CELL BIOL, V149, P1289, DOI 10.1083/jcb.149.6.1289; MIYAKE K, 1991, J EXP MED, V173, P599, DOI 10.1084/jem.173.3.599; Nishimura H, 2001, DEV BIOL, V233, P204, DOI 10.1006/dbio.2001.0166; NISHIMURA SL, 1994, J BIOL CHEM, V269, P28708; NOTO K, 1995, INT IMMUNOL, V7, P835, DOI 10.1093/intimm/7.5.835; PALMER EL, 1993, J CELL BIOL, V123, P1289, DOI 10.1083/jcb.123.5.1289; PASQUALINI R, 1993, J CELL SCI, V105, P101; Pate BJ, 2007, MOL REPROD DEV, V74, P600, DOI 10.1002/mrd.20649; Paulissen G, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-127; Rao HW, 2006, J BONE MINER RES, V21, P1657, DOI 10.1359/JBMR.060718; Retta SF, 2001, MOL BIOL CELL, V12, P3126, DOI 10.1091/mbc.12.10.3126; Reynolds LE, 2002, NAT MED, V8, P27, DOI 10.1038/nm0102-27; RUEGG C, 1992, J CELL BIOL, V117, P179, DOI 10.1083/jcb.117.1.179; Schwander M, 2003, DEV CELL, V4, P673, DOI 10.1016/S1534-5807(03)00118-7; Sengoku K, 2004, HUM REPROD, V19, P639, DOI 10.1093/humrep/deh095; Staniszewska I, 2008, J CELL SCI, V121, P504, DOI 10.1242/jcs.000232; Stein KK, 2005, BIOL REPROD, V73, P1032, DOI 10.1095/biolreprod.105.040972; SUZUKI S, 1986, P NATL ACAD SCI USA, V83, P8614, DOI 10.1073/pnas.83.22.8614; Takada Y, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-215; Takahashi Y, 2001, MOL BIOL CELL, V12, P809, DOI 10.1091/mbc.12.4.809; Taooka Y, 1999, J CELL BIOL, V145, P413, DOI 10.1083/jcb.145.2.413; TARONE G, 1993, DEVELOPMENT, V117, P1369; TEIXIDO J, 1992, J BIOL CHEM, V267, P1786; Tomczuk M, 2003, EXP CELL RES, V290, P68, DOI 10.1016/S0014-4827(03)00307-0; Vjugina U, 2008, FRONT BIOSCI-LANDMRK, V13, P462, DOI 10.2741/2693; Vjugina U, 2009, BIOL REPROD, V80, P833, DOI 10.1095/biolreprod.108.075275; WANG A, 1995, DEV DYNAM, V204, P421, DOI 10.1002/aja.1002040408; Wang A, 1996, AM J RESP CELL MOL, V15, P664, DOI 10.1165/ajrcmb.15.5.8918373; Webb DL, 1996, J CELL BIOCHEM, V61, P127, DOI 10.1002/(SICI)1097-4644(19960401)61:1<127::AID-JCB14>3.0.CO;2-L; WERB Z, 1989, J CELL BIOL, V109, P877, DOI 10.1083/jcb.109.2.877; WILKINS J, 1993, CELL IMMUNOL, V146, P313, DOI 10.1006/cimm.1993.1029; Williams CJ, 1996, MOL REPROD DEV, V44, P315, DOI 10.1002/(SICI)1098-2795(199607)44:3&lt;315::AID-MRD5&gt;3.0.CO;2-P; Wright N, 2002, J IMMUNOL, V168, P5268, DOI 10.4049/jimmunol.168.10.5268; Yang JT, 1996, MOL BIOL CELL, V7, P1737, DOI 10.1091/mbc.7.11.1737; Yang Y, 1998, EUR J IMMUNOL, V28, P995, DOI 10.1002/(SICI)1521-4141(199803)28:03<995::AID-IMMU995>3.0.CO;2-D; YOKOSAKI Y, 1994, J BIOL CHEM, V269, P26691; You WK, 2003, BIOCHEM BIOPH RES CO, V309, P637, DOI 10.1016/j.bbrc.2003.08.049; Zeller Y, 1998, J BIOL CHEM, V273, P6786, DOI 10.1074/jbc.273.12.6786; Zhu XL, 2000, J BIOL CHEM, V275, P7677, DOI 10.1074/jbc.275.11.7677; Zhu XL, 2002, BIOL REPROD, V66, P1193, DOI 10.1095/biolreprod66.4.1193; Ziyyat A, 2006, J CELL SCI, V119, P416, DOI 10.1242/jcs.02730	94	18	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2010	5	10							e13744	10.1371/journal.pone.0013744	http://dx.doi.org/10.1371/journal.pone.0013744			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673FU	21060781	Green Published, gold, Green Submitted			2022-12-27	WOS:000283645300024
J	Chadefaux, T; Helbing, D				Chadefaux, Thomas; Helbing, Dirk			How Wealth Accumulation Can Promote Cooperation	PLOS ONE			English	Article							PRISONERS-DILEMMA GAME; PUBLIC-GOODS GAMES; EVOLUTIONARY GAMES; INDIRECT RECIPROCITY; NETWORKS; EMERGENCE	Explaining the emergence and stability of cooperation has been a central challenge in biology, economics and sociology. Unfortunately, the mechanisms known to promote it either require elaborate strategies or hold only under restrictive conditions. Here, we report the emergence, survival, and frequent domination of cooperation in a world characterized by selfishness and a strong temptation to defect, when individuals can accumulate wealth. In particular, we study games with local adaptation such as the prisoner's dilemma, to which we add heterogeneity in payoffs. In our model, agents accumulate wealth and invest some of it in their interactions. The larger the investment, the more can potentially be gained or lost, so that present gains affect future payoffs. We find that cooperation survives for a far wider range of parameters than without wealth accumulation and, even more strikingly, that it often dominates defection. This is in stark contrast to the traditional evolutionary prisoner's dilemma in particular, in which cooperation rarely survives and almost never thrives. With the inequality we introduce, on the contrary, cooperators do better than defectors, even without any strategic behavior or exogenously imposed strategies. These results have important consequences for our understanding of the type of social and economic arrangements that are optimal and efficient.	[Chadefaux, Thomas; Helbing, Dirk] ETH, Chair Sociol Modeling & Simulat, CLU E1, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Chadefaux, T (corresponding author), ETH, Chair Sociol Modeling & Simulat, CLU E1, Zurich, Switzerland.	thomas.chadefaux@gess.ethz.ch		Chadefaux, Thomas/0000-0002-8456-8124	European Commission [231200]; Center for the Study of Complex Systems at the University of Michigan	European Commission(European CommissionEuropean Commission Joint Research Centre); Center for the Study of Complex Systems at the University of Michigan(University of Michigan System)	This work was partially supported by the Future and Emerging Technologies programme (FP7-COSI-ICT) of the European Commission through the project QLectives (grant number 231200). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We wish to thank Robert Axelrod, Rick Riolo and Sergi Lozano for useful comments and discussions. We are also grateful to the Center for the Study of Complex Systems at the University of Michigan for its support.	Abramson G, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.030901; AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Collier P, 2004, OXFORD ECON PAP, V56, P563, DOI 10.1093/oep/gpf064; Guan JY, 2006, EUROPHYS LETT, V76, P1214, DOI 10.1209/epl/i2006-10381-4; Hauert C, 2004, NATURE, V428, P643, DOI 10.1038/nature02360; Hauert C, 2002, SCIENCE, V296, P1129, DOI 10.1126/science.1070582; Helbing D, 2010, P NATL ACAD SCI USA, V107, P5265, DOI 10.1073/pnas.1000140107; Helbing D, 2009, P NATL ACAD SCI USA, V106, P3680, DOI 10.1073/pnas.0811503106; Holme P, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.030901; HUBERMAN BA, 1993, P NATL ACAD SCI USA, V90, P7716, DOI 10.1073/pnas.90.16.7716; Masuda N, 2007, P R SOC B, V274, P1815, DOI 10.1098/rspb.2007.0294; McNamara JM, 2004, NATURE, V428, P745, DOI 10.1038/nature02432; MERTON RK, 1968, SCIENCE, V159, P56, DOI 10.1126/science.159.3810.56; Nowak MA, 2005, NATURE, V437, P1291, DOI 10.1038/nature04131; NOWAK MA, 1992, NATURE, V359, P826, DOI 10.1038/359826a0; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Ohtsuki H, 2004, J THEOR BIOL, V231, P107, DOI 10.1016/j.jtbi.2004.06.005; Ohtsuki H, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.108106; Oosterbeek H, 2004, EXP ECON, V7, P171, DOI 10.1023/B:EXEC.0000026978.14316.74; Perc M, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.011904; Roca CP, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.046106; Rong ZH, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.027101; Santos FC, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.098104; Santos FC, 2006, J EVOLUTION BIOL, V19, P726, DOI 10.1111/j.1420-9101.2005.01063.x; Santos FC, 2008, NATURE, V454, P213, DOI 10.1038/nature06940; Szabo G, 2007, PHYS REP, V446, P97, DOI 10.1016/j.physrep.2007.04.004; Szolnoki A, 2008, PHYSICA A, V387, P2075, DOI 10.1016/j.physa.2007.11.021; Tomassini M, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.016132; Traulsen A, 2010, P NATL ACAD SCI USA, V107, P2962, DOI 10.1073/pnas.0912515107; Wu ZX, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.041114; Wu ZX, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.021107; Yang HX, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.056107	33	17	17	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2010	5	10							e13471	10.1371/journal.pone.0013471	http://dx.doi.org/10.1371/journal.pone.0013471			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671UN	21048947	Green Published, Green Submitted, gold			2022-12-27	WOS:000283537000002
J	Kam, M; Degen, AA; Khokhlova, IS; Krasnov, BR; Geffen, E				Kam, Michael; Degen, A. Allan; Khokhlova, Irina S.; Krasnov, Boris R.; Geffen, Eli			Do Fleas Affect Energy Expenditure of Their Free-Living Hosts?	PLOS ONE			English	Article							LABELED WATER METHOD; IMMUNE-RESPONSE; THERMOREGULATORY RESPONSES; DESERT RODENT; LIFE-HISTORY; PARASITISM; COSTS; ECTOPARASITES; INFESTATION; TITS	Background: Parasites can cause energetically costly behavioural and immunological responses which potentially can reduce host fitness. However, although most laboratory studies indicate that the metabolic rate of the host increases with parasite infestation, this has never been shown in free-living host populations. In fact, studies thus far have shown no effect of parasitism on field metabolic rate (FMR). Methodology and Results: We tested the effect of parasites on the energy expenditure of a host by measuring FMR using doubly-labelled water in free-living Baluchistan gerbils (Gerbillus nanus) infested by naturally occurring fleas during winter, spring and summer. We showed for the first time that FMR of free-living G. nanus was significantly and positively correlated with parasite load in spring when parasite load was highest; this relationship approached significance in summer when parasite load was lowest but was insignificant in winter. Among seasons, winter FMRs were highest and summer FMRs were lowest in G. nanus. Discussion: The lack of parasite effect on FMR in winter could be related to the fact that FMR rates were highest among seasons. In this season, thermoregulatory costs are high which may indicate that less energy could be allocated to defend against parasites or to compensate for other costly activities. The question about the cost of parasitism in nature is now one of the major themes in ecological physiology. Our study supports the hypothesis that parasites can elevate FMR of their hosts, at least under certain conditions. However, the effect is complex and factors such as season and parasite load are involved.	[Kam, Michael; Degen, A. Allan; Khokhlova, Irina S.] Ben Gurion Univ Negev, Wyler Dept Dryland Agr, Jacob Blaustein Inst Desert Res, IL-84105 Beer Sheva, Israel; [Krasnov, Boris R.] Ben Gurion Univ Negev, Mitrani Dept Desert Ecol, Jacob Blaustein Inst Desert Res, Midreshet Ben Gurion, Israel; [Geffen, Eli] Tel Aviv Univ, Dept Zool, IL-69978 Tel Aviv, Israel	Ben Gurion University; Ben Gurion University; Tel Aviv University	Kam, M (corresponding author), Ben Gurion Univ Negev, Wyler Dept Dryland Agr, Jacob Blaustein Inst Desert Res, IL-84105 Beer Sheva, Israel.	mkam@bgu.ac.il	Krasnov, Boris R./ABG-8403-2021; Khokhlova, Irina/F-2235-2012; Krasnov, Boris R./F-2234-2012; Kam, Michael/Q-8764-2019	Krasnov, Boris R./0000-0002-0382-3331; Khokhlova, Irina/0000-0003-0169-7770; Krasnov, Boris R./0000-0002-0382-3331; Kam, Michael/0000-0002-1062-7654	Israel Scientific Foundation (ISF) [1171/07]; Bi-National Science Foundation, USA - Israel	Israel Scientific Foundation (ISF)(Israel Science Foundation); Bi-National Science Foundation, USA - Israel(US-Israel Binational Science Foundation)	This study was funded by the Israel Scientific Foundation (ISF) under grant number 1171/07 and the Bi-National Science Foundation, USA - Israel. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOOTH DT, 1993, P ROY SOC B-BIOL SCI, V253, P125, DOI 10.1098/rspb.1993.0091; Careau V, 2010, OECOLOGIA, V162, P303, DOI 10.1007/s00442-009-1466-y; Charmantier A, 2004, EVOLUTION, V58, P203, DOI 10.1111/j.0014-3820.2004.tb01588.x; COX FEG, 1981, NATURE, V294, P515, DOI 10.1038/294515a0; De Bellocq JG, 2006, FUNCT ECOL, V20, P637, DOI 10.1111/j.1365-2435.2006.01140.x; Degen A. A, 1997, ECOPHYSIOLOGY SMALL, P93; Degen AA, 2006, MICROMAMMALS AND MACROPARASITES: FROM EVOLUTIONARY ECOLOGY TO MANAGEMENT, P371, DOI 10.1007/978-4-431-36025-4_19; DEGEN AA, 1995, ECOSCIENCE, V2, P48, DOI 10.1080/11956860.1995.11682268; Degen AA, 1997, FUNCT ECOL, V11, P53, DOI 10.1046/j.1365-2435.1997.00059.x; DELOPE F, 1993, OECOLOGIA, V95, P234, DOI 10.1007/BF00323495; Demas GE, 1997, AM J PHYSIOL-REG I, V273, pR1631, DOI 10.1152/ajpregu.1997.273.5.R1631; Devevey G, 2008, FUNCT ECOL, V22, P1091, DOI 10.1111/j.1365-2435.2008.01493.x; Faro CJ, 2000, AM J PHYSIOL-REG I, V278, pR118, DOI 10.1152/ajpregu.2000.278.1.R118; Fitze PS, 2004, ECOLOGY, V85, P2018, DOI 10.1890/03-0138; Fitze PS, 2004, J ANIM ECOL, V73, P216, DOI 10.1111/j.0021-8790.2004.00799.x; Gallizzi K, 2008, BEHAV ECOL, V19, P1225, DOI 10.1093/beheco/arn083; Gallizzi K, 2008, AUK, V125, P915, DOI 10.1525/auk.2008.07175; Giorgi MS, 2001, P ROY SOC B-BIOL SCI, V268, P2071, DOI 10.1098/rspb.2001.1686; Haim A, 1998, COMP BIOCHEM PHYS A, V120, P187, DOI 10.1016/S1095-6433(98)10030-2; Hawlena H, 2006, PARASITOLOGY, V133, P187, DOI 10.1017/S0031182006000308; Hawlena H, 2006, FUNCT ECOL, V20, P1028, DOI 10.1111/j.1365-2435.2006.01190.x; HUNTER DM, 1974, CAN J ZOOL, V52, P209, DOI 10.1139/z74-025; KAM M, 1997, AM J PHYSIOL-REG I, V272, pR1336; Khokhlova IS, 2002, J ZOOL, V258, P349, DOI 10.1017/S0952836902001498; Khokhlova IS, 2004, J EXP BIOL, V207, P2725, DOI 10.1242/jeb.01090; Krasnov B, 2002, ECOLOGY, V83, P164, DOI 10.1890/0012-9658(2002)083[0164:TEOHDO]2.0.CO;2; KRASNOV B. R., 2008, FUNCTIONAL EVOLUTION; Krasnov BR, 2006, PARASITOL RES, V99, P541, DOI 10.1007/s00436-006-0201-4; Kyriazakis I, 1998, ANIM BEHAV, V56, P265, DOI 10.1006/anbe.1998.0761; LEHMANN T, 1994, J MED ENTOMOL, V31, P257, DOI 10.1093/jmedent/31.2.257; LIFSON N, 1966, J THEOR BIOL, V12, P46, DOI 10.1016/0022-5193(66)90185-8; Lochmiller RL, 2000, OIKOS, V88, P87, DOI 10.1034/j.1600-0706.2000.880110.x; Lovegrove BG, 2005, J COMP PHYSIOL B, V175, P231, DOI 10.1007/s00360-005-0477-1; MOLLER AP, 1994, OECOLOGIA, V98, P263, DOI 10.1007/BF00324213; Moret Y, 2000, SCIENCE, V290, P1166, DOI 10.1126/science.290.5494.1166; NAGY KA, 1980, AM J PHYSIOL, V238, pR466; Nagy KA, 1983, UCLA PUBL; Nilsson JA, 2003, BEHAV ECOL, V14, P175, DOI 10.1093/beheco/14.2.175; Raberg L, 2000, ECOL LETT, V3, P382, DOI 10.1046/j.1461-0248.2000.00154.x; Robbins C.T., 1983, WILDLIFE FEEDING NUT; Scantlebury M, 2007, P ROY SOC B-BIOL SCI, V274, P2169, DOI 10.1098/rspb.2007.0690; Stern E., 1986, ATLAS NEGEV; Tripet F, 2002, IBIS, V144, P461, DOI 10.1046/j.1474-919X.2002.00018.x; Tripet F, 2008, TRENDS PARASITOL, V24, P219, DOI 10.1016/j.pt.2008.02.008; Tschirren B, 2006, P ROY SOC B-BIOL SCI, V273, P1773, DOI 10.1098/rspb.2006.3524; UNESCO, 1977, 7 UNESCO MAB	46	16	16	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2010	5	10							e13686	10.1371/journal.pone.0013686	http://dx.doi.org/10.1371/journal.pone.0013686			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671UN	21060688	Green Submitted, Green Published, gold			2022-12-27	WOS:000283537000051
J	Mejia, JS; Toot-Zimmer, AL; Schultheiss, PC; Beaty, BJ; Titus, RG				Mejia, J. Santiago; Toot-Zimmer, Amanda L.; Schultheiss, Patricia C.; Beaty, Barry J.; Titus, Richard G.			BluePort: A Platform to Study the Eosinophilic Response of Mice to the Bite of a Vector of Leishmania Parasites, Lutzomyia longipalpis Sand Flies	PLOS ONE			English	Article							EXPERIMENTAL CUTANEOUS LEISHMANIASIS; VISCERAL LEISHMANIASIS; IMMUNE-RESPONSE; NATURAL MODEL; FLY SALIVA; INFECTION; NEUTROPHILS; PROTEINS; IDENTIFICATION; TRANSCRIPTOME	Background: Visceral Leishmaniasis is a serious human disease transmitted, in the New World, by Lutzomyia longipalpis sand flies. Natural resistance to Leishmania transmission in residents of endemic areas has been attributed to the acquisition of immunity to sand fly salivary proteins. One theoretical way to accelerate the acquisition of this immunity is to increase the density of antigen-presenting cells at the sand fly bite site. Here we describe a novel tissue platform that can be used for this purpose. Methodology/Principal Findings: BluePort is a well-vascularized and macrophage-rich compartment induced in the subcutaneous tissue of mice via injection of agarose beads covered with Cibacron blue. We describe the sequence of inflammatory events leading to its formation and how it can be used to study the dermal response to the bite of L. longipalpis sand flies. Results presented indicate that a shift in the inflammatory response, from neutrophilic to eosinophilic, is the main histopathological feature associated with the immunity acquired through repeated exposure to the bite of sand flies, and that the BluePort tissue compartment could be used to accelerate this process. In addition, changes observed inside the BluePort parenchyma indicate that it could be used to study complex immunobiological processes, and to develop ectopic secondary lymphoid structures. Conclusions/Significance: Understanding the characteristics of the dermal response to the bite of sand flies is a critical element of strategies to control leishmaniasis using vaccines that target salivary proteins. Finding that dermal eosinophilia is such a prominent component of the anti-salivary immunity induced by repeated exposure to sand fly bites raises one important consideration: how to avoid the immunological conflict derived from a protective Th2-driven immunity directed to sand fly saliva with a protective Th1-driven immunity directed to the parasite. The BluePort platform is an ideal tool to address experimentally this conundrum.	[Mejia, J. Santiago; Toot-Zimmer, Amanda L.; Schultheiss, Patricia C.; Titus, Richard G.] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA; [Beaty, Barry J.] Colorado State Univ, MicroRx Infect Dis Supercluster, Ft Collins, CO 80523 USA	Colorado State University; Colorado State University	Mejia, JS (corresponding author), Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.	jsmejia@colostate.edu	Mejia, J. Santiago/E-2552-2012		National Institutes of Health [AI 065784]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI065784] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a grant from the National Institutes of Health (AI 065784). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmann F, 2007, INT ARCH ALLERGY IMM, V142, P99, DOI 10.1159/000096114; Andrade BB, 2007, SCAND J IMMUNOL, V66, P122, DOI 10.1111/j.1365-3083.2007.01964.x; BARRALNETTO M, 1987, AM J PATHOL, V127, P271; Belkaid Y, 1998, J EXP MED, V188, P1941, DOI 10.1084/jem.188.10.1941; Belkaid Y, 2000, J IMMUNOL, V165, P969, DOI 10.4049/jimmunol.165.2.969; Brinkmann V, 2007, NAT REV MICROBIOL, V5, P577, DOI 10.1038/nrmicro1710; Calvo E, 2006, J BIOL CHEM, V281, P1935, DOI 10.1074/jbc.M510359200; Champagne Donald E., 2004, Current Drug Targets - Cardiovascular & Haematological Disorders, V4, P375, DOI 10.2174/1568006043335862; Chang KP, 2003, ACTA TROP, V85, P375, DOI 10.1016/S0001-706X(02)00238-3; Charmoy M, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/719361; Conlan JW, 1997, INFECT IMMUN, V65, P630, DOI 10.1128/IAI.65.2.630-635.1997; David CV, 2009, DERMATOL THER, V22, P491, DOI 10.1111/j.1529-8019.2009.01272.x; Donnelly KB, 1998, J PARASITOL, V84, P97, DOI 10.2307/3284537; Faria DR, 2009, PARASITE IMMUNOL, V31, P432, DOI 10.1111/j.1365-3024.2009.01125.x; Gomes RB, 2002, J INFECT DIS, V186, P1530, DOI 10.1086/344733; Gramiccia M, 2005, INT J PARASITOL, V35, P1169, DOI 10.1016/j.ijpara.2005.07.001; Guerin PJ, 2002, LANCET INFECT DIS, V2, P494, DOI 10.1016/S1473-3099(02)00347-X; Harn DA, 2009, IMMUNOL REV, V230, P247, DOI 10.1111/j.1600-065X.2009.00799.x; Hokke CH, 2001, GLYCOCONJUGATE J, V18, P573, DOI 10.1023/A:1020634602161; Iskratsch T, 2009, ANAL BIOCHEM, V386, P133, DOI 10.1016/j.ab.2008.12.005; Jmeian Y, 2009, ELECTROPHORESIS, V30, P249, DOI 10.1002/elps.200800639; Jordan SW, 2007, J VASC SURG, V45, p104A, DOI 10.1016/j.jvs.2007.02.048; KILLICKKENDRICK R, 1977, J MED ENTOMOL, V13, P429, DOI 10.1093/jmedent/13.4-5.429; Kumar S, 2009, J CHROMATOGR B, V877, P3610, DOI 10.1016/j.jchromb.2009.08.045; Lainson R, 2005, MEM I OSWALDO CRUZ, V100, P811, DOI 10.1590/S0074-02762005000800001; Laurenti MD, 2009, SCAND J IMMUNOL, V70, P389, DOI 10.1111/j.1365-3083.2009.02310.x; Li J, 2007, CLIN DERMATOL, V25, P9, DOI 10.1016/j.clindermatol.2006.09.007; Liu D, 2009, INFECT IMMUN, V77, P3272, DOI 10.1128/IAI.01447-08; Lucas T, 2010, J IMMUNOL, V184, P3964, DOI 10.4049/jimmunol.0903356; MALEY F, 1989, ANAL BIOCHEM, V180, P195, DOI 10.1016/0003-2697(89)90115-2; Martin K, 2009, DEMENT GERIATR COGN, V27, P451, DOI 10.1159/000216840; Mejia JS, 2006, TRENDS PARASITOL, V22, P367, DOI 10.1016/j.pt.2006.06.001; Mejia JS, 2004, TRENDS PARASITOL, V20, P508, DOI 10.1016/j.pt.2004.08.005; MODI GB, 1983, J MED ENTOMOL, V20, P568, DOI 10.1093/jmedent/20.5.568; Monteiro MC, 2007, AM J TROP MED HYG, V76, P88, DOI 10.4269/ajtmh.2007.76.88; Neves JS, 2009, CURR OPIN IMMUNOL, V21, P694, DOI 10.1016/j.coi.2009.07.011; Norsworthy NB, 2004, INFECT IMMUN, V72, P1240, DOI 10.1128/IAI.72.3.1240-1247.2004; Oliveira F, 2006, VACCINE, V24, P374, DOI 10.1016/j.vaccine.2005.07.085; Oliveira F, 2009, PARASITOL INT, V58, P1, DOI 10.1016/j.parint.2008.07.004; Oliveira SHP, 1998, PARASITE IMMUNOL, V20, P405, DOI 10.1046/j.1365-3024.1998.00159.x; PAGE RB, 1982, AM J PHYSIOL, V243, pE427, DOI 10.1152/ajpendo.1982.243.6.E427; Pearce EJ, 2004, IMMUNOL REV, V201, P117, DOI 10.1111/j.0105-2896.2004.00187.x; Pearson RD, 1996, CLIN INFECT DIS, V22, P1, DOI 10.1093/clinids/22.1.1; Peters NC, 2008, SCIENCE, V321, P970, DOI 10.1126/science.1159194; PRENNER C, 1992, BIOCHEM J, V284, P377, DOI 10.1042/bj2840377; Reithinger R, 2007, LANCET INFECT DIS, V7, P581, DOI 10.1016/S1473-3099(07)70209-8; Rogers KA, 2003, PARASITE IMMUNOL, V25, P127, DOI 10.1046/j.1365-3024.2003.00623.x; Rogers KA, 2002, FEMS MICROBIOL LETT, V209, P1, DOI 10.1111/j.1574-6968.2002.tb11101.x; Rothenberg ME, 2006, ANNU REV IMMUNOL, V24, P147, DOI 10.1146/annurev.immunol.24.021605.090720; Sacks D, 2001, ANNU REV MICROBIOL, V55, P453, DOI 10.1146/annurev.micro.55.1.453; Sakthianandeswaren A, 2009, TRENDS PARASITOL, V25, P383, DOI 10.1016/j.pt.2009.05.004; Sharma Umakant, 2008, Journal of Vector Borne Diseases, V45, P255; Silva F, 2005, AM J TROP MED HYG, V72, P94, DOI 10.4269/ajtmh.2005.72.94; Specht S, 2006, INFECT IMMUN, V74, P5236, DOI 10.1128/IAI.00329-06; Titus RG, 2006, PARASITE IMMUNOL, V28, P131, DOI 10.1111/j.1365-3024.2006.00807.x; Valenzuela JG, 2004, J EXP BIOL, V207, P3717, DOI 10.1242/jeb.01185; van Ree R, 2002, INT ARCH ALLERGY IMM, V129, P189, DOI 10.1159/000066770; van Zandbergen G, 2004, J IMMUNOL, V173, P6521, DOI 10.4049/jimmunol.173.11.6521; VANDAM GJ, 1994, EUR J BIOCHEM, V225, P467, DOI 10.1111/j.1432-1033.1994.00467.x; Vanloubbeeck Y, 2004, ANN NY ACAD SCI, V1026, P267, DOI 10.1196/annals.1307.041; Vinhas V, 2007, EUR J IMMUNOL, V37, P3111, DOI 10.1002/eji.200737431; Volfova V, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000294; Zhang K, 2010, MOL BIOCHEM PARASIT, V170, P55, DOI 10.1016/j.molbiopara.2009.12.004; Zijistra EE, 2003, LANCET INFECT DIS, V3, P87, DOI 10.1016/S1473-3099(03)00517-6; Zuluaga AF, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-55	65	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2010	5	10							e13546	10.1371/journal.pone.0013546	http://dx.doi.org/10.1371/journal.pone.0013546			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671UN	21048957	Green Submitted, Green Published, gold			2022-12-27	WOS:000283537000006
J	Wang, T; Zeng, Z; Li, T; Liu, J; Li, JY; Li, Y; Zhao, QA; Wei, ZY; Wang, Y; Li, BJ; Feng, GY; He, L; Shi, YY				Wang, Ti; Zeng, Zhen; Li, Tao; Liu, Jie; Li, Junyan; Li, You; Zhao, Qian; Wei, Zhiyun; Wang, Yang; Li, Baojie; Feng, Guoyin; He, Lin; Shi, Yongyong			Common SNPs in Myelin Transcription Factor 1-Like (MYT1L): Association with Major Depressive Disorder in the Chinese Han Population	PLOS ONE			English	Article							ZINC-FINGER; GENETICS; NEURONS; GENOME; MEMBER; FAMILY; GENES	Background: Myelin transcription factor 1-like (MYT1L) is a member of the myelin transcription factor 1 (MYT1) gene family, and the neural specific, zinc-finger-containing, DNA-binding protein that it encodes plays a role in the development of the nervous system. On the basis of a recent copy number variation (CNV) study showing that this gene is disrupted in mental disorder patients, we investigated whether MYT1L also plays a role in MDD. Methods: In this study, 8 SNPs were analyzed in 1139 MDD patients and 1140 controls of Chinese Han origin. Results: Statistically significant differences were noted between cases and controls for rs3748989 (allele: permutated p = 0.0079, corrected p = 0.0048, genotype: corrected p = 0.0204). A haplotype of rs1617213 and rs6759709 G-C was also significant (permutated p = 0.00007). Conclusion: Our results indicate that MYT1L may be a potential risk gene for MDD in the Chinese Han population.	[Wang, Ti; Zeng, Zhen; Li, Tao; Liu, Jie; Li, Junyan; Wang, Yang; He, Lin; Shi, Yongyong] Shanghai Jiao Tong Univ, Minist Educ, Bio X Ctr, Shanghai 200030, Peoples R China; [Wang, Ti; Zeng, Zhen; Li, Tao; Liu, Jie; Li, Junyan; Wang, Yang; He, Lin; Shi, Yongyong] Shanghai Jiao Tong Univ, Minist Educ, Affiliated Changning Mental Hlth Ctr, Key Lab Genet Dev & Neuropsychiat Disorders, Shanghai 200030, Peoples R China; [Wang, Ti; Li, You; Zhao, Qian; Wei, Zhiyun; He, Lin; Shi, Yongyong] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Shanghai, Peoples R China; [Li, Baojie; Feng, Guoyin] Shanghai Inst Mental Hlth, Shanghai, Peoples R China; [He, Lin] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Fudan University	Wang, T (corresponding author), Shanghai Jiao Tong Univ, Minist Educ, Bio X Ctr, Shanghai 200030, Peoples R China.	shiyongyong@gmail.com	Zeng, Zhen/R-6292-2016; Shi, Yongyong/GSO-1627-2022; Li, Junyan/AFV-3987-2022; Wang, Yang/HCG-9543-2022; Wei, Zhiyun/E-2008-2016	Shi, Yongyong/0000-0003-1710-1505; Wei, Zhiyun/0000-0002-3554-4142	863 Program [2006AA02A407]; Shanghai Changning Health Bureau [2008406002]; Shanghai Municipal Health Bureau [2008095]; 973 Program [2010CB529600, 2006CB910601, 2007CB914703, 2007CB947300]; Shanghai Municipal Commission of Science and Technology [09DJ1400601, 07DZ22917]; National Key Project for Investigational New Drug [2008ZX09312-003]; Shanghai Leading Academic Discipline Project [B205]	863 Program(National High Technology Research and Development Program of China); Shanghai Changning Health Bureau; Shanghai Municipal Health Bureau; 973 Program(National Basic Research Program of China); Shanghai Municipal Commission of Science and Technology; National Key Project for Investigational New Drug; Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project)	This work was supported by the 863 Program 2006AA02A407, the Shanghai Changning Health Bureau program 2008406002, the Shanghai Municipal Health Bureau program (2008095), the 973 Program (2010CB529600, 2006CB910601, 2007CB914703, 2007CB947300), the Shanghai Municipal Commission of Science and Technology Program (09DJ1400601, 07DZ22917), the National Key Project for Investigational New Drug 2008ZX09312-003, and the Shanghai Leading Academic Discipline Project (B205). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARMSTRONG RC, 1995, GLIA, V14, P303, DOI 10.1002/glia.440140407; Bareiss S, 2010, J NEUROSCI RES, V88, P2350, DOI 10.1002/jnr.22414; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; DAVIDBARBEAU, 1994, NEUROBIOLOGY; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; Glessner JT, 2009, NATURE, V459, P569, DOI 10.1038/nature07953; Hashimoto R, 2006, HUM MOL GENET, V15, P3024, DOI 10.1093/hmg/ddl244; Hennah W, 2009, MOL PSYCHIATR, V14, P865, DOI 10.1038/mp.2008.22; KALUS PFP, 2008, STRUCTURAL FUNCTIONA; Kim JG, 1997, J NEUROSCI RES, V50, P272, DOI 10.1002/(SICI)1097-4547(19971015)50:2<272::AID-JNR16>3.0.CO;2-A; Levinson DF, 2006, BIOL PSYCHIAT, V60, P84, DOI 10.1016/j.biopsych.2005.08.024; Numata S, 2009, J PSYCHIATR NEUROSCI, V34, P195; O'Donovan MC, 2009, HUM GENET, V126, P3, DOI 10.1007/s00439-009-0703-0; Orr N, 2008, ADV GENET, V62, P1, DOI 10.1016/S0065-2660(08)00601-9; Romm E, 2005, J NEUROCHEM, V93, P1444, DOI 10.1111/j.1471-4159.2005.03131.x; Vrijenhoek T, 2008, AM J HUM GENET, V83, P504, DOI 10.1016/j.ajhg.2008.09.011; Wang S, 2007, MECH DEVELOP, V124, P898, DOI 10.1016/j.mod.2007.08.004; Yee KSY, 1998, J BIOL CHEM, V273, P5366, DOI 10.1074/jbc.273.9.5366; 2004, AM J HUM GENET, V74, P5; 1991, BR J PSYCHIAT	20	31	32	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2010	5	10							e13662	10.1371/journal.pone.0013662	http://dx.doi.org/10.1371/journal.pone.0013662			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671UN	21048971	Green Submitted, Green Published, gold			2022-12-27	WOS:000283537000031
J	Kosubek, A; Klein-Hitpass, L; Rademacher, K; Horsthemke, B; Ryffel, GU				Kosubek, Anna; Klein-Hitpass, Ludger; Rademacher, Katrin; Horsthemke, Bernhard; Ryffel, Gerhart U.			Aging of Xenopus tropicalis Eggs Leads to Deadenylation of a Specific Set of Maternal mRNAs and Loss of Developmental Potential	PLOS ONE			English	Article							GENE-EXPRESSION; TRANSLATIONAL CONTROL; DELAYED FERTILIZATION; OOCYTE MATURATION; MOUSE OOCYTE; EMBRYO; IDENTIFICATION; MICROARRAY; COMPETENCE; SEQUENCES	As first shown more than 100 years ago, fertilization of an aged (overripe) egg increases the rate of malformations and embryonic loss in several vertebrates, including possibly humans as well. Since the molecular events in aging eggs may be similar in these species, we established in the frog Xenopus tropicalis a defined protocol for delayed fertilization of eggs. A three-hour delayed fertilization led to a dramatic increase in malformation and mortality. Gene expression profiling revealed that 14% of the polyadenylated maternal transcripts were downregulated upon aging. These transcripts were not degraded, but rather deadenylated as shown for specific maternal mRNAs. The affected transcripts are characterized by a relatively short 39UTR and a paucity of cytoplasmic polyadenylation elements (CPE) and polyadenylation signals (PAS). Furthermore, maternal mRNAs known to be deadenylated during egg maturation as well as after fertilization were preferentially deadenylated in aged eggs. Taken together our analysis of aging eggs reveals that unfertilized eggs are in a dynamic state that was previously not realized. On the one hand deadenylation of transcripts that are typically deadenylated during egg maturation continues and this implies overripeness of the aged egg in the truest sense of the word. On the other hand transcripts that normally are deadenylated after fertilization loose their poly(A) in the aged egg and this implies that the egg awaiting fertilization starts processes that are normally only observed after fertilization. Based on our novel finding we postulate that the imbalance of the polyadenylated maternal transcripts upon egg aging contributes to the loss of developmental potential. Based on this hypothesis the developmental consequences of downregulation of specific transcripts can be analyzed in future.	[Kosubek, Anna; Klein-Hitpass, Ludger; Ryffel, Gerhart U.] Univ Duisburg Essen, Univ Klinikum Essen, Inst Zellbiol Tumorforsch, Essen, Germany; [Kosubek, Anna; Rademacher, Katrin; Horsthemke, Bernhard] Univ Duisburg Essen, Univ Klinikum Essen, Inst Humangenet, Essen, Germany	University of Duisburg Essen; University of Duisburg Essen	Kosubek, A (corresponding author), Univ Duisburg Essen, Univ Klinikum Essen, Inst Zellbiol Tumorforsch, Essen, Germany.	gerhart.ryffel@uni-due.de			Deutsche Forschungsgemeinschaft [GRK1431]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft (GRK1431). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aegerter S, 2005, MOL REPROD DEV, V72, P377, DOI 10.1002/mrd.20361; Aegerter S, 2004, MOL REPROD DEV, V67, P127, DOI 10.1002/mrd.10384; Andersen AN, 2008, HUM REPROD, V23, P756, DOI 10.1093/humrep/den014; Audic Y, 2001, MOL CELL BIOL, V21, P1662, DOI 10.1128/MCB.21.5.1662-1671.2001; Beaudoing E, 2000, GENOME RES, V10, P1001, DOI 10.1101/gr.10.7.1001; Blandau RJ, 1939, AM J ANAT, V64, P303, DOI 10.1002/aja.1000640204; Blandau RJ, 1941, AM J ANAT, V68, P275, DOI 10.1002/aja.1000680206; Bonnet E, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-55; Bowes JB, 2010, NUCLEIC ACIDS RES, V38, pD607, DOI 10.1093/nar/gkp953; Brook M, 2009, REPRODUCTION, V137, P595, DOI 10.1530/REP-08-0524; Charlesworth A, 2004, J BIOL CHEM, V279, P17650, DOI 10.1074/jbc.M313837200; Chatterjee S, 2009, BIOL CELL, V101, P251, DOI 10.1042/BC20080104; Cooke A, 2010, J BIOL CHEM, V285, P28506, DOI 10.1074/jbc.M110.150763; De Ferrari L, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-277; Evsikov AV, 2009, MOL REPROD DEV, V76, P805, DOI 10.1002/mrd.21038; Fair T, 2007, THERIOGENOLOGY, V68, pS91, DOI 10.1016/j.theriogenology.2007.04.018; Graindorge A, 2006, NUCLEIC ACIDS RES, V34, P986, DOI 10.1093/nar/gkj492; Graindorge A, 2008, NUCLEIC ACIDS RES, V36, P1861, DOI 10.1093/nar/gkn031; Grondahl ML, 2010, HUM REPROD, V25, P957, DOI 10.1093/humrep/deq014; Hansen M, 2005, HUM REPROD, V20, P328, DOI 10.1093/humrep/deh593; Heasman J, 2006, DEVELOPMENT, V133, P1205, DOI 10.1242/dev.02304; Hellsten U, 2010, SCIENCE, V328, P633, DOI 10.1126/science.1183670; Hogan B, 1994, MANIPULATING MOUSE E; Huang JC, 2007, BIOL REPROD, V77, P666, DOI 10.1095/biolreprod.107.062703; JONGBLOET PH, 1987, J MED GENET, V24, P616, DOI 10.1136/jmg.24.10.616; Khokha MK, 2002, DEV DYNAM, V225, P499, DOI 10.1002/dvdy.10184; Korner CG, 1998, EMBO J, V17, P5427, DOI 10.1093/emboj/17.18.5427; Lacham-Kaplan O, 2008, REPROD BIOL ENDOCRIN, V6, DOI 10.1186/1477-7827-6-58; Liang XW, 2008, BIOCHEM BIOPH RES CO, V371, P16, DOI 10.1016/j.bbrc.2008.03.105; Miao YL, 2009, HUM REPROD UPDATE, V15, P573, DOI 10.1093/humupd/dmp014; MIKAMO K, 1968, CYTOGENETICS, V7, P212, DOI 10.1159/000129985; Nieuwkoop P. D., 1975, NORMAL TABLE XENOPUS; Paillard L, 1998, EMBO J, V17, P278, DOI 10.1093/emboj/17.1.278; PAYNTON BV, 1988, DEV BIOL, V129, P304, DOI 10.1016/0012-1606(88)90377-6; PFLUGER E, 1882, ARCH GES PHYSL, V29, P76; Pique M, 2008, CELL, V132, P434, DOI 10.1016/j.cell.2007.12.038; Rassa JC, 2000, VIROLOGY, V274, P438, DOI 10.1006/viro.2000.0494; Richter JD, 2008, CELL, V132, P335, DOI 10.1016/j.cell.2008.01.024; Showell C, 2007, GENESIS, V45, P418, DOI 10.1002/dvg.20286; Sive Hazel L., 2000, EARLY DEV XENOPUS LA; Vallee M, 2008, REPRODUCTION, V135, P439, DOI 10.1530/REP-07-0342; VARNUM SM, 1990, GENE DEV, V4, P2278, DOI 10.1101/gad.4.12b.2278; Voeltz GK, 1998, MOL CELL BIOL, V18, P7537, DOI 10.1128/MCB.18.12.7537; Wilcox AJ, 1998, HUM REPROD, V13, P394, DOI 10.1093/humrep/13.2.394; WITSCHI E, 1952, CANCER RES, V12, P763; Zheng Q, 2008, NUCLEIC ACIDS RES, V36, pW358, DOI 10.1093/nar/gkn276	46	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2010	5	10							e13532	10.1371/journal.pone.0013532	http://dx.doi.org/10.1371/journal.pone.0013532			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	670KA	21042572	gold, Green Published, Green Submitted			2022-12-27	WOS:000283419100003
J	Wagner, J; Sim, WH; Ellis, JA; Ong, EK; Catto-Smith, AG; Cameron, DJS; Bishop, RF; Kirkwood, CD				Wagner, Josef; Sim, Winnie H.; Ellis, Justine A.; Ong, Eng K.; Catto-Smith, Anthony G.; Cameron, Donald J. S.; Bishop, Ruth F.; Kirkwood, Carl D.			Interaction of Crohn's Disease Susceptibility Genes in an Australian Paediatric Cohort	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; GENOME-WIDE ASSOCIATION; IBD5 LOCUS; OCTN1/2 VARIANTS; HARDY-WEINBERG; DLG5 VARIANTS; ADULT-ONSET; IRGM; POLYMORPHISMS; POPULATION	Genetic susceptibility is an important contributor to the pathogenesis of Crohn's disease (CD). We investigated multiple CD susceptibility genes in an Australian paediatric onset CD cohort. Newly diagnosed paediatric onset CD patients (n = 72) and controls (n = 98) were genotyped for 34 single nucleotide polymorphisms (SNPs) in 18 genetic loci. Gene-gene interaction analysis, gene-disease phenotype analysis and genetic risk profiling were performed for all SNPs and all genes. Of the 34 SNPs analysed, four polymorphisms on three genes (NOD2, IL23R, and region 3p21) were significantly associated with CD status (p<0.05). All three CD specific paediatric polymorphisms on PSMG1 and TNFRSF6B showed a trend of association with p<0.1. An additive gene-gene interaction involving TLR4, PSMG1, TNFRSF6B and IRGM was identified with CD. Genes involved in microbial processing (TLR4, PSMG1, NOD2) were significantly associated either at the individual level or in gene-gene interactive roles. Colonic disease was significantly associated with disease SNP rs7517847 (IL23R) (p<0.05) and colonic and ileal/colonic disease was significantly associated with disease SNP rs125221868 (IBD5) and SLC22A4 & SLC22A4/5 variants (p<0.05). We were able to demonstrate genetic association of several genes to CD in a paediatric onset cohort. Several of the observed associations have not been reported previously in association with paediatric CD patients. Our findings demonstrate that CD genetic susceptibility in paediatric patients presents as a complex interaction between numerous genes.	[Wagner, Josef; Sim, Winnie H.; Bishop, Ruth F.; Kirkwood, Carl D.] Murdoch Childrens Res Inst, Enter Virus Grp, Melbourne, Vic, Australia; [Ong, Eng K.] Murdoch Childrens Res Inst, Sequenom Platform Facil, Melbourne, Vic, Australia; [Catto-Smith, Anthony G.; Bishop, Ruth F.; Kirkwood, Carl D.] Univ Melbourne, Dept Paediat, Melbourne, Vic 3010, Australia; [Catto-Smith, Anthony G.; Cameron, Donald J. S.] Royal Childrens Hosp, Dept Gastroenterol & Clin Nutr, Melbourne, Vic, Australia	Murdoch Children's Research Institute; Murdoch Children's Research Institute; University of Melbourne; Royal Children's Hospital Melbourne	Wagner, J (corresponding author), Murdoch Childrens Res Inst, Enter Virus Grp, Melbourne, Vic, Australia.	josef.wagner@mcri.edu.au	Catto-Smith, Anthony G/H-3698-2012; Ellis, Justine A/G-5006-2011; Catto-Smith, Anthony/AAG-1485-2019	Ellis, Justine/0000-0003-4103-4445	Jack Brockhoff Foundation, Australia; Murdoch Children Research Institute, Australia; Eli and Edythe Broad Foundation, USA; National Health and Medical Research Council, Australia [607347]; National Health and Medical Research Council	Jack Brockhoff Foundation, Australia; Murdoch Children Research Institute, Australia; Eli and Edythe Broad Foundation, USA; National Health and Medical Research Council, Australia(National Health and Medical Research Council (NHMRC) of Australia); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	The project was supported by research grants from the Jack Brockhoff Foundation, Australia, the Murdoch Children Research Institute, Australia, and from the Broad Medical Research Program, The Eli and Edythe Broad Foundation, USA. C. Kirkwood is supported by a Career Development Awards fellowship from the National Health and Medical Research Council, Australia (607347). J Ellis is supported by a National Health and Medical Research Council Capacity Building Grant in Population Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation to the manuscript.	Amre DK, 2008, AM J GASTROENTEROL, V103, P615, DOI 10.1111/j.1572-0241.2007.01661.x; Amre DK, 2009, AM J GASTROENTEROL, V104, P2824, DOI 10.1038/ajg.2009.430; Amre DK, 2009, INFLAMM BOWEL DIS, V15, P501, DOI 10.1002/ibd.20785; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Bonen DK, 2003, GASTROENTEROLOGY, V124, P140, DOI 10.1053/gast.2003.50019; Browning BL, 2007, INFLAMM BOWEL DIS, V13, P1069, DOI 10.1002/ibd.20157; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cosgrove M, 1996, ARCH DIS CHILD-FETAL, V74, pF122, DOI 10.1136/fn.74.2.F122; Cucchiara S, 2007, WORLD J GASTROENTERO, V13, P1221, DOI 10.3748/wjg.v13.i8.1221; Cummings JRF, 2007, INFLAMM BOWEL DIS, V13, P941, DOI 10.1002/ibd.20162; de Ridder L, 2007, INFLAMM BOWEL DIS, V13, P1083, DOI 10.1002/ibd.20171; Deng HW, 2000, AM J HUM GENET, V66, P1027, DOI 10.1086/302804; Duan JB, 2003, HUM MOL GENET, V12, P205, DOI 10.1093/hmg/ddg055; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Economou M, 2008, INFLAMM BOWEL DIS, V14, P709, DOI 10.1002/ibd.20352; Ferraris A, 2005, J PEDIATR-US, V147, P272, DOI 10.1016/j.jpeds.2005.03.039; Fiocchi C, 1998, GASTROENTEROLOGY, V115, P182, DOI 10.1016/S0016-5085(98)70381-6; Fitzpatrick LR, 2007, DIS COLON RECTUM, V50, P337, DOI 10.1007/s10350-006-0796-7; Franchimont D, 2004, GUT, V53, P987, DOI 10.1136/gut.2003.030205; Franke A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000691; Gasche C, 2003, J IMMUNOL, V170, P5578, DOI 10.4049/jimmunol.170.11.5578; Glas J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000819; Hampe J, 2007, NAT GENET, V39, P207, DOI 10.1038/ng1954; Hausmann M, 2002, GASTROENTEROLOGY, V122, P1987, DOI 10.1053/gast.2002.33662; Hayashi T, 2000, J BIOL CHEM, V275, P5238, DOI 10.1074/jbc.275.7.5238; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Hugot JP, 1996, NATURE, V379, P821, DOI 10.1038/379821a0; Inohara N, 2003, J BIOL CHEM, V278, P5509, DOI 10.1074/jbc.C200673200; Inohara N, 2003, NAT REV IMMUNOL, V3, P371, DOI 10.1038/nri1086; Jurinke Christian, 2002, Methods Mol Biol, V187, P179; Kirkwood CD, 2009, INFLAMM BOWEL DIS, V15, P1643, DOI 10.1002/ibd.20967; KRUPOVES A, 2008, INFLAMM BOWEL DIS; Kugathasan S, 2008, NAT GENET, V40, P1211, DOI 10.1038/ng.203; Lakner L, 2009, INT J COLORECTAL DIS, V24, P503, DOI 10.1007/s00384-009-0670-x; Latiano A, 2008, ALIMENT PHARM THER, V27, P241, DOI 10.1111/j.1365-2036.2007.03551.x; LATIANO A, 2010, INFLAMM BOWEL DIS; LATIANO A, 2009, INFLAMM BOWEL DIS; Latiano A, 2008, WORLD J GASTROENTERO, V14, P4643, DOI 10.3748/wjg.14.4643; Lee WC, 2003, AM J EPIDEMIOL, V158, P397, DOI 10.1093/aje/kwg150; Lesage S, 2002, AM J HUM GENET, V70, P845, DOI 10.1086/339432; Libioulle C, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030058; Marquez A, 2009, GENES IMMUN, V10, P631, DOI 10.1038/gene.2009.56; McCarroll SA, 2008, NAT GENET, V40, P1107, DOI 10.1038/ng.215; McGovern DPB, 2005, HUM MOL GENET, V14, P1245, DOI 10.1093/hmg/ddi135; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Newman WG, 2006, HUM MUTAT, V27, P353, DOI 10.1002/humu.20301; Noble CL, 2005, GASTROENTEROLOGY, V129, P1854, DOI 10.1053/j.gastro.2005.09.025; Noble CL, 2005, GUT, V54, pA96; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Parkes M, 2007, NAT GENET, V39, P830, DOI 10.1038/ng2061; Peltekova VD, 2004, NAT GENET, V36, P471, DOI 10.1038/ng1339; Peterson N, 2008, GUT, V57, P1336, DOI 10.1136/gut.2008.152207; Phavichitr N, 2003, J GASTROEN HEPATOL, V18, P329, DOI 10.1046/j.1440-1746.2003.02975.x; Prescott NJ, 2007, GASTROENTEROLOGY, V132, P1665, DOI 10.1053/j.gastro.2007.03.034; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rigoli L, 2008, WORLD J GASTROENTERO, V14, P4454, DOI 10.3748/wjg.14.4454; Rioux JD, 2001, NAT GENET, V29, P223, DOI 10.1038/ng1001-223; Roberts RL, 2008, GENES IMMUN, V9, P561, DOI 10.1038/gene.2008.49; Rosenzweig R, 2008, BIOCHEM SOC T, V36, P807, DOI 10.1042/BST0360807; Russell RK, 2006, GUT, V55, P1114, DOI 10.1136/gut.2005.082107; Sartor RB, 2006, NAT CLIN PRACT GASTR, V3, P390, DOI 10.1038/ncpgasthep0528; Shanahan F, 2002, LANCET, V359, P62, DOI 10.1016/S0140-6736(02)07284-7; Silverberg MS, 2005, CAN J GASTROENTEROL, V19, p5A, DOI 10.1155/2005/269076; Stohwasser R, 2000, GLIA, V29, P355, DOI 10.1002/(SICI)1098-1136(20000215)29:4<355::AID-GLIA6>3.0.CO;2-4; Stoll M, 2004, NAT GENET, V36, P476, DOI 10.1038/ng1345; Tomer G, 2003, AM J GASTROENTEROL, V98, P2479, DOI 10.1016/S0002-9270(03)01706-4; Van Limbergen J, 2009, GUT, V58, P610, DOI 10.1136/gut.2008.160721; Van Limbergen JE, 2007, GUT, V56, pA122; Vind I, 2006, AM J GASTROENTEROL, V101, P1274, DOI 10.1111/j.1572-0241.2006.00552.x; Visekruna A, 2009, INT J COLORECTAL DIS, V24, P1133, DOI 10.1007/s00384-009-0679-1; Wacholder S, 2004, J NATL CANCER I, V96, P434, DOI 10.1093/jnci/djh075; Wagner J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003578; Waller S, 2006, GUT, V55, P809, DOI 10.1136/gut.2005.084574; Waschke KA, 2005, AM J GASTROENTEROL, V100, P1126, DOI 10.1111/j.1572-0241.2005.40534.x; Weersma RK, 2009, AM J GASTROENTEROL, V104, P630, DOI 10.1038/ajg.2008.112; Yamazaki K, 2009, GUT, V58, P228, DOI 10.1136/gut.2007.140764; Yamazaki K, 2002, J HUM GENET, V47, P469, DOI 10.1007/s100380200067; Yu W, 2009, J CROHNS COLITIS, V3, P189, DOI 10.1016/j.crohns.2009.04.003	79	22	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2010	5	11							e15376	10.1371/journal.pone.0015376	http://dx.doi.org/10.1371/journal.pone.0015376			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	676NU	21079743	Green Submitted, Green Published, gold			2022-12-27	WOS:000283920000019
J	Gronberg, A; Zettergren, L; Bergh, K; Stahle, M; Heilborn, J; Angeby, K; Small, PL; Akuffo, H; Britton, S				Gronberg, Alvar; Zettergren, Louise; Bergh, Kerstin; Stahle, Mona; Heilborn, Johan; Angeby, Kristian; Small, Pamela L.; Akuffo, Hannah; Britton, Sven			Antioxidants Protect Keratinocytes against M-ulcerans Mycolactone Cytotoxicity	PLOS ONE			English	Article							SIGNAL-TRANSDUCTION PATHWAY; MONOCYTES IN-VITRO; REACTIVE OXYGEN; OXIDATIVE STRESS; BURULI ULCER; ANTIMYCIN-A; PULMONARY TUBERCULOSIS; CYTOKINE PRODUCTION; IMMUNE-RESPONSE; IRON OVERLOAD	Background: Mycobacterium ulcerans is the causative agent of necrotizing skin ulcerations in distinctive geographical areas. M. ulcerans produces a macrolide toxin, mycolactone, which has been identified as an important virulence factor in ulcer formation. Mycolactone is cytotoxic to fibroblasts and adipocytes in vitro and has modulating activity on immune cell functions. The effect of mycolactone on keratinocytes has not been reported previously and the mechanism of mycolactone toxicity is presently unknown. Many other macrolide substances have cytotoxic and immunosuppressive activities and mediate some of their effects via production of reactive oxygen species (ROS). We have studied the effect of mycolactone in vitro on human keratinocytes-key cells in wound healing-and tested the hypothesis that the cytotoxic effect of mycolactone is mediated by ROS. Methodology/Principal Findings: The effect of mycolactone on primary skin keratinocyte growth and cell numbers was investigated in serum free growth medium in the presence of different antioxidants. A concentration and time dependent reduction in keratinocyte cell numbers was observed after exposure to mycolactone. Several different antioxidants inhibited this effect partly. The ROS inhibiting substance deferoxamine, which acts via chelation of Fe2+, completely prevented mycolactone mediated cytotoxicity. Conclusions/Significance: This study demonstrates that mycolactone mediated cytotoxicity can be inhibited by deferoxamine, suggesting a role of iron and ROS in mycolactone induced cytotoxicity of keratinocytes. The data provide a basis for the understanding of Buruli ulcer pathology and the development of improved therapies for this disease.	[Gronberg, Alvar; Zettergren, Louise; Bergh, Kerstin; Stahle, Mona] Karolinska Inst, Ctr Mol Med, Dept Med, Stockholm, Sweden; [Stahle, Mona; Heilborn, Johan] Karolinska Univ Hosp, Dept Dermatol & Venereol, Stockholm, Sweden; [Angeby, Kristian] Karolinska Univ Hosp, Dept Clin Microbiol, Stockholm, Sweden; [Angeby, Kristian; Akuffo, Hannah] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden; [Small, Pamela L.] Univ Tennessee, Dept Microbiol, Knoxville, TN 37996 USA; [Britton, Sven] Karolinska Univ Hosp, Unit Infect Med, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; University of Tennessee System; University of Tennessee Knoxville; Karolinska Institutet; Karolinska University Hospital	Gronberg, A (corresponding author), Karolinska Inst, Ctr Mol Med, Dept Med, Stockholm, Sweden.	alvar.gronberg@ki.se		Akuffo, Hannah/0000-0003-1854-3591	Sida/SAREC Grant [SWE-2008-088]; Lipopeptide AB	Sida/SAREC Grant; Lipopeptide AB	The study was supported by Sida/SAREC Grant no. SWE-2008-088 (www. sida. se) and by Lipopeptide AB (www. lipopeptide. se). The funder had a role in study design, data collection and analysis, decision to publish and preparation of the manuscript.	Adusumilli S, 2005, CELL MICROBIOL, V7, P1295, DOI 10.1111/j.1462-5822.2005.00557.x; Boulkroun S, 2010, J IMMUNOL, V184, P1436, DOI 10.4049/jimmunol.0902854; BOZZO C, 2010, MICROBES INFECT 0825; Cemerski S, 2002, J BIOL CHEM, V277, P19585, DOI 10.1074/jbc.M111451200; Choi SJN, 2008, TRANSPL P, V40, P2737, DOI 10.1016/j.transproceed.2008.08.029; Choi SJN, 2008, TRANSPL P, V40, P2734, DOI 10.1016/j.transproceed.2008.08.028; Coutanceau E, 2007, J EXP MED, V204, P1395, DOI 10.1084/jem.20070234; Cronje L, 2005, FEMS IMMUNOL MED MIC, V45, P103, DOI 10.1016/j.femsim.2005.02.007; Dobos KM, 2001, INFECT IMMUN, V69, P7182, DOI 10.1128/IAI.69.11.7182-7186.2001; Gangaidzo IT, 2001, J INFECT DIS, V184, P936, DOI 10.1086/323203; Gelderman KA, 2007, J CLIN INVEST, V117, P3020, DOI 10.1172/JCI31935; Gelderman KA, 2006, P NATL ACAD SCI USA, V103, P12831, DOI 10.1073/pnas.0604571103; George KM, 1998, INFECT IMMUN, V66, P587, DOI 10.1128/IAI.66.2.587-593.1998; George KM, 1999, SCIENCE, V283, P854, DOI 10.1126/science.283.5403.854; George KM, 2000, INFECT IMMUN, V68, P877, DOI 10.1128/IAI.68.2.877-883.2000; Gil J, 2003, FREE RADICAL BIO MED, V35, P1500, DOI 10.1016/j.freeradbiomed.2003.08.022; Gooding TM, 2003, CLIN INFECT DIS, V36, P1076, DOI 10.1086/368315; Gooding TM, 2002, INFECT IMMUN, V70, P5562, DOI 10.1128/IAI.70.10.5562-5567.2002; Gooding TM, 2001, INFECT IMMUN, V69, P1704, DOI 10.1128/IAI.69.3.1704-1707.2001; Gordeuk VR, 2009, INT J TUBERC LUNG D, V13, P1267; Gordeuk VR, 2003, BLOOD CELL MOL DIS, V31, P299, DOI 10.1016/S1079-9796(03)00164-5; Gordeuk VR, 2002, SEMIN HEMATOL, V39, P263, DOI 10.1053/shem.2002.35636; Han SY, 2006, TRANSPL P, V38, P2242, DOI 10.1016/j.transproceed.2006.06.033; Han YH, 2008, ONCOL REP, V20, P689, DOI 10.3892/or_00000061; Han YH, 2008, LIFE SCI, V83, P346, DOI 10.1016/j.lfs.2008.06.023; HARDWICK JS, 1995, P NATL ACAD SCI USA, V92, P4527, DOI 10.1073/pnas.92.10.4527; HERCBERG S, 1988, PUBLIC HEALTH, V102, P73, DOI 10.1016/S0033-3506(88)80013-1; Hong F, 2002, FASEB J, V16, P1633, DOI 10.1096/fj.02-0060fje; Hong H, 2008, NAT PROD REP, V25, P447, DOI 10.1039/b803101k; Hong H, 2007, CHEMBIOCHEM, V8, P2043, DOI 10.1002/cbic.200700411; Karbowski M, 1999, FREE RADICAL BIO MED, V26, P396, DOI 10.1016/S0891-5849(98)00209-3; Laochumroonvorapong P, 1997, INFECT IMMUN, V65, P4850, DOI 10.1128/IAI.65.11.4850-4857.1997; Lee HM, 2009, CELL MICROBIOL, V11, P678, DOI 10.1111/j.1462-5822.2009.01285.x; Manca C, 1999, INFECT IMMUN, V67, P74, DOI 10.1128/IAI.67.1.74-79.1999; Mve-Obiang A, 2003, INFECT IMMUN, V71, P774, DOI 10.1128/IAI.71.2.774-783.2003; NAKAMURA K, 1993, ONCOGENE, V8, P3133; Navarro-Antolin J, 1998, KIDNEY INT, V54, pS20, DOI 10.1046/j.1523-1755.1998.06807.x; Pahlevan AA, 1999, J IMMUNOL, V163, P3928; Park WH, 2007, J CELL BIOCHEM, V102, P98, DOI 10.1002/jcb.21280; Phillips R, 2006, CLIN VACCINE IMMUNOL, V13, P253, DOI 10.1128/CVI.13.2.253-257.2006; Phillips R, 2004, ANTIMICROB AGENTS CH, V48, P3130, DOI 10.1128/AAC.48.8.3130-3132.2004; Phillips R, 2004, ANTIMICROB AGENTS CH, V48, P2866, DOI 10.1128/AAC.48.8.2866-2870.2004; Piskemik C, 2008, BBA-MOL BASIS DIS, V1782, P280, DOI 10.1016/j.bbadis.2008.01.007; Prevot G, 2004, PRESSE MED, V33, P1516, DOI 10.1016/S0755-4982(04)98974-9; Ray RS, 2001, DRUG CHEM TOXICOL, V24, P191, DOI 10.1081/DCT-100102610; Reddan J, 1992, Lens Eye Toxic Res, V9, P385; Roberts B, 1996, J MED MICROBIOL, V45, P383, DOI 10.1099/00222615-45-5-383; SARFO FS, PLOS NEGL TROP DIS, V4, pE577; Schafer M, 2008, PHARMACOL RES, V58, P165, DOI 10.1016/j.phrs.2008.06.004; Simmonds RE, 2009, J IMMUNOL, V182, P2194, DOI 10.4049/jimmunol.0802294; Sinha A, 2006, J IMMUNOL, V177, P468, DOI 10.4049/jimmunol.177.1.468; Srinivasan S, 2004, CLIN CHIM ACTA, V350, P57, DOI 10.1016/j.cccn.2004.07.001; Stienstra Y, 2006, GENES IMMUN, V7, P185, DOI 10.1038/sj.gene.6364281; Subbian S, 2007, INFECT IMMUN, V75, P127, DOI 10.1128/IAI.01000-06; Tunon MJ, 2003, BIOCHEM PHARMACOL, V66, P439, DOI 10.1016/S0006-2952(03)00288-0; Van Zandt KE, 2008, J LEUKOCYTE BIOL, V84, P689, DOI 10.1189/jlb.1107781; Vijayaraghavan R, 2005, EUR J CLIN NUTR, V59, P1121, DOI 10.1038/sj.ejcn.1602221; Westenbrink BD, 2005, CLIN DIAGN LAB IMMUN, V12, P125, DOI 10.1128/CDLI.12.1.125-129.2005; Yeboah-Manu D, 2006, J LEUKOCYTE BIOL, V79, P1150, DOI 10.1189/jlb.1005581; Zahrt TC, 2002, ANTIOXID REDOX SIGN, V4, P141, DOI 10.1089/152308602753625924; Zhou XM, 2004, KIDNEY INT, V65, P139, DOI 10.1111/j.1523-1755.2004.00380.x	61	16	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2010	5	11							e13839	10.1371/journal.pone.0013839	http://dx.doi.org/10.1371/journal.pone.0013839			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675NY	21079804	Green Submitted, Green Published, gold			2022-12-27	WOS:000283838600014
J	Han, ST; Fukazawa, T; Yamatsuji, T; Matsuoka, J; Miyachi, H; Maeda, Y; Durbin, M; Naomoto, Y				Han, Shaoteng; Fukazawa, Takuya; Yamatsuji, Tomoki; Matsuoka, Junji; Miyachi, Hiroyuki; Maeda, Yutaka; Durbin, Mary; Naomoto, Yoshio			Anti-Tumor Effect in Human Lung Cancer by a Combination Treatment of Novel Histone Deacetylase Inhibitors: SL142 or SL325 and Retinoic Acids	PLOS ONE			English	Article							PML-RAR-ALPHA; GROWTH-INHIBITION; RESPONSE ELEMENT; HDAC INHIBITOR; RECEPTOR-BETA; CELL-LINES; ALL-TRANS; APOPTOSIS; EXPRESSION; GENE	Histone deacetylase (HDAC) inhibitors arrest cancer cell growth and cause apoptosis with low toxicity thereby constituting a promising treatment for cancer. In this study, we investigated the anti-tumor activity in lung cancer cells of the novel cyclic amide-bearing hydroxamic acid based HDAC inhibitors SL142 and SL325. In A549 and H441 lung cancer cells both SL142 and SL325 induced more cell growth inhibition and cell death than the hydroxamic acid-based HDAC inhibitor suberoylanilide hydroxamic acid (SAHA). Moreover, the combination treatment using retinoid drugs ATRA or 9-cis RA along with SL142 or SL325 significantly induced more apoptosis and suppressed colony formation than the single use of either. The expression of the retinoic acid receptors RAR alpha, RAR beta, RXR alpha and RXR beta were unchanged with the treatment. However a luciferase reporter construct (pGL4. RARE 7x) containing seven tandem repeats of the retinoic acid responsible element (RARE) generated significant transcriptional activity after the combination treatment of retinoic acids and SL142 or SL325 in H441 lung cancer cells. Moreover, apoptosis-promoting Bax expression and caspase-3 activity was increased after the combination treatment. These results suggest that the combination treatment of SL142 or SL325 with retinoic acids exerts significant anti-tumor activity and is a promising therapeutic candidate to treat human lung cancer.	[Han, Shaoteng; Matsuoka, Junji] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Surg Gastroenterol, Okayama 7008530, Japan; [Miyachi, Hiroyuki] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Div Pharmaceut Sci, Okayama 7008530, Japan; [Fukazawa, Takuya; Yamatsuji, Tomoki; Naomoto, Yoshio] Kawasaki Med Sch, Dept Gen Surg, Okayama, Japan; [Han, Shaoteng] China Med Univ, Shengjing Hosp, Dept Hepatobiliary Surg, Shenyang, Peoples R China; [Maeda, Yutaka] Cincinnati Childrens Hosp, Med Ctr, Div Pulm Biol, Cincinnati, OH USA; [Durbin, Mary] Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92717 USA	Okayama University; Okayama University; Kawasaki Medical School; China Medical University; Cincinnati Children's Hospital Medical Center; University of California System; University of California Irvine	Han, ST (corresponding author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Surg Gastroenterol, Okayama 7008530, Japan.	FukazawaT@aol.com	Fukazawa, Takuya/GLR-7099-2022		Ministry of Education, Science, and Culture, Japan	Ministry of Education, Science, and Culture, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	The Ministry of Education, Science, and Culture, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aranda A, 2001, PHYSIOL REV, V81, P1269, DOI 10.1152/physrev.2001.81.3.1269; BOEHM MF, 1994, J MED CHEM, V37, P408, DOI 10.1021/jm00029a013; Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Brabender J, 2005, CARCINOGENESIS, V26, P525, DOI 10.1093/carcin/bgi006; Brabender J, 2002, CLIN CANCER RES, V8, P438; Chambon Pierre, 1994, Seminars in Cell Biology, V5, P115, DOI 10.1006/scel.1994.1015; Coffey DC, 2000, MED PEDIATR ONCOL, V35, P577, DOI 10.1002/1096-911X(20001201)35:6<577::AID-MPO18>3.0.CO;2-3; Santos MDL, 2007, MOL CANCER THER, V6, P1425, DOI 10.1158/1535-7163.MCT-06-0623; DETHE H, 1991, CELL, V66, P675, DOI 10.1016/0092-8674(91)90113-D; DETHE H, 1990, NATURE, V343, P177, DOI 10.1038/343177a0; Eck-Enriquez K, 2000, BREAST CANCER RES TR, V61, P229, DOI 10.1023/A:1006442017658; Epping MT, 2007, P NATL ACAD SCI USA, V104, P17777, DOI 10.1073/pnas.0702518104; Ferrara FF, 2001, CANCER RES, V61, P2; Giannini F, 1997, INT J CANCER, V70, P194; Grignani F, 1998, NATURE, V391, P815, DOI 10.1038/35901; Gui CY, 2004, P NATL ACAD SCI USA, V101, P1241, DOI 10.1073/pnas.0307708100; HALL RK, 1992, MOL CELL BIOL, V12, P5527, DOI 10.1128/MCB.12.12.5527; He LZ, 1998, NAT GENET, V18, P126, DOI 10.1038/ng0298-126; Herbst RS, 2008, NEW ENGL J MED, V359, P1367, DOI 10.1056/NEJMra0802714; Hoang T, 2002, SURG ONCOL, V11, P229, DOI 10.1016/S0960-7404(02)00056-7; Hoffman AD, 1996, CLIN CANCER RES, V2, P1077; Horn L, 2009, J CLIN ONCOL, V27, P4232, DOI 10.1200/JCO.2009.23.6661; HUSMANN M, 1992, BIOCHEM BIOPH RES CO, V187, P1558, DOI 10.1016/0006-291X(92)90480-9; Imre G, 2006, CANCER RES, V66, P5409, DOI 10.1158/0008-5472.CAN-05-4225; Javelaud D, 2002, J BIOL CHEM, V277, P37949, DOI 10.1074/jbc.M204497200; Jetten A M, 1992, J Natl Cancer Inst Monogr, P93; Johnstone RW, 2002, NAT REV DRUG DISCOV, V1, P287, DOI 10.1038/nrd772; Joung KE, 2006, CANCER RES, V66, P5394, DOI 10.1158/0008-5472.CAN-05-3835; Jurgensmeier JM, 1998, P NATL ACAD SCI USA, V95, P4997, DOI 10.1073/pnas.95.9.4997; Kato Y, 2007, MOL CANCER THER, V6, P70, DOI 10.1158/1535-7163.MCT-06-0125; KELLOFF GJ, 1993, J CELL BIOCHEM, P2; Kelly WK, 2005, NAT CLIN PRACT ONCOL, V2, P150, DOI 10.1038/ncponc0106; Komatsu N, 2006, ONCOL REP, V15, P187; Kumagai T, 2007, INT J CANCER, V121, P656, DOI 10.1002/ijc.22558; Lavelle D, 2001, AM J HEMATOL, V68, P170, DOI 10.1002/ajh.1174; Levkau B, 1998, MOL CELL, V1, P553, DOI 10.1016/S1097-2765(00)80055-6; Lin RJ, 1998, NATURE, V391, P811, DOI 10.1038/35895; Liu M, 1996, J BIOL CHEM, V271, P31723, DOI 10.1074/jbc.271.49.31723; Marks PA, 2001, NAT REV CANCER, V1, P194, DOI 10.1038/35106079; Marks PA, 2000, JNCI-J NATL CANCER I, V92, P1210, DOI 10.1093/jnci/92.15.1210; Minucci S, 2006, NAT REV CANCER, V6, P38, DOI 10.1038/nrc1779; MITCHELL CE, 1995, ANAL BIOCHEM, V224, P148, DOI 10.1006/abio.1995.1020; Miyachi H, 1998, J MED CHEM, V41, P263, DOI 10.1021/jm970624o; MIYASHITA T, 1995, CELL, V80, P293; Monneret C, 2005, EUR J MED CHEM, V40, P1, DOI 10.1016/j.ejmech.2004.10.001; Monneret C, 2007, ANTI-CANCER DRUG, V18, P363, DOI 10.1097/CAD.0b013e328012a5db; Muraoka M, 1996, ONCOGENE, V12, P1565; Nagpal S, 2004, J INVEST DERMATOL, V123, pXX, DOI 10.1111/j.0022-202X.2004.23533.x; Orlandi A, 2004, J INVEST DERMATOL, V122, P1037, DOI 10.1111/j.0022-202X.2004.22414.x; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Parmigiani RB, 2008, P NATL ACAD SCI USA, V105, P9633, DOI 10.1073/pnas.0803749105; PASTORINO U, 1993, J CLIN ONCOL, V11, P1216, DOI 10.1200/JCO.1993.11.7.1216; Pettersson F, 2002, BRIT J CANCER, V87, P555, DOI 10.1038/sj.bjc.6600496; Pfahl Magnus, 1994, Seminars in Cell Biology, V5, P95, DOI 10.1006/scel.1994.1013; Picard E, 1999, J NATL CANCER I, V91, P1059, DOI 10.1093/jnci/91.12.1059; Richon VM, 2000, P NATL ACAD SCI USA, V97, P10014, DOI 10.1073/pnas.180316197; Rosato RR, 2003, CANCER BIOL THER, V2, P30; Roth W, 2002, NAT MED, V8, P216, DOI 10.1038/nm0302-216; SHERR CJ, 1995, GENE DEV, V9, P1149, DOI 10.1101/gad.9.10.1149; Shinji C, 2005, BIOORG MED CHEM LETT, V15, P4427, DOI 10.1016/j.bmcl.2005.07.048; Shinji C, 2006, BIOORGAN MED CHEM, V14, P7625, DOI 10.1016/j.bmc.2006.07.008; Steinman RA, 2000, MOL MED, V6, P736, DOI 10.1007/BF03402190; Struhl K, 1998, GENE DEV, V12, P599, DOI 10.1101/gad.12.5.599; Tanvetyanon T, 2007, J THORAC ONCOL, V2, P1091, DOI 10.1097/JTO.0b013e31815cff64; Wang XF, 2005, CLIN CANCER RES, V11, P3535, DOI 10.1158/1078-0432.CCR-04-1092; Wang ZG, 1998, SCIENCE, V279, P1547; Weber E, 1999, INT J CANCER, V80, P935, DOI 10.1002/(SICI)1097-0215(19990315)80:6<935::AID-IJC21>3.0.CO;2-E; Xu WS, 2007, ONCOGENE, V26, P5541, DOI 10.1038/sj.onc.1210620; Zhang H, 2004, INT J ONCOL, V25, P303; Zhang XH, 2008, CANCER BIOL THER, V7, P1390, DOI 10.4161/cbt.7.9.6415; Zhang YA, 2000, GENE THER, V7, P2041, DOI 10.1038/sj.gt.3301331	71	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2010	5	11							e13834	10.1371/journal.pone.0013834	http://dx.doi.org/10.1371/journal.pone.0013834			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675NY	21079797	Green Published, gold			2022-12-27	WOS:000283838600009
J	Biuw, M; Nost, OA; Stien, A; Zhou, Q; Lydersen, C; Kovacs, KM				Biuw, Martin; Nost, Ole Anders; Stien, Audun; Zhou, Qin; Lydersen, Christian; Kovacs, Kit M.			Effects of Hydrographic Variability on the Spatial, Seasonal and Diel Diving Patterns of Southern Elephant Seals in the Eastern Weddell Sea	PLOS ONE			English	Article							ANTARCTIC FUR SEALS; KING-GEORGE ISLAND; PENGUINS APTENODYTES-FORSTERI; MIROUNGA-LEONINA; EMPEROR PENGUINS; ARCTOCEPHALUS-GAZELLA; VERTICAL-DISTRIBUTION; FORAGING ECOLOGY; ADULT MALE; PLEURAGRAMMA-ANTARCTICUM	Weddell Sea hydrography and circulation is driven by influx of Circumpolar Deep Water (CDW) from the Antarctic Circumpolar Current (ACC) at its eastern margin. Entrainment and upwelling of this high-nutrient, oxygen-depleted water mass within the Weddell Gyre also supports the mesopelagic ecosystem within the gyre and the rich benthic community along the Antarctic shelf. We used Conductivity-Temperature-Depth Satellite Relay Data Loggers (CTD-SRDLs) to examine the importance of hydrographic variability, ice cover and season on the movements and diving behavior of southern elephant seals in the eastern Weddell Sea region during their overwinter feeding trips from Bouvetoya. We developed a model describing diving depth as a function of local time of day to account for diel variation in diving behavior. Seals feeding in pelagic ice-free waters during the summer months displayed clear diel variation, with daytime dives reaching 500-1500 m and night-time targeting of the subsurface temperature and salinity maxima characteristic of CDW around 150-300 meters. This pattern was especially clear in the Weddell Cold and Warm Regimes within the gyre, occurred in the ACC, but was absent at the Dronning Maud Land shelf region where seals fed benthically. Diel variation was almost absent in pelagic feeding areas covered by winter sea ice, where seals targeted deep layers around 500-700 meters. Thus, elephant seals appear to switch between feeding strategies when moving between oceanic regimes or in response to seasonal environmental conditions. While they are on the shelf, they exploit the locally-rich benthic ecosystem, while diel patterns in pelagic waters in summer are probably a response to strong vertical migration patterns within the copepod-based pelagic food web. Behavioral flexibility that permits such switching between different feeding strategies may have important consequences regarding the potential for southern elephant seals to adapt to variability or systematic changes in their environment resulting from climate change.	[Biuw, Martin; Nost, Ole Anders; Zhou, Qin; Lydersen, Christian; Kovacs, Kit M.] Norwegian Polar Res Inst, Polar Environm Ctr, Tromso, Norway; [Stien, Audun] Norwegian Inst Nat Res, Polar Environm Ctr, Tromso, Norway	Norwegian Polar Institute; Norwegian Institute Nature Research	Biuw, M (corresponding author), Norwegian Polar Res Inst, Polar Environm Ctr, Tromso, Norway.	martin.biuw@npolar.no	Biuw, Martin/AAF-9895-2021	Stien, Audun/0000-0001-8046-7337; Nost, Ole Anders/0000-0002-6139-4088; Biuw, Martin/0000-0001-8051-3399	Research Council of Norway; Natural Environment Research Council [NE/E018289/1] Funding Source: researchfish; NERC [NE/E018289/1] Funding Source: UKRI	Research Council of Norway(Research Council of Norway); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This study is part of MEOP (Marine Mammals Exploring the Oceans Pole to pole), Norway, an International Polar Year (IPY) programme funded by the Research Council of Norway (Grant number to be provided). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amante C., 2009, ETOPO1 1 ARC MINUTE; Andrews RD, 2008, POLAR BIOL, V31, P1461, DOI 10.1007/s00300-008-0487-z; Atkinson A, 2000, POLAR BIOL, V23, P46, DOI 10.1007/s003000050007; Bailleul F, 2007, PHILOS T R SOC B, V362, P2169, DOI 10.1098/rstb.2007.2109; Bailleul F, 2007, DEEP-SEA RES PT II, V54, P343, DOI 10.1016/j.dsr2.2006.11.005; Bailleul F, 2010, MAR ECOL PROG SER, V408, P251, DOI 10.3354/meps08560; BAKER JR, 1988, VET REC, V123, P287, DOI 10.1136/vr.123.11.287; Bates D., 2010, IME4 LINEAR MIXED EF; Bennett KA, 2001, J EXP BIOL, V204, P649; Bester MN, 2002, ANTARCT SCI, V14, P123, DOI 10.1017/S0954102002000676; Biuw M, 2007, P NATL ACAD SCI USA, V104, P13705, DOI 10.1073/pnas.0701121104; Biuw M, 2009, MAR ECOL PROG SER, V385, P271, DOI 10.3354/meps08025; Boehme L, 2009, OCEAN SCI, V5, P685, DOI 10.5194/os-5-685-2009; Boehme L, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004647; Boehme L, 2008, LIMNOL OCEANOGR, V53, P2350, DOI 10.4319/lo.2008.53.5_part_2.2350; Bornemann H, 2000, ANTARCT SCI, V12, P3, DOI 10.1017/S095410200000002X; Bost CA, 2002, MAR ECOL PROG SER, V227, P51, DOI 10.3354/meps227051; Boyd IL, 1994, BIOMASS ENERGY CONSU, P98; Bradshaw CJA, 2003, P ROY SOC B-BIOL SCI, V270, P1283, DOI 10.1098/rspb.2003.2371; BURNS JM, 1997, DEV CHANGES DIURNAL, P328; CAMPAGNA C, 1995, J ZOOL, V236, P55, DOI 10.1111/j.1469-7998.1995.tb01784.x; Campagna C, 1999, J MAMMAL, V80, P1341, DOI 10.2307/1383185; Campagna C, 2006, DEEP-SEA RES PT I, V53, P1907, DOI 10.1016/j.dsr.2006.08.015; Charrassin JB, 2008, P NATL ACAD SCI USA, V105, P11634, DOI 10.1073/pnas.0800790105; Charrassin JB, 1998, OECOLOGIA, V114, P194, DOI 10.1007/s004420050436; Cherel Y, 1999, MAR BIOL, V134, P375, DOI 10.1007/s002270050554; Cherel Y, 2008, MAR ECOL PROG SER, V370, P239, DOI 10.3354/meps07673; Cisewski B, 2010, DEEP-SEA RES PT I, V57, P78, DOI 10.1016/j.dsr.2009.10.005; CROXALL JP, 1985, J ANIM ECOL, V54, P1, DOI 10.2307/4616; Daneri GA, 2002, POLAR BIOL, V25, P739, DOI 10.1007/s00300-002-0408-5; DEACON GER, 1979, DEEP-SEA RES, V26, P981, DOI 10.1016/0198-0149(79)90044-X; Egevang C, 2010, P NATL ACAD SCI USA, V107, P2078, DOI 10.1073/pnas.0909493107; EKAU W, 1990, ANTARCT SCI, V2, P129, DOI 10.1017/S0954102090000165; Fauchald P, 2006, OECOLOGIA, V149, P383, DOI 10.1007/s00442-006-0463-7; Fedak M, 2002, INTEGR COMP BIOL, V42, P3, DOI 10.1093/icb/42.1.3; Fedak Mike, 2004, Memoirs of National Institute of Polar Research Special Issue, V58, P133; Field I, 2001, ANTARCT SCI, V13, P371, DOI 10.1017/S0954102001000529; Field IC, 2005, OECOLOGIA, V142, P127, DOI 10.1007/s00442-004-1704-2; Field IC, 2002, VET REC, V151, P235, DOI 10.1136/vr.151.8.235; Flores H, 2008, MAR ECOL PROG SER, V367, P271, DOI 10.3354/meps07530; GERDES D, 1992, POLAR BIOL, V12, P291; GODLEWSKA M, 1987, POLAR BIOL, V8, P17, DOI 10.1007/BF00297159; GOURETSKI VV, 1993, DEEP-SEA RES PT I, V40, P561, DOI 10.1016/0967-0637(93)90146-T; Guinet C, 2001, MAR ECOL PROG SER, V219, P251, DOI 10.3354/meps219251; Hamer KC, 2007, MAR ECOL PROG SER, V338, P295, DOI 10.3354/meps338295; Hays GC, 2003, HYDROBIOLOGIA, V503, P163, DOI 10.1023/B:HYDR.0000008476.23617.b0; HINDELL MA, 1991, AUST J MAR FRESH RES, V42, P115; HINDELL MA, 1991, AUST J ZOOL, V39, P595, DOI 10.1071/ZO9910595; Hindell MA, 1999, CAN J ZOOL, V77, P1807, DOI 10.1139/cjz-77-11-1807; Hoppema M, 2004, DEEP-SEA RES PT I, V51, P1169, DOI 10.1016/j.dsr.2004.02.011; Horning M, 1999, P ROY SOC B-BIOL SCI, V266, P1127, DOI 10.1098/rspb.1999.0753; HUBOLD G, 1984, POLAR BIOL, V3, P231, DOI 10.1007/BF00292628; HUBOLD G, 1985, POLAR BIOL, V5, P43, DOI 10.1007/BF00446044; HUNTLEY M, 1991, DEEP-SEA RES, V38, P1145, DOI 10.1016/0198-0149(91)90100-T; *IFR CERS, 2010, SSMI PSI SSM I SEA I; Jonker FC, 1998, ANTARCT SCI, V10, P21, DOI 10.1017/S0954102098000042; JOUVENTIN P, 1990, NATURE, V343, P746, DOI 10.1038/343746a0; Kirkwood R, 1997, ECOL MONOGR, V67, P155, DOI 10.1890/0012-9615(1997)067[0155:TFEOFE]2.0.CO;2; KOOYMAN GL, 1995, CONDOR, V97, P536, DOI 10.2307/1369039; KOOYMAN GL, 1975, J MAMMAL, V56, P563, DOI 10.2307/1379469; Kozlov A.N., 1995, CCAMLR Science, V2, P71; LAWS RM, 1994, HIST PRESENT STATUS, P49; Lea MA, 2002, POLAR BIOL, V25, P269, DOI 10.1007/s00300-001-0339-6; Lydersen C, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015462; MCCONNELL BJ, 1992, ANTARCT SCI, V4, P393, DOI 10.1017/S0954102092000580; McMahon CR, 2000, VET REC, V146, P251, DOI 10.1136/vr.146.9.251; MORRIS DJ, 1984, MAR ECOL PROG SER, V20, P203, DOI 10.3354/meps020203; Moteki M, 2009, POLAR BIOL, V32, P1461, DOI 10.1007/s00300-009-0643-0; Nicholls KW, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL035742; ORSI AH, 1993, DEEP-SEA RES PT I, V40, P169, DOI 10.1016/0967-0637(93)90060-G; Pakhomov EA, 1996, MAR ECOL PROG SER, V134, P1, DOI 10.3354/meps134001; Pasternak AF, 2001, POLAR BIOL, V24, P771, DOI 10.1007/s003000100283; Piatkowski U, 2002, J MAR BIOL ASSOC UK, V82, P913, DOI 10.1017/S0025315402006343; PIATKOWSKI U, 1994, ANTARCT SCI, V6, P241, DOI 10.1017/S0954102094000374; Pinaud D, 2005, J ANIM ECOL, V74, P852, DOI 10.1111/j.1365-2656.2005.00984.x; PLOTZ J, 1986, POLAR BIOL, V6, P97, DOI 10.1007/BF00258259; Plotz J, 2001, POLAR BIOL, V24, P901, DOI 10.1007/s003000100297; PLOTZ J, 1991, POLAR BIOL, V11, P305; Pusch C, 2004, DEEP-SEA RES PT I, V51, P1685, DOI 10.1016/j.dsr.2004.06.008; R Core Team, 2020, R LANG ENV STAT COMP; RODHOUSE PG, 1992, CAN J ZOOL, V70, P1007, DOI 10.1139/z92-143; Roquet F, 2009, J MARINE SYST, V78, P377, DOI 10.1016/j.jmarsys.2008.11.017; RUCKSTUHL A, 2009, ROBUSTBASE BASIC ROB; Schnack-Schiel SB, 2001, HYDROBIOLOGIA, V453, P9, DOI 10.1023/A:1013195329066; Schroder M, 1999, DEEP-SEA RES PT II, V46, P501, DOI 10.1016/S0967-0645(98)00112-X; Shimode S, 2009, AQUAT BIOL, V7, P295, DOI 10.3354/ab00201; Smedsrud LH, 2005, DEEP-SEA RES PT I, V52, P241, DOI 10.1016/j.dsr.2004.10.004; Spiridonov VA, 1996, J MARINE SYST, V9, P211, DOI 10.1016/S0924-7963(95)00049-6; Spiridonov VA, 1997, MAR ECOL PROG SER, V157, P233, DOI 10.3354/meps157233; Straneo F, 2010, NAT GEOSCI, V3, P182, DOI 10.1038/NGEO764; Tosh CA, 2009, ANTARCT SCI, V21, P113, DOI 10.1017/S0954102008001557; Tynan CT, 1998, NATURE, V392, P708, DOI 10.1038/33675; WHITE MG, 1993, POLAR BIOL, V13, P41; WHITWORTH T, 1987, J GEOPHYS RES-OCEANS, V92, P6462, DOI 10.1029/JC092iC06p06462; Wienecke BC, 1997, MAR ECOL PROG SER, V159, P249, DOI 10.3354/meps159249; WILSON RP, 1993, MAR ECOL PROG SER, V94, P101; Wunsch C, 2009, OCEANOGRAPHY, V22, P88, DOI 10.5670/oceanog.2009.41; Zimmer I, 2008, AQUAT BIOL, V3, P217, DOI 10.3354/ab00082; [No title captured]	99	49	50	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2010	5	11							e13816	10.1371/journal.pone.0013816	http://dx.doi.org/10.1371/journal.pone.0013816			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	674WJ	21072199	gold, Green Submitted, Green Published			2022-12-27	WOS:000283780800014
J	Sugimoto, M; Sasaki, S; Watanabe, T; Nishimura, S; Ideta, A; Yamazaki, M; Matsuda, K; Yuzaki, M; Sakimura, K; Aoyagi, Y; Sugimoto, Y				Sugimoto, Mayumi; Sasaki, Shinji; Watanabe, Toshio; Nishimura, Shota; Ideta, Atsushi; Yamazaki, Maya; Matsuda, Keiko; Yuzaki, Michisuke; Sakimura, Kenji; Aoyagi, Yoshito; Sugimoto, Yoshikazu			Ionotropic Glutamate Receptor AMPA 1 Is Associated with Ovulation Rate	PLOS ONE			English	Article							GONADOTROPIN-RELEASING-HORMONE; D-ASPARTATE RECEPTORS; LUTEINIZING-HORMONE; LINKAGE DISEQUILIBRIUM; PLASMA-CONCENTRATIONS; EMBRYO-TRANSFER; NR2 SUBUNITS; DAIRY-CATTLE; PROGESTERONE; ESTRADIOL	Ionotropic glutamate receptors mediate most excitatory neurotransmission in the central nervous system by opening ion channels upon the binding of glutamate. Despite the essential roles of glutamate in the control of reproduction and anterior pituitary hormone secretion, there is a limited understanding of how glutamate receptors control ovulation. Here we reveal the function of the ionotropic glutamate receptor AMPA-1 (GRIA1) in ovulation. Based on a genome-wide association study in Bos taurus, we found that ovulation rate is influenced by a variation in the N-terminal leucine/isoleucine/valine-binding protein (LIVBP) domain of GRIA1, in which serine is replaced by asparagine. GRIA1(Asn) has a weaker affinity to glutamate than GRIA1(Ser), both in Xenopus oocytes and in the membrane fraction of bovine brain. This single amino acid substitution leads to the decreased release of gonadotropin-releasing hormone (GnRH) in immortalized hypothalamic GT1-7 cells. Cows with GRIA1(Asn) have a slower luteinizing hormone (LH) surge than cows with GRIA1(Ser). In addition, cows with GRIA1(Asn) possess fewer immature ovarian follicles before superovulation and have a lower response to hormone treatment than cows with GRIA1(Ser). Our work identified that GRIA1 is a critical mediator of ovulation and that GRIA1 might be a useful target for reproductive therapy.	[Sugimoto, Mayumi] Natl Livestock Breeding Ctr, Nishigo, Japan; [Sasaki, Shinji; Watanabe, Toshio; Nishimura, Shota; Sugimoto, Yoshikazu] Shirakawa Inst Anim Genet, Nishigo, Japan; [Ideta, Atsushi; Aoyagi, Yoshito] Embryo Transfer Ctr ZEN NOH, Kamishihoro, Japan; [Yamazaki, Maya; Sakimura, Kenji] Niigata Univ, Brain Res Inst, Niigata, Japan; [Matsuda, Keiko; Yuzaki, Michisuke] Keio Univ, Sch Med, Dept Physiol, Tokyo 160, Japan	Niigata University; Keio University	Sugimoto, M (corresponding author), Natl Livestock Breeding Ctr, Nishigo, Japan.	kazusugi@siag.or.jp	Yamazaki, Maya/C-6952-2012; Yuzaki, Michisuke/K-5328-2013	Yuzaki, Michisuke/0000-0002-5750-3544	Japan Racing and Livestock Promotion Foundation	Japan Racing and Livestock Promotion Foundation	This work was supported by the Japan Racing and Livestock Promotion Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEVERS MM, 1987, ANIM REPROD SCI, V15, P37, DOI 10.1016/0378-4320(87)90004-2; Brann DW, 1997, ENDOCR REV, V18, P678, DOI 10.1210/er.18.5.678; Chen GQ, 1997, P NATL ACAD SCI USA, V94, P13431, DOI 10.1073/pnas.94.25.13431; Choi JH, 2006, J CLIN ENDOCR METAB, V91, P4562, DOI 10.1210/jc.2006-1147; CROSIGNANI PG, 1991, HUM REPROD, V6, P953, DOI 10.1093/oxfordjournals.humrep.a137468; Devlin B, 2001, THEOR POPUL BIOL, V60, P155, DOI 10.1006/tpbi.2001.1542; Dingledine R, 1999, PHARMACOL REV, V51, P7; El-Etr M, 2006, ENDOCRINOLOGY, V147, P2737, DOI 10.1210/en.2005-1191; FELIG P, ENDOCRINOLOGY METABO; Fortune JE, 2000, MOL CELL ENDOCRINOL, V163, P53, DOI 10.1016/S0303-7207(99)00240-3; FUNAHASHI T, 2008, 31 ANN M JAP NEUR SO; Gielen M, 2009, NATURE, V459, P703, DOI 10.1038/nature07993; Gonda MG, 2004, ANIM GENET, V35, P298, DOI 10.1111/j.1365-2052.2004.01162.x; HASLER JF, 1992, J DAIRY SCI, V75, P2857, DOI 10.3168/jds.S0022-0302(92)78049-7; Heifetz EM, 2005, GENETICS, V171, P1173, DOI 10.1534/genetics.105.040782; Ihara N, 2004, GENOME RES, V14, P1987, DOI 10.1101/gr.2741704; Ikeno K, 2001, NEUROSCI RES, V41, P193, DOI 10.1016/S0168-0102(01)00277-2; Ireland JJ, 2009, BIOL REPROD, V80, P954, DOI 10.1095/biolreprod.108.073791; Kengaku K, 2007, J REPROD DEVELOP, V53, P987, DOI 10.1262/jrd.18107; Konig S, 2007, J DAIRY SCI, V90, P3945, DOI 10.3168/jds.2007-0089; Madry C, 2007, MOL PHARMACOL, V72, P1535, DOI 10.1124/mol.107.040071; Matsuda S, 2005, J BIOL CHEM, V280, P20021, DOI 10.1074/jbc.M410513200; Matsuda S, 2002, EUR J NEUROSCI, V16, P1507, DOI 10.1046/j.1460-9568.2002.02219.x; Matzuk MM, 2008, NAT MED, V14, P1197, DOI 10.1038/nm.f.1895; MIKOSHIBA K, 1990, MANUALS NEUROBIOCHEM; MORI Y, 1984, J REPROD FERTIL, V72, P223, DOI 10.1530/jrf.0.0720223; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Nomura T, 2001, J ANIM SCI, V79, P366; Ojeda SR, 2006, ENDOCRINOLOGY, V147, P1166, DOI 10.1210/en.2005-1136; Pritchard JK, 2000, GENETICS, V155, P945; Schally A V, 1970, Res Reprod, V2, P2; Shimshek DR, 2006, MOL ENDOCRINOL, V20, P219, DOI 10.1210/me.2005-0262; SVED J A, 1971, Theoretical Population Biology, V2, P125; Taft R, 1996, J ANIM SCI, V74, P2985; Wang Y, 2003, EUR J NEUROSCI, V17, P1581, DOI 10.1046/j.1460-9568.2003.02595.x; Watanabe T, 2008, ANIM GENET, V39, P374, DOI 10.1111/j.1365-2052.2008.01742.x; WETSEL WC, 1992, P NATL ACAD SCI USA, V89, P4149, DOI 10.1073/pnas.89.9.4149; Yamazaki M, 2004, NEUROSCI RES, V50, P369, DOI 10.1016/j.neures.2004.10.002; Zamanillo D, 1999, SCIENCE, V284, P1805, DOI 10.1126/science.284.5421.1805	39	25	25	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2010	5	11							e13817	10.1371/journal.pone.0013817	http://dx.doi.org/10.1371/journal.pone.0013817			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	674WJ	21072200	gold, Green Submitted, Green Published			2022-12-27	WOS:000283780800015
J	Shipp, LE; Lee, JV; Yu, CY; Pufall, M; Zhang, PL; Scott, DK; Wang, JC				Shipp, Lauren E.; Lee, Joyce V.; Yu, Chi-Yi; Pufall, Miles; Zhang, Pili; Scott, Donald K.; Wang, Jen-Chywan			Transcriptional Regulation of Human Dual Specificity Protein Phosphatase 1 (DUSP1) Gene by Glucocorticoids	PLOS ONE			English	Article							PHOSPHOENOLPYRUVATE CARBOXYKINASE GENE; ALPHA-1-ACID GLYCOPROTEIN GENE; CAMP RESPONSE ELEMENT; MAPK PHOSPHATASE-1; ACCESSORY FACTOR; RECEPTOR; BINDING; KINASE; EXPRESSION; TARGET	Background: Glucocorticoids are potent anti-inflammatory agents commonly used to treat inflammatory diseases. They convey signals through the intracellular glucocorticoid receptor (GR), which upon binding to ligands, associates with genomic glucocorticoid response elements (GREs) to regulate transcription of associated genes. One mechanism by which glucocorticoids inhibit inflammation is through induction of the dual specificity phosphatase-1 (DUSP1, a.k.a. mitogen-activated protein kinase phosphatase-1, MKP-1) gene. Methodology/Principal Findings: We found that glucocorticoids rapidly increased transcription of DUSP1 within 10 minutes in A549 human lung adenocarcinoma cells. Using chromatin immunoprecipitation (ChIP) scanning, we located a GR binding region between -1421 and -1118 upstream of the DUSP1 transcription start site. This region is active in a reporter system, and mutagenesis analyses identified a functional GRE located between -1337 and -1323. We found that glucocorticoids increased DNase I hypersensitivity, reduced nucleosome density, and increased histone H3 and H4 acetylation within genomic regions surrounding the GRE. ChIP experiments showed that p300 was recruited to the DUSP1 GRE, and RNA interference experiments demonstrated that reduction of p300 decreased glucocorticoid-stimulated DUSP1 gene expression and histone H3 hyperacetylation. Furthermore, overexpression of p300 potentiated glucocorticoid-stimulated activity of a reporter gene containing the DUSP1 GRE, and this coactivation effect was compromised when the histone acetyltransferase domain was mutated. ChIP-reChIP experiments using GR followed by p300 antibodies showed significant enrichment of the DUSP1 GRE upon glucocorticoid treatment, suggesting that GR and p300 are in the same protein complex recruited to the DUSP1 GRE. Significance: Our studies identified a functional GRE for the DUSP1 gene. Moreover, the transcriptional activation of DUSP1 by glucocorticoids requires p300 and a rapid modification of the chromatin structure surrounding the GRE. Overall, understanding the mechanism of glucocorticoid-induced DUSP1 gene transcription could provide insights into therapeutic approaches against inflammatory diseases.	[Shipp, Lauren E.; Lee, Joyce V.; Yu, Chi-Yi; Wang, Jen-Chywan] Univ Calif Berkeley, Dept Nutr Sci & Toxicol, Berkeley, CA 94720 USA; [Pufall, Miles] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA; [Zhang, Pili; Scott, Donald K.] Univ Pittsburgh, Div Endocrinol, Dept Med, Pittsburgh, PA USA	University of California System; University of California Berkeley; University of California System; University of California San Francisco; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Shipp, LE (corresponding author), Univ Calif Berkeley, Dept Nutr Sci & Toxicol, Berkeley, CA 94720 USA.	walwang@berkeley.edu	Wang, Jen-Chywan/AAX-4445-2020	Wang, Jen-Chywan/0000-0001-6030-6886; Pufall, Miles/0000-0002-7022-6916	University of California [17KT-0028]; NATIONAL CANCER INSTITUTE [K99CA149088, R00CA149088] Funding Source: NIH RePORTER	University of California(University of California System); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study is supported by a New Investigator Award (17KT-0028) from University of California Tobacco-related Diseases Research Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham SM, 2006, BIOCHEM SOC T, V34, P1018, DOI 10.1042/BST0341018; Abraham SM, 2006, J EXP MED, V203, P1883, DOI 10.1084/jem.20060336; ALAM T, 1993, J BIOL CHEM, V268, P15681; Barnes PJ, 2006, EUR J PHARMACOL, V533, P2, DOI 10.1016/j.ejphar.2005.12.052; Barnes PJ, 2006, EUR RESPIR J, V27, P413, DOI 10.1183/09031936.06.00125404; Bhattacharyya S, 2007, BLOOD, V109, P4313, DOI 10.1182/blood-2006-10-048215; Bolton EC, 2007, GENE DEV, V21, P2005, DOI 10.1101/gad.1564207; Brook M, 2006, MOL CELL BIOL, V26, P2408, DOI 10.1128/MCB.26.6.2408-2418.2006; Chinenov Y, 2007, MOL CELL ENDOCRINOL, V275, P30, DOI 10.1016/j.mce.2007.04.014; Clark AR, 2007, MOL CELL ENDOCRINOL, V275, P79, DOI 10.1016/j.mce.2007.04.013; Dong C, 2002, ANNU REV IMMUNOL, V20, P55, DOI 10.1146/annurev.immunol.20.091301.131133; ESPINAS ML, 1994, MOL CELL BIOL, V14, P4116, DOI 10.1128/MCB.14.6.4116; Furst R, 2007, FASEB J, V21, P74, DOI 10.1096/fj.06-6752com; Girdwood D, 2003, MOL CELL, V11, P1043, DOI 10.1016/S1097-2765(03)00141-2; Hermoso MA, 2004, MOL CELL BIOL, V24, P4743, DOI 10.1128/MCB.24.11.4743-4756.2004; Hitti E, 2006, MOL CELL BIOL, V26, P2399, DOI 10.1128/MCB.26.6.2399-2407.2006; IMAI E, 1993, J BIOL CHEM, V268, P5353; IMAI E, 1990, MOL CELL BIOL, V10, P4712, DOI 10.1128/MCB.10.9.4712; Johansson-Haque K, 2008, J MOL ENDOCRINOL, V41, P239, DOI 10.1677/JME-08-0015; John S, 2008, MOL CELL, V29, P611, DOI 10.1016/j.molcel.2008.02.010; Kaminska B, 2005, BBA-PROTEINS PROTEOM, V1754, P253, DOI 10.1016/j.bbapap.2005.08.017; Kim JH, 2006, NUCLEIC ACIDS RES, V34, P2736, DOI 10.1093/nar/gkl361; Koliwad SK, 2009, J BIOL CHEM, V284, P25593, DOI 10.1074/jbc.M109.025452; Lang R, 2006, J IMMUNOL, V177, P7497, DOI 10.4049/jimmunol.177.11.7497; LUCAS PC, 1992, ANNU REV BIOCHEM, V61, P1131; Luecke HF, 2005, GENE DEV, V19, P1116, DOI 10.1101/gad.1297105; LUISI BF, 1991, NATURE, V352, P497, DOI 10.1038/352497a0; MINER JN, 1991, TRENDS BIOCHEM SCI, V16, P423, DOI 10.1016/0968-0004(91)90168-U; NISHIO Y, 1993, MOL CELL BIOL, V13, P1854, DOI 10.1128/MCB.13.3.1854; Owens DM, 2007, ONCOGENE, V26, P3203, DOI 10.1038/sj.onc.1210412; Reddy TE, 2009, GENOME RES, V19, P2163, DOI 10.1101/gr.097022.109; Rhen T, 2005, NEW ENGL J MED, V353, P1711, DOI 10.1056/NEJMra050541; Rogatsky I, 2001, EMBO J, V20, P6071, DOI 10.1093/emboj/20.21.6071; ROUX J, 1995, DNA CELL BIOL, V14, P385, DOI 10.1089/dna.1995.14.385; Salojin KV, 2006, J IMMUNOL, V176, P1899, DOI 10.4049/jimmunol.176.3.1899; Sankar N, 2008, ONCOGENE, V27, P5717, DOI 10.1038/onc.2008.181; Scott DK, 1996, J BIOL CHEM, V271, P31909, DOI 10.1074/jbc.271.50.31909; Shahbazian MD, 2007, ANNU REV BIOCHEM, V76, P75, DOI 10.1146/annurev.biochem.76.052705.162114; So AYL, 2007, PLOS GENET, V3, P927, DOI 10.1371/journal.pgen.0030094; Tchen CR, 2010, J BIOL CHEM, V285, P2642, DOI 10.1074/jbc.M109.037309; Trotter KW, 2007, MOL CELL ENDOCRINOL, V265, P162, DOI 10.1016/j.mce.2006.12.015; Vander Kooi BT, 2005, MOL ENDOCRINOL, V19, P3001, DOI 10.1210/me.2004-0497; Wang JC, 2006, GENE DEV, V20, P689, DOI 10.1101/gad.1400506; Wang JC, 2004, P NATL ACAD SCI USA, V101, P15603, DOI 10.1073/pnas.0407008101; Wang JC, 1999, MOL ENDOCRINOL, V13, P604, DOI 10.1210/me.13.4.604; Wyszomierski SL, 2001, MOL ENDOCRINOL, V15, P228, DOI 10.1210/me.15.2.228; Yamada K, 1999, J BIOL CHEM, V274, P5880, DOI 10.1074/jbc.274.9.5880; YAMAMOTO KR, 1985, ANNU REV GENET, V19, P209, DOI 10.1146/annurev.genet.19.1.209; Zhao Q, 2006, J EXP MED, V203, P131, DOI 10.1084/jem.20051794	49	79	80	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2010	5	10							e13754	10.1371/journal.pone.0013754	http://dx.doi.org/10.1371/journal.pone.0013754			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673FU	21060794	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000283645300033
J	Oliveira, MT; Kaguni, LS				Oliveira, Marcos T.; Kaguni, Laurie S.			Functional Roles of the N- and C-Terminal Regions of the Human Mitochondrial Single-Stranded DNA-Binding Protein	PLOS ONE			English	Article							GENE 2.5 PROTEIN; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; POLYMERASE GAMMA; DROSOPHILA-MELANOGASTER; ACCESSORY SUBUNIT; BACTERIOPHAGE T7; REPLICATION FORK; COOH TERMINUS; IN-VITRO	Biochemical studies of the mitochondrial DNA (mtDNA) replisome demonstrate that the mtDNA polymerase and the mtDNA helicase are stimulated by the mitochondrial single-stranded DNA-binding protein (mtSSB). Unlike Escherichia coli SSB, bacteriophage T7 gp2.5 and bacteriophage T4 gp32, mtSSBs lack a long, negatively charged C-terminal tail. Furthermore, additional residues at the N-terminus (notwithstanding the mitochondrial presequence) are present in the sequence of species across the animal kingdom. We sought to analyze the functional importance of the N- and C-terminal regions of the human mtSSB in the context of mtDNA replication. We produced the mature wild-type human mtSSB and three terminal deletion variants, and examined their physical and biochemical properties. We demonstrate that the recombinant proteins adopt a tetrameric form, and bind single-stranded DNA with similar affinities. They also stimulate similarly the DNA unwinding activity of the human mtDNA helicase (up to 8-fold). Notably, we find that unlike the high level of stimulation that we observed previously in the Drosophila system, stimulation of DNA synthesis catalyzed by human mtDNA polymerase is only moderate, and occurs over a narrow range of salt concentrations. Interestingly, each of the deletion variants of human mtSSB stimulates DNA synthesis at a higher level than the wild-type protein, indicating that the termini modulate negatively functional interactions with the mitochondrial replicase. We discuss our findings in the context of species-specific components of the mtDNA replisome, and in comparison with various prokaryotic DNA replication machineries.	[Oliveira, Marcos T.] Michigan State Univ, Dept Biochem & Mol Biol, Ctr Mitochondrial Sci & Med, E Lansing, MI 48824 USA; Michigan State Univ, Grad Program Genet, E Lansing, MI 48824 USA	Michigan State University; Michigan State University	Oliveira, MT (corresponding author), Michigan State Univ, Dept Biochem & Mol Biol, Ctr Mitochondrial Sci & Med, E Lansing, MI 48824 USA.	lskaguni@msu.edu	Oliveira, Marcos Túlio/AAN-2804-2020; Oliveira, Marcos/B-3249-2014	Oliveira, Marcos/0000-0003-4779-5755	National Institutes of Health [GM45295]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045295] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM45295. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bochkarev A, 1997, NATURE, V385, P176, DOI 10.1038/385176a0; BURKE RL, 1980, J BIOL CHEM, V255, P1484; CLAYTON DA, 1982, CELL, V28, P693, DOI 10.1016/0092-8674(82)90049-6; Curth U, 1996, NUCLEIC ACIDS RES, V24, P2706, DOI 10.1093/nar/24.14.2706; CURTH U, 1994, EUR J BIOCHEM, V221, P435, DOI 10.1111/j.1432-1033.1994.tb18756.x; Fan L, 2001, BIOCHEMISTRY-US, V40, P4780, DOI 10.1021/bi010102h; Farr CL, 1999, J BIOL CHEM, V274, P14779, DOI 10.1074/jbc.274.21.14779; Farr CL, 2004, J BIOL CHEM, V279, P17047, DOI 10.1074/jbc.M400283200; Gray MW, 1999, SCIENCE, V283, P1476, DOI 10.1126/science.283.5407.1476; HACKENBR.CR, 1968, P NATL ACAD SCI USA, V61, P598, DOI 10.1073/pnas.61.2.598; He ZG, 2003, J BIOL CHEM, V278, P29538, DOI 10.1074/jbc.M304318200; Hollis T, 2001, P NATL ACAD SCI USA, V98, P9557, DOI 10.1073/pnas.171317698; Holt IJ, 2000, CELL, V100, P515, DOI 10.1016/S0092-8674(00)80688-1; Hyland EM, 2003, J BIOL CHEM, V278, P7247, DOI 10.1074/jbc.M210605200; KIM YT, 1994, J BIOL CHEM, V269, P5270; KIM YT, 1992, J BIOL CHEM, V267, P15022; KIM YT, 1993, P NATL ACAD SCI USA, V90, P10173, DOI 10.1073/pnas.90.21.10173; Korhonen JA, 2004, EMBO J, V23, P2423, DOI 10.1038/sj.emboj.7600257; Korhonen JA, 2003, J BIOL CHEM, V278, P48627, DOI 10.1074/jbc.M306981200; Kornberg A, 1992, DNA REPLICATION, pxiv; Kozlov AG, 2010, J BIOL CHEM, V285, P17246, DOI 10.1074/jbc.M110.118273; KRASSA KB, 1991, P NATL ACAD SCI USA, V88, P4010, DOI 10.1073/pnas.88.9.4010; Lee YS, 2009, CELL, V139, P312, DOI 10.1016/j.cell.2009.07.050; LEE YS, 2009, J BIOL CHEM; Lim SE, 1999, J BIOL CHEM, V274, P38197, DOI 10.1074/jbc.274.53.38197; Luo NG, 2005, J BIOL CHEM, V280, P2491, DOI 10.1074/jbc.M411447200; Maier D, 2001, MOL BIOL CELL, V12, P821, DOI 10.1091/mbc.12.4.821; Marintcheva B, 2008, P NATL ACAD SCI USA, V105, P1855, DOI 10.1073/pnas.0711919105; NAKAI H, 1988, J BIOL CHEM, V263, P9831; Oliveira MT, 2009, METHODS MOL BIOL, V554, P37, DOI 10.1007/978-1-59745-521-3_3; Raghunathan S, 1997, P NATL ACAD SCI USA, V94, P6652, DOI 10.1073/pnas.94.13.6652; Ruhanen H, 2010, BBA-MOL CELL RES, V1803, P931, DOI 10.1016/j.bbamcr.2010.04.008; SHAMOO Y, 1995, NATURE, V376, P362, DOI 10.1038/376362a0; Shereda RD, 2009, J MOL BIOL, V386, P612, DOI 10.1016/j.jmb.2008.12.065; Shereda RD, 2008, CRIT REV BIOCHEM MOL, V43, P289, DOI [10.1080/10409230802341296, 10.1080/10409230802341296 ]; SRERE PA, 1980, TRENDS BIOCHEM SCI, V5, P120, DOI 10.1016/0968-0004(80)90051-1; THOMMES P, 1995, J BIOL CHEM, V270, P21137, DOI 10.1074/jbc.270.36.21137; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tomaska L, 2001, BIOL CHEM, V382, P179, DOI 10.1515/BC.2001.025; VANDYCK E, 1992, EMBO J, V11, P3421, DOI 10.1002/j.1460-2075.1992.tb05421.x; Wallace DC, 2010, MITOCHONDRION, V10, P12, DOI 10.1016/j.mito.2009.09.006; Wang YX, 1999, J BIOL CHEM, V274, P28972, DOI 10.1074/jbc.274.41.28972; WERNETTE CM, 1986, J BIOL CHEM, V261, P4764; WILLIAMS AJ, 1995, J BIOL CHEM, V270, P860, DOI 10.1074/jbc.270.2.860; Wold MS, 1997, ANNU REV BIOCHEM, V66, P61, DOI 10.1146/annurev.biochem.66.1.61; Yakubovskaya E, 2006, J BIOL CHEM, V281, P374, DOI 10.1074/jbc.M509730200; Yang C, 1997, NAT STRUCT BIOL, V4, P153, DOI 10.1038/nsb0297-153; Yang MY, 2002, CELL, V111, P495, DOI 10.1016/S0092-8674(02)01075-9; Ziebarth TD, 2007, J MOL BIOL, V367, P1382, DOI 10.1016/j.jmb.2007.01.079	49	27	27	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2010	5	10							e15379	10.1371/journal.pone.0015379	http://dx.doi.org/10.1371/journal.pone.0015379			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	672HN	21060847	Green Published, gold, Green Submitted			2022-12-27	WOS:000283573800024
J	Bishop, JG; O'Hara, NB; Titus, JH; Apple, JL; Gill, RA; Wynn, L				Bishop, John G.; O'Hara, Niamh B.; Titus, Jonathan H.; Apple, Jennifer L.; Gill, Richard A.; Wynn, Louise			N-P Co-Limitation of Primary Production and Response of Arthropods to N and P in Early Primary Succession on Mount St. Helens Volcano	PLOS ONE			English	Article							BOTTOM-UP FORCES; NITROGEN-FIXATION; ECOSYSTEM DEVELOPMENT; FEEDING GRASSHOPPER; INSECT HERBIVORES; PHOSPHORUS; PLANT; QUALITY; GROWTH; PERFORMANCE	Background: The effect of low nutrient availability on plant-consumer interactions during early succession is poorly understood. The low productivity and complexity of primary successional communities are expected to limit diversity and abundance of arthropods, but few studies have examined arthropod responses to enhanced nutrient supply in this context. We investigated the effects of nitrogen (N) and phosphorus (P) addition on plant productivity and arthropod abundance on 24-yr-old soils at Mount St. Helens volcano. Methodology/Principal Findings: We measured the relative abundance of eight arthropod orders and five families in plots that received N, P, or no nutrients for 3-5 years. We also measured plant % cover, leaf % N, and plant diversity. Vegetation responded rapidly to N addition but showed a lagged response to P that, combined with evidence of increased N fixation, suggested P-limitation to N availability. After 3 yrs of fertilization, orthopterans (primarily Anabrus simplex (Tettigoniidae) and Melanoplus spp (Acrididae)) showed a striking attraction to P addition plots, while no other taxa responded to fertilization. After 5 yrs of fertilization, orthopteran density in the same plots increased 80%-130% with P addition and 40% with N. Using structural equation modeling, we show that in year 3 orthopteran abundance was associated with a P-mediated increase in plant cover (or correlated increases in resource quality), whereas in year 5 orthopteran density was not related to cover, diversity or plant % N, but rather to unmeasured effects of P, such as its influence on other aspects of resource quality. Conclusions/Significance: The marked surprising response to P by orthopterans, combined with a previous observation of P-limitation in lepidopteran herbivores at these sites, suggests that P-mediated effects of food quantity or quality are critical to insect herbivores in this N-P co-limited primary successional system. Our results also support a previous suggestion that the availability of N in these soils is P-limited.	[Bishop, John G.; O'Hara, Niamh B.; Apple, Jennifer L.; Wynn, Louise] Washington State Univ, Sch Biol Sci, Vancouver, WA USA; [Titus, Jonathan H.] SUNY Coll Fredonia, Dept Biol, Fredonia, NY USA; [Gill, Richard A.] Brigham Young Univ, Provo, UT 84602 USA	Washington State University; State University of New York (SUNY) System; SUNY Fredonia; Brigham Young University	Bishop, JG (corresponding author), Washington State Univ, Sch Biol Sci, Vancouver, WA USA.	bishopj@vancouver.wsu.edu	Gill, Richard/AAC-8137-2021	Gill, Richard/0000-0001-8981-0621	National Science Foundation (NSF) [DEB-0089843, DEB-0614538]; M.J. Murdock Charitable Trust	National Science Foundation (NSF)(National Science Foundation (NSF)); M.J. Murdock Charitable Trust	This work was supported by National Science Foundation (NSF) awards DEB-0089843 and DEB-0614538 and a grant from the M.J. Murdock Charitable Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apple JL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007807; Ayres MP, 2000, ECOLOGY, V81, P2198, DOI 10.1890/0012-9658(2000)081[2198:NBOPFB]2.0.CO;2; BEHMER ST, 1993, FUNCT ECOL, V7, P522, DOI 10.2307/2390127; Behmer ST, 2005, FUNCT ECOL, V19, P55, DOI 10.1111/j.0269-8463.2005.00943.x; Behmer ST, 2002, ECOLOGY, V83, P2489, DOI 10.1890/0012-9658(2002)083[2489:HFICHE]2.0.CO;2; BERTRAM SM, J INSECT SC IN PRESS; Bertram SM, 2006, ANIM BEHAV, V72, P899, DOI 10.1016/j.anbehav.2006.02.012; Bishop JG, 2005, ECOLOGICAL RESPONSES TO THE 1980 ERUPTION OF MOUNT ST. HELENS, P151, DOI 10.1007/0-387-28150-9_11; Bishop JG, 2002, ECOLOGY, V83, P191; Bishop JG, 1998, ECOLOGY, V79, P534, DOI 10.1890/0012-9658(1998)079[0534:VIFPAI]2.0.CO;2; Busch JW, 1999, ECOL ENTOMOL, V24, P132, DOI 10.1046/j.1365-2311.1999.00185.x; Campo J, 2003, J TROP ECOL, V19, P525, DOI 10.1017/S0266467403003572; CHAPIN DM, 1991, CAN J BOT, V69, P2744, DOI 10.1139/b91-345; CLANCY KM, 1993, ECOLOGY, V74, P442, DOI 10.2307/1939306; del Moral R, 2005, PLANT ECOL, V181, P203, DOI 10.1007/s11258-005-6627-4; del Moral R, 2009, J VEG SCI, V20, P1145, DOI 10.1111/j.1654-1103.2009.01113.x; Denno RF, 2002, ECOLOGY, V83, P1443, DOI 10.1890/0012-9658(2002)083[1443:BUFMNE]2.0.CO;2; Elser JJ, 2000, NATURE, V408, P578, DOI 10.1038/35046058; Fagan WF, 2005, AM NAT, V166, P669, DOI 10.1086/497621; Fagan WF, 2004, ECOL ENTOMOL, V29, P398, DOI 10.1111/j.0307-6946.2004.00616.x; Fagan WF, 2000, AM NAT, V155, P238, DOI 10.1086/303320; Fox J, 2006, STRUCT EQU MODELING, V13, P465, DOI 10.1207/s15328007sem1303_7; Gill RA, 2006, OECOLOGIA, V148, P312, DOI 10.1007/s00442-006-0358-7; Gruner DS, 2004, ECOLOGY, V85, P3010, DOI 10.1890/04-0020; GRUNER DS, 2005, ECOLOGICAL ENTOMOLOG, P428; Haddad NM, 2000, OECOLOGIA, V124, P73, DOI 10.1007/s004420050026; Halvorson JJ, 2005, ECOLOGICAL RESPONSES TO THE 1980 ERUPTION OF MOUNT ST. HELENS, P243, DOI 10.1007/0-387-28150-9_17; HUNTER MD, 1991, OECOLOGIA, V86, P62, DOI 10.1007/BF00317390; Joern A, 1998, ECOL ENTOMOL, V23, P174, DOI 10.1046/j.1365-2311.1998.00112.x; JOHNSTON J, 2001, GRASSHOPPER MO UNPUB; Jonas JL, 2008, ECOL ENTOMOL, V33, P546, DOI 10.1111/j.1365-2311.2008.01004.x; Jost L, 2006, OIKOS, V113, P363, DOI 10.1111/j.2006.0030-1299.14714.x; LIPMAN PW, 1981, 1980 ERUPTIONS M STH; Loaiza V, 2008, ENVIRON ENTOMOL, V37, P333, DOI 10.1603/0046-225X(2008)37[333:DDPAFA]2.0.CO;2; McNeill S., 1978, BIOCH ASPECTS PLANT, P77; MULKERN GB, 1969, FOOD HABITS PREFEREN; Neumann G, 2002, TRENDS PLANT SCI, V7, P162, DOI 10.1016/S1360-1385(02)02241-0; Oksanen J., 2007, VEGAN COMMUNITY ECOL; ONSAGER JA, 1977, ACRIDA, V6, P231; Perkins MC, 2004, ARCH INSECT BIOCHEM, V55, P153, DOI 10.1002/arch.10133; POPP MP, 1989, ENVIRON ENTOMOL, V18, P795, DOI 10.1093/ee/18.5.795; Raich JW, 1996, BIOGEOCHEMISTRY, V32, P1, DOI 10.1007/BF00001529; Raubenheimer D, 2004, ECOLOGY, V85, P1203, DOI 10.1890/02-0248; Raubenheimer D, 2003, J EXP BIOL, V206, P1669, DOI 10.1242/jeb.00336; Richardson SJ, 2004, OECOLOGIA, V139, P267, DOI 10.1007/s00442-004-1501-y; RITCHIE ME, 1995, ECOLOGY, V76, P2648, DOI 10.2307/2265835; Ritchie ME, 2000, ECOLOGY, V81, P1601, DOI 10.1890/0012-9658(2000)081[1601:NLATVA]2.0.CO;2; Rowe EC, 2006, BIOL CONSERV, V131, P510, DOI 10.1016/j.biocon.2006.02.023; SCHADE JD, 2003, ECOL LETT, V6, P1; SCHOENFELDER A, OECOLOGIA UNPUB; SLANSKY F, 1977, ECOL MONOGR, V47, P209, DOI 10.2307/1942617; Stiling P, 2005, OECOLOGIA, V142, P413, DOI 10.1007/s00442-004-1739-4; Strengbom J, 2005, OECOLOGIA, V143, P241, DOI 10.1007/s00442-004-1799-5; Throop HL, 2004, ECOSYSTEMS, V7, P109, DOI 10.1007/s10021-003-0225-x; Tilman D, 1997, ECOLOGY, V78, P81, DOI 10.1890/0012-9658(1997)078[0081:CIRLAG]2.0.CO;2; Uliassi DD, 2002, ECOLOGY, V83, P88, DOI 10.1890/0012-9658(2002)083[0088:LTSNFI]2.0.CO;2; VITOUSEK PM, 1987, SCIENCE, V238, P802, DOI 10.1126/science.238.4828.802; Vitousek PM, 1999, ECOSYSTEMS, V2, P505, DOI 10.1007/s100219900098; Vitousek PM, 1987, COLONIZATION SUCCESS, P207; WALKER LR, 1986, ECOLOGY, V67, P1508, DOI 10.2307/1939082; Wardle DA, 2004, SCIENCE, V305, P509, DOI 10.1126/science.1098778; White T. C. R., 1993, INADEQUATE ENV NITRO	62	34	34	2	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2010	5	10							e13598	10.1371/journal.pone.0013598	http://dx.doi.org/10.1371/journal.pone.0013598			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671GB	21049006	Green Published, gold			2022-12-27	WOS:000283487400007
J	Wainwright, DA; Sengupta, S; Han, Y; Ulasov, IV; Lesniak, MS				Wainwright, Derek A.; Sengupta, Sadhak; Han, Yu; Ulasov, Ilya V.; Lesniak, Maciej S.			The Presence of IL-17A and T Helper 17 Cells in Experimental Mouse Brain Tumors and Human Glioma	PLOS ONE			English	Article							TH17 LYMPHOCYTES; EXPRESSION; MICE; GLIOBLASTOMA; INHIBITION; ACTIVATION; PHENOTYPE; DEPLETION; T(H)17	Background: Recently, CD4(+)IL-17A(+) T helper 17 (Th17) cells were identified and reported in several diseased states, including autoimmunity, infection and various peripheral nervous system tumors. However, the presence of Th17 in glia-derived tumors of the central nervous system has not been studied. Methodology/Principal Findings: In this report, we demonstrate that mRNA expression for the Th17 cell cytokine IL-17A, as well as Th17 cells, are present in human glioma. The mRNA expression for IL-17A in glioma was recapitulated in an immunocompetent mouse model of malignant glioma. Furthermore, the presence of Th17 cells was confirmed in both human and mouse glioma. Interestingly, some Th17 cells present in mouse glioma co-expressed the Th1 and Th2 lineage markers, IFN-gamma and IL-4, respectively, but predominantly co-expressed the Treg lineage marker FoxP3. Conclusions: These data confirm the presence of Th17 cells in glia-derived CNS tumors and provide the rationale for further investigation into the role of Th17 cells in malignant glioma.	[Wainwright, Derek A.; Sengupta, Sadhak; Han, Yu; Ulasov, Ilya V.; Lesniak, Maciej S.] Univ Chicago, Brain Tumor Ctr, Chicago, IL 60637 USA	University of Chicago	Wainwright, DA (corresponding author), Univ Chicago, Brain Tumor Ctr, Chicago, IL 60637 USA.	mlesniak@surgery.bsd.uchicago.edu	Sengupta, Sadhak/D-2526-2009; Han, Yu/GZA-9220-2022; Ulasov, Ilya/A-2352-2014	Ulasov, Ilya/0000-0002-0818-0363; Wainwright, Derek/0000-0001-7232-4264	NIH [R01CA138587]; NATIONAL CANCER INSTITUTE [R01CA138587] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the NIH grant R01CA138587. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Curtin JF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001983; DeAngelis LM, 2001, NEW ENGL J MED, V344, P114, DOI 10.1056/NEJM200101113440207; El Andaloussi A, 2006, NEURO-ONCOLOGY, V8, P234, DOI 10.1215/15228517-2006-006; El Andaloussi A, 2007, J NEURO-ONCOL, V83, P145, DOI 10.1007/s11060-006-9314-y; El Andaloussi A, 2006, J NEUROSURG, V105, P430, DOI 10.3171/jns.2006.105.3.430; Emamaullee JA, 2009, DIABETES, V58, P1302, DOI 10.2337/db08-1113; GEROSA M, 1981, SURG NEUROL, V16, P48, DOI 10.1016/S0090-3019(81)80065-1; Gocke AR, 2007, J IMMUNOL, V178, P1341, DOI 10.4049/jimmunol.178.3.1341; Gounaris E, 2009, CANCER RES, V69, P5490, DOI 10.1158/0008-5472.CAN-09-0304; Kostianovsky AM, 2008, J IMMUNOL, V181, P5425, DOI 10.4049/jimmunol.181.8.5425; Kryczek I, 2007, J IMMUNOL, V178, P6730, DOI 10.4049/jimmunol.178.11.6730; Schwartzbaum JA, 2010, NEURO-ONCOLOGY, V12, P320, DOI 10.1093/neuonc/nop035; Sharma MD, 2009, BLOOD, V113, P6102, DOI 10.1182/blood-2008-12-195354; Siciliano NA, 2006, J IMMUNOL, V177, P7131, DOI 10.4049/jimmunol.177.10.7131; Steinman L, 2010, NAT IMMUNOL, V11, P41, DOI 10.1038/ni.1803; Su XM, 2010, J IMMUNOL, V184, P1630, DOI 10.4049/jimmunol.0902813; Sundrud MS, 2009, SCIENCE, V324, P1334, DOI 10.1126/science.1172638; Wainwright DA, 2009, ASN NEURO, V1, DOI 10.1042/AN20090017; Wainwright DA, 2010, NEUROSCI LETT, V471, P10, DOI 10.1016/j.neulet.2009.12.076; Wainwright DA, 2009, J NEUROIMMUNOL, V216, P66, DOI 10.1016/j.jneuroim.2009.09.009; Wong CK, 2009, IMMUNOL INVEST, V38, P652, DOI 10.1080/08820130903062756; YOO ZB, 1995, J IMMUNOL, V155, P5483	23	44	45	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2010	5	10							e15390	10.1371/journal.pone.0015390	http://dx.doi.org/10.1371/journal.pone.0015390			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	670KG	21060663	Green Published, gold, Green Submitted			2022-12-27	WOS:000283419700001
J	Caillier, M; Thenot, S; Tribollet, V; Birot, AM; Samarut, J; Mey, A				Caillier, Maia; Thenot, Sandrine; Tribollet, Violaine; Birot, Anne-Marie; Samarut, Jacques; Mey, Anne			Role of the Epigenetic Regulator HP1 gamma in the Control of Embryonic Stem Cell Properties	PLOS ONE			English	Article							HETEROCHROMATIN PROTEIN-1 HP1; H3 LYSINE-9 METHYLATION; SELF-RENEWAL; IN-VIVO; RNAI SCREEN; ES CELLS; CHROMATIN; DIFFERENTIATION; PLURIPOTENCY; EXPRESSION	The unique properties of embryonic stem cells (ESC) rely on long-lasting self-renewal and their ability to switch in all adult cell type programs. Recent advances have shown that regulations at the chromatin level sustain both ESC properties along with transcription factors. We have focused our interest on the epigenetic modulator HP1 gamma (Heterochromatin Protein 1, isoform gamma) that binds histones H3 methylated at lysine 9 (meH3K9) and is highly plastic in its distribution and association with the transcriptional regulation of specific genes during cell fate transitions. These characteristics of HP1 gamma make it a good candidate to sustain the ESC flexibility required for rapid program changes during differentiation. Using RNA interference, we describe the functional role of HP1 gamma in mouse ESC. The analysis of HP1 gamma deprived cells in proliferative and in various differentiating conditions was performed combining functional assays with molecular approaches (RT-qPCR, microarray). We show that HP1 gamma deprivation slows down the cell cycle of ESC and decreases their resistance to differentiating conditions, rendering the cells poised to differentiate. In addition, HP1 gamma depletion hampers the differentiation to the endoderm as compared with the differentiation to the neurectoderm or the mesoderm. Altogether, our results reveal the role of HP1 gamma in ESC self-renewal and in the balance between the pluripotent and the differentiation programs.	[Caillier, Maia; Thenot, Sandrine; Tribollet, Violaine; Birot, Anne-Marie; Samarut, Jacques; Mey, Anne] Univ Lyon 1, Ecole Normale Super Lyon, CNRS,INRA, Inst Genom Fonct Lyon, F-69622 Villeurbanne, France	INRAE; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON)	Caillier, M (corresponding author), Univ Lyon 1, Ecole Normale Super Lyon, CNRS,INRA, Inst Genom Fonct Lyon, F-69622 Villeurbanne, France.	Jacques.Samarut@ens-lyon.fr; Anne.Mey@lyon.inra.fr	Samarut, Jacques/AAD-2587-2019	MEY, Anne/0000-0002-2643-5702	ANR (Agence Nationale por la Recherche) Genanimal [ANR-06-GANI-007-01]; INRA (Institut National pour la Recherche Agronomique); ABIES doctoral school; FRM (Fondation pour la Recherche Medicale)	ANR (Agence Nationale por la Recherche) Genanimal(French National Research Agency (ANR)); INRA (Institut National pour la Recherche Agronomique); ABIES doctoral school; FRM (Fondation pour la Recherche Medicale)(Fondation pour la Recherche Medicale)	This work was supported by a grant from the ANR (Agence Nationale por la Recherche) Genanimal (ANR-06-GANI-007-01). Maia Caillier was supported by a PhD fellowship from INRA (Institut National pour la Recherche Agronomique), the ABIES doctoral school and the FRM (Fondation pour la Recherche Medicale) PhD program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold SJ, 2000, MECH DEVELOP, V91, P249, DOI 10.1016/S0925-4773(99)00309-3; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Bartova E, 2008, DIFFERENTIATION, V76, P24, DOI 10.1111/j.1432-0436.2007.00192.x; Blomen VA, 2007, CELL MOL LIFE SCI, V64, P3084, DOI 10.1007/s00018-007-7271-z; Cammas F, 2004, GENE DEV, V18, P2147, DOI 10.1101/gad.302904; Cammas F, 2007, DIFFERENTIATION, V75, P627, DOI 10.1111/j.1432-0436.2007.00166.x; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Dialynas GK, 2007, J CELL SCI, V120, P3415, DOI 10.1242/jcs.012914; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Efroni S, 2008, CELL STEM CELL, V2, P437, DOI 10.1016/j.stem.2008.03.021; Fazzio TG, 2008, CELL, V134, P162, DOI 10.1016/j.cell.2008.05.031; Francastel C, 2000, NAT REV MOL CELL BIO, V1, P137, DOI 10.1038/35040083; Gaspar-Maia A, 2009, NATURE, V460, P863, DOI 10.1038/nature08212; Hediger F, 2006, CURR OPIN GENET DEV, V16, P143, DOI 10.1016/j.gde.2006.02.013; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Hu G, 2009, GENE DEV, V23, P837, DOI 10.1101/gad.1769609; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Kourmouli N, 2005, BIOCHEM BIOPH RES CO, V337, P901, DOI 10.1016/j.bbrc.2005.09.132; Kwon SH, 2008, MOL CELLS, V26, P217; Lavigne M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000769; Loh YH, 2007, GENE DEV, V21, P2545, DOI 10.1101/gad.1588207; Lomberk G, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-228; Masui S, 2007, NAT CELL BIOL, V9, P625, DOI 10.1038/ncb1589; Mateescu B, 2008, EMBO REP, V9, P267, DOI 10.1038/embor.2008.1; Meshorer E, 2006, DEV CELL, V10, P105, DOI 10.1016/j.devcel.2005.10.017; Meshorer E, 2006, NAT REV MOL CELL BIO, V7, P540, DOI 10.1038/nrm1938; METEZEAU P., 1988, CYTOMETRIE FLUX ETUD; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Minc E, 2000, CYTOGENET CELL GENET, V90, P279, DOI 10.1159/000056789; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Negre D, 2000, GENE THER, V7, P1613, DOI 10.1038/sj.gt.3301292; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Nielsen AL, 1999, EMBO J, V18, P6385, DOI 10.1093/emboj/18.22.6385; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; O'Shea KS, 2004, BIOL REPROD, V71, P1755, DOI 10.1095/biolreprod.104.028100; Obuse C, 2004, NAT CELL BIOL, V6, P1135, DOI 10.1038/ncb1187; Peters AHFM, 2002, NAT GENET, V30, P77, DOI 10.1038/ng789; SINGH PB, 1991, NUCLEIC ACIDS RES, V19, P789, DOI 10.1093/nar/19.4.789; Smallwood A, 2008, NAT STRUCT MOL BIOL, V15, P318, DOI 10.1038/nsmb.1385; SMITH AG, 1988, NATURE, V336, P688, DOI 10.1038/336688a0; Tachibana M, 2002, GENE DEV, V16, P1779, DOI 10.1101/gad.989402; Takanashi M, 2009, AM J PATHOL, V174, P309, DOI 10.2353/ajpath.2009.080148; Vakoc CR, 2005, MOL CELL, V19, P381, DOI 10.1016/j.molcel.2005.06.011; VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I; Wen B, 2009, NAT GENET, V41, P246, DOI 10.1038/ng.297; Yeap LS, 2009, EPIGENET CHROMATIN, V2, DOI 10.1186/1756-8935-2-12; YEE JK, 1994, METHOD CELL BIOL, V43, P99; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Zhao XD, 2007, CELL STEM CELL, V1, P286, DOI 10.1016/j.stem.2007.08.004; Zufferey R, 1997, NAT BIOTECHNOL, V15, P871, DOI 10.1038/nbt0997-871	51	21	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2010	5	11							e15507	10.1371/journal.pone.0015507	http://dx.doi.org/10.1371/journal.pone.0015507			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	680KW	21085495	Green Published, gold, Green Submitted			2022-12-27	WOS:000284231800039
J	Fossette, S; Girard, C; Lopez-Mendilaharsu, M; Miller, P; Domingo, A; Evans, D; Kelle, L; Plot, V; Prosdocimi, L; Verhage, S; Gaspar, P; Georges, JY				Fossette, Sabrina; Girard, Charlotte; Lopez-Mendilaharsu, Milagros; Miller, Philip; Domingo, Andres; Evans, Daniel; Kelle, Laurent; Plot, Virginie; Prosdocimi, Laura; Verhage, Sebastian; Gaspar, Philippe; Georges, Jean-Yves			Atlantic Leatherback Migratory Paths and Temporary Residence Areas	PLOS ONE			English	Article							TURTLES DERMOCHELYS-CORIACEA; SEA-TURTLES; FORAGING BEHAVIOR; MARINE PREDATOR; SATELLITE TRACKING; DIVING BEHAVIOR; THERMAL NICHE; GREEN TURTLES; MOVEMENTS; PREY	Background: Sea turtles are long-distance migrants with considerable behavioural plasticity in terms of migratory patterns, habitat use and foraging sites within and among populations. However, for the most widely migrating turtle, the leatherback turtle Dermochelys coriacea, studies combining data from individuals of different populations are uncommon. Such studies are however critical to better understand intra- and inter-population variability and take it into account in the implementation of conservation strategies of this critically endangered species. Here, we investigated the movements and diving behaviour of 16 Atlantic leatherback turtles from three different nesting sites and one foraging site during their post-breeding migration to assess the potential determinants of intra- and inter-population variability in migratory patterns. Methodology/Principal Findings: Using satellite-derived behavioural and oceanographic data, we show that turtles used Temporary Residence Areas (TRAs) distributed all around the Atlantic Ocean: 9 in the neritic domain and 13 in the oceanic domain. These TRAs did not share a common oceanographic determinant but on the contrary were associated with mesoscale surface oceanographic features of different types (i.e., altimetric features and/or surface chlorophyll a concentration). Conversely, turtles exhibited relatively similar horizontal and vertical behaviours when in TRAs (i.e., slow swimming velocity/sinuous path/shallow dives) suggesting foraging activity in these productive regions. Migratory paths and TRAs distribution showed interesting similarities with the trajectories of passive satellite-tracked drifters, suggesting that the general dispersion pattern of adults from the nesting sites may reflect the extent of passive dispersion initially experienced by hatchlings. Conclusions/Significance: Intra- and inter-population behavioural variability may therefore be linked with initial hatchling drift scenarios and be highly influenced by environmental conditions. This high degree of behavioural plasticity in Atlantic leatherback turtles makes species-targeted conservation strategies challenging and stresses the need for a larger dataset (>100 individuals) for providing general recommendations in terms of conservation.	[Fossette, Sabrina; Girard, Charlotte; Plot, Virginie; Georges, Jean-Yves] Univ Strasbourg, IPHC, Dept Ecol Physiol & Ethol, Strasbourg, France; [Fossette, Sabrina; Girard, Charlotte; Plot, Virginie; Georges, Jean-Yves] CNRS, UMR7178, Strasbourg, France; [Girard, Charlotte; Gaspar, Philippe] Collecte Localisat Satellites, Satellite Oceanog Div, Ramonville St Agne, France; [Lopez-Mendilaharsu, Milagros] Univ Estado Rio de Janeiro, Dept Ecol, BR-20550011 Rio De Janeiro, Brazil; [Lopez-Mendilaharsu, Milagros] Villa Dolores Zoo, Karumbe, Montevideo, Uruguay; [Miller, Philip] Ctr Invest & Conservac Marina, El Pinar, Canelones, Uruguay; [Domingo, Andres] Direcc Nacl Recursos Acuat, Montevideo, Uruguay; [Evans, Daniel] Sea Turtle Conservancy, Gainesville, FL USA; [Kelle, Laurent] WWF Guianas, Cayenne, French Guiana; [Prosdocimi, Laura] PRICTMA, Reg Program Sea Turtles Res & Conservat Argentina, Buenos Aires, DF, Argentina; [Verhage, Sebastian] WWF Gabon, Libreville, Gabon	UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Universidade do Estado do Rio de Janeiro; World Wildlife Fund; World Wildlife Fund	Fossette, S (corresponding author), Swansea Univ, Dept Pure & Appl Ecol, Swansea, W Glam, Wales.	sabrina.fossette@gmail.com	Prosdocimi, Laura LP/H-5988-2013	Prosdocimi, Laura LP/0000-0001-7565-9713; GEORGES, Jean Yves/0000-0003-1161-2275; Miller, Philip/0000-0003-4908-2716; Fossette, Sabrina/0000-0001-8580-9084	French Ministry of Research; French Spatial Agency (CNES); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Agence Nationale pour la Recherche (ANR); Convention on Migratory Species; CNRS for French Guiana; People Trust for Endangered Species for Uruguay; WWF	French Ministry of Research(Ministry of Research, FranceEuropean Commission); French Spatial Agency (CNES)(Centre National D'etudes Spatiales); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Agence Nationale pour la Recherche (ANR)(French National Research Agency (ANR)); Convention on Migratory Species; CNRS for French Guiana; People Trust for Endangered Species for Uruguay; WWF	S.F. was supported by a studentship from the French Ministry of Research. C.G. was supported by a postdoctoral grant from the French Spatial Agency (CNES). M.L.M. was supported by a grant from the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES). V.P. is supported by a studentship from the French Ministry of Research as part of the project MIRETTE (http://projetmirette.fr) funded by Agence Nationale pour la Recherche (ANR). Funding was provided by grants from the Convention on Migratory Species and the WWF as part of the Trans-Atlantic Leatherback Conservation Initiative (www.panda.org/atlantic_leatherbacks), from Programme Amazonie du CNRS for French Guiana and from People Trust for Endangered Species for Uruguay. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acha EM, 2008, CONT SHELF RES, V28, P1579, DOI 10.1016/j.csr.2007.01.031; Billes Alexis, 2006, Marine Turtle Newsletter, V111, P13; Bjorndal Karen A., 1997, P199; Bost CA, 2009, J MARINE SYST, V78, P363, DOI 10.1016/j.jmarsys.2008.11.022; Bowen WD, 2001, FUNCT ECOL, V15, P325, DOI 10.1046/j.1365-2435.2001.00530.x; Boyd IL, 1997, TRENDS ECOL EVOL, V12, P213, DOI 10.1016/S0169-5347(97)01054-9; Brandini FP, 2000, DEEP-SEA RES PT I, V47, P1015, DOI 10.1016/S0967-0637(99)00075-8; Broderick AC, 2007, P ROY SOC B-BIOL SCI, V274, P1533, DOI 10.1098/rspb.2007.0211; Cabreira AG, 2006, ICES J MAR SCI, V63, P1718, DOI 10.1016/j.icesjms.2006.04.026; Colombo GA, 2003, ICES J MAR SCI, V60, P650, DOI 10.1016/S1054-3139(03)00051-1; Cotte C, 2007, P R SOC B, V274, P2385, DOI 10.1098/rspb.2007.0775; Doyle Thomas K., 2008, Endangered Species Research, V4, P23, DOI 10.3354/esr00076; Doyle TK, 2007, HYDROBIOLOGIA, V579, P29, DOI 10.1007/s10750-006-0362-2; Eckert SA, 2006, CHELONIAN CONSERV BI, V5, P239, DOI 10.2744/1071-8443(2006)5[239:IAPMAF]2.0.CO;2; Eckert SA, 2006, MAR BIOL, V149, P1257, DOI 10.1007/s00227-006-0262-z; EVANS D, 2008, SATELLITE TRACKING L; Ferraroli S, 2004, NATURE, V429, P521, DOI 10.1038/429521a; Fossette Sabrina, 2008, Endangered Species Research, V4, P33, DOI 10.3354/esr00039; Fossette S, 2010, J MARINE SYST, V81, P225, DOI 10.1016/j.jmarsys.2009.12.002; Gaspar P, 2006, P ROY SOC B-BIOL SCI, V273, P2697, DOI 10.1098/rspb.2006.3623; Georges JY, 2000, ECOLOGY, V81, P295, DOI 10.2307/177427; Girard C, 2006, MAR ECOL PROG SER, V322, P281, DOI 10.3354/meps322281; Girard C, 2009, MAR BIOL, V156, P1827, DOI 10.1007/s00227-009-1216-z; Godley B. J., 2008, Endangered Species Research, V4, P3, DOI 10.3354/esr00060; Graham WM, 2001, HYDROBIOLOGIA, V451, P199, DOI 10.1023/A:1011876004427; Gremillet D, 2004, FUNCT ECOL, V18, P793, DOI 10.1111/j.0269-8463.2004.00914.x; Hamer KC, 2001, MAR ECOL PROG SER, V224, P283, DOI 10.3354/meps224283; Hays GC, 2000, ANIM BEHAV, V59, P577, DOI 10.1006/anbe.1999.1326; Hays GC, 2004, NATURE, V429, P522, DOI 10.1038/429522a; Hays GC, 2006, ECOLOGY, V87, P2647, DOI 10.1890/0012-9658(2006)87[2647:FFMOLT]2.0.CO;2; Hays GC, 2010, J R SOC INTERFACE, V7, P1319, DOI 10.1098/rsif.2010.0009; James MC, 2005, MAR BIOL, V147, P845, DOI 10.1007/s00227-005-1581-1; James MC, 2005, ECOL LETT, V8, P195, DOI 10.1111/j.1461-0248.2004.00710.x; James MC, 2005, P ROY SOC B-BIOL SCI, V272, P1547, DOI 10.1098/rspb.2005.3110; James MC, 2006, J EXP MAR BIOL ECOL, V335, P221, DOI 10.1016/j.jembe.2006.03.013; Jonsen ID, 2007, MAR ECOL PROG SER, V337, P255, DOI 10.3354/meps337255; Laidre KL, 2003, MAR ECOL PROG SER, V261, P269, DOI 10.3354/meps261269; Lopez-Mendilaharsu M, 2009, J EXP MAR BIOL ECOL, V378, P31, DOI 10.1016/j.jembe.2009.07.010; Luschi P, 2006, S AFR J SCI, V102, P51; McMahon CR, 2006, GLOBAL CHANGE BIOL, V12, P1330, DOI 10.1111/j.1365-2486.2006.01174.x; Mianzan H, 2001, ECOL STU AN, V144, P185; MITTELSTAEDT E, 1991, PROG OCEANOGR, V26, P307, DOI 10.1016/0079-6611(91)90011-A; Monzon-Arguello C, 2010, J BIOGEOGR, V37, P1752, DOI 10.1111/j.1365-2699.2010.02326.x; O'Donoghue M, 1998, OIKOS, V82, P169, DOI 10.2307/3546927; Olson D., 1994, OCEANOGRAPHY, V7, P52, DOI DOI 10.5670/OCEANOG.1994.03; Paiva VH, 2010, MAR ECOL PROG SER, V398, P259, DOI 10.3354/meps08319; Pichegru L, 2009, MAR ECOL PROG SER, V391, P199, DOI 10.3354/meps08283; Pichegru L., 2010, BIOL LETT; Pichegru L, 2007, MAR ECOL PROG SER, V350, P127, DOI 10.3354/meps07128; Sale A, 2006, J EXP MAR BIOL ECOL, V328, P197, DOI 10.1016/j.jembe.2005.07.006; Schofield G, 2007, J EXP MAR BIOL ECOL, V347, P58, DOI 10.1016/j.jembe.2007.03.009; Shillinger GL, 2008, PLOS BIOL, V6, P1408, DOI 10.1371/journal.pbio.0060171; Sims DW, 2006, P ROY SOC B-BIOL SCI, V273, P1195, DOI 10.1098/rspb.2005.3444; Sims DW, 1998, NATURE, V393, P460, DOI 10.1038/30959; Tremblay Y, 2003, MAR ECOL PROG SER, V251, P279, DOI 10.3354/meps251279; Tremblay Y, 2007, J EXP BIOL, V210, P935, DOI 10.1242/jeb.02710; Votier SC, 2004, NATURE, V427, P727, DOI 10.1038/nature02315; Weimerskirch H, 2007, AM NAT, V170, P734, DOI 10.1086/522059; Weimerskirch H, 2007, DEEP-SEA RES PT II, V54, P211, DOI 10.1016/j.dsr2.2006.11.013; Witt MJ, 2007, MAR ECOL PROG SER, V337, P231, DOI 10.3354/meps337231; Zavala-Hidalgo J, 2006, OCEAN DYNAM, V56, P333, DOI 10.1007/s10236-006-0072-3	61	40	43	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2010	5	11							e13908	10.1371/journal.pone.0013908	http://dx.doi.org/10.1371/journal.pone.0013908			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	677ZE	21085472	Green Published, Green Submitted, gold			2022-12-27	WOS:000284035900015
J	Zandbelt, BB; Vink, M				Zandbelt, Bram B.; Vink, Matthijs			On the Role of the Striatum in Response Inhibition	PLOS ONE			English	Article							STOP-SIGNAL PARADIGM; PRIMARY MOTOR CORTEX; REACTION-TIME-TASK; BASAL GANGLIA; COUNTERMANDING SACCADES; SUBTHALAMIC NUCLEUS; FUNCTIONAL MRI; PARKINSONS-DISEASE; PREFRONTAL CORTEX; FRONTAL-CORTEX	Background: Stopping a manual response requires suppression of the primary motor cortex (M1) and has been linked to activation of the striatum. Here, we test three hypotheses regarding the role of the striatum in stopping: striatum activation during successful stopping may reflect suppression of M1, anticipation of a stop-signal occurring, or a slower response build-up. Methodology/Principal Findings: Twenty-four healthy volunteers underwent functional magnetic resonance imaging (fMRI) while performing a stop-signal paradigm, in which anticipation of stopping was manipulated using a visual cue indicating stop-signal probability, with their right hand. We observed activation of the striatum and deactivation of left M1 during successful versus unsuccessful stopping. In addition, striatum activation was proportional to the degree of left M1 deactivation during successful stopping, implicating the striatum in response suppression. Furthermore, striatum activation increased as a function of stop-signal probability and was to linked to activation in the supplementary motor complex (SMC) and right inferior frontal cortex (rIFC) during successful stopping, suggesting a role in anticipation of stopping. Finally, trial-to-trial variations in response time did not affect striatum activation. Conclusions/Significance: The results identify the striatum as a critical node in the neural network associated with stopping motor responses. As striatum activation was related to both suppression of M1 and anticipation of a stop-signal occurring, these findings suggest that the striatum is involved in proactive inhibitory control over M1, most likely in interaction with SMC and rIFC.	[Zandbelt, Bram B.; Vink, Matthijs] Univ Med Ctr Utrecht, Dept Psychiat, Rudolf Magnus Inst Neurosci, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center	Zandbelt, BB (corresponding author), Univ Med Ctr Utrecht, Dept Psychiat, Rudolf Magnus Inst Neurosci, Utrecht, Netherlands.	b.b.zandbelt@umcutrecht.nl	Zandbelt, Bram/A-3326-2009	Zandbelt, Bram/0000-0002-6491-1247; Vink, Matthijs/0000-0002-1235-8347	Netherlands Organization for Scientific Research	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	This work was supported by the Netherlands Organization for Scientific Research (Veni grant to M. V.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER GE, 1990, TRENDS NEUROSCI; Aron AR, 2007, J NEUROSCI, V27, P3743, DOI 10.1523/JNEUROSCI.0519-07.2007; Aron AR, 2006, J NEUROSCI, V26, P2424, DOI 10.1523/JNEUROSCI.4682-05.2006; Aron AR, 2005, BIOL PSYCHIAT, V57, P1285, DOI 10.1016/j.biopsych.2004.10.026; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Ashburner J, 1999, HUM BRAIN MAPP, V7, P254, DOI 10.1002/(SICI)1097-0193(1999)7:4<254::AID-HBM4>3.0.CO;2-G; Blazquez PM, 2002, NEURON, V33, P973, DOI 10.1016/S0896-6273(02)00627-X; BOEHLER CN, 2010, NEUROIMAGE; Boucher L, 2007, PSYCHOL REV, V114, P376, DOI 10.1037/0033-295X.114.2.376; Braver T. S., 2007, VARIATION WORKING ME, P76, DOI DOI 10.1093/ACPROF:OSO/9780195168648.003.0004; Buch ER, 2010, J NEUROSCI, V30, P1395, DOI 10.1523/JNEUROSCI.4882-09.2010; Cai WD, 2009, BRAIN RES, V1261, P20, DOI 10.1016/j.brainres.2008.12.073; Chambers CD, 2009, NEUROSCI BIOBEHAV R, V33, P631, DOI 10.1016/j.neubiorev.2008.08.016; Chao HHA, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-75; Chikazoe J, 2007, J COGNITIVE NEUROSCI, V19, P69, DOI 10.1162/jocn.2007.19.1.69; Chikazoe J, 2009, J NEUROSCI, V29, P15870, DOI 10.1523/JNEUROSCI.3645-09.2009; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Coxon JP, 2007, J NEUROPHYSIOL, V97, P2480, DOI 10.1152/jn.01284.2006; Coxon JP, 2006, J NEUROPHYSIOL, V95, P3371, DOI 10.1152/jn.01334.2005; DEJONG R, 1990, J EXP PSYCHOL HUMAN, V16, P164, DOI 10.1037/0096-1523.16.1.164; Draganski B, 2008, J NEUROSCI, V28, P7143, DOI 10.1523/JNEUROSCI.1486-08.2008; Duann JR, 2009, J NEUROSCI, V29, P10171, DOI 10.1523/JNEUROSCI.1300-09.2009; Duvernoy H.M., 1999, HUMAN BRAIN SURFACE; Eagle DM, 2008, CEREB CORTEX, V18, P178, DOI 10.1093/cercor/bhm044; Eagle DM, 2003, BEHAV NEUROSCI, V117, P1302, DOI 10.1037/0735-7044.117.6.1302; Forstmann BU, 2008, P NATL ACAD SCI USA, V105, P17538, DOI 10.1073/pnas.0805903105; Frank MJ, 2005, J COGNITIVE NEUROSCI, V17, P51, DOI 10.1162/0898929052880093; Friston KJ, 1995, HUM BRAIN MAPP, V3, P165, DOI 10.1002/hbm.460030303; Friston KJ, 1997, NEUROIMAGE, V6, P218, DOI 10.1006/nimg.1997.0291; Garavan H, 1999, P NATL ACAD SCI USA, V96, P8301, DOI 10.1073/pnas.96.14.8301; Gauggel S, 2004, J NEUROL NEUROSUR PS, V75, P539; Gitelman DR, 2003, NEUROIMAGE, V19, P200, DOI 10.1016/S1053-8119(03)00058-2; Graybiel AM, 2000, CURR BIOL, V10, pR509, DOI 10.1016/S0960-9822(00)00593-5; Grinband J, 2008, NEUROIMAGE, V43, P509, DOI 10.1016/j.neuroimage.2008.07.065; Haber SN, 2000, J NEUROSCI, V20, P2369; Hanes DP, 1998, J NEUROPHYSIOL, V79, P817, DOI 10.1152/jn.1998.79.2.817; Isoda M, 2008, J NEUROSCI, V28, P7209, DOI 10.1523/JNEUROSCI.0487-08.2008; Jahfari S, 2010, J COGNITIVE NEUROSCI, V22, P1479, DOI 10.1162/jocn.2009.21307; Lauwereyns J, 2002, NATURE, V418, P413, DOI 10.1038/nature00892; Leh SE, 2007, NEUROSCI LETT, V419, P113, DOI 10.1016/j.neulet.2007.04.049; Lehericy S, 2004, ANN NEUROL, V55, P522, DOI 10.1002/ana.20030; Lehericy S, 2004, CEREB CORTEX, V14, P1302, DOI 10.1093/cercor/bhh091; Leotti LA, 2010, J EXP PSYCHOL HUMAN, V36, P430, DOI 10.1037/a0016802; Lo CC, 2006, NAT NEUROSCI, V9, P956, DOI 10.1038/nn1722; Lo CC, 2009, J NEUROSCI, V29, P9059, DOI 10.1523/JNEUROSCI.6164-08.2009; LOGAN GD, 1984, PSYCHOL REV, V91, P295, DOI 10.1037/0033-295X.91.3.295; Mars RB, 2009, J NEUROSCI, V29, P6926, DOI 10.1523/JNEUROSCI.1396-09.2009; Menon V, 2004, P NATL ACAD SCI USA, V101, P3615, DOI 10.1073/pnas.0304544101; Morein-Zamir S, 2006, EXP BRAIN RES, V175, P453, DOI 10.1007/s00221-006-0564-x; Nambu A, 2002, NEUROSCI RES, V43, P111, DOI 10.1016/S0168-0102(02)00027-5; Padmala S, 2010, NEUROPSYCHOLOGIA, V48, P558, DOI 10.1016/j.neuropsychologia.2009.10.017; Pare M, 2003, J NEUROSCI, V23, P6480; Ramautar JR, 2004, BRAIN COGNITION, V56, P234, DOI 10.1016/j.bandc.2004.07.002; Ridderinkhof KR, 1999, ACTA PSYCHOL, V101, P315; Robbins TW, 2007, PHILOS T R SOC B, V362, P917, DOI 10.1098/rstb.2007.2097; Rubia K, 1999, AM J PSYCHIAT, V156, P891, DOI 10.1176/ajp.156.6.891; RUBIA K, 2005, AM J PSYCHIAT; SASAKI K, 1989, BRAIN RES, V495, P100, DOI 10.1016/0006-8993(89)91222-5; Shattuck DW, 2008, NEUROIMAGE, V39, P1064, DOI 10.1016/j.neuroimage.2007.09.031; Simmonds DJ, 2008, NEUROPSYCHOLOGIA, V46, P224, DOI 10.1016/j.neuropsychologia.2007.07.015; SLATERHAMMEL AT, 1960, RES QUART, V31, P217, DOI 10.1080/10671188.1960.10613098; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Stephan KE, 2004, J ANAT, V205, P443, DOI 10.1111/j.0021-8782.2004.00359.x; Stinear CM, 2009, NEUROSCI BIOBEHAV R, V33, P662, DOI 10.1016/j.neubiorev.2008.08.013; Stuphorn V, 2006, NAT NEUROSCI, V9, P925, DOI 10.1038/nn1714; van den Wildenberg WPM, 2006, J COGNITIVE NEUROSCI, V18, P626, DOI 10.1162/jocn.2006.18.4.626; Van der Schoot M, 2005, SCAND J PSYCHOL, V46, P331, DOI 10.1111/j.1467-9450.2005.00463.x; van Gaal S, 2009, J EXP PSYCHOL HUMAN, V35, P1129, DOI 10.1037/a0013551; VANDENWILDENBER.W, 2010, COGNITIVE NEUROSCIEN, V22, P225; Verbruggen F, 2009, NEUROSCI BIOBEHAV R, V33, P647, DOI 10.1016/j.neubiorev.2008.08.014; Verbruggen F, 2009, J EXP PSYCHOL HUMAN, V35, P835, DOI 10.1037/a0012726; Vink M, 2005, HUM BRAIN MAPP, V25, P336, DOI 10.1002/hbm.20111; Vink M, 2006, BIOL PSYCHIAT, V60, P32, DOI 10.1016/j.biopsych.2005.11.026; Woolley J, 2008, BRIT J PSYCHIAT, V192, P25, DOI 10.1192/bjp.bp.107.036558; Yamada H, 2007, J NEUROPHYSIOL, V98, P3557, DOI 10.1152/jn.00779.2007	75	220	221	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2010	5	11							e13848	10.1371/journal.pone.0013848	http://dx.doi.org/10.1371/journal.pone.0013848			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675NY	21079814	Green Published, Green Submitted, gold			2022-12-27	WOS:000283838600020
J	Dore-Savard, L; Otis, V; Belleville, K; Lemire, M; Archambault, M; Tremblay, L; Beaudoin, JF; Beaudet, N; Lecomte, R; Lepage, M; Gendron, L; Sarret, P				Dore-Savard, Louis; Otis, Valerie; Belleville, Karine; Lemire, Myriam; Archambault, Melanie; Tremblay, Luc; Beaudoin, Jean-Francois; Beaudet, Nicolas; Lecomte, Roger; Lepage, Martin; Gendron, Louis; Sarret, Philippe			Behavioral, Medical Imaging and Histopathological Features of a New Rat Model of Bone Cancer Pain	PLOS ONE			English	Article							BREAST-CANCER; METASTASES; BISPHOSPHONATES	Pre-clinical bone cancer pain models mimicking the human condition are required to respond to clinical realities. Breast or prostate cancer patients coping with bone metastases experience intractable pain, which affects their quality of life. Advanced monitoring is thus required to clarify bone cancer pain mechanisms and refine treatments. In our model of rat femoral mammary carcinoma MRMT-1 cell implantation, pain onset and tumor growth were monitored for 21 days. The surgical procedure performed without arthrotomy allowed recording of incidental pain in free-moving rats. Along with the gradual development of mechanical allodynia and hyperalgesia, behavioral signs of ambulatory pain were detected at day 14 by using a dynamic weight-bearing apparatus. Osteopenia was revealed from day 14 concomitantly with disorganization of the trabecular architecture (mu CT). Bone metastases were visualized as early as day 8 by MRI (T-1-Gd-DTPA) before pain detection. PET (Na F-18) co-registration revealed intra-osseous activity, as determined by anatomical superimposition over MRI in accordance with osteoclastic hyperactivity (TRAP staining). Pain and bone destruction were aggravated with time. Bone remodeling was accompanied by c-Fos (spinal) and ATF3 (DRG) neuronal activation, sustained by astrocyte (GFAP) and microglia (Iba1) reactivity in lumbar spinal cord. Our animal model demonstrates the importance of simultaneously recording pain and tumor progression and will allow us to better characterize therapeutic strategies in the future.	[Dore-Savard, Louis; Otis, Valerie; Belleville, Karine; Lemire, Myriam; Beaudet, Nicolas; Gendron, Louis; Sarret, Philippe] Univ Sherbrooke, Dept Physiol & Biophys, Sherbrooke, PQ J1K 2R1, Canada; [Archambault, Melanie; Tremblay, Luc; Beaudoin, Jean-Francois; Lecomte, Roger; Lepage, Martin] Univ Sherbrooke, Dept Med Nucl & Radiobiol, Sherbrooke, PQ J1K 2R1, Canada; [Archambault, Melanie; Tremblay, Luc; Beaudoin, Jean-Francois; Lecomte, Roger; Lepage, Martin] Univ Sherbrooke, Ctr Imagerie Mol Sherbrooke, Sherbrooke, PQ J1K 2R1, Canada	University of Sherbrooke; University of Sherbrooke; University of Sherbrooke	Dore-Savard, L (corresponding author), Univ Sherbrooke, Dept Physiol & Biophys, Sherbrooke, PQ J1K 2R1, Canada.	Philippe.Sarret@USherbrooke.ca	LECOMTE, Roger/F-2582-2011	LECOMTE, Roger/0000-0002-8541-0783; Beaudet, Nicolas/0000-0003-2349-2362; Sarret, Philippe/0000-0002-7627-701X; Lepage, Martin/0000-0002-5363-9487; Gendron, Louis/0000-0002-2058-8863	Cancer Research Society; Canadian Pain Society; AstraZeneca Inc.; CIHR Institute of Aging; CIHR Institute of Musculoskeletal Health and Arthritis; CIHR Institute of Neurosciences; Mental Health and Addiction; Quebec Bio-Imaging Network; CIHR Frederick Banting; Charles Best, FRSQ; Canadian Arthritis Network and RSBO	Cancer Research Society; Canadian Pain Society; AstraZeneca Inc.(AstraZeneca); CIHR Institute of Aging(Canadian Institutes of Health Research (CIHR)); CIHR Institute of Musculoskeletal Health and Arthritis(Canadian Institutes of Health Research (CIHR)); CIHR Institute of Neurosciences(Canadian Institutes of Health Research (CIHR)); Mental Health and Addiction; Quebec Bio-Imaging Network; CIHR Frederick Banting(Canadian Institutes of Health Research (CIHR)); Charles Best, FRSQ(Fonds de la Recherche en Sante du Quebec); Canadian Arthritis Network and RSBO	This work is supported by grants from the Cancer Research Society (P. S.) and from the CIHR/Rx&D collaborative research program in partnership with the Canadian Pain Society, AstraZeneca Inc., CIHR Institute of Aging, CIHR Institute of Musculoskeletal Health and Arthritis, CIHR Institute of Neurosciences, Mental Health and Addiction (P.S.) and The Quebec Bio-Imaging Network. L.D.-S. holds CIHR Frederick Banting and Charles Best, FRSQ, Canadian Arthritis Network and RSBO scholarships. P.S. is a CIHR new investigator. L.G. is a FRSQ Junior 1-new investigator. P.S., M. L., L.G. and R.L. are members of the FRSQ-funded Centre de Recherche Clinique Etienne-Le Bel. P.S. and L.G are members of the Quebec Pain Research Network, M.L. and R. L. are members of the Quebec Bio-Imaging Network. M.L. is the Canada Research Chair in Magnetic Resonance Imaging. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebi M, 2003, EUR SPINE J, V12, pS202, DOI 10.1007/s00586-003-0609-9; Aloisi AM, 2006, HORM BEHAV, V50, P1, DOI 10.1016/j.yhbeh.2005.12.002; Armamento-Villareal R, 2009, CALCIFIED TISSUE INT, V85, P37, DOI 10.1007/s00223-009-9263-5; Bauerle T, 2005, INT J CANCER, V115, P177, DOI 10.1002/ijc.20840; Beyreuther BK, 2007, EUR J PHARMACOL, V565, P98, DOI 10.1016/j.ejphar.2007.02.041; Cairns BE, 2009, MATURITAS, V63, P292, DOI 10.1016/j.maturitas.2009.06.004; Canon JR, 2008, CLIN EXP METASTAS, V25, P119, DOI 10.1007/s10585-007-9127-1; Clemons MJ, 2006, J CLIN ONCOL, V24, P4895, DOI 10.1200/JCO.2006.05.9212; COLEMAN RE, 1987, BRIT J CANCER, V55, P61, DOI 10.1038/bjc.1987.13; COLEMAN RE, 1985, CANCER TREAT REV, V12, P251, DOI 10.1016/0305-7372(85)90008-8; Coleman R, 2007, CLIN BREAST CANCER, V7, pS29, DOI 10.3816/CBC.2007.s.004; Coleman RE, 2006, CLIN CANCER RES, V12, p6243S, DOI 10.1158/1078-0432.CCR-06-0931; Costelloe CM, 2009, LANCET ONCOL, V10, P606, DOI 10.1016/S1470-2045(09)70088-9; Denes A, 2005, NEUROSCIENCE, V134, P947, DOI 10.1016/j.neuroscience.2005.03.060; Donovan-Rodriguez T, 2006, NEUROSCI LETT, V393, P237, DOI 10.1016/j.neulet.2005.09.073; Donovan-Rodriguez T, 2005, ANESTHESIOLOGY, V102, P132, DOI 10.1097/00000542-200501000-00022; Donovan-Rodriguez T, 2004, NEUROSCI LETT, V360, P29, DOI 10.1016/j.neulet.2004.01.048; Donthineni R, 2009, ORTHOP CLIN N AM, V40, P1, DOI 10.1016/j.ocl.2008.10.001; Dworkin RH, 2002, CLIN J PAIN, V18, P343, DOI 10.1097/00002508-200211000-00001; Edoff K, 2000, CELL TISSUE RES, V299, P193, DOI 10.1007/s004410050017; El Mouedden M, 2007, PHARMACOL BIOCHEM BE, V86, P458, DOI 10.1016/j.pbb.2007.01.003; Fox A, 2004, PAIN, V107, P33, DOI 10.1016/j.pain.2003.09.003; Ghilardi JR, 2005, J NEUROSCI, V25, P3126, DOI 10.1523/JNEUROSCI.3815-04.2005; HAHN M, 1992, BONE, V13, P327, DOI 10.1016/8756-3282(92)90078-B; Hald A, 2008, PHARMACOL BIOCHEM BE, V91, P38, DOI 10.1016/j.pbb.2008.04.021; Hald A, 2009, EUR J PAIN, V13, P138, DOI 10.1016/j.ejpain.2008.03.014; Halvorson KG, 2006, CLIN J PAIN, V22, P587, DOI 10.1097/01.ajp.0000210902.67849.e6; HARADA Y, 1975, ACTA PATHOL JAPON, V25, P451; Harvey HA, 2007, CLIN BREAST CANCER, V7, pS7, DOI 10.3816/CBC.2007.s.001; Honore P, 2000, NEUROSCIENCE, V98, P585, DOI 10.1016/S0306-4522(00)00110-X; Honore P, 2000, Prog Brain Res, V129, P389; Honore P, 2000, PAIN MED, V1, P303, DOI 10.1046/j.1526-4637.2000.00047.x; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; King T, 2007, PAIN, V132, P154, DOI 10.1016/j.pain.2007.06.026; Kingsley LA, 2007, MOL CANCER THER, V6, P2609, DOI 10.1158/1535-7163.MCT-07-0234; Kirou-Mauro AN, 2009, J PAIN SYMPTOM MANAG, V37, P77, DOI 10.1016/j.jpainsymman.2007.12.014; LEE YTNM, 1983, J SURG ONCOL, V23, P175, DOI 10.1002/jso.2930230311; Lipton A, 2007, CLIN BREAST CANCER, V7, pS14, DOI 10.3816/CBC.2007.s.002; Luger NM, 2001, CANCER RES, V61, P4038; Luger NM, 2002, PAIN, V99, P397, DOI 10.1016/S0304-3959(02)00102-1; Mach DB, 2002, NEUROSCIENCE, V113, P155, DOI 10.1016/S0306-4522(02)00165-3; Malden NJ, 2007, BRIT DENT J, V203, P93, DOI 10.1038/bdj.2007.636; Mao-Ying QL, 2006, BIOCHEM BIOPH RES CO, V345, P1292, DOI 10.1016/j.bbrc.2006.04.186; Medhurst SJ, 2002, PAIN, V96, P129, DOI 10.1016/S0304-3959(01)00437-7; Menendez L, 2003, NEUROREPORT, V14, P867, DOI 10.1097/01.wnr.0000069963.11849.af; Mercadante S, 1997, PAIN, V69, P1, DOI 10.1016/S0304-3959(96)03267-8; Mercadante S, 2007, CURR OPIN ONCOL, V19, P308, DOI 10.1097/CCO.0b013e3281214400; Mercadante S, 2009, CLIN J PAIN, V25, P648, DOI 10.1097/AJP.0b013e3181a68a85; Mogil JS, 2009, NAT REV NEUROSCI, V10, P283, DOI 10.1038/nrn2606; Muller-Horvat C, 2006, EUR J CANCER, V42, P342, DOI 10.1016/j.ejca.2005.10.008; Nagae M, 2007, J BONE MINER METAB, V25, P99, DOI 10.1007/s00774-006-0734-8; Nicholson B, 2003, DRUGS, V63, P17, DOI 10.2165/00003495-200363010-00002; Niiyama Y, 2009, BRIT J ANAESTH, V102, P251, DOI 10.1093/bja/aen347; Niv D, 2003, PAIN, V105, P387, DOI 10.1016/S0304-3959(03)00277-X; Obata K, 2003, PAIN, V101, P65, DOI 10.1016/S0304-3959(02)00296-8; Ogawa K, 2007, J NUCL MED, V48, P122; Omoumi P, 2009, RADIOL CLIN N AM, V47, P595, DOI 10.1016/j.rcl.2009.04.005; Peters CM, 2005, EXP NEUROL, V193, P85, DOI 10.1016/j.expneurol.2004.11.028; Petren-Mallmin M, 1998, SKELETAL RADIOL, V27, P72, DOI 10.1007/s002560050340; Pichler BJ, 2008, SEMIN NUCL MED, V38, P199, DOI 10.1053/j.semnuclmed.2008.02.001; Rauch F, 2009, ENDOCR DEV, V16, P49, DOI 10.1159/000223688; Riccio AI, 2007, AM FAM PHYSICIAN, V76, P1489; Roato I, 2004, FASEB J, V18, P228, DOI 10.1096/fj.04-1823fje; Romero-Sandoval A, 2008, ANESTHESIOLOGY, V108, P722, DOI 10.1097/ALN.0b013e318167af74; Roodman GD, 2008, CANCER TREAT REV, V34, P92, DOI 10.1016/j.ctrv.2007.09.002; Rozel S, 2009, J CELL BIOCHEM, V107, P58, DOI 10.1002/jcb.22056; Sabino MAC, 2003, INT J CANCER, V104, P550, DOI 10.1002/ijc.10999; Schirrmeister H, 1999, J NUCL MED, V40, P1623; Schirrmeister H, 2007, RADIOL CLIN N AM, V45, P669, DOI 10.1016/j.rcl.2007.05.007; Schmidt GP, 2009, SEMIN MUSCULOSKEL R, V13, P120, DOI 10.1055/s-0029-1220883; Scholz J, 2007, NAT NEUROSCI, V10, P1361, DOI 10.1038/nn1992; Schwei MJ, 1999, J NEUROSCI, V19, P10886, DOI 10.1523/JNEUROSCI.19-24-10886.1999; Sevcik MA, 2005, PAIN, V115, P128, DOI 10.1016/j.pain.2005.02.022; Sevcik MA, 2004, PAIN, V111, P169, DOI 10.1016/j.pain.2004.06.015; Tsujino H, 2000, MOL CELL NEUROSCI, V15, P170, DOI 10.1006/mcne.1999.0814; Urch CE, 2005, J PAIN, V6, P837, DOI 10.1016/j.jpain.2005.08.005; Urch CE, 2003, PAIN, V106, P347, DOI 10.1016/j.pain.2003.08.002; Vallabhajosula S, 2007, SEMIN NUCL MED, V37, P400, DOI 10.1053/j.semnuclmed.2007.08.004; Vestergaard P, 2006, J INTERN MED, V260, P76, DOI 10.1111/j.1365-2796.2006.01667.x; Wacnik PW, 2001, J NEUROSCI, V21, P9355, DOI 10.1523/JNEUROSCI.21-23-09355.2001; Walker K, 2002, PAIN, V100, P219, DOI 10.1016/S0304-3959(02)00040-4; Watson C, 2009, SPINAL CORD: A CHRISTOPHER AND DANA REEVE FOUNDATION TEXT AND ATLAS, P1; Zhang RX, 2005, PAIN, V118, P125, DOI 10.1016/j.pain.2005.08.001; Zwolak P, 2008, INT J CANCER, V122, P681, DOI 10.1002/ijc.23157	84	43	47	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2010	5	10							e13774	10.1371/journal.pone.0013774	http://dx.doi.org/10.1371/journal.pone.0013774			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673FU	21048940	Green Published, Green Submitted, gold			2022-12-27	WOS:000283645300048
J	Sulatskaya, AI; Maskevich, AA; Kuznetsova, IM; Uversky, VN; Turoverov, KK				Sulatskaya, Anna I.; Maskevich, Alexander A.; Kuznetsova, Irina M.; Uversky, Vladimir N.; Turoverov, Konstantin K.			Fluorescence Quantum Yield of Thioflavin T in Rigid Isotropic Solution and Incorporated into the Amyloid Fibrils	PLOS ONE			English	Article							TORSIONAL RELAXATION; BINDING-SITES; PROTEIN; DISEASE; AGGREGATION; PEPTIDES; SOLVENTS; KINETICS; INSULIN; DYE	In this work, the fluorescence of thioflavin T (ThT) was studied in a wide range of viscosity and temperature. It was shown that ThT fluorescence quantum yield varies from 0.0001 in water at room temperature to 0.28 in rigid isotropic solution (T/eta -> 0). The deviation of the fluorescence quantum yield from unity in rigid isotropic solution suggests that fluorescence quantum yield depends not only on the ultra-fast oscillation of ThT fragments relative to each other in an excited state as was suggested earlier, but also depends on the molecular configuration in the ground state. This means that the fluorescence quantum yield of the dye incorporated into amyloid fibrils must depend on its conformation, which, in turn, depends on the ThT environment. Therefore, the fluorescence quantum yield of ThT incorporated into amyloid fibrils can differ from that in the rigid isotropic solution. In particular, the fluorescence quantum yield of ThT incorporated into insulin fibrils was determined to be 0.43. Consequently, the ThT fluorescence quantum yield could be used to characterize the peculiarities of the fibrillar structure, which opens some new possibilities in the ThT use for structural characterization of the amyloid fibrils.	[Sulatskaya, Anna I.; Kuznetsova, Irina M.; Turoverov, Konstantin K.] Russian Acad Sci, Inst Cytol, St Petersburg 194064, Russia; [Maskevich, Alexander A.] Yanka Kupala Grodno State Univ, Grodno, BELARUS; [Uversky, Vladimir N.] Russian Acad Sci, Inst Biol Instrumentat, Pushchino 142292, Russia; [Uversky, Vladimir N.] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN USA	Russian Academy of Sciences; St. Petersburg Scientific Centre of the Russian Academy of Sciences; Institute of Cytology RAS; Yanka Kupala State University of Grodno; Russian Academy of Sciences; Indiana University System; Indiana University Bloomington	Sulatskaya, AI (corresponding author), Russian Acad Sci, Inst Cytol, St Petersburg 194064, Russia.	vuversky@iupui.edu; kkt@mail.cytspb.rssi.ru	Uversky, Vladimir N./F-4515-2011; Sulatskaya, Anna/I-6042-2014; Kuznetsova, Irina M./R-9844-2017; Turoverov, Konstantin/S-2079-2016	Uversky, Vladimir N./0000-0002-4037-5857; Sulatskaya, Anna/0000-0002-1207-3384; Kuznetsova, Irina M./0000-0002-3336-4834; Turoverov, Konstantin/0000-0002-6977-1896	Belorussian Foundation of Basic Research [X10P-227]; Russian Foundation of Basic Research [10-04-90038_Bel]; Program Molecular and Cell Biology; Russian Academy of Sciences; Dmitry Zimin's Russian Charitable Foundation	Belorussian Foundation of Basic Research; Russian Foundation of Basic Research(Russian Foundation for Basic Research (RFBR)); Program Molecular and Cell Biology; Russian Academy of Sciences(Russian Academy of Sciences); Dmitry Zimin's Russian Charitable Foundation	This work was supported in part by the Belorussian Foundation of Basic Research (grant X10P-227), the Russian Foundation of Basic Research (grant 10-04-90038_Bel), Program "Molecular and Cell Biology,'' Russian Academy of Sciences, and Dmitry Zimin's Russian Charitable Foundation "Dynasty.'' The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allsop D, 2001, BIOCHEM BIOPH RES CO, V285, P58, DOI 10.1006/bbrc.2001.5123; Ban T, 2003, J BIOL CHEM, V278, P16462, DOI 10.1074/jbc.C300049200; Biancalana M, 2009, J MOL BIOL, V385, P1052, DOI 10.1016/j.jmb.2008.11.006; Carrell RW, 1998, CURR OPIN STRUC BIOL, V8, P799, DOI 10.1016/S0959-440X(98)80101-2; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Dobson CM, 1999, TRENDS BIOCHEM SCI, V24, P329, DOI 10.1016/S0968-0004(99)01445-0; Fandrich M, 2001, NATURE, V410, P165, DOI 10.1038/35065514; Goers J, 2002, BIOCHEMISTRY-US, V41, P12546, DOI 10.1021/bi0262698; Groenning M., 2009, J CHEM BIOL; Harper JD, 1997, CHEM BIOL, V4, P951, DOI 10.1016/S1074-5521(97)90303-3; Hashimoto M, 1999, BRAIN PATHOL, V9, P707; Kelly JW, 1997, STRUCTURE, V5, P595, DOI 10.1016/S0969-2126(97)00215-3; Koo EH, 1999, P NATL ACAD SCI USA, V96, P9989, DOI 10.1073/pnas.96.18.9989; Krebs MRH, 2005, J STRUCT BIOL, V149, P30, DOI 10.1016/j.jsb.2004.08.002; Kumita JR, 2003, BIOCHEMISTRY-US, V42, P4492, DOI 10.1021/bi026856t; Lakowicz J.R., 2006, PRINCIPLES FLUORESCE; LeVine H, 1999, METHOD ENZYMOL, V309, P274; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; LeVine H, 1997, ARCH BIOCHEM BIOPHYS, V342, P306, DOI 10.1006/abbi.1997.0137; LEVINE H, 1995, AMYLOID, V2, P1, DOI 10.3109/13506129509031881; Lockhart A, 2005, J BIOL CHEM, V280, P7677, DOI 10.1074/jbc.M412056200; Loksztejn A, 2008, J MOL BIOL, V379, P9, DOI 10.1016/j.jmb.2008.03.057; LOUTFY RO, 1982, J PHYS CHEM-US, V86, P4205, DOI 10.1021/j100218a023; MARQUARDT DW, 1963, J SOC IND APPL MATH, V11, P431, DOI 10.1137/0111030; Maskevich AA, 2007, J PROTEOME RES, V6, P1392, DOI 10.1021/pr0605567; NAIKI H, 1989, ANAL BIOCHEM, V177, P244, DOI 10.1016/0003-2697(89)90046-8; NAIKI H, 1990, LAB INVEST, V62, P768; Nielsen L, 2001, BIOCHEMISTRY-US, V40, P6036, DOI 10.1021/bi002555c; Pertinhez TA, 2001, FEBS LETT, V495, P184, DOI 10.1016/S0014-5793(01)02384-5; Segur J.B., 1953, PHYS PROPERTIES GLYC, P238; Singh PK, 2010, J PHYS CHEM B, V114, P5920, DOI 10.1021/jp100371s; Singh PK, 2009, J PHYS CHEM B, V113, P8532, DOI 10.1021/jp902207k; Stsiapura VI, 2007, J PHYS CHEM A, V111, P4829, DOI 10.1021/jp070590o; Stsiapura VI, 2008, J PHYS CHEM B, V112, P15893, DOI 10.1021/jp805822c; Turoverov K K, 1998, Tsitologiia, V40, P806; TUROVEROV KK, 2007, P SOC PHOTO OPT INS, V6733, pNI198; Uversky V.N., 1999, MED SCI MONITOR, V5, P1001; Uversky V.N., 1999, MED SCI MONITOR, V5, P1238; Uversky VN, 2004, BBA-PROTEINS PROTEOM, V1698, P131, DOI 10.1016/j.bbapap.2003.12.008; Voropai E. S., 2003, Journal of Applied Spectroscopy, V70, P868, DOI 10.1023/B:JAPS.0000016303.37573.7e; Ye L, 2005, J BIOL CHEM, V280, P23599, DOI 10.1074/jbc.M501285200; Yoshiike Y, 2003, J BIOL CHEM, V278, P23648, DOI 10.1074/jbc.M212785200; Zhu L, 2003, J MOL BIOL, V328, P235, DOI 10.1016/S0022-2836(03)00249-3	43	130	134	3	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2010	5	10							e15385	10.1371/journal.pone.0015385	http://dx.doi.org/10.1371/journal.pone.0015385			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673FU	21048945	Green Published, Green Submitted, gold			2022-12-27	WOS:000283645300052
J	Namadurai, S; Jain, D; Kulkarni, DS; Tabib, CR; Friedhoff, P; Rao, DN; Nair, DT				Namadurai, Sivakumar; Jain, Deepti; Kulkarni, Dhananjay S.; Tabib, Chaitanya R.; Friedhoff, Peter; Rao, Desirazu N.; Nair, Deepak T.			The C-Terminal Domain of the MutL Homolog from Neisseria gonorrhoeae Forms an Inverted Homodimer	PLOS ONE			English	Article							DNA MISMATCH REPAIR; SACCHAROMYCES-CEREVISIAE; ENDONUCLEASE ACTIVITY; DIFFRACTION DATA; ALPHA; HETERODIMER; RECOGNITION; MUTATIONS; INTERFACE; PROTEINS	The mismatch repair (MMR) pathway serves to maintain the integrity of the genome by removing mispaired bases from the newly synthesized strand. In E. coli, MutS, MutL and MutH coordinate to discriminate the daughter strand through a mechanism involving lack of methylation on the new strand. This facilitates the creation of a nick by MutH in the daughter strand to initiate mismatch repair. Many bacteria and eukaryotes, including humans, do not possess a homolog of MutH. Although the exact strategy for strand discrimination in these organisms is yet to be ascertained, the required nicking endonuclease activity is resident in the C-terminal domain of MutL. This activity is dependent on the integrity of a conserved metal binding motif. Unlike their eukaryotic counterparts, MutL in bacteria like Neisseria exist in the form of a homodimer. Even though this homodimer would possess two active sites, it still acts a nicking endonuclease. Here, we present the crystal structure of the C-terminal domain (CTD) of the MutL homolog of Neisseria gonorrhoeae (NgoL) determined to a resolution of 2.4 A. The structure shows that the metal binding motif exists in a helical configuration and that four of the six conserved motifs in the MutL family, including the metal binding site, localize together to form a composite active site. NgoL-CTD exists in the form of an elongated inverted homodimer stabilized by a hydrophobic interface rich in leucines. The inverted arrangement places the two composite active sites in each subunit on opposite lateral sides of the homodimer. Such an arrangement raises the possibility that one of the active sites is occluded due to interaction of NgoL with other protein factors involved in MMR. The presentation of only one active site to substrate DNA will ensure that nicking of only one strand occurs to prevent inadvertent and deleterious double stranded cleavage.	[Namadurai, Sivakumar; Jain, Deepti; Nair, Deepak T.] Natl Ctr Biol Sci, Lab 4, Bangalore, Karnataka, India; [Kulkarni, Dhananjay S.; Tabib, Chaitanya R.; Rao, Desirazu N.] Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India; [Friedhoff, Peter] Univ Giessen, Inst Biochem FB 08, Giessen, Germany	Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS); Indian Institute of Science (IISC) - Bangalore; Justus Liebig University Giessen	Namadurai, S (corresponding author), Natl Ctr Biol Sci, Lab 4, Bangalore, Karnataka, India.	deepaknair@ncbs.res.in	Nair, Deepak T/AAR-5234-2020; Friedhoff, Peter/G-7905-2012; Jain, Deepti/G-6921-2011	Friedhoff, Peter/0000-0003-1946-1117; Jain, Deepti/0000-0002-8631-7230; Kulkarni, Dhananjaya/0000-0002-0417-4468; Nair, Deepak/0000-0002-0677-9444	Department of Science and Technology (DST), Government of India (GOI); Department of Biotechnology (DBT), GOI; National Centre for Biogical Sciences; Department of Biotechnology and Department of Science and Technology, Government of India; MRC [G0500367] Funding Source: UKRI; Medical Research Council [G0500367] Funding Source: researchfish	Department of Science and Technology (DST), Government of India (GOI)(Department of Science & Technology (India)); Department of Biotechnology (DBT), GOI(Department of Biotechnology (DBT) India); National Centre for Biogical Sciences; Department of Biotechnology and Department of Science and Technology, Government of India; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	DJ is the recipient of a Young Investigator Grant from the Department of Science and Technology (DST), Government of India (GOI). DSK is the recipient of a Research Associateship from Department of Biotechnology (DBT), GOI. This work was funded in part by a startup grant provided by the National Centre for Biogical Sciences. Funding for travel to the ESRF synchrotron was provided by the DBT, GOI under the BM-14 project. DNR is a recipient of a JC Bose Fellowship from DST, GOI. DTN is a recipient of a Ramanujan Fellowship from DST, GOI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Viswanandham D and Chiranjeevi B for help in the initial part of this work. All members of the DNR laboratory are acknowledged for critical reading of the manuscript and useful discussions. DTN thanks the X-ray diffraction facility located in the Molecular Biophysics Unit of Indian Institute of Science (funded by Department of Biotechnology and Department of Science and Technology, Government of India) for facilitating screening and data collection. DTN acknowledges the help rendered by Dr. Chitra Rajendran (SLS), Dr. Meitian Wang (SLS) and Dr. Hassan Belrahli (ESRF) during data collection at the X06DA and BM-14 beamlines of SLS and ESRF, respectively.	Acharya S, 2003, MOL CELL, V12, P233, DOI 10.1016/S1097-2765(03)00219-3; Allen DJ, 1997, EMBO J, V16, P4467, DOI 10.1093/emboj/16.14.4467; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; da Silva FCC, 2009, SAO PAULO MED J, V127, P46, DOI 10.1590/S1516-31802009000100010; Cutalo JM, 2006, BIOCHEMISTRY-US, V45, P15458, DOI 10.1021/bi061392a; DeLano WL., 2020, PYMOL MOL GRAPHICS S; Deschenes SM, 2007, CANCER LETT, V249, P148, DOI 10.1016/j.canlet.2006.08.008; Duppatla V, 2009, BIOCHEM J, V423, P265, DOI 10.1042/BJ20090626; Erdeniz N, 2007, DNA REPAIR, V6, P1463, DOI 10.1016/j.dnarep.2007.04.013; FRIEDBERG EC, 1995, DNA REPAIR MUTAGENES; Fukui K, 2008, J BIOL CHEM, V283, P12136, DOI 10.1074/jbc.M800110200; Guarne A, 2004, EMBO J, V23, P4134, DOI 10.1038/sj.emboj.7600412; Habraken Y, 1997, CURR BIOL, V7, P790, DOI 10.1016/S0960-9822(06)00337-X; Habraken Y, 1998, J BIOL CHEM, V273, P9837, DOI 10.1074/jbc.273.16.9837; Iyer RR, 2006, CHEM REV, V106, P302, DOI 10.1021/cr0404794; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Joseph N, 2006, PROG NUCLEIC ACID RE, V81, P1, DOI 10.1016/S0079-6603(06)81001-9; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kadyrov FA, 2007, J BIOL CHEM, V282, P37181, DOI 10.1074/jbc.M707617200; Kadyrov FA, 2006, CELL, V126, P297, DOI 10.1016/j.cell.2006.05.039; Kirsch RD, 1998, NUCLEIC ACIDS RES, V26, P1848, DOI 10.1093/nar/26.7.1848; Kosinski J, 2005, J MOL BIOL, V351, P895, DOI 10.1016/j.jmb.2005.06.044; Kosinski J, 2008, J MOL BIOL, V382, P610, DOI 10.1016/j.jmb.2008.06.056; Kosinski J, 2010, HUM MUTAT, V31, P975, DOI 10.1002/humu.21301; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Larrea AA, 2010, CELL, V141, DOI 10.1016/j.cell.2010.05.002; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee JY, 2005, MOL CELL, V20, P155, DOI 10.1016/j.molcel.2005.08.019; de Saro FJL, 2006, J BIOL CHEM, V281, P14340, DOI 10.1074/jbc.M601264200; Mauris J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007175; Mohd AB, 2006, DNA REPAIR, V5, P347, DOI 10.1016/j.dnarep.2005.11.001; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nishant KT, 2008, GENETICS, V179, P747, DOI 10.1534/genetics.108.086645; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perera S, 2008, HUM MUTAT, V29, P332, DOI 10.1002/humu.9523; Pillon MC, 2010, MOL CELL, V39, P145, DOI 10.1016/j.molcel.2010.06.027; PLUCIENNIK A, 2010, P NATL ACAD SCI 0816, P1; Polosina YY, 2010, BIOESSAYS, V32, P51, DOI 10.1002/bies.200900089; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; SHEN P, 1989, MOL GEN GENET, V218, P358, DOI 10.1007/BF00331291; SULLIVAN MA, 1987, NUCLEIC ACIDS RES, V15, P2059, DOI 10.1093/nar/15.5.2059; Yang W, 2007, DNA REPAIR, V6, P135, DOI 10.1016/j.dnarep.2006.10.021	44	25	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2010	5	10							e13726	10.1371/journal.pone.0013726	http://dx.doi.org/10.1371/journal.pone.0013726			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	672HN	21060849	Green Submitted, gold, Green Accepted, Green Published			2022-12-27	WOS:000283573800020
J	Ahmed, A; Singh, J; Khan, Y; Seshan, SV; Girardi, G				Ahmed, Abdulwahab; Singh, Jameel; Khan, Ysodra; Seshan, Surya V.; Girardi, Guillermina			A New Mouse Model to Explore Therapies for Preeclampsia	PLOS ONE			English	Article							PREGNANCY-INDUCED HYPERTENSION; BLOOD-PRESSURE; PLACENTAL ISCHEMIA; ANGIOGENIC FACTORS; MICE; PATHOPHYSIOLOGY; PATHOGENESIS; COMPLEMENT; ACTIVATION; ABORTION	Background: Pre-eclampsia, a pregnancy-specific multisystemic disorder is a leading cause of maternal and perinatal mortality and morbidity. This syndrome has been known to medical science since ancient times. However, despite considerable research, the cause/s of preeclampsia remain unclear, and there is no effective treatment. Development of an animal model that recapitulates this complex pregnancy-related disorder may help to expand our understanding and may hold great potential for the design and implementation of effective treatment. Methodology/Principal Findings: Here we show that the CBA/J x DBA/2 mouse model of recurrent miscarriage is also a model of immunologically-mediated preeclampsia (PE). DBA/J mated CBA/J females spontaneously develop many features of human PE (primigravidity, albuminuria, endotheliosis, increased sensitivity to angiotensin II and increased plasma leptin levels) that correlates with bad pregnancy outcomes. We previously reported that antagonism of vascular endothelial growth factor (VEGF) signaling by soluble VEGF receptor 1 (sFlt-1) is involved in placental and fetal injury in CBA/J x DBA/2 mice. Using this animal model that recapitulates many of the features of preeclampsia in women, we found that pravastatin restores angiogenic balance, ameliorates glomerular injury, diminishes hypersensitivity to angiotensin II and protects pregnancies. Conclusions/Significance: We described a new mouse model of PE, were the relevant key features of human preeclampsia develop spontaneously. The CBA/J x DBA/2 model, that recapitulates this complex disorder, helped us identify pravastatin as a candidate therapy to prevent preeclampsia and its related complications. We recognize that these studies were conducted in mice and that clinical trials are needed to confirm its application to humans.	[Ahmed, Abdulwahab; Singh, Jameel; Khan, Ysodra; Girardi, Guillermina] CUNY, York Coll, Dept Biol, New York, NY 10021 USA; [Seshan, Surya V.] Weill Cornell Med Coll, Dept Pathol, New York, NY USA	City University of New York (CUNY) System; Cornell University	Ahmed, A (corresponding author), CUNY, York Coll, Dept Biol, New York, NY 10021 USA.	guillerminagirardi@gmail.com	Ahmed, Asif/ABE-9544-2020	Ahmed, Asif/0000-0002-8755-8546; Girardi, Guillermina/0000-0002-5797-7731; Singh, Jameel/0000-0003-1868-0377	York College, CUNY	York College, CUNY	This work was funded by an Institutional Grant from York College, CUNY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbdAlla S, 2001, NAT MED, V7, P1003, DOI 10.1038/nm0901-1003; BOBE P, 1986, CELL IMMUNOL, V98, P477, DOI 10.1016/0008-8749(86)90306-0; Bowen JA, 1999, BIOL REPROD, V60, P428, DOI 10.1095/biolreprod60.2.428; BROWN CEL, 1990, AM J OBSTET GYNECOL, V163, P1853, DOI 10.1016/0002-9378(90)90764-X; Burke SD, 2010, HYPERTENSION, V55, P729, DOI 10.1161/HYPERTENSIONAHA.109.144253; Clark DA, 1998, J IMMUNOL, V160, P545; Cudmore M, 2007, CIRCULATION, V115, P1789, DOI 10.1161/CIRCULATIONAHA.106.660134; Davison JM, 2004, J AM SOC NEPHROL, V15, P2440, DOI 10.1097/01.ASN.0000135975.90889.60; Falcao S, 2009, HYPERTENSION, V54, P1401, DOI 10.1161/HYPERTENSIONAHA.109.137356; Feldstein CA, 2010, AM J THER, V17, P255, DOI 10.1097/MJT.0b013e3181c0695e; Feng MJ, 2009, METHODS MOL BIOL, V573, P45, DOI 10.1007/978-1-60761-247-6_3; Gilbert JS, 2008, AM J PHYSIOL-HEART C, V294, pH541, DOI 10.1152/ajpheart.01113.2007; Gilbert JS, 2010, HYPERTENSION, V55, P380, DOI 10.1161/HYPERTENSIONAHA.109.141937; Girardi G, 2006, J EXP MED, V203, P2165, DOI 10.1084/jem.20061022; Granger JP, 2006, METH MOLEC MED, V122, P383; HAEGER M, 1992, OBSTET GYNECOL, V79, P19; Kanasaki K, 2008, NATURE, V453, P1117, DOI 10.1038/nature06951; Lain KY, 2002, JAMA-J AM MED ASSOC, V287, P3183, DOI 10.1001/jama.287.24.3183; Levine RJ, 2004, NEW ENGL J MED, V350, P672, DOI 10.1056/NEJMoa031884; LI Z, 2001, HYPERTENSION, V50, P686; Maynard SE, 2003, J CLIN INVEST, V111, P649, DOI 10.1172/JCI200317189; Mise H, 1998, J CLIN ENDOCR METAB, V83, P3225, DOI 10.1210/jc.83.9.3225; Redecha P, 2009, BLOOD, V113, P4101, DOI 10.1182/blood-2008-12-194258; Redman CW, 2005, SCIENCE, V308, P1592, DOI 10.1126/science.1111726; REDMAN CW, 1987, REPROD PERINATAL, P5; REDMAN CW, 1997, LANCET, V2, P1249; Redman CWG, 1999, AM J OBSTET GYNECOL, V180, P499, DOI 10.1016/S0002-9378(99)70239-5; Roberts JM, 2001, LANCET, V357, P53, DOI 10.1016/S0140-6736(00)03577-7; ROBERTS JM, 1993, LANCET, V341, P1447, DOI 10.1016/0140-6736(93)90889-O; ROBILLARD PY, 1994, LANCET, V344, P973, DOI 10.1016/S0140-6736(94)91638-1; Robillard PY, 1999, EUR J OBSTET GYN R B, V84, P37, DOI 10.1016/S0301-2115(98)00250-4; SANCHEZRAMOS L, 1994, OBSTET GYNECOL, V84, P349; Stillman IE, 2007, J AM SOC NEPHROL, V18, P2281, DOI 10.1681/ASN.2007020255; Takemoto M, 2001, ARTERIOSCL THROM VAS, V21, P1712, DOI 10.1161/hq1101.098486; Wong AYH, 2002, AM J PHYSIOL-HEART C, V282, pH918, DOI 10.1152/ajpheart.00641.2001; Zhou CC, 2008, NAT MED, V14, P855, DOI 10.1038/nm.1856	36	102	104	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2010	5	10							e13663	10.1371/journal.pone.0013663	http://dx.doi.org/10.1371/journal.pone.0013663			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671UN	21048973	Green Published, gold			2022-12-27	WOS:000283537000032
J	Helm, S; Lehmann, C; Nagel, A; Stanway, RR; Horstmann, S; Llinas, M; Heussler, VT				Helm, Susanne; Lehmann, Christine; Nagel, Andreas; Stanway, Rebecca R.; Horstmann, Sebastian; Llinas, Manuel; Heussler, Volker T.			Identification and Characterization of a Liver Stage-Specific Promoter Region of the Malaria Parasite Plasmodium	PLOS ONE			English	Article							CONDITIONAL MUTAGENESIS; TRANSCRIPTION FACTORS; DNA-BINDING; FALCIPARUM; BERGHEI; PROTEIN; GENE; EXPRESSION; LUCIFERASE; CELLS	During the blood meal of a Plasmodium-infected mosquito, 10 to 100 parasites are inoculated into the skin and a proportion of these migrate via the bloodstream to the liver where they infect hepatocytes. The Plasmodium liver stage, despite its clinical silence, represents a highly promising target for antimalarial drug and vaccine approaches. Successfully invaded parasites undergo a massive proliferation in hepatocytes, producing thousands of merozoites that are transported into a blood vessel to infect red blood cells. To successfully develop from the liver stage into infective merozoites, a tight regulation of gene expression is needed. Although this is a very interesting aspect in the biology of Plasmodium, little is known about gene regulation in Plasmodium parasites in general and in the liver stage in particular. We have functionally analyzed a novel promoter region of the rodent parasite Plasmodium berghei that is exclusively active during the liver stage of the parasite. To prove stage-specific activity of the promoter, GFP and luciferase reporter assays have been successfully established, allowing both qualitative and accurate quantitative analysis. To further characterize the promoter region, the transcription start site was mapped by rapid amplification of cDNA ends (59-RACE). Using promoter truncation experiments and site-directed mutagenesis within potential transcription factor binding sites, we suggest that the minimal promoter contains more than one binding site for the recently identified parasite-specific ApiAP2 transcription factors. The identification of a liver stage-specific promoter in P. berghei confirms that the parasite is able to tightly regulate gene expression during its life cycle. The identified promoter region might now be used to study the biology of the Plasmodium liver stage, which has thus far proven problematic on a molecular level. Stage-specific expression of dominant-negative mutant proteins and overexpression of proteins normally active in other life cycle stages will help to understand the function of the proteins investigated.	[Helm, Susanne; Lehmann, Christine; Nagel, Andreas; Stanway, Rebecca R.; Horstmann, Sebastian; Heussler, Volker T.] Bernhard Nocht Inst Trop Med, Malaria Lab 1, Hamburg, Germany; [Llinas, Manuel] Princeton Univ, Carl Icahn Lab, Princeton, NJ 08544 USA	Bernhard Nocht Institut fur Tropenmedizin; Princeton University	Helm, S (corresponding author), Bernhard Nocht Inst Trop Med, Malaria Lab 1, Hamburg, Germany.	heussler@bni-hamburg.de	Heussler, Volker/H-9322-2019	Heussler, Volker/0000-0001-8028-9825	Deutsche Forschungsgemeinschaft [HE 4497/1-2]; EU	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); EU(European Commission)	This work was supported by a Deutsche Forschungsgemeinschaft grant to VH (HE 4497/1-2) and the FP7 EU project MALSIG (Signalling in life cycle stages of malaria parasites). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong CM, 2007, NAT METHODS, V4, P1007, DOI 10.1038/nmeth1132; ATKINSON CT, 1992, AM J TROP MED HYG, V46, P533, DOI 10.4269/ajtmh.1992.46.533; Balaji S, 2005, NUCLEIC ACIDS RES, V33, P3994, DOI 10.1093/nar/gki709; Cann H, 2004, MOL BIOCHEM PARASIT, V137, P239, DOI 10.1016/j.molbiopara.2004.06.005; Carvalho TG, 2004, P NATL ACAD SCI USA, V101, P14931, DOI 10.1073/pnas.0404416101; Combe A, 2009, CELL HOST MICROBE, V5, P386, DOI 10.1016/j.chom.2009.03.008; de Koning-Ward TF, 1999, MOL BIOCHEM PARASIT, V100, P141, DOI 10.1016/S0166-6851(99)00042-0; De Silva EK, 2008, P NATL ACAD SCI USA, V105, P8393, DOI 10.1073/pnas.0801993105; DEWET JR, 1987, MOL CELL BIOL, V7, P725, DOI 10.1128/MCB.7.2.725; Garcia JE, 2004, J MOL MED, V82, P600, DOI 10.1007/s00109-004-0573-9; GOPALAKRISHNAN AM, 2010, PARASITOL RES; GUERINMARCHAND C, 1987, NATURE, V329, P164, DOI 10.1038/329164a0; Ishino T, 2009, CELL MICROBIOL, V11, P1329, DOI 10.1111/j.1462-5822.2009.01333.x; Janse CJ, 2006, NAT PROTOC, V1, P346, DOI 10.1038/nprot.2006.53; MATTHEWS JC, 1977, BIOCHEMISTRY-US, V16, P85, DOI 10.1021/bi00620a014; MCANDREW MB, 1993, GENE, V124, P165, DOI 10.1016/0378-1119(93)90390-O; MUHLE RA, 2009, INT J PARASITOL; Oguariri RM, 2006, MOL BIOCHEM PARASIT, V146, P163, DOI 10.1016/j.molbiopara.2005.12.004; Ruvalcaba-Salazar OK, 2005, MOL BIOCHEM PARASIT, V140, P183, DOI 10.1016/j.molbiopara.2005.01.002; Sacci JB, 2005, MOL BIOCHEM PARASIT, V142, P177, DOI 10.1016/j.molbiopara.2005.03.018; Schramm G, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.22.e96; Tarun AS, 2008, P NATL ACAD SCI USA, V105, P305, DOI 10.1073/pnas.0710780104; VANDERBERG JP, 1977, EXP PARASITOL, V42, P169, DOI 10.1016/0014-4894(77)90075-3; Vaughan AM, 2010, HUM VACCINES, V6, P107, DOI 10.4161/hv.6.1.9654; Yu Min, 2008, Cell Host Microbe, V4, P567, DOI 10.1016/j.chom.2008.11.001; Yuda M, 2010, MOL MICROBIOL, V75, P854, DOI 10.1111/j.1365-2958.2009.07005.x; Yuda M, 2009, MOL MICROBIOL, V71, P1402, DOI 10.1111/j.1365-2958.2009.06609.x	27	31	32	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2010	5	10							e13653	10.1371/journal.pone.0013653	http://dx.doi.org/10.1371/journal.pone.0013653			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671UN	21048918	Green Published, gold, Green Submitted			2022-12-27	WOS:000283537000024
J	Peiperl, L; Morgan, C; Moodie, Z; Li, HL; Russell, N; Graham, BS; Tomaras, GD; De Rosa, SC; McElrath, MJ				Peiperl, Laurence; Morgan, Cecilia; Moodie, Zoe; Li, Hongli; Russell, Nina; Graham, Barney S.; Tomaras, Georgia D.; De Rosa, Stephen C.; McElrath, M. Juliana		NIAID HIV Vaccine Trials Network	Safety and Immunogenicity of a Replication-Defective Adenovirus Type 5 HIV Vaccine in Ad5-Seronegative Persons: A Randomized Clinical Trial (HVTN 054)	PLOS ONE			English	Article							T-CELL RESPONSES; NEUTRALIZING ANTIBODIES; CANDIDATE VACCINE; HEALTHY-ADULTS; PHASE-1 SAFETY; GAG VACCINES; VIRUS; DNA; VECTOR; IMMUNITY	Background: Individuals without prior immunity to a vaccine vector may be more sensitive to reactions following injection, but may also show optimal immune responses to vaccine antigens. To assess safety and maximal tolerated dose of an adenoviral vaccine vector in volunteers without prior immunity, we evaluated a recombinant replication-defective adenovirus type 5 (rAd5) vaccine expressing HIV-1 Gag, Pol, and multiclade Env proteins, VRC-HIVADV014-00-VP, in a randomized, double-blind, dose-escalation, multicenter trial (HVTN study 054) in HIV-1-seronegative participants without detectable neutralizing antibodies (nAb) to the vector. As secondary outcomes, we also assessed T-cell and antibody responses. Methodology/Principal Findings: Volunteers received one dose of vaccine at either 10(10) or 10(11) adenovector particle units, or placebo. T-cell responses were measured against pools of global potential T-cell epitope peptides. HIV-1 binding and neutralizing antibodies were assessed. Systemic reactogenicity was greater at the higher dose, but the vaccine was well tolerated at both doses. Although no HIV infections occurred, commercial diagnostic assays were positive in 87% of vaccinees one year after vaccination. More than 85% of vaccinees developed HIV-1-specific T-cell responses detected by IFN-gamma ELISpot and ICS assays at day 28. T-cell responses were: CD8-biased; evenly distributed across the three HIV-1 antigens; not substantially increased at the higher dose; and detected at similar frequencies one year following injection. The vaccine induced binding antibodies against at least one HIV-1 Env antigen in all recipients. Conclusions/Significance: This vaccine appeared safe and was highly immunogenic following a single dose in human volunteers without prior nAb against the vector.	[Peiperl, Laurence] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Morgan, Cecilia; Moodie, Zoe; Li, Hongli; De Rosa, Stephen C.; McElrath, M. Juliana] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Seattle, WA 98104 USA; [Russell, Nina] Bill & Melinda Gates Fdn, Seattle, WA USA; [Graham, Barney S.] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; [Tomaras, Georgia D.] Duke Univ, Durham, NC USA; [De Rosa, Stephen C.; McElrath, M. Juliana] Univ Washington, Seattle, WA 98195 USA	University of California System; University of California San Francisco; Fred Hutchinson Cancer Center; Bill & Melinda Gates Foundation; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Duke University; University of Washington; University of Washington Seattle	Peiperl, L (corresponding author), Univ Calif San Francisco, San Francisco, CA 94143 USA.	jmcelrat@fhcrc.org	Graham, Barney S./AAC-5898-2019; Tomaras, Georgia/J-5041-2016	Graham, Barney S./0000-0001-8112-0853; Peiperl, Laurence/0000-0003-1237-4846	Division of AIDS, National Institute of Allergy and Infectious Diseases (NIAID), United States National Institutes of Health (NIH); NIAID; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI068618, P30AI027757, ZIAAI005035] Funding Source: NIH RePORTER	Division of AIDS, National Institute of Allergy and Infectious Diseases (NIAID), United States National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The study was sponsored by the Division of AIDS, National Institute of Allergy and Infectious Diseases (NIAID), United States National Institutes of Health (NIH) and conducted through the NIAID-funded HIV Vaccine Trials Network (HVTN). Study vaccine and placebo were provided by the Dale and Betty Bumpers Vaccine Research Center (VRC), NIAID, NIH. VRC and HVTN both contributed to the study design, decision to publish, and preparation of the manuscript. The clinical trial and data analyses were conducted by HVTN and the Statistical Center for HIV/AIDS Research and Prevention (SCHARP).	Agresti A, 1998, AM STAT, V52, P119, DOI 10.2307/2685469; Asmuth DM, 2010, J INFECT DIS, V201, P132, DOI 10.1086/648591; Barouch DH, 2001, J VIROL, V75, P5151, DOI 10.1128/JVI.75.11.5151-5158.2001; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Brough DE, 1996, J VIROL, V70, P6497, DOI 10.1128/JVI.70.9.6497-6501.1996; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; Bull M, 2007, J IMMUNOL METHODS, V322, P57, DOI 10.1016/j.jim.2007.02.003; Butman BT, 2006, DEV BIOLOGICALS, V123, P225; BUTMAN BT, 2006, DEV BIOL BASEL, V123, P265; Catanzaro AT, 2006, J INFECT DIS, V194, P1638, DOI 10.1086/509258; Cheng C, 2010, J VIROL, V84, P630, DOI 10.1128/JVI.00866-09; CHURCHYARD G, 2007, PHASE IIA TRIAL EVAL; Cleghorn F, 2007, JAIDS-J ACQ IMM DEF, V46, P222, DOI 10.1097/QAI.0b013e318149297d; Cox KS, 2008, J VIROL, V82, P8161, DOI 10.1128/JVI.00620-08; Goepfert PA, 2005, J INFECT DIS, V192, P1249, DOI 10.1086/432915; Goepfert PA, 2007, VACCINE, V25, P510, DOI 10.1016/j.vaccine.2006.07.050; Graham BS, 2006, J INFECT DIS, V194, P1650, DOI 10.1086/509259; Harro CD, 2009, AIDS RES HUM RETROV, V25, P103, DOI 10.1089/aid.2008.0212; Horton H, 2007, J IMMUNOL METHODS, V323, P39, DOI 10.1016/j.jim.2007.03.002; JAOKO W, 2010, PLOS ONE IN PRESS; [Joint United Nations Program on HIV/AIDS (UNAIDS) World Health Organization (WHO)], 2007, AIDS EP UPD 2007; Kent SJ, 1998, J VIROL, V72, P10180, DOI 10.1128/JVI.72.12.10180-10188.1998; Kibuuka H, 2010, J INFECT DIS, V201, P600, DOI 10.1086/650299; Kostense S, 2004, AIDS, V18, P1213, DOI 10.1097/00002030-200405210-00019; Koup RA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009015; Koup RA, 2009, J VIROL, V83, P6318, DOI 10.1128/JVI.00384-09; Letvin NL, 2006, SCIENCE, V312, P1530, DOI 10.1126/science.1124226; Li FS, 2006, VACCINE, V24, P6893, DOI 10.1016/j.vaccine.2006.06.009; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; Mast TC, 2010, VACCINE, V28, P950, DOI 10.1016/j.vaccine.2009.10.145; McElrath MJ, 2008, LANCET, V372, P1894, DOI 10.1016/S0140-6736(08)61592-5; MONTEFIORI D, 2004, CURRENT PROTOCOLS IM; Moodie Z, 2010, CANCER IMMUNOL IMMUN, V59, P1489, DOI 10.1007/s00262-010-0875-4; Nwanegbo E, 2004, CLIN DIAGN LAB IMMUN, V11, P351, DOI 10.1128/CDLI.11.2.351-357.2004; Priddy FH, 2008, CLIN INFECT DIS, V46, P1769, DOI 10.1086/587993; Rasmussen H, 2002, CANCER GENE THER, V9, P951, DOI 10.1038/sj.cgt.7700518; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Robinson HL, 1999, NAT MED, V5, P526, DOI 10.1038/8406; Russell ND, 2007, JAIDS-J ACQ IMM DEF, V44, P203, DOI 10.1097/01.qai.0000248356.48501.ff; Schulz KF, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000251; Shiver JW, 2002, NATURE, V415, P331, DOI 10.1038/415331a; Sprangers MC, 2003, J CLIN MICROBIOL, V41, P5046, DOI 10.1128/JCM.41.11.5046-5052.2003; Thorner AR, 2006, J CLIN MICROBIOL, V44, P3781, DOI 10.1128/JCM.01249-06; Tomaras GD, 2008, J VIROL, V82, P12449, DOI 10.1128/JVI.01708-08; Westfall P.H., 1993, RESAMPLING BASED MUL, V279	45	42	43	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2010	5	10							e13579	10.1371/journal.pone.0013579	http://dx.doi.org/10.1371/journal.pone.0013579			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671UN	21048953	gold, Green Published, Green Submitted			2022-12-27	WOS:000283537000011
J	Liu, YM; Suckale, J; Masjkur, J; Magro, MG; Steffen, A; Anastassiadis, K; Solimena, M				Liu, Yanmei; Suckale, Jakob; Masjkur, Jimmy; Magro, Maria Grazia; Steffen, Anja; Anastassiadis, Konstantinos; Solimena, Michele			Tamoxifen-Independent Recombination in the RIP-CreER Mouse	PLOS ONE			English	Article								Background: The inducible Cre-lox system is a valuable tool to study gene function in a spatial and time restricted fashion in mouse models. This strategy relies on the limited background activity of the modified Cre recombinase (CreER) in the absence of its inducer, the competitive estrogen receptor ligand, tamoxifen. The RIP-CreER mouse (Tg (Ins2-cre/Esr1) 1Dam) is among the few available beta-cell specific CreER mouse lines and thus it has been often used to manipulate gene expression in the insulin-producing cells of the endocrine pancreas. Principal Findings: Here, we report the detection of tamoxifen-independent Cre activity as early as 2 months of age in RIP-CreER mice crossed with three distinct reporter strains. Significance: Evidence of Cre-mediated recombination of floxed alleles even in the absence of tamoxifen administration should warrant cautious use of this mouse for the study of pancreatic beta-cells.	[Liu, Yanmei; Suckale, Jakob; Masjkur, Jimmy; Magro, Maria Grazia; Steffen, Anja; Solimena, Michele] Tech Univ Dresden, Sch Med, Paul Langerhans Inst Dresden, Mol Diabetol, Dresden, Germany; [Liu, Yanmei; Suckale, Jakob; Masjkur, Jimmy; Magro, Maria Grazia; Steffen, Anja; Solimena, Michele] Tech Univ Dresden, Univ Clin Carl Gustav Carus, Dresden, Germany; [Liu, Yanmei; Magro, Maria Grazia; Solimena, Michele] Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany; [Steffen, Anja] Tech Univ Dresden, Univ Clin Carl Gustav Carus, Med Clin 3, Dresden, Germany; [Anastassiadis, Konstantinos] Tech Univ Dresden, BioInnovat Zentrum, Genet Engn Stem Cells, Dresden, Germany; [Anastassiadis, Konstantinos; Solimena, Michele] Tech Univ Dresden, Ctr Regenerat Therapies Dresden, Dresden, Germany	Technische Universitat Dresden; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Max Planck Society; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Technische Universitat Dresden; Technische Universitat Dresden	Solimena, M (corresponding author), Tech Univ Dresden, Sch Med, Paul Langerhans Inst Dresden, Mol Diabetol, Dresden, Germany.	michele.solimena@tu-dresden.de	Solimena, Michele/E-1275-2011; Solimena, Michele/GVS-5990-2022; Anastassiadis, Konstantinos/A-8944-2010	Anastassiadis, Konstantinos/0000-0002-9814-0559	DFG [SFB 655]; Max Planck Society; BMBF Network of Competence for Diabetes; Center for Regenerative Therapies Dresden; MedDrive Grant from the Medical School of Dresden University of Technology; Dresden International Graduate School for Biomedicine and Bioengineering (DIGS-BB)	DFG(German Research Foundation (DFG)); Max Planck Society(Max Planck SocietyFoundation CELLEX); BMBF Network of Competence for Diabetes; Center for Regenerative Therapies Dresden; MedDrive Grant from the Medical School of Dresden University of Technology; Dresden International Graduate School for Biomedicine and Bioengineering (DIGS-BB)	These studies have been supported in part with funds from the DFG-SFB 655, the Max Planck Society, and the BMBF Network of Competence for Diabetes to MS and from the Center for Regenerative Therapies Dresden to K.A. Y.L. and J.S. are the recipients of a MedDrive Grant from the Medical School of Dresden University of Technology. M.G.M is supported by a fellowship from the Dresden International Graduate School for Biomedicine and Bioengineering (DIGS-BB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buelow B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003264; Danielian PS, 1998, CURR BIOL, V8, P1323, DOI 10.1016/S0960-9822(07)00562-3; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; Feil R, 2007, Handb Exp Pharmacol, P3; Feil R, 1996, P NATL ACAD SCI USA, V93, P10887, DOI 10.1073/pnas.93.20.10887; GOTOH M, 1985, TRANSPLANTATION, V40, P437, DOI 10.1097/00007890-198510000-00018; Gu GQ, 2002, DEVELOPMENT, V129, P2447; Indra AK, 1999, NUCLEIC ACIDS RES, V27, P4324, DOI 10.1093/nar/27.22.4324; Joyner AL, 2006, DEV DYNAM, V235, P2376, DOI 10.1002/dvdy.20884; Knoch KP, 2006, CELL METAB, V3, P123, DOI 10.1016/j.cmet.2005.12.008; Knoch KP, 2004, NAT CELL BIOL, V6, P207, DOI 10.1038/ncb1099; METZGER D, 1995, P NATL ACAD SCI USA, V92, P6991, DOI 10.1073/pnas.92.15.6991; Mziaut H, 2006, NAT CELL BIOL, V8, P435, DOI 10.1038/ncb1395; SAUER B, 1989, NUCLEIC ACIDS RES, V17, P147, DOI 10.1093/nar/17.1.147; Sohal DS, 2001, CIRC RES, V89, P20, DOI 10.1161/hh1301.092687; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Trajkovski M, 2008, J BIOL CHEM, V283, P33719, DOI 10.1074/jbc.M804928200; Walter T, 2010, NAT METHODS, V7, pS26, DOI [10.1038/nmeth.1431, 10.1038/NMETH.1431]	18	38	39	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2010	5	10							e13533	10.1371/journal.pone.0013533	http://dx.doi.org/10.1371/journal.pone.0013533			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	VI4QE	21063464	Green Submitted, Green Published, gold			2022-12-27	WOS:000488488500001
J	Nourizadeh-Lillabadi, R; Torgersen, JS; Vestrheim, O; Konig, M; Alestrom, P; Syed, M				Nourizadeh-Lillabadi, Rasoul; Torgersen, Jacob Seilo; Vestrheim, Olav; Konig, Melanie; Alestrom, Peter; Syed, Mohasina			Early Embryonic Gene Expression Profiling of Zebrafish Prion Protein (Prp2) Morphants	PLOS ONE			English	Article							SONIC-HEDGEHOG; PARKINSONS-DISEASE; NEURONS; NEUROGENESIS; SCRAPIE; MODELS; GROWTH; DEATH	Background: The Prion protein (PRNP/Prp) plays a crucial role in transmissible spongiform encephalopathies (TSEs) like Creutzfeldt-Jakob disease (CJD), scrapie and mad cow disease. Notwithstanding the importance in human and animal disease, fundamental aspects of PRNP/Prp function and transmission remains unaccounted for. Methodology/Principal Findings: The zebrafish (Danio rerio) genome contains three Prp encoding genes assigned prp1, prp2 and prp3. Currently, the second paralogue is believed to be the most similar to the mammalian PRNP gene in structure and function. Functional studies of the PRNP gene ortholog was addressed by prp2 morpholino (MO) knockdown experiments. Investigation of Prp2 depleted embryos revealed high mortality and apoptosis at 24 hours post fertilization (hpf) as well as impaired brain and neuronal development. In order to elucidate the underlying mechanisms, a genome-wide transcriptome analysis was carried out in viable 24 hpf morphants. The resulting changes in gene expression profiles revealed 249 differently expressed genes linked to biological processes like cell death, neurogenesis and embryonic development. Conclusions/Significance: The current study contributes to the understanding of basic Prp functions and demonstrates that the zebrafish is an excellent model to address the role of Prp in vertebrates. The gene knockdown of prp2 indicates an essential biological function for the zebrafish ortholog with a morphant phenotype that suggests a neurodegenerative action and gene expression effects which are apoptosis related and effects gene networks controlling neurogenesis and embryo development.	[Nourizadeh-Lillabadi, Rasoul; Torgersen, Jacob Seilo; Vestrheim, Olav; Konig, Melanie; Alestrom, Peter; Syed, Mohasina] Norwegian Sch Vet Sci, Dept Basic Sci & Aquat Med, Oslo, Norway	Norwegian University of Life Sciences	Nourizadeh-Lillabadi, R (corresponding author), Norwegian Sch Vet Sci, Dept Basic Sci & Aquat Med, Oslo, Norway.	Mohasina.Syed@nvh.no			Research Council of Norway [159329/S10 KO-ZFISH]; EU [QLK5-2002-0086]	Research Council of Norway(Research Council of Norway); EU(European Commission)	Financial support was provided by The FUGE Program, Research Council of Norway (via Grant 159329/S10 KO-ZFISH), and EU project: TSE IN FISH (nr. QLK5-2002-0086). The funders had no role in study design, data collection and analysis, decision or preparation of the manyscript.	Aguzzi A, 2008, ANNU REV NEUROSCI, V31, P439, DOI 10.1146/annurev.neuro.31.060407.125620; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bretaud S, 2007, J NEUROCHEM, V100, P1626, DOI 10.1111/j.1471-4159.2006.04291.x; BUELER H, 1992, NATURE, V356, P577, DOI 10.1038/356577a0; Charron F, 2003, CELL, V113, P11, DOI 10.1016/S0092-8674(03)00199-5; Cotto E, 2005, FEBS J, V272, P500, DOI 10.1111/j.1742-4658.2004.04492.x; da Costa CA, 2003, J BIOL CHEM, V278, P37330, DOI 10.1074/jbc.M306083200; Dahmane N, 1999, DEVELOPMENT, V126, P3089; Dahmane N, 2001, DEVELOPMENT, V128, P5201; Deckwerth TL, 1996, NEURON, V17, P401, DOI 10.1016/S0896-6273(00)80173-7; Herzog W, 2003, DEV BIOL, V254, P36, DOI 10.1016/S0012-1606(02)00124-0; Hwang D, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.10; JAY P, 1995, GENOMICS, V29, P541, DOI 10.1006/geno.1995.9970; Jost CA, 1997, NATURE, V389, P191, DOI 10.1038/38298; Lewis KE, 2001, DEVELOPMENT, V128, P3485; Malaga-Trillo E, 2009, PLOS BIOL, V7, P576, DOI 10.1371/journal.pbio.1000055; Menet V, 2003, P NATL ACAD SCI USA, V100, P8999, DOI 10.1073/pnas.1533187100; METCALFE WK, 1990, DEVELOPMENT, V110, P491; Miesbauer M, 2006, BIOCHEM BIOPH RES CO, V341, P218, DOI 10.1016/j.bbrc.2005.12.168; Mizugishi K, 2005, MOL CELL BIOL, V25, P11113, DOI 10.1128/MCB.25.24.11113-11121.2005; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Newman M, 2007, BBA-MOL BASIS DIS, V1772, P285, DOI 10.1016/j.bbadis.2006.12.001; Nourizadeh-Lillabadi R, 2009, J TOXICOL ENV HEAL A, V72, P112, DOI 10.1080/15287390802537255; Olivera S, 2003, MOL CELL NEUROSCI, V23, P96, DOI 10.1016/S1044-7431(03)00021-6; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Rivera-Milla E, 2006, FASEB J, V20, P317, DOI 10.1096/fj.05-4279fje; Salta E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006175; Santuccione A, 2005, J CELL BIOL, V169, P341, DOI 10.1083/jcb.200409127; Scholpp S, 2006, DEVELOPMENT, V133, P855, DOI 10.1242/dev.02248; Shou J, 1999, NAT NEUROSCI, V2, P339, DOI 10.1038/7251; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Sorensen G, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-114; Steele AD, 2006, P NATL ACAD SCI USA, V103, P3416, DOI 10.1073/pnas.0511290103; Westergard L, 2007, BBA-MOL BASIS DIS, V1772, P629, DOI 10.1016/j.bbadis.2007.02.011; Xiang W, 2005, ANN NEUROL, V58, P242, DOI 10.1002/ana.20551	37	18	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2010	5	10							e13573	10.1371/journal.pone.0013573	http://dx.doi.org/10.1371/journal.pone.0013573			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	670KA	21042590	Green Submitted, gold, Green Published			2022-12-27	WOS:000283419100013
J	Sun, GH; Hasebe, T; Fujimoto, K; Lu, R; Fu, LZ; Matsuda, H; Kajita, M; Ishizuya-Oka, A; Shi, YB				Sun, Guihong; Hasebe, Takashi; Fujimoto, Kenta; Lu, Rosemary; Fu, Liezhen; Matsuda, Hiroki; Kajita, Mitsuko; Ishizuya-Oka, Atsuko; Shi, Yun-Bo			Spatio-Temporal Expression Profile of Stem Cell-Associated Gene LGR5 in the Intestine during Thyroid Hormone-Dependent Metamorphosis in Xenopus laevis	PLOS ONE			English	Article							EPITHELIUM; RECEPTORS; PROTEIN; IDENTIFICATION; PROLIFERATION; RENEWAL	Background: The intestinal epithelium undergoes constant self-renewal throughout adult life across vertebrates. This is accomplished through the proliferation and subsequent differentiation of the adult stem cells. This self-renewal system is established in the so-called postembryonic developmental period in mammals when endogenous thyroid hormone (T3) levels are high. Methodology/Principal Findings: The T3-dependent metamorphosis in anurans like Xenopus laevis resembles the mammalian postembryonic development and offers a unique opportunity to study how the adult stem cells are developed. The tadpole intestine is predominantly a monolayer of larval epithelial cells. During metamorphosis, the larval epithelial cells undergo apoptosis and, concurrently, adult epithelial stem/progenitor cells develop de novo, rapidly proliferate, and then differentiate to establish a trough-crest axis of the epithelial fold, resembling the crypt-villus axis in the adult mammalian intestine. The leucine-rich repeat-containing G protein-coupled receptor 5 (LGR5) is a well-established stem cell marker in the adult mouse intestinal crypt. Here we have cloned and analyzed the spatiotemporal expression profile of LGR5 gene during frog metamorphosis. We show that the two duplicated LGR5 genes in Xenopus laevis and the LGR5 gene in Xenopus tropicalis are highly homologous to the LGR5 in other vertebrates. The expression of LGR5 is induced in the limb, tail, and intestine by T3 during metamorphosis. More importantly, LGR5 mRNA is localized to the developing adult epithelial stem cells of the intestine. Conclusions/Significance: These results suggest that LGR5-expressing cells are the stem/progenitor cells of the adult intestine and that LGR5 plays a role in the development and/or maintenance of the adult intestinal stem cells during postembryonic development in vertebrates.	[Sun, Guihong; Fujimoto, Kenta; Lu, Rosemary; Fu, Liezhen; Matsuda, Hiroki; Shi, Yun-Bo] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Mol Morphogenesis, Lab Gene Regulat & Dev, PCRM,NIH, Bethesda, MD USA; [Hasebe, Takashi; Ishizuya-Oka, Atsuko] Nippon Med Sch, Dept Biol, Kawasaki Ku, Kanagawa, Japan; [Kajita, Mitsuko; Ishizuya-Oka, Atsuko] Nippon Med Sch, Inst Dev & Aging Sci, Dept Mol Biol, Kawasaki Ku, Kanagawa, Japan	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Nippon Medical School; Nippon Medical School	Sun, GH (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Mol Morphogenesis, Lab Gene Regulat & Dev, PCRM,NIH, Bethesda, MD USA.	Shi@helix.nih.gov	Matsuda, Hiroki/K-5055-2019	Shi, Yun-Bo/0000-0002-6330-0639; Hasebe, Takashi/0000-0001-7200-8173	National Institute of Child Health and Human Development, National Institutes of Health; Narishige Zoological Science Award; Grants-in-Aid for Scientific Research [20570060] Funding Source: KAKEN; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008858] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Narishige Zoological Science Award; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This research was supported in part by the Intramural Research Program of National Institute of Child Health and Human Development, National Institutes of Health and in part by Narishige Zoological Science Award to T.H. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano T, 1998, DEV GROWTH DIFFER, V40, P177; Barker N, 2008, GENE DEV, V22, P1856, DOI 10.1101/gad.1674008; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Buchholz DR, 2007, DEV BIOL, V303, P576, DOI 10.1016/j.ydbio.2006.11.037; Buchholz DR, 2004, MOL CELL BIOL, V24, P9026, DOI 10.1128/MCB.24.20.9026-9037.2004; Crosnier C, 2006, NAT REV GENET, V7, P349, DOI 10.1038/nrg1840; Garcia MI, 2009, DEV BIOL, V331, P58, DOI 10.1016/j.ydbio.2009.04.020; Gilbert L.I., 1996, METAMORPHOSIS POSTEM; Hasebe T, 2006, CELL TISSUE RES, V324, P105, DOI 10.1007/s00441-005-0099-7; Hsu SY, 1998, MOL ENDOCRINOL, V12, P1830, DOI 10.1210/me.12.12.1830; Hsu SY, 2002, SCIENCE, V295, P671, DOI 10.1126/science.1065654; Ishizuya-Oka A, 1997, DEV BIOL, V192, P149, DOI 10.1006/dbio.1997.8749; Ishizuya-Oka A, 2003, J CELL SCI, V116, P3157, DOI 10.1242/jcs.00616; Ishizuya-Oka A, 2007, DEV DYN; Ishizuya-Oka A, 2009, FASEB J, V23, P2568, DOI 10.1096/fj.08-128124; Ishizuya-Oka A, 2006, DEV DYNAM, V235, P3240, DOI 10.1002/dvdy.20969; ISHIZUYAOKA A, 1991, IN VITRO CELL DEV B, V27, P853; Kong RCK, 2010, MOL CELL ENDOCRINOL, V320, P1, DOI 10.1016/j.mce.2010.02.003; Kumagai J, 2002, J BIOL CHEM, V277, P31283, DOI 10.1074/jbc.C200398200; LELOUP J, 1977, CR ACAD SCI D NAT, V284, P2261; Luo CW, 2005, P NATL ACAD SCI USA, V102, P2820, DOI 10.1073/pnas.0409916102; MACDONALD WC, 1964, GASTROENTEROLOGY, V46, P405; MCAVOY JW, 1977, J EXP ZOOL, V202, P129, DOI 10.1002/jez.1402020115; Morita H, 2004, MOL CELL BIOL, V24, P9736, DOI 10.1128/MCB.24.22.9736-9743.2004; Nieuwkoop PD., 1956, DEVELOPMENT, DOI [DOI 10.1242/DEV.200356, 10.1242/dev.200356]; Sancho E, 2004, ANNU REV CELL DEV BI, V20, P695, DOI 10.1146/annurev.cellbio.20.010403.092805; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Schreiber AM, 2005, P NATL ACAD SCI USA, V102, P3720, DOI 10.1073/pnas.0409868102; Shi Y.-B., 1999, AMPHIBIAN METAMORPHO; Shi YB, 1996, CURR TOP DEV BIOL, V32, P205, DOI 10.1016/S0070-2153(08)60429-9; SHI YB, 1994, BBA-GENE STRUCT EXPR, V1217, P227, DOI 10.1016/0167-4781(94)90042-6; TATA JR, 1993, BIOESSAYS, V15, P239, DOI 10.1002/bies.950150404; Toner P. G., 1971, DIGESTIVE SYSTEM ULT; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; van der Flier LG, 2009, ANNU REV PHYSIOL, V71, P241, DOI 10.1146/annurev.physiol.010908.163145	35	32	33	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2010	5	10							e13605	10.1371/journal.pone.0013605	http://dx.doi.org/10.1371/journal.pone.0013605			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	670KA	21042589	Green Published, Green Submitted, gold			2022-12-27	WOS:000283419100024
J	Ballinger, MN; Welliver, T; Straight, S; Peters-Golden, M; Swanson, JA				Ballinger, Megan N.; Welliver, Timothy; Straight, Samuel; Peters-Golden, Marc; Swanson, Joel A.			Transient Increase in Cyclic AMP Localized to Macrophage Phagosomes	PLOS ONE			English	Article							RECEPTOR-MEDIATED PHAGOCYTOSIS; COMPARTMENTALIZED PHOSPHODIESTERASES; ALVEOLAR MACROPHAGES; CAMP SYNTHESIS; LIVING CELLS; DEGRADATION; SHIP-1; BURST; CGMP	Cyclic AMP (cAMP) regulates many biological processes and cellular functions. The importance of spatially localized intracellular gradients of cAMP is increasingly appreciated. Previous work in macrophages has shown that cAMP is produced during phagocytosis and that elevated cAMP levels suppress host defense functions, including generation of proinflammatory mediators, phagocytosis and killing. However, the spatial and kinetic characteristics of cAMP generation in phagocytosing macrophages have yet to be examined. Using a Forster resonance energy transfer (FRET)-based cAMP biosensor, we measured the generation of cAMP in live macrophages. We detected no difference in bulk intracellular cAMP levels between resting cells and cells actively phagocytosing IgG-opsonized particles. However, analysis with the biosensor revealed a rapid decrease in FRET signal corresponding to a transient burst of cAMP production localized to the forming phagosome. cAMP levels returned to baseline after the particle was internalized. These studies indicate that localized increases in cAMP accompany phagosome formation and provide a framework for a more complete understanding of how cAMP regulates macrophage host defense functions.	[Ballinger, Megan N.; Peters-Golden, Marc] Univ Michigan Hlth Syst, Div Pulm & Crit Care Med, Dept Med, Ann Arbor, MI USA; [Welliver, Timothy; Straight, Samuel; Swanson, Joel A.] Univ Michigan Hlth Syst, Dept Microbiol & Immunol, Ann Arbor, MI USA; [Welliver, Timothy; Peters-Golden, Marc; Swanson, Joel A.] Univ Michigan Hlth Syst, Program Immunol, Ann Arbor, MI USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Ballinger, MN (corresponding author), Univ Michigan Hlth Syst, Div Pulm & Crit Care Med, Dept Med, Ann Arbor, MI USA.	jswan@umich.edu	Swanson, Joel A/P-4362-2014	Swanson, Joel A/0000-0003-0900-8212; Ballinger, Megan/0000-0002-2202-3049	National Institutes of Health [HL58897, AI64668]; Hartwell Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058897, R56HL058897] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064668, R01AI035950] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hartwell Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants HL58897 (M. P. G.), National Institutes of Health AI64668 (J.A.S.) and The Hartwell Foundation (M.N.B). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aronoff DM, 2005, J IMMUNOL, V174, P595, DOI 10.4049/jimmunol.174.2.595; Aronoff DM, 2004, J IMMUNOL, V173, P559, DOI 10.4049/jimmunol.173.1.559; Baillie GS, 2009, FEBS J, V276, P1790, DOI 10.1111/j.1742-4658.2009.06926.x; Beemiller P, 2006, PLOS BIOL, V4, P987, DOI 10.1371/journal.pbio.0040162; BIRMELIN M, 1984, EUR J BIOCHEM, V142, P219, DOI 10.1111/j.1432-1033.1984.tb08274.x; BROOKER G, 1988, METHOD ENZYMOL, V159, P45; Campagne MV, 2007, CELL MICROBIOL, V9, P2095, DOI 10.1111/j.1462-5822.2007.00981.x; Cheng XD, 2008, ACTA BIOCH BIOPH SIN, V40, P651, DOI 10.1111/j.1745-7270.2008.00438.x; Cooper DMF, 2005, BIOCHEM SOC T, V33, P1319, DOI 10.1042/BST0331319; Forman HJ, 2002, AM J RESP CRIT CARE, V166, pS4, DOI 10.1164/rccm.2206007; FULOP T, 1984, MECH AGEING DEV, V27, P233; HERLIN T, 1983, IMMUNOLOGY, V48, P17; Hoppe A, 2002, BIOPHYS J, V83, P3652, DOI 10.1016/S0006-3495(02)75365-4; Hoppe AD, 2004, MOL BIOL CELL, V15, P3509, DOI 10.1091/mbc.E03-11-0847; Kalamidas SA, 2006, J CELL SCI, V119, P3686, DOI 10.1242/jcs.03091; Kamen LA, 2008, J IMMUNOL, V180, P7497, DOI 10.4049/jimmunol.180.11.7497; Kamen LA, 2007, MOL BIOL CELL, V18, P2463, DOI 10.1091/mbc.e07-01-0061; KNAPP PE, 1990, J CELL SCI, V95, P433; Lee SP, 2009, J IMMUNOL, V182, P530, DOI 10.4049/jimmunol.182.1.530; Lissandron V, 2006, J MUSCLE RES CELL M, V27, P399, DOI 10.1007/s10974-006-9077-2; Medzhitov R, 2009, IMMUNITY, V30, P766, DOI 10.1016/j.immuni.2009.06.004; Nikolaev VO, 2006, PHYSIOLOGY, V21, P86, DOI 10.1152/physiol.00057.2005; Nikolaev VO, 2004, J BIOL CHEM, V279, P37215, DOI 10.1074/jbc.C400302200; Omori K, 2007, CIRC RES, V100, P309, DOI 10.1161/01.RES.0000256354.95791.f1; Peters-Golden M, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.275pe37; Pryzwansky Katherine B., 1998, Cell Biochemistry and Biophysics, V28, P251, DOI 10.1007/BF02737813; PRYZWANSKY KB, 1981, SCIENCE, V211, P407, DOI 10.1126/science.6261328; Serezani CH, 2008, AM J RESP CELL MOL, V39, P127, DOI 10.1165/rcmb.2008-0091TR; Serezani CH, 2007, AM J RESP CELL MOL, V37, P562, DOI 10.1165/rcmb.2007-0153OC; Swanson JA, 2004, J LEUKOCYTE BIOL, V76, P1093, DOI 10.1189/jlb.0804439; TANG WJ, 2009, MOL ASPECTS MED; Terrin A, 2006, J CELL BIOL, V175, P441, DOI 10.1083/jcb.200605050; Willoughby D, 2008, NAT METHODS, V5, P29, DOI 10.1038/NMETH1135	33	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2010	5	11							e13962	10.1371/journal.pone.0013962	http://dx.doi.org/10.1371/journal.pone.0013962			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	678OA	21085604	Green Published, gold, Green Submitted			2022-12-27	WOS:000284087800021
J	Biffi, A; Plourde, A; Shen, YP; Onofrio, R; Smith, EE; Frosch, M; Prada, CM; Gusella, J; Greenberg, SM; Rosand, J				Biffi, Alessandro; Plourde, Anna; Shen, Yiping; Onofrio, Robert; Smith, Eric E.; Frosch, Matthew; Prada, Claudia M.; Gusella, James; Greenberg, Steven M.; Rosand, Jonathan			Screening for Familial APP Mutations in Sporadic Cerebral Amyloid Angiopathy	PLOS ONE			English	Article							WHITE-MATTER LESIONS; INTRACEREBRAL HEMORRHAGE; DIAGNOSIS; SUBSTITUTIONS; HEREDITARY; COGNITION; DEMENTIA; GENE	Background: Advances in genetic technology have revealed that variation in the same gene can cause both rare familial and common sporadic forms of the same disease. Cerebral amyloid angiopathy (CAA), a common cause of symptomatic intracerebral hemorrhage (ICH) in the elderly, can also occur in families in an autosomal dominant pattern. The majority of affected families harbor mutations in the Beta amyloid Peptide (Ab) coding region of the gene for amyloid precursor protein (APP) or have duplications of chromosomal segments containing APP. Methodology/Principal Findings: A total of 58 subjects with a diagnosis of probable or definite CAA according to validated criteria were included in the present study. We sequenced the Ab coding region of APP in 58 individuals and performed multiplex ligation-dependent probe amplification to determine APP gene dosage in 60. No patient harbored a known or novel APP mutation or gene duplication. The frequency of mutations investigated in the present study is estimated to range from 0% to 8% in individuals with probable CAA in the general population, based on the ascertained sample size. Conclusions/Significance: We found no evidence that variants at loci associated with familial CAA play a role in sporadic CAA. Based on our findings, these rare highly-penetrant mutations are unlikely to be seen in sporadic CAA patients. Therefore, our results do not support systematic genetic screening of CAA patients who lack a strong family history of hemorrhage or dementia.	[Biffi, Alessandro; Plourde, Anna; Shen, Yiping; Gusella, James; Rosand, Jonathan] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Biffi, Alessandro; Plourde, Anna; Greenberg, Steven M.; Rosand, Jonathan] Massachusetts Gen Hosp, Hemorrhag Stroke Res Grp, Boston, MA 02114 USA; [Biffi, Alessandro; Plourde, Anna; Onofrio, Robert; Gusella, James; Rosand, Jonathan] Broad Inst MIT & Harvard, Program Med & Populat Genet, Cambridge, MA USA; [Smith, Eric E.] Univ Calgary, Dept Clin Neurosci, Calgary, AB, Canada; [Frosch, Matthew; Prada, Claudia M.] Massachusetts Gen Hosp, Inst Neurodegenerat Dis, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Calgary; Harvard University; Massachusetts General Hospital	Biffi, A (corresponding author), Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA.	jrosand@partners.org	Demchuk, Andrew M/E-1103-2012; Smith, Eric E/C-5443-2012; Frosch, Matthew P/ABD-7456-2021	Demchuk, Andrew M/0000-0002-4930-7789; Smith, Eric E/0000-0003-3956-1668; Frosch, Matthew P/0000-0002-3940-9861	National Institute of Neurological Disorders and Stroke (NINDS) [K23NS042695]; Massachusetts General Hospital Deane Institute for Integrative Research in Atrial Fibrillation and Stroke; American Heart Association/Bugher Foundation for Stroke Prevention Research; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K23NS042695] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Massachusetts General Hospital Deane Institute for Integrative Research in Atrial Fibrillation and Stroke; American Heart Association/Bugher Foundation for Stroke Prevention Research(American Heart Association); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by National Institute of Neurological Disorders and Stroke (NINDS) grant K23NS042695 awarded to Dr. Rosand and by the Massachusetts General Hospital Deane Institute for Integrative Research in Atrial Fibrillation and Stroke. Dr Biffi receives support from the American Heart Association/Bugher Foundation for Stroke Prevention Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; BAKKER E, 1991, AM J HUM GENET, V49, P518; Chen YW, 2006, NEUROLOGY, V67, P83, DOI 10.1212/01.wnl.0000223613.57229.24; Cohen JC, 2004, SCIENCE, V305, P869, DOI 10.1126/science.1099870; Fernando MS, 2004, J NEUROL SCI, V226, P13, DOI 10.1016/j.jns.2004.09.004; Florez JC, 2004, DIABETES, V53, P1360, DOI 10.2337/diabetes.53.5.1360; Gloyn AL, 2003, DIABETES, V52, P568, DOI 10.2337/diabetes.52.2.568; Grabowski TJ, 2001, ANN NEUROL, V49, P697, DOI 10.1002/ana.1009; Greenberg SM, 1997, STROKE, V28, P1418, DOI 10.1161/01.STR.28.7.1418; HENDRIKS L, 1992, NAT GENET, V1, P218, DOI 10.1038/ng0692-218; Knudsen KA, 2001, NEUROLOGY, V56, P537, DOI 10.1212/WNL.56.4.537; Miravalle L, 2000, J BIOL CHEM, V275, P27110; Nickerson DA, 1997, NUCLEIC ACIDS RES, V25, P2745, DOI 10.1093/nar/25.14.2745; Nilsberth C., 1999, Society for Neuroscience Abstracts, V25, P297; Obici L, 2005, ANN NEUROL, V58, P639, DOI 10.1002/ana.20571; Rosner B., 2000, FUNDAMENTAL BIOSTATI; Rovelet-Lecrux A, 2006, NAT GENET, V38, P24, DOI 10.1038/ng1718; Smith EE, 2004, NEUROLOGY, V63, P1606, DOI 10.1212/01.WNL.0000142966.22886.20; Vaxillaire M, 2008, ENDOCR REV, V29, P254, DOI 10.1210/er.2007-0024; VONSATTEL JPG, 1991, ANN NEUROL, V30, P637, DOI 10.1002/ana.410300503; Woo D, 2002, STROKE, V33, P1190, DOI 10.1161/01.STR.0000014774.88027.22; Zhang-Nunes SX, 2006, BRAIN PATHOL, V16, P30, DOI 10.1111/j.1750-3639.2006.tb00559.x	22	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2010	5	11							e13949	10.1371/journal.pone.0013949	http://dx.doi.org/10.1371/journal.pone.0013949			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	678OA	21085603	Green Published, gold			2022-12-27	WOS:000284087800015
J	Filipowicz, M; Bernsmeier, C; Terracciano, L; Duong, FHT; Heim, MH				Filipowicz, Magdalena; Bernsmeier, Christine; Terracciano, Luigi; Duong, Francois H. T.; Heim, Markus H.			S-Adenosyl-Methionine and Betaine Improve Early Virological Response in Chronic Hepatitis C Patients with Previous Nonresponse	PLOS ONE			English	Article							INTERFERON-ALPHA-2B PLUS RIBAVIRIN; JAK-STAT PATHWAY; ARGININE METHYLATION; COMBINATION THERAPY; INHIBITS INTERFERON; VIRUS-INFECTION; UP-REGULATION; PEGINTERFERON; EXPRESSION; LIVER	Background/Aims: Treatment of chronic hepatitis C (CHC) with pegylated interferon alpha (pegIFN alpha) and ribavirin results in a sustained response in approximately half of patients. Viral interference with IFN alpha signal transduction through the Jak-STAT pathway might be an important factor underlying treatment failure. S-adenosyl-L-methionine (SAMe) and betaine potentiate IFN alpha signaling in cultured cells that express hepatitis C virus (HCV) proteins, and enhance the inhibitory effect of IFN alpha on HCV replicons. We have performed a clinical study with the aim to evaluate efficacy and safety of the addition of SAMe and betaine to treatment of CHC with pegIFN alpha/ribavirin. Methods: In this open-label pilot study, 29 patients with CHC who failed previous therapy with (peg) IFN alpha/ribavirin were treated with SAMe, betaine, pegIFN alpha 2b and ribavirin. Treatment duration was 6 or 12 months, depending on genotype, and the protocol comprised a stopping rule at week 12 if early virological response (EVR) was not achieved. Virological and biochemical response and safety were assessed throughout the treatment. Results: 29 patients were enrolled and treated according to the study protocol. 79% of the patients were infected with genotype 1, 72% had advanced fibrosis, 76% had previously received pegIFN alpha/ribavirin, and only 14% achieved EVR to the previous treatment. When treated with the study medications, 17 patients (59%) showed an EVR, only 3 (10%) however achieved a sustained virological response (SVR). SAMe and betaine were found to be safe when used with pegIFN alpha/ribavirin. Conclusion: The addition of SAMe and betaine to pegIFN alpha/ribavirin improves early virological response in CHC.	[Filipowicz, Magdalena; Bernsmeier, Christine; Duong, Francois H. T.; Heim, Markus H.] Univ Basel Hosp, Dept Biomed, Hepatol Lab, CH-4031 Basel, Switzerland; [Filipowicz, Magdalena; Bernsmeier, Christine; Heim, Markus H.] Univ Basel Hosp, Dept Gastroenterol & Hepatol, CH-4031 Basel, Switzerland; [Terracciano, Luigi] Univ Basel Hosp, Inst Pathol, CH-4031 Basel, Switzerland	University of Basel; University of Basel; University of Basel	Filipowicz, M (corresponding author), Univ Basel Hosp, Dept Biomed, Hepatol Lab, CH-4031 Basel, Switzerland.	markus.heim@unibas.ch	Heim, Markus/A-7526-2008; Terracciano, Luigi M./AAB-5335-2022	Heim, Markus/0000-0002-7523-4894; Terracciano, Luigi M./0000-0002-9393-9660; Filipowicz, Magdalena/0000-0002-0356-8836; DUONG, Hong Tuan Francois/0000-0003-0928-2123; Bernsmeier, Christine/0000-0002-5558-0503	Swiss National Science Foundation [32-116106]; Swiss Cancer League grant [KLS-01832-02-2006]; Essex Chemie AG Schweiz	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss Cancer League grant; Essex Chemie AG Schweiz	This work was supported by Swiss National Science Foundation grant 32-116106, the Swiss Cancer League grant KLS-01832-02-2006, and by a grant from Essex Chemie AG Schweiz. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter MJ, 1999, NEW ENGL J MED, V341, P556, DOI 10.1056/NEJM199908193410802; Asselah T, 2008, GUT, V57, P516, DOI 10.1136/gut.2007.128611; BARAK AJ, 1993, ALCOHOL CLIN EXP RES, V17, P552, DOI 10.1111/j.1530-0277.1993.tb00798.x; Biron C.A., 2001, FIELDS VIROLOGY, P321; Blindenbacher A, 2003, GASTROENTEROLOGY, V124, P1465, DOI 10.1016/S0016-5085(03)00290-7; Chen LM, 2005, GASTROENTEROLOGY, V128, P1437, DOI 10.1053/j.gastro.2005.01.059; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Duong FHT, 2006, HEPATOLOGY, V43, P796, DOI 10.1002/hep.21116; Duong FHT, 2005, J VIROL, V79, P15342, DOI 10.1128/JVI.79.24.15342-15350.2005; Duong FHT, 2004, GASTROENTEROLOGY, V126, P263, DOI 10.1053/j.gastro.2003.10.076; FINKELSTEIN JD, 1972, ARCH BIOCHEM BIOPHYS, V153, P320, DOI 10.1016/0003-9861(72)90451-1; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Heim MH, 1999, J VIROL, V73, P8469, DOI 10.1128/JVI.73.10.8469-8475.1999; Heim MH, 1999, J RECEPT SIGNAL TR R, V19, P75, DOI 10.3109/10799899909036638; Hezode C, 2009, NEW ENGL J MED, V360, P1839, DOI 10.1056/NEJMoa0807650; Kwo PY, 2010, LANCET, V376, P705, DOI 10.1016/S0140-6736(10)60934-8; Manns MP, 2009, J HEPATOL, V50, pS384, DOI 10.1016/S0168-8278(09)61058-8; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; Mato JM, 1999, J HEPATOL, V30, P1081, DOI 10.1016/S0168-8278(99)80263-3; Moucari R, 2007, J HEPATOL, V46, P596, DOI 10.1016/j.jhep.2006.10.016; Mowen KA, 2001, CELL, V104, P731, DOI 10.1016/S0092-8674(02)08085-6; Parise E., 2006, Braz J Infect Dis, V10, P11, DOI 10.1590/S1413-86702006000100003; Poynard T, 2009, GASTROENTEROLOGY, V136, P1618, DOI 10.1053/j.gastro.2009.01.039; Sarasin-Filipowicz M, 2008, P NATL ACAD SCI USA, V105, P7034, DOI 10.1073/pnas.0707882105; Schwab U, 2006, J NUTR, V136, P34, DOI 10.1093/jn/136.1.34; Sherman M, 2006, GUT, V55, P1631, DOI 10.1136/gut.2005.083113; Taliani G, 2006, GASTROENTEROLOGY, V130, P1098, DOI 10.1053/j.gastro.2006.02.016; Weber S, 2009, GENE DEV, V23, P118, DOI 10.1101/gad.489409	28	19	21	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2010	5	11							e15492	10.1371/journal.pone.0015492	http://dx.doi.org/10.1371/journal.pone.0015492			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	676NU	21079746	Green Published, gold, Green Submitted			2022-12-27	WOS:000283920000028
J	Wang, ZY; Che, PL; Du, JA; Ha, B; Yarema, KJ				Wang, Zhiyun; Che, Pao-Lin; Du, Jian; Ha, Barbara; Yarema, Kevin J.			Static Magnetic Field Exposure Reproduces Cellular Effects of the Parkinson's Disease Drug Candidate ZM241385	PLOS ONE			English	Article							ADENOSINE A(2A) RECEPTORS; RAT PC12 CELLS; BOUND IRON UPTAKE; NEURITE OUTGROWTH; PROTEIN-KINASE; NITRIC-OXIDE; DOWN-REGULATION; CALCIUM; EXPRESSION; ACTIVATION	Background: This study was inspired by coalescing evidence that magnetic therapy may be a viable treatment option for certain diseases. This premise is based on the ability of moderate strength fields (i. e., 0.1 to 1 Tesla) to alter the biophysical properties of lipid bilayers and in turn modulate cellular signaling pathways. In particular, previous results from our laboratory (Wang et al., BMC Genomics, 10, 356 (2009)) established that moderate strength static magnetic field (SMF) exposure altered cellular endpoints associated with neuronal function and differentiation. Building on this background, the current paper investigated SMF by focusing on the adenosine A(2A) receptor (A(2A)R) in the PC12 rat adrenal pheochromocytoma cell line that displays metabolic features of Parkinson's disease (PD). Methodology and Principal Findings: SMF reproduced several responses elicited by ZM241385, a selective A(2A)R antagonist, in PC12 cells including altered calcium flux, increased ATP levels, reduced cAMP levels, reduced nitric oxide production, reduced p44/42 MAPK phosphorylation, inhibited proliferation, and reduced iron uptake. SMF also counteracted several PD-relevant endpoints exacerbated by A(2A)R agonist CGS21680 in a manner similar to ZM241385; these include reduction of increased expression of A(2A)R, reversal of altered calcium efflux, dampening of increased adenosine production, reduction of enhanced proliferation and associated p44/42 MAPK phosphorylation, and inhibition of neurite outgrowth. Conclusions and Significance: When measured against multiple endpoints, SMF elicited qualitatively similar responses as ZM241385, a PD drug candidate. Provided that the in vitro results presented in this paper apply in vivo, SMF holds promise as an intriguing non-invasive approach to treat PD and potentially other neurological disorders.	[Wang, Zhiyun; Che, Pao-Lin; Du, Jian; Ha, Barbara; Yarema, Kevin J.] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21218 USA	Johns Hopkins University	Wang, ZY (corresponding author), Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21218 USA.	kyarema1@jhu.edu	RIVADULLA, CASTO/K-8425-2012; Yarema, Kevin/A-3329-2010	RIVADULLA, CASTO/0000-0001-5580-3917; DU, JIAN/0000-0001-7154-8987	Arnold and Mabel Beckman Foundation; Whitaker Biomedical Institute (through the Department of Biomedical Engineering at the Johns Hopkins University); National Institutes of Health (NIBIB) [5R01EB5692]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB005692] Funding Source: NIH RePORTER	Arnold and Mabel Beckman Foundation; Whitaker Biomedical Institute (through the Department of Biomedical Engineering at the Johns Hopkins University); National Institutes of Health (NIBIB)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	Funding for this project was provided by the Arnold and Mabel Beckman Foundation, the Whitaker Biomedical Institute (through the Department of Biomedical Engineering at the Johns Hopkins University) and from the National Institutes of Health (NIBIB, 5R01EB5692). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arendash GW, 2010, J ALZHEIMERS DIS, V19, P191, DOI 10.3233/JAD-2010-1228; Arslan G, 1997, NEUROPHARMACOLOGY, V36, P1319, DOI 10.1016/S0028-3908(97)00090-7; Arslan G, 2002, N-S ARCH PHARMACOL, V365, P150, DOI 10.1007/s002100100456; AZANZA MJ, 1989, BRAIN RES, V489, P195, DOI 10.1016/0006-8993(89)90025-5; Beitner-Johnson D, 1998, BIOCHEM BIOPH RES CO, V242, P61, DOI 10.1006/bbrc.1997.7907; Belcastro V, 2009, EXP NEUROL, V217, P231, DOI 10.1016/j.expneurol.2009.01.010; Benabid AL, 2009, LANCET NEUROL, V8, P67, DOI 10.1016/S1474-4422(08)70291-6; Biber K, 2001, NEUROPSYCHOPHARMACOL, V24, P86, DOI 10.1016/S0893-133X(00)00169-X; Blum D, 2000, NEUROSCI LETT, V283, P193, DOI 10.1016/S0304-3940(00)00948-4; BRAGANZA LF, 1984, BIOCHIM BIOPHYS ACTA, V801, P66, DOI 10.1016/0304-4165(84)90213-7; Brambilla R, 2003, GLIA, V43, P190, DOI 10.1002/glia.10243; Cen S, 2004, J BIOL CHEM, V279, P33177, DOI 10.1074/jbc.M402062200; Chan SL, 2000, J BIOL CHEM, V275, P18195, DOI 10.1074/jbc.M000040200; Charles MP, 2003, BIOCHEM BIOPH RES CO, V304, P795, DOI 10.1016/S0006-291X(03)00666-1; Cheng HC, 2002, J BIOL CHEM, V277, P33930, DOI 10.1074/jbc.M201206200; Colbert AP, 2009, EVID-BASED COMPL ALT, V6, P133, DOI 10.1093/ecam/nem131; Cunha RA, 1997, BRIT J PHARMACOL, V122, P1279, DOI 10.1038/sj.bjp.0701507; De Nicola M, 2006, ANN NY ACAD SCI, V1090, P59, DOI 10.1196/annals.1378.006; Engstrom S, 2002, BIOELECTROMAGNETICS, V23, P475, DOI 10.1002/bem.10035; FERRE S, 1993, J NEUROSCI, V13, P5402, DOI 10.1523/JNEUROSCI.13-12-05402.1993; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Hattori N, 2009, PARKINSONISM RELAT D, V15, pS35, DOI 10.1016/S1353-8020(09)70010-0; Hernan MA, 2002, ANN NEUROL, V52, P276, DOI 10.1002/ana.10277; Hove-Madsen L, 2006, CARDIOVASC RES, V72, P292, DOI 10.1016/j.cardiores.2006.07.020; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Jang JH, 2005, BIOCHEM BIOPH RES CO, V331, P1421, DOI 10.1016/j.bbrc.2005.04.057; Kanda T, 1998, NEUROREPORT, V9, P2857, DOI 10.1097/00001756-199808240-00032; Karcz-Kubicha M, 2003, NEUROPSYCHOPHARMACOL, V28, P1281, DOI 10.1038/sj.npp.1300167; Kobayashi S, 1998, J PHYSIOL-LONDON, V512, P351, DOI 10.1111/j.1469-7793.1998.351be.x; Kobayashi S, 1998, J PHYSIOL-LONDON, V508, P95, DOI 10.1111/j.1469-7793.1998.095br.x; Kobayashi S, 2000, J NEUROCHEM, V74, P621, DOI 10.1046/j.1471-4159.2000.740621.x; LeWitt PA, 2008, NEW ENGL J MED, V359, P2468, DOI 10.1056/NEJMct0800326; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Gatto EM, 2002, NEUROTOX RES, V4, P141, DOI 10.1080/10298420290015881; MALLY J, 1994, J PHARM PHARMACOL, V46, P515, DOI 10.1111/j.2042-7158.1994.tb03840.x; Mandel S, 2003, CNS DRUGS, V17, P729, DOI 10.2165/00023210-200317100-00004; Mckay JC, 2007, BIOELECTROMAGNETICS, V28, P81, DOI 10.1002/bem.20284; Meng HW, 2007, INT J DEV NEUROSCI, V25, P509, DOI 10.1016/j.ijdevneu.2007.09.010; Moreau JL, 1999, BRAIN RES REV, V31, P65, DOI 10.1016/S0165-0173(99)00059-4; Mori Y, 2004, CELL STRUCT FUNCT, V29, P101, DOI 10.1247/csf.29.101; Morris CE, 2007, J APPL PHYSIOL, V103, P629, DOI 10.1152/japplphysiol.01133.2006; Mwanjewe J, 2000, J BIOL CHEM, V275, P33512, DOI 10.1074/jbc.M005435200; Mwanjewe J, 2004, BIOCHEM J, V378, P975, DOI 10.1042/BJ20031187; Narkar VA, 2001, J AM SOC NEPHROL, V12, P1844, DOI 10.1681/ASN.V1291844; Nuccitelli S, 2006, ANN NY ACAD SCI, V1090, P217, DOI 10.1196/annals.1378.024; O'Driscoll CM, 2005, NEUROSCIENCE, V131, P321, DOI 10.1016/j.neuroscience.2004.11.015; Okano H, 2008, BIOELECTROMAGNETICS, V29, P233, DOI 10.1002/bem.20376; Okano H, 2007, BIOELECTROMAGNETICS, V28, P497, DOI 10.1002/bem.20330; Okano H, 2006, BIOELECTROMAGNETICS, V27, P628, DOI 10.1002/bem.20246; OLAH ME, 1995, ANNU REV PHARMACOL, V35, P581, DOI 10.1146/annurev.pa.35.040195.003053; Park TJ, 1998, J NEUROCHEM, V71, P1251; Petrov E, 2007, EUR BIOPHYS J BIOPHY, V36, P95, DOI 10.1007/s00249-006-0109-z; Pilla Arthur A., 1994, Reviews on Environmental Health, V10, P155; Popoli P, 2007, PROG NEUROBIOL, V81, P331, DOI 10.1016/j.pneurobio.2006.12.005; POUCHER SM, 1995, BRIT J PHARMACOL, V115, P1096, DOI 10.1111/j.1476-5381.1995.tb15923.x; Regaya I, 2004, LIFE SCI, V76, P367, DOI 10.1016/j.lfs.2004.06.023; Riemer J, 2004, ANAL BIOCHEM, V331, P370, DOI 10.1016/j.ab.2004.03.049; Rosen AD, 2003, CELL BIOCHEM BIOPHYS, V39, P163, DOI 10.1385/CBB:39:2:163; Rosen AD, 2003, BIOELECTROMAGNETICS, V24, P517, DOI 10.1002/bem.10124; Rozen S, 2000, Methods Mol Biol, V132, P365; SANDYK R, 1992, INT J NEUROSCI, V63, P141, DOI 10.3109/00207459208986664; Schonfeld E, 2007, NEUROCHEM RES, V32, P1673, DOI 10.1007/s11064-007-9378-x; Strehler B. L., 1974, METHOD ENZYMAT AN, P2112, DOI [10.1016/b978-0-12-091304-6.50065-3, DOI 10.1016/B978-0-12-091304-6.50065-3]; STURROCK A, 1990, J BIOL CHEM, V265, P3139; Takahashi RN, 2008, FRONT BIOSCI-LANDMRK, V13, P2614, DOI 10.2741/2870; Taniguchi N, 2004, EVID-BASED COMPL ALT, V1, P187, DOI 10.1093/ecam/neh024; Tenuzzo B, 2009, TISSUE CELL, V41, P169, DOI 10.1016/j.tice.2008.09.004; Tenuzzo B, 2006, BIOELECTROMAGNETICS, V27, P560, DOI 10.1002/bem.20252; Theodosis DT, 1999, J NEUROSCI, V19, P10228; TRACEY WR, 1990, J PHARMACOL EXP THER, V252, P922; Triantafilou M, 2004, J CELL SCI, V117, P4007, DOI 10.1242/jcs.01270; VAJANAPHANICH M, 1995, J CLIN INVEST, V96, P386, DOI 10.1172/JCI118046; Vu CB, 2004, J MED CHEM, V47, P4291, DOI 10.1021/jm0498405; Wang ZY, 2006, J BIOL CHEM, V281, P27016, DOI 10.1074/jbc.M604903200; Wang ZY, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-356; WRIGHT TL, 1986, J BIOL CHEM, V261, P909; Wyatt AW, 2002, FASEB J, V16, P1584, DOI 10.1096/fasebj.16.12.1584; Yang M, 2007, N-S ARCH PHARMACOL, V375, P133, DOI 10.1007/s00210-007-0135-0; Zhang L, 2006, PHARMACOL THERAPEUT, V109, P33, DOI 10.1016/j.pharmthera.2005.05.007; Zhang XJ, 1998, CHEM PHYS LIPIDS, V97, P55, DOI 10.1016/S0009-3084(98)00092-9; ZHANG Y, 1991, AM J PHYSIOL, V260, pG658, DOI 10.1152/ajpgi.1991.260.4.G658	81	39	39	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2010	5	11							e13883	10.1371/journal.pone.0013883	http://dx.doi.org/10.1371/journal.pone.0013883			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	676NU	21079735	Green Published, Green Submitted, gold			2022-12-27	WOS:000283920000015
J	Creech, CC; Neumann, DM				Creech, Clinton C.; Neumann, Donna M.			Changes to Euchromatin on LAT and ICP4 Following Reactivation Are More Prevalent in an Efficiently Reactivating Strain of HSV-1	PLOS ONE			English	Article							SIMPLEX-VIRUS TYPE-1; FACULTATIVE HETEROCHROMATIN; LYTIC INFECTION; GENE PROMOTERS; EARLY TIMES; HISTONE H3; VIRAL-DNA; LATENCY; PROTEIN; ESTABLISHMENT	Background: Epigenetic mechanisms, via post-translational histone modifications, have roles in the establishment and maintenance of latency of the HSV-1 genome in the sensory neurons. Considering that many post-translational histone marks are reversible in nature, epigenetic mechanisms may also play a critical role in the process of induced HSV-1 reactivation. Methodology/Principal Findings: This study utilized the rabbit ocular model of HSV-1 infection and reactivation, induced by the transcorneal iontophoresis of epinephrine (TCIE), to characterize changes to chromatin that occur between 0.5 and 4 h following the application of the reactivation stimulus. Our goal was to explore the hypothesis that chromatin remodeling is an early and essential step in the process of HSV-1 reactivation. Analysis of the HSV-1 latently infected rabbit trigeminal ganglia (TG) showed that enrichment of the euchromatic marker H3K4me2 significantly decreased in the LAT 5'exon region (similar to 2.5-fold) and significantly increased in the lytic ICP4 promoter region (similar to 3-fold) by 1 h post-TCIE in the highly efficient reactivating McKrae strain of HSV-1. In contrast, we observed no significant change in the euchromatic marks of H3K4me2 associated with LAT 5'exon or ICP4 promoter regions of the poorly reactivating KOS strain of HSV-1 following TCIE through 4 h. The implication that these observed epigenetic changes were linked to transcriptional activity was confirmed by qRT-PCR examining both LAT and lytic transcript abundance following TCIE. We found a significant decrease in the abundance of LAT RNA by 2 h post-iontophoresis of epinephrine coupled to an increase in the transcript abundance of ICP4 in the McKrae strain of HSV-1. By comparison, we observed no change in the LAT or ICP4 transcript abundance of the poor reactivator KOS following iontophoresis of epinephrine through 4 h. Conclusions/Significance: Our results implicate that chromatin remodeling is an early and essential step involved in the process of in vivo HSV-1 reactivation.	[Creech, Clinton C.; Neumann, Donna M.] Louisiana State Univ, Hlth Sci Ctr, Dept Ophthalmol, LSU Eye Ctr Excellence, New Orleans, LA USA; [Neumann, Donna M.] Louisiana State Univ, Hlth Sci Ctr, Dept Genet, New Orleans, LA USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Creech, CC (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Dept Ophthalmol, LSU Eye Ctr Excellence, New Orleans, LA USA.	dneum1@lsuhsc.edu			Louisiana State University Health Sciences Center Eye Center Core [P30EY002377]; Louisiana State University Health Sciences Center Chancellor's Translational Research Initiative; Louisiana Lions Eye Foundation; Research to Prevent Blindness, New York, NY (Louisiana State University Health Sciences Center Department of Ophthalmology); NATIONAL EYE INSTITUTE [P30EY002377] Funding Source: NIH RePORTER	Louisiana State University Health Sciences Center Eye Center Core; Louisiana State University Health Sciences Center Chancellor's Translational Research Initiative; Louisiana Lions Eye Foundation; Research to Prevent Blindness, New York, NY (Louisiana State University Health Sciences Center Department of Ophthalmology)(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported in part by the P30EY002377 (Louisiana State University Health Sciences Center Eye Center Core), Louisiana State University Health Sciences Center Chancellor's Translational Research Initiative award (DMN), funding from the Louisiana Lions Eye Foundation and by an unrestricted grant from Research to Prevent Blindness, New York, NY (Louisiana State University Health Sciences Center Department of Ophthalmology). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott K C, 1986, J Ocul Pharmacol, V2, P41, DOI 10.1089/jop.1986.2.41; Amelio AL, 2006, J VIROL, V80, P2358, DOI 10.1128/JVI.80.5.2358-2368.2006; Amelio AL, 2006, J VIROL, V80, P2063, DOI 10.1128/JVI.80.4.2063-2068.2006; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Bloom DC, 2010, BBA-GENE REGUL MECH, V1799, P246, DOI 10.1016/j.bbagrm.2009.12.001; Bloom DC, 2004, INT REV IMMUNOL, V23, P187, DOI 10.1080/08830180490265592; Bloom DC, 1996, J VIROL, V70, P2449, DOI 10.1128/JVI.70.4.2449-2459.1996; Bloom DC, 2006, ALPHA HERPESVIRUSES, P325; CAI WH, 1993, J VIROL, V67, P7501, DOI 10.1128/JVI.67.12.7501-7512.1993; CAI WZ, 1992, J VIROL, V66, P2904, DOI 10.1128/JVI.66.5.2904-2915.1992; Chen SH, 1997, J VIROL, V71, P5878, DOI 10.1128/JVI.71.8.5878-5884.1997; Cliffe AR, 2009, J VIROL, V83, P8182, DOI 10.1128/JVI.00712-09; Cliffe AR, 2008, J VIROL, V82, P12030, DOI 10.1128/JVI.01575-08; Coleman HM, 2008, J GEN VIROL, V89, P68, DOI 10.1099/vir.0.83272-0; Danaher RJ, 2005, J NEUROVIROL, V11, P306, DOI 10.1080/13550280590952817; Davido DJ, 1996, J GEN VIROL, V77, P1853, DOI 10.1099/0022-1317-77-8-1853; DESHMANE SL, 1989, J VIROL, V63, P943, DOI 10.1128/JVI.63.2.943-947.1989; Ellis DJP, 2008, BIOCHEM BIOPH RES CO, V367, P656, DOI 10.1016/j.bbrc.2007.12.157; Giordani NV, 2008, J VIROL, V82, P6056, DOI 10.1128/JVI.02661-07; Gu HD, 2007, P NATL ACAD SCI USA, V104, P17134, DOI 10.1073/pnas.0707266104; Halford WP, 2001, J VIROL, V75, P6143, DOI 10.1128/JVI.75.13.6143-6153.2001; Halford WP, 2001, J VIROL, V75, P3240, DOI 10.1128/JVI.75.7.3240-3249.2001; Herrera FJ, 2004, J VIROL, V78, P9689, DOI 10.1128/JVI.78.18.9689-9696.2004; HILL JM, 1985, INVEST OPHTH VIS SCI, V26, P1299; HILL JM, 1987, CURR EYE RES, V6, P91, DOI 10.3109/02713688709020074; HILL JM, 1983, INVEST OPHTH VIS SCI, V24, P243; HILL JM, 1993, OPHTHALMIC DRUG DELI, P331; Ho AK, 2007, ENDOCRINOLOGY, V148, P4592, DOI 10.1210/en.2007-0578; Huang J, 2006, J VIROL, V80, P5740, DOI 10.1128/JVI.00169-06; Kent JR, 2004, J VIROL, V78, P10178, DOI 10.1128/JVI.78.18.10178-10186.2004; Kubat NJ, 2004, J VIROL, V78, P1139, DOI 10.1128/JVI.78.3.1139-1149.2004; Kubat NJ, 2004, J VIROL, V78, P12508, DOI 10.1128/JVI.78.22.12508-12518.2004; Kwiatkowski DL, 2009, J VIROL, V83, P8173, DOI 10.1128/JVI.00686-09; LEIB DA, 1989, J VIROL, V63, P759, DOI 10.1128/JVI.63.2.759-768.1989; Liang Y, 2009, NAT MED, V15, P1312, DOI 10.1038/nm.2051; Miller CS, 2006, J VIROL, V80, P3360, DOI 10.1128/JVI.80.7.3360-3368.2006; Narayanan A, 2007, P NATL ACAD SCI USA, V104, P10835, DOI 10.1073/pnas.0704351104; Neumann DM, 2007, J VIROL, V81, P13248, DOI 10.1128/JVI.01569-07; Neumann DM, 2007, J VIROL, V81, P6106, DOI 10.1128/JVI.00070-07; Newton SS, 2006, MOL PHARMACOL, V70, P440, DOI 10.1124/mol.106.027078; Ng HH, 2003, MOL CELL, V11, P709, DOI 10.1016/S1097-2765(03)00092-3; Perng GC, 2000, SCIENCE, V287, P1500, DOI 10.1126/science.287.5457.1500; Perng GC, 2000, J VIROL, V74, P1885, DOI 10.1128/JVI.74.4.1885-1891.2000; Perng GC, 1999, J VIROL, V73, P920, DOI 10.1128/JVI.73.2.920-929.1999; Poon APW, 2006, P NATL ACAD SCI USA, V103, P9993, DOI 10.1073/pnas.0604142103; Reston CAP, 2007, J VIROL, V81, P11781, DOI 10.1128/JVI.01234-07; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Sawtell NM, 1998, J VIROL, V72, P5343, DOI 10.1128/JVI.72.7.5343-5350.1998; SPIVACK JG, 1987, J VIROL, V61, P3841, DOI 10.1128/JVI.61.12.3841-3847.1987; SPIVACK JG, 1988, J VIROL, V62, P663; STEVENS JG, 1987, SCIENCE, V235, P1056, DOI 10.1126/science.2434993; Thompson RL, 2006, J VIROL, V80, P10919, DOI 10.1128/JVI.01253-06; Thompson RL, 1997, J VIROL, V71, P5432, DOI 10.1128/JVI.71.7.5432-5440.1997; Thompson RL, 2001, J VIROL, V75, P6660, DOI 10.1128/JVI.75.14.6660-6675.2001; Toma Hassanain S, 2008, Semin Ophthalmol, V23, P249, DOI 10.1080/08820530802111085; Trojer P, 2007, MOL CELL, V28, P1, DOI 10.1016/j.molcel.2007.09.011; Wagner EK, 1997, CLIN MICROBIOL REV, V10, P419, DOI 10.1128/CMR.10.3.419; Wang QY, 2005, P NATL ACAD SCI USA, V102, P16055, DOI 10.1073/pnas.0505850102; Wilcox CL, 1997, J VIROL, V71, P6777, DOI 10.1128/JVI.71.9.6777-6785.1997	59	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2010	5	11							e15416	10.1371/journal.pone.0015416	http://dx.doi.org/10.1371/journal.pone.0015416			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675NY	21079815	gold, Green Submitted, Green Published			2022-12-27	WOS:000283838600027
J	Hegyi, G; Herenyi, M; Wilson, AJ; Garamszegi, LZ; Rosivall, B; Eens, M; Torok, J				Hegyi, Gergely; Herenyi, Marton; Wilson, Alastair J.; Garamszegi, Laszlo Zsolt; Rosivall, Balazs; Eens, Marcel; Toeroek, Janos			Breeding Experience and the Heritability of Female Mate Choice in Collared Flycatchers	PLOS ONE			English	Article							SEXUALLY SELECTED TRAIT; WILD BIRD POPULATION; MATING PREFERENCES; PIED FLYCATCHERS; PASSERINE BIRD; ZEBRA FINCH; LEK PARADOX; QUANTITATIVE GENETICS; PHENOTYPIC PLASTICITY; REPRODUCTIVE SUCCESS	Background: Heritability in mate preferences is assumed by models of sexual selection, and preference evolution may contribute to adaptation to changing environments. However, mate preference is difficult to measure in natural populations as detailed data on mate availability and mate sampling are usually missing. Often the only available information is the ornamentation of the actual mate. The single long-term quantitative genetic study of a wild population found low heritability in female mate ornamentation in Swedish collared flycatchers. One potentially important cause of low heritability in mate ornamentation at the population level is reduced mate preference expression among inexperienced individuals. Methodology/Principal Findings: Applying animal model analyses to 21 years of data from a Hungarian collared flycatcher population, we found that additive genetic variance was 50 percent and significant for ornament expression in males, but less than 5 percent and non-significant for mate ornamentation treated as a female trait. Female breeding experience predicted breeding date and clutch size, but mate ornamentation and its variance components were unrelated to experience. Although we detected significant area and year effects on mate ornamentation, more than 85 percent of variance in this trait remained unexplained. Moreover, the effects of area and year on mate ornamentation were also highly positively correlated between inexperienced and experienced females, thereby acting to remove difference between the two groups. Conclusions/Significance: The low heritability of mate ornamentation was apparently not explained by the presence of inexperienced individuals. Our results further indicate that the expression of mate ornamentation is dominated by temporal and spatial constraints and unmeasured background factors. Future studies should reduce unexplained variance or use alternative measures of mate preference. The heritability of mate preference in the wild remains a principal but unresolved question in evolutionary ecology.	[Hegyi, Gergely; Herenyi, Marton; Rosivall, Balazs; Toeroek, Janos] Eotvos Lorand Univ, Dept Systemat Zool & Ecol, Behav Ecol Grp, Budapest, Hungary; [Wilson, Alastair J.] Univ Edinburgh, Sch Biol Sci, Inst Evolutionary Biol, Edinburgh, Midlothian, Scotland; [Garamszegi, Laszlo Zsolt] CSIC, Estac Biol Donana, Dept Evolutionary Ecol, E-41080 Seville, Spain; [Eens, Marcel] Univ Antwerp, Dept Biol, Antwerp, Belgium	Eotvos Lorand University; University of Edinburgh; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); University of Antwerp	Hegyi, G (corresponding author), Eotvos Lorand Univ, Dept Systemat Zool & Ecol, Behav Ecol Grp, Budapest, Hungary.	everest@ludens.elte.hu	Rosivall, Balázs/T-1057-2017; Hegyi, Gergely/AAG-4988-2021; Eens, Marcel/AAC-8466-2020; Torok, Janos/C-6144-2008; Garamszegi, Laszlo/M-1488-2015; Garamszegi, Laszlo Z/B-5089-2011; Wilson, Alastair/F-3118-2010	Rosivall, Balázs/0000-0002-0732-1160; Hegyi, Gergely/0000-0002-4906-3550; Torok, Janos/0000-0002-4799-5522; Garamszegi, Laszlo/0000-0001-8920-2183; Wilson, Alastair/0000-0002-5045-2051	Orszagos Tudomanyos Kutatasi Alapprogramok [T49650, T49678, K75618, PD72117]; Bolyai Janos fellowship; Pilis Park Forestry; Erdok a Kozjoert Alapitvany	Orszagos Tudomanyos Kutatasi Alapprogramok(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Bolyai Janos fellowship(Hungarian Academy of Sciences); Pilis Park Forestry; Erdok a Kozjoert Alapitvany	This study was supported by Orszagos Tudomanyos Kutatasi Alapprogramok (grants T49650, T49678, K75618 and PD72117 to J.T., L.Z.G. and G.H.), a Bolyai Janos fellowship to G. H., the Pilis Park Forestry, and the Erdok a Kozjoert Alapitvany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALATALO RV, 1986, NATURE, V323, P152, DOI 10.1038/323152a0; Badyaev AV, 2000, EVOLUTION, V54, P2134, DOI 10.1111/j.0014-3820.2000.tb01255.x; BAKKER TCM, 1995, J EVOLUTION BIOL, V8, P129, DOI 10.1046/j.1420-9101.1995.8020129.x; Balbontin J, 2007, J ANIM ECOL, V76, P915, DOI 10.1111/j.1365-2656.2007.01269.x; BENSCH S, 1992, ANIM BEHAV, V44, P301, DOI 10.1016/0003-3472(92)90036-9; Benton TG, 1998, BEHAV ECOL SOCIOBIOL, V44, P91, DOI 10.1007/s002650050520; Blums P, 1997, AUK, V114, P737, DOI 10.2307/4089293; Both C, 2006, NATURE, V441, P81, DOI 10.1038/nature04539; Both C, 2001, NATURE, V411, P296, DOI 10.1038/35077063; Boughman JW, 2001, NATURE, V411, P944, DOI 10.1038/35082064; Brooks R, 2001, EVOLUTION, V55, P1644, DOI 10.1111/j.0014-3820.2001.tb00684.x; Buchholz R, 2004, BEHAV ECOL, V15, P687, DOI 10.1093/beheco/arh066; Bussiere LF, 2008, GENETICA, V134, P69, DOI 10.1007/s10709-007-9220-z; Charmantier A, 2005, MOL ECOL, V14, P2839, DOI 10.1111/j.1365-294X.2005.02619.x; Chenoweth SF, 2006, NAT REV GENET, V7, P681, DOI 10.1038/nrg1924; Cichon M, 2003, OECOLOGIA, V134, P78, DOI 10.1007/s00442-002-1099-x; Coltman DW, 2003, NATURE, V426, P655, DOI 10.1038/nature02177; Cotton S, 2006, CURR BIOL, V16, pR755, DOI 10.1016/j.cub.2006.08.022; DALE S, 1992, BEHAV ECOL SOCIOBIOL, V30, P165, DOI 10.1007/BF00166699; Dale S, 1996, BEHAVIOUR, V133, P903, DOI 10.1163/156853996X00305; Doligez B, 2002, SCIENCE, V297, P1168, DOI 10.1126/science.1072838; FORSLUND P, 1995, TRENDS ECOL EVOL, V10, P374, DOI 10.1016/S0169-5347(00)89141-7; Forstmeier W, 2004, ANIM BEHAV, V68, P1017, DOI 10.1016/j.anbehav.2004.02.007; Forstmeier W, 2004, EVOLUTION, V58, P2574; Garamszegi LZ, 2004, BEHAV ECOL, V15, P148, DOI 10.1093/beheco/arg108; GOMULKIEWICZ R, 1991, AM NAT, V138, P1396, DOI 10.1086/285293; GRAFEN A, 1990, J THEOR BIOL, V144, P517, DOI 10.1016/S0022-5193(05)80088-8; Greene E, 2000, NATURE, V407, P1000, DOI 10.1038/35039500; Griffith SC, 1999, P ROY SOC B-BIOL SCI, V266, P765; Hedrick A, 1998, BEHAV ECOL, V9, P582, DOI 10.1093/beheco/9.6.582; Hegyi G, 2006, J EVOLUTION BIOL, V19, P228, DOI 10.1111/j.1420-9101.2005.00970.x; Hegyi G, 2002, J EVOLUTION BIOL, V15, P710, DOI 10.1046/j.1420-9101.2002.00449.x; Hegyi G, 2008, NATURWISSENSCHAFTEN, V95, P993, DOI 10.1007/s00114-008-0408-6; Hegyi G, 2008, ANIM BEHAV, V75, P977, DOI 10.1016/j.anbehav.2007.08.009; Hegyi G, 2007, BEHAV ECOL, V18, P1116, DOI 10.1093/beheco/arm085; Hegyi G, 2007, EVOL ECOL RES, V9, P905; Hegyi G, 2010, NATURWISSENSCHAFTEN, V97, P567, DOI 10.1007/s00114-010-0672-0; HEISLER IL, 1987, SEXUAL SELECTION TES, P96; Hoekstra HE, 2001, P NATL ACAD SCI USA, V98, P9157, DOI 10.1073/pnas.161281098; HOELZER GA, 1989, ANIM BEHAV, V38, P1067, DOI 10.1016/S0003-3472(89)80146-0; Hoglund J., 1995, LEKS, DOI DOI 10.1515/9781400864157; Holland B, 1998, EVOLUTION, V52, P1, DOI 10.1111/j.1558-5646.1998.tb05132.x; Holveck MJ, 2010, P ROY SOC B-BIOL SCI, V277, P153, DOI 10.1098/rspb.2009.1222; Jang YW, 2000, HEREDITY, V84, P73, DOI 10.1046/j.1365-2540.2000.00631.x; Jennions MD, 1997, BIOL REV, V72, P283, DOI 10.1017/S0006323196005014; Johnstone RA, 1996, EVOLUTION, V50, P1382, DOI [10.2307/2410876, 10.1111/j.1558-5646.1996.tb03912.x]; Kirkpatrick M, 2002, AM NAT, V159, pS22, DOI 10.1086/338370; KLOMP H, 1970, ARDEA, V58, P1; Kokko H, 2006, ANNU REV ECOL EVOL S, V37, P43, DOI 10.1146/annurev.ecolsys.37.091305.110259; Kraaijeveld K, 2007, ANIM BEHAV, V74, P657, DOI 10.1016/j.anbehav.2006.12.027; Kruger O, 2001, EVOLUTION, V55, P1207; Kruuk LEB, 2007, J EVOLUTION BIOL, V20, P1890, DOI 10.1111/j.1420-9101.2007.01377.x; Kruuk LEB, 2004, PHILOS T R SOC B, V359, P873, DOI 10.1098/rstb.2003.1437; Lorch PD, 2003, EVOL ECOL RES, V5, P867; Ludwig SC, 2008, BEHAV ECOL SOCIOBIOL, V62, P1601, DOI 10.1007/s00265-008-0589-1; Lynch M., 1998, GENETICS ANAL QUANTI; McGuigan K, 2008, AM NAT, V172, P194, DOI 10.1086/588075; Michl G, 2002, P NATL ACAD SCI USA, V99, P5466, DOI 10.1073/pnas.082036699; Mitchell DP, 2007, ANIM BEHAV, V73, P165, DOI 10.1016/j.anbehav.2006.07.006; Moller AP, 2006, EVOLUTION, V60, P856; Moller AP, 2005, J EVOLUTION BIOL, V18, P481, DOI 10.1111/j.1420-9101.2004.00807.x; Moller AP, 1999, P ROY SOC B-BIOL SCI, V266, P85, DOI 10.1098/rspb.1999.0607; Moller AP, 2002, J EVOLUTION BIOL, V15, P495, DOI 10.1046/j.1420-9101.2002.00386.x; Murphy CG, 2000, EVOLUTION, V54, P660; NEWTON I, 1994, BIOL CONSERV, V70, P265, DOI 10.1016/0006-3207(94)90172-4; POMIANKOWSKI A, 1995, P ROY SOC B-BIOL SCI, V260, P21, DOI 10.1098/rspb.1995.0054; Postma E, 2006, NATURE, V444, pE16, DOI 10.1038/nature05501; POTTI J, 1991, ORNIS SCAND, V22, P45, DOI 10.2307/3676620; Price TD, 2008, AM NAT, V172, pS49, DOI 10.1086/588257; Qvarnstrom A, 2006, NATURE, V441, P84, DOI 10.1038/nature04564; Qvarnstrom A, 2000, NATURE, V405, P344, DOI 10.1038/35012605; Qvarnstrom A, 2004, BEHAV ECOL, V15, P543, DOI 10.1093/beheco/arh043; Qvarnstrom A, 2006, NATURE, V444, pE16, DOI 10.1038/nature05502; Radwan J, 2008, GENETICA, V134, P113, DOI 10.1007/s10709-007-9203-0; REID ML, 1990, ANIM BEHAV, V40, P538, DOI 10.1016/S0003-3472(05)80534-2; Reinhold K, 2002, ANIM BEHAV, V64, P245, DOI 10.1006/anbe.2002.3061; Ritchie MG, 1996, P NATL ACAD SCI USA, V93, P14628, DOI 10.1073/pnas.93.25.14628; Robertson RJ, 2001, J ANIM ECOL, V70, P1014, DOI 10.1046/j.0021-8790.2001.00555.x; Rosivall B, 2009, ANIM BEHAV, V77, P611, DOI 10.1016/j.anbehav.2008.11.009; Roulin A, 1999, BEHAV ECOL, V10, P688, DOI 10.1093/beheco/10.6.688; Roulin A, 2007, J ETHOL, V25, P99, DOI 10.1007/s10164-006-0006-z; Rowe L, 1996, P ROY SOC B-BIOL SCI, V263, P1415, DOI 10.1098/rspb.1996.0207; Rutstein AN, 2007, ANIM BEHAV, V74, P1277, DOI 10.1016/j.anbehav.2007.02.022; Saetre GP, 1997, NATURE, V387, P589; Seehausen O, 2008, NATURE, V455, P620, DOI 10.1038/nature07285; SHAW RG, 1987, EVOLUTION, V41, P812, DOI 10.1111/j.1558-5646.1987.tb05855.x; Svensson EI, 2007, FUNCT ECOL, V21, P422, DOI 10.1111/j.1365-2435.2007.01265.x; Tomkins JL, 2004, TRENDS ECOL EVOL, V19, P323, DOI 10.1016/j.tree.2004.03.029; TOROK J, 1988, J ANIM ECOL, V57, P251, DOI 10.2307/4776; Torok J, 2004, OECOLOGIA, V141, P432, DOI 10.1007/s00442-004-1667-3; vonSchantz T, 1996, P ROY SOC B-BIOL SCI, V263, P265, DOI 10.1098/rspb.1996.0041; Wagner WE, 1998, ANIM BEHAV, V55, P1029, DOI 10.1006/anbe.1997.0635; Widemo F, 1999, TRENDS ECOL EVOL, V14, P26, DOI 10.1016/S0169-5347(98)01531-6; Wilson AJ, 2008, J EVOLUTION BIOL, V21, P647, DOI 10.1111/j.1420-9101.2008.01500.x	94	5	5	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2010	5	11							e13855	10.1371/journal.pone.0013855	http://dx.doi.org/10.1371/journal.pone.0013855			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675NY	21079813	Green Published, Green Submitted, gold			2022-12-27	WOS:000283838600023
J	Xu, H; Yan, YP; Williams, MS; Carey, GB; Yang, JX; Li, HM; Zhang, GX; Rostami, A				Xu, Hui; Yan, Yaping; Williams, Mark S.; Carey, Gregory B.; Yang, Jingxian; Li, Hongmei; Zhang, Guang-Xian; Rostami, Abdolmohamad			MS4a4B, a CD20 Homologue in T Cells, Inhibits T Cell Propagation by Modulation of Cell Cycle	PLOS ONE			English	Article							ANTIGEN; BP35; B1	MS4a4B, a CD20 homologue in T cells, is a novel member of the MS4A gene family in mice. The MS4A family includes CD20, Fc epsilon RI beta, HTm4 and at least 26 novel members that are characterized by their structural features: with four membrane-spanning domains, two extracellular domains and two cytoplasmic regions. CD20, Fc epsilon RI beta and HTm4 have been found to function in B cells, mast cells and hematopoietic cells respectively. However, little is known about the function of MS4a4B in T cell regulation. We demonstrate here that MS4a4B negatively regulates mouse T cell proliferation. MS4a4B is highly expressed in primary T cells, natural killer cells (NK) and some T cell lines. But its expression in all malignant T cells, including thymoma and T hybridoma tested, was silenced. Interestingly, its expression was regulated during T cell activation. Viral vector-driven overexpression of MS4a4B in primary T cells and EL4 thymoma cells reduced cell proliferation. In contrast, knockdown of MS4a4B accelerated T cell proliferation. Cell cycle analysis showed that MS4a4B regulated T cell proliferation by inhibiting entry of the cells into S-G2/M phase. MS4a4B-mediated inhibition of cell cycle was correlated with upregulation of Cdk inhibitory proteins and decreased levels of Cdk2 activity, subsequently leading to inhibition of cell cycle progression. Our data indicate that MS4a4B negatively regulates T cell proliferation. MS4a4B, therefore, may serve as a modulator in the negative-feedback regulatory loop of activated T cells	[Xu, Hui; Yan, Yaping; Yang, Jingxian; Li, Hongmei; Zhang, Guang-Xian; Rostami, Abdolmohamad] Thomas Jefferson Univ, Dept Neurol, Philadelphia, PA 19107 USA; [Williams, Mark S.; Carey, Gregory B.] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA	Jefferson University; University System of Maryland; University of Maryland Baltimore	Xu, H (corresponding author), Thomas Jefferson Univ, Dept Neurol, Philadelphia, PA 19107 USA.	hui.xu@jefferson.edu			American Heart Association [0830072N]; National Institutes of Health [NS040085]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI070823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040085] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the American Heart Association (0830072N) (H. X.) and from the National Institutes of Health (NS040085) (A.M.R.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arens R, 2004, J EXP MED, V199, P1595, DOI 10.1084/jem.20031111; Baumann Sven, 2002, Current Molecular Medicine (Hilversum), V2, P257, DOI 10.2174/1566524024605671; BUBIEN JK, 1993, J CELL BIOL, V121, P1121, DOI 10.1083/jcb.121.5.1121; Dayde D, 2009, BLOOD, V113, P3765, DOI 10.1182/blood-2008-08-175125; GOLAY JT, 1985, J IMMUNOL, V135, P3795; Howie D, 2009, J IMMUNOL, V183, P4197, DOI 10.4049/jimmunol.0901070; Riley LK, 2000, SEMIN ONCOL, V27, P17, DOI 10.1053/sonc.2000.20424; STAMENKOVIC I, 1988, J EXP MED, V167, P1975, DOI 10.1084/jem.167.6.1975; TEDDER TF, 1989, J IMMUNOL, V142, P2555; Xu H, 2006, BLOOD, V107, P2400, DOI 10.1182/blood-2005-08-3340	10	10	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2010	5	11							e13780	10.1371/journal.pone.0013780	http://dx.doi.org/10.1371/journal.pone.0013780			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673FY	21072172	Green Published, Green Submitted, gold			2022-12-27	WOS:000283645700005
J	Wolfrum, K; Wang, Y; Prigione, A; Sperling, K; Lehrach, H; Adjaye, J				Wolfrum, Katharina; Wang, Ying; Prigione, Alessandro; Sperling, Karl; Lehrach, Hans; Adjaye, James			The LARGE Principle of Cellular Reprogramming: Lost, Acquired and Retained Gene Expression in Foreskin and Amniotic Fluid-Derived Human iPS Cells	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; HUMAN FIBROBLASTS; SOMATIC-CELLS; IN-VITRO; DIFFERENTIATION; SENESCENCE; PATHWAY; TRANSPLANTATION; CARDIOMYOPLASTY; GENERATION	Human amniotic fluid cells (AFCs) are routinely obtained for prenatal diagnostics procedures. Recently, it has been illustrated that these cells may also serve as a valuable model system to study developmental processes and for application in regenerative therapies. Cellular reprogramming is a means of assigning greater value to primary AFCs by inducing self-renewal and pluripotency and, thus, bypassing senescence. Here, we report the generation and characterization of human amniotic fluid-derived induced pluripotent stem cells (AFiPSCs) and demonstrate their ability to differentiate into the trophoblast lineage after stimulation with BMP2/BMP4. We further carried out comparative transcriptome analyses of primary human AFCs, AFiPSCs, fibroblast-derived iPSCs (FiPSCs) and embryonic stem cells (ESCs). This revealed that the expression of key senescence-associated genes are down-regulated upon the induction of pluripotency in primary AFCs (AFiPSCs). By defining distinct and overlapping gene expression patterns and deriving the LARGE (Lost, Acquired and Retained Gene Expression) Principle of Cellular Reprogramming, we could further highlight that AFiPSCs, FiPSCs and ESCs share a core self-renewal gene regulatory network driven by OCT4, SOX2 and NANOG. Nevertheless, these cell types are marked by distinct gene expression signatures. For example, expression of the transcription factors, SIX6, EGR2, PKNOX2, HOXD4, HOXD10, DLX5 and RAXL1, known to regulate developmental processes, are retained in AFiPSCs and FiPSCs. Surprisingly, expression of the self-renewal-associated gene PRDM14 or the developmental processes-regulating genes WNT3A and GSC are restricted to ESCs. Implications of this, with respect to the stability of the undifferentiated state and long-term differentiation potential of iPSCs, warrant further studies.	[Wolfrum, Katharina; Wang, Ying; Prigione, Alessandro; Lehrach, Hans; Adjaye, James] Max Planck Inst Mol Genet, Dept Vertebrate Genom, Mol Embryol & Aging Grp, Berlin, Germany; [Wolfrum, Katharina] Free Univ Berlin, Inst Chem & Biochem, Dept Biol Chem & Pharm, D-1000 Berlin, Germany; [Sperling, Karl] Charite, Inst Human Genet, D-13353 Berlin, Germany; [Adjaye, James] King Saud Univ, Coll Med, Dept Anat, Stem Cell Unit, Riyadh 11461, Saudi Arabia	Max Planck Society; Free University of Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; King Saud University	Wolfrum, K (corresponding author), Max Planck Inst Mol Genet, Dept Vertebrate Genom, Mol Embryol & Aging Grp, Berlin, Germany.	adjaye@molgen.mpg.de	Prigione, Alessandro/ABA-1584-2021; Alessandro, Prigione/B-2959-2013	Alessandro, Prigione/0000-0001-9457-1952	Bundesministerium fur Bildung und Forschung (BMBF, Federal Ministry of Education and Research) [01GN0807, 0315398G]; Max Planck Society; Deutsche Forschungsgemeinschaft (DFG) through the Berlin-Brandenburg School for Regenerative Therapies (BSRT) [GSC 203]; Adjaye lab	Bundesministerium fur Bildung und Forschung (BMBF, Federal Ministry of Education and Research)(Federal Ministry of Education & Research (BMBF)); Max Planck Society(Max Planck Society); Deutsche Forschungsgemeinschaft (DFG) through the Berlin-Brandenburg School for Regenerative Therapies (BSRT)(German Research Foundation (DFG)); Adjaye lab	The authors acknowledge support from the Bundesministerium fur Bildung und Forschung (BMBF, Federal Ministry of Education and Research, www.bmbf.de; A.P.: 01GN0807; Y.W., J.A.: 0315398G) and the Max Planck Society (www.mpg.de). Contributions of K. W. were also made possible by funding from the Deutsche Forschungsgemeinschaft (DFG, www.dfg.de) through the Berlin-Brandenburg School for Regenerative Therapies (BSRT, www.bsrt.de) GSC 203. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank the other members of the Adjaye lab for support and fruitful discussion and A. Sabah at the microarray facility. We would also like to thank Prof. Dr. Wegner and PD Dr. Stumm of the prenatal diagnosis clinic (Zentrum fur Pranataldiagnostik, Kudamm-199, Berlin, Germany) for providing AFCs. We further acknowledge Dr. Korinna Johrens (Institute for Pathology, Charite - Universitatsmedizin Berlin, Berlin, Germany) for the interpretation of histological structures.	Adewumi O, 2007, NAT BIOTECHNOL, V25, P803, DOI 10.1038/nbt1318; Adjaye J, 2005, STEM CELLS, V23, P1514, DOI 10.1634/stemcells.2005-0113; Agarwal S, 2010, NATURE, V464, P292, DOI 10.1038/nature08792; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Babaie Y, 2007, STEM CELLS, V25, P500, DOI 10.1634/stemcells.2006-0426; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Brown JP, 1997, SCIENCE, V277, P831, DOI 10.1126/science.277.5327.831; Carraro G, 2008, STEM CELLS, V26, P2902, DOI 10.1634/stemcells.2008-0090; Carrour TL, 2010, OPEN BIOINFORMATICS, V4, P5, DOI [10.2174/1875036201004010005, DOI 10.2174/1875036201004010005]; CERDAN C, 2007, CURR PROTOC STEM CEL, pCH1; Chang BD, 2000, P NATL ACAD SCI USA, V97, P4291, DOI 10.1073/pnas.97.8.4291; Chavez L, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-314; Chiavegato A, 2007, J MOL CELL CARDIOL, V42, P746, DOI 10.1016/j.yjmcc.2006.12.008; Cipriani S, 2007, CELL BIOL INT, V31, P845, DOI 10.1016/j.cellbi.2007.01.037; De Coppi P, 2007, NAT BIOTECHNOL, V25, P100, DOI 10.1038/nbt1274; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Ditadi A, 2009, BLOOD, V113, P3953, DOI 10.1182/blood-2008-10-182105; Evans PM, 2008, ACTA BIOCH BIOPH SIN, V40, P554, DOI 10.1111/j.1745-7270.2008.00439.x; Falschlehner C, 2009, IMMUNOLOGY, V127, P145, DOI 10.1111/j.1365-2567.2009.03058.x; Fauza D, 2004, BEST PRACT RES CL OB, V18, P877, DOI 10.1016/j.bpobgyn.2004.07.001; GALENDE E, 2009, CLONING STE IN PRESS; Gekas J, 2010, CLIN EXP MED, V10, P1, DOI 10.1007/s10238-009-0060-2; Ghosh Z, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008975; Greber B, 2007, STEM CELLS, V25, P455, DOI 10.1634/stemcells.2006-0476; Greber B, 2008, STEM CELLS DEV, V17, P1065, DOI 10.1089/scd.2008.0035; Hasegawa T, 2008, CIRC RES, V103, P1410, DOI 10.1161/CIRCRESAHA.108.180059; Hu BY, 2010, P NATL ACAD SCI USA, V107, P4335, DOI 10.1073/pnas.0910012107; Huang BY, 2009, AGING-US, V1, P845, DOI 10.18632/aging.100091; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Iacovitti L, 2009, STEM CELLS DEV, V18, P1003; Imoto I, 2001, BIOCHEM BIOPH RES CO, V287, P270, DOI 10.1006/bbrc.2001.5578; in 'tAnker PS, 2003, BLOOD, V102, P1548, DOI 10.1182/blood-2003-04-1291; Jung M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010709; Karlmark KR, 2005, INT J MOL MED, V16, P987; Li CL, 2009, HUM MOL GENET, V18, P4340, DOI 10.1093/hmg/ddp386; Longhi MP, 2006, TRENDS IMMUNOL, V27, P102, DOI 10.1016/j.it.2005.12.008; Maherali N, 2008, CELL STEM CELL, V3, P595, DOI 10.1016/j.stem.2008.11.008; Marchetto MCN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007076; Mosquera A, 1999, J MED GENET, V36, P494; Nandan MO, 2009, HISTOL HISTOPATHOL, V24, P1343, DOI 10.14670/HH-24.1343; Nunes Fabio Daumas, 2003, Pesqui Odontol Bras, V17, P94; Panganiban G, 2002, DEVELOPMENT, V129, P4371; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Perin L, 2007, CELL PROLIFERAT, V40, P936, DOI 10.1111/j.1365-2184.2007.00478.x; Prigione A, 2010, STEM CELLS, V28, P721, DOI 10.1002/stem.404; Prusa AR, 2004, AM J OBSTET GYNECOL, V191, P309, DOI 10.1016/j.ajog.2003.12.014; Prusa AR, 2003, HUM REPROD, V18, P1489, DOI 10.1093/humrep/deg279; Roubelakis MG, 2007, STEM CELLS DEV, V16, P931, DOI 10.1089/scd.2007.0036; Saha K, 2009, CELL STEM CELL, V5, P584, DOI 10.1016/j.stem.2009.11.009; Sarnat HB, 2005, J CHILD NEUROL, V20, P637, DOI 10.1177/08830738050200080101; Schmitt S, 2009, INVEST OPHTH VIS SCI, V50, P5901, DOI 10.1167/iovs.08-3067; Schulz LC, 2008, PLACENTA, V29, pS10, DOI 10.1016/j.placenta.2007.10.009; Serr D M, 1955, Bull Res Counc Isr, V5B, P137; Suhr ST, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0008124, 10.1371/journal.pone.0014095]; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Trovato L, 2009, J ENDOCRINOL INVEST, V32, P873, DOI [10.1007/BF03345764, 10.3275/6401]; Tsai MS, 2004, HUM REPROD, V19, P1450, DOI 10.1093/humrep/deh279; Tsuneyoshi N, 2008, BIOCHEM BIOPH RES CO, V367, P899, DOI 10.1016/j.bbrc.2007.12.189; Vallier L, 2009, STEM CELLS, V27, P2655, DOI 10.1002/stem.199; Vaziri H, 2010, REGEN MED, V5, P345, DOI 10.2217/RME.10.21; Walther G, 2009, CATHETER CARDIO INTE, V73, P917, DOI 10.1002/ccd.22016; Wang Han, 2008, Sheng Wu Gong Cheng Xue Bao, V24, P1582; Wang QL, 2004, HUM MOL GENET, V13, P1025, DOI 10.1093/hmg/ddh117; Wang Y, 2010, STEM CELL REV REP, V6, P282, DOI 10.1007/s12015-010-9137-2; XURH, 2006, MOL MED */* METHODS, V121, P189; Ye L, 2009, P NATL ACAD SCI USA, V106, P9826, DOI 10.1073/pnas.0904689106; Yeh YC, 2010, TISSUE ENG PT A, V16, P1925, DOI [10.1089/ten.tea.2009.0728, 10.1089/ten.TEA.2009.0728]; You Q, 2009, J INT MED RES, V37, P105, DOI 10.1177/147323000903700112; Young JI, 2001, J BIOL CHEM, V276, P19610, DOI 10.1074/jbc.M009470200; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhao R, 2008, J CELL BIOCHEM, V105, P949, DOI 10.1002/jcb.21871; Zheng QH, 2006, J CELL BIOCHEM, V98, P1230, DOI 10.1002/jcb.20838	73	57	61	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2010	5	10							e13703	10.1371/journal.pone.0013703	http://dx.doi.org/10.1371/journal.pone.0013703			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673FU	21060825	Green Published, Green Accepted, gold			2022-12-27	WOS:000283645300007
J	Al-Adsani, A; Burke, ZD; Eberhard, D; Lawrence, KL; Shen, CN; Rustgi, AK; Sakaue, H; Farrant, JM; Tosh, D				Al-Adsani, Amani; Burke, Zoe D.; Eberhard, Daniel; Lawrence, Katherine L.; Shen, Chia-Ning; Rustgi, Anil K.; Sakaue, Hiroshi; Farrant, J. Mark; Tosh, David			Dexamethasone Treatment Induces the Reprogramming of Pancreatic Acinar Cells to Hepatocytes and Ductal Cells	PLOS ONE			English	Article							HUMAN EXOCRINE PANCREAS; TRANSGENIC MICE; GROWTH-FACTOR; TRANSDIFFERENTIATED HEPATOCYTES; MOLECULAR-BASIS; MESSENGER-RNA; RAT PANCREAS; IN-VITRO; LIVER; EXPRESSION	Background: The pancreatic exocrine cell line AR42J-B13 can be reprogrammed to hepatocytes following treatment with dexamethasone. The question arises whether dexamethasone also has the capacity to induce ductal cells as well as hepatocytes. Methodology/Principal Findings: AR42J-B13 cells were treated with and without dexamethasone and analyzed for the expression of pancreatic exocrine, hepatocyte and ductal markers. Addition of dexamethasone inhibited pancreatic amylase expression, induced expression of the hepatocyte marker transferrin as well as markers typical of ductal cells: cytokeratin 7 and 19 and the lectin peanut agglutinin. However, the number of ductal cells was low compared to hepatocytes. The proportion of ductal cells was enhanced by culture with dexamethasone and epidermal growth factor (EGF). We established several features of the mechanism underlying the transdifferentiation of pancreatic exocrine cells to ductal cells. Using a CK19 promoter reporter, we show that a proportion of the ductal cells arise from differentiated pancreatic exocrine-like cells. We also examined whether C/EBP beta (a transcription factor important in the conversion of pancreatic cells to hepatocytes) could alter the conversion from acinar cells to a ductal phenotype. Overexpression of an activated form of C/EBP beta in dexamethasone/EGF-treated cells provoked the expression of hepatocyte markers and inhibited the expression of ductal markers. Conversely, ectopic expression of a dominant-negative form of C/EBP beta, liver inhibitory protein, inhibited hepatocyte formation in dexamethasone-treated cultures and enhanced the ductal phenotype. Conclusions/Significance: These results indicate that hepatocytes and ductal cells may be induced from pancreatic exocrine AR42J-B13 cells following treatment with dexamethasone. The conversion from pancreatic to hepatocyte or ductal cells is dependent upon the expression of C/EBP beta.	[Al-Adsani, Amani; Burke, Zoe D.; Eberhard, Daniel; Lawrence, Katherine L.; Tosh, David] Univ Bath, Ctr Regenerat Med, Dept Biol & Biochem, Bath BA2 7AY, Avon, England; [Shen, Chia-Ning] Acad Sinica, Genom Res Ctr, Stem Cell Program, Taipei 115, Taiwan; [Rustgi, Anil K.] Univ Penn, Abramson Canc Ctr, Dept Med & Genet, Philadelphia, PA 19104 USA; [Sakaue, Hiroshi] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Nutr & Metab, Tokushima 770, Japan; [Farrant, J. Mark] Royal United Hosp, Dept Gastroenterol, Bath BA1 3NG, Avon, England	University of Bath; Academia Sinica - Taiwan; University of Pennsylvania; Pennsylvania Medicine; Tokushima University	Al-Adsani, A (corresponding author), Univ Bath, Ctr Regenerat Med, Dept Biol & Biochem, Bath BA2 7AY, Avon, England.	d.tosh@bath.ac.uk	Sakaue, Hiroshi/ABE-2337-2021; SHEN, CHIA-NING/C-6878-2011	Sakaue, Hiroshi/0000-0002-2468-2363; SHEN, CHIA-NING/0000-0002-0747-217X	Government of Kuwait; Wellcome Trust [073381]; Grants-in-Aid for Scientific Research [21591151] Funding Source: KAKEN	Government of Kuwait; Wellcome Trust(Wellcome TrustEuropean Commission); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Government of Kuwait and the Wellcome Trust (073381). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARIAS AE, 1993, LAB INVEST, V69, P518; Arnush M, 1996, LAB INVEST, V74, P985; Bouwens L, 2004, CELL BIOCHEM BIOPHYS, P81; Bouwens L, 1996, J HISTOCHEM CYTOCHEM, V44, P947, DOI 10.1177/44.9.8773559; Brembeck FH, 2000, J BIOL CHEM, V275, P28230; Brembeck FH, 2001, GASTROENTEROLOGY, V120, P1720, DOI 10.1053/gast.2001.24846; Burke ZD, 2006, J CELL PHYSIOL, V206, P147, DOI 10.1002/jcp.20438; CHRISTOPHE J, 1994, AM J PHYSIOL, V266, pG963, DOI 10.1152/ajpgi.1994.266.6.G963; Cingolani N, 2000, HUM PATHOL, V31, P938, DOI 10.1053/hupa.2000.9075; DABEVA MD, 1995, AM J PATHOL, V147, P1633; DELISLE RC, 1990, EUR J CELL BIOL, V51, P64; DESCOMBES P, 1991, CELL, V67, P569, DOI 10.1016/0092-8674(91)90531-3; Duncan SA, 2003, MECH DEVELOP, V120, P19, DOI 10.1016/S0925-4773(02)00328-3; HALL PA, 1992, J PATHOL, V166, P97, DOI 10.1002/path.1711660203; Hezel AF, 2006, GENE DEV, V20, P1218, DOI 10.1101/gad.1415606; Kurash JK, 2004, EXP CELL RES, V292, P342, DOI 10.1016/j.yexcr.2003.09.002; Li WC, 2005, J CELL MOL MED, V9, P569, DOI 10.1111/j.1582-4934.2005.tb00489.x; Li WC, 2005, MECH DEVELOP, V122, P835, DOI 10.1016/j.mod.2005.01.001; LONGNECKER DS, 1979, CANCER LETT, V7, P197, DOI 10.1016/S0304-3835(79)80080-4; Mashima H, 1996, ENDOCRINOLOGY, V137, P3969, DOI 10.1210/en.137.9.3969; Means AL, 2005, DEVELOPMENT, V132, P3767, DOI 10.1242/dev.01925; Miyatsuka T, 2006, GENE DEV, V20, P1435, DOI 10.1101/gad.1412806; Paner GP, 2000, CANCER, V88, P1582, DOI 10.1002/(SICI)1097-0142(20000401)88:7<1582::AID-CNCR12>3.0.CO;2-A; PARSA I, 1985, CANCER RES, V45, P1285; Quintana JM, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-24; Ramji DP, 2002, BIOCHEM J, V365, P561, DOI 10.1042/BJ20020508; REDDY JK, 1984, J CELL BIOL, V98, P2082, DOI 10.1083/jcb.98.6.2082; Schmid RM, 2002, J CLIN INVEST, V109, P1403, DOI 10.1172/JCI200215889; Schreiber FS, 2004, GASTROENTEROLOGY, V127, P250, DOI 10.1053/j.gastro.2004.03.058; Shen CN, 2000, NAT CELL BIOL, V2, P879, DOI 10.1038/35046522; Strobel O, 2007, GASTROENTEROLOGY, V133, P1999, DOI 10.1053/j.gastro.2007.09.009; Tosh D, 2002, BIOCHEM SOC T, V30, P51, DOI 10.1042/BST0300051; Tosh D, 2002, HEPATOLOGY, V36, P534, DOI 10.1053/jhep.2002.35060; VILA MR, 1994, LAB INVEST, V71, P423; Wagner M, 1998, GASTROENTEROLOGY, V115, P1254, DOI 10.1016/S0016-5085(98)70098-8; WANG RN, 1995, DIABETOLOGIA, V38, P1405, DOI 10.1007/BF00400600; Wang X, 2001, AM J PATHOL, V158, P571, DOI 10.1016/S0002-9440(10)63999-5; Wu SY, 2010, GASTROENTEROLOGY, V138, P2519, DOI 10.1053/j.gastro.2010.02.011; ZVIBEL I, 1995, J CELL PHYSIOL, V162, P36, DOI 10.1002/jcp.1041620106	39	22	24	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2010	5	10							e13650	10.1371/journal.pone.0013650	http://dx.doi.org/10.1371/journal.pone.0013650			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671UN	21048969	Green Published, Green Submitted, gold			2022-12-27	WOS:000283537000022
J	Penna, F; Costamagna, D; Fanzani, A; Bonelli, G; Baccino, FM; Costelli, P				Penna, Fabio; Costamagna, Domiziana; Fanzani, Alessandro; Bonelli, Gabriella; Baccino, Francesco M.; Costelli, Paola			Muscle Wasting and Impaired Myogenesis in Tumor Bearing Mice Are Prevented by ERK Inhibition	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; EXPERIMENTAL CANCER CACHEXIA; DISTINCT SIGNALING PATHWAYS; SKELETAL-MUSCLE; INDUCED HYPERTROPHY; SELF-RENEWAL; STEM-CELLS; P38 MAPK; DIFFERENTIATION; EXPRESSION	Background: The onset of cachexia is a frequent feature in cancer patients. Prominent characteristic of this syndrome is the loss of body and muscle weight, this latter being mainly supported by increased protein breakdown rates. While the signaling pathways dependent on IGF-1 or myostatin were causally involved in muscle atrophy, the role of the Mitogen-Activated-Protein-Kinases is still largely debated. The present study investigated this point on mice bearing the C26 colon adenocarcinoma. Methodology/Principal Findings: C26-bearing mice display a marked loss of body weight and muscle mass, this latter associated with increased phosphorylated (p)-ERK. Administration of the ERK inhibitor PD98059 to tumor bearers attenuates muscle depletion and weakness, while restoring normal atrogin-1 expression. In C26 hosts, muscle wasting is also associated with increased Pax7 expression and reduced myogenin levels. Such pattern, suggestive of impaired myogenesis, is reversed by PD98059. Increased p-ERK and reduced myosin heavy chain content can be observed in TNF alpha-treated C2C12 myotubes, while decreased myogenin and MyoD levels occur in differentiating myoblasts exposed to the cytokine. All these changes are prevented by PD98059. Conclusions/Significance: These results demonstrate that ERK is involved in the pathogenesis of muscle wasting in cancer cachexia and could thus be proposed as a therapeutic target.	[Penna, Fabio; Costamagna, Domiziana; Bonelli, Gabriella; Baccino, Francesco M.; Costelli, Paola] Univ Turin, Dept Expt Med & Oncol, Turin, Italy; [Fanzani, Alessandro] Univ Brescia, Dept Biomed Sci & Biotechnol, Brescia, Italy	University of Turin; University of Brescia	Penna, F (corresponding author), Univ Turin, Dept Expt Med & Oncol, Turin, Italy.	paola.costelli@unito.it	Penna, Fabio/K-5090-2016	Penna, Fabio/0000-0002-2774-6027; FANZANI, Alessandro/0000-0001-7475-2668; Costamagna, Domiziana/0000-0001-7370-9385; Bonelli, Gabriella/0000-0002-5164-8902	Associazione Italiana per la Ricerca sul Cancro (AIRC), Milano [Fabio Penna-MFAG6211, Paola Costelli-IG9153]; Ministero per l'Universita e la Ricerca, Roma; University of Torino; Regione Piemonte; Compagnia di San Paolo, Torino	Associazione Italiana per la Ricerca sul Cancro (AIRC), Milano(Fondazione AIRC per la ricerca sul cancro); Ministero per l'Universita e la Ricerca, Roma; University of Torino; Regione Piemonte(Regione Piemonte); Compagnia di San Paolo, Torino(Compagnia di San Paolo)	Grant support: Fabio Penna-MFAG6211-Associazione Italiana per la Ricerca sul Cancro (AIRC), Milano; Paola Costelli-IG9153 AIRC, Milano, Ministero per l'Universita e la Ricerca, Roma (PRIN projects), University of Torino (ex-60% funds), Regione Piemonte, Compagnia di San Paolo, Torino. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharyya S, 2005, CANCER CELL, V8, P421, DOI 10.1016/j.ccr.2005.10.004; Acharyya S, 2007, CLIN CANCER RES, V13, P1356, DOI 10.1158/1078-0432.CCR-06-2307; Alapat DV, 2009, CELL SIGNAL, V21, P128, DOI 10.1016/j.cellsig.2008.09.020; Berardi E, 2008, NEUROL RES, V30, P160, DOI 10.1179/174313208X281046; Bonetto A, 2009, CURR CANCER DRUG TAR, V9, P608, DOI 10.2174/156800909789057015; BONETTO A, AMINO ACIDS; Bossola M, 2003, ANN SURG, V237, P384, DOI 10.1097/00000658-200303000-00013; Carlson ME, 2009, EMBO MOL MED, V1, P381, DOI 10.1002/emmm.200900045; Coletti D, 2005, GENESIS, V43, P120, DOI 10.1002/gene.20160; Collins CA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004475; Coolican SA, 1997, J BIOL CHEM, V272, P6653, DOI 10.1074/jbc.272.10.6653; Costelli P, 2008, EUR J CLIN INVEST, V38, P531, DOI 10.1111/j.1365-2362.2008.01970.x; Costelli P, 2005, INT J ONCOL, V26, P1663; Crepaldi T, 2007, J BIOL CHEM, V282, P6812, DOI 10.1074/jbc.M610916200; Glass DJ, 2005, INT J BIOCHEM CELL B, V37, P1974, DOI 10.1016/j.biocel.2005.04.018; Guttridge DC, 2000, SCIENCE, V289, P2363, DOI 10.1126/science.289.5488.2363; Haddad F, 2004, J APPL PHYSIOL, V96, P203, DOI 10.1152/japplphysiol.00856.2003; Halevy O, 2004, DEV DYNAM, V231, P489, DOI 10.1002/dvdy.20151; Hasselgren PO, 2002, BIOCHEM BIOPH RES CO, V290, P1, DOI 10.1006/bbrc.2001.5849; Hemdan DII, 2009, J MED INVESTIG, V56, P26, DOI 10.2152/jmi.56.26; Kato K, 2002, FASEB J, V16, P1432, DOI 10.1096/fj.02-0129fje; Keren A, 2006, MOL CELL ENDOCRINOL, V252, P224, DOI 10.1016/j.mce.2006.03.017; Kornasio R, 2009, BBA-MOL CELL RES, V1793, P755, DOI 10.1016/j.bbamcr.2008.12.017; Kumar A, 2002, J BIOL CHEM, V277, P46493, DOI 10.1074/jbc.M203654200; Lecker SH, 2004, FASEB J, V18, P39, DOI 10.1096/fj.03-0610com; Lenk K, 2009, EUR J HEART FAIL, V11, P342, DOI 10.1093/eurjhf/hfp020; Li YP, 2005, FASEB J, V19, P362, DOI 10.1096/fj.04-2364com; Liu CM, 2008, GENE THER, V15, P155, DOI 10.1038/sj.gt.3303016; Mammucari C, 2007, CELL METAB, V6, P458, DOI 10.1016/j.cmet.2007.11.001; Marinovic AC, 2002, J BIOL CHEM, V277, P16673, DOI 10.1074/jbc.M200501200; McFarlane C, 2008, EXP CELL RES, V314, P317, DOI 10.1016/j.yexcr.2007.09.012; Mitchell PO, 2004, AM J PHYSIOL-CELL PH, V287, pC1753, DOI 10.1152/ajpcell.00292.2004; Miyake T, 2009, J BIOL CHEM, V284, P19679, DOI 10.1074/jbc.M109.017319; Moore-Carrasco R, 2006, FEBS LETT, V580, P691, DOI 10.1016/j.febslet.2005.12.084; Moresi V, 2008, STEM CELLS, V26, P997, DOI 10.1634/stemcells.2007-0493; Morissette MR, 2009, AM J PHYSIOL-CELL PH, V297, pC1124, DOI 10.1152/ajpcell.00043.2009; Murgia M, 2000, NAT CELL BIOL, V2, P142, DOI 10.1038/35004013; Nicolas N, 2005, DEV BIOL, V281, P171, DOI 10.1016/j.ydbio.2005.02.022; Olguin HC, 2004, DEV BIOL, V275, P375, DOI 10.1016/j.ydbio.2004.08.015; PENNA F, 2009, INT J CANC; Puri PL, 2000, GENE DEV, V14, P574; Ramamoorthy S, 2009, AM J PHYSIOL-ENDOC M, V297, pE392, DOI 10.1152/ajpendo.90529.2008; Raman M, 2007, ONCOGENE, V26, P3100, DOI 10.1038/sj.onc.1210392; Rommel C, 1999, SCIENCE, V286, P1738, DOI 10.1126/science.286.5445.1738; Samuel DS, 1999, HORM METAB RES, V31, P55, DOI 10.1055/s-2007-978699; Shi H, 2007, AM J PHYSIOL-CELL PH, V292, pC1681, DOI 10.1152/ajpcell.00466.2006; Shi H, 2008, FASEB J, V22, P2990, DOI 10.1096/fj.07-097600; Shi H, 2009, AM J PHYSIOL-CELL PH, V296, pC1040, DOI 10.1152/ajpcell.00475.2008; STRASSMANN G, 1992, J CLIN INVEST, V89, P1681, DOI 10.1172/JCI115767; Szalay K, 1997, EUR J CELL BIOL, V74, P391; Trendelenburg AU, 2009, AM J PHYSIOL-CELL PH, V296, pC1258, DOI 10.1152/ajpcell.00105.2009; YANG SY, LAB INVEST, V90, P391; Yang W, 2006, CANCER RES, V66, P1320, DOI 10.1158/0008-5472.CAN-05-3060; ZHANG L, 2001, J AM SOC NEPHROL, V21, P419	54	118	121	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2010	5	10							e13604	10.1371/journal.pone.0013604	http://dx.doi.org/10.1371/journal.pone.0013604			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671UN	21048967	Green Submitted, gold, Green Published			2022-12-27	WOS:000283537000015
J	Welsh, M; Sharpe, RM; Moffat, L; Atanassova, N; Saunders, PTK; Kilter, S; Bergh, A; Smith, LB				Welsh, Michelle; Sharpe, Richard M.; Moffat, Lindsey; Atanassova, Nina; Saunders, Philippa T. K.; Kilter, Sigrid; Bergh, Anders; Smith, Lee B.			Androgen Action via Testicular Arteriole Smooth Muscle Cells Is Important for Leydig Cell Function, Vasomotion and Testicular Fluid Dynamics	PLOS ONE			English	Article							HUMAN CHORIONIC-GONADOTROPIN; SEMINIFEROUS TUBULE FLUID; ENDOTHELIAL GROWTH-FACTOR; MALE-MICE LACKING; INTERSTITIAL FLUID; HORMONAL-REGULATION; SELECTIVE KNOCKOUT; VENOUS-BLOOD; RECEPTOR; TESTOSTERONE	Regulation of blood flow through the testicular microvasculature by vasomotion is thought to be important for normal testis function as it regulates interstitial fluid (IF) dynamics which is an important intra-testicular transport medium. Androgens control vasomotion, but how they exert these effects remains unclear. One possibility is by signalling via androgen receptors (AR) expressed in testicular arteriole smooth muscle cells. To investigate this and determine the overall importance of this mechanism in testis function, we generated a blood vessel smooth muscle cell-specific AR knockout mouse (SMARKO). Gross reproductive development was normal in SMARKO mice but testis weight was reduced in adulthood compared to control littermates; this reduction was not due to any changes in germ cell volume or to deficits in testosterone, LH or FSH concentrations and did not cause infertility. However, seminiferous tubule lumen volume was reduced in adult SMARKO males while interstitial volume was increased, perhaps indicating altered fluid dynamics; this was associated with compensated Leydig cell failure. Vasomotion was impaired in adult SMARKO males, though overall testis blood flow was normal and there was an increase in the overall blood vessel volume per testis in adult SMARKOs. In conclusion, these results indicate that ablating arteriole smooth muscle AR does not grossly alter spermatogenesis or affect male fertility but does subtly impair Leydig cell function and testicular fluid exchange, possibly by locally regulating microvascular blood flow within the testis.	[Welsh, Michelle; Sharpe, Richard M.; Moffat, Lindsey; Saunders, Philippa T. K.; Smith, Lee B.] Queens Med Res Inst, Ctr Reprod Biol, MRC, Human Reprod Sci Unit, Edinburgh, Midlothian, Scotland; [Atanassova, Nina] Bulgarian Acad Sci, Inst Expt Morphol & Anthropol Museum, Sofia, Bulgaria; [Kilter, Sigrid; Bergh, Anders] Umea Univ, Dept Anat & Pathol, Umea, Sweden	University of Edinburgh; Bulgarian Academy of Sciences; Umea University	Welsh, M (corresponding author), Queens Med Res Inst, Ctr Reprod Biol, MRC, Human Reprod Sci Unit, Edinburgh, Midlothian, Scotland.	l.smith@hrsu.mrc.ac.uk	Smith, Lee B/J-4861-2013; Atanassova, Nina/AAH-2722-2021; welsh, michelle/G-2261-2010; Sharpe, Richard M/D-2725-2013; Saunders, Philippa TK/C-7489-2013	Atanassova, Nina/0000-0002-9032-3588; Sharpe, Richard M/0000-0003-1686-8085; Saunders, Philippa TK/0000-0001-9051-9380; Smith, Lee/0000-0002-4103-3074	UK Medical Research Council [WBS U.1276.00.002.0003.01]; Tenovus Scotland [E08/6]; Medical Research Council [MC_U127685841, MC_U127684422, MC_U127685844] Funding Source: researchfish; MRC [MC_U127684422, MC_U127685844, MC_U127685841] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Tenovus Scotland; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank the UK Medical Research Council (WBS U.1276.00.002.0003.01) and Tenovus Scotland (Project grant E08/6) for funding these studies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand RJK, 2003, BIOL REPROD, V68, P1663, DOI 10.1095/biolreprod.102.009795; BERGH A, 1992, INT J ANDROL, V15, P425, DOI 10.1111/j.1365-2605.1992.tb01357.x; BERGH A, 1988, HORM RES, V30, P207, DOI 10.1159/000181061; Bergh A., 1993, MOL BIOL MALE REPROD, P439, DOI [10.1016/B978-0-08-091764-1.50017-9, DOI 10.1016/B978-0-08-091764-1.50017-9]; BREMNER WJ, 1994, ENDOCRINOLOGY, V135, P1227, DOI 10.1210/en.135.3.1227; Brennan J, 2002, DEV BIOL, V244, P418, DOI 10.1006/dbio.2002.0578; Chang CS, 2004, P NATL ACAD SCI USA, V101, P6876, DOI 10.1073/pnas.0307306101; COLLIN O, 1993, J REPROD FERTIL, V97, P115; Collin O, 2000, ASIAN J ANDROL, V2, P297; CORKER CS, 1978, J STEROID BIOCHEM, V9, P373, DOI 10.1016/0022-4731(78)90634-9; Coveney D, 2008, P NATL ACAD SCI USA, V105, P7212, DOI 10.1073/pnas.0707674105; DAMBER JE, 1992, INT J ANDROL, V15, P385, DOI 10.1111/j.1365-2605.1992.tb01353.x; DAMBER JE, 1986, ACTA PHYSIOL SCAND, V126, P371, DOI 10.1111/j.1748-1716.1986.tb07829.x; DAMBER JE, 1978, J REPROD FERTIL, V52, P265; De Gendt K, 2004, P NATL ACAD SCI USA, V101, P1327, DOI 10.1073/pnas.0308114100; Denolet E, 2006, MOL ENDOCRINOL, V20, P321, DOI 10.1210/me.2005-0113; Ergun S, 1997, MOL CELL ENDOCRINOL, V131, P9, DOI 10.1016/S0303-7207(97)00082-8; Ergun S, 1997, ADV EXP MED BIOL, V424, P163; Fisher JS, 2003, HUM REPROD, V18, P1383, DOI 10.1093/humrep/deg273; FREE MJ, 1972, AM J PHYSIOL, V223, P241, DOI 10.1152/ajplegacy.1972.223.1.241; Frutkin AD, 2006, J MOL CELL CARDIOL, V41, P724, DOI 10.1016/j.yjmcc.2006.06.067; George Frederick W., 1994, P3; Holtwick R, 2002, P NATL ACAD SCI USA, V99, P7142, DOI 10.1073/pnas.102650499; JEGOU B, 1982, BIOL REPROD, V27, P590, DOI 10.1095/biolreprod27.3.590; Johnston DS, 2001, ENDOCRINOLOGY, V142, P2405, DOI 10.1210/en.142.6.2405; Jones RD, 2003, EUR J ENDOCRINOL, V148, P111, DOI 10.1530/eje.0.1480111; KOTITE NJ, 1978, BIOL REPROD, V18, P65, DOI 10.1095/biolreprod18.1.65; Lissbrant E, 1997, J ANDROL, V18, P385; Liu PY, 2003, ENDOCR REV, V24, P313, DOI 10.1210/er.2003-0005; MADDOCKS S, 1989, J ENDOCRINOL, V121, P311, DOI 10.1677/joe.0.1210311; McLachlan RI, 2002, RECENT PROG HORM RES, V57, P149, DOI 10.1210/rp.57.1.149; McNeilly JR, 2000, ENDOCRINOLOGY, V141, P4284, DOI 10.1210/en.141.11.4284; Mordan-McCombs SE, 2009, FASEB J, V23; Paul C, 2009, BIOL REPROD, V80, P913, DOI 10.1095/biolreprod.108.071779; QUIGLEY CA, 1995, ENDOCR REV, V16, P271, DOI 10.1210/er.16.3.271; SETCHELL BP, 1981, J ENDOCRINOL, V91, P245, DOI 10.1677/joe.0.0910245; SETCHELL BP, 1990, REPROD FERT DEVELOP, V2, P291, DOI 10.1071/RD9900291; SHARPE RM, 1979, J REPROD FERTIL, V55, P365, DOI 10.1530/jrf.0.0550365; SHARPE RM, 1994, J REPROD FERTIL, V101, P193, DOI 10.1530/jrf.0.1010193; SHARPE RM, 1983, J REPROD FERTIL, V69, P125, DOI 10.1530/jrf.0.0690125; Stallone JN, 2001, J APPL PHYSIOL, V91, P2602, DOI 10.1152/jappl.2001.91.6.2602; Tsai MY, 2006, P NATL ACAD SCI USA, V103, P18975, DOI 10.1073/pnas.0608565103; Walker WH, 2005, REPRODUCTION, V130, P15, DOI 10.1530/rep.1.00358; Weidemann W, 2002, CARDIOVASC DRUG REV, V20, P175; Welsh M, 2006, ENDOCRINOLOGY, V147, P4820, DOI 10.1210/en.2006-0149; Welsh M, 2009, FASEB J, V23, P4218, DOI 10.1096/fj.09-138347; WIDMARK A, 1986, J ENDOCRINOL, V109, P419, DOI 10.1677/joe.0.1090419; WIDMARK A, 1989, ACTA ENDOCRINOL-COP, V121, P621, DOI 10.1530/acta.0.1210621; Zhang CX, 2006, P NATL ACAD SCI USA, V103, P17718, DOI 10.1073/pnas.0608556103	49	31	34	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2010	5	10							e13632	10.1371/journal.pone.0013632	http://dx.doi.org/10.1371/journal.pone.0013632			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671GB	21049031	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000283487400022
J	Zeuner, KE; Knutzen, A; Al-Ali, A; Hallett, M; Deuschl, G; Bergmann, TO; Siebner, HR				Zeuner, Kirsten E.; Knutzen, Arne; Al-Ali, Asmaa; Hallett, Mark; Deuschl, Guenther; Bergmann, Til O.; Siebner, Hartwig R.			Associative Stimulation of the Supraorbital Nerve Fails to Induce Timing-Specific Plasticity in the Human Blink Reflex	PLOS ONE			English	Article							HUMAN MOTOR CORTEX; TRANSCRANIAL MAGNETIC STIMULATION; LONG-TERM POTENTIATION; SYNAPTIC PLASTICITY; HOMEOSTATIC PLASTICITY; HAND DYSTONIA; BLEPHAROSPASM; METAPLASTICITY; INTERNEURONS; HIPPOCAMPUS	Background: Associative high-frequency electrical stimulation (HFS) of the supraorbital nerve in five healthy individuals induced long-term potentiation (LTP)-like or depression (LTD)-like changes in the human blink reflex circuit according to the rules of spike timing-dependent plasticity (Mao and Evinger, 2001). HFS given at the onset of the R2 component of the blink reflex (HFSLTP) produced a lasting facilitation of the R2, whereas HFS given shortly before R2 (HFSLTD) caused a lasting suppression of the R2. In patients with benign essential blepharospasm (BEB), a focal dystonia affecting the orbicularis oculi muscles, HFSLTP induced excessive LTP-like associative plasticity relative to healthy controls, which was normalized after botulinum toxin (BTX) injections (Quartarone et al, 2006). Methodology/Principal Findings: We used HFS conditioning of the supraorbital nerve to study homeostatic metaplasticity of the blink reflex circuit in healthy subjects and dystonic patients. On separate days, we tested the conditioning effects on the R2 response and paired-pulse R2 inhibition after (i) HFSLTP, (ii) HFSLTP followed by HFSLTP, and (iii) HFSLTP followed by HFSLTD. Controls also received (iv) HFSLTD alone and (v) a non-intervention protocol. In BEB patients, HFSLTP followed by HFSLTD was given before and after BTX treatment. We were not able to replicate the bidirectional timing-dependent effects of HFSLTP and HFSLTD alone. All HFS protocols produced a non-specific reduction of the R2 response and a relative decrease in paired-pulse inhibition. These R2 changes also occurred in controls when no HFS was applied. There was also no trace of a homeostatic response pattern in BEB patients before or after BTX treatment. Conclusion/Significance: Our data challenge the efficacy of associative HFS to produce bidirectional plasticity in the human blink reflex circuit. The non-specific decrease of the R2 response might indicate habituation of the blink reflex following repeated electrical supraorbital stimulation. The increase of inhibition after paired pulse stimulation might reflect homeostatic behaviour to prevent further down regulation of the R2 response to preserve the protection of this adverse-effects reflex.	[Zeuner, Kirsten E.; Knutzen, Arne; Al-Ali, Asmaa; Deuschl, Guenther; Bergmann, Til O.; Siebner, Hartwig R.] Univ Kiel, Dept Neurol, D-2300 Kiel, Germany; [Hallett, Mark] Natl Inst Neurol Disorders & Stroke, Human Motor Control Sect, Med Neurol Branch, NIH, Bethesda, MD USA; [Siebner, Hartwig R.] Copenhagen Univ Hosp Hvidovre, Danish Res Ctr Magnet Resonance, Hvidovre, Denmark; [Siebner, Hartwig R.] Univ Copenhagen, Inst Neurol Psychiat & Senses, Fac Med, Copenhagen, Denmark	University of Kiel; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); NIH National Institute of Neurological Disorders & Stroke (NINDS); University of Copenhagen; University of Copenhagen	Zeuner, KE (corresponding author), Univ Kiel, Dept Neurol, D-2300 Kiel, Germany.	k.zeuner@neurologie.uni-kiel.de	Siebner, Hartwig R/G-4052-2016; Bergmann, Til Ole/F-9453-2010; Deuschl, Gunther/A-7986-2010	Bergmann, Til Ole/0000-0002-2282-6618; Deuschl, Gunther/0000-0002-4176-9196	Benign Essential Blepharospasm Foundation, USA; Deutsche Forschungsgemeinschaft [DE 438/7-1, 7-2]; National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health (NIH); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS002669] Funding Source: NIH RePORTER	Benign Essential Blepharospasm Foundation, USA; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work has been supported by Benign Essential Blepharospasm Foundation, USA to K.E.Z., G.D. and H.S. and a grant from the Deutsche Forschungsgemeinschaft to G.D. and H.S. (DE 438/7-1 and 7-2). M.H. is supported by the Intramural Program of the National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health (NIH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham WC, 1997, PROG NEUROBIOL, V52, P303, DOI 10.1016/S0301-0082(97)00018-X; Abraham WC, 1996, TRENDS NEUROSCI, V19, P126, DOI 10.1016/S0166-2236(96)80018-X; Bear MF, 2003, PHILOS T ROY SOC B, V358, P649, DOI 10.1098/rstb.2002.1255; BERARDELLI A, 1985, BRAIN, V108, P593, DOI 10.1093/brain/108.3.593; Berardelli A, 1998, BRAIN, V121, P1195, DOI 10.1093/brain/121.7.1195; BIENENSTOCK EL, 1982, J NEUROSCI, V2, P32, DOI 10.1523/jneurosci.02-01-00032.1982; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P357, DOI 10.1113/jphysiol.1973.sp010274; Caporale N, 2008, ANNU REV NEUROSCI, V31, P25, DOI 10.1146/annurev.neuro.31.060407.125639; Citri A, 2008, NEUROPSYCHOPHARMACOL, V33, P18, DOI 10.1038/sj.npp.1301559; Delvendahl I, 2010, CLIN NEUROPHYSIOL, V121, P594, DOI 10.1016/j.clinph.2009.09.034; Ellrich J, 1998, BRAIN RES, V803, P161, DOI 10.1016/S0006-8993(98)00646-5; Esteban A, 1999, NEUROPHYSIOL CLIN, V29, P7, DOI 10.1016/S0987-7053(99)80039-2; Fahn S., 1989, QUANTIFICATION NEURO; Fathi D, 2010, CLIN NEUROPHYSIOL, V121, P90, DOI 10.1016/j.clinph.2009.07.048; Floel A, 2005, ANN NEUROL, V58, P121, DOI 10.1002/ana.20536; HEBB, 1949, ORG BEHAV NEUROPSYCH; KIMURA J, 1973, BRAIN, V96, P87, DOI 10.1093/brain/96.1.87; Lang N, 2004, BIOL PSYCHIAT, V56, P634, DOI 10.1016/j.biopsych.2004.07.017; Mao JB, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-12-j0002.2001; Muller-Dahlhaus JFM, 2008, J PHYSIOL-LONDON, V586, P495, DOI 10.1113/jphysiol.2007.142059; Quartarone A, 2005, BRAIN, V128, P1943, DOI 10.1093/brain/awh527; Quartarone A, 2006, TRENDS NEUROSCI, V29, P192, DOI 10.1016/j.tins.2006.02.007; Quartarone A, 2006, J NEUROSCI, V26, P716, DOI 10.1523/JNEUROSCI.3948-05.2006; Siebner HR, 2010, CLIN NEUROPHYSIOL, V121, P461, DOI 10.1016/j.clinph.2009.12.009; Siebner HR, 2004, J NEUROSCI, V24, P3379, DOI 10.1523/JNEUROSCI.5316-03.2004; Sommer M, 2001, CLIN NEUROPHYSIOL, V112, P2293, DOI 10.1016/S1388-2457(01)00701-5; STANTON PK, 1989, NATURE, V339, P215, DOI 10.1038/339215a0; Stefan K, 2000, BRAIN, V123, P572, DOI 10.1093/brain/123.3.572; Svendsen F, 1997, NEUROREPORT, V8, P3427, DOI 10.1097/00001756-199711100-00002; Tecchio F, 2008, CLIN NEUROPHYSIOL, V119, P675, DOI 10.1016/j.clinph.2007.10.023; Tolosa E, 1988, Adv Neurol, V50, P517; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; Turrigiano GG, 2000, CURR OPIN NEUROBIOL, V10, P358, DOI 10.1016/S0959-4388(00)00091-X; VALLSSOLE J, 1991, J NEUROL NEUROSUR PS, V54, P310, DOI 10.1136/jnnp.54.4.310; Wang HY, 1999, J NEUROPHYSIOL, V82, P2024, DOI 10.1152/jn.1999.82.4.2024; Wolters A, 2003, J NEUROPHYSIOL, V89, P2339, DOI 10.1152/jn.00900.2002	36	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2010	5	10							e13602	10.1371/journal.pone.0013602	http://dx.doi.org/10.1371/journal.pone.0013602			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671GB	21049057	Green Submitted, gold, Green Published			2022-12-27	WOS:000283487400009
J	Slezak, DF; Suarez, C; Cecchi, GA; Marshall, G; Stolovitzky, G				Fernandez Slezak, Diego; Suarez, Cecilia; Cecchi, Guillermo A.; Marshall, Guillermo; Stolovitzky, Gustavo			When the Optimal Is Not the Best: Parameter Estimation in Complex Biological Models	PLOS ONE			English	Article							MULTICELL TUMOR SPHEROIDS; SYSTEMS BIOLOGY; FUNCTION MINIMIZATION; MATHEMATICAL-MODELS; GROWTH SATURATION; NECROSIS; CELL	Background: The vast computational resources that became available during the past decade enabled the development and simulation of increasingly complex mathematical models of cancer growth. These models typically involve many free parameters whose determination is a substantial obstacle to model development. Direct measurement of biochemical parameters in vivo is often difficult and sometimes impracticable, while fitting them under data-poor conditions may result in biologically implausible values. Results: We discuss different methodological approaches to estimate parameters in complex biological models. We make use of the high computational power of the Blue Gene technology to perform an extensive study of the parameter space in a model of avascular tumor growth. We explicitly show that the landscape of the cost function used to optimize the model to the data has a very rugged surface in parameter space. This cost function has many local minima with unrealistic solutions, including the global minimum corresponding to the best fit. Conclusions: The case studied in this paper shows one example in which model parameters that optimally fit the data are not necessarily the best ones from a biological point of view. To avoid force-fitting a model to a dataset, we propose that the best model parameters should be found by choosing, among suboptimal parameters, those that match criteria other than the ones used to fit the model. We also conclude that the model, data and optimization approach form a new complex system and point to the need of a theory that addresses this problem more generally.	[Fernandez Slezak, Diego; Suarez, Cecilia; Marshall, Guillermo] Univ Buenos Aires, FCEyN, Dept Computac, Lab Sistemas Complejos, Buenos Aires, DF, Argentina; [Cecchi, Guillermo A.; Stolovitzky, Gustavo] IBM Corp, TJ Watson Res Ctr, Computat Biol Ctr, Yorktown Hts, NY USA	University of Buenos Aires; International Business Machines (IBM)	Slezak, DF (corresponding author), Univ Buenos Aires, FCEyN, Dept Computac, Lab Sistemas Complejos, Buenos Aires, DF, Argentina.	dfslezak@dc.uba.ar; gustavo@us.ibm.com	Slezak, Diego Fernandez/AAD-9543-2019; , Cecilia/I-5244-2016	, Cecilia/0000-0003-0134-8618; Fernandez Slezak, Diego/0000-0001-6348-1559	Buenos Aires University [UBA X132/08, UBACYT M415]; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) [PIP 5756/06]; Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT) [PICTR 184, PAV 127/03]; Fundacion YPF	Buenos Aires University(University of Buenos Aires); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT)(ANPCyT); Fundacion YPF	This work was partially supported by grants from Buenos Aires University (UBA X132/08 and UBACYT M415), Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) (PIP 5756/06), Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT) (PICTR 184 and PAV 127/03). DFS acknowledges support through a Fundacion YPF scholarship and the summer internship program provided by the IBM Computational Biology Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adiga N., 2002, P 2002 ACM IEEE C SU, DOI DOI 10.1109/SC.2002.10017; Araujo RP, 2004, B MATH BIOL, V66, P1039, DOI 10.1016/j.bulm.2003.11.002; Ashyraliyev M, 2009, FEBS J, V276, P886, DOI 10.1111/j.1742-4658.2008.06844.x; Bjorck A., 1996, NUMERICAL METHODS LE; Cedersund G, 2009, FEBS J, V276, P903, DOI 10.1111/j.1742-4658.2008.06845.x; Daniels BC, 2008, CURR OPIN BIOTECH, V19, P389, DOI 10.1016/j.copbio.2008.06.008; FLETCHER R, 1970, COMPUT J, V13, P317, DOI 10.1093/comjnl/13.3.317; Fracasso G, 2000, CRIT REV ONCOL HEMAT, V36, P159, DOI 10.1016/S1040-8428(00)00084-6; FREYER JP, 1980, CANCER RES, V40, P3956; FREYER JP, 1983, ADV EXP MED BIOL, V159, P463; FREYER JP, 1986, CANCER RES, V46, P3504; FREYER JP, 1988, CANCER RES, V48, P2432; Gara A, 2005, IBM J RES DEV, V49, P195, DOI 10.1147/rd.492.0195; Gompertz B., 1825, PHILOS T ROYAL SOC L, V115, P515, DOI [DOI 10.1098/RSTL.1825.0026, 10.1098/rstl.1825.0026]; Gutenkunst RN, 2007, PLOS COMPUT BIOL, V3, P1871, DOI 10.1371/journal.pcbi.0030189; JAMES F, 1975, COMPUT PHYS COMMUN, V10, P343, DOI 10.1016/0010-4655(75)90039-9; Jiang Y, 2005, BIOPHYS J, V89, P3884, DOI 10.1529/biophysj.105.060640; Jolliffe I., 2005, SPRINGERLINK PRINCIP, DOI 10.1007/b98835; Kitano H, 2002, NATURE, V420, P206, DOI 10.1038/nature01254; Kreutz C, 2009, FEBS J, V276, P923, DOI 10.1111/j.1742-4658.2008.06843.x; Kunz-Schughart LA, 2004, J BIOMOL SCREEN, V9, P273, DOI 10.1177/1087057104265040; Levenberg K., 1944, Q APPL MATH, V2, P164, DOI [10.1090/qam/10666, DOI 10.1090/QAM/10666]; MARINARI E, 1992, EUROPHYS LETT, V19, P451, DOI 10.1209/0295-5075/19/6/002; MARQUARDT DW, 1963, J SOC IND APPL MATH, V11, P431, DOI 10.1137/0111030; MARUSIC M, 1994, B MATH BIOL, V56, P617, DOI 10.1007/BF02460714; MARUSIC M, 1994, CELL PROLIFERAT, V27, P73, DOI 10.1111/j.1365-2184.1994.tb01407.x; Moles CG, 2003, GENOME RES, V13, P2467, DOI 10.1101/gr.1262503; NELDER JA, 1965, COMPUT J, V7, P308, DOI 10.1093/comjnl/7.4.308; Pacheco Peter., 1997, PARALLEL PROGRAMMING; Preziosi L., 2003, CANC MODELLING SIMUL; Rodriguez-Fernandez M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-483; Slezaka D. F., 2007, MECANICA COMPUTACION, V26, P1788; SUTHERLAND RM, 1988, SCIENCE, V240, P177, DOI 10.1126/science.2451290; Ward JP, 1997, IMA J MATH APPL MED, V14, P39; Wise SM, 2008, J THEOR BIOL, V253, P524, DOI 10.1016/j.jtbi.2008.03.027; Zwolak JW, 2005, IEE P SYST BIOL, V152, P81, DOI 10.1049/ip-syb:20045032; Zwolak JW, 2005, J COMPUT BIOL, V12, P48, DOI 10.1089/cmb.2005.12.48	37	41	41	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2010	5	10							e13283	10.1371/journal.pone.0013283	http://dx.doi.org/10.1371/journal.pone.0013283			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	670LB	21049094	Green Published, Green Submitted, gold			2022-12-27	WOS:000283422100001
J	Graveel, CR; DeGroot, JD; Sigler, RE; Vande Woude, GF				Graveel, Carrie R.; DeGroot, Jack D.; Sigler, Robert E.; Vande Woude, George F.			Germline Met Mutations in Mice Reveal Mutation- and Background-Associated Differences in Tumor Profiles	PLOS ONE			English	Article							PAPILLARY RENAL-CARCINOMAS; TYROSINE KINASE RECEPTOR; HEPATOCYTE GROWTH-FACTOR; C-MET; LUNG-CANCER; BREAST-CANCER; SOMATIC MUTATIONS; SCATTER FACTOR; PROTOONCOGENE; AMPLIFICATION	Background: The receptor tyrosine kinase Met is involved in the progression and metastasis of numerous human cancers. Although overexpression and autocrine activation of the Met signaling pathway are commonly found in human cancers, mutational activation of Met has been observed in small cell and non-small cell lung cancers, lung adenocarcinomas, renal carcinomas, and mesotheliomas. Methodology/Principal Findings: To investigate the influence of mutationally activated Met in tumorigenesis, we utilized a novel mouse model. Previously, we observed that various Met mutations developed unique mutation-specific tumor spectra on a C57BL/6 background. Here, we assessed the effect of genetic background on the tumorigenic potential of mutationally activated Met. For this purpose, we created congenic knock-in lines of the Met mutations D1226N, M1248T, and Y1228C on the FVB/N background. Consistent with the mutation-specific tumor spectra, several of the mutations were associated with the same tumor types as observed on C57BL/6 background. However, on the FVB/N background most developed a high incidence of mammary carcinomas with diverse histopathologies. Conclusions/Significance: This study demonstrates that on two distinct mouse backgrounds, Met is able to initiate tumorigenesis in multiple cell types, including epithelial, hematopoietic, and endothelial. Furthermore, these observations emphasize that even a modest increase in Met activation can initiate tumorigenesis with both the Met mutational spectra and host background having profound influence on the type of tumor generated. Greater insight into the interaction of genetic modifiers and Met signaling will significantly enhance our ability to tailor combination therapies for Met-driven cancers.	[Graveel, Carrie R.; DeGroot, Jack D.; Vande Woude, George F.] Van Andel Res Inst, Dept Mol Oncol, Grand Rapids, MI USA; [Sigler, Robert E.] Res Essential Serv LLC, Plymouth, MI USA	Van Andel Institute	Graveel, CR (corresponding author), Van Andel Res Inst, Dept Mol Oncol, Grand Rapids, MI USA.	carrie.graveel@vai.org			Breast Cancer Research Foundation; Jay and Betty Van Andel Foundation	Breast Cancer Research Foundation; Jay and Betty Van Andel Foundation	This work was supported by the Breast Cancer Research Foundation and the Jay and Betty Van Andel Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellon SF, 2008, J BIOL CHEM, V283, P2675, DOI 10.1074/jbc.M705774200; Berthou S, 2004, ONCOGENE, V23, P5387, DOI 10.1038/sj.onc.1207691; Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; BOTTARO DP, 1991, SCIENCE, V251, P802, DOI 10.1126/science.1846706; Camp RL, 1999, CANCER, V86, P2259, DOI 10.1002/(SICI)1097-0142(19991201)86:11<2259::AID-CNCR13>3.0.CO;2-2; Eder JP, 2009, CLIN CANCER RES, V15, P2207, DOI 10.1158/1078-0432.CCR-08-1306; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Ghoussoub RAD, 1998, CANCER, V82, P1513, DOI 10.1002/(SICI)1097-0142(19980415)82:8<1513::AID-CNCR13>3.0.CO;2-7; Graveel C, 2004, P NATL ACAD SCI USA, V101, P17198, DOI 10.1073/pnas.0407651101; Graveel CR, 2009, P NATL ACAD SCI USA, V106, P12909, DOI 10.1073/pnas.0810403106; HARVEY M, 1993, FASEB J, V7, P938, DOI 10.1096/fasebj.7.10.8344491; Jagadeeswaran R, 2006, CANCER RES, V66, P352, DOI 10.1158/0008-5472.CAN-04-4567; Jeffers M, 1998, ONCOGENE, V17, P2691, DOI 10.1038/sj.onc.1202209; Jeffers M, 1998, P NATL ACAD SCI USA, V95, P14417, DOI 10.1073/pnas.95.24.14417; Jeffers M, 1997, P NATL ACAD SCI USA, V94, P11445, DOI 10.1073/pnas.94.21.11445; Kong-Beltran M, 2006, CANCER RES, V66, P283, DOI 10.1158/0008-5472.CAN-05-2749; Lee JH, 2000, ONCOGENE, V19, P4947, DOI 10.1038/sj.onc.1203874; Lengyel E, 2005, INT J CANCER, V113, P678, DOI 10.1002/ijc.20598; Ma PC, 2008, GENE CHROMOSOME CANC, V47, P1025, DOI 10.1002/gcc.20604; Ma PC, 2003, CANCER RES, V63, P6272; Nieto AI, 2003, COMPARATIVE MED, V53, P433; Olive KP, 2004, CELL, V119, P847, DOI 10.1016/j.cell.2004.11.004; Schmidt L, 1997, NAT GENET, V16, P68, DOI 10.1038/ng0597-68; Schmidt L, 1999, ONCOGENE, V18, P2343, DOI 10.1038/sj.onc.1202547; Sharma SV, 2007, NAT REV CANCER, V7, P169, DOI 10.1038/nrc2088; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; SONNENBERG E, 1993, J CELL BIOL, V123, P223, DOI 10.1083/jcb.123.1.223; Stirewalt DL, 2003, NAT REV CANCER, V3, P650, DOI 10.1038/nrc1169; STOKER M, 1987, NATURE, V327, P239, DOI 10.1038/327239a0; Timofeevski SL, 2009, BIOCHEMISTRY-US, V48, P5339, DOI 10.1021/bi900438w; TURKE AB, CANC CELL, V17, P77; Ward JM, 2000, PATHOLOGY OF GENETICALLY ENGINEERED MICE, P161; Zeng ZS, 2008, CANCER LETT, V265, P258, DOI 10.1016/j.canlet.2008.02.049; Zhuang ZP, 1998, NAT GENET, V20, P66, DOI 10.1038/1727	34	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2010	5	10							e13586	10.1371/journal.pone.0013586	http://dx.doi.org/10.1371/journal.pone.0013586			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	670LB	21049054	Green Published, Green Submitted, gold			2022-12-27	WOS:000283422100008
J	Doerck, S; Gobel, K; Weise, G; Schneider-Hohendorf, T; Reinhardt, M; Hauff, P; Schwab, N; Linker, R; Maurer, M; Meuth, SG; Wiendl, H				Doerck, Sebastian; Goebel, Kerstin; Weise, Gesa; Schneider-Hohendorf, Tilman; Reinhardt, Michael; Hauff, Peter; Schwab, Nicholas; Linker, Ralf; Maeurer, Mathias; Meuth, Sven G.; Wiendl, Heinz			Temporal Pattern of ICAM-I Mediated Regulatory T Cell Recruitment to Sites of Inflammation in Adoptive Transfer Model of Multiple Sclerosis	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; IMMUNOLOGICAL SELF-TOLERANCE; BLOOD-BRAIN-BARRIER; IMMUNE-RESPONSES; ANIMAL-MODELS; MIGRATION; DISEASE; CNS; INHIBITION	Migration of immune cells to the target organ plays a key role in autoimmune disorders like multiple sclerosis (MS). However, the exact underlying mechanisms of this active process during autoimmune lesion pathogenesis remain elusive. To test if pro-inflammatory and regulatory T cells migrate via a similar molecular mechanism, we analyzed the expression of different adhesion molecules, as well as the composition of infiltrating T cells in an in vivo model of MS, adoptive transfer experimental autoimmune encephalomyelitis in rats. We found that the upregulation of ICAM-I and VCAM-I parallels the development of clinical disease onset, but persists on elevated levels also in the phase of clinical remission. However, the composition of infiltrating T cells found in the developing versus resolving lesion phase changed over time, containing increased numbers of regulatory T cells (FoxP3) only in the phase of clinical remission. In order to test the relevance of the expression of cell adhesion molecules, animals were treated with purified antibodies to ICAM-I and VCAM-I either in the phase of active disease or in early remission. Treatment with a blocking ICAM-I antibody in the phase of disease progression led to a milder disease course. However, administration during early clinical remission aggravates clinical symptoms. Treatment with anti-VCAM-I at different timepoints had no significant effect on the disease course. In summary, our results indicate that adhesion molecules are not only important for capture and migration of pro-inflammatory T cells into the central nervous system, but also permit access of anti-inflammatory cells, such as regulatory T cells. Therefore it is likely to assume that intervention at the blood brain barrier is time dependent and could result in different therapeutic outcomes depending on the phase of CNS lesion development.	[Doerck, Sebastian; Weise, Gesa; Meuth, Sven G.] Univ Wurzburg, Dept Neurol, D-8700 Wurzburg, Germany; [Goebel, Kerstin; Schneider-Hohendorf, Tilman; Schwab, Nicholas; Meuth, Sven G.; Wiendl, Heinz] Univ Munster, Dept Neurol Inflammatory Disorders Nervous Syst &, Munster, Germany; [Reinhardt, Michael; Hauff, Peter] Schering AG, Res Labs, D-1000 Berlin, Germany; [Linker, Ralf] Univ Erlangen Nurnberg, Dept Neurol, D-8520 Erlangen, Germany; [Maeurer, Mathias] Caritas Hosp Bad Mergentheim, Bad Mergentheim, Germany; [Meuth, Sven G.] Inst Physiol I Neuropathophysiol, Munster, Germany	University of Wurzburg; University of Munster; Schering AG; University of Erlangen Nuremberg; Caritas Hospital Bad Mergentheim	Doerck, S (corresponding author), Univ Wurzburg, Dept Neurol, Josef Schneider Str 11, D-8700 Wurzburg, Germany.	Heinz.wiendl@ukmuenster.de	Wiendl, Heinz/AAX-6041-2021; Meuth, Sven G/HHM-8941-2022; Schwab, Nicholas/H-4516-2019; Linker, Ralf/AAD-8884-2020	Meuth, Sven G/0000-0003-2571-3501; Wiendl, Heinz/0000-0003-4310-3432; Schwab, Nicholas/0000-0001-5494-9885; Schneider-Hohendorf, Tilman/0000-0002-3717-5176	Deutsche Forschungsgemeinschaft [1722/7-1];  [SFB581];  [TP A8]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); ; 	This work was supported by SFB581, TP A8, and Deutsche Forschungsgemeinschaft grant 1722/7-1 to HW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030; Archelos JJ, 1999, TRENDS NEUROSCI, V22, P30, DOI 10.1016/S0166-2236(98)01287-9; ARCHELOS JJ, 1993, ANN NEUROL, V34, P145, DOI 10.1002/ana.410340209; Beyersdorf N, 2005, J EXP MED, V202, P445, DOI 10.1084/jem.20051060; Bluestone JA, 2005, CURR OPIN IMMUNOL, V17, P638, DOI 10.1016/j.coi.2005.09.002; Correale J, 2010, ANN NEUROL, V67, P625, DOI 10.1002/ana.21944; Engelhardt B, 2006, J NEURAL TRANSM, V113, P477, DOI 10.1007/s00702-005-0409-y; Engelhardt B, 2003, CELL TISSUE RES, V314, P119, DOI 10.1007/s00441-003-0751-z; Engelhardt B, 1998, CURR TOP MICROBIOL, V231, P51; Engelhardt B, 1998, J CLIN INVEST, V102, P2096, DOI 10.1172/JCI4271; Feger U, 2007, CLIN EXP IMMUNOL, V147, P412, DOI 10.1111/j.1365-2249.2006.03271.x; Gartner D, 2006, J NEUROIMMUNOL, V172, P73, DOI 10.1016/j.jneuroim.2005.11.003; Gold R, 2000, MOL MED TODAY, V6, P88, DOI 10.1016/S1357-4310(99)01639-1; Gold R, 2006, BRAIN, V129, P1953, DOI 10.1093/brain/awl075; Herman AE, 2004, J EXP MED, V199, P1479, DOI 10.1084/jem.20040179; Hiura T, 2005, J IMMUNOL, V175, P5058, DOI 10.4049/jimmunol.175.8.5058; Huang YH, 2009, ANN NEUROL, V66, P171, DOI 10.1002/ana.21705; Kohm AP, 2002, J IMMUNOL, V169, P4712, DOI 10.4049/jimmunol.169.9.4712; Korn T, 2007, NAT MED, V13, P423, DOI 10.1038/nm1564; Laschinger M, 2002, EUR J IMMUNOL, V32, P3598, DOI 10.1002/1521-4141(200212)32:12<3598::AID-IMMU3598>3.0.CO;2-6; Lee JH, 2007, J IMMUNOL, V178, P301, DOI 10.4049/jimmunol.178.1.301; Linker RA, 2005, J AUTOIMMUN, V25, P199, DOI 10.1016/j.jaut.2005.09.019; Linker RA, 2002, NAT MED, V8, P620, DOI 10.1038/nm0602-620; Magnus T, 2005, J NEUROSCI, V25, P2537, DOI 10.1523/JNEUROSCI.4794-04.2005; Man SM, 2007, BRAIN PATHOL, V17, P243, DOI 10.1111/j.1750-3639.2007.00067.x; McGeachy MJ, 2005, J IMMUNOL, V175, P3025, DOI 10.4049/jimmunol.175.5.3025; Morgan ME, 2003, ARTHRITIS RHEUM, V48, P1452, DOI 10.1002/art.11063; Morrissey SP, 1996, J NEUROIMMUNOL, V69, P85; O'Connor RA, 2007, J IMMUNOL, V179, P958, DOI 10.4049/jimmunol.179.2.958; Piccirillo CA, 2005, ANN NY ACAD SCI, V1051, P72, DOI 10.1196/annals.1361.048; Polman CH, 2006, NEW ENGL J MED, V354, P899, DOI 10.1056/NEJMoa044397; Reinhardt M, 2005, INVEST RADIOL, V40, P2; Rose JW, 1999, J NEUROIMMUNOL, V97, P110, DOI 10.1016/S0165-5728(99)00064-8; Rudick RA, 2006, NEW ENGL J MED, V354, P911, DOI 10.1056/NEJMoa044396; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; Takahashi T, 1998, INT IMMUNOL, V10, P1969, DOI 10.1093/intimm/10.12.1969; Tang QZ, 2008, NAT IMMUNOL, V9, P239, DOI 10.1038/ni1572; Tischner D, 2006, BRAIN, V129, P2635, DOI 10.1093/brain/awl213; Vajkoczy P, 2001, J CLIN INVEST, V108, P557; WILLENBORG DO, 1993, J NEUROIMMUNOL, V45, P147, DOI 10.1016/0165-5728(93)90175-X; Zozulya AL, 2008, NAT CLIN PRACT NEURO, V4, P384, DOI 10.1038/ncpneuro0832	41	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2010	5	11							e15478	10.1371/journal.pone.0015478	http://dx.doi.org/10.1371/journal.pone.0015478			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	680KW	21085578	gold, Green Published, Green Submitted			2022-12-27	WOS:000284231800035
J	Rybczynski, N; Ross, EM; Samuels, JX; Korth, WW				Rybczynski, Natalia; Ross, Elizabeth M.; Samuels, Joshua X.; Korth, William W.			Re-Evaluation of Sinocastor (Rodentia: Castoridae) with Implications on the Origin of Modern Beavers	PLOS ONE			English	Article							GEOMETRIC MORPHOMETRICS; CRANIAL MORPHOLOGY; POSTNATAL ONTOGENY; MOLAR SHAPE; MIOCENE; SKULL; ADAPTATIONS; EVOLUTION; PALEOPHYLOGEOGRAPHY; SYSTEMATICS	The extant beaver, Castor, has played an important role shaping landscapes and ecosystems in Eurasia and North America, yet the origins and early evolution of this lineage remain poorly understood. Here we use a geometric morphometric approach to help re-evaluate the phylogenetic affinities of a fossil skull from the Late Miocene of China. This specimen was originally considered Sinocastor, and later transferred to Castor. The aim of this study was to determine whether this form is an early member of Castor, or if it represents a lineage outside of Castor. The specimen was compared to 38 specimens of modern Castor (both C. canadensis and C. fiber) as well as fossil specimens of C. fiber (Pleistocene), C. californicus (Pliocene) and the early castorids Steneofiber eseri (early Miocene). The results show that the specimen falls outside the Castor morphospace and that compared to Castor, Sinocastor possesses a: 1) narrower post-orbital constriction, 2) anteroposteriorly shortened basioccipital depression, 3) shortened incisive foramen, 4) more posteriorly located palatine foramen, 5) longer rostrum, and 6) longer braincase. Also the specimen shows a much shallower basiocciptal depression than what is seen in living Castor, as well as prominently rooted molars. We conclude that Sinocastor is a valid genus. Given the prevalence of apparently primitive traits, Sinocastor might be a near relative of the lineage that gave rise to Castor, implying a possible Asiatic origin for Castor.	[Rybczynski, Natalia] Canadian Museum Nat, Ottawa, ON K1P 6P4, Canada; [Ross, Elizabeth M.] Carleton Univ, Ottawa, ON K1S 5B6, Canada; [Samuels, Joshua X.] John Day Fossil Beds Natl Monument, Kimberly, OR USA; [Korth, William W.] Rochester Inst Vertebrate Paleontol, Rochester, NY USA	Carleton University	Rybczynski, N (corresponding author), Canadian Museum Nat, POB 3443 Stn D, Ottawa, ON K1P 6P4, Canada.	nrybczynski@mus-nature.ca			National Science and Engineering Research Council (Canada)	National Science and Engineering Research Council (Canada)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was funded by a National Science and Engineering Research Council (Canada) Discovery Grant (http://www.nserc-crsng.gc.ca/) awarded to NR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1995, ZOOGEOMORPHOLOGY ANI; BARISONE G, 2003, BEAVER BACCINELLO V3; Barnosky AD, 2003, P ROY SOC B-BIOL SCI, V270, P2585, DOI 10.1098/rspb.2003.2543; Cardini A, 2006, J MAMMAL, V87, P201, DOI 10.1644/05-MAMM-A-242R1.1; Cardini A, 2005, ZOOMORPHOLOGY, V124, P189, DOI 10.1007/s00435-005-0008-3; Cardini A, 2009, ETHOL ECOL EVOL, V21, P209, DOI 10.1080/08927014.2009.9522476; Caumul R, 2005, EVOLUTION, V59, P2460; DECHARDIN PT, 1942, I GEOBIOLOGIE, V9, P4; Depecker M, 2006, J ANAT, V208, P35, DOI 10.1111/j.1469-7580.2006.00512.x; Durka W, 2005, MOL ECOL, V14, P3843, DOI 10.1111/j.1365-294X.2005.02704.x; Flynn LJ, 2008, EVOLUTION OF TERTIARY MAMMALS OF NORTH AMERICA, VOL 2, P391; GINGERICH PD, 1985, PALEOBIOLOGY, V11, P27, DOI 10.1017/S0094837300011374; Grine FE, 2007, SCIENCE, V315, P226, DOI 10.1126/science.1136294; Guy F, 2003, AM J PHYS ANTHROPOL, V121, P198, DOI 10.1002/ajpa.10261; Harvati K, 2007, J HUM EVOL, V53, P732, DOI 10.1016/j.jhevol.2007.09.009; Hemprich W., 1820, GRUNDRISS NATURGESCH; HUGUENEY M, 1999, MIOCENE LAND MAMMALS; Ives Ronald L., 1942, JOUR GEOMORPH, V5, P191; Korth W.W., 1994, TERTIARY RECORD RODE; Korth WW, 2008, ACTA PALAEONTOL POL, V53, P169, DOI 10.4202/app.2008.0201; Korth WW, 2007, J PALEONTOL, V81, P1533, DOI 10.1666/05-110.1; Korth WW, 2007, ANN CARNEGIE MUS, V76, P117, DOI 10.2992/0097-4463(2007)76[117:ANGOBR]2.0.CO;2; Korth WW, 2006, ANN CARNEGIE MUS, V75, P237, DOI 10.2992/0097-4463(2006)75[237:ECBRCF]2.0.CO;2; Korth WW, 2003, J VERTEBR PALEONTOL, V23, P667, DOI 10.1671/2371; KORTH WW, 2002, J MAMMAL EVOL, V0008, P00279; Linnaeus C, 1766, SYSTEMA NATURAE REGN; Lucas S.G., 2002, CHINESE FOSSIL VERTE; MARTIN JE, 2008, PALUDICOLA, V6, P115; Martin Larry D., 1987, Dakoterra, V3, P73; MARTIN LD, 1977, PALAEOGEOGR PALAEOCL, V22, P173, DOI 10.1016/0031-0182(77)90027-X; MAYR E., 1991, PRINCIPLES SYSTEMATI, V2nd; McKenna MC, 1997, CLASSIFICATION MAMMA; Monteiro LR, 2005, J ZOOL SYST EVOL RES, V43, P332, DOI 10.1111/j.1439-0469.2005.00323.x; Mors T, 2010, ACTA PALAEONTOL POL, V55, P189, DOI 10.4202/app.2009.0013; Muller-Schwarze D., 2003, BEAVER NATURAL HIST; NAIMAN RJ, 1988, BIOSCIENCE, V38, P753, DOI 10.2307/1310784; Novak M., 1987, WILD FURBEARER MANAG, P283; Odling-Smee FJ, 2003, NICHE CONSTRUCTION N; Polly PD, 2003, MAMMALIA, V67, P233, DOI 10.1515/mamm.2003.67.2.233; Polly PD, 2003, J MAMMAL, V84, P369, DOI 10.1644/1545-1542(2003)084<0369:PTTOGD>2.0.CO;2; Rekovets Leonid, 2009, Acta Zoologica Cracoviensia Ser. A - Vertebrata, V52A, P95, DOI 10.3409/azc.52a_1-2.95-105; ROBERTSON RA, 1954, J MAMMAL, V35, P197, DOI 10.2307/1376033; Rohlf F. J., 2006, TPSRELW VERSION 1 44; ROHLF FJ, 2006, TPSDIG2 VERSION 2 05; ROHLF FJ, 2004, TPSREGR VERSION 1 28; Rybczynski Natalia, 2007, Journal of Mammalian Evolution, V14, P1, DOI 10.1007/s10914-006-9017-3; Samuels JX, 2008, J MORPHOL, V269, P1387, DOI 10.1002/jmor.10662; Samuels JX, 2009, ZOOL J LINN SOC-LOND, V156, P864, DOI 10.1111/j.1096-3642.2009.00502.x; Samuels JX, 2009, J VERTEBR PALEONTOL, V29, P254, DOI 10.1080/02724634.2009.10010376; Schlosser M., 1924, Palaeontologia Sinica Series C, V1, P1; Schreuder A., 1931, Palaeontologische Zeitschrift Berlin, V13, P148; SHOTWELL JA, 1970, B MUSEUM NATURAL HIS, V17, P1; Singleton M, 2009, J HUM EVOL, V56, P25, DOI 10.1016/j.jhevol.2008.07.012; Stayton CT, 2006, PALAEONTOLOGY, V49, P307, DOI 10.1111/j.1475-4983.2006.00523.x; Stefen C, 2005, NEUES JAHRB GEOL P-M, P577; Stefen Clara, 2009, Kaupia Darmstaedter Beitraege zur Naturgeschichte, V16, P161; Stirton R. A., 1935, University of California Publications in Geology, V23, P391; Teilhard de Chardin P, 1931, PALAEONTOLOGIA SIN C, V9, P1; Wright JP, 2002, OECOLOGIA, V132, P96, DOI 10.1007/s00442-002-0929-1; XU XF, 1994, RODENT LAGOMORPH FAM, P77; Young C. C., 1934, Palaeontologia Sinica, VC8, P1; YOUNG CC, 1927, PALAEONTOLOGIA SIN C, V5, P10; Zelditch ML, 2004, EVOL DEV, V6, P194, DOI 10.1111/j.1525-142X.2004.04025.x; ZELDITCH ML, 1992, EVOLUTION, V46, P1164, DOI 10.1111/j.1558-5646.1992.tb00626.x; ZELDITCH ML, 1993, J EVOLUTION BIOL, V6, P621, DOI 10.1046/j.1420-9101.1993.6050621.x	65	14	14	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2010	5	11							e13990	10.1371/journal.pone.0013990	http://dx.doi.org/10.1371/journal.pone.0013990			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	680KW	21085579	Green Published, gold, Green Submitted			2022-12-27	WOS:000284231800020
J	Dimon, MT; Sorber, K; DeRisi, JL				Dimon, Michelle T.; Sorber, Katherine; DeRisi, Joseph L.			HMMSplicer: A Tool for Efficient and Sensitive Discovery of Known and Novel Splice Junctions in RNA-Seq Data	PLOS ONE			English	Article							MESSENGER-RNA; SEQUENCE; TRANSCRIPTOME; ALIGNMENT	Background: High-throughput sequencing of an organism's transcriptome, or RNA-Seq, is a valuable and versatile new strategy for capturing snapshots of gene expression. However, transcriptome sequencing creates a new class of alignment problem: mapping short reads that span exon-exon junctions back to the reference genome, especially in the case where a splice junction is previously unknown. Methodology/Principal Findings: Here we introduce HMMSplicer, an accurate and efficient algorithm for discovering canonical and non-canonical splice junctions in short read datasets. HMMSplicer identifies more splice junctions than currently available algorithms when tested on publicly available A. thaliana, P. falciparum, and H. sapiens datasets without a reduction in specificity. Conclusions/Significance: HMMSplicer was found to perform especially well in compact genomes and on genes with low expression levels, alternative splice isoforms, or non-canonical splice junctions. Because HHMSplicer does not rely on pre-built gene models, the products of inexact splicing are also detected. For H. sapiens, we find 3.6% of 3' splice sites and 1.4% of 5' splice sites are inexact, typically differing by 3 bases in either direction. In addition, HMMSplicer provides a score for every predicted junction allowing the user to set a threshold to tune false positive rates depending on the needs of the experiment. HMMSplicer is implemented in Python. Code and documentation are freely available at http://derisilab.ucsf.edu/software/hmmsplicer.	[Dimon, Michelle T.; Sorber, Katherine; DeRisi, Joseph L.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; [Dimon, Michelle T.] Univ Calif San Francisco, Biol & Med Informat Program, San Francisco, CA 94143 USA; [DeRisi, Joseph L.] Howard Hughes Med Inst, Bethesda, MD 20817 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute	Dimon, MT (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA.	joe@derisilab.ucsf.edu		Lontok, Katherine/0000-0001-7127-340X	Howard Hughes Medical Institute	Howard Hughes Medical Institute(Howard Hughes Medical Institute)	This work was supported by the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameur A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r34; AU KF, 2010, NUCL ACIDS RES; BAUM LE, 1970, ANN MATH STAT, V41, P164, DOI 10.1214/aoms/1177697196; Benson DA, 2004, NUCLEIC ACIDS RES, V32, pD23, DOI 10.1093/nar/gkh045; BRYANT DW, 2010, BIOINFORMATICS; Cox JS, 1996, CELL, V87, P391, DOI 10.1016/S0092-8674(00)81360-4; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; De Bona F, 2008, BIOINFORMATICS, V24, pI174, DOI 10.1093/bioinformatics/btn300; Deutsch M, 1999, NUCLEIC ACIDS RES, V27, P3219, DOI 10.1093/nar/27.15.3219; Dohm JC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn425; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Heap GA, 2010, HUM MOL GENET, V19, P122, DOI 10.1093/hmg/ddp473; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Lu FL, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-255; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Nagasaki H, 2005, GENE, V364, P53, DOI 10.1016/j.gene.2005.07.027; Nilsen TW, 2010, NATURE, V463, P457, DOI 10.1038/nature08909; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Pruitt KD, 2005, NUCLEIC ACIDS RES, V33, pD501, DOI 10.1093/nar/gki025; Ramskold D, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000598; Richard H, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq041; SEN S, 2010, J BIOL CHEM; Shepard PJ, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-242; Sidrauski C, 1996, CELL, V87, P405, DOI 10.1016/S0092-8674(00)81361-6; Sorber K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003495; Stamm S, 2006, NUCLEIC ACIDS RES, V34, pD46, DOI 10.1093/nar/gkj031; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wilhelm BT, 2008, NATURE, V453, P1239, DOI 10.1038/nature07002; Yano M, 2010, NEURON, V66, P848, DOI 10.1016/j.neuron.2010.05.007; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0	42	37	40	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2010	5	11							e13875	10.1371/journal.pone.0013875	http://dx.doi.org/10.1371/journal.pone.0013875			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	676NU	21079731	Green Published, gold			2022-12-27	WOS:000283920000009
J	Aide, P; Aponte, JJ; Renom, M; Nhampossa, T; Sacarlal, J; Mandomando, I; Bassat, Q; Manaca, MN; Leach, A; Lievens, M; Vekemans, J; Dubois, MC; Loucq, C; Ballou, WR; Cohen, J; Alonso, PL				Aide, Pedro; Aponte, John J.; Renom, Montse; Nhampossa, Tacilta; Sacarlal, Jahit; Mandomando, Inacio; Bassat, Quique; Manaca, Maria Nelia; Leach, Amanda; Lievens, Marc; Vekemans, Johan; Dubois, Marie-Claude; Loucq, Christian; Ballou, W. Ripley; Cohen, Joe; Alonso, Pedro L.			Safety, Immunogenicity and Duration of Protection of the RTS,S/AS02(D) Malaria Vaccine: One Year Follow-Up of a Randomized Controlled Phase I/IIb Trial	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM INFECTION; EFFICACY; CHILDREN; MOZAMBIQUE; INFANTS; DISEASE	Background: The RTS,S/AS02(D) vaccine has been shown to have a promising safety profile, to be immunogenic and to confer protection against malaria in children and infants. Methods and Findings: We did a randomized, controlled, phase I/IIb trial of RTS,S/AS02(D) given at 10, 14 and 18 weeks of age staggered with routine immunization vaccines in 214 Mozambican infants. The study was double-blind until the young child completed 6 months of follow-up over which period vaccine efficacy against new Plasmodium falciparum infections was estimated at 65.9% (95% CI 42.6-79.8, p<0.0001). We now report safety, immunogenicity and estimated efficacy against clinical malaria up to 14 months after study start. Vaccine efficacy was assessed using Cox regression models. The frequency of serious adverse events was 32.7% in the RTS, S/AS02(D) and 31.8% in the control group. The geometric mean titers of anti-circumsporozoite antibodies declined from 199.9 to 7.3 EU/mL from one to 12 months post dose three of RTS, S/AS02(D), remaining 15-fold higher than in the control group. Vaccine efficacy against clinical malaria was 33% (95% CI: -4.3-56.9, p = 0.076) over 14 months of follow-up. The hazard rate of disease per 2-fold increase in anti-CS titters was reduced by 84% (95% CI 35.1-88.2, p = 0.003). Conclusion: The RTS,S/AS02(D) malaria vaccine administered to young infants has a good safety profile and remains efficacious over 14 months. A strong association between anti-CS antibodies and risk of clinical malaria has been described for the first time. The results also suggest a decrease of both anti-CS antibodies and vaccine efficacy over time.	[Aide, Pedro; Aponte, John J.; Renom, Montse; Nhampossa, Tacilta; Sacarlal, Jahit; Mandomando, Inacio; Bassat, Quique; Manaca, Maria Nelia; Alonso, Pedro L.] Ctr Invest Saude Manhica CISM, Maputo, Mozambique; [Aponte, John J.; Renom, Montse; Bassat, Quique; Alonso, Pedro L.] Univ Barcelona, Hosp Clin, Barcelona Ctr Int Hlth Res, Barcelona, Spain; [Aide, Pedro; Nhampossa, Tacilta; Mandomando, Inacio] Minist Saude, Inst Nacl Saude, Maputo, Mozambique; [Sacarlal, Jahit] Univ Eduardo Mondlane, Fac Med, Maputo, Mozambique; [Leach, Amanda; Lievens, Marc; Vekemans, Johan; Dubois, Marie-Claude; Ballou, W. Ripley; Cohen, Joe] Glaxo SmithKline Biol, Rixensart, Belgium; [Loucq, Christian] PATH Malaria Vaccine Initiat, Bethesda, MD USA	Centro de Investigacao em Saude de Manhica; ISGlobal; CRESIB; University of Barcelona; Hospital Clinic de Barcelona; Eduardo Mondlane University; GlaxoSmithKline	Aide, P (corresponding author), Ctr Invest Saude Manhica CISM, Maputo, Mozambique.	pedro.aide@manhica.net	Leach, Amanda/AAS-1120-2020; Mandomando, Inacio/ABD-8007-2020; Alonso, Pedro L/AAZ-3645-2020; Sacarlal, Jahit/R-3172-2016; Bassat, Quique/P-2341-2016; Aide, Pedro/D-8771-2018	Leach, Amanda/0000-0002-7114-9967; Mandomando, Inacio/0000-0002-1078-2187; Alonso, Pedro L/0000-0003-3292-3443; Sacarlal, Jahit/0000-0003-1059-217X; Bassat, Quique/0000-0003-0875-7596; 	PATH Malaria Vaccine Initiative (MVI); Bill & Melinda Gates Foundation; Spanish Agency for International Cooperation (AECI)	PATH Malaria Vaccine Initiative (MVI); Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); Spanish Agency for International Cooperation (AECI)	GlaxoSmithKline and Centro de Investigacao em Saude de Manhica both received financial support from the PATH Malaria Vaccine Initiative (MVI), which was involved in all aspects of the study design and interpretation. MVI funded this work through a grant from the Bill & Melinda Gates Foundation. Core funding for CISM is provided by the Spanish Agency for International Cooperation (AECI). The funders had no role in data collection and analysis, decision to publish, or preparation of the manuscript.	ABDULLA S, 2008, N ENGL J MED; Alonso PL, 2005, LANCET, V366, P2012, DOI 10.1016/S0140-6736(05)67669-6; Alonso PL, 2004, LANCET, V364, P1411, DOI 10.1016/S0140-6736(04)17223-1; [Anonymous], 2008, INT C HARM TECHN REQ; [Anonymous], 2008, WORLD MAL REP 2008; APONTE JJ, 2009, LANCET; Aponte JJ, 2007, LANCET, V370, P1543, DOI 10.1016/S0140-6736(07)61542-6; BEJON P, 2008, N ENGL J MED; Bojang KA, 2001, LANCET, V358, P1927, DOI 10.1016/S0140-6736(01)06957-4; Cambron P, 2009, CLIN VACCINE IMMUNOL, V16, P1236, DOI 10.1128/CVI.00431-08; Guinovart C, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-36; Guinovart C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005165; Hutton G, 2006, AM J TROP MED HYG, V75, P119, DOI 10.4269/ajtmh.2006.75.119; Macete E, 2007, TROP MED INT HEALTH, V12, P37, DOI 10.1111/j.1365-3156.2006.01754.x; Nhacolo AQ, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-291; Sacarlal J, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-67; Sacarlal J, 2009, J INFECT DIS, V200, P329, DOI 10.1086/600119; Saute F, 2003, T ROY SOC TROP MED H, V97, P661, DOI 10.1016/S0035-9203(03)80098-6; Schellenberg D, 2001, LANCET, V357, P1471, DOI 10.1016/S0140-6736(00)04643-2; Stoute JA, 1997, NEW ENGL J MED, V336, P86, DOI 10.1056/NEJM199701093360202	20	32	34	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2010	5	11							e13838	10.1371/journal.pone.0013838	http://dx.doi.org/10.1371/journal.pone.0013838			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675NY	21079803	Green Submitted, Green Published, gold			2022-12-27	WOS:000283838600013
J	Zhang, J				Zhang, Jun			Ancestral Informative Marker Selection and Population Structure Visualization Using Sparse Laplacian Eigenfunctions	PLOS ONE			English	Article							MISSPECIFIED RELATIONSHIPS; ADMIXTURE; STRATIFICATION; DIVERSITY; INFERENCE; SAMPLES; MODEL	Identification of a small panel of population structure informative markers can reduce genotyping cost and is useful in various applications, such as ancestry inference in association mapping, forensics and evolutionary theory in population genetics. Traditional methods to ascertain ancestral informative markers usually require the prior knowledge of individual ancestry and have difficulty for admixed populations. Recently Principal Components Analysis (PCA) has been employed with success to select SNPs which are highly correlated with top significant principal components (PCs) without use of individual ancestral information. The approach is also applicable to admixed populations. Here we propose a novel approach based on our recent result on summarizing population structure by graph Laplacian eigenfunctions, which differs from PCA in that it is geometric and robust to outliers. Our approach also takes advantage of the priori sparseness of informative markers in the genome. Through simulation of a ring population and the real global population sample HGDP of 650K SNPs genotyped in 940 unrelated individuals, we validate the proposed algorithm at selecting most informative markers, a small fraction of which can recover the similar underlying population structure efficiently. Employing a standard Support Vector Machine (SVM) to predict individuals' continental memberships on HGDP dataset of seven continents, we demonstrate that the selected SNPs by our method are more informative but less redundant than those selected by PCA. Our algorithm is a promising tool in genome-wide association studies and population genetics, facilitating the selection of structure informative markers, efficient detection of population substructure and ancestral inference.	Univ Chicago, Dept Radiol, Chicago, IL 60637 USA	University of Chicago	Zhang, J (corresponding author), Univ Chicago, Dept Radiol, Chicago, IL 60637 USA.	junzhang@galton.uchicago.edu	zhang, jun/B-5061-2012					Bauchet M, 2007, AM J HUM GENET, V80, P948, DOI 10.1086/513477; BELKIN M, 2002, P ADV NEURAL INFORM, V14; Candes EJ, 2008, IEEE SIGNAL PROC MAG, V25, P21, DOI 10.1109/MSP.2007.914731; CAVALLISFORZA L, 1965, GENETICS TODAY, V3; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chen HS, 2003, ANN HUM GENET, V67, P250, DOI 10.1046/j.1469-1809.2003.00036.x; Chung, 1997, SPECTRAL GRAPH THEOR, DOI DOI 10.1090/CBMS/092; Collins-Schramm HE, 2002, AM J HUM GENET, V70, P737, DOI 10.1086/339368; Coop G, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000500; Donoho DL, 2006, IEEE T INFORM THEORY, V52, P1289, DOI 10.1109/TIT.2006.871582; Hudson RR, 2002, BIOINFORMATICS, V18, P337, DOI 10.1093/bioinformatics/18.2.337; Lao O, 2006, AM J HUM GENET, V78, P680, DOI 10.1086/501531; LEE A, 2009, GENETIC EPIDEMIOLOGY, V33; MANTEL N, 1967, CANCER RES, V27, P209; McPeek MS, 2000, AM J HUM GENET, V66, P1076, DOI 10.1086/302800; MENOZZI P, 1978, SCIENCE, V201, P786, DOI 10.1126/science.356262; Novembre J, 2008, NATURE, V456, P98, DOI 10.1038/nature07331; Parra EJ, 1998, AM J HUM GENET, V63, P1839, DOI 10.1086/302148; Paschou P, 2007, PLOS GENET, V3, P1672, DOI 10.1371/journal.pgen.0030160; Paschou P, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000114; Price AL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0030236; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pritchard JK, 2000, GENETICS, V155, P945; Rosenberg NA, 2003, AM J HUM GENET, V73, P1402, DOI 10.1086/380416; Rosenberg NA, 2006, ANN HUM GENET, V70, P841, DOI 10.1111/j.1469-1809.2006.00285.x; SHAMEEK B, 2009, AM J HUM GENET, V84, P641; Shawe-Taylor J, 2004, KERNEL METHODS PATTE; Sun L, 2002, HUM HERED, V54, P99, DOI 10.1159/000067666; Sun L, 2001, GENET EPIDEMIOL, V21, pS36, DOI 10.1002/gepi.2001.21.s1.s36; Tang H, 2005, GENET EPIDEMIOL, V28, P289, DOI 10.1002/gepi.20064; Tian C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040004; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Vapnik V., 1998, STAT LEARNING THEORY, V3, DOI DOI 10.1007/978-1-4419-1428-6_5864; von Luxburg U, 2007, STAT COMPUT, V17, P395, DOI 10.1007/s11222-007-9033-z; Zhang J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006274; Zhang Jun, 2009, BMC Proc, V3 Suppl 7, pS110; Zhu XF, 2002, GENET EPIDEMIOL, V23, P181, DOI 10.1002/gepi.210; Zou H, 2006, J COMPUT GRAPH STAT, V15, P265, DOI 10.1198/106186006X113430	39	7	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2010	5	11							e13734	10.1371/journal.pone.0013734	http://dx.doi.org/10.1371/journal.pone.0013734			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675NY	21079796	Green Published, gold, Green Submitted			2022-12-27	WOS:000283838600005
J	Wang, GH; Wang, YD; Shen, CY; Huang, YW; Huang, K; Huang, THM; Nephew, KP; Li, L; Liu, YL				Wang, Guohua; Wang, Yadong; Shen, Changyu; Huang, Yi-wen; Huang, Kun; Huang, Tim H. M.; Nephew, Kenneth P.; Li, Lang; Liu, Yunlong			RNA Polymerase II Binding Patterns Reveal Genomic Regions Involved in MicroRNA Gene Regulation	PLOS ONE			English	Article							BREAST-CANCER CELLS; CHROMATIN IMMUNOPRECIPITATION; NUCLEAR EXPORT; EXPRESSION; MIRNA; TRANSCRIPTION; BIOGENESIS; PRECURSORS; PROMOTERS; ENHANCERS	MicroRNAs are small non-coding RNAs involved in post-transcriptional regulation of gene expression. Due to the poor annotation of primary microRNA (pri-microRNA) transcripts, the precise location of promoter regions driving expression of many microRNA genes is enigmatic. This deficiency hinders our understanding of microRNA-mediated regulatory networks. In this study, we develop a computational approach to identify the promoter region and transcription start site (TSS) of pri-microRNAs actively transcribed using genome-wide RNA Polymerase II (RPol II) binding patterns derived from ChIP-seq data. Based upon the assumption that the distribution of RPol II binding patterns around the TSS of microRNA and protein coding genes are similar, we designed a statistical model to mimic RPol II binding patterns around the TSS of highly expressed, well-annotated promoter regions of protein coding genes. We used this model to systematically scan the regions upstream of all intergenic microRNAs for RPol II binding patterns similar to those of TSS from protein coding genes. We validated our findings by examining the conservation, CpG content, and activating histone marks in the identified promoter regions. We applied our model to assess changes in microRNA transcription in steroid hormone-treated breast cancer cells. The results demonstrate many microRNA genes have lost hormone-dependent regulation in tamoxifen-resistant breast cancer cells. MicroRNA promoter identification based upon RPol II binding patterns provides important temporal and spatial measurements regarding the initiation of transcription, and therefore allows comparison of transcription activities between different conditions, such as normal and disease states.	[Wang, Guohua; Shen, Changyu; Li, Lang; Liu, Yunlong] Indiana Univ, Sch Med, Ctr Computat Biol & Bioinformat, Indianapolis, IN 46204 USA; [Wang, Guohua; Wang, Yadong] Harbin Inst Technol, Sch Comp Sci & Technol, Harbin 150006, Peoples R China; [Wang, Guohua; Shen, Changyu; Li, Lang; Liu, Yunlong] Indiana Univ, Sch Med, Div Biostat, Indianapolis, IN USA; [Huang, Yi-wen; Huang, Tim H. M.] Ohio State Univ, Div Human Canc Genet, Columbus, OH 43210 USA; [Huang, Yi-wen; Huang, Tim H. M.] Ohio State Univ, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA; [Huang, Yi-wen; Huang, Kun; Huang, Tim H. M.] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA; [Huang, Kun] Ohio State Univ, Dept Biomed Informat, Columbus, OH 43210 USA; [Nephew, Kenneth P.] Indiana Univ, Sch Med, Bloomington, IN USA; [Nephew, Kenneth P.] Indiana Univ, Sch Med, Dept Cellular & Integrat Physiol, Indianapolis, IN USA; [Nephew, Kenneth P.; Li, Lang] Indiana Univ, Sch Med, Simon Canc Ctr, Indianapolis, IN USA; [Li, Lang; Liu, Yunlong] Indiana Univ, Sch Med, Dept Med & Mol Genet, Indianapolis, IN 46202 USA; [Liu, Yunlong] Indiana Univ, Sch Med, Ctr Med Genom, Indianapolis, IN USA	Indiana University System; Indiana University-Purdue University Indianapolis; Harbin Institute of Technology; Indiana University System; Indiana University-Purdue University Indianapolis; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis	Wang, GH (corresponding author), Indiana Univ, Sch Med, Ctr Computat Biol & Bioinformat, Indianapolis, IN 46204 USA.	yunliu@iupui.edu	Huang, Kun/E-3272-2011; Wang, Guohua/GLR-7939-2022		United States National Institutes of Health [AA017941, CA113001, GM088076, GM085121]; China 863 High-Tech Program [2007AA02Z302]; China Natural Science Foundation [60901075]; NATIONAL CANCER INSTITUTE [U54CA113001] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085121, R01GM088076] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R21AA017941] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); China 863 High-Tech Program(National High Technology Research and Development Program of China); China Natural Science Foundation(National Natural Science Foundation of China (NSFC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work is supported by United States National Institutes of Health grants AA017941 (Y.L.), CA113001 (T. H-M. H. and K.P.N), GM088076 (Y.L. and L. L.), GM085121 (Y.L.), China 863 High-Tech Program 2007AA02Z302 (Y.L.), and China Natural Science Foundation 60901075 (G. W.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bhat-Nakshatri P, 2009, NUCLEIC ACIDS RES, V37, P4850, DOI 10.1093/nar/gkp500; Borchert GM, 2006, NAT STRUCT MOL BIOL, V13, P1097, DOI 10.1038/nsmb1167; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Carrington JC, 2003, SCIENCE, V301, P336, DOI 10.1126/science.1085242; Cheng AM, 2005, NUCLEIC ACIDS RES, V33, P1290, DOI 10.1093/nar/gki200; Corcoran DL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005279; Cullen BR, 2004, MOL CELL, V16, P861, DOI 10.1016/j.molcel.2004.12.002; Davuluri RV, 2008, TRENDS GENET, V24, P167, DOI 10.1016/j.tig.2008.01.008; Fan MY, 2006, CANCER RES, V66, P11954, DOI 10.1158/0008-5472.CAN-06-1666; Feng WX, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S2-S23; Fujita S, 2008, BIOINFORMATICS, V24, P303, DOI 10.1093/bioinformatics/btm589; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Gu J, 2006, MAMM GENOME, V17, P1033, DOI 10.1007/s00335-006-0007-9; He HSHS, 2010, NAT GENET, V42, P343, DOI 10.1038/ng.545; He SM, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-236; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Karolchik D, 2008, NUCLEIC ACIDS RES, V36, pD773, DOI 10.1093/nar/gkm966; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Krichevsky AM, 2003, RNA, V9, P1274, DOI 10.1261/rna.5980303; Lai EC, 2002, NAT GENET, V30, P363, DOI 10.1038/ng865; Lee R, 2004, CELL, V116, pS96; Lee Rosalind, 2004, Cell, VS116, pS89, DOI 10.1016/S0092-8674(04)00035-2; Lee TI, 2006, NAT PROTOC, V1, P729, DOI 10.1038/nprot.2006.98; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Lee Y, 2002, EMBO J, V21, P4663, DOI 10.1093/emboj/cdf476; Lund E, 2004, SCIENCE, V303, P95, DOI 10.1126/science.1090599; Mardis ER, 2008, TRENDS GENET, V24, P133, DOI 10.1016/j.tig.2007.12.007; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Ozsolak F, 2008, GENE DEV, V22, P3172, DOI 10.1101/gad.1706508; Robertson G, 2007, NAT METHODS, V4, P651, DOI 10.1038/NMETH1068; Rodriguez A, 2004, GENOME RES, V14, P1902, DOI 10.1101/gr.2722704; Rozowsky J, 2009, NAT BIOTECHNOL, V27, P66, DOI 10.1038/nbt.1518; Saini HK, 2007, P NATL ACAD SCI USA, V104, P17719, DOI 10.1073/pnas.0703890104; Trinklein ND, 2004, GENOME RES, V14, P62, DOI 10.1101/gr.1982804; Wang XW, 2009, GENOME RES, V19, P266, DOI 10.1101/gr.081638.108; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519; Yi R, 2003, GENE DEV, V17, P3011, DOI 10.1101/gad.1158803; Zhou XF, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100143	43	44	48	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2010	5	11							e13798	10.1371/journal.pone.0013798	http://dx.doi.org/10.1371/journal.pone.0013798			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	674VY	21072189	Green Published, gold, Green Submitted			2022-12-27	WOS:000283779700010
J	Castellano-Munoz, M; Israel, SH; Hudspeth, AJ				Castellano-Munoz, Manuel; Israel, Samuel H.; Hudspeth, A. J.			Efferent Control of the Electrical and Mechanical Properties of Hair Cells in the Bullfrog's Sacculus	PLOS ONE			English	Article							FROG SACCULUS; POTASSIUM CURRENTS; ALLIGATOR COCHLEA; BASILAR PAPILLA; TURTLE COCHLEA; LATERAL-LINE; INNER-EAR; INHIBITION; SYNAPSE; SYSTEM	Background: Hair cells in the auditory, vestibular, and lateral-line systems respond to mechanical stimulation and transmit information to afferent nerve fibers. The sensitivity of mechanoelectrical transduction is modulated by the efferent pathway, whose activity usually reduces the responsiveness of hair cells. The basis of this effect remains unknown. Methodology and Principal Findings: We employed immunocytological, electrophysiological, and micromechanical approaches to characterize the anatomy of efferent innervation and the effect of efferent activity on the electrical and mechanical properties of hair cells in the bullfrog's sacculus. We found that efferent fibers form extensive synaptic terminals on all macular and extramacular hair cells. Macular hair cells expressing the Ca(2+)-buffering protein calretinin contain half as many synaptic ribbons and are innervated by twice as many efferent terminals as calretinin-negative hair cells. Efferent activity elicits inhibitory postsynaptic potentials in hair cells and thus inhibits their electrical resonance. In hair cells that exhibit spiking activity, efferent stimulation suppresses the generation of action potentials. Finally, efferent activity triggers a displacement of the hair bundle's resting position. Conclusions and Significance: The hair cells of the bullfrog's sacculus receive a rich efferent innervation with the heaviest projection to calretinin-containing cells. Stimulation of efferent axons desensitizes the hair cells and suppresses their spiking activity. Although efferent activation influences mechanoelectrical transduction, the mechanical effects on hair bundles are inconsistent.	[Castellano-Munoz, Manuel] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA; Rockefeller Univ, Lab Sensory Neurosci, New York, NY 10021 USA	Howard Hughes Medical Institute; Rockefeller University; Rockefeller University	Castellano-Munoz, M (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA.	hudspaj@rockefeller.edu			National Institutes of Health [DC000241]; Spanish Ministry of Education and Science [EX-2006-1539]; Rockefeller University; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC000241, F32DC000241] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Spanish Ministry of Education and Science(Spanish Government); Rockefeller University; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This project was supported by National Institutes of Health grant DC000241. M. C.-M. was supported by postdoctoral fellowship EX-2006-1539 from the Spanish Ministry of Education and Science and S. H. I. by the Bard-Rockefeller Semester in Science Program and the Rockefeller University Summer Undergraduate Research Fellowship Program. A.J.H. is an Investigator of Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLBRITTON NL, 1992, SCIENCE, V258, P1812, DOI 10.1126/science.1465619; ART JJ, 1984, J PHYSIOL-LONDON, V356, P525, DOI 10.1113/jphysiol.1984.sp015481; ART JJ, 1987, J PHYSIOL-LONDON, V385, P207, DOI 10.1113/jphysiol.1987.sp016492; ART JJ, 1982, PROC R SOC SER B-BIO, V216, P377, DOI 10.1098/rspb.1982.0081; ART JJ, 1984, J PHYSIOL-LONDON, V356, P507, DOI 10.1113/jphysiol.1984.sp015480; ASHMORE JF, 1982, J PHYSIOL-LONDON, V329, pP25; ASHMORE JF, 1983, NATURE, V304, P536, DOI 10.1038/304536a0; Chabbert CH, 1997, PFLUG ARCH EUR J PHY, V435, P82, DOI 10.1007/s004240050486; Chiappe ME, 2007, J NEUROSCI, V27, P11978, DOI 10.1523/JNEUROSCI.3679-07.2007; Cooper NP, 2006, J PHYSIOL-LONDON, V576, P49, DOI 10.1113/jphysiol.2006.114991; CORWIN JT, 1985, P NATL ACAD SCI USA, V82, P3911, DOI 10.1073/pnas.82.11.3911; Edmonds B, 2000, NAT NEUROSCI, V3, P786, DOI 10.1038/77687; EVANS MG, 1987, BIOPHYS J, V52, P649, DOI 10.1016/S0006-3495(87)83256-3; FLOCK A, 1973, J PHYSIOL-LONDON, V235, P591, DOI 10.1113/jphysiol.1973.sp010406; FUCHS PA, 1990, P ROY SOC B-BIOL SCI, V241, P122, DOI 10.1098/rspb.1990.0075; FUCHS PA, 1988, J COMP PHYSIOL A, V164, P151, DOI 10.1007/BF00603947; FUCHS PA, 2006, VERTEBRATE HAIR CELL; FURUKAWA T, 1981, J PHYSIOL-LONDON, V315, P203, DOI 10.1113/jphysiol.1981.sp013742; Gale JE, 2000, JARO-J ASSOC RES OTO, V1, P172, DOI 10.1007/s101620010037; Glowatzki E, 2000, SCIENCE, V288, P2366, DOI 10.1126/science.288.5475.2366; Goutman JD, 2005, J PHYSIOL-LONDON, V566, P49, DOI 10.1113/jphysiol.2005.087460; Habets RLP, 2006, J NEUROPHYSIOL, V96, P2868, DOI 10.1152/jn.00427.2006; Heller S, 2002, JARO, V3, P488, DOI 10.1007/s10162-002-2050-x; Hellmann B, 1996, BRAIN BEHAV EVOLUT, V47, P185, DOI 10.1159/000113238; HIGHSTEIN SM, 1991, NEUROSCI RES, V12, P13, DOI 10.1016/0168-0102(91)90096-H; Holt JC, 2006, J NEUROSCI, V26, P13180, DOI 10.1523/JNEUROSCI.3539-06.2006; Hudspeth AJ, 2008, NEURON, V59, P530, DOI 10.1016/j.neuron.2008.07.012; HUDSPETH AJ, 1977, P NATL ACAD SCI USA, V74, P2407, DOI 10.1073/pnas.74.6.2407; HUDSPETH AJ, 1978, AM J PHYSIOL, V234, pC56, DOI 10.1152/ajpcell.1978.234.1.C56; JACOBS RA, 1990, COLD SPRING HARB SYM, V55, P547; Kao HT, 1999, J EXP ZOOL, V285, P360, DOI 10.1002/(SICI)1097-010X(19991215)285:4<360::AID-JEZ4>3.3.CO;2-V; Kong JH, 2008, J PHYSIOL-LONDON, V586, P5471, DOI 10.1113/jphysiol.2008.160077; LEWIS ER, 1982, SCIENCE, V215, P1641, DOI 10.1126/science.6978525; Li GL, 2009, J NEUROSCI, V29, P7558, DOI 10.1523/JNEUROSCI.0514-09.2009; Lioudyno M, 2004, J NEUROSCI, V24, P11160, DOI 10.1523/JNEUROSCI.3674-04.2004; LLINAS R, 1969, EXP BRAIN RES, V9, P16; Marcotti W, 2003, J PHYSIOL-LONDON, V548, P383, DOI 10.1113/jphysiol.2002.034801; Martin P, 2003, J NEUROSCI, V23, P4533; Masetto S, 2003, J NEUROPHYSIOL, V90, P1266, DOI 10.1152/jn.01157.2002; PRIGIONI I, 1983, BRAIN RES, V269, P83, DOI 10.1016/0006-8993(83)90964-2; Ricci AJ, 2002, J NEUROSCI, V22, P44, DOI 10.1523/JNEUROSCI.22-01-00044.2002; Rutherford MA, 2009, J NEUROSCI, V29, P10025, DOI 10.1523/JNEUROSCI.1798-09.2009; Safieddine S, 1999, EUR J NEUROSCI, V11, P803, DOI 10.1046/j.1460-9568.1999.00487.x; STRUTZ J, 1984, BRAIN RES, V299, P174, DOI 10.1016/0006-8993(84)90803-5; SUGAI T, 1991, JPN J PHYSIOL, V41, P217, DOI 10.2170/jjphysiol.41.217; SUGAI T, 1992, HEARING RES, V61, P56, DOI 10.1016/0378-5955(92)90036-M; SUGIHARA I, 1989, J NEUROPHYSIOL, V62, P1330, DOI 10.1152/jn.1989.62.6.1330; Tank DW, 1995, J NEUROSCI, V15, P7940; Tinevez JY, 2007, BIOPHYS J, V93, P4053, DOI 10.1529/biophysj.107.108498; Zidanic M, 1996, AUDIT NEUROSCI, V2, P347	50	21	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2010	5	10							e13777	10.1371/journal.pone.0013777	http://dx.doi.org/10.1371/journal.pone.0013777			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673FU	21048944	gold, Green Published, Green Submitted			2022-12-27	WOS:000283645300051
J	Daneman, R; Zhou, L; Agalliu, D; Cahoy, JD; Kaushal, A; Barres, BA				Daneman, Richard; Zhou, Lu; Agalliu, Dritan; Cahoy, John D.; Kaushal, Amit; Barres, Ben A.			The Mouse Blood-Brain Barrier Transcriptome: A New Resource for Understanding the Development and Function of Brain Endothelial Cells	PLOS ONE			English	Article							TIGHT-JUNCTION PROTEIN; VASCULAR DEVELOPMENT; PHENOTYPIC HETEROGENEITY; PROGENITOR CELLS; GLIAL-CELLS; EXPRESSION; MICE; ANGIOGENESIS; PERMEABILITY; GENOMICS	The blood-brain barrier (BBB) maintains brain homeostasis and limits the entry of toxins and pathogens into the brain. Despite its importance, little is known about the molecular mechanisms regulating the development and function of this crucial barrier. In this study we have developed methods to highly purify and gene profile endothelial cells from different tissues, and by comparing the transcriptional profile of brain endothelial cells with those purified from the liver and lung, we have generated a comprehensive resource of transcripts that are enriched in the BBB forming endothelial cells of the brain. Through this comparison we have identified novel tight junction proteins, transporters, metabolic enzymes, signaling components, and unknown transcripts whose expression is enriched in central nervous system (CNS) endothelial cells. This analysis has identified that RXRalpha signaling cascade is specifically enriched at the BBB, implicating this pathway in regulating this vital barrier. This dataset provides a resource for understanding CNS endothelial cells and their interaction with neural and hematogenous cells.	[Daneman, Richard] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; [Zhou, Lu; Agalliu, Dritan; Barres, Ben A.] Stanford Univ, Dept Neurobiol, Sch Med, Stanford, CA 94305 USA; [Cahoy, John D.] Stanford Univ, Dept Dev Biol, Sch Med, Stanford, CA 94305 USA; [Kaushal, Amit] Stanford Univ, Sch Med, Dept Biomed Informat, Stanford, CA 94305 USA	University of California System; University of California San Francisco; Stanford University; Stanford University; Stanford University	Daneman, R (corresponding author), Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA.	richard.daneman@ucsf.edu		Kaushal, Amit/0000-0003-0831-4365	National Institute of Neurological Disease [R01 NS045621]; Myelin Repair Foundation; National Multiple Sclerosis Society [RG3936A7]; American Heart Association; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045621] Funding Source: NIH RePORTER	National Institute of Neurological Disease; Myelin Repair Foundation; National Multiple Sclerosis Society(National Multiple Sclerosis Society); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institute of Neurological Disease (R01 NS045621; B. A. B.), http://www.ninds.nih.gov/; the Myelin Repair Foundation (B. A. B, R. D.), http://www.myelinrepair.org/; the National Multiple Sclerosis Society RG3936A7 (B. A. B.), http://www.nationalmssociety.org/index.aspx; and the American Heart Association Graduate Fellowship (R. D.), http://www.americanheart.org/presenter.jhtml?identifier = 1200000. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Aird WC, 2007, CIRC RES, V100, P158, DOI 10.1161/01.RES.0000255691.76142.4a; Aird WC, 2007, CIRC RES, V100, P174, DOI 10.1161/01.RES.0000255690.03436.ae; Ballabh P, 2004, NEUROBIOL DIS, V16, P1, DOI 10.1016/j.nbd.2003.12.016; Bertolini F, 2006, NAT REV CANCER, V6, P833, DOI 10.1039/nrc1971; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Calabria AR, 2006, DRUG DISCOV TODAY, V11, P792, DOI 10.1016/j.drudis.2006.07.006; Cornford Eain M, 2005, NeuroRx, V2, P27, DOI 10.1007/BF03206640; Daneman R, 2009, P NATL ACAD SCI USA, V106, P641, DOI 10.1073/pnas.0805165106; ElHafny B, 1997, NEUROSCI LETT, V236, P107, DOI 10.1016/S0304-3940(97)00679-4; Enerson BE, 2006, J CEREBR BLOOD F MET, V26, P959, DOI 10.1038/sj.jcbfm.9600249; Gloor SM, 2001, BRAIN RES REV, V36, P258, DOI 10.1016/S0165-0173(01)00102-3; Gu CH, 2003, DEV CELL, V5, P45, DOI 10.1016/S1534-5807(03)00169-2; Gu CH, 2005, SCIENCE, V307, P265, DOI 10.1126/science.1105416; Hawkins BT, 2004, BRAIN RES, V1027, P48, DOI 10.1016/j.brainres.2004.08.043; Hirase T, 1997, J CELL SCI, V110, P1603; Hoffman LM, 2006, J CELL BIOL, V172, P771, DOI 10.1083/jcb.200512115; HUETTNER JE, 1986, J NEUROSCI, V6, P3044; IDA JA, 1993, J NEUROSCI RES, V36, P596, DOI 10.1002/jnr.490360512; Ikenouchi J, 2005, J CELL BIOL, V171, P939, DOI 10.1083/jcb.200510043; JANZER RC, 1987, NATURE, V325, P253, DOI 10.1038/325253a0; Kioka N, 2002, CELL STRUCT FUNCT, V27, P1, DOI 10.1247/csf.27.1; LECHARDEUR D, 1995, EXP CELL RES, V220, P161, DOI 10.1006/excr.1995.1302; Lee SW, 2003, NAT MED, V9, P900, DOI 10.1038/nm889; Li JY, 2002, J CEREBR BLOOD F MET, V22, P1319, DOI 10.1097/01.WCB.0000040944.89393.0f; Li JY, 2001, J CEREBR BLOOD F MET, V21, P61, DOI 10.1097/00004647-200101000-00008; Liebner S, 2008, J CELL BIOL, V183, P409, DOI 10.1083/jcb.200806024; Lindahl P, 1998, CURR OPIN LIPIDOL, V9, P407, DOI 10.1097/00041433-199810000-00004; Lindahl P, 1997, SCIENCE, V277, P242, DOI 10.1126/science.277.5323.242; Macara AG, 2004, CURR BIOL, V14, pR160, DOI 10.1016/j.cub.2004.01.048; Macdonald JA, 2010, J NEUROSCI RES, V88, P1457, DOI 10.1002/jnr.22316; Maysami S, 2006, NEUROREPORT, V17, P1187, DOI 10.1097/01.wnr.0000227985.92551.9a; Morita K, 1999, J CELL BIOL, V147, P185, DOI 10.1083/jcb.147.1.185; Motoike T, 2000, GENESIS, V28, P75, DOI 10.1002/1526-968X(200010)28:2<75::AID-GENE50>3.0.CO;2-S; Nitta T, 2003, J CELL BIOL, V161, P653, DOI 10.1083/jcb.200302070; Noonan Douglas M., 2007, V174, P219; Ohnishi H, 2004, J BIOL CHEM, V279, P46014, DOI 10.1074/jbc.M402616200; Pardridge WM, 2007, DRUG DISCOV TODAY, V12, P54, DOI 10.1016/j.drudis.2006.10.013; PRINGLE NP, 1992, DEVELOPMENT, V115, P535; Proctor JM, 2005, J NEUROSCI, V25, P9940, DOI 10.1523/JNEUROSCI.3467-05.2005; Riazuddin S, 2006, AM J HUM GENET, V79, P1040, DOI 10.1086/510022; Rubin LL, 1999, ANNU REV NEUROSCI, V22, P11, DOI 10.1146/annurev.neuro.22.1.11; RUBIN LL, 1991, J CELL BIOL, V115, P1725, DOI 10.1083/jcb.115.6.1725; Saitou M, 2000, MOL BIOL CELL, V11, P4131, DOI 10.1091/mbc.11.12.4131; SAWADA M, 1993, NEUROSCI LETT, V160, P131, DOI 10.1016/0304-3940(93)90396-3; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Shen Q, 2004, SCIENCE, V304, P1338, DOI 10.1126/science.1095505; Srinivasan K, 2003, DEV CELL, V4, P371, DOI 10.1016/S1534-5807(03)00054-6; Stenman JM, 2008, SCIENCE, V322, P1247, DOI 10.1126/science.1164594; STEWART PA, 1981, DEV BIOL, V84, P183, DOI 10.1016/0012-1606(81)90382-1; Suzuki A, 2006, J CELL SCI, V119, P979, DOI 10.1242/jcs.02898; Ueno M, 2007, CURR MED CHEM, V14, P1199, DOI 10.2174/092986707780597943; Wang YW, 2005, J LIPID RES, V46, P2377, DOI 10.1194/jlr.M500134-JLR200; Weidenfeller C, 2007, J NEUROCHEM, V101, P555, DOI 10.1111/j.1471-4159.2006.04394.x; Zhang M, 2006, EMBO J, V25, P5284, DOI 10.1038/sj.emboj.7601406; Zhang YJ, 2002, J BIOL CHEM, V277, P38328, DOI 10.1074/jbc.M205576200; Zlokovic BV, 2008, NEURON, V57, P178, DOI 10.1016/j.neuron.2008.01.003	57	375	392	3	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2010	5	10							e13741	10.1371/journal.pone.0013741	http://dx.doi.org/10.1371/journal.pone.0013741			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673FU	21060791	Green Published, gold, Green Submitted			2022-12-27	WOS:000283645300021
J	Osanai, M; Tanaka, S; Takeno, Y; Takimoto, S; Yagi, T				Osanai, Makoto; Tanaka, Satoshi; Takeno, Yusuke; Takimoto, Shouta; Yagi, Tetsuya			Spatiotemporal Properties of the Action Potential Propagation in the Mouse Visual Cortical Slice Analyzed by Calcium Imaging	PLOS ONE			English	Article							IN-VITRO; ORIENTATION SELECTIVITY; INTRINSIC CONNECTIONS; SYNAPTIC ACTIVITY; CORTEX; RAT; NEURONS; CAT; EXCITATION; MICROCIRCUITRY	The calcium ion (Ca2+) is an important messenger for signal transduction, and the intracellular Ca2+ concentration ([Ca2+]i) changes in response to an excitation of the cell. To reveal the spatiotemporal properties of the propagation of an excitatory signal with action potentials in the primary visual cortical circuit, we conducted a Ca2+ imaging study on slices of the mouse visual cortex. Electrical stimulation of layer 4 evoked [Ca2+]i transients around the stimulus electrode. Subsequently, the high [Ca2+]i region mainly propagated perpendicular to the cortical layer (vertical propagation), with horizontal propagation being restricted. When the excitatory synaptic transmission was blocked, only weak and concentric [Ca2+]i transients were observed. When the action potential was blocked, the [Ca2+]i transients disappeared almost completely. These results suggested that the action potential contributed to the induction of the [Ca2+]i transients, and that excitatory synaptic connections were involved in the propagation of the high [Ca2+]i region in the primary visual cortical circuit. To elucidate the involvement of inhibitory synaptic connections in signal propagation in the primary visual cortex, the GABA(A) receptor inhibitor bicuculline was applied. In this case, the evoked signal propagated from layer 4 to the entire field of view, and the prolonged [Ca2+]i transients were observed compared with the control condition. Our results suggest that excitatory neurons are widely connected to each other over the entire primary visual cortex with recurrent synapses, and inhibitory neurons play a fundamental role in the organization of functional sub-networks by restricting the propagation of excitation signals.	[Osanai, Makoto; Tanaka, Satoshi; Takeno, Yusuke; Takimoto, Shouta; Yagi, Tetsuya] Osaka Univ, Grad Sch Engn, Div Elect Elect & Informat Engn, Suita, Osaka, Japan	Osaka University	Osanai, M (corresponding author), Tohoku Univ, Dept Radiol Imaging & Informat, Grad Sch Med, Sendai, Miyagi 980, Japan.	yagi@eei.eng.osaka-u.ac.jp	Osanai, Makoto/B-7048-2009	Osanai, Makoto/0000-0002-3572-8195	Japan Society for the Promotion of Science [19300105, 19206041]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Grant-in-Aid for Scientific Research (KAKENHI) (B) (19300105) to MO and KAKENHI (A) (19206041) to TY from Japan Society for the Promotion of Science (http://www.jsps.go.jp/english/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBOWITZ B, 1993, EUR J NEUROSCI, V5, P1349, DOI 10.1111/j.1460-9568.1993.tb00921.x; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Berridge MJ, 1998, NEURON, V21, P13, DOI 10.1016/S0896-6273(00)80510-3; BURKHALTER A, 1989, J COMP NEUROL, V279, P171, DOI 10.1002/cne.902790202; Contreras D, 2001, J NEUROSCI, V21, P9403, DOI 10.1523/JNEUROSCI.21-23-09403.2001; Deisz RA, 1997, SYNAPSE, V25, P62, DOI 10.1002/(SICI)1098-2396(199701)25:1<62::AID-SYN8>3.0.CO;2-D; Domenici L, 1995, J NEUROPHYSIOL, V74, P2649, DOI 10.1152/jn.1995.74.6.2649; DOUGLAS RJ, 1995, SCIENCE, V269, P981, DOI 10.1126/science.7638624; FRIAUF E, 1991, J NEUROPHYSIOL, V66, P2059, DOI 10.1152/jn.1991.66.6.2059; Fukuda M, 1998, NEUROSCI RES, V31, P9, DOI 10.1016/S0168-0102(98)00018-2; GILBERT CD, 1983, ANNU REV NEUROSCI, V6, P217, DOI 10.1146/annurev.ne.06.030183.001245; GILBERT CD, 1983, J NEUROSCI, V3, P1116; Gonchar Yuri, 2007, Front Neuroanat, V1, P3, DOI 10.3389/neuro.05.003.2007; Gordon JA, 1996, J NEUROSCI, V16, P3274; GRINVALD A, 1994, J NEUROSCI, V14, P2545; Hansel C, 1997, EUR J NEUROSCI, V9, P2309, DOI 10.1111/j.1460-9568.1997.tb01648.x; HATA Y, 1988, NATURE, V335, P815, DOI 10.1038/335815a0; Heistek TS, 2010, BRAIN RES, V1321, P31, DOI 10.1016/j.brainres.2010.01.047; HUBEL DH, 1968, J PHYSIOL-LONDON, V195, P215, DOI 10.1113/jphysiol.1968.sp008455; Ikegaya Y, 2005, NEUROSCI RES, V52, P132, DOI 10.1016/j.neures.2005.02.004; Janders M, 1997, P IEEE EMBS, V18, P245, DOI 10.1109/IEMBS.1996.656936; Jimbo Y, 1999, BIOPHYS J, V76, P670, DOI 10.1016/S0006-3495(99)77234-6; KENANVAKNIN G, 1994, BRAIN RES, V635, P37, DOI 10.1016/0006-8993(94)91421-4; Khawaled R, 1999, PFLUG ARCH EUR J PHY, V438, P314, DOI 10.1007/s004240050915; KOMATSU Y, 1994, NEUROSCI RES, V20, P209, DOI 10.1016/0168-0102(94)90089-2; Laaris N, 2000, J NEUROSCI, V20, P1529; MITZDORF U, 1985, PHYSIOL REV, V65, P37, DOI 10.1152/physrev.1985.65.1.37; Murayama M, 2005, EUR J NEUROSCI, V21, P3349, DOI 10.1111/j.1460-9568.2005.04167.x; Nicholls J., 2001, NEURON BRAIN; NICOLL RA, 1988, NEURON, V1, P97, DOI 10.1016/0896-6273(88)90193-6; Nowak LG, 1997, EXP BRAIN RES, V117, P219, DOI 10.1007/s002210050218; Oka H, 1999, J NEUROSCI METH, V93, P61, DOI 10.1016/S0165-0270(99)00113-2; OSANAI M, 2007, 2007 NEUR M PLANN SA; OSANAI M, 2008, P ISBPE 22 BPES, P153; Osanai M, 2006, NEUROSCI LETT, V402, P81, DOI 10.1016/j.neulet.2006.04.012; Petersen CCH, 2001, J NEUROSCI, V21, P8435, DOI 10.1523/JNEUROSCI.21-21-08435.2001; Sato H, 1996, J PHYSIOL-LONDON, V494, P757, DOI 10.1113/jphysiol.1996.sp021530; Shao ZW, 1999, J NEUROPHYSIOL, V81, P1014, DOI 10.1152/jn.1999.81.3.1014; SILLITO AM, 1975, J PHYSIOL-LONDON, V250, P305, DOI 10.1113/jphysiol.1975.sp011056; Smetters D, 1999, METHODS, V18, P215, DOI 10.1006/meth.1999.0774; STONE J, 1972, INVEST OPHTH VISUAL, V11, P338; TANAKA S, 2006, 2006 NEUR M PLANN AT; Tanifuji M, 1996, BRAIN RES, V738, P83, DOI 10.1016/0006-8993(96)00767-6; TANIFUJI M, 1994, SCIENCE, V266, P1057, DOI 10.1126/science.7973662; Thomson AM, 2002, CEREB CORTEX, V12, P936, DOI 10.1093/cercor/12.9.936; TSUMOTO T, 1979, EXP BRAIN RES, V34, P351; West AE, 2001, P NATL ACAD SCI USA, V98, P11024, DOI 10.1073/pnas.191352298; Yoshimura Y, 2005, NATURE, V433, P868, DOI 10.1038/nature03252; Yoshimura Y, 2005, NAT NEUROSCI, V8, P1552, DOI 10.1038/nn1565; Yuste R, 1997, CEREB CORTEX, V7, P546, DOI 10.1093/cercor/7.6.546; Zheng JQ, 2007, ANNU REV CELL DEV BI, V23, P375, DOI 10.1146/annurev.cellbio.23.090506.123221	51	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2010	5	10							e13738	10.1371/journal.pone.0013738	http://dx.doi.org/10.1371/journal.pone.0013738			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673FU	21060776	Green Published, Green Submitted, gold			2022-12-27	WOS:000283645300018
J	Poluch, S; Juliano, SL				Poluch, Sylvie; Juliano, Sharon L.			Populations of Radial Glial Cells Respond Differently to Reelin and Neuregulin1 in a Ferret Model of Cortical Dysplasia	PLOS ONE			English	Article							DEVELOPING CEREBRAL-CORTEX; LIPID-BINDING PROTEIN; APOE RECEPTOR 2; NEURONAL MIGRATION; ERBB RECEPTORS; SOMATOSENSORY CORTEX; NEURAL DEVELOPMENT; PROGENITOR CELLS; VISUAL-CORTEX; VLDL RECEPTOR	Radial glial cells play an essential role during corticogenesis through their function as neural precursors and guides of neuronal migration. Both reelin and neuregulin1 (NRG1) maintain the radial glial scaffold; they also induce expression of Brain Lipid Binding Protein (BLBP), a well known marker of radial glia. Although radial glia in normal ferrets express both vimentin and BLBP, this coexpression diverges at P3; vimentin is expressed in the radial glial processes, while BLBP appears in cells detached from the ventricular zone. Our lab developed a model of cortical dysplasia in the ferret, resulting in impaired migration of neurons into the cortical plate and disordered radial glia. This occurs after exposure to the antimitotic methylazoxymethanol (MAM) on the 24th day of development (E24). Ferrets treated with MAM on E24 result in an overall decrease of BLBP expression; radial glia that continue to express BLBP, however, show only mild disruption compared with the strongly disrupted vimentin expressing radial glia. When E24 MAM-treated organotypic slices are exposed to reelin or NRG1, the severely disrupted vimentin+ radial glial processes are repaired but the slightly disordered BLBP+ processes are not. The realignment of vimentin+ processes was linked with an increase of their BLBP expression. BLBP expressing radial glia are distinguished by being both less affected by MAM treatment and by attempts at repair. We further investigated the effects induced by reelin and found that signaling was mediated via VLDLR/Dab1/Pi3K activation while NRG1 signaling was mediated via erbB3/erbB4/PI3K. We then tested whether radial glial repair correlated with improved neuronal migration. Repairing the radial glial scaffold is not sufficient to restore neuronal migration; although reelin improves migration of neurons toward the cortical plate signaling through ApoER2/Dab1/PI3K activation, NRG1 does not.	[Poluch, Sylvie; Juliano, Sharon L.] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA	Uniformed Services University of the Health Sciences - USA	Poluch, S (corresponding author), Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA.	sjuliano@usuhs.edu	Juliano, Sharon/AAO-1030-2020		PHS NIH NIMH [RO1 MH62721]; PHS [RO1 NS24014]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH062721] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS024014] Funding Source: NIH RePORTER	PHS NIH NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); PHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by PHS NIH NIMH RO1 MH62721 (SLJ) and PHS RO1 NS24014 (SLJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen OM, 2003, BIOCHEMISTRY-US, V42, P9355, DOI 10.1021/bi034475p; Anthony TE, 2005, GENE DEV, V19, P1028, DOI 10.1101/gad.1302105; Anton ES, 1997, DEVELOPMENT, V124, P3501; Arnaud L, 2003, MOL CELL BIOL, V23, P9293, DOI 10.1128/MCB.23.24.9293-9302.2003; Beffert U, 2002, J BIOL CHEM, V277, P49958, DOI 10.1074/jbc.M209205200; Birchmeier C, 2009, EXP CELL RES, V315, P611, DOI 10.1016/j.yexcr.2008.10.035; Borrell V, 2006, CEREB CORTEX, V16, P1571, DOI 10.1093/cercor/bhj094; Campbell K, 2002, TRENDS NEUROSCI, V25, P235, DOI 10.1016/S0166-2236(02)02156-2; CAVINESS VS, 1973, J COMP NEUROL, V148, P141, DOI 10.1002/cne.901480202; Chen S, 2006, J NEUROSCI, V26, P3079, DOI 10.1523/JNEUROSCI.3785-05.2006; Choi BH, 1996, TOXICOL APPL PHARM, V141, P357, DOI 10.1006/taap.1996.0300; Corbin JG, 2008, J NEUROCHEM, V106, P2272, DOI 10.1111/j.1471-4159.2008.05522.x; Corfas G, 2004, NAT NEUROSCI, V7, P575, DOI 10.1038/nn1258; D'Arcangelo G, 1999, NEURON, V24, P471, DOI 10.1016/S0896-6273(00)80860-0; DARCANGELO G, 1995, NATURE, V374, P719, DOI 10.1038/374719a0; Dulabon L, 2000, NEURON, V27, P33, DOI 10.1016/S0896-6273(00)00007-6; FENG L, 1994, NEURON, V12, P895, DOI 10.1016/0896-6273(94)90341-7; Ferguson KM, 2000, EMBO J, V19, P4632, DOI 10.1093/emboj/19.17.4632; Fietz SA, 2010, NAT NEUROSCI, V13, P690, DOI 10.1038/nn.2553; Fish JL, 2008, J CELL SCI, V121, P2783, DOI 10.1242/jcs.023465; Flames N, 2004, NEURON, V44, P251, DOI 10.1016/j.neuron.2004.09.028; Frotscher M, 2003, CEREB CORTEX, V13, P634, DOI 10.1093/cercor/13.6.634; Gaiano N, 2000, NEURON, V26, P395, DOI 10.1016/S0896-6273(00)81172-1; Gierdalski M, 2005, J NEUROSCI, V25, P8498, DOI 10.1523/JNEUROSCI.1476-05.2005; Hack I, 2007, DEVELOPMENT, V134, P3883, DOI 10.1242/dev.005447; Hartfuss E, 2001, DEV BIOL, V229, P15, DOI 10.1006/dbio.2000.9962; Hartfuss E, 2003, DEVELOPMENT, V130, P4597, DOI 10.1242/dev.00654; Hasling TA, 2003, EUR J NEUROSCI, V17, P467, DOI 10.1046/j.1460-9568.2003.02468.x; Hiesberger T, 1999, NEURON, V24, P481, DOI 10.1016/S0896-6273(00)80861-2; Howard B, 2006, GLIA, V53, P57, DOI 10.1002/glia.20259; Howard BM, 2008, NEUROSCIENTIST, V14, P459, DOI 10.1177/1073858407313512; Howell BW, 1997, NATURE, V389, P733, DOI 10.1038/39607; HunterSchaedle KE, 1997, J NEUROBIOL, V33, P459, DOI 10.1002/(SICI)1097-4695(199710)33:4<459::AID-NEU9>3.0.CO;2-9; JACKSON CA, 1989, J NEUROSCI, V9, P1242; Jossin Y, 2004, J NEUROSCI, V24, P514, DOI 10.1523/JNEUROSCI.3408-03.2004; Jossin Y, 2007, MOL CELL BIOL, V27, P7113, DOI 10.1128/MCB.00928-07; Juliano SL, 1996, J COMP NEUROL, V374, P259, DOI 10.1002/(SICI)1096-9861(19961014)374:2<259::AID-CNE8>3.0.CO;2-1; Keilani S, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-69; Lemmon MA, 2009, EXP CELL RES, V315, P638, DOI 10.1016/j.yexcr.2008.10.024; LEVITT P, 1980, J COMP NEUROL, V193, P815, DOI 10.1002/cne.901930316; Luque JM, 2003, DEV BRAIN RES, V140, P195, DOI 10.1016/S0165-3806(02)00604-1; Mart CR, 2006, CARDIOL YOUNG, V16, P152, DOI 10.1017/S1047951106000084; Mei L, 2008, NAT REV NEUROSCI, V9, P437, DOI 10.1038/nrn2392; MILLER MW, 1993, J COMP NEUROL, V337, P253, DOI 10.1002/cne.903370206; Nadarajah B, 2003, CEREB CORTEX, V13, P607, DOI 10.1093/cercor/13.6.607; Nadarajah B, 2001, NAT NEUROSCI, V4, P143, DOI 10.1038/83967; Noctor SC, 1997, J COMP NEUROL, V387, P179; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; Noctor SC, 1999, CEREB CORTEX, V9, P121, DOI 10.1093/cercor/9.2.121; Nomura T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001454; Pang T, 2008, NEUROLOGIST, V14, P181, DOI 10.1097/NRL.0b013e31816606b9; Patten BA, 2003, J NEUROSCI, V23, P6132, DOI 10.1523/JNEUROSCI.23-14-06132.2003; PINTOLORD MC, 1982, DEV BRAIN RES, V4, P379, DOI 10.1016/0165-3806(82)90181-X; Poluch S, 2008, CEREB CORTEX, V18, P78, DOI 10.1093/cercor/bhm032; Poluch S, 2007, GLIA, V55, P822, DOI 10.1002/glia.20488; Rahmatullah M, 1998, MOL CELL BIOL, V18, P6245, DOI 10.1128/MCB.18.11.6245; Rakic P, 2007, BRAIN RES REV, V55, P204, DOI 10.1016/j.brainresrev.2007.02.010; Rio C, 1997, NEURON, V19, P39, DOI 10.1016/S0896-6273(00)80346-3; Roper SN, 1997, DEV NEUROSCI-BASEL, V19, P521, DOI 10.1159/000111249; Ross ME, 2002, INT REV NEUROBIOL, V49, P333; Schaefer A, 2008, DEV NEUROBIOL, V68, P590, DOI 10.1002/dneu.20601; SCHMECHEL DE, 1979, ANAT EMBRYOL, V156, P115, DOI 10.1007/BF00300010; Schmid RS, 2003, P NATL ACAD SCI USA, V100, P4251, DOI 10.1073/pnas.0630496100; Senzaki K, 1999, CELL, V99, P635, DOI 10.1016/S0092-8674(00)81552-4; Shibata T, 1997, J NEUROSCI, V17, P9212; Spalice A, 2009, ACTA PAEDIATR, V98, P421, DOI 10.1111/j.1651-2227.2008.01160.x; Stockinger W, 2000, J BIOL CHEM, V275, P25625, DOI 10.1074/jbc.M004119200; Strasser V, 2004, MOL CELL BIOL, V24, P1378, DOI 10.1128/MCB.24.3.1378-1386.2004; Tabata H, 2003, J NEUROSCI, V23, P9996; Trommsdorff M, 1999, CELL, V97, P689, DOI 10.1016/S0092-8674(00)80782-5; Uchida T, 2009, J NEUROSCI, V29, P10653, DOI 10.1523/JNEUROSCI.0345-09.2009; VERROTTI A, 2009, EUR J PAEDIAT NEUROL; VOIGT T, 1989, J COMP NEUROL, V289, P74, DOI 10.1002/cne.902890106; Weissman T, 2003, CEREB CORTEX, V13, P550, DOI 10.1093/cercor/13.6.550; Welker W., 1990, Cerebral Cortex, V8B, P3; Yap TA, 2008, CURR OPIN PHARMACOL, V8, P393, DOI 10.1016/j.coph.2008.08.004; Yau HJ, 2003, CEREB CORTEX, V13, P252, DOI 10.1093/cercor/13.3.252; Zecevic N, 2004, GLIA, V48, P27, DOI 10.1002/glia.20044	78	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2010	5	10							e13709	10.1371/journal.pone.0013709	http://dx.doi.org/10.1371/journal.pone.0013709			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	672HN	21060844	Green Published, gold, Green Submitted			2022-12-27	WOS:000283573800010
J	Yang, AC; Huang, NE; Peng, CK; Tsai, SJ				Yang, Albert C.; Huang, Norden E.; Peng, Chung-Kang; Tsai, Shih-Jen			Do Seasons Have an Influence on the Incidence of Depression? The Use of an Internet Search Engine Query Data as a Proxy of Human Affect	PLOS ONE			English	Article							EMPIRICAL MODE DECOMPOSITION; PREVALENCE; SEROTONIN; LATITUDE; CLIMATE; HEALTH; SLEEP; MOOD; WEB	Background: Seasonal depression has generated considerable clinical interest in recent years. Despite a common belief that people in higher latitudes are more vulnerable to low mood during the winter, it has never been demonstrated that human's moods are subject to seasonal change on a global scale. The aim of this study was to investigate large-scale seasonal patterns of depression using Internet search query data as a signature and proxy of human affect. Methodology/Principal Findings: Our study was based on a publicly available search engine database, Google Insights for Search, which provides time series data of weekly search trends from January 1, 2004 to June 30, 2009. We applied an empirical mode decomposition method to isolate seasonal components of health-related search trends of depression in 54 geographic areas worldwide. We identified a seasonal trend of depression that was opposite between the northern and southern hemispheres; this trend was significantly correlated with seasonal oscillations of temperature (USA: r = -0.872, p < 0.001; Australia: r = -0.656, p < 0.001). Based on analyses of search trends over 54 geological locations worldwide, we found that the degree of correlation between searching for depression and temperature was latitude-dependent (northern hemisphere: r = -0.686; p < 0.001; southern hemisphere: r = 0.871; p < 0.0001). Conclusions/Significance: Our findings indicate that Internet searches for depression from people in higher latitudes are more vulnerable to seasonal change, whereas this phenomenon is obscured in tropical areas. This phenomenon exists universally across countries, regardless of language. This study provides novel, Internet-based evidence for the epidemiology of seasonal depression.	[Yang, Albert C.] Chu Tung Vet Hosp, Dept Psychiat, Jhudong Township, Taiwan; [Yang, Albert C.; Tsai, Shih-Jen] Natl Yang Ming Univ, Div Psychiat, Sch Med, Taipei 112, Taiwan; [Yang, Albert C.] Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan; [Huang, Norden E.] Natl Cent Univ, Res Ctr Adapt Data Anal, Chungli 32054, Taiwan; [Peng, Chung-Kang] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Interdisciplinary Med & Biotechnol, Boston, MA 02215 USA; [Peng, Chung-Kang] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Margret & HA Rey Inst Nonlinear Dynam Med, Boston, MA 02215 USA; Harvard Univ, Wyss Inst Biologically Inspired Engn, Boston, MA 02215 USA; [Tsai, Shih-Jen] Taipei Vet Gen Hosp, Dept Psychiat, Taipei, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Central University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Taipei Veterans General Hospital	Yang, AC (corresponding author), Chu Tung Vet Hosp, Dept Psychiat, Jhudong Township, Taiwan.	ccyang@physionet.org; sjtsai@vghtpe.gov.tw	Peng, Chung-Kang/N-1308-2019; Tsai, Shih-Jen/AAK-7944-2020; Peng, Chung-Kang/E-1489-2011	Peng, Chung-Kang/0000-0003-3666-9833; Tsai, Shih-Jen/0000-0002-9987-022X; Peng, Chung-Kang/0000-0003-3666-9833; Yang, Albert Chih-Chieh/0000-0003-2794-9649	National Science Council of Taiwan [NSC 95-2314-B-075-111, NSC 96-2314-B-075-075]; Taipei Veterans General Hospital [V97A-061]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Taipei Veterans General Hospital(Taipei Veterans General Hospital)	This work was supported by the National Science Council of Taiwan (NSC 95-2314-B-075-111; NSC 96-2314-B-075-075) and Taipei Veterans General Hospital (V97A-061). These funders had no role in the design and conduct of the study, collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript.	ASCHOFF J, 1981, HDB BEHAVIORAL NEURO, P475; BALZER I, 1991, INT J BIOMETEOROL, V34, P231, DOI 10.1007/BF01041834; Bauer M, 2009, J AFFECT DISORDERS, V116, P152, DOI 10.1016/j.jad.2008.11.013; BRAS RL, 1990, HYDROLOGY; Brownstein JS, 2009, NEW ENGL J MED, V360, P2153, DOI 10.1056/NEJMp0904012; COHN EG, 1990, BRIT J CRIMINOL, V30, P51, DOI 10.1093/oxfordjournals.bjc.a047980; Cummings DAT, 2004, NATURE, V427, P344, DOI 10.1038/nature02225; Ginsberg J, 2009, NATURE, V457, P1012, DOI 10.1038/nature07634; Hippocrates, 1923, WORKS HIPPOCRATES; HONMA KI, 1992, AM J PHYSIOL, V262, pR885, DOI 10.1152/ajpregu.1992.262.5.R885; Huang NE, 1998, P ROY SOC A-MATH PHY, V454, P903, DOI 10.1098/rspa.1998.0193; Huang NE, 2008, REV GEOPHYS, V46, DOI 10.1029/2007RG000228; Hulth A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004378; JAMES WH, 1990, J BIOSOC SCI, V22, P113, DOI 10.1017/S0021932000018423; KASPER S, 1989, ARCH GEN PSYCHIAT, V46, P823; Kegel M, 2009, NORD J PSYCHIAT, V63, P331, DOI 10.1080/08039480902799040; Levitt AJ, 2002, CAN J PSYCHIAT, V47, P361, DOI 10.1177/070674370204700407; Lo MT, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.061924; McMichael AJ, 2006, LANCET, V367, P859, DOI 10.1016/S0140-6736(06)68079-3; Mercer JG, 1998, COMP BIOCHEM PHYS C, V119, P295, DOI 10.1016/S0742-8413(98)00018-8; MOUL DE, 1992, AM J PSYCHIAT, V149, P852; NIKOLAOS A, 2009, APPL EC Q, V55, P107; Novak V, 2004, BIOMED ENG ONLINE, V3, DOI 10.1186/1475-925X-3-39; Partonen T, 1998, LANCET, V352, P1369, DOI 10.1016/S0140-6736(98)01015-0; Polgreen PM, 2008, CLIN INFECT DIS, V47, P1443, DOI 10.1086/593098; Praschak-Rieder N, 2008, ARCH GEN PSYCHIAT, V65, P1072, DOI 10.1001/archpsyc.65.9.1072; Rajendran PR, 2001, JAMA-J AM MED ASSOC, V285, P804, DOI 10.1001/jama.285.6.804-a; SARRIAS MJ, 1989, BIOL PSYCHIAT, V26, P695, DOI 10.1016/0006-3223(89)90104-2; Spink A., 2009, HDB RES WEB LOG ANAL, P1; Sweeney-Reed CM, 2007, J COMPUT NEUROSCI, V23, P79, DOI 10.1007/s10827-007-0020-3; Tang HW, 2006, BRIT MED J, V333, P1143, DOI 10.1136/bmj.39003.640567.AE; WEHR TA, 1989, AM J PSYCHIAT, V146, P829; WEHR TA, 1991, J CLIN ENDOCR METAB, V73, P1276, DOI 10.1210/jcem-73-6-1276; WILSON K, 2009, CMAJ; WIRZJUSTICE A, 1986, AM J PSYCHIAT, V143, P932; Wu ZH, 2004, P ROY SOC A-MATH PHY, V460, P1597, DOI 10.1098/rspa.2003.1221; Wu ZH, 2007, P NATL ACAD SCI USA, V104, P14889, DOI 10.1073/pnas.0701020104; Wu ZH, 2009, ADV DATA SCI ADAPT, V1, P1, DOI 10.1142/S1793536909000047; Yang AC, 2011, J AFFECT DISORDERS, V129, P275, DOI 10.1016/j.jad.2010.08.010; ZUNG WWK, 1974, ARCH GEN PSYCHIAT, V30, P89	40	88	91	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2010	5	10							e13728	10.1371/journal.pone.0013728	http://dx.doi.org/10.1371/journal.pone.0013728			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	672HN	21060851	Green Published, Green Submitted, gold			2022-12-27	WOS:000283573800022
J	McHardy, I; Keegan, C; Sim, JH; Shi, WY; Lux, R				McHardy, Ian; Keegan, Caroline; Sim, Jee-Hyun; Shi, Wenyuan; Lux, Renate			Transcriptional Profiles of Treponema denticola in Response to Environmental Conditions	PLOS ONE			English	Article							OUTER SHEATH PROTEIN; PORPHYROMONAS-GINGIVALIS; INFECTIVE ENDOCARDITIS; OXYGEN-METABOLISM; OXIDATIVE STRESS; DENTAL PLAQUE; IDENTIFICATION; CHEMOTAXIS; EXPRESSION; GENE	The periodontal pathogen T. denticola resides in a stressful environment rife with challenges, the human oral cavity. Knowledge of the stress response capabilities of this invasive spirochete is currently very limited. Whole genome expression profiles in response to different suspected stresses including heat shock, osmotic downshift, oxygen and blood exposure were examined. Most of the genes predicted to encode conserved heat shock proteins (HSPs) were found to be induced under heat and oxygen stress. Several of these HSPs also seem to be important for survival in hypotonic solutions and blood. In addition to HSPs, differential regulation of many genes encoding metabolic proteins, hypothetical proteins, transcriptional regulators and transporters was observed in patterns that could betoken functional associations. In summary, stress responses in T. denticola exhibit many similarities to the corresponding stress responses in other organisms but also employ unique components including the induction of hypothetical proteins.	[McHardy, Ian; Keegan, Caroline; Shi, Wenyuan] Univ Calif Los Angeles, Dept Microbiol Mol Genet & Immunol, Los Angeles, CA 90024 USA; [Sim, Jee-Hyun; Shi, Wenyuan; Lux, Renate] Univ Calif Los Angeles, Sch Dent, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	McHardy, I (corresponding author), Univ Calif Los Angeles, Dept Microbiol Mol Genet & Immunol, Los Angeles, CA 90024 USA.	lux@ucla.edu	SHI, wen/GPW-9531-2022	Keegan, Caroline/0000-0002-0852-5077; McHardy, Ian/0000-0002-2121-5460	National Institutes of Health (NIH) [5T32DE007298-12]	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	IM was supported by a T32 training grant in oral biology: National Institutes of Health (NIH) T32 #5T32DE007298-12. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bohin JP, 2000, FEMS MICROBIOL LETT, V186, P11, DOI 10.1016/S0378-1097(00)00110-5; Booth IR, 1999, CURR OPIN MICROBIOL, V2, P166, DOI 10.1016/S1369-5274(99)80029-0; Bowden GHW, 1998, CRIT REV ORAL BIOL M, V9, P54, DOI 10.1177/10454411980090010401; Brissette CA, 2004, ORAL MICROBIOL IMMUN, V19, P403, DOI 10.1111/j.1399-302x.2004.00177.x; Brissette CA, 2002, INFECT IMMUN, V70, P3982, DOI 10.1128/IAI.70.7.3982-3984.2002; Busenlehner LS, 2003, FEMS MICROBIOL REV, V27, P131, DOI 10.1016/S0168-6445(03)00054-8; Caldwell CE, 1999, ORAL MICROBIOL IMMUN, V14, P66, DOI 10.1034/j.1399-302X.1999.140109.x; Capone R, 2008, ORAL MICROBIOL IMMUN, V23, P165, DOI 10.1111/j.1399-302X.2007.00404.x; Carmona IT, 2003, ARCH GERONTOL GERIAT, V36, P49, DOI 10.1016/S0167-4943(02)00054-7; Cohen DJ, 2004, ANN THORAC SURG, V77, P537, DOI 10.1016/S0003-4975(03)01454-1; da Silva APB, 2004, CELL MICROBIOL, V6, P485, DOI 10.1111/j.1462-5822.2004.00377.x; Diaz PI, 2006, J BACTERIOL, V188, P2454, DOI 10.1128/JB.188.7.2454-2462.2006; Gottesman S, 1997, GENE DEV, V11, P815, DOI 10.1101/gad.11.7.815; Goulhen F, 2003, CRIT REV ORAL BIOL M, V14, P399, DOI 10.1177/154411130301400603; Ilbert M, 2006, ANTIOXID REDOX SIGN, V8, P835, DOI 10.1089/ars.2006.8.835; Kaplan Mitchell, 1993, Dysphagia, V8, P225, DOI 10.1007/BF01354542; Lai YL, 2008, APPL ENVIRON MICROB, V74, P73, DOI 10.1128/AEM.01972-07; Lee JY, 2006, J PERIODONTAL RES, V41, P10, DOI 10.1111/j.1600-0765.2005.00832.x; Li H, 1999, INFECT IMMUN, V67, P694, DOI 10.1128/IAI.67.2.694-699.1999; LINDQUIST S, 1986, ANNU REV BIOCHEM, V55, P1151, DOI 10.1146/annurev.bi.55.070186.005443; Lopatin DE, 1999, J PERIODONTOL, V70, P1185, DOI 10.1902/jop.1999.70.10.1185; Lux R, 2001, INFECT IMMUN, V69, P6276, DOI 10.1128/IAI.69.10.6276-6283.2001; Magalhaes MAO, 2008, CELL MICROBIOL, V10, P344, DOI 10.1111/j.1462-5822.2007.01045.x; MARQUIS RE, 1995, J IND MICROBIOL, V15, P198, DOI 10.1007/BF01569826; McDowell JV, 2007, INFECT IMMUN, V75, P1050, DOI 10.1128/IAI.01458-06; Meuric V, 2008, ORAL MICROBIOL IMMUN, V23, P308, DOI 10.1111/j.1399-302X.2007.00429.x; Mitchell HL, 2010, MICROBIOL-SGM, V156, P774, DOI 10.1099/mic.0.033654-0; Miyamoto M, 2006, INFECT IMMUN, V74, P2462, DOI 10.1128/IAI.74.4.2462-2467.2006; Nagata E, 2005, EUR J ORAL SCI, V113, P499, DOI 10.1111/j.1600-0722.2005.00258.x; OHTA K, 1986, INFECT IMMUN, V53, P213, DOI 10.1128/IAI.53.1.213-220.1986; Poolman B, 2002, MOL MICROBIOL, V44, P889, DOI 10.1046/j.1365-2958.2002.02894.x; Raivio TL, 2005, MOL MICROBIOL, V56, P1119, DOI 10.1111/j.1365-2958.2005.04625.x; Rozen S, 2000, Methods Mol Biol, V132, P365; Schumann W, 2003, CELL STRESS CHAPERON, V8, P207, DOI 10.1379/1466-1268(2003)008<0207:TBSHSS>2.0.CO;2; Seshadri G, 2004, P NATL ACAD SCI USA, V101, P5646, DOI 10.1073/pnas.0307639101; STAMM LV, 1991, INFECT IMMUN, V59, P1572, DOI 10.1128/IAI.59.4.1572-1575.1991; Strom BL, 2000, CIRCULATION, V102, P2842; SYED SA, 1993, RES MICROBIOL, V144, P317, DOI 10.1016/0923-2508(93)90016-U; Thomas BP, 2006, INFECT IMMUN, V74, P1954, DOI 10.1128/IAI.74.3.1954-1957.2006; VAYSSIER C, 1994, FEMS MICROBIOL LETT, V121, P303, DOI 10.1016/0378-1097(94)90308-5; WARAASWAPATI WPN, 2009, ORAL DIS, V9999; Xu QL, 2007, MOL MICROBIOL, V64, P220, DOI 10.1111/j.1365-2958.2007.05636.x; Yoshida A, 2004, ORAL MICROBIOL IMMUN, V19, P196, DOI 10.1111/j.0902-0055.2004.00142.x; Yura T, 2000, BACTERIAL STRESS RESPONSES, P3	44	16	17	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2010	5	10							e13655	10.1371/journal.pone.0013655	http://dx.doi.org/10.1371/journal.pone.0013655			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671UN	21048920	Green Published, Green Submitted, gold			2022-12-27	WOS:000283537000026
J	Drescher, J; Bluthgen, N; Schmitt, T; Buhler, J; Feldhaar, H				Drescher, Jochen; Bluethgen, Nico; Schmitt, Thomas; Buehler, Jana; Feldhaar, Heike			Societies Drifting Apart? Behavioural, Genetic and Chemical Differentiation between Supercolonies in the Yellow Crazy Ant Anoplolepis gracilipes	PLOS ONE			English	Article							MULTILOCUS GENOTYPE DATA; NESTMATE RECOGNITION; POPULATION-STRUCTURE; ARGENTINE ANT; CUTICULAR HYDROCARBONS; INTRASPECIFIC AGGRESSION; EVOLUTION; INFERENCE; CUES; HYMENOPTERA	Background: In populations of most social insects, gene flow is maintained through mating between reproductive individuals from different colonies in periodic nuptial flights followed by dispersal of the fertilized foundresses. Some ant species, however, form large polygynous supercolonies, in which mating takes place within the maternal nest (intranidal mating) and fertilized queens disperse within or along the boundary of the supercolony, leading to supercolony growth (colony budding). As a consequence, gene flow is largely confined within supercolonies. Over time, such supercolonies may diverge genetically and, thus, also in recognition cues (cuticular hydrocarbons, CHC's) by a combination of genetic drift and accumulation of colony-specific, neutral mutations. Methodology/Principal Findings: We tested this hypothesis for six supercolonies of the invasive ant Anoplolepis gracilipes in north-east Borneo. Within supercolonies, workers from different nests tolerated each other, were closely related and showed highly similar CHC profiles. Between supercolonies, aggression ranged from tolerance to mortal encounters and was negatively correlated with relatedness and CHC profile similarity. Supercolonies were genetically and chemically distinct, with mutually aggressive supercolony pairs sharing only 33.1%+/- 17.5% (mean +/- SD) of their alleles across six microsatellite loci and 73.8%+/- 11.6% of the compounds in their CHC profile. Moreover, the proportion of alleles that differed between supercolony pairs was positively correlated to the proportion of qualitatively different CHC compounds. These qualitatively differing CHC compounds were found across various substance classes including alkanes, alkenes and mono-, di- and trimethyl-branched alkanes. Conclusions: We conclude that positive feedback between genetic, chemical and behavioural traits may further enhance supercolony differentiation through genetic drift and neutral evolution, and may drive colonies towards different evolutionary pathways, possibly including speciation.	[Drescher, Jochen; Bluethgen, Nico] Univ Wurzburg, Dept Anim Ecol & Trop Biol, Wurzburg, Germany; [Schmitt, Thomas; Buehler, Jana] Univ Freiburg, Fac Biol, Dept Evolutionary Biol & Anim Ecol, Freiburg, Germany; [Feldhaar, Heike] Univ Wurzburg, Dept Behav Physiol & Sociobiol, Wurzburg, Germany; [Feldhaar, Heike] Univ Osnabruck, Dept Behav Biol, Osnabruck, Germany	University of Wurzburg; University of Freiburg; University of Wurzburg; University Osnabruck	Drescher, J (corresponding author), Univ Wurzburg, Dept Anim Ecol & Trop Biol, Wurzburg, Germany.	feldhaar@biologie.uni-osnabrueck.de	Schmitt, Thomas/H-3033-2013; Blüthgen, Nico/F-5983-2010; Feldhaar, Heike/AAB-8678-2020; Drescher, Jochen/AAO-8885-2020	Drescher, Jochen/0000-0002-5162-9779; Feldhaar, Heike/0000-0001-6797-5126	Deutsche Forschungsgemeinschaft DFG [SFB 554, E2]	Deutsche Forschungsgemeinschaft DFG(German Research Foundation (DFG))	This work was funded by the Deutsche Forschungsgemeinschaft DFG (SFB 554 Eolution and mechanisms of arthropod behaviour, project E2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS ES, 1991, P NATL ACAD SCI USA, V88, P2031, DOI 10.1073/pnas.88.5.2031; Akino T, 2004, APPL ENTOMOL ZOOL, V39, P381, DOI 10.1303/aez.2004.381; Blight O, 2010, BIOL INVASIONS, V12, P1491, DOI 10.1007/s10530-009-9561-x; BLIGHT O, BIOL INVASI IN PRESS; Brandstaetter AS, 2008, NATURWISSENSCHAFTEN, V95, P601, DOI 10.1007/s00114-008-0360-5; Brandt M, 2009, MOL ECOL, V18, P997, DOI 10.1111/j.1365-294X.2008.04056.x; Dapporto L, 2009, BIOCHEM SYST ECOL, V37, P341, DOI 10.1016/j.bse.2009.05.018; DRESCHER J, 2010, BIOTROPICA IN PRESS; Drescher J, 2007, MOL ECOL, V16, P1453, DOI 10.1111/j.1365-294X.2007.03260.x; Dronnet S, 2006, J CHEM ECOL, V32, P1027, DOI 10.1007/s10886-006-9043-x; Elmes GW, 2002, OECOLOGIA, V130, P525, DOI 10.1007/s00442-001-0857-5; Errard C, 2005, NATURWISSENSCHAFTEN, V92, P319, DOI 10.1007/s00114-005-0628-y; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Falush D, 2003, GENETICS, V164, P1567; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; Feldhaar H, 2006, MOL ECOL NOTES, V6, P912, DOI 10.1111/j.1471-8286.2006.01397.x; Florane CB, 2004, J CHEM ECOL, V30, P2559, DOI 10.1007/s10886-004-7950-2; Fournier D, 2009, MOL ECOL, V18, P186, DOI 10.1111/j.1365-294X.2008.04018.x; FRANKS N, 1990, J CHEM ECOL, V16, P1431, DOI 10.1007/BF01014079; Giraud T, 2002, P NATL ACAD SCI USA, V99, P6075, DOI 10.1073/pnas.092694199; Hefetz Abraham, 2007, Myrmecological News, V10, P59; Helantera H, 2009, TRENDS ECOL EVOL, V24, P341, DOI 10.1016/j.tree.2009.01.013; Holldobler B., 2009, SUPERORGANISM; Holway DA, 2002, ANNU REV ECOL SYST, V33, P181, DOI 10.1146/annurev.ecolsys.33.010802.150444; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Jaquiery J, 2005, MOL ECOL, V14, P589, DOI 10.1111/j.1365-294X.2005.02433.x; Lahav S, 1999, NATURWISSENSCHAFTEN, V86, P246, DOI 10.1007/s001140050609; Le Breton J, 2004, J INSECT BEHAV, V17, P263, DOI 10.1023/B:JOIR.0000028575.28700.71; Lenoir A, 1999, INFORMATION PROCESSING IN SOCIAL INSECTS, P219; Liang D, 2000, NATURWISSENSCHAFTEN, V87, P412, DOI 10.1007/s001140050752; Martin SJ, 2009, INSECT SOC, V56, P375, DOI 10.1007/s00040-009-0035-z; Martin S, 2009, J CHEM ECOL, V35, P1151, DOI 10.1007/s10886-009-9695-4; Martin SJ, 2008, BIOL J LINN SOC, V95, P131, DOI 10.1111/j.1095-8312.2008.01038.x; Martin SJ, 2008, J CHEM ECOL, V34, P1072, DOI 10.1007/s10886-008-9482-7; Mayr E., 1942, P1; O'Dowd DJ, 2003, ECOL LETT, V6, P812, DOI 10.1046/j.1461-0248.2003.00512.x; Pedersen JS, 2006, EVOLUTION, V60, P782, DOI 10.1111/j.0014-3820.2006.tb01156.x; Pennanec'h M, 1997, J INSECT PHYSIOL, V43, P1111, DOI 10.1016/S0022-1910(97)00082-6; Pritchard JK, 2000, GENETICS, V155, P945; QUELLER DC, 1989, EVOLUTION, V43, P258, DOI 10.2307/2409206; Suarez AV, 2002, ANIM BEHAV, V64, P697, DOI 10.1006/anbe.2002.4011; Sunamura E, 2009, INSECT SOC, V56, P143, DOI 10.1007/s00040-009-0001-9; Sunamura E, 2009, BIOL INVASIONS, V11, P2329, DOI 10.1007/s10530-008-9419-7; Takahashi A, 2001, P NATL ACAD SCI USA, V98, P3920, DOI 10.1073/pnas.061465098; Thomas ML, 2006, MOL ECOL, V15, P4303, DOI 10.1111/j.1365-294X.2006.03038.x; Thomas ML, 2010, BIOL INVASIONS, V12, P677, DOI 10.1007/s10530-009-9473-9; Torres CW, 2007, INSECT SOC, V54, P363, DOI 10.1007/s00040-007-0954-5; Ugelvig LV, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-11; van Wilgenburg E, 2010, EVOL APPL, V3, P136, DOI 10.1111/j.1752-4571.2009.00114.x; van Zweden JS, 2010, J EVOLUTION BIOL, V23, P1498, DOI 10.1111/j.1420-9101.2010.02020.x; van Zweden JS, 2009, J INSECT PHYSIOL, V55, P158, DOI 10.1016/j.jinsphys.2008.11.001; Vander Meer Robert K., 1998, P79; Vogel V, 2010, DIVERS DISTRIB, V16, P170, DOI 10.1111/j.1472-4642.2009.00630.x; Vogel V, 2009, EVOLUTION, V63, P1627, DOI 10.1111/j.1558-5646.2009.00628.x	54	31	34	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2010	5	10							e13581	10.1371/journal.pone.0013581	http://dx.doi.org/10.1371/journal.pone.0013581			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	670KA	21042578	Green Published, Green Submitted, gold			2022-12-27	WOS:000283419100018
J	Huang, SJ; Zhang, XF; Jiang, HM; Yan, QA; Ai, X; Wang, YJ; Cai, JP; Jiang, L; Wu, T; Wang, ZZ; Guan, L; Shih, JWK; Ng, MH; Zhu, FC; Zhang, J; Xia, NS				Huang, Shoujie; Zhang, Xuefeng; Jiang, Hanmin; Yan, Qiang; Ai, Xing; Wang, Yijun; Cai, Jiaping; Jiang, Lang; Wu, Ting; Wang, Zhongze; Guan, Li; Shih, J. Wai Kuo; Ng, Mun-Hon; Zhu, Fengcai; Zhang, Jun; Xia, Ningshao			Profile of Acute Infectious Markers in Sporadic Hepatitis E	PLOS ONE			English	Article							E VIRUS-INFECTION; IMMUNOGLOBULIN-M; UNITED-STATES; OUTBREAK; ASSAYS; DISEASE; ANTIBODIES; DIAGNOSIS; ZOONOSIS; NAMIBIA	Laboratory diagnosis of acute infection of hepatitis E virus (HEV) is commonly based on the detection of HEV RNA, IgM and/or rising IgG levels. However, the profile of these markers when the patients present have not been well determined. To clarify the extent of misdiagnosed sporadic hepatitis E in the initial laboratory detection, serial sera of 271 sporadic acute hepatitis cases were collected, detected and the dynamics of each acute marker during the illness course were analyzed. 91 confirmed cases of hepatitis E were identified based on the presentation of HEV RNA, IgM or at least 4 fold rising of IgG levels. 21 (23.1%) hepatitis E cases were false negative for the viral RNA and 40 (44.0%) for rising IgG, because occurrence of these markers were confined to acute phase of infection and viremia had already subsided and antibody level peaked when these patients presented. IgM was detected in 82 (90.1%) cases. It is the most prevalent of the three markers, because the antibody persisted until early convalescence. Nine cases negative for IgM were positive for rising IgG and one was also positive for the viral RNA; all of these nine cases showed high avid IgG in their acute phase sera, which indicated reinfection. In summary, it is not practicable to determine the true occurrence of sporadic hepatitis E. Nevertheless, it could be closely approximated by approach using a combination of all three acute markers.	[Huang, Shoujie; Yan, Qiang; Jiang, Lang; Wu, Ting; Guan, Li; Shih, J. Wai Kuo; Ng, Mun-Hon; Zhang, Jun; Xia, Ningshao] Xiamen Univ, Natl Inst Diagnost & Vaccine Dev Infect Dis, Xiamen, Peoples R China; [Huang, Shoujie] Xiamen Univ, Coll Med, Dept Prevent Med, Xiamen, Peoples R China; [Zhang, Xuefeng; Ai, Xing; Zhu, Fengcai] Jiangsu Prov Ctr Dis Control & Prevent, Nanjing, Peoples R China; [Jiang, Hanmin; Wang, Yijun; Cai, Jiaping; Wang, Zhongze] Dongtai Ctr Dis Control & Prevent, Dongtai, Peoples R China	Xiamen University; Xiamen University; Jiangsu Provincial Center for Disease Control & Prevention	Huang, SJ (corresponding author), Xiamen Univ, Natl Inst Diagnost & Vaccine Dev Infect Dis, Xiamen, Peoples R China.	zhangj@xmu.edu.cn	Wang, Yijun/GXW-1763-2022; Zhang, Jun/G-4598-2010; Xia, NS/G-4647-2010	Zhang, Jun/0000-0002-6601-9180; Xia, Ningshao/0000-0003-0179-5266; Wu, Ting/0000-0002-1806-3056	National Advanced Technology Research and Development Program [2006AA02A209]; National Science and Technique Major Project [2008ZX10404, 2009ZX10004-704]; National Science Fund for Distinguished Young Scholars [30925030]; Fujian Provincial Science Fund for Distinguished Young Scholars [2009J06020]	National Advanced Technology Research and Development Program; National Science and Technique Major Project; National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); Fujian Provincial Science Fund for Distinguished Young Scholars	Work was funded by National Advanced Technology Research and Development Program (No. 2006AA02A209), National Science and Technique Major Project (No. 2008ZX10404, 2009ZX10004-704), National Science Fund for Distinguished Young Scholars (30925030), and Fujian Provincial Science Fund for Distinguished Young Scholars (2009J06020). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya SK, 2007, J HEPATOL, V46, P387, DOI 10.1016/j.jhep.2006.09.016; Amon JJ, 2006, J MED VIROL, V78, P741, DOI 10.1002/jmv.20617; Bendall R, 2008, J MED VIROL, V80, P95, DOI 10.1002/jmv.21033; Chen HY, 2005, CLIN DIAGN LAB IMMUN, V12, P593, DOI 10.1128/CDLI.12.5.593-598.2005; Clayson ET, 1998, J MED VIROL, V54, P178, DOI 10.1002/(SICI)1096-9071(199803)54:3&lt;178::AID-JMV6&gt;3.0.CO;2-2; Corwin AL, 1996, AM J TROP MED HYG, V54, P559, DOI 10.4269/ajtmh.1996.54.559; Curry JA, 2009, ANN INTERN MED, V150, P226, DOI 10.7326/0003-4819-150-3-200902030-00028; Dalton HR, 2008, LANCET INFECT DIS, V8, P698, DOI 10.1016/S1473-3099(08)70255-X; Hamid SS, 2002, HEPATOLOGY, V36, P474, DOI 10.1053/jhep.2002.34856; Herremans M, 2007, CLIN VACCINE IMMUNOL, V14, P562, DOI 10.1128/CVI.00231-06; Im SWK, 2001, VACCINE, V19, P3726, DOI 10.1016/S0264-410X(01)00100-1; Isaacson M, 2000, AM J TROP MED HYG, V62, P619, DOI 10.4269/ajtmh.2000.62.619; Khuroo MS, 2003, J VIRAL HEPATITIS, V10, P61, DOI 10.1046/j.1365-2893.2003.00398.x; Kuniholm MH, 2009, J INFECT DIS, V200, P48, DOI 10.1086/599319; Legrand-Abravanel F, 2009, CLIN VACCINE IMMUNOL, V16, P772, DOI 10.1128/CVI.00438-08; Li RC, 2006, EMERG INFECT DIS, V12, P1682, DOI 10.3201/eid1211.060332; Li SW, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000537; Lu L, 2006, REV MED VIROL, V16, P5, DOI 10.1002/rmv.482; Maila HT, 2004, J GEN VIROL, V85, P89, DOI 10.1099/vir.0.19587-0; Myint KSA, 2006, J CLIN MICROBIOL, V44, P1581, DOI 10.1128/JCM.44.4.1581-1583.2006; Myint KSA, 2005, AM J TROP MED HYG, V73, P942, DOI 10.4269/ajtmh.2005.73.942; Pavio N, 2008, FRONT BIOSCI-LANDMRK, V13, P7172, DOI 10.2741/3219; Purcell RH, 2008, J HEPATOL, V48, P494, DOI 10.1016/j.jhep.2007.12.008; Rab MA, 1997, AM J TROP MED HYG, V57, P151, DOI 10.4269/ajtmh.1997.57.151; Sailaja B, 2009, EPIDEMIOL INFECT, V137, P234, DOI 10.1017/S0950268808000952; Seriwatana J, 2002, CLIN DIAGN LAB IMMUN, V9, P1072, DOI 10.1128/CDLI.9.5.1072-1078.2002; Takahashi M, 2007, J CLIN MICROBIOL, V45, P3671, DOI 10.1128/JCM.01086-07; Thomas DL, 1997, J CLIN MICROBIOL, V35, P1244, DOI 10.1128/JCM.35.5.1244-1247.1997; Zhang J, 2005, VACCINE, V23, P2881, DOI 10.1016/j.vaccine.2004.11.065; Zhang J, 2003, J MED VIROL, V71, P518, DOI 10.1002/jmv.10523; Zhang J, 2009, VACCINE, V27, P1869, DOI 10.1016/j.vaccine.2008.12.061	31	95	99	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2010	5	10							e13560	10.1371/journal.pone.0013560	http://dx.doi.org/10.1371/journal.pone.0013560			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	668TQ	21042408	Green Published, Green Submitted, gold			2022-12-27	WOS:000283293800022
J	Kirin, M; McQuillan, R; Franklin, CS; Campbell, H; McKeigue, PM; Wilson, JF				Kirin, Mirna; McQuillan, Ruth; Franklin, Christopher S.; Campbell, Harry; McKeigue, Paul M.; Wilson, James F.			Genomic Runs of Homozygosity Record Population History and Consanguinity	PLOS ONE			English	Article							QUANTITATIVE TRAITS; PAKISTAN; SCHIZOPHRENIA; MARRIAGES; DISEASE	The human genome is characterised by many runs of homozygous genotypes, where identical haplotypes were inherited from each parent. The length of each run is determined partly by the number of generations since the common ancestor: offspring of cousin marriages have long runs of homozygosity (ROH), while the numerous shorter tracts relate to shared ancestry tens and hundreds of generations ago. Human populations have experienced a wide range of demographic histories and hold diverse cultural attitudes to consanguinity. In a global population dataset, genome-wide analysis of long and shorter ROH allows categorisation of the mainly indigenous populations sampled here into four major groups in which the majority of the population are inferred to have: (a) recent parental relatedness (south and west Asians); (b) shared parental ancestry arising hundreds to thousands of years ago through long term isolation and restricted effective population size (N-e), but little recent inbreeding (Oceanians); (c) both ancient and recent parental relatedness (Native Americans); and (d) only the background level of shared ancestry relating to continental N-e (predominantly urban Europeans and East Asians; lowest of all in sub-Saharan African agriculturalists), and the occasional cryptically inbred individual. Moreover, individuals can be positioned along axes representing this demographic historic space. Long runs of homozygosity are therefore a globally widespread and under-appreciated characteristic of our genomes, which record past consanguinity and population isolation and provide a distinctive record of the demographic history of an individual's ancestors. Individual ROH measures will also allow quantification of the disease risk arising from polygenic recessive effects.	[Kirin, Mirna; McQuillan, Ruth; Franklin, Christopher S.; Campbell, Harry; McKeigue, Paul M.; Wilson, James F.] Univ Edinburgh, Ctr Populat Hlth Sci, Edinburgh, Midlothian, Scotland	University of Edinburgh	Kirin, M (corresponding author), Univ Edinburgh, Ctr Populat Hlth Sci, Edinburgh, Midlothian, Scotland.	jim.wilson@hgu.mrc.ac.uk	Campbell, Harry/E-2959-2010; Wilson, James F/A-5704-2009	Campbell, Harry/0000-0002-6169-6262; Wilson, James F/0000-0001-5751-9178	Royal Society; MS Society UK; University of Edinburgh; Economic and Social Research Council	Royal Society(Royal Society of London); MS Society UK; University of Edinburgh; Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	There was no specific funding for this project. JFW is supported by the Royal Society, RM by the MS Society UK, MK by the University of Edinburgh and CSF by the Economic and Social Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auton A, 2009, GENOME RES, V19, P795, DOI 10.1101/gr.088898.108; Bittles A, GLOBAL PREVALENCE CO; Broman KW, 1999, AM J HUM GENET, V65, P1493, DOI 10.1086/302661; Campbell H, 2007, HUM MOL GENET, V16, P233, DOI 10.1093/hmg/ddl473; Clark AG, 2005, GENOME RES, V15, P1496, DOI 10.1101/gr.4107905; Curtis D, 2008, ANN HUM GENET, V72, P261, DOI 10.1111/j.1469-1809.2007.00411.x; Dawson KP, 2000, QJM-MON J ASSOC PHYS, V93, P313, DOI 10.1093/qjmed/93.5.313; Fentress Elizabeth, 1996, BERBERS; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gibson J, 2006, HUM MOL GENET, V15, P789, DOI 10.1093/hmg/ddi493; Hussain R, 1998, J BIOSOC SCI, V30, P261, DOI 10.1017/S0021932098002612; Hussain R, 1999, J BIOSOC SCI, V31, P449, DOI 10.1017/S0021932099004496; Keinan A, 2007, NAT GENET, V39, P1251, DOI 10.1038/ng2116; Knight HM, 2008, EUR J HUM GENET, V16, P750, DOI 10.1038/ejhg.2008.11; Lencz T, 2007, P NATL ACAD SCI USA, V104, P19942, DOI 10.1073/pnas.0710021104; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Li LH, 2006, HUM MUTAT, V27, P1115, DOI 10.1002/humu.20399; McQuillan R, 2008, AM J HUM GENET, V83, P359, DOI 10.1016/j.ajhg.2008.08.007; Mohyuddin A, 2003, TISSUE ANTIGENS, V61, P286, DOI 10.1034/j.1399-0039.2003.00049.x; Murray J., 1910, REPORTS SCI EXPEDITI, P17; PASTNER S, 1972, MAN, V7, P128, DOI 10.2307/2799861; Pedersen J, 2002, Community Genet, V5, P178, DOI 10.1159/000066333; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Rudan I, 2003, GENETICS, V163, P1011; Sheffield VC, 1998, TRENDS GENET, V14, P391, DOI 10.1016/S0168-9525(98)01556-X; SHI W, 2009, MOL BIOL EVOL   1012; Shlush LI, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002105; Weiss LA, 2006, NAT GENET, V38, P218, DOI 10.1038/ng1726; Woods CG, 2006, AM J HUM GENET, V78, P889, DOI 10.1086/503875	30	283	293	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2010	5	11							e13996	10.1371/journal.pone.0013996	http://dx.doi.org/10.1371/journal.pone.0013996			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	680KW	21085596	Green Submitted, gold, Green Published			2022-12-27	WOS:000284231800025
J	Ropelewski, AJ; Nicholas, HB; Mendez, RRG				Ropelewski, Alexander J.; Nicholas, Hugh B., Jr.; Mendez, Ricardo R. Gonzalez			MPI-PHYLIP: Parallelizing Computationally Intensive Phylogenetic Analysis Routines for the Analysis of Large Protein Families	PLOS ONE			English	Article							ALDEHYDE DEHYDROGENASE; TREE; RECONSTRUCTION; PHYLOGENOMICS; ALGORITHM	Background: Phylogenetic study of protein sequences provides unique and valuable insights into the molecular and genetic basis of important medical and epidemiological problems as well as insights about the origins and development of physiological features in present day organisms. Consensus phylogenies based on the bootstrap and other resampling methods play a crucial part in analyzing the robustness of the trees produced for these analyses. Methodology: Our focus was to increase the number of bootstrap replications that can be performed on large protein datasets using the maximum parsimony, distance matrix, and maximum likelihood methods. We have modified the PHYLIP package using MPI to enable large-scale phylogenetic study of protein sequences, using a statistically robust number of bootstrapped datasets, to be performed in a moderate amount of time. This paper discusses the methodology used to parallelize the PHYLIP programs and reports the performance of the parallel PHYLIP programs that are relevant to the study of protein evolution on several protein datasets. Conclusions: Calculations that currently take a few days on a state of the art desktop workstation are reduced to calculations that can be performed over lunchtime on a modern parallel computer. Of the three protein methods tested, the maximum likelihood method scales the best, followed by the distance method, and then the maximum parsimony method. However, the maximum likelihood method requires significant memory resources, which limits its application to more moderately sized protein datasets.	[Ropelewski, Alexander J.; Nicholas, Hugh B., Jr.] Carnegie Mellon Univ, Pittsburgh Supercomp Ctr, Pittsburgh, PA 15213 USA; [Mendez, Ricardo R. Gonzalez] Univ Puerto Rico, Sch Med, Dept Radiol Sci, San Juan, PR 00936 USA	Carnegie Mellon University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus	Ropelewski, AJ (corresponding author), Carnegie Mellon Univ, Pittsburgh Supercomp Ctr, Pittsburgh, PA 15213 USA.	ropelews@psc.edu			United States National Institutes of Health National Institute of General Medical Sciences [2 T36GM008789]; Pittsburgh Supercomputing Center National Resource for Biomedical Supercomputing through the United States National Institutes of Health National Center for Research Resources [2 P41 RR06009]; United States National Institutes of Health through the National Center for Research Resources; United States National Science Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR006009] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T36GM008789] Funding Source: NIH RePORTER	United States National Institutes of Health National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Pittsburgh Supercomputing Center National Resource for Biomedical Supercomputing through the United States National Institutes of Health National Center for Research Resources; United States National Institutes of Health through the National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); United States National Science Foundation(National Science Foundation (NSF)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project was supported through the United States National Institutes of Health National Institute of General Medical Sciences grant No. 2 T36GM008789 and the Pittsburgh Supercomputing Center National Resource for Biomedical Supercomputing funded through the United States National Institutes of Health National Center for Research Resources grant 2 P41 RR06009. Funding for the shared-memory parallel Altix systems used for the tests in this paper was provided through grants from the United States National Institutes of Health through the National Center for Research Resources and the United States National Science Foundation through TeraGrid. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altekar G, 2004, BIOINFORMATICS, V20, P407, DOI 10.1093/bioinformatics/btg427; Bridgham JT, 2006, SCIENCE, V312, P97, DOI 10.1126/science.1123348; Ciccarelli FD, 2006, SCIENCE, V311, P1283, DOI 10.1126/science.1123061; Darling AE, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000128; Delsuc F, 2005, NAT REV GENET, V6, P361, DOI 10.1038/nrg1603; Douady CJ, 2003, MOL BIOL EVOL, V20, P248, DOI 10.1093/molbev/msg042; Durand D, 2006, TRENDS GENET, V22, P156, DOI 10.1016/j.tig.2006.01.002; Durand D, 2006, J COMPUT BIOL, V13, P320, DOI 10.1089/cmb.2006.13.320; Felsenstein J, 1996, MOL BIOL EVOL, V13, P93, DOI 10.1093/oxfordjournals.molbev.a025575; Felsenstein J, 2004, INFERRING PHYLOGENIE; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Hamacher K, 2010, BIONFORMATICS 2010: PROCEEDINGS OF THE FIRST INTERNATIONAL CONFERENCE ON BIOINFORMATICS, P114; HEDGES SB, 1992, MOL BIOL EVOL, V9, P366; Hempel J, 2003, CHEM-BIOL INTERACT, V143, P23, DOI 10.1016/S0009-2797(02)00165-5; Janies DA, 2002, MOLECULAR SYSTEMATICS AND EVOLUTION: THEORY AND PRACTICE, P115; Keane TM, 2007, NUCLEIC ACIDS RES, V35, pW33, DOI 10.1093/nar/gkm359; Keane TM, 2005, BIOINFORMATICS, V21, P969, DOI 10.1093/bioinformatics/bti100; Kordis D, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-266; Li KB, 2003, BIOINFORMATICS, V19, P1585, DOI 10.1093/bioinformatics/btg192; Mayr E., 2001, WHAT EVOLUTION IS; Minh BQ, 2005, BIOINFORMATICS, V21, P3794, DOI 10.1093/bioinformatics/bti594; OLSEN GJ, 1994, COMPUT APPL BIOSCI, V10, P41; Opperdoes FR, 2009, PHYLOGENETIC HANDBOOK: A PRACTICAL APPROACH TO PHYLOGENETIC ANALYSIS AND HYPOTHESIS TESTING, 2ND EDITION, P313; Perozich J, 1999, PROTEIN SCI, V8, P137, DOI 10.1110/ps.8.1.137; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Reva B, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r232; Russo CAM, 1996, MOL BIOL EVOL, V13, P525, DOI 10.1093/oxfordjournals.molbev.a025613; Sanderson MJ, 2003, TRENDS PLANT SCI, V8, P374, DOI 10.1016/S1360-1385(03)00165-1; Sankararaman S, 2008, BIOINFORMATICS, V24, P2445, DOI 10.1093/bioinformatics/btn474; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Sheps JA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r15; Stamatakis A, 2005, BIOINFORMATICS, V21, P456, DOI 10.1093/bioinformatics/bti191; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stamatakis AP, 2002, CSB2002: IEEE COMPUTER SOCIETY BIOINFORMATICS CONFERENCE, P21, DOI 10.1109/CSB.2002.1039325; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; WILLIAMS TL, 2006, PARALLEL COMPUTING B, P369; Wymore T, 2003, CHEM-BIOL INTERACT, V143, P75, DOI 10.1016/S0009-2797(02)00175-8; Yang S, 2005, P NATL ACAD SCI USA, V102, P373, DOI 10.1073/pnas.0408810102	40	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2010	5	11							e13999	10.1371/journal.pone.0013999	http://dx.doi.org/10.1371/journal.pone.0013999			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	680KW	21085574	Green Published, Green Submitted, gold			2022-12-27	WOS:000284231800026
J	Witton, MP; Habib, MB				Witton, Mark P.; Habib, Michael B.			On the Size and Flight Diversity of Giant Pterosaurs, the Use of Birds as Pterosaur Analogues and Comments on Pterosaur Flightlessness	PLOS ONE			English	Article							BODY-MASS; SAFETY FACTORS; BONE STRENGTH; BIOMECHANICS; ALLOMETRY; EVOLUTION; SEABIRDS; SKELETON; POSTURE; STRAIN	The size and flight mechanics of giant pterosaurs have received considerable research interest for the last century but are confused by conflicting interpretations of pterosaur biology and flight capabilities. Avian biomechanical parameters have often been applied to pterosaurs in such research but, due to considerable differences in avian and pterosaur anatomy, have lead to systematic errors interpreting pterosaur flight mechanics. Such assumptions have lead to assertions that giant pterosaurs were extremely lightweight to facilitate flight or, if more realistic masses are assumed, were flightless. Reappraisal of the proportions, scaling and morphology of giant pterosaur fossils suggests that bird and pterosaur wing structure, gross anatomy and launch kinematics are too different to be considered mechanically interchangeable. Conclusions assuming such interchangeability-including those indicating that giant pterosaurs were flightless-are found to be based on inaccurate and poorly supported assumptions of structural scaling and launch kinematics. Pterosaur bone strength and flap-gliding performance demonstrate that giant pterosaur anatomy was capable of generating sufficient lift and thrust for powered flight as well as resisting flight loading stresses. The retention of flight characteristics across giant pterosaur skeletons and their considerable robustness compared to similarly-massed terrestrial animals suggest that giant pterosaurs were not flightless. Moreover, the term 'giant pterosaur' includes at least two radically different forms with very distinct palaeoecological signatures and, accordingly, all but the most basic sweeping conclusions about giant pterosaur flight should be treated with caution. Reappraisal of giant pterosaur material also reveals that the size of the largest pterosaurs, previously suggested to have wingspans up to 13 m and masses up to 544 kg, have been overestimated. Scaling of fragmentary giant pterosaur remains have been misled by distorted fossils or used inappropriate scaling techniques, indicating that 10-11 m wingspans and masses of 200-250 kg are the most reliable upper estimates of known pterosaur size.	[Witton, Mark P.] Univ Portsmouth, Sch Earth & Environm Sci, Portsmouth, Hants, England; [Habib, Michael B.] Chatham Univ, Dept Sci, Pittsburgh, PA USA	University of Portsmouth	Witton, MP (corresponding author), Univ Portsmouth, Sch Earth & Environm Sci, Portsmouth, Hants, England.	mark.witton@port.ac.uk	Witton, Mark/B-9368-2013					Alexander D. E, 2002, NATURES FLYERS BIRDS; Askew GN, 2002, J EXP BIOL, V205, P2153; Averianov AO, 2007, PALEONTOL J+, V41, P79, DOI 10.1134/S003103010701008X; BENNETT CS, 1997, HIST BIOL, V12, P265; Bennett S.C., 1990, Journal of Vertebrate Paleontology, V10, P80; Bennett S. Christopher, 2003, Geological Society Special Publication, V217, P191, DOI 10.1144/GSL.SP.2003.217.01.12; Bennett S. Christopher, 2001, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V260, P1; Bennett SC, 1996, ZOOL J LINN SOC-LOND, V118, P261, DOI 10.1111/j.1096-3642.1996.tb01267.x; BENNETT SC, 2005, J PALEONTOL, V79, P625; Benton MJ, 1999, PHILOS T ROY SOC B, V354, P1423, DOI 10.1098/rstb.1999.0489; BIEWENER AA, 1995, J MORPHOL, V225, P61, DOI 10.1002/jmor.1052250106; BIEWENER AA, 1982, J EXP BIOL, V98, P289; Blob RW, 1999, J EXP BIOL, V202, P1023; BRAMWELL CD, 1974, PHILOS T R SOC B, V267, P503, DOI 10.1098/rstb.1974.0007; Brower J.C., 1983, Journal of Vertebrate Paleontology, V3, P84; BROWER JC, 1981, U KANSAS PALEONTOLOG, V105, P1; Brown Barnum, 1943, NAT HIST [NEW YORK], V52, P104; Brown RE, 1996, J EXP ZOOL, V276, P112, DOI 10.1002/(SICI)1097-010X(19961001)276:2<112::AID-JEZ4>3.0.CO;2-R; Buffetaut E, 2002, NATURWISSENSCHAFTEN, V89, P180, DOI 10.1007/s00114-002-0307-1; Buffetaut E, 1996, B SOC GEOL FR, V167, P753; Buffetaut E, 1997, GEOL MAG, V134, P553, DOI 10.1017/S0016756897007449; Buffetaut Eric, 2003, Geological Society Special Publication, V217, P91, DOI 10.1144/GSL.SP.2003.217.01.09; Butler RJ, 2009, BIOL LETTERS, V5, P557, DOI 10.1098/rsbl.2009.0139; Cai Zhengquan, 1994, Vertebrata Palasiatica, V32, P181; CAMPBELL KE, 1983, AUK, V100, P390, DOI 10.1093/auk/100.2.390; Carpenter Kenneth, 2003, Geological Society Special Publication, V217, P45, DOI 10.1144/GSL.SP.2003.217.01.04; Carrano MT, 1999, J MORPHOL, V240, P237, DOI 10.1002/(SICI)1097-4687(199906)240:3<237::AID-JMOR3>3.3.CO;2-E; CARTER DR, 1978, J BIOMECH, V11, P199, DOI 10.1016/0021-9290(78)90013-1; Chatterjee S., 2004, GEOLOGICAL SOC AM SP, V376, P1, DOI DOI 10.1130/0-8137-2376-0.1; Chatterjee S, 2007, P NATL ACAD SCI USA, V104, P12398, DOI 10.1073/pnas.0702040104; Christiansen P, 2002, J MORPHOL, V251, P195, DOI 10.1002/jmor.1083; Claessens LPAM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004497; Codorniu L, 2004, CAN J EARTH SCI, V41, P9, DOI 10.1139/E03-080; Company J., 2001, Journal of Vertebrate Paleontology, V21, p41A; ELGIN RA, ACTA PALAEO IN PRESS; Everhart M. J., 2005, OCEANS KANSAS NATURA; Fastnacht M, 2005, ACTA PALAEONTOL POL, V50, P273; Frey Eberhard, 2003, Geological Society Special Publication, V217, P267, DOI 10.1144/GSL.SP.2003.217.01.15; Frey Eberhard, 1996, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V199, P221; Gere J. G, 1990, MECH MAT; GREENEWALT CH, 1975, T AM PHILOS SOC, V65, P5; Habib M. B., 2008, ZITTELIANA B, V28, P161; Habib MB, 2008, ZOOL J LINN SOC-LOND, V153, P601, DOI 10.1111/j.1096-3642.2008.00402.x; Hankin E. H., 1914, Aeronautical Journal, V18, P324; HAZLEHURST GA, 1992, PALEOBIOLOGY, V18, P447, DOI 10.1017/S009483730001099X; Henderson Donald M., 1999, Journal of Vertebrate Paleontology, V19, p50A; Henderson DM, 2010, J VERTEBR PALEONTOL, V30, P768, DOI 10.1080/02724631003758334; Hertel F, 1999, CONDOR, V101, P549, DOI 10.2307/1370184; Hildebrand M., 1995, ANAL VERTEBRATE STRU; Hone David W. E., 2008, Zitteliana Reihe B, V28, P35; Hui CA, 2002, J MORPHOL, V251, P284, DOI 10.1002/jmor.1089; Hwang KG, 2002, GEOL MAG, V139, P421, DOI 10.1017/S0016756802006647; Ibrahim N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010875; Jerison HJ., 1973, EVOLUTION BRAIN INTE; Kellner AWA, 2010, P ROY SOC B-BIOL SCI, V277, P321, DOI 10.1098/rspb.2009.0846; Kellner AWA, 1996, J VERTEBR PALEONTOL, V16, P222, DOI 10.1080/02724634.1996.10011310; KIRKPATRICK SJ, 1994, J EXP BIOL, V190, P195; LANGSTON W, 1981, SCI AM, V244, P92; LAWSON DA, 1975, SCIENCE, V187, P947, DOI 10.1126/science.187.4180.947; Lockley Martin G., 1995, Ichnos, V4, P7; MARDEN JH, 1994, AM J PHYSIOL, V266, pR1077, DOI 10.1152/ajpregu.1994.266.4.R1077; Martill David M., 1998, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V207, P57; Mayr G, 2008, J VERTEBR PALEONTOL, V28, P762, DOI 10.1671/0272-4634(2008)28[762:ASOAVL]2.0.CO;2; Mazin Jean-Michel, 2003, Geological Society Special Publication, V217, P283, DOI 10.1144/GSL.SP.2003.217.01.17; McGowen Michael R., 2002, Paleobios, V22, P1; MCMAHON TA, 1975, AM NAT, V109, P547, DOI 10.1086/283026; Meyers RA, 2005, J MORPHOL, V263, P12, DOI 10.1002/jmor.10284; NORBERG UM, 1987, PHILOS T R SOC B, V316, P337; O'Keefe F. Robin, 2006, Paludicola, V5, P206; PADIAN K, 1985, PALAEONTOLOGY, V28, P413; Padian K., 1992, Journal of Vertebrate Paleontology, V12, P87; PADIAN K, 1993, AM J SCI, V293A, P91, DOI 10.2475/ajs.293.A.91; PADIAN K, 1983, POSTILLA, V189, P1; Parrish J. Michael, 2006, P201; Paul G.S., 1991, Modern Geology, V16, P69; Paul G. S., 2002, DINOSAURS AIR EVOLUT; Pennycuick CJ, 2008, THEOR ECOL SER, P1; PENNYCUICK CJ, 1987, J EXP BIOL, V128, P335; PENNYCUICK CJ, 1971, J EXP BIOL, V55, P13; PENNYCUICK CJ, 1979, ENERGY COSTS LOCOMOT, P164; Pennycuik Colin J., 2002, Avian Science, V2, P1; Pereda Suberbiola X, 2003, GEOLOGICAL SOC SPECI, V217, P79; Polk JD, 2000, J HUM EVOL, V39, P297, DOI 10.1006/jhev.2000.0420; PRANGE HD, 1979, AM NAT, V113, P103, DOI 10.1086/283367; Prondvai E, 2008, HIST BIOL, V20, P237, DOI 10.1080/08912960902859334; Prozesky OPM., 1970, FIELD GUIDE BIRDS SO; Rayner J.M.V., 1988, Current Ornithology, V5, P1; RUBIN CT, 1982, J EXP BIOL, V101, P187; Ruff CB, 2000, J HUM EVOL, V38, P269, DOI 10.1006/jhev.1999.0322; Ruff CB, 2002, AM J PHYS ANTHROPOL, V119, P305, DOI 10.1002/ajpa.10117; Sato K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005400; SAVILE DBO, 1957, EVOLUTION, V11, P212, DOI 10.2307/2406051; Schmidt-Nielsen K., 1984, SCALING WHY IS ANIMA; SEAMANS TW, 1995, IBIS, V137, P424; SELKER F, 1989, J BIOMECH, V22, P1175, DOI 10.1016/0021-9290(89)90219-4; SMITH AC, 2007, THESIS MICHIGAN STAT; Song A, 2008, 46 AIAA AER SCI M EX; Spear LB, 1997, IBIS, V139, P221, DOI 10.1111/j.1474-919X.1997.tb04620.x; Steel Lorna, 1997, Geological Curator, V6, P305; STEIN RS, 1975, J PALEONTOL, V49, P534; STRANG KA, 2009, 47 AIAA AER SCI M P, V1; Swartz SM, 2008, CELLS TISSUES ORGANS, V187, P59, DOI 10.1159/000109964; SWARTZ SM, 1992, NATURE, V359, P726, DOI 10.1038/359726a0; Taquet P, 2004, CR PALEVOL, V3, P157, DOI 10.1016/j.crpv.2004.02.002; Templin RJ, 2000, PROG AEROSP SCI, V36, P393, DOI 10.1016/S0376-0421(00)00007-5; TICKELL, 2000, ALBATROSSES; TSCHANZ K, 1988, PALAEONTOLOGY, V31, P997; Unwin D.M., 1988, Modern Geology, V13, P57; Unwin D. M, 2005, PTEROSAURS DEEP TIME; Unwin David M., 2003, Geological Society Special Publication, V217, P139, DOI 10.1144/GSL.SP.2003.217.01.11; Unwin David M., 2000, Mitteilungen aus dem Museum fuer Naturkunde in Berlin Geowissenschaftliche Reihe, V3, P181; Unwin DM, 1996, LETHAIA, V29, P373, DOI 10.1111/j.1502-3931.1996.tb01673.x; Wellnhofer P., 1988, Historical Biology, V1, P3; Wellnhofer P., 1970, ABH BAYER AKAD WISS, V141, P1; WELLNHOFER P, 1978, HDB PALAOHERPETOL 19; Wellnhofer P, 1991, ILLUSTRATED ENCY PTE; Wilkinson MT, 2008, ZOOL J LINN SOC-LOND, V154, P27, DOI 10.1111/j.1096-3642.2008.00409.x; Witmer LM, 2003, NATURE, V425, P950, DOI 10.1038/nature02048; Witton MP, 2009, CRETACEOUS RES, V30, P676, DOI 10.1016/j.cretres.2008.12.004; Witton Mark P., 2008, Zitteliana Reihe B, V28, P143; Witton MP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002271; WITTON MP, 2008, THESIS U PORTSMOUTH	122	75	75	13	87	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2010	5	11							e13982	10.1371/journal.pone.0013982	http://dx.doi.org/10.1371/journal.pone.0013982			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	680KW	21085624	Green Published, Green Submitted, gold			2022-12-27	WOS:000284231800012
J	Martinkova, N; Backor, P; Bartonicka, T; Blazkova, P; Cerveny, J; Falteisek, L; Gaisler, J; Hanzal, V; Horacek, D; Hubalek, Z; Jahelkova, H; Kolarik, M; Korytar, L; Kubatova, A; Lehotska, B; Lehotsky, R; Lucan, RK; Majek, O; Mateju, J; Rehak, Z; Safar, J; Tajek, P; Tkadlec, E; Uhrin, M; Wagner, J; Weinfurtova, D; Zima, J; Zukal, J; Horacek, I				Martinkova, Natalia; Backor, Peter; Bartonicka, Tomas; Blazkova, Pavla; Cerveny, Jaroslav; Falteisek, Lukas; Gaisler, Jiri; Hanzal, Vladimir; Horacek, Daniel; Hubalek, Zdenek; Jahelkova, Helena; Kolarik, Miroslav; Korytar, L'ubos; Kubatova, Alena; Lehotska, Blanka; Lehotsky, Roman; Lucan, Radek K.; Majek, Ondrej; Mateju, Jan; Rehak, Zdenek; Safar, Jiri; Tajek, Premysl; Tkadlec, Emil; Uhrin, Marcel; Wagner, Josef; Weinfurtova, Dita; Zima, Jan; Zukal, Jan; Horacek, Ivan			Increasing Incidence of Geomyces destructans Fungus in Bats from the Czech Republic and Slovakia	PLOS ONE			English	Article							WHITE-NOSE SYNDROME	Background: White-nose syndrome is a disease of hibernating insectivorous bats associated with the fungus Geomyces destructans. It first appeared in North America in 2006, where over a million bats died since then. In Europe, G. destructans was first identified in France in 2009. Its distribution, infection dynamics, and effects on hibernating bats in Europe are largely unknown. Methodology/Principal Findings: We screened hibernacula in the Czech Republic and Slovakia for the presence of the fungus during the winter seasons of 2008/2009 and 2009/2010. In winter 2009/2010, we found infected bats in 76 out of 98 surveyed sites, in which the majority had been previously negative. A photographic record of over 6000 hibernating bats, taken since 1994, revealed bats with fungal growths since 1995; however, the incidence of such bats increased in Myotis myotis from 2% in 2007 to 14% by 2010. Microscopic, cultivation and molecular genetic evaluations confirmed the identity of the recently sampled fungus as G. destructans, and demonstrated its continuous distribution in the studied area. At the end of the hibernation season we recorded pathologic changes in the skin of the affected bats, from which the fungus was isolated. We registered no mass mortality caused by the fungus, and the recorded population decline in the last two years of the most affected species, M. myotis, is within the population trend prediction interval. Conclusions/Significance: G. destructans was found to be widespread in the Czech Republic and Slovakia, with an epizootic incidence in bats during the most recent years. Further development of the situation urgently requires a detailed pan-European monitoring scheme.	[Martinkova, Natalia; Hubalek, Zdenek; Tkadlec, Emil; Zima, Jan; Zukal, Jan] Acad Sci Czech Republic, Inst Vertebrate Biol, Brno, Czech Republic; [Martinkova, Natalia; Majek, Ondrej] Masaryk Univ, Inst Biostat & Anal, Brno, Czech Republic; [Backor, Peter] Matej Bel Univ, Dept Biol & Ecol, Banska Bystrica, Slovakia; [Bartonicka, Tomas; Gaisler, Jiri; Rehak, Zdenek; Zukal, Jan] Masaryk Univ, Dept Bot & Zool, Brno, Czech Republic; [Blazkova, Pavla; Tajek, Premysl] Agcy Nat Conservat & Landscape Protect Czech Repu, Marianske Lazne, Czech Republic; [Blazkova, Pavla] Univ S Bohemia, Dept Zool, Ceske Budejovice, Czech Republic; [Cerveny, Jaroslav] Czech Univ Life Sci Prague, Dept Forest Protect & Game Management, Prague, Czech Republic; [Falteisek, Lukas; Jahelkova, Helena; Lucan, Radek K.; Mateju, Jan; Weinfurtova, Dita; Horacek, Ivan] Charles Univ Prague, Fac Sci, Dept Zool, Prague, Czech Republic; [Hanzal, Vladimir] Agcy Nat Conservat & Landscape Protect Czech Repu, Prague, Czech Republic; [Kolarik, Miroslav; Kubatova, Alena] Charles Univ Prague, Fac Sci, Dept Bot, Prague, Czech Republic; [Korytar, L'ubos] Univ Vet Med & Pharm, Kosice, Slovakia; [Lehotska, Blanka] Comenius Univ, Dept Landscape Ecol, Bratislava, Slovakia; [Lehotsky, Roman] Miniopterus Principal Org Slovak Union Nat & Land, Bratislava, Slovakia; [Mateju, Jan] Agcy Nat Conservat & Landscape Protect Czech Repu, Karlovy Vary, Czech Republic; [Safar, Jiri] Agcy Nat Conservat & Landsape Protect Czech Repub, Olomouc, Czech Republic; [Tkadlec, Emil] Palacky Univ, Dept Ecol & Environm Sci, CR-77147 Olomouc, Czech Republic; [Uhrin, Marcel] Safarik Univ, Inst Biol & Ecol, Kosice, Slovakia; [Wagner, Josef] Czech Speleol Soc, ZO CSS ORCUS Bohumin 7 01, Bohumin, Czech Republic	Czech Academy of Sciences; Institute of Vertebrate Biology of the Czech Academy of Sciences; Institute of Biostatistics & Analyses; Masaryk University Brno; Matej Bel University; Masaryk University Brno; University of South Bohemia Ceske Budejovice; Czech University of Life Sciences Prague; Charles University Prague; Charles University Prague; University of Veterinary Medicine Kosice; Comenius University Bratislava; Palacky University Olomouc; University of Pavol Jozef Safarik Kosice	Martinkova, N (corresponding author), Acad Sci Czech Republic, Inst Vertebrate Biol, Brno, Czech Republic.	martinkova@ivb.cz	Korytár, Ľuboš/AAR-5966-2021; Červený, Jaroslav/A-2809-2015; Martínková, Natália/C-2939-2008; Bartonička, Tomáš/J-2756-2014; Falteisek, Lukáš/P-9293-2017; Hubalek, Zdenek/AAF-8071-2019; Korytár, Ľuboš/GRE-9414-2022; Horacek, Ivan/V-9741-2017; Zima, Jan/G-1118-2011; Uhrin, Marcel/C-7211-2011; Lucan, Radek/B-7412-2015; Červený, Jaroslav/AGZ-6188-2022; Kolařík, Miroslav/A-1680-2008; Majek, Ondrej/E-4521-2011; Zukal, Jan/G-1180-2014; Hubalek, Zdenek/G-1111-2014; Kubatova, Alena/D-7918-2016; Tkadlec, Emil/A-6230-2014	Korytár, Ľuboš/0000-0002-8559-3559; Martínková, Natália/0000-0003-4556-4363; Falteisek, Lukáš/0000-0003-1585-4140; Korytár, Ľuboš/0000-0002-8559-3559; Horacek, Ivan/0000-0002-8356-5554; Lucan, Radek/0000-0002-9575-3173; Červený, Jaroslav/0000-0002-2723-0936; Kolařík, Miroslav/0000-0003-4016-0335; Majek, Ondrej/0000-0002-0034-3084; Zukal, Jan/0000-0003-4967-6880; Hubalek, Zdenek/0000-0003-4732-0987; Kubatova, Alena/0000-0002-2837-1087; Tkadlec, Emil/0000-0003-3782-8867; Lehotska, Blanka/0000-0002-1154-5183	Ministry of Education, Youth and Sports of the Czech Republic [MSM0021620828, LC06073]	Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic)	Funding: This study was supported by grants MSM0021620828 and LC06073 provided by Ministry of Education, Youth and Sports of the Czech Republic. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauerova Z., 1989, P499; Blehert DS, 2009, SCIENCE, V323, P227, DOI 10.1126/science.1163874; Boyles JG, 2010, FRONT ECOL ENVIRON, V8, P92, DOI 10.1890/080187; Boyles JG, 2009, J MAMMAL, V90, P9, DOI 10.1644/08-MAMM-A-205.1; Chaturvedi V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010783; Courtin F, 2010, VET PATHOL, V47, P214, DOI 10.1177/0300985809358614; DENNIS B, 1991, ECOL MONOGR, V61, P115, DOI 10.2307/1943004; FELDMANN R, 1984, TEICHFLEDERMAUS MYOT, P107; Fenton MB, 2006, SCIENCE, V311, P1098; Fernandes EKK, 2009, J APPL MICROBIOL, V107, P760, DOI 10.1111/j.1365-2672.2009.04258.x; Fournier A, 2010, FUNGAL BIOL-UK, V114, P498, DOI 10.1016/j.funbio.2010.03.012; Frick WF, 2010, SCIENCE, V329, P679, DOI 10.1126/science.1188594; Frick WF, 2010, J ANIM ECOL, V79, P128, DOI 10.1111/j.1365-2656.2009.01615.x; GAISLER J, 1975, ACTA SCI NAT BRNO, V9, P1; Gargas A, 2009, MYCOTAXON, V108, P147, DOI 10.5248/108.147; HAKULINEN T, 1994, STAT MED, V13, P1513, DOI 10.1002/sim.4780131503; HORACEK I., 2000, P 8 EBRS, V1, P11; HORACEK I, 2001, VESPERTILIO, V5, P3; Hutson A. M., 2008, IUCN 2010 IUCN RED L; Lorch JM, 2010, J VET DIAGN INVEST, V22, P224, DOI 10.1177/104063871002200208; Meteyer CU, 2009, J VET DIAGN INVEST, V21, P411, DOI 10.1177/104063870902100401; Puechmaille SJ, 2010, EMERG INFECT DIS, V16, P290, DOI 10.3201/eid1602.091391; Reichard JD, 2009, ACTA CHIROPTEROL, V11, P457, DOI 10.3161/150811009X485684; Samson R., 2004, INTRO FOOD AIRBORNE; Uhrin M, 2010, BIOLOGIA, V65, P349, DOI 10.2478/s11756-010-0020-z; *WHIT NOS SYNDR CO, 2010, POT THREAT WHIT NOS; Wibbelt G, 2010, EMERG INFECT DIS, V16, P1237, DOI 10.3201/eid1608.100002; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478	28	73	78	1	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2010	5	11							e13853	10.1371/journal.pone.0013853	http://dx.doi.org/10.1371/journal.pone.0013853			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675OD	21079781	Green Submitted, gold, Green Published			2022-12-27	WOS:000283839100010
J	Mason, OU; Nakagawa, T; Rosner, M; Van Nostrand, JD; Zhou, JZ; Maruyama, A; Fisk, MR; Giovannoni, SJ				Mason, Olivia U.; Nakagawa, Tatsunori; Rosner, Martin; Van Nostrand, Joy D.; Zhou, Jizhong; Maruyama, Akihiko; Fisk, Martin R.; Giovannoni, Stephen J.			First Investigation of the Microbiology of the Deepest Layer of Ocean Crust	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; MID-ATLANTIC RIDGE; CITY HYDROTHERMAL FIELD; GRADIENT GEL-ELECTROPHORESIS; RALSTONIA-PICKETTII PKO1; SEA-FLOOR BASALT; SP-NOV; METHYLOCOCCUS-CAPSULATUS; ALKANE HYDROXYLASE; SEQUENCE-ANALYSIS	The gabbroic layer comprises the majority of ocean crust. Opportunities to sample this expansive crustal environment are rare because of the technological demands of deep ocean drilling; thus, gabbroic microbial communities have not yet been studied. During the Integrated Ocean Drilling Program Expeditions 304 and 305, igneous rock samples were collected from 0.45-1391.01 meters below seafloor at Hole 1309D, located on the Atlantis Massif (30 degrees N, 42 degrees W). Microbial diversity in the rocks was analyzed by denaturing gradient gel electrophoresis and sequencing (Expedition 304), and terminal restriction fragment length polymorphism, cloning and sequencing, and functional gene microarray analysis (Expedition 305). The gabbroic microbial community was relatively depauperate, consisting of a low diversity of proteobacterial lineages closely related to Bacteria from hydrocarbon-dominated environments and to known hydrocarbon degraders, and there was little evidence of Archaea. Functional gene diversity in the gabbroic samples was analyzed with a microarray for metabolic genes ("GeoChip"), producing further evidence of genomic potential for hydrocarbon degradation - genes for aerobic methane and toluene oxidation. Genes coding for anaerobic respirations, such as nitrate reduction, sulfate reduction, and metal reduction, as well as genes for carbon fixation, nitrogen fixation, and ammonium-oxidation, were also present. Our results suggest that the gabbroic layer hosts a microbial community that can degrade hydrocarbons and fix carbon and nitrogen, and has the potential to employ a diversity of non-oxygen electron acceptors. This rare glimpse of the gabbroic ecosystem provides further support for the recent finding of hydrocarbons in deep ocean gabbro from Hole 1309D. It has been hypothesized that these hydrocarbons might originate abiotically from serpentinization reactions that are occurring deep in the Earth's crust, raising the possibility that the lithic microbial community reported here might utilize carbon sources produced independently of the surface biosphere.	[Mason, Olivia U.; Fisk, Martin R.] Oregon State Univ, Coll Ocean & Atmospher Sci, Corvallis, OR 97331 USA; [Nakagawa, Tatsunori] Tohoku Univ, Dept Earth Sci, Sendai, Miyagi 980, Japan; [Rosner, Martin] Univ Bremen, Bremen, Germany; [Van Nostrand, Joy D.; Zhou, Jizhong] Univ Oklahoma, Dept Bot & Microbiol, Inst Environm Genom, Norman, OK 73019 USA; [Maruyama, Akihiko] Natl Inst Adv Ind Sci & Technol, Res Inst Biol Resources, Tsukuba, Japan; [Giovannoni, Stephen J.] Oregon State Univ, Dept Microbiol, Corvallis, OR 97331 USA	Oregon State University; Tohoku University; University of Bremen; University of Oklahoma System; University of Oklahoma - Norman; National Institute of Advanced Industrial Science & Technology (AIST); Oregon State University	Mason, OU (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Lab, Div Earth Sci, Berkeley, CA 94720 USA.	steve.giovannoni@oregonstate.edu	Van Nostrand, Joy D/F-1740-2016; 吴, 昊/AAB-1620-2020; Rosner, Martin/B-9264-2009; Mason, Olivia/AAP-2627-2021	Van Nostrand, Joy D/0000-0001-9548-6450; 	Joint Oceanographic Institutions award; Gordon and Betty Moore Foundation; National Science Foundation IGERT; United States Department of Energy under Virtual Institute of Microbial Stress and Survival of the Office of Biological and Environmental Research, Office of Science	Joint Oceanographic Institutions award; Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); National Science Foundation IGERT(National Science Foundation (NSF)); United States Department of Energy under Virtual Institute of Microbial Stress and Survival of the Office of Biological and Environmental Research, Office of Science(United States Department of Energy (DOE))	Funding: This work was supported by a Joint Oceanographic Institutions award to M. R. Fisk, a Marine Microbiology Initiative Investigator Award from the Gordon and Betty Moore Foundation to S. J. Giovannoni, and a National Science Foundation IGERT Subsurface Biosphere Fellowship to O. U. Mason. The GeoChip microarray analysis was supported in part by the United States Department of Energy under the Genomics: GTL Program to J. Z. Zhou through the Virtual Institute of Microbial Stress and Survival (VIMSS; http://vimss.lbl.gov) of the Office of Biological and Environmental Research, Office of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashelford KE, 2005, APPL ENVIRON MICROB, V71, P7724, DOI 10.1128/AEM.71.12.7724-7736.2005; Ashelford KE, 2006, APPL ENVIRON MICROB, V72, P5734, DOI 10.1128/AEM.00556-06; Atreya SK, 2007, PLANET SPACE SCI, V55, P358, DOI 10.1016/j.pss.2006.02.005; Bairoch A, 2005, NUCLEIC ACIDS RES, V33, pD154, DOI 10.1093/nar/gki070; Benson DA, 2005, NUCLEIC ACIDS RES, V33, pD34, DOI 10.1093/nar/gki063; Berndt ME, 1996, GEOLOGY, V24, P351, DOI 10.1130/0091-7613(1996)024<0351:ROCDSO>2.3.CO;2; BIRD CW, 1971, NATURE, V230, P473, DOI 10.1038/230473a0; Blackman DK, 2002, MAR GEOPHYS RES, V23, P443, DOI 10.1023/B:MARI.0000018232.14085.75; Blackman DK., 2006, P IODP, DOI [10.2204/iodp.proc.304305.2006, DOI 10.2204/IODP.PROC.304305.2006]; Bodour AA, 2003, ENVIRON MICROBIOL, V5, P888, DOI 10.1046/j.1462-2920.2003.00481.x; Brazelton WJ, 2006, APPL ENVIRON MICROB, V72, P6257, DOI 10.1128/AEM.00574-06; Busigny V, 2005, CHEM GEOL, V223, P249, DOI 10.1016/j.chemgeo.2005.08.002; CACCAVO F, 1994, APPL ENVIRON MICROB, V60, P3752, DOI 10.1128/AEM.60.10.3752-3759.1994; Cann JR, 1997, NATURE, V385, P329, DOI 10.1038/385329a0; Casamayor EO, 2000, APPL ENVIRON MICROB, V66, P499, DOI 10.1128/AEM.66.2.499-508.2000; Coenye T, 2003, INT J SYST EVOL MICR, V53, P1075, DOI 10.1099/ijs.0.02555-0; Dekas AE, 2009, SCIENCE, V326, P422, DOI 10.1126/science.1178223; DELACOUR A, 2008, SYSTEM, V72, P3681; DELACOUR A, 2008, GEOPH RES ABSTR, V10; Delacour A, 2008, CHEM GEOL, V254, P19, DOI 10.1016/j.chemgeo.2008.05.018; DELONG EF, 1992, P NATL ACAD SCI USA, V89, P5685, DOI 10.1073/pnas.89.12.5685; Deutsch C, 2007, NATURE, V445, P163, DOI 10.1038/nature05392; Einen J, 2008, FEMS MICROBIOL LETT, V282, P182, DOI 10.1111/j.1574-6968.2008.01119.x; Fisk MR, 2003, GEOCHEM GEOPHY GEOSY, V4, DOI 10.1029/2002GC000387; Formisano V, 2004, SCIENCE, V306, P1758, DOI 10.1126/science.1101732; Gallego V, 2005, INT J SYST EVOL MICR, V55, P281, DOI 10.1099/ijs.0.63319-0; Hallam SJ, 2004, SCIENCE, V305, P1457, DOI 10.1126/science.1100025; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; He ZL, 2007, ISME J, V1, P67, DOI 10.1038/ismej.2007.2; Huber JA, 2006, ENVIRON MICROBIOL, V8, P88, DOI 10.1111/j.1462-2920.2005.00872.x; Huber JA, 2009, ENVIRON MICROBIOL, V11, P1292, DOI 10.1111/j.1462-2920.2008.01857.x; Ibrahim A, 1997, INT J SYST BACTERIOL, V47, P837, DOI 10.1099/00207713-47-3-837; JANECKY DR, 1986, GEOCHIM COSMOCHIM AC, V50, P1357, DOI 10.1016/0016-7037(86)90311-X; Kahng HY, 2000, J BACTERIOL, V182, P1232, DOI 10.1128/JB.182.5.1232-1242.2000; Kelley DS, 1999, J GEOPHYS RES-SOL EA, V104, P10439, DOI 10.1029/1999JB900058; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI DOI 10.1007/S00227-012-2133-0; LANE DJ, 1985, P NATL ACAD SCI USA, V82, P6955, DOI 10.1073/pnas.82.20.6955; Lanoil BD, 2001, APPL ENVIRON MICROB, V67, P5143, DOI 10.1128/AEM.67.11.5143-5153.2001; Ludwig W, 1998, ELECTROPHORESIS, V19, P554, DOI 10.1002/elps.1150190416; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; LYSNES K, 2004, P OCEAN DRILLING PRO, V0187; Lysnes K, 2004, FEMS MICROBIOL ECOL, V50, P213, DOI 10.1016/j.femsec.2004.06.014; Mason OU, 2007, ENVIRON MICROBIOL, V9, P2539, DOI 10.1111/j.1462-2920.2007.01372.x; Mason OU, 2009, ISME J, V3, P231, DOI 10.1038/ismej.2008.92; Massana R, 1997, APPL ENVIRON MICROB, V63, P50, DOI 10.1128/AEM.63.1.50-56.1997; McCollom TM, 2006, EARTH PLANET SC LETT, V243, P74, DOI 10.1016/j.epsl.2006.01.027; Mikesell Mark D., 1993, Biodegradation, V4, P249, DOI 10.1007/BF00695973; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; NEUNLIST S, 1985, BIOCHEM J, V231, P635, DOI 10.1042/bj2310635; Orcutt B, 2009, ENVIRON MICROBIOL, V11, P1728, DOI 10.1111/j.1462-2920.2009.01899.x; Orphan VJ, 2000, APPL ENVIRON MICROB, V66, P700, DOI 10.1128/AEM.66.2.700-711.2000; Park J, 2002, APPL ENVIRON MICROB, V68, P5231, DOI 10.1128/AEM.68.11.5231-5240.2002; Perner M, 2007, ENVIRON MICROBIOL, V9, P1186, DOI 10.1111/j.1462-2920.2007.01241.x; Proskurowski G, 2008, SCIENCE, V319, P604, DOI 10.1126/science.1151194; ROHMER M, 1979, P NATL ACAD SCI USA, V76, P847, DOI 10.1073/pnas.76.2.847; Rojo F, 2005, J BACTERIOL, V187, P19, DOI 10.1128/JB.187.1.19-22.2005; RUETER P, 1994, NATURE, V372, P455, DOI 10.1038/372455a0; Santelli CM, 2008, NATURE, V453, P653, DOI 10.1038/nature06899; Santelli CM, 2009, ENVIRON MICROBIOL, V11, P86, DOI 10.1111/j.1462-2920.2008.01743.x; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Schouten S, 2000, FEMS MICROBIOL LETT, V186, P193, DOI 10.1111/j.1574-6968.2000.tb09103.x; Schrenk MO, 2010, ANNU REV MAR SCI, V2, P279, DOI 10.1146/annurev-marine-120308-081000; Schrenk MO, 2004, ENVIRON MICROBIOL, V6, P1086, DOI 10.1111/j.1462-2920.2004.00650.x; Sentchilo VS, 2000, APPL ENVIRON MICROB, V66, P2842, DOI 10.1128/AEM.66.7.2842-2852.2000; Smits THM, 1999, ENVIRON MICROBIOL, V1, P307, DOI 10.1046/j.1462-2920.1999.00037.x; Spotl C, 2003, RAPID COMMUN MASS SP, V17, P1004, DOI 10.1002/rcm.1010; Thorseth IH, 2001, EARTH PLANET SC LETT, V194, P31, DOI 10.1016/S0012-821X(01)00537-4; Throne-Holst M, 2006, APPL MICROBIOL BIOT, V72, P353, DOI 10.1007/s00253-005-0262-9; TORNABENE TG, 1979, J MOL EVOL, V13, P73, DOI 10.1007/BF01732755; Van Aken B, 2004, INT J SYST EVOL MICR, V54, P1191, DOI 10.1099/ijs.0.02796-0; Volkman JK, 2003, APPL MICROBIOL BIOT, V60, P495, DOI 10.1007/s00253-002-1172-8; Wu LY, 2006, APPL ENVIRON MICROB, V72, P4931, DOI 10.1128/AEM.02738-05	72	100	101	1	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2010	5	11							e15399	10.1371/journal.pone.0015399	http://dx.doi.org/10.1371/journal.pone.0015399			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675OD	21079766	Green Submitted, Green Published, gold			2022-12-27	WOS:000283839100021
J	Huang, YQ; Liu, ZR				Huang, Yongqi; Liu, Zhirong			Nonnative Interactions in Coupled Folding and Binding Processes of Intrinsically Disordered Proteins	PLOS ONE			English	Article							DENATURED STATE ENSEMBLE; FLY-CASTING MECHANISM; TRANSITION-STATES; MOLECULAR-DYNAMICS; NATIVE TOPOLOGY; GO MODELS; ELECTROSTATIC INTERACTIONS; HYDROPHOBIC INTERACTIONS; UNSTRUCTURED PROTEINS; KINETIC COOPERATIVITY	Proteins function by interacting with other molecules, where both native and nonnative interactions play important roles. Native interactions contribute to the stability and specificity of a complex, whereas nonnative interactions mainly perturb the binding kinetics. For intrinsically disordered proteins (IDPs), which do not adopt rigid structures when being free in solution, the role of nonnative interactions may be more prominent in binding processes due to their high flexibilities. In this work, we investigated the effect of nonnative hydrophobic interactions on the coupled folding and binding processes of IDPs and its interplay with chain flexibility by conducting molecular dynamics simulations. Our results showed that the free-energy profiles became rugged, and intermediate states occurred when nonnative hydrophobic interactions were introduced. The binding rate was initially accelerated and subsequently dramatically decreased as the strength of the nonnative hydrophobic interactions increased. Both thermodynamic and kinetic analysis showed that disordered systems were more readily affected by nonnative interactions than ordered systems. Furthermore, it was demonstrated that the kinetic advantage of IDPs ("fly-casting'' mechanism) was enhanced by nonnative hydrophobic interactions. The relationship between chain flexibility and protein aggregation is also discussed.	[Huang, Yongqi; Liu, Zhirong] Peking Univ, Coll Chem & Mol Engn, State Key Lab Struct Chem Unstable & Stable Speci, Beijing 100871, Peoples R China; [Huang, Yongqi; Liu, Zhirong] Peking Univ, Ctr Theoret Biol, Beijing 100871, Peoples R China; [Huang, Yongqi; Liu, Zhirong] Peking Univ, Beijing Natl Lab Mol Sci, Beijing 100871, Peoples R China	Chinese Academy of Sciences; Peking University; Peking University; Chinese Academy of Sciences; Peking University	Huang, YQ (corresponding author), Peking Univ, Coll Chem & Mol Engn, State Key Lab Struct Chem Unstable & Stable Speci, Beijing 100871, Peoples R China.	LiuZhiRong@pku.edu.cn	Liu, Zhirong/K-8703-2012		Ministry of Science and Technology of China [2009CB918500]; National Natural Science Foundation of China [20973016, 10721403]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Ministry of Science and Technology of China (No. 2009CB918500) (http://www.most.gov.cn/) and the National Natural Science Foundation of China (No. 20973016 and No. 10721403) (http://www.nsfc.gov.cn/Portal0/default124.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsallaq R, 2008, PROTEINS, V71, P320, DOI 10.1002/prot.21679; Azia A, 2009, J MOL BIOL, V393, P527, DOI 10.1016/j.jmb.2009.08.010; Badasyan A, 2008, J MOL BIOL, V384, P512, DOI 10.1016/j.jmb.2008.09.023; Blanco FJ, 1997, FOLD DES, V2, P123, DOI 10.1016/S1359-0278(97)00017-5; BOCZKO EM, 1993, J PHYS CHEM-US, V97, P4509, DOI 10.1021/j100119a043; BRYNGELSON JD, 1995, PROTEINS, V21, P167, DOI 10.1002/prot.340210302; Canet D, 2003, J MOL BIOL, V330, P397, DOI 10.1016/S0022-2836(03)00507-2; Capaldi AP, 2002, NAT STRUCT BIOL, V9, P209, DOI 10.1038/nsb757; CHAN HS, 1994, J CHEM PHYS, V100, P9238, DOI 10.1063/1.466677; Chen YT, 2010, PROTEINS, V78, P2090, DOI 10.1002/prot.22724; Cho JH, 2005, J MOL BIOL, V353, P174, DOI 10.1016/j.jmb.2005.08.019; Cho JH, 2004, J MOL BIOL, V338, P827, DOI 10.1016/j.jmb.2004.02.073; CHRIVIA JC, 1993, NATURE, V365, P855, DOI 10.1038/365855a0; Cieplak M, 2002, INT J MOD PHYS C, V13, P1231, DOI 10.1142/S012918310200408X; Clementi C, 2000, J MOL BIOL, V298, P937, DOI 10.1006/jmbi.2000.3693; Clementi C, 2004, PROTEIN SCI, V13, P1750, DOI 10.1110/ps.03580104; Curcio R, 2005, PROTEIN SCI, V14, P2499, DOI 10.1110/ps.041280705; Di Nardo AA, 2004, P NATL ACAD SCI USA, V101, P7954, DOI 10.1073/pnas.0400550101; Dill KA, 1997, NAT STRUCT BIOL, V4, P10, DOI 10.1038/nsb0197-10; Dyson HJ, 2002, CURR OPIN STRUC BIOL, V12, P54, DOI 10.1016/S0959-440X(02)00289-0; Fan K, 2002, EUR PHYS J B, V30, P381, DOI 10.1140/epjb/e2002-00393-4; Gao M, 2010, ACTA PHYS-CHIM SIN, V26, P1998, DOI 10.3866/PKU.WHXB20100733; Gardino AK, 2009, CELL, V139, P1109, DOI 10.1016/j.cell.2009.11.022; Gin BC, 2009, J MOL BIOL, V392, P1303, DOI 10.1016/j.jmb.2009.06.058; Givaty O, 2009, J MOL BIOL, V385, P1087, DOI 10.1016/j.jmb.2008.11.016; GO N, 1983, ANNU REV BIOPHYS BIO, V12, P183, DOI 10.1146/annurev.bb.12.060183.001151; Goldschmidt L, 2010, P NATL ACAD SCI USA, V107, P3487, DOI 10.1073/pnas.0915166107; Huang YQ, 2010, ACTA PHYS-CHIM SIN, V26, P2061, DOI 10.3866/PKU.WHXB20100644; Huang YQ, 2010, PROTEINS, V78, P3251, DOI 10.1002/prot.22820; Huang YQ, 2009, J MOL BIOL, V393, P1143, DOI 10.1016/j.jmb.2009.09.010; Karanicolas J, 2003, J MOL BIOL, V334, P309, DOI 10.1016/j.jmb.2003.09.047; Kaya H, 2004, J MOL BIOL, V337, P1069, DOI 10.1016/j.jmb.2004.02.025; Kaya H, 2003, J MOL BIOL, V326, P911, DOI 10.1016/S0022-2836(02)01434-1; Kriwacki RW, 1996, P NATL ACAD SCI USA, V93, P11504, DOI 10.1073/pnas.93.21.11504; Kuhlman B, 2003, SCIENCE, V302, P1364, DOI 10.1126/science.1089427; Levy Y, 2005, J MOL BIOL, V346, P1121, DOI 10.1016/j.jmb.2004.12.021; Levy Y, 2007, J AM CHEM SOC, V129, P738, DOI 10.1021/ja065531n; Li L, 2000, NAT STRUCT BIOL, V7, P336; Liu ZR, 2005, PHYS BIOL, V2, pS75, DOI 10.1088/1478-3975/2/4/S01; Liu ZR, 2005, J MOL BIOL, V349, P872, DOI 10.1016/j.jmb.2005.03.084; Lu Q, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.128105; Meszaros B, 2007, J MOL BIOL, V372, P549, DOI 10.1016/j.jmb.2007.07.004; Micheletti C, 1999, PHYS REV LETT, V82, P3372, DOI 10.1103/PhysRevLett.82.3372; Midic U, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-S1-S12; Morton VL, 2007, J MOL BIOL, V371, P554, DOI 10.1016/j.jmb.2007.05.010; Neudecker P, 2006, J MOL BIOL, V363, P958, DOI 10.1016/j.jmb.2006.08.047; Oldfield CJ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S1-S1; Oldfield CJ, 2005, BIOCHEMISTRY-US, V44, P1989, DOI 10.1021/bi047993o; Otzen D, 2005, PROTEIN ENG DES SEL, V18, P547, DOI 10.1093/protein/gzi063; Paci E, 2005, J PHYS-CONDENS MAT, V17, pS1617, DOI 10.1088/0953-8984/17/18/017; Paci E, 2002, BIOPHYS J, V83, P3032, DOI 10.1016/S0006-3495(02)75308-3; Pechmann S, 2009, P NATL ACAD SCI USA, V106, P10159, DOI 10.1073/pnas.0812414106; Plotkin SS, 2001, PROTEINS, V45, P337, DOI 10.1002/prot.1154; Qi YF, 2010, BIOPHYS J, V98, P321, DOI 10.1016/j.bpj.2009.10.018; Radhakrishnan I, 1997, CELL, V91, P741, DOI 10.1016/S0092-8674(00)80463-8; Rothwarf DM, 1996, BIOCHEMISTRY-US, V35, P13797, DOI 10.1021/bi9608119; Salvatella X, 2005, P NATL ACAD SCI USA, V102, P12389, DOI 10.1073/pnas.0408226102; Sanchez IE, 2010, P NATL ACAD SCI USA, V107, P7751, DOI 10.1073/pnas.0911734107; Shoemaker BA, 2000, P NATL ACAD SCI USA, V97, P8868, DOI 10.1073/pnas.160259697; Sobolev V, 1999, BIOINFORMATICS, V15, P327, DOI 10.1093/bioinformatics/15.4.327; Sugase K, 2007, NATURE, V447, P1021, DOI 10.1038/nature05858; Tang C, 2006, NATURE, V444, P383, DOI 10.1038/nature05201; Tsai CJ, 1999, PROTEIN SCI, V8, P1181, DOI 10.1110/ps.8.6.1181; Turjanski AG, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000060; Turoverov KK, 2010, PROG BIOPHYS MOL BIO, V102, P73, DOI 10.1016/j.pbiomolbio.2010.01.003; UEDA Y, 1978, BIOPOLYMERS, V17, P1531, DOI 10.1002/bip.1978.360170612; Uversky VN, 2010, BBA-PROTEINS PROTEOM, V1804, P1231, DOI 10.1016/j.bbapap.2010.01.017; Vavouri T, 2009, CELL, V138, P198, DOI 10.1016/j.cell.2009.04.029; Viguera AR, 2002, P NATL ACAD SCI USA, V99, P5349, DOI 10.1073/pnas.072387799; Wallin S, 2007, J MOL BIOL, V368, P884, DOI 10.1016/j.jmb.2007.02.035; Wang J, 2006, PLOS COMPUT BIOL, V2, P842, DOI 10.1371/journal.pcbi.0020078; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; Wrabl JO, 1996, PROTEIN SCI, V5, P2343, DOI 10.1002/pro.5560051121; Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110; Zarrine-Afsar A, 2008, P NATL ACAD SCI USA, V105, P9999, DOI 10.1073/pnas.0801874105; Zhang ZQ, 2010, P NATL ACAD SCI USA, V107, P2920, DOI 10.1073/pnas.0911844107; Zhang ZQ, 2009, BIOPHYS J, V96, pL25, DOI 10.1016/j.bpj.2008.11.004; Zhou HX, 2005, PHYS BIOL, V2, pR1, DOI 10.1088/1478-3975/2/3/R01; Zhou HX, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.178101	79	33	33	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2010	5	11							e15375	10.1371/journal.pone.0015375	http://dx.doi.org/10.1371/journal.pone.0015375			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675NY	21079758	Green Published, Green Submitted, gold			2022-12-27	WOS:000283838600024
J	Tong, JS; Zhang, QH; Wang, ZB; Li, S; Yang, CR; Fu, XQ; Hou, Y; Wang, ZY; Sheng, J; Sun, QY				Tong, Jing-Shan; Zhang, Qing-Hua; Wang, Zhen-Bo; Li, Sen; Yang, Cai-Rong; Fu, Xue-Qi; Hou, Yi; Wang, Zhao-Yi; Sheng, Jun; Sun, Qing-Yuan			ER-alpha 36, a Novel Variant of ER-alpha, Mediates Estrogen-Stimulated Proliferation of Endometrial Carcinoma Cells via the PKC delta/ERK Pathway	PLOS ONE			English	Article							PROTEIN-KINASE-C; BREAST-CANCER CELLS; CYCLIN D1; RECEPTOR-ALPHA; SIGNALING PATHWAY; NUCLEAR RECEPTORS; MAPK ACTIVATION; TUMOR-CELLS; EXPRESSION; 17-BETA-ESTRADIOL	Background: Recently, a variant of ER-alpha, ER-alpha 36 was identified and cloned. ER-alpha 36 lacks intrinsic transcription activity and mainly mediates non-genomic estrogen signaling. The purpose of this study was to investigate the function and the underlying mechanisms of ER-alpha 36 in growth regulation of endometrial Ishikawa cancer cells. Methods: The cellular localization of ER-alpha 36 and ER-alpha 66 were determined by immunofluorescence in the Ishikawa cells. Ishikawa endometrial cancer control cells transfected with an empty expression vector, Ishikawa cells with shRNA knockdown of ER-alpha 36 (Ishikawa/RNAiER36) and Ishikawa cells with shRNA knockdown of ER-alpha 66 (Ishikawa/RNAiER66) were treated with E2 and E2-conjugated to bovine serum albumin (E2-BSA, membrane impermeable) in the absence and presence of different kinase inhibitors HBDDE, bisindolylmaleimide, rottlerin, H89 and U0126. The phosphorylation levels of signaling molecules and cyclin D1/cdk4 expression were examined with Western blot analysis and cell growth was monitored with the MTT assay. Results: Immunofluorescence staining of Ishikawa cells demonstrated that ER-alpha 36 was expressed mainly on the plasma membrane and in the cytoplasm, while ER-alpha 66 was predominantly localized in the cell nucleus. Both E2 and E2-BSA rapidly activated PKC delta not PKC alpha in Ishikawa cells, which could be abrogated by ER-alpha 36 shRNA expression. E2-and E2-BSA-induced ERK phosphorylation required ER-alpha 36 and PKCd. However, only E2 was able to induce Camp-dependent protein kinase A (PKA) phosphorylation. Furthermore, E2 enhances cyclin D1/cdk4 expression via ER-alpha 36. Conclusion: E2 activates the PKC delta/ERK pathway and enhances cyclin D1/cdk4 expression via the membrane-initiated signaling pathways mediated by ER-alpha 36, suggesting a possible involvement of ER-alpha 36 in E2-dependent growth-promoting effects in endometrial cancer cells.	[Tong, Jing-Shan; Fu, Xue-Qi; Sheng, Jun] Jilin Univ, Coll Life Sci, Changchun 130023, Peoples R China; [Tong, Jing-Shan; Zhang, Qing-Hua; Wang, Zhen-Bo; Li, Sen; Yang, Cai-Rong; Hou, Yi; Sun, Qing-Yuan] Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing, Peoples R China; [Wang, Zhao-Yi] Creighton Univ, Sch Med, Dept Med Microbiol & Immunol, Omaha, NE USA; [Sheng, Jun] Yunnan Agr Univ, Kunming, Peoples R China	Jilin University; Chinese Academy of Sciences; Institute of Zoology, CAS; Creighton University; Yunnan Agricultural University	Tong, JS (corresponding author), Jilin Univ, Coll Life Sci, Changchun 130023, Peoples R China.	shengj63@126.com; sunqy@ioz.ac.cn	Yang, Cairong/AAB-1440-2021	Yang, Cairong/0000-0001-9594-0529; Tong, Jingshan/0000-0003-1640-5769	Major State Basic Research Program of China; National Institute of Health [DK84328]; Nebraska Tobacco Settlement Biomedical Research Program [LB595]	Major State Basic Research Program of China(National Basic Research Program of China); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Nebraska Tobacco Settlement Biomedical Research Program	This work was supported by Major State Basic Research Program of China to QYS and also supported by National Institute of Health Grant, DK84328 and the Nebraska Tobacco Settlement Biomedical Research Program LB595 to ZYW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acconcia F, 2005, MOL BIOL CELL, V16, P231, DOI 10.1091/mbc.e04-07-0547; Boyan BD, 2003, ENDOCRINOLOGY, V144, P1812, DOI 10.1210/en.2002-221018; Brodie C, 2003, APOPTOSIS, V8, P19, DOI 10.1023/A:1021640817208; Caldon CE, 2009, MOL CELL BIOL, V29, P4623, DOI 10.1128/MCB.00269-09; Cao QJ, 2002, INT J GYNECOL PATHOL, V21, P147, DOI 10.1097/00004347-200204000-00007; Chaudhry P, 2009, ENDOCR-RELAT CANCER, V16, P363, DOI 10.1677/ERC-08-0266; Collins P, 1999, NAT MED, V5, P1130, DOI 10.1038/13453; Deucher A, 2002, J BIOL CHEM, V277, P17032, DOI 10.1074/jbc.M109076200; Grossoni VC, 2007, MOL CARCINOGEN, V46, P381, DOI 10.1002/mc.20287; Guo RX, 2006, J STEROID BIOCHEM, V99, P9, DOI 10.1016/j.jsbmb.2005.11.013; Henderson BE, 2000, CARCINOGENESIS, V21, P427, DOI 10.1093/carcin/21.3.427; Hsieh YC, 2007, AM J PATHOL, V170, P1210, DOI 10.2353/ajpath.2007.060883; Jiang XH, 2004, CANCER RES, V64, P5787, DOI 10.1158/0008-5472.CAN-03-1172; Kashima H, 2009, ENDOCR-RELAT CANCER, V16, P113, DOI 10.1677/ERC-08-0117; Knudsen KE, 1998, J BIOL CHEM, V273, P20213, DOI 10.1074/jbc.273.32.20213; Koivunen J, 2006, CANCER LETT, V235, P1, DOI 10.1016/j.canlet.2005.03.033; Koivunen J, 2004, CANCER RES, V64, P5693, DOI 10.1158/0008-5472.CAN-03-3511; Leirdal M, 1999, BRIT J CANCER, V80, P1558, DOI 10.1038/sj.bjc.6690560; Li WQ, 1998, MOL CELL BIOL, V18, P5888, DOI 10.1128/MCB.18.10.5888; Lin SL, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-102; LIN SL, PLOS ONE, V5, pE9013; Liu JF, 2002, BIOCHEM BIOPH RES CO, V293, P1174, DOI 10.1016/S0006-291X(02)00350-9; Marino M, 2006, CURR GENOMICS, V7, P497, DOI 10.2174/138920206779315737; Muchekehu RW, 2008, CELL CALCIUM, V44, P276, DOI 10.1016/j.ceca.2007.12.001; Muramatsu M, 2000, BIOCHEM BIOPH RES CO, V270, P1, DOI 10.1006/bbrc.2000.2214; Nakagawa S, 2003, MOL CARCINOGEN, V38, P106, DOI 10.1002/mc.10150; Newton AC, 1997, CURR OPIN CELL BIOL, V9, P161, DOI 10.1016/S0955-0674(97)80058-0; NISHIZUKA Y, 1995, FASEB J, V9, P484, DOI 10.1096/fasebj.9.7.7737456; NISHIZUKA Y, 1988, NATURE, V334, P661, DOI 10.1038/334661a0; NISHIZUKA Y, 1986, SCIENCE, V233, P305, DOI 10.1126/science.3014651; Ordonez-Moran P, 2009, CELL CYCLE, V8, P1675, DOI 10.4161/cc.8.11.8579; QIU ZH, 1994, J BIOL CHEM, V269, P19480; Quddus MR, 2002, ARCH PATHOL LAB MED, V126, P459; QUELLE DE, 1993, GENE DEV, V7, P1559, DOI 10.1101/gad.7.8.1559; Reyland ME, 2007, BIOCHEM SOC T, V35, P1001, DOI 10.1042/BST0351001; Rosenfeld MG, 2001, J BIOL CHEM, V276, P36865, DOI 10.1074/jbc.R100041200; Roy PG, 2006, BREAST, V15, P718, DOI 10.1016/j.breast.2006.02.005; SCHMITT JM, MOL CELL BIOCH, V335, P155; Shang YF, 2006, NAT REV CANCER, V6, P360, DOI 10.1038/nrc1879; Shiozawa T, 2004, ONCOGENE, V23, P8603, DOI 10.1038/sj.onc.1207849; Singleton DW, 2003, ENDOCRINOLOGY, V144, P121, DOI 10.1210/en.2002-220625; Sinha R, 1999, CANCER LETT, V146, P135, DOI 10.1016/S0304-3835(99)00250-5; Song RXD, 2002, MOL ENDOCRINOL, V16, P116, DOI 10.1210/me.16.1.116; Ueda Y, 1996, J BIOL CHEM, V271, P23512, DOI 10.1074/jbc.271.38.23512; Vivacqua A, 2006, MOL ENDOCRINOL, V20, P631, DOI 10.1210/me.2005-0280; Wang ZY, 2006, P NATL ACAD SCI USA, V103, P9063, DOI 10.1073/pnas.0603339103; Wang ZY, 2005, BIOCHEM BIOPH RES CO, V336, P1023, DOI 10.1016/j.bbrc.2005.08.226; Watson CS, 1999, EXP PHYSIOL, V84, P1013, DOI 10.1111/j.1469-445X.1999.01903.x; Way KJ, 2000, TRENDS PHARMACOL SCI, V21, P181, DOI 10.1016/S0165-6147(00)01468-1; Zhang LL, 2009, J CELL BIOCHEM, V106, P553, DOI 10.1002/jcb.22017; Zhang YJ, 2003, CHINESE MED J-PEKING, V116, P383; Zhang ZG, 2002, BIOCHEM BIOPH RES CO, V294, P926, DOI 10.1016/S0006-291X(02)00348-0; Zou Y, 2009, FEBS LETT, V583, P1368, DOI 10.1016/j.febslet.2009.03.047	53	59	71	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2010	5	11							e15408	10.1371/journal.pone.0015408	http://dx.doi.org/10.1371/journal.pone.0015408			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675NY	21079811	Green Published, gold, Green Submitted			2022-12-27	WOS:000283838600026
J	Ma, L; Li, W; Zhu, HP; Li, Z; Sun, ZJ; Liu, XP; Zhao, J; Zhang, JS; Zhang, YQ				Ma, Li; Li, Wei; Zhu, Hua-Ping; Li, Zhen; Sun, Zhi-Jian; Liu, Xin-Ping; Zhao, Jie; Zhang, Jin-Shan; Zhang, Yuan-Qiang			Localization and Androgen Regulation of Metastasis-Associated Protein 1 in Mouse Epididymis	PLOS ONE			English	Article							RAT EPIDIDYMIS; EFFERENT DUCTS; EPITHELIAL-CELLS; MALE-MICE; EXPRESSION; GENES; SPERM; SPERMATOGENESIS; IDENTIFICATION; RECEPTOR	Background: Metastasis-associated protein 1 (MTA1), the founding member of the MTA family of genes, can modulate transcription by influencing the status of chromatin remodeling. Despite its strong correlation with the metastatic potential of cancer cells, MTA1 can also regulate crucial cellular pathways by modifying the acetylation status. We have previously reported the presence of MTA1/MTA1 in human and mouse testes, providing the evidence for its involvement in the regulation of testicular function during murine spermatogenesis. The objective of present study was to further assess the localization of MTA1 in mouse epididymis on both transcriptional and translational level, and then to explore whether MTA1 expression is regulated by androgens and postnatal epididymal development. Methodology/Principal Findings: Mice were deprived of circulating androgen by bilaterally castration and were then supplemented with exogenous testosterone propionate for one week. MTA1 was immunolocalized in the epithelium of the entire epididymis with the maximal expression in the nuclei of principal cells and of clear cells in proximal region. Its expression decreased gradually after castration, whereas testosterone treatment could restore the expression, indicating that the expression of this gene is dependent on androgen. During postnatal development, the protein expression in the epididymis began to appear from day 7 to day 14, increased dramatically from postnatal day 28, and peaked at adulthood onwards, coinciding with both the well differentiated status of epididymis and the mature levels of circulating androgens. This region-and cell-specific pattern was also conservative in normal human epididymis. Conclusions: Our data suggest that the expression of MTA1 protein could be regulated by androgen pathway and its expression level is closely associated with the postnatal development of the epididymis, giving rise to the possibility that this gene plays a potential role in sperm maturation and fertility.	[Ma, Li; Li, Wei; Zhu, Hua-Ping; Li, Zhen; Sun, Zhi-Jian; Zhao, Jie; Zhang, Jin-Shan; Zhang, Yuan-Qiang] Fourth Mil Med Univ, Dept Human Anat & Histol & Embryol, Xian 710032, Peoples R China; [Liu, Xin-Ping] Fourth Mil Med Univ, Dept Biochem & Mol Biol, Xian 710032, Peoples R China	Air Force Military Medical University; Air Force Military Medical University	Ma, L (corresponding author), Fourth Mil Med Univ, Dept Human Anat & Histol & Embryol, Xian 710032, Peoples R China.	zhangyq@fmmu.edu.cn			Natural Science Foundation of China (NSFC) [30800395, 30771138]; Military Medical Foundation [06MA216]	Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Military Medical Foundation	This work was supported by the Natural Science Foundation of China (NSFC) (30800395, 2008; 30771138, 2007) and by the Military Medical Foundation (06MA216) (http://www.nsfc.gov.cn/Portal0/default124.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABOUHAILA A, 1985, INT J ANDROL, V8, P441, DOI 10.1111/j.1365-2605.1985.tb00858.x; Aramaki Y, 2005, FEBS LETT, V579, P3731, DOI 10.1016/j.febslet.2005.05.069; Bagheri-Yarmand R, 2004, DEVELOPMENT, V131, P3469, DOI 10.1242/dev.01213; Baska KM, 2008, J CELL PHYSIOL, V215, P684, DOI 10.1002/jcp.21349; Belleannee C, 2009, BIOL REPROD, V80, P134, DOI 10.1095/biolreprod.108.070797; Beumer TL, 1998, CELL DEATH DIFFER, V5, P669, DOI 10.1038/sj.cdd.4400396; Bomgardner D, 2003, BIOL REPROD, V68, P644, DOI 10.1095/biolreprod.102.009324; CHAREST NJ, 1989, ENDOCRINOLOGY, V125, P942, DOI 10.1210/endo-125-2-942; Chauvin TR, 2004, BIOL REPROD, V71, P560, DOI 10.1095/biolreprod.103.026302; CORNWALL GA, 1995, J ANDROL, V16, P379; FAYE JC, 1980, BIOL REPROD, V23, P423, DOI 10.1095/biolreprod23.2.423; Fouchecourt S, 2003, ENDOCRINOLOGY, V144, P887, DOI 10.1210/en.2002-220932; GALLON C, 1989, J ANDROL, V10, P188; HERMO L, 1992, ANAT RECORD, V232, P202, DOI 10.1002/ar.1092320206; Hermo L, 2008, J HISTOCHEM CYTOCHEM, V56, P1121, DOI 10.1369/jhc.2008.951947; Hu YX, 2003, ENDOCRINOLOGY, V144, P1612, DOI 10.1210/en.2002-220915; KIMURA M, 1974, P NATL ACAD SCI USA, V71, P2848, DOI 10.1073/pnas.71.7.2848; Kirchhoff C, 2008, REPRODUCTION, V136, P235, DOI 10.1530/REP-08-0078; Kumar R, 2003, SEMIN ONCOL, V30, P30, DOI 10.1053/j.seminoncol.2003.08.005; Li DQ, 2009, J BIOL CHEM, V284, P34545, DOI 10.1074/jbc.M109.056499; Li W, 2008, FEBS LETT, V582, P869, DOI 10.1016/j.febslet.2008.02.013; Li W, 2007, CELL TISSUE RES, V329, P351, DOI 10.1007/s00441-007-0412-8; Li W, 2007, ASIAN J ANDROL, V9, P345, DOI 10.1111/j.1745-7262.2007.00245.x; Li W, 2009, TISSUE CELL, V41, P390, DOI 10.1016/j.tice.2009.04.002; Li Z, 2010, FERTIL STERIL, V93, P2661, DOI 10.1016/j.fertnstert.2010.01.053; Manavathi B, 2007, J BIOL CHEM, V282, P1529, DOI 10.1074/jbc.R600029200; Nicolson GL, 1998, IN VIVO, V12, P579; Oh J, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-314; Pietrement C, 2006, BIOL REPROD, V74, P185, DOI 10.1095/biolreprod.105.043752; Prabagaran E, 2007, J ANDROL, V28, P755, DOI 10.2164/jandrol.106.002394; Raymond AS, 2009, J CELL SCI, V122, P849, DOI 10.1242/jcs.041731; Robaire B, 2007, ASIAN J ANDROL, V9, P545, DOI 10.1111/j.1745-7262.2007.00316.x; Schurmann A, 2002, MOL CELL BIOL, V22, P2761, DOI 10.1128/MCB.22.8.2761-2768.2002; Shum WWC, 2009, J EXP BIOL, V212, P1753, DOI 10.1242/jeb.027284; Suarez-Quian CA, 1999, J CLIN ENDOCR METAB, V84, P350, DOI 10.1210/jc.84.1.350; TOH Y, 1994, J BIOL CHEM, V269, P22958; Tomaszewski J, 2007, P NATL ACAD SCI USA, V104, P11322, DOI 10.1073/pnas.0703445104; VERI JP, 1993, J ANDROL, V14, P23; Wennemuth G, 2000, J BIOL CHEM, V275, P21210, DOI 10.1074/jbc.M002068200; Zhen W, 2009, BIOL REPROD, V80, P696, DOI 10.1095/biolreprod.108.071589; Zhou X, 2007, ACTA BIOCH BIOPH SIN, V39, P939, DOI 10.1111/j.1745-7270.2007.00359.x; Zhou YC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004106; Zhu CF, 2007, BIOL REPROD, V76, P63, DOI 10.1095/biolreprod.106.054635	43	16	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2010	5	11							e15439	10.1371/journal.pone.0015439	http://dx.doi.org/10.1371/journal.pone.0015439			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	800AR	21082030	Green Published, Green Submitted, gold			2022-12-27	WOS:000293329500007
J	Zhong, SF; Israel, S; Shalev, I; Xue, H; Ebstein, RP; Chew, SH				Zhong, Songfa; Israel, Salomon; Shalev, Idan; Xue, Hong; Ebstein, Richard P.; Chew, Soo Hong			Dopamine D4 Receptor Gene Associated with Fairness Preference in Ultimatum Game	PLOS ONE			English	Article							EXON-III POLYMORPHISM; DRD4 GENE; GLUCOCORTICOID-RECEPTOR; PERSONALITY-TRAITS; ENVIRONMENT INTERACTION; EPIGENETIC REGULATION; BIRTH VARIATIONS; D-4 RECEPTOR; METAANALYSIS; SEASON	In experimental economics, the preference for reciprocal fairness has been observed in the controlled and incentivized laboratory setting of the ultimatum game, in which two individuals decide on how to divide a sum of money, with one proposing the share while the second deciding whether to accept. Should the proposal be accepted, the amount is divided accordingly. Otherwise, both would receive no money. A recent twin study has shown that fairness preference inferred from responder behavior is heritable, yet its neurogenetic basis remains unknown. The D4 receptor (DRD4) exon3 is a well-characterized functional polymorphism, which is known to be associated with attention deficit hyperactivity disorder and personality traits including novelty seeking and self-report altruism. Applying a neurogenetic approach, we find that DRD4 is significantly associated with fairness preference. Additionally, the interaction among this gene, season of birth, and gender is highly significant. This is the first result to link preference for reciprocal fairness to a specific gene and suggests that gene x environment interactions contribute to economic decision making.	[Zhong, Songfa; Chew, Soo Hong] Natl Univ Singapore, Dept Econ, Singapore 117548, Singapore; [Israel, Salomon; Shalev, Idan; Ebstein, Richard P.] Hebrew Univ Jerusalem, Scheinfeld Ctr Human Genet Social Sci, Jerusalem, Israel; [Xue, Hong] Hong Kong Univ Sci & Technol, Appl Genom Ctr, Kowloon, Hong Kong, Peoples R China; [Ebstein, Richard P.] Natl Univ Singapore, Dept Psychol, Singapore 117548, Singapore; [Zhong, Songfa; Chew, Soo Hong] Hong Kong Univ Sci & Technol, Dept Econ, Kowloon, Hong Kong, Peoples R China; [Chew, Soo Hong] Natl Univ Singapore, Dept Finance, Singapore 117548, Singapore; [Chew, Soo Hong] Hong Kong Univ Sci & Technol, Ctr Expt Business Res, Kowloon, Hong Kong, Peoples R China	National University of Singapore; Hebrew University of Jerusalem; Hong Kong University of Science & Technology; National University of Singapore; Hong Kong University of Science & Technology; National University of Singapore; Hong Kong University of Science & Technology	Zhong, SF (corresponding author), Natl Univ Singapore, Dept Econ, Singapore 117548, Singapore.	rpebstein@gmail.com; chew.soohong@gmail.com	Zhong, Songfa Z/I-4718-2016; Shalev, Idan/H-1943-2011	Israel, Salomon/0000-0003-3629-2466; Xue, Hong/0000-0002-8133-9828; Ebstein, Richard/0000-0002-3626-541X; Chew, Soo Hong/0000-0003-1245-0909	Hong Kong University of Science and Technology [AOE-MG/H-03/06]; National University of Singapore [R-122-000-125-133, HSS-1001-P02]	Hong Kong University of Science and Technology; National University of Singapore(National University of Singapore)	Financial support is from the Hong Kong University of Science and Technology (grant number: AOE-MG/H-03/06; www.ust.hk) and National University of Singapore (grant number: R-122-000-125-133 and HSS-1001-P02; www.nus.edu.sg). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASGHARI V, 1994, MOL PHARMACOL, V46, P364; ASGHARI V, 1995, J NEUROCHEM, V65, P1157, DOI 10.1046/j.1471-4159.1995.65031157.x; Bachner-Melman R, 2005, MOL PSYCHIATR, V10, P333, DOI 10.1038/sj.mp.4001635; Bakermans-Kranenburg MJ, 2006, DEV PSYCHOBIOL, V48, P406, DOI 10.1002/dev.20152; Ben Zion IZ, 2006, MOL PSYCHIATR, V11, P782, DOI 10.1038/sj.mp.4001832; Bookman EB, 2002, MOL PSYCHIATR, V7, P786, DOI 10.1038/sj.mp.4001075; Boyd R, 2002, J THEOR BIOL, V215, P287, DOI 10.1006/jtbi.2001.2515; Burnham TC, 2007, P ROY SOC B-BIOL SCI, V274, P2327, DOI 10.1098/rspb.2007.0546; Camerer C, 2005, J ECON LIT, V43, P9, DOI 10.1257/0022051053737843; Camerer C.F., 2003, BEHAV GAME THEORY EX, DOI 10.1257/jep.9.2.209; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; Cesarini D, 2009, Q J ECON, V124, P809, DOI 10.1162/qjec.2009.124.2.809; Chotai J, 2001, NEUROPSYCHOBIOLOGY, V44, P19, DOI 10.1159/000054909; CRISAN LG, 2009, SOCIAL COGN IN PRESS; Crockett MJ, 2008, SCIENCE, V320, P1739, DOI 10.1126/science.1155577; DAVIDSON R, 1981, ECONOMETRICA, V49, P781, DOI 10.2307/1911522; de Jonge LV, 2002, APPETITE, V38, P181, DOI 10.1006/appe.2002.0477; Ding YC, 2002, P NATL ACAD SCI USA, V99, P309, DOI 10.1073/pnas.012464099; Dreber A, 2009, EVOL HUM BEHAV, V30, P85, DOI 10.1016/j.evolhumbehav.2008.11.001; Ebstein RP, 2010, NEURON, V65, P831, DOI 10.1016/j.neuron.2010.02.020; Ebstein RP, 1996, NAT GENET, V12, P78, DOI 10.1038/ng0196-78; Eckel C, 2008, NEGOTIATION J, V24, P429, DOI 10.1111/j.1571-9979.2008.00196.x; Eckel CC, 2001, ECON INQ, V39, P171, DOI 10.1093/ei/39.2.171; Eisenberg DTA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001216; Eisenberg DTA, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-173; EISENEGGER C, 2009, NATURE; Faraone SV, 2009, PSYCHOL MED, V39, P685, DOI 10.1017/S0033291708003917; Faraone SV, 2001, AM J PSYCHIAT, V158, P1052, DOI 10.1176/appi.ajp.158.7.1052; Gicquel C, 2008, BEST PRACT RES CL EN, V22, P1, DOI 10.1016/j.beem.2007.07.009; Godoy R, 2008, AM J HUM BIOL, V20, P23, DOI 10.1002/ajhb.20679; GUTH W, 1982, J ECON BEHAV ORGAN, V3, P367, DOI 10.1016/0167-2681(82)90011-7; Harbaugh WT, 2007, SCIENCE, V316, P1622, DOI 10.1126/science.1140738; Henrich J, 2001, AM ECON REV, V91, P73, DOI 10.1257/aer.91.2.73; HOFFMAN E, 1994, GAME ECON BEHAV, V7, P346, DOI 10.1006/game.1994.1056; Israel S, 2009, PLOS ONE, V4; Jakobsdottir J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000337; Jongbloet P, 2008, BRIT J PSYCHIAT, V192, P313, DOI 10.1192/bjp.192.4.313a; Jordaan E, 2006, AUST NZ J PSYCHIAT, V40, P698, DOI 10.1111/j.1440-1614.2006.01870.x; Jovanovic V, 1999, PHARMACOGENETICS, V9, P561, DOI 10.1097/00008571-199910000-00003; KAHNEMAN D, 1986, AM ECON REV, V76, P728; Kamakura S, 1997, BIOCHEM BIOPH RES CO, V235, P321, DOI 10.1006/bbrc.1997.6770; Kang JI, 2008, NEUROSCI LETT, V430, P252, DOI 10.1016/j.neulet.2007.11.005; Kazmi MA, 2000, BIOCHEMISTRY-US, V39, P3734, DOI 10.1021/bi992354c; Keltikangas-Jarvinen L, 2004, MOL PSYCHIATR, V9, P308, DOI 10.1038/sj.mp.4001433; Kim B, 2009, PSYCHIAT INVEST, V6, P216, DOI 10.4306/pi.2009.6.3.216; Kirkpatrick B, 2008, SCHIZOPHR RES, V103, P151, DOI 10.1016/j.schres.2007.12.479; Kluger AN, 2002, MOL PSYCHIATR, V7, P712, DOI 10.1038/sj.mp.4001082; Knafo A, 2008, GENES BRAIN BEHAV, V7, P266, DOI 10.1111/j.1601-183X.2007.00341.x; KNIGHT J, 2008, STAT GENETICS GENE M, P423; Knoch D, 2006, SCIENCE, V314, P829, DOI 10.1126/science.1129156; Kuhnen CM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004362; LAIRD PW, 2010, NAT REV GENET; Laucht M, 2007, BIOL PSYCHIAT, V61, P87, DOI 10.1016/j.biopsych.2006.05.025; Leung PWL, 2005, AM J MED GENET B, V133B, P54, DOI 10.1002/ajmg.b.30129; Lucock M, 2010, AM J HUM BIOL, V22, P484, DOI 10.1002/ajhb.21022; Lutchmaya S, 2004, EARLY HUM DEV, V77, P23, DOI 10.1016/j.earlhumdev.2003.12.002; McClernon FJ, 2007, PSYCHOPHARMACOLOGY, V194, P433, DOI 10.1007/s00213-007-0860-6; McDermott R, 2009, P NATL ACAD SCI USA, V106, P2118, DOI 10.1073/pnas.0808376106; McGowan PO, 2009, NAT NEUROSCI, V12, P342, DOI 10.1038/nn.2270; MCGOWAN PO, 2010, NEUROBIOL DIS; Moll J, 2006, P NATL ACAD SCI USA, V103, P15623, DOI 10.1073/pnas.0604475103; Mueller BR, 2008, J NEUROSCI, V28, P9055, DOI 10.1523/JNEUROSCI.1424-08.2008; Munafo MR, 2008, BIOL PSYCHIAT, V63, P197, DOI 10.1016/j.biopsych.2007.04.006; Munafo MR, 2009, AM J MED GENET B, V150B, P271, DOI 10.1002/ajmg.b.30808; Oberlander TF, 2008, EPIGENETICS-US, V3, P97, DOI 10.4161/epi.3.2.6034; Perez de Castro I, 1997, PHARMACOGENETICS, V7, P345; Pfaff JJ, 2006, PSYCHIAT RES, V144, P217, DOI 10.1016/j.psychres.2006.04.019; Reist C, 2007, AM J MED GENET B, V144B, P453, DOI 10.1002/ajmg.b.30473; Riala K, 2007, NEUROPSYCHOBIOLOGY, V56, P14, DOI 10.1159/000109972; Richerson PJ., 2005, NOT GENES ALONE CULT; Risch N, 2009, JAMA-J AM MED ASSOC, V301, P2462, DOI 10.1001/jama.2009.878; Rivera A, 2008, NEUROSCIENCE, V155, P997, DOI 10.1016/j.neuroscience.2008.05.060; Roe BE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006704; Sanfey AG, 2003, SCIENCE, V300, P1755, DOI 10.1126/science.1082976; Schoots O, 2003, PHARMACOGENOMICS J, V3, P343, DOI 10.1038/sj.tpj.6500208; Seeger G, 2004, NEUROSCI LETT, V366, P282, DOI 10.1016/j.neulet.2004.05.049; Shao CH, 2006, PSYCHOPHARMACOLOGY, V186, P185, DOI 10.1007/s00213-006-0375-6; Shaw P, 2007, ARCH GEN PSYCHIAT, V64, P921, DOI 10.1001/archpsyc.64.8.921; SMITH VL, 1982, AM ECON REV, V72, P923; Solnick SJ, 2001, ECON INQ, V39, P189, DOI 10.1093/ei/39.2.189; Tochigi M, 2006, NEUROSCI LETT, V398, P333, DOI 10.1016/j.neulet.2006.01.020; Turner JD, 2008, NUCLEIC ACIDS RES, V36, P7207, DOI 10.1093/nar/gkn897; Uher R, 2008, MOL PSYCHIATR, V13, P131, DOI 10.1038/sj.mp.4002067; Van Craenenbroeck K, 2005, J BIOL CHEM, V280, P19350, DOI 10.1074/jbc.M414043200; Van den Bergh B, 2006, P R SOC B, V273, P2091, DOI 10.1098/rspb.2006.3550; VANTOL HHM, 1992, NATURE, V358, P149; Vogel CIG, 2006, J NEURAL TRANSM, V113, P1935, DOI 10.1007/s00702-006-0497-3; Wallace B, 2007, P NATL ACAD SCI USA, V104, P15631, DOI 10.1073/pnas.0706642104; Wang E, 2004, AM J HUM GENET, V74, P931, DOI 10.1086/420854; Weaver ICG, 2007, EPIGENETICS, V2, P22, DOI 10.4161/epi.2.1.3881; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Yang AS, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh032; Zak PJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008330; Zethraeus N, 2009, P NATL ACAD SCI USA, V106, P6535, DOI 10.1073/pnas.0812757106; Zhang DD, 2007, P NATL ACAD SCI USA, V104, P19214, DOI 10.1073/pnas.0703073104; Zhang DD, 2006, CLIMATIC CHANGE, V76, P459, DOI 10.1007/s10584-005-9024-z; Zhong SF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008516; Zhong SF, 2009, P ROY SOC B-BIOL SCI, V276, P4181, DOI 10.1098/rspb.2009.1312	99	36	41	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2010	5	11							e13765	10.1371/journal.pone.0013765	http://dx.doi.org/10.1371/journal.pone.0013765			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	674WJ	21072167	Green Published, Green Submitted, gold			2022-12-27	WOS:000283780800003
J	Kranzer, K; Zeinecker, J; Ginsberg, P; Orrell, C; Kalawe, NN; Lawn, SD; Bekker, LG; Wood, R				Kranzer, Katharina; Zeinecker, Jennifer; Ginsberg, Philip; Orrell, Catherine; Kalawe, Nosindiso N.; Lawn, Stephen D.; Bekker, Linda-Gail; Wood, Robin			Linkage to HIV Care and Antiretroviral Therapy in Cape Town, South Africa	PLOS ONE			English	Article							FOLLOW-UP; RISK-FACTORS; INFECTED PATIENTS; EARLY MORTALITY; SURVIVAL; TUBERCULOSIS; ADULTS; ADHERENCE; COUNTRIES; PROGRAMS	Background: Antiretroviral therapy (ART) has been scaled-up rapidly in Africa. Programme reports typically focus on loss to follow-up and mortality among patients receiving ART. However, little is known about linkage and retention in care of individuals prior to starting ART. Methodology: Data on adult residents from a periurban community in Cape Town were collected at a primary care clinic and hospital. HIV testing registers, CD4 count results provided by the National Health Laboratory System and ART registers were linked. A random sample (n = 885) was drawn from adults testing HIV positive through antenatal care, sexual transmitted disease and voluntary testing and counseling services between January 2004 and March 2009. All adults (n = 103) testing HIV positive through TB services during the same time period were also included in the study. Linkage to HIV care was defined as attending for a CD4 count measurement within 6 months of HIV diagnosis. Linkage to ART care was defined as initiating ART within 6 months of HIV diagnosis in individuals with a CD4 count <= 200 cells/mu l taken within 6 months of HIV diagnosis. Findings: Only 62.6% of individuals attended for a CD4 count measurement within 6 months of testing HIV positive. Individuals testing through sexually transmitted infection services had the best (84.1%) and individuals testing on their own initiative (53.5%) the worst linkage to HIV care. One third of individuals with timely CD4 counts were eligible for ART and 66.7% of those were successfully linked to ART care. Linkage to ART care was highest among antenatal care clients. Among individuals not yet eligible for ART only 46.3% had a repeat CD4 count. Linkage to HIV care improved in patients tested in more recent calendar period. Conclusion: Linkage to HIV and ART care was low in this poor peri-urban community despite free services available within close proximity. More efforts are needed to link VCT scale-up to subsequent care.	[Kranzer, Katharina; Zeinecker, Jennifer; Ginsberg, Philip; Orrell, Catherine; Lawn, Stephen D.; Bekker, Linda-Gail; Wood, Robin] Univ Cape Town, Inst Infect Dis & Mol Med, Desmond Tutu HIV Ctr, Fac Hlth Sci,Dept Med, ZA-7925 Cape Town, South Africa; [Kranzer, Katharina; Lawn, Stephen D.] London Sch Hyg & Trop Med, Dept Infect & Trop Dis, Clin Res Unit, London WC1, England; [Kalawe, Nosindiso N.] False Bay Hosp, Cape Town, South Africa	University of Cape Town; University of London; London School of Hygiene & Tropical Medicine	Kranzer, K (corresponding author), Univ Cape Town, Inst Infect Dis & Mol Med, Desmond Tutu HIV Ctr, Fac Hlth Sci,Dept Med, ZA-7925 Cape Town, South Africa.	katharina.kranzer@lshtm.ac.uk	Wood, Robin/G-8509-2011; Orrell, Catherine/AAF-3405-2019; Bekker, Linda-Gail/AAZ-8929-2020; Kranzer, Katharina/O-8845-2014	Orrell, Catherine/0000-0003-1134-7475; Kranzer, Katharina/0000-0001-5691-7270; BEKKER, LINDA-GAIL/0000-0002-0755-4386	Wellcome Trust, London, UK; National Institutes of Health (NIH) through CIPRA [1U19AI53217-01, A1058736-01A1]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI053217, R01AI058736] Funding Source: NIH RePORTER	Wellcome Trust, London, UK(Wellcome Trust); National Institutes of Health (NIH) through CIPRA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	KK and SDL are funded by the Wellcome Trust, London, UK. RW and LGB are funded in part by the National Institutes of Health (NIH) through a CIPRA grant 1U19AI53217-01 and RO1 grant (A1058736-01A1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam MA, 2009, SAMJ S AFR MED J, V99, P661; Amuron B, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-290; Bassett IV, 2009, JAIDS-J ACQ IMM DEF, V51, P135, DOI 10.1097/QAI.0b013e3181a44ef2; Brinkhof MWG, 2008, B WORLD HEALTH ORGAN, V86, P559, DOI 10.2471/BLT.07.044248; Brinkhof MWG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005790; Cornell M, 2009, TROP MED INT HEALTH, V14, P722, DOI 10.1111/j.1365-3156.2009.02290.x; Fairall LR, 2008, ARCH INTERN MED, V168, P86, DOI 10.1001/archinternmed.2007.10; GHEBREYESUS TA, 1957, LANCET, V375, P1757; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; KARIM SS, 2009, LANCET, V24, P24; Kitahata MM, 2002, BMJ-BRIT MED J, V325, P954, DOI 10.1136/bmj.325.7370.954; LARSON BA, 2010, B WHO; Larson BA, 2010, TROP MED INT HEALTH, V15, P43, DOI 10.1111/j.1365-3156.2010.02511.x; Lawn SD, 2008, AIDS, V22, P1897, DOI 10.1097/QAD.0b013e32830007cd; Lawn SD, 2009, CLIN CHEST MED, V30, P685, DOI 10.1016/j.ccm.2009.08.010; Losina E, PLOS ONE, V5, pe9538; MacPherson P, 2009, T ROY SOC TROP MED H, V103, P588, DOI 10.1016/j.trstmh.2008.10.001; Manosuthi W, 2007, J INFECTION, V55, P464, DOI 10.1016/j.jinf.2007.07.002; Manosuthi W, 2006, JAIDS-J ACQ IMM DEF, V43, P42, DOI 10.1097/01.qai.0000230521.86964.86; McNutt LA, 2003, AM J EPIDEMIOL, V157, P940, DOI 10.1093/aje/kwg074; Micek MA, 2009, JAIDS-J ACQ IMM DEF, V52, P397, DOI 10.1097/QAI.0b013e3181ab73e2; MIDDELKOOP K, 2009, WIDESPREAD ART ASS D; Mills EJ, 2006, PLOS MED, V3, P2039, DOI 10.1371/journal.pmed.0030438; Muula AS, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-63; Nachega JB, 2006, JAIDS-J ACQ IMM DEF, V43, P78, DOI 10.1097/01.qai.0000225015.43266.46; Nacher M, 2006, AM J TROP MED HYG, V74, P915, DOI 10.4269/ajtmh.2006.74.915; Remien RH, 2009, JAIDS-J ACQ IMM DEF, V51, pS106, DOI 10.1097/QAI.0b013e3181aafd66; Rosen S, 2007, PLOS MED, V4, P1691, DOI 10.1371/journal.pmed.0040298; *S AFR AIDS COUNC, 2010, S AFR ANT TREATM GUI; *S AFR GOV, 2003, OP PLAN COMPR HIV AI; Sanguanwongse N, 2008, JAIDS-J ACQ IMM DEF, V48, P181, DOI 10.1097/QAI.0b013e318177594e; Sieleunou I, 2009, TROP MED INT HEALTH, V14, P36, DOI 10.1111/j.1365-3156.2008.02183.x; Sweat M, 2000, LANCET, V356, P113, DOI 10.1016/S0140-6736(00)02447-8; UNAIDS, 2003, HDB ACC HIV AIDS REL; UNAIDS/WHO Working Group on Global HIV/AIDS and STI Surveillance, 2008, EP FACT SHEET HIV AI; Velasco M, 2009, JAIDS-J ACQ IMM DEF, V50, P148, DOI 10.1097/QAI.0b013e31819367e7; WHO, 2010, ANT THER HIV INF AD; Wood R, 2007, AM J RESP CRIT CARE, V175, P87, DOI 10.1164/rccm.200606-759OC; World Health Organization, 2003, TREATM TUB GUID NAT, DOI DOI 10.1016/S0035-9203(99)90185-2; Zachariah R, 2009, TROP MED INT HEALTH, V14, P713, DOI 10.1111/j.1365-3156.2009.02291.x	40	125	126	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2010	5	11							e13801	10.1371/journal.pone.0013801	http://dx.doi.org/10.1371/journal.pone.0013801			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	674VY	21072191	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000283779700013
J	Lubarsky, HV; Hubas, C; Chocholek, M; Larson, F; Manz, W; Paterson, DM; Gerbersdorf, SU				Lubarsky, Helen V.; Hubas, Cedric; Chocholek, Melanie; Larson, Fredrik; Manz, Werner; Paterson, David M.; Gerbersdorf, Sabine U.			The Stabilisation Potential of Individual and Mixed Assemblages of Natural Bacteria and Microalgae	PLOS ONE			English	Article							EXTRACELLULAR POLYMERIC SUBSTANCES; STRENGTH METER CSM; INTERTIDAL SEDIMENTS; MICROBIAL BIOFILMS; EPIPELIC DIATOMS; GROWTH; ALGAE; POLYSACCHARIDES; STABILITY; ADHESION	It is recognized that microorganisms inhabiting natural sediments significantly mediate the erosive response of the bed ("ecosystem engineers") through the secretion of naturally adhesive organic material (EPS: extracellular polymeric substances). However, little is known about the individual engineering capability of the main biofilm components (heterotrophic bacteria and autotrophic microalgae) in terms of their individual contribution to the EPS pool and their relative functional contribution to substratum stabilisation. This paper investigates the engineering effects on a non-cohesive test bed as the surface was colonised by natural benthic assemblages (prokaryotic, eukaryotic and mixed cultures) of bacteria and microalgae. MagPI (Magnetic Particle Induction) and CSM (Cohesive Strength Meter) respectively determined the adhesive capacity and the cohesive strength of the culture surface. Stabilisation was significantly higher for the bacterial assemblages (up to a factor of 2) than for axenic microalgal assemblages. The EPS concentration and the EPS composition (carbohydrates and proteins) were both important in determining stabilisation. The peak of engineering effect was significantly greater in the mixed assemblage as compared to the bacterial (x 1.2) and axenic diatom (x 1.7) cultures. The possibility of synergistic effects between the bacterial and algal cultures in terms of stability was examined and rejected although the concentration of EPS did show a synergistic elevation in mixed culture. The rapid development and overall stabilisation potential of the various assemblages was impressive (x 7.5 and x9.5, for MagPI and CSM, respectively, as compared to controls). We confirmed the important role of heterotrophic bacteria in "biostabilisation" and highlighted the interactions between autotrophic and heterotrophic biofilm consortia. This information contributes to the conceptual understanding of the microbial sediment engineering that represents an important ecosystem function and service in aquatic habitats.	[Lubarsky, Helen V.; Hubas, Cedric; Chocholek, Melanie; Larson, Fredrik; Paterson, David M.; Gerbersdorf, Sabine U.] Univ St Andrews, Scottish Oceans Inst, Sediment Ecol Res Grp, St Andrews, Fife, Scotland; [Lubarsky, Helen V.; Gerbersdorf, Sabine U.] Univ Stuttgart, Inst Hydraul Engn, Stuttgart, Germany; [Hubas, Cedric] MNHN CNRS UPMC IRD, Museum Natl Hist Nat, UMR BOREA, DMPA, Paris, France; [Larson, Fredrik] Swedish Board Fisheries, Gothenburg, Sweden; [Manz, Werner] Univ Koblenz Landau, Inst Integrated Nat Sci, Koblenz, Germany	University of St Andrews; University of Stuttgart; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Museum National d'Histoire Naturelle (MNHN); University of Koblenz & Landau	Lubarsky, HV (corresponding author), Univ St Andrews, Scottish Oceans Inst, Sediment Ecol Res Grp, St Andrews, Fife, Scotland.	sabine.gerbersdorf@iws.uni-stuttgart.de	Hubas, Cédric/P-4200-2019; Larson, Fredrik/D-8024-2011; BOREA, UMR BOREA/C-6165-2008; Gerbersdorf, Sabine U/B-7875-2009; Paterson, David/D-5202-2013	Hubas, Cédric/0000-0002-9110-9292; Larson, Fredrik/0000-0002-5751-7997; BOREA, UMR BOREA/0000-0002-9110-9292; Lubarsky, Helen/0000-0001-8247-3618; Paterson, David/0000-0003-1174-6476	European Union [RTN-CT-2006-035695, 25524]; Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (Formas)	European Union(European Commission); Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (Formas)(Swedish Research Council Formas)	The European Union has funded the positions of H. V. Lubarsky by Marie Curie Research Training Network (RTN-CT-2006-035695, Project KEYBIOEFFECT), and S. U. Gerbersdorf by Marie Curie Individual Fellowship (FP6, Project 25524, BioMech) as well as the consumables for this experiment (MCIF project 25524, BioMech). The Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (Formas), has financed the postdoctoral scholarship for F. Larson. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Battin TJ, 2003, NATURE, V426, P439, DOI 10.1038/nature02152; *BMEPC, 1988, BALTIC MARINE ENV D, V27, P16; Boivin MEY, 2007, ENVIRON POLLUT, V145, P884, DOI 10.1016/j.envpol.2006.05.003; Boogert NJ, 2006, BIOSCIENCE, V56, P570, DOI 10.1641/0006-3568(2006)56[570:TIONCA]2.0.CO;2; Bowen JL, 2009, LIMNOL OCEANOGR, V54, P713, DOI 10.4319/lo.2009.54.3.0713; Bruckner CG, 2008, APPL ENVIRON MICROB, V74, P7740, DOI 10.1128/AEM.01399-08; Campa-Cordova AI, 2006, AQUACULTURE, V260, P145, DOI 10.1016/j.aquaculture.2006.06.014; CHO BC, 1990, MAR ECOL PROG SER, V63, P253, DOI 10.3354/meps063253; Czaczyk K, 2007, POL J ENVIRON STUD, V16, P799; Dade WB, 1996, J SEDIMENT RES, V66, P39; Defew EC, 2002, HYDROL EARTH SYST SC, V6, P971, DOI 10.5194/hess-6-971-2002; Defew EC, 2002, MAR ECOL PROG SER, V237, P15, DOI 10.3354/meps237015; DUBOIS M, 1956, ANAL CHEM, V28, P380; EDGAR LA, 1983, PROC R SOC SER B-BIO, V218, P331, DOI 10.1098/rspb.1983.0042; Elifantz H, 2005, APPL ENVIRON MICROB, V71, P7799, DOI 10.1128/AEM.71.12.7799-7805.2005; Fang HHP, 2000, J MICROBIOL METH, V40, P89, DOI 10.1016/S0167-7012(99)00137-2; Flemming HC, 2002, CHEM UNSERER ZEIT, V36, P30, DOI 10.1002/1521-3781(200202)36:1<30::AID-CIUZ30>3.0.CO;2-O; Flemming HC, 2001, WATER SCI TECHNOL, V43, pVII; FUHRMAN JA, 1982, MAR BIOL, V66, P109, DOI 10.1007/BF00397184; Fukami K, 1997, HYDROBIOLOGIA, V358, P185, DOI 10.1023/A:1003139402315; Garet MJ, 1996, J MICROBIOL METH, V25, P1, DOI 10.1016/0167-7012(95)00071-2; Gerbersdorf SU, 2008, FEMS MICROBIOL ECOL, V66, P282, DOI 10.1111/j.1574-6941.2008.00586.x; Gerbersdorf SU, 2009, J SOIL SEDIMENT, V9, P640, DOI 10.1007/s11368-009-0142-5; Goto N, 2001, J EXP MAR BIOL ECOL, V257, P73, DOI 10.1016/S0022-0981(00)00329-4; Grossart HP, 2007, AQUAT MICROB ECOL, V47, P163, DOI 10.3354/ame047163; Guerrini F, 1998, AQUAT MICROB ECOL, V15, P247, DOI 10.3354/ame015247; Haynes K, 2007, APPL ENVIRON MICROB, V73, P6112, DOI 10.1128/AEM.00551-07; Hubas C, 2007, MAR ECOL PROG SER, V344, P39, DOI 10.3354/meps06947; Hubas C, 2007, MAR BIOL, V151, P41, DOI 10.1007/s00227-006-0446-6; Jain A, 2007, BIOFOULING, V23, P171, DOI 10.1080/08927010701269641; Jeffrey SW, 1999, MAR FRESHWATER RES, V50, P879, DOI 10.1071/MF99109; Klug JL, 2005, CAN J FISH AQUAT SCI, V62, P472, DOI 10.1139/F04-229; Krammer K., 1986, SUSSWASSERFLORA MITT; Lai HT, 2009, ECOTOX ENVIRON SAFE, V72, P329, DOI 10.1016/j.ecoenv.2008.03.005; Lange-Bertalot, 1997, LAUTERBORNIA, V31, P117; Larson F, 2009, LIMNOL OCEANOGR-METH, V7, P490, DOI 10.4319/lom.2009.7.490; Le Hir P, 2007, CONT SHELF RES, V27, P1116, DOI 10.1016/j.csr.2005.11.016; LEE S, 1987, APPL ENVIRON MICROB, V53, P1298, DOI 10.1128/AEM.53.6.1298-1303.1987; Leon-Morales CF, 2007, SEDIMENT DYNAMICS PO, P358; Levy JL, 2009, CHEMOSPHERE, V74, P1266, DOI 10.1016/j.chemosphere.2008.10.049; Long RA, 1996, AQUAT MICROB ECOL, V10, P213, DOI 10.3354/ame010213; Lundkvist M, 2007, CONT SHELF RES, V27, P1143, DOI 10.1016/j.csr.2006.01.021; MANZ W, 1992, SYST APPL MICROBIOL, V15, P593, DOI 10.1016/S0723-2020(11)80121-9; Manz W, 1999, METHOD ENZYMOL, V310, P79; Mu RM, 2007, J ENVIRON SCI-CHINA, V19, P1336, DOI 10.1016/S1001-0742(07)60218-6; Pankow H., 1990, OSTEE ALGENFLORA; PATERSON DM, 1989, LIMNOL OCEANOGR, V34, P223, DOI 10.4319/lo.1989.34.1.0223; Pennisi E, 2002, SCIENCE, V296, P250, DOI 10.1126/science.296.5566.250; Raszka A, 2006, ACTA HYDROCH HYDROB, V34, P411, DOI 10.1002/aheh.200500640; RAUNKJAER K, 1994, WATER RES, V28, P251, DOI 10.1016/0043-1354(94)90261-5; Ribalet F, 2008, AQUAT TOXICOL, V86, P249, DOI 10.1016/j.aquatox.2007.11.005; Riethmuller R, 2000, CONT SHELF RES, V20, P1351, DOI 10.1016/S0278-4343(00)00027-3; ROLLER C, 1994, MICROBIOL-UK, V140, P2849, DOI 10.1099/00221287-140-10-2849; Schafer H, 2002, FEMS MICROBIOL ECOL, V42, P25, DOI 10.1111/j.1574-6941.2002.tb00992.x; SIMONSEN R, 1962, HYDROBIOLOGIA, V1, P1; Stal LJ, 2000, EUR J PHYCOL, V35, P97, DOI 10.1080/09670260010001735681; Stal LJ, 2003, GEOMICROBIOL J, V20, P463, DOI 10.1080/713851126; Tolhurst TJ, 1999, ESTUAR COAST SHELF S, V49, P281, DOI 10.1006/ecss.1999.0512; Underwood GJC, 1998, EUR J PHYCOL, V33, P173, DOI 10.1017/S0967026298001565; Underwood GJC, 2003, ADV BOT RES, V40, P183, DOI 10.1016/S0065-2296(05)40005-1; Vardy S, 2007, CONT SHELF RES, V27, P1190, DOI 10.1016/j.csr.2006.01.022; Vu B, 2009, MOLECULES, V14, P2535, DOI 10.3390/molecules14072535; Wichard T, 2005, J CHROMATOGR B, V814, P155, DOI 10.1016/j.jchromb.2004.10.021; Witkowski A., 2000, DIATOM FLORA MARINE; Wotton RS, 2004, SCI MAR, V68, P13, DOI 10.3989/scimar.2004.68s113; Yallop ML, 2000, MICROB ECOL, V39, P116, DOI 10.1007/s002489900186	66	74	77	1	89	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2010	5	11							e13794	10.1371/journal.pone.0013794	http://dx.doi.org/10.1371/journal.pone.0013794			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	674VY	21072186	gold, Green Published, Green Submitted			2022-12-27	WOS:000283779700008
J	Boberek, JM; Stach, J; Good, L				Boberek, Jaroslaw M.; Stach, Jem; Good, Liam			Genetic Evidence for Inhibition of Bacterial Division Protein FtsZ by Berberine	PLOS ONE			English	Article							ESCHERICHIA-COLI; CELL-DIVISION; HYDRASTIS-CANADENSIS; ANTIMICROBIAL ACTIVITY; SMALL-MOLECULE; CANCER-CELLS; IN-VITRO; RING; APOPTOSIS; BINDING	Background: Berberine is a plant alkaloid that is widely used as an anti-infective in traditional medicine. Escherichia coli exposed to berberine form filaments, suggesting an antibacterial mechanism that involves inhibition of cell division. Berberine is a DNA ligand and may induce filamentation through induction of the SOS response. Also, there is biochemical evidence for berberine inhibition of the cell division protein FtsZ. Here we aimed to assess possible berberine mechanism(s) of action in growing bacteria using genetics tools. Methodology/Principal Findings: First, we tested whether berberine inhibits bacterial growth through DNA damage and induction of the SOS response. The SOS response induced by berberine was much lower compared to that induced by mitomycin C in an SOS response reporter strain. Also, cell filamentation was observed in an SOS-negative E. coli strain. To test whether berberine inhibits FtsZ, we assessed its effects on formation of the cell division Z-rings, and observed a dramatic reduction in Z-rings in the presence of berberine. We next used two different strategies for RNA silencing of ftsZ and both resulted in sensitisation of bacteria to berberine, visible as a drop in the Minimum Inhibitory Concentration (MIC). Furthermore, Fractional Inhibitory Concentration Indices (FICIs) showed a high level of synergy between ftsZ silencing and berberine treatment (FICI values of 0.23 and 0.25 for peptide nucleic acid-and expressed antisense RNA-based silencing of ftsZ, respectively). Finally, over-expression of ftsZ led to a mild rescue effect in berberine-treated cells. Conclusions: The results argue against DNA binding as the primary mechanism of action of berberine and support the hypothesis that its antibacterial properties are due to inhibition of the cell division protein FtsZ. In addition, the genetic approach used here provides a means to rapidly test the activity of other putative FtsZ inhibitors.	[Boberek, Jaroslaw M.; Good, Liam] Univ London Royal Vet Coll, Dept Pathol & Infect Dis, London, England; [Stach, Jem] Newcastle Univ, Sch Biol, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	University of London; University of London Royal Veterinary College; Newcastle University - UK	Boberek, JM (corresponding author), Univ London Royal Vet Coll, Dept Pathol & Infect Dis, London, England.	lgood@rvc.ac.uk		Good, Liam/0000-0002-2798-8640; Stach, James/0000-0001-8787-2407	University of London; Bloomsbury Colleges Consortium; Innovation China UK; STFC [ST/H000429/1] Funding Source: UKRI	University of London; Bloomsbury Colleges Consortium; Innovation China UK; STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	The authors would like to thank the University of London Central Research Fund and Innovation China UK for research support and the Bloomsbury Colleges Consortium for scholarship support to JMB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMIN AH, 1969, CAN J MICROBIOL, V15, P1067, DOI 10.1139/m69-190; Beuria TK, 2005, BIOCHEMISTRY-US, V44, P16584, DOI 10.1021/bi050767+; Bhadra K, 2008, BBA-GEN SUBJECTS, V1780, P1054, DOI 10.1016/j.bbagen.2008.05.005; BI E, 1993, J BACTERIOL, V175, P1118, DOI 10.1128/JB.175.4.1118-1125.1993; BI E, 1991, NATURE, V354, P161, DOI 10.1038/354161a0; Choi MS, 2008, ANTICANCER RES, V28, P3777; Das S, 2003, J BIOMOL STRUCT DYN, V20, P703, DOI 10.1080/07391102.2003.10506887; Domadia P, 2007, BIOCHEM PHARMACOL, V74, P831, DOI 10.1016/j.bcp.2007.06.029; Domadia PN, 2008, BIOCHEMISTRY-US, V47, P3225, DOI 10.1021/bi7018546; Dryselius R, 2005, J ANTIMICROB CHEMOTH, V56, P97, DOI 10.1093/jac/dki173; Dziadek J, 2002, MICROBIOL-SGM, V148, P961, DOI 10.1099/00221287-148-4-961; ERICKSON HP, 1995, CELL, V80, P367, DOI 10.1016/0092-8674(95)90486-7; Gentry EJ, 1998, J NAT PROD, V61, P1187, DOI 10.1021/np9701889; Giri P, 2010, MOL BIOSYST, V6, P81, DOI 10.1039/b910706a; Goh S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006061; Haney SA, 2001, J BIOL CHEM, V276, P11980, DOI 10.1074/jbc.M009810200; Ho YT, 2009, ANTICANCER RES, V29, P4063; Honrubia-Marcos MP, 2005, CAN J MICROBIOL, V51, P85, DOI 10.1139/W04-105; Hur JM, 2009, J CELL BIOCHEM, V107, P955, DOI 10.1002/jcb.22198; Hwang BY, 2003, PLANTA MED, V69, P623, DOI 10.1055/s-2003-41115; Islam MM, 2009, DNA CELL BIOL, V28, P637, DOI 10.1089/dna.2009.0930; Jaiswal R, 2007, BIOCHEMISTRY-US, V46, P4211, DOI 10.1021/bi602573e; Jeong HW, 2009, AM J PHYSIOL-ENDOC M, V296, pE955, DOI 10.1152/ajpendo.90599.2008; Katiyar SK, 2009, MOL CARCINOGEN, V48, P24, DOI 10.1002/mc.20453; KIM JB, 2009, PHYTOMEDICINE; Kitagawa M, 2005, DNA RES, V12, P291, DOI 10.1093/dnares/dsi012; Lau IF, 2003, MOL MICROBIOL, V49, P731, DOI 10.1046/j.1365-2958.2003.03640.x; Li WY, 1998, SPECTROSC LETT, V31, P1287, DOI 10.1080/00387019808003303; Lock RL, 2008, NAT REV DRUG DISCOV, V7, P324, DOI 10.1038/nrd2510; Mahady GB, 2003, PHYTOTHER RES, V17, P217, DOI 10.1002/ptr.1108; Mantena SK, 2006, MOL CANCER THER, V5, P296, DOI 10.1158/1535-7163.MCT-05-0448; Margalit DN, 2004, P NATL ACAD SCI USA, V101, P11821, DOI 10.1073/pnas.0404439101; Margolin W, 2005, NAT REV MOL CELL BIO, V6, P862, DOI 10.1038/nrm1745; McCool JD, 2004, MOL MICROBIOL, V53, P1343, DOI 10.1111/j.1365-2958.2004.04225.x; Nakashima N, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl697; Nogales E, 1998, NAT STRUCT BIOL, V5, P451, DOI 10.1038/nsb0698-451; Odds FC, 2003, J ANTIMICROB CHEMOTH, V52, P1, DOI 10.1093/jac/dkg301; PASQUAL MS, 1993, MUTAT RES, V286, P243, DOI 10.1016/0027-5107(93)90189-M; Pichoff S, 2001, J BACTERIOL, V183, P6630, DOI 10.1128/JB.183.22.6630-6635.2001; Salimnia H, 2000, ARCH MICROBIOL, V173, P10, DOI 10.1007/s002030050002; Serafim TL, 2008, CANCER CHEMOTH PHARM, V61, P1007, DOI 10.1007/s00280-007-0558-9; Tegos G, 2002, ANTIMICROB AGENTS CH, V46, P3133, DOI 10.1128/AAC.46.10.3133-3141.2002; Turner N, 2008, DIABETES, V57, P1414, DOI 10.2337/db07-1552; Villinski JR, 2003, PHARM BIOL, V41, P551, DOI 10.1080/13880200390500768; Wang J, 2003, J BIOL CHEM, V278, P44424, DOI 10.1074/jbc.M307625200; Weiss DS, 2004, MOL MICROBIOL, V54, P588, DOI 10.1111/j.1365-2958.2004.04283.x; Yadav RC, 2005, BIOORGAN MED CHEM, V13, P165, DOI 10.1016/j.bmc.2004.09.045; Yin J, 2008, METABOLISM, V57, P712, DOI 10.1016/j.metabol.2008.01.013; Yin J, 2008, AM J PHYSIOL-ENDOC M, V294, pE148, DOI 10.1152/ajpendo.00211.2007; Yu HH, 2005, J MED FOOD, V8, P454, DOI 10.1089/jmf.2005.8.454; Zhang H, 2010, METABOLISM, V59, P285, DOI 10.1016/j.metabol.2009.07.029	51	121	130	3	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2010	5	10							e13745	10.1371/journal.pone.0013745	http://dx.doi.org/10.1371/journal.pone.0013745			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673FU	21060782	gold, Green Published, Green Submitted			2022-12-27	WOS:000283645300025
J	Kile, ML; Baccarelli, A; Tarantini, L; Hoffman, E; Wright, RO; Christiani, DC				Kile, Molly L.; Baccarelli, Andrea; Tarantini, Letizia; Hoffman, Elaine; Wright, Robert O.; Christiani, David C.			Correlation of Global and Gene-Specific DNA Methylation in Maternal-Infant Pairs	PLOS ONE			English	Article							NONPOLYPOSIS COLORECTAL-CANCER; BLOOD LEUKOCYTE DNA; EPIGENETIC INHERITANCE; GERMLINE EPIMUTATION; PROMOTER METHYLATION; HYPOMETHYLATION; HYPERMETHYLATION; CELLS; ALU; ASSOCIATION	The inheritance of DNA methylation patterns is a popular theory to explain the influence of parental genetic and environmental factors on the phenotype of their offspring but few studies have examined this relationship in humans. Using 120 paired maternal-umbilical cord blood samples randomly selected from a prospective birth cohort in Bangladesh, we quantified DNA methylation by pyrosequencing seven CpG positions in the promoter region of p16, four CpG positions in the promoter region of p53, LINE-1 and Alu. Positive correlations were observed between maternal and umbilical cord blood at p16, LINE-1, and Alu but not p53. Multiple linear regression models observed a significant association between maternal and umbilical cord blood at LINE-1 and Alu (LINE-1: beta = 0.63, p<0.0001; Alu: beta = 0.28, p = 0.009). After adjusting for multiple comparisons, maternal methylation of p16 at position 4 significantly predicted methylation at the same position in umbilical cord blood (beta = 0.43, p = <0.0001). These models explained 48%, 5% and 16% of the observed variability in umbilical cord % 5mC for LINE-1, Alu and p16 at position 4, respectively. These results suggest that DNA methylation in maternal blood was correlated with her offspring at LINE-1, Alu, and p16 but not p53. Additional studies are needed to confirm whether these observed associations were due to the inheritance of epigenetic events or the shared environment between mother and fetus. Future studies should also use a multi-generational family-based design that would quantify both maternal and paternal contributions to DNA methylation in offspring across more than one generation.	[Kile, Molly L.; Baccarelli, Andrea; Hoffman, Elaine; Wright, Robert O.; Christiani, David C.] Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA; [Baccarelli, Andrea; Tarantini, Letizia] Univ Milan, Dept Environm & Occupat Hlth, Ctr Mol & Genet Epidemiol, Ca Granda Osped Maggiore Policlin IRCCS Fdn, Milan, Italy	Harvard University; Harvard T.H. Chan School of Public Health; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan	Kile, ML (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA.	mkile@hsph.harvard.edu	Kile, Molly/A-8582-2012	Baccarelli, Andrea/0000-0002-3436-0640	Harvard School of Public Health National Institute of Environmental Health Sciences Center [P30ES00002]; National Institute of Environmental Health Sciences [R01ES015533, K01ES017800]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES020268, R01ES015533, P30ES000002, P42ES016454, K01ES017800] Funding Source: NIH RePORTER	Harvard School of Public Health National Institute of Environmental Health Sciences Center; National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by Harvard School of Public Health National Institute of Environmental Health Sciences Center Pilot Grant P30ES00002, National Institute of Environmental Health Sciences R01ES015533 and K01ES017800. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baccarelli A, 2009, AM J RESP CRIT CARE, V180, P1030, DOI 10.1164/ajrccm.180.10.1030a; Baylin SB, 2000, TRENDS GENET, V16, P168, DOI 10.1016/S0168-9525(99)01971-X; BIRD AP, 1986, NATURE, V321, P209, DOI 10.1038/321209a0; Bollati V, 2010, HEREDITY, V105, P105, DOI 10.1038/hdy.2010.2; Bollati V, 2007, CANCER RES, V67, P876, DOI 10.1158/0008-5472.CAN-06-2995; Bollati V, 2009, MECH AGEING DEV, V130, P234, DOI 10.1016/j.mad.2008.12.003; BRINK RA, 1968, SCIENCE, V159, P161, DOI 10.1126/science.159.3811.161; Cavalli G, 1999, SCIENCE, V286, P955, DOI 10.1126/science.286.5441.955; Chalitchagorn K, 2004, ONCOGENE, V23, P8841, DOI 10.1038/sj.onc.1208137; Chan TL, 2006, NAT GENET, V38, P1178, DOI 10.1038/ng1866; Chanda S, 2006, TOXICOL SCI, V89, P431, DOI 10.1093/toxsci/kfj030; Chen RZ, 1998, NATURE, V395, P89, DOI 10.1038/25779; Choi IS, 2007, MODERN PATHOL, V20, P802, DOI 10.1038/modpathol.3800825; Choi JY, 2009, CARCINOGENESIS, V30, P1889, DOI 10.1093/carcin/bgp143; Daskalos A, 2009, INT J CANCER, V124, P81, DOI 10.1002/ijc.23849; Esteller M, 2002, ONCOGENE, V21, P5427, DOI 10.1038/sj.onc.1205600; Flanagan JM, 2006, AM J HUM GENET, V79, P67, DOI 10.1086/504729; Fryer AA, 2009, EPIGENETICS-US, V4, P292; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; Geiman TM, 2010, MOL REPROD DEV, V77, P105, DOI 10.1002/mrd.21118; Gluckman PD, 2009, NAT REV ENDOCRINOL, V5, P401, DOI 10.1038/nrendo.2009.102; Grewal SIS, 1996, CELL, V86, P95, DOI 10.1016/S0092-8674(00)80080-X; HALL JM, 1995, BLOOD, V86, P2829; Herman JG, 2003, NEW ENGL J MED, V349, P2042, DOI 10.1056/NEJMra023075; Hillemacher T, 2008, EUR NEUROPSYCHOPHARM, V18, P295, DOI 10.1016/j.euroneuro.2007.12.005; Hitchins M, 2005, GASTROENTEROLOGY, V129, P1392, DOI 10.1053/j.gastro.2005.09.003; Hitchins MP, 2007, NEW ENGL J MED, V356, P697, DOI 10.1056/NEJMoa064522; Hou LF, 2010, INT J CANCER, V127, P1866, DOI 10.1002/ijc.25190; Ji WZ, 1997, MUTAT RES-FUND MOL M, V379, P33, DOI 10.1016/S0027-5107(97)00088-2; Jintaridth P, 2010, PHYSIOL GENOMICS, V41, P194, DOI 10.1152/physiolgenomics.00146.2009; KOCHANEK S, 1993, EMBO J, V12, P1141, DOI 10.1002/j.1460-2075.1993.tb05755.x; Li TH, 2001, GENE, V276, P135, DOI 10.1016/S0378-1119(01)00637-0; Liu JY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010028; MERLO A, 1995, NAT MED, V1, P686, DOI 10.1038/nm0795-686; Mirabello L, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-77; Morgan DK, 2008, MAMM GENOME, V19, P394, DOI 10.1007/s00335-008-9124-y; Morgan HD, 1999, NAT GENET, V23, P314, DOI 10.1038/15490; Moverare-Skrtic S, 2009, ENDOCRINE, V35, P204, DOI 10.1007/s12020-009-9153-7; Ng HH, 1999, CURR OPIN GENET DEV, V9, P158, DOI 10.1016/S0959-437X(99)80024-0; Pilsner JR, 2007, AM J CLIN NUTR, V86, P1179, DOI 10.1093/ajcn/86.4.1179; Pogribny IP, 2009, CELL MOL LIFE SCI, V66, P2249, DOI 10.1007/s00018-009-0015-5; Rakyan VK, 2003, P NATL ACAD SCI USA, V100, P2538, DOI 10.1073/pnas.0436776100; Rakyan VK, 2002, TRENDS GENET, V18, P348, DOI 10.1016/S0168-9525(02)02709-9; Reik W, 2007, NATURE, V447, P425, DOI 10.1038/nature05918; Sandovici I, 2005, HUM MOL GENET, V14, P2135, DOI 10.1093/hmg/ddi218; Sasaki H, 2008, NAT REV GENET, V9, P129, DOI 10.1038/nrg2295; Shaw RJ, 2006, BRIT J CANCER, V94, P561, DOI 10.1038/sj.bjc.6602972; Sun YV, 2010, HUM GENET, V127, P651, DOI 10.1007/s00439-010-0810-y; Suter CM, 2004, NAT GENET, V36, P497, DOI 10.1038/ng1342; Tarantini L, 2009, ENVIRON HEALTH PERSP, V117, P217, DOI 10.1289/ehp.11898; Weisenberger DJ, 2005, NUCLEIC ACIDS RES, V33, P6823, DOI 10.1093/nar/gki987; Wright RO, 2010, ENVIRON HEALTH PERSP, V118, P790, DOI 10.1289/ehp.0901429	52	60	62	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2010	5	10							e13730	10.1371/journal.pone.0013730	http://dx.doi.org/10.1371/journal.pone.0013730			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673FU	21060777	Green Published, Green Submitted, gold			2022-12-27	WOS:000283645300011
J	Sun, JY; Oma, Y; Harata, M; Kono, K; Shima, H; Kinomura, A; Ikura, T; Suzuki, H; Mizutani, S; Kanaar, R; Tashiro, S				Sun, Jiying; Oma, Yukako; Harata, Masahiko; Kono, Kazuteru; Shima, Hiroki; Kinomura, Aiko; Ikura, Tsuyoshi; Suzuki, Hidekazu; Mizutani, Shuki; Kanaar, Roland; Tashiro, Satoshi			ATM Modulates the Loading of Recombination Proteins onto a Chromosomal Translocation Breakpoint Hotspot	PLOS ONE			English	Article							HOMOLOGOUS RECOMBINATION; DNA-DAMAGE; TOPOISOMERASE-II; MAMMALIAN-CELLS; SACCHAROMYCES-CEREVISIAE; GENOMIC STABILITY; ACUTE-LEUKEMIA; REPAIR; MLL; CHROMATIN	Chromosome translocations induced by DNA damaging agents, such as ionizing radiation and certain chemotherapies, alter genetic information resulting in malignant transformation. Abrogation or loss of the ataxia-telangiectasia mutated (ATM) protein, a DNA damage signaling regulator, increases the incidence of chromosome translocations. However, how ATM protects cells from chromosome translocations is still unclear. Chromosome translocations involving the MLL gene on 11q23 are the most frequent chromosome abnormalities in secondary leukemias associated with chemotherapy employing etoposide, a topoisomerase II poison. Here we show that ATM deficiency results in the excessive binding of the DNA recombination protein RAD51 at the translocation breakpoint hotspot of 11q23 chromosome translocation after etoposide exposure. Binding of Replication protein A (RPA) and the chromatin remodeler INO80, which facilitate RAD51 loading on damaged DNA, to the hotspot were also increased by ATM deficiency. Thus, in addition to activating DNA damage signaling, ATM may avert chromosome translocations by preventing excessive loading of recombinational repair proteins onto translocation breakpoint hotspots.	[Sun, Jiying; Kono, Kazuteru; Shima, Hiroki; Kinomura, Aiko; Suzuki, Hidekazu; Tashiro, Satoshi] Hiroshima Univ, RIRBM, Dept Cellular Biol, Hiroshima, Japan; [Oma, Yukako; Harata, Masahiko] Tohoku Univ, Grad Sch Agr Sci, Mol Biol Lab, Sendai, Miyagi 980, Japan; [Ikura, Tsuyoshi] Kyoto Univ, RBC, Lab Chromatin Regulatory Network, Kyoto, Japan; [Mizutani, Shuki] Tokyo Med & Dent Univ, Grad Sch Med, Dept Pediat & Dev Biol, Tokyo, Japan; [Kanaar, Roland] Erasmus MC, Canc Genom Ctr, Dept Cell Biol & Genet, Dept Radiat Oncol, Rotterdam, Netherlands	Hiroshima University; Tohoku University; Kyoto University; Tokyo Medical & Dental University (TMDU); Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute	Sun, JY (corresponding author), Hiroshima Univ, RIRBM, Dept Cellular Biol, Hiroshima, Japan.	ktashiro@hiroshima-u.ac.jp	Harata, Masahiko/T-5281-2019		Ministry of Education, Science and Culture of Japan; Japan Society for the Promotion of Science	Ministry of Education, Science and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This research was supported by grants-in-aids for Scientific Research from the Ministry of Education, Science and Culture of Japan and Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander FE, 2001, CANCER RES, V61, P2542; Aoyama N, 2008, EXP CELL RES, V314, P859, DOI 10.1016/j.yexcr.2007.11.020; Bishop AJR, 2000, CANCER RES, V60, P395; Broeker PLS, 1996, BLOOD, V87, P1912, DOI 10.1182/blood.V87.5.1912.bloodjournal8751912; Callen E, 2007, CELL, V130, P63, DOI 10.1016/j.cell.2007.06.016; Difilippantonio MJ, 2000, NATURE, V404, P510, DOI 10.1038/35006670; Dinkelmann M, 2009, NAT STRUCT MOL BIOL, V16, P808, DOI 10.1038/nsmb.1639; Felix CA, 2001, MED PEDIATR ONCOL, V36, P525, DOI 10.1002/mpo.1125; Felix CA, 2006, DNA REPAIR, V5, P1093, DOI 10.1016/j.dnarep.2006.05.031; Flygare J, 2001, EXP CELL RES, V268, P61, DOI 10.1006/excr.2001.5265; Franco S, 2006, MOL CELL, V21, P201, DOI 10.1016/j.molcel.2006.01.005; Frasca D, 1998, MECH AGEING DEV, V100, P197, DOI 10.1016/S0047-6374(97)00137-1; Gao YJ, 2000, NATURE, V404, P897, DOI 10.1038/35009138; HAAF T, 1995, P NATL ACAD SCI USA, V92, P2298, DOI 10.1073/pnas.92.6.2298; Harper DP, 2008, CANCER RES, V68, P10024, DOI 10.1158/0008-5472.CAN-08-2208; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Hess JL, 2004, TRENDS MOL MED, V10, P500, DOI 10.1016/j.molmed.2004.08.005; Kabotyanski EB, 1998, NUCLEIC ACIDS RES, V26, P5333, DOI 10.1093/nar/26.23.5333; Khanna KK, 2000, JNCI-J NATL CANCER I, V92, P795, DOI 10.1093/jnci/92.10.795; KOMATSU K, 1990, MUTAT RES, V235, P59, DOI 10.1016/0921-8777(90)90058-D; Lee DH, 2010, NAT STRUCT MOL BIOL, V17, P365, DOI 10.1038/nsmb.1769; Lee K, 2008, NATURE, V454, P543, DOI 10.1038/nature07054; Lin CR, 2009, CELL, V139, P1069, DOI 10.1016/j.cell.2009.11.030; Martin SA, 2008, CURR OPIN GENET DEV, V18, P80, DOI 10.1016/j.gde.2008.01.016; Mimitou EP, 2009, DNA REPAIR, V8, P983, DOI 10.1016/j.dnarep.2009.04.017; Morrison AJ, 2004, CELL, V119, P767, DOI 10.1016/j.cell.2004.11.037; Nakada S, 2006, J CLIN INVEST, V116, P80, DOI 10.1172/JCI25716; Oguchi K, 2003, BLOOD, V101, P3622, DOI 10.1182/blood-2002-02-0570; Raderschall E, 2002, CANCER RES, V62, P219; Rass E, 2009, NAT STRUCT MOL BIOL, V16, P819, DOI 10.1038/nsmb.1641; Richardson C, 2004, ONCOGENE, V23, P546, DOI 10.1038/sj.onc.1207098; Shcherbakova OG, 2000, MUTAT RES-DNA REPAIR, V459, P65, DOI 10.1016/S0921-8777(99)00059-2; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Sigurdsson S, 2001, J BIOL CHEM, V276, P8798, DOI 10.1074/jbc.M010011200; Soutoglou E, 2007, NAT CELL BIOL, V9, P675, DOI 10.1038/ncb1591; Sun JY, 2004, P NATL ACAD SCI USA, V101, P1461, DOI 10.1073/pnas.0308083100; Sung PA, 2006, DNA REPAIR, V5, P1109, DOI 10.1016/j.dnarep.2006.05.018; Tashiro S, 2000, J CELL BIOL, V150, P283, DOI 10.1083/jcb.150.2.283; Tsukuda T, 2005, NATURE, V438, P379, DOI 10.1038/nature04148; van Attikum H, 2004, CELL, V119, P777, DOI 10.1016/j.cell.2004.11.033; Wu S, 2007, NAT STRUCT MOL BIOL, V14, P1165, DOI 10.1038/nsmb1332; Wyman C, 2006, ANNU REV GENET, V40, P363, DOI 10.1146/annurev.genet.40.110405.090451; Xia SJJ, 1997, MOL CELL BIOL, V17, P7151, DOI 10.1128/MCB.17.12.7151; Xie AY, 2009, NAT STRUCT MOL BIOL, V16, P814, DOI 10.1038/nsmb.1640; Zhang YM, 2006, DNA REPAIR, V5, P1282, DOI 10.1016/j.dnarep.2006.05.020	45	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2010	5	10							e13554	10.1371/journal.pone.0013554	http://dx.doi.org/10.1371/journal.pone.0013554			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671UN	21048951	Green Published, Green Submitted, gold			2022-12-27	WOS:000283537000008
J	Artzy-Randrup, Y; Alonso, D; Pascual, M				Artzy-Randrup, Yael; Alonso, David; Pascual, Mercedes			Transmission Intensity and Drug Resistance in Malaria Population Dynamics: Implications for Climate Change	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM MALARIA; ACQUIRED-IMMUNITY; HOLOENDEMIC AREA; PUZZLING LINKS; RECOVERY RATES; MODEL; SPREAD; INFECTION; CHLOROQUINE; MUTATIONS	Although the spread of drug resistance and the influence of climate change on malaria are most often considered separately, these factors have the potential to interact through altered levels of transmission intensity. The influence of transmission intensity on the evolution of drug resistance has been addressed in theoretical studies from a population genetics' perspective; less is known however on how epidemiological dynamics at the population level modulates this influence. We ask from a theoretical perspective, whether population dynamics can explain non-trivial, non-monotonic, patterns of treatment failure with transmission intensity, and, if so, under what conditions. We then address the implications of warmer temperatures in an East African highland, where, as in other similar regions at the altitudinal edge of malaria's distribution, there has been a pronounced increase of cases from the 1970s to the 1990s. Our theoretical analyses, with a transmission model that includes different levels of immunity, demonstrate that an increase in transmission beyond a threshold can lead to a decrease in drug resistance, as previously shown [1], but that a second threshold may occur and lead to the re-establishment of drug resistance. Estimates of the increase in transmission intensity from the 1970s to the 1990s for the Kenyan time series, obtained by fitting the two-stage version of the model with an explicit representation of vector dynamics, suggest that warmer temperatures are likely to have moved the system towards the first threshold, and in so doing, to have promoted the faster spread of drug resistance. Climate change and drug resistance can interact and need not be considered as alternative explanations for trends in disease incidence in this region. Non-monotonic patterns of treatment failure with transmission intensity similar to those described as the 'valley phenomenon' for Uganda can result from epidemiological dynamics but under poorly understood assumptions.	[Artzy-Randrup, Yael; Pascual, Mercedes] Univ Michigan, Howard Hughes Med Inst, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA; [Alonso, David] Univ Groningen, Ctr Ecol & Evolutionary Studies, Community & Conservat Ecol Grp, Groningen, Netherlands	Howard Hughes Medical Institute; University of Michigan System; University of Michigan; University of Groningen	Artzy-Randrup, Y (corresponding author), Univ Michigan, Howard Hughes Med Inst, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA.	YArtzy@umich.edu	Alonso, David/A-5406-2008	Alonso, David/0000-0002-8888-1644	Howard Hughes Medical Institute; James S. McDonnell Foundation	Howard Hughes Medical Institute(Howard Hughes Medical Institute); James S. McDonnell Foundation	Howard Hughes Medical Institute (http://www.hhmi.org/) and the James S. McDonnell Foundation (http://www.jsmf.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALONSO D, 2010, P R SOC L B IN PRESS; Ariey F, 2003, TRENDS PARASITOL, V19, P158, DOI 10.1016/S1471-4922(03)00054-0; ARON JL, 1983, MATH BIOSCI, V64, P249, DOI 10.1016/0025-5564(83)90007-X; BABIKER H, 2009, TRENDS PARASITOLOGY, V25; Babiker HA, 2005, ACTA TROP, V94, P260, DOI 10.1016/j.actatropica.2005.04.007; BAIRD JK, 1995, PARASITOL TODAY, V11, P105, DOI 10.1016/0169-4758(95)80167-7; Barry AE, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030034; BEKESSY A, 1976, B WORLD HEALTH ORGAN, V54, P685; Bonnet S, 2003, T ROY SOC TROP MED H, V97, P53, DOI 10.1016/S0035-9203(03)90022-8; CURTIS CF, 1986, T ROY SOC TROP MED H, V80, P889, DOI 10.1016/0035-9203(86)90248-8; DIETZ K, 1974, B WORLD HEALTH ORGAN, V50, P347; Dye C, 1997, P ROY SOC B-BIOL SCI, V264, P61, DOI 10.1098/rspb.1997.0009; Escalante AA, 2009, TRENDS PARASITOL, V25, P557, DOI 10.1016/j.pt.2009.09.008; GITHEKO AK, 1992, T ROY SOC TROP MED H, V86, P355, DOI 10.1016/0035-9203(92)90216-Y; Gouagna LC, 2004, PARASITOLOGY, V128, P235, DOI 10.1017/S003118200300444X; GUPTA S, 1994, PARASITE IMMUNOL, V16, P361, DOI 10.1111/j.1365-3024.1994.tb00361.x; GUPTA S, 1994, SCIENCE, V263, P961, DOI 10.1126/science.8310293; HASTINGS I, 2000, PARASITOLOGY TODAY, V16; Hastings IA, 2005, DRUG RESIST UPDATE, V8, P43, DOI 10.1016/j.drup.2005.03.003; Hastings IM, 1997, PARASITOLOGY, V115, P133, DOI 10.1017/S0031182097001261; Hastings IM, 2003, TRENDS PARASITOL, V19, P160, DOI 10.1016/S1471-4922(03)00053-9; Hastings IM, 2003, TRENDS PARASITOL, V19, P70, DOI 10.1016/S1471-4922(02)00017-X; Hastings IM, 2005, ACTA TROP, V94, P218, DOI 10.1016/j.actatropica.2005.04.003; Hastings IM, 1998, PARASITOLOGY, V117, P411, DOI 10.1017/S0031182098003291; HAY S, 2002, EMERGING INFECT DIS, V8; Hay SI, 2002, NATURE, V415, P905, DOI 10.1038/415905a; Hayward R, 2005, MOL MICROBIOL, V55, P1285, DOI 10.1111/j.1365-2958.2004.04470.x; Killeen GF, 2000, AM J TROP MED HYG, V62, P535, DOI 10.4269/ajtmh.2000.62.535; Klein EY, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-67; Koella JC, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-3; Lafferty KD, 2009, ECOLOGY, V90, P932, DOI 10.1890/08-1767.1; Laufer MK, 2004, DRUG RESIST UPDATE, V7, P279, DOI 10.1016/j.drup.2004.08.003; Macdonald G., 1957, EPIDEMIOLOGY CONTROL; Maire N, 2006, AM J TROP MED HYG, V75, P19, DOI 10.4269/ajtmh.2006.75.19; MASABA SC, 1985, B WORLD HEALTH ORGAN, V63, P593; Mharakurwa S, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-35; MOLINEAUX L, 1980, GRAMICCIA GARKI PROJ; Paaijmans KP, 2009, P NATL ACAD SCI USA, V106, P13844, DOI 10.1073/pnas.0903423106; Pascual M, 2006, P NATL ACAD SCI USA, V103, P5829, DOI 10.1073/pnas.0508929103; Pascual M, 2009, P NATL ACAD SCI USA, V106, P13645, DOI 10.1073/pnas.0906909106; Pascual M, 2009, ECOLOGY, V90, P906, DOI 10.1890/08-0730.1; Patz JA, 2006, P NATL ACAD SCI USA, V103, P5635, DOI 10.1073/pnas.0601493103; Patz JA, 2002, NATURE, V420, P627, DOI 10.1038/420627a; Pongtavornpinyo W, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-229; RAPUODA BA, 1996, MALARIA INFECT DIS A, V8, P25; Read AF, 2009, EVOL APPL, V2, P40, DOI 10.1111/j.1752-4571.2008.00066.x; Reyburn H, 2005, JAMA-J AM MED ASSOC, V293, P1461, DOI 10.1001/jama.293.12.1461; SCHMIDT KF, 1995, SCIENCE, V269, P1670, DOI 10.1126/science.7569890; Shanks GD, 2005, EMERGING INFECT DIS, V11; Smith DL, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-13; Smith T, 2004, AM J TROP MED HYG, V71, P80, DOI 10.4269/ajtmh.2004.71.80; Smith T, 2003, STAT MED, V22, P1709, DOI 10.1002/sim.1274; Snow RW, 2002, ADV PARASIT, V52, P235, DOI 10.1016/S0065-308X(02)52013-3; Snow RW, 1997, LANCET, V349, P1650, DOI 10.1016/S0140-6736(97)02038-2; Talisuna AO, 2007, AM J TROP MED HYG, V77, P170; Talisuna AO, 2003, INT J PARASITOL, V33, P1051, DOI 10.1016/S0020-7519(03)00156-5; Talisuna AO, 2002, T ROY SOC TROP MED H, V96, P310, DOI 10.1016/S0035-9203(02)90108-2; TRAPE JF, 1994, AM J TROP MED HYG, V51, P123, DOI 10.4269/ajtmh.1994.51.123; White NJ, 2003, P ROY SOC B-BIOL SCI, V270, P545, DOI 10.1098/rspb.2002.2241; White NJ, 1998, DRUG RESIST UPDATE, V1, P3, DOI 10.1016/S1368-7646(98)80208-2	60	23	24	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2010	5	10							e13588	10.1371/journal.pone.0013588	http://dx.doi.org/10.1371/journal.pone.0013588			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671GB	21060886	Green Published, Green Submitted, gold			2022-12-27	WOS:000283487400005
J	Field, J; Browning, SR; Johnson, LJ; Danoy, P; Varney, MD; Tait, BD; Gandhi, KS; Charlesworth, JC; Heard, RN; Stewart, GJ; Kilpatrick, TJ; Foote, SJ; Bahlo, M; Butzkueven, H; Wiley, J; Booth, DR; Taylor, BV; Brown, MA; Rubio, JP; Stankovich, J				Field, Judith; Browning, Sharon R.; Johnson, Laura J.; Danoy, Patrick; Varney, Michael D.; Tait, Brian D.; Gandhi, Kaushal S.; Charlesworth, Jac C.; Heard, Robert N.; Stewart, Graeme J.; Kilpatrick, Trevor J.; Foote, Simon J.; Bahlo, Melanie; Butzkueven, Helmut; Wiley, James; Booth, David R.; Taylor, Bruce V.; Brown, Matthew A.; Rubio, Justin P.; Stankovich, Jim		Australia New Zealand Multiple Scl	A Polymorphism in the HLA-DPB1 Gene Is Associated with Susceptibility to Multiple Sclerosis	PLOS ONE			English	Article							CLASS-I REGION; CLINICAL-COURSE; RISK; MHC; HLA-DRB1; ALLELES; LOCI; COMPLEX; HETEROGENEITY; REPLICATION	We conducted an association study across the human leukocyte antigen (HLA) complex to identify loci associated with multiple sclerosis (MS). Comparing 1927 SNPs in 1618 MS cases and 3413 controls of European ancestry, we identified seven SNPs that were independently associated with MS conditional on the others (each P <= 4 x 10(-6)). All associations were significant in an independent replication cohort of 2212 cases and 2251 controls (P <= 0.001) and were highly significant in the combined dataset (P <= 6 x 10(-8)). The associated SNPs included proxies for HLA-DRB1*15:01 and HLA-DRB1*03:01, and SNPs in moderate linkage disequilibrium (LD) with HLA-A*02:01, HLA-DRB1*04:01 and HLA-DRB1*13:03. We also found a strong association with rs9277535 in the class II gene HLA-DPB1 (discovery set P = 9 x 10(-9), replication set P = 7 x 10(-4), combined P = 2 x 10(-10)). HLA-DPB1 is located centromeric of the more commonly typed class II genes HLA-DRB1, -DQA1 and -DQB1. It is separated from these genes by a recombination hotspot, and the association is not affected by conditioning on genotypes at DRB1, DQA1 and DQB1. Hence rs9277535 represents an independent MS-susceptibility locus of genomewide significance. It is correlated with the HLA-DPB1*03:01 allele, which has been implicated previously in MS in smaller studies. Further genotyping in large datasets is required to confirm and resolve this association.	[Field, Judith; Johnson, Laura J.; Kilpatrick, Trevor J.; Butzkueven, Helmut; Wiley, James; Rubio, Justin P.] Univ Melbourne, Florey Neurosci Inst, Melbourne, Vic, Australia; [Field, Judith; Johnson, Laura J.; Kilpatrick, Trevor J.] Univ Melbourne, Ctr Neurosci, Melbourne, Vic, Australia; [Browning, Sharon R.] Univ Auckland, Dept Stat, Auckland 1, New Zealand; [Danoy, Patrick; Brown, Matthew A.] Univ Queensland, Princess Alexandra Hosp, Univ Queensland Diamantina Inst, Brisbane, Qld, Australia; [Varney, Michael D.; Tait, Brian D.] Australian Red Cross Blood Serv, Melbourne, Vic, Australia; [Gandhi, Kaushal S.; Heard, Robert N.; Stewart, Graeme J.; Booth, David R.] Univ Sydney, Westmead Millenium Inst, Sydney, NSW 2006, Australia; [Charlesworth, Jac C.] SW Fdn Biomed Res, Dept Genet, San Antonio, TX USA; [Kilpatrick, Trevor J.] Royal Melbourne Hosp, Melbourne, Vic, Australia; [Foote, Simon J.; Taylor, Bruce V.; Stankovich, Jim] Univ Tasmania, Menzies Res Inst, Hobart, Tas, Australia; [Bahlo, Melanie] Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia; [Butzkueven, Helmut] Univ Melbourne, Dept Med, Melbourne, Vic, Australia; [Butzkueven, Helmut] Box Hill Hosp, Dept Neurol, Box Hill, Vic, Australia; [Brown, Matthew A.] Univ Oxford, Botnar Res Ctr, Nuffield Dept Orthopaed Surg, Oxford, England; [Rubio, Justin P.] GlaxoSmithKline, Harlow, Essex, England	Florey Institute of Neuroscience & Mental Health; University of Melbourne; University of Melbourne; University of Auckland; University of Queensland; Australian Red Cross Blood Service; University of Sydney; Westmead Institute for Medical Research; Texas Biomedical Research Institute; Royal Melbourne Hospital; University of Tasmania; Menzies Institute for Medical Research; Walter & Eliza Hall Institute; University of Melbourne; Box Hill Hospital; University of Oxford; GlaxoSmithKline	Field, J (corresponding author), Univ Melbourne, Florey Neurosci Inst, Melbourne, Vic, Australia.	J.Stankovich@utas.edu.au	Brown, Matthew A/E-5749-2010; Foote, Simon J/F-2802-2013; Charlesworth, Jac/J-7661-2014; Kermode, Allan/G-3568-2019; Browning, Sharon/B-1530-2008; Scott, Rodney/B-2827-2013; Slee, Mark/J-4731-2015	Brown, Matthew A/0000-0003-0538-8211; Charlesworth, Jac/0000-0001-6201-3518; Kermode, Allan/0000-0002-4476-4016; Browning, Sharon/0000-0001-7251-9715; Wiley, James/0000-0001-9421-4154; Kilpatrick, Trevor/0000-0003-3999-085X; Butzkueven, Helmut/0000-0003-3940-8727; Lechner-Scott, Jeannette/0000-0002-3850-447X; Stankovich, Jim/0000-0001-9344-7749; RUBIO, JUSTIN/0000-0003-3750-917X; Griffiths, Lyn/0000-0002-6774-5475; Foote, Simon/0000-0002-9142-2107; Scott, Rodney/0000-0001-7724-3404; Moscato, Pablo/0000-0003-2570-5966; Slee, Mark/0000-0003-4323-2453; Bahlo, Melanie/0000-0001-5132-0774; Field, Judith/0000-0002-7089-0999	National Health and Medical Research Council of Australia [509184]; Australian Research Council [LP0776744]; Multiple Sclerosis Research Australia; John T. Reid Charitable Trusts; Trish MS Research Foundation; Medical Research Council [G0000934]; Wellcome Trust [068545/Z/02]; MRC [G0000934] Funding Source: UKRI	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); Multiple Sclerosis Research Australia; John T. Reid Charitable Trusts; Trish MS Research Foundation; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the National Health and Medical Research Council of Australia (Project Grant number 509184, Career Development Awards to M.B., H.B. and J.P.R., Principal Research Fellowship to M. A. B.), the Australian Research Council (Linkage Project Grant number LP0776744), Multiple Sclerosis Research Australia (Linkage Project Grant, Post-doctoral Fellowship to J.F.), John T. Reid Charitable Trusts, and the Trish MS Research Foundation. J.P.R. is currently employed by GlaxoSmithKline. Genotype data from the British 1958 Birth Cohort DNA collection was funded by the Medical Research Council grant G0000934 and the Wellcome Trust Grant 068545/Z/02. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Olama AA, 2009, NAT GENET, V41, P1058, DOI 10.1038/ng.452; Aulchenko YS, 2008, NAT GENET, V40, P1402, DOI 10.1038/ng.251; Bahlo M, 2009, NAT GENET, V41, P824, DOI 10.1038/ng.396; Ban M, 2009, EUR J HUM GENET, V17, P1309, DOI 10.1038/ejhg.2009.41; Barcellos LF, 2006, HUM MOL GENET, V15, P2813, DOI 10.1093/hmg/ddl223; Bergamaschi L, 2010, GENES IMMUN, V11, P173, DOI 10.1038/gene.2009.101; Bronson PG, 2010, HUM MOL GENET, V19, P2331, DOI 10.1093/hmg/ddq101; Browning BL, 2007, GENET EPIDEMIOL, V31, P365, DOI 10.1002/gepi.20216; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Browning SR, 2006, AM J HUM GENET, V78, P903, DOI 10.1086/503876; Burfoot RK, 2008, TISSUE ANTIGENS, V71, P42, DOI 10.1111/j.1399-0039.2007.00962.x; Cree BAC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011296; D'Alfonso S, 2008, GENES IMMUN, V9, P7, DOI 10.1038/sj.gene.6364437; de Bakker PIW, 2006, NAT GENET, V38, P1166, DOI 10.1038/ng1885; De Jager PL, 2009, NAT GENET, V41, P776, DOI 10.1038/ng.401; DEKKER JW, 1993, TISSUE ANTIGENS, V41, P31, DOI 10.1111/j.1399-0039.1993.tb01974.x; Dyment DA, 2005, HUM MOL GENET, V14, P2019, DOI 10.1093/hmg/ddi206; Fernando MMA, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000024; Fogdell-Hahn A, 2000, TISSUE ANTIGENS, V55, P140, DOI 10.1034/j.1399-0039.2000.550205.x; Fukazawa T, 2006, MULT SCLER J, V12, P19, DOI 10.1191/135248506ms1252oa; Hafler DA, 2007, NEW ENGL J MED, V357, P851, DOI 10.1056/NEJMoa073493; Hafler JP, 2009, GENES IMMUN, V10, P5, DOI 10.1038/gene.2008.82; Handel AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010142; Harbo HF, 2004, TISSUE ANTIGENS, V63, P237, DOI 10.1111/j.0001-2815.2004.00173.x; Hoppenbrouwers IA, 2008, GENES IMMUN, V9, P334, DOI 10.1038/gene.2008.22; Jakkula E, 2010, AM J HUM GENET, V86, P285, DOI 10.1016/j.ajhg.2010.01.017; Leslie S, 2008, AM J HUM GENET, V82, P48, DOI 10.1016/j.ajhg.2007.09.001; Lincoln MR, 2009, P NATL ACAD SCI USA, V106, P7542, DOI 10.1073/pnas.0812664106; Marrosu M, 2006, J NEUROL, V253, P208, DOI 10.1007/s00415-005-0957-y; Marrosu MG, 2001, HUM MOL GENET, V10, P2907, DOI 10.1093/hmg/10.25.2907; Marrosu MG, 1998, HUM MOL GENET, V7, P1235, DOI 10.1093/hmg/7.8.1235; McCauley JL, 2010, HUM MOL GENET, V19, P953, DOI 10.1093/hmg/ddp542; McDonnell GV, 1999, J NEUROL SCI, V165, P77, DOI 10.1016/S0022-510X(99)00084-2; McElroy JP, 2010, HUM MOL GENET, V19, P3080, DOI 10.1093/hmg/ddq197; Nejentsev S, 2007, NATURE, V450, P887, DOI 10.1038/nature06406; PAWELEC G, 1990, CELL IMMUNOL, V127, P520, DOI 10.1016/0008-8749(90)90152-H; Portales-Casamar E, 2010, NUCLEIC ACIDS RES, V38, pD105, DOI 10.1093/nar/gkp950; Ramagopalan SV, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000369; Rioux JD, 2009, P NATL ACAD SCI USA, V106, P18680, DOI 10.1073/pnas.0909307106; Rubio JP, 2008, GENES IMMUN, V9, P624, DOI 10.1038/gene.2008.59; Sawcer S, 2008, LANCET NEUROL, V7, P567, DOI 10.1016/S1474-4422(08)70122-4; Stankovich J, 2009, TISSUE ANTIGENS, V74, P17, DOI 10.1111/j.1399-0039.2009.01262.x; Tiwari J L, 1981, Prog Clin Biol Res, V58, P151; van der Mei IAF, 2010, ANN NEUROL, V67, P261, DOI 10.1002/ana.21849; Wiendl H, 2005, BRAIN, V128, P2689, DOI 10.1093/brain/awh609; Wu JS, 2010, MULT SCLER J, V16, P526, DOI 10.1177/1352458510362997; Wu XM, 2009, MULT SCLER J, V15, P1422, DOI 10.1177/1352458509345905; Yamasaki K, 1999, BRAIN, V122, P1689, DOI 10.1093/brain/122.9.1689; Yeo TW, 2007, ANN NEUROL, V61, P228, DOI 10.1002/ana.21063; Yu M, 1998, HUM IMMUNOL, V59, P15, DOI 10.1016/S0198-8859(97)00252-8; YU VC, 1991, CELL, V67, P1251, DOI 10.1016/0092-8674(91)90301-E	51	42	43	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2010	5	10							e13454	10.1371/journal.pone.0013454	http://dx.doi.org/10.1371/journal.pone.0013454			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671GB	21049023	Green Published, gold, Green Submitted			2022-12-27	WOS:000283487400001
J	Nunez, CMV; Adelman, JS; Rubenstein, DI				Nunez, Cassandra M. V.; Adelman, James S.; Rubenstein, Daniel I.			Immunocontraception in Wild Horses (Equus caballus) Extends Reproductive Cycling Beyond the Normal Breeding Season	PLOS ONE			English	Article							FERAL HORSES; SEXUAL-BEHAVIOR; TIME-BUDGETS; POPULATION; EXPOSURE; SUCCESS; LENGTH; ESTRUS; MICE	Background: Although the physiological effects of immunocontraceptive treatment with porcine zona pellucida (PZP) have been well studied, little is known about PZP's effects on the scheduling of reproductive cycling. Recent behavioral research has suggested that recipients of PZP extend the receptive breeding period into what is normally the non-breeding season. Methodology/Principal Findings: To determine if this is the case, we compiled foaling data from wild horses (Equus caballus) living on Shackleford Banks, North Carolina for 4 years pre- and 8 years post-contraception management with PZP (pre-contraception, n = 65 births from 45 mares; post-contraception, n = 97 births from 46 mares). Gestation lasts approximately 11-12 months in wild horses, placing conception at approximately 11.5 months prior to birth. Since the contraception program began in January 2000, foaling has occurred over a significantly broader range than it had before the contraception program. Foaling in PZP recipients (n = 45 births from 27 mares) has consistently occurred over a broader range than has foaling in non-recipients (n = 52 births from 19 mares). In addition, current recipients of PZP foaled later in the year than did prior recipient and non-recipient mares. Females receiving more consecutive PZP applications gave birth later in the season than did females receiving fewer applications. Finally, the efficacy of PZP declined with increasing consecutive applications before reaching 100% after five consecutive applications. Conclusions/Significance: For a gregarious species such as the horse, the extension of reproductive cycling into the fall months has important social consequences, including decreased group stability and the extension of male reproductive behavior. In addition, reproductive cycling into the fall months could have long-term effects on foal survivorship. Managers should consider these factors before enacting immunocontraceptive programs in new populations. We suggest minor alterations to management strategies to help alleviate such unintended effects in new populations.	[Nunez, Cassandra M. V.; Adelman, James S.; Rubenstein, Daniel I.] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA	Princeton University	Nunez, CMV (corresponding author), Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA.	cmvnunez@princeton.edu		Adelman, James/0000-0002-5577-8798; Nunez, Cassandra/0000-0002-6702-0730	National Science Foundation [IIS-0705311]	National Science Foundation(National Science Foundation (NSF))	This research was funded by the National Science Foundation, IIS-0705311 to D.I. Rubenstein, http://www.nsf.gov/ and a National Science Foundation Graduate Research Fellowship to J.S. Adelman. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asa Cheryl S., 2002, P113; ASA CS, 1980, HORM BEHAV, V14, P46, DOI 10.1016/0018-506X(80)90014-8; ASA CS, 1979, HORM BEHAV, V13, P49, DOI 10.1016/0018-506X(79)90034-5; Ball Gregory F., 2002, P649; BOS H, 1980, LIVEST PROD SCI, V7, P181, DOI 10.1016/0301-6226(80)90105-0; Cameron EZ, 2003, BEHAV ECOL SOCIOBIOL, V53, P92, DOI 10.1007/s00265-002-0556-1; Churcher C.S., 1993, Mammalian Species, V453, P1; Crawley M.J., 2007, R BOOK; Crowell-Davis SL, 2007, HORM BEHAV, V52, P12, DOI 10.1016/j.yhbeh.2007.03.020; Davies Morel M C G, 2003, EQUINE REPROD PHYSL, V2nd; Delsink AK, 2006, S AFR J SCI, V102, P403; DUNCAN P, 1985, BEHAVIOUR, V92, P188, DOI 10.1163/156853985X00442; EBERHARDT LL, 1982, J WILDLIFE MANAGE, V46, P367, DOI 10.2307/3808648; Feh C, 1999, ANIM BEHAV, V57, P705, DOI 10.1006/anbe.1998.1009; FEIST JD, 1976, Z TIERPSYCHOL, V41, P337; Goldsby RA, 2000, KUBY IMMUNOLOGY; Groux H, 1997, NATURE, V389, P737, DOI 10.1038/39614; GRUBB P, 1981, MAMMALIAN SPECIES, V157, P1; Heilmann TJ, 1998, J WILDLIFE MANAGE, V62, P243, DOI 10.2307/3802284; HORNBUCKLE T, 1995, THERIOGENOLOGY, V43, P411, DOI 10.1016/0093-691X(94)00034-R; KASEDA Y, 1995, EQUINE VET J, V27, P368, DOI 10.1111/j.2042-3306.1995.tb04072.x; KEARNS M, 2009, MALE HARASSMENT INFL; KEIPER R, 1984, AM J VET RES, V45, P991; Kirkpatrick J. F., 1995, NATL PARK SERVICE MO; Kirkpatrick Jay F., 2003, Journal of Applied Animal Welfare Science, V6, P301, DOI 10.1207/s15327604jaws0604_4; Kirkpatrick JF, 1996, J REPROD FERTIL, P183; Kirkpatrick JF, 1997, REPROD FERT DEVELOP, V9, P105, DOI 10.1071/R96052; Kirkpatrick JF, 2002, REPRODUCTION, P197; KIRKPATRICK JF, 1991, J WILDLIFE MANAGE, V55, P649, DOI 10.2307/3809514; KIRKPATRICK JF, 1992, J REPROD FERTIL, V94, P437, DOI 10.1530/jrf.0.0940437; Lane VM, 2007, REPROD FERT DEVELOP, V19, P617, DOI 10.1071/RD06154; Lea J, 2001, ANIM BEHAV, V61, P373, DOI 10.1006/anbe.2000.1604; LINDZEY J, 1988, HORM BEHAV, V22, P279, DOI 10.1016/0018-506X(88)90001-3; LIU IKM, 1989, J REPROD FERTIL, V85, P19, DOI 10.1530/jrf.0.0850019; Lyda RO, 2005, J ZOO WILDLIFE MED, V36, P610, DOI 10.1638/04104.1; MARSDEN HM, 1964, SCIENCE, V144, P1469, DOI 10.1126/science.144.3625.1469; MCCOMB K, 1987, NATURE, V330, P648, DOI 10.1038/330648a0; McShea WJ, 1997, J WILDLIFE MANAGE, V61, P560, DOI 10.2307/3802615; Morel MCGD, 2006, ANIM SCI, V82, P581, DOI 10.1079/ASC200669; Morris J, 2001, IN PRACTICE, V23, P606, DOI 10.1136/inpract.23.10.606; Nunez CMV, 2009, APPL ANIM BEHAV SCI, V117, P74, DOI 10.1016/j.applanim.2008.12.001; NUNEZ CMV, 2000, THESIS PRINCETON U P; NUNEZ CMV, 2009, EQUINC REPROD; Pacheco MA, 1997, J MAMMAL, V78, P15, DOI 10.2307/1382634; Pinheiro J. C., 2000, MIXED EFFECTS MODELS, pXVI; POLLOCK J, 1980, BEHAV ECOLOGY BODY C, P63; Powell D. M., 2001, Journal of Applied Animal Welfare Science, V4, P271, DOI 10.1207/S15327604JAWS0404_04; Powell D M, 1999, J Appl Anim Welf Sci, V2, P321, DOI 10.1207/s15327604jaws0204_6; Ransom JI, 2010, APPL ANIM BEHAV SCI, V124, P51, DOI 10.1016/j.applanim.2010.01.015; Rubenstein D.I., 1986, P282; Rubenstein DI, 2009, REPRODUCTIVE SKEW IN VERTEBRATES: PROXIMATE AND ULTIMATE CAUSES, P196, DOI 10.1017/CBO9780511641954.010; RUBENSTEIN DI, 1981, EQUINE VET J, V13, P27, DOI 10.1111/j.2042-3306.1981.tb03443.x; SACCO AG, 1977, BIOL REPROD, V16, P164, DOI 10.1095/biolreprod16.2.164; Sadleir R.M.F.S., 1969, ECOLOGY REPROD WILD; STEVENS EF, 1990, BEHAVIOUR, V112, P149, DOI 10.1163/156853990X00167; Sundaresan SR, 2007, BEHAV ECOL, V18, P860, DOI 10.1093/beheco/arm055; TORIBIO RE, 1995, ACTA VET SCAND, V36, P343; TURNER A, 2002, EFFECTS IMMUNOCONTRA, P187; TURNER JW, 2005, J WILDLIFE MANAGE, V71, P662; Valera M, 2006, ANIM REPROD SCI, V95, P75, DOI 10.1016/j.anireprosci.2005.09.008; Venables WN, 2002, MODERN APPL STAT S, pxi; WHITTEN WK, 1968, SCIENCE, V161, P584, DOI 10.1126/science.161.3841.584	62	30	31	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2010	5	10							e13635	10.1371/journal.pone.0013635	http://dx.doi.org/10.1371/journal.pone.0013635			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671GB	21049017	gold, Green Published			2022-12-27	WOS:000283487400025
J	Stern, RF; Horak, A; Andrew, RL; Coffroth, MA; Andersen, RA; Kupper, FC; Jameson, I; Hoppenrath, M; Veron, B; Kasai, F; Brand, J; James, ER; Keeling, PJ				Stern, Rowena F.; Horak, Ales; Andrew, Rose L.; Coffroth, Mary-Alice; Andersen, Robert A.; Kuepper, Frithjof C.; Jameson, Ian; Hoppenrath, Mona; Veron, Benoit; Kasai, Fumai; Brand, Jerry; James, Erick R.; Keeling, Patrick J.			Environmental Barcoding Reveals Massive Dinoflagellate Diversity in Marine Environments	PLOS ONE			English	Article							SP-NOV DINOPHYCEAE; GENETIC DIVERSITY; FRESH-WATER; TOXIC DINOFLAGELLATE; MOLECULAR PHYLOGENY; NATURAL-ENVIRONMENT; COASTAL WATERS; GENUS; SYMBIODINIUM; MORPHOLOGY	Background: Dinoflagellates are an ecologically important group of protists with important functions as primary producers, coral symbionts and in toxic red tides. Although widely studied, the natural diversity of dinoflagellates is not well known. DNA barcoding has been utilized successfully for many protist groups. We used this approach to systematically sample known "species", as a reference to measure the natural diversity in three marine environments. Methodology/Principal Findings: In this study, we assembled a large cytochrome c oxidase 1 (COI) barcode database from 8 public algal culture collections plus 3 private collections worldwide resulting in 336 individual barcodes linked to specific cultures. We demonstrate that COI can identify to the species level in 15 dinoflagellate genera, generally in agreement with existing species names. Exceptions were found in species belonging to genera that were generally already known to be taxonomically challenging, such as Alexandrium or Symbiodinium. Using this barcode database as a baseline for cultured dinoflagellate diversity, we investigated the natural diversity in three diverse marine environments (Northeast Pacific, Northwest Atlantic, and Caribbean), including an evaluation of single-cell barcoding to identify uncultivated groups. From all three environments, the great majority of barcodes were not represented by any known cultured dinoflagellate, and we also observed an explosion in the diversity of genera that previously contained a modest number of known species, belonging to Kareniaceae. In total, 91.5% of non-identical environmental barcodes represent distinct species, but only 51 out of 603 unique environmental barcodes could be linked to cultured species using a conservative cut-off based on distances between cultured species. Conclusions/Significance: COI barcoding was successful in identifying species from 70% of cultured genera. When applied to environmental samples, it revealed a massive amount of natural diversity in dinoflagellates. This highlights the extent to which we underestimate microbial diversity in the environment.	[Stern, Rowena F.; Horak, Ales; Andrew, Rose L.; James, Erick R.; Keeling, Patrick J.] Univ British Columbia, Biodivers Res Ctr, Vancouver, BC V5Z 1M9, Canada; [Coffroth, Mary-Alice] SUNY Buffalo, Dept Geol, Buffalo, NY 14260 USA; [Andersen, Robert A.] Bigelow Lab Ocean Sci, Provasoli Guillard Natl Ctr Culture Marine Phytop, W Boothbay Harbor, ME USA; [Kuepper, Frithjof C.] Scottish Marine Inst, Scottish Assoc Marine Sci, Oban, Argyll, Scotland; [Jameson, Ian] CSIRO Marine & Atmospher Res, Australian Natl Algae Culture Collect, Hobart, Tas, Australia; [Hoppenrath, Mona] DZMB, Forschungsinst Senckenberg, Wilhelmshaven, Germany; [Veron, Benoit] Univ Caen Basse Normandie, Algobank Caen, Caen, France; [Veron, Benoit; Kasai, Fumai] Natl Inst Environm Studies, Tsukuba, Ibaraki, Japan; [Brand, Jerry] Univ Texas Austin, Sch Biol Sci, Austin, TX 78712 USA	University of British Columbia; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Bigelow Laboratory for Ocean Sciences; UHI Millennium Institute; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Senckenberg Gesellschaft fur Naturforschung (SGN); Universite de Caen Normandie; National Institute for Environmental Studies - Japan; University of Texas System; University of Texas Austin	Stern, RF (corresponding author), Univ British Columbia, Biodivers Res Ctr, Vancouver, BC V5Z 1M9, Canada.	rstern71@yahoo.com	Horak, Ales/H-6723-2012; /AAY-2080-2020; Perez, Pilar/B-4948-2010; James, Erick R/D-4725-2012; Véron, Benoît/I-2942-2012; Brand, JJ/GQR-2139-2022; Andrew, Rose/B-5929-2008	Horak, Ales/0000-0002-3364-7383; /0000-0002-1365-9723; Perez, Pilar/0000-0003-3557-2247; Véron, Benoît/0000-0002-8434-8981; Andrew, Rose/0000-0003-0099-8336; Keeling, Patrick/0000-0002-7644-0745; Kuepper, Frithjof/0000-0003-1273-7109	Genome Canada; Canadian Barcode of Life Network; NERC [dml010007, SAH01001] Funding Source: UKRI; Natural Environment Research Council [SAH01001, dml010007] Funding Source: researchfish	Genome Canada(Genome Canada); Canadian Barcode of Life Network; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This project was funded by Genome Canada and the Canadian Barcode of Life Network. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amato A, 2007, PROTIST, V158, P193, DOI 10.1016/j.protis.2006.10.001; ANDERSON DM, 1987, NATURE, V325, P616, DOI 10.1038/325616a0; Bergholtz T, 2006, J PHYCOL, V42, P170, DOI 10.1111/j.1529-8817.2006.00172.x; Biegala IC, 2003, APPL ENVIRON MICROB, V69, P5519, DOI 10.1128/AEM.69.9.5519-5529.2003; BRALEWSKA JM, 1995, MAR ECOL PROG SER, V117, P241, DOI 10.3354/meps117241; Carlos AA, 1999, J PHYCOL, V35, P1054, DOI 10.1046/j.1529-8817.1999.3551054.x; Cavalier-Smith T, 2008, PROTIST, V159, P591, DOI 10.1016/j.protis.2008.04.002; Chantangsi C, 2007, INT J SYST EVOL MICR, V57, P2412, DOI 10.1099/ijs.0.64865-0; Clarkston BE, 2010, BOTANY, V88, P119, DOI 10.1139/B09-101; Coffroth MA, 2005, PROTIST, V156, P19, DOI 10.1016/j.protis.2005.02.004; Daugbjerg N, 2000, PHYCOLOGIA, V39, P302, DOI 10.2216/i0031-8884-39-4-302.1; de Salas MF, 2008, J PHYCOL, V44, P241, DOI 10.1111/j.1529-8817.2007.00458.x; Delwiche Charles F., 2007, P191; Evans KM, 2007, PROTIST, V158, P349, DOI 10.1016/j.protis.2007.04.001; Fenchel T, 2005, AQUAT MICROB ECOL, V41, P49, DOI 10.3354/ame041049; Finlay BJ, 2004, PHILOS T R SOC B, V359, P599, DOI 10.1098/rstb.2003.1450; Finlay BJ, 2002, SCIENCE, V296, P1061, DOI 10.1126/science.1070710; Foissner W, 2008, BIODIVERS CONSERV, V17, P235, DOI 10.1007/s10531-007-9248-5; FULLER N, 2006, AQUAT MICROB ECOL, V43; Gast RJ, 2007, ENVIRON MICROBIOL, V9, P39, DOI 10.1111/j.1462-2920.2006.01109.x; Gast RJ, 2006, J PHYCOL, V42, P233, DOI 10.1111/j.1529-8817.2006.00183.x; Glasgow HB, 2001, PHYCOLOGIA, V40, P234, DOI 10.2216/i0031-8884-40-3-234.1; Gomez Fernando, 2005, Acta Botanica Croatica, V64, P129; Gottschling M, 2005, MOL PHYLOGENET EVOL, V36, P444, DOI 10.1016/j.ympev.2005.03.036; Guillou L, 2008, ENVIRON MICROBIOL, V10, P3349, DOI 10.1111/j.1462-2920.2008.01731.x; Guillou L, 2002, PROTIST, V153, P223, DOI 10.1078/1434-4610-00100; Gunderson JH, 2002, J EUKARYOT MICROBIOL, V49, P469, DOI 10.1111/j.1550-7408.2002.tb00230.x; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; HALLEGRAEFF GM, 1993, PHYCOLOGIA, V32, P79, DOI 10.2216/i0031-8884-32-2-79.1; Harper JT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006577; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hoef-Emden K, 2002, J MOL EVOL, V55, P161, DOI 10.1007/s00239-002-2313-5; Hoef-Emden K, 2003, PROTIST, V154, P371, DOI 10.1078/143446103322454130; Hoef-Emden Kerstin, 2007, Protist, V158, P135, DOI 10.1016/j.protis.2007.02.001; Hoppenrath M, 2005, J PHYCOL, V41, P1284, DOI 10.1111/j.1529-8817.2005.00155.x; Hoppenrath M, 2004, J PHYCOL, V40, P946, DOI 10.1111/j.1529-8817.2004.03045.x; HOPPENRATH M, 2003, PHYCOL RES, V51, P61; Hoppenrath M, 2008, J PHYCOL, V44, P451, DOI 10.1111/j.1529-8817.2008.00483.x; Howe AT, 2009, PROTIST, V160, P159, DOI 10.1016/j.protis.2008.11.007; Jeong HJ, 2005, J EUKARYOT MICROBIOL, V52, P382, DOI 10.1111/j.1550-7408.2005.00051.x; Kooistra WHCF, 2008, PROTIST, V159, P177, DOI 10.1016/j.protis.2007.09.004; Kucera H, 2008, BOTANY, V86, P1065, DOI 10.1139/B08-056; LaJeunesse TC, 2005, J PHYCOL, V41, P880, DOI 10.1111/j.0022-3646.2005.04231.x; LaJeunesse TC, 2001, J PHYCOL, V37, P866, DOI 10.1046/j.1529-8817.2001.01031.x; LaJeunesse TC, 2000, BIOL BULL, V199, P126, DOI 10.2307/1542872; LaJeunesse TC, 2010, J BIOGEOGR, V37, P785, DOI 10.1111/j.1365-2699.2010.02273.x; Lane CE, 2007, MOL PHYLOGENET EVOL, V44, P634, DOI 10.1016/j.ympev.2007.03.016; Lefevre E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002324; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Lilly EL, 2007, J PHYCOL, V43, P1329, DOI 10.1111/j.1529-8817.2007.00420.x; Lin S, 2009, APPL ENVIRON MICROB, V75, P1279, DOI 10.1128/AEM.01578-08; Litaker RW, 2007, J PHYCOL, V43, P344, DOI 10.1111/j.1529-8817.2007.00320.x; LOGARES R, 2007, MICROBIAL EVOLUTION; Logares R, 2008, ENVIRON MICROBIOL, V10, P1231, DOI 10.1111/j.1462-2920.2007.01538.x; Lopez-Garcia P, 2001, NATURE, V409, P603, DOI 10.1038/35054537; Marshall HG, 2006, HARMFUL ALGAE, V5, P481, DOI 10.1016/j.hal.2006.05.001; Mason PL, 2007, J PHYCOL, V43, P799, DOI 10.1111/j.1529-8817.2007.00370.x; Masseret E, 2009, APPL ENVIRON MICROB, V75, P2037, DOI 10.1128/AEM.01686-08; MCGLONE ML, 2008, MAR POLLUT B, V57, P295; McLachlin J, 1997, PHYCOLOGIA, V36, P48; Meier R, 2008, SYST BIOL, V57, P809, DOI 10.1080/10635150802406343; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Montresor M, 2003, PHYCOLOGIA, V42, P56, DOI 10.2216/i0031-8884-42-1-56.1; Moon-van der Staay SY, 2001, NATURE, V409, P607, DOI 10.1038/35054541; MOORE RB, 2006, MOL ECOLOGY PHYLOGEN; Murray S, 2005, PROTIST, V156, P269, DOI 10.1016/j.protis.2005.05.003; Murray S, 2007, PHYCOL RES, V55, P176, DOI 10.1111/j.1440-1835.2007.00460.x; Murray S, 2009, PROTIST, V160, P245, DOI 10.1016/j.protis.2008.12.004; Nash EA, 2007, MOL BIOL EVOL, V24, P1528, DOI 10.1093/molbev/msm074; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pochon X, 2006, MOL PHYLOGENET EVOL, V38, P20, DOI 10.1016/j.ympev.2005.04.028; Potter D, 1997, BIODIVERS CONSERV, V6, P99, DOI 10.1023/A:1018379716868; Richards TA, 2005, ENVIRON MICROBIOL, V7, P1413, DOI 10.1111/j.1462-2920.2005.00828.x; ROWAN R, 1992, P NATL ACAD SCI USA, V89, P3639, DOI 10.1073/pnas.89.8.3639; Saldarriaga JF, 2004, EUR J PROTISTOL, V40, P85, DOI 10.1016/j.ejop.2003.11.003; Sampayo EM, 2009, MOL ECOL, V18, P500, DOI 10.1111/j.1365-294X.2008.04037.x; SANTOS S, 2002, MOL PHYLOGENET EVOL, V23; Santos SR, 2004, J PHYCOL, V40, P395, DOI 10.1111/j.1529-8817.2004.03186.x; Santos SR, 2003, MAR BIOTECHNOL, V5, P130, DOI 10.1007/s10126-002-0076-9; Santos SR, 2001, J PHYCOL, V37, P900, DOI 10.1046/j.1529-8817.2001.00194.x; Saunders GW, 2005, PHILOS T R SOC B, V360, P1879, DOI 10.1098/rstb.2005.1719; Scheckenbach F, 2006, APPL ENVIRON MICROB, V72, P6638, DOI 10.1128/AEM.02547-05; SCHOLIN CA, 1994, J PHYCOL, V30, P999, DOI 10.1111/j.0022-3646.1994.00999.x; Sims PA, 2006, PHYCOLOGIA, V45, P361, DOI 10.2216/05-22.1; Smirnov AV, 2008, EUR J PROTISTOL, V44, P35, DOI 10.1016/j.ejop.2007.08.001; Smith VS, 2005, SYST BIOL, V54, P841, DOI 10.1080/10635150500354894; Steidinger KA, 1996, J PHYCOL, V32, P157, DOI 10.1111/j.0022-3646.1996.00157.x; Steidinger KA, 2006, J PHYCOL, V42, P951, DOI 10.1111/j.1529-8817.2006.00248.x; Sunamura M, 2004, APPL ENVIRON MICROB, V70, P1190, DOI 10.1128/AEM.70.2.1190-1198.2004; Swofford D. L, 2002, PAUP PHYLOGENETIC AN; Takabayashi M, 2004, J PHYCOL, V40, P160, DOI 10.1111/j.0022-3646.2003.03-097.x; TAKAHASHI M, 1978, J EXP MAR BIOL ECOL, V31, P283, DOI 10.1016/0022-0981(78)90064-3; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Taylor FJR, 2008, BIODIVERS CONSERV, V17, P407, DOI 10.1007/s10531-007-9258-3; TAYLOR FJR, 1987, BIOL DINOFLAGELLATES, P1; Tengs T, 2000, MOL BIOL EVOL, V17, P718, DOI 10.1093/oxfordjournals.molbev.a026350; Thornhill DJ, 2007, MOL ECOL, V16, P5326, DOI 10.1111/j.1365-294X.2007.03576.x; Touzet N, 2007, APPL ENVIRON MICROB, V73, P3333, DOI 10.1128/AEM.02161-06; Vaulot D, 2008, FEMS MICROBIOL REV, V32, P795, DOI 10.1111/j.1574-6976.2008.00121.x; von der Heyden S, 2005, INT J SYST EVOL MICR, V55, P2605, DOI 10.1099/ijs.0.63606-0; Von der Heyden S, 2004, EUR J PHYCOL, V39, P343, DOI 10.1080/09670260400005567; Wilcox TP, 1998, MOL PHYLOGENET EVOL, V10, P436, DOI 10.1006/mpev.1998.0546; Zaikova E, 2010, ENVIRON MICROBIOL, V12, P172, DOI 10.1111/j.1462-2920.2009.02058.x; ZARDOYA R, 1995, J MOL EVOL, V41, P637; Zhang H, 2008, APPL ENVIRON MICROB, V74, P1546, DOI 10.1128/AEM.02103-07; Zhang H, 2007, J MOL EVOL, V65, P463, DOI 10.1007/s00239-007-9038-4; Zhang ZD, 2002, MOL BIOL EVOL, V19, P489, DOI 10.1093/oxfordjournals.molbev.a004104	107	93	99	2	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2010	5	11							e13991	10.1371/journal.pone.0013991	http://dx.doi.org/10.1371/journal.pone.0013991			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	680KW	21085582	gold, Green Published, Green Submitted			2022-12-27	WOS:000284231800021
J	Wang, YH; Li, JN; Tang, LH; Wang, Y; Charnigo, R; de Villiers, W; Eckhardt, E				Wang, Yuehui; Li, Jianing; Tang, Lihua; Wang, Yu; Charnigo, Richard; de Villiers, Willem; Eckhardt, Erik			T-Lymphocyte Responses to Intestinally Absorbed Antigens Can Contribute to Adipose Tissue Inflammation and Glucose Intolerance during High Fat Feeding	PLOS ONE			English	Article							DIET-INDUCED OBESITY; INSULIN-RESISTANCE; METABOLIC SYNDROME; MICE; DISEASE; HUMANS; CELLS; ENDOTOXEMIA; ADIPOCYTES; MECHANISMS	Background: Obesity is associated with inflammation of visceral adipose tissues, which increases the risk for insulin resistance. Animal models suggest that T-lymphocyte infiltration is an important early step, although it is unclear why these cells are attracted. We have recently demonstrated that dietary triglycerides, major components of high fat diets, promote intestinal absorption of a protein antigen (ovalbumin, "OVA''). The antigen was partly transported on chylomicrons, which are prominently cleared in adipose tissues. We hypothesized that intestinally absorbed gut antigens may cause T-lymphocyte associated inflammation in adipose tissue. Methodology/Principal Findings: Triglyceride absorption promoted intestinal absorption of OVA into adipose tissue, in a chylomicron-dependent manner. Absorption tended to be higher in mesenteric than subcutaneous adipose tissue, and was lowest in gonadal tissue. OVA immunoreactivity was detected in stromal vascular cells, including endothelial cells. In OVA-sensitized mice, OVA feeding caused marked accumulation of CD3+ and osteopontin+ cells in mesenteric adipose tissue. The accumulating T-lymphocytes were mainly CD4+. As expected, high-fat (60% kCal) diets promoted mesenteric adipose tissue inflammation compared to low-fat diets (10% Kcal), as reflected by increased expression of osteopontin and interferon-gamma. Immune responses to dietary OVA further increased diet-induced osteopontin and interferon-gamma expression in mesenteric adipose. Inflammatory gene expression in subcutaneous tissue did not respond significantly to OVA or dietary fat content. Lastly, whereas OVA responses did not significantly affect bodyweight or adiposity, they significantly impaired glucose tolerance. Conclusions/Significance: Our results suggest that loss or lack of immunological tolerance to intestinally absorbed T-lymphocyte antigens can contribute to mesenteric adipose tissue inflammation and defective glucose metabolism during high-fat dieting.	[Wang, Yuehui; Li, Jianing; Tang, Lihua; Wang, Yu; de Villiers, Willem; Eckhardt, Erik] Univ Kentucky, Grad Ctr Nutrit Sci, Lexington, KY 40506 USA; [Wang, Yuehui; Li, Jianing; Tang, Lihua; Wang, Yu; de Villiers, Willem; Eckhardt, Erik] Univ Kentucky, Dept Internal Med, Lexington, KY USA; [Charnigo, Richard] Univ Kentucky, Dept Biostat, Lexington, KY USA	University of Kentucky; University of Kentucky; University of Kentucky	Wang, YH (corresponding author), Univ Kentucky, Grad Ctr Nutrit Sci, Lexington, KY 40506 USA.	erik.eckhardt@uky.edu	WANG, YUE/GWQ-9256-2022; Eckhardt, Erik/G-1567-2010; Gorvel, Jean-Pierre/O-1332-2018	Eckhardt, Erik/0000-0002-3015-5180; Gorvel, Jean-Pierre/0000-0002-2829-9804	NIH [1P20RR021954-01A2, 1R21AI088605-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR021954] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI088605] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The work was supported by NIH grants 1P20RR021954-01A2 and 1R21AI088605-01. The funding agency had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backhed F, 2007, P NATL ACAD SCI USA, V104, P979, DOI 10.1073/pnas.0605374104; Bickerton AST, 2007, DIABETES, V56, P168, DOI 10.2337/db06-0822; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Chehade M, 2005, J ALLERGY CLIN IMMUN, V115, P3, DOI 10.1016/j.jaci.2004.11.008; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; Ding SZ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009875; Erridge C, 2007, AM J CLIN NUTR, V86, P1286, DOI 10.1093/ajcn/86.5.1286; Fain JN, 2004, ENDOCRINOLOGY, V145, P2273, DOI 10.1210/en.2003-1336; Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002; Fontana L, 2007, DIABETES, V56, P1010, DOI 10.2337/db06-1656; Ghoshal S, 2009, J LIPID RES, V50, P90, DOI 10.1194/jlr.M800156-JLR200; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; HUBERT HB, 1983, CIRCULATION, V67, P968, DOI 10.1161/01.CIR.67.5.968; Karpe F, 1997, J LIPID RES, V38, P2335; KINTSCHER U, 2008, ARTERIOSCLEROSI 0419; KVIETYS PR, 1991, AM J PHYSIOL, V261, pG384, DOI 10.1152/ajpgi.1991.261.3.G384; Liu J, 2009, NAT MED, V15, P940, DOI 10.1038/nm.1994; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; Nomiyama T, 2007, J CLIN INVEST, V117, P2877, DOI 10.1172/JCI31986; Rabot S, 2010, FASEB J; Rocha VZ, 2008, CIRC RES, V103, P467, DOI 10.1161/CIRCRESAHA.108.177105; Schaffler A, 2005, NAT CLIN PRACT GASTR, V2, P103, DOI 10.1038/ncpgasthep0090; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Suganami T, 2007, ARTERIOSCL THROM VAS, V27, P84, DOI 10.1161/01.ATV.0000251608.09329.9a; TSO P, 1981, AM J PHYSIOL, V241, pG487, DOI 10.1152/ajpgi.1981.241.6.G487; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Vijay-Kumar M, 2010, SCIENCE, V328, P228, DOI 10.1126/science.1179721; Wang Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004899; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Weiss R, 2004, NEW ENGL J MED, V350, P2362, DOI 10.1056/NEJMoa031049; Winer S, 2009, NAT MED, V15, P921, DOI 10.1038/nm.2001; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yamamoto K, 2005, GUT, V54, P789, DOI 10.1136/gut.2004.046516	33	80	82	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2010	5	11							e13951	10.1371/journal.pone.0013951	http://dx.doi.org/10.1371/journal.pone.0013951			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	678OA	21085605	Green Published, Green Submitted, gold			2022-12-27	WOS:000284087800016
J	Chiu, YW; Lo, MT; Tsai, MR; Chang, YC; Hsu, RB; Yu, HY; Sun, CK; Ho, YL				Chiu, Yu-Wei; Lo, Men Tzung; Tsai, Ming-Rung; Chang, Yi-Chung; Hsu, Rong-Bin; Yu, Hsu-Yu; Sun, Chi-Kuang; Ho, Yi-Lwun			Applying Harmonic Optical Microscopy for Spatial Alignment of Atrial Collagen Fibers	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX; 2ND-HARMONIC GENERATION; FIBRILLATION; EXPRESSION; FIBROSIS; MECHANISMS; TISSUE	Background: Atrial fibrosis creates a vulnerable tissue for atrial fibrillation (AF), but the spatial disarray of collagen fibers underlying atrial fibrosis is not fully elucidated. Objective: This study hypothesizes that harmonics optical microscopy can illuminate the spatial mal-alignment of collagen fibers in AF via a layer-by-layer approach. Patients and Methods: Atrial tissues taken from patients who underwent open-heart surgery were examined by harmonics optical microscopy. Using the two-dimensional Fourier transformation method, a spectral-energy description of image texture was constituted and its entropy was used to quantify the mal-alignment of collagen fibers. The amount of collagen fiber was derived from its area ratio to total atrial tissue in each image. Serum C-terminal pro-collagen pro-peptide (CICP), pro-matrix metalloproteinase-1 (pro-MMP-1), and tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) were also evaluated. Results: 46 patients were evaluated, including 20 with normal sinus rhythm and 26 with AF. The entropy of spectral-energy distribution of collagen alignment was significantly higher in AF than that in sinus rhythm (3.97 +/- 0.33 vs. 2.80 +/- 0.18, p<0.005). This difference was more significant in the permanent AF group. The amount of collagen was also significantly higher in AF patients (0.39 +/- 0.13 vs. 0.18 +/- 0.06, p<0.005) but serum markers of cardiac fibrosis were not significantly different between the two groups. Conclusions: Harmonics optical microscopy can quantify the spatial mal-alignment of collagen fibers in AF. The entropy of spectral-energy distribution of collagen alignment is a potential tool for research in atrial remodeling.	[Chiu, Yu-Wei] Far Eastern Mem Hosp, Div Cardiol, Dept Internal Med, Taipei, Taiwan; [Lo, Men Tzung] Natl Cent Univ, Res Ctr Adapt Data Anal, Tao Yuan, Taiwan; [Tsai, Ming-Rung; Sun, Chi-Kuang] Natl Taiwan Univ, Dept Elect Engn, Grad Inst Photon & Optoelect, Taipei 10764, Taiwan; [Chang, Yi-Chung] Natl Taiwan Univ, Grad Inst Commun Engn, Taipei 10764, Taiwan; [Hsu, Rong-Bin; Yu, Hsu-Yu] Natl Taiwan Univ Hosp, Dept Surg, Taipei 100, Taiwan; [Hsu, Rong-Bin; Yu, Hsu-Yu; Ho, Yi-Lwun] Natl Taiwan Univ, Coll Med, Taipei 10764, Taiwan; [Ho, Yi-Lwun] Natl Taiwan Univ Hosp, Grad Inst Clin Med, Taipei 100, Taiwan; [Ho, Yi-Lwun] Natl Taiwan Univ Hosp, Dept Internal Med, Div Cardiol, Taipei 100, Taiwan	Far Eastern Memorial Hospital; National Central University; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital	Chiu, YW (corresponding author), Far Eastern Mem Hosp, Div Cardiol, Dept Internal Med, Taipei, Taiwan.	ylho@ntu.edu.tw	huang, yuting/T-4341-2019; Wang, Pa-Chun/AAD-4094-2019	HO, YI-LWUN/0000-0002-8936-9570; Sun, Chi-Kuang/0000-0002-4467-2509	National Science Council, Taipei, Taiwan [NSC 97-2314-B-002-139]; Department of Health, Executive Yuan, Taipei, Taiwan [DOH99-TD-B-111-001]; Far-Eastern Memorial Hospital, Taipei, Taiwan [FEMH-96-C-019]; NSC (Taiwan, ROC) [99-2627-B-008-003-]; foundation of CGH [99CGH-NCU-A4]; foundation of NCU [99CGH-NCU-A4]	National Science Council, Taipei, Taiwan(Ministry of Science and Technology, Taiwan); Department of Health, Executive Yuan, Taipei, Taiwan; Far-Eastern Memorial Hospital, Taipei, Taiwan; NSC (Taiwan, ROC)(Ministry of Science and Technology, Taiwan); foundation of CGH; foundation of NCU	This study was supported in part by the National Science Council, Taipei, Taiwan (grant NSC 97-2314-B-002-139), in part by the Department of Health, Executive Yuan, Taipei, Taiwan (grant DOH99-TD-B-111-001) and by Far-Eastern Memorial Hospital, Taipei, Taiwan (grant FEMH-96-C-019). M-T Lo was supported by NSC (Taiwan, ROC), Grant No 99-2627-B-008-003-, and joint foundation of CGH and NCU, 99CGH-NCU-A4. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allessie M, 2002, CARDIOVASC RES, V54, P230, DOI 10.1016/S0008-6363(02)00258-4; Anne W, 2005, CARDIOVASC RES, V67, P655, DOI 10.1016/j.cardiores.2005.04.016; Ausma J, 1997, CIRCULATION, V96, P3157, DOI 10.1161/01.CIR.96.9.3157; Bayan C, 2009, J APPL PHYS, V105, DOI 10.1063/1.3116626; Boldt A, 2004, HEART, V90, P400, DOI 10.1136/hrt.2003.015347; BOYDEN PA, 1984, CIRCULATION, V69, P1036, DOI 10.1161/01.CIR.69.5.1036; BOYDEN PA, 1982, AM J CARDIOL, V49, P1896, DOI 10.1016/0002-9149(82)90208-9; Burstein B, 2008, J AM COLL CARDIOL, V51, P802, DOI 10.1016/j.jacc.2007.09.064; Campagnola PJ, 2003, NAT BIOTECHNOL, V21, P1356, DOI 10.1038/nbt894; CHAUDHURI S, 1987, IEEE T BIO-MED ENG, V34, P509, DOI 10.1109/TBME.1987.325980; Chiu YT, 2005, J CARDIOVASC ELECTR, V16, P753, DOI 10.1046/j.1540-8167.2005.40794.x; CHU SW, 2007, J MED BIOL ENG, V27, P177; Duffy HS, 2007, HEART RHYTHM, V4, P950, DOI 10.1016/j.hrthm.2007.03.039; Gonzalez R C, 1992, DIGITAL IMAGE PROCES; Gramley F, 2007, J CARDIOVASC ELECTR, V18, P1076, DOI 10.1111/j.1540-8167.2007.00906.x; Ho YL, 2009, CLIN BIOCHEM, V42, P1407, DOI 10.1016/j.clinbiochem.2009.06.013; Kallergis EM, 2008, J AM COLL CARDIOL, V52, P211, DOI 10.1016/j.jacc.2008.03.045; Lin CS, 2007, HEART RHYTHM, V4, P938, DOI 10.1016/j.hrthm.2007.03.034; Lo Li-Wei, 2007, J Chin Med Assoc, V70, P303, DOI 10.1016/S1726-4901(08)70010-8; Marquez JP, 2006, INT J SOLIDS STRUCT, V43, P6413, DOI 10.1016/j.ijsolstr.2005.11.003; Matteini P, 2009, OPT EXPRESS, V17, P4868, DOI 10.1364/OE.17.004868; Okumura K, 2007, J CARDIOVASC ELECTR, V18, P1083, DOI 10.1111/j.1540-8167.2007.00918.x; Oron D, 2004, J STRUCT BIOL, V147, P3, DOI 10.1016/S1047-8477(03)00125-4; PATT WK, 1991, DIGITAL IMAGE PROCES; Plotnikov S, 2006, BIOPHYS J, V90, P328, DOI 10.1529/biophysj.105.066944; Polyakova V, 2008, J CELL MOL MED, V12, P189, DOI 10.1111/j.1582-4934.2008.00219.x; Pope AJ, 2008, AM J PHYSIOL-HEART C, V295, pH1243, DOI 10.1152/ajpheart.00484.2008; Sakabe M, 2004, J AM COLL CARDIOL, V43, p110A, DOI 10.1016/S0735-1097(04)90456-1; Schenke-Layland K, 2005, J BIOMED OPT, V10, DOI 10.1117/1.1896966; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; Stoller P, 2002, BIOPHYS J, V82, P3330, DOI 10.1016/S0006-3495(02)75673-7; Sun CK, 2005, ADV BIOCHEM ENG BIOT, V95, P17, DOI 10.1007/b102209; Takemoto M, 2001, J CLIN INVEST, V108, P1429, DOI 10.1172/JCI200113350; Tsai MR, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3365943; Tziakas DN, 2007, EUROPACE, V9, P589, DOI 10.1093/europace/eum072; Williams RM, 2005, BIOPHYS J, V88, P1377, DOI 10.1529/biophysj.104.047308; Xia Y, 2001, J MICROSC-OXFORD, V204, P3, DOI 10.1046/j.1365-2818.2001.00925.x; Xu J, 2004, CIRCULATION, V109, P363, DOI 10.1161/01.CIR.0000109495.02213.52; Yelin D, 1999, OPT EXPRESS, V5, P169, DOI 10.1364/OE.5.000169	39	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2010	5	11							e13917	10.1371/journal.pone.0013917	http://dx.doi.org/10.1371/journal.pone.0013917			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	677ZE	21085489	Green Published, gold, Green Submitted			2022-12-27	WOS:000284035900022
J	Micol, R; Tajahmady, A; Lortholary, O; Balkan, S; Quillet, C; Dousset, JP; Chanroeun, H; Madec, Y; Fontanet, A; Yazdanpanah, Y				Micol, Romain; Tajahmady, Ayden; Lortholary, Olivier; Balkan, Suna; Quillet, Catherine; Dousset, Jean-Philippe; Chanroeun, Hak; Madec, Yoann; Fontanet, Arnaud; Yazdanpanah, Yazdan			Cost-Effectiveness of Primary Prophylaxis of AIDS Associated Cryptococcosis in Cambodia	PLOS ONE			English	Article							RECONSTITUTION INFLAMMATORY SYNDROME; SYSTEMIC FUNGAL-INFECTIONS; ANTIRETROVIRAL THERAPY; FLUCONAZOLE RESISTANCE; MENINGITIS; ANTIGENEMIA; PREVENTION; THAILAND; DISEASE; UTILITY	Background: Cryptococcal infection is a frequent cause of mortality in Cambodian HIV-infected patients with CD4+ count <= 100 cells/mu l. This study assessed the cost-effectiveness of three strategies for cryptococcosis prevention in HIV-infected patients. Methods: A Markov decision tree was used to compare the following strategies at the time of HIV diagnosis: no intervention, one time systematic serum cryptococcal antigen (CRAG) screening and treatment of positive patients, and systematic primary prophylaxis with fluconazole. The trajectory of a hypothetical cohort of HIV-infected patients with CD4+ count <= 100 cells/mu l initiating care was simulated over a 1-year period (cotrimoxazole initiation at enrollment; antiretroviral therapy within 3 months). Natural history and cost data (US$ 2009) were from Cambodia. Efficacy data were from international literature. Results: In a population in which 81% of patients had a CD4+ count <= 50 cells/mu l and 19% a CD4+ count between 51-100 cells/mu l, the proportion alive 1 year after enrolment was 61% (cost $ 472) with no intervention, 70% (cost $ 483) with screening, and 72% (cost $ 492) with prophylaxis. After one year of follow-up, the cost-effectiveness of screening vs. no intervention was US$ 180/life year gained (LYG). The cost-effectiveness of prophylaxis vs. screening was $ 511/LYG. The cost-effectiveness of prophylaxis vs. screening was estimated at $1538/LYG if the proportion of patients with CD4+ count <= 50 cells/mu l decreased by 75%. Conclusion: In a high endemic area of cryptococcosis and HIV infection, serum CRAG screening and prophylaxis are two cost effective strategies to prevent AIDS associated cryptococcosis in patients with CD4+ count <= 100 cells/mu l, at a short-term horizon, screening being more cost-effective but less effective than prophylaxis. Systematic primary prophylaxis may be preferred in patients with CD4+ below 50 cells/mu l while systematic serum CRAG screening for early targeted treatment may be preferred in patients with CD4+ between 51-100 cells/mu l.	[Micol, Romain; Madec, Yoann; Fontanet, Arnaud] Inst Pasteur, Unite Epidemiol Malad Emergentes, Paris, France; [Micol, Romain] Univ Paris Descartes EA 36 20, Hop Necker Enfants Malad, Virol Lab, Paris, France; [Tajahmady, Ayden] Mission Natl Expertise & Audit Hosp, Paris, France; [Lortholary, Olivier] CNRS, URA3012, Ctr Natl Reference Mycol & Antifong, Unite Mycol Mol,Inst Pasteur, Paris, France; [Lortholary, Olivier] Univ Paris 05, Serv Malad Infect & Trop, Ctr Infectiol Necker Pasteur, Hop Necker Enfants Malad, Paris, France; [Balkan, Suna; Quillet, Catherine] Med Sans Frontieres, Paris, France; [Dousset, Jean-Philippe] Hop Kosamak, Phnom Penh, Cambodia; [Chanroeun, Hak] Hop Calmette, Serv Malad Infect, Phnom Penh, Cambodia; [Yazdanpanah, Yazdan] INSERM, U995, Avenir ATIP Unit, Paris, France; [Yazdanpanah, Yazdan] Fac Med Lille, CH Tourcoing, Serv Univ Malad Infect & Voyageur, F-59045 Lille, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Doctors Without Borders; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille	Micol, R (corresponding author), Inst Merieux, Lyon, France.	romain.micol@gmail.com		Madec, Yoann/0000-0002-6201-1261; , arnaud/0000-0002-5239-6110	SIDACTION - Ensemble Contre le Sida; Bristol-Myers Squibb; Gilead; Glaxo-SmithKline; Merck; Pfizer; Roche; Tibotec	SIDACTION - Ensemble Contre le Sida; Bristol-Myers Squibb(Bristol-Myers Squibb); Gilead(Gilead Sciences); Glaxo-SmithKline(GlaxoSmithKline); Merck(Merck & Company); Pfizer(Pfizer); Roche(Roche Holding); Tibotec	This work was financed by SIDACTION - Ensemble Contre le Sida. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Y. Yazdanpanah has received travel grants, honoraria for presentation at workshops and consultancy honoraria from Bristol-Myers Squibb, Gilead, Glaxo-SmithKline, Merck, Pfizer, Roche and Tibotec. O. Lortholary is a member of the speaker's bureau of Pfizer, MSD, Astellas, Schering Plough and Gilead Sciences and consultant for Astellas. R. Micol has received travel grants from Pfizer. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Amornkul PN, 2003, AIDS RES HUM RETROV, V19, P85, DOI 10.1089/088922203762688586; Apisarnthanarak A, 2008, JAIDS-J ACQ IMM DEF, V47, P644, DOI 10.1097/QAI.0b013e31815bad0c; Bicanic T, 2006, CLIN INFECT DIS, V43, P1069, DOI 10.1086/507895; Chariyalertsak S, 2001, CLIN INFECT DIS, V32, P955, DOI 10.1086/319348; Chariyalertsak S, 2002, CLIN INFECT DIS, V34, P277, DOI 10.1086/338154; Chhin S, 2004, INT J STD AIDS, V15, P48, DOI 10.1258/095646204322637263; Freedberg KA, 1998, JAMA-J AM MED ASSOC, V279, P130, DOI 10.1001/jama.279.2.130; GADE W, 1991, J CLIN MICROBIOL, V29, P1616, DOI 10.1128/JCM.29.8.1616-1619.1991; Goldie SJ, 2006, NEW ENGL J MED, V355, P1141, DOI 10.1056/NEJMsa060247; Jarvis JN, 2009, AIDS, V23, P1182, DOI 10.1097/QAD.0b013e32832be0fc; Jarvis JN, 2009, CLIN INFECT DIS, V48, P856, DOI 10.1086/597262; John L, 2004, HIV MED, V5, P131, DOI 10.1111/j.1468-1293.2004.00199.x; Liechty CA, 2007, TROP MED INT HEALTH, V12, P929, DOI 10.1111/j.1365-3156.2007.01874.x; Lortholary O, 2005, AIDS, V19, P1043, DOI 10.1097/01.aids.0000174450.70874.30; Lortholary O, 2006, AIDS, V20, P2183, DOI 10.1097/01.aids.0000252060.80704.68; Madec Y, 2007, AIDS, V21, P351, DOI 10.1097/QAD.0b013e328012c54f; McCarthy KM, 2006, AIDS, V20, P2199, DOI 10.1097/QAD.0b013e3280106d6a; Mellors JW, 1997, ANN INTERN MED, V126, P946, DOI 10.7326/0003-4819-126-12-199706150-00003; Meya DB, 2010, CLIN INFECT DIS, V51, P448, DOI 10.1086/655143; Micol R, 2007, JAIDS-J ACQ IMM DEF, V45, P555, DOI 10.1097/QAI.0b013e31811ed32c; *MIN HLTH NCFHA DE, 2009, 2 Q COMPR REP; Park BJ, 2009, AIDS, V23, P525, DOI 10.1097/QAD.0b013e328322ffac; Perfect JR, 2010, CLIN INFECT DIS, V50, P291, DOI 10.1086/649858; Pichith K, 2001, Sante, V11, P17; Pongsai P, 2010, J INFECTION, V60, P474, DOI 10.1016/j.jinf.2010.03.015; Scharfstein JA, 1997, MED DECIS MAKING, V17, P373, DOI 10.1177/0272989X9701700402; Shrestha RK, 2007, INT J TUBERC LUNG D, V11, P747; Sungkanuparph S, 2009, CLIN INFECT DIS, V49, P931, DOI 10.1086/605497; Walensky RP, 2009, ANN INTERN MED, V151, P157, DOI 10.7326/0003-4819-151-3-200908040-00138; WERTHEIMER AI, 2004, J INT ASS PHYS AIDS, V3, P84; Wertheimer Albert I, 2004, J Int Assoc Physicians AIDS Care (Chic), V3, P74, DOI 10.1177/154510970400300302; WHO Commission on Macroeconomics and Health, MACR HLTH INV HLTH E; Yazdanpanah Y, 2005, AIDS, V19, P1299, DOI 10.1097/01.aids.0000180101.80888.c6; Yazdanpanah Y, 2003, CLIN INFECT DIS, V36, P86, DOI 10.1086/344902	34	32	32	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2010	5	11							e13856	10.1371/journal.pone.0013856	http://dx.doi.org/10.1371/journal.pone.0013856			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	677ZE	21085478	gold, Green Published, Green Submitted			2022-12-27	WOS:000284035900003
J	Mochida, T; Gomi, H; Kashino, M				Mochida, Takemi; Gomi, Hiroaki; Kashino, Makio			Rapid Change in Articulatory Lip Movement Induced by Preceding Auditory Feedback during Production of Bilabial Plosives	PLOS ONE			English	Article							SPEECH PRODUCTION; SENSORIMOTOR ADAPTATION; PERTURBATIONS; RESPONSES; CORTEX; DYNAMICS; SYSTEM	Background: There has been plentiful evidence of kinesthetically induced rapid compensation for unanticipated perturbation in speech articulatory movements. However, the role of auditory information in stabilizing articulation has been little studied except for the control of voice fundamental frequency, voice amplitude and vowel formant frequencies. Although the influence of auditory information on the articulatory control process is evident in unintended speech errors caused by delayed auditory feedback, the direct and immediate effect of auditory alteration on the movements of articulators has not been clarified. Methodology/Principal Findings: This work examined whether temporal changes in the auditory feedback of bilabial plosives immediately affects the subsequent lip movement. We conducted experiments with an auditory feedback alteration system that enabled us to replace or block speech sounds in real time. Participants were asked to produce the syllable /pa/ repeatedly at a constant rate. During the repetition, normal auditory feedback was interrupted, and one of three pre-recorded syllables /pa/, /Phi a/, or /pi/, spoken by the same participant, was presented once at a different timing from the anticipated production onset, while no feedback was presented for subsequent repetitions. Comparisons of the labial distance trajectories under altered and normal feedback conditions indicated that the movement quickened during the short period immediately after the alteration onset, when /pa/ was presented 50 ms before the expected timing. Such change was not significant under other feedback conditions we tested. Conclusions/Significance: The earlier articulation rapidly induced by the progressive auditory input suggests that a compensatory mechanism helps to maintain a constant speech rate by detecting errors between the internally predicted and actually provided auditory information associated with self movement. The timing-and context-dependent effects of feedback alteration suggest that the sensory error detection works in a temporally asymmetric window where acoustic features of the syllable to be produced may be coded.	[Mochida, Takemi; Gomi, Hiroaki; Kashino, Makio] NTT Corp, Human & Informat Sci Lab, NTT Commun Sci Labs, Atsugi, Kanagawa, Japan; [Gomi, Hiroaki; Kashino, Makio] Japan Sci & Technol Agcy, Shimojo Implicit Brain Funct Project, Kawaguchi, Saitama, Japan; [Kashino, Makio] Tokyo Inst Technol, Dept Informat Proc, Interdisciplinary Grad Sch Sci & Engn, Tokyo 152, Japan	Nippon Telegraph & Telephone Corporation; Japan Science & Technology Agency (JST); Tokyo Institute of Technology	Mochida, T (corresponding author), NTT Corp, Human & Informat Sci Lab, NTT Commun Sci Labs, Atsugi, Kanagawa, Japan.	mochida@idea.brl.ntt.co.jp	Gomi, Hiroaki/AEL-2645-2022; Gomi, Hiroaki/C-5269-2013	Gomi, Hiroaki/0000-0003-3541-2251	Nippon Telegraph and Telephone Co.	Nippon Telegraph and Telephone Co.	The authors received annual research funding from Nippon Telegraph and Telephone Co. The employees of the funder carried out study design, data collection and analysis, decision to publish, and preparation of the manuscript.	ABBS JH, 1984, J NEUROPHYSIOL, V51, P705, DOI 10.1152/jn.1984.51.4.705; BLUMSTEIN SE, 1979, J ACOUST SOC AM, V66, P1001, DOI 10.1121/1.383319; BORDEN GJ, 1979, BRAIN LANG, V7, P307, DOI 10.1016/0093-934X(79)90025-7; Burnett TA, 2002, J ACOUST SOC AM, V112, P1058, DOI 10.1121/1.1487844; Burnett TA, 1998, J ACOUST SOC AM, V103, P3153, DOI 10.1121/1.423073; Callan DE, 2000, J SPEECH LANG HEAR R, V43, P721, DOI 10.1044/jslhr.4303.721; Curio G, 2000, HUM BRAIN MAPP, V9, P183, DOI 10.1002/(SICI)1097-0193(200004)9:4<183::AID-HBM1>3.0.CO;2-Z; Eliades SJ, 2005, CEREB CORTEX, V15, P1510, DOI 10.1093/cercor/bhi030; Fairbanks G, 1955, J SPEECH HEAR DISORD, V20, P333, DOI 10.1044/jshd.2004.333; GRACCO VL, 1988, EXP BRAIN RES, V71, P515, DOI 10.1007/BF00248744; GRACCO VL, 1985, J NEUROPHYSIOL, V54, P418, DOI 10.1152/jn.1985.54.2.418; Guenther FH, 1998, PSYCHOL REV, V105, P611, DOI 10.1037/0033-295X.105.4.611-633; Guenther FH, 2006, J COMMUN DISORD, V39, P350, DOI 10.1016/j.jcomdis.2006.06.013; Heinks-Maldonado TH, 2005, PSYCHOPHYSIOLOGY, V42, P180, DOI 10.1111/j.1469-8986.2005.00272.x; Hibi S., 1983, Journal of the Acoustical Society of Japan (E), V4, P83, DOI 10.1250/ast.4.83; Houde JF, 1998, SCIENCE, V279, P1213, DOI 10.1126/science.279.5354.1213; Houde JF, 2002, J COGNITIVE NEUROSCI, V14, P1125, DOI 10.1162/089892902760807140; Jones JA, 2005, CURR BIOL, V15, P1768, DOI 10.1016/j.cub.2005.08.063; Kawahara H, 1996, VOCAL FOLD, P263; KELSO JAS, 1984, J EXP PSYCHOL HUMAN, V10, P812, DOI 10.1037/0096-1523.10.6.812; KELSO JAS, 1985, J ACOUST SOC AM, V77, P266, DOI 10.1121/1.392268; LEE BS, 1950, J ACOUST SOC AM, V22, P824, DOI 10.1121/1.1906696; Lombard E, 1911, ANN MALADIES OREILLE, P101; MUELLER HG, 1994, HEARING J, V47, P29; Nonaka S, 1997, NEUROSCI RES, V29, P283, DOI 10.1016/S0168-0102(97)00097-7; Peters RW, 1954, J SPEECH HEAR DISORD, V19, P483, DOI 10.1044/jshd.1904.483; Postma A, 2000, COGNITION, V77, P97, DOI 10.1016/S0010-0277(00)00090-1; Saltzman E, 1998, EXP BRAIN RES, V123, P412, DOI 10.1007/s002210050586; SAPIR S, 1983, J ACOUST SOC AM, V73, P315, DOI 10.1121/1.388812; Stuart A, 2002, J ACOUST SOC AM, V111, P2237, DOI 10.1121/1.1466868; TIFFANY WR, 1952, SCIENCE, V115, P59, DOI 10.1126/science.115.2977.59; Tourville JA, 2008, NEUROIMAGE, V39, P1429, DOI 10.1016/j.neuroimage.2007.09.054; VATIKIOTISBATESON E, 1993, J PHONETICS, V21, P231, DOI 10.1016/S0095-4470(19)31338-5; Villacorta VM, 2007, J ACOUST SOC AM, V122, P2306, DOI 10.1121/1.2773966; Zanini S, 1999, PERCEPT MOTOR SKILL, V89, P1095, DOI 10.2466/PMS.89.7.1095-1109	35	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2010	5	11							e13866	10.1371/journal.pone.0013866	http://dx.doi.org/10.1371/journal.pone.0013866			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	676NU	21079783	gold, Green Published, Green Submitted			2022-12-27	WOS:000283920000003
J	de Morree, A; Hensbergen, PJ; van Haagen, HHHBM; Dragan, I; Deelder, AM; 't Hoen, PAC'; Frants, RR; van der Maarel, SM				de Morree, Antoine; Hensbergen, Paul J.; van Haagen, Herman H. H. B. M.; Dragan, Irina; Deelder, Andre M.; 't Hoen, Peter A. C.; Frants, Rune R.; van der Maarel, Silvere M.			Proteomic Analysis of the Dysferlin Protein Complex Unveils Its Importance for Sarcolemmal Maintenance and Integrity	PLOS ONE			English	Article							GIRDLE MUSCULAR-DYSTROPHY; NORMAL MYOBLAST FUSION; FOCAL ADHESION KINASE; SKELETAL-MUSCLE; MEMBRANE REPAIR; PLASMA-MEMBRANE; REGULATED EXOCYTOSIS; MIYOSHI MYOPATHY; GENE; ENDOCYTOSIS	Dysferlin is critical for repair of muscle membranes after damage. Mutations in dysferlin lead to a progressive muscular dystrophy. Recent studies suggest additional roles for dysferlin. We set out to study dysferlin's protein-protein interactions to obtain comprehensive knowledge of dysferlin functionalities in a myogenic context. We developed a robust and reproducible method to isolate dysferlin protein complexes from cells and tissue. We analyzed the composition of these complexes in cultured myoblasts, myotubes and skeletal muscle tissue by mass spectrometry and subsequently inferred potential protein functions through bioinformatics analyses. Our data confirm previously reported interactions and support a function for dysferlin as a vesicle trafficking protein. In addition novel potential functionalities were uncovered, including phagocytosis and focal adhesion. Our data reveal that the dysferlin protein complex has a dynamic composition as a function of myogenic differentiation. We provide additional experimental evidence and show dysferlin localization to, and interaction with the focal adhesion protein vinculin at the sarcolemma. Finally, our studies reveal evidence for cross-talk between dysferlin and its protein family member myoferlin. Together our analyses show that dysferlin is not only a membrane repair protein but also important for muscle membrane maintenance and integrity.	[de Morree, Antoine; van Haagen, Herman H. H. B. M.; 't Hoen, Peter A. C.; Frants, Rune R.; van der Maarel, Silvere M.] Leiden Univ, Ctr Human Genet, Med Ctr, Leiden, Netherlands; [Hensbergen, Paul J.; Dragan, Irina; Deelder, Andre M.] Leiden Univ, Biomol Mass Spectrometry Unit, Med Ctr, Dept Parasitol, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	de Morree, A (corresponding author), Leiden Univ, Ctr Human Genet, Med Ctr, Leiden, Netherlands.	maarel@lumc.nl	't Hoen, Peter/A-4857-2012; Hoen, Peter A 't/D-3950-2018; van der Maarel, Silvere/X-3631-2018	Hoen, Peter A 't/0000-0003-4450-3112; van der Maarel, Silvere/0000-0001-8103-711X; de Morree, Antoine/0000-0002-8316-4531; Hensbergen, Paul/0000-0002-3193-5445	Dutch Prinses Beatrix Fonds [MAR05-0112]; Jain Foundation	Dutch Prinses Beatrix Fonds; Jain Foundation	Funding: This work was supported by grants from the Dutch Prinses Beatrix Fonds (MAR05-0112) and the Jain Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ampong Beryl N, 2005, Acta Myol, V24, P134; Anderson LVB, 1999, HUM MOL GENET, V8, P855, DOI 10.1093/hmg/8.5.855; Azakir BA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010122; Bansal D, 2003, NATURE, V423, P168, DOI 10.1038/nature01573; Bashir R, 1998, NAT GENET, V20, P37, DOI 10.1038/1689; Beckmann JS, 2008, NEUROMUSCULAR DISORD, V18, P913, DOI 10.1016/j.nmd.2008.08.005; Borgonovo B, 2002, NAT CELL BIOL, V4, P955, DOI 10.1038/ncb888; Bushby Kate, 2009, Pract Neurol, V9, P314, DOI 10.1136/jnnp.2009.193938; Cai CX, 2009, J BIOL CHEM, V284, P15894, DOI 10.1074/jbc.M109.009589; Cai CX, 2009, NAT CELL BIOL, V11, P56, DOI 10.1038/ncb1812; Chiu YH, 2009, HUM MOL GENET, V18, P1976, DOI 10.1093/hmg/ddp121; Cocucci E, 2007, TRAFFIC, V8, P742, DOI 10.1111/j.1600-0854.2007.00566.x; Collinet C, 2010, NATURE, V464, P243, DOI 10.1038/nature08779; Covian-Nares JF, 2010, J CELL SCI, V123, P1884, DOI 10.1242/jcs.066084; Davis DB, 2000, HUM MOL GENET, V9, P217, DOI 10.1093/hmg/9.2.217; De Luna N, 2007, NEUROMUSCULAR DISORD, V17, P69, DOI 10.1016/j.nmd.2006.09.006; De Luna N, 2010, J NEUROPATH EXP NEUR, V69, P643, DOI 10.1097/NEN.0b013e3181e0d01c; Disatnik MH, 1999, J BIOL CHEM, V274, P32486, DOI 10.1074/jbc.274.45.32486; Doherty KR, 2005, DEVELOPMENT, V132, P5565, DOI 10.1242/dev.02155; Foxton RM, 2004, EUR J HUM GENET, V12, P127, DOI 10.1038/sj.ejhg.5201092; Fujita E, 2007, HUM MOL GENET, V16, P618, DOI 10.1093/hmg/ddm002; Hayashi YK, 1998, NAT GENET, V19, P94, DOI 10.1038/ng0598-94; Hernandez-Deviez DJ, 2008, J BIOL CHEM, V283, P6476, DOI 10.1074/jbc.M708776200; Hernandez-Deviez DJ, 2006, HUM MOL GENET, V15, P129, DOI 10.1093/hmg/ddi434; Ho MF, 2002, ANN NEUROL, V51, P129, DOI 10.1002/ana.10080; Huang YC, 2008, HUM MOL GENET, V17, P1855, DOI 10.1093/hmg/ddn081; Huang YC, 2007, FASEB J, V21, P732, DOI 10.1096/fj.06-6628com; Huang YC, 2005, EUR J HUM GENET, V13, P721, DOI 10.1038/sj.ejhg.5201414; Illa I, 2001, ANN NEUROL, V49, P130, DOI 10.1002/1531-8249(200101)49:1<130::AID-ANA22>3.0.CO;2-0; Impagliazzo A, 2010, FEBS LETT, V584, P1558, DOI 10.1016/j.febslet.2010.03.010; Ishihama Y, 2005, MOL CELL PROTEOMICS, V4, P1265, DOI 10.1074/mcp.M500061-MCP200; Izzedine H, 2006, AM J KIDNEY DIS, V48, P143, DOI 10.1053/j.ajkd.2006.04.074; Jelier R, 2008, INT J MED INFORM, V77, P354, DOI 10.1016/j.ijmedinf.2007.07.004; Klinge L, 2007, FASEB J, V21, P1768, DOI 10.1096/fj.06-7659com; Krajacic P, 2009, PHYSIOL GENOMICS, V40, P8, DOI 10.1152/physiolgenomics.00106.2009; Lennon NJ, 2003, J BIOL CHEM, V278, P50466, DOI 10.1074/jbc.M307247200; Liu J, 1998, NAT GENET, V20, P31, DOI 10.1038/1682; Lorusso A, 2006, EMBO J, V25, P5443, DOI 10.1038/sj.emboj.7601419; Luft FC, 2007, J MOL MED, V85, P1157, DOI 10.1007/s00109-007-0252-8; Martinez LO, 2003, NATURE, V421, P75, DOI 10.1038/nature01250; Matsuda C, 2005, J NEUROPATH EXP NEUR, V64, P334, DOI 10.1093/jnen/64.4.334; Matsuda C, 2001, HUM MOL GENET, V10, P1761, DOI 10.1093/hmg/10.17.1761; Matsuda C, 2008, FEBS LETT, V582, P1189, DOI 10.1016/j.febslet.2008.01.064; McNeil AK, 2006, J BIOL CHEM, V281, P35202, DOI 10.1074/jbc.M606406200; Mellgren RL, 2007, J BIOL CHEM, V282, P2567, DOI 10.1074/jbc.M604560200; Mellgren RL, 2009, BBA-MOL CELL RES, V1793, P1886, DOI 10.1016/j.bbamcr.2009.09.013; MORGAN JE, 1994, DEV BIOL, V162, P486, DOI 10.1006/dbio.1994.1103; MUNOZ P, 1995, BIOCHEM J, V307, P273, DOI 10.1042/bj3070273; Nagaraju K, 2008, AM J PATHOL, V172, P774, DOI 10.2353/ajpath.2008.070327; Olson TM, 2002, CIRCULATION, V105, P431, DOI 10.1161/hc0402.102930; Patel P, 2008, J MOL BIOL, V379, P981, DOI 10.1016/j.jmb.2008.04.046; Pramono ZAD, 2006, HUM GENET, V120, P410, DOI 10.1007/s00439-006-0230-1; Quach NL, 2009, MOL BIOL CELL, V20, P3422, DOI 10.1091/mbc.E09-02-0175; Quach NL, 2006, DEV BIOL, V293, P38, DOI 10.1016/j.ydbio.2005.12.040; Roche JA, 2008, NEUROREPORT, V19, P1579, DOI 10.1097/WNR.0b013e328311ca35; Roux I, 2006, CELL, V127, P277, DOI 10.1016/j.cell.2006.08.040; Rutgers KS, 2009, NEUROBIOL AGING; Therrien C, 2009, BIOCHEMISTRY-US, V48, P2377, DOI 10.1021/bi802242r; Washington NL, 2006, J CELL SCI, V119, P2552, DOI 10.1242/jcs.02980; Wein N, 2010, NEUROMUSCULAR DISORD, V20, P57, DOI 10.1016/j.nmd.2009.08.004; Wenzel Katrin, 2006, Hum Mutat, V27, P599, DOI 10.1002/humu.9424; Yamaji S, 2004, J CELL BIOL, V165, P539, DOI 10.1083/jcb.200308141; Yasunaga S, 2000, AM J HUM GENET, V67, P591, DOI 10.1086/303049; Yasunaga S, 1999, NAT GENET, V21, P363, DOI 10.1038/7693	64	51	52	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2010	5	11							e13854	10.1371/journal.pone.0013854	http://dx.doi.org/10.1371/journal.pone.0013854			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675OD	21079765	gold, Green Published, Green Submitted			2022-12-27	WOS:000283839100011
J	Baas, DC; Despriet, DD; Gorgels, TGMF; Bergeron-Sawitzke, J; Uitterlinden, AG; Hofman, A; van Duijn, CM; Merriam, JE; Smith, RT; Barile, GR; ten Brink, JB; Vingerling, JR; Klaver, CCW; Allikmets, R; Dean, M; Bergen, AAB				Baas, Dominique C.; Despriet, Dominiek D.; Gorgels, Theo G. M. F.; Bergeron-Sawitzke, Julie; Uitterlinden, Andre G.; Hofman, Albert; van Duijn, Cornelia M.; Merriam, Joanna E.; Smith, R. Theodore; Barile, Gaetano R.; ten Brink, Jacoline B.; Vingerling, Johannes R.; Klaver, Caroline C. W.; Allikmets, Rando; Dean, Michael; Bergen, Arthur A. B.			The ERCC6 Gene and Age-Related Macular Degeneration	PLOS ONE			English	Article							COMPLEMENT FACTOR-H; COCKAYNE-SYNDROME; OXIDATIVE STRESS; RISK; REPAIR; POLYMORPHISM; MACULOPATHY; ROTTERDAM; VARIANT; DAMAGE	Background: Age-related macular degeneration (AMD) is the leading cause of irreversible visual loss in the developed countries and is caused by both environmental and genetic factors. A recent study (Tuo et al., PNAS) reported an association between AMD and a single nucleotide polymorphism (SNP) (rs3793784) in the ERCC6 (NM_000124) gene. The risk allele also increased ERCC6 expression. ERCC6 is involved in DNA repair and mutations in ERCC6 cause Cockayne syndrome (CS). Amongst others, photosensitivity and pigmentary retinopathy are hallmarks of CS. Methodology/Principal Findings: Separate and combined data from three large AMD case-control studies and a prospective population-based study (The Rotterdam Study) were used to analyse the genetic association between ERCC6 and AMD (2682 AMD cases and 3152 controls). We also measured ERCC6 mRNA levels in retinal pigment epithelium (RPE) cells of healthy and early AMD affected human donor eyes. Rs3793784 conferred a small increase in risk for late AMD in the Dutch population (The Rotterdam and AMRO-NL study), but this was not replicated in two non-European studies (AREDS, Columbia University). In addition, the AMRO-NL study revealed no significant association for 9 other variants spanning ERCC6. Finally, we determined that ERCC6 expression in the human RPE did not depend on rs3793784 genotype, but, interestingly, on AMD status: Early AMD-affected donor eyes had a 50% lower ERCC6 expression than healthy donor eyes (P = 0.018). Conclusions/Significance: Our meta-analysis of four Caucasian cohorts does not replicate the reported association between SNPs in ERCC6 and AMD. Nevertheless, our findings on ERCC6 expression in the RPE suggest that ERCC6 may be functionally involved in AMD. Combining our data with those of the literature, we hypothesize that the AMD-related reduced transcriptional activity of ERCC6 may be caused by diverse, small and heterogeneous genetic and/or environmental determinants.	[Baas, Dominique C.; Gorgels, Theo G. M. F.; ten Brink, Jacoline B.; Bergen, Arthur A. B.] Royal Netherlands Acad Arts & Sci KNAW, Dept Clin & Mol Ophthalmogenet, Netherlands Inst Neurosci NIN, Amsterdam, Netherlands; [Despriet, Dominiek D.; Uitterlinden, Andre G.; Hofman, Albert; van Duijn, Cornelia M.; Vingerling, Johannes R.; Klaver, Caroline C. W.] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [Bergeron-Sawitzke, Julie] SAIC Frederick, Basic Sci Program, Human Genet Sect, Frederick, MD USA; [Uitterlinden, Andre G.] Erasmus MC, Dept Internal Med, Rotterdam, Netherlands; [Merriam, Joanna E.; Smith, R. Theodore; Barile, Gaetano R.; Allikmets, Rando] Columbia Univ, Dept Ophthalmol, New York, NY 10027 USA; [Merriam, Joanna E.; Smith, R. Theodore; Barile, Gaetano R.; Allikmets, Rando] Columbia Univ, Dept Pathol & Cell Biol, New York, NY 10027 USA; [Dean, Michael] NCI, Expt Immunol Lab, Canc & Inflammat Program, Frederick, MD 21701 USA; [Bergen, Arthur A. B.] Univ Amsterdam, Acad Med Ctr, Dept Ophthalmol, NL-1105 AZ Amsterdam, Netherlands; [Bergen, Arthur A. B.] Univ Amsterdam, Acad Med Ctr, Dept Clin Genet, NL-1105 AZ Amsterdam, Netherlands	Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); Erasmus University Rotterdam; Erasmus MC; Science Applications International Corporation (SAIC); SAIC-Frederick; Erasmus University Rotterdam; Erasmus MC; Columbia University; Columbia University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam	Baas, DC (corresponding author), Royal Netherlands Acad Arts & Sci KNAW, Dept Clin & Mol Ophthalmogenet, Netherlands Inst Neurosci NIN, Amsterdam, Netherlands.	a.bergen@nin.knaw.nl	Bergen, Arthur/J-3637-2013; Dean, Michael C/G-8172-2012; Dean, Michael/R-7501-2019; Klaver, Caroline C.W./A-2013-2016; Allikmets, Rando/ABD-4533-2021	Dean, Michael C/0000-0003-2234-0631; Sawitzke, Julie/0000-0002-1715-4626; Baas, Dominique C./0000-0003-0989-9828; Klaver, Caroline/0000-0002-2355-5258; smith, theodore/0000-0002-1693-943X; Van Duijn, Cornelia/0000-0002-2374-9204; Bergen, Arthur/0000-0002-6333-9576	Merck & Co, Inc., NJ, USA; Nederlandse Vereniging ter Voorkoming van Blindheid; Dutch Macula Foundation; LSBS; Oogfonds Nederland; de Rotterdamse Vereniging Blindenbelangen; Netherlands Organization of Scientific Research NWO Investments [175.010.2005.011, 911-03-012]; Research Institute for Diseases in the Elderly [014-93-015, RIDE2]; Netherlands Genomics Initiative (NGI)/Netherlands Organization for Scientific Research (NWO) [050-060-810]; Erasmus Medical Center; Erasmus University, Rotterdam; Netherlands Organization for the Health Research and Development (ZonMw); Research Institute for Diseases in the Elderly (RIDE),; Ministry for Health, Welfare and Sports; European Commission; Municipality of Rotterdam; National Eye Institute [EY13435, EY017404]; Macula Vision Research Foundation; Kaplen Foundation; Wigdeon Point Charitable Foundation; Research to Prevent Blindness, Inc.; Merck Co; Ministry of Education, Culture and Science; NATIONAL CANCER INSTITUTE [ZIABC011301] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R24EY017404, R01EY013435] Funding Source: NIH RePORTER	Merck & Co, Inc., NJ, USA(Merck & Company); Nederlandse Vereniging ter Voorkoming van Blindheid; Dutch Macula Foundation; LSBS; Oogfonds Nederland; de Rotterdamse Vereniging Blindenbelangen; Netherlands Organization of Scientific Research NWO Investments(Netherlands Organization for Scientific Research (NWO)); Research Institute for Diseases in the Elderly; Netherlands Genomics Initiative (NGI)/Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Erasmus Medical Center; Erasmus University, Rotterdam; Netherlands Organization for the Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development); Research Institute for Diseases in the Elderly (RIDE),; Ministry for Health, Welfare and Sports; European Commission(European CommissionEuropean Commission Joint Research Centre); Municipality of Rotterdam; National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Macula Vision Research Foundation; Kaplen Foundation; Wigdeon Point Charitable Foundation; Research to Prevent Blindness, Inc.(Research to Prevent Blindness (RPB)); Merck Co(Merck & Company); Ministry of Education, Culture and Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was in part supported by an unrestricted research grant from Merck & Co, Inc., NJ, USA and the Nederlandse Vereniging ter Voorkoming van Blindheid, The Dutch Macula Foundation, the LSBS, the Oogfonds Nederland, de Rotterdamse Vereniging Blindenbelangen (to A. A. B.). The generation and management of GWAS genotype data for the Rotterdam Study is supported by the Netherlands Organization of Scientific Research NWO Investments (nr. 175.010.2005.011, 911-03-012). This study is funded by the Research Institute for Diseases in the Elderly (014-93-015; RIDE2), the Netherlands Genomics Initiative (NGI)/Netherlands Organization for Scientific Research (NWO) project nr. 050-060-810, and funding from the Erasmus Medical Center and Erasmus University, Rotterdam, Netherlands Organization for the Health Research and Development (ZonMw), the Research Institute for Diseases in the Elderly (RIDE), the Ministry of Education, Culture and Science, the Ministry for Health, Welfare and Sports, the European Commission (DG XII), and the Municipality of Rotterdam. The Columbia University study population is supported in part by the grants from the National Eye Institute EY13435 and EY017404; the Macula Vision Research Foundation; Kaplen Foundation; Wigdeon Point Charitable Foundation and an unrestricted grant to the Department of Ophthalmology, Columbia University, from Research to Prevent Blindness, Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The funding of Merck & Co was an unrestricted grant to A. A. B. and did not, in any way, interfere with the conception and/or design and/or outcome and/or publication of this study. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Age related eye disease study research group, 2001, ARCH OPHTHALMOL, V119, P1439; Age-Related Eye Dis Study Res Grp, 2001, AM J OPHTHALMOL, V132, P668; Assink JJM, 1997, AM J HUM GENET, V61, P934, DOI 10.1086/514884; Baas DC, 2010, OPHTHALMOLOGY, V117, P500, DOI 10.1016/j.ophtha.2009.08.032; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Beatty S, 2000, SURV OPHTHALMOL, V45, P115, DOI 10.1016/S0039-6257(00)00140-5; Bergeron-Sawitzke J, 2009, EUR J HUM GENET, V17, P1190, DOI 10.1038/ejhg.2009.23; BIRD AEC, 1995, SURV OPHTHALMOL, V39, P367, DOI 10.1016/S0039-6257(05)80092-X; Booij JC, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-164; Chen W, 2010, P NATL ACAD SCI USA, V107, P7401, DOI 10.1073/pnas.0912702107; Coleman HR, 2008, LANCET, V372, P1835, DOI 10.1016/S0140-6736(08)61759-6; de Waard H, 2003, DNA REPAIR, V2, P13, DOI 10.1016/S1568-7864(02)00188-X; Despriet DDG, 2006, JAMA-J AM MED ASSOC, V296, P301, DOI 10.1001/jama.296.3.301; Dewan A, 2006, SCIENCE, V314, P989, DOI 10.1126/science.1133807; Dianov G, 1999, NUCLEIC ACIDS RES, V27, P1365, DOI 10.1093/nar/27.5.1365; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P564; Gold B, 2006, NAT GENET, V38, P458, DOI 10.1038/ng1750; Gorgels TGMF, 2007, MOL CELL BIOL, V27, P1433, DOI 10.1128/MCB.01037-06; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Hanawalt PC, 2002, ONCOGENE, V21, P8949, DOI 10.1038/sj.onc.1206096; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; Hasty P, 2003, SCIENCE, V299, P1355, DOI 10.1126/science.1079161; HOFMAN A, 1991, EUR J EPIDEMIOL, V7, P403, DOI 10.1007/BF00145007; Hofman A, 2007, EUR J EPIDEMIOL, V22, P819, DOI 10.1007/s10654-007-9199-x; HOSMER DW, 1992, EPIDEMIOLOGY, V3, P452, DOI 10.1097/00001648-199209000-00012; Hu XF, 2004, GENET TEST, V8, P292, DOI 10.1089/gte.2004.8.292; Kanda A, 2007, P NATL ACAD SCI USA, V104, P16227, DOI 10.1073/pnas.0703933104; Klaver CCW, 1998, ARCH OPHTHALMOL-CHIC, V116, P1646, DOI 10.1001/archopht.116.12.1646; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Maller JB, 2007, NAT GENET, V39, P1200, DOI 10.1038/ng2131; Mallery DL, 1998, AM J HUM GENET, V62, P77, DOI 10.1086/301686; NANCE MA, 1992, AM J MED GENET, V42, P68, DOI 10.1002/ajmg.1320420115; Rivera A, 2005, HUM MOL GENET, V14, P3227, DOI 10.1093/hmg/ddi353; Seddon JM, 2005, ARCH OPHTHALMOL-CHIC, V123, P321, DOI 10.1001/archopht.123.3.321; Shen JK, 2007, HISTOL HISTOPATHOL, V22, P1301, DOI 10.14670/HH-22.1301; Spivak G, 2006, DNA REPAIR, V5, P13, DOI 10.1016/j.dnarep.2005.06.017; Tuo JS, 2006, P NATL ACAD SCI USA, V103, P9256, DOI 10.1073/pnas.0603485103; Tuo JS, 2003, FASEB J, V17, P668, DOI 10.1096/fj.02-0851com; van der Pluijm I, 2007, PLOS BIOL, V5, P23, DOI 10.1371/journal.pbio.0050002; van Soest SS, 2007, MOL VIS, V13, P1608; vanderHorst GTJ, 1997, CELL, V89, P425, DOI 10.1016/S0092-8674(00)80223-8; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; VENEMA J, 1990, P NATL ACAD SCI USA, V87, P4707, DOI 10.1073/pnas.87.12.4707; VINGERLING JR, 1995, OPHTHALMOLOGY, V102, P205; Wang GF, 2010, HUM GENET, V127, P595, DOI 10.1007/s00439-010-0805-8; Wozniak K, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/827562; Yang ZL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000836; Yates JRW, 2007, NEW ENGL J MED, V357, P553, DOI 10.1056/NEJMoa072618	50	20	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2010	5	11							e13786	10.1371/journal.pone.0013786	http://dx.doi.org/10.1371/journal.pone.0013786			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673FY	21072178	Green Submitted, Green Published, gold			2022-12-27	WOS:000283645700009
J	Huang, D; Zhou, XB; Lyon, CJ; Hsueh, WA; Wong, STC				Huang, Di; Zhou, Xiaobo; Lyon, Christopher J.; Hsueh, Willa A.; Wong, Stephen T. C.			MicroRNA-Integrated and Network-Embedded Gene Selection with Diffusion Distance	PLOS ONE			English	Article							EXPRESSION DATA; CLASSIFICATION; DIAGNOSIS; MAPS	Gene network information has been used to improve gene selection in microarray-based studies by selecting marker genes based both on their expression and the coordinate expression of genes within their gene network under a given condition. Here we propose a new network-embedded gene selection model. In this model, we first address the limitations of microarray data. Microarray data, although widely used for gene selection, measures only mRNA abundance, which does not always reflect the ultimate gene phenotype, since it does not account for post-transcriptional effects. To overcome this important (critical in certain cases) but ignored-in-almost-all-existing-studies limitation, we design a new strategy to integrate together microarray data with the information of microRNA, the major post-transcriptional regulatory factor. We also handle the challenges led by gene collaboration mechanism. To incorporate the biological facts that genes without direct interactions may work closely due to signal transduction and that two genes may be functionally connected through multi paths, we adopt the concept of diffusion distance. This concept permits us to simulate biological signal propagation and therefore to estimate the collaboration probability for all gene pairs, directly or indirectly-connected, according to multi paths connecting them. We demonstrate, using type 2 diabetes (DM2) as an example, that the proposed strategies can enhance the identification of functional gene partners, which is the key issue in a network-embedded gene selection model. More importantly, we show that our gene selection model outperforms related ones. Genes selected by our model 1) have improved classification capability; 2) agree with biological evidence of DM2-association; and 3) are involved in many well-known DM2-associated pathways.	[Huang, Di; Lyon, Christopher J.; Hsueh, Willa A.] Cornell Univ, Methodist Hosp, Res Inst, Weill Med Coll,Diabet Res Ctr, Houston, TX USA	Cornell University; The Methodist Hospital System; The Methodist Hospital - Houston	Huang, D (corresponding author), Cornell Univ, Methodist Hosp, Res Inst, Weill Med Coll,Diabet Res Ctr, Houston, TX USA.	STWong@tmhs.org			Methodist Hospital Research Institute; NATIONAL LIBRARY OF MEDICINE [R01LM010185] Funding Source: NIH RePORTER	Methodist Hospital Research Institute; NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	2010 Research Scholars Seed Grant, The Methodist Hospital Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Calin GA, 2005, NEW ENGL J MED, V353, P1793, DOI 10.1056/NEJMoa050995; Chuang HY, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100180; Coifman RR, 2005, P NATL ACAD SCI USA, V102, P7432, DOI 10.1073/pnas.0500896102; Diaz-Uriarte R, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-3; Duursma AM, 2008, RNA, V14, P872, DOI 10.1261/rna.972008; Futcher B, 1999, MOL CELL BIOL, V19, P7357; GOLUB TR, 1999, MOL CLASSIFICATION C, P531; Guyon I, 2002, MACH LEARN, V46, P389, DOI 10.1023/A:1012487302797; Helman P, 2004, J COMPUT BIOL, V11, P581, DOI 10.1089/1066527041887294; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Lafon S, 2006, IEEE T PATTERN ANAL, V28, P1393, DOI 10.1109/TPAMI.2006.184; Lajoix AD, 2006, DIABETES, V55, P3279, DOI 10.2337/db06-0257; Lu HF, 2008, MOL CELL PROTEOMICS, V7, P1434, DOI 10.1074/mcp.M700478-MCP200; Ma S, 2008, BRIEF BIOINFORM, V9, P392, DOI 10.1093/bib/bbn027; MOOTHA VK, 2003, NAT GENET, P1; Muhonen P, 2009, NEPHROL DIAL TRANSPL, V24, P1088, DOI 10.1093/ndt/gfn728; NADLER B, 2005, ADV NEURAL INFORM PR, V18, P955; Nielsen CB, 2007, RNA, V13, P1894, DOI 10.1261/rna.768207; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; RAHNENFUHRER J, 2004, MOLECULAR BIOL */* S, V3, P16; Rajewsky N, 2006, NAT GENET, V38, pS8, DOI 10.1038/ng1798; Rapaport F, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-35; ROBIN L, 2007, UTR UTR P Natl Acad, V104, P9667; Samanta MP, 2003, P NATL ACAD SCI USA, V100, P12579, DOI 10.1073/pnas.2132527100; Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Washburn MP, 2003, P NATL ACAD SCI USA, V100, P3107, DOI 10.1073/pnas.0634629100; Wei Z, 2007, BIOINFORMATICS, V23, P1537, DOI 10.1093/bioinformatics/btm129; Xu M, 2003, APPL GENOMICS PROTEO, V2, P79; Xu R, 2007, P ANN INT IEEE EMBS, P4613, DOI 10.1109/IEMBS.2007.4353367; Yu W, 2008, NAT GENET, V40, P124, DOI 10.1038/ng0208-124	34	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2010	5	10							e13748	10.1371/journal.pone.0013748	http://dx.doi.org/10.1371/journal.pone.0013748			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673FU	21060785	Green Published, Green Submitted, gold			2022-12-27	WOS:000283645300028
J	Jeong, HK; Ji, KM; Kim, B; Kim, J; Jou, I; Joe, EH				Jeong, Hey-Kyeong; Ji, Kyung-min; Kim, Beomsue; Kim, Jun; Jou, Ilo; Joe, Eun-hye			Inflammatory Responses Are Not Sufficient to Cause Delayed Neuronal Death in ATP-Induced Acute Brain Injury	PLOS ONE			English	Article							CEREBRAL-ARTERY OCCLUSION; CENTRAL-NERVOUS-SYSTEM; NITRIC-OXIDE SYNTHASE; TUMOR-NECROSIS-FACTOR; IN-VIVO; ALZHEIMERS-DISEASE; MICROGLIAL CELLS; RECEPTOR MODULATION; ACTIVATED MICROGLIA; RAT HIPPOCAMPUS	Background: Brain inflammation is accompanied by brain injury. However, it is controversial whether inflammatory responses are harmful or beneficial to neurons. Because many studies have been performed using cultured microglia and neurons, it has not been possible to assess the influence of multiple cell types and diverse factors that dynamically and continuously change in vivo. Furthermore, behavior of microglia and other inflammatory cells could have been overlooked since most studies have focused on neuronal death. Therefore, it is essential to analyze the precise roles of microglia and brain inflammation in the injured brain, and determine their contribution to neuronal damage in vivo from the onset of injury. Methods and Findings: Acute neuronal damage was induced by stereotaxic injection of ATP into the substantia nigra pars compacta (SNpc) and the cortex of the rat brain. Inflammatory responses and their effects on neuronal damage were investigated by immunohistochemistry, electron microscopy, quantitative RT-PCR, and stereological counting, etc. ATP acutely caused death of microglia as well as neurons in a similar area within 3 h. We defined as the core region the area where both TH(+) and Iba-1(+) cells acutely died, and as the penumbra the area surrounding the core where Iba-1+ cells showed activated morphology. In the penumbra region, morphologically activated microglia arranged around the injury sites. Monocytes filled the damaged core after neurons and microglia died. Interestingly, neither activated microglia nor monocytes expressed iNOS, a major neurotoxic inflammatory mediator. Monocytes rather expressed CD68, a marker of phagocytic activity. Importantly, the total number of dopaminergic neurons in the SNpc at 3 h (similar to 80% of that in the contralateral side) did not decrease further at 7 d. Similarly, in the cortex, ATP-induced neuron-damage area detected at 3 h did not increase for up to 7 d. Conclusions: Different cellular components (microglia, astrocytes, monocytes, and neutrophils) and different factors (proinflammatory and neurotrophic) could be produced in inflammatory processes depending on the nature of the injury. The results in this study suggest that the inflammatory responses of microglia and monocytes in response to ATP-induced acute injury could not be neurotoxic.	[Jeong, Hey-Kyeong; Ji, Kyung-min; Kim, Beomsue; Kim, Jun; Jou, Ilo; Joe, Eun-hye] Ajou Univ, Sch Med, Grad Program Neurosci, Suwon 441749, South Korea; [Jeong, Hey-Kyeong; Ji, Kyung-min; Kim, Beomsue; Kim, Jun; Jou, Ilo; Joe, Eun-hye] Ajou Univ, Sch Med, Dept Pharmacol, Suwon 441749, South Korea; [Jeong, Hey-Kyeong; Ji, Kyung-min; Kim, Beomsue; Kim, Jun; Joe, Eun-hye] Ajou Univ, Sch Med, Brain Dis Res Ctr, Suwon 441749, South Korea; [Jou, Ilo] Ajou Univ, Sch Med, Chron Inflammatory Dis Res Ctr, Suwon 441749, South Korea	Ajou University; Ajou University; Ajou University; Ajou University	Jeong, HK (corresponding author), Ajou Univ, Sch Med, Grad Program Neurosci, Suwon 441749, South Korea.	ehjoe@ajou.ac.kr	Kim, Beomsue/X-3045-2019	Kim, Beomsue/0000-0003-1207-7876	Korean government (MEST) [2-2008025-0]; Ministry of Science and Technology, Republic of Korea [M103KV010011-06K2201-01110]; KOSEF through Chronic Inflammatory Disease Research Center (CIDRC) at Ajou University [R13-2003-019]	Korean government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); Ministry of Science and Technology, Republic of Korea(Ministry of Science & Technology (MOST), Republic of Korea); KOSEF through Chronic Inflammatory Disease Research Center (CIDRC) at Ajou University	This work was supported by the KOSEF NRL Program grant funded by the Korean government (MEST) (2-2008025-0) and a grant (M103KV010011-06K2201-01110) from the Brain Research Center of the 21st Century Frontier Research Program funded by the Ministry of Science and Technology, Republic of Korea, and KOSEF through Chronic Inflammatory Disease Research Center (CIDRC) at Ajou University (Grant R13-2003-019) to E Joe. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amadio S, 2002, NEUROPHARMACOLOGY, V42, P489, DOI 10.1016/S0028-3908(01)00197-6; Batchelor PE, 1999, J NEUROSCI, V19, P1708; Bohatschek M, 2001, EXP NEUROL, V172, P137, DOI 10.1006/exnr.2001.7764; Campanella M, 2002, STROKE, V33, P586, DOI 10.1161/hs0202.103399; Cavaliere F, 2001, NEUROCHEM INT, V38, P199, DOI 10.1016/S0197-0186(00)00087-5; Cavaliere F, 2001, NEUROCHEM INT, V38, P189, DOI 10.1016/S0197-0186(00)00088-7; CHAO CC, 1992, J IMMUNOL, V149, P2736; Choi SH, 2003, J NEUROSCI, V23, P5877; Connolly ES, 1996, J CLIN INVEST, V97, P209, DOI 10.1172/JCI118392; da Silva RP, 1999, BIOCHEM J, V338, P687, DOI 10.1042/bj3380687; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; de Bock F, 1998, EUR J NEUROSCI, V10, P3107, DOI 10.1046/j.1460-9568.1998.00317.x; del Zoppo G, 2000, BRAIN PATHOL, V10, P95; Elkabes S, 1996, J NEUROSCI, V16, P2508; FORD AL, 1995, J IMMUNOL, V154, P4309; Gautier S, 2009, BRIT J PHARMACOL, V156, P673, DOI 10.1111/j.1476-5381.2009.00068.x; GIULIAN D, 1993, J NEUROSCI RES, V36, P681, DOI 10.1002/jnr.490360609; HALLENBECK JM, 1986, STROKE, V17, P246, DOI 10.1161/01.STR.17.2.246; Hide I, 2000, J NEUROCHEM, V75, P965, DOI 10.1046/j.1471-4159.2000.0750965.x; Holt MP, 2008, J LEUKOCYTE BIOL, V84, P1410, DOI 10.1189/jlb.0308173; Inoue K, 2003, LIFE SCI, V74, P189, DOI 10.1016/j.lfs.2003.09.006; Inoue K, 2002, GLIA, V40, P156, DOI 10.1002/glia.10150; Ishida Y, 2008, J IMMUNOL, V180, P569, DOI 10.4049/jimmunol.180.1.569; Ji KA, 2008, GLIA, V56, P1039, DOI 10.1002/glia.20677; Ji KA, 2007, GLIA, V55, P1577, DOI 10.1002/glia.20571; Kang J, 2007, J CELL BIOL, V179, P1219, DOI 10.1083/jcb.200705046; Kaushal V, 2008, J NEUROSCI, V28, P2221, DOI 10.1523/JNEUROSCI.5643-07.2008; Kharlamov A, 2002, EXP BRAIN RES, V147, P353, DOI 10.1007/s00221-002-1251-1; KIRINO T, 1984, ACTA NEUROPATHOL, V62, P209, DOI 10.1007/BF00691854; Kitamura Y, 1996, GLIA, V18, P233, DOI 10.1002/(SICI)1098-1136(199611)18:3<233::AID-GLIA7>3.0.CO;2-#; KOCHANEK PM, 1992, STROKE, V23, P1367, DOI 10.1161/01.STR.23.9.1367; Kroemer G, 2005, CELL DEATH DIFFER, V12, P1463, DOI 10.1038/sj.cdd.4401724; Lehner M, 2002, INT ARCH ALLERGY IMM, V128, P73, DOI 10.1159/000058006; Lehrmann E, 1998, GLIA, V24, P437, DOI 10.1002/(SICI)1098-1136(199812)24:4<437::AID-GLIA9>3.0.CO;2-X; MAJNO G, 1995, AM J PATHOL, V146, P3; Malm TM, 2005, NEUROBIOL DIS, V18, P134, DOI 10.1016/j.nbd.2004.09.009; Matsumoto H, 2007, J NEUROSCI RES, V85, P994, DOI 10.1002/jnr.21198; MATSUO Y, 1994, STROKE, V25, P1469, DOI 10.1161/01.STR.25.7.1469; Melani A, 2005, NEUROCHEM INT, V47, P442, DOI 10.1016/j.neuint.2005.05.014; Melani A, 2006, J CEREBR BLOOD F MET, V26, P974, DOI 10.1038/sj.jcbfm.9600250; Min KJ, 2006, J NEUROSCI, V26, P1880, DOI 10.1523/JNEUROSCI.3696-05.2006; Motyl T, 2006, J PHYSIOL PHARMACOL, V57, P17; Napoli I, 2010, EXP NEUROL, V225, P24, DOI 10.1016/j.expneurol.2009.04.024; Nerlich AG, 2002, SPINE, V27, P2484, DOI 10.1097/00007632-200211150-00012; Parvathenani LK, 2003, J BIOL CHEM, V278, P13309, DOI 10.1074/jbc.M209478200; Paxinos G., 2005, RAT BRAIN STEREOTAXI, V5th Edn, DOI 10.1016/c2009-0-63235-9; PETERS A, 1991, FINE STRUCTURE NERVO, V494, P10; Pyo H, 2003, NEUROSCI LETT, V346, P141, DOI 10.1016/S0304-3940(03)00505-6; Rezaie P, 2005, NEUROSCI LETT, V377, P189, DOI 10.1016/j.neulet.2004.12.002; Ryu JK, 2007, GLIA, V55, P439, DOI 10.1002/glia.20479; Ryu JK, 2004, GLIA, V48, P85, DOI 10.1002/glia.20051; Sanz JM, 2000, J IMMUNOL, V164, P4893, DOI 10.4049/jimmunol.164.9.4893; Scali C, 2000, EUR J NEUROSCI, V12, P1900, DOI 10.1046/j.1460-9568.2000.00075.x; Schoettle R J, 1990, J Neurotrauma, V7, P207, DOI 10.1089/neu.1990.7.207; Scorrano L, 2002, DEV CELL, V2, P55, DOI 10.1016/S1534-5807(01)00116-2; SEDGWICK JD, 1991, P NATL ACAD SCI USA, V88, P7438, DOI 10.1073/pnas.88.16.7438; Simard AR, 2006, NEURON, V49, P489, DOI 10.1016/j.neuron.2006.01.022; Streit WJ, 2005, BRAIN RES REV, V48, P234, DOI 10.1016/j.brainresrev.2004.12.013; Streit WJ, 2002, GLIA, V40, P133, DOI 10.1002/glia.10154; Suzuki T, 2004, J NEUROSCI, V24, P1, DOI 10.1523/JNEUROSCI.3792-03.2004; ZHANG ZG, 1995, BRAIN RES, V698, P79, DOI 10.1016/0006-8993(95)00830-J; Zhao JW, 2009, EUR J NEUROSCI, V29, P1853, DOI 10.1111/j.1460-9568.2009.06736.x	62	31	31	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2010	5	10							e13756	10.1371/journal.pone.0013756	http://dx.doi.org/10.1371/journal.pone.0013756			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673FU	21060796	Green Published, gold, Green Submitted			2022-12-27	WOS:000283645300035
J	Schwarzkopf, DS; Schindler, A; Rees, G				Schwarzkopf, Dietrich Samuel; Schindler, Andreas; Rees, Geraint			Knowing with Which Eye We See: Utrocular Discrimination and Eye-Specific Signals in Human Visual Cortex	PLOS ONE			English	Article							OCULAR DOMINANCE COLUMNS; SURFACE-BASED ANALYSIS; ORIENTATION; DOMAINS; PATTERN; CATS	Neurophysiological and behavioral reports converge to suggest that monocular neurons in the primary visual cortex are biased toward low spatial frequencies, while binocular neurons favor high spatial frequencies. Here we tested this hypothesis with functional magnetic resonance imaging (fMRI). Human participants viewed flickering gratings at one of two spatial frequencies presented to either the left or the right eye, and judged which of the two eyes was being stimulated (utrocular discrimination). Using multivoxel pattern analysis we found that local spatial patterns of signals in primary visual cortex (V1) allowed successful decoding of the eye-of-origin. Decoding was above chance for low but not high spatial frequencies, confirming the presence of a bias reported by animal studies in human visual cortex. Behaviorally, we found that reliable judgment of the eye-of-origin did not depend on spatial frequency. We further analyzed the mean response in visual cortex to our stimuli and revealed a weak difference between left and right eye stimulation. Our results are thus consistent with the interpretation that participants use overall levels of neural activity in visual cortex, perhaps arising due to local luminance differences, to judge the eye-of-origin. Taken together, we show that it is possible to decode eye-specific voxel pattern information in visual cortex but, at least in healthy participants with normal binocular vision, these patterns are unrelated to awareness of which eye is being stimulated.	[Schwarzkopf, Dietrich Samuel; Schindler, Andreas; Rees, Geraint] UCL, Inst Cognit Neurosci, London, England; [Schwarzkopf, Dietrich Samuel; Rees, Geraint] UCL, Wellcome Trust Ctr Neuroimaging, London, England; [Schindler, Andreas] Max Planck Inst Biol Cybernet, Werner Reichardt Ctr Integrat Neurosci, Tubingen, Germany	University of London; University College London; University of London; University College London; Eberhard Karls University of Tubingen; Max Planck Society	Schwarzkopf, DS (corresponding author), UCL, Inst Cognit Neurosci, London, England.	s.schwarzkopf@fil.ion.ucl.ac.uk	Rees, Geraint/C-1493-2008; Schwarzkopf, D. Sam/F-5285-2012	Rees, Geraint/0000-0002-9623-7007; Schwarzkopf, D. Sam/0000-0003-3686-1622	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DL, 2007, J NEUROSCI, V27, P10391, DOI 10.1523/JNEUROSCI.2923-07.2007; Adams DL, 2009, NEUROSCIENTIST, V15, P62, DOI 10.1177/1073858408327806; Chaimow D, 2010, NEUROIMAGE; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Durad AC, 1910, J AMER MED ASSOC, V55, P369, DOI 10.1001/jama.1910.04330050007004; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; GARDNER JL, 2008, J VIS, V8; Haynes JD, 2005, CURR BIOL, V15, P1301, DOI 10.1016/j.cub.2005.06.026; Haynes JD, 2005, NAT NEUROSCI, V8, P686, DOI 10.1038/nn1445; HU B, 1997, J NEUROSCI, V17, P9270; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Kamitani Y, 2005, NAT NEUROSCI, V8, P679, DOI 10.1038/nn1444; KAUL C, 2009, J VIS, V9; Kriegeskorte N, 2010, NEUROIMAGE, V49, P1965, DOI 10.1016/j.neuroimage.2009.09.059; Lowel S, 1998, EUR J NEUROSCI, V10, P2629, DOI 10.1046/j.1460-9568.1998.t01-1-00274.x; MISAKI M, 2010, NEUROIMAGE; Op de Beeck HP, 2010, NEUROIMAGE, V50, P567, DOI 10.1016/j.neuroimage.2009.12.072; Op de Beeck HP, 2010, NEUROIMAGE, V49, P1943, DOI 10.1016/j.neuroimage.2009.02.047; Sasaki Y, 2001, P NATL ACAD SCI USA, V98, P2077, DOI 10.1073/pnas.98.4.2077; Schwarzkopf DS, 2010, NEUROIMAGE; Shmuel A, 2010, NEUROIMAGE, V49, P1957, DOI 10.1016/j.neuroimage.2009.08.040; Shoham D, 1997, NATURE, V385, P529, DOI 10.1038/385529a0; SMITH S, 1945, J EXP PSYCHOL, V35, P1, DOI 10.1037/h0059224; Swisher JD, 2010, J NEUROSCI, V30, P325, DOI 10.1523/JNEUROSCI.4811-09.2010; Weiskopf N, 2007, MAGN RESON IMAGING, V25, P989, DOI 10.1016/j.mri.2007.02.007	25	24	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2010	5	10							e13775	10.1371/journal.pone.0013775	http://dx.doi.org/10.1371/journal.pone.0013775			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673FU	21048942	Green Published, gold, Green Submitted			2022-12-27	WOS:000283645300049
J	Chen, JR; Lazarenko, OP; Wu, XL; Tong, YD; Blackburn, ML; Shankar, K; Badger, TM; Ronis, MJJ				Chen, Jin-Ran; Lazarenko, Oxana P.; Wu, Xianli; Tong, Yudong; Blackburn, Michael L.; Shankar, Kartik; Badger, Thomas M.; Ronis, Martin J. J.			Obesity Reduces Bone Density Associated with Activation of PPAR gamma and Suppression of Wnt/beta-Catenin in Rapidly Growing Male Rats	PLOS ONE			English	Article							KAPPA-B LIGAND; ADIPOCYTE DIFFERENTIATION; MINERAL DENSITY; FEMALE RATS; FAT; MASS; OSTEOPOROSIS; ETHANOL; DIET; OSTEOBLASTS	Background: It is well established that excessive consumption of a high fat diet (HFD) results in obesity; however, the consequences of obesity on postnatal skeletal development have not been well studied. Methodology and Principal Findings: Total enteral nutrition (TEN) was used to feed postnatal day 27 male rats intragastrically with a high 45% fat diet (HFD) for four weeks to induce obesity. Fat mass was increased compared to rats fed TEN diets containing 25% fat (medium fat diet, MFD) or a chow diet (low fat diet, LFD) fed ad libitum with matched body weight gains. Serum leptin and total non-esterified fatty acids (NEFA) were elevated in HFD rats, which also had reduced bone mass compared to LFD-fed animals. This was accompanied by decreases in bone formation, but increases in the bone resorption. Bone marrow adiposity and expression of adipogenic genes, PPAR gamma and aP2 were increased, whereas osteoblastogenic markers osteocalcin and Runx2 were decreased, in bone in HFD rats compared to LFD controls. The diversion of stromal cell differentiation in response to HFD stemmed from down-regulation of the key canonical Wnt signaling molecule beta-catenin protein and reciprocal up-regulation of nuclear PPAR gamma expression in bone. In a set of in vitro studies using pluripotent ST2 bone marrow mesenchymal stromal cells treated with serum from rats on the different diets or using the free fatty acid composition of NEFA quantified in rat serum from HFD-fed animals by GC-MS, we were able to recapitulate our in vivo findings. Conclusions/Significance: These observations strongly suggest that increased NEFA in serum from rats made obese by HFD-feeding impaired bone formation due to stimulation of bone marrow adipogenesis. These effects of obesity on bone in early life may result in impaired attainment of peak bone mass and therefore increase the prevalence of osteoporosis later on in life.	[Chen, Jin-Ran; Shankar, Kartik; Badger, Thomas M.] Univ Arkansas Med Sci, Dept Pediat, Little Rock, AR 72205 USA; [Lazarenko, Oxana P.; Wu, Xianli; Blackburn, Michael L.; Badger, Thomas M.] Univ Arkansas Med Sci, Dept Physiol & Biophys, Little Rock, AR 72205 USA; [Ronis, Martin J. J.] Univ Arkansas Med Sci, Dept Pharmacol & Toxicol, Little Rock, AR 72205 USA; [Chen, Jin-Ran; Lazarenko, Oxana P.; Wu, Xianli; Tong, Yudong; Blackburn, Michael L.; Shankar, Kartik; Badger, Thomas M.; Ronis, Martin J. J.] Arkansas Childrens Nutr Ctr, Little Rock, AR USA	University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences	Chen, JR (corresponding author), Univ Arkansas Med Sci, Dept Pediat, Little Rock, AR 72205 USA.	chenjinran@uams.edu		Shankar, Kartik/0000-0002-7964-9026	United States Department of Agriculture (USDA)/Agricultural Research Service (ARS) [6251-51000-003]	United States Department of Agriculture (USDA)/Agricultural Research Service (ARS)(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This work was supported by United States Department of Agriculture (USDA)/Agricultural Research Service (ARS) #6251-51000-003 to the Arkansas Children's Nutrition Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akridge M, 2007, AM J ORTHOD DENTOFAC, V132, P185, DOI 10.1016/j.ajodo.2005.12.034; Bielohuby M, 2010, J BONE MINER RES, V25, P275, DOI 10.1359/jbmr.090813; Cao JJ, 2009, BONE, V44, P1097, DOI 10.1016/j.bone.2009.02.017; Chan G, 2009, CURR OPIN PEDIATR, V21, P65, DOI 10.1097/MOP.0b013e328320a914; Chen JR, 2008, EXP BIOL MED, V233, P1348, DOI 10.3181/0802-RM-63; Chen JR, 2008, J PHARMACOL EXP THER, V324, P50, DOI 10.1124/jpet.107.130351; Chen JR, 2006, J PHARMACOL EXP THER, V319, P1182, DOI 10.1124/jpet.106.109454; Chen JR, 2009, J NUTR, V139, P1839, DOI 10.3945/jn.109.109041; Chen JR, 2009, J BONE MINER RES, V24, P221, DOI 10.1359/JBMR.081011; Cui LH, 2005, OSTEOPOROSIS INT, V16, P1975, DOI 10.1007/s00198-005-1977-2; FELSON DT, 1993, J BONE MINER RES, V8, P567, DOI 10.1002/jbmr.5650080507; Gimble JM, 2006, J CELL BIOCHEM, V98, P251, DOI 10.1002/jcb.20777; Hong JH, 2005, SCIENCE, V309, P1074, DOI 10.1126/science.1110955; Kennedy ET, 1999, J AM COLL NUTR, V18, P207, DOI 10.1080/07315724.1999.10718853; Krishnan V, 2006, J CLIN INVEST, V116, P1202, DOI 10.1172/JCI28551; Kyung TW, 2009, J NUTR, V139, P502, DOI 10.3945/jn.108.100032; Leonard MB, 2004, AM J CLIN NUTR, V80, P514, DOI 10.1093/ajcn/80.2.514; MARECKI JC, 2010, J NUTR BIOC IN PRESS; OH SR, 2009, J LIPID RES     0411; Parhami F, 2001, J BONE MINER RES, V16, P182, DOI 10.1359/jbmr.2001.16.1.182; REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939; Rosen CJ, 2006, NAT CLIN PRACT RHEUM, V2, P35, DOI 10.1038/ncprheum0070; SCHELLER LE, 2010, STEM CELLS IN PRESS; Shankar K, 2008, J BONE MINER RES, V23, P338, DOI 10.1359/JBMR.071023; Shankar K, 2010, ENDOCRINOLOGY, V151, P2577, DOI 10.1210/en.2010-0017; Smas CM, 1999, J BIOL CHEM, V274, P12632, DOI 10.1074/jbc.274.18.12632; Takeda S, 2002, CELL, V111, P305, DOI 10.1016/S0092-8674(02)01049-8; Tintut Y, 2004, ARTERIOSCL THROM VAS, V24, pE6, DOI 10.1161/01.ATV.0000112023.62695.7f; Tzameli I, 2004, J BIOL CHEM, V279, P36093, DOI 10.1074/jbc.M405346200; Verma S, 2002, J CLIN PATHOL, V55, P693, DOI 10.1136/jcp.55.9.693; Weiler HA, 2000, BONE, V27, P203, DOI 10.1016/S8756-3282(00)00314-8; Yajnik CS, 2004, LANCET, V363, P163, DOI 10.1016/S0140-6736(03)15269-5; Yeung DKW, 2005, J MAGN RESON IMAGING, V22, P279, DOI 10.1002/jmri.20367; Zhao LJ, 2008, J BONE MINER RES, V23, P17, DOI 10.1359/JBMR.070813; Zhao LJ, 2007, J CLIN ENDOCR METAB, V92, P1640, DOI 10.1210/jc.2006-0572; Zhou QD, 2009, P NATL ACAD SCI USA, V106, P10740, DOI 10.1073/pnas.0904412106	36	126	133	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2010	5	10							e13704	10.1371/journal.pone.0013704	http://dx.doi.org/10.1371/journal.pone.0013704			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	672HN	21060836	Green Published, gold, Green Submitted			2022-12-27	WOS:000283573800006
J	Ferman, S; Karni, A				Ferman, Sara; Karni, Avi			No Childhood Advantage in the Acquisition of Skill in Using an Artificial Language Rule	PLOS ONE			English	Article							CRITICAL-PERIOD; DEVELOPMENTAL DIFFERENCES; 2ND-LANGUAGE ACQUISITION; MEMORY; AGE; IMPLICIT; CHILDREN; CONSTRAINTS; ATTAINMENT; ENGLISH	A leading notion is that language skill acquisition declines between childhood and adulthood. While several lines of evidence indicate that declarative ("what'', explicit) memory undergoes maturation, it is commonly assumed that procedural ("how-to'', implicit) memory, in children, is well established. The language superiority of children has been ascribed to the childhood reliance on implicit learning. Here we show that when 8-year-olds, 12-year-olds and young adults were provided with an equivalent multi-session training experience in producing and judging an artificial morphological rule (AMR), adults were superior to children of both age groups and the 8-year-olds were the poorest learners in all task parameters including in those that were clearly implicit. The AMR consisted of phonological transformations of verbs expressing a semantic distinction: whether the preceding noun was animate or inanimate. No explicit instruction of the AMR was provided. The 8-year-olds, unlike most adults and 12-year-olds, failed to explicitly uncover the semantic aspect of the AMR and subsequently to generalize it accurately to novel items. However, all participants learned to apply the AMR to repeated items and to generalize its phonological patterns to novel items, attaining accurate and fluent production, and exhibiting key characteristics of procedural memory. Nevertheless, adults showed a clear advantage in learning implicit task aspects, and in their long-term retention. Thus, our findings support the notion of age-dependent maturation in the establishment of declarative but also of procedural memory in a complex language task. In line with recent reports of no childhood advantage in non-linguistic skill learning, we propose that under some learning conditions adults can effectively express their language skill acquisition potential. Altogether, the maturational effects in the acquisition of an implicit AMR do not support a simple notion of a language skill learning advantage in children.	[Ferman, Sara] Tel Aviv Univ, Sackler Fac Med, Dept Commun Disorders, IL-69978 Tel Aviv, Israel; [Karni, Avi] Univ Haifa, Fac Sci, Dept Human Biol, IL-31999 Haifa, Israel; [Karni, Avi] Univ Haifa, Fac Educ, Edmond J Safra Brain Res Ctr Learning & Learning, IL-31999 Haifa, Israel	Tel Aviv University; Sackler Faculty of Medicine; University of Haifa; University of Haifa	Ferman, S (corresponding author), Tel Aviv Univ, Sackler Fac Med, Dept Commun Disorders, IL-69978 Tel Aviv, Israel.	saraf@post.tau.ac.il			Israel Ministry of Education (Chief Scientist's Office)	Israel Ministry of Education (Chief Scientist's Office)	This study was supported by a grant from the Israel Ministry of Education (Chief Scientist's Office). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abutalebi J, 2008, ACTA PSYCHOL, V128, P466, DOI 10.1016/j.actpsy.2008.03.014; ASHER JJ, 1967, CHILD DEV, V38, P1219, DOI 10.2307/1127119; BERMAN RA, 2004, TRENDS LANGUAGE ACQU, P9; Bialystok E., 1999, BILING-LANG COGN, V2, P127, DOI DOI 10.1017/S1366728999000231; BIRDSONG D, 1992, LANGUAGE, V68, P706, DOI 10.2307/416851; Birdsong D, 2006, LANG LEARN, V56, P9, DOI 10.1111/j.1467-9922.2006.00353.x; Bitan T, 2005, COGNITIVE BRAIN RES, V25, P90, DOI 10.1016/j.cogbrainres.2005.04.014; Bongaerts T, 1999, SEC LANG ACQ RES, P133; BORNSTEIN MH, 1989, PSYCHOL BULL, V105, P179, DOI 10.1037/0033-2909.105.2.179; BRAINE MDS, 1990, J MEM LANG, V29, P591, DOI 10.1016/0749-596X(90)90054-4; Clahsen H, 2006, APPL PSYCHOLINGUIST, V27, P3, DOI 10.1017/S0142716406060024; Cleeremans A, 1998, TRENDS COGN SCI, V2, P406, DOI 10.1016/S1364-6613(98)01232-7; Curtiss S., 1977, GENIE PSYCHOLINGUIST; DeKeyser R., 2005, HDB BILINGUALISM PSY, P88; DeKeyser R. M., 1997, STUD SECOND LANG ACQ, V19, P195, DOI DOI 10.1017/S0272263197002040; DeKeyser Robert M., 2000, STUD SECOND LANG ACQ, V22, P499, DOI 10.1017/S0272263100004022; DIGIULIO DV, 1994, BRAIN COGNITION, V25, P79, DOI 10.1006/brcg.1994.1024; Dorfberger S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000240; Ferman S, 2009, J NEUROLINGUIST, V22, P384, DOI 10.1016/j.jneuroling.2008.12.002; Flege J., 2001, STUD SECOND LANG ACQ, V23, P527, DOI [10.1017/S0272263101004041, DOI 10.1017/S0272263101004041]; Flege JE, 2006, J PHONETICS, V34, P153, DOI 10.1016/j.wocn.2005.05.001; Flege JE, 1999, J MEM LANG, V41, P78, DOI 10.1006/jmla.1999.2638; Friederici AD, 2002, P NATL ACAD SCI USA, V99, P529, DOI 10.1073/pnas.012611199; GOMEZ R, 2009, OXFORD HDB PSYCHOLIN, P601; GOSWAMI U, 2008, COGNITIVE DEV LEARNI, P25; Hakuta K, 2003, PSYCHOL SCI, V14, P31, DOI 10.1111/1467-9280.01415; Hauptmann B, 2002, COGNITIVE BRAIN RES, V13, P313, DOI 10.1016/S0926-6410(01)00124-0; Hulstijn J.H, 1997, STUDIES 2 LANGUAGE A, V19, P131, DOI [DOI 10.1017/S0272263197002015, https://doi.org/10.1017/S0272263197002015]; Hyltenstam K., 2003, HDB 2 LANGUAGE ACQUI, P539, DOI DOI 10.1002/9780470756492.CH17; Ioup G., 1994, STUD SECOND LANG ACQ, V16, P73, DOI DOI 10.1017/S0272263100012596; ITARD JMG, 1932, WILD BOY AVEYRON, P1; JOHNSON JS, 1989, COGNITIVE PSYCHOL, V21, P60, DOI 10.1016/0010-0285(89)90003-0; Kail R, 2000, J SCHOOL PSYCHOL, V38, P51, DOI 10.1016/S0022-4405(99)00036-9; KARNI A, 1993, NATURE, V365, P250, DOI 10.1038/365250a0; Karni A, 1998, P NATL ACAD SCI USA, V95, P861, DOI 10.1073/pnas.95.3.861; Karni A, 1996, COGNITIVE BRAIN RES, V5, P39, DOI 10.1016/S0926-6410(96)00039-0; Kersten AW, 2001, J MEM LANG, V44, P250, DOI 10.1006/jmla.2000.2751; Keuroghlian AS, 2007, PROG NEUROBIOL, V82, P109, DOI 10.1016/j.pneurobio.2007.03.005; Kim KHS, 1997, NATURE, V388, P171, DOI 10.1038/40623; KLEIN D, 1995, P NATL ACAD SCI USA, V92, P2899, DOI 10.1073/pnas.92.7.2899; KOPKE B, 2009, LANGUAGE ATTRITION T; Korman M, 2003, P NATL ACAD SCI USA, V100, P12492, DOI 10.1073/pnas.2035019100; KRASHEN SD, 1979, TESOL QUART, V13, P573, DOI 10.2307/3586451; Lenneberg, 1967, BIOL FDN LANGUAGE, DOI 10.1080/21548331.1967.11707799; LOGAN GD, 1988, PSYCHOL REV, V95, P492, DOI 10.1037/0033-295X.95.4.492; Long Michael, 1990, STUDIES 2 LANGUAGE A, V12, P251, DOI [10.1017/S0272263100009165, DOI 10.1017/S0272263100009165]; MACKAY DG, 1982, PSYCHOL REV, V89, P483, DOI 10.1037/0033-295X.89.5.483; Marinova-Todd SH, 2000, TESOL QUART, V34, P9, DOI 10.2307/3588095; MAYBERRY RI, 1993, J SPEECH HEAR RES, V36, P1258, DOI 10.1044/jshr.3606.1258; McClelland J L, 1999, Prog Brain Res, V121, P75; Mishkin M., 1988, NEUROBIOLOGY LEARNIN, P64; Munakata Y, 2004, DEVELOPMENTAL SCI, V7, P141, DOI 10.1111/j.1467-7687.2004.00331.x; NEWPORT EL, 1990, COGNITIVE SCI, V14, P11, DOI 10.1207/s15516709cog1401_2; OYAMA S, 1976, J PSYCHOLINGUIST RES, V5, P261, DOI 10.1007/BF01067377; Penfield W., 1959, SPEECH BRAIN MECH; Perez LA, 1998, J EXP CHILD PSYCHOL, V70, P167, DOI 10.1006/jecp.1998.2449; REBER AS, 1989, J EXP PSYCHOL GEN, V118, P219, DOI 10.1037/0096-3445.118.3.219; Roth DAE, 2005, LEARN MEMORY, V12, P159, DOI 10.1101/87505; Seidenberg MS, 2006, ATTENTION PERFORM, P585; SNOW CE, 1978, CHILD DEV, V49, P1114, DOI 10.2307/1128751; Squire LR, 1996, P NATL ACAD SCI USA, V93, P13515, DOI 10.1073/pnas.93.24.13515; Stowe L.A., 2005, IRAL-INT REV APPL LI, V43, P329; Thomas KM, 2004, J COGNITIVE NEUROSCI, V16, P1339, DOI 10.1162/0898929042304688; Tomblin JB, 2007, INT J AUDIOL, V46, P512, DOI 10.1080/14992020701383043; Ullman M.T., 2001, BILING-LANG COGN, V4, P105, DOI [10.1017/S1366728901000220, DOI 10.1017/S1366728901000220]; Uylings HBM, 2006, LANG LEARN, V56, P59, DOI 10.1111/j.1467-9922.2006.00355.x; Walker MP, 2006, ANNU REV PSYCHOL, V57, P139, DOI 10.1146/annurev.psych.56.091103.070307; WHITE L, 1996, 2 LANGUAGE RES, V0012; YANG LR, 1997, STUDIES 2 LANGUAGE A, V19, P173	69	34	34	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2010	5	10							e13648	10.1371/journal.pone.0013648	http://dx.doi.org/10.1371/journal.pone.0013648			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	671UN	21048965	Green Published, gold, Green Submitted			2022-12-27	WOS:000283537000020
J	Piaggi, P; Lippi, C; Fierabracci, P; Maffei, M; Calderone, A; Mauri, M; Anselmino, M; Cassano, GB; Vitti, P; Pinchera, A; Landi, A; Santini, F				Piaggi, Paolo; Lippi, Chita; Fierabracci, Paola; Maffei, Margherita; Calderone, Alba; Mauri, Mauro; Anselmino, Marco; Cassano, Giovanni Battista; Vitti, Paolo; Pinchera, Aldo; Landi, Alberto; Santini, Ferruccio			Artificial Neural Networks in the Outcome Prediction of Adjustable Gastric Banding in Obese Women	PLOS ONE			English	Article							BARIATRIC SURGERY; WEIGHT-LOSS; PSYCHOSOCIAL PREDICTORS; MORBID-OBESITY; DISORDERS	Background: Obesity is unanimously regarded as a global epidemic and a major contributing factor to the development of many common illnesses. Laparoscopic Adjustable Gastric Banding (LAGB) is one of the most popular surgical approaches worldwide. Yet, substantial variability in the results and significant rate of failure can be expected, and it is still debated which categories of patients are better suited to this type of bariatric procedure. The aim of this study was to build a statistical model based on both psychological and physical data to predict weight loss in obese patients treated by LAGB, and to provide a valuable instrument for the selection of patients that may benefit from this procedure. Methodology/Principal Findings: The study population consisted of 172 obese women, with a mean+/-SD presurgical and postsurgical Body Mass Index (BMI) of 42.5+/-5.1 and 32.4+/-4.8 kg/m(2), respectively. Subjects were administered the comprehensive test of psychopathology Minnesota Multiphasic Personality Inventory-2 (MMPI-2). Main goal of the study was to use presurgical data to predict individual therapeutical outcome in terms of Excess Weight Loss (EWL) after 2 years. Multiple linear regression analysis using the MMPI-2 scores, BMI and age was performed to determine the variables that best predicted the EWL. Based on the selected variables including age, and 3 psychometric scales, Artificial Neural Networks (ANNs) were employed to improve the goodness of prediction. Linear and non linear models were compared in their classification and prediction tasks: non linear model resulted to be better at data fitting (36% vs. 10% variance explained, respectively) and provided more reliable parameters for accuracy and mis-classification rates (70% and 30% vs. 66% and 34%, respectively). Conclusions/Significance: ANN models can be successfully applied for prediction of weight loss in obese women treated by LAGB. This approach may constitute a valuable tool for selection of the best candidates for surgery, taking advantage of an integrated multidisciplinary approach.	[Piaggi, Paolo; Landi, Alberto] Univ Pisa, Dept Elect Syst & Automat, Pisa, Italy; [Lippi, Chita; Fierabracci, Paola; Maffei, Margherita; Calderone, Alba; Anselmino, Marco; Vitti, Paolo; Pinchera, Aldo; Santini, Ferruccio] Univ Hosp Pisa, Dept Endocrinol & Metab, Pisa, Italy; [Maffei, Margherita] Univ Hosp Pisa, Dulbecco Telethon Inst, Pisa, Italy; [Mauri, Mauro; Cassano, Giovanni Battista] Univ Pisa, Sch Med, Dept Psychiat Neurobiol Pharmacol & Biotechnol, I-56100 Pisa, Italy	University of Pisa; University of Pisa; Azienda Ospedaliero Universitaria Pisana; Fondazione Telethon; Dulbecco Telethon Institute (DTI); University of Pisa; Azienda Ospedaliero Universitaria Pisana; University of Pisa	Piaggi, P (corresponding author), Univ Pisa, Dept Elect Syst & Automat, Pisa, Italy.	paolo.piaggi@gmail.com	Santini, Ferruccio/J-9272-2018; LANDI, ALBERTO/CAE-9552-2022; Piaggi, Paolo/E-2539-2011; Landi, Alberto/A-7466-2016	Santini, Ferruccio/0000-0002-1706-0822; LANDI, ALBERTO/0000-0002-0105-5121; Piaggi, Paolo/0000-0003-2774-9161; Landi, Alberto/0000-0002-0105-5121	Telethon [TCR07007] Funding Source: Medline	Telethon(Fondazione Telethon)		Bessesen DH, 2008, J CLIN ENDOCR METAB, V93, P2027, DOI 10.1210/jc.2008-0520; Bishop C.M., 1995, NEURAL NETWORKS PATT; Bueter M, 2007, OBES SURG, V17, P1608, DOI 10.1007/s11695-007-9263-3; Busetto L, 2002, OBES SURG, V12, P83, DOI 10.1381/096089202321144649; Busetto L, 2008, OBESITY, V16, P334, DOI 10.1038/oby.2007.85; Butcher J. N., 2001, MMPI 2 MINNESOTA MUL, VRev; Cherkassky V., 2007, LEARNING DATA CONCEP; Chevallier JM, 2007, ANN SURG, V246, P1034, DOI 10.1097/SLA.0b013e31813e8a56; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Colles SL, 2008, OBES SURG, V18, P833, DOI 10.1007/s11695-007-9409-3; Cunneen SA, 2008, SURG OBES RELAT DIS, V4, pS47, DOI 10.1016/j.soard.2008.04.007; De Panfilis C, 2006, OBES SURG, V16, P842, DOI 10.1381/096089206777822278; Dixon JB, 2002, AM J SURG, V184, p17S, DOI 10.1016/S0002-9610(02)01174-1; Graham J., 2006, MMPI 2 ASSESSING PER; Hainer V, 2008, DIABETES CARE, V31, pS269, DOI 10.2337/dc08-s265; Haykin S, 1999, P842; Hudson SM, 2002, OBES SURG, V12, P789, DOI 10.1381/096089202320995565; Kinzl JF, 2006, OBES SURG, V16, P1609, DOI 10.1381/096089206779319301; Kral JG, 2001, INT J OBESITY, V25, pS107, DOI 10.1038/sj.ijo.0801712; Landi A, 2007, INT CONF ON CYBERNETICS AND INFORMATION TECHNOLOGIES, SYSTEMS AND APPLICATIONS/INT CONF ON COMPUTING, COMMUNICATIONS AND CONTROL TECHNOLOGIES, VOL 1, P76; Lee YC, 2007, OBES SURG, V17, P1235, DOI 10.1007/BF02802096; Lorentz FH, 1929, KLIN WOCHENSCHR, V16, P734, DOI DOI 10.1007/BF01738018; Mardia K., 1979, MULTIVARIATE ANAL, V15, P518; Martin LF, 2007, AM J SURG, V194, P333, DOI 10.1016/j.amjsurg.2007.03.002; Mauri M, 2008, OBES METAB-MILAN, V4, P99; Mauri M, 2008, J CLIN PSYCHIAT, V69, P295, DOI 10.4088/JCP.v69n0216; Myers R., 1990, CLASSICAL MODERN REG; Neter J, 1985, APPL LINEAR REGRESSI; PANCHERI P, 1997, MMPI 2 MINNESOTA MUL; Pontiroli AE, 2007, OBES SURG, V17, P1492, DOI 10.1007/s11695-008-9428-8; Provost F, 1998, MACH LEARN, V30, P127, DOI 10.1023/A:1007442505281; Rojas R., 1996, NEURAL NETWORKS SYST, DOI [10.1007/978-3-642-61068-4{\_}7, DOI 10.1007/978-3-642-61068-4]; ROSEN JC, 1992, ADV PSYCHOL ASSESSME; Rumelhart G.E., 1986, PARALLEL DISTRIBUTED, P318, DOI DOI 10.1016/B978-1-4832-1446-7.50035-2; Singhal R, 2009, OBES SURG, V19, P418, DOI 10.1007/s11695-008-9617-5; Steffen R, 2008, SURG OBES RELAT DIS, V4, pS7, DOI 10.1016/j.soard.2008.04.002; Tessier DJ, 2008, CURR PROB SURG, V45, P62, DOI [10.1067/j.cpsurg.2007.12.006, 10.1067/j.cpsurg.2007.12.003]; Tsushima WT, 2004, OBES SURG, V14, P528, DOI 10.1381/096089204323013550; van Hout GCM, 2005, OBES SURG, V15, P552, DOI 10.1381/0960892053723484; Wolnerhanssen BK, 2008, SURG OBES RELAT DIS, V4, P500, DOI 10.1016/j.soard.2008.03.252; Zijlstra H, 2009, OBES SURG, V19, P725, DOI 10.1007/s11695-008-9572-1	41	25	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2010	5	10							e13624	10.1371/journal.pone.0013624	http://dx.doi.org/10.1371/journal.pone.0013624			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671UN	21048960	gold, Green Submitted, Green Published			2022-12-27	WOS:000283537000017
J	Stein, S; Lohmann, C; Handschin, C; Stenfeldt, E; Boren, J; Luscher, TF; Matter, CM				Stein, Sokrates; Lohmann, Christine; Handschin, Christoph; Stenfeldt, Elin; Boren, Jan; Luescher, Thomas F.; Matter, Christian M.			ApoE-/- PGC-1 alpha-/- Mice Display Reduced IL-18 Levels and Do Not Develop Enhanced Atherosclerosis	PLOS ONE			English	Article							TRANSMEMBRANE CXC-CHEMOKINE; CORONARY-ARTERY-DISEASE; C-REACTIVE PROTEIN; E-DEFICIENT MICE; ADIPOSE-TISSUE; ACCELERATES ATHEROSCLEROSIS; TRANSCRIPTIONAL COACTIVATOR; HEPATIC GLUCONEOGENESIS; SCAVENGER RECEPTOR; CHOLESTEROL EFFLUX	Background: Atherosclerosis is a chronic inflammatory disease that evolves from the interaction of activated endothelial cells, macrophages, lymphocytes and modified lipoproteins (LDLs). In the last years many molecules with crucial metabolic functions have been shown to prevent important steps in the progression of atherogenesis, including peroxisome proliferator activated receptors (PPARs) and the class III histone deacetylase (HDAC) SIRT1. The PPAR gamma coactivator 1 alpha (Ppargc1a or PGC-1 alpha) was identified as an important transcriptional cofactor of PPAR gamma and is activated by SIRT1. The aim of this study was to analyze total PGC-1 alpha deficiency in an atherosclerotic mouse model. Methodology/Principal Findings: To investigate if total PGC-1 alpha deficiency affects atherosclerosis, we compared ApoE(-/-) PGC-1 alpha(-/-) and ApoE(-/-) PGC-1 alpha(+/+) mice kept on a high cholesterol diet. Despite having more macrophages and a higher ICAM-1 expression in plaques, ApoE(-/-) PGC-1 alpha(-/-) did not display more or larger atherosclerotic plaques than their ApoE(-/-) PGC-1 alpha(+/+) littermates. In line with the previously published phenotype of PGC-1 alpha(-/-) mice, ApoE(-/-) PGC-1 alpha(-/-) mice had marked reduced body, liver and epididymal white adipose tissue (WAT) weight. VLDL/LDL-cholesterol and triglyceride contents were also reduced. Aortic expression of PPAR alpha and PPAR gamma, two crucial regulators for adipocyte differentitation and glucose and lipid metabolism, as well as the expression of some PPAR target genes was significantly reduced in ApoE(-/-) PGC-1 alpha(-/-) mice. Importantly, the epididymal WAT and aortic expression of IL-18 and IL-18 plasma levels, a pro-atherosclerotic cytokine, was markedly reduced in ApoE(-/-) PGC-1 alpha(-/-) mice. Conclusions/Significance: ApoE(-/-) PGC-1 alpha(-/-) mice, similar as PGC-1 alpha(-/-) mice exhibit markedly reduced total body and visceral fat weight. Since inflammation of visceral fat is a crucial trigger of atherogenesis, decreased visceral fat in PGC-1 alpha-deficient mice may explain why these mice do not develop enhanced atherosclerosis.	[Stein, Sokrates; Lohmann, Christine; Luescher, Thomas F.; Matter, Christian M.] Univ Zurich, Inst Physiol, Zurich, Switzerland; [Stein, Sokrates; Lohmann, Christine; Luescher, Thomas F.; Matter, Christian M.] Univ Zurich, Zurich Ctr Integrat Human Physiol ZIHP, Zurich, Switzerland; [Stein, Sokrates; Lohmann, Christine; Luescher, Thomas F.; Matter, Christian M.] Univ Zurich Hosp, Ctr Cardiovasc, CH-8091 Zurich, Switzerland; [Handschin, Christoph] Univ Basel, Biozentrum, Basel, Switzerland; [Stenfeldt, Elin; Boren, Jan] Univ Gothenburg, Sahlgrenska Ctr Cardiovasc & Metab Res, Gothenburg, Sweden	University of Zurich; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); University of Zurich; University Zurich Hospital; University of Basel; University of Gothenburg	Stein, S (corresponding author), Univ Zurich, Inst Physiol, Zurich, Switzerland.	christian.matter@access.uzh.ch	Stein, Sokrates/D-4661-2009; Handschin, Christoph/E-6886-2015	Handschin, Christoph/0000-0003-0603-1097; Stein, Sokrates/0000-0001-6984-6934	University of Zurich; Swiss National Science Foundation [31-114094/1, 310030-130626/1, 3100-068118]	University of Zurich; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was funded by the University Research Priority Program 'Integrative Human Physiology' at the University of Zurich and the Swiss National Science Foundation (#31-114094/1, #310030-130626/1, and #3100-068118). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel S, 2004, J IMMUNOL, V172, P6362, DOI 10.4049/jimmunol.172.10.6362; Akiyama TE, 2002, MOL CELL BIOL, V22, P2607, DOI 10.1128/MCB.22.8.2607-2619.2002; Chawla A, 2001, MOL CELL, V7, P161, DOI 10.1016/S1097-2765(01)00164-2; COOK KS, 1987, SCIENCE, V237, P402, DOI 10.1126/science.3299705; Desvergne B, 1999, ENDOCR REV, V20, P649, DOI 10.1210/er.20.5.649; Elhage R, 2003, CARDIOVASC RES, V59, P234, DOI 10.1016/S0008-6363(03)00343-2; FLIER JS, 1987, SCIENCE, V237, P405, DOI 10.1126/science.3299706; Glass CK, 2001, CELL, V104, P503, DOI 10.1016/S0092-8674(01)00238-0; Gough PJ, 2004, J IMMUNOL, V172, P3678, DOI 10.4049/jimmunol.172.6.3678; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Hulthe J, 2006, ATHEROSCLEROSIS, V188, P450, DOI 10.1016/j.atherosclerosis.2005.11.013; Kim HJ, 2007, ANTIOXID REDOX SIGN, V9, P301, DOI 10.1089/ars.2006.1456; Kressler D, 2002, J BIOL CHEM, V277, P13918, DOI 10.1074/jbc.M201134200; Lakka HM, 2002, EUR HEART J, V23, P706, DOI 10.1053/euhj.2001.2889; Lehrke M, 2009, EUR J ENDOCRINOL, V161, P339, DOI 10.1530/EJE-09-0380; Li AC, 2000, J CLIN INVEST, V106, P523, DOI 10.1172/JCI10370; Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Lutgens E, 1999, NAT MED, V5, P1313, DOI 10.1038/15271; Mallat Z, 2001, CIRC RES, V89, pE41, DOI 10.1161/hh1901.098735; Matloubian M, 2000, NAT IMMUNOL, V1, P298, DOI 10.1038/79738; MIN HY, 1986, NUCLEIC ACIDS RES, V14, P8879; Mitsuoka H, 2009, J ATHEROSCLER THROMB, V16, P586, DOI 10.5551/jat.1081; Mussig K, 2009, METABOLISM, V58, P519, DOI 10.1016/j.metabol.2008.11.011; Oberkofler H, 2003, BIOCHEM J, V371, P89, DOI 10.1042/BJ20021665; Ohman MK, 2008, CIRCULATION, V117, P798, DOI 10.1161/CIRCULATIONAHA.107.717595; Ploplis VA, 2001, ANN NY ACAD SCI, V936, P466; PLUMP AS, 1992, CELL, V71, P343, DOI 10.1016/0092-8674(92)90362-G; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; PURCELLHUYNH DA, 1995, J CLIN INVEST, V95, P2246, DOI 10.1172/JCI117915; Qian H, 2008, GENE THER, V15, P224, DOI 10.1038/sj.gt.3303069; Recinos A, 2004, PHYSIOL GENOMICS, V19, P131, DOI 10.1152/physiolgenomics.00146.2003; See R, 2007, J AM COLL CARDIOL, V50, P752, DOI 10.1016/j.jacc.2007.04.066; Shimaoka T, 2004, J BIOL CHEM, V279, P26807, DOI 10.1074/jbc.C400163200; Shimaoka T, 2000, J BIOL CHEM, V275, P40663, DOI 10.1074/jbc.C000761200; Shimaoka T, 2004, J LEUKOCYTE BIOL, V75, P267, DOI 10.1189/jlb.1003465; Stein S, 2010, EUR HEART J, V31, P2301, DOI 10.1093/eurheartj/ehq107; Suchanek H, 2005, EUR CYTOKINE NETW, V16, P177; Tenger C, 2005, ARTERIOSCL THROM VAS, V25, P791, DOI 10.1161/01.ATV.0000153516.02782.65; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Vaughan DE, 2005, J THROMB HAEMOST, V3, P1879, DOI 10.1111/j.1538-7836.2005.01420.x; Vega RB, 2000, MOL CELL BIOL, V20, P1868, DOI 10.1128/MCB.20.5.1868-1876.2000; Wang YX, 2003, CELL, V113, P159, DOI 10.1016/S0092-8674(03)00269-1; WHITE RT, 1992, J BIOL CHEM, V267, P9210; Whitman SC, 2002, CIRC RES, V90, pE34, DOI 10.1161/hh0202.105292; Wittamer V, 2003, J EXP MED, V198, P977, DOI 10.1084/jem.20030382; Won JC, 2010, ARTERIOSCL THROM VAS, V30, P290, DOI 10.1161/ATVBAHA.109.198721; Xie Gaoqiang, 2007, BMC Cardiovasc Disord, V7, P33, DOI 10.1186/1471-2261-7-33; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050; Zhang YG, 2008, CLIN EXP PHARM PHYSL	52	26	27	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2010	5	10							e13539	10.1371/journal.pone.0013539	http://dx.doi.org/10.1371/journal.pone.0013539			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	670KA	21042583	Green Accepted, Green Submitted, gold, Green Published			2022-12-27	WOS:000283419100005
J	Verschoor, ML; Wilson, LA; Verschoor, CP; Singh, G				Verschoor, Meghan L.; Wilson, Leigh A.; Verschoor, Chris P.; Singh, Gurmit			Ets-1 Regulates Energy Metabolism in Cancer Cells	PLOS ONE			English	Article							TRANSCRIPTION FACTOR ETS-1; MESSENGER-RNA EXPRESSION; OXIDATIVE STRESS; MARKER; IMBALANCE; CARCINOMA; ANGIOGENESIS; INHIBITION; ACTIVATION; SURVIVAL	Cancer cells predominantly utilize glycolysis for ATP production even in the presence of abundant oxygen, an environment that would normally result in energy production through oxidative phosphorylation. Although the molecular mechanism for this metabolic switch to aerobic glycolysis has not been fully elucidated, it is likely that mitochondrial damage to the electron transport chain and the resulting increased production of reactive oxygen species are significant driving forces. In this study, we have investigated the role of the transcription factor Ets-1 in the regulation of mitochondrial function and metabolism. Ets-1 was over-expressed using a stably-incorporated tetracycline-inducible expression vector in the ovarian cancer cell line 2008, which does not express detectable basal levels of Ets-1 protein. Microarray analysis of the effects of Ets-1 over-expression in these ovarian cancer cells shows that Ets-1 up-regulates key enzymes involved in glycolysis and associated feeder pathways, fatty acid metabolism, and antioxidant defense. In contrast, Ets-1 down-regulates genes involved in the citric acid cycle, electron transport chain, and mitochondrial proteins. At the functional level, we have found that Ets-1 expression is directly correlated with cellular oxygen consumption whereby increased expression causes decreased oxygen consumption. Ets-1 over-expression also caused increased sensitivity to glycolytic inhibitors, as well as growth inhibition in a glucose-depleted culture environment. Collectively our findings demonstrate that Ets-1 is involved in the regulation of cellular metabolism and response to oxidative stress in ovarian cancer cells.	[Verschoor, Meghan L.; Wilson, Leigh A.; Singh, Gurmit] Juravinski Canc Ctr, Dept Res, Hamilton, ON, Canada; [Verschoor, Meghan L.] McMaster Univ, Dept Med Sci, Hamilton, ON, Canada; [Verschoor, Chris P.; Singh, Gurmit] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada	McMaster University; McMaster University; McMaster University	Verschoor, ML (corresponding author), Juravinski Canc Ctr, Dept Res, Hamilton, ON, Canada.	gurmit.singh@jcc.hhsc.ca	Singh, Gurmit/C-6744-2014		Canadian Institutes of Health Research (CIHR)	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This work was supported by grant funding from the Canadian Institutes of Health Research (CIHR). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akinci M, 2008, ACTA CIR BRAS, V23, P551, DOI 10.1590/S0102-86502008000600013; ANDREWS PA, 1992, CANCER RES, V52, P1895; Arsova-Sarafinovska Z, 2009, CLIN BIOCHEM, V42, P1228, DOI 10.1016/j.clinbiochem.2009.05.009; Avril N, 1996, J CLIN ONCOL, V14, P1848, DOI 10.1200/JCO.1996.14.6.1848; Carew Jennifer S, 2002, Mol Cancer, V1, P9, DOI 10.1186/1476-4598-1-9; Chen K, 2003, J BIOL CHEM, V278, P39527, DOI 10.1074/jbc.M304423200; CHUNGMAN HJ, 2001, CANCER RES, V61, P8578; Davidson B, 2001, AM J SURG PATHOL, V25, P1493, DOI 10.1097/00000478-200112000-00004; Davidson B, 2001, CLIN CANCER RES, V7, P551; Dittmer Jurgen, 2003, Mol Cancer, V2, P29, DOI 10.1186/1476-4598-2-29; Fujimoto J, 2002, ANN ONCOL, V13, P1598, DOI 10.1093/annonc/mdf248; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; GOKUL S, 2009, ORAL DIS; Hackstadt AJ, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-11; Hahne JC, 2008, MINI-REV MED CHEM, V8, P1095, DOI 10.2174/138955708785909934; Hutter E, 2006, EXP GERONTOL, V41, P103, DOI 10.1016/j.exger.2005.09.011; Klaunig JE, 2004, ANNU REV PHARMACOL, V44, P239, DOI 10.1146/annurev.pharmtox.44.101802.121851; KONSTANTINOV AA, 1987, BIOCHIM BIOPHYS ACTA, V894, P1, DOI 10.1016/0005-2728(87)90206-4; Lee HC, 2009, INT J MOL SCI, V10, P674, DOI 10.3390/ijms10020674; Lefter LP, 2009, CANCER GENE THER, V16, P137, DOI 10.1038/cgt.2008.65; Martindale JL, 2002, J CELL PHYSIOL, V192, P1, DOI 10.1002/jcp.10119; MEDES G, 1953, CANCER RES, V13, P27; Murie C, 2008, BIOINFORMATICS, V24, P1735, DOI 10.1093/bioinformatics/btn211; Nakayama T, 1996, AM J PATHOL, V149, P1931; Nomura M, 2000, CARCINOGENESIS, V21, P1885, DOI 10.1093/carcin/21.10.1885; Oberley TD, 1997, HISTOL HISTOPATHOL, V12, P525; Oda N, 1999, J CELL PHYSIOL, V178, P121, DOI 10.1002/(SICI)1097-4652(199902)178:2<121::AID-JCP1>3.3.CO;2-6; Okuducu AF, 2006, HISTOPATHOLOGY, V48, P836, DOI 10.1111/j.1365-2559.2006.02432.x; Park YH, 2008, BIOCHEM BIOPH RES CO, V377, P389, DOI 10.1016/j.bbrc.2008.09.135; Pelicano H, 2009, CANCER RES, V69, P2375, DOI 10.1158/0008-5472.CAN-08-3359; Petros JA, 2005, P NATL ACAD SCI USA, V102, P719, DOI 10.1073/pnas.0408894102; Picardo M, 1996, J INVEST DERMATOL, V107, P322, DOI 10.1111/1523-1747.ep12363163; Policastro L, 2004, MOL CARCINOGEN, V39, P103, DOI 10.1002/mc.20001; R Development Core Team, 2005, R LANG ENV STAT COMP; Rothhammer T, 2004, CELL MOL LIFE SCI, V61, P118, DOI 10.1007/s00018-003-3337-8; Scarpulla RC, 2002, BBA-GENE STRUCT EXPR, V1576, P1, DOI 10.1016/S0167-4781(02)00343-3; SCHATZ G, 1995, BBA-MOL BASIS DIS, V1271, P123, DOI 10.1016/0925-4439(95)00018-Y; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; SINHA S, 2009, INT J BIOMETEOROL; Span PN, 2002, ONCOGENE, V21, P8506, DOI 10.1038/sj.onc.1206040; SZATROWSKI TP, 1991, CANCER RES, V51, P794; Takai N, 2002, INT J MOL MED, V9, P287; Trojanowska M, 2000, ONCOGENE, V19, P6464, DOI 10.1038/sj.onc.1204043; WAHL RL, 1990, J NUCL MED, V31, P1831; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Watabe T, 1998, INT J CANCER, V77, P128, DOI 10.1002/(SICI)1097-0215(19980703)77:1<128::AID-IJC20>3.0.CO;2-9; Wilson LA, 2005, FASEB J, V19, P2085, DOI 10.1096/fj.05-4401fje; Wilson LA, 2004, MOL CANCER THER, V3, P823; Yecies JL, 2010, CELL, V140, P28, DOI 10.1016/j.cell.2009.12.037	49	40	40	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2010	5	10							e13565	10.1371/journal.pone.0013565	http://dx.doi.org/10.1371/journal.pone.0013565			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	670KA	21042593	Green Submitted, gold, Green Published			2022-12-27	WOS:000283419100009
J	Maminiaina, OF; Gil, P; Briand, FX; Albina, E; Keita, D; Andriamanivo, HR; Chevalier, V; Lancelot, R; Martinez, D; Rakotondravao, R; Rajaonarison, JJ; Koko, M; Andriantsimahavandy, AA; Jestin, V; de Almeida, RS				Maminiaina, Olivier F.; Gil, Patricia; Briand, Francois-Xavier; Albina, Emmanuel; Keita, Djeneba; Andriamanivo, Harentsoaniaina Rasamoelina; Chevalier, Veronique; Lancelot, Renaud; Martinez, Dominique; Rakotondravao, R.; Rajaonarison, Jean-Joseph; Koko, M.; Andriantsimahavandy, Abel A.; Jestin, Veronique; de Almeida, Renata Servan			Newcastle Disease Virus in Madagascar: Identification of an Original Genotype Possibly Deriving from a Died Out Ancestor of Genotype IV	PLOS ONE			English	Article							HEMAGGLUTININ-NEURAMINIDASE PROTEIN; ACID BINDING-SITE; PHYLOGENETIC ANALYSIS; FUSION GLYCOPROTEIN; NUCLEOTIDE-SEQUENCE; MONOCLONAL-ANTIBODIES; CLEAVAGE-ACTIVATION; VIRULENT-STRAINS; OUTBREAKS; HN	In Madagascar, Newcastle disease (ND) has become enzootic after the first documented epizootics in 1946, with recurrent annual outbreaks causing mortality up to 40%. Four ND viruses recently isolated in Madagascar were genotypically and pathotypically characterised. By phylogenetic inference based on the F and HN genes, and also full-genome sequence analyses, the NDV Malagasy isolates form a cluster distant enough to constitute a new genotype hereby proposed as genotype XI. This new genotype is presumably deriving from an ancestor close to genotype IV introduced in the island probably more than 50 years ago. Our data show also that all the previously described neutralising epitopes are conserved between Malagasy and vaccine strains. However, the potential implication in vaccination failures of specific amino acid substitutions predominantly found on surface-exposed epitopes of F and HN proteins is discussed.	[Maminiaina, Olivier F.; Andriamanivo, Harentsoaniaina Rasamoelina; Rakotondravao, R.] FOFIFA DRZV, Antananarivo, Madagascar; [Gil, Patricia; Albina, Emmanuel; Keita, Djeneba; Lancelot, Renaud; Martinez, Dominique; de Almeida, Renata Servan] CIRAD, BIOS Dept, UMR CMAEE, Montpellier, France; [Briand, Francois-Xavier; Jestin, Veronique] Anses Ploufragan Plouzane Lab, VIPAC Unit, Ploufragan, France; [Chevalier, Veronique] CIRAD, ES Dept, UPR AGIRS, Montpellier, France; [Rajaonarison, Jean-Joseph; Koko, M.; Andriantsimahavandy, Abel A.] Antananarivo Univ Madagascar, Antananarivo, Madagascar	CIRAD; Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); CIRAD	Maminiaina, OF (corresponding author), FOFIFA DRZV, Antananarivo, Madagascar.	renata.almeida@cirad.fr	Lancelot, Renaud/HGE-1086-2022	Lancelot, Renaud/0000-0002-5826-5242; BRIAND, Francois-Xavier/0000-0002-8094-9368; Albina, Emmanuel/0000-0002-6613-3047	French Ministry of Foreign Affairs (MAE) [GRIPAVI 2006-26]; EU [016236, 01/06/2006-31/05/2011]	French Ministry of Foreign Affairs (MAE); EU(European Commission)	This study was mainly funded by the French Ministry of Foreign Affairs (MAE) via the FSP project [GRIPAVI 2006-26] and partly by the EU network of excellence project [EPIZONE (016236, 01/06/2006-31/05/2011, http://www.epizone-eu.net/default.aspx)]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.l	Abolnik C, 2004, ARCH VIROL, V149, P603, DOI 10.1007/s00705-003-0218-2; Aldous EW, 2003, AVIAN PATHOL, V32, P239, DOI 10.1080/030794503100009783; Alexander DJ, 2000, VET MICROBIOL, V74, P3, DOI 10.1016/S0378-1135(00)00160-7; ALEXANDER DJ, 1985, AVIAN PATHOL, V14, P365, DOI 10.1080/03079458508436238; Alexander DJ, 1997, AVIAN PATHOL, V26, P399, DOI 10.1080/03079459708419222; Alexander DJ, 2003, DIS POULTRY, P63; Bogoyavlenskiy A, 2005, VIRUS GENES, V31, P13, DOI 10.1007/s11262-004-2195-2; Chen L, 2001, STRUCTURE, V9, P255, DOI 10.1016/S0969-2126(01)00581-0; Cho SH, 2007, VIRUS GENES, V35, P293, DOI 10.1007/s11262-007-0078-z; Connaris H, 2002, J VIROL, V76, P1816, DOI 10.1128/JVI.76.4.1816-1824.2002; Crennell S, 2000, NAT STRUCT BIOL, V7, P1068; Czegledi A, 2003, AVIAN PATHOL, V32, P271, DOI 10.1080/0307945031000097868; Czegledi A, 2002, EPIDEMIOL INFECT, V129, P679, DOI 10.1017/S0950268802007732; Czegledi A, 2006, VIRUS RES, V120, P36, DOI 10.1016/j.virusres.2005.11.009; de Almeida RS, 2009, VACCINE, V27, P3127, DOI 10.1016/j.vaccine.2009.03.076; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fields B. N, 1996, FIELDS VIROLOGY, V1, P1177; GOTOH B, 1992, J VIROL, V66, P6391, DOI 10.1128/JVI.66.11.6391-6397.1992; Gravel KA, 2003, J VIROL, V77, P11040, DOI 10.1128/JVI.77.20.11040-11049.2003; Han GZ, 2008, VIROLOGY, V371, P54, DOI 10.1016/j.virol.2007.09.038; Herczeg J, 1999, ARCH VIROL, V144, P2087, DOI 10.1007/s007050050624; Huang ZH, 2004, J VIROL, V78, P4176, DOI 10.1128/JVI.78.8.4176-4184.2004; Huovilainen A, 2001, ARCH VIROL, V146, P1775, DOI 10.1007/s007050170063; IORIO RM, 1989, VIRUS RES, V13, P245, DOI 10.1016/0168-1702(89)90019-1; IORIO RM, 1991, J VIROL, V65, P4999, DOI 10.1128/JVI.65.9.4999-5006.1991; JORGENSEN ED, 1987, VIROLOGY, V156, P12, DOI 10.1016/0042-6822(87)90431-4; Kapczynski DR, 2005, VACCINE, V23, P3424, DOI 10.1016/j.vaccine.2005.01.140; Kattenbelt JA, 2006, VET MICROBIOL, V114, P134, DOI 10.1016/j.vetmic.2005.10.041; Kim LM, 2007, J VIROL, V81, P12641, DOI 10.1128/JVI.00843-07; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; KIMURA S, 2004, CHEMBIO INFORMATICS, V4, P1; Koko M., 2006, International Atomic Energy Agency Technical Documents (IAEA-TECDOCs), P157; Lee YJ, 2004, AVIAN PATHOL, V33, P482, DOI 10.1080/03079450400003700; Lien YY, 2007, VET MICROBIOL, V123, P194, DOI 10.1016/j.vetmic.2007.03.006; Liu HL, 2007, J VIROL METHODS, V140, P206, DOI 10.1016/j.jviromet.2006.10.012; Liu XF, 2003, ARCH VIROL, V148, P1387, DOI 10.1007/s00705-003-0014-z; Lomniczi B, 1998, ARCH VIROL, V143, P49, DOI 10.1007/s007050050267; Maminiaina OF, 2007, REV SCI TECH OIE, V26, P691, DOI 10.20506/rst.26.3.1776; Martin S, 2009, J GEN VIROL, V90, P1527, DOI 10.1099/vir.0.008193-0; Mayo M A, 2002, Arch Virol, V147, P1071, DOI 10.1007/s007050200036; Mayo MA, 2002, ARCH VIROL, V147, P1655, DOI 10.1007/s007050200039; Meulemans G, 2002, AVIAN PATHOL, V31, P515, DOI 10.1080/0307945021000005897; MILLAR NS, 1986, J GEN VIROL, V67, P1917, DOI 10.1099/0022-1317-67-9-1917; Miller PJ, 2007, VACCINE, V25, P7238, DOI 10.1016/j.vaccine.2007.07.017; Miller PJ, 2010, INFECT GENET EVOL, V10, P26, DOI 10.1016/j.meegid.2009.09.012; Miller PJ, 2009, VIROLOGY, V391, P64, DOI 10.1016/j.virol.2009.05.033; MILLER PJ, 2009, INFECT GENETICS EVOL; OIE, 2004, MAN DIAGN TESTS VACC, P270; OIE, 2009, MAN DIAGN TESTS VACC, P576; Panda A, 2004, J VIROL, V78, P4965, DOI 10.1128/JVI.78.10.4965-4975.2004; Peeters BPH, 2000, ARCH VIROL, V145, P1829, DOI 10.1007/s007050070059; Qin ZM, 2008, VIRUS RES, V131, P299, DOI 10.1016/j.virusres.2007.10.001; Qin Zhuoming, 2008, Weishengwu Xuebao, V48, P226; RAJAONARISON JJ, 1991, P WORKSH NEWC DIS VA, P135; Romer-Oberdorfer A, 2003, J GEN VIROL, V84, P3121, DOI 10.1099/vir.0.19416-0; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Seal Bruce S., 2004, Functional & Integrative Genomics, V4, P246; Sinkovics JG, 2000, J CLIN VIROL, V16, P1, DOI 10.1016/S1386-6532(99)00072-4; Snoeck CJ, 2009, ARCH VIROL, V154, P47, DOI 10.1007/s00705-008-0269-5; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Terregino C, 2003, AVIAN PATHOL, V32, P63, DOI 10.1080/0307945021000070732; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; TOYODA T, 1987, VIROLOGY, V158, P242, DOI 10.1016/0042-6822(87)90261-3; Tsai HJ, 2004, VET MICROBIOL, V104, P19, DOI 10.1016/j.vetmic.2004.09.005; Ujvari D, 2003, VIRUS RES, V96, P63, DOI 10.1016/S0168-1702(03)00173-4; Wang ZL, 2006, ANN NY ACAD SCI, V1081, P228, DOI 10.1196/annals.1373.027; Wehmann E, 2003, VET MICROBIOL, V94, P269, DOI 10.1016/S0378-1135(03)00133-0; Xu M, 2008, ARCH VIROL, V153, P1281, DOI 10.1007/s00705-008-0115-9; Yang CY, 1999, AVIAN DIS, V43, P125, DOI 10.2307/1592771; Yu L, 2001, J CLIN MICROBIOL, V39, P3512, DOI 10.1128/JCM.39.10.3512-3519.2001; YUSOFF K, 1988, VIRUS RES, V11, P319, DOI 10.1016/0168-1702(88)90005-6; YUSOFF K, 1989, J GEN VIROL, V70, P3105, DOI 10.1099/0022-1317-70-11-3105; Zaitsev V, 2004, J VIROL, V78, P3733, DOI 10.1128/JVI.78.7.3733-3741.2004; Zou J, 2005, VIRUS GENES, V30, P13, DOI 10.1007/s11262-004-4577-x	74	57	64	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2010	5	11							e13987	10.1371/journal.pone.0013987	http://dx.doi.org/10.1371/journal.pone.0013987			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	680KW	21085573	Green Published, gold			2022-12-27	WOS:000284231800017
J	Perlot, T; Pawlitzky, I; Manis, JP; Zarrin, AA; Brodeur, PH; Alt, FW				Perlot, Thomas; Pawlitzky, Inka; Manis, John P.; Zarrin, Ali A.; Brodeur, Peter H.; Alt, Frederick W.			Analysis of Mice Lacking DNaseI Hypersensitive Sites at the 5 ' End of the IgH Locus	PLOS ONE			English	Article							HEAVY-CHAIN LOCUS; LYMPHOCYTE DEVELOPMENT; IMMUNOGLOBULIN LOCI; V(D)J RECOMBINATION; ENHANCER; REGION; GENE; COMPARTMENTALIZATION; REARRANGEMENTS; MECHANISM	The 5' end of the IgH locus contains a cluster of DNaseI hypersensitive sites, one of which (HS1) was shown to be pro-B cell specific and to contain binding sites for the transcription factors PU. 1, E2A, and Pax5. These data as well as the location of the hypersensitive sites at the 5' border of the IgH locus suggested a possible regulatory function for these elements with respect to the IgH locus. To test this notion, we generated mice carrying targeted deletions of either the pro-B cell specific site HS1 or the whole cluster of DNaseI hypersensitive sites. Lymphocytes carrying these deletions appear to undergo normal development, and mutant B cells do not exhibit any obvious defects in V(D)J recombination, allelic exclusion, or class switch recombination. We conclude that deletion of these DNaseI hypersensitive sites does not have an obvious impact on the IgH locus or B cell development.	[Perlot, Thomas; Zarrin, Ali A.; Alt, Frederick W.] Harvard Univ, Sch Med, Howard Hughes Med Inst, Childrens Hosp,Immune Dis Inst, Boston, MA 02115 USA; [Perlot, Thomas; Zarrin, Ali A.; Alt, Frederick W.] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; [Pawlitzky, Inka; Brodeur, Peter H.] Tufts Univ, Sch Med, Sackler Sch Grad Biomed Sci, Program Immunol, Boston, MA 02111 USA; [Manis, John P.] Harvard Univ, Sch Med, Childrens Hosp Boston, Boston, MA USA; [Manis, John P.] Harvard Univ, Sch Med, Joint Program Transfus Med, Boston, MA USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Tufts University; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard Medical School	Perlot, T (corresponding author), Austrian Acad Sci, Inst Mol Biotechnol, IMBA, A-1010 Vienna, Austria.	alt@enders.tch.harvard.edu			National Institutes of Health [R01 AI020047, GM36064]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI020047] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM036064] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by National Institutes of Health R01 AI020047 (to FWA) and GM36064 (to PHB). FWA is an Investigator of the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALT FW, 1984, EMBO J, V3, P1209, DOI 10.1002/j.1460-2075.1984.tb01955.x; Chaudhuri Jayanta, 2007, Adv Immunol, V94, P157, DOI 10.1016/S0065-2776(06)94006-1; CHEN JZ, 1993, P NATL ACAD SCI USA, V90, P4528, DOI 10.1073/pnas.90.10.4528; Chowdhury D, 2001, EMBO J, V20, P6394, DOI 10.1093/emboj/20.22.6394; Dudley DD, 2003, J EXP MED, V198, P1439, DOI 10.1084/jem.20030627; Franco S, 2006, MOL CELL, V21, P201, DOI 10.1016/j.molcel.2006.01.005; Fuxa M, 2004, GENE DEV, V18, P411, DOI 10.1101/gad.291504; Hewitt SL, 2008, NAT IMMUNOL, V9, P396, DOI 10.1038/ni1567; Jolly CJ, 1997, NUCLEIC ACIDS RES, V25, P1913, DOI 10.1093/nar/25.10.1913; Jung D, 2006, ANNU REV IMMUNOL, V24, P541, DOI 10.1146/annurev.immunol.23.021704.115830; Khamlichi AA, 2000, ADV IMMUNOL, V75, P317, DOI 10.1016/S0065-2776(00)75008-5; Kosak ST, 2002, SCIENCE, V296, P158, DOI 10.1126/science.1068768; Mostoslavsky R, 2004, CELL, V118, P539, DOI 10.1016/j.cell.2004.08.023; Pawlitzky I, 2006, J IMMUNOL, V176, P6839, DOI 10.4049/jimmunol.176.11.6839; Perlot T, 2005, P NATL ACAD SCI USA, V102, P14362, DOI 10.1073/pnas.0507090102; Perlot T, 2008, ADV IMMUNOL, V99, P1, DOI 10.1016/S0065-2776(08)00601-9; Reddy KL, 2008, NATURE, V452, P243, DOI 10.1038/nature06727; Sakai E, 1999, P NATL ACAD SCI USA, V96, P1526, DOI 10.1073/pnas.96.4.1526; Sleckman BP, 1997, IMMUNITY, V7, P505, DOI 10.1016/S1074-7613(00)80372-6; Yang QX, 2005, MOL CELL BIOL, V25, P6021, DOI 10.1128/MCB.25.14.6021-6030.2005	20	10	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2010	5	11							e13992	10.1371/journal.pone.0013992	http://dx.doi.org/10.1371/journal.pone.0013992			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	680KW	21085586	Green Published, Green Submitted, gold			2022-12-27	WOS:000284231800022
J	Flatz, R; Gerber, LR				Flatz, Ramona; Gerber, Leah R.			First Evidence for Adoption in California Sea Lions	PLOS ONE			English	Article							FOSTERING BEHAVIOR; EUMETOPIAS-JUBATUS; RELATEDNESS; CARE	Demographic parameters such as birth and death rates determine the persistence of populations. Understanding the mechanisms that influence these rates is essential to developing effective management strategies. Alloparental behavior, or the care of non-filial young, has been documented in many species and has been shown to influence offspring survival. However, the role of alloparental behavior in maintaining population viability has not been previously studied. Here, we provide the first evidence for adoption in California sea lions and show that adoption potentially works to maintain a high survival rate of young and may ultimately contribute to population persistence. Alloparental behavior should have a positive effect on the population growth rate when the sum of the effects on fitness for the alloparent and beneficiary is positive.	[Flatz, Ramona; Gerber, Leah R.] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA	Arizona State University; Arizona State University-Tempe	Flatz, R (corresponding author), Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA.	Rflatz@Willamette.edu		Gerber, Leah/0000-0002-6763-6842	National Science Foundation [0347960]	National Science Foundation(National Science Foundation (NSF))	The research was supported by the National Science Foundation (grant no. 0347960 to LG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthony LL, 2000, BIOL CONSERV, V95, P303, DOI 10.1016/S0006-3207(00)00037-9; BONESS DJ, 1990, BEHAV ECOL SOCIOBIOL, V27, P113, DOI 10.1007/BF00168454; Bowen W.D., 1991, P66; BRANDBURY RB, 2001, TRENDS ECOL EVOL, V16, P440; Childerhouse S, 2001, NEW ZEAL J ZOOL, V28, P189, DOI 10.1080/03014223.2001.9518263; Gerber LR, 2006, FRONT ECOL ENVIRON, V4, P419, DOI 10.1890/1540-9295(2006)4[419:IBDIDM]2.0.CO;2; Gonzalez-Suarez M, 2009, MOL ECOL, V18, P1088, DOI 10.1111/j.1365-294X.2009.04093.x; Hoberecht LK, 2006, MAR MAMMAL SCI, V22, P683, DOI 10.1111/j.1748-7692.2006.00046.x; HOFFMAN JI, 2005, P R SOC B, V272, P2063; Insley SJ, 2000, NATURE, V406, P404, DOI 10.1038/35019064; Insley Stephen J., 2003, Aquatic Mammals, V29, P181, DOI 10.1578/016754203101024149; Maniscalco JM, 2007, J ETHOL, V25, P125, DOI 10.1007/s10164-006-0001-4; Marshall TC, 1998, MOL ECOL, V7, P639, DOI 10.1046/j.1365-294x.1998.00374.x; McAndrew FT, 2002, CURR DIR PSYCHOL SCI, V11, P79, DOI 10.1111/1467-8721.00173; ONO KA, 1987, BEHAV ECOL SOCIOBIOL, V21, P109, DOI 10.1007/BF02395438; PACKER C, 1992, ANIM BEHAV, V43, P265, DOI 10.1016/S0003-3472(05)80222-2; QUELLER DC, 1989, EVOLUTION, V43, P258, DOI 10.2307/2409206; RIEDMAN M, 1990, PINNIPEDS SEALS SEA; RIEDMAN ML, 1982, BEHAV ECOL SOCIOBIOL, V11, P203, DOI 10.1007/BF00300063; RIEDMAN ML, 1982, Q REV BIOL, V57, P405, DOI 10.1086/412936; Roulin A, 2002, ANIM BEHAV, V63, P201, DOI 10.1006/anbe.2001.1895; Schaeff CM, 1999, ANIM BEHAV, V57, P427, DOI 10.1006/anbe.1998.1001; Szteren D, 2006, LOW WAKE FI, P369; Valsecchi E, 2002, MOL ECOL, V11, P507, DOI 10.1046/j.0962-1083.2001.01459.x; Wilson AB, 2009, MOL ECOL, V18, P1307, DOI 10.1111/j.1365-294X.2009.04103.x	25	5	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2010	5	11							e13873	10.1371/journal.pone.0013873	http://dx.doi.org/10.1371/journal.pone.0013873			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	676NU	21079727	Green Published, gold			2022-12-27	WOS:000283920000007
J	Mhawech-Fauceglia, P; Wang, D; Kesterson, J; Clark, K; Monhollen, L; Odunsi, K; Lele, S; Liu, S				Mhawech-Fauceglia, Paulette; Wang, Dan; Kesterson, Joshua; Clark, Kimberly; Monhollen, Laketa; Odunsi, Kunle; Lele, Shashikant; Liu, Song			Microarray Analysis Reveals Distinct Gene Expression Profiles Among Different Tumor Histology, Stage and Disease Outcomes in Endometrial Adenocarcinoma	PLOS ONE			English	Article							LYSOPHOSPHATIDIC ACID; TRANSCRIPTION FACTOR; TREFOIL FACTOR-3; OVARIAN-CANCER; RHO-GTPASES; CARCINOMA; GRADE; SUBFAMILY; INVASION; SUBTYPES	Background: Endometrial cancer is the most common gynecologic malignancy in developed countries and little is known about the underlying mechanism of stage and disease outcomes. The goal of this study was to identify differentially expressed genes (DEG) between late vs. early stage endometrioid adenocarcinoma (EAC) and uterine serous carcinoma (USC), as well as between disease outcomes in each of the two histological subtypes. Methodology/Principal Finding: Gene expression profiles of 20 cancer samples were analyzed (EAC = 10, USC = 10) using the human genome wide illumina bead microarrays. There was little overlap in the DEG sets between late vs. early stages in EAC and USC, and there was an insignificant overlap in DEG sets between good and poor prognosis in EAC and USC. Remarkably, there was no overlap between the stage-derived DEGs and the prognosis-derived DEGs for each of the two histological subtypes. Further functional annotation of differentially expressed genes showed that the composition of enriched function terms were different among different DEG sets. Gene expression differences for selected genes of various stages and outcomes were confirmed by qRT-PCR with a high validation rate. Conclusion: This data, although preliminary, suggests that there might be involvement of distinct groups of genes in tumor progression (late vs. early stage) in each of the EAC and USC. It also suggests that these genes are different from those involved in tumor outcome (good vs. poor prognosis). These involved genes, once clinically verified, may be important for predicting tumor progression and tumor outcome.	[Mhawech-Fauceglia, Paulette; Monhollen, Laketa] Roswell Pk Canc Inst, Dept Pathol, Buffalo, NY 14263 USA; [Wang, Dan; Liu, Song] Roswell Pk Canc Inst, Dept Biostat, Buffalo, NY 14263 USA; [Kesterson, Joshua; Odunsi, Kunle; Lele, Shashikant] Roswell Pk Canc Inst, Dept Gynecol Oncol Surg, Buffalo, NY 14263 USA; [Clark, Kimberly] Roswell Pk Canc Inst, Dept Canc Genet, Buffalo, NY 14263 USA	Roswell Park Cancer Institute; Roswell Park Cancer Institute; Roswell Park Cancer Institute; Roswell Park Cancer Institute	Mhawech-Fauceglia, P (corresponding author), Roswell Pk Canc Inst, Dept Pathol, Buffalo, NY 14263 USA.	pmhawech1@yahoo.com; song.liu@roswellaprk.org			NATIONAL CANCER INSTITUTE [T32CA108456] Funding Source: NIH RePORTER; NCI NIH HHS [T32 CA108456] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aznar S, 2004, CANCER LETT, V206, P181, DOI 10.1016/j.canlet.2003.08.035; Babyatsky M, 2009, CLIN EXP METASTAS, V26, P143, DOI 10.1007/s10585-008-9224-9; Benito V, 2009, INT J GYNECOL CANCER, V19, P1364, DOI 10.1111/IGC.0b013e3181b7a1d5; Berthold J, 2008, ACTA PHARMACOL SIN, V29, P285, DOI 10.1111/j.1745-7254.2008.00773.x; Bignotti E, 2008, BRIT J CANCER, V99, P768, DOI 10.1038/sj.bjc.6604546; Campbell TN, 2008, CURR ISSUES MOL BIOL, V10, P61; CHENG YY, BR J CANC, V99, P2083; Corson TW, 2006, INT J CANCER, V119, P1088, DOI 10.1002/ijc.21954; Corson TW, 2005, ONCOGENE, V24, P4741, DOI 10.1038/sj.onc.1208641; del Pulgar TG, 2005, BIOESSAYS, V27, P602, DOI 10.1002/bies.20238; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Gallagher WM, 2005, TRENDS MOL MED, V11, P336, DOI 10.1016/j.molmed.2005.06.001; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Herath NI, 2009, BRIT J CANCER, V100, P1095, DOI 10.1038/sj.bjc.6604970; Herath NI, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-144; Huang DW, 2007, NUCLEIC ACIDS RES, V35, pW169, DOI 10.1093/nar/gkm415; Idaghdour Y, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000052; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Kieback DG, 1996, ANTICANCER RES, V16, P3371; Kim TM, 2008, INT J CANCER, V123, P2808, DOI 10.1002/ijc.23901; Kitchener HC, 2009, INT J GYNECOL CANCER, V19, P134, DOI 10.1111/IGC.0b013e3181995f90; KOHLER MF, 1992, CANCER RES, V52, P1622; LUKES AS, 1994, CANCER, V73, P2380, DOI 10.1002/1097-0142(19940501)73:9<2380::AID-CNCR2820730922>3.0.CO;2-G; Maitra A, 2003, CLIN CANCER RES, V9, P5988; Markowski J, 2009, J PHYSIOL PHARMACOL, V60, P57; Maxwell GL, 2005, CLIN CANCER RES, V11, P4056, DOI 10.1158/1078-0432.CCR-04-2001; Mills GB, 2003, NAT REV CANCER, V3, P582, DOI 10.1038/nrc1143; Moreno-Bueno G, 2003, CANCER RES, V63, P5697; National Comprehensive Cancer Network (NCCN), 2011, NCCN CLIN PRACT GUID; Naumann RW, 2008, CURR ONCOL REP, V10, P505, DOI 10.1007/s11912-008-0076-x; Osborne J, 1998, J SOC GYNECOL INVEST, V5, P277, DOI 10.1016/S1071-5576(98)00020-3; Planaguma J, 2004, CANCER RES, V64, P8846, DOI 10.1158/0008-5472.CAN-04-2066; Richter AM, 2009, BBA-REV CANCER, V1796, P114, DOI 10.1016/j.bbcan.2009.03.004; Risinger JI, 2003, CANCER RES, V63, P6; RISINGER JI, 1993, CANCER RES, V53, P5100; Santin AD, 2005, BRIT J CANCER, V92, P1561, DOI 10.1038/sj.bjc.6602480; Schafer G, 2008, CANCER RES, V68, P457, DOI 10.1158/0008-5472.CAN-07-5136; Sherwood V, 2008, MOL BIOL CELL, V19, P1772, DOI 10.1091/mbc.E07-07-0652; Smid-Koopman E, 2004, GYNECOL ONCOL, V93, P292, DOI 10.1016/j.ygyno.2004.01.022; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Soslow RA, 2007, AM J SURG PATHOL, V31, P979, DOI 10.1097/PAS.0b013e31802ee494; Su JL, 2006, CANCER RES, V66, P2553, DOI 10.1158/0008-5472.CAN-05-2645; Sutton G, 2005, GYNECOL ONCOL, V97, P755, DOI 10.1016/j.ygyno.2005.03.011; Tashiro H, 1997, CANCER RES, V57, P3935; Taylor HS, 2000, SEMIN REPROD MED, V18, P81, DOI 10.1055/s-2000-13478; van der Weyden L, 2007, BBA-REV CANCER, V1776, P58, DOI 10.1016/j.bbcan.2007.06.003; Wlazlinski A, 2007, PROSTATE, V67, P1770, DOI 10.1002/pros.20667; Yu SX, 2008, JNCI-J NATL CANCER I, V100, P1630, DOI 10.1093/jnci/djn378; Zhou J, 1998, ONCOGENE, V17, P2719, DOI 10.1038/sj.onc.1202198; Zorn KK, 2005, CLIN CANCER RES, V11, P6422, DOI 10.1158/1078-0432.CCR-05-0508	51	14	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2010	5	11							e15415	10.1371/journal.pone.0015415	http://dx.doi.org/10.1371/journal.pone.0015415			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	676NU	21079744	gold, Green Published			2022-12-27	WOS:000283920000022
J	Schollenberger, L; Gronemeyer, T; Huber, CM; Lay, D; Wiese, S; Meyer, HE; Warscheid, B; Saffrich, R; Peranen, J; Gorgas, K; Just, WW				Schollenberger, Lukas; Gronemeyer, Thomas; Huber, Christoph M.; Lay, Dorothee; Wiese, Sebastian; Meyer, Helmut E.; Warscheid, Bettina; Saffrich, Rainer; Peranen, Johan; Gorgas, Karin; Just, Wilhelm W.			RhoA Regulates Peroxisome Association to Microtubules and the Actin Cytoskeleton	PLOS ONE			English	Article							RAT-LIVER; LYSOPHOSPHATIDIC ACID; MASS-SPECTROMETRY; ADP-RIBOSYLATION; CELL MOTILITY; MYOSIN-VI; VISUALIZATION; BINDING; DIVISION; DYNAMICS	The current view of peroxisome inheritance provides for the formation of new peroxisomes by both budding from the endoplasmic reticulum and autonomous division. Here we investigate peroxisome-cytoskeleton interactions and show by proteomics, biochemical and immunofluorescence analyses that actin, non-muscle myosin IIA (NMM IIA), RhoA, Rho kinase II (ROCKII) and Rab8 associate with peroxisomes. Our data provide evidence that (i) RhoA in its inactive state, maintained for example by C. botulinum toxin exoenzyme C3, dissociates from peroxisomes enabling microtubule-based peroxisomal movements and (ii) dominant-active RhoA targets to peroxisomes, uncouples the organelles from microtubules and favors Rho kinase recruitment to peroxisomes. We suggest that ROCKII activates NMM IIA mediating local peroxisomal constrictions. Although our understanding of peroxisome-cytoskeleton interactions is still incomplete, a picture is emerging demonstrating alternate RhoA-dependent association of peroxisomes to the microtubular and actin cytoskeleton. Whereas association of peroxisomes to microtubules clearly serves bidirectional, long-range saltatory movements, peroxisome-actomyosin interactions may support biogenetic functions balancing peroxisome size, shape, number, and clustering.	[Schollenberger, Lukas; Huber, Christoph M.; Lay, Dorothee; Just, Wilhelm W.] Heidelberg Univ, Heidelberg Ctr Biochem, Heidelberg, Germany; [Gronemeyer, Thomas; Wiese, Sebastian; Meyer, Helmut E.; Warscheid, Bettina] Univ Bochum, Med Proteom Ctr, Bochum, Germany; [Gronemeyer, Thomas] Univ Ulm, Dept Mol Genet & Cell Biol, Ulm, Germany; [Saffrich, Rainer] Heidelberg Univ, Dept Internal Med 5, Heidelberg, Germany; [Peranen, Johan] Univ Helsinki, Inst Biotechnol, FIN-00014 Helsinki, Finland; [Gorgas, Karin] Heidelberg Univ, Dept Anat & Med Cell Biol, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Ruhr University Bochum; Ulm University; Ruprecht Karls University Heidelberg; University of Helsinki; Ruprecht Karls University Heidelberg	Schollenberger, L (corresponding author), Heidelberg Univ, Heidelberg Ctr Biochem, Heidelberg, Germany.	wilhelm.just@bzh.uni-heidelberg.de		Warscheid, Bettina/0000-0001-5096-1975; Saffrich, Rainer/0000-0002-0547-4550	European Union [LSGH-CT-2004-512018]; Deutsche Forschungsgemeinschaft [SFB 642]	European Union(European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the FP6 European Union Project "Peroxisomes in health and disease'' (LSGH-CT-2004-512018) as well as by funds from the Deutsche Forschungsgemeinschaft (SFB 642). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMSON P, 1992, J CELL BIOL, V119, P617, DOI 10.1083/jcb.119.3.617; Armstrong J, 1996, J CELL SCI, V109, P1265; Boukharov AA, 1998, BIOCHEM J, V330, P1391, DOI 10.1042/bj3301391; Buss F, 2002, TRAFFIC, V3, P851, DOI 10.1034/j.1600-0854.2002.31201.x; Chakraborty AK, 2003, CELL TISSUE RES, V314, P381, DOI 10.1007/s00441-003-0773-6; Chen JL, 2005, J CELL BIOL, V169, P383, DOI 10.1083/jcb.200501157; Chen S, 2001, J BIOL CHEM, V276, P13209, DOI 10.1074/jbc.M010798200; Chevrier V, 2002, J CELL BIOL, V157, P807, DOI 10.1083/jcb.200203034; Coudrier E, 2007, PIGM CELL RES, V20, P153, DOI 10.1111/j.1600-0749.2007.00376.x; De Vos KJ, 2005, CURR BIOL, V15, P678, DOI 10.1016/j.cub.2005.02.064; Even-Ram S, 2007, NAT CELL BIOL, V9, P299, DOI 10.1038/ncb1540; Fagarasanu A, 2007, ANNU REV CELL DEV BI, V23, P321, DOI 10.1146/annurev.cellbio.23.090506.123456; Fransen M, 2008, BBA-MOL CELL RES, V1783, P864, DOI 10.1016/j.bbamcr.2008.02.013; FRITZ G, 1994, BIOCHEM J, V300, P133, DOI 10.1042/bj3000133; Fukata Y, 2001, TRENDS PHARMACOL SCI, V22, P32, DOI 10.1016/S0165-6147(00)01596-0; GARRETT MD, 1989, J BIOL CHEM, V264, P10; GORGAS K, 1989, J LIPID RES, V30, P1859; Grosshans BL, 2006, P NATL ACAD SCI USA, V103, P11821, DOI 10.1073/pnas.0601617103; Hales CM, 2002, J BIOL CHEM, V277, P50415, DOI 10.1074/jbc.M209270200; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Harada A, 1998, J CELL BIOL, V141, P51, DOI 10.1083/jcb.141.1.51; HARTL FU, 1985, ARCH BIOCHEM BIOPHYS, V237, P124, DOI 10.1016/0003-9861(85)90261-9; Hattula K, 2006, J CELL SCI, V119, P4866, DOI 10.1242/jcs.03275; Hering F, 1997, EXP FLUIDS, V23, P472, DOI 10.1007/s003480050137; Herr Stefan, 1993, Methods in Molecular and Cellular Biology, V4, P164; Hoepfner D, 2001, J CELL BIOL, V155, P979, DOI 10.1083/jcb.200107028; HUBER C, 1999, THESIS U HEIDELBERG; Huber CM, 2000, PROTOPLASMA, V213, P18, DOI 10.1007/BF01280501; Huber CM, 1997, J CELL SCI, V110, P2955; Huber CN, 1999, EMBO J, V18, P5476, DOI 10.1093/emboj/18.20.5476; Hume AN, 2001, J CELL BIOL, V152, P795, DOI 10.1083/jcb.152.4.795; Ikonen E, 1997, J CELL SCI, V110, P2155; Jeynov B, 2006, FEBS LETT, V580, P5917, DOI 10.1016/j.febslet.2006.09.058; Kawano Y, 1999, J CELL BIOL, V147, P1023, DOI 10.1083/jcb.147.5.1023; Knodler A, 2010, P NATL ACAD SCI USA, V107, P6346, DOI 10.1073/pnas.1002401107; Koch A, 2003, J BIOL CHEM, V278, P8597, DOI 10.1074/jbc.M211761200; KOSTER A, 1986, BIOCHEM BIOPH RES CO, V137, P626, DOI 10.1016/0006-291X(86)91124-1; Kranenburg O, 1999, MOL BIOL CELL, V10, P1851, DOI 10.1091/mbc.10.6.1851; Lay D, 2005, J BIOL CHEM, V280, P34489, DOI 10.1074/jbc.M503497200; Lay D, 2006, BBA-MOL CELL RES, V1763, P1678, DOI 10.1016/j.bbamcr.2006.08.036; Li XL, 2003, J BIOL CHEM, V278, P17012, DOI 10.1074/jbc.M212031200; Liu HB, 2004, ANAL CHEM, V76, P4193, DOI 10.1021/ac0498563; Ma C, 2009, IUBMB LIFE, V61, P713, DOI 10.1002/iub.196; Marelli M, 2004, J CELL BIOL, V167, P1099, DOI 10.1083/jcb.200404119; Mathur J, 2002, PLANT PHYSIOL, V128, P1031, DOI 10.1104/pp.011018; McNiven MA, 2000, TRENDS BIOCHEM SCI, V25, P115, DOI 10.1016/S0968-0004(99)01538-8; Meinecke M, 2010, NAT CELL BIOL, V12, P273, DOI 10.1038/ncb2027; Mejillano MR, 2004, CELL, V118, P363, DOI 10.1016/j.cell.2004.07.019; Moolenaar WH, 2004, BIOESSAYS, V26, P870, DOI 10.1002/bies.20081; Nie ZZ, 2006, J CELL SCI, V119, P1203, DOI 10.1242/jcs.02924; Noma K, 2006, AM J PHYSIOL-CELL PH, V290, pC661, DOI 10.1152/ajpcell.00459.2005; Orth JD, 2002, P NATL ACAD SCI USA, V99, P167, DOI 10.1073/pnas.012607899; Passreiter M, 1998, J CELL BIOL, V141, P373, DOI 10.1083/jcb.141.2.373; Pinner S, 2008, NAT CELL BIOL, V10, P127, DOI 10.1038/ncb1675; Qualmann B, 2003, BIOCHEM J, V371, P233, DOI 10.1042/bj20030139; Ramalho JS, 2009, PIGM CELL MELANOMA R, V22, P461, DOI 10.1111/j.1755-148X.2009.00567.x; Rapp S, 1996, J CELL SCI, V109, P837; Rasure J., 1990, International Journal of Imaging Systems and Technology, V2, P183, DOI 10.1002/ima.1850020304; Ridley AJ, 2006, TRENDS CELL BIOL, V16, P522, DOI 10.1016/j.tcb.2006.08.006; Rottensteiner H, 2003, MOL BIOL CELL, V14, P4316, DOI 10.1091/mbc.E03-03-0153; Rumenapp U, 1999, FEBS LETT, V459, P313, DOI 10.1016/S0014-5793(99)01270-3; Sahlender DA, 2005, J CELL BIOL, V169, P285, DOI 10.1083/jcb.200501162; Sato T, 2007, NATURE, V448, P366, DOI 10.1038/nature05929; Seabra MC, 2004, TRAFFIC, V5, P393, DOI 10.1111/j.1398-9219.2004.00190.x; Soldati T, 2006, NAT REV MOL CELL BIO, V7, P897, DOI 10.1038/nrm2060; Sorkin A, 2004, CURR OPIN CELL BIOL, V16, P392, DOI 10.1016/j.ceb.2004.06.001; Southwick FS, 2003, CELL MOTIL CYTOSKEL, V54, P41, DOI 10.1002/cm.10083; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; Tam YYC, 2003, MOL BIOL CELL, V14, P4089, DOI 10.1091/mbc.E03-03-0150; Tanaka Y, 1998, CELL, V93, P1147, DOI 10.1016/S0092-8674(00)81459-2; Thoms S, 2005, FEBS J, V272, P5169, DOI 10.1111/j.1742-4658.2005.04939.x; Tvarusko W, 1999, P NATL ACAD SCI USA, V96, P7950, DOI 10.1073/pnas.96.14.7950; Wiemer EAC, 1997, J CELL BIOL, V136, P71, DOI 10.1083/jcb.136.1.71; Wiese S, 2007, MOL CELL PROTEOMICS, V6, P2045, DOI 10.1074/mcp.M700169-MCP200; Woodcroft BJ, 2009, CYTOM PART A, V75A, P941, DOI 10.1002/cyto.a.20786; Wu XF, 1998, J CELL BIOL, V143, P1899, DOI 10.1083/jcb.143.7.1899; Wu XF, 2001, J CELL SCI, V114, P1091; Yan MD, 2005, CURR OPIN CELL BIOL, V17, P376, DOI 10.1016/j.ceb.2005.06.003; Yumura S, 2001, J CELL BIOL, V154, P137, DOI 10.1083/jcb.200011013	80	24	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2010	5	11							e13886	10.1371/journal.pone.0013886	http://dx.doi.org/10.1371/journal.pone.0013886			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	676NU	21079737	Green Published, gold, Green Submitted			2022-12-27	WOS:000283920000017
J	Viviani, R; Lo, HN; Sim, EJ; Beschoner, P; Stingl, JC; Horn, AB				Viviani, Roberto; Lo, Hanna; Sim, Eun-Jin; Beschoner, Petra; Stingl, Julia C.; Horn, Andrea B.			The Neural Substrate of Positive Bias in Spontaneous Emotional Processing	PLOS ONE			English	Article							CONSCIOUS RESTING STATE; WORKING-MEMORY CAPACITY; MENTAL CONTROL; INDIVIDUAL-DIFFERENCES; PREFRONTAL CORTEX; IRONIC PROCESSES; HUMAN BRAIN; BLOOD-FLOW; DEPRESSION; SUPPRESSION	Even in the presence of negative information, healthy human beings display an optimistic tendency when thinking of past success and future chances, giving a positive bias to everyday's cognition. The tendency to actively select positive thoughts suggests the existence of a mechanism to exclude negative content, raising the issue of its dependence on mechanisms like those of effortful control. Using perfusion imaging, we examined how brain activations differed according to whether participants were left to prefer positive thoughts spontaneously, or followed an explicit instruction to the same effect, finding a widespread dissociation of brain perfusion patterns. Under spontaneous processing of emotional material, recruitment of areas associated with effortful attention, such as the dorsolateral prefrontal cortex, was reduced relative to instructed avoidance of negative material (F-1,F-58 = 26.24, p = 0.047, corrected). Under spontaneous avoidance perfusion increments were observed in several areas that were deactivated by the task, including the perigenual medial prefrontal cortex. Furthermore, individual differences in executive capacity were not associated with positive bias. These findings suggest that spontaneous positive cognitive emotion regulation in health may result from processes that, while actively suppressing emotionally salient information, differ from those associated with effortful and directed control.	[Viviani, Roberto] Univ Cambridge, Dept Psychiat, Human Brain Mapping Unit, Cambridge, England; [Viviani, Roberto; Lo, Hanna; Sim, Eun-Jin; Beschoner, Petra] Univ Ulm, Dept Psychiat & Psychotherapy 3, Ulm, Germany; [Beschoner, Petra] Univ Ulm, Psychotherapy & Psychosomat Clin, Ulm, Germany; [Stingl, Julia C.] Univ Ulm, Dept Clin Pharmacol, Ulm, Germany; [Horn, Andrea B.] Univ Zurich, Dept Psychol, Div Psychopathol & Clin Intervent, Zurich, Switzerland	University of Cambridge; Ulm University; Ulm University; Ulm University; University of Zurich	Viviani, R (corresponding author), Univ Cambridge, Dept Psychiat, Human Brain Mapping Unit, Cambridge, England.	rv103@hermes.cam.ac.uk	Stingl, Julia/H-2410-2013; Viviani, Roberto/A-8787-2015; Stingl, Julia C./ABA-7201-2020	Stingl, Julia/0000-0002-1566-8156; Stingl, Julia C./0000-0002-1566-8156; Horn, Andrea B./0000-0003-2729-7062; Viviani, Roberto/0000-0002-7517-6006				Aguirre GK, 2002, NEUROIMAGE, V15, P488, DOI 10.1006/nimg.2001.0990; ANDREASEN NC, 1995, AM J PSYCHIAT, V152, P1576; [Anonymous], 1993, HDB MENTAL CONTROL; Baddeley A., WORKING MEMORY THOUG, DOI [10.1093/acprof:oso/9780198528012.001.0001, DOI 10.1093/ACPROF:OSO/9780198528012.001.0001]; Badre D, 2009, NAT REV NEUROSCI, V10, P659, DOI 10.1038/nrn2667; Bar M, 2007, TRENDS COGN SCI, V11, P280, DOI 10.1016/j.tics.2007.05.005; Bargh JA, 2000, PSYCHOL BULL, V126, P925, DOI 10.1037//0033-2909.126.6.925; Bargh John A., 2007, HDB EMOTION REGULATI, P429, DOI DOI 10.1037/A0017745; Barrett LF, 2004, PSYCHOL BULL, V130, P553, DOI 10.1037/0033-2909.130.4.553; Beck A., 1976, COGNITIVE THEORY EMO; Binder JR, 2009, CEREB CORTEX, V19, P2767, DOI 10.1093/cercor/bhp055; Binder JR, 1999, J COGNITIVE NEUROSCI, V11, P80, DOI 10.1162/089892999563265; BRADLEY MM, 1994, J BEHAV THER EXP PSY, V25, P49, DOI 10.1016/0005-7916(94)90063-9; Braver TS, 1997, NEUROIMAGE, V5, P49, DOI 10.1006/nimg.1996.0247; Brewin CR, 2002, BEHAV RES THER, V40, P923, DOI 10.1016/S0005-7967(01)00127-9; Buckner RL, 2007, TRENDS COGN SCI, V11, P49, DOI 10.1016/j.tics.2006.11.004; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Corbetta M, 2008, NEURON, V58, P306, DOI 10.1016/j.neuron.2008.04.017; Damasio A.R., 2005, DESCARTES ERROR EMOT; de Fockert JW, 2001, SCIENCE, V291, P1803, DOI 10.1126/science.1056496; De Martino B, 2006, SCIENCE, V313, P684, DOI 10.1126/science.1128356; De Neys W, 2006, Q J EXP PSYCHOL, V59, P1070, DOI 10.1080/02724980543000123; DeRubeis RJ, 2008, NAT REV NEUROSCI, V9, P788, DOI 10.1038/nrn2345; Detre JA, 2000, MED RAD DIA IMG, P47; Drevets WC, 2000, BIOL PSYCHIAT, V48, P813, DOI 10.1016/S0006-3223(00)01020-9; Drevets WC, 1998, COGNITION EMOTION, V12, P353, DOI 10.1080/026999398379646; Egner T, 2008, CEREB CORTEX, V18, P1475, DOI 10.1093/cercor/bhm179; FRISTON KJ, 1991, P ROY SOC B-BIOL SCI, V244, P101, DOI 10.1098/rspb.1991.0057; GRASBY PM, 1994, BRAIN, V117, P1271, DOI 10.1093/brain/117.6.1271; Hautzinger M., 1993, ALLGEMEINE DEPRESSIO; Holmes AP, 1996, J CEREBR BLOOD F MET, V16, P7, DOI 10.1097/00004647-199601000-00002; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Kahneman D., 2011, THINKING FAST SLOW; Kalisch R, 2006, NEUROIMAGE, V30, P1458, DOI 10.1016/j.neuroimage.2005.11.011; Kincade JM, 2005, J NEUROSCI, V25, P4593, DOI 10.1523/JNEUROSCI.0236-05.2005; Mauss IB, 2007, SOC PERSONAL PSYCHOL, V1, P146, DOI 10.1111/j.1751-9004.2007.00005.x; Mayberg HS, 1999, AM J PSYCHIAT, V156, P675; Mazoyer B, 2001, BRAIN RES BULL, V54, P287, DOI 10.1016/S0361-9230(00)00437-8; Ochsner KN, 2005, TRENDS COGN SCI, V9, P242, DOI 10.1016/j.tics.2005.03.010; Ohman A, 2001, J EXP PSYCHOL GEN, V130, P466, DOI 10.1037/0096-3445.130.3.466; Paus T, 1996, NEUROPSYCHOLOGIA, V34, P475, DOI 10.1016/0028-3932(95)00134-4; Phan KL, 2005, BIOL PSYCHIAT, V57, P210, DOI 10.1016/j.biopsych.2004.10.030; Phelps EA, 2004, NEURON, V43, P897, DOI 10.1016/j.neuron.2004.08.042; Phillips M, 2008, MOL PSYCHIATR, V13, P833, DOI 10.1038/mp.2008.65; Phillips ML, 2003, BIOL PSYCHIAT, V54, P504, DOI 10.1016/S0006-3223(03)00168-9; Phillips ML, 2003, BIOL PSYCHIAT, V54, P515, DOI 10.1016/S0006-3223(03)00171-9; Pinheiro J, 2001, MIXED EFFECTS MODELS; Poldrack RA, 1999, NEUROIMAGE, V10, P15, DOI 10.1006/nimg.1999.0441; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Rorden C, 2007, J COGNITIVE NEUROSCI, V19, P1081, DOI 10.1162/jocn.2007.19.7.1081; Rude SS, 2003, COGNITIVE THER RES, V27, P415, DOI 10.1023/A:1025472413805; Rude SS, 2002, COGNITION EMOTION, V16, P423, DOI 10.1080/02699930143000554; Rypma B, 1999, P NATL ACAD SCI USA, V96, P6558, DOI 10.1073/pnas.96.11.6558; Serences JT, 2005, PSYCHOL SCI, V16, P114, DOI 10.1111/j.0956-7976.2005.00791.x; Sharot T, 2007, NATURE, V450, P102, DOI 10.1038/nature06280; Shulman GL, 1997, J COGNITIVE NEUROSCI, V9, P648, DOI 10.1162/jocn.1997.9.5.648; Simpson JR, 2001, P NATL ACAD SCI USA, V98, P688, DOI 10.1073/pnas.98.2.688; Sloman SA, 1996, PSYCHOL BULL, V119, P3, DOI 10.1037/0033-2909.119.1.3; Slovic P, 2002, HEURISTICS BIASES PS, P397, DOI [DOI 10.1017/CBO9780511808098.025, 10.1017/CBO9780511808098.025]; Stanovich KE, 1998, J EXP PSYCHOL GEN, V127, P161, DOI 10.1037/0096-3445.127.2.161; TAYLOR SE, 1988, PSYCHOL BULL, V103, P193, DOI 10.1037/0033-2909.103.2.193; Thayer JF, 2000, J AFFECT DISORDERS, V61, P201, DOI 10.1016/S0165-0327(00)00338-4; TURNER ML, 1989, J MEM LANG, V28, P127, DOI 10.1016/0749-596X(89)90040-5; TVERSKY A, 1983, PSYCHOL REV, V90, P293, DOI 10.1037/0033-295X.90.4.293; Unsworth N., 2005, COGNITIVE LIMITATION, P19, DOI [10.1017/CBO9780511720413.003, DOI 10.1017/CBO9780511720413.003]; Van Essen DC, 2005, NEUROIMAGE, V28, P635, DOI 10.1016/j.neuroimage.2005.06.058; Vigneau M, 2006, NEUROIMAGE, V30, P1414, DOI 10.1016/j.neuroimage.2005.11.002; Viviani R, 2009, NEUROIMAGE, V46, P12, DOI 10.1016/j.neuroimage.2009.01.041; Vuilleumier P, 2005, TRENDS COGN SCI, V9, P585, DOI 10.1016/j.tics.2005.10.011; Vuilleumier P, 2001, NEURON, V30, P829, DOI 10.1016/S0896-6273(01)00328-2; Wager TD, 2008, NEURON, V59, P1037, DOI 10.1016/j.neuron.2008.09.006; Wang JJ, 2005, RADIOLOGY, V235, P218, DOI 10.1148/radiol.2351031663; WEGNER DM, 1993, J PERS SOC PSYCHOL, V65, P1093, DOI 10.1037/0022-3514.65.6.1093; WEGNER DM, 1994, PSYCHOL REV, V101, P34, DOI 10.1037/0033-295X.101.1.34; WENZLAFF RM, 1988, J PERS SOC PSYCHOL, V55, P882, DOI 10.1037/0022-3514.55.6.882; Wenzlaff RM, 1998, J PERS SOC PSYCHOL, V75, P1559, DOI 10.1037/0022-3514.75.6.1559; Zeintl M, 2007, PSYCHOL AGING, V22, P826, DOI 10.1037/0882-7974.22.4.826	78	23	23	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2010	5	11							e15454	10.1371/journal.pone.0015454	http://dx.doi.org/10.1371/journal.pone.0015454			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	676NU	21079747	Green Submitted, Green Published, gold			2022-12-27	WOS:000283920000026
J	Glatman-Freedman, A; Cohen, ML; Nichols, KA; Porges, RF; Saludes, IR; Steffens, K; Rodwin, VG; Britt, DW				Glatman-Freedman, Aharona; Cohen, Mary-Louise; Nichols, Katherine A.; Porges, Robert F.; Saludes, Ivy Rayos; Steffens, Kevin; Rodwin, Victor G.; Britt, David W.			Factors Affecting the Introduction of New Vaccines to Poor Nations: A Comparative Study of the Haemophilus influenzae Type B and Hepatitis B Vaccines	PLOS ONE			English	Article							MORTALITY; DISEASE; TRENDS	Background: A major effort to introduce new vaccines into poor nations of the world was initiated in recent years with the help of the GAVI alliance. The first vaccines introduced have been the Haemophilus influenzae type B (Hib) and the hepatitis B (Hep B) vaccines. The introduction of these vaccines during the first phase of GAVI's operations demonstrated considerable variability. We set out to study the factors affecting the introduction of these vaccines. The African Region (AFRO), where new vaccines were introduced to a substantial number of countries during the first phase of GAVI's funding, was selected for this study. Methodology/Principal Findings: GAVI-eligible AFRO countries with a population of 0.5 million or more were included in the study. Countries were analyzed and compared for new vaccine introduction, healthcare indicators, financial indicators related to healthcare and country-level Governance Indicators, using One Way ANOVA, correlation analysis and Qualitative Comparative Analysis (QCA). Introduction of new vaccines into AFRO nations was associated primarily with high country-level Governance Indicator scores. The use of individual Governance Indicator scores, as well as a combined Governance Indicator score we developed, demonstrated similar results. Conclusions/Significance: Our study results indicate that good country-level governance is an imperative pre-requisite for the successful early introduction of new vaccines into poor African nations. Enhanced support measures may be required to effectively introduce new vaccines to countries with low governance scores. The combined governance score we developed may thus constitute a useful tool for helping philanthropic organizations make decisions regarding the type of support needed by different countries to achieve success.	[Glatman-Freedman, Aharona; Cohen, Mary-Louise; Nichols, Katherine A.; Porges, Robert F.; Saludes, Ivy Rayos; Steffens, Kevin] NYU, Global Publ Hlth Masters Program, New York, NY 10003 USA; [Glatman-Freedman, Aharona] New York Med Coll, Dept Family & Community Med, Valhalla, NY 10595 USA; [Glatman-Freedman, Aharona] Albert Einstein Coll Med, Dept Pediat, Bronx, NY 10467 USA; [Porges, Robert F.] NYU, Dept Obstet & Gynecol, New York, NY 10016 USA; [Rodwin, Victor G.] NYU, Robert F Wagner Grad Sch Publ Serv, New York, NY 10003 USA; [Britt, David W.] Univ Louisville, Dept Hlth & Sports Sci, Louisville, KY 40292 USA	New York University; New York Medical College; Yeshiva University; Albert Einstein College of Medicine; New York University; New York University; University of Louisville	Glatman-Freedman, A (corresponding author), NYU, Global Publ Hlth Masters Program, New York, NY 10003 USA.	af1200@nyu.edu						Akumu AO, 2007, B WORLD HEALTH ORGAN, V85, P511, DOI 10.2471/BLT.06.034686; Aylward RB, 2010, NEW GENERATION VACCI, P91; Berthelemy JC, 2006, REV DEV ECON, V10, P179, DOI 10.1111/j.1467-9361.2006.00311.x; Duclos P, 2009, BMC INT HEALTH HUM R, V9, DOI 10.1186/1472-698X-9-S1-S2; Jacobs L, 2010, NEW GENERATION VACCI, P101; Levine Ruth, 2004, MILLIONS SAVED PROVE; Mahoney RT, 2000, VACCINE, V18, P2625, DOI 10.1016/S0264-410X(00)00073-6; Mathers CD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P45; Murray CJL, 2007, LANCET, V370, P1040, DOI 10.1016/S0140-6736(07)61478-0; Outreville JF, 2007, EUR J HEALTH ECON, V8, P305, DOI 10.1007/s10198-006-0010-9; Ragin C.C., 1987, COMPUT METHOD BIOMEC; Ravishankar N, 2009, LANCET, V373, P2113, DOI 10.1016/S0140-6736(09)60881-3; Rossi IA, 2007, VACCINE, V25, P7075, DOI 10.1016/j.vaccine.2007.07.058; Roush SW, 2007, JAMA-J AM MED ASSOC, V298, P2155, DOI 10.1001/jama.298.18.2155; Watt JP, 2009, LANCET, V374, P903, DOI 10.1016/S0140-6736(09)61203-4; Watt JP, 2003, J PEDIATR-US, V143, pS163, DOI 10.1067/S0022-3476(03)00576-6; Zanetti AR, 2008, VACCINE, V26, P6266, DOI 10.1016/j.vaccine.2008.09.056; 2006, MMWR, V55, P511	18	21	21	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2010	5	11							e13802	10.1371/journal.pone.0013802	http://dx.doi.org/10.1371/journal.pone.0013802			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	674VY	21072192	gold, Green Published, Green Submitted			2022-12-27	WOS:000283779700014
J	Pino-Yanes, M; Corrales, A; Casula, M; Blanco, J; Muriel, A; Espinosa, E; Garcia-Bello, M; Torres, A; Ferrer, M; Zavala, E; Villar, J; Flores, C				Pino-Yanes, Maria; Corrales, Almudena; Casula, Milena; Blanco, Jesus; Muriel, Arturo; Espinosa, Elena; Garcia-Bello, Miguel; Torres, Antoni; Ferrer, Miguel; Zavala, Elizabeth; Villar, Jesus; Flores, Carlos		GRECIA Grp; GEN SEP Grp	Common Variants of TLR1 Associate with Organ Dysfunction and Sustained Pro-Inflammatory Responses during Sepsis	PLOS ONE			English	Article							INTENSIVE-CARE UNITS; INNATE IMMUNITY; POLYMORPHISM; RECEPTOR; HAPLOTYPE; OUTCOMES; DEFINITIONS; LEPROSY; GENE; SET	Background: Toll-like receptors (TLRs) are critical components for host pathogen recognition and variants in genes participating in this response influence susceptibility to infections. Recently, TLR1 gene polymorphisms have been found correlated with whole blood hyper-inflammatory responses to pathogen-associated molecules and associated with sepsis-associated multiorgan dysfunction and acute lung injury (ALI). We examined the association of common variants of TLR1 gene with sepsis-derived complications in an independent study and with serum levels for four inflammatory biomarkers among septic patients. Methodology/Principal Findings: Seven tagging single nucleotide polymorphisms of the TLR1 gene were genotyped in samples from a prospective multicenter case-only study of patients with severe sepsis admitted into a network of intensive care units followed for disease severity. Interleukin (IL)-1 beta, IL-6, IL-10, and C-reactive protein (CRP) serum levels were measured at study entry, at 48 h and at 7(th) day. Alleles-7202G and 248Ser, and the 248Ser-602Ile haplotype were associated with circulatory dysfunction among severe septic patients (0.001 <= p <= 0.022), and with reduced IL-10 (0.012 <= p <= 0.047) and elevated CRP (0.011 <= p <= 0.036) serum levels during the first week of sepsis development. Additionally, the -7202GG genotype was found to be associated with hospital mortality (p = 0.017) and ALI (p = 0.050) in a combined analysis with European Americans, suggesting common risk effects among studies. Conclusions/Significance: These results partially replicate and extend previous findings, supporting that variants of TLR1 gene are determinants of severe complications during sepsis.	[Pino-Yanes, Maria; Corrales, Almudena; Casula, Milena; Blanco, Jesus; Muriel, Arturo; Torres, Antoni; Ferrer, Miguel; Zavala, Elizabeth; Villar, Jesus; Flores, Carlos] Inst Salud Carlos III, CIBER Enfermedades Resp, Madrid, Spain; [Pino-Yanes, Maria; Corrales, Almudena; Flores, Carlos] Hosp Univ NS de Candelaria, Res Unit, Tenerife, Spain; [Casula, Milena; Garcia-Bello, Miguel; Villar, Jesus] Hosp Univ Dr Negrin, Multidisciplinary Organ Dysfunct Evaluat Res Netw, Res Unit, Las Palmas Gran Canaria, Spain; [Espinosa, Elena] Hosp Univ NS de Candelaria, Dept Anaesthesia, Tenerife, Spain; [Torres, Antoni; Ferrer, Miguel] Hosp Clin Barcelona, Dept Pneumol, Clin Inst Thorax, Barcelona, Spain; [Torres, Antoni; Ferrer, Miguel] Univ Barcelona, IDIBAPS, Barcelona, Spain; [Zavala, Elizabeth] Hosp Clin Barcelona, Dept Anesthesia, Surg Intens Care Unit, Barcelona, Spain; [Villar, Jesus] St Michaels Hosp, Keenan Res Ctr, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1W8, Canada	CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Instituto de Salud Carlos III; University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Hospital Clinic de Barcelona; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto	Pino-Yanes, M (corresponding author), Inst Salud Carlos III, CIBER Enfermedades Resp, Madrid, Spain.	jesus.villar54@gmail.com; cflores@ull.es	Flores, Carlos/R-1159-2019; Casula, Milena/AAA-7461-2019; Villar, Jesús/R-4526-2019; Pino-Yanes, Maria/C-8498-2017; Torres, Antoni/H-6128-2017; Corrales, Almudena/G-5391-2017; Garcia-Bello, Miguel-Angel/F-7436-2016	Villar, Jesús/0000-0001-5687-3562; Pino-Yanes, Maria/0000-0003-0332-437X; Torres, Antoni/0000-0002-8643-2167; Corrales, Almudena/0000-0002-2207-5463; Flores, Carlos/0000-0001-5352-069X; Ferrer, Miguel/0000-0001-8171-6673; CASULA, Milena/0000-0002-5079-9864; Garcia-Bello, Miguel-Angel/0000-0001-6913-2552	Ministry of Science of Spain [SAF 2004-06833]; Fundacion Canaria de Investigacion y Salud [53/04]; Instituto de Salud Carlos III and Gobierno de Canarias [EMER07/001]	Ministry of Science of Spain(Spanish Government); Fundacion Canaria de Investigacion y Salud; Instituto de Salud Carlos III and Gobierno de Canarias	This work was supported by grants from Ministry of Science of Spain (SAF 2004-06833), Fundacion Canaria de Investigacion y Salud (53/04), and by a specific agreement between Instituto de Salud Carlos III and Gobierno de Canarias (EMER07/001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadi KR, 2005, NAT GENET, V37, P84, DOI 10.1038/ng1488; Alves JC, 2009, P NATL ACAD SCI USA, V106, P4018, DOI 10.1073/pnas.0900196106; Arbour NC, 2000, NAT GENET, V25, P187, DOI 10.1038/76048; Arcaroli J, 2006, AM J RESP CRIT CARE, V173, P1335, DOI 10.1164/rccm.200603-341OC; Aziz RK, 2007, GENES IMMUN, V8, P404, DOI 10.1038/sj.gene.6364402; Barreiro LB, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000562; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Baudouin SV, 2005, LANCET, V366, P2118, DOI 10.1016/S0140-6736(05)67890-7; BERNARD GR, 1994, AM J RESP CRIT CARE, V149, P818, DOI 10.1164/ajrccm.149.3.7509706; Blanco J, 2008, CRIT CARE, V12, DOI 10.1186/cc7157; Clark MF, 2006, INTENS CARE MED, V32, P1706, DOI 10.1007/s00134-006-0327-y; de Craen AJM, 2005, GENES IMMUN, V6, P167, DOI 10.1038/sj.gene.6364162; de Leon AC, 2008, REV ESP SALUD PUBLIC, V82, P519, DOI 10.1590/S1135-57272008000500007; Flores C, 2009, CRIT CARE MED, V37, P2759, DOI 10.1097/CCM.0b013e3181a57b90; Flores C, 2008, CRIT CARE, V12, DOI 10.1186/cc7098; Georgel P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007803; Gonzalez JR, 2007, BIOINFORMATICS, V23, P644, DOI 10.1093/bioinformatics/btm025; Hamann L, 2010, INFECT GENET EVOL, V10, P785, DOI 10.1016/j.meegid.2010.05.005; Hawn TR, 2007, EUR J IMMUNOL, V37, P2280, DOI 10.1002/eji.200737034; Johnson CM, 2007, J IMMUNOL, V178, P7520, DOI 10.4049/jimmunol.178.12.7520; Khor CC, 2007, NAT GENET, V39, P523, DOI 10.1038/ng1976; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; Ma X, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001318; Matthay MA, 2005, AM J RESP CELL MOL, V33, P319, DOI 10.1165/rcmb.F305; Misch EA, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000231; Roger T, 2009, P NATL ACAD SCI USA, V106, P2348, DOI 10.1073/pnas.0808146106; Schuring RP, 2009, J INFECT DIS, V199, P1816, DOI 10.1086/599121; SHEY MS, GENES IMMUN IN PRESS; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Tregouet DA, 2004, ANN HUM GENET, V68, P165, DOI 10.1046/j.1529-8817.2003.00085.x; Trinchieri G, 2007, NAT REV IMMUNOL, V7, P179, DOI 10.1038/nri2038; Villar J, 2007, CRIT CARE MED, V35, P2292, DOI 10.1097/01.CCM.0000284511.73556.59; Villar J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006818; Vincent JL, 1998, CRIT CARE MED, V26, P1793, DOI 10.1097/00003246-199811000-00016; Vincent JL, 2006, CRIT CARE MED, V34, P344, DOI 10.1097/01.CCM.0000194725.48928.3A; Wang K, 2009, GENET EPIDEMIOL, V33, P637, DOI 10.1002/gepi.20415; Wigginton JE, 2005, AM J HUM GENET, V76, P887, DOI 10.1086/429864; Wurfel MM, 2008, AM J RESP CRIT CARE, V178, P710, DOI 10.1164/rccm.200803-462OC; Wurfel MM, 2005, J IMMUNOL, V175, P2570, DOI 10.4049/jimmunol.175.4.2570	39	36	38	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2010	5	10							e13759	10.1371/journal.pone.0013759	http://dx.doi.org/10.1371/journal.pone.0013759			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673FU	21048935	Green Published, Green Submitted, gold			2022-12-27	WOS:000283645300038
J	Yoshida, S; Nagumo, H; Yokomine, T; Araki, H; Suzuki, A; Matsuoka, H				Yoshida, Shigeto; Nagumo, Hiroshi; Yokomine, Takashi; Araki, Hitomi; Suzuki, Ayaka; Matsuoka, Hiroyuki			Plasmodium berghei Circumvents Immune Responses Induced by Merozoite Surface Protein 1-and Apical Membrane Antigen 1-Based Vaccines	PLOS ONE			English	Article							CARBOXYL-TERMINAL FRAGMENT; GROWTH-INHIBITORY ANTIBODIES; BLOOD-STAGE INFECTION; MALARIA VACCINE; ERYTHROCYTE INVASION; PARASITE GROWTH; CIRCUMSPOROZOITE PROTEIN; RODENT MALARIA; DOMAIN-III; IN-VITRO	Background: Two current leading malaria blood-stage vaccine candidate antigens for Plasmodium falciparum, the C-terminal region of merozoite surface protein 1 (MSP1(19)) and apical membrane antigen 1 (AMA1), have been prioritized because of outstanding protective efficacies achieved in a rodent malaria Plasmodium yoelii model. However, P. falciparum vaccines based on these antigens have had disappointing outcomes in clinical trials. Discrepancies in the vaccine efficacies observed between the P. yoelii model and human clinical trials still remain problematic. Methodology and Results: In this study, we assessed the protective efficacies of a series of MSP1(19)- and AMA1-based vaccines using the P. berghei rodent malarial parasite and its transgenic models. Immunization of mice with a baculoviral-based vaccine (BBV) expressing P. falciparum MSP1(19) induced high titers of PfMSP1(19)-specific antibodies that strongly reacted with P. falciparum blood-stage parasites. However, no protection was achieved following lethal challenge with transgenic P. berghei expressing PfMSP1(19) in place of native PbMSP1(19). Similarly, neither P. berghei MSP1(19)- nor AMA1-BBV was effective against P. berghei. In contrast, immunization with P. yoelii MSP1(19)- and AMA1-BBVs provided 100% and 40% protection, respectively, against P. yoelii lethal challenge. Mice that naturally acquired sterile immunity against P. berghei became cross-resistant to P. yoelii, but not vice versa. Conclusion: This is the first study to address blood-stage vaccine efficacies using both P. berghei and P. yoelii models at the same time. P. berghei completely circumvents immune responses induced by MSP1(19)- and AMA1-based vaccines, suggesting that P. berghei possesses additional molecules and/or mechanisms that circumvent the host's immune responses to MSP1(19) and AMA1, which are lacking in P. yoelii. Although it is not known whether P. falciparum shares these escape mechanisms with P. berghei, P. berghei and its transgenic models may have potential as useful tools for identifying and evaluating new blood-stage vaccine candidate antigens for P. falciparum.	[Yoshida, Shigeto; Nagumo, Hiroshi; Yokomine, Takashi; Araki, Hitomi; Suzuki, Ayaka; Matsuoka, Hiroyuki] Jichi Med Univ, Div Med Zool, Dept Infect & Immun, Shimotsuke, Tochigi, Japan	Jichi Medical University	Yoshida, S (corresponding author), Kanazawa Univ, Lab Vaccinol & Appl Immunol, Sch Med Sci, Kanazawa, Ishikawa, Japan.	shigeto@p.kanazawa-u.ac.jp		Matsuoka, Hiroyuki/0000-0001-8839-0012	Ministry of Education, Culture, Sports and Science of Japan [21390126]	Ministry of Education, Culture, Sports and Science of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants from the Ministry of Education, Culture, Sports and Science of Japan (21390126). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlborg N, 2002, INFECT IMMUN, V70, P820, DOI 10.1128/IAI.70.2.820-825.2002; Badell E, 2000, J EXP MED, V192, P1653, DOI 10.1084/jem.192.11.1653; BLACKMAN MJ, 1990, J EXP MED, V172, P379, DOI 10.1084/jem.172.1.379; BLACKMAN MJ, 1994, J EXP MED, V180, P389, DOI 10.1084/jem.180.1.389; BLAGBOROUGH AM, 2010, VACCINE IN PRESS; Cao Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006894; CHANG SP, 1992, J IMMUNOL, V149, P548; DALY TM, 1995, J IMMUNOL, V155, P236; DALY TM, 1993, INFECT IMMUN, V61, P2462, DOI 10.1128/IAI.61.6.2462-2467.1993; de Koning-Ward TF, 2003, J EXP MED, V198, P869, DOI 10.1084/jem.20030085; Egan AF, 1999, PARASITE IMMUNOL, V21, P133, DOI 10.1046/j.1365-3024.1999.00209.x; Fraser TS, 2001, MOL BIOCHEM PARASIT, V117, P49, DOI 10.1016/S0166-6851(01)00326-7; Hirunpetcharat C, 1999, J IMMUNOL, V162, P7309; Hodder AN, 1996, J BIOL CHEM, V271, P29446, DOI 10.1074/jbc.271.46.29446; Hodder AN, 2001, INFECT IMMUN, V69, P3286, DOI 10.1128/IAI.69.5.3286-3294.2001; HOLDER AA, 1994, BIOCHEM SOC T, V22, P291, DOI 10.1042/bst0220291; HOLDER AA, 1988, PROG ALLERGY, V41, P72; Holder Anthony A., 1996, P77; Jennings VM, 1998, INFECT IMMUN, V66, P5972, DOI 10.1128/IAI.66.12.5972-5979.1998; Kato K, 2005, P NATL ACAD SCI USA, V102, P5552, DOI 10.1073/pnas.0501594102; Kennedy MC, 2002, INFECT IMMUN, V70, P6948, DOI 10.1128/IAI.70.12.6948-6960.2002; Kocken CHM, 2002, INFECT IMMUN, V70, P4471, DOI 10.1128/IAI.70.8.4471-4476.2002; Lyon JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002830; Mambo G, 2008, INFECT IMMUN, V76, P2018, DOI 10.1128/IAI.01409-07; MCCOLM AA, 1983, ANN TROP MED PARASIT, V77, P355, DOI 10.1080/00034983.1983.11811724; McIntosh RS, 2007, PLOS PATHOG, V3, P647, DOI 10.1371/journal.ppat.0030072; MILLER LH, 1993, MOL BIOCHEM PARASIT, V59, P1, DOI 10.1016/0166-6851(93)90002-F; MLAMBO G, 2010, VACCINE IN PRESS; Morgan WD, 1999, J MOL BIOL, V289, P113, DOI 10.1006/jmbi.1999.2753; Mueller MS, 2003, INFECT IMMUN, V71, P4749, DOI 10.1128/IAI.71.8.4749-4758.2003; Murhandarwati EEH, 2010, INFECT IMMUN, V78, P680, DOI 10.1128/IAI.00939-09; Narum DL, 2000, INFECT IMMUN, V68, P2899, DOI 10.1128/IAI.68.5.2899-2906.2000; Near KA, 2002, INFECT IMMUN, V70, P692, DOI 10.1128/IAI.70.2.692-701.2002; Persson C, 2002, J IMMUNOL, V169, P6681, DOI 10.4049/jimmunol.169.12.6681; Pizarro JC, 2005, SCIENCE, V308, P408, DOI 10.1126/science.1107449; Ramjanee S, 2007, VACCINE, V25, P886, DOI 10.1016/j.vaccine.2006.09.035; Reed ZH, 2009, VACCINE, V27, P1651, DOI 10.1016/j.vaccine.2008.10.093; Rotman HL, 1998, J IMMUNOL, V161, P1908; Saul A, 2005, VACCINE, V23, P3076, DOI 10.1016/j.vaccine.2004.09.040; Schofield L, 2005, NAT REV IMMUNOL, V5, P722, DOI 10.1038/nri1686; Stowers AW, 2002, INFECT IMMUN, V70, P6961, DOI 10.1128/IAI.70.12.6961-6967.2002; Tanabe K, 2000, GENE, V241, P325, DOI 10.1016/S0378-1119(99)00472-2; Tian JH, 1996, J IMMUNOL, V157, P1176; Triglia T, 2000, MOL MICROBIOL, V38, P706, DOI 10.1046/j.1365-2958.2000.02175.x; Wykes MN, 2005, J IMMUNOL, V175, P2510, DOI 10.4049/jimmunol.175.4.2510; Yoneto T, 2001, J IMMUNOL, V166, P6236, DOI 10.4049/jimmunol.166.10.6236; Yoshida S, 2003, VIROLOGY, V316, P161, DOI 10.1016/j.virol.2003.08.003; Yoshida S, 2003, BLOOD, V101, P2300, DOI 10.1182/blood-2002-03-0831; Yoshida S, 2010, INFECT IMMUN, V78, P595, DOI 10.1128/IAI.00877-09	49	19	20	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2010	5	10							e13727	10.1371/journal.pone.0013727	http://dx.doi.org/10.1371/journal.pone.0013727			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	672HN	21060850	Green Published, Green Submitted, gold			2022-12-27	WOS:000283573800021
J	Monk, CE; Hutvagner, G; Arthur, JSC				Monk, Claire E.; Hutvagner, Gyoergy; Arthur, J. Simon C.			Regulation of miRNA Transcription in Macrophages in Response to Candida albicans	PLOS ONE			English	Article							KAPPA-B-KINASE; RECOGNITION; ACTIVATION; EXPRESSION; INHIBITOR; MSK1; AP-1; LIPOPOLYSACCHARIDE; MICRORNA-155; RECEPTORS	Macrophages detect pathogens via pattern recognition receptors (PRRs), which trigger several intracellular signaling cascades including the MAPK and NFkB pathways. These in turn mediate the up-regulation of pro-inflammatory cytokines that are essential to combat the pathogen. However as the over-production of pro-inflammatory cytokines results in tissue damage or septic shock, precise control of these signaling pathways is essential and achieved via the induction of multiple negative feedback mechanisms. miRNAs are small regulatory RNAs that are able to affect protein expression, via the regulation of either mRNA stability or translation. Up-regulation of specific miRNAs could have the potential to modulate PRR signaling, as has been shown for both miR-146 and miR-155. Here we have analysed which miRNAs are up-regulated in mouse macrophages in response to the fungal pathogen heat killed Candida albicans and compared the profile to that obtained with the TLR4 ligand LPS. We found that in addition to miR-146 and miR-155, both Candida albicans and LPS were also able to up-regulate miR-455 and miR-125a. Analysis of the signaling pathways required showed that NFkB was necessary for the transcription of all 4 pri-miRNAs, while the ERK1/2 and p38 MAPK pathways were also required for pri-miR-125a transcription. In addition the anti-inflammatory cytokine IL-10 was found to be able to induce miR-146a and b, but inhibited miR-155 induction. These results suggest that miR-455, miR-125, miR-146 and miR-155 may play important roles in regulating macrophage function following PRR stimulation.	[Monk, Claire E.; Arthur, J. Simon C.] Univ Dundee, Coll Life Sci, MRC Prot Phosphorylat Unit, Dundee, Scotland; [Hutvagner, Gyoergy] Univ Dundee, Coll Life Sci, Wellcome Trust Ctr Gene Regulat & Express, Dundee, Scotland	University of Dundee; University of Dundee	Monk, CE (corresponding author), Univ Dundee, Coll Life Sci, MRC Prot Phosphorylat Unit, Sir James Black Complex, Dundee, Scotland.	j.s.c.arthur@dundee.ac.uk	Arthur, J. Simon/B-8058-2010	Arthur, J. Simon/0000-0002-8135-1958; Hutvagner, Gyorgy/0000-0002-7231-9446	United Kingdom Medical Research Council; Wellcome Trust; EU; AstraZeneca; Boehringer Ingelheim; GlaxoSmithKline; Merck-Serono; Pfizer; MRC [MC_U127081014] Funding Source: UKRI; Medical Research Council [MC_U127081014] Funding Source: researchfish	United Kingdom Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); EU(European Commission); AstraZeneca(AstraZeneca); Boehringer Ingelheim(Boehringer Ingelheim); GlaxoSmithKline(GlaxoSmithKline); Merck-Serono(Merck & Company); Pfizer(Pfizer); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The work was supported by the United Kingdom Medical Research Council, Wellcome Trust, EU FP6 (SIROCCO), AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Merck-Serono, and Pfizer. GH holds a Wellcome Trust Career Development Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Ananieva O, 2008, NAT IMMUNOL, V9, P1028, DOI 10.1038/ni.1644; Androulidaki A, 2009, IMMUNITY, V31, P220, DOI 10.1016/j.immuni.2009.06.024; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Beinke S, 2004, MOL CELL BIOL, V24, P9658, DOI 10.1128/MCB.24.21.9658-9667.2004; Burke JR, 2003, J BIOL CHEM, V278, P1450, DOI 10.1074/jbc.M209677200; Cameron JE, 2008, J VIROL, V82, P1946, DOI 10.1128/JVI.02136-07; Costinean S, 2009, BLOOD, V114, P1374, DOI 10.1182/blood-2009-05-220814; Darragh J, 2010, BIOCHEM J, V425, P595, DOI 10.1042/BJ20091062; Denli AM, 2004, NATURE, V432, P231, DOI 10.1038/nature03049; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Hess J, 2004, J CELL SCI, V117, P5965, DOI 10.1242/jcs.01589; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Lam LT, 2005, CLIN CANCER RES, V11, P28; Martin M, 2005, NAT IMMUNOL, V6, P777, DOI 10.1038/ni1221; Martinez-Nunez RT, 2009, J BIOL CHEM, V284, P16334, DOI 10.1074/jbc.M109.011601; McCoy CE, 2010, J BIOL CHEM, V285, P20492, DOI 10.1074/jbc.M110.102111; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Motsch N, 2007, RNA BIOL, V4, P131, DOI 10.4161/rna.4.3.5206; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; O'Connell RM, 2009, P NATL ACAD SCI USA, V106, P7113, DOI 10.1073/pnas.0902636106; Reid DM, 2009, CURR OPIN IMMUNOL, V21, P30, DOI 10.1016/j.coi.2009.01.003; Remenyi J, 2010, BIOCHEM J, V428, P281, DOI 10.1042/BJ20100024; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tang B, 2010, FEBS LETT, V584, P1481, DOI 10.1016/j.febslet.2010.02.063; Tang YJ, 2009, ARTHRITIS RHEUM-US, V60, P1065, DOI 10.1002/art.24436; Taylor PR, 2007, NAT IMMUNOL, V8, P31, DOI 10.1038/ni1408; Tili E, 2007, J IMMUNOL, V179, P5082, DOI 10.4049/jimmunol.179.8.5082; Underhill DM, 2007, IMMUNOL REV, V219, P75, DOI 10.1111/j.1600-065X.2007.00548.x; Waterfield M, 2004, MOL CELL BIOL, V24, P6040, DOI 10.1128/MCB.24.13.6040-6048.2004; Yin QY, 2008, J BIOL CHEM, V283, P2654, DOI 10.1074/jbc.M708218200; Zhou R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000681; Ziegelbauer K, 2005, BRIT J PHARMACOL, V145, P178, DOI 10.1038/sj.bjp.0706176	35	98	103	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2010	5	10							e13669	10.1371/journal.pone.0013669	http://dx.doi.org/10.1371/journal.pone.0013669			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671UN	21060679	Green Published, gold			2022-12-27	WOS:000283537000037
J	Pungaliya, PP; Bai, YC; Lipinski, K; Anand, VS; Sen, S; Brown, EL; Bates, B; Reinhart, PH; West, AB; Hirst, WD; Braithwaite, SP				Pungaliya, Pooja P.; Bai, Yuchen; Lipinski, Kerri; Anand, Vasanti S.; Sen, Saurabh; Brown, Eugene L.; Bates, Brian; Reinhart, Peter H.; West, Andrew B.; Hirst, Warren D.; Braithwaite, Steven P.			Identification and Characterization of a Leucine-Rich Repeat Kinase 2 (LRRK2) Consensus Phosphorylation Motif	PLOS ONE			English	Article							DISEASE-ASSOCIATED MUTATIONS; FAMILIAL PARKINSONS-DISEASE; RAS P21 PROTEIN; ALPHA-SYNUCLEIN; LEUCINE-RICH-REPEAT-KINASE-2 LRRK2; NEURONAL TOXICITY; UBIQUITIN LIGASE; CELLULAR-MODEL; GTP-BINDING; GENE	Mutations in LRRK2 (leucine-rich repeat kinase 2) have been identified as major genetic determinants of Parkinson's disease (PD). The most prevalent mutation, G2019S, increases LRRK2's kinase activity, therefore understanding the sites and substrates that LRRK2 phosphorylates is critical to understanding its role in disease aetiology. Since the physiological substrates of this kinase are unknown, we set out to reveal potential targets of LRRK2 G2019S by identifying its favored phosphorylation motif. A non-biased screen of an oriented peptide library elucidated F/Y-x-T-x-R/K as the core dependent substrate sequence. Bioinformatic analysis of the consensus phosphorylation motif identified several novel candidate substrates that potentially function in neuronal pathophysiology. Peptides corresponding to the most PD relevant proteins were efficiently phosphorylated by LRRK2 in vitro. Interestingly, the phosphomotif was also identified within LRRK2 itself. Autophosphorylation was detected by mass spectrometry and biochemical means at the only F-x-T-x-R site (Thr 1410) within LRRK2. The relevance of this site was assessed by measuring effects of mutations on autophosphorylation, kinase activity, GTP binding, GTP hydrolysis, and LRRK2 multimerization. These studies indicate that modification of Thr1410 subtly regulates GTP hydrolysis by LRRK2, but with minimal effects on other parameters measured. Together the identification of LRRK2's phosphorylation consensus motif, and the functional consequences of its phosphorylation, provide insights into downstream LRRK2-signaling pathways.	[Pungaliya, Pooja P.; Bai, Yuchen; Brown, Eugene L.; Bates, Brian] Pfizer Inc, Global Biotherapeut Technol, Cambridge, MA USA; [Lipinski, Kerri; Anand, Vasanti S.; Reinhart, Peter H.; Hirst, Warren D.; Braithwaite, Steven P.] Pfizer Inc, Neurosci Res Unit, Princeton, NJ USA; [Sen, Saurabh; West, Andrew B.] Univ Alabama Birmingham, Dept Neurol, Ctr Neurodegenerat & Expt Therapeut, Birmingham, AL 35294 USA	Pfizer; Pfizer; University of Alabama System; University of Alabama Birmingham	Pungaliya, PP (corresponding author), Pfizer Inc, Global Biotherapeut Technol, Cambridge, MA USA.	pooja.pungaliya@pfizer.com		West, Andrew/0000-0002-3034-4061; Hirst, Warren/0000-0003-0389-8891; Reinhart, Peter/0000-0003-0123-7846	Michael J. Fox Foundation; Pfizer, Inc.; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064934] Funding Source: NIH RePORTER	Michael J. Fox Foundation; Pfizer, Inc.(Pfizer); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors are grateful for grant support from the Michael J. Fox Foundation. The Michael J. Fox Foundation had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was funded by Pfizer, Inc. The company had a role in this study due to employment of one or more authors of this study.	Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Alegre-Abarrategui J, 2009, HUM MOL GENET, V18, P4022, DOI 10.1093/hmg/ddp346; Anand VS, 2009, FEBS J, V276, P466, DOI 10.1111/j.1742-4658.2008.06789.x; Bembom O, 2007, STAT APPL GENET MOL, V6; Biskup S, 2008, J NEUROL, V255, P8, DOI 10.1007/s00415-008-5005-2; Chan EYW, 2007, J BIOL CHEM, V282, P25464, DOI 10.1074/jbc.M703663200; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dehmelt L, 2005, GENOME BIOL, V6; Deng JP, 2008, P NATL ACAD SCI USA, V105, P1499, DOI 10.1073/pnas.0709098105; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Dorsey FC, 2009, J PROTEOME RES, V8, P5253, DOI 10.1021/pr900583m; Fujii K, 2004, P NATL ACAD SCI USA, V101, P13744, DOI 10.1073/pnas.0401881101; Garcia-Regalado A, 2008, MOL BIOL CELL, V19, P4188, DOI 10.1091/mbc.E07-10-1089; Giasson BI, 2008, NEUROSIGNALS, V16, P99, DOI 10.1159/000109764; Gloeckner CJ, 2010, J PROTEOME RES, V9, P1738, DOI 10.1021/pr9008578; Gloeckner CJ, 2006, HUM MOL GENET, V15, P223, DOI 10.1093/hmg/ddi439; Greggio E, 2008, J BIOL CHEM, V283, P16906, DOI 10.1074/jbc.M708718200; Greggio E, 2009, BIOCHEM BIOPH RES CO, V389, P449, DOI 10.1016/j.bbrc.2009.08.163; Guo LX, 2007, EXP CELL RES, V313, P3658, DOI 10.1016/j.yexcr.2007.07.007; Henchcliffe C, 2008, NAT CLIN PRACT NEURO, V4, P600, DOI 10.1038/ncpneuro0924; Hill JJ, 2002, J BIOL CHEM, V277, P40735, DOI 10.1074/jbc.M206379200; Ho CCY, 2009, J NEUROSCI, V29, P1011, DOI 10.1523/JNEUROSCI.5175-08.2009; HUANG Q, APOPTOSIS; Hunter T, 2007, MOL CELL, V28, P730, DOI 10.1016/j.molcel.2007.11.019; Hutti JE, 2004, NAT METHODS, V1, P27, DOI 10.1038/NMETH708; Imai Y, 2008, EMBO J, V27, P2432, DOI 10.1038/emboj.2008.163; Ito G, 2007, BIOCHEMISTRY-US, V46, P1380, DOI 10.1021/bi061960m; Jaeger PA, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-16; Jaleel M, 2007, BIOCHEM J, V405, P307, DOI 10.1042/BJ20070209; Kamikawaji S, 2009, BIOCHEMISTRY-US, V48, P10963, DOI 10.1021/bi9011379; Karnoub AE, 2008, NAT REV MOL CELL BIO, V9, P517, DOI 10.1038/nrm2438; Klein CL, 2009, J NEUROCHEM, V111, P703, DOI 10.1111/j.1471-4159.2009.06358.x; KUMAR A, PLOS ONE, V5, pE8730; Lewis PA, 2007, BIOCHEM BIOPH RES CO, V357, P668, DOI 10.1016/j.bbrc.2007.04.006; Li XT, 2007, J NEUROCHEM, V103, P238, DOI 10.1111/j.1471-4159.2007.04743.x; Lin X, 2009, NEURON, V64, P807, DOI 10.1016/j.neuron.2009.11.006; LIU M, BIOCHEMISTRY, V49, P2008; Lotharius J, 2002, NAT REV NEUROSCI, V3, P932, DOI 10.1038/nrn983; Lower BH, 2000, J BACTERIOL, V182, P3452, DOI 10.1128/JB.182.12.3452-3459.2000; MacLeod D, 2006, NEURON, V52, P587, DOI 10.1016/j.neuron.2006.10.008; Mata IF, 2006, TRENDS NEUROSCI, V29, P286, DOI 10.1016/j.tins.2006.03.006; MCGRATH JP, 1984, NATURE, V310, P644, DOI 10.1038/310644a0; Mishra L, 1997, ONCOGENE, V15, P2361, DOI 10.1038/sj.onc.1201405; Moore DJ, 2005, ANNU REV NEUROSCI, V28, P57, DOI 10.1146/annurev.neuro.28.061604.135718; Nichols RJ, 2009, BIOCHEM J, V424, P47, DOI 10.1042/BJ20091035; O'Neill T, 2000, J BIOL CHEM, V275, P22719, DOI 10.1074/jbc.M001002200; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Paisan-Ruiz C, 2004, NEURON, V44, P595, DOI 10.1016/j.neuron.2004.10.023; Paleologou KE, 2008, J BIOL CHEM, V283, P16895, DOI 10.1074/jbc.M800747200; Parisiadou L, 2009, J NEUROSCI, V29, P13971, DOI 10.1523/JNEUROSCI.3799-09.2009; Plowey ED, 2008, J NEUROCHEM, V105, P1048, DOI 10.1111/j.1471-4159.2008.05217.x; Quan A, 2005, METHOD ENZYMOL, V404, P556, DOI 10.1016/S0076-6879(05)04049-8; Richter K, 2009, J BIOL CHEM, V284, P30652, DOI 10.1074/jbc.M109.014506; Roach ES, 2007, ARCH NEUROL-CHICAGO, V64, P143, DOI 10.1001/archneur.64.1.143; Roger B, 2004, CURR BIOL, V14, P363, DOI 10.1016/j.cub.2004.01.058; Sanchez C, 2000, PROG NEUROBIOL, V61, P133, DOI 10.1016/S0301-0082(99)00046-5; Sasaki A, 2002, J BIOL CHEM, V277, P22541, DOI 10.1074/jbc.M109728200; Schaefer EM, 1998, ANAL BIOCHEM, V261, P100, DOI 10.1006/abio.1998.2716; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Schulz JB, 1999, CURR OPIN NEUROL, V12, P433, DOI 10.1097/00019052-199908000-00010; Schulz JB, 2008, J NEUROL, V255, P3, DOI 10.1007/s00415-008-5011-4; SEN S, 2009, J BIOL CHEM; Shin N, 2008, EXP CELL RES, V314, P2055, DOI 10.1016/j.yexcr.2008.02.015; Smith WLW, 2006, NAT NEUROSCI, V9, P1231, DOI 10.1038/nn1776; Songyang Z, 1996, MOL CELL BIOL, V16, P6486; TRAHEY M, 1987, MOL CELL BIOL, V7, P541, DOI 10.1128/MCB.7.1.541; Tu C, 2009, P NATL ACAD SCI USA, V106, P14843, DOI 10.1073/pnas.0904032106; Turk BE, 2006, NAT PROTOC, V1, P375, DOI 10.1038/nprot.2006.57; West AB, 2005, P NATL ACAD SCI USA, V102, P16842, DOI 10.1073/pnas.0507360102; West AB, 2007, HUM MOL GENET, V16, P223, DOI 10.1093/hmg/ddl471; XIONG Y, PLOS GENET, V6; Yang DQ, 2000, NAT CELL BIOL, V2, P893, DOI 10.1038/35046542; Yu P, 2002, GENOMICS, V79, P869, DOI 10.1006/geno.2002.6770; ZHOU SY, 1994, CURR BIOL, V4, P973, DOI 10.1016/S0960-9822(00)00221-9; Zimprich A, 2004, AM J HUM GENET, V74, P11, DOI 10.1086/380647	75	55	56	4	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2010	5	10							e13672	10.1371/journal.pone.0013672	http://dx.doi.org/10.1371/journal.pone.0013672			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671UN	21060682	gold, Green Published, Green Submitted			2022-12-27	WOS:000283537000039
J	Vanneste, S; Plazier, M; van der Loo, E; Van de Heyning, P; De Ridder, D				Vanneste, Sven; Plazier, Mark; van der Loo, Elsa; Van de Heyning, Paul; De Ridder, Dirk			The Differences in Brain Activity between Narrow Band Noise and Pure Tone Tinnitus	PLOS ONE			English	Article							AUDITORY-CORTEX; ELECTROMAGNETIC TOMOGRAPHY; ANTERIOR THALAMUS; RHESUS-MONKEY; PARAHIPPOCAMPAL REGION; CORTICAL AFFERENTS; NEURAL MECHANISMS; CINGULATE CORTEX; STIMULATION; PET	Background: Tinnitus is an auditory sensation characterized by the perception of sound or noise in the absence of any external sound source. Based on neurobiological research, it is generally accepted that most forms of tinnitus are attributable to maladaptive plasticity due to damage to auditory system. Changes have been observed in auditory structures such as the inferior colliculus, the thalamus and the auditory cortex as well as in non-auditory brain areas. However, the observed changes show great variability, hence lacking a conclusive picture. One of the reasons might be the selection of inhomogeneous groups in data analysis. Methodology: The aim of the present study was to delineate the differences between the neural networks involved in narrow band noise and pure tone tinnitus conducting LORETA based source analysis of resting state EEG. Conclusions: Results demonstrated that narrow band noise tinnitus patients differ from pure tone tinnitus patients in the lateral frontopolar (BA 10), PCC and the parahippocampal area for delta, beta and gamma frequency bands, respectively. The parahippocampal-PCC current density differences might be load dependent, as noise-like tinnitus constitutes multiple frequencies in contrast to pure tone tinnitus. The lateral frontopolar differences might be related to pitch specific memory retrieval.	[Vanneste, Sven; Plazier, Mark; van der Loo, Elsa; Van de Heyning, Paul; De Ridder, Dirk] Univ Antwerp Hosp, TRI, Edegem, Belgium; [Vanneste, Sven; Plazier, Mark; van der Loo, Elsa; De Ridder, Dirk] Univ Antwerp Hosp, Dept Neurosurg, Edegem, Belgium; [Van de Heyning, Paul] Univ Antwerp Hosp, ENT, Edegem, Belgium	University of Antwerp; University of Antwerp; University of Antwerp	Vanneste, S (corresponding author), Univ Antwerp Hosp, TRI, Edegem, Belgium.	sven.vanneste@ua.ac.be	Heyning, Paul H Vande/I-8278-2017	Heyning, Paul H Vande/0000-0002-8424-3717; Vanneste, Sven/0000-0003-1513-5752	Tinnitus Research Initiative (TRI)	Tinnitus Research Initiative (TRI)	This research was supported by a grant of the Tinnitus Research Initiative (TRI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre GK, 1996, CEREB CORTEX, V6, P823, DOI 10.1093/cercor/6.6.823; Andersson G, 2000, ACTA OTO-LARYNGOL, V120, P967, DOI 10.1080/00016480050218717; Arnold W, 1996, ORL J OTO-RHINO-LARY, V58, P195, DOI 10.1159/000276835; Ashton H, 2007, NEUROSCI LETT, V426, P23, DOI 10.1016/j.neulet.2007.08.034; AXELSSON A, 1989, British Journal of Audiology, V23, P53, DOI 10.3109/03005368909077819; Babiloni C, 2006, HUM BRAIN MAPP, V27, P162, DOI 10.1002/hbm.20175; Blood AJ, 1999, NAT NEUROSCI, V2, P382, DOI 10.1038/7299; Boutros NN, 2008, HIPPOCAMPUS, V18, P310, DOI 10.1002/hipo.20388; BUNSEY M, 1993, BEHAV NEUROSCI, V107, P740, DOI 10.1037/0735-7044.107.5.740; Cacace AT, 1999, AUDIOL NEURO-OTOL, V4, P258, DOI 10.1159/000013849; Congedo M., 2002, EUREKA VERSION 3 0 C; De Ridder D., 2009, J NEUROSURG; De Ridder Dirk, 2007, Int J Med Sci, V4, P242; De Ridder Dirk, 2007, Int J Med Sci, V4, P237; Dierks T, 2000, CLIN NEUROPHYSIOL, V111, P1817, DOI 10.1016/S1388-2457(00)00427-2; Eichhammer P, 2003, BIOL PSYCHIAT, V54, P862, DOI 10.1016/S0006-3223(02)01896-6; Engelien A, 2000, ANN NY ACAD SCI, V911, P477; FLOR H, 1995, NATURE, V375, P482, DOI 10.1038/375482a0; Fuchs M, 2002, CLIN NEUROPHYSIOL, V113, P702, DOI 10.1016/S1388-2457(02)00030-5; Goycoolea M, 2005, ACTA OTO-LARYNGOL, V125, P513, DOI 10.1080/00016480510026250; Hall NM, 2008, BEHAV BRAIN RES, V186, P261, DOI 10.1016/j.bbr.2007.08.026; Heller AJ, 2003, OTOLARYNG CLIN N AM, V36, P239, DOI 10.1016/S0030-6665(02)00160-3; JASTREBOFF PJ, 1990, NEUROSCI RES, V8, P221, DOI 10.1016/0168-0102(90)90031-9; Jurcak V, 2007, NEUROIMAGE, V34, P1600, DOI 10.1016/j.neuroimage.2006.09.024; Kobayashi Y, 2003, J COMP NEUROL, V466, P48, DOI 10.1002/cne.10883; Llinas RR, 1999, P NATL ACAD SCI USA, V96, P15222, DOI 10.1073/pnas.96.26.15222; Lockwood AH, 1999, SCAND AUDIOL, V28, P47; Lockwood AH, 1998, NEUROLOGY, V50, P114, DOI 10.1212/WNL.50.1.114; MEEUS O, 2009, OTOL NEUROTOL; Mirz F, 1999, HEARING RES, V134, P133, DOI 10.1016/S0378-5955(99)00075-1; Mirz F, 2000, NEUROREPORT, V11, P633, DOI 10.1097/00001756-200002280-00039; Moazami-Goudarzi M, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-40; Muhlnickel W, 1998, P NATL ACAD SCI USA, V95, P10340, DOI 10.1073/pnas.95.17.10340; Mulert C, 2004, NEUROIMAGE, V22, P83, DOI 10.1016/j.neuroimage.2003.10.051; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Pascual-Marqui RD, 2002, METHOD FIND EXP CLIN, V24, P5; Pizzagalli D, 2001, AM J PSYCHIAT, V158, P405, DOI 10.1176/appi.ajp.158.3.405; Pizzagalli DA, 2004, MOL PSYCHIATR, V9, P393, DOI 10.1038/sj.mp.4001469; Rauschecker JP, 2004, J NEUROPHYSIOL, V91, P2578, DOI 10.1152/jn.00834.2003; RAUSCHECKER JP, 1995, SCIENCE, V268, P111, DOI 10.1126/science.7701330; ROUILLER EM, 1990, EXP BRAIN RES, V80, P501, DOI 10.1007/BF00227991; Schlee W, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-11; Smits M, 2007, NEURORADIOLOGY, V49, P669, DOI 10.1007/s00234-007-0231-3; Tian B, 2001, SCIENCE, V292, P290, DOI 10.1126/science.1058911; van der Loo E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007396; VANNESTE S, 2010, EUR J NEUROL; Vanneste S, 2010, NEUROIMAGE, V52, P470, DOI 10.1016/j.neuroimage.2010.04.029; Vitacco D, 2002, HUM BRAIN MAPP, V17, P4, DOI 10.1002/hbm.10038; VOGT BA, 1992, CEREB CORTEX, V2, P435, DOI 10.1093/cercor/2.6.435-a; VOGT BA, 1987, J COMP NEUROL, V262, P271, DOI 10.1002/cne.902620208; Volpe U, 2007, BRAIN RES BULL, V73, P220, DOI 10.1016/j.brainresbull.2007.03.003; Weisz N, 2007, J NEUROSCI, V27, P1479, DOI 10.1523/JNEUROSCI.3711-06.2007; Weisz N, 2007, PROG BRAIN RES, V166, P61, DOI 10.1016/S0079-6123(07)66006-3; Worrell GA, 2000, BRAIN TOPOGR, V12, P273, DOI 10.1023/A:1023407521772; Zatorre RJ, 2001, ANN NY ACAD SCI, V930, P193, DOI 10.1111/j.1749-6632.2001.tb05734.x; ZATORRE RJ, 1994, J NEUROSCI, V14, P1908, DOI 10.1523/jneurosci.14-04-01908.1994; ZOLAMORGAN S, 1989, J NEUROSCI, V9, P4355; Zumsteg D, 2006, CLIN NEUROPHYSIOL, V117, P192, DOI 10.1016/j.clinph.2005.09.015; Zumsteg D, 2005, NEUROLOGY, V65, P1657, DOI 10.1212/01.wnl.0000184516.32369.1a; Zumsteg D, 2006, EPILEPSIA, V47, P1958, DOI 10.1111/j.1528-1167.2006.00824.x; Zumsteg D, 2006, CLIN NEUROPHYSIOL, V117, P1602, DOI 10.1016/j.clinph.2006.04.008	61	51	53	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2010	5	10							e13618	10.1371/journal.pone.0013618	http://dx.doi.org/10.1371/journal.pone.0013618			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671UN	21048975	Green Published, gold, Green Submitted			2022-12-27	WOS:000283537000016
J	Abdool, A; Donahue, AC; Wohlgemuth, JG; Yeh, CH				Abdool, Adam; Donahue, Amber C.; Wohlgemuth, Jay G.; Yeh, Chen-Hsiung			Detection, Analysis and Clinical Validation of Chromosomal Aberrations by Multiplex Ligation-Dependent Probe Amplification in Chronic Leukemia	PLOS ONE			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; COMPARATIVE GENOMIC HYBRIDIZATION; CANCER; ABNORMALITIES; DNA	Current diagnostic screening strategies based on karyotyping or fluorescent in situ hybridization (FISH) for detection of chromosomal abnormalities in chronic lymphocytic leukemia (CLL) are laborious, time-consuming, costly, and have limitations in resolution. Multiplex ligation-dependent probe amplification (MLPA) can simultaneously detect copy number changes of multiple loci in one simple PCR reaction, making it an attractive alternative to FISH. To enhance the clinical robustness and further harness MLPA technology for routine laboratory operations, we have developed and validated a protocol for comprehensive, automatic data analysis and interpretation. A training set of 50 normal samples was used to establish reference ranges for each individual probe, for the calling of statistically significant copy number changes. The maximum normal ranges of 2 and 3 standard deviations (SD) are distributed between 0.82 and 1.18 (Mean +/- 2SD, 95% CI, P = 0.05), and between 0.73 and 1.27 (Mean +/- 3SD, 99% CI, P = 0.01), respectively. We found an excellent correlation between MLPA and FISH with 93.6% concordance (P<0.0001) from a testing cohort of 100 clinically suspected CLL cases. MLPA analyses done on 94/100 patients showed sensitivity and specificity of 94.2% and 92.9%, respectively. MLPA detected additional copy number gains on 18q21.1 and chromosome 19, and novel micro-deletions at 19q13.43 and 19p13.2 loci in six samples. Three FISH-failed samples were tested positive by MLPA, while three 13q- cases with a low percentage of leukemia cells (7%, 12% and 19%) were not detected by MLPA. The improved CLL MLPA represents a high-throughput, accurate, cost-effective and user-friendly platform that can be used as a first-line screening test in a clinical laboratory.	[Abdool, Adam; Donahue, Amber C.; Wohlgemuth, Jay G.; Yeh, Chen-Hsiung] Quest Diagnost Nichols Inst, Dept Hematol & Oncol, San Juan Capistrano, CA USA	Nichols Institute	Abdool, A (corresponding author), Quest Diagnost Nichols Inst, Dept Hematol & Oncol, San Juan Capistrano, CA USA.	chenhsiung.x.yeh@questdiagnostics.com		Donahue, Amber/0000-0003-2846-1119				Al Zaabi EA, 2010, J MOL DIAGN, V12, P197, DOI 10.2353/jmoldx.2010.090046; Barrett MT, 2004, P NATL ACAD SCI USA, V101, P17765, DOI 10.1073/pnas.0407979101; Coll-Mulet L, 2008, BRIT J HAEMATOL, V142, P793, DOI 10.1111/j.1365-2141.2008.07268.x; Croce CM, 2008, NEW ENGL J MED, V358, P502, DOI 10.1056/NEJMra072367; Dohner H, 2000, NEW ENGL J MED, V343, P1910, DOI 10.1056/NEJM200012283432602; Dohner H, 1999, J MOL MED-JMM, V77, P266, DOI 10.1007/s001090050350; Greshock J, 2007, CANCER RES, V67, P10173, DOI 10.1158/0008-5472.CAN-07-2102; Grever MR, 2007, J CLIN ONCOL, V25, P799, DOI 10.1200/JCO.2006.08.3089; Guipaud O, 2003, LANCET ONCOL, V4, P506, DOI 10.1016/S1470-2045(03)01171-9; Hallek M, 2008, BLOOD, V111, P5446, DOI 10.1182/blood-2007-06-093906; JULIUSSON G, 1990, NEW ENGL J MED, V323, P720, DOI 10.1056/NEJM199009133231105; Kim WY, 2006, CELL, V127, P265, DOI 10.1016/j.cell.2006.10.003; Liehr T, 2004, HISTOL HISTOPATHOL, V19, P229, DOI 10.14670/HH-19.229; Pinkel D, 2005, NAT GENET, V37, pS11, DOI 10.1038/ng1569; Potti A, 2006, NAT MED, V12, P1294, DOI 10.1038/nm1491; Schiemann WP, 2004, CANCER DETECT PREV, V28, P57, DOI 10.1016/j.cdp.2003.11.001; Schutte M, 1999, ANN ONCOL, V10, P56, DOI 10.1023/A:1008336703450; Schwaenen C, 2004, P NATL ACAD SCI USA, V101, P1039, DOI 10.1073/pnas.0304717101; Sellmann L, 2007, BRIT J HAEMATOL, V138, P217, DOI 10.1111/j.1365-2141.2007.06636.x; Stevens-Kroef M, 2009, CANCER GENET CYTOGEN, V195, P97, DOI 10.1016/j.cancergencyto.2009.06.020; Tsang HTH, 2006, GENOMICS, V88, P333, DOI 10.1016/j.ygeno.2006.04.003; Van Bockstaele F, 2009, BLOOD REV, V23, P25, DOI 10.1016/j.blre.2008.05.003	22	21	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2010	5	10							e15407	10.1371/journal.pone.0015407	http://dx.doi.org/10.1371/journal.pone.0015407			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	670LB	21049055	gold, Green Published, Green Submitted			2022-12-27	WOS:000283422100024
J	Otero, JM; Papadakis, MA; Udatha, DBRKG; Nielsen, J; Panagiotou, G				Otero, Jose M.; Papadakis, Manos A.; Udatha, D. B. R. K. Gupta; Nielsen, Jens; Panagiotou, Gianni			Yeast Biological Networks Unfold the Interplay of Antioxidants, Genome and Phenotype, and Reveal a Novel Regulator of the Oxidative Stress Response	PLOS ONE			English	Article							FERULIC ACID; SACCHAROMYCES-CEREVISIAE; FUNGICIDE MANCOZEB; BINDING-SITES; PROTEIN; DOCKING; IDENTIFICATION; GROWTH; MECHANISMS; PREDICTION	Background: Identifying causative biological networks associated with relevant phenotypes is essential in the field of systems biology. We used ferulic acid (FA) as a model antioxidant to characterize the global expression programs triggered by this small molecule and decipher the transcriptional network controlling the phenotypic adaptation of the yeast Saccharomyces cerevisiae. Methodology/Principal Findings: By employing a strict cut off value during gene expression data analysis, 106 genes were found to be involved in the cell response to FA, independent of aerobic or anaerobic conditions. Network analysis of the system guided us to a key target node, the FMP43 protein, that when deleted resulted in marked acceleration of cellular growth (similar to 15% in both minimal and rich media). To extend our findings to human cells and identify proteins that could serve as drug targets, we replaced the yeast FMP43 protein with its human ortholog BRP44 in the genetic background of the yeast strain Delta fmp43. The conservation of the two proteins was phenotypically evident, with BRP44 restoring the normal specific growth rate of the wild type. We also applied homology modeling to predict the 3D structure of the FMP43 and BRP44 proteins. The binding sites in the homology models of FMP43 and BRP44 were computationally predicted, and further docking studies were performed using FA as the ligand. The docking studies demonstrated the affinity of FA towards both FMP43 and BRP44. Conclusions: This study proposes a hypothesis on the mechanisms yeast employs to respond to antioxidant molecules, while demonstrating how phenome and metabolome yeast data can serve as biomarkers for nutraceutical discovery and development. Additionally, we provide evidence for a putative therapeutic target, revealed by replacing the FMP43 protein with its human ortholog BRP44, a brain protein, and functionally characterizing the relevant mutant strain.	[Otero, Jose M.; Panagiotou, Gianni] Tech Univ Denmark, Ctr Microbial Biotechnol, Dept Syst Biol, DK-2800 Lyngby, Denmark; [Papadakis, Manos A.; Panagiotou, Gianni] Tech Univ Denmark, Ctr Biol Sequence Anal, Dept Syst Biol, DK-2800 Lyngby, Denmark; [Otero, Jose M.; Udatha, D. B. R. K. Gupta; Nielsen, Jens] Chalmers Univ Technol, Dept Chem & Biol Engn, S-41296 Gothenburg, Sweden	Technical University of Denmark; Technical University of Denmark; Chalmers University of Technology	Otero, JM (corresponding author), Tech Univ Denmark, Ctr Microbial Biotechnol, Dept Syst Biol, DK-2800 Lyngby, Denmark.	gpa@bio.dtu.dk	Panagiotou, Ioannis/B-7083-2013; Udatha, D.B.R.K. Gupta/B-1544-2012; Nielsen, Jens/Q-1347-2017	Udatha, D.B.R.K. Gupta/0000-0003-0163-9407; Nielsen, Jens/0000-0002-9955-6003	Danish Research Agency for Technology and Production Sciences; Merck Research Labs, Merck Co., Inc	Danish Research Agency for Technology and Production Sciences; Merck Research Labs, Merck Co., Inc(Merck & Company)	This study was financed by the Danish Research Agency for Technology and Production Sciences (GPA). This work was in part supported by Merck Research Labs, Merck & Co., Inc, through the awarding of a Merck Doctoral Fellowship to J.M.O. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AFF, 2007, 702232 PN AFF; Almqvist J, 2007, PROTEIN SCI, V16, P1819, DOI 10.1110/ps.072944707; Balasubashini MS, 2004, PHYTOTHER RES, V18, P310, DOI 10.1002/ptr.1440; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Carmona-Saez P, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r3; Cook M, 2007, CURR OPIN BIOTECH, V18, P341, DOI 10.1016/j.copbio.2007.07.006; Domico LM, 2007, NEUROTOXICOLOGY, V28, P1079, DOI 10.1016/j.neuro.2007.04.008; Duverna R, 2010, CURR CANCER DRUG TAR, V10, P634, DOI 10.2174/156800910791859443; Erdeniz N, 1997, GENOME RES, V7, P1174, DOI 10.1101/gr.7.12.1174; Fay LB, 2008, CURR OPIN BIOTECH, V19, P121, DOI 10.1016/j.copbio.2008.02.010; Ferguson LR, 2001, MUTAT RES-FUND MOL M, V475, P89, DOI 10.1016/S0027-5107(01)00073-2; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gietz RD, 1997, MOL CELL BIOCHEM, V172, P67, DOI 10.1023/A:1006859319926; Goranov AI, 2009, GENE DEV, V23, P1408, DOI 10.1101/gad.1777309; Henrich S, 2010, J MOL RECOGNIT, V23, P209, DOI 10.1002/jmr.984; Hillenmeyer ME, 2008, SCIENCE, V320, P362, DOI 10.1126/science.1150021; Hirashima A, 2008, COMPUT BIOL CHEM, V32, P185, DOI 10.1016/j.compbiolchem.2008.03.001; Hood L, 2004, SCIENCE, V306, P640, DOI 10.1126/science.1104635; Hopkins AL, 2008, NAT CHEM BIOL, V4, P682, DOI 10.1038/nchembio.118; HUANG ZX, 1993, APPL ENVIRON MICROB, V59, P2244, DOI 10.1128/AEM.59.7.2244-2250.1993; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jang MS, 1997, SCIENCE, V275, P218, DOI 10.1126/science.275.5297.218; JONES G, 1995, CURR OPIN BIOTECH, V6, P652, DOI 10.1016/0958-1669(95)80107-3; Ju DH, 2004, J BIOL CHEM, V279, P23851, DOI 10.1074/jbc.C400111200; Kann MG, 2007, BRIEF BIOINFORM, V8, P333, DOI 10.1093/bib/bbm031; KATHERINE EM, 2004, ACTA CRYSTALLOGR D, V60, P878; Khanduja KL, 2006, BBA-GEN SUBJECTS, V1760, P283, DOI 10.1016/j.bbagen.2005.12.017; Kornberg RD, 2005, TRENDS BIOCHEM SCI, V30, P235, DOI 10.1016/j.tibs.2005.03.011; Larsson S, 2000, APPL BIOCHEM BIOTECH, V84-6, P617, DOI 10.1385/ABAB:84-86:1-9:617; Laurie ATR, 2006, CURR PROTEIN PEPT SC, V7, P395; Legrain P, 2001, TRENDS GENET, V17, P346, DOI 10.1016/S0168-9525(01)02323-X; Lin SS, 2003, J BIOL CHEM, V278, P13390, DOI 10.1074/jbc.M212818200; London MK, 2004, FEBS LETT, V567, P259, DOI 10.1016/j.febslet.2004.04.078; Martinez-Azorin F, 2008, BIOCHEM J, V413, P527, DOI 10.1042/BJ20080049; McRobb FM, 2010, J CHEM INF MODEL, V50, P626, DOI 10.1021/ci900444q; Middleton E, 2000, PHARMACOL REV, V52, P673; MORGENSEN J, 1999, J CLIN INVEST, V103, P39; Niu W, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000120; Oda A., 2009, CHEM-BIO INFORM J, V9, P52, DOI [10.1273/cbij.9.52, DOI 10.1273/CBIJ.9.52]; Oliveira AP, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-17; Ou SY, 2004, J SCI FOOD AGR, V84, P1261, DOI 10.1002/jsfa.1873; Panagiotou G, 2007, J BIOTECHNOL, V130, P219, DOI 10.1016/j.jbiotec.2007.04.011; Panagiotou G, 2006, METAB ENG, V8, P474, DOI 10.1016/j.ymben.2006.04.004; Pold M, 1999, GENOMICS, V59, P161, DOI 10.1006/geno.1999.5870; Prates JAM, 2001, STRUCTURE, V9, P1183, DOI 10.1016/S0969-2126(01)00684-0; Rist MJ, 2006, TRENDS BIOTECHNOL, V24, P172, DOI 10.1016/j.tibtech.2006.02.001; Santos PM, 2009, PROTEOMICS, V9, P657, DOI 10.1002/pmic.200800452; SCHMITT ME, 1990, NUCLEIC ACIDS RES, V18, P3091, DOI 10.1093/nar/18.10.3091; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shoichet BK, 2002, CURR OPIN CHEM BIOL, V6, P439, DOI 10.1016/S1367-5931(02)00339-3; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Srinivasan M, 2007, J CLIN BIOCHEM NUTR, V40, P92, DOI 10.3164/jcbn.40.92; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Stover PJ, 2006, NUTR REV, V64, pS60, DOI 10.1301/nr.2006.may.S60-S71; Subbiah MTR, 2007, TRANSL RES, V149, P55, DOI 10.1016/j.trsl.2006.09.003; TAN K, 2007, PNAS, V105, P2934; Thakur JK, 2008, NATURE, V452, P604, DOI 10.1038/nature06836; Valencia A, 2002, CURR OPIN STRUC BIOL, V12, P368, DOI 10.1016/S0959-440X(02)00333-0; van der Greef J, 2007, J PROTEOME RES, V6, P1540, DOI 10.1021/pr0606530; Van Slyke C, 2003, NUCLEIC ACIDS RES, V31, P4597, DOI 10.1093/nar/gkg638; VERDUYN C, 1992, YEAST, V8, P501, DOI 10.1002/yea.320080703; Villas-Boas SG, 2003, ANAL BIOCHEM, V322, P134, DOI 10.1016/j.ab.2003.07.018; Villas-Boas SG, 2005, BIOCHEM J, V388, P669, DOI 10.1042/BJ20041162; Wang HB, 1999, NATURE, V397, P69, DOI 10.1038/16264; Wang XG, 2008, GENETICS, V180, P1945, DOI 10.1534/genetics.108.094524; Yabe T, 2010, NEUROSCIENCE, V165, P515, DOI 10.1016/j.neuroscience.2009.10.023	68	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2010	5	10							e13606	10.1371/journal.pone.0013606	http://dx.doi.org/10.1371/journal.pone.0013606			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	670LB	21049050	gold, Green Submitted, Green Published			2022-12-27	WOS:000283422100014
J	Prosperi, MCF; De Luca, A; Di Giambenedetto, S; Bracciale, L; Fabbiani, M; Cauda, R; Salemi, M				Prosperi, Mattia C. F.; De Luca, Andrea; Di Giambenedetto, Simona; Bracciale, Laura; Fabbiani, Massimiliano; Cauda, Roberto; Salemi, Marco			The Threshold Bootstrap Clustering: A New Approach to Find Families or Transmission Clusters within Molecular Quasispecies	PLOS ONE			English	Article							PHYLOGENETIC TREES; MAXIMUM-LIKELIHOOD; RECONSTRUCTION; SEQUENCES; ALGORITHM; INFECTION; MATRIX	Background: Phylogenetic methods produce hierarchies of molecular species, inferring knowledge about taxonomy and evolution. However, there is not yet a consensus methodology that provides a crisp partition of taxa, desirable when considering the problem of intra/inter-patient quasispecies classification or infection transmission event identification. We introduce the threshold bootstrap clustering (TBC), a new methodology for partitioning molecular sequences, that does not require a phylogenetic tree estimation. Methodology/Principal Findings: The TBC is an incremental partition algorithm, inspired by the stochastic Chinese restaurant process, and takes advantage of resampling techniques and models of sequence evolution. TBC uses as input a multiple alignment of molecular sequences and its output is a crisp partition of the taxa into an automatically determined number of clusters. By varying initial conditions, the algorithm can produce different partitions. We describe a procedure that selects a prime partition among a set of candidate ones and calculates a measure of cluster reliability. TBC was successfully tested for the identification of type-1 human immunodeficiency and hepatitis C virus subtypes, and compared with previously established methodologies. It was also evaluated in the problem of HIV-1 intra-patient quasispecies clustering, and for transmission cluster identification, using a set of sequences from patients with known transmission event histories. Conclusion: TBC has been shown to be effective for the subtyping of HIV and HCV, and for identifying intra-patient quasispecies. To some extent, the algorithm was able also to infer clusters corresponding to events of infection transmission. The computational complexity of TBC is quadratic in the number of taxa, lower than other established methods; in addition, TBC has been enhanced with a measure of cluster reliability. The TBC can be useful to characterise molecular quasipecies in a broad context.	[Prosperi, Mattia C. F.; De Luca, Andrea; Di Giambenedetto, Simona; Bracciale, Laura; Fabbiani, Massimiliano; Cauda, Roberto] Univ Cattolica Sacro Cuore, Infect Dis Clin, I-00168 Rome, Italy; [Prosperi, Mattia C. F.; Salemi, Marco] Univ Florida, Coll Med, Dept Pathol Immunol & Lab Med, Gainesville, FL USA; [Prosperi, Mattia C. F.; Salemi, Marco] Univ Florida, Emerging Pathogens Inst, Gainesville, FL USA; [De Luca, Andrea] Univ Hosp Siena, Infect Dis Unit 2, Siena, Italy	Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of Siena; University Hospital of Siena	Prosperi, MCF (corresponding author), Univ Cattolica Sacro Cuore, Infect Dis Clin, I-00168 Rome, Italy.	ahnven@yahoo.it	De Luca, Andrea/G-8810-2011; Fabbiani, Massimiliano/K-8842-2016; digiambenedetto, simona/AAL-4429-2020	De Luca, Andrea/0000-0002-9561-9193; Fabbiani, Massimiliano/0000-0002-1343-812X; CAUDA, Roberto/0000-0002-1498-4229	DynaNets [233847]; Collaborative HIV and Anti-HIV Drug Resistance Network (CHAIN); Seventh Framework Programme [FP7 2007-2013, 223131]; NIH, NINDS [GRANTR01 NS063897-01A2]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS063897] Funding Source: NIH RePORTER	DynaNets; Collaborative HIV and Anti-HIV Drug Resistance Network (CHAIN); Seventh Framework Programme(European Commission); NIH, NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The work was funded by DynaNets project (www.dynanets.org), a Future and Emerging Technologies (FET)-Open grant # 233847; Collaborative HIV and Anti-HIV Drug Resistance Network (CHAIN) project (http://ec.europa.eu/research/health/infectious-diseases/poverty-diseases/projects/185_en.htm), Seventh Framework Programme (FP7 2007-2013), grant # 223131; NIH, NINDS GRANTR01 NS063897-01A2 (Feb 2009-Jan 2014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldous D., 1985, LECT NOTES MATH, V1117; Archer J, 2007, BIOINFORMATICS, V23, P2952, DOI 10.1093/bioinformatics/btm410; Brown AE, 2009, J INFECT DIS, V199, P427, DOI 10.1086/596049; Chiu S., 1994, J INTELL FUZZY SYST, V2, P267, DOI DOI 10.3233/IFS-1994-2306; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Dunn J.C., 1974, J CYBERNETICS, V4, P95, DOI 10.1080/01969727408546059; Felsenstein J., 2004, INFERRING PHYLOGENIE; FERGUSON TS, 1973, ANN STAT, V1, P209, DOI 10.1214/aos/1176342360; FITCH WM, 1967, SCIENCE, V155, P279, DOI 10.1126/science.155.3760.279; GOODMAN LA, 1954, J AM STAT ASSOC, V49, P732, DOI 10.2307/2281536; GOTOH O, 1982, J MOL BIOL, V162, P705, DOI 10.1016/0022-2836(82)90398-9; Hendy M. D., 1982, MATH BIOSCI, V60, P133, DOI DOI 10.1016/0025-5564(82)90027-X; HUBERT L, 1985, J CLASSIF, V2, P193, DOI 10.1007/BF01908075; Hue S, 2004, AIDS, V18, P719, DOI [10.1097/00002030-200403260-00002, 10.1097/01.aids.0000111455.61782.c3]; Hughes GJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000590; Alcantara LCJ, 2009, NUCLEIC ACIDS RES, V37, pW634, DOI 10.1093/nar/gkp455; Kaufman L., 1990, FINDING GROUPS DATA, DOI 10.1002/9780470316801; Kuncheva LI, 2006, IEEE T PATTERN ANAL, V28, P1798, DOI 10.1109/TPAMI.2006.226; Lemey P, 2009, PHYLOGENETIC HANDBOOK: A PRACTICAL APPROACH TO PHYLOGENETIC ANALYSIS AND HYPOTHESIS TESTING, 2ND EDITION, P1; Lewis F, 2008, PLOS MED, V5, P392, DOI 10.1371/journal.pmed.0050050; Massingham T, 2007, MOL BIOL EVOL, V24, P2277, DOI 10.1093/molbev/msm160; Plantier JC, 2009, NAT MED, V15, P871, DOI 10.1038/nm.2016; Pol D, 2004, SYST BIOL, V53, P949, DOI 10.1080/10635150490888868; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; Qin ZS, 2006, BIOINFORMATICS, V22, P1988, DOI 10.1093/bioinformatics/btl284; R Core Team, 2018, R LANG ENV STAT COMP; Resik S, 2007, AIDS RES HUM RETROV, V23, P347, DOI 10.1089/aid.2006.0158; RUSMUSSEN C, 2000, ADV NEURAL INFORM PR, V12, P554; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Shankarappa R, 1999, J VIROL, V73, P10489, DOI 10.1128/JVI.73.12.10489-10502.1999; Simmonds P, 2005, HEPATOLOGY, V42, P962, DOI 10.1002/hep.20819; Spath H., 1980, CLUSTER ANAL ALGORIT; Strehl A., 2003, Journal of Machine Learning Research, V3, P583, DOI 10.1162/153244303321897735; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Yang ZH, 1997, MOL BIOL EVOL, V14, P717, DOI 10.1093/oxfordjournals.molbev.a025811; Zagordi O, 2010, J COMPUT BIOL, V17, P417, DOI 10.1089/cmb.2009.0164; 2010, LOS ALAMOS HIV RESP; 2010, HIV 1 SUBTYPE CIRCUL	40	12	12	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2010	5	10							e13619	10.1371/journal.pone.0013619	http://dx.doi.org/10.1371/journal.pone.0013619			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	670LB	21049051	Green Published, gold			2022-12-27	WOS:000283422100021
J	Gandhi, G; Londono, D; Whetstine, CR; Sethi, N; Kim, KS; Zuckert, WR; Cadavid, D				Gandhi, Gaurav; Londono, Diana; Whetstine, Christine R.; Sethi, Nilay; Kim, Kwang S.; Zueckert, Wolfram R.; Cadavid, Diego			Interaction of Variable Bacterial Outer Membrane Lipoproteins with Brain Endothelium	PLOS ONE			English	Article							RELAPSING FEVER SPIROCHETE; BORRELIA-BURGDORFERI; TRANSENDOTHELIAL MIGRATION; PERSISTENT INFECTION; NEUROTROPIC STRAIN; CRYSTAL-STRUCTURE; SURFACE PROTEIN; BLOOD; CELLS; INTERLEUKIN-10	Background: Previously we reported that the variable outer membrane lipoprotein Vsp1 from the relapsing fever spirochete Borrelia turicatae disseminates from blood to brain better than the closely related Vsp2 [1]. Here we studied the interaction between Vsp1 and Vsp2 with brain endothelium in more detail. Methodology/Principal Findings: We compared Vsp1 to Vsp2 using human brain microvascular endothelial cell (HBMEC) association assays with aminoacid radiolabeled Vsp-expressing clones of recombinant Borrelia burgdorferi and lanthanide-labeled purified lipidated Vsp1 (LVsp1) and Vsp2 (LVsp2) and inoculations of the lanthanide-labeled proteins into mice. The results showed that heterologous expression of LVsp1 or LVsp2 in B. burgdorferi increased its association with HBMEC to a similar degree. Purified lanthanide- labeled lipidated Vsp1 (LVsp1) and LVsp2 by themselves were capable of associating with HBMEC. The association of LVsp1 with brain endothelium was time-dependent, saturable, and required the lipidation. The association of Vsp1 with HBMEC was inhibited by incubation at lower temperature or with excess unlabeled LVsp1 or LVsp2 but not with excess rVsp1 or mouse albumin or an anti Vsp1 monoclonal antibody. The association of LVsp2 with HBMEC and its movement from blood to brain parenchyma significantly increased in the presence of LVsp1. Conclusions/Significance: Variable bacterial outer membrane lipoproteins interact with brain endothelium differently; the lipidation and variable features at the protein dome region are key modulators of this interaction.	[Gandhi, Gaurav; Londono, Diana; Sethi, Nilay; Cadavid, Diego] UMDNJ New Jersey Med Sch, Dept Neurol & Neurosci, Newark, NJ USA; [Gandhi, Gaurav; Londono, Diana; Sethi, Nilay; Cadavid, Diego] UMDNJ New Jersey Med Sch, Ctr Study Emerging Pathogens, Newark, NJ USA; [Londono, Diana; Cadavid, Diego] Massachusetts Gen Hosp, Ctr Immunol & Inflammatory Dis, Boston, MA 02114 USA; [Whetstine, Christine R.; Zueckert, Wolfram R.] Univ Kansas, Med Ctr, Dept Microbiol Mol Genet & Immunol, Kansas City, KS 66103 USA; [Kim, Kwang S.] Johns Hopkins Univ, Sch Med, Baltimore, MD USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Harvard University; Massachusetts General Hospital; University of Kansas; University of Kansas Medical Center; Johns Hopkins University	Gandhi, G (corresponding author), UMDNJ New Jersey Med Sch, Dept Neurol & Neurosci, Newark, NJ USA.	dcadavid@partners.org			National Institutes of Health [NS053997, 7R21NS057545-02, AI059468, AI063261]; Foundation of UMDNJ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI063261] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS053997, R21NS057545] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation of UMDNJ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	These studies were supported by National Institutes of Health grants NS053997 and 7R21NS057545-02 to D. C. and AI059468 and AI063261 to W. R. Z. The support of the Foundation of UMDNJ to D. C. is also greatly appreciated. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonara S, 2007, MOL MICROBIOL, V66, P262, DOI 10.1111/j.1365-2958.2007.05924.x; BARBOUR AG, 1986, ZBL BAKT-INT J MED M, V263, P83; Baron C, 1997, J BACTERIOL, V179, P1211, DOI 10.1128/jb.179.4.1211-1218.1997; Bunikis J, 2001, MOL MICROBIOL, V40, P387, DOI 10.1046/j.1365-2958.2001.02382.x; Burns MJ, 1997, INFECT IMMUN, V65, P1217, DOI 10.1128/IAI.65.4.1217-1222.1997; Cadavid D, 2006, J INFECT DIS, V193, P1451, DOI 10.1086/503367; Cadavid D, 1998, CLIN INFECT DIS, V26, P151, DOI 10.1086/516276; CADAVID D, 1994, J EXP MED, V179, P631, DOI 10.1084/jem.179.2.631; Cadavid D, 1997, INFECT IMMUN, V65, P3352, DOI 10.1128/IAI.65.8.3352-3360.1997; Cadavid D, 2009, CLIN MICROBIOL INFEC, V15, P415, DOI 10.1111/j.1469-0691.2009.02785.x; Cadavid D, 2001, INFECT IMMUN, V69, P3389, DOI 10.1128/IAI.69.5.3389-3397.2001; Cadavid D, 2007, J INFECT DIS, V195, P1686, DOI 10.1086/516783; Cadavid D, 2006, WIEN KLIN WOCHENSCHR, V118, P653, DOI 10.1007/s00508-006-0692-0; Cadavid Diego, 2010, Handb Clin Neurol, V96, P179, DOI 10.1016/S0072-9752(09)96012-2; CARTER CJ, 1994, INFECT IMMUN, V62, P2792, DOI 10.1128/IAI.62.7.2792-2799.1994; COBURN J, 1993, P NATL ACAD SCI USA, V90, P7059, DOI 10.1073/pnas.90.15.7059; COMSTOCK LE, 1991, MICROB PATHOGENESIS, V10, P137, DOI 10.1016/0882-4010(91)90074-K; COMSTOCK LE, 1989, INFECT IMMUN, V57, P1626, DOI 10.1128/IAI.57.5.1626-1628.1989; Dame TM, 2007, J IMMUNOL, V178, P1172, DOI 10.4049/jimmunol.178.2.1172; DIAMANDIS EP, 1990, ANAL CHEM, V62, pA1149, DOI 10.1021/ac00221a001; Elias AF, 2002, INFECT IMMUN, V70, P2139, DOI 10.1128/IAI.70.4.2139-2150.2002; Gelderblom H, 2007, J NEUROPATH EXP NEUR, V66, P208, DOI 10.1097/01.jnen.0000248556.30209.6d; Gelderblom H, 2007, AM J PATHOL, V170, P251, DOI 10.2353/ajpath.2007.060407; Gergel EI, 2001, INFECT IMMUN, V69, P2190, DOI 10.1128/IAI.69.4.2190-2197.2001; GOLDSTEIN JL, 1983, METHOD ENZYMOL, V98, P241; Grab DJ, 2005, INFECT IMMUN, V73, P1014, DOI 10.1128/IAI.73.2.1014-1022.2005; Guo BP, 1998, MOL MICROBIOL, V30, P711, DOI 10.1046/j.1365-2958.1998.01103.x; GUO BP, 1995, INFECT IMMUN, V63, P3467, DOI 10.1128/IAI.63.9.3467-3472.1995; HARA H, 1981, BIOCHIM BIOPHYS ACTA, V673, P37, DOI 10.1016/0304-4165(81)90308-1; Ivey NS, 2005, J NEUROSCI METH, V142, P91, DOI 10.1016/j.jneumeth.2004.07.015; Kawabata H, 2004, INFECT IMMUN, V72, P7147, DOI 10.1128/IAI.72.12.7147-7154.2004; Kumaran D, 2001, EMBO J, V20, P971, DOI 10.1093/emboj/20.5.971; Labandeira-Rey M, 2001, INFECT IMMUN, V69, P446, DOI 10.1128/IAI.69.1.446-455.2001; Lawson CL, 2006, J BACTERIOL, V188, P4522, DOI 10.1128/JB.00028-06; Leong JM, 1998, INFECT IMMUN, V66, P994, DOI 10.1128/IAI.66.3.994-999.1998; Lisinski TJ, 2002, J LEUKOCYTE BIOL, V72, P503; Londono D, 2005, INFECT IMMUN, V73, P7669, DOI 10.1128/IAI.73.11.7669-7676.2005; Londono D, 2008, J NEUROPATH EXP NEUR, V67, P976, DOI 10.1097/NEN.0b013e318187a279; Londono D, 2008, J IMMUNOL, V181, P2076, DOI 10.4049/jimmunol.181.3.2076; Londono D, 2010, AM J PATHOL, V176, P2848, DOI 10.2353/ajpath.2010.091235; MA Y, 1991, INFECT IMMUN, V59, P671, DOI 10.1128/IAI.59.2.671-678.1991; Magoun L, 2000, MOL MICROBIOL, V36, P886, DOI 10.1046/j.1365-2958.2000.01906.x; Mehra R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007597; MONCO JCG, 1992, NEUROLOGY, V42, P1341, DOI 10.1212/WNL.42.7.1341; Nassif X, 2002, TRENDS MICROBIOL, V10, P227, DOI 10.1016/S0966-842X(02)02349-1; Norman MU, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000169; Pennington PM, 1999, MOL MICROBIOL, V34, P1120, DOI 10.1046/j.1365-2958.1999.01675.x; Pennington PM, 1999, INFECT IMMUN, V67, P4637, DOI 10.1128/IAI.67.9.4637-4645.1999; Prasadarao NV, 1999, INFECT IMMUN, V67, P5775, DOI 10.1128/IAI.67.11.5775-5783.1999; Prasadarao NV, 1999, INFECT IMMUN, V67, P1131, DOI 10.1128/IAI.67.3.1131-1138.1999; Purser JE, 2003, MOL MICROBIOL, V48, P753, DOI 10.1046/j.1365-2958.2003.03452.x; SADZIENE A, 1995, INFECT IMMUN, V63, P1573, DOI 10.1128/IAI.63.4.1573-1580.1995; Salazar JC, 2005, CLIN DIAGN LAB IMMUN, V12, P949, DOI 10.1128/CDLI.12.8.949-958.2005; Samuels D S, 1995, Methods Mol Biol, V47, P253; Schlachetzki F, 2002, J NEUROCHEM, V81, P203, DOI 10.1046/j.1471-4159.2002.00840.x; SELLATI TJ, 1995, INFECT IMMUN, V63, P4439, DOI 10.1128/IAI.63.11.4439-4447.1995; Sellati TJ, 1996, INFECT IMMUN, V64, P3180, DOI 10.1128/IAI.64.8.3180-3187.1996; Sethi N, 2006, INFECT IMMUN, V74, P6408, DOI 10.1128/IAI.00538-06; Shamaei-Tousi A, 2000, CELL MICROBIOL, V2, P591, DOI 10.1046/j.1462-5822.2000.00083.x; Stewart PE, 2001, MOL MICROBIOL, V39, P714, DOI 10.1046/j.1365-2958.2001.02256.x; SZCZEPANSKI A, 1990, J CLIN INVEST, V85, P1637, DOI 10.1172/JCI114615; THOMAS DD, 1989, INFECT IMMUN, V57, P1324, DOI 10.1128/IAI.57.4.1324-1326.1989; THOMAS DD, 1994, J INFECT DIS, V169, P445, DOI 10.1093/infdis/169.2.445; YAZAKI T, 1995, CANCER RES, V55, P4752; Zambrano MC, 2004, INFECT IMMUN, V72, P3138, DOI 10.1128/IAI.72.6.3138-3146.2004; Zucker WR, 2001, J BIOL CHEM, V276, P457, DOI 10.1074/jbc.M008449200; Zuckert WR, 2004, INFECT IMMUN, V72, P1463, DOI 10.1128/IAI.72.3.1463-1469.2004	67	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2010	5	10							e13257	10.1371/journal.pone.0013257	http://dx.doi.org/10.1371/journal.pone.0013257			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	670KA	21063459	Green Published, Green Submitted, gold			2022-12-27	WOS:000283419100002
J	Sankey, C; Henry, S; Gorecka-Bruzda, A; Richard-Yris, MA; Hausberger, M				Sankey, Carol; Henry, Severine; Gorecka-Bruzda, Aleksandra; Richard-Yris, Marie-Annick; Hausberger, Martine			The Way to a Man's Heart Is through His Stomach: What about Horses?	PLOS ONE			English	Article							OXYTOCIN; STRESS	Background: How do we bond to one another? While in some species, like humans, physical contact plays a role in the process of attachment, it has been suggested that tactile contact's value may greatly differ according to the species considered. Nevertheless, grooming is often considered as a pleasurable experience for domestic animals, even though scientific data is lacking. On another hand, food seems to be involved in the creation of most relationships in a variety of species. Methodology/Principal Findings: In this study, we used the horse training context to test the effects of food versus grooming during repeated human-horse interactions. The results reveal that food certainly holds a key role in the attachment process, while tactile contact was here clearly insufficient for bonding to occur. Conclusion/Significance: This study raises important questions on the way tactile contact is perceived, and shows that large inter-species differences are to be expected.	[Sankey, Carol; Henry, Severine; Richard-Yris, Marie-Annick; Hausberger, Martine] Univ Rennes 1, UMR CNRS6552, Biol Stn, Paimpont, France; [Gorecka-Bruzda, Aleksandra] Polish Acad Sci, Inst Genet & Anim Breeding, Jastrzebiec, Wolka Kosowska, Poland	Universite de Rennes; Institute of Genetics & Animal Biotechnology, Polish Academy of Sciences; Polish Academy of Sciences	Sankey, C (corresponding author), Univ Rennes 1, UMR CNRS6552, Biol Stn, Paimpont, France.	carol.sankey@univ-rennes1.fr	Gorecka-Bruzda, Aleksandra/F-7399-2010	Gorecka-Bruzda, Aleksandra/0000-0002-2770-2278; Sankey, Carol/0000-0001-9890-9287	Comite d'Orientation Scientifique et Technique (COST, Les Haras Nationaux); Region Bretagne	Comite d'Orientation Scientifique et Technique (COST, Les Haras Nationaux); Region Bretagne(Region Bretagne)	Funding was provided by Comite d'Orientation Scientifique et Technique (COST, Les Haras Nationaux, http://www.haras-nationaux.fr/portail/) and Region Bretagne (http://www.bretagne.fr/internet/jcms/j_6/accueil). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnard K., 1990, TOUCH FDN EXPERIENCE; Beck AM, 2003, AM BEHAV SCI, V47, P79, DOI 10.1177/0002764203255214; BOWLBY J, 2005, MAKING BREAKING AFFE, pCH4; BOYD LE, 1988, APPL ANIM BEHAV SCI, V21, P5, DOI 10.1016/0168-1591(88)90098-6; Cloutier S, 2008, APPL ANIM BEHAV SCI, V112, P158, DOI 10.1016/j.applanim.2007.07.003; De Kort SR, 2006, ANIM BEHAV, V72, P297, DOI 10.1016/j.anbehav.2005.10.016; Ditzen B, 2007, PSYCHONEUROENDOCRINO, V32, P565, DOI 10.1016/j.psyneuen.2007.03.011; Donaldson ZR, 2008, SCIENCE, V322, P900, DOI 10.1126/science.1158668; Emery NJ, 2007, PHILOS T R SOC B, V362, P489, DOI 10.1098/rstb.2006.1991; FEH C, 1993, ANIM BEHAV, V46, P1191, DOI 10.1006/anbe.1993.1309; FEH C, 2005, DOMESTIC HORSE; Hausberger M, 2007, J COMP PSYCHOL, V121, P109, DOI 10.1037/0735-7036.121.1.109; Hausberger M, 2008, APPL ANIM BEHAV SCI, V109, P1, DOI 10.1016/j.applanim.2007.04.015; Henry S, 2007, DEV PSYCHOBIOL, V49, P514, DOI 10.1002/dev.20225; Henry S, 2006, DEV PSYCHOBIOL, V48, P712, DOI 10.1002/dev.20189; Holden M. D., 2006, International Zoo Yearbook, V40, P144, DOI 10.1111/j.1748-1090.2006.00144.x; Jansen J, 2008, DEV REV, V28, P503, DOI 10.1016/j.dr.2008.07.001; Jezierski T, 1999, APPL ANIM BEHAV SCI, V62, P1, DOI 10.1016/S0168-1591(98)00209-3; KELLEHER ROGER T., 1962, JOUR EXPTL ANALYSIS BEHAVIOR, V5, P543, DOI 10.1901/jeab.1962.5-s543; Laule Gail E., 2003, Journal of Applied Animal Welfare Science, V6, P163, DOI 10.1207/S15327604JAWS0603_02; Lower SE, 2001, ANIM BEHAV, V61, P231, DOI 10.1006/anbe.2000.1545; McKinley Jean, 2003, Journal of Applied Animal Welfare Science, V6, P209, DOI 10.1207/S15327604JAWS0603_06; Normando S, 2003, VET RES COMMUN, V27, P615, DOI 10.1023/B:VERC.0000014230.52006.df; Prescott Mark J., 2003, Journal of Applied Animal Welfare Science, V6, P157, DOI 10.1207/S15327604JAWS0603_01; Price EO, 1999, APPL ANIM BEHAV SCI, V65, P245, DOI 10.1016/S0168-1591(99)00087-8; Reinhardt V., 1991, Animal Technology, V42, P11; Sankey C, 2010, ANIM COGN, V13, P753, DOI 10.1007/s10071-010-0326-9; Sankey C, 2010, ANIM BEHAV, V79, P869, DOI 10.1016/j.anbehav.2009.12.037; Skinner B. F., 1938, BEHAV ORGAN EXP ANAL; SKINNER BF, 1981, SCIENCE, V213, P501, DOI 10.1126/science.7244649; Tallet C, 2005, APPL ANIM BEHAV SCI, V94, P59, DOI 10.1016/j.applanim.2005.02.007; Uvnas-Moberg K, 1998, PSYCHONEUROENDOCRINO, V23, P819, DOI 10.1016/S0306-4530(98)00056-0; Wauters AM, 2003, CR BIOL, V326, P677, DOI 10.1016/S1631-0691(03)00128-8; Yin S, 2008, APPL ANIM BEHAV SCI, V113, P123, DOI 10.1016/j.applanim.2007.11.001	34	21	21	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2010	5	11							e15446	10.1371/journal.pone.0015446	http://dx.doi.org/10.1371/journal.pone.0015446			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	680KW	21085576	Green Published, gold, Green Submitted			2022-12-27	WOS:000284231800032
J	Yu, WF; Liu, JA; Shi, MA; Wang, JA; Xiang, MX; Kitamoto, S; Wang, B; Sukhova, GK; Murphy, GF; Orasanu, G; Grubb, A; Shi, GP				Yu, Weifang; Liu, Jian; Shi, Michael A.; Wang, Jianan; Xiang, Meixiang; Kitamoto, Shiro; Wang, Bing; Sukhova, Galina K.; Murphy, George F.; Orasanu, Gabriela; Grubb, Anders; Shi, Guo-Ping			Cystatin C Deficiency Promotes Epidermal Dysplasia in K14-HPV16 Transgenic Mice	PLOS ONE			English	Article							HUMAN GLIOBLASTOMA CELLS; CHAIN VARIABLE FRAGMENT; MMP-9 GENE-EXPRESSION; HUMAN-MELANOMA CELLS; CATHEPSIN-B; TUMOR-GROWTH; MULTISTAGE TUMORIGENESIS; CYSTEINE PROTEASES; CANCER-CELLS; LUNG-CANCER	Background: Cysteine protease cathepsins are important in extracellular matrix protein degradation, cell apoptosis, and angiogenesis. Mice lacking cathepsins are protected from tumor progression in several animal models, suggesting that the regulation of cathepsin activities controls the growth of various malignant tumors. Methods and Results: We tested the role of cathepsins using a mouse model of multistage epithelial carcinogenesis, in which the human keratin-14 promoter/enhancer drove the expression of human papillomavirus type 16 (HPV16) early region E6/E7 transgenes. During the progression of premalignant dysplasia, we observed increased expression of cysteine protease cathepsin S, but concomitantly reduced expression of cathepsin endogenous inhibitor cystatin C in the skin tissue extract. Absence of cystatin C in these transgenic mice resulted in more progression of dysplasia to carcinoma in situ on the face, ear, chest, and tail. Chest and ear skin extract real time PCR and immunoblot analysis, mouse serum sample ELISA, tissue immunohistological analysis, and tissue extract-mediated in vitro elastinolysis and collagenolysis assays demonstrated that cystatin C deficiency significantly increased cathepsin expression and activity. In skin from both the chest and ear, we found that the absence of cystatin C reduced epithelial cell apoptosis but increased proliferation. From the same tissue preparations, we detected significantly higher levels of pro-angiogenic laminin 5-derived c2 peptides and concurrently increased neovascularization in cystatin C-deficient mice, compared to those from wild-type control mice. Conclusion: Enhanced cathepsin expression and activity in cystatin C-deficient mice contributed to the progression of dysplasia by altering premalignant tissue epithelial proliferation, apoptosis, and neovascularization.	[Yu, Weifang; Liu, Jian; Shi, Michael A.; Kitamoto, Shiro; Wang, Bing; Sukhova, Galina K.; Orasanu, Gabriela; Shi, Guo-Ping] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Yu, Weifang; Liu, Jian; Shi, Michael A.; Kitamoto, Shiro; Wang, Bing; Sukhova, Galina K.; Murphy, George F.; Orasanu, Gabriela; Shi, Guo-Ping] Harvard Univ, Sch Med, Boston, MA USA; [Yu, Weifang; Wang, Jianan; Xiang, Meixiang] Zhejiang Univ, Coll Med, Affiliated Hosp 2, Dept Cardiol, Hangzhou 310003, Zhejiang, Peoples R China; [Liu, Jian] Hefei Univ Technol, Sch Biotechnol & Food Engn, Dept Life Sci, Hefei, Peoples R China; [Murphy, George F.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Grubb, Anders] Univ Lund Hosp, Dept Clin Chem, S-22185 Lund, Sweden	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Zhejiang University; Hefei University of Technology; Harvard University; Brigham & Women's Hospital; Lund University; Skane University Hospital	Yu, WF (corresponding author), Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA.	gshi@rics.bwh.harvard.edu		Grubb, Anders/0000-0002-0125-3662; Shi, Michael/0000-0003-3243-4439	National Institutes of Health [HL60942, HL81090, HL88547, HL56985]; American Heart Association [0840118N]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081090, R01HL088547, R01HL060942] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study is supported by National Institutes of Health grants HL60942, HL81090, HL88547 (GPS); HL56985 (PL); and Established Investigator Award (0840118N) from the American Heart Association (GPS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burden RE, 2009, CLIN CANCER RES, V15, P6042, DOI 10.1158/1078-0432.CCR-09-1262; Coussens LM, 1996, AM J PATHOL, V149, P1899; Daniel D, 2003, J EXP MED, V197, P1017, DOI 10.1084/jem.20021047; ERDEL M, 1990, J HISTOCHEM CYTOCHEM, V38, P1313, DOI 10.1177/38.9.2201737; Ervin H, 2005, CANCER CELL INT, V5, DOI 10.1186/1475-2867-5-14; Evan GI, 2001, NATURE, V411, P342, DOI 10.1038/35077213; Frade R, 2008, CANCER GENE THER, V15, P591, DOI 10.1038/cgt.2008.51; Gocheva V, 2006, GENE DEV, V20, P543, DOI 10.1101/gad.1407406; GUINEC N, 1993, BIOL CHEM H-S, V374, P1135, DOI 10.1515/bchm3.1993.374.7-12.1135; Hirai K, 1999, HUM PATHOL, V30, P680, DOI 10.1016/S0046-8177(99)90094-1; Huh CG, 1999, J CLIN PATHOL-MOL PA, V52, P332, DOI 10.1136/mp.52.6.332; Jiborn T, 2006, BJU INT, V98, P189, DOI 10.1111/j.1464-410X.2006.06345.x; Joyce JA, 2004, CANCER CELL, V5, P443, DOI 10.1016/S1535-6108(04)00111-4; Kaznelson DW, 2004, VIROLOGY, V320, P301, DOI 10.1016/j.virol.2003.12.018; Kenig S, 2010, CANCER LETT, V289, P53, DOI 10.1016/j.canlet.2009.07.014; Kitamoto S, 2007, CIRCULATION, V115, P2065, DOI 10.1161/CIRCULATIONAHA.107.688523; Klein S, 2005, NAT REV CANCER, V5, P573, DOI 10.1038/nrc1651; Konduri SD, 2002, ONCOGENE, V21, P8705, DOI 10.1038/sj.onc.1205949; Kopitz C, 2005, CANCER RES, V65, P8608, DOI 10.1158/0008-5472.CAN-05-1572; Krepela E, 1998, NEOPLASMA, V45, P318; Kruszewski WJ, 2004, NEOPLASMA, V51, P38; Lakka SS, 2004, ONCOGENE, V23, P4681, DOI 10.1038/sj.onc.1207616; Mohamed MM, 2006, NAT REV CANCER, V6, P764, DOI 10.1038/nrc1949; Moin K, 1998, BIOL CHEM, V379, P1093, DOI 10.1515/bchm.1998.379.8-9.1093; Mundel TM, 2007, MICROVASC RES, V74, P85, DOI 10.1016/j.mvr.2007.05.005; Nakabayashi H, 2005, HUM PATHOL, V36, P1008, DOI 10.1016/j.humpath.2005.06.021; NEUCHRIST C, 1990, BRIT J CANCER, V62, P748, DOI 10.1038/bjc.1990.371; Nishikawa H, 2004, GYNECOL ONCOL, V92, P881, DOI 10.1016/j.ygyno.2003.11.017; Ortegel JW, 2000, CANCER IMMUNOL IMMUN, V48, P627, DOI 10.1007/s002620050011; Pennacchio LA, 1998, NAT GENET, V20, P251, DOI 10.1038/3059; Premzl A, 2003, EXP CELL RES, V283, P206, DOI 10.1016/S0014-4827(02)00055-1; Rousselet N, 2004, CANCER RES, V64, P146, DOI 10.1158/0008-5472.CAN-03-1717; Sasaki T, 2001, J MOL BIOL, V314, P751, DOI 10.1006/jmbi.2001.5176; Shi GP, 2000, J EXP MED, V191, P1177, DOI 10.1084/jem.191.7.1177; SHI GP, 1994, J BIOL CHEM, V269, P11530; Sokol JP, 2004, MOL CANCER RES, V2, P183; Stoka V, 2001, J BIOL CHEM, V276, P3149, DOI 10.1074/jbc.M008944200; Strojan P, 2004, CLIN CHIM ACTA, V344, P155, DOI 10.1016/j.cccn.2004.02.011; Sukhova GK, 2005, CIRC RES, V96, P368, DOI 10.1161/01.RES.0000155964.34150.F7; Sukhova GK, 1998, J CLIN INVEST, V102, P576, DOI 10.1172/JCI181; Sun JS, 2009, CIRCULATION, V120, P973, DOI 10.1161/CIRCULATIONAHA.109.849679; Szpaderska AM, 2001, CANCER RES, V61, P3493; Tummalapalli P, 2007, INT J ONCOL, V31, P1039; Urbich C, 2005, NAT MED, V11, P206, DOI 10.1038/nm1182; Wang B, 2006, J BIOL CHEM, V281, P6020, DOI 10.1074/jbc.M509134200; Yanamandra N, 2004, ONCOGENE, V23, P2224, DOI 10.1038/sj.onc.1207338; Yasuda Y, 2005, ADV DRUG DELIVER REV, V57, P973, DOI 10.1016/j.addr.2004.12.013; YOSHII A, 1995, ARCH DERMATOL RES, V287, P209, DOI 10.1007/BF01262334	48	21	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2010	5	11							e13973	10.1371/journal.pone.0013973	http://dx.doi.org/10.1371/journal.pone.0013973			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	680KW	21085595	Green Submitted, Green Published, gold			2022-12-27	WOS:000284231800008
J	Zhang, ZF; Shively, JE				Zhang, Zhifang; Shively, John E.			Generation of Novel Bone Forming Cells (Monoosteophils) from the Cathelicidin-Derived Peptide LL-37 Treated Monocytes	PLOS ONE			English	Article							HUMAN DENDRITIC CELLS; HUMAN ANTIBACTERIAL CATHELICIDIN; ENDOTHELIAL PROGENITOR CELLS; PERIPHERAL-BLOOD; GROWTH-FACTORS; ANTIMICROBIAL PEPTIDES; DIFFERENTIATION; OSTEOCLASTS; RECEPTOR; HCAP-18	Background: Bone generation and maintenance involve osteoblasts, osteoclasts, and osteocytes which originate from unique precursors and rely on key growth factors for differentiation. However, an incomplete understanding of bone forming cells during wound healing has led to an unfilled clinical need such as nonunion of bone fractures. Since circulating monocytes are often recruited to sites of injury and may differentiate into various cell types including osteoclasts, we investigated the possibility that circulating monocytes in the context of tissue injury may also contribute to bone repair. In particular, we hypothesized that LL-37 (produced from hCAP-18, cathelicidin), which recruits circulating monocytes during injury, may play a role in bone repair. Methods and Findings: Treatment of monocytes from blood with LL-37 for 6 days resulted in their differentiation to large adherent cells. Growth of LL-37-differentiated monocytes on osteologic discs reveals bone-like nodule formation by scanning electron microscopy (SEM). In vivo transplantation studies in NOD/SCID mice show that LL-37-differentiated monocytes form bone-like structures similar to endochondral bone formation. Importantly, LL-37-differentiated monocytes are distinct from conventional monocyte-derived osteoclasts, macrophages, and dendritic cells and do not express markers of the mesenchymal stem cells (MSC) lineage, distinguishing them from the conventional precursors of osteoblasts. Furthermore, LL-37 differentiated monocytes express intracellular proteins of both the osteoblast and osteoclast lineage including osteocalcin (OC), osteonectin (ON), bone sialoprotein II (BSP II), osteopontin (OP), RANK, RANKL, MMP-9, tartrate resistant acid phosphatase (TRAP), and cathepsin K (CK). Conclusion: Blood derived monocytes treated with LL-37 can be differentiated into a novel bone forming cell that functions both in vitro and in vivo. We propose the name monoosteophil to indicate their monocyte derived lineage and their bone forming phenotype. These cells may have wide ranging implications in the clinic including repair of broken bones and treatment of osteoporosis.	[Zhang, Zhifang; Shively, John E.] City Hope Natl Med Ctr, Beckman Res Inst, Dept Immunol, Duarte, CA USA	City of Hope; Beckman Research Institute of City of Hope	Zhang, ZF (corresponding author), City Hope Natl Med Ctr, Beckman Res Inst, Dept Immunol, Duarte, CA USA.	jshively@coh.org			National Institutes of Health (NIH) [CA84202]; NATIONAL CANCER INSTITUTE [R01CA084202] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health (NIH), CA84202. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agerberth B, 2000, BLOOD, V96, P3086, DOI 10.1182/blood.V96.9.3086.h8003086_3086_3093; Bandholtz L, 2006, SCAND J IMMUNOL, V63, P410, DOI 10.1111/j.1365-3083.2006.001752.x; Davidson DJ, 2004, J IMMUNOL, V172, P1146, DOI 10.4049/jimmunol.172.2.1146; Ducy P, 2000, SCIENCE, V289, P1501, DOI 10.1126/science.289.5484.1501; FALZONI S, 1995, J CLIN INVEST, V95, P1207, DOI 10.1172/JCI117770; Franc NC, 1996, IMMUNITY, V4, P431, DOI 10.1016/S1074-7613(00)80410-0; Frohm M, 1996, EUR J BIOCHEM, V237, P86, DOI 10.1111/j.1432-1033.1996.0086n.x; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; GORDON S, 1995, BIOESSAYS, V17, P977, DOI 10.1002/bies.950171111; Hayman AR, 2000, J HISTOCHEM CYTOCHEM, V48, P219, DOI 10.1177/002215540004800207; Heilborn JD, 2003, J INVEST DERMATOL, V120, P379, DOI 10.1046/j.1523-1747.2003.12069.x; Isenmann S, 2009, STEM CELLS, V27, P2457, DOI 10.1002/stem.181; Jilka RL, 1998, J BONE MINER RES, V13, P793, DOI 10.1359/jbmr.1998.13.5.793; Johansson J, 1998, J BIOL CHEM, V273, P3718, DOI 10.1074/jbc.273.6.3718; Kake T, 2009, AM J PHYSIOL-ENDOC M, V297, pE1339, DOI 10.1152/ajpendo.00272.2009; Kandler K, 2006, INT IMMUNOL, V18, P1729, DOI 10.1093/intimm/dxl107; Khosla S, 2008, J CLIN INVEST, V118, P421, DOI 10.1172/JCI33612; Koczulla R, 2003, J CLIN INVEST, V111, P1665, DOI 10.1172/JCI200317545; Kuwana M, 2003, J LEUKOCYTE BIOL, V74, P833, DOI 10.1189/jlb.0403170; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Malm J, 2000, INFECT IMMUN, V68, P4297, DOI 10.1128/IAI.68.7.4297-4302.2000; Manolagas SC, 2000, ENDOCR REV, V21, P115, DOI 10.1210/er.21.2.115; Miyamoto T, 2001, BLOOD, V98, P2544, DOI 10.1182/blood.V98.8.2544; Naito M, 1997, MICROSC RES TECHNIQ, V39, P350, DOI 10.1002/(SICI)1097-0029(19971115)39:4<350::AID-JEMT5>3.0.CO;2-L; Niyonsaba F, 2002, IMMUNOLOGY, V106, P20, DOI 10.1046/j.1365-2567.2002.01398.x; Nuttall ME, 2004, CURR OPIN PHARMACOL, V4, P290, DOI 10.1016/j.coph.2004.03.002; Ong PY, 2002, NEW ENGL J MED, V347, P1151, DOI 10.1056/NEJMoa021481; Palucka KA, 1999, J LEUKOCYTE BIOL, V65, P232, DOI 10.1002/jlb.65.2.232; Puig-Kroger A, 2000, J IMMUNOL, V165, P4338, DOI 10.4049/jimmunol.165.8.4338; Pujol BF, 2000, DIFFERENTIATION, V65, P287, DOI 10.1046/j.1432-0436.2000.6550287.x; Randolph GJ, 1999, IMMUNITY, V11, P753, DOI 10.1016/S1074-7613(00)80149-1; Rehman J, 2003, CIRCULATION, V107, P1164, DOI 10.1161/01.CIR.0000058702.69484.A0; Romani N, 1996, J IMMUNOL METHODS, V196, P137, DOI 10.1016/0022-1759(96)00078-6; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Schaller-Bals S, 2002, AM J RESP CRIT CARE, V165, P992, DOI 10.1164/ajrccm.165.7.200110-020; Schmeisser A, 2001, CARDIOVASC RES, V49, P671, DOI 10.1016/S0008-6363(00)00270-4; Scott MG, 2002, J IMMUNOL, V169, P3883, DOI 10.4049/jimmunol.169.7.3883; Servet-Delprat Christine, 2002, BMC Immunol, V3, P15, DOI 10.1186/1471-2172-3-15; Shapiro F, 2008, EUR CELLS MATER, V15, P53, DOI 10.22203/eCM.v015a05; Sorensen MG, 2007, J BONE MINER METAB, V25, P36, DOI 10.1007/s00774-006-0725-9; Sorensen O, 1997, BLOOD, V90, P2796; Sorensen O, 1999, J BIOL CHEM, V274, P22445, DOI 10.1074/jbc.274.32.22445; Sorensen OE, 2003, J IMMUNOL, V170, P5583, DOI 10.4049/jimmunol.170.11.5583; Sorensen OE, 2001, BLOOD, V97, P3951, DOI 10.1182/blood.V97.12.3951; Teitelbaum SL, 2003, NAT REV GENET, V4, P638, DOI 10.1038/nrg1122; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; Tjabringa GS, 2003, J IMMUNOL, V171, P6690, DOI 10.4049/jimmunol.171.12.6690; Tosello V, 2009, EUR J IMMUNOL, V39, P56, DOI 10.1002/eji.200738098; Urbich C, 2003, CIRCULATION, V108, P2511, DOI 10.1161/01.CIR.0000096483.29777.50; van der Does AM, 2010, J IMMUNOL, V185, P1442, DOI 10.4049/jimmunol.1000376; Verreck FAW, 2004, P NATL ACAD SCI USA, V101, P4560, DOI 10.1073/pnas.0400983101; Waskow C, 2008, NAT IMMUNOL, V9, P676, DOI 10.1038/ni.1615; Yang D, 2000, J EXP MED, V192, P1069, DOI 10.1084/jem.192.7.1069; Yuasa K, 2007, BIOCHEM BIOPH RES CO, V356, P354, DOI 10.1016/j.bbrc.2007.02.118; Zhang ZF, 2008, EXP BIOL MED, V233, P1171, DOI 10.3181/0712-RM-328; Zhang ZF, 2008, J LEUKOCYTE BIOL, V84, P780, DOI 10.1189/jlb.0208086; Zhang ZF, 2009, EUR J IMMUNOL, V39, P3181, DOI 10.1002/eji.200939496; Zhao Y, 2003, P NATL ACAD SCI USA, V100, P2426, DOI 10.1073/pnas.0536882100; Zhou LJ, 1996, P NATL ACAD SCI USA, V93, P2588, DOI 10.1073/pnas.93.6.2588	59	39	41	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2010	5	11							e13985	10.1371/journal.pone.0013985	http://dx.doi.org/10.1371/journal.pone.0013985			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	680KW	21085494	Green Submitted, Green Published, gold			2022-12-27	WOS:000284231800015
J	Barz, M; Beimgraben, C; Staller, T; Germer, F; Opitz, F; Marquardt, C; Schwarz, C; Gutekunst, K; Vanselow, KH; Schmitz, R; LaRoche, J; Schulz, R; Appel, J				Barz, Martin; Beimgraben, Christian; Staller, Torsten; Germer, Frauke; Opitz, Friederike; Marquardt, Claudia; Schwarz, Christoph; Gutekunst, Kirstin; Vanselow, Klaus Heinrich; Schmitz, Ruth; LaRoche, Julie; Schulz, Ruediger; Appel, Jens			Distribution Analysis of Hydrogenases in Surface Waters of Marine and Freshwater Environments	PLOS ONE			English	Article							OCEAN SAMPLING EXPEDITION; SP PCC 6803; MOLECULAR-HYDROGEN; ALCALIGENES-EUTROPHUS; NITROGEN-FIXATION; NIFE-HYDROGENASE; BIDIRECTIONAL HYDROGENASE; DISSOLVED HYDROGEN; RALSTONIA-EUTROPHA; ESCHERICHIA-COLI	Background: Surface waters of aquatic environments have been shown to both evolve and consume hydrogen and the ocean is estimated to be the principal natural source. In some marine habitats, H-2 evolution and uptake are clearly due to biological activity, while contributions of abiotic sources must be considered in others. Until now the only known biological process involved in H-2 metabolism in marine environments is nitrogen fixation. Principal Findings: We analyzed marine and freshwater environments for the presence and distribution of genes of all known hydrogenases, the enzymes involved in biological hydrogen turnover. The total genomes and the available marine metagenome datasets were searched for hydrogenase sequences. Furthermore, we isolated DNA from samples from the North Atlantic, Mediterranean Sea, North Sea, Baltic Sea, and two fresh water lakes and amplified and sequenced part of the gene encoding the bidirectional NAD(P)-linked hydrogenase. In 21% of all marine heterotrophic bacterial genomes from surface waters, one or several hydrogenase genes were found, with the membrane-bound H-2 uptake hydrogenase being the most widespread. A clear bias of hydrogenases to environments with terrestrial influence was found. This is exemplified by the cyanobacterial bidirectional NAD(P)-linked hydrogenase that was found in freshwater and coastal areas but not in the open ocean. Significance: This study shows that hydrogenases are surprisingly abundant in marine environments. Due to its ecological distribution the primary function of the bidirectional NAD(P)-linked hydrogenase seems to be fermentative hydrogen evolution. Moreover, our data suggests that marine surface waters could be an interesting source of oxygen-resistant uptake hydrogenases. The respective genes occur in coastal as well as open ocean habitats and we presume that they are used as additional energy scavenging devices in otherwise nutrient limited environments. The membrane-bound H-2-evolving hydrogenases might be useful as marker for bacteria living inside of marine snow particles.	[Barz, Martin; Beimgraben, Christian; Germer, Frauke; Opitz, Friederike; Marquardt, Claudia; Schulz, Ruediger] Univ Kiel, Inst Bot, D-2300 Kiel, Germany; [Staller, Torsten; Vanselow, Klaus Heinrich] Univ Kiel, Forsch & Technol Zentrum Westkuste FTZ, Busum, Germany; [Schwarz, Christoph; Gutekunst, Kirstin; Appel, Jens] Arizona State Univ, Sch Life Sci, Tempe, AZ USA; [Schmitz, Ruth] Univ Kiel, Inst Allgemeine Mikrobiol, D-2300 Kiel, Germany; [LaRoche, Julie] IFM GEOMAR, Leibniz Inst Marine Sci, Kiel, Germany	University of Kiel; University of Kiel; Arizona State University; Arizona State University-Tempe; University of Kiel; Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel	Barz, M (corresponding author), Univ Kiel, Inst Bot, Olshausenstr 40, D-2300 Kiel, Germany.	jens.appel@asu.edu	LaRoche, Julie/A-1109-2010	Gutekunst, Kirstin/0000-0003-4366-423X; Appel, Jens/0000-0002-0658-7899; LaRoche, Julie/0000-0003-4809-6411	Innovationsfond Schleswig-Holstein, Linde AG; cluster of excellence "Future Ocean"	Innovationsfond Schleswig-Holstein, Linde AG; cluster of excellence "Future Ocean"	Funding: Financial support was from the Innovationsfond Schleswig-Holstein, Linde AG and from the cluster of excellence "Future Ocean". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Appel J, 2000, ARCH MICROBIOL, V173, P333, DOI 10.1007/s002030000139; Appel J, 1996, BBA-PROTEIN STRUCT M, V1298, P141, DOI 10.1016/S0167-4838(96)00176-8; Appel J, 1998, J PHOTOCH PHOTOBIO B, V47, P1, DOI 10.1016/S1011-1344(98)00179-1; Arahal DR, 2007, INT J SYST EVOL MICR, V57, P1000, DOI 10.1099/ijs.0.64524-0; BALLANTINE SP, 1986, EUR J BIOCHEM, V156, P277, DOI 10.1111/j.1432-1033.1986.tb09578.x; Bernhard M, 1996, J BACTERIOL, V178, P4522, DOI 10.1128/jb.178.15.4522-4529.1996; Boyd ES, 2009, APPL ENVIRON MICROB, V75, P4620, DOI 10.1128/AEM.00582-09; BOYD ES, 2010, ISME J          0610; Buhrke T, 2004, MOL MICROBIOL, V51, P1677, DOI 10.1111/j.1365-2958.2003.03933.x; Buhrke T, 1998, ARCH MICROBIOL, V170, P460, DOI 10.1007/s002030050667; Burgdorf T, 2005, J MOL MICROB BIOTECH, V10, P181, DOI 10.1159/000091564; CONRAD R, 1980, J GEOPHYS RES-OCEANS, V85, P5493, DOI 10.1029/JC085iC10p05493; Conrad R, 1996, MICROBIOL REV, V60, P609, DOI 10.1128/MMBR.60.4.609-640.1996; CONRAD R, 1988, DEEP-SEA RES, V35, P1903, DOI 10.1016/0198-0149(88)90116-1; CONRAD R, 1983, APPL ENVIRON MICROB, V45, P502, DOI 10.1128/AEM.45.2.502-510.1983; Constant P, 2010, ENVIRON MICROBIOL, V12, P821, DOI 10.1111/j.1462-2920.2009.02130.x; Cournac L, 2004, J BACTERIOL, V186, P1737, DOI 10.1128/JB.186.6.1737-1746.2003; Cournac L, 2002, INT J HYDROGEN ENERG, V27, P1229, DOI 10.1016/S0360-3199(02)00105-2; Cracknell JA, 2008, J AM CHEM SOC, V130, P424, DOI 10.1021/ja078299+; Cummings L, 2002, FEMS MICROBIOL LETT, V216, P133, DOI 10.1016/S0378-1097(02)00955-2; DeLong EE, 2005, NAT REV MICROBIOL, V3, P459, DOI 10.1038/nrmicro1158; Ehhalt DH, 2009, TELLUS B, V61, P500, DOI 10.1111/j.1600-0889.2009.00416.x; Elsen S, 2003, J BACTERIOL, V185, P7111, DOI 10.1128/JB.185.24.7111-7119.2003; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; FITCH WM, 1967, SCIENCE, V155, P279, DOI 10.1126/science.155.3760.279; Fong AA, 2008, ISME J, V2, P663, DOI 10.1038/ismej.2008.22; Fontecilla-Camps JC, 2007, CHEM REV, V107, P4273, DOI 10.1021/cr050195z; Giovannoni SJ, 2005, NATURE, V437, P343, DOI 10.1038/nature04158; Gonzalez JM, 1997, APPL ENVIRON MICROB, V63, P4237; Gutekunst K, 2006, INT J HYDROGEN ENERG, V31, P1452, DOI 10.1016/j.ijhydene.2006.06.010; Gutthann F, 2007, BBA-BIOENERGETICS, V1767, P161, DOI 10.1016/j.bbabio.2006.12.003; Hedderich R, 2005, J MOL MICROB BIOTECH, V10, P92, DOI 10.1159/000091557; HERR FL, 1984, DEEP-SEA RES, V31, P13, DOI 10.1016/0198-0149(84)90069-4; HERR FL, 1981, DEEP-SEA RES, V28, P1001, DOI 10.1016/0198-0149(81)90014-5; Hoehler TM, 2001, NATURE, V412, P324, DOI 10.1038/35085554; IARSMARTINEZ E, 2008, ISME J, V2, P1194; King GM, 2007, NAT REV MICROBIOL, V5, P107, DOI 10.1038/nrmicro1595; King GM, 2003, APPL ENVIRON MICROB, V69, P7266, DOI 10.1128/AEM.69.12.7266-7272.2003; Langlois RJ, 2008, APPL ENVIRON MICROB, V74, P1922, DOI 10.1128/AEM.01720-07; Lechner S, 1997, FEMS MICROBIOL ECOL, V22, P193, DOI 10.1016/S0168-6496(96)00090-6; Lenz O, 1998, P NATL ACAD SCI USA, V95, P12474, DOI 10.1073/pnas.95.21.12474; Lindberg P, 2004, APPL ENVIRON MICROB, V70, P2137, DOI 10.1128/AEM.70.4.2137-2145.2004; Ludwig M, 2006, J MOL EVOL, V63, P758, DOI 10.1007/s00239-006-0001-6; Ludwig M, 2009, J BIOL CHEM, V284, P2159, DOI 10.1074/jbc.M808488200; Lukey MJ, 2010, J BIOL CHEM, V285, P3928, DOI 10.1074/jbc.M109.067751; Maroti G, 2009, APPL ENVIRON MICROB, V75, P5821, DOI 10.1128/AEM.00580-09; MITSUI A, 1995, CURR MICROBIOL, V30, P1, DOI 10.1007/BF00294515; Montoya JP, 2004, NATURE, V430, P1027, DOI 10.1038/nature02824; Moran MA, 2007, NAT REV MICROBIOL, V5, P792, DOI 10.1038/nrmicro1746; Morita RY, 1999, MICROB ECOL, V38, P307, DOI 10.1007/s002489901002; Ng G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004695; Novelli PC, 1999, J GEOPHYS RES-ATMOS, V104, P30427, DOI 10.1029/1999JD900788; ORTEGA-CALVO JJ, 1991, J GEN MICROBIOL, V137, P1789; Paulmier A, 2009, PROG OCEANOGR, V80, P113, DOI 10.1016/j.pocean.2008.08.001; Pedros-Alio C, 2006, TRENDS MICROBIOL, V14, P257, DOI 10.1016/j.tim.2006.04.007; Ploug H, 1997, AQUAT MICROB ECOL, V13, P285, DOI 10.3354/ame013285; Poretsky RS, 2009, ENVIRON MICROBIOL, V11, P1358, DOI 10.1111/j.1462-2920.2008.01863.x; Price H, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD008152; Punshon S, 2008, MAR CHEM, V108, P215, DOI 10.1016/j.marchem.2007.11.010; Punshon S, 2007, MAR CHEM, V105, P129, DOI 10.1016/j.marchem.2007.01.009; Redwood MD, 2008, FEMS MICROBIOL LETT, V278, P48, DOI 10.1111/j.1574-6968.2007.00966.x; RHAN T, 2003, NATURE, V424, P918; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Sawers RG, 2005, BIOCHEM SOC T, V33, P42, DOI 10.1042/BST0330042; SCHMIDT U, 1993, LIMNOL OCEANOGR, V38, P1214, DOI 10.4319/lo.1993.38.6.1214; Schmitz O, 1996, NATURWISSENSCHAFTEN, V83, P525; SCHUTZ H, 1988, BIOGEOCHEMISTRY, V5, P295, DOI 10.1007/BF02180069; SCHWARTZ E, 2005, HDB BIOL BACTERIA EC, V2, P496; SCRANTON MI, 1982, J MAR RES, V40, P873; SCRANTON MI, 1987, LIMNOL OCEANOGR, V32, P998, DOI 10.4319/lo.1987.32.4.0998; Sorokin YI., 2002, BIO INL WAT; Tamagnini P, 2007, FEMS MICROBIOL REV, V31, P692, DOI 10.1111/j.1574-6976.2007.00085.x; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tripp HJ, 2010, NATURE, V464, P90, DOI 10.1038/nature08786; Troshina O, 2002, INT J HYDROGEN ENERG, V27, P1283, DOI 10.1016/S0360-3199(02)00103-9; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Vignais PM, 2007, CHEM REV, V107, P4206, DOI 10.1021/cr050196r; Vignais PM, 2005, BIOCHEM SOC T, V33, P28, DOI 10.1042/BST0330028; Vignais PM, 2001, FEMS MICROBIOL REV, V25, P455, DOI 10.1111/j.1574-6976.2001.tb00587.x; Vincent KA, 2006, CHEM COMMUN, P5033, DOI 10.1039/b614272a; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578; Yooseph S, 2007, PLOS BIOL, V5, P432, DOI 10.1371/journal.pbio.0050016; Yutin N, 2007, ENVIRON MICROBIOL, V9, P1464, DOI 10.1111/j.1462-2920.2007.01265.x; Zehr JP, 2008, SCIENCE, V322, P1110, DOI 10.1126/science.1165340; Zehr JP, 2001, NATURE, V412, P635, DOI 10.1038/35088063	86	39	41	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2010	5	11							e13846	10.1371/journal.pone.0013846	http://dx.doi.org/10.1371/journal.pone.0013846			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675OD	21079771	Green Published, gold, Green Accepted			2022-12-27	WOS:000283839100007
J	Nordstrand, LM; Svard, J; Larsen, E; Nilsen, A; Ougland, R; Furu, K; Lien, GF; Rognes, T; Namekawa, SH; Lee, JT; Klungland, A				Nordstrand, Line M.; Svard, Jessica; Larsen, Elisabeth; Nilsen, Anja; Ougland, Rune; Furu, Kari; Lien, Guro F.; Rognes, Torbjorn; Namekawa, Satoshi H.; Lee, Jeannie T.; Klungland, Arne			Mice Lacking Alkbh1 Display Sex-Ratio Distortion and Unilateral Eye Defects	PLOS ONE			English	Article							GERM-CELL APOPTOSIS; ALKYLATION DAMAGE; OXIDATIVE DEMETHYLATION; MOUSE DEVELOPMENT; ESCHERICHIA-COLI; GENE ENCODES; DNA-DAMAGE; PROTEIN; RNA; EXPRESSION	Background: Eschericia coli AlkB is a 2-oxoglutarate- and iron-dependent dioxygenase that reverses alkylated DNA damage by oxidative demethylation. Mouse AlkB homolog 1 (Alkbh1) is one of eight members of the newly discovered family of mammalian dioxygenases. Methods and Findings: In the present study we show non-Mendelian inheritance of the Alkbh1 targeted allele in mice. Both Alkbh1(-/-) and heterozygous Alkbh1(+/-) offspring are born at a greatly reduced frequency. Additionally, the sex-ratio is considerably skewed against female offspring, with one female born for every three to four males. Most mechanisms that cause segregation distortion, act in the male gametes and affect male fertility. The skewing of the sexes appears to be of paternal origin, and might be set in the pachythene stage of meiosis during spermatogenesis, in which Alkbh1 is upregulated more than 10-fold. In testes, apoptotic spermatids were revealed in 5-10% of the tubules in Alkbh1(-/-) adults. The deficiency of Alkbh1 also causes misexpression of Bmp2, 4 and 7 at E11.5 during embryonic development. This is consistent with the incompletely penetrant phenotypes observed, particularly recurrent unilateral eye defects and craniofacial malformations. Conclusions: Genetic and phenotypic assessment suggests that Alkbh1 mediates gene regulation in spermatogenesis, and that Alkbh1 is essential for normal sex-ratio distribution and embryonic development in mice.	[Nordstrand, Line M.; Svard, Jessica; Larsen, Elisabeth; Nilsen, Anja; Ougland, Rune; Furu, Kari; Lien, Guro F.; Rognes, Torbjorn; Klungland, Arne] Oslo Univ Hosp, Inst Med Microbiol, Ctr Mol Biol & Neurosci, Oslo, Norway; [Rognes, Torbjorn] Univ Oslo, Dept Informat, N-0316 Oslo, Norway; [Larsen, Elisabeth; Ougland, Rune; Namekawa, Satoshi H.; Lee, Jeannie T.] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Klungland, Arne] Univ Oslo, Inst Basic Med Sci, Oslo, Norway; [Lee, Jeannie T.] Massachusetts Gen Hosp, Howard Hughes Med Inst, Boston, MA 02114 USA	University of Oslo; University of Oslo; Harvard University; Massachusetts General Hospital; University of Oslo; Harvard University; Massachusetts General Hospital; Howard Hughes Medical Institute	Nordstrand, LM (corresponding author), Oslo Univ Hosp, Inst Med Microbiol, Ctr Mol Biol & Neurosci, Oslo, Norway.	arne.klungland@rr-research.no	Rognes, Torbjørn/A-9692-2008; Klungland, Arne/X-1233-2019	Rognes, Torbjørn/0000-0002-9329-9974; Klungland, Arne/0000-0001-7274-3661	Norwegian Research Council; Norwegian Cancer Society; European Union	Norwegian Research Council(Research Council of NorwayEuropean Commission); Norwegian Cancer Society(Norwegian Cancer Society); European Union(European Commission)	This work was supported by the National Program in Functional Genomics (FUGE) sponsored by the Norwegian Research Council, the Norwegian Cancer Society and the European Union program 'DNA repair'. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aas PA, 2003, NATURE, V421, P859, DOI 10.1038/nature01363; Avraham S, 1997, GENE, V204, P5, DOI 10.1016/S0378-1119(97)00420-4; Baldridge D, 2010, ANNU REV GENOM HUM G, V11, P189, DOI 10.1146/annurev-genom-082908-150158; Bandyopadhyay A, 2006, PLOS GENET, V2, P2116, DOI 10.1371/journal.pgen.0020216; BELLVE AR, 1993, METHOD ENZYMOL, V225, P84; Beltran PJ, 2003, J COMP NEUROL, V456, P384, DOI 10.1002/cne.10532; Boissel S, 2009, AM J HUM GENET, V85, P106, DOI 10.1016/j.ajhg.2009.06.002; BOSE J, 2004, J BIOL LONDON, V3, pNIL5; Castranio T, 2009, DEV DYNAM, V238, P110, DOI 10.1002/dvdy.21829; Chang BS, 2007, SCIENCE, V318, P444, DOI 10.1126/science.1145801; Copp AJ, 2003, NAT REV GENET, V4, P784, DOI 10.1038/nrg1181; Deng W, 2002, DEV CELL, V2, P819, DOI 10.1016/S1534-5807(02)00165-X; Dix DJ, 1996, P NATL ACAD SCI USA, V93, P3264, DOI 10.1073/pnas.93.8.3264; Ducy P, 2000, KIDNEY INT, V57, P2207, DOI 10.1046/j.1523-1755.2000.00081.x; Duncan T, 2002, P NATL ACAD SCI USA, V99, P16660, DOI 10.1073/pnas.262589799; Dunn NR, 1997, DEV BIOL, V188, P235, DOI 10.1006/dbio.1997.8664; Falnes PO, 2007, NEUROSCIENCE, V145, P1222, DOI 10.1016/j.neuroscience.2006.11.018; Falnes PO, 2002, NATURE, V419, P178, DOI 10.1038/nature01048; Fu D, 2010, MOL CELL BIOL, V30, P2449, DOI 10.1128/MCB.01604-09; Gerken T, 2007, SCIENCE, V318, P1469, DOI 10.1126/science.1151710; Glazier AM, 2002, SCIENCE, V298, P2345, DOI 10.1126/science.1076641; Graw J, 2003, NAT REV GENET, V4, P876, DOI 10.1038/nrg1202; Hall BK, 2000, BIOESSAYS, V22, P138, DOI 10.1002/(SICI)1521-1878(200002)22:2<138::AID-BIES5>3.3.CO;2-W; Han ZF, 2010, NATURE, V464, P1205, DOI 10.1038/nature08921; KATAOKA H, 1983, J BACTERIOL, V153, P1301, DOI 10.1128/JB.153.3.1301-1307.1983; Kawakatsu T, 2005, J BIOL CHEM, V280, P4940, DOI 10.1074/jbc.M408710200; Kurowski MA, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-48; Lee DH, 2005, J BIOL CHEM, V280, P39448, DOI 10.1074/jbc.M509881200; Li MO, 2003, SCIENCE, V302, P1560, DOI 10.1126/science.1087621; Liu D, 1998, NAT GENET, V20, P377, DOI 10.1038/3855; Liu Y, 2004, BIOCHEM BIOPH RES CO, V322, P497, DOI 10.1016/j.bbrc.2004.07.161; LIU Z, 2009, J BIOL CHEM; Loenarz C, 2008, NAT CHEM BIOL, V4, P152, DOI 10.1038/nchembio0308-152; Martianov I, 2001, MOL CELL, V7, P509, DOI 10.1016/S1097-2765(01)00198-8; Monsen VT, 2010, NUCLEIC ACIDS RES, V38, P6447, DOI 10.1093/nar/gkq518; Ohkubo Y, 2002, NEUROSCIENCE, V111, P1, DOI 10.1016/S0306-4522(01)00616-9; Pan ZS, 2008, DEV DYNAM, V237, P316, DOI 10.1002/dvdy.21418; Raya A, 2004, NATURE, V427, P121, DOI 10.1038/nature02190; Ringvoll J, 2006, EMBO J, V25, P2189, DOI 10.1038/sj.emboj.7601109; Rizzoti K, 2007, DEVELOPMENT, V134, P3437, DOI 10.1242/dev.007906; Robert B, 2007, DEV GROWTH DIFFER, V49, P455, DOI 10.1111/j.1440-169x.2007.00946.x; Ruggiu M, 1997, NATURE, V389, P73, DOI 10.1038/37987; Sedgwick B, 2004, NAT REV MOL CELL BIO, V5, P148, DOI 10.1038/nrm1312; Sedgwick B, 2006, METHOD ENZYMOL, V408, P108, DOI 10.1016/S0076-6879(06)08008-6; Shimada K, 2009, CANCER RES, V69, P3157, DOI 10.1158/0008-5472.CAN-08-3530; Sinha KM, 2010, EMBO J, V29, P68, DOI 10.1038/emboj.2009.332; SOLARI AJ, 1974, INT REV CYTOL, V38, P273, DOI 10.1016/S0074-7696(08)60928-6; Songe-Moller L, 2010, MOL CELL BIOL, V30, P1814, DOI 10.1128/MCB.01602-09; Tachibana M, 2007, EMBO J, V26, P3346, DOI 10.1038/sj.emboj.7601767; Tanaka SS, 2000, GENE DEV, V14, P841; Taylor DR, 2003, GENETICA, V117, P27, DOI 10.1023/A:1022308414864; Trewick SC, 2002, NATURE, V419, P174, DOI 10.1038/nature00908; Tsujikawa K, 2007, J CELL MOL MED, V11, P1105, DOI 10.1111/j.1582-4934.2007.00094.x; Tsukada Y, 2006, NATURE, V439, P811, DOI 10.1038/nature04433; Uchimura T, 2009, GENESIS, V47, P374, DOI 10.1002/dvg.20511; van Heyningen V, 2004, HUM MOL GENET, V13, pR225, DOI 10.1093/hmg/ddh254; Wang SS, 2004, DEVELOPMENT, V131, P4381, DOI 10.1242/dev.01269; Westbye MP, 2008, J BIOL CHEM, V283, P25046, DOI 10.1074/jbc.M803776200; Wordinger RJ, 2007, EXP BIOL MED, V232, P979, DOI 10.3181/0510-MR-345; Wyatt AW, 2010, HUM MUTAT, V31, P781, DOI 10.1002/humu.21280; Zhang D, 2001, SCIENCE, V292, P1153, DOI 10.1126/science.1059188; Zhu DH, 1997, DEVELOPMENT, V124, P3007	62	51	53	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2010	5	11							e13827	10.1371/journal.pone.0013827	http://dx.doi.org/10.1371/journal.pone.0013827			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	674WJ	21072209	Green Published, Green Submitted, gold			2022-12-27	WOS:000283780800024
J	Schroeder, M; Shbiro, L; Moran, TH; Weller, A				Schroeder, Mariana; Shbiro, Liat; Moran, Timothy H.; Weller, Aron			Maternal Environmental Contribution to Adult Sensitivity and Resistance to Obesity in Long Evans Rats	PLOS ONE			English	Article							DIET-INDUCED OBESITY; OLETF RATS; FAT; EXPRESSION; SUSCEPTIBILITY; BEHAVIOR; IMPROVES; ONSET	Background: The OLETF rat is an animal model of early onset hyperphagia induced obesity, presenting multiple pre-obese characteristics during the suckling period. In the present study, we used a cross-fostering strategy to assess whether interactions with obese dams in the postnatal environment contributed to the development of obesity. Methodology: On postnatal Day (PND)-1 OLETF and control LETO pups were cross-fostered to same or opposite strain dams. An independent ingestion test was performed on PND11 and a nursing test on PND18. Rats were sacrificed at weaning or on PND90, and plasma leptin, insulin, cholesterol, triglycerides and alanine aminotransferase (ALT) were assayed. Fat pads were collected and weighed and adipocyte size and number were estimated. Body weight and intake, as well as the estrous cycle of the female offspring were monitored. Principal Findings: During the suckling period, the pups' phenotype was almost completely determined by the strain of the mother. However, pups independently ingested food according to their genotype, regardless of their actual phenotype. At adulthood, cross fostered males of both strains and LETO females were affected in regard of their adiposity levels in the direction of the foster dam. On the other hand, OLETF females showed almost no alterations in adiposity but were affected by the strain of the dams in parameters related to the metabolic syndrome. Thus, OLETF females showed reduced liver adiposity and circulating levels of ALT, while LETO females presented a disrupted estrous cycle and increased cholesterol and triglycerides in the long term. Conclusions: The present study provides further support for the early postnatal environment playing a sex-divergent role in programming later life phenotype. In addition, it plays a more central role in determining the functioning of mechanisms involved in energy balance that may provide protection from or sensitivity to later life obesity and pathologies related to the metabolic syndrome.	[Schroeder, Mariana; Shbiro, Liat; Weller, Aron] Bar Ilan Univ, Dept Psychol, Ramat Gan, Israel; [Schroeder, Mariana; Shbiro, Liat; Weller, Aron] Bar Ilan Univ, Gonda Goldschmied Brain Res Ctr, Ramat Gan, Israel; [Moran, Timothy H.] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA	Bar Ilan University; Bar Ilan University; Johns Hopkins University	Schroeder, M (corresponding author), Bar Ilan Univ, Dept Psychol, Ramat Gan, Israel.	schatzyo@gmail.com	Schroeder, Mariana/AAA-9216-2020; Weller, Aron/AAU-3074-2020	Schroeder, Mariana/0000-0002-9517-4243; Weller, Aron/0000-0002-0663-4384	NIH/NIDDK [RO1 DK57609]; Bar-Ilan University; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK057609, P30DK079637] Funding Source: NIH RePORTER	NIH/NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Bar-Ilan University; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH/NIDDK - RO1 DK57609. The first two authors (MS and LS) were supported by President's Fellowships, Bar-Ilan University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASHWELL M, 1976, J LIPID RES, V17, P190; Attig L, 2008, INT J OBESITY, V32, P1153, DOI 10.1038/ijo.2008.39; Bergman RN, 2006, OBESITY, V14, p16S, DOI 10.1038/oby.2006.277; Blumberg S, 2006, AM J PHYSIOL-REG I, V290, pR208, DOI 10.1152/ajpregu.00379.2005; GIBBS J, 1973, NATURE, V245, P323, DOI 10.1038/245323a0; Gorski JN, 2006, AM J PHYSIOL-REG I, V291, pR768, DOI 10.1152/ajpregu.00138.2006; Gorski JN, 2007, AM J PHYSIOL-REG I, V292, pR1782, DOI 10.1152/ajpregu.00749.2006; KAWANO K, 1994, DIABETES RES CLIN PR, V24, pS317, DOI 10.1016/0168-8227(94)90269-0; KAWANO K, 1992, DIABETES, V41, P1422, DOI 10.2337/diabetes.41.11.1422; Lavi-Avnon Y, 2007, DEV PSYCHOBIOL, V49, P685, DOI 10.1002/dev.20235; Levin BE, 1998, AM J PHYSIOL-REG I, V275, pR1374, DOI 10.1152/ajpregu.1998.275.4.R1374; MacLean PS, 2006, AM J PHYSIOL-REG I, V290, pR1577, DOI 10.1152/ajpregu.00810.2005; Moran TH, 2006, DEV PSYCHOBIOL, V48, P360, DOI 10.1002/dev.20149; Morris RT, 2008, J APPL PHYSIOL, V104, P708, DOI 10.1152/japplphysiol.01034.2007; Nakamura H, 1998, J GASTROENTEROL, V33, P702, DOI 10.1007/s005350050158; Park SY, 2005, ARCH BIOCHEM BIOPHYS, V436, P276, DOI 10.1016/j.abb.2005.01.010; Plagemann A, 2006, HORM RES, V65, P83, DOI 10.1159/000091511; Reifsnyder PC, 2000, GENOME RES, V10, P1568, DOI 10.1101/gr.147000; Schroeder M, 2007, DEV PSYCHOBIOL, V49, P323, DOI 10.1002/dev.20206; Schroeder M, 2006, PHYSIOL BEHAV, V89, P402, DOI 10.1016/j.physbeh.2006.07.008; Schroeder M, 2009, AM J PHYSIOL-REG I, V297, pR1749, DOI 10.1152/ajpregu.00461.2009; Schroeder M, 2009, AM J PHYSIOL-REG I, V296, pR224, DOI 10.1152/ajpregu.90697.2008; Schroeder M, 2009, DEV PSYCHOBIOL, V51, P358, DOI 10.1002/dev.20374; Srinivasan M, 2006, AM J PHYSIOL-ENDOC M, V291, pE792, DOI 10.1152/ajpendo.00078.2006; Tamashiro KLK, 2009, DIABETES, V58, P1116, DOI 10.2337/db08-1129; Taylor PD, 2007, EXP PHYSIOL, V92, P287, DOI 10.1113/expphysiol.2005.032854; Trottier G, 1998, ENDOCRINOLOGY, V139, P3704, DOI 10.1210/en.139.9.3704; Watanobe H, 2001, NEUROPEPTIDES, V35, P45, DOI 10.1054/npep.2000.0842; Weller A, 2006, DEV PSYCHOBIOL, V48, P368, DOI 10.1002/dev.20148; Yura S, 2005, CELL METAB, V1, P371, DOI 10.1016/j.cmet.2005.05.005; Yura S, 2008, OBESITY, V16, P1289, DOI 10.1038/oby.2008.57	31	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2010	5	11							e13825	10.1371/journal.pone.0013825	http://dx.doi.org/10.1371/journal.pone.0013825			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	674WJ	21072207	gold, Green Published, Green Submitted			2022-12-27	WOS:000283780800022
J	Muradrasoli, S; Balint, A; Wahlgren, J; Waldenstrom, J; Belak, S; Blomberg, J; Olsen, B				Muradrasoli, Shaman; Balint, Adam; Wahlgren, John; Waldenstrom, Jonas; Belak, Sandor; Blomberg, Jonas; Olsen, Bjorn			Prevalence and Phylogeny of Coronaviruses in Wild Birds from the Bering Strait Area (Beringia)	PLOS ONE			English	Article							INFECTIOUS-BRONCHITIS VIRUS; SEQUENCE; IDENTIFICATION; RESERVOIRS; REVEALS; HKU1	Coronaviruses (CoVs) can cause mild to severe disease in humans and animals, their host range and environmental spread seem to have been largely underestimated, and they are currently being investigated for their potential medical relevance. Infectious bronchitis virus (IBV) belongs to gamma-coronaviruses and causes a costly respiratory viral disease in chickens. The role of wild birds in the epidemiology of IBV is poorly understood. In the present study, we examined 1,002 cloacal and faecal samples collected from 26 wild bird species in the Beringia area for the presence of CoVs, and then we performed statistical and phylogenetic analyses. We detected diverse CoVs by RT-PCR in wild birds in the Beringia area. Sequence analysis showed that the detected viruses are gamma-coronaviruses related to IBV. These findings suggest that wild birds are able to carry gamma-coronaviruses asymptomatically. We concluded that CoVs are widespread among wild birds in Beringia, and their geographic spread and frequency is higher than previously realised. Thus, Avian CoV can be efficiently disseminated over large distances and could be a genetic reservoir for future emerging pathogenic CoVs. Considering the great animal health and economic impact of IBV as well as the recent emergence of novel coronaviruses such as SARS-coronavirus, it is important to investigate the role of wildlife reservoirs in CoV infection biology and epidemiology.	[Muradrasoli, Shaman; Blomberg, Jonas] Uppsala Univ, Dept Med Sci, Sect Clin Virol, Uppsala, Sweden; [Muradrasoli, Shaman] Swedish Univ Agr Sci, Dept Biomed Sci & Vet Publ Hlth, Sect Bacteriol & Food Safety, Uppsala, Sweden; [Balint, Adam; Belak, Sandor] Swedish Univ Agr Sci, Dept Virol, Joint Res & Dev Div, Uppsala, Sweden; [Balint, Adam; Belak, Sandor] Swedish Univ Agr Sci, Dept Parasitol, Joint Res & Dev Div, Uppsala, Sweden; [Balint, Adam; Belak, Sandor] Natl Vet Inst, S-75007 Uppsala, Sweden; [Wahlgren, John] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden; [Wahlgren, John; Waldenstrom, Jonas] Swedish Inst Infect Dis Control, Solna, Sweden; [Olsen, Bjorn] Linneaus Univ, Sect Zoonot Ecol & Epidemiol, Kalmar, Sweden; [Olsen, Bjorn] Uppsala Univ, Dept Med Sci, Infect Dis Sect, Uppsala, Sweden	Uppsala University; Swedish University of Agricultural Sciences; Swedish University of Agricultural Sciences; Swedish University of Agricultural Sciences; National Veterinary Institute SVA; Karolinska Institutet; Swedish Institute for Infectious Disease Control; Linnaeus University; Uppsala University	Muradrasoli, S (corresponding author), Uppsala Univ, Dept Med Sci, Sect Clin Virol, Uppsala, Sweden.	shaman.muradrasoli@bvf.slu.se	Belak, Sandor/AAP-4759-2021; Waldenström, Jonas/E-4460-2013	Waldenström, Jonas/0000-0002-1152-4235; Blomberg, Jonas/0000-0001-6492-2491; Olsen, Bjorn/0000-0002-4646-691X	Swedish Research Council [2004-5489, 2008-6892]; Research Council FORMAS [2005-51]; Swedish University of Agriculture	Swedish Research Council(Swedish Research CouncilEuropean Commission); Research Council FORMAS(Swedish Research Council Formas); Swedish University of Agriculture	This work was financially supported by the Swedish Research Council VR (2004-5489, 2008-6892) (http://www.vr.se), and the Research Council FORMAS (2005-51) (http://www.formas.se/). This work was also supported by the Award of Excellence of the Swedish University of Agriculture (2007) granted to Prof. Sandor Belak. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cao J, 2008, VIRUS RES, V136, P43, DOI 10.1016/j.virusres.2008.04.015; Cavanagh D, 2005, AVIAN PATHOL, V34, P439, DOI 10.1080/03079450500367682; Cavanagh D, 2005, AVIAN PATHOL, V34, P20, DOI 10.1080/03079450400025414; Cavanagh D, 1997, ARCH VIROL, V142, P629; Cavanagh D, 2002, AVIAN PATHOL, V31, P81, DOI 10.1080/03079450120106651; Cavanagh D, 2001, AVIAN PATHOL, V30, P355, DOI 10.1080/03079450120066368; Cavanagh D, 2007, VET RES, V38, P281, DOI 10.1051/vetres:2006055; Chua KB, 2000, SCIENCE, V288, P1432, DOI 10.1126/science.288.5470.1432; Dong BQ, 2007, J VIROL, V81, P6920, DOI 10.1128/JVI.00299-07; Escutenaire S, 2007, ARCH VIROL, V152, P41, DOI 10.1007/s00705-006-0840-x; Felsenstein J., 2004, PHYLIP PHYLOGENY INF; Gomaa MH, 2008, VIRUS RES, V135, P237, DOI 10.1016/j.virusres.2008.03.020; Gonzaalez JM, 2003, ARCH VIROL, V148, P2207, DOI 10.1007/s00705-003-0162-1; GORMAN OT, 1992, CURR TOP MICROBIOL, V176, P75; GUYJS, 2000, AVIAN PATHOL, V29, P207; HALL TA, 1999, Windows Nucl Acids S, V41, P95; HANKS J, 1976, 33 TISS CULT ASS; Hughes LA, 2009, EMERG INFECT DIS, V15, P1091, DOI 10.3201/eid1507.090067; Jonassen CM, 2005, J GEN VIROL, V86, P1597, DOI 10.1099/vir.0.80927-0; Keele BF, 2006, SCIENCE, V313, P523, DOI 10.1126/science.1126531; Leroy EM, 2005, NATURE, V438, P575, DOI 10.1038/438575a; Lindstrom Ake, 2005, Wader Study Group Bulletin, V107, P50; Liu SW, 2005, J GEN VIROL, V86, P719, DOI 10.1099/vir.0.80546-0; Mihindukulasuriya KA, 2008, J VIROL, V82, P5084, DOI 10.1128/JVI.02722-07; MURADRASOLI S, 2009, J VIROL METHODS; Pedersen NC, 2009, J FELINE MED SURG, V11, P225, DOI 10.1016/j.jfms.2008.09.008; Saif LJ, 2004, REV SCI TECH OIE, V23, P643, DOI 10.20506/rst.23.2.1513; Saif Y. M., 2008, DIS POULTRY; Stavrinides J, 2004, J VIROL, V78, P76, DOI 10.1128/JVI.78.1.76-82.2004; Subbarao K, 1998, SCIENCE, V279, P393, DOI 10.1126/science.279.5349.393; Sun L, 2007, VIRUS RES, V130, P121, DOI 10.1016/j.virusres.2007.06.003; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; van der Hoek L, 2006, FEMS MICROBIOL REV, V30, P760, DOI 10.1111/j.1574-6976.2006.00032.x; Vijgen L, 2006, J VIROL, V80, P7270, DOI 10.1128/JVI.02675-05; Wahlgren J, 2008, VECTOR-BORNE ZOONOT, V8, P783, DOI 10.1089/vbz.2007.0274; Woo PCY, 2006, J VIROL, V80, P7136, DOI 10.1128/JVI.00509-06; Woo PCY, 2009, J VIROL, V83, P908, DOI 10.1128/JVI.01977-08; Woo PCY, 2005, J VIROL, V79, P884, DOI 10.1128/JVI.79.2.884-895.2005	38	50	53	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2010	5	10							e13640	10.1371/journal.pone.0013640	http://dx.doi.org/10.1371/journal.pone.0013640			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673FU	21060827	Green Published, Green Submitted, gold			2022-12-27	WOS:000283645300002
J	Song, YQ; Willer, JR; Scherer, PC; Panzer, JA; Kugath, A; Skordalakes, E; Gregg, RG; Willer, GB; Balice-Gordon, RJ				Song, Yuanquan; Willer, Jason R.; Scherer, Paul C.; Panzer, Jessica A.; Kugath, Amy; Skordalakes, Emmanuel; Gregg, Ronald G.; Willer, Gregory B.; Balice-Gordon, Rita J.			Neural and Synaptic Defects in slytherin, a Zebrafish Model for Human Congenital Disorders of Glycosylation	PLOS ONE			English	Article							GDP-FUCOSE TRANSPORTER; ADHESION DEFICIENCY-II; O-LINKED FUCOSE; UBIQUITIN LIGASE; NOTCH; DELTA; IDENTIFICATION; FRINGE; GENES; EXPRESSION	Congenital disorder of glycosylation type IIc (CDG IIc) is characterized by mental retardation, slowed growth and severe immunodeficiency, attributed to the lack of fucosylated glycoproteins. While impaired Notch signaling has been implicated in some aspects of CDG IIc pathogenesis, the molecular and cellular mechanisms remain poorly understood. We have identified a zebrafish mutant slytherin (srn), which harbors a missense point mutation in GDP-mannose 4,6 dehydratase (GMDS), the rate-limiting enzyme in protein fucosylation, including that of Notch. Here we report that some of the mechanisms underlying the neural phenotypes in srn and in CGD IIc are Notch-dependent, while others are Notch-independent. We show, for the first time in a vertebrate in vivo, that defects in protein fucosylation leads to defects in neuronal differentiation, maintenance, axon branching, and synapse formation. Srn is thus a useful and important vertebrate model for human CDG IIc that has provided new insights into the neural phenotypes that are hallmarks of the human disorder and has also highlighted the role of protein fucosylation in neural development.	[Song, Yuanquan; Scherer, Paul C.; Panzer, Jessica A.; Kugath, Amy; Balice-Gordon, Rita J.] Univ Penn, Sch Med, Dept Neurosci, Philadelphia, PA 19104 USA; [Skordalakes, Emmanuel] Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA; [Willer, Jason R.; Gregg, Ronald G.; Willer, Gregory B.] Univ Louisville, Dept Biochem & Mol Biol, Louisville, KY 40292 USA	University of Pennsylvania; The Wistar Institute; University of Louisville	Song, YQ (corresponding author), Univ Penn, Sch Med, Dept Neurosci, Philadelphia, PA 19104 USA.	rbaliceg@mail.med.upenn.edu	Song, Yuanquan/E-2603-2012; Skordalakes, Emmanuel/H-7071-2019	Gregg, Ronald/0000-0001-5805-224X; Skordalakes, Emmanuel/0000-0002-7600-2833; Balice-Gordon, Rita/0000-0002-9950-7965; Willer, Jason/0000-0002-5869-3992	National Institutes of Health [NS050524]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088332] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050524] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Supported by National Institutes of Health grant NS050524 to R.B.-G. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amsterdam A, 2004, P NATL ACAD SCI USA, V101, P12792, DOI 10.1073/pnas.0403929101; Appel B, 2001, BMC Dev Biol, V1, P13, DOI 10.1186/1471-213X-1-13; Appel B, 1998, DEVELOPMENT, V125, P371; Bae YK, 2005, DEVELOPMENT, V132, P1375, DOI 10.1242/dev.01710; Becker DJ, 1999, BBA-MOL BASIS DIS, V1455, P193, DOI 10.1016/S0925-4439(99)00071-X; Bernardos RL, 2005, DEV BIOL, V278, P381, DOI 10.1016/j.ydbio.2004.11.018; Choe EA, 2007, J NEUROSCI, V27, P9503, DOI 10.1523/JNEUROSCI.1408-07.2007; Cornell RA, 2000, DEVELOPMENT, V127, P2873; Etzioni A, 2002, AM J MED GENET, V110, P131, DOI 10.1002/ajmg.10423; FRYDMAN M, 1992, AM J MED GENET, V44, P297, DOI 10.1002/ajmg.1320440307; Geling A, 2002, EMBO REP, V3, P688, DOI 10.1093/embo-reports/kvf124; Golling G, 2002, NAT GENET, V31, P135, DOI 10.1038/ng896; Gray M, 2001, DEV BIOL, V237, P306, DOI 10.1006/dbio.2001.0381; HARRIS RJ, 1993, GLYCOBIOLOGY, V3, P219, DOI 10.1093/glycob/3.3.219; HARRIS RJ, 1993, BIOCHEMISTRY-US, V32, P6539, DOI 10.1021/bi00077a007; Hegde A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001479; Hellbusch CC, 2007, J BIOL CHEM, V282, P10762, DOI 10.1074/jbc.M700314200; Hutchinson SA, 2006, DEVELOPMENT, V133, P2137, DOI 10.1242/dev.02355; Ishikawa HO, 2005, P NATL ACAD SCI USA, V102, P18532, DOI 10.1073/pnas.0504115102; Itoh M, 2003, DEV CELL, V4, P67, DOI 10.1016/S1534-5807(02)00409-4; Jaeken J, 2007, ANNU REV GENOM HUM G, V8, P261, DOI 10.1146/annurev.genom.8.080706.092327; KIM J, 1995, CELL, V82, P795, DOI 10.1016/0092-8674(95)90476-X; KOCHIBE N, 1980, BIOCHEMISTRY-US, V19, P2841, DOI 10.1021/bi00554a004; Koo BK, 2005, DEVELOPMENT, V132, P3459, DOI 10.1242/dev.01922; Lee JS, 2004, NEURON, V44, P947, DOI 10.1016/j.neuron.2004.11.029; Lowe JB, 2001, CELL, V104, P809, DOI 10.1016/S0092-8674(01)00277-X; Lubke T, 2001, NAT GENET, V28, P73, DOI 10.1038/88299; Luhn K, 2004, EXP CELL RES, V301, P242, DOI 10.1016/j.yexcr.2004.08.043; Luhn K, 2001, NAT GENET, V28, P69, DOI 10.1038/ng0501-69; Moloney DJ, 1999, GLYCOBIOLOGY, V9, P679, DOI 10.1093/glycob/9.7.679; Moloney DJ, 2000, NATURE, V406, P369, DOI 10.1038/35019000; Nikolaou N, 2009, DEVELOPMENT, V136, P2523, DOI 10.1242/dev.034736; NONA SN, 1989, GLIA, V2, P189, DOI 10.1002/glia.440020308; Ohata S, 2009, DEVELOPMENT, V136, P1653, DOI 10.1242/dev.033290; Panin VM, 1997, NATURE, V387, P908, DOI 10.1038/43191; Panzer JA, 2005, DEV BIOL, V285, P340, DOI 10.1016/j.ydbio.2005.06.027; Park HC, 2003, DEVELOPMENT, V130, P3747, DOI 10.1242/dev.00576; Rauskolb C, 1999, NATURE, V401, P476, DOI 10.1038/46786; Raya A, 2003, GENE DEV, V17, P1213, DOI 10.1101/gad.1084403; Salama-Cohen P, 2006, J NEUROCHEM, V97, P1269, DOI 10.1111/j.1471-4159.2006.03783.x; Scheer N, 2002, MECH DEVELOP, V112, P9, DOI 10.1016/S0925-4773(01)00621-9; Shin J, 2007, DEVELOPMENT, V134, P1911, DOI 10.1242/dev.001602; Smith PL, 2002, J CELL BIOL, V158, P801, DOI 10.1083/jcb.200203125; Sturla L, 2003, J BIOL CHEM, V278, P26727, DOI 10.1074/jbc.M304068200; Thisse B, 2005, HIGH THROUGHPUT EXPR; Thisse B., 2001, EXPRESSION ZEBRAFISH; Thisse B, 2004, ZFIN DIRECT DATA SUB; Wang Y, 2004, P NATL ACAD SCI USA, V101, P9458, DOI 10.1073/pnas.0308126101; Willer GB, 2005, GENETICS, V170, P1827, DOI 10.1534/genetics.105.041608; Yoon K, 2005, NAT NEUROSCI, V8, P709, DOI 10.1038/nn1475; Zecchin E, 2007, DEV BIOL, V301, P192, DOI 10.1016/j.ydbio.2006.09.041	51	39	40	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2010	5	10							e13743	10.1371/journal.pone.0013743	http://dx.doi.org/10.1371/journal.pone.0013743			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673FU	21060795	Green Published, Green Submitted, gold			2022-12-27	WOS:000283645300023
J	Viswanathan, K; Koh, X; Chandrasekaran, A; Pappas, C; Raman, R; Srinivasan, A; Shriver, Z; Tumpey, TM; Sasisekharan, R				Viswanathan, Karthik; Koh, Xiaoying; Chandrasekaran, Aarthi; Pappas, Claudia; Raman, Rahul; Srinivasan, Aravind; Shriver, Zachary; Tumpey, Terrence M.; Sasisekharan, Ram			Determinants of Glycan Receptor Specificity of H2N2 Influenza A Virus Hemagglutinin	PLOS ONE			English	Article							PANDEMIC INFLUENZA; NORTH-AMERICA; TRANSMISSION; BINDING; ORIGIN; SWINE; MICROARRAY; TOPOLOGY; CHICKEN; CELLS	The H2N2 subtype of influenza A virus was responsible for the Asian pandemic of 1957-58. However, unlike other subtypes that have caused pandemics such as H1N1 and H3N2, which continue to circulate among humans, H2N2 stopped circulating in the human population in 1968. Strains of H2 subtype still continue to circulate in birds and occasionally pigs and could be reintroduced into the human population through antigenic drift or shift. Such an event is a potential global health concern because of the waning population immunity to H2 hemagglutinin (HA). The first step in such a cross-species transmission and human adaptation of influenza A virus is the ability for its surface glycoprotein HA to bind to glycan receptors expressed in the human upper respiratory epithelia. Recent structural and biochemical studies have focused on understanding the glycan receptor binding specificity of the 1957-58 pandemic H2N2 HA. However, there has been considerable HA sequence divergence in the recent avian-adapted H2 strains from the pandemic H2N2 strain. Using a combination of structural modeling, quantitative glycan binding and human respiratory tissue binding methods, we systematically identify mutations in the HA from a recent avian-adapted H2N2 strain (A/Chicken/PA/2004) that make its quantitative glycan receptor binding affinity (defined using an apparent binding constant) comparable to that of a prototypic pandemic H2N2 (A/Albany/6/58) HA.	[Viswanathan, Karthik; Koh, Xiaoying; Chandrasekaran, Aarthi; Raman, Rahul; Srinivasan, Aravind; Shriver, Zachary; Sasisekharan, Ram] MIT, Koch Inst Integrat Canc Res, Singapore MIT Alliance Res & Technol, Harvard MIT Div Hlth Sci & Technol,Dept Biol Engn, Cambridge, MA 02139 USA; [Pappas, Claudia; Tumpey, Terrence M.] Ctr Dis Control & Prevent, Influenza Div, Atlanta, GA USA	Harvard University; Massachusetts Institute of Technology (MIT); Singapore-MIT Alliance for Research & Technology Centre (SMART); Centers for Disease Control & Prevention - USA	Viswanathan, K (corresponding author), MIT, Koch Inst Integrat Canc Res, Singapore MIT Alliance Res & Technol, Harvard MIT Div Hlth Sci & Technol,Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	rams@mit.edu		Koh-Stenta, Carol Xiaoying/0000-0001-9888-0488	National Institute of General Medical Sciences of the NIH [GM57073, U54 GM62116]; Singapore-MIT Alliance for Research and Technology; Agency for Science, Technology and Research (A*STAR) in Singapore; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057073, U54GM062116, R37GM057073] Funding Source: NIH RePORTER	National Institute of General Medical Sciences of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Singapore-MIT Alliance for Research and Technology(Singapore-MIT Alliance for Research & Technology Centre (SMART)); Agency for Science, Technology and Research (A*STAR) in Singapore(Agency for Science Technology & Research (A*STAR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported by the National Institute of General Medical Sciences of the NIH (GM57073 and U54 GM62116) and the Singapore-MIT Alliance for Research and Technology. X.K. is supported by Agency for Science, Technology and Research (A*STAR) in Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BASLER C, 2002, ENCY MOL MED, P1741; Chandrasekaran A, 2008, NAT BIOTECHNOL, V26, P107, DOI 10.1038/nbt1375; Childs RA, 2009, NAT BIOTECHNOL, V27, P797, DOI 10.1038/nbt0909-797; Gambaryan AS, 2003, AVIAN DIS, V47, P1154, DOI 10.1637/0005-2086-47.s3.1154; Glaser L, 2006, GLYCOCONJUGATE J, V23, P93, DOI 10.1007/s10719-006-5441-0; Hensley SE, 2009, SCIENCE, V326, P734, DOI 10.1126/science.1178258; Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260; Liu JF, 2009, P NATL ACAD SCI USA, V106, P17175, DOI 10.1073/pnas.0906849106; Ma W, 2007, P NATL ACAD SCI USA, V104, P20949, DOI 10.1073/pnas.0710286104; Maines TR, 2006, P NATL ACAD SCI USA, V103, P12121, DOI 10.1073/pnas.0605134103; Maines TR, 2009, SCIENCE, V325, P484, DOI 10.1126/science.1177238; Makarova NA, 1999, J GEN VIROL, V80, P3167, DOI 10.1099/0022-1317-80-12-3167; PAPPAS C, 2010, PLOS ONE IN PRESS; Russell CJ, 2005, CELL, V123, P368, DOI 10.1016/j.cell.2005.10.019; SCHAFER JR, 1993, VIROLOGY, V194, P781, DOI 10.1006/viro.1993.1319; Shinya K, 2006, NATURE, V440, P435, DOI 10.1038/440435a; Shriver Z, 2009, CHEM BIOL, V16, P803, DOI 10.1016/j.chembiol.2009.08.002; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Srinivasan A, 2008, P NATL ACAD SCI USA, V105, P2800, DOI 10.1073/pnas.0711963105; Stevens J, 2004, SCIENCE, V303, P1866, DOI 10.1126/science.1093373; Stevens J, 2008, J MOL BIOL, V381, P1382, DOI 10.1016/j.jmb.2008.04.016; Stevens J, 2006, NAT REV MICROBIOL, V4, P857, DOI 10.1038/nrmicro1530; Tumpey TM, 2007, SCIENCE, V315, P655, DOI 10.1126/science.1136212; Tumpey TM, 2005, SCIENCE, V310, P77, DOI 10.1126/science.1119392; Van Hoeven N, 2009, P NATL ACAD SCI USA, V106, P3366, DOI 10.1073/pnas.0813172106; van Riel D, 2007, AM J PATHOL, V171, P1215, DOI 10.2353/ajpath.2007.070248; Wan HQ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002923; Wei CJ, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000799; Xu D, 2009, J MOL BIOL, V387, P465, DOI 10.1016/j.jmb.2009.01.040; XU R, 2009, J VIROL; Yen HL, 2009, CURR TOP MICROBIOL, V333, P3, DOI 10.1007/978-3-540-92165-3_1	31	30	36	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2010	5	10							e13768	10.1371/journal.pone.0013768	http://dx.doi.org/10.1371/journal.pone.0013768			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673FU	21060797	Green Submitted, Green Published, gold			2022-12-27	WOS:000283645300043
J	Merchan, JR; Kovacs, K; Railsback, JW; Kurtoglu, M; Jing, YQ; Pina, Y; Gao, NG; Murray, TG; Lehrman, MA; Lampidis, TJ				Merchan, Jaime R.; Kovacs, Krisztina; Railsback, Jaclyn W.; Kurtoglu, Metin; Jing, Yuqi; Pina, Yolanda; Gao, Ningguo; Murray, Timothy G.; Lehrman, Mark A.; Lampidis, Theodore J.			Antiangiogenic Activity of 2-Deoxy-D-Glucose	PLOS ONE			English	Article							ENDOTHELIAL-CELL PROLIFERATION; GLUCOSE-TRANSPORTER EXPRESSION; IN-VITRO; CLINICAL-TRIALS; F-18-FDG UPTAKE; GROWTH-FACTOR; ANGIOGENESIS; CANCER; RETINOBLASTOMA; INHIBITION	Background: During tumor angiogenesis, endothelial cells (ECs) are engaged in a number of energy consuming biological processes, such as proliferation, migration, and capillary formation. Since glucose uptake and metabolism are increased to meet this energy need, the effects of the glycolytic inhibitor 2-deoxy-D-glucose (2-DG) on in vitro and in vivo angiogenesis were investigated. Methodology/Principal Findings: In cell culture, 2-DG inhibited EC growth, induced cytotoxicity, blocked migration, and inhibited actively forming but not established endothelial capillaries. Surprisingly, 2-DG was a better inhibitor of these EC properties than two more efficacious glycolytic inhibitors, 2-fluorodeoxy-D-glucose and oxamate. As an alternative to a glycolytic inhibitory mechanism, we considered 2-DG's ability to interfere with endothelial N-linked glycosylation. 2-DG's effects were reversed by mannose, an N-linked glycosylation precursor, and at relevant concentrations 2-DG also inhibited synthesis of the lipid linked oligosaccharide (LLO) N-glycosylation donor in a mannose-reversible manner. Inhibition of LLO synthesis activated the unfolded protein response (UPR), which resulted in induction of GADD153/CHOP and EC apoptosis (TUNEL assay). Thus, 2-DG's effects on ECs appeared primarily due to inhibition of LLOs synthesis, not glycolysis. 2-DG was then evaluated in two mouse models, inhibiting angiogenesis in both the matrigel plug assay and the LH(BETA)T(AG) transgenic retinoblastoma model. Conclusions/Significance: In conclusion, 2-DG inhibits endothelial cell angiogenesis in vitro and in vivo, at concentrations below those affecting tumor cells directly, most likely by interfering with N-linked glycosylation rather than glycolysis. Our data underscore the importance of glucose metabolism on neovascularization, and demonstrate a novel approach for anti-angiogenic strategies.	[Merchan, Jaime R.; Kovacs, Krisztina; Railsback, Jaclyn W.; Kurtoglu, Metin; Jing, Yuqi] Univ Miami, Miller Sch Med, Dept Med, Miami, FL 33136 USA; [Merchan, Jaime R.; Kovacs, Krisztina; Railsback, Jaclyn W.; Kurtoglu, Metin; Jing, Yuqi; Lampidis, Theodore J.] Sylvester Comprehens Canc Ctr, Miami, FL USA; [Lampidis, Theodore J.] Univ Miami, Miller Sch Med, Dept Cell Biol, Miami, FL 33136 USA; [Pina, Yolanda; Murray, Timothy G.] Univ Miami, Miller Sch Med, Dept Ophthalmol, Bascom Palmer Eye Inst, Miami, FL 33136 USA; [Gao, Ningguo; Lehrman, Mark A.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA	University of Miami; University of Miami; Bascom Palmer Eye Institute; University of Miami; University of Texas System; University of Texas Southwestern Medical Center Dallas	Merchan, JR (corresponding author), Univ Miami, Miller Sch Med, Dept Med, Miami, FL 33136 USA.	jmerchan2@med.miami.edu			National Institutes of Health [CA 119545-02, CA 37109, GM 38545, R01 EY013629, P30 EY014801]; University of Miami/Sylvester Comprehensive Cancer Center; PAP Corps; Welch Foundation [I-1168]; Research to prevent blindness, INC; NATIONAL CANCER INSTITUTE [R21CA119545, R01CA037109] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY013629, P30EY014801] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R56GM038545, R01GM038545] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Miami/Sylvester Comprehensive Cancer Center; PAP Corps; Welch Foundation(The Welch Foundation); Research to prevent blindness, INC(Research to Prevent Blindness (RPB)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health (CA 119545-02 to J.R.M.; CA 37109 to T.J.L.; GM 38545 to M. A. L.; R01 EY013629, P30 EY014801 to T. G. M.); the University of Miami/Sylvester Comprehensive Cancer Center and the PAP Corps (to J.R.M., T.J.L., and T. G. M.); the Welch Foundation (I-1168 to M. A. L.); and an unrestricted grant to the University of Miami from Research to prevent blindness, INC (to T. G. M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abaci HE, 2010, AM J PHYSIOL-CELL PH, V298, pC1527, DOI 10.1152/ajpcell.00484.2009; Aft RL, 2002, BRIT J CANCER, V87, P805, DOI 10.1038/sj.bjc.6600547; Belhocine T, 2003, EUR J NUCL MED MOL I, V30, P1305, DOI 10.1007/s00259-003-1209-y; Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; Bocci G, 2003, P NATL ACAD SCI USA, V100, P12917, DOI 10.1073/pnas.2135406100; Bos R, 2002, J CLIN ONCOL, V20, P379, DOI 10.1200/JCO.20.2.379; BOURKE CA, 1993, AUST VET J, V70, P188, DOI 10.1111/j.1751-0813.1993.tb06131.x; BOUTRID H, 2008, INVEST OPHTHALMOL VI; Buck AK, 2004, J NUCL MED, V45, P461; Cao Y, 2010, EXP CELL RES, V316, P1304, DOI 10.1016/j.yexcr.2010.02.031; Chan B, 2003, MICROVASC RES, V66, P1, DOI 10.1016/S0026-2862(03)00037-2; Chander SK, 2007, BRIT J CANCER, V96, P1368, DOI 10.1038/sj.bjc.6603727; DATEMA R, 1979, BIOCHEM J, V184, P113, DOI 10.1042/bj1840113; Davidson SM, 2007, CIRC RES, V100, P1128, DOI 10.1161/01.RES.0000261970.18328.1d; Folkman J, 2007, NAT REV DRUG DISCOV, V6, P273, DOI 10.1038/nrd2115; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Gatenby RA, 2007, INT J BIOCHEM CELL B, V39, P1358, DOI 10.1016/j.biocel.2007.03.021; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Jain RK, 2006, NAT CLIN PRACT ONCOL, V3, P24, DOI 10.1038/ncponc0403; Jockovich ME, 2007, INVEST OPHTH VIS SCI, V48, P2476, DOI 10.1167/iovs.06-1397; Jockovich ME, 2006, INVEST OPHTH VIS SCI, V47, P1264, DOI 10.1167/iovs.05-1194; Kaufman RJ, 2002, J CLIN INVEST, V110, P1389, DOI 10.1172/JC1200216886; Kim JW, 2006, CANCER RES, V66, P8927, DOI 10.1158/0008-5472.CAN-06-1501; KRUTZFELDT A, 1990, J MOL CELL CARDIOL, V22, P1393, DOI 10.1016/0022-2828(90)90984-A; Kurtoglu M, 2007, MOL CANCER THER, V6, P3049, DOI 10.1158/1535-7163.MCT-07-0310; Kurtoglu M, 2007, ANTIOXID REDOX SIGN, V9, P1383, DOI 10.1089/ars.2007.1714; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Lin TY, 1999, J CELL BIOCHEM, V74, P638, DOI 10.1002/(SICI)1097-4644(19990915)74:4<638::AID-JCB13>3.0.CO;2-C; LOIKE JD, 1992, AM J PHYSIOL, V263, pC326, DOI 10.1152/ajpcell.1992.263.2.C326; Maeshima Y, 2000, J BIOL CHEM, V275, P21340, DOI 10.1074/jbc.M001956200; Maeshima Y, 2001, J BIOL CHEM, V276, P31959, DOI 10.1074/jbc.M103024200; Maher JC, 2005, PANCREAS, V30, pE34, DOI 10.1097/01.mpa.0000153327.46945.26; Maher JC, 2007, MOL CANCER THER, V6, P732, DOI 10.1158/1535-7163.MCT-06-0407; Mann GE, 2003, PHYSIOL REV, V83, P183, DOI 10.1152/physrev.00022.2002; Marback EF, 2003, BRIT J OPHTHALMOL, V87, P1224, DOI 10.1136/bjo.87.10.1224; Martinez JA, 1999, CELL MOL BIOL, V45, P137; Martinez JA, 2000, ADV EXP MED BIOL, V476, P197; Martinez JA, 2006, GLYCOCONJUGATE J, V23, P209, DOI 10.1007/s10719-006-7926-2; Maschauer S, 2004, J NUCL MED, V45, P455; Maschek G, 2004, CANCER RES, V64, P31, DOI 10.1158/0008-5472.CAN-03-3294; Merchan JR, 2003, J NATL CANCER I, V95, P388, DOI 10.1093/jnci/95.5.388; Mohanti BK, 1996, INT J RADIAT ONCOL, V35, P103, DOI 10.1016/S0360-3016(96)85017-6; Pelicano H, 2006, ONCOGENE, V25, P4633, DOI 10.1038/sj.onc.1209597; PILI R, 1995, CANCER RES, V55, P2920; Rossler J, 2004, AM J PATHOL, V164, P391, DOI 10.1016/S0002-9440(10)63129-X; RUPRECHT RM, 1989, J ACQ IMMUN DEF SYND, V2, P149; SAUL R, 1985, P NATL ACAD SCI USA, V82, P93, DOI 10.1073/pnas.82.1.93; Sone H, 2000, INVEST OPHTH VIS SCI, V41, P1876; Stein M, 2010, PROSTATE, V70, P1388, DOI 10.1002/pros.21172; WINDLE JJ, 1990, NATURE, V343, P665, DOI 10.1038/343665a0; Yeh WL, 2008, MOL PHARMACOL, V73, P170, DOI 10.1124/mol.107.038851; Yun MJ, 2002, SEMIN NUCL MED, V32, P70, DOI 10.1053/snuc.2002.29279	52	88	93	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2010	5	10							e13699	10.1371/journal.pone.0013699	http://dx.doi.org/10.1371/journal.pone.0013699			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671UN	21060881	Green Published, gold, Green Submitted			2022-12-27	WOS:000283537000058
J	Bonnefond, A; Durand, E; Sand, O; De Graeve, F; Gallina, S; Busiah, K; Lobbens, S; Simon, A; Bellanne-Chantelot, C; Letourneau, L; Scharfmann, R; Delplanque, J; Sladek, R; Polak, M; Vaxillaire, M; Froguel, P				Bonnefond, Amelie; Durand, Emmanuelle; Sand, Olivier; De Graeve, Franck; Gallina, Sophie; Busiah, Kanetee; Lobbens, Stephane; Simon, Albane; Bellanne-Chantelot, Christine; Letourneau, Louis; Scharfmann, Raphael; Delplanque, Jerome; Sladek, Robert; Polak, Michel; Vaxillaire, Martine; Froguel, Philippe			Molecular Diagnosis of Neonatal Diabetes Mellitus Using Next-Generation Sequencing of the Whole Exome	PLOS ONE			English	Article							ACTIVATING MUTATIONS; GENE; INSULIN; KIR6.2	Background: Accurate molecular diagnosis of monogenic non-autoimmune neonatal diabetes mellitus (NDM) is critical for patient care, as patients carrying a mutation in KCNJ11 or ABCC8 can be treated by oral sulfonylurea drugs instead of insulin therapy. This diagnosis is currently based on Sanger sequencing of at least 42 PCR fragments from the KCNJ11, ABCC8, and INS genes. Here, we assessed the feasibility of using the next-generation whole exome sequencing (WES) for the NDM molecular diagnosis. Methodology/Principal Findings: We carried out WES for a patient presenting with permanent NDM, for whom mutations in KCNJ11, ABCC8 and INS and abnormalities in chromosome 6q24 had been previously excluded. A solution hybridization selection was performed to generate WES in 76 bp paired-end reads, by using two channels of the sequencing instrument. WES quality was assessed using a high-resolution oligonucleotide whole-genome genotyping array. From our WES with high-quality reads, we identified a novel non-synonymous mutation in ABCC8 (c.1455G>C/p.Q485H), despite a previous negative sequencing of this gene. This mutation, confirmed by Sanger sequencing, was not present in 348 controls and in the patient's mother, father and young brother, all of whom are normoglycemic. Conclusions/Significance: WES identified a novel de novo ABCC8 mutation in a NDM patient. Compared to the current Sanger protocol, WES is a comprehensive, cost-efficient and rapid method to identify mutations in NDM patients. We suggest WES as a near future tool of choice for further molecular diagnosis of NDM cases, negative for chr6q24, KCNJ11 and INS abnormalities.	[Bonnefond, Amelie; Durand, Emmanuelle; Sand, Olivier; De Graeve, Franck; Gallina, Sophie; Lobbens, Stephane; Delplanque, Jerome; Vaxillaire, Martine; Froguel, Philippe] Univ Lille Nord France, UDSL, CNRS, UMR 8199, Lille, France; [Busiah, Kanetee; Simon, Albane; Scharfmann, Raphael; Polak, Michel] Univ Paris 05, Hop Necker Enfants Malad, Dept Pediat Endocrinol, Inserm U845, Paris, France; [Bellanne-Chantelot, Christine] Hop La Pitie Salpetriere, Dept Genet, Paris, France; [Letourneau, Louis; Sladek, Robert] McGill Univ, Dept Human Genet, Fac Med, Montreal, PQ, Canada; [Letourneau, Louis; Sladek, Robert] Genome Quebec Innovat Ctr, Montreal, PQ, Canada; [Froguel, Philippe] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Hammersmith Hosp, Dept Genom Common Dis, London, England	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; McGill University; Imperial College London	Bonnefond, A (corresponding author), Univ Lille Nord France, UDSL, CNRS, UMR 8199, Lille, France.	p.froguel@imperial.ac.uk	Kanetee, BUSIAH/AAP-8292-2020; scharfmann, raphael/L-3296-2017; Bonnefond, Amélie/O-2784-2017; FROGUEL, Philippe/O-6799-2017; Sladek, Robert/R-2391-2019	Kanetee, BUSIAH/0000-0002-1059-0791; Bonnefond, Amélie/0000-0001-9976-3005; FROGUEL, Philippe/0000-0003-2972-0784; Sladek, Robert/0000-0002-2730-1204; Scharfmann, Raphael/0000-0001-7619-337X; Gallina, Sophie/0000-0002-6194-3649; Sand, Olivier/0000-0003-1465-1640	Conseil Regional du Nord Pas de Calais (France); Centre National de la Recherche Scientifique (CNRS); ANR [ANR-07-MRAR-000, ERANET 09 RARE 005]; European Union [LSHM-CT-2006-518153]; Medical Research Council [G0600331] Funding Source: researchfish; MRC [G0600331] Funding Source: UKRI	Conseil Regional du Nord Pas de Calais (France)(Region Hauts-de-FranceRegion Ile-de-France); Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); ANR(French National Research Agency (ANR)); European Union(European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	AB is funded by a research fellowship from the Conseil Regional du Nord Pas de Calais (France) and the Centre National de la Recherche Scientifique (CNRS). This study was supported by the ANR-MRAR research program ("Programme Pluriannuel National de Recherche sur les Maladies Rares'', ANR-07-MRAR-000, to MP), a transnational European research grant on Rare Diseases (ERANET 09 RARE 005, to MV and MP) and the European Union (Integrated Project EuroDia LSHM-CT-2006-518153 in the Framework Programme 6 [FP6] of the European-Community, to PF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Aguilar-Bryan L, 2008, ENDOCR REV, V29, P265, DOI 10.1210/er.2007-0029; Babenko AP, 2006, NEW ENGL J MED, V355, P456, DOI 10.1056/NEJMoa055068; EDGHILL EL, JOP, V11, P14; Ellard S, 2007, AM J HUM GENET, V81, P375, DOI 10.1086/519174; Gloyn AL, 2004, NEW ENGL J MED, V350, P1838, DOI 10.1056/NEJMoa032922; Hattersley A, 2009, PEDIATR DIABETES, V10, P33, DOI 10.1111/j.1399-5448.2009.00571.x; Murphy R, 2008, NAT CLIN PRACT ENDOC, V4, P200, DOI 10.1038/ncpendmet0778; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; Pearson ER, 2006, NEW ENGL J MED, V355, P467, DOI 10.1056/NEJMoa061759; Polak M, 2008, DIABETES, V57, P1115, DOI 10.2337/db07-1358; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Vaxillaire M, 2007, DIABETES, V56, P1737, DOI 10.2337/db06-1540; Vaxillaire Martine, 2009, Pediatr Endocrinol Rev, V6, P405	14	83	90	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2010	5	10							e13630	10.1371/journal.pone.0013630	http://dx.doi.org/10.1371/journal.pone.0013630			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671GB	21049026	Green Published, gold, Green Submitted			2022-12-27	WOS:000283487400020
J	Zhang, Y; Hu, YB; Yang, BY; Ma, F; Lu, P; Li, LM; Wan, CS; Rayner, S; Chen, SY				Zhang, Yong; Hu, Yangbo; Yang, Baoyu; Ma, Fang; Lu, Pei; Li, Lamei; Wan, Chengsong; Rayner, Simon; Chen, Shiyun			Duckweed (Lemna minor) as a Model Plant System for the Study of Human Microbial Pathogenesis	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA VIRULENCE; RESISTANT STAPHYLOCOCCUS-AUREUS; CAENORHABDITIS-ELEGANS; ARABIDOPSIS-THALIANA; BIOFILM FORMATION; INFECTION MODEL; INNATE IMMUNITY; PATHOGENICITY; HOST; ANIMALS	Background: Plant infection models provide certain advantages over animal models in the study of pathogenesis. However, current plant models face some limitations, e. g., plant and pathogen cannot co-culture in a contained environment. Development of such a plant model is needed to better illustrate host-pathogen interactions. Methodology/Principal Findings: We describe a novel model plant system for the study of human pathogenic bacterial infection on a large scale. This system was initiated by co-cultivation of axenic duckweed (Lemna minor) plants with pathogenic bacteria in 24-well polystyrene cell culture plate. Pathogenesis of bacteria to duckweed was demonstrated with Pseudomonas aeruginosa and Staphylococcus aureus as two model pathogens. P. aeruginosa PAO1 caused severe detriment to duckweed as judged from inhibition to frond multiplication and chlorophyll formation. Using a GFP-marked PAO1 strain, we demonstrated that bacteria colonized on both fronds and roots and formed biofilms. Virulence of PAO1 to duckweed was attenuated in its quorum sensing (QS) mutants and in recombinant strains overexpressing the QS quenching enzymes. RN4220, a virulent strain of S. aureus, caused severe toxicity to duckweed while an avirulent strain showed little effect. Using this system for antimicrobial chemical selection, green tea polyphenols exhibited inhibitory activity against S. aureus virulence. This system was further confirmed to be effective as a pathogenesis model using a number of pathogenic bacterial species. Conclusions/Significance: Our results demonstrate that duckweed can be used as a fast, inexpensive and reproducible model plant system for the study of host-pathogen interactions, could serve as an alternative choice for the study of some virulence factors, and could also potentially be used in large-scale screening for the discovery of antimicrobial chemicals.	[Zhang, Yong; Hu, Yangbo; Yang, Baoyu; Ma, Fang; Lu, Pei; Li, Lamei; Rayner, Simon; Chen, Shiyun] Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan, Peoples R China; [Wan, Chengsong] So Med Univ, Sch Publ Hlth & Trop Med, Dept Microbiol, Guangzhou, Guangdong, Peoples R China; [Hu, Yangbo; Ma, Fang; Lu, Pei; Li, Lamei] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China	Chinese Academy of Sciences; Wuhan Institute of Virology, CAS; Southern Medical University - China; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Zhang, Y (corresponding author), Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan, Peoples R China.	sychen@wh.iov.cn	rayner, simon/N-7715-2013	rayner, simon/0000-0001-8703-9140; chen, shi yun/0000-0002-6224-2975; Zhang, Yong/0000-0003-0510-1655	National Science Foundation of China [30771239]; China National Science and Technology Specific Projects [2008ZX08009-003]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); China National Science and Technology Specific Projects	National Science Foundation of China (30771239) and China National Science and Technology Specific Projects (2008ZX08009-003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adonizio A, 2008, J MED MICROBIOL, V57, P809, DOI 10.1099/jmm.0.47802-0; Attila C, 2008, MICROB BIOTECHNOL, V1, P17, DOI 10.1111/j.1751-7915.2007.00002.x; Ausubel FM, 2005, NAT IMMUNOL, V6, P973, DOI 10.1038/ni1253; Basset A, 2000, P NATL ACAD SCI USA, V97, P3376, DOI 10.1073/pnas.070357597; Bernier SP, 2003, INFECT IMMUN, V71, P5306, DOI 10.1128/IAI.71.9.5306-5313.2003; Brain RA, 2007, NAT PROTOC, V2, P979, DOI 10.1038/nprot.2007.146; Cox KM, 2006, NAT BIOTECHNOL, V24, P1591, DOI 10.1038/nbt1260; Dong YH, 2001, NATURE, V411, P813, DOI 10.1038/35081101; Filiatrault MJ, 2006, INFECT IMMUN, V74, P4237, DOI 10.1128/IAI.02014-05; Gopalan S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003891; Guttman DS, 2004, BIOTECHNOL ADV, V22, P363, DOI 10.1016/j.biotechadv.2003.11.001; Hu YB, 2009, MICROBIOL-SGM, V155, P2522, DOI 10.1099/mic.0.028381-0; Hu ZQ, 2002, ANTIMICROB AGENTS CH, V46, P558, DOI 10.1128/AAC.46.2.558-560.2002; Hu ZQ, 2001, J ANTIMICROB CHEMOTH, V48, P361, DOI 10.1093/jac/48.3.361; Irie Y, 2008, CURR TOP MICROBIOL, V322, P67; Jha AK, 2005, INFECT IMMUN, V73, P464, DOI 10.1128/IAI.73.1.464-475.2005; Lugtenberg BJJ, 2002, ANTON LEEUW INT J G, V81, P373, DOI 10.1023/A:1020596903142; Ma F, 2009, APPL MICROBIOL BIOT, V83, P135, DOI 10.1007/s00253-009-1890-2; Moy TI, 2006, P NATL ACAD SCI USA, V103, P10414, DOI 10.1073/pnas.0604055103; Nurnberger T, 2004, IMMUNOL REV, V198, P249, DOI 10.1111/j.0105-2896.2004.0119.x; Peleg AY, 2008, P NATL ACAD SCI USA, V105, P14585, DOI 10.1073/pnas.0805048105; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; PrimoParmo SL, 1996, GENOMICS, V33, P498, DOI 10.1006/geno.1996.0225; Prithiviraj B, 2005, PLANT J, V42, P417, DOI 10.1111/j.1365-313X.2005.02385.x; Prithiviraj B, 2005, CELL MICROBIOL, V7, P315, DOI 10.1111/j.1462-5822.2005.00494.x; Prouty MG, 2003, FEMS MICROBIOL LETT, V225, P177, DOI 10.1016/S0378-1097(03)00446-4; QUESSY S, 1995, INFECT IMMUN, V63, P1975, DOI 10.1128/IAI.63.5.1975-1979.1995; Rabea EI, 2003, BIOMACROMOLECULES, V4, P1457, DOI 10.1021/bm034130m; RAHME LG, 1995, SCIENCE, V268, P1899, DOI 10.1126/science.7604262; Rahme LG, 1997, P NATL ACAD SCI USA, V94, P13245, DOI 10.1073/pnas.94.24.13245; Rahme LG, 2000, P NATL ACAD SCI USA, V97, P8815, DOI 10.1073/pnas.97.16.8815; SCHENK RU, 1972, CAN J BOTANY, V50, P199, DOI 10.1139/b72-026; Scherr C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003133; Sifri CD, 2003, INFECT IMMUN, V71, P2208, DOI 10.1128/IAI.71.4.2208-2217.2003; Silo-Suh L, 2002, P NATL ACAD SCI USA, V99, P15699, DOI 10.1073/pnas.242343999; Starkey M, 2009, NAT PROTOC, V4, P117, DOI 10.1038/nprot.2008.224; Tan MW, 1999, P NATL ACAD SCI USA, V96, P2408, DOI 10.1073/pnas.96.5.2408; Tekstra J, 1999, CLIN EXP IMMUNOL, V117, P489; Tzou P, 2002, CURR OPIN MICROBIOL, V5, P102, DOI 10.1016/S1369-5274(02)00294-1; van Baarlen P, 2007, FEMS MICROBIOL REV, V31, P239, DOI 10.1111/j.1574-6976.2007.00065.x; van Baarlen P, 2007, DRUG DISCOV TODAY, V12, P167, DOI 10.1016/j.drudis.2006.12.007; Vunsh R, 2007, PLANT CELL REP, V26, P1511, DOI 10.1007/s00299-007-0361-4; Walker TS, 2004, PLANT PHYSIOL, V134, P320, DOI 10.1104/pp.103.027888; Wang Y, 2007, SCI CHINA SER C, V50, P385, DOI 10.1007/s11427-007-0044-y; Wu H, 2001, MICROBIOL-SGM, V147, P1105, DOI 10.1099/00221287-147-5-1105; Xiong N, 2009, ARCH MICROBIOL, V191, P879, DOI 10.1007/s00203-009-0520-9; Xu J, 2008, ANTIVIR RES, V78, P242, DOI 10.1016/j.antiviral.2007.11.011	47	11	12	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2010	5	10							e13527	10.1371/journal.pone.0013527	http://dx.doi.org/10.1371/journal.pone.0013527			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	670LB	21049039	Green Submitted, gold, Green Published			2022-12-27	WOS:000283422100005
J	Lewis, TW; Woolliams, JA; Blott, SC				Lewis, Thomas W.; Woolliams, John A.; Blott, Sarah C.			Genetic Evaluation of the Nine Component Features of Hip Score in UK Labrador Retrievers	PLOS ONE			English	Article							MOUNTAIN DOG; DYSPLASIA	The aim of this study was to explore the genetic relationship between the nine component traits comprising the British Veterinary Association (BVA) total hip score in UK registered Labrador Retrievers. Data consisted of 11,928 single records of trait scores of dogs aged between one and four years (365-1459 days) old, from radiographs evaluated between 2000 and 2007. Pedigree information was provided by the UK Kennel Club. The distribution of trait scores showed only small numbers of dogs with visible malformation in the six traits that were scored according to the severity of osteoarthritis. Linear mixed models were fitted using ASREML. Estimates of heritability ranged from 0.15 to 0.38, and litter effects from 0.04 to 0.10. Genetic correlations between all nine traits were extremely high ranging from 0.71 to 1.0, implying considerable genetic similarity. The decomposition demonstrated that aggregate scores of only the 3 traits indicative of laxity in one year old dogs was predictive of the phenotype of the remaining six scored on osteoarthritic severity in dogs at 4+ years old. The application of selection index methodology in selecting against hip dysplasia using the trait scores was explored and potential improvements in accuracy (directly related to response to selection) of over 10% are reported compared to the current total hip score. This study demonstrates that traits descriptive of joint laxity are valuable early-age predictors of osteoarthritis and shows that there is scope for improvement in the way data from the UK hip score scheme are used for selection against hip dysplasia in Labradors. This was verified via use of selection indices, which identified substantial increases in accuracy, not only via optimum coefficients, but also through an easily applicable aggregate of scores of just two or three traits only compared with the current total hip score.	[Lewis, Thomas W.; Blott, Sarah C.] Anim Hlth Trust, Kennel Club Genet Ctr, Newmarket, Suffolk, England; [Woolliams, John A.] Univ Edinburgh, Roslin Inst, Roslin, Midlothian, Scotland; [Woolliams, John A.] Univ Edinburgh, Royal Dick Sch Vet Studies, Roslin, Midlothian, Scotland	Animal Health Trust; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh	Lewis, TW (corresponding author), Anim Hlth Trust, Kennel Club Genet Ctr, Newmarket, Suffolk, England.	tom.lewis@aht.org.uk		Blott, Sarah/0000-0003-0233-6846; Lewis, Thomas/0000-0003-4166-7955	Kennel Club Charitable Trust; BBSRC through ISPG; BBSRC [BBS/E/D/05191133] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/D/05191133] Funding Source: researchfish	Kennel Club Charitable Trust; BBSRC through ISPG(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by the Kennel Club Charitable Trust. JAW is grateful to BBSRC for funding through an ISPG. The funders had no role in study design, data analysis, decision to publish, or preparation of the manuscript. Hip score and pedigree data is collated and provided by the Kennel Club.	BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; BRASS W, 1989, J SMALL ANIM PRACT, V30, P166, DOI 10.1111/j.1748-5827.1989.tb01525.x; Cameron N.D., 1997, SELECTION INDICES PR; Gibbs C, 1997, VET REC, V141, P275; Gilmour A., 2006, ASREML USER GUIDE RE; Hou YL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009410; Leppanen M, 1999, PREV VET MED, V42, P121, DOI 10.1016/S0167-5877(99)00059-8; LEWIS TW, 2010, PLOS ONE IN PRESS; Maki K, 2004, THESIS U HELSINKI; Malm S, 2008, J ANIM BREED GENET, V125, P403, DOI 10.1111/j.1439-0388.2008.00725.x; Ohlerth S, 1998, DEUT TIERARZTL WOCH, V105, P378; Silvestre AM, 2007, J ANIM SCI, V85, P1880, DOI 10.2527/jas.2007-0166; Willis MB, 1997, J AM VET MED ASSOC, V210, P1480; Wood JLN, 2002, PREV VET MED, V55, P95, DOI 10.1016/S0167-5877(02)00090-9	14	18	18	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2010	5	10							e13610	10.1371/journal.pone.0013610	http://dx.doi.org/10.1371/journal.pone.0013610			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	670KA	21042594	gold, Green Published, Green Submitted			2022-12-27	WOS:000283419100026
J	Tsuruyama, T; Nakai, T; Hiratsuka, T; Jin, GA; Nakamura, T; Yoshikawa, K				Tsuruyama, Tatsuaki; Nakai, Tonau; Hiratsuka, Takuya; Jin, Guang; Nakamura, Takuro; Yoshikawa, Kenichi			In Vitro HIV-1 Selective Integration into the Target Sequence and Decoy-Effect of the Modified Sequence	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; HUMAN GENOME; PREFERENCES; MOLECULE; SITES	Although there have been a few reports that the HIV-1 genome can be selectively integrated into the genomic DNA of cultured host cell, the biochemistry of integration selectivity has not been fully understood. We modified the in vitro integration reaction protocol and developed a reaction system with higher efficiency. We used a substrate repeat, 59(GTCCCTTCCCAGT)(n)(ACTGGGAAGGGAC)(n)-3', and a modified sequence DNA ligated into a circular plasmid. CAGT and ACTG (shown in italics in the above sequence) in the repeat units originated from the HIV-1 proviral genome ends. Following the incubation of the HIV-1 genome end cDNA and recombinant integrase for the formation of the pre-integration (PI) complex, substrate DNA was reacted with this complex. It was confirmed that the integration selectively occurred in the middle segment of the repeat sequence. In addition, integration frequency and selectivity were positively correlated with repeat number n. On the other hand, both frequency and selectivity decreased markedly when using sequences with deletion of CAGT in the middle position of the original target sequence. Moreover, on incubation with the deleted DNAs and original sequence, the integration efficiency and selectivity for the original target sequence were significantly reduced, which indicated interference effects by the deleted sequence DNAs. Efficiency and selectivity were also found to vary discontinuously with changes in manganese dichloride concentration in the reaction buffer, probably due to its influence on the secondary structure of substrate DNA. Finally, integrase was found to form oligomers on the binding site and substrate DNA formed a loop-like structure. In conclusion, there is a considerable selectivity in HIV-integration into the specified sequence; however, similar DNA sequences can interfere with the integration process, and it is therefore difficult for in vivo integration to occur selectively in the actual host genome DNA.	[Tsuruyama, Tatsuaki] Kyoto Univ, Grad Sch Med, Dept Forens Med & Mol Pathol, Kyoto, Japan; [Nakai, Tonau; Yoshikawa, Kenichi] Kyoto Univ, Dept Phys, Grad Sch Sci, Kyoto 606, Japan; [Hiratsuka, Takuya] Noe Saiseikai Hosp, Pathol Lab, Osaka, Japan; [Jin, Guang; Nakamura, Takuro] Japanese Fdn Canc Res, Inst Canc, Div Carcinogenesis, Koto Ku, Tokyo 170, Japan	Kyoto University; Kyoto University; Japanese Foundation for Cancer Research	Tsuruyama, T (corresponding author), Kyoto Univ, Grad Sch Med, Dept Forens Med & Mol Pathol, Kyoto, Japan.	tsuruyam@fp.med.kyoto-u.ac.jp	Yoshikawa, Kenichi/N-1867-2019	Yoshikawa, Kenichi/0000-0002-2751-7136	Ministry of Education, Culture, Sports, Science, and Technology, Japan; Ministry of Health, Labor, and Welfare, Japan [17013086]	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor, and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported by a Grant-in-Aid for Cancer Research from the Ministry of Education, Culture, Sports, Science, and Technology, Japan, and a Grant for Strategic Research on Cancer from the Ministry of Health, Labor, and Welfare, Japan. Grant number is 17013086. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARMAGEN T, 2010, J VIROL; Christ F, 2010, NAT CHEM BIOL, V6, P442, DOI 10.1038/nchembio.370; FARNET CM, 1990, P NATL ACAD SCI USA, V87, P4164, DOI 10.1073/pnas.87.11.4164; Grinsztejn B, 2007, LANCET, V369, P1261, DOI 10.1016/S0140-6736(07)60597-2; Holman AG, 2005, P NATL ACAD SCI USA, V102, P6103, DOI 10.1073/pnas.0501646102; Iwaki T, 2008, J CHEM PHYS, V129, DOI 10.1063/1.2967860; KITAMURA Y, 1992, P NATL ACAD SCI USA, V89, P5532, DOI 10.1073/pnas.89.12.5532; Mitchell RS, 2004, PLOS BIOL, V2, P1127, DOI 10.1371/journal.pbio.0020234; Schroder ARW, 2002, CELL, V110, P521, DOI 10.1016/S0092-8674(02)00864-4; Ueda M, 1996, PHYS REV LETT, V77, P2133, DOI 10.1103/PhysRevLett.77.2133; VERDIN E, 1991, J VIROL, V65, P6790, DOI 10.1128/JVI.65.12.6790-6799.1991; VINK C, 1991, NUCLEIC ACIDS RES, V19, P6691, DOI 10.1093/nar/19.24.6691; Wu XL, 2003, SCIENCE, V300, P1749, DOI 10.1126/science.1083413; YOSHINAGA T, 1995, J VIROL, V69, P3233, DOI 10.1128/JVI.69.5.3233-3236.1995	14	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2010	5	11							e13841	10.1371/journal.pone.0013841	http://dx.doi.org/10.1371/journal.pone.0013841			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675NY	21079805	gold, Green Published			2022-12-27	WOS:000283838600015
J	Barron, DA; Strand, DW; Ressler, SJ; Dang, TD; Hayward, SW; Yang, F; Ayala, GE; Ittmann, M; Rowley, DR				Barron, David A.; Strand, Douglas W.; Ressler, Steven J.; Dang, Truong D.; Hayward, Simon W.; Yang, Feng; Ayala, Gustavo E.; Ittmann, Michael; Rowley, David R.			TGF-beta 1 Induces an Age-Dependent Inflammation of Nerve Ganglia and Fibroplasia in the Prostate Gland Stroma of a Novel Transgenic Mouse	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; CANCER-REACTIVE STROMA; XENOGRAFT MODEL; TRANSFORMING GROWTH-FACTOR-BETA-1; MESENCHYMAL TRANSITION; IN-VIVO; EXPRESSION; MYOFIBROBLAST; ANGIOGENESIS; HYPERPLASIA	TGF-beta 1 is overexpressed in wound repair and in most proliferative disorders including benign prostatic hyperplasia and prostate cancer. The stromal microenvironment at these sites is reactive and typified by altered phenotype, matrix deposition, inflammatory responses, and alterations in nerve density and biology. TGF-beta 1 is known to modulate several stromal responses; however there are few transgenic models to study its integrated biology. To address the actions of TGF-beta 1 in prostate disorders, we targeted expression of an epitope tagged and constitutively active TGF-beta 1 via the enhanced probasin promoter to the murine prostate gland epithelium. Transgenic mice developed age-dependent lesions leading to severe, yet focal attenuation of epithelium, and a discontinuous basal lamina. These changes were associated with elevated fibroplasia and frequency of collagenous micronodules in collapsed acini, along with an induced inflammation in nerve ganglia and small vessels. Elevated recruitment of CD115+ myeloid cells but not mature macrophages was observed in nerve ganglia, also in an age-dependent manner. Similar phenotypic changes were observed using a human prostate epithelium tissue recombination xenograft model, where epithelial cells engineered to overexpress TGF-beta 1 induced fibrosis and altered matrix deposition concurrent with inflammation in the stromal compartment. Together, these data suggest that elevated TGF-beta 1 expression induces a fibroplasia stromal response associated with breach of epithelial wall structure and inflammatory involvement of nerve ganglia and vessels. The novel findings of ganglia and vessel inflammation associated with formation of collagenous micronodules in collapsed acini is important as each of these are observed in human prostate carcinoma and may play a role in disease progression.	[Barron, David A.; Ressler, Steven J.; Dang, Truong D.; Yang, Feng; Rowley, David R.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Strand, Douglas W.; Hayward, Simon W.] Vanderbilt Univ, Med Ctr, Dept Urol Surg, Vanderbilt Ingram Canc Ctr, Nashville, TN USA; [Ayala, Gustavo E.; Ittmann, Michael] Baylor Coll Med, Dept Pathol, Dan L Duncan Canc Ctr, Houston, TX 77030 USA	Baylor College of Medicine; Vanderbilt University; Baylor College of Medicine	Barron, DA (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA.	drowley@bcm.tmc.edu	Strand, Douglas/K-4003-2019; Strand, Douglas/A-1702-2011; Ayala, Gustavo/ABC-6625-2020	Strand, Douglas/0000-0002-0746-927X; Hayward, Simon/0000-0002-6059-6550	National Institutes of Health [R01 CA58093]; Diana Helis Henry Medical Research Foundation; Tumor Microenvironment Network of National Cancer Institute [U54 CA126568]; U.S. Department of Defens [W81XWH-08-10059, W81XWH-08-07-0479]; NATIONAL CANCER INSTITUTE [U54CA126568, R01CA058093] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK083293] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Diana Helis Henry Medical Research Foundation; Tumor Microenvironment Network of National Cancer Institute; U.S. Department of Defens; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Support for David R. Rowley was made possible via U54 CA126568 through the Tumor Microenvironment Network of National Cancer Institute (http://tmen.nci.nih.gov/), via R01 CA58093 through the National Institutes of Health (http://grants.nih.gov/grants/funding/r01.htm), and from the Diana Helis Henry Medical Research Foundation through its direct engagement in the continuous active conduct of medical research in conjunction with Baylor College of Medicine. Support for Simon W. Hayward was made possible via U54 CA126568 through the Tumor Microenvironment Network of National Cancer Institute (http://tmen.nci.nih.gov/). Support for David Barron was made possible via the Predoctoral Prostate Cancer Training Grant W81XWH-08-10059 through the U.S. Department of Defense (http://cdmrp.army.mil/pcrp/). Support for Douglas Strand was made possible via the Postdoctoral Prostate Cancer Training Grant W81XWH-08-07-0479 through the U.S. Department of Defense (http://cdmrp.army.mil/pcrp/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo VD, 2007, CANCER CELL, V12, P559, DOI 10.1016/j.ccr.2007.11.004; Alonso-Magdalena P, 2009, P NATL ACAD SCI USA, V106, P2859, DOI 10.1073/pnas.0812666106; Ao MF, 2007, CANCER RES, V67, P4244, DOI 10.1158/0008-5472.CAN-06-3946; Ayala G, 2003, CLIN CANCER RES, V9, P4792; Desmouliere A, 2005, WOUND REPAIR REGEN, V13, P7, DOI 10.1111/j.1067-1927.2005.130102.x; Epstein JI, 2004, MODERN PATHOL, V17, P307, DOI 10.1038/modpathol.3800050; Gabbiani G, 2003, J PATHOL, V200, P500, DOI 10.1002/path.1427; Gann PH, 1999, PROSTATE, V40, P248, DOI 10.1002/(SICI)1097-0045(19990901)40:4<248::AID-PROS6>3.0.CO;2-M; Hall BE, 2010, LAB INVEST, V90, P543, DOI 10.1038/labinvest.2010.5; Jiang M, 2010, STEM CELLS, V28, P344, DOI 10.1002/stem.284; Kopp JB, 1996, LAB INVEST, V74, P991; Massague J, 1999, NAT CELL BIOL, V1, pE117, DOI 10.1038/12944; McAlhany SJ, 2003, CANCER RES, V63, P5859; PIERCE DF, 1995, P NATL ACAD SCI USA, V92, P4254, DOI 10.1073/pnas.92.10.4254; SANDERSON N, 1995, P NATL ACAD SCI USA, V92, P2572, DOI 10.1073/pnas.92.7.2572; Sanvito F, 1995, BIOCHEM BIOPH RES CO, V217, P1279, DOI 10.1006/bbrc.1995.2906; Schauer IG, 2008, UROLOGY, V72, P205, DOI 10.1016/j.urology.2007.11.083; Schauer IG, 2009, PROSTATE, V69, P373, DOI 10.1002/pros.20886; Shoskes DA, 2002, J UROLOGY, V168, P331, DOI 10.1016/S0022-5347(05)64916-6; Tuxhorn JA, 2002, CANCER RES, V62, P6021; Tuxhorn JA, 2002, CLIN CANCER RES, V8, P2912; Tuxhorn JA, 2001, J UROLOGY, V166, P2472, DOI 10.1016/S0022-5347(05)65620-0; Tuxhorn JA, 2002, CANCER RES, V62, P3298; Wolfraim LA, 2002, J IMMUNOL METHODS, V266, P7, DOI 10.1016/S0022-1759(02)00090-X; Yang F, 2008, ONCOGENE, V27, P450, DOI 10.1038/sj.onc.1210663; Yang F, 2005, CANCER RES, V65, P8887, DOI 10.1158/0008-5472.CAN-05-1702; Yang G, 1997, PROSTATE, V33, P151, DOI 10.1002/(SICI)1097-0045(19971101)33:3<151::AID-PROS1>3.0.CO;2-M; Zhang JF, 2000, ENDOCRINOLOGY, V141, P4698, DOI 10.1210/en.141.12.4698	28	28	29	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2010	5	10							e13751	10.1371/journal.pone.0013751	http://dx.doi.org/10.1371/journal.pone.0013751			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673FU	21060787	gold, Green Published, Green Submitted			2022-12-27	WOS:000283645300030
J	Nolan, ST; Lamichhane, G				Nolan, Scott T.; Lamichhane, Gyanu			Protective Efficacy of BCG Overexpressing an L, D-Transpeptidase against M. tuberculosis Infection	PLOS ONE			English	Article							MYCOBACTERIUM-BOVIS BCG; ENHANCED PROTECTION; HYPOXIC RESPONSE; VACCINE EFFICACY; INTERFERON-GAMMA; IMMUNITY; MODEL; EXPRESSION; ANTIGENS; GENE	Background: M. bovis Bacille Calmette-Guerin (BCG), currently the only available vaccine against tuberculosis (TB), fails to adequately protect individuals from active and latent TB infection. New vaccines are desperately needed to decrease the worldwide burden of TB. Methods and Findings: We created a recombinant strain of BCG that overproduces an L, D-transpeptidase in order to alter the bacterial peptidoglycan layer and consequently increase the ability of this immunogen to protect against virulent M. tuberculosis (Mtb). We demonstrate that this novel recombinant BCG protects mice against virulent Mtb at least as well as control BCG, as measured by its ability to reduce bacterial burden in lungs and spleen, reduce lung histopathology, and prolong survival. A nutrient starved recombinant BCG preparation, while offering comparable protection, elicited a response characterized by elevated levels of select Th1 cytokines. Conclusions: Recombinant BCG overexpressing a L, D-transpeptidase that is nutrient starved elicits a stronger Th1 type response and is at least as protective as parent BCG. Results from this study suggest that nutrient starvation treatment of live BCG vaccines should be further investigated as a way to increase host induction of Th-1 related cytokines in the development of experimental anti-TB vaccines.	[Nolan, Scott T.; Lamichhane, Gyanu] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA	Johns Hopkins University	Nolan, ST (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA.	lamichhane@jhu.edu		Lamichhane, Gyanu/0000-0002-2214-0114	Bill and Melinda Gates Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI087749] Funding Source: NIH RePORTER	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a Bill and Melinda Gates Foundation Grand Challenges grant to GL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMBERSON JB, 1938, NEW ENGL J MED, V219, P4; Barker LF, 2009, CURR OPIN IMMUNOL, V21, P331, DOI 10.1016/j.coi.2009.05.017; Betts JC, 2002, MOL MICROBIOL, V43, P717, DOI 10.1046/j.1365-2958.2002.02779.x; Bhatt K, 2007, J CLIN IMMUNOL, V27, P347, DOI 10.1007/s10875-007-9084-0; Black GF, 2009, CLIN VACCINE IMMUNOL, V16, P1203, DOI 10.1128/CVI.00111-09; Brandt L, 2002, INFECT IMMUN, V70, P672, DOI 10.1128/IAI.70.2.672-678.2002; Clarke TB, 2010, NAT MED, V16, P228, DOI 10.1038/nm.2087; COOPER AM, 1993, J EXP MED, V178, P2243, DOI 10.1084/jem.178.6.2243; Dannenberg AM, 2006, PATHOGENESIS OF HUMAN PULMONARY TUBERCULOSIS: INSIGHTS FROM THE RABBIT MODEL, P1; Davis SL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006297; Demissie A, 2006, CLIN VACCINE IMMUNOL, V13, P179, DOI 10.1128/CVI.13.2.179-186.2006; DING AH, 1988, J IMMUNOL, V141, P2407; DUBOS R J, 1956, Am Rev Tuberc, V74, P683; FINE PEM, 1995, LANCET, V346, P1339, DOI 10.1016/S0140-6736(95)92348-9; Fisher MA, 2002, J BACTERIOL, V184, P4025, DOI 10.1128/JB.184.14.4025-4032.2002; FLYNN JL, 1993, J EXP MED, V178, P2249, DOI 10.1084/jem.178.6.2249; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; Girardi E, 2000, AIDS, V14, pS47; Grode L, 2005, J CLIN INVEST, V115, P2472, DOI 10.1172/JCI24617; Gupta R, 2010, NAT MED, V16, P466, DOI 10.1038/nm.2120; Hatfull GF, 2000, MOL GENETICS MYCOBAC; Hoft DF, 2008, J INFECT DIS, V198, P1491, DOI 10.1086/592450; Horwitz MA, 2000, P NATL ACAD SCI USA, V97, P13853, DOI 10.1073/pnas.250480397; Jasmer RM, 2002, NEW ENGL J MED, V347, P1860, DOI 10.1056/NEJMcp021045; Kavanagh H, 2010, CLIN EXP ALLERGY, V40, P933, DOI 10.1111/j.1365-2222.2010.03459.x; Lavollay M, 2008, J BACTERIOL, V190, P4360, DOI 10.1128/JB.00239-08; Maniatis T., 1982, MOL CLONING LAB MANU; Marks GB, 2003, J ALLERGY CLIN IMMUN, V111, P541, DOI 10.1067/mai.2003.171; Orme IM, 2006, VACCINE, V24, P2, DOI 10.1016/j.vaccine.2005.07.078; Orme IM, 2003, TUBERCULOSIS, V83, P112, DOI 10.1016/S1472-9792(02)00069-0; Park HD, 2003, MOL MICROBIOL, V48, P833, DOI 10.1046/j.1365-2958.2003.03474.x; Pym AS, 2003, NAT MED, V9, P533, DOI 10.1038/nm859; Qie YQ, 2009, SCAND J IMMUNOL, V69, P342, DOI 10.1111/j.1365-3083.2009.02231.x; Sambandamurthy VK, 2005, INFECT IMMUN, V73, P1196, DOI 10.1128/IAI.73.2.1196-1203.2005; Saviola B, 2003, INFECT IMMUN, V71, P1379, DOI 10.1128/IAI.71.3.1379-1388.2003; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; SELWYN PA, 1989, NEW ENGL J MED, V320, P545, DOI 10.1056/NEJM198903023200901; Shafferman A.N.Z., 2010, RECOMBINANT BCG TUBE; Sherman DR, 2001, P NATL ACAD SCI USA, V98, P7534, DOI 10.1073/pnas.121172498; STEAD WW, 1967, AM REV RESPIR DIS, V95, P729; STOVER CK, 1991, NATURE, V351, P456, DOI 10.1038/351456a0; Sun R, 2009, VACCINE, V27, P4412, DOI 10.1016/j.vaccine.2009.05.048; van Dissel JT, 2010, VACCINE, V28, P3571, DOI 10.1016/j.vaccine.2010.02.094; Voskuil MI, 2003, J EXP MED, V198, P705, DOI 10.1084/jem.20030205; Wayne LG, 2001, ANNU REV MICROBIOL, V55, P139, DOI 10.1146/annurev.micro.55.1.139; Wedlock DN, 2008, CLIN VACCINE IMMUNOL, V15, P765, DOI 10.1128/CVI.00034-08; World Health Organization, 2009, GLOB TUB CONTR EP ST; Wright A, 2009, LANCET, V373, P1861, DOI 10.1016/S0140-6736(09)60331-7	48	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2010	5	10							e13773	10.1371/journal.pone.0013773	http://dx.doi.org/10.1371/journal.pone.0013773			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673FU	21048936	Green Submitted, Green Published, gold			2022-12-27	WOS:000283645300047
J	Torras-Llort, M; Medina-Giro, S; Moreno-Moreno, O; Azorin, F				Torras-Llort, Monica; Medina-Giro, Sonia; Moreno-Moreno, Olga; Azorin, Fernando			A Conserved Arginine-Rich Motif within the Hypervariable N-Domain of Drosophila Centromeric Histone H3 (CenH3(CID)) Mediates BubR1 Recruitment	PLOS ONE			English	Article							ACCURATE CHROMOSOME SEGREGATION; SPINDLE CHECKPOINT PROTEINS; CENP-A NUCLEOSOMES; ROUGH-DEAL; PHOSPHORYLATION; RECOGNITION; MUTATIONS; EVOLUTION; COMPONENT; COMPLEX	Background: Centromere identity is determined epigenetically by deposition of CenH3, a centromere-specific histone H3 variant that dictates kinetochore assembly. The molecular basis of the contribution of CenH3 to centromere/kinetochore functions is, however, incompletely understood, as its interactions with the rest of centromere/kinetochore components remain largely uncharacterised at the molecular/structural level. Principal Findings: Here, we report on the contribution of Drosophila CenH3(CID) to recruitment of BubR1, a conserved kinetochore protein that is a core component of the spindle attachment checkpoint (SAC). This interaction is mediated by the N-terminal domain of CenH3(CID) (NCenH3(CID)), as tethering NCenH3(CID) to an ectopic reporter construct results in BubR1 recruitment and BubR1-dependent silencing of the reporter gene. Here, we also show that this interaction depends on a short arginine (R)-rich motif and that, most remarkably, it appears to be evolutionarily conserved, as tethering constructs carrying the highly divergent NCenH3 of budding yeast and human also induce silencing of the reporter. Interestingly, though NCenH3 shows an exceedingly low degree of conservation, the presence of R-rich motives is a common feature of NCenH3 from distant species. Finally, our results also indicate that two other conserved sequence motives within NCenH3(CID) might also be involved in interactions with kinetochore components. Conclusions: These results unveil an unexpected contribution of the hypervariable N-domain of CenH3 to recruitment of kinetochore components, identifying simple R-rich motives within it as evolutionary conserved structural determinants involved in BubR1 recruitment.	[Torras-Llort, Monica] CSIC, Inst Mol Biol Barcelona, Barcelona, Spain; IRB Barcelona, Inst Res Biomed, Barcelona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biologia Molecular de Barcelona (IBMB); Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona	Torras-Llort, M (corresponding author), CSIC, Inst Mol Biol Barcelona, Barcelona, Spain.	fambmc@ibmb.csic.es	Azorin, Fernando/N-4388-2014; Torras, Monica/ABE-8392-2021	Azorin, Fernando/0000-0002-8426-7858; Torras-Llort, Monica/0000-0003-1208-905X	MCINN; Ministerio de Ciencia e Innovacion [BFU2009-07111, CSD2006-00049]; Comissio 'Interdepartamental de Recerca i Innovacio Tecnologica [2009SGR1023]	MCINN(European Commission); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Comissio 'Interdepartamental de Recerca i Innovacio Tecnologica	SMG acknowledges receipt of a FPU fellowship from MCINN. This work was financed by grants from "Ministerio de Ciencia e Innovacion'' (BFU2009-07111; CSD2006-00049) and "Comissio 'Interdepartamental de Recerca i Innovacio Tecnologica'' (2009SGR1023). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allshire RC, 2008, NAT REV GENET, V9, P923, DOI 10.1038/nrg2466; Basto R, 2000, NAT CELL BIOL, V2, P939, DOI 10.1038/35046592; Basu J, 1999, J CELL BIOL, V146, P13, DOI 10.1083/jcb.146.1.13; Bloom K, 2007, CURR OPIN GENET DEV, V17, P151, DOI 10.1016/j.gde.2007.02.009; Blower MD, 2001, NAT CELL BIOL, V3, P730, DOI 10.1038/35087045; Blower MD, 2006, PLOS GENET, V2, P1025, DOI 10.1371/journal.pgen.0020110; Carroll CW, 2010, J CELL BIOL, V189, P1143, DOI 10.1083/jcb.201001013; Carroll CW, 2009, NAT CELL BIOL, V11, P896, DOI 10.1038/ncb1899; Chen YH, 2000, MOL CELL BIOL, V20, P7037, DOI 10.1128/MCB.20.18.7037-7048.2000; Ekwall K, 2007, ANNU REV GENET, V41, P63, DOI 10.1146/annurev.genet.41.110306.130127; Ephrussi B, 1944, GENETICS, V29, P148; Foltz DR, 2006, NAT CELL BIOL, V8, P458, DOI 10.1038/ncb1397; Font-Burgada J, 2008, GENE DEV, V22, P3007, DOI 10.1101/gad.481408; GATTI M, 1994, METHOD CELL BIOL, V44, P371, DOI 10.1016/S0091-679X(08)60924-3; Heeger S, 2005, GENE DEV, V19, P2041, DOI 10.1101/gad.347805; Heun P, 2006, DEV CELL, V10, P303, DOI 10.1016/j.devcel.2006.01.014; Hoffman DB, 2001, MOL BIOL CELL, V12, P1995, DOI 10.1091/mbc.12.7.1995; Kawashima SA, 2010, SCIENCE, V327, P172, DOI 10.1126/science.1180189; Keith KC, 1999, MOL CELL BIOL, V19, P6130; Lew DJ, 2003, ANNU REV GENET, V37, P251, DOI 10.1146/annurev.genet.37.042203.120656; Li YH, 2003, DEVELOPMENT, V130, P1817, DOI 10.1242/dev.00405; LLAMAZARES S, 1991, GENE DEV, V5, P2153, DOI 10.1101/gad.5.12a.2153; Logarinho E, 2004, J CELL SCI, V117, P1757, DOI 10.1242/jcs.01033; Logarinho E, 1998, J CELL SCI, V111, P2897; Malik HS, 2009, CELL, V138, P1067, DOI 10.1016/j.cell.2009.08.036; Malik HS, 2002, P NATL ACAD SCI USA, V99, P1449, DOI 10.1073/pnas.032664299; Malik HS, 2001, GENETICS, V157, P1293; Malmanche N, 2007, CURR BIOL, V17, P1489, DOI 10.1016/j.cub.2007.07.042; Morris CA, 2007, CELL, V128, P647, DOI 10.1016/j.cell.2007.02.002; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Nagao T, 1998, P NATL ACAD SCI USA, V95, P3737, DOI 10.1073/pnas.95.7.3737; Okada M, 2006, NAT CELL BIOL, V8, P446, DOI 10.1038/ncb1396; Rahmani Z, 2009, J CELL BIOL, V187, P597, DOI 10.1083/jcb.200905026; Regnier V, 2005, MOL CELL BIOL, V25, P3967, DOI 10.1128/MCB.25.10.3967-3981.2005; Scaerou F, 1999, J CELL SCI, V112, P3757; Smith MM, 2002, CURR OPIN CELL BIOL, V14, P279, DOI 10.1016/S0955-0674(02)00331-9; Straight AF, 1997, CURR BIOL, V7, pR613, DOI 10.1016/S0960-9822(06)00315-0; Sullivan KF, 2001, CURR OPIN GENET DEV, V11, P182, DOI 10.1016/S0959-437X(00)00177-5; Tang TTL, 1998, GENE DEV, V12, P3843, DOI 10.1101/gad.12.24.3843; Torras-Llort M, 2009, EMBO J, V28, P2337, DOI 10.1038/emboj.2009.174; Williams BC, 2003, MOL BIOL CELL, V14, P1379, DOI 10.1091/mbc.E02-09-0624	41	7	7	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2010	5	10							e13747	10.1371/journal.pone.0013747	http://dx.doi.org/10.1371/journal.pone.0013747			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673FU	21060784	Green Published, Green Submitted, gold			2022-12-27	WOS:000283645300027
J	Xi, SC; Yang, MC; Tao, YG; Xu, H; Shan, JG; Inchauste, S; Zhang, M; Mercedes, L; Hong, JA; Rao, M; Schrump, DS				Xi, Sichuan; Yang, Maocheng; Tao, Yongguang; Xu, Hong; Shan, Jigui; Inchauste, Suzanne; Zhang, Mary; Mercedes, Leandro; Hong, Julie A.; Rao, Mahadev; Schrump, David S.			Cigarette Smoke Induces C/EBP-beta-Mediated Activation of miR-31 in Normal Human Respiratory Epithelia and Lung Cancer Cells	PLOS ONE			English	Article							GENE-EXPRESSION; MICRORNA EXPRESSION; LET-7; TRANSFORMATION; WNT; PROLIFERATION; PROFILES; PATHWAYS; TARGETS; BINDING	Background: Limited information is available regarding mechanisms by which miRNAs contribute to pulmonary carcinogenesis. The present study was undertaken to examine expression and function of miRNAs induced by cigarette smoke condensate (CSC) in normal human respiratory epithelia and lung cancer cells. Methodology: Micro-array and quantitative RT-PCR (qRT-PCR) techniques were used to assess miRNA and host gene expression in cultured cells, and surgical specimens. Software-guided analysis, RNA cross-link immunoprecipitation (CLIP), 39 UTR luciferase reporter assays, qRT-PCR, focused super-arrays and western blot techniques were used to identify and confirm targets of miR-31. Chromatin immunoprecipitation (ChIP) techniques were used to evaluate histone marks and transcription factors within the LOC554202 promoter. Cell count and xenograft experiments were used to assess effects of miR-31 on proliferation and tumorigenicity of lung cancer cells. Results: CSC significantly increased miR-31 expression and activated LOC554202 in normal respiratory epithelia and lung cancer cells; miR-31 and LOC554202 expression persisted following discontinuation of CSC exposure. miR-31 and LOC554202 expression levels were significantly elevated in lung cancer specimens relative to adjacent normal lung tissues. CLIP and reporter assays demonstrated direct interaction of miR-31 with Dickkopf-1 (Dkk-1) and DACT-3. Over-expression of miR-31 markedly diminished Dkk-1 and DACT3 expression levels in normal respiratory epithelia and lung cancer cells. Knock-down of miR-31 increased Dkk-1 and DACT3 levels, and abrogated CSC-mediated decreases in Dkk-1 and DACT-3 expression. Furthermore, over-expression of miR-31 diminished SFRP1, SFRP4, and WIF-1, and increased Wnt-5a expression. CSC increased H3K4Me3, H3K9/14Ac and C/EBP-beta levels within the LOC554202 promoter. Knock-down of C/EBP-beta abrogated CSC-mediated activation of LOC554202. Over-expression of miR-31 significantly enhanced proliferation and tumorigenicity of lung cancer cells; knock-down of miR-31 inhibited growth of these cells. Conclusions: Cigarette smoke induces expression of miR-31 targeting several antagonists of cancer stem cell signaling in normal respiratory epithelia and lung cancer cells. miR-31 functions as an oncomir during human pulmonary carcinogenesis.	[Xi, Sichuan; Yang, Maocheng; Inchauste, Suzanne; Zhang, Mary; Mercedes, Leandro; Hong, Julie A.; Rao, Mahadev; Schrump, David S.] NCI, Thorac Oncol Sect, Surg Branch, Ctr Canc Res, Bethesda, MD 20892 USA; [Tao, Yongguang; Xu, Hong] NCI, Lab Canc Prevent, Frederick, MD 21701 USA; [Shan, Jigui] NCI, Adv Biomed Comp Ctr, SAIC Frederick, Frederick, MD 21701 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick	Xi, SC (corresponding author), NCI, Thorac Oncol Sect, Surg Branch, Ctr Canc Res, Bethesda, MD 20892 USA.	David_Schrump@nih.gov			National Institutes of Health; NATIONAL CANCER INSTITUTE [ZIABC011418] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health intramural funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandi N, 2009, CANCER RES, V69, P5553, DOI 10.1158/0008-5472.CAN-08-4277; Barh D, 2010, CURR ONCOL, V17, P70; Bishop JA, 2010, CLIN CANCER RES, V16, P610, DOI 10.1158/1078-0432.CCR-09-2638; Borchert GM, 2006, NAT STRUCT MOL BIOL, V13, P1097, DOI 10.1038/nsmb1167; Carro MS, 2010, NATURE, V463, P318, DOI 10.1038/nature08712; Chi SW, 2009, NATURE, V460, P479, DOI 10.1038/nature08170; Connors SK, 2009, ONCOGENE, V28, P921, DOI 10.1038/onc.2008.429; Corcoran DL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005279; Creighton CJ, 2010, CANCER RES, V70, P1906, DOI 10.1158/0008-5472.CAN-09-3875; Davalos V, 2010, CURR OPIN ONCOL, V22, P35, DOI 10.1097/CCO.0b013e328333dcbb; Deng WG, 2008, CANCER GENE THER, V15, P29, DOI 10.1038/sj.cgt.7701094; Droge P, 2008, CELL STEM CELL, V2, P8, DOI 10.1016/j.stem.2007.12.003; Du LQ, 2010, CANCER METAST REV, V29, P109, DOI 10.1007/s10555-010-9204-9; Du LQ, 2009, MOL CANCER RES, V7, P1234, DOI 10.1158/1541-7786.MCR-08-0507; Espada J, 2009, CLIN TRANSL ONCOL, V11, P411, DOI 10.1007/s12094-009-0380-4; Gluschnaider U, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009060; Glynn T, 2010, CA-CANCER J CLIN, V60, P50, DOI 10.3322/caac.20052; He XY, 2010, J CANCER RES CLIN, V136, P1023, DOI 10.1007/s00432-009-0747-5; Hong JA, 2005, CANCER RES, V65, P7763, DOI 10.1158/0008-5472.CAN-05-0823; Hussain M, 2009, CANCER RES, V69, P3570, DOI 10.1158/0008-5472.CAN-08-2807; Inui M, 2010, NAT REV MOL CELL BIO, V11, P252, DOI 10.1038/nrm2868; Ivanov SV, 2010, J BIOL CHEM, V285, P22807, DOI 10.1074/jbc.M110.100354; Izzotti A, 2010, CARCINOGENESIS, V31, P894, DOI 10.1093/carcin/bgq037; Jensen Kirk B., 2008, V488, P85, DOI 10.1007/978-1-60327-475-3_6; Jiang X, 2008, CANCER CELL, V13, P529, DOI 10.1016/j.ccr.2008.04.019; Johnson CD, 2007, CANCER RES, V67, P7713, DOI 10.1158/0008-5472.CAN-07-1083; Kim MH, 2009, PROSTATE, V69, P1435, DOI 10.1002/pros.20993; Konigshoff M, 2010, AM J RESP CELL MOL, V42, P21, DOI 10.1165/rcmb.2008-0485TR; Kumar MS, 2008, P NATL ACAD SCI USA, V105, P3903, DOI 10.1073/pnas.0712321105; Licatalosi DD, 2008, NATURE, V456, P464, DOI 10.1038/nature07488; Liu F, 2010, ONCOGENE, V29, P3650, DOI 10.1038/onc.2010.129; Liu X, 2010, J CLIN INVEST, V120, P1298, DOI 10.1172/JCI39566; Liu XQ, 2009, COMP FUNCT GENOM, DOI 10.1155/2009/837514; Lu Z, 2008, ONCOGENE, V27, P4373, DOI 10.1038/onc.2008.72; McDonald SL, 2009, BRIT J CANCER, V101, P209, DOI 10.1038/sj.bjc.6605174; Melkamu T, 2010, CARCINOGENESIS, V31, P252, DOI 10.1093/carcin/bgp208; Miko E, 2009, EXP LUNG RES, V35, P646, DOI 10.3109/01902140902822312; Narayan S, 2004, ONCOGENE, V23, P5880, DOI 10.1038/sj.onc.1207792; Navarro A, 2009, ONCOLOGY-BASEL, V76, P162, DOI 10.1159/000201569; Pal R, 2009, BLOOD, V114, P3890, DOI 10.1182/blood-2009-01-201111; Patnaik SK, 2010, CANCER RES, V70, P36, DOI 10.1158/0008-5472.CAN-09-3153; Raponi M, 2009, CANCER RES, V69, P5776, DOI 10.1158/0008-5472.CAN-09-0587; Samet JM, 2009, CLIN CANCER RES, V15, P5626, DOI 10.1158/1078-0432.CCR-09-0376; Schrump D, 2008, CANC PRINCIPLES PRAC, P896; Seike M, 2009, P NATL ACAD SCI USA, V106, P12085, DOI 10.1073/pnas.0905234106; Sioud M, 2010, METHODS MOL BIOL, V629, P255, DOI 10.1007/978-1-60761-657-3_16; Staiger J, 2009, CARCINOGENESIS, V30, P832, DOI 10.1093/carcin/bgn273; Suzuki M, 2007, CLIN CANCER RES, V13, P6087, DOI 10.1158/1078-0432.CCR-07-0591; Taulli R, 2010, CELL CYCLE, V9, P918, DOI 10.4161/cc.9.5.10864; Thun MJ, 2010, CARCINOGENESIS, V31, P100, DOI 10.1093/carcin/bgp263; Valastyan S, 2009, CELL, V137, P1032, DOI 10.1016/j.cell.2009.03.047; Vermeulen L, 2010, NAT CELL BIOL, V12, P468, DOI 10.1038/ncb2048; Volinia S, 2010, GENOME RES, V20, P589, DOI 10.1101/gr.098046.109; Wang CJ, 2009, DIS MARKERS, V26, P27, DOI [10.3233/DMA-2009-0601, 10.1155/2009/921907]; WESTFALL T, 1993, RESAMPLING BASED MUL; Xi SC, 2007, P NATL ACAD SCI USA, V104, P14366, DOI 10.1073/pnas.0703669104; Xi SC, 2009, STEM CELLS, V27, P2691, DOI 10.1002/stem.183; Yang HS, 2009, CLIN CANCER RES, V15, P5744, DOI 10.1158/1078-0432.CCR-09-0385; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054; Zhang JG, 2010, CLIN CHIM ACTA, V411, P846, DOI 10.1016/j.cca.2010.02.074; Zhu SM, 2008, CELL RES, V18, P350, DOI 10.1038/cr.2008.24	61	95	105	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2010	5	10							e13764	10.1371/journal.pone.0013764	http://dx.doi.org/10.1371/journal.pone.0013764			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673FU	21048943	gold, Green Published, Green Submitted			2022-12-27	WOS:000283645300042
J	Ertel, KA; Koenen, KC; Rich-Edwards, JW; Gillman, MW				Ertel, Karen A.; Koenen, Karestan C.; Rich-Edwards, Janet W.; Gillman, Matthew W.			Maternal Depressive Symptoms Not Associated with Reduced Height in Young Children in a US Prospective Cohort Study	PLOS ONE			English	Article							FAILURE-TO-THRIVE; CORTICOTROPIN-RELEASING HORMONE; BRITISH WOMENS HEART; POSTNATAL DEPRESSION; ADULT HEIGHT; INFANT GROWTH; RISK-FACTORS; LEG LENGTH; NUTRITIONAL-STATUS; FEEDING PRACTICES	Background: Shorter stature is associated with greater all cause and heart disease mortality, but taller stature with increased risk of cancer mortality. Though childhood environment is important in determining height, limited data address how maternal depression affects linear growth in children. We examined the relationships between antenatal and postpartum depressive symptoms and child height and linear growth from birth to age 3 years in a U. S. sample. Methods: Subjects were 872 mother-child pairs in Project Viva, a prospective pre-birth cohort study. The study population is relatively advantaged with high levels of income and education and low risk of food insecurity. We assessed maternal depression at mid-pregnancy (mean 28 weeks' gestation) and 6 months postpartum with the Edinburgh Postnatal Depression Scale (score >= 13 on 0-30 scale indicating probable depression). Child outcomes at age 3 were height-for-age z-score (HAZ) and leg length. HAZ was also available at birth and ages 6 months, 1, 2, and 3 years. Findings: Seventy (8.0%) women experienced antenatal depression and 64 (7.3%) experienced postpartum depression. The mean (SD) height for children age 3 was 97.2 cm (4.2), with leg length of 41.6 cm (2.6). In multivariable linear regression models, exposure to postpartum depression was associated with greater HAZ (0.37 [95% confidence interval: 0.16, 0.58]) and longer leg length (0.88 cm [0.35, 1.41]). The relationship between postpartum depression and greater HAZ was evident starting at 6 months and continued to age 3. We found minimal relationships between antenatal depression and child height outcomes. Conclusion: Our findings do not support the hypothesis that maternal depression is associated with reduced height in children in this relatively advantaged sample in a high-income country.	[Ertel, Karen A.; Koenen, Karestan C.] Harvard Univ, Sch Publ Hlth, Dept Soc Human Dev & Hlth, Boston, MA 02115 USA; [Ertel, Karen A.; Koenen, Karestan C.] Harvard Univ, Sch Publ Hlth, Kellogg Hlth Scholars Program, Boston, MA 02115 USA; [Koenen, Karestan C.; Rich-Edwards, Janet W.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Koenen, Karestan C.] Harvard Univ, Ctr Developing Child, Cambridge, MA 02138 USA; [Rich-Edwards, Janet W.] Brigham & Womens Hosp, Ctr Womens Hlth & Gender Biol, Boston, MA 02115 USA; [Gillman, Matthew W.] Harvard Univ, Sch Med, Dept Populat Med, Obes Prevent Program, Boston, MA USA; [Gillman, Matthew W.] Harvard Pilgrim Hlth Care Inst, Boston, MA USA; [Gillman, Matthew W.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard Pilgrim Health Care; Harvard University; Harvard T.H. Chan School of Public Health	Ertel, KA (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Soc Human Dev & Hlth, 665 Huntington Ave, Boston, MA 02115 USA.	kertel@hsph.harvard.edu	Koenen, Karestan/K-5402-2014	Koenen, Karestan/0000-0003-3293-4281	National Institutes of Health [HD 34568, HL 64925, HL 68041]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD034568] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K24HL068041, R01HL064925] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Project Viva is supported by grants from the National Institutes of Health (HD 34568, HL 64925, HL 68041). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adewuya AO, 2008, J AFFECT DISORDERS, V108, P191, DOI 10.1016/j.jad.2007.09.013; ALBANES D, 1988, CANCER RES, V48, P1658; Anoop S, 2004, ARCH DIS CHILD, V89, P325, DOI 10.1136/adc.2002.009738; Azar R, 2007, BIOL PSYCHIAT, V62, P573, DOI 10.1016/j.biopsych.2006.11.009; BINKIN NJ, 1988, PEDIATRICS, V82, P828; Black MM, 2009, AM J CLIN NUTR, V89, p951S, DOI 10.3945/ajcn.2008.26692E; BREUNLIN DC, 1983, INT J EAT DISORDER, V2, P25, DOI 10.1002/1098-108X(198321)2:3<25::AID-EAT2260020304>3.0.CO;2-V; Bugental DB, 2003, HORM BEHAV, V43, P237, DOI 10.1016/S0018-506X(02)00008-9; Burke L, 2003, INT REV PSYCHIATR, V15, P243, DOI 10.1080/0954026031000136866; COX JL, 1987, BRIT J PSYCHIAT, V150, P782, DOI 10.1192/bjp.150.6.782; Dawson G, 1999, CHILD DEV, V70, P1058, DOI 10.1111/1467-8624.00078; De Stavola BL, 2004, AM J EPIDEMIOL, V159, P671, DOI 10.1093/aje/kwh097; Drewett R, 2004, J CHILD PSYCHOL PSYC, V45, P359, DOI 10.1111/j.1469-7610.2004.00226.x; Ertel KA, 2010, PAEDIATR PERINAT EP, V24, P179, DOI 10.1111/j.1365-3016.2010.01098.x; EVANS SL, 1972, J AMER ACAD CHILD PS, V11, P440, DOI 10.1016/S0002-7138(09)61202-4; Farrow CV, 2005, OBES RES, V13, P1999, DOI 10.1038/oby.2005.245; Field T, 2006, INFANT BEHAV DEV, V29, P445, DOI 10.1016/j.infbeh.2006.03.003; Gavin NI, 2005, OBSTET GYNECOL, V106, P1071, DOI 10.1097/01.AOG.0000183597.31630.db; Gillman MW, 2006, OBESITY, V14, P1647, DOI 10.1038/oby.2006.189; Gunnell D, 2003, J EPIDEMIOL COMMUN H, V57, P141, DOI 10.1136/jech.57.2.141; Gunnell D, 2001, EPIDEMIOL REV, V23, P313, DOI 10.1093/oxfordjournals.epirev.a000809; Gunnell DJ, 1998, J EPIDEMIOL COMMUN H, V52, P142, DOI 10.1136/jech.52.3.142; Hall Judith G., 2007, HDB PHYS MEASUREMENT; Halligan SL, 2004, BIOL PSYCHIAT, V55, P376, DOI 10.1016/j.biopsych.2003.09.013; Harpham T, 2005, J EPIDEMIOL COMMUN H, V59, P1060, DOI 10.1136/jech.2005.039180; Hebert PR, 1997, CANCER CAUSE CONTROL, V8, P591, DOI 10.1023/A:1018442329319; Heron J, 2004, J AFFECT DISORDERS, V80, P65, DOI 10.1016/j.jad.2003.08.004; Hilakivi-Clarke L, 2001, BRIT J CANCER, V85, P1680, DOI 10.1054/bjoc.2001.2109; Hurley KM, 2008, J NUTR, V138, P799, DOI 10.1093/jn/138.4.799; Institute of Medicine, 1990, NUTR PREGN; Jousilahti P, 2000, AM J EPIDEMIOL, V151, P1112, DOI 10.1093/oxfordjournals.aje.a010155; Kaltiala-Heino R, 2003, J ADOLESCENCE, V26, P531, DOI 10.1016/S0140-1971(03)00053-8; Lawlor DA, 2002, DIABETOLOGIA, V45, P1097, DOI 10.1007/s00125-002-0887-5; Lawlor DA, 2004, HEART, V90, P745, DOI 10.1136/hrt.2003.019950; Lovejoy MC, 2000, CLIN PSYCHOL REV, V20, P561, DOI 10.1016/S0272-7358(98)00100-7; Martins C, 2000, J CHILD PSYCHOL PSYC, V41, P737, DOI 10.1111/1469-7610.00661; Matthey S, 2006, ARCH WOMEN MENT HLTH, V9, P309, DOI 10.1007/s00737-006-0152-x; McLearn KT, 2006, PEDIATRICS, V118, pE174, DOI 10.1542/peds.2005-1551; Murray D, 1990, J REPROD INFANT PSYC, V8, P99, DOI DOI 10.1080/02646839008403615; Murray L, 2003, Arch Womens Ment Health, V6 Suppl 2, pS71, DOI 10.1007/s00737-003-0007-7; National Center for Health Statistics, 2000, CDC GROWTH CHARTS; O'Brien LM, 2004, PEDIATRICS, V113, P1242, DOI 10.1542/peds.113.5.1242; OCALLAGHAN MJ, 1978, ARCH DIS CHILD, V53, P788, DOI 10.1136/adc.53.10.788; Oken Emily, 2003, BMC Pediatr, V3, P6, DOI 10.1186/1471-2431-3-6; Overpeck MD, 2000, J PEDIATR-US, V137, P205, DOI 10.1067/mpd.2000.107163; Patel V, 2003, ARCH DIS CHILD, V88, P34, DOI 10.1136/adc.88.1.34; PECK AMN, 1989, J EPIDEMIOL COMMUN H, V43, P380, DOI 10.1136/jech.43.4.380; Rahman A, 2004, ARCH GEN PSYCHIAT, V61, P946, DOI 10.1001/archpsyc.61.9.946; Ramsay M, 2002, DEV MED CHILD NEUROL, V44, P405, DOI 10.1017/S0012162201002286; Reck C, 2004, PSYCHOPATHOLOGY, V37, P272, DOI 10.1159/000081983; Remsberg KE, 2005, J CLIN ENDOCR METAB, V90, P2718, DOI 10.1210/jc.2004-1991; Rich-Edwards JW, 2008, J CLIN ENDOCR METAB, V93, P1946, DOI 10.1210/jc.2007-2535; Rich-Edwards JW, 2006, J EPIDEMIOL COMMUN H, V60, P221, DOI 10.1136/jech.2005.039370; RIFASSHIMAN S, 2005, MEDSCAPE GEN MED, V7, P55; Salsberry PJ, 2009, NURS RES, V58, P382, DOI 10.1097/NNR.0b013e3181b4b921; Silventoinen K, 2003, J BIOSOC SCI, V35, P263, DOI 10.1017/S0021932003002633; SINGER LT, 1990, J PEDIATR PSYCHOL, V15, P711, DOI 10.1093/jpepsy/15.6.711; Smith GD, 2000, J EPIDEMIOL COMMUN H, V54, P97, DOI 10.1136/jech.54.2.97; Song YM, 2008, AM J EPIDEMIOL, V168, P497, DOI 10.1093/aje/kwn187; Stewart RC, 2007, MATERN CHILD NUTR, V3, P94, DOI 10.1111/j.1740-8709.2007.00088.x; Stratakis Constantine A, 2006, Pediatr Endocrinol Rev, V3 Suppl 2, P333; Surkan PJ, 2008, J EPIDEMIOL COMMUN H, V62, DOI 10.1136/jech.2007.065664; Surkan PJ, 2008, AM J PUBLIC HEALTH, V98, P125, DOI 10.2105/AJPH.2006.108332; Surkan PJ, 2007, SOC SCI MED, V64, P375, DOI 10.1016/j.socscimed.2006.09.021; Tanner J., 1990, FETUS MAN PHYS GROWT; Tomlinson M, 2006, CHILD CARE HLTH DEV, V32, P81, DOI 10.1111/j.1365-2214.2006.00598.x; WAALER HT, 1984, ACTA MED SCAND, P1; Waynforth D, 2007, DEV PSYCHOBIOL, V49, P640, DOI 10.1002/dev.20248; WHO Multicentre Growth Reference Study Group, 2006, WHO CHILD GROWTH STA; Wright CM, 2006, ARCH DIS CHILD, V91, P312, DOI 10.1136/adc.2005.077750	70	29	29	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2010	5	10							e13656	10.1371/journal.pone.0013656	http://dx.doi.org/10.1371/journal.pone.0013656			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	671UN	21048958	Green Published, gold			2022-12-27	WOS:000283537000027
J	Lewis-Tuffin, LJ; Rodriguez, F; Giannini, C; Scheithauer, B; Necela, BM; Sarkaria, JN; Anastasiadis, PZ				Lewis-Tuffin, Laura J.; Rodriguez, Fausto; Giannini, Caterina; Scheithauer, Bernd; Necela, Brian M.; Sarkaria, Jann N.; Anastasiadis, Panos Z.			Misregulated E-Cadherin Expression Associated with an Aggressive Brain Tumor Phenotype	PLOS ONE			English	Article							CELL-CELL ADHESION; EPITHELIAL-MESENCHYMAL TRANSITIONS; CENTRAL-NERVOUS-SYSTEM; GROWTH-FACTOR RECEPTOR; XENOGRAFT TEST PANEL; N-CADHERIN; DIFFERENTIAL EXPRESSION; GLIOBLASTOMA-MULTIFORME; BETA-CATENIN; P120 CATENIN	Background: Cadherins are essential components of the adherens junction complexes that mediate cell-cell adhesion and regulate cell motility. During tissue morphogenesis, changes in cadherin expression (known as cadherin switching) are a common mechanism for altering cell fate. Cadherin switching is also common during epithelial tumor progression, where it is thought to promote tumor invasion and metastasis. E-cadherin is the predominant cadherin expressed in epithelial tissues, but its expression is very limited in normal brain. Methodology/Principal Findings: We identified E-cadherin expression in a retrospective series of glioblastomas exhibiting epithelial or pseudoepithelial differentiation. Unlike in epithelial tissues, E-cadherin expression in gliomas correlated with an unfavorable clinical outcome. Western blotting of two panels of human GBM cell lines propagated either as xenografts in nude mice or grown under conventional cell culture conditions confirmed that E-cadherin expression is rare. However, a small number of xenograft lines did express E-cadherin, its expression correlating with increased invasiveness when the cells were implanted orthotopically in mouse brain. In the conventionally cultured SF767 glioma cell line, E-cadherin expression was localized throughout the plasma membrane rather than being restricted to areas of cell-cell contact. ShRNA knockdown of E-cadherin in these cells resulted in decreased proliferation and migration in vitro. Conclusions/Significance: Our data shows an unexpected correlation between the abnormal expression of E-cadherin in a subset of GBM tumor cells and the growth and migration of this aggressive brain tumor subtype.	[Lewis-Tuffin, Laura J.; Necela, Brian M.; Anastasiadis, Panos Z.] Mayo Clin Jacksonville, Dept Canc Cell Biol, Jacksonville, FL 32224 USA; [Rodriguez, Fausto; Giannini, Caterina; Scheithauer, Bernd] Mayo Clin, Dept Pathol, Rochester, MN USA; [Sarkaria, Jann N.] Mayo Clin, Dept Radiat Oncol, Rochester, MN USA	Mayo Clinic; Mayo Clinic; Mayo Clinic	Lewis-Tuffin, LJ (corresponding author), Mayo Clin Jacksonville, Dept Canc Cell Biol, 4500 San Pablo Rd, Jacksonville, FL 32224 USA.	panos@mayo.edu	Giannini, Caterina/AAB-7551-2022		National Institutes of Health [R01 CA100467, R01 NS069753, R21 NS070117, P50 CA108961]; Mayo Clinic SPORE in Brain Cancer; Research Training in Neuro-Oncology [T32NS07494]; NATIONAL CANCER INSTITUTE [R01CA100467, P50CA108961] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS069753, R21NS070117, T32NS007494] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Clinic SPORE in Brain Cancer; Research Training in Neuro-Oncology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The work was supported by National Institutes of Health R01 CA100467, R01 NS069753, and R21 NS070117 (PZ Anastasiadis), P50 CA108961 Mayo Clinic SPORE in Brain Cancer (C Giannini and JN Sarkaria), and T32NS07494 "Research Training in Neuro-Oncology" (PI/PD: BP O'Neill). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anastasiadis PZ, 2007, BBA-MOL CELL RES, V1773, P34, DOI 10.1016/j.bbamcr.2006.08.040; Asano K, 2000, NEUROSURG REV, V23, P39, DOI 10.1007/s101430050030; Asano K, 2004, J NEURO-ONCOL, V70, P3, DOI 10.1023/B:NEON.0000040811.14908.f2; Asano K, 1997, Brain Tumor Pathol, V14, P27, DOI 10.1007/BF02478865; Barami Kaveh, 2006, Neurosurg Focus, V21, pE13; Bible KC, 1999, ANAL BIOCHEM, V267, P217, DOI 10.1006/abio.1998.2980; Cavallaro U, 2004, NAT REV CANCER, V4, P118, DOI 10.1038/nrc1276; Christofori G, 1999, TRENDS BIOCHEM SCI, V24, P73, DOI 10.1016/S0968-0004(98)01343-7; DeLeeuw WJF, 1997, J PATHOL, V183, P404, DOI 10.1002/(SICI)1096-9896(199712)183:4<404::AID-PATH1148>3.0.CO;2-9; Demuth T, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-54; du Plessis DG, 2004, CLIN NEUROPATHOL, V23, P141; FIGARELLABRANGER D, 1994, MODERN PATHOL, V7, P752; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Giannini C, 2005, NEURO-ONCOLOGY, V7, P164, DOI 10.1215/S1152851704000821; Giese A, 2003, J CLIN ONCOL, V21, P1624, DOI 10.1200/JCO.2003.05.063; Gumbiner BM, 2005, NAT REV MOL CELL BIO, V6, P622, DOI 10.1038/nrm1699; Gumbiner BM, 2000, J CELL BIOL, V148, P399, DOI 10.1083/jcb.148.3.399; Howng SL, 2002, CANCER LETT, V183, P95, DOI 10.1016/S0304-3835(02)00085-X; Karpowicz P, 2009, J NEUROSCI, V29, P3885, DOI 10.1523/JNEUROSCI.0037-09.2009; Kislin KL, 2009, NEOPLASIA, V11, P377, DOI 10.1593/neo.81572; Leuraud P, 2003, BRIT J CANCER, V89, P2327, DOI 10.1038/sj.bjc.6601466; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Louis DN, 2007, ACTA NEUROPATHOL, V114, P547, DOI 10.1007/s00401-007-0278-6; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Motta FJN, 2008, GENET MOL RES, V7, P295, DOI 10.4238/vol7-2gmr424; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; Ohgaki H, 2007, AM J PATHOL, V170, P1445, DOI 10.2353/ajpath.2007.070011; Ordonez NG, 2003, HUM PATHOL, V34, P749, DOI 10.1016/S0046-8177(03)00285-5; Ozawa T, 1998, IN VIVO, V12, P369; Ozolek JA, 2004, MODERN PATHOL, V17, P739, DOI 10.1038/modpathol.3800109; Pandita A, 2004, GENE CHROMOSOME CANC, V39, P29, DOI 10.1002/gcc.10300; Perego C, 2002, J CELL SCI, V115, P3331; Perez TD, 2008, J BIOL CHEM, V283, P5014, DOI 10.1074/jbc.M705209200; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Reddy P, 2005, MOL ENDOCRINOL, V19, P2564, DOI 10.1210/me.2004-0342; Redies C, 2000, PROG NEUROBIOL, V61, P611, DOI 10.1016/S0301-0082(99)00070-2; Rodriguez FJ, 2008, CANCER, V113, P2779, DOI 10.1002/cncr.23899; Sarkaria JN, 2007, MOL CANCER THER, V6, P1167, DOI 10.1158/1535-7163.MCT-06-0691; Sarkaria JN, 2006, CLIN CANCER RES, V12, P2264, DOI 10.1158/1078-0432.CCR-05-2510; Schwechheimer K, 1998, VIRCHOWS ARCH, V432, P163, DOI 10.1007/s004280050151; SHINOURA N, 1995, BRIT J CANCER, V72, P627, DOI 10.1038/bjc.1995.384; Soto E, 2008, J CELL BIOL, V183, P737, DOI 10.1083/jcb.200805113; Steinberg MS, 1999, CURR OPIN CELL BIOL, V11, P554, DOI 10.1016/S0955-0674(99)00027-7; Sundfeldt K, 2003, MOL CELL ENDOCRINOL, V202, P89, DOI 10.1016/S0303-7207(03)00068-6; Suzuki SC, 2008, DEV GROWTH DIFFER, V50, pS119, DOI 10.1111/j.1440-169X.2008.01002.x; Takeichi M, 2000, PHILOS T ROY SOC B, V355, P885, DOI 10.1098/rstb.2000.0624; TAKEICHI M, 1995, CURR OPIN CELL BIOL, V7, P619, DOI 10.1016/0955-0674(95)80102-2; Takeichi M, 2007, NAT REV NEUROSCI, V8, P11, DOI 10.1038/nrn2043; Takeichi M, 1993, CURR OPIN CELL BIOL, V5, P806, DOI 10.1016/0955-0674(93)90029-P; The WHO, 2020, CLASSIFICATION TUMOU; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; TOHMA Y, 1992, CANCER RES, V52, P1981; Troyanovsky SM, 1999, CURR OPIN CELL BIOL, V11, P561, DOI 10.1016/S0955-0674(99)00021-6; Utsuki S, 2002, J NEURO-ONCOL, V57, P187, DOI 10.1023/A:1015720220602; Wheelock MJ, 2008, J CELL SCI, V121, P727, DOI 10.1242/jcs.000455; Wijnhoven BPL, 2000, BRIT J SURG, V87, P992, DOI 10.1046/j.1365-2168.2000.01513.x; Xia M, 2010, J NEURO-ONCOL, V97, P225, DOI 10.1007/s11060-009-0015-1; Yamada S, 2007, J CELL BIOL, V178, P517, DOI 10.1083/jcb.200701058; Yanagisawa M, 2006, J CELL BIOL, V174, P1087, DOI 10.1083/jcb.200605022; Yang L, 2008, CLIN CANCER RES, V14, P3993, DOI 10.1158/1078-0432.CCR-07-4152	61	119	124	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2010	5	10							e13665	10.1371/journal.pone.0013665	http://dx.doi.org/10.1371/journal.pone.0013665			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671UN	21060868	gold, Green Published, Green Submitted			2022-12-27	WOS:000283537000034
J	Liangos, O; Domhan, S; Schwager, C; Zeier, M; Huber, PE; Addabbo, F; Goligorsky, MS; Hlatky, L; Jaber, BL; Abdollahi, A				Liangos, Orfeas; Domhan, Sophie; Schwager, Christian; Zeier, Martin; Huber, Peter E.; Addabbo, Francesco; Goligorsky, Michael S.; Hlatky, Lynn; Jaber, Bertrand L.; Abdollahi, Amir			Whole Blood Transcriptomics in Cardiac Surgery Identifies a Gene Regulatory Network Connecting Ischemia Reperfusion with Systemic Inflammation	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; ARTERY-BYPASS-SURGERY; OFF-PUMP; ON-PUMP; CARDIOPULMONARY BYPASS; NATIONAL DATABASE; LONG PENTRAXIN; RESISTIN; EXPRESSION; INJURY	Background: Cardiac surgery with cardiopulmonary bypass (CS/CPB) is associated with increased risk for postoperative complications causing substantial morbidity and mortality. To identify the molecular mechanisms underlying CS/CPB-induced pathophysiology we employed an integrative systems biology approach using the whole blood transcriptome as the sentinel organ. Methodology/Principal Findings: Total RNA was isolated and globin mRNA depleted from whole blood samples prospectively collected from 10 patients at time points prior (0), 2 and 24 hours following CS/CPB. Genome-wide transcriptional analysis revealed differential expression of 610 genes after CS/CPB (p<0.01). Among the 375 CS/CPB-upregulated genes, we found a gene-regulatory network consisting of 50 genes, reminiscent of activation of a coordinated genetic program triggered by CS/CPB. Intriguingly, the highly connected hub nodes of the identified network included key sensors of ischemia-reperfusion (HIF-1alpha and C/EBPbeta). Activation of this network initiated a concerted inflammatory response via upregulation of TLR-4/5, IL1R2/IL1RAP, IL6, IL18/IL18R1/IL18RAP, MMP9, HGF/HGFR, CalgranulinA/B, and coagulation factors F5/F12 among others. Differential regulation of 13 candidate genes including novel, not hitherto CS/CBP-associated genes, such as PTX3, PGK1 and Resistin, was confirmed using real-time quantitative RT-PCR. In support of the mRNA data, differential expression of MMP9, MIP1alpha and MIP1beta plasma proteins was further confirmed in 34 additional patients. Conclusions: Analysis of blood transcriptome uncovered critical signaling pathways governing the CS/CPB-induced pathophysiology. The molecular signaling underlying ischemia reperfusion and inflammatory response is highly intertwined and includes pro-inflammatory as well as cardioprotective elements. The herein identified candidate genes and pathways may provide promising prognostic biomarker and therapeutic targets.	[Liangos, Orfeas; Jaber, Bertrand L.] Tufts Univ, Sch Med, Caritas St Elizabeths Med Ctr, Kidney & Dialysis Res Lab,Div Nephrol, Boston, MA 02111 USA; [Domhan, Sophie; Hlatky, Lynn; Abdollahi, Amir] Tufts Univ, Sch Med, Caritas St Elizabeths Med Ctr, Ctr Canc Syst Biol, Boston, MA 02111 USA; [Domhan, Sophie; Zeier, Martin] Univ Med Sch, Dept Nephrol, Heidelberg, Germany; [Domhan, Sophie; Schwager, Christian; Zeier, Martin; Huber, Peter E.; Abdollahi, Amir] German Canc Res Ctr, D-6900 Heidelberg, Germany; [Schwager, Christian; Huber, Peter E.; Abdollahi, Amir] Univ Med Sch, Dept Radiat Oncol, Heidelberg, Germany; [Addabbo, Francesco; Goligorsky, Michael S.] New York Med Coll, Div Nephrol, Valhalla, NY 10595 USA	St. Elizabeth's Medical Center; Tufts University; St. Elizabeth's Medical Center; Tufts University; University of Hamburg; University Medical Center Hamburg-Eppendorf; Helmholtz Association; German Cancer Research Center (DKFZ); University of Hamburg; University Medical Center Hamburg-Eppendorf; New York Medical College	Liangos, O (corresponding author), Tufts Univ, Sch Med, Caritas St Elizabeths Med Ctr, Kidney & Dialysis Res Lab,Div Nephrol, Boston, MA 02111 USA.	liangos_o@hotmail.com; amir.abdollahi@tufts.edu			American Heart Association (AHA) [0535367N]; National Institutes of Health [DK065102, DK077751, DK084394]; NASA Specialized Center of Research (NSCOR) [NNJ04HJ12G]; Westchester Artificial Kidney Foundation; German Krebshilfe [107691, 107689, Max-Eder 108876]; BMBF [03NUK004A/C]; DFG (German Research Foundation) [SPP1190]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK084394, R03DK077751, K23DK065102] Funding Source: NIH RePORTER	American Heart Association (AHA)(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NASA Specialized Center of Research (NSCOR); Westchester Artificial Kidney Foundation; German Krebshilfe(Deutsche Krebshilfe); BMBF(Federal Ministry of Education & Research (BMBF)); DFG (German Research Foundation)(German Research Foundation (DFG)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the following agencies: 1) American Heart Association (AHA #0535367N, to OL), which funded the principal author (OL) as well as the parent study that provided the samples and clinical data for this manuscript. 2) National Institutes of Health (DK065102 and DK077751, to BLJ), funded the co-author (BLJ). 3) NASA Specialized Center of Research (NSCOR, NNJ04HJ12G, to LH and AA), which provides funding for the infrastructure and major equipment used for the manuscript. 4) DK084394 and Westchester Artificial Kidney Foundation (to MSG), which funded the plasma protein measurement experiments. 5) German Krebshilfe (107691 & 107689, to PH and AA), German Krebshilfe (Max-Eder 108876, to AA), BMBF (03NUK004A/C, to PH and AA), DFG (German Research Foundation) SPP1190 (to PH and AA), which funded the respective authors as listed with their initials. 6) Institutional research funds (to OL), which funded the supplies and consumables for the analytic tests. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdollahi A, 2005, J EXP MED, V201, P925, DOI 10.1084/jem.20041393; Abdollahi A, 2004, MOL CELL, V13, P649, DOI 10.1016/S1097-2765(04)00102-9; Abdollahi A, 2007, P NATL ACAD SCI USA, V104, P12890, DOI 10.1073/pnas.0705505104; Almog N, 2009, CANCER RES, V69, P836, DOI 10.1158/0008-5472.CAN-08-2590; Castellheim A, 2008, ANN THORAC SURG, V85, P1994, DOI 10.1016/j.athoracsur.2008.03.012; Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075; Chandrasekar B, 1999, CIRCULATION, V99, P427, DOI 10.1161/01.CIR.99.3.427; Christenson J T, 1996, Cardiovasc Surg, V4, P15, DOI 10.1016/0967-2109(96)83778-1; Clark SC, 2006, PERFUSION-UK, V21, P225, DOI 10.1191/0267659106pf872oa; Cohen G, 2008, J IMMUNOL, V181, P3761, DOI 10.4049/jimmunol.181.6.3761; Croome KP, 2009, CAN J SURG, V52, P125; Daly Richard C, 2005, Mayo Clin Proc, V80, P636; DAVIES SW, 1993, J THORAC CARDIOV SUR, V105, P979, DOI 10.1016/S0022-5223(19)33769-9; Domhan S, 2008, MOL CANCER THER, V7, P1656, DOI 10.1158/1535-7163.MCT-08-0193; Emani S, 2009, J THORAC CARDIOV SUR, V138, P185, DOI 10.1016/j.jtcvs.2008.12.024; Fransen E, 1998, CHEST, V113, P1290, DOI 10.1378/chest.113.5.1290; Grover FL, 1999, ANN THORAC SURG, V68, P367, DOI 10.1016/S0003-4975(99)00599-8; Grover FW, 1999, ANN THORAC SURG, V68, P374; Hall RI, 1997, ANESTH ANALG, V85, P766, DOI 10.1097/00000539-199710000-00011; Harmoinen A, 2006, SCAND CARDIOVASC J, V40, P110, DOI 10.1080/14017430500401220; Hill WD, 2004, J NEUROPATH EXP NEUR, V63, P84, DOI 10.1093/jnen/63.1.84; Hung HF, 2008, J HYPERTENS, V26, P2349, DOI 10.1097/HJH.0b013e328311fa30; Jain U, 1997, ANESTHESIOLOGY, V86, P576, DOI 10.1097/00000542-199703000-00009; JANSEN NJG, 1991, EUR J CARDIO-THORAC, V5, P211, DOI 10.1016/1010-7940(91)90032-F; Kielstein JT, 2003, AM J KIDNEY DIS, V42, P62, DOI 10.1016/S0272-6386(03)00409-8; KOLLEF MH, 1995, CHEST, V107, P1395, DOI 10.1378/chest.107.5.1395; Laffey JG, 2002, ANESTHESIOLOGY, V97, P215; Lee SH, 2009, CORONARY ARTERY DIS, V20, P33, DOI 10.1097/MCA.0b013e328318ecb0; Li H, 1996, J BIOL CHEM, V271, P21262, DOI 10.1074/jbc.271.35.21262; Mangano CM, 1998, ANN INTERN MED, V128, P194, DOI 10.7326/0003-4819-128-3-199802010-00005; Mangano DT, 1997, JAMA-J AM MED ASSOC, V277, P325, DOI 10.1001/jama.277.4.325; Meldrum DR, 1999, J SURG RES, V85, P185, DOI 10.1006/jsre.1999.5660; Oyama J, 2004, CIRCULATION, V109, P784, DOI 10.1161/01.CIR.0000112575.66565.84; Patel L, 2003, BIOCHEM BIOPH RES CO, V300, P472, DOI 10.1016/S0006-291X(02)02841-3; Peri G, 2000, CIRCULATION, V102, P636, DOI 10.1161/01.CIR.102.6.636; Ramlawi B, 2007, ANN THORAC SURG, V84, P1166, DOI 10.1016/j.athoracsur.2007.04.126; Ramlawi B, 2007, J THORAC CARDIOV SUR, V134, P996, DOI 10.1016/j.jtcvs.2007.01.096; Roach GW, 1996, NEW ENGL J MED, V335, P1857, DOI 10.1056/NEJM199612193352501; Rothwell SE, 2006, BIOCHEM BIOPH RES CO, V349, P400, DOI 10.1016/j.bbrc.2006.08.052; Salio M, 2008, CIRCULATION, V117, P1055, DOI 10.1161/CIRCULATIONAHA.107.749234; Seeburger J, 2005, CIRCULATION, V112, pI224, DOI 10.1161/CIRCULATIONAHA.104.525378; Stallwood MI, 2004, ANN THORAC SURG, V77, P968, DOI 10.1016/j.athoracsur.2003.09.063; Steppan CM, 2001, NATURE, V409, P307, DOI 10.1038/35053000; STOKMAN G, NEPHROL DIAL TRANSPL; Suzuki S, 2008, AM HEART J, V155, P75, DOI 10.1016/j.ahj.2007.08.013; Tomic V, 2005, CIRCULATION, V112, P2912, DOI 10.1161/CIRCULATIONAHA.104.531152; Vartanian K, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-2; Wan S, 1997, CHEST, V112, P676, DOI 10.1378/chest.112.3.676; Westhuyzen J, 1997, J THORAC CARDIOV SUR, V113, P942, DOI 10.1016/S0022-5223(97)70268-X; Yamashita Chojiro, 1998, Kobe Journal of Medical Sciences, V44, P199; Zhang M, 2007, FASEB J, V21, P3197, DOI 10.1096/fj.06-6558com	51	28	30	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2010	5	10							e13658	10.1371/journal.pone.0013658	http://dx.doi.org/10.1371/journal.pone.0013658			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671UN	21048961	gold, Green Submitted, Green Published			2022-12-27	WOS:000283537000029
J	Pathak, PK; Singh, A; Subramanian, SV				Pathak, Praveen Kumar; Singh, Abhishek; Subramanian, S. V.			Economic Inequalities in Maternal Health Care: Prenatal Care and Skilled Birth Attendance in India, 1992-2006	PLOS ONE			English	Article							MILLENNIUM DEVELOPMENT GOALS; RURAL UTTAR-PRADESH; SAFE-MOTHERHOOD; ANTENATAL CARE; DELIVERY CARE; NUTRITIONAL-STATUS; WOMENS AUTONOMY; SERVICES; POOR; MORTALITY	Background: The use of maternal health care is limited in India despite several programmatic efforts for its improvement since the late 1980's. The use of maternal health care is typically patterned on socioeconomic and cultural contours. However, there is no clear perspective about how socioeconomic differences over time have contributed towards the use of maternal health care in India. Methodology/Principal Findings: Using data from three rounds of National Family Health Survey (NFHS) conducted during 1992-2006, we analyse the trends and patterns in utilization of prenatal care (PNC) in first trimester with four or more antenatal care visits and skilled birth attendance (SBA) among poor and nonpoor mothers, disaggregated by area of residence in India and three contrasting provinces, namely, Uttar Pradesh, Maharashtra and Tamil Nadu. In addition, we investigate the relative contribution of public and private health facilities in meeting the demand for SBA, especially among poor mothers. We also examine the role of salient socioeconomic, demographic and cultural factors in influencing aforementioned outcomes. Bivariate analyses, concentration curve and concentration index, logistic regression and multinomial logistic regression models are used to understand the trends, patterns and predictors of the two outcome variables. Results indicate sluggish progress in utilization of PNC and SBA in India and selected provinces during 1992-2006. Enormous inequalities in utilization of PNC and SBA were observed largely to the disadvantage of the poor. Multivariate analysis suggests growing inequalities in utilization of the two outcomes across different economic groups. Conclusions: The use of PNC and SBA remains disproportionately lower among poor mothers in India irrespective of area of residence and province. Despite several governmental efforts to increase access and coverage of delivery services to poor, it is clear that the poor (a) do not use SBA and (b) even if they had SBA, they were more likely to use the private providers.	[Pathak, Praveen Kumar; Singh, Abhishek] Int Inst Populat Sci, Dept Publ Hlth & Mortal Studies, Mumbai, Maharashtra, India; [Subramanian, S. V.] Harvard Univ, Sch Publ Hlth, Dept Soc Human Dev & Hlth, Boston, MA 02115 USA	International Institute for Population Sciences; Harvard University; Harvard T.H. Chan School of Public Health	Pathak, PK (corresponding author), Int Inst Populat Sci, Dept Publ Hlth & Mortal Studies, Mumbai, Maharashtra, India.	pkp_pathak@rediffmail.com	Pathak, Praveen Kumar/GPG-1695-2022; Pathak, Praveen Kumar/M-6010-2014; Singh, Abhishek/ABC-7813-2020	Pathak, Praveen Kumar/0000-0003-1571-7859; Singh, Abhishek/0000-0001-6263-4410	University Grants Commission, Government of India; National Institutes of Health [NHLBI K25 HL081275]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K25HL081275] Funding Source: NIH RePORTER	University Grants Commission, Government of India(University Grants Commission, India); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	No direct financial support or funding was obtained to conduct this study. PKP is supported by a University Grants Commission Senior Research Fellowhip Award, Government of India. Dr. Subramanian is supported by a National Institutes of Health Career Development Award (NHLBI K25 HL081275).	AbouZahr C, 2001, B WORLD HEALTH ORGAN, V79, P561; Adam T, 2005, BMJ-BRIT MED J, V331, P1107, DOI 10.1136/bmj.331.7525.1107; Allendorf K, 2007, STUD FAMILY PLANN, V38, P35, DOI 10.1111/j.1728-4465.2007.00114.x; [Anonymous], 2001, ASIA PAC POPUL J, DOI DOI 10.1136/BMJ.I2851; [Anonymous], 2003, 131 IFPRI; Anwar I, 2008, B WORLD HEALTH ORGAN, V86, P252, DOI 10.2471/BLT.07.042754; BARBIERI M, 2005, POPULATION E, V60, P617; Beegle K, 2001, STUD FAMILY PLANN, V32, P130, DOI 10.1111/j.1728-4465.2001.00130.x; Bell J, 2003, DHS ANAL STUDIES, V7; Bhat BNM, 1999, ECON POLIT WEEKLY, V34, P3008; Bhatia JC., 1995, HLTH TRANSITION REV, V5, P127; Bloom SS, 2001, DEMOGRAPHY, V38, P67, DOI 10.1353/dem.2001.0001; Bose A, 1991, DEMOGRAPHIC DIVERSIT; Brugha R, 2003, B WORLD HEALTH ORGAN, V81, P616; Collin Simon M, 2007, Int J Equity Health, V6, P9, DOI 10.1186/1475-9276-6-9; DEBROUWERE V, 1998, UNMET OBSTET NEEDS; DYSON T, 1983, POPUL DEV REV, V9, P35, DOI 10.2307/1972894; Filippi V, 2006, LANCET, V368, P1535, DOI 10.1016/S0140-6736(06)69384-7; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; FREEDMAN L, 2003, BACKGROUND PAPER TAS; Freedman LP, 2007, LANCET, V370, P1383, DOI 10.1016/S0140-6736(07)61581-5; *GOV IND PLANN COM, 2002, NAT HUM DEV REP 2001; Government of India Planning Commission, 2007, POV EST 2004 05; Graham W.J., 2001, SAFE MOTHERHOOD STRA, P97; Graham WJ, 2004, LANCET, V363, P23, DOI 10.1016/S0140-6736(03)15165-3; Griffiths P, 2002, SOC SCI MED, V55, P775, DOI 10.1016/S0277-9536(01)00202-7; Gwatkin DR, 2005, LANCET, V365, P813, DOI 10.1016/S0140-6736(05)17992-6; Gwatkin DR, SOCIOECONOMIC DIFFER; Hatt L, 2007, B WORLD HEALTH ORGAN, V85, P774, DOI 10.2471/BLT.06.033472; Houweling TAJ, 2007, B WORLD HEALTH ORGAN, V85, P745, DOI 10.2471/BLT.06.038588; Human Rights Watch (HRW), 2009, NO TALL ANG ACC MAT; IIPS, 2007, IND NAT FAM HLTH SUR, V1; IIPS & ORC Macro, 1995, NATL FAMILY HLTH SUR; *IIPS ORC MACRO, 2000, NAT FAM HLTH SURV NF; JEJEEBHOY S, 1997, J FAM WELFARE, V43, P31; Koblinsky MA, 1999, B WORLD HEALTH ORGAN, V77, P399; Koblinsky M, 2006, LANCET, V368, P1377, DOI 10.1016/S0140-6736(06)69382-3; Lawn JE, 2006, LANCET, V368, P1474, DOI 10.1016/S0140-6736(06)69387-2; Lim SS, 2010, LANCET, V375, P2009, DOI 10.1016/S0140-6736(10)60744-1; MASON KO, 1997, CONTINUING DEMOGRAPH, P158; Mavalankar D, 2008, B WORLD HEALTH ORGAN, V86, P243, DOI 10.2471/BLT.07.048454; MCCAWBINNS A, 2007, SOC SCI MED, V40, P1003; Mishra V, 2004, POPUL DEV REV, V30, P269, DOI 10.1111/j.1728-4457.2004.013_1.x; Mistry R, 2009, SOC SCI MED, V69, P926, DOI 10.1016/j.socscimed.2009.07.008; Mohanty SK, 2009, J BIOSOC SCI, V41, P381, DOI 10.1017/S002193200800309X; Mohanty Sanjay K., 2009, Genus, V65, P113; Montgomery MR, 2000, DEMOGRAPHY, V37, P155, DOI 10.2307/2648118; Nanda G., 2005, ACCELERATING PROGR A; Navaneetham K, 2002, SOC SCI MED, V55, P1849, DOI 10.1016/S0277-9536(01)00313-6; ODonnell O., ANAL HLTH EQUITY USI; *OFF REG GEN, 2009, SPEC B MAT MORT IND; Office of Registrar General, 2007, SAMPL REG SYST SRS S; Padmanaban P, 2009, J HEALTH POPUL NUTR, V27, P202; Pallikadavath S, 2004, SOC SCI MED, V59, P1147, DOI 10.1016/j.socscimed.2003.11.045; PATHAK PK, POP ASS AM PAA DETR; Pathak PK, 2010, ASIAN POPUL STUD, V6, P173, DOI 10.1080/17441730.2010.494444; PETERS DH, 2002, BETTER HLTH SYSTEM I; Ram F, 2006, J HLTH DEV, V2, P67; RAM F, 2004, J FAM WELFARE, V50, P26; RAM F, 2004, POPULATION HLTH DEV, P40; Ram F, 2006, J BIOSOC SCI, V38, P433, DOI 10.1017/S0021932005026453; RamaRao S, 2001, HEALTH POLICY PLANN, V16, P256, DOI 10.1093/heapol/16.3.256; Rani M, 2008, INT J QUAL HEALTH C, V20, P62, DOI 10.1093/intqhc/mzm052; Ronsmans C, 2006, LANCET, V368, P1189, DOI 10.1016/S0140-6736(06)69380-X; ROSENFIELD A, 1985, LANCET, V2, P83; Rosenfield A, 2006, LANCET, V368, P1133, DOI 10.1016/S0140-6736(06)69386-0; Salam A, 2006, J OBSTET GYN INDIA, V56, P123; Say L, 2007, B WORLD HEALTH ORGAN, V85, P812, DOI 10.2471/BLT.06.035659; SELVARAJ S, 1980, EC POLITICAL WE 1003, V44; Sjngh A, 2009, B WORLD HEALTH ORGAN, V87, P960, DOI 10.2471/BLT.08.060228; Stanton C, 2007, J BIOSOC SCI, V39, P109, DOI 10.1017/S0021932006001271; Statacorp, 2007, STAT STAT SOFTW REL; Stephenson R, 2002, STUD FAMILY PLANN, V33, P309, DOI 10.1111/j.1728-4465.2002.00309.x; Sunil TS, 2006, SOC SCI MED, V62, P1943, DOI 10.1016/j.socscimed.2005.09.004; UNICEF, 2008, STAT WORLDS CHILDR R; van Doorslaer E, 2006, LANCET, V368, P1357, DOI 10.1016/S0140-6736(06)69560-3; Vora KS, 2009, J HEALTH POPUL NUTR, V27, P184, DOI 10.3329/jhpn.v27i2.3363; Vyas S, 2006, HEALTH POLICY PLANN, V21, P459, DOI 10.1093/heapol/czl029; WARDLAW T, 1999, SAFE MOTHERHOOD INIT, P24; *WHO, 2005, P62 WHO; *WHO UNICEF UNFPA, 2008, EST DEV WHO UNICEF U; Wirth ME, 2006, B WORLD HEALTH ORGAN, V84, P519, DOI 10.2471/BLT.04.019984; Wolff B., 2000, CULTURE HLTH SEXUALI, V3, P1; World Health Organization (WHO), 2004, MAK PREGN SAF CRIT R; World Health Organization (WHO), 2009, SAF PREGN TAM NAD VI; World Health Organization(WHO), 2006, PROV EFF ANT CAR INT; Zere E, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-78	87	121	122	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2010	5	10							e13593	10.1371/journal.pone.0013593	http://dx.doi.org/10.1371/journal.pone.0013593			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	671UN	21048964	Green Published, Green Submitted, gold			2022-12-27	WOS:000283537000014
J	Bertola, A; Bonnafous, S; Anty, R; Patouraux, S; Saint-Paul, MC; Iannelli, A; Gugenheim, J; Barr, J; Mato, JM; Le Marchand-Brustel, Y; Tran, A; Gual, P				Bertola, Adeline; Bonnafous, Stephanie; Anty, Rodolphe; Patouraux, Stephanie; Saint-Paul, Marie-Christine; Iannelli, Antonio; Gugenheim, Jean; Barr, Jonathan; Mato, Jose M.; Le Marchand-Brustel, Yannick; Tran, Albert; Gual, Philippe			Hepatic Expression Patterns of Inflammatory and Immune Response Genes Associated with Obesity and NASH in Morbidly Obese Patients	PLOS ONE			English	Article							FATTY LIVER-DISEASE; OMENTAL ADIPOSE-TISSUE; TOLL-LIKE RECEPTOR-4; NONALCOHOLIC STEATOHEPATITIS; INSULIN-RESISTANCE; MACROPHAGE ACCUMULATION; MICE; OSTEOPONTIN; CELLS; SYSTEM	Background: Obesity modulates inflammation and activation of immune pathways which can lead to liver complications. We aimed at identifying expression patterns of inflammatory and immune response genes specifically associated with obesity and NASH in the liver of morbidly obese patients. Methodology/Principal Findings: Expression of 222 genes was evaluated by quantitative RT-PCR in the liver of morbidly obese patients with histologically normal liver (n = 6), or with severe steatosis without (n = 6) or with NASH (n = 6), and in lean controls (n = 5). Hepatic expression of 58 out of 222 inflammatory and immune response genes was upregulated in NASH patients. The most notable changes occurred in genes encoding chemokines and chemokine receptors involved in leukocyte recruitment, CD and cytokines involved in the T cell activation towards a Th1 phenotype, and immune semaphorins. This regulation seems to be specific for the liver since visceral adipose tissue expression and serum levels of MCP1, IP10, TNF alpha and IL6 were not modified. Importantly, 47 other genes were already upregulated in histologically normal liver (e.g. CRP, Toll-like receptor (TLR) pathway). Interestingly, serum palmitate, known to activate the TLR pathway, was increased with steatosis. Conclusion/Significance: The liver of obese patients without histological abnormalities already displayed a low-grade inflammation and could be more responsive to activators of the TLR pathway. NASH was then characterized by a specific gene signature. These findings help to identify new potential actors of the pathogenesis of NAFLD.	[Bertola, Adeline; Bonnafous, Stephanie; Anty, Rodolphe; Saint-Paul, Marie-Christine; Gugenheim, Jean; Le Marchand-Brustel, Yannick; Tran, Albert; Gual, Philippe] INSERM, U895, Team Hepat Complicat Obes 8, Nice, France; [Bertola, Adeline; Bonnafous, Stephanie; Anty, Rodolphe; Saint-Paul, Marie-Christine; Gugenheim, Jean; Le Marchand-Brustel, Yannick; Tran, Albert; Gual, Philippe] Univ Nice Sophia Antipolis, Fac Med, Nice, France; [Bonnafous, Stephanie; Anty, Rodolphe; Iannelli, Antonio; Gugenheim, Jean; Le Marchand-Brustel, Yannick; Tran, Albert; Gual, Philippe] Ctr Hosp Univ Nice, Digest Unit, Nice, France; [Patouraux, Stephanie; Saint-Paul, Marie-Christine] Ctr Hosp Univ Nice, Biol Unit, Nice, France; [Barr, Jonathan] OWL Genom, Bizkaia, Spain; [Mato, Jose M.] Ciberehd, CIC BioGUNE, Bizkaia, Spain	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; UDICE-French Research Universities; Universite Cote d'Azur; CHU Nice; CHU Nice; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; CIC bioGUNE	Bertola, A (corresponding author), INSERM, U895, Team Hepat Complicat Obes 8, Nice, France.	gual@unice.fr	Gual, Philippe/M-8787-2017; Gual, Philippe/P-9833-2019; Iannelli, Antonio/E-6521-2012; MATO, JOSE/A-5187-2011	Gual, Philippe/0000-0001-7393-8356; Gual, Philippe/0000-0001-7393-8356; MATO, JOSE/0000-0003-1264-3153; Iannelli, Antonio/0000-0002-1611-071X; GUGENHEIM, Jean/0000-0002-2624-3014; Anty, Rodolphe/0000-0001-8194-9805; Anty, Rodolphe/0000-0002-8053-1957; Bertola, Adeline/0000-0002-4885-8423; patouraux, stephanie/0000-0001-6004-7685	Institut National de la Sante et de la Recherche Medicale (France) [ANR-05-PCOD-025-02]; University of Nice; Programme Hospitalier de Recherche Clinique (Centre Hospitalier Universitaire of Nice); Societe Francophone du Diabete/Association de Langue Francaise pour l'Etude du Diabete et des Maladie Metaboliques (SFD/ALFEDIAM); Association Francaise pour l'Etude du Foie (AFEF)/Schering-Plough; European Commission [LSHM-CT-2005-018734]; Association pour la Recherche sur le Cancer (France); CHU of Nice	Institut National de la Sante et de la Recherche Medicale (France)(Institut National de la Sante et de la Recherche Medicale (Inserm)); University of Nice; Programme Hospitalier de Recherche Clinique (Centre Hospitalier Universitaire of Nice); Societe Francophone du Diabete/Association de Langue Francaise pour l'Etude du Diabete et des Maladie Metaboliques (SFD/ALFEDIAM); Association Francaise pour l'Etude du Foie (AFEF)/Schering-Plough(Merck & CompanySchering Plough Corporation); European Commission(European CommissionEuropean Commission Joint Research Centre); Association pour la Recherche sur le Cancer (France)(Fondation ARC pour la Recherche sur le Cancer); CHU of Nice	This work was supported by grants from the Institut National de la Sante et de la Recherche Medicale (France) (ANR-05-PCOD-025-02 and PNRHGE to PG), the University of Nice, the Programme Hospitalier de Recherche Clinique (Centre Hospitalier Universitaire of Nice), and charities (Societe Francophone du Diabete/Association de Langue Francaise pour l'Etude du Diabete et des Maladie Metaboliques (SFD/ALFEDIAM) and Association Francaise pour l'Etude du Foie (AFEF)/Schering-Plough to PG). This work is part of the project "Hepatic and adipose tissue and functions in the metabolic syndrome" (HEPADIP, see http://www.hepadip.org/), which is supported by the European Commission as an Integrated Project under the 6th Framework Programme (Contract LSHM-CT-2005-018734). AB was successively supported by the Programme Hospitalier de Recherche Clinique (Centre Hospitalier Universitaire of Nice) and the Association pour la Recherche sur le Cancer (France). SB was supported by ANR-05-PCOD-025-02. YLMB and PG are the recipients of an Interface Grant from CHU of Nice. Jonathan Barr belongs to the OWL Genomics Company, Bizkaia Technology Park, Spain, who did have a role in study design, data collection and analysis. Indeed, JB has determined the palmitate level in the serum samples from the patients and has analyzed the values (Figure 5). The other funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albano E, 2005, GUT, V54, P987, DOI 10.1136/gut.2004.057968; Anty R, 2008, OBES SURG, V18, P709, DOI 10.1007/s11695-007-9276-y; Anty R, 2006, AM J GASTROENTEROL, V101, P1824, DOI 10.1111/j.1572-0241.2006.00724.x; Ashkar S, 2000, SCIENCE, V287, P860, DOI 10.1126/science.287.5454.860; Baranova A, 2007, OBES SURG, V17, P1111, DOI 10.1007/s11695-007-9187-y; Bekri S, 2006, GASTROENTEROLOGY, V131, P788, DOI 10.1053/j.gastro.2006.07.007; Bertola A, 2009, DIABETES, V58, P125, DOI 10.2337/db08-0400; Bigorgne AE, 2008, GASTROENTEROLOGY, V134, P1459, DOI 10.1053/j.gastro.2008.02.055; Brunt EM, 2001, SEMIN LIVER DIS, V21, P3, DOI 10.1055/s-2001-12925; Cancello R, 2006, DIABETES, V55, P1554, DOI 10.2337/db06-0133; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Cayon A, 2008, REV ESP ENFERM DIG, V100, P212, DOI 10.4321/s1130-01082008000400004; Cortez-Pinto H, 2006, J HEPATOL, V44, P197, DOI 10.1016/j.jhep.2005.09.002; Crespo J, 2001, HEPATOLOGY, V34, P1158, DOI 10.1053/jhep.2001.29628; Diao HY, 2004, IMMUNITY, V21, P539, DOI 10.1016/j.immuni.2004.08.012; Donnelly KL, 2005, J CLIN INVEST, V115, P1343, DOI 10.1172/JCI200523621; Elinav E, 2006, J PATHOL, V208, P74, DOI 10.1002/path.1869; Estep JM, 2009, OBES SURG, V19, P617, DOI 10.1007/s11695-009-9814-x; Guebre-Xabier M, 2000, HEPATOLOGY, V31, P633, DOI 10.1002/hep.510310313; Haukeland JW, 2006, J HEPATOL, V44, P1167, DOI 10.1016/j.jhep.2006.02.011; Huang W, 2010, DIABETES, V59, P347, DOI 10.2337/db09-0016; Ito S, 2007, ALCOHOL CLIN EXP RES, V31, p83S, DOI 10.1111/j.1530-0277.2006.00292.x; Joshi-Barve S, 2007, HEPATOLOGY, V46, P823, DOI 10.1002/hep.21752; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; LANTHIER N, 2009, AM J PHYSL GASTROINT; Lee JY, 2001, J BIOL CHEM, V276, P16683, DOI 10.1074/jbc.M011695200; Li ZP, 2005, HEPATOLOGY, V42, P880, DOI 10.1002/hep.20826; Li ZP, 2003, HEPATOLOGY, V37, P343, DOI 10.1053/jhep.2003.50048; Li ZP, 2002, GASTROENTEROLOGY, V123, P1304, DOI 10.1053/gast.2002.35997; Loffreda S, 1998, FASEB J, V12, P57, DOI 10.1096/fasebj.12.1.57; Maher JJ, 2008, HEPATOLOGY, V48, P670, DOI 10.1002/hep.22399; McCullough AJ, 2006, J CLIN GASTROENTEROL, V40, pS17; Mimura S, 2004, J GASTROENTEROL, V39, P867, DOI 10.1007/s00535-004-1403-0; Mizui M, 2009, J CLIN IMMUNOL, V29, P1, DOI 10.1007/s10875-008-9263-7; Neuschwander-Tetri BA, 2003, HEPATOLOGY, V37, P1202, DOI 10.1053/jhep.2003.50193; Pacifico L, 2006, EUR J ENDOCRINOL, V154, P691, DOI 10.1530/eje.1.02138; Poggi M, 2007, DIABETOLOGIA, V50, P1267, DOI 10.1007/s00125-007-0654-8; Rivera CA, 2007, J HEPATOL, V47, P571, DOI 10.1016/j.jhep.2007.04.019; Sanyal AJ, 2001, GASTROENTEROLOGY, V120, P1183, DOI 10.1053/gast.2001.23256; Seki E, 2008, HEPATOLOGY, V48, P322, DOI 10.1002/hep.22306; Solga SF, 2003, J HEPATOL, V38, P681, DOI 10.1016/S0168-8278(03)00097-7; Suzuki A, 2009, WOMENS HEALTH, V5, P191, DOI 10.2217/17455057.5.2.191; Suzuki K, 2008, NAT IMMUNOL, V9, P17, DOI 10.1038/ni1553; Szabo G, 2005, ALCOHOL CLIN EXP RES, V29, p140S, DOI 10.1097/01.alc.0000189287.83544.33; Tilg H, 2000, NEW ENGL J MED, V343, P1467, DOI 10.1056/NEJM200011163432007; Tilg H, 2009, GASTROENTEROLOGY, V136, P1476, DOI 10.1053/j.gastro.2009.03.030; Tordjman J, 2009, J HEPATOL, V51, P354, DOI 10.1016/j.jhep.2009.02.031; VALENTI L, 2009, SEMIN IMMUNOPATHOL; Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487; Waxman DJ, 2009, MOL PHARMACOL, V76, P215, DOI 10.1124/mol.109.056705; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wieckowska A, 2008, AM J GASTROENTEROL, V103, P1372, DOI 10.1111/j.1572-0241.2007.01774.x; Xu CF, 2007, WORLD J GASTROENTERO, V13, P4504; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yang SQ, 1997, P NATL ACAD SCI USA, V94, P2557, DOI 10.1073/pnas.94.6.2557; Yokoyama Y, 2005, J SURG RES, V128, P147, DOI 10.1016/j.jss.2005.04.017	56	169	175	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2010	5	10							e13577	10.1371/journal.pone.0013577	http://dx.doi.org/10.1371/journal.pone.0013577			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	670KA	21042596	Green Submitted, gold, Green Published			2022-12-27	WOS:000283419100016
J	Hult, M; Tornhammar, P; Ueda, P; Chima, C; Bonamy, AKE; Ozumba, B; Norman, M				Hult, Martin; Tornhammar, Per; Ueda, Peter; Chima, Charles; Bonamy, Anna-Karin Edstedt; Ozumba, Benjamin; Norman, Mikael			Hypertension, Diabetes and Overweight: Looming Legacies of the Biafran Famine	PLOS ONE			English	Article							IMPAIRED GLUCOSE-TOLERANCE; SYSTOLIC BLOOD-PRESSURE; BODY-MASS INDEX; BIRTH-WEIGHT; FETAL ORIGINS; LATER LIFE; IN-UTERO; CHILD UNDERNUTRITION; PRENATAL EXPOSURE; ADULT DISEASE	Background: Sub-Saharan Africa is facing rapidly increasing prevalences of cardiovascular disease, obesity, diabetes and hypertension. Previous and ongoing undernutrition among pregnant women may contribute to this development as suggested by epidemiological studies from high income countries linking undernutrition in fetal life with increased burden of non-communicable diseases in later life. We undertook to study the risks for hypertension, glucose intolerance and overweight forty years after fetal exposure to famine afflicted Biafra during the Nigerian civil war (1967-1970). Methods and Findings: Cohort study performed in June 27-July 31, 2009 in Enugu, Nigeria. Adults (n = 1,339) born before (1965-67), during (1968-January 1970), or after (1971-73) the years of famine were included. Blood pressure (BP), random plasma glucose (p-glucose) and anthropometrics, as well as prevalence of hypertension (BP>140/90 mmHg), impaired glucose tolerance (IGT; p-glucose 7.8-11.0 mmol/l), diabetes (DM; p-glucose >= 11.1 mmol/l), or overweight (BMI>25 kg/m(2)) were compared between the three groups. Fetal-infant exposure to famine was associated with elevated systolic (+7 mmHg; p<0.001) and diastolic (+5 mmHg; p<0.001) BP, increased p-glucose (+0.3 mmol/L; p<0.05) and waist circumference (+3cm, p<0.001), increased risk of systolic hypertension (adjusted OR 2.87; 95% CI 1.90-4.34), IGT (OR 1.65; 95% CI 1.02-2.69) and overweight (OR 1.41; 95% CI 1.03-1.93) as compared to people born after the famine. Limitations of this study include the lack of birth weight data and the inability to separate effects of fetal and infant famine. Conclusions: Fetal and infant undernutrition is associated with significantly increased risk of hypertension and impaired glucose tolerance in 40-year-old Nigerians. Prevention of undernutrition during pregnancy and in infancy should therefore be given high priority in health, education, and economic agendas.	[Hult, Martin; Tornhammar, Per; Ueda, Peter; Norman, Mikael] Karolinska Inst, Dept Clin Sci Intervent & Technol, Stockholm, Sweden; [Bonamy, Anna-Karin Edstedt] Karolinska Inst, Dept Womens & Childrens Hlth, Stockholm, Sweden; [Chima, Charles; Ozumba, Benjamin] Univ Nigeria Teaching Hosp, Enugu, Nigeria	Karolinska Institutet; Karolinska Institutet; University of Nigeria	Hult, M (corresponding author), Karolinska Inst, Dept Clin Sci Intervent & Technol, Stockholm, Sweden.	mikael.norman@ki.se	Ueda, Peter/AGH-9915-2022; Ueda, Peter/AAB-8961-2020; Bonamy, Anna-Karin E/B-7106-2012	Ueda, Peter/0000-0002-3275-8743; Ueda, Peter/0000-0002-3275-8743; Bonamy, Anna-Karin E/0000-0003-4552-9912; Norman, Mikael/0000-0003-4191-3781	Karolinska Institute; Swedish International Development Cooperation Agency; Carl-Eriks Levins Foundation	Karolinska Institute(Karolinska Institutet); Swedish International Development Cooperation Agency; Carl-Eriks Levins Foundation	Funding was received from the Karolinska Institute, Swedish International Development Cooperation Agency and Carl-Eriks Levins Foundation. Funding was unrestricted and the funders had no role in the study design, data collection, analysis, decision to publish or preparation of the manuscript.	Aall C, 1970, J Trop Pediatr (1967), V16, P70; Adair LS, 2003, HYPERTENSION, V41, P451, DOI 10.1161/01.HYP.0000054212.23528.B2; [Anonymous], 2010, BMC RES NOTES; Armitage JA, 2004, J PHYSIOL-LONDON, V561, P355, DOI 10.1113/jphysiol.2004.072009; Barker DJP, 2002, INT J EPIDEMIOL, V31, P1235, DOI 10.1093/ije/31.6.1235; BARKER DJP, 1993, LANCET, V341, P938, DOI 10.1016/0140-6736(93)91224-A; Barker DJP, 1998, MOTHERS BABIES HLTH; Bergvall N, 2007, CIRCULATION, V115, P2931, DOI 10.1161/CIRCULATIONAHA.106.674812; Bhargava SK, 2004, NEW ENGL J MED, V350, P865, DOI 10.1056/NEJMoa035698; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; BLUM JD, 1969, HARVARD CRIMSON 0225; Clausson B, 2000, BRIT J OBSTET GYNAEC, V107, P375, DOI 10.1111/j.1471-0528.2000.tb13234.x; Eriksson J, 2000, HYPERTENSION, V36, P790, DOI 10.1161/01.HYP.36.5.790; Gluckman PD, 2004, SCIENCE, V305, P1733, DOI 10.1126/science.1095292; Gluckman PD, 2009, LANCET, V373, P1654, DOI 10.1016/S0140-6736(09)60234-8; Grajeda Ruben, 2005, Food and Nutrition Bulletin, V26, pS15; HALES CN, 1991, BMJ-BRIT MED J, V303, P1019, DOI 10.1136/bmj.303.6809.1019; Holmes MD, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000244; Huxley R, 2002, LANCET, V360, P659, DOI 10.1016/S0140-6736(02)09834-3; Huxley RR, 2000, J HYPERTENS, V18, P815, DOI 10.1097/00004872-200018070-00002; Ike S O, 2009, Niger J Med, V18, P68; Johansson S, 2007, J INTERN MED, V261, P480, DOI 10.1111/j.1365-2796.2007.01776.x; Kaijser M, 2009, DIABETES, V58, P523, DOI 10.2337/db08-0558; Koupil I, 2007, EUR J EPIDEMIOL, V22, P223, DOI 10.1007/s10654-007-9113-6; Lawlor DA, 2002, AM J EPIDEMIOL, V156, P1100, DOI 10.1093/aje/kwf154; Leon DA, 1996, BRIT MED J, V312, P401, DOI 10.1136/bmj.312.7028.401; Lucas A, 1999, BRIT MED J, V319, P245, DOI 10.1136/bmj.319.7204.245; Miller J P, 1970, Lancet, V760, P1330; Moore SE, 2001, DIABETIC MED, V18, P646, DOI 10.1046/j.1464-5491.2001.00565.x; Nwagwu MO, 2000, BRIT J NUTR, V83, P79, DOI 10.1017/S0007114500000118; Oladapo OO, 2010, CARDIOVASC J AFR, V21, P26; Ravelli ACJ, 1999, AM J CLIN NUTR, V70, P811; Ravelli ACJ, 1998, LANCET, V351, P173, DOI 10.1016/S0140-6736(97)07244-9; Richter LM, 2004, PAEDIATR PERINAT EP, V18, P290, DOI 10.1111/j.1365-3016.2004.00572.x; Roseboom TJ, 2001, J HYPERTENS, V19, P29, DOI 10.1097/00004872-200101000-00004; Roseboom TJ, 1999, J HYPERTENS, V17, P325, DOI 10.1097/00004872-199917030-00004; Sachdev HS, 2005, AM J CLIN NUTR, V82, P456, DOI 10.1093/ajcn/82.2.456; Shepherd PR, 1997, BRIT J NUTR, V78, P121, DOI 10.1079/BJN19970124; Stanner SA, 1997, BMJ-BRIT MED J, V315, P1342, DOI 10.1136/bmj.315.7119.1342; Stein AD, 2006, EUR J EPIDEMIOL, V21, P759, DOI 10.1007/s10654-006-9065-2; Topouchian JA, 2006, BLOOD PRESS MONIT, V11, P165, DOI 10.1097/01.mbp.0000209078.17246.34; Unwin N, 2001, HEALTH POLICY PLANN, V16, P351, DOI 10.1093/heapol/16.4.351; Victora CG, 2008, LANCET, V371, P340, DOI 10.1016/S0140-6736(07)61692-4; Victora Cesar G., 2003, Cad. Saúde Pública, V19, P1241, DOI 10.1590/S0102-311X2003000500003; World Health Organization/International Diabetes Federation, 2006, DEF DIAGN DIAB MELL; Yach D, 2004, JAMA-J AM MED ASSOC, V291, P2616, DOI 10.1001/jama.291.21.2616; Yusuf S, 2000, NEW ENGL J MED, V342, P145; 1991, AM J EPIDEMIOL, V133, P185	48	189	194	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2010	5	10							e13582	10.1371/journal.pone.0013582	http://dx.doi.org/10.1371/journal.pone.0013582			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	670KA	21042579	Green Published, Green Submitted, gold			2022-12-27	WOS:000283419100019
J	Mazur, PK; Gruner, BM; Nakhai, H; Sipos, B; Zimber-Strobl, U; Strobl, LJ; Radtke, F; Schmid, RM; Siveke, JT				Mazur, Pawel K.; Gruener, Barbara M.; Nakhai, Hassan; Sipos, Bence; Zimber-Strobl, Ursula; Strobl, Lothar J.; Radtke, Freddy; Schmid, Roland M.; Siveke, Jens T.			Identification of Epidermal Pdx1 Expression Discloses Different Roles of Notch1 and Notch2 in Murine Kras(G12D)-Induced Skin Carcinogenesis In Vivo	PLOS ONE			English	Article							TRANSCRIPTION FACTOR PDX-1; BETA-CATENIN; KERATINOCYTE GROWTH; TUMOR-SUPPRESSOR; STEM-CELLS; MOUSE; ACTIVATION; MICE; GENE; RAS	Background: The Ras and Notch signaling pathways are frequently activated during development to control many diverse cellular processes and are often dysregulated during tumorigenesis. To study the role of Notch and oncogenic Kras signaling in a progenitor cell population, Pdx1-Cre mice were utilized to generate conditional oncogenic Kras(G12D) mice with ablation of Notch1 and/or Notch2. Methodology/Principal Findings: Surprisingly, mice with activated Kras(G12D) and Notch1 but not Notch2 ablation developed skin papillomas progressing to squamous cell carcinoma providing evidence for Pdx1 expression in the skin. Immunostaining and lineage tracing experiments indicate that PDX1 is present predominantly in the suprabasal layers of the epidermis and rarely in the basal layer. Further analysis of keratinocytes in vitro revealed differentiation-dependent expression of PDX1 in terminally differentiated keratinocytes. PDX1 expression was also increased during wound healing. Further analysis revealed that loss of Notch1 but not Notch2 is critical for skin tumor development. Reasons for this include distinct Notch expression with Notch1 in all layers and Notch2 in the suprabasal layer as well as distinctive p21 and beta-catenin signaling inhibition capabilities. Conclusions/Significance: Our results provide strong evidence for epidermal expression of Pdx1 as of yet not identified function. In addition, this finding may be relevant for research using Pdx1-Cre transgenic strains. Additionally, our study confirms distinctive expression and functions of Notch1 and Notch2 in the skin supporting the importance of careful dissection of the contribution of individual Notch receptors.	[Mazur, Pawel K.; Gruener, Barbara M.; Schmid, Roland M.; Siveke, Jens T.] Tech Univ Munich, Klinikum Rechts Isar Univ Hosp, Dept Internal Med 2, Munich, Germany; [Nakhai, Hassan] Univ Warwick, Dept Biol Sci, Coventry CV4 7AL, W Midlands, England; [Sipos, Bence] Univ Tubingen, Univ Hosp, Inst Pathol, Tubingen, Germany; [Zimber-Strobl, Ursula; Strobl, Lothar J.] German Res Ctr Environm Hlth, Helmholtz Zentrum, Dept Gene Vectors, Munich, Germany; [Radtke, Freddy] Ecole Polytech Fed Lausanne EPFL SV ISREC, ISREC, Lausanne, Switzerland	Technical University of Munich; University of Warwick; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute Experimental Cancer Research	Mazur, PK (corresponding author), Tech Univ Munich, Klinikum Rechts Isar Univ Hosp, Dept Internal Med 2, Munich, Germany.	jens.siveke@lrz.tum.de	Zimber-Strobl, Ursula/M-4618-2014; Grüner, Barbara/AAB-9246-2020; Grüner, Barbara M/T-1298-2018; Radtke, Freddy/Q-3198-2017; Strobl, Lothar J/M-7357-2014; Siveke, Jens/AAQ-6170-2021; Mazur, Pawel K./AAU-6343-2021	Zimber-Strobl, Ursula/0000-0002-9765-5251; Grüner, Barbara/0000-0003-0974-4826; Grüner, Barbara M/0000-0003-0974-4826; Radtke, Freddy/0000-0003-4315-4045; Strobl, Lothar J/0000-0001-8389-1862; Mazur, Pawel K./0000-0002-5820-8344	German Cancer Aid [107195]; The Lustgarten Foundation [RFP05-14, 06-12]; German Research Foundation [SI 1549/1-1]	German Cancer Aid(Deutsche Krebshilfe); The Lustgarten Foundation; German Research Foundation(German Research Foundation (DFG))	This work was supported by grants from the German Cancer Aid (#107195), The Lustgarten Foundation (RFP05-14 and 06-12) and the German Research Foundation (SI 1549/1-1; all to J.T.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagheri MM, 2001, CLIN DERMATOL, V19, P244, DOI 10.1016/S0738-081X(01)00179-1; Besseyrias V, 2007, J EXP MED, V204, P331, DOI 10.1084/jem.20061442; Blanpain C, 2006, GENE DEV, V20, P3022, DOI 10.1101/gad.1477606; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Brissova M, 2002, J BIOL CHEM, V277, P11225, DOI 10.1074/jbc.M111272200; Buettner M, 2004, MODERN PATHOL, V17, P56, DOI 10.1038/modpathol.3800015; Chan EF, 1999, NAT GENET, V21, P410, DOI 10.1038/7747; Chigurupati S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001167; Demehri S, 2009, CANCER CELL, V16, P55, DOI 10.1016/j.ccr.2009.05.016; Di Cunto F, 1998, SCIENCE, V280, P1069, DOI 10.1126/science.280.5366.1069; Dotto GP, 2008, ONCOGENE, V27, P5115, DOI 10.1038/onc.2008.225; Fan X, 2004, CANCER RES, V64, P7787, DOI 10.1158/0008-5472.CAN-04-1446; Gannon M, 2000, GENESIS, V26, P143, DOI 10.1002/(SICI)1526-968X(200002)26:2<143::AID-GENE13>3.0.CO;2-L; Gannon M, 2001, DEV BIOL, V238, P185, DOI 10.1006/dbio.2001.0359; Geisler F, 2008, HEPATOLOGY, V48, P607, DOI 10.1002/hep.22381; GREENHALGH DA, 1993, MOL CARCINOGEN, V7, P99, DOI 10.1002/mc.2940070208; Gu GQ, 2002, DEVELOPMENT, V129, P2447; Hakkinen Lari, 2001, Methods in Cell Science, V23, P189, DOI 10.1023/A:1016385109922; Hamada Y, 1999, DEVELOPMENT, V126, P3415; HENNINGS H, 1980, CELL, V19, P245, DOI 10.1016/0092-8674(80)90406-7; Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X; Hingorani SR, 2005, CANCER CELL, V7, P469, DOI 10.1016/j.ccr.2005.04.023; Huelsken J, 2001, CELL, V105, P533, DOI 10.1016/S0092-8674(01)00336-1; JONSSON J, 1994, NATURE, V371, P606, DOI 10.1038/371606a0; Kawamori D, 2003, DIABETES, V52, P2896, DOI 10.2337/diabetes.52.12.2896; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Larsson LI, 1996, MECH DEVELOP, V60, P175, DOI 10.1016/S0925-4773(96)00609-0; Lefort K, 2004, SEMIN CANCER BIOL, V14, P374, DOI 10.1016/j.semcancer.2004.04.017; Lewis AK, 1998, MECH DEVELOP, V78, P159, DOI 10.1016/S0925-4773(98)00165-8; Lin MH, 2000, DEVELOPMENT, V127, P2421; Lowell S, 2000, CURR BIOL, V10, P491, DOI 10.1016/S0960-9822(00)00451-6; Macfarlane WM, 1999, J BIOL CHEM, V274, P1011, DOI 10.1074/jbc.274.2.1011; Mammucari C, 2005, DEV CELL, V8, P665, DOI 10.1016/j.devcel.2005.02.016; MAZUR PK, 2010, P NATL ACAD IN PRESS; Moellering RE, 2009, NATURE, V462, P182, DOI 10.1038/nature08543; Moriyama M, 2008, DEV CELL, V14, P594, DOI 10.1016/j.devcel.2008.01.017; Nakhai H, 2008, DEVELOPMENT, V135, P2757, DOI 10.1242/dev.013722; Nicolas M, 2003, NAT GENET, V33, P416, DOI 10.1038/ng1099; Novak A, 2000, GENESIS, V28, P147, DOI 10.1002/1526-968X(200011/12)28:3/4<147::AID-GENE90>3.0.CO;2-G; Offield MF, 1996, DEVELOPMENT, V122, P983; Pan YH, 2004, DEV CELL, V7, P731, DOI 10.1016/j.devcel.2004.09.014; Radtke F, 1999, IMMUNITY, V10, P547, DOI 10.1016/S1074-7613(00)80054-0; Rangarajan A, 2001, EMBO J, V20, P3427, DOI 10.1093/emboj/20.13.3427; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Sakai T, 2001, NAT MED, V7, P324, DOI 10.1038/85471; Siveke JT, 2007, CANCER CELL, V12, P266, DOI 10.1016/j.ccr.2007.08.002; Sivere JT, 2008, GASTROENTEROLOGY, V134, P544, DOI 10.1053/j.gastro.2007.11.003; Oskarsson T, 2006, GENE DEV, V20, P2024, DOI 10.1101/gad.381206; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Tarutani M, 1997, P NATL ACAD SCI USA, V94, P7400, DOI 10.1073/pnas.94.14.7400; Tarutani M, 2003, CANCER RES, V63, P319; Tuveson DA, 2004, CANCER CELL, V5, P375, DOI 10.1016/S1535-6108(04)00085-6; Uyttendaele H, 2004, DIFFERENTIATION, V72, P396, DOI 10.1111/j.1432-0436.2004.07208006.x; Vauclair S, 2005, DEV BIOL, V284, P184, DOI 10.1016/j.ydbio.2005.05.018; Vitale-Cross L, 2004, CANCER RES, V64, P8804, DOI 10.1158/0008-5472.CAN-04-2623; Wescott MP, 2009, MOL BIOL CELL, V20, P4838, DOI 10.1091/mbc.E09-03-0203; Wu Y, 2010, NATURE, V464, P1052, DOI 10.1038/nature08878; Xia XF, 2001, P NATL ACAD SCI USA, V98, P10863, DOI 10.1073/pnas.191284198	58	32	34	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2010	5	10							e13578	10.1371/journal.pone.0013578	http://dx.doi.org/10.1371/journal.pone.0013578			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	670KA	21042537	Green Published, gold, Green Submitted			2022-12-27	WOS:000283419100017
J	Accordi, B; Espina, V; Giordan, M; VanMeter, A; Milani, G; Galla, L; Ruzzene, M; Sciro, M; Trentin, L; De Maria, R; Kronnie, GT; Petricoin, E; Liotta, L; Basso, G				Accordi, Benedetta; Espina, Virginia; Giordan, Marco; VanMeter, Amy; Milani, Gloria; Galla, Luisa; Ruzzene, Maria; Sciro, Manuela; Trentin, Luca; De Maria, Ruggero; Kronnie, Geertruy Te; Petricoin, Emanuel; Liotta, Lance; Basso, Giuseppe			Functional Protein Network Activation Mapping Reveals New Potential Molecular Drug Targets for Poor Prognosis Pediatric BCP-ALL	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; NITRIC-OXIDE; SYNTHASE ACTIVITY; KINASE; PATHWAY; APOPTOSIS; ASSOCIATION; MECHANISMS; CANCER; BCL-2	Background: In spite of leukemia therapy improvements obtained over the last decades, therapy is not yet effective in all cases. Current approaches in Acute Lymphoblastic Leukemia (ALL) research focus on identifying new molecular targets to improve outcome for patients with a dismal prognosis. In this light phosphoproteomics seems to hold great promise for the identification of proteins suitable for targeted therapy. Methodology/Principal Findings: We employed Reverse Phase Protein Microarrays to identify aberrantly activated proteins in 118 pediatric B-cell precursor (BCP)-ALL patients. Signal transduction pathways were assayed for activation/expression status of 92 key signalling proteins. We observed an increased activation/expression of several pathways involved in cell proliferation in poor clinical prognosis patients. MLL-rearranged tumours revealed BCL-2 hyperphosphorylation through AMPK activation, which indicates that AMPK could provide a functional role in inhibiting apoptosis in MLL-rearranged patients, and could be considered as a new potential therapeutic target. Second, in patients with poor clinical response to prednisone we observed the up-modulation of LCK activity with respect to patients with good response. This tyrosine-kinase can be down-modulated with clinically used inhibitors, thus modulating LCK activity could be considered for further studies as a new additional therapy for prednisone-resistant patients. Further we also found an association between high levels of CYCLIN E and relapse incidence. Moreover, CYCLIN E is more expressed in early relapsed patients, who usually show an unfavourable prognosis. Conclusions/Significance: We conclude that functional protein pathway activation mapping revealed specific deranged signalling networks in BCP-ALL that could be potentially modulated to produce a better clinical outcome for patients resistant to standard-of-care therapies.	[Accordi, Benedetta; Giordan, Marco; Milani, Gloria; Galla, Luisa; Sciro, Manuela; Trentin, Luca; Kronnie, Geertruy Te; Basso, Giuseppe] Univ Padua, Dept Pediat, Oncohematol Lab, Padua, Italy; [Espina, Virginia; VanMeter, Amy; Petricoin, Emanuel; Liotta, Lance] George Mason Univ, Ctr Appl Prote & Mol Med, Manassas, VA USA; [Ruzzene, Maria] Univ Padua, Dept Biol Chem, Padua, Italy; [Ruzzene, Maria] Univ Padua, VIMM, Padua, Italy; [De Maria, Ruggero] Ist Super Sanita, Dept Hematol Oncol & Mol Med, I-00161 Rome, Italy	University of Padua; George Mason University; University of Padua; University of Padua; Veneto Institute Molecular Medicine; Istituto Superiore di Sanita (ISS)	Accordi, B (corresponding author), Univ Padua, Dept Pediat, Oncohematol Lab, Padua, Italy.	benedetta.accordi@unipd.it	Kronnie, Geertruy te/L-1014-2016; Giordan, Marco/A-3301-2012; De Maria, Ruggero/S-6385-2019	De Maria, Ruggero/0000-0003-2255-0583; Espina, Virginia/0000-0001-5080-5972; BASSO, GIUSEPPE/0000-0002-2634-9302; /0000-0001-5636-1006; Galla, Luisa/0000-0001-8160-6052; Ruzzene, Maria/0000-0001-8712-8151; te Kronnie, Geertruy/0000-0001-7143-4795; TRENTIN, LUCA/0000-0002-7447-2946	Italian Istituto Superiore di Sanita in the framework of the Italy/USA cooperation agreement between the U.S. Department of Health and Human Services, George Mason University; Italian Ministry of Public Health; Fondazione Citta' della Speranza; Ministero della Salute; Associazione Italiana Ricerca sul Cancro; PRIN MIUR	Italian Istituto Superiore di Sanita in the framework of the Italy/USA cooperation agreement between the U.S. Department of Health and Human Services, George Mason University; Italian Ministry of Public Health(Ministry of Health, Italy); Fondazione Citta' della Speranza; Ministero della Salute(Ministry of Health, Italy); Associazione Italiana Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); PRIN MIUR(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN))	This work was supported by grants from the Italian Istituto Superiore di Sanita in the framework of the Italy/USA cooperation agreement between the U.S. Department of Health and Human Services, George Mason University, and the Italian Ministry of Public Health; the Fondazione Citta' della Speranza; the Ministero della Salute (Ricerca Finalizzata 2006- Programma Integrato Oncologia); the Associazione Italiana Ricerca sul Cancro; the PRIN MIUR EX 40%, and the EX 60%. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amundadottir LT, 1998, ONCOGENE, V16, P737, DOI 10.1038/sj.onc.1201829; Bachmann PS, 2007, CANCER RES, V67, P4482, DOI 10.1158/0008-5472.CAN-06-4244; Basso G, 2001, HAEMATOLOGICA, V86, P675; Baumann P, 2007, ANTI-CANCER DRUG, V18, P405, DOI 10.1097/CAD.0b013e32801416b6; BERGMAN M, 1992, EMBO J, V11, P2919, DOI 10.1002/j.1460-2075.1992.tb05361.x; Blake S, 2008, CLIN IMMUNOL, V127, P330, DOI 10.1016/j.clim.2008.02.006; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Choi BM, 2002, J BIOCHEM MOL BIOL, V35, P116; Drew BG, 2004, P NATL ACAD SCI USA, V101, P6999, DOI 10.1073/pnas.0306266101; GENARO AM, 1995, J CLIN INVEST, V95, P1884, DOI 10.1172/JCI117869; Goeman JJ, 2004, BIOINFORMATICS, V20, P93, DOI 10.1093/bioinformatics/btg382; Haferlach T, 2010, J CLIN ONCOL, V28, P2529, DOI 10.1200/JCO.2009.23.4732; HENZE G, 1991, BLOOD, V78, P1166; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Kornblau SM, 2009, BLOOD, V113, P154, DOI 10.1182/blood-2007-10-119438; Lauten M, 2001, KLIN PADIATR, V213, P169, DOI 10.1055/s-2001-16848; Liotta LA, 2003, CANCER CELL, V3, P317, DOI 10.1016/S1535-6108(03)00086-2; MANNICK JB, 1994, CELL, V79, P1137, DOI 10.1016/0092-8674(94)90005-1; Moroy T, 2004, INT J BIOCHEM CELL B, V36, P1424, DOI 10.1016/S1357-2725(03)00432-1; Morrow VA, 2003, J BIOL CHEM, V278, P31629, DOI 10.1074/jbc.M212831200; Petricoin EF, 2005, J CLIN ONCOL, V23, P3614, DOI 10.1200/JCO.2005.02.509; Petricoin EF, 2007, CANCER RES, V67, P3431, DOI 10.1158/0008-5472.CAN-06-1344; Pierobon M, 2009, CLIN COLORECTAL CANC, V8, P110, DOI 10.3816/CCC.2009.n.018; Pollard K. S., 2008, MULTTEST RESAMPLING; Pui CH, 2003, LEUKEMIA, V17, P700, DOI 10.1038/sj.leu.2402883; Pui CH, 2006, NEW ENGL J MED, V354, P166, DOI 10.1056/NEJMra052603; Redaelli A, 2005, EUR J CANCER CARE, V14, P53, DOI 10.1111/j.1365-2354.2005.00513.x; REITER A, 1994, BLOOD, V84, P3122, DOI 10.1182/blood.V84.9.3122.3122; Robinson BW, 2008, BRIT J HAEMATOL, V141, P827, DOI 10.1111/j.1365-2141.2008.07100.x; RUDD CE, 1988, P NATL ACAD SCI USA, V85, P5190, DOI 10.1073/pnas.85.14.5190; Schneider A, 2008, NEOPLASIA, V10, P1295, DOI 10.1593/neo.08586; Schrappe M, 2000, BLOOD, V95, P3310; Scuderi R, 1996, BLOOD, V87, P3360, DOI 10.1182/blood.V87.8.3360.bloodjournal8783360; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; THOMSEN LL, 1995, BRIT J CANCER, V72, P41, DOI 10.1038/bjc.1995.274; van Rhenen A, 2005, CLIN CANCER RES, V11, P6520, DOI 10.1158/1078-0432.CCR-05-0468; Wulfkuhle JD, 2003, PROTEOMICS, V3, P2085, DOI 10.1002/pmic.200300591; Xu WM, 2002, CELL RES, V12, P311, DOI 10.1038/sj.cr.7290133	38	36	37	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2010	5	10							e13552	10.1371/journal.pone.0013552	http://dx.doi.org/10.1371/journal.pone.0013552			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	668TQ	21042412	Green Submitted, Green Published, gold			2022-12-27	WOS:000283293800018
J	Ledevin, R; Quere, JP; Renaud, S				Ledevin, Ronan; Quere, Jean-Pierre; Renaud, Sabrina			Morphometrics as an Insight Into Processes Beyond Tooth Shape Variation in a Bank Vole Population	PLOS ONE			English	Article							DEVELOPMENTAL CONSTRAINTS; MAMMALIAN TEETH; BODY-SIZE; EVOLUTION; PATTERNS; PHYLOGENY; RADIATION; RODENTIA; HABITAT; HISTORY	Phenotype variation is a key feature in evolution, being produced by development and the target of the screening by selection. We focus here on a variable morphological feature: the third upper molar (UM3) of the bank vole, aiming at identifying the sources of this variation. Size and shape of the UM3 occlusal surface was quantified in successive samples of a bank vole population. The first source of variation was the season of trapping, due to differences in the age structure of the population in turn affecting the wear of the teeth. The second direction of variation corresponded to the occurrence, or not, of an additional triangle on the tooth. This intra-specific variation was attributed to the space available at the posterior end of the UM3, allowing or not the addition of a further triangle. This size variation triggering the shape polymorphism is not controlled by the developmental cascade along the molar row. This suggests that other sources of size variation, possibly epigenetic, might be involved. They would trigger an important shape variation as side-effect by affecting the termination of the sequential addition of triangles on the tooth.	[Ledevin, Ronan; Renaud, Sabrina] Univ Lyon 1, CNRS, UMR 5125, F-69622 Villeurbanne, France; [Quere, Jean-Pierre] INRA, UMR CBGP 1064, Montferrier Sur Lez, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; INRAE; Institut de Recherche pour le Developpement (IRD)	Ledevin, R (corresponding author), Univ Lyon 1, CNRS, UMR 5125, F-69622 Villeurbanne, France.	ronan.ledevin@pepsmail.univ-lyon1.fr	Renaud, Sabrina/AAV-3141-2020; Renaud, Sabrina/D-4247-2009	Renaud, Sabrina/0000-0002-8730-3113; Renaud, Sabrina/0000-0002-8730-3113	ANR; Rhone-Alpes Emergence	ANR(French National Research Agency (ANR)); Rhone-Alpes Emergence(Region Auvergne-Rhone-Alpes)	This study has been supported by the ANR "Quenottes" and the program Rhone-Alpes Emergence. Altai samples were collected in the framework of the French-Chinese Programme of Advanced Research: Pra E95-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAUCHAU V, 1987, MAMMALIA, V51, P588; Beldade P, 2002, NATURE, V416, P844, DOI 10.1038/416844a; Chaline J, 1999, ANN ZOOL FENN, V36, P239; Contoli Longino, 1993, Hystrix, V4, P1; COWLEY DE, 1989, GENETICS, V122, P193; CRAMPTON JS, 1995, LETHAIA, V28, P179, DOI 10.1111/j.1502-3931.1995.tb01611.x; Deffontaine V, 2005, MOL ECOL, V14, P1727, DOI 10.1111/j.1365-294X.2005.02506.x; Dempsey PJ, 2001, HEREDITY, V86, P685, DOI 10.1046/j.1365-2540.2001.00878.x; FERSON S, 1985, SYST ZOOL, V34, P59, DOI 10.2307/2413345; GARN SM, 1979, AM J PHYS ANTHROPOL, V51, P665, DOI 10.1002/ajpa.1330510416; GIRAUDOUX P, 1994, ACTA OECOL, V15, P385; Giraudoux P, 2008, MAMMALIA, V72, P309, DOI 10.1515/MAMM.2008.048; Guerecheau A, 2010, MAMM BIOL, V75, P311, DOI 10.1016/j.mambio.2009.03.013; GUTHRIE R D, 1971, Zeitschrift fuer Saeugetierkunde, V36, P37; JEANNET M, 1978, B MENS SOC LINN LYON, V5, P206; Jernvall J, 2000, P NATL ACAD SCI USA, V97, P2641, DOI 10.1073/pnas.050586297; Jernvall J, 2000, P NATL ACAD SCI USA, V97, P14444, DOI 10.1073/pnas.97.26.14444; Kaneko Y, 1998, RES POPUL ECOL, V40, P21, DOI 10.1007/BF02765219; Kassai Y, 2005, SCIENCE, V309, P2067, DOI 10.1126/science.1116848; Kavanagh KD, 2007, NATURE, V449, P427, DOI 10.1038/nature06153; Koskela E, 1998, OECOLOGIA, V115, P379, DOI 10.1007/s004420050531; KOZAKIEWICZ M, 1976, Acta Theriologica, V21, P314; KUHL FP, 1982, COMPUT VISION GRAPH, V18, P236, DOI 10.1016/0146-664X(82)90034-X; Laffont R, 2009, EVOL DEV, V11, P302, DOI 10.1111/j.1525-142X.2009.00332.x; Ledevin R, 2010, BIOL J LINN SOC, V100, P681, DOI 10.1111/j.1095-8312.2010.01445.x; LIENARD E, 2003, CONTRIBUTION ETUDE C, P1; Markova E, 2010, J MAMM EVOL, V17, P121, DOI 10.1007/s10914-009-9128-8; MATSON CW, 2001, MOL BIOL EVOL, V18, P23; Natsume A, 2008, ARCH ORAL BIOL, V53, P95, DOI 10.1016/j.archoralbio.2007.07.013; Navarro N, 2004, BIOL J LINN SOC, V83, P243, DOI 10.1111/j.1095-8312.2004.00385.x; Oksanen TA, 2007, EVOLUTION, V61, P2822, DOI 10.1111/j.1558-5646.2007.00245.x; Pantalacci S, 2009, EVOL DEV, V11, P422, DOI 10.1111/j.1525-142X.2009.00348.x; Polly PD, 2007, NATURE, V449, P413, DOI 10.1038/449413a; Renaud S, 2005, MAMM BIOL, V70, P157, DOI 10.1016/j.mambio.2004.10.004; Renaud S, 1996, PALEOBIOLOGY, V22, P255, DOI 10.1017/S0094837300016201; Renaud S, 2007, ZOOL SCR, V36, P525, DOI 10.1111/j.1463-6409.2007.00297.x; Renaud S, 2009, EVOL DEV, V11, P590, DOI 10.1111/j.1525-142X.2009.00365.x; Renvoise E, 2009, EVOLUTION, V63, P1327, DOI 10.1111/j.1558-5646.2009.00639.x; ROHLF FJ, 1984, SYST ZOOL, V33, P302, DOI 10.2307/2413076; Rohlf FJ., 1990, P MICH MORPH WORKSH, P169; Salazar-Ciudad I, 2004, EVOL DEV, V6, P6, DOI 10.1111/j.1525-142X.2004.04002.x; Salazar-Ciudad I, 2002, P NATL ACAD SCI USA, V99, P8116, DOI 10.1073/pnas.132069499; Schluter D, 1996, EVOLUTION, V50, P1766, DOI 10.1111/j.1558-5646.1996.tb03563.x; Steppan SJ, 2005, MOL PHYLOGENET EVOL, V37, P370, DOI 10.1016/j.ympev.2005.04.016; Tkadlec E, 1998, EVOL ECOL, V12, P191, DOI 10.1023/A:1006583713042	45	20	21	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2010	5	11							e15470	10.1371/journal.pone.0015470	http://dx.doi.org/10.1371/journal.pone.0015470			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	680KW	21085584	Green Published, gold, Green Submitted			2022-12-27	WOS:000284231800034
J	Murshid, A; Chou, SD; Prince, T; Zhang, Y; Bharti, A; Calderwood, SK				Murshid, Ayesha; Chou, Shiuh-Dih; Prince, Thomas; Zhang, Yue; Bharti, Ajit; Calderwood, Stuart K.			Protein Kinase A Binds and Activates Heat Shock Factor 1	PLOS ONE			English	Article							TRANSCRIPTION FACTOR-I; DNA-BINDING; GENE-TRANSCRIPTION; CYCLIC-AMP; PHOSPHORYLATION; STRESS; CELLS; HSF1; GRANULES; DOMAIN	Background: Many inducible transcription factors are regulated through batteries of posttranslational modifications that couple their activity to inducing stimuli. We have studied such regulation of Heat Shock Factor 1 (HSF1), a key protein in control of the heat shock response, and a participant in carcinogenisis, neurological health and aging. As the mechanisms involved in the intracellular regulation of HSF1 in good health and its dysregulation in disease are still incomplete we are investigating the role of posttranslational modifications in such regulation. Methodology/Principal Findings: In a proteomic study of HSF1 binding partners, we have discovered its association with the pleiotropic protein kinase A (PKA). HSF1 binds avidly to the catalytic subunit of PKA, (PKAc alpha) and becomes phosphorylated on a novel serine phosphorylation site within its central regulatory domain (serine 320 or S320), both in vitro and in vivo. Intracellular PKAc alpha levels and phosphorylation of HSF1 at S320 were both required for HSF1 to be localized to the nucleus, bind to response elements in the promoter of an HSF1 target gene (hsp70.1) and activate hsp70.1 after stress. Reduction in PKAc alpha levels by small hairpin RNA led to HSF1 exclusion from the nucleus, its exodus from the hsp70.1 promoter and decreased hsp70.1 transcription. Likewise, null mutation of HSF1 at S320 by alanine substitution for serine led to an HSF1 species excluded from the nucleus and deficient in hsp70.1 activation. Conclusions: These findings of PKA regulation of HSF1 through S320 phosphorylation add to our knowledge of the signaling networks converging on this factor and may contribute to elucidating its complex roles in the stress response and understanding HSF1 dysregulation in disease.	[Murshid, Ayesha; Chou, Shiuh-Dih; Prince, Thomas; Zhang, Yue; Calderwood, Stuart K.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Boston, MA 02215 USA; [Bharti, Ajit] Boston Univ, Med Ctr, Stress Response Ctr, Boston, MA USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Boston University	Murshid, A (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Boston, MA 02215 USA.	scalderw@bidmc.harvard.edu		Bharti, Ajit/0000-0001-7972-6688	NIH [2RO1CA047407, RO1CA077465]; Department of Radiation Oncology; Beth Israel Medical Center; NATIONAL CANCER INSTITUTE [R01CA077465, R01CA047407] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Radiation Oncology; Beth Israel Medical Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Studies were supported by NIH research grants 2RO1CA047407 and RO1CA077465. These are peer-reviewed National Institutes of Health RO-1 grants intended to investigate the role of cell signaling in the heat shock/stress response. The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.; We thank Fabrice Soncin, Md Abdul Khaleque and Christine Mieck for contributions to developing this project. We thank the Department of Radiation Oncology, Beth Israel Medical Center for support and encouragement.	Anckar J, 2007, BIOCHEM SOC T, V35, P1409, DOI 10.1042/BST0351409; BRUCE JL, 1993, CANCER RES, V53, P12; Calderwood SK, 2006, TRENDS BIOCHEM SCI, V31, P164, DOI 10.1016/j.tibs.2006.01.006; CALDERWOOD SK, 1985, BIOCHEM BIOPH RES CO, V126, P911, DOI 10.1016/0006-291X(85)90272-4; CALDERWOOD SK, 2010, SIGNAL TRANSDUCTION, V3, P13; CALDERWOOD SK, 2009, GERONTOLOGY; Chen CM, 1997, J BIOL CHEM, V272, P26803, DOI 10.1074/jbc.272.43.26803; CHOI HS, 1991, J BIOL CHEM, V266, P11858; Chu BY, 1998, J BIOL CHEM, V273, P18640, DOI 10.1074/jbc.273.29.18640; Chu BY, 1996, J BIOL CHEM, V271, P30847, DOI 10.1074/jbc.271.48.30847; Dai C, 2007, CELL, V130, P1005, DOI 10.1016/j.cell.2007.07.020; Dessauer CW, 2009, MOL PHARMACOL, V76, P935, DOI 10.1124/mol.109.059345; GREEN M, 1995, MOL CELL BIOL, V15, P3354; Guettouche Toumy, 2005, BMC Biochemistry, V6, DOI 10.1186/1471-2091-6-4; He B, 1998, MOL CELL BIOL, V18, P6624, DOI 10.1128/MCB.18.11.6624; HENSOLD JO, 1990, MOL CELL BIOL, V10, P1600, DOI 10.1128/MCB.10.4.1600; Hietakangas V, 2003, MOL CELL BIOL, V23, P2953, DOI 10.1128/MCB.23.8.2953-2968.2003; Holmberg CI, 2000, CELL STRESS CHAPERON, V5, P219, DOI 10.1379/1466-1268(2000)005<0219:FONHGV>2.0.CO;2; Holmberg CI, 2001, EMBO J, V20, P3800, DOI 10.1093/emboj/20.14.3800; KEMP BE, 1975, P NATL ACAD SCI USA, V72, P3448, DOI 10.1073/pnas.72.9.3448; Khaleque M, 2008, ONCOGENE, V27, P1886, DOI 10.1038/sj.onc.1210834; Khaleque MA, 2005, ONCOGENE, V24, P6564, DOI 10.1038/sj.onc.1208798; Kline MP, 1997, MOL CELL BIOL, V17, P2107, DOI 10.1128/MCB.17.4.2107; Knauf U, 1996, GENE DEV, V10, P2782, DOI 10.1101/gad.10.21.2782; Metz A, 2004, J CELL SCI, V117, P4551, DOI 10.1242/jcs.01329; MEZGER V, 1987, DEV BIOL, V124, P544, DOI 10.1016/0012-1606(87)90507-0; Min JN, 2007, ONCOGENE, V26, P5086, DOI 10.1038/sj.onc.1210317; MIVECHI NF, 1995, CANCER RES, V55, P5512; Mosser DD, 2004, ONCOGENE, V23, P2907, DOI 10.1038/sj.onc.1207529; Newton EM, 1996, MOL CELL BIOL, V16, P839; PEARSON RB, 1991, METHOD ENZYMOL A, V200, P62; PRICE BD, 1991, MOL CELL BIOL, V11, P3365, DOI 10.1128/MCB.11.6.3365; RABINDRAN SK, 1991, P NATL ACAD SCI USA, V88, P6906, DOI 10.1073/pnas.88.16.6906; RABINDRAN SK, 1993, SCIENCE, V259, P230, DOI 10.1126/science.8421783; SARGE KD, 1993, MOL CELL BIOL, V13, P1392, DOI 10.1128/MCB.13.3.1392; SARGE KD, 1991, GENE DEV, V5, P1902, DOI 10.1101/gad.5.10.1902; SHELDON LA, 1993, GENE DEV, V7, P1549, DOI 10.1101/gad.7.8.1549; SORGER PK, 1989, CELL, V59, P807, DOI 10.1016/0092-8674(89)90604-1; SORGER PK, 1988, CELL, V54, P855, DOI 10.1016/S0092-8674(88)91219-6; Takacs-Vellai K, 2007, DEV BIOL, V302, P661, DOI 10.1016/j.ydbio.2006.09.049; Tang D, 2005, CELL STRESS CHAPERON, V10, P46, DOI 10.1379/CSC-44R.1; Tonkiss J, 2005, INT J HYPERTHER, V21, P433, DOI 10.1080/02656730500165514; Vujanac M, 2005, TRAFFIC, V6, P214, DOI 10.1111/j.1600-0854.2005.00266.x; Wang XZ, 2006, J BIOL CHEM, V281, P782, DOI 10.1074/jbc.M505822200; Wang XZ, 2004, J BIOL CHEM, V279, P49460, DOI 10.1074/jbc.M406059200; Wang XZ, 2003, MOL CELL BIOL, V23, P6013, DOI 10.1128/MCB.23.17.6013-6026.2003; Westerheide SD, 2009, SCIENCE, V323, P1063, DOI 10.1126/science.1165946; WESTWOOD T, 1993, MOL CELL BIOL, V13, P3481; WIEDERRECHT G, 1988, CELL, V54, P841, DOI 10.1016/S0092-8674(88)91197-X; Wu C, 1995, ANNU REV CELL DEV BI, V11, P441, DOI 10.1146/annurev.cellbio.11.1.441; Xavier IJ, 2000, J BIOL CHEM, V275, P29147, DOI 10.1074/jbc.M002169200; Xia WL, 1997, J BIOL CHEM, V272, P4094, DOI 10.1074/jbc.272.7.4094; Xu W, 2007, EMBO J, V26, P2890, DOI 10.1038/sj.emboj.7601734; Yoon C, 2008, J NEUROSCI, V28, P3738, DOI 10.1523/JNEUROSCI.4439-07.2008; ZUO JR, 1994, MOL CELL BIOL, V14, P7557, DOI 10.1128/MCB.14.11.7557; ZUO JR, 1995, MOL CELL BIOL, V15, P4319	56	55	56	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2010	5	11							e13830	10.1371/journal.pone.0013830	http://dx.doi.org/10.1371/journal.pone.0013830			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	677ZE	21085490	Green Submitted, Green Published, gold			2022-12-27	WOS:000284035900002
J	Borst, JW; Willemse, M; Slijkhuis, R; van der Krogt, G; Laptenok, SP; Jalink, K; Wieringa, B; Fransen, JAM				Borst, Jan Willem; Willemse, Marieke; Slijkhuis, Rik; van der Krogt, Gerard; Laptenok, Sergey P.; Jalink, Kees; Wieringa, Be; Fransen, Jack A. M.			ATP Changes the Fluorescence Lifetime of Cyan Fluorescent Protein via an Interaction with His148	PLOS ONE			English	Article							ENERGY-TRANSFER; VARIANT; FRET; CELL; SPECTROSCOPY; CHROMOPHORE; BINDING; DECAYS	Recently, we described that ATP induces changes in YFP/CFP fluorescence intensities of Fluorescence Resonance Energy Transfer (FRET) sensors based on CFP-YFP. To get insight into this phenomenon, we employed fluorescence lifetime spectroscopy to analyze the influence of ATP on these fluorescent proteins in more detail. Using different donor and acceptor pairs we found that ATP only affected the CFP-YFP based versions. Subsequent analysis of purified monomers of the used proteins showed that ATP has a direct effect on the fluorescence lifetime properties of CFP. Since the fluorescence lifetime analysis of CFP is rather complicated by the existence of different lifetimes, we tested a variant of CFP, i.e. Cerulean, as a monomer and in our FRET constructs. Surprisingly, this CFP variant shows no ATP concentration dependent changes in the fluorescence lifetime. The most important difference between CFP and Cerulean is a histidine residue at position 148. Indeed, changing this histidine in CFP into an aspartic acid results in identical fluorescence properties as observed for the Cerulean fluorescent based FRET sensor. We therefore conclude that the changes in fluorescence lifetime of CFP are affected specifically by possible electrostatic interactions of the negative charge of ATP with the positively charged histidine at position 148. Clearly, further physicochemical characterization is needed to explain the sensitivity of CFP fluorescence properties to changes in environmental (i.e. ATP concentrations) conditions.	[Borst, Jan Willem; Slijkhuis, Rik; Laptenok, Sergey P.] Wageningen Univ, Microspect Ctr, Biochem Lab, Wageningen, Netherlands; [Willemse, Marieke; Wieringa, Be; Fransen, Jack A. M.] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, Dept Cell Biol, NL-6525 ED Nijmegen, Netherlands; [van der Krogt, Gerard; Jalink, Kees] Netherlands Canc Inst, Div Cell Biol, Amsterdam, Netherlands	Wageningen University & Research; Radboud University Nijmegen; Netherlands Cancer Institute	Borst, JW (corresponding author), Wageningen Univ, Microspect Ctr, Biochem Lab, Wageningen, Netherlands.	j.fransen@ncmls.ru.nl	Borst, Jan Willem/B-1259-2011; Fransen, Jack/E-8924-2010; Wieringa, Berend/A-5346-2011	Fransen, Jack/0000-0002-0571-7639; Wieringa, Berend/0000-0001-9192-8020; Jalink, Kees/0000-0001-7019-3440; Laptenok, Sergey/0000-0002-6468-3010	ZonMw HORIZON [050-71-019]; NKB-KWF [KUN-2004-3125, KUN-2005-3333]	ZonMw HORIZON; NKB-KWF	Funding: This work was supported by ZonMw HORIZON Breakthrough Grant 050-71-019 and NKB-KWF grants KUN-2004-3125 and KUN-2005-3333. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae JH, 2003, J MOL BIOL, V328, P1071, DOI 10.1016/S0022-2836(03)00364-4; Berg J, 2009, NAT METHODS, V6, P161, DOI [10.1038/NMETH.1288, 10.1038/nmeth.1288]; Berg JM, 2002, BIOCHEMISTRY-US, V5th; BOENS N, 1990, PHOTOCHEM PHOTOBIOL, V52, P911, DOI 10.1111/j.1751-1097.1990.tb08702.x; Borst JW, 2008, BIOPHYS J, V95, P5399, DOI 10.1529/biophysj.107.114587; Borst JW, 2005, J FLUORESC, V15, P153, DOI 10.1007/s10895-005-2523-5; Digris AV, 1999, EUR BIOPHYS J BIOPHY, V28, P526, DOI 10.1007/s002490050235; Evers TH, 2006, BIOCHEMISTRY-US, V45, P13183, DOI 10.1021/bi061288t; Goedhart J, 2010, NAT METHODS, V7, P137, DOI [10.1038/nmeth.1415, 10.1038/NMETH.1415]; Grailhe R, 2006, CHEMPHYSCHEM, V7, P1442, DOI 10.1002/cphc.200600057; HO CJ, 1989, CHEM PHYS LETT, V158, P51, DOI 10.1016/0009-2614(89)87292-6; Hoffman J F, 1997, Curr Opin Hematol, V4, P112; Imamura H, 2009, P NATL ACAD SCI USA, V106, P15651, DOI 10.1073/pnas.0904764106; Kim J, 2009, MOL BIOSYST, V5, P151, DOI 10.1039/b815445g; Kneen M, 1998, BIOPHYS J, V74, P1591, DOI 10.1016/S0006-3495(98)77870-1; Kuiper JWP, 2008, PLOS BIOL, V6, P568, DOI 10.1371/journal.pbio.0060051; Malo GD, 2007, BIOCHEMISTRY-US, V46, P9865, DOI 10.1021/bi602664c; Mao LS, 2004, J MOL BIOL, V336, P787, DOI 10.1016/j.jmb.2003.12.056; Pyrkov TV, 2007, PROTEINS, V66, P388, DOI 10.1002/prot.21122; Rizzo MA, 2004, NAT BIOTECHNOL, V22, P445, DOI 10.1038/nbt945; Seifert MH, 2002, J AM CHEM SOC, V124, P7932, DOI 10.1021/ja0257725; Suhling K, 2005, PHOTOCH PHOTOBIO SCI, V4, P13, DOI 10.1039/b412924p; UEDA T, 1987, EXP CELL RES, V169, P191, DOI 10.1016/0014-4827(87)90237-0; van der Krogt GNM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001916; van Horssen R, 2009, J BIOL CHEM, V284, P1620, DOI 10.1074/jbc.M806974200; Villoing A, 2008, BIOCHEMISTRY-US, V47, P12483, DOI 10.1021/bi801400d; WEISS JN, 1989, J GEN PHYSIOL, V94, P911, DOI 10.1085/jgp.94.5.911; Willemse M, 2007, NAT BIOTECHNOL, V25, P170, DOI 10.1038/nbt0207-170	28	18	18	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2010	5	11							e13862	10.1371/journal.pone.0013862	http://dx.doi.org/10.1371/journal.pone.0013862			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675OD	21079777	Green Published, gold			2022-12-27	WOS:000283839100015
J	Hartsperger, ML; Strache, R; Stumpflen, V				Hartsperger, Mara L.; Strache, Robert; Stuempflen, Volker			HiNO: An Approach for Inferring Hierarchical Organization from Regulatory Networks	PLOS ONE			English	Article							TRANSCRIPTIONAL REGULATION; ESCHERICHIA-COLI; MOTIFS; CELLS; P53	Background: Gene expression as governed by the interplay of the components of regulatory networks is indeed one of the most complex fundamental processes in biological systems. Although several methods have been published to unravel the hierarchical structure of regulatory networks, weaknesses such as the incorrect or inconsistent assignment of elements to their hierarchical levels, the incapability to cope with cyclic dependencies within the networks or the need for a manual curation to retrieve non-overlapping levels remain unsolved. Methodology/Results: We developed HiNO as a significant improvement of the so-called breadth-first-search (BFS) method. While BFS is capable of determining the overall hierarchical structures from gene regulatory networks, it especially has problems solving feed-forward type of loops leading to conflicts within the level assignments. We resolved these problems by adding a recursive correction approach consisting of two steps. First each vertex is placed on the lowest level that this vertex and its regulating vertices are assigned to (downgrade procedure). Second, vertices are assigned to the next higher level (upgrade procedure) if they have successors with the same level assignment and have themselves no regulators. We evaluated HiNO by comparing it with the BFS method by applying them to the regulatory networks from Saccharomyces cerevisiae and Escherichia coli, respectively. The comparison shows clearly how conflicts in level assignment are resolved in HiNO in order to produce correct hierarchical structures even on the local levels in an automated fashion. Conclusions: We showed that the resolution of conflicting assignments clearly improves the BFS-method. While we restricted our analysis to gene regulatory networks, our approach is suitable to deal with any directed hierarchical networks structure such as the interaction of microRNAs or the action of non-coding RNAs in general. Furthermore we provide a user-friendly web-interface for HiNO that enables the extraction of the hierarchical structure of any directed regulatory network.	[Hartsperger, Mara L.; Strache, Robert; Stuempflen, Volker] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Bioinformat & Syst Biol MIPS, Neuherberg, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Hartsperger, ML (corresponding author), German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Bioinformat & Syst Biol MIPS, Neuherberg, Germany.	mara.hartsperger@helmholtz-muenchen.de			Helmholtz Alliance on Systems Biology; Federal Ministry of Education and Research [FKZ: 0315494A]; Graduate School for Information Science in Health (GSISH)	Helmholtz Alliance on Systems Biology; Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Graduate School for Information Science in Health (GSISH)	This work was supported by the Helmholtz Alliance on Systems Biology (project 'CoReNe'), the Federal Ministry of Education and Research (project SysMBo, FKZ: 0315494A) and the Graduate School for Information Science in Health (GSISH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Balazsi G, 2005, P NATL ACAD SCI USA, V102, P7841, DOI 10.1073/pnas.0500365102; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Clauset A, 2008, NATURE, V453, P98, DOI 10.1038/nature06830; Cormen T. H., 2009, INTRO ALGORITHMS, P1312; Hasler J, 2006, NUCLEIC ACIDS RES, V34, P5491, DOI 10.1093/nar/gkl706; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Hobert O, 2008, SCIENCE, V319, P1785, DOI 10.1126/science.1151651; Jothi R, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.52; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Ma HW, 2004, NUCLEIC ACIDS RES, V32, P6643, DOI 10.1093/nar/gkh1009; Ma HW, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-199; Magnusson M, 2007, BLOOD, V109, P3687, DOI 10.1182/blood-2006-10-054676; Oltvai ZN, 2002, SCIENCE, V298, P763, DOI 10.1126/science.1078563; Ravasi T, 2010, CELL, V140, P744, DOI 10.1016/j.cell.2010.01.044; Ravasz E, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.026112; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Yu HY, 2006, P NATL ACAD SCI USA, V103, P14724, DOI 10.1073/pnas.0508637103	19	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2010	5	11							e13698	10.1371/journal.pone.0013698	http://dx.doi.org/10.1371/journal.pone.0013698			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675NY	21079808	Green Submitted, Green Published, gold			2022-12-27	WOS:000283838600004
J	Gervassi, AL; Collins, LJ; Britschgi, TB				Gervassi, Ana L.; Collins, Laura J.; Britschgi, Theresa B.			Global Health: A Successful Context for Precollege Training and Advocacy	PLOS ONE			English	Article								Despite a flourishing biomedical and global health industry [1] too few of Washington state's precollege students are aware of this growing sector and emerging ideas on bacteria, fungi, parasites and viruses. Against the backdrop of numerous reports regarding declining precollege student interest in science [2], a precollege program was envisioned at Seattle Biomedical Research Institute (as of 2010, Seattle BioMed) to increase youth engagement in biomedical research and global health, increase community interest in infectious diseases and mobilize a future biomedical workforce. Since 2005, 169 rising high school juniors have participated in the BioQuest Academy precollege immersion program at Seattle BioMed. Assembling in groups of 12, students conduct laboratory experiments (e. g., anopheline mosquito dissection, gene expression informed tuberculosis drug design and optimizing HIV immunization strategies) related to global health alongside practicing scientific mentors, all within the footprint the institute. Laudable short-term impacts of the program include positive influences on student interest in global health (as seen in the students' subsequent school projects and their participation in Seattle BioMed community events), biomedical careers and graduate school (e.g., 16.9% of teens departing 2008-2009 Academy report revised goals of attaining a doctorate rather than a baccalaureate diploma). Long-term, 97% of alumni (2005-2008) are attending postsecondary schools throughout North America; eight graduates have already published scientific articles in peer-reviewed journals and/or presented their scientific data at national and international meetings, and 26 have been retained by Seattle BioMed researchers as compensated technicians and interns. Providing precollege students with structured access to practicing scientists and authentic research environments within the context of advancing global health has been a robust means of both building a future pool of talented leaders and engaged citizenry and increasing the visibility of health disparities within the community.	[Gervassi, Ana L.; Britschgi, Theresa B.] Seattle Biomed Res Inst, Seattle, WA 98109 USA; [Collins, Laura J.] Ctr Res & Learning, Snohomish, WA USA	Center for Infectious Disease Research	Gervassi, AL (corresponding author), Seattle Biomed Res Inst, 4 Nickerson St, Seattle, WA 98109 USA.	theresa.britschgi@seattlebiomed.org			Byron and Alice Lockwood Foundation; Ginger and Barry Ackerley Foundation; Silver Family Foundation; National Center for Research Resources [R25RR024260]; NATIONAL CENTER FOR RESEARCH RESOURCES [R25RR024260] Funding Source: NIH RePORTER	Byron and Alice Lockwood Foundation; Ginger and Barry Ackerley Foundation; Silver Family Foundation; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	The authors gratefully acknowledge support from the Byron and Alice Lockwood Foundation, the Ginger and Barry Ackerley Foundation (www.ackerleyfoundation.org), the Silver Family Foundation and the Science Education Partnership Award program (http://ncrrsepa.org) at the National Center for Research Resources (#R25RR024260). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*BIOQUEST, 2010, INF BIOQUEST; *BIOQUEST, 2009, INF AC GRAD PUBL; Brand JE, 2010, AM SOCIOL REV, V75, P273, DOI 10.1177/0003122410363567; Bridgeland J.M., 2006, SILENT EPIDEMIC PERS; CARRION A, 2009, GOV MONITOR     1104; GONZALES P, 2007, TRENDS INT MATH SCI; HOTLZMAN C, 2009, PUGET SOUND BUS 1120; Koplan JP, 2009, LANCET, V373, P1993, DOI 10.1016/S0140-6736(09)60332-9; MERSON MS, 2008, DRAMATIC EXPANSION U; *NAT CTR RES RES, 2010, AC CURR EV REP; National Science Foundation, 2007, NAT ACT PLAN ADDR CR; Oliver BG, 2008, MICROBIOL-SGM, V154, P960, DOI 10.1099/mic.0.2007/013805-0; SOMMERS P, 2003, OCCUPATIONAL DEMAND; Trimnell AR, 2006, MOL BIOCHEM PARASIT, V148, P169, DOI 10.1016/j.molbiopara.2006.03.012; US Bureau of the Census, 2008, SCH ENR SOC EC CHAR	15	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2010	5	11							e13814	10.1371/journal.pone.0013814	http://dx.doi.org/10.1371/journal.pone.0013814			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	674WJ	21072198	Green Submitted, gold, Green Published			2022-12-27	WOS:000283780800012
J	Kelso, JK; Halder, N; Milne, GJ				Kelso, Joel K.; Halder, Nilimesh; Milne, George J.			The Impact of Case Diagnosis Coverage and Diagnosis Delays on the Effectiveness of Antiviral Strategies in Mitigating Pandemic Influenza A/H1N1 2009	PLOS ONE			English	Article							NEURAMINIDASE INHIBITOR OSELTAMIVIR; INFECTION; DISEASE; DESIGN; TIME	Background: Neuraminidase inhibitors were used to reduce the transmission of pandemic influenza A/H1N1 2009 at the early stages of the 2009/2010 pandemic. Policies for diagnosis of influenza for the purposes of antiviral intervention differed markedly between and within countries, leading to differences in the timing and scale of antiviral usage. Methodology/Principal Findings: The impact of the percentage of symptomatic infected individuals who were diagnosed, and of delays to diagnosis, for three antiviral intervention strategies (each with and without school closure) were determined using a simulation model of an Australian community. Epidemic characteristics were based on actual data from the A/H1N1 2009 pandemic including reproduction number, serial interval and age-specific infection rate profile. In the absence of intervention an illness attack rate (AR) of 24.5% was determined from an estimated R-o of 1.5; this was reduced to 21%, 16.5% or 13% by treatment-only, treatment plus household prophylaxis, or treatment plus household plus extended prophylaxis antiviral interventions respectively, assuming that diagnosis occurred 24 hours after symptoms arose and that 50% of symptomatic cases were diagnosed. If diagnosis occurred without delay, ARs decreased to 17%, 12.2% or 8.8% respectively. If 90% of symptomatic cases were diagnosed (with a 24 hour delay), ARs decreased to 17.8%, 11.1% and 7.6%, respectively. Conclusion: The ability to rapidly diagnose symptomatic cases and to diagnose a high proportion of cases was shown to improve the effectiveness of all three antiviral strategies. For epidemics with R-o<=1.5 our results suggest that when the case diagnosis coverage exceeds similar to 70% the size of the antiviral stockpile required to implement the extended prophylactic strategy decreases. The addition of at least four weeks of school closure was found to further reduce cumulative and peak attack rates and the size of the required antiviral stockpile.	[Kelso, Joel K.; Halder, Nilimesh; Milne, George J.] Univ Western Australia, Sch Comp Sci & Software Engn, Crawley, WA, Australia	University of Western Australia	Kelso, JK (corresponding author), Univ Western Australia, Sch Comp Sci & Software Engn, Crawley, WA, Australia.	joel@csse.uwa.edu.au	Kelso, Joel/C-2433-2013; Milne, George/C-6839-2013	Kelso, Joel/0000-0001-9814-6435; Milne, George/0000-0002-9796-0600				Arinaminpathy N, 2008, J R SOC INTERFACE, V5, P545, DOI 10.1098/rsif.2007.1152; Australian Commonwealth Department of Health and Ageing, 2009, AUSTR HLTH MAN PLAN; Carrat F, 2008, AM J EPIDEMIOL, V167, P775, DOI 10.1093/aje/kwm375; CHIN J, 2009, J R SOC INT IN PRESS; De Serres G, 2010, EMERG INFECT DIS, V16, P783, DOI 10.3201/eid1605.091894; degli Atti MLC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001790; ECDC, 2009, ECDC RISK ASS 2009 I; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017; FOX JP, 1982, AM J EPIDEMIOL, V116, P212, DOI 10.1093/oxfordjournals.aje.a113407; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Germann TC, 2006, P NATL ACAD SCI USA, V103, P5935, DOI 10.1073/pnas.0601266103; Glass RJ, 2006, EMERG INFECT DIS, V12, P1671, DOI 10.3201/eid1211.060255; Halder N, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-168; Hayden FG, 1999, JAMA-J AM MED ASSOC, V282, P1240, DOI 10.1001/jama.282.13.1240; Kelso JK, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-117; Kramarz P, 2009, EUROSURVEILLANCE, V14; Lee VJ, 2007, EMERG INFECT DIS, V13, P449, DOI 10.3201/eid1303.060309; Lee VJ, 2006, EMERG INFECT DIS, V12, P95; Longini IM, 2004, AM J EPIDEMIOL, V159, P623, DOI 10.1093/aje/kwh092; Longini IM, 2005, SCIENCE, V309, P1083, DOI 10.1126/science.1115717; MCBRYDE E, 2009, EUR SURVEILL, V14; Mccaw JM, 2007, MATH BIOSCI, V209, P336, DOI 10.1016/j.mbs.2007.02.003; Miller E, 2010, LANCET, V375, P1100, DOI 10.1016/S0140-6736(09)62126-7; Milne G, 2010, J R SOC INTERFACE, V7, P573, DOI 10.1098/rsif.2009.0312; Milne GJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004005; MONTO AS, 1985, AM J EPIDEMIOL, V121, P811, DOI 10.1093/oxfordjournals.aje.a114052; Moscona A, 2005, NEW ENGL J MED, V353, P1363, DOI 10.1056/NEJMra050740; Munayco CV, 2009, EUROSURVEILLANCE, V14, P6; Nishiura H, 2009, EUROSURVEILLANCE, V14; Nishiura H, 2010, THEOR BIOL MED MODEL, V7, DOI 10.1186/1742-4682-7-1; Nishiura H, 2009, NEW ZEAL MED J, V122, P73; Smith DW, 2010, MED J AUSTRALIA, V192, P541, DOI 10.5694/j.1326-5377.2010.tb03625.x; Treanor JJ, 2000, JAMA-J AM MED ASSOC, V283, P1016, DOI 10.1001/jama.283.8.1016; *UK DEP HLTH, 2007, PAND FLU NAT FRAM RE; *US DEP HHS, 2009, PAND INFL PLAN; Wilson N, 2009, EUROSURVEILLANCE, V14; Wu JT, 2006, PLOS MED, V3, P1532, DOI 10.1371/journal.pmed.0030361; Wu JT, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000085; Yang Y, 2006, J ROY STAT SOC C-APP, V55, P317, DOI 10.1111/j.1467-9876.2006.00539.x	40	16	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2010	5	11							e13797	10.1371/journal.pone.0013797	http://dx.doi.org/10.1371/journal.pone.0013797			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	674WJ	21072188	gold, Green Published, Green Submitted			2022-12-27	WOS:000283780800007
J	Kitsios, GD; Tangri, N; Castaldi, PJ; Ioannidis, JPA				Kitsios, Georgios D.; Tangri, Navdeep; Castaldi, Peter J.; Ioannidis, John P. A.			Laboratory Mouse Models for the Human Genome-Wide Associations	PLOS ONE			English	Article							PHENOTYPE ONTOLOGY; COMMON DISEASES; LOCI; VARIANTS; INSIGHTS; SH2-B; TOOL	The agnostic screening performed by genome-wide association studies (GWAS) has uncovered associations for previously unsuspected genes. Knowledge about the functional role of these genes is crucial and laboratory mouse models can provide such information. Here, we describe a systematic juxtaposition of human GWAS-discovered loci versus mouse models in order to appreciate the availability of mouse models data, to gain biological insights for the role of these genes and to explore the extent of concordance between these two lines of evidence. We perused publicly available data (NHGRI database for human associations and Mouse Genome Informatics database for mouse models) and employed two alternative approaches for cross-species comparisons, phenotype-and gene-centric. A total of 293 single gene-phenotype human associations (262 unique genes and 69 unique phenotypes) were evaluated. In the phenotype-centric approach, we identified all mouse models and related ortholog genes for the 51 human phenotypes with a comparable phenotype in mice. A total of 27 ortholog genes were found to be associated with the same phenotype in humans and mice, a concordance that was significantly larger than expected by chance (p<0.001). In the gene-centric approach, we were able to locate at least 1 knockout model for 60% of the 262 genes. The knockouts for 35% of these orthologs displayed pre- or post-natal lethality. For the remaining non-lethal orthologs, the same organ system was involved in mice and humans in 71% of the cases (p<0.001). Our project highlights the wealth of available information from mouse models for human GWAS, catalogues extensive information on plausible physiologic implications for many genes, provides hypothesis-generating findings for additional GWAS analyses and documents that the concordance between human and mouse genetic association is larger than expected by chance and can be informative.	[Kitsios, Georgios D.; Tangri, Navdeep; Castaldi, Peter J.; Ioannidis, John P. A.] Tufts Med Ctr, Inst Clin Res & Hlth Policy Studies, Boston, MA USA; [Castaldi, Peter J.; Ioannidis, John P. A.] Tufts Univ, Sch Med, Boston, MA 02111 USA; [Ioannidis, John P. A.] Univ Ioannina, Sch Med, Dept Hyg & Epidemiol, GR-45110 Ioannina, Greece; [Ioannidis, John P. A.] Fdn Res & Technol Hellas, Biomed Res Inst, Ioannina, Greece; [Kitsios, Georgios D.; Castaldi, Peter J.; Ioannidis, John P. A.] Tufts Med Ctr, Tufts Clin & Translat Sci Inst, Boston, MA USA; [Castaldi, Peter J.; Ioannidis, John P. A.] Tufts Univ, Sch Med, Dept Med, Ctr Genet Epidemiol & Modeling,Tufts Med Ctr, Boston, MA 02111 USA; [Tangri, Navdeep] Tufts Med Ctr, Div Nephrol, Boston, MA USA; [Ioannidis, John P. A.] Harvard Univ, Dept Epidemiol, Harvard Sch Publ Hlth, Boston, MA 02115 USA; [Ioannidis, John P. A.] Stanford Univ, Stanford Prevent Res Ctr, Sch Med, Stanford, CA 94305 USA	Tufts Medical Center; Tufts University; University of Ioannina; Foundation for Research & Technology - Hellas (FORTH); Tufts Medical Center; Tufts Medical Center; Tufts University; Tufts Medical Center; Harvard University; Harvard T.H. Chan School of Public Health; Stanford University	Kitsios, GD (corresponding author), Tufts Med Ctr, Inst Clin Res & Hlth Policy Studies, Boston, MA USA.	jioannid@stanford.edu	Ioannidis, John P. A./G-9836-2011	Kitsios, Georgios/0000-0002-1018-948X; Tangri, Navdeep/0000-0002-5075-6370	Pfizer/Tufts Medical Center; National Center for Research Resources [UL1RR025752]; KRESCENT; Kidney Foundation of Canada; Canadian Institute of Health Research; Canadian Society of Nephrology; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025752] Funding Source: NIH RePORTER	Pfizer/Tufts Medical Center(Pfizer); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); KRESCENT; Kidney Foundation of Canada; Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Society of Nephrology; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Georgios D. Kitsios was a recipient of a Pfizer/Tufts Medical Center career development award. The project described was partially supported by Award Number UL1RR025752 from the National Center for Research Resources. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Center for Research Resources or the National Institutes of Health. Navdeep Tangri is a recipient of the KRESCENT Post-Doctoral Fellowship award, a joint initiative of the Kidney Foundation of Canada, the Canadian Institute of Health Research and the Canadian Society of Nephrology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin CP, 2004, NAT GENET, V36, P921, DOI 10.1038/ng0904-921; Bezerra JA, 1998, J CLIN INVEST, V101, P1175, DOI 10.1172/JCI1744; Bult CJ, 2008, NUCLEIC ACIDS RES, V36, pD724, DOI 10.1093/nar/gkm961; Cirulli ET, 2010, NAT REV GENET, V11, P415, DOI 10.1038/nrg2779; Duan CJ, 2004, MOL CELL BIOL, V24, P7435, DOI 10.1128/MCB.24.17.7435-7443.2004; Duan WM, 2005, ONCOGENE, V24, P1510, DOI 10.1038/sj.onc.1208229; Edmondson AC, 2009, J CLIN INVEST, V119, P1042, DOI 10.1172/JCI37176; Hindorff LA, 2009, CATALOG PUBLISHED GE; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hoggart CJ, 2008, GENET EPIDEMIOL, V32, P179, DOI 10.1002/gepi.20292; Ioannidis JPA, 2009, NAT REV GENET, V10, P318, DOI 10.1038/nrg2544; Kitsios GD, 2009, ANN HUM GENET, V73, P514, DOI 10.1111/j.1469-1809.2009.00533.x; Manolio TA, 2008, J CLIN INVEST, V118, P1590, DOI 10.1172/JCI34772; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; McGary KL, 2010, P NATL ACAD SCI USA, V107, P6544, DOI 10.1073/pnas.0910200107; Mungall CJ, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-1-r2; Ohtsuka S, 2002, MOL CELL BIOL, V22, P3066, DOI 10.1128/MCB.22.9.3066-3077.2002; Panagiotou OA, 2010, AM J EPIDEMIOL, V172, P869, DOI 10.1093/aje/kwq234; Robinson PN, 2008, AM J HUM GENET, V83, P610, DOI 10.1016/j.ajhg.2008.09.017; Siontis KCM, 2010, EUR J HUM GENET, V18, P832, DOI 10.1038/ejhg.2010.26; Smith CL, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2004-6-1-r7; Smith CL, 2009, WIRES SYST BIOL MED, V1, P390, DOI 10.1002/wsbm.44; Stefansson H, 2009, NAT GENET, V41, P277, DOI 10.1038/ng.299; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Torkamani A, 2008, GENOMICS, V92, P265, DOI 10.1016/j.ygeno.2008.07.011; Turgeon B, 2009, PHYSIOL REV, V89, P1, DOI 10.1152/physrev.00040.2007; Washington NL, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000247; Zhang YQ, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-1	28	20	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2010	5	11							e13782	10.1371/journal.pone.0013782	http://dx.doi.org/10.1371/journal.pone.0013782			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673FY	21072174	Green Submitted, gold, Green Published			2022-12-27	WOS:000283645700007
J	Palidwor, GA; Perkins, TJ; Xia, XH				Palidwor, Gareth A.; Perkins, Theodore J.; Xia, Xuhua			A General Model of Codon Bias Due to GC Mutational Bias	PLOS ONE			English	Article							ESCHERICHIA-COLI; RESPECTIVE CODONS; PROTEIN GENES; TRANSFER-RNAS; USAGE; ISOCHORES; ABUNDANCE; PRESSURE; PATTERNS; HUMANS	Background: In spite of extensive research on the effect of mutation and selection on codon usage, a general model of codon usage bias due to mutational bias has been lacking. Because most amino acids allow synonymous GC content changing substitutions in the third codon position, the overall GC bias of a genome or genomic region is highly correlated with GC3, a measure of third position GC content. For individual amino acids as well, G/C ending codons usage generally increases with increasing GC bias and decreases with increasing AT bias. Arginine and leucine, amino acids that allow GC-changing synonymous substitutions in the first and third codon positions, have codons which may be expected to show different usage patterns. Principal Findings: In analyzing codon usage bias in hundreds of prokaryotic and plant genomes and in human genes, we find that two G-ending codons, AGG (arginine) and TTG (leucine), unlike all other G/C-ending codons, show overall usage that decreases with increasing GC bias, contrary to the usual expectation that G/C-ending codon usage should increase with increasing genomic GC bias. Moreover, the usage of some codons appears nonlinear, even nonmonotone, as a function of GC bias. To explain these observations, we propose a continuous-time Markov chain model of GC-biased synonymous substitution. This model correctly predicts the qualitative usage patterns of all codons, including nonlinear codon usage in isoleucine, arginine and leucine. The model accounts for 72%, 64% and 52% of the observed variability of codon usage in prokaryotes, plants and human respectively. When codons are grouped based on common GC content, 87%, 80% and 68% of the variation in usage is explained for prokaryotes, plants and human respectively. Conclusions: The model clarifies the sometimes-counterintuitive effects that GC mutational bias can have on codon usage, quantifies the influence of GC mutational bias and provides a natural null model relative to which other influences on codon bias may be measured.	[Palidwor, Gareth A.; Perkins, Theodore J.] Ottawa Hosp Res Inst, Ottawa, ON, Canada; [Xia, Xuhua] Univ Ottawa, Dept Biol, Ottawa, ON, Canada; [Xia, Xuhua] Univ Ottawa, CAREG, Ottawa, ON, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Ottawa	Palidwor, GA (corresponding author), Ottawa Hosp Res Inst, Ottawa, ON, Canada.	gpalidwor@ohri.ca	Xia, Xuhua/E-5264-2010	Xia, Xuhua/0000-0002-3092-7566; Palidwor, Gareth/0000-0001-5317-319X; Perkins, Theodore J./0000-0002-6622-8003	Canadian Natural Sciences and Engineering Research Council; Ontario Research Fund; Ottawa Hospital Research Institute	Canadian Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Ontario Research Fund; Ottawa Hospital Research Institute	This work was supported by Discovery and Response to Intervention (RTI) grants from the Canadian Natural Sciences and Engineering Research Council, the Ontario Research Fund, and the Ottawa Hospital Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Bernardi G, 2000, GENE, V241, P3, DOI 10.1016/S0378-1119(99)00485-0; BERNARDI G, 1993, MOL BIOL EVOL, V10, P186; BULMER M, 1991, GENETICS, V129, P897; Chamary JV, 2006, NAT REV GENET, V7, P98, DOI 10.1038/nrg1770; Comeron JM, 2004, GENETICS, V167, P1293, DOI 10.1534/genetics.104.026351; Faith JJ, 2003, GENETICS, V165, P735; GOUY M, 1982, NUCLEIC ACIDS RES, V10, P7055, DOI 10.1093/nar/10.22.7055; Harvey A.C., 1977, J ECONOMETRICS, V6, P103, DOI DOI 10.1016/0304-4076(77)90057-4; Hershberg R, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000556; Hubbard TJP, 2009, NUCLEIC ACIDS RES, V37, pD690, DOI 10.1093/nar/gkn828; IKEMURA T, 1982, J MOL BIOL, V158, P573, DOI 10.1016/0022-2836(82)90250-9; IKEMURA T, 1981, J MOL BIOL, V151, P389, DOI 10.1016/0022-2836(81)90003-6; Jia WL, 2008, MOL BIOL EVOL, V25, P339, DOI 10.1093/molbev/msm259; Kliman RM, 2005, GENE, V352, P92, DOI 10.1016/j.gene.2005.04.001; KNIGHT RD, 2001, GENOME BIOL, V2; Marin A, 2008, J THEOR BIOL, V253, P508, DOI 10.1016/j.jtbi.2008.04.004; MUTO A, 1987, P NATL ACAD SCI USA, V84, P166, DOI 10.1073/pnas.84.1.166; Nakamura Y, 2000, NUCLEIC ACIDS RES, V28, P292, DOI 10.1093/nar/28.1.292; Semon M, 2006, MOL BIOL EVOL, V23, P523, DOI 10.1093/molbev/msj053; Stabenau A, 2004, GENOME RES, V14, P929, DOI 10.1101/gr.1857204; SUEOKA N, 1988, P NATL ACAD SCI USA, V85, P2653, DOI 10.1073/pnas.85.8.2653; Tatarinova T, 2003, BIOINFORMATICS, V19, pi313, DOI 10.1093/bioinformatics/btg1043; Urbina D, 2006, J MOL EVOL, V62, P340, DOI 10.1007/s00239-005-0051-1; Xia XH, 1998, GENETICS, V149, P37; Xie G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-r14; Zeileis A., 2002, R NEWS, V2, P7, DOI DOI 10.HTTPS://CRAN.R-PR0JECT.0RG/D0C/RNEWS/; Zhang BC, 2016, J BASIC MICROB, V56, P670, DOI 10.1002/jobm.201500751	28	105	114	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2010	5	10							e13431	10.1371/journal.pone.0013431	http://dx.doi.org/10.1371/journal.pone.0013431			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671UN	21048949	gold, Green Submitted, Green Published			2022-12-27	WOS:000283537000001
J	Wang, CZ; Peyron, P; Mestre, O; Kaplan, G; van Soolingen, D; Gao, QA; Gicquel, B; Neyrolles, O				Wang, Chongzhen; Peyron, Pascale; Mestre, Olga; Kaplan, Gilla; van Soolingen, Dick; Gao, Qian; Gicquel, Brigitte; Neyrolles, Olivier			Innate Immune Response to Mycobacterium tuberculosis Beijing and Other Genotypes	PLOS ONE			English	Article							GENOMIC DELETIONS; IN-VITRO; STRAINS; INSIGHTS; LINEAGE; PATHOGENESIS; MACROPHAGES; EXPRESSION; PHYLOGENY; INDUCTION	Background: As a species, Mycobacterium tuberculosis is more diverse than previously thought. In particular, the Beijing family of M. tuberculosis strains is spreading and evoluating throughout the world and this is giving rise to public health concerns. Genetic diversity within this family has recently been delineated further and a specific genotype, called Bmyc10, has been shown to represent over 60% of all Beijing clinical isolates in several parts of the world. How the host immune system senses and responds to various M. tuberculosis strains may profoundly influence clinical outcome and the relative epidemiological success of the different mycobacterial lineages. We hypothesised that the success of the Bmyc10 group may, at least in part, rely upon its ability to alter innate immune responses and the secretion of cytokines and chemokines by host phagocytes. Methodology/Principal Findings: We infected human macrophages and dendritic cells with a collection of genetically well-defined M. tuberculosis clinical isolates belonging to various mycobacterial families, including Beijing. We analyzed cytokine and chemokine secretion on a semi-global level using antibody arrays allowing the detection of sixty-five immunity-related soluble molecules. Our data indicate that Beijing strains induce significantly less interleukin (IL)-6, tumor necrosis factor (TNF), IL-10 and GRO-alpha than the H37Rv reference strain, a feature that is variously shared by other modern and ancient M. tuberculosis families and which constitutes a signature of the Beijing family as a whole. However, Beijing strains did not differ relative to each other in their ability to modulate cytokine secretion. Conclusions/Significance: Our results confirm and expand upon previous reports showing that M. tuberculosis Beijing strains in general are poor in vitro cytokine inducers in human phagocytes. The results suggest that the epidemiological success of the Beijing Bmyc10 is unlikely to rely upon any specific ability of this group of strains to impair anti-mycobacterial innate immunity.	[Wang, Chongzhen; Peyron, Pascale; Neyrolles, Olivier] Inst Pharmacol & Biol Struct, CNRS, Toulouse, France; [Wang, Chongzhen; Peyron, Pascale; Neyrolles, Olivier] Univ Toulouse 3, Inst Pharmacol & Biol Struct, F-31062 Toulouse, France; [Mestre, Olga; Gicquel, Brigitte] Inst Pasteur, Unit Mycobacterial Genet, Paris, France; [Kaplan, Gilla] Univ Med & Dent New Jersey, Publ Hlth Res Inst Ctr, Lab Mycobacterial Immun & Pathogenesis, Newark, NJ 07103 USA; [van Soolingen, Dick] Natl Inst Publ Hlth & Environm, TB Reference Lab, NL-3720 BA Bilthoven, Netherlands; [van Soolingen, Dick] Radboud Univ Nijmegen, Dept Pulm Dis, NL-6525 ED Nijmegen, Netherlands; [van Soolingen, Dick] Radboud Univ Nijmegen, Dept Med Microbiol, NL-6525 ED Nijmegen, Netherlands; [Gao, Qian] Fudan Univ, Shanghai Med Coll, Key Lab Med Mol Virol, Shanghai 200433, Peoples R China	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Rutgers State University New Brunswick; Rutgers State University Medical Center; Netherlands National Institute for Public Health & the Environment; Radboud University Nijmegen; Radboud University Nijmegen; Fudan University	Wang, CZ (corresponding author), Inst Pharmacol & Biol Struct, CNRS, Toulouse, France.	olivier.neyrolles@ipbs.fr	Neyrolles, Olivier B/A-3184-2011; Neyrolles, Olivier/AAG-3692-2019; Wang, Chongzhen/GMX-1772-2022; Mestre, Olga/D-7418-2013	Neyrolles, Olivier/0000-0003-0047-5885; Wang, Chongzhen/0000-0001-9368-6029; Mestre, Olga/0000-0002-0993-2248	Centre de la Recherche Scientifique (CNRS); Institut Pasteur; European Community [200973, LSHP-CT-2006-037919]; CNRS-ATIP	Centre de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Institut Pasteur(European Commission); European Community(European Commission); CNRS-ATIP(Centre National de la Recherche Scientifique (CNRS))	This work was supported by the Centre de la Recherche Scientifique (CNRS), the Institut Pasteur, and the European Community (FP7 project TB-VIR, Grant no 200973, and FP6 project TB-ADAPT, Grant no LSHP-CT-2006-037919). ON is a fellow of a CNRS-ATIP grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bifani PJ, 2002, TRENDS MICROBIOL, V10, P45, DOI 10.1016/S0966-842X(01)02277-6; Brosch R, 2002, P NATL ACAD SCI USA, V99, P3684, DOI 10.1073/pnas.052548299; Caminero JA, 2001, AM J RESP CRIT CARE, V164, P1165, DOI 10.1164/ajrccm.164.7.2101031; Caws M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000034; Chacon-Salinas R, 2005, CLIN EXP IMMUNOL, V140, P443, DOI 10.1111/j.1365-2249.2005.02797.x; Cooper AM, 2008, IMMUNOL REV, V226, P191, DOI 10.1111/j.1600-065X.2008.00702.x; Cooper AM, 2009, ANNU REV IMMUNOL, V27, P393, DOI 10.1146/annurev.immunol.021908.132703; de Jong BC, 2008, J INFECT DIS, V198, P1037, DOI 10.1086/591504; Dos Vultos T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001538; Filliol I, 2006, J BACTERIOL, V188, P759, DOI 10.1128/JB.188.2.759-772.2006; Gagneux S, 2006, P NATL ACAD SCI USA, V103, P2869, DOI 10.1073/pnas.0511240103; Gagneux S, 2007, LANCET INFECT DIS, V7, P328, DOI 10.1016/S1473-3099(07)70108-1; Huet G, 2009, J BIOL CHEM, V284, P27101, DOI 10.1074/jbc.M109.041939; Kong Y, 2007, J CLIN MICROBIOL, V45, P409, DOI 10.1128/JCM.01459-06; Korbel DS, 2008, MICROBES INFECT, V10, P995, DOI 10.1016/j.micinf.2008.07.039; Lopez B, 2003, CLIN EXP IMMUNOL, V133, P30, DOI 10.1046/j.1365-2249.2003.02171.x; Manca C, 2005, J INTERF CYTOK RES, V25, P694, DOI 10.1089/jir.2005.25.694; Manca C, 2004, INFECT IMMUN, V72, P5511, DOI 10.1128/IAI.72.9.5511-5514.2004; Manca C, 2001, P NATL ACAD SCI USA, V98, P5752, DOI 10.1073/pnas.091096998; MESTRE O, PHYLOGENY MYCO UNPUB; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Mostowy S, 2002, J INFECT DIS, V186, P74, DOI 10.1086/341068; Parwati I, 2010, LANCET INFECT DIS, V10, P103, DOI 10.1016/S1473-3099(09)70330-5; Parwati I, 2010, J INFECT DIS, V201, P553, DOI 10.1086/650311; Puissegur MP, 2004, CELL MICROBIOL, V6, P423, DOI 10.1111/j.1462-5822.2004.00371.x; Reed MB, 2004, NATURE, V431, P84, DOI 10.1038/nature02837; Russell DG, 2007, NAT REV MICROBIOL, V5, P39, DOI 10.1038/nrmicro1538; Sinsimer D, 2008, INFECT IMMUN, V76, P3027, DOI 10.1128/IAI.01663-07; Sohn H, 2009, SCAND J IMMUNOL, V69, P43, DOI 10.1111/j.1365-3083.2008.02188.x; Tailleux L, 2003, J IMMUNOL, V170, P1939, DOI 10.4049/jimmunol.170.4.1939; Tanveer M, 2009, T ROY SOC TROP MED H, V103, P581, DOI 10.1016/j.trstmh.2009.03.014; Thwaites G, 2008, J CLIN MICROBIOL, V46, P1363, DOI 10.1128/JCM.02180-07; Tsenova L, 2005, J INFECT DIS, V192, P98, DOI 10.1086/430614; Tsolaki AG, 2005, J CLIN MICROBIOL, V43, P3185, DOI 10.1128/JCM.43.7.3185-3191.2005; Tsolaki AG, 2004, P NATL ACAD SCI USA, V101, P4865, DOI 10.1073/pnas.0305634101; van Crevel R, 2002, CLIN MICROBIOL REV, V15, P294, DOI 10.1128/CMR.15.2.294-309.2002; van Crevel R, 2009, J INFECT DIS, V200, P1671, DOI 10.1086/648477; van der Spuy GD, 2009, TUBERCULOSIS, V89, P120, DOI 10.1016/j.tube.2008.09.003; WHO, 2009, GLOB TUB CONTR 2009; 2006, EMERG INFECT DIS, V12, P736	40	63	63	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2010	5	10							e13594	10.1371/journal.pone.0013594	http://dx.doi.org/10.1371/journal.pone.0013594			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	670LB	21049036	Green Submitted, Green Published, gold			2022-12-27	WOS:000283422100011
J	Bunce, D; Anstey, KJ; Cherbuin, N; Burns, R; Christensen, H; Wen, W; Sachdev, PS				Bunce, David; Anstey, Kaarin J.; Cherbuin, Nicolas; Burns, Richard; Christensen, Helen; Wen, Wei; Sachdev, Perminder S.			Cognitive Deficits Are Associated with Frontal and Temporal Lobe White Matter Lesions in Middle-Aged Adults Living in the Community	PLOS ONE			English	Article							WITHIN-PERSON VARIABILITY; HYPERINTENSITIES; HEALTH; MEMORY; BRAIN; ABNORMALITIES; RECOGNITION; PERFORMANCE; TOPOGRAPHY; MRI	Background: The association between brain white matter lesions and cognitive impairment in old age is well established. However, little is known about this association in midlife. As this information will inform policy for early preventative healthcare initiatives, we investigated non-periventricular frontal, temporal, parietal and occipital lobe white matter hyperintensities (WMH) in relation to cognitive function in 428 (232 women) community-dwelling adults aged 44 to 48 years. Results: Frontal white matter lesions were significantly associated with greater intraindividual RT variability in women, while temporal WMH were associated with face recognition deficits in men. Parietal and occipital lobe lesions were unrelated to cognitive performance. These findings did not differ when education and a range of health variables, including vascular risk factors, were taken into account. Conclusion: Gender differences in WMH-cognition associations are discussed, and we conclude that small vessel disease is present in midlife and has functional consequences which are generally not recognized. Preventative strategies should, therefore, begin early in life.	[Bunce, David; Anstey, Kaarin J.; Cherbuin, Nicolas; Burns, Richard; Christensen, Helen] Australian Natl Univ, Mental Hlth Res Ctr, Canberra, ACT, Australia; [Bunce, David] Brunel Univ, Dept Psychol, London, England; [Wen, Wei; Sachdev, Perminder S.] Prince Wales Hosp, Inst Neuropsychiat, Randwick, NSW 2031, Australia; [Wen, Wei; Sachdev, Perminder S.] Univ New S Wales, Sch Psychiat, Sydney, NSW, Australia	Australian National University; Brunel University; University of New South Wales Sydney	Bunce, D (corresponding author), Australian Natl Univ, Mental Hlth Res Ctr, Canberra, ACT, Australia.	david.bunce@brunel.ac.uk	Cherbuin, Nicolas/A-8515-2008; Anstey, Kaarin/A-3852-2008; Christensen, Helen/F-5053-2012; Sachdev, Perminder/ABC-1137-2020; Burns, Richard A/C-4231-2011	Cherbuin, Nicolas/0000-0001-6481-0748; Anstey, Kaarin/0000-0002-9706-9316; Christensen, Helen/0000-0003-0435-2065; Sachdev, Perminder/0000-0002-9595-3220; Burns, Richard A/0000-0002-7750-4341; Bunce, David/0000-0003-3265-2700; Wen, Wei/0000-0003-2753-3870	Leverhulme Trust; British Academy; NHMRC of Australia [973302, 179805]; NHMRC [471501, 366756]; Australian Brewers Foundation; Australian Rotary Health	Leverhulme Trust(Leverhulme Trust); British Academy; NHMRC of Australia(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Australian Brewers Foundation; Australian Rotary Health	David Bunce's collaboration in this work was supported by the Leverhulme Trust and the British Academy. The study was funded by NHMRC of Australia Unit Grant No. 973302, Program Grant No. 179805, NHMRC project grant No. 157125, grants from the Australian Rotary Health Research Fund and the Australian Brewers Foundation. Nicolas Cherbuin is funded by NHMRC Research Fellowship No. 471501. Kaarin Anstey is funded by NHMRC Research Fellowship No. 366756. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADOLPHS R, 1994, NATURE, V372, P669, DOI 10.1038/372669a0; [Anonymous], 1997, ARCH INTERN MED, V157, P2413; Anstey KJ, 2005, Q J EXP PSYCHOL-A, V58, P5, DOI 10.1080/02724980443000232; Ashburner J, 1997, NEUROIMAGE, V6, P209, DOI 10.1006/nimg.1997.0290; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Ashburner J, 1999, HUM BRAIN MAPP, V7, P254, DOI 10.1002/(SICI)1097-0193(1999)7:4<254::AID-HBM4>3.0.CO;2-G; Baddeley A, 1992, SPOT WORD TEST; Bellgrove MA, 2004, NEUROPSYCHOLOGIA, V42, P1910, DOI 10.1016/j.neuropsychologia.2004.05.007; Bunce D, 2004, BRAIN COGNITION, V56, P320, DOI 10.1016/j.bandc.2004.08.006; Bunce D, 2008, J GERONTOL B-PSYCHOL, V63, pP67, DOI 10.1093/geronb/63.2.P67; Bunce D, 2007, NEUROPSYCHOLOGIA, V45, P2009, DOI 10.1016/j.neuropsychologia.2007.02.006; Bunce D, 2008, PSYCHOL AGING, V23, P848, DOI 10.1037/a0013678; BUNCE DJ, 1993, PSYCHOL AGING, V8, P26, DOI 10.1037/0882-7974.8.1.26; CHERBUIN N, AM J GERIAT IN PRESS; Crane J, 2002, NEUROPSYCHOLOGIA, V40, P530, DOI 10.1016/S0028-3932(01)00131-2; Delis DC., 2000, CALIFORNIA VERBAL LE; FAZEKAS F, 1987, AM J ROENTGENOL, V149, P351, DOI 10.2214/ajr.149.2.351; FAZEKAS F, 1993, NEUROLOGY, V43, P1683, DOI 10.1212/WNL.43.9.1683; Gunning-Dixon FM, 2009, INT J GERIATR PSYCH, V24, P109, DOI 10.1002/gps.2087; Gunning-Dixon FM, 2000, NEUROPSYCHOLOGY, V14, P224, DOI 10.1037//0894-4105.14.2.224; Hultsch D. F., 2008, HDB AGING COGNITION, V3rd, P491, DOI DOI 10.1017/CB09781107415324.004; Kennedy KM, 2009, NEUROPSYCHOLOGIA, V47, P916, DOI 10.1016/j.neuropsychologia.2009.01.001; Madden DJ, 2009, J COGNITIVE NEUROSCI, V21, P289, DOI 10.1162/jocn.2009.21047; Perani D, 1999, BRAIN, V122, P2337, DOI 10.1093/brain/122.12.2337; Raz N, 2007, NEUROPSYCHOLOGY, V21, P149, DOI 10.1037/0894-4105.21.2.149; Raz N, 2006, NEUROSCI BIOBEHAV R, V30, P730, DOI 10.1016/j.neubiorev.2006.07.001; Schafer JL, 2002, PSYCHOL METHODS, V7, P147, DOI 10.1037//1082-989X.7.2.147; Sullivan EV, 2006, NEUROSCI BIOBEHAV R, V30, P749, DOI 10.1016/j.neubiorev.2006.06.002; Wechsler D., 1991, WECHSLER MEMORY SCAL; Wegesin DJ, 2004, NEUROPSYCHOLOGY, V18, P646, DOI 10.1037/0894-4105.18.4.646; Wells W M 3rd, 1996, Med Image Anal, V1, P35; Wen W, 2004, STROKE, V35, P2813, DOI 10.1161/01.STR.0000147034.25760.3d; Wen W, 2004, NEUROIMAGE, V22, P144, DOI 10.1016/j.neuroimage.2003.12.027; Wen W, 2009, HUM BRAIN MAPP, V30, P1155, DOI 10.1002/hbm.20586; West R, 2002, BRAIN COGNITION, V49, P402, DOI 10.1006/brcg.2001.1507	35	43	44	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2010	5	10							e13567	10.1371/journal.pone.0013567	http://dx.doi.org/10.1371/journal.pone.0013567			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	668TQ	21042415	Green Published, gold			2022-12-27	WOS:000283293800025
J	Cox, HS; McDermid, C; Azevedo, V; Muller, O; Coetzee, D; Simpson, J; Barnard, M; Coetzee, G; van Cutsem, G; Goemaere, E				Cox, Helen S.; McDermid, Cheryl; Azevedo, Virginia; Muller, Odelia; Coetzee, David; Simpson, John; Barnard, Marinus; Coetzee, Gerrit; van Cutsem, Gilles; Goemaere, Eric			Epidemic Levels of Drug Resistant Tuberculosis (MDR and XDR-TB) in a High HIV Prevalence Setting in Khayelitsha, South Africa	PLOS ONE			English	Article							MULTIDRUG-RESISTANT; MYCOBACTERIUM-TUBERCULOSIS; RISK-FACTORS	Background: Although multidrug-resistant tuberculosis (MDR-TB) is emerging as a significant threat to tuberculosis control in high HIV prevalence countries such as South Africa, limited data is available on the burden of drug resistant tuberculosis and any association with HIV in such settings. We conducted a community-based representative survey to assess the MDR-TB burden in Khayelitsha, an urban township in South Africa with high HIV and TB prevalence. Methodology/Principal Findings: A cross-sectional survey was conducted among adult clinic attendees suspected for pulmonary tuberculosis in two large primary care clinics, together constituting 50% of the tuberculosis burden in Khayelitsha. Drug susceptibility testing (DST) for isoniazid and rifampicin was conducted using a line probe assay on positive sputum cultures, and with culture-based DST for first and second-line drugs. Between May and November 2008, culture positive pulmonary tuberculosis was diagnosed in 271 new and 264 previously treated tuberculosis suspects (sample enriched with previously treated cases). Among those with known HIV status, 55% and 71% were HIV infected respectively. MDR-TB was diagnosed in 3.3% and 7.7% of new and previously treated cases. These figures equate to an estimated case notification rate for MDR-TB of 51/100,000/year, with new cases constituting 55% of the estimated MDR-TB burden. HIV infection was not significantly associated with rifampicin resistance in multivariate analyses. Conclusions/Significance: There is an extremely high burden of MDR-TB in this setting, most likely representing ongoing transmission. These data highlight the need to diagnose drug resistance among all TB cases, and for innovative models of case detection and treatment for MDR-TB, in order to interrupt transmission and control this emerging epidemic.	[Cox, Helen S.] Burnet Inst, Melbourne, Vic, Australia; [Cox, Helen S.; McDermid, Cheryl; Muller, Odelia; van Cutsem, Gilles; Goemaere, Eric] Med Sans Frontieres, Cape Town, South Africa; [Cox, Helen S.] Monash Univ, Melbourne, Vic 3004, Australia; [Azevedo, Virginia] City Cape Town Hlth, Cape Town, South Africa; [Coetzee, David; van Cutsem, Gilles; Goemaere, Eric] Univ Cape Town, ZA-7925 Cape Town, South Africa; [Simpson, John; Barnard, Marinus] Natl Hlth Lab Serv, Cape Town, South Africa; [Coetzee, Gerrit] Natl Hlth Lab Serv, Johannesburg, South Africa	Burnet Institute; Monash University; University of Cape Town; National Health Laboratory Service	Cox, HS (corresponding author), Burnet Inst, Melbourne, Vic, Australia.	hcox@burnet.edu.au	Van Cutsem, Gilles/ABB-1171-2021	Van Cutsem, Gilles/0000-0002-8972-4480; Cox, Helen/0000-0002-6538-7192	Medecins Sans Frontieres, Belgium	Medecins Sans Frontieres, Belgium	This study was funded by Medecins Sans Frontieres, Belgium. The funders were involved in study design, data collection and analysis. However, final preparation of the manuscript and the decision to publish rests with the first author.	ALLEN BW, 1984, MED LAB SCI, V41, P400; Andrews JR, 2008, J INFECT DIS, V198, P1582, DOI 10.1086/592991; [Anonymous], 2010, MULTIDRUG EXTENSIVEL; [Anonymous], 2008, 4 WHO; Barnard M, 2008, AM J RESP CRIT CARE, V177, P787, DOI 10.1164/rccm.200709-1436OC; *CIT CAP TOWN HLTH, 2009, HLTH STAT; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; *DEP HLTH, 2007, W CAP HIV ANT SER SU; Enarson D.A., 2000, MANAGEMENT TUBERCULO; Gandhi NR, 2010, AM J RESP CRIT CARE, V181, P80, DOI 10.1164/rccm.200907-0989OC; HOSMER DW, 1980, COMMUN STAT A-THEOR, V9, P1043, DOI 10.1080/03610928008827941; Jenny-Avital Elizabeth R, 2002, AIDS Clin Care, V14, P72; Lawn SD, 2005, AIDS, V19, P2109, DOI 10.1097/01.aids.0000194808.20035.c1; March F, 1997, CLIN INFECT DIS, V25, P1044, DOI 10.1086/516065; Medecins Sans Frontieres, 2009, PAT CTR APPR DRUG RE; Mitchison DA, 1998, INT J TUBERC LUNG D, V2, P10; Panjabi R, 2007, INT J TUBERC LUNG D, V11, P828; PELOQUIN CA, 1993, NEW ENGL J MED, V329, P1122, DOI 10.1056/NEJM199310073291513; Sahai J, 1997, ANN INTERN MED, V127, P289, DOI 10.7326/0003-4819-127-4-199708150-00006; Scarparo C, 2004, J CLIN MICROBIOL, V42, P1109, DOI 10.1128/JCM.42.3.1109-1114.2004; Vernon A, 1999, LANCET, V353, P1843, DOI 10.1016/S0140-6736(98)11467-8; Weyer K, 2007, SAMJ S AFR MED J, V97, P1120; Zager EM, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-10	23	60	61	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2010	5	11							e13901	10.1371/journal.pone.0013901	http://dx.doi.org/10.1371/journal.pone.0013901			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	680KW	21085569	Green Published, gold			2022-12-27	WOS:000284231800002
J	Lalonde, MS; Arts, EJ				Lalonde, Matthew S.; Arts, Eric J.			DNA Suspension Arrays: Silencing Discrete Artifacts for High-Sensitivity Applications	PLOS ONE			English	Article							OLIGONUCLEOTIDE LIGATION ASSAY; NEVIRAPINE RESISTANCE MUTATIONS; REVERSE-TRANSCRIPTASE; DRUG-RESISTANCE; HIV-1; INFECTION; VARIANTS	Detection of low frequency single nucleotide polymorphisms (SNPs) has important implications in early screening for tumorgenesis, genetic disorders and pathogen drug resistance. Nucleic acid arrays are a powerful tool for genome-scale SNP analysis, but detection of low-frequency SNPs in a mixed population on an array is problematic. We demonstrate a model assay for HIV-1 drug resistance mutations, wherein ligase discrimination products are collected on a suspension array. In developing this system, we discovered that signal from multiple polymorphisms was obscured by two discrete hybridization artifacts. Specifically: 1) tethering of unligated probes on the template DNA elicited false signal and 2) unpredictable probe secondary structures impaired probe capture and suppressed legitimate signal from the array. Two sets of oligonucleotides were used to disrupt these structures; one to displace unligated reporter labels from the bead-bound species and another to occupy sequences which interfered with array hybridization. This artifact silencing system resulted in a mean 21-fold increased sensitivity for 29 minority variants of 17 codons in our model assay for mutations most commonly associated with HIV-1 drug resistance. Furthermore, since the artifacts we characterized are not unique to our system, their specific inhibition might improve the quality of data from solid-state microarrays as well as from the growing number of multiple analyte suspension arrays relying on sequence-specific nucleic acid target capture.	[Lalonde, Matthew S.; Arts, Eric J.] Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA; [Arts, Eric J.] Case Western Reserve Univ, Div Infect Dis, Dept Med, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University	Lalonde, MS (corresponding author), Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA.	eja3@case.edu	Lalonde, Matthew/I-1134-2012	Arts, Eric/0000-0002-4880-7968	National Institutes of Health [AI49170, AI36219]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI049170, R01AI049170, R21AI049170, P30AI036219] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grant number AI49170. Core facilities were provided by the Case Western Reserve/University Hospitals Center for AIDS Research, supported by National Institutes of Health grant number AI36219. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cai FP, 2007, NAT METHODS, V4, P123, DOI 10.1038/nmeth995; Carnevale EP, 2007, J CLIN MICROBIOL, V45, P752, DOI 10.1128/JCM.01683-06; Carson RT, 1999, J IMMUNOL METHODS, V227, P41, DOI 10.1016/S0022-1759(99)00069-1; CHEN HB, 1990, NUCLEIC ACIDS RES, V18, P871, DOI 10.1093/nar/18.4.871; Cooper DA, 2008, NEW ENGL J MED, V359, P355, DOI 10.1056/NEJMoa0708978; Dare JT, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-57; Dent AE, 2007, AM J TROP MED HYG, V77, P250, DOI 10.4269/ajtmh.2007.77.250; Descamps D, 2009, HIV CLIN TRIALS, V10, P385, DOI 10.1310/hct1006-385; Einstein MH, 2009, CLIN CANCER RES, V15, P1019, DOI 10.1158/1078-0432.CCR-08-1207; Lalonde MS, 2007, J CLIN MICROBIOL, V45, P2604, DOI 10.1128/JCM.00431-07; Li J, 2008, NAT MED, V14, P579, DOI 10.1038/nm1708; Markham Nicholas R., 2008, V453, P3, DOI 10.1007/978-1-60327-429-6_1; McNamara DT, 2006, AM J TROP MED HYG, V74, P413, DOI 10.4269/ajtmh.2006.74.413; Palmer S, 2006, P NATL ACAD SCI USA, V103, P7094, DOI 10.1073/pnas.0602033103; Pozhitkov Alex E., 2007, Briefings in Functional Genomics & Proteomics, V6, P141, DOI 10.1093/bfgp/elm014; Rahimian M, 2008, J PHYS CHEM B, V112, P8770, DOI 10.1021/jp801997v; Taylor JD, 2001, BIOTECHNIQUES, V30, P661, DOI 10.2144/01303dd04; Troyer RM, 2008, AIDS RES HUM RETROV, V24, P235, DOI 10.1089/aid.2007.0138; Varghese V, 2009, JAIDS-J ACQ IMM DEF, V52, P309, DOI 10.1097/QAI.0b013e3181bca669; Villahermosa ML, 2001, J HUMAN VIROL, V4, P238	20	4	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2010	5	11							e15476	10.1371/journal.pone.0015476	http://dx.doi.org/10.1371/journal.pone.0015476			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	676NU	21079742	Green Published, Green Submitted, gold			2022-12-27	WOS:000283920000027
J	Brown, BK; Cox, J; Gillis, A; VanCott, TC; Marovich, M; Milazzo, M; Antonille, TS; Wieczorek, L; McKee, KT; Metcalfe, K; Mallory, RM; Birx, D; Polonis, VR; Robb, ML				Brown, Bruce K.; Cox, Josephine; Gillis, Anita; VanCott, Thomas C.; Marovich, Mary; Milazzo, Mark; Antonille, Tanya Santelli; Wieczorek, Lindsay; McKee, Kelly T., Jr.; Metcalfe, Karen; Mallory, Raburn M.; Birx, Deborah; Polonis, Victoria R.; Robb, Merlin L.			Phase I Study of Safety and Immunogenicity of an Escherichia coli-Derived Recombinant Protective Antigen (rPA) Vaccine to Prevent Anthrax in Adults	PLOS ONE			English	Article							INHALATION ANTHRAX; MULTICENTER TRIAL; RHESUS MACAQUES; RESPONSES; TOLERANCE; CORRELATE; EFFICACY; IMMUNITY; RABBITS; TOXIN	Background: The fatal disease caused by Bacillus anthracis is preventable with a prophylactic vaccine. The currently available anthrax vaccine requires a lengthy immunization schedule, and simpler and more immunogenic options for protection against anthrax are a priority for development. In this report we describe a phase I clinical trial testing the safety and immunogenicity of an anthrax vaccine using recombinant Escherichia coli-derived, B. anthracis protective antigen (rPA). Methodology/Principal Findings: A total of 73 healthy adults ages 18-40 were enrolled and 67 received 2 injections separated by 4 weeks of either buffered saline placebo, or rPA formulated with or without 704 mu g/ml Alhydrogel (R) adjuvant in increasing doses (5, 25, 50, 100 mu g) of rPA. Participants were followed for one year and safety and immunologic data were assessed. Tenderness and warmth were the most common post-injection site reactions. No serious adverse events related to the vaccine were observed. The most robust humoral immune responses were observed in subjects receiving 50 mu g of rPA formulated with Alhydrogel (R) with a geometric mean concentration of anti-rPA IgG antibodies of 283 mu g/ml and a toxin neutralizing geometric 50% reciprocal geometric mean titer of 1061. The highest lymphoproliferative peak cellular response (median Lymphocyte Stimulation Index of 29) was observed in the group receiving 25 mu g Alhydrogel (R)-formulated rPA. Conclusions/Significance: The vaccine was safe, well tolerated and stimulated a robust humoral and cellular response after two doses.	[Brown, Bruce K.; Cox, Josephine; Gillis, Anita; VanCott, Thomas C.; Milazzo, Mark; Antonille, Tanya Santelli; Wieczorek, Lindsay; Robb, Merlin L.] Henry M Jackson Fdn, US Mil HIV Res Program, Rockville, MD USA; [Marovich, Mary; Birx, Deborah; Polonis, Victoria R.] Walter Reed Army Inst Res, US Mil HIV Res Program, Rockville, MD USA; [McKee, Kelly T., Jr.; Metcalfe, Karen; Mallory, Raburn M.] DynPort Vaccine Co LLC, Frederick, MD USA	Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc; Walter Reed Army Institute of Research (WRAIR); United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR)	Brown, BK (corresponding author), Henry M Jackson Fdn, US Mil HIV Res Program, Rockville, MD USA.	mrobb@hivresearch.org		Cox, Josephine/0000-0003-1301-7373	Chemical Biological Medical Systems-Joint Vaccine Acquisition Program; DynPort Vaccine Company LLC	Chemical Biological Medical Systems-Joint Vaccine Acquisition Program; DynPort Vaccine Company LLC	Funding: This study was funded by the Chemical Biological Medical Systems-Joint Vaccine Acquisition Program (http://www.jpeocbd.osd.mil). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. DynPort Vaccine Company (DVC) supported Dr. McKee, Ms. Metcalfe, and Dr. Mallory, all of whom participated in the design of the study and review of the manuscript.; Competing Interests: Dr. Mallory was previously an employee of DynPort Vaccine Company LLC, a CSC company, and is currently employed by MedImmune LLC, a subsidiary of AstraZeneca. Dr. Kelly T. McKee Jr. was previously an employee of DynPort Vaccine Company LLC, a CSC company, and is currently employed by Quintiles Transnational Corporation. Dr. Josephine Cox was previously an employee of the US Military HIV Research Program and is currently employed by the International AIDS Vaccine Initiative. Dr. Thomas C. VanCott was previously an employee of the US Military HIV Research Program and is currently employed by Advanced BioScience Laboratories. Dr. Deborah Birx was previously an employee of the US Military HIV Research Program and is currently employed by the US Centers for Disease Control. DynPort Vaccine Company LLC was the study sponsor. None of the declared conflicting interests impede data sharing as described in the PLoS sharing guidelines.	Allen JS, 2006, CLIN INFECT DIS, V43, P1, DOI 10.1086/504806; BRACHMAN PS, 1962, AM J PUBLIC HEALTH N, V52, P632, DOI 10.2105/AJPH.52.4.632; Campbell JD, 2007, HUM VACCINES, V3, P205, DOI 10.4161/hv.3.5.4459; DARLOW HM, 1956, LANCET, V271, P476; Doolan DL, 2007, J INFECT DIS, V195, P174, DOI 10.1086/510312; Fellows PF, 2001, VACCINE, V19, P3241, DOI 10.1016/S0264-410X(01)00021-4; Gorse GJ, 2007, VACCINE, V25, P7285, DOI 10.1016/j.vaccine.2007.08.010; Gorse GJ, 2006, VACCINE, V24, P5950, DOI 10.1016/j.vaccine.2006.05.044; Ivins B.E., 1996, SALISBURY MED B, V87, P125; Ivins BE, 1998, VACCINE, V16, P1141, DOI 10.1016/S0264-410X(98)80112-6; Keitel WA, 2006, EXPERT REV VACCINES, V5, P417, DOI 10.1586/14760584.5.4.417; Little SF, 2004, VACCINE, V22, P422, DOI 10.1016/j.vaccine.2003.07.004; Niu MT, 2009, VACCINE, V27, P290, DOI 10.1016/j.vaccine.2008.10.044; Pitt MLM, 2001, VACCINE, V19, P4768, DOI 10.1016/S0264-410X(01)00234-1; Pittman PR, 2006, VACCINE, V24, P3654, DOI 10.1016/j.vaccine.2006.01.054; Quinn CP, 2004, J INFECT DIS, V190, P1228, DOI 10.1086/423937; Quinn CP, 2002, EMERG INFECT DIS, V8, P1103, DOI 10.3201/eid0810.020380; Ratto-Kim S, 2004, J INFECT DIS, V189, P1988, DOI 10.1086/386285; Reuveny S, 2001, INFECT IMMUN, V69, P2888, DOI 10.1128/IAI.69.5.2888-2893.2001; TURNBULL PCB, 1991, VACCINE, V9, P533, DOI 10.1016/0264-410X(91)90237-Z; Young JAT, 2007, ANNU REV BIOCHEM, V76, P243, DOI 10.1146/annurev.biochem.75.103004.142728; Zink TK, 2007, VACCINE, V25, P2766, DOI 10.1016/j.vaccine.2006.11.040; 2002, ANTHRAX VACCINE ADSO; 2008, ANTHRAX VACCINE ADSO	24	24	29	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2010	5	11							e13849	10.1371/journal.pone.0013849	http://dx.doi.org/10.1371/journal.pone.0013849			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675OD	21079762	Green Published, gold, Green Submitted			2022-12-27	WOS:000283839100008
J	Yang, JS; Kim, JT; Jeon, J; Park, HS; Kang, GH; Park, KS; Lee, HK; Kim, S; Cho, YM				Yang, Jae-Seong; Kim, Jin Taek; Jeon, Jouhyun; Park, Ho Sun; Kang, Gyeong Hoon; Park, Kyong Soo; Lee, Hong Kyu; Kim, Sanguk; Cho, Young Min			Changes in Hepatic Gene Expression upon Oral Administration of Taurine-Conjugated Ursodeoxycholic Acid in ob/ob Mice	PLOS ONE			English	Article							NONALCOHOLIC FATTY LIVER; TAUROURSODEOXYCHOLIC ACID; INSULIN-RESISTANCE; OXIDATIVE STRESS; STEATOHEPATITIS; DISEASE; METABOLISM; STEATOSIS; MODEL; RATS	Nonalcoholic fatty liver disease (NAFLD) is highly prevalent and associated with considerable morbidities. Unfortunately, there is no currently available drug established to treat NAFLD. It was recently reported that intraperitoneal administration of taurine-conjugated ursodeoxycholic acid (TUDCA) improved hepatic steatosis in ob/ob mice. We hereby examined the effect of oral TUDCA treatment on hepatic steatosis and associated changes in hepatic gene expression in ob/ob mice. We administered TUDCA to ob/ob mice at a dose of 500 mg/kg twice a day by gastric gavage for 3 weeks. Body weight, glucose homeostasis, endoplasmic reticulum (ER) stress, and hepatic gene expression were examined in comparison with control ob/ob mice and normal littermate C57BL/6J mice. Compared to the control ob/ob mice, TUDCA treated ob/ob mice revealed markedly reduced liver fat stained by oil red O (44.2 +/- 5.8% vs. 21.1 +/- 10.4%, P<0.05), whereas there was no difference in body weight, oral glucose tolerance, insulin sensitivity, and ER stress. Microarray analysis of hepatic gene expression demonstrated that oral TUDCA treatment mainly decreased the expression of genes involved in de novo lipogenesis among the components of lipid homeostasis. At pathway levels, oral TUDCA altered the genes regulating amino acid, carbohydrate, and drug metabolism in addition to lipid metabolism. In summary, oral TUDCA treatment decreased hepatic steatosis in ob/ob mice by cooperative regulation of multiple metabolic pathways, particularly by reducing the expression of genes known to regulate de novo lipogenesis.	[Yang, Jae-Seong; Kim, Sanguk] Pohang Univ Sci & Technol, Sch Interdisciplinary Biosci & Bioengn, Pohang, South Korea; [Kim, Jin Taek; Park, Ho Sun; Park, Kyong Soo; Lee, Hong Kyu; Cho, Young Min] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea; [Jeon, Jouhyun; Kim, Sanguk] Pohang Univ Sci & Technol, Dept Life Sci, Pohang, South Korea; [Kang, Gyeong Hoon] Seoul Natl Univ, Coll Med, Dept Pathol, Seoul 151, South Korea	Pohang University of Science & Technology (POSTECH); Seoul National University (SNU); Pohang University of Science & Technology (POSTECH); Seoul National University (SNU)	Yang, JS (corresponding author), Pohang Univ Sci & Technol, Sch Interdisciplinary Biosci & Bioengn, Pohang, South Korea.	sukim@postech.ac.kr; ymchomd@snu.ac.kr	Kang, Gyeong Hoon/F-1051-2010; Park, Kyong Soo/C-2265-2008; Cho, Young Min/J-5669-2012; Yang, Jae-Seong/AAH-6965-2019	Kang, Gyeong Hoon/0000-0003-2380-6675; Park, Kyong Soo/0000-0003-3597-342X; Yang, Jae-Seong/0000-0001-9910-3170; Park, Ho Seon/0000-0003-1200-4626; Kim, Sanguk/0000-0002-3449-3814	Ministry of Education, Science and Technology [20090084155, M10753020006-07N5302-00500, R31-2008-000-10100-0]; Daewoong Co. LTD., Seoul, South Korea	Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Daewoong Co. LTD., Seoul, South Korea	Funding: This work was supported by grants from the National Research Foundation Grant (MEST) (No. 20090084155, M10753020006-07N5302-00500), and the World Class University (No. R31-2008-000-10100-0), which is funded by the Ministry of Education, Science and Technology, and Daewoong Co. LTD., Seoul, South Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelmalek MF, 2007, MED CLIN N AM, V91, P1125, DOI 10.1016/j.mcna.2007.06.001; Adams LA, 2007, ANN EPIDEMIOL, V17, P863, DOI 10.1016/j.annepidem.2007.05.013; Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80; Aragno M, 2009, FREE RADICAL BIO MED, V47, P1067, DOI 10.1016/j.freeradbiomed.2009.07.016; Bellentani S, 1996, BIOCHEM BIOPH RES CO, V220, P479, DOI 10.1006/bbrc.1996.0430; Bellentani S, 2008, HEPATOLOGY, V47, P746, DOI 10.1002/hep.22009; Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466; Caldwell SH, 1999, HEPATOLOGY, V29, P664, DOI 10.1002/hep.510290347; Charlton M, 2004, CLIN GASTROENTEROL H, V2, P1048, DOI 10.1016/S1542-3565(04)00440-9; Diraison F, 2003, DIABETES METAB, V29, P478, DOI 10.1016/S1262-3636(07)70061-7; Donnelly KL, 2005, J CLIN INVEST, V115, P1343, DOI 10.1172/JCI200523621; Edmison John, 2007, Clin Liver Dis, V11, P75, DOI 10.1016/j.cld.2007.02.011; Ellis EM, 2007, PHARMACOL THERAPEUT, V115, P13, DOI 10.1016/j.pharmthera.2007.03.015; Greenfield V, 2008, CURR OPIN GASTROEN, V24, P320, DOI 10.1097/MOG.0b013e3282fbccf2; Hussein O, 2007, DIGEST DIS SCI, V52, P2512, DOI 10.1007/s10620-006-9631-1; KARS M, DIABETES; KITANI K, 1985, AM J PHYSIOL, V248, pG407, DOI 10.1152/ajpgi.1985.248.4.G407; Kotronen A, 2008, ARTERIOSCL THROM VAS, V28, P27, DOI 10.1161/ATVBAHA.107.147538; Laurin J, 1996, HEPATOLOGY, V23, P1464; Lazaridis KN, 2001, J HEPATOL, V35, P134, DOI 10.1016/S0168-8278(01)00092-7; Li TG, 2009, PPAR RES, V2009, DOI 10.1155/2009/501739; Lindor KD, 2004, HEPATOLOGY, V39, P770, DOI 10.1002/hep.20092; Lukivskaya O, 2007, LIFE SCI, V80, P2397, DOI 10.1016/j.lfs.2007.02.042; Lundasen T, 2003, J BIOL CHEM, V278, P43224, DOI 10.1074/jbc.M302645200; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Marchesini G, 2003, HEPATOLOGY, V37, P917, DOI 10.1053/jhep.2003.50161; Matsusue K, 2003, J CLIN INVEST, V111, P737, DOI 10.1172/JCI200317223; NAKAI T, 1992, BIOCHEM J, V288, P613, DOI 10.1042/bj2880613; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Parks EJ, 2006, J LIPID RES, V47, P1651, DOI 10.1194/jlr.R600018-JLR200; Postic C, 2008, J CLIN INVEST, V118, P829, DOI 10.1172/JCI34275; Reigner BG, 2002, EUR J CLIN PHARMACOL, V57, P835, DOI 10.1007/s00228-001-0405-6; Rizos CV, 2009, EXPERT OPIN DRUG SAF, V8, P15, DOI [10.1517/14740330802597821 , 10.1517/14740330802597821]; Rodrigues CMP, 1998, MOL MED, V4, P165, DOI 10.1007/BF03401914; Rodrigues CMP, 2001, BIOCHEM BIOPH RES CO, V281, P468, DOI 10.1006/bbrc.2001.4370; Rudolph G, 2002, EUR J CLIN INVEST, V32, P575, DOI 10.1046/j.1365-2362.2002.01030.x; Sabuncu Tevfik, 2003, Rom J Gastroenterol, V12, P189; Sanyal AJ, N ENGL J MED, V362, P1675; Schreuder TCMA, 2008, WORLD J GASTROENTERO, V14, P2474, DOI 10.3748/wjg.14.2474; Sekiya M, 2008, BIOCHEM BIOPH RES CO, V375, P602, DOI 10.1016/j.bbrc.2008.08.068; Setchell KDR, 1996, GUT, V38, P439, DOI 10.1136/gut.38.3.439; Stefan N, 2008, ENDOCR REV, V29, P939, DOI 10.1210/er.2008-0009; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Svegliati-Baroni G, 2006, AM J PATHOL, V169, P846, DOI 10.2353/ajpath.2006.050953; Targher G, 2007, DIABETES CARE, V30, P2119, DOI 10.2337/dc07-0349; Tilg H, 2005, NAT CLIN PRACT GASTR, V2, P148, DOI 10.1038/ncpgasthep0116; TSUKAHARA K, 1993, LIVER, V13, P262; Yu W, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-528	49	37	39	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2010	5	11							e13858	10.1371/journal.pone.0013858	http://dx.doi.org/10.1371/journal.pone.0013858			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675OD	21079772	Green Published, Green Submitted, gold			2022-12-27	WOS:000283839100012
J	Brideau, CM; Kauppinen, KP; Holmes, R; Soloway, PD				Brideau, Chelsea M.; Kauppinen, Krista P.; Holmes, Rebecca; Soloway, Paul D.			A Non-Coding RNA Within the Rasgrf1 Locus in Mouse Is Imprinted and Regulated by Its Homologous Chromosome in Trans	PLOS ONE			English	Article							H19 GENE; DNA METHYLATION; X-INACTIVATION; CTCF; EXPRESSION; IGF2; CIS; RECEPTOR; ELEMENT; ALLELE	Background: Rasgrf1 is imprinted in mouse, displaying paternal allele specific expression in neonatal brain. Paternal expression is accompanied by paternal-specific DNA methylation at a differentially methylated domain (DMD) within the locus. The cis-acting elements necessary for Rasgrf1 imprinting are known. A series of tandem DNA repeats control methylation of the adjacent DMD, which is a methylation sensitive enhancer-blocking element. These two sequences constitute a binary switch that controls imprinting and represents the Imprinting Control Region (ICR). One paternally transmitted mutation, which helped define the ICR, induced paramutation, in trans, on the maternal allele. Like many imprinted genes, Rasgrf1 lies within an imprinted cluster. One of four noncoding transcripts in the cluster, AK015891, is known to be imprinted. Methodology/Principal Findings: Here we demonstrate that an additional noncoding RNA, AK029869, is imprinted and paternally expressed in brain throughout development. Intriguingly, any of several maternally inherited ICR mutations affected expression of the paternal AK029869 transcript in trans. Furthermore, we found that the ICR mutations exert different trans effects on AK029869 at different developmental times. Conclusions/Significance: Few trans effects have been defined in mammals and, those that exist, do not show the great variation seen at the Rasgrf1 imprinted domain, either in terms of the large number of mutations that produce the effects or the range of phenotypes that emerge when they are seen. These results suggest that trans regulation of gene expression may be more common than originally appreciated and that where trans regulation occurs it can change dynamically during development.	[Brideau, Chelsea M.; Kauppinen, Krista P.; Holmes, Rebecca; Soloway, Paul D.] Cornell Univ, Coll Agr & Life Sci, Div Nutr Sci, Ithaca, NY 14853 USA	Cornell University	Brideau, CM (corresponding author), Cornell Univ, Coll Agr & Life Sci, Div Nutr Sci, Ithaca, NY 14853 USA.	soloway@cornell.edu	Soloway, Paul/T-8243-2019	Soloway, Paul/0000-0003-1967-0437; McLean, Chelsea/0000-0002-3548-3482	National Institutes of Health (NIH) [CA098597, T32GM007617]; NATIONAL CANCER INSTITUTE [R01CA098597] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007617] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding was from the National Institutes of Health (NIH) to PDS (CA098597). CMB was supported in part by NIH Training Grant T32GM007617. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN WR, 1969, NATURE, V223, P64, DOI 10.1038/223064a0; Augui S, 2007, SCIENCE, V318, P1632, DOI 10.1126/science.1149420; BARLOW DP, 1991, NATURE, V349, P84, DOI 10.1038/349084a0; BARTOLOMEI MS, 1991, NATURE, V351, P153, DOI 10.1038/351153a0; BARTON SC, 1984, NATURE, V311, P374, DOI 10.1038/311374a0; Bell AC, 2000, NATURE, V405, P482, DOI 10.1038/35013100; Birger Y, 1999, NATURE, V397, P84, DOI 10.1038/16291; de la Puente A, 2002, GENE, V291, P287, DOI 10.1016/S0378-1119(02)00601-7; Delaval K, 2007, EMBO J, V26, P720, DOI 10.1038/sj.emboj.7601513; Drake NM, 2009, MAMM GENOME, V20, P654, DOI 10.1007/s00335-009-9192-7; Duvillie B, 1998, GENOMICS, V47, P52, DOI 10.1006/geno.1997.5070; ENGEL E, 1980, AM J MED GENET, V6, P137, DOI 10.1002/ajmg.1320060207; FERGUSONSMITH AC, 1993, NATURE, V362, P751, DOI 10.1038/362751a0; Forne T, 1997, P NATL ACAD SCI USA, V94, P10243, DOI 10.1073/pnas.94.19.10243; Fuss SH, 2007, CELL, V130, P373, DOI 10.1016/j.cell.2007.06.023; Hark AT, 2000, NATURE, V405, P486, DOI 10.1038/35013106; Herman H, 2003, NAT GENET, V34, P199, DOI 10.1038/ng1162; Hikichi T, 2003, NUCLEIC ACIDS RES, V31, P1398, DOI 10.1093/nar/gkg232; Holmes R, 2006, MOL CELL BIOL, V26, P9564, DOI 10.1128/MCB.00058-06; Hu JF, 1997, J BIOL CHEM, V272, P20715, DOI 10.1074/jbc.272.33.20715; Kanduri C, 2000, CURR BIOL, V10, P853, DOI 10.1016/S0960-9822(00)00597-2; Kato Y, 2005, BIOESSAYS, V27, P1, DOI 10.1002/bies.20171; Landers M, 2005, NUCLEIC ACIDS RES, V33, P3976, DOI 10.1093/nar/gki705; LaSalle JM, 1996, SCIENCE, V272, P725, DOI 10.1126/science.272.5262.725; Lee GR, 2006, IMMUNITY, V24, P369, DOI 10.1016/j.immuni.2006.03.007; Lewandoski M, 1997, CURR BIOL, V7, P148, DOI 10.1016/S0960-9822(06)00059-5; LI E, 1993, NATURE, V366, P362, DOI 10.1038/366362a0; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Lindroth AM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000145; Ling JQ, 2006, SCIENCE, V312, P269, DOI 10.1126/science.1123191; Lomvardas S, 2006, CELL, V126, P403, DOI 10.1016/j.cell.2006.06.035; MCGRATH J, 1984, SCIENCE, V226, P1317, DOI 10.1126/science.6542249; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Murrell A, 2004, NAT GENET, V36, P889, DOI 10.1038/ng1402; Nagano T, 2008, SCIENCE, V322, P1717, DOI 10.1126/science.1163802; Peters J, 2008, MAMM GENOME, V19, P493, DOI 10.1007/s00335-008-9139-4; Plass C, 1996, NAT GENET, V14, P106, DOI 10.1038/ng0996-106; Qiu XW, 2008, MOL ENDOCRINOL, V22, P1476, DOI 10.1210/me.2007-0474; Shemer R, 2000, NAT GENET, V26, P440, DOI 10.1038/82571; Shykind BM, 2005, HUM MOL GENET, V14, pR33, DOI 10.1093/hmg/ddi105; Spilianakis CG, 2005, NATURE, V435, P637, DOI 10.1038/nature03574; Srivastava M, 2003, J BIOL CHEM, V278, P5977, DOI 10.1074/jbc.M208437200; STOGER R, 1993, CELL, V73, P61, DOI 10.1016/0092-8674(93)90160-R; SURANI MAH, 1984, NATURE, V308, P548, DOI 10.1038/308548a0; SWAIN JL, 1987, CELL, V50, P719, DOI 10.1016/0092-8674(87)90330-8; Takada S, 2002, HUM MOL GENET, V11, P77, DOI 10.1093/hmg/11.1.77; Tallquist MD, 2000, GENESIS, V26, P113, DOI 10.1002/(SICI)1526-968X(200002)26:2<113::AID-GENE3>3.0.CO;2-2; Tsai TF, 2003, GENESIS, V37, P151, DOI 10.1002/gene.10237; Wu MY, 2006, GENE DEV, V20, P2859, DOI 10.1101/gad.1452206; Wutz A, 2007, CURR OPIN GENET DEV, V17, P387, DOI 10.1016/j.gde.2007.08.001; Xu N, 2006, SCIENCE, V311, P1149, DOI 10.1126/science.1122984; Yoon B, 2005, MOL CELL BIOL, V25, P11184, DOI 10.1128/MCB.25.24.11184-11190.2005; Yoon BJ, 2002, NAT GENET, V30, P92, DOI 10.1038/ng795; Zhao Z, 2006, NAT GENET, V38, P1341, DOI 10.1038/ng1891	54	9	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2010	5	11							e13784	10.1371/journal.pone.0013784	http://dx.doi.org/10.1371/journal.pone.0013784			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	674VY	21072176	Green Published, Green Submitted, gold			2022-12-27	WOS:000283779700004
J	Gupta, L; Noh, JY; Jo, YH; Oh, SH; Kumar, S; Noh, MY; Lee, YS; Cha, SJ; Seo, SJ; Kim, I; Han, YS; Barillas-Mury, C				Gupta, Lalita; Noh, Ju Young; Jo, Yong Hun; Oh, Seung Han; Kumar, Sanjeev; Noh, Mi Young; Lee, Yong Seok; Cha, Sung-Jae; Seo, Sook Jae; Kim, Iksoo; Han, Yeon Soo; Barillas-Mury, Carolina			Apolipophorin-III Mediates Antiplasmodial Epithelial Responses in Anopheles gambiae (G3) Mosquitoes	PLOS ONE			English	Article							INSECT IMMUNE ACTIVATION; LIPID-BINDING PROPERTIES; PLASMODIUM-BERGHEI; HELIX-BUNDLE; EXCHANGEABLE APOLIPOPROTEIN; MIDGUT CELLS; HEMOLYMPH; LIPOPHORIN; CDNA	Background: Apolipophorin-III (ApoLp-III) is known to play an important role in lipid transport and innate immunity in lepidopteran insects. However, there is no evidence of involvement of ApoLp-IIIs in the immune responses of dipteran insects such as Drosophila and mosquitoes. Methodology/Principal Findings: We report the molecular and functional characterization of An. gambiae apolipophorin-III (AgApoLp-III). Mosquito ApoLp-IIIs have diverged extensively from those of lepidopteran insects; however, the predicted tertiary structure of AgApoLp-III is similar to that of Manduca sexta (tobacco hornworm). We found that AgApoLp-III mRNA expression is strongly induced in the midgut of An. gambiae (G3 strain) mosquitoes in response to Plasmodium berghei infection. Furthermore, immunofluorescence stainings revealed that high levels of AgApoLp-III protein accumulate in the cytoplasm of Plasmodium-invaded cells and AgApoLp-III silencing increases the intensity of P. berghei infection by five fold. Conclusion: There are broad differences in the midgut epithelial responses to Plasmodium invasion between An. gambiae strains. In the G3 strain of An. gambiae AgApoLp-III participates in midgut epithelial defense responses that limit Plasmodium infection.	[Gupta, Lalita; Kumar, Sanjeev; Barillas-Mury, Carolina] NIAID, Mosquito Immun & Vector Competence Unit, Lab Malaria & Vector Res, NIH, Rockville, MD USA; [Noh, Ju Young; Jo, Yong Hun; Oh, Seung Han; Noh, Mi Young; Kim, Iksoo; Han, Yeon Soo] Chonnam Natl Univ, Coll Agr & Life Sci, Dept Agr Biol, Kwangju, South Korea; [Lee, Yong Seok] Inje Univ, Coll Med & Frontier Inje Res Sci & Technol, Dept Parasitol, Pusan, South Korea; [Cha, Sung-Jae] Johns Hopkins Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD USA; [Cha, Sung-Jae] Johns Hopkins Sch Publ Hlth, Malaria Res Inst, Baltimore, MD USA; [Seo, Sook Jae] Gyeongsang Natl Univ, Div Appl Life Sci, Jinju, South Korea	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Chonnam National University; Inje University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Gyeongsang National University	Gupta, L (corresponding author), Birla Inst Technol & Sci, Biol Sci Grp, Pilani, Rajasthan, India.	hanys@chonnam.ac.kr; cbarillas@niaid.nih.gov	Gupta, Lalita/R-1111-2019	GUPTA, LALITA/0000-0002-0712-8512; Lee, Yongseok/0000-0002-8687-589X; Kumar, Sanjeev/0000-0003-3866-4593	Korean Government [KRF 2008 531 C00064]; Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000947] Funding Source: NIH RePORTER	Korean Government(Korean Government); Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Intramural Research Program of the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health and by the National Research Foundation of Korea Grant funded by the Korean Government (KRF 2008 531 C00064). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atella GC, 2006, INSECT BIOCHEM MOLEC, V36, P375, DOI 10.1016/j.ibmb.2006.01.019; Billker O, 1997, PARASITOLOGY, V115, P1, DOI 10.1017/S0031182097008895; Canavoso LE, 2001, ANNU REV NUTR, V21, P23, DOI 10.1146/annurev.nutr.21.1.23; Chung KT, 2002, COMP BIOCHEM PHYS B, V132, P505, DOI 10.1016/S1096-4959(02)00064-7; Colton CA, 2001, BBA-MOL BASIS DIS, V1535, P134, DOI 10.1016/S0925-4439(00)00092-2; Dettloff M, 2001, J INSECT PHYSIOL, V47, P789, DOI 10.1016/S0022-1910(01)00069-5; Dettloff M, 2001, BIOCHEMISTRY-US, V40, P3150, DOI 10.1021/bi0013804; Fan DP, 2003, J BIOL CHEM, V278, P21212, DOI 10.1074/jbc.M208486200; Franke-Fayard B, 2004, MOL BIOCHEM PARASIT, V137, P23, DOI 10.1016/j.molbiopara.2004.04.007; Halwani AE, 2000, J INVERTEBR PATHOL, V76, P233, DOI 10.1006/jipa.2000.4978; Halwani AE, 1999, DEV COMP IMMUNOL, V23, P563, DOI 10.1016/S0145-305X(99)00037-3; Han YS, 2000, EMBO J, V19, P6030, DOI 10.1093/emboj/19.22.6030; Iimura Y, 1998, ARCH INSECT BIOCHEM, V38, P119, DOI 10.1002/(SICI)1520-6327(1998)38:3&lt;119::AID-ARCH2&gt;3.0.CO;2-N; Jaramillo-Gutierrez G, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-154; Kim HJ, 2004, INSECT BIOCHEM MOLEC, V34, P1011, DOI 10.1016/j.ibmb.2004.05.005; Kumar S, 2004, J BIOL CHEM, V279, P53475, DOI 10.1074/jbc.M409905200; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Marinotti O, 2006, COMP BIOCHEM PHYS B, V144, P101, DOI 10.1016/j.cbpb.2006.01.012; Mendes AM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000069; Mullen LM, 2004, J INSECT PHYSIOL, V50, P409, DOI 10.1016/j.jinsphys.2004.02.008; Narayanaswami V, 1999, P NATL ACAD SCI USA, V96, P4366, DOI 10.1073/pnas.96.8.4366; Niere M, 1999, BBA-PROTEIN STRUCT M, V1433, P16, DOI 10.1016/S0167-4838(99)00148-X; Niere M, 2001, BIOCHEMISTRY-US, V40, P11502, DOI 10.1021/bi010117f; Park SY, 2005, DEV COMP IMMUNOL, V29, P43, DOI 10.1016/j.dci.2004.06.001; Pratt CC, 2004, BIOL CHEM, V385, P1113, DOI 10.1515/BC.2004.145; Sahoo D, 2002, J MOL BIOL, V321, P201, DOI 10.1016/S0022-2836(02)00618-6; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SALAZAR CE, 1993, NUCLEIC ACIDS RES, V21, P4147, DOI 10.1093/nar/21.17.4147; Seo SJ, 2008, COMP BIOCHEM PHYS B, V151, P433, DOI 10.1016/j.cbpb.2008.09.081; SUN DH, 1995, J NEUROBIOL, V26, P119, DOI 10.1002/neu.480260110; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Wang JJ, 2002, P NATL ACAD SCI USA, V99, P1188, DOI 10.1073/pnas.032565999; WEERS PMM, 1993, J BIOL CHEM, V268, P4300; Weers PMM, 2006, INSECT BIOCHEM MOLEC, V36, P231, DOI 10.1016/j.ibmb.2006.01.001; Whitten MMA, 2004, J IMMUNOL, V172, P2177, DOI 10.4049/jimmunol.172.4.2177; Wiesner A, 1997, J INSECT PHYSIOL, V43, P383, DOI 10.1016/S0022-1910(96)00113-8; Yamauchi Y, 2000, ARCH INSECT BIOCHEM, V43, P16, DOI 10.1002/(SICI)1520-6327(200001)43:1&lt;16::AID-ARCH3&gt;3.0.CO;2-W	37	44	45	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2010	5	11							e15410	10.1371/journal.pone.0015410	http://dx.doi.org/10.1371/journal.pone.0015410			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	674VY	21072214	Green Published, gold, Green Submitted			2022-12-27	WOS:000283779700018
J	Nakahira, M; Macedo, JNA; Seraphim, TV; Cavalcante, N; Souza, TACB; Damalio, JCP; Reyes, LF; Assmann, EM; Alborghetti, MR; Garratt, RC; Araujo, APU; Zanchin, NIT; Barbosa, JARG; Kobarg, J				Nakahira, Marcel; Alves Macedo, Joci Neuby; Seraphim, Thiago Vargas; Cavalcante, Nayara; Souza, Tatiana A. C. B.; Pissuti Damalio, Julio Cesar; Reyes, Luis Fernando; Assmann, Eliana M.; Alborghetti, Marcos R.; Garratt, Richard C.; Araujo, Ana Paula U.; Zanchin, Nilson I. T.; Barbosa, Joao A. R. G.; Kobarg, Joerg			A Draft of the Human Septin Interactome	PLOS ONE			English	Article							PROTEIN-KINASE; GTP-BINDING; CENP-F; INTERACTION PARTNER; IDENTIFICATION; FAMILY; SUMO; ORGANIZATION; EXPRESSION; PHOSPHORYLATION	Background: Septins belong to the GTPase superclass of proteins and have been functionally implicated in cytokinesis and the maintenance of cellular morphology. They are found in all eukaryotes, except in plants. In mammals, 14 septins have been described that can be divided into four groups. It has been shown that mammalian septins can engage in homo- and heterooligomeric assemblies, in the form of filaments, which have as a basic unit a hetero-trimeric core. In addition, it has been speculated that the septin filaments may serve as scaffolds for the recruitment of additional proteins. Methodology/Principal Findings: Here, we performed yeast two-hybrid screens with human septins 1-10, which include representatives of all four septin groups. Among the interactors detected, we found predominantly other septins, confirming the tendency of septins to engage in the formation of homo- and heteropolymeric filaments. Conclusions/Significance: If we take as reference the reported arrangement of the septins 2, 6 and 7 within the heterofilament, (7-6-2-2-6-7), we note that the majority of the observed interactions respect the "group rule", i.e. members of the same group (e. g. 6, 8, 10 and 11) can replace each other in the specific position along the heterofilament. Septins of the SEPT6 group preferentially interacted with septins of the SEPT2 group (p<0.001), SEPT3 group (p<0.001) and SEPT7 group (p<0.001). SEPT2 type septins preferentially interacted with septins of the SEPT6 group (p<0.001) aside from being the only septin group which interacted with members of its own group. Finally, septins of the SEPT3 group interacted preferentially with septins of the SEPT7 group (p<0.001). Furthermore, we found non-septin interactors which can be functionally attributed to a variety of different cellular activities, including: ubiquitin/sumoylation cycles, microtubular transport and motor activities, cell division and the cell cycle, cell motility, protein phosphorylation/signaling, endocytosis, and apoptosis.	[Nakahira, Marcel; Souza, Tatiana A. C. B.; Assmann, Eliana M.; Alborghetti, Marcos R.; Kobarg, Joerg] Ctr Nacl Pesquisa Energia & Mat, Lab Nacl Biociencias, Campinas, SP, Brazil; [Nakahira, Marcel; Seraphim, Thiago Vargas; Alborghetti, Marcos R.; Kobarg, Joerg] Univ Estadual Campinas, Dept Bioquim, Programa Posgrad Biol Func & Mol, Campinas, SP, Brazil; [Alves Macedo, Joci Neuby; Cavalcante, Nayara; Pissuti Damalio, Julio Cesar; Reyes, Luis Fernando; Garratt, Richard C.; Araujo, Ana Paula U.] Univ Sao Paulo, Ctr Biotecnol Mol Estrutural, Sao Carlos, SP, Brazil; [Zanchin, Nilson I. T.] Univ Estadual Campinas, Ctr Biol Mol & Engn Genet, Campinas, SP, Brazil; [Zanchin, Nilson I. T.] Univ Estadual Campinas, Fac Ciencias Aplicadas, Campinas, SP, Brazil; [Barbosa, Joao A. R. G.] Univ Catolica Brasilia, Brasilia, DF, Brazil	Universidade Estadual de Campinas; Universidade de Sao Paulo; Universidade Estadual de Campinas; Universidade Estadual de Campinas; Universidade Catolica de Brasilia	Nakahira, M (corresponding author), Ctr Nacl Pesquisa Energia & Mat, Lab Nacl Biociencias, Campinas, SP, Brazil.	jorg.kobarg@lnbio.org.br	Araujo, Ana Paula U/I-6664-2012; Macedo, Joci/I-7230-2013; Kobarg, Jörg/T-4736-2019; 4, INCT/H-4499-2013; Barbosa, João Alexandre/E-2261-2012; Seraphim, Thiago V/J-9949-2013; garratt, richard c/F-6921-2011; Barbosa, João/GVT-7916-2022; Zanchin, Nilson Ivo Tonin/AAB-4907-2019; Inbeqmedi, Inct/I-1929-2013; Alborghetti, Marcos Rodrigo/K-7547-2012	Araujo, Ana Paula U/0000-0001-5455-084X; Kobarg, Jörg/0000-0002-9419-0145; Barbosa, João Alexandre/0000-0002-0534-481X; Zanchin, Nilson Ivo Tonin/0000-0002-1153-0694; Vargas Seraphim, Thiago/0000-0002-8682-8962; Alborghetti, Marcos Rodrigo/0000-0003-4517-5579; garratt, richard/0000-0002-2016-3179	Fundao de Amparo a Pesquisa do Estado Sao Paulo (Fapesp); CAPES: Coordenao de Aperfeioamento de Pessoal de Navel Superior; Conselho Nacional de Pesquisa e Desenvolvimento (CNPq); Laboratorio Nacional de Biociencias-Centro Nacional de Pesquisa em Energia e Materais (LNBio-CNPEM)	Fundao de Amparo a Pesquisa do Estado Sao Paulo (Fapesp)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CAPES: Coordenao de Aperfeioamento de Pessoal de Navel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Pesquisa e Desenvolvimento (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Laboratorio Nacional de Biociencias-Centro Nacional de Pesquisa em Energia e Materais (LNBio-CNPEM)	Financially supported by: Fundao de Amparo a Pesquisa do Estado Sao Paulo (Fapesp), CAPES: Coordenao de Aperfeioamento de Pessoal de Navel Superior, Conselho Nacional de Pesquisa e Desenvolvimento (CNPq) and the Laboratorio Nacional de Biociencias-Centro Nacional de Pesquisa em Energia e Materais (LNBio-CNPEM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, R LANG ENV STAT COMP; Assmann EM, 2006, J BIOL CHEM, V281, P9869, DOI 10.1074/jbc.M513280200; Barral Y, 1999, GENE DEV, V13, P176, DOI 10.1101/gad.13.2.176; BARTEL PL, 1995, METHOD ENZYMOL, V254, P241; Bertin A, 2008, P NATL ACAD SCI USA, V105, P8274, DOI 10.1073/pnas.0803330105; Blaser S, 2006, J PATHOL, V210, P103, DOI 10.1002/path.2013; Blaser S, 2004, THROMB HAEMOSTASIS, V91, P959, DOI 10.1160/TH03-09-0578; Cao LH, 2007, FEBS LETT, V581, P5526, DOI 10.1016/j.febslet.2007.10.032; Cao LH, 2009, CELL MOL LIFE SCI, V66, P3309, DOI 10.1007/s00018-009-0087-2; CHIEN CT, 1991, P NATL ACAD SCI USA, V88, P9578, DOI 10.1073/pnas.88.21.9578; Ding XM, 2008, MOL CELLS, V25, P385; Dobbelaere J, 2004, SCIENCE, V305, P393, DOI 10.1126/science.1099892; Douglas LM, 2005, EUKARYOT CELL, V4, P1503, DOI 10.1128/EC.4.9.1503-1512.2005; Fujishima K, 2007, J NEUROCHEM, V102, P77, DOI 10.1111/j.1471-4159.2007.04478.x; Gonzalez ME, 2007, CANCER RES, V67, P8554, DOI 10.1158/0008-5472.CAN-07-1474; Gonzalez-Novo A, 2006, MICROBIOL IMMUNOL, V50, P499, DOI 10.1111/j.1348-0421.2006.tb03820.x; Gout I, 2000, EMBO J, V19, P4015, DOI 10.1093/emboj/19.15.4015; Grigoryan G, 2008, CURR OPIN STRUC BIOL, V18, P477, DOI 10.1016/j.sbi.2008.04.008; Hall PA, 2005, J PATHOL, V206, P269, DOI 10.1002/path.1789; Havrylov S, 2009, PROTEOME SCI, V7, DOI 10.1186/1477-5956-7-21; Hickson GRX, 2008, BIOCHEM SOC T, V36, P439, DOI 10.1042/BST0360439; Huang YW, 2008, MOL BIOL CELL, V19, P1717, DOI 10.1091/mbc.E07-07-0641; Ihara M, 2003, J BIOL CHEM, V278, P24095, DOI 10.1074/jbc.M301352200; Jackson PK, 2001, GENE DEV, V15, P3053, DOI 10.1101/gad.955501; Johnson ES, 1999, J CELL BIOL, V147, P981, DOI 10.1083/jcb.147.5.981; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Johnson ES, 2001, CELL, V106, P735, DOI 10.1016/S0092-8674(01)00491-3; Joo E, 2005, TRAFFIC, V6, P626, DOI 10.1111/j.1600-0854.2005.00305.x; Kinoshita A, 1998, AM J PATHOL, V153, P1551, DOI 10.1016/S0002-9440(10)65743-4; Kinoshita M, 2006, CURR OPIN CELL BIOL, V18, P54, DOI 10.1016/j.ceb.2005.12.005; Kinoshita M, 2003, J BIOCHEM, V134, P491, DOI 10.1093/jb/mvg182; Kinoshita M, 2002, DEV CELL, V3, P791, DOI 10.1016/S1534-5807(02)00366-0; Kishi K, 2009, MOL CELL BIOL, V29, P3134, DOI 10.1128/MCB.01663-08; Kozubowski L, 2010, MOL MICROBIOL, V75, P658, DOI 10.1111/j.1365-2958.2009.06983.x; Kuhlenbaumer G, 2005, NAT GENET, V37, P1044, DOI 10.1038/ng1649; LIAO H, 1995, J CELL BIOL, V130, P507, DOI 10.1083/jcb.130.3.507; Longtine MS, 1998, J CELL BIOL, V143, P719, DOI 10.1083/jcb.143.3.719; Macara IG, 2002, MOL BIOL CELL, V13, p2A; Martin SW, 2004, J BIOL CHEM, V279, P40861, DOI 10.1074/jbc.M406422200; Martinez C, 2004, BIOCHEM J, V382, P783, DOI 10.1042/BJ20040372; McIlhatton MA, 2001, ONCOGENE, V20, P5930, DOI 10.1038/sj.onc.1204752; Moraes KCM, 2003, BIOL CHEM, V384, P25, DOI 10.1515/BC.2003.004; Mostowy S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004196; Nagata K, 2004, J BIOL CHEM, V279, P55895, DOI 10.1074/jbc.M406153200; Nagata KI, 2005, ONCOGENE, V24, P65, DOI 10.1038/sj.onc.1208101; Nery FC, 2004, J BIOL CHEM, V279, P11444, DOI 10.1074/jbc.M306672200; Ogawa Y, 2009, J NEUROSCI RES, V87, P3502, DOI 10.1002/jnr.21984; Pan FF, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-103; Parks WT, 2001, J BIOL CHEM, V276, P19332, DOI 10.1074/jbc.M100606200; Peterson EA, 2007, MAMM GENOME, V18, P796, DOI 10.1007/s00335-007-9065-x; Qin HM, 2007, CURR BIOL, V17, P193, DOI 10.1016/j.cub.2006.12.040; RATTNER JB, 1993, CELL MOTIL CYTOSKEL, V26, P214, DOI 10.1002/cm.970260305; Rochat-Steiner V, 2000, J EXP MED, V192, P1165, DOI 10.1084/jem.192.8.1165; Rose A, 2004, CELL MOL LIFE SCI, V61, P1996, DOI 10.1007/s00018-004-4039-6; Schmidt D, 2003, CELL MOL LIFE SCI, V60, P2561, DOI 10.1007/s00018-003-3129-1; Schmidt MHH, 2003, J CELL SCI, V116, P2845, DOI 10.1242/jcs.00522; Sirajuddin M, 2007, NATURE, V449, P311, DOI 10.1038/nature06052; Sirajuddin M, 2009, P NATL ACAD SCI USA, V106, P16592, DOI 10.1073/pnas.0902858106; Spiliotis ET, 2005, SCIENCE, V307, P1781, DOI 10.1126/science.1106823; Surka MC, 2002, MOL BIOL CELL, V13, P3532, DOI 10.1091/mbc.E02-01-0042; Surpili MJ, 2003, BIOCHEMISTRY-US, V42, P15369, DOI 10.1021/bi034575v; Take H, 2000, BIOCHEM BIOPH RES CO, V268, P321, DOI 10.1006/bbrc.2000.2147; van der Flier A, 2001, BBA-MOL CELL RES, V1538, P99, DOI 10.1016/S0167-4889(01)00072-6; Varis A, 2006, CHROMOSOMA, V115, P288, DOI 10.1007/s00412-005-0046-0; Wassmer T, 2007, J CELL SCI, V120, P45, DOI 10.1242/jcs.03302; Weirich CS, 2008, NAT REV MOL CELL BIO, V9, P478, DOI 10.1038/nrm2407; Xie YL, 2007, CURR BIOL, V17, P1746, DOI 10.1016/j.cub.2007.08.042; Zhang J, 2009, CELL RES, V19, P733, DOI 10.1038/cr.2009.51; Zhang JS, 1999, CURR BIOL, V9, P1458, DOI 10.1016/S0960-9822(00)80115-3; Zhu M, 2008, J BIOL CHEM, V283, P18916, DOI 10.1074/jbc.M710591200; [No title captured]; [No title captured]; [No title captured]	73	64	66	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2010	5	11							e13799	10.1371/journal.pone.0013799	http://dx.doi.org/10.1371/journal.pone.0013799			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	674VY	21082023	Green Published, Green Submitted, gold			2022-12-27	WOS:000283779700011
J	Oda-Ishii, I; Ishii, Y; Mikawa, T				Oda-Ishii, Izumi; Ishii, Yasuo; Mikawa, Takashi			Eph Regulates Dorsoventral Asymmetry of the Notochord Plate and Convergent Extension-Mediated Notochord Formation	PLOS ONE			English	Article							PLANAR CELL POLARITY; CIONA-INTESTINALIS; BOUNDARY FORMATION; GENE; EXPRESSION; APKC; DIFFERENTIATION; GASTRULATION; PRICKLE; EPHRINS	Background: The notochord is a signaling center required for the patterning of the vertebrate embryic midline, however, the molecular and cellular mechanisms involved in the formation of this essential embryonic tissue remain unclear. The urochordate Ciona intestinalis develops a simple notochord from 40 specific postmitotic mesodermal cells. The precursors intercalate mediolaterally and establish a single array of disk-shaped notochord cells along the midline. However, the role that notochord precursor polarization, particularly along the dorsoventral axis, plays in this morphogenetic process remains poorly understood. Methodology/Principal Findings: Here we show that the notochord preferentially accumulates an apical cell polarity marker, aPKC, ventrally and a basement membrane marker, laminin, dorsally. This asymmetric accumulation of apicobasal cell polarity markers along the embryonic dorsoventral axis was sustained in notochord precursors during convergence and extension. Further, of several members of the Eph gene family implicated in cellular and tissue morphogenesis, only Ci-Eph4 was predominantly expressed in the notochord throughout cell intercalation. Introduction of a dominant-negative Ci-Eph4 to notochord precursors diminished asymmetric accumulation of apicobasal cell polarity markers, leading to defective intercalation. In contrast, misexpression of a dominant-negative mutant of a planar cell polarity gene Dishevelled preserved asymmetric accumulation of aPKC and laminin in notochord precursors, although their intercalation was incomplete. Conclusions/Significance: Our data support a model in which in ascidian embryos Eph-dependent dorsoventral polarity of notochord precursors plays a crucial role in mediolateral cell intercalation and is required for proper notochord morphogenesis.	[Oda-Ishii, Izumi; Ishii, Yasuo; Mikawa, Takashi] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Oda-Ishii, I (corresponding author), Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA.	takashi.mikawa@ucsf.edu			National Institutes of Health-National Heart, Lung and Blood Institute [R01092429]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092429, R01HL078921] Funding Source: NIH RePORTER	National Institutes of Health-National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health-National Heart, Lung and Blood Institute R01092429. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS DS, 1990, DEVELOPMENT, V110, P115; BANCROFT M, 1976, J EMBRYOL EXP MORPH, V35, P383; Bertrand V, 2003, CELL, V115, P615, DOI 10.1016/S0092-8674(03)00928-0; Chalmers AD, 2005, DEVELOPMENT, V132, P977, DOI 10.1242/dev.01645; Chan J, 2001, DEV BIOL, V234, P470, DOI 10.1006/dbio.2001.0281; Cleaver O, 2001, DEV BIOL, V234, P1, DOI 10.1006/dbio.2001.0214; Cooke JE, 2005, CURR BIOL, V15, P536, DOI 10.1016/j.cub.2005.02.019; Corbo JC, 1997, DEVELOPMENT, V124, P589; Cosgrove D, 1996, GENE DEV, V10, P2981, DOI 10.1101/gad.10.23.2981; Coulthard MG, 2002, INT J DEV BIOL, V46, P375; Darken RS, 2002, EMBO J, V21, P976, DOI 10.1093/emboj/21.5.976; Dearborn R, 2002, J NEUROSCI, V22, P1338, DOI 10.1523/JNEUROSCI.22-04-01338.2002; Djiane A, 2005, CELL, V121, P621, DOI 10.1016/j.cell.2005.03.014; Dodd J, 1998, SCIENCE, V282, P1654, DOI 10.1126/science.282.5394.1654; Durbin L, 1998, GENE DEV, V12, P3096, DOI 10.1101/gad.12.19.3096; Egea J, 2007, TRENDS CELL BIOL, V17, P230, DOI 10.1016/j.tcb.2007.03.004; Fitsialos G, 2008, J CELL SCI, V121, P2992, DOI 10.1242/jcs.029256; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; Glaser V, 2005, ZEBRAFISH, V1, P319; Gould DB, 2005, SCIENCE, V308, P1167, DOI 10.1126/science.1109418; Hotta K, 2007, DEV DYNAM, V236, P1790, DOI 10.1002/dvdy.21188; Huot J, 2004, PROG NEURO-PSYCHOPH, V28, P813, DOI 10.1016/j.pnpbp.2004.05.025; Ikuta T, 2004, P NATL ACAD SCI USA, V101, P15118, DOI 10.1073/pnas.0401389101; IMOH H, 1988, J EXP ZOOL, V246, P258, DOI 10.1002/jez.1402460306; Izumi Y, 1998, J CELL BIOL, V143, P95, DOI 10.1083/jcb.143.1.95; Jiang D, 2005, CURR BIOL, V15, P79; Jiang D, 2007, DEV DYNAM, V236, P1748, DOI 10.1002/dvdy.21184; Jones C, 2007, BIOESSAYS, V29, P120, DOI 10.1002/bies.20526; JURAND A, 1962, J EMBRYOL EXP MORPH, V10, P602; Keller R, 2002, SCIENCE, V298, P1950, DOI 10.1126/science.1079478; Keys DN, 2002, DEV BIOL, V246, P329, DOI 10.1006/dbio.2002.0656; Kida YS, 2007, P NATL ACAD SCI USA, V104, P6708, DOI 10.1073/pnas.0608946104; Kullander K, 2002, NAT REV MOL CELL BIO, V3, P475, DOI 10.1038/nrm856; LeBleu VS, 2007, EXP BIOL MED, V232, P1121, DOI 10.3181/0703-MR-72; Mikawa T, 2004, DEV DYNAM, V229, P422, DOI 10.1002/dvdy.10458; Miyagoe Y, 1997, FEBS LETT, V415, P33, DOI 10.1016/S0014-5793(97)01007-7; Munro EM, 2002, DEVELOPMENT, V129, P13; Munro EM, 2002, DEVELOPMENT, V129, P1; Naruse-Nakajima C, 2001, MECH DEVELOP, V102, P95, DOI 10.1016/S0925-4773(01)00290-8; Oda-Ishii I, 2007, DEV DYNAM, V236, P1806, DOI 10.1002/dvdy.21213; Ohno S, 2001, CURR OPIN CELL BIOL, V13, P641, DOI 10.1016/S0955-0674(00)00264-7; Palmer A, 2003, GENE DEV, V17, P1429, DOI 10.1101/gad.1093703; Parsons MJ, 2002, DEVELOPMENT, V129, P3137; Pasquale EB, 2005, NAT REV MOL CELL BIO, V6, P462, DOI 10.1038/nrm1662; Patalano S, 2006, J CELL SCI, V119, P1592, DOI 10.1242/jcs.02873; Picco V, 2007, DEVELOPMENT, V134, P1491, DOI 10.1242/dev.003939; Poschl E, 2004, DEVELOPMENT, V131, P1619, DOI 10.1242/dev.01037; Reese DE, 2004, DEV CELL, V6, P699, DOI 10.1016/S1534-5807(04)00127-3; Rothbacher U, 2000, EMBO J, V19, P1010, DOI 10.1093/emboj/19.5.1010; Satoh N, 2003, NAT REV GENET, V4, P285, DOI 10.1038/nrg1042; Satoh N., 1994, DEV BIOL ASCIDIANS; Satou Y, 2003, DEV GENES EVOL, V213, P213, DOI 10.1007/s00427-003-0319-7; Shi WY, 2009, DEVELOPMENT, V136, P23, DOI 10.1242/dev.029157; Smith A, 1997, CURR BIOL, V7, P561, DOI 10.1016/S0960-9822(06)00255-7; Smyth N, 1999, J CELL BIOL, V144, P151, DOI 10.1083/jcb.144.1.151; Sokol SY, 1996, CURR BIOL, V6, P1456, DOI 10.1016/S0960-9822(96)00750-6; Stemple DL, 2005, DEVELOPMENT, V132, P2503, DOI 10.1242/dev.01812; Suzuki A, 2002, J CELL SCI, V115, P3565, DOI 10.1242/jcs.00032; Suzuki AS, 2002, DEV GROWTH DIFFER, V44, P127; Takahashi Y, 2005, INT J DEV BIOL, V49, P221, DOI 10.1387/ijdb.041960yt; Takeuchi M, 2003, CURR BIOL, V13, P674, DOI 10.1016/S0960-9822(03)00245-8; Veeman MT, 2008, DEVELOPMENT, V135, P33, DOI 10.1242/dev.010892; Veeman MT, 2003, CURR BIOL, V13, P680, DOI 10.1016/S0960-9822(03)00240-9; Vihanto MM, 2005, FASEB J, V19, P1689, DOI 10.1096/fj.04-3647fje; Xu QL, 1996, NATURE, V381, P319, DOI 10.1038/381319a0; Xu QL, 1995, DEVELOPMENT, V121, P4005	66	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2010	5	10							e13689	10.1371/journal.pone.0013689	http://dx.doi.org/10.1371/journal.pone.0013689			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673FU	21060822	Green Submitted, Green Published, gold			2022-12-27	WOS:000283645300006
J	Andreatta, M; Nielsen, M; Aarestrup, FM; Lund, O				Andreatta, Massimo; Nielsen, Morten; Aarestrup, Frank Moller; Lund, Ole			In Silico Prediction of Human Pathogenicity in the gamma-Proteobacteria	PLOS ONE			English	Article							ESCHERICHIA-COLI; FRANCISELLA-TULARENSIS; GENOME; VIRULENCE; EVOLUTION; ASSOCIATION; PROKARYOTES; ADAPTATION; PHYLOGENY; PROTEINS	In Background: Although the majority of bacteria are innocuous or even beneficial for their host, others are highly infectious pathogens that can cause widespread and deadly diseases. When investigating the relationships between bacteria and other living organisms, it is therefore essential to be able to separate pathogenic organisms from non-pathogenic ones. Using traditional experimental methods for this purpose can be very costly and time-consuming, and also uncertain since animal models are not always good predictors for pathogenicity in humans. Bioinformatics-based methods are therefore strongly needed to mine the fast growing number of genome sequences and assess in a rapid and reliable way the pathogenicity of novel bacteria. Methodology/Principal Findings: We describe a new in silico method for the prediction of bacterial pathogenicity, based on the identification in microbial genomes of features that appear to correlate with virulence. The method does not rely on identifying genes known to be involved in pathogenicity (for instance virulence factors), but rather it inherently builds families of proteins that, irrespective of their function, are consistently present in only one of the two kinds of organisms, pathogens or non-pathogens. Whether a new bacterium carries proteins contained in these families determines its prediction as pathogenic or non-pathogenic. The application of the method on a set of known genomes correctly classified the virulence potential of 86% of the organisms tested. An additional validation on an independent test-set assigned correctly 22 out of 24 bacteria. Conclusions: The proposed approach was demonstrated to go beyond the species bias imposed by evolutionary relatedness, and performs better than predictors based solely on taxonomy or sequence similarity. A set of protein families that differentiate pathogenic and non-pathogenic strains were identified, including families of yet uncharacterized proteins that are suggested to be involved in bacterial pathogenicity.	[Andreatta, Massimo; Nielsen, Morten; Lund, Ole] Tech Univ Denmark, Ctr Biol Sequence Anal, DK-2800 Lyngby, Denmark; [Aarestrup, Frank Moller] Tech Univ Denmark, Natl Food Inst, Copenhagen, Denmark	Technical University of Denmark; Technical University of Denmark	Andreatta, M (corresponding author), Tech Univ Denmark, Ctr Biol Sequence Anal, DK-2800 Lyngby, Denmark.	massimo@cbs.dtu.dk	Andreatta, Massimo/AAA-4061-2020; Nielsen, Morten/AAL-8700-2020; Nielsen, Morten/E-7754-2011; Lund, Ole/F-4437-2014	Andreatta, Massimo/0000-0002-8036-2647; Nielsen, Morten/0000-0001-7885-4311; Nielsen, Morten/0000-0001-7885-4311; Lund, Ole/0000-0003-1108-0491; Aarestrup, Frank/0000-0002-7116-2723	Center for Genomic Epidemiology at the Technical University of Denmark; Danish Council for Strategic Research	Center for Genomic Epidemiology at the Technical University of Denmark; Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF))	This study was supported by the Center for Genomic Epidemiology at the Technical University of Denmark, and funded by the Danish Council for Strategic Research (http://en.fi.dk/councils-commissions/the-danish-council-for-strategic-research). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd H, 2003, APPL ENVIRON MICROB, V69, P600, DOI 10.1128/AEM.69.1.600-606.2003; Abergel Chantal, 2003, Journal of Structural and Functional Genomics, V4, P141, DOI 10.1023/A:1026177202925; ALTSCHUL SF, 1997, NUCLEIC ACIDS RES, V25, pD412; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Ciccarelli FD, 2006, SCIENCE, V311, P1283, DOI 10.1126/science.1123061; Day WA, 2001, INFECT IMMUN, V69, P7471, DOI 10.1128/IAI.69.12.7471-7480.2001; Deeds EJ, 2005, GENOME RES, V15, P393, DOI 10.1101/gr.3033805; Doolittle WF, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9-116; Falkow S, 1997, ASM NEWS, V63, P359; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Frost LS, 2005, NAT REV MICROBIOL, V3, P722, DOI 10.1038/nrmicro1235; GARG A, 2008, BMC BIOINFORMATICS; Gogarten JP, 2005, NAT REV MICROBIOL, V3, P679, DOI 10.1038/nrmicro1204; Gogarten JP, 2002, MOL BIOL EVOL, V19, P2226, DOI 10.1093/oxfordjournals.molbev.a004046; Hacker J, 2000, ANNU REV MICROBIOL, V54, P641, DOI 10.1146/annurev.micro.54.1.641; Heusipp G, 2007, INT J MED MICROBIOL, V297, P1, DOI 10.1016/j.ijmm.2006.10.002; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; Lan RT, 2002, MICROBES INFECT, V4, P1125, DOI 10.1016/S1286-4579(02)01637-4; Lerat E, 2003, PLOS BIOL, V1, P101, DOI 10.1371/journal.pbio.0000019; Lin J, 2000, GENOME RES, V10, P808, DOI 10.1101/gr.10.6.808; Manning SD, 2008, P NATL ACAD SCI USA, V105, P4868, DOI 10.1073/pnas.0710834105; Maurelli AT, 2007, FEMS MICROBIOL LETT, V267, P1, DOI 10.1111/j.1574-6968.2006.00526.x; Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X; Nanni L, 2009, EXPERT SYST APPL, V36, P7458, DOI 10.1016/j.eswa.2008.09.036; PAINE K, 2002, J MOL MICROBIOL BIOT, V4; Perna NT, 2001, NATURE, V409, P529, DOI 10.1038/35054089; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Sayers EW, 2010, NUCLEIC ACIDS RES, V38, pD5, DOI 10.1093/nar/gkp967; Severi E, 2007, MICROBIOL-SGM, V153, P2817, DOI 10.1099/mic.0.2007/009480-0; Subramanya HS, 1996, BIOCHEMISTRY-US, V35, P792, DOI 10.1021/bi951732k; Suen G, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000743; Sui SJH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008094; Tekaia F, 2005, PLOS COMPUT BIOL, V1, P604, DOI 10.1371/journal.pcbi.0010075; Thomson NR, 2008, GENOME RES, V18, P1624, DOI 10.1101/gr.077404.108; Titball RW, 2003, TRENDS MICROBIOL, V11, P118, DOI 10.1016/S0966-842X(03)00020-9; Turner SM, 2005, BIOCHEM J, V388, P545, DOI 10.1042/BJ20041766; Ueda K, 1999, J BACTERIOL, V181, P78, DOI 10.1128/JB.181.1.78-82.1999; Wang HZ, 2006, APPL ENVIRON MICROB, V72, P4455, DOI 10.1128/AEM.02095-05; Wassenaar TM, 2001, FEMS MICROBIOL LETT, V201, P1; Wertz JE, 2003, J EVOLUTION BIOL, V16, P1236, DOI 10.1046/j.1420-9101.2003.00612.x; WOESE CR, 1990, P NATL ACAD SCI USA, V87, P4576, DOI 10.1073/pnas.87.12.4576; Wu HW, 2010, GENOMICS, V96, P27, DOI 10.1016/j.ygeno.2010.03.007; Yap WH, 1999, J BACTERIOL, V181, P5201, DOI 10.1128/JB.181.17.5201-5209.1999; Yue M, 2009, J BACTERIOL, V191, P1359, DOI 10.1128/JB.01682-08	46	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2010	5	10							e13680	10.1371/journal.pone.0013680	http://dx.doi.org/10.1371/journal.pone.0013680			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671UN	21048922	Green Submitted, Green Published, gold			2022-12-27	WOS:000283537000046
J	Chang, AS; Bennett, SM; Noor, MAF				Chang, Audrey S.; Bennett, Sarah M.; Noor, Mohamed A. F.			Epistasis among Drosophila persimilis Factors Conferring Hybrid Male Sterility with D-pseudoobscura bogotana	PLOS ONE			English	Article							REPRODUCTIVE ISOLATION; GENETIC DISSECTION; SEGREGATION DISTORTION; COMPLEX EPISTASIS; NATURAL-SELECTION; SPECIATION GENE; MAURITIANA; SIMULANS; INCOMPATIBILITIES; LOCI	The Bateson-Dobzhansky-Muller model posits that hybrid incompatibilities result from genetic changes that accumulate during population divergence. Indeed, much effort in recent years has been devoted to identifying genes associated with hybrid incompatibilities, often with limited success, suggesting that hybrid sterility and inviability are frequently caused by complex interactions between multiple loci and not by single or a small number of gene pairs. Our previous study showed that the nature of epistasis between sterility-conferring QTL in the Drosophila persimilis-D. pseudoobscura bogotana species pair is highly specific. Here, we further dissect one of the three QTL underlying hybrid male sterility between these species and provide evidence for multiple factors within this QTL. This result indicates that the number of loci thought to contribute to hybrid dysfunction may have been underestimated, and we discuss how linkage and complex epistasis may be characteristic of the genetics of hybrid incompatibilities. We further pinpoint the location of one locus that confers hybrid male sterility when homozygous, dubbed "mule-like", to roughly 250 kilobases.	[Chang, Audrey S.; Bennett, Sarah M.; Noor, Mohamed A. F.] Duke Univ, Dept Biol, Durham, NC 27706 USA; [Chang, Audrey S.] NYU, Dept Biol, New York, NY 10003 USA	Duke University; New York University	Chang, AS (corresponding author), Duke Univ, Dept Biol, Durham, NC 27706 USA.	noor@duke.edu		Noor, Mohamed/0000-0002-5400-4408	National Science Foundation [0715484]; National Institutes of Health [GM076051, GM086445]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086445, R01GM076051] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding was provided by National Science Foundation award 0715484 and National Institutes of Health awards GM076051 and GM086445. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bateson W., 1909, DARWIN MODERN SCI; CABOT EL, 1994, GENETICS, V137, P175; Chang AS, 2007, GENETICS, V176, P343, DOI 10.1534/genetics.106.067314; Chang AS, 2010, EVOLUTION, V64, P253, DOI 10.1111/j.1558-5646.2009.00823.x; COYNE JA, 1984, P NATL ACAD SCI-BIOL, V81, P4444, DOI 10.1073/pnas.81.14.4444; Davis AW, 1996, GENETICS, V143, P1287; Dobzhansky T, 1936, GENETICS, V21, P113; Gadau J, 1999, GENETICS, V153, P1731; Kao KC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001038; Kyoichi S, 2004, GENETICS, V166, P789, DOI 10.1534/genetics.166.2.789; Lee HY, 2008, CELL, V135, P1065, DOI 10.1016/j.cell.2008.10.047; Leman SC, 2005, GENETICS, V171, P1419, DOI 10.1534/genetics.104.040402; Long YM, 2008, P NATL ACAD SCI USA, V105, P18871, DOI 10.1073/pnas.0810108105; Masly JP, 2006, SCIENCE, V313, P1448, DOI 10.1126/science.1128721; Mihola O, 2009, SCIENCE, V323, P373, DOI 10.1126/science.1163601; Muller HJ, 1942, BIOL S, V6, P71; NOOR MA, 1995, NATURE, V375, P674, DOI 10.1038/375674a0; Orr HA, 2001, GENETICS, V158, P1089; PALOPOLI MF, 1994, GENETICS, V138, P329; PEREZ DE, 1995, GENETICS, V140, P201; Phadnis N, 2009, SCIENCE, V323, P376, DOI 10.1126/science.1163934; Reed LK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003076; Richards S, 2005, GENOME RES, V15, P1, DOI 10.1101/gr.3059305; Sawamura K, 2000, P NATL ACAD SCI USA, V97, P2652, DOI 10.1073/pnas.050558597; Sun S, 2004, SCIENCE, V305, P81, DOI 10.1126/science.1093904; Tao Y, 2003, EVOLUTION, V57, P2580; Tao Y, 2003, GENETICS, V164, P1383; Tao Y, 2003, GENETICS, V164, P1399; Tao Y, 2001, P NATL ACAD SCI USA, V98, P13183, DOI 10.1073/pnas.231478798; Ting CT, 1998, SCIENCE, V282, P1501, DOI 10.1126/science.282.5393.1501; True JR, 1996, GENETICS, V142, P819; Wang RL, 1997, GENETICS, V147, P1091	32	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2010	5	10							e15377	10.1371/journal.pone.0015377	http://dx.doi.org/10.1371/journal.pone.0015377			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671UN	21060872	Green Published, Green Submitted, gold			2022-12-27	WOS:000283537000061
J	Nyirenda, TS; Seeley, AE; Mandala, WL; Drayson, MT; MacLennan, CA				Nyirenda, Tonney S.; Seeley, Anna E.; Mandala, Wilson L.; Drayson, Mark T.; MacLennan, Calman A.			Early Interferon-gamma Production in Human Lymphocyte Subsets in Response to Nontyphoidal Salmonella Demonstrates Inherent Capacity in Innate Cells	PLOS ONE			English	Article							ENTERICA SEROVAR TYPHIMURIUM; NATURAL-KILLER-CELLS; DELTA-T-CELLS; CHRONIC GRANULOMATOUS-DISEASE; NECROSIS-FACTOR-ALPHA; INHERITED INTERLEUKIN-12 DEFICIENCY; NON-TYPHOIDAL SALMONELLA; IFN-GAMMA; IMMUNE-RESPONSE; MURINE SALMONELLOSIS	Background: Nontyphoidal Salmonellae frequently cause life-threatening bacteremia in sub-Saharan Africa. Young children and HIV-infected adults are particularly susceptible. High case-fatality rates and increasing antibiotic resistance require new approaches to the management of this disease. Impaired cellular immunity caused by defects in the T helper 1 pathway lead to intracellular disease with Salmonella that can be countered by IFN gamma administration. This report identifies the lymphocyte subsets that produce IFN gamma early in Salmonella infection. Methodology: Intracellular cytokine staining was used to identify IFN gamma production in blood lymphocyte subsets of ten healthy adults with antibodies to Salmonella (as evidence of immunity to Salmonella), in response to stimulation with live and heat-killed preparations of the D23580 invasive African isolate of Salmonella Typhimurium. The absolute number of IFN gamma-producing cells in innate, innate-like and adaptive lymphocyte subpopulations was determined. Principal Findings: Early IFN gamma production was found in the innate/innate-like lymphocyte subsets: gamma delta-T cells, NK cells and NK-like T cells. Significantly higher percentages of such cells produced IFN gamma compared to adaptive alpha beta-T cells (Student's t test, P < 0.001 and <= 0.02 for each innate subset compared, respectively, with CD4(+)- and CD8(+)-T cells). The absolute numbers of IFN gamma-producing cells showed similar differences. The proportion of IFN gamma-producing gamma delta-T cells, but not other lymphocytes, was significantly higher when stimulated with live compared with heat-killed bacteria (P<0.0001). Conclusion/Significance: Our findings indicate an inherent capacity of innate/innate-like lymphocyte subsets to produce IFN gamma early in the response to Salmonella infection. This may serve to control intracellular infection and reduce the threat of extracellular spread of disease with bacteremia which becomes life-threatening in the absence of protective antibody. These innate cells may also help mitigate against the effect on IFN gamma production of depletion of Salmonella-specific CD4(+)-T lymphocytes in HIV infection.	[Nyirenda, Tonney S.; Seeley, Anna E.; Drayson, Mark T.; MacLennan, Calman A.] Univ Birmingham, Coll Med & Dent Sci, Sch Immun & Infect, Med Res Council Ctr Immune Regulat & Clin Immunol, Birmingham, W Midlands, England; [Nyirenda, Tonney S.; Seeley, Anna E.; Drayson, Mark T.; MacLennan, Calman A.] Univ Birmingham, Coll Med & Dent Sci, Sch Immun & Infect, Clin Immunol Serv, Birmingham, W Midlands, England; [Nyirenda, Tonney S.; Mandala, Wilson L.] Univ Malawi, Malawi Liverpool Wellcome Trust Clin Res Programm, Coll Med, Blantyre, Malawi; [Mandala, Wilson L.] Univ Malawi, Coll Med, Dept Biochem, Blantyre, Malawi; [MacLennan, Calman A.] Univ Liverpool, Sch Infect & Host Def, Div Med Microbiol, Liverpool L69 3BX, Merseyside, England	University of Birmingham; University of Birmingham; University of Malawi; University of Malawi; University of Liverpool	Nyirenda, TS (corresponding author), Univ Birmingham, Coll Med & Dent Sci, Sch Immun & Infect, Med Res Council Ctr Immune Regulat & Clin Immunol, Birmingham, W Midlands, England.	c.maclennan@bham.ac.uk	MacLennan, Calman A/L-9343-2014	MacLennan, Calman A/0000-0001-9694-0846; Seeley, Anna Elizabeth/0000-0001-5354-5889; Mandala, Wilson/0000-0001-9386-9239; Drayson, Mark/0000-0002-1528-7564	Wellcome Trust [085836/Z/08/Z]; GlaxoSmithKline; GlaxoSmithKline through the University of Birmingham; Medical Research Council [G9818340B] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); GlaxoSmithKline(GlaxoSmithKline); GlaxoSmithKline through the University of Birmingham; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by a Master's Training Fellowship in Public Health and Tropical Medicine from the Wellcome Trust (Grant Number 085836/Z/08/Z) to TS Nyirenda and a Clinical Research Fellowship from GlaxoSmithKline to CA MacLennan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; CA MacLennan is a recipient of a Clinical Research Fellowship from GlaxoSmithKline, awarded through the University of Birmingham. This award is part of the charitable giving of GlaxoSmithKline and involves no employment, consultancy, patents, products in development or marketed products with GlaxoSmithKline. The award does not alter the adherence of CA MacLennan to all the PLoS ONE policies on sharing data and materials.	al-Ramadi BK, 2001, INFECT IMMUN, V69, P3980, DOI 10.1128/IAI.69.6.3980-3988.2001; Altare F, 1998, J CLIN INVEST, V102, P2035, DOI 10.1172/JCI4950; Bailer RT, 1999, J IMMUNOL, V162, P7534; Brent AJ, 2006, PEDIATR INFECT DIS J, V25, P230, DOI 10.1097/01.inf.0000202066.02212.ff; Bustarnante J, 2008, CURR OPIN IMMUNOL, V20, P39, DOI 10.1016/j.coi.2007.10.005; CLERICI M, 1993, IMMUNOL TODAY, V14, P107, DOI 10.1016/0167-5699(93)90208-3; Cunningham AF, 2007, J IMMUNOL, V178, P6200, DOI 10.4049/jimmunol.178.10.6200; de Jong R, 1998, SCIENCE, V280, P1435; Eckmann L, 1996, J IMMUNOL, V156, P2894; EMOTO M, 1992, J EXP MED, V176, P363, DOI 10.1084/jem.176.2.363; EZEKOWITZ RAB, 1988, NEW ENGL J MED, V319, P146, DOI 10.1056/NEJM198807213190305; Fan J, 1997, ARCH VIROL, V142, P1035, DOI 10.1007/s007050050139; FIELDS PI, 1986, P NATL ACAD SCI USA, V83, P5189, DOI 10.1073/pnas.83.14.5189; Foster N, 2003, INFECT IMMUN, V71, P4733, DOI 10.1128/IAI.71.8.4733-4741.2003; GILKS CF, 1990, LANCET, V336, P545, DOI 10.1016/0140-6736(90)92096-Z; GONDWE EN, 2010, P NATL ACAD IN PRESS; Gordon MA, 2005, INFECT IMMUN, V73, P3445, DOI 10.1128/IAI.73.6.3445-3452.2005; Gordon MA, 2002, AIDS, V16, P1633, DOI 10.1097/00002030-200208160-00009; Gordon MA, 2008, CLIN INFECT DIS, V46, P963, DOI 10.1086/529146; Graham SM, 2000, PEDIATR INFECT DIS J, V19, P1189, DOI 10.1097/00006454-200012000-00016; Gulig PA, 1997, INFECT IMMUN, V65, P5191, DOI 10.1128/IAI.65.12.5191-5197.1997; HARA T, 1992, J CLIN INVEST, V90, P204, DOI 10.1172/JCI115837; Harrington L, 2007, FEMS IMMUNOL MED MIC, V51, P372, DOI 10.1111/j.1574-695X.2007.00313.x; Harrison JA, 1997, IMMUNOLOGY, V90, P618, DOI 10.1046/j.1365-2567.1997.00158.x; Hess J, 1996, J IMMUNOL, V156, P3321; Hirose K, 1999, J LEUKOCYTE BIOL, V66, P382, DOI 10.1002/jlb.66.3.382; HORMAECHE CE, 1990, IMMUNOLOGY, V70, P247; Imami N, 1999, AIDS RES HUM RETROV, V15, P1499, DOI 10.1089/088922299309784; Janssen R, 2002, J IMMUNOL, V169, P3900, DOI 10.4049/jimmunol.169.7.3900; Jason J, 2000, J INFECT DIS, V182, P474, DOI 10.1086/315740; John B, 2002, J IMMUNOL, V169, P2545, DOI 10.4049/jimmunol.169.5.2545; Jouanguy E, 1999, CURR OPIN IMMUNOL, V11, P346, DOI 10.1016/S0952-7915(99)80055-7; KAGAYA K, 1989, INFECT IMMUN, V57, P609, DOI 10.1128/IAI.57.2.609-615.1989; Kariuki S, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-101; Kedzierska Katherine, 2001, Antiviral Chemistry and Chemotherapy, V12, P133; Kelleher AD, 1999, CLIN EXP IMMUNOL, V115, P147; Kingsley RA, 2009, GENOME RES, V19, P2279, DOI 10.1101/gr.091017.109; Lapaque N, 2009, J IMMUNOL, V182, P4339, DOI 10.4049/jimmunol.0803329; LAZARUS GM, 1975, J PEDIATR-US, V86, P415, DOI 10.1016/S0022-3476(75)80975-9; MacLennan C, 2004, J INFECT DIS, V190, P1755, DOI 10.1086/425021; MacLennan CA, 2008, J CLIN INVEST, V118, P1553, DOI 10.1172/JCI33998; MacLennan CA, 2010, SCIENCE, V328, P508, DOI 10.1126/science.1180346; Mandala WL, 2010, J ALLERGY CLIN IMMUN, V125, P203, DOI 10.1016/j.jaci.2009.10.010; MASTROENI P, 1992, MICROB PATHOGENESIS, V13, P477, DOI 10.1016/0882-4010(92)90014-F; Mastroeni P, 1998, INFECT IMMUN, V66, P4767, DOI 10.1128/IAI.66.10.4767-4776.1998; Mastroeni P, 1999, INFECT IMMUN, V67, P478, DOI 10.1128/IAI.67.2.478-483.1999; MATSUI K, 1992, MICROBIOL IMMUNOL, V36, P269, DOI 10.1111/j.1348-0421.1992.tb01664.x; Mittrucker HW, 1999, J IMMUNOL, V163, P6769; Mittrucker HW, 2002, INFECT IMMUN, V70, P199, DOI 10.1128/IAI.70.1.199-203.2002; MIXTER PF, 1994, INFECT IMMUN, V62, P4618, DOI 10.1128/IAI.62.10.4618-4621.1994; Mizuno Y, 2003, CLIN EXP IMMUNOL, V131, P111, DOI 10.1046/j.1365-2249.2003.02060.x; Morpeth SC, 2009, CLIN INFECT DIS, V49, P606, DOI 10.1086/603553; MOUY R, 1989, J PEDIATR-US, V114, P555, DOI 10.1016/S0022-3476(89)80693-6; Mtove G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009244; MUOTIALA A, 1990, MICROB PATHOGENESIS, V8, P135, DOI 10.1016/0882-4010(90)90077-4; MUOTIALA A, 1993, INFECT IMMUN, V61, P4248, DOI 10.1128/IAI.61.10.4248-4253.1993; Musso T, 2001, J LEUKOCYTE BIOL, V69, P605; Nadjm B, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1350; NAUCIEL C, 1990, J IMMUNOL, V145, P1265; NAUCIEL C, 1992, INFECT IMMUN, V60, P450, DOI 10.1128/IAI.60.2.450-454.1992; Nishimura H, 1996, J IMMUNOL, V156, P663; OBRIEN AD, 1982, J IMMUNOL, V129, P1349; Pashine A, 1999, INT IMMUNOL, V11, P481, DOI 10.1093/intimm/11.4.481; Picard C, 2002, AM J HUM GENET, V70, P336, DOI 10.1086/338625; Pie S, 1997, INFECT IMMUN, V65, P4509, DOI 10.1128/IAI.65.11.4509-4514.1997; RAMARATHINAM L, 1991, MICROB PATHOGENESIS, V11, P347, DOI 10.1016/0882-4010(91)90020-B; RAMARATHINAM L, 1993, J IMMUNOL, V150, P3973; SCHAFER R, 1992, INFECT IMMUN, V60, P791, DOI 10.1128/IAI.60.3.791-797.1992; Sigauque B, 2009, PEDIATR INFECT DIS J, V28, P108, DOI 10.1097/INF.0b013e318187a87d; Sinha K, 1997, INFECT IMMUN, V65, P1566, DOI 10.1128/IAI.65.4.1566-1569.1997; SKEEN MJ, 1993, J EXP MED, V178, P971, DOI 10.1084/jem.178.3.971; Srinivasan A, 2004, J IMMUNOL, V172, P6884, DOI 10.4049/jimmunol.172.11.6884; THATTE J, 1993, INT IMMUNOL, V5, P1431, DOI 10.1093/intimm/5.11.1431; Ugrinovic S, 2003, INFECT IMMUN, V71, P6808, DOI 10.1128/IAI.71.12.6808-6819.2003; van de Vosse E, 2009, LANCET INFECT DIS, V9, P688, DOI 10.1016/S1473-3099(09)70255-5; Vazquez-Torres A, 2000, J EXP MED, V192, P227, DOI 10.1084/jem.192.2.227; Weintraub BC, 1997, INFECT IMMUN, V65, P2306, DOI 10.1128/IAI.65.6.2306-2312.1997	77	21	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2010	5	10							e13667	10.1371/journal.pone.0013667	http://dx.doi.org/10.1371/journal.pone.0013667			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671UN	21048923	gold, Green Submitted, Green Published			2022-12-27	WOS:000283537000036
J	Pinnock, SB; Blake, AM; Platt, NJ; Herbert, J				Pinnock, Scarlett B.; Blake, Alastair M.; Platt, Nicola J.; Herbert, Joe			The Roles of BDNF, pCREB and Wnt3a in the Latent Period Preceding Activation of Progenitor Cell Mitosis in The Adult Dentate Gyrus by Fluoxetine	PLOS ONE			English	Article							HIPPOCAMPAL NEUROGENESIS; NEUROTROPHIC FACTOR; ANTIDEPRESSANT DRUGS; TREATMENT INCREASES; BALB/CJ MICE; RAT-BRAIN; DEPRESSION; CORTICOSTERONE; SURVIVAL; PROLIFERATION	The formation of new neurons continues into adult life in the dentate gyrus of the rat hippocampus, as in many other species. Neurogenesis itself turns out to be highly labile, and is regulated by a number of factors. One of these is the serotoninergic system: treatment with drugs (such as the SSRI fluoxetine) markedly stimulates mitosis in the progenitor cells of the dentate gyrus. But this process has one remarkable feature: it takes at least 14 days of continuous treatment to be effective. This is despite the fact that the pharmacological action of fluoxetine occurs within an hour or so of first administration. This paper explores the role of BDNF in this process, using the effect of a Trk antagonist (K252a) on the labelling of progenitor cells with the mitosis marker Ki67 and the associated expression of pCREB and Wnt3a. These experiments show that (i) Fluoxetine increased Ki67 counts, as well as pCREB and Wnt3a expression in the dentate gyrus. The action of fluoxetine on the progenitor cells and on pCREB (but not Wnt3a) depends upon Trk receptor activation, since it was prevented by icv infusion of K252a. (ii) These receptors are required for both the first 7 days of fluoxetine action, during which no apparent change in progenitor mitosis occurs, as well as the second 7 days. Increased pCREB was always associated with progenitor cell mitosis, but Wnt3a expression may be necessary but not sufficient for increased progenitor cell proliferation. These results shed new light on the action of fluoxetine on neurogenesis in the adult dentate gyrus, and have both clinical and experimental interest.	[Pinnock, Scarlett B.] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge, England; Univ Cambridge, Cambridge Ctr Brain Repair, Dept Clin Neurosci, Cambridge, England	University of Cambridge; University of Cambridge	Pinnock, SB (corresponding author), Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge, England.	jh24@cam.ac.uk	Herbert, Joe/K-5877-2013		Wellcome Trust [RG 45642]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Wellcome Trust, grant number RG 45642. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. wellcome.ac.uk	Al-Majed AA, 2000, EUR J NEUROSCI, V12, P4381, DOI 10.1046/j.1460-9568.2000.01341.x; Balu DT, 2009, NEUROPSYCHOPHARMACOL, V34, P1764, DOI 10.1038/npp.2008.234; Benmansour S, 2008, EUR J PHARMACOL, V587, P90, DOI 10.1016/j.ejphar.2008.03.048; Boldrini M, 2009, NEUROPSYCHOPHARMACOL, V34, P2376, DOI 10.1038/npp.2009.75; Bradley J, 1999, BRAIN RES, V815, P140, DOI 10.1016/S0006-8993(98)01112-3; Clelland CD, 2009, SCIENCE, V325, P210, DOI 10.1126/science.1173215; Cuppini R, 2006, HIPPOCAMPUS, V16, P141, DOI 10.1002/hipo.20140; Davidson KC, 2007, MOL CELL NEUROSCI, V36, P408, DOI 10.1016/j.mcn.2007.07.013; De Foubert G, 2004, NEUROSCIENCE, V128, P597, DOI 10.1016/j.neuroscience.2004.06.054; Deltheil T, 2008, NEUROPHARMACOLOGY, V55, P1006, DOI 10.1016/j.neuropharm.2008.08.001; Favaro R, 2009, NAT NEUROSCI, V12, P1248, DOI 10.1038/nn.2397; Gass P, 2007, BIOESSAYS, V29, P957, DOI 10.1002/bies.20658; Holick KA, 2008, NEUROPSYCHOPHARMACOL, V33, P406, DOI 10.1038/sj.npp.1301399; Huang GJ, 2008, MOL PSYCHIATR, V13, P119, DOI 10.1038/sj.mp.4002104; Huang GJ, 2006, BIOL PSYCHIAT, V59, P619, DOI 10.1016/j.biopsych.2005.09.016; Huang GJ, 2005, NEUROSCIENCE, V135, P803, DOI 10.1016/j.neuroscience.2005.05.056; Inestrosa NC, 2010, NAT REV NEUROSCI, V11, P77, DOI 10.1038/nrn2755; Jacobs BL, 2000, MOL PSYCHIATR, V5, P262, DOI 10.1038/sj.mp.4000712; Jagasia R, 2009, J NEUROSCI, V29, P7966, DOI 10.1523/JNEUROSCI.1054-09.2009; Jessberger S, 2009, TRENDS PHARMACOL SCI, V30, P61, DOI 10.1016/j.tips.2008.11.003; Lazarovici P, 1996, ADV EXP MED BIOL, V391, P367; Li GN, 2005, DEV NEUROSCI-BASEL, V27, P93, DOI 10.1159/000085980; Liang FQ, 2000, J NEUROSCI, V20, P2978; Lie DC, 2005, NATURE, V437, P1370, DOI 10.1038/nature04108; Malberg JE, 2005, CURR PHARM DESIGN, V11, P145, DOI 10.2174/1381612053382223; Malberg JE, 2000, J NEUROSCI, V20, P9104, DOI 10.1523/jneurosci.20-24-09104.2000; Maya-Vetencourt JF, 2008, SCIENCE, V320, P385, DOI 10.1126/science.1150516; Monteggia LM, 2004, P NATL ACAD SCI USA, V101, P10827, DOI 10.1073/pnas.0402141101; Muller MB, 2001, EUR J NEUROSCI, V14, P1603, DOI 10.1046/j.0953-816x.2001.01784.x; Nestler EJ, 2002, NEURON, V34, P13, DOI 10.1016/S0896-6273(02)00653-0; NIBUYA M, 1995, J NEUROSCI, V15, P7539; Paxinos G, 1998, RAT BRAIN STEROTAXIC; Pinnock SB, 2008, EUR J NEUROSCI, V27, P2493, DOI 10.1111/j.1460-9568.2008.06250.x; Pinnock SB, 2007, NEUROPSYCHOPHARMACOL, V32, P493, DOI 10.1038/sj.npp.1301245; ROSS AH, 1995, J NEUROCHEM, V65, P2748; Russo-Neustadt AA, 2005, CURR PHARM DESIGN, V11, P1495, DOI 10.2174/1381612053764788; Saarelainen T, 2003, J NEUROSCI, V23, P349; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Shors TJ, 2001, NATURE, V410, P372, DOI 10.1038/35066584; Solberg N, 2008, DEV DYNAM, V237, P1799, DOI 10.1002/dvdy.21586; Tashiro A, 2007, J NEUROSCI, V27, P3252, DOI 10.1523/JNEUROSCI.4941-06.2007; Tsankova NM, 2006, NAT NEUROSCI, V9, P519, DOI 10.1038/nn1659; Varea E, 2007, NEUROPSYCHOPHARMACOL, V32, P803, DOI 10.1038/sj.npp.1301183; Wong EYH, 2006, NEUROSCIENCE, V137, P83, DOI 10.1016/j.neuroscience.2005.08.073; Wong EYH, 2005, EUR J NEUROSCI, V22, P785, DOI 10.1111/j.1460-9568.2005.04277.x; Wong EYH, 2004, EUR J NEUROSCI, V20, P2491, DOI 10.1111/j.1460-9568.2004.03717.x; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033	47	62	66	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2010	5	10							e13652	10.1371/journal.pone.0013652	http://dx.doi.org/10.1371/journal.pone.0013652			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671UN	21048974	Green Published, Green Submitted, gold			2022-12-27	WOS:000283537000023
J	Danalache, BA; Gutkowska, J; Slusarz, MJ; Berezowska, I; Jankowski, M				Danalache, Bogdan A.; Gutkowska, Jolanta; Slusarz, Magdalena J.; Berezowska, Irena; Jankowski, Marek			Oxytocin-Gly-Lys-Arg: A Novel Cardiomyogenic Peptide	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; ATRIAL-NATRIURETIC-PEPTIDE; NITRIC-OXIDE SYNTHASE; CARDIAC DIFFERENTIATION; ENDOTHELIAL-CELLS; RAT-HEART; IN-VITRO; VASOPRESSIN; RECEPTORS; CARDIOMYOCYTES	Background: Oxytocin (OT), synthesized in the heart, has the ability to heal injured hearts and to promote cardiomyogenesis from stem cells. Recently, we reported that the OT-GKR molecule, a processing intermediate of OT, potently increased the spontaneous formation of cardiomyocytes (CM) in embryonic stem D3 cells and augmented glucose uptake in newborn rat CM above the level stimulated by OT. In the present experiments, we investigated whether OT-GKR exists in fetal and newborn rodent hearts, interacts with the OT receptors (OTR) and primes the generation of contracting cells expressing CM markers in P19 cells, a model for the study of early heart differentiation. Methodology/Principal Findings: High performance liquid chromatography of newborn rat heart extracts indicated that OT-GKR was a dominant form of OT. Immunocytochemistry of mouse embryos (embryonic day 15) showed cardiac OT-GKR accumulation and OTR expression. Computerized molecular modeling revealed OT-GKR docking to active OTR sites and to V1a receptor of vasopressin. In embryonic P19 cells, OT-GKR induced contracting cell colonies and ventricular CM markers more potently than OT, an effect being suppressed by OT antagonists and OTR-specific small interfering (si) RNA. The V1a receptor antagonist and specific si-RNA also significantly reduced OT-GKR-stimulated P19 contracting cells. In comparison to OT, OT-GKR induced in P19 cells less a-actinin, myogenin and MyoD mRNA, skeletal muscle markers. Conclusions/Significance: These results raise the possibility that C-terminally extended OT molecules stimulate CM differentiation and contribute to heart growth during fetal life.	[Danalache, Bogdan A.; Gutkowska, Jolanta; Jankowski, Marek] Univ Montreal CRCHUM Hotel Dieu, Ctr Hosp, Res Ctr, Montreal, PQ, Canada; [Gutkowska, Jolanta; Jankowski, Marek] Univ Montreal, Dept Med, Montreal, PQ H3C 3J7, Canada; [Slusarz, Magdalena J.] Univ Gdansk, Fac Chem, PL-80952 Gdansk, Poland; [Berezowska, Irena] Clin Res Inst Montreal, Lab Chem Biol & Peptide Res, Montreal, PQ H2W 1R7, Canada	Universite de Montreal; Fahrenheit Universities; University of Gdansk; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal	Danalache, BA (corresponding author), Univ Montreal CRCHUM Hotel Dieu, Ctr Hosp, Res Ctr, Montreal, PQ, Canada.	marek.jankowski@umontreal.ca	Jankowski, Marek/AAF-7643-2019; Danalache, Bogdan Alexandru 1/B-3958-2010	Jankowski, Marek/0000-0002-1245-0733; Slusarz, Magdalena J./0000-0002-9411-4679	Canadian Institutes of Health Research [MOP-97992, MOP-62901]; Canadian Heart and Stroke Foundation	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Heart and Stroke Foundation(Heart & Stroke Foundation of Canada)	This research was supported by the Canadian Institutes of Health Research (MOP-97992, MOP-62901 to JG and MJ) and the Canadian Heart and Stroke Foundation (to JG and MJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelalim EM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005341; ALTSTEIN M, 1988, PEPTIDES, V9, P87, DOI 10.1016/0196-9781(88)90014-9; ALTSTEIN M, 1988, J NEUROSCI, V8, P3967; Barberis C, 1998, J ENDOCRINOL, V156, P223, DOI 10.1677/joe.0.1560223; Bloch W, 1999, CARDIOVASC RES, V43, P675, DOI 10.1016/S0008-6363(99)00160-1; BROWNSTEIN MJ, 1980, SCIENCE, V207, P373, DOI 10.1126/science.6153132; Burbach JPH, 2001, PHYSIOL REV, V81, P1197, DOI 10.1152/physrev.2001.81.3.1197; Cattaneo MG, 2008, BRIT J PHARMACOL, V153, P728, DOI 10.1038/sj.bjp.0707609; Danalache BA, 2007, STEM CELLS, V25, P679, DOI 10.1634/stemcells.2005-0610; Dudzinski DM, 2006, ANNU REV PHARMACOL, V46, P235, DOI 10.1146/annurev.pharmtox.44.101802.121844; Elabd C, 2008, STEM CELLS, V26, P2399, DOI 10.1634/stemcells.2008-0127; Fanelli F, 1999, MOL PHARMACOL, V56, P214, DOI 10.1124/mol.56.1.214; Fathi F, 2009, INT J CARDIOL, V134, P75, DOI 10.1016/j.ijcard.2008.01.046; Favaretto AIV, 1997, PEPTIDES, V18, P1377, DOI 10.1016/S0196-9781(97)00209-X; Florian M, 2010, ENDOCRINOLOGY, V151, P482, DOI 10.1210/en.2009-0624; Gassanov N, 2008, STEM CELLS, V26, P45, DOI 10.1634/stemcells.2007-0289; Gassanov N, 2007, J BIOL CHEM, V282, P11255, DOI 10.1074/jbc.M610769200; Gimpl G, 2008, PROG BRAIN RES, V170, P193, DOI 10.1016/S0079-6123(08)00417-2; Gutkowska J, 1997, P NATL ACAD SCI USA, V94, P11704, DOI 10.1073/pnas.94.21.11704; Hatami L, 2007, INT J CARDIOL, V117, P80, DOI 10.1016/j.ijcard.2006.04.054; Holmes CL, 2003, CRIT CARE, V7, P427, DOI 10.1186/cc2337; Hopkins WE, 2004, CIRCULATION, V109, P2872, DOI 10.1161/01.CIR.0000129305.25115.80; Iseri SO, 2005, J SURG RES, V126, P73, DOI 10.1016/j.jss.2005.01.021; Jankowski M, 1998, P NATL ACAD SCI USA, V95, P14558, DOI 10.1073/pnas.95.24.14558; Jankowski M, 2004, P NATL ACAD SCI USA, V101, P13074, DOI 10.1073/pnas.0405324101; Jankowski M, 2010, BASIC RES CARDIOL, V105, P205, DOI 10.1007/s00395-009-0076-5; Kanno S, 2004, P NATL ACAD SCI USA, V101, P12277, DOI 10.1073/pnas.0401557101; Kobayashi H, 2009, J CARDIOVASC PHARM, V54, P510, DOI 10.1097/FJC.0b013e3181bfac02; Loichot C, 2001, N-S ARCH PHARMACOL, V363, P369, DOI 10.1007/s002100000372; Mitchell BF, 1998, BIOL REPROD, V59, P1321, DOI 10.1095/biolreprod59.6.1321; Moore JC, 2004, INT J DEV BIOL, V48, P47, DOI 10.1387/ijdb.15005574; Mora-Castilla S, 2010, CELL DEATH DIFFER, V17, P1025, DOI 10.1038/cdd.2009.204; MORRIS M, 1992, AM J PHYSIOL, V263, pR738, DOI 10.1152/ajpregu.1992.263.3.R738; Mujoo K, 2008, P NATL ACAD SCI USA, V105, P18924, DOI 10.1073/pnas.0810230105; Nakamura Y, 2000, EUR J PHARMACOL, V391, P39, DOI 10.1016/S0014-2999(99)00775-X; Ondrejcakova M, 2009, CAN J PHYSIOL PHARM, V87, P137, DOI 10.1139/Y08-108; Paquin J, 2002, P NATL ACAD SCI USA, V99, P9550, DOI 10.1073/pnas.152302499; Postina R, 1996, J BIOL CHEM, V271, P31593, DOI 10.1074/jbc.271.49.31593; SKERJANC IS, 1994, DEV BIOL, V163, P125, DOI 10.1006/dbio.1994.1128; Skerjanc IS, 1999, TRENDS CARDIOVAS MED, V9, P139, DOI 10.1016/S1050-1738(99)00017-1; Slusarz MJ, 2006, J PEPT SCI, V12, P171, DOI 10.1002/psc.713; Szeto A, 2008, AM J PHYSIOL-ENDOC M, V295, pE1495, DOI 10.1152/ajpendo.90718.2008; Tamma R, 2009, P NATL ACAD SCI USA, V106, P7149, DOI 10.1073/pnas.0901890106; Thibonnier M, 1999, ENDOCRINOLOGY, V140, P1301, DOI 10.1210/en.140.3.1301; Thomsen R, 2006, J MED CHEM, V49, P3315, DOI 10.1021/jm051197e; VIERO C, 2010, CNS NEUROSCI THER; Wobus AM, 2005, PHYSIOL REV, V85, P635, DOI 10.1152/physrev.00054.2003; Yamamoto K, 1997, HYPERTENSION, V30, P1112, DOI 10.1161/01.HYP.30.5.1112	48	19	21	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2010	5	10							e13643	10.1371/journal.pone.0013643	http://dx.doi.org/10.1371/journal.pone.0013643			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671GB	21048978	Green Submitted, gold, Green Published			2022-12-27	WOS:000283487400030
J	Isamah, N; Faison, W; Payne, ME; MacFall, J; Steffens, DC; Beyer, JL; Krishnan, KR; Taylor, WD				Isamah, Nneka; Faison, Warachal; Payne, Martha E.; MacFall, James; Steffens, David C.; Beyer, John L.; Krishnan, K. Ranga; Taylor, Warren D.			Variability in Frontotemporal Brain Structure: The Importance of Recruitment of African Americans in Neuroscience Research	PLOS ONE			English	Article							OLDER-ADULTS; VOLUME MEASUREMENT; ETHNIC-DIFFERENCES; EUROPEAN-AMERICAN; AMYGDALA ACTIVITY; SEX-DIFFERENCES; RACE; PARTICIPATION; POLYMORPHISM; DEPRESSION	Background: Variation in brain structure is both genetically and environmentally influenced. The question about potential differences in brain anatomy across populations of differing race and ethnicity remains a controversial issue. There are few studies specifically examining racial or ethnic differences and also few studies that test for race-related differences in context of other neuropsychiatric research, possibly due to the underrepresentation of ethnic minorities in clinical research. It is within this context that we conducted a secondary data analysis examining volumetric MRI data from healthy participants and compared the volumes of the amygdala, hippocampus, lateral ventricles, caudate nucleus, orbitofrontal cortex (OFC) and total cerebral volume between Caucasian and African-American participants. We discuss the importance of this finding in context of neuroimaging methodology, but also the need for improved recruitment of African Americans in clinical research and its broader implications for a better understanding of the neural basis of neuropsychiatric disorders. Methodology/Principal Findings: This was a case control study in the setting of an academic medical center outpatient service. Participants consisted of 44 Caucasians and 33 ethnic minorities. The following volumetric data were obtained: amygdala, hippocampus, lateral ventricles, caudate nucleus, orbitofrontal cortex (OFC) and total cerebrum. Each participant completed a 1.5 T magnetic resonance imaging (MRI). Our primary finding in analyses of brain subregions was that when compared to Caucasians, African Americans exhibited larger left OFC volumes (F (1,68) = 7.50, p = 0.008). Conclusions: The biological implications of our findings are unclear as we do not know what factors may be contributing to these observed differences. However, this study raises several questions that have important implications for the future of neuropsychiatric research.	[Isamah, Nneka; Payne, Martha E.; MacFall, James; Beyer, John L.; Taylor, Warren D.] Duke Univ, Med Ctr, Duke Neuropsychiat Imaging Res Lab, Durham, NC 27706 USA; [Isamah, Nneka] Duke Univ, Med Ctr, Sch Med, Durham, NC USA; [Payne, Martha E.; Steffens, David C.; Beyer, John L.; Krishnan, K. Ranga; Taylor, Warren D.] Duke Univ, Med Ctr, Dept Psychiat, Durham, NC 27710 USA; [MacFall, James] Duke Univ, Med Ctr, Dept Radiol, Durham, NC 27710 USA; [Faison, Warachal] Med Univ S Carolina, Alzheimers Res & Clin Programs, Dept Neurosci, Charleston, SC 29425 USA; [Krishnan, K. Ranga] Duke NUS Grad Med Sch, Singapore, Singapore	Duke University; Duke University; Duke University; Duke University; Medical University of South Carolina; National University of Singapore	Isamah, N (corresponding author), Duke Univ, Med Ctr, Duke Neuropsychiat Imaging Res Lab, Durham, NC 27706 USA.	Taylo066@mc.duke.edu	Taylor, Warren D/J-3687-2014		NIH [5R01MH057027-10, 5R01MH077745-03]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH057027, R01MH077745] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Work was supported by NIH grants 5R01MH057027-10 and 5R01MH077745-03. The funding source had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANGIER N, 2000, NY TIMES, pR1; Apostolova LG, 2006, BRAIN, V129, P2867, DOI 10.1093/brain/awl274; Arean PA, 1996, J CONSULT CLIN PSYCH, V64, P875, DOI 10.1037/0022-006X.64.5.875; BECKERDEA, 1992, NIH PUBL; Beyer JL, 2004, AM J GERIAT PSYCHIAT, V12, P613, DOI 10.1176/appi.ajgp.12.6.613; Beyer JL, 2004, INT J GERIATR PSYCH, V19, P109, DOI 10.1002/gps.1030; Burchard EG, 2003, NEW ENGL J MED, V348, P1170, DOI 10.1056/NEJMsb025007; Carmichael OT, 2007, NEUROBIOL AGING, V28, P1316, DOI 10.1016/j.neurobiolaging.2006.06.016; CARTER WB, 1991, GERONTOLOGIST, V31, P584, DOI 10.1093/geront/31.5.584; Coleman EA, 1997, AM J PREV MED, V13, P51, DOI 10.1016/S0749-3797(18)30094-1; Corbie-Smith G, 2004, AM J MED, V116, P249, DOI 10.1016/j.amjmed.2003.09.032; Cosgrove KP, 2007, BIOL PSYCHIAT, V62, P847, DOI 10.1016/j.biopsych.2007.03.001; Cunningham WA, 2004, PSYCHOL SCI, V15, P806, DOI 10.1111/j.0956-7976.2004.00760.x; Dannlowski U, 2007, GENES BRAIN BEHAV, V6, P672, DOI 10.1111/j.1601-183X.2006.00297.x; Doty TJ, 2008, PSYCHIAT RES-NEUROIM, V163, P84, DOI 10.1016/j.pscychresns.2007.08.003; Faison WE, 2007, INT PSYCHOGERIATR, V19, P539, DOI 10.1017/S104161020700511X; Gelernter J, 1997, HUM GENET, V101, P243, DOI 10.1007/s004390050624; Gelernter J, 1998, AM J PSYCHIAT, V155, P1332, DOI 10.1176/ajp.155.10.1332; Golby AJ, 2001, NAT NEUROSCI, V4, P845, DOI 10.1038/90565; Gore S, 2003, J HEALTH SOC BEHAV, V44, P370, DOI 10.2307/1519785; Greenberg DL, 2008, NEUROBIOL AGING, V29, P290, DOI 10.1016/j.neurobiolaging.2006.09.016; GUOZEA, 2000, J MENTAL HLTH AGING, V6, P91; Hackman DA, 2009, TRENDS COGN SCI, V13, P65, DOI 10.1016/j.tics.2008.11.003; Hariri AR, 2002, SCIENCE, V297, P400, DOI 10.1126/science.1071829; Hart AJ, 2000, NEUROREPORT, V11, P2351, DOI 10.1097/00001756-200008030-00004; Kim JS, 2006, NEUROSCI LETT, V397, P279, DOI 10.1016/j.neulet.2005.12.061; Knutson B, 2001, BIOL PSYCHIAT, V50, P685, DOI 10.1016/S0006-3223(01)01220-3; Kochunov P, 2003, NEUROREPORT, V14, P961, DOI 10.1097/01.wnr.0000075417.59944.00; Lai TJ, 2000, BIOL PSYCHIAT, V48, P971, DOI 10.1016/S0006-3223(00)01042-8; Leonard CM, 2008, CEREB CORTEX, V18, P2920, DOI 10.1093/cercor/bhn052; Lieberman MD, 2005, NAT NEUROSCI, V8, P720, DOI 10.1038/nn1465; Lovato LC, 1997, CONTROL CLIN TRIALS, V18, P328, DOI 10.1016/S0197-2456(96)00236-X; McNeilly M, 2000, RECRUITMENT AND RETENTION IN MINORITY POPULATIONS, P91; Moody L E, 1995, J Am Acad Nurse Pract, V7, P483, DOI 10.1111/j.1745-7599.1995.tb01116.x; MORSE EV, 1995, APPL NURS RES, V8, P8, DOI 10.1016/S0897-1897(95)80240-1; Mouton CP, 1997, J NATL MED ASSOC, V89, P721; Noble KG, 2007, DEVELOPMENTAL SCI, V10, P464, DOI 10.1111/j.1467-7687.2007.00600.x; Olin JT, 2002, ALZ DIS ASSOC DIS, V16, pS82, DOI 10.1097/00002093-200200002-00009; Paskett ED, 2008, CONTEMP CLIN TRIALS, V29, P847, DOI 10.1016/j.cct.2008.07.006; Payne ME, 2002, PSYCHIAT RES-NEUROIM, V115, P63, DOI 10.1016/S0925-4927(02)00009-4; Peper JS, 2007, HUM BRAIN MAPP, V28, P464, DOI 10.1002/hbm.20398; Petrella JR, 2008, RADIOLOGY, V246, P20, DOI 10.1148/radiol.2461061994; Pezawas L, 2005, NAT NEUROSCI, V8, P828, DOI 10.1038/nn1463; Plant EA, 2004, J CONSULT CLIN PSYCH, V72, P41, DOI 10.1037/0022-006X.72.1.41; Rimol LM, 2010, BIOL PSYCHIAT, V67, P493, DOI 10.1016/j.biopsych.2009.09.032; Risch N., 2002, GENOME BIOL, V3, pcomm, DOI [10.1186/gb-2002-3-7-comment2007, 10.1186/GB-2002-3-7-COMMENT2007]; Sen Bisakha, 2004, J Ment Health Policy Econ, V7, P133; Shen JJ, 2010, ETHNIC DIS, V20, P35; Sinclair S, 2000, RECRUITMENT AND RETENTION IN MINORITY POPULATIONS, P39; Smolka MN, 2007, MOL PSYCHIATR, V12, P307, DOI 10.1038/sj.mp.4001946; STOY DB, 1995, J NATL MED ASSOC, V87, P280; Sullivan EV, 2007, BRIT J RADIOL, V80, pS99, DOI 10.1259/bjr/22893432; Tang YC, 2010, NEUROIMAGE, V51, P33, DOI 10.1016/j.neuroimage.2010.01.111; Vadakkumpadan F, 2006, INT J NEUROSCI, V116, P407, DOI 10.1080/00207450500505662; Wendler D, 2006, PLOS MED, V3, P201, DOI 10.1371/journal.pmed.0030019; Wright CI, 2006, CEREB CORTEX, V16, P1809, DOI 10.1093/cercor/bhj118	56	32	31	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2010	5	10							e13642	10.1371/journal.pone.0013642	http://dx.doi.org/10.1371/journal.pone.0013642			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	671GB	21049028	Green Published, gold			2022-12-27	WOS:000283487400029
J	Zhou, Q; Snider, NT; Liao, JA; Li, DH; Hong, A; Ku, NO; Cartwright, CA; Omary, MB				Zhou, Qin; Snider, Natasha T.; Liao, Jian; Li, Daniel H.; Hong, Anita; Ku, Nam-On; Cartwright, Christine A.; Omary, M. Bishr			Characterization of In Vivo Keratin 19 Phosphorylation on Tyrosine-391	PLOS ONE			English	Article							SIMPLE EPITHELIAL KERATINS; INTERMEDIATE-FILAMENTS; DISEASE; PROTEIN; CELLS; ORGANIZATION; VIMENTIN; DYNAMICS; SEQUENCE; HEALTH	Background: Keratin polypeptide 19 (K19) is a type I intermediate filament protein that is expressed in stratified and simple-type epithelia. Although K19 is known to be phosphorylated on tyrosine residue(s), conclusive site-specific characterization of these residue(s) and identification potential kinases that may be involved has not been reported. Methodology/Principal Findings: In this study, biochemical, molecular and immunological approaches were undertaken in order to identify and characterize K19 tyrosine phosphorylation. Upon treatment with pervanadate, a tyrosine phosphatase inhibitor, human K19 (hK19) was phosphorylated on tyrosine 391, located in the 'tail' domain of the protein. K19 Y391 phosphorylation was confirmed using site-directed mutagenesis and cell transfection coupled with the generation of a K19 phospho (p)-Y391-specific rabbit antibody. The antibody also recognized mouse phospho-K19 (K19 pY394). This tyrosine residue is not phosphorylated under basal conditions, but becomes phosphorylated in the presence of Src kinase in vitro and in cells expressing constitutively-active Src. Pervanadate treatment in vivo resulted in phosphorylation of K19 Y394 and Y391 in colonic epithelial cells of non-transgenic mice and hK19-overexpressing mice, respectively. Conclusions/Significance: Human K19 tyrosine 391 is phosphorylated, potentially by Src kinase, and is the first well-defined tyrosine phosphorylation site of any keratin protein. The lack of detection of K19 pY391 in the absence of tyrosine phosphatase inhibition suggests that its phosphorylation is highly dynamic.	[Zhou, Qin; Cartwright, Christine A.] Stanford Univ, Sch Med, Dept Med, Palo Alto, CA 94304 USA; [Snider, Natasha T.; Omary, M. Bishr] Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, Ann Arbor, MI USA; [Liao, Jian] Appl Biom Inc, Hayward, CA USA; [Li, Daniel H.; Hong, Anita] Anaspec Inc, Fremont, CA USA; [Ku, Nam-On] Yonsei Univ, Dept Biomed Sci, Seoul 120749, South Korea	Stanford University; University of Michigan System; University of Michigan; Yonsei University	Zhou, Q (corresponding author), Stanford Univ, Sch Med, Dept Med, Palo Alto, CA 94304 USA.	mbishr@umich.edu		Omary, Bishr/0000-0002-8624-2347	National Institutes of Health [DK47918]; Department of Veterans Affairs; University of Michigan [UL1RR024986]; Korean Research WCU [R31-2008-000-10086-0 N-OK]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024986] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK047918] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); University of Michigan(University of Michigan System); Korean Research WCU; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health grant DK47918 and the Department of Veterans Affairs (MBO); a University of Michigan Postdoctoral Translational Scholars Program Award UL1RR024986 (NTS); and Korean Research WCU grant R31-2008-000-10086-0 N-OK). DHL and AH are paid employees of Anaspec, Inc., which produced and supplied the anti-phosphotyrosine antibody (K19 pY391) that was used in this study. All other funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelastro JM, 1998, J NEUROCHEM, V70, P540; BADER BL, 1986, EMBO J, V5, P1865, DOI 10.1002/j.1460-2075.1986.tb04438.x; Barberis L, 2009, EUR J IMMUNOL, V39, P1136, DOI 10.1002/eji.200838884; Boyer B, 2002, ONCOGENE, V21, P2347, DOI 10.1038/sj.onc.1205298; CARTWRIGHT CA, 1987, CELL, V49, P83, DOI 10.1016/0092-8674(87)90758-6; CHOU CF, 1992, J BIOL CHEM, V267, P3901; Coulombe PA, 2002, CURR OPIN CELL BIOL, V14, P110, DOI 10.1016/S0955-0674(01)00301-5; ECKERT RL, 1988, P NATL ACAD SCI USA, V85, P1114, DOI 10.1073/pnas.85.4.1114; Feng L, 1999, J CELL SCI, V112, P2081; Fuchs E, 1998, SCIENCE, V279, P514, DOI 10.1126/science.279.5350.514; FUCHS E, 1994, ANNU REV BIOCHEM, V63, P345, DOI 10.1146/annurev.biochem.63.1.345; Goldman RD, 2008, CURR OPIN CELL BIOL, V20, P28, DOI 10.1016/j.ceb.2007.11.003; Inagaki M, 1996, BIOESSAYS, V18, P481, DOI 10.1002/bies.950180610; Kim HT, 2009, INT J APPL CERAM TEC, V6, P587, DOI 10.1111/j.1744-7402.2009.02381.x; Ku NO, 2004, METHOD CELL BIOL, V78, P489; Ku NO, 2000, J CELL BIOL, V149, P547, DOI 10.1083/jcb.149.3.547; Ku NO, 1999, AM J PHYSIOL-GASTR L, V277, pG1108, DOI 10.1152/ajpgi.1999.277.6.G1108; Marceau N, 2007, EXP CELL RES, V313, P2265, DOI 10.1016/j.yexcr.2007.03.038; Omary M B, 1998, Subcell Biochem, V31, P105; Omary MB, 2006, TRENDS BIOCHEM SCI, V31, P383, DOI 10.1016/j.tibs.2006.05.008; Omary MB, 2009, J CLIN INVEST, V119, P1794, DOI 10.1172/JCI37762; Omary MB, 2009, J CLIN INVEST, V119, P1756, DOI 10.1172/JCI39894; Omary MB, 2004, NEW ENGL J MED, V351, P2087, DOI 10.1056/NEJMra040319; Omary MB, 2002, HEPATOLOGY, V35, P251, DOI 10.1053/jhep.2002.31165; Porter RM, 2003, TRENDS GENET, V19, P278, DOI 10.1016/S0168-9525(03)00071-4; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; Schweizer J, 2006, J CELL BIOL, V174, P169, DOI 10.1083/jcb.200603161; STEINERT PM, 1982, BIOCHEMISTRY-US, V21, P177, DOI 10.1021/bi00530a030; Strnad P, 2002, J CELL SCI, V115, P4133, DOI 10.1242/jcs.00096; Toivola DM, 2010, TRENDS CELL BIOL, V20, P79, DOI 10.1016/j.tcb.2009.11.004; Toivola DM, 2005, TRENDS CELL BIOL, V15, P608, DOI 10.1016/j.tcb.2005.09.004; Uitto J, 2007, EXP CELL RES, V313, P1995, DOI 10.1016/j.yexcr.2007.03.029; Valgeirsdottir S, 1998, J CELL SCI, V111, P1973; Vijayaraj Preethi, 2007, Methods Mol Biol, V360, P203; Zhou XJ, 1999, J BIOL CHEM, V274, P12861, DOI 10.1074/jbc.274.18.12861	35	13	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2010	5	10							e13538	10.1371/journal.pone.0013538	http://dx.doi.org/10.1371/journal.pone.0013538			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	670LB	21049038	Green Published, gold, Green Submitted			2022-12-27	WOS:000283422100006
J	Daniels, SI; Davis, DA; Soule, EE; Stahl, SJ; Tebbs, IR; Wingfield, P; Yarchoan, R				Daniels, Sarah I.; Davis, David A.; Soule, Erin E.; Stahl, Stephen J.; Tebbs, Irene R.; Wingfield, Paul; Yarchoan, Robert			The Initial Step in Human Immunodeficiency Virus Type 1 GagProPol Processing Can Be Regulated by Reversible Oxidation	PLOS ONE			English	Article							NF-KAPPA-B; HIV-1 PROTEASE; VIRAL INFECTIVITY; SEQUENTIAL STEPS; GAGPOL PRECURSOR; CLEAVAGE SITES; IN-VITRO; ACTIVATION; DIMERIZATION; INHIBITION	Background: Maturation of human immunodeficiency virus type 1 (HIV-1) occurs upon activation of HIV-1 protease embedded within GagProPol precursors and cleavage of Gag and GagProPol polyproteins. Although reversible oxidation can regulate mature protease activity as well as retrovirus maturation, it is possible that the effects of oxidation on viral maturation are mediated in whole, or part, through effects on the initial intramolecular cleavage event of GagProPol. In order assess the effect of reversible oxidation on this event, we developed a system to isolate the first step in protease activation involving GagProPol. Methodology/Principal Findings: To determine if oxidation influences this step, we created a GagProPol plasmid construct (pGPfs-1C) that encoded mutations at all cleavage sites except p2/NC, the initial cleavage site in GagProPol. pGPfs-1C was used in an in vitro translation assay to observe the behavior of this initial step without interference from subsequent processing events. Diamide, a sulfhydral oxidizing agent, inhibited processing at p2/NC by >60% for pGPfs-1C and was readily reversed with the reductant, dithiothreitol. The ability to regulate processing by reversible oxidation was lost when the cysteines of the embedded protease were mutated to alanine. Unlike mature protease, which requires only oxidation of cys95 for inhibition, both cysteines of the embedded protease contributed to this inhibition. Conclusions/Significance: We developed a system that can be used to study the first step in the cascade of HIV-1 GagProPol processing and show that reversible oxidation of cysteines of HIV-1 protease embedded in GagProPol can block this initial GagProPol autoprocessing. This type of regulation may be broadly applied to the majority of retroviruses.	[Daniels, Sarah I.; Davis, David A.; Soule, Erin E.; Tebbs, Irene R.; Yarchoan, Robert] NCI, HIV & AIDS Malignancy Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Stahl, Stephen J.; Wingfield, Paul] NIAMSD, Prot Express Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)	Daniels, SI (corresponding author), NCI, HIV & AIDS Malignancy Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	dadavis@helix.nih.gov		Wingfield, Paul/0000-0002-9515-4752	NATIONAL CANCER INSTITUTE [ZIASC006737] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AUKRUST P, 1995, BLOOD, V86, P258, DOI 10.1182/blood.V86.1.258.bloodjournal861258; BURSTEIN H, 1991, J VIROL, V65, P6165, DOI 10.1128/JVI.65.11.6165-6172.1991; Ciriolo MR, 1997, J BIOL CHEM, V272, P2700, DOI 10.1074/jbc.272.5.2700; Coffin J, 1997, RETROVIRUSES; DARKE PL, 1994, BIOCHEMISTRY-US, V33, P98, DOI 10.1021/bi00167a013; Davis DA, 1996, BIOCHEMISTRY-US, V35, P2482, DOI 10.1021/bi951525k; Davis DA, 2003, J VIROL, V77, P3319, DOI 10.1128/JVI.77.5.3319-3325.2003; Davis DA, 1999, J VIROL, V73, P1156, DOI 10.1128/JVI.73.2.1156-1164.1999; Davis DA, 2002, METHOD ENZYMOL, V348, P249, DOI 10.1016/S0076-6879(02)48643-0; Davis DA, 1997, J BIOL CHEM, V272, P25935, DOI 10.1074/jbc.272.41.25935; Davis DA, 2000, BIOCHEM J, V346, P305, DOI 10.1042/0264-6021:3460305; Davis DA, 2006, ANTIVIR RES, V72, P89, DOI 10.1016/j.antiviral.2006.03.015; Davis DA, 2009, BIOCHEM J, V419, P497, DOI 10.1042/BJ20082068; GOTTLINGER HG, 1989, P NATL ACAD SCI USA, V86, P5781, DOI 10.1073/pnas.86.15.5781; KARACOSTAS V, 1993, VIROLOGY, V193, P661, DOI 10.1006/viro.1993.1174; Koh Y, 2007, J BIOL CHEM, V282, P28709, DOI 10.1074/jbc.M703938200; KOSOWER EM, 1969, NATURE, V224, P117, DOI 10.1038/224117a0; KRAUSSLICH HG, 1991, P NATL ACAD SCI USA, V88, P3213, DOI 10.1073/pnas.88.8.3213; KUIKEN CL, 2004, HIV SEQUENCE COMPEND; Kurata SI, 1996, J BIOL CHEM, V271, P21798, DOI 10.1074/jbc.271.36.21798; Mascolini M, 2008, ANTIVIR THER, V13, P319; Parker SD, 2001, P NATL ACAD SCI USA, V98, P14631, DOI 10.1073/pnas.251460998; PENG C, 1989, J VIROL, V63, P2550, DOI 10.1128/JVI.63.6.2550-2556.1989; PETTIT SC, 1991, J BIOL CHEM, V266, P14539; PETTIT SC, 1994, J VIROL, V68, P8017, DOI 10.1128/JVI.68.12.8017-8027.1994; Pettit SC, 2005, J VIROL, V79, P10601, DOI 10.1128/JVI.79.16.10601-10607.2005; Pettit SC, 2004, J VIROL, V78, P8477, DOI 10.1128/JVI.78.16.8477-8485.2004; Pettit SC, 2003, J VIROL, V77, P366, DOI 10.1128/JVI.77.1.366-374.2003; RICHARDS AD, 1990, J BIOL CHEM, V265, P7733; SAPPEY C, 1995, AIDS RES HUM RETROV, V11, P1049, DOI 10.1089/aid.1995.11.1049; SCHARF SJ, 1986, SCIENCE, V233, P1076, DOI 10.1126/science.3461561; SCHUPPE I, 1992, BIOCHEM PHARMACOL, V44, P1757, DOI 10.1016/0006-2952(92)90069-U; Turpin JA, 1996, J VIROL, V70, P6180, DOI 10.1128/JVI.70.9.6180-6189.1996; WESTENDORP MO, 1995, EMBO J, V14, P546, DOI 10.1002/j.1460-2075.1995.tb07030.x; Wiegers K, 1998, J VIROL, V72, P2846, DOI 10.1128/JVI.72.4.2846-2854.1998	35	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2010	5	10							e13595	10.1371/journal.pone.0013595	http://dx.doi.org/10.1371/journal.pone.0013595			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	670KA	21042582	Green Published, Green Submitted, gold			2022-12-27	WOS:000283419100021
J	Walker, MF; Tian, J; Shan, XY; Tamargo, RJ; Ying, H; Zee, DS				Walker, Mark F.; Tian, Jing; Shan, Xiaoyan; Tamargo, Rafael J.; Ying, Howard; Zee, David S.			The Cerebellar Nodulus/Uvula Integrates Otolith Signals for the Translational Vestibulo-Ocular Reflex	PLOS ONE			English	Article							EYE-MOVEMENTS; SQUIRREL-MONKEY; OCULAR REFLEX; SPATIAL ORIENTATION; NEURAL INTEGRATOR; VIEWING DISTANCE; RHESUS-MONKEYS; HEAD MOTION; BRAIN-STEM; UVULA	Background: The otolith-driven translational vestibulo-ocular reflex (tVOR) generates compensatory eye movements to linear head accelerations. Studies in humans indicate that the cerebellum plays a critical role in the neural control of the tVOR, but little is known about mechanisms of this control or the functions of specific cerebellar structures. Here, we chose to investigate the contribution of the nodulus and uvula, which have been shown by prior studies to be involved in the processing of otolith signals in other contexts. Methodology/Principal Findings: We recorded eye movements in two rhesus monkeys during steps of linear motion along the interaural axis before and after surgical lesions of the cerebellar uvula and nodulus. The lesions strikingly reduced eye velocity during constant-velocity motion but had only a small effect on the response to initial head acceleration. We fit eye velocity to a linear combination of head acceleration and velocity and to a dynamic mathematical model of the tVOR that incorporated a specific integrator of head acceleration. Based on parameter optimization, the lesion decreased the gain of the pathway containing this new integrator by 62%. The component of eye velocity that depended directly on head acceleration changed little (gain decrease of 13%). In a final set of simulations, we compared our data to the predictions of previous models of the tVOR, none of which could account for our experimental findings. Conclusions/Significance: Our results provide new and important information regarding the neural control of the tVOR. Specifically, they point to a key role for the cerebellar nodulus and uvula in the mathematical integration of afferent linear head acceleration signals. This function is likely to be critical not only for the tVOR but also for the otolith-mediated reflexes that control posture and balance.	[Walker, Mark F.; Tian, Jing; Shan, Xiaoyan; Zee, David S.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Walker, Mark F.; Ying, Howard; Zee, David S.] Johns Hopkins Univ, Sch Med, Dept Ophthalmol, Baltimore, MD 21205 USA; [Tamargo, Rafael J.] Johns Hopkins Univ, Sch Med, Dept Neurosurg, Baltimore, MD 21205 USA; [Tamargo, Rafael J.; Zee, David S.] Johns Hopkins Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Baltimore, MD 21205 USA; [Zee, David S.] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; [Walker, Mark F.] Case Western Reserve Univ, Dept Neurol, Cleveland, OH 44106 USA; [Walker, Mark F.] Vet Affairs Med Ctr, Cleveland, OH USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Case Western Reserve University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center	Walker, MF (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA.	mark.walker@case.edu			National Institutes of Health [RO1-EY01849]; Arnold Chiari Foundation; Albert Pennington Fund; NATIONAL EYE INSTITUTE [R01EY001849] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Arnold Chiari Foundation; Albert Pennington Fund; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was supported by the National Institutes of Health (RO1-EY01849), by the Arnold Chiari Foundation, and by the Albert Pennington Fund. Dr. Walker was a Pollin Scholar. Dr. Tian was a Betty and Paul Cinquegrana Scholar. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of this manuscript.	ANGELAKI DE, 1995, J NEUROPHYSIOL, V73, P1729; Angelaki DE, 1999, J NEUROPHYSIOL, V82, P1651, DOI 10.1152/jn.1999.82.3.1651; Angelaki DE, 2004, J NEUROPHYSIOL, V92, P20, DOI 10.1152/jn.00047.2004; Angelaki DE, 2002, ARCH ITAL BIOL, V140, P315; Angelaki DE, 1998, J NEUROPHYSIOL, V80, P680, DOI 10.1152/jn.1998.80.2.680; Angelaki DE, 2001, J NEUROSCI, V21, P3968, DOI 10.1523/JNEUROSCI.21-11-03968.2001; ANGELAKI DE, 1994, J NEUROPHYSIOL, V72, P1443, DOI 10.1152/jn.1994.72.3.1443; BARMACK NH, 1993, J COMP NEUROL, V327, P521, DOI 10.1002/cne.903270405; Buttner-Ennever JA, 1999, ANN NY ACAD SCI, V871, P51, DOI 10.1111/j.1749-6632.1999.tb09175.x; CANNON SC, 1987, J NEUROPHYSIOL, V57, P1383, DOI 10.1152/jn.1987.57.5.1383; COHEN H, 1992, EXP BRAIN RES, V90, P526; Crane BT, 2003, EXP BRAIN RES, V148, P247, DOI 10.1007/s00221-002-1301-8; Crane BT, 2000, EXP BRAIN RES, V130, P486, DOI 10.1007/s002219900266; FUCHS AF, 1988, J NEUROPHYSIOL, V60, P1874, DOI 10.1152/jn.1988.60.6.1874; Gordon CR, 2003, J NEUROL NEUROSUR PS, V74, P1403, DOI 10.1136/jnnp.74.10.1403; Green AM, 1998, J NEUROPHYSIOL, V80, P2222, DOI 10.1152/jn.1998.80.4.2222; Green AM, 2003, J NEUROSCI, V23, P9265; GREEN AM, 2004, J NEUROPHYSIOL; Green AM, 2007, J NEUROSCI, V27, P1346, DOI 10.1523/JNEUROSCI.3822-06.2007; HAIN TC, 1988, ACTA OTO-LARYNGOL, V105, P13, DOI 10.3109/00016488809119440; Lewis RF, 2003, CEREBELLUM, V2, P123, DOI 10.1080/14734220309407; Liao K, 2008, ANN NEUROL, V64, P224, DOI 10.1002/ana.21407; LUEBKE AE, 1988, VISION RES, V28, P941, DOI 10.1016/0042-6989(88)90103-4; Maklad A, 2003, DEV BRAIN RES, V140, P223, DOI 10.1016/S0165-3806(02)00609-0; Migliaccio AA, 2004, BRAIN, V127, P280, DOI 10.1093/brain/awh030; Miles FA, 1999, ANN NY ACAD SCI, V871, P260, DOI 10.1111/j.1749-6632.1999.tb09190.x; Minor LB, 1999, J NEUROPHYSIOL, V82, P1254, DOI 10.1152/jn.1999.82.3.1254; Musallam S, 2002, J NEUROPHYSIOL, V88, P2104, DOI 10.1152/jn.2002.88.4.2104; Musallam WS, 1999, J NEUROPHYSIOL, V82, P2010, DOI 10.1152/jn.1999.82.4.2010; Newlands SD, 2003, J COMP NEUROL, V466, P31, DOI 10.1002/cne.10876; PAIGE GD, 1991, J NEUROPHYSIOL, V65, P1183, DOI 10.1152/jn.1991.65.5.1183; Ramat S, 2003, J NEUROPHYSIOL, V90, P887, DOI 10.1152/jn.01121.2002; RAPHAN T, 1979, EXP BRAIN RES, V35, P229; SCHWARZ U, 1991, J NEUROPHYSIOL, V66, P851, DOI 10.1152/jn.1991.66.3.851; Shan XY, 2007, INVEST OPHTH VIS SCI, V48, P2602, DOI 10.1167/iovs.06-1316; Sheliga BM, 1999, ANN NY ACAD SCI, V871, P94, DOI 10.1111/j.1749-6632.1999.tb09178.x; Telford L, 1997, J NEUROPHYSIOL, V78, P1775, DOI 10.1152/jn.1997.78.4.1775; THURSTON SE, 1987, NEUROLOGY, V37, P53, DOI 10.1212/WNL.37.1.53; Tian J, 2007, VISION RES, V47, P1003, DOI 10.1016/j.visres.2006.12.011; WAESPE W, 1985, SCIENCE, V228, P199, DOI 10.1126/science.3871968; Walker MF, 2008, J NEUROPHYSIOL, V100, P1813, DOI 10.1152/jn.01193.2007; Walker MF, 2008, PROG BRAIN RES, V171, P167, DOI 10.1016/S0079-6123(08)00622-5; Walker MF, 2005, J NEUROPHYSIOL, V94, P3417, DOI 10.1152/jn.00375.2005; Walker MF, 2004, VISION RES, V44, P613, DOI 10.1016/j.visres.2003.10.009; WALKER MF, 2008, ADV UNDERSTANDING ME; Wearne S, 1997, PROG BRAIN RES, V114, P321; Wearne S, 1998, J NEUROPHYSIOL, V79, P2690, DOI 10.1152/jn.1998.79.5.2690; Wiest G, 2001, BRAIN, V124, P2407, DOI 10.1093/brain/124.12.2407; Wyatt HJ, 1998, VISION RES, V38, P2147, DOI 10.1016/S0042-6989(97)00410-0; Yakusheva T, 2008, J NEUROSCI, V28, P9997, DOI 10.1523/JNEUROSCI.2232-08.2008; ZEE DS, 1976, BRAIN, V99, P207, DOI 10.1093/brain/99.2.207; ZEE DS, 1981, J NEUROPHYSIOL, V46, P878, DOI 10.1152/jn.1981.46.4.878; Zee DS, 2002, ANN NY ACAD SCI, V956, P178, DOI 10.1111/j.1749-6632.2002.tb02818.x; Zhou W, 2003, J NEUROSCI, V23, P4288	54	25	25	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2010	5	11							e13981	10.1371/journal.pone.0013981	http://dx.doi.org/10.1371/journal.pone.0013981			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	680KW	21085587	Green Published, Green Submitted, gold			2022-12-27	WOS:000284231800011
J	Maloberti, PM; Duarte, AB; Orlando, UD; Pasqualini, ME; Solano, AR; Lopez-Otin, C; Podesta, EJ				Maloberti, Paula M.; Duarte, Alejandra B.; Orlando, Ulises D.; Pasqualini, Maria E.; Solano, Angela R.; Lopez-Otin, Carlos; Podesta, Ernesto J.			Functional Interaction between Acyl-CoA Synthetase 4, Lipooxygenases and Cyclooxygenase-2 in the Aggressive Phenotype of Breast Cancer Cells	PLOS ONE			English	Article							ARACHIDONIC-ACID RELEASE; HUMAN HEPATOCELLULAR-CARCINOMA; BENZODIAZEPINE-RECEPTOR PBR; EPIDERMAL-GROWTH-FACTOR; RAT-LIVER; TUMOR PROGRESSION; CYCLIC-AMP; CHOLESTEROL TRANSPORT; STEROIDOGENIC CELLS; LEYDIG-CELLS	The acyl-CoA synthetase 4 (ACSL4) is increased in breast cancer, colon and hepatocellular carcinoma. ACSL4 mainly esterifies arachidonic acid (AA) into arachidonoyl-CoA, reducing free AA intracellular levels, which is in contradiction with the need for AA metabolites in tumorigenesis. Therefore, the causal role of ACSL4 is still not established. This study was undertaken to determine the role of ACSL4 in AA metabolic pathway in breast cancer cells. The first novel finding is that ACSL4 regulates the expression of cyclooxygenase-2 (COX-2) and the production of prostaglandin in MDA-MB-231 cells. We also found that ACSL4 is significantly up-regulated in the highly aggressive MDA-MB-231 breast cancer cells. In terms of its overexpression and inhibition, ACSL4 plays a causal role in the control of the aggressive phenotype. These results were confirmed by the increase in the aggressive behaviour of MCF-7 cells stably transfected with a Tet-off ACSL4 vector. Concomitantly, another significant finding was that intramitochondrial AA levels are significantly higher in the aggressive cells. Thus, the esterification of AA by ACSL4 compartmentalizes the release of AA in mitochondria, a mechanism that serves to drive the specific lipooxygenase metabolization of the fatty acid. To our knowledge, this is the first report that ACSL4 expression controls both lipooxygenase and cyclooxygenase metabolism of AA. Thus, this functional interaction represents an integrated system that regulates the proliferating and metastatic potential of cancer cells. Therefore, the development of combinatory therapies that profit from the ACSL4, lipooxygenase and COX-2 synergistic action may allow for lower medication doses and avoidance of side effects.	[Maloberti, Paula M.; Duarte, Alejandra B.; Orlando, Ulises D.; Solano, Angela R.; Podesta, Ernesto J.] Univ Buenos Aires, Inst Invest Mol Enfermedades Hormonales Neurodege, Dept Human Biochem, Sch Med, Buenos Aires, DF, Argentina; [Pasqualini, Maria E.] Natl Univ Cordoba, Sch Med, Inst Biol Celular, Cordoba, Argentina; [Lopez-Otin, Carlos] Univ Oviedo, Inst Univ Oncol, Dept Biochem & Mol Biol, Oviedo, Spain	University of Buenos Aires; National University of Cordoba; University of Oviedo; Instituto Universitario de Oncologia de Asturias	Maloberti, PM (corresponding author), Univ Buenos Aires, Inst Invest Mol Enfermedades Hormonales Neurodege, Dept Human Biochem, Sch Med, Buenos Aires, DF, Argentina.	ernestopodesta@yahoo.com.ar	Maloberti, Paula/AAU-5216-2020; López-Otín, Carlos/AAB-2106-2020	López-Otín, Carlos/0000-0001-6964-1904	CONICET [112-200801-01976]; FONCyT [200600819, 25368, 32527]	CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); FONCyT(FONCyT)	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was supported by CONICET (112-200801-01976) http://www.conicet.gov.ar/, Podesta; UBA (M059, M810) Podesta, Maloberti, http://www.uba.ar/homepage.php; FONCyT (200600819, 25368, 32527) Podesta, Podesta, Maloberti; http://www.agencia.mincyt.gov.ar/, Bunge & Born Foundation, Podesta, Solano, http://www.fundacionbyb.org/ing_investigacion_cientifica.asp; and Ministerio de Ciencia e Innovacion-Spain, http://www.micinn.es/portal/site/MICINN/, Fundacion "M. Botin", http://www. fundacionmbotin.org/, and European Union (FP7 MicroEnviMet) http://ec.europa.eu/research/health/medical-research/cancer/fp7-projects/microenvimet_en.html, Lopez Otin.	Alonso M, 2004, J NEUROCHEM, V89, P248, DOI 10.1111/j.1471-4159.2004.02323.x; Alvarez-Diaz S, 2010, CELL CYCLE, V9, P32, DOI 10.4161/cc.9.1.10266; Avis I, 2001, FASEB J, V15, P2007, DOI 10.1096/fj.00-0866fje; Basu GD, 2004, MOL CANCER RES, V2, P632; BLUMBERG PM, 1975, CELL, V6, P137, DOI 10.1016/0092-8674(75)90004-5; Cao Y, 2000, FEBS LETT, V467, P263, DOI 10.1016/S0014-5793(00)01159-5; Cao Y, 2000, P NATL ACAD SCI USA, V97, P11280, DOI 10.1073/pnas.200367597; Cao Y, 2001, CANCER RES, V61, P8429; CARNEY DH, 1977, NATURE, V268, P602, DOI 10.1038/268602a0; Castilla R, 2008, ENDOCRINOLOGY, V149, P3743, DOI 10.1210/en.2007-1580; Castillo AF, 2006, FEBS J, V273, P5011, DOI 10.1111/j.1742-4658.2006.05496.x; Castillo F, 2004, ENDOCR RES, V30, P623, DOI 10.1081/ERC-200043795; Darmoul D, 2001, BRIT J CANCER, V85, P772, DOI 10.1054/bjoc.2001.1976; Distler AM, 2007, BBA-PROTEINS PROTEOM, V1774, P628, DOI 10.1016/j.bbapap.2007.03.012; Duarte A, 2007, FEBS LETT, V581, P4023, DOI 10.1016/j.febslet.2007.07.040; Eisenberg E, 2003, TRENDS GENET, V19, P362, DOI 10.1016/S0168-9525(03)00140-9; Gonzalez-Periz A, 2007, CURR TOP MED CHEM, V7, P297, DOI 10.2174/156802607779941378; Gupta S, 2001, CANCER-AM CANCER SOC, V91, P737, DOI 10.1002/1097-0142(20010215)91:4<737::AID-CNCR1059>3.0.CO;2-F; Gutierrez-Fernandez A, 2008, CANCER RES, V68, P2755, DOI 10.1158/0008-5472.CAN-07-5154; Half E, 2002, CANCER RES, V62, P1676; Han ZQ, 2003, J RECEPT SIG TRANSD, V23, P225, DOI 10.1081/RRS-120025210; Hardwick M, 1999, CANCER RES, V59, P831; Hayashi T, 2006, INT J UROL, V13, P1086, DOI 10.1111/j.1442-2042.2006.01485.x; Hennig R, 2002, AM J PATHOL, V161, P421, DOI 10.1016/S0002-9440(10)64198-3; Hong SH, 1999, CANCER RES, V59, P2223; Hyde CAC, 2009, INT IMMUNOPHARMACOL, V9, P701, DOI 10.1016/j.intimp.2009.02.003; Ihara A, 2007, J PHARMACOL SCI, V103, P24, DOI 10.1254/jphs.FP0060651; Jiang WG, 2003, PROSTAG LEUKOTR ESS, V69, P275, DOI 10.1016/S0952-3278(03)00110-8; Kang MJ, 1997, P NATL ACAD SCI USA, V94, P2880, DOI 10.1073/pnas.94.7.2880; Larkins TL, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-181; Lewin TM, 2002, ARCH BIOCHEM BIOPHYS, V404, P263, DOI 10.1016/S0003-9861(02)00247-3; Lewin TM, 2001, J BIOL CHEM, V276, P24674, DOI 10.1074/jbc.M102036200; Li W, 2007, BIOCHEM PHARMACOL, V73, P491, DOI 10.1016/j.bcp.2006.10.025; Liang YC, 2005, WORLD J GASTROENTERO, V11, P2557, DOI 10.3748/wjg.v11.i17.2557; Maloberti P, 2007, MOL CELL ENDOCRINOL, V265, P113, DOI 10.1016/j.mce.2006.12.026; Maloberti P, 2005, FEBS J, V272, P1804, DOI 10.1111/j.1742-4658.2005.04616.x; Maloberti P, 2002, EUR J BIOCHEM, V269, P5599, DOI 10.1046/j.1432-1033.2002.03267.x; Monaco ME, 2010, TRANSL ONCOL, V3, P91, DOI 10.1593/tlo.09202; Natarajan R, 1997, J CLIN ENDOCR METAB, V82, P1790, DOI 10.1210/jc.82.6.1790; Panguluri RCK, 2004, CARCINOGENESIS, V25, P961, DOI 10.1093/carcin/bgh100; Papadopoulos V, 2006, TRENDS PHARMACOL SCI, V27, P402, DOI 10.1016/j.tips.2006.06.005; Pasqualini ME, 2003, PROSTAG LEUKOTR ESS, V68, P9, DOI 10.1016/S0952-3278(02)00230-2; Pidgeon GP, 2007, CANCER METAST REV, V26, P503, DOI 10.1007/s10555-007-9098-3; Poderoso C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001443; Romano M, 2003, FASEB J, V17, P1986, DOI 10.1096/fj.03-0053rev; Singh-Ranger G, 2008, BREAST CANCER RES TR, V109, P189, DOI 10.1007/s10549-007-9641-5; SOLANO AR, 1988, J MOL ENDOCRINOL, V1, P147, DOI 10.1677/jme.0.0010147; Soslow RA, 2000, CANCER, V89, P2637, DOI 10.1002/1097-0142(20001215)89:12<2637::AID-CNCR17>3.0.CO;2-B; Soupene E, 2008, EXP BIOL MED, V233, P507, DOI 10.3181/0710-MR-287; STOCCO DM, 1983, ANAL BIOCHEM, V131, P453, DOI 10.1016/0003-2697(83)90198-7; Sung YK, 2003, CANCER SCI, V94, P421, DOI 10.1111/j.1349-7006.2003.tb01458.x; Sung YK, 2007, EXP MOL MED, V39, P477, DOI 10.1038/emm.2007.52; Wang MT, 2007, CANCER METAST REV, V26, P525, DOI 10.1007/s10555-007-9096-5; Wang XJ, 2003, J STEROID BIOCHEM, V85, P159, DOI 10.1016/S0960-0760(03)00189-4; Wikstrom K, 2003, BIOCHEM BIOPH RES CO, V302, P330, DOI 10.1016/S0006-291X(03)00187-6; YOSHIMOTO T, 1982, BIOCHIM BIOPHYS ACTA, V713, P470	56	67	68	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2010	5	11							e15540	10.1371/journal.pone.0015540	http://dx.doi.org/10.1371/journal.pone.0015540			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	678OA	21085606	Green Published, gold, Green Submitted			2022-12-27	WOS:000284087800029
J	Parapuram, SK; Cojocaru, RI; Chang, JR; Khanna, R; Brooks, M; Othman, M; Zareparsi, S; Khan, NW; Gotoh, N; Cogliati, T; Swaroop, A				Parapuram, Sunil K.; Cojocaru, Radu I.; Chang, Jessica R.; Khanna, Ritu; Brooks, Matthew; Othman, Mohammad; Zareparsi, Sepideh; Khan, Naheed W.; Gotoh, Norimoto; Cogliati, Tiziana; Swaroop, Anand			Distinct Signature of Altered Homeostasis in Aging Rod Photoreceptors: Implications for Retinal Diseases	PLOS ONE			English	Article							GENE-EXPRESSION PROFILE; FATTY-ACIDS; RECEPTOR-ALPHA; LIFE-SPAN; IN-VITRO; MECHANISMS; MICE; IDENTIFICATION; INFLAMMATION; ACTIVATION	Background: Advanced age contributes to clinical manifestations of many retinopathies and represents a major risk factor for age-related macular degeneration, a leading cause of visual impairment and blindness in the elderly. Rod photoreceptors are especially vulnerable to genetic defects and changes in microenvironment, and are among the first neurons to die in normal aging and in many retinal degenerative diseases. The molecular mechanisms underlying rod photoreceptor vulnerability and potential biomarkers of the aging process in this highly specialized cell type are unknown. Methodology/Principal Findings: To discover aging-associated adaptations that may influence rod function, we have generated gene expression profiles of purified rod photoreceptors from mouse retina at young adult to early stages of aging (1.5, 5, and 12 month old mice). We identified 375 genes that showed differential expression in rods from 5 and 12 month old mouse retina compared to that of 1.5 month old retina. Quantitative RT-PCR experiments validated expression change for a majority of the 25 genes that were examined. Macroanalysis of differentially expressed genes using gene class testing and protein interaction networks revealed overrepresentation of cellular pathways that are potentially photoreceptor-specific (angiogenesis and lipid/retinoid metabolism), in addition to age-related pathways previously described in several tissue types (oxidative phosphorylation, stress and immune response). Conclusions/Significance: Our study suggests a progressive shift in cellular homeostasis that may underlie aging-associated functional decline in rod photoreceptors and contribute to a more permissive state for pathological processes involved in retinal diseases.	[Parapuram, Sunil K.; Cojocaru, Radu I.; Khanna, Ritu; Brooks, Matthew; Othman, Mohammad; Zareparsi, Sepideh; Khan, Naheed W.; Swaroop, Anand] Univ Michigan, Kellogg Eye Ctr, Dept Ophthalmol & Visual Sci, Ann Arbor, MI 48109 USA; [Cojocaru, Radu I.; Chang, Jessica R.; Brooks, Matthew; Gotoh, Norimoto; Cogliati, Tiziana; Swaroop, Anand] NEI, Neurobiol Neurodegenerat & Repair Lab, NIH, Bethesda, MD 20892 USA; [Chang, Jessica R.] Natl Inst Hlth Res Scholars Program, Howard Hughes Med Inst, Bethesda, MD USA	University of Michigan System; University of Michigan; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); Howard Hughes Medical Institute; National Institutes of Health (NIH) - USA	Parapuram, SK (corresponding author), Univ Michigan, Kellogg Eye Ctr, Dept Ophthalmol & Visual Sci, Ann Arbor, MI 48109 USA.	swaroopa@nei.nih.gov		Swaroop, Anand/0000-0002-1975-1141; Chang, Jessica/0000-0001-6663-2519	National Eye Institute; National Institutes of Health [EY11115, EY07003, DK20572]; Foundation Fighting Blindness; Elmer and Sylvia Sramek Foundation; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [R01EY011115, ZIAEY000451, P30EY007003, ZIAEY000475, F31EY007003] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020572, P30DK020572] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation Fighting Blindness(European Commission); Elmer and Sylvia Sramek Foundation; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by intramural funds of the National Eye Institute and by grants (EY11115, EY07003, DK20572) from the National Institutes of Health, http://grants.nih.gov/grants/oer.htm, the Foundation Fighting Blindness, http://www.blindness.org/, the Elmer and Sylvia Sramek Foundation, and Research to Prevent Blindness, http://www.rpbusa.org/rpb/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akimoto M, 2006, P NATL ACAD SCI USA, V103, P3890, DOI 10.1073/pnas.0508214103; Akiyama H, 2005, AM J PHYSIOL-CELL PH, V288, pC913, DOI 10.1152/ajpcell.00116.2004; Antonetti DA, 2006, DIABETES, V55, P2401, DOI 10.2337/db05-1635; Atherton HJ, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.18; Baba T, 2010, AM J PATHOL, V176, P3085, DOI 10.2353/ajpath.2010.090989; Barbieri M, 2003, AM J PHYSIOL-ENDOC M, V285, pE1064, DOI 10.1152/ajpendo.00296.2003; Bauer ME, 2009, ANN NY ACAD SCI, V1153, P139, DOI 10.1111/j.1749-6632.2008.03966.x; Birch DG, 1999, OPHTHALMOLOGY, V106, P258, DOI 10.1016/S0161-6420(99)90064-7; Bishop NA, 2007, NAT REV GENET, V8, P835, DOI 10.1038/nrg2188; Bishop NA, 2010, NATURE, V464, P529, DOI 10.1038/nature08983; Bonnel S, 2003, EXP GERONTOL, V38, P825, DOI 10.1016/S0531-5565(03)00093-7; Bordone L, 2007, AGING CELL, V6, P759, DOI 10.1111/j.1474-9726.2007.00335.x; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Cao JN, 2010, AGING CELL, V9, P19, DOI 10.1111/j.1474-9726.2009.00534.x; Carter TA, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-6-r48; Chen D, 2008, GENE DEV, V22, P1753, DOI 10.1101/gad.1650608; Chen H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001602; Chowers I, 2003, HUM MOL GENET, V12, P2881, DOI 10.1093/hmg/ddg326; Chung JH, 2008, AGEING RES REV, V7, P126, DOI 10.1016/j.arr.2008.01.001; Curcio CA, 2001, EYE, V15, P376, DOI 10.1038/eye.2001.140; CURCIO CA, 1993, INVEST OPHTH VIS SCI, V34, P3278; Curcio CA, 1996, INVEST OPHTH VIS SCI, V37, P1236; DOBRZYN P, 2010, BIOCH BIOPHYS ACTA; Duncan T, 1999, MOL VIS, V5, pU1; Ethen CM, 2005, INVEST OPHTH VIS SCI, V46, P769, DOI 10.1167/iovs.04-0810; Flurkey K, 2007, MOUSE BIOMEDICAL RES, P637, DOI DOI 10.1016/B978-012369454-6/50074-1; GAO H, 1992, INVEST OPHTH VIS SCI, V33, P1; Gehrs K. M., ARCH OPHTHALMOL, V128, P349; Gresh J, 2003, VISUAL NEUROSCI, V20, P211, DOI 10.1017/S0952523803202108; Hicks D, 1999, INVEST OPHTH VIS SCI, V40, pS583; Hollyfield JG, 2008, NAT MED, V14, P194, DOI 10.1038/nm1709; Hsin H, 1999, NATURE, V399, P362, DOI 10.1038/20694; Hulbert AJ, 2006, MECH AGEING DEV, V127, P653, DOI 10.1016/j.mad.2006.03.002; HUSSONG SA, 2010, J NEUROCHEM; Ida H, 2003, PHYSIOL GENOMICS, V15, P258, DOI 10.1152/physiolgenomics.00126.2003; *ING SYST, 2010, DAT WER AN US ING PA; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; KELLER H, 1993, P NATL ACAD SCI USA, V90, P2160, DOI 10.1073/pnas.90.6.2160; Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980; Kolesnikov AV, 2010, J NEUROSCI, V30, P11222, DOI 10.1523/JNEUROSCI.4239-09.2010; Lee CK, 1999, SCIENCE, V285, P1390, DOI 10.1126/science.285.5432.1390; Lee CK, 2000, NAT GENET, V25, P294, DOI 10.1038/77046; Lee SA, 2008, BBA-MOL BASIS DIS, V1782, P421, DOI 10.1016/j.bbadis.2008.03.004; Leveillard T, 2004, NAT GENET, V36, P755, DOI 10.1038/ng1386; Lu T, 2004, NATURE, V429, P883, DOI 10.1038/nature02661; Marchette LD, 2010, FREE RADICAL BIO MED, V48, P16, DOI 10.1016/j.freeradbiomed.2009.08.005; *METACORE, 2010, NETW REC WAS MAD MET; Michaud K, 2009, BRAIN COGNITION, V71, P1, DOI 10.1016/j.bandc.2009.02.013; Milton RC, 2005, OPHTHALMOLOGY, V112, P533, DOI 10.1016/j.ophtha.2004.10.047; Murgatroyd C, 2010, AGING-US, V2, P107; Navarro A, 2007, AM J PHYSIOL-CELL PH, V292, pC670, DOI 10.1152/ajpcell.00213.2006; Neschen S, 2007, DIABETES, V56, P1034, DOI 10.2337/db06-1206; Oberdoerffer P, 2007, NAT REV MOL CELL BIO, V8, P692, DOI 10.1038/nrm2238; Oh ECT, 2008, BRAIN RES, V1236, P16, DOI 10.1016/j.brainres.2008.01.028; Park SK, 2009, AGING CELL, V8, P484, DOI 10.1111/j.1474-9726.2009.00496.x; Preston CC, 2008, MECH AGEING DEV, V129, P304, DOI 10.1016/j.mad.2008.02.010; Resnikoff S, 2004, B WORLD HEALTH ORGAN, V82, P844; Rothman SM, 2010, NEUROMOL MED, V12, P56, DOI 10.1007/s12017-009-8107-9; SanGiovanni JP, 2005, PROG RETIN EYE RES, V24, P87, DOI 10.1016/j.preteyeres.2004.06.002; Sheehan B, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-468; Shen SM, 2008, NEUROBIOL AGING, V29, P452, DOI 10.1016/j.neurobiolaging.2006.10.026; Spaide RF, 1999, RETINA-J RET VIT DIS, V19, P141, DOI 10.1097/00006982-199902000-00010; Streichert LC, 1999, J NEUROBIOL, V39, P475, DOI 10.1002/(SICI)1097-4695(19990615)39:4<475::AID-NEU2>3.0.CO;2-#; STRUNNIKOVA NV, 2010, HUM MOL GENET; Swaroop A, 2009, ANNU REV GENOM HUM G, V10, P19, DOI 10.1146/annurev.genom.9.081307.164350; Tamai K, 2002, EXP EYE RES, V74, P301, DOI 10.1006/exer.2001.1121; Trifunovic A, 2008, J INTERN MED, V263, P167, DOI 10.1111/j.1365-2796.2007.01905.x; Wang L, 2009, INVEST OPHTH VIS SCI, V50, P870, DOI 10.1167/iovs.08-2376; Winkler BS, 1999, MOL VIS, V5; Xu HP, 2009, PROG RETIN EYE RES, V28, P348, DOI 10.1016/j.preteyeres.2009.06.001; Yan DG, 2007, ARTERIOSCL THROM VAS, V27, P1108, DOI 10.1161/ATVBAHA.106.138545; Yan JB, 2006, J EXP MED, V203, P647, DOI 10.1084/jem.20052271; Yang P, 2009, INVEST OPHTH VIS SCI, V50, P3473, DOI 10.1167/iovs.08-3202; Yankner BA, 2008, ANNU REV PATHOL-MECH, V3, P41, DOI 10.1146/annurev.pathmechdis.2.010506.092044; Yoshida S, 2002, INVEST OPHTH VIS SCI, V43, P2554; Zahn JM, 2007, PLOS GENET, V3, P2326, DOI 10.1371/journal.pgen.0030201	76	24	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2010	5	11							e13885	10.1371/journal.pone.0013885	http://dx.doi.org/10.1371/journal.pone.0013885			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	676NU	21079736	Green Published, gold			2022-12-27	WOS:000283920000016
J	Lessi, F; Beggs, A; de Palo, M; Anti, M; Palmieri, RM; Francesconi, S; Gomes, V; Bevilacqua, G; Tomlinson, I; Segditsas, S				Lessi, Francesca; Beggs, Andrew; de Palo, Mariagrazia; Anti, Marcello; Palmieri, Raffaele Macarone; Francesconi, Simona; Gomes, Vito; Bevilacqua, Generoso; Tomlinson, Ian; Segditsas, Stefania			Down-Regulation of Serum/Glucocorticoid Regulated Kinase 1 in Colorectal Tumours Is Largely Independent of Promoter Hypermethylation	PLOS ONE			English	Article							THREONINE PROTEIN-KINASE; INDUCIBLE KINASE; GENE-EXPRESSION; DNA METHYLATION; MESSENGER-RNA; COLON-CANCER; CYCLIC-AMP; SERUM; SGK; CELLS	Background: We have previously shown that serum/glucocorticoid regulated kinase 1 (SGK1) is down-regulated in colorectal cancers (CRC) with respect to normal tissue. As hyper-methylation of promoter regions is a well-known mechanism of gene silencing in cancer, we tested whether the SGK1 promoter region was methylated in colonic tumour samples. Methodology/Principal Findings: We investigated the methylation profile of the two CpG islands present in the promoter region of SGK1 in a panel of 5 colorectal cancer cell lines by sequencing clones of bisulphite-treated DNA samples. We further confirmed our findings in a panel of 10 normal and 10 tumour colonic tissue samples of human origin. We observed CpG methylation only in the smaller and more distal CpG island in the promoter region of SGK1 in both normal and tumour samples of colonic origin. We further identified a single nucleotide polymorphism (SNP, rs1743963) which affects methylation of the corresponding CpG. Conclusions/Significance: Our results show that even though partial methylation of the promoter region of SGK1 is present, this does not account for the different expression levels seen between normal and tumour tissue.	[Lessi, Francesca; Beggs, Andrew; Tomlinson, Ian; Segditsas, Stefania] Univ Oxford, Wellcome Trust Ctr Human Genet, Mol & Populat Genet Lab, Oxford, England; [de Palo, Mariagrazia; Anti, Marcello; Palmieri, Raffaele Macarone; Francesconi, Simona; Gomes, Vito] Presidio Osped Belcolle Viterbo, Viterbo, Italy; [Lessi, Francesca; Bevilacqua, Generoso] Univ Pisa, Dept Oncol, Div Surg Mol & Ultrastructural Pathol, Pisa, Italy; [Lessi, Francesca; Bevilacqua, Generoso] Univ Hosp, Pisa, Italy	University of Oxford; Wellcome Centre for Human Genetics; University of Pisa; University of Pisa; Azienda Ospedaliero Universitaria Pisana	Lessi, F (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Mol & Populat Genet Lab, Oxford, England.	stefania.segditsas@well.ox.ac.uk	Lessi, Francesca/AAE-6812-2022; Beggs, Andrew D/A-6912-2013; Beggs, Andrew/F-5902-2010	Lessi, Francesca/0000-0002-3346-4296; Beggs, Andrew D/0000-0003-0784-2967; Beggs, Andrew/0000-0003-0784-2967; BEVILACQUA, GENEROSO/0000-0001-8857-2609	Nuffield Department for Clinical Medicine [H55160]; Wellcome Trust [075491/Z/04]	Nuffield Department for Clinical Medicine; Wellcome Trust(Wellcome TrustEuropean Commission)	Funding: This work was supported by the Nuffield Department for Clinical Medicine [H55160] and the Wellcome Trust [075491/Z/04]. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Allan LA, 2000, MOL CELL BIOL, V20, P1291, DOI 10.1128/MCB.20.4.1291-1298.2000; Alliston TN, 1997, MOL ENDOCRINOL, V11, P1934, DOI 10.1210/me.11.13.1934; Baylin SB, 1998, ADV CANCER RES, V72, P141; Bhargava A, 2001, ENDOCRINOLOGY, V142, P1587, DOI 10.1210/en.142.4.1587; BLAY J, 1984, CELL BIOL INT REP, V8, P551, DOI 10.1016/0309-1651(84)90054-7; Brennan FE, 2000, MOL CELL ENDOCRINOL, V166, P129, DOI 10.1016/S0303-7207(00)00274-4; Chen SY, 1999, P NATL ACAD SCI USA, V96, P2514, DOI 10.1073/pnas.96.5.2514; Chu S, 2002, MOL HUM REPROD, V8, P426, DOI 10.1093/molehr/8.5.426; Cowling RT, 2000, J LEUKOCYTE BIOL, V67, P240, DOI 10.1002/jlb.67.2.240; Cunningham JM, 1998, CANCER RES, V58, P3455; David S, 2005, FEBS LETT, V579, P1534, DOI 10.1016/j.febslet.2005.01.040; de la Rosa DA, 2003, J PHYSIOL-LONDON, V551, P455, DOI 10.1113/jphysiol.2003.042903; Failor KL, 2007, MOL ENDOCRINOL, V21, P2403, DOI 10.1210/me.2007-0143; Firestone GL, 2003, CELL PHYSIOL BIOCHEM, V13, P1, DOI 10.1159/000070244; Grady WM, 2004, CANCER METAST REV, V23, P11, DOI 10.1023/A:1025861527711; HERMAN JG, 1995, CANCER RES, V55, P4525; Hertweck M, 2004, DEV CELL, V6, P577, DOI 10.1016/S1534-5807(04)00095-4; Hong F, 2008, MOL CELL, V30, P701, DOI 10.1016/j.molcel.2008.04.027; Lang F, 2006, PHYSIOL REV, V86, P1151, DOI 10.1152/physrev.00050.2005; Lang F, 2009, CURR OPIN NEPHROL HY, V18, P439, DOI 10.1097/MNH.0b013e32832f125e; Leong MLL, 2003, J BIOL CHEM, V278, P5871, DOI 10.1074/jbc.M211649200; Mikosz CA, 2001, J BIOL CHEM, V276, P16649, DOI 10.1074/jbc.M010842200; Perrotti N, 2001, J BIOL CHEM, V276, P9406, DOI 10.1074/jbc.M007052200; Rauhala HE, 2005, INT J CANCER, V117, P738, DOI 10.1002/ijc.21270; SAKAI T, 1991, AM J HUM GENET, V48, P880; Segditsas S, 2009, ONCOGENE, V28, P146, DOI 10.1038/onc.2008.361; Segditsas S, 2008, HUM MOL GENET, V17, P3864, DOI 10.1093/hmg/ddn286; Toyota M, 1999, P NATL ACAD SCI USA, V96, P8681, DOI 10.1073/pnas.96.15.8681; Waldegger S, 1999, GASTROENTEROLOGY, V116, P1081, DOI 10.1016/S0016-5085(99)70011-9; Waldegger S, 1997, P NATL ACAD SCI USA, V94, P4440, DOI 10.1073/pnas.94.9.4440; WEBSTER MK, 1993, MOL CELL BIOL, V13, P2031, DOI 10.1128/MCB.13.4.2031; WEBSTER MK, 1993, J BIOL CHEM, V268, P11482; You H, 2004, P NATL ACAD SCI USA, V101, P14057, DOI 10.1073/pnas.0406286101; Zhang BH, 2001, J BIOL CHEM, V276, P31620, DOI 10.1074/jbc.M102808200	34	7	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2010	5	11							e13840	10.1371/journal.pone.0013840	http://dx.doi.org/10.1371/journal.pone.0013840			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675OD	21079778	Green Published, Green Submitted, gold			2022-12-27	WOS:000283839100005
J	Liu, FW; Liu, J; Weng, D; Chen, Y; Song, LY; He, QC; Chen, J				Liu, Fangwei; Liu, Jie; Weng, Dong; Chen, Ying; Song, Laiyu; He, Qincheng; Chen, Jie			CD4+CD25+Foxp3+Regulatory T Cells Depletion May Attenuate the Development of Silica-Induced Lung Fibrosis in Mice	PLOS ONE			English	Article							AIRWAY INFLAMMATION; NALP3 INFLAMMASOME; CYTOKINE PRODUCTION; IN-VIVO; RESPONSES; ACTIVATION; DISEASE; POLARIZATION; SUPPRESSION; PHENOTYPE	Background: Silicosis is an occupational lung disease caused by inhalation of silica dust characterized by lung inflammation and fibrosis. Previous study showed that Th1 and Th2 cytokines are involved in silicosis, but Th1/Th2 polarization during the development of silicosis is still a matter of debate. Regulatory T cells (Treg cells) represent a crucial role in modulation of immune homeostasis by regulating Th1/Th2 polarization, but their possible implication in silicosis remains to be explored. Methodology/Principal Findings: To evaluate the implication of Treg cells in the development of silicosis, we generated the Treg-depleted mice model by administration of anti-CD25 mAbs and mice were exposed to silica by intratracheal instillation to establish experimental model of silica-induced lung fibrosis. The pathologic examinations show that the Treg-depleted mice are susceptive to severer inflammation in the early stage, with enhanced infiltration of inflammatory cells. Also, depletion of Treg cells causes a delay of the progress of silica-induced lung fibrosis in mice model. Further study of mRNA expression of cytokines reveals that depletion of Tregs leads to the increased production of Th1-cytokines and decreased production of Th2-cytokine. The Flow Cytometry and realtime PCR study show that Treg cells exert the modulation function both directly by expressing CTLA-4 at the inflammatory stage, and indirectly by secreting increasing amount of IL-10 and TGF-beta during the fibrotic stage in silica-induced lung fibrosis. Conclusion/Significance: Our study suggests that depletion of Tregs may attenuate the progress of silica-induced lung fibrosis and enhance Th1 response and decelerate Th1/Th2 balance toward a Th2 phenotype in silica-induced lung fibrosis. The regulatory function of Treg cells may depend on direct mechanism and indirect mechanism during the inflammatory stage of silicosis.	[Liu, Fangwei; Liu, Jie; Weng, Dong; Chen, Ying; Song, Laiyu; He, Qincheng; Chen, Jie] China Med Univ, Sch Publ Hlth, Div Pneumoconiosis, Shenyang, Peoples R China	China Medical University	Liu, FW (corresponding author), China Med Univ, Sch Publ Hlth, Div Pneumoconiosis, Shenyang, Peoples R China.	chenjie@mail.cmu.edu.cn	Liu, FW/GQZ-5182-2022	Song, Laiyu/0000-0001-7979-8294	National Natural Science Foundation of China [30800924, 30771791]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The funding for this study is supported by grants from the National Natural Science Foundation of China (No. 30800924 and No. 30771791). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arras M, 2001, AM J RESP CELL MOL, V24, P368, DOI 10.1165/ajrcmb.24.4.4249; Barbarin V, 2005, AM J PHYSIOL-LUNG C, V288, pL841, DOI 10.1152/ajplung.00329.2004; Belkaid Y, 2002, NATURE, V420, P502, DOI 10.1038/nature01152; Bellinghausen I, 2003, J ALLERGY CLIN IMMUN, V111, P862, DOI 10.1067/mai.2003.1412; Brown JM, 2007, AM J RESP CELL MOL, V36, P43, DOI 10.1165/rcmb.2006-0197OC; Brown JM, 2004, INHAL TOXICOL, V16, P133, DOI 10.1080/08958370490270936; Cassel SL, 2008, P NATL ACAD SCI USA, V105, P9035, DOI 10.1073/pnas.0803933105; Chen Y, 2005, TOXICOL LETT, V155, P353, DOI 10.1016/j.toxlet.2004.10.011; Dai ZH, 2004, J CLIN INVEST, V113, P310, DOI 10.1172/JCI200419727; Davis Gerald S., 2001, Journal of Environmental Pathology Toxicology and Oncology, V20, P53; Doganci A, 2005, J CLIN INVEST, V115, P313, DOI 10.1172/JCI200522433; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Edinger M, 2003, NAT MED, V9, P1144, DOI 10.1038/nm915; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Grindebacke H, 2004, CLIN EXP ALLERGY, V34, P1364, DOI 10.1111/j.1365-2222.2004.02067.x; Gutcher I, 2007, J CLIN INVEST, V117, P1119, DOI 10.1172/JCI31720; Haeryfar SMM, 2005, J IMMUNOL, V174, P3344, DOI 10.4049/jimmunol.174.6.3344; Hawrylowicz CM, 2005, NAT REV IMMUNOL, V5, P271, DOI 10.1038/nri1589; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Huaux F, 2007, CURR OPIN ALLERGY CL, V7, P168, DOI 10.1097/ACI.0b013e32802bf8a5; Jaffar Z, 2004, J IMMUNOL, V172, P3842, DOI 10.4049/jimmunol.172.6.3842; Kearley J, 2005, J EXP MED, V202, P1539, DOI 10.1084/jem.20051166; Knutson KL, 2005, CANCER IMMUNOL IMMUN, V54, P721, DOI 10.1007/s00262-004-0653-2; Kuhlmann UC, 2009, LIFE SCI, V84, P1, DOI 10.1016/j.lfs.2008.10.001; Lewkowich IP, 2005, J EXP MED, V202, P1549, DOI 10.1084/jem.20051506; Li MO, 2006, ANNU REV IMMUNOL, V24, P99, DOI 10.1146/annurev.immunol.24.021605.090737; Ling EM, 2004, LANCET, V363, P608, DOI 10.1016/S0140-6736(04)15592-X; Misson P, 2007, AM J PHYSIOL-LUNG C, V292, pL107, DOI 10.1152/ajplung.00503.2005; O'Garra A, 2008, IMMUNOL REV, V223, P114, DOI 10.1111/j.1600-065X.2008.00635.x; ROM WN, 1992, CHEST, V101, P779, DOI 10.1378/chest.101.3.779; Roncarolo MG, 2006, IMMUNOL REV, V212, P28; Saito K, 2008, J IMMUNOL, V181, P6889, DOI 10.4049/jimmunol.181.10.6889; Suto A, 2001, AM J RESP CRIT CARE, V164, P680, DOI 10.1164/ajrccm.164.4.2010170; Suvas S, 2003, J EXP MED, V198, P889, DOI 10.1084/jem.20030171; Suzuki NL, 1996, THORAX, V51, P1036, DOI 10.1136/thx.51.10.1036; UEKI A, 1994, IMMUNOLOGY, V82, P332; Vignali DAA, 2008, NAT REV IMMUNOL, V8, P523, DOI 10.1038/nri2343; Wan YSY, 2005, P NATL ACAD SCI USA, V102, P5126, DOI 10.1073/pnas.0501701102; Wu P, 2006, INT J IMMUNOPATH PH, V19, P357, DOI 10.1177/039463200601900212	39	89	97	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2010	5	11							e15404	10.1371/journal.pone.0015404	http://dx.doi.org/10.1371/journal.pone.0015404			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	674WJ	21072213	Green Published, Green Submitted, gold			2022-12-27	WOS:000283780800027
J	Borrelli, S; Fanoni, D; Dolfini, D; Alotto, D; Ravo, M; Grober, OMV; Weisz, A; Castagnoli, C; Berti, E; Vigano, MA; Mantovani, R				Borrelli, Serena; Fanoni, Daniele; Dolfini, Diletta; Alotto, Daniela; Ravo, Maria; Grober, Oli Maria Victoria; Weisz, Alessandro; Castagnoli, Carlotta; Berti, Emilio; Vigano, M. Alessandra; Mantovani, Roberto			C/EBP delta Gene Targets in Human Keratinocytes	PLOS ONE			English	Article							BINDING-PROTEIN-DELTA; MAMMARY EPITHELIAL-CELLS; BREAST-CANCER; 1,25-DIHYDROXYVITAMIN D-3; TRANSCRIPTION FACTORS; SKIN TUMORIGENESIS; NETHERTON-SYNDROME; HUMAN EPIDERMIS; DEFICIENT MICE; HAIR FOLLICLE	C/EBPs are a family of B-Zip transcription factors -TFs-involved in the regulation of differentiation in several tissues. The two most studied members -C/EBP alpha and C/EBP beta- play important roles in skin homeostasis and their ablation reveals cells with stem cells signatures. Much less is known about C/EBP delta which is highly expressed in the granular layer of interfollicular epidermis and is a direct target of p63, the master regular of multilayered epithelia. We identified C/EBP delta target genes in human primary keratinocytes by ChIP on chip and profiling of cells functionally inactivated with siRNA. Categorization suggests a role in differentiation and control of cell-cycle, particularly of G2/M genes. Among positively controlled targets are numerous genes involved in barrier function. Functional inactivation of C/EBP delta as well as overexpressions of two TF targets -MafB and SOX2- affect expression of markers of keratinocyte differentiation. We performed IHC on skin tumor tissue arrays: expression of C/EBP delta is lost in Basal Cell Carcinomas, but a majority of Squamous Cell Carcinomas showed elevated levels of the protein. Our data indicate that C/EBP delta plays a role in late stages of keratinocyte differentiation.	[Borrelli, Serena; Dolfini, Diletta; Vigano, M. Alessandra; Mantovani, Roberto] Univ Milan, Dipartimento Sci Biomol & Biotecnol, Milan, Italy; [Fanoni, Daniele; Berti, Emilio] Univ Milan, IRCCS Fdn Osped Maggiore Policlin, Ist Sci Dermatol, Milan, Italy; [Alotto, Daniela; Castagnoli, Carlotta] Osped CTO, Dipartimento Chirurg Plast Banca Cute, Turin, Italy; [Ravo, Maria; Grober, Oli Maria Victoria; Weisz, Alessandro] Univ Naples 2, Dipartimento Patol Gen, Naples, Italy; [Ravo, Maria; Grober, Oli Maria Victoria; Weisz, Alessandro] Univ Naples 2, Ctr Grandi Apparecchiature, Naples, Italy; [Weisz, Alessandro] CEINGE Biotecnol Avanzate, AIRC Naples Oncogenom Ctr, Naples, Italy; [Berti, Emilio] Univ Milano Bicocca, Milan, Italy	University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; Universita della Campania Vanvitelli; Universita della Campania Vanvitelli; CEINGE Biotecnologie Avanzate; University of Milano-Bicocca	Borrelli, S (corresponding author), Univ Milan, Dipartimento Sci Biomol & Biotecnol, Milan, Italy.	mantor@unimi.it	DOLFINI, DILETTA/D-8286-2017; Berti, Emilio/F-5256-2012; Weisz, Alessandro/A-1317-2014	Weisz, Alessandro/0000-0003-0455-2083; vigano, maria alessandra/0000-0003-2009-0384; Berti, Emilio/0000-0001-6753-4910; Ravo, Maria/0000-0003-1003-2922; DOLFINI, DILETTA/0000-0002-5346-6096	European Union [LSHB-CT-2005-019067, LSHM-CT-2005-018652]; Fondazione CARIPLO (Cassa di Risparmio delle Provincie Lombarde) Nobel,; MIUR (Ministero dell'Universitae della Ricerca Scientifica); Associazione Italiana per la Ricerca sul Cancro	European Union; Fondazione CARIPLO (Cassa di Risparmio delle Provincie Lombarde) Nobel,; MIUR (Ministero dell'Universitae della Ricerca Scientifica); Associazione Italiana per la Ricerca sul Cancro	This work was supported by European Union Integrated Projects EPISTEM LSHB-CT-2005-019067 and CRESCENDO LSHM-CT-2005-018652, Fondazione CARIPLO (Cassa di Risparmio delle Provincie Lombarde) Nobel, MIUR (Ministero dell'Universitae della Ricerca Scientifica) PRIN; Associazione Italiana per la Ricerca sul Cancro. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbaro V, 2007, J CELL BIOL, V177, P1037, DOI 10.1083/jcb.200703003; Barbieri CE, 2006, CANCER RES, V66, P7589, DOI 10.1158/0008-5472.CAN-06-2020; BORRELLI S, 2010, CELL DEATH IN PRESS; Borrelli S, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-85; Bull JJ, 2002, J INVEST DERMATOL, V118, P17, DOI 10.1046/j.0022-202x.2001.01629.x; Carroll DK, 2006, NAT CELL BIOL, V8, P551, DOI 10.1038/ncb1420; Chikh A, 2007, BIOCHEM BIOPH RES CO, V361, P1, DOI 10.1016/j.bbrc.2007.06.069; CORDANI N, 2010, ONCOGENE IN PRESS; Dai X, 2004, CURR OPIN GENET DEV, V14, P485, DOI 10.1016/j.gde.2004.07.002; Della Gatta G, 2008, GENOME RES, V18, P939, DOI 10.1101/gr.073601.107; Descargues P, 2005, NAT GENET, V37, P56, DOI 10.1038/ng1493; DeYoung MP, 2007, ONCOGENE, V26, P5169, DOI 10.1038/sj.onc.1210337; Eckert RL, 2009, AMINO ACIDS, V36, P739, DOI 10.1007/s00726-008-0123-9; Ewing SJ, 2008, CELL DEATH DIFFER, V15, P1734, DOI 10.1038/cdd.2008.105; Eychene A, 2008, NAT REV CANCER, V8, P683, DOI 10.1038/nrc2460; Famulski JK, 2007, CURR BIOL, V17, P2143, DOI 10.1016/j.cub.2007.11.037; Fan ZP, 2009, NAT CELL BIOL, V11, P1002, DOI 10.1038/ncb1913; Gigliotti AP, 2003, EXP BIOL MED, V228, P278, DOI 10.1177/153537020322800306; Gosselet FP, 2007, CELL SIGNAL, V19, P731, DOI 10.1016/j.cellsig.2006.09.006; Grimm SL, 2003, J MAMMARY GLAND BIOL, V8, P191, DOI 10.1023/A:1025900908026; Hewett DR, 2005, HUM MOL GENET, V14, P335, DOI 10.1093/hmg/ddi030; Huang AM, 2004, ONCOGENE, V23, P1549, DOI 10.1038/sj.onc.1207285; Hutt JA, 2000, J BIOL CHEM, V275, P29123, DOI 10.1074/jbc.M004476200; Hutt JA, 2002, MOL CANCER THER, V1, P601; Ikezoe T, 2005, CANCER RES, V65, P4762, DOI 10.1158/0008-5472.CAN-03-3619; Ingraham CR, 2006, NAT GENET, V38, P1335, DOI 10.1038/ng1903; Jackson B, 2005, J INVEST DERMATOL, V124, P1062, DOI 10.1111/j.0022-202X.2005.23699.x; Koizumi H, 1996, BRIT J DERMATOL, V134, P686, DOI 10.1111/j.1365-2133.1996.tb06971.x; Komatsu N, 2003, J INVEST DERMATOL, V121, P542, DOI 10.1046/j.1523-1747.2003.12363.x; Komuves LG, 2002, DEV DYNAM, V224, P58, DOI 10.1002/dvdy.10085; Lefterova MI, 2008, GENE DEV, V22, P2941, DOI 10.1101/gad.1709008; Leong J, 1996, EXP CELL RES, V224, P79, DOI 10.1006/excr.1996.0113; Loomis KD, 2007, CANCER RES, V67, P6768, DOI 10.1158/0008-5472.CAN-07-0139; Loots GG, 2002, GENOME RES, V12, P832, DOI 10.1101/gr.225502; Lopez RG, 2009, NAT CELL BIOL, V11, P1181, DOI 10.1038/ncb1960; Magert HJ, 2002, EUR J MED RES, V7, P49; Martin N, 2004, GENOME RES, V14, P2430, DOI 10.1101/gr.2709404; Maytin EV, 1998, J INVEST DERMATOL, V110, P238, DOI 10.1046/j.1523-1747.1998.00123.x; Motohashi H, 2004, P NATL ACAD SCI USA, V101, P6379, DOI 10.1073/pnas.0305902101; Ness SL, 1998, J BIOL CHEM, V273, P23904, DOI 10.1074/jbc.273.37.23904; Neufang G, 2001, P NATL ACAD SCI USA, V98, P7629, DOI 10.1073/pnas.121574098; Nishio H, 2001, J ANAT, V198, P581, DOI 10.1046/j.1469-7580.2001.19850581.x; Ogata A, 2004, ACTA HISTOCHEM, V106, P65, DOI 10.1016/j.acthis.2003.10.001; Oh HS, 1998, J INVEST DERMATOL, V110, P939, DOI 10.1046/j.1523-1747.1998.00199.x; Oh WJ, 2007, CANCER RES, V67, P1867, DOI 10.1158/0008-5472.CAN-06-2746; ORourke J, 1997, J BIOL CHEM, V272, P6291, DOI 10.1074/jbc.272.10.6291; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Pabst T, 2009, CLIN CANCER RES, V15, P5303, DOI 10.1158/1078-0432.CCR-08-2941; Patel M, 2010, STEM CELL REV REP, V6, P367, DOI 10.1007/s12015-010-9123-8; Pozzi S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005008; Pusapati RV, 2010, MOL CARCINOGEN, V49, P152, DOI 10.1002/mc.20584; Raghunath M, 1998, J INVEST DERMATOL, V111, P559, DOI 10.1046/j.1523-1747.1998.00339.x; Ramji DP, 2002, BIOCHEM J, V365, P561, DOI 10.1042/BJ20020508; Richardson RJ, 2006, NAT GENET, V38, P1329, DOI 10.1038/ng1894; Romeo G, 2002, J INTERF CYTOK RES, V22, P39, DOI 10.1089/107999002753452647; Ruchaud S, 2007, NAT REV MOL CELL BIO, V8, P798, DOI 10.1038/nrm2257; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pD91, DOI 10.1093/nar/gkh012; Sanford DC, 2005, PROSTATE, V63, P143, DOI 10.1002/pros.20159; SCREPANTI I, 1995, EMBO J, V14, P1932, DOI 10.1002/j.1460-2075.1995.tb07185.x; Sebastian T, 2006, CELL CYCLE, V5, P953, DOI 10.4161/cc.5.9.2733; Segre JA, 1999, NAT GENET, V22, P356, DOI 10.1038/11926; Sivko GS, 2004, J CELL BIOCHEM, V93, P830, DOI 10.1002/jcb.20223; Smith C, 2004, BIOCHEM J, V380, P757, DOI 10.1042/BJ20040077; Sterneck E, 2006, ONCOGENE, V25, P1272, DOI 10.1038/sj.onc.1209144; Sterneck E, 1998, P NATL ACAD SCI USA, V95, P10908, DOI 10.1073/pnas.95.18.10908; Sterneck E, 1997, GENE DEV, V11, P2153, DOI 10.1101/gad.11.17.2153; Strong CD, 2006, J CELL BIOL, V175, P661, DOI 10.1083/jcb.200605057; Tada T, 2006, JNCI-J NATL CANCER I, V98, P396, DOI 10.1093/jnci/djj093; Tanaka T, 1997, EMBO J, V16, P7432, DOI 10.1093/emboj/16.24.7432; Tang D, 2006, BREAST CANCER RES TR, V95, P161, DOI 10.1007/s10549-005-9061-3; Testa A, 2005, J BIOL CHEM, V280, P13606, DOI 10.1074/jbc.M414039200; Testoni B, 2006, CELL CYCLE, V5, P2805, DOI 10.4161/cc.5.23.3525; Thangaraju M, 2005, DEVELOPMENT, V132, P4675, DOI 10.1242/dev.02050; Tong YG, 2009, J MOL ENDOCRINOL, V43, P179, DOI 10.1677/JME-08-0176; Truong AB, 2006, GENE DEV, V20, P3185, DOI 10.1101/gad.1463206; Tsubooka N, 2009, GENES CELLS, V14, P683, DOI 10.1111/j.1365-2443.2009.01301.x; van der Fits L, 2003, J PATHOL, V199, P107, DOI 10.1002/path.1263; Verlinden L, 2005, J BIOL CHEM, V280, P37319, DOI 10.1074/jbc.M503587200; Vigano MA, 2006, EMBO J, V25, P5105, DOI 10.1038/sj.emboj.7601375; Vogler R, 2003, J INVEST DERMATOL, V120, P693, DOI 10.1046/j.1523-1747.2003.12096.x; WANG ND, 1995, SCIENCE, V269, P1108, DOI 10.1126/science.7652557; Wenzel J, 2008, INT J CANCER, V123, P2605, DOI 10.1002/ijc.23799; Yamanaka R, 1997, P NATL ACAD SCI USA, V94, P13187, DOI 10.1073/pnas.94.24.13187; Yang JC, 2008, BLOOD, V112, P805, DOI 10.1182/blood-2007-11-126326; Yang T, 2004, GENE DEV, V18, P2354, DOI 10.1101/gad.1232104; Yoon K, 2007, ONCOGENE, V26, P360, DOI 10.1038/sj.onc.1209797; Zhang YX, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-69; Zhu SY, 2002, P NATL ACAD SCI USA, V99, P207, DOI 10.1073/pnas.012437299; Zhu SY, 1999, MOL CELL BIOL, V19, P7181	89	11	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2010	5	11							e13789	10.1371/journal.pone.0013789	http://dx.doi.org/10.1371/journal.pone.0013789			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	674VY	21072181	Green Published, Green Submitted, gold			2022-12-27	WOS:000283779700006
J	Coudriet, GM; He, J; Trucco, M; Mars, WM; Piganelli, JD				Coudriet, Gina M.; He, Jing; Trucco, Massimo; Mars, Wendy M.; Piganelli, Jon D.			Hepatocyte Growth Factor Modulates Interleukin-6 Production in Bone Marrow Derived Macrophages: Implications for Inflammatory Mediated Diseases	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE-3; ACUTE-PHASE PROTEINS; FACTOR-KAPPA-B; ANTIINFLAMMATORY ACTION; IL-10 PRODUCTION; EXPRESSION; RECEPTOR; KIDNEY; CELLS; GSK3	The generation of the pro-inflammatory cytokines IL-6, TNF-alpha, and IL-1 beta fuel the acute phase response (APR). To maintain body homeostasis, the increase of inflammatory proteins is resolved by acute phase proteins via presently unknown mechanisms. Hepatocyte growth factor (HGF) is transcribed in response to IL-6. Since IL-6 production promotes the generation of HGF and induces the APR, we posited that accumulating HGF might be a likely candidate for quelling excess inflammation under non-pathological conditions. We sought to assess the role of HGF and how it influences the regulation of inflammation utilizing a well-defined model of inflammatory activation, lipopolysaccharide (LPS)-stimulation of bone marrow derived macrophages (BMM). BMM were isolated from C57BL6 mice and were stimulated with LPS in the presence or absence of HGF. When HGF was present, there was a decrease in production of the pro-inflammatory cytokine IL-6, along with an increase in the anti-inflammatory cytokine IL-10. Altered cytokine production correlated with an increase in phosphorylated GSK3 beta, increased retention of the phosphorylated NF kappa B p65 subunit in the cytoplasm, and an enhanced interaction between CBP and phospho-CREB. These changes were a direct result of signaling through the HGF receptor, MET, as effects were reversed in the presence of a selective inhibitor of MET (SU11274) or when using BMM from macrophage-specific conditional MET knockout mice. Combined, these data provide compelling evidence that under normal circumstances, HGF acts to suppress the inflammatory response.	[Coudriet, Gina M.; Mars, Wendy M.] Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA 15260 USA; [He, Jing; Trucco, Massimo; Piganelli, Jon D.] UPMC, Childrens Hosp Pittsburgh, Dept Pediat, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Coudriet, GM (corresponding author), Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA 15260 USA.	jdp51@pitt.edu			American Heart Association; Children's Hospital of Pittsburgh of University of Pittsburgh Medical Center; Juvenile Diabetes Research Foundation [76-01]; American Diabetes Association [CDA 7.07 CD16]	American Heart Association(American Heart Association); Children's Hospital of Pittsburgh of University of Pittsburgh Medical Center; Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); American Diabetes Association(American Diabetes Association)	This work was supported by an American Heart Association pre-doctoral award (GMC), a Research Advisory Council pre-doctoral award by Children's Hospital of Pittsburgh of University of Pittsburgh Medical Center (GMC), a Juvenile Diabetes Research Foundation (76-01) (JDP), and the American Diabetes Association (CDA 7.07 CD16) (JDP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes PJ, 1997, NEW ENGL J MED, V336, P1066, DOI 10.1056/NEJM199704103361506; Berthou S, 2004, ONCOGENE, V23, P5387, DOI 10.1038/sj.onc.1207691; Beurel E, 2010, TRENDS IMMUNOL, V31, P24, DOI 10.1016/j.it.2009.09.007; Demarchi F, 2003, J BIOL CHEM, V278, P39583, DOI 10.1074/jbc.M305676200; Eldar-Finkelman H, 1999, DIABETES, V48, P1662, DOI 10.2337/diabetes.48.8.1662; Gabay C, 1999, NEW ENGL J MED, V340, P448, DOI 10.1056/NEJM199902113400607; Gabay C, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1917; Giannopoulou M, 2008, AM J PATHOL, V173, P30, DOI 10.2353/ajpath.2008.070583; Goetschel F, 2008, EXP CELL RES, V314, P1351, DOI 10.1016/j.yexcr.2007.12.015; Gong RJ, 2004, J AM SOC NEPHROL, V15, P2868, DOI 10.1097/01.ASN.0000141962.44300.3A; Gong RJ, 2008, CURR OPIN INVEST DR, V9, P1163; Gong RJ, 2008, J BIOL CHEM, V283, P7401, DOI 10.1074/jbc.M710396200; Gong RJ, 2006, J AM SOC NEPHROL, V17, P2464, DOI 10.1681/ASN.2006020185; Homsi E, 2009, AM J NEPHROL, V29, P283, DOI 10.1159/000159275; Hu XY, 2006, IMMUNITY, V24, P563, DOI 10.1016/j.immuni.2006.02.014; Huh CG, 2004, P NATL ACAD SCI USA, V101, P4477, DOI 10.1073/pnas.0306068101; Ito W, 2008, INT ARCH ALLERGY IMM, V146, P82, DOI 10.1159/000126067; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Jope RS, 2007, NEUROCHEM RES, V32, P577, DOI 10.1007/s11064-006-9128-5; Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004; Kamimoto M, 2009, INT J MOL MED, V24, P161, DOI 10.3892/ijmm_00000219; Li W, 2001, HEPATOLOGY, V33, P1377, DOI 10.1053/jhep.2001.24431; LIU YH, 1994, J BIOL CHEM, V269, P4152; MARS WM, 1995, HEPATOLOGY, V21, P1695, DOI 10.1016/0270-9139(95)90477-8; Martin M, 2005, NAT IMMUNOL, V6, P777, DOI 10.1038/ni1221; Medzhitov R, 2000, NEW ENGL J MED, V343, P338, DOI 10.1056/NEJM200008033430506; Nikoulina SE, 2000, DIABETES, V49, P263, DOI 10.2337/diabetes.49.2.263; Rutella S, 2006, BLOOD, V108, P218, DOI 10.1182/blood-2005-08-3141; Sander LE, 2010, J EXP MED, V207, P1453, DOI 10.1084/jem.20091474; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; Sattler M, 2003, CANCER RES, V63, P5462; Tjin EPM, 2006, BLOOD, V107, P760, DOI 10.1182/blood-2005-05-1929; To Y, 2002, AM J RESP CELL MOL, V27, P220, DOI 10.1165/ajrcmb.27.2.4804; Tse HM, 2004, FREE RADICAL BIO MED, V36, P233, DOI 10.1016/j.freeradbiomed.2003.10.029; Vines A, 2006, J BIOL CHEM, V281, P16985, DOI 10.1074/jbc.M602446200; Woodgett JR, 2005, NAT IMMUNOL, V6, P751, DOI 10.1038/ni0805-751; Xing Z, 1998, J CLIN INVEST, V101, P311, DOI 10.1172/JCI1368; ZARNEGAR R, 1995, J CELL BIOL, V129, P1177, DOI 10.1083/jcb.129.5.1177; Zhong HH, 1998, MOL CELL, V1, P661, DOI 10.1016/S1097-2765(00)80066-0	39	104	108	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2010	5	11							e15384	10.1371/journal.pone.0015384	http://dx.doi.org/10.1371/journal.pone.0015384			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	674VY	21072211	Green Published, Green Accepted, gold			2022-12-27	WOS:000283779700017
J	Sayagues, JM; Fontanillo, C; Abad, MD; Gonzalez-Gonzalez, M; Sarasquete, ME; Chillon, MD; Garcia, E; Bengoechea, O; Fonseca, E; Gonzalez-Diaz, M; De Las Rivas, J; Munoz-Bellvis, L; Orfao, A				Maria Sayagues, Jose; Fontanillo, Celia; del Mar Abad, Maria; Gonzalez-Gonzalez, Maria; Eugenia Sarasquete, Maria; del Carmen Chillon, Maria; Garcia, Eva; Bengoechea, Oscar; Fonseca, Emilio; Gonzalez-Diaz, Marcos; De Las Rivas, Javier; Munoz-Bellvis, Luis; Orfao, Alberto			Mapping of Genetic Abnormalities of Primary Tumours from Metastatic CRC by High-Resolution SNP Arrays	PLOS ONE			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; IN-SITU HYBRIDIZATION; COPY NUMBER CHANGES; COLORECTAL-CANCER PROGRESSION; CHROMOSOME 18Q DELETION; LYMPH-NODE METASTASIS; LIVER METASTASIS; GASTRIC-CANCER; ALLELIC LOSSES; MESSENGER-RNA	Background: For years, the genetics of metastatic colorectal cancer (CRC) have been studied using a variety of techniques. However, most of the approaches employed so far have a relatively limited resolution which hampers detailed characterization of the common recurrent chromosomal breakpoints as well as the identification of small regions carrying genetic changes and the genes involved in them. Methodology/Principal Findings: Here we applied 500K SNP arrays to map the most common chromosomal lesions present at diagnosis in a series of 23 primary tumours from sporadic CRC patients who had developed liver metastasis. Overall our results confirm that the genetic profile of metastatic CRC is defined by imbalanced gains of chromosomes 7, 8q, 11q, 13q, 20q and X together with losses of the 1p, 8p, 17p and 18q chromosome regions. In addition, SNP-array studies allowed the identification of small (< 1.3 Mb) and extensive/large (> 1.5 Mb) altered DNA sequences, many of which contain cancer genes known to be involved in CRC and the metastatic process. Detailed characterization of the breakpoint regions for the altered chromosomes showed four recurrent breakpoints at chromosomes 1p12, 8p12, 17p11.2 and 20p12.1; interestingly, the most frequently observed recurrent chromosomal breakpoint was localized at 17p11.2 and systematically targeted the FAM27L gene, whose role in CRC deserves further investigations. Conclusions/Significance: In summary, in the present study we provide a detailed map of the genetic abnormalities of primary tumours from metastatic CRC patients, which confirm and extend on previous observations as regards the identification of genes potentially involved in development of CRC and the metastatic process.	[Maria Sayagues, Jose; Gonzalez-Gonzalez, Maria; Orfao, Alberto] Univ Salamanca, Dept Med, Serv Gen Citometria, E-37008 Salamanca, Spain; [Fontanillo, Celia; De Las Rivas, Javier] Univ Salamanca, Ctr Invest Canc IBMCC CSIC USAL, Grp Invest Bioinformat & Genom Func, E-37008 Salamanca, Spain; [del Mar Abad, Maria; Bengoechea, Oscar] Hosp Univ Salamanca, Dept Patol, Salamanca, Spain; [del Carmen Chillon, Maria; Gonzalez-Diaz, Marcos] Univ Hosp, Serv Hematol, Ctr Invest Canc IBMCC CSIC USAL, Salamanca, Spain; [Garcia, Eva] Univ Salamanca, Unidad Genom & Prote, Ctr Invest Canc IBMCC CSIC USAL, E-37008 Salamanca, Spain; [Fonseca, Emilio] Hosp Univ Salamanca, Med Oncol Serv, Dept Cirugia, Salamanca, Spain; [Munoz-Bellvis, Luis] Hosp Univ Salamanca, Unidad Cirugia Hepatobiliopancreat, Dept Cirugia, Salamanca, Spain	University of Salamanca; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion del Cancer (CIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca; University of Salamanca; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion del Cancer (CIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion del Cancer (CIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca; University of Salamanca; University of Salamanca	Sayagues, JM (corresponding author), Univ Salamanca, Dept Med, Serv Gen Citometria, E-37008 Salamanca, Spain.	orfao@usal.es	IBSAL, Secretaría/H-3719-2011; Muñoz-Bellvis, Luis/A-2245-2016; Muñoz-Bellvis, Luis/AAU-7364-2021; Orfao, Alberto/B-5801-2017; sarasquete, Maria E/U-8063-2018; Garcia-Sanz, Ramon/B-7986-2017; Chillón, M. Carmen/E-1339-2018; De Las Rivas, Javier/G-5936-2014	Muñoz-Bellvis, Luis/0000-0002-7809-5201; Muñoz-Bellvis, Luis/0000-0002-7809-5201; sarasquete, Maria E/0000-0001-7335-3657; Garcia-Sanz, Ramon/0000-0003-4120-2787; Chillón, M. Carmen/0000-0003-1624-6059; De Las Rivas, Javier/0000-0002-0984-9946; , Maria Gonzalez-Gonzalez/0000-0001-8115-1086; Gonzalez Diaz, Marcos/0000-0001-6637-1072; Fontanillo, Celia/0000-0002-3631-7881	Consejeria de Sanidad, Junta de Castilla y Leon, Valladolid, Spain [SAN191/SA09/06, SAN673/SA39/08]; Fundacion Memoria de Don Samuel Solorzano Barruso, Salamanca, Spain; Caja de Burgos (Obra Social), Burgos, Spain; Grupo Excelencia de Castilla y Leon [GR37]; Instituto de Salud Carlos III (ISCIII), Ministerio de Ciencia e Innovacion, Madrid, Spain [RD06/0020/0035-FEDER]; ISCIII, Ministerio de Ciencia e Innovacion, Madrid, Spain [CP05/00321, FI08/00721, CA08/00212, CA/07/00077]	Consejeria de Sanidad, Junta de Castilla y Leon, Valladolid, Spain(Junta de Castilla y Leon); Fundacion Memoria de Don Samuel Solorzano Barruso, Salamanca, Spain; Caja de Burgos (Obra Social), Burgos, Spain; Grupo Excelencia de Castilla y Leon; Instituto de Salud Carlos III (ISCIII), Ministerio de Ciencia e Innovacion, Madrid, Spain(Instituto de Salud Carlos IIIMinistry of Science and Innovation, Spain (MICINN)Spanish Government); ISCIII, Ministerio de Ciencia e Innovacion, Madrid, Spain(Instituto de Salud Carlos IIIMinistry of Science and Innovation, Spain (MICINN)Spanish Government)	This work has been partially supported by grants from the Consejeria de Sanidad, Junta de Castilla y Leon, Valladolid, Spain (SAN191/SA09/06 and SAN673/SA39/08), Fundacion Memoria de Don Samuel Solorzano Barruso, Salamanca, Spain, Caja de Burgos (Obra Social), Burgos, Spain, Grupo Excelencia de Castilla y Leon (GR37) and the RTICC from the Instituto de Salud Carlos III (ISCIII), Ministerio de Ciencia e Innovacion, Madrid, Spain (RD06/0020/0035-FEDER). JM Sayagues, M Gonzalez, ME Sarasquete and MC Chillon are supported by grants (CP05/00321, FI08/00721, CA08/00212 and CA/07/00077, respectively) from the ISCIII, Ministerio de Ciencia e Innovacion, Madrid, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Mulla F, 2006, J CLIN PATHOL, V59, P624, DOI 10.1136/jcp.2005.033167; Bai C, 2000, P NATL ACAD SCI USA, V97, P1230, DOI 10.1073/pnas.97.3.1230; Bengtsson H, 2008, BIOINFORMATICS, V24, P759, DOI 10.1093/bioinformatics/btn016; Buffart TE, 2005, CELL ONCOL, V27, P57; Camps J, 2008, CANCER RES, V68, P1284, DOI 10.1158/0008-5472.CAN-07-2864; Camps J, 2009, GENE CHROMOSOME CANC, V48, P1002, DOI 10.1002/gcc.20699; Carvalho B, 2009, GUT, V58, P79, DOI 10.1136/gut.2007.143065; Chen LH, 2007, CANCER BIOL THER, V6, P965, DOI 10.4161/cbt.6.6.4193; Chu D, 2009, ANN SURG ONCOL, V16, P3259, DOI 10.1245/s10434-009-0655-6; De Angelis PM, 1999, BRIT J CANCER, V80, P526; Diep CB, 2006, GENE CHROMOSOME CANC, V45, P31, DOI 10.1002/gcc.20261; Diep CB, 2003, GENE CHROMOSOME CANC, V36, P189, DOI 10.1002/gcc.10162; Fijneman RJA, 2007, CANCER LETT, V258, P223, DOI 10.1016/j.canlet.2007.09.013; Garcia J, 2003, CYTOM PART B-CLIN CY, V51B, P14, DOI 10.1002/cyto.b.10006; Gemignani F, 2004, ONCOGENE, V23, P1954, DOI 10.1038/sj.onc.1207305; Ghadimi BM, 2006, CELL ONCOL, V28, P273; Greene FL, 2007, LANCET ONCOL, V8, P572, DOI 10.1016/S1470-2045(07)70185-7; Gui XY, 2008, PEPTIDES, V29, P1609, DOI 10.1016/j.peptides.2008.04.014; Habermann JK, 2007, GENE CHROMOSOME CANC, V46, P10, DOI 10.1002/gcc.20382; Hoglund M, 2002, CANCER RES, V62, P5939; Hu XT, 2008, ONCOL REP, V19, P441; Junnila S, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-73; Knutsen T, 2010, GENE CHROMOSOME CANC, V49, P204, DOI 10.1002/gcc.20730; Korn WM, 1999, GENE CHROMOSOME CANC, V25, P82, DOI 10.1002/(SICI)1098-2264(199906)25:2<82::AID-GCC2>3.0.CO;2-6; Lassmann S, 2007, J MOL MED-JMM, V85, P289, DOI 10.1007/s00109-006-0126-5; Lehner F, 2007, FASEB J, V21, P1445, DOI 10.1096/fj.06-6575com; Macartney-Coxson DP, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-187; Sayagues JM, 2010, J PATHOL, V221, P308, DOI 10.1002/path.2712; Mild G, 2002, INT J CANCER, V102, P254, DOI 10.1002/ijc.10711; Miotto E, 2004, CANCER RES, V64, P8156, DOI 10.1158/0008-5472.CAN-04-3000; Miyoshi N, 2010, ANN SURG ONCOL, V17, P967, DOI 10.1245/s10434-009-0865-y; Ooi A, 1996, VIRCHOWS ARCH, V428, P243; OOKAWA K, 1993, INT J CANCER, V53, P382, DOI 10.1002/ijc.2910530307; Oue N, 2007, ONCOLOGY-BASEL, V72, P371, DOI 10.1159/000113147; Pang J, 2010, J PROTEOME RES, V9, P216, DOI 10.1021/pr900953s; Paredes-Zaglul A, 1998, CLIN CANCER RES, V4, P879; Pitti RM, 1998, NATURE, V396, P699, DOI 10.1038/25387; Provenzani A, 2006, CARCINOGENESIS, V27, P1323, DOI 10.1093/carcin/bgi377; Rigola MA, 2002, CANCER GENET CYTOGEN, V137, P49, DOI 10.1016/S0165-4608(02)00544-7; Sato T, 2009, ONCOL REP, V21, P211, DOI 10.3892/or_00000210; Sayagues JM, 2004, J MOL DIAGN, V6, P316, DOI 10.1016/S1525-1578(10)60527-2; Sheffer M, 2009, P NATL ACAD SCI USA, V106, P7131, DOI 10.1073/pnas.0902232106; Spillman MA, 2007, GYNECOL ONCOL, V105, P312, DOI 10.1016/j.ygyno.2006.12.017; Tanaka T, 2006, BRIT J CANCER, V95, P1562, DOI 10.1038/sj.bjc.6603460; Tanaka T, 2008, J SURG ONCOL, V97, P69, DOI 10.1002/jso.20896; Tanaka T, 2009, DIAGN MOL PATHOL, V18, P219, DOI 10.1097/PDM.0b013e3181910f17; Thean LF, 2010, GENE CHROMOSOME CANC, V49, P99, DOI 10.1002/gcc.20724; Tsai MS, 2007, ANN SURG ONCOL, V14, P786, DOI 10.1245/s10434-006-9215-5; Tsuruga T, 2007, ONCOL RES, V16, P431, DOI 10.3727/000000007783980855; Venkatraman ES, 2007, BIOINFORMATICS, V23, P657, DOI 10.1093/bioinformatics/btl646; VINDELOV LL, 1983, CYTOMETRY, V3, P323, DOI 10.1002/cyto.990030503; Walker BA, 2006, CLIN LYMPHOMA MYELOM, V7, P186, DOI 10.3816/CLM.2006.n.057; World Health Organization, 1988, WHO INT HIST CLASS T, V1-25; World Health Organization, 1967, WHO INT HIST CLASS T, V1-25; Wu CW, 2006, CANCER LETT, V242, P95, DOI 10.1016/j.canlet.2005.10.046; Yang HY, 2004, CLIN EXP METASTAS, V21, P719, DOI 10.1007/s10585-004-8251-4; Zagon IS, 2009, AM J PHYSIOL-REG I, V297, pR1154, DOI 10.1152/ajpregu.00414.2009	58	22	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2010	5	10							e13752	10.1371/journal.pone.0013752	http://dx.doi.org/10.1371/journal.pone.0013752			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673FU	21060790	Green Published, gold			2022-12-27	WOS:000283645300031
J	Echaubard, P; Little, K; Pauli, B; Lesbarreres, D				Echaubard, Pierre; Little, Kevin; Pauli, Bruce; Lesbarreres, David			Context-Dependent Effects of Ranaviral Infection on Northern Leopard Frog Life History Traits	PLOS ONE			English	Article							IMMUNE-SYSTEM; RANA-PIPIENS; MOLECULAR CHARACTERIZATION; VIRULENCE; VIRUS; TRANSMISSION; IRIDOVIRUS; MORTALITY; POPULATION; RESISTANCE	Pathogens have important effects on host life-history traits, but the magnitude of these effects is often strongly context-dependent. The outcome of an interaction between a host and an infectious agent is often associated with the level of stress experienced by the host. Ranavirus causes disease and mortality in amphibian populations in various locations around the world, but most known cases of ranaviral infection have occurred in North America and the United Kingdom. While Ranavirus virulence has been investigated, the outcome of Ranavirus infection has seldom been related to the host environment. In a factorial experiment, we exposed Northern leopard frog (Lithobates pipiens, formerly Rana pipiens) tadpoles to different concentrations of Ranavirus and investigated the effect of host density on certain life-history traits, namely survival, growth rate, developmental stage and number of days from virus exposure to death. Our results suggest a prominent role of density in driving the direction of the interaction between L. pipiens tadpoles and Ranavirus. We showed that increasing animal holding density is detrimental for host fitness as mortality rate is higher, day of death earlier, development longer and growth rate significantly lower in high-density tanks. We observed a linear increase of detrimental effects when Ranavirus doses increased in low-density conditions, with control tadpoles having a significantly higher overall relative fitness. However, this pattern was no longer observed in high-density conditions, where the effects of increasing Ranavirus dose were limited. Infected and control animals fitness were consequently similar. We speculate that the host may eventually diverts the energy required for a metabolic/immune response triggered by the infection (i.e., direct costs of the infection) to better cope with the increase in environmental "stress" associated with high density (i.e., indirect benefits of the infection). Our results illustrate how the net fitness of organisms may be shaped by ecological context and emphasize the necessity of examining the direct/indirect costs and benefits balance to fully understand host-pathogen interactions.	[Echaubard, Pierre; Little, Kevin; Lesbarreres, David] Laurentian Univ, Dept Biol, Genet & Ecol Amphibians Res Grp, Sudbury, ON P3E 2C6, Canada; [Pauli, Bruce] Carleton Univ, Environm Canada, Sci & Technol Branch, Natl Wildlife Res Ctr, Ottawa, ON K1S 5B6, Canada	Laurentian University; Carleton University; Environment & Climate Change Canada; Canadian Wildlife Service; National Wildlife Research Centre - Canada	Echaubard, P (corresponding author), Laurentian Univ, Dept Biol, Genet & Ecol Amphibians Res Grp, Sudbury, ON P3E 2C6, Canada.	dlesbarreres@laurentian.ca	Echaubard, Pierre/H-3500-2019	Echaubard, Pierre/0000-0001-6213-1346; Lesbarreres, David/0000-0002-5505-1935	Natural Science and Engineering Research Council [20-61094]; Innovation/Ontario Innovation Trust [20-61679]	Natural Science and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Innovation/Ontario Innovation Trust	This work was supported by the Natural Science and Engineering Research Council (grant #20-61094) and the Canadian Fund for Innovation/Ontario Innovation Trust (grant #20-61679) to DL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arneberg P, 1998, P ROY SOC B-BIOL SCI, V265, P1283, DOI 10.1098/rspb.1998.0431; Arneberg P, 2002, ECOGRAPHY, V25, P88, DOI 10.1034/j.1600-0587.2002.250110.x; Bedhomme S, 2005, ECOL ENTOMOL, V30, P1, DOI 10.1111/j.0307-6946.2005.00665.x; Bensadia F, 2006, J INSECT PHYSIOL, V52, P146, DOI 10.1016/j.jinsphys.2005.09.011; Bollinger TK, 1999, J WILDLIFE DIS, V35, P413, DOI 10.7589/0090-3558-35.3.413; Brown MJF, 2000, OIKOS, V91, P421, DOI 10.1034/j.1600-0706.2000.910302.x; Brunner JL, 2007, DIS AQUAT ORGAN, V77, P87, DOI 10.3354/dao01845; Brunner JL, 2005, OECOLOGIA, V144, P399, DOI 10.1007/s00442-005-0093-5; Burgett AA, 2007, HERPETOL CONSERV BIO, V2, P29; Carius HJ, 2001, EVOLUTION, V55, P1136, DOI 10.1111/j.0014-3820.2001.tb00633.x; Chinchar VG, 2002, ARCH VIROL, V147, P447, DOI 10.1007/s007050200000; Christin MS, 2003, ENVIRON TOXICOL CHEM, V22, P1127, DOI [10.1897/1551-5028(2003)022&lt;1127:EOAPOT&gt;2.0.CO;2, 10.1002/etc.5620220522]; Coors A, 2008, OIKOS, V117, P1840, DOI 10.1111/j.1600-0706.2008.17028.x; Cunningham AA, 1996, PHILOS T ROY SOC B, V351, P1539, DOI 10.1098/rstb.1996.0140; CUNNINGHAM AA, 2001, THESIS U LONDON LOND; CUNNINGHAM AA, 1998, CONSERV BIOL, V12, P1428; Daszak P, 1999, EMERG INFECT DIS, V5, P735, DOI 10.3201/eid0506.990601; DASZAK P, 1999, TRENDS ECOL EVOL, V14, P5347; Docherty DE, 2003, J WILDLIFE DIS, V39, P556, DOI 10.7589/0090-3558-39.3.556; DRURY SEN, 1995, VET REC, V137, P72, DOI 10.1136/vr.137.3.72; Duffus ALJ, 2008, J WILDLIFE DIS, V44, P109, DOI 10.7589/0090-3558-44.1.109; DUPASQUIER L, 1989, ANNU REV IMMUNOL, V7, P251, DOI 10.1146/annurev.immunol.7.1.251; Flajnik MF, 1996, VET IMMUNOL IMMUNOP, V54, P145, DOI 10.1016/S0165-2427(96)05685-1; Gantress J, 2003, VIROLOGY, V311, P254, DOI 10.1016/S0042-6822(03)00151-X; Gosner K. L., 1960, Herpetologica, V16, P183; GRANOFF A, 1965, ANN NY ACAD SCI, V126, P237, DOI 10.1111/j.1749-6632.1965.tb14278.x; Greer AL, 2005, DIS AQUAT ORGAN, V67, P9, DOI 10.3354/dao067009; Guay JF, 2009, J INSECT PHYSIOL, V55, P919, DOI 10.1016/j.jinsphys.2009.06.006; Harp EM, 2006, J WILDLIFE DIS, V42, P307, DOI 10.7589/0090-3558-42.2.307; Harvell CD, 1999, SCIENCE, V285, P1505, DOI 10.1126/science.285.5433.1505; Hyatt AD, 2002, J WILDLIFE DIS, V38, P239, DOI 10.7589/0090-3558-38.2.239; Jancovich JK, 1997, DIS AQUAT ORGAN, V31, P161, DOI 10.3354/dao031161; Jancovich JK, 2001, DIS AQUAT ORGAN, V46, P159, DOI 10.3354/dao046159; Jofre MB, 1999, ENVIRON TOXICOL CHEM, V18, P1806, DOI 10.1002/etc.5620180829; Joshi A, 1996, EVOL ECOL, V10, P463, DOI 10.1007/BF01237879; KHAN RA, 1990, B ENVIRON CONTAM TOX, V44, P759, DOI 10.1007/BF01701799; Kiesecker JM, 2001, ECOLOGY, V82, P1956, DOI 10.1890/0012-9658(2001)082[1956:EODAPD]2.0.CO;2; Koprivnikar J, 2006, CAN J ZOOL, V84, P1623, DOI 10.1139/Z06-158; Lafferty KD, 2003, ECOL LETT, V6, P654, DOI 10.1046/j.1461-0248.2003.00480.x; Lafferty Kevin D., 2005, P113; Lebarbenchon C, 2008, MOL ECOL, V17, P475, DOI 10.1111/j.1365-294X.2007.03375.x; Lipsitch M, 1996, EVOLUTION, V50, P1729, DOI [10.2307/2410731, 10.1111/j.1558-5646.1996.tb03560.x]; Loreau Michel, 2005, P13; Mao JH, 1997, VIROLOGY, V229, P212, DOI 10.1006/viro.1996.8435; MICHALAKIS Y, 2007, ECOLOGY EVOLUTION PA, P19; Mussmann R, 1998, EUR J IMMUNOL, V28, P2947, DOI 10.1002/(SICI)1521-4141(199809)28:09<2947::AID-IMMU2947>3.0.CO;2-A; Pagan I, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000531; Pearman PB, 2004, J WILDLIFE DIS, V40, P660, DOI 10.7589/0090-3558-40.4.660; Poulin R, 1999, PARASITOL TODAY, V15, P474, DOI 10.1016/S0169-4758(99)01554-9; Poulin R., 2007, EVOLUTIONARY ECOLOGY, DOI [10.1515/9781400840809, DOI 10.1515/9781400840809]; RENSHAW M, 1993, ECOL ENTOMOL, V18, P223, DOI 10.1111/j.1365-2311.1993.tb01094.x; Robert J, 2009, DEV DYNAM, V238, P1249, DOI 10.1002/dvdy.21891; Schmid-Hempel P, 2009, PHILOS T R SOC B, V364, P85, DOI 10.1098/rstb.2008.0157; Schock DM, 2008, COPEIA, P133, DOI 10.1643/CP-06-134; Seppala O, 2008, OIKOS, V117, P749, DOI 10.1111/j.0030-1299.2008.16396.x; Sokal R. H., 1995, BIOMETRY PRINCIPLES; St-Amour V, 2008, EMERG INFECT DIS, V14, P1175, DOI 10.3201/eid1407.070602; STAMOUR V, 2007, CONSERV GENET, V3, P1247; Su M, 2009, ECOL RES, V24, P889, DOI 10.1007/s11284-008-0568-z; TEACHER AG, 2010, ANIMAL CONSERVATION, P1; WAKELIN D, 1989, PARASITOLOGY, V99, pS21, DOI 10.1017/S0031182000083396; Werner J. Kirwin, 2003, Northwestern Naturalist, V84, P24, DOI 10.2307/3536719; Wilson GA, 2008, CAN J ZOOL, V86, P863, DOI 10.1139/Z08-062; WRIGHT PA, 1995, J EXP BIOL, V198, P273; Yang EV, 2002, INT IMMUNOPHARMACOL, V2, P315, DOI 10.1016/S1567-5769(01)00182-5	65	21	22	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2010	5	10							e13723	10.1371/journal.pone.0013723	http://dx.doi.org/10.1371/journal.pone.0013723			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	672HN	21060894	Green Submitted, Green Published, gold			2022-12-27	WOS:000283573800018
J	Harrer, A; Lang, R; Grims, R; Braitsch, M; Hawranek, T; Aberer, W; Vogel, L; Schmid, W; Ferreira, F; Himly, M				Harrer, Andrea; Lang, Roland; Grims, Robert; Braitsch, Michaela; Hawranek, Thomas; Aberer, Werner; Vogel, Lothar; Schmid, Walther; Ferreira, Fatima; Himly, Martin			Diclofenac Hypersensitivity: Antibody Responses to the Parent Drug and Relevant Metabolites	PLOS ONE			English	Article							ACYL GLUCURONIDES; IMMUNOGLOBULIN-E; DIAGNOSIS; STANDARDIZATION; BIOACTIVATION; ASPIRIN; BINDING; ROLES	Background: Hypersensitivity reactions against nonsteroidal antiinflammatory drugs (NSAIDs) like diclofenac (DF) can manifest as Type I-like allergic reactions including systemic anaphylaxis. However, except for isolated case studies experimental evidence for an IgE-mediated pathomechanism of DF hypersensitivity is lacking. In this study we aimed to investigate the possible involvement of drug-and/or metabolite-specific antibodies in selective DF hypersensitivity. Methodology/Principal Findings: DF, an organochemically synthesized linkage variant, and five major Phase I metabolites were covalently coupled to carrier proteins. Drug conjugates were analyzed for coupling degree and capacity to crosslink receptor-bound IgE antibodies from drug-sensitized mice. With these conjugates, the presence of hapten-specific IgE antibodies was investigated in patients' samples by ELISA, mediator release assay, and basophil activation test. Production of sulfidoleukotrienes by drug conjugates was determined in PBMCs from DF-hypersensitive patients. All conjugates were shown to carry more than two haptens per carrier molecule. Immunization of mice with drug conjugates induced drug-specific IgE antibodies capable of triggering mediator release. Therefore, the conjugates are suitable tools for detection of drug-specific antibodies and for determination of their anaphylactic activity. Fifty-nine patients were enrolled and categorized as hypersensitive either selectively to DF or to multiple NSAIDs. In none of the patients' samples evidence for drug/metabolite-specific IgE in serum or bound to allergic effector cells was found. In contrast, a small group of patients (8/59, 14%) displayed drug/metabolite-specific IgG. Conclusions/Significance: We found no evidence for an IgE-mediated effector mechanism based on haptenation of protein carriers in DF-hypersensitive patients. Furthermore, a potential involvement of the most relevant metabolites in DF hypersensitivity reactions could be excluded.	[Harrer, Andrea; Ferreira, Fatima; Himly, Martin] Salzburg Univ, Div Allergy & Immunol, Dept Mol Biol, A-5020 Salzburg, Austria; [Lang, Roland; Hawranek, Thomas] Paracelsus Med Univ Salzburg, Dept Dermatol, Salzburg, Austria; [Grims, Robert; Aberer, Werner] Med Univ Graz, Dept Dermatol, Graz, Austria; [Braitsch, Michaela; Schmid, Walther] Univ Vienna, Inst Organ Chem, A-1090 Vienna, Austria; [Vogel, Lothar] Paul Ehrlich Inst, Div Allergol, D-6070 Langen, Germany	Salzburg University; Paracelsus Private Medical University; Medical University of Graz; University of Vienna; Paul Ehrlich Institute	Harrer, A (corresponding author), Salzburg Univ, Div Allergy & Immunol, Dept Mol Biol, A-5020 Salzburg, Austria.	martin.himly@sbg.ac.at	Ferreira, Fatima/E-4889-2011; Ferreira, Fatima/AAB-4321-2019; Himly, Martin/D-1568-2015	Ferreira, Fatima/0000-0003-0989-2335; Ferreira, Fatima/0000-0003-0989-2335; Himly, Martin/0000-0001-5416-085X; Harrer, Andrea/0000-0001-7717-6125	Austrian Science Fund (FWF) [P18820-B13]	Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported financially by grant P18820-B13 of the Austrian Science Fund (FWF). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberer W, 2003, ALLERGY, V58, P854, DOI 10.1034/j.1398-9995.2003.00279.x; ASERO R, 2010, 4 HYP M ROM IT APR 2; Bircher Andreas J., 2007, P352, DOI 10.1159/000104212; Bluth MH, 2007, ANN CLIN LAB SCI, V37, P362; BORT R, BIOCH PHARM, V58, P787; Bougie D, 1997, BLOOD, V90, P407; de Weck AL, 2006, CURR PHARM DESIGN, V12, P3347, DOI 10.2174/138161206778193971; DING A, 1993, P NATL ACAD SCI USA, V90, P3797, DOI 10.1073/pnas.90.9.3797; GUZMAN M, 2005, ALLERGY CLIN IMMUN S, V1, P151; Hartl A, 2004, METHODS, V32, P328, DOI 10.1016/j.ymeth.2003.08.014; Himly M, 2003, J ALLERGY CLIN IMMUN, V111, P882, DOI 10.1067/mai.2003.163; Himly M, 2009, ALLERGY, V64, P1038, DOI 10.1111/j.1398-9995.2009.01957.x; Karasuyama H, 2009, NAT REV IMMUNOL, V9, P9, DOI 10.1038/nri2458; Kaul S, 2007, CLIN EXP ALLERGY, V37, P141, DOI 10.1111/j.1365-2222.2006.02618.x; Kenny JR, 2004, J MED CHEM, V47, P2816, DOI 10.1021/jm030891w; Kvedariene V, 2006, ALLERGY, V61, P311, DOI 10.1111/j.1398-9995.2006.00978.x; MULDER GJ, 1992, ANNU REV PHARMACOL, V32, P25; Naisbitt DJ, 2007, TOXICOL LETT, V168, P45, DOI 10.1016/j.toxlet.2006.10.014; PUMFORD NR, 1993, CHEM RES TOXICOL, V6, P147, DOI 10.1021/tx00032a002; Riemer AB, 2010, CLIN EXP ALLERGY, V40, P486, DOI 10.1111/j.1365-2222.2009.03363.x; RING J, 1977, LANCET, V1, P466; Roberts L.J., 2001, GOODMAN GILMANS PHAR, V10th, P687; Salama A, 1996, BRIT J HAEMATOL, V95, P640, DOI 10.1046/j.1365-2141.1996.d01-1947.x; Sirichaiwat C, 2004, J MED CHEM, V47, P345, DOI 10.1021/jm0303352; SPAHNLANGGUTH H, 1992, DRUG METAB REV, V24, P5; Szczeklik A, 2003, J ALLERGY CLIN IMMUN, V111, P913, DOI 10.1067/mai.2003.1487; Tang W, 2003, CURR DRUG METAB, V4, P319, DOI 10.2174/1389200033489398; Tang W, 1999, DRUG METAB DISPOS, V27, P365; Tang W, 1999, CHEM RES TOXICOL, V12, P192, DOI 10.1021/tx9802217; Tojo G, 2006, BASIC REACT ORG SYNT, P1; Vogel L, 2005, ALLERGY, V60, P1021, DOI 10.1111/j.1398-9995.2005.00803.x; Wen J, 1996, ANAL BIOCHEM, V240, P155, DOI 10.1006/abio.1996.0345; WILKINSON GR, 2001, GOODMAN GILMANS PHAR, P3; Yan ZY, 2005, DRUG METAB DISPOS, V33, P706, DOI 10.1124/dmd.104.003095; ZIAAMIRHOSSEINI P, 1995, NAT MED, V1, P2, DOI 10.1038/nm0195-2b	35	50	50	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2010	5	10							e13707	10.1371/journal.pone.0013707	http://dx.doi.org/10.1371/journal.pone.0013707			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	672HN	21060839	gold, Green Published			2022-12-27	WOS:000283573800008
J	Coler, RN; Baldwin, SL; Shaverdian, N; Bertholet, S; Reed, SJ; Raman, VS; Lu, XH; DeVos, J; Hancock, K; Katz, JM; Vedvick, TS; Duthie, MS; Clegg, CH; Van Hoeven, N; Reed, SG				Coler, Rhea N.; Baldwin, Susan L.; Shaverdian, Narek; Bertholet, Sylvie; Reed, Steven J.; Raman, Vanitha S.; Lu, Xiuhua; DeVos, Joshua; Hancock, Kathy; Katz, Jacqueline M.; Vedvick, Thomas S.; Duthie, Malcolm S.; Clegg, Christopher H.; Van Hoeven, Neal; Reed, Steven G.			A Synthetic Adjuvant to Enhance and Expand Immune Responses to Influenza Vaccines	PLOS ONE			English	Article							T-CELL RESPONSES; IN-VIVO; ANTIBODY; AGE; VACCINATION; INFECTION; EMULSION; ADULTS; TRIAL; MICE	Safe, effective adjuvants that enhance vaccine potency, including induction of neutralizing Abs against a broad range of variant strains, is an important strategy for the development of seasonal influenza vaccines which can provide optimal protection, even during seasons when available vaccines are not well matched to circulating viruses. We investigated the safety and ability of Glucopyranosyl Lipid Adjuvant-Stable Emulsion (GLA-SE), a synthetic Toll-like receptor (TLR) 4 agonist formulation, to adjuvant Fluzone(R) in mice and non-human primates. The GLA-SE adjuvanted Fluzone vaccine caused no adverse reactions, increased the induction of T helper type 1 (TH1)-biased cytokines such as IFN gamma, TNF and IL-2, and broadened serological responses against drifted A/H1N1 and A/H3N2 influenza variants. These results suggest that synthetic TLR4 adjuvants can enhance the magnitude and quality of protective immunity induced by influenza vaccines.	[Coler, Rhea N.; Baldwin, Susan L.; Shaverdian, Narek; Bertholet, Sylvie; Reed, Steven J.; Raman, Vanitha S.; Vedvick, Thomas S.; Duthie, Malcolm S.; Reed, Steven G.] Infect Dis Res Inst, Seattle, WA USA; [Lu, Xiuhua; DeVos, Joshua; Hancock, Kathy; Katz, Jacqueline M.] Ctr Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, Atlanta, GA USA; [Clegg, Christopher H.; Van Hoeven, Neal; Reed, Steven G.] Immune Design Corp, Seattle, WA USA	Centers for Disease Control & Prevention - USA	Coler, RN (corresponding author), Infect Dis Res Inst, Seattle, WA USA.	sreed@idri.org		Reed, Jim/0000-0002-3348-123X; Duthie, Malcolm/0000-0002-8515-5516; Shaverdian, Narek/0000-0002-0294-8749	National Institutes of Health [AI-044373, AI-25479]; Bill and Melinda Gates Foundation [42387]; Immune Design Corporation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044373] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Immune Design Corporation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by National Institutes of Health grant AI-044373 and contract AI-25479, by grant 42387 from the Bill and Melinda Gates Foundation, and by Immune Design Corporation. Immune Design Corporation had a role in study design and data collection and review of the manuscript.	Alderson MR, 2006, J ENDOTOXIN RES, V12, P313, DOI 10.1179/096805106X118753; Anderson RC, 2010, COLLOID SURFACE B, V75, P123, DOI 10.1016/j.colsurfb.2009.08.022; Baldwin SL, 2009, VACCINE, V27, P5956, DOI 10.1016/j.vaccine.2009.07.081; Baldwin SL, 2009, VACCINE, V27, P3063, DOI 10.1016/j.vaccine.2009.03.018; Banzhoff A, 2003, GERONTOLOGY, V49, P177, DOI 10.1159/000069172; Barr IG, 2010, VACCINE, V28, P1156, DOI 10.1016/j.vaccine.2009.11.043; Baudner BC, 2009, PHARM RES-DORDR, V26, P1477, DOI 10.1007/s11095-009-9859-5; Baumgarth N, 1996, J VIROL, V70, P4411, DOI 10.1128/JVI.70.7.4411-4418.1996; Belz GT, 2002, J VIROL, V76, P12388, DOI 10.1128/JVI.76.23.12388-12393.2002; Bridges CB, 2000, JAMA-J AM MED ASSOC, V284, P1655, DOI 10.1001/jama.284.13.1655; Brown DM, 2004, SEMIN IMMUNOL, V16, P171, DOI 10.1016/j.smim.2004.02.004; Carrat F, 2007, VACCINE, V25, P6852, DOI 10.1016/j.vaccine.2007.07.027; de Jong J C, 2003, Dev Biol (Basel), V115, P63; de Jong JC, 2000, J MED VIROL, V61, P94, DOI 10.1002/(SICI)1096-9071(200005)61:1&lt;94::AID-JMV15&gt;3.0.CO;2-C; Deng YP, 2004, J IMMUNOL, V172, P3437, DOI 10.4049/jimmunol.172.6.3437; Doherty PC, 1997, IMMUNOL REV, V159, P105, DOI 10.1111/j.1600-065X.1997.tb01010.x; Draize, 1959, APPRAISAL SAFETY CHE; Katz JM, 2009, POULTRY SCI, V88, P872, DOI 10.3382/ps.2008-00465; KENDAL AP, 1982, CONCEPTS PROCEDURES, pB17; Lu XH, 2002, VACCINE, V20, P1019, DOI 10.1016/S0264-410X(01)00452-2; Mbawuike IN, 1996, CELL IMMUNOL, V173, P64, DOI 10.1006/cimm.1996.0252; McElhaney JE, 2006, J IMMUNOL, V176, P6333, DOI 10.4049/jimmunol.176.10.6333; Pasare C, 2005, NATURE, V438, P364, DOI 10.1038/nature04267; Singh M, 1998, VACCINE, V16, P1822, DOI 10.1016/S0264-410X(98)00179-0; SLIFKA MK, 1995, J VIROL, V69, P1895, DOI 10.1128/JVI.69.3.1895-1902.1995; Stoute JA, 2006, AM J TROP MED HYG, V75, P166, DOI 10.4269/ajtmh.2006.75.166; Vogel FR, 2009, EXPERT REV VACCINES, V8, P483, DOI [10.1586/erv.09.5, 10.1586/ERV.09.5]; Wack A, 2008, VACCINE, V26, P552, DOI 10.1016/j.vaccine.2007.11.054; Weksler ME, 2000, J CLIN IMMUNOL, V20, P240, DOI 10.1023/A:1006659401385; *WHO, 2009, 211 WHO; WONG GHW, 1986, NATURE, V323, P819, DOI 10.1038/323819a0	31	112	125	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2010	5	10							e13677	10.1371/journal.pone.0013677	http://dx.doi.org/10.1371/journal.pone.0013677			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671UN	21060869	Green Submitted, gold, Green Published			2022-12-27	WOS:000283537000043
J	Pirih, FQ; Michalski, MN; Cho, SW; Koh, AJ; Berry, JE; Ghaname, E; Kamarajan, P; Bonnelye, E; Ross, CW; Kapila, YL; Jurdic, P; McCauley, LK				Pirih, Flavia Q.; Michalski, Megan N.; Cho, Sun W.; Koh, Amy J.; Berry, Janice E.; Ghaname, Eduardo; Kamarajan, Pachiyappan; Bonnelye, Edith; Ross, Charles W.; Kapila, Yvonne L.; Jurdic, Pierre; McCauley, Laurie K.			Parathyroid Hormone Mediates Hematopoietic Cell Expansion through Interleukin-6	PLOS ONE			English	Article							LEUKEMIA INHIBITORY FACTOR; COLONY-STIMULATING FACTOR; BONE-MARROW; FLT3 LIGAND; STEM-CELLS; IN-VIVO; PROGENITOR CELLS; ANABOLIC ACTIONS; STROMAL CELLS; MICE	Parathyroid hormone (PTH) stimulates hematopoietic cells through mechanisms of action that remain elusive. Interleukin-6 (IL-6) is upregulated by PTH and stimulates hematopoiesis. The purpose of this investigation was to identify actions of PTH and IL-6 in hematopoietic cell expansion. Bone marrow cultures from C57B6 mice were treated with fms-like tyrosine kinase-3 ligand (Flt-3L), PTH, Flt-3L plus PTH, or vehicle control. Flt-3L alone increased adherent and non-adherent cells. PTH did not directly impact hematopoietic or osteoclastic cells but acted in concert with Flt-3L to further increase cell numbers. Flt-3L alone stimulated proliferation, while PTH combined with Flt-3L decreased apoptosis. Flt-3L increased blasts early in culture, and later increased CD45(+) and CD11b(+) cells. In parallel experiments, IL-6 acted additively with Flt-3L to increase cell numbers and IL-6-deficient bone marrow cultures (compared to wildtype controls) but failed to amplify in response to Flt-3L and PTH, suggesting that IL-6 mediated the PTH effect. In vivo, PTH increased Lin(-)Sca-1(+)c-Kit(+) (LSK) hematopoietic progenitor cells after PTH treatment in wildtype mice, but failed to increase LSKs in IL-6-deficient mice. In conclusion, PTH acts with Flt-3L to maintain hematopoietic cells by limiting apoptosis. IL-6 is a critical mediator of bone marrow cell expansion and is responsible for PTH actions in hematopoietic cell expansion.	[Pirih, Flavia Q.; Michalski, Megan N.; Cho, Sun W.; Koh, Amy J.; Berry, Janice E.; Ghaname, Eduardo; Kamarajan, Pachiyappan; Kapila, Yvonne L.; McCauley, Laurie K.] Univ Michigan, Sch Dent, Ann Arbor, MI 48109 USA; [Jurdic, Pierre] Univ Lyon 1, Inst Genom Fonct Lyon, CNRS, INRA,Ecole Normale Super Lyon, F-69365 Lyon, France; [Ross, Charles W.; McCauley, Laurie K.] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Bonnelye, Edith] Fac Med RTH Laennec, Lyon, France	University of Michigan System; University of Michigan; INRAE; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); University of Michigan System; University of Michigan	Pirih, FQ (corresponding author), Univ Michigan, Sch Dent, Ann Arbor, MI 48109 USA.	mccauley@umich.edu	McCauley, Laurie/G-4041-2012; Bonnelye, Edith/AAT-9134-2021; Kapila, Yvonne/AAG-5418-2021		National Institutes of Health (NIH) [DK53904, T-90 DK70071-03]; American Academy of Periodontology Foundation; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [T32DE007057] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T90DK070071, R01DK053904] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Academy of Periodontology Foundation; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health (NIH) DK53904 (L. K. M.), NIH Institutional grant T-90 DK70071-03 (F. Q. P.) and the American Academy of Periodontology Foundation (F. Q. P.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams GB, 2007, NAT BIOTECHNOL, V25, P238, DOI 10.1038/nbt1281; Ballen KK, 2007, BIOL BLOOD MARROW TR, V13, P838, DOI 10.1016/j.bbmt.2007.03.007; BERNAD A, 1994, IMMUNITY, V1, P725, DOI 10.1016/S1074-7613(94)80014-6; Blaskovich MA, 2003, CANCER RES, V63, P1270; Brasel K, 1996, BLOOD, V88, P2004, DOI 10.1182/blood.V88.6.2004.bloodjournal8862004; Brunner S, 2007, AM J PHYSIOL-ENDOC M, V293, pE1670, DOI 10.1152/ajpendo.00287.2007; Bryden AAG, 2002, BRIT J CANCER, V86, P322, DOI 10.1038/sj/bjc/6600115; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Chang MK, 2008, J IMMUNOL, V181, P1232, DOI 10.4049/jimmunol.181.2.1232; Chauhan D, 1997, BLOOD, V89, P227, DOI 10.1182/blood.V89.1.227.227_227_234; Chen HL, 2002, J BIOL CHEM, V277, P19374, DOI 10.1074/jbc.M108913200; Demiralp B, 2002, ENDOCRINOLOGY, V143, P4038, DOI 10.1210/en.2002-220221; Dempster DW, 2005, J CELL BIOCHEM, V95, P139, DOI 10.1002/jcb.20388; Drexler HG, 2004, GROWTH FACTORS, V22, P71, DOI 10.1080/08977190410001700989; Erices A, 2002, EXP CELL RES, V280, P24, DOI 10.1006/excr.2002.5627; Gay CV, 2003, J CELL BIOCHEM, V89, P902, DOI 10.1002/jcb.10579; GAY CV, 1991, CALCIFIED TISSUE INT, V49, P153, DOI 10.1007/BF02556108; GREENFIELD EM, 1993, J BONE MINER RES, V8, P1163; HIRAYAMA F, 1995, BLOOD, V85, P1762, DOI 10.1182/blood.V85.7.1762.bloodjournal8571762; Hory BG, 2000, J ENDOCRINOL INVEST, V23, P273, DOI 10.1007/BF03343723; IKEBUCHI K, 1987, P NATL ACAD SCI USA, V84, P9035, DOI 10.1073/pnas.84.24.9035; Jilka RL, 1999, J CLIN INVEST, V104, P439, DOI 10.1172/JCI6610; Jung YG, 2008, STEM CELLS, V26, P2042, DOI 10.1634/stemcells.2008-0149; Jurdic P, 2006, EUR J CELL BIOL, V85, P195, DOI 10.1016/j.ejcb.2005.09.008; KAWANO MM, 1995, BLOOD, V85, P487; KISHIMOTO T, 1995, BLOOD, V86, P1243, DOI 10.1182/blood.V86.4.1243.bloodjournal8641243; Koh AJ, 2005, ENDOCRINOLOGY, V146, P4584, DOI 10.1210/en.2005-0333; Komarova SV, 2005, ENDOCRINOLOGY, V146, P3589, DOI 10.1210/en.2004-1642; KOPF M, 1994, NATURE, V368, P339, DOI 10.1038/368339a0; Lean JM, 2001, BLOOD, V98, P2707, DOI 10.1182/blood.V98.9.2707; Lee SK, 1999, ENDOCRINOLOGY, V140, P3552, DOI 10.1210/en.140.8.3552; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MCCAULEY LK, 1992, ENDOCRINOLOGY, V130, P300, DOI 10.1210/en.130.1.300; MICHALEVICZ R, 1989, SCANNING MICROSCOPY, V3, P1143; O'Brien CA, 2005, AM J PHYSIOL-ENDOC M, V289, pE784, DOI 10.1152/ajpendo.00029.2005; Palmqvist P, 2002, J IMMUNOL, V169, P3353, DOI 10.4049/jimmunol.169.6.3353; Peters M, 2001, EXP HEMATOL, V29, P146, DOI 10.1016/S0301-472X(00)00650-0; Pettway GJ, 2008, BONE, V42, P806, DOI 10.1016/j.bone.2007.11.017; Philbrick WM, 1998, P NATL ACAD SCI USA, V95, P11846, DOI 10.1073/pnas.95.20.11846; Phinney DG, 1999, J CELL BIOCHEM, V72, P570; POLI V, 1994, EMBO J, V13, P1189, DOI 10.1002/j.1460-2075.1994.tb06368.x; Rodriguez MDC, 2004, BLOOD, V103, P3349, DOI 10.1182/blood-2003-10-3438; Rusten LS, 1996, BLOOD, V87, P1317, DOI 10.1182/blood.V87.4.1317.bloodjournal8741317; Saltel F, 2006, J BONE MINER RES, V21, P1913, DOI 10.1359/JBMR.060821; Schirmacher P, 1998, AM J PATHOL, V153, P639, DOI 10.1016/S0002-9440(10)65605-2; Servet-Delprat Christine, 2002, BMC Immunol, V3, P15, DOI 10.1186/1471-2172-3-15; Shibutani T, 2000, J BIOMED MATER RES, V50, P153, DOI 10.1002/(SICI)1097-4636(200005)50:2<153::AID-JBM9>3.0.CO;2-R; TAICHMAN RS, 1994, J EXP MED, V179, P1677, DOI 10.1084/jem.179.5.1677; Terauchi M, 2009, CELL METAB, V10, P229, DOI 10.1016/j.cmet.2009.07.010; Way KJ, 2009, J LEUKOCYTE BIOL, V85, P766, DOI 10.1189/jlb.1108689; Wysolmerski JJ, 2008, PRINCIPLES OF BONE BIOLOGY, VOL 1, 3RD EDITION, P713, DOI 10.1016/B978-0-12-373884-4.00051-3; Zaruba MM, 2008, CARDIOVASC RES, V77, P722, DOI 10.1093/cvr/cvm080	52	30	31	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2010	5	10							e13657	10.1371/journal.pone.0013657	http://dx.doi.org/10.1371/journal.pone.0013657			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671UN	21048959	gold, Green Published, Green Submitted			2022-12-27	WOS:000283537000028
J	Wyatt, ASJ; Waite, AM; Humphries, S				Wyatt, Alex S. J.; Waite, Anya M.; Humphries, Stuart			Variability in Isotope Discrimination Factors in Coral Reef Fishes: Implications for Diet and Food Web Reconstruction	PLOS ONE			English	Article							TROPHIC-STEP FRACTIONATION; STABLE-ISOTOPES; LIPID EXTRACTION; GUT-CONTENT; BODY-SIZE; CARBON; NITROGEN; DELTA-N-15; DELTA-C-13; TISSUES	Interpretation of stable isotope ratios of carbon and nitrogen (delta C-13 and delta N-15) is generally based on the assumption that with each trophic level there is a constant enrichment in the heavier isotope, leading to diet-tissue discrimination factors of 3.4% for N-15 (Delta N) and similar to 0.5 parts per thousand for C-13 (Delta C). Diet-tissue discrimination factors determined from paired tissue and gut samples taken from 152 individuals from 26 fish species at Ningaloo Reef, Western Australia demonstrate a large amount of variability around constant values. While caution is necessary in using gut contents to represent diet due to the potential for high temporal variability, there were significant effects of trophic position and season that may also lead to variability in Delta N under natural conditions. Nitrogen enrichment increased significantly at higher trophic levels (higher tissue delta N-15), with significantly higher Delta N in carnivorous species. Changes in diet led to significant changes in Delta N, but not tissue delta N-15, between seasons for several species: Acanthurus triostegus, Chromis viridis, Parupeneus signatus and Pomacentrus moluccensis. These results confirm that the use of meta-analysis averages for Delta N is likely to be inappropriate for accurately determining diets and trophic relationships using tissue stable isotope ratios. Where feasible, discrimination factors should be directly quantified for each species and trophic link in question, acknowledging the potential for significant variation away from meta-analysis averages and, perhaps, controlled laboratory diets and conditions.	[Wyatt, Alex S. J.; Waite, Anya M.] Univ Western Australia, Oceans Inst, Crawley, Australia; [Wyatt, Alex S. J.; Waite, Anya M.] Univ Western Australia, Sch Environm Syst Engn, Crawley, Australia; [Humphries, Stuart] Univ Hull, Dept Biol Sci, Kingston Upon Hull, Yorks, England	University of Western Australia; University of Western Australia; University of Hull	Wyatt, ASJ (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA.	awyatt@graduate.uwa.edu.au	Waite, Anya M/A-5492-2015; Wyatt, Alex S.J./A-9402-2008; Humphries, Stuart/A-5664-2008	Waite, Anya M/0000-0003-2965-0296; Wyatt, Alex S.J./0000-0002-1339-9546; Humphries, Stuart/0000-0001-9766-6404	Natural Environment Research Council; British Ecological Society; University of Western Australia; Faculty of Engineering, Computing and Mathematical Sciences; Western Australian Marine Science Institution; Australian Research Council (ARC) [DP0663670]; Australian Coral Reef Society; CSIRO Wealth from Oceans; NERC [NE/B500690/3] Funding Source: UKRI; Natural Environment Research Council [NE/B500690/3] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); British Ecological Society; University of Western Australia; Faculty of Engineering, Computing and Mathematical Sciences; Western Australian Marine Science Institution; Australian Research Council (ARC)(Australian Research Council); Australian Coral Reef Society; CSIRO Wealth from Oceans; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Funding was provided by a Natural Environment Research Council Advanced Fellowship and a grant from the British Ecological Society to SH, grants from The University of Western Australia, the Faculty of Engineering, Computing and Mathematical Sciences, and the Western Australian Marine Science Institution (Node 3) to AMW, an Australian Research Council (ARC) Discovery Grant #DP0663670 to AMW et al., an Australian Coral Reef Society Fellowship to ASJW and CSIRO Wealth from Oceans funding to ASJW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes C, 2007, FUNCT ECOL, V21, P356, DOI 10.1111/j.1365-2435.2006.01224.x; Bearhop S, 2002, PHYSIOL BIOCHEM ZOOL, V75, P451, DOI 10.1086/342800; Carassou L, 2008, AQUAT LIVING RESOUR, V21, P1, DOI 10.1051/alr:2008017; Caut S, 2009, J APPL ECOL, V46, P443, DOI 10.1111/j.1365-2664.2009.01620.x; de la Moriniere EC, 2003, MAR ECOL PROG SER, V246, P279; Deb D, 1997, OIKOS, V78, P191, DOI 10.2307/3545816; DENIRO MJ, 1978, GEOCHIM COSMOCHIM AC, V42, P495, DOI 10.1016/0016-7037(78)90199-0; Elsdon TS, 2010, MAR ECOL PROG SER, V408, P195, DOI 10.3354/meps08518; Froese R., 2021, FISHBASE WORLD WIDE; FRY B, 1984, CONTRIB MAR SCI, V27, P13; FRY B, 1982, OECOLOGIA, V54, P200, DOI 10.1007/BF00378393; Gannes LZ, 1997, ECOLOGY, V78, P1271, DOI 10.1890/0012-9658(1997)078[1271:SIIAEA]2.0.CO;2; Granek EF, 2009, ECOSYSTEMS, V12, P462, DOI 10.1007/s10021-009-9235-7; Grey J, 2002, FRESHWATER BIOL, V47, P1235, DOI 10.1046/j.1365-2427.2002.00838.x; Guelinckx J, 2008, J FISH BIOL, V72, P301, DOI 10.1111/j.1095-8649.2007.01692.x; Hill JM, 2009, HYDROBIOLOGIA, V635, P81, DOI 10.1007/s10750-009-9865-y; Ho CT, 2009, ZOOL STUD, V48, P649; Hobson KA, 1999, OECOLOGIA, V120, P314, DOI 10.1007/s004420050865; Hussey NE, 2010, COMP BIOCHEM PHYS A, V155, P445, DOI 10.1016/j.cbpa.2009.09.023; Kolasinski J, 2009, MAR ECOL PROG SER, V386, P181, DOI 10.3354/meps08081; Logan JM, 2008, RAPID COMMUN MASS SP, V22, P1081, DOI 10.1002/rcm.3471; MacNeil MA, 2006, CAN J FISH AQUAT SCI, V63, P345, DOI 10.1139/F05-219; McCutchan JH, 2003, OIKOS, V102, P378, DOI 10.1034/j.1600-0706.2003.12098.x; Mill AC, 2007, FUNCT ECOL, V21, P1137, DOI 10.1111/j.1365-2435.2007.01330.x; MINAGAWA M, 1984, GEOCHIM COSMOCHIM AC, V48, P1135, DOI 10.1016/0016-7037(84)90204-7; Moore JW, 2008, ECOL LETT, V11, P470, DOI 10.1111/j.1461-0248.2008.01163.x; Nagelkerken I, 2009, J FISH BIOL, V75, P1123, DOI 10.1111/j.1095-8649.2009.02303.x; Olive PJW, 2003, J ANIM ECOL, V72, P608, DOI 10.1046/j.1365-2656.2003.00730.x; Parnell AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009672; Ponsard S, 1999, RAPID COMMUN MASS SP, V13, P1305; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.2307/3071875; Robbins CT, 2010, OECOLOGIA, V162, P571, DOI 10.1007/s00442-009-1485-8; Sotiropoulos MA, 2004, ECOL FRESHW FISH, V13, P155, DOI 10.1111/j.1600-0633.2004.00056.x; Sweeting CJ, 2007, J EXP MAR BIOL ECOL, V352, P165, DOI 10.1016/j.jembe.2007.07.007; Sweeting CJ, 2007, J EXP MAR BIOL ECOL, V340, P1, DOI 10.1016/j.jembe.2006.07.023; Sweeting CJ, 2006, RAPID COMMUN MASS SP, V20, P595, DOI 10.1002/rcm.2347; Sweeting CJ, 2005, FUNCT ECOL, V19, P777, DOI 10.1111/j.1365-2435.2005.01019.x; Vander Zanden MJ, 2001, LIMNOL OCEANOGR, V46, P2061; Wyatt ASJ, 2010, MAR ECOL PROG SER, V405, P113, DOI 10.3354/meps08508	39	50	51	2	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2010	5	10							e13682	10.1371/journal.pone.0013682	http://dx.doi.org/10.1371/journal.pone.0013682			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671UN	21060681	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000283537000048
J	Xu, K; Cui, JA; Olman, V; Yang, Q; Puett, D; Xu, Y				Xu, Kun; Cui, Juan; Olman, Victor; Yang, Qing; Puett, David; Xu, Ying			A Comparative Analysis of Gene-Expression Data of Multiple Cancer Types	PLOS ONE			English	Article							HUMAN BREAST-CANCER; PROSTATE-CANCER; LUNG ADENOCARCINOMA; COLORECTAL-CANCER; TOPOISOMERASE-II; DOWN-REGULATION; CELL CARCINOMA; GROWTH; METASTASIS; SERUM	A comparative study of public gene-expression data of seven types of cancers (breast, colon, kidney, lung, pancreatic, prostate and stomach cancers) was conducted with the aim of deriving marker genes, along with associated pathways, that are either common to multiple types of cancers or specific to individual cancers. The analysis results indicate that (a) each of the seven cancer types can be distinguished from its corresponding control tissue based on the expression patterns of a small number of genes, e. g., 2, 3 or 4; (b) the expression patterns of some genes can distinguish multiple cancer types from their corresponding control tissues, potentially serving as general markers for all or some groups of cancers; (c) the proteins encoded by some of these genes are predicted to be blood secretory, thus providing potential cancer markers in blood; (d) the numbers of differentially expressed genes across different cancer types in comparison with their control tissues correlate well with the five-year survival rates associated with the individual cancers; and (e) some metabolic and signaling pathways are abnormally activated or deactivated across all cancer types, while other pathways are more specific to certain cancers or groups of cancers. The novel findings of this study offer considerable insight into these seven cancer types and have the potential to provide exciting new directions for diagnostic and therapeutic development.	[Xu, Kun; Cui, Juan; Olman, Victor; Puett, David; Xu, Ying] Univ Georgia, Dept Biochem & Mol Biol, Inst Bioinformat, Athens, GA 30602 USA; [Xu, Kun] Univ Georgia, Dept Stat, Athens, GA 30602 USA; [Yang, Qing; Xu, Ying] Jilin Univ, Joint Ctr Syst Biol, Changchun 130023, Peoples R China; [Xu, Ying] Jilin Univ, Coll Comp Sci & Technol, Changchun 130023, Peoples R China	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; Jilin University; Jilin University	Xu, K (corresponding author), Univ Georgia, Dept Biochem & Mol Biol, Inst Bioinformat, Athens, GA 30602 USA.	xyn@bmb.uga.edu	Puett, J. David/AIE-8612-2022; Yang, Qing/H-5342-2012	Yang, Qing/0000-0002-5068-6085	National Science Foundation [DBI-0354771, ITR-IIS-0407204, CCF-0621700, DBI-0542119]; National Institutes of Health [1R01GM075331]; Georgia Cancer Coalition; University of Georgia; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075331] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Georgia Cancer Coalition; University of Georgia; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported in part by National Science Foundation (DBI-0354771, ITR-IIS-0407204, CCF-0621700, DBI-0542119), the National Institutes of Health (1R01GM075331), a "Distinguished Scholar" grant from the Georgia Cancer Coalition, and seed funding from the University of Georgia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ababneh M, 2001, BIOCHEM BIOPH RES CO, V283, P507, DOI 10.1006/bbrc.2001.4792; [Anonymous], 2006, DAT STAT; Aota Yasuo, 2004, Haematologica, V89, pEIM17; Badea L, 2008, HEPATO-GASTROENTEROL, V55, P2016; Behrens P, 2003, INT J CANCER, V107, P183, DOI 10.1002/ijc.11336; Bridges JP, 2003, J BIOL CHEM, V278, P52739, DOI 10.1074/jbc.M309599200; Broutet N, 2003, BRIT J CANCER, V88, P1239, DOI 10.1038/sj.bjc.6600877; CATALONA WJ, 1995, JAMA-J AM MED ASSOC, V274, P1214; Chan JM, 2002, J NATL CANCER I, V94, P1099; Chandran UR, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-45; Chekerov R, 2006, NEOPLASIA, V8, P38, DOI 10.1593/neo.05580; Chen WB, 2002, J BIOL CHEM, V277, P36118, DOI 10.1074/jbc.M203709200; Chen X, 2003, MOL BIOL CELL, V14, P3208, DOI 10.1091/mbc.E02-12-0833; Cui J, 2008, BIOINFORMATICS, V24, P2370, DOI 10.1093/bioinformatics/btn418; D'Errico M, 2009, EUR J CANCER, V45, P461, DOI 10.1016/j.ejca.2008.10.032; Dalgliesh GL, 2010, NATURE, V463, P360, DOI 10.1038/nature08672; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dhanasekaran SM, 2001, NATURE, V412, P822, DOI 10.1038/35090585; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Eguchi T, 2007, ONCOGENE, V26, P509, DOI 10.1038/sj.onc.1209810; GROUNDWATER P, 1990, BRIT J CANCER, V62, P816, DOI 10.1038/bjc.1990.384; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hart TC, 2002, J MED GENET, V39, P882, DOI 10.1136/jmg.39.12.882; Herb F, 2008, HUM MOL GENET, V17, P1052, DOI 10.1093/hmg/ddm378; Ho CC, 2002, AM J PATHOL, V161, P1647, DOI 10.1016/S0002-9440(10)64442-2; Jiang WG, 2003, INT J CANCER, V106, P752, DOI 10.1002/ijc.11302; Jiang X, 2008, CANCER CELL, V13, P529, DOI 10.1016/j.ccr.2008.04.019; Jones J, 2005, CLIN CANCER RES, V11, P5730, DOI 10.1158/1078-0432.CCR-04-2225; Kane R, 2008, MOL VIS, V14, P1138; Kholodnyuk ID, 2006, INT J CANCER, V119, P99, DOI 10.1002/ijc.21794; Ki DH, 2007, INT J CANCER, V121, P2005, DOI 10.1002/ijc.22975; Koren R, 2004, ONCOL REP, V12, P915; Landi MT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001651; Lapointe J, 2004, P NATL ACAD SCI USA, V101, P811, DOI 10.1073/pnas.0304146101; Le Jan S, 2003, AM J PATHOL, V162, P1521, DOI 10.1016/S0002-9440(10)64285-X; Lee HY, 2005, BIOCHEM BIOPH RES CO, V330, P989, DOI 10.1016/j.bbrc.2005.03.069; Li H, 2007, XI BAO YU FEN ZI MIA, V23, P312; Lin C.-J., 2001, LIBSVM LIB SUPPORT V; Matei D, 2002, ONCOGENE, V21, P6289, DOI 10.1038/sj.onc.1205785; Mechtcheriakova D, 2007, CELL SIGNAL, V19, P748, DOI 10.1016/j.cellsig.2006.09.004; Miyoshi Y, 2003, CLIN CANCER RES, V9, P5699; Mulla CM, 2009, PANCREAS, V38, P197, DOI 10.1097/MPA.0b013e31818d14a8; NI IBP, 2010, PATHOL RES PRACT; Ning Pei-fang, 2004, Zhonghua Yi Xue Za Zhi, V84, P818; Ohlsson G, 2005, MOL CELL PROTEOMICS, V4, P570, DOI 10.1074/mcp.M500017-MCP200; Park SS, 2005, HISTOPATHOLOGY, V47, P625, DOI 10.1111/j.1365-2559.2005.02303.x; Parr C, 2004, CLIN CANCER RES, V10, P202, DOI 10.1158/1078-0432.CCR-0553-3; Pedraza V, 2010, CANCER-AM CANCER SOC, V116, P486, DOI 10.1002/cncr.24805; Pei HD, 2009, CANCER CELL, V16, P259, DOI 10.1016/j.ccr.2009.07.016; Piovan E, 2005, BLOOD, V105, P931, DOI 10.1182/blood-2004-03-0799; Rhodes DR, 2004, P NATL ACAD SCI USA, V101, P9309, DOI 10.1073/pnas.0401994101; Ries L MD, 2008, SEER CANC STAT REV 1; Sloan EK, 2004, ONCOGENE, V23, P7893, DOI 10.1038/sj.onc.1208062; Someya S, 2008, NEUROBIOL AGING, V29, P1080, DOI 10.1016/j.neurobiolaging.2007.01.014; Soulitzis N, 2006, INT J ONCOL, V29, P305; Su LJ, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-140; Tang L, 2006, CLIN CANCER RES, V12, P3716, DOI 10.1158/1078-0432.CCR-06-0030; Varadhachary A, 2004, INT J CANCER, V111, P398, DOI 10.1002/ijc.20271; Varis A, 2004, INT J CANCER, V109, P548, DOI 10.1002/ijc.20001; Wang WS, 2006, CARCINOGENESIS, V27, P1113, DOI 10.1093/carcin/bgi351; Zhang JH, 2005, CARCINOGENESIS, V26, P1748, DOI 10.1093/carcin/bgi144	61	26	30	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2010	5	10							e13696	10.1371/journal.pone.0013696	http://dx.doi.org/10.1371/journal.pone.0013696			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671UN	21060876	Green Published, gold			2022-12-27	WOS:000283537000057
J	Reside, AE; VanDerWal, JJ; Kutt, AS; Perkins, GC				Reside, April E.; VanDerWal, Jeremy J.; Kutt, Alex S.; Perkins, Genevieve C.			Weather, Not Climate, Defines Distributions of Vagile Bird Species	PLOS ONE			English	Article							DISTRIBUTION MODELS; COMMUNITY STRUCTURE; BIOTIC INTERACTIONS; IMPROVE PREDICTION; NORTHERN-TERRITORY; TEMPORAL VARIATION; MOVEMENT PATTERNS; ENVELOPE MODELS; CHANGE IMPACTS; RAIN-FORESTS	Background: Accurate predictions of species distributions are essential for climate change impact assessments. However the standard practice of using long-term climate averages to train species distribution models might mute important temporal patterns of species distribution. The benefit of using temporally explicit weather and distribution data has not been assessed. We hypothesized that short-term weather associated with the time a species was recorded should be superior to long-term climate measures for predicting distributions of mobile species. Methodology: We tested our hypothesis by generating distribution models for 157 bird species found in Australian tropical savannas (ATS) using modelling algorithm Maxent. The variable weather of the ATS supports a bird assemblage with variable movement patterns and a high incidence of nomadism. We developed "weather" models by relating climatic variables (mean temperature, rainfall, rainfall seasonality and temperature seasonality) from the three month, six month and one year period preceding each bird record over a 58 year period (1950-2008). These weather models were compared against models built using long-term (30 year) averages of the same climatic variables. Conclusions: Weather models consistently achieved higher model scores than climate models, particularly for wide-ranging, nomadic and desert species. Climate models predicted larger range areas for species, whereas weather models quantified fluctuations in habitat suitability across months, seasons and years. Models based on long-term climate averages overestimate availability of suitable habitat and species' climatic tolerances, masking species potential vulnerability to climate change. Our results demonstrate that dynamic approaches to distribution modelling, such as incorporating organism-appropriate temporal scales, improves understanding of species distributions.	[Reside, April E.; Kutt, Alex S.; Perkins, Genevieve C.] Commonwealth Sci & Ind Res Org, Climate Adaptat Flagship & Ecosyst Sci, Townsville, Qld, Australia; [Reside, April E.; VanDerWal, Jeremy J.] James Cook Univ, Sch Marine & Trop Biol, Ctr Trop Biodivers & Climate Change, Townsville, Qld, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); James Cook University	Reside, AE (corresponding author), Commonwealth Sci & Ind Res Org, Climate Adaptat Flagship & Ecosyst Sci, Townsville, Qld, Australia.	april.reside@gmail.com	VanDerWal, Jeremy/C-7457-2009; Perkins, Genevieve/D-3338-2011; Kutt, Alex S/B-2020-2008; Reside, April/H-4940-2011	Kutt, Alex S/0000-0001-9679-2206; Reside, April/0000-0002-0760-9527; VanDerWal, Jeremy/0000-0001-7439-8953	CSIRO	CSIRO(Commonwealth Scientific & Industrial Research Organisation (CSIRO))	This work was funded by the CSIRO Climate Adaptation Flagship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen CR, 2002, ECOSYSTEMS, V5, P348, DOI 10.1007/s10021-001-0079-2; [Anonymous], P 21 INT C MACH LEAR; Araujo MB, 2007, GLOBAL ECOL BIOGEOGR, V16, P743, DOI 10.1111/j.1466-8238.2007.00359.x; Austin GE, 2005, GLOBAL CHANGE BIOL, V11, P31, DOI 10.1111/j.1529-8817.2003.00876.x; Barrett G.W., 2003, NEW ATLAS AUSTR BIRD; Beaumont LJ, 2002, GLOBAL CHANGE BIOL, V8, P954, DOI 10.1046/j.1365-2486.2002.00490.x; Blakers M., 1984, ATLAS AUSTR BIRDS; Brotons L, 2007, DIVERS DISTRIB, V13, P276, DOI 10.1111/j.1472-4642.2007.00339.x; CAI W, 2004, CLIMATE CHANGE QUEEN; Carr MH, 2003, ECOL APPL, V13, pS90; Chan K, 2001, EMU, V101, P281, DOI 10.1071/MU00034; Chan Ken, 1999, Tropical Ecology, V40, P63; Collins DA, 2000, AUST METEOROL MAG, V49, P277; DAVIES SJJF, 1984, J ARID ENVIRON, V7, P183; Dingle H, 2008, EMU, V108, P341, DOI 10.1071/MU08010; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Environmental Protection Agency, 2004, WILDNET DAT; Fensham RJ, 2009, GLOBAL CHANGE BIOL, V15, P380, DOI 10.1111/j.1365-2486.2008.01718.x; Foody GM, 2008, ECOL INFORM, V3, P228, DOI 10.1016/j.ecoinf.2008.02.002; FRANKLIN DC, 1989, EMU, V89, P140, DOI 10.1071/MU9890140; Garnett ST, 2010, RANGELAND J, V32, P215, DOI 10.1071/RJ09083; Grant I, 2008, METEOROLOGICAL REMOT; Green K, 2008, ARCT ANTARCT ALP RES, V40, P74, DOI 10.1657/1523-0430(06-100)[GREEN]2.0.CO;2; Griffioen PA, 2002, EMU, V102, P99, DOI 10.1071/MU01024; Heikkinen RK, 2006, DIVERS DISTRIB, V12, P502, DOI 10.1111/j.1366-9516.2006.00284.x; Heikkinen RK, 2007, GLOBAL ECOL BIOGEOGR, V16, P754, DOI 10.1111/j.1466-8238.2007.00345.x; Higgins P. J., 2002, HDB AUSTR NZ ANTARCT, V6; Higgins P.J., 2006, VOLUME 7 BOATBILL ST; Higgins P. J., 2001, HDB AUSTR NZ ANTARCT, V5; Higgins PJ, 1999, HDB AUSTR NZ ANTARCT, V4; Hilbert DW, 2004, BIOL CONSERV, V116, P367, DOI 10.1016/S0006-3207(03)00230-1; HOBBS J, 1988, IMPACT CLIMATE VARIA; Huston MA, 1999, OIKOS, V86, P393, DOI 10.2307/3546645; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; Jiguet F, 2006, ECOL LETT, V9, P1321, DOI 10.1111/j.1461-0248.2006.00986.x; Jones D.A., 2007, CLIMATE DATA AUSTR W; Kearney M, 2009, ECOL LETT, V12, P334, DOI 10.1111/j.1461-0248.2008.01277.x; Keast A., 1961, Bulletin of the Museum of Comparative Zoology, V123, P305; LING CX, 2003, ADV ARTIFICIAL INTEL; Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x; Lowry H, 2007, WILDLIFE RES, V34, P624, DOI 10.1071/WR07025; Mac Nally R, 2000, BIOL CONSERV, V92, P335, DOI 10.1016/S0006-3207(99)00100-7; Mac Nally R, 1996, AUST J ECOL, V21, P280, DOI 10.1111/j.1442-9993.1996.tb00610.x; Marchant S., 1990, HDB AUSTR NZ ANTARCT, V1; Marchant S., 1993, HDB AUSTR NZ ANTARCT, V2; MARGULES CR, 1994, CONSERV BIOL, V8, P398, DOI 10.1046/j.1523-1739.1994.08020398.x; Marini MA, 2009, CONSERV BIOL, V23, P1558, DOI 10.1111/j.1523-1739.2009.01258.x; Maron M, 2005, AUSTRAL ECOL, V30, P383, DOI 10.1111/j.1442-9993.2005.01480.x; Nebel S, 2008, BIOL CONSERV, V141, P971, DOI 10.1016/j.biocon.2008.01.017; Nicholls A. O., 1998, CONSERVATION CHANGIN; NIX H, 1976, P 16 INT ORN C AUSTR; Ogutu JO, 2008, J ANIM ECOL, V77, P814, DOI 10.1111/j.1365-2656.2008.01392.x; Osborne PE, 2007, DIVERS DISTRIB, V13, P313, DOI 10.1111/j.1472-4642.2007.00344.x; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Petrie SA, 2004, CAN J ZOOL, V82, P1082, DOI 10.1139/Z04-085; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Porter WP, 2000, AM ZOOL, V40, P597, DOI 10.1668/0003-1569(2000)040[0597:CCEOBA]2.0.CO;2; Prates-Clark CD, 2008, ECOL MODEL, V211, P309, DOI 10.1016/j.ecolmodel.2007.09.024; Pressey RL, 2007, TRENDS ECOL EVOL, V22, P583, DOI 10.1016/j.tree.2007.10.001; Price B, 2009, ECOGRAPHY, V32, P745, DOI 10.1111/j.1600-0587.2009.05670.x; Price OF, 1999, BIOL CONSERV, V91, P169, DOI 10.1016/S0006-3207(99)00081-6; Roshier D, 2008, IBIS, V150, P474, DOI 10.1111/j.1474-919X.2008.00806.x; Rowley I., 1975, BIRD LIFE; SCHODDE R, 1982, EVOLUTION FLORA FAUN; Schwinning S, 2004, OECOLOGIA, V141, P191, DOI 10.1007/s00442-004-1683-3; VanDerWal J, 2009, AM NAT, V174, P282, DOI 10.1086/600087; Watterson I, 2007, REGIONAL CLIMATE CHA; WEAVER CM, 1982, EMU, V82, P2, DOI 10.1071/MU9820002; WIENS JA, 1976, ANNU REV ECOL SYST, V7, P81, DOI 10.1146/annurev.es.07.110176.000501; WIENS JA, 1974, CONDOR, V76, P385, DOI 10.2307/1365813; Williams SE, 2003, P ROY SOC B-BIOL SCI, V270, P1887, DOI 10.1098/rspb.2003.2464; Woinarski JCZ, 2006, ECOSYSTEMS, V9, P689, DOI 10.1007/s10021-006-0077-2; WOINARSKI JCZ, 1992, GLOBAL ECOL BIOGEOGR, V2, P1, DOI 10.2307/2997325; Woinarski John C. Z., 2000, Pacific Conservation Biology, V6, P61; Ziembicki Mark, 2007, Pacific Conservation Biology, V13, P128; Zimmermann NE, 2009, P NATL ACAD SCI USA, V106, P19723, DOI 10.1073/pnas.0901643106	79	101	105	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2010	5	10							e13569	10.1371/journal.pone.0013569	http://dx.doi.org/10.1371/journal.pone.0013569			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	670KA	21042575	Green Published, Green Accepted, gold			2022-12-27	WOS:000283419100010
J	Ghigo, E; Barry, AO; Pretat, L; Al Moussawi, K; Desnues, B; Capo, C; Kornfeld, H; Mege, JL				Ghigo, Eric; Barry, Abdoulaye Oury; Pretat, Lionel; Al Moussawi, Khatoun; Desnues, Benoit; Capo, Christian; Kornfeld, Hardy; Mege, Jean-Louis			IL-16 Promotes T. whipplei Replication by Inhibiting Phagosome Conversion and Modulating Macrophage Activation	PLOS ONE			English	Article							TROPHERYMA-WHIPPLEI; HUMAN EOSINOPHILS; LYMPHOCYTE; EXPRESSION; MATURATION; MONOCYTES; CYTOKINES; SURVIVAL; DISEASE; CELLS	The replication of Tropheryma whipplei (the agent of Whipple's disease) within human macrophages is associated with the expression of IL-16, a cytokine known for its chemotactic and inflammatory properties. In this study, we asked whether IL-16 acts on T. whipplei replication by interfering with the endocytic pathway. We observed that in macrophages, T. whipplei was located within late phagosomes that were unable to fuse with lysosomes; in monocytes, T. whipplei was eliminated in phagolysosomes. Moreover, adding IL-16 to monocytes induced bacterial replication and inhibited phagolysosome formation. On the other hand, blocking IL-16 activity, either with anti-IL-16 antibodies in human macrophages or by using murine IL-16(-/-) bone marrow-derived macrophages, inhibited T. whipplei replication and rescued phagolysosome biogenesis. Furthermore, we propose that IL-16-mediated interference with the endocytic pathway is likely related to macrophage activation. First, IFN gamma induced T. whipplei elimination and phagolysosome formation and inhibited IL-16 production by macrophages. Second, the full transcriptional response of murine macrophages to T. whipplei showed that T. whipplei specifically modulated the expression of 231 probes in IL-16(-/-) macrophages. Gene Ontology analysis revealed that 10 of 13 over-represented terms were linked to immune responses, including proinflammatory transcriptional factors of the NF-kappa B family. Our results demonstrated a previously unreported function for IL-16 in promoting bacterial replication through inhibited phagolysosome biogenesis and modulated macrophage activation program.	[Ghigo, Eric; Barry, Abdoulaye Oury; Pretat, Lionel; Al Moussawi, Khatoun; Desnues, Benoit; Capo, Christian; Mege, Jean-Louis] Univ Mediterranee, URMITE, CNRS UMR 6236, IRD 3R198, Marseille, France; [Kornfeld, Hardy] Univ Massachusetts, Sch Med, Dept Med, Div Pulm & Crit Care Med, Worcester, MA USA	UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD); University of Massachusetts System; University of Massachusetts Worcester	Ghigo, E (corresponding author), Univ Mediterranee, URMITE, CNRS UMR 6236, IRD 3R198, Marseille, France.	jean-louis.mege@univmed.fr	Eric, Ghigo/N-9427-2016; MEGE, JEAN-LOUIS/O-6063-2016; Desnues, Benoit/P-4725-2016; Kornfeld, Hardy/AAS-2903-2021	Desnues, Benoit/0000-0003-1422-4294; 	Agence National de la Recherche (ANR) [05-MIIM-043-01]; Fondation pour la Recherche Medicale	Agence National de la Recherche (ANR)(French National Research Agency (ANR)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	This work was supported by the Agence National de la Recherche (ANR, ANR-Microbiology 05-MIIM-043-01). Lionel Pretat is funded as a research assistant by the Fondation pour la Recherche Medicale. Khatoun Al Moussawi and Abdoulaye Oury Barry are fellows of the Scientific Cooperation Foundation "Infectiopole Sud". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the paper.	Al Moussawi K, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000722; Al-Shahrour F, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-114; Alvarez-Dominguez C, 1998, J BIOL CHEM, V273, P33901, DOI 10.1074/jbc.273.51.33901; Baier M, 1997, P NATL ACAD SCI USA, V94, P5273, DOI 10.1073/pnas.94.10.5273; BELLINI A, 1993, J ALLERGY CLIN IMMUN, V92, P412, DOI 10.1016/0091-6749(93)90120-5; Benoit M, 2008, J IMMUNOL, V181, P3733, DOI 10.4049/jimmunol.181.6.3733; BERMAN JS, 1985, CELL IMMUNOL, V95, P105, DOI 10.1016/0008-8749(85)90299-0; Bhattacharya M, 2006, EMBO J, V25, P2878, DOI 10.1038/sj.emboj.7601170; Brurnell JH, 2007, MICROBIOL MOL BIOL R, V71, P636, DOI 10.1128/MMBR.00023-07; Chu JJH, 2004, J VIROL, V78, P10543, DOI 10.1128/JVI.78.19.10543-10555.2004; Clemens DL, 1996, J EXP MED, V184, P1349, DOI 10.1084/jem.184.4.1349; Cook P, 2007, IMMUNOLOGY, V122, P222, DOI 10.1111/j.1365-2567.2007.02631.x; Cruikshank W, 2008, CRIT REV IMMUNOL, V28, P467; CRUIKSHANK WW, 1987, J IMMUNOL, V138, P3817; Desnues B, 2005, J INFECT DIS, V192, P1642, DOI 10.1086/491745; Desnues B, 2005, J IMMUNOL, V175, P4575, DOI 10.4049/jimmunol.175.7.4575; Dupont N, 2009, CELL HOST MICROBE, V6, P137, DOI 10.1016/j.chom.2009.07.005; Elssner A, 2004, J IMMUNOL, V172, P7721, DOI 10.4049/jimmunol.172.12.7721; Fenollar F, 2002, J CLIN MICROBIOL, V40, P1119, DOI 10.1128/JCM.40.3.1119-1120.2002; Flannagan RS, 2009, NAT REV MICROBIOL, V7, P355, DOI 10.1038/nrmicro2128; Ghigo E, 2004, J INFECT DIS, V190, P1767, DOI 10.1086/425041; Ghigo E, 2002, J IMMUNOL, V169, P4488, DOI 10.4049/jimmunol.169.8.4488; Ghigo E, 2001, INFECT IMMUN, V69, P2345, DOI 10.1128/IAI.69.4.2345-2352.2001; Ghigo E, 2002, INFECT IMMUN, V70, P1501, DOI 10.1128/IAI.70.3.1501-1506.2002; Gorvel JP, 2002, VET MICROBIOL, V90, P281, DOI 10.1016/S0378-1135(02)00214-6; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; Haas A, 2007, TRAFFIC, V8, P311, DOI 10.1111/j.1600-0854.2006.00531.x; Kaser A, 2000, J IMMUNOL, V165, P2474, DOI 10.4049/jimmunol.165.5.2474; LIM KG, 1995, INT ARCH ALLERGY IMM, V107, P342, DOI 10.1159/000237023; Liu C, 2007, CYTOKINE, V38, P145, DOI 10.1016/j.cyto.2007.05.016; Marth T, 2003, LANCET, V361, P239, DOI 10.1016/S0140-6736(03)12274-X; Marth T, 2002, GASTROENTEROLOGY, V123, P1468, DOI 10.1053/gast.2002.36583; Mathy NL, 2000, IMMUNOLOGY, V100, P63, DOI 10.1046/j.1365-2567.2000.00997.x; Mege JL, 2006, LANCET INFECT DIS, V6, P557, DOI 10.1016/S1473-3099(06)70577-1; Moos V, 2006, J IMMUNOL, V177, P2015, DOI 10.4049/jimmunol.177.3.2015; Philips JA, 2008, CELL MICROBIOL, V10, P2408, DOI 10.1111/j.1462-5822.2008.01239.x; PITT A, 1992, J CLIN INVEST, V90, P1978, DOI 10.1172/JCI116077; Prada-Delgado A, 2001, J BIOL CHEM, V276, P19059, DOI 10.1074/jbc.M101639200; RAND TH, 1991, J EXP MED, V173, P1521, DOI 10.1084/jem.173.6.1521; Ren FC, 2005, J IMMUNOL, V174, P2738, DOI 10.4049/jimmunol.174.5.2738; Schaible UE, 1998, J IMMUNOL, V160, P1290; Schneider T, 2008, LANCET INFECT DIS, V8, P179, DOI 10.1016/S1473-3099(08)70042-2; Smith AJP, 2009, CYTOKINE GROWTH F R, V20, P43, DOI 10.1016/j.cytogfr.2008.11.006; Steele-Mortimer O, 2008, CURR OPIN MICROBIOL, V11, P38, DOI 10.1016/j.mib.2008.01.002; Trost M, 2009, IMMUNITY, V30, P143, DOI 10.1016/j.immuni.2008.11.006; Via LE, 1998, J CELL SCI, V111, P897; Zhang YJ, 1998, J BIOL CHEM, V273, P1144, DOI 10.1074/jbc.273.2.1144	47	29	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2010	5	10							e13561	10.1371/journal.pone.0013561	http://dx.doi.org/10.1371/journal.pone.0013561			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	668TQ	21042409	gold, Green Published, Green Submitted			2022-12-27	WOS:000283293800023
J	Odegaard, AO; Pereira, MA; Koh, WP; Gross, MD; Duval, S; Yu, MC; Yuan, JM				Odegaard, Andrew O.; Pereira, Mark A.; Koh, Woon-Puay; Gross, Myron D.; Duval, Sue; Yu, Mimi C.; Yuan, Jian-Min			BMI, All-Cause and Cause-Specific Mortality in Chinese Singaporean Men and Women: The Singapore Chinese Health Study	PLOS ONE			English	Article							BODY-MASS INDEX; POPULATION-BASED SAMPLE; OLDER CHINESE; OBESITY; WEIGHT; CANCER; RISK; OVERWEIGHT; FREQUENCY; COHORT	Background: The optimal range of relative weight for morbidity and mortality in Asian populations is an important question in need of more thorough investigation, especially as obesity rates increase. We aimed to examine the association between body mass index (BMI), all cause and cause-specific mortality to determine the optimal range of BMI in relation to mortality in Chinese men and women in Singapore. Methodology/Principal Findings: We analyzed data from a prospective cohort study of 51,251 middle-aged or older (4574) Chinese men and women in the Singapore Chinese Health Study. Participants were enrolled and data on body weight and covariates were collected in 1993-1998 and participants were followed through 2008. The analysis accounted for potential methodological issues through stratification on smoking and age, thorough adjustment of demographic and lifestyle confounders and exclusion of deaths early in the follow-up. Conclusions/Significance: Increased risk of mortality was apparent in underweight (<18.5) and obese BMI categories (>= 27.5) independent of age and smoking. Regardless of age or BMI, smoking considerably increased the rate of mortality and modified the association between BMI and mortality. The most favorable range of BMI for mortality rates and risk in non-smoking persons below age 65 was 18.5-21.4 kg/m(2), and for non-smoking persons aged 65 and above was 21.5-24.4 kg/m(2).	[Odegaard, Andrew O.; Pereira, Mark A.; Gross, Myron D.; Duval, Sue; Yu, Mimi C.; Yuan, Jian-Min] Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN 55455 USA; [Koh, Woon-Puay] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Epidemiol & Publ Hlth, Singapore 117595, Singapore	University of Minnesota System; University of Minnesota Twin Cities; National University of Singapore	Odegaard, AO (corresponding author), Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN 55455 USA.	odeg0025@umn.edu	Duval, Susan/AAI-1874-2020	Pereira, Mark/0000-0002-6704-5276; Yuan, Jian-Min/0000-0002-4620-3108; Duval, Sue/0000-0003-1025-8665	National Institutes of Health (NCI) [R01 CA55069, R35 CA53890, R01 CA80205]; National Institutes of Health (NIDDK) [R01 DK80720-01A1]; NATIONAL CANCER INSTITUTE [R01CA080205, R01CA055069, R35CA053890] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080720] Funding Source: NIH RePORTER	National Institutes of Health (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded by the National Institutes of Health (NCI R01 CA55069, R35 CA53890 and R01 CA80205 NIDDK R01 DK80720-01A1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Butler LM, 2008, BRIT J CANCER, V99, P1511, DOI 10.1038/sj.bjc.6604678; Calle EE, 2004, NAT REV CANCER, V4, P579, DOI 10.1038/nrc1408; Ceschi M, 2007, SWISS MED WKLY, V137, P50; Cooper RS, 2008, INT J OBESITY, V32, pS47, DOI 10.1038/ijo.2008.85; Deurenberg P, 1998, INT J OBESITY, V22, P1164, DOI 10.1038/sj/ijo/0800741; Deurenberg P, 2002, Obes Rev, V3, P141, DOI 10.1046/j.1467-789X.2002.00065.x; Durazo-Arvizu RA, 2008, INT J OBESITY, V32, pS52, DOI 10.1038/ijo.2008.86; Flanders WD, 2008, INT J OBESITY, V32, pS42, DOI 10.1038/ijo.2008.84; Fontaine K. R., 2004, HDB OBESITY ETIOLOGY, P767; Gu DF, 2006, JAMA-J AM MED ASSOC, V295, P776, DOI 10.1001/jama.295.7.776; Hankin JH, 2001, NUTR CANCER, V39, P187, DOI 10.1207/S15327914nc392_5; Hu FB, 2008, OBESITY EPIDEMIOLOGY, V1; Jee SH, 2006, NEW ENGL J MED, V355, P779, DOI 10.1056/NEJMoa054017; KALMIJN S, 1998, INT J OBESITY, V23, P395; Koh WP, 2010, BRIT J CANCER, V102, P610, DOI 10.1038/sj.bjc.6605496; Koh WP, 2005, J NUTR, V135, P2473, DOI 10.1093/jn/135.10.2473; Lavie CJ, 2009, J AM COLL CARDIOL, V53, P1925, DOI 10.1016/j.jacc.2008.12.068; Manson JE, 2007, J WOMENS HEALTH, V16, P168, DOI 10.1089/jwh.2006.0080; Miller SL, 2008, J NUTR HEALTH AGING, V12, P487, DOI 10.1007/BF02982710; Mizoue T, 2007, CANCER SCI, V98, P1254, DOI 10.1111/j.1349-7006.2007.00511.x; Odegaard AO, 2009, DIABETES CARE, V32, P1104, DOI 10.2337/dc08-1674; Rothman KJ, 2008, INT J OBESITY, V32, pS56, DOI 10.1038/ijo.2008.87; Seow A, 1998, CANCER EPIDEM BIOMAR, V7, P135; Seow A, 1998, CANCER EPIDEM BIOMAR, V7, P775; Song YM, 2007, ANN EPIDEMIOL, V17, P556, DOI 10.1016/j.annepidem.2007.01.028; Stevens J, 2008, INT J OBESITY, V32, pS60, DOI 10.1038/ijo.2008.88; Tsugane S, 2002, INT J OBESITY, V26, P529, DOI 10.1038/sj.ijo.0801961; Van Gaal LF, 2006, NATURE, V444, P875, DOI 10.1038/nature05487; Wada K, 2005, INT J OBESITY, V29, P1093, DOI 10.1038/sj.ijo.0803012; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; WHO, 2004, LANCET, V363, P902; Yoon KH, 2006, LANCET, V368, P1681, DOI 10.1016/S0140-6736(06)69703-1; Yuan JM, 1998, INT J EPIDEMIOL, V27, P824, DOI 10.1093/ije/27.5.824; Zhang X, 2008, INT J OBESITY, V32, P1130, DOI 10.1038/ijo.2008.63	34	21	22	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2010	5	11							e14000	10.1371/journal.pone.0014000	http://dx.doi.org/10.1371/journal.pone.0014000			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	680KW	21085577	Green Submitted, Green Published, gold			2022-12-27	WOS:000284231800027
J	Vanzella, P; Schellenberg, EG				Vanzella, Patricia; Schellenberg, E. Glenn			Absolute Pitch: Effects of Timbre on Note-Naming Ability	PLOS ONE			English	Article							MUSICAL PITCH; RELATIVE PITCH; PERCEPTION; IDENTIFICATION; MEMORY; VOICE; RECOGNITION; PREVALENCE; INTERVALS; AMERICAN	Background: Absolute pitch (AP) is the ability to identify or produce isolated musical tones. It is evident primarily among individuals who started music lessons in early childhood. Because AP requires memory for specific pitches as well as learned associations with verbal labels (i.e., note names), it represents a unique opportunity to study interactions in memory between linguistic and nonlinguistic information. One untested hypothesis is that the pitch of voices may be difficult for AP possessors to identify. A musician's first instrument may also affect performance and extend the sensitive period for acquiring accurate AP. Methods/Principal Findings: A large sample of AP possessors was recruited on-line. Participants were required to identity test tones presented in four different timbres: piano, pure tone, natural (sung) voice, and synthesized voice. Note-naming accuracy was better for non-vocal (piano and pure tones) than for vocal (natural and synthesized voices) test tones. This difference could not be attributed solely to vibrato (pitch variation), which was more pronounced in the natural voice than in the synthesized voice. Although starting music lessons by age 7 was associated with enhanced note-naming accuracy, equivalent abilities were evident among listeners who started music lessons on piano at a later age. Conclusions/Significance: Because the human voice is inextricably linked to language and meaning, it may be processed automatically by voice-specific mechanisms that interfere with note naming among AP possessors. Lessons on piano or other fixed-pitch instruments appear to enhance AP abilities and to extend the sensitive period for exposure to music in order to develop accurate AP.	[Vanzella, Patricia] Univ Brasilia, Dept Mus, Brasilia, DF, Brazil; [Schellenberg, E. Glenn] Univ Toronto, Dept Psychol, Mississauga, ON L5L 1C6, Canada	Universidade de Brasilia; University of Toronto; University Toronto Mississauga	Vanzella, P (corresponding author), Univ Brasilia, Dept Mus, Brasilia, DF, Brazil.	g.schellenberg@utoronto.ca	Vanzella, Patricia M/K-6184-2016	Vanzella, Patricia M/0000-0002-7709-1495; Schellenberg, Glenn/0000-0003-3681-6020	Natural Sciences and Engineering Research Council of Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by the Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Athos EA, 2007, P NATL ACAD SCI USA, V104, P14795, DOI 10.1073/pnas.0703868104; Bachem A, 1937, J ACOUST SOC AM, V9, P146, DOI 10.1121/1.1915919; Baharloo S, 1998, AM J HUM GENET, V62, P224, DOI 10.1086/301704; Baharloo S, 2000, AM J HUM GENET, V67, P755, DOI 10.1086/303057; Belin P, 2004, TRENDS COGN SCI, V8, P129, DOI 10.1016/j.tics.2004.01.008; Belin P, 2002, COGNITIVE BRAIN RES, V13, P17, DOI 10.1016/S0926-6410(01)00084-2; Belin P, 2000, NATURE, V403, P309, DOI 10.1038/35002078; Bermudez P, 2009, MUSIC PERCEPT, V27, P89, DOI 10.1525/MP.2009.27.2.89; Boersma P., 2010, PRAAT DOING PHONETIC; BRAMMER LM, 1951, J EXP PSYCHOL, V41, P336, DOI 10.1037/h0058974; Brenton JN, 2008, PEDIATR NEUROL, V39, P137, DOI 10.1016/j.pediatrneurol.2008.05.004; Charest I, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-127; DAMATO MR, 1988, MUSIC PERCEPT, V5, P453; Deutsch D, 2006, J ACOUST SOC AM, V119, P719, DOI 10.1121/1.2151799; Deutsch D, 2002, CURR DIR PSYCHOL SCI, V11, P200, DOI 10.1111/1467-8721.00200; Deutsch D, 2009, J ACOUST SOC AM, V125, P2398, DOI 10.1121/1.3081389; Gregersen PK, 1999, AM J HUM GENET, V65, P911, DOI 10.1086/302541; Gregersen PK, 2001, AM J MED GENET, V98, P280, DOI 10.1002/1096-8628(20010122)98:3<280::AID-AJMG1083>3.0.CO;2-6; HALPERN AR, 1989, MEM COGNITION, V17, P572, DOI 10.3758/BF03197080; Heaton P, 1998, MUSIC PERCEPT, V15, P291; Heaton P, 2008, NEUROPSYCHOLOGIA, V46, P2095, DOI 10.1016/j.neuropsychologia.2008.02.006; Henthorn T, 2007, AM J MED GENET A, V143A, P102, DOI 10.1002/ajmg.a.31596; Hsieh IH, 2008, HEARING RES, V240, P73, DOI 10.1016/j.heares.2008.01.017; HULSE SH, 1985, J COMP PSYCHOL, V99, P176, DOI 10.1037/0735-7036.99.2.176; Lenhoff HM, 2001, MUSIC PERCEPT, V18, P491, DOI 10.1525/mp.2001.18.4.491; Levitin DJ, 2005, TRENDS COGN SCI, V9, P26, DOI 10.1016/j.tics.2004.11.007; Levitin DJ, 2003, MUSIC PERCEPT, V21, P105, DOI 10.1525/mp.2003.21.1.105; LEVITIN DJ, 1994, PERCEPT PSYCHOPHYS, V56, P414, DOI 10.3758/BF03206733; Levitin DJ., NEW GROVE DICT MUSIC, V2001, P37; Levy DA, 2001, NEUROREPORT, V12, P2653, DOI 10.1097/00001756-200108280-00013; Levy DA, 2003, PSYCHOPHYSIOLOGY, V40, P291, DOI 10.1111/1469-8986.00031; LOCKHEAD GR, 1981, J ACOUST SOC AM, V70, P387, DOI 10.1121/1.386773; MIYAZAKI K, 1988, PERCEPT PSYCHOPHYS, V44, P501, DOI 10.3758/BF03207484; Miyazaki K, 2004, JPN PSYCHOL RES, V46, P270, DOI 10.1111/j.1468-5584.2004.00260.x; Miyazaki K, 2002, PERCEPT PSYCHOPHYS, V64, P1337, DOI 10.3758/BF03194776; MIYAZAKI K, 1993, MUSIC PERCEPT, V11, P55; MIYAZAKI K, 1990, MUSIC PERCEPT, V8, P177; MIYAZAKI K, 1989, MUSIC PERCEPT, V7, P1; MIYAZAKI K, 1995, PERCEPT PSYCHOPHYS, V57, P962, DOI 10.3758/BF03205455; MIYAZAKI KI, 1992, MUSIC PERCEPT, V9, P413; NYGAARD LC, 1994, PSYCHOL SCI, V5, P42, DOI 10.1111/j.1467-9280.1994.tb00612.x; Oechslin MS, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/neuro.09.076.2009; Oechslin MS, 2010, CEREB CORTEX, V20, P447, DOI 10.1093/cercor/bhp113; PROFITA J, 1988, AM J MED GENET, V29, P763, DOI 10.1002/ajmg.1320290405; Ryalls BO, 1997, DEV PSYCHOL, V33, P441, DOI 10.1037/0012-1649.33.3.441; Schellenberg EG, 2008, MUSIC PERCEPT, V25, P241, DOI 10.1525/MP.2008.25.3.241; Schellenberg EG, 2003, PSYCHOL SCI, V14, P262, DOI 10.1111/1467-9280.03432; Schulze K, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-106; SETHARES WA, 2005, TUNING TIMBRE; Smith NA, 2008, J ACOUST SOC AM, V123, pEL77, DOI 10.1121/1.2896106; TAKEUCHI AH, 1993, PSYCHOL BULL, V113, P345, DOI 10.1037/0033-2909.113.2.345; Theusch E, 2009, AM J HUM GENET, V85, P112, DOI 10.1016/j.ajhg.2009.06.010; Trainor LJ, 2005, DEV PSYCHOBIOL, V46, P262, DOI 10.1002/dev.20059; Trehub SE, 2008, J EXP CHILD PSYCHOL, V100, P40, DOI 10.1016/j.jecp.2008.01.007; Volkova A, 2006, DEVELOPMENTAL SCI, V9, P583, DOI 10.1111/j.1467-7687.2006.00536.x; Ward W.D., 1999, PSYCHOL MUSIC PP, P265, DOI DOI 10.1016/B978-012213564-4/50009-3; Yonan CA, 2000, PSYCHOL AGING, V15, P88, DOI 10.1037/0882-7974.15.1.88; Zatorre RJ, 2003, NAT NEUROSCI, V6, P692, DOI 10.1038/nn1085	58	26	28	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2010	5	11							e15449	10.1371/journal.pone.0015449	http://dx.doi.org/10.1371/journal.pone.0015449			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	678OA	21085598	gold, Green Submitted, Green Published			2022-12-27	WOS:000284087800024
J	Youngleson, MS; Nkurunziza, P; Jennings, K; Arendse, J; Mate, KS; Barker, P				Youngleson, Michele S.; Nkurunziza, Paul; Jennings, Karen; Arendse, Juanita; Mate, Kedar S.; Barker, Pierre			Improving a Mother to Child HIV Transmission Programme through Health System Redesign: Quality Improvement, Protocol Adjustment and Resource Addition	PLOS ONE			English	Article							STATISTICAL PROCESS-CONTROL; WIDE PROGRAM; PREVENTION; LESSONS	Background: Health systems that deliver prevention of mother to child transmission (PMTCT) services in low and middle income countries continue to underperform, resulting in thousands of unnecessary HIV infections of newborns each year. We used a combination of approaches to health systems strengthening to reduce transmission of HIV from mother to infant in a multi-facility public health system in South Africa. Methodology/Principal Findings: All primary care sites and specialized birthing centers in a resource constrained subdistrict of Cape Metro District, South Africa, were enrolled in a quality improvement (QI) programme. All pregnant women receiving antenatal, intrapartum and postnatal infant care in the sub-district between January 2006 and March 2009 were included in the intervention that had a prototype-innovation phase and a rapid spread phase. System changes were introduced to help frontline healthcare workers to identify and improve performance gaps at each step of the PMTCT pathway. Improvement was facilitated and spread through the use of a Breakthrough Series Collaborative that accelerated learning and the spread of successful changes. Protocol changes and additional resources were introduced by provincial and municipal government. The proportion of HIV-exposed infants testing positive declined from 7.6% to 5%. Key intermediate PMTCT processes improved (antenatal AZT increased from 74% to 86%, PMTCT clients on HAART at the time of labour increased from 10% to 25%, intrapartum AZT increased from 43% to 84%, and postnatal HIV testing from 79% to 95%) compared to baseline. Conclusions/Significance: System improvement methods, protocol changes and addition/reallocation of resources contributed to improved PMTCT processes and outcomes in a resource constrained setting. The intervention requires a clear design, leadership buy-in, building local capacity to use systems improvement methods, and a reliable data system. A systems improvement approach offers a much needed approach to rapidly improve under-performing PMTCT implementation programmes at scale in sub-Saharan Africa.	[Youngleson, Michele S.; Mate, Kedar S.; Barker, Pierre] Inst Healthcare Improvement, Cambridge, MA USA; [Nkurunziza, Paul; Jennings, Karen] City Hlth Dept, Cape Town, South Africa; [Mate, Kedar S.] Weill Cornell Med Coll, Dept Med, New York, NY USA; [Barker, Pierre] Univ N Carolina, Dept Pediat, Chapel Hill, NC USA	Institute for Healthcare Improvement; Cornell University; University of North Carolina; University of North Carolina Chapel Hill	Youngleson, MS (corresponding author), Inst Healthcare Improvement, Cambridge, MA USA.	pbarker@med.unc.edu		Mate, Kedar/0000-0001-7579-6697	Institute for Health Care Improvement	Institute for Health Care Improvement	No external funding was obtained for the execution of this project. Part of the salaries of SMY, KM and PB were supported by the Institute for Health Care Improvement. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], REPORT UNICEF SCALIN; [Anonymous], 2003, BREAKTHR SER IHIS CO; Balas E A, 2000, Yearb Med Inform, P65; Benneyan JC, 2003, QUAL SAF HEALTH CARE, V12, P458, DOI 10.1136/qhc.12.6.458; Berwick DM, 2006, JAMA-J AM MED ASSOC, V295, P324, DOI 10.1001/jama.295.3.324; Berwick DM, 2004, BRIT MED J, V328, P1124, DOI 10.1136/bmj.328.7448.1124; Berwick DM, 2008, JAMA-J AM MED ASSOC, V299, P1182, DOI 10.1001/jama.299.10.1182; Catsambas TT, 2008, EVALUATING HLTH CARE; *CDC, 2007, CAS HIV INF AIDS US, V17; *CDC, 2007, CAS HIV INF AIDS US, V19; Chopra M, 2009, LANCET, V374, P835, DOI 10.1016/S0140-6736(09)61123-5; Coetzee D, 2005, B WORLD HEALTH ORGAN, V83, P489; Day C, 2010, DISTRICT HLTH BAROME; DRAPER B, 2005, 3 IAS C HIV PATH TRE; *ENG HLTH, 2003, EM OBST CAR LEAD MAN; Finison L J, 1996, J Healthc Qual, V18, P32; Fisher ES, 2009, NEW ENGL J MED, V360, P849, DOI 10.1056/NEJMp0809794; HORWOOD C, 2009, KZN IMPACTS RESULTS; *I HEALTHC IMPR 20, 2009, IHI FAC IMPR GUID; Kayongo M, 2006, INT J GYNECOL OBSTET, V92, P308, DOI 10.1016/j.ijgo.2005.12.003; Lallemant M, 2004, NEW ENGL J MED, V351, P217, DOI 10.1056/NEJMoa033500; Langley GL., 2009, IMPROVEMENT GUIDE PR, V2nd; McKenna MT, 2007, AM J OBSTET GYNECOL, V197, pS10, DOI 10.1016/j.ajog.2007.02.032; Mills Peter D, 2004, Jt Comm J Qual Saf, V30, P152; Paintsil E, 2009, CURR OPIN PEDIATR, V21, P94, DOI 10.1097/MOP.0b013e32831ec353; Rollins N, 2007, AIDS, V21, P1341, DOI 10.1097/QAD.0b013e32814db7d4; *S AFR DEP HLTH, 2008, 2008 NAT ANT SENT HI; *S AFR DEP OF HLTH, 2007, NAT STRAT PLAN HIV A; Schouten LMT, 2008, BMJ-BRIT MED J, V336, P1491, DOI 10.1136/bmj.39570.749884.BE; Stringer EM, 2008, B WORLD HEALTH ORGAN, V86, P57, DOI 10.2471/BLT.07.043117; Stringer JSA, 2005, AIDS, V19, P1309, DOI 10.1097/01.aids.0000180102.88511.7d; Teasdale CA, 2008, S AFR J HIV MED, P60; Thor J, 2007, QUAL SAF HEALTH CARE, V16, P387, DOI 10.1136/qshc.2006.022194; UNAIDS, 2009, AIDS EP UPD NOV 2009; *W CAP DEP HLTH HA, 2006, STAT REP PREV MOTH C; WHO, 2012, WHO GUID HIV INF FEE; Wilson Tim, 2003, Jt Comm J Qual Saf, V29, P85; WOODALL WH, 2006, J QUALITY TECHNOLOGY	38	75	77	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2010	5	11							e13891	10.1371/journal.pone.0013891	http://dx.doi.org/10.1371/journal.pone.0013891			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	677ZE	21085479	gold, Green Published, Green Submitted			2022-12-27	WOS:000284035900008
J	Sheridan, P; Kamimura, T; Shimodaira, H				Sheridan, Paul; Kamimura, Takeshi; Shimodaira, Hidetoshi			A Scale-Free Structure Prior for Graphical Models with Applications in Functional Genomics	PLOS ONE			English	Article							BAYESIAN PHYLOGENETIC INFERENCE; REGULATORY NETWORKS; ESTROGEN-RECEPTOR; BREAST-CANCER; GENE; EXPRESSION; LIKELIHOOD; TARGET; GROWTH	The problem of reconstructing large-scale, gene regulatory networks from gene expression data has garnered considerable attention in bioinformatics over the past decade with the graphical modeling paradigm having emerged as a popular framework for inference. Analysis in a full Bayesian setting is contingent upon the assignment of a so-called structure prior-a probability distribution on networks, encoding a priori biological knowledge either in the form of supplemental data or high-level topological features. A key topological consideration is that a wide range of cellular networks are approximately scale-free, meaning that the fraction, P(k), of nodes in a network with degree k is roughly described by a power-law P(k) proportional to k(-gamma) with exponent gamma between 2 and 3. The standard practice, however, is to utilize a random structure prior, which favors networks with binomially distributed degree distributions. In this paper, we introduce a scale-free structure prior for graphical models based on the formula for the probability of a network under a simple scale-free network model. Unlike the random structure prior, its scale-free counterpart requires a node labeling as a parameter. In order to use this prior for large-scale network inference, we design a novel Metropolis-Hastings sampler for graphical models that includes a node labeling as a state space variable. In a simulation study, we demonstrate that the scale-free structure prior outperforms the random structure prior at recovering scale-free networks while at the same time retains the ability to recover random networks. We then estimate a gene association network from gene expression data taken from a breast cancer tumor study, showing that scale-free structure prior recovers hubs, including the previously unknown hub SLC39A6, which is a zinc transporter that has been implicated with the spread of breast cancer to the lymph nodes. Our analysis of the breast cancer expression data underscores the value of the scale-free structure prior as an instrument to aid in the identification of candidate hub genes with the potential to direct the hypotheses of molecular biologists, and thus drive future experiments.	[Sheridan, Paul; Kamimura, Takeshi; Shimodaira, Hidetoshi] Tokyo Inst Technol, Dept Math & Comp Sci, Tokyo 152, Japan	Tokyo Institute of Technology	Sheridan, P (corresponding author), Tokyo Inst Technol, Dept Math & Comp Sci, Tokyo 152, Japan.	sherida6@is.titech.ac.jp	Shimodaira, Hidetoshi/B-9127-2008	Shimodaira, Hidetoshi/0000-0002-3371-7724	Japan Society for the Promotion of Science (JSPS) Global Centers for Excellence (COE)	Japan Society for the Promotion of Science (JSPS) Global Centers for Excellence (COE)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	Funding: This research was supported in part by Computationism as a Foundation for the Sciences, a program of the Japan Society for the Promotion of Science (JSPS) Global Centers for Excellence (COE) (http://compview.titech.ac.jp/front-page-en/view?set_language=en). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamic L.A., 2002, GLOTTOMETRICS, V3, P143; Albert R, 2005, J CELL SCI, V118, P4947, DOI 10.1242/jcs.02714; ALBERT R, 2002, REV MODERN PHYS, V74; Bansal M, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100120; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; BARNARD A, 2005, PSB 05, P459; Basso K, 2005, NAT GENET, V37, P382, DOI 10.1038/ng1532; Beck S, 1999, DNA CELL BIOL, V18, P157, DOI 10.1089/104454999315547; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Burda Z, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.046118; Butte AJ, 2000, P NATL ACAD SCI USA, V97, P12182, DOI 10.1073/pnas.220392197; Carroll JS, 2006, MOL ENDOCRINOL, V20, P1707, DOI 10.1210/me.2005-0334; Carvalho LE, 2008, P NATL ACAD SCI USA, V105, P3209, DOI 10.1073/pnas.0712329105; CASTELO R, 2006, J MACHINE LEARNING R, V7; DEMPSTER AP, 1972, BIOMETRICS, V28, P157, DOI 10.2307/2528966; Dobra A, 2004, J MULTIVARIATE ANAL, V90, P196, DOI 10.1016/j.jmva.2004.02.009; Dorogovtsev SN, 2002, ADV PHYS, V51, P1079, DOI 10.1080/00018730110112519; Edwards D., 2000, INTRO GRAPHICAL MODE; ERDOS P, 1960, B INT STATIST INST, V38, P343; Farkas I, 2003, PHYSICA A, V318, P601, DOI 10.1016/S0378-4371(02)01731-4; Friedman N, 2000, J COMPUT BIOL, V7, P601, DOI 10.1089/106652700750050961; FRYDENBERG M, 1989, BIOMETRIKA, V76, P539, DOI 10.1093/biomet/76.3.539; Giangrande PH, 2003, MOL CELL BIOL, V23, P3707, DOI 10.1128/MCB.23.11.3707-3720.2003; Giudici P, 1999, BIOMETRIKA, V86, P785, DOI 10.1093/biomet/86.4.785; Goh KI, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.278701; Grzegorczyk M, 2008, ANALYSIS OF MICROARRAY DATA: A NETWORK-BASED APPROACH, P101, DOI 10.1002/9783527622818.ch5; Hartemink AJ, 2005, NAT BIOTECHNOL, V23, P554, DOI 10.1038/nbt0505-554; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Husmeier D, 2003, BIOINFORMATICS, V19, P2271, DOI 10.1093/bioinformatics/btg313; Imoto S, 2003, PROCEEDINGS OF THE 2003 IEEE BIOINFORMATICS CONFERENCE, P104, DOI 10.1109/CSB.2003.1227309; Jones B, 2005, STAT SCI, V20, P388, DOI 10.1214/088342305000000304; Kim SK, 2001, SCIENCE, V293, P2087, DOI 10.1126/science.1061603; Lauritzen S.L.., 1996, GRAPHICAL MODELS; Lee DS, 2005, PRAMANA-J PHYS, V64, P1149, DOI 10.1007/BF02704176; Magwene PM, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-12-r100; Margolin AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S7; Markowetz F, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S6-S5; Matsuoka S, 2008, CH CRC COMP SCI SER, P289; Meinshausen N, 2006, ANN STAT, V34, P1436, DOI 10.1214/009053606000000281; Nakshatri H, 2007, EXPERT OPIN THER TAR, V11, P507, DOI 10.1517/14728222.11.4.507; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Ohno S., 1970, P1; Pastor-Satorras R, 2003, J THEOR BIOL, V222, P199, DOI 10.1016/S0022-5193(03)00028-6; Pe'er Dana, 2002, Bioinformatics, V18 Suppl 1, pS258; Rannala B, 1996, J MOL EVOL, V43, P304, DOI 10.1007/PL00006090; Ratmann O, 2007, PLOS COMPUT BIOL, V3, P2266, DOI 10.1371/journal.pcbi.0030230; Renyi A., 1959, PUBL MATH-DEBRECEN, V6, P290, DOI DOI 10.2307/1999405; SAHLIN L, 1994, J STEROID BIOCHEM, V51, P57, DOI 10.1016/0960-0760(94)90115-5; Schafer J, 2005, STAT APPL GENET MO B, V4, DOI 10.2202/1544-6115.1175; Schafer J, 2005, BIOINFORMATICS, V21, P754, DOI 10.1093/bioinformatics/bti062; Schlitt T, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S6-S9; Segal E, 2003, NAT GENET, V34, P166, DOI 10.1038/ng1165; Sheridan P, 2008, ANN I STAT MATH, V60, P747, DOI 10.1007/s10463-008-0181-5; Smith E D, 2002, ADV COMPLEX SYST, V5, P43, DOI DOI 10.1142/S021952590200047X; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Tamada Y, 2003, BIOINFORMATICS, V19, pII227, DOI 10.1093/bioinformatics/btg1082; Taylor KM, 2008, BIOCHEM SOC T, V36, P1247, DOI 10.1042/BST0361247; Werhli AV, 2007, STAT APPL GENET MOL, V6; West M, 2001, P NATL ACAD SCI USA, V98, P11462, DOI 10.1073/pnas.201162998; Whittaker J., 1990, GRAPHICAL MODELS APP; Wille A, 2006, STAT APPL GENET MOL, V5; Wiuf C, 2006, P NATL ACAD SCI USA, V103, P7566, DOI 10.1073/pnas.0600061103; Wong F, 2003, BIOMETRIKA, V90, P809, DOI 10.1093/biomet/90.4.809; Yang ZH, 1997, MOL BIOL EVOL, V14, P717, DOI 10.1093/oxfordjournals.molbev.a025811; Yu J, 2004, BIOINFORMATICS, V20, P3594, DOI 10.1093/bioinformatics/bth448	66	22	22	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2010	5	11							e13580	10.1371/journal.pone.0013580	http://dx.doi.org/10.1371/journal.pone.0013580			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675OD	21079769	Green Published, Green Submitted, gold			2022-12-27	WOS:000283839100001
J	Swettenham, JB; Anderson, SJ; Thai, NJ				Swettenham, Jennifer B.; Anderson, Stephen J.; Thai, Ngoc J.			MEG Responses to the Perception of Global Structure within Glass Patterns	PLOS ONE			English	Article							HUMAN VISUAL-CORTEX; EVENT-RELATED POTENTIALS; TASK-RELATED CHANGES; FORM VISION; HUMAN BRAIN; CORTICAL SYNCHRONIZATION; ORIENTATION STRUCTURE; BEAMFORMER IMAGES; AREAS; MOTION	Background: The perception of global form requires integration of local visual cues across space and is the foundation for object recognition. Here we used magnetoencephalography (MEG) to study the location and time course of neuronal activity associated with the perception of global structure from local image features. To minimize neuronal activity to low-level stimulus properties, such as luminance and contrast, the local image features were held constant during all phases of the MEG recording. This allowed us to assess the relative importance of striate (V1) versus extrastriate cortex in global form perception. Methodology/Principal Findings: Stimuli were horizontal, rotational and radial Glass patterns. Glass patterns without coherent structure were viewed during the baseline period to ensure neuronal responses reflected perception of structure and not changes in local image features. The spatial distribution of task-related changes in source power was mapped using Synthetic Aperture Magnetometry (SAM), and the time course of activity within areas of maximal power change was determined by calculating time-frequency plots using a Hilbert transform. For six out of eight observers, passive viewing of global structure was associated with a reduction in 10-20 Hz cortical oscillatory power within extrastriate occipital cortex. The location of greatest power change was the same for each pattern type, being close to or within visual area V3a. No peaks of activity were observed in area V1. Time-frequency analyses indicated that neural activity was least for horizontal patterns. Conclusions: We conclude: (i) visual area V3a is involved in the analysis of global form; (ii) the neural signature for perception of structure, as assessed using MEG, is a reduction in 10-20 Hz oscillatory power; (iii) different neural processes may underlie the perception of horizontal as opposed to radial or rotational structure; and (iv) area V1 is not strongly activated by global form in Glass patterns.	[Swettenham, Jennifer B.] Cardiff Univ, Sch Psychol, CUBRIC, Cardiff, S Glam, Wales; [Anderson, Stephen J.; Thai, Ngoc J.] Aston Univ, Sch Life & Hlth Sci, Wellcome Trust Lab MEG Studies, Birmingham B4 7ET, W Midlands, England	Cardiff University; Aston University	Swettenham, JB (corresponding author), Cardiff Univ, Sch Psychol, CUBRIC, Cardiff, S Glam, Wales.	jennifer.swettenham@psych.ox.ac.uk		Swettenham, Jennifer/0000-0001-7527-4602; Thai, Ngoc Jade/0000-0001-6125-7326	Wellcome Trust; Dr Hadwen Trust for Humane Research	Wellcome Trust(Wellcome TrustEuropean Commission); Dr Hadwen Trust for Humane Research	Funding: The MEG system was supported with funds from The Wellcome Trust. MEG running costs were supported by funding from the Dr Hadwen Trust for Humane Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmann CF, 2003, CURR BIOL, V13, P342, DOI 10.1016/S0960-9822(03)00052-6; Amunts K, 2000, NEUROIMAGE, V11, P66, DOI 10.1006/nimg.1999.0516; Anderson SJ, 2006, STRABISMUS, V14, P21, DOI 10.1080/09273970500538082; Aspell JE, 2010, EXP BRAIN RES, V202, P669, DOI 10.1007/s00221-010-2173-y; Barnes GR, 2004, HUM BRAIN MAPP, V23, P120, DOI 10.1002/hbm.20047; Barnes GR, 2003, HUM BRAIN MAPP, V18, P1, DOI 10.1002/hbm.10072; Braddick OJ, 2001, PERCEPTION, V30, P61, DOI 10.1068/p3048; Braddick OJ, 2000, CURR BIOL, V10, P731, DOI 10.1016/S0960-9822(00)00540-6; Brookes MJ, 2008, NEUROIMAGE, V39, P1788, DOI 10.1016/j.neuroimage.2007.09.050; Cheyne DL, 2003, COGNITIVE BRAIN RES, V17, P599, DOI 10.1016/S0926-6410(03)00173-3; Dakin SC, 2002, VISION RES, V42, P2013, DOI 10.1016/S0042-6989(02)00057-3; Dumoulin SO, 2007, VISION RES, V47, P1608, DOI 10.1016/j.visres.2007.01.031; Gallant JL, 2000, NEURON, V27, P227, DOI 10.1016/S0896-6273(00)00032-5; GLASS L, 1969, NATURE, V223, P578, DOI 10.1038/223578a0; Hasnain MK, 1998, HUM BRAIN MAPP, V6, P301, DOI 10.1002/(SICI)1097-0193(1998)6:4<301::AID-HBM8>3.0.CO;2-7; Hillebrand A, 2005, INT REV NEUROBIOL, V68, P149, DOI 10.1016/S0074-7742(05)68006-3; Hillebrand A, 2005, HUM BRAIN MAPP, V25, P199, DOI 10.1002/hbm.20102; Hillebrand A, 2002, NEUROIMAGE, V16, P638, DOI 10.1006/nimg.2002.1102; Huang MX, 1999, PHYS MED BIOL, V44, P423, DOI 10.1088/0031-9155/44/2/010; Kelly DM, 2001, PSYCHOL SCI, V12, P338, DOI 10.1111/1467-9280.00362; Kilner JM, 2005, NEUROIMAGE, V28, P280, DOI 10.1016/j.neuroimage.2005.06.008; Kinsey K, 2009, INT J PSYCHOPHYSIOL, V73, P265, DOI 10.1016/j.ijpsycho.2009.04.004; Kourtzi Z, 2003, NEURON, V37, P333, DOI 10.1016/S0896-6273(02)01174-1; Kourtzi Z, 2005, NEUROIMAGE, V28, P440, DOI 10.1016/j.neuroimage.2005.06.017; Krekelberg B, 2005, J NEUROPHYSIOL, V94, P4373, DOI 10.1152/jn.00690.2005; Kurki I, 2004, NEUROSCI LETT, V360, P100, DOI 10.1016/j.neulet.2004.01.053; Lerner Y, 2001, CEREB CORTEX, V11, P287, DOI 10.1093/cercor/11.4.287; Mannion DJ, 2009, NEUROIMAGE, V46, P511, DOI 10.1016/j.neuroimage.2009.01.052; Maratos FA, 2007, NEUROIMAGE, V34, P371, DOI 10.1016/j.neuroimage.2006.09.017; Murray SO, 2004, NEURAL NETWORKS, V17, P695, DOI 10.1016/j.neunet.2004.03.010; Ohla K, 2005, VISION RES, V45, P2668, DOI 10.1016/j.visres.2005.03.015; Ostwald D, 2008, J NEUROPHYSIOL, V99, P2456, DOI 10.1152/jn.01307.2007; Palomares M, 2010, J COGNITIVE NEUROSCI, V22, P1557, DOI 10.1162/jocn.2009.21323; Pei F, 2005, NEUROREPORT, V16, P1427, DOI 10.1097/01.wnr.0000177003.12322.9b; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; Robinson S.E., 1999, RECENT ADV BIOMAGNET, P302; Ross J, 2000, CURR BIOL, V10, P679, DOI 10.1016/S0960-9822(00)00524-8; Ross J, 2004, VISION RES, V44, P441, DOI 10.1016/j.visres.2003.10.002; Seu L, 2001, VISION RES, V41, P3785, DOI 10.1016/S0042-6989(01)00235-8; SINGER W, 1995, ANNU REV NEUROSCI, V18, P555, DOI 10.1146/annurev.neuro.18.1.555; Singh KD, 2003, NEUROIMAGE, V19, P1589, DOI 10.1016/S1053-8119(03)00249-0; Singh KD, 2002, NEUROIMAGE, V16, P103, DOI 10.1006/nimg.2001.1050; Tallon-Baudry C, 1999, TRENDS COGN SCI, V3, P151, DOI 10.1016/S1364-6613(99)01299-1; Taniguchi M, 2000, NEUROIMAGE, V12, P298, DOI 10.1006/nimg.2000.0611; Tootell RBH, 1997, J NEUROSCI, V17, P7060; VANESSEN DC, 1978, J PHYSIOL-LONDON, V277, P193; VanVeen BD, 1997, IEEE T BIO-MED ENG, V44, P867, DOI 10.1109/10.623056; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Vinberg J, 2008, J NEUROPHYSIOL, V99, P1380, DOI 10.1152/jn.01223.2007; Webb BS, 2008, J VISION, V8, DOI 10.1167/8.9.16; Wilkinson F, 2000, CURR BIOL, V10, P1455, DOI 10.1016/S0960-9822(00)00800-9; Wilson HR, 1998, VISION RES, V38, P2933, DOI 10.1016/S0042-6989(98)00109-6; Wilson HR, 1997, VISION RES, V37, P2325, DOI 10.1016/S0042-6989(97)00104-1; Winterer G, 2007, HUM BRAIN MAPP, V28, P805, DOI 10.1002/hbm.20322; ZEKI SM, 1978, J PHYSIOL-LONDON, V277, P273, DOI 10.1113/jphysiol.1978.sp012272	55	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2010	5	11							e13865	10.1371/journal.pone.0013865	http://dx.doi.org/10.1371/journal.pone.0013865			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675OD	21079764	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000283839100017
J	Heider, B; Nathanson, JL; Isacoff, EY; Callaway, EM; Siegel, RM				Heider, Barbara; Nathanson, Jason L.; Isacoff, Ehud Y.; Callaway, Edward M.; Siegel, Ralph M.			Two-Photon Imaging of Calcium in Virally Transfected Striate Cortical Neurons of Behaving Monkey	PLOS ONE			English	Article							ADENOASSOCIATED VIRUS VECTORS; VISUAL ASSOCIATION CORTEX; CENTRAL-NERVOUS-SYSTEM; IN-VIVO; NEURAL ACTIVITY; FUNCTIONAL ARCHITECTURE; RECEPTIVE-FIELDS; DIRECTION SELECTIVITY; CELLULAR RESOLUTION; GENE DELIVERY	Two-photon scanning microscopy has advanced our understanding of neural signaling in non-mammalian species and mammals. Various developments are needed to perform two-photon scanning microscopy over prolonged periods in non-human primates performing a behavioral task. In striate cortex in two macaque monkeys, cortical neurons were transfected with a genetically encoded fluorescent calcium sensor, memTNXL, using AAV1 as a viral vector. By constructing an extremely rigid and stable apparatus holding both the two-photon scanning microscope and the monkey's head, single neurons were imaged at high magnification for prolonged periods with minimal motion artifacts for up to ten months. Structural images of single neurons were obtained at high magnification. Changes in calcium during visual stimulation were measured as the monkeys performed a fixation task. Overall, functional responses and orientation tuning curves were obtained in 18.8% of the 234 labeled and imaged neurons. This demonstrated that the two-photon scanning microscopy can be successfully obtained in behaving primates.	[Heider, Barbara; Siegel, Ralph M.] Rutgers State Univ, Ctr Mol & Behav Neurosci, Newark, NJ 07102 USA; [Nathanson, Jason L.; Callaway, Edward M.] Salk Inst Biol Studies, Syst Neurobiol Labs, La Jolla, CA 92037 USA; [Isacoff, Ehud Y.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	Rutgers State University Newark; Rutgers State University New Brunswick; Salk Institute; University of California System; University of California Berkeley	Heider, B (corresponding author), Rutgers State Univ, Ctr Mol & Behav Neurosci, Newark, NJ 07102 USA.	axon@cortex.rutgers.edu	isacoff, ehud/AAP-1459-2020; Callaway, Edward/D-4336-2011	Callaway, Edward/0000-0002-6366-5267; Isacoff, Ehud Y./0000-0003-4775-9359	NIH Whitehall Foundation; NIH [EY010742, NS050833]; NATIONAL EYE INSTITUTE [R01EY010742, PN2EY018241] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050833] Funding Source: NIH RePORTER	NIH Whitehall Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NIH Whitehall Foundation (RMS); NIH EY010742 (EMC); NIH NS050833 (EYI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albright TD, 2002, ANNU REV NEUROSCI, V25, P339, DOI 10.1146/annurev.neuro.25.112701.142900; Arieli A, 2002, J NEUROSCI METH, V114, P119, DOI 10.1016/S0165-0270(01)00507-6; Bartho P, 2004, J NEUROPHYSIOL, V92, P600, DOI 10.1152/jn.01170.2003; Blab GA, 2001, CHEM PHYS LETT, V350, P71, DOI 10.1016/S0009-2614(01)01282-9; Broekman MLD, 2006, NEUROSCIENCE, V138, P501, DOI 10.1016/j.neuroscience.2005.11.057; Burger C, 2004, MOL THER, V10, P302, DOI 10.1016/j.ymthe.2004.05.024; Buschman TJ, 2007, SCIENCE, V315, P1860, DOI 10.1126/science.1138071; Cearley CN, 2008, MOL THER, V16, P1710, DOI 10.1038/mt.2008.166; Chanda B, 2005, NAT NEUROSCI, V8, P1619, DOI 10.1038/nn1558; Chen Y, 2008, NAT NEUROSCI, V11, P974, DOI 10.1038/nn.2147; Cossart R, 2003, NATURE, V423, P283, DOI 10.1038/nature01614; CRICK FHC, 1979, SCI AM, V241, P219, DOI 10.1038/scientificamerican0979-219; Davidson BL, 2003, NAT REV NEUROSCI, V4, P353, DOI 10.1038/nrn1104; Deisseroth K, 2006, J NEUROSCI, V26, P10380, DOI 10.1523/JNEUROSCI.3863-06.2006; DENK W, 1994, J NEUROSCI METH, V54, P151, DOI 10.1016/0165-0270(94)90189-9; Dombeck DA, 2007, NEURON, V56, P43, DOI 10.1016/j.neuron.2007.08.003; EVARTS EV, 1964, J NEUROPHYSIOL, V27, P152, DOI 10.1152/jn.1964.27.2.152; Gallant JL, 1998, NEUROREPORT, V9, P2153, DOI 10.1097/00001756-199806220-00045; GOLDMANRAKIC PS, 1995, NEURON, V14, P477, DOI 10.1016/0896-6273(95)90304-6; Griesbeck O, 2001, J BIOL CHEM, V276, P29188, DOI 10.1074/jbc.M102815200; GRINVALD A, 1991, P NATL ACAD SCI USA, V88, P11559, DOI 10.1073/pnas.88.24.11559; Grinvald A, 2004, NAT REV NEUROSCI, V5, P874, DOI 10.1038/nrn1536; Guerrero G, 2005, NAT NEUROSCI, V8, P1188, DOI 10.1038/nn1526; Gur M, 2005, CEREB CORTEX, V15, P1207, DOI 10.1093/cercor/bhi003; Hasan MT, 2004, PLOS BIOL, V2, P763, DOI 10.1371/journal.pbio.0020163; Heider B, 2005, CEREB CORTEX, V15, P460, DOI 10.1093/cercor/bhh148; Heider B, 2000, EUR J NEUROSCI, V12, P4117, DOI 10.1046/j.1460-9568.2000.00293.x; Heim N, 2007, NAT METHODS, V4, P127, DOI 10.1038/nmeth1009; Helmchen F, 2005, NAT METHODS, V2, P932, DOI 10.1038/NMETH818; Helmchen F, 2001, NEURON, V31, P903, DOI 10.1016/S0896-6273(01)00421-4; Hendel T, 2008, J NEUROSCI, V28, P7399, DOI 10.1523/JNEUROSCI.1038-08.2008; Hires SA, 2008, BRAIN CELL BIOL, V36, P69, DOI 10.1007/s11068-008-9029-4; Hollis ER, 2008, MOL THER, V16, P296, DOI 10.1038/sj.mt.6300367; Holtmaat A, 2006, NATURE, V441, P979, DOI 10.1038/nature04783; HUBEL DH, 1968, J PHYSIOL-LONDON, V195, P215, DOI 10.1113/jphysiol.1968.sp008455; Johnson I, 1998, HISTOCHEM J, V30, P123, DOI 10.1023/A:1003287101868; Jung JC, 2004, J NEUROPHYSIOL, V92, P3121, DOI 10.1152/jn.00234.2004; Kagan I, 2002, J NEUROPHYSIOL, V88, P2557, DOI 10.1152/jn.00858.2001; KURTZ R, 2007, MODERN RES ED TOPICS; LEVENTHAL AG, 1995, J NEUROSCI, V15, P1808, DOI 10.1523/JNEUROSCI.15-03-01808.1995; Likhtik E, 2006, J NEUROPHYSIOL, V96, P3257, DOI 10.1152/jn.00577.2006; Luo L, 2008, NEURON, V57, P634, DOI 10.1016/j.neuron.2008.01.002; Mainen ZF, 1999, METHODS, V18, P231, DOI 10.1006/meth.1999.0776; Majewska AK, 2006, J NEUROSCI, V26, P3021, DOI 10.1523/JNEUROSCI.4454-05.2006; Mank M, 2006, BIOPHYS J, V90, P1790, DOI 10.1529/biophysj.105.073536; Mank M, 2008, NAT METHODS, V5, P805, DOI 10.1038/NMETH.1243; Mank M, 2008, CHEM REV, V108, P1550, DOI 10.1021/cr078213v; Mao T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001796; McCown TJ, 1996, BRAIN RES, V713, P99, DOI 10.1016/0006-8993(95)01488-8; Mitchell JF, 2007, NEURON, V55, P131, DOI 10.1016/j.neuron.2007.06.018; MOUNTCAS.VB, 1967, SCIENCE, V155, P597, DOI 10.1126/science.155.3762.597; MOUNTCASTLE VB, 1987, J NEUROSCI, V7, P2239; Nathanson JL, 2009, NEUROSCIENCE, V161, P441, DOI 10.1016/j.neuroscience.2009.03.032; Nowak LG, 2008, CEREB CORTEX, V18, P1058, DOI 10.1093/cercor/bhm137; Ohki K, 2005, NATURE, V433, P597, DOI 10.1038/nature03274; Ohki K, 2006, NATURE, V442, P925, DOI 10.1038/nature05019; Pologruto TA, 2003, BIOMED ENG ONLINE, V2, DOI 10.1186/1475-925X-2-13; Quraishi S, 2007, CEREB CORTEX, V17, P1841, DOI 10.1093/cercor/bhl093; Raffi M, 2005, J NEUROSCI, V25, P5171, DOI 10.1523/JNEUROSCI.5201-04.2005; Raffi M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000200; Reiff DF, 2005, J NEUROSCI, V25, P4766, DOI 10.1523/JNEUROSCI.4900-04.2005; Ringach DL, 2002, J NEUROSCI, V22, P5639; Royo NC, 2008, BRAIN RES, V1190, P15, DOI 10.1016/j.brainres.2007.11.015; SAS Institute Inc, 1989, SAS STAT US GUID VER; SCHILLER PH, 1976, J NEUROPHYSIOL, V39, P1288, DOI 10.1152/jn.1976.39.6.1288; Sekar RB, 2003, J CELL BIOL, V160, P629, DOI 10.1083/jcb.200210140; Shtoyerman E, 2000, J NEUROSCI, V20, P8111; Siegel RM, 2003, J NEUROPHYSIOL, V90, P1279, DOI 10.1152/jn.01179.2002; Souslova EA, 2007, BIOCHEMISTRY-MOSCOW+, V72, P683, DOI 10.1134/S0006297907070012; Takao K, 2005, J NEUROSCI, V25, P3107, DOI 10.1523/JNEUROSCI.0085-05.2005; Tallini YN, 2006, P NATL ACAD SCI USA, V103, P4753, DOI 10.1073/pnas.0509378103; Tan EM, 2006, NEURON, V51, P157, DOI 10.1016/j.neuron.2006.06.018; TIAN L, 2009, NATURE METHODS; Truong K, 2001, NAT STRUCT BIOL, V8, P1069, DOI 10.1038/nsb728; Tsai PS, 2002, METH NE FRO NEUROSCI, P113; VONDERHEYDT R, 1992, J NEUROSCI, V12, P1416; Wickersham IR, 2007, NEURON, V53, P639, DOI 10.1016/j.neuron.2007.01.033; Xiao X, 1997, EXP NEUROL, V144, P113, DOI 10.1006/exnr.1996.6396	79	41	41	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2010	5	11							e13829	10.1371/journal.pone.0013829	http://dx.doi.org/10.1371/journal.pone.0013829			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675NY	21079806	Green Published, gold, Green Submitted			2022-12-27	WOS:000283838600007
J	Wang, HR; Wu, M; Zhu, WG; Shen, J; Shi, XM; Yang, J; Zhao, QH; Ni, CA; Xu, YC; Shen, HB; Shen, C; Gu, HF				Wang, Hairu; Wu, Ming; Zhu, Weiguang; Shen, Jin; Shi, Xiaoming; Yang, Jie; Zhao, Qihui; Ni, Chuan; Xu, Yaochu; Shen, Hongbing; Shen, Chong; Gu, Harvest F.			Evaluation of the Association between the AC3 Genetic Polymorphisms and Obesity in a Chinese Han Population	PLOS ONE			English	Article							TYPE-2 DIABETES-MELLITUS; PROMOTER REGION; LINKAGE PHASE; ADIPONECTIN; GLUCOSE; RISK; HAPLOTYPES; TESTS	Background: AC3 is one of adenylyl cyclase isoforms involved in cAMP and insulin signaling pathway. Recent reports have demonstrated that the AC3 genetic polymorphisms are associated with obesity in a Swedish population. AC3 knock out mice exhibit obese when they age. These findings suggest that AC3 plays an important role in the regulation of body weight. Methodology/Principal Findings: In the present study, we evaluated the association between the AC3 genetic polymorphisms and obesity in a Han Chinese population. A total of 2580 adults, including 1490 lean (BMI = 18.5-23.9), 677 overweight (BMI 24.0-27.9) and 413 obese (BMI >= 28.0) subjects were genotyped for 5 TagSNPs in the AC3 gene. Single maker association analyses indicated that SNP rs753529 was significantly associated with BMI in obese subjects (P = 0.022, OR = 0.775 95% CI = 0.623-0.963), but not in overweight subjects (P = 0.818). Multiple maker association analyses showed that the haplotype (G-G-G) constructed with SNPs rs1127568, rs7604576 and rs753529 was significantly associated with obesity (P = 0.029). Further genotyping of SNP rs753529 in 816 children, including 361 overweight subjects (BMI > P-80) and 455 controls (BMI = P20-50) were performed, and no significant association with BMI was found. All tests were adjusted for age, sex, physical activity index, household income and/or diet expenses. Conclusions: The present study provides replication evidence that the AC3 genetic polymorphisms are associated with decreased risk of obesity among adults but not in children in a Chinese Han population. The data also suggest that the AC3 genetic effects on BMI may have interaction with the factors related to ageing and environment.	[Wang, Hairu; Xu, Yaochu; Shen, Hongbing; Shen, Chong] Nanjing Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Nanjing, Peoples R China; [Wu, Ming; Yang, Jie] Ctr Dis Control Jiangsu Prov, Nanjing, Peoples R China; [Zhu, Weiguang; Shen, Jin; Zhao, Qihui; Ni, Chuan] Ctr Dis Control Suqian City, Suqian, Peoples R China; [Shi, Xiaoming] Chinese Ctr Dis Control & Prevent, Div Chron Dis Control & Community Hlth, Beijing, Peoples R China; [Gu, Harvest F.] Karolinska Univ Hosp Solna, Karolinska Inst, Rolf Luft Ctr Diabet Res, Dept Mol Med & Surg, Stockholm, Sweden	Nanjing Medical University; Chinese Center for Disease Control & Prevention; Karolinska Institutet; Karolinska University Hospital	Wang, HR (corresponding author), Nanjing Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Nanjing, Peoples R China.	sc@njmu.edu.cn; harvest.gu@ki.se	Shi, Xiaoming/V-2119-2018	Shi, Xiaoming/0000-0002-7071-571X	National Basic Research Program of China [30800947]; Nanjing Medical University [06NMU2010]; Program of Preventive Medicine of Jiangsu [Y200707]	National Basic Research Program of China(National Basic Research Program of China); Nanjing Medical University; Program of Preventive Medicine of Jiangsu	This work was supported by the National Basic Research Program of China (Grant No. 30800947), Development Fund of Nanjing Medical University (Grant No. 06NMU2010) and Program of Preventive Medicine of Jiangsu (Grant No. Y200707). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; Batty GD, 2009, CANCER EPIDEMIOL, V33, P469, DOI 10.1016/j.canep.2009.09.010; Du SF, 2004, SOC SCI MED, V59, P1505, DOI 10.1016/j.socscimed.2004.01.021; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; FAN Y, 2010, BMC PUBLIC HEALTH, DOI DOI 10.1186/1471-2350-10-118; Gu HF, 2009, BIOMARK INSIGHTS, V4, P123; Gu HF, 2004, DIABETES, V53, pS31, DOI 10.2337/diabetes.53.2007.S31; GU HF, 2010, OPEN DIABETES J, V3, P11; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; Hanoune J, 2001, ANNU REV PHARMACOL, V41, P145, DOI 10.1146/annurev.pharmtox.41.1.145; Hara K, 2002, DIABETES, V51, P536, DOI 10.2337/diabetes.51.2.536; Jakicic JM, 2009, OBESITY, V17, pS34, DOI 10.1038/oby.2009.386; Ji CY, 2008, OBES REV, V9, P78, DOI 10.1111/j.1467-789X.2007.00443.x; Ji CY, 2010, BIOMED ENVIRON SCI, V23, P12, DOI 10.1016/S0895-3988(10)60026-8; Jia WP, 2010, BIOMED ENVIRON SCI, V23, P4, DOI 10.1016/S0895-3988(10)60025-6; Joseph S, 2001, MOL CLONING LAB MANU; Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508; Lake SL, 2003, HUM HERED, V55, P56, DOI 10.1159/000071811; Lee YY, 2005, DIABETIC MED, V22, P569, DOI 10.1111/j.1464-5491.2005.01460.x; Maes HHM, 1997, BEHAV GENET, V27, P325, DOI 10.1023/A:1025635913927; Mitri J, 2009, EXPERT OPIN DRUG SAF, V8, P573, DOI 10.1517/14740330903081725; Miyake K, 2009, J HUM GENET, V54, P236, DOI 10.1038/jhg.2009.17; Nicolucci A, 2010, ACTA DIABETOL, V47, P87, DOI 10.1007/s00592-010-0187-3; Nordman S, 2008, INT J OBESITY, V32, P407, DOI 10.1038/sj.ijo.0803742; O'Rahilly S, 2009, NATURE, V462, P307, DOI 10.1038/nature08532; Qu Ning-ning, 2004, Zhonghua Liu Xing Bing Xue Za Zhi, V25, P265; Saxena R, 2010, NAT GENET, V42, P142, DOI 10.1038/ng.521; Schaid DJ, 2002, AM J HUM GENET, V70, P425, DOI 10.1086/338688; Schwarz PEH, 2006, HORM METAB RES, V38, P447, DOI 10.1055/s-2006-947842; Vasseur F, 2002, HUM MOL GENET, V11, P2607, DOI 10.1093/hmg/11.21.2607; Wang Z, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004246; Zacharova J, 2005, DIABETES, V54, P893, DOI 10.2337/diabetes.54.3.893	32	23	24	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2010	5	11							e13851	10.1371/journal.pone.0013851	http://dx.doi.org/10.1371/journal.pone.0013851			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675NY	21079816	gold, Green Published, Green Submitted			2022-12-27	WOS:000283838600021
J	Xu, X; Wang, KB; Zhao, XJ; Sullivan, C; Chen, SQ				Xu, Xing; Wang, Kebai; Zhao, Xijin; Sullivan, Corwin; Chen, Shuqing			A New Leptoceratopsid (Ornithischia: Ceratopsia) from the Upper Cretaceous of Shandong, China and Its Implications for Neoceratopsian Evolution	PLOS ONE			English	Article							DINOSAUR; MONGOLIA; ALBERTA; EUROPE; GEN.	Background: The ceratopsians represent one of the last dinosaurian radiations. Traditionally the only universally accepted speciose clade within the group was the Ceratopsidae. However, recent discoveries and phylogenetic analyses have led to the recognition of a new speciose clade, the Leptoceratopsidae, which is predominantly known from the Upper Cretaceous of North America. Methodology/Principal Findings: Here we report a new leptoceratopsid taxon, Zhuchengceratops inexpectus gen. et sp. nov., based on a partial, articulated skeleton recovered from the Upper Cretaceous Wangshi Group of Zhucheng, Shandong Province, China. Although Zhuchengceratops is significantly different from other known leptoceratopsids, it is recovered as a derived member of the group by our phylogenetic analysis. Furthermore, Zhuchengceratops exhibits several features previously unknown in leptoceratopsids but seen in ceratopsids and their close relatives, suggesting that the distribution of morphological features within ceratopsians is more complex than previously realized. Conclusion/Significance: The discovery of Zhuchengceratops increases both the taxonomic diversity and the morphological disparity of the Leptoceratopsidae, providing further support for the hypothesis that this clade represents a successful radiation of horned dinosaurs in parallel with the Ceratopsidae in the Late Cretaceous. This documents a surprising case of the coexistence and radiation of two closely-related lineages with contrasting suites of jaw and dental features that reflect adaptation to different food resources.	[Xu, Xing; Zhao, Xijin; Sullivan, Corwin] Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Key Lab Evolutionary Systemat Vertebrates, Beijing, Peoples R China; [Wang, Kebai; Chen, Shuqing] Bur Tourism, Zhucheng Dinosaur Museum, Zhucheng, Shandong, Peoples R China	Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS	Xu, X (corresponding author), Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Key Lab Evolutionary Systemat Vertebrates, Beijing, Peoples R China.	xingxu@vip.sina.com		Sullivan, Corwin/0000-0002-5488-6797	Chinese Academy of Sciences; Zhucheng City Government	Chinese Academy of Sciences(Chinese Academy of Sciences); Zhucheng City Government	Grants from the Chinese Academy of Sciences and Zhucheng City Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alifanov V, 2008, PALEONTOL J+, V42, P621, DOI 10.1134/S0031030108060087; Alifanov VR, 2003, PALEONTOL J+, V37, P524; Brown B, 1914, B AM MUS NAT HIST, V33, P567; BROWN BARNUM, 1940, ANN NEW YORK ACAD SCI, V40, P133; Brown Barnum, 1942, AMER MUS NOVITATES, V1169, P1; Chinnery B, 2004, J VERTEBR PALEONTOL, V24, P572, DOI 10.1671/0272-4634(2004)024[0572:DOPPGE]2.0.CO;2; Chinnery BJ, 1998, J VERTEBR PALEONTOL, V18, P569, DOI 10.1080/02724634.1998.10011085; Chinnery BJ, 2007, J VERTEBR PALEONTOL, V27, P625, DOI 10.1671/0272-4634(2007)27[625:ANNDLN]2.0.CO;2; DODSON P, 1996, HORNED DINOAURS; Dodson P, 2004, DINOSAURIA, 2ND EDITION, P494; Fang, 2001, SHANTUNGOSAURUS GIGA; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; HATCHER JB, 1907, MONOGR US GEOL SURV, V49, P1; Hu C.Z., 1973, ACTA GEOL SINICA, V2, P179; KURZANOV S, 1990, PALEONTOL J, V4, P85; KURZANOV SM, 1992, PALEONTOL ZH, P81; Lindgren J, 2007, PALAEONTOLOGY, V50, P929, DOI 10.1111/j.1475-4983.2007.00690.x; Makovicky Peter J., 2010, P68; Makovicky PJ, 2006, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2006)3530[1:YDANPC]2.0.CO;2; Makovicky Peter J., 2001, P243; MAKOVICKY PJ, 2002, TAXONOMIC REVISION P; Marsh O.C., 1890, AM J SCI, V39, P418, DOI DOI 10.2475/AJS.S3-39.233.418; MARYANSKA T, 1975, Palaeontologia Polonica, V33, P133; NESSOV LA, 1989, THEORETICAL APPL ASP, P144; Nopcsa, 1923, FORTSCHRITTE GEOLOGI, V2, P1; Osi A, 2010, NATURE, V465, P466, DOI 10.1038/nature09019; RICH R, 2003, RECORDS QUEEN VICTOR, V113, P1; RUSSELL DA, 1993, CAN J EARTH SCI, V30, P2002, DOI 10.1139/e93-176; SEELEY HG, 1888, 1887 BRIT ASS ADV SC, P698; SERENO PC, 1986, NATL GEOGR RES, V2, P234; Sereno PC, 1999, SCIENCE, V284, P2137, DOI 10.1126/science.284.5423.2137; SERENO PC, 2002, AGE DINOSAURS RUSSIA, P480; Sternberg CM, 1951, NATIONAL MUSEUM CANA, V123, P225; Wilson JA, 1999, J VERTEBR PALEONTOL, V19, P639, DOI 10.1080/02724634.1999.10011178; Wu XC, 2007, CAN J EARTH SCI, V44, P1243, DOI 10.1139/e07-011; Xu X, 2010, CHINESE SCI BULL, V55, P1631, DOI 10.1007/s11434-009-3614-5; You Hailu, 2004, P478; You HL, 2003, ACTA GEOL SIN-ENGL, V77, P299	38	33	38	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2010	5	11							e13835	10.1371/journal.pone.0013835	http://dx.doi.org/10.1371/journal.pone.0013835			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675NY	21079798	Green Published, Green Submitted, gold			2022-12-27	WOS:000283838600010
J	Grubb, MS; Burrone, J				Grubb, Matthew S.; Burrone, Juan			Channelrhodopsin-2 Localised to the Axon Initial Segment	PLOS ONE			English	Article							ACTION-POTENTIAL INITIATION; CEREBELLAR PURKINJE-CELLS; PYRAMIDAL NEURONS; NEURAL CIRCUITRY; ANKYRIN-BINDING; SODIUM-CHANNELS; IN-VIVO; PHOTORECEPTOR DEGENERATION; ADHESION MOLECULES; OPTICAL INDUCTION	The light-gated cation channel Channelrhodopsin-2 (ChR2) is a powerful and versatile tool for controlling neuronal activity. Currently available versions of ChR2 either distribute uniformly throughout the plasma membrane or are localised specifically to somatodendritic or synaptic domains. Localising ChR2 instead to the axon initial segment (AIS) could prove an extremely useful addition to the optogenetic repertoire, targeting the channel directly to the site of action potential initiation, and limiting depolarisation and associated calcium entry elsewhere in the neuron. Here, we describe a ChR2 construct that we localised specifically to the AIS by adding the ankyrinG-binding loop of voltage-gated sodium channels (NavII-III) to its intracellular terminus. Expression of ChR2-YFP-NavII-III did not significantly affect the passive or active electrical properties of cultured rat hippocampal neurons. However, the tiny ChR2 currents and small membrane depolarisations resulting from AIS targeting meant that optogenetic control of action potential firing with ChR2-YFP-NavII-III was unsuccessful in baseline conditions. We did succeed in stimulating action potentials with light in some ChR2-YFP-NavII-III-expressing neurons, but only when blocking KCNQ voltage-gated potassium channels. We discuss possible alternative approaches to obtaining precise control of neuronal spiking with AIS-targeted optogenetic constructs and propose potential uses for our ChR2-YFP-NavII-III probe where subthreshold modulation of action potential initiation is desirable.	[Grubb, Matthew S.; Burrone, Juan] Kings Coll London, MRC, Ctr Dev Neurobiol, London WC2R 2LS, England	University of London; King's College London	Grubb, MS (corresponding author), Kings Coll London, MRC, Ctr Dev Neurobiol, London WC2R 2LS, England.	matthew.grubb@kcl.ac.uk	Grubb, Matthew S/B-4939-2008	Grubb, Matthew S/0000-0002-2673-274X; Burrone, Juan/0000-0003-1233-668X	Wellcome Trust; MRC [G0901899] Funding Source: UKRI; Medical Research Council [G0901899] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adesnik H, 2010, NATURE, V464, P1155, DOI 10.1038/nature08935; Alilain WJ, 2008, J NEUROSCI, V28, P11862, DOI 10.1523/JNEUROSCI.3378-08.2008; Arenkiel BR, 2007, NEURON, V54, P205, DOI 10.1016/j.neuron.2007.03.005; Bamann C, 2010, BIOCHEMISTRY-US, V49, P267, DOI 10.1021/bi901634p; Banghart M, 2004, NAT NEUROSCI, V7, P1381, DOI 10.1038/nn1356; Barker AT, 1999, EEG CL N SU, P3; Bellmann D, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00027; Benabid AL, 2009, LANCET NEUROL, V8, P67, DOI 10.1016/S1474-4422(08)70291-6; Bender KJ, 2009, NEURON, V61, P259, DOI 10.1016/j.neuron.2008.12.004; Berndt A, 2010, BIOPHYS J, V98, P753, DOI 10.1016/j.bpj.2009.10.052; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Bi AD, 2006, NEURON, V50, P23, DOI 10.1016/j.neuron.2006.02.026; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Brackenbury WJ, 2010, P NATL ACAD SCI USA, V107, P2283, DOI 10.1073/pnas.0909434107; Brechet A, 2008, J CELL BIOL, V183, P1101, DOI 10.1083/jcb.200805169; Chow BY, 2010, NATURE, V463, P98, DOI 10.1038/nature08652; Clark BD, 2009, NEUROSCIENTIST, V15, P651, DOI 10.1177/1073858409341973; Colbert CM, 1996, J NEUROSCI, V16, P6676; COOMBS JS, 1957, J PHYSIOL-LONDON, V139, P232, DOI 10.1113/jphysiol.1957.sp005888; Cruikshank SJ, 2010, NEURON, V65, P230, DOI 10.1016/j.neuron.2009.12.025; DAVIS JQ, 1993, J CELL BIOL, V121, P121, DOI 10.1083/jcb.121.1.121; Deisseroth K, 2006, J NEUROSCI, V26, P10380, DOI 10.1523/JNEUROSCI.3863-06.2006; Douglass AD, 2008, CURR BIOL, V18, P1133, DOI 10.1016/j.cub.2008.06.077; Ellis-Davies GCR, 2007, NAT METHODS, V4, P619, DOI 10.1038/NMETH1072; Fache MP, 2004, J CELL BIOL, V166, P571, DOI 10.1083/jcb.200312155; FATT P, 1957, J NEUROPHYSIOL, V20, P61, DOI 10.1152/jn.1957.20.1.61; Fleidervish IA, 2010, NAT NEUROSCI, V13, P852, DOI 10.1038/nn.2574; Foust A, 2010, J NEUROSCI, V30, P6891, DOI 10.1523/JNEUROSCI.0552-10.2010; FUORTES MGF, 1957, J GEN PHYSIOL, V40, P735, DOI 10.1085/jgp.40.5.735; Garrido JJ, 2003, SCIENCE, V300, P2091, DOI 10.1126/science.1085167; Garver TD, 1997, J CELL BIOL, V137, P703, DOI 10.1083/jcb.137.3.703; Glickfeld LL, 2009, NAT NEUROSCI, V12, P21, DOI 10.1038/nn.2230; Gradinaru V, 2007, J NEUROSCI, V27, P14231, DOI 10.1523/JNEUROSCI.3578-07.2007; Gradinaru V, 2010, CELL, V141, P154, DOI 10.1016/j.cell.2010.02.037; Gradinaru V, 2009, SCIENCE, V324, P354, DOI 10.1126/science.1167093; Gradinaru V, 2008, BRAIN CELL BIOL, V36, P129, DOI 10.1007/s11068-008-9027-6; Grubb MS, 2010, CURR OPIN NEUROBIOL, V20, P481, DOI 10.1016/j.conb.2010.04.012; Grubb MS, 2010, NATURE, V465, P1070, DOI 10.1038/nature09160; Gunaydin LA, 2010, NAT NEUROSCI, V13, P387, DOI 10.1038/nn.2495; Hagglund M, 2010, NAT NEUROSCI, V13, P246, DOI 10.1038/nn.2482; Hales Chadwick M, 2010, J Vis Exp, DOI 10.3791/2056; Han X, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000299; Hedstrom KL, 2008, J CELL BIOL, V183, P635, DOI 10.1083/jcb.200806112; Hu WQ, 2009, NAT NEUROSCI, V12, P996, DOI 10.1038/nn.2359; Huber D, 2008, NATURE, V451, P61, DOI 10.1038/nature06445; Khirug S, 2008, J NEUROSCI, V28, P4635, DOI 10.1523/JNEUROSCI.0908-08.2008; Kole MHP, 2008, NAT NEUROSCI, V11, P178, DOI 10.1038/nn2040; Kole MHP, 2007, NEURON, V55, P633, DOI 10.1016/j.neuron.2007.07.031; Kramer RH, 2009, CURR OPIN NEUROBIOL, V19, P544, DOI 10.1016/j.conb.2009.09.004; Kuba H, 2010, NATURE, V465, P1075, DOI 10.1038/nature09087; Laezza F, 2007, J NEUROSCI, V27, P12033, DOI 10.1523/JNEUROSCI.2282-07.2007; Lagali PS, 2008, NAT NEUROSCI, V11, P667, DOI 10.1038/nn.2117; Lemaillet G, 2003, J BIOL CHEM, V278, P27333, DOI 10.1074/jbc.M303327200; LETERRIER C, 2010, NEUROSCI LETT; Lewis TL, 2009, NAT NEUROSCI, V12, P568, DOI 10.1038/nn.2318; Li X, 2005, P NATL ACAD SCI USA, V102, P17816, DOI 10.1073/pnas.0509030102; Lin JY, 2009, BIOPHYS J, V96, P1803, DOI 10.1016/j.bpj.2008.11.034; Mainen ZF, 1995, NEURON, V15, P1427, DOI 10.1016/0896-6273(95)90020-9; Meeks JP, 2007, J NEUROPHYSIOL, V97, P3460, DOI 10.1152/jn.01288.2006; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Nagel G, 2005, CURR BIOL, V15, P2279, DOI 10.1016/j.cub.2005.11.032; Ogawa Y, 2008, CURR OPIN NEUROBIOL, V18, P307, DOI 10.1016/j.conb.2008.08.008; Ogawa Y, 2008, J NEUROSCI, V28, P5731, DOI 10.1523/JNEUROSCI.4431-07.2008; Palmer LM, 2006, J NEUROSCI, V26, P1854, DOI 10.1523/JNEUROSCI.4812-05.2006; Palmer LM, 2010, J PHYSIOL-LONDON, V588, P1709, DOI 10.1113/jphysiol.2010.188300; Pan ZM, 2006, J NEUROSCI, V26, P2599, DOI 10.1523/JNEUROSCI.4314-05.2006; Petreanu L, 2007, NAT NEUROSCI, V10, P663, DOI 10.1038/nn1891; Petreanu L, 2009, NATURE, V457, P1142, DOI 10.1038/nature07709; Rasband MN, 2010, NAT REV NEUROSCI, V11, P552, DOI 10.1038/nrn2852; Rasmussen HB, 2007, J CELL SCI, V120, P953, DOI 10.1242/jcs.03396; Rush AM, 2005, J PHYSIOL-LONDON, V564, P803, DOI 10.1113/jphysiol.2005.083089; Schafer DP, 2009, J NEUROSCI, V29, P13242, DOI 10.1523/JNEUROSCI.3376-09.2009; Schoonheim PJ, 2010, J NEUROSCI, V30, P7111, DOI 10.1523/JNEUROSCI.5193-09.2010; Shah MM, 2008, P NATL ACAD SCI USA, V105, P7869, DOI 10.1073/pnas.0802805105; Shu YS, 2007, J NEUROPHYSIOL, V97, P746, DOI 10.1152/jn.00922.2006; Sobotzik JM, 2009, P NATL ACAD SCI USA, V106, P17564, DOI 10.1073/pnas.0909267106; SOMOGYI P, 1983, BRAIN RES, V259, P137, DOI 10.1016/0006-8993(83)91076-4; Song AH, 2009, CELL, V136, P1148, DOI 10.1016/j.cell.2009.01.016; STUART G, 1994, NEURON, V13, P703, DOI 10.1016/0896-6273(94)90037-X; STUART GJ, 1994, NATURE, V367, P69, DOI 10.1038/367069a0; Stuber GD, 2010, J NEUROSCI, V30, P8229, DOI 10.1523/JNEUROSCI.1754-10.2010; Szabadics J, 2006, SCIENCE, V311, P233, DOI 10.1126/science.1121325; Taddese A, 2002, NEURON, V33, P587, DOI 10.1016/S0896-6273(02)00574-3; Tehovnik EJ, 2006, J NEUROPHYSIOL, V96, P512, DOI 10.1152/jn.00126.2006; Thyagarajan S, 2010, J NEUROSCI, V30, P8745, DOI 10.1523/JNEUROSCI.4417-09.2010; Tomita H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007679; Toni N, 2008, NAT NEUROSCI, V11, P901, DOI 10.1038/nn.2156; TOREBJORK HE, 1987, BRAIN, V110, P1509, DOI 10.1093/brain/110.6.1509; Tsai HC, 2009, SCIENCE, V324, P1080, DOI 10.1126/science.1168878; Tufail Y, 2010, NEURON, V66, P681, DOI 10.1016/j.neuron.2010.05.008; Tyler WJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003511; Volgraf M, 2006, NAT CHEM BIOL, V2, P47, DOI 10.1038/nchembio756; Wang H, 2007, P NATL ACAD SCI USA, V104, P8143, DOI 10.1073/pnas.0700384104; Wang H, 2009, J NEUROSCI, V29, P13202, DOI 10.1523/JNEUROSCI.3248-09.2009; Wilson BS, 2008, HEARING RES, V242, P3, DOI 10.1016/j.heares.2008.06.005; Winckler B, 1999, NATURE, V397, P698, DOI 10.1038/17789; Yang Y, 2007, J CELL BIOL, V176, P509, DOI 10.1083/jcb.200610128; Yu YG, 2008, J NEUROSCI, V28, P7260, DOI 10.1523/JNEUROSCI.1613-08.2008; Yu YG, 2010, J NEUROSCI, V30, P11858, DOI 10.1523/JNEUROSCI.2651-10.2010; Zhang F, 2008, NAT NEUROSCI, V11, P631, DOI 10.1038/nn.2120; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744; Zhang F, 2010, NAT PROTOC, V5, P439, DOI 10.1038/nprot.2009.226; Zhang YP, 2008, P NATL ACAD SCI USA, V105, P12039, DOI 10.1073/pnas.0802940105; Zhang YP, 2007, NAT METHODS, V4, P139, DOI 10.1038/nmeth988; Zhou DX, 1998, J CELL BIOL, V143, P1295, DOI 10.1083/jcb.143.5.1295	105	41	41	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2010	5	10							e13761	10.1371/journal.pone.0013761	http://dx.doi.org/10.1371/journal.pone.0013761			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673FU	21048938	Green Published, gold, Green Submitted			2022-12-27	WOS:000283645300039
J	Ni, H; Huang, L; Chen, N; Zhang, FY; Liu, DB; Ge, M; Guan, SD; Zhu, Y; Wang, JH				Ni, Hong; Huang, Li; Chen, Na; Zhang, Fengyu; Liu, Dongbo; Ge, Ming; Guan, Sudong; Zhu, Yan; Wang, Jin-Hui			Upregulation of Barrel GABAergic Neurons Is Associated with Cross-Modal Plasticity in Olfactory Deficit	PLOS ONE			English	Article							SENSORIMOTOR SYSTEM; CYTOCHROME-OXIDASE; AUDITORY-CORTEX; INTERNEURONS; HIPPOCAMPUS; HOMEOSTASIS; INHIBITION; MECHANISMS; NEOCORTEX; RATS	Background: Loss of a sensory function is often followed by the hypersensitivity of other modalities in mammals, which secures them well-awareness to environmental changes. Cellular and molecular mechanisms underlying cross-modal sensory plasticity remain to be documented. Methodology/Principal Findings: Multidisciplinary approaches, such as electrophysiology, behavioral task and immunohistochemistry, were used to examine the involvement of specific types of neurons in cross-modal plasticity. We have established a mouse model that olfactory deficit leads to a whisking upregulation, and studied how GABAergic neurons are involved in this cross-modal plasticity. In the meantime of inducing whisker tactile hypersensitivity, the olfactory injury recruits more GABAergic neurons and their fine processes in the barrel cortex, as well as upregulates their capacity of encoding action potentials. The hyperpolarization driven by inhibitory inputs strengthens the encoding ability of their target cells. Conclusion/Significance: The upregulation of GABAergic neurons and the functional enhancement of neuronal networks may play an important role in cross-modal sensory plasticity. This finding provides the clues for developing therapeutic approaches to help sensory recovery and substitution.	[Ni, Hong; Huang, Li; Liu, Dongbo; Ge, Ming; Guan, Sudong; Zhu, Yan; Wang, Jin-Hui] Bengbu Med Coll, Dept Physiol, Bengbu, Anhui, Peoples R China; [Chen, Na; Zhang, Fengyu; Wang, Jin-Hui] Chinese Acad Sci, Inst Biophys, State Key Lab Brain & Cognit Sci, Beijing 100080, Peoples R China	Bengbu Medical College; Chinese Academy of Sciences; Institute of Biophysics, CAS	Ni, H (corresponding author), Bengbu Med Coll, Dept Physiol, Bengbu, Anhui, Peoples R China.	jhw@ibp.ac.cn			National Award for Outstanding Young Scientist [30325021]; National Basic Research Program [2006CB500804]; Natural Science Foundation China [30621130077, 30870517, 30990261]; Chinese Academy of Sciences [KSCX2-YWR-39]	National Award for Outstanding Young Scientist; National Basic Research Program(National Basic Research Program of China); Natural Science Foundation China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences)	This study is supported by the National Award for Outstanding Young Scientist (30325021), National Basic Research Program (2006CB500804), Natural Science Foundation China (30621130077, 30870517 and 30990261), Program in Chinese Academy of Sciences for Knowledge Innovation (KSCX2-YWR-39) to JHW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bavelier D, 2002, NAT REV NEUROSCI, V3, P443, DOI 10.1038/nrn848; Beierlein M, 2000, NAT NEUROSCI, V3, P904, DOI 10.1038/78809; Buck LB, 2000, SMELL TASTE CHEM SEN; Chen N, 2006, BIOCHEM BIOPH RES CO, V340, P151, DOI 10.1016/j.bbrc.2005.11.170; Chen N, 2008, J CELL SCI, V121, P2961, DOI 10.1242/jcs.022368; Chen N, 2006, BIOCHEM BIOPH RES CO, V346, P281, DOI 10.1016/j.bbrc.2006.05.120; Chen N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011868; Ciani L, 2005, NAT REV NEUROSCI, V6, P351, DOI 10.1038/nrn1665; Collignon O, 2009, EXP BRAIN RES, V192, P343, DOI 10.1007/s00221-008-1553-z; Davis E, 2007, CELL, V130, P593, DOI 10.1016/j.cell.2007.08.007; Diamond ME, 2008, NAT REV NEUROSCI, V9, P601, DOI 10.1038/nrn2411; Dye MWG, 2008, ANN NY ACAD SCI, V1145, P71, DOI 10.1196/annals.1416.013; Fanselow EE, 2008, J NEUROPHYSIOL, V100, P2640, DOI 10.1152/jn.90691.2008; Finney EM, 2001, NAT NEUROSCI, V4, P1171, DOI 10.1038/nn763; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Ge RJ, 2009, BIOCHEM BIOPH RES CO, V387, P585, DOI 10.1016/j.bbrc.2009.07.066; Gulyas AI, 2006, EUR J NEUROSCI, V23, P2581, DOI 10.1111/j.1460-9568.2006.04814.x; HEVNER RF, 1989, J NEUROSCI, V9, P3884; Kadosh RC, 2006, CURR BIOL, V16, pR962, DOI 10.1016/j.cub.2006.10.017; Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381; Kleinfeld D, 2006, CURR OPIN NEUROBIOL, V16, P435, DOI 10.1016/j.conb.2006.06.009; Lie DC, 2005, NATURE, V437, P1370, DOI 10.1038/nature04108; Long MA, 2005, NAT NEUROSCI, V8, P61, DOI 10.1038/nn1361; Maier DL, 1997, EXP NEUROL, V145, P71, DOI 10.1006/exnr.1997.6426; McBain CJ, 2001, NAT REV NEUROSCI, V2, P11, DOI 10.1038/35049047; Neville H, 2002, PROG BRAIN RES, V138, P177, DOI 10.1016/S0079-6123(02)38078-6; Petersen CCH, 2007, NEURON, V56, P339, DOI 10.1016/j.neuron.2007.09.017; Petersen CCH, 2003, PFLUG ARCH EUR J PHY, V447, P126, DOI 10.1007/s00424-003-1167-z; Ptito M, 2005, BRAIN, V128, P606, DOI 10.1093/brain/awh380; Ptito Maurice, 2005, Journal of Integrative Neuroscience, V4, P479, DOI 10.1142/S0219635205000951; Qi YL, 2009, BIOCHEM BIOPH RES CO, V381, P129, DOI 10.1016/j.bbrc.2009.02.058; Sanchez-Vives MV, 2006, PROG BRAIN RES, V155, P287, DOI 10.1016/S0079-6123(06)55017-4; Somogyi P, 2005, J PHYSIOL-LONDON, V562, P9, DOI 10.1113/jphysiol.2004.078915; Towal RB, 2006, J NEUROSCI, V26, P8838, DOI 10.1523/JNEUROSCI.0581-06.2006; Wang JH, 2003, BRAIN RES BULL, V60, P53, DOI 10.1016/S0361-9230(03)00026-1; Wang JH, 2001, J PHYSIOL-LONDON, V533, P407, DOI 10.1111/j.1469-7793.2001.0407a.x; Wang JH, 2008, J CELL SCI, V121, P2951, DOI 10.1242/jcs.025684; Wehr M, 2003, NATURE, V426, P442, DOI 10.1038/nature02116; Wieloch T, 2006, CURR OPIN NEUROBIOL, V16, P258, DOI 10.1016/j.conb.2006.05.011; WONGRILEY MTT, 1989, TRENDS NEUROSCI, V12, P94, DOI 10.1016/0166-2236(89)90165-3; Yan ZQ, 2008, NEURON, V58, P613, DOI 10.1016/j.neuron.2008.03.012	41	43	44	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2010	5	10							e13736	10.1371/journal.pone.0013736	http://dx.doi.org/10.1371/journal.pone.0013736			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673FU	21060832	Green Published, Green Submitted, gold			2022-12-27	WOS:000283645300016
J	Jiang, L; Liu, JF; Sun, DX; Ma, PP; Ding, XD; Yu, Y; Zhang, Q				Jiang, Li; Liu, Jianfeng; Sun, Dongxiao; Ma, Peipei; Ding, Xiangdong; Yu, Ying; Zhang, Qin			Genome Wide Association Studies for Milk Production Traits in Chinese Holstein Population	PLOS ONE			English	Article							SOMATIC-CELL SCORE; TRANSMISSION DISEQUILIBRIUM TEST; GENERALIZED ESTIMATING EQUATIONS; SINGLE-NUCLEOTIDE POLYMORPHISM; ECONOMICALLY IMPORTANT TRAITS; GROWTH-HORMONE RECEPTOR; AYRSHIRE DAIRY-CATTLE; QUANTITATIVE TRAIT; LINKAGE DISEQUILIBRIUM; COMPLEX TRAITS	Genome-wide association studies (GWAS) based on high throughput SNP genotyping technologies open a broad avenue for exploring genes associated with milk production traits in dairy cattle. Motivated by pinpointing novel quantitative trait nucleotide (QTN) across Bos Taurus genome, the present study is to perform GWAS to identify genes affecting milk production traits using current state-of-the-art SNP genotyping technology, i.e., the Illumina BovineSNP50 BeadChip. In the analyses, the five most commonly evaluated milk production traits are involved, including milk yield (MY), milk fat yield (FY), milk protein yield (PY), milk fat percentage (FP) and milk protein percentage (PP). Estimated breeding values (EBVs) of 2,093 daughters from 14 paternal half-sib families are considered as phenotypes within the framework of a daughter design. Association tests between each trait and the 54K SNPs are achieved via two different analysis approaches, a paternal transmission disequilibrium test (TDT)-based approach (L1-TDT) and a mixed model based regression analysis (MMRA). In total, 105 SNPs were detected to be significantly associated genome-wise with one or multiple milk production traits. Of the 105 SNPs, 38 were commonly detected by both methods, while four and 63 were solely detected by L1-TDT and MMRA, respectively. The majority (86 out of 105) of the significant SNPs is located within the reported QTL regions and some are within or close to the reported candidate genes. In particular, two SNPs, ARS-BFGL-NGS-4939 and BFGL-NGS-118998, are located close to the DGAT1 gene (160bp apart) and within the GHR gene, respectively. Our findings herein not only provide confirmatory evidences for previously findings, but also explore a suite of novel SNPs associated with milk production traits, and thus form a solid basis for eventually unraveling the causal mutations for milk production traits in dairy cattle.	[Jiang, Li; Liu, Jianfeng; Sun, Dongxiao; Ma, Peipei; Ding, Xiangdong; Yu, Ying; Zhang, Qin] China Agr Univ, Coll Anim Sci & Technol, Minist Agr, Key Lab Anim Genet & Breeding, Beijing 100094, Peoples R China	China Agricultural University; Ministry of Agriculture & Rural Affairs	Jiang, L (corresponding author), China Agr Univ, Coll Anim Sci & Technol, Minist Agr, Key Lab Anim Genet & Breeding, Beijing 100094, Peoples R China.	qzhang@cau.edu.cn		Jiang, Li/0000-0002-0648-2173; Liu, Jian-Feng/0000-0002-5766-7864	State High-Tech Development Plan of China [2008AA101002]; National Natural Science Foundations of China [30972092, 30800776]; National Key Basic Research Program of China [2006CB102104]; China Agricultural University	State High-Tech Development Plan of China; National Natural Science Foundations of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Program of China(National Basic Research Program of China); China Agricultural University	This work was supported by the State High-Tech Development Plan of China (Grant No. 2008AA101002), the National Natural Science Foundations of China (Grant No. 30972092,30800776), the National Key Basic Research Program of China (Grant No. 2006CB102104), and the Graduate R&D Innovation Project of China Agricultural University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison DB, 1998, AM J HUM GENET, V63, P1190, DOI 10.1086/302038; Amills M, 2005, J ANIM SCI, V83, P493; Andersson L, 2004, NAT REV GENET, V5, P202, DOI 10.1038/nrg1294; Ashwell MS, 2001, J DAIRY SCI, V84, P2535, DOI 10.3168/jds.S0022-0302(01)74705-4; Ashwell MS, 2004, J DAIRY SCI, V87, P468, DOI 10.3168/jds.S0022-0302(04)73186-0; Awad A, 2010, ANIM GENET, V41, P1, DOI 10.1111/j.1365-2052.2009.01957.x; Bagnato A, 2008, J DAIRY SCI, V91, P767, DOI 10.3168/jds.2007-0507; Bennewitz J, 2004, J DAIRY SCI, V87, P431, DOI 10.3168/jds.S0022-0302(04)73182-3; Bennewitz J, 2003, GENET SEL EVOL, V35, P319, DOI [10.1051/gse:2003011, 10.1186/1297-9686-35-3-319]; Benyamin B, 2009, PHARMACOGENOMICS, V10, P181, DOI 10.2217/14622416.10.2.181; Blott S, 2003, GENETICS, V163, P253; Boichard D, 2003, GENET SEL EVOL, V35, P77, DOI 10.1051/gse:2002037; Brym Pawel, 2005, Journal of Applied Genetics, V46, P179; Cohen-Zinder M, 2005, GENOME RES, V15, P936, DOI 10.1101/gr.3806705; Coon KD, 2007, J CLIN PSYCHIAT, V68, P613, DOI 10.4088/JCP.v68n0419; Coppieters W, 1998, MAMM GENOME, V9, P540, DOI 10.1007/s003359900815; Craig DW, 2005, EXPERT REV MOL DIAGN, V5, P159, DOI 10.1586/14737159.5.2.159; Daetwyler HD, 2008, J DAIRY SCI, V91, P3225, DOI 10.3168/jds.2007-0333; Daw EW, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-S1-S32; EWENS WJ, 1995, AM J HUM GENET, V57, P455; Farnir F, 2002, GENETICS, V161, P275; Gao H, 2009, HEREDITY, V103, P368, DOI 10.1038/hdy.2009.71; Gauderman W. James, 1999, Journal of the National Cancer Institute Monographs, P31; GEORGES M, 1995, GENETICS, V139, P907; Georges M, 2007, ANNU REV GENOM HUM G, V8, P131, DOI 10.1146/annurev.genom.8.080706.092408; Goddard ME, 2009, NAT REV GENET, V10, P381, DOI 10.1038/nrg2575; Grapes L, 2004, GENETICS, V166, P1561, DOI 10.1534/genetics.166.3.1561; Grisart B, 2004, P NATL ACAD SCI USA, V101, P2398, DOI 10.1073/pnas.0308518100; Haegeman A, 2003, ANIM GENET, V34, P349, DOI 10.1046/j.1365-2052.2003.01008.x; Harder B, 2006, J ANIM BREED GENET, V123, P89, DOI 10.1111/j.1439-0388.2006.00577.x; Heyen DW, 1999, PHYSIOL GENOMICS, V1, P165, DOI 10.1152/physiolgenomics.1999.1.3.165; Hirschhorn JN, 2005, NAT REV GENET, V6, P95, DOI 10.1038/nrg1521; Horin P, 2008, DEV BIOLOGICALS, V132, P347, DOI 10.1159/000317184; Huang JA, 2003, AM J HUM GENET, V72, P949, DOI 10.1086/374568; Kaminski S, 2008, ANIM BIOTECHNOL, V19, P43, DOI 10.1080/10495390701880946; Kaupe B, 2007, J ANIM SCI, V85, P11, DOI 10.2527/jas.2005-753; Kolbehdari D, 2006, J ANIM BREED GENET, V123, P191, DOI 10.1111/j.1439-0388.2006.00579.x; Kolbehdari D, 2009, J ANIM BREED GENET, V126, P216, DOI 10.1111/j.1439-0388.2008.00793.x; Kuss AW, 2003, J DAIRY SCI, V86, P2213, DOI 10.3168/jds.S0022-0302(03)73811-9; Lange C, 2001, GENETICS, V159, P1325; Little J, 2002, AM J EPIDEMIOL, V156, P300, DOI 10.1093/oxfordjournals.aje.a000179; Liu JF, 2007, AM J HUM GENET, V81, P304, DOI 10.1086/519495; Liu JF, 2009, GENET EPIDEMIOL, V33, P217, DOI 10.1002/gepi.20372; Liu YZ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006827; Looft C, 2001, MAMM GENOME, V12, P646, DOI 10.1007/s003350020003; Lund MS, 2008, J DAIRY SCI, V91, P4028, DOI 10.3168/jds.2007-0290; Lund MS, 2008, GENET SEL EVOL, V40, P177, DOI 10.1051/gse:2007043; Matukumalli LK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005350; Meuwissen THE, 2001, GENET SEL EVOL, V33, P605, DOI 10.1051/gse:2001134; Ng CC, 2009, J HUM GENET, V54, P392, DOI 10.1038/jhg.2009.49; OGOREVC J, 2009, ANIM GENET; Pearson TA, 2008, JAMA-J AM MED ASSOC, V299, P1335, DOI 10.1001/jama.299.11.1335; Rodriguez-Zas SL, 2002, J DAIRY SCI, V85, P2681, DOI 10.3168/jds.S0022-0302(02)74354-3; Schaeffer LR, 2000, J DAIRY SCI, V83, P1135, DOI 10.3168/jds.S0022-0302(00)74979-4; Schulman NF, 2008, GENET SEL EVOL, V40, P195, DOI 10.1051/gse:2007044; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Sun FZ, 2000, ANN HUM GENET, V64, P555, DOI 10.1017/S000348000000840X; Thomas DC, 2005, AM J HUM GENET, V77, P337, DOI 10.1086/432962; Thomsen H, 2001, J ANIM BREED GENET, V118, P357, DOI 10.1046/j.1439-0388.2001.00302.x; THOMSEN H, 2006, 8 WORLD C GEN APPL L; Vallet JL, 2005, J ANIM SCI, V83, P1860; Vallet JL, 2005, ANIM GENET, V36, P97, DOI 10.1111/j.1365-2052.2005.01233.x; Viitala S, 2006, GENETICS, V173, P2151, DOI 10.1534/genetics.105.046730; Viitala SM, 2003, J DAIRY SCI, V86, P1828, DOI 10.3168/jds.S0022-0302(03)73769-2; Wiener P, 2000, ANIM GENET, V31, P385, DOI 10.1046/j.1365-2052.2000.00689.x; Williams KJ, 2009, ARTERIOSCL THROM VAS, V29, P792, DOI 10.1161/ATVBAHA.109.187823; Zhao HH, 2007, GENETICS, V175, P1975, DOI 10.1534/genetics.106.066480	67	172	190	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2010	5	10							e13661	10.1371/journal.pone.0013661	http://dx.doi.org/10.1371/journal.pone.0013661			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671UN	21048968	Green Published, Green Submitted, gold			2022-12-27	WOS:000283537000030
J	Schreeg, LA; Kress, WJ; Erickson, DL; Swenson, NG				Schreeg, Laura A.; Kress, W. John; Erickson, David L.; Swenson, Nathan G.			Phylogenetic Analysis of Local-Scale Tree Soil Associations in a Lowland Moist Tropical Forest	PLOS ONE			English	Article							HABITAT ASSOCIATIONS; RAIN-FOREST; MANGANESE TOXICITY; ALUMINUM ACCUMULATION; SPECIES DISTRIBUTION; COMMUNITY STRUCTURE; EDAPHIC FACTORS; BARRO-COLORADO; MYCORRHIZAL; DIVERSITY	Background: Local plant-soil associations are commonly studied at the species-level, while associations at the level of nodes within a phylogeny have been less well explored. Understanding associations within a phylogenetic context, however, can improve our ability to make predictions across systems and can advance our understanding of the role of evolutionary history in structuring communities. Methodology/Principal Findings: Here we quantified evolutionary signal in plant-soil associations using a DNA sequence-based community phylogeny and several soil variables (e. g., extractable phosphorus, aluminum and manganese, pH, and slope as a proxy for soil water). We used published plant distributional data from the 50-ha plot on Barro Colorado Island (BCI), Republic of Panama. Our results suggest some groups of closely related species do share similar soil associations. Most notably, the node shared by Myrtaceae and Vochysiaceae was associated with high levels of aluminum, a potentially toxic element. The node shared by Apocynaceae was associated with high extractable phosphorus, a nutrient that could be limiting on a taxon specific level. The node shared by the large group of Laurales and Magnoliales was associated with both low extractable phosphorus and with steeper slope. Despite significant node-specific associations, this study detected little to no phylogeny-wide signal. We consider the majority of the 'traits' (i.e., soil variables) evaluated to fall within the category of ecological traits. We suggest that, given this category of traits, phylogeny-wide signal might not be expected while node-specific signals can still indicate phylogenetic structure with respect to the variable of interest. Conclusions: Within the BCI forest dynamics plot, distributions of some plant taxa are associated with local-scale differences in soil variables when evaluated at individual nodes within the phylogenetic tree, but they are not detectable by phylogeny-wide signal. Trends highlighted in this analysis suggest how plant-soil associations may drive plant distributions and diversity at the local-scale.	[Schreeg, Laura A.] Univ Florida, Sch Nat Resources & Environm, Dept Biol, Gainesville, FL 32611 USA; [Schreeg, Laura A.] Smithsonian Trop Res Inst, Balboa, Ancon, Panama; [Kress, W. John; Erickson, David L.] Smithsonian Inst, Dept Bot, Natl Museum Nat Hist, Washington, DC 20560 USA; [Swenson, Nathan G.] Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA	State University System of Florida; University of Florida; Smithsonian Institution; Smithsonian Tropical Research Institute; Smithsonian Institution; Smithsonian National Museum of Natural History; Michigan State University	Schreeg, LA (corresponding author), Univ Florida, Sch Nat Resources & Environm, Dept Biol, Gainesville, FL 32611 USA.	schreeg@ufl.edu	Swenson, Nathan/A-3514-2012	Swenson, Nathan/0000-0003-3819-9767	National Science Foundation; University of Florida (UF); Smithsonian Tropical Research Institute; NSF [DEB021104, 021115, 0212284, 0212818, OISE 0314581]	National Science Foundation(National Science Foundation (NSF)); University of Florida (UF)(University of Florida); Smithsonian Tropical Research Institute(Smithsonian InstitutionSmithsonian Tropical Research Institute); NSF(National Science Foundation (NSF))	NGS was supported by a National Science Foundation Post-Doctoral Fellowship in Bioinformatics while this work was being performed. LAS was supported by fellowships from University of Florida (UF) and the Smithsonian Tropical Research Institute during this work. This project was initiated during the Organization for Tropical Studies (OTS) Plant Systematics course. LAS's participation and travel was supported by OTS, UF Department of Botany, UF Office of Research, a Field Research Grant through the UF Tropical Conservation and Development Program and Michelle Mack's Ecosystem Ecology lab. The soil data used in the analysis were collected by STRI Soils Initiative and CTFS, led by Jim Dalling and Kyle Harms with support from NSF DEB021104, 021115, 0212284, 0212818 and OISE 0314581 and the field assistance of Paolo Segre and Juan Di Trani. The plant distribution data used in this work were collected through the Center for Tropical Forest Science and are cited accordingly. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiba S, 2004, PLANT ECOL, V174, P147, DOI 10.1023/B:VEGE.0000046059.92806.49; BAILLIE I, 2006, SEMIDETAILLED SOIL S; Barthold FK, 2008, FOREST ECOL MANAG, V255, P1135, DOI 10.1016/j.foreco.2007.09.089; BECKER P, 1988, J TROP ECOL, V4, P173, DOI 10.1017/S0266467400002674; Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; Blomberg SP, 2002, J EVOLUTION BIOL, V15, P899, DOI 10.1046/j.1420-9101.2002.00472.x; Bohning-Gaese K, 1999, EVOL ECOL RES, V1, P347; Clark DB, 1999, ECOLOGY, V80, P2662, DOI 10.1890/0012-9658(1999)080[2662:EFATLS]2.0.CO;2; Comita LS, 2007, J ECOL, V95, P482, DOI 10.1111/j.1365-2745.2007.01229.x; Condit R, 1999, PHILOS T R SOC B, V354, P1739, DOI 10.1098/rstb.1999.0517; Condit R, 2000, SCIENCE, V288, P1414, DOI 10.1126/science.288.5470.1414; Condit R, 1996, J ECOL, V84, P549, DOI 10.2307/2261477; DALLING J, 2009, SOIL MAPS BARRO COLO; Davies SJ, 2005, ECOL STU AN, V174, P22; Daws MI, 2002, PLANT SOIL, V238, P79, DOI 10.1023/A:1014289930621; Ducic T, 2006, NEW PHYTOL, V170, P11, DOI 10.1111/j.1469-8137.2006.01666.x; El-Jaoual T, 1998, J PLANT NUTR, V21, P353, DOI 10.1080/01904169809365409; Engelbrecht BMJ, 2007, NATURE, V447, P80, DOI 10.1038/nature05747; Fine PVA, 2005, EVOLUTION, V59, P1464; Fitter AH, 1996, PHILOS T R SOC B, V351, P1367, DOI 10.1098/rstb.1996.0120; GENTRY AH, 1982, ANN MO BOT GARD, V69, P557, DOI 10.2307/2399084; Gunatilleke CVS, 2006, J TROP ECOL, V22, P371, DOI 10.1017/S0266467406003282; Hall JS, 2004, ECOLOGY, V85, P2171, DOI 10.1890/03-0043; Harms KE, 2001, J ECOL, V89, P947, DOI 10.1111/j.1365-2745.2001.00615.x; Harms KE, 2004, FOREST DYNAMICS PLOT; Hubbell S.P., 1986, COMMUNITY ECOLOGY, P314; HUBBELL SP, 1983, BRIT ECOLOGICAL SOC, V2, P25; Hubbell SP, 1986, CONSERVATION BIOL SC, P205; Hue NV, 2001, SOIL SCI SOC AM J, V65, P153, DOI 10.2136/sssaj2001.651153x; Husband R, 2002, MOL ECOL, V11, P2669, DOI 10.1046/j.1365-294X.2002.01647.x; Jansen S, 2002, ANN BOT-LONDON, V90, P53, DOI 10.1093/aob/mcf142; Jansen S, 2002, BOT REV, V68, P235, DOI 10.1663/0006-8101(2002)068[0235:AHIAAR]2.0.CO;2; Jansen S, 2000, ANN BOT-LONDON, V85, P91, DOI 10.1006/anbo.1999.1000; JANSEN S, 2004, EVOLUTION PLANT PHYS, P467; John R, 2007, P NATL ACAD SCI USA, V104, P864, DOI 10.1073/pnas.0604666104; Kaspari M, 2008, ECOL LETT, V11, P35, DOI 10.1111/j.1461-0248.2007.01124.x; Kembel SW, 2006, ECOLOGY, V87, pS86, DOI 10.1890/0012-9658(2006)87[86:TPSOAN]2.0.CO;2; KEMBEL SW, BIOINFORMAT IN PRESS; Kiers ET, 2000, ECOL LETT, V3, P106, DOI 10.1046/j.1461-0248.2000.00126.x; Kitao M, 2001, ENVIRON POLLUT, V111, P89, DOI 10.1016/S0269-7491(99)00332-2; Kress WJ, 2005, P NATL ACAD SCI USA, V102, P8369, DOI 10.1073/pnas.0503123102; Lambers H, 2008, TRENDS ECOL EVOL, V23, P95, DOI 10.1016/j.tree.2007.10.008; Ma JF, 2001, TRENDS PLANT SCI, V6, P273, DOI 10.1016/S1360-1385(01)01961-6; Marschner H., 1986, Mineral nutrition of higher plants.; McQuattie CH, 2000, CAN J FOREST RES, V30, P456, DOI 10.1139/cjfr-30-3-456; MEHLICH A, 1984, COMMUN SOIL SCI PLAN, V15, P1409, DOI 10.1080/00103628409367568; Moles AT, 2005, SCIENCE, V307, P576, DOI 10.1126/science.1104863; MORRIS HD, 1949, AGRON J, V41, P107, DOI 10.2134/agronj1949.00021962004100030003x; Niinemets U, 2006, ECOL MONOGR, V76, P521, DOI 10.1890/0012-9615(2006)076[0521:TTSDAW]2.0.CO;2; PEREZ R, 2005, METODOLOGIA EMPLEADA, P1; Phillips OL, 2003, J ECOL, V91, P757, DOI 10.1046/j.1365-2745.2003.00815.x; Russo SE, 2005, J ECOL, V93, P879, DOI 10.1111/j.1365-2745.2005.01030.x; SANDERS FE, 1971, NATURE, V233, P278, DOI 10.1038/233278c0; Smith S., 1997, MYCORRHIZAL SYMBIOSI, V2nd Edn; SMITH SE, 1982, NEW PHYTOL, V90, P293, DOI 10.1111/j.1469-8137.1982.tb03261.x; Sollins P, 1998, ECOLOGY, V79, P23, DOI 10.1890/0012-9658(1998)079[0023:FISCIT]2.0.CO;2; St Clair SB, 2005, TREE PHYSIOL, V25, P85, DOI 10.1093/treephys/25.1.85; Stevens P.F., ANGIOSPERM PHYLOGENY; Svenning JC, 2004, ECOLOGY, V85, P2526, DOI 10.1890/03-0396; Swenson NG, 2007, ECOLOGY, V88, P1770, DOI 10.1890/06-1499.1; Swenson NG, 2007, AM J BOT, V94, P451, DOI 10.3732/ajb.94.3.451; Swenson NG, 2006, ECOLOGY, V87, P2418, DOI 10.1890/0012-9658(2006)87[2418:TPAPOS]2.0.CO;2; Swenson NG, 2009, ECOLOGY, V90, P2161, DOI 10.1890/08-1025.1; Tateno R, 2003, ECOL RES, V18, P559, DOI 10.1046/j.1440-1703.2003.00578.x; TILMAN D, 1988; Tuomisto H, 2003, SCIENCE, V299, P241, DOI 10.1126/science.1078037; Turner BL, 2008, J ECOL, V96, P698, DOI 10.1111/j.1365-2745.2008.01384.x; van der Heijden MGA, 2007, NEW PHYTOL, V174, P244, DOI 10.1111/j.1469-8137.2007.02041.x; van der Heijden MGA, 1998, NATURE, V396, P69, DOI 10.1038/23932; Vandenkoornhuyse P, 2003, MOL ECOL, V12, P3085, DOI 10.1046/j.1365-294X.2003.01967.x; Vitousek PM, 1997, BIOGEOCHEMISTRY, V37, P63, DOI 10.1023/A:1005757218475; WALKER TW, 1976, GEODERMA, V15, P1, DOI 10.1016/0016-7061(76)90066-5; Webb CO, 2008, BIOINFORMATICS, V24, P2098, DOI 10.1093/bioinformatics/btn358; Webb CO, 2005, MOL ECOL NOTES, V5, P181, DOI 10.1111/j.1471-8286.2004.00829.x; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448; Webb CO, 2000, AM NAT, V156, P145, DOI 10.1086/303378; WEBB CO, 2008, PHYLOCOM SOFTWARE AN; WEBB L. J., 1954, AUSTRALIAN JOUR BOT, V2, P176, DOI 10.1071/BT9540176; YAVITT JB, 1988, BIOTROPICA, V20, P2, DOI 10.2307/2388420; Zimmerman JK, 2007, J TROP ECOL, V23, P231, DOI 10.1017/S0266467406003890	80	39	41	3	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2010	5	10							e13685	10.1371/journal.pone.0013685	http://dx.doi.org/10.1371/journal.pone.0013685			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671UN	21060686	Green Submitted, gold, Green Published			2022-12-27	WOS:000283537000050
J	Dong, BC; Zhang, MX; Alpert, P; Lei, GC; Yu, FH				Dong, Bi-Cheng; Zhang, Ming-Xiang; Alpert, Peter; Lei, Guang-Chun; Yu, Fei-Hai			Effects of Orientation on Survival and Growth of Small Fragments of the Invasive, Clonal Plant Alternanthera philoxeroides	PLOS ONE			English	Article							TRIFOLIUM-REPENS L; NITROGEN RESERVES; REGENERATION; STORAGE; REMOBILIZATION; INTEGRATION; REGROWTH	Background: The ability of small clonal fragments to establish and grow after disturbance is an important ecological advantage of clonal growth in plants and a major factor in the invasiveness of some introduced, clonal species. We hypothesized that orientation in the horizontal position (typical for stoloniferous plants) can increase the survival and growth of dispersed clonal fragments, and that this effect of orientation can be stronger when fragments are smaller and thus have fewer reserves to support initial growth. Methodology/Principal Findings: To test these hypotheses, we compared performance of single-node pieces of stolon fragments of Alternanthera philoxeroides planted at angles of 0, 45 or 90 degrees away from the horizontal position, with either the distal or the proximal end of the fragment up and with either 1 or 3 cm of stolon left attached both distal and proximal to the ramet. As expected, survival and growth were greatest when fragments were positioned horizontally. Contrary to expectations, some of these effects of orientation were stronger when attached stolons were longer. Orientation had smaller effects than stolon length on the performance of fragments; survival of fragments was about 60% with shorter stolons and 90% with longer stolons. Conclusions/Significance: Results supported the hypothesis that orientation can affect establishment of small clonal fragments, suggested that effects of orientation can be stronger in larger rather than smaller fragments, and indicated that orientation may have less effect on establishment than amount of stored resources.	[Dong, Bi-Cheng; Zhang, Ming-Xiang; Lei, Guang-Chun; Yu, Fei-Hai] Beijing Forestry Univ, Coll Nat Conservat, Beijing, Peoples R China; [Alpert, Peter] Univ Massachusetts, Dept Biol, Amherst, MA 01003 USA	Beijing Forestry University; University of Massachusetts System; University of Massachusetts Amherst	Dong, BC (corresponding author), Beijing Forestry Univ, Coll Nat Conservat, Beijing, Peoples R China.	zmx1972@126.com; feihaiyu@bjfu.edu.cn	Yu, Fei-Hai/O-9395-2016; Guangchun, Lei/ABC-8081-2021	Yu, Fei-Hai/0000-0001-5007-1745; Dong, Bi-Cheng/0000-0002-9658-9969	Fundamental Research Funds for the Central Universities [BLJ200910]; Forestry Commonwealth Project	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Forestry Commonwealth Project	This work was supported by the Fundamental Research Funds for the Central Universities (BLJ200910) and a Forestry Commonwealth Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrat-Segretain MH, 2000, HYDROBIOLOGIA, V421, P31, DOI 10.1023/A:1003980927853; BAURHOCH B, 1990, J EXP BOT, V41, P573, DOI 10.1093/jxb/41.5.573; Corre N, 1996, J EXP BOT, V47, P1111, DOI 10.1093/jxb/47.8.1111; DANCKWERTS JE, 1989, ANN BOT-LONDON, V64, P533, DOI 10.1093/oxfordjournals.aob.a087875; Decruyenaere JG, 2001, WEED SCI, V49, P760, DOI 10.1614/0043-1745(2001)049[0760:SOCPIG]2.0.CO;2; Dong BC, 2010, EVOL ECOL, V24, P1447, DOI 10.1007/s10682-010-9390-5; Holm L., 1997, WORLD WEEDS NATURAL; Iwasa Y, 1997, EVOL ECOL, V11, P41, DOI 10.1023/A:1018483429029; JULIEN MH, 1995, J AQUAT PLANT MANAGE, V33, P55; Klimes L, 1997, ECOLOGY AND EVOLUTION OF CLONAL PLANTS, P1; Klimesova J, 2008, WEED RES, V48, P131, DOI 10.1111/j.1365-3180.2007.00608.x; Klimesova J, 2007, PERSPECT PLANT ECOL, V8, P115, DOI 10.1016/j.ppees.2006.10.002; Latzel V, 2009, ACTA OECOL, V35, P541, DOI 10.1016/j.actao.2009.04.003; [马瑞燕 Ma Ruiyan], 2005, [应用与环境生物学报, Chinese Journal of Applied and Environmental Biology], V11, P246; Morris DA, 2004, PLANT HORMONES: BIOSYNTHESIS, SIGNAL TRANSDUCTION, ACTION, P437; Muday GK, 2001, J PLANT GROWTH REGUL, V20, P226, DOI 10.1007/s003440010027; Pan XY, 2007, ACTA PHYTOTAXON SIN, V45, P884, DOI 10.1360/aps06134; Puijalon S, 2008, EVOL ECOL, V22, P493, DOI 10.1007/s10682-007-9177-5; Sainty G., 1997, WETLANDS ECOLOGY MAN, V5, P195, DOI DOI 10.1023/A:1008248921849; Stuefer JF, 1999, ECOL LETT, V2, P135; Suzuki Jun-ichirou, 1999, Plant Species Biology, V14, P11, DOI 10.1046/j.1442-1984.1999.00002.x; Volenec JJ, 1996, PHYSIOL PLANTARUM, V97, P185, DOI 10.1111/j.1399-3054.1996.tb00496.x; Wang N, 2008, ANN BOT-LONDON, V101, P671, DOI 10.1093/aob/mcn005; Wijte AHBM, 2005, INT J PLANT SCI, V166, P507, DOI 10.1086/428915; Xu CY, 2010, J ECOL, V98, P833, DOI 10.1111/j.1365-2745.2010.01668.x; Ye WH, 2003, WEED RES, V43, P297, DOI 10.1046/j.1365-3180.2003.00346.x	26	28	37	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2010	5	10							e13631	10.1371/journal.pone.0013631	http://dx.doi.org/10.1371/journal.pone.0013631			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671GB	21049029	Green Published, gold			2022-12-27	WOS:000283487400021
J	Gangolf, M; Czerniecki, J; Radermecker, M; Detry, O; Nisolle, M; Jouan, C; Martin, D; Chantraine, F; Lakaye, B; Wins, P; Grisar, T; Bettendorff, L				Gangolf, Marjorie; Czerniecki, Jan; Radermecker, Marc; Detry, Olivier; Nisolle, Michelle; Jouan, Caroline; Martin, Didier; Chantraine, Frederic; Lakaye, Bernard; Wins, Pierre; Grisar, Thierry; Bettendorff, Lucien			Thiamine Status in Humans and Content of Phosphorylated Thiamine Derivatives in Biopsies and Cultured Cells	PLOS ONE			English	Article							PERFORMANCE LIQUID-CHROMATOGRAPHY; CYTOSOLIC ADENYLATE KINASE; REDUCED FOLATE CARRIER; PHOSPHATE-ESTERS; RAT-BRAIN; METABOLIZING ENZYMES; ALZHEIMERS-DISEASE; HEART-FAILURE; WHOLE-BLOOD; NUCLEOSIDE-DIPHOSPHATASE	Background: Thiamine (vitamin B1) is an essential molecule for all life forms because thiamine diphosphate (ThDP) is an indispensable cofactor for oxidative energy metabolism. The less abundant thiamine monophosphate (ThMP), thiamine triphosphate (ThTP) and adenosine thiamine triphosphate (AThTP), present in many organisms, may have still unidentified physiological functions. Diseases linked to thiamine deficiency (polyneuritis, Wernicke-Korsakoff syndrome) remain frequent among alcohol abusers and other risk populations. This is the first comprehensive study on the distribution of thiamine derivatives in human biopsies, body fluids and cell lines. Methodology and Principal Findings: Thiamine derivatives were determined by HPLC. In human tissues, the total thiamine content is lower than in other animal species. ThDP is the major thiamine compound and tissue levels decrease at high age. In semen, ThDP content correlates with the concentration of spermatozoa but not with their motility. The proportion of ThTP is higher in humans than in rodents, probably because of a lower 25-kDa ThTPase activity. The expression and activity of this enzyme seems to correlate with the degree of cell differentiation. ThTP was present in nearly all brain and muscle samples and in similar to 60% of other tissue samples, in particular fetal tissue and cultured cells. A low ([ThTP]+[ThMP])/([Thiamine]+[ThMP]) ratio was found in cardiovascular tissues of patients with cardiac insufficiency. AThTP was detected only sporadically in adult tissues but was found more consistently in fetal tissues and cell lines. Conclusions and Significance: The high sensitivity of humans to thiamine deficiency is probably linked to low circulating thiamine concentrations and low ThDP tissue contents. ThTP levels are relatively high in many human tissues, as a result of low expression of the 25-kDa ThTPase. Another novel finding is the presence of ThTP and AThTP in poorly differentiated fast-growing cells, suggesting a hitherto unsuspected link between these compounds and cell division or differentiation.	[Gangolf, Marjorie; Czerniecki, Jan; Lakaye, Bernard; Wins, Pierre; Grisar, Thierry; Bettendorff, Lucien] Univ Liege, GIGA Neurosci, Liege, Belgium; [Radermecker, Marc] Univ Liege, Univ Hosp, Dept Cardiovasc Surg, Liege, Belgium; [Detry, Olivier] Univ Liege, Univ Hosp, Dept Abdominal Surg & Transplantat, Liege, Belgium; [Nisolle, Michelle; Jouan, Caroline; Chantraine, Frederic] Univ Liege, Univ Hosp, Dept Obstet Gynecol, Liege, Belgium; [Martin, Didier] Univ Liege, Univ Hosp, Dept Neurosurg, Liege, Belgium	University of Liege; University of Liege; University of Liege; University of Liege; University of Liege	Gangolf, M (corresponding author), Univ Liege, GIGA Neurosci, Liege, Belgium.	L.Bettendorff@ulg.ac.be	Detry, Olivier/I-9333-2019; Czerniecki, Jan/H-7168-2017	Detry, Olivier/0000-0002-9436-6673; Czerniecki, Jan/0000-0002-8889-8382; MARTIN, Didier Herman/0000-0001-7325-4958				AUGER J, 1989, J ANDROL, V10, P439; BALAGHI M, 1966, J NUTR, V89, P127, DOI 10.1093/jn/89.2.127; BARCHI RL, 1972, J BIOL CHEM, V247, P7668; Benton D, 1997, PSYCHOPHARMACOLOGY, V129, P66, DOI 10.1007/s002130050163; BETTENDORFF L, 1993, J MEMBRANE BIOL, V136, P281; BETTENDORFF L, 1994, BBA-MOL CELL RES, V1222, P1, DOI 10.1016/0167-4889(94)90018-3; BETTENDORFF L, 1991, ANAL BIOCHEM, V198, P52, DOI 10.1016/0003-2697(91)90505-N; BETTENDORFF L, 1988, BIOCHEM BIOPH RES CO, V154, P942, DOI 10.1016/0006-291X(88)90230-6; Bettendorff L, 2003, ANAL BIOCHEM, V322, P190, DOI 10.1016/j.ab.2003.08.013; BETTENDORFF L, 1994, BBA-MOL CELL RES, V1222, P7, DOI 10.1016/0167-4889(94)90019-1; Bettendorff L, 1996, J NEUROCHEM, V66, P250; Bettendorff L, 1997, J NEUROCHEM, V69, P2005; BETTENDORFF L, 1986, J CHROMATOGR, V382, P297, DOI 10.1016/S0378-4347(00)83533-1; BETTENDORFF L, 1989, J NEUROCHEM, V53, P80, DOI 10.1111/j.1471-4159.1989.tb07297.x; BETTENDORFF L, 1987, J NEUROCHEM, V49, P495, DOI 10.1111/j.1471-4159.1987.tb02891.x; Bettendorff L, 2007, NAT CHEM BIOL, V3, P211, DOI 10.1038/nchembio867; Bettendorff L, 2009, FEBS J, V276, P2917, DOI 10.1111/j.1742-4658.2009.07019.x; BRUNNEKREEFT JWI, 1989, J CHROMATOGR-BIOMED, V491, P89, DOI 10.1016/S0378-4347(00)82822-4; BUTTERWORTH RF, 1991, METAB BRAIN DIS, V6, P207, DOI 10.1007/BF00996920; Butterworth RF, 2009, METAB BRAIN DIS, V24, P189, DOI 10.1007/s11011-008-9129-y; Carpenter KJ, 2000, BERIBERI WHITE RICE; CASIROLA D, 1990, J MEMBRANE BIOL, V118, P11, DOI 10.1007/BF01872201; Chaggar PS, 2009, CARDIOVASC THER, V27, P187, DOI 10.1111/j.1755-5922.2009.00094.x; Chen MF, 1996, J AM COLL NUTR, V15, P231; COOPER JR, 1969, SCIENCE, V164, P74, DOI 10.1126/science.164.3875.74; Czerniecki J, 2004, NEUROSCIENCE, V125, P833, DOI 10.1016/j.neuroscience.2004.02.033; DECARO L, 1961, INT Z VITAMINFORSCH, V31, P333; DREYFUS PM, 1961, J NEUROCHEM, V8, P139, DOI 10.1111/j.1471-4159.1961.tb13535.x; EGI Y, 1992, BIOCHIM BIOPHYS ACTA, V1160, P171, DOI 10.1016/0167-4838(92)90004-W; EGI Y, 1986, BIOCHEM INT, V12, P385; Fattal-Valevski A, 2005, PEDIATRICS, V115, pE233, DOI 10.1542/peds.2004-1255; Fayol V, 1997, METHOD ENZYMOL, V279, P57; FLORIDI A, 1984, INT J VITAM NUTR RES, V54, P165; Frederich M, 2009, FEBS J, V276, P3256, DOI 10.1111/j.1742-4658.2009.07040.x; Fukuwatari T, 2010, J NUTR SCI VITAMINOL, V56, P19, DOI 10.3177/jnsv.56.19; Gadau S, 2006, DIABETOLOGIA, V49, P405, DOI 10.1007/s00125-005-0103-5; Gangolf M, 2010, J BIOL CHEM, V285, P583, DOI 10.1074/jbc.M109.054379; GASTALDI G, 1992, BIOCHIM BIOPHYS ACTA, V1105, P271, DOI 10.1016/0005-2736(92)90204-Y; Gigliobianco T, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-148; Gigliobianco T, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-16; Gioda CR, 2010, AM J PHYSIOL-HEART C, V298, pH2039, DOI 10.1152/ajpheart.00820.2009; Gioda CR, 2009, EUR J HEART FAIL, V11, P1126, DOI 10.1093/eurjhf/hfp146; GOLD M, 1995, ARCH NEUROL-CHICAGO, V52, P1081, DOI 10.1001/archneur.1995.00540350075019; Gong CL, 2006, RNA, V12, P1468, DOI 10.1261/rna.119806; Harper C, 2006, EUR J NEUROL, V13, P1078, DOI 10.1111/j.1468-1331.2006.01530.x; HARPER CG, 1986, J NEUROL NEUROSUR PS, V49, P341, DOI 10.1136/jnnp.49.4.341; Hazell AS, 2009, ALCOHOL ALCOHOLISM, V44, P141, DOI 10.1093/alcalc/agn120; Heroux M, 1996, METAB BRAIN DIS, V11, P81, DOI 10.1007/BF02080933; HINTING A, 1988, INT J ANDROL, V11, P277, DOI 10.1111/j.1365-2605.1988.tb01001.x; HOORN RKJ, 1975, CLIN CHIM ACTA, V61, P151, DOI 10.1016/0009-8981(75)90309-5; IBER FL, 1982, AM J CLIN NUTR, V36, P1067, DOI 10.1093/ajcn/36.5.1067; Iyer LM, 2002, BMC GENOMICS, V3, DOI 10.1186/1471-2164-3-33; Kawasaki T., 1992, MODERN CHROMATOGRAPH, P319; KIMURA M, 1985, J CHROMATOGR, V332, P181, DOI 10.1016/S0021-9673(01)83295-7; KIMURA M, 1982, CLIN CHEM, V28, P29; Klooster A, 2007, MED HYPOTHESES, V69, P873, DOI 10.1016/j.mehy.2007.01.067; Kopelman MD, 2009, ALCOHOL ALCOHOLISM, V44, P148, DOI 10.1093/alcalc/agn118; KRUGER TF, 1988, FERTIL STERIL, V49, P112; Laforenza U, 1997, AM J CLIN NUTR, V66, P320, DOI 10.1093/ajcn/66.2.320; Lakaye B, 2004, INT J BIOCHEM CELL B, V36, P2032, DOI 10.1016/j.biocel.2004.03.004; Lakaye B, 2004, INT J BIOCHEM CELL B, V36, P1348, DOI 10.1016/j.biocel.2003.11.013; Lakaye B, 2002, J BIOL CHEM, V277, P13771, DOI 10.1074/jbc.M111241200; Lu J, 2008, CLIN CHEM, V54, P901, DOI 10.1373/clinchem.2007.099077; Makarchikov AF, 2003, CELL MOL LIFE SCI, V60, P1477, DOI 10.1007/s00018-003-3098-4; MAKARCHIKOV AF, 1992, BIOCHIM BIOPHYS ACTA, V1117, P326, DOI 10.1016/0304-4165(92)90032-P; Makarchikov Alexander F., 2007, BMC Biochemistry, V8, P17, DOI 10.1186/1471-2091-8-17; Mastrogiacomo F, 1996, ANN NEUROL, V39, P585, DOI 10.1002/ana.410390507; MATSUDA T, 1989, J NEUROCHEM, V52, P842, DOI 10.1111/j.1471-4159.1989.tb02530.x; McCandless D, 2009, THIAMINE DEFICIENCY; MCCANDLESS DW, 1968, J CLIN INVEST, V47, P2268, DOI 10.1172/JCI105912; MIYOSHI K, 1990, J BIOCHEM-TOKYO, V108, P267, DOI 10.1093/oxfordjournals.jbchem.a123192; Molina JA, 2002, J NEURAL TRANSM, V109, P1035, DOI 10.1007/s007020200087; Muri RM, 1999, CLIN NUTR, V18, P375, DOI 10.1016/S0261-5614(99)80019-3; Nascimento JM, 2008, J CELL PHYSIOL, V217, P745, DOI 10.1002/jcp.21549; Nghiem HO, 2000, FASEB J, V14, P543, DOI 10.1096/fasebj.14.3.543; Oishi K, 2004, DEV BIOL, V266, P299, DOI 10.1016/j.ydbio.2003.10.026; Pekovich SR, 1998, J NUTR BIOCHEM, V9, P215, DOI 10.1016/S0955-2863(97)00187-3; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; PINCUS JH, 1970, EXP NEUROL, V28, P477, DOI 10.1016/0014-4886(70)90184-6; PINCUS JH, 1976, ARCH NEUROL-CHICAGO, V33, P759, DOI 10.1001/archneur.1976.00500110027005; Reidling JC, 2002, BBA-BIOMEMBRANES, V1561, P180, DOI 10.1016/S0005-2736(02)00341-3; RINDI G, 1981, EXPERIENTIA, V37, P975, DOI 10.1007/BF01971788; Sacca L, 2009, CIRC-HEART FAIL, V2, P151, DOI 10.1161/CIRCHEARTFAILURE.108.821892; SANO S, 1988, EUR J BIOCHEM, V171, P231, DOI 10.1111/j.1432-1033.1988.tb13781.x; SCHRIJVER J, 1978, NEUROCHEM RES, V3, P699, DOI 10.1007/BF00965993; SCILEPPI KP, 1984, J AM GERIATR SOC, V32, P709, DOI 10.1111/j.1532-5415.1984.tb04168.x; SHIKATA H, 1989, BIOCHEM INT, V18, P933; Shimomura T, 1998, ARCH NEUROL-CHICAGO, V55, P1242, DOI 10.1001/archneur.55.9.1242; Shin BH, 2004, MOL CELLS, V18, P133; Siesjo B.K., 1978, BRAIN ENERGY METABOL; SMIDT LJ, 1991, J GERONTOL, V46, pM16, DOI 10.1093/geronj/46.1.M16; Song JK, 2008, J BIOL CHEM, V283, P10939, DOI 10.1074/jbc.M709675200; Szyniarowski P, 2005, BBA-GEN SUBJECTS, V1725, P93, DOI 10.1016/j.bbagen.2005.05.026; TALLAKSEN CME, 1991, J CHROMATOGR-BIOMED, V564, P127, DOI 10.1016/0378-4347(91)80075-N; VANZAANEN HCT, 1992, CANCER, V69, P1710, DOI 10.1002/1097-0142(19920401)69:7<1710::AID-CNCR2820690711>3.0.CO;2-D; Vognar L, 2009, J AM GERIATR SOC, V57, P2166, DOI 10.1111/j.1532-5415.2009.02542.x; Wang YH, 2001, BBA-BIOMEMBRANES, V1513, P49, DOI 10.1016/S0005-2736(01)00340-6; WEBER W, 1985, EUR J CLIN PHARMACOL, V28, P213, DOI 10.1007/BF00609694; Wilkinson TJ, 1997, AM J CLIN NUTR, V66, P925, DOI 10.1093/ajcn/66.4.925; Williams AC, 2004, BIOL REPROD, V71, P1309, DOI 10.1095/biolreprod.104.028407; Williams RD, 1940, ARCH INTERN MED, V66, P785, DOI 10.1001/archinte.1940.00190160002001; YAMAZAKI M, 1968, J BIOL CHEM, V243, P2934; ZEMPLENI J, 1992, INT J VITAM NUTR RES, V62, P165; Zhao RB, 2002, AM J PHYSIOL-CELL PH, V282, pC1512, DOI 10.1152/ajpcell.00547.2001	104	133	138	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2010	5	10							e13616	10.1371/journal.pone.0013616	http://dx.doi.org/10.1371/journal.pone.0013616			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	670LB	21049048	Green Published, gold			2022-12-27	WOS:000283422100020
J	Greenfield, A; Madar, A; Ostrer, H; Bonneau, R				Greenfield, Alex; Madar, Aviv; Ostrer, Harry; Bonneau, Richard			DREAM4: Combining Genetic and Dynamic Information to Identify Biological Networks and Dynamical Models	PLOS ONE			English	Article							REGULATORY NETWORKS; CLUSTER-ANALYSIS; CHIP-SEQ; INFERENCE; RECONSTRUCTION	Background: Current technologies have lead to the availability of multiple genomic data types in sufficient quantity and quality to serve as a basis for automatic global network inference. Accordingly, there are currently a large variety of network inference methods that learn regulatory networks to varying degrees of detail. These methods have different strengths and weaknesses and thus can be complementary. However, combining different methods in a mutually reinforcing manner remains a challenge. Methodology: We investigate how three scalable methods can be combined into a useful network inference pipeline. The first is a novel t-test-based method that relies on a comprehensive steady-state knock-out dataset to rank regulatory interactions. The remaining two are previously published mutual information and ordinary differential equation based methods (tlCLR and Inferelator 1.0, respectively) that use both time-series and steady-state data to rank regulatory interactions; the latter has the added advantage of also inferring dynamic models of gene regulation which can be used to predict the system's response to new perturbations. Conclusion/Significance: Our t-test based method proved powerful at ranking regulatory interactions, tying for first out of 19 methods in the DREAM4 100-gene in-silico network inference challenge. We demonstrate complementarity between this method and the two methods that take advantage of time-series data by combining the three into a pipeline whose ability to rank regulatory interactions is markedly improved compared to either method alone. Moreover, the pipeline is able to accurately predict the response of the system to new conditions (in this case new double knock-out genetic perturbations). Our evaluation of the performance of multiple methods for network inference suggests avenues for future methods development and provides simple considerations for genomic experimental design. Our code is publicly available at http://err.bio.nyu.edu/inferelator/.	[Greenfield, Alex; Bonneau, Richard] NYU, Sackler Sch Med, Computat Biol Program, New York, NY 10012 USA; [Madar, Aviv; Bonneau, Richard] NYU, Dept Biol, Ctr Genom & Syst Biol, New York, NY 10003 USA; [Ostrer, Harry] NYU, Dept Pediat, Langone Med Ctr, Human Genet Program, New York, NY 10016 USA; [Bonneau, Richard] NYU, Courant Inst Math Sci, Dept Comp Sci, New York, NY 10012 USA	New York University; New York University; New York University; NYU Langone Medical Center; New York University	Greenfield, A (corresponding author), NYU, Sackler Sch Med, Computat Biol Program, New York, NY 10012 USA.	Bonneau@nyu.edu	Bonneau, Richard/ABD-6737-2021; Bonneau, Richard/GZL-2900-2022; Madar, Aviv/D-1023-2013; Madar, Aviv/AAO-1540-2020		National Science Foundation (NSF) [DBI-0820757]; National Institutes of Health (NIH) [I U54CA143907-01]; University of Luxembourg/Luxembourg Centre for Systems Biomedicine; National Institutes of Health through the NIH Roadmap for Medical Research [PN2 EY016586]; NATIONAL CANCER INSTITUTE [U54CA143907] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [PN2EY016586] Funding Source: NIH RePORTER	National Science Foundation (NSF)(National Science Foundation (NSF)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Luxembourg/Luxembourg Centre for Systems Biomedicine; National Institutes of Health through the NIH Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The authors were funded by National Science Foundation (NSF) grant DBI-0820757, National Institutes of Health (NIH) PSOC # I U54CA143907-01, the University of Luxembourg/Luxembourg Centre for Systems Biomedicine, and the National Institutes of Health through the NIH Roadmap for Medical Research (PN2 EY016586). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALVAREZ M, 2009, P 12 INT WORKSH ART, V5, P9; Bansal M, 2006, BIOINFORMATICS, V22, P815, DOI 10.1093/bioinformatics/btl003; Bansal M, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100120; Basso K, 2005, NAT GENET, V37, P382, DOI 10.1038/ng1532; Bergmann S, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.031902; Bonneau R, 2008, NAT CHEM BIOL, V4, P658, DOI 10.1038/nchembio.122; Bonneau R, 2007, CELL, V131, P1354, DOI 10.1016/j.cell.2007.10.053; Bonneau R, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-r36; Butte A J, 2000, Pac Symp Biocomput, P418; Cantone I, 2009, CELL, V137, P172, DOI 10.1016/j.cell.2009.01.055; D'haeseleer P, 2000, BIOINFORMATICS, V16, P707, DOI 10.1093/bioinformatics/16.8.707; di Bernardo D, 2005, NAT BIOTECHNOL, V23, P377, DOI 10.1038/nbt1075; EFRON B, 2004, LEAST ANGLE REGRESSI, P407; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Facciotti MT, 2007, P NATL ACAD SCI USA, V104, P4630, DOI 10.1073/pnas.0611663104; Faith JJ, 2007, PLOS BIOL, V5, P54, DOI 10.1371/journal.pbio.0050008; Friedman N, 1999, UNCERTAINTY IN ARTIFICIAL INTELLIGENCE, PROCEEDINGS, P206; Gama-Castro S, 2008, NUCLEIC ACIDS RES, V36, pD120, DOI 10.1093/nar/gkm994; GARDNER TS, 2003, INFERRING GENETIC NE, P102; Haynes BC, 2009, BIOINFORMATICS, V25, P801, DOI 10.1093/bioinformatics/btp068; He F, 2009, J BIOTECHNOL, V144, P190, DOI 10.1016/j.jbiotec.2009.07.013; Hecker M, 2009, BIOSYSTEMS, V96, P86, DOI 10.1016/j.biosystems.2008.12.004; Horak CE, 2002, METHOD ENZYMOL, V350, P469, DOI 10.1016/S0076-6879(02)50979-4; Ihmels J, 2002, NAT GENET, V31, P370, DOI 10.1038/ng941; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Kerr MK, 2001, P NATL ACAD SCI USA, V98, P8961, DOI 10.1073/pnas.161273698; Kirk PDW, 2009, BIOINFORMATICS, V25, P1300, DOI 10.1093/bioinformatics/btp139; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; Liang KC, 2008, EURASIP J BIOINFORM, DOI 10.1155/2008/253894; MADAR A, 2009, C P ANN INT C IEEE E, V1, P5448; Madar A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009803; Marbach D, 2010, P NATL ACAD SCI USA, V107, P6286, DOI 10.1073/pnas.0913357107; Marbach D, 2009, ANN NY ACAD SCI, V1158, P102, DOI 10.1111/j.1749-6632.2008.03945.x; Marbach D, 2009, J COMPUT BIOL, V16, P229, DOI 10.1089/cmb.2008.09TT; Mardis ER, 2007, NAT METHODS, V4, P613, DOI 10.1038/nmeth0807-613; Margolin A. A., 2006, BMC BIOINFORMATICS, V15, P1; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; Mazur J, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-448; Mendes P, 2003, BIOINFORMATICS, V19, pII122, DOI 10.1093/bioinformatics/btg1069; Prill RJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009202; REISS DJ, 2006, BMC BIOINFORMATICS, V7; Schmid CD, 2007, CELL, V131, P831, DOI 10.1016/j.cell.2007.11.017; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; SHASHA D, 2008, STAT IS EASY, DOI DOI 10.2200/S00142ED1V01Y200807MAS001; Smith V Anne, 2003, Pac Symp Biocomput, P164; Tanay Amos, 2002, Bioinformatics, V18 Suppl 1, pS136; van Someren EP, 2006, BIOINFORMATICS, V22, P477, DOI 10.1093/bioinformatics/bti816; Yip KY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008121	49	152	154	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2010	5	10							e13397	10.1371/journal.pone.0013397	http://dx.doi.org/10.1371/journal.pone.0013397			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	670LB	21049040	Green Published, Green Submitted, gold			2022-12-27	WOS:000283422100003
J	Love, D; Li, FQ; Burke, MC; Cyge, B; Ohmitsu, M; Cabello, J; Larson, JE; Brody, SL; Cohen, JC; Takemaru, KI				Love, Damon; Li, Feng-Qian; Burke, Michael C.; Cyge, Benjamin; Ohmitsu, Masao; Cabello, Jeffrey; Larson, Janet E.; Brody, Steven L.; Cohen, J. Craig; Takemaru, Ken-Ichi			Altered Lung Morphogenesis, Epithelial Cell Differentiation and Mechanics in Mice Deficient in the Wnt/beta-Catenin Antagonist Chibby	PLOS ONE			English	Article							TRANSCRIPTION FACTOR HFH-4; BETA-CATENIN; STEM-CELLS; MOUSE; CILIOGENESIS; EXPRESSION; PATHWAY; CILIARY	The canonical Wnt/beta-catenin pathway plays crucial roles in various aspects of lung morphogenesis and regeneration/repair. Here, we examined the lung phenotype and function in mice lacking the Wnt/b-catenin antagonist Chibby (Cby). In support of its inhibitory role in canonical Wnt signaling, expression of beta-catenin target genes is elevated in the Cby(-/-) lung. Notably, Cby protein is prominently associated with the centrosome/basal body microtubule structures in embryonic lung epithelial progenitor cells, and later enriches as discrete foci at the base of motile cilia in airway ciliated cells. At birth, Cby(-/-) lungs are grossly normal but spontaneously develop alveolar airspace enlargement with reduced proliferation and abnormal differentiation of lung epithelial cells, resulting in altered pulmonary function. Consistent with the Cby expression pattern, airway ciliated cells exhibit a marked paucity of motile cilia with apparent failure of basal body docking. Moreover, we demonstrate that Cby is a direct downstream target for the master ciliogenesis transcription factor Foxj1. Collectively, our results demonstrate that Cby facilitates proper postnatal lung development and function.	[Love, Damon; Li, Feng-Qian; Cyge, Benjamin; Ohmitsu, Masao; Cabello, Jeffrey; Takemaru, Ken-Ichi] SUNY Stony Brook, Dept Pharmacol Sci, Stony Brook, NY 11794 USA; [Love, Damon; Li, Feng-Qian; Cyge, Benjamin; Takemaru, Ken-Ichi] SUNY Stony Brook, Grad Program Mol & Cellular Pharmacol, Stony Brook, NY 11794 USA; [Burke, Michael C.] SUNY Stony Brook, Med Scientist Program MSTP, Stony Brook, NY 11794 USA; [Burke, Michael C.; Takemaru, Ken-Ichi] SUNY Stony Brook, Grad Program Genet, Stony Brook, NY 11794 USA; [Larson, Janet E.; Cohen, J. Craig] SUNY Stony Brook, Dept Pediat, Sect Neonatol, Stony Brook, NY 11794 USA; [Brody, Steven L.] Washington Univ, Sch Med, Dept Internal Med, Div Pulm & Crit Care, St Louis, MO 63110 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Washington University (WUSTL)	Love, D (corresponding author), SUNY Stony Brook, Dept Pharmacol Sci, Stony Brook, NY 11794 USA.	takemaru@pharm.stonybrook.edu			National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [DK073191, DK073191-S1]; Brady Russell Fund; New York State Department of Health; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK073191] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008444] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Brady Russell Fund; New York State Department of Health; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) grant DK073191 to K.-I. Takemaru, an NIDDK research supplemental grant DK073191-S1 to D. Love, and funding from Brady Russell Fund and New York State Department of Health to J.C. Cohen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blatt EN, 1999, AM J RESP CELL MOL, V21, P168, DOI 10.1165/ajrcmb.21.2.3691; Brody SL, 2000, AM J RESP CELL MOL, V23, P45, DOI 10.1165/ajrcmb.23.1.4070; Cardoso WV, 2006, DEVELOPMENT, V133, P1611, DOI 10.1242/dev.02310; Chen JC, 1998, J CLIN INVEST, V102, P1077, DOI 10.1172/JCI4786; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Cohen JC, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-21; Cohen JC, 2005, BMC DEV BIOL, V5, DOI 10.1186/1471-213X-5-2; Corbit KC, 2008, NAT CELL BIOL, V10, P70, DOI 10.1038/ncb1670; Feige E, 2002, MECH DEVELOP, V117, P369, DOI 10.1016/S0925-4773(02)00217-4; Fumoto K, 2009, EMBO REP, V10, P606, DOI 10.1038/embor.2009.45; HANTOS Z, 1992, J APPL PHYSIOL, V72, P168, DOI 10.1152/jappl.1992.72.1.168; Hogg C, 2009, PAEDIATR RESPIR REV, V10, P44, DOI 10.1016/j.prrv.2008.10.001; JAIN R, 2010, AM J RESP CELL MOL B; Klaus A, 2008, NAT REV CANCER, V8, P387, DOI 10.1038/nrc2389; Larson JE, 2006, AM J PHYSIOL-LUNG C, V291, pL4, DOI 10.1152/ajplung.00372.2005; Leigh MW, 2009, GENET MED, V11, P473, DOI 10.1097/GIM.0b013e3181a53562; Li FQ, 2008, J CELL BIOL, V181, P1141, DOI 10.1083/jcb.200709091; Li FQ, 2010, MOL BIOL CELL, V21, P311, DOI 10.1091/mbc.E09-05-0437; Lim L, 1997, P NATL ACAD SCI USA, V94, P3094, DOI 10.1073/pnas.94.7.3094; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maretto S, 2003, P NATL ACAD SCI USA, V100, P3299, DOI 10.1073/pnas.0434590100; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Morrisey EE, 2003, AM J PATHOL, V162, P1393, DOI 10.1016/S0002-9440(10)64271-X; Mucenski ML, 2005, AM J PHYSIOL-LUNG C, V289, pL971, DOI 10.1152/ajplung.00172.2005; Mucenski ML, 2003, J BIOL CHEM, V278, P40231, DOI 10.1074/jbc.M305892200; Okubo Tadashi, 2004, J Biol, V3, P11, DOI 10.1186/jbiol3; Pan JH, 2007, J CELL SCI, V120, P1868, DOI 10.1242/jcs.005306; Park TJ, 2008, NAT GENET, V40, P871, DOI 10.1038/ng.104; Perl AKT, 2009, AM J PHYSIOL-LUNG C, V297, pL299, DOI 10.1152/ajplung.00008.2009; Pinto D, 2005, EXP CELL RES, V306, P357, DOI 10.1016/j.yexcr.2005.02.022; Pongracz JE, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-15; Rawlins EL, 2006, DEVELOPMENT, V133, P2455, DOI 10.1242/dev.02407; Reynolds SD, 2008, STEM CELLS, V26, P1337, DOI 10.1634/stemcells.2008-0053; SALAZAR E, 1964, J APPL PHYSIOL, V19, P97, DOI 10.1152/jappl.1964.19.1.97; SCHUESSLER TF, 1995, IEEE T BIO-MED ENG, V42, P860, DOI 10.1109/10.412653; Shu WG, 2005, DEV BIOL, V283, P226, DOI 10.1016/j.ydbio.2005.04.014; Singh AM, 2007, CIRCULATION, V115, P617, DOI 10.1161/CIRCULATIONAHA.106.642298; Snyder JC, 2009, J PATHOL, V217, P254, DOI 10.1002/path.2473; Takemaru K. -I., 2008, V186, P261, DOI 10.1007/978-3-540-72843-6_11; Takemaru KI, 2009, CELL CYCLE, V8, P210, DOI 10.4161/cc.8.2.7394; Takemaru KI, 2003, NATURE, V422, P905, DOI 10.1038/nature01570; TAKEMARU KI, 2006, UCSD NATURE MOL PAGE, DOI DOI 10.1038/MP.A000506.01; Van Scoyk M, 2008, TRANSL RES, V151, P175, DOI 10.1016/j.trsl.2007.12.011; Voronina VA, 2009, J CELL BIOL, V185, P225, DOI 10.1083/jcb.200809144; Warburton D, 2000, MECH DEVELOP, V92, P55, DOI 10.1016/S0925-4773(99)00325-1; Willert K, 2006, GENE DEV, V20, P1394, DOI 10.1101/gad.1424006; Yu XW, 2008, NAT GENET, V40, P1445, DOI 10.1038/ng.263; ZHANG Y, 2008, NAT GENET	48	27	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2010	5	10							e13600	10.1371/journal.pone.0013600	http://dx.doi.org/10.1371/journal.pone.0013600			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	670LB	21049041	gold, Green Submitted, Green Published			2022-12-27	WOS:000283422100013
J	Zilbauer, M; Jenke, A; Wenzel, G; Postberg, J; Heusch, A; Phillips, AD; Noble-Jamieson, G; Torrente, F; Salvestrini, C; Heuschkel, R; Wirth, S				Zilbauer, Matthias; Jenke, Andreas; Wenzel, Gundula; Postberg, Jan; Heusch, Andreas; Phillips, Alan D.; Noble-Jamieson, Gabriele; Torrente, Franco; Salvestrini, Camilla; Heuschkel, Robert; Wirth, Stefan			Expression of Human Beta-Defensins in Children with Chronic Inflammatory Bowel Disease	PLOS ONE			English	Article							INTESTINAL INNATE IMMUNITY; HUMAN BETA-DEFENSIN-2; ULCERATIVE-COLITIS; CROHNS-DISEASE; EPITHELIAL-CELLS	Background: Human beta-defensins (hBDs) are antimicrobial peptides known to play a major role in intestinal innate host defence. Altered mucosal expression of hBDs has been suggested to be implicated in chronic inflammatory bowel disease pathogenesis. However, little is known about expression of these peptides in children. Methods: Intestinal biopsies were obtained from the duodenum (n = 88), terminal ileum (n = 90) and ascending colon (n = 105) of children with Crohn's disease (n = 26), ulcerative colitis (n = 11) and healthy controls (n = 16). Quantitative real-time (RT) PCR was performed and absolute mRNA copy numbers analyzed for hBD1-3 as well as inflammatory cytokines IL-8 and TNF-alpha. Results: Significant induction of hBD2 and hBD3 was observed in the inflamed terminal ileum and ascending colon of IBD children. In the ascending colon induction of hBD2 was found to be significantly lower in children with Crohn's disease compared to ulcerative colitis. A strong correlation was found between inducible defensins hBD2 and 3 and the inflammatory cytokines IL-8 and TNF-alpha, both in the terminal ileum and ascending colon. Conclusion: Our study demonstrates distinct changes in hBD expression throughout the intestinal tract of children with IBD, lending further support for their potential role in disease pathogenesis.	[Zilbauer, Matthias; Jenke, Andreas; Wenzel, Gundula; Postberg, Jan; Heusch, Andreas; Wirth, Stefan] HELIOS Klinikum Wuppertal, Dept Paediat, Wuppertal, Germany; [Zilbauer, Matthias; Noble-Jamieson, Gabriele; Torrente, Franco; Salvestrini, Camilla; Heuschkel, Robert] Addenbrookes Hosp, Dept Paediat Gastroenterol, Cambridge, England; [Phillips, Alan D.] Royal Free Hosp, Ctr Paediat Gastroenterol, London NW3 2QG, England	Helios Kliniken; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School	Zilbauer, M (corresponding author), HELIOS Klinikum Wuppertal, Dept Paediat, Wuppertal, Germany.	mz304@medschl.cam.ac.uk	Zilbauer, Matthias/AAZ-2740-2020; Jenke, Andreas/AAO-2291-2020	Zilbauer, Matthias/0000-0002-7272-0547; Jenke, Andreas/0000-0002-4008-7185; Postberg, Jan/0000-0002-8562-3316	German society of Paediatric Gastroenterology (GPGE); Witten/Herdecke University; Crohn's in Childhood Research Association (CICRA); Crohn's and Colitis in Childhood (3Cs) charity	German society of Paediatric Gastroenterology (GPGE); Witten/Herdecke University; Crohn's in Childhood Research Association (CICRA); Crohn's and Colitis in Childhood (3Cs) charity	This study was funded by the German society of Paediatric Gastroenterology (GPGE), Witten/Herdecke University, the Crohn's in Childhood Research Association (CICRA) and the Crohn's and Colitis in Childhood (3Cs) charity. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bowdish DME, 2006, CURR TOP MICROBIOL, V306, P27; Chan M, 2008, ENRICH COMMUN, V2, P1; Dhaliwal W, 2003, MOL IMMUNOL, V40, P469, DOI 10.1016/S0161-5890(03)00156-1; Doss M, 2010, J LEUKOCYTE BIOL, V87, P79, DOI 10.1189/jlb.0609382; Eckmann L, 2005, CURR OPIN GASTROEN, V21, P147, DOI 10.1097/01.mog.0000153311.97832.8c; Fahlgren A, 2004, CLIN EXP IMMUNOL, V137, P379, DOI 10.1111/j.1365-2249.2004.02543.x; Fahlgren A, 2003, CLIN EXP IMMUNOL, V131, P90, DOI 10.1046/j.1365-2249.2003.02035.x; Fellermann K, 2006, AM J HUM GENET, V79, P439, DOI 10.1086/505915; Kocsis AK, 2008, SCAND J GASTROENTERO, V43, P299, DOI 10.1080/00365520701682615; Lehrer RI, 2004, NAT REV MICROBIOL, V2, P727, DOI 10.1038/nrmicro976; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Otte JM, 2008, J CELL BIOCHEM, V104, P2286, DOI 10.1002/jcb.21787; Selsted ME, 2005, NAT IMMUNOL, V6, P551, DOI 10.1038/ni1206; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wehkamp J, 2003, INFLAMM BOWEL DIS, V9, P215, DOI 10.1097/00054725-200307000-00001; Wehkamp J, 2002, EUR J GASTROEN HEPAT, V14, P745, DOI 10.1097/00042737-200207000-00006; Zilbauer M, 2005, INFECT IMMUN, V73, P7281, DOI 10.1128/IAI.73.11.7281-7289.2005	17	31	32	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2010	5	10							e15389	10.1371/journal.pone.0015389	http://dx.doi.org/10.1371/journal.pone.0015389			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	670KA	21042595	Green Submitted, Green Published, gold			2022-12-27	WOS:000283419100028
J	Haarmann, A; Deiss, A; Prochaska, J; Foerch, C; Weksler, B; Romero, I; Couraud, PO; Stoll, G; Rieckmann, P; Buttmann, M				Haarmann, Axel; Deiss, Annika; Prochaska, Juergen; Foerch, Christian; Weksler, Babette; Romero, Ignacio; Couraud, Pierre-Olivier; Stoll, Guido; Rieckmann, Peter; Buttmann, Mathias			Evaluation of Soluble Junctional Adhesion Molecule-A as a Biomarker of Human Brain Endothelial Barrier Breakdown	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; TUMOR-NECROSIS-FACTOR; TIGHT JUNCTION; MULTIPLE-SCLEROSIS; TRANSENDOTHELIAL MIGRATION; CEREBROSPINAL-FLUID; CELLS; STROKE; INVOLVEMENT; EXPRESSION	Background: An inducible release of soluble junctional adhesion molecule-A (sJAM-A) under pro-inflammatory conditions was described in cultured non-CNS endothelial cells (EC) and increased sJAM-A serum levels were found to indicate inflammation in non-CNS vascular beds. Here we studied the regulation of JAM-A expression in cultured brain EC and evaluated sJAM-A as a serum biomarker of blood-brain barrier (BBB) function. Methodology/Principal Findings: As previously reported in non-CNS EC types, pro-inflammatory stimulation of primary or immortalized (hCMEC/D3) human brain microvascular EC (HBMEC) induced a redistribution of cell-bound JAM-A on the cell surface away from tight junctions, along with a dissociation from the cytoskeleton. This was paralleled by reduced immunocytochemical staining of occludin and zonula occludens-1 as well as by increased paracellular permeability for dextran 3000. Both a self-developed ELISA test and Western blot analysis detected a constitutive sJAM-A release by HBMEC into culture supernatants, which importantly was unaffected by pro-inflammatory or hypoxia/reoxygenation challenge. Accordingly, serum levels of sJAM-A were unaltered in 14 patients with clinically active multiple sclerosis compared to 45 stable patients and remained unchanged in 13 patients with acute ischemic non-small vessel stroke over time. Conclusion: Soluble JAM-A was not suited as a biomarker of BBB breakdown in our hands. The unexpected non-inducibility of sJAM-A release at the human BBB might contribute to a particular resistance of brain EC to inflammatory stimuli, protecting the CNS compartment.	[Haarmann, Axel; Deiss, Annika; Prochaska, Juergen; Stoll, Guido; Rieckmann, Peter; Buttmann, Mathias] Univ Wurzburg, Dept Neurol, D-8700 Wurzburg, Germany; [Foerch, Christian] Goethe Univ Frankfurt, Dept Neurol, Frankfurt, Germany; [Weksler, Babette] Cornell Univ, Div Hematol & Med Oncol, Weill Med Coll, New York, NY 10021 USA; [Romero, Ignacio] Open Univ, Dept Biol Sci, Milton Keynes MK7 6AA, Bucks, England; [Couraud, Pierre-Olivier] Univ Paris 05, Inst Cochin, Paris, France	University of Wurzburg; Goethe University Frankfurt; Cornell University; Open University - UK; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Haarmann, A (corresponding author), Univ Wurzburg, Dept Neurol, Josef Schneider Str 11, D-8700 Wurzburg, Germany.	m.buttmann@uni-wuerzburg.de	Buttmann, Mathias/R-7301-2019; Buttmann, Mathias/AAD-7488-2021	Buttmann, Mathias/0000-0001-8309-7685; Buttmann, Mathias/0000-0001-8309-7685; Prochaska, Jurgen/0000-0001-5078-9992; Romero, Ignacio/0000-0002-0322-9180	Teva/Sanofi-Aventis; Deutsche Forschungsgemeinschaft [SFB 688, A6]; State of Bavaria	Teva/Sanofi-Aventis(Sanofi-Aventis); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); State of Bavaria	This study was supported by a research grant from Teva/Sanofi-Aventis, by a grant from the Deutsche Forschungsgemeinschaft (SFB 688, Teilprojekt A6), and by University research funds from the State of Bavaria. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALVAREZ JI, BIOCHIM BIOPHYS ACTA; BANKS WA, BIOCHIM BIOPHYS ACTA, V1802, P881; Betz AL, 1996, ADV NEUROL, V71, P301; Bitsch A, 1998, STROKE, V29, P2129, DOI 10.1161/01.STR.29.10.2129; Blann A, 1999, BLOOD COAGUL FIBRIN, V10, P277, DOI 10.1097/00001721-199907000-00009; Buttmann M, 2007, J NEUROCHEM, V102, P1001, DOI 10.1111/j.1471-4159.2007.04563.x; Cavusoglu E, 2007, J AM COLL CARDIOL, V50, P1768, DOI 10.1016/j.jacc.2007.05.051; Corada M, 2005, P NATL ACAD SCI USA, V102, P10634, DOI 10.1073/pnas.0500147102; Del Maschio A, 1999, J EXP MED, V190, P1351, DOI 10.1084/jem.190.9.1351; DOREDUFFY P, 1995, ANN NEUROL, V37, P55, DOI 10.1002/ana.410370111; Dvorak F, 2009, CEREBROVASC DIS, V27, P37, DOI 10.1159/000172632; HARTUNG HP, 1995, ANN NEUROL, V38, P186, DOI 10.1002/ana.410380210; HOU Y, 2009, ANN RHEUM DIS; Huang W, 2009, FASEB J, V23, P1596, DOI 10.1096/fj.08-121624; Hummel V, 2001, J NEUROPATH EXP NEUR, V60, P320, DOI 10.1093/jnen/60.4.320; Kallmann BA, 2002, FASEB J, V16, P589, DOI 10.1096/fj.01-0594fje; Khandoga A, 2005, BLOOD, V106, P725, DOI 10.1182/blood-2004-11-4416; Koenen RR, 2009, BLOOD, V113, P4799, DOI 10.1182/blood-2008-04-152330; KORNECKI E, 1990, J BIOL CHEM, V265, P10042; Liang TW, 2000, AM J PHYSIOL-CELL PH, V279, pC1733, DOI 10.1152/ajpcell.2000.279.6.C1733; Liu Y, 2000, J CELL SCI, V113, P2363; Mandell KJ, 2006, INVEST OPHTH VIS SCI, V47, P2408, DOI 10.1167/iovs.05-0745; Mandell KJ, 2004, J BIOL CHEM, V279, P16254, DOI 10.1074/jbc.M309483200; Martin-Padura I, 1998, J CELL BIOL, V142, P117, DOI 10.1083/jcb.142.1.117; Martinez-Estrada OM, 2005, AM J PHYSIOL-LUNG C, V288, pL1081, DOI 10.1152/ajplung.00289.2004; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; Ong KL, 2009, AM J HYPERTENS, V22, P500, DOI 10.1038/ajh.2009.23; Ostermann G, 2005, ARTERIOSCL THROM VAS, V25, P729, DOI 10.1161/01.ATV.0000157154.14474.3b; Ostermann G, 2002, NAT IMMUNOL, V3, P151, DOI 10.1038/ni755; Ozaki H, 1999, J IMMUNOL, V163, P553; Padden M, 2007, ACTA NEUROPATHOL, V113, P177, DOI 10.1007/s00401-006-0145-x; Salifu MO, 2007, J INVEST MED, V55, P115, DOI 10.2310/6650.2007.06041; Sandoval KE, 2008, NEUROBIOL DIS, V32, P200, DOI 10.1016/j.nbd.2008.08.005; Severson EA, 2009, ANN NY ACAD SCI, V1165, P10, DOI 10.1111/j.1749-6632.2009.04034.x; Shaw SK, 2004, J EXP MED, V200, P1571, DOI 10.1084/jem.20040965; Singh RJR, 2005, CARDIOVASC RES, V67, P39, DOI 10.1016/j.cardiores.2005.02.020; STEED E, TRENDS CELL BIOL, V20, P142; VESTWEBER D, CURR OPIN HEMATOL, V17, P230; Weber C, 2007, NAT REV IMMUNOL, V7, P467, DOI 10.1038/nri2096; Weksler BB, 2005, FASEB J, V19, P1872, DOI 10.1096/fj.04-3458fje; Williams LA, 1999, MOL IMMUNOL, V36, P1175, DOI 10.1016/S0161-5890(99)00122-4; Yeung D, 2008, ACTA NEUROPATHOL, V115, P635, DOI 10.1007/s00401-008-0364-4; Zernecke A, 2006, ARTERIOSCL THROM VAS, V26, pE10, DOI 10.1161/01.ATV.0000197852.24529.4f	43	36	38	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2010	5	10							e13568	10.1371/journal.pone.0013568	http://dx.doi.org/10.1371/journal.pone.0013568			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	668TQ	21060661	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000283293800026
J	Currier, JR; Ngauy, V; de Souza, MS; Ratto-Kim, S; Cox, JH; Polonis, VR; Earl, P; Moss, B; Peel, S; Slike, B; Sriplienchan, S; Thongcharoen, P; Paris, RM; Robb, ML; Kim, J; Michael, NL; Marovich, MA				Currier, Jeffrey R.; Ngauy, Viseth; de Souza, Mark S.; Ratto-Kim, Silvia; Cox, Josephine H.; Polonis, Victoria R.; Earl, Patricia; Moss, Bernard; Peel, Sheila; Slike, Bonnie; Sriplienchan, Somchai; Thongcharoen, Prasert; Paris, Robert M.; Robb, Merlin L.; Kim, Jerome; Michael, Nelson L.; Marovich, Mary A.			Phase I Safety and Immunogenicity Evaluation of MVA-CMDR, a Multigenic, Recombinant Modified Vaccinia Ankara-HIV-1 Vaccine Candidate	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; T-CELL RESPONSES; HIV-1 VACCINE; BOOST VACCINE; SMALLPOX VACCINATION; IMMUNE-RESPONSES; SUBTYPE-B; NYVAC-C; DNA; PRIME	Background: We conducted a Phase I randomized, dose-escalation, route-comparison trial of MVA-CMDR, a candidate HIV-1 vaccine based on a recombinant modified vaccinia Ankara viral vector expressing HIV-1 genes env/gag/pol. The HIV sequences were derived from circulating recombinant form CRF01_AE, which predominates in Thailand. The objective was to evaluate safety and immunogenicity of MVA-CMDR in human volunteers in the US and Thailand. Methodology/Principal Findings: MVA-CMDR or placebo was administered intra-muscularly (IM; 10(7) or 10(8) pfu) or intradermally (ID; 10(6) or 10(7) pfu) at months 0, 1 and 3, to 48 healthy volunteers at low risk for HIV-1 infection. Twelve volunteers in each dosage group were randomized to receive MVA-CMDR or placebo (10: 2). Volunteers were actively monitored for local and systemic reactogenicity and adverse events post vaccination. Cellular immunogenicity was assessed by a validated IFN gamma Elispot assay, an intracellular cytokine staining assay, lymphocyte proliferation and a Cr-51-release assay. Humoral immunogenicity was assessed by ADCC for gp120 and binding antibody ELISAs for gp120 and p24. MVA-CMDR was safe and well tolerated with no vaccine related serious adverse events. Cell-mediated immune responses were: (i) moderate in magnitude (median IFN gamma Elispot of 78 SFC/10(6) PBMC at 10(8) pfu IM), but high in response rate (70% Cr-51-release positive; 90% Elispot positive; 100% ICS positive, at 10(8) pfu IM); (ii) predominantly HIV Env-specific CD4(+) T cells, with a high proliferative capacity and durable for at least 6 months (100% LPA response rate by the IM route); (iv) dose- and route-dependent with 10(8) pfu IM being the most immunogenic treatment. Binding antibodies against gp120 and p24 were detectable in all vaccination groups with ADCC capacity detectable at the highest dose (40% positive at 10(8) pfu IM). Conclusions/Significance: MVA-CMDR delivered both intramuscularly and intradermally was safe, well-tolerated and elicited durable cell-mediated and humoral immune responses.	[Currier, Jeffrey R.; Ratto-Kim, Silvia; Polonis, Victoria R.; Peel, Sheila; Slike, Bonnie; Robb, Merlin L.; Kim, Jerome; Michael, Nelson L.; Marovich, Mary A.] US Mil HIV Res Program, Rockville, MD USA; [Ngauy, Viseth; de Souza, Mark S.; Sriplienchan, Somchai; Paris, Robert M.] Armed Forces Res Inst Med Sci, Bangkok 10400, Thailand; [Cox, Josephine H.] Int AIDS Vaccine Initiat, New York, NY USA; [Earl, Patricia; Moss, Bernard] NIAID, Viral Dis Lab, NIH, Bethesda, MD 20892 USA; [Thongcharoen, Prasert] Mahidol Univ, Bangkok 10700, Thailand	Walter Reed Army Institute of Research (WRAIR); United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Armed Forces Research Institute of Medical Science (AFRIMS); International AIDS Vaccine Initiative; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Mahidol University	Currier, JR (corresponding author), US Mil HIV Res Program, Rockville, MD USA.	jcurrier@hivresearch.org		Cox, Josephine/0000-0003-1301-7373; Moss, Bernard/0000-0002-2154-8564; Ratto-Kim, Silvia/0000-0003-2025-6399	U.S. Army Medical Research and Materiel Command [W81XWH-04-02-0005]; Henry M. Jackson Foundation for the Advancement of Military Medicine; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000416] Funding Source: NIH RePORTER	U.S. Army Medical Research and Materiel Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); Henry M. Jackson Foundation for the Advancement of Military Medicine; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the U.S. Army Medical Research and Materiel Command and its Cooperative Agreement (W81XWH-04-02-0005) with the Henry M. Jackson Foundation for the Advancement of Military Medicine. The opinions expressed herein are those of the authors and do not represent the official position of the U. S. Army or Department of Defense. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABOUD S, 2010, CLIN VACCINE IMMUNOL; Barouch DH, 2010, ANNU REV MED, V61, P153, DOI 10.1146/annurev.med.042508.093728; Bart PA, 2008, VACCINE, V26, P3153, DOI 10.1016/j.vaccine.2008.03.083; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; Burgers WA, 2009, J GEN VIROL, V90, P468, DOI 10.1099/vir.0.004614-0; Carr JK, 1996, J VIROL, V70, P5935, DOI 10.1128/JVI.70.9.5935-5943.1996; Catanzaro AT, 2006, J INFECT DIS, V194, P1638, DOI 10.1086/509258; Cox JH, 1999, AIDS RES HUM RETROV, V15, P847, DOI 10.1089/088922299310755; Currier JR, 2002, J IMMUNOL METHODS, V260, P157, DOI 10.1016/S0022-1759(01)00535-X; Earl PL, 2009, VACCINE, V27, P5885, DOI 10.1016/j.vaccine.2009.07.039; Eller MA, 2007, VACCINE, V25, P7737, DOI 10.1016/j.vaccine.2007.08.056; Frahm N, 2004, J VIROL, V78, P2187, DOI 10.1128/JVI.78.5.2187-2200.2004; Frey SE, 2003, JAMA-J AM MED ASSOC, V289, P3295, DOI 10.1001/jama.289.24.3295; Geldmacher C, 2007, J VIROL, V81, P2440, DOI 10.1128/JVI.01847-06; Graham BS, 2006, J INFECT DIS, V194, P1650, DOI 10.1086/509259; Gudmundsdotter L, 2009, VACCINE, V27, P4468, DOI 10.1016/j.vaccine.2009.05.018; Guimaraes-Walker A, 2008, VACCINE, V26, P6671, DOI 10.1016/j.vaccine.2008.09.016; Harari A, 2008, J EXP MED, V205, P63, DOI 10.1084/jem.20071331; Harro C, 2009, CLIN VACCINE IMMUNOL, V16, P1285, DOI 10.1128/CVI.00144-09; HOCHSTEI.V, 1972, ZENTRALBL BAKTER PAR, V156, P15; Jaoko W, 2008, VACCINE, V26, P2788, DOI 10.1016/j.vaccine.2008.02.071; Karnasuta C, 2005, VACCINE, V23, P2522, DOI 10.1016/j.vaccine.2004.10.028; Kibuuka H, 2010, J INFECT DIS, V201, P600, DOI 10.1086/650299; Kiepiela P, 2007, NAT MED, V13, P46, DOI 10.1038/nm1520; Korber BT, 2009, J VIROL, V83, P8300, DOI 10.1128/JVI.00114-09; Koup RA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009015; MAYR A, 1978, ZBL BAKT MIK HYG B, V167, P375; McCormack S, 2008, VACCINE, V26, P3162, DOI 10.1016/j.vaccine.2008.02.072; McElrath MJ, 2008, LANCET, V372, P1894, DOI 10.1016/S0140-6736(08)61592-5; Nitayaphan S, 2004, J INFECT DIS, V190, P702, DOI 10.1086/422258; Ramanathan VD, 2009, AIDS RES HUM RETROV, V25, P1107, DOI 10.1089/aid.2009.0096; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Rutebemberwa A, 2007, AIDS RES HUM RETROV, V23, P532, DOI 10.1089/aid.2006.0136; Sandstrom E, 2008, J INFECT DIS, V198, P1482, DOI 10.1086/592507; Thongcharoen P, 2007, JAIDS-J ACQ IMM DEF, V46, P48; *UNAIDS, 2009, UNAIDS0936EJC1700E; Vasan S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008617; Walker BD, 2008, SCIENCE, V320, P760, DOI 10.1126/science.1152622	39	68	68	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2010	5	11							e13983	10.1371/journal.pone.0013983	http://dx.doi.org/10.1371/journal.pone.0013983			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	680KW	21085591	Green Published, Green Submitted, gold			2022-12-27	WOS:000284231800013
J	Nteta, TP; Mokgatle-Nthabu, M; Oguntibeju, OO				Nteta, Thembi P.; Mokgatle-Nthabu, Matilda; Oguntibeju, Oluwafemi O.			Utilization of the Primary Health Care Services in the Tshwane Region of Gauteng Province, South Africa	PLOS ONE			English	Article							IMPACT	Background: In South Africa, the provision of primary health care is a basic service designed to be cost effective and bring healthcare as close as possible to the population, particularly to those people of low economic status. It is a service which is provided free of charge by the South African government and as part of the millennium health goals, it is intended that the service should be accessible to the populace and be effectively utilized. Objective: This study was designed to investigate the accessibility and utilization of the primary health care services in three community health care centres in the Tshwane of the Gauteng Province, South Africa. Methodology: Data were obtained from participants attending three Community Health Care Centres in the Tshwane Region using self-administered structured questionnaires. A document review of the Community Health Care Centres records was conducted to investigate the utilization trends of the services provided and descriptive statistics were used to analyze the data obtained. Results: The results showed that the Community Health Care Centres in the Tshwane Region are accessible to most participants who lived within 5 km of such centres and who traveled 30 minutes or less to the clinic. Using a taxi or walking were found to be the most common means of transport used to gain access to such a clinic. The findings showed that generally, participants were satisfied with the services provided. Conclusion: Participants of this study have access to the community health care centres in the Tshwane Region and there seems to be effective utilization by patients attending them.	[Nteta, Thembi P.; Mokgatle-Nthabu, Matilda] Univ Limpopo, MEDUNSA, Sch Publ Hlth, Pretoria, South Africa; [Oguntibeju, Oluwafemi O.] Cape Peninsula Univ Technol, Fac Hlth & Wellness Sci, Dept Biomed Sci, Bellville, South Africa	Sefako Makgatho Health Sciences University; University of Limpopo; Cape Peninsula University of Technology	Nteta, TP (corresponding author), Univ Limpopo, MEDUNSA, Sch Publ Hlth, Pretoria, South Africa.	oguntibejuo@cput.ac.za	Oguntibeju, Oluwafemi/AAR-2256-2020	Oguntibeju, Oluwafemi/0000-0002-7299-1128				Bediako M A, 2006, Curationis, V29, P12; Bell R, 2002, B WORLD HEALTH ORGAN, V80, P675; Chatora R., 2004, PRIM HEALTH CARE RES, V5, P296; *DEP HLTH S AFR, 2001, COMPR PRIM HLTH CAR, P22; Department of Health Medical Research Council OrcMacro, 2007, S AFR DEM HLTH SURV; Duong DV, 2004, SOC SCI MED, V59, P2585, DOI 10.1016/j.socscimed.2004.04.007; Islam A, 2002, HEALTH POLICY, V60, P151, DOI 10.1016/S0168-8510(01)00211-1; Mashego T A B, 2005, Curationis, V28, P13; Parikh A, 2008, SAMJ S AFR MED J, V98, P468; Peltzer K, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-117; PILLAY K, TRACKING S AFRICAS P; REAGON G, 2004, HLTH SYSTEMS TRUST, V6, P34; RISPEL L, 1996, CONFRONTING NEED AFF; Shaikh BT, 2005, J PUBLIC HEALTH-UK, V27, P49, DOI 10.1093/pubmed/fdh207; Shisana O, 2005, S AFRICA NATL HIV PR; Smith M., 1999, 2 KAISER FAMILY FDN; *STAT S AFR, 2007, 6 ANN REP STAT S AFR; Tanser F, 2006, SOC SCI MED, V63, P691, DOI 10.1016/j.socscimed.2006.01.015; Tlebere P, 2007, J MIDWIFERY WOM HEAL, V52, P342, DOI 10.1016/j.jmwh.2007.03.016; *UN, 2001, EL DRAFT DECL HUM RI; Uzma A, 1999, SOC SCI MED, V48, P313, DOI 10.1016/S0277-9536(98)00319-0; WHITE CJ, 2002, RES METHODS TECHNIQU	22	40	42	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2010	5	11							e13909	10.1371/journal.pone.0013909	http://dx.doi.org/10.1371/journal.pone.0013909			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	677ZE	21085475	Green Published, Green Submitted, gold			2022-12-27	WOS:000284035900016
J	Kintzer, AF; Sterling, HJ; Tang, II; Williams, ER; Krantz, BA				Kintzer, Alexander F.; Sterling, Harry J.; Tang, Iok I.; Williams, Evan R.; Krantz, Bryan A.			Anthrax Toxin Receptor Drives Protective Antigen Oligomerization and Stabilizes the Heptameric and Octameric Oligomer by a Similar Mechanism	PLOS ONE			English	Article							BACILLUS-ANTHRACIS; LETHAL FACTOR; CRYSTAL-STRUCTURE; EDEMA FACTOR; PROTEOLYTIC INACTIVATION; ADENYLATE-CYCLASE; DEPENDENT PROCESS; EUKARYOTIC CELLS; PORE FORMATION; KINASE-KINASE	Background: Anthrax toxin is comprised of protective antigen (PA), lethal factor (LF), and edema factor (EF). These proteins are individually nontoxic; however, when PA assembles with LF and EF, it produces lethal toxin and edema toxin, respectively. Assembly occurs either on cell surfaces or in plasma. In each milieu, PA assembles into a mixture of heptameric and octameric complexes that bind LF and EF. While octameric PA is the predominant form identified in plasma under physiological conditions (pH 7.4, 37 degrees C), heptameric PA is more prevalent on cell surfaces. The difference between these two environments is that the anthrax toxin receptor (ANTXR) binds to PA on cell surfaces. It is known that the extracellular ANTXR domain serves to stabilize toxin complexes containing the PA heptamer by preventing premature PA channel formation-a process that inactivates the toxin. The role of ANTXR in PA oligomerization and in the stabilization of toxin complexes containing octameric PA are not understood. Methodology: Using a fluorescence assembly assay, we show that the extracellular ANTXR domain drives PA oligomerization. Moreover, a dimeric ANTXR construct increases the extent of and accelerates the rate of PA assembly relative to a monomeric ANTXR construct. Mass spectrometry analysis shows that heptameric and octameric PA oligomers bind a full stoichiometric complement of ANTXR domains. Electron microscopy and circular dichroism studies reveal that the two different PA oligomers are equally stabilized by ANTXR interactions. Conclusions: We propose that PA oligomerization is driven by dimeric ANTXR complexes on cell surfaces. Through their interaction with the ANTXR, toxin complexes containing heptameric and octameric PA oligomers are similarly stabilized. Considering both the relative instability of the PA heptamer and extracellular assembly pathway identified in plasma, we propose a means to regulate the development of toxin gradients around sites of infection during anthrax pathogenesis.	[Kintzer, Alexander F.; Sterling, Harry J.; Tang, Iok I.; Williams, Evan R.; Krantz, Bryan A.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Williams, Evan R.; Krantz, Bryan A.] Univ Calif Berkeley, Calif Inst Quantitat Biomed Res QB3, Berkeley, CA 94720 USA; [Krantz, Bryan A.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Kintzer, AF (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.	bakrantz@berkeley.edu	Williams, Evan/I-3924-2013	Kintzer, Alexander/0000-0001-9630-7258; Krantz, Bryan/0000-0002-4911-5824	University of California; National Institutes of Health [R01-AI077703, R01-GM064712]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI077703] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064712] Funding Source: NIH RePORTER	University of California(University of California System); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by University of California start-up funds and the following National Institutes of Health research grants: R01-AI077703 (to B.A.K.) and R01-GM064712 (to E.R.W.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrami L, 2003, J CELL BIOL, V160, P321, DOI 10.1083/jcb.200211018; BEALL FA, 1962, J BACTERIOL, V83, P1274, DOI 10.1128/JB.83.6.1274-1280.1962; Beauregard KE, 2000, CELL MICROBIOL, V2, P251, DOI 10.1046/j.1462-5822.2000.00052.x; BLAUSTEIN RO, 1989, P NATL ACAD SCI USA, V86, P2209, DOI 10.1073/pnas.86.7.2209; Bradley KA, 2001, NATURE, V414, P225, DOI 10.1038/n35101999; Christensen KA, 2006, BIOCHEMISTRY-US, V45, P2380, DOI 10.1021/bi051830y; Cunningham K, 2002, P NATL ACAD SCI USA, V99, P7049, DOI 10.1073/pnas.062160399; Drum CL, 2002, NATURE, V415, P396, DOI 10.1038/415396a; Duesbery NS, 1998, SCIENCE, V280, P734, DOI 10.1126/science.280.5364.734; Duesbery NS, 1999, J APPL MICROBIOL, V87, P289, DOI 10.1046/j.1365-2672.1999.00892.x; Elliott JL, 2000, BIOCHEMISTRY-US, V39, P6706, DOI 10.1021/bi000310u; Ezzell JW, 2009, INFECT IMMUN, V77, P749, DOI 10.1128/IAI.00764-08; EZZELL JW, 1992, J GEN MICROBIOLOGY, V138; Fabrini R, 2009, BIOCHEMISTRY-US, V48, P10473, DOI 10.1021/bi901238t; FISH DC, 1968, J BACTERIOL, V95, P919, DOI 10.1128/JB.95.3.919-924.1968; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; FRIEDLANDER AM, 1986, J BIOL CHEM, V261, P7123; Go MY, 2006, J MOL BIOL, V360, P145, DOI 10.1016/j.jmb.2006.04.072; JI X, 1993, BIOCHEMISTRY-US, V32, P12949, DOI 10.1021/bi00211a001; Katayama H, 2008, NAT STRUCT MOL BIOL, V15, P754, DOI 10.1038/nsmb.1442; Kintzer AF, 2010, J MOL BIOL, V399, P741, DOI 10.1016/j.jmb.2010.04.041; Kintzer AF, 2009, J MOL BIOL, V392, P614, DOI 10.1016/j.jmb.2009.07.037; Lacy DB, 2004, P NATL ACAD SCI USA, V101, P6367, DOI 10.1073/pnas.0401506101; Lacy DB, 2004, P NATL ACAD SCI USA, V101, P13147, DOI 10.1073/pnas.0405405101; Lacy DB, 2002, J BIOL CHEM, V277, P3006, DOI 10.1074/jbc.M109997200; LEPPLA SH, 1984, ADV CYCLIC NUCL PROT, V17, P189; LEPPLA SH, 1982, P NATL ACAD SCI-BIOL, V79, P3162, DOI 10.1073/pnas.79.10.3162; Liu SH, 2003, J BIOL CHEM, V278, P5227, DOI 10.1074/jbc.M210321200; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Mabry R, 2006, CLIN VACCINE IMMUNOL, V13, P671, DOI 10.1128/CVI.00023-06; Miller CJ, 1999, BIOCHEMISTRY-US, V38, P10432, DOI 10.1021/bi990792d; MILNE JC, 1994, J BIOL CHEM, V269, P20607; MMITH H, 1954, NATURE, V173, P689; Pannifer AD, 2001, NATURE, V414, P229, DOI 10.1038/n35101998; Petosa C, 1997, NATURE, V385, P833, DOI 10.1038/385833a0; PEZARD C, 1991, INFECT IMMUN, V59, P3472, DOI 10.1128/IAI.59.10.3472-3477.1991; Santelli E, 2004, NATURE, V430, P905, DOI 10.1038/nature02763; Scobie HM, 2003, P NATL ACAD SCI USA, V100, P5170, DOI 10.1073/pnas.0431098100; STANLEY JL, 1961, J GEN MICROBIOL, V26, P49, DOI 10.1099/00221287-26-1-49; STARK H, 1995, STRUCTURE, V3, P815, DOI 10.1016/S0969-2126(01)00216-7; Sun JJ, 2007, J BIOL CHEM, V282, P1059, DOI 10.1074/jbc.M609869200; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; Vernier G, 2009, PROTEIN SCI, V18, P1882, DOI 10.1002/pro.199; Wigelsworth DJ, 2004, J BIOL CHEM, V279, P23349, DOI 10.1074/jbc.M401292200; Young JAT, 2007, ANNU REV BIOCHEM, V76, P243, DOI 10.1146/annurev.biochem.75.103004.142728	45	37	37	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2010	5	11							e13888	10.1371/journal.pone.0013888	http://dx.doi.org/10.1371/journal.pone.0013888			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	676NU	21079738	Green Submitted, Green Published, gold			2022-12-27	WOS:000283920000018
J	Prieto, L; Astorga, D; Navarro, G; Ruiz, J				Prieto, Laura; Astorga, Diana; Navarro, Gabriel; Ruiz, Javier			Environmental Control of Phase Transition and Polyp Survival of a Massive-Outbreaker Jellyfish	PLOS ONE			English	Article							LIFE-HISTORY; AURELIA-AURITA; CTENOPHORE MNEMIOPSIS; RHOPILEMA-NOMADICA; NEMOPILEMA-NOMURAI; BLACK-SEA; SCYPHOZOA; STROBILATION; CNIDARIA; TEMPERATURE	A number of causes have been proposed to account for the occurrence of gelatinous zooplankton (both jellyfish and ctenophore) blooms. Jellyfish species have a complex life history involving a benthic asexual phase (polyp) and a pelagic sexual phase (medusa). Strong environmental control of jellyfish life cycles is suspected, but not fully understood. This study presents a comprehensive analysis on the physicochemical conditions that control the survival and phase transition of Cotylorhiza tuberculata; a scyphozoan that generates large outbreaks in the Mediterranean Sea. Laboratory experiments indicated that the influence of temperature on strobilation and polyp survival was the critical factor controlling the capacity of this species to proliferate. Early life stages were less sensitive to other factors such as salinity variations or the competitive advantage provided by zooxanthellae in a context of coastal eutrophication. Coherently with laboratory results, the presence/absence of outbreaks of this jellyfish in a particular year seems to be driven by temperature. This is the first time the environmental forcing of the mechanism driving the life cycle of a jellyfish has been disentangled via laboratory experimentation. Projecting this understanding to a field population under climatological variability results in a pattern coherent with in situ records.	[Prieto, Laura; Astorga, Diana; Navarro, Gabriel; Ruiz, Javier] CSIC, Inst Ciencias Marinas Andalucia, Dept Ecol & Coastal Management, Cadiz, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM); CSIC - Instituto de Ciencias Marinas de Andalucia (ICMAN)	Prieto, L (corresponding author), CSIC, Inst Ciencias Marinas Andalucia, Dept Ecol & Coastal Management, Cadiz, Spain.	laura.prieto@icman.csic.es	Ruiz, Javier/G-3184-2016; Navarro, Gabriel/G-1960-2010; Prieto, Laura/B-3986-2009; Navarro, Gabriel/AAA-9528-2020	Ruiz, Javier/0000-0002-3375-2327; Navarro, Gabriel/0000-0002-8919-0060; Prieto, Laura/0000-0003-4704-7757; Navarro, Gabriel/0000-0002-8919-0060	Consejer-ia de Ciencia, Innovacion y Empresa (Junta de Andaluc-ia) [PO7-RNM-02976]; European Commission [FP6-036949 GOCE]; Spanish MIC; i3P-CSIC; Consejeri-a de Educacion y Ciencia (Junta de Andaluci-a)	Consejer-ia de Ciencia, Innovacion y Empresa (Junta de Andaluc-ia); European Commission(European CommissionEuropean Commission Joint Research Centre); Spanish MIC; i3P-CSIC; Consejeri-a de Educacion y Ciencia (Junta de Andaluci-a)(Junta de Andalucia)	The meteorological results of San Javier Station were obtained from the information provided by the Spanish "Agencia Estatal de Meteorologia (Ministerio de Medio Ambiente)", for which contribution is acknowledged. This work was financially supported by Consejer-ia de Ciencia, Innovacion y Empresa (Junta de Andaluc-ia, project PO7-RNM-02976), and European Commission Project SESAME (FP6-036949 GOCE). Two research grants to LP, one by the Consejeri-a de Educacion y Ciencia (Junta de Andaluci-a) and one from Ramon y Cajal Programme of Spanish MIC, and an i3P-CSIC doctoral fellowship to DA, are also acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai MN, 2001, HYDROBIOLOGIA, V451, P69, DOI 10.1023/A:1011840123140; Barz K, 2007, MAR BIOL, V151, P1021, DOI 10.1007/s00227-006-0545-4; Berking S, 2005, INT J DEV BIOL, V49, P969, DOI 10.1387/ijdb.052024sb; CALDER DR, 1982, BIOL BULL, V162, P149, DOI 10.2307/1540810; CALDER DR, 1973, MAR BIOL, V21, P109, DOI 10.1007/BF00354606; Colin SP, 2002, ESTUARIES, V25, P70, DOI 10.1007/BF02696050; *ECOS, 2004, POBL MED MAR MEN; Gibbons MJ, 2009, HYDROBIOLOGIA, V616, P51, DOI 10.1007/s10750-008-9593-8; Hansen J, 2006, P NATL ACAD SCI USA, V103, P14288, DOI 10.1073/pnas.0606291103; HENROTH L, 1983, OPHELIA, V22, P189; HOFMANN DK, 1978, MAR BIOL, V47, P161, DOI 10.1007/BF00395637; Holst S, 2007, MAR BIOL, V151, P863, DOI 10.1007/s00227-006-0530-y; Holst S, 2010, HYDROBIOLOGIA, V645, P53, DOI 10.1007/s10750-010-0214-y; Hoover RA, 2009, HYDROBIOLOGIA, V616, P259, DOI 10.1007/s10750-008-9595-6; Kawahara M, 2006, MAR ECOL PROG SER, V307, P161, DOI 10.3354/meps307161; KIKINGER R, 1992, MAR ECOL-P S Z N I, V13, P333, DOI 10.1111/j.1439-0485.1992.tb00359.x; Kogovsek T, 2010, HYDROBIOLOGIA, V645, P81, DOI 10.1007/s10750-010-0217-8; Liu WC, 2009, HYDROBIOLOGIA, V616, P247, DOI 10.1007/s10750-008-9597-4; LOTAN A, 1994, MAR ECOL PROG SER, V109, P59, DOI 10.3354/meps109059; LOTAN A, 1992, MAR BIOL, V112, P237, DOI 10.1007/BF00702467; Lucas CH, 2001, HYDROBIOLOGIA, V451, P229, DOI 10.1023/A:1011836326717; Malej A, 2007, MAR BIOL, V151, P827, DOI 10.1007/s00227-006-0503-1; Malej A, 2004, NATO SCI S SS IV EAR, V35, P273; Mills CE, 2001, HYDROBIOLOGIA, V451, P55, DOI 10.1023/A:1011888006302; PAGES F, 2001, GELATINOUS ZOOPLANKT, V14, P69; Parsons T. R., 2002, Mer (Tokyo), V40, P111; PASPALEFF BW, 1938, TRUD CHERNOMORSK BIO, V7, P1; Pauly D, 2002, NATURE, V418, P689, DOI 10.1038/nature01017; PELLICIER M, MEDUSAS LLEGAN ESTE; Perez-Ruzafa A, 2002, HYDROBIOLOGIA, V475, P359, DOI 10.1023/A:1020343510060; Pierce J., 2005, International Zoo Yearbook, V39, P62; PITT KA, 2009, HYDROBIOLOGIA, V616, P289; Pitt KA, 2009, HYDROBIOLOGIA, V616, P133, DOI 10.1007/s10750-008-9584-9; Purcell JE, 2001, HYDROBIOLOGIA, V451, P145, DOI 10.1023/A:1011826618539; Purcell JE, 2005, J MAR BIOL ASSOC UK, V85, P461, DOI 10.1017/S0025315405011409; PURCELL JE, 2010, HYDROBIOLOGIA, V645, P234; Purcell JE, 2007, MAR ECOL PROG SER, V350, P153, DOI 10.3354/meps07093; Purcell JE, 2007, MAR ECOL PROG SER, V348, P183, DOI 10.3354/meps07056; SANTOS SR, 1995, ULTRAVIOLET RAD CORA, P165; Schiariti A, 2008, MAR BIOL, V156, P1, DOI 10.1007/s00227-008-1050-8; Shiganova T.A., 2003, BIOL BULL, V2, P225; Shiganova TA, 2001, MAR BIOL, V139, P431; SILVERSTONE M, 1977, GEN COMP ENDOCR, V32, P108, DOI 10.1016/0016-6480(77)90087-9; SPANGENB.DB, 1965, J EXP ZOOL, V160, P1, DOI 10.1002/jez.1401600102; SUGIURA Y, 1965, BIOL BULL, V128, P493, DOI 10.2307/1539908; Sugiura Y., 1963, Annotationes Zoologicae Japonenses, V36, P194; Velasco J, 2006, WATER AIR SOIL POLL, V176, P37, DOI 10.1007/s11270-006-2859-8; Willcox S, 2008, MAR BIOL, V154, P661, DOI 10.1007/s00227-008-0959-2; Yamamoto J, 2008, MAR BIOL, V153, P311, DOI 10.1007/s00227-007-0807-9	49	64	67	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2010	5	11							e13793	10.1371/journal.pone.0013793	http://dx.doi.org/10.1371/journal.pone.0013793			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	674WJ	21072185	Green Published, Green Submitted, gold			2022-12-27	WOS:000283780800006
J	Kristjansson, A; Eyjolfsdottir, KO; Jonsdottir, A; Arnkelsson, G				Kristjansson, Arni; Eyjolfsdottir, Katrin Osk; Jonsdottir, Anna; Arnkelsson, Gudmundur			Temporal Consistency Is Currency in Shifts of Transient Visual Attention	PLOS ONE			English	Article							TARGET REPETITION; POP-OUT; SEARCH; MEMORY; TIME; DISCRIMINATION; SPACE; PROBABILITY; FOREPERIOD; COMPONENTS	Background: Observers respond more accurately to targets in visual search tasks that share properties with previously presented items, and transient attention can learn featural consistencies on a precue, irrespective of its absolute location. Methodology/Principal Findings: We investigated whether such attentional benefits also apply to temporal consistencies. Would performance on a precued Vernier acuity discrimination task, followed by a mask, improve if the cue-lead times (CLTs; 50, 100, 150 or 200 ms) remained constant between trials compared to when they changed? The results showed that if CLTs remained constant for a few trials in a row, Vernier acuity performance gradually improved while changes in CLT from one trial to the next led to worse than average discrimination performance. The results show that transient attention can quickly adjust to temporal regularities, similarly to spatial and featural regularities. Further experiments show that this form of learning is not under voluntary control. Conclusions/Significance: The results add to a growing literature showing how consistency in visual presentation improves visual performance, in this case temporal consistency.	[Kristjansson, Arni; Eyjolfsdottir, Katrin Osk; Jonsdottir, Anna; Arnkelsson, Gudmundur] Univ Iceland, Dept Psychol, Reykjavik, Iceland	University of Iceland	Kristjansson, A (corresponding author), Univ Iceland, Dept Psychol, Reykjavik, Iceland.	ak@hi.is			University of Iceland	University of Iceland	The experiments were supported by the research fund of the University of Iceland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker SI, 2008, ACTA PSYCHOL, V127, P324, DOI 10.1016/j.actpsy.2007.07.005; Chun MM, 1998, COGNITIVE PSYCHOL, V36, P28, DOI 10.1006/cogp.1998.0681; Coull JT, 1998, J NEUROSCI, V18, P7426; Edelman JA, 2007, J VISION, V7, DOI 10.1167/7.6.12; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; Egeth HE, 1997, ANNU REV PSYCHOL, V48, P269, DOI 10.1146/annurev.psych.48.1.269; Fecteau JH, 2007, J VISION, V7, DOI 10.1167/7.6.1; FISCHER B, 1993, BEHAV BRAIN SCI, V16, P553, DOI 10.1017/S0140525X00031575; Fiser J, 2001, PSYCHOL SCI, V12, P499, DOI 10.1111/1467-9280.00392; Fuggetta G, 2007, VIS COGN, V15, P834, DOI 10.1080/13506280600992432; Fuggetta G, 2009, SPATIAL VISION, V22, P147, DOI 10.1163/156856809787465618; Geng JJ, 2005, PERCEPT PSYCHOPHYS, V67, P1252, DOI 10.3758/BF03193557; Geyer T, 2006, PERCEPT PSYCHOPHYS, V68, P736, DOI 10.3758/BF03193697; GIBSON EJ, 1963, ANNU REV PSYCHOL, V14, P29, DOI 10.1146/annurev.ps.14.020163.000333; GRIFFIN IC, 2001, FRONT BIOSCI, V6, P660; Hommel B, 2006, PSYCHOL RES-PSYCH FO, V70, P425, DOI 10.1007/s00426-005-0009-3; JONIDES J, 1981, ATTENTION PERFORM, V9, P1187; KARLIN L, 1959, J EXP PSYCHOL, V58, P185, DOI 10.1037/h0049152; Kristjansson A, 2006, VIS COGN, V13, P324, DOI 10.1080/13506280544000039; Kristjansson A, 2005, PERCEPTION, V34, P40; Kristjansson A, 2003, PERCEPT PSYCHOPHYS, V65, P711, DOI 10.3758/BF03194808; Kristjansson A, 2002, VISION RES, V42, P2039, DOI 10.1016/S0042-6989(02)00129-3; Kristjansson A, 2002, COGNITION, V85, P37, DOI 10.1016/S0010-0277(02)00074-4; Kristjansson A, 2001, PERCEPTION, V30, P1375, DOI 10.1068/p3251; Kristjansson A, 2008, PERCEPTION, V37, P747, DOI 10.1068/p5922; Kristjansson A, 2008, VISION RES, V48, P1217, DOI 10.1016/j.visres.2008.02.007; Kristjansson A, 2008, FRONT BIOSCI-LANDMRK, V13, P1171, DOI 10.2741/2753; Kristjansson A, 2007, SCAND J PSYCHOL, V48, P97, DOI 10.1111/j.1467-9450.2007.00537.x; Kristjansson A, 2006, VISION RES, V46, P2554, DOI 10.1016/j.visres.2006.01.015; Kristjansson A, 2010, ATTEN PERCEPT PSYCHO, V72, P5, DOI 10.3758/APP.72.1.5; Kristjansson A, 2009, J VISION, V9, DOI 10.1167/9.4.21; Lamy D, 2005, PSYCHON B REV, V12, P1112, DOI 10.3758/BF03206452; Lamy D, 2006, PERCEPT PSYCHOPHYS, V68, P919, DOI 10.3758/BF03193355; LASLEY DJ, 1981, J OPT SOC AM, V71, P845, DOI 10.1364/JOSA.71.000845; MALJKOVIC V, 1994, MEM COGNITION, V22, P657, DOI 10.3758/BF03209251; Maljkovic V, 2005, VISION RES, V45, P2831, DOI 10.1016/j.visres.2005.05.019; Martens S, 2005, MEM COGNITION, V33, P234, DOI 10.3758/BF03195312; Meeter M, 2006, VIS COGN, V13, P202, DOI 10.1080/13506280500277488; MILLER J, 1988, J EXP PSYCHOL HUMAN, V14, P453, DOI 10.1037/0096-1523.14.3.453; Milliken B, 2003, PSYCHON B REV, V10, P877, DOI 10.3758/BF03196547; Montagna B, 2009, VISION RES, V49, P735, DOI 10.1016/j.visres.2009.02.001; Mooney CZ, 1993, SAGE U PAPER SERIES; MULLER HJ, 1988, ACTA PSYCHOL, V69, P129, DOI 10.1016/0001-6918(88)90003-0; NAKAYAMA K, 1989, VISION RES, V29, P1631, DOI 10.1016/0042-6989(89)90144-2; Nakayama K, 2004, COGNITIVE NEUROSCIENCES III, THIRD EDITION, P397; NIEMI P, 1981, PSYCHOL BULL, V89, P133, DOI 10.1037/0033-2909.89.1.133; Nobre AC, 2001, NEUROSCI BIOBEHAV R, V25, P477, DOI 10.1016/S0149-7634(01)00028-8; Olivers CNL, 2008, PSYCHOL REV, V115, P836, DOI 10.1037/a0013395; Pashler HE, 1998, PSYCHOL ATTENTION; RAYMOND JE, 1992, J EXP PSYCHOL HUMAN, V18, P849, DOI 10.1037/0096-1523.18.3.849; Seitz A, 2005, TRENDS COGN SCI, V9, P329, DOI 10.1016/j.tics.2005.05.010; Sigurdardottir HM, 2008, VIS COGN, V16, P643, DOI 10.1080/13506280701218364; Solomon JA, 1997, J OPT SOC AM A, V14, P2443, DOI 10.1364/JOSAA.14.002443; TEICHNER WH, 1954, PSYCHOL BULL, V51, P128, DOI 10.1037/h0060900; THEEUWES J, 1991, PERCEPT PSYCHOPHYS, V49, P83, DOI 10.3758/BF03211619; Westheimer G, 1996, J OPT SOC AM A, V13, P884, DOI 10.1364/JOSAA.13.000884; Woodrow H, 1914, PSYCHOL MONOGR, V17, P1; YANTIS S, 1984, J EXP PSYCHOL HUMAN, V10, P601, DOI 10.1037/0096-1523.10.5.601; Yeshurun Y, 1999, VISION RES, V39, P293, DOI 10.1016/S0042-6989(98)00114-X	59	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2010	5	10							e13660	10.1371/journal.pone.0013660	http://dx.doi.org/10.1371/journal.pone.0013660			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	672HN	21060888	Green Published, Green Submitted, gold			2022-12-27	WOS:000283573800001
J	Li, Y; Wang, N; Perkins, EJ; Zhang, CY; Gong, P				Li, Ying; Wang, Nan; Perkins, Edward J.; Zhang, Chaoyang; Gong, Ping			Identification and Optimization of Classifier Genes from Multi-Class Earthworm Microarray Dataset	PLOS ONE			English	Article							SUPPORT VECTOR MACHINES; CANCER CLASSIFICATION; FEATURE-SELECTION; BINDING-PROTEIN; VARIABLE SELECTION; EXPRESSION; DISCOVERY; RECOGNITION; RESPONSES	Monitoring, assessment and prediction of environmental risks that chemicals pose demand rapid and accurate diagnostic assays. A variety of toxicological effects have been associated with explosive compounds TNT and RDX. One important goal of microarray experiments is to discover novel biomarkers for toxicity evaluation. We have developed an earthworm microarray containing 15,208 unique oligo probes and have used it to profile gene expression in 248 earthworms exposed to TNT, RDX or neither. We assembled a new machine learning pipeline consisting of several well-established feature filtering/selection and classification techniques to analyze the 248-array dataset in order to construct classifier models that can separate earthworm samples into three groups: control, TNT-treated, and RDX-treated. First, a total of 869 genes differentially expressed in response to TNT or RDX exposure were identified using a univariate statistical algorithm of class comparison. Then, decision tree-based algorithms were applied to select a subset of 354 classifier genes, which were ranked by their overall weight of significance. A multiclass support vector machine (MC-SVM) method and an unsupervised K-mean clustering method were applied to independently refine the classifier, producing a smaller subset of 39 and 30 classifier genes, separately, with 11 common genes being potential biomarkers. The combined 58 genes were considered the refined subset and used to build MC-SVM and clustering models with classification accuracy of 83.5% and 56.9%, respectively. This study demonstrates that the machine learning approach can be used to identify and optimize a small subset of classifier/biomarker genes from high dimensional datasets and generate classification models of acceptable precision for multiple classes.	[Li, Ying; Wang, Nan; Zhang, Chaoyang] Univ So Mississippi, Sch Comp, Hattiesburg, MS 39406 USA; [Perkins, Edward J.] USA, Environm Lab, Engn Res & Dev Ctr, Vicksburg, MS USA; [Gong, Ping] SpecPro Inc, Environm Serv, Vicksburg, MS USA	University of Southern Mississippi; United States Department of Defense; United States Army; U.S. Army Corps of Engineers; U.S. Army Engineer Research & Development Center (ERDC)	Li, Y (corresponding author), Univ So Mississippi, Sch Comp, Hattiesburg, MS 39406 USA.	ping.gong@usace.army.mil			U.S. Army Environmental Quality Technology Research; ERDC; U.S. Army Chief of Engineers	U.S. Army Environmental Quality Technology Research; ERDC(United States Department of DefenseUnited States Army); U.S. Army Chief of Engineers	This work was supported by the U.S. Army Environmental Quality Technology Research Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. SpecPro Inc. supported Ping Gong through a contract granted by ERDC, and through this employment is considered by PLoS ONE to have played a role in the research. Permission to publish this information was granted by the U.S. Army Chief of Engineers.	Abeel T, 2010, BIOINFORMATICS, V26, P392, DOI 10.1093/bioinformatics/btp630; Anand A, 2009, J THEOR BIOL, V259, P533, DOI 10.1016/j.jtbi.2009.04.013; Ankley GT, 2006, ENVIRON SCI TECHNOL, V40, P4055, DOI 10.1021/es0630184; Antonov AV, 2004, BIOINFORMATICS, V20, P644, DOI 10.1093/bioinformatics/btg462; Arcuri F, 2005, BIOL REPROD, V73, P745, DOI 10.1095/biolreprod.105.042077; Boutros PC, 2005, BRIEF BIOINFORM, V6, P331, DOI 10.1093/bib/6.4.331; Chi JT, 2007, PLOS GENET, V3, P1770, DOI 10.1371/journal.pgen.0030164; Choi JK, 2005, BIOINFORMATICS, V21, P4348, DOI 10.1093/bioinformatics/bti722; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Falciani F, 2008, AQUAT TOXICOL, V90, P92, DOI 10.1016/j.aquatox.2008.07.020; Frank E, 2004, BIOINFORMATICS, V20, P2479, DOI 10.1093/bioinformatics/bth261; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; GONG P, 2010, PLOS ONE UNPUB; Gong P, 2007, ENVIRON SCI TECHNOL, V41, P8195, DOI 10.1021/es0716352; Gong P, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S1-S15; Horng JT, 2009, EXPERT SYST APPL, V36, P9072, DOI 10.1016/j.eswa.2008.12.037; Huang LT, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-25; Jeffery IB, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-359; Jorgensen R, 2006, BIOCHEM SOC T, V34, P1; Kuperman R.G., 2009, ECOTOXICOLOGY EXPLOS, P35, DOI 10.1201/9781420004342; Lu Y, 2003, INFORM SYST, V28, P243, DOI 10.1016/S0306-4379(02)00072-8; MCLACHLAN GJ, 2008, PARAMETRICS INTERDIS, P364; Moens LN, 2006, TOXICOL SCI, V93, P298, DOI 10.1093/toxsci/kfl057; Mosser DD, 2000, MOL CELL BIOL, V20, P7146, DOI 10.1128/MCB.20.19.7146-7159.2000; Nota B, 2010, TOXICOL SCI, V115, P34, DOI 10.1093/toxsci/kfq043; Platt JC, 1999, ADVANCES IN KERNEL METHODS, P185; Powell W, 2007, APPROXIMATE DYNAMIC; Poynton HC, 2008, ENVIRON SCI TECHNOL, V42, P6257, DOI 10.1021/es800262k; Rocke DM, 2009, BIOINFORMATICS, V25, P701, DOI 10.1093/bioinformatics/btp038; Saeys Y, 2007, BIOINFORMATICS, V23, P2507, DOI 10.1093/bioinformatics/btm344; Simon R, 2007, CANCER INFORM, V3, P11; Song HW, 2000, CELL, V100, P311, DOI 10.1016/S0092-8674(00)80667-4; Southby J, 1999, MOL CELL BIOL, V19, P2699; Statnikov A, 2005, BIOINFORMATICS, V21, P631, DOI 10.1093/bioinformatics/bti033; Suzuki T, 2005, GENE, V362, P11, DOI 10.1016/j.gene.2005.07.039; Svendsen C, 2008, ENVIRON SCI TECHNOL, V42, P4208, DOI 10.1021/es702745d; Tan PJ, 2007, LECT NOTES COMPUT SC, V4830, P589; Tonevitsky EA, 2009, B EXP BIOL MED+, V147, P733, DOI 10.1007/s10517-009-0593-0; Trabucchi M, 2009, NATURE, V459, P1010, DOI 10.1038/nature08025; Trevino V, 2006, BIOINFORMATICS, V22, P1154, DOI 10.1093/bioinformatics/btl074; Wang RL, 2008, ENVIRON TOXICOL CHEM, V27, P664, DOI 10.1897/07-192.1; Wang Y, 2005, COMPUT BIOL CHEM, V29, P37, DOI 10.1016/j.compbiolchem.2004.11.001; Yang YL, 2009, DRUG DISCOV TODAY, V14, P147, DOI 10.1016/j.drudis.2008.12.005; Yu CG, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-52; Yu L, 2004, J MACH LEARN RES, V5, P1205; Zhang CY, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S4-S15; [No title captured]	48	11	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2010	5	10							e13715	10.1371/journal.pone.0013715	http://dx.doi.org/10.1371/journal.pone.0013715			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	672HN	21060837	Green Published, gold, Green Submitted			2022-12-27	WOS:000283573800014
J	Li, F; Wang, LP; Shen, XM; Tsien, JZ				Li, Fei; Wang, L. Phillip; Shen, Xiaoming; Tsien, Joe Z.			Balanced Dopamine Is Critical for Pattern Completion during Associative Memory Recall	PLOS ONE			English	Article							DEFICIT HYPERACTIVITY DISORDER; ANTERIOR CINGULATE CORTEX; RAT PREFRONTAL CORTEX; PARKINSONS-DISEASE; SPATIAL MEMORY; MICE LACKING; ATTENTION; TRANSPORTER; RETRIEVAL; HIPPOCAMPUS	Pattern completion, the ability to retrieve complete memories initiated by partial cues, is a critical feature of the memory process. However, little is known regarding the molecular and cellular mechanisms underlying this process. To study the role of dopamine in memory recall, we have analyzed dopamine transporter heterozygous knockout mice (DAT(+/-)), and found that while these mice possess normal learning, consolidation, and memory recall under full cue conditions, they exhibit specific deficits in pattern completion under partial cue condition. This form of memory recall deficit in the dopamine transporter heterozygous knockout mice can be reversed by a low dose of the dopamine antagonist haloperidol, further confirming that the inability to retrieve memory patterns is a result of dopamine imbalance. Therefore, our results reveal that a delicate control of the brain's dopamine level is critical for pattern completion during associative memory recall.	[Li, Fei; Shen, Xiaoming] Shanghai Jiao Tong Univ, Sch Med, Dept Dev & Behav Pediat, Shanghai Childrens Med Ctr, Shanghai 200030, Peoples R China; [Li, Fei; Shen, Xiaoming] Shanghai Jiao Tong Univ, Sch Med, Shanghai Key Lab Childrens Environm Hlth, XinHua Hosp, Shanghai 200030, Peoples R China; [Li, Fei; Wang, L. Phillip; Tsien, Joe Z.] Med Coll Georgia, Brain & Behav Discovery Inst, Augusta, GA 30912 USA	Shanghai Jiao Tong University; Shanghai Jiao Tong University; University System of Georgia; Augusta University	Li, F (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Dept Dev & Behav Pediat, Shanghai Childrens Med Ctr, Shanghai 200030, Peoples R China.	xmshen@shsmu.edu.cn; jtsien@mcg.edu			NIMH [MH060236]; NIA [AG024022, AG034663, AG025918]; Georgia Research Alliance, and Science and Technology Commission of Shanghai Municipality [101409005003]; National Science Foundation of China [81000592]; Science and Technology Commission of Shanghai Municipality [10DZ2272200, 09DZ2200900, 10PJ1407500, 10JC1411200]; Shanghai Municipal Education Commission [11ZZ103];  [USAMRA00002]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060236] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG024022, R01AG034663, R01AG025918] Funding Source: NIH RePORTER	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Georgia Research Alliance, and Science and Technology Commission of Shanghai Municipality; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Shanghai Municipal Education Commission(Shanghai Municipal Education Commission (SHMEC)); ; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by funds from NIMH (MH060236), NIA (AG024022, AG034663 & AG025918), USAMRA00002, Georgia Research Alliance, and Science and Technology Commission of Shanghai Municipality (10140900500) (all to JZT). National Science Foundation of China (81000592), Science and Technology Commission of Shanghai Municipality (10DZ2272200, 09DZ2200900, 10PJ1407500 and 10JC1411200), Shanghai Municipal Education Commission (11ZZ103) to FL and XMS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benoit-Marand M, 2000, EUR J NEUROSCI, V12, P2985, DOI 10.1046/j.1460-9568.2000.00155.x; Brennan AR, 2008, ANN NY ACAD SCI, V1129, P236, DOI 10.1196/annals.1417.007; Cao XH, 2008, NEURON, V60, P353, DOI 10.1016/j.neuron.2008.08.027; Carr DB, 2000, J NEUROSCI, V20, P3864, DOI 10.1523/JNEUROSCI.20-10-03864.2000; Chen GF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008256; Chen X, 2005, NAT NEUROSCI, V8, P925, DOI 10.1038/nn1482; Cools R, 2001, CEREB CORTEX, V11, P1136, DOI 10.1093/cercor/11.12.1136; Cui ZZ, 2004, NEURON, V41, P781, DOI 10.1016/S0896-6273(04)00072-8; CUMMINGS JL, 1988, EUR NEUROL, V28, P15; Dujardin K, 2003, CURR OPIN NEUROL, V16, pS11, DOI 10.1097/00019052-200312002-00003; Faraone SV, 2005, BIOL PSYCHIAT, V57, P1313, DOI 10.1016/j.biopsych.2004.11.024; Frankland PW, 2004, SCIENCE, V304, P881, DOI 10.1126/science.1094804; Gill M, 1997, MOL PSYCHIATR, V2, P311, DOI 10.1038/sj.mp.4000290; Giros B, 1996, NATURE, V379, P606, DOI 10.1038/379606a0; GoldmanRakic PS, 1996, P NATL ACAD SCI USA, V93, P13473, DOI 10.1073/pnas.93.24.13473; Granon S, 2000, J NEUROSCI, V20, P1208, DOI 10.1523/JNEUROSCI.20-03-01208.2000; Han CJ, 2003, P NATL ACAD SCI USA, V100, P13087, DOI 10.1073/pnas.2132313100; Ito R, 2002, J NEUROSCI, V22, P6247; Jones SR, 1998, P NATL ACAD SCI USA, V95, P4029, DOI 10.1073/pnas.95.7.4029; Kauer JA, 2007, NAT REV NEUROSCI, V8, P844, DOI 10.1038/nrn2234; Kentros CG, 2004, NEURON, V42, P283, DOI 10.1016/S0896-6273(04)00192-8; Kirwan CB, 2010, P NATL ACAD SCI USA, V107, P344, DOI 10.1073/pnas.0912543107; Korz V, 2007, LEARN MEMORY, V14, P160, DOI 10.1101/lm.459807; Leon WC, 2010, LEARN MEMORY, V17, P297, DOI 10.1101/lm.1804410; Lisman JE, 2005, NEURON, V46, P703, DOI 10.1016/j.neuron.2005.05.002; Matus-Amat P, 2004, J NEUROSCI, V24, P2431, DOI 10.1523/JNEUROSCI.1598-03.2004; Mirenowicz J, 1996, NATURE, V379, P449, DOI 10.1038/379449a0; Morice E, 2007, NEUROPSYCHOPHARMACOL, V32, P2108, DOI 10.1038/sj.npp.1301354; Muzzio IA, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000140; Nakazawa K, 2002, SCIENCE, V297, P211, DOI 10.1126/science.1071795; Nieoullon A, 2002, PROG NEUROBIOL, V67, P53, DOI 10.1016/S0301-0082(02)00011-4; Ouyang M, 2008, P NATL ACAD SCI USA, V105, P11993, DOI 10.1073/pnas.0804172105; Pezze MA, 2004, PROG NEUROBIOL, V74, P301, DOI 10.1016/j.pneurobio.2004.09.004; Phillips AG, 2004, J NEUROSCI, V24, P547, DOI 10.1523/JNEUROSCI.4653-03.2004; Rampon C, 2000, NAT NEUROSCI, V3, P238, DOI 10.1038/72945; Ridley RM, 2006, BEHAV BRAIN RES, V166, P253, DOI 10.1016/j.bbr.2005.08.007; Rodriguiz RM, 2004, BEHAV BRAIN RES, V148, P185, DOI 10.1016/S0166-4328(03)00187-6; ROLLS ET, 1994, PROG BRAIN RES, V102, P335; SARA SJ, 1985, ANN NY ACAD SCI, V444, P178, DOI 10.1111/j.1749-6632.1985.tb37588.x; Schultz W, 2002, NEURON, V36, P241, DOI 10.1016/S0896-6273(02)00967-4; Tang YP, 1999, NATURE, V401, P63, DOI 10.1038/43432; Taubenfeld SM, 2010, P NATL ACAD SCI USA, V107, P12345, DOI 10.1073/pnas.1003152107; Thompson RE, 2005, ANNU REV PSYCHOL, V56, P1, DOI 10.1146/annurev.psych.56.091103.070239; Tirapu-Ustarroz J, 2005, REV NEUROLOGIA, V41, P475, DOI 10.33588/rn.4108.2005240; Waldman ID, 1998, AM J HUM GENET, V63, P1767, DOI 10.1086/302132; Walf AA, 2007, NAT PROTOC, V2, P322, DOI 10.1038/nprot.2007.44; Weintraub Daniel, 2004, Cogn Behav Neurol, V17, P195; Wise RA, 2004, NAT REV NEUROSCI, V5, P483, DOI 10.1038/nrn1406; Zhuang XX, 2001, P NATL ACAD SCI USA, V98, P1982, DOI 10.1073/pnas.98.4.1982	49	16	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2010	5	10							e15401	10.1371/journal.pone.0015401	http://dx.doi.org/10.1371/journal.pone.0015401			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671UN	21060884	Green Published, Green Submitted, gold			2022-12-27	WOS:000283537000064
J	Narayanan, R; Jiang, JM; Gusev, Y; Jones, A; Kearbey, JD; Miller, DD; Schmittgen, TD; Dalton, JT				Narayanan, Ramesh; Jiang, Jinmai; Gusev, Yuriy; Jones, Amanda; Kearbey, Jeffrey D.; Miller, Duane D.; Schmittgen, Thomas D.; Dalton, James T.			MicroRNAs Are Mediators of Androgen Action in Prostate and Muscle	PLOS ONE			English	Article							NUCLEAR RECEPTOR; HORMONE-RECEPTOR; BODY-COMPOSITION; CANCER; MODULATORS; MOUSE; IDENTIFICATION; ORGANOGENESIS; INACTIVATION; COACTIVATOR	Androgen receptor (AR) function is critical for the development of male reproductive organs, muscle, bone and other tissues. Functionally impaired AR results in androgen insensitivity syndrome (AIS). The interaction between AR and microRNA (miR) signaling pathways was examined to understand the role of miRs in AR function. Reduction of androgen levels in Sprague-Dawley rats by castration inhibited the expression of a large set of miRs in prostate and muscle, which was reversed by treatment of castrated rats with 3 mg/day dihydrotestosterone (DHT) or selective androgen receptor modulators. Knockout of the miR processing enzyme, DICER, in LNCaP prostate cancer cells or tissue specifically in mice inhibited AR function leading to AIS. Since the only function of miRs is to bind to 39 UTR and inhibit translation of target genes, androgens might induce miRs to inhibit repressors of AR function. In concordance, knock-down of DICER in LNCaP cells and in tissues in mice induced the expression of corepressors, NCoR and SMRT. These studies demonstrate a feedback loop between miRs, corepressors and AR and the imperative role of miRs in AR function in non-cancerous androgen-responsive tissues.	[Narayanan, Ramesh; Jones, Amanda; Kearbey, Jeffrey D.; Miller, Duane D.; Dalton, James T.] GTx Inc, Preclin Res & Dev, Memphis, TN USA; [Jiang, Jinmai; Schmittgen, Thomas D.] Ohio State Univ, Coll Pharm, Columbus, OH 43210 USA; [Gusev, Yuriy] Georgetown Univ, Lombardi Canc Ctr, Washington, DC USA	University System of Ohio; Ohio State University; Georgetown University	Narayanan, R (corresponding author), GTx Inc, Preclin Res & Dev, Memphis, TN USA.	rnarayanan@gtxinc.com; jdalton@gtxinc.com		Gusev, Yuriy/0000-0001-7371-4715; Dalton, James T/0000-0002-3915-7326	GTx Inc.	GTx Inc.	No external funding sources for this study. As some of the authors are employees of GTx Inc. (www.gtxinc.com), the studies were funded as part of the preclinical research and development program of GTx Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asli NS, 2008, CURR MOL MED, V8, P698, DOI 10.2174/156652408786733739; Backman SA, 2004, P NATL ACAD SCI USA, V101, P1725, DOI 10.1073/pnas.0308217100; Bala S, 2009, WORLD J GASTROENTERO, V15, P5633, DOI 10.3748/wjg.15.5633; Bethke A, 2009, SCIENCE, V324, P95, DOI 10.1126/science.1164899; Bohl CE, 2005, J BIOL CHEM, V280, P37747, DOI 10.1074/jbc.M507464200; Catalucci D, 2009, CIRC-CARDIOVASC GENE, V2, P402, DOI 10.1161/CIRCGENETICS.109.857425; Chen TS, 2008, CURR OPIN CHEM BIOL, V12, P418, DOI 10.1016/j.cbpa.2008.07.001; Clarke BL, 2009, CURR OPIN RHEUMATOL, V21, P374, DOI 10.1097/BOR.0b013e32832ca447; Cortez MA, 2009, EXPERT OPIN BIOL TH, V9, P703, DOI [10.1517/14712590902932889, 10.1517/14712590902932889 ]; Damiani D, 2008, J NEUROSCI, V28, P4878, DOI 10.1523/JNEUROSCI.0828-08.2008; De Bosscher K, 2010, CURR OPIN PHARMACOL, V10, P497, DOI 10.1016/j.coph.2010.04.007; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fineberg SK, 2009, NEURON, V64, P303, DOI 10.1016/j.neuron.2009.10.020; Gao WQ, 2005, ENDOCRINOLOGY, V146, P4887, DOI 10.1210/en.2005-0572; Gentile MA, 2010, J MOL ENDOCRINOL, V44, P55, DOI 10.1677/JME-09-0048; Gonzalez G, 2009, MOL REPROD DEV, V76, P678, DOI 10.1002/mrd.21010; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Gusev Y, 2008, METHODS, V44, P61, DOI 10.1016/j.ymeth.2007.10.005; Hong XM, 2008, ENDOCRINOLOGY, V149, P6207, DOI 10.1210/en.2008-0294; Jinek M, 2009, NATURE, V457, P405, DOI 10.1038/nature07755; Kai ZS, 2010, NAT STRUCT MOL BIOL, V17, P5, DOI 10.1038/nsmb.1762; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lee Y, 2002, EMBO J, V21, P4663, DOI 10.1093/emboj/cdf476; Lesche R, 2002, GENESIS, V32, P148, DOI 10.1002/gene.10036; Li J, 2009, MATURITAS, V63, P142, DOI 10.1016/j.maturitas.2009.03.008; Lonard DM, 2007, MOL CELL, V27, P691, DOI 10.1016/j.molcel.2007.08.012; MARTINI L, 1990, ANN NY ACAD SCI, V595, P184, DOI 10.1111/j.1749-6632.1990.tb34292.x; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Mohler ML, 2009, J MED CHEM, V52, P3597, DOI 10.1021/jm900280m; Narayanan R, 2005, MOL CELL BIOL, V25, P264, DOI 10.1128/MCB.25.1.264-277.2005; Narayanan R, 2008, MOL ENDOCRINOL, V22, P2448, DOI 10.1210/me.2008-0160; Narayanan R, 2010, CANCER RES, V70, P842, DOI 10.1158/0008-5472.CAN-09-3206; Narayanan Ramesh, 2008, Nucl Recept Signal, V6, pe010, DOI 10.1621/nrs.06010; Pan W, 2002, BIOINFORMATICS, V18, P546, DOI 10.1093/bioinformatics/18.4.546; Prins G S, 2000, Mayo Clin Proc, V75 Suppl, pS32; Ribas J, 2009, CANCER RES, V69, P7165, DOI 10.1158/0008-5472.CAN-09-1448; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Shi XB, 2007, P NATL ACAD SCI USA, V104, P19983, DOI 10.1073/pnas.0706641104; Thomson AA, 2008, DIFFERENTIATION, V76, P587, DOI 10.1111/j.1432-0436.2008.00296.x; TREMBLAY RR, 1977, STEROIDS, V29, P185, DOI 10.1016/0039-128X(77)90038-1; TSAI MJ, 1994, ANNU REV BIOCHEM, V63, P451, DOI 10.1146/annurev.bi.63.070194.002315; Vlassov VV, 2010, CURR MOL MED, V10, P142, DOI 10.2174/156652410790963295; WELCH BL, 1947, BIOMETRIKA, V34, P28, DOI 10.2307/2332510; Xu JM, 2009, NAT REV CANCER, V9, P615, DOI 10.1038/nrc2695; Yamagata K, 2009, MOL CELL, V36, P340, DOI 10.1016/j.molcel.2009.08.017; Yin DH, 2003, J PHARMACOL EXP THER, V304, P1334, DOI 10.1124/jpet.102.040840; Yoon HG, 2006, MOL ENDOCRINOL, V20, P1048, DOI 10.1210/me.2005-0324	47	44	52	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2010	5	10							e13637	10.1371/journal.pone.0013637	http://dx.doi.org/10.1371/journal.pone.0013637			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671UN	21048966	Green Published, Green Submitted, gold			2022-12-27	WOS:000283537000018
J	Saavedra, S; Smith, D; Reed-Tsochas, F				Saavedra, Serguei; Smith, David; Reed-Tsochas, Felix			Cooperation under Indirect Reciprocity and Imitative Trust	PLOS ONE			English	Article							EVOLUTION; BEHAVIOR; OTHERS	Indirect reciprocity, a key concept in behavioral experiments and evolutionary game theory, provides a mechanism that allows reciprocal altruism to emerge in a population of self-regarding individuals even when repeated interactions between pairs of actors are unlikely. Recent empirical evidence show that humans typically follow complex assessment strategies involving both reciprocity and social imitation when making cooperative decisions. However, currently, we have no systematic understanding of how imitation, a mechanism that may also generate negative effects via a process of cumulative advantage, affects cooperation when repeated interactions are unlikely or information about a recipient's reputation is unavailable. Here we extend existing evolutionary models, which use an image score for reputation to track how individuals cooperate by contributing resources, by introducing a new imitative-trust score, which tracks whether actors have been the recipients of cooperation in the past. We show that imitative trust can co-exist with indirect reciprocity mechanisms up to a threshold and then cooperation reverses-revealing the elusive nature of cooperation. Moreover, we find that when information about a recipient's reputation is limited, trusting the action of third parties towards her (i.e. imitating) does favor a higher collective cooperation compared to random-trusting and share-alike mechanisms. We believe these results shed new light on the factors favoring social imitation as an adaptive mechanism in populations of cooperating social actors.	[Saavedra, Serguei] Northwestern Univ, NW Inst Complex Syst, Evanston, IL 60208 USA; [Saavedra, Serguei] Northwestern Univ, Kellogg Sch Management, Evanston, IL USA; [Smith, David; Reed-Tsochas, Felix] Univ Oxford, CABDyN Complex Ctr, Oxford, England; [Smith, David] Univ Oxford, Oxford Ctr Integrated Syst Biol, Oxford, England; [Smith, David] Univ Oxford, Ctr Math Biol, Oxford, England; [Reed-Tsochas, Felix] Univ Oxford, Said Business Sch, Inst Sci Innovat & Soc, Oxford, England	Northwestern University; Northwestern University; University of Oxford; University of Oxford; University of Oxford; University of Oxford	Saavedra, S (corresponding author), Northwestern Univ, NW Inst Complex Syst, Evanston, IL 60208 USA.	s-saavedra@northwestern.edu			Northwestern Institute on Complex Systems; Oxford University Corporate Reputation Centre; EPSRC (Engineering and Physical Sciences Research Council) [EP/E056997/1]; Engineering and Physical Sciences Research Council [EP/E056997/1] Funding Source: researchfish; EPSRC [EP/E056997/1] Funding Source: UKRI	Northwestern Institute on Complex Systems; Oxford University Corporate Reputation Centre; EPSRC (Engineering and Physical Sciences Research Council)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by Northwestern Institute on Complex Systems (http://www.northwestern.edu/nico/), Oxford University Corporate Reputation Centre (http://www.sbs.ox.ac.uk/centres/reputation/Pages/default.aspx), EPSRC (Engineering and Physical Sciences Research Council) grant EP/E056997/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander R., 2008, ESSAYS PEDAGOGY; AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; Axtell RL, 2001, SCIENCE, V293, P1818, DOI 10.1126/science.1062081; BANERJEE AV, 1992, Q J ECON, V107, P797, DOI 10.2307/2118364; Basu S, 2009, P NATL ACAD SCI USA, V106, P1009, DOI 10.1073/pnas.0811967106; Bikhchandani S, 1998, J ECON PERSPECT, V12, P151, DOI 10.1257/jep.12.3.151; Boero R., 2009, J SOCIO-ECON, V38, P871, DOI DOI 10.1016/J.SOCEC.2009.05.004; Bolton GE, 2005, J PUBLIC ECON, V89, P1457, DOI 10.1016/j.jpubeco.2004.03.008; Bowles S, 2008, SCIENCE, V320, P1605, DOI 10.1126/science.1152110; Brandt H, 2006, J THEOR BIOL, V239, P183, DOI 10.1016/j.jtbi.2005.08.045; Cialdini RB, 2004, ANNU REV PSYCHOL, V55, P591, DOI 10.1146/annurev.psych.55.090902.142015; Fehr E, 2003, NATURE, V425, P785, DOI 10.1038/nature02043; Fehr E, 2008, NATURE, V454, P1079, DOI 10.1038/nature07155; Fowler JH, 2010, P NATL ACAD SCI USA, V107, P5334, DOI 10.1073/pnas.0913149107; Gergely G, 2002, NATURE, V415, P755, DOI 10.1038/415755a; Gini C., 1921, ECON J, V31, P124, DOI [10.2307/2223319, DOI 10.2307/2223319]; Gintis H., 2005, MORAL SENTIMENTS MAT; Goldstein DG, 2002, PSYCHOL REV, V109, P75, DOI 10.1037//0033-295X.109.1.75; Hammerstein P., 2003, GENETIC CULTURAL EVO; HOFBAUER J, 1987, EVOLUTIONARY GAMES P; Ijiri Y, 1977, SKEW DISTRIBUTIONS S; Lehmann L, 2008, TRENDS ECOL EVOL, V23, P664, DOI 10.1016/j.tree.2008.07.012; Leimar O, 2001, P ROY SOC B-BIOL SCI, V268, P745, DOI 10.1098/rspb.2000.1573; MERTON RK, 1968, SCIENCE, V159, P56, DOI 10.1126/science.159.3810.56; Milinski M, 1998, P NATL ACAD SCI USA, V95, P13755, DOI 10.1073/pnas.95.23.13755; MOHTSUKI H, 2004, J THEOR BIOL, V227, P299; NA JP, 2009, PHYS REV E, V80; Nowak MA, 1998, NATURE, V393, P573, DOI 10.1038/31225; Ostrom E, 1999, SCIENCE, V284, P278, DOI 10.1126/science.284.5412.278; Ostrom E., 2003, TRUST RECIPROCITY IN; Pacheco JM, 2006, PLOS COMPUT BIOL, V2, P1634, DOI 10.1371/journal.pcbi.0020178; Pingle M., 1995, J SOCIOECONOMICS, V24, P281, DOI DOI 10.1016/1053-5357(95)90023-3); PODOLNY JM, 2005, SOCIOLOGICAL SIGNALS; PRICE DJD, 1976, J AM SOC INFORM SCI, V27, P292, DOI 10.1002/asi.4630270505; Rankin DJ, 2009, P R SOC B, V276, P1339, DOI 10.1098/rspb.2008.1715; Rendell L, 2010, SCIENCE, V328, P208, DOI 10.1126/science.1184719; Roberts G, 2008, P R SOC B, V275, P173, DOI 10.1098/rspb.2007.1134; Saavedra S, 2009, NATURE, V457, P463, DOI 10.1038/nature07532; Salganik MJ, 2006, SCIENCE, V311, P854, DOI 10.1126/science.1121066; Seinen I, 2006, EUR ECON REV, V50, P581, DOI 10.1016/j.euroecorev.2004.10.005; Sommerfeld RD, 2007, P NATL ACAD SCI USA, V104, P17435, DOI 10.1073/pnas.0704598104; Tomasello M, 2008, NATURE, V454, P1057, DOI 10.1038/4541057a; Tomasello M, 2008, JEAN NICOD LECT, P1; Wedekind C, 2000, SCIENCE, V288, P850, DOI 10.1126/science.288.5467.850; Zipf GK, 1942, SOCIOMETRY, V5, P48, DOI 10.2307/2784953	45	5	5	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2010	5	10							e13475	10.1371/journal.pone.0013475	http://dx.doi.org/10.1371/journal.pone.0013475			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	671UN	21048950	Green Published, gold			2022-12-27	WOS:000283537000003
J	Krashia, P; Moroni, M; Broadbent, S; Hofmann, G; Kracun, S; Beato, M; Groot-Kormelink, PJ; Sivilotti, LG				Krashia, Paraskevi; Moroni, Mirko; Broadbent, Steven; Hofmann, Giovanna; Kracun, Sebastian; Beato, Marco; Groot-Kormelink, Paul J.; Sivilotti, Lucia G.			Human alpha 3 beta 4 Neuronal Nicotinic Receptors Show Different Stoichiometry if They Are Expressed in Xenopus Oocytes or Mammalian HEK293 Cells	PLOS ONE			English	Article							SINGLE-CHANNEL CONDUCTANCE; RAT SYMPATHETIC NEURONS; ACETYLCHOLINE-RECEPTORS; ALTERNATE STOICHIOMETRIES; KINETIC-PROPERTIES; MICE LACKING; DETERMINANTS; SENSITIVITY; CHAPERONE; EXPOSURE	Background: The neuronal nicotinic receptors that mediate excitatory transmission in autonomic ganglia are thought to be formed mainly by the alpha 3 and beta 4 subunits. Expressing this composition in oocytes fails to reproduce the properties of ganglionic receptors, which may also incorporate the alpha 5 and/or beta 2 subunits. We compared the properties of human alpha 3 beta 4 neuronal nicotinic receptors expressed in Human embryonic kidney cells (HEK293) and in Xenopus oocytes, to examine the effect of the expression system and alpha:beta subunit ratio. Methodology/Principal Findings: Two distinct channel forms were observed: these are likely to correspond to different stoichiometries of the receptor, with two or three copies of the alpha subunit, as reported for alpha 4 beta 2 channels. This interpretation is supported by the pattern of change in acetylcholine (ACh) sensitivity observed when a hydrophilic Leu to Thr mutation was inserted in position 9' of the second transmembrane domain, as the effect of mutating the more abundant subunit is greater. Unlike alpha 4 beta 2 channels, for alpha 3 beta 4 receptors the putative two-alpha form is the predominant one in oocytes (at 1:1 alpha:beta cRNA ratio). This two-alpha form has a slightly higher ACh sensitivity (about 3-fold in oocytes), and displays potentiation by zinc. The putative three-alpha form is the predominant one in HEK cells transfected with a 1:1 alpha:beta DNA ratio or in oocytes at 9:1 alpha:beta RNA ratio, and is more sensitive to dimethylphenylpiperazinium (DMPP) than to ACh. In outside-out single-channel recordings, the putative two-alpha form opened to distinctive long bursts (100 ms or more) with low conductance (26 pS), whereas the three-alpha form gave rise to short bursts (14 ms) of high conductance (39 pS). Conclusions/Significance: Like other neuronal nicotinic receptors, the alpha 3 beta 4 receptor can exist in two different stoichiometries, depending on whether it is expressed in oocytes or in mammalian cell lines and on the ratio of subunits transfected.	[Krashia, Paraskevi; Moroni, Mirko; Hofmann, Giovanna; Beato, Marco; Sivilotti, Lucia G.] UCL, Dept Neurosci Physiol & Pharmacol, London, England; [Broadbent, Steven] Newcastle Univ, Sch Med, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Kracun, Sebastian] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90024 USA; [Groot-Kormelink, Paul J.] Novartis Inst Biomed Res, Novartis Horsham Res Ctr, Horsham, W Sussex, England	University of London; University College London; Newcastle University - UK; University of California System; University of California Los Angeles; Novartis	Krashia, P (corresponding author), UCL, Dept Neurosci Physiol & Pharmacol, London, England.	l.sivilotti@ucl.ac.uk	Krashia, Paraskevi/K-7973-2016; Sivilotti, Lucia/D-8919-2011; Moroni, Mirko/Q-1524-2018; Beato, Marco/C-1713-2008	Krashia, Paraskevi/0000-0002-8476-9233; Sivilotti, Lucia/0000-0003-2510-8424; Broadbent, Steven/0000-0002-7872-3968; Beato, Marco/0000-0002-7283-8318	Wellcome Trust [064652]; MRC [G0400869]; Royal Society; Medical Research Council [G0400869] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Royal Society(Royal Society of London); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Wellcome Trust (http://www.wellcome.ac.uk/) (project grant 064652, LGS; PhD studentship, SK); the MRC (http://www.mrc.ac.uk/index.htm) (programme grant G0400869, LGS; PhD studentship, SB); and the Royal Society (http://royalsociety.org/) (University Research Fellowship, MB; European Exchange grant, GH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boorman JPB, 2000, J PHYSIOL-LONDON, V529, P565, DOI 10.1111/j.1469-7793.2000.00565.x; Britt JC, 1997, PFLUG ARCH EUR J PHY, V434, P38, DOI 10.1007/s004240050360; Broadbent S, 2006, MOL PHARMACOL, V70, P1350, DOI 10.1124/mol.106.026682; Buisson B, 2001, J NEUROSCI, V21, P1819, DOI 10.1523/JNEUROSCI.21-06-01819.2001; Colquhoun D, 1998, BRIT J PHARMACOL, V125, P924; Colquhoun D., 2003, BURGERS MED CHEM DRU, P357; Colquhoun D, 1971, LECT BIOSTATISTICS; Colquhoun David, 1995, P483; CONROY WG, 1995, J BIOL CHEM, V270, P4424, DOI 10.1074/jbc.270.9.4424; COVERNTON PJO, 1994, J PHYSIOL-LONDON, V481, P27, DOI 10.1113/jphysiol.1994.sp020416; DERKACH VA, 1987, J PHYSIOL-LONDON, V388, P141, DOI 10.1113/jphysiol.1987.sp016606; Drenan RM, 2008, MOL PHARMACOL, V73, P27, DOI 10.1124/mol.107.039180; Exley R, 2006, J NEUROCHEM, V98, P876, DOI 10.1111/j.1471-4159.2006.03915.x; Figl A, 2000, J PHYSIOL-LONDON, V524, P685, DOI 10.1111/j.1469-7793.2000.00685.x; Fischer H, 2005, J PHYSIOL-LONDON, V563, P119, DOI 10.1113/jphysiol.2004.075788; Groot-Kormelink PJ, 2002, J NEUROSCI METH, V113, P207, DOI 10.1016/S0165-0270(01)00500-3; Hales TG, 2006, J BIOL CHEM, V281, P8062, DOI 10.1074/jbc.M513222200; Hsiao B, 2001, J NEUROSCI, V21, P1848, DOI 10.1523/JNEUROSCI.21-06-01848.2001; IMOTO K, 1988, NATURE, V335, P645, DOI 10.1038/335645a0; Kristufek D, 1999, J PHYSIOL-LONDON, V516, P739, DOI 10.1111/j.1469-7793.1999.0739u.x; Kuryatov A, 2005, MOL PHARMACOL, V68, P1839, DOI 10.1124/mol.105.012419; LABARCA C, 1995, NATURE, V376, P514, DOI 10.1038/376514a0; Lewis TM, 1997, J PHYSIOL-LONDON, V505, P299, DOI 10.1111/j.1469-7793.1997.299bb.x; MATHIE A, 1991, J PHYSIOL-LONDON, V439, P717, DOI 10.1113/jphysiol.1991.sp018690; Moroni M, 2008, J NEUROSCI, V28, P6884, DOI 10.1523/JNEUROSCI.1228-08.2008; Moroni M, 2006, MOL PHARMACOL, V70, P755, DOI 10.1124/mol.106.023044; Nelson ME, 1999, J PHYSIOL-LONDON, V516, P657, DOI 10.1111/j.1469-7793.1999.0657u.x; Nelson ME, 2003, MOL PHARMACOL, V63, P332, DOI 10.1124/mol.63.2.332; PAPKE RL, 1991, J PHYSIOL-LONDON, V440, P95, DOI 10.1113/jphysiol.1991.sp018698; PAPKE RL, 1989, NEURON, V3, P589, DOI 10.1016/0896-6273(89)90269-9; Peters JA, 2005, TRENDS PHARMACOL SCI, V26, P587, DOI 10.1016/j.tips.2005.09.011; RUST G, 1994, EUR J NEUROSCI, V6, P478, DOI 10.1111/j.1460-9568.1994.tb00290.x; Sigel E, 1997, TRENDS PHARMACOL SCI, V18, P425, DOI 10.1016/S0165-6147(97)90675-1; Sivilotti LG, 1997, J PHYSIOL-LONDON, V500, P123, DOI 10.1113/jphysiol.1997.sp022004; Tapia L, 2007, MOL PHARMACOL, V71, P769, DOI 10.1124/mol.106.030445; Xu W, 1999, P NATL ACAD SCI USA, V96, P5746, DOI 10.1073/pnas.96.10.5746; Xu W, 1999, J NEUROSCI, V19, P9298; Zhao LK, 2003, J PHARMACOL EXP THER, V305, P1132, DOI 10.1124/jpet.103.048777; Zwart R, 1998, MOL PHARMACOL, V54, P1124, DOI 10.1124/mol.54.6.1124	39	56	57	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2010	5	10							e13611	10.1371/journal.pone.0013611	http://dx.doi.org/10.1371/journal.pone.0013611			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671GB	21049012	gold, Green Published, Green Submitted			2022-12-27	WOS:000283487400010
J	Kuczma, M; Kopij, M; Pawlikowska, I; Wang, CY; Rempala, GA; Kraj, P				Kuczma, Michal; Kopij, Magdalena; Pawlikowska, Iwona; Wang, Cong-Yi; Rempala, Grzegorz A.; Kraj, Piotr			Intratumoral Convergence of the TCR Repertoires of Effector and Foxp3(+) CD4(+) T cells	PLOS ONE			English	Article							REGULATORY-CELLS; TUMOR-IMMUNITY; TGF-BETA; TOLERANCE INDUCTION; PANCREATIC-CANCER; ANTIGEN; EXPRESSION; MELANOMA; IMMUNOTHERAPY; PROGRESSION	The presence of Foxp3(+) regulatory CD4(+) T cells in tumor lesions is considered one of the major causes of ineffective immune response in cancer. It is not clear whether intratumoral T-reg cells represent T-reg cells pre-existing in healthy mice, or arise from tumor-specific effector CD4(+) T cells and thus representing adaptive T-reg cells. The generation of T-reg population in tumors could be further complicated by recent evidence showing that both in humans and mice the peripheral population of T-reg cells is heterogenous and consists of subsets which may differentially respond to tumor-derived antigens. We have studied T-reg cells in cancer in experimental mice that express naturally selected, polyclonal repertoire of CD4(+) T cells and which preserve the heterogeneity of the T-reg population. The majority of T-reg cells present in healthy mice maintained a stable suppressor phenotype, expressed high level of Foxp3 and an exclusive set of TCRs not used by naive CD4(+) T cells. A small T-reg subset, utilized TCRs shared with effector T cells and expressed a lower level of Foxp3. We show that response to tumor-derived antigens induced efficient clonal recruitment and expansion of antigen-specific effector and T-reg cells. However, the population of T-reg cells in tumors was dominated by cells expressing TCRs shared with effector CD4(+) T cells. In contrast, T-reg cells expressing an exclusive set of TCRs, that dominate in healthy mice, accounted for only a small fraction of all T-reg cells in tumor lesions. Our results suggest that the T-reg repertoire in tumors is generated by conversion of effector CD4(+) T cells or expansion of a minor subset of T-reg cells. In conclusion, successful cancer immunotherapy may depend on the ability to block upregulation of Foxp3 in effector CD4(+) T cells and/or selectively inhibiting the expansion of a minor T-reg subset.	[Kuczma, Michal; Kopij, Magdalena; Wang, Cong-Yi; Kraj, Piotr] Med Coll Georgia, Ctr Biotechnol & Genom Med, Augusta, GA 30912 USA; [Pawlikowska, Iwona; Rempala, Grzegorz A.] Med Coll Georgia, Dept Biostat, Augusta, GA 30912 USA; [Pawlikowska, Iwona; Rempala, Grzegorz A.] Med Coll Georgia, Ctr Canc, Augusta, GA 30912 USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University	Kuczma, M (corresponding author), Med Coll Georgia, Ctr Biotechnol & Genom Med, Augusta, GA 30912 USA.	pkraj@mail.mcg.edu		Wang, Cong-Yi/0000-0001-7914-168X	National Institutes of Health [R01 CA107349-01A1, 1R01DE019243-01, DMS 0840695]; NATIONAL CANCER INSTITUTE [R01CA107349, R01CA152158] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE019243] Funding Source: NIH RePORTER; Direct For Mathematical & Physical Scien [0840695] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported by National Institutes of Health grants R01 CA107349-01A1 to PK and 1R01DE019243-01 and DMS 0840695 to GAR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler AJ, 2000, J IMMUNOL, V164, P649, DOI 10.4049/jimmunol.164.2.649; Ahmadzadeh M, 2008, BLOOD, V112, P4953, DOI 10.1182/blood-2008-06-163048; Allan SE, 2008, IMMUNOL REV, V223, P391, DOI 10.1111/j.1600-065X.2008.00634.x; Bluestone JA, 2003, NAT REV IMMUNOL, V3, P253, DOI 10.1038/nri1032; CHAO A, 1984, SCAND J STAT, V11, P265; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Chikamatsu K, 2009, CANCER IMMUNOL IMMUN, V58, P1441, DOI 10.1007/s00262-009-0661-3; Chmielowski B, 1999, J IMMUNOL, V162, P95; Chmielowski B, 2002, P NATL ACAD SCI USA, V99, P15012, DOI 10.1073/pnas.222463499; Clark CE, 2007, CANCER RES, V67, P9518, DOI 10.1158/0008-5472.CAN-07-0175; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; Curiel TJ, 2008, CURR OPIN IMMUNOL, V20, P241, DOI 10.1016/j.coi.2008.04.008; Darrasse-Jeze G, 2009, J CLIN INVEST, V119, P2648, DOI 10.1172/JCI36628; Dunn GP, 2004, ANNU REV IMMUNOL, V22, P329, DOI 10.1146/annurev.immunol.22.012703.104803; GAO XM, 1989, J IMMUNOL, V143, P3007; Getnet D, 2009, J IMMUNOL, V182, P4675, DOI 10.4049/jimmunol.0803400; Haribhai D, 2009, J IMMUNOL, V182, P3461, DOI 10.4049/jimmunol.0802535; Horwitz DA, 2008, TRENDS IMMUNOL, V29, P429, DOI 10.1016/j.it.2008.06.005; Hsieh CS, 2004, IMMUNITY, V21, P267, DOI 10.1016/j.immuni.2004.07.009; IGNATOWICZ L, 1995, J IMMUNOL, V154, P3852; Ito T, 2008, IMMUNITY, V28, P870, DOI 10.1016/j.immuni.2008.03.018; Joncker NT, 2006, INT J CANCER, V118, P1205, DOI 10.1002/ijc.21472; Komatsu N, 2009, P NATL ACAD SCI USA, V106, P1903, DOI 10.1073/pnas.0811556106; Kraj P, 2001, J IMMUNOL, V166, P2251, DOI 10.4049/jimmunol.166.4.2251; Kretschmer K, 2005, NAT IMMUNOL, V6, P1219, DOI 10.1038/ni1265; Kubuschok B, 2006, CLIN CANCER RES, V12, P1365, DOI 10.1158/1078-0432.CCR-05-1672; Kuczma M, 2009, J IMMUNOL, V183, P3118, DOI 10.4049/jimmunol.0900514; KULLBACK S, 1951, ANN MATH STAT, V22, P79, DOI 10.1214/aoms/1177729694; Lehe C, 2008, CANCER RES, V68, P6350, DOI 10.1158/0008-5472.CAN-08-0050; Liang S, 2005, J EXP MED, V201, P127, DOI 10.1084/jem.20041201; Liu VC, 2007, J IMMUNOL, V178, P2883, DOI 10.4049/jimmunol.178.5.2883; Liyanage UK, 2002, J IMMUNOL, V169, P2756, DOI 10.4049/jimmunol.169.5.2756; Lund JM, 2008, SCIENCE, V320, P1220, DOI 10.1126/science.1155209; Malherbe L, 2004, IMMUNITY, V21, P669, DOI 10.1016/j.immuni.2004.09.008; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Miyara M, 2009, IMMUNITY, V30, P899, DOI 10.1016/j.immuni.2009.03.019; Morgan ME, 2005, HUM IMMUNOL, V66, P13, DOI 10.1016/j.humimm.2004.05.016; Nishikawa H, 2001, P NATL ACAD SCI USA, V98, P14571, DOI 10.1073/pnas.251547298; Nishikawa H, 2005, J EXP MED, V201, P681, DOI 10.1084/jem.20041959; Nishikawa H, 2005, BLOOD, V106, P1008, DOI 10.1182/blood-2005-02-0607; Pacholczyk R, 2006, IMMUNITY, V25, P249, DOI 10.1016/j.immuni.2006.05.016; Quezada SA, 2010, J EXP MED, V207, P637, DOI 10.1084/jem.20091918; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; Sakaguchi S, 2001, IMMUNOL REV, V182, P18, DOI 10.1034/j.1600-065X.2001.1820102.x; Sasada T, 2003, CANCER-AM CANCER SOC, V98, P1089, DOI 10.1002/cncr.11618; Sauer S, 2008, P NATL ACAD SCI USA, V105, P7797, DOI 10.1073/pnas.0800928105; Segal NH, 2008, CANCER RES, V68, P889, DOI 10.1158/0008-5472.CAN-07-3095; Shimizu J, 1999, J IMMUNOL, V163, P5211; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Sotomayor EM, 2001, BLOOD, V98, P1070, DOI 10.1182/blood.V98.4.1070; Srivastava PK, 2000, NAT IMMUNOL, V1, P363, DOI 10.1038/80795; Staveley-O'Carroll K, 1998, P NATL ACAD SCI USA, V95, P1178, DOI 10.1073/pnas.95.3.1178; Strauss L, 2008, J IMMUNOL, V180, P2967, DOI 10.4049/jimmunol.180.5.2967; Turk MJ, 2004, J EXP MED, V200, P771, DOI 10.1084/jem.20041130; Valzasina B, 2006, CANCER RES, V66, P4488, DOI 10.1158/0008-5472.CAN-05-4217; Wang CL, 2010, P NATL ACAD SCI USA, V107, P1518, DOI 10.1073/pnas.0913939107; Welters MJP, 2008, CLIN CANCER RES, V14, P178, DOI 10.1158/1078-0432.CCR-07-1880; Yu P, 2005, J EXP MED, V201, P779, DOI 10.1084/jem.20041684; Zhou G, 2006, BLOOD, V107, P628, DOI 10.1182/blood-2005-07-2737; Zhou G, 2007, J IMMUNOL, V178, P2155, DOI 10.4049/jimmunol.178.4.2155; Zou WP, 2006, NAT REV IMMUNOL, V6, P295, DOI 10.1038/nri1806	61	13	13	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2010	5	10							e13623	10.1371/journal.pone.0013623	http://dx.doi.org/10.1371/journal.pone.0013623			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671GB	21049016	gold, Green Published, Green Submitted			2022-12-27	WOS:000283487400016
J	Caglayan, E; Romeo, GR; Kappert, K; Odenthal, M; Sudkamp, M; Body, SC; Shernan, SK; Hackbusch, D; Vantler, M; Kazlauskas, A; Rosenkranz, S				Caglayan, Evren; Romeo, Giulio R.; Kappert, Kai; Odenthal, Margarete; Suedkamp, Michael; Body, Simon C.; Shernan, Stanton K.; Hackbusch, Daniel; Vantler, Marius; Kazlauskas, Andrius; Rosenkranz, Stephan			Profilin-1 Is Expressed in Human Atherosclerotic Plaques and Induces Atherogenic Effects on Vascular Smooth Muscle Cells	PLOS ONE			English	Article							ACTIVATED RECEPTOR-GAMMA; ACTIN-BINDING PROTEIN; RAT MESANGIAL CELLS; GROWTH-FACTOR; INSULIN-RESISTANCE; DNA-SYNTHESIS; CHEMOTAXIS; INFLAMMATION; DYSFUNCTION; DISEASE	Background: Profilin-1 is an ubiquitous actin binding protein. Under pathological conditions such as diabetes, profilin-1 levels are increased in the vascular endothelium. We recently demonstrated that profilin-1 overexpression triggers indicators of endothelial dysfunction downstream of LDL signaling, and that attenuated expression of profilin-1 confers protection from atherosclerosis in vivo. Methodology: Here we monitored profilin-1 expression in human atherosclerotic plaques by immunofluorescent staining. The effects of recombinant profilin-1 on atherogenic signaling pathways and cellular responses such as DNA synthesis (BrdU-incorporation) and chemotaxis (modified Boyden-chamber) were evaluated in cultured rat aortic and human coronary vascular smooth muscle cells (VSMCs). Furthermore, the correlation between profilin-1 serum levels and the degree of atherosclerosis was assessed in humans. Principal Findings: In coronary arteries from patients with coronary heart disease, we found markedly enhanced profilin expression in atherosclerotic plaques compared to the normal vessel wall. Stimulation of rat aortic and human coronary VSMCs with recombinant profilin-1 (10(-6) M) in vitro led to activation of intracellular signaling cascades such as phosphorylation of Erk1/2, p70(S6) kinase and PI3K/Akt within 10 minutes. Furthermore, profilin-1 concentration-dependently induced DNA-synthesis and migration of both rat and human VSMCs, respectively. Inhibition of PI3K (Wortmannin, LY294002) or Src-family kinases (SU6656, PP2), but not PLC gamma (U73122), completely abolished profilin-induced cell cycle progression, whereas PI3K inhibition partially reduced the chemotactic response. Finally, we found that profilin-1 serum levels were significantly elevated in patients with severe atherosclerosis in humans (p<0.001 vs. no atherosclerosis or control group). Conclusions: Profilin-1 expression is significantly enhanced in human atherosclerotic plaques compared to the normal vessel wall, and the serum levels of profilin-1 correlate with the degree of atherosclerosis in humans. The atherogenic effects exerted by profilin-1 on VSMCs suggest an auto-/paracrine role within the plaque. These data indicate that profilin-1 might critically contribute to atherogenesis and may represent a novel therapeutic target.	[Caglayan, Evren; Vantler, Marius; Rosenkranz, Stephan] Univ Cologne, Innere Med Klin 3, Cologne, Germany; [Caglayan, Evren; Vantler, Marius; Rosenkranz, Stephan] Univ Cologne, CMMC, Cologne, Germany; [Romeo, Giulio R.] Joslin Diabet Ctr, Dept Cellular & Mol Physiol, Boston, MA 02215 USA; [Kappert, Kai; Hackbusch, Daniel] Charite, CCR, Inst Pharmakol, D-13353 Berlin, Germany; [Odenthal, Margarete] Univ Cologne, Inst Pathol, D-5000 Cologne, Germany; [Suedkamp, Michael] Univ Freiburg Klinikum, Freiburg, Germany; [Body, Simon C.; Shernan, Stanton K.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA; [Kazlauskas, Andrius] Harvard Univ, Schepens Eye Res Inst, Sch Med, Boston, MA USA	University of Cologne; University of Cologne; Harvard University; Joslin Diabetes Center, Inc.; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Cologne; University of Freiburg; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Schepens Eye Research Institute	Caglayan, E (corresponding author), Univ Cologne, Innere Med Klin 3, Cologne, Germany.	stephan.rosenkranz@uk-koeln.de	Body, Simon/AAQ-7572-2020; Kappert, Kai/H-4116-2017; Body, Simon C/O-2605-2013; Caglayan, Evren/ABB-8674-2020	Body, Simon/0000-0001-6721-7050; Kappert, Kai/0000-0001-6976-0428; Body, Simon C/0000-0001-6721-7050; 	Deutsche Forschungsgemeinschaft [Ro 1306/2-1, Ro 1306/2-2]; Center for Molecular Medicine (CMMC) of the University of Cologne [A6]; Maria-Pesch-Stiftung; Medical Faculty; University of Cologne; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL068774, R01HL098601] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Center for Molecular Medicine (CMMC) of the University of Cologne; Maria-Pesch-Stiftung; Medical Faculty; University of Cologne; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by the Deutsche Forschungsgemeinschaft (to SR; Ro 1306/2-1 and 2-2), the Center for Molecular Medicine (CMMC) of the University of Cologne (to SR; A6), the Maria-Pesch-Stiftung (to EC), and by the Koeln Fortune Program (Medical Faculty; University of Cologne, to KK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bromann PA, 2004, ONCOGENE, V23, P7957, DOI 10.1038/sj.onc.1208079; Caglayan E, 2008, DIABETES, V57, P2470, DOI 10.2337/db07-0924; CHAMLEYCAMPBELL J, 1979, PHYSIOL REV, V59, P1, DOI 10.1152/physrev.1979.59.1.1; Dandona P, 2003, J CLIN ENDOCR METAB, V88, P2422, DOI 10.1210/jc.2003-030178; Haffner SM, 1998, NEW ENGL J MED, V339, P229, DOI 10.1056/NEJM199807233390404; HAUGWITZ M, 1994, CELL, V79, P303, DOI 10.1016/0092-8674(94)90199-6; Hsueh WA, 2004, HYPERTENSION, V43, P297, DOI 10.1161/01.HYP.0000113626.76571.5b; Hsueh WA, 2003, AM J CARDIOL, V92, p10J, DOI 10.1016/S0002-9149(03)00611-8; KWIATKOWSKI DJ, 1988, J BIOL CHEM, V263, P5910; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Machesky Laura M., 1993, Trends in Cell Biology, V3, P381, DOI 10.1016/0962-8924(93)90087-H; Marx N, 2004, ARTERIOSCL THROM VAS, V24, P540, DOI 10.1161/01.ATV.0000116027.81513.68; Moustafa-Bayoumi M, 2007, J BIOL CHEM, V282, P37632, DOI 10.1074/jbc.M703227200; Paavilainen VO, 2004, TRENDS CELL BIOL, V14, P386, DOI 10.1016/j.tcb.2004.05.002; Romeo G, 2004, FASEB J, V18, P725, DOI 10.1096/fj.03-0841fje; Romeo GR, 2007, CIRC RES, V101, P357, DOI 10.1161/CIRCRESAHA.107.151399; Rosenkranz S, 1999, J BIOL CHEM, V274, P28335, DOI 10.1074/jbc.274.40.28335; Rosenkranz S, 2002, FASEB J, V16, P1958, DOI 10.1096/fj.02-0207fje; Suzuki LA, 2001, DIABETES, V50, P851, DOI 10.2337/diabetes.50.4.851; Tallquist M, 2004, CYTOKINE GROWTH F R, V15, P205, DOI 10.1016/j.cytogfr.2004.03.003; Tamura M, 2000, J AM SOC NEPHROL, V11, P423, DOI 10.1681/ASN.V113423; Tamura M, 2000, J AM SOC NEPHROL, V11, P1620, DOI 10.1681/ASN.V1191620; Walcher D, 2006, CIRC RES, V99, P1181, DOI 10.1161/01.RES.0000251231.16993.88; Waltenberger J, 2000, CIRCULATION, V102, P185, DOI 10.1161/01.CIR.102.2.185; Witke W, 2004, TRENDS CELL BIOL, V14, P461, DOI 10.1016/j.tcb.2004.07.003; Witke W, 2001, P NATL ACAD SCI USA, V98, P3832, DOI 10.1073/pnas.051515498; Yarmola EG, 2006, TRENDS BIOCHEM SCI, V31, P197, DOI 10.1016/j.tibs.2006.02.006; Yarovinsky F, 2005, SCIENCE, V308, P1626, DOI 10.1126/science.1109893	28	42	44	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2010	5	10							e13608	10.1371/journal.pone.0013608	http://dx.doi.org/10.1371/journal.pone.0013608			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	670LB	21049052	Green Published, Green Submitted, gold			2022-12-27	WOS:000283422100015
J	Hasegawa, D; Fujii, R; Yagishita, N; Matsumoto, N; Aratani, S; Izumi, T; Azakami, K; Nakazawa, M; Fujita, H; Sato, T; Araya, N; Koike, J; Tadokoro, M; Suzuki, N; Nagata, K; Senoo, H; Friedman, SL; Nishioka, K; Yamano, Y; Itoh, F; Nakajima, T				Hasegawa, Daisuke; Fujii, Ryoji; Yagishita, Naoko; Matsumoto, Nobuyuki; Aratani, Satoko; Izumi, Toshihiko; Azakami, Kazuko; Nakazawa, Minako; Fujita, Hidetoshi; Sato, Tomoo; Araya, Natsumi; Koike, Junki; Tadokoro, Mamoru; Suzuki, Noboru; Nagata, Kazuhiro; Senoo, Haruki; Friedman, Scott L.; Nishioka, Kusuki; Yamano, Yoshihisa; Itoh, Fumio; Nakajima, Toshihiro			E3 Ubiquitin Ligase Synoviolin Is Involved in Liver Fibrogenesis	PLOS ONE			English	Article							INDUCED CELL-DEATH; ENDOPLASMIC-RETICULUM; HEPATIC-FIBROSIS; ER STRESS; IN-VIVO; MISFOLDED PROCOLLAGEN; RHEUMATOID-ARTHRITIS; STELLATE CELLS; HUMAN HRD1; COLLAGEN	Background and Aim: Chronic hepatic damage leads to liver fibrosis, which is characterized by the accumulation of collagen-rich extracellular matrix. However, the mechanism by which E3 ubiquitin ligase is involved in collagen synthesis in liver fibrosis is incompletely understood. This study aimed to explore the involvement of the E3 ubiquitin ligase synoviolin (Syno) in liver fibrosis. Methods: The expression and localization of synoviolin in the liver were analyzed in CCl(4)-induced hepatic injury models and human cirrhosis tissues. The degree of liver fibrosis and the number of activated hepatic stellate cells (HSCs) was compared between wild type (wt) and Syno(+/-) mice in the chronic hepatic injury model. We compared the ratio of apoptosis in activated HSCs between wt and Syno(+/-) mice. We also analyzed the effect of synoviolin on collagen synthesis in the cell line from HSCs (LX-2) using siRNA-synoviolin and a mutant synoviolin in which E3 ligase activity was abolished. Furthermore, we compared collagen synthesis between wt and Syno(-/-) mice embryonic fibroblasts (MEF) using quantitative RT-PCR, western blotting, and collagen assay; then, we immunohistochemically analyzed the localization of collagen in Syno(-/-) MEF cells. Results: In the hepatic injury model as well as in cirrhosis, synoviolin was upregulated in the activated HSCs, while Syno(+/-) mice developed significantly less liver fibrosis than in wt mice. The number of activated HSCs was decreased in Syno(+/-) mice, and some of these cells showed apoptosis. Furthermore, collagen expression in LX-2 cells was upregulated by synoviolin overexpression, while synoviolin knockdown led to reduced collagen expression. Moreover, in Syno(-/-) MEF cells, the amounts of intracellular and secreted mature collagen were significantly decreased, and procollagen was abnormally accumulated in the endoplasmic reticulum. Conclusion: Our findings demonstrate the importance of the E3 ubiquitin ligase synoviolin in liver fibrosis.	[Hasegawa, Daisuke; Fujii, Ryoji; Yagishita, Naoko; Aratani, Satoko; Izumi, Toshihiko; Azakami, Kazuko; Nakazawa, Minako; Fujita, Hidetoshi; Sato, Tomoo; Araya, Natsumi; Nishioka, Kusuki; Yamano, Yoshihisa; Nakajima, Toshihiro] St Marianna Univ, Sch Med, Inst Med Sci, Kawasaki, Kanagawa, Japan; [Hasegawa, Daisuke; Matsumoto, Nobuyuki; Itoh, Fumio] St Marianna Univ, Sch Med, Div Gastroenterol & Hepatol, Kawasaki, Kanagawa, Japan; [Koike, Junki; Tadokoro, Mamoru] St Marianna Univ, Sch Med, Dept Pathol, Kawasaki, Kanagawa, Japan; [Suzuki, Noboru] St Marianna Univ, Sch Med, Dept Immunol, Kawasaki, Kanagawa, Japan; [Suzuki, Noboru] St Marianna Univ, Sch Med, Dept Med, Kawasaki, Kanagawa, Japan; [Nagata, Kazuhiro] Kyoto Univ, Inst Frontier Med Sci, Dept Mol & Cellular Biol, Kyoto, Japan; [Senoo, Haruki] Akita Univ, Sch Med, Dept Cell Biol & Histol, Hondo, Japan; [Friedman, Scott L.] Mt Sinai Sch Med, Div Liver Dis, New York, NY USA; [Nishioka, Kusuki; Nakajima, Toshihiro] Tokyo Med Univ, Inst Med Sci, Tokyo, Japan; [Nakajima, Toshihiro] Fukushimura Hosp, Choju Med Inst, Toyohasi, Japan; [Nakajima, Toshihiro] Misato Marine Hosp, Kochi, Japan	Saint Marianna University; Saint Marianna University; Saint Marianna University; Saint Marianna University; Saint Marianna University; Kyoto University; Akita University; Icahn School of Medicine at Mount Sinai; Tokyo Medical University	Hasegawa, D (corresponding author), St Marianna Univ, Sch Med, Inst Med Sci, Kawasaki, Kanagawa, Japan.	nakashit@marianna-u.ac.jp	Sato, Tomoo/E-3262-2010; Matsumoto, Nobuyuki/AAK-6459-2020; Yamano, Yoshihisa/AAG-3955-2020	Sato, Tomoo/0000-0001-8439-3128; 	Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science and Technology, Japanese Ministry of Health, Labour, and Welfare; National Institute of Biomedical Innovation; Uehara Memorial Foundation; Nagao Takeshi Nanbyo Foundation; Kanagawa Nanbyo Foundation; Mishima Kaiun Memorial Foundation; Takeda Science Foundation; ITSUU Laboratory Research Foundation; Kanae Foundation for Life and Socio-Medical Science; Japan Research Foundation for Clinical Pharmacology; Kanagawa Academy of Science and Technology; Japan College of Rheumatology; Nakajima Foundation; Osaka Foundation for Cancer Research; New Energy and Industrial Technology Development Organization; Mochida Pharmaceutical Company, Ltd.; Kanagawa High-Technology Foundation; Kanto Bureau of Economy, Trade and Industry; Mitsui Life Insurance Company, Ltd.; Heiwa Nakajima Foundation; Sagawa Foundation for Promotion of Cancer Research; Tokyo Biochemical Research Foundation; National Institutes of Health [DK56621]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK056621, R01DK056621] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [20249052] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology, Japanese Ministry of Health, Labour, and Welfare; National Institute of Biomedical Innovation(National Institute of Biomedical Innovation); Uehara Memorial Foundation(Uehara Memorial Foundation); Nagao Takeshi Nanbyo Foundation; Kanagawa Nanbyo Foundation(Kanagawa Nanbyo Foundation); Mishima Kaiun Memorial Foundation(Mishima Kaiun Memorial Foundation); Takeda Science Foundation(Takeda Science Foundation (TSF)); ITSUU Laboratory Research Foundation; Kanae Foundation for Life and Socio-Medical Science; Japan Research Foundation for Clinical Pharmacology; Kanagawa Academy of Science and Technology; Japan College of Rheumatology; Nakajima Foundation; Osaka Foundation for Cancer Research; New Energy and Industrial Technology Development Organization(New Energy and Industrial Technology Development Organization (NEDO)); Mochida Pharmaceutical Company, Ltd.; Kanagawa High-Technology Foundation; Kanto Bureau of Economy, Trade and Industry; Mitsui Life Insurance Company, Ltd.; Heiwa Nakajima Foundation; Sagawa Foundation for Promotion of Cancer Research; Tokyo Biochemical Research Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was partially supported by a Grant-in Aid for Scientific Research from Japan Society for the Promotion of Science; The Ministry of Education, Culture, Sports, Science and Technology, Japanese Ministry of Health, Labour, and Welfare; National Institute of Biomedical Innovation; Uehara Memorial Foundation; Nagao Takeshi Nanbyo Foundation; Kanagawa Nanbyo Foundation; Mishima Kaiun Memorial Foundation; Takeda Science Foundation; ITSUU Laboratory Research Foundation; Kanae Foundation for Life and Socio-Medical Science; Japan Research Foundation for Clinical Pharmacology; Kanagawa Academy of Science and Technology (research grants); Japan College of Rheumatology; Nakajima Foundation; Osaka Foundation for Cancer Research; New Energy and Industrial Technology Development Organization; Mochida Pharmaceutical Company, Ltd.; Kanagawa High-Technology Foundation; Kanto Bureau of Economy, Trade and Industry; Mitsui Life Insurance Company, Ltd.; Heiwa Nakajima Foundation; Sagawa Foundation for Promotion of Cancer Research; Tokyo Biochemical Research Foundation and National Institutes of Health (DK56621). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano T, 2003, GENE DEV, V17, P2436, DOI 10.1101/gad.1096603; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Bateman JF, 2009, NAT REV GENET, V10, P173, DOI 10.1038/nrg2520; Bonfanti L, 1998, CELL, V95, P993, DOI 10.1016/S0092-8674(00)81723-7; Boot-Handford RP, 2010, CELL TISSUE RES, V339, P197, DOI 10.1007/s00441-009-0877-8; Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003; Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007; FRIEDMAN SL, 1993, NEW ENGL J MED, V328, P1828; FRIEDMAN SL, 1985, P NATL ACAD SCI USA, V82, P8681, DOI 10.1073/pnas.82.24.8681; Gao BX, 2008, EMBO REP, V9, P480, DOI 10.1038/embor.2008.37; Hellerbrand C, 1999, J HEPATOL, V30, P77, DOI 10.1016/S0168-8278(99)80010-5; Imai Y, 2000, J BIOL CHEM, V275, P35661, DOI 10.1074/jbc.C000447200; Ishida Y, 2006, MOL BIOL CELL, V17, P2346, DOI 10.1091/mbc.E05-11-1065; Ishida Y, 2009, AUTOPHAGY, V5, P1217, DOI 10.4161/auto.5.8.10168; Ishida Y, 2009, MOL BIOL CELL, V20, P2744, DOI 10.1091/mbc.E08-11-1092; Izumi T, 2009, ARTHRITIS RHEUM-US, V60, P63, DOI 10.1002/art.24178; Kaneko M, 2002, FEBS LETT, V532, P147, DOI 10.1016/S0014-5793(02)03660-8; Kikkert M, 2004, J BIOL CHEM, V279, P3525, DOI 10.1074/jbc.M307453200; Kimmelman AC, 2004, ONCOGENE, V23, P5077, DOI 10.1038/sj.onc.1207662; Koide T, 2005, TOP CURR CHEM, V247, P85, DOI 10.1007/b103820; Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049; Lisse TS, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040007; Mehtani S, 1998, J BIOL CHEM, V273, P13236, DOI 10.1074/jbc.273.21.13236; Myllyharju J, 2004, TRENDS GENET, V20, P33, DOI 10.1016/j.tig.2003.11.004; Nadav E, 2003, BIOCHEM BIOPH RES CO, V303, P91, DOI 10.1016/S0006-291X(03)00279-1; Passino MA, 2007, SCIENCE, V315, P1853, DOI 10.1126/science.1137603; Perez F, 2002, J CELL BIOL, V156, P631, DOI 10.1083/jcb.200111003; PROCKOP DJ, 1995, ANNU REV BIOCHEM, V64, P403, DOI 10.1146/annurev.biochem.64.1.403; Ratziu V, 1998, P NATL ACAD SCI USA, V95, P9500, DOI 10.1073/pnas.95.16.9500; Sawa T, 1999, INFECT IMMUN, V67, P1450, DOI 10.1128/IAI.67.3.1450-1454.1999; Stefanovic B, 2004, MOL CELL BIOL, V24, P1758, DOI 10.1128/MCB.24.4.1758-1768.2004; Toh ML, 2006, ARTHRITIS RHEUM-US, V54, P2109, DOI 10.1002/art.21926; van Wijk SJL, 2010, FASEB J, V24, P981, DOI 10.1096/fj.09-136259; Xu L, 2005, GUT, V54, P142, DOI 10.1136/gut.2004.042127; Yagishita N, 2005, J BIOL CHEM, V280, P7909, DOI 10.1074/jbc.M410863200; Yagishita N, 2008, NAT CLIN PRACT RHEUM, V4, P91, DOI 10.1038/ncprheum0699; Yamano Y, 2010, NAT REV RHEUMATOL, V6, P106, DOI 10.1038/nrrheum.2009.257; Yamasaki S, 2005, ARTHRITIS RES THER, V7, P181, DOI 10.1186/ar1808; Yamasaki S, 2007, EMBO J, V26, P113, DOI 10.1038/sj.emboj.7601490; Yamasaki S, 2006, INT J MOL MED, V18, P113	40	30	31	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2010	5	10							e13590	10.1371/journal.pone.0013590	http://dx.doi.org/10.1371/journal.pone.0013590			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	670LB	21049091	Green Published, Green Submitted, gold			2022-12-27	WOS:000283422100010
J	Tan, W; Dean, M; Law, AJ				Tan, Wei; Dean, Michael; Law, Amanda J.			Molecular Cloning and Characterization of the Human ErbB4 Gene: Identification of Novel Splice Isoforms in the Developing and Adult Brain	PLOS ONE			English	Article							SCHIZOPHRENIA; EXPRESSION; NEUREGULIN-1; TRANSLATION; VARIANTS; DISEASE; CODE	ErbB4 is a growth factor receptor tyrosine kinase essential for neurodevelopment. Genetic variation in ErbB4 is associated with schizophrenia and risk-associated polymorphisms predict overexpression of ErbB4 CYT-1 isoforms in the brain in the disorder. The molecular mechanism of association is unclear because the polymorphisms flank exon 3 of the gene and reside 700 kb distal to the CYT-1 defining exon. We hypothesized that the polymorphisms are indirectly associated with ErbB4 CYT-1 via splicing of exon 3 on the CYT-1 background. We report via cloning and sequencing of adult and fetal human brain cDNA libraries the identification of novel splice isoforms of ErbB4, whereby exon 3 is skipped (del. 3). ErbB4 del. 3 transcripts exist as CYT-2 isoforms and are predicted to produce truncated proteins. Furthermore, our data refine the structure of the human ErbB4 gene, clarify that juxtamembrane (JM) splice variants of ErbB4, JM-a and JM-b respectively, are characterized by the replacement of a 75 nucleotide (nt) sequence with a 45-nt insertion, and demonstrate that there are four alternative exons in the gene. Our analyses reveal that novel splice variants of ErbB4 exist in the developing and adult human brain and, given the failure to identify ErbB4 del. 3 CYT-1 transcripts, suggest that the association of risk polymorphisms in the ErbB4 gene with CYT-1 transcript levels is not mediated via an exon 3 splicing event.	[Tan, Wei] Natl Canc Inst Frederick, Basic Sci Program, Sci Applicat Int Corp Frederick, Frederick, MD USA; [Dean, Michael] Natl Canc Inst Frederick, Expt Immunol Lab, Canc & Inflammat Program, Ctr Canc Res, Frederick, MD USA; [Law, Amanda J.] NIMH, Clin Brain Disorders Branch, Intramural Res Program, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Tan, W (corresponding author), Natl Canc Inst Frederick, Basic Sci Program, Sci Applicat Int Corp Frederick, Frederick, MD USA.	lawa@mail.nih.gov	Law, Amanda J/G-6372-2012; Dean, Michael/R-7501-2019; Dean, Michael C/G-8172-2012; Pethe, Kevin/L-1199-2013	Law, Amanda J/0000-0002-2574-1564; Dean, Michael C/0000-0003-2234-0631; Pethe, Kevin/0000-0003-0297-0150; Dick, Thomas/0000-0002-9604-9452; Cliff, Penelope/0000-0001-6558-6039; Pethe, Kevin/0000-0003-0916-8873	National Institute of Mental Health, National Institutes of Health (NIH), Bethesda, MD; National Cancer Institute, National Institutes of Health [HHSN26120080001E]; NIH, National Cancer Institute, Center for Cancer Research; MRC [G120/997] Funding Source: UKRI; Medical Research Council [G120/997] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [ZIABC011301] Funding Source: NIH RePORTER	National Institute of Mental Health, National Institutes of Health (NIH), Bethesda, MD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the Intramural Research Program of the National Institute of Mental Health, National Institutes of Health (NIH), Bethesda, MD 20892, USA and federal funds from the National Cancer Institute, National Institutes of Health, under contract HHSN26120080001E. This research was also supported in part by the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Elenius K, 1997, J BIOL CHEM, V272, P26761, DOI 10.1074/jbc.272.42.26761; Elenius K, 1999, ONCOGENE, V18, P2607, DOI 10.1038/sj.onc.1202612; Harrison PJ, 2006, BIOL PSYCHIAT, V60, P132, DOI 10.1016/j.biopsych.2005.11.002; Junttila TT, 2003, CLIN CANCER RES, V9, P5346; Konrad A, 2009, NEUROPSYCHOPHARMACOL, V34, P641, DOI 10.1038/npp.2008.112; Kozak M, 2002, GENE, V299, P1, DOI 10.1016/S0378-1119(02)01056-9; Law AJ, 2007, HUM MOL GENET, V16, P129, DOI 10.1093/hmg/ddl449; LUUKKONEN BGM, 1995, J VIROL, V69, P4086, DOI 10.1128/JVI.69.7.4086-4094.1995; Matlin AJ, 2005, NAT REV MOL CELL BIO, V6, P386, DOI 10.1038/nrm1645; Modrek B, 2002, NAT GENET, V30, P13, DOI 10.1038/ng0102-13; Nicholson P, 2010, CELL MOL LIFE SCI, V67, P677, DOI 10.1007/s00018-009-0177-1; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Rudloff U, 2010, CELL CYCLE, V9, P1487, DOI 10.4161/cc.9.8.11239; Silberberg G, 2006, AM J MED GENET B, V141B, P142, DOI 10.1002/ajmg.b.30275; Stefansson H, 2002, AM J HUM GENET, V71, P877, DOI 10.1086/342734; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; Wang GS, 2007, NAT REV GENET, V8, P749, DOI 10.1038/nrg2164	17	94	95	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2010	5	9							e12924	10.1371/journal.pone.0012924	http://dx.doi.org/10.1371/journal.pone.0012924			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653KV	21048946	gold, Green Published, Green Submitted			2022-12-27	WOS:000282091100028
J	Del Genio, CI; Kim, H; Toroczkai, Z; Bassler, KE				Del Genio, Charo I.; Kim, Hyunju; Toroczkai, Zoltan; Bassler, Kevin E.			Efficient and Exact Sampling of Simple Graphs with Given Arbitrary Degree Sequence	PLOS ONE			English	Article								Uniform sampling from graphical realizations of a given degree sequence is a fundamental component in simulation-based measurements of network observables, with applications ranging from epidemics, through social networks to Internet modeling. Existing graph sampling methods are either link-swap based (Markov-Chain Monte Carlo algorithms) or stub-matching based (the Configuration Model). Both types are ill-controlled, with typically unknown mixing times for link-swap methods and uncontrolled rejections for the Configuration Model. Here we propose an efficient, polynomial time algorithm that generates statistically independent graph samples with a given, arbitrary, degree sequence. The algorithm provides a weight associated with each sample, allowing the observable to be measured either uniformly over the graph ensemble, or, alternatively, with a desired distribution. Unlike other algorithms, this method always produces a sample, without backtracking or rejections. Using a central limit theorem-based reasoning, we argue, that for large N, and for degree sequences admitting many realizations, the sample weights are expected to have a lognormal distribution. As examples, we apply our algorithm to generate networks with degree sequences drawn from power-law distributions and from binomial distributions.	[Del Genio, Charo I.; Bassler, Kevin E.] Univ Houston, Dept Phys, Houston, TX 77004 USA; [Del Genio, Charo I.; Bassler, Kevin E.] Univ Houston, Texas Ctr Superconduct TcSUH, Houston, TX USA; [Kim, Hyunju; Toroczkai, Zoltan] Univ Notre Dame, Interdisciplinary Ctr Network Sci & Applicat ICeN, Notre Dame, IN 46556 USA	University of Houston System; University of Houston; University of Houston System; University of Houston; University of Notre Dame	Del Genio, CI (corresponding author), Univ Houston, Dept Phys, Houston, TX 77004 USA.	Kevin.E.Bassler@mail.uh.edu	Toroczkai, Zoltan/AAC-8446-2019; del Genio, Charo I/F-7249-2010	Toroczkai, Zoltan/0000-0002-6602-2849; del Genio, Charo I/0000-0001-9958-017X	National Science Foundation (NSF) [DMR-0908286]; Norman Hackerman Advanced Research Program [95921]; NSF [BCS-0826958]; Defense Threat Reduction Agency (DTRA) [HDTRA 201473-35045]	National Science Foundation (NSF)(National Science Foundation (NSF)National Research Foundation of Korea); Norman Hackerman Advanced Research Program; NSF(National Science Foundation (NSF)); Defense Threat Reduction Agency (DTRA)(United States Department of DefenseDefense Threat Reduction Agency)	CIDG and KEB are supported by the National Science Foundation (NSF) through grant DMR-0908286 and by the Norman Hackerman Advanced Research Program through grant 95921. HK and ZT are supported in part by the NSF BCS-0826958 and by the Defense Threat Reduction Agency (DTRA) through HDTRA 201473-35045. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; BENDER EA, 1978, J COMB THEORY A, V24, P296, DOI 10.1016/0097-3165(78)90059-6; Bianconi G, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.016114; Bianconi G, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.036114; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Boguna M, 2004, EUR PHYS J B, V38, P205, DOI 10.1140/epjb/e2004-00038-8; Bollobas B., 1980, EUROPEAN J COMBIN, V1, P311, DOI [10.1016/S0195-6698(80)80030-8, DOI 10.1016/S0195-6698(80)80030-8]; Burda Z, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.046118; Catanzaro M, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.027103; Chung F., 2002, ANN COMB, V6, P125, DOI [10.1007/PL00012580, 10.1007/PL00012580.pdf, DOI 10.1007/PL00012580.PDF]; Cochran W.G., 1977, SAMPLING TECHNIQUE, V3rd ed.; Cooper C, 2007, COMB PROBAB COMPUT, V16, P557, DOI 10.1017/S0963548306007978; ERDOS P, 1960, MAT LAPOK, V11, P477; HAKIMI SL, 1962, J SOC IND APPL MATH, V10, P496, DOI 10.1137/0110037; Havel V., 1955, CASOPIS PROPESTOV MA, V80, P477, DOI DOI 10.21136/CPM.1955.108220; Kannan R, 1999, RANDOM STRUCT ALGOR, V14, P293, DOI 10.1002/(SICI)1098-2418(199907)14:4<293::AID-RSA1>3.0.CO;2-G; Kim H, 2009, J PHYS A-MATH THEOR, V42, DOI 10.1088/1751-8113/42/39/392001; KOREN M, 1976, J COMB THEORY B, V21, P235, DOI 10.1016/S0095-8956(76)80007-X; Liljeros F, 2001, NATURE, V411, P907, DOI 10.1038/35082140; MOLLOY M, 1995, RANDOM STRUCT ALGOR, V6, P161, DOI 10.1002/rsa.3240060204; Newman M., 1999, MONTE CARLO METHODS; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Newman MEJ, 2001, PHYS REV E, V64, DOI [10.1103/PhysRevE.64.016131, 10.1103/PhysRevE.64.016132]; Newman MEJ., 2006, STRUCTURE DYNAMICS N; TAYLOR R, 1982, SIAM J ALGEBRA DISCR, V3, P114, DOI 10.1137/0603011; Tripathi A, 2003, DISCRETE MATH, V265, P417, DOI 10.1016/S0012-365X(02)00886-5; Viger F, 2005, LECT NOTES COMPUT SC, V3595, P440, DOI 10.1007/11533719_45	28	113	113	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2010	5	4							e10012	10.1371/journal.pone.0010012	http://dx.doi.org/10.1371/journal.pone.0010012			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580WT	20386694	Green Submitted, Green Published, gold			2022-12-27	WOS:000276482000005
